id|nct_id|result_group_id|ctgov_group_code|period|reason|count
709|NCT03489551|2026|P1|Overall Study|Withdrawal by Subject|2
710|NCT03405818|2030|P1|Overall Study|Lost to Follow-up|4
711|NCT03405818|2030|P1|Overall Study|Withdrawal by Subject|4
712|NCT03349099|2138|P2|Overall Study|Stone migrated from the kidney|0
713|NCT03349099|2139|P1|Overall Study|Stone migrated from the kidney|1
714|NCT03349099|2138|P2|Overall Study|Physician Decision|4
715|NCT03349099|2139|P1|Overall Study|Physician Decision|3
716|NCT03256552|2179|P1|Overall Study|Withdrawal by Subject|2
717|NCT03256552|2179|P1|Overall Study|Adverse Event|1
718|NCT03256552|2179|P1|Overall Study|Physician Decision|1
719|NCT03256552|2179|P1|Overall Study|Protocol Violation|1
720|NCT03255733|2201|P1|Overall Study|Lost to Follow-up|4
721|NCT03255655|2208|P2|Overall Study|Lost to Follow-up|4
722|NCT03255655|2209|P1|Overall Study|Lost to Follow-up|7
723|NCT03254602|2217|P1|Overall Study|Lost to Follow-up|4
724|NCT03238924|2242|P2|Overall Study|Withdrawal by Subject|2
725|NCT03238924|2243|P1|Overall Study|Withdrawal by Subject|2
726|NCT03238001|2253|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
727|NCT03238001|2253|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
728|NCT03238001|2253|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
729|NCT03238001|2253|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
730|NCT03238001|2253|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
731|NCT03238001|2253|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
732|NCT03238001|2253|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
733|NCT03238001|2253|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
734|NCT03231371|2298|P1|Overall Study|chose or were ineligible to have MRI|12
735|NCT03231371|2298|P1|Overall Study|Withdrawal by Subject|1
736|NCT03218163|2308|P1|Overall Study|Study termination|1
737|NCT03191552|2315|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
738|NCT03191552|2316|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
739|NCT03191552|2317|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
740|NCT03191552|2315|P3|Overall Study|Lost to Follow-up|0
741|NCT03191552|2316|P2|Overall Study|Lost to Follow-up|0
742|NCT03191552|2317|P1|Overall Study|Lost to Follow-up|1
743|NCT03151226|2406|P1|Overall Study|not wear device correctly|1
744|NCT03151226|2406|P1|Overall Study|Withdrawal by Subject|2
745|NCT03128307|2418|P1|Overall Study|Withdrawal by Subject|5
746|NCT03128307|2418|P1|Overall Study|Lost to Follow-up|29
747|NCT03124784|2465|P1|Overall Study|Computer/Equip Malfunction|1
748|NCT03124784|2465|P1|Overall Study|Adverse Event|1
749|NCT03124199|2481|P1|Overall Study|Lost to Follow-up|4
750|NCT03073798|2575|P1|Overall Study|Withdrawal by Subject|1
751|NCT03073798|2575|P1|Overall Study|Adverse Event|1
752|NCT03072719|2588|P2|Overall Study|Adverse Event|1
753|NCT03072719|2589|P1|Overall Study|Adverse Event|1
754|NCT03069313|2735|P1|Overall Study|Adverse Event|5
755|NCT03065933|2742|P1|Overall Study|study terminated|5
756|NCT03055221|2770|P1|Overall Study|Study terminated by Sponsor|3
757|NCT03055221|2770|P1|Overall Study|Physician Decision|1
758|NCT03055221|2770|P1|Overall Study|Death|6
759|NCT03055221|2770|P1|Overall Study|Withdrawal by Subject|4
760|NCT03055221|2770|P1|Overall Study|Adverse Event|2
761|NCT03044431|2907|P1|Overall Study|Lost to Follow-up|59
762|NCT03035916|3002|P3|Overall Study|Puncture failed|0
763|NCT03035916|3003|P2|Overall Study|Puncture failed|2
764|NCT03035916|3004|P1|Overall Study|Puncture failed|0
765|NCT03023137|3170|P2|Overall Study|Lost the baby in a car accident|0
766|NCT03023137|3171|P1|Overall Study|Lost the baby in a car accident|1
767|NCT03023137|3170|P2|Overall Study|Protocol Violation|4
768|NCT03023137|3171|P1|Overall Study|Protocol Violation|0
769|NCT03023137|3170|P2|Overall Study|Lost to Follow-up|1
770|NCT03023137|3171|P1|Overall Study|Lost to Follow-up|1
771|NCT03023137|3170|P2|Overall Study|Multiple pregnancy|4
772|NCT03023137|3171|P1|Overall Study|Multiple pregnancy|2
773|NCT03022422|3229|P6|Overall Study|3 subjects consented but not vaccinated|0
774|NCT03022422|3230|P5|Overall Study|3 subjects consented but not vaccinated|0
775|NCT03022422|3231|P4|Overall Study|3 subjects consented but not vaccinated|0
776|NCT03022422|3232|P3|Overall Study|3 subjects consented but not vaccinated|3
777|NCT03022422|3233|P2|Overall Study|3 subjects consented but not vaccinated|0
778|NCT03022422|3234|P1|Overall Study|3 subjects consented but not vaccinated|0
779|NCT03021304|3296|P1|Overall Study|Lack of Efficacy|1
780|NCT03020576|3303|P2|Overall Study|Withdrawal by Subject|2
781|NCT03020576|3304|P1|Overall Study|Withdrawal by Subject|1
782|NCT03018106|3374|P2|Overall Study|Lost to Follow-up|1
783|NCT03018106|3375|P1|Overall Study|Lost to Follow-up|0
784|NCT03017612|3383|P1|Overall Study|Adverse Event|2
785|NCT03016078|3391|P1|Overall Study|Protocol Violation|1
786|NCT03016078|3391|P1|Overall Study|Protocol Violation|1
787|NCT03011099|3404|P2|Overall Study|Withdrawal by Subject|2
788|NCT03011099|3405|P1|Overall Study|Withdrawal by Subject|0
789|NCT02990910|3502|P2|Overall Study|Lack of Efficacy|10
790|NCT02990910|3503|P1|Overall Study|Lack of Efficacy|6
791|NCT02988622|3524|P1|Overall Study|Lost to Follow-up|17
792|NCT02988219|3548|P2|Overall Study|Withdrawal by Subject|2
793|NCT02988219|3549|P1|Overall Study|Withdrawal by Subject|0
794|NCT02988219|3548|P2|Overall Study|Lack of Efficacy|1
795|NCT02988219|3549|P1|Overall Study|Lack of Efficacy|1
796|NCT02987205|3569|P1|Overall Study|Withdrawal by Subject|3
797|NCT02987205|3569|P1|Overall Study|Adverse Event|1
798|NCT02977572|3604|P2|Overall Study|Exclusion criterion|2
799|NCT02977572|3605|P1|Overall Study|Exclusion criterion|2
800|NCT02974543|3629|P2|Overall Study|Withdrawal by Subject|0
801|NCT02974543|3630|P1|Overall Study|Withdrawal by Subject|1
802|NCT02971670|3654|P4|Overall Study|Withdrawal by Subject|2
803|NCT02971670|3655|P3|Overall Study|Withdrawal by Subject|1
804|NCT02971670|3656|P2|Overall Study|Withdrawal by Subject|1
805|NCT02971670|3657|P1|Overall Study|Withdrawal by Subject|4
806|NCT02968173|3675|P1|Overall Study|Withdrawal by Subject|1
807|NCT02966509|3758|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
808|NCT02966509|3759|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
809|NCT02966509|3758|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
810|NCT02966509|3759|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
811|NCT02966509|3758|P2|6 Month Satisfaction Survey|Refused to Answer|11
812|NCT02966509|3759|P1|6 Month Satisfaction Survey|Refused to Answer|8
813|NCT02966509|3758|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
814|NCT02966509|3759|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
815|NCT02966509|3758|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
816|NCT02966509|3759|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
817|NCT02966509|3758|P2|6 Month Satisfaction Survey|Death|33
818|NCT02966509|3759|P1|6 Month Satisfaction Survey|Death|36
819|NCT02966509|3758|P2|4-Month Satisfaction Decision Survey|Refused to Answer|2
820|NCT02966509|3759|P1|4-Month Satisfaction Decision Survey|Refused to Answer|0
821|NCT02966509|3758|P2|4-Month Satisfaction Decision Survey|Lost to Follow-up|1
822|NCT02966509|3759|P1|4-Month Satisfaction Decision Survey|Lost to Follow-up|1
823|NCT02966509|3758|P2|4-Month Satisfaction Decision Survey|Withdrawal by Subject|3
824|NCT02966509|3759|P1|4-Month Satisfaction Decision Survey|Withdrawal by Subject|2
825|NCT02966509|3758|P2|4-Month Satisfaction Decision Survey|Death|25
826|NCT02966509|3759|P1|4-Month Satisfaction Decision Survey|Death|22
827|NCT02966509|3758|P2|Baseline Satisfaction Survey|Refused to Answer|2
828|NCT02966509|3759|P1|Baseline Satisfaction Survey|Refused to Answer|1
829|NCT02966509|3758|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
830|NCT02966509|3759|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
831|NCT02966509|3758|P2|Baseline Satisfaction Survey|Death|1
832|NCT02966509|3759|P1|Baseline Satisfaction Survey|Death|0
833|NCT02966509|3758|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
834|NCT02966509|3759|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
835|NCT02966015|3785|P2|Inclusion Visit|did not answer questionnaire|3
836|NCT02966015|3786|P1|Inclusion Visit|did not answer questionnaire|8
837|NCT02966002|3792|P1|Overall Study|Lost to Follow-up|1
838|NCT02966002|3792|P1|Overall Study|Adverse Event|1
839|NCT02966002|3792|P1|Overall Study|Withdrawal by Subject|2
840|NCT02965833|3799|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
841|NCT02965833|3800|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
842|NCT02965833|3799|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
843|NCT02965833|3800|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
844|NCT02965833|3799|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
845|NCT02965833|3800|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
846|NCT02965833|3799|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
847|NCT02965833|3800|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
848|NCT02965833|3799|P2|Period 1, First 30 Days of Wear|Adverse Event|1
849|NCT02965833|3800|P1|Period 1, First 30 Days of Wear|Adverse Event|0
850|NCT02965820|3806|P2|Period 2, Second 30 Days|Adverse Event|1
851|NCT02965820|3807|P1|Period 2, Second 30 Days|Adverse Event|1
852|NCT02962882|3823|P1|Overall Study|Transfer from ICU|32
853|NCT02962882|3823|P1|Overall Study|Withdrawal by Subject|2
854|NCT02962882|3823|P1|Overall Study|Adverse Event|2
855|NCT02961244|3834|P2|Overall Study|İnadequate data|2
856|NCT02961244|3835|P1|Overall Study|İnadequate data|0
857|NCT02961244|3834|P2|Overall Study|Lost to Follow-up|2
858|NCT02961244|3835|P1|Overall Study|Lost to Follow-up|0
859|NCT02961244|3834|P2|Overall Study|Surgery plan change after study approval|2
860|NCT02961244|3835|P1|Overall Study|Surgery plan change after study approval|0
861|NCT02961244|3834|P2|Overall Study|Withdrawal by Subject|2
862|NCT02961244|3835|P1|Overall Study|Withdrawal by Subject|1
863|NCT02961244|3834|P2|Overall Study|Protocol Violation|1
864|NCT02961244|3835|P1|Overall Study|Protocol Violation|0
865|NCT02956460|3933|P2|Lens 1|Lost to Follow-up|0
866|NCT02956460|3934|P1|Lens 1|Lost to Follow-up|1
867|NCT02951767|3960|P1|Overall Study|Lost to Follow-up|1
868|NCT02951767|3960|P1|Overall Study|Death|59
869|NCT02951767|3960|P1|Overall Study|Withdrawal by Subject|5
870|NCT02951767|3960|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
871|NCT02948582|4139|P6|Washout Period 4|Adverse Event|0
872|NCT02948582|4140|P5|Washout Period 4|Adverse Event|0
873|NCT02948582|4141|P4|Washout Period 4|Adverse Event|0
874|NCT02948582|4142|P3|Washout Period 4|Adverse Event|1
875|NCT02948582|4143|P2|Washout Period 4|Adverse Event|0
876|NCT02948582|4144|P1|Washout Period 4|Adverse Event|1
877|NCT02948582|4139|P6|Washout Period 2|personal reasons|0
878|NCT02948582|4140|P5|Washout Period 2|personal reasons|0
879|NCT02948582|4141|P4|Washout Period 2|personal reasons|1
880|NCT02948582|4142|P3|Washout Period 2|personal reasons|0
881|NCT02948582|4143|P2|Washout Period 2|personal reasons|0
882|NCT02948582|4144|P1|Washout Period 2|personal reasons|0
883|NCT02948582|4139|P6|Washout Period 2|Adverse Event|0
884|NCT02948582|4140|P5|Washout Period 2|Adverse Event|0
885|NCT02948582|4141|P4|Washout Period 2|Adverse Event|0
886|NCT02948582|4142|P3|Washout Period 2|Adverse Event|0
887|NCT02948582|4143|P2|Washout Period 2|Adverse Event|1
888|NCT02948582|4144|P1|Washout Period 2|Adverse Event|0
889|NCT02948582|4139|P6|Washout Period 1|Protocol Violation|1
890|NCT02948582|4140|P5|Washout Period 1|Protocol Violation|0
891|NCT02948582|4141|P4|Washout Period 1|Protocol Violation|0
892|NCT02948582|4142|P3|Washout Period 1|Protocol Violation|0
893|NCT02948582|4143|P2|Washout Period 1|Protocol Violation|0
894|NCT02948582|4144|P1|Washout Period 1|Protocol Violation|0
895|NCT02948582|4139|P6|Washout Period 1|Adverse Event|0
896|NCT02948582|4140|P5|Washout Period 1|Adverse Event|0
897|NCT02948582|4141|P4|Washout Period 1|Adverse Event|0
898|NCT02948582|4142|P3|Washout Period 1|Adverse Event|0
899|NCT02948582|4143|P2|Washout Period 1|Adverse Event|2
900|NCT02948582|4144|P1|Washout Period 1|Adverse Event|0
901|NCT02947022|4252|P1|Overall Study|Study Stopped|1
902|NCT02945254|4273|P2|Overall Study|Withdrawal by Subject|0
903|NCT02945254|4274|P1|Overall Study|Withdrawal by Subject|1
904|NCT02945254|4273|P2|Overall Study|Lost to Follow-up|0
905|NCT02945254|4274|P1|Overall Study|Lost to Follow-up|1
906|NCT02937870|4380|P1|Overall Study|Protocol Deviation|2
907|NCT02937870|4380|P1|Overall Study|Adverse Event|1
908|NCT02923245|4469|P2|Overall Study|ultrasound order was cancelled|1
909|NCT02923245|4470|P1|Overall Study|ultrasound order was cancelled|2
910|NCT02920957|4564|P2|Second Intervention: 1 Month|Lost to Follow-up|1
911|NCT02920957|4565|P1|Second Intervention: 1 Month|Lost to Follow-up|0
912|NCT02920957|4564|P2|First Intervention : 1 Month|Adverse Event|0
913|NCT02920957|4565|P1|First Intervention : 1 Month|Adverse Event|1
914|NCT02920957|4564|P2|First Intervention : 1 Month|Lost to Follow-up|0
915|NCT02920957|4565|P1|First Intervention : 1 Month|Lost to Follow-up|1
916|NCT02920957|4564|P2|First Intervention : 1 Month|Withdrawal by Subject|0
917|NCT02920957|4565|P1|First Intervention : 1 Month|Withdrawal by Subject|2
918|NCT02915978|4661|P3|Overall Study|Adverse Event|0
919|NCT02915978|4662|P2|Overall Study|Adverse Event|1
920|NCT02915978|4663|P1|Overall Study|Adverse Event|2
921|NCT02915302|4715|P2|Overall Study|Other|0
922|NCT02915302|4716|P1|Overall Study|Other|1
923|NCT02915302|4715|P2|Overall Study|Withdrawal by Subject|29
924|NCT02915302|4716|P1|Overall Study|Withdrawal by Subject|22
925|NCT02915302|4715|P2|Overall Study|Lost to Follow-up|22
926|NCT02915302|4716|P1|Overall Study|Lost to Follow-up|19
927|NCT02915302|4715|P2|Overall Study|Protocol Violation|27
928|NCT02915302|4716|P1|Overall Study|Protocol Violation|20
929|NCT02915302|4715|P2|Overall Study|Adverse Event|0
930|NCT02915302|4716|P1|Overall Study|Adverse Event|3
931|NCT02914236|4726|P1|Overall Study|Lost to Follow-up|1
932|NCT02912650|4738|P4|Overall Study|Adverse Event|0
933|NCT02912650|4739|P3|Overall Study|Adverse Event|1
934|NCT02912650|4740|P2|Overall Study|Adverse Event|0
935|NCT02912650|4741|P1|Overall Study|Adverse Event|0
936|NCT02912650|4738|P4|Overall Study|Withdrawal by Subject|5
937|NCT02912650|4739|P3|Overall Study|Withdrawal by Subject|1
938|NCT02912650|4740|P2|Overall Study|Withdrawal by Subject|0
939|NCT02912650|4741|P1|Overall Study|Withdrawal by Subject|1
940|NCT02903238|4861|P1|Overall Study|Lost to Follow-up|4
941|NCT02901054|4870|P1|Overall Study|Withdrawal by Subject|3
942|NCT02901054|4870|P1|Overall Study|Physician Decision|1
943|NCT02895347|4876|P2|Overall Study|Withdrawal by Subject|1
944|NCT02895347|4877|P1|Overall Study|Withdrawal by Subject|3
945|NCT02886338|4904|P1|Overall Study|Withdrawal by Subject|1
946|NCT02882152|4929|P2|Overall Study|Lost to Follow-up|0
947|NCT02882152|4930|P1|Overall Study|Lost to Follow-up|1
948|NCT02877082|4994|P1|Overall Study|Trial was closed early|5
949|NCT02873429|5028|P2|16 Weeks|Lost to Follow-up|0
950|NCT02873429|5029|P1|16 Weeks|Lost to Follow-up|3
951|NCT02873429|5028|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
952|NCT02873429|5029|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
953|NCT02873429|5028|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
954|NCT02873429|5029|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
955|NCT02871375|5054|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
956|NCT02871375|5055|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
957|NCT02865083|5109|P2|Overall Study|Early Termination|1
958|NCT02865083|5110|P1|Overall Study|Early Termination|3
959|NCT02862730|5155|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
960|NCT02862730|5156|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
961|NCT02862730|5157|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
962|NCT02862730|5158|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
963|NCT02862730|5159|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
964|NCT02862730|5160|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
965|NCT02862730|5161|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
966|NCT02862730|5155|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
967|NCT02862730|5156|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
968|NCT02862730|5157|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
969|NCT02862730|5158|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
970|NCT02862730|5159|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
971|NCT02862730|5160|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
972|NCT02862730|5161|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
973|NCT02862730|5155|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
974|NCT02862730|5156|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
975|NCT02862730|5157|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
976|NCT02862730|5158|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
977|NCT02862730|5159|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
978|NCT02862730|5160|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
979|NCT02862730|5161|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
980|NCT02862730|5155|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
981|NCT02862730|5156|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
982|NCT02862730|5157|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
983|NCT02862730|5158|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
984|NCT02862730|5159|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
985|NCT02862730|5160|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
986|NCT02862730|5161|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
987|NCT02862600|5216|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
988|NCT02862600|5216|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
989|NCT02862600|5216|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
990|NCT02862600|5216|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
991|NCT02862106|5229|P2|Overall Study|Subjects moved to other city|0
992|NCT02862106|5230|P1|Overall Study|Subjects moved to other city|1
993|NCT02862106|5229|P2|Overall Study|Withdrawal by Subject|0
994|NCT02862106|5230|P1|Overall Study|Withdrawal by Subject|2
995|NCT02862106|5229|P2|Overall Study|Lost to Follow-up|5
996|NCT02862106|5230|P1|Overall Study|Lost to Follow-up|15
997|NCT02862106|5229|P2|Overall Study|Protocol Violation|1
998|NCT02862106|5230|P1|Overall Study|Protocol Violation|16
999|NCT02862106|5229|P2|Overall Study|Adverse Event|0
1000|NCT02862106|5230|P1|Overall Study|Adverse Event|4
1001|NCT02856880|5288|P1|Overall Study|Withdrawal of consent|1
1002|NCT02855411|5312|P1|Overall Study|Does not meet entrance criteria|14
1003|NCT02855411|5312|P1|Overall Study|Study terminated by sponsor|21
1004|NCT02852434|5345|P2|Overall Study|Unsuccessful Dilator Procedure|0
1005|NCT02852434|5346|P1|Overall Study|Unsuccessful Dilator Procedure|2
1006|NCT02852434|5345|P2|Overall Study|Withdrawal by Subject|1
1007|NCT02852434|5346|P1|Overall Study|Withdrawal by Subject|0
1008|NCT02849678|5379|P2|Overall Study|Protocol Violation|6
1009|NCT02849678|5380|P1|Overall Study|Protocol Violation|3
1010|NCT02847260|5411|P1|Overall Study|Physician Decision|1
1011|NCT02847260|5411|P1|Overall Study|Clinical Deterioration|1
1012|NCT02847260|5411|P1|Overall Study|Withdrawal by Subject|2
1013|NCT02847260|5411|P1|Overall Study|Adverse Event|3
1014|NCT02844543|5474|P1|Overall Study|Did not meet eligibility criteria|1
1015|NCT02844543|5474|P1|Overall Study|Withdrawal by Subject|4
1016|NCT02838901|5536|P2|Overall Study|Lost to Follow-up|1
1017|NCT02838901|5537|P1|Overall Study|Lost to Follow-up|1
1018|NCT02838901|5536|P2|Overall Study|Withdrawal by Subject|1
1019|NCT02838901|5537|P1|Overall Study|Withdrawal by Subject|1
1020|NCT02837952|5567|P2|Overall Study|Medication Error|0
1021|NCT02837952|5568|P1|Overall Study|Medication Error|1
1022|NCT02837952|5567|P2|Overall Study|Withdrawal by Subject|5
1023|NCT02837952|5568|P1|Overall Study|Withdrawal by Subject|4
1024|NCT02837952|5567|P2|Overall Study|Adverse Event|1
1025|NCT02837952|5568|P1|Overall Study|Adverse Event|0
1026|NCT02836249|5582|P2|Overall Study|Still on Study|55
1027|NCT02836249|5583|P1|Overall Study|Still on Study|121
1028|NCT02836249|5582|P2|Overall Study|Lost to Follow-up|1
1029|NCT02836249|5583|P1|Overall Study|Lost to Follow-up|0
1030|NCT02836249|5582|P2|Overall Study|Withdrew Consent|1
1031|NCT02836249|5583|P1|Overall Study|Withdrew Consent|0
1032|NCT02836249|5582|P2|Overall Study|Pregnancy|0
1033|NCT02836249|5583|P1|Overall Study|Pregnancy|2
1034|NCT02836249|5582|P2|Overall Study|Randomized but Never Treated|1
1035|NCT02836249|5583|P1|Overall Study|Randomized but Never Treated|0
1036|NCT02836236|5601|P2|Overall Study|Still on Study|49
1037|NCT02836236|5602|P1|Overall Study|Still on Study|101
1038|NCT02836236|5601|P2|Overall Study|Investigator's Discretion|0
1039|NCT02836236|5602|P1|Overall Study|Investigator's Discretion|1
1040|NCT02836236|5601|P2|Overall Study|Adverse Event|1
1041|NCT02836236|5602|P1|Overall Study|Adverse Event|0
1042|NCT02836236|5601|P2|Overall Study|Withdrew Consent|0
119406|NCT00906399|437170|P2|Year 1|Death|1
1043|NCT02836236|5602|P1|Overall Study|Withdrew Consent|2
1044|NCT02836236|5601|P2|Overall Study|Randomized but Never Treated|0
1045|NCT02836236|5602|P1|Overall Study|Randomized but Never Treated|1
1046|NCT02832375|5640|P2|Overall Study|Withdrawal of Consent|0
1047|NCT02832375|5641|P1|Overall Study|Withdrawal of Consent|1
1048|NCT02832375|5640|P2|Overall Study|Lost to Follow-up|0
1049|NCT02832375|5641|P1|Overall Study|Lost to Follow-up|1
1050|NCT02829996|5660|P5|Overall Study|Withdrawal by Subject|0
1051|NCT02829996|5661|P4|Overall Study|Withdrawal by Subject|0
1052|NCT02829996|5662|P3|Overall Study|Withdrawal by Subject|0
1053|NCT02829996|5663|P2|Overall Study|Withdrawal by Subject|0
1054|NCT02829996|5664|P1|Overall Study|Withdrawal by Subject|1
1055|NCT02829775|5687|P1|Overall Study|Disease remission|1
1056|NCT02829775|5687|P1|Overall Study|Withdrawal by Subject|3
1057|NCT02829775|5687|P1|Overall Study|Death|1
1058|NCT02829138|5703|P2|Overall Study|Withdrawal by Subject|0
1059|NCT02829138|5704|P1|Overall Study|Withdrawal by Subject|1
1060|NCT02826421|5740|P4|Overall Study|Reason not given|0
1061|NCT02826421|5741|P3|Overall Study|Reason not given|1
1062|NCT02826421|5742|P2|Overall Study|Reason not given|0
1063|NCT02826421|5743|P1|Overall Study|Reason not given|1
1064|NCT02826421|5740|P4|Overall Study|Withdrawal by Subject|1
1065|NCT02826421|5741|P3|Overall Study|Withdrawal by Subject|1
1066|NCT02826421|5742|P2|Overall Study|Withdrawal by Subject|3
1067|NCT02826421|5743|P1|Overall Study|Withdrawal by Subject|1
1068|NCT02826421|5740|P4|Overall Study|Adverse Event|1
1069|NCT02826421|5741|P3|Overall Study|Adverse Event|0
1070|NCT02826421|5742|P2|Overall Study|Adverse Event|0
1071|NCT02826421|5743|P1|Overall Study|Adverse Event|1
1072|NCT02823964|5768|P1|Overall Study|Withdrawal by Subject|1
1073|NCT02823964|5768|P1|Overall Study|Lack of Efficacy|1
1074|NCT02823964|5768|P1|Overall Study|Physician Decision|1
1075|NCT02823964|5768|P1|Overall Study|Adverse Event|2
1076|NCT02815735|5860|P2|Second Intervention (4 Weeks)|Protocol Violation|0
1077|NCT02815735|5861|P1|Second Intervention (4 Weeks)|Protocol Violation|1
1078|NCT02815735|5860|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
1079|NCT02815735|5861|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
1080|NCT02815735|5860|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
1081|NCT02815735|5861|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
1082|NCT02815735|5860|P2|First Intervention (4 Weeks)|Discomfort|0
1083|NCT02815735|5861|P1|First Intervention (4 Weeks)|Discomfort|1
1084|NCT02815397|5876|P1|Overall Study|Physician Decision|2
1085|NCT02814643|5885|P2|Overall Study|Withdrawal by Subject|2
1086|NCT02814643|5886|P1|Overall Study|Withdrawal by Subject|1
1087|NCT02814643|5885|P2|Overall Study|Lost to Follow-up|1
1088|NCT02814643|5886|P1|Overall Study|Lost to Follow-up|0
1089|NCT02809833|5985|P1|Overall Study|Missing Information|52
1090|NCT02809833|5985|P1|Overall Study|Not Specified|5
1091|NCT02809833|5985|P1|Overall Study|Adverse Event (AE)|24
1092|NCT02809833|5985|P1|Overall Study|Lost to Follow-up|35
1093|NCT02809833|5985|P1|Overall Study|Withdrawal by Subject|34
1094|NCT02809833|5985|P1|Overall Study|Noncompliance|1
1095|NCT02809833|5985|P1|Overall Study|Remission/Treatment No Longer Needed|3
1096|NCT02809833|5985|P1|Overall Study|Lack of Efficacy|89
1097|NCT02809833|5985|P1|Overall Study|Intolerance|54
1098|NCT02809833|5985|P1|Overall Study|Death|3
1099|NCT02806505|6120|P2|Overall Study|Insufficient therapeutic response|4
1100|NCT02806505|6121|P1|Overall Study|Insufficient therapeutic response|2
1101|NCT02806505|6120|P2|Overall Study|Failure to return|1
1102|NCT02806505|6121|P1|Overall Study|Failure to return|0
1103|NCT02806505|6120|P2|Overall Study|Did not cooperate/refused treatment|3
1104|NCT02806505|6121|P1|Overall Study|Did not cooperate/refused treatment|3
1105|NCT02806505|6120|P2|Overall Study|Death|0
1106|NCT02806505|6121|P1|Overall Study|Death|4
1107|NCT02806505|6120|P2|Overall Study|Adverse event/intercurrent illness|3
1108|NCT02806505|6121|P1|Overall Study|Adverse event/intercurrent illness|1
1109|NCT02805907|6133|P2|Overall Study|Lost to Follow-up|3
1110|NCT02805907|6134|P1|Overall Study|Lost to Follow-up|3
1111|NCT02802878|6148|P2|Overall Study|Protocol Violation|0
1112|NCT02802878|6149|P1|Overall Study|Protocol Violation|1
1113|NCT02802878|6148|P2|Overall Study|Withdrawal by Subject|3
1114|NCT02802878|6149|P1|Overall Study|Withdrawal by Subject|3
1115|NCT02802592|6163|P1|Overall Study|Study terminated due to loss of funding|4
1116|NCT02801396|6191|P6|Period 1|Withdrawal by Subject|0
1117|NCT02801396|6192|P5|Period 1|Withdrawal by Subject|1
1118|NCT02801396|6193|P4|Period 1|Withdrawal by Subject|0
1119|NCT02801396|6194|P3|Period 1|Withdrawal by Subject|0
1120|NCT02801396|6195|P2|Period 1|Withdrawal by Subject|0
1121|NCT02801396|6196|P1|Period 1|Withdrawal by Subject|0
1122|NCT02799082|6241|P2|Overall Study|Protocol Violation|1
1123|NCT02799082|6242|P1|Overall Study|Protocol Violation|0
1124|NCT02799082|6241|P2|Overall Study|Refused second PDT or withdraw consent|3
1125|NCT02799082|6242|P1|Overall Study|Refused second PDT or withdraw consent|4
1126|NCT02799069|6279|P3|Overall Study|Protocol Violation|2
1127|NCT02799069|6280|P2|Overall Study|Protocol Violation|0
1128|NCT02799069|6281|P1|Overall Study|Protocol Violation|1
119407|NCT00906399|437171|P1|Year 1|Death|2
1129|NCT02799069|6279|P3|Overall Study|Withdrawal by Subject|3
1130|NCT02799069|6280|P2|Overall Study|Withdrawal by Subject|4
1131|NCT02799069|6281|P1|Overall Study|Withdrawal by Subject|4
1132|NCT02799069|6279|P3|Overall Study|Lost to Follow-up|0
1133|NCT02799069|6280|P2|Overall Study|Lost to Follow-up|1
1134|NCT02799069|6281|P1|Overall Study|Lost to Follow-up|1
1135|NCT02799069|6279|P3|Overall Study|Lack of Efficacy|0
1136|NCT02799069|6280|P2|Overall Study|Lack of Efficacy|0
1137|NCT02799069|6281|P1|Overall Study|Lack of Efficacy|2
1138|NCT02799069|6279|P3|Overall Study|Adverse Event|2
1139|NCT02799069|6280|P2|Overall Study|Adverse Event|2
1140|NCT02799069|6281|P1|Overall Study|Adverse Event|0
1141|NCT02797080|6395|P1|Overall Study|Withdrawal by Subject|1
1142|NCT02797080|6395|P1|Overall Study|Lost to Follow-up|1
1143|NCT02796963|6403|P4|Overall Study|Lost to Follow-up|72
1144|NCT02796963|6404|P3|Overall Study|Lost to Follow-up|69
1145|NCT02796963|6405|P2|Overall Study|Lost to Follow-up|76
1146|NCT02796963|6406|P1|Overall Study|Lost to Follow-up|89
1147|NCT02796651|6468|P1|Overall Study|Not specified|10
1148|NCT02796651|6468|P1|Overall Study|Lack of Efficacy|1
1149|NCT02796651|6468|P1|Overall Study|Protocol Violation|4
1150|NCT02796651|6468|P1|Overall Study|Withdrawal by Subject|4
1151|NCT02796651|6468|P1|Overall Study|Lost to Follow-up|1
1152|NCT02796651|6468|P1|Overall Study|Adverse Event|6
1153|NCT02794480|6550|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1154|NCT02794480|6551|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1155|NCT02794480|6552|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1156|NCT02794480|6553|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1157|NCT02794480|6550|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1158|NCT02794480|6551|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1159|NCT02794480|6552|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
1160|NCT02794480|6553|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1161|NCT02794480|6550|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
1162|NCT02794480|6551|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1163|NCT02794480|6552|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1164|NCT02794480|6553|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1165|NCT02794480|6550|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1166|NCT02794480|6551|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
1167|NCT02794480|6552|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1168|NCT02794480|6553|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1169|NCT02794480|6550|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1170|NCT02794480|6551|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
1171|NCT02794480|6552|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1172|NCT02794480|6553|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1173|NCT02793947|6573|P2|Overall Study|Physician Decision|5
1174|NCT02793947|6574|P1|Overall Study|Physician Decision|1
1175|NCT02793947|6573|P2|Overall Study|Death|0
1176|NCT02793947|6574|P1|Overall Study|Death|1
1177|NCT02792062|6661|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1178|NCT02792062|6662|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1179|NCT02792062|6663|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1180|NCT02792062|6664|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1181|NCT02792062|6665|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1182|NCT02792062|6666|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
1183|NCT02791659|6717|P2|Overall Study|Protocol Violation|1
1184|NCT02791659|6718|P1|Overall Study|Protocol Violation|0
1185|NCT02791269|6726|P2|Overall Study|Lost to Follow-up|1
1186|NCT02791269|6727|P1|Overall Study|Lost to Follow-up|0
1187|NCT02788357|6749|P2|Overall Study|Lost to Follow-up|0
1188|NCT02788357|6750|P1|Overall Study|Lost to Follow-up|3
1189|NCT02786927|6790|P1|Overall Study|Protocol Violation|4
1190|NCT02786927|6790|P1|Overall Study|Adverse Event|1
1191|NCT02784106|6826|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1192|NCT02784106|6827|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1193|NCT02784106|6828|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1194|NCT02784106|6829|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1195|NCT02784106|6826|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
1196|NCT02784106|6827|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
1197|NCT02784106|6828|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1198|NCT02784106|6829|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1199|NCT02784106|6826|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1200|NCT02784106|6827|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1201|NCT02784106|6828|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1202|NCT02784106|6829|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
1203|NCT02784106|6826|P4|Double-Blind Treatment Period (12 Weeks)|Not specified|0
1204|NCT02784106|6827|P3|Double-Blind Treatment Period (12 Weeks)|Not specified|0
1205|NCT02784106|6828|P2|Double-Blind Treatment Period (12 Weeks)|Not specified|0
1206|NCT02784106|6829|P1|Double-Blind Treatment Period (12 Weeks)|Not specified|2
1207|NCT02784106|6826|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1208|NCT02784106|6827|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1209|NCT02784106|6828|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
1210|NCT02784106|6829|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
1211|NCT02784106|6826|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1212|NCT02784106|6827|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1213|NCT02784106|6828|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
1214|NCT02784106|6829|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
1215|NCT02782676|6890|P2|Overall Study|Lost to Follow-up|1
1216|NCT02782676|6891|P1|Overall Study|Lost to Follow-up|0
1217|NCT02782169|6921|P2|Overall Study|Lost to Follow-up|2
1218|NCT02782169|6922|P1|Overall Study|Lost to Follow-up|1
1219|NCT02781818|6939|P3|Overall Study|Lost to Follow-up|1
1220|NCT02781818|6940|P2|Overall Study|Lost to Follow-up|2
1221|NCT02781818|6941|P1|Overall Study|Lost to Follow-up|4
1222|NCT02780167|7034|P5|Overall Study|Other|2
1223|NCT02780167|7035|P4|Overall Study|Other|1
1224|NCT02780167|7036|P3|Overall Study|Other|3
1225|NCT02780167|7037|P2|Overall Study|Other|0
1226|NCT02780167|7038|P1|Overall Study|Other|0
1227|NCT02780167|7034|P5|Overall Study|Withdrawal by Subject|4
1228|NCT02780167|7035|P4|Overall Study|Withdrawal by Subject|3
1229|NCT02780167|7036|P3|Overall Study|Withdrawal by Subject|4
1230|NCT02780167|7037|P2|Overall Study|Withdrawal by Subject|4
1231|NCT02780167|7038|P1|Overall Study|Withdrawal by Subject|6
1232|NCT02780167|7034|P5|Overall Study|Protocol Violation|2
1233|NCT02780167|7035|P4|Overall Study|Protocol Violation|1
1234|NCT02780167|7036|P3|Overall Study|Protocol Violation|1
1235|NCT02780167|7037|P2|Overall Study|Protocol Violation|5
1236|NCT02780167|7038|P1|Overall Study|Protocol Violation|5
1237|NCT02780167|7034|P5|Overall Study|No longer meets eligibility criteria|1
1238|NCT02780167|7035|P4|Overall Study|No longer meets eligibility criteria|1
1239|NCT02780167|7036|P3|Overall Study|No longer meets eligibility criteria|0
1240|NCT02780167|7037|P2|Overall Study|No longer meets eligibility criteria|0
1241|NCT02780167|7038|P1|Overall Study|No longer meets eligibility criteria|0
1242|NCT02780167|7034|P5|Overall Study|Does not meet entrance criteria|0
1243|NCT02780167|7035|P4|Overall Study|Does not meet entrance criteria|0
1244|NCT02780167|7036|P3|Overall Study|Does not meet entrance criteria|1
1245|NCT02780167|7037|P2|Overall Study|Does not meet entrance criteria|0
1246|NCT02780167|7038|P1|Overall Study|Does not meet entrance criteria|0
1247|NCT02780167|7034|P5|Overall Study|Lost to Follow-up|0
1248|NCT02780167|7035|P4|Overall Study|Lost to Follow-up|0
1249|NCT02780167|7036|P3|Overall Study|Lost to Follow-up|1
1250|NCT02780167|7037|P2|Overall Study|Lost to Follow-up|0
1251|NCT02780167|7038|P1|Overall Study|Lost to Follow-up|2
1252|NCT02780167|7034|P5|Overall Study|Lack of Efficacy|0
1253|NCT02780167|7035|P4|Overall Study|Lack of Efficacy|1
1254|NCT02780167|7036|P3|Overall Study|Lack of Efficacy|6
1255|NCT02780167|7037|P2|Overall Study|Lack of Efficacy|5
1256|NCT02780167|7038|P1|Overall Study|Lack of Efficacy|6
1257|NCT02780167|7034|P5|Overall Study|Adverse Event|8
1258|NCT02780167|7035|P4|Overall Study|Adverse Event|12
1259|NCT02780167|7036|P3|Overall Study|Adverse Event|8
1260|NCT02780167|7037|P2|Overall Study|Adverse Event|8
1261|NCT02780167|7038|P1|Overall Study|Adverse Event|9
1262|NCT02777242|7207|P1|Overall Study|Withdrawal by Subject|1
1263|NCT02777242|7207|P1|Overall Study|Sponsor's request|1
1264|NCT02777242|7207|P1|Overall Study|Multiple|1
1265|NCT02777242|7207|P1|Overall Study|Lost to Follow-up|1
1266|NCT02777242|7207|P1|Overall Study|Other|2
1267|NCT02777125|7213|P2|Overall Study|Protocol Violation|12
1268|NCT02777125|7214|P1|Overall Study|Protocol Violation|8
1269|NCT02777125|7213|P2|Overall Study|Assent form violation|23
1270|NCT02777125|7214|P1|Overall Study|Assent form violation|21
1271|NCT02777125|7213|P2|Overall Study|Consent form violation|12
1272|NCT02777125|7214|P1|Overall Study|Consent form violation|14
1273|NCT02774278|7267|P1|Overall Study|Protocol Violation|2
1274|NCT02774278|7267|P1|Overall Study|Withdrawal by Subject|3
1275|NCT02774278|7267|P1|Overall Study|Administrative reasons|6
1276|NCT02774278|7267|P1|Overall Study|Refused treatment/did not cooperate|9
1277|NCT02774278|7267|P1|Overall Study|Adverse event/intercurrent illness|16
1278|NCT02774278|7267|P1|Overall Study|Death|29
1279|NCT02774278|7267|P1|Overall Study|Lack of Efficacy|199
1280|NCT02770248|7325|P2|Overall Study|Randomized in error, prior to treatment|1
1281|NCT02770248|7326|P1|Overall Study|Randomized in error, prior to treatment|0
1282|NCT02770248|7325|P2|Overall Study|Adverse Event|1
1283|NCT02770248|7326|P1|Overall Study|Adverse Event|0
1284|NCT02769858|7338|P1|Overall Study|Withdrawal by Subject|2
1285|NCT02768194|7344|P6|Period 3|Other (Reason not specified)|0
1286|NCT02768194|7345|P5|Period 3|Other (Reason not specified)|0
1287|NCT02768194|7346|P4|Period 3|Other (Reason not specified)|0
1288|NCT02768194|7347|P3|Period 3|Other (Reason not specified)|0
1289|NCT02768194|7348|P2|Period 3|Other (Reason not specified)|1
1290|NCT02768194|7349|P1|Period 3|Other (Reason not specified)|0
1291|NCT02768194|7344|P6|Period 2|Other (Reason not specified)|0
1292|NCT02768194|7345|P5|Period 2|Other (Reason not specified)|0
1293|NCT02768194|7346|P4|Period 2|Other (Reason not specified)|0
1294|NCT02768194|7347|P3|Period 2|Other (Reason not specified)|0
1295|NCT02768194|7348|P2|Period 2|Other (Reason not specified)|0
1296|NCT02768194|7349|P1|Period 2|Other (Reason not specified)|1
1297|NCT02768194|7344|P6|Period 1|Adverse Event|0
1298|NCT02768194|7345|P5|Period 1|Adverse Event|0
1299|NCT02768194|7346|P4|Period 1|Adverse Event|1
1300|NCT02768194|7347|P3|Period 1|Adverse Event|0
1301|NCT02768194|7348|P2|Period 1|Adverse Event|0
1302|NCT02768194|7349|P1|Period 1|Adverse Event|0
1303|NCT02767765|7366|P1|Overall Study|Withdrawal by Subject|1
1304|NCT02767765|7366|P1|Overall Study|Non-Compliance|1
1305|NCT02767765|7366|P1|Overall Study|Investigator decision|1
1306|NCT02767765|7366|P1|Overall Study|Lost to Follow-up|2
1307|NCT02767765|7366|P1|Overall Study|Insufficient response|1
1308|NCT02767765|7366|P1|Overall Study|Death|1
1309|NCT02767765|7366|P1|Overall Study|Adverse Event|4
1310|NCT02766400|7377|P2|Overall Study|Withdrawal by Subject|0
1311|NCT02766400|7378|P1|Overall Study|Withdrawal by Subject|1
1312|NCT02766400|7377|P2|Overall Study|Death|2
1313|NCT02766400|7378|P1|Overall Study|Death|1
1314|NCT02766283|7384|P1|Overall Study|Lost to Follow-up|27
1315|NCT02763189|7449|P2|Overall Study|Device failure|2
1316|NCT02763189|7450|P1|Overall Study|Device failure|0
1317|NCT02762370|7460|P2|Overall Study|Protocol Violation|0
1318|NCT02762370|7461|P1|Overall Study|Protocol Violation|1
1319|NCT02761733|7483|P4|Overall Study|Cognitive Impairment|0
1320|NCT02761733|7484|P3|Overall Study|Cognitive Impairment|1
1321|NCT02761733|7485|P2|Overall Study|Cognitive Impairment|0
1322|NCT02761733|7486|P1|Overall Study|Cognitive Impairment|5
1323|NCT02761733|7483|P4|Overall Study|Discharged from Study Site|11
1324|NCT02761733|7484|P3|Overall Study|Discharged from Study Site|25
1325|NCT02761733|7485|P2|Overall Study|Discharged from Study Site|9
1326|NCT02761733|7486|P1|Overall Study|Discharged from Study Site|10
1327|NCT02761733|7483|P4|Overall Study|Withdrawal by Subject|0
1328|NCT02761733|7484|P3|Overall Study|Withdrawal by Subject|0
1329|NCT02761733|7485|P2|Overall Study|Withdrawal by Subject|0
1330|NCT02761733|7486|P1|Overall Study|Withdrawal by Subject|2
1331|NCT02761733|7483|P4|Overall Study|Physician Decision|0
1332|NCT02761733|7484|P3|Overall Study|Physician Decision|0
1333|NCT02761733|7485|P2|Overall Study|Physician Decision|0
1334|NCT02761733|7486|P1|Overall Study|Physician Decision|4
1335|NCT02761733|7483|P4|Overall Study|Lost to Follow-up|3
1336|NCT02761733|7484|P3|Overall Study|Lost to Follow-up|0
1337|NCT02761733|7485|P2|Overall Study|Lost to Follow-up|7
1338|NCT02761733|7486|P1|Overall Study|Lost to Follow-up|6
1339|NCT02761733|7483|P4|Overall Study|Death|1
1340|NCT02761733|7484|P3|Overall Study|Death|1
1341|NCT02761733|7485|P2|Overall Study|Death|5
1342|NCT02761733|7486|P1|Overall Study|Death|3
1343|NCT02761629|7518|P2|Overall Study|Randomized But Not Treated|4
1344|NCT02761629|7519|P1|Overall Study|Randomized But Not Treated|8
1345|NCT02761629|7518|P2|Overall Study|Lost to Follow-up|1
1346|NCT02761629|7519|P1|Overall Study|Lost to Follow-up|4
1347|NCT02761629|7518|P2|Overall Study|Other|2
1348|NCT02761629|7519|P1|Overall Study|Other|0
1349|NCT02761629|7518|P2|Overall Study|Withdrawal by Subject|3
1350|NCT02761629|7519|P1|Overall Study|Withdrawal by Subject|0
1351|NCT02761629|7518|P2|Overall Study|Protocol Violation|2
1352|NCT02761629|7519|P1|Overall Study|Protocol Violation|2
1353|NCT02761629|7518|P2|Overall Study|Did not Cooperate/Refused Treatment|4
1354|NCT02761629|7519|P1|Overall Study|Did not Cooperate/Refused Treatment|2
1355|NCT02761629|7518|P2|Overall Study|Failure to Return|4
1356|NCT02761629|7519|P1|Overall Study|Failure to Return|2
1357|NCT02761629|7518|P2|Overall Study|Insufficient Therapeutic Response|7
1358|NCT02761629|7519|P1|Overall Study|Insufficient Therapeutic Response|2
1359|NCT02761629|7518|P2|Overall Study|Adverse Event/Intercurrent Illness|5
1360|NCT02761629|7519|P1|Overall Study|Adverse Event/Intercurrent Illness|7
1361|NCT02760810|7539|P1|Overall Study|Protocol Violation|1
1362|NCT02760654|7547|P2|Overall Study|Withdrawal by Subject|3
1363|NCT02760654|7548|P1|Overall Study|Withdrawal by Subject|4
1364|NCT02760654|7547|P2|Overall Study|Lost to Follow-up|3
1365|NCT02760654|7548|P1|Overall Study|Lost to Follow-up|3
1366|NCT02759692|7572|P2|Period 2|Test article no longer available|1
1367|NCT02759692|7573|P1|Period 2|Test article no longer available|0
1368|NCT02759692|7572|P2|Period 2|Lost to Follow-up|0
1369|NCT02759692|7573|P1|Period 2|Lost to Follow-up|1
1370|NCT02759692|7572|P2|Period 1|Miss-Randomized|1
1371|NCT02759692|7573|P1|Period 1|Miss-Randomized|1
1372|NCT02759692|7572|P2|Period 1|No longer meets eligibility criteria.|0
1373|NCT02759692|7573|P1|Period 1|No longer meets eligibility criteria.|1
1374|NCT02759692|7572|P2|Period 1|Test article no longer available|1
1375|NCT02759692|7573|P1|Period 1|Test article no longer available|1
1376|NCT02759471|7589|P1|Overall Study|discomfort|2
1377|NCT02758613|7603|P4|Treatment|Withdrawal by Subject|0
1378|NCT02758613|7604|P3|Treatment|Withdrawal by Subject|1
1379|NCT02758613|7605|P2|Treatment|Withdrawal by Subject|0
1380|NCT02758613|7606|P1|Treatment|Withdrawal by Subject|1
1381|NCT02758613|7603|P4|Treatment|Physician and Sponsor Decision|0
1382|NCT02758613|7604|P3|Treatment|Physician and Sponsor Decision|0
1383|NCT02758613|7605|P2|Treatment|Physician and Sponsor Decision|0
1384|NCT02758613|7606|P1|Treatment|Physician and Sponsor Decision|1
1385|NCT02758171|7633|P2|Wash-out|Other reason|0
1386|NCT02758171|7634|P1|Wash-out|Other reason|1
1387|NCT02758171|7633|P2|Wash-out|Withdrawal by Subject|0
1388|NCT02758171|7634|P1|Wash-out|Withdrawal by Subject|1
1389|NCT02756637|7667|P2|Overall Study|Did not complete curative therapy|0
1390|NCT02756637|7668|P1|Overall Study|Did not complete curative therapy|33
1391|NCT02756637|7667|P2|Overall Study|No available NLR value|44
1392|NCT02756637|7668|P1|Overall Study|No available NLR value|44
1393|NCT02756637|7667|P2|Overall Study|Not eligible for initial SWOG study|10
1394|NCT02756637|7668|P1|Overall Study|Not eligible for initial SWOG study|10
1395|NCT02755805|7707|P2|Overall Study|Withdrawal by Subject|2
1396|NCT02755805|7708|P1|Overall Study|Withdrawal by Subject|0
1397|NCT02755805|7707|P2|Overall Study|Refused assessments|0
1398|NCT02755805|7708|P1|Overall Study|Refused assessments|1
1399|NCT02755805|7707|P2|Overall Study|Lost to Follow-up|2
1400|NCT02755805|7708|P1|Overall Study|Lost to Follow-up|1
1401|NCT02755090|7722|P2|Overall Study|equipment malfunction|0
1402|NCT02755090|7723|P1|Overall Study|equipment malfunction|1
1403|NCT02754492|7735|P4|Overall Study|Venous access issues not resulting in AE|4
1404|NCT02754492|7736|P3|Overall Study|Venous access issues not resulting in AE|0
1405|NCT02754492|7737|P2|Overall Study|Venous access issues not resulting in AE|0
1406|NCT02754492|7738|P1|Overall Study|Venous access issues not resulting in AE|0
1407|NCT02754492|7735|P4|Overall Study|Adverse Event|13
1408|NCT02754492|7736|P3|Overall Study|Adverse Event|0
1409|NCT02754492|7737|P2|Overall Study|Adverse Event|0
1410|NCT02754492|7738|P1|Overall Study|Adverse Event|0
1411|NCT02754492|7735|P4|Overall Study|Equipment malfuntion|5
1412|NCT02754492|7736|P3|Overall Study|Equipment malfuntion|2
1413|NCT02754492|7737|P2|Overall Study|Equipment malfuntion|0
1414|NCT02754492|7738|P1|Overall Study|Equipment malfuntion|0
1415|NCT02754492|7735|P4|Overall Study|Withdrawal by Subject|0
1416|NCT02754492|7736|P3|Overall Study|Withdrawal by Subject|0
1417|NCT02754492|7737|P2|Overall Study|Withdrawal by Subject|0
1418|NCT02754492|7738|P1|Overall Study|Withdrawal by Subject|2
1419|NCT02754492|7735|P4|Overall Study|Protocol Violation|1
1420|NCT02754492|7736|P3|Overall Study|Protocol Violation|0
1421|NCT02754492|7737|P2|Overall Study|Protocol Violation|2
1422|NCT02754492|7738|P1|Overall Study|Protocol Violation|2
1423|NCT02754440|7754|P4|Overall Study|Subject issues not resulting in AE|12
1424|NCT02754440|7755|P3|Overall Study|Subject issues not resulting in AE|0
1425|NCT02754440|7756|P2|Overall Study|Subject issues not resulting in AE|0
1426|NCT02754440|7757|P1|Overall Study|Subject issues not resulting in AE|0
1427|NCT02754440|7754|P4|Overall Study|Equipment failure|7
1428|NCT02754440|7755|P3|Overall Study|Equipment failure|5
1429|NCT02754440|7756|P2|Overall Study|Equipment failure|5
1430|NCT02754440|7757|P1|Overall Study|Equipment failure|0
1431|NCT02754440|7754|P4|Overall Study|Withdrawal by Subject|1
1432|NCT02754440|7755|P3|Overall Study|Withdrawal by Subject|0
1433|NCT02754440|7756|P2|Overall Study|Withdrawal by Subject|0
1434|NCT02754440|7757|P1|Overall Study|Withdrawal by Subject|0
1435|NCT02754440|7754|P4|Overall Study|Adverse Event|9
1436|NCT02754440|7755|P3|Overall Study|Adverse Event|0
1437|NCT02754440|7756|P2|Overall Study|Adverse Event|1
1438|NCT02754440|7757|P1|Overall Study|Adverse Event|3
1439|NCT02754440|7754|P4|Overall Study|Protocol Violation|6
1440|NCT02754440|7755|P3|Overall Study|Protocol Violation|2
1441|NCT02754440|7756|P2|Overall Study|Protocol Violation|2
1442|NCT02754440|7757|P1|Overall Study|Protocol Violation|3
1443|NCT02753075|7826|P3|Overall Study|Physician Decision|0
1444|NCT02753075|7827|P2|Overall Study|Physician Decision|1
1445|NCT02753075|7828|P1|Overall Study|Physician Decision|3
1446|NCT02753075|7826|P3|Overall Study|Withdrawal of Consent|3
1447|NCT02753075|7827|P2|Overall Study|Withdrawal of Consent|1
1448|NCT02753075|7828|P1|Overall Study|Withdrawal of Consent|1
1449|NCT02753075|7826|P3|Overall Study|Lost to Follow-up|0
1450|NCT02753075|7827|P2|Overall Study|Lost to Follow-up|0
1451|NCT02753075|7828|P1|Overall Study|Lost to Follow-up|2
1452|NCT02753075|7826|P3|Overall Study|Adverse Event|0
1453|NCT02753075|7827|P2|Overall Study|Adverse Event|1
1454|NCT02753075|7828|P1|Overall Study|Adverse Event|2
1455|NCT02752802|7855|P2|Overall Study|Contrast Volume Not Collected|0
1456|NCT02752802|7856|P1|Overall Study|Contrast Volume Not Collected|1
1457|NCT02752633|7865|P1|Overall Study|Withdrawal by Subject|1
1458|NCT02751450|7894|P2|Overall Study|Adverse Event|0
1459|NCT02751450|7895|P1|Overall Study|Adverse Event|1
1460|NCT02751320|7907|P1|Overall Study|Withdrawal by Subject|1
1461|NCT02751320|7907|P1|Overall Study|Adverse Event|2
1462|NCT02750943|7945|P2|Overall Study|Withdrawal by Subject|7
1463|NCT02750943|7946|P1|Overall Study|Withdrawal by Subject|5
1464|NCT02750943|7945|P2|Overall Study|Lost to Follow-up|2
1465|NCT02750943|7946|P1|Overall Study|Lost to Follow-up|1
1466|NCT02750930|7960|P1|Overall Study|Study closed/terminated|8
1555|NCT02739594|8506|P2|Overall Study|Protocol Violation|6
1467|NCT02750813|7972|P2|Period 1, First 14 Days of Wear|Reason not given|1
1468|NCT02750813|7973|P1|Period 1, First 14 Days of Wear|Reason not given|0
1469|NCT02750813|7972|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
1470|NCT02750813|7973|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
1471|NCT02750709|7982|P6|Treatment Period 1|Adverse Event|1
1472|NCT02750709|7983|P5|Treatment Period 1|Adverse Event|0
1473|NCT02750709|7984|P4|Treatment Period 1|Adverse Event|0
1474|NCT02750709|7985|P3|Treatment Period 1|Adverse Event|0
1475|NCT02750709|7986|P2|Treatment Period 1|Adverse Event|0
1476|NCT02750709|7987|P1|Treatment Period 1|Adverse Event|0
1477|NCT02750345|8013|P6|Intervention 1|Adverse Event|0
1478|NCT02750345|8014|P5|Intervention 1|Adverse Event|1
1479|NCT02750345|8015|P4|Intervention 1|Adverse Event|0
1480|NCT02750345|8016|P3|Intervention 1|Adverse Event|0
1481|NCT02750345|8017|P2|Intervention 1|Adverse Event|0
1482|NCT02750345|8018|P1|Intervention 1|Adverse Event|0
1483|NCT02750332|8044|P2|Treatment Period 1|Withdrawal by Subject|1
1484|NCT02750332|8045|P1|Treatment Period 1|Withdrawal by Subject|0
1485|NCT02748213|8106|P2|Overall Study|Not Specified|29
1486|NCT02748213|8107|P1|Overall Study|Not Specified|30
1487|NCT02748213|8106|P2|Overall Study|Failure to Return|0
1488|NCT02748213|8107|P1|Overall Study|Failure to Return|1
1489|NCT02748213|8106|P2|Overall Study|Refused Treatment*|6
1490|NCT02748213|8107|P1|Overall Study|Refused Treatment*|6
1491|NCT02748213|8106|P2|Overall Study|Protocol Violation|4
1492|NCT02748213|8107|P1|Overall Study|Protocol Violation|6
1493|NCT02748213|8106|P2|Overall Study|Violation of Selection Criteria|0
1494|NCT02748213|8107|P1|Overall Study|Violation of Selection Criteria|2
1495|NCT02748213|8106|P2|Overall Study|Insufficient Therapeutic Response|57
1496|NCT02748213|8107|P1|Overall Study|Insufficient Therapeutic Response|56
1497|NCT02748213|8106|P2|Overall Study|Death|3
1498|NCT02748213|8107|P1|Overall Study|Death|5
1499|NCT02748213|8106|P2|Overall Study|Adverse Event or Intercurrent Illness|11
1500|NCT02748213|8107|P1|Overall Study|Adverse Event or Intercurrent Illness|5
1501|NCT02748213|8106|P2|Overall Study|Abnormal Laboratory Test|0
1502|NCT02748213|8107|P1|Overall Study|Abnormal Laboratory Test|1
1503|NCT02748213|8106|P2|Overall Study|Withdrawal Prior to Treatment|2
1504|NCT02748213|8107|P1|Overall Study|Withdrawal Prior to Treatment|1
1505|NCT02746679|8143|P2|Overall Study|Lost to Follow-up|6
1506|NCT02746679|8144|P1|Overall Study|Lost to Follow-up|4
1507|NCT02745392|8228|P4|Overall Study|Lost to Follow-up|0
1508|NCT02745392|8229|P3|Overall Study|Lost to Follow-up|0
1509|NCT02745392|8230|P2|Overall Study|Lost to Follow-up|1
1510|NCT02745392|8231|P1|Overall Study|Lost to Follow-up|0
1511|NCT02743962|8247|P2|Overall Study|Atrophic vaginitis diagnosed|0
1512|NCT02743962|8248|P1|Overall Study|Atrophic vaginitis diagnosed|1
1513|NCT02743780|8283|P5|Part 3 (7 Days)|Adverse Event|0
1514|NCT02743780|8284|P4|Part 3 (7 Days)|Adverse Event|0
1515|NCT02743780|8285|P3|Part 3 (7 Days)|Adverse Event|1
1516|NCT02743780|8286|P2|Part 3 (7 Days)|Adverse Event|0
1517|NCT02743780|8287|P1|Part 3 (7 Days)|Adverse Event|0
1518|NCT02743117|8343|P2|Overall Study|Other|0
1519|NCT02743117|8344|P1|Overall Study|Other|1
1520|NCT02743117|8343|P2|Overall Study|Lost to Follow-up|1
1521|NCT02743117|8344|P1|Overall Study|Lost to Follow-up|0
1522|NCT02742818|8369|P2|Overall Study|Protocol Violation|1
1523|NCT02742818|8370|P1|Overall Study|Protocol Violation|0
1524|NCT02742818|8369|P2|Overall Study|Adverse Event|1
1525|NCT02742818|8370|P1|Overall Study|Adverse Event|0
1526|NCT02741245|8389|P5|Overall Study|Withdrawal by Subject|0
1527|NCT02741245|8390|P4|Overall Study|Withdrawal by Subject|1
1528|NCT02741245|8391|P3|Overall Study|Withdrawal by Subject|0
1529|NCT02741245|8392|P2|Overall Study|Withdrawal by Subject|0
1530|NCT02741245|8393|P1|Overall Study|Withdrawal by Subject|0
1531|NCT02741245|8389|P5|Overall Study|Protocol Violation|0
1532|NCT02741245|8390|P4|Overall Study|Protocol Violation|1
1533|NCT02741245|8391|P3|Overall Study|Protocol Violation|0
1534|NCT02741245|8392|P2|Overall Study|Protocol Violation|1
1535|NCT02741245|8393|P1|Overall Study|Protocol Violation|0
1536|NCT02741245|8389|P5|Overall Study|Adverse Event|2
1537|NCT02741245|8390|P4|Overall Study|Adverse Event|2
1538|NCT02741245|8391|P3|Overall Study|Adverse Event|0
1539|NCT02741245|8392|P2|Overall Study|Adverse Event|0
1540|NCT02741245|8393|P1|Overall Study|Adverse Event|0
1541|NCT02739594|8506|P2|Overall Study|Not Specified|2
1542|NCT02739594|8507|P1|Overall Study|Not Specified|6
1543|NCT02739594|8506|P2|Overall Study|Elevated Serum Creatinine|1
1544|NCT02739594|8507|P1|Overall Study|Elevated Serum Creatinine|0
1545|NCT02739594|8506|P2|Overall Study|Lost to Follow-up|1
1546|NCT02739594|8507|P1|Overall Study|Lost to Follow-up|0
1547|NCT02739594|8506|P2|Overall Study|Withdrawal by Subject|1
1548|NCT02739594|8507|P1|Overall Study|Withdrawal by Subject|1
1549|NCT02739594|8506|P2|Overall Study|Administrative Reasons|3
1550|NCT02739594|8507|P1|Overall Study|Administrative Reasons|1
1551|NCT02739594|8506|P2|Overall Study|Renal Insufficiency|6
1552|NCT02739594|8507|P1|Overall Study|Renal Insufficiency|4
1553|NCT02739594|8506|P2|Overall Study|Death|2
1554|NCT02739594|8507|P1|Overall Study|Death|4
1556|NCT02739594|8507|P1|Overall Study|Protocol Violation|5
1557|NCT02739594|8506|P2|Overall Study|Violation of Eligibility Criteria|2
1558|NCT02739594|8507|P1|Overall Study|Violation of Eligibility Criteria|1
1559|NCT02739594|8506|P2|Overall Study|Undesired Event|4
1560|NCT02739594|8507|P1|Overall Study|Undesired Event|3
1561|NCT02739321|8539|P2|Overall Study|Withdrawal by Subject|2
1562|NCT02739321|8540|P1|Overall Study|Withdrawal by Subject|1
1563|NCT02739321|8539|P2|Overall Study|Lost to Follow-up|1
1564|NCT02739321|8540|P1|Overall Study|Lost to Follow-up|1
1565|NCT02739321|8539|P2|Overall Study|Lack of Efficacy|1
1566|NCT02739321|8540|P1|Overall Study|Lack of Efficacy|1
1567|NCT02738333|8603|P3|Overall Study|Lost to Follow-up|0
1568|NCT02738333|8604|P2|Overall Study|Lost to Follow-up|0
1569|NCT02738333|8605|P1|Overall Study|Lost to Follow-up|1
1570|NCT02738333|8603|P3|Overall Study|Death|0
1571|NCT02738333|8604|P2|Overall Study|Death|0
1572|NCT02738333|8605|P1|Overall Study|Death|1
1573|NCT02738138|8681|P2|Overall Study|Other - not further specified|0
1574|NCT02738138|8682|P1|Overall Study|Other - not further specified|1
1575|NCT02738138|8681|P2|Overall Study|Lost to Follow-up|0
1576|NCT02738138|8682|P1|Overall Study|Lost to Follow-up|2
1577|NCT02738138|8681|P2|Overall Study|Adverse Event|1
1578|NCT02738138|8682|P1|Overall Study|Adverse Event|0
1579|NCT02737852|8689|P1|Overall Study|Withdrawal by Subject|2
1580|NCT02737618|8699|P1|Overall Study|Withdrawal by Subject|9
1581|NCT02737592|8704|P1|Overall Study|Withdrawal by Subject|1
1582|NCT02736721|8709|P1|Overall Study|Other|5
1583|NCT02736721|8709|P1|Overall Study|Lost to Follow-up|3
1584|NCT02736721|8709|P1|Overall Study|Adverse Event|8
1585|NCT02735200|8731|P2|Overall Study|Withdrawal by Subject|0
1586|NCT02735200|8732|P1|Overall Study|Withdrawal by Subject|8
1587|NCT02735200|8731|P2|Overall Study|Lost to Follow-up|5
1588|NCT02735200|8732|P1|Overall Study|Lost to Follow-up|0
1589|NCT02734810|8765|P2|Overall Study|Lack of Efficacy|0
1590|NCT02734810|8766|P1|Overall Study|Lack of Efficacy|1
1591|NCT02734810|8765|P2|Overall Study|Adverse Event|0
1592|NCT02734810|8766|P1|Overall Study|Adverse Event|1
1593|NCT02734212|8807|P2|Overall Study|Lost to Follow-up|10
1594|NCT02734212|8808|P1|Overall Study|Lost to Follow-up|5
1595|NCT02732639|8838|P1|Overall Study|Lost to Follow-up|1
1596|NCT02732561|8851|P2|Overall Study|Withdrawal by Subject|0
1597|NCT02732561|8852|P1|Overall Study|Withdrawal by Subject|1
1598|NCT02732561|8851|P2|Overall Study|Lost to Follow-up|1
1599|NCT02732561|8852|P1|Overall Study|Lost to Follow-up|1
1600|NCT02732327|8862|P2|Overall Study|Protocol Violation|1
1601|NCT02732327|8863|P1|Overall Study|Protocol Violation|0
1602|NCT02732210|8871|P2|Overall Study|Missing|8
1603|NCT02732210|8872|P1|Overall Study|Missing|0
1604|NCT02732210|8871|P2|Overall Study|Other|103
1605|NCT02732210|8872|P1|Overall Study|Other|35
1606|NCT02732210|8871|P2|Overall Study|Death|15
1607|NCT02732210|8872|P1|Overall Study|Death|4
1608|NCT02732210|8871|P2|Overall Study|Lost to Follow-up|57
1609|NCT02732210|8872|P1|Overall Study|Lost to Follow-up|5
1610|NCT02732210|8871|P2|Overall Study|Withdrawal by Subject|87
1611|NCT02732210|8872|P1|Overall Study|Withdrawal by Subject|28
1612|NCT02732210|8871|P2|Overall Study|Study Ended|13
1613|NCT02732210|8872|P1|Overall Study|Study Ended|13
1614|NCT02732210|8871|P2|Overall Study|Site Closed|11
1615|NCT02732210|8872|P1|Overall Study|Site Closed|0
1616|NCT02731131|8924|P2|Overall Study|Refused Therapy|1
1617|NCT02731131|8925|P1|Overall Study|Refused Therapy|0
1618|NCT02731131|8924|P2|Overall Study|Psychiatric Disorder|1
1619|NCT02731131|8925|P1|Overall Study|Psychiatric Disorder|0
1620|NCT02730819|8941|P1|Overall Study|Lost to Follow-up|9
1621|NCT02730351|8947|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
1622|NCT02730351|8948|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
1623|NCT02730351|8947|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
1624|NCT02730351|8948|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
1625|NCT02730351|8947|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
1626|NCT02730351|8948|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
1627|NCT02730351|8947|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
1628|NCT02730351|8948|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
1629|NCT02730351|8947|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
1630|NCT02730351|8948|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
1631|NCT02726022|9040|P1|Overall Study|Treatment Failure and Poor Compliance|1
1632|NCT02726022|9040|P1|Overall Study|Poor Compliance|13
1633|NCT02726022|9040|P1|Overall Study|Treatment Failure|8
1634|NCT02726022|9040|P1|Overall Study|Adverse Event|14
1635|NCT02725788|9051|P2|Overall Study|Protocol Violation|1
1636|NCT02725788|9052|P1|Overall Study|Protocol Violation|0
1637|NCT02725788|9051|P2|Overall Study|Lost to Follow-up|1
1638|NCT02725788|9052|P1|Overall Study|Lost to Follow-up|1
1639|NCT02724644|9060|P2|Overall Study|Administrative|0
1640|NCT02724644|9061|P1|Overall Study|Administrative|1
1641|NCT02724644|9060|P2|Overall Study|Withdrawal by Subject|1
1642|NCT02724644|9061|P1|Overall Study|Withdrawal by Subject|7
1643|NCT02724644|9060|P2|Overall Study|Lost to Follow-up|2
1644|NCT02724644|9061|P1|Overall Study|Lost to Follow-up|6
1645|NCT02724644|9060|P2|Overall Study|Adverse Event|1
1646|NCT02724644|9061|P1|Overall Study|Adverse Event|7
1647|NCT02724111|9095|P2|Overall Study|Protocol Violation|5
1648|NCT02724111|9096|P1|Overall Study|Protocol Violation|2
1649|NCT02723201|9119|P3|Second Intervention Period|Adverse Event|0
1650|NCT02723201|9120|P2|Second Intervention Period|Adverse Event|0
1651|NCT02723201|9121|P1|Second Intervention Period|Adverse Event|1
1652|NCT02723201|9119|P3|Second Intervention Period|Protocol Violation|0
1653|NCT02723201|9120|P2|Second Intervention Period|Protocol Violation|0
1654|NCT02723201|9121|P1|Second Intervention Period|Protocol Violation|1
1655|NCT02723188|9180|P3|Overall Study|Withdrawal by Subject|0
1656|NCT02723188|9181|P2|Overall Study|Withdrawal by Subject|0
1657|NCT02723188|9182|P1|Overall Study|Withdrawal by Subject|1
1658|NCT02722967|9196|P3|Overall Study|Non-adherence of the patch to the skin|2
1659|NCT02722967|9197|P2|Overall Study|Non-adherence of the patch to the skin|0
1660|NCT02722967|9198|P1|Overall Study|Non-adherence of the patch to the skin|0
1661|NCT02722967|9196|P3|Overall Study|Physician Decision|0
1662|NCT02722967|9197|P2|Overall Study|Physician Decision|0
1663|NCT02722967|9198|P1|Overall Study|Physician Decision|1
1664|NCT02722967|9196|P3|Overall Study|Withdrawal by Subject|1
1665|NCT02722967|9197|P2|Overall Study|Withdrawal by Subject|0
1666|NCT02722967|9198|P1|Overall Study|Withdrawal by Subject|1
1667|NCT02722967|9196|P3|Overall Study|Non-compliance with patch wearing|1
1668|NCT02722967|9197|P2|Overall Study|Non-compliance with patch wearing|1
1669|NCT02722967|9198|P1|Overall Study|Non-compliance with patch wearing|2
1670|NCT02722967|9196|P3|Overall Study|Lost to Follow-up|0
1671|NCT02722967|9197|P2|Overall Study|Lost to Follow-up|1
1672|NCT02722967|9198|P1|Overall Study|Lost to Follow-up|0
1673|NCT02722967|9196|P3|Overall Study|Adverse Event|0
1674|NCT02722967|9197|P2|Overall Study|Adverse Event|0
1675|NCT02722967|9198|P1|Overall Study|Adverse Event|1
1676|NCT02722278|9212|P2|Overall Study|Site closure not study related|1
1677|NCT02722278|9213|P1|Overall Study|Site closure not study related|0
1678|NCT02722278|9212|P2|Overall Study|Subject declined after tx assignment|1
1679|NCT02722278|9213|P1|Overall Study|Subject declined after tx assignment|0
1680|NCT02722278|9212|P2|Overall Study|High PSA pre-study/ not eligible|1
1681|NCT02722278|9213|P1|Overall Study|High PSA pre-study/ not eligible|0
1682|NCT02722278|9212|P2|Overall Study|Protocol Violation|0
1683|NCT02722278|9213|P1|Overall Study|Protocol Violation|1
1684|NCT02722278|9212|P2|Overall Study|Lost to Follow-up|0
1685|NCT02722278|9213|P1|Overall Study|Lost to Follow-up|2
1686|NCT02722278|9212|P2|Overall Study|Adverse Event|1
1687|NCT02722278|9213|P1|Overall Study|Adverse Event|4
1688|NCT02722278|9212|P2|Overall Study|Withdrawal by Subject|3
1689|NCT02722278|9213|P1|Overall Study|Withdrawal by Subject|5
1690|NCT02722044|9237|P1|Overall Study|Did Not Meet Criteria at Week 14|1
1691|NCT02722044|9237|P1|Overall Study|Withdrawal by Subject|1
1692|NCT02722044|9237|P1|Overall Study|Physician Decision|1
1693|NCT02722044|9237|P1|Overall Study|Adverse Event|2
1694|NCT02718898|9310|P2|Overall Study|Lost to Follow-up|0
1695|NCT02718898|9311|P1|Overall Study|Lost to Follow-up|2
1696|NCT02718898|9310|P2|Overall Study|Lack of Efficacy|0
1697|NCT02718898|9311|P1|Overall Study|Lack of Efficacy|1
1698|NCT02718898|9310|P2|Overall Study|Physician Decision|0
1699|NCT02718898|9311|P1|Overall Study|Physician Decision|1
1700|NCT02718898|9310|P2|Overall Study|Adverse Event|1
1701|NCT02718898|9311|P1|Overall Study|Adverse Event|5
1702|NCT02717754|9345|P6|Overall Study|Incorrect Infusion Duration|20
1703|NCT02717754|9346|P5|Overall Study|Incorrect Infusion Duration|20
1704|NCT02717754|9347|P4|Overall Study|Incorrect Infusion Duration|10
1705|NCT02717754|9348|P3|Overall Study|Incorrect Infusion Duration|0
1706|NCT02717754|9349|P2|Overall Study|Incorrect Infusion Duration|0
1707|NCT02717754|9350|P1|Overall Study|Incorrect Infusion Duration|0
1708|NCT02716779|9381|P3|Combination Therapy|Adverse Event|1
1709|NCT02716779|9382|P2|Combination Therapy|Adverse Event|2
1710|NCT02716779|9383|P1|Combination Therapy|Adverse Event|0
1711|NCT02716779|9381|P3|Monotherapy|Adverse Event|1
1712|NCT02716779|9382|P2|Monotherapy|Adverse Event|1
1713|NCT02716779|9383|P1|Monotherapy|Adverse Event|0
1714|NCT02716298|9456|P2|First Intervention (1 Month)|Lens discomfort|1
1715|NCT02716298|9457|P1|First Intervention (1 Month)|Lens discomfort|1
1716|NCT02714062|9475|P3|Overall Study|Protocol Violation|0
1717|NCT02714062|9476|P2|Overall Study|Protocol Violation|1
1718|NCT02714062|9477|P1|Overall Study|Protocol Violation|0
1719|NCT02714062|9475|P3|Overall Study|Withdrawal by Subject|1
1720|NCT02714062|9476|P2|Overall Study|Withdrawal by Subject|0
1721|NCT02714062|9477|P1|Overall Study|Withdrawal by Subject|1
1722|NCT02714062|9475|P3|Overall Study|Adverse Event|2
1723|NCT02714062|9476|P2|Overall Study|Adverse Event|0
1724|NCT02714062|9477|P1|Overall Study|Adverse Event|0
1725|NCT02713594|9523|P2|Overall Study|Lost to Follow-up|374
1726|NCT02713594|9524|P1|Overall Study|Lost to Follow-up|358
1727|NCT02713594|9523|P2|Overall Study|Withdrawal by Subject|22
1728|NCT02713594|9524|P1|Overall Study|Withdrawal by Subject|32
1729|NCT02712333|9542|P2|First Period|Withdrawal by Subject|2
1730|NCT02712333|9543|P1|First Period|Withdrawal by Subject|3
1731|NCT02711995|9580|P1|Washout (90 Days)|Conflicting medication|1
1732|NCT02710292|9655|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
1733|NCT02710292|9656|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
1734|NCT02710292|9655|P2|Period 1, First 10 Days of Wear|Adverse Event|1
1735|NCT02710292|9656|P1|Period 1, First 10 Days of Wear|Adverse Event|0
1736|NCT02709577|9665|P4|Overall Study|Withdrawal by Subject|0
1737|NCT02709577|9666|P3|Overall Study|Withdrawal by Subject|2
1738|NCT02709577|9667|P2|Overall Study|Withdrawal by Subject|3
1739|NCT02709577|9668|P1|Overall Study|Withdrawal by Subject|2
1740|NCT02709577|9665|P4|Overall Study|procedural complication|0
1741|NCT02709577|9666|P3|Overall Study|procedural complication|0
1742|NCT02709577|9667|P2|Overall Study|procedural complication|1
1743|NCT02709577|9668|P1|Overall Study|procedural complication|0
1744|NCT02709577|9665|P4|Overall Study|non-accommodating anatomy|0
1745|NCT02709577|9666|P3|Overall Study|non-accommodating anatomy|0
1746|NCT02709577|9667|P2|Overall Study|non-accommodating anatomy|1
1747|NCT02709577|9668|P1|Overall Study|non-accommodating anatomy|0
1748|NCT02709096|9682|P2|Overall Study|non-compliance|1
1749|NCT02709096|9683|P1|Overall Study|non-compliance|1
1750|NCT02708524|9693|P4|Overall Study|Subject lost study lens|0
1751|NCT02708524|9694|P3|Overall Study|Subject lost study lens|0
1752|NCT02708524|9695|P2|Overall Study|Subject lost study lens|0
1753|NCT02708524|9696|P1|Overall Study|Subject lost study lens|1
1754|NCT02708524|9693|P4|Overall Study|Did not wear lens at final visit|0
1755|NCT02708524|9694|P3|Overall Study|Did not wear lens at final visit|0
1756|NCT02708524|9695|P2|Overall Study|Did not wear lens at final visit|1
1757|NCT02708524|9696|P1|Overall Study|Did not wear lens at final visit|0
1758|NCT02708524|9693|P4|Overall Study|Dispensed incorrect study lens|0
1759|NCT02708524|9694|P3|Overall Study|Dispensed incorrect study lens|1
1760|NCT02708524|9695|P2|Overall Study|Dispensed incorrect study lens|1
1761|NCT02708524|9696|P1|Overall Study|Dispensed incorrect study lens|0
1762|NCT02708524|9693|P4|Overall Study|Withdrawal by Subject|0
1763|NCT02708524|9694|P3|Overall Study|Withdrawal by Subject|0
1764|NCT02708524|9695|P2|Overall Study|Withdrawal by Subject|1
1765|NCT02708524|9696|P1|Overall Study|Withdrawal by Subject|1
1766|NCT02708524|9693|P4|Overall Study|Protocol Violation|0
1767|NCT02708524|9694|P3|Overall Study|Protocol Violation|0
1768|NCT02708524|9695|P2|Overall Study|Protocol Violation|1
1769|NCT02708524|9696|P1|Overall Study|Protocol Violation|0
1770|NCT02708524|9693|P4|Overall Study|Lost to Follow-up|0
1771|NCT02708524|9694|P3|Overall Study|Lost to Follow-up|1
1772|NCT02708524|9695|P2|Overall Study|Lost to Follow-up|1
1773|NCT02708524|9696|P1|Overall Study|Lost to Follow-up|1
1774|NCT02708524|9693|P4|Overall Study|Lens Discomfort|0
1775|NCT02708524|9694|P3|Overall Study|Lens Discomfort|1
1776|NCT02708524|9695|P2|Overall Study|Lens Discomfort|0
1777|NCT02708524|9696|P1|Overall Study|Lens Discomfort|1
1778|NCT02708524|9693|P4|Overall Study|Adverse Event|0
1779|NCT02708524|9694|P3|Overall Study|Adverse Event|0
1780|NCT02708524|9695|P2|Overall Study|Adverse Event|1
1781|NCT02708524|9696|P1|Overall Study|Adverse Event|0
1782|NCT02708355|9745|P3|Overall Study|Adverse Event|0
1783|NCT02708355|9746|P2|Overall Study|Adverse Event|0
1784|NCT02708355|9747|P1|Overall Study|Adverse Event|1
1785|NCT02708277|9760|P2|Overall Study|Lost to Follow-up|4
1786|NCT02708277|9761|P1|Overall Study|Lost to Follow-up|7
1787|NCT02707640|9804|P2|Overall Study|Sponsor Discretion|0
1788|NCT02707640|9805|P1|Overall Study|Sponsor Discretion|1
1789|NCT02707640|9804|P2|Overall Study|Participant's Personal Decision|2
1790|NCT02707640|9805|P1|Overall Study|Participant's Personal Decision|1
1791|NCT02707640|9804|P2|Overall Study|Withdrawal by Subject|1
1792|NCT02707640|9805|P1|Overall Study|Withdrawal by Subject|0
1793|NCT02707640|9804|P2|Overall Study|Physician Decision|0
1794|NCT02707640|9805|P1|Overall Study|Physician Decision|2
1795|NCT02707640|9804|P2|Overall Study|Death|2
1796|NCT02707640|9805|P1|Overall Study|Death|1
1797|NCT02707640|9804|P2|Overall Study|Adverse Event|2
1798|NCT02707640|9805|P1|Overall Study|Adverse Event|4
1799|NCT02706327|9831|P3|Overall Study|Lost to Follow-up|2
1800|NCT02706327|9832|P2|Overall Study|Lost to Follow-up|1
1801|NCT02706327|9833|P1|Overall Study|Lost to Follow-up|1
1802|NCT02705716|9885|P2|Overall Study|Withdrawal of Consent|1
1803|NCT02705716|9886|P1|Overall Study|Withdrawal of Consent|1
1804|NCT02705716|9885|P2|Overall Study|Protocol Violation|0
1805|NCT02705716|9886|P1|Overall Study|Protocol Violation|3
1806|NCT02705716|9885|P2|Overall Study|Adverse Event|1
1807|NCT02705716|9886|P1|Overall Study|Adverse Event|0
1808|NCT02704689|9907|P1|Overall Study|Study device not implanted|2
1809|NCT02704689|9907|P1|Overall Study|Physician Decision|1
1810|NCT02702011|9932|P4|Overall Study|Withdrawal by Subject|0
1811|NCT02702011|9933|P3|Overall Study|Withdrawal by Subject|0
1812|NCT02702011|9934|P2|Overall Study|Withdrawal by Subject|1
1813|NCT02702011|9935|P1|Overall Study|Withdrawal by Subject|0
1814|NCT02701361|9962|P3|Overall Study|incarceration|1
1815|NCT02701361|9963|P2|Overall Study|incarceration|0
1816|NCT02701361|9964|P1|Overall Study|incarceration|0
1817|NCT02701361|9962|P3|Overall Study|timed out in rehab center|0
1818|NCT02701361|9963|P2|Overall Study|timed out in rehab center|1
1819|NCT02701361|9964|P1|Overall Study|timed out in rehab center|0
1820|NCT02701361|9962|P3|Overall Study|Withdrawal by Subject|0
1821|NCT02701361|9963|P2|Overall Study|Withdrawal by Subject|0
1822|NCT02701361|9964|P1|Overall Study|Withdrawal by Subject|4
1823|NCT02701361|9962|P3|Overall Study|Lost to Follow-up|1
1824|NCT02701361|9963|P2|Overall Study|Lost to Follow-up|2
1825|NCT02701361|9964|P1|Overall Study|Lost to Follow-up|5
1826|NCT02701296|10005|P2|Overall Study|Incomplete Data|2
1827|NCT02701296|10006|P1|Overall Study|Incomplete Data|0
1828|NCT02699892|10039|P1|Overall Study|Other|36
1829|NCT02699684|10044|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
1830|NCT02699684|10045|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
1831|NCT02699593|10062|P2|Period 2|Torn Contact Lens|0
1832|NCT02699593|10063|P1|Period 2|Torn Contact Lens|1
1833|NCT02699593|10062|P2|Period 2|Lost Contact Lens|1
1834|NCT02699593|10063|P1|Period 2|Lost Contact Lens|0
1835|NCT02699593|10062|P2|Period 2|Adverse Event|1
1836|NCT02699593|10063|P1|Period 2|Adverse Event|1
1837|NCT02699593|10062|P2|Period 1|Adverse Event|1
1838|NCT02699593|10063|P1|Period 1|Adverse Event|1
1839|NCT02699593|10062|P2|Period 1|Withdrawal by Subject|1
1840|NCT02699593|10063|P1|Period 1|Withdrawal by Subject|0
1841|NCT02699593|10062|P2|Period 1|Protocol Violation|1
1842|NCT02699593|10063|P1|Period 1|Protocol Violation|0
1843|NCT02699593|10062|P2|Period 1|Torn Contact Len|3
1844|NCT02699593|10063|P1|Period 1|Torn Contact Len|4
1845|NCT02699593|10062|P2|Period 1|Unsatisfactory Visual Response|1
1846|NCT02699593|10063|P1|Period 1|Unsatisfactory Visual Response|0
1847|NCT02698436|10080|P2|Overall Study|Non-compliance with study regimen|0
1848|NCT02698436|10081|P1|Overall Study|Non-compliance with study regimen|1
1849|NCT02698436|10080|P2|Overall Study|Lost to Follow-up|4
1850|NCT02698436|10081|P1|Overall Study|Lost to Follow-up|2
1851|NCT02698436|10080|P2|Overall Study|Withdrawal by Subject|3
1852|NCT02698436|10081|P1|Overall Study|Withdrawal by Subject|3
1853|NCT02698436|10080|P2|Overall Study|Adverse Event|0
1854|NCT02698436|10081|P1|Overall Study|Adverse Event|1
1855|NCT02698423|10121|P2|Overall Study|Lost to Follow-up|24
1856|NCT02698423|10122|P1|Overall Study|Lost to Follow-up|19
1857|NCT02696317|10143|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
1858|NCT02696317|10144|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
1859|NCT02696317|10143|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
1860|NCT02696317|10144|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
1861|NCT02696226|10188|P4|Overall Study|Study terminated - lack of enrollment|0
1862|NCT02696226|10189|P3|Overall Study|Study terminated - lack of enrollment|2
1863|NCT02696226|10190|P2|Overall Study|Study terminated - lack of enrollment|0
1864|NCT02696226|10191|P1|Overall Study|Study terminated - lack of enrollment|1
1865|NCT02694744|10232|P2|Overall Study|Taking potassium supplement: exclusion 6|1
1866|NCT02694744|10233|P1|Overall Study|Taking potassium supplement: exclusion 6|0
1867|NCT02694744|10232|P2|Overall Study|Lost to Follow-up|0
1868|NCT02694744|10233|P1|Overall Study|Lost to Follow-up|1
1869|NCT02694744|10232|P2|Overall Study|Physician Decision|2
1870|NCT02694744|10233|P1|Overall Study|Physician Decision|1
1871|NCT02694744|10232|P2|Overall Study|Withdrawal by Subject|1
1872|NCT02694744|10233|P1|Overall Study|Withdrawal by Subject|2
1873|NCT02694744|10232|P2|Overall Study|Adverse Event|1
1874|NCT02694744|10233|P1|Overall Study|Adverse Event|2
1875|NCT02694718|10241|P1|Overall Study|Withdrawal by Subject|1
1876|NCT02694718|10241|P1|Overall Study|Death|1
1877|NCT02694536|10251|P1|Overall Study|Not Specified|22
1878|NCT02694536|10251|P1|Overall Study|Death|8
1879|NCT02694536|10251|P1|Overall Study|Withdrawal by Subject|8
1880|NCT02694536|10251|P1|Overall Study|Study Drug-Related Adverse Event|1
1881|NCT02694536|10251|P1|Overall Study|Lost to Follow-up|1
1882|NCT02694536|10251|P1|Overall Study|Progressive Disease|40
1883|NCT02692703|10304|P1|Overall Study|Not Specified|1
1884|NCT02692703|10304|P1|Overall Study|Lost to Follow-up|1
1885|NCT02692560|10312|P2|Overall Study|Withdrawal by Subject|6
1886|NCT02692560|10313|P1|Overall Study|Withdrawal by Subject|0
1887|NCT02691507|10353|P2|Overall Study|Missed Visit 3|1
1888|NCT02691507|10354|P1|Overall Study|Missed Visit 3|0
1889|NCT02690727|10529|P2|Overall Study|Adverse Event|2
1890|NCT02690727|10530|P1|Overall Study|Adverse Event|2
1891|NCT02689804|10542|P2|Overall Study|Withdrawal by Subject|0
1892|NCT02689804|10543|P1|Overall Study|Withdrawal by Subject|2
1893|NCT02689206|10574|P5|Overall Study|Withdrawal by Subject|0
1894|NCT02689206|10575|P4|Overall Study|Withdrawal by Subject|0
1895|NCT02689206|10576|P3|Overall Study|Withdrawal by Subject|1
1896|NCT02689206|10577|P2|Overall Study|Withdrawal by Subject|0
1897|NCT02689206|10578|P1|Overall Study|Withdrawal by Subject|1
1898|NCT02689206|10574|P5|Overall Study|Physician Decision|0
1899|NCT02689206|10575|P4|Overall Study|Physician Decision|0
1900|NCT02689206|10576|P3|Overall Study|Physician Decision|0
1901|NCT02689206|10577|P2|Overall Study|Physician Decision|0
1902|NCT02689206|10578|P1|Overall Study|Physician Decision|1
1903|NCT02689206|10574|P5|Overall Study|Other: Reached stopping criteria|4
1904|NCT02689206|10575|P4|Overall Study|Other: Reached stopping criteria|3
1905|NCT02689206|10576|P3|Overall Study|Other: Reached stopping criteria|2
1906|NCT02689206|10577|P2|Overall Study|Other: Reached stopping criteria|1
1907|NCT02689206|10578|P1|Overall Study|Other: Reached stopping criteria|0
1908|NCT02689206|10574|P5|Overall Study|Protocol Violation|2
1909|NCT02689206|10575|P4|Overall Study|Protocol Violation|1
1910|NCT02689206|10576|P3|Overall Study|Protocol Violation|0
1911|NCT02689206|10577|P2|Overall Study|Protocol Violation|0
1912|NCT02689206|10578|P1|Overall Study|Protocol Violation|1
1913|NCT02689206|10574|P5|Overall Study|Adverse Event|2
1914|NCT02689206|10575|P4|Overall Study|Adverse Event|0
1915|NCT02689206|10576|P3|Overall Study|Adverse Event|1
1916|NCT02689206|10577|P2|Overall Study|Adverse Event|0
1917|NCT02689206|10578|P1|Overall Study|Adverse Event|0
1918|NCT02685488|10815|P2|Overall Study|Withdrawal by Subject|1
1919|NCT02685488|10816|P1|Overall Study|Withdrawal by Subject|0
1920|NCT02685202|10830|P1|Overall Study|Lost to Follow-up|9
1921|NCT02683746|10976|P2|Overall Study|Physician Decision|1
1922|NCT02683746|10977|P1|Overall Study|Physician Decision|2
1923|NCT02683746|10976|P2|Overall Study|Withdrawal by Subject|5
1924|NCT02683746|10977|P1|Overall Study|Withdrawal by Subject|6
1925|NCT02683746|10976|P2|Overall Study|Lost to Follow-up|6
1926|NCT02683746|10977|P1|Overall Study|Lost to Follow-up|5
1927|NCT02683746|10976|P2|Overall Study|Adverse Event|2
1928|NCT02683746|10977|P1|Overall Study|Adverse Event|3
1929|NCT02681510|11088|P1|Overall Study|Lost to Follow-up|9
1930|NCT02681510|11088|P1|Overall Study|Withdrawal by Subject|1
1931|NCT02678923|11121|P2|Overall Study|Did Not Return for Study Visits|0
1932|NCT02678923|11122|P1|Overall Study|Did Not Return for Study Visits|1
1933|NCT02678923|11121|P2|Overall Study|Lost to Follow-up|0
1934|NCT02678923|11122|P1|Overall Study|Lost to Follow-up|1
1935|NCT02678923|11121|P2|Overall Study|Withdrawal by Subject|2
1936|NCT02678923|11122|P1|Overall Study|Withdrawal by Subject|3
1937|NCT02678923|11121|P2|Overall Study|Protocol Deviation (Not Dosed)|3
1938|NCT02678923|11122|P1|Overall Study|Protocol Deviation (Not Dosed)|1
1939|NCT02678676|11138|P2|Overall Study|Unconfirmed for lost to follow-up|67
1940|NCT02678676|11139|P1|Overall Study|Unconfirmed for lost to follow-up|85
1941|NCT02678676|11138|P2|Overall Study|Lost to Follow-up|151
1942|NCT02678676|11139|P1|Overall Study|Lost to Follow-up|171
1943|NCT02678676|11138|P2|Overall Study|Withdrawal by Subject|5
1944|NCT02678676|11139|P1|Overall Study|Withdrawal by Subject|13
1945|NCT02678676|11138|P2|Overall Study|Death|649
1946|NCT02678676|11139|P1|Overall Study|Death|619
1947|NCT02678286|11149|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1948|NCT02678286|11150|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1949|NCT02678286|11149|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
1950|NCT02678286|11150|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
1951|NCT02678286|11149|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
1952|NCT02678286|11150|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
1953|NCT02678286|11149|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
1954|NCT02678286|11150|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
1955|NCT02678286|11149|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
1956|NCT02678286|11150|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
1957|NCT02675907|11232|P2|Study Overall|Lost to Follow-up|2
1958|NCT02675907|11233|P1|Study Overall|Lost to Follow-up|0
1959|NCT02675907|11232|P2|Study Overall|Withdrawal by Subject|2
1960|NCT02675907|11233|P1|Study Overall|Withdrawal by Subject|2
1961|NCT02675907|11232|P2|Study Overall|Lack of Efficacy|0
1962|NCT02675907|11233|P1|Study Overall|Lack of Efficacy|1
1963|NCT02675907|11232|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1964|NCT02675907|11233|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1965|NCT02675907|11232|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1966|NCT02675907|11233|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1967|NCT02675634|11263|P6|Test Period 2|Adverse Event|1
1968|NCT02675634|11264|P5|Test Period 2|Adverse Event|0
1969|NCT02675634|11265|P4|Test Period 2|Adverse Event|0
1970|NCT02675634|11266|P3|Test Period 2|Adverse Event|0
1971|NCT02675634|11267|P2|Test Period 2|Adverse Event|0
1972|NCT02675634|11268|P1|Test Period 2|Adverse Event|0
1973|NCT02675634|11263|P6|Test Period 2|Lack of Efficacy|0
1974|NCT02675634|11264|P5|Test Period 2|Lack of Efficacy|0
1975|NCT02675634|11265|P4|Test Period 2|Lack of Efficacy|0
1976|NCT02675634|11266|P3|Test Period 2|Lack of Efficacy|0
1977|NCT02675634|11267|P2|Test Period 2|Lack of Efficacy|0
1978|NCT02675634|11268|P1|Test Period 2|Lack of Efficacy|1
1979|NCT02675634|11263|P6|Test Period 1|Device deficiency that did not lead to A|0
1980|NCT02675634|11264|P5|Test Period 1|Device deficiency that did not lead to A|0
1981|NCT02675634|11265|P4|Test Period 1|Device deficiency that did not lead to A|0
1982|NCT02675634|11266|P3|Test Period 1|Device deficiency that did not lead to A|1
1983|NCT02675634|11267|P2|Test Period 1|Device deficiency that did not lead to A|0
1984|NCT02675634|11268|P1|Test Period 1|Device deficiency that did not lead to A|0
1985|NCT02675634|11263|P6|Test Period 1|Adverse Event|0
1986|NCT02675634|11264|P5|Test Period 1|Adverse Event|0
1987|NCT02675634|11265|P4|Test Period 1|Adverse Event|1
1988|NCT02675634|11266|P3|Test Period 1|Adverse Event|0
1989|NCT02675634|11267|P2|Test Period 1|Adverse Event|1
1990|NCT02675634|11268|P1|Test Period 1|Adverse Event|0
1991|NCT02674334|11287|P2|Overall Study|NIRS not recording|0
1992|NCT02674334|11288|P1|Overall Study|NIRS not recording|1
1993|NCT02674334|11287|P2|Overall Study|participant difficulty breathing|0
1994|NCT02674334|11288|P1|Overall Study|participant difficulty breathing|1
1995|NCT02674334|11287|P2|Overall Study|Lost to Follow-up|3
1996|NCT02674334|11288|P1|Overall Study|Lost to Follow-up|5
1997|NCT02673619|11305|P4|Overall Study|Lack of Efficacy|0
1998|NCT02673619|11306|P3|Overall Study|Lack of Efficacy|1
1999|NCT02673619|11307|P2|Overall Study|Lack of Efficacy|0
2000|NCT02673619|11308|P1|Overall Study|Lack of Efficacy|0
2001|NCT02673619|11305|P4|Overall Study|Adverse Event|0
2002|NCT02673619|11306|P3|Overall Study|Adverse Event|1
2003|NCT02673619|11307|P2|Overall Study|Adverse Event|0
2004|NCT02673619|11308|P1|Overall Study|Adverse Event|0
2005|NCT02673619|11305|P4|Overall Study|Withdrawal by Subject|0
2006|NCT02673619|11306|P3|Overall Study|Withdrawal by Subject|1
2007|NCT02673619|11307|P2|Overall Study|Withdrawal by Subject|1
2008|NCT02673619|11308|P1|Overall Study|Withdrawal by Subject|1
2009|NCT02673619|11305|P4|Overall Study|Lost to Follow-up|0
2010|NCT02673619|11306|P3|Overall Study|Lost to Follow-up|0
2011|NCT02673619|11307|P2|Overall Study|Lost to Follow-up|0
2012|NCT02673619|11308|P1|Overall Study|Lost to Follow-up|1
2013|NCT02673489|11400|P2|Follow Up Period|Unable to return for follow-up|1
2014|NCT02673489|11401|P1|Follow Up Period|Unable to return for follow-up|0
2015|NCT02673489|11400|P2|Follow Up Period|Unable to return for week 24 follow-up|1
2016|NCT02673489|11401|P1|Follow Up Period|Unable to return for week 24 follow-up|0
2017|NCT02673489|11400|P2|Treatment Period|Adverse Event|1
2018|NCT02673489|11401|P1|Treatment Period|Adverse Event|0
2019|NCT02673489|11400|P2|Treatment Period|Participant was incarcerated|1
2020|NCT02673489|11401|P1|Treatment Period|Participant was incarcerated|0
2021|NCT02673489|11400|P2|Treatment Period|Participant moved to another province|0
2022|NCT02673489|11401|P1|Treatment Period|Participant moved to another province|1
2023|NCT02673489|11400|P2|Treatment Period|Participant request to discontinue|1
2024|NCT02673489|11401|P1|Treatment Period|Participant request to discontinue|1
2025|NCT02673489|11400|P2|Treatment Period|Lost to Follow-up|0
2026|NCT02673489|11401|P1|Treatment Period|Lost to Follow-up|3
2027|NCT02671760|11423|P3|Overall Study|Lost to Follow-up|0
2028|NCT02671760|11424|P2|Overall Study|Lost to Follow-up|1
2029|NCT02671760|11425|P1|Overall Study|Lost to Follow-up|0
2030|NCT02670473|11470|P1|Overall Study|Withdrawal by Subject|1
2031|NCT02669095|11529|P2|Overall Study|Visit 5 assessments not completed|1
2032|NCT02669095|11530|P1|Overall Study|Visit 5 assessments not completed|0
2033|NCT02669095|11529|P2|Overall Study|Torn Lens|1
2034|NCT02669095|11530|P1|Overall Study|Torn Lens|0
2035|NCT02669095|11529|P2|Overall Study|Unsatisfactory Lens Fitting|1
2036|NCT02669095|11530|P1|Overall Study|Unsatisfactory Lens Fitting|0
2037|NCT02669095|11529|P2|Overall Study|Adverse Event|0
2038|NCT02669095|11530|P1|Overall Study|Adverse Event|1
2039|NCT02669043|11538|P1|Overall Study|Didn't meet I/E criteria|4
2040|NCT02668822|11565|P2|Overall Study|Study Terminated by Sponsor|9
2041|NCT02668822|11566|P1|Overall Study|Study Terminated by Sponsor|7
2042|NCT02668822|11565|P2|Overall Study|Protocol Violation|0
2043|NCT02668822|11566|P1|Overall Study|Protocol Violation|2
2044|NCT02668783|11588|P2|Overall Study|Withdrawal by Subject|0
2045|NCT02668783|11589|P1|Overall Study|Withdrawal by Subject|1
2046|NCT02668783|11588|P2|Overall Study|Subject moved|0
2047|NCT02668783|11589|P1|Overall Study|Subject moved|1
2048|NCT02668783|11588|P2|Overall Study|Study terminated by sponsor|10
2049|NCT02668783|11589|P1|Overall Study|Study terminated by sponsor|9
2050|NCT02668783|11588|P2|Overall Study|Protocol Violation|1
2051|NCT02668783|11589|P1|Overall Study|Protocol Violation|2
2052|NCT02668783|11588|P2|Overall Study|Pregnancy|1
2053|NCT02668783|11589|P1|Overall Study|Pregnancy|0
2054|NCT02667288|11626|P1|Overall Study|Withdrawal by Subject|5
2055|NCT02667288|11626|P1|Overall Study|Lost to Follow-up|3
2056|NCT02667288|11626|P1|Overall Study|Protocol Violation|5
2057|NCT02667275|11633|P2|Overall Study|Discontinued early without completing|1
2058|NCT02667275|11634|P1|Overall Study|Discontinued early without completing|0
2059|NCT02667275|11633|P2|Overall Study|Withdrawal by Subject|5
2060|NCT02667275|11634|P1|Overall Study|Withdrawal by Subject|0
2061|NCT02667275|11633|P2|Overall Study|Lost to Follow-up|2
2062|NCT02667275|11634|P1|Overall Study|Lost to Follow-up|0
2063|NCT02667275|11633|P2|Overall Study|Protocol Violation|7
2064|NCT02667275|11634|P1|Overall Study|Protocol Violation|11
2065|NCT02667236|11644|P2|Overall Study|Withdrawal by Subject|0
2066|NCT02667236|11645|P1|Overall Study|Withdrawal by Subject|2
2067|NCT02667236|11644|P2|Overall Study|Adverse Event|1
2068|NCT02667236|11645|P1|Overall Study|Adverse Event|1
2069|NCT02666222|11670|P1|Overall Study|Death|2
2070|NCT02665455|11678|P1|Overall Study|Protocol Violation|1
2071|NCT02665455|11678|P1|Overall Study|Adverse Event|1
2072|NCT02665455|11678|P1|Overall Study|Lost to Follow-up|1
2073|NCT02665455|11678|P1|Overall Study|Withdrawal by Subject|6
2074|NCT02663453|11768|P2|Overall Study|Withdrawal by Subject|0
2075|NCT02663453|11769|P1|Overall Study|Withdrawal by Subject|1
2076|NCT02663453|11768|P2|Overall Study|Death|4
2077|NCT02663453|11769|P1|Overall Study|Death|4
2078|NCT02662556|11816|P1|Overall Study|Lack of Efficacy|4
2079|NCT02662556|11816|P1|Overall Study|Adverse Event|4
2080|NCT02661594|11838|P4|Overall Study|Protocol Violation|0
2081|NCT02661594|11839|P3|Overall Study|Protocol Violation|1
2082|NCT02661594|11840|P2|Overall Study|Protocol Violation|0
2083|NCT02661594|11841|P1|Overall Study|Protocol Violation|1
2084|NCT02658149|11884|P2|Overall Study|Physician Decision|0
2085|NCT02658149|11885|P1|Overall Study|Physician Decision|1
2086|NCT02657031|11930|P2|Overall Study|Adverse Event|2
2087|NCT02657031|11931|P1|Overall Study|Adverse Event|1
2088|NCT02654145|11973|P1|Overall Study|Withdrawal by Subject|5
2089|NCT02654145|11973|P1|Overall Study|Protocol Violation|1
2090|NCT02654145|11973|P1|Overall Study|Lack of Efficacy|1
2091|NCT02653495|12030|P2|Overall Study|Screening Failure|0
2092|NCT02653495|12031|P1|Overall Study|Screening Failure|10
2093|NCT02653495|12030|P2|Overall Study|Lost to Follow-up|0
2094|NCT02653495|12031|P1|Overall Study|Lost to Follow-up|2
2095|NCT02651922|12065|P1|Overall Study|due to exclusion criteria|2
2096|NCT02651467|12085|P3|Overall Study|Other (Not specified)|2
2097|NCT02651467|12086|P2|Overall Study|Other (Not specified)|0
2098|NCT02651467|12087|P1|Overall Study|Other (Not specified)|1
2099|NCT02651467|12085|P3|Overall Study|Withdrawal by Subject|2
2100|NCT02651467|12086|P2|Overall Study|Withdrawal by Subject|0
2101|NCT02651467|12087|P1|Overall Study|Withdrawal by Subject|0
2102|NCT02651194|12106|P1|Overall Study|Not Specified|2
2103|NCT02651194|12106|P1|Overall Study|Lost to Follow-up|3
2104|NCT02649634|12146|P2|Overall Study|Lost to Follow-up|1
2105|NCT02649634|12147|P1|Overall Study|Lost to Follow-up|0
2106|NCT02649634|12146|P2|Overall Study|Withdrawal by Subject|5
2107|NCT02649634|12147|P1|Overall Study|Withdrawal by Subject|3
2108|NCT02648438|12206|P3|Overall Study|Withdrawal by Subject|0
2109|NCT02648438|12207|P2|Overall Study|Withdrawal by Subject|1
2110|NCT02648438|12208|P1|Overall Study|Withdrawal by Subject|1
2111|NCT02648438|12206|P3|Overall Study|Protocol Violation|0
2112|NCT02648438|12207|P2|Overall Study|Protocol Violation|0
2113|NCT02648438|12208|P1|Overall Study|Protocol Violation|2
2114|NCT02648438|12206|P3|Overall Study|Eligibility criteria not fulfilled|0
2115|NCT02648438|12207|P2|Overall Study|Eligibility criteria not fulfilled|2
2116|NCT02648438|12208|P1|Overall Study|Eligibility criteria not fulfilled|0
2117|NCT02648204|12252|P4|Overall Study|Adverse Event|0
2118|NCT02648204|12253|P3|Overall Study|Adverse Event|1
2119|NCT02648204|12254|P2|Overall Study|Adverse Event|0
2120|NCT02648204|12255|P1|Overall Study|Adverse Event|0
2121|NCT02648204|12252|P4|Overall Study|Death|2
2122|NCT02648204|12253|P3|Overall Study|Death|2
2123|NCT02648204|12254|P2|Overall Study|Death|1
2124|NCT02648204|12255|P1|Overall Study|Death|1
2125|NCT02648204|12252|P4|Overall Study|Missing follow-up information|2
2126|NCT02648204|12253|P3|Overall Study|Missing follow-up information|4
2127|NCT02648204|12254|P2|Overall Study|Missing follow-up information|4
2128|NCT02648204|12255|P1|Overall Study|Missing follow-up information|4
2129|NCT02648204|12252|P4|Overall Study|Lost to Follow-up|6
2130|NCT02648204|12253|P3|Overall Study|Lost to Follow-up|4
2131|NCT02648204|12254|P2|Overall Study|Lost to Follow-up|8
2132|NCT02648204|12255|P1|Overall Study|Lost to Follow-up|5
2133|NCT02648204|12252|P4|Overall Study|Withdrawal by Subject|6
2134|NCT02648204|12253|P3|Overall Study|Withdrawal by Subject|2
2135|NCT02648204|12254|P2|Overall Study|Withdrawal by Subject|8
2136|NCT02648204|12255|P1|Overall Study|Withdrawal by Subject|12
2137|NCT02647944|12388|P2|Overall Study|Adverse Event|0
2138|NCT02647944|12389|P1|Overall Study|Adverse Event|2
2139|NCT02647944|12388|P2|Overall Study|Withdrawal by Subject|3
2140|NCT02647944|12389|P1|Overall Study|Withdrawal by Subject|0
2141|NCT02647320|12418|P5|Overall Study|Disposition Missing Due to Fire at Site|4
2142|NCT02647320|12419|P4|Overall Study|Disposition Missing Due to Fire at Site|3
2143|NCT02647320|12420|P3|Overall Study|Disposition Missing Due to Fire at Site|4
2144|NCT02647320|12421|P2|Overall Study|Disposition Missing Due to Fire at Site|3
2145|NCT02647320|12422|P1|Overall Study|Disposition Missing Due to Fire at Site|2
2146|NCT02647320|12418|P5|Overall Study|Lack of Efficacy|0
2147|NCT02647320|12419|P4|Overall Study|Lack of Efficacy|1
2148|NCT02647320|12420|P3|Overall Study|Lack of Efficacy|0
2149|NCT02647320|12421|P2|Overall Study|Lack of Efficacy|0
2150|NCT02647320|12422|P1|Overall Study|Lack of Efficacy|0
2151|NCT02647320|12418|P5|Overall Study|Develop anemia|0
2152|NCT02647320|12419|P4|Overall Study|Develop anemia|0
2153|NCT02647320|12420|P3|Overall Study|Develop anemia|0
2154|NCT02647320|12421|P2|Overall Study|Develop anemia|0
2155|NCT02647320|12422|P1|Overall Study|Develop anemia|1
2156|NCT02647320|12418|P5|Overall Study|Lost to Follow-up|0
2157|NCT02647320|12419|P4|Overall Study|Lost to Follow-up|0
2158|NCT02647320|12420|P3|Overall Study|Lost to Follow-up|0
2159|NCT02647320|12421|P2|Overall Study|Lost to Follow-up|1
2160|NCT02647320|12422|P1|Overall Study|Lost to Follow-up|1
2161|NCT02647320|12418|P5|Overall Study|Reason not provided|2
2162|NCT02647320|12419|P4|Overall Study|Reason not provided|0
2163|NCT02647320|12420|P3|Overall Study|Reason not provided|1
2164|NCT02647320|12421|P2|Overall Study|Reason not provided|0
2165|NCT02647320|12422|P1|Overall Study|Reason not provided|0
2166|NCT02647320|12418|P5|Overall Study|Study terminated by sponsor|2
2167|NCT02647320|12419|P4|Overall Study|Study terminated by sponsor|1
2168|NCT02647320|12420|P3|Overall Study|Study terminated by sponsor|1
2169|NCT02647320|12421|P2|Overall Study|Study terminated by sponsor|1
2170|NCT02647320|12422|P1|Overall Study|Study terminated by sponsor|1
2171|NCT02647320|12418|P5|Overall Study|Persistent hyperglycemia|1
2172|NCT02647320|12419|P4|Overall Study|Persistent hyperglycemia|1
2173|NCT02647320|12420|P3|Overall Study|Persistent hyperglycemia|1
2174|NCT02647320|12421|P2|Overall Study|Persistent hyperglycemia|1
2175|NCT02647320|12422|P1|Overall Study|Persistent hyperglycemia|0
2176|NCT02647320|12418|P5|Overall Study|Withdrawal by Subject|7
2177|NCT02647320|12419|P4|Overall Study|Withdrawal by Subject|2
2178|NCT02647320|12420|P3|Overall Study|Withdrawal by Subject|2
2179|NCT02647320|12421|P2|Overall Study|Withdrawal by Subject|4
2180|NCT02647320|12422|P1|Overall Study|Withdrawal by Subject|7
2181|NCT02647320|12418|P5|Overall Study|Protocol Violation|0
2182|NCT02647320|12419|P4|Overall Study|Protocol Violation|0
2183|NCT02647320|12420|P3|Overall Study|Protocol Violation|3
2184|NCT02647320|12421|P2|Overall Study|Protocol Violation|0
2185|NCT02647320|12422|P1|Overall Study|Protocol Violation|0
2186|NCT02647320|12418|P5|Overall Study|Adverse Event|1
2187|NCT02647320|12419|P4|Overall Study|Adverse Event|2
2188|NCT02647320|12420|P3|Overall Study|Adverse Event|3
2189|NCT02647320|12421|P2|Overall Study|Adverse Event|1
2190|NCT02647320|12422|P1|Overall Study|Adverse Event|0
2191|NCT02644356|12678|P1|Overall Study|Withdrawal by Subject|2
2192|NCT02644109|12690|P2|Overall Study|Adverse Event|4
2193|NCT02644109|12691|P1|Overall Study|Adverse Event|0
2194|NCT02644096|12699|P2|Overall Study|Withdrawal by Subject|25
2195|NCT02644096|12700|P1|Overall Study|Withdrawal by Subject|28
2196|NCT02643394|12734|P2|Overall Study|Protocol Violation|5
2197|NCT02643394|12735|P1|Overall Study|Protocol Violation|4
2198|NCT02643251|12745|P2|Overall Study|PI Decision to terminate patient|0
2199|NCT02643251|12746|P1|Overall Study|PI Decision to terminate patient|1
2200|NCT02643251|12745|P2|Overall Study|Protocol Violation|0
2201|NCT02643251|12746|P1|Overall Study|Protocol Violation|1
2202|NCT02643251|12745|P2|Overall Study|Lost to Follow-up|1
2203|NCT02643251|12746|P1|Overall Study|Lost to Follow-up|4
2204|NCT02643251|12745|P2|Overall Study|Withdrawal by Subject|0
2205|NCT02643251|12746|P1|Overall Study|Withdrawal by Subject|2
2206|NCT02643251|12745|P2|Overall Study|Adverse Event|1
2207|NCT02643251|12746|P1|Overall Study|Adverse Event|3
2208|NCT02642679|12828|P1|Overall Study|Physician Decision|1
2209|NCT02642679|12828|P1|Overall Study|Physician Decision|1
2210|NCT02642679|12828|P1|Overall Study|Withdrawal by Subject|1
2211|NCT02642432|12869|P1|Overall Study|Not Specified|3
2212|NCT02642432|12869|P1|Overall Study|Lost to Follow-up|2
2213|NCT02642432|12869|P1|Overall Study|Withdrew Consent|1
2214|NCT02642432|12869|P1|Overall Study|Adverse Event|2
2215|NCT02642159|12877|P2|Overall Study|Other than specified above|3
2216|NCT02642159|12878|P1|Overall Study|Other than specified above|10
2217|NCT02642159|12877|P2|Overall Study|Poor compliance to study protocol|0
2218|NCT02642159|12878|P1|Overall Study|Poor compliance to study protocol|1
2219|NCT02642159|12877|P2|Overall Study|Withdrawal by Subject|1
2220|NCT02642159|12878|P1|Overall Study|Withdrawal by Subject|9
2221|NCT02642159|12877|P2|Overall Study|Adverse Event|4
2222|NCT02642159|12878|P1|Overall Study|Adverse Event|10
2223|NCT02642159|12877|P2|Overall Study|Randomized but not treated|0
2224|NCT02642159|12878|P1|Overall Study|Randomized but not treated|1
2225|NCT02641379|13103|P11|Overall Study|PCR positive|0
2226|NCT02641379|13104|P10|Overall Study|PCR positive|0
2227|NCT02641379|13105|P9|Overall Study|PCR positive|0
2228|NCT02641379|13106|P8|Overall Study|PCR positive|0
2229|NCT02641379|13107|P7|Overall Study|PCR positive|1
2230|NCT02641379|13108|P6|Overall Study|PCR positive|0
2231|NCT02641379|13109|P5|Overall Study|PCR positive|0
2232|NCT02641379|13110|P4|Overall Study|PCR positive|0
2233|NCT02641379|13111|P3|Overall Study|PCR positive|0
2234|NCT02641379|13112|P2|Overall Study|PCR positive|0
2235|NCT02641379|13113|P1|Overall Study|PCR positive|0
2236|NCT02641379|13103|P11|Overall Study|Missing PCR result at Week 8|0
2237|NCT02641379|13104|P10|Overall Study|Missing PCR result at Week 8|1
2238|NCT02641379|13105|P9|Overall Study|Missing PCR result at Week 8|0
2239|NCT02641379|13106|P8|Overall Study|Missing PCR result at Week 8|0
2240|NCT02641379|13107|P7|Overall Study|Missing PCR result at Week 8|0
2241|NCT02641379|13108|P6|Overall Study|Missing PCR result at Week 8|0
2242|NCT02641379|13109|P5|Overall Study|Missing PCR result at Week 8|0
2243|NCT02641379|13110|P4|Overall Study|Missing PCR result at Week 8|0
2244|NCT02641379|13111|P3|Overall Study|Missing PCR result at Week 8|0
2245|NCT02641379|13112|P2|Overall Study|Missing PCR result at Week 8|0
2246|NCT02641379|13113|P1|Overall Study|Missing PCR result at Week 8|0
2247|NCT02641379|13103|P11|Overall Study|Participant treated after Week 24|0
2248|NCT02641379|13104|P10|Overall Study|Participant treated after Week 24|0
2249|NCT02641379|13105|P9|Overall Study|Participant treated after Week 24|1
2250|NCT02641379|13106|P8|Overall Study|Participant treated after Week 24|0
2251|NCT02641379|13107|P7|Overall Study|Participant treated after Week 24|0
2252|NCT02641379|13108|P6|Overall Study|Participant treated after Week 24|0
2253|NCT02641379|13109|P5|Overall Study|Participant treated after Week 24|0
2254|NCT02641379|13110|P4|Overall Study|Participant treated after Week 24|0
2255|NCT02641379|13111|P3|Overall Study|Participant treated after Week 24|0
2256|NCT02641379|13112|P2|Overall Study|Participant treated after Week 24|0
2257|NCT02641379|13113|P1|Overall Study|Participant treated after Week 24|0
2258|NCT02641379|13103|P11|Overall Study|Participant’s PCR high|0
2259|NCT02641379|13104|P10|Overall Study|Participant’s PCR high|0
2260|NCT02641379|13105|P9|Overall Study|Participant’s PCR high|0
2261|NCT02641379|13106|P8|Overall Study|Participant’s PCR high|1
2262|NCT02641379|13107|P7|Overall Study|Participant’s PCR high|0
2263|NCT02641379|13108|P6|Overall Study|Participant’s PCR high|0
2264|NCT02641379|13109|P5|Overall Study|Participant’s PCR high|0
2265|NCT02641379|13110|P4|Overall Study|Participant’s PCR high|0
2266|NCT02641379|13111|P3|Overall Study|Participant’s PCR high|0
2267|NCT02641379|13112|P2|Overall Study|Participant’s PCR high|0
2268|NCT02641379|13113|P1|Overall Study|Participant’s PCR high|0
2269|NCT02641379|13103|P11|Overall Study|Negative PCR result|0
2270|NCT02641379|13104|P10|Overall Study|Negative PCR result|1
2271|NCT02641379|13105|P9|Overall Study|Negative PCR result|0
2272|NCT02641379|13106|P8|Overall Study|Negative PCR result|0
2273|NCT02641379|13107|P7|Overall Study|Negative PCR result|0
2274|NCT02641379|13108|P6|Overall Study|Negative PCR result|0
2275|NCT02641379|13109|P5|Overall Study|Negative PCR result|0
2276|NCT02641379|13110|P4|Overall Study|Negative PCR result|0
2277|NCT02641379|13111|P3|Overall Study|Negative PCR result|0
2278|NCT02641379|13112|P2|Overall Study|Negative PCR result|0
2279|NCT02641379|13113|P1|Overall Study|Negative PCR result|0
2280|NCT02641379|13103|P11|Overall Study|No 2 Log drop at Week 12|1
2281|NCT02641379|13104|P10|Overall Study|No 2 Log drop at Week 12|0
2282|NCT02641379|13105|P9|Overall Study|No 2 Log drop at Week 12|0
2283|NCT02641379|13106|P8|Overall Study|No 2 Log drop at Week 12|0
2284|NCT02641379|13107|P7|Overall Study|No 2 Log drop at Week 12|0
2285|NCT02641379|13108|P6|Overall Study|No 2 Log drop at Week 12|0
2286|NCT02641379|13109|P5|Overall Study|No 2 Log drop at Week 12|0
2287|NCT02641379|13110|P4|Overall Study|No 2 Log drop at Week 12|0
2288|NCT02641379|13111|P3|Overall Study|No 2 Log drop at Week 12|0
2289|NCT02641379|13112|P2|Overall Study|No 2 Log drop at Week 12|0
2290|NCT02641379|13113|P1|Overall Study|No 2 Log drop at Week 12|0
2291|NCT02641379|13103|P11|Overall Study|Non-response Week 12|0
2292|NCT02641379|13104|P10|Overall Study|Non-response Week 12|0
2293|NCT02641379|13105|P9|Overall Study|Non-response Week 12|0
2294|NCT02641379|13106|P8|Overall Study|Non-response Week 12|1
2295|NCT02641379|13107|P7|Overall Study|Non-response Week 12|0
2296|NCT02641379|13108|P6|Overall Study|Non-response Week 12|0
2297|NCT02641379|13109|P5|Overall Study|Non-response Week 12|0
2298|NCT02641379|13110|P4|Overall Study|Non-response Week 12|0
2299|NCT02641379|13111|P3|Overall Study|Non-response Week 12|0
2300|NCT02641379|13112|P2|Overall Study|Non-response Week 12|0
2301|NCT02641379|13113|P1|Overall Study|Non-response Week 12|0
2302|NCT02641379|13103|P11|Overall Study|Participant showed weight reduction|0
2303|NCT02641379|13104|P10|Overall Study|Participant showed weight reduction|0
2304|NCT02641379|13105|P9|Overall Study|Participant showed weight reduction|0
2305|NCT02641379|13106|P8|Overall Study|Participant showed weight reduction|1
2306|NCT02641379|13107|P7|Overall Study|Participant showed weight reduction|0
2307|NCT02641379|13108|P6|Overall Study|Participant showed weight reduction|0
2308|NCT02641379|13109|P5|Overall Study|Participant showed weight reduction|0
2309|NCT02641379|13110|P4|Overall Study|Participant showed weight reduction|0
2310|NCT02641379|13111|P3|Overall Study|Participant showed weight reduction|0
2311|NCT02641379|13112|P2|Overall Study|Participant showed weight reduction|0
2312|NCT02641379|13113|P1|Overall Study|Participant showed weight reduction|0
2313|NCT02641379|13103|P11|Overall Study|Source data not found|0
2314|NCT02641379|13104|P10|Overall Study|Source data not found|0
2315|NCT02641379|13105|P9|Overall Study|Source data not found|0
2316|NCT02641379|13106|P8|Overall Study|Source data not found|0
2317|NCT02641379|13107|P7|Overall Study|Source data not found|0
2318|NCT02641379|13108|P6|Overall Study|Source data not found|1
2319|NCT02641379|13109|P5|Overall Study|Source data not found|0
2320|NCT02641379|13110|P4|Overall Study|Source data not found|0
2321|NCT02641379|13111|P3|Overall Study|Source data not found|0
2322|NCT02641379|13112|P2|Overall Study|Source data not found|0
2323|NCT02641379|13113|P1|Overall Study|Source data not found|0
2324|NCT02641379|13103|P11|Overall Study|Lost to Follow-up|0
2325|NCT02641379|13104|P10|Overall Study|Lost to Follow-up|0
2326|NCT02641379|13105|P9|Overall Study|Lost to Follow-up|1
2327|NCT02641379|13106|P8|Overall Study|Lost to Follow-up|0
2328|NCT02641379|13107|P7|Overall Study|Lost to Follow-up|0
2329|NCT02641379|13108|P6|Overall Study|Lost to Follow-up|0
2330|NCT02641379|13109|P5|Overall Study|Lost to Follow-up|0
2331|NCT02641379|13110|P4|Overall Study|Lost to Follow-up|0
2332|NCT02641379|13111|P3|Overall Study|Lost to Follow-up|0
2333|NCT02641379|13112|P2|Overall Study|Lost to Follow-up|0
2334|NCT02641379|13113|P1|Overall Study|Lost to Follow-up|0
2335|NCT02641379|13103|P11|Overall Study|Participation in sili rescue study|0
2336|NCT02641379|13104|P10|Overall Study|Participation in sili rescue study|0
2337|NCT02641379|13105|P9|Overall Study|Participation in sili rescue study|0
2338|NCT02641379|13106|P8|Overall Study|Participation in sili rescue study|0
2339|NCT02641379|13107|P7|Overall Study|Participation in sili rescue study|0
2340|NCT02641379|13108|P6|Overall Study|Participation in sili rescue study|1
2341|NCT02641379|13109|P5|Overall Study|Participation in sili rescue study|0
2342|NCT02641379|13110|P4|Overall Study|Participation in sili rescue study|0
2343|NCT02641379|13111|P3|Overall Study|Participation in sili rescue study|0
2344|NCT02641379|13112|P2|Overall Study|Participation in sili rescue study|0
2345|NCT02641379|13113|P1|Overall Study|Participation in sili rescue study|0
2346|NCT02641379|13103|P11|Overall Study|Protocol Violation|0
2347|NCT02641379|13104|P10|Overall Study|Protocol Violation|0
2348|NCT02641379|13105|P9|Overall Study|Protocol Violation|1
2349|NCT02641379|13106|P8|Overall Study|Protocol Violation|0
2350|NCT02641379|13107|P7|Overall Study|Protocol Violation|0
2351|NCT02641379|13108|P6|Overall Study|Protocol Violation|0
2352|NCT02641379|13109|P5|Overall Study|Protocol Violation|2
2353|NCT02641379|13110|P4|Overall Study|Protocol Violation|0
2354|NCT02641379|13111|P3|Overall Study|Protocol Violation|0
2355|NCT02641379|13112|P2|Overall Study|Protocol Violation|0
2356|NCT02641379|13113|P1|Overall Study|Protocol Violation|0
2357|NCT02641379|13103|P11|Overall Study|Blood could not be drawn|0
2358|NCT02641379|13104|P10|Overall Study|Blood could not be drawn|0
2359|NCT02641379|13105|P9|Overall Study|Blood could not be drawn|0
2360|NCT02641379|13106|P8|Overall Study|Blood could not be drawn|0
2361|NCT02641379|13107|P7|Overall Study|Blood could not be drawn|0
2362|NCT02641379|13108|P6|Overall Study|Blood could not be drawn|0
2363|NCT02641379|13109|P5|Overall Study|Blood could not be drawn|1
2364|NCT02641379|13110|P4|Overall Study|Blood could not be drawn|0
2365|NCT02641379|13111|P3|Overall Study|Blood could not be drawn|0
2366|NCT02641379|13112|P2|Overall Study|Blood could not be drawn|0
2367|NCT02641379|13113|P1|Overall Study|Blood could not be drawn|0
2368|NCT02641379|13103|P11|Overall Study|Baseline viral load unavailable|0
2369|NCT02641379|13104|P10|Overall Study|Baseline viral load unavailable|0
2370|NCT02641379|13105|P9|Overall Study|Baseline viral load unavailable|0
2371|NCT02641379|13106|P8|Overall Study|Baseline viral load unavailable|0
2372|NCT02641379|13107|P7|Overall Study|Baseline viral load unavailable|0
2373|NCT02641379|13108|P6|Overall Study|Baseline viral load unavailable|0
2374|NCT02641379|13109|P5|Overall Study|Baseline viral load unavailable|0
2375|NCT02641379|13110|P4|Overall Study|Baseline viral load unavailable|1
2376|NCT02641379|13111|P3|Overall Study|Baseline viral load unavailable|0
2377|NCT02641379|13112|P2|Overall Study|Baseline viral load unavailable|0
2378|NCT02641379|13113|P1|Overall Study|Baseline viral load unavailable|0
2379|NCT02641379|13103|P11|Overall Study|Inclusion criteria not fulfilled|0
2380|NCT02641379|13104|P10|Overall Study|Inclusion criteria not fulfilled|0
2381|NCT02641379|13105|P9|Overall Study|Inclusion criteria not fulfilled|0
2382|NCT02641379|13106|P8|Overall Study|Inclusion criteria not fulfilled|0
2383|NCT02641379|13107|P7|Overall Study|Inclusion criteria not fulfilled|0
2384|NCT02641379|13108|P6|Overall Study|Inclusion criteria not fulfilled|0
2385|NCT02641379|13109|P5|Overall Study|Inclusion criteria not fulfilled|0
2386|NCT02641379|13110|P4|Overall Study|Inclusion criteria not fulfilled|1
2387|NCT02641379|13111|P3|Overall Study|Inclusion criteria not fulfilled|0
2388|NCT02641379|13112|P2|Overall Study|Inclusion criteria not fulfilled|0
2389|NCT02641379|13113|P1|Overall Study|Inclusion criteria not fulfilled|0
2390|NCT02641379|13103|P11|Overall Study|PCR sample for Week 4 not drawn|0
2391|NCT02641379|13104|P10|Overall Study|PCR sample for Week 4 not drawn|0
2392|NCT02641379|13105|P9|Overall Study|PCR sample for Week 4 not drawn|0
2393|NCT02641379|13106|P8|Overall Study|PCR sample for Week 4 not drawn|0
2394|NCT02641379|13107|P7|Overall Study|PCR sample for Week 4 not drawn|0
2395|NCT02641379|13108|P6|Overall Study|PCR sample for Week 4 not drawn|0
2396|NCT02641379|13109|P5|Overall Study|PCR sample for Week 4 not drawn|0
2397|NCT02641379|13110|P4|Overall Study|PCR sample for Week 4 not drawn|1
2398|NCT02641379|13111|P3|Overall Study|PCR sample for Week 4 not drawn|0
2399|NCT02641379|13112|P2|Overall Study|PCR sample for Week 4 not drawn|0
2400|NCT02641379|13113|P1|Overall Study|PCR sample for Week 4 not drawn|0
2401|NCT02641379|13103|P11|Overall Study|PCR positive at Week 28|0
2402|NCT02641379|13104|P10|Overall Study|PCR positive at Week 28|0
2403|NCT02641379|13105|P9|Overall Study|PCR positive at Week 28|0
2404|NCT02641379|13106|P8|Overall Study|PCR positive at Week 28|0
2405|NCT02641379|13107|P7|Overall Study|PCR positive at Week 28|0
2406|NCT02641379|13108|P6|Overall Study|PCR positive at Week 28|0
2407|NCT02641379|13109|P5|Overall Study|PCR positive at Week 28|0
2408|NCT02641379|13110|P4|Overall Study|PCR positive at Week 28|0
2409|NCT02641379|13111|P3|Overall Study|PCR positive at Week 28|1
2410|NCT02641379|13112|P2|Overall Study|PCR positive at Week 28|0
2411|NCT02641379|13113|P1|Overall Study|PCR positive at Week 28|0
2412|NCT02641379|13103|P11|Overall Study|No PCR at baseline|0
2413|NCT02641379|13104|P10|Overall Study|No PCR at baseline|0
2414|NCT02641379|13105|P9|Overall Study|No PCR at baseline|0
2415|NCT02641379|13106|P8|Overall Study|No PCR at baseline|0
2416|NCT02641379|13107|P7|Overall Study|No PCR at baseline|0
2417|NCT02641379|13108|P6|Overall Study|No PCR at baseline|0
2418|NCT02641379|13109|P5|Overall Study|No PCR at baseline|0
2419|NCT02641379|13110|P4|Overall Study|No PCR at baseline|0
2420|NCT02641379|13111|P3|Overall Study|No PCR at baseline|1
2421|NCT02641379|13112|P2|Overall Study|No PCR at baseline|0
2422|NCT02641379|13113|P1|Overall Study|No PCR at baseline|0
2423|NCT02641379|13103|P11|Overall Study|PCR not performed at Week 12|0
2424|NCT02641379|13104|P10|Overall Study|PCR not performed at Week 12|0
2425|NCT02641379|13105|P9|Overall Study|PCR not performed at Week 12|0
2426|NCT02641379|13106|P8|Overall Study|PCR not performed at Week 12|0
2427|NCT02641379|13107|P7|Overall Study|PCR not performed at Week 12|0
2428|NCT02641379|13108|P6|Overall Study|PCR not performed at Week 12|0
2429|NCT02641379|13109|P5|Overall Study|PCR not performed at Week 12|0
2430|NCT02641379|13110|P4|Overall Study|PCR not performed at Week 12|0
2431|NCT02641379|13111|P3|Overall Study|PCR not performed at Week 12|1
2432|NCT02641379|13112|P2|Overall Study|PCR not performed at Week 12|0
2433|NCT02641379|13113|P1|Overall Study|PCR not performed at Week 12|0
2434|NCT02641379|13103|P11|Overall Study|PCR positive at Week 48|0
2435|NCT02641379|13104|P10|Overall Study|PCR positive at Week 48|0
2436|NCT02641379|13105|P9|Overall Study|PCR positive at Week 48|0
2437|NCT02641379|13106|P8|Overall Study|PCR positive at Week 48|0
2438|NCT02641379|13107|P7|Overall Study|PCR positive at Week 48|0
2439|NCT02641379|13108|P6|Overall Study|PCR positive at Week 48|0
2440|NCT02641379|13109|P5|Overall Study|PCR positive at Week 48|0
2441|NCT02641379|13110|P4|Overall Study|PCR positive at Week 48|0
2442|NCT02641379|13111|P3|Overall Study|PCR positive at Week 48|0
2443|NCT02641379|13112|P2|Overall Study|PCR positive at Week 48|1
2444|NCT02641379|13113|P1|Overall Study|PCR positive at Week 48|0
2445|NCT02641379|13103|P11|Overall Study|PCR positive at Week 68|0
2446|NCT02641379|13104|P10|Overall Study|PCR positive at Week 68|0
2447|NCT02641379|13105|P9|Overall Study|PCR positive at Week 68|0
2448|NCT02641379|13106|P8|Overall Study|PCR positive at Week 68|0
2449|NCT02641379|13107|P7|Overall Study|PCR positive at Week 68|0
2450|NCT02641379|13108|P6|Overall Study|PCR positive at Week 68|0
2451|NCT02641379|13109|P5|Overall Study|PCR positive at Week 68|0
2452|NCT02641379|13110|P4|Overall Study|PCR positive at Week 68|0
2453|NCT02641379|13111|P3|Overall Study|PCR positive at Week 68|0
2454|NCT02641379|13112|P2|Overall Study|PCR positive at Week 68|1
2455|NCT02641379|13113|P1|Overall Study|PCR positive at Week 68|0
2456|NCT02641379|13103|P11|Overall Study|Financial problems|0
2457|NCT02641379|13104|P10|Overall Study|Financial problems|0
2458|NCT02641379|13105|P9|Overall Study|Financial problems|0
2459|NCT02641379|13106|P8|Overall Study|Financial problems|0
2460|NCT02641379|13107|P7|Overall Study|Financial problems|0
2461|NCT02641379|13108|P6|Overall Study|Financial problems|0
2462|NCT02641379|13109|P5|Overall Study|Financial problems|0
2463|NCT02641379|13110|P4|Overall Study|Financial problems|0
2464|NCT02641379|13111|P3|Overall Study|Financial problems|0
2465|NCT02641379|13112|P2|Overall Study|Financial problems|1
2466|NCT02641379|13113|P1|Overall Study|Financial problems|0
2467|NCT02641379|13103|P11|Overall Study|Therapy stopped due to misunderstanding|0
2468|NCT02641379|13104|P10|Overall Study|Therapy stopped due to misunderstanding|0
2469|NCT02641379|13105|P9|Overall Study|Therapy stopped due to misunderstanding|0
2470|NCT02641379|13106|P8|Overall Study|Therapy stopped due to misunderstanding|0
2471|NCT02641379|13107|P7|Overall Study|Therapy stopped due to misunderstanding|0
2472|NCT02641379|13108|P6|Overall Study|Therapy stopped due to misunderstanding|0
2473|NCT02641379|13109|P5|Overall Study|Therapy stopped due to misunderstanding|0
2474|NCT02641379|13110|P4|Overall Study|Therapy stopped due to misunderstanding|0
2475|NCT02641379|13111|P3|Overall Study|Therapy stopped due to misunderstanding|0
2476|NCT02641379|13112|P2|Overall Study|Therapy stopped due to misunderstanding|0
2477|NCT02641379|13113|P1|Overall Study|Therapy stopped due to misunderstanding|1
2478|NCT02641379|13103|P11|Overall Study|Participant stopped study/treatment|0
2479|NCT02641379|13104|P10|Overall Study|Participant stopped study/treatment|0
2480|NCT02641379|13105|P9|Overall Study|Participant stopped study/treatment|1
2481|NCT02641379|13106|P8|Overall Study|Participant stopped study/treatment|0
2482|NCT02641379|13107|P7|Overall Study|Participant stopped study/treatment|2
2483|NCT02641379|13108|P6|Overall Study|Participant stopped study/treatment|1
2484|NCT02641379|13109|P5|Overall Study|Participant stopped study/treatment|0
2485|NCT02641379|13110|P4|Overall Study|Participant stopped study/treatment|0
2486|NCT02641379|13111|P3|Overall Study|Participant stopped study/treatment|1
2487|NCT02641379|13112|P2|Overall Study|Participant stopped study/treatment|3
2488|NCT02641379|13113|P1|Overall Study|Participant stopped study/treatment|1
2489|NCT02641379|13103|P11|Overall Study|Participant showed relapse|0
2490|NCT02641379|13104|P10|Overall Study|Participant showed relapse|0
2491|NCT02641379|13105|P9|Overall Study|Participant showed relapse|0
2492|NCT02641379|13106|P8|Overall Study|Participant showed relapse|0
2493|NCT02641379|13107|P7|Overall Study|Participant showed relapse|1
2494|NCT02641379|13108|P6|Overall Study|Participant showed relapse|0
2495|NCT02641379|13109|P5|Overall Study|Participant showed relapse|0
2496|NCT02641379|13110|P4|Overall Study|Participant showed relapse|0
2497|NCT02641379|13111|P3|Overall Study|Participant showed relapse|0
2498|NCT02641379|13112|P2|Overall Study|Participant showed relapse|0
2499|NCT02641379|13113|P1|Overall Study|Participant showed relapse|1
2500|NCT02641379|13103|P11|Overall Study|PCR positive at follow up 2|0
2501|NCT02641379|13104|P10|Overall Study|PCR positive at follow up 2|0
2502|NCT02641379|13105|P9|Overall Study|PCR positive at follow up 2|0
2503|NCT02641379|13106|P8|Overall Study|PCR positive at follow up 2|0
2504|NCT02641379|13107|P7|Overall Study|PCR positive at follow up 2|0
2505|NCT02641379|13108|P6|Overall Study|PCR positive at follow up 2|0
2506|NCT02641379|13109|P5|Overall Study|PCR positive at follow up 2|0
2507|NCT02641379|13110|P4|Overall Study|PCR positive at follow up 2|0
2508|NCT02641379|13111|P3|Overall Study|PCR positive at follow up 2|0
2509|NCT02641379|13112|P2|Overall Study|PCR positive at follow up 2|0
2510|NCT02641379|13113|P1|Overall Study|PCR positive at follow up 2|1
2511|NCT02641379|13103|P11|Overall Study|PCR positive at Week 24|0
2512|NCT02641379|13104|P10|Overall Study|PCR positive at Week 24|1
2513|NCT02641379|13105|P9|Overall Study|PCR positive at Week 24|0
2514|NCT02641379|13106|P8|Overall Study|PCR positive at Week 24|8
2515|NCT02641379|13107|P7|Overall Study|PCR positive at Week 24|3
2516|NCT02641379|13108|P6|Overall Study|PCR positive at Week 24|6
2517|NCT02641379|13109|P5|Overall Study|PCR positive at Week 24|0
2518|NCT02641379|13110|P4|Overall Study|PCR positive at Week 24|0
2519|NCT02641379|13111|P3|Overall Study|PCR positive at Week 24|62
2520|NCT02641379|13112|P2|Overall Study|PCR positive at Week 24|21
2521|NCT02641379|13113|P1|Overall Study|PCR positive at Week 24|15
2522|NCT02641379|13103|P11|Overall Study|Participant cannot be reached|1
2523|NCT02641379|13104|P10|Overall Study|Participant cannot be reached|2
2524|NCT02641379|13105|P9|Overall Study|Participant cannot be reached|0
2525|NCT02641379|13106|P8|Overall Study|Participant cannot be reached|1
2526|NCT02641379|13107|P7|Overall Study|Participant cannot be reached|0
2527|NCT02641379|13108|P6|Overall Study|Participant cannot be reached|1
2528|NCT02641379|13109|P5|Overall Study|Participant cannot be reached|2
2529|NCT02641379|13110|P4|Overall Study|Participant cannot be reached|8
2530|NCT02641379|13111|P3|Overall Study|Participant cannot be reached|0
2531|NCT02641379|13112|P2|Overall Study|Participant cannot be reached|4
2532|NCT02641379|13113|P1|Overall Study|Participant cannot be reached|4
2533|NCT02641379|13103|P11|Overall Study|Participant’s compliance|1
2534|NCT02641379|13104|P10|Overall Study|Participant’s compliance|1
2535|NCT02641379|13105|P9|Overall Study|Participant’s compliance|1
2536|NCT02641379|13106|P8|Overall Study|Participant’s compliance|0
2537|NCT02641379|13107|P7|Overall Study|Participant’s compliance|0
2538|NCT02641379|13108|P6|Overall Study|Participant’s compliance|2
2539|NCT02641379|13109|P5|Overall Study|Participant’s compliance|0
2540|NCT02641379|13110|P4|Overall Study|Participant’s compliance|1
2541|NCT02641379|13111|P3|Overall Study|Participant’s compliance|0
2542|NCT02641379|13112|P2|Overall Study|Participant’s compliance|1
2543|NCT02641379|13113|P1|Overall Study|Participant’s compliance|0
2544|NCT02641379|13103|P11|Overall Study|Participant unable to attend study visit|0
2545|NCT02641379|13104|P10|Overall Study|Participant unable to attend study visit|2
2546|NCT02641379|13105|P9|Overall Study|Participant unable to attend study visit|0
2547|NCT02641379|13106|P8|Overall Study|Participant unable to attend study visit|1
2548|NCT02641379|13107|P7|Overall Study|Participant unable to attend study visit|1
2549|NCT02641379|13108|P6|Overall Study|Participant unable to attend study visit|1
2550|NCT02641379|13109|P5|Overall Study|Participant unable to attend study visit|5
2551|NCT02641379|13110|P4|Overall Study|Participant unable to attend study visit|2
2552|NCT02641379|13111|P3|Overall Study|Participant unable to attend study visit|1
2553|NCT02641379|13112|P2|Overall Study|Participant unable to attend study visit|10
2554|NCT02641379|13113|P1|Overall Study|Participant unable to attend study visit|4
2555|NCT02641379|13103|P11|Overall Study|Lack of Efficacy|0
2556|NCT02641379|13104|P10|Overall Study|Lack of Efficacy|0
2557|NCT02641379|13105|P9|Overall Study|Lack of Efficacy|0
2558|NCT02641379|13106|P8|Overall Study|Lack of Efficacy|5
2559|NCT02641379|13107|P7|Overall Study|Lack of Efficacy|0
2560|NCT02641379|13108|P6|Overall Study|Lack of Efficacy|2
2561|NCT02641379|13109|P5|Overall Study|Lack of Efficacy|0
2562|NCT02641379|13110|P4|Overall Study|Lack of Efficacy|0
2563|NCT02641379|13111|P3|Overall Study|Lack of Efficacy|2
2564|NCT02641379|13112|P2|Overall Study|Lack of Efficacy|0
2565|NCT02641379|13113|P1|Overall Study|Lack of Efficacy|0
2566|NCT02641379|13103|P11|Overall Study|Adverse Event|5
2567|NCT02641379|13104|P10|Overall Study|Adverse Event|1
2568|NCT02641379|13105|P9|Overall Study|Adverse Event|1
2569|NCT02641379|13106|P8|Overall Study|Adverse Event|0
2570|NCT02641379|13107|P7|Overall Study|Adverse Event|5
2571|NCT02641379|13108|P6|Overall Study|Adverse Event|1
2572|NCT02641379|13109|P5|Overall Study|Adverse Event|5
2573|NCT02641379|13110|P4|Overall Study|Adverse Event|2
2574|NCT02641379|13111|P3|Overall Study|Adverse Event|2
2575|NCT02641379|13112|P2|Overall Study|Adverse Event|8
2576|NCT02641379|13113|P1|Overall Study|Adverse Event|7
2577|NCT02641379|13103|P11|Overall Study|Withdrawal of informed consent|0
2578|NCT02641379|13104|P10|Overall Study|Withdrawal of informed consent|0
2579|NCT02641379|13105|P9|Overall Study|Withdrawal of informed consent|0
2580|NCT02641379|13106|P8|Overall Study|Withdrawal of informed consent|1
2581|NCT02641379|13107|P7|Overall Study|Withdrawal of informed consent|0
2582|NCT02641379|13108|P6|Overall Study|Withdrawal of informed consent|0
2583|NCT02641379|13109|P5|Overall Study|Withdrawal of informed consent|0
2584|NCT02641379|13110|P4|Overall Study|Withdrawal of informed consent|0
2585|NCT02641379|13111|P3|Overall Study|Withdrawal of informed consent|0
2586|NCT02641379|13112|P2|Overall Study|Withdrawal of informed consent|1
2587|NCT02641379|13113|P1|Overall Study|Withdrawal of informed consent|0
2588|NCT02641379|13103|P11|Overall Study|Exclusion criterion during screening|0
2589|NCT02641379|13104|P10|Overall Study|Exclusion criterion during screening|0
2590|NCT02641379|13105|P9|Overall Study|Exclusion criterion during screening|0
2591|NCT02641379|13106|P8|Overall Study|Exclusion criterion during screening|0
2592|NCT02641379|13107|P7|Overall Study|Exclusion criterion during screening|0
2593|NCT02641379|13108|P6|Overall Study|Exclusion criterion during screening|0
2594|NCT02641379|13109|P5|Overall Study|Exclusion criterion during screening|2
2595|NCT02641379|13110|P4|Overall Study|Exclusion criterion during screening|1
2596|NCT02641379|13111|P3|Overall Study|Exclusion criterion during screening|0
2597|NCT02641379|13112|P2|Overall Study|Exclusion criterion during screening|0
2598|NCT02641379|13113|P1|Overall Study|Exclusion criterion during screening|1
2599|NCT02640482|13189|P2|Overall Study|Lost to Follow-up|0
2600|NCT02640482|13190|P1|Overall Study|Lost to Follow-up|3
2601|NCT02640404|13202|P2|Overall Study|Withdrawal by Subject|0
2602|NCT02640404|13203|P1|Overall Study|Withdrawal by Subject|1
2603|NCT02640404|13202|P2|Overall Study|Protocol Violation|0
2604|NCT02640404|13203|P1|Overall Study|Protocol Violation|1
2605|NCT02640157|13214|P3|Overall Study|Randomized in error; did not receive Tx|0
2606|NCT02640157|13215|P2|Overall Study|Randomized in error; did not receive Tx|1
2607|NCT02640157|13216|P1|Overall Study|Randomized in error; did not receive Tx|0
2608|NCT02640157|13214|P3|Overall Study|Lost to Follow-up|7
2609|NCT02640157|13215|P2|Overall Study|Lost to Follow-up|2
2610|NCT02640157|13216|P1|Overall Study|Lost to Follow-up|9
2611|NCT02640157|13214|P3|Overall Study|Withdrew consent|2
2612|NCT02640157|13215|P2|Overall Study|Withdrew consent|0
2613|NCT02640157|13216|P1|Overall Study|Withdrew consent|2
2614|NCT02640157|13214|P3|Overall Study|Adverse Event|1
2615|NCT02640157|13215|P2|Overall Study|Adverse Event|2
2616|NCT02640157|13216|P1|Overall Study|Adverse Event|2
2617|NCT02639338|13235|P2|Overall Study|Randomized but Not Treated|1
2618|NCT02639338|13236|P1|Overall Study|Randomized but Not Treated|0
2619|NCT02639338|13235|P2|Overall Study|Death|0
2620|NCT02639338|13236|P1|Overall Study|Death|1
2621|NCT02639338|13235|P2|Overall Study|Withdrew Consent|2
2622|NCT02639338|13236|P1|Overall Study|Withdrew Consent|1
2623|NCT02639338|13235|P2|Overall Study|Lost to Follow-up|2
2624|NCT02639338|13236|P1|Overall Study|Lost to Follow-up|2
2625|NCT02639247|13254|P2|Overall Study|Protocol Violation|0
2626|NCT02639247|13255|P1|Overall Study|Protocol Violation|1
2627|NCT02639247|13254|P2|Overall Study|Withdrew Consent|1
2628|NCT02639247|13255|P1|Overall Study|Withdrew Consent|0
2629|NCT02639247|13254|P2|Overall Study|Death|0
2630|NCT02639247|13255|P1|Overall Study|Death|2
2631|NCT02639247|13254|P2|Overall Study|Lost to Follow-up|1
2632|NCT02639247|13255|P1|Overall Study|Lost to Follow-up|2
2633|NCT02639052|13271|P1|Overall Study|Lost to Follow-up|1
2634|NCT02638493|13288|P3|Overall Study|Inability to provide semen samples|0
2635|NCT02638493|13289|P2|Overall Study|Inability to provide semen samples|0
2636|NCT02638493|13290|P1|Overall Study|Inability to provide semen samples|2
2637|NCT02638259|13321|P2|Treatment Period 2|Withdrawal by Subject|7
2638|NCT02638259|13322|P1|Treatment Period 2|Withdrawal by Subject|1
2639|NCT02638259|13321|P2|Treatment Period 2|Adverse Event|4
2640|NCT02638259|13322|P1|Treatment Period 2|Adverse Event|5
2641|NCT02638259|13321|P2|Treatment Period 1|Withdrawn per sponsor decision|2
2642|NCT02638259|13322|P1|Treatment Period 1|Withdrawn per sponsor decision|0
2643|NCT02638259|13321|P2|Treatment Period 1|Withdrawal by Subject|6
2644|NCT02638259|13322|P1|Treatment Period 1|Withdrawal by Subject|4
2645|NCT02638259|13321|P2|Treatment Period 1|Protocol Violation|3
2646|NCT02638259|13322|P1|Treatment Period 1|Protocol Violation|0
2647|NCT02638259|13321|P2|Treatment Period 1|Lack of Efficacy|1
2648|NCT02638259|13322|P1|Treatment Period 1|Lack of Efficacy|0
2649|NCT02638259|13321|P2|Treatment Period 1|Death|1
2650|NCT02638259|13322|P1|Treatment Period 1|Death|0
2651|NCT02638259|13321|P2|Treatment Period 1|Adverse Event|5
2652|NCT02638259|13322|P1|Treatment Period 1|Adverse Event|1
2653|NCT02638129|13334|P2|Overall Study|Study terminated|30
2654|NCT02638129|13335|P1|Overall Study|Study terminated|28
2655|NCT02637323|13508|P2|Overall Study|Protocol Violation|1
2656|NCT02637323|13509|P1|Overall Study|Protocol Violation|0
2657|NCT02637323|13508|P2|Overall Study|Lost to Follow-up|0
2658|NCT02637323|13509|P1|Overall Study|Lost to Follow-up|2
2659|NCT02637063|13520|P3|Overall Study|Withdrawal by Subject|3
2660|NCT02637063|13521|P2|Overall Study|Withdrawal by Subject|2
2661|NCT02637063|13522|P1|Overall Study|Withdrawal by Subject|2
2662|NCT02637063|13520|P3|Overall Study|Lost to Follow-up|3
2663|NCT02637063|13521|P2|Overall Study|Lost to Follow-up|2
2664|NCT02637063|13522|P1|Overall Study|Lost to Follow-up|3
2665|NCT02637037|13550|P2|Overall Study|Adverse Event|0
2666|NCT02637037|13551|P1|Overall Study|Adverse Event|1
2667|NCT02637037|13550|P2|Overall Study|Withdrawal by Subject|1
2668|NCT02637037|13551|P1|Overall Study|Withdrawal by Subject|2
2669|NCT02637037|13550|P2|Overall Study|Positive drug screen at admission|0
2670|NCT02637037|13551|P1|Overall Study|Positive drug screen at admission|1
2671|NCT02636907|13617|P1|Overall Study|Withdrawal by Subject|2
2672|NCT02636907|13617|P1|Overall Study|Adverse Event|2
2673|NCT02636595|13624|P1|Overall Study|Not specified|1
2674|NCT02636595|13624|P1|Overall Study|Lost to Follow-up|1
2675|NCT02635204|13646|P2|Overall Study|Lost to Follow-up|1
2676|NCT02635204|13647|P1|Overall Study|Lost to Follow-up|1
2677|NCT02635204|13646|P2|Overall Study|Adverse Event|0
2678|NCT02635204|13647|P1|Overall Study|Adverse Event|1
2679|NCT02634788|13661|P4|Overall Study|Withdrawal by Subject|0
2680|NCT02634788|13662|P3|Overall Study|Withdrawal by Subject|1
2681|NCT02634788|13663|P2|Overall Study|Withdrawal by Subject|1
2682|NCT02634788|13664|P1|Overall Study|Withdrawal by Subject|0
2683|NCT02634788|13661|P4|Overall Study|Lost to Follow-up|0
2684|NCT02634788|13662|P3|Overall Study|Lost to Follow-up|0
2685|NCT02634788|13663|P2|Overall Study|Lost to Follow-up|1
2686|NCT02634788|13664|P1|Overall Study|Lost to Follow-up|0
2687|NCT02634788|13661|P4|Overall Study|Lack of Efficacy|4
2688|NCT02634788|13662|P3|Overall Study|Lack of Efficacy|1
2689|NCT02634788|13663|P2|Overall Study|Lack of Efficacy|0
2690|NCT02634788|13664|P1|Overall Study|Lack of Efficacy|4
2691|NCT02634788|13661|P4|Overall Study|Adverse Event|1
2692|NCT02634788|13662|P3|Overall Study|Adverse Event|3
2693|NCT02634788|13663|P2|Overall Study|Adverse Event|8
2694|NCT02634788|13664|P1|Overall Study|Adverse Event|0
2695|NCT02633787|13819|P1|Overall Study|Withdrawal by Subject|1
2696|NCT02633215|13827|P2|Overall Study|Lost to Follow-up|3
2697|NCT02633215|13828|P1|Overall Study|Lost to Follow-up|2
2698|NCT02632110|13864|P10|Overall Study|Withdrawal by Subject|1
2699|NCT02632110|13865|P9|Overall Study|Withdrawal by Subject|1
2700|NCT02632110|13866|P8|Overall Study|Withdrawal by Subject|3
2701|NCT02632110|13867|P7|Overall Study|Withdrawal by Subject|3
2702|NCT02632110|13868|P6|Overall Study|Withdrawal by Subject|1
2703|NCT02632110|13869|P5|Overall Study|Withdrawal by Subject|1
2704|NCT02632110|13870|P4|Overall Study|Withdrawal by Subject|0
2705|NCT02632110|13871|P3|Overall Study|Withdrawal by Subject|0
2706|NCT02632110|13872|P2|Overall Study|Withdrawal by Subject|1
2707|NCT02632110|13873|P1|Overall Study|Withdrawal by Subject|1
2708|NCT02630563|14366|P1|Overall Study|Administrative|1
2709|NCT02628938|14403|P3|Overall Study|Failure to comply with the instructions|3
2710|NCT02628938|14404|P2|Overall Study|Failure to comply with the instructions|0
2711|NCT02628938|14405|P1|Overall Study|Failure to comply with the instructions|3
2712|NCT02628938|14403|P3|Overall Study|Did not attend the follow up recall|1
2713|NCT02628938|14404|P2|Overall Study|Did not attend the follow up recall|2
2714|NCT02628938|14405|P1|Overall Study|Did not attend the follow up recall|2
2715|NCT02628418|14421|P2|Overall Study|Lost to Follow-up|2
2716|NCT02628418|14422|P1|Overall Study|Lost to Follow-up|1
2717|NCT02627144|14497|P1|Overall Study|Other|17
2718|NCT02627144|14497|P1|Overall Study|Enrolled, not treated|6
2719|NCT02627144|14497|P1|Overall Study|Lost to Follow-up|8
2720|NCT02627144|14497|P1|Overall Study|Administrative reasons|65
2721|NCT02627144|14497|P1|Overall Study|Refusal of treatment / poor cooperation|38
2722|NCT02627144|14497|P1|Overall Study|Death from other cause|8
2723|NCT02627144|14497|P1|Overall Study|Death from cancer|20
2724|NCT02627144|14497|P1|Overall Study|Cancer progression|171
2725|NCT02627144|14497|P1|Overall Study|Serious adverse event|32
2726|NCT02625259|14590|P5|First Intervention (Day 1)|Withdrawal by Subject|0
2727|NCT02625259|14591|P4|First Intervention (Day 1)|Withdrawal by Subject|1
2728|NCT02625259|14592|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2729|NCT02625259|14593|P2|First Intervention (Day 1)|Withdrawal by Subject|0
2730|NCT02625259|14594|P1|First Intervention (Day 1)|Withdrawal by Subject|0
2731|NCT02625259|14590|P5|First Intervention (Day 1)|Adverse Event|0
2732|NCT02625259|14591|P4|First Intervention (Day 1)|Adverse Event|0
2733|NCT02625259|14592|P3|First Intervention (Day 1)|Adverse Event|0
2734|NCT02625259|14593|P2|First Intervention (Day 1)|Adverse Event|1
2735|NCT02625259|14594|P1|First Intervention (Day 1)|Adverse Event|2
2736|NCT02625259|14590|P5|First Intervention (Day 1)|Other|0
2737|NCT02625259|14591|P4|First Intervention (Day 1)|Other|0
2738|NCT02625259|14592|P3|First Intervention (Day 1)|Other|1
2739|NCT02625259|14593|P2|First Intervention (Day 1)|Other|0
2740|NCT02625259|14594|P1|First Intervention (Day 1)|Other|0
2741|NCT02625233|14631|P2|Overall Study|Adverse Event|0
2742|NCT02625233|14632|P1|Overall Study|Adverse Event|2
2743|NCT02625220|14640|P1|Overall Study|Study discontinued at site|2
2744|NCT02625220|14640|P1|Overall Study|Protocol Violation|1
2745|NCT02625220|14640|P1|Overall Study|Lost to Follow-up|2
2746|NCT02625220|14640|P1|Overall Study|Adverse Event|2
2747|NCT02624791|14740|P6|Overall Study|Withdrawal by Subject|0
2748|NCT02624791|14741|P5|Overall Study|Withdrawal by Subject|0
2749|NCT02624791|14742|P4|Overall Study|Withdrawal by Subject|0
2750|NCT02624791|14743|P3|Overall Study|Withdrawal by Subject|0
2751|NCT02624791|14744|P2|Overall Study|Withdrawal by Subject|0
2752|NCT02624791|14745|P1|Overall Study|Withdrawal by Subject|2
2753|NCT02622568|14752|P2|Overall Study|Lost to Follow-up|5
2754|NCT02622568|14753|P1|Overall Study|Lost to Follow-up|5
2755|NCT02622321|14763|P4|Overall Study|Withdrawal by Subject|0
2756|NCT02622321|14764|P3|Overall Study|Withdrawal by Subject|0
2757|NCT02622321|14765|P2|Overall Study|Withdrawal by Subject|0
2758|NCT02622321|14766|P1|Overall Study|Withdrawal by Subject|1
2759|NCT02622321|14763|P4|Overall Study|Ongoing treatment with emicizumab|7
2760|NCT02622321|14764|P3|Overall Study|Ongoing treatment with emicizumab|49
2761|NCT02622321|14765|P2|Overall Study|Ongoing treatment with emicizumab|13
2762|NCT02622321|14766|P1|Overall Study|Ongoing treatment with emicizumab|31
2763|NCT02622321|14763|P4|Overall Study|Ongoing in safety follow-up|0
2764|NCT02622321|14764|P3|Overall Study|Ongoing in safety follow-up|0
2765|NCT02622321|14765|P2|Overall Study|Ongoing in safety follow-up|0
2766|NCT02622321|14766|P1|Overall Study|Ongoing in safety follow-up|3
2767|NCT02622321|14763|P4|Overall Study|Ongoing treatment with no emicizumab|0
2768|NCT02622321|14764|P3|Overall Study|Ongoing treatment with no emicizumab|0
2769|NCT02622321|14765|P2|Overall Study|Ongoing treatment with no emicizumab|5
2770|NCT02622321|14766|P1|Overall Study|Ongoing treatment with no emicizumab|0
2771|NCT02621034|14812|P3|Overall Study|Lost to Follow-up|5
2772|NCT02621034|14813|P2|Overall Study|Lost to Follow-up|2
2773|NCT02621034|14814|P1|Overall Study|Lost to Follow-up|3
2774|NCT02619812|14840|P4|Overall Study|Withdrawal by Subject|2
2775|NCT02619812|14841|P3|Overall Study|Withdrawal by Subject|1
2776|NCT02619812|14842|P2|Overall Study|Withdrawal by Subject|0
2777|NCT02619812|14843|P1|Overall Study|Withdrawal by Subject|0
2778|NCT02615990|15020|P2|Overall Study|study terminated|1
2779|NCT02615990|15021|P1|Overall Study|study terminated|1
2780|NCT02614079|15165|P1|Overall Study|Withdrawal by Subject|1
2781|NCT02613910|15169|P1|Overall Study|Termination of study|1
2782|NCT02613871|15218|P1|Overall Study|On Study|111
2783|NCT02613403|15237|P5|Overall Study|Withdrawal by Subject|0
2784|NCT02613403|15238|P4|Overall Study|Withdrawal by Subject|0
2785|NCT02613403|15239|P3|Overall Study|Withdrawal by Subject|0
2786|NCT02613403|15240|P2|Overall Study|Withdrawal by Subject|0
2787|NCT02613403|15241|P1|Overall Study|Withdrawal by Subject|2
2788|NCT02613403|15237|P5|Overall Study|Lost to Follow-up|0
2789|NCT02613403|15238|P4|Overall Study|Lost to Follow-up|0
2790|NCT02613403|15239|P3|Overall Study|Lost to Follow-up|0
2791|NCT02613403|15240|P2|Overall Study|Lost to Follow-up|1
2792|NCT02613403|15241|P1|Overall Study|Lost to Follow-up|0
2793|NCT02612610|15287|P4|Overall Study|Cough Improvement|0
2794|NCT02612610|15288|P3|Overall Study|Cough Improvement|1
2795|NCT02612610|15289|P2|Overall Study|Cough Improvement|0
2796|NCT02612610|15290|P1|Overall Study|Cough Improvement|0
2797|NCT02612610|15287|P4|Overall Study|Noncompliance|0
2798|NCT02612610|15288|P3|Overall Study|Noncompliance|0
2799|NCT02612610|15289|P2|Overall Study|Noncompliance|0
2800|NCT02612610|15290|P1|Overall Study|Noncompliance|1
2801|NCT02612610|15287|P4|Overall Study|Physician Decision|0
2802|NCT02612610|15288|P3|Overall Study|Physician Decision|0
2803|NCT02612610|15289|P2|Overall Study|Physician Decision|1
2804|NCT02612610|15290|P1|Overall Study|Physician Decision|0
2805|NCT02612610|15287|P4|Overall Study|Lack of Efficacy|1
2806|NCT02612610|15288|P3|Overall Study|Lack of Efficacy|0
2807|NCT02612610|15289|P2|Overall Study|Lack of Efficacy|2
2808|NCT02612610|15290|P1|Overall Study|Lack of Efficacy|1
2809|NCT02612610|15287|P4|Overall Study|Protocol Violation|0
2810|NCT02612610|15288|P3|Overall Study|Protocol Violation|1
2811|NCT02612610|15289|P2|Overall Study|Protocol Violation|1
2812|NCT02612610|15290|P1|Overall Study|Protocol Violation|0
2813|NCT02612610|15287|P4|Overall Study|Lost to Follow-up|0
2814|NCT02612610|15288|P3|Overall Study|Lost to Follow-up|0
2815|NCT02612610|15289|P2|Overall Study|Lost to Follow-up|1
2816|NCT02612610|15290|P1|Overall Study|Lost to Follow-up|0
2817|NCT02612610|15287|P4|Overall Study|Adverse Event|10
2818|NCT02612610|15288|P3|Overall Study|Adverse Event|3
2819|NCT02612610|15289|P2|Overall Study|Adverse Event|2
2820|NCT02612610|15290|P1|Overall Study|Adverse Event|2
2821|NCT02612610|15287|P4|Overall Study|Withdrawal by Subject|2
2822|NCT02612610|15288|P3|Overall Study|Withdrawal by Subject|0
2823|NCT02612610|15289|P2|Overall Study|Withdrawal by Subject|1
2824|NCT02612610|15290|P1|Overall Study|Withdrawal by Subject|1
2825|NCT02612077|15532|P1|Overall Study|Unknown reason|2
2826|NCT02612077|15532|P1|Overall Study|Disease Progression|3
2827|NCT02612077|15532|P1|Overall Study|Enrollment in a Clinical Trial|1
2828|NCT02612077|15532|P1|Overall Study|Moved or Changed Medical Team|23
2829|NCT02612077|15532|P1|Overall Study|Death|377
2830|NCT02612077|15532|P1|Overall Study|Lost to Follow-up|20
2831|NCT02612077|15532|P1|Overall Study|Protocol Violation|28
2832|NCT02612077|15532|P1|Overall Study|Withdrawal by Subject|9
2833|NCT02612077|15532|P1|Overall Study|Adverse Event|3
2834|NCT02612064|15544|P2|Overall Study|Not Specified|2
2835|NCT02612064|15545|P1|Overall Study|Not Specified|0
2836|NCT02612064|15544|P2|Overall Study|Withdrawal by Subject|1
2837|NCT02612064|15545|P1|Overall Study|Withdrawal by Subject|1
2838|NCT02609672|15602|P2|Overall Study|Lost to Follow-up|1
2839|NCT02609672|15603|P1|Overall Study|Lost to Follow-up|3
2840|NCT02609659|15637|P1|Overall Study|Not Specified|1
2841|NCT02609659|15637|P1|Overall Study|Lost to Follow-up|6
2842|NCT02609659|15637|P1|Overall Study|Adverse Event|1
2843|NCT02609633|15647|P2|Overall Study|Reason not Specified|1
2844|NCT02609633|15648|P1|Overall Study|Reason not Specified|2
2845|NCT02609633|15647|P2|Overall Study|Non-Compliant with Study Procedures|0
2846|NCT02609633|15648|P1|Overall Study|Non-Compliant with Study Procedures|2
2847|NCT02609633|15647|P2|Overall Study|Protocol Deviation|0
2848|NCT02609633|15648|P1|Overall Study|Protocol Deviation|1
2849|NCT02609633|15647|P2|Overall Study|Consent Withdrawn|1
2850|NCT02609633|15648|P1|Overall Study|Consent Withdrawn|0
2851|NCT02609178|15673|P6|First Crown|Withdrawal by Subject|0
2852|NCT02609178|15674|P5|First Crown|Withdrawal by Subject|0
2853|NCT02609178|15675|P4|First Crown|Withdrawal by Subject|1
2854|NCT02609178|15676|P3|First Crown|Withdrawal by Subject|1
2855|NCT02609178|15677|P2|First Crown|Withdrawal by Subject|0
2856|NCT02609178|15678|P1|First Crown|Withdrawal by Subject|0
2857|NCT02607800|15733|P2|Overall Study|Randomized/Enrolled but Not Treated|1
2858|NCT02607800|15734|P1|Overall Study|Randomized/Enrolled but Not Treated|1
2859|NCT02607800|15733|P2|Overall Study|Withdrew Consent|0
2860|NCT02607800|15734|P1|Overall Study|Withdrew Consent|2
2861|NCT02607800|15733|P2|Overall Study|Lost to Follow-up|10
2862|NCT02607800|15734|P1|Overall Study|Lost to Follow-up|7
2863|NCT02607735|15752|P2|Overall Study|Withdrew Consent|0
2864|NCT02607735|15753|P1|Overall Study|Withdrew Consent|2
2865|NCT02607735|15752|P2|Overall Study|Lost to Follow-up|0
2866|NCT02607735|15753|P1|Overall Study|Lost to Follow-up|4
2867|NCT02607735|15752|P2|Overall Study|Randomized/ Enrolled but Never Treated|0
2868|NCT02607735|15753|P1|Overall Study|Randomized/ Enrolled but Never Treated|1
2869|NCT02606279|15781|P2|Overall Study|Lost to Follow-up|1
2870|NCT02606279|15782|P1|Overall Study|Lost to Follow-up|0
2871|NCT02605928|15794|P1|Overall Study|Lack of Efficacy|5
2872|NCT02605928|15794|P1|Overall Study|Model tuning phase|28
2873|NCT02604589|15833|P3|Overall Study|catheter dislodgement|1
2874|NCT02604589|15834|P2|Overall Study|catheter dislodgement|0
2875|NCT02604589|15835|P1|Overall Study|catheter dislodgement|0
2876|NCT02604550|15863|P2|Overall Study|Incomplete data using paper journal|19
2877|NCT02604550|15864|P1|Overall Study|Incomplete data using paper journal|18
2878|NCT02604550|15863|P2|Overall Study|Withdrawal by Subject|1
2879|NCT02604550|15864|P1|Overall Study|Withdrawal by Subject|0
2880|NCT02604550|15863|P2|Overall Study|Lost to Follow-up|6
2881|NCT02604550|15864|P1|Overall Study|Lost to Follow-up|7
2882|NCT02604407|15891|P3|Overall Study|Other|4
2883|NCT02604407|15892|P2|Overall Study|Other|1
2884|NCT02604407|15893|P1|Overall Study|Other|3
2885|NCT02604407|15891|P3|Overall Study|Lack of Efficacy|0
2886|NCT02604407|15892|P2|Overall Study|Lack of Efficacy|0
2887|NCT02604407|15893|P1|Overall Study|Lack of Efficacy|1
2888|NCT02604407|15891|P3|Overall Study|Lost to Follow-up|2
2889|NCT02604407|15892|P2|Overall Study|Lost to Follow-up|1
2890|NCT02604407|15893|P1|Overall Study|Lost to Follow-up|2
2891|NCT02604407|15891|P3|Overall Study|Withdrawal by Subject|5
2892|NCT02604407|15892|P2|Overall Study|Withdrawal by Subject|3
2893|NCT02604407|15893|P1|Overall Study|Withdrawal by Subject|3
2894|NCT02604407|15891|P3|Overall Study|Protocol Violation|0
2895|NCT02604407|15892|P2|Overall Study|Protocol Violation|0
2896|NCT02604407|15893|P1|Overall Study|Protocol Violation|2
2897|NCT02604407|15891|P3|Overall Study|Adverse Event|5
2898|NCT02604407|15892|P2|Overall Study|Adverse Event|7
2899|NCT02604407|15893|P1|Overall Study|Adverse Event|0
2900|NCT02604342|15906|P2|Overall Study|Ongoing|25
2901|NCT02604342|15907|P1|Overall Study|Ongoing|52
2902|NCT02604342|15906|P2|Overall Study|Withdrawal by Subject|3
2903|NCT02604342|15907|P1|Overall Study|Withdrawal by Subject|3
2904|NCT02604342|15906|P2|Overall Study|Progression of disease|0
2905|NCT02604342|15907|P1|Overall Study|Progression of disease|1
2906|NCT02604342|15906|P2|Overall Study|Death|7
2907|NCT02604342|15907|P1|Overall Study|Death|16
2908|NCT02604264|15959|P2|Overall Study|Had central venous catheter <21 days|242
2909|NCT02604264|15960|P1|Overall Study|Had central venous catheter <21 days|200
2910|NCT02604017|15987|P2|Overall Study|Not Specified|0
2911|NCT02604017|15988|P1|Overall Study|Not Specified|1
2912|NCT02604017|15987|P2|Overall Study|Lost to Follow-up|6
2913|NCT02604017|15988|P1|Overall Study|Lost to Follow-up|5
2914|NCT02604017|15987|P2|Overall Study|Withdrew Consent|2
2915|NCT02604017|15988|P1|Overall Study|Withdrew Consent|0
2916|NCT02601573|16038|P5|Overall Study|Withdrawal by Subject|0
2917|NCT02601573|16039|P4|Overall Study|Withdrawal by Subject|1
2918|NCT02601573|16040|P3|Overall Study|Withdrawal by Subject|0
2919|NCT02601573|16041|P2|Overall Study|Withdrawal by Subject|1
2920|NCT02601573|16042|P1|Overall Study|Withdrawal by Subject|0
2921|NCT02601573|16038|P5|Overall Study|Lost to Follow-up|2
2922|NCT02601573|16039|P4|Overall Study|Lost to Follow-up|0
2923|NCT02601573|16040|P3|Overall Study|Lost to Follow-up|1
2924|NCT02601573|16041|P2|Overall Study|Lost to Follow-up|3
2925|NCT02601573|16042|P1|Overall Study|Lost to Follow-up|0
2926|NCT02601560|16077|P8|Overall Study|Other|0
2927|NCT02601560|16078|P7|Overall Study|Other|1
2928|NCT02601560|16079|P6|Overall Study|Other|0
2929|NCT02601560|16080|P5|Overall Study|Other|0
2930|NCT02601560|16081|P4|Overall Study|Other|0
2931|NCT02601560|16082|P3|Overall Study|Other|0
2932|NCT02601560|16083|P2|Overall Study|Other|0
2933|NCT02601560|16084|P1|Overall Study|Other|0
2934|NCT02600871|16268|P2|Overall Study|Lost to Follow-up|10
2935|NCT02600871|16269|P1|Overall Study|Lost to Follow-up|13
2936|NCT02600845|16279|P1|Overall Study|Consent Withdrawal|5
2937|NCT02600845|16279|P1|Overall Study|Non-compliance with Study Procedures|10
2938|NCT02600845|16279|P1|Overall Study|Reason Not Specified|3
2939|NCT02600351|16330|P4|Overall Study|Randomized but Not Treated|3
2940|NCT02600351|16331|P3|Overall Study|Randomized but Not Treated|1
2941|NCT02600351|16332|P2|Overall Study|Randomized but Not Treated|0
2942|NCT02600351|16333|P1|Overall Study|Randomized but Not Treated|1
2943|NCT02600351|16330|P4|Overall Study|Lost to Follow-up|0
2944|NCT02600351|16331|P3|Overall Study|Lost to Follow-up|0
2945|NCT02600351|16332|P2|Overall Study|Lost to Follow-up|0
2946|NCT02600351|16333|P1|Overall Study|Lost to Follow-up|1
2947|NCT02600351|16330|P4|Overall Study|Lack of Efficacy|2
2948|NCT02600351|16331|P3|Overall Study|Lack of Efficacy|5
2949|NCT02600351|16332|P2|Overall Study|Lack of Efficacy|0
2950|NCT02600351|16333|P1|Overall Study|Lack of Efficacy|3
2951|NCT02599129|16365|P2|Overall Study|Withdrawal by Subject|1
2952|NCT02599129|16366|P1|Overall Study|Withdrawal by Subject|2
2953|NCT02599129|16365|P2|Overall Study|Lost to Follow-up|0
2954|NCT02599129|16366|P1|Overall Study|Lost to Follow-up|1
2955|NCT02599129|16365|P2|Overall Study|Lack of Efficacy|2
2956|NCT02599129|16366|P1|Overall Study|Lack of Efficacy|2
2957|NCT02598934|16382|P2|Overall Study|Protocol Violation|2
2958|NCT02598934|16383|P1|Overall Study|Protocol Violation|1
2959|NCT02598934|16382|P2|Overall Study|Administrative|1
2960|NCT02598934|16383|P1|Overall Study|Administrative|2
2961|NCT02598934|16382|P2|Overall Study|Withdrawal by Subject|3
2962|NCT02598934|16383|P1|Overall Study|Withdrawal by Subject|2
2963|NCT02598934|16382|P2|Overall Study|Failure to Return|3
2964|NCT02598934|16383|P1|Overall Study|Failure to Return|3
2965|NCT02598934|16382|P2|Overall Study|Adverse Event|13
2966|NCT02598934|16383|P1|Overall Study|Adverse Event|11
2967|NCT02598622|16395|P2|Overall Study|Physician Decision|0
2968|NCT02598622|16396|P1|Overall Study|Physician Decision|3
2969|NCT02598622|16395|P2|Overall Study|Withdrawal by Subject|0
2970|NCT02598622|16396|P1|Overall Study|Withdrawal by Subject|3
2971|NCT02598128|16423|P4|Period A: Days -7 to -1|Adverse Event|0
2972|NCT02598128|16424|P3|Period A: Days -7 to -1|Adverse Event|0
2973|NCT02598128|16425|P2|Period A: Days -7 to -1|Adverse Event|0
2974|NCT02598128|16426|P1|Period A: Days -7 to -1|Adverse Event|1
2975|NCT02597855|16449|P2|Overall Study|Lost to Follow-up|1
2976|NCT02597855|16450|P1|Overall Study|Lost to Follow-up|2
2977|NCT02597049|16499|P3|Overall Study|Noncompliant with Study Visits|0
2978|NCT02597049|16500|P2|Overall Study|Noncompliant with Study Visits|0
2979|NCT02597049|16501|P1|Overall Study|Noncompliant with Study Visits|1
2980|NCT02597049|16499|P3|Overall Study|Death|0
2981|NCT02597049|16500|P2|Overall Study|Death|0
2982|NCT02597049|16501|P1|Overall Study|Death|2
2983|NCT02597049|16499|P3|Overall Study|Adverse Event|0
2984|NCT02597049|16500|P2|Overall Study|Adverse Event|0
2985|NCT02597049|16501|P1|Overall Study|Adverse Event|2
2986|NCT02597049|16499|P3|Overall Study|Withdrawal by Subject|1
2987|NCT02597049|16500|P2|Overall Study|Withdrawal by Subject|2
2988|NCT02597049|16501|P1|Overall Study|Withdrawal by Subject|2
2989|NCT02597049|16499|P3|Overall Study|Lost to Follow-up|2
2990|NCT02597049|16500|P2|Overall Study|Lost to Follow-up|3
2991|NCT02597049|16501|P1|Overall Study|Lost to Follow-up|0
2992|NCT02596958|16539|P1|Overall Study|Excluded Due to Second Line Treatment|9
2993|NCT02596958|16539|P1|Overall Study|Missing|32
2994|NCT02596958|16539|P1|Overall Study|Lost to Follow-up|33
2995|NCT02596958|16539|P1|Overall Study|Administrative Reasons/Other|231
2996|NCT02596958|16539|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
2997|NCT02596958|16539|P1|Overall Study|Death From Other Cause|33
2998|NCT02596958|16539|P1|Overall Study|Death From Cancer|112
2999|NCT02596958|16539|P1|Overall Study|Cancer Progression|441
3000|NCT02596958|16539|P1|Overall Study|Serious Adverse Drug Reactions|44
3001|NCT02596945|16551|P1|Overall Study|Missing|1
3002|NCT02596945|16551|P1|Overall Study|Withdrawal by Subject|1
3003|NCT02596945|16551|P1|Overall Study|Other Erythropoietin stimulating agent|4
3004|NCT02596945|16551|P1|Overall Study|Change to hemodialysis|15
3005|NCT02596945|16551|P1|Overall Study|Other|32
3006|NCT02596945|16551|P1|Overall Study|No documentation of study drug dosing|3
3007|NCT02596854|16562|P1|Overall Study|Withdrawn|8
3008|NCT02596620|16568|P2|Overall Study|Lost to Follow-up|1
3009|NCT02596620|16569|P1|Overall Study|Lost to Follow-up|1
3010|NCT02595502|16615|P2|Period 3|Received Incorrect Treatment at period 3|1
3011|NCT02595502|16616|P1|Period 3|Received Incorrect Treatment at period 3|0
3012|NCT02595502|16615|P2|Period 3|Lost to Follow-up|0
3013|NCT02595502|16616|P1|Period 3|Lost to Follow-up|1
3014|NCT02595502|16615|P2|Period 3|Protocol Violation|1
3015|NCT02595502|16616|P1|Period 3|Protocol Violation|0
3016|NCT02595502|16615|P2|Period 2|Received incorrect lens at Period 1|1
3017|NCT02595502|16616|P1|Period 2|Received incorrect lens at Period 1|0
3018|NCT02595502|16615|P2|Period 2|Adverse Event|1
3019|NCT02595502|16616|P1|Period 2|Adverse Event|1
3020|NCT02595502|16615|P2|Period 1|Lost to Follow-up|1
3021|NCT02595502|16616|P1|Period 1|Lost to Follow-up|0
3022|NCT02595502|16615|P2|Period 1|Withdrawal by Subject|0
3023|NCT02595502|16616|P1|Period 1|Withdrawal by Subject|1
3024|NCT02595502|16615|P2|Period 1|Adverse Event|1
3025|NCT02595502|16616|P1|Period 1|Adverse Event|0
3026|NCT02595450|16622|P1|Overall Study|Enrolled, but not treated|8
3027|NCT02595450|16622|P1|Overall Study|Unspecified (only completed 1 cycle)|73
3028|NCT02593773|16637|P1|Overall Study|Death|1
3029|NCT02593773|16637|P1|Overall Study|Study Terminated by Sponsor|31
3030|NCT02593773|16637|P1|Overall Study|Voluntary Withdrawal|3
3031|NCT02591290|16687|P1|Overall Study|Withdrawal by Subject|2
3032|NCT02591238|16697|P4|Overall Study|personal circumstances|0
3033|NCT02591238|16698|P3|Overall Study|personal circumstances|0
3034|NCT02591238|16699|P2|Overall Study|personal circumstances|1
3035|NCT02591238|16700|P1|Overall Study|personal circumstances|0
3036|NCT02591238|16697|P4|Overall Study|personal circumstances|1
3037|NCT02591238|16698|P3|Overall Study|personal circumstances|0
3038|NCT02591238|16699|P2|Overall Study|personal circumstances|0
3039|NCT02591238|16700|P1|Overall Study|personal circumstances|0
3040|NCT02591238|16697|P4|Overall Study|influenza|1
3041|NCT02591238|16698|P3|Overall Study|influenza|0
3042|NCT02591238|16699|P2|Overall Study|influenza|0
3043|NCT02591238|16700|P1|Overall Study|influenza|0
3044|NCT02591238|16697|P4|Overall Study|Withdrawal by Subject|1
3045|NCT02591238|16698|P3|Overall Study|Withdrawal by Subject|0
3046|NCT02591238|16699|P2|Overall Study|Withdrawal by Subject|0
3047|NCT02591238|16700|P1|Overall Study|Withdrawal by Subject|0
3048|NCT02591238|16697|P4|Overall Study|Pregnancy|0
3049|NCT02591238|16698|P3|Overall Study|Pregnancy|0
3050|NCT02591238|16699|P2|Overall Study|Pregnancy|0
3051|NCT02591238|16700|P1|Overall Study|Pregnancy|1
3052|NCT02590939|16736|P2|Overall Study|Failed the nociceptive test|1
3053|NCT02590939|16737|P1|Overall Study|Failed the nociceptive test|2
3054|NCT02590939|16736|P2|Overall Study|Withdrawal by Subject|1
3055|NCT02590939|16737|P1|Overall Study|Withdrawal by Subject|3
3056|NCT02590588|16757|P1|Overall Study|Adverse Event|1
3057|NCT02590562|16765|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
3058|NCT02590003|16824|P2|Overall Study|Death|2
3059|NCT02590003|16825|P1|Overall Study|Death|1
3060|NCT02587819|16872|P1|Overall Study|Lost to Follow-up|1
3061|NCT02587819|16872|P1|Overall Study|Adverse Event|1
3062|NCT02587234|16881|P2|Overall Study|Lost to Follow-up|2
3063|NCT02587234|16882|P1|Overall Study|Lost to Follow-up|0
3064|NCT02587234|16881|P2|Overall Study|Withdrawal by Subject|1
3065|NCT02587234|16882|P1|Overall Study|Withdrawal by Subject|1
3066|NCT02586805|16907|P4|Overall Study|Physician Decision|0
3067|NCT02586805|16908|P3|Overall Study|Physician Decision|0
3068|NCT02586805|16909|P2|Overall Study|Physician Decision|0
3069|NCT02586805|16910|P1|Overall Study|Physician Decision|1
3070|NCT02586805|16907|P4|Overall Study|Lost to Follow-up|0
3071|NCT02586805|16908|P3|Overall Study|Lost to Follow-up|1
3072|NCT02586805|16909|P2|Overall Study|Lost to Follow-up|0
3073|NCT02586805|16910|P1|Overall Study|Lost to Follow-up|0
3074|NCT02586805|16907|P4|Overall Study|Adverse Event|0
3075|NCT02586805|16908|P3|Overall Study|Adverse Event|1
3076|NCT02586805|16909|P2|Overall Study|Adverse Event|0
3077|NCT02586805|16910|P1|Overall Study|Adverse Event|2
3078|NCT02586805|16907|P4|Overall Study|Withdrawal by Subject|2
3079|NCT02586805|16908|P3|Overall Study|Withdrawal by Subject|1
3080|NCT02586805|16909|P2|Overall Study|Withdrawal by Subject|1
3081|NCT02586805|16910|P1|Overall Study|Withdrawal by Subject|3
3082|NCT02586506|16932|P1|Overall Study|Other Reason|2
3083|NCT02586506|16932|P1|Overall Study|Lost to Follow-up|1
3084|NCT02586506|16932|P1|Overall Study|Protocol Violation|6
3085|NCT02586493|16938|P1|Overall Study|Withdrawal by Subject|1
3086|NCT02586493|16938|P1|Overall Study|Lost to Follow-up|1
3087|NCT02586493|16938|P1|Overall Study|Protocol Violation|6
3088|NCT02586493|16938|P1|Overall Study|Adverse Event|4
3089|NCT02585999|16944|P1|Overall Study|Protocol Violation|1
3090|NCT02585999|16944|P1|Overall Study|Lost to Follow-up|1
3091|NCT02585778|16971|P2|Overall Study|Other than specified above|2
3092|NCT02585778|16972|P1|Overall Study|Other than specified above|6
3093|NCT02585778|16971|P2|Overall Study|Randomized but not treated|2
3094|NCT02585778|16972|P1|Overall Study|Randomized but not treated|1
3095|NCT02585778|16971|P2|Overall Study|Death|1
3096|NCT02585778|16972|P1|Overall Study|Death|0
3097|NCT02585778|16971|P2|Overall Study|Poor compliance to study protocol|2
3098|NCT02585778|16972|P1|Overall Study|Poor compliance to study protocol|0
3099|NCT02585778|16971|P2|Overall Study|Participant did not wish to continue|4
3100|NCT02585778|16972|P1|Overall Study|Participant did not wish to continue|9
3101|NCT02585778|16971|P2|Overall Study|Adverse Event|4
3102|NCT02585778|16972|P1|Overall Study|Adverse Event|17
3103|NCT02584660|17143|P2|Overall Study|Other|1
3104|NCT02584660|17144|P1|Overall Study|Other|0
3105|NCT02584660|17143|P2|Overall Study|Withdrawal by Subject|2
3106|NCT02584660|17144|P1|Overall Study|Withdrawal by Subject|0
3107|NCT02584660|17143|P2|Overall Study|Protocol Violation|1
3108|NCT02584660|17144|P1|Overall Study|Protocol Violation|0
3109|NCT02584660|17143|P2|Overall Study|Lost to Follow-up|4
3110|NCT02584660|17144|P1|Overall Study|Lost to Follow-up|3
3111|NCT02584660|17143|P2|Overall Study|Adverse Event|0
3112|NCT02584660|17144|P1|Overall Study|Adverse Event|4
3113|NCT02584504|17163|P3|Open-label Treatment|Entered but not treated|1
3114|NCT02584504|17164|P2|Open-label Treatment|Entered but not treated|1
3115|NCT02584504|17165|P1|Open-label Treatment|Entered but not treated|0
3116|NCT02584504|17163|P3|Open-label Treatment|Ongoing in the study|52
3117|NCT02584504|17164|P2|Open-label Treatment|Ongoing in the study|49
3118|NCT02584504|17165|P1|Open-label Treatment|Ongoing in the study|54
3119|NCT02584504|17163|P3|Open-label Treatment|Adverse Event|0
3120|NCT02584504|17164|P2|Open-label Treatment|Adverse Event|1
3121|NCT02584504|17165|P1|Open-label Treatment|Adverse Event|0
3122|NCT02584504|17163|P3|Open-label Treatment|Participant withdrew consent|2
3123|NCT02584504|17164|P2|Open-label Treatment|Participant withdrew consent|0
3124|NCT02584504|17165|P1|Open-label Treatment|Participant withdrew consent|0
3125|NCT02584504|17163|P3|Double-blind Treatment|Family Matter|0
3126|NCT02584504|17164|P2|Double-blind Treatment|Family Matter|1
3127|NCT02584504|17165|P1|Double-blind Treatment|Family Matter|0
3128|NCT02584504|17163|P3|Double-blind Treatment|Adverse Event|0
3129|NCT02584504|17164|P2|Double-blind Treatment|Adverse Event|1
3130|NCT02584504|17165|P1|Double-blind Treatment|Adverse Event|0
3131|NCT02584504|17163|P3|Double-blind Treatment|Participant withdrew consent|1
3132|NCT02584504|17164|P2|Double-blind Treatment|Participant withdrew consent|0
3133|NCT02584504|17165|P1|Double-blind Treatment|Participant withdrew consent|0
3134|NCT02583425|17216|P1|Treatment Period|Adverse Event|1
3135|NCT02583425|17216|P1|Baseline|Did not meet continued criteria|5
3136|NCT02583425|17216|P1|Screening|Did not meet entry criteria|12
3137|NCT02582983|17221|P1|Overall Study|Adverse Event|1
3138|NCT02582983|17221|P1|Overall Study|Withdrawal by Subject|2
3139|NCT02582983|17221|P1|Overall Study|Death|3
3140|NCT02582684|17236|P1|Overall Study|Found to be ineligible after enrollment|2
3141|NCT02582684|17236|P1|Overall Study|Subject withdrew consent|1
3142|NCT02582684|17236|P1|Overall Study|Subject not able to get to clinic|10
3143|NCT02582684|17236|P1|Overall Study|Unable to contact subject/parent|4
3144|NCT02582632|17255|P1|Overall Study|Not Specified|1
3145|NCT02582242|17270|P2|Overall Study|Unclassified|1
3146|NCT02582242|17271|P1|Overall Study|Unclassified|2
3147|NCT02582242|17270|P2|Overall Study|Withdrawal by Subject|11
3148|NCT02582242|17271|P1|Overall Study|Withdrawal by Subject|11
3149|NCT02582242|17270|P2|Overall Study|Lost to Follow-up|1
3150|NCT02582242|17271|P1|Overall Study|Lost to Follow-up|0
3151|NCT02582242|17270|P2|Overall Study|Protocol Violation|1
3152|NCT02582242|17271|P1|Overall Study|Protocol Violation|3
3153|NCT02582242|17270|P2|Overall Study|Adverse Event|3
3154|NCT02582242|17271|P1|Overall Study|Adverse Event|4
3155|NCT02581410|17328|P2|Overall Study|Migrated/moved from study area|1
3156|NCT02581410|17329|P1|Overall Study|Migrated/moved from study area|0
3157|NCT02581410|17328|P2|Overall Study|Withdrawal by Subject|1
3158|NCT02581410|17329|P1|Overall Study|Withdrawal by Subject|0
3159|NCT02581410|17328|P2|Overall Study|Adverse Event|1
3160|NCT02581410|17329|P1|Overall Study|Adverse Event|2
3161|NCT02580357|17374|P3|Overall Study|Protocol Violation|0
3162|NCT02580357|17375|P2|Overall Study|Protocol Violation|0
3163|NCT02580357|17376|P1|Overall Study|Protocol Violation|1
3164|NCT02580357|17374|P3|Overall Study|Lost to Follow-up|0
3165|NCT02580357|17375|P2|Overall Study|Lost to Follow-up|0
3166|NCT02580357|17376|P1|Overall Study|Lost to Follow-up|2
3167|NCT02580240|17393|P2|Overall Study|Physician Decision|0
3168|NCT02580240|17394|P1|Overall Study|Physician Decision|2
3169|NCT02579603|17404|P2|Overall Study|Other than stated|0
3170|NCT02579603|17405|P1|Overall Study|Other than stated|1
3171|NCT02579603|17404|P2|Overall Study|Adverse Event|2
3172|NCT02579603|17405|P1|Overall Study|Adverse Event|2
3173|NCT02579603|17404|P2|Overall Study|Not treated|0
3174|NCT02579603|17405|P1|Overall Study|Not treated|1
3175|NCT02578992|17431|P2|Overall Study|equipment not available or malfunction|3
3176|NCT02578992|17432|P1|Overall Study|equipment not available or malfunction|3
3177|NCT02578706|17447|P3|Overall Study|Physician Decision|0
3178|NCT02578706|17448|P2|Overall Study|Physician Decision|1
3179|NCT02578706|17449|P1|Overall Study|Physician Decision|0
3180|NCT02578706|17447|P3|Overall Study|Lost to Follow-up|0
3181|NCT02578706|17448|P2|Overall Study|Lost to Follow-up|4
3182|NCT02578706|17449|P1|Overall Study|Lost to Follow-up|0
3183|NCT02578706|17447|P3|Overall Study|Withdrawal by Subject|0
3184|NCT02578706|17448|P2|Overall Study|Withdrawal by Subject|0
3185|NCT02578706|17449|P1|Overall Study|Withdrawal by Subject|1
3186|NCT02578316|17526|P1|Extension Phase|Progression of disease|6
3187|NCT02578186|17555|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
3188|NCT02578186|17556|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
3189|NCT02578186|17555|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
3190|NCT02578186|17556|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
3191|NCT02577718|17562|P1|Overall Study|Withdrawal by Subject|2
3192|NCT02577718|17562|P1|Overall Study|Death|6
3193|NCT02577315|17597|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
3194|NCT02577315|17598|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
3195|NCT02577107|17616|P2|Overall Study|Protocol deviation|1
3196|NCT02577107|17617|P1|Overall Study|Protocol deviation|0
3197|NCT02577016|17631|P2|Overall Study|Physician Decision|1
3198|NCT02577016|17632|P1|Overall Study|Physician Decision|0
3199|NCT02577016|17631|P2|Overall Study|Adverse Event|1
3200|NCT02577016|17632|P1|Overall Study|Adverse Event|2
3201|NCT02577003|17650|P2|Overall Study|Withdrawal by Subject|1
3202|NCT02577003|17651|P1|Overall Study|Withdrawal by Subject|0
3203|NCT02577003|17650|P2|Overall Study|Adverse Event|4
3204|NCT02577003|17651|P1|Overall Study|Adverse Event|2
3205|NCT02576938|17672|P3|Overall Study|Met Exclusion Criteria|0
3206|NCT02576938|17673|P2|Overall Study|Met Exclusion Criteria|1
3207|NCT02576938|17674|P1|Overall Study|Met Exclusion Criteria|0
3208|NCT02576938|17672|P3|Overall Study|Physician Decision|0
3209|NCT02576938|17673|P2|Overall Study|Physician Decision|1
3210|NCT02576938|17674|P1|Overall Study|Physician Decision|0
3211|NCT02576938|17672|P3|Overall Study|Lost to Follow-up|1
3212|NCT02576938|17673|P2|Overall Study|Lost to Follow-up|0
3213|NCT02576938|17674|P1|Overall Study|Lost to Follow-up|2
3214|NCT02576938|17672|P3|Overall Study|Lack of Efficacy|0
3215|NCT02576938|17673|P2|Overall Study|Lack of Efficacy|4
3216|NCT02576938|17674|P1|Overall Study|Lack of Efficacy|9
3217|NCT02576938|17672|P3|Overall Study|Withdrawal by Subject|4
3218|NCT02576938|17673|P2|Overall Study|Withdrawal by Subject|2
3219|NCT02576938|17674|P1|Overall Study|Withdrawal by Subject|3
3220|NCT02576938|17672|P3|Overall Study|Protocol Violation|1
3221|NCT02576938|17673|P2|Overall Study|Protocol Violation|1
3222|NCT02576938|17674|P1|Overall Study|Protocol Violation|1
3223|NCT02576938|17672|P3|Overall Study|Adverse Event|6
3224|NCT02576938|17673|P2|Overall Study|Adverse Event|3
3225|NCT02576938|17674|P1|Overall Study|Adverse Event|5
3226|NCT02576639|17707|P5|Overall Study|Physician Decision|1
3227|NCT02576639|17708|P4|Overall Study|Physician Decision|0
3228|NCT02576639|17709|P3|Overall Study|Physician Decision|0
3229|NCT02576639|17710|P2|Overall Study|Physician Decision|0
3230|NCT02576639|17711|P1|Overall Study|Physician Decision|0
3231|NCT02576639|17707|P5|Overall Study|Adverse Event|2
3232|NCT02576639|17708|P4|Overall Study|Adverse Event|1
3233|NCT02576639|17709|P3|Overall Study|Adverse Event|1
3234|NCT02576639|17710|P2|Overall Study|Adverse Event|0
3235|NCT02576639|17711|P1|Overall Study|Adverse Event|1
3236|NCT02576639|17707|P5|Overall Study|Withdrawal by Subject|1
3237|NCT02576639|17708|P4|Overall Study|Withdrawal by Subject|0
3238|NCT02576639|17709|P3|Overall Study|Withdrawal by Subject|1
3239|NCT02576639|17710|P2|Overall Study|Withdrawal by Subject|2
3240|NCT02576639|17711|P1|Overall Study|Withdrawal by Subject|1
3241|NCT02576535|17768|P1|Overall Study|Withdrawal by Subject|2
3242|NCT02576145|17792|P2|Overall Study|Tetanus Titers Decreased|1
3243|NCT02576145|17793|P1|Overall Study|Tetanus Titers Decreased|0
3244|NCT02576145|17792|P2|Overall Study|Acute rejection|0
3245|NCT02576145|17793|P1|Overall Study|Acute rejection|1
3246|NCT02576145|17792|P2|Overall Study|Withdrawal by Subject|0
3247|NCT02576145|17793|P1|Overall Study|Withdrawal by Subject|1
3248|NCT02576145|17792|P2|Overall Study|Adverse Event|0
3249|NCT02576145|17793|P1|Overall Study|Adverse Event|1
3250|NCT02575911|17835|P1|Overall Study|Lost to Follow-up|1
3251|NCT02574845|17864|P6|Overall Study|Adverse Event|1
3252|NCT02574845|17865|P5|Overall Study|Adverse Event|0
3253|NCT02574845|17866|P4|Overall Study|Adverse Event|0
3254|NCT02574845|17867|P3|Overall Study|Adverse Event|0
3255|NCT02574845|17868|P2|Overall Study|Adverse Event|1
3256|NCT02574845|17869|P1|Overall Study|Adverse Event|0
3257|NCT02574845|17864|P6|Overall Study|Consent withdrawn further participation|0
3258|NCT02574845|17865|P5|Overall Study|Consent withdrawn further participation|1
3259|NCT02574845|17866|P4|Overall Study|Consent withdrawn further participation|0
3260|NCT02574845|17867|P3|Overall Study|Consent withdrawn further participation|0
3261|NCT02574845|17868|P2|Overall Study|Consent withdrawn further participation|0
3262|NCT02574845|17869|P1|Overall Study|Consent withdrawn further participation|0
3263|NCT02574260|17899|P1|Overall Study|Disease Progression|1
3264|NCT02574247|17908|P3|Overall Study|Did not meet inclusion criteria|5
3265|NCT02574247|17909|P2|Overall Study|Did not meet inclusion criteria|3
3266|NCT02574247|17910|P1|Overall Study|Did not meet inclusion criteria|4
3267|NCT02574247|17908|P3|Overall Study|Withdrawal by Subject|0
3268|NCT02574247|17909|P2|Overall Study|Withdrawal by Subject|0
3269|NCT02574247|17910|P1|Overall Study|Withdrawal by Subject|1
3270|NCT02573870|17924|P2|Overall Study|Other: Fail to Meet Visit|2
3271|NCT02573870|17925|P1|Overall Study|Other: Fail to Meet Visit|0
3272|NCT02573870|17924|P2|Overall Study|Lost to Follow-up|1
3273|NCT02573870|17925|P1|Overall Study|Lost to Follow-up|0
3274|NCT02573870|17924|P2|Overall Study|Other: Reached defined stopping criteria|1
3275|NCT02573870|17925|P1|Overall Study|Other: Reached defined stopping criteria|0
3276|NCT02573870|17924|P2|Overall Study|Lack of Efficacy|1
3277|NCT02573870|17925|P1|Overall Study|Lack of Efficacy|0
3278|NCT02573870|17924|P2|Overall Study|Adverse Event|2
3279|NCT02573870|17925|P1|Overall Study|Adverse Event|0
3280|NCT02573467|17935|P4|Post-treatment Follow up Epoch|Technical problems|0
3281|NCT02573467|17936|P3|Post-treatment Follow up Epoch|Technical problems|1
3282|NCT02573467|17937|P2|Post-treatment Follow up Epoch|Technical problems|0
3283|NCT02573467|17938|P1|Post-treatment Follow up Epoch|Technical problems|0
3284|NCT02573467|17935|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
3285|NCT02573467|17936|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
3286|NCT02573467|17937|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
3287|NCT02573467|17938|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
3288|NCT02573467|17935|P4|Post-treatment Follow up Epoch|Death|1
3289|NCT02573467|17936|P3|Post-treatment Follow up Epoch|Death|0
3290|NCT02573467|17937|P2|Post-treatment Follow up Epoch|Death|1
3291|NCT02573467|17938|P1|Post-treatment Follow up Epoch|Death|1
3292|NCT02573467|17935|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
3293|NCT02573467|17936|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
3294|NCT02573467|17937|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
3295|NCT02573467|17938|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
3296|NCT02573467|17935|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
3297|NCT02573467|17936|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
3298|NCT02573467|17937|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
3299|NCT02573467|17938|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
3300|NCT02573467|17935|P4|Double-blind Treatment Epoch|Adverse Event|0
3301|NCT02573467|17936|P3|Double-blind Treatment Epoch|Adverse Event|1
3302|NCT02573467|17937|P2|Double-blind Treatment Epoch|Adverse Event|0
3303|NCT02573467|17938|P1|Double-blind Treatment Epoch|Adverse Event|1
3304|NCT02573467|17935|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
3305|NCT02573467|17936|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
3306|NCT02573467|17937|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
3307|NCT02573467|17938|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
3308|NCT02570165|18138|P7|Overall Study|Withdrawal Request by GSK|0
3309|NCT02570165|18139|P6|Overall Study|Withdrawal Request by GSK|0
3310|NCT02570165|18140|P5|Overall Study|Withdrawal Request by GSK|0
3311|NCT02570165|18141|P4|Overall Study|Withdrawal Request by GSK|0
3312|NCT02570165|18142|P3|Overall Study|Withdrawal Request by GSK|2
3313|NCT02570165|18143|P2|Overall Study|Withdrawal Request by GSK|0
3314|NCT02570165|18144|P1|Overall Study|Withdrawal Request by GSK|0
3315|NCT02570165|18138|P7|Overall Study|Par. did not Meet Continuation Criteria|0
3316|NCT02570165|18139|P6|Overall Study|Par. did not Meet Continuation Criteria|1
3317|NCT02570165|18140|P5|Overall Study|Par. did not Meet Continuation Criteria|0
3318|NCT02570165|18141|P4|Overall Study|Par. did not Meet Continuation Criteria|0
3319|NCT02570165|18142|P3|Overall Study|Par. did not Meet Continuation Criteria|0
3320|NCT02570165|18143|P2|Overall Study|Par. did not Meet Continuation Criteria|0
3321|NCT02570165|18144|P1|Overall Study|Par. did not Meet Continuation Criteria|0
3322|NCT02570165|18138|P7|Overall Study|Withdrawal by Subject|0
3323|NCT02570165|18139|P6|Overall Study|Withdrawal by Subject|0
3324|NCT02570165|18140|P5|Overall Study|Withdrawal by Subject|1
3325|NCT02570165|18141|P4|Overall Study|Withdrawal by Subject|2
3326|NCT02570165|18142|P3|Overall Study|Withdrawal by Subject|0
3327|NCT02570165|18143|P2|Overall Study|Withdrawal by Subject|0
3328|NCT02570165|18144|P1|Overall Study|Withdrawal by Subject|0
3329|NCT02570165|18138|P7|Overall Study|Physician Decision|0
3330|NCT02570165|18139|P6|Overall Study|Physician Decision|0
3331|NCT02570165|18140|P5|Overall Study|Physician Decision|0
3332|NCT02570165|18141|P4|Overall Study|Physician Decision|0
3333|NCT02570165|18142|P3|Overall Study|Physician Decision|0
3334|NCT02570165|18143|P2|Overall Study|Physician Decision|1
3335|NCT02570165|18144|P1|Overall Study|Physician Decision|0
3336|NCT02570165|18138|P7|Overall Study|Lost to Follow-up|0
3337|NCT02570165|18139|P6|Overall Study|Lost to Follow-up|0
3338|NCT02570165|18140|P5|Overall Study|Lost to Follow-up|0
3339|NCT02570165|18141|P4|Overall Study|Lost to Follow-up|1
3340|NCT02570165|18142|P3|Overall Study|Lost to Follow-up|1
3341|NCT02570165|18143|P2|Overall Study|Lost to Follow-up|0
3342|NCT02570165|18144|P1|Overall Study|Lost to Follow-up|0
3343|NCT02570165|18138|P7|Overall Study|Par. Reached Stopping Criteria|0
3344|NCT02570165|18139|P6|Overall Study|Par. Reached Stopping Criteria|1
3345|NCT02570165|18140|P5|Overall Study|Par. Reached Stopping Criteria|1
3346|NCT02570165|18141|P4|Overall Study|Par. Reached Stopping Criteria|2
3347|NCT02570165|18142|P3|Overall Study|Par. Reached Stopping Criteria|0
3348|NCT02570165|18143|P2|Overall Study|Par. Reached Stopping Criteria|1
3349|NCT02570165|18144|P1|Overall Study|Par. Reached Stopping Criteria|1
3350|NCT02570165|18138|P7|Overall Study|Lack of Efficacy|0
3351|NCT02570165|18139|P6|Overall Study|Lack of Efficacy|0
3352|NCT02570165|18140|P5|Overall Study|Lack of Efficacy|4
3353|NCT02570165|18141|P4|Overall Study|Lack of Efficacy|0
3354|NCT02570165|18142|P3|Overall Study|Lack of Efficacy|0
3355|NCT02570165|18143|P2|Overall Study|Lack of Efficacy|1
3356|NCT02570165|18144|P1|Overall Study|Lack of Efficacy|0
3357|NCT02570165|18138|P7|Overall Study|Adverse Event|0
3358|NCT02570165|18139|P6|Overall Study|Adverse Event|0
3359|NCT02570165|18140|P5|Overall Study|Adverse Event|0
3360|NCT02570165|18141|P4|Overall Study|Adverse Event|0
3361|NCT02570165|18142|P3|Overall Study|Adverse Event|2
3362|NCT02570165|18143|P2|Overall Study|Adverse Event|0
3363|NCT02570165|18144|P1|Overall Study|Adverse Event|1
3364|NCT02570126|18169|P2|Overall Study|Withdrawal by Subject|7
3365|NCT02570126|18170|P1|Overall Study|Withdrawal by Subject|3
3366|NCT02570126|18169|P2|Overall Study|Protocol Violation|1
3367|NCT02570126|18170|P1|Overall Study|Protocol Violation|0
3368|NCT02570126|18169|P2|Overall Study|Violation Of Procedures GSK|1
3369|NCT02570126|18170|P1|Overall Study|Violation Of Procedures GSK|0
3370|NCT02570126|18169|P2|Overall Study|Unable To Arrange Visit 3|0
3371|NCT02570126|18170|P1|Overall Study|Unable To Arrange Visit 3|1
3372|NCT02570126|18169|P2|Overall Study|Lost to Follow-up|0
3373|NCT02570126|18170|P1|Overall Study|Lost to Follow-up|2
3374|NCT02569996|18205|P1|Overall Study|Unknown reason|1
3375|NCT02569996|18205|P1|Overall Study|Complete remission|7
3376|NCT02569996|18205|P1|Overall Study|Lost to Follow-up|5
3377|NCT02569996|18205|P1|Overall Study|Withdrawal by Subject|5
3378|NCT02569996|18205|P1|Overall Study|Non-compliance|9
3379|NCT02569996|18205|P1|Overall Study|New anti-lymphoma treatment|1
3380|NCT02569996|18205|P1|Overall Study|Progression of the disease|18
3381|NCT02569996|18205|P1|Overall Study|Physician Decision|3
3382|NCT02569996|18205|P1|Overall Study|Adverse Event|6
3383|NCT02569957|18217|P2|Overall Study|Withdrawal by Subject|1
3384|NCT02569957|18218|P1|Overall Study|Withdrawal by Subject|0
3385|NCT02569437|18269|P2|Overall Study|Lost to Follow-up|14
3386|NCT02569437|18270|P1|Overall Study|Lost to Follow-up|12
3387|NCT02568384|18328|P1|Overall Study|Mobile devices incompatible with App|2
3388|NCT02568254|18342|P6|Period 3|Unstatisfactory Lens fitting|0
3389|NCT02568254|18343|P5|Period 3|Unstatisfactory Lens fitting|1
3390|NCT02568254|18344|P4|Period 3|Unstatisfactory Lens fitting|0
3391|NCT02568254|18345|P3|Period 3|Unstatisfactory Lens fitting|0
3392|NCT02568254|18346|P2|Period 3|Unstatisfactory Lens fitting|0
3393|NCT02568254|18347|P1|Period 3|Unstatisfactory Lens fitting|0
3394|NCT02568254|18342|P6|Period 2|Adverse Event|0
3395|NCT02568254|18343|P5|Period 2|Adverse Event|0
3396|NCT02568254|18344|P4|Period 2|Adverse Event|0
3397|NCT02568254|18345|P3|Period 2|Adverse Event|1
3398|NCT02568254|18346|P2|Period 2|Adverse Event|0
3399|NCT02568254|18347|P1|Period 2|Adverse Event|0
3400|NCT02567552|18357|P2|Overall Study|Adverse Event|1
3401|NCT02567552|18358|P1|Overall Study|Adverse Event|0
3402|NCT02567188|18388|P1|Overall Study|Protocol Violation|5
3403|NCT02567188|18388|P1|Overall Study|Started Hemodialysis|2
3404|NCT02567188|18388|P1|Overall Study|Moved and Changed Clinic|1
3405|NCT02567188|18388|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
3406|NCT02567188|18388|P1|Overall Study|Withdrawal by Subject|1
3407|NCT02567188|18388|P1|Overall Study|Adverse Event|1
3408|NCT02567188|18388|P1|Overall Study|Lost to Follow-up|5
3409|NCT02567188|18388|P1|Overall Study|Terminated Mircera Treatment|9
3410|NCT02567188|18388|P1|Overall Study|Death|10
3411|NCT02566759|18434|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
3412|NCT02566759|18435|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3413|NCT02566759|18436|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3414|NCT02566759|18437|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3415|NCT02566759|18438|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3416|NCT02566759|18439|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3417|NCT02566759|18440|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3418|NCT02566759|18441|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3419|NCT02566759|18442|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3420|NCT02566759|18443|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3421|NCT02566759|18444|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3422|NCT02566759|18445|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3423|NCT02566759|18446|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3424|NCT02566759|18447|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3425|NCT02566759|18448|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3426|NCT02566759|18449|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3427|NCT02566759|18450|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
3428|NCT02566759|18434|P17|All Parts|Other|0
3429|NCT02566759|18435|P16|All Parts|Other|0
3430|NCT02566759|18436|P15|All Parts|Other|0
3431|NCT02566759|18437|P14|All Parts|Other|2
3432|NCT02566759|18438|P13|All Parts|Other|0
3433|NCT02566759|18439|P12|All Parts|Other|0
3434|NCT02566759|18440|P11|All Parts|Other|0
3435|NCT02566759|18441|P10|All Parts|Other|0
3436|NCT02566759|18442|P9|All Parts|Other|0
3437|NCT02566759|18443|P8|All Parts|Other|0
3438|NCT02566759|18444|P7|All Parts|Other|0
3439|NCT02566759|18445|P6|All Parts|Other|0
3440|NCT02566759|18446|P5|All Parts|Other|0
3441|NCT02566759|18447|P4|All Parts|Other|0
3442|NCT02566759|18448|P3|All Parts|Other|0
3443|NCT02566759|18449|P2|All Parts|Other|0
3444|NCT02566759|18450|P1|All Parts|Other|0
3445|NCT02566759|18434|P17|All Parts|Adverse Event|0
3446|NCT02566759|18435|P16|All Parts|Adverse Event|0
3447|NCT02566759|18436|P15|All Parts|Adverse Event|0
3448|NCT02566759|18437|P14|All Parts|Adverse Event|3
3449|NCT02566759|18438|P13|All Parts|Adverse Event|1
3450|NCT02566759|18439|P12|All Parts|Adverse Event|0
3451|NCT02566759|18440|P11|All Parts|Adverse Event|0
3452|NCT02566759|18441|P10|All Parts|Adverse Event|0
3453|NCT02566759|18442|P9|All Parts|Adverse Event|0
3454|NCT02566759|18443|P8|All Parts|Adverse Event|0
3455|NCT02566759|18444|P7|All Parts|Adverse Event|0
3456|NCT02566759|18445|P6|All Parts|Adverse Event|0
3457|NCT02566759|18446|P5|All Parts|Adverse Event|0
3458|NCT02566759|18447|P4|All Parts|Adverse Event|0
3459|NCT02566759|18448|P3|All Parts|Adverse Event|0
3460|NCT02566759|18449|P2|All Parts|Adverse Event|0
3461|NCT02566759|18450|P1|All Parts|Adverse Event|0
3462|NCT02566759|18434|P17|All Parts|Withdrawal by Subject|0
3463|NCT02566759|18435|P16|All Parts|Withdrawal by Subject|0
3464|NCT02566759|18436|P15|All Parts|Withdrawal by Subject|0
3465|NCT02566759|18437|P14|All Parts|Withdrawal by Subject|0
3466|NCT02566759|18438|P13|All Parts|Withdrawal by Subject|0
3467|NCT02566759|18439|P12|All Parts|Withdrawal by Subject|0
3468|NCT02566759|18440|P11|All Parts|Withdrawal by Subject|0
3469|NCT02566759|18441|P10|All Parts|Withdrawal by Subject|0
3470|NCT02566759|18442|P9|All Parts|Withdrawal by Subject|0
3471|NCT02566759|18443|P8|All Parts|Withdrawal by Subject|0
3472|NCT02566759|18444|P7|All Parts|Withdrawal by Subject|0
3473|NCT02566759|18445|P6|All Parts|Withdrawal by Subject|0
3474|NCT02566759|18446|P5|All Parts|Withdrawal by Subject|0
3475|NCT02566759|18447|P4|All Parts|Withdrawal by Subject|0
3476|NCT02566759|18448|P3|All Parts|Withdrawal by Subject|0
3477|NCT02566759|18449|P2|All Parts|Withdrawal by Subject|1
3478|NCT02566759|18450|P1|All Parts|Withdrawal by Subject|0
3479|NCT02566005|18603|P2|Overall Study|labor after randomization|4
3480|NCT02566005|18604|P1|Overall Study|labor after randomization|0
3481|NCT02566005|18603|P2|Overall Study|did not receive foley|1
3482|NCT02566005|18604|P1|Overall Study|did not receive foley|0
3483|NCT02566005|18603|P2|Overall Study|received foley|0
3484|NCT02566005|18604|P1|Overall Study|received foley|8
3485|NCT02566005|18603|P2|Overall Study|vaginal bleeding|1
3486|NCT02566005|18604|P1|Overall Study|vaginal bleeding|0
3487|NCT02565381|18666|P3|Overall Study|Lost to Follow-up|1
3488|NCT02565381|18667|P2|Overall Study|Lost to Follow-up|0
3489|NCT02565381|18668|P1|Overall Study|Lost to Follow-up|1
3490|NCT02564211|18706|P1|Overall Study|Adverse Event|4
3491|NCT02564055|18718|P6|Overall Study|Withdrawal by Subject|10
3492|NCT02564055|18719|P5|Overall Study|Withdrawal by Subject|10
3493|NCT02564055|18720|P4|Overall Study|Withdrawal by Subject|3
3494|NCT02564055|18721|P3|Overall Study|Withdrawal by Subject|3
3495|NCT02564055|18722|P2|Overall Study|Withdrawal by Subject|4
3496|NCT02564055|18723|P1|Overall Study|Withdrawal by Subject|4
3497|NCT02564055|18718|P6|Overall Study|Physician Decision|0
3498|NCT02564055|18719|P5|Overall Study|Physician Decision|0
3499|NCT02564055|18720|P4|Overall Study|Physician Decision|0
3500|NCT02564055|18721|P3|Overall Study|Physician Decision|1
3501|NCT02564055|18722|P2|Overall Study|Physician Decision|0
3502|NCT02564055|18723|P1|Overall Study|Physician Decision|0
3503|NCT02564055|18718|P6|Overall Study|Lost to Follow-up|0
3504|NCT02564055|18719|P5|Overall Study|Lost to Follow-up|1
3505|NCT02564055|18720|P4|Overall Study|Lost to Follow-up|2
3506|NCT02564055|18721|P3|Overall Study|Lost to Follow-up|4
3507|NCT02564055|18722|P2|Overall Study|Lost to Follow-up|1
3508|NCT02564055|18723|P1|Overall Study|Lost to Follow-up|0
3509|NCT02564055|18718|P6|Overall Study|Reached stopping criteria|1
3510|NCT02564055|18719|P5|Overall Study|Reached stopping criteria|0
3511|NCT02564055|18720|P4|Overall Study|Reached stopping criteria|0
3512|NCT02564055|18721|P3|Overall Study|Reached stopping criteria|0
3513|NCT02564055|18722|P2|Overall Study|Reached stopping criteria|0
3514|NCT02564055|18723|P1|Overall Study|Reached stopping criteria|0
3515|NCT02564055|18718|P6|Overall Study|Protocol Violation|0
3516|NCT02564055|18719|P5|Overall Study|Protocol Violation|0
3517|NCT02564055|18720|P4|Overall Study|Protocol Violation|0
3518|NCT02564055|18721|P3|Overall Study|Protocol Violation|0
3519|NCT02564055|18722|P2|Overall Study|Protocol Violation|0
3520|NCT02564055|18723|P1|Overall Study|Protocol Violation|1
3521|NCT02564055|18718|P6|Overall Study|Adverse Event|1
3522|NCT02564055|18719|P5|Overall Study|Adverse Event|4
3523|NCT02564055|18720|P4|Overall Study|Adverse Event|1
3524|NCT02564055|18721|P3|Overall Study|Adverse Event|4
3525|NCT02564055|18722|P2|Overall Study|Adverse Event|0
3526|NCT02564055|18723|P1|Overall Study|Adverse Event|1
3527|NCT02564042|18977|P6|Overall Study|Withdrawal by Subject|12
3528|NCT02564042|18978|P5|Overall Study|Withdrawal by Subject|10
3529|NCT02564042|18979|P4|Overall Study|Withdrawal by Subject|2
3530|NCT02564042|18980|P3|Overall Study|Withdrawal by Subject|2
3531|NCT02564042|18981|P2|Overall Study|Withdrawal by Subject|3
3532|NCT02564042|18982|P1|Overall Study|Withdrawal by Subject|5
3533|NCT02564042|18977|P6|Overall Study|Physician Decision|0
3534|NCT02564042|18978|P5|Overall Study|Physician Decision|0
3535|NCT02564042|18979|P4|Overall Study|Physician Decision|1
3536|NCT02564042|18980|P3|Overall Study|Physician Decision|0
3537|NCT02564042|18981|P2|Overall Study|Physician Decision|0
3538|NCT02564042|18982|P1|Overall Study|Physician Decision|1
3539|NCT02564042|18977|P6|Overall Study|Lost to Follow-up|1
3540|NCT02564042|18978|P5|Overall Study|Lost to Follow-up|1
3541|NCT02564042|18979|P4|Overall Study|Lost to Follow-up|0
3542|NCT02564042|18980|P3|Overall Study|Lost to Follow-up|1
3543|NCT02564042|18981|P2|Overall Study|Lost to Follow-up|1
3544|NCT02564042|18982|P1|Overall Study|Lost to Follow-up|1
3545|NCT02564042|18977|P6|Overall Study|Adverse Event|1
3546|NCT02564042|18978|P5|Overall Study|Adverse Event|0
3547|NCT02564042|18979|P4|Overall Study|Adverse Event|0
3548|NCT02564042|18980|P3|Overall Study|Adverse Event|3
3549|NCT02564042|18981|P2|Overall Study|Adverse Event|4
3550|NCT02564042|18982|P1|Overall Study|Adverse Event|4
3551|NCT02563899|19239|P4|Overall Study|Withdrawal by Subject|0
3552|NCT02563899|19240|P3|Overall Study|Withdrawal by Subject|1
3553|NCT02563899|19241|P2|Overall Study|Withdrawal by Subject|0
3554|NCT02563899|19242|P1|Overall Study|Withdrawal by Subject|0
3555|NCT02563899|19239|P4|Overall Study|Protocol Violation|0
3556|NCT02563899|19240|P3|Overall Study|Protocol Violation|0
3557|NCT02563899|19241|P2|Overall Study|Protocol Violation|0
3558|NCT02563899|19242|P1|Overall Study|Protocol Violation|1
3559|NCT02563106|19304|P2|Overall Study|Other reason - not specified|1
3560|NCT02563106|19305|P1|Overall Study|Other reason - not specified|2
3561|NCT02563106|19304|P2|Overall Study|Physician Decision|1
3562|NCT02563106|19305|P1|Overall Study|Physician Decision|3
3563|NCT02563106|19304|P2|Overall Study|Lost to Follow-up|2
3564|NCT02563106|19305|P1|Overall Study|Lost to Follow-up|3
3565|NCT02563106|19304|P2|Overall Study|Use of non-permitted concurrent therapy|2
3566|NCT02563106|19305|P1|Overall Study|Use of non-permitted concurrent therapy|1
3567|NCT02563106|19304|P2|Overall Study|Protocol Violation|0
3568|NCT02563106|19305|P1|Overall Study|Protocol Violation|1
3569|NCT02563106|19304|P2|Overall Study|Adverse Event|15
3570|NCT02563106|19305|P1|Overall Study|Adverse Event|17
3571|NCT02563106|19304|P2|Overall Study|Withdrawal by Subject|7
3572|NCT02563106|19305|P1|Overall Study|Withdrawal by Subject|7
3573|NCT02561806|19363|P2|Overall Study|Withdrawal by Subject|2
3574|NCT02561806|19364|P1|Overall Study|Withdrawal by Subject|0
3575|NCT02561806|19363|P2|Overall Study|Adverse Event|2
3576|NCT02561806|19364|P1|Overall Study|Adverse Event|0
3577|NCT02561806|19363|P2|Overall Study|Protocol Violation|0
3578|NCT02561806|19364|P1|Overall Study|Protocol Violation|1
3579|NCT02561572|19427|P2|Overall Study|Protocol Violation|1
3580|NCT02561572|19428|P1|Overall Study|Protocol Violation|0
3581|NCT02561572|19427|P2|Overall Study|Inadequate time before surgery|1
3582|NCT02561572|19428|P1|Overall Study|Inadequate time before surgery|2
3583|NCT02561195|19450|P6|Overall Study|Randomized but not treated|0
3584|NCT02561195|19451|P5|Overall Study|Randomized but not treated|0
3585|NCT02561195|19452|P4|Overall Study|Randomized but not treated|0
3586|NCT02561195|19453|P3|Overall Study|Randomized but not treated|0
3587|NCT02561195|19454|P2|Overall Study|Randomized but not treated|0
3588|NCT02561195|19455|P1|Overall Study|Randomized but not treated|1
3589|NCT02561195|19450|P6|Overall Study|Withdrawal by Subject|0
3590|NCT02561195|19451|P5|Overall Study|Withdrawal by Subject|6
3591|NCT02561195|19452|P4|Overall Study|Withdrawal by Subject|2
3592|NCT02561195|19453|P3|Overall Study|Withdrawal by Subject|4
3593|NCT02561195|19454|P2|Overall Study|Withdrawal by Subject|4
3594|NCT02561195|19455|P1|Overall Study|Withdrawal by Subject|3
3595|NCT02561195|19450|P6|Overall Study|Death|0
3596|NCT02561195|19451|P5|Overall Study|Death|0
3597|NCT02561195|19452|P4|Overall Study|Death|2
3598|NCT02561195|19453|P3|Overall Study|Death|0
3599|NCT02561195|19454|P2|Overall Study|Death|1
3600|NCT02561195|19455|P1|Overall Study|Death|2
3601|NCT02561195|19450|P6|Overall Study|Protocol Violation|2
3602|NCT02561195|19451|P5|Overall Study|Protocol Violation|5
3603|NCT02561195|19452|P4|Overall Study|Protocol Violation|2
3604|NCT02561195|19453|P3|Overall Study|Protocol Violation|1
3605|NCT02561195|19454|P2|Overall Study|Protocol Violation|0
3606|NCT02561195|19455|P1|Overall Study|Protocol Violation|1
3607|NCT02561195|19450|P6|Overall Study|Other|1
3608|NCT02561195|19451|P5|Overall Study|Other|5
3609|NCT02561195|19452|P4|Overall Study|Other|7
3610|NCT02561195|19453|P3|Overall Study|Other|1
3611|NCT02561195|19454|P2|Overall Study|Other|3
3612|NCT02561195|19455|P1|Overall Study|Other|7
3613|NCT02561195|19450|P6|Overall Study|No longer willing to participate|3
3614|NCT02561195|19451|P5|Overall Study|No longer willing to participate|1
3615|NCT02561195|19452|P4|Overall Study|No longer willing to participate|4
3616|NCT02561195|19453|P3|Overall Study|No longer willing to participate|0
3617|NCT02561195|19454|P2|Overall Study|No longer willing to participate|4
3618|NCT02561195|19455|P1|Overall Study|No longer willing to participate|2
3619|NCT02561195|19450|P6|Overall Study|No longer meets eligibility criteria|1
3620|NCT02561195|19451|P5|Overall Study|No longer meets eligibility criteria|4
3621|NCT02561195|19452|P4|Overall Study|No longer meets eligibility criteria|4
3622|NCT02561195|19453|P3|Overall Study|No longer meets eligibility criteria|0
3623|NCT02561195|19454|P2|Overall Study|No longer meets eligibility criteria|1
3624|NCT02561195|19455|P1|Overall Study|No longer meets eligibility criteria|0
3625|NCT02561195|19450|P6|Overall Study|Lost to Follow-up|3
3626|NCT02561195|19451|P5|Overall Study|Lost to Follow-up|3
3627|NCT02561195|19452|P4|Overall Study|Lost to Follow-up|2
3628|NCT02561195|19453|P3|Overall Study|Lost to Follow-up|0
3629|NCT02561195|19454|P2|Overall Study|Lost to Follow-up|4
3630|NCT02561195|19455|P1|Overall Study|Lost to Follow-up|3
3631|NCT02561195|19450|P6|Overall Study|Adverse Event|0
3632|NCT02561195|19451|P5|Overall Study|Adverse Event|4
3633|NCT02561195|19452|P4|Overall Study|Adverse Event|3
3634|NCT02561195|19453|P3|Overall Study|Adverse Event|0
3635|NCT02561195|19454|P2|Overall Study|Adverse Event|5
3636|NCT02561195|19455|P1|Overall Study|Adverse Event|4
3637|NCT02559622|19607|P4|Overall Study|Patient/guardian decision|1
3638|NCT02559622|19608|P3|Overall Study|Patient/guardian decision|0
3639|NCT02559622|19609|P2|Overall Study|Patient/guardian decision|2
3640|NCT02559622|19610|P1|Overall Study|Patient/guardian decision|1
3641|NCT02559622|19607|P4|Overall Study|Adverse Event|2
3642|NCT02559622|19608|P3|Overall Study|Adverse Event|2
3643|NCT02559622|19609|P2|Overall Study|Adverse Event|2
3644|NCT02559622|19610|P1|Overall Study|Adverse Event|0
3645|NCT02559622|19607|P4|Overall Study|Progressive disease|0
3646|NCT02559622|19608|P3|Overall Study|Progressive disease|0
3647|NCT02559622|19609|P2|Overall Study|Progressive disease|1
3648|NCT02559622|19610|P1|Overall Study|Progressive disease|0
3649|NCT02559414|19692|P3|Overall Study|Other|1
3650|NCT02559414|19693|P2|Overall Study|Other|1
3651|NCT02559414|19694|P1|Overall Study|Other|0
3652|NCT02559414|19692|P3|Overall Study|Withdrawal by Subject|1
3653|NCT02559414|19693|P2|Overall Study|Withdrawal by Subject|0
3654|NCT02559414|19694|P1|Overall Study|Withdrawal by Subject|1
3655|NCT02559414|19692|P3|Overall Study|Lost to Follow-up|0
3656|NCT02559414|19693|P2|Overall Study|Lost to Follow-up|1
3657|NCT02559414|19694|P1|Overall Study|Lost to Follow-up|0
3658|NCT02558790|19751|P1|Overall Study|Screen Fail|3
3659|NCT02558790|19751|P1|Overall Study|Withdrawal by Subject|1
3660|NCT02558790|19751|P1|Overall Study|Physician Decision|1
3661|NCT02558790|19751|P1|Overall Study|Lost to Follow-up|2
3662|NCT02557646|19833|P1|Overall Study|Other|14
3663|NCT02557646|19833|P1|Overall Study|Lost to Follow-up|17
3664|NCT02557646|19833|P1|Overall Study|Withdrawal by Subject|18
3665|NCT02557646|19833|P1|Overall Study|Lack of Efficacy|186
3666|NCT02557646|19833|P1|Overall Study|Death|1
3667|NCT02557646|19833|P1|Overall Study|Adverse Event|40
3668|NCT02557399|19858|P2|Overall Study|Withdrawal by Subject|1
3669|NCT02557399|19859|P1|Overall Study|Withdrawal by Subject|1
3670|NCT02557399|19858|P2|Overall Study|Protocol-defined stopping criteria|1
3671|NCT02557399|19859|P1|Overall Study|Protocol-defined stopping criteria|0
3672|NCT02557399|19858|P2|Overall Study|Protocol Violation|1
3673|NCT02557399|19859|P1|Overall Study|Protocol Violation|0
3674|NCT02557399|19858|P2|Overall Study|Adverse Event|5
3675|NCT02557399|19859|P1|Overall Study|Adverse Event|6
3676|NCT02556632|19894|P3|Overall Study|Treatment or Change Delay|1
3677|NCT02556632|19895|P2|Overall Study|Treatment or Change Delay|0
3678|NCT02556632|19896|P1|Overall Study|Treatment or Change Delay|0
3679|NCT02556632|19894|P3|Overall Study|Disliked Study Procedures|1
3680|NCT02556632|19895|P2|Overall Study|Disliked Study Procedures|0
3681|NCT02556632|19896|P1|Overall Study|Disliked Study Procedures|0
3682|NCT02556632|19894|P3|Overall Study|Ineligible|0
3683|NCT02556632|19895|P2|Overall Study|Ineligible|1
3684|NCT02556632|19896|P1|Overall Study|Ineligible|0
3685|NCT02556632|19894|P3|Overall Study|Did Not Start RT|0
3686|NCT02556632|19895|P2|Overall Study|Did Not Start RT|1
3687|NCT02556632|19896|P1|Overall Study|Did Not Start RT|0
3688|NCT02556632|19894|P3|Overall Study|Possibly Related Adverse Event|1
3689|NCT02556632|19895|P2|Overall Study|Possibly Related Adverse Event|0
3690|NCT02556632|19896|P1|Overall Study|Possibly Related Adverse Event|0
3691|NCT02556632|19894|P3|Overall Study|Related Adverse Event|0
3692|NCT02556632|19895|P2|Overall Study|Related Adverse Event|1
3693|NCT02556632|19896|P1|Overall Study|Related Adverse Event|0
3694|NCT02556632|19894|P3|Overall Study|Unrelated Adverse Event|3
3695|NCT02556632|19895|P2|Overall Study|Unrelated Adverse Event|0
3696|NCT02556632|19896|P1|Overall Study|Unrelated Adverse Event|1
3697|NCT02556632|19894|P3|Overall Study|Withdrew (Unrelated Medical)|0
3698|NCT02556632|19895|P2|Overall Study|Withdrew (Unrelated Medical)|0
3699|NCT02556632|19896|P1|Overall Study|Withdrew (Unrelated Medical)|1
3700|NCT02556632|19894|P3|Overall Study|Changed Mind|0
3701|NCT02556632|19895|P2|Overall Study|Changed Mind|1
3702|NCT02556632|19896|P1|Overall Study|Changed Mind|0
3703|NCT02556632|19894|P3|Overall Study|Personal Issues|1
3704|NCT02556632|19895|P2|Overall Study|Personal Issues|1
3705|NCT02556632|19896|P1|Overall Study|Personal Issues|0
3706|NCT02556632|19894|P3|Overall Study|No Reason|1
3707|NCT02556632|19895|P2|Overall Study|No Reason|0
3708|NCT02556632|19896|P1|Overall Study|No Reason|1
3709|NCT02556632|19894|P3|Overall Study|Disliked Intervention|1
3710|NCT02556632|19895|P2|Overall Study|Disliked Intervention|1
3711|NCT02556632|19896|P1|Overall Study|Disliked Intervention|1
3712|NCT02556632|19894|P3|Overall Study|Lost to Follow-up|0
3713|NCT02556632|19895|P2|Overall Study|Lost to Follow-up|0
3714|NCT02556632|19896|P1|Overall Study|Lost to Follow-up|1
3715|NCT02556307|19914|P1|Overall Study|Enrolled but not treated|2
3716|NCT02556307|19914|P1|Overall Study|Change to triple therapy|4
3717|NCT02556307|19914|P1|Overall Study|Lost to Follow-up|36
3718|NCT02556307|19914|P1|Overall Study|Premature treatment interruption|11
3719|NCT02556138|19924|P1|Overall Study|Withdrawal by Subject|1
3720|NCT02555722|19932|P2|Month 2|Adverse Event|0
3721|NCT02555722|19933|P1|Month 2|Adverse Event|3
3722|NCT02555722|19932|P2|Month 1|Withdrawal by Subject|0
3723|NCT02555722|19933|P1|Month 1|Withdrawal by Subject|2
3724|NCT02555722|19932|P2|Week 2|Lens Discomfort|1
3725|NCT02555722|19933|P1|Week 2|Lens Discomfort|0
3726|NCT02555722|19932|P2|Week 1|Withdrawal by Subject|0
3727|NCT02555722|19933|P1|Week 1|Withdrawal by Subject|1
3728|NCT02555618|20093|P2|Overall Study|Sponsor's Circumstances|0
3729|NCT02555618|20094|P1|Overall Study|Sponsor's Circumstances|1
3730|NCT02554981|20151|P1|Overall Study|Other Miscellaneous Reasons|3
3731|NCT02554981|20151|P1|Overall Study|Administrative Reasons|1
3732|NCT02554981|20151|P1|Overall Study|Adverse Event|1
3733|NCT02554877|20179|P4|Overall Study|No longer willing to participate|0
3734|NCT02554877|20180|P3|Overall Study|No longer willing to participate|2
3735|NCT02554877|20181|P2|Overall Study|No longer willing to participate|2
3736|NCT02554877|20182|P1|Overall Study|No longer willing to participate|0
3737|NCT02554877|20179|P4|Overall Study|Insufficient clinical response|0
3738|NCT02554877|20180|P3|Overall Study|Insufficient clinical response|0
3739|NCT02554877|20181|P2|Overall Study|Insufficient clinical response|0
3740|NCT02554877|20182|P1|Overall Study|Insufficient clinical response|4
3741|NCT02554877|20179|P4|Overall Study|Other|3
3742|NCT02554877|20180|P3|Overall Study|Other|0
3743|NCT02554877|20181|P2|Overall Study|Other|3
3744|NCT02554877|20182|P1|Overall Study|Other|1
3745|NCT02554877|20179|P4|Overall Study|Protocol Violation|0
3746|NCT02554877|20180|P3|Overall Study|Protocol Violation|1
3747|NCT02554877|20181|P2|Overall Study|Protocol Violation|1
3748|NCT02554877|20182|P1|Overall Study|Protocol Violation|3
3749|NCT02554877|20179|P4|Overall Study|No longer met eligibility criteria|1
3750|NCT02554877|20180|P3|Overall Study|No longer met eligibility criteria|1
3751|NCT02554877|20181|P2|Overall Study|No longer met eligibility criteria|0
3752|NCT02554877|20182|P1|Overall Study|No longer met eligibility criteria|1
3753|NCT02554877|20179|P4|Overall Study|Did not meet entrance criteria|0
3754|NCT02554877|20180|P3|Overall Study|Did not meet entrance criteria|1
3755|NCT02554877|20181|P2|Overall Study|Did not meet entrance criteria|0
3756|NCT02554877|20182|P1|Overall Study|Did not meet entrance criteria|0
3757|NCT02554877|20179|P4|Overall Study|Lost to Follow-up|2
3758|NCT02554877|20180|P3|Overall Study|Lost to Follow-up|1
3759|NCT02554877|20181|P2|Overall Study|Lost to Follow-up|1
3760|NCT02554877|20182|P1|Overall Study|Lost to Follow-up|1
3761|NCT02554877|20179|P4|Overall Study|Adverse Event|1
3762|NCT02554877|20180|P3|Overall Study|Adverse Event|0
3763|NCT02554877|20181|P2|Overall Study|Adverse Event|0
3764|NCT02554877|20182|P1|Overall Study|Adverse Event|2
3765|NCT02554279|20246|P2|Overall Study|Other reason|6
3766|NCT02554279|20247|P1|Overall Study|Other reason|19
3767|NCT02554279|20246|P2|Overall Study|Protocol Violation|1
3768|NCT02554279|20247|P1|Overall Study|Protocol Violation|2
3769|NCT02554279|20246|P2|Overall Study|Withdrawal by Subject|4
3770|NCT02554279|20247|P1|Overall Study|Withdrawal by Subject|6
3771|NCT02554279|20246|P2|Overall Study|Lost to Follow-up|2
3772|NCT02554279|20247|P1|Overall Study|Lost to Follow-up|3
3773|NCT02554279|20246|P2|Overall Study|Adverse Event|5
3774|NCT02554279|20247|P1|Overall Study|Adverse Event|2
3775|NCT02553772|20281|P2|Overall Study|Other Miscellaneous Reasons|1
3776|NCT02553772|20282|P1|Overall Study|Other Miscellaneous Reasons|0
3777|NCT02553772|20281|P2|Overall Study|Lack of Efficacy|0
3778|NCT02553772|20282|P1|Overall Study|Lack of Efficacy|1
3779|NCT02553772|20281|P2|Overall Study|Withdrawal of Consent|1
3780|NCT02553772|20282|P1|Overall Study|Withdrawal of Consent|1
3781|NCT02553772|20281|P2|Overall Study|Lost to Follow-up|1
3782|NCT02553772|20282|P1|Overall Study|Lost to Follow-up|2
3783|NCT02553772|20281|P2|Overall Study|Adverse Event|3
3784|NCT02553772|20282|P1|Overall Study|Adverse Event|2
3785|NCT02553629|20298|P2|Overall Study|Logistic reasons|6
3786|NCT02553629|20299|P1|Overall Study|Logistic reasons|3
3787|NCT02553538|20315|P2|Overall Study|Died or Left Network|56
3788|NCT02553538|20316|P1|Overall Study|Died or Left Network|54
3789|NCT02553538|20315|P2|Overall Study|Could Not Reach by Telephone|0
3790|NCT02553538|20316|P1|Overall Study|Could Not Reach by Telephone|133
3791|NCT02553421|20338|P2|Overall Study|Improper Device Placement|0
3792|NCT02553421|20339|P1|Overall Study|Improper Device Placement|3
3793|NCT02553421|20338|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
3794|NCT02553421|20339|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
3795|NCT02553421|20338|P2|Overall Study|Lost to Follow-up|1
3796|NCT02553421|20339|P1|Overall Study|Lost to Follow-up|21
3797|NCT02552303|20370|P4|Follow-Up|ineligible|0
3798|NCT02552303|20371|P3|Follow-Up|ineligible|0
3799|NCT02552303|20372|P2|Follow-Up|ineligible|2
3800|NCT02552303|20373|P1|Follow-Up|ineligible|0
3801|NCT02552303|20370|P4|Follow-Up|Lost to Follow-up|0
3802|NCT02552303|20371|P3|Follow-Up|Lost to Follow-up|1
3803|NCT02552303|20372|P2|Follow-Up|Lost to Follow-up|0
3804|NCT02552303|20373|P1|Follow-Up|Lost to Follow-up|0
3805|NCT02552303|20370|P4|Allocation|ineligible|0
3806|NCT02552303|20371|P3|Allocation|ineligible|0
3807|NCT02552303|20372|P2|Allocation|ineligible|1
3808|NCT02552303|20373|P1|Allocation|ineligible|1
3809|NCT02552303|20370|P4|Allocation|Withdrawal by Subject|1
3810|NCT02552303|20371|P3|Allocation|Withdrawal by Subject|1
3811|NCT02552303|20372|P2|Allocation|Withdrawal by Subject|1
3812|NCT02552303|20373|P1|Allocation|Withdrawal by Subject|2
3813|NCT02550288|20430|P5|Overall Study|Withdrawal by Subject|0
3814|NCT02550288|20431|P4|Overall Study|Withdrawal by Subject|1
3815|NCT02550288|20432|P3|Overall Study|Withdrawal by Subject|0
3816|NCT02550288|20433|P2|Overall Study|Withdrawal by Subject|0
3817|NCT02550288|20434|P1|Overall Study|Withdrawal by Subject|0
3818|NCT02550288|20430|P5|Overall Study|Participant moved|0
3819|NCT02550288|20431|P4|Overall Study|Participant moved|1
3820|NCT02550288|20432|P3|Overall Study|Participant moved|0
3821|NCT02550288|20433|P2|Overall Study|Participant moved|0
3822|NCT02550288|20434|P1|Overall Study|Participant moved|0
3823|NCT02550288|20430|P5|Overall Study|Protocol Violation|3
3824|NCT02550288|20431|P4|Overall Study|Protocol Violation|0
3825|NCT02550288|20432|P3|Overall Study|Protocol Violation|1
3826|NCT02550288|20433|P2|Overall Study|Protocol Violation|2
3827|NCT02550288|20434|P1|Overall Study|Protocol Violation|2
3828|NCT02550288|20430|P5|Overall Study|Physician Decision|0
3829|NCT02550288|20431|P4|Overall Study|Physician Decision|1
3830|NCT02550288|20432|P3|Overall Study|Physician Decision|0
3831|NCT02550288|20433|P2|Overall Study|Physician Decision|0
3832|NCT02550288|20434|P1|Overall Study|Physician Decision|0
3833|NCT02550288|20430|P5|Overall Study|Adverse Event|0
3834|NCT02550288|20431|P4|Overall Study|Adverse Event|0
3835|NCT02550288|20432|P3|Overall Study|Adverse Event|0
3836|NCT02550288|20433|P2|Overall Study|Adverse Event|1
3837|NCT02550288|20434|P1|Overall Study|Adverse Event|0
3838|NCT02549573|20589|P2|Overall Study|Protocol Violation|1
3839|NCT02549573|20590|P1|Overall Study|Protocol Violation|0
3840|NCT02549573|20589|P2|Overall Study|Withdrawal by Subject|2
3841|NCT02549573|20590|P1|Overall Study|Withdrawal by Subject|0
3842|NCT02549027|20632|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
3843|NCT02549027|20633|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
3844|NCT02549027|20634|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
3845|NCT02549027|20635|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
3846|NCT02549027|20636|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
3847|NCT02549027|20637|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
3848|NCT02549027|20632|P6|Washout After Period 4|Withdrawal by Subject|0
3849|NCT02549027|20633|P5|Washout After Period 4|Withdrawal by Subject|0
3850|NCT02549027|20634|P4|Washout After Period 4|Withdrawal by Subject|1
3851|NCT02549027|20635|P3|Washout After Period 4|Withdrawal by Subject|1
3852|NCT02549027|20636|P2|Washout After Period 4|Withdrawal by Subject|1
3853|NCT02549027|20637|P1|Washout After Period 4|Withdrawal by Subject|0
3854|NCT02548455|20765|P1|Overall Study|Visit not completed|173
3855|NCT02548455|20765|P1|Overall Study|Lost to Follow-up|14
3856|NCT02548455|20765|P1|Overall Study|Death|26
3857|NCT02548455|20765|P1|Overall Study|Withdrawal by Subject|27
3858|NCT02548156|20769|P6|Washout Period 1|Lost to Follow-up|0
3859|NCT02548156|20770|P5|Washout Period 1|Lost to Follow-up|1
3860|NCT02548156|20771|P4|Washout Period 1|Lost to Follow-up|0
3861|NCT02548156|20772|P3|Washout Period 1|Lost to Follow-up|0
3862|NCT02548156|20773|P2|Washout Period 1|Lost to Follow-up|0
3863|NCT02548156|20774|P1|Washout Period 1|Lost to Follow-up|0
3864|NCT02548078|20793|P2|Overall Study|Lost to Follow-up|3
3865|NCT02548078|20794|P1|Overall Study|Lost to Follow-up|1
3866|NCT02548078|20793|P2|Overall Study|Moved from study area|3
3867|NCT02548078|20794|P1|Overall Study|Moved from study area|3
3868|NCT02548078|20793|P2|Overall Study|Serious adverse event/Adverse event|0
3869|NCT02548078|20794|P1|Overall Study|Serious adverse event/Adverse event|1
3870|NCT02547454|20992|P1|Overall Study|No data|11
3871|NCT02547454|20992|P1|Overall Study|Other|39
3872|NCT02547454|20992|P1|Overall Study|Lost to Follow-up|26
3873|NCT02547454|20992|P1|Overall Study|Death|38
3874|NCT02547454|20992|P1|Overall Study|Due to no further need to treat|4
3875|NCT02547454|20992|P1|Overall Study|Due to transplantation|1
3876|NCT02547454|20992|P1|Overall Study|Due to hemodialysis|53
3877|NCT02546986|21051|P2|Survival Follow-Up Phase|Lost to Follow-up|2
3878|NCT02546986|21052|P1|Survival Follow-Up Phase|Lost to Follow-up|2
3879|NCT02546986|21051|P2|Survival Follow-Up Phase|Alive|16
3880|NCT02546986|21052|P1|Survival Follow-Up Phase|Alive|13
3881|NCT02546986|21051|P2|Survival Follow-Up Phase|Death|12
3882|NCT02546986|21052|P1|Survival Follow-Up Phase|Death|18
3883|NCT02546986|21051|P2|Survival Follow-Up Phase|Missing Status|5
3884|NCT02546986|21052|P1|Survival Follow-Up Phase|Missing Status|3
3885|NCT02546986|21051|P2|Treatment Period|Miscellaneous|9
3886|NCT02546986|21052|P1|Treatment Period|Miscellaneous|7
3887|NCT02546986|21051|P2|Treatment Period|Study Terminated by Sponsor|1
3888|NCT02546986|21052|P1|Treatment Period|Study Terminated by Sponsor|0
3889|NCT02546986|21051|P2|Treatment Period|Non-compliance with Study Drug|1
3890|NCT02546986|21052|P1|Treatment Period|Non-compliance with Study Drug|0
3891|NCT02546986|21051|P2|Treatment Period|Withdrawal by Subject|1
3892|NCT02546986|21052|P1|Treatment Period|Withdrawal by Subject|1
3893|NCT02546986|21051|P2|Treatment Period|Protocol Violation|0
3894|NCT02546986|21052|P1|Treatment Period|Protocol Violation|1
3895|NCT02546986|21051|P2|Treatment Period|Physician Decision|2
3896|NCT02546986|21052|P1|Treatment Period|Physician Decision|1
3897|NCT02546986|21051|P2|Treatment Period|Death|4
3898|NCT02546986|21052|P1|Treatment Period|Death|3
3899|NCT02546986|21051|P2|Treatment Period|Symptomatic Deterioration|3
3900|NCT02546986|21052|P1|Treatment Period|Symptomatic Deterioration|4
3901|NCT02546986|21051|P2|Treatment Period|Adverse Event|6
3902|NCT02546986|21052|P1|Treatment Period|Adverse Event|14
3903|NCT02546986|21051|P2|Treatment Period|Progressive Disease|22
3904|NCT02546986|21052|P1|Treatment Period|Progressive Disease|20
3905|NCT02546609|21078|P3|Overall Study|travel or work schedule restriction|2
3906|NCT02546609|21079|P2|Overall Study|travel or work schedule restriction|0
3907|NCT02546609|21080|P1|Overall Study|travel or work schedule restriction|0
3908|NCT02546609|21078|P3|Overall Study|Lost to Follow-up|1
3909|NCT02546609|21079|P2|Overall Study|Lost to Follow-up|3
3910|NCT02546609|21080|P1|Overall Study|Lost to Follow-up|2
3911|NCT02546609|21078|P3|Overall Study|Protocol Violation|1
3912|NCT02546609|21079|P2|Overall Study|Protocol Violation|1
3913|NCT02546609|21080|P1|Overall Study|Protocol Violation|0
3914|NCT02546609|21078|P3|Overall Study|Adverse Event|1
3915|NCT02546609|21079|P2|Overall Study|Adverse Event|6
3916|NCT02546609|21080|P1|Overall Study|Adverse Event|0
3917|NCT02546609|21078|P3|Overall Study|Withdrawal by Subject|2
3918|NCT02546609|21079|P2|Overall Study|Withdrawal by Subject|1
3919|NCT02546609|21080|P1|Overall Study|Withdrawal by Subject|0
3920|NCT02545543|21123|P2|Overall Study|Enrolment of subject at >1 study site|1
3921|NCT02545543|21124|P1|Overall Study|Enrolment of subject at >1 study site|1
3922|NCT02545543|21123|P2|Overall Study|Noncomplaince|0
3923|NCT02545543|21124|P1|Overall Study|Noncomplaince|1
3924|NCT02545543|21123|P2|Overall Study|Withdrawal by Subject|8
3925|NCT02545543|21124|P1|Overall Study|Withdrawal by Subject|9
3926|NCT02545543|21123|P2|Overall Study|Physician Decision|0
3927|NCT02545543|21124|P1|Overall Study|Physician Decision|3
3928|NCT02545543|21123|P2|Overall Study|Lost to Follow-up|25
3929|NCT02545543|21124|P1|Overall Study|Lost to Follow-up|67
3930|NCT02545322|21148|P1|Overall Study|Withdrawal by Subject|3
3931|NCT02544074|21191|P21|Overall Study|Tablet error|0
3932|NCT02544074|21192|P20|Overall Study|Tablet error|0
3933|NCT02544074|21193|P19|Overall Study|Tablet error|0
3934|NCT02544074|21194|P18|Overall Study|Tablet error|0
3935|NCT02544074|21195|P17|Overall Study|Tablet error|0
3936|NCT02544074|21196|P16|Overall Study|Tablet error|0
3937|NCT02544074|21197|P15|Overall Study|Tablet error|0
3938|NCT02544074|21198|P14|Overall Study|Tablet error|0
3939|NCT02544074|21199|P13|Overall Study|Tablet error|0
3940|NCT02544074|21200|P12|Overall Study|Tablet error|0
3941|NCT02544074|21201|P11|Overall Study|Tablet error|0
3942|NCT02544074|21202|P10|Overall Study|Tablet error|1
3943|NCT02544074|21203|P9|Overall Study|Tablet error|0
3944|NCT02544074|21204|P8|Overall Study|Tablet error|0
3945|NCT02544074|21205|P7|Overall Study|Tablet error|0
3946|NCT02544074|21206|P6|Overall Study|Tablet error|1
3947|NCT02544074|21207|P5|Overall Study|Tablet error|0
3948|NCT02544074|21208|P4|Overall Study|Tablet error|0
3949|NCT02544074|21209|P3|Overall Study|Tablet error|0
3950|NCT02544074|21210|P2|Overall Study|Tablet error|0
3951|NCT02544074|21211|P1|Overall Study|Tablet error|0
3952|NCT02544074|21191|P21|Overall Study|Withdrawal by Subject|0
3953|NCT02544074|21192|P20|Overall Study|Withdrawal by Subject|0
3954|NCT02544074|21193|P19|Overall Study|Withdrawal by Subject|0
3955|NCT02544074|21194|P18|Overall Study|Withdrawal by Subject|0
3956|NCT02544074|21195|P17|Overall Study|Withdrawal by Subject|0
3957|NCT02544074|21196|P16|Overall Study|Withdrawal by Subject|0
3958|NCT02544074|21197|P15|Overall Study|Withdrawal by Subject|0
3959|NCT02544074|21198|P14|Overall Study|Withdrawal by Subject|0
3960|NCT02544074|21199|P13|Overall Study|Withdrawal by Subject|0
3961|NCT02544074|21200|P12|Overall Study|Withdrawal by Subject|0
3962|NCT02544074|21201|P11|Overall Study|Withdrawal by Subject|0
3963|NCT02544074|21202|P10|Overall Study|Withdrawal by Subject|0
3964|NCT02544074|21203|P9|Overall Study|Withdrawal by Subject|0
3965|NCT02544074|21204|P8|Overall Study|Withdrawal by Subject|0
3966|NCT02544074|21205|P7|Overall Study|Withdrawal by Subject|0
3967|NCT02544074|21206|P6|Overall Study|Withdrawal by Subject|0
3968|NCT02544074|21207|P5|Overall Study|Withdrawal by Subject|0
3969|NCT02544074|21208|P4|Overall Study|Withdrawal by Subject|0
3970|NCT02544074|21209|P3|Overall Study|Withdrawal by Subject|0
3971|NCT02544074|21210|P2|Overall Study|Withdrawal by Subject|1
3972|NCT02544074|21211|P1|Overall Study|Withdrawal by Subject|0
3973|NCT02543918|21247|P2|Overall Study|Adverse Event|1
3974|NCT02543918|21248|P1|Overall Study|Adverse Event|1
3975|NCT02543918|21247|P2|Overall Study|Withdrawal by Subject|1
3976|NCT02543918|21248|P1|Overall Study|Withdrawal by Subject|1
3977|NCT02543918|21247|P2|Overall Study|Lost to Follow-up|1
3978|NCT02543918|21248|P1|Overall Study|Lost to Follow-up|1
3979|NCT02543918|21247|P2|Overall Study|Never treated|1
3980|NCT02543918|21248|P1|Overall Study|Never treated|0
3981|NCT02543528|21254|P5|Extended Wear Period|Withdrawal by Subject|0
3982|NCT02543528|21255|P4|Extended Wear Period|Withdrawal by Subject|5
3983|NCT02543528|21256|P3|Extended Wear Period|Withdrawal by Subject|10
3984|NCT02543528|21257|P2|Extended Wear Period|Withdrawal by Subject|9
3985|NCT02543528|21258|P1|Extended Wear Period|Withdrawal by Subject|4
3986|NCT02543528|21254|P5|Extended Wear Period|Lost to Follow-up|0
3987|NCT02543528|21255|P4|Extended Wear Period|Lost to Follow-up|1
3988|NCT02543528|21256|P3|Extended Wear Period|Lost to Follow-up|0
3989|NCT02543528|21257|P2|Extended Wear Period|Lost to Follow-up|1
3990|NCT02543528|21258|P1|Extended Wear Period|Lost to Follow-up|2
3991|NCT02543528|21254|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
3992|NCT02543528|21255|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
3993|NCT02543528|21256|P3|Extended Wear Period|Unsatisfactory Lens Fitting|1
3994|NCT02543528|21257|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
3995|NCT02543528|21258|P1|Extended Wear Period|Unsatisfactory Lens Fitting|0
3996|NCT02543528|21254|P5|Extended Wear Period|Missed too many scheduled visits|0
3997|NCT02543528|21255|P4|Extended Wear Period|Missed too many scheduled visits|3
3998|NCT02543528|21256|P3|Extended Wear Period|Missed too many scheduled visits|0
3999|NCT02543528|21257|P2|Extended Wear Period|Missed too many scheduled visits|0
4000|NCT02543528|21258|P1|Extended Wear Period|Missed too many scheduled visits|1
4001|NCT02543528|21254|P5|Extended Wear Period|Adverse Event|0
4002|NCT02543528|21255|P4|Extended Wear Period|Adverse Event|3
4003|NCT02543528|21256|P3|Extended Wear Period|Adverse Event|17
4004|NCT02543528|21257|P2|Extended Wear Period|Adverse Event|11
4005|NCT02543528|21258|P1|Extended Wear Period|Adverse Event|16
4006|NCT02543528|21254|P5|Adaptation Period|Adverse Event|2
4007|NCT02543528|21255|P4|Adaptation Period|Adverse Event|0
4008|NCT02543528|21256|P3|Adaptation Period|Adverse Event|0
4009|NCT02543528|21257|P2|Adaptation Period|Adverse Event|0
4010|NCT02543528|21258|P1|Adaptation Period|Adverse Event|0
4011|NCT02543528|21254|P5|Adaptation Period|Lost to Follow-up|14
4012|NCT02543528|21255|P4|Adaptation Period|Lost to Follow-up|0
4013|NCT02543528|21256|P3|Adaptation Period|Lost to Follow-up|0
4014|NCT02543528|21257|P2|Adaptation Period|Lost to Follow-up|0
4015|NCT02543528|21258|P1|Adaptation Period|Lost to Follow-up|0
4016|NCT02543528|21254|P5|Adaptation Period|Lens Handling Difficultes|8
4017|NCT02543528|21255|P4|Adaptation Period|Lens Handling Difficultes|0
4018|NCT02543528|21256|P3|Adaptation Period|Lens Handling Difficultes|0
4019|NCT02543528|21257|P2|Adaptation Period|Lens Handling Difficultes|0
4020|NCT02543528|21258|P1|Adaptation Period|Lens Handling Difficultes|0
4021|NCT02543528|21254|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
4022|NCT02543528|21255|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
4023|NCT02543528|21256|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
4024|NCT02543528|21257|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
4025|NCT02543528|21258|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
4026|NCT02542943|21294|P3|Overall Study|Withdrawal by Subject|0
4027|NCT02542943|21295|P2|Overall Study|Withdrawal by Subject|1
4028|NCT02542943|21296|P1|Overall Study|Withdrawal by Subject|0
4029|NCT02542943|21294|P3|Overall Study|Lost to Follow-up|0
4030|NCT02542943|21295|P2|Overall Study|Lost to Follow-up|0
4031|NCT02542943|21296|P1|Overall Study|Lost to Follow-up|1
4032|NCT02542072|21351|P2|Second Intervention (1 Month)|Lens discomfort|0
4033|NCT02542072|21352|P1|Second Intervention (1 Month)|Lens discomfort|1
4034|NCT02542072|21351|P2|Second Intervention (1 Month)|Lost to Follow-up|0
4035|NCT02542072|21352|P1|Second Intervention (1 Month)|Lost to Follow-up|1
4036|NCT02542072|21351|P2|First Intervention (1 Month)|Protocol Violation|0
4037|NCT02542072|21352|P1|First Intervention (1 Month)|Protocol Violation|1
4038|NCT02542072|21351|P2|First Intervention (1 Month)|Lens discomfort|2
4039|NCT02542072|21352|P1|First Intervention (1 Month)|Lens discomfort|1
4040|NCT02542072|21351|P2|First Intervention (1 Month)|Lost to Follow-up|0
4041|NCT02542072|21352|P1|First Intervention (1 Month)|Lost to Follow-up|2
4042|NCT02542072|21351|P2|First Intervention (1 Month)|Adverse Event|1
4043|NCT02542072|21352|P1|First Intervention (1 Month)|Adverse Event|1
4044|NCT02540850|21471|P3|Overall Study|Lost to Follow-up|34
4045|NCT02540850|21472|P2|Overall Study|Lost to Follow-up|66
4046|NCT02540850|21473|P1|Overall Study|Lost to Follow-up|69
4047|NCT02540356|21544|P2|Overall Study|Terminated due to disease progression|0
4048|NCT02540356|21545|P1|Overall Study|Terminated due to disease progression|1
4049|NCT02540265|21579|P3|Overall Study|Lost to Follow-up|1
4050|NCT02540265|21580|P2|Overall Study|Lost to Follow-up|0
4051|NCT02540265|21581|P1|Overall Study|Lost to Follow-up|0
4052|NCT02540213|21601|P1|Overall Study|Enrolled but not treated|2
4053|NCT02540213|21601|P1|Overall Study|Consent withdrawn|7
4054|NCT02540213|21601|P1|Overall Study|Lack of Efficacy|6
4055|NCT02540213|21601|P1|Overall Study|Kidney transplant|3
4056|NCT02540213|21601|P1|Overall Study|Administrative reasons|3
4057|NCT02540213|21601|P1|Overall Study|Death/adverse event|18
4058|NCT02539797|21653|P3|Overall Study|Lost to Follow-up|0
4059|NCT02539797|21654|P2|Overall Study|Lost to Follow-up|1
4060|NCT02539797|21655|P1|Overall Study|Lost to Follow-up|0
4061|NCT02539134|21672|P6|Overall Study|Lost to Follow-up|0
4062|NCT02539134|21673|P5|Overall Study|Lost to Follow-up|0
4063|NCT02539134|21674|P4|Overall Study|Lost to Follow-up|0
4064|NCT02539134|21675|P3|Overall Study|Lost to Follow-up|0
4065|NCT02539134|21676|P2|Overall Study|Lost to Follow-up|0
4066|NCT02539134|21677|P1|Overall Study|Lost to Follow-up|1
4067|NCT02538107|21759|P1|Overall Study|Not recorded|7
4068|NCT02538107|21759|P1|Overall Study|Other|7
4069|NCT02538107|21759|P1|Overall Study|Surgery|1
4070|NCT02538107|21759|P1|Overall Study|Adverse Event|4
4071|NCT02538107|21759|P1|Overall Study|Administrative reason|5
4072|NCT02538107|21759|P1|Overall Study|Death|4
4073|NCT02538107|21759|P1|Overall Study|Withdrawal by Subject|17
4074|NCT02538107|21759|P1|Overall Study|No further treatment necessary|18
4075|NCT02538107|21759|P1|Overall Study|Administration of other ESA|11
4076|NCT02538107|21759|P1|Overall Study|Necessity of dialysis|20
4077|NCT02538107|21759|P1|Overall Study|Missing|5
4078|NCT02538107|21759|P1|Overall Study|Did not receive any Mircera dose|11
4079|NCT02537522|21792|P4|Phase II - Period 1 Bilateral|Adverse Event|1
4080|NCT02537522|21793|P3|Phase II - Period 1 Bilateral|Adverse Event|0
4081|NCT02537522|21794|P2|Phase II - Period 1 Bilateral|Adverse Event|0
4082|NCT02537522|21795|P1|Phase II - Period 1 Bilateral|Adverse Event|0
4083|NCT02537522|21792|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
4084|NCT02537522|21793|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
4085|NCT02537522|21794|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
4086|NCT02537522|21795|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
4087|NCT02537522|21792|P4|Phase I - Contralateral|incorrect randomization|0
4088|NCT02537522|21793|P3|Phase I - Contralateral|incorrect randomization|0
4089|NCT02537522|21794|P2|Phase I - Contralateral|incorrect randomization|1
4090|NCT02537522|21795|P1|Phase I - Contralateral|incorrect randomization|0
4091|NCT02537522|21792|P4|Phase I - Contralateral|Withdrawal by Subject|0
4092|NCT02537522|21793|P3|Phase I - Contralateral|Withdrawal by Subject|0
4093|NCT02537522|21794|P2|Phase I - Contralateral|Withdrawal by Subject|1
4094|NCT02537522|21795|P1|Phase I - Contralateral|Withdrawal by Subject|0
4095|NCT02537522|21792|P4|Phase I - Contralateral|Subject no longer eligible|0
4096|NCT02537522|21793|P3|Phase I - Contralateral|Subject no longer eligible|0
4097|NCT02537522|21794|P2|Phase I - Contralateral|Subject no longer eligible|7
4098|NCT02537522|21795|P1|Phase I - Contralateral|Subject no longer eligible|15
4099|NCT02536781|21805|P2|Overall Study|Lost to Follow-up|0
4100|NCT02536781|21806|P1|Overall Study|Lost to Follow-up|2
4101|NCT02536664|21816|P2|Overall Study|Missing|20
4102|NCT02536664|21817|P1|Overall Study|Missing|53
4103|NCT02536664|21816|P2|Overall Study|Other|24
4104|NCT02536664|21817|P1|Overall Study|Other|18
4105|NCT02536664|21816|P2|Overall Study|Withdrawal by Subject|5
4106|NCT02536664|21817|P1|Overall Study|Withdrawal by Subject|8
4107|NCT02536664|21816|P2|Overall Study|Intolerability|6
4108|NCT02536664|21817|P1|Overall Study|Intolerability|8
4109|NCT02536664|21816|P2|Overall Study|Death due to other reason|2
4110|NCT02536664|21817|P1|Overall Study|Death due to other reason|3
4111|NCT02536664|21816|P2|Overall Study|Death due to lymphoma|1
4112|NCT02536664|21817|P1|Overall Study|Death due to lymphoma|2
4113|NCT02536664|21816|P2|Overall Study|Progression|18
4114|NCT02536664|21817|P1|Overall Study|Progression|13
4115|NCT02536664|21816|P2|Overall Study|Inadequate completion of documentation|4
4116|NCT02536664|21817|P1|Overall Study|Inadequate completion of documentation|2
4117|NCT02536313|21837|P2|Overall Study|Lack of Efficacy|1
4118|NCT02536313|21838|P1|Overall Study|Lack of Efficacy|0
4119|NCT02535741|21854|P1|Overall Study|Missing data|6
4120|NCT02535741|21854|P1|Overall Study|Exclusion criteria: Bilateral implant|4
4121|NCT02535741|21854|P1|Overall Study|Lost to Follow-up|10
4122|NCT02535741|21854|P1|Overall Study|Withdrawal by Subject|9
4123|NCT02535741|21854|P1|Overall Study|Adverse Event|3
4124|NCT02535416|21871|P9|Overall Study|Family bereavement overseas|0
4125|NCT02535416|21872|P8|Overall Study|Family bereavement overseas|0
4126|NCT02535416|21873|P7|Overall Study|Family bereavement overseas|0
4127|NCT02535416|21874|P6|Overall Study|Family bereavement overseas|0
4128|NCT02535416|21875|P5|Overall Study|Family bereavement overseas|0
4129|NCT02535416|21876|P4|Overall Study|Family bereavement overseas|0
4130|NCT02535416|21877|P3|Overall Study|Family bereavement overseas|0
4131|NCT02535416|21878|P2|Overall Study|Family bereavement overseas|0
4132|NCT02535416|21879|P1|Overall Study|Family bereavement overseas|1
4133|NCT02534935|21986|P3|Overall Study|Lost to Follow-up|1
4134|NCT02534935|21987|P2|Overall Study|Lost to Follow-up|1
4135|NCT02534935|21988|P1|Overall Study|Lost to Follow-up|0
4136|NCT02534935|21986|P3|Overall Study|Adverse Event|0
4137|NCT02534935|21987|P2|Overall Study|Adverse Event|2
4138|NCT02534935|21988|P1|Overall Study|Adverse Event|0
4139|NCT02534935|21986|P3|Overall Study|No longer meets the eligibility criteria|0
4140|NCT02534935|21987|P2|Overall Study|No longer meets the eligibility criteria|3
4141|NCT02534935|21988|P1|Overall Study|No longer meets the eligibility criteria|0
4142|NCT02534935|21986|P3|Overall Study|Withdrawal by Subject|3
4143|NCT02534935|21987|P2|Overall Study|Withdrawal by Subject|3
4144|NCT02534935|21988|P1|Overall Study|Withdrawal by Subject|0
4145|NCT02534935|21986|P3|Overall Study|No longer willing to participate|1
4146|NCT02534935|21987|P2|Overall Study|No longer willing to participate|1
4147|NCT02534935|21988|P1|Overall Study|No longer willing to participate|0
4148|NCT02534493|22146|P1|Overall Study|Withdrawal by Subject|1
4149|NCT02534493|22146|P1|Overall Study|Lost to Follow-up|1
4150|NCT02534324|22157|P2|Overall Study|Adverse Event|0
4151|NCT02534324|22158|P1|Overall Study|Adverse Event|1
4152|NCT02534324|22157|P2|Overall Study|Lost to Follow-up|7
4153|NCT02534324|22158|P1|Overall Study|Lost to Follow-up|20
4154|NCT02534324|22157|P2|Overall Study|Protocol Violation|1
4155|NCT02534324|22158|P1|Overall Study|Protocol Violation|4
4156|NCT02533999|22177|P2|Overall Study|Randomized but intervention not received|1
4157|NCT02533999|22178|P1|Overall Study|Randomized but intervention not received|0
4158|NCT02533999|22177|P2|Overall Study|Adverse Event|1
4159|NCT02533999|22178|P1|Overall Study|Adverse Event|0
4160|NCT02533999|22177|P2|Overall Study|Protocol Violation|0
4161|NCT02533999|22178|P1|Overall Study|Protocol Violation|3
4162|NCT02533999|22177|P2|Overall Study|Lost to Follow-up|5
4163|NCT02533999|22178|P1|Overall Study|Lost to Follow-up|3
4164|NCT02533531|22207|P1|Overall Study|Device did not turn on|1
4165|NCT02533401|22239|P1|Overall Study|Violation of Selection Criteria|1
4166|NCT02533401|22239|P1|Overall Study|Lost to Follow-up|1
4167|NCT02533401|22239|P1|Overall Study|Insufficient Response/Progressed Disease|1
4168|NCT02533401|22239|P1|Overall Study|Death|5
4169|NCT02533401|22239|P1|Overall Study|Adverse Event/Intercurrent Disease|3
4170|NCT02533258|22247|P1|Overall Study|Lack of Efficacy|2
4171|NCT02533258|22247|P1|Overall Study|Progression of pleural effusion|1
4172|NCT02533258|22247|P1|Overall Study|Economic factor|1
4173|NCT02533258|22247|P1|Overall Study|Other|1
4174|NCT02533258|22247|P1|Overall Study|Death|2
4175|NCT02533258|22247|P1|Overall Study|Adverse Event|1
4176|NCT02532374|22341|P1|Overall Study|Physician Decision|1
4177|NCT02532374|22341|P1|Overall Study|Withdrawal by Subject|1
4178|NCT02532179|22365|P1|Overall Study|Subject received depot steroid injection|1
4179|NCT02532179|22365|P1|Overall Study|Pregnancy|1
4180|NCT02532179|22365|P1|Overall Study|Lost to Follow-up|1
4181|NCT02531698|22380|P2|Overall Study|Lost to Follow-up|0
4182|NCT02531698|22381|P1|Overall Study|Lost to Follow-up|1
4183|NCT02531698|22380|P2|Overall Study|Protocol Violation|0
4184|NCT02531698|22381|P1|Overall Study|Protocol Violation|2
4185|NCT02531698|22380|P2|Overall Study|Withdrawal by Subject|1
4186|NCT02531698|22381|P1|Overall Study|Withdrawal by Subject|6
4187|NCT02531698|22380|P2|Overall Study|Adverse Event|1
4188|NCT02531698|22381|P1|Overall Study|Adverse Event|2
4189|NCT02531646|22628|P3|Overall Study|equip. image processing issue|0
4190|NCT02531646|22629|P2|Overall Study|equip. image processing issue|1
4191|NCT02531646|22630|P1|Overall Study|equip. image processing issue|5
4192|NCT02531373|22653|P9|Overall Study|Withdrawal by Subject|0
4193|NCT02531373|22654|P8|Overall Study|Withdrawal by Subject|0
4194|NCT02531373|22655|P7|Overall Study|Withdrawal by Subject|0
4195|NCT02531373|22656|P6|Overall Study|Withdrawal by Subject|0
4196|NCT02531373|22657|P5|Overall Study|Withdrawal by Subject|3
4197|NCT02531373|22658|P4|Overall Study|Withdrawal by Subject|0
4198|NCT02531373|22659|P3|Overall Study|Withdrawal by Subject|0
4199|NCT02531373|22660|P2|Overall Study|Withdrawal by Subject|0
4200|NCT02531373|22661|P1|Overall Study|Withdrawal by Subject|0
4201|NCT02531373|22653|P9|Overall Study|Withdrawal by Parent/Guardian|3
4202|NCT02531373|22654|P8|Overall Study|Withdrawal by Parent/Guardian|1
4203|NCT02531373|22655|P7|Overall Study|Withdrawal by Parent/Guardian|4
4204|NCT02531373|22656|P6|Overall Study|Withdrawal by Parent/Guardian|3
4205|NCT02531373|22657|P5|Overall Study|Withdrawal by Parent/Guardian|0
4206|NCT02531373|22658|P4|Overall Study|Withdrawal by Parent/Guardian|0
4207|NCT02531373|22659|P3|Overall Study|Withdrawal by Parent/Guardian|0
4208|NCT02531373|22660|P2|Overall Study|Withdrawal by Parent/Guardian|0
4209|NCT02531373|22661|P1|Overall Study|Withdrawal by Parent/Guardian|0
4210|NCT02531373|22653|P9|Overall Study|Protocol Violation|1
4211|NCT02531373|22654|P8|Overall Study|Protocol Violation|0
4212|NCT02531373|22655|P7|Overall Study|Protocol Violation|1
4213|NCT02531373|22656|P6|Overall Study|Protocol Violation|1
4214|NCT02531373|22657|P5|Overall Study|Protocol Violation|0
4215|NCT02531373|22658|P4|Overall Study|Protocol Violation|0
4216|NCT02531373|22659|P3|Overall Study|Protocol Violation|0
4217|NCT02531373|22660|P2|Overall Study|Protocol Violation|0
4218|NCT02531373|22661|P1|Overall Study|Protocol Violation|0
4219|NCT02531373|22653|P9|Overall Study|Physician Decision|0
4220|NCT02531373|22654|P8|Overall Study|Physician Decision|0
4221|NCT02531373|22655|P7|Overall Study|Physician Decision|0
4222|NCT02531373|22656|P6|Overall Study|Physician Decision|1
4223|NCT02531373|22657|P5|Overall Study|Physician Decision|2
4224|NCT02531373|22658|P4|Overall Study|Physician Decision|0
4225|NCT02531373|22659|P3|Overall Study|Physician Decision|0
4226|NCT02531373|22660|P2|Overall Study|Physician Decision|0
4227|NCT02531373|22661|P1|Overall Study|Physician Decision|0
4228|NCT02531373|22653|P9|Overall Study|Lost to Follow-up|0
4229|NCT02531373|22654|P8|Overall Study|Lost to Follow-up|0
4230|NCT02531373|22655|P7|Overall Study|Lost to Follow-up|2
4231|NCT02531373|22656|P6|Overall Study|Lost to Follow-up|2
4232|NCT02531373|22657|P5|Overall Study|Lost to Follow-up|0
4233|NCT02531373|22658|P4|Overall Study|Lost to Follow-up|0
4234|NCT02531373|22659|P3|Overall Study|Lost to Follow-up|0
4235|NCT02531373|22660|P2|Overall Study|Lost to Follow-up|0
4236|NCT02531373|22661|P1|Overall Study|Lost to Follow-up|0
4237|NCT02531373|22653|P9|Overall Study|Lack of Efficacy|5
4238|NCT02531373|22654|P8|Overall Study|Lack of Efficacy|8
4239|NCT02531373|22655|P7|Overall Study|Lack of Efficacy|4
4240|NCT02531373|22656|P6|Overall Study|Lack of Efficacy|2
4241|NCT02531373|22657|P5|Overall Study|Lack of Efficacy|3
4242|NCT02531373|22658|P4|Overall Study|Lack of Efficacy|0
4243|NCT02531373|22659|P3|Overall Study|Lack of Efficacy|0
4244|NCT02531373|22660|P2|Overall Study|Lack of Efficacy|0
4245|NCT02531373|22661|P1|Overall Study|Lack of Efficacy|0
4246|NCT02530671|22724|P2|Overall Study|Withdrawal by Subject|0
4247|NCT02530671|22725|P1|Overall Study|Withdrawal by Subject|1
4248|NCT02530671|22724|P2|Overall Study|Lost to Follow-up|0
4249|NCT02530671|22725|P1|Overall Study|Lost to Follow-up|2
4250|NCT02530125|22750|P1|Followed for Survival for 2 Years|Early termination of study|3
4251|NCT02530125|22750|P1|Completed Treatment|Early termination of study|1
4252|NCT02529995|22764|P2|Part B|Discontinued Study|5
4253|NCT02529995|22765|P1|Part B|Discontinued Study|6
4254|NCT02529995|22764|P2|Part B|Ongoing Study at Data Cut-off|7
4255|NCT02529995|22765|P1|Part B|Ongoing Study at Data Cut-off|0
4256|NCT02529995|22764|P2|Part A|Discontinued Study|0
4257|NCT02529995|22765|P1|Part A|Discontinued Study|1
4258|NCT02529995|22764|P2|Part A|Ongoing Study at Data Cut-off|16
4259|NCT02529995|22765|P1|Part A|Ongoing Study at Data Cut-off|14
4260|NCT02529488|22799|P1|Overall Study|Death|3
4261|NCT02529488|22799|P1|Overall Study|Adverse Event|1
4262|NCT02528331|22824|P1|Overall Study|Withdrawal by Subject|2
4263|NCT02528305|22831|P1|Overall Study|Physician Decision|1
4264|NCT02528305|22831|P1|Overall Study|Adverse Event|1
4265|NCT02528305|22831|P1|Overall Study|Withdrawal by Subject|1
4266|NCT02527161|22884|P1|Overall Study|Consent violation|4
4267|NCT02527161|22884|P1|Overall Study|MRI contraindication|2
4268|NCT02527161|22884|P1|Overall Study|Delay in or unfit for surgery|5
4269|NCT02527161|22884|P1|Overall Study|Exclusion RA diagnosis|1
4270|NCT02527161|22884|P1|Overall Study|Exclusion for excessive deformity|1
4271|NCT02527161|22884|P1|Overall Study|Exclusion for BMI|2
4272|NCT02527161|22884|P1|Overall Study|Shape Match not used in surgery|2
4273|NCT02527161|22884|P1|Overall Study|Withdrawal by Subject|6
4274|NCT02527161|22884|P1|Overall Study|Failed MRI|39
4275|NCT02527148|22903|P2|Overall Study|Did not receive study intervention|0
4276|NCT02527148|22904|P1|Overall Study|Did not receive study intervention|1
4277|NCT02526550|22922|P1|Overall Study|Lost to Follow-up|1
4278|NCT02526524|22934|P6|Overall Study|Sponsor Decision|0
4279|NCT02526524|22935|P5|Overall Study|Sponsor Decision|0
4280|NCT02526524|22936|P4|Overall Study|Sponsor Decision|0
4281|NCT02526524|22937|P3|Overall Study|Sponsor Decision|0
4282|NCT02526524|22938|P2|Overall Study|Sponsor Decision|0
4283|NCT02526524|22939|P1|Overall Study|Sponsor Decision|1
4284|NCT02526524|22934|P6|Overall Study|Physician Decision|0
4285|NCT02526524|22935|P5|Overall Study|Physician Decision|1
4286|NCT02526524|22936|P4|Overall Study|Physician Decision|0
4287|NCT02526524|22937|P3|Overall Study|Physician Decision|0
4288|NCT02526524|22938|P2|Overall Study|Physician Decision|0
4289|NCT02526524|22939|P1|Overall Study|Physician Decision|0
4290|NCT02526524|22934|P6|Overall Study|Loss of Glucose Control|0
4291|NCT02526524|22935|P5|Overall Study|Loss of Glucose Control|2
4292|NCT02526524|22936|P4|Overall Study|Loss of Glucose Control|0
4293|NCT02526524|22937|P3|Overall Study|Loss of Glucose Control|3
4294|NCT02526524|22938|P2|Overall Study|Loss of Glucose Control|0
4295|NCT02526524|22939|P1|Overall Study|Loss of Glucose Control|0
4296|NCT02526524|22934|P6|Overall Study|Protocol Violation|3
4297|NCT02526524|22935|P5|Overall Study|Protocol Violation|4
4298|NCT02526524|22936|P4|Overall Study|Protocol Violation|3
4299|NCT02526524|22937|P3|Overall Study|Protocol Violation|5
4300|NCT02526524|22938|P2|Overall Study|Protocol Violation|1
4301|NCT02526524|22939|P1|Overall Study|Protocol Violation|3
4302|NCT02526524|22934|P6|Overall Study|Lost to Follow-up|5
4303|NCT02526524|22935|P5|Overall Study|Lost to Follow-up|2
4304|NCT02526524|22936|P4|Overall Study|Lost to Follow-up|1
4305|NCT02526524|22937|P3|Overall Study|Lost to Follow-up|8
4306|NCT02526524|22938|P2|Overall Study|Lost to Follow-up|3
4307|NCT02526524|22939|P1|Overall Study|Lost to Follow-up|2
4308|NCT02526524|22934|P6|Overall Study|Adverse Event|8
4309|NCT02526524|22935|P5|Overall Study|Adverse Event|6
4310|NCT02526524|22936|P4|Overall Study|Adverse Event|2
4311|NCT02526524|22937|P3|Overall Study|Adverse Event|4
4312|NCT02526524|22938|P2|Overall Study|Adverse Event|2
4313|NCT02526524|22939|P1|Overall Study|Adverse Event|3
4314|NCT02526524|22934|P6|Overall Study|Withdrawal by Subject|5
4315|NCT02526524|22935|P5|Overall Study|Withdrawal by Subject|9
4316|NCT02526524|22936|P4|Overall Study|Withdrawal by Subject|1
4317|NCT02526524|22937|P3|Overall Study|Withdrawal by Subject|6
4318|NCT02526524|22938|P2|Overall Study|Withdrawal by Subject|3
4319|NCT02526524|22939|P1|Overall Study|Withdrawal by Subject|3
4320|NCT02526290|22953|P1|Overall Study|Physician Decision|1
4321|NCT02526290|22953|P1|Overall Study|Withdrawal by Subject|4
4322|NCT02526290|22953|P1|Overall Study|Adverse Event|3
4323|NCT02525094|23038|P2|Overall Study|Not Treated|1
4324|NCT02525094|23039|P1|Overall Study|Not Treated|1
4325|NCT02525094|23038|P2|Overall Study|Withdrawal by Subject|6
4326|NCT02525094|23039|P1|Overall Study|Withdrawal by Subject|5
4327|NCT02525094|23038|P2|Overall Study|Lost to Follow-up|1
4328|NCT02525094|23039|P1|Overall Study|Lost to Follow-up|2
4329|NCT02524665|23066|P1|Overall Study|Lost to Follow-up|1
4330|NCT02524288|23117|P1|Overall Study|Physician Decision|2
4331|NCT02524288|23117|P1|Overall Study|Pregnancy|22
4332|NCT02524288|23117|P1|Overall Study|Withdrawal by Subject|76
4333|NCT02524288|23117|P1|Overall Study|Subject Moved|32
4334|NCT02524288|23117|P1|Overall Study|Study Terminated By Sponsor|1417
4335|NCT02524288|23117|P1|Overall Study|Site Discontinued Study Participation|1
4336|NCT02524288|23117|P1|Overall Study|Screen Failure|2
4337|NCT02524288|23117|P1|Overall Study|Protocol Violation|6
4338|NCT02524288|23117|P1|Overall Study|Pregnancy Wish|6
4339|NCT02524288|23117|P1|Overall Study|Non-Compliance With Study Drug|14
4340|NCT02524288|23117|P1|Overall Study|Non-Compliance With Protocol|32
4341|NCT02524288|23117|P1|Overall Study|Lost to Follow-up|216
4342|NCT02524288|23117|P1|Overall Study|Adverse Event|115
4343|NCT02524158|23127|P2|6-month Assessment|Lost to Follow-up|20
4344|NCT02524158|23128|P1|6-month Assessment|Lost to Follow-up|21
4345|NCT02524158|23127|P2|6-month Assessment|Withdrawal by Subject|1
4346|NCT02524158|23128|P1|6-month Assessment|Withdrawal by Subject|1
4347|NCT02524158|23127|P2|12-weeks Assessment|Lost to Follow-up|12
4348|NCT02524158|23128|P1|12-weeks Assessment|Lost to Follow-up|18
4349|NCT02524158|23127|P2|12-weeks Assessment|Withdrawal by Subject|1
4350|NCT02524158|23128|P1|12-weeks Assessment|Withdrawal by Subject|1
4351|NCT02522624|23157|P2|Overall Study|Technical failure|0
4352|NCT02522624|23158|P1|Overall Study|Technical failure|1
4353|NCT02520726|23176|P2|Overall Study|Lost to Follow-up|2
4354|NCT02520726|23177|P1|Overall Study|Lost to Follow-up|3
4355|NCT02519855|23191|P2|Overall Study|Lost to Follow-up|3
4356|NCT02519855|23192|P1|Overall Study|Lost to Follow-up|3
4357|NCT02519855|23191|P2|Overall Study|Adverse Event|1
4358|NCT02519855|23192|P1|Overall Study|Adverse Event|0
4359|NCT02519842|23210|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
4360|NCT02519842|23211|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
4361|NCT02519842|23212|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
4362|NCT02519842|23210|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
4363|NCT02519842|23211|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
4364|NCT02519842|23212|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
4365|NCT02519842|23210|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
4366|NCT02519842|23211|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
4367|NCT02519842|23212|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
4368|NCT02519842|23210|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
4369|NCT02519842|23211|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
4370|NCT02519842|23212|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
4371|NCT02519842|23210|P3|Optional Extension: Cycles 2-6|Death|1
4372|NCT02519842|23211|P2|Optional Extension: Cycles 2-6|Death|0
4373|NCT02519842|23212|P1|Optional Extension: Cycles 2-6|Death|0
4374|NCT02519842|23210|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
4375|NCT02519842|23211|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
4376|NCT02519842|23212|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
4377|NCT02519842|23210|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
4378|NCT02519842|23211|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
4379|NCT02519842|23212|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
4380|NCT02519842|23210|P3|Optional Extension: Cycles 2-6|Adverse Event|1
4381|NCT02519842|23211|P2|Optional Extension: Cycles 2-6|Adverse Event|0
4382|NCT02519842|23212|P1|Optional Extension: Cycles 2-6|Adverse Event|0
4383|NCT02519842|23210|P3|Optional Extension: Cycles 2-6|Physician Decision|5
4384|NCT02519842|23211|P2|Optional Extension: Cycles 2-6|Physician Decision|0
4385|NCT02519842|23212|P1|Optional Extension: Cycles 2-6|Physician Decision|0
4386|NCT02519842|23210|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
4387|NCT02519842|23211|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
4388|NCT02519842|23212|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
4389|NCT02519842|23210|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
4390|NCT02519842|23211|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
4391|NCT02519842|23212|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
4392|NCT02519842|23210|P3|Base Study: Cycle 1|Adverse Event|0
4393|NCT02519842|23211|P2|Base Study: Cycle 1|Adverse Event|0
4394|NCT02519842|23212|P1|Base Study: Cycle 1|Adverse Event|1
4395|NCT02519842|23210|P3|Base Study: Cycle 1|Screening Failure|0
4396|NCT02519842|23211|P2|Base Study: Cycle 1|Screening Failure|1
4397|NCT02519842|23212|P1|Base Study: Cycle 1|Screening Failure|1
4398|NCT02519712|23231|P1|Overall Study|Accruals are donors|2
4399|NCT02519712|23231|P1|Overall Study|Disease Progression|1
4400|NCT02519712|23231|P1|Overall Study|Disease Relapse|1
4401|NCT02519595|23238|P3|Overall Study|Protocol Violation|16
4402|NCT02519595|23239|P2|Overall Study|Protocol Violation|22
4403|NCT02519595|23240|P1|Overall Study|Protocol Violation|8
4404|NCT02518048|23271|P1|Overall Study|Withdrawal by Subject|1
4405|NCT02517515|23300|P2|Overall Study|Not Specified|0
4406|NCT02517515|23301|P1|Overall Study|Not Specified|1
4407|NCT02517515|23300|P2|Overall Study|Lost to Follow-up|0
4408|NCT02517515|23301|P1|Overall Study|Lost to Follow-up|1
4409|NCT02517515|23300|P2|Overall Study|Withdrew Consent|1
4410|NCT02517515|23301|P1|Overall Study|Withdrew Consent|0
4411|NCT02517515|23300|P2|Overall Study|Adverse Event|1
4412|NCT02517515|23301|P1|Overall Study|Adverse Event|0
4413|NCT02516306|23325|P2|Period 2: Day 8 - 91|Protocol Violation|2
4414|NCT02516306|23326|P1|Period 2: Day 8 - 91|Protocol Violation|1
4415|NCT02516163|23332|P1|Overall Study|MRI contraindication exclusion|6
4416|NCT02516163|23332|P1|Overall Study|Data not recorded|2
4417|NCT02516163|23332|P1|Overall Study|Use of incorrect measurement technique|5
4418|NCT02516163|23332|P1|Overall Study|Unfit/delay in surgery|3
4419|NCT02516163|23332|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
4420|NCT02516163|23332|P1|Overall Study|Withdrawal by Subject|1
4421|NCT02516098|23346|P2|Period 2|Withdrawal by Subject|1
4422|NCT02516098|23347|P1|Period 2|Withdrawal by Subject|0
4423|NCT02516098|23346|P2|Washout After Period 1|Adverse Event|1
4424|NCT02516098|23347|P1|Washout After Period 1|Adverse Event|0
4425|NCT02516098|23346|P2|Period 1|Protocol Violation|0
4426|NCT02516098|23347|P1|Period 1|Protocol Violation|1
4427|NCT02515994|23361|P2|Overall Study|Withdrawal by Subject|0
4428|NCT02515994|23362|P1|Overall Study|Withdrawal by Subject|2
4429|NCT02515994|23361|P2|Overall Study|Adverse Event|1
4430|NCT02515994|23362|P1|Overall Study|Adverse Event|3
4431|NCT02515994|23361|P2|Overall Study|No Longer Meets Eligibility Criteria|1
4432|NCT02515994|23362|P1|Overall Study|No Longer Meets Eligibility Criteria|2
4433|NCT02515994|23361|P2|Overall Study|Protocol Violation|5
4434|NCT02515994|23362|P1|Overall Study|Protocol Violation|3
4435|NCT02515279|23389|P1|Overall Study|Other|22
4436|NCT02515279|23389|P1|Overall Study|End-of-treatment visit not attended|17
4437|NCT02515279|23389|P1|Overall Study|Withdrawal by Subject|18
4438|NCT02515279|23389|P1|Overall Study|Lost to Follow-up|9
4439|NCT02515279|23389|P1|Overall Study|Lack of Efficacy|31
4440|NCT02515279|23389|P1|Overall Study|Adverse Event|7
4441|NCT02515045|23408|P3|Overall Study|Lost to Follow-up|1
4442|NCT02515045|23409|P2|Overall Study|Lost to Follow-up|1
4443|NCT02515045|23410|P1|Overall Study|Lost to Follow-up|0
4444|NCT02515045|23408|P3|Overall Study|Adverse Event|3
4445|NCT02515045|23409|P2|Overall Study|Adverse Event|3
4446|NCT02515045|23410|P1|Overall Study|Adverse Event|0
4447|NCT02514772|23447|P2|Overall Study|Withdrawal by Subject|1
4448|NCT02514772|23448|P1|Overall Study|Withdrawal by Subject|2
4449|NCT02514772|23447|P2|Overall Study|Death|1
4450|NCT02514772|23448|P1|Overall Study|Death|0
4451|NCT02514772|23447|P2|Overall Study|Adverse Event|0
4452|NCT02514772|23448|P1|Overall Study|Adverse Event|1
4453|NCT02514473|23462|P2|Overall Study|Other|1
4454|NCT02514473|23463|P1|Overall Study|Other|1
4455|NCT02514473|23462|P2|Overall Study|Lost to Follow-up|1
4456|NCT02514473|23463|P1|Overall Study|Lost to Follow-up|0
4457|NCT02514473|23462|P2|Overall Study|Withdrawal by Subject|1
4458|NCT02514473|23463|P1|Overall Study|Withdrawal by Subject|2
4459|NCT02514473|23462|P2|Overall Study|Adverse Event|2
4460|NCT02514473|23463|P1|Overall Study|Adverse Event|0
4461|NCT02513771|23506|P2|Overall Study|Not being able to get to clinic|0
4462|NCT02513771|23507|P1|Overall Study|Not being able to get to clinic|1
4463|NCT02513771|23506|P2|Overall Study|Lost to Follow-up|1
4464|NCT02513771|23507|P1|Overall Study|Lost to Follow-up|1
4465|NCT02513550|23536|P3|Overall Study|Death|2
4466|NCT02513550|23537|P2|Overall Study|Death|0
4467|NCT02513550|23538|P1|Overall Study|Death|1
4468|NCT02513550|23536|P3|Overall Study|Due to personal business|1
4469|NCT02513550|23537|P2|Overall Study|Due to personal business|0
4470|NCT02513550|23538|P1|Overall Study|Due to personal business|2
4471|NCT02513550|23536|P3|Overall Study|Met exclusion criteria and was not dosed|1
4472|NCT02513550|23537|P2|Overall Study|Met exclusion criteria and was not dosed|0
4473|NCT02513550|23538|P1|Overall Study|Met exclusion criteria and was not dosed|0
4474|NCT02513550|23536|P3|Overall Study|Site terminated by sponsor|3
4475|NCT02513550|23537|P2|Overall Study|Site terminated by sponsor|1
4476|NCT02513550|23538|P1|Overall Study|Site terminated by sponsor|1
4477|NCT02513550|23536|P3|Overall Study|Physician Decision|4
4478|NCT02513550|23537|P2|Overall Study|Physician Decision|0
4479|NCT02513550|23538|P1|Overall Study|Physician Decision|2
4480|NCT02513550|23536|P3|Overall Study|Protocol Violation|4
4481|NCT02513550|23537|P2|Overall Study|Protocol Violation|1
4482|NCT02513550|23538|P1|Overall Study|Protocol Violation|1
4483|NCT02513550|23536|P3|Overall Study|Lack of Efficacy|6
4484|NCT02513550|23537|P2|Overall Study|Lack of Efficacy|5
4485|NCT02513550|23538|P1|Overall Study|Lack of Efficacy|4
4486|NCT02513550|23536|P3|Overall Study|Lost to Follow-up|11
4487|NCT02513550|23537|P2|Overall Study|Lost to Follow-up|7
4488|NCT02513550|23538|P1|Overall Study|Lost to Follow-up|9
4489|NCT02513550|23536|P3|Overall Study|Adverse Event|17
4490|NCT02513550|23537|P2|Overall Study|Adverse Event|13
4491|NCT02513550|23538|P1|Overall Study|Adverse Event|5
4492|NCT02513550|23536|P3|Overall Study|Withdrawal by Subject|25
4493|NCT02513550|23537|P2|Overall Study|Withdrawal by Subject|11
4494|NCT02513550|23538|P1|Overall Study|Withdrawal by Subject|11
4495|NCT02513160|23605|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
4496|NCT02513160|23606|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
4497|NCT02513160|23607|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
4498|NCT02513160|23608|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
4499|NCT02513160|23605|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
4500|NCT02513160|23606|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
4501|NCT02513160|23607|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
4502|NCT02513160|23608|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
4503|NCT02513160|23605|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
4504|NCT02513160|23606|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
4505|NCT02513160|23607|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
4506|NCT02513160|23608|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
4507|NCT02513160|23605|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
4508|NCT02513160|23606|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
4509|NCT02513160|23607|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
4510|NCT02513160|23608|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
4511|NCT02513160|23605|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
4512|NCT02513160|23606|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
4513|NCT02513160|23607|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
4514|NCT02513160|23608|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
4515|NCT02513160|23605|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
4516|NCT02513160|23606|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
4517|NCT02513160|23607|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
4518|NCT02513160|23608|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
4519|NCT02513160|23605|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
4520|NCT02513160|23606|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
4521|NCT02513160|23607|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
4522|NCT02513160|23608|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
4523|NCT02513160|23605|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
4524|NCT02513160|23606|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
4525|NCT02513160|23607|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
4526|NCT02513160|23608|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
4527|NCT02513160|23605|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
4528|NCT02513160|23606|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
4529|NCT02513160|23607|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
4530|NCT02513160|23608|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
4531|NCT02513160|23605|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
4532|NCT02513160|23606|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
4533|NCT02513160|23607|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
4534|NCT02513160|23608|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
4535|NCT02513160|23605|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
4536|NCT02513160|23606|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
4537|NCT02513160|23607|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
4538|NCT02513160|23608|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
4539|NCT02513160|23605|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
4540|NCT02513160|23606|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
4541|NCT02513160|23607|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
4542|NCT02513160|23608|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
4543|NCT02513095|23645|P2|Overall Study|Stampede resulted in transfers out of ER|16
4544|NCT02513095|23646|P1|Overall Study|Stampede resulted in transfers out of ER|14
4545|NCT02511782|23815|P3|Overall Study|Withdrawal by Subject|0
4546|NCT02511782|23816|P2|Overall Study|Withdrawal by Subject|0
4547|NCT02511782|23817|P1|Overall Study|Withdrawal by Subject|1
4548|NCT02511431|23846|P6|Treatment|Lost to Follow-up|1
4549|NCT02511431|23847|P5|Treatment|Lost to Follow-up|0
4550|NCT02511431|23848|P4|Treatment|Lost to Follow-up|0
4551|NCT02511431|23849|P3|Treatment|Lost to Follow-up|1
4552|NCT02511431|23850|P2|Treatment|Lost to Follow-up|0
4553|NCT02511431|23851|P1|Treatment|Lost to Follow-up|0
4554|NCT02510820|23871|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
4555|NCT02510820|23872|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4556|NCT02510820|23871|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
4557|NCT02510820|23872|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
4558|NCT02510014|23912|P2|Treatment Period|Incarceration, pregnancy, misc|5
4559|NCT02510014|23913|P1|Treatment Period|Incarceration, pregnancy, misc|29
4560|NCT02510014|23912|P2|Treatment Period|Protocol Violation|4
4561|NCT02510014|23913|P1|Treatment Period|Protocol Violation|4
4562|NCT02510014|23912|P2|Treatment Period|Withdrawn by the investigator|1
4563|NCT02510014|23913|P1|Treatment Period|Withdrawn by the investigator|7
4564|NCT02510014|23912|P2|Treatment Period|Withdrawal by Subject|24
4565|NCT02510014|23913|P1|Treatment Period|Withdrawal by Subject|67
4566|NCT02510014|23912|P2|Treatment Period|Physician Decision|0
4567|NCT02510014|23913|P1|Treatment Period|Physician Decision|5
4568|NCT02510014|23912|P2|Treatment Period|Lost to Follow-up|19
4569|NCT02510014|23913|P1|Treatment Period|Lost to Follow-up|80
4570|NCT02510014|23912|P2|Treatment Period|Withdrawal symptoms|0
4571|NCT02510014|23913|P1|Treatment Period|Withdrawal symptoms|3
4572|NCT02510014|23912|P2|Treatment Period|Adverse Event|4
4573|NCT02510014|23913|P1|Treatment Period|Adverse Event|11
4574|NCT02510014|23912|P2|Run-In Period (Days -14 to Day -1)|Not specified|1
4575|NCT02510014|23913|P1|Run-In Period (Days -14 to Day -1)|Not specified|19
4576|NCT02510014|23912|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
4577|NCT02510014|23913|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
4578|NCT02510014|23912|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
4579|NCT02510014|23913|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
4580|NCT02510014|23912|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
4581|NCT02510014|23913|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
4582|NCT02510014|23912|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
4583|NCT02510014|23913|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
4584|NCT02510014|23912|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
4585|NCT02510014|23913|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
4586|NCT02510014|23912|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
4587|NCT02510014|23913|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
4588|NCT02510014|23912|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
4589|NCT02510014|23913|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
4590|NCT02508194|23935|P2|Overall Study|Principal Investigator Decision|2
4591|NCT02508194|23936|P1|Overall Study|Principal Investigator Decision|1
4592|NCT02508194|23935|P2|Overall Study|Error in Randomization|3
4593|NCT02508194|23936|P1|Overall Study|Error in Randomization|1
4594|NCT02508194|23935|P2|Overall Study|Withdrawal by Subject|18
4595|NCT02508194|23936|P1|Overall Study|Withdrawal by Subject|20
4596|NCT02508194|23935|P2|Overall Study|Lost to Follow-up|18
4597|NCT02508194|23936|P1|Overall Study|Lost to Follow-up|25
4598|NCT02508194|23935|P2|Overall Study|Death|3
4599|NCT02508194|23936|P1|Overall Study|Death|5
4600|NCT02507752|23985|P1|Overall Study|Participant didn't perform visit Week 24|1
4601|NCT02507752|23985|P1|Overall Study|Participant didn't perform visit Week 12|1
4602|NCT02507752|23985|P1|Overall Study|Infusion reaction at first infusion|1
4603|NCT02507752|23985|P1|Overall Study|Lost to Follow-up|7
4604|NCT02507752|23985|P1|Overall Study|Protocol Violation|6
4605|NCT02507752|23985|P1|Overall Study|Adverse Event|1
4606|NCT02507375|24029|P2|Overall Study|Adverse Event|1
4607|NCT02507375|24030|P1|Overall Study|Adverse Event|0
4608|NCT02507375|24029|P2|Overall Study|Refused treatment|1
4609|NCT02507375|24030|P1|Overall Study|Refused treatment|0
4610|NCT02507375|24029|P2|Overall Study|Death|1
4611|NCT02507375|24030|P1|Overall Study|Death|0
4612|NCT02507375|24029|P2|Overall Study|Progressive Disease|5
4613|NCT02507375|24030|P1|Overall Study|Progressive Disease|4
4614|NCT02507219|24047|P6|Overall Study|Withdrawal by Subject|0
4615|NCT02507219|24048|P5|Overall Study|Withdrawal by Subject|1
4616|NCT02507219|24049|P4|Overall Study|Withdrawal by Subject|0
4617|NCT02507219|24050|P3|Overall Study|Withdrawal by Subject|0
4618|NCT02507219|24051|P2|Overall Study|Withdrawal by Subject|0
4619|NCT02507219|24052|P1|Overall Study|Withdrawal by Subject|0
4620|NCT02507219|24047|P6|Overall Study|Physician Decision|0
4621|NCT02507219|24048|P5|Overall Study|Physician Decision|0
4622|NCT02507219|24049|P4|Overall Study|Physician Decision|0
4623|NCT02507219|24050|P3|Overall Study|Physician Decision|0
4624|NCT02507219|24051|P2|Overall Study|Physician Decision|0
4625|NCT02507219|24052|P1|Overall Study|Physician Decision|1
4626|NCT02506881|24064|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
4627|NCT02506881|24065|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
4628|NCT02506881|24066|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
4629|NCT02506881|24067|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
4630|NCT02506881|24064|P4|First Intervention (Day 1)|Withdrawal by Subject|0
4631|NCT02506881|24065|P3|First Intervention (Day 1)|Withdrawal by Subject|0
4632|NCT02506881|24066|P2|First Intervention (Day 1)|Withdrawal by Subject|0
4633|NCT02506881|24067|P1|First Intervention (Day 1)|Withdrawal by Subject|1
4634|NCT02506881|24064|P4|First Intervention (Day 1)|Protocol Violation|0
4635|NCT02506881|24065|P3|First Intervention (Day 1)|Protocol Violation|1
4636|NCT02506881|24066|P2|First Intervention (Day 1)|Protocol Violation|0
4637|NCT02506881|24067|P1|First Intervention (Day 1)|Protocol Violation|0
4638|NCT02506257|24120|P4|Overall Study|Protocol Violation|0
4639|NCT02506257|24121|P3|Overall Study|Protocol Violation|1
4640|NCT02506257|24122|P2|Overall Study|Protocol Violation|0
4641|NCT02506257|24123|P1|Overall Study|Protocol Violation|0
4642|NCT02506257|24120|P4|Overall Study|Adverse Event|0
4643|NCT02506257|24121|P3|Overall Study|Adverse Event|3
4644|NCT02506257|24122|P2|Overall Study|Adverse Event|2
4645|NCT02506257|24123|P1|Overall Study|Adverse Event|0
4646|NCT02506101|24155|P2|Overall Study|No enrollment and staff unavailability|0
4647|NCT02506101|24156|P1|Overall Study|No enrollment and staff unavailability|1
4648|NCT02506101|24155|P2|Overall Study|Transportation issues|0
4649|NCT02506101|24156|P1|Overall Study|Transportation issues|1
4650|NCT02504541|24209|P1|Overall Study|Multiple|5
4651|NCT02504541|24209|P1|Overall Study|Other|2
4652|NCT02504541|24209|P1|Overall Study|Termination by Sponsor|1
4653|NCT02504541|24209|P1|Overall Study|Protocol Violation|2
4654|NCT02504541|24209|P1|Overall Study|Met Stopping Criteria|1
4655|NCT02504541|24209|P1|Overall Study|Lost to Follow-up|1
4656|NCT02504541|24209|P1|Overall Study|Withdrawal by Subject|4
4657|NCT02504541|24209|P1|Overall Study|Adverse Event|4
4658|NCT02504502|24215|P2|Crossover to Enhanced Report|Lost to Follow-up|0
4659|NCT02504502|24216|P1|Crossover to Enhanced Report|Lost to Follow-up|5
4660|NCT02504502|24215|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
4661|NCT02504502|24216|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
4662|NCT02504320|24226|P4|Treatment Period 3|Adverse Event|0
4663|NCT02504320|24227|P3|Treatment Period 3|Adverse Event|1
4664|NCT02504320|24228|P2|Treatment Period 3|Adverse Event|0
4665|NCT02504320|24229|P1|Treatment Period 3|Adverse Event|0
4666|NCT02504320|24226|P4|Treatment Period 3|Positive Drug Screen|1
4667|NCT02504320|24227|P3|Treatment Period 3|Positive Drug Screen|0
4668|NCT02504320|24228|P2|Treatment Period 3|Positive Drug Screen|0
4669|NCT02504320|24229|P1|Treatment Period 3|Positive Drug Screen|0
4670|NCT02504320|24226|P4|Treatment Period 2|Positive Drug Screen|0
4671|NCT02504320|24227|P3|Treatment Period 2|Positive Drug Screen|0
4672|NCT02504320|24228|P2|Treatment Period 2|Positive Drug Screen|1
4673|NCT02504320|24229|P1|Treatment Period 2|Positive Drug Screen|0
4674|NCT02504320|24226|P4|Treatment Period 1|Positive Drug Screen|0
4675|NCT02504320|24227|P3|Treatment Period 1|Positive Drug Screen|1
4676|NCT02504320|24228|P2|Treatment Period 1|Positive Drug Screen|0
4677|NCT02504320|24229|P1|Treatment Period 1|Positive Drug Screen|0
4678|NCT02503865|24268|P3|Overall Study|Refused treatment|2
4679|NCT02503865|24269|P2|Overall Study|Refused treatment|39
4680|NCT02503865|24270|P1|Overall Study|Refused treatment|4
4681|NCT02503865|24268|P3|Overall Study|Moved out of area|0
4682|NCT02503865|24269|P2|Overall Study|Moved out of area|8
4683|NCT02503865|24270|P1|Overall Study|Moved out of area|1
4684|NCT02503787|24290|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
4685|NCT02503787|24290|P1|Implant to 3 Month Endpoint|Adverse Event|2
4686|NCT02503787|24290|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
4687|NCT02503787|24290|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
4688|NCT02503787|24290|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
4689|NCT02503787|24290|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
4690|NCT02503787|24290|P1|Enrollment|Unable to be programmed|1
4691|NCT02503787|24290|P1|Enrollment|Inability to implant system|1
4692|NCT02503787|24290|P1|Enrollment|Protocol Violation|1
4693|NCT02503787|24290|P1|Enrollment|Adverse Event|1
4694|NCT02503787|24290|P1|Enrollment|Study closure|1
4695|NCT02503787|24290|P1|Enrollment|Lost to Follow-up|1
4696|NCT02503787|24290|P1|Enrollment|Insurance issue|2
4697|NCT02503787|24290|P1|Enrollment|Physician Decision|2
4698|NCT02503787|24290|P1|Enrollment|Inclusion/exclusion criteria not met|4
4699|NCT02503787|24290|P1|Enrollment|Withdrawal by Subject|6
4700|NCT02503215|24313|P1|Overall Study|Unable to use positive airway pressure|2
4701|NCT02503215|24313|P1|Overall Study|Unable to wear compression stockings|1
4702|NCT02503085|24319|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
4703|NCT02503085|24320|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
4704|NCT02503085|24321|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
4705|NCT02503085|24322|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
4706|NCT02502734|24361|P2|Washout Period|Adverse Event|0
4707|NCT02502734|24362|P1|Washout Period|Adverse Event|1
4708|NCT02502734|24361|P2|Double-blind Treatment Period 1|Adverse Event|0
4709|NCT02502734|24362|P1|Double-blind Treatment Period 1|Adverse Event|1
4710|NCT02502526|24373|P3|Overall Study|Enrollment suspension|1
4711|NCT02502526|24374|P2|Overall Study|Enrollment suspension|1
4712|NCT02502526|24375|P1|Overall Study|Enrollment suspension|4
4713|NCT02502526|24373|P3|Overall Study|Disqualified due to cataract grading|1
4714|NCT02502526|24374|P2|Overall Study|Disqualified due to cataract grading|0
4715|NCT02502526|24375|P1|Overall Study|Disqualified due to cataract grading|0
4716|NCT02502526|24373|P3|Overall Study|Withdrawal by Subject|1
4717|NCT02502526|24374|P2|Overall Study|Withdrawal by Subject|1
4718|NCT02502526|24375|P1|Overall Study|Withdrawal by Subject|0
4719|NCT02502526|24373|P3|Overall Study|Lost to Follow-up|3
4720|NCT02502526|24374|P2|Overall Study|Lost to Follow-up|2
4721|NCT02502526|24375|P1|Overall Study|Lost to Follow-up|2
4722|NCT02502149|24461|P5|Intermediate|Discontinued prematurely|0
4723|NCT02502149|24462|P4|Intermediate|Discontinued prematurely|0
4724|NCT02502149|24463|P3|Intermediate|Discontinued prematurely|0
4725|NCT02502149|24464|P2|Intermediate|Discontinued prematurely|0
4726|NCT02502149|24465|P1|Intermediate|Discontinued prematurely|1
4727|NCT02500758|24609|P2|Second Intervention (2 Minutes)|Protocol Violation|1
4728|NCT02500758|24610|P1|Second Intervention (2 Minutes)|Protocol Violation|1
4729|NCT02500758|24609|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
4730|NCT02500758|24610|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
4731|NCT02500758|24609|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
4732|NCT02500758|24610|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
4733|NCT02500758|24609|P2|Washout (1 Week)|Lost to Follow-up|2
4734|NCT02500758|24610|P1|Washout (1 Week)|Lost to Follow-up|2
4735|NCT02500758|24609|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
4736|NCT02500758|24610|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
4737|NCT02500537|24633|P2|Overall Study|Withdrawal by Subject|0
4738|NCT02500537|24634|P1|Overall Study|Withdrawal by Subject|1
4739|NCT02500537|24633|P2|Overall Study|Lost to Follow-up|1
4740|NCT02500537|24634|P1|Overall Study|Lost to Follow-up|0
4741|NCT02500537|24633|P2|Overall Study|Death|0
4742|NCT02500537|24634|P1|Overall Study|Death|2
4743|NCT02500056|24703|P2|Overall Study|Death|1
4744|NCT02500056|24704|P1|Overall Study|Death|3
4745|NCT02500056|24703|P2|Overall Study|Recurrence|0
4746|NCT02500056|24704|P1|Overall Study|Recurrence|1
4747|NCT02500056|24703|P2|Overall Study|Lost to Follow-up|7
4748|NCT02500056|24704|P1|Overall Study|Lost to Follow-up|3
4749|NCT02499952|24714|P1|Overall Study|Death|9
4750|NCT02499952|24714|P1|Overall Study|Lost to Follow-up|1
4751|NCT02499575|24732|P2|Overall Study|Protocol Violation|1
4752|NCT02499575|24733|P1|Overall Study|Protocol Violation|0
4753|NCT02498821|24745|P2|Overall Study|Screen failure|5
4754|NCT02498821|24746|P1|Overall Study|Screen failure|3
4755|NCT02498678|24775|P2|Overall Study|interference from the surgical team|2
4756|NCT02498678|24776|P1|Overall Study|interference from the surgical team|0
4757|NCT02498652|24792|P2|Overall Study|Protocol Violation|1
4758|NCT02498652|24793|P1|Overall Study|Protocol Violation|0
4759|NCT02497976|24903|P2|Overall Study|Moved out of area|1
4760|NCT02497976|24904|P1|Overall Study|Moved out of area|0
4761|NCT02497976|24903|P2|Overall Study|Withdrawal by Subject|0
4762|NCT02497976|24904|P1|Overall Study|Withdrawal by Subject|2
4763|NCT02497781|24922|P2|Overall Study|Lost to Follow-up|1
4764|NCT02497781|24923|P1|Overall Study|Lost to Follow-up|1
4765|NCT02497781|24922|P2|Overall Study|Randomised but not treated|1
4766|NCT02497781|24923|P1|Overall Study|Randomised but not treated|1
4767|NCT02497781|24922|P2|Overall Study|Lack of Efficacy|1
4768|NCT02497781|24923|P1|Overall Study|Lack of Efficacy|0
4769|NCT02497781|24922|P2|Overall Study|Withdrawal by Subject|0
4770|NCT02497781|24923|P1|Overall Study|Withdrawal by Subject|2
4771|NCT02497755|24986|P2|Overall Study|Protocol Violation|0
4772|NCT02497755|24987|P1|Overall Study|Protocol Violation|1
4773|NCT02496533|25054|P2|Overall Study|Late for radiologic testing|2
4774|NCT02496533|25055|P1|Overall Study|Late for radiologic testing|0
4775|NCT02496533|25054|P2|Overall Study|Patient did not complete all measures|4
4776|NCT02496533|25055|P1|Overall Study|Patient did not complete all measures|0
4777|NCT02496533|25054|P2|Overall Study|Lack of data on outcome|0
4778|NCT02496533|25055|P1|Overall Study|Lack of data on outcome|3
4779|NCT02496221|25067|P2|Treatment Period 2 - 4 Days|Physician Decision|0
4780|NCT02496221|25068|P1|Treatment Period 2 - 4 Days|Physician Decision|1
4781|NCT02496221|25067|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
4782|NCT02496221|25068|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
4783|NCT02496221|25067|P2|Treatment Period 2 - 4 Days|Adverse Event|1
4784|NCT02496221|25068|P1|Treatment Period 2 - 4 Days|Adverse Event|0
4785|NCT02496039|25102|P1|Overall Study|Protocol Violation|1
4786|NCT02496039|25102|P1|Overall Study|Adverse Event|3
4787|NCT02496000|25117|P3|Overall Study|undetermined|0
4788|NCT02496000|25118|P2|Overall Study|undetermined|1
4789|NCT02496000|25119|P1|Overall Study|undetermined|0
4790|NCT02496000|25117|P3|Overall Study|Non-compliance or lack of cooperation|0
4791|NCT02496000|25118|P2|Overall Study|Non-compliance or lack of cooperation|2
4792|NCT02496000|25119|P1|Overall Study|Non-compliance or lack of cooperation|0
4793|NCT02496000|25117|P3|Overall Study|Protocol Violation|1
4794|NCT02496000|25118|P2|Overall Study|Protocol Violation|0
4795|NCT02496000|25119|P1|Overall Study|Protocol Violation|0
4796|NCT02496000|25117|P3|Overall Study|Lost to Follow-up|1
4797|NCT02496000|25118|P2|Overall Study|Lost to Follow-up|0
4798|NCT02496000|25119|P1|Overall Study|Lost to Follow-up|1
4799|NCT02496000|25117|P3|Overall Study|Withdrawal by Subject|0
4800|NCT02496000|25118|P2|Overall Study|Withdrawal by Subject|2
4801|NCT02496000|25119|P1|Overall Study|Withdrawal by Subject|1
4802|NCT02495948|25128|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
4803|NCT02495948|25129|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
4804|NCT02495948|25128|P2|Period 1, First 30 Days of Wear|Adverse Event|1
4805|NCT02495948|25129|P1|Period 1, First 30 Days of Wear|Adverse Event|0
4806|NCT02494596|25204|P3|Overall Study|Refused Treatment|0
4807|NCT02494596|25205|P2|Overall Study|Refused Treatment|1
4808|NCT02494596|25206|P1|Overall Study|Refused Treatment|0
4809|NCT02494596|25204|P3|Overall Study|Adverse Event|0
4810|NCT02494596|25205|P2|Overall Study|Adverse Event|1
4811|NCT02494596|25206|P1|Overall Study|Adverse Event|0
4812|NCT02494596|25204|P3|Overall Study|Insufficient Therapeutic Response|1
4813|NCT02494596|25205|P2|Overall Study|Insufficient Therapeutic Response|3
4814|NCT02494596|25206|P1|Overall Study|Insufficient Therapeutic Response|3
4815|NCT02493855|25258|P3|Overall Study|Withdrawal by Subject|0
4816|NCT02493855|25259|P2|Overall Study|Withdrawal by Subject|0
4817|NCT02493855|25260|P1|Overall Study|Withdrawal by Subject|1
4818|NCT02493855|25258|P3|Overall Study|Adverse Event|0
4819|NCT02493855|25259|P2|Overall Study|Adverse Event|1
4820|NCT02493855|25260|P1|Overall Study|Adverse Event|0
4821|NCT02493855|25258|P3|Overall Study|Non-compliance|0
4822|NCT02493855|25259|P2|Overall Study|Non-compliance|0
4823|NCT02493855|25260|P1|Overall Study|Non-compliance|1
4824|NCT02493127|25270|P2|Overall Study|Lost to Follow-up|1
4825|NCT02493127|25271|P1|Overall Study|Lost to Follow-up|1
4826|NCT02492984|25304|P2|Overall Study|Withdrawal by Subject|0
4827|NCT02492984|25305|P1|Overall Study|Withdrawal by Subject|1
4828|NCT02492984|25304|P2|Overall Study|Protocol Violation|0
4829|NCT02492984|25305|P1|Overall Study|Protocol Violation|1
4830|NCT02492984|25304|P2|Overall Study|Adverse Event|0
4831|NCT02492984|25305|P1|Overall Study|Adverse Event|1
4832|NCT02492841|25328|P3|Overall Study|Lost to Follow-up|35
4833|NCT02492841|25329|P2|Overall Study|Lost to Follow-up|31
4834|NCT02492841|25330|P1|Overall Study|Lost to Follow-up|34
4835|NCT02492763|25345|P4|Overall Study|Study Terminated by Sponsor|10
4836|NCT02492763|25346|P3|Overall Study|Study Terminated by Sponsor|6
4837|NCT02492763|25347|P2|Overall Study|Study Terminated by Sponsor|10
4838|NCT02492763|25348|P1|Overall Study|Study Terminated by Sponsor|13
4839|NCT02492763|25345|P4|Overall Study|Screen Failure|1
4840|NCT02492763|25346|P3|Overall Study|Screen Failure|0
4841|NCT02492763|25347|P2|Overall Study|Screen Failure|0
4842|NCT02492763|25348|P1|Overall Study|Screen Failure|0
4843|NCT02492763|25345|P4|Overall Study|Non-Compliance With Study Drug|0
4844|NCT02492763|25346|P3|Overall Study|Non-Compliance With Study Drug|0
4845|NCT02492763|25347|P2|Overall Study|Non-Compliance With Study Drug|1
4846|NCT02492763|25348|P1|Overall Study|Non-Compliance With Study Drug|0
4847|NCT02492763|25345|P4|Overall Study|Lost to Follow-up|0
4848|NCT02492763|25346|P3|Overall Study|Lost to Follow-up|1
4849|NCT02492763|25347|P2|Overall Study|Lost to Follow-up|0
4850|NCT02492763|25348|P1|Overall Study|Lost to Follow-up|0
4851|NCT02492763|25345|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
4852|NCT02492763|25346|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
4853|NCT02492763|25347|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
4854|NCT02492763|25348|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
4855|NCT02492763|25345|P4|Overall Study|Death|0
4856|NCT02492763|25346|P3|Overall Study|Death|1
4857|NCT02492763|25347|P2|Overall Study|Death|0
4858|NCT02492763|25348|P1|Overall Study|Death|0
4859|NCT02492763|25345|P4|Overall Study|Adverse Event|2
4860|NCT02492763|25346|P3|Overall Study|Adverse Event|1
4861|NCT02492763|25347|P2|Overall Study|Adverse Event|1
4862|NCT02492763|25348|P1|Overall Study|Adverse Event|3
4863|NCT02492763|25345|P4|Overall Study|Withdrawal by Subject|0
4864|NCT02492763|25346|P3|Overall Study|Withdrawal by Subject|1
4865|NCT02492763|25347|P2|Overall Study|Withdrawal by Subject|2
4866|NCT02492763|25348|P1|Overall Study|Withdrawal by Subject|0
4867|NCT02492165|25419|P4|Overall Study|Withdrawal by Subject|0
4868|NCT02492165|25420|P3|Overall Study|Withdrawal by Subject|0
4869|NCT02492165|25421|P2|Overall Study|Withdrawal by Subject|1
4870|NCT02492165|25422|P1|Overall Study|Withdrawal by Subject|0
4871|NCT02491892|25466|P2|Overall Study|Lost to Follow-up|0
4872|NCT02491892|25467|P1|Overall Study|Lost to Follow-up|1
4873|NCT02491892|25466|P2|Overall Study|Refused Treatment|0
4874|NCT02491892|25467|P1|Overall Study|Refused Treatment|1
4875|NCT02491892|25466|P2|Overall Study|Lack of Efficacy|36
4876|NCT02491892|25467|P1|Overall Study|Lack of Efficacy|37
4877|NCT02491892|25466|P2|Overall Study|Death|1
4878|NCT02491892|25467|P1|Overall Study|Death|1
4879|NCT02491892|25466|P2|Overall Study|Adverse Event|1
4880|NCT02491892|25467|P1|Overall Study|Adverse Event|1
4881|NCT02491073|25513|P2|Overall Study|screen failure|0
4882|NCT02491073|25514|P1|Overall Study|screen failure|1
4883|NCT02490475|25555|P4|Period 2: Extension Phase|Adverse Event|0
4884|NCT02490475|25556|P3|Period 2: Extension Phase|Adverse Event|1
4885|NCT02490475|25557|P2|Period 2: Extension Phase|Adverse Event|0
4886|NCT02490475|25558|P1|Period 2: Extension Phase|Adverse Event|0
4887|NCT02490475|25555|P4|Period 2: Extension Phase|Refused Treatment|1
4888|NCT02490475|25556|P3|Period 2: Extension Phase|Refused Treatment|0
4889|NCT02490475|25557|P2|Period 2: Extension Phase|Refused Treatment|0
4890|NCT02490475|25558|P1|Period 2: Extension Phase|Refused Treatment|0
4891|NCT02490475|25555|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
4892|NCT02490475|25556|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
4893|NCT02490475|25557|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
4894|NCT02490475|25558|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
4895|NCT02490475|25555|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
4896|NCT02490475|25556|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
4897|NCT02490475|25557|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
4898|NCT02490475|25558|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
4899|NCT02490475|25555|P4|Period 1: First 6 Cycles|Refused Treatment|0
4900|NCT02490475|25556|P3|Period 1: First 6 Cycles|Refused Treatment|0
4901|NCT02490475|25557|P2|Period 1: First 6 Cycles|Refused Treatment|0
4902|NCT02490475|25558|P1|Period 1: First 6 Cycles|Refused Treatment|1
4903|NCT02490475|25555|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
4904|NCT02490475|25556|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
4905|NCT02490475|25557|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
4906|NCT02490475|25558|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
4907|NCT02490475|25555|P4|Period 1: First 6 Cycles|Adverse Event|1
4908|NCT02490475|25556|P3|Period 1: First 6 Cycles|Adverse Event|0
4909|NCT02490475|25557|P2|Period 1: First 6 Cycles|Adverse Event|1
4910|NCT02490475|25558|P1|Period 1: First 6 Cycles|Adverse Event|2
4911|NCT02489799|25647|P2|Overall Study|Death|1
4912|NCT02489799|25648|P1|Overall Study|Death|0
4913|NCT02489799|25647|P2|Overall Study|Withdrawal by Subject|1
4914|NCT02489799|25648|P1|Overall Study|Withdrawal by Subject|1
4915|NCT02489799|25647|P2|Overall Study|Failure to Maintain Eligibility|6
4916|NCT02489799|25648|P1|Overall Study|Failure to Maintain Eligibility|4
4917|NCT02489799|25647|P2|Overall Study|Lost to Follow-up|1
4918|NCT02489799|25648|P1|Overall Study|Lost to Follow-up|4
4919|NCT02488980|25675|P3|Overall Study|Protocol Violation|2
4920|NCT02488980|25676|P2|Overall Study|Protocol Violation|2
4921|NCT02488980|25677|P1|Overall Study|Protocol Violation|2
4922|NCT02488681|25694|P1|Overall Study|Implant unsuccessful|7
4923|NCT02487771|25729|P2|Overall Study|Withdrawal by Subject|5
4924|NCT02487771|25730|P1|Overall Study|Withdrawal by Subject|3
4925|NCT02487771|25729|P2|Overall Study|Moved out of area|6
4926|NCT02487771|25730|P1|Overall Study|Moved out of area|5
4927|NCT02487771|25729|P2|Overall Study|Lost to Follow-up|3
4928|NCT02487771|25730|P1|Overall Study|Lost to Follow-up|2
4929|NCT02487498|25880|P2|Period: Period 2|Physician Decision|0
4930|NCT02487498|25881|P1|Period: Period 2|Physician Decision|1
4931|NCT02487498|25880|P2|Period: Period 2|Death|1
4932|NCT02487498|25881|P1|Period: Period 2|Death|0
4933|NCT02487498|25880|P2|Period: Period 2|Lost to Follow-up|1
4934|NCT02487498|25881|P1|Period: Period 2|Lost to Follow-up|1
4935|NCT02487498|25880|P2|Period: Period 2|Subject/guardian decision|1
4936|NCT02487498|25881|P1|Period: Period 2|Subject/guardian decision|2
4937|NCT02487498|25880|P2|Period: Period 2|Adverse Event|2
4938|NCT02487498|25881|P1|Period: Period 2|Adverse Event|2
4939|NCT02487498|25880|P2|Period: Washout|Non-compliance with study treatment|1
4940|NCT02487498|25881|P1|Period: Washout|Non-compliance with study treatment|0
4941|NCT02487498|25880|P2|Period: Washout|Physician Decision|0
4942|NCT02487498|25881|P1|Period: Washout|Physician Decision|1
4943|NCT02487498|25880|P2|Period: Washout|Lack of Efficacy|1
4944|NCT02487498|25881|P1|Period: Washout|Lack of Efficacy|1
4945|NCT02487498|25880|P2|Period: Washout|Subject/guardian decision|5
4946|NCT02487498|25881|P1|Period: Washout|Subject/guardian decision|0
4947|NCT02487498|25880|P2|Period: Period 1|Protocol deviation|0
4948|NCT02487498|25881|P1|Period: Period 1|Protocol deviation|1
4949|NCT02487498|25880|P2|Period: Period 1|Physician Decision|1
4950|NCT02487498|25881|P1|Period: Period 1|Physician Decision|0
4951|NCT02487498|25880|P2|Period: Period 1|Lack of Efficacy|0
4952|NCT02487498|25881|P1|Period: Period 1|Lack of Efficacy|1
4953|NCT02487498|25880|P2|Period: Period 1|Lost to Follow-up|2
4954|NCT02487498|25881|P1|Period: Period 1|Lost to Follow-up|0
4955|NCT02487498|25880|P2|Period: Period 1|Subject/guardian decision|4
4956|NCT02487498|25881|P1|Period: Period 1|Subject/guardian decision|2
4957|NCT02487498|25880|P2|Period: Period 1|Adverse Event|4
4958|NCT02487498|25881|P1|Period: Period 1|Adverse Event|2
4959|NCT02487446|25904|P2|Period 2|Adverse Event|2
4960|NCT02487446|25905|P1|Period 2|Adverse Event|6
4961|NCT02487446|25904|P2|Period 2|Withdrawal by Subject|1
4962|NCT02487446|25905|P1|Period 2|Withdrawal by Subject|1
4963|NCT02487446|25904|P2|Period 2|Lost to Follow-up|1
4964|NCT02487446|25905|P1|Period 2|Lost to Follow-up|1
4965|NCT02487446|25904|P2|Period 2|Protocol deviation|1
4966|NCT02487446|25905|P1|Period 2|Protocol deviation|0
4967|NCT02487446|25904|P2|Washout|Adverse Event|2
4968|NCT02487446|25905|P1|Washout|Adverse Event|2
4969|NCT02487446|25904|P2|Washout|Withdrawal by Subject|4
4970|NCT02487446|25905|P1|Washout|Withdrawal by Subject|1
4971|NCT02487446|25904|P2|Washout|Lost to Follow-up|2
4972|NCT02487446|25905|P1|Washout|Lost to Follow-up|0
4973|NCT02487446|25904|P2|Period 1|Adverse Event|5
4974|NCT02487446|25905|P1|Period 1|Adverse Event|5
4975|NCT02487446|25904|P2|Period 1|Withdrawal by Subject|0
4976|NCT02487446|25905|P1|Period 1|Withdrawal by Subject|2
4977|NCT02487446|25904|P2|Period 1|Lost to Follow-up|0
4978|NCT02487446|25905|P1|Period 1|Lost to Follow-up|2
4979|NCT02487446|25904|P2|Period 1|Protocol deviation|2
4980|NCT02487446|25905|P1|Period 1|Protocol deviation|3
4981|NCT02487446|25904|P2|Period 1|Lack of Efficacy|0
4982|NCT02487446|25905|P1|Period 1|Lack of Efficacy|1
4983|NCT02487446|25904|P2|Period 1|Physician Decision|1
4984|NCT02487446|25905|P1|Period 1|Physician Decision|0
4985|NCT02487199|25930|P2|Overall Study|Withdrew Consent|1
4986|NCT02487199|25931|P1|Overall Study|Withdrew Consent|0
4987|NCT02487030|25950|P7|Overall Study|Death|0
4988|NCT02487030|25951|P6|Overall Study|Death|0
4989|NCT02487030|25952|P5|Overall Study|Death|1
4990|NCT02487030|25953|P4|Overall Study|Death|0
4991|NCT02487030|25954|P3|Overall Study|Death|0
4992|NCT02487030|25955|P2|Overall Study|Death|0
4993|NCT02487030|25956|P1|Overall Study|Death|0
4994|NCT02487030|25950|P7|Overall Study|Adverse Event|0
4995|NCT02487030|25951|P6|Overall Study|Adverse Event|0
4996|NCT02487030|25952|P5|Overall Study|Adverse Event|0
4997|NCT02487030|25953|P4|Overall Study|Adverse Event|1
4998|NCT02487030|25954|P3|Overall Study|Adverse Event|0
4999|NCT02487030|25955|P2|Overall Study|Adverse Event|0
5000|NCT02487030|25956|P1|Overall Study|Adverse Event|0
5001|NCT02487030|25950|P7|Overall Study|Lost to Follow-up|0
5002|NCT02487030|25951|P6|Overall Study|Lost to Follow-up|1
5003|NCT02487030|25952|P5|Overall Study|Lost to Follow-up|0
5004|NCT02487030|25953|P4|Overall Study|Lost to Follow-up|1
5005|NCT02487030|25954|P3|Overall Study|Lost to Follow-up|1
5006|NCT02487030|25955|P2|Overall Study|Lost to Follow-up|0
5007|NCT02487030|25956|P1|Overall Study|Lost to Follow-up|0
5008|NCT02487030|25950|P7|Overall Study|Lack of Efficacy|0
5009|NCT02487030|25951|P6|Overall Study|Lack of Efficacy|0
5010|NCT02487030|25952|P5|Overall Study|Lack of Efficacy|1
5011|NCT02487030|25953|P4|Overall Study|Lack of Efficacy|0
5012|NCT02487030|25954|P3|Overall Study|Lack of Efficacy|1
5013|NCT02487030|25955|P2|Overall Study|Lack of Efficacy|4
5014|NCT02487030|25956|P1|Overall Study|Lack of Efficacy|2
5015|NCT02486952|25987|P1|Overall Study|Other|2
5016|NCT02486952|25987|P1|Overall Study|Lost to Follow-up|26
5017|NCT02486952|25987|P1|Overall Study|Lack of Efficacy|3
5018|NCT02486952|25987|P1|Overall Study|Death|15
5019|NCT02486952|25987|P1|Overall Study|Adverse Event|1
5020|NCT02486952|25987|P1|Overall Study|Not Started Induction Therapy|3
5021|NCT02485483|25994|P2|Overall Study|Discontinued after baseline|0
5022|NCT02485483|25995|P1|Overall Study|Discontinued after baseline|39
5023|NCT02485483|25994|P2|Overall Study|Depression at baseline|0
5024|NCT02485483|25995|P1|Overall Study|Depression at baseline|15
5025|NCT02485353|26010|P1|Overall Study|Disease Progression|1
5026|NCT02485353|26010|P1|Overall Study|Death|1
5027|NCT02485301|26017|P2|Overall Study|Other|4
5028|NCT02485301|26018|P1|Overall Study|Other|3
5029|NCT02485301|26017|P2|Overall Study|Lost to Follow-up|17
5030|NCT02485301|26018|P1|Overall Study|Lost to Follow-up|17
5031|NCT02485301|26017|P2|Overall Study|Migrated/moved from study area|19
5032|NCT02485301|26018|P1|Overall Study|Migrated/moved from study area|10
5033|NCT02485301|26017|P2|Overall Study|Withdrawal by Subject|7
5034|NCT02485301|26018|P1|Overall Study|Withdrawal by Subject|6
5035|NCT02485301|26017|P2|Overall Study|Protocol Violation|1
5036|NCT02485301|26018|P1|Overall Study|Protocol Violation|0
5037|NCT02485301|26017|P2|Overall Study|Serious Adverse Events|1
5038|NCT02485301|26018|P1|Overall Study|Serious Adverse Events|2
5039|NCT02485158|26068|P1|Overall Study|expected drug side effect|1
5040|NCT02485158|26068|P1|Overall Study|Withdrawal by Subject|3
5041|NCT02484911|26157|P2|Overall Study|Protocol Violation|1
5042|NCT02484911|26158|P1|Overall Study|Protocol Violation|2
5043|NCT02484911|26157|P2|Overall Study|Withdrawal by Subject|1
5044|NCT02484911|26158|P1|Overall Study|Withdrawal by Subject|2
5045|NCT02484729|26200|P10|Overall Study|Failure of IntelliCap Error|1
5046|NCT02484729|26201|P9|Overall Study|Failure of IntelliCap Error|0
5047|NCT02484729|26202|P8|Overall Study|Failure of IntelliCap Error|0
5048|NCT02484729|26203|P7|Overall Study|Failure of IntelliCap Error|0
5049|NCT02484729|26204|P6|Overall Study|Failure of IntelliCap Error|0
5050|NCT02484729|26205|P5|Overall Study|Failure of IntelliCap Error|0
5051|NCT02484729|26206|P4|Overall Study|Failure of IntelliCap Error|0
5052|NCT02484729|26207|P3|Overall Study|Failure of IntelliCap Error|0
5053|NCT02484729|26208|P2|Overall Study|Failure of IntelliCap Error|0
5054|NCT02484729|26209|P1|Overall Study|Failure of IntelliCap Error|0
5055|NCT02483975|26407|P2|Overall Study|Physician Decision|0
5056|NCT02483975|26408|P1|Overall Study|Physician Decision|2
5057|NCT02483975|26407|P2|Overall Study|Lost to Follow-up|1
5058|NCT02483975|26408|P1|Overall Study|Lost to Follow-up|0
5059|NCT02483975|26407|P2|Overall Study|Adverse Event|1
5060|NCT02483975|26408|P1|Overall Study|Adverse Event|0
5061|NCT02483611|26425|P3|Overall Study|Protocol Violation|1
5062|NCT02483611|26426|P2|Overall Study|Protocol Violation|0
5063|NCT02483611|26427|P1|Overall Study|Protocol Violation|0
5064|NCT02482805|26540|P3|Overall Study|Lost to Follow-up|0
5065|NCT02482805|26541|P2|Overall Study|Lost to Follow-up|4
5066|NCT02482805|26542|P1|Overall Study|Lost to Follow-up|4
5067|NCT02482571|26556|P1|Overall Study|Withdrawal by Subject|4
5068|NCT02482571|26556|P1|Overall Study|Scanner or Respiract failure|3
5069|NCT02482571|26556|P1|Overall Study|Adverse Event|1
5070|NCT02482428|26568|P5|Overall Study|subject/guardian decision|2
5071|NCT02482428|26569|P4|Overall Study|subject/guardian decision|0
5072|NCT02482428|26570|P3|Overall Study|subject/guardian decision|0
5073|NCT02482428|26571|P2|Overall Study|subject/guardian decision|2
5074|NCT02482428|26572|P1|Overall Study|subject/guardian decision|4
5075|NCT02482428|26568|P5|Overall Study|protocol deviation|0
5076|NCT02482428|26569|P4|Overall Study|protocol deviation|0
5077|NCT02482428|26570|P3|Overall Study|protocol deviation|0
5078|NCT02482428|26571|P2|Overall Study|protocol deviation|1
5079|NCT02482428|26572|P1|Overall Study|protocol deviation|1
5080|NCT02482428|26568|P5|Overall Study|Physician Decision|1
5081|NCT02482428|26569|P4|Overall Study|Physician Decision|0
5082|NCT02482428|26570|P3|Overall Study|Physician Decision|0
5083|NCT02482428|26571|P2|Overall Study|Physician Decision|0
5084|NCT02482428|26572|P1|Overall Study|Physician Decision|0
5085|NCT02482428|26568|P5|Overall Study|Lost to Follow-up|4
5086|NCT02482428|26569|P4|Overall Study|Lost to Follow-up|2
5087|NCT02482428|26570|P3|Overall Study|Lost to Follow-up|1
5088|NCT02482428|26571|P2|Overall Study|Lost to Follow-up|9
5089|NCT02482428|26572|P1|Overall Study|Lost to Follow-up|4
5090|NCT02482298|26595|P3|Overall Study|Lost to Follow-up|0
5091|NCT02482298|26596|P2|Overall Study|Lost to Follow-up|1
5092|NCT02482298|26597|P1|Overall Study|Lost to Follow-up|0
5093|NCT02482298|26595|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
5094|NCT02482298|26596|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
5095|NCT02482298|26597|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
5096|NCT02482298|26595|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
5097|NCT02482298|26596|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
5098|NCT02482298|26597|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
5099|NCT02482298|26595|P3|Overall Study|Withdrawal by Subject|2
5100|NCT02482298|26596|P2|Overall Study|Withdrawal by Subject|1
5101|NCT02482298|26597|P1|Overall Study|Withdrawal by Subject|2
5102|NCT02482129|26619|P2|Overall Study|Criteria not met|0
5103|NCT02482129|26620|P1|Overall Study|Criteria not met|1
5104|NCT02482129|26619|P2|Overall Study|Withdrawal by Subject|0
5105|NCT02482129|26620|P1|Overall Study|Withdrawal by Subject|2
5106|NCT02482129|26619|P2|Overall Study|Adverse Event|0
5107|NCT02482129|26620|P1|Overall Study|Adverse Event|1
5108|NCT02482129|26619|P2|Overall Study|Criteria not met-prior to treatment|0
5109|NCT02482129|26620|P1|Overall Study|Criteria not met-prior to treatment|1
5110|NCT02482129|26619|P2|Overall Study|Unable to draw blood-prior to treatment|0
5111|NCT02482129|26620|P1|Overall Study|Unable to draw blood-prior to treatment|1
5112|NCT02482129|26619|P2|Overall Study|Withdrawal by subject-prior to treatment|1
5113|NCT02482129|26620|P1|Overall Study|Withdrawal by subject-prior to treatment|0
5114|NCT02482129|26619|P2|Overall Study|Adverse Event-prior to treatment|1
5115|NCT02482129|26620|P1|Overall Study|Adverse Event-prior to treatment|0
5116|NCT02481934|26647|P1|Overall Study|Death|2
5117|NCT02480712|26726|P1|Overall Study|Lack of Efficacy|1
5118|NCT02480712|26726|P1|Overall Study|Death|1
5119|NCT02480712|26726|P1|Overall Study|Withdrew Consent|3
5120|NCT02480712|26726|P1|Overall Study|Lost to Follow-up|5
5121|NCT02480712|26726|P1|Overall Study|Enrolled but Never Treated|1
5122|NCT02480621|26745|P2|Follow Up|Lost to Follow-up|2
5123|NCT02480621|26746|P1|Follow Up|Lost to Follow-up|4
5124|NCT02480621|26745|P2|Randomization|Surgeon did not give intervention|1
5125|NCT02480621|26746|P1|Randomization|Surgeon did not give intervention|0
5126|NCT02480621|26745|P2|Randomization|Withdrawal by Subject|0
5127|NCT02480621|26746|P1|Randomization|Withdrawal by Subject|1
5128|NCT02480153|26823|P2|Overall Study|Randomized but not treated|1
5129|NCT02480153|26824|P1|Overall Study|Randomized but not treated|0
5130|NCT02480153|26823|P2|Overall Study|Withdrew treatment; continued in study|14
5131|NCT02480153|26824|P1|Overall Study|Withdrew treatment; continued in study|6
5132|NCT02480153|26823|P2|Overall Study|Discontinued from treatment and study|12
5133|NCT02480153|26824|P1|Overall Study|Discontinued from treatment and study|5
5134|NCT02480010|26832|P2|Overall Study|Refused Treatment|3
5135|NCT02480010|26833|P1|Overall Study|Refused Treatment|0
5136|NCT02480010|26832|P2|Overall Study|Insufficient therapeutic response|29
5137|NCT02480010|26833|P1|Overall Study|Insufficient therapeutic response|31
5138|NCT02480010|26832|P2|Overall Study|Death|0
5139|NCT02480010|26833|P1|Overall Study|Death|1
5140|NCT02480010|26832|P2|Overall Study|Adverse Event|1
5141|NCT02480010|26833|P1|Overall Study|Adverse Event|3
5142|NCT02479412|26895|P9|Overall Study|Randomization to wrong PK sampling group|0
5143|NCT02479412|26896|P8|Overall Study|Randomization to wrong PK sampling group|0
5144|NCT02479412|26897|P7|Overall Study|Randomization to wrong PK sampling group|0
5145|NCT02479412|26898|P6|Overall Study|Randomization to wrong PK sampling group|0
5146|NCT02479412|26899|P5|Overall Study|Randomization to wrong PK sampling group|1
5147|NCT02479412|26900|P4|Overall Study|Randomization to wrong PK sampling group|0
5148|NCT02479412|26901|P3|Overall Study|Randomization to wrong PK sampling group|0
5149|NCT02479412|26902|P2|Overall Study|Randomization to wrong PK sampling group|0
5150|NCT02479412|26903|P1|Overall Study|Randomization to wrong PK sampling group|0
5151|NCT02479412|26895|P9|Overall Study|Study-specific withdrawal criteria|1
5152|NCT02479412|26896|P8|Overall Study|Study-specific withdrawal criteria|1
5153|NCT02479412|26897|P7|Overall Study|Study-specific withdrawal criteria|0
5154|NCT02479412|26898|P6|Overall Study|Study-specific withdrawal criteria|0
5155|NCT02479412|26899|P5|Overall Study|Study-specific withdrawal criteria|0
5156|NCT02479412|26900|P4|Overall Study|Study-specific withdrawal criteria|1
5157|NCT02479412|26901|P3|Overall Study|Study-specific withdrawal criteria|1
5158|NCT02479412|26902|P2|Overall Study|Study-specific withdrawal criteria|0
5159|NCT02479412|26903|P1|Overall Study|Study-specific withdrawal criteria|0
5160|NCT02479412|26895|P9|Overall Study|Adverse Event|0
5161|NCT02479412|26896|P8|Overall Study|Adverse Event|0
5162|NCT02479412|26897|P7|Overall Study|Adverse Event|0
5163|NCT02479412|26898|P6|Overall Study|Adverse Event|0
5164|NCT02479412|26899|P5|Overall Study|Adverse Event|0
5165|NCT02479412|26900|P4|Overall Study|Adverse Event|0
5166|NCT02479412|26901|P3|Overall Study|Adverse Event|1
5167|NCT02479412|26902|P2|Overall Study|Adverse Event|0
5168|NCT02479412|26903|P1|Overall Study|Adverse Event|0
5169|NCT02479139|26980|P6|Overall Study|Other Miscellaneous Reasons|0
5170|NCT02479139|26981|P5|Overall Study|Other Miscellaneous Reasons|1
5171|NCT02479139|26982|P4|Overall Study|Other Miscellaneous Reasons|1
5172|NCT02479139|26983|P3|Overall Study|Other Miscellaneous Reasons|1
5173|NCT02479139|26984|P2|Overall Study|Other Miscellaneous Reasons|0
5174|NCT02479139|26985|P1|Overall Study|Other Miscellaneous Reasons|1
5175|NCT02479139|26980|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
5176|NCT02479139|26981|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
5177|NCT02479139|26982|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
5178|NCT02479139|26983|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
5179|NCT02479139|26984|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
5180|NCT02479139|26985|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
5181|NCT02479139|26980|P6|Overall Study|Withdrew Consent|1
5182|NCT02479139|26981|P5|Overall Study|Withdrew Consent|1
5183|NCT02479139|26982|P4|Overall Study|Withdrew Consent|4
5184|NCT02479139|26983|P3|Overall Study|Withdrew Consent|1
5185|NCT02479139|26984|P2|Overall Study|Withdrew Consent|6
5186|NCT02479139|26985|P1|Overall Study|Withdrew Consent|5
5187|NCT02479139|26980|P6|Overall Study|Lost to Follow-up|5
5188|NCT02479139|26981|P5|Overall Study|Lost to Follow-up|3
5189|NCT02479139|26982|P4|Overall Study|Lost to Follow-up|2
5190|NCT02479139|26983|P3|Overall Study|Lost to Follow-up|4
5191|NCT02479139|26984|P2|Overall Study|Lost to Follow-up|4
5192|NCT02479139|26985|P1|Overall Study|Lost to Follow-up|2
5193|NCT02478632|27018|P2|Overall Study|Other (Withdrawal from parent study)|5
5194|NCT02478632|27019|P1|Overall Study|Other (Withdrawal from parent study)|4
5195|NCT02478372|27046|P2|Overall Study|Death|2
5196|NCT02478372|27047|P1|Overall Study|Death|0
5197|NCT02478372|27046|P2|Overall Study|Lost to Follow-up|4
5198|NCT02478372|27047|P1|Overall Study|Lost to Follow-up|1
5199|NCT02478372|27046|P2|Overall Study|Protocol Violation|8
5200|NCT02478372|27047|P1|Overall Study|Protocol Violation|12
5201|NCT02478164|27069|P1|Overall Study|Withdrawal by Subject|1
5202|NCT02478164|27069|P1|Overall Study|Adverse Event|1
5203|NCT02478164|27069|P1|Overall Study|Lack of Efficacy|13
5204|NCT02477605|27082|P2|Overall Study|Administered gas during surgery|1
5205|NCT02477605|27083|P1|Overall Study|Administered gas during surgery|0
5206|NCT02477605|27082|P2|Overall Study|Withdrawal by Subject|1
5207|NCT02477605|27083|P1|Overall Study|Withdrawal by Subject|0
5208|NCT02477605|27082|P2|Overall Study|Lost to Follow-up|2
5209|NCT02477605|27083|P1|Overall Study|Lost to Follow-up|0
5210|NCT02477605|27082|P2|Overall Study|Discontinued prior to treatment|0
5211|NCT02477605|27083|P1|Overall Study|Discontinued prior to treatment|1
5212|NCT02477527|27097|P1|Overall Study|Screen Failure|3
5213|NCT02477527|27097|P1|Overall Study|Withdrawal by Subject|1
5214|NCT02477527|27097|P1|Overall Study|Lost to Follow-up|2
5215|NCT02477020|27107|P2|Overall Study|Lack of Efficacy|5
5216|NCT02477020|27108|P1|Overall Study|Lack of Efficacy|14
5217|NCT02477020|27107|P2|Overall Study|Reason not Specified|1
5218|NCT02477020|27108|P1|Overall Study|Reason not Specified|3
5219|NCT02477020|27107|P2|Overall Study|Voluntary Withdrawal|16
5220|NCT02477020|27108|P1|Overall Study|Voluntary Withdrawal|7
5221|NCT02477020|27107|P2|Overall Study|Pretreatment Event/Adverse Event|6
5222|NCT02477020|27108|P1|Overall Study|Pretreatment Event/Adverse Event|6
5223|NCT02476994|27138|P2|Overall Study|Based on feedback from FDA|0
5224|NCT02476994|27139|P1|Overall Study|Based on feedback from FDA|1
5225|NCT02476617|27208|P1|Overall Study|Lost to Follow-up|1
5226|NCT02476617|27208|P1|Overall Study|Adverse Event|1
5227|NCT02476422|27237|P2|Overall Study|Subject/guardian decision|1
5228|NCT02476422|27238|P1|Overall Study|Subject/guardian decision|0
5229|NCT02476175|27268|P1|Overall Study|Adverse Event|2
5230|NCT02475980|27292|P1|Overall Study|Withdrawal by Subject|1
5231|NCT02475980|27292|P1|Overall Study|Lost to Follow-up|4
5232|NCT02475564|27303|P2|Overall Study|Intense Menstrual bleeding|0
5233|NCT02475564|27304|P1|Overall Study|Intense Menstrual bleeding|1
5234|NCT02475564|27303|P2|Overall Study|Lost to Follow-up|1
5235|NCT02475564|27304|P1|Overall Study|Lost to Follow-up|2
5236|NCT02475564|27303|P2|Overall Study|Withdrawal by Subject|0
5237|NCT02475564|27304|P1|Overall Study|Withdrawal by Subject|1
5238|NCT02475395|27316|P2|Overall Study|Protocol Violation|3
5239|NCT02475395|27317|P1|Overall Study|Protocol Violation|30
5240|NCT02475278|27327|P1|Overall Study|Reason Not Specified|1
5241|NCT02475278|27327|P1|Overall Study|Lost to Follow-up|1
5242|NCT02474589|27374|P2|Overall Study|Inability to complete study procedures|1
5243|NCT02474589|27375|P1|Overall Study|Inability to complete study procedures|5
5244|NCT02474589|27374|P2|Overall Study|Withdrawal by Subject|0
5245|NCT02474589|27375|P1|Overall Study|Withdrawal by Subject|4
5246|NCT02474589|27374|P2|Overall Study|Protocol Violation|1
5247|NCT02474589|27375|P1|Overall Study|Protocol Violation|4
5248|NCT02474589|27374|P2|Overall Study|Lost to Follow-up|1
5249|NCT02474589|27375|P1|Overall Study|Lost to Follow-up|6
5250|NCT02474589|27374|P2|Overall Study|Adverse Event|2
5251|NCT02474589|27375|P1|Overall Study|Adverse Event|6
5252|NCT02474082|27405|P2|Overall Study|Protocol deviation|1
5253|NCT02474082|27406|P1|Overall Study|Protocol deviation|0
5254|NCT02474082|27405|P2|Overall Study|Non-compliance with study treatment|2
5255|NCT02474082|27406|P1|Overall Study|Non-compliance with study treatment|0
5256|NCT02474082|27405|P2|Overall Study|Participant/guardian decision|2
5257|NCT02474082|27406|P1|Overall Study|Participant/guardian decision|1
5258|NCT02474082|27405|P2|Overall Study|Dose tapering not achieved|4
5259|NCT02474082|27406|P1|Overall Study|Dose tapering not achieved|0
5260|NCT02474082|27405|P2|Overall Study|Lost to Follow-up|2
5261|NCT02474082|27406|P1|Overall Study|Lost to Follow-up|2
5262|NCT02474082|27405|P2|Overall Study|Withdrawal of informed consent|11
5263|NCT02474082|27406|P1|Overall Study|Withdrawal of informed consent|1
5264|NCT02474082|27405|P2|Overall Study|Adverse Event|32
5265|NCT02474082|27406|P1|Overall Study|Adverse Event|2
5266|NCT02473640|27480|P1|Treatment Period 1|Adverse Event|1
5267|NCT02473523|27489|P1|Overall Study|Lost to Follow-up|1
5268|NCT02473523|27489|P1|Overall Study|Death|1
5269|NCT02473510|27510|P2|Overall Study|Lost to Follow-up|2
5270|NCT02473510|27511|P1|Overall Study|Lost to Follow-up|1
5271|NCT02473471|27525|P1|Overall Study|Lost to Follow-up|1
5272|NCT02473471|27525|P1|Overall Study|poor oral hygiene|2
5273|NCT02473445|27556|P1|Overall Study|Sponsor Decision|20
5274|NCT02473445|27556|P1|Overall Study|Withdrawal by Subject|2
5275|NCT02473367|27562|P1|Period 4|Lost to Follow-up|1
5276|NCT02473367|27562|P1|Wait 1|Withdrawal by Subject|1
5277|NCT02472977|27583|P3|Overall Study|Subject request to discontinue treatment|0
5278|NCT02472977|27584|P2|Overall Study|Subject request to discontinue treatment|1
5279|NCT02472977|27585|P1|Overall Study|Subject request to discontinue treatment|0
5280|NCT02472977|27583|P3|Overall Study|Study drug toxicity|2
5281|NCT02472977|27584|P2|Overall Study|Study drug toxicity|0
5282|NCT02472977|27585|P1|Overall Study|Study drug toxicity|2
5283|NCT02472977|27583|P3|Overall Study|Withdrawal by Subject|0
5284|NCT02472977|27584|P2|Overall Study|Withdrawal by Subject|1
5285|NCT02472977|27585|P1|Overall Study|Withdrawal by Subject|0
5286|NCT02472977|27583|P3|Overall Study|Disease progression|6
5287|NCT02472977|27584|P2|Overall Study|Disease progression|25
5288|NCT02472977|27585|P1|Overall Study|Disease progression|4
5289|NCT02472886|27611|P3|Overall Study|Lack of Efficacy|1
5290|NCT02472886|27612|P2|Overall Study|Lack of Efficacy|2
5291|NCT02472886|27613|P1|Overall Study|Lack of Efficacy|0
5292|NCT02472847|27641|P2|Overall Study|Withdrawal by Subject|5
5293|NCT02472847|27642|P1|Overall Study|Withdrawal by Subject|1
5294|NCT02472756|27648|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
5295|NCT02472756|27648|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
5296|NCT02472756|27648|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
5297|NCT02472756|27648|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
5298|NCT02472756|27648|P1|Induction (Approximately 6 Months)|Adverse Event|1
5299|NCT02472639|27656|P2|Overall Study|Physician Decision|3
5300|NCT02472639|27657|P1|Overall Study|Physician Decision|4
5301|NCT02472366|27706|P2|Overall Study|Lost to Follow-up|0
5302|NCT02472366|27707|P1|Overall Study|Lost to Follow-up|1
5303|NCT02471755|27723|P2|Overall Study|Lost to Follow-up|1
5304|NCT02471755|27724|P1|Overall Study|Lost to Follow-up|0
5305|NCT02471755|27723|P2|Overall Study|Withdrawal by Subject|0
5306|NCT02471755|27724|P1|Overall Study|Withdrawal by Subject|1
5307|NCT02471612|27740|P1|Overall Study|Lost to Follow-up|2
5308|NCT02471183|27762|P1|Extended Treatment Period|Lack of Efficacy|1
5309|NCT02471183|27762|P1|Main Treatment Period|Withdrawal by Subject|1
5310|NCT02471183|27762|P1|Main Treatment Period|Adverse Event|1
5311|NCT02470429|27798|P2|Overall Study|Withdrawal by Subject|0
5312|NCT02470429|27799|P1|Overall Study|Withdrawal by Subject|1
5313|NCT02470429|27798|P2|Overall Study|Adverse Event|0
5314|NCT02470429|27799|P1|Overall Study|Adverse Event|1
5315|NCT02470403|27817|P5|Overall Study|Subject/guardian decision|0
5316|NCT02470403|27818|P4|Overall Study|Subject/guardian decision|4
5317|NCT02470403|27819|P3|Overall Study|Subject/guardian decision|0
5318|NCT02470403|27820|P2|Overall Study|Subject/guardian decision|0
5319|NCT02470403|27821|P1|Overall Study|Subject/guardian decision|1
5320|NCT02470403|27817|P5|Overall Study|Lost to Follow-up|0
5321|NCT02470403|27818|P4|Overall Study|Lost to Follow-up|0
5322|NCT02470403|27819|P3|Overall Study|Lost to Follow-up|0
5323|NCT02470403|27820|P2|Overall Study|Lost to Follow-up|1
5324|NCT02470403|27821|P1|Overall Study|Lost to Follow-up|0
5325|NCT02470403|27817|P5|Overall Study|Adverse Event|0
5326|NCT02470403|27818|P4|Overall Study|Adverse Event|0
5327|NCT02470403|27819|P3|Overall Study|Adverse Event|0
5328|NCT02470403|27820|P2|Overall Study|Adverse Event|0
5329|NCT02470403|27821|P1|Overall Study|Adverse Event|1
5330|NCT02469961|27890|P2|Overall Study|Physician Decision|1
5331|NCT02469961|27891|P1|Overall Study|Physician Decision|4
5332|NCT02469415|27926|P1|Overall Study|Investigational agent placed on hold|2
5333|NCT02469415|27926|P1|Overall Study|Withdrawal by Subject|1
5334|NCT02469298|27934|P4|Overall Study|Withdrawal by Subject|1
5335|NCT02469298|27935|P3|Overall Study|Withdrawal by Subject|0
5336|NCT02469298|27936|P2|Overall Study|Withdrawal by Subject|0
5337|NCT02469298|27937|P1|Overall Study|Withdrawal by Subject|0
5338|NCT02469298|27934|P4|Overall Study|Physician Decision|1
5339|NCT02469298|27935|P3|Overall Study|Physician Decision|0
5340|NCT02469298|27936|P2|Overall Study|Physician Decision|0
5341|NCT02469298|27937|P1|Overall Study|Physician Decision|0
5342|NCT02469298|27934|P4|Overall Study|Lost to Follow-up|0
5343|NCT02469298|27935|P3|Overall Study|Lost to Follow-up|1
5344|NCT02469298|27936|P2|Overall Study|Lost to Follow-up|0
5345|NCT02469298|27937|P1|Overall Study|Lost to Follow-up|1
5346|NCT02469298|27934|P4|Overall Study|Protocol Violation|0
5347|NCT02469298|27935|P3|Overall Study|Protocol Violation|1
5348|NCT02469298|27936|P2|Overall Study|Protocol Violation|1
5349|NCT02469298|27937|P1|Overall Study|Protocol Violation|0
5350|NCT02469168|28077|P2|Overall Study|Trial closed|0
5351|NCT02469168|28078|P1|Overall Study|Trial closed|1
5352|NCT02468414|28122|P2|Overall Study|Screen Failure|0
5353|NCT02468414|28123|P1|Overall Study|Screen Failure|1
5354|NCT02468414|28122|P2|Overall Study|Poor in-vitro secreting TARGTs|0
5355|NCT02468414|28123|P1|Overall Study|Poor in-vitro secreting TARGTs|1
5356|NCT02468414|28122|P2|Overall Study|Early Study Termination by Sponsor|0
5357|NCT02468414|28123|P1|Overall Study|Early Study Termination by Sponsor|1
5358|NCT02466659|28183|P2|Overall Study|Lost to Follow-up|2
5359|NCT02466659|28184|P1|Overall Study|Lost to Follow-up|5
5360|NCT02466425|28194|P2|Overall Study|Withdrawal by Parent/Guardian|0
5361|NCT02466425|28195|P1|Overall Study|Withdrawal by Parent/Guardian|2
5362|NCT02466425|28194|P2|Overall Study|Other|3
5363|NCT02466425|28195|P1|Overall Study|Other|1
5364|NCT02466425|28194|P2|Overall Study|Withdrawal by Subject|1
5365|NCT02466425|28195|P1|Overall Study|Withdrawal by Subject|0
5366|NCT02466425|28194|P2|Overall Study|Protocol Violation|0
5367|NCT02466425|28195|P1|Overall Study|Protocol Violation|1
5368|NCT02466425|28194|P2|Overall Study|Lost to Follow-up|0
5369|NCT02466425|28195|P1|Overall Study|Lost to Follow-up|3
5370|NCT02466425|28194|P2|Overall Study|Lack of Efficacy|1
5371|NCT02466425|28195|P1|Overall Study|Lack of Efficacy|4
5372|NCT02466425|28194|P2|Overall Study|Adverse Event|11
5373|NCT02466425|28195|P1|Overall Study|Adverse Event|3
5374|NCT02465866|28215|P4|Period 3|Withdrawal by Subject|0
5375|NCT02465866|28216|P3|Period 3|Withdrawal by Subject|0
5376|NCT02465866|28217|P2|Period 3|Withdrawal by Subject|1
5377|NCT02465866|28218|P1|Period 3|Withdrawal by Subject|0
5378|NCT02465489|28304|P1|Overall Study|Adverse Event|5
5379|NCT02465463|28333|P2|Overall Study|Protocol Violation|0
5380|NCT02465463|28334|P1|Overall Study|Protocol Violation|1
5381|NCT02465463|28333|P2|Overall Study|Death|0
5382|NCT02465463|28334|P1|Overall Study|Death|1
5383|NCT02465463|28333|P2|Overall Study|Lost to Follow-up|1
5384|NCT02465463|28334|P1|Overall Study|Lost to Follow-up|2
5385|NCT02465203|28381|P3|Overall Study|Patient/guardian decision|1
5386|NCT02465203|28382|P2|Overall Study|Patient/guardian decision|1
5387|NCT02465203|28383|P1|Overall Study|Patient/guardian decision|1
5388|NCT02465203|28381|P3|Overall Study|New therapy for study indication|0
5389|NCT02465203|28382|P2|Overall Study|New therapy for study indication|0
5390|NCT02465203|28383|P1|Overall Study|New therapy for study indication|4
5391|NCT02465203|28381|P3|Overall Study|Study terminated by sponsor|11
5392|NCT02465203|28382|P2|Overall Study|Study terminated by sponsor|34
5393|NCT02465203|28383|P1|Overall Study|Study terminated by sponsor|50
5394|NCT02465203|28381|P3|Overall Study|Protocol Violation|1
5395|NCT02465203|28382|P2|Overall Study|Protocol Violation|1
5396|NCT02465203|28383|P1|Overall Study|Protocol Violation|1
5397|NCT02463409|28478|P1|Overall Study|Screen failure|1
5398|NCT02463409|28478|P1|Overall Study|Withdrawal by Subject|1
5399|NCT02463331|28486|P2|Overall Study|Physician Decision|0
5400|NCT02463331|28487|P1|Overall Study|Physician Decision|3
5401|NCT02463331|28486|P2|Overall Study|Lack of Efficacy|0
5402|NCT02463331|28487|P1|Overall Study|Lack of Efficacy|6
5403|NCT02463331|28486|P2|Overall Study|Pregnancy|3
5404|NCT02463331|28487|P1|Overall Study|Pregnancy|2
5405|NCT02463331|28486|P2|Overall Study|Lost to Follow-up|1
5406|NCT02463331|28487|P1|Overall Study|Lost to Follow-up|1
5407|NCT02463331|28486|P2|Overall Study|Adverse Event|2
5408|NCT02463331|28487|P1|Overall Study|Adverse Event|4
5409|NCT02463097|28503|P1|Overall Study|Withdrawal by Subject|1
5410|NCT02462720|28509|P2|Part 2|Protocol Violation|1
5411|NCT02462720|28510|P1|Part 2|Protocol Violation|0
5412|NCT02462720|28509|P2|Part 2|Withdrawal by Subject|0
5413|NCT02462720|28510|P1|Part 2|Withdrawal by Subject|1
5414|NCT02462473|28520|P1|Overall Study|Other|3
5415|NCT02462473|28520|P1|Overall Study|Death|1
5416|NCT02461589|28627|P10|Overall Study|Withdrawal from trial before exposure|1
5417|NCT02461589|28628|P9|Overall Study|Withdrawal from trial before exposure|0
5418|NCT02461589|28629|P8|Overall Study|Withdrawal from trial before exposure|0
5419|NCT02461589|28630|P7|Overall Study|Withdrawal from trial before exposure|0
5420|NCT02461589|28631|P6|Overall Study|Withdrawal from trial before exposure|0
5421|NCT02461589|28632|P5|Overall Study|Withdrawal from trial before exposure|0
5422|NCT02461589|28633|P4|Overall Study|Withdrawal from trial before exposure|0
5423|NCT02461589|28634|P3|Overall Study|Withdrawal from trial before exposure|0
5424|NCT02461589|28635|P2|Overall Study|Withdrawal from trial before exposure|0
5425|NCT02461589|28636|P1|Overall Study|Withdrawal from trial before exposure|0
5426|NCT02461589|28627|P10|Overall Study|Missing follow-up information|0
5427|NCT02461589|28628|P9|Overall Study|Missing follow-up information|0
5428|NCT02461589|28629|P8|Overall Study|Missing follow-up information|0
5429|NCT02461589|28630|P7|Overall Study|Missing follow-up information|1
5430|NCT02461589|28631|P6|Overall Study|Missing follow-up information|0
5431|NCT02461589|28632|P5|Overall Study|Missing follow-up information|0
5432|NCT02461589|28633|P4|Overall Study|Missing follow-up information|0
5433|NCT02461589|28634|P3|Overall Study|Missing follow-up information|0
5434|NCT02461589|28635|P2|Overall Study|Missing follow-up information|1
5435|NCT02461589|28636|P1|Overall Study|Missing follow-up information|1
5436|NCT02461589|28627|P10|Overall Study|Unclassified|2
5437|NCT02461589|28628|P9|Overall Study|Unclassified|0
5438|NCT02461589|28629|P8|Overall Study|Unclassified|0
5439|NCT02461589|28630|P7|Overall Study|Unclassified|1
5440|NCT02461589|28631|P6|Overall Study|Unclassified|0
5441|NCT02461589|28632|P5|Overall Study|Unclassified|0
5442|NCT02461589|28633|P4|Overall Study|Unclassified|0
5443|NCT02461589|28634|P3|Overall Study|Unclassified|0
5444|NCT02461589|28635|P2|Overall Study|Unclassified|0
5445|NCT02461589|28636|P1|Overall Study|Unclassified|0
5446|NCT02461589|28627|P10|Overall Study|Death|0
5447|NCT02461589|28628|P9|Overall Study|Death|0
5448|NCT02461589|28629|P8|Overall Study|Death|1
5449|NCT02461589|28630|P7|Overall Study|Death|0
5450|NCT02461589|28631|P6|Overall Study|Death|0
5451|NCT02461589|28632|P5|Overall Study|Death|0
5452|NCT02461589|28633|P4|Overall Study|Death|0
5453|NCT02461589|28634|P3|Overall Study|Death|0
5454|NCT02461589|28635|P2|Overall Study|Death|0
5455|NCT02461589|28636|P1|Overall Study|Death|0
5456|NCT02461589|28627|P10|Overall Study|Lost to Follow-up|1
5457|NCT02461589|28628|P9|Overall Study|Lost to Follow-up|3
5458|NCT02461589|28629|P8|Overall Study|Lost to Follow-up|1
5459|NCT02461589|28630|P7|Overall Study|Lost to Follow-up|3
5460|NCT02461589|28631|P6|Overall Study|Lost to Follow-up|1
5461|NCT02461589|28632|P5|Overall Study|Lost to Follow-up|1
5462|NCT02461589|28633|P4|Overall Study|Lost to Follow-up|3
5463|NCT02461589|28634|P3|Overall Study|Lost to Follow-up|2
5464|NCT02461589|28635|P2|Overall Study|Lost to Follow-up|0
5465|NCT02461589|28636|P1|Overall Study|Lost to Follow-up|0
5466|NCT02461589|28627|P10|Overall Study|Withdrawal by Subject|1
5467|NCT02461589|28628|P9|Overall Study|Withdrawal by Subject|3
5468|NCT02461589|28629|P8|Overall Study|Withdrawal by Subject|3
5469|NCT02461589|28630|P7|Overall Study|Withdrawal by Subject|1
5470|NCT02461589|28631|P6|Overall Study|Withdrawal by Subject|2
5471|NCT02461589|28632|P5|Overall Study|Withdrawal by Subject|1
5472|NCT02461589|28633|P4|Overall Study|Withdrawal by Subject|2
5473|NCT02461589|28634|P3|Overall Study|Withdrawal by Subject|3
5474|NCT02461589|28635|P2|Overall Study|Withdrawal by Subject|1
5475|NCT02461589|28636|P1|Overall Study|Withdrawal by Subject|5
5476|NCT02461290|28721|P1|Overall Study|Lost to Follow-up|3
5477|NCT02461290|28721|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
5478|NCT02461134|28728|P1|Overall Study|Adverse Event|1
5479|NCT02460991|28736|P2|Overall Study|Withdrawal by Subject|2
5480|NCT02460991|28737|P1|Overall Study|Withdrawal by Subject|0
5481|NCT02460822|28743|P1|Overall Study|Withdrawal by Subject|1
5482|NCT02460159|28760|P2|Overall Study|Withdrawal by Subject|0
5483|NCT02460159|28761|P1|Overall Study|Withdrawal by Subject|2
5484|NCT02460159|28760|P2|Overall Study|Adverse Event|1
5485|NCT02460159|28761|P1|Overall Study|Adverse Event|4
5486|NCT02459418|28791|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
5487|NCT02459418|28792|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
5488|NCT02459418|28791|P2|Overall Study|Elevated Creatine Kinase|0
5489|NCT02459418|28792|P1|Overall Study|Elevated Creatine Kinase|1
5490|NCT02459418|28791|P2|Overall Study|Withdrawal by Subject|1
5491|NCT02459418|28792|P1|Overall Study|Withdrawal by Subject|1
5492|NCT02459418|28791|P2|Overall Study|Adverse Event|1
5493|NCT02459418|28792|P1|Overall Study|Adverse Event|0
5494|NCT02459418|28791|P2|Overall Study|Endometrial thickness of >5 mm|0
5495|NCT02459418|28792|P1|Overall Study|Endometrial thickness of >5 mm|1
5496|NCT02459418|28791|P2|Overall Study|Physician Decision|2
5497|NCT02459418|28792|P1|Overall Study|Physician Decision|0
5498|NCT02459418|28791|P2|Overall Study|Protocol Violation|2
5499|NCT02459418|28792|P1|Overall Study|Protocol Violation|0
5500|NCT02459418|28791|P2|Overall Study|Exclusion Criteria|0
5501|NCT02459418|28792|P1|Overall Study|Exclusion Criteria|4
5502|NCT02458287|28848|P4|Overall Study|Relocated Out of State|1
5503|NCT02458287|28849|P3|Overall Study|Relocated Out of State|0
5504|NCT02458287|28850|P2|Overall Study|Relocated Out of State|0
5505|NCT02458287|28851|P1|Overall Study|Relocated Out of State|0
5506|NCT02458287|28848|P4|Overall Study|Withdrawal by Subject|1
5507|NCT02458287|28849|P3|Overall Study|Withdrawal by Subject|2
5508|NCT02458287|28850|P2|Overall Study|Withdrawal by Subject|2
5509|NCT02458287|28851|P1|Overall Study|Withdrawal by Subject|0
5510|NCT02458287|28848|P4|Overall Study|Protocol Violation|0
5511|NCT02458287|28849|P3|Overall Study|Protocol Violation|0
5512|NCT02458287|28850|P2|Overall Study|Protocol Violation|1
5513|NCT02458287|28851|P1|Overall Study|Protocol Violation|0
5514|NCT02458287|28848|P4|Overall Study|Lost to Follow-up|0
5515|NCT02458287|28849|P3|Overall Study|Lost to Follow-up|1
5516|NCT02458287|28850|P2|Overall Study|Lost to Follow-up|1
5517|NCT02458287|28851|P1|Overall Study|Lost to Follow-up|0
5518|NCT02458287|28848|P4|Overall Study|Adverse Event|1
5519|NCT02458287|28849|P3|Overall Study|Adverse Event|0
5520|NCT02458287|28850|P2|Overall Study|Adverse Event|0
5521|NCT02458287|28851|P1|Overall Study|Adverse Event|0
5522|NCT02457611|28900|P1|Overall Study|Lost to Follow-up|3
5523|NCT02457247|28916|P4|Period 2|Voluntary Withdrawal|0
5524|NCT02457247|28917|P3|Period 2|Voluntary Withdrawal|0
5525|NCT02457247|28918|P2|Period 2|Voluntary Withdrawal|1
5526|NCT02457247|28919|P1|Period 2|Voluntary Withdrawal|1
5527|NCT02457247|28916|P4|Period 2|Lost to Follow-up|0
5528|NCT02457247|28917|P3|Period 2|Lost to Follow-up|0
5529|NCT02457247|28918|P2|Period 2|Lost to Follow-up|1
5530|NCT02457247|28919|P1|Period 2|Lost to Follow-up|0
5531|NCT02457247|28916|P4|Period 2|Significant Protocol Deviation|0
5532|NCT02457247|28917|P3|Period 2|Significant Protocol Deviation|0
5533|NCT02457247|28918|P2|Period 2|Significant Protocol Deviation|0
5534|NCT02457247|28919|P1|Period 2|Significant Protocol Deviation|1
5535|NCT02457247|28916|P4|Period 2|Pretreatment Event/Adverse Event|0
5536|NCT02457247|28917|P3|Period 2|Pretreatment Event/Adverse Event|0
5537|NCT02457247|28918|P2|Period 2|Pretreatment Event/Adverse Event|1
5538|NCT02457247|28919|P1|Period 2|Pretreatment Event/Adverse Event|0
5539|NCT02457247|28916|P4|Period 1|Voluntary Withdrawal|0
5540|NCT02457247|28917|P3|Period 1|Voluntary Withdrawal|0
5541|NCT02457247|28918|P2|Period 1|Voluntary Withdrawal|0
5542|NCT02457247|28919|P1|Period 1|Voluntary Withdrawal|1
5543|NCT02457247|28916|P4|Period 1|Significant Protocol Deviation|0
5544|NCT02457247|28917|P3|Period 1|Significant Protocol Deviation|0
5545|NCT02457247|28918|P2|Period 1|Significant Protocol Deviation|1
5546|NCT02457247|28919|P1|Period 1|Significant Protocol Deviation|1
5547|NCT02457247|28916|P4|Period 1|Pretreatment Event/Adverse Event|0
5548|NCT02457247|28917|P3|Period 1|Pretreatment Event/Adverse Event|0
5549|NCT02457247|28918|P2|Period 1|Pretreatment Event/Adverse Event|1
5550|NCT02457247|28919|P1|Period 1|Pretreatment Event/Adverse Event|0
5551|NCT02455518|28943|P4|Overall Study|Protocol Violation|3
5552|NCT02455518|28944|P3|Overall Study|Protocol Violation|1
5553|NCT02455518|28945|P2|Overall Study|Protocol Violation|1
5554|NCT02455518|28946|P1|Overall Study|Protocol Violation|0
5555|NCT02455050|28964|P4|Treatment Period 2|Lost to Follow-up|1
5556|NCT02455050|28965|P3|Treatment Period 2|Lost to Follow-up|2
5557|NCT02455050|28966|P2|Treatment Period 2|Lost to Follow-up|0
5558|NCT02455050|28967|P1|Treatment Period 2|Lost to Follow-up|1
5559|NCT02455050|28964|P4|Treatment Period 1|Lost to Follow-up|2
5560|NCT02455050|28965|P3|Treatment Period 1|Lost to Follow-up|1
5561|NCT02455050|28966|P2|Treatment Period 1|Lost to Follow-up|1
5562|NCT02455050|28967|P1|Treatment Period 1|Lost to Follow-up|1
5563|NCT02454959|29031|P1|Overall Study|Adverse Event|2
5564|NCT02454959|29031|P1|Overall Study|Withdrawal by Subject|3
5565|NCT02454959|29031|P1|Overall Study|Physician Decision|1
5566|NCT02454959|29031|P1|Overall Study|Protocol-Specified Criteria|3
5567|NCT02454608|29051|P2|Overall Study|Lack of Efficacy|2
5568|NCT02454608|29052|P1|Overall Study|Lack of Efficacy|0
5569|NCT02454101|29141|P2|Overall Study|Lost to Follow-up|4
5570|NCT02454101|29142|P1|Overall Study|Lost to Follow-up|3
5571|NCT02454101|29141|P2|Overall Study|Adverse Event|3
5572|NCT02454101|29142|P1|Overall Study|Adverse Event|2
5573|NCT02453321|29202|P3|Overall Study|Deep Venous Thrombosis|0
5574|NCT02453321|29203|P2|Overall Study|Deep Venous Thrombosis|1
5575|NCT02453321|29204|P1|Overall Study|Deep Venous Thrombosis|0
5576|NCT02453321|29202|P3|Overall Study|Weakness|2
5577|NCT02453321|29203|P2|Overall Study|Weakness|1
5578|NCT02453321|29204|P1|Overall Study|Weakness|1
5579|NCT02452892|29236|P4|Follow-up|Subject left town on Day 42|0
5580|NCT02452892|29237|P3|Follow-up|Subject left town on Day 42|0
5581|NCT02452892|29238|P2|Follow-up|Subject left town on Day 42|0
5582|NCT02452892|29239|P1|Follow-up|Subject left town on Day 42|1
5583|NCT02452892|29236|P4|Follow-up|Withdrawal by Subject|1
5584|NCT02452892|29237|P3|Follow-up|Withdrawal by Subject|0
5585|NCT02452892|29238|P2|Follow-up|Withdrawal by Subject|0
5586|NCT02452892|29239|P1|Follow-up|Withdrawal by Subject|0
5670|NCT02448810|29628|P1|Overall Study|Other (Progressive disease)|2
5587|NCT02452892|29236|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5588|NCT02452892|29237|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5589|NCT02452892|29238|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5590|NCT02452892|29239|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
5591|NCT02452892|29236|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
5592|NCT02452892|29237|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5593|NCT02452892|29238|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5594|NCT02452892|29239|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5595|NCT02452892|29236|P4|Week 1 Initial Randommization|Lost to Follow-up|0
5596|NCT02452892|29237|P3|Week 1 Initial Randommization|Lost to Follow-up|1
5597|NCT02452892|29238|P2|Week 1 Initial Randommization|Lost to Follow-up|0
5598|NCT02452892|29239|P1|Week 1 Initial Randommization|Lost to Follow-up|0
5599|NCT02452892|29236|P4|Week 1 Initial Randommization|Adverse Event|0
5600|NCT02452892|29237|P3|Week 1 Initial Randommization|Adverse Event|0
5601|NCT02452892|29238|P2|Week 1 Initial Randommization|Adverse Event|0
5602|NCT02452892|29239|P1|Week 1 Initial Randommization|Adverse Event|1
5603|NCT02452320|29305|P2|Overall Study|Adverse Event|1
5604|NCT02452320|29306|P1|Overall Study|Adverse Event|0
5605|NCT02451917|29318|P2|First Intervention (24 Weeks)|Adverse Event|2
5606|NCT02451917|29319|P1|First Intervention (24 Weeks)|Adverse Event|0
5607|NCT02451917|29318|P2|First Intervention (24 Weeks)|Death|1
5608|NCT02451917|29319|P1|First Intervention (24 Weeks)|Death|0
5609|NCT02451917|29318|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
5610|NCT02451917|29319|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
5611|NCT02451358|29341|P4|Overall Study|Protocol Violation|0
5612|NCT02451358|29342|P3|Overall Study|Protocol Violation|1
5613|NCT02451358|29343|P2|Overall Study|Protocol Violation|1
5614|NCT02451358|29344|P1|Overall Study|Protocol Violation|0
5615|NCT02451358|29341|P4|Overall Study|Withdrawal by Subject|0
5616|NCT02451358|29342|P3|Overall Study|Withdrawal by Subject|0
5617|NCT02451358|29343|P2|Overall Study|Withdrawal by Subject|1
5618|NCT02451358|29344|P1|Overall Study|Withdrawal by Subject|1
5619|NCT02449915|29465|P2|Overall Study|Abnormal preop lab|1
5620|NCT02449915|29466|P1|Overall Study|Abnormal preop lab|0
5621|NCT02449915|29465|P2|Overall Study|Intraoperative surgical findings|1
5622|NCT02449915|29466|P1|Overall Study|Intraoperative surgical findings|1
5623|NCT02449915|29465|P2|Overall Study|Withdrawal by Subject|2
5624|NCT02449915|29466|P1|Overall Study|Withdrawal by Subject|0
5625|NCT02449915|29465|P2|Overall Study|Exclusion criteria - drug use|0
5626|NCT02449915|29466|P1|Overall Study|Exclusion criteria - drug use|1
5627|NCT02449902|29474|P2|Overall Study|Withdrawal by Subject|1
5628|NCT02449902|29475|P1|Overall Study|Withdrawal by Subject|0
5629|NCT02449902|29474|P2|Overall Study|Adverse Event|1
5630|NCT02449902|29475|P1|Overall Study|Adverse Event|0
5631|NCT02449044|29530|P1|Overall Study|Sponsor Discontinued Trial|3
5632|NCT02449044|29530|P1|Overall Study|Physician Decision|9
5633|NCT02449044|29530|P1|Overall Study|Met Withdrawal Criteria|7
5634|NCT02449044|29530|P1|Overall Study|Adverse Event|30
5635|NCT02449044|29530|P1|Overall Study|Withdrawal by Subject|13
5636|NCT02449044|29530|P1|Overall Study|Lost to Follow-up|2
5637|NCT02449018|29551|P2|Overall Study|Patient decision|0
5638|NCT02449018|29552|P1|Overall Study|Patient decision|2
5639|NCT02449018|29551|P2|Overall Study|Protocol deviation|0
5640|NCT02449018|29552|P1|Overall Study|Protocol deviation|4
5641|NCT02449018|29551|P2|Overall Study|Adverse Event|1
5642|NCT02449018|29552|P1|Overall Study|Adverse Event|5
5643|NCT02449018|29551|P2|Overall Study|Administrative problems|0
5644|NCT02449018|29552|P1|Overall Study|Administrative problems|1
5645|NCT02449018|29551|P2|Overall Study|Abnormal laboratory value|1
5646|NCT02449018|29552|P1|Overall Study|Abnormal laboratory value|0
5647|NCT02448810|29621|P8|Overall Study|Other (unspecified)|0
5648|NCT02448810|29622|P7|Overall Study|Other (unspecified)|2
5649|NCT02448810|29623|P6|Overall Study|Other (unspecified)|0
5650|NCT02448810|29624|P5|Overall Study|Other (unspecified)|0
5651|NCT02448810|29625|P4|Overall Study|Other (unspecified)|0
5652|NCT02448810|29626|P3|Overall Study|Other (unspecified)|0
5653|NCT02448810|29627|P2|Overall Study|Other (unspecified)|0
5654|NCT02448810|29628|P1|Overall Study|Other (unspecified)|0
5655|NCT02448810|29621|P8|Overall Study|Lost to Follow-up|0
5656|NCT02448810|29622|P7|Overall Study|Lost to Follow-up|0
5657|NCT02448810|29623|P6|Overall Study|Lost to Follow-up|0
5658|NCT02448810|29624|P5|Overall Study|Lost to Follow-up|0
5659|NCT02448810|29625|P4|Overall Study|Lost to Follow-up|0
5660|NCT02448810|29626|P3|Overall Study|Lost to Follow-up|0
5661|NCT02448810|29627|P2|Overall Study|Lost to Follow-up|1
5662|NCT02448810|29628|P1|Overall Study|Lost to Follow-up|0
5663|NCT02448810|29621|P8|Overall Study|Other (Progressive disease)|5
5664|NCT02448810|29622|P7|Overall Study|Other (Progressive disease)|14
5665|NCT02448810|29623|P6|Overall Study|Other (Progressive disease)|9
5666|NCT02448810|29624|P5|Overall Study|Other (Progressive disease)|23
5667|NCT02448810|29625|P4|Overall Study|Other (Progressive disease)|3
5668|NCT02448810|29626|P3|Overall Study|Other (Progressive disease)|0
5669|NCT02448810|29627|P2|Overall Study|Other (Progressive disease)|2
5671|NCT02448810|29621|P8|Overall Study|Death|0
5672|NCT02448810|29622|P7|Overall Study|Death|0
5673|NCT02448810|29623|P6|Overall Study|Death|0
5674|NCT02448810|29624|P5|Overall Study|Death|1
5675|NCT02448810|29625|P4|Overall Study|Death|0
5676|NCT02448810|29626|P3|Overall Study|Death|1
5677|NCT02448810|29627|P2|Overall Study|Death|0
5678|NCT02448810|29628|P1|Overall Study|Death|1
5679|NCT02448810|29621|P8|Overall Study|Other (study terminated by sponsor)|1
5680|NCT02448810|29622|P7|Overall Study|Other (study terminated by sponsor)|2
5681|NCT02448810|29623|P6|Overall Study|Other (study terminated by sponsor)|2
5682|NCT02448810|29624|P5|Overall Study|Other (study terminated by sponsor)|4
5683|NCT02448810|29625|P4|Overall Study|Other (study terminated by sponsor)|0
5684|NCT02448810|29626|P3|Overall Study|Other (study terminated by sponsor)|0
5685|NCT02448810|29627|P2|Overall Study|Other (study terminated by sponsor)|0
5686|NCT02448810|29628|P1|Overall Study|Other (study terminated by sponsor)|0
5687|NCT02448810|29621|P8|Overall Study|Withdrawal by Subject|2
5688|NCT02448810|29622|P7|Overall Study|Withdrawal by Subject|0
5689|NCT02448810|29623|P6|Overall Study|Withdrawal by Subject|5
5690|NCT02448810|29624|P5|Overall Study|Withdrawal by Subject|3
5691|NCT02448810|29625|P4|Overall Study|Withdrawal by Subject|0
5692|NCT02448810|29626|P3|Overall Study|Withdrawal by Subject|1
5693|NCT02448810|29627|P2|Overall Study|Withdrawal by Subject|0
5694|NCT02448810|29628|P1|Overall Study|Withdrawal by Subject|0
5695|NCT02448810|29621|P8|Overall Study|Adverse Event|0
5696|NCT02448810|29622|P7|Overall Study|Adverse Event|0
5697|NCT02448810|29623|P6|Overall Study|Adverse Event|0
5698|NCT02448810|29624|P5|Overall Study|Adverse Event|0
5699|NCT02448810|29625|P4|Overall Study|Adverse Event|0
5700|NCT02448810|29626|P3|Overall Study|Adverse Event|1
5701|NCT02448810|29627|P2|Overall Study|Adverse Event|0
5702|NCT02448810|29628|P1|Overall Study|Adverse Event|0
5703|NCT02448563|29698|P2|Overall Study|Withdrawal by Subject|1
5704|NCT02448563|29699|P1|Overall Study|Withdrawal by Subject|0
5705|NCT02448563|29698|P2|Overall Study|Lost to Follow-up|10
5706|NCT02448563|29699|P1|Overall Study|Lost to Follow-up|16
5707|NCT02448537|29721|P3|Overall Study|Withdrawal by Subject|1
5708|NCT02448537|29722|P2|Overall Study|Withdrawal by Subject|1
5709|NCT02448537|29723|P1|Overall Study|Withdrawal by Subject|1
5710|NCT02447848|29737|P1|Overall Study|Withdrawal by Subject|4
5711|NCT02447848|29737|P1|Overall Study|Lack of Efficacy|4
5712|NCT02447848|29737|P1|Overall Study|Patient discharged|3
5713|NCT02447458|29749|P6|Overall Study|Other|0
5714|NCT02447458|29750|P5|Overall Study|Other|0
5715|NCT02447458|29751|P4|Overall Study|Other|0
5716|NCT02447458|29752|P3|Overall Study|Other|1
5717|NCT02447458|29753|P2|Overall Study|Other|0
5718|NCT02447458|29754|P1|Overall Study|Other|0
5719|NCT02447432|29852|P2|Epoch 001|Lost to Follow-up|3
5720|NCT02447432|29853|P1|Epoch 001|Lost to Follow-up|1
5721|NCT02447432|29852|P2|Epoch 001|Migrated/moved from study area|5
5722|NCT02447432|29853|P1|Epoch 001|Migrated/moved from study area|3
5723|NCT02447432|29852|P2|Epoch 001|Withdrawal by Subject|4
5724|NCT02447432|29853|P1|Epoch 001|Withdrawal by Subject|0
5725|NCT02447432|29852|P2|Epoch 001|Adverse Event|1
5726|NCT02447432|29853|P1|Epoch 001|Adverse Event|1
5727|NCT02447328|29885|P1|Overall Study|Withdrawal by Subject|1
5728|NCT02447029|29897|P2|Overall Study|Withdrawal by Subject|2
5729|NCT02447029|29898|P1|Overall Study|Withdrawal by Subject|3
5730|NCT02446990|29918|P2|Overall Study|Withdrawal by Subject|199
5731|NCT02446990|29919|P1|Overall Study|Withdrawal by Subject|231
5732|NCT02446990|29918|P2|Overall Study|Physician Decision|0
5733|NCT02446990|29919|P1|Overall Study|Physician Decision|1
5734|NCT02446990|29918|P2|Overall Study|Lost to Follow-up|1
5735|NCT02446990|29919|P1|Overall Study|Lost to Follow-up|3
5736|NCT02446990|29918|P2|Overall Study|Death|458
5737|NCT02446990|29919|P1|Overall Study|Death|485
5738|NCT02446743|29953|P2|Overall Study|Other|3
5739|NCT02446743|29954|P1|Overall Study|Other|2
5740|NCT02446743|29953|P2|Overall Study|Adverse Event|1
5741|NCT02446743|29954|P1|Overall Study|Adverse Event|1
5742|NCT02446743|29953|P2|Overall Study|Lost to Follow-up|0
5743|NCT02446743|29954|P1|Overall Study|Lost to Follow-up|1
5744|NCT02446743|29953|P2|Overall Study|Withdrawal by Subject|1
5745|NCT02446743|29954|P1|Overall Study|Withdrawal by Subject|1
5746|NCT02446717|30086|P5|Overall Study|Withdrew consent|0
5747|NCT02446717|30087|P4|Overall Study|Withdrew consent|1
5748|NCT02446717|30088|P3|Overall Study|Withdrew consent|0
5749|NCT02446717|30089|P2|Overall Study|Withdrew consent|0
5750|NCT02446717|30090|P1|Overall Study|Withdrew consent|0
5751|NCT02446717|30086|P5|Overall Study|Lost to Follow-up|1
5752|NCT02446717|30087|P4|Overall Study|Lost to Follow-up|0
5753|NCT02446717|30088|P3|Overall Study|Lost to Follow-up|1
5754|NCT02446717|30089|P2|Overall Study|Lost to Follow-up|1
5755|NCT02446717|30090|P1|Overall Study|Lost to Follow-up|0
5756|NCT02446717|30086|P5|Overall Study|Adverse Event|0
5757|NCT02446717|30087|P4|Overall Study|Adverse Event|0
5758|NCT02446717|30088|P3|Overall Study|Adverse Event|1
5759|NCT02446717|30089|P2|Overall Study|Adverse Event|0
5760|NCT02446717|30090|P1|Overall Study|Adverse Event|0
5761|NCT02446171|30171|P4|Overall Study|Withdrawal by Subject|0
5762|NCT02446171|30172|P3|Overall Study|Withdrawal by Subject|2
5763|NCT02446171|30173|P2|Overall Study|Withdrawal by Subject|0
5764|NCT02446171|30174|P1|Overall Study|Withdrawal by Subject|0
5765|NCT02446015|30245|P2|Overall Study|Withdrawal by Subject|0
5766|NCT02446015|30246|P1|Overall Study|Withdrawal by Subject|1
5767|NCT02446015|30245|P2|Overall Study|Adverse Event|1
5768|NCT02446015|30246|P1|Overall Study|Adverse Event|0
5769|NCT02445755|30270|P1|Overall Study|Screen Failure|5
5770|NCT02445755|30270|P1|Overall Study|Protocol Violation|6
5771|NCT02445755|30270|P1|Overall Study|Withdrawal by Subject|2
5772|NCT02445573|30279|P2|Overall Study|Lost to Follow-up|1
5773|NCT02445573|30280|P1|Overall Study|Lost to Follow-up|0
5774|NCT02445573|30279|P2|Overall Study|Withdrawal by Subject|1
5775|NCT02445573|30280|P1|Overall Study|Withdrawal by Subject|1
5776|NCT02444533|30388|P2|Overall Study|Only gave post-procedure complications|2
5777|NCT02444533|30389|P1|Overall Study|Only gave post-procedure complications|2
5778|NCT02444533|30388|P2|Overall Study|Not able to complete forms|2
5779|NCT02444533|30389|P1|Overall Study|Not able to complete forms|0
5780|NCT02444182|30405|P2|Overall Study|Lost to Follow-up|4
5781|NCT02444182|30406|P1|Overall Study|Lost to Follow-up|0
5782|NCT02444182|30405|P2|Overall Study|non-compliance|1
5783|NCT02444182|30406|P1|Overall Study|non-compliance|2
5784|NCT02443883|30418|P4|Overall Study|Randomized, but never treated|1
5785|NCT02443883|30419|P3|Overall Study|Randomized, but never treated|1
5786|NCT02443883|30420|P2|Overall Study|Randomized, but never treated|0
5787|NCT02443883|30421|P1|Overall Study|Randomized, but never treated|2
5788|NCT02443883|30418|P4|Overall Study|Withdrawal by Subject|1
5789|NCT02443883|30419|P3|Overall Study|Withdrawal by Subject|2
5790|NCT02443883|30420|P2|Overall Study|Withdrawal by Subject|0
5791|NCT02443883|30421|P1|Overall Study|Withdrawal by Subject|1
5792|NCT02443883|30418|P4|Overall Study|Physician Decision|3
5793|NCT02443883|30419|P3|Overall Study|Physician Decision|0
5794|NCT02443883|30420|P2|Overall Study|Physician Decision|1
5795|NCT02443883|30421|P1|Overall Study|Physician Decision|2
5796|NCT02443883|30418|P4|Overall Study|Lost to Follow-up|0
5797|NCT02443883|30419|P3|Overall Study|Lost to Follow-up|0
5798|NCT02443883|30420|P2|Overall Study|Lost to Follow-up|2
5799|NCT02443883|30421|P1|Overall Study|Lost to Follow-up|1
5800|NCT02443883|30418|P4|Overall Study|Adverse Event|2
5801|NCT02443883|30419|P3|Overall Study|Adverse Event|1
5802|NCT02443883|30420|P2|Overall Study|Adverse Event|2
5803|NCT02443883|30421|P1|Overall Study|Adverse Event|0
5804|NCT02443740|30460|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5805|NCT02443740|30461|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5806|NCT02443740|30462|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5807|NCT02443740|30463|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5808|NCT02443740|30464|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5809|NCT02443740|30465|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
5810|NCT02443740|30466|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5811|NCT02443740|30467|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5812|NCT02443740|30468|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5813|NCT02443740|30469|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5814|NCT02443740|30470|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5815|NCT02443740|30460|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
5816|NCT02443740|30461|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
5817|NCT02443740|30462|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
5818|NCT02443740|30463|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
5819|NCT02443740|30464|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
5820|NCT02443740|30465|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
5821|NCT02443740|30466|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
5822|NCT02443740|30467|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
5823|NCT02443740|30468|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
5824|NCT02443740|30469|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
5825|NCT02443740|30470|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
5826|NCT02443740|30460|P11|Intervention Period 1 (3 Days)|Adverse Event|0
5827|NCT02443740|30461|P10|Intervention Period 1 (3 Days)|Adverse Event|0
5828|NCT02443740|30462|P9|Intervention Period 1 (3 Days)|Adverse Event|0
5829|NCT02443740|30463|P8|Intervention Period 1 (3 Days)|Adverse Event|0
5830|NCT02443740|30464|P7|Intervention Period 1 (3 Days)|Adverse Event|0
5831|NCT02443740|30465|P6|Intervention Period 1 (3 Days)|Adverse Event|1
5832|NCT02443740|30466|P5|Intervention Period 1 (3 Days)|Adverse Event|0
5833|NCT02443740|30467|P4|Intervention Period 1 (3 Days)|Adverse Event|0
5834|NCT02443740|30468|P3|Intervention Period 1 (3 Days)|Adverse Event|0
5835|NCT02443740|30469|P2|Intervention Period 1 (3 Days)|Adverse Event|0
5836|NCT02443740|30470|P1|Intervention Period 1 (3 Days)|Adverse Event|0
5837|NCT02443402|30651|P2|Overall Study|Screen Failure|2
5838|NCT02443402|30652|P1|Overall Study|Screen Failure|1
5839|NCT02443402|30651|P2|Overall Study|Withdrawal by Subject|1
5840|NCT02443402|30652|P1|Overall Study|Withdrawal by Subject|3
5841|NCT02443103|30712|P1|Overall Study|Noncompliance|1
5842|NCT02443103|30712|P1|Overall Study|Adverse Event|2
5843|NCT02442804|30719|P2|Overall Study|Adverse Event|0
5844|NCT02442804|30720|P1|Overall Study|Adverse Event|1
5845|NCT02442804|30719|P2|Overall Study|Withdrawal by Subject|1
5846|NCT02442804|30720|P1|Overall Study|Withdrawal by Subject|0
5847|NCT02442349|30759|P1|Overall Study|On-going Study at Data Cut-off|149
5848|NCT02442349|30759|P1|Overall Study|Withdrawal by Subject|8
5849|NCT02442349|30759|P1|Overall Study|Death|14
5850|NCT02442310|30764|P1|Overall Study|Withdrawal by Subject|1
5851|NCT02442310|30764|P1|Overall Study|Adverse Event|2
5852|NCT02442284|30786|P1|Overall Study|Not Specified|1
5853|NCT02442284|30786|P1|Overall Study|Lost to Follow-up|3
5854|NCT02442284|30786|P1|Overall Study|Withdrew Consent|2
5855|NCT02442284|30786|P1|Overall Study|Adverse Event|1
5856|NCT02442271|30793|P1|Overall Study|Not Specified|1
5857|NCT02442271|30793|P1|Overall Study|Lost to Follow-up|1
5858|NCT02442271|30793|P1|Overall Study|Withdrew Consent|1
5859|NCT02442271|30793|P1|Overall Study|Adverse Event|1
5860|NCT02441946|30820|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
5861|NCT02441946|30821|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
5862|NCT02441946|30822|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
5863|NCT02441946|30820|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
5864|NCT02441946|30821|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
5865|NCT02441946|30822|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
5866|NCT02441946|30820|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
5867|NCT02441946|30821|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
5868|NCT02441946|30822|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
5869|NCT02441946|30820|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
5870|NCT02441946|30821|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
5871|NCT02441946|30822|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
5872|NCT02441946|30820|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
5873|NCT02441946|30821|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
5874|NCT02441946|30822|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
5875|NCT02441946|30820|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
5876|NCT02441946|30821|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
5877|NCT02441946|30822|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
5878|NCT02441946|30820|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
5879|NCT02441946|30821|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
5880|NCT02441946|30822|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
5881|NCT02441946|30820|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
5882|NCT02441946|30821|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
5883|NCT02441946|30822|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
5884|NCT02441946|30820|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
5885|NCT02441946|30821|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
5886|NCT02441946|30822|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
5887|NCT02441517|30834|P1|Overall Study|Study Terminated by Sponsor|1
5888|NCT02441517|30834|P1|Overall Study|Withdrawal by Subject|2
5889|NCT02441517|30834|P1|Overall Study|Lost to Follow-up|1
5890|NCT02441218|30846|P2|Overall Study|Lost to Follow-up|1
5891|NCT02441218|30847|P1|Overall Study|Lost to Follow-up|2
5892|NCT02441218|30846|P2|Overall Study|Withdrawal by Subject|58
5893|NCT02441218|30847|P1|Overall Study|Withdrawal by Subject|73
5894|NCT02441218|30846|P2|Overall Study|Death|553
5895|NCT02441218|30847|P1|Overall Study|Death|503
5896|NCT02441179|30873|P2|Overall Study|Withdrawal by Subject|1
5897|NCT02441179|30874|P1|Overall Study|Withdrawal by Subject|1
5898|NCT02441114|30892|P1|Washout2|Withdrawal by Subject|4
5899|NCT02439138|30946|P1|Overall Study|PI decision to terminate the study|2
5900|NCT02439138|30946|P1|Overall Study|Adverse Event|1
5901|NCT02438137|31002|P2|Overall Study|Physician Decision|1
5902|NCT02438137|31003|P1|Overall Study|Physician Decision|0
5903|NCT02438137|31002|P2|Overall Study|Withdrawal by Subject|3
5904|NCT02438137|31003|P1|Overall Study|Withdrawal by Subject|4
5905|NCT02438137|31002|P2|Overall Study|Adverse Event|0
5906|NCT02438137|31003|P1|Overall Study|Adverse Event|1
5907|NCT02438137|31002|P2|Overall Study|Lost to Follow-up|2
5908|NCT02438137|31003|P1|Overall Study|Lost to Follow-up|3
5909|NCT02437903|31011|P1|Overall Study|Lost to Follow-up|3
5910|NCT02437903|31011|P1|Overall Study|Withdrawal by Subject|1
5911|NCT02437903|31011|P1|Overall Study|Adverse Event|1
5912|NCT02437513|31019|P1|Overall Study|Withdrawal by Subject|2
5913|NCT02437409|31027|P1|Overall Study|Screening failure|12
5914|NCT02437409|31027|P1|Overall Study|Withdrawal by Subject|3
5915|NCT02437305|31042|P2|Overall Study|Lost to Follow-up|12
5916|NCT02437305|31043|P1|Overall Study|Lost to Follow-up|18
5917|NCT02437162|31071|P3|Overall Study|Randomized but not treated|1
5918|NCT02437162|31072|P2|Overall Study|Randomized but not treated|0
5919|NCT02437162|31073|P1|Overall Study|Randomized but not treated|0
5920|NCT02437162|31071|P3|Overall Study|Withdrawal by Subject|0
5921|NCT02437162|31072|P2|Overall Study|Withdrawal by Subject|0
5922|NCT02437162|31073|P1|Overall Study|Withdrawal by Subject|3
5923|NCT02437162|31071|P3|Overall Study|Protocol Violation|0
5924|NCT02437162|31072|P2|Overall Study|Protocol Violation|1
5925|NCT02437162|31073|P1|Overall Study|Protocol Violation|0
5926|NCT02436811|31084|P3|Overall Study|Lost to Follow-up|7
5927|NCT02436811|31085|P2|Overall Study|Lost to Follow-up|9
5928|NCT02436811|31086|P1|Overall Study|Lost to Follow-up|2
5929|NCT02436577|31100|P6|Overall Study|Protocol Deviation|0
5930|NCT02436577|31101|P5|Overall Study|Protocol Deviation|0
5931|NCT02436577|31102|P4|Overall Study|Protocol Deviation|0
5932|NCT02436577|31103|P3|Overall Study|Protocol Deviation|0
5933|NCT02436577|31104|P2|Overall Study|Protocol Deviation|1
5934|NCT02436577|31105|P1|Overall Study|Protocol Deviation|0
5935|NCT02436330|31160|P2|Cohort 6|Withdrawal by Subject|1
5936|NCT02436330|31161|P1|Cohort 6|Withdrawal by Subject|1
5937|NCT02436330|31160|P2|Cohort 6|Lost to Follow-up|0
5938|NCT02436330|31161|P1|Cohort 6|Lost to Follow-up|2
5939|NCT02436330|31160|P2|Cohort 5|Withdrawal by Subject|2
5940|NCT02436330|31161|P1|Cohort 5|Withdrawal by Subject|3
5941|NCT02436330|31160|P2|Cohort 5|Lost to Follow-up|2
5942|NCT02436330|31161|P1|Cohort 5|Lost to Follow-up|3
5943|NCT02436330|31160|P2|Cohort 4|Withdrawal by Subject|0
5944|NCT02436330|31161|P1|Cohort 4|Withdrawal by Subject|1
5945|NCT02436330|31160|P2|Cohort 4|Lost to Follow-up|0
5946|NCT02436330|31161|P1|Cohort 4|Lost to Follow-up|1
5947|NCT02436330|31160|P2|Cohort 3|Withdrawal by Subject|0
5948|NCT02436330|31161|P1|Cohort 3|Withdrawal by Subject|4
5949|NCT02436330|31160|P2|Cohort 3|Lost to Follow-up|0
5950|NCT02436330|31161|P1|Cohort 3|Lost to Follow-up|1
5951|NCT02436330|31160|P2|Cohort 2|Withdrawal by Subject|3
5952|NCT02436330|31161|P1|Cohort 2|Withdrawal by Subject|2
5953|NCT02436330|31160|P2|Cohort 2|Lost to Follow-up|0
5954|NCT02436330|31161|P1|Cohort 2|Lost to Follow-up|2
5955|NCT02436330|31160|P2|Cohort 1|Withdrawal by Subject|1
5956|NCT02436330|31161|P1|Cohort 1|Withdrawal by Subject|0
5957|NCT02436330|31160|P2|Cohort 1|Lost to Follow-up|2
5958|NCT02436330|31161|P1|Cohort 1|Lost to Follow-up|5
5959|NCT02436304|31206|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
5960|NCT02436304|31207|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
5961|NCT02436304|31208|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
5962|NCT02436304|31206|P3|Overall Study|Withdrawal by Subject|0
5963|NCT02436304|31207|P2|Overall Study|Withdrawal by Subject|1
5964|NCT02436304|31208|P1|Overall Study|Withdrawal by Subject|0
5965|NCT02436304|31206|P3|Overall Study|Lost to Follow-up|0
5966|NCT02436304|31207|P2|Overall Study|Lost to Follow-up|1
5967|NCT02436304|31208|P1|Overall Study|Lost to Follow-up|0
5968|NCT02435966|31237|P3|Overall Study|Withdrawal by Subject|0
5969|NCT02435966|31238|P2|Overall Study|Withdrawal by Subject|1
5970|NCT02435966|31239|P1|Overall Study|Withdrawal by Subject|0
5971|NCT02435836|31247|P1|Overall Study|AE of Worsening Schizophrenia|96
5972|NCT02435836|31247|P1|Overall Study|Met Withdrawal Criteria|7
5973|NCT02435836|31247|P1|Overall Study|Protocol Violation|6
5974|NCT02435836|31247|P1|Overall Study|Noncompliance|27
5975|NCT02435836|31247|P1|Overall Study|Sponsor discontinued trial|167
5976|NCT02435836|31247|P1|Overall Study|Adverse Event|44
5977|NCT02435836|31247|P1|Overall Study|Insufficient Clinical Response|26
5978|NCT02435836|31247|P1|Overall Study|Withdrawal by Subject|236
5979|NCT02435836|31247|P1|Overall Study|Lack of Efficacy|1
5980|NCT02435836|31247|P1|Overall Study|Lost to Follow-up|21
5981|NCT02435277|31267|P4|Overall Study|Withdrawal by Subject|0
5982|NCT02435277|31268|P3|Overall Study|Withdrawal by Subject|0
5983|NCT02435277|31269|P2|Overall Study|Withdrawal by Subject|0
5984|NCT02435277|31270|P1|Overall Study|Withdrawal by Subject|1
5985|NCT02435277|31267|P4|Overall Study|Adverse Event|0
5986|NCT02435277|31268|P3|Overall Study|Adverse Event|0
5987|NCT02435277|31269|P2|Overall Study|Adverse Event|1
5988|NCT02435277|31270|P1|Overall Study|Adverse Event|1
5989|NCT02434939|31286|P2|Overall Study|Adverse Event|1
5990|NCT02434939|31287|P1|Overall Study|Adverse Event|0
5991|NCT02434939|31286|P2|Overall Study|Withdrawal by Subject|0
5992|NCT02434939|31287|P1|Overall Study|Withdrawal by Subject|3
5993|NCT02434939|31286|P2|Overall Study|Lack of Efficacy|48
5994|NCT02434939|31287|P1|Overall Study|Lack of Efficacy|34
5995|NCT02434471|31414|P1|Overall Study|Physician Decision|9
5996|NCT02433834|31433|P1|Overall Study|Physician Decision|1
5997|NCT02433834|31433|P1|Overall Study|Adverse Event|6
5998|NCT02433834|31433|P1|Overall Study|Withdrawal by Subject|14
5999|NCT02433834|31433|P1|Overall Study|Lost to Follow-up|6
6000|NCT02433834|31433|P1|Overall Study|Protocol Violation|3
6001|NCT02433834|31433|P1|Overall Study|Protocol-specified criteria|7
6002|NCT02433483|31491|P1|Overall Study|Other antineoplastic therapy/HSCT|1
6003|NCT02433483|31491|P1|Overall Study|Unacceptable toxicity|1
6004|NCT02433340|31518|P4|Overall Study|Not Specified|0
6005|NCT02433340|31519|P3|Overall Study|Not Specified|0
6006|NCT02433340|31520|P2|Overall Study|Not Specified|1
6007|NCT02433340|31521|P1|Overall Study|Not Specified|0
6008|NCT02433340|31518|P4|Overall Study|Required Alternative/Prohibited Therapy|0
6009|NCT02433340|31519|P3|Overall Study|Required Alternative/Prohibited Therapy|0
6010|NCT02433340|31520|P2|Overall Study|Required Alternative/Prohibited Therapy|0
6011|NCT02433340|31521|P1|Overall Study|Required Alternative/Prohibited Therapy|1
6012|NCT02433340|31518|P4|Overall Study|Lost to Follow-up|0
6013|NCT02433340|31519|P3|Overall Study|Lost to Follow-up|0
6014|NCT02433340|31520|P2|Overall Study|Lost to Follow-up|1
6015|NCT02433340|31521|P1|Overall Study|Lost to Follow-up|0
6016|NCT02433340|31518|P4|Overall Study|Withdrawal by Subject|2
6017|NCT02433340|31519|P3|Overall Study|Withdrawal by Subject|1
6018|NCT02433340|31520|P2|Overall Study|Withdrawal by Subject|0
6019|NCT02433340|31521|P1|Overall Study|Withdrawal by Subject|1
6020|NCT02433340|31518|P4|Overall Study|Adverse Event|0
6021|NCT02433340|31519|P3|Overall Study|Adverse Event|1
6022|NCT02433340|31520|P2|Overall Study|Adverse Event|0
6023|NCT02433340|31521|P1|Overall Study|Adverse Event|0
6024|NCT02432105|32434|P3|Overall Study|Randomized in error|2
6025|NCT02432105|32435|P2|Overall Study|Randomized in error|0
6026|NCT02432105|32436|P1|Overall Study|Randomized in error|0
6027|NCT02432105|32434|P3|Overall Study|Culture positive for yeast|0
6028|NCT02432105|32435|P2|Overall Study|Culture positive for yeast|1
6029|NCT02432105|32436|P1|Overall Study|Culture positive for yeast|0
6030|NCT02432105|32434|P3|Overall Study|Withdrawal by Subject|1
6031|NCT02432105|32435|P2|Overall Study|Withdrawal by Subject|0
6032|NCT02432105|32436|P1|Overall Study|Withdrawal by Subject|1
6033|NCT02432105|32434|P3|Overall Study|Lost to Follow-up|0
6034|NCT02432105|32435|P2|Overall Study|Lost to Follow-up|1
6035|NCT02432105|32436|P1|Overall Study|Lost to Follow-up|1
6036|NCT02432040|32453|P2|Overall Study|Physician Decision|1
6037|NCT02432040|32454|P1|Overall Study|Physician Decision|1
6038|NCT02432040|32453|P2|Overall Study|Lost to Follow-up|5
6039|NCT02432040|32454|P1|Overall Study|Lost to Follow-up|4
6040|NCT02432040|32453|P2|Overall Study|Lack of Efficacy|0
6041|NCT02432040|32454|P1|Overall Study|Lack of Efficacy|3
6042|NCT02430870|32567|P8|Part 2|Other Reason Not Specified|1
6043|NCT02430870|32568|P7|Part 2|Other Reason Not Specified|0
6044|NCT02430870|32569|P6|Part 2|Other Reason Not Specified|0
6045|NCT02430870|32570|P5|Part 2|Other Reason Not Specified|0
6046|NCT02430870|32571|P4|Part 2|Other Reason Not Specified|0
6047|NCT02430870|32572|P3|Part 2|Other Reason Not Specified|0
6048|NCT02430870|32573|P2|Part 2|Other Reason Not Specified|0
6049|NCT02430870|32574|P1|Part 2|Other Reason Not Specified|0
6050|NCT02430870|32567|P8|Part 2|Voluntary Withdrawal|0
6051|NCT02430870|32568|P7|Part 2|Voluntary Withdrawal|1
6052|NCT02430870|32569|P6|Part 2|Voluntary Withdrawal|0
6053|NCT02430870|32570|P5|Part 2|Voluntary Withdrawal|0
6054|NCT02430870|32571|P4|Part 2|Voluntary Withdrawal|0
6055|NCT02430870|32572|P3|Part 2|Voluntary Withdrawal|0
6056|NCT02430870|32573|P2|Part 2|Voluntary Withdrawal|0
6057|NCT02430870|32574|P1|Part 2|Voluntary Withdrawal|0
6058|NCT02430532|32648|P2|Overall Study|Adverse Event|1
6059|NCT02430532|32649|P1|Overall Study|Adverse Event|0
6060|NCT02430532|32648|P2|Overall Study|Consent Withdrawn|2
6061|NCT02430532|32649|P1|Overall Study|Consent Withdrawn|0
6062|NCT02430532|32648|P2|Overall Study|Sponsor Decision to Stop Study Early|25
6063|NCT02430532|32649|P1|Overall Study|Sponsor Decision to Stop Study Early|30
6064|NCT02429791|32689|P2|Overall Study|Withdrawal by Subject|7
6065|NCT02429791|32690|P1|Overall Study|Withdrawal by Subject|3
6066|NCT02429791|32689|P2|Overall Study|Protocol Violation|4
6067|NCT02429791|32690|P1|Overall Study|Protocol Violation|1
6068|NCT02429791|32689|P2|Overall Study|Lost to Follow-up|2
6069|NCT02429791|32690|P1|Overall Study|Lost to Follow-up|1
6070|NCT02429791|32689|P2|Overall Study|Lack of Efficacy|1
6071|NCT02429791|32690|P1|Overall Study|Lack of Efficacy|2
6072|NCT02429791|32689|P2|Overall Study|Physician Decision|2
6073|NCT02429791|32690|P1|Overall Study|Physician Decision|0
6074|NCT02429791|32689|P2|Overall Study|Adverse Event|2
6075|NCT02429791|32690|P1|Overall Study|Adverse Event|6
6076|NCT02429258|32762|P2|Overall Study|Protocol Violation|1
6077|NCT02429258|32763|P1|Overall Study|Protocol Violation|0
6078|NCT02429258|32762|P2|Overall Study|Withdrawal by Subject|0
6079|NCT02429258|32763|P1|Overall Study|Withdrawal by Subject|2
6080|NCT02428413|32800|P2|Overall Study|Nurse Refusal|0
6081|NCT02428413|32801|P1|Overall Study|Nurse Refusal|1
6082|NCT02428413|32800|P2|Overall Study|Missed Cases|2
6083|NCT02428413|32801|P1|Overall Study|Missed Cases|1
6084|NCT02428413|32800|P2|Overall Study|Case Cancelled|0
6085|NCT02428413|32801|P1|Overall Study|Case Cancelled|2
6086|NCT02428413|32800|P2|Overall Study|Protocol Violation|2
6087|NCT02428413|32801|P1|Overall Study|Protocol Violation|1
6088|NCT02428413|32800|P2|Overall Study|Device to measure WAG malfunctioned|5
6089|NCT02428413|32801|P1|Overall Study|Device to measure WAG malfunctioned|3
6090|NCT02428231|32815|P2|Overall Study|Adverse Event|0
6091|NCT02428231|32816|P1|Overall Study|Adverse Event|3
6092|NCT02428231|32815|P2|Overall Study|Required Symptomatic Therapy|1
6093|NCT02428231|32816|P1|Overall Study|Required Symptomatic Therapy|0
6094|NCT02428231|32815|P2|Overall Study|Not Specified|16
6095|NCT02428231|32816|P1|Overall Study|Not Specified|10
6096|NCT02427984|32833|P3|Overall Study|Lost to Follow-up|18
6097|NCT02427984|32834|P2|Overall Study|Lost to Follow-up|5
6098|NCT02427984|32835|P1|Overall Study|Lost to Follow-up|13
6099|NCT02427477|32877|P2|Period 1|Adverse Event|0
6100|NCT02427477|32878|P1|Period 1|Adverse Event|1
6101|NCT02427399|32891|P5|Overall Study|Protocol Violation|15
6102|NCT02427399|32892|P4|Overall Study|Protocol Violation|18
6103|NCT02427399|32893|P3|Overall Study|Protocol Violation|12
6104|NCT02427399|32894|P2|Overall Study|Protocol Violation|16
6105|NCT02427399|32895|P1|Overall Study|Protocol Violation|14
6106|NCT02426541|32919|P2|Overall Study|Protocol Violation|0
6107|NCT02426541|32920|P1|Overall Study|Protocol Violation|1
6108|NCT02425826|32937|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
6109|NCT02425826|32938|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
6110|NCT02425826|32939|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
6111|NCT02425826|32937|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
6112|NCT02425826|32938|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
6113|NCT02425826|32939|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
6114|NCT02425826|32937|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
6115|NCT02425826|32938|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
6116|NCT02425826|32939|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
6117|NCT02425826|32937|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
6118|NCT02425826|32938|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
6119|NCT02425826|32939|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
6120|NCT02425826|32937|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
6121|NCT02425826|32938|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
6122|NCT02425826|32939|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
6123|NCT02425826|32937|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
6124|NCT02425826|32938|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
6125|NCT02425826|32939|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
6126|NCT02425826|32937|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
6127|NCT02425826|32938|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
6128|NCT02425826|32939|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
6129|NCT02425826|32937|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
6130|NCT02425826|32938|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
6131|NCT02425826|32939|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
6132|NCT02425826|32937|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
6133|NCT02425826|32938|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
6134|NCT02425826|32939|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
6135|NCT02425826|32937|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
6136|NCT02425826|32938|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
6137|NCT02425826|32939|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
6138|NCT02424591|32995|P2|Overall Study|Protocol Violation|3
6139|NCT02424591|32996|P1|Overall Study|Protocol Violation|2
6140|NCT02424578|33008|P2|Overall Study|Withdrawal by Subject|1
6141|NCT02424578|33009|P1|Overall Study|Withdrawal by Subject|0
6142|NCT02424565|33015|P2|Period 1 (D0)|Protocol Violation|1
6143|NCT02424565|33016|P1|Period 1 (D0)|Protocol Violation|0
6144|NCT02424149|33035|P2|Overall Study|Withdrawal by Subject|1
6145|NCT02424149|33036|P1|Overall Study|Withdrawal by Subject|0
6146|NCT02424149|33035|P2|Overall Study|surgery cancelled|0
6147|NCT02424149|33036|P1|Overall Study|surgery cancelled|2
6148|NCT02423798|33097|P1|Overall Study|Withdrawal by Subject|3
6149|NCT02423291|33163|P1|Overall Study|Adverse Event|1
6150|NCT02423291|33163|P1|Overall Study|Lack of Efficacy|14
6151|NCT02423109|33178|P2|Lens 1|Adverse Event|0
6152|NCT02423109|33179|P1|Lens 1|Adverse Event|1
6153|NCT02422797|33189|P2|Overall Study|Withdrawal by Subject|7
6154|NCT02422797|33190|P1|Overall Study|Withdrawal by Subject|2
6155|NCT02422797|33189|P2|Overall Study|Other; Reached stopping criteria|1
6156|NCT02422797|33190|P1|Overall Study|Other; Reached stopping criteria|1
6157|NCT02422797|33189|P2|Overall Study|Protocol Violation|3
6158|NCT02422797|33190|P1|Overall Study|Protocol Violation|0
6159|NCT02422797|33189|P2|Overall Study|Lost to Follow-up|1
6160|NCT02422797|33190|P1|Overall Study|Lost to Follow-up|1
6161|NCT02422797|33189|P2|Overall Study|Lack of Efficacy|2
6162|NCT02422797|33190|P1|Overall Study|Lack of Efficacy|1
6163|NCT02422797|33189|P2|Overall Study|Physician Decision|1
6164|NCT02422797|33190|P1|Overall Study|Physician Decision|0
6165|NCT02422797|33189|P2|Overall Study|Adverse Event|1
6166|NCT02422797|33190|P1|Overall Study|Adverse Event|11
6167|NCT02422303|33262|P2|Overall Study|Lost to Follow-up|1
6168|NCT02422303|33263|P1|Overall Study|Lost to Follow-up|1
6169|NCT02421419|33272|P3|Overall Study|Physician Decision|1
6170|NCT02421419|33273|P2|Overall Study|Physician Decision|0
6171|NCT02421419|33274|P1|Overall Study|Physician Decision|0
6172|NCT02421120|33359|P1|Overall Study|Adverse Event|1
6173|NCT02420262|33388|P2|Overall Study|Unclassified|1
6174|NCT02420262|33389|P1|Overall Study|Unclassified|0
6175|NCT02420262|33388|P2|Overall Study|Withdrawal by Subject|4
6176|NCT02420262|33389|P1|Overall Study|Withdrawal by Subject|1
6177|NCT02420262|33388|P2|Overall Study|Adverse Event|0
6178|NCT02420262|33389|P1|Overall Study|Adverse Event|1
6179|NCT02420093|33415|P2|Overall Study|Withdrawal by Subject|1
6180|NCT02420093|33416|P1|Overall Study|Withdrawal by Subject|1
6181|NCT02419937|33459|P2|Overall Study|Lost to Follow-up|0
6182|NCT02419937|33460|P1|Overall Study|Lost to Follow-up|1
6183|NCT02419755|33468|P2|Overall Study|Withdrawal by Subject|0
6184|NCT02419755|33469|P1|Overall Study|Withdrawal by Subject|1
6185|NCT02419755|33468|P2|Overall Study|Ineligible|0
6186|NCT02419755|33469|P1|Overall Study|Ineligible|1
6187|NCT02419755|33468|P2|Overall Study|Relapse|1
6188|NCT02419755|33469|P1|Overall Study|Relapse|0
6189|NCT02419755|33468|P2|Overall Study|Death|3
6190|NCT02419755|33469|P1|Overall Study|Death|1
6191|NCT02419313|33505|P2|Second Intervention|Lost to Follow-up|0
6192|NCT02419313|33506|P1|Second Intervention|Lost to Follow-up|1
6193|NCT02419313|33505|P2|First Intervention|Lost to Follow-up|0
6194|NCT02419313|33506|P1|First Intervention|Lost to Follow-up|2
6195|NCT02419001|33518|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
6196|NCT02419001|33519|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
6197|NCT02418468|33547|P2|Overall Study|Withdrawal of informed consent|1
6198|NCT02418468|33548|P1|Overall Study|Withdrawal of informed consent|1
6199|NCT02418468|33547|P2|Overall Study|Adverse Event|0
6200|NCT02418468|33548|P1|Overall Study|Adverse Event|1
6201|NCT02417961|33598|P1|Overall Study|Withdrawal by Subject|2
6202|NCT02417961|33598|P1|Overall Study|Lost to Follow-up|1
6203|NCT02417961|33598|P1|Overall Study|Adverse Event|1
6204|NCT02417753|33608|P1|Overall Study|Death|1
6205|NCT02417532|33618|P1|Overall Study|unable to complete exercises|4
6206|NCT02416934|33702|P2|Overall Study|re-operation|0
6207|NCT02416934|33703|P1|Overall Study|re-operation|1
6208|NCT02416934|33702|P2|Overall Study|surgery started late|1
6209|NCT02416934|33703|P1|Overall Study|surgery started late|0
6210|NCT02416934|33702|P2|Overall Study|Protocol Violation|1
6211|NCT02416934|33703|P1|Overall Study|Protocol Violation|0
6212|NCT02416934|33702|P2|Overall Study|recruited during continuing renewal proc|1
6213|NCT02416934|33703|P1|Overall Study|recruited during continuing renewal proc|0
6214|NCT02416934|33702|P2|Overall Study|Withdrawal by Subject|0
6215|NCT02416934|33703|P1|Overall Study|Withdrawal by Subject|1
6216|NCT02416934|33702|P2|Overall Study|Lost to Follow-up|2
6217|NCT02416934|33703|P1|Overall Study|Lost to Follow-up|0
6218|NCT02416934|33702|P2|Overall Study|given steroids|2
6219|NCT02416934|33703|P1|Overall Study|given steroids|1
6220|NCT02416180|33713|P1|Overall Study|Withdrawal by Subject|1
6221|NCT02415959|33725|P5|Overall Study|Protocol Violation|0
6222|NCT02415959|33726|P4|Overall Study|Protocol Violation|1
6223|NCT02415959|33727|P3|Overall Study|Protocol Violation|0
6224|NCT02415959|33728|P2|Overall Study|Protocol Violation|0
6225|NCT02415959|33729|P1|Overall Study|Protocol Violation|0
6226|NCT02415959|33725|P5|Overall Study|Adverse Event|0
6227|NCT02415959|33726|P4|Overall Study|Adverse Event|0
6228|NCT02415959|33727|P3|Overall Study|Adverse Event|0
6229|NCT02415959|33728|P2|Overall Study|Adverse Event|1
6230|NCT02415959|33729|P1|Overall Study|Adverse Event|0
6231|NCT02415127|33875|P2|Overall Study|Adverse Event|0
6232|NCT02415127|33876|P1|Overall Study|Adverse Event|1
6233|NCT02414828|33894|P4|Overall Study|Lost to Follow-up|2
6234|NCT02414828|33895|P3|Overall Study|Lost to Follow-up|1
6235|NCT02414828|33896|P2|Overall Study|Lost to Follow-up|1
6236|NCT02414828|33897|P1|Overall Study|Lost to Follow-up|0
6237|NCT02414152|33935|P1|Overall Study|Lack of Efficacy|1
6238|NCT02414152|33935|P1|Overall Study|Withdrawal by Subject|1
6239|NCT02413593|33952|P1|Overall Study|Adverse Event|1
6240|NCT02413593|33952|P1|Overall Study|Lost to Follow-up|3
6241|NCT02413346|33963|P2|Overall Study|Other Miscellaneous Reasons|3
6242|NCT02413346|33964|P1|Overall Study|Other Miscellaneous Reasons|4
6243|NCT02413346|33963|P2|Overall Study|Protocol Violation|0
6244|NCT02413346|33964|P1|Overall Study|Protocol Violation|2
6245|NCT02413346|33963|P2|Overall Study|Lost to Follow-up|21
6246|NCT02413346|33964|P1|Overall Study|Lost to Follow-up|17
6247|NCT02413346|33963|P2|Overall Study|Withdrawal by Subject|40
6248|NCT02413346|33964|P1|Overall Study|Withdrawal by Subject|30
6249|NCT02413346|33963|P2|Overall Study|Adverse Event|6
6250|NCT02413346|33964|P1|Overall Study|Adverse Event|6
6251|NCT02413333|33974|P2|Period 2|Protocol Deviation|0
6252|NCT02413333|33975|P1|Period 2|Protocol Deviation|1
6253|NCT02413333|33974|P2|Period 1|Reason Not Specified|1
6254|NCT02413333|33975|P1|Period 1|Reason Not Specified|0
6255|NCT02413333|33974|P2|Period 1|Adverse Event|0
6256|NCT02413333|33975|P1|Period 1|Adverse Event|1
6257|NCT02413294|33983|P1|Overall Study|Withdrawal by Subject|1
6258|NCT02412657|34038|P3|Overall Study|Protocol Violation|3
6259|NCT02412657|34039|P2|Overall Study|Protocol Violation|2
6260|NCT02412657|34040|P1|Overall Study|Protocol Violation|0
6261|NCT02412657|34038|P3|Overall Study|Lost to Follow-up|0
6262|NCT02412657|34039|P2|Overall Study|Lost to Follow-up|0
6263|NCT02412657|34040|P1|Overall Study|Lost to Follow-up|1
6264|NCT02411747|34089|P2|Overall Study|Protocol Violation|4
6265|NCT02411747|34090|P1|Overall Study|Protocol Violation|2
6266|NCT02411747|34089|P2|Overall Study|Withdrawal by Subject|0
6267|NCT02411747|34090|P1|Overall Study|Withdrawal by Subject|1
6268|NCT02411578|34098|P2|Crossover Trial Phase|Pregnancy|1
6269|NCT02411578|34099|P1|Crossover Trial Phase|Pregnancy|0
6270|NCT02411539|34141|P2|Overall Study|Confounding medical condition|1
6271|NCT02411539|34142|P1|Overall Study|Confounding medical condition|0
6272|NCT02411539|34141|P2|Overall Study|Lost to Follow-up|0
6273|NCT02411539|34142|P1|Overall Study|Lost to Follow-up|2
6274|NCT02411292|34217|P1|Overall Study|Lost to Follow-up|3
6275|NCT02411292|34217|P1|Overall Study|Death|2
6276|NCT02411292|34217|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
6277|NCT02411201|34223|P1|Overall Study|Age group completed|2
6278|NCT02411201|34223|P1|Overall Study|Withdrawal by Subject|2
6279|NCT02411201|34223|P1|Overall Study|Adverse Event|2
6280|NCT02411110|34236|P2|Treatment Period 2|Personal Reasons|2
6281|NCT02411110|34237|P1|Treatment Period 2|Personal Reasons|0
6282|NCT02411110|34236|P2|Treatment Period 2|Lost to Follow-up|2
6283|NCT02411110|34237|P1|Treatment Period 2|Lost to Follow-up|0
6284|NCT02411110|34236|P2|Treatment Period 2|Adverse Event|0
6285|NCT02411110|34237|P1|Treatment Period 2|Adverse Event|1
6286|NCT02411110|34236|P2|Treatment Period 1|Other Miscellaneous Reasons|0
6287|NCT02411110|34237|P1|Treatment Period 1|Other Miscellaneous Reasons|2
6288|NCT02411110|34236|P2|Treatment Period 1|Personal Reasons|5
6289|NCT02411110|34237|P1|Treatment Period 1|Personal Reasons|2
6290|NCT02411110|34236|P2|Treatment Period 1|Lost to Follow-up|0
6291|NCT02411110|34237|P1|Treatment Period 1|Lost to Follow-up|1
6292|NCT02411110|34236|P2|Treatment Period 1|Adverse Event|2
6293|NCT02411110|34237|P1|Treatment Period 1|Adverse Event|4
6294|NCT02410824|34245|P2|First Intervention (One Week)|Headache|1
6295|NCT02410824|34246|P1|First Intervention (One Week)|Headache|0
6296|NCT02410200|34294|P1|Overall Study|Adverse Event|2
6297|NCT02408068|34356|P6|Treatment 3 (1.5 Days)|Adverse Event|0
6298|NCT02408068|34357|P5|Treatment 3 (1.5 Days)|Adverse Event|0
6299|NCT02408068|34358|P4|Treatment 3 (1.5 Days)|Adverse Event|0
6300|NCT02408068|34359|P3|Treatment 3 (1.5 Days)|Adverse Event|1
6301|NCT02408068|34360|P2|Treatment 3 (1.5 Days)|Adverse Event|0
6302|NCT02408068|34361|P1|Treatment 3 (1.5 Days)|Adverse Event|0
6303|NCT02407704|34388|P4|Overall Study|Withdrawal by Subject|0
6304|NCT02407704|34389|P3|Overall Study|Withdrawal by Subject|1
6305|NCT02407704|34390|P2|Overall Study|Withdrawal by Subject|0
6306|NCT02407704|34391|P1|Overall Study|Withdrawal by Subject|0
6307|NCT02407704|34388|P4|Overall Study|Protocol Violation|1
6308|NCT02407704|34389|P3|Overall Study|Protocol Violation|0
6309|NCT02407704|34390|P2|Overall Study|Protocol Violation|0
6310|NCT02407704|34391|P1|Overall Study|Protocol Violation|0
6311|NCT02407704|34388|P4|Overall Study|Lost to Follow-up|2
6312|NCT02407704|34389|P3|Overall Study|Lost to Follow-up|0
6313|NCT02407704|34390|P2|Overall Study|Lost to Follow-up|0
6314|NCT02407704|34391|P1|Overall Study|Lost to Follow-up|0
6315|NCT02406586|34489|P3|Overall Study|Withdrawal by Subject|0
6316|NCT02406586|34490|P2|Overall Study|Withdrawal by Subject|0
6317|NCT02406586|34491|P1|Overall Study|Withdrawal by Subject|1
6318|NCT02406586|34489|P3|Overall Study|Lost to Follow-up|2
6319|NCT02406586|34490|P2|Overall Study|Lost to Follow-up|4
6320|NCT02406586|34491|P1|Overall Study|Lost to Follow-up|0
6321|NCT02404649|34625|P2|Overall Study|Adverse Event|2
6322|NCT02404649|34626|P1|Overall Study|Adverse Event|1
6323|NCT02404545|34634|P2|Overall Study|Sponsor Termination|6
6324|NCT02404545|34635|P1|Overall Study|Sponsor Termination|6
6325|NCT02404493|34644|P2|Overall Study|Adverse Event|1
6326|NCT02404493|34645|P1|Overall Study|Adverse Event|1
6327|NCT02404389|34890|P5|Overall Study|Subject/guardian decision|1
6328|NCT02404389|34891|P4|Overall Study|Subject/guardian decision|1
6329|NCT02404389|34892|P3|Overall Study|Subject/guardian decision|0
6330|NCT02404389|34893|P2|Overall Study|Subject/guardian decision|0
6331|NCT02404389|34894|P1|Overall Study|Subject/guardian decision|1
6332|NCT02404389|34890|P5|Overall Study|Adverse Event|2
6333|NCT02404389|34891|P4|Overall Study|Adverse Event|0
6334|NCT02404389|34892|P3|Overall Study|Adverse Event|1
6335|NCT02404389|34893|P2|Overall Study|Adverse Event|0
6336|NCT02404389|34894|P1|Overall Study|Adverse Event|1
6337|NCT02404103|34932|P2|Overall Study|Lost to Follow-up|3
6338|NCT02404103|34933|P1|Overall Study|Lost to Follow-up|3
6339|NCT02404103|34932|P2|Overall Study|Adverse Event|0
6340|NCT02404103|34933|P1|Overall Study|Adverse Event|1
6341|NCT02403674|34966|P2|Overall Study|Protocol Violation|2
6342|NCT02403674|34967|P1|Overall Study|Protocol Violation|4
6343|NCT02403674|34966|P2|Overall Study|Pregnancy|1
6344|NCT02403674|34967|P1|Overall Study|Pregnancy|1
6345|NCT02403674|34966|P2|Overall Study|Not treated with study drug|2
6346|NCT02403674|34967|P1|Overall Study|Not treated with study drug|4
6347|NCT02403674|34966|P2|Overall Study|Physician Decision|2
6348|NCT02403674|34967|P1|Overall Study|Physician Decision|2
6349|NCT02403674|34966|P2|Overall Study|Withdrawal by Subject|11
6350|NCT02403674|34967|P1|Overall Study|Withdrawal by Subject|8
6351|NCT02403674|34966|P2|Overall Study|Noncompliance with study drug|2
6352|NCT02403674|34967|P1|Overall Study|Noncompliance with study drug|1
6353|NCT02403674|34966|P2|Overall Study|Lost to Follow-up|7
6354|NCT02403674|34967|P1|Overall Study|Lost to Follow-up|6
6355|NCT02403674|34966|P2|Overall Study|Lack of Efficacy|10
6356|NCT02403674|34967|P1|Overall Study|Lack of Efficacy|18
6357|NCT02403674|34966|P2|Overall Study|Death|3
6358|NCT02403674|34967|P1|Overall Study|Death|1
6359|NCT02403674|34966|P2|Overall Study|Adverse Event|23
6360|NCT02403674|34967|P1|Overall Study|Adverse Event|10
6361|NCT02403206|35008|P2|Overall Study|Reason not given|4
6362|NCT02403206|35009|P1|Overall Study|Reason not given|2
6363|NCT02403206|35008|P2|Overall Study|Withdrawal by Subject|3
6364|NCT02403206|35009|P1|Overall Study|Withdrawal by Subject|3
6365|NCT02403206|35008|P2|Overall Study|Physician Decision|0
6366|NCT02403206|35009|P1|Overall Study|Physician Decision|2
6367|NCT02403206|35008|P2|Overall Study|Lost to Follow-up|3
6368|NCT02403206|35009|P1|Overall Study|Lost to Follow-up|4
6369|NCT02403180|35020|P2|Period 2 (5 Days)|Withdrawal by Subject|1
6370|NCT02403180|35021|P1|Period 2 (5 Days)|Withdrawal by Subject|0
6371|NCT02403180|35020|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
6372|NCT02403180|35021|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
6373|NCT02402933|35050|P1|Overall Study|Sponsor Decision|10
6374|NCT02402933|35050|P1|Overall Study|Withdrawal by Subject|4
6375|NCT02402322|35068|P3|Follow-up|Withdrawal by Subject|24
6376|NCT02402322|35069|P2|Follow-up|Withdrawal by Subject|3
6377|NCT02402322|35070|P1|Follow-up|Withdrawal by Subject|6
6378|NCT02402322|35068|P3|Pretreatment|Withdrawal by Subject|1
6379|NCT02402322|35069|P2|Pretreatment|Withdrawal by Subject|1
6380|NCT02402322|35070|P1|Pretreatment|Withdrawal by Subject|3
6381|NCT02401867|35139|P1|Analysis|Cervical assay could not be conducted|9
6382|NCT02401867|35139|P1|Specimen Collection|Didn't receive 1 or more tests|10
6383|NCT02401529|35159|P2|Overall Study|Protocol Violation|0
6384|NCT02401529|35160|P1|Overall Study|Protocol Violation|5
6385|NCT02401529|35159|P2|Overall Study|Physician Decision|6
6386|NCT02401529|35160|P1|Overall Study|Physician Decision|2
6387|NCT02401529|35159|P2|Overall Study|Lost to Follow-up|1
6388|NCT02401529|35160|P1|Overall Study|Lost to Follow-up|2
6389|NCT02401256|35225|P1|Overall Study|Withdrawal by Subject|12
6390|NCT02401256|35225|P1|Overall Study|Adverse Event|5
6391|NCT02401230|35234|P3|Overall Study|Lost to Follow-up|3
6392|NCT02401230|35235|P2|Overall Study|Lost to Follow-up|3
6393|NCT02401230|35236|P1|Overall Study|Lost to Follow-up|1
6394|NCT02401230|35234|P3|Overall Study|Withdrawal by Subject|1
6395|NCT02401230|35235|P2|Overall Study|Withdrawal by Subject|1
6396|NCT02401230|35236|P1|Overall Study|Withdrawal by Subject|2
6397|NCT02401230|35234|P3|Overall Study|Adverse Event|0
6398|NCT02401230|35235|P2|Overall Study|Adverse Event|2
6399|NCT02401230|35236|P1|Overall Study|Adverse Event|3
6400|NCT02400580|35295|P2|Overall Study|Adverse Event|0
6401|NCT02400580|35296|P1|Overall Study|Adverse Event|1
6402|NCT02400580|35295|P2|Overall Study|Withdrawal by Subject|1
6403|NCT02400580|35296|P1|Overall Study|Withdrawal by Subject|1
6404|NCT02400346|35306|P1|Overall Study|Lost to Follow-up|1
6405|NCT02400346|35306|P1|Overall Study|Administrative or other reason(s)|2
6406|NCT02400346|35306|P1|Overall Study|Withdrawal by Subject|7
6407|NCT02400346|35306|P1|Overall Study|Non-compliance with IMP|1
6408|NCT02400346|35306|P1|Overall Study|Lack of Efficacy|9
6409|NCT02400346|35306|P1|Overall Study|Adverse Event|24
6410|NCT02400333|35314|P4|Overall Study|Protocol Violation|1
6411|NCT02400333|35315|P3|Overall Study|Protocol Violation|2
6412|NCT02400333|35316|P2|Overall Study|Protocol Violation|0
6413|NCT02400333|35317|P1|Overall Study|Protocol Violation|1
6414|NCT02400333|35314|P4|Overall Study|Withdrawal by Subject|1
6415|NCT02400333|35315|P3|Overall Study|Withdrawal by Subject|0
6416|NCT02400333|35316|P2|Overall Study|Withdrawal by Subject|1
6417|NCT02400333|35317|P1|Overall Study|Withdrawal by Subject|0
6418|NCT02399163|35381|P1|Overall Study|Withdrawal by Participant|5
6419|NCT02399163|35381|P1|Overall Study|Protocol Deviation|2
6420|NCT02399163|35381|P1|Overall Study|Adverse Event|2
6421|NCT02397915|35426|P4|Period 1|Physician Decision|0
6422|NCT02397915|35427|P3|Period 1|Physician Decision|0
6423|NCT02397915|35428|P2|Period 1|Physician Decision|0
6424|NCT02397915|35429|P1|Period 1|Physician Decision|1
6425|NCT02397915|35426|P4|Period 1|Protocol Violation|0
6426|NCT02397915|35427|P3|Period 1|Protocol Violation|0
6427|NCT02397915|35428|P2|Period 1|Protocol Violation|1
6428|NCT02397915|35429|P1|Period 1|Protocol Violation|0
6429|NCT02397694|35528|P2|Open Label Extension Phase|Withdrawal by Subject|0
6430|NCT02397694|35529|P1|Open Label Extension Phase|Withdrawal by Subject|1
6431|NCT02397694|35528|P2|Open Label Extension Phase|Still on Study Drug|30
6432|NCT02397694|35529|P1|Open Label Extension Phase|Still on Study Drug|61
6433|NCT02397694|35528|P2|Double-Blinded Phase|Lost to Follow-up|1
6434|NCT02397694|35529|P1|Double-Blinded Phase|Lost to Follow-up|1
6435|NCT02397694|35528|P2|Double-Blinded Phase|Withdrawal by Subject|0
6436|NCT02397694|35529|P1|Double-Blinded Phase|Withdrawal by Subject|1
6437|NCT02397694|35528|P2|Double-Blinded Phase|Non-compliance with study drug|2
6438|NCT02397694|35529|P1|Double-Blinded Phase|Non-compliance with study drug|0
6439|NCT02397694|35528|P2|Double-Blinded Phase|Adverse Event|0
6440|NCT02397694|35529|P1|Double-Blinded Phase|Adverse Event|1
6441|NCT02397655|35567|P1|Overall Study|data not completed|1301
6442|NCT02396537|35597|P2|Overall Study|Protocol Violation|1
6443|NCT02396537|35598|P1|Overall Study|Protocol Violation|0
6444|NCT02396316|35606|P2|Overall Study|Treatment unblinded|1
6445|NCT02396316|35607|P1|Overall Study|Treatment unblinded|0
6446|NCT02396316|35606|P2|Overall Study|Protocol Violation|1
6447|NCT02396316|35607|P1|Overall Study|Protocol Violation|0
6448|NCT02396316|35606|P2|Overall Study|Progressive disease|3
6449|NCT02396316|35607|P1|Overall Study|Progressive disease|6
6450|NCT02396316|35606|P2|Overall Study|Physician Decision|0
6451|NCT02396316|35607|P1|Overall Study|Physician Decision|1
6452|NCT02395822|35705|P1|Overall Study|Death|1
6453|NCT02395822|35705|P1|Overall Study|Withdrawal by Subject|1
6454|NCT02395653|35713|P1|Overall Study|Lost to Follow-up|1
6455|NCT02395653|35713|P1|Overall Study|Withdrawal by Subject|1
6456|NCT02395653|35713|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
6457|NCT02395653|35713|P1|Overall Study|Investigator Decision at Screening|1
6458|NCT02395653|35713|P1|Overall Study|SSEC Application But With 0 Dose|1
6459|NCT02395653|35713|P1|Overall Study|Consent Withdrawn at Screening|1
6460|NCT02395653|35713|P1|Overall Study|Exclusion Criteria Met at Screening|4
6461|NCT02395536|35722|P2|Overall Study|Insurance issue|1
6462|NCT02395536|35723|P1|Overall Study|Insurance issue|0
6463|NCT02395536|35722|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
6464|NCT02395536|35723|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
6465|NCT02395536|35722|P2|Overall Study|Withdrawal by Subject|17
6466|NCT02395536|35723|P1|Overall Study|Withdrawal by Subject|9
6467|NCT02395536|35722|P2|Overall Study|Physician Decision|6
6468|NCT02395536|35723|P1|Overall Study|Physician Decision|4
6469|NCT02395536|35722|P2|Overall Study|Death|0
6470|NCT02395536|35723|P1|Overall Study|Death|2
6471|NCT02395536|35722|P2|Overall Study|Lost to Follow-up|4
6472|NCT02395536|35723|P1|Overall Study|Lost to Follow-up|4
6473|NCT02395302|35729|P1|Overall Study|Physician Decision|2
6474|NCT02395302|35729|P1|Overall Study|Withdrawal by Subject|2
6475|NCT02395302|35729|P1|Overall Study|Run In Failure|7
6476|NCT02395302|35729|P1|Overall Study|Screen Failure|3
6477|NCT02395055|35749|P2|Overall Study|Withdrawal by Subject|3
6478|NCT02395055|35750|P1|Overall Study|Withdrawal by Subject|7
6479|NCT02394925|35760|P1|Overall Study|Unsatisfactory Visual Response|5
6480|NCT02394925|35760|P1|Overall Study|No longer meet eligibility criteria|1
6481|NCT02394925|35760|P1|Overall Study|Protocol Violation|5
6482|NCT02394925|35760|P1|Overall Study|Lost to Follow-up|9
6483|NCT02394925|35760|P1|Overall Study|Lens handling difficulities|5
6484|NCT02394925|35760|P1|Overall Study|Lens Discomfort|3
6485|NCT02394925|35760|P1|Overall Study|Adverse Event|1
6486|NCT02394808|35764|P2|Period 2|Lost to Follow-up|0
6487|NCT02394808|35765|P1|Period 2|Lost to Follow-up|1
6488|NCT02394808|35764|P2|Period 1|Unsatisfactory lens fitting|1
6489|NCT02394808|35765|P1|Period 1|Unsatisfactory lens fitting|0
6490|NCT02394756|35773|P6|Period 2|Unsatisfactory Visual Response|0
6491|NCT02394756|35774|P5|Period 2|Unsatisfactory Visual Response|1
6492|NCT02394756|35775|P4|Period 2|Unsatisfactory Visual Response|0
6493|NCT02394756|35776|P3|Period 2|Unsatisfactory Visual Response|0
6494|NCT02394756|35777|P2|Period 2|Unsatisfactory Visual Response|0
6495|NCT02394756|35778|P1|Period 2|Unsatisfactory Visual Response|0
6496|NCT02394756|35773|P6|Period 1|Withdrawal by Subject|0
6497|NCT02394756|35774|P5|Period 1|Withdrawal by Subject|0
6498|NCT02394756|35775|P4|Period 1|Withdrawal by Subject|1
6499|NCT02394756|35776|P3|Period 1|Withdrawal by Subject|1
6500|NCT02394756|35777|P2|Period 1|Withdrawal by Subject|1
6501|NCT02394756|35778|P1|Period 1|Withdrawal by Subject|0
6502|NCT02394756|35773|P6|Period 1|Lens Discomfort|1
6503|NCT02394756|35774|P5|Period 1|Lens Discomfort|0
6504|NCT02394756|35775|P4|Period 1|Lens Discomfort|0
6505|NCT02394756|35776|P3|Period 1|Lens Discomfort|0
6506|NCT02394756|35777|P2|Period 1|Lens Discomfort|0
6507|NCT02394756|35778|P1|Period 1|Lens Discomfort|0
6508|NCT02394665|35792|P3|Overall Study|Physician Decision|0
6509|NCT02394665|35793|P2|Overall Study|Physician Decision|0
6510|NCT02394665|35794|P1|Overall Study|Physician Decision|1
6511|NCT02394600|35816|P2|Overall Study|Protocol Violation|0
6512|NCT02394600|35817|P1|Overall Study|Protocol Violation|1
6513|NCT02394600|35816|P2|Overall Study|Withdrawal by Subject|1
6514|NCT02394600|35817|P1|Overall Study|Withdrawal by Subject|0
6515|NCT02394600|35816|P2|Overall Study|Lost to Follow-up|1
6516|NCT02394600|35817|P1|Overall Study|Lost to Follow-up|0
6517|NCT02394600|35816|P2|Overall Study|Adverse Event|0
6518|NCT02394600|35817|P1|Overall Study|Adverse Event|3
6519|NCT02393950|35846|P2|Overall Study|Withdrawal by Subject|1
6520|NCT02393950|35847|P1|Overall Study|Withdrawal by Subject|0
6521|NCT02393950|35846|P2|Overall Study|Adverse Event|0
6522|NCT02393950|35847|P1|Overall Study|Adverse Event|1
6523|NCT02393547|35921|P1|Overall Study|Lost to Follow-up|1
6524|NCT02393547|35921|P1|Overall Study|Withdrawal by Subject|3
6525|NCT02393547|35921|P1|Overall Study|Adverse Event|2
6526|NCT02393209|35930|P4|Overall Study|Lost to Follow-up|0
6527|NCT02393209|35931|P3|Overall Study|Lost to Follow-up|0
6528|NCT02393209|35932|P2|Overall Study|Lost to Follow-up|1
6529|NCT02393209|35933|P1|Overall Study|Lost to Follow-up|0
6530|NCT02393209|35930|P4|Overall Study|Patient Seen by Another Oncologist|0
6531|NCT02393209|35931|P3|Overall Study|Patient Seen by Another Oncologist|0
6532|NCT02393209|35932|P2|Overall Study|Patient Seen by Another Oncologist|1
6533|NCT02393209|35933|P1|Overall Study|Patient Seen by Another Oncologist|0
6534|NCT02393209|35930|P4|Overall Study|Death from Legionella Infection|0
6535|NCT02393209|35931|P3|Overall Study|Death from Legionella Infection|0
6536|NCT02393209|35932|P2|Overall Study|Death from Legionella Infection|1
6537|NCT02393209|35933|P1|Overall Study|Death from Legionella Infection|0
6538|NCT02393209|35930|P4|Overall Study|Death due to Disease Progression|0
6539|NCT02393209|35931|P3|Overall Study|Death due to Disease Progression|0
6540|NCT02393209|35932|P2|Overall Study|Death due to Disease Progression|2
6541|NCT02393209|35933|P1|Overall Study|Death due to Disease Progression|2
6542|NCT02393209|35930|P4|Overall Study|Death|0
6543|NCT02393209|35931|P3|Overall Study|Death|0
6544|NCT02393209|35932|P2|Overall Study|Death|2
6545|NCT02393209|35933|P1|Overall Study|Death|2
6546|NCT02393209|35930|P4|Overall Study|Withdrawal by Patient|0
6547|NCT02393209|35931|P3|Overall Study|Withdrawal by Patient|0
6548|NCT02393209|35932|P2|Overall Study|Withdrawal by Patient|0
6549|NCT02393209|35933|P1|Overall Study|Withdrawal by Patient|1
6550|NCT02393209|35930|P4|Overall Study|Study Terminated by Sponsor|0
6551|NCT02393209|35931|P3|Overall Study|Study Terminated by Sponsor|0
6552|NCT02393209|35932|P2|Overall Study|Study Terminated by Sponsor|1
6553|NCT02393209|35933|P1|Overall Study|Study Terminated by Sponsor|1
6554|NCT02392624|36022|P3|Overall Study|Other|1
6555|NCT02392624|36023|P2|Overall Study|Other|1
6556|NCT02392624|36024|P1|Overall Study|Other|49
6557|NCT02392624|36022|P3|Overall Study|Sponsor/Investigator Decision|0
6558|NCT02392624|36023|P2|Overall Study|Sponsor/Investigator Decision|1
6559|NCT02392624|36024|P1|Overall Study|Sponsor/Investigator Decision|2
6560|NCT02392624|36022|P3|Overall Study|Protocol Violation|1
6561|NCT02392624|36023|P2|Overall Study|Protocol Violation|0
6562|NCT02392624|36024|P1|Overall Study|Protocol Violation|0
6563|NCT02392624|36022|P3|Overall Study|Pregnancy|0
6564|NCT02392624|36023|P2|Overall Study|Pregnancy|0
6565|NCT02392624|36024|P1|Overall Study|Pregnancy|1
6566|NCT02392624|36022|P3|Overall Study|Adverse Event|2
6567|NCT02392624|36023|P2|Overall Study|Adverse Event|1
6568|NCT02392624|36024|P1|Overall Study|Adverse Event|4
6569|NCT02392624|36022|P3|Overall Study|Withdrawal by Subject|9
6570|NCT02392624|36023|P2|Overall Study|Withdrawal by Subject|12
6571|NCT02392624|36024|P1|Overall Study|Withdrawal by Subject|15
6572|NCT02392377|36039|P2|Overall Study|Withdrawal by Subject|1
6573|NCT02392377|36040|P1|Overall Study|Withdrawal by Subject|0
6574|NCT02392247|36064|P1|Overall Study|Surgery cancelled; no data|1
6575|NCT02392247|36064|P1|Overall Study|Withdrawal by Subject|1
6576|NCT02392000|36079|P1|Overall Study|Lost to Follow-up|8
6577|NCT02392000|36079|P1|Overall Study|Withdrawal by Subject|1
6578|NCT02392000|36079|P1|Overall Study|Greater than mild sleep apnea exclusion|18
6579|NCT02391311|36102|P2|Overall Study|deemed ineligible after baseline|1
6580|NCT02391311|36103|P1|Overall Study|deemed ineligible after baseline|1
6581|NCT02391311|36102|P2|Overall Study|Lost to Follow-up|1
6582|NCT02391311|36103|P1|Overall Study|Lost to Follow-up|2
6583|NCT02391116|36111|P1|Survival Follow-up|Ongoing with Survival Follow-up|12
6584|NCT02391116|36111|P1|Survival Follow-up|Withdrawal by Subject|2
6585|NCT02391116|36111|P1|Active Follow-up|Switching to Other Therapy|2
6586|NCT02391116|36111|P1|Active Follow-up|Withdrawal by Subject|1
6587|NCT02391116|36111|P1|Safety Follow-up|Deterioration of General Conditions|3
6588|NCT02391116|36111|P1|Safety Follow-up|No Follow Up|1
6589|NCT02391116|36111|P1|Safety Follow-up|Switching to Other Therapy|4
6590|NCT02391116|36111|P1|Safety Follow-up|Withdrawal by Subject|4
6591|NCT02391116|36111|P1|Safety Follow-up|Adverse Event|1
6592|NCT02391116|36111|P1|Treatment|Ongoing with Treatment|1
6593|NCT02391116|36111|P1|Treatment|AE with Clinical PD|3
6594|NCT02391116|36111|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
6595|NCT02391116|36111|P1|Treatment|Protocol Violation|1
6596|NCT02391116|36111|P1|Treatment|Withdrawal by Subject|1
6597|NCT02391038|36164|P3|Overall Study|Progressive disease|6
6598|NCT02391038|36165|P2|Overall Study|Progressive disease|3
6599|NCT02391038|36166|P1|Overall Study|Progressive disease|3
6600|NCT02390219|36280|P1|Overall Study|Other|2
6601|NCT02390219|36280|P1|Overall Study|Lost to Follow-up|2
6602|NCT02390219|36280|P1|Overall Study|Withdrawal by Subject|1
6603|NCT02390219|36280|P1|Overall Study|Adverse Event|6
6604|NCT02390219|36280|P1|Overall Study|Physician Decision|1
6605|NCT02390219|36280|P1|Overall Study|Death|1
6606|NCT02390167|36290|P1|Overall Study|Lost to Follow-up|1
6607|NCT02389452|36371|P1|Overall Study|Enrolled but Not Eligible for Study|6
6608|NCT02389452|36371|P1|Overall Study|Withdrawal by Subject|5
6609|NCT02389452|36371|P1|Overall Study|Adverse Event|1
6610|NCT02389452|36371|P1|Overall Study|Lost to Follow-up|13
6611|NCT02388776|36481|P1|Overall Study|Lost to Follow-up|1
6612|NCT02388776|36481|P1|Overall Study|Death|1
6613|NCT02388763|36486|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
6614|NCT02388763|36487|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
6615|NCT02388763|36486|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
6616|NCT02388763|36487|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
6617|NCT02388347|36503|P5|Overall Study|Withdrawal by Subject|0
6618|NCT02388347|36504|P4|Overall Study|Withdrawal by Subject|0
6619|NCT02388347|36505|P3|Overall Study|Withdrawal by Subject|1
6620|NCT02388347|36506|P2|Overall Study|Withdrawal by Subject|0
6621|NCT02388347|36507|P1|Overall Study|Withdrawal by Subject|0
6622|NCT02388295|36586|P3|Treatment Weeks 3 to 12|Adverse Event|0
6623|NCT02388295|36587|P2|Treatment Weeks 3 to 12|Adverse Event|1
6624|NCT02388295|36588|P1|Treatment Weeks 3 to 12|Adverse Event|1
6625|NCT02388295|36586|P3|Dose Escalation Week 2|Determined not eligible|1
6626|NCT02388295|36587|P2|Dose Escalation Week 2|Determined not eligible|1
6627|NCT02388295|36588|P1|Dose Escalation Week 2|Determined not eligible|1
6628|NCT02388295|36586|P3|Dose Escalation Week 2|Protocol Violation|0
6629|NCT02388295|36587|P2|Dose Escalation Week 2|Protocol Violation|1
6630|NCT02388295|36588|P1|Dose Escalation Week 2|Protocol Violation|0
6631|NCT02388295|36586|P3|Dose Escalation Week 1|Determined not eligible|1
6632|NCT02388295|36587|P2|Dose Escalation Week 1|Determined not eligible|1
6633|NCT02388295|36588|P1|Dose Escalation Week 1|Determined not eligible|1
6634|NCT02388295|36586|P3|Dose Escalation Week 1|Adverse Event|1
6635|NCT02388295|36587|P2|Dose Escalation Week 1|Adverse Event|2
6636|NCT02388295|36588|P1|Dose Escalation Week 1|Adverse Event|1
6637|NCT02388269|36606|P3|Overall Study|Screen Failure|10
6638|NCT02388269|36607|P2|Overall Study|Screen Failure|0
6639|NCT02388269|36608|P1|Overall Study|Screen Failure|0
6640|NCT02388269|36606|P3|Overall Study|Protocol Violation|0
6641|NCT02388269|36607|P2|Overall Study|Protocol Violation|0
6642|NCT02388269|36608|P1|Overall Study|Protocol Violation|2
6643|NCT02388269|36606|P3|Overall Study|no diary data|0
6644|NCT02388269|36607|P2|Overall Study|no diary data|0
6645|NCT02388269|36608|P1|Overall Study|no diary data|3
6646|NCT02388269|36606|P3|Overall Study|less than 50% stimulations|0
6647|NCT02388269|36607|P2|Overall Study|less than 50% stimulations|0
6648|NCT02388269|36608|P1|Overall Study|less than 50% stimulations|1
6649|NCT02388269|36606|P3|Overall Study|Withdrawal by Subject|0
6650|NCT02388269|36607|P2|Overall Study|Withdrawal by Subject|2
6651|NCT02388269|36608|P1|Overall Study|Withdrawal by Subject|1
6652|NCT02388269|36606|P3|Overall Study|Adverse Event|0
6653|NCT02388269|36607|P2|Overall Study|Adverse Event|0
6654|NCT02388269|36608|P1|Overall Study|Adverse Event|2
6655|NCT02388191|36640|P2|Overall Study|Patient did not receive IUD|0
6656|NCT02388191|36641|P1|Overall Study|Patient did not receive IUD|1
6657|NCT02388074|36655|P1|Overall Study|Sample Not Returned|1
6658|NCT02388074|36655|P1|Overall Study|Lost in Transit|2
6659|NCT02387996|36659|P1|Overall Study|Poor/Non-Compliance|1
6660|NCT02387996|36659|P1|Overall Study|Lost to Follow-up|1
6661|NCT02387996|36659|P1|Overall Study|Subject Withdrew Consent|1
6662|NCT02387996|36659|P1|Overall Study|Subject Request to Discontinue Treatment|9
6663|NCT02387996|36659|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
6664|NCT02387996|36659|P1|Overall Study|Study Drug Toxicity|14
6665|NCT02387996|36659|P1|Overall Study|Disease Progression|144
6666|NCT02387983|36670|P1|Overall Study|Withdrawal by Subject|2
6667|NCT02387983|36670|P1|Overall Study|Protocol Violation|1
6668|NCT02387983|36670|P1|Overall Study|Adverse Event|4
6669|NCT02387580|36729|P6|Overall Study|Withdrawal by Subject|0
6670|NCT02387580|36730|P5|Overall Study|Withdrawal by Subject|0
6671|NCT02387580|36731|P4|Overall Study|Withdrawal by Subject|1
6672|NCT02387580|36732|P3|Overall Study|Withdrawal by Subject|0
6673|NCT02387580|36733|P2|Overall Study|Withdrawal by Subject|0
6674|NCT02387580|36734|P1|Overall Study|Withdrawal by Subject|0
6675|NCT02384538|36832|P2|Overall Study|Not Specified|3
6676|NCT02384538|36833|P1|Overall Study|Not Specified|1
6677|NCT02384538|36832|P2|Overall Study|Withdrew Consent|4
6678|NCT02384538|36833|P1|Overall Study|Withdrew Consent|0
6679|NCT02384538|36832|P2|Overall Study|Lack of Efficacy|4
6680|NCT02384538|36833|P1|Overall Study|Lack of Efficacy|4
6681|NCT02384538|36832|P2|Overall Study|Adverse Event|4
6682|NCT02384538|36833|P1|Overall Study|Adverse Event|1
6683|NCT02383862|36872|P2|3 Month Follow up|Lost to Follow-up|21
6684|NCT02383862|36873|P1|3 Month Follow up|Lost to Follow-up|23
6685|NCT02383758|36906|P2|Overall Study|Withdrawal by Subject|2
6686|NCT02383758|36907|P1|Overall Study|Withdrawal by Subject|0
6687|NCT02383576|36925|P2|Overall Study|Administrative/Other|4
6688|NCT02383576|36926|P1|Overall Study|Administrative/Other|2
6689|NCT02383576|36925|P2|Overall Study|Investigator's Decision|1
6690|NCT02383576|36926|P1|Overall Study|Investigator's Decision|0
6691|NCT02383576|36925|P2|Overall Study|Withdrew Consent|6
6692|NCT02383576|36926|P1|Overall Study|Withdrew Consent|1
6693|NCT02383576|36925|P2|Overall Study|Lost to Follow-up|1
6694|NCT02383576|36926|P1|Overall Study|Lost to Follow-up|7
6695|NCT02383576|36925|P2|Overall Study|Death|33
6696|NCT02383576|36926|P1|Overall Study|Death|53
6697|NCT02382640|37046|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
6698|NCT02382640|37047|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
6699|NCT02382640|37048|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
6700|NCT02382640|37049|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
6701|NCT02382133|37087|P1|Overall Study|pressure injury both sites|1
6702|NCT02382133|37087|P1|Overall Study|arterial catheter loss|4
6703|NCT02382133|37087|P1|Overall Study|Physician Decision|2
6704|NCT02382133|37087|P1|Overall Study|transfer out of ICU|4
6705|NCT02382133|37087|P1|Overall Study|Death|22
6706|NCT02381795|37092|P1|Overall Study|Study Terminated|2
6707|NCT02381795|37092|P1|Overall Study|Withdrawal by Subject|1
6708|NCT02380742|37163|P2|Overall Study|Withdrawal by Subject|0
6709|NCT02380742|37164|P1|Overall Study|Withdrawal by Subject|1
6710|NCT02380287|37184|P8|Overall Study|Adverse Event|0
6711|NCT02380287|37185|P7|Overall Study|Adverse Event|0
6712|NCT02380287|37186|P6|Overall Study|Adverse Event|0
6713|NCT02380287|37187|P5|Overall Study|Adverse Event|0
6714|NCT02380287|37188|P4|Overall Study|Adverse Event|0
6715|NCT02380287|37189|P3|Overall Study|Adverse Event|1
6716|NCT02380287|37190|P2|Overall Study|Adverse Event|0
6717|NCT02380287|37191|P1|Overall Study|Adverse Event|0
6718|NCT02380248|37207|P1|Overall Study|Withdrawal by Subject|3
6719|NCT02380248|37207|P1|Overall Study|Lost to Follow-up|11
6720|NCT02379637|37214|P2|Overall Study|Withdrawal by Subject|0
6721|NCT02379637|37215|P1|Overall Study|Withdrawal by Subject|1
6722|NCT02379637|37214|P2|Overall Study|Adverse Event|0
6723|NCT02379637|37215|P1|Overall Study|Adverse Event|1
6724|NCT02379637|37214|P2|Overall Study|Protocol Violation|1
6725|NCT02379637|37215|P1|Overall Study|Protocol Violation|0
6726|NCT02378961|37252|P4|Overall Study|Death|0
6727|NCT02378961|37253|P3|Overall Study|Death|1
6728|NCT02378961|37254|P2|Overall Study|Death|0
6729|NCT02378961|37255|P1|Overall Study|Death|0
6730|NCT02378961|37252|P4|Overall Study|Lack of Efficacy|1
6731|NCT02378961|37253|P3|Overall Study|Lack of Efficacy|0
6732|NCT02378961|37254|P2|Overall Study|Lack of Efficacy|2
6733|NCT02378961|37255|P1|Overall Study|Lack of Efficacy|4
6734|NCT02378935|37292|P7|Overall Study|Death|0
6735|NCT02378935|37293|P6|Overall Study|Death|0
6736|NCT02378935|37294|P5|Overall Study|Death|0
6737|NCT02378935|37295|P4|Overall Study|Death|0
6738|NCT02378935|37296|P3|Overall Study|Death|1
6739|NCT02378935|37297|P2|Overall Study|Death|0
6740|NCT02378935|37298|P1|Overall Study|Death|0
6741|NCT02378935|37292|P7|Overall Study|Lack of Efficacy|0
6742|NCT02378935|37293|P6|Overall Study|Lack of Efficacy|0
6743|NCT02378935|37294|P5|Overall Study|Lack of Efficacy|0
6744|NCT02378935|37295|P4|Overall Study|Lack of Efficacy|6
6745|NCT02378935|37296|P3|Overall Study|Lack of Efficacy|2
6746|NCT02378935|37297|P2|Overall Study|Lack of Efficacy|0
6747|NCT02378935|37298|P1|Overall Study|Lack of Efficacy|10
6748|NCT02378506|37370|P1|Overall Study|Randomized But Not Treated|1
6749|NCT02378506|37370|P1|Overall Study|Adverse Event|14
6750|NCT02378506|37370|P1|Overall Study|Death|1
6751|NCT02378506|37370|P1|Overall Study|Protocol Violation|2
6752|NCT02378506|37370|P1|Overall Study|Withdrawal by Subject|4
6753|NCT02378506|37370|P1|Overall Study|Lack of Efficacy|3
6754|NCT02377427|37389|P2|Overall Study|Withdrawal by Subject|0
6755|NCT02377427|37390|P1|Overall Study|Withdrawal by Subject|2
6756|NCT02377427|37389|P2|Overall Study|Other: AE of Asthma Exacerbation|0
6757|NCT02377427|37390|P1|Overall Study|Other: AE of Asthma Exacerbation|1
6758|NCT02377427|37389|P2|Overall Study|Physician Decision|0
6759|NCT02377427|37390|P1|Overall Study|Physician Decision|1
6760|NCT02376166|37442|P1|Overall Study|Discontinued metformin early|2
6761|NCT02376166|37442|P1|Overall Study|Adverse Event|1
6762|NCT02375724|37469|P2|Overall Study|Adverse Event|4
6763|NCT02375724|37470|P1|Overall Study|Adverse Event|2
6764|NCT02375724|37469|P2|Overall Study|Protocol Violation|0
6765|NCT02375724|37470|P1|Overall Study|Protocol Violation|1
6766|NCT02375724|37469|P2|Overall Study|Lost to Follow-up|0
6767|NCT02375724|37470|P1|Overall Study|Lost to Follow-up|1
6768|NCT02375724|37469|P2|Overall Study|Withdrawal by Subject|1
6769|NCT02375724|37470|P1|Overall Study|Withdrawal by Subject|1
6770|NCT02375724|37469|P2|Overall Study|Lack of Efficacy|1
6771|NCT02375724|37470|P1|Overall Study|Lack of Efficacy|1
6772|NCT02375373|37480|P1|Overall Study|Withdrawal by Subject|11
6773|NCT02375347|37484|P1|Overall Study|Protocol Violation|1
6774|NCT02374593|37490|P2|Overall Study|non-compliant|0
6775|NCT02374593|37491|P1|Overall Study|non-compliant|2
6776|NCT02374346|37534|P1|Overall Study|operated or discharged during weekend|48
6777|NCT02373202|37566|P4|Overall Study|Not specified|0
6778|NCT02373202|37567|P3|Overall Study|Not specified|0
6779|NCT02373202|37568|P2|Overall Study|Not specified|1
6780|NCT02373202|37569|P1|Overall Study|Not specified|0
6781|NCT02373202|37566|P4|Overall Study|Lack of Efficacy|0
6782|NCT02373202|37567|P3|Overall Study|Lack of Efficacy|1
6783|NCT02373202|37568|P2|Overall Study|Lack of Efficacy|0
6784|NCT02373202|37569|P1|Overall Study|Lack of Efficacy|0
6785|NCT02373202|37566|P4|Overall Study|Adverse Event|1
6786|NCT02373202|37567|P3|Overall Study|Adverse Event|2
6787|NCT02373202|37568|P2|Overall Study|Adverse Event|5
6788|NCT02373202|37569|P1|Overall Study|Adverse Event|2
6789|NCT02372071|37664|P1|Overall Study|Protocol Violation|18
6790|NCT02372058|37669|P1|Overall Study|Withdrawal by Subject|3
6791|NCT02371759|37698|P8|Overall Study|Withdrawal by Subject|1
6792|NCT02371759|37699|P7|Overall Study|Withdrawal by Subject|0
6793|NCT02371759|37700|P6|Overall Study|Withdrawal by Subject|0
6794|NCT02371759|37701|P5|Overall Study|Withdrawal by Subject|0
6795|NCT02371759|37702|P4|Overall Study|Withdrawal by Subject|0
6796|NCT02371759|37703|P3|Overall Study|Withdrawal by Subject|0
6797|NCT02371759|37704|P2|Overall Study|Withdrawal by Subject|0
6798|NCT02371759|37705|P1|Overall Study|Withdrawal by Subject|0
6799|NCT02371759|37698|P8|Overall Study|Protocol Violation|3
6800|NCT02371759|37699|P7|Overall Study|Protocol Violation|0
6801|NCT02371759|37700|P6|Overall Study|Protocol Violation|1
6802|NCT02371759|37701|P5|Overall Study|Protocol Violation|3
6803|NCT02371759|37702|P4|Overall Study|Protocol Violation|0
6804|NCT02371759|37703|P3|Overall Study|Protocol Violation|1
6805|NCT02371759|37704|P2|Overall Study|Protocol Violation|1
6806|NCT02371759|37705|P1|Overall Study|Protocol Violation|3
6807|NCT02371616|37917|P2|Overall Study|Other (Not specified)|5
6808|NCT02371616|37918|P1|Overall Study|Other (Not specified)|1
6809|NCT02371616|37917|P2|Overall Study|Withdrawal of Consent|0
6810|NCT02371616|37918|P1|Overall Study|Withdrawal of Consent|1
6811|NCT02371616|37917|P2|Overall Study|Adverse Event|1
6812|NCT02371616|37918|P1|Overall Study|Adverse Event|0
6813|NCT02371616|37917|P2|Overall Study|Protocol Violation|1
6814|NCT02371616|37918|P1|Overall Study|Protocol Violation|2
6815|NCT02370914|37930|P1|Overall Study|Protocol Violation|2
6816|NCT02370667|37937|P3|Overall Study|Lost to Follow-up|0
6817|NCT02370667|37938|P2|Overall Study|Lost to Follow-up|1
6818|NCT02370667|37939|P1|Overall Study|Lost to Follow-up|0
6819|NCT02370615|38003|P2|Overall Study|Adverse Event|0
6820|NCT02370615|38004|P1|Overall Study|Adverse Event|1
6821|NCT02370602|38047|P6|Overall Study|Pretreatment Event/Adverse Event|0
6822|NCT02370602|38048|P5|Overall Study|Pretreatment Event/Adverse Event|0
6823|NCT02370602|38049|P4|Overall Study|Pretreatment Event/Adverse Event|0
6824|NCT02370602|38050|P3|Overall Study|Pretreatment Event/Adverse Event|0
6825|NCT02370602|38051|P2|Overall Study|Pretreatment Event/Adverse Event|0
6826|NCT02370602|38052|P1|Overall Study|Pretreatment Event/Adverse Event|1
6827|NCT02370537|38146|P3|Part B|Withdrawal by Subject|0
6828|NCT02370537|38147|P2|Part B|Withdrawal by Subject|1
6829|NCT02370537|38148|P1|Part B|Withdrawal by Subject|0
6830|NCT02370537|38146|P3|Part B|Not randomised to receive treatment|259
6831|NCT02370537|38147|P2|Part B|Not randomised to receive treatment|2
6832|NCT02370537|38148|P1|Part B|Not randomised to receive treatment|1
6833|NCT02370537|38146|P3|Part A (Open-label Recruitment)|Adverse Event|1
6834|NCT02370537|38147|P2|Part A (Open-label Recruitment)|Adverse Event|0
6835|NCT02370537|38148|P1|Part A (Open-label Recruitment)|Adverse Event|0
6836|NCT02370537|38146|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
6837|NCT02370537|38147|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
6838|NCT02370537|38148|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
6839|NCT02370420|38197|P2|Overall Study|Lost to Follow-up|9
6840|NCT02370420|38198|P1|Overall Study|Lost to Follow-up|11
6841|NCT02370420|38197|P2|Overall Study|Physician Decision|3
6842|NCT02370420|38198|P1|Overall Study|Physician Decision|3
6843|NCT02370394|38235|P2|Overall Study|Withdrawal by Subject|1
6844|NCT02370394|38236|P1|Overall Study|Withdrawal by Subject|0
6845|NCT02370394|38235|P2|Overall Study|Lost to Follow-up|1
6846|NCT02370394|38236|P1|Overall Study|Lost to Follow-up|2
6847|NCT02370121|38252|P2|Overall Study|Lost to Follow-up|1
6848|NCT02370121|38253|P1|Overall Study|Lost to Follow-up|1
6849|NCT02369848|38291|P1|Overall Study|Lost to Follow-up|1
6850|NCT02369848|38291|P1|Overall Study|Withdrawal by Subject|2
6851|NCT02369848|38291|P1|Overall Study|Death|1
6852|NCT02369510|38356|P3|Overall Study|Epidural Activation|5
6853|NCT02369510|38357|P2|Overall Study|Epidural Activation|1
6854|NCT02369510|38358|P1|Overall Study|Epidural Activation|1
6855|NCT02369510|38356|P3|Overall Study|Spilled Medication|1
6856|NCT02369510|38357|P2|Overall Study|Spilled Medication|2
6857|NCT02369510|38358|P1|Overall Study|Spilled Medication|1
6858|NCT02369341|38389|P2|Overall Study|Migrated/moved from study area|0
6859|NCT02369341|38390|P1|Overall Study|Migrated/moved from study area|1
6860|NCT02368314|38457|P2|Overall Study|Adverse Event|2
6861|NCT02368314|38458|P1|Overall Study|Adverse Event|1
6862|NCT02368314|38457|P2|Overall Study|Withdrawal by Subject|1
6863|NCT02368314|38458|P1|Overall Study|Withdrawal by Subject|2
6864|NCT02367885|38480|P3|Overall Study|Withdrawal by Subject|0
6865|NCT02367885|38481|P2|Overall Study|Withdrawal by Subject|0
6866|NCT02367885|38482|P1|Overall Study|Withdrawal by Subject|1
6867|NCT02367885|38480|P3|Overall Study|Lost to Follow-up|0
6868|NCT02367885|38481|P2|Overall Study|Lost to Follow-up|0
6869|NCT02367885|38482|P1|Overall Study|Lost to Follow-up|1
6870|NCT02366936|38810|P1|Overall Study|Physician Decision|2
6871|NCT02366936|38810|P1|Overall Study|Lost to Follow-up|4
6872|NCT02366936|38810|P1|Overall Study|Withdrawal by Subject|2
6873|NCT02366923|38815|P1|Overall Study|High Astigmatism|3
6874|NCT02366923|38815|P1|Overall Study|Positive Slit Lamp Findings|2
6875|NCT02366923|38815|P1|Overall Study|Withdrawal by Subject|1
6876|NCT02366910|38828|P1|Overall Study|Screen Failure|3
6877|NCT02366910|38828|P1|Overall Study|Withdrawal by Subject|2
6878|NCT02366767|38842|P2|Overall Study|left for home after 1 day at camp|0
6879|NCT02366767|38843|P1|Overall Study|left for home after 1 day at camp|1
6880|NCT02366689|38856|P3|Overall Study|Pregnancy|1
6881|NCT02366689|38857|P2|Overall Study|Pregnancy|1
6882|NCT02366689|38858|P1|Overall Study|Pregnancy|0
6883|NCT02366689|38856|P3|Overall Study|Lost to Follow-up|0
6884|NCT02366689|38857|P2|Overall Study|Lost to Follow-up|2
6885|NCT02366689|38858|P1|Overall Study|Lost to Follow-up|3
6886|NCT02366689|38856|P3|Overall Study|Withdrawal by Subject|1
6887|NCT02366689|38857|P2|Overall Study|Withdrawal by Subject|0
6888|NCT02366689|38858|P1|Overall Study|Withdrawal by Subject|1
6889|NCT02366637|38910|P2|Second Intervention Period|Study Terminated by Sponsor|1
6890|NCT02366637|38911|P1|Second Intervention Period|Study Terminated by Sponsor|1
6891|NCT02366637|38910|P2|First Intervention Period|Study Terminated by Sponsor|4
6892|NCT02366637|38911|P1|First Intervention Period|Study Terminated by Sponsor|6
6893|NCT02366637|38910|P2|First Intervention Period|Adverse Event|1
6894|NCT02366637|38911|P1|First Intervention Period|Adverse Event|0
6895|NCT02365519|38960|P3|Randomized and Treated|Withdrawal by Subject|1
6896|NCT02365519|38961|P2|Randomized and Treated|Withdrawal by Subject|1
6897|NCT02365519|38962|P1|Randomized and Treated|Withdrawal by Subject|0
6898|NCT02365519|38960|P3|Randomized and Treated|Adverse Event|0
6899|NCT02365519|38961|P2|Randomized and Treated|Adverse Event|1
6900|NCT02365519|38962|P1|Randomized and Treated|Adverse Event|0
6901|NCT02365298|38983|P2|Period 2|Protocol Violation|1
6902|NCT02365298|38984|P1|Period 2|Protocol Violation|0
6903|NCT02365298|38983|P2|Period 2|Test Article longer available|1
6904|NCT02365298|38984|P1|Period 2|Test Article longer available|0
6905|NCT02365298|38983|P2|Period 2|Discontinued at request of Sponsor|0
6906|NCT02365298|38984|P1|Period 2|Discontinued at request of Sponsor|1
6907|NCT02365298|38983|P2|Period 2|incorrect Rx dispensed|0
6908|NCT02365298|38984|P1|Period 2|incorrect Rx dispensed|1
6909|NCT02364180|39023|P1|Overall Study|Screen Fail|1
6910|NCT02363478|39036|P1|Overall Study|Adverse Event|4
6911|NCT02363478|39036|P1|Overall Study|Lost to Follow-up|4
6912|NCT02363439|39043|P1|Overall Study|Lack of Efficacy|4
6913|NCT02362412|39056|P2|Treatment Period III|Lost to Follow-up|1
6914|NCT02362412|39057|P1|Treatment Period III|Lost to Follow-up|0
6915|NCT02362360|39091|P2|Period 1|Withdrawal by Subject|1
6916|NCT02362360|39092|P1|Period 1|Withdrawal by Subject|2
6917|NCT02362360|39091|P2|Period 1|Lack of Efficacy|0
6918|NCT02362360|39092|P1|Period 1|Lack of Efficacy|1
6919|NCT02361580|39130|P2|Overall Study|Lost to Follow-up|3
6920|NCT02361580|39131|P1|Overall Study|Lost to Follow-up|6
6921|NCT02360995|39144|P3|Overall Study|Withdrawal by Subject|0
6922|NCT02360995|39145|P2|Overall Study|Withdrawal by Subject|1
6923|NCT02360995|39146|P1|Overall Study|Withdrawal by Subject|0
6924|NCT02360995|39144|P3|Overall Study|Lost to Follow-up|2
6925|NCT02360995|39145|P2|Overall Study|Lost to Follow-up|0
6926|NCT02360995|39146|P1|Overall Study|Lost to Follow-up|2
6927|NCT02360475|39173|P4|Overall Study|Migrated/moved from study area|1
6928|NCT02360475|39174|P3|Overall Study|Migrated/moved from study area|0
6929|NCT02360475|39175|P2|Overall Study|Migrated/moved from study area|0
6930|NCT02360475|39176|P1|Overall Study|Migrated/moved from study area|0
6931|NCT02360475|39173|P4|Overall Study|Withdrawal by Subject|0
6932|NCT02360475|39174|P3|Overall Study|Withdrawal by Subject|2
6933|NCT02360475|39175|P2|Overall Study|Withdrawal by Subject|1
6934|NCT02360475|39176|P1|Overall Study|Withdrawal by Subject|0
6935|NCT02360475|39173|P4|Overall Study|Lost to Follow-up|4
6936|NCT02360475|39174|P3|Overall Study|Lost to Follow-up|6
6937|NCT02360475|39175|P2|Overall Study|Lost to Follow-up|12
6938|NCT02360475|39176|P1|Overall Study|Lost to Follow-up|4
6939|NCT02360228|39237|P3|Overall Study|Unstable symptoms during screening|1
6940|NCT02360228|39238|P2|Overall Study|Unstable symptoms during screening|0
6941|NCT02360228|39239|P1|Overall Study|Unstable symptoms during screening|0
6942|NCT02360228|39237|P3|Overall Study|Self-discontinued medication|0
6943|NCT02360228|39238|P2|Overall Study|Self-discontinued medication|1
6944|NCT02360228|39239|P1|Overall Study|Self-discontinued medication|0
6945|NCT02360228|39237|P3|Overall Study|Withdrawal by Subject|0
6946|NCT02360228|39238|P2|Overall Study|Withdrawal by Subject|0
6947|NCT02360228|39239|P1|Overall Study|Withdrawal by Subject|1
6948|NCT02359903|39344|P2|Overall Study|Adverse Event|2
6949|NCT02359903|39345|P1|Overall Study|Adverse Event|0
6950|NCT02359890|39353|P1|Overall Study|Never treated with study catheter|6
6951|NCT02359890|39353|P1|Overall Study|Not meeting eligibility|4
6952|NCT02359877|39363|P4|Overall Study|Adverse Event|1
6953|NCT02359877|39364|P3|Overall Study|Adverse Event|0
6954|NCT02359877|39365|P2|Overall Study|Adverse Event|0
6955|NCT02359877|39366|P1|Overall Study|Adverse Event|0
6956|NCT02359877|39363|P4|Overall Study|Withdrawal by Subject|2
6957|NCT02359877|39364|P3|Overall Study|Withdrawal by Subject|0
6958|NCT02359877|39365|P2|Overall Study|Withdrawal by Subject|0
6959|NCT02359877|39366|P1|Overall Study|Withdrawal by Subject|1
6960|NCT02359851|39416|P1|Overall Study|Disease progression|1
6961|NCT02359851|39416|P1|Overall Study|Death|1
6962|NCT02359435|39426|P2|Overall Study|Lost to Follow-up|4
6963|NCT02359435|39427|P1|Overall Study|Lost to Follow-up|4
6964|NCT02359045|39487|P2|Overall Study|Adverse Event|1
6965|NCT02359045|39488|P1|Overall Study|Adverse Event|0
6966|NCT02359045|39487|P2|Overall Study|Lost to Follow-up|1
6967|NCT02359045|39488|P1|Overall Study|Lost to Follow-up|1
6968|NCT02359045|39487|P2|Overall Study|Eligibility criteria not fulfilled|1
6969|NCT02359045|39488|P1|Overall Study|Eligibility criteria not fulfilled|3
6970|NCT02358668|39728|P3|Overall Study|Withdrawal by Subject|0
6971|NCT02358668|39729|P2|Overall Study|Withdrawal by Subject|1
6972|NCT02358668|39730|P1|Overall Study|Withdrawal by Subject|0
6973|NCT02358668|39728|P3|Overall Study|Adverse Event|0
6974|NCT02358668|39729|P2|Overall Study|Adverse Event|0
6975|NCT02358668|39730|P1|Overall Study|Adverse Event|2
6976|NCT02358044|39872|P2|Overall Study|Withdrawal by Subject|4
6977|NCT02358044|39873|P1|Overall Study|Withdrawal by Subject|0
6978|NCT02358044|39872|P2|Overall Study|Physician Decision|1
6979|NCT02358044|39873|P1|Overall Study|Physician Decision|0
6980|NCT02358044|39872|P2|Overall Study|Lost to Follow-up|1
6981|NCT02358044|39873|P1|Overall Study|Lost to Follow-up|2
6982|NCT02358044|39872|P2|Overall Study|Adverse Event|1
6983|NCT02358044|39873|P1|Overall Study|Adverse Event|0
6984|NCT02357940|39891|P2|Overall Study|Investigator's judgement|1
6985|NCT02357940|39892|P1|Overall Study|Investigator's judgement|0
6986|NCT02357940|39891|P2|Overall Study|Adverse Event|1
6987|NCT02357940|39892|P1|Overall Study|Adverse Event|0
6988|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
6989|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
6990|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
6991|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
6992|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
6993|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
6994|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
6995|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
6996|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
6997|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
6998|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
6999|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
7000|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7001|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7002|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7003|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7004|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
7005|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7006|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7007|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
7008|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7009|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
7010|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
7011|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7012|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
7013|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
7014|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
7015|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
7016|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
7017|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
7018|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
7019|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
7020|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
7021|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
7022|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
7023|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
7024|NCT02357901|40019|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
7025|NCT02357901|40020|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
7026|NCT02357901|40021|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
7027|NCT02357901|40022|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
7028|NCT02357901|40019|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7029|NCT02357901|40020|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7030|NCT02357901|40021|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7031|NCT02357901|40022|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
7032|NCT02357459|40083|P3|Overall Study|Job Commitments|1
7033|NCT02357459|40084|P2|Overall Study|Job Commitments|0
7034|NCT02357459|40085|P1|Overall Study|Job Commitments|0
7035|NCT02357459|40083|P3|Overall Study|Pre-planned Knee surgery|2
7036|NCT02357459|40084|P2|Overall Study|Pre-planned Knee surgery|0
7037|NCT02357459|40085|P1|Overall Study|Pre-planned Knee surgery|0
7038|NCT02357459|40083|P3|Overall Study|Incarceration|1
7039|NCT02357459|40084|P2|Overall Study|Incarceration|0
7040|NCT02357459|40085|P1|Overall Study|Incarceration|0
7041|NCT02357459|40083|P3|Overall Study|Instruction from PCP|0
7042|NCT02357459|40084|P2|Overall Study|Instruction from PCP|0
7043|NCT02357459|40085|P1|Overall Study|Instruction from PCP|1
7044|NCT02357459|40083|P3|Overall Study|Patient Relocated|0
7045|NCT02357459|40084|P2|Overall Study|Patient Relocated|0
7046|NCT02357459|40085|P1|Overall Study|Patient Relocated|2
7047|NCT02357459|40083|P3|Overall Study|Lack of Efficacy|4
7048|NCT02357459|40084|P2|Overall Study|Lack of Efficacy|4
7049|NCT02357459|40085|P1|Overall Study|Lack of Efficacy|7
7050|NCT02357459|40083|P3|Overall Study|Lost to Follow-up|0
7051|NCT02357459|40084|P2|Overall Study|Lost to Follow-up|3
7052|NCT02357459|40085|P1|Overall Study|Lost to Follow-up|1
7053|NCT02357459|40083|P3|Overall Study|Protocol Violation|0
7054|NCT02357459|40084|P2|Overall Study|Protocol Violation|1
7055|NCT02357459|40085|P1|Overall Study|Protocol Violation|1
7056|NCT02357459|40083|P3|Overall Study|Physician Decision|0
7057|NCT02357459|40084|P2|Overall Study|Physician Decision|2
7058|NCT02357459|40085|P1|Overall Study|Physician Decision|0
7059|NCT02357459|40083|P3|Overall Study|Withdrawal by Subject|3
7060|NCT02357459|40084|P2|Overall Study|Withdrawal by Subject|3
7061|NCT02357459|40085|P1|Overall Study|Withdrawal by Subject|5
7062|NCT02357459|40083|P3|Overall Study|Adverse Event|1
7063|NCT02357459|40084|P2|Overall Study|Adverse Event|1
7064|NCT02357459|40085|P1|Overall Study|Adverse Event|0
7065|NCT02357342|40129|P2|First 6 Months|Death|0
7066|NCT02357342|40130|P1|First 6 Months|Death|2
7067|NCT02356783|40194|P2|Overall Study|Lost to Follow-up|3
7068|NCT02356783|40195|P1|Overall Study|Lost to Follow-up|1
7069|NCT02356588|40205|P2|Overall Study|Protocol Violation|1
7070|NCT02356588|40206|P1|Overall Study|Protocol Violation|0
7071|NCT02356588|40205|P2|Overall Study|Withdrawal by Subject|0
7072|NCT02356588|40206|P1|Overall Study|Withdrawal by Subject|1
7073|NCT02356588|40205|P2|Overall Study|Adverse Event|2
7074|NCT02356588|40206|P1|Overall Study|Adverse Event|0
7075|NCT02356588|40205|P2|Overall Study|Lack of Efficacy|10
7076|NCT02356588|40206|P1|Overall Study|Lack of Efficacy|4
7077|NCT02356562|40240|P2|Overall Study|site closure|0
7078|NCT02356562|40241|P1|Overall Study|site closure|1
7079|NCT02356562|40240|P2|Overall Study|Re-entered treatment in a previous study|0
7080|NCT02356562|40241|P1|Overall Study|Re-entered treatment in a previous study|1
7081|NCT02356562|40240|P2|Overall Study|Withdrawal by Subject|1
7082|NCT02356562|40241|P1|Overall Study|Withdrawal by Subject|0
7083|NCT02355743|40274|P1|Overall Study|Lost to Follow-up|1
7084|NCT02355743|40274|P1|Overall Study|Withdrawal by Subject|1
7085|NCT02355691|40282|P2|Overall Study|Loss of Research Personnel|9
7086|NCT02355691|40283|P1|Overall Study|Loss of Research Personnel|7
7087|NCT02355028|40302|P2|Overall Study|Deemed ineligible after randomization|4
7088|NCT02355028|40303|P1|Overall Study|Deemed ineligible after randomization|8
7089|NCT02355028|40302|P2|Overall Study|Withdrawal by Subject|1
7090|NCT02355028|40303|P1|Overall Study|Withdrawal by Subject|1
7091|NCT02355028|40302|P2|Overall Study|Adverse Event|0
7092|NCT02355028|40303|P1|Overall Study|Adverse Event|2
7093|NCT02354599|40370|P6|Overall Study|Withdrawal by Subject|0
7094|NCT02354599|40371|P5|Overall Study|Withdrawal by Subject|0
7095|NCT02354599|40372|P4|Overall Study|Withdrawal by Subject|0
7096|NCT02354599|40373|P3|Overall Study|Withdrawal by Subject|0
7097|NCT02354599|40374|P2|Overall Study|Withdrawal by Subject|1
7098|NCT02354599|40375|P1|Overall Study|Withdrawal by Subject|1
7099|NCT02354599|40370|P6|Overall Study|Pretreatment Event/Adverse Event|1
7100|NCT02354599|40371|P5|Overall Study|Pretreatment Event/Adverse Event|0
7101|NCT02354599|40372|P4|Overall Study|Pretreatment Event/Adverse Event|0
7102|NCT02354599|40373|P3|Overall Study|Pretreatment Event/Adverse Event|0
7103|NCT02354599|40374|P2|Overall Study|Pretreatment Event/Adverse Event|0
7104|NCT02354599|40375|P1|Overall Study|Pretreatment Event/Adverse Event|0
7105|NCT02353871|40447|P2|Overall Study|Lost to Follow-up|0
7106|NCT02353871|40448|P1|Overall Study|Lost to Follow-up|2
7107|NCT02353871|40447|P2|Overall Study|Consent withdrawn|8
7108|NCT02353871|40448|P1|Overall Study|Consent withdrawn|1
7109|NCT02353871|40447|P2|Overall Study|Protocol deviation|1
7110|NCT02353871|40448|P1|Overall Study|Protocol deviation|0
7111|NCT02353572|40481|P1|Overall Study|Study terminated|2
7112|NCT02353572|40481|P1|Overall Study|Withdrawal by Subject|1
7113|NCT02353468|40485|P1|Overall Study|Study terminated|3
7114|NCT02353442|40491|P2|Overall Study|Withdrawal by Subject|4
7115|NCT02353442|40492|P1|Overall Study|Withdrawal by Subject|3
7116|NCT02352779|40546|P3|Overall Study|No Reason|1
7117|NCT02352779|40547|P2|Overall Study|No Reason|0
7118|NCT02352779|40548|P1|Overall Study|No Reason|0
7119|NCT02352779|40546|P3|Overall Study|Other Medical Reason|1
7120|NCT02352779|40547|P2|Overall Study|Other Medical Reason|0
7121|NCT02352779|40548|P1|Overall Study|Other Medical Reason|0
7122|NCT02352779|40546|P3|Overall Study|Absence of Symptoms|0
7123|NCT02352779|40547|P2|Overall Study|Absence of Symptoms|0
7124|NCT02352779|40548|P1|Overall Study|Absence of Symptoms|1
7125|NCT02352779|40546|P3|Overall Study|Study Related Symptoms|0
7126|NCT02352779|40547|P2|Overall Study|Study Related Symptoms|0
7127|NCT02352779|40548|P1|Overall Study|Study Related Symptoms|1
7128|NCT02352779|40546|P3|Overall Study|Changed Mind|0
7129|NCT02352779|40547|P2|Overall Study|Changed Mind|0
7130|NCT02352779|40548|P1|Overall Study|Changed Mind|1
7131|NCT02352779|40546|P3|Overall Study|Disliked Intervention|0
7132|NCT02352779|40547|P2|Overall Study|Disliked Intervention|0
7133|NCT02352779|40548|P1|Overall Study|Disliked Intervention|1
7134|NCT02352779|40546|P3|Overall Study|Feeling Overwhelmed|0
7135|NCT02352779|40547|P2|Overall Study|Feeling Overwhelmed|0
7136|NCT02352779|40548|P1|Overall Study|Feeling Overwhelmed|1
7137|NCT02352779|40546|P3|Overall Study|Too Many Forms|0
7138|NCT02352779|40547|P2|Overall Study|Too Many Forms|0
7139|NCT02352779|40548|P1|Overall Study|Too Many Forms|2
7140|NCT02352779|40546|P3|Overall Study|Personal Issues|0
7141|NCT02352779|40547|P2|Overall Study|Personal Issues|1
7142|NCT02352779|40548|P1|Overall Study|Personal Issues|1
7143|NCT02351960|40563|P2|Overall Study|Significant Protocol Deviation|5
7144|NCT02351960|40564|P1|Overall Study|Significant Protocol Deviation|0
7145|NCT02351960|40563|P2|Overall Study|Voluntary Withdrawal|4
7146|NCT02351960|40564|P1|Overall Study|Voluntary Withdrawal|5
7147|NCT02351960|40563|P2|Overall Study|Pretreatment Event/Adverse Event|3
7148|NCT02351960|40564|P1|Overall Study|Pretreatment Event/Adverse Event|6
7149|NCT02351934|40585|P2|Follow-Up|2 ERAS Components Noncompliant|4
7150|NCT02351934|40586|P1|Follow-Up|2 ERAS Components Noncompliant|0
7151|NCT02351934|40585|P2|Follow-Up|1 ERAS Component Noncompliant|6
7152|NCT02351934|40586|P1|Follow-Up|1 ERAS Component Noncompliant|0
7153|NCT02351934|40585|P2|Follow-Up|No documentation|0
7154|NCT02351934|40586|P1|Follow-Up|No documentation|2
7155|NCT02351934|40585|P2|Follow-Up|Hypotension|0
7156|NCT02351934|40586|P1|Follow-Up|Hypotension|3
7157|NCT02351934|40585|P2|Follow-Up|Early dismissal|0
7158|NCT02351934|40586|P1|Follow-Up|Early dismissal|3
7159|NCT02351934|40585|P2|Follow-Up|Acute Kidney Injury|0
7160|NCT02351934|40586|P1|Follow-Up|Acute Kidney Injury|1
7161|NCT02351934|40585|P2|Follow-Up|POD weight<pre-op weight|0
7162|NCT02351934|40586|P1|Follow-Up|POD weight<pre-op weight|3
7163|NCT02351934|40585|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
7164|NCT02351934|40586|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
7165|NCT02351934|40585|P2|Allocation|Hypotension preventing administration|0
7166|NCT02351934|40586|P1|Allocation|Hypotension preventing administration|2
7167|NCT02351934|40585|P2|Allocation|POD weight<pre-op weight|0
7168|NCT02351934|40586|P1|Allocation|POD weight<pre-op weight|3
7169|NCT02351817|40602|P2|Period 2|Protocol Violation|0
7170|NCT02351817|40603|P1|Period 2|Protocol Violation|1
7171|NCT02351817|40602|P2|Period 2|Adverse Event|2
7172|NCT02351817|40603|P1|Period 2|Adverse Event|0
7173|NCT02351817|40602|P2|Period 1|Lack of Efficacy|1
7174|NCT02351817|40603|P1|Period 1|Lack of Efficacy|0
7175|NCT02351817|40602|P2|Period 1|Adverse Event|2
7176|NCT02351817|40603|P1|Period 1|Adverse Event|1
7177|NCT02349711|40661|P2|Overall Study|Lost to Follow-up|1
7178|NCT02349711|40662|P1|Overall Study|Lost to Follow-up|1
7179|NCT02349711|40661|P2|Overall Study|Withdrawal by Subject|1
7180|NCT02349711|40662|P1|Overall Study|Withdrawal by Subject|2
7181|NCT02349542|40690|P1|Overall Study|Withdrawal by Subject|5
7182|NCT02349451|40699|P4|Overall Study|Withdrawal by Subject|1
7183|NCT02349451|40700|P3|Overall Study|Withdrawal by Subject|2
7184|NCT02349451|40701|P2|Overall Study|Withdrawal by Subject|1
7185|NCT02349451|40702|P1|Overall Study|Withdrawal by Subject|0
7186|NCT02349360|40751|P2|Overall Study|Withdrawal by Subject|1
7187|NCT02349360|40752|P1|Overall Study|Withdrawal by Subject|0
7188|NCT02349295|40763|P5|IR (Week 16-24)|Lack of Efficacy|1
7189|NCT02349295|40764|P4|IR (Week 16-24)|Lack of Efficacy|0
7190|NCT02349295|40765|P3|IR (Week 16-24)|Lack of Efficacy|0
7191|NCT02349295|40766|P2|IR (Week 16-24)|Lack of Efficacy|0
7192|NCT02349295|40767|P1|IR (Week 16-24)|Lack of Efficacy|0
7193|NCT02349295|40763|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7194|NCT02349295|40764|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7195|NCT02349295|40765|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7196|NCT02349295|40766|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7197|NCT02349295|40767|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7198|NCT02349295|40763|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7199|NCT02349295|40764|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7200|NCT02349295|40765|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7201|NCT02349295|40766|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7202|NCT02349295|40767|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
7203|NCT02349295|40763|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7204|NCT02349295|40764|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7205|NCT02349295|40765|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7206|NCT02349295|40766|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7207|NCT02349295|40767|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
7208|NCT02349295|40763|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7209|NCT02349295|40764|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7210|NCT02349295|40765|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
7211|NCT02349295|40766|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
7212|NCT02349295|40767|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
7213|NCT02349295|40763|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
7214|NCT02349295|40764|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
7215|NCT02349295|40765|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
7216|NCT02349295|40766|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
7217|NCT02349295|40767|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
7218|NCT02349048|40870|P2|Overall Study|Lost to Follow-up|0
7219|NCT02349048|40871|P1|Overall Study|Lost to Follow-up|1
7220|NCT02349048|40870|P2|Overall Study|Withdrawal by Subject|0
7221|NCT02349048|40871|P1|Overall Study|Withdrawal by Subject|4
7222|NCT02348723|40893|P2|Overall Study|Adverse Event|1
7223|NCT02348723|40894|P1|Overall Study|Adverse Event|3
7224|NCT02348723|40893|P2|Overall Study|Reason other than specified|1
7225|NCT02348723|40894|P1|Overall Study|Reason other than specified|1
7226|NCT02348723|40893|P2|Overall Study|Consent withdrawn|3
7227|NCT02348723|40894|P1|Overall Study|Consent withdrawn|1
7228|NCT02348723|40893|P2|Overall Study|Lost to Follow-up|1
7229|NCT02348723|40894|P1|Overall Study|Lost to Follow-up|1
7230|NCT02348723|40893|P2|Overall Study|Non-compliant with Protocol|0
7231|NCT02348723|40894|P1|Overall Study|Non-compliant with Protocol|1
7232|NCT02348723|40893|P2|Overall Study|No ablation|20
7233|NCT02348723|40894|P1|Overall Study|No ablation|21
7234|NCT02347774|40944|P3|On Study Treatment|ranomized in error|1
7235|NCT02347774|40945|P2|On Study Treatment|ranomized in error|0
7236|NCT02347774|40946|P1|On Study Treatment|ranomized in error|0
7237|NCT02347774|40944|P3|On Study Treatment|Met Prolonged QT criteria|0
7238|NCT02347774|40945|P2|On Study Treatment|Met Prolonged QT criteria|0
7239|NCT02347774|40946|P1|On Study Treatment|Met Prolonged QT criteria|1
7240|NCT02347774|40944|P3|On Study Treatment|Lost to Follow-up|1
7241|NCT02347774|40945|P2|On Study Treatment|Lost to Follow-up|6
7242|NCT02347774|40946|P1|On Study Treatment|Lost to Follow-up|2
7243|NCT02347774|40944|P3|On Study Treatment|withdrew consent|12
7244|NCT02347774|40945|P2|On Study Treatment|withdrew consent|8
7245|NCT02347774|40946|P1|On Study Treatment|withdrew consent|9
7246|NCT02347774|40944|P3|On Study Treatment|Protocol Violation|1
7247|NCT02347774|40945|P2|On Study Treatment|Protocol Violation|0
7248|NCT02347774|40946|P1|On Study Treatment|Protocol Violation|0
7249|NCT02347774|40944|P3|On Study Treatment|non-complicance with study medication|0
7250|NCT02347774|40945|P2|On Study Treatment|non-complicance with study medication|2
7251|NCT02347774|40946|P1|On Study Treatment|non-complicance with study medication|0
7252|NCT02347774|40944|P3|On Study Treatment|Lack of Efficacy|2
7253|NCT02347774|40945|P2|On Study Treatment|Lack of Efficacy|0
7254|NCT02347774|40946|P1|On Study Treatment|Lack of Efficacy|3
7255|NCT02347774|40944|P3|On Study Treatment|Adverse Event|19
7256|NCT02347774|40945|P2|On Study Treatment|Adverse Event|15
7257|NCT02347774|40946|P1|On Study Treatment|Adverse Event|9
7258|NCT02347774|40944|P3|Study Participation|randomized in error|1
7259|NCT02347774|40945|P2|Study Participation|randomized in error|0
7260|NCT02347774|40946|P1|Study Participation|randomized in error|0
7261|NCT02347774|40944|P3|Study Participation|incarceration|0
7262|NCT02347774|40945|P2|Study Participation|incarceration|0
7263|NCT02347774|40946|P1|Study Participation|incarceration|1
7264|NCT02347774|40944|P3|Study Participation|non-compliance with study drug|0
7265|NCT02347774|40945|P2|Study Participation|non-compliance with study drug|1
7266|NCT02347774|40946|P1|Study Participation|non-compliance with study drug|0
7267|NCT02347774|40944|P3|Study Participation|Met Prolonged QT criteria|0
7268|NCT02347774|40945|P2|Study Participation|Met Prolonged QT criteria|0
7269|NCT02347774|40946|P1|Study Participation|Met Prolonged QT criteria|1
7270|NCT02347774|40944|P3|Study Participation|withdrew consent|1
7271|NCT02347774|40945|P2|Study Participation|withdrew consent|1
7272|NCT02347774|40946|P1|Study Participation|withdrew consent|1
7273|NCT02347774|40944|P3|Study Participation|Adverse Event|6
7274|NCT02347774|40945|P2|Study Participation|Adverse Event|4
7275|NCT02347774|40946|P1|Study Participation|Adverse Event|1
7276|NCT02347774|40944|P3|Study Participation|Withdrawal by Subject|15
7277|NCT02347774|40945|P2|Study Participation|Withdrawal by Subject|9
7278|NCT02347774|40946|P1|Study Participation|Withdrawal by Subject|8
7279|NCT02347774|40944|P3|Study Participation|Lost to Follow-up|2
7280|NCT02347774|40945|P2|Study Participation|Lost to Follow-up|6
7281|NCT02347774|40946|P1|Study Participation|Lost to Follow-up|3
7282|NCT02347761|41002|P3|On Study Treatment|Adverse Event|20
7283|NCT02347761|41003|P2|On Study Treatment|Adverse Event|8
7284|NCT02347761|41004|P1|On Study Treatment|Adverse Event|10
7285|NCT02347761|41002|P3|On Study Treatment|durg not working|1
7286|NCT02347761|41003|P2|On Study Treatment|durg not working|1
7287|NCT02347761|41004|P1|On Study Treatment|durg not working|0
7288|NCT02347761|41002|P3|On Study Treatment|investigator discretion|0
7289|NCT02347761|41003|P2|On Study Treatment|investigator discretion|0
7290|NCT02347761|41004|P1|On Study Treatment|investigator discretion|2
7291|NCT02347761|41002|P3|On Study Treatment|Lost to Follow-up|1
7292|NCT02347761|41003|P2|On Study Treatment|Lost to Follow-up|1
7293|NCT02347761|41004|P1|On Study Treatment|Lost to Follow-up|2
7294|NCT02347761|41002|P3|On Study Treatment|dissastisfaction with device|4
7295|NCT02347761|41003|P2|On Study Treatment|dissastisfaction with device|1
7296|NCT02347761|41004|P1|On Study Treatment|dissastisfaction with device|2
7297|NCT02347761|41002|P3|On Study Treatment|move/travel|5
7298|NCT02347761|41003|P2|On Study Treatment|move/travel|6
7299|NCT02347761|41004|P1|On Study Treatment|move/travel|2
7300|NCT02347761|41002|P3|On Study Treatment|Withdrawal by Subject|5
7301|NCT02347761|41003|P2|On Study Treatment|Withdrawal by Subject|3
7302|NCT02347761|41004|P1|On Study Treatment|Withdrawal by Subject|7
7303|NCT02347761|41002|P3|On Study Treatment|non-compliance with study medication|2
7304|NCT02347761|41003|P2|On Study Treatment|non-compliance with study medication|0
7305|NCT02347761|41004|P1|On Study Treatment|non-compliance with study medication|0
7306|NCT02347761|41002|P3|On Study Treatment|Lack of Efficacy|4
7307|NCT02347761|41003|P2|On Study Treatment|Lack of Efficacy|3
7308|NCT02347761|41004|P1|On Study Treatment|Lack of Efficacy|2
7309|NCT02347761|41002|P3|All Collected|moved/travel|0
7310|NCT02347761|41003|P2|All Collected|moved/travel|1
7311|NCT02347761|41004|P1|All Collected|moved/travel|0
7312|NCT02347761|41002|P3|All Collected|exacerbation of COPD|1
7313|NCT02347761|41003|P2|All Collected|exacerbation of COPD|0
7314|NCT02347761|41004|P1|All Collected|exacerbation of COPD|0
7315|NCT02347761|41002|P3|All Collected|instillation site pain|1
7316|NCT02347761|41003|P2|All Collected|instillation site pain|0
7317|NCT02347761|41004|P1|All Collected|instillation site pain|0
7318|NCT02347761|41002|P3|All Collected|invetigator disretion|0
7319|NCT02347761|41003|P2|All Collected|invetigator disretion|0
7320|NCT02347761|41004|P1|All Collected|invetigator disretion|2
7321|NCT02347761|41002|P3|All Collected|Withdrawal by Subject|22
7322|NCT02347761|41003|P2|All Collected|Withdrawal by Subject|11
7323|NCT02347761|41004|P1|All Collected|Withdrawal by Subject|11
7324|NCT02347761|41002|P3|All Collected|Lost to Follow-up|3
7325|NCT02347761|41003|P2|All Collected|Lost to Follow-up|2
7326|NCT02347761|41004|P1|All Collected|Lost to Follow-up|3
7327|NCT02347761|41002|P3|All Collected|Death|0
7328|NCT02347761|41003|P2|All Collected|Death|0
7329|NCT02347761|41004|P1|All Collected|Death|1
7330|NCT02347189|41095|P1|Overall Study|No primary outcome data available|2
7331|NCT02347189|41095|P1|Overall Study|No implant attempted of study device|9
7332|NCT02347176|41103|P4|Overall Study|Other|0
7333|NCT02347176|41104|P3|Overall Study|Other|2
7334|NCT02347176|41105|P2|Overall Study|Other|2
7335|NCT02347176|41106|P1|Overall Study|Other|1
7336|NCT02347176|41103|P4|Overall Study|Withdrawal by Subject|3
7337|NCT02347176|41104|P3|Overall Study|Withdrawal by Subject|5
7338|NCT02347176|41105|P2|Overall Study|Withdrawal by Subject|5
7339|NCT02347176|41106|P1|Overall Study|Withdrawal by Subject|9
7340|NCT02347176|41103|P4|Overall Study|Lost to Follow-up|1
7341|NCT02347176|41104|P3|Overall Study|Lost to Follow-up|1
7342|NCT02347176|41105|P2|Overall Study|Lost to Follow-up|3
7343|NCT02347176|41106|P1|Overall Study|Lost to Follow-up|2
7344|NCT02347085|41189|P1|Overall Study|Protocol Criteria|2
7345|NCT02347085|41189|P1|Overall Study|Lost to Follow-up|1
7346|NCT02347085|41189|P1|Overall Study|Withdrawal by Subject|4
7347|NCT02347085|41189|P1|Overall Study|Lack of Efficacy|1
7348|NCT02347085|41189|P1|Overall Study|Adverse Event|2
7349|NCT02347072|41211|P1|Overall Study|Disc due to Protocol-specified Criteria|6
7350|NCT02347072|41211|P1|Overall Study|Protocol Violation|1
7351|NCT02347072|41211|P1|Overall Study|Lost to Follow-up|2
7352|NCT02347072|41211|P1|Overall Study|Physician Decision|1
7353|NCT02347072|41211|P1|Overall Study|Withdrawal by Subject|6
7354|NCT02347072|41211|P1|Overall Study|Adverse Event|2
7355|NCT02346877|41245|P2|Overall Study|Missing|0
7356|NCT02346877|41246|P1|Overall Study|Missing|5
7357|NCT02346877|41245|P2|Overall Study|Sponsor Decision|0
7358|NCT02346877|41246|P1|Overall Study|Sponsor Decision|12
7359|NCT02346877|41245|P2|Overall Study|Administrative Decision|0
7360|NCT02346877|41246|P1|Overall Study|Administrative Decision|1
7361|NCT02346877|41245|P2|Overall Study|Adverse Event|0
7362|NCT02346877|41246|P1|Overall Study|Adverse Event|1
7363|NCT02346721|41256|P1|Overall Study|Lack of Efficacy|1
7364|NCT02346721|41256|P1|Overall Study|Withdrew Consent|3
7365|NCT02345330|41291|P1|Overall Study|Progressive Disease|2
7366|NCT02345330|41291|P1|Overall Study|Death|1
7367|NCT02345252|41303|P2|Overall Study|Still in Study up to the Data Cut Date|300
7368|NCT02345252|41304|P1|Overall Study|Still in Study up to the Data Cut Date|304
7369|NCT02345252|41303|P2|Overall Study|Randomized but Never Treated|2
7370|NCT02345252|41304|P1|Overall Study|Randomized but Never Treated|0
7371|NCT02345252|41303|P2|Overall Study|Lost to Follow-up|3
7372|NCT02345252|41304|P1|Overall Study|Lost to Follow-up|2
7373|NCT02345252|41303|P2|Overall Study|Withdrew Consent|9
7374|NCT02345252|41304|P1|Overall Study|Withdrew Consent|7
7375|NCT02345252|41303|P2|Overall Study|Protocol Violation|0
7376|NCT02345252|41304|P1|Overall Study|Protocol Violation|1
7377|NCT02345252|41303|P2|Overall Study|Investigator's Discretion|1
7378|NCT02345252|41304|P1|Overall Study|Investigator's Discretion|0
7379|NCT02345252|41303|P2|Overall Study|Death|1
7380|NCT02345252|41304|P1|Overall Study|Death|1
7381|NCT02345252|41303|P2|Overall Study|Adverse Event|0
7382|NCT02345252|41304|P1|Overall Study|Adverse Event|1
7383|NCT02345226|41320|P2|Overall Study|Still in Study up to the Data Cut Date|409
7384|NCT02345226|41321|P1|Overall Study|Still in Study up to the Data Cut Date|405
7385|NCT02345226|41320|P2|Overall Study|Randomized but Never Treated|4
7386|NCT02345226|41321|P1|Overall Study|Randomized but Never Treated|2
7387|NCT02345226|41320|P2|Overall Study|Lost to Follow-up|6
7388|NCT02345226|41321|P1|Overall Study|Lost to Follow-up|7
7389|NCT02345226|41320|P2|Overall Study|Withdrew Consent|16
7390|NCT02345226|41321|P1|Overall Study|Withdrew Consent|18
7391|NCT02345226|41320|P2|Overall Study|Non-Compliance with Study Drug|0
7392|NCT02345226|41321|P1|Overall Study|Non-Compliance with Study Drug|1
7393|NCT02345226|41320|P2|Overall Study|Investigator's Discretion|1
7394|NCT02345226|41321|P1|Overall Study|Investigator's Discretion|3
7395|NCT02345226|41320|P2|Overall Study|Lack of Efficacy|0
7396|NCT02345226|41321|P1|Overall Study|Lack of Efficacy|1
7397|NCT02345226|41320|P2|Overall Study|Pregnancy|1
7398|NCT02345226|41321|P1|Overall Study|Pregnancy|0
7399|NCT02345226|41320|P2|Overall Study|Death|0
7400|NCT02345226|41321|P1|Overall Study|Death|1
7401|NCT02345226|41320|P2|Overall Study|Adverse Event|4
7402|NCT02345226|41321|P1|Overall Study|Adverse Event|2
7403|NCT02344745|41354|P2|Overall Study|Data collection sheets were lost|0
7404|NCT02344745|41355|P1|Overall Study|Data collection sheets were lost|2
7405|NCT02344342|41387|P4|Overall Study|Industry partner dropped out|10
7406|NCT02344342|41388|P3|Overall Study|Industry partner dropped out|14
7407|NCT02344342|41389|P2|Overall Study|Industry partner dropped out|9
7408|NCT02344342|41390|P1|Overall Study|Industry partner dropped out|11
7409|NCT02343159|41445|P3|Overall Study|Enrollment Error|0
7410|NCT02343159|41446|P2|Overall Study|Enrollment Error|0
7411|NCT02343159|41447|P1|Overall Study|Enrollment Error|1
7412|NCT02343159|41445|P3|Overall Study|Sponsor Decision|0
7413|NCT02343159|41446|P2|Overall Study|Sponsor Decision|1
7414|NCT02343159|41447|P1|Overall Study|Sponsor Decision|0
7415|NCT02343159|41445|P3|Overall Study|Adverse Event|2
7416|NCT02343159|41446|P2|Overall Study|Adverse Event|4
7417|NCT02343159|41447|P1|Overall Study|Adverse Event|4
7418|NCT02343159|41445|P3|Overall Study|Lost to Follow-up|2
7419|NCT02343159|41446|P2|Overall Study|Lost to Follow-up|2
7420|NCT02343159|41447|P1|Overall Study|Lost to Follow-up|0
7421|NCT02343159|41445|P3|Overall Study|Withdrawal by Subject|2
7422|NCT02343159|41446|P2|Overall Study|Withdrawal by Subject|0
7423|NCT02343159|41447|P1|Overall Study|Withdrawal by Subject|3
7424|NCT02343159|41445|P3|Overall Study|Physician Decision|1
7425|NCT02343159|41446|P2|Overall Study|Physician Decision|0
7426|NCT02343159|41447|P1|Overall Study|Physician Decision|2
7427|NCT02343159|41445|P3|Overall Study|Early Study Termination|23
7428|NCT02343159|41446|P2|Overall Study|Early Study Termination|19
7429|NCT02343159|41447|P1|Overall Study|Early Study Termination|16
7430|NCT02343003|41491|P2|Overall Study|terminated by sponsor|0
7431|NCT02343003|41492|P1|Overall Study|terminated by sponsor|2
7432|NCT02343003|41491|P2|Overall Study|exclusion criteria met|1
7433|NCT02343003|41492|P1|Overall Study|exclusion criteria met|1
7434|NCT02343003|41491|P2|Overall Study|Death|1
7435|NCT02343003|41492|P1|Overall Study|Death|0
7436|NCT02343003|41491|P2|Overall Study|Protocol Violation|0
7437|NCT02343003|41492|P1|Overall Study|Protocol Violation|1
7438|NCT02343003|41491|P2|Overall Study|Lost to Follow-up|1
7439|NCT02343003|41492|P1|Overall Study|Lost to Follow-up|5
7440|NCT02343003|41491|P2|Overall Study|Withdrawal by Subject|4
7441|NCT02343003|41492|P1|Overall Study|Withdrawal by Subject|9
7442|NCT02342704|41510|P2|Overall Study|Adverse Event|3
7443|NCT02342704|41511|P1|Overall Study|Adverse Event|1
7444|NCT02342704|41510|P2|Overall Study|Lost to Follow-up|1
7445|NCT02342704|41511|P1|Overall Study|Lost to Follow-up|2
7446|NCT02342704|41510|P2|Overall Study|Withdrawal by Subject|0
7447|NCT02342704|41511|P1|Overall Study|Withdrawal by Subject|1
7448|NCT02342704|41510|P2|Overall Study|Not Specified|1
7449|NCT02342704|41511|P1|Overall Study|Not Specified|0
7450|NCT02342704|41510|P2|Overall Study|Sponsor Termination|43
7451|NCT02342704|41511|P1|Overall Study|Sponsor Termination|49
7452|NCT02342704|41510|P2|Overall Study|Physician Decision|3
7453|NCT02342704|41511|P1|Overall Study|Physician Decision|0
7454|NCT02342548|41548|P3|Overall Study|Other|1
7455|NCT02342548|41549|P2|Overall Study|Other|1
7456|NCT02342548|41550|P1|Overall Study|Other|1
7457|NCT02342548|41548|P3|Overall Study|Withdrawal by Subject|4
7458|NCT02342548|41549|P2|Overall Study|Withdrawal by Subject|3
7459|NCT02342548|41550|P1|Overall Study|Withdrawal by Subject|1
7460|NCT02342548|41548|P3|Overall Study|Protocol Violation|0
7461|NCT02342548|41549|P2|Overall Study|Protocol Violation|1
7462|NCT02342548|41550|P1|Overall Study|Protocol Violation|0
7463|NCT02342548|41548|P3|Overall Study|Study terminated by sponsor|25
7464|NCT02342548|41549|P2|Overall Study|Study terminated by sponsor|39
7465|NCT02342548|41550|P1|Overall Study|Study terminated by sponsor|20
7466|NCT02342548|41548|P3|Overall Study|Lost to Follow-up|0
7467|NCT02342548|41549|P2|Overall Study|Lost to Follow-up|1
7468|NCT02342548|41550|P1|Overall Study|Lost to Follow-up|0
7469|NCT02342548|41548|P3|Overall Study|Adverse Event|13
7470|NCT02342548|41549|P2|Overall Study|Adverse Event|17
7471|NCT02342548|41550|P1|Overall Study|Adverse Event|12
7472|NCT02342418|41594|P2|Overall Study|Adverse Event|1
7473|NCT02342418|41595|P1|Overall Study|Adverse Event|0
7474|NCT02342288|41605|P2|Overall Study|coordinator not available|2
7475|NCT02342288|41606|P1|Overall Study|coordinator not available|0
7476|NCT02342288|41605|P2|Overall Study|subject cannot tolerate numbing drops|1
7477|NCT02342288|41606|P1|Overall Study|subject cannot tolerate numbing drops|0
7478|NCT02342288|41605|P2|Overall Study|coordinator contaminated with blood|1
7479|NCT02342288|41606|P1|Overall Study|coordinator contaminated with blood|0
7480|NCT02342288|41605|P2|Overall Study|Withdrawal by Subject|0
7481|NCT02342288|41606|P1|Overall Study|Withdrawal by Subject|1
7482|NCT02342288|41605|P2|Overall Study|anesthesia leak in system|0
7483|NCT02342288|41606|P1|Overall Study|anesthesia leak in system|1
7484|NCT02342288|41605|P2|Overall Study|no protocol anesthesiologist available|2
7485|NCT02342288|41606|P1|Overall Study|no protocol anesthesiologist available|3
7486|NCT02342223|41612|P1|Overall Study|Lost to Follow-up|1
7487|NCT02341482|41784|P1|Overall Study|Adverse Event|1
7488|NCT02341417|41813|P3|Overall Study|Death|1
7489|NCT02341417|41814|P2|Overall Study|Death|0
7490|NCT02341417|41815|P1|Overall Study|Death|0
7491|NCT02341417|41813|P3|Overall Study|Decision by sponsor|0
7492|NCT02341417|41814|P2|Overall Study|Decision by sponsor|0
7493|NCT02341417|41815|P1|Overall Study|Decision by sponsor|2
7494|NCT02341417|41813|P3|Overall Study|Withdrawal by Subject|0
7495|NCT02341417|41814|P2|Overall Study|Withdrawal by Subject|2
7496|NCT02341417|41815|P1|Overall Study|Withdrawal by Subject|0
7497|NCT02340000|41921|P2|Time Period 2|Lost to Follow-up|8
7498|NCT02340000|41922|P1|Time Period 2|Lost to Follow-up|10
7499|NCT02340000|41921|P2|Time Period 2|Withdrawal by Subject|7
7500|NCT02340000|41922|P1|Time Period 2|Withdrawal by Subject|9
7501|NCT02340000|41921|P2|Time Period 1|Lost to Follow-up|7
7502|NCT02340000|41922|P1|Time Period 1|Lost to Follow-up|6
7503|NCT02340000|41921|P2|Time Period 1|Withdrawal by Subject|8
7504|NCT02340000|41922|P1|Time Period 1|Withdrawal by Subject|6
7505|NCT02339584|41976|P2|Overall Study|Withdrawal by Subject|4
7506|NCT02339584|41977|P1|Overall Study|Withdrawal by Subject|2
7507|NCT02339584|41976|P2|Overall Study|Protocol Violation|1
7508|NCT02339584|41977|P1|Overall Study|Protocol Violation|1
7509|NCT02339584|41976|P2|Overall Study|Physician Decision|2
7510|NCT02339584|41977|P1|Overall Study|Physician Decision|1
7511|NCT02339584|41976|P2|Overall Study|Lack of Efficacy|1
7512|NCT02339584|41977|P1|Overall Study|Lack of Efficacy|0
7513|NCT02339584|41976|P2|Overall Study|Adverse Event|7
7514|NCT02339584|41977|P1|Overall Study|Adverse Event|11
7515|NCT02339506|41983|P2|Washout (Period 2)|Withdrawal by Subject|0
7516|NCT02339506|41984|P1|Washout (Period 2)|Withdrawal by Subject|2
7517|NCT02339506|41983|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
7518|NCT02339506|41984|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
7519|NCT02339155|42015|P2|Overall Study|Withdrawal by Subject|4
7520|NCT02339155|42016|P1|Overall Study|Withdrawal by Subject|4
7521|NCT02339155|42015|P2|Overall Study|Physician Decision|1
7522|NCT02339155|42016|P1|Overall Study|Physician Decision|2
7523|NCT02339155|42015|P2|Overall Study|Lost to Follow-up|9
7524|NCT02339155|42016|P1|Overall Study|Lost to Follow-up|8
7525|NCT02339155|42015|P2|Overall Study|Death|1
7526|NCT02339155|42016|P1|Overall Study|Death|1
7527|NCT02339155|42015|P2|Overall Study|Adverse Event|6
7528|NCT02339155|42016|P1|Overall Study|Adverse Event|0
7529|NCT02338843|42048|P2|Overall Study|Discontinued prior to randomizat|0
7530|NCT02338843|42049|P1|Overall Study|Discontinued prior to randomizat|1
7531|NCT02338843|42048|P2|Overall Study|Subject Recovered|2
7532|NCT02338843|42049|P1|Overall Study|Subject Recovered|0
7533|NCT02338843|42048|P2|Overall Study|Withdrawal by Subject|2
7534|NCT02338843|42049|P1|Overall Study|Withdrawal by Subject|0
7535|NCT02338843|42048|P2|Overall Study|Physician Decision|0
7536|NCT02338843|42049|P1|Overall Study|Physician Decision|1
7537|NCT02338843|42048|P2|Overall Study|Death|53
7538|NCT02338843|42049|P1|Overall Study|Death|40
7539|NCT02338843|42048|P2|Overall Study|Adverse Event|1
7540|NCT02338843|42049|P1|Overall Study|Adverse Event|2
7541|NCT02338492|42077|P1|Overall Study|Reason not captured above|6
7542|NCT02338492|42077|P1|Overall Study|Lost to Follow-up|4
7543|NCT02338492|42077|P1|Overall Study|Adverse Event|3
7544|NCT02338492|42077|P1|Overall Study|Death|32
7545|NCT02337491|42134|P2|Overall Study|On Treatment|0
7546|NCT02337491|42135|P1|Overall Study|On Treatment|2
7547|NCT02337491|42134|P2|Overall Study|Progressive Disease|28
7548|NCT02337491|42135|P1|Overall Study|Progressive Disease|44
7549|NCT02337491|42134|P2|Overall Study|Withdrawal by Subject|0
7550|NCT02337491|42135|P1|Overall Study|Withdrawal by Subject|3
7551|NCT02337491|42134|P2|Overall Study|Adverse Event|1
7552|NCT02337491|42135|P1|Overall Study|Adverse Event|0
7553|NCT02337491|42134|P2|Overall Study|Death|1
7554|NCT02337491|42135|P1|Overall Study|Death|1
7555|NCT02336607|42183|P4|Overall Study|Withdrawal by Subject|20
7556|NCT02336607|42184|P3|Overall Study|Withdrawal by Subject|0
7557|NCT02336607|42185|P2|Overall Study|Withdrawal by Subject|2
7558|NCT02336607|42186|P1|Overall Study|Withdrawal by Subject|0
7559|NCT02336607|42183|P4|Overall Study|Adverse Event|26
7560|NCT02336607|42184|P3|Overall Study|Adverse Event|2
7561|NCT02336607|42185|P2|Overall Study|Adverse Event|2
7562|NCT02336607|42186|P1|Overall Study|Adverse Event|0
7563|NCT02336607|42183|P4|Overall Study|Protocol Violation|3
7564|NCT02336607|42184|P3|Overall Study|Protocol Violation|1
7565|NCT02336607|42185|P2|Overall Study|Protocol Violation|1
7566|NCT02336607|42186|P1|Overall Study|Protocol Violation|0
7567|NCT02336607|42183|P4|Overall Study|Lost to Follow-up|21
7568|NCT02336607|42184|P3|Overall Study|Lost to Follow-up|0
7569|NCT02336607|42185|P2|Overall Study|Lost to Follow-up|1
7570|NCT02336607|42186|P1|Overall Study|Lost to Follow-up|2
7571|NCT02336607|42183|P4|Overall Study|Lack of Efficacy|2
7572|NCT02336607|42184|P3|Overall Study|Lack of Efficacy|0
7573|NCT02336607|42185|P2|Overall Study|Lack of Efficacy|0
7574|NCT02336607|42186|P1|Overall Study|Lack of Efficacy|1
7575|NCT02336607|42183|P4|Overall Study|Physician Decision|15
7576|NCT02336607|42184|P3|Overall Study|Physician Decision|3
7577|NCT02336607|42185|P2|Overall Study|Physician Decision|4
7578|NCT02336607|42186|P1|Overall Study|Physician Decision|1
7579|NCT02336425|42300|P4|Overall Study|Study terminated.|3
7580|NCT02336425|42301|P3|Overall Study|Study terminated.|3
7581|NCT02336425|42302|P2|Overall Study|Study terminated.|2
7582|NCT02336425|42303|P1|Overall Study|Study terminated.|2
7583|NCT02336178|42353|P1|Overall Study|Other|1
7584|NCT02336178|42353|P1|Overall Study|Withdrawal by Subject|1
7585|NCT02336178|42353|P1|Overall Study|Protocol Violation|1
7586|NCT02336178|42353|P1|Overall Study|Lost to Follow-up|1
7587|NCT02335489|42467|P1|Overall Study|Lack of Efficacy|1
7588|NCT02335489|42467|P1|Overall Study|Physician Decision|2
7589|NCT02335489|42467|P1|Overall Study|Withdrawal by Subject|2
7590|NCT02335489|42467|P1|Overall Study|Lost to Follow-up|1
7591|NCT02335489|42467|P1|Overall Study|Sponsor terminated study|4
7592|NCT02335346|42471|P1|Overall Study|Withdrawal by Subject|1
7593|NCT02335346|42471|P1|Overall Study|Adverse Event|11
7594|NCT02332889|42782|P1|Overall Study|Physician Decision|1
7595|NCT02332798|42789|P3|Overall Study|Abnormal laboratory findings|0
7596|NCT02332798|42790|P2|Overall Study|Abnormal laboratory findings|0
7597|NCT02332798|42791|P1|Overall Study|Abnormal laboratory findings|1
7598|NCT02332798|42789|P3|Overall Study|Positive urine drug test|0
7599|NCT02332798|42790|P2|Overall Study|Positive urine drug test|1
7600|NCT02332798|42791|P1|Overall Study|Positive urine drug test|0
7601|NCT02332798|42789|P3|Overall Study|Unwilling to participate in study|1
7602|NCT02332798|42790|P2|Overall Study|Unwilling to participate in study|1
7603|NCT02332798|42791|P1|Overall Study|Unwilling to participate in study|0
7604|NCT02332707|42859|P18|Overall Study|Withdrawal by Subject|0
7605|NCT02332707|42860|P17|Overall Study|Withdrawal by Subject|0
7606|NCT02332707|42861|P16|Overall Study|Withdrawal by Subject|0
7607|NCT02332707|42862|P15|Overall Study|Withdrawal by Subject|0
7608|NCT02332707|42863|P14|Overall Study|Withdrawal by Subject|0
7609|NCT02332707|42864|P13|Overall Study|Withdrawal by Subject|0
7610|NCT02332707|42865|P12|Overall Study|Withdrawal by Subject|0
7611|NCT02332707|42866|P11|Overall Study|Withdrawal by Subject|0
7612|NCT02332707|42867|P10|Overall Study|Withdrawal by Subject|3
7613|NCT02332707|42868|P9|Overall Study|Withdrawal by Subject|0
7614|NCT02332707|42869|P8|Overall Study|Withdrawal by Subject|0
7615|NCT02332707|42870|P7|Overall Study|Withdrawal by Subject|0
7616|NCT02332707|42871|P6|Overall Study|Withdrawal by Subject|0
7617|NCT02332707|42872|P5|Overall Study|Withdrawal by Subject|0
7618|NCT02332707|42873|P4|Overall Study|Withdrawal by Subject|0
7619|NCT02332707|42874|P3|Overall Study|Withdrawal by Subject|1
7620|NCT02332707|42875|P2|Overall Study|Withdrawal by Subject|0
7621|NCT02332707|42876|P1|Overall Study|Withdrawal by Subject|0
7622|NCT02332707|42859|P18|Overall Study|Physician Decision|0
7623|NCT02332707|42860|P17|Overall Study|Physician Decision|0
7624|NCT02332707|42861|P16|Overall Study|Physician Decision|0
7625|NCT02332707|42862|P15|Overall Study|Physician Decision|0
7626|NCT02332707|42863|P14|Overall Study|Physician Decision|0
7627|NCT02332707|42864|P13|Overall Study|Physician Decision|1
7628|NCT02332707|42865|P12|Overall Study|Physician Decision|0
7629|NCT02332707|42866|P11|Overall Study|Physician Decision|0
7630|NCT02332707|42867|P10|Overall Study|Physician Decision|0
7631|NCT02332707|42868|P9|Overall Study|Physician Decision|0
7632|NCT02332707|42869|P8|Overall Study|Physician Decision|0
7633|NCT02332707|42870|P7|Overall Study|Physician Decision|0
7634|NCT02332707|42871|P6|Overall Study|Physician Decision|0
7635|NCT02332707|42872|P5|Overall Study|Physician Decision|0
7636|NCT02332707|42873|P4|Overall Study|Physician Decision|1
7637|NCT02332707|42874|P3|Overall Study|Physician Decision|0
7638|NCT02332707|42875|P2|Overall Study|Physician Decision|0
7639|NCT02332707|42876|P1|Overall Study|Physician Decision|0
7640|NCT02332707|42859|P18|Overall Study|Lost to Follow-up|0
7641|NCT02332707|42860|P17|Overall Study|Lost to Follow-up|0
7642|NCT02332707|42861|P16|Overall Study|Lost to Follow-up|0
7643|NCT02332707|42862|P15|Overall Study|Lost to Follow-up|0
7644|NCT02332707|42863|P14|Overall Study|Lost to Follow-up|0
7645|NCT02332707|42864|P13|Overall Study|Lost to Follow-up|3
7646|NCT02332707|42865|P12|Overall Study|Lost to Follow-up|0
7647|NCT02332707|42866|P11|Overall Study|Lost to Follow-up|2
7648|NCT02332707|42867|P10|Overall Study|Lost to Follow-up|0
7649|NCT02332707|42868|P9|Overall Study|Lost to Follow-up|0
7650|NCT02332707|42869|P8|Overall Study|Lost to Follow-up|0
7651|NCT02332707|42870|P7|Overall Study|Lost to Follow-up|0
7652|NCT02332707|42871|P6|Overall Study|Lost to Follow-up|1
7653|NCT02332707|42872|P5|Overall Study|Lost to Follow-up|0
7654|NCT02332707|42873|P4|Overall Study|Lost to Follow-up|0
7655|NCT02332707|42874|P3|Overall Study|Lost to Follow-up|0
7656|NCT02332707|42875|P2|Overall Study|Lost to Follow-up|0
7657|NCT02332707|42876|P1|Overall Study|Lost to Follow-up|0
7658|NCT02332707|42859|P18|Overall Study|Adverse Event|0
7659|NCT02332707|42860|P17|Overall Study|Adverse Event|0
7660|NCT02332707|42861|P16|Overall Study|Adverse Event|0
7661|NCT02332707|42862|P15|Overall Study|Adverse Event|0
7662|NCT02332707|42863|P14|Overall Study|Adverse Event|0
7663|NCT02332707|42864|P13|Overall Study|Adverse Event|1
7664|NCT02332707|42865|P12|Overall Study|Adverse Event|0
7665|NCT02332707|42866|P11|Overall Study|Adverse Event|0
7666|NCT02332707|42867|P10|Overall Study|Adverse Event|0
7667|NCT02332707|42868|P9|Overall Study|Adverse Event|0
7668|NCT02332707|42869|P8|Overall Study|Adverse Event|0
7669|NCT02332707|42870|P7|Overall Study|Adverse Event|0
7670|NCT02332707|42871|P6|Overall Study|Adverse Event|0
7671|NCT02332707|42872|P5|Overall Study|Adverse Event|0
7672|NCT02332707|42873|P4|Overall Study|Adverse Event|0
7673|NCT02332707|42874|P3|Overall Study|Adverse Event|0
7674|NCT02332707|42875|P2|Overall Study|Adverse Event|0
7675|NCT02332707|42876|P1|Overall Study|Adverse Event|0
7676|NCT02332590|42970|P2|Overall Study|Other than specified above|5
7677|NCT02332590|42971|P1|Overall Study|Other than specified above|6
7678|NCT02332590|42970|P2|Overall Study|Randomized but not treated|0
7679|NCT02332590|42971|P1|Overall Study|Randomized but not treated|1
7680|NCT02332590|42970|P2|Overall Study|Poor compliance to protocol|1
7681|NCT02332590|42971|P1|Overall Study|Poor compliance to protocol|3
7682|NCT02332590|42970|P2|Overall Study|Lack of Efficacy|2
7683|NCT02332590|42971|P1|Overall Study|Lack of Efficacy|4
7684|NCT02332590|42970|P2|Overall Study|Adverse Event|11
7685|NCT02332590|42971|P1|Overall Study|Adverse Event|15
7686|NCT02332239|43035|P2|Overall Study|Lost to Follow-up|6
7687|NCT02332239|43036|P1|Overall Study|Lost to Follow-up|4
7688|NCT02331446|43083|P4|Overall Study|Lost before baseline analysis|0
7689|NCT02331446|43084|P3|Overall Study|Lost before baseline analysis|1
7690|NCT02331446|43085|P2|Overall Study|Lost before baseline analysis|1
7691|NCT02331446|43086|P1|Overall Study|Lost before baseline analysis|0
7692|NCT02331446|43083|P4|Overall Study|Physician Decision|1
7693|NCT02331446|43084|P3|Overall Study|Physician Decision|0
7694|NCT02331446|43085|P2|Overall Study|Physician Decision|1
7695|NCT02331446|43086|P1|Overall Study|Physician Decision|0
7696|NCT02331446|43083|P4|Overall Study|Disease|1
7697|NCT02331446|43084|P3|Overall Study|Disease|2
7698|NCT02331446|43085|P2|Overall Study|Disease|2
7699|NCT02331446|43086|P1|Overall Study|Disease|0
7700|NCT02331446|43083|P4|Overall Study|Personal Problem|0
7701|NCT02331446|43084|P3|Overall Study|Personal Problem|0
7702|NCT02331446|43085|P2|Overall Study|Personal Problem|0
7703|NCT02331446|43086|P1|Overall Study|Personal Problem|2
7704|NCT02331446|43083|P4|Overall Study|Lost to Follow-up|1
7705|NCT02331446|43084|P3|Overall Study|Lost to Follow-up|0
7706|NCT02331446|43085|P2|Overall Study|Lost to Follow-up|1
7707|NCT02331446|43086|P1|Overall Study|Lost to Follow-up|2
7708|NCT02330055|43274|P2|Overall Study|participant did not sleep|1
7709|NCT02330055|43275|P1|Overall Study|participant did not sleep|0
7710|NCT02330055|43274|P2|Overall Study|data for less than 60 minutes|3
7711|NCT02330055|43275|P1|Overall Study|data for less than 60 minutes|3
7712|NCT02330055|43274|P2|Overall Study|participant forgot to wear device|5
7713|NCT02330055|43275|P1|Overall Study|participant forgot to wear device|5
7714|NCT02330055|43274|P2|Overall Study|technical issues|0
7715|NCT02330055|43275|P1|Overall Study|technical issues|2
7716|NCT02329730|43322|P12|Overall Study|Withdrawal by Subject|0
7717|NCT02329730|43323|P11|Overall Study|Withdrawal by Subject|0
7718|NCT02329730|43324|P10|Overall Study|Withdrawal by Subject|1
7719|NCT02329730|43325|P9|Overall Study|Withdrawal by Subject|1
7720|NCT02329730|43326|P8|Overall Study|Withdrawal by Subject|1
7721|NCT02329730|43327|P7|Overall Study|Withdrawal by Subject|1
7722|NCT02329730|43328|P6|Overall Study|Withdrawal by Subject|0
7723|NCT02329730|43329|P5|Overall Study|Withdrawal by Subject|1
7724|NCT02329730|43330|P4|Overall Study|Withdrawal by Subject|0
7725|NCT02329730|43331|P3|Overall Study|Withdrawal by Subject|0
7726|NCT02329730|43332|P2|Overall Study|Withdrawal by Subject|0
7727|NCT02329730|43333|P1|Overall Study|Withdrawal by Subject|0
7728|NCT02329730|43322|P12|Overall Study|Protocol Violation|0
7729|NCT02329730|43323|P11|Overall Study|Protocol Violation|0
7730|NCT02329730|43324|P10|Overall Study|Protocol Violation|0
7731|NCT02329730|43325|P9|Overall Study|Protocol Violation|0
7732|NCT02329730|43326|P8|Overall Study|Protocol Violation|0
7733|NCT02329730|43327|P7|Overall Study|Protocol Violation|0
7734|NCT02329730|43328|P6|Overall Study|Protocol Violation|2
7735|NCT02329730|43329|P5|Overall Study|Protocol Violation|2
7736|NCT02329730|43330|P4|Overall Study|Protocol Violation|0
7737|NCT02329730|43331|P3|Overall Study|Protocol Violation|0
7738|NCT02329730|43332|P2|Overall Study|Protocol Violation|0
7739|NCT02329730|43333|P1|Overall Study|Protocol Violation|0
7740|NCT02329431|43444|P2|Overall Study|Lost to Follow-up|13
7741|NCT02329431|43445|P1|Overall Study|Lost to Follow-up|20
7742|NCT02329223|43464|P3|Overall Study|Adverse Event|0
7743|NCT02329223|43465|P2|Overall Study|Adverse Event|1
7744|NCT02329223|43466|P1|Overall Study|Adverse Event|0
7745|NCT02329223|43464|P3|Overall Study|Physician Decision|1
7746|NCT02329223|43465|P2|Overall Study|Physician Decision|0
7747|NCT02329223|43466|P1|Overall Study|Physician Decision|0
7748|NCT02329223|43464|P3|Overall Study|Withdrawal by Subject|5
7749|NCT02329223|43465|P2|Overall Study|Withdrawal by Subject|2
7750|NCT02329223|43466|P1|Overall Study|Withdrawal by Subject|1
7751|NCT02328937|43516|P6|Period 2|Adverse Event|0
7752|NCT02328937|43517|P5|Period 2|Adverse Event|0
7753|NCT02328937|43518|P4|Period 2|Adverse Event|0
7754|NCT02328937|43519|P3|Period 2|Adverse Event|1
7755|NCT02328937|43520|P2|Period 2|Adverse Event|0
7756|NCT02328937|43521|P1|Period 2|Adverse Event|0
7757|NCT02328937|43516|P6|Period 1|Lost to Follow-up|0
7758|NCT02328937|43517|P5|Period 1|Lost to Follow-up|0
7759|NCT02328937|43518|P4|Period 1|Lost to Follow-up|1
7760|NCT02328937|43519|P3|Period 1|Lost to Follow-up|0
7761|NCT02328937|43520|P2|Period 1|Lost to Follow-up|0
7762|NCT02328937|43521|P1|Period 1|Lost to Follow-up|0
7763|NCT02327013|43601|P5|Overall Study|Withdrawal before treatment|0
7764|NCT02327013|43602|P4|Overall Study|Withdrawal before treatment|0
7765|NCT02327013|43603|P3|Overall Study|Withdrawal before treatment|5
7766|NCT02327013|43604|P2|Overall Study|Withdrawal before treatment|1
7767|NCT02327013|43605|P1|Overall Study|Withdrawal before treatment|2
7768|NCT02327013|43601|P5|Overall Study|Protocol Violation|1
7769|NCT02327013|43602|P4|Overall Study|Protocol Violation|0
7770|NCT02327013|43603|P3|Overall Study|Protocol Violation|3
7771|NCT02327013|43604|P2|Overall Study|Protocol Violation|0
7772|NCT02327013|43605|P1|Overall Study|Protocol Violation|0
7773|NCT02327013|43601|P5|Overall Study|Administrative or other reason(s)|1
7774|NCT02327013|43602|P4|Overall Study|Administrative or other reason(s)|1
7775|NCT02327013|43603|P3|Overall Study|Administrative or other reason(s)|11
7776|NCT02327013|43604|P2|Overall Study|Administrative or other reason(s)|5
7777|NCT02327013|43605|P1|Overall Study|Administrative or other reason(s)|1
7778|NCT02327013|43601|P5|Overall Study|Lost to Follow-up|0
7779|NCT02327013|43602|P4|Overall Study|Lost to Follow-up|0
7780|NCT02327013|43603|P3|Overall Study|Lost to Follow-up|5
7781|NCT02327013|43604|P2|Overall Study|Lost to Follow-up|4
7782|NCT02327013|43605|P1|Overall Study|Lost to Follow-up|2
7783|NCT02327013|43601|P5|Overall Study|Withdrawal of Consent|0
7784|NCT02327013|43602|P4|Overall Study|Withdrawal of Consent|0
7785|NCT02327013|43603|P3|Overall Study|Withdrawal of Consent|3
7786|NCT02327013|43604|P2|Overall Study|Withdrawal of Consent|0
7787|NCT02327013|43605|P1|Overall Study|Withdrawal of Consent|1
7788|NCT02327013|43601|P5|Overall Study|Non-compliance with IMP|0
7789|NCT02327013|43602|P4|Overall Study|Non-compliance with IMP|0
7790|NCT02327013|43603|P3|Overall Study|Non-compliance with IMP|7
7791|NCT02327013|43604|P2|Overall Study|Non-compliance with IMP|2
7792|NCT02327013|43605|P1|Overall Study|Non-compliance with IMP|1
7793|NCT02327013|43601|P5|Overall Study|Lack of Efficacy|1
7794|NCT02327013|43602|P4|Overall Study|Lack of Efficacy|0
7795|NCT02327013|43603|P3|Overall Study|Lack of Efficacy|5
7796|NCT02327013|43604|P2|Overall Study|Lack of Efficacy|0
7797|NCT02327013|43605|P1|Overall Study|Lack of Efficacy|2
7798|NCT02327013|43601|P5|Overall Study|Adverse Event|1
7799|NCT02327013|43602|P4|Overall Study|Adverse Event|0
7800|NCT02327013|43603|P3|Overall Study|Adverse Event|3
7801|NCT02327013|43604|P2|Overall Study|Adverse Event|4
7802|NCT02327013|43605|P1|Overall Study|Adverse Event|4
7803|NCT02325713|43816|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7804|NCT02325713|43817|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7805|NCT02325713|43818|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7806|NCT02325713|43819|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7807|NCT02325713|43820|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7808|NCT02325713|43821|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7809|NCT02325713|43822|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
7810|NCT02325713|43823|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7811|NCT02325713|43824|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7812|NCT02325713|43825|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7813|NCT02325713|43826|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7814|NCT02325713|43827|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7815|NCT02325713|43828|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7816|NCT02325713|43829|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7817|NCT02325713|43830|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7818|NCT02325713|43831|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7819|NCT02325713|43816|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7820|NCT02325713|43817|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7821|NCT02325713|43818|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7822|NCT02325713|43819|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7823|NCT02325713|43820|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7824|NCT02325713|43821|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7825|NCT02325713|43822|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7826|NCT02325713|43823|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7827|NCT02325713|43824|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7828|NCT02325713|43825|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7829|NCT02325713|43826|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7830|NCT02325713|43827|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7831|NCT02325713|43828|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7832|NCT02325713|43829|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7833|NCT02325713|43830|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7834|NCT02325713|43831|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
7835|NCT02325713|43816|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7836|NCT02325713|43817|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7837|NCT02325713|43818|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7838|NCT02325713|43819|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7839|NCT02325713|43820|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7840|NCT02325713|43821|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
7841|NCT02325713|43822|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7842|NCT02325713|43823|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7843|NCT02325713|43824|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7844|NCT02325713|43825|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7845|NCT02325713|43826|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7846|NCT02325713|43827|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7847|NCT02325713|43828|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7848|NCT02325713|43829|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7849|NCT02325713|43830|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7850|NCT02325713|43831|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7851|NCT02325518|43926|P2|Overall Study|Withdrawal by Subject|1
7852|NCT02325518|43927|P1|Overall Study|Withdrawal by Subject|0
7853|NCT02325518|43926|P2|Overall Study|Physician Decision|1
7854|NCT02325518|43927|P1|Overall Study|Physician Decision|0
7855|NCT02325518|43926|P2|Overall Study|Adverse Event|1
7856|NCT02325518|43927|P1|Overall Study|Adverse Event|4
7857|NCT02322892|44062|P2|Overall Study|Protocol Violation|0
7858|NCT02322892|44063|P1|Overall Study|Protocol Violation|1
7859|NCT02322892|44062|P2|Overall Study|Met exclusion criteria|1
7860|NCT02322892|44063|P1|Overall Study|Met exclusion criteria|0
7861|NCT02322892|44062|P2|Overall Study|Surgery cancelled|2
7862|NCT02322892|44063|P1|Overall Study|Surgery cancelled|1
7863|NCT02322879|44079|P2|First Intervention|Physician Decision|0
7864|NCT02322879|44080|P1|First Intervention|Physician Decision|1
7865|NCT02322866|44088|P2|Overall Study|Other Miscellaneous Reasons|6
7866|NCT02322866|44089|P1|Overall Study|Other Miscellaneous Reasons|6
7867|NCT02322866|44088|P2|Overall Study|Lack of Efficacy|1
7868|NCT02322866|44089|P1|Overall Study|Lack of Efficacy|3
7869|NCT02322866|44088|P2|Overall Study|Noncompliance with Treatment|4
7870|NCT02322866|44089|P1|Overall Study|Noncompliance with Treatment|3
7871|NCT02322866|44088|P2|Overall Study|Protocol Violation|0
7872|NCT02322866|44089|P1|Overall Study|Protocol Violation|1
7873|NCT02322866|44088|P2|Overall Study|Lost to Follow-up|39
7874|NCT02322866|44089|P1|Overall Study|Lost to Follow-up|36
7875|NCT02322866|44088|P2|Overall Study|Withdrawal of Consent|25
7876|NCT02322866|44089|P1|Overall Study|Withdrawal of Consent|16
7877|NCT02322866|44088|P2|Overall Study|Adverse Event|11
7878|NCT02322866|44089|P1|Overall Study|Adverse Event|6
7879|NCT02322775|44126|P2|Overall Study|Not willing to perform all FU visits|1
7880|NCT02322775|44127|P1|Overall Study|Not willing to perform all FU visits|0
7881|NCT02322775|44126|P2|Overall Study|Withdrawal by Subject|4
7882|NCT02322775|44127|P1|Overall Study|Withdrawal by Subject|3
7883|NCT02322775|44126|P2|Overall Study|Protocol Violation|0
7884|NCT02322775|44127|P1|Overall Study|Protocol Violation|1
7885|NCT02322775|44126|P2|Overall Study|Lost to Follow-up|1
7886|NCT02322775|44127|P1|Overall Study|Lost to Follow-up|0
7887|NCT02322775|44126|P2|Overall Study|Adverse Event|0
7888|NCT02322775|44127|P1|Overall Study|Adverse Event|1
7889|NCT02322749|44153|P6|Period 3|Withdrawal by Subject|0
7890|NCT02322749|44154|P5|Period 3|Withdrawal by Subject|0
7891|NCT02322749|44155|P4|Period 3|Withdrawal by Subject|0
7892|NCT02322749|44156|P3|Period 3|Withdrawal by Subject|1
7893|NCT02322749|44157|P2|Period 3|Withdrawal by Subject|0
7894|NCT02322749|44158|P1|Period 3|Withdrawal by Subject|0
7895|NCT02322749|44153|P6|Period 2|Withdrawal by Subject|0
7896|NCT02322749|44154|P5|Period 2|Withdrawal by Subject|0
7897|NCT02322749|44155|P4|Period 2|Withdrawal by Subject|1
7898|NCT02322749|44156|P3|Period 2|Withdrawal by Subject|0
7899|NCT02322749|44157|P2|Period 2|Withdrawal by Subject|0
7900|NCT02322749|44158|P1|Period 2|Withdrawal by Subject|0
7901|NCT02322749|44153|P6|Period 2|Adverse Event|0
7902|NCT02322749|44154|P5|Period 2|Adverse Event|0
7903|NCT02322749|44155|P4|Period 2|Adverse Event|1
7904|NCT02322749|44156|P3|Period 2|Adverse Event|0
7905|NCT02322749|44157|P2|Period 2|Adverse Event|0
7906|NCT02322749|44158|P1|Period 2|Adverse Event|0
7907|NCT02322216|44188|P2|Overall Study|Withdrawal by Subject|4
7908|NCT02322216|44189|P1|Overall Study|Withdrawal by Subject|1
7909|NCT02322216|44188|P2|Overall Study|Adverse Event|0
7910|NCT02322216|44189|P1|Overall Study|Adverse Event|1
7911|NCT02321436|44202|P2|Overall Study|Lost to Follow-up|1
7912|NCT02321436|44203|P1|Overall Study|Lost to Follow-up|0
7913|NCT02321436|44202|P2|Overall Study|Withdrawal by Subject|0
7914|NCT02321436|44203|P1|Overall Study|Withdrawal by Subject|1
7915|NCT02320903|44222|P3|Overall Study|Lost to Follow-up|5
7916|NCT02320903|44223|P2|Overall Study|Lost to Follow-up|5
7917|NCT02320903|44224|P1|Overall Study|Lost to Follow-up|0
7918|NCT02320903|44222|P3|Overall Study|Exited therapy; no longer eligible|2
7919|NCT02320903|44223|P2|Overall Study|Exited therapy; no longer eligible|2
7920|NCT02320903|44224|P1|Overall Study|Exited therapy; no longer eligible|8
7921|NCT02320903|44222|P3|Overall Study|Withdrawal by Subject|9
7922|NCT02320903|44223|P2|Overall Study|Withdrawal by Subject|9
7923|NCT02320903|44224|P1|Overall Study|Withdrawal by Subject|0
7924|NCT02320721|44328|P2|Overall Study|Other than specified above|20
7925|NCT02320721|44329|P1|Overall Study|Other than specified above|15
7926|NCT02320721|44328|P2|Overall Study|Hypoglycemia|0
7927|NCT02320721|44329|P1|Overall Study|Hypoglycemia|1
7928|NCT02320721|44328|P2|Overall Study|Randomized but not treated|1
7929|NCT02320721|44329|P1|Overall Study|Randomized but not treated|0
7930|NCT02320721|44328|P2|Overall Study|Poor compliance to protocol|7
7931|NCT02320721|44329|P1|Overall Study|Poor compliance to protocol|3
7932|NCT02320721|44328|P2|Overall Study|Lack of Efficacy|0
7933|NCT02320721|44329|P1|Overall Study|Lack of Efficacy|2
7934|NCT02320721|44328|P2|Overall Study|Adverse Event|6
7935|NCT02320721|44329|P1|Overall Study|Adverse Event|6
7936|NCT02320487|44384|P1|Overall Study|Adverse Event|11
7937|NCT02320487|44384|P1|Overall Study|Death|3
7938|NCT02320487|44384|P1|Overall Study|Withdrawal by Subject|1
7939|NCT02320487|44384|P1|Overall Study|Physician Decision|5
7940|NCT02320487|44384|P1|Overall Study|Reason not Specified|1
7941|NCT02320396|44404|P2|Overall Study|Withdrawal by Subject|0
7942|NCT02320396|44405|P1|Overall Study|Withdrawal by Subject|2
7943|NCT02320396|44404|P2|Overall Study|Protocol Violation|1
7944|NCT02320396|44405|P1|Overall Study|Protocol Violation|0
7945|NCT02320396|44404|P2|Overall Study|Pregnancy|1
7946|NCT02320396|44405|P1|Overall Study|Pregnancy|0
7947|NCT02320396|44404|P2|Overall Study|Adverse Event|2
7948|NCT02320396|44405|P1|Overall Study|Adverse Event|2
7949|NCT02320149|44447|P2|Overall Study|Other Miscellaneous Reasons|3
7950|NCT02320149|44448|P1|Overall Study|Other Miscellaneous Reasons|2
7951|NCT02320149|44447|P2|Overall Study|Lack of Efficacy|1
7952|NCT02320149|44448|P1|Overall Study|Lack of Efficacy|0
7953|NCT02320149|44447|P2|Overall Study|Noncompliance with Study Treatment|2
7954|NCT02320149|44448|P1|Overall Study|Noncompliance with Study Treatment|7
7955|NCT02320149|44447|P2|Overall Study|Protocol Violation|1
7956|NCT02320149|44448|P1|Overall Study|Protocol Violation|2
7957|NCT02320149|44447|P2|Overall Study|Lost to Follow-up|34
7958|NCT02320149|44448|P1|Overall Study|Lost to Follow-up|21
7959|NCT02320149|44447|P2|Overall Study|Withdrawal of Consent|32
7960|NCT02320149|44448|P1|Overall Study|Withdrawal of Consent|28
7961|NCT02320149|44447|P2|Overall Study|Adverse Event|7
7962|NCT02320149|44448|P1|Overall Study|Adverse Event|3
7963|NCT02319668|44494|P2|Overall Study|Other (Not specified)|2
7964|NCT02319668|44495|P1|Overall Study|Other (Not specified)|0
7965|NCT02319525|44509|P2|Overall Study|Withdrawal by Subject|1
7966|NCT02319525|44510|P1|Overall Study|Withdrawal by Subject|2
7967|NCT02319148|44546|P4|Second Intervention Period|Other|1
7968|NCT02319148|44547|P3|Second Intervention Period|Other|0
7969|NCT02319148|44548|P2|Second Intervention Period|Other|0
7970|NCT02319148|44549|P1|Second Intervention Period|Other|0
7971|NCT02319148|44546|P4|Second Intervention Period|No longer willing to participate|0
7972|NCT02319148|44547|P3|Second Intervention Period|No longer willing to participate|0
7973|NCT02319148|44548|P2|Second Intervention Period|No longer willing to participate|1
7974|NCT02319148|44549|P1|Second Intervention Period|No longer willing to participate|0
7975|NCT02319148|44546|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
7976|NCT02319148|44547|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
7977|NCT02319148|44548|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
7978|NCT02319148|44549|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
7979|NCT02319031|44611|P2|Treatment Period|Death|0
7980|NCT02319031|44612|P1|Treatment Period|Death|1
7981|NCT02318940|44624|P2|Overall Study|lost the record|0
7982|NCT02318940|44625|P1|Overall Study|lost the record|1
7983|NCT02318797|44639|P2|Overall Study|Lost to Follow-up|96
7984|NCT02318797|44640|P1|Overall Study|Lost to Follow-up|85
7985|NCT02318797|44639|P2|Overall Study|Death|6
7986|NCT02318797|44640|P1|Overall Study|Death|3
7987|NCT02318693|44680|P2|Overall Study|Protocol Violation|1
7988|NCT02318693|44681|P1|Overall Study|Protocol Violation|0
7989|NCT02317809|44724|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
7990|NCT02317809|44725|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
7991|NCT02317809|44724|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
7992|NCT02317809|44725|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
7993|NCT02317510|44814|P2|Overall Study|Adverse Event|1
7994|NCT02317510|44815|P1|Overall Study|Adverse Event|0
7995|NCT02317016|44843|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
7996|NCT02317016|44843|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
7997|NCT02317016|44843|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
7998|NCT02317016|44843|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
7999|NCT02317016|44843|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
8000|NCT02317016|44843|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
8001|NCT02317016|44843|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
8002|NCT02316769|44871|P2|Overall Study|Withdrawal by Subject|0
8003|NCT02316769|44872|P1|Overall Study|Withdrawal by Subject|1
8004|NCT02316769|44871|P2|Overall Study|Physician Decision|0
8005|NCT02316769|44872|P1|Overall Study|Physician Decision|1
8006|NCT02316613|44889|P1|Overall Study|Did not met selection criteria|14
8007|NCT02316613|44889|P1|Overall Study|No data and duplicate cases|5
8008|NCT02316613|44889|P1|Overall Study|Participant moved/changed medical team|11
8009|NCT02316613|44889|P1|Overall Study|Lymphoma transformation|2
8010|NCT02316613|44889|P1|Overall Study|Lost to Follow-up|9
8011|NCT02316613|44889|P1|Overall Study|Death|63
8012|NCT02316548|44928|P2|Overall Study|Protocol Violation|1
8013|NCT02316548|44929|P1|Overall Study|Protocol Violation|0
8014|NCT02314637|45103|P2|Overall Study|Other Reason|0
8015|NCT02314637|45104|P1|Overall Study|Other Reason|1
8016|NCT02314637|45103|P2|Overall Study|Withdrawal by Subject|4
8017|NCT02314637|45104|P1|Overall Study|Withdrawal by Subject|5
8018|NCT02314637|45103|P2|Overall Study|Physician Decision|2
8019|NCT02314637|45104|P1|Overall Study|Physician Decision|5
8020|NCT02314637|45103|P2|Overall Study|Lack of Efficacy|0
8021|NCT02314637|45104|P1|Overall Study|Lack of Efficacy|1
8022|NCT02314637|45103|P2|Overall Study|Adverse Event|8
8023|NCT02314637|45104|P1|Overall Study|Adverse Event|4
8024|NCT02314117|45169|P2|Overall Study|No post-discontinuation follow-up|19
8025|NCT02314117|45170|P1|Overall Study|No post-discontinuation follow-up|21
8026|NCT02314117|45169|P2|Overall Study|Withdrawal by Subject|2
8027|NCT02314117|45170|P1|Overall Study|Withdrawal by Subject|2
8028|NCT02314117|45169|P2|Overall Study|On Treatment|6
8029|NCT02314117|45170|P1|Overall Study|On Treatment|10
8030|NCT02314117|45169|P2|Overall Study|Lost to Follow-up|11
8031|NCT02314117|45170|P1|Overall Study|Lost to Follow-up|8
8032|NCT02313766|45226|P3|Overall Study|Adverse Event|0
8033|NCT02313766|45227|P2|Overall Study|Adverse Event|1
8034|NCT02313766|45228|P1|Overall Study|Adverse Event|0
8035|NCT02313766|45226|P3|Overall Study|Lost to Follow-up|0
8036|NCT02313766|45227|P2|Overall Study|Lost to Follow-up|2
8037|NCT02313766|45228|P1|Overall Study|Lost to Follow-up|0
8038|NCT02313766|45226|P3|Overall Study|surgery cancelled|0
8039|NCT02313766|45227|P2|Overall Study|surgery cancelled|0
8040|NCT02313766|45228|P1|Overall Study|surgery cancelled|1
8041|NCT02313558|45265|P2|Overall Study|Lost to Follow-up|4
8042|NCT02313558|45266|P1|Overall Study|Lost to Follow-up|4
8043|NCT02313558|45265|P2|Overall Study|Withdrawal by Subject|0
8044|NCT02313558|45266|P1|Overall Study|Withdrawal by Subject|2
8045|NCT02313233|45280|P2|Overall Study|Administrative reason|1
8046|NCT02313233|45281|P1|Overall Study|Administrative reason|1
8047|NCT02313233|45280|P2|Overall Study|Withdrawal by Subject|2
8048|NCT02313233|45281|P1|Overall Study|Withdrawal by Subject|1
8049|NCT02313155|45303|P2|Overall Study|Lost to Follow-up|1
8050|NCT02313155|45304|P1|Overall Study|Lost to Follow-up|0
8051|NCT02311881|45499|P3|Overall Study|Serious Adverse Event|0
8052|NCT02311881|45500|P2|Overall Study|Serious Adverse Event|1
8053|NCT02311881|45501|P1|Overall Study|Serious Adverse Event|0
8054|NCT02311881|45499|P3|Overall Study|Participant taking another medication|1
8055|NCT02311881|45500|P2|Overall Study|Participant taking another medication|0
8056|NCT02311881|45501|P1|Overall Study|Participant taking another medication|0
8057|NCT02311881|45499|P3|Overall Study|Medical Monitor Discretion|1
8058|NCT02311881|45500|P2|Overall Study|Medical Monitor Discretion|0
8059|NCT02311881|45501|P1|Overall Study|Medical Monitor Discretion|0
8060|NCT02311881|45499|P3|Overall Study|Physician Decision|1
8061|NCT02311881|45500|P2|Overall Study|Physician Decision|0
8062|NCT02311881|45501|P1|Overall Study|Physician Decision|0
8063|NCT02311881|45499|P3|Overall Study|Non-Compliance|2
8064|NCT02311881|45500|P2|Overall Study|Non-Compliance|0
8065|NCT02311881|45501|P1|Overall Study|Non-Compliance|1
8066|NCT02311881|45499|P3|Overall Study|Protocol Deviation|0
8067|NCT02311881|45500|P2|Overall Study|Protocol Deviation|0
8068|NCT02311881|45501|P1|Overall Study|Protocol Deviation|1
8069|NCT02311881|45499|P3|Overall Study|Sponsor Decision|1
8070|NCT02311881|45500|P2|Overall Study|Sponsor Decision|1
8071|NCT02311881|45501|P1|Overall Study|Sponsor Decision|1
8072|NCT02311881|45499|P3|Overall Study|Withdrawal by Subject|4
8073|NCT02311881|45500|P2|Overall Study|Withdrawal by Subject|1
8074|NCT02311881|45501|P1|Overall Study|Withdrawal by Subject|3
8075|NCT02311881|45499|P3|Overall Study|Subject has border line pregnancy test|0
8076|NCT02311881|45500|P2|Overall Study|Subject has border line pregnancy test|0
8077|NCT02311881|45501|P1|Overall Study|Subject has border line pregnancy test|1
8078|NCT02311881|45499|P3|Overall Study|Lack of Efficacy|0
8079|NCT02311881|45500|P2|Overall Study|Lack of Efficacy|2
8080|NCT02311881|45501|P1|Overall Study|Lack of Efficacy|1
8081|NCT02311881|45499|P3|Overall Study|Not Specified|1
8082|NCT02311881|45500|P2|Overall Study|Not Specified|0
8083|NCT02311881|45501|P1|Overall Study|Not Specified|0
8084|NCT02311881|45499|P3|Overall Study|Withdrawal of consent|17
8085|NCT02311881|45500|P2|Overall Study|Withdrawal of consent|16
8086|NCT02311881|45501|P1|Overall Study|Withdrawal of consent|14
8087|NCT02311881|45499|P3|Overall Study|Protocol Violation|3
8088|NCT02311881|45500|P2|Overall Study|Protocol Violation|2
8089|NCT02311881|45501|P1|Overall Study|Protocol Violation|1
8090|NCT02311881|45499|P3|Overall Study|Lost to Follow-up|2
8091|NCT02311881|45500|P2|Overall Study|Lost to Follow-up|3
8092|NCT02311881|45501|P1|Overall Study|Lost to Follow-up|3
8093|NCT02311881|45499|P3|Overall Study|Adverse Event|8
8094|NCT02311881|45500|P2|Overall Study|Adverse Event|15
8095|NCT02311881|45501|P1|Overall Study|Adverse Event|7
8096|NCT02311881|45499|P3|Overall Study|Did not meet the study criteria|0
8097|NCT02311881|45500|P2|Overall Study|Did not meet the study criteria|2
8098|NCT02311881|45501|P1|Overall Study|Did not meet the study criteria|2
8099|NCT02310789|45552|P1|Overall Study|Adverse Event|1
8100|NCT02310750|45572|P16|HP Washout 2|Lost to Follow-up|0
8101|NCT02310750|45573|P15|HP Washout 2|Lost to Follow-up|0
8102|NCT02310750|45574|P14|HP Washout 2|Lost to Follow-up|0
8103|NCT02310750|45575|P13|HP Washout 2|Lost to Follow-up|0
8104|NCT02310750|45576|P12|HP Washout 2|Lost to Follow-up|0
8105|NCT02310750|45577|P11|HP Washout 2|Lost to Follow-up|0
8106|NCT02310750|45578|P10|HP Washout 2|Lost to Follow-up|0
8107|NCT02310750|45579|P9|HP Washout 2|Lost to Follow-up|0
8108|NCT02310750|45580|P8|HP Washout 2|Lost to Follow-up|0
8109|NCT02310750|45581|P7|HP Washout 2|Lost to Follow-up|7
8110|NCT02310750|45582|P6|HP Washout 2|Lost to Follow-up|0
8111|NCT02310750|45583|P5|HP Washout 2|Lost to Follow-up|1
8112|NCT02310750|45584|P4|HP Washout 2|Lost to Follow-up|0
8113|NCT02310750|45585|P3|HP Washout 2|Lost to Follow-up|0
8114|NCT02310750|45586|P2|HP Washout 2|Lost to Follow-up|0
8115|NCT02310750|45587|P1|HP Washout 2|Lost to Follow-up|0
8116|NCT02310750|45572|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8117|NCT02310750|45573|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8118|NCT02310750|45574|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8119|NCT02310750|45575|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8120|NCT02310750|45576|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8121|NCT02310750|45577|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8122|NCT02310750|45578|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8123|NCT02310750|45579|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
8124|NCT02310750|45580|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
8125|NCT02310750|45581|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8126|NCT02310750|45582|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8127|NCT02310750|45583|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8128|NCT02310750|45584|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8129|NCT02310750|45585|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8130|NCT02310750|45586|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8131|NCT02310750|45587|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
8132|NCT02310750|45572|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8133|NCT02310750|45573|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8134|NCT02310750|45574|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8135|NCT02310750|45575|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8136|NCT02310750|45576|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8137|NCT02310750|45577|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8138|NCT02310750|45578|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
8139|NCT02310750|45579|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
8140|NCT02310750|45580|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
8141|NCT02310750|45581|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8142|NCT02310750|45582|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8143|NCT02310750|45583|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8144|NCT02310750|45584|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8145|NCT02310750|45585|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8146|NCT02310750|45586|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8147|NCT02310750|45587|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
8148|NCT02310750|45572|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8149|NCT02310750|45573|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8150|NCT02310750|45574|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8151|NCT02310750|45575|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8152|NCT02310750|45576|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8153|NCT02310750|45577|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8154|NCT02310750|45578|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
8155|NCT02310750|45579|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8156|NCT02310750|45580|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8157|NCT02310750|45581|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8158|NCT02310750|45582|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8159|NCT02310750|45583|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8160|NCT02310750|45584|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8161|NCT02310750|45585|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8162|NCT02310750|45586|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8163|NCT02310750|45587|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
8164|NCT02310750|45572|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8165|NCT02310750|45573|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8166|NCT02310750|45574|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8167|NCT02310750|45575|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8168|NCT02310750|45576|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8169|NCT02310750|45577|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8170|NCT02310750|45578|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
8171|NCT02310750|45579|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
8172|NCT02310750|45580|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8173|NCT02310750|45581|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8174|NCT02310750|45582|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
8175|NCT02310750|45583|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8176|NCT02310750|45584|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
8177|NCT02310750|45585|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8178|NCT02310750|45586|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8179|NCT02310750|45587|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
8180|NCT02310750|45572|P16|HP Washout 1|Lost to Follow-up|0
8181|NCT02310750|45573|P15|HP Washout 1|Lost to Follow-up|0
8182|NCT02310750|45574|P14|HP Washout 1|Lost to Follow-up|0
8183|NCT02310750|45575|P13|HP Washout 1|Lost to Follow-up|0
8184|NCT02310750|45576|P12|HP Washout 1|Lost to Follow-up|0
8185|NCT02310750|45577|P11|HP Washout 1|Lost to Follow-up|0
8186|NCT02310750|45578|P10|HP Washout 1|Lost to Follow-up|0
8187|NCT02310750|45579|P9|HP Washout 1|Lost to Follow-up|0
8188|NCT02310750|45580|P8|HP Washout 1|Lost to Follow-up|0
8189|NCT02310750|45581|P7|HP Washout 1|Lost to Follow-up|3
8190|NCT02310750|45582|P6|HP Washout 1|Lost to Follow-up|2
8191|NCT02310750|45583|P5|HP Washout 1|Lost to Follow-up|2
8192|NCT02310750|45584|P4|HP Washout 1|Lost to Follow-up|1
8193|NCT02310750|45585|P3|HP Washout 1|Lost to Follow-up|1
8194|NCT02310750|45586|P2|HP Washout 1|Lost to Follow-up|0
8195|NCT02310750|45587|P1|HP Washout 1|Lost to Follow-up|0
8196|NCT02310750|45572|P16|HP Period 1|Withdrawal by Subject|0
8197|NCT02310750|45573|P15|HP Period 1|Withdrawal by Subject|0
8198|NCT02310750|45574|P14|HP Period 1|Withdrawal by Subject|0
8199|NCT02310750|45575|P13|HP Period 1|Withdrawal by Subject|0
8200|NCT02310750|45576|P12|HP Period 1|Withdrawal by Subject|0
8201|NCT02310750|45577|P11|HP Period 1|Withdrawal by Subject|0
8202|NCT02310750|45578|P10|HP Period 1|Withdrawal by Subject|0
8203|NCT02310750|45579|P9|HP Period 1|Withdrawal by Subject|0
8204|NCT02310750|45580|P8|HP Period 1|Withdrawal by Subject|0
8205|NCT02310750|45581|P7|HP Period 1|Withdrawal by Subject|0
8206|NCT02310750|45582|P6|HP Period 1|Withdrawal by Subject|0
8207|NCT02310750|45583|P5|HP Period 1|Withdrawal by Subject|0
8208|NCT02310750|45584|P4|HP Period 1|Withdrawal by Subject|1
8209|NCT02310750|45585|P3|HP Period 1|Withdrawal by Subject|0
8210|NCT02310750|45586|P2|HP Period 1|Withdrawal by Subject|0
8211|NCT02310750|45587|P1|HP Period 1|Withdrawal by Subject|1
8212|NCT02310750|45572|P16|HP Period 1|Lost to Follow-up|0
8213|NCT02310750|45573|P15|HP Period 1|Lost to Follow-up|0
8214|NCT02310750|45574|P14|HP Period 1|Lost to Follow-up|0
8215|NCT02310750|45575|P13|HP Period 1|Lost to Follow-up|0
8216|NCT02310750|45576|P12|HP Period 1|Lost to Follow-up|0
8217|NCT02310750|45577|P11|HP Period 1|Lost to Follow-up|0
8218|NCT02310750|45578|P10|HP Period 1|Lost to Follow-up|0
8219|NCT02310750|45579|P9|HP Period 1|Lost to Follow-up|0
8220|NCT02310750|45580|P8|HP Period 1|Lost to Follow-up|0
8221|NCT02310750|45581|P7|HP Period 1|Lost to Follow-up|1
8222|NCT02310750|45582|P6|HP Period 1|Lost to Follow-up|0
8223|NCT02310750|45583|P5|HP Period 1|Lost to Follow-up|0
8224|NCT02310750|45584|P4|HP Period 1|Lost to Follow-up|0
8225|NCT02310750|45585|P3|HP Period 1|Lost to Follow-up|0
8226|NCT02310750|45586|P2|HP Period 1|Lost to Follow-up|0
8227|NCT02310750|45587|P1|HP Period 1|Lost to Follow-up|0
8228|NCT02310646|46028|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
8229|NCT02310646|46029|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
8230|NCT02310646|46028|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
8231|NCT02310646|46029|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
8232|NCT02310581|46057|P4|Overall Study|Withdrawal by Subject|1
8233|NCT02310581|46058|P3|Overall Study|Withdrawal by Subject|0
8234|NCT02310581|46059|P2|Overall Study|Withdrawal by Subject|1
8235|NCT02310581|46060|P1|Overall Study|Withdrawal by Subject|2
8236|NCT02310581|46057|P4|Overall Study|Adverse Event|0
8237|NCT02310581|46058|P3|Overall Study|Adverse Event|1
8238|NCT02310581|46059|P2|Overall Study|Adverse Event|1
8239|NCT02310581|46060|P1|Overall Study|Adverse Event|1
8240|NCT02310568|46099|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
8241|NCT02310568|46100|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
8242|NCT02310568|46101|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
8243|NCT02310568|46102|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
8244|NCT02310568|46103|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
8245|NCT02310568|46099|P5|Stage 2 (4 Weeks)|Protocol Violation|0
8246|NCT02310568|46100|P4|Stage 2 (4 Weeks)|Protocol Violation|1
8247|NCT02310568|46101|P3|Stage 2 (4 Weeks)|Protocol Violation|0
8248|NCT02310568|46102|P2|Stage 2 (4 Weeks)|Protocol Violation|0
8249|NCT02310568|46103|P1|Stage 2 (4 Weeks)|Protocol Violation|0
8250|NCT02310568|46099|P5|Stage 2 (4 Weeks)|Adverse Event|1
8251|NCT02310568|46100|P4|Stage 2 (4 Weeks)|Adverse Event|1
8252|NCT02310568|46101|P3|Stage 2 (4 Weeks)|Adverse Event|0
8253|NCT02310568|46102|P2|Stage 2 (4 Weeks)|Adverse Event|0
8254|NCT02310568|46103|P1|Stage 2 (4 Weeks)|Adverse Event|0
8255|NCT02310568|46099|P5|Stage 2 (4 Weeks)|Other|0
8256|NCT02310568|46100|P4|Stage 2 (4 Weeks)|Other|0
8257|NCT02310568|46101|P3|Stage 2 (4 Weeks)|Other|1
8258|NCT02310568|46102|P2|Stage 2 (4 Weeks)|Other|1
8259|NCT02310568|46103|P1|Stage 2 (4 Weeks)|Other|0
8260|NCT02310568|46099|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
8261|NCT02310568|46100|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
8262|NCT02310568|46101|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
8263|NCT02310568|46102|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
8264|NCT02310568|46103|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
8265|NCT02310568|46099|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
8266|NCT02310568|46100|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
8267|NCT02310568|46101|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
8268|NCT02310568|46102|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
8269|NCT02310568|46103|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
8270|NCT02310568|46099|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
8271|NCT02310568|46100|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
8272|NCT02310568|46101|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
8273|NCT02310568|46102|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
8274|NCT02310568|46103|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
8275|NCT02310568|46099|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
8276|NCT02310568|46100|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
8277|NCT02310568|46101|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
8278|NCT02310568|46102|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
8279|NCT02310568|46103|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
8280|NCT02310568|46099|P5|Stage 1 ( 4 Weeks)|Other|0
8281|NCT02310568|46100|P4|Stage 1 ( 4 Weeks)|Other|0
8282|NCT02310568|46101|P3|Stage 1 ( 4 Weeks)|Other|0
8283|NCT02310568|46102|P2|Stage 1 ( 4 Weeks)|Other|1
8284|NCT02310568|46103|P1|Stage 1 ( 4 Weeks)|Other|1
8285|NCT02310568|46099|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
8286|NCT02310568|46100|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
8287|NCT02310568|46101|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
8288|NCT02310568|46102|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
8289|NCT02310568|46103|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
8290|NCT02310568|46099|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
8291|NCT02310568|46100|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
8292|NCT02310568|46101|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
8293|NCT02310568|46102|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
8294|NCT02310568|46103|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
8295|NCT02310126|46183|P2|Period 1 (15 Minutes)|Protocol Violation|1
8296|NCT02310126|46184|P1|Period 1 (15 Minutes)|Protocol Violation|0
8297|NCT02310126|46183|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
8298|NCT02310126|46184|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
8299|NCT02309723|46193|P3|Overall Study|Withdrawal by Subject|24
8300|NCT02309723|46194|P2|Overall Study|Withdrawal by Subject|23
8301|NCT02309723|46195|P1|Overall Study|Withdrawal by Subject|24
8302|NCT02309294|46209|P1|Overall Study|Withdrawal by Subject|2
8303|NCT02309112|46216|P3|Overall Study|Lost to Follow-up|0
8304|NCT02309112|46217|P2|Overall Study|Lost to Follow-up|1
8305|NCT02309112|46218|P1|Overall Study|Lost to Follow-up|0
8306|NCT02309112|46216|P3|Overall Study|Withdrawal by Subject|1
8307|NCT02309112|46217|P2|Overall Study|Withdrawal by Subject|0
8308|NCT02309112|46218|P1|Overall Study|Withdrawal by Subject|1
8309|NCT02308748|46254|P10|Period 5|Adverse Event|0
8310|NCT02308748|46255|P9|Period 5|Adverse Event|1
8311|NCT02308748|46256|P8|Period 5|Adverse Event|0
8312|NCT02308748|46257|P7|Period 5|Adverse Event|0
8313|NCT02308748|46258|P6|Period 5|Adverse Event|0
8314|NCT02308748|46259|P5|Period 5|Adverse Event|0
8315|NCT02308748|46260|P4|Period 5|Adverse Event|0
8316|NCT02308748|46261|P3|Period 5|Adverse Event|0
8317|NCT02308748|46262|P2|Period 5|Adverse Event|0
8318|NCT02308748|46263|P1|Period 5|Adverse Event|1
8319|NCT02308748|46254|P10|Period 3|Protocol Violation|1
8320|NCT02308748|46255|P9|Period 3|Protocol Violation|0
8321|NCT02308748|46256|P8|Period 3|Protocol Violation|0
8322|NCT02308748|46257|P7|Period 3|Protocol Violation|0
8323|NCT02308748|46258|P6|Period 3|Protocol Violation|0
8324|NCT02308748|46259|P5|Period 3|Protocol Violation|0
8325|NCT02308748|46260|P4|Period 3|Protocol Violation|0
8326|NCT02308748|46261|P3|Period 3|Protocol Violation|0
8327|NCT02308748|46262|P2|Period 3|Protocol Violation|0
8328|NCT02308748|46263|P1|Period 3|Protocol Violation|0
8329|NCT02308748|46254|P10|Period 2|Adverse Event|0
8330|NCT02308748|46255|P9|Period 2|Adverse Event|0
8331|NCT02308748|46256|P8|Period 2|Adverse Event|1
8332|NCT02308748|46257|P7|Period 2|Adverse Event|0
8333|NCT02308748|46258|P6|Period 2|Adverse Event|0
8334|NCT02308748|46259|P5|Period 2|Adverse Event|0
8335|NCT02308748|46260|P4|Period 2|Adverse Event|0
8336|NCT02308748|46261|P3|Period 2|Adverse Event|0
8337|NCT02308748|46262|P2|Period 2|Adverse Event|0
8338|NCT02308748|46263|P1|Period 2|Adverse Event|0
8339|NCT02308748|46254|P10|Period 1|Withdrawal by Subject|0
8340|NCT02308748|46255|P9|Period 1|Withdrawal by Subject|0
8341|NCT02308748|46256|P8|Period 1|Withdrawal by Subject|0
8342|NCT02308748|46257|P7|Period 1|Withdrawal by Subject|0
8343|NCT02308748|46258|P6|Period 1|Withdrawal by Subject|0
8344|NCT02308748|46259|P5|Period 1|Withdrawal by Subject|0
8345|NCT02308748|46260|P4|Period 1|Withdrawal by Subject|0
8346|NCT02308748|46261|P3|Period 1|Withdrawal by Subject|1
8347|NCT02308748|46262|P2|Period 1|Withdrawal by Subject|0
8348|NCT02308748|46263|P1|Period 1|Withdrawal by Subject|0
8349|NCT02308124|46295|P3|Overall Study|Adverse Event|2
8350|NCT02308124|46296|P2|Overall Study|Adverse Event|2
8351|NCT02308124|46297|P1|Overall Study|Adverse Event|0
8352|NCT02308124|46295|P3|Overall Study|Lost to Follow-up|6
8353|NCT02308124|46296|P2|Overall Study|Lost to Follow-up|6
8354|NCT02308124|46297|P1|Overall Study|Lost to Follow-up|6
8355|NCT02307266|46389|P3|Overall Study|Lost to Follow-up|0
8356|NCT02307266|46390|P2|Overall Study|Lost to Follow-up|0
8357|NCT02307266|46391|P1|Overall Study|Lost to Follow-up|3
8358|NCT02307266|46389|P3|Overall Study|Withdrawal by Subject|1
8359|NCT02307266|46390|P2|Overall Study|Withdrawal by Subject|0
8360|NCT02307266|46391|P1|Overall Study|Withdrawal by Subject|2
8361|NCT02307266|46389|P3|Overall Study|Adverse Event|5
8362|NCT02307266|46390|P2|Overall Study|Adverse Event|1
8363|NCT02307266|46391|P1|Overall Study|Adverse Event|3
8364|NCT02305446|46433|P1|Overall Study|Adverse Event|1
8365|NCT02305381|46441|P3|Overall Study|Unclassified|7
8366|NCT02305381|46442|P2|Overall Study|Unclassified|5
8367|NCT02305381|46443|P1|Overall Study|Unclassified|5
8368|NCT02305238|46556|P3|Overall Study|Randomized failure|8
8369|NCT02305238|46557|P2|Overall Study|Randomized failure|0
8370|NCT02305238|46558|P1|Overall Study|Randomized failure|0
8371|NCT02305238|46556|P3|Overall Study|Withdrawal by Subject|0
8372|NCT02305238|46557|P2|Overall Study|Withdrawal by Subject|2
8373|NCT02305238|46558|P1|Overall Study|Withdrawal by Subject|2
8374|NCT02305238|46556|P3|Overall Study|Adverse Event|0
8375|NCT02305238|46557|P2|Overall Study|Adverse Event|1
8376|NCT02305238|46558|P1|Overall Study|Adverse Event|3
8377|NCT02305238|46556|P3|Overall Study|Physician Decision|0
8378|NCT02305238|46557|P2|Overall Study|Physician Decision|0
8379|NCT02305238|46558|P1|Overall Study|Physician Decision|1
8380|NCT02305238|46556|P3|Overall Study|Protocol Violation|0
8381|NCT02305238|46557|P2|Overall Study|Protocol Violation|1
8382|NCT02305238|46558|P1|Overall Study|Protocol Violation|0
8383|NCT02305238|46556|P3|Overall Study|Logistical difficulties|0
8384|NCT02305238|46557|P2|Overall Study|Logistical difficulties|1
8385|NCT02305238|46558|P1|Overall Study|Logistical difficulties|1
8386|NCT02305238|46556|P3|Overall Study|Progressive disease|0
8387|NCT02305238|46557|P2|Overall Study|Progressive disease|2
8388|NCT02305238|46558|P1|Overall Study|Progressive disease|4
8389|NCT02305238|46556|P3|Overall Study|Death|0
8390|NCT02305238|46557|P2|Overall Study|Death|0
8391|NCT02305238|46558|P1|Overall Study|Death|2
8392|NCT02304926|46590|P2|Overall Study|Lost to Follow-up|1
8393|NCT02304926|46591|P1|Overall Study|Lost to Follow-up|2
8394|NCT02303704|46683|P2|Overall Study|Protocol Violation|9
8395|NCT02303704|46684|P1|Overall Study|Protocol Violation|5
8396|NCT02302807|46702|P2|Overall Study|Death|322
8397|NCT02302807|46703|P1|Overall Study|Death|345
8398|NCT02302807|46702|P2|Overall Study|Lost to Follow-up|3
8399|NCT02302807|46703|P1|Overall Study|Lost to Follow-up|3
8400|NCT02302807|46702|P2|Overall Study|Withdrawal by Subject|9
8401|NCT02302807|46703|P1|Overall Study|Withdrawal by Subject|27
8402|NCT02302716|46750|P2|Overall Study|Protocol Violation|1
8403|NCT02302716|46751|P1|Overall Study|Protocol Violation|0
8404|NCT02302716|46750|P2|Overall Study|Withdrawal by Subject|7
8405|NCT02302716|46751|P1|Overall Study|Withdrawal by Subject|13
8406|NCT02302716|46750|P2|Overall Study|Physician Decision|4
8407|NCT02302716|46751|P1|Overall Study|Physician Decision|3
8408|NCT02302716|46750|P2|Overall Study|Lost to Follow-up|4
8409|NCT02302716|46751|P1|Overall Study|Lost to Follow-up|2
8410|NCT02302716|46750|P2|Overall Study|Lack of Efficacy|1
8411|NCT02302716|46751|P1|Overall Study|Lack of Efficacy|0
8412|NCT02302716|46750|P2|Overall Study|Death|1
8413|NCT02302716|46751|P1|Overall Study|Death|0
8414|NCT02302716|46750|P2|Overall Study|Adverse Event|1
8415|NCT02302716|46751|P1|Overall Study|Adverse Event|1
8416|NCT02301975|46825|P3|Overall Study|Withdrawal by Subject|11
8417|NCT02301975|46826|P2|Overall Study|Withdrawal by Subject|12
8418|NCT02301975|46827|P1|Overall Study|Withdrawal by Subject|15
8419|NCT02301975|46825|P3|Overall Study|Physician Decision|3
8420|NCT02301975|46826|P2|Overall Study|Physician Decision|2
8421|NCT02301975|46827|P1|Overall Study|Physician Decision|4
8422|NCT02301975|46825|P3|Overall Study|Lost to Follow-up|2
8423|NCT02301975|46826|P2|Overall Study|Lost to Follow-up|2
8424|NCT02301975|46827|P1|Overall Study|Lost to Follow-up|0
8425|NCT02301975|46825|P3|Overall Study|Protocol Violation|3
8426|NCT02301975|46826|P2|Overall Study|Protocol Violation|5
8427|NCT02301975|46827|P1|Overall Study|Protocol Violation|3
8428|NCT02301975|46825|P3|Overall Study|Lack of Efficacy|1
8429|NCT02301975|46826|P2|Overall Study|Lack of Efficacy|1
8430|NCT02301975|46827|P1|Overall Study|Lack of Efficacy|1
8431|NCT02301975|46825|P3|Overall Study|Adverse Event|2
8432|NCT02301975|46826|P2|Overall Study|Adverse Event|3
8433|NCT02301975|46827|P1|Overall Study|Adverse Event|8
8434|NCT02301936|46855|P2|Overall Study|Lost to Follow-up|0
8435|NCT02301936|46856|P1|Overall Study|Lost to Follow-up|1
8436|NCT02301429|46878|P1|Overall Study|not acceptable vascular anatomy|3
8437|NCT02301169|46904|P2|Overall Study|Adverse Event|0
8438|NCT02301169|46905|P1|Overall Study|Adverse Event|1
8439|NCT02300558|46919|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
8440|NCT02300558|46919|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
8441|NCT02300558|46919|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
8442|NCT02300558|46919|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
8443|NCT02300311|46932|P2|Overall Study|Refused to continue taking medication|0
8444|NCT02300311|46933|P1|Overall Study|Refused to continue taking medication|18
8445|NCT02300311|46932|P2|Overall Study|Other than the reason specified|0
8446|NCT02300311|46933|P1|Overall Study|Other than the reason specified|1
8447|NCT02300129|46945|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
8448|NCT02300129|46946|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
8449|NCT02300129|46947|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
8450|NCT02300129|46948|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
8451|NCT02300129|46945|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
8452|NCT02300129|46946|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
8453|NCT02300129|46947|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
8454|NCT02300129|46948|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
8455|NCT02300129|46945|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
8456|NCT02300129|46946|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
8457|NCT02300129|46947|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
8458|NCT02300129|46948|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
8459|NCT02300103|46958|P1|Overall Study|Withdrew Consent|2
8460|NCT02300103|46958|P1|Overall Study|Protocol Violation|1
8461|NCT02300103|46958|P1|Overall Study|Lack of Efficacy|3
8462|NCT02299635|47055|P1|Overall Study|Other|3
8463|NCT02299635|47055|P1|Overall Study|Withdrawal by Subject|2
8464|NCT02299635|47055|P1|Overall Study|Objective progression or relapse|10
8465|NCT02299635|47055|P1|Overall Study|Global deterioration of health status|1
8466|NCT02299635|47055|P1|Overall Study|Death|1
8467|NCT02299635|47055|P1|Overall Study|Adverse Event|2
8468|NCT02299427|47076|P2|Overall Study|not adherent to dog website use|0
8469|NCT02299427|47077|P1|Overall Study|not adherent to dog website use|21
8470|NCT02299427|47076|P2|Overall Study|Lost to Follow-up|3
8471|NCT02299427|47077|P1|Overall Study|Lost to Follow-up|1
8472|NCT02299427|47076|P2|Overall Study|Withdrawal by Subject|0
8473|NCT02299427|47077|P1|Overall Study|Withdrawal by Subject|1
8474|NCT02299206|47107|P1|Overall Study|Withdrawal by Subject|1
8475|NCT02299206|47107|P1|Overall Study|Lost to Follow-up|1
8476|NCT02299076|47168|P2|Overall Study|Fraudulent Entries|14
8477|NCT02299076|47169|P1|Overall Study|Fraudulent Entries|20
8478|NCT02298868|47177|P1|Overall Study|Patient underwent transplant|1
8479|NCT02298868|47177|P1|Overall Study|Death|1
8480|NCT02298868|47177|P1|Overall Study|Adverse Event|1
8481|NCT02298192|47248|P2|Overall Study|Adverse Event|2
8482|NCT02298192|47249|P1|Overall Study|Adverse Event|6
8483|NCT02298192|47248|P2|Overall Study|Lost to Follow-up|1
8484|NCT02298192|47249|P1|Overall Study|Lost to Follow-up|2
8485|NCT02298192|47248|P2|Overall Study|Withdrawal by Subject|1
8486|NCT02298192|47249|P1|Overall Study|Withdrawal by Subject|6
8487|NCT02298192|47248|P2|Overall Study|Withdrawal criteria|0
8488|NCT02298192|47249|P1|Overall Study|Withdrawal criteria|2
8489|NCT02298192|47248|P2|Overall Study|Unclassified|2
8490|NCT02298192|47249|P1|Overall Study|Unclassified|3
8491|NCT02297841|47261|P1|Overall Study|Protocol Violation|7
8492|NCT02297841|47261|P1|Overall Study|Withdrawal by Subject|1
8493|NCT02297815|47267|P2|Overall Study|Lost to Follow-up|140
8494|NCT02297815|47268|P1|Overall Study|Lost to Follow-up|236
8495|NCT02296931|47333|P2|Overall Study|Protocol Violation|2
8496|NCT02296931|47334|P1|Overall Study|Protocol Violation|0
8497|NCT02296840|47342|P2|Overall Study|Lost to Follow-up|17
8498|NCT02296840|47343|P1|Overall Study|Lost to Follow-up|6
8499|NCT02296840|47342|P2|Overall Study|Protocol Violation|1
8500|NCT02296840|47343|P1|Overall Study|Protocol Violation|2
8501|NCT02296840|47342|P2|Overall Study|Adverse Event|1
8502|NCT02296840|47343|P1|Overall Study|Adverse Event|1
8503|NCT02296476|47358|P3|Overall Study|Disease Progression|2
8504|NCT02296476|47359|P2|Overall Study|Disease Progression|4
8505|NCT02296476|47360|P1|Overall Study|Disease Progression|6
8506|NCT02295774|47440|P1|Overall Study|Withdrawal by Subject|2
8507|NCT02295774|47440|P1|Overall Study|Lost to Follow-up|1
8508|NCT02295644|47448|P4|Overall Study|Did not meet inclusion criterion|2
8509|NCT02295644|47449|P3|Overall Study|Did not meet inclusion criterion|1
8510|NCT02295644|47450|P2|Overall Study|Did not meet inclusion criterion|0
8511|NCT02295644|47451|P1|Overall Study|Did not meet inclusion criterion|0
8512|NCT02295280|47471|P2|Overall Study|Adverse Event|1
8513|NCT02295280|47472|P1|Overall Study|Adverse Event|0
8514|NCT02295020|47480|P2|Overall Study|Withdrawal by Subject|2
8515|NCT02295020|47481|P1|Overall Study|Withdrawal by Subject|3
8516|NCT02295020|47480|P2|Overall Study|Adverse Event|1
8517|NCT02295020|47481|P1|Overall Study|Adverse Event|0
8518|NCT02294773|47513|P2|Overall Study|Withdrawal by Subject|2
8519|NCT02294773|47514|P1|Overall Study|Withdrawal by Subject|0
8520|NCT02294734|47530|P2|Overall Study|Withdrawal by Subject|2
8521|NCT02294734|47531|P1|Overall Study|Withdrawal by Subject|4
8522|NCT02294734|47530|P2|Overall Study|Physician Decision|1
8523|NCT02294734|47531|P1|Overall Study|Physician Decision|2
8524|NCT02294734|47530|P2|Overall Study|Lost to Follow-up|0
8525|NCT02294734|47531|P1|Overall Study|Lost to Follow-up|2
8526|NCT02294734|47530|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
8527|NCT02294734|47531|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
8528|NCT02294734|47530|P2|Overall Study|Adverse Event|5
8529|NCT02294734|47531|P1|Overall Study|Adverse Event|5
8530|NCT02294682|47583|P2|Overall Study|Could not swallow pills|0
8531|NCT02294682|47584|P1|Overall Study|Could not swallow pills|1
8532|NCT02294604|47627|P3|Overall Study|Culture contamination|0
8533|NCT02294604|47628|P2|Overall Study|Culture contamination|2
8534|NCT02294604|47629|P1|Overall Study|Culture contamination|1
8535|NCT02294604|47627|P3|Overall Study|Did not provide samples for culture|0
8536|NCT02294604|47628|P2|Overall Study|Did not provide samples for culture|1
8537|NCT02294604|47629|P1|Overall Study|Did not provide samples for culture|0
8538|NCT02294474|47648|P2|Overall Study|Other than specified above|12
8539|NCT02294474|47649|P1|Overall Study|Other than specified above|12
8540|NCT02294474|47648|P2|Overall Study|Protocol Violation|2
8541|NCT02294474|47649|P1|Overall Study|Protocol Violation|4
8542|NCT02294474|47648|P2|Overall Study|Lack of Efficacy|1
8543|NCT02294474|47649|P1|Overall Study|Lack of Efficacy|2
8544|NCT02294474|47648|P2|Overall Study|Adverse Event|7
8545|NCT02294474|47649|P1|Overall Study|Adverse Event|7
8546|NCT02294461|47673|P2|Overall Study|Miscellaneous|32
8547|NCT02294461|47674|P1|Overall Study|Miscellaneous|11
8548|NCT02294461|47673|P2|Overall Study|Adverse Event|10
8549|NCT02294461|47674|P1|Overall Study|Adverse Event|11
8550|NCT02294461|47673|P2|Overall Study|Disease Progression|39
8551|NCT02294461|47674|P1|Overall Study|Disease Progression|23
8552|NCT02294461|47673|P2|Overall Study|Withdrawal by Subject|45
8553|NCT02294461|47674|P1|Overall Study|Withdrawal by Subject|14
8554|NCT02294461|47673|P2|Overall Study|Protocol Violation|2
8555|NCT02294461|47674|P1|Overall Study|Protocol Violation|0
8556|NCT02294461|47673|P2|Overall Study|Death|3
8557|NCT02294461|47674|P1|Overall Study|Death|3
8558|NCT02294019|47726|P1|Overall Study|Withdrawal by Subject|1
8559|NCT02294019|47726|P1|Overall Study|Other|1
8560|NCT02294019|47726|P1|Overall Study|Lost to Follow-up|31
8561|NCT02294019|47726|P1|Overall Study|Protocol Violation|68
8562|NCT02294019|47726|P1|Overall Study|Adverse Event|2
8563|NCT02293902|47734|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
8564|NCT02293902|47735|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
8565|NCT02293902|47736|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
8566|NCT02293902|47737|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
8567|NCT02293902|47738|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
8568|NCT02293902|47734|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
8569|NCT02293902|47735|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
8570|NCT02293902|47736|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
8571|NCT02293902|47737|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
8572|NCT02293902|47738|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
8573|NCT02293902|47734|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
8574|NCT02293902|47735|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
8575|NCT02293902|47736|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
8576|NCT02293902|47737|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
8577|NCT02293902|47738|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
8578|NCT02293902|47734|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
8579|NCT02293902|47735|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
8580|NCT02293902|47736|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
8581|NCT02293902|47737|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
8582|NCT02293902|47738|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
8583|NCT02293902|47734|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
8584|NCT02293902|47735|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
8585|NCT02293902|47736|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
8586|NCT02293902|47737|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
8587|NCT02293902|47738|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
8588|NCT02293538|47799|P2|Overall Study|Withdrawal by Subject|1
8589|NCT02293538|47800|P1|Overall Study|Withdrawal by Subject|0
8590|NCT02293538|47799|P2|Overall Study|Lost to Follow-up|0
8591|NCT02293538|47800|P1|Overall Study|Lost to Follow-up|1
8592|NCT02293538|47799|P2|Overall Study|Adverse Event|1
8593|NCT02293538|47800|P1|Overall Study|Adverse Event|0
8594|NCT02293395|47815|P2|Overall Study|Withdrawal by Subject|7
8595|NCT02293395|47816|P1|Overall Study|Withdrawal by Subject|8
8596|NCT02293395|47815|P2|Overall Study|Lost to Follow-up|0
8597|NCT02293395|47816|P1|Overall Study|Lost to Follow-up|1
8598|NCT02292849|47825|P3|Overall Study|Physician Decision|0
8599|NCT02292849|47826|P2|Overall Study|Physician Decision|0
8600|NCT02292849|47827|P1|Overall Study|Physician Decision|4
8601|NCT02292849|47825|P3|Overall Study|Lost to Follow-up|2
8602|NCT02292849|47826|P2|Overall Study|Lost to Follow-up|2
8603|NCT02292849|47827|P1|Overall Study|Lost to Follow-up|0
8604|NCT02292212|47948|P1|ViE Phase|Protocol Violation|2
8605|NCT02292212|47948|P1|ViE Phase|Withdrawal by Subject|1
8606|NCT02291861|47984|P4|Overall Study|Not specified|1
8607|NCT02291861|47985|P3|Overall Study|Not specified|0
8608|NCT02291861|47986|P2|Overall Study|Not specified|0
8609|NCT02291861|47987|P1|Overall Study|Not specified|0
8610|NCT02291861|47984|P4|Overall Study|Lost to Follow-up|0
8611|NCT02291861|47985|P3|Overall Study|Lost to Follow-up|4
8612|NCT02291861|47986|P2|Overall Study|Lost to Follow-up|1
8613|NCT02291861|47987|P1|Overall Study|Lost to Follow-up|2
8614|NCT02291861|47984|P4|Overall Study|Noncompliance|1
8615|NCT02291861|47985|P3|Overall Study|Noncompliance|2
8616|NCT02291861|47986|P2|Overall Study|Noncompliance|1
8617|NCT02291861|47987|P1|Overall Study|Noncompliance|1
8618|NCT02291861|47984|P4|Overall Study|Withdrawal by Subject|4
8619|NCT02291861|47985|P3|Overall Study|Withdrawal by Subject|1
8620|NCT02291861|47986|P2|Overall Study|Withdrawal by Subject|2
8621|NCT02291861|47987|P1|Overall Study|Withdrawal by Subject|1
8622|NCT02291861|47984|P4|Overall Study|Protocol Violation|1
8623|NCT02291861|47985|P3|Overall Study|Protocol Violation|0
8624|NCT02291861|47986|P2|Overall Study|Protocol Violation|0
8625|NCT02291861|47987|P1|Overall Study|Protocol Violation|1
8626|NCT02291861|47984|P4|Overall Study|Death|1
8627|NCT02291861|47985|P3|Overall Study|Death|1
8628|NCT02291861|47986|P2|Overall Study|Death|0
8629|NCT02291861|47987|P1|Overall Study|Death|0
8630|NCT02291861|47984|P4|Overall Study|Adverse Event|2
8631|NCT02291861|47985|P3|Overall Study|Adverse Event|1
8632|NCT02291861|47986|P2|Overall Study|Adverse Event|4
8633|NCT02291861|47987|P1|Overall Study|Adverse Event|2
8634|NCT02291679|48050|P3|Overall Study|Not Specified|2
8635|NCT02291679|48051|P2|Overall Study|Not Specified|4
8636|NCT02291679|48052|P1|Overall Study|Not Specified|2
8637|NCT02291679|48050|P3|Overall Study|Insufficient Therapeutic Response|7
8638|NCT02291679|48051|P2|Overall Study|Insufficient Therapeutic Response|5
8639|NCT02291679|48052|P1|Overall Study|Insufficient Therapeutic Response|5
8640|NCT02291679|48050|P3|Overall Study|Lost to Follow-up|9
8641|NCT02291679|48051|P2|Overall Study|Lost to Follow-up|10
8642|NCT02291679|48052|P1|Overall Study|Lost to Follow-up|12
8643|NCT02291679|48050|P3|Overall Study|Withdrew Consent|15
8644|NCT02291679|48051|P2|Overall Study|Withdrew Consent|10
8645|NCT02291679|48052|P1|Overall Study|Withdrew Consent|18
8646|NCT02291679|48050|P3|Overall Study|Protocol Violation|7
8647|NCT02291679|48051|P2|Overall Study|Protocol Violation|1
8648|NCT02291679|48052|P1|Overall Study|Protocol Violation|5
8649|NCT02291679|48050|P3|Overall Study|Adverse Event|19
8650|NCT02291679|48051|P2|Overall Study|Adverse Event|12
8651|NCT02291679|48052|P1|Overall Study|Adverse Event|2
8652|NCT02291510|48085|P4|Overall Study|Adverse Event|1
8653|NCT02291510|48086|P3|Overall Study|Adverse Event|0
8654|NCT02291510|48087|P2|Overall Study|Adverse Event|0
8655|NCT02291510|48088|P1|Overall Study|Adverse Event|0
8656|NCT02291419|48104|P2|Overall Study|Early study termination|5
8657|NCT02291419|48105|P1|Overall Study|Early study termination|1
8658|NCT02291237|48123|P2|Overall Study|Subject Required Prohibited Medication|0
8659|NCT02291237|48124|P1|Overall Study|Subject Required Prohibited Medication|2
8660|NCT02291237|48123|P2|Overall Study|Lost to Follow-up|2
8661|NCT02291237|48124|P1|Overall Study|Lost to Follow-up|0
8662|NCT02291237|48123|P2|Overall Study|Withdrew Consent|11
8663|NCT02291237|48124|P1|Overall Study|Withdrew Consent|11
8664|NCT02291237|48123|P2|Overall Study|Investigator's Discretion|3
8665|NCT02291237|48124|P1|Overall Study|Investigator's Discretion|0
8666|NCT02291237|48123|P2|Overall Study|Adverse Event|3
8667|NCT02291237|48124|P1|Overall Study|Adverse Event|1
8668|NCT02291237|48123|P2|Overall Study|Study Terminated by Sponsor|67
8669|NCT02291237|48124|P1|Overall Study|Study Terminated by Sponsor|72
8670|NCT02290821|48142|P2|Overall Study|Lost to Follow-up|2
8671|NCT02290821|48143|P1|Overall Study|Lost to Follow-up|3
8672|NCT02290821|48142|P2|Overall Study|Unable or unwilling to cooperate with|0
8673|NCT02290821|48143|P1|Overall Study|Unable or unwilling to cooperate with|2
8674|NCT02290821|48142|P2|Overall Study|Withdrawal by Subject|1
8675|NCT02290821|48143|P1|Overall Study|Withdrawal by Subject|1
8676|NCT02290691|48151|P2|Overall Study|Lost to Follow-up|7
8677|NCT02290691|48152|P1|Overall Study|Lost to Follow-up|7
8678|NCT02290691|48151|P2|Overall Study|Withdrawal by Subject|1
8679|NCT02290691|48152|P1|Overall Study|Withdrawal by Subject|1
8680|NCT02290691|48151|P2|Overall Study|Noncompliance|1
8681|NCT02290691|48152|P1|Overall Study|Noncompliance|0
8682|NCT02289963|48202|P2|Overall Study|Other than specified above|2
8683|NCT02289963|48203|P1|Overall Study|Other than specified above|0
8684|NCT02289963|48202|P2|Overall Study|End treatment visit outside visit window|4
8685|NCT02289963|48203|P1|Overall Study|End treatment visit outside visit window|0
8686|NCT02289963|48202|P2|Overall Study|Last injection missed|2
8687|NCT02289963|48203|P1|Overall Study|Last injection missed|2
8688|NCT02289963|48202|P2|Overall Study|Withdrawal by Subject|0
8689|NCT02289963|48203|P1|Overall Study|Withdrawal by Subject|1
8690|NCT02289963|48202|P2|Overall Study|Poor compliance to protocol|0
8691|NCT02289963|48203|P1|Overall Study|Poor compliance to protocol|1
8692|NCT02289963|48202|P2|Overall Study|Adverse Event|2
8693|NCT02289963|48203|P1|Overall Study|Adverse Event|1
8694|NCT02289833|48253|P2|Overall Study|Death|8
8695|NCT02289833|48254|P1|Overall Study|Death|15
8696|NCT02289833|48253|P2|Overall Study|Lost to Follow-up|0
8697|NCT02289833|48254|P1|Overall Study|Lost to Follow-up|2
8698|NCT02289833|48253|P2|Overall Study|Disease Progression|3
8699|NCT02289833|48254|P1|Overall Study|Disease Progression|0
8700|NCT02289833|48253|P2|Overall Study|Clinical Progression|1
8701|NCT02289833|48254|P1|Overall Study|Clinical Progression|0
8702|NCT02289833|48253|P2|Overall Study|Continued Participation in Study|8
8703|NCT02289833|48254|P1|Overall Study|Continued Participation in Study|12
8704|NCT02289820|48292|P7|Overall Study|withdrawal of consent|0
8705|NCT02289820|48293|P6|Overall Study|withdrawal of consent|0
8706|NCT02289820|48294|P5|Overall Study|withdrawal of consent|0
8707|NCT02289820|48295|P4|Overall Study|withdrawal of consent|0
8708|NCT02289820|48296|P3|Overall Study|withdrawal of consent|0
8709|NCT02289820|48297|P2|Overall Study|withdrawal of consent|1
8710|NCT02289820|48298|P1|Overall Study|withdrawal of consent|0
8711|NCT02289820|48292|P7|Overall Study|Lost to Follow-up|1
8712|NCT02289820|48293|P6|Overall Study|Lost to Follow-up|1
8713|NCT02289820|48294|P5|Overall Study|Lost to Follow-up|0
8714|NCT02289820|48295|P4|Overall Study|Lost to Follow-up|1
8715|NCT02289820|48296|P3|Overall Study|Lost to Follow-up|3
8716|NCT02289820|48297|P2|Overall Study|Lost to Follow-up|0
8717|NCT02289820|48298|P1|Overall Study|Lost to Follow-up|0
8718|NCT02289820|48292|P7|Overall Study|Death|0
8719|NCT02289820|48293|P6|Overall Study|Death|0
8720|NCT02289820|48294|P5|Overall Study|Death|0
8721|NCT02289820|48295|P4|Overall Study|Death|0
8722|NCT02289820|48296|P3|Overall Study|Death|1
8723|NCT02289820|48297|P2|Overall Study|Death|0
8724|NCT02289820|48298|P1|Overall Study|Death|0
8725|NCT02289820|48292|P7|Overall Study|Withdrawal by Subject|1
8726|NCT02289820|48293|P6|Overall Study|Withdrawal by Subject|0
8727|NCT02289820|48294|P5|Overall Study|Withdrawal by Subject|0
8728|NCT02289820|48295|P4|Overall Study|Withdrawal by Subject|1
8729|NCT02289820|48296|P3|Overall Study|Withdrawal by Subject|2
8730|NCT02289820|48297|P2|Overall Study|Withdrawal by Subject|1
8731|NCT02289820|48298|P1|Overall Study|Withdrawal by Subject|2
8732|NCT02289742|48416|P4|Third Wear Period|Reason not given|1
8733|NCT02289742|48417|P3|Third Wear Period|Reason not given|0
8734|NCT02289742|48418|P2|Third Wear Period|Reason not given|0
8735|NCT02289742|48419|P1|Third Wear Period|Reason not given|0
8736|NCT02289742|48416|P4|Third Wear Period|Adverse Event|0
8737|NCT02289742|48417|P3|Third Wear Period|Adverse Event|0
8738|NCT02289742|48418|P2|Third Wear Period|Adverse Event|1
8739|NCT02289742|48419|P1|Third Wear Period|Adverse Event|0
8740|NCT02289742|48416|P4|First Wear Period|Other prior to treatment|1
8741|NCT02289742|48417|P3|First Wear Period|Other prior to treatment|0
8742|NCT02289742|48418|P2|First Wear Period|Other prior to treatment|0
8743|NCT02289742|48419|P1|First Wear Period|Other prior to treatment|0
8744|NCT02289742|48416|P4|First Wear Period|Adverse Event|0
8745|NCT02289742|48417|P3|First Wear Period|Adverse Event|1
8746|NCT02289742|48418|P2|First Wear Period|Adverse Event|0
8747|NCT02289742|48419|P1|First Wear Period|Adverse Event|0
8748|NCT02289742|48416|P4|First Wear Period|Adverse event prior to treatment|0
8749|NCT02289742|48417|P3|First Wear Period|Adverse event prior to treatment|0
8750|NCT02289742|48418|P2|First Wear Period|Adverse event prior to treatment|1
8751|NCT02289742|48419|P1|First Wear Period|Adverse event prior to treatment|0
8752|NCT02289469|48438|P2|Overall Study|Unable to match a control|0
8753|NCT02289469|48439|P1|Overall Study|Unable to match a control|6
8754|NCT02289456|48447|P1|Monotherapy Period|Miscellaneous|1
8755|NCT02289456|48447|P1|Monotherapy Period|Study Terminated by Sponsor|2
8756|NCT02289456|48447|P1|Monotherapy Period|Withdrawal by Subject|2
8757|NCT02289456|48447|P1|Monotherapy Period|Symptomatic Deterioration|1
8758|NCT02289456|48447|P1|Monotherapy Period|Progressive Disease (PD)|8
8759|NCT02289456|48447|P1|Monotherapy Period|Adverse Event|1
8760|NCT02289456|48447|P1|Monotherapy Period|Death|1
8761|NCT02289456|48447|P1|Induction Period|Miscellaneous|1
8762|NCT02289456|48447|P1|Induction Period|Withdrawal by Subject|2
8763|NCT02289456|48447|P1|Induction Period|Symptomatic Deterioration|4
8764|NCT02289456|48447|P1|Induction Period|Progressive Disease (PD)|4
8765|NCT02289456|48447|P1|Induction Period|Adverse Event|11
8766|NCT02289456|48447|P1|Induction Period|Death|2
8767|NCT02289079|48482|P2|Overall Study|Lost to Follow-up|1
8768|NCT02289079|48483|P1|Overall Study|Lost to Follow-up|0
8769|NCT02289079|48482|P2|Overall Study|Physician Decision|0
8770|NCT02289079|48483|P1|Overall Study|Physician Decision|2
8771|NCT02288312|48525|P3|Overall Study|Pregnancy|0
8772|NCT02288312|48526|P2|Overall Study|Pregnancy|0
8773|NCT02288312|48527|P1|Overall Study|Pregnancy|1
8774|NCT02288091|48565|P1|Overall Study|Screen fail|7
8775|NCT02288091|48565|P1|Overall Study|Lost to Follow-up|1
8776|NCT02287883|48575|P2|Overall Study|Non-response to survey|237
8777|NCT02287883|48576|P1|Overall Study|Non-response to survey|229
8778|NCT02287883|48575|P2|Overall Study|No longer eligible|182
8779|NCT02287883|48576|P1|Overall Study|No longer eligible|222
8780|NCT02287883|48575|P2|Overall Study|Death|7
8781|NCT02287883|48576|P1|Overall Study|Death|8
8782|NCT02287623|48741|P2|Overall Study|Protocol Violation|1
8783|NCT02287623|48742|P1|Overall Study|Protocol Violation|0
8784|NCT02287610|48758|P1|Overall Study|Excluded-investigator non-responsiveness|5
8785|NCT02287610|48758|P1|Overall Study|Withdrawal by Subject|8
8786|NCT02287610|48758|P1|Overall Study|Lost to Follow-up|3
8787|NCT02287402|48797|P1|Follow-up|Voluntary Withdrawal|2
8788|NCT02287402|48797|P1|Follow-up|Lost to Follow-up|1
8789|NCT02287402|48797|P1|Treatment Period|Voluntary Withdrawal|10
8790|NCT02287402|48797|P1|Treatment Period|Adverse Event|17
8791|NCT02287025|48902|P2|Overall Study|Screening failed|1
8792|NCT02287025|48903|P1|Overall Study|Screening failed|1
8793|NCT02287025|48902|P2|Overall Study|Withdrawal by Subject|2
8794|NCT02287025|48903|P1|Overall Study|Withdrawal by Subject|2
8795|NCT02287025|48902|P2|Overall Study|Adverse Event|4
8796|NCT02287025|48903|P1|Overall Study|Adverse Event|2
8797|NCT02287025|48902|P2|Overall Study|Progression of disease|2
8798|NCT02287025|48903|P1|Overall Study|Progression of disease|3
8799|NCT02287025|48902|P2|Overall Study|Not treated|0
8800|NCT02287025|48903|P1|Overall Study|Not treated|2
8801|NCT02286193|49079|P1|Overall Study|Referred: Declined service|38
8802|NCT02286193|49079|P1|Overall Study|Referred: unable to reach/resource sent|104
8803|NCT02286193|49079|P1|Overall Study|Referred: CRS unable to make contact|62
8804|NCT02286102|49086|P2|Overall Study|Screen Failure|1
8805|NCT02286102|49087|P1|Overall Study|Screen Failure|1
8806|NCT02285998|49099|P2|Overall Study|Other Reasons|10
8807|NCT02285998|49100|P1|Overall Study|Other Reasons|7
8808|NCT02285998|49099|P2|Overall Study|Withdrawal by Subject|61
8809|NCT02285998|49100|P1|Overall Study|Withdrawal by Subject|53
8810|NCT02285998|49099|P2|Overall Study|Lost to Follow-up|172
8811|NCT02285998|49100|P1|Overall Study|Lost to Follow-up|176
8812|NCT02285998|49099|P2|Overall Study|Physician Decision|2
8813|NCT02285998|49100|P1|Overall Study|Physician Decision|1
8814|NCT02285998|49099|P2|Overall Study|Adverse Event|8
8815|NCT02285998|49100|P1|Overall Study|Adverse Event|9
8816|NCT02285777|49152|P2|Overall Study|Lost to Follow-up|2
8817|NCT02285777|49153|P1|Overall Study|Lost to Follow-up|4
8818|NCT02285777|49152|P2|Overall Study|Withdrawal by Subject|1
8819|NCT02285777|49153|P1|Overall Study|Withdrawal by Subject|1
8820|NCT02285270|49185|P1|Overall Study|Determined to be ineligible|1
8821|NCT02285270|49185|P1|Overall Study|Physician Decision|3
8822|NCT02285270|49185|P1|Overall Study|Lost to Follow-up|1
8823|NCT02284347|49278|P1|Overall Study|Withdrawn prior to treatment|1
8824|NCT02284347|49278|P1|Overall Study|Lost to Follow-up|2
8825|NCT02284243|49286|P2|Overall Study|Adverse Event|0
8826|NCT02284243|49287|P1|Overall Study|Adverse Event|1
8827|NCT02284243|49286|P2|Overall Study|Lack of Efficacy|3
8828|NCT02284243|49287|P1|Overall Study|Lack of Efficacy|3
8829|NCT02283788|49383|P4|Overall Study|Withdrawal by Subject|1
8830|NCT02283788|49384|P3|Overall Study|Withdrawal by Subject|0
8831|NCT02283788|49385|P2|Overall Study|Withdrawal by Subject|1
8832|NCT02283788|49386|P1|Overall Study|Withdrawal by Subject|0
8833|NCT02283788|49383|P4|Overall Study|Adverse Event|1
8834|NCT02283788|49384|P3|Overall Study|Adverse Event|5
8835|NCT02283788|49385|P2|Overall Study|Adverse Event|3
8836|NCT02283788|49386|P1|Overall Study|Adverse Event|1
8837|NCT02283411|49396|P1|Overall Study|Screen Failed|28
8838|NCT02283411|49396|P1|Overall Study|Withdrawal by Subject|3
8839|NCT02283268|49404|P1|Overall Study|Withdrawal by Subject|1
8840|NCT02282982|49465|P1|Overall Study|Other, not specified|18
8841|NCT02282982|49465|P1|Overall Study|Palivizumab is ended|11
8842|NCT02282982|49465|P1|Overall Study|Lack of product|156
8843|NCT02282982|49465|P1|Overall Study|Death|4
8844|NCT02282982|49465|P1|Overall Study|Withdrew consent|2
8845|NCT02282982|49465|P1|Overall Study|Lost to Follow-up|15
8846|NCT02282813|49483|P3|Overall Study|Administrative reasons|0
8847|NCT02282813|49484|P2|Overall Study|Administrative reasons|1
8848|NCT02282813|49485|P1|Overall Study|Administrative reasons|0
8849|NCT02282813|49483|P3|Overall Study|Lack of Efficacy|0
8850|NCT02282813|49484|P2|Overall Study|Lack of Efficacy|0
8851|NCT02282813|49485|P1|Overall Study|Lack of Efficacy|1
8852|NCT02282813|49483|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
8853|NCT02282813|49484|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
8854|NCT02282813|49485|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
8855|NCT02282813|49483|P3|Overall Study|Lost to Follow-up|1
8856|NCT02282813|49484|P2|Overall Study|Lost to Follow-up|0
8857|NCT02282813|49485|P1|Overall Study|Lost to Follow-up|2
8858|NCT02282813|49483|P3|Overall Study|Physician Decision|1
8859|NCT02282813|49484|P2|Overall Study|Physician Decision|3
8860|NCT02282813|49485|P1|Overall Study|Physician Decision|0
8861|NCT02282813|49483|P3|Overall Study|Subject non-compliance|0
8862|NCT02282813|49484|P2|Overall Study|Subject non-compliance|4
8863|NCT02282813|49485|P1|Overall Study|Subject non-compliance|1
8864|NCT02282813|49483|P3|Overall Study|Adverse Event|1
8865|NCT02282813|49484|P2|Overall Study|Adverse Event|10
8866|NCT02282813|49485|P1|Overall Study|Adverse Event|3
8867|NCT02282813|49483|P3|Overall Study|Withdrawal by Subject|0
8868|NCT02282813|49484|P2|Overall Study|Withdrawal by Subject|5
8869|NCT02282813|49485|P1|Overall Study|Withdrawal by Subject|4
8870|NCT02282631|49531|P2|Overall Study|Lost to Follow-up|0
8871|NCT02282631|49532|P1|Overall Study|Lost to Follow-up|2
8872|NCT02282605|49573|P3|Overall Study|negative SA result on Day -1|0
8873|NCT02282605|49574|P2|Overall Study|negative SA result on Day -1|0
8874|NCT02282605|49575|P1|Overall Study|negative SA result on Day -1|3
8875|NCT02282527|49597|P2|Overall Study|Lack of home health aid|0
8876|NCT02282527|49598|P1|Overall Study|Lack of home health aid|1
8877|NCT02282527|49597|P2|Overall Study|Lost to Follow-up|1
8878|NCT02282527|49598|P1|Overall Study|Lost to Follow-up|0
8879|NCT02281773|49613|P5|Overall Study|Other Reason|1
8880|NCT02281773|49614|P4|Overall Study|Other Reason|3
8881|NCT02281773|49615|P3|Overall Study|Other Reason|2
8882|NCT02281773|49616|P2|Overall Study|Other Reason|4
8883|NCT02281773|49617|P1|Overall Study|Other Reason|0
8884|NCT02281773|49613|P5|Overall Study|Withdrawal by Subject|8
8885|NCT02281773|49614|P4|Overall Study|Withdrawal by Subject|6
8886|NCT02281773|49615|P3|Overall Study|Withdrawal by Subject|6
8887|NCT02281773|49616|P2|Overall Study|Withdrawal by Subject|8
8888|NCT02281773|49617|P1|Overall Study|Withdrawal by Subject|2
8889|NCT02281773|49613|P5|Overall Study|Lost to Follow-up|10
8890|NCT02281773|49614|P4|Overall Study|Lost to Follow-up|2
8891|NCT02281773|49615|P3|Overall Study|Lost to Follow-up|6
8892|NCT02281773|49616|P2|Overall Study|Lost to Follow-up|2
8893|NCT02281773|49617|P1|Overall Study|Lost to Follow-up|2
8894|NCT02281773|49613|P5|Overall Study|Protocol Violation|2
8895|NCT02281773|49614|P4|Overall Study|Protocol Violation|2
8896|NCT02281773|49615|P3|Overall Study|Protocol Violation|0
8897|NCT02281773|49616|P2|Overall Study|Protocol Violation|0
8898|NCT02281773|49617|P1|Overall Study|Protocol Violation|1
8899|NCT02281773|49613|P5|Overall Study|Adverse Event|9
8900|NCT02281773|49614|P4|Overall Study|Adverse Event|8
8901|NCT02281773|49615|P3|Overall Study|Adverse Event|4
8902|NCT02281773|49616|P2|Overall Study|Adverse Event|1
8903|NCT02281773|49617|P1|Overall Study|Adverse Event|6
8904|NCT02281357|49758|P2|Overall Study|Withdrawal by Subject|3
8905|NCT02281357|49759|P1|Overall Study|Withdrawal by Subject|4
8906|NCT02281357|49758|P2|Overall Study|Lost to Follow-up|0
8907|NCT02281357|49759|P1|Overall Study|Lost to Follow-up|1
8908|NCT02281357|49758|P2|Overall Study|Adverse Event|1
8909|NCT02281357|49759|P1|Overall Study|Adverse Event|2
8910|NCT02281318|49773|P2|Overall Study|Withdrawal by Subject|2
8911|NCT02281318|49774|P1|Overall Study|Withdrawal by Subject|6
8912|NCT02281318|49773|P2|Overall Study|Physician Decision|0
8913|NCT02281318|49774|P1|Overall Study|Physician Decision|2
8914|NCT02281318|49773|P2|Overall Study|Lost to Follow-up|1
8915|NCT02281318|49774|P1|Overall Study|Lost to Follow-up|2
8916|NCT02281318|49773|P2|Overall Study|Lack of Efficacy|0
8917|NCT02281318|49774|P1|Overall Study|Lack of Efficacy|2
8918|NCT02281318|49773|P2|Overall Study|Adverse Event|2
8919|NCT02281318|49774|P1|Overall Study|Adverse Event|2
8920|NCT02280499|49877|P1|Overall Study|Adverse Event|5
8921|NCT02280499|49877|P1|Overall Study|Lost to Follow-up|42
8922|NCT02280499|49877|P1|Overall Study|Death|14
8923|NCT02280473|49885|P2|Overall Study|Lost to Follow-up|1
8924|NCT02280473|49886|P1|Overall Study|Lost to Follow-up|0
8925|NCT02280473|49885|P2|Overall Study|Lack of Efficacy|1
8926|NCT02280473|49886|P1|Overall Study|Lack of Efficacy|0
8927|NCT02280473|49885|P2|Overall Study|Adverse Event|1
8928|NCT02280473|49886|P1|Overall Study|Adverse Event|1
8929|NCT02280187|49905|P1|Overall Study|Lost to Follow-up|218
8930|NCT02279420|50011|P1|Overall Study|Lost to Follow-up|23
8931|NCT02279407|50019|P4|Overall Study|Adverse Event|0
8932|NCT02279407|50020|P3|Overall Study|Adverse Event|2
8933|NCT02279407|50021|P2|Overall Study|Adverse Event|1
8934|NCT02279407|50022|P1|Overall Study|Adverse Event|1
8935|NCT02279407|50019|P4|Overall Study|Withdrawal by Subject|1
8936|NCT02279407|50020|P3|Overall Study|Withdrawal by Subject|1
8937|NCT02279407|50021|P2|Overall Study|Withdrawal by Subject|0
8938|NCT02279407|50022|P1|Overall Study|Withdrawal by Subject|1
8939|NCT02279407|50019|P4|Overall Study|Couldn't swallow IP; noncompliance|0
8940|NCT02279407|50020|P3|Overall Study|Couldn't swallow IP; noncompliance|2
8941|NCT02279407|50021|P2|Overall Study|Couldn't swallow IP; noncompliance|0
8942|NCT02279407|50022|P1|Overall Study|Couldn't swallow IP; noncompliance|0
8943|NCT02278614|50078|P2|Overall Study|left eye was not eligible|0
8944|NCT02278614|50079|P1|Overall Study|left eye was not eligible|1
8945|NCT02278614|50078|P2|Overall Study|Adverse Event|0
8946|NCT02278614|50079|P1|Overall Study|Adverse Event|1
8947|NCT02278614|50078|P2|Overall Study|Withdrawal by Subject|5
8948|NCT02278614|50079|P1|Overall Study|Withdrawal by Subject|3
8949|NCT02278003|50126|P2|Overall Study|Recognition task improperly completed|0
8950|NCT02278003|50127|P1|Overall Study|Recognition task improperly completed|7
8951|NCT02278003|50126|P2|Overall Study|Not Treated|0
8952|NCT02278003|50127|P1|Overall Study|Not Treated|1
8953|NCT02278003|50126|P2|Overall Study|Withdrawal by Subject|0
8954|NCT02278003|50127|P1|Overall Study|Withdrawal by Subject|11
8955|NCT02277769|50138|P3|Overall Study|Other than specified above|5
8956|NCT02277769|50139|P2|Overall Study|Other than specified above|8
8957|NCT02277769|50140|P1|Overall Study|Other than specified above|12
8958|NCT02277769|50138|P3|Overall Study|Adverse Event|4
8959|NCT02277769|50139|P2|Overall Study|Adverse Event|2
8960|NCT02277769|50140|P1|Overall Study|Adverse Event|14
8961|NCT02277769|50138|P3|Overall Study|Lack of Efficacy|4
8962|NCT02277769|50139|P2|Overall Study|Lack of Efficacy|0
8963|NCT02277769|50140|P1|Overall Study|Lack of Efficacy|17
8964|NCT02277769|50138|P3|Overall Study|Protocol Violation|5
8965|NCT02277769|50139|P2|Overall Study|Protocol Violation|3
8966|NCT02277769|50140|P1|Overall Study|Protocol Violation|3
8967|NCT02277743|50211|P3|Overall Study|Other than specified above|16
8968|NCT02277743|50212|P2|Overall Study|Other than specified above|5
8969|NCT02277743|50213|P1|Overall Study|Other than specified above|18
8970|NCT02277743|50211|P3|Overall Study|Lack of Efficacy|3
8971|NCT02277743|50212|P2|Overall Study|Lack of Efficacy|4
8972|NCT02277743|50213|P1|Overall Study|Lack of Efficacy|11
8973|NCT02277743|50211|P3|Overall Study|Adverse Event|6
8974|NCT02277743|50212|P2|Overall Study|Adverse Event|6
8975|NCT02277743|50213|P1|Overall Study|Adverse Event|10
8976|NCT02277743|50211|P3|Overall Study|Protocol Violation|1
8977|NCT02277743|50212|P2|Overall Study|Protocol Violation|1
8978|NCT02277743|50213|P1|Overall Study|Protocol Violation|1
8979|NCT02277691|50281|P1|Overall Study|Used Other Antihypertensive Drug|1
8980|NCT02277691|50281|P1|Overall Study|Lack of Efficacy|5
8981|NCT02277691|50281|P1|Overall Study|Voluntary Withdrawal|7
8982|NCT02277691|50281|P1|Overall Study|Pretreatment Event/Adverse Event|33
8983|NCT02277119|50327|P3|Overall Study|Protocol Violation|7
8984|NCT02277119|50328|P2|Overall Study|Protocol Violation|3
8985|NCT02277119|50329|P1|Overall Study|Protocol Violation|2
8986|NCT02277119|50327|P3|Overall Study|Lack of Efficacy|1
8987|NCT02277119|50328|P2|Overall Study|Lack of Efficacy|1
8988|NCT02277119|50329|P1|Overall Study|Lack of Efficacy|1
8989|NCT02276612|50356|P2|Overall Study|Lost to Follow-up|0
8990|NCT02276612|50357|P1|Overall Study|Lost to Follow-up|1
8991|NCT02276612|50356|P2|Overall Study|Withdrew Consent|0
8992|NCT02276612|50357|P1|Overall Study|Withdrew Consent|1
8993|NCT02276612|50356|P2|Overall Study|Pregnancy|0
8994|NCT02276612|50357|P1|Overall Study|Pregnancy|1
8995|NCT02276612|50356|P2|Overall Study|Death|0
8996|NCT02276612|50357|P1|Overall Study|Death|1
8997|NCT02276560|50380|P3|Overall Study|Adverse Event|0
8998|NCT02276560|50381|P2|Overall Study|Adverse Event|0
8999|NCT02276560|50382|P1|Overall Study|Adverse Event|1
9000|NCT02276222|50503|P2|Overall Study|subject withdrew after randomization|0
9001|NCT02276222|50504|P1|Overall Study|subject withdrew after randomization|1
9002|NCT02276222|50503|P2|Overall Study|sheduling conflict|0
9003|NCT02276222|50504|P1|Overall Study|sheduling conflict|1
9004|NCT02276222|50503|P2|Overall Study|Physician Decision|1
9005|NCT02276222|50504|P1|Overall Study|Physician Decision|2
9006|NCT02276222|50503|P2|Overall Study|Lost to Follow-up|5
9007|NCT02276222|50504|P1|Overall Study|Lost to Follow-up|15
9008|NCT02276222|50503|P2|Overall Study|sponsor decision|3
9009|NCT02276222|50504|P1|Overall Study|sponsor decision|0
9010|NCT02276222|50503|P2|Overall Study|non compliance with study medication|2
9011|NCT02276222|50504|P1|Overall Study|non compliance with study medication|6
9012|NCT02276222|50503|P2|Overall Study|Withdrawal by Subject|33
9013|NCT02276222|50504|P1|Overall Study|Withdrawal by Subject|79
9014|NCT02276222|50503|P2|Overall Study|Protocol Violation|2
9015|NCT02276222|50504|P1|Overall Study|Protocol Violation|3
9016|NCT02276222|50503|P2|Overall Study|Lack of Efficacy|3
9017|NCT02276222|50504|P1|Overall Study|Lack of Efficacy|13
9018|NCT02276222|50503|P2|Overall Study|Death|4
9019|NCT02276222|50504|P1|Overall Study|Death|3
9020|NCT02276222|50503|P2|Overall Study|Adverse Event|11
9021|NCT02276222|50504|P1|Overall Study|Adverse Event|62
9022|NCT02276040|50528|P1|Overall Study|Physician Decision|15
9023|NCT02275611|50552|P4|Inpatient Withdrawal|Withdrawal by Subject|0
9024|NCT02275611|50553|P3|Inpatient Withdrawal|Withdrawal by Subject|0
9025|NCT02275611|50554|P2|Inpatient Withdrawal|Withdrawal by Subject|0
9026|NCT02275611|50555|P1|Inpatient Withdrawal|Withdrawal by Subject|1
9027|NCT02275546|50567|P2|Treatment Period 2|Protocol Violation|1
9028|NCT02275546|50568|P1|Treatment Period 2|Protocol Violation|0
9029|NCT02275546|50567|P2|Treatment Period 2|Withdrawal by Subject|1
9030|NCT02275546|50568|P1|Treatment Period 2|Withdrawal by Subject|2
9031|NCT02275481|50578|P2|Overall Study|Physician Decision|1
9032|NCT02275481|50579|P1|Overall Study|Physician Decision|0
9033|NCT02275481|50578|P2|Overall Study|all other reasons combined|1
9034|NCT02275481|50579|P1|Overall Study|all other reasons combined|2
9035|NCT02275481|50578|P2|Overall Study|Withdrawal by Subject|0
9036|NCT02275481|50579|P1|Overall Study|Withdrawal by Subject|3
9037|NCT02275481|50578|P2|Overall Study|Lost to Follow-up|0
9038|NCT02275481|50579|P1|Overall Study|Lost to Follow-up|2
9039|NCT02275481|50578|P2|Overall Study|Death|1
9040|NCT02275481|50579|P1|Overall Study|Death|2
9041|NCT02275364|50585|P2|Period 1|Other reason|0
9042|NCT02275364|50586|P1|Period 1|Other reason|1
9043|NCT02275364|50585|P2|Period 1|Withdrawal by Subject|0
9044|NCT02275364|50586|P1|Period 1|Withdrawal by Subject|1
9045|NCT02275052|50647|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
9046|NCT02275052|50648|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
9047|NCT02275052|50649|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
9048|NCT02275052|50650|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
9049|NCT02275052|50647|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
9050|NCT02275052|50648|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
9051|NCT02275052|50649|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
9052|NCT02275052|50650|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
9053|NCT02275052|50647|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
9054|NCT02275052|50648|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
9055|NCT02275052|50649|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
9056|NCT02275052|50650|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
9057|NCT02275052|50647|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
9058|NCT02275052|50648|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
9059|NCT02275052|50649|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
9060|NCT02275052|50650|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
9061|NCT02275052|50647|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
9062|NCT02275052|50648|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
9063|NCT02275052|50649|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
9064|NCT02275052|50650|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
9065|NCT02275052|50647|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
9066|NCT02275052|50648|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
9067|NCT02275052|50649|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
9068|NCT02275052|50650|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
9069|NCT02275052|50647|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
9070|NCT02275052|50648|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
9071|NCT02275052|50649|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
9072|NCT02275052|50650|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
9073|NCT02275052|50647|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
9074|NCT02275052|50648|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
9075|NCT02275052|50649|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
9076|NCT02275052|50650|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
9077|NCT02275052|50647|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
9078|NCT02275052|50648|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
9079|NCT02275052|50649|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
9080|NCT02275052|50650|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
9081|NCT02275052|50647|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
9082|NCT02275052|50648|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
9083|NCT02275052|50649|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
9084|NCT02275052|50650|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
9085|NCT02275052|50647|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
9086|NCT02275052|50648|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
9087|NCT02275052|50649|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
9088|NCT02275052|50650|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
9089|NCT02274948|50664|P2|Overall Study|Left the area|3
9090|NCT02274948|50665|P1|Overall Study|Left the area|4
9091|NCT02274948|50664|P2|Overall Study|Stopped on family Practitioner advice|5
9092|NCT02274948|50665|P1|Overall Study|Stopped on family Practitioner advice|2
9093|NCT02274948|50664|P2|Overall Study|Withdrawal by Subject|58
9094|NCT02274948|50665|P1|Overall Study|Withdrawal by Subject|64
9095|NCT02274948|50664|P2|Overall Study|Lost to Follow-up|25
9096|NCT02274948|50665|P1|Overall Study|Lost to Follow-up|28
9097|NCT02274792|50679|P1|Overall Study|Sponsor Decision|2
9098|NCT02274792|50679|P1|Overall Study|Protocol Specified Criteria|2
9099|NCT02274792|50679|P1|Overall Study|Lost to Follow-up|8
9100|NCT02274792|50679|P1|Overall Study|Withdrawal by Subject|13
9101|NCT02274766|50689|P2|Overall Study|Adverse Event|1
9102|NCT02274766|50690|P1|Overall Study|Adverse Event|0
9103|NCT02274766|50689|P2|Overall Study|Subject Unwilling to Proceed|1
9104|NCT02274766|50690|P1|Overall Study|Subject Unwilling to Proceed|0
9105|NCT02274766|50689|P2|Overall Study|Did Not Receive Study Drug|1
9106|NCT02274766|50690|P1|Overall Study|Did Not Receive Study Drug|1
9107|NCT02274766|50689|P2|Overall Study|Withdrawal by Subject|6
9108|NCT02274766|50690|P1|Overall Study|Withdrawal by Subject|3
9109|NCT02274558|50736|P3|Overall Study|Physician Decision|1
9110|NCT02274558|50737|P2|Overall Study|Physician Decision|2
9111|NCT02274558|50738|P1|Overall Study|Physician Decision|0
9112|NCT02274558|50736|P3|Overall Study|Lost to Follow-up|1
9113|NCT02274558|50737|P2|Overall Study|Lost to Follow-up|1
9114|NCT02274558|50738|P1|Overall Study|Lost to Follow-up|2
9115|NCT02274558|50736|P3|Overall Study|Death|1
9116|NCT02274558|50737|P2|Overall Study|Death|0
9117|NCT02274558|50738|P1|Overall Study|Death|0
9118|NCT02274558|50736|P3|Overall Study|Withdrawal by Subject|4
9119|NCT02274558|50737|P2|Overall Study|Withdrawal by Subject|5
9120|NCT02274558|50738|P1|Overall Study|Withdrawal by Subject|1
9121|NCT02274558|50736|P3|Overall Study|Non-compliance|0
9122|NCT02274558|50737|P2|Overall Study|Non-compliance|1
9123|NCT02274558|50738|P1|Overall Study|Non-compliance|2
9124|NCT02274558|50736|P3|Overall Study|Adverse Event|2
9125|NCT02274558|50737|P2|Overall Study|Adverse Event|4
9126|NCT02274558|50738|P1|Overall Study|Adverse Event|2
9127|NCT02273973|50754|P2|Overall Study|Reason not specified|1
9128|NCT02273973|50755|P1|Overall Study|Reason not specified|0
9129|NCT02273973|50754|P2|Overall Study|Physician Decision|1
9130|NCT02273973|50755|P1|Overall Study|Physician Decision|0
9131|NCT02273973|50754|P2|Overall Study|Lost to Follow-up|1
9132|NCT02273973|50755|P1|Overall Study|Lost to Follow-up|0
9133|NCT02273973|50754|P2|Overall Study|Progression of disease|2
9134|NCT02273973|50755|P1|Overall Study|Progression of disease|0
9135|NCT02273973|50754|P2|Overall Study|Protocol Violation|0
9136|NCT02273973|50755|P1|Overall Study|Protocol Violation|1
9137|NCT02273973|50754|P2|Overall Study|Non-compliance|0
9138|NCT02273973|50755|P1|Overall Study|Non-compliance|1
9139|NCT02273973|50754|P2|Overall Study|Death|0
9140|NCT02273973|50755|P1|Overall Study|Death|1
9141|NCT02273973|50754|P2|Overall Study|Withdrawal by Subject|3
9142|NCT02273973|50755|P1|Overall Study|Withdrawal by Subject|2
9143|NCT02273973|50754|P2|Overall Study|Adverse Event|0
9144|NCT02273973|50755|P1|Overall Study|Adverse Event|4
9145|NCT02273908|50797|P2|Overall Study|Withdrawal by Subject|2
9146|NCT02273908|50798|P1|Overall Study|Withdrawal by Subject|4
9147|NCT02273908|50797|P2|Overall Study|Did not meet entrance criteria|2
9148|NCT02273908|50798|P1|Overall Study|Did not meet entrance criteria|3
9149|NCT02273908|50797|P2|Overall Study|Lost to Follow-up|1
9150|NCT02273908|50798|P1|Overall Study|Lost to Follow-up|10
9151|NCT02273908|50797|P2|Overall Study|Adverse Event|0
9152|NCT02273908|50798|P1|Overall Study|Adverse Event|16
9153|NCT02273752|50820|P1|Overall Study|Trial was terminated early|2
9154|NCT02273180|50864|P2|Overall Study|Other than specified above|10
9155|NCT02273180|50865|P1|Overall Study|Other than specified above|21
9156|NCT02273180|50864|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
9157|NCT02273180|50865|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
9158|NCT02273180|50864|P2|Overall Study|Randomized but not treated|0
9159|NCT02273180|50865|P1|Overall Study|Randomized but not treated|1
9160|NCT02273180|50864|P2|Overall Study|Protocol Violation|7
9161|NCT02273180|50865|P1|Overall Study|Protocol Violation|1
9162|NCT02273180|50864|P2|Overall Study|Lack of Efficacy|0
9163|NCT02273180|50865|P1|Overall Study|Lack of Efficacy|1
9164|NCT02273180|50864|P2|Overall Study|Adverse Event|2
9165|NCT02273180|50865|P1|Overall Study|Adverse Event|2
9166|NCT02273167|50890|P3|Overall Study|Various|8
9167|NCT02273167|50891|P2|Overall Study|Various|9
9168|NCT02273167|50892|P1|Overall Study|Various|10
9169|NCT02273167|50890|P3|Overall Study|Withdrawal by Subject|11
9170|NCT02273167|50891|P2|Overall Study|Withdrawal by Subject|12
9171|NCT02273167|50892|P1|Overall Study|Withdrawal by Subject|10
9172|NCT02273167|50890|P3|Overall Study|Lost to Follow-up|1
9173|NCT02273167|50891|P2|Overall Study|Lost to Follow-up|1
9174|NCT02273167|50892|P1|Overall Study|Lost to Follow-up|0
9175|NCT02273167|50890|P3|Overall Study|Protocol Violation|1
9176|NCT02273167|50891|P2|Overall Study|Protocol Violation|1
9177|NCT02273167|50892|P1|Overall Study|Protocol Violation|3
9178|NCT02273167|50890|P3|Overall Study|Adverse Event|0
9179|NCT02273167|50891|P2|Overall Study|Adverse Event|0
9180|NCT02273167|50892|P1|Overall Study|Adverse Event|1
9181|NCT02273141|50917|P2|Overall Study|Various|6
9182|NCT02273141|50918|P1|Overall Study|Various|6
9183|NCT02273141|50917|P2|Overall Study|Withdrawal by Subject|15
9184|NCT02273141|50918|P1|Overall Study|Withdrawal by Subject|10
9185|NCT02273141|50917|P2|Overall Study|Lost to Follow-up|3
9186|NCT02273141|50918|P1|Overall Study|Lost to Follow-up|1
9187|NCT02273141|50917|P2|Overall Study|Adverse Event|1
9188|NCT02273141|50918|P1|Overall Study|Adverse Event|0
9189|NCT02273050|50986|P3|Overall Study|Protocol Violation|4
9190|NCT02273050|50987|P2|Overall Study|Protocol Violation|1
9191|NCT02273050|50988|P1|Overall Study|Protocol Violation|3
9192|NCT02273050|50986|P3|Overall Study|Lost to Follow-up|3
9193|NCT02273050|50987|P2|Overall Study|Lost to Follow-up|2
9194|NCT02273050|50988|P1|Overall Study|Lost to Follow-up|0
9195|NCT02273050|50986|P3|Overall Study|Withdrawal by Subject|16
9196|NCT02273050|50987|P2|Overall Study|Withdrawal by Subject|14
9197|NCT02273050|50988|P1|Overall Study|Withdrawal by Subject|17
9198|NCT02273050|50986|P3|Overall Study|Lack of Efficacy|1
9199|NCT02273050|50987|P2|Overall Study|Lack of Efficacy|1
9200|NCT02273050|50988|P1|Overall Study|Lack of Efficacy|0
9201|NCT02273050|50986|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
9202|NCT02273050|50987|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
9203|NCT02273050|50988|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
9204|NCT02273050|50986|P3|Overall Study|Death|1
9205|NCT02273050|50987|P2|Overall Study|Death|0
9206|NCT02273050|50988|P1|Overall Study|Death|0
9207|NCT02273050|50986|P3|Overall Study|Adverse Event|3
9208|NCT02273050|50987|P2|Overall Study|Adverse Event|3
9209|NCT02273050|50988|P1|Overall Study|Adverse Event|4
9210|NCT02272803|51016|P2|Overall Study|Withdrawal by Subject|0
9211|NCT02272803|51017|P1|Overall Study|Withdrawal by Subject|1
9212|NCT02272803|51016|P2|Overall Study|Poor/non-compliance|1
9213|NCT02272803|51017|P1|Overall Study|Poor/non-compliance|0
9214|NCT02272803|51016|P2|Overall Study|Subject moved to care facility|1
9215|NCT02272803|51017|P1|Overall Study|Subject moved to care facility|0
9216|NCT02272803|51016|P2|Overall Study|Maximum clinical benefit|1
9217|NCT02272803|51017|P1|Overall Study|Maximum clinical benefit|1
9218|NCT02272803|51016|P2|Overall Study|Subj request to discontinue study trt|4
9219|NCT02272803|51017|P1|Overall Study|Subj request to discontinue study trt|1
9220|NCT02272803|51016|P2|Overall Study|Study drug toxicity|4
9221|NCT02272803|51017|P1|Overall Study|Study drug toxicity|1
9222|NCT02272803|51016|P2|Overall Study|Adverse Event unrelated to study drug|4
9223|NCT02272803|51017|P1|Overall Study|Adverse Event unrelated to study drug|1
9224|NCT02272803|51016|P2|Overall Study|Disease progression|2
9225|NCT02272803|51017|P1|Overall Study|Disease progression|4
9226|NCT02272725|51030|P2|Overall Study|equipment malfunction|0
9227|NCT02272725|51031|P1|Overall Study|equipment malfunction|2
9228|NCT02271984|51041|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9229|NCT02271984|51042|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9230|NCT02271984|51043|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9231|NCT02271984|51044|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9232|NCT02271984|51045|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
9233|NCT02271984|51046|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9234|NCT02271984|51047|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
9235|NCT02271984|51048|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9236|NCT02271984|51049|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9237|NCT02271984|51050|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9238|NCT02271984|51051|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9239|NCT02271984|51052|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
9240|NCT02271945|51141|P2|Overall Study|Other|1
9241|NCT02271945|51142|P1|Overall Study|Other|1
9242|NCT02271945|51141|P2|Overall Study|Withdrawal by Subject|1
9243|NCT02271945|51142|P1|Overall Study|Withdrawal by Subject|1
9244|NCT02271945|51141|P2|Overall Study|Death|3
9245|NCT02271945|51142|P1|Overall Study|Death|3
9246|NCT02271880|51180|P2|Overall Study|Premature discontinuation of study|4
9247|NCT02271880|51181|P1|Overall Study|Premature discontinuation of study|3
9248|NCT02271854|51187|P1|Overall Study|Lost to Follow-up|1
9249|NCT02271854|51187|P1|Overall Study|Unable or unwilling to cooperate with st|1
9250|NCT02271854|51187|P1|Overall Study|Withdrawal by Subject|2
9251|NCT02271529|51227|P1|Overall Study|Withdrawal by Subject|1
9252|NCT02270944|51264|P2|Overall Study|Withdrawal by Subject|1
9253|NCT02270944|51265|P1|Overall Study|Withdrawal by Subject|2
9254|NCT02270944|51264|P2|Overall Study|Lost to Follow-up|4
9255|NCT02270944|51265|P1|Overall Study|Lost to Follow-up|9
9256|NCT02270684|51281|P2|Overall Study|Study terminated|0
9257|NCT02270684|51282|P1|Overall Study|Study terminated|1
9258|NCT02270684|51281|P2|Overall Study|Lost to Follow-up|3
9259|NCT02270684|51282|P1|Overall Study|Lost to Follow-up|0
9260|NCT02270515|51288|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
9261|NCT02270515|51288|P1|Intervention Period 3: 12-18 Months|Death|3
9262|NCT02270515|51288|P1|Intervention Period 3: 12-18 Months|Received transplant|2
9263|NCT02270515|51288|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
9264|NCT02270515|51288|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
9265|NCT02270515|51288|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
9266|NCT02270515|51288|P1|Intervention Period 2: 6-12 Months|Death|5
9267|NCT02270515|51288|P1|Intervention Period 2: 6-12 Months|Received transplant|1
9268|NCT02270515|51288|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
9269|NCT02270515|51288|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
9270|NCT02270515|51288|P1|Intervention Period 1: 0-6 Months|Death|7
9271|NCT02270515|51288|P1|Intervention Period 1: 0-6 Months|Received transplant|3
9272|NCT02270515|51288|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
9273|NCT02270515|51288|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
9274|NCT02269709|51303|P1|Six Month Follow-up|Lost to Follow-up|12
9275|NCT02269709|51303|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
9276|NCT02269709|51303|P1|Time of Enrollment|Withdrawal by Subject|3
9277|NCT02269657|51308|P1|Overall Study|Protocol Violation|3
9278|NCT02269475|51328|P2|Overall Study|Withdrawal by Subject|1
9279|NCT02269475|51329|P1|Overall Study|Withdrawal by Subject|0
9280|NCT02269475|51328|P2|Overall Study|Meet Exclusion Criteria No. 17|0
9281|NCT02269475|51329|P1|Overall Study|Meet Exclusion Criteria No. 17|3
9282|NCT02269098|51342|P2|Overall Study|Lost to Follow-up|9
9283|NCT02269098|51343|P1|Overall Study|Lost to Follow-up|14
9284|NCT02268864|51390|P3|Overall Study|Death|0
9285|NCT02268864|51391|P2|Overall Study|Death|1
9286|NCT02268864|51392|P1|Overall Study|Death|0
9287|NCT02268864|51390|P3|Overall Study|Withdrawal by Subject|0
9288|NCT02268864|51391|P2|Overall Study|Withdrawal by Subject|0
9289|NCT02268864|51392|P1|Overall Study|Withdrawal by Subject|2
9290|NCT02268526|51417|P3|Overall Study|Subject/guardian decision|3
9291|NCT02268526|51418|P2|Overall Study|Subject/guardian decision|7
9292|NCT02268526|51419|P1|Overall Study|Subject/guardian decision|0
9293|NCT02268526|51417|P3|Overall Study|Physician Decision|1
9294|NCT02268526|51418|P2|Overall Study|Physician Decision|0
9295|NCT02268526|51419|P1|Overall Study|Physician Decision|0
9296|NCT02268526|51417|P3|Overall Study|protocol deviation|0
9297|NCT02268526|51418|P2|Overall Study|protocol deviation|1
9298|NCT02268526|51419|P1|Overall Study|protocol deviation|0
9299|NCT02268526|51417|P3|Overall Study|Death|0
9300|NCT02268526|51418|P2|Overall Study|Death|11
9301|NCT02268526|51419|P1|Overall Study|Death|1
9302|NCT02268526|51417|P3|Overall Study|Adverse Event|1
9303|NCT02268526|51418|P2|Overall Study|Adverse Event|2
9304|NCT02268526|51419|P1|Overall Study|Adverse Event|0
9305|NCT02268396|51440|P1|Overall Study|2 Subjects no Day 29 Assessment|2
9306|NCT02268396|51440|P1|Overall Study|Protocol-Specified Criteria|2
9307|NCT02268396|51440|P1|Overall Study|Lost to Follow-up|2
9308|NCT02268396|51440|P1|Overall Study|Withdrawal by Subject|1
9309|NCT02268396|51440|P1|Overall Study|Administrative|2
9310|NCT02268396|51440|P1|Overall Study|Adverse Event|3
9311|NCT02268214|51452|P3|Overall Study|Other reasons|3
9312|NCT02268214|51453|P2|Overall Study|Other reasons|2
9313|NCT02268214|51454|P1|Overall Study|Other reasons|3
9314|NCT02268214|51452|P3|Overall Study|Poor/non-compliance|2
9315|NCT02268214|51453|P2|Overall Study|Poor/non-compliance|0
9316|NCT02268214|51454|P1|Overall Study|Poor/non-compliance|2
9317|NCT02268214|51452|P3|Overall Study|Subject request to discontinue treatment|4
9318|NCT02268214|51453|P2|Overall Study|Subject request to discontinue treatment|5
9319|NCT02268214|51454|P1|Overall Study|Subject request to discontinue treatment|6
9320|NCT02268214|51452|P3|Overall Study|Withdrawal by Subject|6
9321|NCT02268214|51453|P2|Overall Study|Withdrawal by Subject|2
9322|NCT02268214|51454|P1|Overall Study|Withdrawal by Subject|3
9323|NCT02268214|51452|P3|Overall Study|Adverse Event|9
9324|NCT02268214|51453|P2|Overall Study|Adverse Event|8
9325|NCT02268214|51454|P1|Overall Study|Adverse Event|6
9326|NCT02268214|51452|P3|Overall Study|Lack of Efficacy|1
9327|NCT02268214|51453|P2|Overall Study|Lack of Efficacy|0
9328|NCT02268214|51454|P1|Overall Study|Lack of Efficacy|1
9329|NCT02268214|51452|P3|Overall Study|Lost to Follow-up|2
9330|NCT02268214|51453|P2|Overall Study|Lost to Follow-up|2
9331|NCT02268214|51454|P1|Overall Study|Lost to Follow-up|2
9332|NCT02268214|51452|P3|Overall Study|Pregnancy|1
9333|NCT02268214|51453|P2|Overall Study|Pregnancy|2
9334|NCT02268214|51454|P1|Overall Study|Pregnancy|1
9335|NCT02268214|51452|P3|Overall Study|Subject no longer meets study criteria|0
9336|NCT02268214|51453|P2|Overall Study|Subject no longer meets study criteria|2
9337|NCT02268214|51454|P1|Overall Study|Subject no longer meets study criteria|0
9338|NCT02268058|51484|P4|Overall Study|Protocol Violation|0
9339|NCT02268058|51485|P3|Overall Study|Protocol Violation|0
9340|NCT02268058|51486|P2|Overall Study|Protocol Violation|0
9341|NCT02268058|51487|P1|Overall Study|Protocol Violation|1
9342|NCT02267824|51529|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
9343|NCT02267824|51530|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
9344|NCT02267824|51529|P2|Overall Study|Protocol Violation|0
9345|NCT02267824|51530|P1|Overall Study|Protocol Violation|3
9346|NCT02267824|51529|P2|Overall Study|Lost to Follow-up|0
9347|NCT02267824|51530|P1|Overall Study|Lost to Follow-up|4
9348|NCT02267824|51529|P2|Overall Study|Pregnancy|1
9349|NCT02267824|51530|P1|Overall Study|Pregnancy|1
9350|NCT02267187|51573|P1|Overall Study|Physician Decision|2
9351|NCT02267135|51581|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
9352|NCT02267135|51582|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
9353|NCT02267135|51581|P2|Period 2 (Randomized Set)|Adverse Event|0
9354|NCT02267135|51582|P1|Period 2 (Randomized Set)|Adverse Event|2
9355|NCT02267135|51581|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
9356|NCT02267135|51582|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
9357|NCT02267135|51581|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
9358|NCT02267135|51582|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
9359|NCT02267135|51581|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
9360|NCT02267135|51582|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
9361|NCT02266875|51622|P2|Overall Study|Lost to Follow-up|0
9362|NCT02266875|51623|P1|Overall Study|Lost to Follow-up|2
9363|NCT02266875|51622|P2|Overall Study|Withdrawal by Subject|0
9364|NCT02266875|51623|P1|Overall Study|Withdrawal by Subject|9
9365|NCT02266381|51701|P3|Overall Study|Physician Decision|4
9366|NCT02266381|51702|P2|Overall Study|Physician Decision|5
9367|NCT02266381|51703|P1|Overall Study|Physician Decision|3
9368|NCT02265796|51770|P2|Overall Study|Withdrawal by Subject|1
9369|NCT02265796|51771|P1|Overall Study|Withdrawal by Subject|1
9370|NCT02265796|51770|P2|Overall Study|started on excluded medication|0
9371|NCT02265796|51771|P1|Overall Study|started on excluded medication|1
9372|NCT02265796|51770|P2|Overall Study|Death|0
9373|NCT02265796|51771|P1|Overall Study|Death|1
9374|NCT02265237|51789|P4|As Treated (Overall Study)|Other|1
9375|NCT02265237|51790|P3|As Treated (Overall Study)|Other|3
9376|NCT02265237|51791|P2|As Treated (Overall Study)|Other|0
9377|NCT02265237|51792|P1|As Treated (Overall Study)|Other|2
9378|NCT02265237|51789|P4|As Treated (Overall Study)|Lost to Follow-up|0
9379|NCT02265237|51790|P3|As Treated (Overall Study)|Lost to Follow-up|6
9380|NCT02265237|51791|P2|As Treated (Overall Study)|Lost to Follow-up|2
9381|NCT02265237|51792|P1|As Treated (Overall Study)|Lost to Follow-up|1
9382|NCT02265237|51789|P4|As Treated (Overall Study)|Withdrawal by Subject|0
9383|NCT02265237|51790|P3|As Treated (Overall Study)|Withdrawal by Subject|1
9384|NCT02265237|51791|P2|As Treated (Overall Study)|Withdrawal by Subject|0
9385|NCT02265237|51792|P1|As Treated (Overall Study)|Withdrawal by Subject|1
9386|NCT02265237|51789|P4|As Treated (Overall Study)|Adverse Event|0
9387|NCT02265237|51790|P3|As Treated (Overall Study)|Adverse Event|0
9388|NCT02265237|51791|P2|As Treated (Overall Study)|Adverse Event|1
9389|NCT02265237|51792|P1|As Treated (Overall Study)|Adverse Event|1
9390|NCT02264821|51822|P3|Overall Study|Protocol Violation|6
9391|NCT02264821|51823|P2|Overall Study|Protocol Violation|3
9392|NCT02264821|51824|P1|Overall Study|Protocol Violation|1
9393|NCT02263365|51886|P2|Overall Study|Physician Decision|18
9394|NCT02263365|51887|P1|Overall Study|Physician Decision|22
9395|NCT02262754|51942|P3|Overall Study|Other|2
9396|NCT02262754|51943|P2|Overall Study|Other|0
9397|NCT02262754|51944|P1|Overall Study|Other|4
9398|NCT02262754|51942|P3|Overall Study|Withdrawal by Subject|1
9399|NCT02262754|51943|P2|Overall Study|Withdrawal by Subject|0
9400|NCT02262754|51944|P1|Overall Study|Withdrawal by Subject|1
9401|NCT02262754|51942|P3|Overall Study|Protocol Violation|0
9402|NCT02262754|51943|P2|Overall Study|Protocol Violation|0
9403|NCT02262754|51944|P1|Overall Study|Protocol Violation|1
9404|NCT02262754|51942|P3|Overall Study|Study terminated by sponsor|4
9405|NCT02262754|51943|P2|Overall Study|Study terminated by sponsor|4
9406|NCT02262754|51944|P1|Overall Study|Study terminated by sponsor|5
9407|NCT02262754|51942|P3|Overall Study|No longer meets eligibility criteria|0
9408|NCT02262754|51943|P2|Overall Study|No longer meets eligibility criteria|1
9409|NCT02262754|51944|P1|Overall Study|No longer meets eligibility criteria|0
9410|NCT02262754|51942|P3|Overall Study|Lost to Follow-up|1
9411|NCT02262754|51943|P2|Overall Study|Lost to Follow-up|0
9412|NCT02262754|51944|P1|Overall Study|Lost to Follow-up|0
9413|NCT02262754|51942|P3|Overall Study|Lack of Efficacy|1
9414|NCT02262754|51943|P2|Overall Study|Lack of Efficacy|0
9415|NCT02262754|51944|P1|Overall Study|Lack of Efficacy|2
9416|NCT02262754|51942|P3|Overall Study|Adverse Event|0
9417|NCT02262754|51943|P2|Overall Study|Adverse Event|4
9418|NCT02262754|51944|P1|Overall Study|Adverse Event|3
9419|NCT02261974|52080|P2|Overall Study|Adverse Event|0
9420|NCT02261974|52081|P1|Overall Study|Adverse Event|1
9421|NCT02261974|52080|P2|Overall Study|Lost to Follow-up|0
9422|NCT02261974|52081|P1|Overall Study|Lost to Follow-up|2
9423|NCT02261974|52080|P2|Overall Study|Received partial treatment; FU to 1 mo|1
9424|NCT02261974|52081|P1|Overall Study|Received partial treatment; FU to 1 mo|3
9425|NCT02261974|52080|P2|Overall Study|Missed treatment cut-off date|3
9426|NCT02261974|52081|P1|Overall Study|Missed treatment cut-off date|6
9427|NCT02261974|52080|P2|Overall Study|Pregnancy|1
9428|NCT02261974|52081|P1|Overall Study|Pregnancy|0
9429|NCT02261974|52080|P2|Overall Study|Withdrawal by Subject|2
9430|NCT02261974|52081|P1|Overall Study|Withdrawal by Subject|3
9431|NCT02261493|52125|P3|Overall Study|Adverse Event|0
9432|NCT02261493|52126|P2|Overall Study|Adverse Event|1
9433|NCT02261493|52127|P1|Overall Study|Adverse Event|0
9434|NCT02261493|52125|P3|Overall Study|Lack of Efficacy|0
9435|NCT02261493|52126|P2|Overall Study|Lack of Efficacy|1
9436|NCT02261493|52127|P1|Overall Study|Lack of Efficacy|0
9437|NCT02261493|52125|P3|Overall Study|Pregnancy|0
9438|NCT02261493|52126|P2|Overall Study|Pregnancy|2
9439|NCT02261493|52127|P1|Overall Study|Pregnancy|1
9440|NCT02261493|52125|P3|Overall Study|Lost to Follow-up|8
9441|NCT02261493|52126|P2|Overall Study|Lost to Follow-up|27
9442|NCT02261493|52127|P1|Overall Study|Lost to Follow-up|14
9443|NCT02261493|52125|P3|Overall Study|Personal Reasons|16
9444|NCT02261493|52126|P2|Overall Study|Personal Reasons|14
9445|NCT02261493|52127|P1|Overall Study|Personal Reasons|14
9446|NCT02261493|52125|P3|Overall Study|Protocol Violation|0
9447|NCT02261493|52126|P2|Overall Study|Protocol Violation|0
9448|NCT02261493|52127|P1|Overall Study|Protocol Violation|1
9449|NCT02261493|52125|P3|Overall Study|Undisclosed alcohol abuse|0
9450|NCT02261493|52126|P2|Overall Study|Undisclosed alcohol abuse|1
9451|NCT02261493|52127|P1|Overall Study|Undisclosed alcohol abuse|0
9452|NCT02261493|52125|P3|Overall Study|Physician Decision|0
9453|NCT02261493|52126|P2|Overall Study|Physician Decision|1
9454|NCT02261493|52127|P1|Overall Study|Physician Decision|0
9455|NCT02261493|52125|P3|Overall Study|Noncompliance|2
9456|NCT02261493|52126|P2|Overall Study|Noncompliance|0
9457|NCT02261493|52127|P1|Overall Study|Noncompliance|0
9458|NCT02261467|52155|P2|Overall Study|Adverse Event|1
9459|NCT02261467|52156|P1|Overall Study|Adverse Event|1
9460|NCT02261467|52155|P2|Overall Study|Lost to Follow-up|13
9461|NCT02261467|52156|P1|Overall Study|Lost to Follow-up|2
9462|NCT02261467|52155|P2|Overall Study|Personal Reasons|22
9463|NCT02261467|52156|P1|Overall Study|Personal Reasons|17
9464|NCT02261467|52155|P2|Overall Study|Protocol Violation|1
9465|NCT02261467|52156|P1|Overall Study|Protocol Violation|0
9466|NCT02261467|52155|P2|Overall Study|Enrolled in Error|0
9467|NCT02261467|52156|P1|Overall Study|Enrolled in Error|1
9468|NCT02260986|52198|P3|Overall Study|Pregnancy|0
9469|NCT02260986|52199|P2|Overall Study|Pregnancy|0
9470|NCT02260986|52200|P1|Overall Study|Pregnancy|2
9471|NCT02260986|52198|P3|Overall Study|Lost to Follow-up|3
9472|NCT02260986|52199|P2|Overall Study|Lost to Follow-up|0
9473|NCT02260986|52200|P1|Overall Study|Lost to Follow-up|4
9474|NCT02260986|52198|P3|Overall Study|Lack of investigation product supply|1
9475|NCT02260986|52199|P2|Overall Study|Lack of investigation product supply|0
9476|NCT02260986|52200|P1|Overall Study|Lack of investigation product supply|2
9477|NCT02260986|52198|P3|Overall Study|Incorrect randomization|0
9478|NCT02260986|52199|P2|Overall Study|Incorrect randomization|1
9479|NCT02260986|52200|P1|Overall Study|Incorrect randomization|0
9480|NCT02260986|52198|P3|Overall Study|Withdrawal by Subject|9
9481|NCT02260986|52199|P2|Overall Study|Withdrawal by Subject|4
9482|NCT02260986|52200|P1|Overall Study|Withdrawal by Subject|17
9483|NCT02260986|52198|P3|Overall Study|Car accident|1
9484|NCT02260986|52199|P2|Overall Study|Car accident|0
9485|NCT02260986|52200|P1|Overall Study|Car accident|0
9486|NCT02260986|52198|P3|Overall Study|Protocol Violation|16
9487|NCT02260986|52199|P2|Overall Study|Protocol Violation|5
9488|NCT02260986|52200|P1|Overall Study|Protocol Violation|14
9489|NCT02260986|52198|P3|Overall Study|Lack of Efficacy|0
9490|NCT02260986|52199|P2|Overall Study|Lack of Efficacy|3
9491|NCT02260986|52200|P1|Overall Study|Lack of Efficacy|27
9492|NCT02260986|52198|P3|Overall Study|Adverse Event|11
9493|NCT02260986|52199|P2|Overall Study|Adverse Event|0
9494|NCT02260986|52200|P1|Overall Study|Adverse Event|24
9495|NCT02260882|52318|P2|Overall Study|Protocol Violation|1
9496|NCT02260882|52319|P1|Overall Study|Protocol Violation|0
9497|NCT02260791|52343|P2|Overall Study|Protocol deviation|3
9498|NCT02260791|52344|P1|Overall Study|Protocol deviation|2
9499|NCT02260791|52343|P2|Overall Study|Screen failure|1
9500|NCT02260791|52344|P1|Overall Study|Screen failure|0
9501|NCT02260791|52343|P2|Overall Study|Withdrawal by Subject|16
9502|NCT02260791|52344|P1|Overall Study|Withdrawal by Subject|11
9503|NCT02260791|52343|P2|Overall Study|Death|0
9504|NCT02260791|52344|P1|Overall Study|Death|1
9505|NCT02260791|52343|P2|Overall Study|Adverse Event|9
9506|NCT02260791|52344|P1|Overall Study|Adverse Event|13
9507|NCT02260791|52343|P2|Overall Study|Lack of Efficacy|1
9508|NCT02260791|52344|P1|Overall Study|Lack of Efficacy|2
9509|NCT02260791|52343|P2|Overall Study|Lost to Follow-up|4
9510|NCT02260791|52344|P1|Overall Study|Lost to Follow-up|4
9511|NCT02260492|52383|P3|Overall Study|Withdrawal by Subject|2
9512|NCT02260492|52384|P2|Overall Study|Withdrawal by Subject|2
9513|NCT02260492|52385|P1|Overall Study|Withdrawal by Subject|3
9514|NCT02260492|52383|P3|Overall Study|Physician Decision|1
9515|NCT02260492|52384|P2|Overall Study|Physician Decision|0
9516|NCT02260492|52385|P1|Overall Study|Physician Decision|2
9517|NCT02260492|52383|P3|Overall Study|Lost to Follow-up|0
9518|NCT02260492|52384|P2|Overall Study|Lost to Follow-up|9
9519|NCT02260492|52385|P1|Overall Study|Lost to Follow-up|12
9520|NCT02260492|52383|P3|Overall Study|Death|0
9521|NCT02260492|52384|P2|Overall Study|Death|1
9522|NCT02260492|52385|P1|Overall Study|Death|0
9523|NCT02260492|52383|P3|Overall Study|Adverse Event|2
9524|NCT02260492|52384|P2|Overall Study|Adverse Event|1
9525|NCT02260492|52385|P1|Overall Study|Adverse Event|6
9526|NCT02259400|52421|P2|Overall Study|Death|2
9527|NCT02259400|52422|P1|Overall Study|Death|0
9528|NCT02259348|52454|P1|Overall Study|Death|4
9529|NCT02259348|52454|P1|Overall Study|Donors|6
9530|NCT02258529|52466|P1|Overall Study|Adverse Event|1
9531|NCT02258529|52466|P1|Overall Study|Study Terminated by Sponsor|9
9532|NCT02258334|52512|P4|Overall Study|Adverse Event|0
9533|NCT02258334|52513|P3|Overall Study|Adverse Event|0
9534|NCT02258334|52514|P2|Overall Study|Adverse Event|0
9535|NCT02258334|52515|P1|Overall Study|Adverse Event|1
9536|NCT02257918|52544|P3|Overall Study|Pregnancy|1
9537|NCT02257918|52545|P2|Overall Study|Pregnancy|0
9538|NCT02257918|52546|P1|Overall Study|Pregnancy|0
9539|NCT02257918|52544|P3|Overall Study|Withdrawal by Subject|1
9540|NCT02257918|52545|P2|Overall Study|Withdrawal by Subject|0
9541|NCT02257918|52546|P1|Overall Study|Withdrawal by Subject|0
9542|NCT02257918|52544|P3|Overall Study|Lost to Follow-up|0
9543|NCT02257918|52545|P2|Overall Study|Lost to Follow-up|1
9544|NCT02257918|52546|P1|Overall Study|Lost to Follow-up|4
9545|NCT02257684|52596|P1|Overall Study|Sponsor's Decision|1
9546|NCT02257684|52596|P1|Overall Study|Lack of Efficacy|1
9547|NCT02257684|52596|P1|Overall Study|Adverse Event|2
9548|NCT02257385|52606|P2|Overall Study|Withdrawal by Subject|4
9549|NCT02257385|52607|P1|Overall Study|Withdrawal by Subject|4
9550|NCT02257385|52606|P2|Overall Study|Lost to Follow-up|1
9551|NCT02257385|52607|P1|Overall Study|Lost to Follow-up|0
9552|NCT02257385|52606|P2|Overall Study|Protocol Violation|7
9553|NCT02257385|52607|P1|Overall Study|Protocol Violation|5
9554|NCT02257385|52606|P2|Overall Study|Lack of Efficacy|2
9555|NCT02257385|52607|P1|Overall Study|Lack of Efficacy|1
9556|NCT02257385|52606|P2|Overall Study|Adverse Event|8
9557|NCT02257385|52607|P1|Overall Study|Adverse Event|12
9558|NCT02257372|52617|P2|Overall Study|Withdrew consent|0
9559|NCT02257372|52618|P1|Overall Study|Withdrew consent|1
9560|NCT02257372|52617|P2|Overall Study|Lost to Follow-up|1
9561|NCT02257372|52618|P1|Overall Study|Lost to Follow-up|0
9562|NCT02257372|52617|P2|Overall Study|Protocol Violation|1
9563|NCT02257372|52618|P1|Overall Study|Protocol Violation|1
9564|NCT02257372|52617|P2|Overall Study|Lack of Efficacy|1
9565|NCT02257372|52618|P1|Overall Study|Lack of Efficacy|2
9566|NCT02257372|52617|P2|Overall Study|Adverse Event|7
9567|NCT02257372|52618|P1|Overall Study|Adverse Event|3
9568|NCT02256982|52628|P2|Overall Study|Disease Progression|1
9569|NCT02256982|52629|P1|Overall Study|Disease Progression|0
9570|NCT02256969|52638|P3|Overall Study|Screenfailed or withdrew|1
9571|NCT02256969|52639|P2|Overall Study|Screenfailed or withdrew|1
9572|NCT02256969|52640|P1|Overall Study|Screenfailed or withdrew|2
9573|NCT02256891|52659|P2|Overall Study|Equipment Malfunction|1
9574|NCT02256891|52660|P1|Overall Study|Equipment Malfunction|0
9575|NCT02256891|52659|P2|Overall Study|Screen Fail|4
9576|NCT02256891|52660|P1|Overall Study|Screen Fail|5
9577|NCT02256891|52659|P2|Overall Study|Physician Decision|3
9578|NCT02256891|52660|P1|Overall Study|Physician Decision|7
9579|NCT02256891|52659|P2|Overall Study|Lost to Follow-up|3
9580|NCT02256891|52660|P1|Overall Study|Lost to Follow-up|0
9581|NCT02256891|52659|P2|Overall Study|Death|2
9582|NCT02256891|52660|P1|Overall Study|Death|0
9583|NCT02256553|52684|P1|Period III|Adverse Event|3
9584|NCT02256553|52684|P1|Period II|Subject Moved|1
9585|NCT02256553|52684|P1|Period II|Adverse Event|1
9586|NCT02256553|52684|P1|Period I|Protocol Violation|1
9587|NCT02256553|52684|P1|Period I|Adverse Event|5
9588|NCT02256488|52697|P4|Overall Study|Withdrawal by Subject|2
9589|NCT02256488|52698|P3|Overall Study|Withdrawal by Subject|0
9590|NCT02256488|52699|P2|Overall Study|Withdrawal by Subject|0
9591|NCT02256488|52700|P1|Overall Study|Withdrawal by Subject|1
9592|NCT02256488|52697|P4|Overall Study|OTHER|1
9593|NCT02256488|52698|P3|Overall Study|OTHER|1
9594|NCT02256488|52699|P2|Overall Study|OTHER|0
9595|NCT02256488|52700|P1|Overall Study|OTHER|1
9596|NCT02256488|52697|P4|Overall Study|Lost to Follow-up|3
9597|NCT02256488|52698|P3|Overall Study|Lost to Follow-up|9
9598|NCT02256488|52699|P2|Overall Study|Lost to Follow-up|6
9599|NCT02256488|52700|P1|Overall Study|Lost to Follow-up|6
9600|NCT02256436|52716|P2|Overall Study|Ongoing in Study|67
9601|NCT02256436|52717|P1|Overall Study|Ongoing in Study|108
9602|NCT02256436|52716|P2|Overall Study|Withdrawal by Subject|30
9603|NCT02256436|52717|P1|Overall Study|Withdrawal by Subject|7
9604|NCT02256436|52716|P2|Overall Study|Protocol Violation|0
9605|NCT02256436|52717|P1|Overall Study|Protocol Violation|1
9606|NCT02256436|52716|P2|Overall Study|Physician Decision|3
9607|NCT02256436|52717|P1|Overall Study|Physician Decision|1
9608|NCT02256436|52716|P2|Overall Study|Lost to Follow-up|1
9609|NCT02256436|52717|P1|Overall Study|Lost to Follow-up|1
9610|NCT02256436|52716|P2|Overall Study|Death|158
9611|NCT02256436|52717|P1|Overall Study|Death|137
9612|NCT02256436|52716|P2|Overall Study|Adverse Event|13
9613|NCT02256436|52717|P1|Overall Study|Adverse Event|15
9614|NCT02255565|52797|P3|Overall Study|Withdrawal by Subject|0
9615|NCT02255565|52798|P2|Overall Study|Withdrawal by Subject|1
9616|NCT02255565|52799|P1|Overall Study|Withdrawal by Subject|0
9617|NCT02255279|52860|P2|Overall Study|Withdrawal by Subject|6
9618|NCT02255279|52861|P1|Overall Study|Withdrawal by Subject|3
9619|NCT02255279|52860|P2|Overall Study|Protocol Violation|1
9620|NCT02255279|52861|P1|Overall Study|Protocol Violation|0
9621|NCT02255279|52860|P2|Overall Study|Lost to Follow-up|2
9622|NCT02255279|52861|P1|Overall Study|Lost to Follow-up|2
9623|NCT02255149|52887|P1|Overall Study|Implant Failure|1
9624|NCT02255149|52887|P1|Overall Study|Withdrawal by PI|1
9625|NCT02255149|52887|P1|Overall Study|Withdrawal by Subject|1
9626|NCT02255149|52887|P1|Overall Study|Lost to Follow-up|2
9627|NCT02255097|52891|P1|Overall Study|Treatment Ongoing|36
9628|NCT02255097|52891|P1|Overall Study|Allocated but not treated|1
9629|NCT02255097|52891|P1|Overall Study|Withdrawal by Subject|2
9630|NCT02255097|52891|P1|Overall Study|Progressive Disease|80
9631|NCT02255097|52891|P1|Overall Study|Physician Decision|1
9632|NCT02255097|52891|P1|Overall Study|Lost to Follow-up|1
9633|NCT02255097|52891|P1|Overall Study|Death|2
9634|NCT02255097|52891|P1|Overall Study|Excluded Medication|1
9635|NCT02255097|52891|P1|Overall Study|Complete Response|1
9636|NCT02255097|52891|P1|Overall Study|Clinical Progression|23
9637|NCT02255097|52891|P1|Overall Study|Adverse Event|24
9638|NCT02254772|52912|P1|Overall Study|Withdrawal by Subject|1
9639|NCT02254772|52912|P1|Overall Study|Ineligible|1
9640|NCT02254551|52918|P1|Dose Escalation|Dose-limiting toxicity|2
9641|NCT02254551|52918|P1|Dose Escalation|Physician Decision|1
9642|NCT02254486|52928|P2|Overall Study|Various|12
9643|NCT02254486|52929|P1|Overall Study|Various|12
9644|NCT02254486|52928|P2|Overall Study|GFR<60mL/min|21
9645|NCT02254486|52929|P1|Overall Study|GFR<60mL/min|16
9646|NCT02254486|52928|P2|Overall Study|Withdrawal by Subject|15
9647|NCT02254486|52929|P1|Overall Study|Withdrawal by Subject|17
9648|NCT02254486|52928|P2|Overall Study|Protocol Violation|2
9649|NCT02254486|52929|P1|Overall Study|Protocol Violation|1
9650|NCT02254486|52928|P2|Overall Study|Lost to Follow-up|4
9651|NCT02254486|52929|P1|Overall Study|Lost to Follow-up|2
9652|NCT02254486|52928|P2|Overall Study|Lack of Efficacy|0
9653|NCT02254486|52929|P1|Overall Study|Lack of Efficacy|1
9654|NCT02254486|52928|P2|Overall Study|Adverse Event|1
9655|NCT02254486|52929|P1|Overall Study|Adverse Event|1
9656|NCT02254460|52945|P2|Overall Study|Adverse Event|0
9657|NCT02254460|52946|P1|Overall Study|Adverse Event|1
9658|NCT02254421|52954|P2|Overall Study|Withdrew Consent|1
9659|NCT02254421|52955|P1|Overall Study|Withdrew Consent|1
9660|NCT02254421|52954|P2|Overall Study|Death|2
9661|NCT02254421|52955|P1|Overall Study|Death|0
9662|NCT02254421|52954|P2|Overall Study|Randomized but Not Treated|0
9663|NCT02254421|52955|P1|Overall Study|Randomized but Not Treated|1
9664|NCT02254304|52969|P2|Overall Study|Personal decision|0
9665|NCT02254304|52970|P1|Overall Study|Personal decision|1
9666|NCT02254304|52969|P2|Overall Study|Personal causes|1
9667|NCT02254304|52970|P1|Overall Study|Personal causes|4
9668|NCT02254304|52969|P2|Overall Study|Injection site pain and Injection fear|0
9669|NCT02254304|52970|P1|Overall Study|Injection site pain and Injection fear|1
9670|NCT02254304|52969|P2|Overall Study|Withdrawal by Subject|0
9671|NCT02254304|52970|P1|Overall Study|Withdrawal by Subject|3
9672|NCT02254304|52969|P2|Overall Study|Protocol Violation|0
9673|NCT02254304|52970|P1|Overall Study|Protocol Violation|1
9674|NCT02254304|52969|P2|Overall Study|Lost to Follow-up|2
9675|NCT02254304|52970|P1|Overall Study|Lost to Follow-up|2
9676|NCT02254304|52969|P2|Overall Study|Adverse Event|1
9677|NCT02254304|52970|P1|Overall Study|Adverse Event|2
9678|NCT02253654|53042|P2|Overall Study|Did Not Receive Study Treatment|1
9679|NCT02253654|53043|P1|Overall Study|Did Not Receive Study Treatment|4
9680|NCT02253654|53042|P2|Overall Study|Death|7
9681|NCT02253654|53043|P1|Overall Study|Death|4
9682|NCT02253654|53042|P2|Overall Study|Lost to Follow-up|5
9683|NCT02253654|53043|P1|Overall Study|Lost to Follow-up|2
9684|NCT02253654|53042|P2|Overall Study|Decision by Sponsor|1
9685|NCT02253654|53043|P1|Overall Study|Decision by Sponsor|1
9686|NCT02253654|53042|P2|Overall Study|Withdrawal by Subject|4
9687|NCT02253654|53043|P1|Overall Study|Withdrawal by Subject|12
9688|NCT02253147|53305|P1|Overall Study|Withdrawal by Subject|1
9689|NCT02253147|53305|P1|Overall Study|Lost to Follow-up|2
9690|NCT02253147|53305|P1|Overall Study|Conditional re-treatment at W52|5
9691|NCT02253147|53305|P1|Overall Study|Did not consent to study extension|9
9692|NCT02253147|53305|P1|Overall Study|Protocol Violation|30
9693|NCT02252965|53339|P2|Overall Study|Other|5
9694|NCT02252965|53340|P1|Overall Study|Other|4
9695|NCT02252965|53339|P2|Overall Study|Withdrawal by Subject|9
9696|NCT02252965|53340|P1|Overall Study|Withdrawal by Subject|7
9697|NCT02252965|53339|P2|Overall Study|Lack of Efficacy|2
9698|NCT02252965|53340|P1|Overall Study|Lack of Efficacy|0
9699|NCT02252965|53339|P2|Overall Study|Protocol Violation|5
9700|NCT02252965|53340|P1|Overall Study|Protocol Violation|4
9701|NCT02252965|53339|P2|Overall Study|Lost to Follow-up|8
9702|NCT02252965|53340|P1|Overall Study|Lost to Follow-up|16
9703|NCT02252965|53339|P2|Overall Study|Adverse Event|14
9704|NCT02252965|53340|P1|Overall Study|Adverse Event|9
9705|NCT02252939|53367|P1|Overall Study|Lost to Follow-up|3
9706|NCT02252146|53454|P1|Overall Study|Inability to travel to study site|1
9707|NCT02252146|53454|P1|Overall Study|Entered hospice care|1
9708|NCT02252146|53454|P1|Overall Study|Lack of Efficacy|4
9709|NCT02252016|53467|P2|Overall Study|Withdrawal by Subject|2
9710|NCT02252016|53468|P1|Overall Study|Withdrawal by Subject|0
9711|NCT02252016|53467|P2|Overall Study|Physician Decision|0
9712|NCT02252016|53468|P1|Overall Study|Physician Decision|1
9713|NCT02252016|53467|P2|Overall Study|Lost to Follow-up|1
9714|NCT02252016|53468|P1|Overall Study|Lost to Follow-up|2
9715|NCT02251990|53482|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
9716|NCT02251990|53483|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
9717|NCT02251990|53482|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
9718|NCT02251990|53483|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
9719|NCT02251990|53482|P2|Period 1 (Double-blind [DB])|Not Treated|0
9720|NCT02251990|53483|P1|Period 1 (Double-blind [DB])|Not Treated|1
9721|NCT02251990|53482|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
9722|NCT02251990|53483|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
9723|NCT02251990|53482|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
9724|NCT02251990|53483|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
9725|NCT02251990|53482|P2|Period 1 (Double-blind [DB])|Adverse Event|1
9726|NCT02251990|53483|P1|Period 1 (Double-blind [DB])|Adverse Event|1
9727|NCT02251912|53500|P2|Overall Study|Adverse Event|2
9728|NCT02251912|53501|P1|Overall Study|Adverse Event|0
9729|NCT02251912|53500|P2|Overall Study|Withdrawal by Subject|3
9730|NCT02251912|53501|P1|Overall Study|Withdrawal by Subject|2
9731|NCT02251717|53530|P2|Overall Study|Withdrew Consent|0
9732|NCT02251717|53531|P1|Overall Study|Withdrew Consent|1
9733|NCT02251717|53530|P2|Overall Study|Adverse Event|1
9734|NCT02251717|53531|P1|Overall Study|Adverse Event|0
9735|NCT02251652|53543|P1|Overall Study|Withdrawal by Subject|1
9736|NCT02250443|53594|P1|Overall Study|Adverse Event|3
9737|NCT02250443|53594|P1|Overall Study|Administrative problems|7
9738|NCT02250274|53609|P2|Overall Study|Insufficient blood draw amount|6
9739|NCT02250274|53610|P1|Overall Study|Insufficient blood draw amount|7
9740|NCT02248818|53684|P9|Randomised Study|Administrative - randomization error|0
9741|NCT02248818|53685|P8|Randomised Study|Administrative - randomization error|0
9742|NCT02248818|53686|P7|Randomised Study|Administrative - randomization error|0
9743|NCT02248818|53687|P6|Randomised Study|Administrative - randomization error|8
9744|NCT02248818|53688|P5|Randomised Study|Administrative - randomization error|0
9745|NCT02248818|53689|P4|Randomised Study|Administrative - randomization error|0
9746|NCT02248818|53690|P3|Randomised Study|Administrative - randomization error|0
9747|NCT02248818|53691|P2|Randomised Study|Administrative - randomization error|0
9748|NCT02248818|53692|P1|Randomised Study|Administrative - randomization error|0
9749|NCT02248818|53684|P9|Screening|Lost to Follow-up|7
9750|NCT02248818|53685|P8|Screening|Lost to Follow-up|0
9751|NCT02248818|53686|P7|Screening|Lost to Follow-up|0
9752|NCT02248818|53687|P6|Screening|Lost to Follow-up|0
9753|NCT02248818|53688|P5|Screening|Lost to Follow-up|0
9754|NCT02248818|53689|P4|Screening|Lost to Follow-up|0
9755|NCT02248818|53690|P3|Screening|Lost to Follow-up|0
9756|NCT02248818|53691|P2|Screening|Lost to Follow-up|0
9757|NCT02248818|53692|P1|Screening|Lost to Follow-up|0
9758|NCT02248818|53684|P9|Screening|Withdrawal by Subject|6
9759|NCT02248818|53685|P8|Screening|Withdrawal by Subject|0
9760|NCT02248818|53686|P7|Screening|Withdrawal by Subject|0
9761|NCT02248818|53687|P6|Screening|Withdrawal by Subject|0
9762|NCT02248818|53688|P5|Screening|Withdrawal by Subject|0
9763|NCT02248818|53689|P4|Screening|Withdrawal by Subject|0
9764|NCT02248818|53690|P3|Screening|Withdrawal by Subject|0
9765|NCT02248818|53691|P2|Screening|Withdrawal by Subject|0
9766|NCT02248818|53692|P1|Screening|Withdrawal by Subject|0
9767|NCT02248818|53684|P9|Screening|Physician Decision|73
9768|NCT02248818|53685|P8|Screening|Physician Decision|0
9769|NCT02248818|53686|P7|Screening|Physician Decision|0
9770|NCT02248818|53687|P6|Screening|Physician Decision|0
9771|NCT02248818|53688|P5|Screening|Physician Decision|0
9772|NCT02248818|53689|P4|Screening|Physician Decision|0
9773|NCT02248818|53690|P3|Screening|Physician Decision|0
9774|NCT02248818|53691|P2|Screening|Physician Decision|0
9775|NCT02248818|53692|P1|Screening|Physician Decision|0
9776|NCT02248818|53684|P9|Screening|Study fully enrolled|14
9777|NCT02248818|53685|P8|Screening|Study fully enrolled|0
9778|NCT02248818|53686|P7|Screening|Study fully enrolled|0
9779|NCT02248818|53687|P6|Screening|Study fully enrolled|0
9780|NCT02248818|53688|P5|Screening|Study fully enrolled|0
9781|NCT02248818|53689|P4|Screening|Study fully enrolled|0
9782|NCT02248818|53690|P3|Screening|Study fully enrolled|0
9783|NCT02248818|53691|P2|Screening|Study fully enrolled|0
9784|NCT02248818|53692|P1|Screening|Study fully enrolled|0
9785|NCT02248818|53684|P9|Screening|Protocol Violation|7
9786|NCT02248818|53685|P8|Screening|Protocol Violation|0
9787|NCT02248818|53686|P7|Screening|Protocol Violation|0
9788|NCT02248818|53687|P6|Screening|Protocol Violation|0
9789|NCT02248818|53688|P5|Screening|Protocol Violation|0
9790|NCT02248818|53689|P4|Screening|Protocol Violation|0
9791|NCT02248818|53690|P3|Screening|Protocol Violation|0
9792|NCT02248818|53691|P2|Screening|Protocol Violation|0
9793|NCT02248818|53692|P1|Screening|Protocol Violation|0
9794|NCT02248675|53855|P2|Overall Study|Lost to Follow-up|1
9795|NCT02248675|53856|P1|Overall Study|Lost to Follow-up|3
9796|NCT02248480|53883|P2|Overall Study|Other:Physician Decision|1
9797|NCT02248480|53884|P1|Overall Study|Other:Physician Decision|0
9798|NCT02248480|53883|P2|Overall Study|Entry Criteria Not Met|1
9799|NCT02248480|53884|P1|Overall Study|Entry Criteria Not Met|0
9800|NCT02248480|53883|P2|Overall Study|Withdrawal by Subject|4
9801|NCT02248480|53884|P1|Overall Study|Withdrawal by Subject|2
9802|NCT02248480|53883|P2|Overall Study|Adverse Event|2
9803|NCT02248480|53884|P1|Overall Study|Adverse Event|11
9804|NCT02248480|53883|P2|Overall Study|Lack of Efficacy|6
9805|NCT02248480|53884|P1|Overall Study|Lack of Efficacy|4
9806|NCT02247960|53951|P2|Catheter Removed|Lost to Follow-up|10
9807|NCT02247960|53952|P1|Catheter Removed|Lost to Follow-up|7
9808|NCT02247960|53951|P2|Patient Consent and Randomization|Withdrawal by Subject|4
9809|NCT02247960|53952|P1|Patient Consent and Randomization|Withdrawal by Subject|0
9810|NCT02247960|53951|P2|Patient Consent and Randomization|Physician Decision|2
9811|NCT02247960|53952|P1|Patient Consent and Randomization|Physician Decision|2
9812|NCT02247401|53991|P3|Overall Study|Lost to Follow-up|1
9813|NCT02247401|53992|P2|Overall Study|Lost to Follow-up|1
9814|NCT02247401|53993|P1|Overall Study|Lost to Follow-up|1
9815|NCT02247401|53991|P3|Overall Study|Withdrawal by Subject|1
9816|NCT02247401|53992|P2|Overall Study|Withdrawal by Subject|1
9817|NCT02247401|53993|P1|Overall Study|Withdrawal by Subject|4
9818|NCT02247401|53991|P3|Overall Study|Adverse Event|0
9819|NCT02247401|53992|P2|Overall Study|Adverse Event|0
9820|NCT02247401|53993|P1|Overall Study|Adverse Event|1
9821|NCT02247011|54023|P1|Overall Study|Poor quality of radiological results|125
9822|NCT02246998|54044|P4|Overall Study|Randomized but Never Dosed|1
9823|NCT02246998|54045|P3|Overall Study|Randomized but Never Dosed|2
9824|NCT02246998|54046|P2|Overall Study|Randomized but Never Dosed|2
9825|NCT02246998|54047|P1|Overall Study|Randomized but Never Dosed|1
9826|NCT02246998|54044|P4|Overall Study|Lost to Follow-up|1
9827|NCT02246998|54045|P3|Overall Study|Lost to Follow-up|0
9828|NCT02246998|54046|P2|Overall Study|Lost to Follow-up|0
9829|NCT02246998|54047|P1|Overall Study|Lost to Follow-up|1
9830|NCT02246998|54044|P4|Overall Study|Adverse Event|0
9831|NCT02246998|54045|P3|Overall Study|Adverse Event|1
9832|NCT02246998|54046|P2|Overall Study|Adverse Event|1
9833|NCT02246998|54047|P1|Overall Study|Adverse Event|0
9834|NCT02246764|54160|P3|Overall Study|Protocol Violation|1
9835|NCT02246764|54161|P2|Overall Study|Protocol Violation|1
9836|NCT02246764|54162|P1|Overall Study|Protocol Violation|2
9837|NCT02246764|54160|P3|Overall Study|Physician Decision|1
9838|NCT02246764|54161|P2|Overall Study|Physician Decision|2
9839|NCT02246764|54162|P1|Overall Study|Physician Decision|0
9840|NCT02246764|54160|P3|Overall Study|Disallowed Concomitant Medication|0
9841|NCT02246764|54161|P2|Overall Study|Disallowed Concomitant Medication|0
9842|NCT02246764|54162|P1|Overall Study|Disallowed Concomitant Medication|1
9843|NCT02246764|54160|P3|Overall Study|Withdrawal by Subject|1
9844|NCT02246764|54161|P2|Overall Study|Withdrawal by Subject|0
9845|NCT02246764|54162|P1|Overall Study|Withdrawal by Subject|0
9846|NCT02246764|54160|P3|Overall Study|Adverse Event|1
9847|NCT02246764|54161|P2|Overall Study|Adverse Event|29
9848|NCT02246764|54162|P1|Overall Study|Adverse Event|15
9849|NCT02246673|54175|P5|Overall Study|Protocol Violation|0
9850|NCT02246673|54176|P4|Overall Study|Protocol Violation|1
9851|NCT02246673|54177|P3|Overall Study|Protocol Violation|0
9852|NCT02246673|54178|P2|Overall Study|Protocol Violation|0
9853|NCT02246673|54179|P1|Overall Study|Protocol Violation|0
9854|NCT02246673|54175|P5|Overall Study|Lost to Follow-up|0
9855|NCT02246673|54176|P4|Overall Study|Lost to Follow-up|1
9856|NCT02246673|54177|P3|Overall Study|Lost to Follow-up|0
9857|NCT02246673|54178|P2|Overall Study|Lost to Follow-up|0
9858|NCT02246673|54179|P1|Overall Study|Lost to Follow-up|0
9859|NCT02246673|54175|P5|Overall Study|Withdrawal by Subject|1
9860|NCT02246673|54176|P4|Overall Study|Withdrawal by Subject|0
9861|NCT02246673|54177|P3|Overall Study|Withdrawal by Subject|0
9862|NCT02246673|54178|P2|Overall Study|Withdrawal by Subject|0
9863|NCT02246673|54179|P1|Overall Study|Withdrawal by Subject|0
9864|NCT02246673|54175|P5|Overall Study|Sponsor Decision|0
9865|NCT02246673|54176|P4|Overall Study|Sponsor Decision|0
9866|NCT02246673|54177|P3|Overall Study|Sponsor Decision|0
9867|NCT02246673|54178|P2|Overall Study|Sponsor Decision|0
9868|NCT02246673|54179|P1|Overall Study|Sponsor Decision|1
9869|NCT02246660|54287|P3|Overall Study|Death|1
9870|NCT02246660|54288|P2|Overall Study|Death|0
9871|NCT02246660|54289|P1|Overall Study|Death|0
9872|NCT02246660|54287|P3|Overall Study|Withdrawal by Subject|0
9873|NCT02246660|54288|P2|Overall Study|Withdrawal by Subject|1
9874|NCT02246660|54289|P1|Overall Study|Withdrawal by Subject|0
9875|NCT02246621|54299|P2|Overall Study|On Study Treatment/ Follow Up|133
9876|NCT02246621|54300|P1|Overall Study|On Study Treatment/ Follow Up|257
9877|NCT02246621|54299|P2|Overall Study|Lost to Follow-up|1
9878|NCT02246621|54300|P1|Overall Study|Lost to Follow-up|3
9879|NCT02246621|54299|P2|Overall Study|Withdrawal by Subject|14
9880|NCT02246621|54300|P1|Overall Study|Withdrawal by Subject|36
9881|NCT02246582|54326|P2|Overall Study|Withdrawal by Subject|4
9882|NCT02246582|54327|P1|Overall Study|Withdrawal by Subject|3
9883|NCT02246166|54348|P2|Overall Study|Protocol Violation|0
9884|NCT02246166|54349|P1|Overall Study|Protocol Violation|1
9885|NCT02246114|54385|P2|Overall Study|miscarriage|0
9886|NCT02246114|54386|P1|Overall Study|miscarriage|1
9887|NCT02245412|54420|P3|Overall Study|Other|0
9888|NCT02245412|54421|P2|Overall Study|Other|0
9889|NCT02245412|54422|P1|Overall Study|Other|1
9890|NCT02245412|54420|P3|Overall Study|Biopsy did not confirm GI GVHD|0
9891|NCT02245412|54421|P2|Overall Study|Biopsy did not confirm GI GVHD|0
9892|NCT02245412|54422|P1|Overall Study|Biopsy did not confirm GI GVHD|1
9893|NCT02245412|54420|P3|Overall Study|Withdrawal by Subject|0
9894|NCT02245412|54421|P2|Overall Study|Withdrawal by Subject|1
9895|NCT02245412|54422|P1|Overall Study|Withdrawal by Subject|1
9896|NCT02245412|54420|P3|Overall Study|Physician Decision|0
9897|NCT02245412|54421|P2|Overall Study|Physician Decision|1
9898|NCT02245412|54422|P1|Overall Study|Physician Decision|1
9899|NCT02245412|54420|P3|Overall Study|Death|0
9900|NCT02245412|54421|P2|Overall Study|Death|1
9901|NCT02245412|54422|P1|Overall Study|Death|1
9902|NCT02244944|54456|P1|Overall Study|Study Terminated|1
9903|NCT02244944|54456|P1|Overall Study|Withdrawal by Subject|1
9904|NCT02244619|54468|P2|Overall Study|Did not receive study intervention|21
9905|NCT02244619|54469|P1|Overall Study|Did not receive study intervention|8
9906|NCT02244580|54487|P1|Overall Study|No cancer tissues available|241
9907|NCT02243293|54525|P22|Overall Study|Randomized but did'nt receive study drug|0
9908|NCT02243293|54526|P21|Overall Study|Randomized but did'nt receive study drug|0
9909|NCT02243293|54527|P20|Overall Study|Randomized but did'nt receive study drug|1
9910|NCT02243293|54528|P19|Overall Study|Randomized but did'nt receive study drug|0
9911|NCT02243293|54529|P18|Overall Study|Randomized but did'nt receive study drug|0
9912|NCT02243293|54530|P17|Overall Study|Randomized but did'nt receive study drug|0
9913|NCT02243293|54531|P16|Overall Study|Randomized but did'nt receive study drug|0
9914|NCT02243293|54532|P15|Overall Study|Randomized but did'nt receive study drug|0
9915|NCT02243293|54533|P14|Overall Study|Randomized but did'nt receive study drug|0
9916|NCT02243293|54534|P13|Overall Study|Randomized but did'nt receive study drug|0
9917|NCT02243293|54535|P12|Overall Study|Randomized but did'nt receive study drug|0
9918|NCT02243293|54536|P11|Overall Study|Randomized but did'nt receive study drug|0
9919|NCT02243293|54537|P10|Overall Study|Randomized but did'nt receive study drug|1
9920|NCT02243293|54538|P9|Overall Study|Randomized but did'nt receive study drug|0
9921|NCT02243293|54539|P8|Overall Study|Randomized but did'nt receive study drug|0
9922|NCT02243293|54540|P7|Overall Study|Randomized but did'nt receive study drug|0
9923|NCT02243293|54541|P6|Overall Study|Randomized but did'nt receive study drug|0
9924|NCT02243293|54542|P5|Overall Study|Randomized but did'nt receive study drug|1
9925|NCT02243293|54543|P4|Overall Study|Randomized but did'nt receive study drug|0
9926|NCT02243293|54544|P3|Overall Study|Randomized but did'nt receive study drug|0
9927|NCT02243293|54545|P2|Overall Study|Randomized but did'nt receive study drug|0
9928|NCT02243293|54546|P1|Overall Study|Randomized but did'nt receive study drug|0
9929|NCT02243293|54525|P22|Overall Study|Enrolled into a Re-treatment Study|0
9930|NCT02243293|54526|P21|Overall Study|Enrolled into a Re-treatment Study|0
9931|NCT02243293|54527|P20|Overall Study|Enrolled into a Re-treatment Study|0
9932|NCT02243293|54528|P19|Overall Study|Enrolled into a Re-treatment Study|0
9933|NCT02243293|54529|P18|Overall Study|Enrolled into a Re-treatment Study|0
9934|NCT02243293|54530|P17|Overall Study|Enrolled into a Re-treatment Study|0
9935|NCT02243293|54531|P16|Overall Study|Enrolled into a Re-treatment Study|0
9936|NCT02243293|54532|P15|Overall Study|Enrolled into a Re-treatment Study|1
9937|NCT02243293|54533|P14|Overall Study|Enrolled into a Re-treatment Study|0
9938|NCT02243293|54534|P13|Overall Study|Enrolled into a Re-treatment Study|0
9939|NCT02243293|54535|P12|Overall Study|Enrolled into a Re-treatment Study|0
9940|NCT02243293|54536|P11|Overall Study|Enrolled into a Re-treatment Study|0
9941|NCT02243293|54537|P10|Overall Study|Enrolled into a Re-treatment Study|0
9942|NCT02243293|54538|P9|Overall Study|Enrolled into a Re-treatment Study|0
9943|NCT02243293|54539|P8|Overall Study|Enrolled into a Re-treatment Study|0
9944|NCT02243293|54540|P7|Overall Study|Enrolled into a Re-treatment Study|0
9945|NCT02243293|54541|P6|Overall Study|Enrolled into a Re-treatment Study|0
9946|NCT02243293|54542|P5|Overall Study|Enrolled into a Re-treatment Study|0
9947|NCT02243293|54543|P4|Overall Study|Enrolled into a Re-treatment Study|0
9948|NCT02243293|54544|P3|Overall Study|Enrolled into a Re-treatment Study|0
9949|NCT02243293|54545|P2|Overall Study|Enrolled into a Re-treatment Study|0
9950|NCT02243293|54546|P1|Overall Study|Enrolled into a Re-treatment Study|0
9951|NCT02243293|54525|P22|Overall Study|Lost to Follow-up|2
9952|NCT02243293|54526|P21|Overall Study|Lost to Follow-up|1
9953|NCT02243293|54527|P20|Overall Study|Lost to Follow-up|0
9954|NCT02243293|54528|P19|Overall Study|Lost to Follow-up|0
9955|NCT02243293|54529|P18|Overall Study|Lost to Follow-up|1
9956|NCT02243293|54530|P17|Overall Study|Lost to Follow-up|3
9957|NCT02243293|54531|P16|Overall Study|Lost to Follow-up|0
9958|NCT02243293|54532|P15|Overall Study|Lost to Follow-up|0
9959|NCT02243293|54533|P14|Overall Study|Lost to Follow-up|0
9960|NCT02243293|54534|P13|Overall Study|Lost to Follow-up|0
9961|NCT02243293|54535|P12|Overall Study|Lost to Follow-up|2
9962|NCT02243293|54536|P11|Overall Study|Lost to Follow-up|0
9963|NCT02243293|54537|P10|Overall Study|Lost to Follow-up|0
9964|NCT02243293|54538|P9|Overall Study|Lost to Follow-up|0
9965|NCT02243293|54539|P8|Overall Study|Lost to Follow-up|0
9966|NCT02243293|54540|P7|Overall Study|Lost to Follow-up|3
9967|NCT02243293|54541|P6|Overall Study|Lost to Follow-up|0
9968|NCT02243293|54542|P5|Overall Study|Lost to Follow-up|0
9969|NCT02243293|54543|P4|Overall Study|Lost to Follow-up|1
9970|NCT02243293|54544|P3|Overall Study|Lost to Follow-up|1
9971|NCT02243293|54545|P2|Overall Study|Lost to Follow-up|1
9972|NCT02243293|54546|P1|Overall Study|Lost to Follow-up|0
9973|NCT02243293|54525|P22|Overall Study|Withdrawal by Subject|1
9974|NCT02243293|54526|P21|Overall Study|Withdrawal by Subject|0
9975|NCT02243293|54527|P20|Overall Study|Withdrawal by Subject|0
9976|NCT02243293|54528|P19|Overall Study|Withdrawal by Subject|0
9977|NCT02243293|54529|P18|Overall Study|Withdrawal by Subject|0
9978|NCT02243293|54530|P17|Overall Study|Withdrawal by Subject|0
9979|NCT02243293|54531|P16|Overall Study|Withdrawal by Subject|0
9980|NCT02243293|54532|P15|Overall Study|Withdrawal by Subject|0
9981|NCT02243293|54533|P14|Overall Study|Withdrawal by Subject|0
9982|NCT02243293|54534|P13|Overall Study|Withdrawal by Subject|0
9983|NCT02243293|54535|P12|Overall Study|Withdrawal by Subject|1
9984|NCT02243293|54536|P11|Overall Study|Withdrawal by Subject|0
9985|NCT02243293|54537|P10|Overall Study|Withdrawal by Subject|1
9986|NCT02243293|54538|P9|Overall Study|Withdrawal by Subject|0
9987|NCT02243293|54539|P8|Overall Study|Withdrawal by Subject|0
9988|NCT02243293|54540|P7|Overall Study|Withdrawal by Subject|0
9989|NCT02243293|54541|P6|Overall Study|Withdrawal by Subject|0
9990|NCT02243293|54542|P5|Overall Study|Withdrawal by Subject|0
9991|NCT02243293|54543|P4|Overall Study|Withdrawal by Subject|0
9992|NCT02243293|54544|P3|Overall Study|Withdrawal by Subject|0
9993|NCT02243293|54545|P2|Overall Study|Withdrawal by Subject|0
9994|NCT02243293|54546|P1|Overall Study|Withdrawal by Subject|1
9995|NCT02243293|54525|P22|Overall Study|Adverse Event|0
9996|NCT02243293|54526|P21|Overall Study|Adverse Event|1
9997|NCT02243293|54527|P20|Overall Study|Adverse Event|0
9998|NCT02243293|54528|P19|Overall Study|Adverse Event|0
9999|NCT02243293|54529|P18|Overall Study|Adverse Event|0
10000|NCT02243293|54530|P17|Overall Study|Adverse Event|0
10001|NCT02243293|54531|P16|Overall Study|Adverse Event|1
10002|NCT02243293|54532|P15|Overall Study|Adverse Event|0
10003|NCT02243293|54533|P14|Overall Study|Adverse Event|0
10004|NCT02243293|54534|P13|Overall Study|Adverse Event|0
10005|NCT02243293|54535|P12|Overall Study|Adverse Event|0
10006|NCT02243293|54536|P11|Overall Study|Adverse Event|0
10007|NCT02243293|54537|P10|Overall Study|Adverse Event|0
10008|NCT02243293|54538|P9|Overall Study|Adverse Event|0
10009|NCT02243293|54539|P8|Overall Study|Adverse Event|0
10010|NCT02243293|54540|P7|Overall Study|Adverse Event|0
10011|NCT02243293|54541|P6|Overall Study|Adverse Event|0
10012|NCT02243293|54542|P5|Overall Study|Adverse Event|0
10013|NCT02243293|54543|P4|Overall Study|Adverse Event|0
10014|NCT02243293|54544|P3|Overall Study|Adverse Event|0
10015|NCT02243293|54545|P2|Overall Study|Adverse Event|0
10016|NCT02243293|54546|P1|Overall Study|Adverse Event|1
10017|NCT02243280|54645|P11|Treated|Lost to Follow-up|2
10018|NCT02243280|54646|P10|Treated|Lost to Follow-up|0
10019|NCT02243280|54647|P9|Treated|Lost to Follow-up|1
10020|NCT02243280|54648|P8|Treated|Lost to Follow-up|0
10021|NCT02243280|54649|P7|Treated|Lost to Follow-up|0
10022|NCT02243280|54650|P6|Treated|Lost to Follow-up|0
10023|NCT02243280|54651|P5|Treated|Lost to Follow-up|0
10024|NCT02243280|54652|P4|Treated|Lost to Follow-up|0
10025|NCT02243280|54653|P3|Treated|Lost to Follow-up|0
10026|NCT02243280|54654|P2|Treated|Lost to Follow-up|0
10027|NCT02243280|54655|P1|Treated|Lost to Follow-up|0
10028|NCT02243280|54645|P11|Treated|Adverse Event|1
10029|NCT02243280|54646|P10|Treated|Adverse Event|0
10030|NCT02243280|54647|P9|Treated|Adverse Event|0
10031|NCT02243280|54648|P8|Treated|Adverse Event|0
10032|NCT02243280|54649|P7|Treated|Adverse Event|0
10033|NCT02243280|54650|P6|Treated|Adverse Event|0
10034|NCT02243280|54651|P5|Treated|Adverse Event|0
10035|NCT02243280|54652|P4|Treated|Adverse Event|0
10036|NCT02243280|54653|P3|Treated|Adverse Event|0
10037|NCT02243280|54654|P2|Treated|Adverse Event|0
10038|NCT02243280|54655|P1|Treated|Adverse Event|1
10039|NCT02243202|54710|P4|Overall Study|Randomized but not received treatment|1
10040|NCT02243202|54711|P3|Overall Study|Randomized but not received treatment|0
10041|NCT02243202|54712|P2|Overall Study|Randomized but not received treatment|0
10042|NCT02243202|54713|P1|Overall Study|Randomized but not received treatment|0
10043|NCT02243202|54710|P4|Overall Study|Other|2
10044|NCT02243202|54711|P3|Overall Study|Other|1
10045|NCT02243202|54712|P2|Overall Study|Other|3
10046|NCT02243202|54713|P1|Overall Study|Other|1
10047|NCT02243202|54710|P4|Overall Study|Withdrawal by Subject|4
10048|NCT02243202|54711|P3|Overall Study|Withdrawal by Subject|4
10049|NCT02243202|54712|P2|Overall Study|Withdrawal by Subject|6
10050|NCT02243202|54713|P1|Overall Study|Withdrawal by Subject|7
10051|NCT02243202|54710|P4|Overall Study|Protocol Violation|1
10052|NCT02243202|54711|P3|Overall Study|Protocol Violation|2
10053|NCT02243202|54712|P2|Overall Study|Protocol Violation|1
10054|NCT02243202|54713|P1|Overall Study|Protocol Violation|3
10055|NCT02243202|54710|P4|Overall Study|Lost to Follow-up|11
10056|NCT02243202|54711|P3|Overall Study|Lost to Follow-up|14
10057|NCT02243202|54712|P2|Overall Study|Lost to Follow-up|9
10058|NCT02243202|54713|P1|Overall Study|Lost to Follow-up|9
10059|NCT02243202|54710|P4|Overall Study|Adverse Event|4
10060|NCT02243202|54711|P3|Overall Study|Adverse Event|10
10061|NCT02243202|54712|P2|Overall Study|Adverse Event|6
10062|NCT02243202|54713|P1|Overall Study|Adverse Event|5
10063|NCT02243176|54749|P2|Overall Study|Adverse Event|2
10064|NCT02243176|54750|P1|Overall Study|Adverse Event|2
10065|NCT02243176|54749|P2|Overall Study|Withdrawal by Subject|7
10066|NCT02243176|54750|P1|Overall Study|Withdrawal by Subject|8
10067|NCT02243176|54749|P2|Overall Study|Protocol Violation|1
10068|NCT02243176|54750|P1|Overall Study|Protocol Violation|2
10069|NCT02243176|54749|P2|Overall Study|protocol specified withdrawal critera|3
10070|NCT02243176|54750|P1|Overall Study|protocol specified withdrawal critera|1
10071|NCT02243176|54749|P2|Overall Study|Other reason|2
10072|NCT02243176|54750|P1|Overall Study|Other reason|1
10073|NCT02243046|54775|P3|Overall Study|Lost to Follow-up|4
10074|NCT02243046|54776|P2|Overall Study|Lost to Follow-up|1
10075|NCT02243046|54777|P1|Overall Study|Lost to Follow-up|1
10076|NCT02242643|54832|P2|Overall Study|Withdrawal by subject at Visit 2|1
10077|NCT02242643|54833|P1|Overall Study|Withdrawal by subject at Visit 2|0
10078|NCT02242643|54832|P2|Overall Study|Language barrier|0
10079|NCT02242643|54833|P1|Overall Study|Language barrier|1
10080|NCT02242643|54832|P2|Overall Study|Protocol requirements not followed|0
10081|NCT02242643|54833|P1|Overall Study|Protocol requirements not followed|1
10082|NCT02242643|54832|P2|Overall Study|Consent withdrawal by parent|0
10083|NCT02242643|54833|P1|Overall Study|Consent withdrawal by parent|1
10084|NCT02242643|54832|P2|Overall Study|Non-compliance|0
10085|NCT02242643|54833|P1|Overall Study|Non-compliance|1
10086|NCT02242643|54832|P2|Overall Study|Child placed in foster care by family|1
10087|NCT02242643|54833|P1|Overall Study|Child placed in foster care by family|0
10088|NCT02242643|54832|P2|Overall Study|Lost to Follow-up|61
10089|NCT02242643|54833|P1|Overall Study|Lost to Follow-up|54
10090|NCT02242643|54832|P2|Overall Study|Migrated/moved from study area|3
10091|NCT02242643|54833|P1|Overall Study|Migrated/moved from study area|1
10092|NCT02242643|54832|P2|Overall Study|Withdrawal by Subject|10
10093|NCT02242643|54833|P1|Overall Study|Withdrawal by Subject|15
10094|NCT02242643|54832|P2|Overall Study|Protocol Violation|2
10095|NCT02242643|54833|P1|Overall Study|Protocol Violation|1
10096|NCT02242305|54888|P2|Overall Study|Lost to Follow-up|0
10097|NCT02242305|54889|P1|Overall Study|Lost to Follow-up|2
10098|NCT02242305|54888|P2|Overall Study|Subject withdraws inform consent|4
10099|NCT02242305|54889|P1|Overall Study|Subject withdraws inform consent|0
10100|NCT02242305|54888|P2|Overall Study|Non-compliance dosing regimen or visit|2
10101|NCT02242305|54889|P1|Overall Study|Non-compliance dosing regimen or visit|2
10102|NCT02242305|54888|P2|Overall Study|Adverse Event|0
10103|NCT02242305|54889|P1|Overall Study|Adverse Event|1
10104|NCT02242305|54888|P2|Overall Study|Without spasm-like pain during 3 weeks|4
10105|NCT02242305|54889|P1|Overall Study|Without spasm-like pain during 3 weeks|1
10106|NCT02242201|54910|P3|Overall Study|preoperative opioid consumption|0
10107|NCT02242201|54911|P2|Overall Study|preoperative opioid consumption|1
10108|NCT02242201|54912|P1|Overall Study|preoperative opioid consumption|0
10109|NCT02242201|54910|P3|Overall Study|postponed surgery|1
10110|NCT02242201|54911|P2|Overall Study|postponed surgery|0
10111|NCT02242201|54912|P1|Overall Study|postponed surgery|0
10112|NCT02242201|54910|P3|Overall Study|changed surgical procedure|0
10113|NCT02242201|54911|P2|Overall Study|changed surgical procedure|0
10114|NCT02242201|54912|P1|Overall Study|changed surgical procedure|1
10115|NCT02242201|54910|P3|Overall Study|planned post-op anticoagulation|0
10116|NCT02242201|54911|P2|Overall Study|planned post-op anticoagulation|0
10117|NCT02242201|54912|P1|Overall Study|planned post-op anticoagulation|1
10118|NCT02242201|54910|P3|Overall Study|preoperative identified neuropathy|0
10119|NCT02242201|54911|P2|Overall Study|preoperative identified neuropathy|0
10120|NCT02242201|54912|P1|Overall Study|preoperative identified neuropathy|2
10121|NCT02241889|54950|P6|Overall Study|Withdrawal by Subject|1
10122|NCT02241889|54951|P5|Overall Study|Withdrawal by Subject|0
10123|NCT02241889|54952|P4|Overall Study|Withdrawal by Subject|0
10124|NCT02241889|54953|P3|Overall Study|Withdrawal by Subject|0
10125|NCT02241889|54954|P2|Overall Study|Withdrawal by Subject|0
10126|NCT02241889|54955|P1|Overall Study|Withdrawal by Subject|0
10127|NCT02241889|54950|P6|Overall Study|device issues|0
10128|NCT02241889|54951|P5|Overall Study|device issues|0
10129|NCT02241889|54952|P4|Overall Study|device issues|0
10130|NCT02241889|54953|P3|Overall Study|device issues|1
10131|NCT02241889|54954|P2|Overall Study|device issues|0
10132|NCT02241889|54955|P1|Overall Study|device issues|0
10133|NCT02241785|54990|P1|Overall Study|Adverse Event|1
10134|NCT02241785|54990|P1|Overall Study|Lost to Follow-up|2
10135|NCT02241785|54990|P1|Overall Study|Withdrawal by Subject|1
10136|NCT02241785|54990|P1|Overall Study|Sponsor Termination|43
10137|NCT02241187|55006|P1|Overall Study|Protocol closed due to lack of accrual.|2
10138|NCT02240628|55034|P2|Overall Study|Physician Decision|5
10139|NCT02240628|55035|P1|Overall Study|Physician Decision|6
10140|NCT02240368|55069|P3|Overall Study|Entropy failed to detect more than 50%|1
10141|NCT02240368|55070|P2|Overall Study|Entropy failed to detect more than 50%|0
10142|NCT02240368|55071|P1|Overall Study|Entropy failed to detect more than 50%|0
10143|NCT02240368|55069|P3|Overall Study|Surgery lasted less then 20 minutes|0
10144|NCT02240368|55070|P2|Overall Study|Surgery lasted less then 20 minutes|0
10145|NCT02240368|55071|P1|Overall Study|Surgery lasted less then 20 minutes|1
10146|NCT02239978|55122|P2|Overall Study|Withdrawal by Subject|0
10147|NCT02239978|55123|P1|Overall Study|Withdrawal by Subject|2
10148|NCT02239939|55140|P2|Overall Study|Lost to Follow-up|1
10149|NCT02239939|55141|P1|Overall Study|Lost to Follow-up|0
10150|NCT02239939|55140|P2|Overall Study|Withdrawal by Subject|1
10151|NCT02239939|55141|P1|Overall Study|Withdrawal by Subject|1
10152|NCT02239939|55140|P2|Overall Study|Adverse Event|0
10153|NCT02239939|55141|P1|Overall Study|Adverse Event|1
10154|NCT02239926|55157|P2|Overall Study|Withdrawal by Subject|1
10155|NCT02239926|55158|P1|Overall Study|Withdrawal by Subject|0
10156|NCT02239692|55183|P2|Overall Study|Other reason|0
10157|NCT02239692|55184|P1|Overall Study|Other reason|1
10158|NCT02239692|55183|P2|Overall Study|Withdrawal by Subject|5
10159|NCT02239692|55184|P1|Overall Study|Withdrawal by Subject|3
10160|NCT02239692|55183|P2|Overall Study|Lost to Follow-up|4
10161|NCT02239692|55184|P1|Overall Study|Lost to Follow-up|1
10162|NCT02239692|55183|P2|Overall Study|Physician Decision|1
10163|NCT02239692|55184|P1|Overall Study|Physician Decision|0
10164|NCT02239692|55183|P2|Overall Study|Adverse Event|1
10165|NCT02239692|55184|P1|Overall Study|Adverse Event|0
10166|NCT02239692|55183|P2|Overall Study|Incomplete colonoscopy|2
10167|NCT02239692|55184|P1|Overall Study|Incomplete colonoscopy|1
10168|NCT02239679|55203|P3|Overall Study|Withdrawal by Subject|1
10169|NCT02239679|55204|P2|Overall Study|Withdrawal by Subject|3
10170|NCT02239679|55205|P1|Overall Study|Withdrawal by Subject|2
10171|NCT02239679|55203|P3|Overall Study|Lost to Follow-up|0
10172|NCT02239679|55204|P2|Overall Study|Lost to Follow-up|0
10173|NCT02239679|55205|P1|Overall Study|Lost to Follow-up|1
10174|NCT02239094|55436|P1|Overall Study|Remitted before started|1
10175|NCT02239094|55436|P1|Overall Study|Withdrawal by Subject|1
10176|NCT02238483|55455|P2|Overall Study|Illness in family member|0
10177|NCT02238483|55456|P1|Overall Study|Illness in family member|1
10178|NCT02238483|55455|P2|Overall Study|Completion status not recorded|1
10179|NCT02238483|55456|P1|Overall Study|Completion status not recorded|1
10180|NCT02238483|55455|P2|Overall Study|Withdrawn due to physician decision|0
10181|NCT02238483|55456|P1|Overall Study|Withdrawn due to physician decision|1
10182|NCT02238483|55455|P2|Overall Study|Adverse Event|3
10183|NCT02238483|55456|P1|Overall Study|Adverse Event|7
10184|NCT02238483|55455|P2|Overall Study|Death|0
10185|NCT02238483|55456|P1|Overall Study|Death|1
10186|NCT02238483|55455|P2|Overall Study|Protocol Violation|2
10187|NCT02238483|55456|P1|Overall Study|Protocol Violation|1
10188|NCT02238483|55455|P2|Overall Study|Lost to Follow-up|1
10189|NCT02238483|55456|P1|Overall Study|Lost to Follow-up|1
10190|NCT02238483|55455|P2|Overall Study|Withdrawal by Subject|7
10191|NCT02238483|55456|P1|Overall Study|Withdrawal by Subject|2
10192|NCT02238379|55494|P2|Overall Study|Lost to Follow-up|0
10193|NCT02238379|55495|P1|Overall Study|Lost to Follow-up|1
10194|NCT02238080|55521|P1|Overall Study|Other|4
10195|NCT02238080|55521|P1|Overall Study|Withdrawal by Subject|2
10196|NCT02238080|55521|P1|Overall Study|Treatment interrupted|6
10197|NCT02238080|55521|P1|Overall Study|Death|13
10198|NCT02238067|55535|P1|Overall Study|Not completed survey at Month 6|45
10199|NCT02237118|55580|P2|Overall Study|consent withdrawn|0
10200|NCT02237118|55581|P1|Overall Study|consent withdrawn|1
10201|NCT02237118|55580|P2|Overall Study|Protocol Violation|1
10202|NCT02237118|55581|P1|Overall Study|Protocol Violation|0
10203|NCT02236611|55618|P2|Overall Study|Withdrew consent|4
10204|NCT02236611|55619|P1|Overall Study|Withdrew consent|9
10205|NCT02236611|55618|P2|Overall Study|Protocol deviation|5
10206|NCT02236611|55619|P1|Overall Study|Protocol deviation|3
10207|NCT02236611|55618|P2|Overall Study|Lost to Follow-up|2
10208|NCT02236611|55619|P1|Overall Study|Lost to Follow-up|0
10209|NCT02236611|55618|P2|Overall Study|Lack of Efficacy|7
10210|NCT02236611|55619|P1|Overall Study|Lack of Efficacy|4
10211|NCT02236611|55618|P2|Overall Study|Adverse Event|16
10212|NCT02236611|55619|P1|Overall Study|Adverse Event|10
10213|NCT02236598|55627|P2|Overall Study|Withdrawal by Subject|1
10214|NCT02236598|55628|P1|Overall Study|Withdrawal by Subject|0
10215|NCT02236598|55627|P2|Overall Study|Adverse Event|1
10216|NCT02236598|55628|P1|Overall Study|Adverse Event|0
10217|NCT02236130|55664|P2|Overall Study|Lost to Follow-up|12
10218|NCT02236130|55665|P1|Overall Study|Lost to Follow-up|7
10219|NCT02235454|55715|P1|Overall Study|Withdrawal by Subject|2
10220|NCT02235311|55721|P2|Overall Study|Protocol Violation|1
10221|NCT02235311|55722|P1|Overall Study|Protocol Violation|0
10222|NCT02235311|55721|P2|Overall Study|Lost to Follow-up|1
10223|NCT02235311|55722|P1|Overall Study|Lost to Follow-up|0
10224|NCT02235077|55740|P2|Overall Study|Physician Decision|1
10225|NCT02235077|55741|P1|Overall Study|Physician Decision|0
10226|NCT02235077|55740|P2|Overall Study|Withdrawal by Subject|5
10227|NCT02235077|55741|P1|Overall Study|Withdrawal by Subject|8
10228|NCT02235077|55740|P2|Overall Study|Lost to Follow-up|6
10229|NCT02235077|55741|P1|Overall Study|Lost to Follow-up|5
10230|NCT02235077|55740|P2|Overall Study|Death|7
10231|NCT02235077|55741|P1|Overall Study|Death|5
10232|NCT02234479|55809|P2|Overall Study|Withdrawal by Subject|3
10233|NCT02234479|55810|P1|Overall Study|Withdrawal by Subject|1
10234|NCT02234362|55820|P1|Overall Study|Withdrawal by Subject|3
10235|NCT02234362|55820|P1|Overall Study|Lost to Follow-up|6
10236|NCT02234362|55820|P1|Overall Study|Not eligible after first screening visit|17
10237|NCT02233803|55901|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
10238|NCT02233803|55902|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
10239|NCT02233803|55901|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
10240|NCT02233803|55902|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
10241|NCT02233803|55901|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
10242|NCT02233803|55902|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
10243|NCT02233803|55901|P2|Washout Period (4-Wks)|Physician Decision|0
10244|NCT02233803|55902|P1|Washout Period (4-Wks)|Physician Decision|1
10245|NCT02233803|55901|P2|Washout Period (4-Wks)|Lost to Follow-up|1
10246|NCT02233803|55902|P1|Washout Period (4-Wks)|Lost to Follow-up|0
10247|NCT02233803|55901|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
10248|NCT02233803|55902|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
10249|NCT02233803|55901|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
10250|NCT02233803|55902|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
10251|NCT02233803|55901|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
10252|NCT02233803|55902|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
10253|NCT02233803|55901|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
10254|NCT02233803|55902|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
10255|NCT02233647|55912|P1|Overall Study|Adverse Event|1
10256|NCT02233309|55941|P1|Overall Study|Physician Decision|5
10257|NCT02232880|55975|P1|Overall Study|study stopped prior to randomization|1
10258|NCT02232698|55984|P2|Overall Study|Withdrawal by Subject|11
10259|NCT02232698|55985|P1|Overall Study|Withdrawal by Subject|0
10260|NCT02232698|55984|P2|Overall Study|Allocated to control group|3
10261|NCT02232698|55985|P1|Overall Study|Allocated to control group|0
10262|NCT02232698|55984|P2|Overall Study|Non-compliance with study device|4
10263|NCT02232698|55985|P1|Overall Study|Non-compliance with study device|1
10264|NCT02232698|55984|P2|Overall Study|Had device-associated symptoms|0
10265|NCT02232698|55985|P1|Overall Study|Had device-associated symptoms|7
10266|NCT02232698|55984|P2|Overall Study|Met exclusion criteria|1
10267|NCT02232698|55985|P1|Overall Study|Met exclusion criteria|1
10268|NCT02232698|55984|P2|Overall Study|Pregnancy|1
10269|NCT02232698|55985|P1|Overall Study|Pregnancy|1
10270|NCT02231918|56020|P3|Overall Study|Adverse Event|1
10271|NCT02231918|56021|P2|Overall Study|Adverse Event|0
10272|NCT02231918|56022|P1|Overall Study|Adverse Event|0
10273|NCT02231918|56020|P3|Overall Study|Withdrawal by Subject|0
10274|NCT02231918|56021|P2|Overall Study|Withdrawal by Subject|1
10275|NCT02231918|56022|P1|Overall Study|Withdrawal by Subject|0
10276|NCT02231580|56086|P2|Overall Study|Adverse Event|0
10277|NCT02231580|56087|P1|Overall Study|Adverse Event|5
10278|NCT02231164|56204|P2|Overall Study|Withdrawal by Subject|2
10279|NCT02231164|56205|P1|Overall Study|Withdrawal by Subject|1
10280|NCT02231164|56204|P2|Overall Study|Lack of Efficacy|3
10281|NCT02231164|56205|P1|Overall Study|Lack of Efficacy|4
10282|NCT02231164|56204|P2|Overall Study|Adverse Event|1
10283|NCT02231164|56205|P1|Overall Study|Adverse Event|1
10284|NCT02230956|56233|P3|Overall Study|Other Miscellaneous Reason|2
10285|NCT02230956|56234|P2|Overall Study|Other Miscellaneous Reason|1
10286|NCT02230956|56235|P1|Overall Study|Other Miscellaneous Reason|0
10287|NCT02230956|56233|P3|Overall Study|Protocol Violation|1
10288|NCT02230956|56234|P2|Overall Study|Protocol Violation|1
10289|NCT02230956|56235|P1|Overall Study|Protocol Violation|0
10290|NCT02230956|56233|P3|Overall Study|Personal Reasons|1
10291|NCT02230956|56234|P2|Overall Study|Personal Reasons|1
10292|NCT02230956|56235|P1|Overall Study|Personal Reasons|2
10293|NCT02230956|56233|P3|Overall Study|Lost to Follow-up|2
10294|NCT02230956|56234|P2|Overall Study|Lost to Follow-up|1
10295|NCT02230956|56235|P1|Overall Study|Lost to Follow-up|1
10296|NCT02230956|56233|P3|Overall Study|Lack of Efficacy|1
10297|NCT02230956|56234|P2|Overall Study|Lack of Efficacy|1
10298|NCT02230956|56235|P1|Overall Study|Lack of Efficacy|1
10299|NCT02230956|56233|P3|Overall Study|Adverse Event|0
10300|NCT02230956|56234|P2|Overall Study|Adverse Event|1
10301|NCT02230956|56235|P1|Overall Study|Adverse Event|1
10302|NCT02230904|56257|P2|Overall Study|Safety follow up could not take place|1
10303|NCT02230904|56258|P1|Overall Study|Safety follow up could not take place|0
10304|NCT02230683|56291|P1|Overall Study|Adverse Event|1
10305|NCT02230670|56308|P2|Overall Study|Progression to Child-Pugh C|2
10306|NCT02230670|56309|P1|Overall Study|Progression to Child-Pugh C|1
10307|NCT02230670|56308|P2|Overall Study|Protocol Violation|1
10308|NCT02230670|56309|P1|Overall Study|Protocol Violation|0
10309|NCT02230670|56308|P2|Overall Study|Physician Decision|1
10310|NCT02230670|56309|P1|Overall Study|Physician Decision|0
10311|NCT02230670|56308|P2|Overall Study|Withdrawal by Subject|2
10312|NCT02230670|56309|P1|Overall Study|Withdrawal by Subject|2
10313|NCT02230670|56308|P2|Overall Study|Adverse Event|2
10314|NCT02230670|56309|P1|Overall Study|Adverse Event|1
10315|NCT02230384|56348|P2|Phase 2 - Switch|Adverse Event|0
10316|NCT02230384|56349|P1|Phase 2 - Switch|Adverse Event|2
10317|NCT02230384|56348|P2|Phase 2 - Switch|Lost to Follow-up|0
10318|NCT02230384|56349|P1|Phase 2 - Switch|Lost to Follow-up|1
10319|NCT02230384|56348|P2|Phase 2 - Switch|Withdrawal by Subject|1
10320|NCT02230384|56349|P1|Phase 2 - Switch|Withdrawal by Subject|0
10321|NCT02230384|56348|P2|Phase 1|Physician Decision|1
10322|NCT02230384|56349|P1|Phase 1|Physician Decision|0
10323|NCT02230384|56348|P2|Phase 1|Lost to Follow-up|0
10324|NCT02230384|56349|P1|Phase 1|Lost to Follow-up|1
10325|NCT02230332|56357|P2|Overall Study|Protocol Violation|0
10326|NCT02230332|56358|P1|Overall Study|Protocol Violation|1
10327|NCT02230332|56357|P2|Overall Study|Lost to Follow-up|0
10328|NCT02230332|56358|P1|Overall Study|Lost to Follow-up|1
10329|NCT02230332|56357|P2|Overall Study|Adverse Event|1
10330|NCT02230332|56358|P1|Overall Study|Adverse Event|2
10331|NCT02230306|56374|P1|Overall Study|Did not receive study treatment|1
10332|NCT02230085|56385|P1|Overall Study|Withdrawal by Subject|3
10333|NCT02230085|56385|P1|Overall Study|Physician Decision|1
10334|NCT02229864|56389|P1|3 - Year Visit|Death|2
10335|NCT02229864|56389|P1|2 - Year Visit|Missed Visits|1
10336|NCT02229539|56444|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
10337|NCT02229539|56445|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
10338|NCT02229539|56446|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
10339|NCT02229539|56444|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
10340|NCT02229539|56445|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
10341|NCT02229539|56446|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
10342|NCT02229539|56444|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
10343|NCT02229539|56445|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
10344|NCT02229539|56446|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
10345|NCT02229539|56444|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
10346|NCT02229539|56445|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
10347|NCT02229539|56446|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
10348|NCT02229539|56444|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
10349|NCT02229539|56445|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
10350|NCT02229539|56446|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
10351|NCT02229539|56444|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
10352|NCT02229539|56445|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
10353|NCT02229539|56446|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
10354|NCT02229539|56444|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
10355|NCT02229539|56445|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
10356|NCT02229539|56446|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
10357|NCT02229539|56444|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
10358|NCT02229539|56445|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
10359|NCT02229539|56446|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
10360|NCT02229539|56444|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
10361|NCT02229539|56445|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
10362|NCT02229539|56446|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
10363|NCT02229396|56577|P3|Overall Study|Other Eligibility criteria|0
10364|NCT02229396|56578|P2|Overall Study|Other Eligibility criteria|2
10365|NCT02229396|56579|P1|Overall Study|Other Eligibility criteria|0
10366|NCT02229396|56577|P3|Overall Study|Withdrawal by Subject|16
10367|NCT02229396|56578|P2|Overall Study|Withdrawal by Subject|9
10368|NCT02229396|56579|P1|Overall Study|Withdrawal by Subject|15
10369|NCT02229396|56577|P3|Overall Study|Withdrew; no record on termination page|4
10370|NCT02229396|56578|P2|Overall Study|Withdrew; no record on termination page|5
10371|NCT02229396|56579|P1|Overall Study|Withdrew; no record on termination page|2
10372|NCT02229396|56577|P3|Overall Study|Patient was incorrectly randomized|1
10373|NCT02229396|56578|P2|Overall Study|Patient was incorrectly randomized|0
10374|NCT02229396|56579|P1|Overall Study|Patient was incorrectly randomized|0
10375|NCT02229396|56577|P3|Overall Study|Protocol deviation; compliance|0
10376|NCT02229396|56578|P2|Overall Study|Protocol deviation; compliance|0
10377|NCT02229396|56579|P1|Overall Study|Protocol deviation; compliance|1
10378|NCT02229396|56577|P3|Overall Study|Lost to Follow-up|11
10379|NCT02229396|56578|P2|Overall Study|Lost to Follow-up|5
10380|NCT02229396|56579|P1|Overall Study|Lost to Follow-up|4
10381|NCT02229396|56577|P3|Overall Study|Death|1
10382|NCT02229396|56578|P2|Overall Study|Death|3
10383|NCT02229396|56579|P1|Overall Study|Death|1
10384|NCT02229396|56577|P3|Overall Study|Adverse Event|5
10385|NCT02229396|56578|P2|Overall Study|Adverse Event|5
10386|NCT02229396|56579|P1|Overall Study|Adverse Event|2
10387|NCT02229383|56610|P2|Overall Study|Randomized in error|0
10388|NCT02229383|56611|P1|Overall Study|Randomized in error|1
10389|NCT02229383|56610|P2|Overall Study|Investigator decision|4
10390|NCT02229383|56611|P1|Overall Study|Investigator decision|1
10391|NCT02229383|56610|P2|Overall Study|Death|1
10392|NCT02229383|56611|P1|Overall Study|Death|0
10393|NCT02229383|56610|P2|Overall Study|Fire at the study center|4
10394|NCT02229383|56611|P1|Overall Study|Fire at the study center|2
10395|NCT02229383|56610|P2|Overall Study|Withdrawal by Subject|9
10396|NCT02229383|56611|P1|Overall Study|Withdrawal by Subject|5
10397|NCT02229383|56610|P2|Overall Study|Lost to Follow-up|2
10398|NCT02229383|56611|P1|Overall Study|Lost to Follow-up|4
10399|NCT02229383|56610|P2|Overall Study|Adverse Event|4
10400|NCT02229383|56611|P1|Overall Study|Adverse Event|9
10401|NCT02229214|56636|P2|Overall Study|Withdrawal by Subject|0
10402|NCT02229214|56637|P1|Overall Study|Withdrawal by Subject|4
10403|NCT02229214|56636|P2|Overall Study|Adverse Event|0
10404|NCT02229214|56637|P1|Overall Study|Adverse Event|2
10405|NCT02228980|56661|P4|Overall Study|Withdrawal by Subject|3
10406|NCT02228980|56662|P3|Overall Study|Withdrawal by Subject|2
10407|NCT02228980|56663|P2|Overall Study|Withdrawal by Subject|3
10408|NCT02228980|56664|P1|Overall Study|Withdrawal by Subject|3
10409|NCT02228980|56661|P4|Overall Study|Protocol Violation|0
10410|NCT02228980|56662|P3|Overall Study|Protocol Violation|0
10411|NCT02228980|56663|P2|Overall Study|Protocol Violation|0
10412|NCT02228980|56664|P1|Overall Study|Protocol Violation|7
10413|NCT02228980|56661|P4|Overall Study|Adverse Event|0
10414|NCT02228980|56662|P3|Overall Study|Adverse Event|0
10415|NCT02228980|56663|P2|Overall Study|Adverse Event|0
10416|NCT02228980|56664|P1|Overall Study|Adverse Event|14
10417|NCT02228720|56686|P1|Open Label - Day 30|Lost to Follow-up|1
10418|NCT02228395|56694|P3|First Intervention Period|Unable to comply with study dates|1
10419|NCT02228395|56695|P2|First Intervention Period|Unable to comply with study dates|1
10420|NCT02228395|56696|P1|First Intervention Period|Unable to comply with study dates|0
10421|NCT02228395|56694|P3|First Intervention Period|No longer willing to participate|0
10422|NCT02228395|56695|P2|First Intervention Period|No longer willing to participate|0
10423|NCT02228395|56696|P1|First Intervention Period|No longer willing to participate|1
10424|NCT02227784|56779|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
10425|NCT02227784|56780|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
10426|NCT02227784|56781|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
10427|NCT02227784|56782|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
10428|NCT02227784|56783|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
10429|NCT02227784|56779|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
10430|NCT02227784|56780|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
10431|NCT02227784|56781|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
10432|NCT02227784|56782|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
10433|NCT02227784|56783|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
10434|NCT02227784|56779|P5|Open-Label Extension Phase (OLE)|Death|1
10435|NCT02227784|56780|P4|Open-Label Extension Phase (OLE)|Death|0
10436|NCT02227784|56781|P3|Open-Label Extension Phase (OLE)|Death|0
10437|NCT02227784|56782|P2|Open-Label Extension Phase (OLE)|Death|0
10438|NCT02227784|56783|P1|Open-Label Extension Phase (OLE)|Death|0
10439|NCT02227784|56779|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
10440|NCT02227784|56780|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
10441|NCT02227784|56781|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
10442|NCT02227784|56782|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
10443|NCT02227784|56783|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
10444|NCT02227784|56779|P5|Double-Blind Phase|Withdrawal by Subject|0
10445|NCT02227784|56780|P4|Double-Blind Phase|Withdrawal by Subject|2
10446|NCT02227784|56781|P3|Double-Blind Phase|Withdrawal by Subject|5
10447|NCT02227784|56782|P2|Double-Blind Phase|Withdrawal by Subject|1
10448|NCT02227784|56783|P1|Double-Blind Phase|Withdrawal by Subject|2
10449|NCT02227784|56779|P5|Double-Blind Phase|Sponsor Decision|0
10450|NCT02227784|56780|P4|Double-Blind Phase|Sponsor Decision|32
10451|NCT02227784|56781|P3|Double-Blind Phase|Sponsor Decision|14
10452|NCT02227784|56782|P2|Double-Blind Phase|Sponsor Decision|15
10453|NCT02227784|56783|P1|Double-Blind Phase|Sponsor Decision|34
10454|NCT02227784|56779|P5|Double-Blind Phase|Protocol Violation|0
10455|NCT02227784|56780|P4|Double-Blind Phase|Protocol Violation|1
10456|NCT02227784|56781|P3|Double-Blind Phase|Protocol Violation|1
10457|NCT02227784|56782|P2|Double-Blind Phase|Protocol Violation|0
10458|NCT02227784|56783|P1|Double-Blind Phase|Protocol Violation|0
10459|NCT02227784|56779|P5|Double-Blind Phase|Physician Decision|0
10460|NCT02227784|56780|P4|Double-Blind Phase|Physician Decision|1
10461|NCT02227784|56781|P3|Double-Blind Phase|Physician Decision|0
10462|NCT02227784|56782|P2|Double-Blind Phase|Physician Decision|0
10463|NCT02227784|56783|P1|Double-Blind Phase|Physician Decision|1
10464|NCT02227784|56779|P5|Double-Blind Phase|Adverse Event|0
10465|NCT02227784|56780|P4|Double-Blind Phase|Adverse Event|3
10466|NCT02227784|56781|P3|Double-Blind Phase|Adverse Event|1
10467|NCT02227784|56782|P2|Double-Blind Phase|Adverse Event|2
10468|NCT02227784|56783|P1|Double-Blind Phase|Adverse Event|3
10469|NCT02227368|56839|P2|Overall Study|Adverse Event|0
10470|NCT02227368|56840|P1|Overall Study|Adverse Event|1
10471|NCT02227368|56839|P2|Overall Study|Lost to Follow-up|0
10472|NCT02227368|56840|P1|Overall Study|Lost to Follow-up|1
10473|NCT02227368|56839|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
10474|NCT02227368|56840|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
10475|NCT02227108|56861|P1|Overall Study|Adverse Event|6
10476|NCT02227108|56861|P1|Overall Study|Investigator discretion|1
10477|NCT02227108|56861|P1|Overall Study|Initiation of alternative therapy|2
10478|NCT02227108|56861|P1|Overall Study|Progressive disease|17
10479|NCT02227108|56861|P1|Overall Study|Other|3
10480|NCT02227108|56861|P1|Overall Study|Did not receive treatment|2
10481|NCT02226562|56890|P2|Overall Study|Lost to Follow-up|1
10482|NCT02226562|56891|P1|Overall Study|Lost to Follow-up|0
10483|NCT02226549|56909|P2|Overall Study|Lost to Follow-up|1
10484|NCT02226549|56910|P1|Overall Study|Lost to Follow-up|0
10485|NCT02226549|56909|P2|Overall Study|Randomized but Never Treated|0
10486|NCT02226549|56910|P1|Overall Study|Randomized but Never Treated|1
10487|NCT02226198|56920|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
10488|NCT02226198|56921|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
10489|NCT02226198|56922|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
10490|NCT02226198|56920|P3|Lead-in Phase|Protocol Violation|0
10491|NCT02226198|56921|P2|Lead-in Phase|Protocol Violation|0
10492|NCT02226198|56922|P1|Lead-in Phase|Protocol Violation|1
10493|NCT02226172|56995|P1|Overall Study|Ongoing in study|3
10494|NCT02226172|56995|P1|Overall Study|Death|1
10495|NCT02226172|56995|P1|Overall Study|Other|4
10496|NCT02226172|56995|P1|Overall Study|Subject refused further follow-up|5
10497|NCT02226003|57017|P3|Overall Study|Withdrawal by Subject|3
10498|NCT02226003|57018|P2|Overall Study|Withdrawal by Subject|0
10499|NCT02226003|57019|P1|Overall Study|Withdrawal by Subject|0
10500|NCT02226003|57017|P3|Overall Study|Lost to Follow-up|3
10501|NCT02226003|57018|P2|Overall Study|Lost to Follow-up|1
10502|NCT02226003|57019|P1|Overall Study|Lost to Follow-up|2
10503|NCT02224846|57066|P2|Period 2 (Month 12 to Month 24)|On Study Treatment|357
10504|NCT02224846|57067|P1|Period 2 (Month 12 to Month 24)|On Study Treatment|173
10505|NCT02224846|57066|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
10506|NCT02224846|57067|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
10507|NCT02224846|57066|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
10508|NCT02224846|57067|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
10509|NCT02224846|57066|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
10510|NCT02224846|57067|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
10511|NCT02224846|57066|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
10512|NCT02224846|57067|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
10513|NCT02224846|57066|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
10514|NCT02224846|57067|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
10515|NCT02224846|57066|P2|Period 1 (Month 3)|Sponsor Decision|1
10516|NCT02224846|57067|P1|Period 1 (Month 3)|Sponsor Decision|2
10517|NCT02224846|57066|P2|Period 1 (Month 3)|Withdrawal by Subject|18
10518|NCT02224846|57067|P1|Period 1 (Month 3)|Withdrawal by Subject|8
10519|NCT02224846|57066|P2|Period 1 (Month 3)|Protocol Violation|8
10520|NCT02224846|57067|P1|Period 1 (Month 3)|Protocol Violation|4
10521|NCT02224846|57066|P2|Period 1 (Month 3)|Lost to Follow-up|8
10522|NCT02224846|57067|P1|Period 1 (Month 3)|Lost to Follow-up|3
10523|NCT02224846|57066|P2|Period 1 (Month 3)|Adverse Event|1
10524|NCT02224846|57067|P1|Period 1 (Month 3)|Adverse Event|2
10525|NCT02224664|57092|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
10526|NCT02224664|57093|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
10527|NCT02224664|57094|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
10528|NCT02224664|57095|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
10529|NCT02224664|57096|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
10530|NCT02224664|57092|P5|Dose Escalation Period (21 Days)|Adverse Event|7
10531|NCT02224664|57093|P4|Dose Escalation Period (21 Days)|Adverse Event|2
10532|NCT02224664|57094|P3|Dose Escalation Period (21 Days)|Adverse Event|2
10533|NCT02224664|57095|P2|Dose Escalation Period (21 Days)|Adverse Event|0
10534|NCT02224664|57096|P1|Dose Escalation Period (21 Days)|Adverse Event|0
10535|NCT02224664|57092|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
10536|NCT02224664|57093|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
10537|NCT02224664|57094|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
10538|NCT02224664|57095|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
10539|NCT02224664|57096|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
10540|NCT02224625|57176|P1|Sensitization|Adverse Event|55
10541|NCT02224625|57176|P1|Irritation|Adverse Event|6
10542|NCT02224053|57206|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
10543|NCT02224053|57206|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
10544|NCT02224053|57206|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
10545|NCT02224053|57206|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
10546|NCT02224053|57206|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
10547|NCT02223754|57252|P2|Period 2|Test Article No Longer Available|1
10548|NCT02223754|57253|P1|Period 2|Test Article No Longer Available|0
10549|NCT02223754|57252|P2|Period 2|Lost to Follow-up|0
10550|NCT02223754|57253|P1|Period 2|Lost to Follow-up|1
10551|NCT02223754|57252|P2|Period 2|Lens Discomfort|1
10552|NCT02223754|57253|P1|Period 2|Lens Discomfort|1
10553|NCT02223754|57252|P2|Period 2|Protocol Violation|0
10554|NCT02223754|57253|P1|Period 2|Protocol Violation|1
10555|NCT02223754|57252|P2|Period 2|Adverse Event|1
10556|NCT02223754|57253|P1|Period 2|Adverse Event|0
10557|NCT02223754|57252|P2|Period 1|Unsatisfactory Visual Response|1
10558|NCT02223754|57253|P1|Period 1|Unsatisfactory Visual Response|0
10559|NCT02223754|57252|P2|Period 1|Test Article No Longer Available|5
10560|NCT02223754|57253|P1|Period 1|Test Article No Longer Available|1
10561|NCT02223754|57252|P2|Period 1|Withdrawal by Subject|4
10562|NCT02223754|57253|P1|Period 1|Withdrawal by Subject|0
10563|NCT02223754|57252|P2|Period 1|Protocol Violation|4
10564|NCT02223754|57253|P1|Period 1|Protocol Violation|2
10565|NCT02223754|57252|P2|Period 1|Lost to Follow-up|1
10566|NCT02223754|57253|P1|Period 1|Lost to Follow-up|0
10567|NCT02223754|57252|P2|Period 1|Adverse Event|0
10568|NCT02223754|57253|P1|Period 1|Adverse Event|1
10569|NCT02223715|57273|P1|Overall Study|Lost to Follow-up|73
10570|NCT02223715|57273|P1|Overall Study|Death|31
10571|NCT02223364|57351|P3|Overall Study|Physician Decision|0
10572|NCT02223364|57352|P2|Overall Study|Physician Decision|0
10573|NCT02223364|57353|P1|Overall Study|Physician Decision|1
10574|NCT02223364|57351|P3|Overall Study|subject expired before surgery|0
10575|NCT02223364|57352|P2|Overall Study|subject expired before surgery|0
10576|NCT02223364|57353|P1|Overall Study|subject expired before surgery|1
10577|NCT02223364|57351|P3|Overall Study|Protocol Violation|3
10578|NCT02223364|57352|P2|Overall Study|Protocol Violation|0
10579|NCT02223364|57353|P1|Overall Study|Protocol Violation|3
10580|NCT02222818|57468|P2|Period 1|Eligibility criteria not met|3
10581|NCT02222818|57469|P1|Period 1|Eligibility criteria not met|0
10582|NCT02222558|57476|P6|Period 3|Withdrawal by Subject|1
10583|NCT02222558|57477|P5|Period 3|Withdrawal by Subject|0
10584|NCT02222558|57478|P4|Period 3|Withdrawal by Subject|0
10585|NCT02222558|57479|P3|Period 3|Withdrawal by Subject|0
10586|NCT02222558|57480|P2|Period 3|Withdrawal by Subject|0
10587|NCT02222558|57481|P1|Period 3|Withdrawal by Subject|0
10588|NCT02222558|57476|P6|Period 1: Single Dose|Withdrawal by Subject|0
10589|NCT02222558|57477|P5|Period 1: Single Dose|Withdrawal by Subject|0
10590|NCT02222558|57478|P4|Period 1: Single Dose|Withdrawal by Subject|0
10591|NCT02222558|57479|P3|Period 1: Single Dose|Withdrawal by Subject|0
10592|NCT02222558|57480|P2|Period 1: Single Dose|Withdrawal by Subject|0
10593|NCT02222558|57481|P1|Period 1: Single Dose|Withdrawal by Subject|4
10594|NCT02222493|57497|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
10595|NCT02222493|57498|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
10596|NCT02222493|57497|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
10597|NCT02222493|57498|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
10598|NCT02222493|57497|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
10599|NCT02222493|57498|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
10600|NCT02222493|57497|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
10601|NCT02222493|57498|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
10602|NCT02222493|57497|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
10603|NCT02222493|57498|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
10604|NCT02222493|57497|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
10605|NCT02222493|57498|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
10606|NCT02222493|57497|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
10607|NCT02222493|57498|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
10608|NCT02222493|57497|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
10609|NCT02222493|57498|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
10610|NCT02222493|57497|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
10611|NCT02222493|57498|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
10612|NCT02222493|57497|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
10613|NCT02222493|57498|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
10614|NCT02222493|57497|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
10615|NCT02222493|57498|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
10616|NCT02222493|57497|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
10617|NCT02222493|57498|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
10618|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
10619|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
10620|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
10621|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
10622|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
10623|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
10624|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
10625|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
10626|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
10627|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
10628|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
10629|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
10630|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
10631|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
10632|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
10633|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
10634|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
10635|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
10636|NCT02222493|57497|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
10637|NCT02222493|57498|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
10638|NCT02222246|57616|P2|Overall Study|Physician Decision|1
10639|NCT02222246|57617|P1|Overall Study|Physician Decision|0
10640|NCT02222246|57616|P2|Overall Study|No Emergency Department Visits|26
10641|NCT02222246|57617|P1|Overall Study|No Emergency Department Visits|27
10642|NCT02222207|57645|P1|Overall Study|Adverse Event|1
10643|NCT02222207|57645|P1|Overall Study|Other reasons|2
10644|NCT02222207|57645|P1|Overall Study|Death|1
10645|NCT02221674|57689|P3|Overall Study|Lost to Follow-up|0
10646|NCT02221674|57690|P2|Overall Study|Lost to Follow-up|0
10647|NCT02221674|57691|P1|Overall Study|Lost to Follow-up|1
10648|NCT02221648|57707|P2|Overall Study|Withdrawal by Subject|3
10649|NCT02221648|57708|P1|Overall Study|Withdrawal by Subject|3
10650|NCT02220998|57724|P2|Overall Study|Lost to Follow-up|4
10651|NCT02220998|57725|P1|Overall Study|Lost to Follow-up|4
10652|NCT02220998|57724|P2|Overall Study|Lack of Efficacy|5
10653|NCT02220998|57725|P1|Overall Study|Lack of Efficacy|0
10654|NCT02220998|57724|P2|Overall Study|Death|0
10655|NCT02220998|57725|P1|Overall Study|Death|2
10656|NCT02220998|57724|P2|Overall Study|Randomized but Never Treated|2
10657|NCT02220998|57725|P1|Overall Study|Randomized but Never Treated|1
10658|NCT02220920|57743|P2|Overall Study|Conflict with the stopping criteria|2
10659|NCT02220920|57744|P1|Overall Study|Conflict with the stopping criteria|1
10660|NCT02220920|57743|P2|Overall Study|Withdrawal by Subject|0
10661|NCT02220920|57744|P1|Overall Study|Withdrawal by Subject|1
10662|NCT02220920|57743|P2|Overall Study|Lack of Efficacy|1
10663|NCT02220920|57744|P1|Overall Study|Lack of Efficacy|0
10664|NCT02220920|57743|P2|Overall Study|Adverse Event|0
10665|NCT02220920|57744|P1|Overall Study|Adverse Event|1
10666|NCT02220764|57760|P2|Overall Study|Death|0
10667|NCT02220764|57761|P1|Overall Study|Death|1
10668|NCT02220764|57760|P2|Overall Study|Lost to Follow-up|1
10669|NCT02220764|57761|P1|Overall Study|Lost to Follow-up|3
10670|NCT02220205|57773|P2|Overall Study|Withdrawal by Subject|0
10671|NCT02220205|57774|P1|Overall Study|Withdrawal by Subject|1
10672|NCT02219932|57799|P2|Overall Study|Adverse Event|21
10673|NCT02219932|57800|P1|Overall Study|Adverse Event|23
10674|NCT02219932|57799|P2|Overall Study|Lost to Follow-up|2
10675|NCT02219932|57800|P1|Overall Study|Lost to Follow-up|4
10676|NCT02219932|57799|P2|Overall Study|Pregnancy|0
10677|NCT02219932|57800|P1|Overall Study|Pregnancy|1
10678|NCT02219932|57799|P2|Overall Study|Protocol Violation|6
10679|NCT02219932|57800|P1|Overall Study|Protocol Violation|10
10680|NCT02219932|57799|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
10681|NCT02219932|57800|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
10682|NCT02219932|57799|P2|Overall Study|Consent Withdrawn|7
10683|NCT02219932|57800|P1|Overall Study|Consent Withdrawn|11
10684|NCT02219932|57799|P2|Overall Study|Investigator Decision|1
10685|NCT02219932|57800|P1|Overall Study|Investigator Decision|0
10686|NCT02219932|57799|P2|Overall Study|Death|1
10687|NCT02219932|57800|P1|Overall Study|Death|1
10688|NCT02219932|57799|P2|Overall Study|Not Specified|11
10689|NCT02219932|57800|P1|Overall Study|Not Specified|5
10690|NCT02219685|57816|P2|Blinded Treatment Phase|Withdrew Consent|0
10691|NCT02219685|57817|P1|Blinded Treatment Phase|Withdrew Consent|1
10692|NCT02219685|57816|P2|Blinded Treatment Phase|Lost to Follow-up|0
10693|NCT02219685|57817|P1|Blinded Treatment Phase|Lost to Follow-up|1
10694|NCT02219477|57923|P3|Overall Study|Withdrawal by Subject|0
10695|NCT02219477|57924|P2|Overall Study|Withdrawal by Subject|1
10696|NCT02219477|57925|P1|Overall Study|Withdrawal by Subject|0
10697|NCT02219477|57923|P3|Overall Study|Adverse Event|1
10698|NCT02219477|57924|P2|Overall Study|Adverse Event|1
10699|NCT02219477|57925|P1|Overall Study|Adverse Event|0
10700|NCT02219464|57953|P2|Overall Study|catheter malfunction|0
10701|NCT02219464|57954|P1|Overall Study|catheter malfunction|1
10702|NCT02219464|57953|P2|Overall Study|case cancelled|0
10703|NCT02219464|57954|P1|Overall Study|case cancelled|1
10704|NCT02219464|57953|P2|Overall Study|Withdrawal by Subject|0
10705|NCT02219464|57954|P1|Overall Study|Withdrawal by Subject|1
10706|NCT02219087|58114|P2|Overall Study|Randomization envelope pulled out of seq|1
10707|NCT02219087|58115|P1|Overall Study|Randomization envelope pulled out of seq|0
10708|NCT02218697|58135|P2|Overall Study|Withdrawal by Subject|3
10709|NCT02218697|58136|P1|Overall Study|Withdrawal by Subject|2
10710|NCT02218697|58135|P2|Overall Study|Unwilling to be vaccinated in left arm|1
10711|NCT02218697|58136|P1|Overall Study|Unwilling to be vaccinated in left arm|0
10712|NCT02218697|58135|P2|Overall Study|Adverse Event|2
10713|NCT02218697|58136|P1|Overall Study|Adverse Event|0
10714|NCT02218268|58185|P2|24 Hour Washout|Physician Decision|9
10715|NCT02218268|58186|P1|24 Hour Washout|Physician Decision|11
10716|NCT02218216|58194|P3|Overall Study|Study terminated before completed|0
10717|NCT02218216|58195|P2|Overall Study|Study terminated before completed|0
10718|NCT02218216|58196|P1|Overall Study|Study terminated before completed|6
10719|NCT02217982|58228|P2|Overall Study|Adverse Event|1
10720|NCT02217982|58229|P1|Overall Study|Adverse Event|0
10721|NCT02217982|58228|P2|Overall Study|Trial discontinued|0
10722|NCT02217982|58229|P1|Overall Study|Trial discontinued|1
10723|NCT02217878|58239|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
10724|NCT02217878|58240|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
10725|NCT02217878|58239|P2|Overall Study|required morphine due to chest pain|2
10726|NCT02217878|58240|P1|Overall Study|required morphine due to chest pain|1
10727|NCT02217280|58332|P1|Overall Study|Post-consent sceen fail|2
10728|NCT02217280|58332|P1|Overall Study|Withdrawal by Subject|2
10729|NCT02216591|58348|P2|Overall Study|Lost to Follow-up|1
10730|NCT02216591|58349|P1|Overall Study|Lost to Follow-up|0
10731|NCT02216526|58362|P3|Overall Study|Hospitalization|3
10732|NCT02216526|58363|P2|Overall Study|Hospitalization|1
10733|NCT02216526|58364|P1|Overall Study|Hospitalization|2
10734|NCT02216526|58362|P3|Overall Study|Protocol Violation|2
10735|NCT02216526|58363|P2|Overall Study|Protocol Violation|0
10736|NCT02216526|58364|P1|Overall Study|Protocol Violation|2
10737|NCT02216526|58362|P3|Overall Study|Death|3
10738|NCT02216526|58363|P2|Overall Study|Death|1
10739|NCT02216526|58364|P1|Overall Study|Death|0
10740|NCT02216526|58362|P3|Overall Study|Adverse Event|0
10741|NCT02216526|58363|P2|Overall Study|Adverse Event|1
10742|NCT02216526|58364|P1|Overall Study|Adverse Event|1
10743|NCT02216357|58482|P2|Overall Study|Inclusion or exclusion criteria not met|1
10744|NCT02216357|58483|P1|Overall Study|Inclusion or exclusion criteria not met|2
10745|NCT02216123|58509|P2|Overall Study|Withdrawal by Subject|0
10746|NCT02216123|58510|P1|Overall Study|Withdrawal by Subject|2
10747|NCT02216123|58509|P2|Overall Study|Lost to Follow-up|2
10748|NCT02216123|58510|P1|Overall Study|Lost to Follow-up|4
10749|NCT02215954|58602|P3|Overall Study|Not exposed|3
10750|NCT02215954|58603|P2|Overall Study|Not exposed|1
10751|NCT02215954|58604|P1|Overall Study|Not exposed|1
10752|NCT02215954|58602|P3|Overall Study|Withdrawal by Subject|2
10753|NCT02215954|58603|P2|Overall Study|Withdrawal by Subject|0
10754|NCT02215954|58604|P1|Overall Study|Withdrawal by Subject|0
10755|NCT02215954|58602|P3|Overall Study|Adverse Event|1
10756|NCT02215954|58603|P2|Overall Study|Adverse Event|0
10757|NCT02215954|58604|P1|Overall Study|Adverse Event|0
10758|NCT02215252|58627|P3|Overall Study|Other|1
10759|NCT02215252|58628|P2|Overall Study|Other|1
10760|NCT02215252|58629|P1|Overall Study|Other|0
10761|NCT02215252|58627|P3|Overall Study|Withdrawal by Subject|0
10762|NCT02215252|58628|P2|Overall Study|Withdrawal by Subject|0
10763|NCT02215252|58629|P1|Overall Study|Withdrawal by Subject|1
10764|NCT02215252|58627|P3|Overall Study|Protocol Violation|0
10765|NCT02215252|58628|P2|Overall Study|Protocol Violation|1
10766|NCT02215252|58629|P1|Overall Study|Protocol Violation|0
10767|NCT02215252|58627|P3|Overall Study|Does not Meet Entrance Criteria|0
10768|NCT02215252|58628|P2|Overall Study|Does not Meet Entrance Criteria|1
10769|NCT02215252|58629|P1|Overall Study|Does not Meet Entrance Criteria|0
10770|NCT02215252|58627|P3|Overall Study|Lost to Follow-up|1
10771|NCT02215252|58628|P2|Overall Study|Lost to Follow-up|0
10772|NCT02215252|58629|P1|Overall Study|Lost to Follow-up|0
10773|NCT02215252|58627|P3|Overall Study|Adverse Event|2
10774|NCT02215252|58628|P2|Overall Study|Adverse Event|5
10775|NCT02215252|58629|P1|Overall Study|Adverse Event|1
10776|NCT02214225|58735|P3|Overall Study|randomized in error, not vaccinated|1
10777|NCT02214225|58736|P2|Overall Study|randomized in error, not vaccinated|1
10778|NCT02214225|58737|P1|Overall Study|randomized in error, not vaccinated|2
10779|NCT02214225|58735|P3|Overall Study|Death|1
10780|NCT02214225|58736|P2|Overall Study|Death|0
10781|NCT02214225|58737|P1|Overall Study|Death|5
10782|NCT02214225|58735|P3|Overall Study|Withdrawal by Subject|2
10783|NCT02214225|58736|P2|Overall Study|Withdrawal by Subject|0
10784|NCT02214225|58737|P1|Overall Study|Withdrawal by Subject|2
10785|NCT02214225|58735|P3|Overall Study|Lost to Follow-up|18
10786|NCT02214225|58736|P2|Overall Study|Lost to Follow-up|18
10787|NCT02214225|58737|P1|Overall Study|Lost to Follow-up|46
10788|NCT02214186|58796|P2|Overall Study|Protocol Violation|1
10789|NCT02214186|58797|P1|Overall Study|Protocol Violation|1
10790|NCT02214186|58796|P2|Overall Study|Lost to Follow-up|1
10791|NCT02214186|58797|P1|Overall Study|Lost to Follow-up|1
10792|NCT02214121|58822|P3|Part B|Lost to Follow-up|1
10793|NCT02214121|58823|P2|Part B|Lost to Follow-up|0
10794|NCT02214121|58824|P1|Part B|Lost to Follow-up|0
10795|NCT02214121|58822|P3|Part B|Dev. of study-specific withdrawal crit.|0
10796|NCT02214121|58823|P2|Part B|Dev. of study-specific withdrawal crit.|2
10797|NCT02214121|58824|P1|Part B|Dev. of study-specific withdrawal crit.|0
10798|NCT02214121|58822|P3|Part B|Patient decision|0
10799|NCT02214121|58823|P2|Part B|Patient decision|1
10800|NCT02214121|58824|P1|Part B|Patient decision|0
10801|NCT02214121|58822|P3|Part A|Other|0
10802|NCT02214121|58823|P2|Part A|Other|0
10803|NCT02214121|58824|P1|Part A|Other|1
10804|NCT02214121|58822|P3|Part A|Dev. of study-specific withdrawal crit.|0
10805|NCT02214121|58823|P2|Part A|Dev. of study-specific withdrawal crit.|0
10806|NCT02214121|58824|P1|Part A|Dev. of study-specific withdrawal crit.|4
10807|NCT02214121|58822|P3|Part A|Patient decision|0
10808|NCT02214121|58823|P2|Part A|Patient decision|0
10809|NCT02214121|58824|P1|Part A|Patient decision|2
10810|NCT02213666|58916|P1|Overall Study|Withdrawal by Subject|1
10811|NCT02213510|58922|P2|Overall Study|Lost to Follow-up|0
10812|NCT02213510|58923|P1|Overall Study|Lost to Follow-up|1
10813|NCT02213510|58922|P2|Overall Study|Death|1
10814|NCT02213510|58923|P1|Overall Study|Death|0
10815|NCT02213198|58981|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
10816|NCT02213198|58982|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
10817|NCT02213198|58981|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
10818|NCT02213198|58982|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
10819|NCT02213198|58981|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
10820|NCT02213198|58982|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
10821|NCT02213198|58981|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
10822|NCT02213198|58982|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
10823|NCT02213198|58981|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
10824|NCT02213198|58982|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
10825|NCT02213198|58981|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
10826|NCT02213198|58982|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
10827|NCT02213198|58981|P2|Baseline|incarcerated,violent|1
10828|NCT02213198|58982|P1|Baseline|incarcerated,violent|0
10829|NCT02213198|58981|P2|Baseline|Lost to Follow-up|21
10830|NCT02213198|58982|P1|Baseline|Lost to Follow-up|40
10831|NCT02213198|58981|P2|Baseline|transferred out of clinic|9
10832|NCT02213198|58982|P1|Baseline|transferred out of clinic|7
10833|NCT02213198|58981|P2|Baseline|Withdrawal by Subject|11
10834|NCT02213198|58982|P1|Baseline|Withdrawal by Subject|34
10835|NCT02213198|58981|P2|Baseline|No show for intake|9
10836|NCT02213198|58982|P1|Baseline|No show for intake|7
10837|NCT02213055|58992|P2|Overall Study|Did not Return to School|0
10838|NCT02213055|58993|P1|Overall Study|Did not Return to School|5
10839|NCT02213055|58992|P2|Overall Study|Did not meet Inclusion Criteria|0
10840|NCT02213055|58993|P1|Overall Study|Did not meet Inclusion Criteria|6
10841|NCT02213055|58992|P2|Overall Study|Had another Treatment during the Study|0
10842|NCT02213055|58993|P1|Overall Study|Had another Treatment during the Study|3
10843|NCT02213055|58992|P2|Overall Study|Did not have Live Lice|0
10844|NCT02213055|58993|P1|Overall Study|Did not have Live Lice|8
10845|NCT02213055|58992|P2|Overall Study|Documentation Issue during Study|0
10846|NCT02213055|58993|P1|Overall Study|Documentation Issue during Study|10
10847|NCT02213055|58992|P2|Overall Study|Documentation Issue at Enrollment|0
10848|NCT02213055|58993|P1|Overall Study|Documentation Issue at Enrollment|1
10849|NCT02213055|58992|P2|Overall Study|Protocol was not Followed during Study|0
10850|NCT02213055|58993|P1|Overall Study|Protocol was not Followed during Study|1
10851|NCT02213055|58992|P2|Overall Study|Protocol was not Followed at Enrollment|0
10852|NCT02213055|58993|P1|Overall Study|Protocol was not Followed at Enrollment|5
10853|NCT02212457|59031|P6|Overall Study|Other|1
10854|NCT02212457|59032|P5|Overall Study|Other|0
10855|NCT02212457|59033|P4|Overall Study|Other|1
10856|NCT02212457|59034|P3|Overall Study|Other|2
10857|NCT02212457|59035|P2|Overall Study|Other|1
10858|NCT02212457|59036|P1|Overall Study|Other|2
10859|NCT02212457|59031|P6|Overall Study|Protocol Violation|3
10860|NCT02212457|59032|P5|Overall Study|Protocol Violation|2
10861|NCT02212457|59033|P4|Overall Study|Protocol Violation|1
10862|NCT02212457|59034|P3|Overall Study|Protocol Violation|0
10863|NCT02212457|59035|P2|Overall Study|Protocol Violation|1
10864|NCT02212457|59036|P1|Overall Study|Protocol Violation|2
10865|NCT02212457|59031|P6|Overall Study|Lost to Follow-up|4
10866|NCT02212457|59032|P5|Overall Study|Lost to Follow-up|8
10867|NCT02212457|59033|P4|Overall Study|Lost to Follow-up|1
10868|NCT02212457|59034|P3|Overall Study|Lost to Follow-up|4
10869|NCT02212457|59035|P2|Overall Study|Lost to Follow-up|7
10870|NCT02212457|59036|P1|Overall Study|Lost to Follow-up|6
10871|NCT02212457|59031|P6|Overall Study|Withdrawal by Subject|4
10872|NCT02212457|59032|P5|Overall Study|Withdrawal by Subject|5
10873|NCT02212457|59033|P4|Overall Study|Withdrawal by Subject|6
10874|NCT02212457|59034|P3|Overall Study|Withdrawal by Subject|8
10875|NCT02212457|59035|P2|Overall Study|Withdrawal by Subject|10
10876|NCT02212457|59036|P1|Overall Study|Withdrawal by Subject|8
10877|NCT02212457|59031|P6|Overall Study|Adverse Event|1
10878|NCT02212457|59032|P5|Overall Study|Adverse Event|0
10879|NCT02212457|59033|P4|Overall Study|Adverse Event|2
10880|NCT02212457|59034|P3|Overall Study|Adverse Event|2
10881|NCT02212457|59035|P2|Overall Study|Adverse Event|2
10882|NCT02212457|59036|P1|Overall Study|Adverse Event|1
10883|NCT02212301|59074|P2|Period 1|Lost to Follow-up|1
10884|NCT02212301|59075|P1|Period 1|Lost to Follow-up|0
10885|NCT02212197|59086|P3|Overall Study|Need for radiotherapy|0
10886|NCT02212197|59087|P2|Overall Study|Need for radiotherapy|0
10887|NCT02212197|59088|P1|Overall Study|Need for radiotherapy|1
10888|NCT02210208|59164|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
10889|NCT02210208|59164|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
10890|NCT02210208|59164|P1|Period A (Graft Site)|Withdrawal by Subject|1
10891|NCT02210091|59184|P2|Overall Study|Withdrawal by Sponsor|1
10892|NCT02210091|59185|P1|Overall Study|Withdrawal by Sponsor|0
10893|NCT02210091|59184|P2|Overall Study|Physician Decision|1
10894|NCT02210091|59185|P1|Overall Study|Physician Decision|0
10895|NCT02210000|59263|P2|Overall Study|Physician Decision|1
10896|NCT02210000|59264|P1|Overall Study|Physician Decision|0
10897|NCT02210000|59263|P2|Overall Study|Lost to Follow-up|2
10898|NCT02210000|59264|P1|Overall Study|Lost to Follow-up|0
10899|NCT02210000|59263|P2|Overall Study|Adverse Event|5
10900|NCT02210000|59264|P1|Overall Study|Adverse Event|1
10901|NCT02210000|59263|P2|Overall Study|Withdrawal by Subject|1
10902|NCT02210000|59264|P1|Overall Study|Withdrawal by Subject|7
10903|NCT02210000|59263|P2|Overall Study|Study Terminated|12
10904|NCT02210000|59264|P1|Overall Study|Study Terminated|11
10905|NCT02209766|59290|P5|Overall Study|Withdrawal by Subject|0
10906|NCT02209766|59291|P4|Overall Study|Withdrawal by Subject|1
10907|NCT02209766|59292|P3|Overall Study|Withdrawal by Subject|0
10908|NCT02209766|59293|P2|Overall Study|Withdrawal by Subject|0
10909|NCT02209766|59294|P1|Overall Study|Withdrawal by Subject|0
10910|NCT02209506|59345|P5|Overall Study|Withdrawal by Subject|1
10911|NCT02209506|59346|P4|Overall Study|Withdrawal by Subject|0
10912|NCT02209506|59347|P3|Overall Study|Withdrawal by Subject|0
10913|NCT02209506|59348|P2|Overall Study|Withdrawal by Subject|0
10914|NCT02209506|59349|P1|Overall Study|Withdrawal by Subject|0
10915|NCT02209454|59424|P2|Second Period|Adverse Event|0
10916|NCT02209454|59425|P1|Second Period|Adverse Event|1
10917|NCT02209181|59462|P4|Overall Study|Withdrawal by Subject|0
10918|NCT02209181|59463|P3|Overall Study|Withdrawal by Subject|0
10919|NCT02209181|59464|P2|Overall Study|Withdrawal by Subject|1
10920|NCT02209181|59465|P1|Overall Study|Withdrawal by Subject|0
10921|NCT02209181|59462|P4|Overall Study|Adverse Event|0
10922|NCT02209181|59463|P3|Overall Study|Adverse Event|1
10923|NCT02209181|59464|P2|Overall Study|Adverse Event|0
10924|NCT02209181|59465|P1|Overall Study|Adverse Event|1
10925|NCT02207907|59682|P2|Overall Study|Pregnancy|1
10926|NCT02207907|59683|P1|Overall Study|Pregnancy|0
10927|NCT02207907|59682|P2|Overall Study|Did not meet study criteria|0
10928|NCT02207907|59683|P1|Overall Study|Did not meet study criteria|3
10929|NCT02207907|59682|P2|Overall Study|Withdrawal by Subject|6
10930|NCT02207907|59683|P1|Overall Study|Withdrawal by Subject|5
10931|NCT02207907|59682|P2|Overall Study|Lost to Follow-up|1
10932|NCT02207907|59683|P1|Overall Study|Lost to Follow-up|3
10933|NCT02207829|59701|P2|Overall Study|Withdrew consent|14
10934|NCT02207829|59702|P1|Overall Study|Withdrew consent|18
10935|NCT02207829|59701|P2|Overall Study|Protocol deviation|4
10936|NCT02207829|59702|P1|Overall Study|Protocol deviation|5
10937|NCT02207829|59701|P2|Overall Study|Lost to Follow-up|2
10938|NCT02207829|59702|P1|Overall Study|Lost to Follow-up|2
10939|NCT02207829|59701|P2|Overall Study|Lack of Efficacy|5
10940|NCT02207829|59702|P1|Overall Study|Lack of Efficacy|7
10941|NCT02207829|59701|P2|Overall Study|Adverse Event|9
10942|NCT02207829|59702|P1|Overall Study|Adverse Event|10
10943|NCT02207634|59721|P2|Overall Study|Lost to Follow-up|0
10944|NCT02207634|59722|P1|Overall Study|Lost to Follow-up|1
10945|NCT02207634|59721|P2|Overall Study|Withdrawal by Subject|31
10946|NCT02207634|59722|P1|Overall Study|Withdrawal by Subject|21
10947|NCT02207621|59737|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
10948|NCT02207621|59738|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
10949|NCT02207621|59739|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
10950|NCT02207621|59737|P3|Overall Study|Death|0
10951|NCT02207621|59738|P2|Overall Study|Death|0
10952|NCT02207621|59739|P1|Overall Study|Death|2
10953|NCT02207621|59737|P3|Overall Study|Protocol Violation|6
10954|NCT02207621|59738|P2|Overall Study|Protocol Violation|10
10955|NCT02207621|59739|P1|Overall Study|Protocol Violation|4
10956|NCT02207621|59737|P3|Overall Study|Physician Decision|2
10957|NCT02207621|59738|P2|Overall Study|Physician Decision|2
10958|NCT02207621|59739|P1|Overall Study|Physician Decision|1
10959|NCT02207621|59737|P3|Overall Study|Disallowed Concurrent Medication|2
10960|NCT02207621|59738|P2|Overall Study|Disallowed Concurrent Medication|5
10961|NCT02207621|59739|P1|Overall Study|Disallowed Concurrent Medication|2
10962|NCT02207621|59737|P3|Overall Study|Lack of Efficacy|4
10963|NCT02207621|59738|P2|Overall Study|Lack of Efficacy|2
10964|NCT02207621|59739|P1|Overall Study|Lack of Efficacy|10
10965|NCT02207621|59737|P3|Overall Study|Lost to Follow-up|3
10966|NCT02207621|59738|P2|Overall Study|Lost to Follow-up|0
10967|NCT02207621|59739|P1|Overall Study|Lost to Follow-up|1
10968|NCT02207621|59737|P3|Overall Study|Non-Compliant|1
10969|NCT02207621|59738|P2|Overall Study|Non-Compliant|3
10970|NCT02207621|59739|P1|Overall Study|Non-Compliant|3
10971|NCT02207621|59737|P3|Overall Study|Withdrawal by Subject|13
10972|NCT02207621|59738|P2|Overall Study|Withdrawal by Subject|9
10973|NCT02207621|59739|P1|Overall Study|Withdrawal by Subject|9
10974|NCT02207621|59737|P3|Overall Study|Adverse Event|132
10975|NCT02207621|59738|P2|Overall Study|Adverse Event|15
10976|NCT02207621|59739|P1|Overall Study|Adverse Event|71
10977|NCT02207608|59752|P2|Overall Study|Adverse Event|0
10978|NCT02207608|59753|P1|Overall Study|Adverse Event|1
10979|NCT02207491|59779|P2|Overall Study|Protocol Violation|5
10980|NCT02207491|59780|P1|Overall Study|Protocol Violation|3
10981|NCT02207491|59779|P2|Overall Study|Physician Decision|0
10982|NCT02207491|59780|P1|Overall Study|Physician Decision|2
10983|NCT02207491|59779|P2|Overall Study|Lack of Efficacy|0
10984|NCT02207491|59780|P1|Overall Study|Lack of Efficacy|3
10985|NCT02207491|59779|P2|Overall Study|Lost to Follow-up|1
10986|NCT02207491|59780|P1|Overall Study|Lost to Follow-up|0
10987|NCT02207491|59779|P2|Overall Study|Non-compliant|1
10988|NCT02207491|59780|P1|Overall Study|Non-compliant|0
10989|NCT02207491|59779|P2|Overall Study|Withdrawal by Subject|2
10990|NCT02207491|59780|P1|Overall Study|Withdrawal by Subject|3
10991|NCT02207491|59779|P2|Overall Study|Adverse Event|4
10992|NCT02207491|59780|P1|Overall Study|Adverse Event|20
10993|NCT02207413|59805|P6|Overall Study|Migrated/moved from study area|0
10994|NCT02207413|59806|P5|Overall Study|Migrated/moved from study area|1
10995|NCT02207413|59807|P4|Overall Study|Migrated/moved from study area|0
10996|NCT02207413|59808|P3|Overall Study|Migrated/moved from study area|0
10997|NCT02207413|59809|P2|Overall Study|Migrated/moved from study area|0
10998|NCT02207413|59810|P1|Overall Study|Migrated/moved from study area|0
10999|NCT02207413|59805|P6|Overall Study|Adverse Event|1
11000|NCT02207413|59806|P5|Overall Study|Adverse Event|2
11001|NCT02207413|59807|P4|Overall Study|Adverse Event|0
11002|NCT02207413|59808|P3|Overall Study|Adverse Event|0
11003|NCT02207413|59809|P2|Overall Study|Adverse Event|0
11004|NCT02207413|59810|P1|Overall Study|Adverse Event|0
11005|NCT02207413|59805|P6|Overall Study|Lost to Follow-up|5
11006|NCT02207413|59806|P5|Overall Study|Lost to Follow-up|1
11007|NCT02207413|59807|P4|Overall Study|Lost to Follow-up|1
11008|NCT02207413|59808|P3|Overall Study|Lost to Follow-up|0
11009|NCT02207413|59809|P2|Overall Study|Lost to Follow-up|0
11010|NCT02207413|59810|P1|Overall Study|Lost to Follow-up|0
11011|NCT02207413|59805|P6|Overall Study|Withdrawal by Subject|7
11012|NCT02207413|59806|P5|Overall Study|Withdrawal by Subject|3
11013|NCT02207413|59807|P4|Overall Study|Withdrawal by Subject|0
11014|NCT02207413|59808|P3|Overall Study|Withdrawal by Subject|0
11015|NCT02207413|59809|P2|Overall Study|Withdrawal by Subject|0
11016|NCT02207413|59810|P1|Overall Study|Withdrawal by Subject|1
11017|NCT02207400|59906|P2|Overall Study|Positive Urine Pregnancy Test|1
11018|NCT02207400|59907|P1|Overall Study|Positive Urine Pregnancy Test|0
11019|NCT02207400|59906|P2|Overall Study|Withdrawal by Subject|4
11020|NCT02207400|59907|P1|Overall Study|Withdrawal by Subject|8
11021|NCT02207400|59906|P2|Overall Study|Protocol Violation|1
11022|NCT02207400|59907|P1|Overall Study|Protocol Violation|1
11023|NCT02207400|59906|P2|Overall Study|Lost to Follow-up|7
11024|NCT02207400|59907|P1|Overall Study|Lost to Follow-up|6
11025|NCT02207400|59906|P2|Overall Study|Adverse Event|1
11026|NCT02207400|59907|P1|Overall Study|Adverse Event|1
11027|NCT02207244|59928|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
11028|NCT02207244|59929|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
11029|NCT02207244|59930|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
11030|NCT02207244|59931|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
11031|NCT02207244|59932|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
11032|NCT02207244|59933|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
11033|NCT02207244|59934|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
11034|NCT02207244|59935|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
11035|NCT02207244|59936|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
11036|NCT02207244|59928|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
11037|NCT02207244|59929|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
11038|NCT02207244|59930|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
11039|NCT02207244|59931|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
11040|NCT02207244|59932|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
11041|NCT02207244|59933|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
11042|NCT02207244|59934|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
11043|NCT02207244|59935|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
11044|NCT02207244|59936|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
11045|NCT02207244|59928|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
11046|NCT02207244|59929|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
11047|NCT02207244|59930|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
11048|NCT02207244|59931|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
11049|NCT02207244|59932|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
11050|NCT02207244|59933|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
11051|NCT02207244|59934|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
11052|NCT02207244|59935|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
11053|NCT02207244|59936|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
11054|NCT02207244|59928|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
11055|NCT02207244|59929|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
11056|NCT02207244|59930|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
11057|NCT02207244|59931|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
11058|NCT02207244|59932|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
11059|NCT02207244|59933|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
11060|NCT02207244|59934|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
11061|NCT02207244|59935|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
11062|NCT02207244|59936|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
11063|NCT02207244|59928|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
11064|NCT02207244|59929|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
11065|NCT02207244|59930|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
11066|NCT02207244|59931|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
11067|NCT02207244|59932|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
11068|NCT02207244|59933|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
11069|NCT02207244|59934|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
11070|NCT02207244|59935|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
11071|NCT02207244|59936|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
11072|NCT02207244|59928|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
11073|NCT02207244|59929|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
11074|NCT02207244|59930|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
11075|NCT02207244|59931|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
11076|NCT02207244|59932|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
11077|NCT02207244|59933|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
11078|NCT02207244|59934|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
11079|NCT02207244|59935|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
11080|NCT02207244|59936|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
11081|NCT02207244|59928|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
11082|NCT02207244|59929|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
11083|NCT02207244|59930|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
11084|NCT02207244|59931|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
11085|NCT02207244|59932|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
11086|NCT02207244|59933|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
11087|NCT02207244|59934|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
11088|NCT02207244|59935|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
11089|NCT02207244|59936|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
11090|NCT02207244|59928|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
11091|NCT02207244|59929|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
11092|NCT02207244|59930|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
11093|NCT02207244|59931|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
11094|NCT02207244|59932|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
11095|NCT02207244|59933|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
11096|NCT02207244|59934|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
11097|NCT02207244|59935|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
11098|NCT02207244|59936|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
11099|NCT02207244|59928|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
11100|NCT02207244|59929|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
11101|NCT02207244|59930|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
11102|NCT02207244|59931|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
11103|NCT02207244|59932|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
11104|NCT02207244|59933|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
11105|NCT02207244|59934|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
11106|NCT02207244|59935|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
11107|NCT02207244|59936|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
11108|NCT02207244|59928|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
11109|NCT02207244|59929|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
11110|NCT02207244|59930|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
11111|NCT02207244|59931|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
11112|NCT02207244|59932|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
11113|NCT02207244|59933|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
11114|NCT02207244|59934|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
11115|NCT02207244|59935|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
11116|NCT02207244|59936|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
11117|NCT02207244|59928|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
11118|NCT02207244|59929|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
11119|NCT02207244|59930|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
11120|NCT02207244|59931|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
11121|NCT02207244|59932|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
11122|NCT02207244|59933|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
11123|NCT02207244|59934|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
11124|NCT02207244|59935|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
11125|NCT02207244|59936|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
11126|NCT02207244|59928|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
11127|NCT02207244|59929|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
11128|NCT02207244|59930|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
11129|NCT02207244|59931|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
11130|NCT02207244|59932|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
11131|NCT02207244|59933|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
11132|NCT02207244|59934|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
11133|NCT02207244|59935|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
11134|NCT02207244|59936|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
11135|NCT02207244|59928|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
11136|NCT02207244|59929|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
11137|NCT02207244|59930|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
11138|NCT02207244|59931|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
11139|NCT02207244|59932|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
11140|NCT02207244|59933|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
11141|NCT02207244|59934|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
11142|NCT02207244|59935|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
11143|NCT02207244|59936|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
11144|NCT02207244|59928|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
11145|NCT02207244|59929|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
11146|NCT02207244|59930|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
11147|NCT02207244|59931|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
11148|NCT02207244|59932|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
11149|NCT02207244|59933|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
11150|NCT02207244|59934|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
11151|NCT02207244|59935|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
11152|NCT02207244|59936|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
11153|NCT02207244|59928|P9|Placebo Controlled Period: Week 0 - 16|Other|0
11154|NCT02207244|59929|P8|Placebo Controlled Period: Week 0 - 16|Other|0
11155|NCT02207244|59930|P7|Placebo Controlled Period: Week 0 - 16|Other|0
11156|NCT02207244|59931|P6|Placebo Controlled Period: Week 0 - 16|Other|0
11157|NCT02207244|59932|P5|Placebo Controlled Period: Week 0 - 16|Other|0
11158|NCT02207244|59933|P4|Placebo Controlled Period: Week 0 - 16|Other|0
11159|NCT02207244|59934|P3|Placebo Controlled Period: Week 0 - 16|Other|0
11160|NCT02207244|59935|P2|Placebo Controlled Period: Week 0 - 16|Other|1
11161|NCT02207244|59936|P1|Placebo Controlled Period: Week 0 - 16|Other|0
11162|NCT02207244|59928|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
11163|NCT02207244|59929|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
11164|NCT02207244|59930|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
11165|NCT02207244|59931|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
11166|NCT02207244|59932|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
11167|NCT02207244|59933|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
11168|NCT02207244|59934|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
11169|NCT02207244|59935|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
11170|NCT02207244|59936|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
11171|NCT02207244|59928|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
11172|NCT02207244|59929|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
11173|NCT02207244|59930|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
11174|NCT02207244|59931|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
11175|NCT02207244|59932|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
11176|NCT02207244|59933|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
11177|NCT02207244|59934|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
11178|NCT02207244|59935|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
11179|NCT02207244|59936|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
11180|NCT02207244|59928|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
11181|NCT02207244|59929|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
11182|NCT02207244|59930|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
11183|NCT02207244|59931|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
11184|NCT02207244|59932|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
11185|NCT02207244|59933|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
11186|NCT02207244|59934|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
11187|NCT02207244|59935|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
11188|NCT02207244|59936|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
11189|NCT02207244|59928|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
11190|NCT02207244|59929|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
11191|NCT02207244|59930|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
11192|NCT02207244|59931|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
11193|NCT02207244|59932|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
11194|NCT02207244|59933|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
11195|NCT02207244|59934|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
11196|NCT02207244|59935|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
11197|NCT02207244|59936|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
11198|NCT02207244|59928|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
11199|NCT02207244|59929|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
11200|NCT02207244|59930|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
11201|NCT02207244|59931|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
11202|NCT02207244|59932|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
11203|NCT02207244|59933|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
11204|NCT02207244|59934|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
11205|NCT02207244|59935|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
11206|NCT02207244|59936|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
11207|NCT02207244|59928|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
11208|NCT02207244|59929|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
11209|NCT02207244|59930|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
11210|NCT02207244|59931|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
11211|NCT02207244|59932|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
11212|NCT02207244|59933|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
11213|NCT02207244|59934|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
11214|NCT02207244|59935|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
11215|NCT02207244|59936|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
11216|NCT02207231|59977|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
11217|NCT02207231|59978|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
11218|NCT02207231|59979|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
11219|NCT02207231|59977|P3|Active Controlled Period: Week 16 - 48|Other|3
11220|NCT02207231|59978|P2|Active Controlled Period: Week 16 - 48|Other|2
11221|NCT02207231|59979|P1|Active Controlled Period: Week 16 - 48|Other|0
11222|NCT02207231|59977|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
11223|NCT02207231|59978|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
11224|NCT02207231|59979|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
11225|NCT02207231|59977|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
11226|NCT02207231|59978|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
11227|NCT02207231|59979|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
11228|NCT02207231|59977|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
11229|NCT02207231|59978|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
11230|NCT02207231|59979|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
11231|NCT02207231|59977|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
11232|NCT02207231|59978|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
11233|NCT02207231|59979|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
11234|NCT02207231|59977|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
11235|NCT02207231|59978|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
11236|NCT02207231|59979|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
11237|NCT02207231|59977|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
11238|NCT02207231|59978|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
11239|NCT02207231|59979|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
11240|NCT02207231|59977|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
11241|NCT02207231|59978|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
11242|NCT02207231|59979|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
11243|NCT02207231|59977|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
11244|NCT02207231|59978|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
11245|NCT02207231|59979|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
11246|NCT02207231|59977|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
11247|NCT02207231|59978|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
11248|NCT02207231|59979|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
11249|NCT02207231|59977|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
11250|NCT02207231|59978|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
11251|NCT02207231|59979|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
11252|NCT02207231|59977|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
11253|NCT02207231|59978|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
11254|NCT02207231|59979|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
11255|NCT02207231|59977|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
11256|NCT02207231|59978|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
11257|NCT02207231|59979|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
11258|NCT02207088|60011|P1|Overall Study|Adverse Event|2
11259|NCT02206607|60026|P5|Second Intervention Period|Insufficient Clinical Response|0
11260|NCT02206607|60027|P4|Second Intervention Period|Insufficient Clinical Response|1
11261|NCT02206607|60028|P3|Second Intervention Period|Insufficient Clinical Response|0
11262|NCT02206607|60029|P2|Second Intervention Period|Insufficient Clinical Response|0
11263|NCT02206607|60030|P1|Second Intervention Period|Insufficient Clinical Response|0
11264|NCT02206607|60026|P5|Open-Label Run-In|Withdrawal by Subject|0
11265|NCT02206607|60027|P4|Open-Label Run-In|Withdrawal by Subject|0
11266|NCT02206607|60028|P3|Open-Label Run-In|Withdrawal by Subject|0
11267|NCT02206607|60029|P2|Open-Label Run-In|Withdrawal by Subject|0
11268|NCT02206607|60030|P1|Open-Label Run-In|Withdrawal by Subject|3
11269|NCT02205814|60086|P4|Overall Study|not compliant with study procedures|0
11270|NCT02205814|60087|P3|Overall Study|not compliant with study procedures|1
11271|NCT02205814|60088|P2|Overall Study|not compliant with study procedures|0
11272|NCT02205814|60089|P1|Overall Study|not compliant with study procedures|0
11273|NCT02205814|60086|P4|Overall Study|Withdrawal by Subject|1
11274|NCT02205814|60087|P3|Overall Study|Withdrawal by Subject|2
11275|NCT02205814|60088|P2|Overall Study|Withdrawal by Subject|1
11276|NCT02205814|60089|P1|Overall Study|Withdrawal by Subject|0
11277|NCT02205814|60086|P4|Overall Study|Protocol Violation|1
11278|NCT02205814|60087|P3|Overall Study|Protocol Violation|0
11279|NCT02205814|60088|P2|Overall Study|Protocol Violation|0
11280|NCT02205814|60089|P1|Overall Study|Protocol Violation|1
11281|NCT02205814|60086|P4|Overall Study|Physician Decision|0
11282|NCT02205814|60087|P3|Overall Study|Physician Decision|1
11283|NCT02205814|60088|P2|Overall Study|Physician Decision|0
11284|NCT02205814|60089|P1|Overall Study|Physician Decision|0
11285|NCT02205814|60086|P4|Overall Study|Lack of Efficacy|1
11286|NCT02205814|60087|P3|Overall Study|Lack of Efficacy|1
11287|NCT02205814|60088|P2|Overall Study|Lack of Efficacy|0
11288|NCT02205814|60089|P1|Overall Study|Lack of Efficacy|1
11289|NCT02205814|60086|P4|Overall Study|Lost to Follow-up|1
11290|NCT02205814|60087|P3|Overall Study|Lost to Follow-up|0
11291|NCT02205814|60088|P2|Overall Study|Lost to Follow-up|0
11292|NCT02205814|60089|P1|Overall Study|Lost to Follow-up|0
11293|NCT02205476|60142|P2|Overall Study|Study termination by Sponsor|3
11294|NCT02205476|60143|P1|Overall Study|Study termination by Sponsor|7
11295|NCT02205333|60182|P9|Overall Study|Withdrawal by Subject|0
11296|NCT02205333|60183|P8|Overall Study|Withdrawal by Subject|0
11297|NCT02205333|60184|P7|Overall Study|Withdrawal by Subject|2
11298|NCT02205333|60185|P6|Overall Study|Withdrawal by Subject|0
11299|NCT02205333|60186|P5|Overall Study|Withdrawal by Subject|0
11300|NCT02205333|60187|P4|Overall Study|Withdrawal by Subject|1
11301|NCT02205333|60188|P3|Overall Study|Withdrawal by Subject|0
11302|NCT02205333|60189|P2|Overall Study|Withdrawal by Subject|0
11303|NCT02205333|60190|P1|Overall Study|Withdrawal by Subject|1
11304|NCT02205333|60182|P9|Overall Study|Death|0
11305|NCT02205333|60183|P8|Overall Study|Death|2
11306|NCT02205333|60184|P7|Overall Study|Death|3
11307|NCT02205333|60185|P6|Overall Study|Death|3
11308|NCT02205333|60186|P5|Overall Study|Death|5
11309|NCT02205333|60187|P4|Overall Study|Death|6
11310|NCT02205333|60188|P3|Overall Study|Death|2
11311|NCT02205333|60189|P2|Overall Study|Death|6
11312|NCT02205333|60190|P1|Overall Study|Death|5
11313|NCT02204579|60386|P1|Overall Study|Screen failures|2
11314|NCT02204449|60440|P2|Overall Study|Withdrawal by Subject|1
11315|NCT02204449|60441|P1|Overall Study|Withdrawal by Subject|0
11316|NCT02204449|60440|P2|Overall Study|Death|1
11317|NCT02204449|60441|P1|Overall Study|Death|0
11318|NCT02204449|60440|P2|Overall Study|Lost to Follow-up|9
11319|NCT02204449|60441|P1|Overall Study|Lost to Follow-up|7
11320|NCT02204410|60451|P1|Overall Study|Withdrawal by Subject|3
11321|NCT02204410|60451|P1|Overall Study|Protocol Violation|1
11322|NCT02204410|60451|P1|Overall Study|Physician Decision|2
11323|NCT02204410|60451|P1|Overall Study|Lost to Follow-up|5
11324|NCT02204371|60456|P1|Overall Study|Adverse Event|1
11325|NCT02204319|60479|P1|Overall Study|Withdrawal by Subject|2
11326|NCT02204319|60479|P1|Overall Study|Pregnancy|1
11327|NCT02204007|60487|P2|Overall Study|Surgery Canceled|1
11328|NCT02204007|60488|P1|Overall Study|Surgery Canceled|1
11329|NCT02203916|60499|P3|Overall Study|Reason Not Specified|1
11330|NCT02203916|60500|P2|Overall Study|Reason Not Specified|2
11331|NCT02203916|60501|P1|Overall Study|Reason Not Specified|0
11332|NCT02203916|60499|P3|Overall Study|Lack of Efficacy|0
11333|NCT02203916|60500|P2|Overall Study|Lack of Efficacy|0
11334|NCT02203916|60501|P1|Overall Study|Lack of Efficacy|3
11335|NCT02203916|60499|P3|Overall Study|Voluntary Withdrawal|8
11336|NCT02203916|60500|P2|Overall Study|Voluntary Withdrawal|3
11337|NCT02203916|60501|P1|Overall Study|Voluntary Withdrawal|3
11338|NCT02203916|60499|P3|Overall Study|Lost to Follow-up|0
11339|NCT02203916|60500|P2|Overall Study|Lost to Follow-up|1
11340|NCT02203916|60501|P1|Overall Study|Lost to Follow-up|0
11341|NCT02203916|60499|P3|Overall Study|Major Protocol Deviation|0
11342|NCT02203916|60500|P2|Overall Study|Major Protocol Deviation|1
11343|NCT02203916|60501|P1|Overall Study|Major Protocol Deviation|1
11344|NCT02203916|60499|P3|Overall Study|Pretreatment Event/Adverse Event|2
11345|NCT02203916|60500|P2|Overall Study|Pretreatment Event/Adverse Event|3
11346|NCT02203916|60501|P1|Overall Study|Pretreatment Event/Adverse Event|1
11347|NCT02203721|60571|P2|Overall Study|Illness|1
11348|NCT02203721|60572|P1|Overall Study|Illness|0
11349|NCT02203721|60571|P2|Overall Study|Death|2
11350|NCT02203721|60572|P1|Overall Study|Death|0
11351|NCT02203721|60571|P2|Overall Study|Lost to Follow-up|0
11352|NCT02203721|60572|P1|Overall Study|Lost to Follow-up|1
11353|NCT02203331|60602|P6|Overall Study|Lost to Follow-up|0
11354|NCT02203331|60603|P5|Overall Study|Lost to Follow-up|1
11355|NCT02203331|60604|P4|Overall Study|Lost to Follow-up|0
11356|NCT02203331|60605|P3|Overall Study|Lost to Follow-up|0
11357|NCT02203331|60606|P2|Overall Study|Lost to Follow-up|0
11358|NCT02203331|60607|P1|Overall Study|Lost to Follow-up|0
11359|NCT02203331|60602|P6|Overall Study|Protocol Violation|0
11360|NCT02203331|60603|P5|Overall Study|Protocol Violation|1
11361|NCT02203331|60604|P4|Overall Study|Protocol Violation|1
11362|NCT02203331|60605|P3|Overall Study|Protocol Violation|0
11363|NCT02203331|60606|P2|Overall Study|Protocol Violation|2
11364|NCT02203331|60607|P1|Overall Study|Protocol Violation|0
11365|NCT02203331|60602|P6|Overall Study|Lack of Efficacy|1
11366|NCT02203331|60603|P5|Overall Study|Lack of Efficacy|0
11367|NCT02203331|60604|P4|Overall Study|Lack of Efficacy|0
11368|NCT02203331|60605|P3|Overall Study|Lack of Efficacy|1
11369|NCT02203331|60606|P2|Overall Study|Lack of Efficacy|2
11370|NCT02203331|60607|P1|Overall Study|Lack of Efficacy|0
11371|NCT02203331|60602|P6|Overall Study|Other Reasons|0
11372|NCT02203331|60603|P5|Overall Study|Other Reasons|0
11373|NCT02203331|60604|P4|Overall Study|Other Reasons|2
11374|NCT02203331|60605|P3|Overall Study|Other Reasons|0
11375|NCT02203331|60606|P2|Overall Study|Other Reasons|2
11376|NCT02203331|60607|P1|Overall Study|Other Reasons|1
11377|NCT02203331|60602|P6|Overall Study|Adverse Event|3
11378|NCT02203331|60603|P5|Overall Study|Adverse Event|3
11379|NCT02203331|60604|P4|Overall Study|Adverse Event|4
11380|NCT02203331|60605|P3|Overall Study|Adverse Event|3
11381|NCT02203331|60606|P2|Overall Study|Adverse Event|8
11382|NCT02203331|60607|P1|Overall Study|Adverse Event|4
11383|NCT02203331|60602|P6|Overall Study|Withdrawal by Subject|3
11384|NCT02203331|60603|P5|Overall Study|Withdrawal by Subject|0
11385|NCT02203331|60604|P4|Overall Study|Withdrawal by Subject|0
11386|NCT02203331|60605|P3|Overall Study|Withdrawal by Subject|1
11387|NCT02203331|60606|P2|Overall Study|Withdrawal by Subject|0
11388|NCT02203331|60607|P1|Overall Study|Withdrawal by Subject|1
11389|NCT02203331|60602|P6|Overall Study|Pregnancy|0
11390|NCT02203331|60603|P5|Overall Study|Pregnancy|2
11391|NCT02203331|60604|P4|Overall Study|Pregnancy|0
11392|NCT02203331|60605|P3|Overall Study|Pregnancy|0
11393|NCT02203331|60606|P2|Overall Study|Pregnancy|0
11394|NCT02203331|60607|P1|Overall Study|Pregnancy|1
11395|NCT02203149|60666|P5|Part 2|Adverse Event|1
11396|NCT02203149|60667|P4|Part 2|Adverse Event|1
11397|NCT02203149|60668|P3|Part 2|Adverse Event|0
11398|NCT02203149|60669|P2|Part 2|Adverse Event|0
11399|NCT02203149|60670|P1|Part 2|Adverse Event|0
11400|NCT02203149|60666|P5|Part 2|Withdrawal by Subject|0
11401|NCT02203149|60667|P4|Part 2|Withdrawal by Subject|1
11402|NCT02203149|60668|P3|Part 2|Withdrawal by Subject|0
11403|NCT02203149|60669|P2|Part 2|Withdrawal by Subject|0
11404|NCT02203149|60670|P1|Part 2|Withdrawal by Subject|0
11405|NCT02203149|60666|P5|Part 2|Death|0
11406|NCT02203149|60667|P4|Part 2|Death|1
11407|NCT02203149|60668|P3|Part 2|Death|1
11408|NCT02203149|60669|P2|Part 2|Death|0
11409|NCT02203149|60670|P1|Part 2|Death|0
11410|NCT02203149|60666|P5|Part 1|Adverse Event|0
11411|NCT02203149|60667|P4|Part 1|Adverse Event|0
11412|NCT02203149|60668|P3|Part 1|Adverse Event|0
11413|NCT02203149|60669|P2|Part 1|Adverse Event|1
11414|NCT02203149|60670|P1|Part 1|Adverse Event|0
11415|NCT02203032|60703|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
11416|NCT02203032|60704|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
11417|NCT02203032|60705|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
11418|NCT02203032|60706|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
11419|NCT02203032|60703|P4|Blinded Phase (Week 16 to Week 44)|Death|1
11420|NCT02203032|60704|P3|Blinded Phase (Week 16 to Week 44)|Death|0
11421|NCT02203032|60705|P2|Blinded Phase (Week 16 to Week 44)|Death|0
11422|NCT02203032|60706|P1|Blinded Phase (Week 16 to Week 44)|Death|0
11423|NCT02203032|60703|P4|Blinded Phase (Week 16 to Week 44)|Other|15
11424|NCT02203032|60704|P3|Blinded Phase (Week 16 to Week 44)|Other|1
11425|NCT02203032|60705|P2|Blinded Phase (Week 16 to Week 44)|Other|4
11426|NCT02203032|60706|P1|Blinded Phase (Week 16 to Week 44)|Other|0
11427|NCT02203032|60703|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
11428|NCT02203032|60704|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
11429|NCT02203032|60705|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
11430|NCT02203032|60706|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
11431|NCT02203032|60703|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
11432|NCT02203032|60704|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
11433|NCT02203032|60705|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
11434|NCT02203032|60706|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
11435|NCT02203032|60703|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
11436|NCT02203032|60704|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
11437|NCT02203032|60705|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
11438|NCT02203032|60706|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
11439|NCT02203032|60703|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
11440|NCT02203032|60704|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
11441|NCT02203032|60705|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
11442|NCT02203032|60706|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
11443|NCT02203032|60703|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
11444|NCT02203032|60704|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
11445|NCT02203032|60705|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
11446|NCT02203032|60706|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
11447|NCT02203032|60703|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
11448|NCT02203032|60704|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
11449|NCT02203032|60705|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
11450|NCT02203032|60706|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
11451|NCT02203032|60703|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
11452|NCT02203032|60704|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
11453|NCT02203032|60705|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
11454|NCT02203032|60706|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
11455|NCT02203032|60703|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
11456|NCT02203032|60704|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
11457|NCT02203032|60705|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
11458|NCT02203032|60706|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
11459|NCT02203032|60703|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
11460|NCT02203032|60704|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
11461|NCT02203032|60705|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
11462|NCT02203032|60706|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
11463|NCT02202980|60734|P14|Overall Study|Withdrew Consent|0
11464|NCT02202980|60735|P13|Overall Study|Withdrew Consent|0
11465|NCT02202980|60736|P12|Overall Study|Withdrew Consent|0
11466|NCT02202980|60737|P11|Overall Study|Withdrew Consent|0
11467|NCT02202980|60738|P10|Overall Study|Withdrew Consent|0
11468|NCT02202980|60739|P9|Overall Study|Withdrew Consent|1
11469|NCT02202980|60740|P8|Overall Study|Withdrew Consent|0
11470|NCT02202980|60741|P7|Overall Study|Withdrew Consent|0
11471|NCT02202980|60742|P6|Overall Study|Withdrew Consent|0
11472|NCT02202980|60743|P5|Overall Study|Withdrew Consent|0
11473|NCT02202980|60744|P4|Overall Study|Withdrew Consent|0
11474|NCT02202980|60745|P3|Overall Study|Withdrew Consent|2
11475|NCT02202980|60746|P2|Overall Study|Withdrew Consent|1
11476|NCT02202980|60747|P1|Overall Study|Withdrew Consent|0
11477|NCT02202980|60734|P14|Overall Study|Lost to Follow-up|0
11478|NCT02202980|60735|P13|Overall Study|Lost to Follow-up|1
11479|NCT02202980|60736|P12|Overall Study|Lost to Follow-up|0
11480|NCT02202980|60737|P11|Overall Study|Lost to Follow-up|0
11481|NCT02202980|60738|P10|Overall Study|Lost to Follow-up|0
11482|NCT02202980|60739|P9|Overall Study|Lost to Follow-up|1
11483|NCT02202980|60740|P8|Overall Study|Lost to Follow-up|1
11484|NCT02202980|60741|P7|Overall Study|Lost to Follow-up|0
11485|NCT02202980|60742|P6|Overall Study|Lost to Follow-up|0
11486|NCT02202980|60743|P5|Overall Study|Lost to Follow-up|0
11487|NCT02202980|60744|P4|Overall Study|Lost to Follow-up|1
11488|NCT02202980|60745|P3|Overall Study|Lost to Follow-up|1
11489|NCT02202980|60746|P2|Overall Study|Lost to Follow-up|1
11490|NCT02202980|60747|P1|Overall Study|Lost to Follow-up|0
11491|NCT02202980|60734|P14|Overall Study|Protocol Violation|0
11492|NCT02202980|60735|P13|Overall Study|Protocol Violation|0
11493|NCT02202980|60736|P12|Overall Study|Protocol Violation|0
11494|NCT02202980|60737|P11|Overall Study|Protocol Violation|0
11495|NCT02202980|60738|P10|Overall Study|Protocol Violation|0
11496|NCT02202980|60739|P9|Overall Study|Protocol Violation|0
11497|NCT02202980|60740|P8|Overall Study|Protocol Violation|0
11498|NCT02202980|60741|P7|Overall Study|Protocol Violation|0
11499|NCT02202980|60742|P6|Overall Study|Protocol Violation|0
11500|NCT02202980|60743|P5|Overall Study|Protocol Violation|3
11501|NCT02202980|60744|P4|Overall Study|Protocol Violation|3
11502|NCT02202980|60745|P3|Overall Study|Protocol Violation|0
11503|NCT02202980|60746|P2|Overall Study|Protocol Violation|0
11504|NCT02202980|60747|P1|Overall Study|Protocol Violation|0
11505|NCT02202980|60734|P14|Overall Study|Lack of Efficacy|0
11506|NCT02202980|60735|P13|Overall Study|Lack of Efficacy|10
11507|NCT02202980|60736|P12|Overall Study|Lack of Efficacy|3
11508|NCT02202980|60737|P11|Overall Study|Lack of Efficacy|0
11509|NCT02202980|60738|P10|Overall Study|Lack of Efficacy|0
11510|NCT02202980|60739|P9|Overall Study|Lack of Efficacy|2
11511|NCT02202980|60740|P8|Overall Study|Lack of Efficacy|2
11512|NCT02202980|60741|P7|Overall Study|Lack of Efficacy|11
11513|NCT02202980|60742|P6|Overall Study|Lack of Efficacy|1
11514|NCT02202980|60743|P5|Overall Study|Lack of Efficacy|3
11515|NCT02202980|60744|P4|Overall Study|Lack of Efficacy|0
11516|NCT02202980|60745|P3|Overall Study|Lack of Efficacy|7
11517|NCT02202980|60746|P2|Overall Study|Lack of Efficacy|0
11518|NCT02202980|60747|P1|Overall Study|Lack of Efficacy|1
11519|NCT02202785|60836|P3|Overall Study|Reason not Specified|13
11520|NCT02202785|60837|P2|Overall Study|Reason not Specified|7
11521|NCT02202785|60838|P1|Overall Study|Reason not Specified|10
11522|NCT02202785|60836|P3|Overall Study|Lost to Follow-up|0
11523|NCT02202785|60837|P2|Overall Study|Lost to Follow-up|1
11524|NCT02202785|60838|P1|Overall Study|Lost to Follow-up|0
11525|NCT02202785|60836|P3|Overall Study|Withdrawal by Subject|0
11526|NCT02202785|60837|P2|Overall Study|Withdrawal by Subject|1
11527|NCT02202785|60838|P1|Overall Study|Withdrawal by Subject|0
11528|NCT02202785|60836|P3|Overall Study|Study Terminated by Sponsor|4
11529|NCT02202785|60837|P2|Overall Study|Study Terminated by Sponsor|6
11530|NCT02202785|60838|P1|Overall Study|Study Terminated by Sponsor|1
11531|NCT02202759|60875|P3|Overall Study|Reason not Specified|10
11532|NCT02202759|60876|P2|Overall Study|Reason not Specified|11
11533|NCT02202759|60877|P1|Overall Study|Reason not Specified|4
11534|NCT02202759|60875|P3|Overall Study|Withdrawal by Subject|1
11535|NCT02202759|60876|P2|Overall Study|Withdrawal by Subject|1
11536|NCT02202759|60877|P1|Overall Study|Withdrawal by Subject|2
11537|NCT02202759|60875|P3|Overall Study|Study Terminated by Sponsor|3
11538|NCT02202759|60876|P2|Overall Study|Study Terminated by Sponsor|3
11539|NCT02202759|60877|P1|Overall Study|Study Terminated by Sponsor|3
11540|NCT02202538|60911|P1|Overall Study|Investigator Decision|1
11541|NCT02202538|60911|P1|Overall Study|Did not meet all inclusion criteria|2
11542|NCT02202538|60911|P1|Overall Study|Withdrawal by Subject|5
11543|NCT02202317|60922|P1|Overall Study|Lost to Follow-up|1
11544|NCT02202161|60949|P8|Overall Study|Withdrawal by Subject|0
11545|NCT02202161|60950|P7|Overall Study|Withdrawal by Subject|0
11546|NCT02202161|60951|P6|Overall Study|Withdrawal by Subject|0
11547|NCT02202161|60952|P5|Overall Study|Withdrawal by Subject|1
11548|NCT02202161|60953|P4|Overall Study|Withdrawal by Subject|0
11549|NCT02202161|60954|P3|Overall Study|Withdrawal by Subject|0
11550|NCT02202161|60955|P2|Overall Study|Withdrawal by Subject|0
11551|NCT02202161|60956|P1|Overall Study|Withdrawal by Subject|0
11552|NCT02202161|60949|P8|Overall Study|Physician Decision|3
11553|NCT02202161|60950|P7|Overall Study|Physician Decision|0
11554|NCT02202161|60951|P6|Overall Study|Physician Decision|0
11555|NCT02202161|60952|P5|Overall Study|Physician Decision|0
11556|NCT02202161|60953|P4|Overall Study|Physician Decision|0
11557|NCT02202161|60954|P3|Overall Study|Physician Decision|0
11558|NCT02202161|60955|P2|Overall Study|Physician Decision|0
11559|NCT02202161|60956|P1|Overall Study|Physician Decision|0
11560|NCT02202161|60949|P8|Overall Study|Did not meet continuation criteria|3
11561|NCT02202161|60950|P7|Overall Study|Did not meet continuation criteria|0
11562|NCT02202161|60951|P6|Overall Study|Did not meet continuation criteria|0
11563|NCT02202161|60952|P5|Overall Study|Did not meet continuation criteria|0
11564|NCT02202161|60953|P4|Overall Study|Did not meet continuation criteria|0
11565|NCT02202161|60954|P3|Overall Study|Did not meet continuation criteria|0
11566|NCT02202161|60955|P2|Overall Study|Did not meet continuation criteria|0
11567|NCT02202161|60956|P1|Overall Study|Did not meet continuation criteria|0
11568|NCT02202161|60949|P8|Overall Study|Adverse Event|0
11569|NCT02202161|60950|P7|Overall Study|Adverse Event|0
11570|NCT02202161|60951|P6|Overall Study|Adverse Event|1
11571|NCT02202161|60952|P5|Overall Study|Adverse Event|0
11572|NCT02202161|60953|P4|Overall Study|Adverse Event|0
11573|NCT02202161|60954|P3|Overall Study|Adverse Event|0
11574|NCT02202161|60955|P2|Overall Study|Adverse Event|1
11575|NCT02202161|60956|P1|Overall Study|Adverse Event|1
11576|NCT02201953|61116|P2|Overall Study|Death|3
11577|NCT02201953|61117|P1|Overall Study|Death|0
11578|NCT02201953|61116|P2|Overall Study|Adverse Event|5
11579|NCT02201953|61117|P1|Overall Study|Adverse Event|0
11580|NCT02201953|61116|P2|Overall Study|Withdrew Consent|5
11581|NCT02201953|61117|P1|Overall Study|Withdrew Consent|2
11582|NCT02201953|61116|P2|Overall Study|Lost to Follow-up|8
11583|NCT02201953|61117|P1|Overall Study|Lost to Follow-up|8
11584|NCT02201953|61116|P2|Overall Study|Lack of Efficacy|30
11585|NCT02201953|61117|P1|Overall Study|Lack of Efficacy|9
11586|NCT02201953|61116|P2|Overall Study|Randomized but Never Treated|5
11587|NCT02201953|61117|P1|Overall Study|Randomized but Never Treated|1
11588|NCT02201940|61135|P2|Overall Study|Adverse Event|1
11589|NCT02201940|61136|P1|Overall Study|Adverse Event|0
11590|NCT02201940|61135|P2|Overall Study|Death|0
11591|NCT02201940|61136|P1|Overall Study|Death|1
11592|NCT02201940|61135|P2|Overall Study|Investigator's Discretion|1
11593|NCT02201940|61136|P1|Overall Study|Investigator's Discretion|1
11594|NCT02201940|61135|P2|Overall Study|Withdrew Consent|1
11595|NCT02201940|61136|P1|Overall Study|Withdrew Consent|2
11596|NCT02201940|61135|P2|Overall Study|Lost to Follow-up|0
11597|NCT02201940|61136|P1|Overall Study|Lost to Follow-up|5
11598|NCT02201940|61135|P2|Overall Study|Lack of Efficacy|113
11599|NCT02201940|61136|P1|Overall Study|Lack of Efficacy|2
11600|NCT02201940|61135|P2|Overall Study|Randomized/Enrolled but Never Treated|0
11601|NCT02201940|61136|P1|Overall Study|Randomized/Enrolled but Never Treated|1
11602|NCT02201901|61155|P3|Overall Study|Adverse Event|0
11603|NCT02201901|61156|P2|Overall Study|Adverse Event|1
11604|NCT02201901|61157|P1|Overall Study|Adverse Event|1
11605|NCT02201901|61155|P3|Overall Study|Withdrew Consent|2
11606|NCT02201901|61156|P2|Overall Study|Withdrew Consent|0
11607|NCT02201901|61157|P1|Overall Study|Withdrew Consent|2
11608|NCT02201901|61155|P3|Overall Study|Lost to Follow-up|2
11609|NCT02201901|61156|P2|Overall Study|Lost to Follow-up|3
11610|NCT02201901|61157|P1|Overall Study|Lost to Follow-up|2
11611|NCT02201901|61155|P3|Overall Study|Death|3
11612|NCT02201901|61156|P2|Overall Study|Death|3
11613|NCT02201901|61157|P1|Overall Study|Death|3
11614|NCT02201901|61155|P3|Overall Study|Lack of Efficacy|6
11615|NCT02201901|61156|P2|Overall Study|Lack of Efficacy|1
11616|NCT02201901|61157|P1|Overall Study|Lack of Efficacy|7
11617|NCT02201901|61155|P3|Overall Study|Randomized but never treated|0
11618|NCT02201901|61156|P2|Overall Study|Randomized but never treated|1
11619|NCT02201901|61157|P1|Overall Study|Randomized but never treated|0
11620|NCT02201784|61188|P2|Overall Study|Failure to achieve adequate block|0
11621|NCT02201784|61189|P1|Overall Study|Failure to achieve adequate block|2
11622|NCT02201524|61207|P4|Overall Study|Other|0
11623|NCT02201524|61208|P3|Overall Study|Other|0
11624|NCT02201524|61209|P2|Overall Study|Other|1
11625|NCT02201524|61210|P1|Overall Study|Other|1
11626|NCT02201524|61207|P4|Overall Study|Withdrawal by Subject|1
11627|NCT02201524|61208|P3|Overall Study|Withdrawal by Subject|1
11628|NCT02201524|61209|P2|Overall Study|Withdrawal by Subject|0
11629|NCT02201524|61210|P1|Overall Study|Withdrawal by Subject|0
11630|NCT02201524|61207|P4|Overall Study|Protocol Violation|1
11631|NCT02201524|61208|P3|Overall Study|Protocol Violation|0
11632|NCT02201524|61209|P2|Overall Study|Protocol Violation|0
11633|NCT02201524|61210|P1|Overall Study|Protocol Violation|0
11634|NCT02201524|61207|P4|Overall Study|No longer meets eligibility criteria|2
11635|NCT02201524|61208|P3|Overall Study|No longer meets eligibility criteria|0
11636|NCT02201524|61209|P2|Overall Study|No longer meets eligibility criteria|0
11637|NCT02201524|61210|P1|Overall Study|No longer meets eligibility criteria|0
11638|NCT02201524|61207|P4|Overall Study|Lost to Follow-up|0
11639|NCT02201524|61208|P3|Overall Study|Lost to Follow-up|2
11640|NCT02201524|61209|P2|Overall Study|Lost to Follow-up|0
11641|NCT02201524|61210|P1|Overall Study|Lost to Follow-up|0
11642|NCT02201524|61207|P4|Overall Study|Insufficient clinical response|0
11643|NCT02201524|61208|P3|Overall Study|Insufficient clinical response|0
11644|NCT02201524|61209|P2|Overall Study|Insufficient clinical response|0
11645|NCT02201524|61210|P1|Overall Study|Insufficient clinical response|1
11646|NCT02201524|61207|P4|Overall Study|Adverse Event|0
11647|NCT02201524|61208|P3|Overall Study|Adverse Event|1
11648|NCT02201524|61209|P2|Overall Study|Adverse Event|2
11649|NCT02201524|61210|P1|Overall Study|Adverse Event|0
11650|NCT02199795|61436|P2|Overall Study|withdrew due to shoulder pain|0
11651|NCT02199795|61437|P1|Overall Study|withdrew due to shoulder pain|1
11652|NCT02199795|61436|P2|Overall Study|no longer met inclusion criteria|0
11653|NCT02199795|61437|P1|Overall Study|no longer met inclusion criteria|1
11654|NCT02199509|61465|P2|Overall Study|Misunderstood titration schedule|0
11655|NCT02199509|61466|P1|Overall Study|Misunderstood titration schedule|1
11656|NCT02199509|61465|P2|Overall Study|Suicidal Ideation|1
11657|NCT02199509|61466|P1|Overall Study|Suicidal Ideation|0
11658|NCT02198963|61491|P1|Overall Study|Withdrawal by Subject|6
11659|NCT02198963|61491|P1|Overall Study|Adverse Event|1
11660|NCT02198235|61533|P3|Overall Study|Lost to Follow-up|2
11661|NCT02198235|61534|P2|Overall Study|Lost to Follow-up|2
11662|NCT02198235|61535|P1|Overall Study|Lost to Follow-up|3
11663|NCT02198040|61555|P3|Overall Study|Withdrawal by Subject|1
11664|NCT02198040|61556|P2|Overall Study|Withdrawal by Subject|0
11665|NCT02198040|61557|P1|Overall Study|Withdrawal by Subject|0
11666|NCT02198040|61555|P3|Overall Study|Work reasons|0
11667|NCT02198040|61556|P2|Overall Study|Work reasons|1
11668|NCT02198040|61557|P1|Overall Study|Work reasons|0
11669|NCT02197806|61587|P4|Overall Study|Adverse Event|1
11670|NCT02197806|61588|P3|Overall Study|Adverse Event|0
11671|NCT02197806|61589|P2|Overall Study|Adverse Event|1
11672|NCT02197806|61590|P1|Overall Study|Adverse Event|0
11673|NCT02197247|61641|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
11674|NCT02197247|61641|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
11675|NCT02197247|61641|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
11676|NCT02197247|61641|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
11677|NCT02197247|61641|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
11678|NCT02197247|61641|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
11679|NCT02197247|61641|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
11680|NCT02197247|61641|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
11681|NCT02197234|61686|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
11682|NCT02197234|61686|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
11683|NCT02197234|61686|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
11684|NCT02197234|61686|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
11685|NCT02197234|61686|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
11686|NCT02197234|61686|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
11687|NCT02197234|61686|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
11688|NCT02197130|61708|P3|Overall Study|Other|3
11689|NCT02197130|61709|P2|Overall Study|Other|0
11690|NCT02197130|61710|P1|Overall Study|Other|1
11691|NCT02197130|61708|P3|Overall Study|Withdrawal by Subject|4
11692|NCT02197130|61709|P2|Overall Study|Withdrawal by Subject|3
11693|NCT02197130|61710|P1|Overall Study|Withdrawal by Subject|0
11694|NCT02197130|61708|P3|Overall Study|Does not meet entrance criteria|1
11695|NCT02197130|61709|P2|Overall Study|Does not meet entrance criteria|0
11696|NCT02197130|61710|P1|Overall Study|Does not meet entrance criteria|0
11697|NCT02197130|61708|P3|Overall Study|Lost to Follow-up|1
11698|NCT02197130|61709|P2|Overall Study|Lost to Follow-up|0
11699|NCT02197130|61710|P1|Overall Study|Lost to Follow-up|2
11700|NCT02197130|61708|P3|Overall Study|Death|0
11701|NCT02197130|61709|P2|Overall Study|Death|1
11702|NCT02197130|61710|P1|Overall Study|Death|0
11703|NCT02197130|61708|P3|Overall Study|Adverse Event|23
11704|NCT02197130|61709|P2|Overall Study|Adverse Event|4
11705|NCT02197130|61710|P1|Overall Study|Adverse Event|13
11706|NCT02196714|61802|P4|Overall Study|Protocol Violation|0
11707|NCT02196714|61803|P3|Overall Study|Protocol Violation|1
11708|NCT02196714|61804|P2|Overall Study|Protocol Violation|0
11709|NCT02196714|61805|P1|Overall Study|Protocol Violation|0
11710|NCT02196701|61927|P1|Overall Study|Non-adherence to Protocol|1
11711|NCT02196701|61927|P1|Overall Study|Lost to Follow-up|1
11712|NCT02196701|61927|P1|Overall Study|Adverse Event|1
11713|NCT02196675|61986|P3|Overall Study|Death|1
11714|NCT02196675|61987|P2|Overall Study|Death|0
11715|NCT02196675|61988|P1|Overall Study|Death|0
11716|NCT02196675|61986|P3|Overall Study|Protocol Violation|0
11717|NCT02196675|61987|P2|Overall Study|Protocol Violation|1
11718|NCT02196675|61988|P1|Overall Study|Protocol Violation|0
11719|NCT02196675|61986|P3|Overall Study|Intra-operative surgical exclusion|0
11720|NCT02196675|61987|P2|Overall Study|Intra-operative surgical exclusion|1
11721|NCT02196675|61988|P1|Overall Study|Intra-operative surgical exclusion|1
11722|NCT02196675|61986|P3|Overall Study|Withdrawal by Subject|0
11723|NCT02196675|61987|P2|Overall Study|Withdrawal by Subject|0
11724|NCT02196675|61988|P1|Overall Study|Withdrawal by Subject|1
11725|NCT02196259|62011|P3|Overall Study|Partial data analysis|0
11726|NCT02196259|62012|P2|Overall Study|Partial data analysis|3
11727|NCT02196259|62013|P1|Overall Study|Partial data analysis|0
11728|NCT02196259|62011|P3|Overall Study|Researcher choice|1
11729|NCT02196259|62012|P2|Overall Study|Researcher choice|0
11730|NCT02196259|62013|P1|Overall Study|Researcher choice|0
11731|NCT02196077|62041|P1|Overall Study|Protocol Violation|24
11732|NCT02196077|62041|P1|Overall Study|Lost to Follow-up|3
11733|NCT02196077|62041|P1|Overall Study|Physician Decision|1
11734|NCT02196077|62041|P1|Overall Study|Withdrawal by Subject|14
11735|NCT02196077|62041|P1|Overall Study|Lack of Efficacy|1
11736|NCT02196077|62041|P1|Overall Study|Adverse Event|4
11737|NCT02195986|62091|P3|Overall Study|Non-compliance|0
11738|NCT02195986|62092|P2|Overall Study|Non-compliance|1
11739|NCT02195986|62093|P1|Overall Study|Non-compliance|0
11740|NCT02195986|62091|P3|Overall Study|Protocol Violation|1
11741|NCT02195986|62092|P2|Overall Study|Protocol Violation|1
11742|NCT02195986|62093|P1|Overall Study|Protocol Violation|0
11743|NCT02195986|62091|P3|Overall Study|Family Emergency|1
11744|NCT02195986|62092|P2|Overall Study|Family Emergency|0
11745|NCT02195986|62093|P1|Overall Study|Family Emergency|0
11746|NCT02195986|62091|P3|Overall Study|Withdrawal by Subject|0
11747|NCT02195986|62092|P2|Overall Study|Withdrawal by Subject|3
11748|NCT02195986|62093|P1|Overall Study|Withdrawal by Subject|0
11749|NCT02195986|62091|P3|Overall Study|Adverse Event|0
11750|NCT02195986|62092|P2|Overall Study|Adverse Event|0
11751|NCT02195986|62093|P1|Overall Study|Adverse Event|3
11752|NCT02195700|62119|P2|Overall Study|Lost to Follow-up|1
11753|NCT02195700|62120|P1|Overall Study|Lost to Follow-up|1
11754|NCT02195700|62119|P2|Overall Study|Withdrawal by Subject|2
11755|NCT02195700|62120|P1|Overall Study|Withdrawal by Subject|3
11756|NCT02195700|62119|P2|Overall Study|Adverse Event|2
11757|NCT02195700|62120|P1|Overall Study|Adverse Event|1
11758|NCT02195700|62119|P2|Overall Study|Noncompliance|0
11759|NCT02195700|62120|P1|Overall Study|Noncompliance|1
11760|NCT02195700|62119|P2|Overall Study|Protocol Violation|2
11761|NCT02195700|62120|P1|Overall Study|Protocol Violation|0
11762|NCT02195687|62142|P2|Overall Study|Lost to Follow-up|1
11763|NCT02195687|62143|P1|Overall Study|Lost to Follow-up|4
11764|NCT02195687|62142|P2|Overall Study|Personal Reasons|1
11765|NCT02195687|62143|P1|Overall Study|Personal Reasons|1
11766|NCT02195583|62159|P1|Overall Study|Other Reason|2
11767|NCT02195583|62159|P1|Overall Study|Adverse Event|2
11768|NCT02195583|62159|P1|Overall Study|Withdrawal by Subject|4
11769|NCT02195583|62159|P1|Overall Study|Lost to Follow-up|1
11770|NCT02195427|62193|P2|Overall Study|Conditional re-treatment at W52|1
11771|NCT02195427|62194|P1|Overall Study|Conditional re-treatment at W52|2
11772|NCT02195427|62193|P2|Overall Study|Protocol Violation|14
11773|NCT02195427|62194|P1|Overall Study|Protocol Violation|7
11774|NCT02195427|62193|P2|Overall Study|Lost to Follow-up|1
11775|NCT02195427|62194|P1|Overall Study|Lost to Follow-up|0
11776|NCT02195427|62193|P2|Overall Study|Withdrawal by Subject|2
11777|NCT02195427|62194|P1|Overall Study|Withdrawal by Subject|4
11778|NCT02195427|62193|P2|Overall Study|Did not consent to study extension|9
11779|NCT02195427|62194|P1|Overall Study|Did not consent to study extension|13
11780|NCT02194699|62265|P2|With Potential to Receive 52 Weeks of IP|Other|16
11781|NCT02194699|62266|P1|With Potential to Receive 52 Weeks of IP|Other|24
11782|NCT02194699|62265|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
11783|NCT02194699|62266|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
11784|NCT02194699|62265|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
11785|NCT02194699|62266|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
11786|NCT02194699|62265|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
11787|NCT02194699|62266|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
11788|NCT02194699|62265|P2|With Potential to Receive 52 Weeks of IP|Death|3
11789|NCT02194699|62266|P1|With Potential to Receive 52 Weeks of IP|Death|1
11790|NCT02194699|62265|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
11791|NCT02194699|62266|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
11792|NCT02194699|62265|P2|Randomised|Duplicate patient|1
11793|NCT02194699|62266|P1|Randomised|Duplicate patient|2
11794|NCT02194699|62265|P2|Randomised|Without potential for 52 weeks of IP|5
11795|NCT02194699|62266|P1|Randomised|Without potential for 52 weeks of IP|5
11796|NCT02194699|62265|P2|Randomised|Did not receive treatment|5
11797|NCT02194699|62266|P1|Randomised|Did not receive treatment|1
11798|NCT02194621|62374|P3|Overall Study|Withdrawal by Subject|7
11799|NCT02194621|62375|P2|Overall Study|Withdrawal by Subject|4
11800|NCT02194621|62376|P1|Overall Study|Withdrawal by Subject|4
11801|NCT02194621|62374|P3|Overall Study|6 withdrew prior to randomization|2
11802|NCT02194621|62375|P2|Overall Study|6 withdrew prior to randomization|2
11803|NCT02194621|62376|P1|Overall Study|6 withdrew prior to randomization|2
11804|NCT02194062|62409|P3|Overall Study|Lost to Follow-up|5
11805|NCT02194062|62410|P2|Overall Study|Lost to Follow-up|2
11806|NCT02194062|62411|P1|Overall Study|Lost to Follow-up|2
11807|NCT02193828|62426|P4|Overall Study|Withdrawal by Subject|1
11808|NCT02193828|62427|P3|Overall Study|Withdrawal by Subject|1
11809|NCT02193828|62428|P2|Overall Study|Withdrawal by Subject|0
11810|NCT02193828|62429|P1|Overall Study|Withdrawal by Subject|0
11811|NCT02193178|62502|P1|Overall Study|Dry eyes|1
11812|NCT02193178|62502|P1|Overall Study|Lost to Follow-up|1
11813|NCT02193165|62552|P3|6 Week Product Use|Lost to Follow-up|0
11814|NCT02193165|62553|P2|6 Week Product Use|Lost to Follow-up|1
11815|NCT02193165|62554|P1|6 Week Product Use|Lost to Follow-up|0
11816|NCT02193165|62552|P3|4 Week Product Use|Lost to Follow-up|1
11817|NCT02193165|62553|P2|4 Week Product Use|Lost to Follow-up|1
11818|NCT02193165|62554|P1|4 Week Product Use|Lost to Follow-up|1
11819|NCT02193087|62581|P4|Overall Study|Did Not Receive Any Vaccination|1
11820|NCT02193087|62582|P3|Overall Study|Did Not Receive Any Vaccination|0
11821|NCT02193087|62583|P2|Overall Study|Did Not Receive Any Vaccination|3
11822|NCT02193087|62584|P1|Overall Study|Did Not Receive Any Vaccination|2
11823|NCT02193087|62581|P4|Overall Study|Other Reason Not Specified|9
11824|NCT02193087|62582|P3|Overall Study|Other Reason Not Specified|1
11825|NCT02193087|62583|P2|Overall Study|Other Reason Not Specified|2
11826|NCT02193087|62584|P1|Overall Study|Other Reason Not Specified|7
11827|NCT02193087|62581|P4|Overall Study|Withdrawal by Subject|19
11828|NCT02193087|62582|P3|Overall Study|Withdrawal by Subject|1
11829|NCT02193087|62583|P2|Overall Study|Withdrawal by Subject|3
11830|NCT02193087|62584|P1|Overall Study|Withdrawal by Subject|10
11831|NCT02193087|62581|P4|Overall Study|Protocol Violation|2
11832|NCT02193087|62582|P3|Overall Study|Protocol Violation|1
11833|NCT02193087|62583|P2|Overall Study|Protocol Violation|0
11834|NCT02193087|62584|P1|Overall Study|Protocol Violation|2
11835|NCT02193087|62581|P4|Overall Study|Lost to Follow-up|37
11836|NCT02193087|62582|P3|Overall Study|Lost to Follow-up|4
11837|NCT02193087|62583|P2|Overall Study|Lost to Follow-up|6
11838|NCT02193087|62584|P1|Overall Study|Lost to Follow-up|14
11839|NCT02193087|62581|P4|Overall Study|Adverse Event|11
11840|NCT02193087|62582|P3|Overall Study|Adverse Event|0
11841|NCT02193087|62583|P2|Overall Study|Adverse Event|0
11842|NCT02193087|62584|P1|Overall Study|Adverse Event|2
11843|NCT02193074|62629|P2|Overall Study|Adverse Event|13
11844|NCT02193074|62630|P1|Overall Study|Adverse Event|16
11845|NCT02193074|62629|P2|Overall Study|Withdrawal by Subject|2
11846|NCT02193074|62630|P1|Overall Study|Withdrawal by Subject|1
11847|NCT02192905|62662|P1|Overall Study|Lost to Follow-up|1
11848|NCT02192606|62726|P2|Overall Study|3D equipment rep unable to join|1
11849|NCT02192606|62727|P1|Overall Study|3D equipment rep unable to join|0
11850|NCT02192606|62726|P2|Overall Study|Physician Decision|2
11851|NCT02192606|62727|P1|Overall Study|Physician Decision|1
11852|NCT02192606|62726|P2|Overall Study|surgery type was changed|1
11853|NCT02192606|62727|P1|Overall Study|surgery type was changed|1
11854|NCT02192164|62758|P1|Overall Study|Did not meet the exclusion criteria|1
11855|NCT02192164|62758|P1|Overall Study|Physician Decision|4
11856|NCT02192164|62758|P1|Overall Study|Withdrawal by Subject|1
11857|NCT02192164|62758|P1|Overall Study|Other|8
11858|NCT02191267|62802|P3|Overall Study|Withdrawal by Subject|0
11859|NCT02191267|62803|P2|Overall Study|Withdrawal by Subject|0
11860|NCT02191267|62804|P1|Overall Study|Withdrawal by Subject|1
11861|NCT02191137|62815|P1|Follow-up|Adverse Event|1
11862|NCT02191137|62815|P1|Follow-up|Ongoing/unknown|2
11863|NCT02191137|62815|P1|Follow-up|Lost to Follow-up|2
11864|NCT02191137|62815|P1|Treatment|Other|1
11865|NCT02191137|62815|P1|Treatment|Adverse Event|2
11866|NCT02191137|62815|P1|Treatment|Withdrawal by Subject|3
11867|NCT02191137|62815|P1|Treatment|Death|4
11868|NCT02191046|62845|P2|Overall Study|low compliance|1
11869|NCT02191046|62846|P1|Overall Study|low compliance|5
11870|NCT02190604|62884|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11871|NCT02190604|62885|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11872|NCT02190604|62886|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11873|NCT02190604|62887|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11874|NCT02190604|62888|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11875|NCT02190604|62889|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
11876|NCT02190604|62890|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11877|NCT02190604|62891|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11878|NCT02190604|62892|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11879|NCT02190604|62893|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11880|NCT02190604|62894|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11881|NCT02190604|62895|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11882|NCT02190604|62896|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11883|NCT02190604|62897|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11884|NCT02190604|62898|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11885|NCT02190604|62899|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11886|NCT02190604|62900|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11887|NCT02190604|62901|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11888|NCT02190604|62902|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
11889|NCT02190604|62884|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11890|NCT02190604|62885|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11891|NCT02190604|62886|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11892|NCT02190604|62887|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11893|NCT02190604|62888|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
11894|NCT02190604|62889|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11895|NCT02190604|62890|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11896|NCT02190604|62891|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11897|NCT02190604|62892|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11898|NCT02190604|62893|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11899|NCT02190604|62894|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11900|NCT02190604|62895|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11901|NCT02190604|62896|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11902|NCT02190604|62897|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11903|NCT02190604|62898|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11904|NCT02190604|62899|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11905|NCT02190604|62900|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11906|NCT02190604|62901|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11907|NCT02190604|62902|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
11908|NCT02190591|63093|P2|Overall Study|face presentation so she was ineligible|1
11909|NCT02190591|63094|P1|Overall Study|face presentation so she was ineligible|0
11910|NCT02190591|63093|P2|Overall Study|did not use peanut ball as instructed|2
11911|NCT02190591|63094|P1|Overall Study|did not use peanut ball as instructed|0
11912|NCT02190591|63093|P2|Overall Study|Protocol Violation|0
11913|NCT02190591|63094|P1|Overall Study|Protocol Violation|1
11914|NCT02190591|63093|P2|Overall Study|Withdrawal by Subject|8
11915|NCT02190591|63094|P1|Overall Study|Withdrawal by Subject|1
11916|NCT02190435|63106|P2|Overall Study|3 consented screen fails|0
11917|NCT02190435|63107|P1|Overall Study|3 consented screen fails|3
11918|NCT02190435|63106|P2|Overall Study|First 12 patients were lead-ins|0
11919|NCT02190435|63107|P1|Overall Study|First 12 patients were lead-ins|12
11920|NCT02189941|63126|P3|Overall Study|Non-compliance|1
11921|NCT02189941|63127|P2|Overall Study|Non-compliance|0
11922|NCT02189941|63128|P1|Overall Study|Non-compliance|0
11923|NCT02189863|63156|P2|First 2 Weeks|Motion Sickness|2
11924|NCT02189863|63157|P1|First 2 Weeks|Motion Sickness|4
11925|NCT02189837|63172|P4|Overall Study|Sponsor Decision|1
11926|NCT02189837|63173|P3|Overall Study|Sponsor Decision|0
11927|NCT02189837|63174|P2|Overall Study|Sponsor Decision|0
11928|NCT02189837|63175|P1|Overall Study|Sponsor Decision|0
11929|NCT02189837|63172|P4|Overall Study|Withdrawal by Subject|1
11930|NCT02189837|63173|P3|Overall Study|Withdrawal by Subject|3
11931|NCT02189837|63174|P2|Overall Study|Withdrawal by Subject|1
11932|NCT02189837|63175|P1|Overall Study|Withdrawal by Subject|2
11933|NCT02189759|63205|P4|Overall Study|Lost to Follow-up|5
11934|NCT02189759|63206|P3|Overall Study|Lost to Follow-up|2
11935|NCT02189759|63207|P2|Overall Study|Lost to Follow-up|0
11936|NCT02189759|63208|P1|Overall Study|Lost to Follow-up|0
11937|NCT02189252|63254|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
11938|NCT02189252|63255|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
11939|NCT02189252|63256|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
11940|NCT02189252|63257|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
11941|NCT02189252|63254|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
11942|NCT02189252|63255|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
11943|NCT02189252|63256|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
11944|NCT02189252|63257|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
11945|NCT02188849|63316|P2|Overall Study|Lost to Follow-up|8
11946|NCT02188849|63317|P1|Overall Study|Lost to Follow-up|3
11947|NCT02188784|63331|P2|Overall Study|Physician Decision|3
11948|NCT02188784|63332|P1|Overall Study|Physician Decision|2
11949|NCT02188784|63331|P2|Overall Study|Withdrawal by Subject|9
11950|NCT02188784|63332|P1|Overall Study|Withdrawal by Subject|3
11951|NCT02188784|63331|P2|Overall Study|Lost to Follow-up|0
11952|NCT02188784|63332|P1|Overall Study|Lost to Follow-up|1
11953|NCT02188784|63331|P2|Overall Study|Death|1
11954|NCT02188784|63332|P1|Overall Study|Death|3
11955|NCT02187861|63368|P4|Overall Study|Alive in Study Follow-Up|31
11956|NCT02187861|63369|P3|Overall Study|Alive in Study Follow-Up|26
11957|NCT02187861|63370|P2|Overall Study|Alive in Study Follow-Up|10
11958|NCT02187861|63371|P1|Overall Study|Alive in Study Follow-Up|4
11959|NCT02187861|63368|P4|Overall Study|Other|1
11960|NCT02187861|63369|P3|Overall Study|Other|6
11961|NCT02187861|63370|P2|Overall Study|Other|2
11962|NCT02187861|63371|P1|Overall Study|Other|0
11963|NCT02187861|63368|P4|Overall Study|Withdrawal by Subject|3
11964|NCT02187861|63369|P3|Overall Study|Withdrawal by Subject|2
11965|NCT02187861|63370|P2|Overall Study|Withdrawal by Subject|0
11966|NCT02187861|63371|P1|Overall Study|Withdrawal by Subject|0
11967|NCT02187861|63368|P4|Overall Study|Progressive Disease|11
11968|NCT02187861|63369|P3|Overall Study|Progressive Disease|13
11969|NCT02187861|63370|P2|Overall Study|Progressive Disease|35
11970|NCT02187861|63371|P1|Overall Study|Progressive Disease|3
11971|NCT02187861|63368|P4|Overall Study|Physician Decision|3
11972|NCT02187861|63369|P3|Overall Study|Physician Decision|0
11973|NCT02187861|63370|P2|Overall Study|Physician Decision|1
11974|NCT02187861|63371|P1|Overall Study|Physician Decision|0
11975|NCT02187861|63368|P4|Overall Study|Lack of Efficacy|0
11976|NCT02187861|63369|P3|Overall Study|Lack of Efficacy|0
11977|NCT02187861|63370|P2|Overall Study|Lack of Efficacy|1
11978|NCT02187861|63371|P1|Overall Study|Lack of Efficacy|0
11979|NCT02187861|63368|P4|Overall Study|Death|2
11980|NCT02187861|63369|P3|Overall Study|Death|1
11981|NCT02187861|63370|P2|Overall Study|Death|3
11982|NCT02187861|63371|P1|Overall Study|Death|0
11983|NCT02187861|63368|P4|Overall Study|Adverse Event|0
11984|NCT02187861|63369|P3|Overall Study|Adverse Event|3
11985|NCT02187861|63370|P2|Overall Study|Adverse Event|1
11986|NCT02187861|63371|P1|Overall Study|Adverse Event|2
11987|NCT02187809|63467|P1|Overall Study|The study was terminated|3
11988|NCT02187744|63479|P2|Treatment|Participant refused continued treatment|1
11989|NCT02187744|63480|P1|Treatment|Participant refused continued treatment|1
11990|NCT02187744|63479|P2|Treatment|Not specified|0
11991|NCT02187744|63480|P1|Treatment|Not specified|2
11992|NCT02187744|63479|P2|Treatment|Lost to Follow-up|1
11993|NCT02187744|63480|P1|Treatment|Lost to Follow-up|0
11994|NCT02187744|63479|P2|Treatment|Related adverse event, not serious|2
11995|NCT02187744|63480|P1|Treatment|Related adverse event, not serious|0
11996|NCT02187744|63479|P2|Treatment|Related adverse event, serious non-fatal|1
11997|NCT02187744|63480|P1|Treatment|Related adverse event, serious non-fatal|0
11998|NCT02187744|63479|P2|Treatment|Death|0
11999|NCT02187744|63480|P1|Treatment|Death|1
12000|NCT02187744|63479|P2|Study|Related adverse event, serious non-fatal|1
12001|NCT02187744|63480|P1|Study|Related adverse event, serious non-fatal|0
12002|NCT02187744|63479|P2|Study|Death|0
12003|NCT02187744|63480|P1|Study|Death|1
12004|NCT02187744|63479|P2|Study|Related adverse event, not serious|2
12005|NCT02187744|63480|P1|Study|Related adverse event, not serious|0
12006|NCT02187744|63479|P2|Study|Lost to Follow-up|2
12007|NCT02187744|63480|P1|Study|Lost to Follow-up|0
12008|NCT02187744|63479|P2|Study|Not specified|1
12009|NCT02187744|63480|P1|Study|Not specified|2
12010|NCT02187744|63479|P2|Study|Participant refused further follow-up|0
12011|NCT02187744|63480|P1|Study|Participant refused further follow-up|1
12012|NCT02187029|63500|P4|Overall Study|Withdrawal by Subject|0
12013|NCT02187029|63501|P3|Overall Study|Withdrawal by Subject|0
12014|NCT02187029|63502|P2|Overall Study|Withdrawal by Subject|0
12015|NCT02187029|63503|P1|Overall Study|Withdrawal by Subject|1
12016|NCT02187029|63500|P4|Overall Study|Study Terminated by Sponsor|3
12017|NCT02187029|63501|P3|Overall Study|Study Terminated by Sponsor|10
12018|NCT02187029|63502|P2|Overall Study|Study Terminated by Sponsor|0
12019|NCT02187029|63503|P1|Overall Study|Study Terminated by Sponsor|0
12020|NCT02187029|63500|P4|Overall Study|Adverse Event|0
12021|NCT02187029|63501|P3|Overall Study|Adverse Event|1
12022|NCT02187029|63502|P2|Overall Study|Adverse Event|1
12023|NCT02187029|63503|P1|Overall Study|Adverse Event|0
12024|NCT02186873|63614|P2|Overall Study|Withdrawal by Subject|2
12025|NCT02186873|63615|P1|Overall Study|Withdrawal by Subject|7
12026|NCT02186873|63614|P2|Overall Study|Lost to Follow-up|2
12027|NCT02186873|63615|P1|Overall Study|Lost to Follow-up|1
12028|NCT02186873|63614|P2|Overall Study|Lack of Efficacy|1
12029|NCT02186873|63615|P1|Overall Study|Lack of Efficacy|0
12030|NCT02186873|63614|P2|Overall Study|Adverse Event|3
12031|NCT02186873|63615|P1|Overall Study|Adverse Event|1
12032|NCT02186223|63660|P1|Overall Study|Device in place less than 48 hours|9
12033|NCT02186223|63660|P1|Overall Study|Death|3
12034|NCT02186223|63660|P1|Overall Study|Unable to obtain femoral access|3
12035|NCT02186223|63660|P1|Overall Study|Not eligible for device placement|6
12036|NCT02185534|63690|P6|First Washout Period|Protocol Violation|1
12037|NCT02185534|63691|P5|First Washout Period|Protocol Violation|0
12038|NCT02185534|63692|P4|First Washout Period|Protocol Violation|0
12039|NCT02185534|63693|P3|First Washout Period|Protocol Violation|0
12040|NCT02185534|63694|P2|First Washout Period|Protocol Violation|0
12041|NCT02185534|63695|P1|First Washout Period|Protocol Violation|0
12042|NCT02185534|63690|P6|First Washout Period|Withdrawal by Subject|0
12043|NCT02185534|63691|P5|First Washout Period|Withdrawal by Subject|1
12044|NCT02185534|63692|P4|First Washout Period|Withdrawal by Subject|0
12045|NCT02185534|63693|P3|First Washout Period|Withdrawal by Subject|0
12046|NCT02185534|63694|P2|First Washout Period|Withdrawal by Subject|0
12047|NCT02185534|63695|P1|First Washout Period|Withdrawal by Subject|1
12048|NCT02185534|63690|P6|First Period|Withdrawal by Subject|0
12049|NCT02185534|63691|P5|First Period|Withdrawal by Subject|0
12050|NCT02185534|63692|P4|First Period|Withdrawal by Subject|1
12051|NCT02185534|63693|P3|First Period|Withdrawal by Subject|0
12052|NCT02185534|63694|P2|First Period|Withdrawal by Subject|0
12053|NCT02185534|63695|P1|First Period|Withdrawal by Subject|0
12054|NCT02183675|63881|P6|Treatment Period 2 (10 Days)|Adverse Event|2
12055|NCT02183675|63882|P5|Treatment Period 2 (10 Days)|Adverse Event|0
12056|NCT02183675|63883|P4|Treatment Period 2 (10 Days)|Adverse Event|0
12057|NCT02183675|63884|P3|Treatment Period 2 (10 Days)|Adverse Event|0
12058|NCT02183675|63885|P2|Treatment Period 2 (10 Days)|Adverse Event|0
12059|NCT02183675|63886|P1|Treatment Period 2 (10 Days)|Adverse Event|0
12060|NCT02183519|63910|P2|Overall Study|Did not respond to cough inducter|3
12061|NCT02183519|63911|P1|Overall Study|Did not respond to cough inducter|0
12062|NCT02183519|63910|P2|Overall Study|computer error|0
12063|NCT02183519|63911|P1|Overall Study|computer error|3
12064|NCT02182895|63919|P2|Overall Study|Discharged from hospital within 24 hours|4
12065|NCT02182895|63920|P1|Overall Study|Discharged from hospital within 24 hours|2
12066|NCT02181790|63951|P2|Overall Study|study terminated|0
12067|NCT02181790|63952|P1|Overall Study|study terminated|2
12068|NCT02181673|63962|P3|Week 24-Week 60|Physician Decision|1
12069|NCT02181673|63963|P2|Week 24-Week 60|Physician Decision|0
12070|NCT02181673|63964|P1|Week 24-Week 60|Physician Decision|0
12071|NCT02181673|63962|P3|Week 24-Week 60|Lost to Follow-up|1
12072|NCT02181673|63963|P2|Week 24-Week 60|Lost to Follow-up|0
12073|NCT02181673|63964|P1|Week 24-Week 60|Lost to Follow-up|0
12074|NCT02181673|63962|P3|Week 24-Week 60|Lack of Efficacy|1
12075|NCT02181673|63963|P2|Week 24-Week 60|Lack of Efficacy|0
12076|NCT02181673|63964|P1|Week 24-Week 60|Lack of Efficacy|0
12077|NCT02181673|63962|P3|Week 24-Week 60|Pregnancy|1
12078|NCT02181673|63963|P2|Week 24-Week 60|Pregnancy|0
12079|NCT02181673|63964|P1|Week 24-Week 60|Pregnancy|0
12080|NCT02181673|63962|P3|Week 24-Week 60|Withdrawal by Subject|2
12081|NCT02181673|63963|P2|Week 24-Week 60|Withdrawal by Subject|2
12082|NCT02181673|63964|P1|Week 24-Week 60|Withdrawal by Subject|0
12083|NCT02181673|63962|P3|Week 24-Week 60|Other|1
12084|NCT02181673|63963|P2|Week 24-Week 60|Other|2
12085|NCT02181673|63964|P1|Week 24-Week 60|Other|0
12086|NCT02181673|63962|P3|Week 24-Week 60|Adverse Event|10
12087|NCT02181673|63963|P2|Week 24-Week 60|Adverse Event|4
12088|NCT02181673|63964|P1|Week 24-Week 60|Adverse Event|0
12089|NCT02181673|63962|P3|Up to Week 24|Randomized not Treated|1
12090|NCT02181673|63963|P2|Up to Week 24|Randomized not Treated|0
12091|NCT02181673|63964|P1|Up to Week 24|Randomized not Treated|0
12092|NCT02181673|63962|P3|Up to Week 24|Other|3
12093|NCT02181673|63963|P2|Up to Week 24|Other|0
12094|NCT02181673|63964|P1|Up to Week 24|Other|2
12095|NCT02181673|63962|P3|Up to Week 24|Withdrawal by Subject|1
12096|NCT02181673|63963|P2|Up to Week 24|Withdrawal by Subject|0
12097|NCT02181673|63964|P1|Up to Week 24|Withdrawal by Subject|10
12098|NCT02181673|63962|P3|Up to Week 24|Physician Decision|3
12099|NCT02181673|63963|P2|Up to Week 24|Physician Decision|0
12100|NCT02181673|63964|P1|Up to Week 24|Physician Decision|0
12101|NCT02181673|63962|P3|Up to Week 24|Lost to Follow-up|0
12102|NCT02181673|63963|P2|Up to Week 24|Lost to Follow-up|0
12103|NCT02181673|63964|P1|Up to Week 24|Lost to Follow-up|1
12104|NCT02181673|63962|P3|Up to Week 24|Lack of Efficacy|0
12105|NCT02181673|63963|P2|Up to Week 24|Lack of Efficacy|0
12106|NCT02181673|63964|P1|Up to Week 24|Lack of Efficacy|1
12107|NCT02181673|63962|P3|Up to Week 24|Death|0
12108|NCT02181673|63963|P2|Up to Week 24|Death|0
12109|NCT02181673|63964|P1|Up to Week 24|Death|1
12110|NCT02181673|63962|P3|Up to Week 24|Adverse Event|3
12111|NCT02181673|63963|P2|Up to Week 24|Adverse Event|0
12112|NCT02181673|63964|P1|Up to Week 24|Adverse Event|2
12113|NCT02181634|63991|P1|Overall Study|Patient opted to proceed to surgery|1
12114|NCT02181634|63991|P1|Overall Study|Symptomatic progression|1
12115|NCT02181634|63991|P1|Overall Study|Max number of dose reduction|1
12116|NCT02181634|63991|P1|Overall Study|Ineligible|1
12117|NCT02181634|63991|P1|Overall Study|Treatment delayed greater than 4 weeks|3
12118|NCT02181634|63991|P1|Overall Study|Death|2
12119|NCT02181634|63991|P1|Overall Study|Withdrawal by Subject|5
12120|NCT02181634|63991|P1|Overall Study|Physician Decision|8
12121|NCT02181634|63991|P1|Overall Study|Adverse Event|17
12122|NCT02181634|63991|P1|Overall Study|Lack of Efficacy|33
12123|NCT02181504|64040|P3|Overall Study|Adverse Event|1
12124|NCT02181504|64041|P2|Overall Study|Adverse Event|1
12125|NCT02181504|64042|P1|Overall Study|Adverse Event|1
12126|NCT02180438|64135|P1|Overall Study|Lost to Follow-up|1
12127|NCT02180061|64153|P2|Overall Study|Continuing in Study|2
12128|NCT02180061|64154|P1|Overall Study|Continuing in Study|19
12129|NCT02180061|64153|P2|Overall Study|Progressive Disease|4
12130|NCT02180061|64154|P1|Overall Study|Progressive Disease|9
12131|NCT02180061|64153|P2|Overall Study|Clinical Progression|0
12132|NCT02180061|64154|P1|Overall Study|Clinical Progression|3
12133|NCT02180061|64153|P2|Overall Study|Adverse Event|2
12134|NCT02180061|64154|P1|Overall Study|Adverse Event|3
12135|NCT02179398|64207|P2|Overall Study|Lost to Follow-up|1
12136|NCT02179398|64208|P1|Overall Study|Lost to Follow-up|0
12137|NCT02179398|64207|P2|Overall Study|Lack of obligatory data|3
12138|NCT02179398|64208|P1|Overall Study|Lack of obligatory data|3
12139|NCT02178995|64228|P9|Open Label|Adverse Event|0
12140|NCT02178995|64229|P8|Open Label|Adverse Event|0
12141|NCT02178995|64230|P7|Open Label|Adverse Event|0
12142|NCT02178995|64231|P6|Open Label|Adverse Event|0
12143|NCT02178995|64232|P5|Open Label|Adverse Event|0
12144|NCT02178995|64233|P4|Open Label|Adverse Event|0
12145|NCT02178995|64234|P3|Open Label|Adverse Event|0
12146|NCT02178995|64235|P2|Open Label|Adverse Event|0
12147|NCT02178995|64236|P1|Open Label|Adverse Event|2
12148|NCT02178995|64228|P9|Double Blind|Lost to Follow-up|0
12149|NCT02178995|64229|P8|Double Blind|Lost to Follow-up|1
12150|NCT02178995|64230|P7|Double Blind|Lost to Follow-up|0
12151|NCT02178995|64231|P6|Double Blind|Lost to Follow-up|0
12152|NCT02178995|64232|P5|Double Blind|Lost to Follow-up|0
12153|NCT02178995|64233|P4|Double Blind|Lost to Follow-up|0
12154|NCT02178995|64234|P3|Double Blind|Lost to Follow-up|0
12155|NCT02178995|64235|P2|Double Blind|Lost to Follow-up|1
12156|NCT02178995|64236|P1|Double Blind|Lost to Follow-up|0
12157|NCT02178995|64228|P9|Double Blind|Adverse Event|1
12158|NCT02178995|64229|P8|Double Blind|Adverse Event|1
12159|NCT02178995|64230|P7|Double Blind|Adverse Event|0
12160|NCT02178995|64231|P6|Double Blind|Adverse Event|1
12161|NCT02178995|64232|P5|Double Blind|Adverse Event|0
12162|NCT02178995|64233|P4|Double Blind|Adverse Event|0
12163|NCT02178995|64234|P3|Double Blind|Adverse Event|0
12164|NCT02178995|64235|P2|Double Blind|Adverse Event|0
12165|NCT02178995|64236|P1|Double Blind|Adverse Event|0
12166|NCT02178787|64309|P2|Overall Study|Physician Decision|0
12167|NCT02178787|64310|P1|Overall Study|Physician Decision|1
12168|NCT02178787|64309|P2|Overall Study|No TCD window|7
12169|NCT02178787|64310|P1|Overall Study|No TCD window|3
12170|NCT02178787|64309|P2|Overall Study|Withdrawal by Subject|2
12171|NCT02178787|64310|P1|Overall Study|Withdrawal by Subject|0
12172|NCT02178787|64309|P2|Overall Study|Lost to Follow-up|0
12173|NCT02178787|64310|P1|Overall Study|Lost to Follow-up|1
12174|NCT02178059|64339|P2|Washout|Physician Decision|0
12175|NCT02178059|64340|P1|Washout|Physician Decision|1
12176|NCT02177266|64358|P2|Overall Study|Withdrawal by Subject|0
12177|NCT02177266|64359|P1|Overall Study|Withdrawal by Subject|1
12178|NCT02177266|64358|P2|Overall Study|Adverse Event|1
12179|NCT02177266|64359|P1|Overall Study|Adverse Event|0
12180|NCT02177136|64381|P3|Overall Study|Protocol Violation|1
12181|NCT02177136|64382|P2|Overall Study|Protocol Violation|0
12182|NCT02177136|64383|P1|Overall Study|Protocol Violation|0
12183|NCT02177136|64381|P3|Overall Study|Adverse Event|3
12184|NCT02177136|64382|P2|Overall Study|Adverse Event|2
12185|NCT02177136|64383|P1|Overall Study|Adverse Event|3
12186|NCT02177136|64381|P3|Overall Study|Discontinued due to pruritus|0
12187|NCT02177136|64382|P2|Overall Study|Discontinued due to pruritus|3
12188|NCT02177136|64383|P1|Overall Study|Discontinued due to pruritus|1
12189|NCT02177136|64381|P3|Overall Study|Withdrawal by Subject|0
12190|NCT02177136|64382|P2|Overall Study|Withdrawal by Subject|0
12191|NCT02177136|64383|P1|Overall Study|Withdrawal by Subject|2
12192|NCT02177032|64416|P4|Overall Study|Withdrawal by Subject|0
12193|NCT02177032|64417|P3|Overall Study|Withdrawal by Subject|1
12194|NCT02177032|64418|P2|Overall Study|Withdrawal by Subject|0
12195|NCT02177032|64419|P1|Overall Study|Withdrawal by Subject|1
12196|NCT02177032|64416|P4|Overall Study|OTHER|0
12197|NCT02177032|64417|P3|Overall Study|OTHER|1
12198|NCT02177032|64418|P2|Overall Study|OTHER|0
12199|NCT02177032|64419|P1|Overall Study|OTHER|2
12200|NCT02177032|64416|P4|Overall Study|Lost to Follow-up|0
12201|NCT02177032|64417|P3|Overall Study|Lost to Follow-up|0
12202|NCT02177032|64418|P2|Overall Study|Lost to Follow-up|2
12203|NCT02177032|64419|P1|Overall Study|Lost to Follow-up|0
12204|NCT02177032|64416|P4|Overall Study|ADMINISTRATIVE REASON|0
12205|NCT02177032|64417|P3|Overall Study|ADMINISTRATIVE REASON|1
12206|NCT02177032|64418|P2|Overall Study|ADMINISTRATIVE REASON|0
12207|NCT02177032|64419|P1|Overall Study|ADMINISTRATIVE REASON|2
12208|NCT02176655|64457|P1|Overall Study|Subjects did not treat|6
12209|NCT02176642|64480|P2|Overall Study|Withdrawal by Subject|1
12210|NCT02176642|64481|P1|Overall Study|Withdrawal by Subject|0
12211|NCT02176525|64511|P8|Overall Study|not treated|0
12212|NCT02176525|64512|P7|Overall Study|not treated|0
12213|NCT02176525|64513|P6|Overall Study|not treated|1
12214|NCT02176525|64514|P5|Overall Study|not treated|0
12215|NCT02176525|64515|P4|Overall Study|not treated|0
12216|NCT02176525|64516|P3|Overall Study|not treated|0
12217|NCT02176525|64517|P2|Overall Study|not treated|0
12218|NCT02176525|64518|P1|Overall Study|not treated|1
12219|NCT02176525|64511|P8|Overall Study|Adverse Event|0
12220|NCT02176525|64512|P7|Overall Study|Adverse Event|1
12221|NCT02176525|64513|P6|Overall Study|Adverse Event|0
12222|NCT02176525|64514|P5|Overall Study|Adverse Event|1
12223|NCT02176525|64515|P4|Overall Study|Adverse Event|1
12224|NCT02176525|64516|P3|Overall Study|Adverse Event|0
12225|NCT02176525|64517|P2|Overall Study|Adverse Event|0
12226|NCT02176525|64518|P1|Overall Study|Adverse Event|0
12227|NCT02176421|64695|P1|Overall Study|Adverse Event|1
12228|NCT02176421|64695|P1|Overall Study|Lost to Follow-up|4
12229|NCT02176356|64704|P1|Overall Study|Other Miscellaneous Reasons|2
12230|NCT02176356|64704|P1|Overall Study|Personal Reasons|3
12231|NCT02176356|64704|P1|Overall Study|Lost to Follow-up|4
12232|NCT02176356|64704|P1|Overall Study|Screen Failure|14
12233|NCT02176018|64734|P2|Overall Study|Withdrawal by Subject|2
12234|NCT02176018|64735|P1|Overall Study|Withdrawal by Subject|1
12235|NCT02176018|64734|P2|Overall Study|Protocol Violation|1
12236|NCT02176018|64735|P1|Overall Study|Protocol Violation|1
12237|NCT02176018|64734|P2|Overall Study|Lost to Follow-up|1
12238|NCT02176018|64735|P1|Overall Study|Lost to Follow-up|3
12239|NCT02176018|64734|P2|Overall Study|Adverse Event|2
12240|NCT02176018|64735|P1|Overall Study|Adverse Event|0
12241|NCT02175771|64767|P9|Treatment Period|Not specified|0
12242|NCT02175771|64768|P8|Treatment Period|Not specified|2
12243|NCT02175771|64769|P7|Treatment Period|Not specified|0
12244|NCT02175771|64770|P6|Treatment Period|Not specified|0
12245|NCT02175771|64771|P5|Treatment Period|Not specified|1
12246|NCT02175771|64772|P4|Treatment Period|Not specified|3
12247|NCT02175771|64773|P3|Treatment Period|Not specified|0
12248|NCT02175771|64774|P2|Treatment Period|Not specified|1
12249|NCT02175771|64775|P1|Treatment Period|Not specified|0
12250|NCT02175771|64767|P9|Treatment Period|Lack of Efficacy|0
12251|NCT02175771|64768|P8|Treatment Period|Lack of Efficacy|1
12252|NCT02175771|64769|P7|Treatment Period|Lack of Efficacy|0
12253|NCT02175771|64770|P6|Treatment Period|Lack of Efficacy|1
12254|NCT02175771|64771|P5|Treatment Period|Lack of Efficacy|0
12255|NCT02175771|64772|P4|Treatment Period|Lack of Efficacy|0
12256|NCT02175771|64773|P3|Treatment Period|Lack of Efficacy|0
12257|NCT02175771|64774|P2|Treatment Period|Lack of Efficacy|0
12258|NCT02175771|64775|P1|Treatment Period|Lack of Efficacy|0
12259|NCT02175771|64767|P9|Treatment Period|Lost to Follow-up|2
12260|NCT02175771|64768|P8|Treatment Period|Lost to Follow-up|2
12261|NCT02175771|64769|P7|Treatment Period|Lost to Follow-up|1
12262|NCT02175771|64770|P6|Treatment Period|Lost to Follow-up|2
12263|NCT02175771|64771|P5|Treatment Period|Lost to Follow-up|1
12264|NCT02175771|64772|P4|Treatment Period|Lost to Follow-up|3
12265|NCT02175771|64773|P3|Treatment Period|Lost to Follow-up|1
12266|NCT02175771|64774|P2|Treatment Period|Lost to Follow-up|3
12267|NCT02175771|64775|P1|Treatment Period|Lost to Follow-up|0
12268|NCT02175771|64767|P9|Treatment Period|Disease progression|0
12269|NCT02175771|64768|P8|Treatment Period|Disease progression|2
12270|NCT02175771|64769|P7|Treatment Period|Disease progression|0
12271|NCT02175771|64770|P6|Treatment Period|Disease progression|0
12272|NCT02175771|64771|P5|Treatment Period|Disease progression|0
12273|NCT02175771|64772|P4|Treatment Period|Disease progression|0
12274|NCT02175771|64773|P3|Treatment Period|Disease progression|0
12275|NCT02175771|64774|P2|Treatment Period|Disease progression|0
12276|NCT02175771|64775|P1|Treatment Period|Disease progression|0
12277|NCT02175771|64767|P9|Treatment Period|Protocol Violation|0
12278|NCT02175771|64768|P8|Treatment Period|Protocol Violation|1
12279|NCT02175771|64769|P7|Treatment Period|Protocol Violation|0
12280|NCT02175771|64770|P6|Treatment Period|Protocol Violation|0
12281|NCT02175771|64771|P5|Treatment Period|Protocol Violation|0
12282|NCT02175771|64772|P4|Treatment Period|Protocol Violation|0
12283|NCT02175771|64773|P3|Treatment Period|Protocol Violation|0
12284|NCT02175771|64774|P2|Treatment Period|Protocol Violation|0
12285|NCT02175771|64775|P1|Treatment Period|Protocol Violation|0
12286|NCT02175771|64767|P9|Treatment Period|Noncompliance|1
12287|NCT02175771|64768|P8|Treatment Period|Noncompliance|0
12288|NCT02175771|64769|P7|Treatment Period|Noncompliance|0
12289|NCT02175771|64770|P6|Treatment Period|Noncompliance|0
12290|NCT02175771|64771|P5|Treatment Period|Noncompliance|0
12291|NCT02175771|64772|P4|Treatment Period|Noncompliance|0
12292|NCT02175771|64773|P3|Treatment Period|Noncompliance|2
12293|NCT02175771|64774|P2|Treatment Period|Noncompliance|1
12294|NCT02175771|64775|P1|Treatment Period|Noncompliance|0
12295|NCT02175771|64767|P9|Treatment Period|Withdrawal by Subject|2
12296|NCT02175771|64768|P8|Treatment Period|Withdrawal by Subject|9
12297|NCT02175771|64769|P7|Treatment Period|Withdrawal by Subject|2
12298|NCT02175771|64770|P6|Treatment Period|Withdrawal by Subject|4
12299|NCT02175771|64771|P5|Treatment Period|Withdrawal by Subject|2
12300|NCT02175771|64772|P4|Treatment Period|Withdrawal by Subject|6
12301|NCT02175771|64773|P3|Treatment Period|Withdrawal by Subject|3
12302|NCT02175771|64774|P2|Treatment Period|Withdrawal by Subject|9
12303|NCT02175771|64775|P1|Treatment Period|Withdrawal by Subject|0
12304|NCT02175771|64767|P9|Treatment Period|Adverse Event|1
12305|NCT02175771|64768|P8|Treatment Period|Adverse Event|0
12306|NCT02175771|64769|P7|Treatment Period|Adverse Event|2
12307|NCT02175771|64770|P6|Treatment Period|Adverse Event|3
12308|NCT02175771|64771|P5|Treatment Period|Adverse Event|1
12309|NCT02175771|64772|P4|Treatment Period|Adverse Event|1
12310|NCT02175771|64773|P3|Treatment Period|Adverse Event|1
12311|NCT02175771|64774|P2|Treatment Period|Adverse Event|2
12312|NCT02175771|64775|P1|Treatment Period|Adverse Event|0
12313|NCT02175771|64767|P9|Run-In Period (Pre-assignment)|Not specified|0
12314|NCT02175771|64768|P8|Run-In Period (Pre-assignment)|Not specified|0
12315|NCT02175771|64769|P7|Run-In Period (Pre-assignment)|Not specified|0
12316|NCT02175771|64770|P6|Run-In Period (Pre-assignment)|Not specified|0
12317|NCT02175771|64771|P5|Run-In Period (Pre-assignment)|Not specified|0
12318|NCT02175771|64772|P4|Run-In Period (Pre-assignment)|Not specified|0
12319|NCT02175771|64773|P3|Run-In Period (Pre-assignment)|Not specified|0
12320|NCT02175771|64774|P2|Run-In Period (Pre-assignment)|Not specified|0
12321|NCT02175771|64775|P1|Run-In Period (Pre-assignment)|Not specified|8
12322|NCT02175771|64767|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
12323|NCT02175771|64768|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
12324|NCT02175771|64769|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
12325|NCT02175771|64770|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
12326|NCT02175771|64771|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
12327|NCT02175771|64772|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
12328|NCT02175771|64773|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
12329|NCT02175771|64774|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
12330|NCT02175771|64775|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
12331|NCT02175771|64767|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
12332|NCT02175771|64768|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
12333|NCT02175771|64769|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
12334|NCT02175771|64770|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
12335|NCT02175771|64771|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
12336|NCT02175771|64772|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
12337|NCT02175771|64773|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
12338|NCT02175771|64774|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
12339|NCT02175771|64775|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
12340|NCT02175771|64767|P9|Run-In Period (Pre-assignment)|Adverse Event|0
12341|NCT02175771|64768|P8|Run-In Period (Pre-assignment)|Adverse Event|0
12342|NCT02175771|64769|P7|Run-In Period (Pre-assignment)|Adverse Event|0
12343|NCT02175771|64770|P6|Run-In Period (Pre-assignment)|Adverse Event|0
12344|NCT02175771|64771|P5|Run-In Period (Pre-assignment)|Adverse Event|0
12345|NCT02175771|64772|P4|Run-In Period (Pre-assignment)|Adverse Event|0
12346|NCT02175771|64773|P3|Run-In Period (Pre-assignment)|Adverse Event|0
12347|NCT02175771|64774|P2|Run-In Period (Pre-assignment)|Adverse Event|0
12348|NCT02175771|64775|P1|Run-In Period (Pre-assignment)|Adverse Event|9
12349|NCT02175771|64767|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
12350|NCT02175771|64768|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
12351|NCT02175771|64769|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
12352|NCT02175771|64770|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
12353|NCT02175771|64771|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
12354|NCT02175771|64772|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
12355|NCT02175771|64773|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
12356|NCT02175771|64774|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
12357|NCT02175771|64775|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
12358|NCT02175771|64767|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
12359|NCT02175771|64768|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
12360|NCT02175771|64769|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
12361|NCT02175771|64770|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
12362|NCT02175771|64771|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
12363|NCT02175771|64772|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
12364|NCT02175771|64773|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
12365|NCT02175771|64774|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
12366|NCT02175771|64775|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
12367|NCT02175771|64767|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
12368|NCT02175771|64768|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
12369|NCT02175771|64769|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
12370|NCT02175771|64770|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
12371|NCT02175771|64771|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
12372|NCT02175771|64772|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
12373|NCT02175771|64773|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
12374|NCT02175771|64774|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
12375|NCT02175771|64775|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
12376|NCT02175745|64833|P1|Overall Study|Not Eligible|1
12377|NCT02175368|64838|P1|Overall Study|Lost to Follow-up|1
12378|NCT02175199|64861|P2|Overall Study|Sponsor Decision|0
12379|NCT02175199|64862|P1|Overall Study|Sponsor Decision|1
12380|NCT02175199|64861|P2|Overall Study|Randomized in Error|0
12381|NCT02175199|64862|P1|Overall Study|Randomized in Error|1
12382|NCT02175199|64861|P2|Overall Study|Withdrawal by Subject|5
12383|NCT02175199|64862|P1|Overall Study|Withdrawal by Subject|1
12384|NCT02175121|64876|P5|Overall Study|Time issues|0
12385|NCT02175121|64877|P4|Overall Study|Time issues|0
12386|NCT02175121|64878|P3|Overall Study|Time issues|1
12387|NCT02175121|64879|P2|Overall Study|Time issues|0
12388|NCT02175121|64880|P1|Overall Study|Time issues|0
12389|NCT02175121|64876|P5|Overall Study|Schedule conflict|0
12390|NCT02175121|64877|P4|Overall Study|Schedule conflict|0
12391|NCT02175121|64878|P3|Overall Study|Schedule conflict|1
12392|NCT02175121|64879|P2|Overall Study|Schedule conflict|0
12393|NCT02175121|64880|P1|Overall Study|Schedule conflict|0
12394|NCT02175121|64876|P5|Overall Study|Personal emergency|1
12395|NCT02175121|64877|P4|Overall Study|Personal emergency|0
12396|NCT02175121|64878|P3|Overall Study|Personal emergency|0
12397|NCT02175121|64879|P2|Overall Study|Personal emergency|0
12398|NCT02175121|64880|P1|Overall Study|Personal emergency|0
12399|NCT02175121|64876|P5|Overall Study|Lost to Follow-up|0
12400|NCT02175121|64877|P4|Overall Study|Lost to Follow-up|1
12401|NCT02175121|64878|P3|Overall Study|Lost to Follow-up|0
12402|NCT02175121|64879|P2|Overall Study|Lost to Follow-up|1
12403|NCT02175121|64880|P1|Overall Study|Lost to Follow-up|0
12404|NCT02175121|64876|P5|Overall Study|Lack of Efficacy|0
12405|NCT02175121|64877|P4|Overall Study|Lack of Efficacy|0
12406|NCT02175121|64878|P3|Overall Study|Lack of Efficacy|0
12407|NCT02175121|64879|P2|Overall Study|Lack of Efficacy|0
12408|NCT02175121|64880|P1|Overall Study|Lack of Efficacy|1
12409|NCT02173769|65007|P1|Overall Study|Protocol Violation|4
12410|NCT02173054|65110|P3|Overall Study|Withdrawal by Subject|1
12411|NCT02173054|65111|P2|Overall Study|Withdrawal by Subject|0
12412|NCT02173054|65112|P1|Overall Study|Withdrawal by Subject|0
12413|NCT02173054|65110|P3|Overall Study|lack of compliance|0
12414|NCT02173054|65111|P2|Overall Study|lack of compliance|0
12415|NCT02173054|65112|P1|Overall Study|lack of compliance|1
12416|NCT02172625|65157|P2|Overall Study|car accident|1
12417|NCT02172625|65158|P1|Overall Study|car accident|0
12418|NCT02172625|65157|P2|Overall Study|Pregnancy|1
12419|NCT02172625|65158|P1|Overall Study|Pregnancy|0
12420|NCT02172625|65157|P2|Overall Study|Adverse Event|1
12421|NCT02172625|65158|P1|Overall Study|Adverse Event|0
12422|NCT02172040|65180|P4|Overall Study|Family emergency abroad|1
12423|NCT02172040|65181|P3|Overall Study|Family emergency abroad|0
12424|NCT02172040|65182|P2|Overall Study|Family emergency abroad|0
12425|NCT02172040|65183|P1|Overall Study|Family emergency abroad|0
12426|NCT02172040|65180|P4|Overall Study|Not available for Day 13 & 14 visits|0
12427|NCT02172040|65181|P3|Overall Study|Not available for Day 13 & 14 visits|1
12428|NCT02172040|65182|P2|Overall Study|Not available for Day 13 & 14 visits|0
12429|NCT02172040|65183|P1|Overall Study|Not available for Day 13 & 14 visits|0
12430|NCT02172040|65180|P4|Overall Study|Withdrawal by Subject|0
12431|NCT02172040|65181|P3|Overall Study|Withdrawal by Subject|1
12432|NCT02172040|65182|P2|Overall Study|Withdrawal by Subject|0
12433|NCT02172040|65183|P1|Overall Study|Withdrawal by Subject|0
12434|NCT02172040|65180|P4|Overall Study|Protocol Violation|0
12435|NCT02172040|65181|P3|Overall Study|Protocol Violation|0
12436|NCT02172040|65182|P2|Overall Study|Protocol Violation|1
12437|NCT02172040|65183|P1|Overall Study|Protocol Violation|0
12438|NCT02172040|65180|P4|Overall Study|Adverse Event|0
12439|NCT02172040|65181|P3|Overall Study|Adverse Event|0
12440|NCT02172040|65182|P2|Overall Study|Adverse Event|2
12441|NCT02172040|65183|P1|Overall Study|Adverse Event|0
12442|NCT02170779|65385|P2|Overall Study|Lost to Follow-up|1
12443|NCT02170779|65386|P1|Overall Study|Lost to Follow-up|0
12444|NCT02170779|65385|P2|Overall Study|Withdrawal by Subject|0
12445|NCT02170779|65386|P1|Overall Study|Withdrawal by Subject|1
12446|NCT02170688|65413|P5|Overall Study|Physician Decision|0
12447|NCT02170688|65414|P4|Overall Study|Physician Decision|0
12448|NCT02170688|65415|P3|Overall Study|Physician Decision|1
12449|NCT02170688|65416|P2|Overall Study|Physician Decision|0
12450|NCT02170688|65417|P1|Overall Study|Physician Decision|0
12451|NCT02170688|65413|P5|Overall Study|Full dose not received|0
12452|NCT02170688|65414|P4|Overall Study|Full dose not received|0
12453|NCT02170688|65415|P3|Overall Study|Full dose not received|0
12454|NCT02170688|65416|P2|Overall Study|Full dose not received|1
12455|NCT02170688|65417|P1|Overall Study|Full dose not received|0
12456|NCT02170688|65413|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
12457|NCT02170688|65414|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
12458|NCT02170688|65415|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
12459|NCT02170688|65416|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
12460|NCT02170688|65417|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
12461|NCT02170207|65590|P1|Overall Study|Case report forms unavailable|5
12462|NCT02170077|65601|P3|Overall Study|Exacerbation of seizures|1
12463|NCT02170077|65602|P2|Overall Study|Exacerbation of seizures|2
12464|NCT02170077|65603|P1|Overall Study|Exacerbation of seizures|0
12465|NCT02170077|65601|P3|Overall Study|Exclusion criteria|5
12466|NCT02170077|65602|P2|Overall Study|Exclusion criteria|2
12467|NCT02170077|65603|P1|Overall Study|Exclusion criteria|2
12468|NCT02170077|65601|P3|Overall Study|Lost to Follow-up|0
12469|NCT02170077|65602|P2|Overall Study|Lost to Follow-up|1
12470|NCT02170077|65603|P1|Overall Study|Lost to Follow-up|0
12471|NCT02170077|65601|P3|Overall Study|Adverse Event|4
12472|NCT02170077|65602|P2|Overall Study|Adverse Event|4
12473|NCT02170077|65603|P1|Overall Study|Adverse Event|4
12474|NCT02170077|65601|P3|Overall Study|Withdrawal by Subject|2
12475|NCT02170077|65602|P2|Overall Study|Withdrawal by Subject|4
12476|NCT02170077|65603|P1|Overall Study|Withdrawal by Subject|3
12477|NCT02170064|65614|P3|Overall Study|Physician Decision|0
12478|NCT02170064|65615|P2|Overall Study|Physician Decision|1
12479|NCT02170064|65616|P1|Overall Study|Physician Decision|1
12480|NCT02170064|65614|P3|Overall Study|Withdrawal by Subject|1
12481|NCT02170064|65615|P2|Overall Study|Withdrawal by Subject|1
12482|NCT02170064|65616|P1|Overall Study|Withdrawal by Subject|5
12483|NCT02170025|65632|P2|Overall Study|Adverse Event|0
12484|NCT02170025|65633|P1|Overall Study|Adverse Event|2
12485|NCT02169414|65781|P4|Overall Study|Adverse Event|0
12486|NCT02169414|65782|P3|Overall Study|Adverse Event|0
12487|NCT02169414|65783|P2|Overall Study|Adverse Event|1
12488|NCT02169414|65784|P1|Overall Study|Adverse Event|0
12489|NCT02169414|65781|P4|Overall Study|Withdrawal by Subject|0
12490|NCT02169414|65782|P3|Overall Study|Withdrawal by Subject|0
12491|NCT02169414|65783|P2|Overall Study|Withdrawal by Subject|0
12492|NCT02169414|65784|P1|Overall Study|Withdrawal by Subject|1
12493|NCT02169336|65825|P3|Overall Study|Subject declined to continue dosing|1
12494|NCT02169336|65826|P2|Overall Study|Subject declined to continue dosing|0
12495|NCT02169336|65827|P1|Overall Study|Subject declined to continue dosing|0
12496|NCT02169336|65825|P3|Overall Study|Physician Decision|1
12497|NCT02169336|65826|P2|Overall Study|Physician Decision|0
12498|NCT02169336|65827|P1|Overall Study|Physician Decision|0
12499|NCT02169336|65825|P3|Overall Study|Withdrawal by Subject|0
12500|NCT02169336|65826|P2|Overall Study|Withdrawal by Subject|0
12501|NCT02169336|65827|P1|Overall Study|Withdrawal by Subject|1
12502|NCT02169336|65825|P3|Overall Study|Adverse Event|1
12503|NCT02169336|65826|P2|Overall Study|Adverse Event|3
12504|NCT02169336|65827|P1|Overall Study|Adverse Event|2
12505|NCT02169336|65825|P3|Overall Study|Lack of Efficacy|0
12506|NCT02169336|65826|P2|Overall Study|Lack of Efficacy|1
12507|NCT02169336|65827|P1|Overall Study|Lack of Efficacy|1
12508|NCT02168777|65851|P3|Overall Study|Other reason|0
12509|NCT02168777|65852|P2|Overall Study|Other reason|1
12510|NCT02168777|65853|P1|Overall Study|Other reason|0
12511|NCT02168777|65851|P3|Overall Study|Clinical disease progression|2
12512|NCT02168777|65852|P2|Overall Study|Clinical disease progression|1
12513|NCT02168777|65853|P1|Overall Study|Clinical disease progression|0
12514|NCT02168777|65851|P3|Overall Study|Radiological disease progression|5
12515|NCT02168777|65852|P2|Overall Study|Radiological disease progression|5
12516|NCT02168777|65853|P1|Overall Study|Radiological disease progression|0
12517|NCT02168777|65851|P3|Overall Study|Disease recurrence|1
12518|NCT02168777|65852|P2|Overall Study|Disease recurrence|0
12519|NCT02168777|65853|P1|Overall Study|Disease recurrence|0
12520|NCT02168777|65851|P3|Overall Study|Adverse Event|1
12521|NCT02168777|65852|P2|Overall Study|Adverse Event|0
12522|NCT02168777|65853|P1|Overall Study|Adverse Event|1
12523|NCT02168777|65851|P3|Overall Study|Withdrawal by Subject|2
12524|NCT02168777|65852|P2|Overall Study|Withdrawal by Subject|0
12525|NCT02168777|65853|P1|Overall Study|Withdrawal by Subject|1
12526|NCT02168491|65930|P1|Overall Study|Withdrawal by Subject|1
12527|NCT02168478|65936|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
12528|NCT02168478|65936|P1|Overall Study|Did Not Consent to Participation|2
12529|NCT02168478|65936|P1|Overall Study|Withdrawal by Subject|1
12530|NCT02168439|65942|P2|Overall Study|Protocol Violation|2
12531|NCT02168439|65943|P1|Overall Study|Protocol Violation|0
12532|NCT02168387|65961|P2|Overall Study|Death|0
12533|NCT02168387|65962|P1|Overall Study|Death|1
12534|NCT02168387|65961|P2|Overall Study|Planned exubation|3
12535|NCT02168387|65962|P1|Overall Study|Planned exubation|6
12536|NCT02168270|65994|P1|Overall Study|Lack of Efficacy|4
12537|NCT02167893|66001|P1|Overall Study|Case report forms not collected|68
12538|NCT02167893|66001|P1|Overall Study|Investigator health reasons|10
12539|NCT02167893|66001|P1|Overall Study|Investigator transferred|85
12540|NCT02167139|66039|P4|Transition-extension|Lost to Follow-up|0
12541|NCT02167139|66040|P3|Transition-extension|Lost to Follow-up|0
12542|NCT02167139|66041|P2|Transition-extension|Lost to Follow-up|0
12543|NCT02167139|66042|P1|Transition-extension|Lost to Follow-up|1
12544|NCT02167139|66039|P4|Transition-extension|Other|0
12545|NCT02167139|66040|P3|Transition-extension|Other|1
12546|NCT02167139|66041|P2|Transition-extension|Other|0
12547|NCT02167139|66042|P1|Transition-extension|Other|1
12548|NCT02167139|66039|P4|Transition-extension|Lack of Efficacy|1
12549|NCT02167139|66040|P3|Transition-extension|Lack of Efficacy|1
12550|NCT02167139|66041|P2|Transition-extension|Lack of Efficacy|0
12551|NCT02167139|66042|P1|Transition-extension|Lack of Efficacy|0
12552|NCT02167139|66039|P4|Transition-extension|Withdrawal by Subject|1
12553|NCT02167139|66040|P3|Transition-extension|Withdrawal by Subject|4
12554|NCT02167139|66041|P2|Transition-extension|Withdrawal by Subject|0
12555|NCT02167139|66042|P1|Transition-extension|Withdrawal by Subject|2
12556|NCT02167139|66039|P4|Transition-extension|Adverse Event|3
12557|NCT02167139|66040|P3|Transition-extension|Adverse Event|2
12558|NCT02167139|66041|P2|Transition-extension|Adverse Event|0
12559|NCT02167139|66042|P1|Transition-extension|Adverse Event|2
12560|NCT02167139|66039|P4|Randomised, Double-blind|Other|0
12561|NCT02167139|66040|P3|Randomised, Double-blind|Other|0
12562|NCT02167139|66041|P2|Randomised, Double-blind|Other|0
12563|NCT02167139|66042|P1|Randomised, Double-blind|Other|3
12564|NCT02167139|66039|P4|Randomised, Double-blind|Lack of Efficacy|0
12565|NCT02167139|66040|P3|Randomised, Double-blind|Lack of Efficacy|0
12566|NCT02167139|66041|P2|Randomised, Double-blind|Lack of Efficacy|2
12567|NCT02167139|66042|P1|Randomised, Double-blind|Lack of Efficacy|1
12568|NCT02167139|66039|P4|Randomised, Double-blind|Adverse Event|0
12569|NCT02167139|66040|P3|Randomised, Double-blind|Adverse Event|0
12570|NCT02167139|66041|P2|Randomised, Double-blind|Adverse Event|9
12571|NCT02167139|66042|P1|Randomised, Double-blind|Adverse Event|2
12572|NCT02167139|66039|P4|Randomised, Double-blind|Withdrawal by Subject|0
12573|NCT02167139|66040|P3|Randomised, Double-blind|Withdrawal by Subject|0
12574|NCT02167139|66041|P2|Randomised, Double-blind|Withdrawal by Subject|8
12575|NCT02167139|66042|P1|Randomised, Double-blind|Withdrawal by Subject|11
12576|NCT02166697|66056|P1|Overall Study|Protocol Violation|347
12577|NCT02166476|66067|P2|Overall Study|Unable to Come for Visit|3
12578|NCT02166476|66068|P1|Overall Study|Unable to Come for Visit|0
12579|NCT02166476|66067|P2|Overall Study|Physician Decision|0
12580|NCT02166476|66068|P1|Overall Study|Physician Decision|1
12581|NCT02166476|66067|P2|Overall Study|Lost to Follow-up|10
12582|NCT02166476|66068|P1|Overall Study|Lost to Follow-up|5
12583|NCT02166476|66067|P2|Overall Study|Adverse Event|3
12584|NCT02166476|66068|P1|Overall Study|Adverse Event|3
12585|NCT02166476|66067|P2|Overall Study|Withdrawal by Subject|7
12586|NCT02166476|66068|P1|Overall Study|Withdrawal by Subject|5
12587|NCT02165826|66113|P3|Down-Titration Period|Reason Not Specified|2
12588|NCT02165826|66114|P2|Down-Titration Period|Reason Not Specified|0
12589|NCT02165826|66115|P1|Down-Titration Period|Reason Not Specified|1
12590|NCT02165826|66113|P3|Down-Titration Period|Voluntary Withdrawal|2
12591|NCT02165826|66114|P2|Down-Titration Period|Voluntary Withdrawal|1
12592|NCT02165826|66115|P1|Down-Titration Period|Voluntary Withdrawal|2
12593|NCT02165826|66113|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
12755|NCT02161146|66700|P5|Overall Study|Lost to Follow-up|0
12594|NCT02165826|66114|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
12595|NCT02165826|66115|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
12596|NCT02165826|66113|P3|Main Treatment Period|Did Not Receive Study Drug|0
12597|NCT02165826|66114|P2|Main Treatment Period|Did Not Receive Study Drug|2
12598|NCT02165826|66115|P1|Main Treatment Period|Did Not Receive Study Drug|0
12599|NCT02165826|66113|P3|Main Treatment Period|Reason Not Specified|16
12600|NCT02165826|66114|P2|Main Treatment Period|Reason Not Specified|5
12601|NCT02165826|66115|P1|Main Treatment Period|Reason Not Specified|8
12602|NCT02165826|66113|P3|Main Treatment Period|Lack of Efficacy|0
12603|NCT02165826|66114|P2|Main Treatment Period|Lack of Efficacy|0
12604|NCT02165826|66115|P1|Main Treatment Period|Lack of Efficacy|2
12605|NCT02165826|66113|P3|Main Treatment Period|Voluntary Withdrawal|21
12606|NCT02165826|66114|P2|Main Treatment Period|Voluntary Withdrawal|23
12607|NCT02165826|66115|P1|Main Treatment Period|Voluntary Withdrawal|23
12608|NCT02165826|66113|P3|Main Treatment Period|Lost to Follow-up|1
12609|NCT02165826|66114|P2|Main Treatment Period|Lost to Follow-up|2
12610|NCT02165826|66115|P1|Main Treatment Period|Lost to Follow-up|4
12611|NCT02165826|66113|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
12612|NCT02165826|66114|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
12613|NCT02165826|66115|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
12614|NCT02165826|66113|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
12615|NCT02165826|66114|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
12616|NCT02165826|66115|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
12617|NCT02164929|66226|P4|Overall Study|Failed regional block|0
12618|NCT02164929|66227|P3|Overall Study|Failed regional block|1
12619|NCT02164929|66228|P2|Overall Study|Failed regional block|0
12620|NCT02164929|66229|P1|Overall Study|Failed regional block|0
12621|NCT02164929|66226|P4|Overall Study|Converted to open procedure|2
12622|NCT02164929|66227|P3|Overall Study|Converted to open procedure|0
12623|NCT02164929|66228|P2|Overall Study|Converted to open procedure|0
12624|NCT02164929|66229|P1|Overall Study|Converted to open procedure|1
12625|NCT02164916|66273|P2|Overall Study|Not eligible|5
12626|NCT02164916|66274|P1|Overall Study|Not eligible|2
12627|NCT02164916|66273|P2|Overall Study|Reason under review|6
12628|NCT02164916|66274|P1|Overall Study|Reason under review|1
12629|NCT02164916|66273|P2|Overall Study|Not protocol specified|1
12630|NCT02164916|66274|P1|Overall Study|Not protocol specified|5
12631|NCT02164916|66273|P2|Overall Study|Progression|26
12632|NCT02164916|66274|P1|Overall Study|Progression|37
12633|NCT02164916|66273|P2|Overall Study|Refusal unrelated to adverse event|7
12634|NCT02164916|66274|P1|Overall Study|Refusal unrelated to adverse event|3
12635|NCT02164916|66273|P2|Overall Study|Death|1
12636|NCT02164916|66274|P1|Overall Study|Death|1
12637|NCT02164916|66273|P2|Overall Study|Adverse Event|8
12638|NCT02164916|66274|P1|Overall Study|Adverse Event|3
12639|NCT02164539|66297|P7|Treatment Phase C (1 Week)|Physician Decision|1
12640|NCT02164539|66298|P6|Treatment Phase C (1 Week)|Physician Decision|0
12641|NCT02164539|66299|P5|Treatment Phase C (1 Week)|Physician Decision|0
12642|NCT02164539|66300|P4|Treatment Phase C (1 Week)|Physician Decision|0
12643|NCT02164539|66301|P3|Treatment Phase C (1 Week)|Physician Decision|0
12644|NCT02164539|66302|P2|Treatment Phase C (1 Week)|Physician Decision|0
12645|NCT02164539|66303|P1|Treatment Phase C (1 Week)|Physician Decision|0
12646|NCT02164539|66297|P7|Treatment Phase C (1 Week)|Adverse Event|1
12647|NCT02164539|66298|P6|Treatment Phase C (1 Week)|Adverse Event|0
12648|NCT02164539|66299|P5|Treatment Phase C (1 Week)|Adverse Event|0
12649|NCT02164539|66300|P4|Treatment Phase C (1 Week)|Adverse Event|0
12650|NCT02164539|66301|P3|Treatment Phase C (1 Week)|Adverse Event|0
12651|NCT02164539|66302|P2|Treatment Phase C (1 Week)|Adverse Event|0
12652|NCT02164539|66303|P1|Treatment Phase C (1 Week)|Adverse Event|0
12653|NCT02164539|66297|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
12654|NCT02164539|66298|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
12655|NCT02164539|66299|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
12656|NCT02164539|66300|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
12657|NCT02164539|66301|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
12658|NCT02164539|66302|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
12659|NCT02164539|66303|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
12660|NCT02164539|66297|P7|Treatment Phase B (1 Week)|Physician Decision|1
12661|NCT02164539|66298|P6|Treatment Phase B (1 Week)|Physician Decision|0
12662|NCT02164539|66299|P5|Treatment Phase B (1 Week)|Physician Decision|1
12663|NCT02164539|66300|P4|Treatment Phase B (1 Week)|Physician Decision|0
12664|NCT02164539|66301|P3|Treatment Phase B (1 Week)|Physician Decision|0
12665|NCT02164539|66302|P2|Treatment Phase B (1 Week)|Physician Decision|0
12666|NCT02164539|66303|P1|Treatment Phase B (1 Week)|Physician Decision|0
12667|NCT02164539|66297|P7|Treatment Phase B (1 Week)|Adverse Event|0
12668|NCT02164539|66298|P6|Treatment Phase B (1 Week)|Adverse Event|0
12669|NCT02164539|66299|P5|Treatment Phase B (1 Week)|Adverse Event|2
12670|NCT02164539|66300|P4|Treatment Phase B (1 Week)|Adverse Event|0
12671|NCT02164539|66301|P3|Treatment Phase B (1 Week)|Adverse Event|0
12672|NCT02164539|66302|P2|Treatment Phase B (1 Week)|Adverse Event|0
12673|NCT02164539|66303|P1|Treatment Phase B (1 Week)|Adverse Event|0
12674|NCT02164539|66297|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
12675|NCT02164539|66298|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
12676|NCT02164539|66299|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
12677|NCT02164539|66300|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
12678|NCT02164539|66301|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
12679|NCT02164539|66302|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
12680|NCT02164539|66303|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
12681|NCT02164318|66365|P4|Overall Study|Withdrawal by Subject|1
12682|NCT02164318|66366|P3|Overall Study|Withdrawal by Subject|0
12683|NCT02164318|66367|P2|Overall Study|Withdrawal by Subject|1
12684|NCT02164318|66368|P1|Overall Study|Withdrawal by Subject|0
12685|NCT02163915|66391|P5|Overall Study|Physician Decision|0
12686|NCT02163915|66392|P4|Overall Study|Physician Decision|1
12687|NCT02163915|66393|P3|Overall Study|Physician Decision|0
12688|NCT02163915|66394|P2|Overall Study|Physician Decision|0
12689|NCT02163915|66395|P1|Overall Study|Physician Decision|0
12690|NCT02163915|66391|P5|Overall Study|Study termination|2
12691|NCT02163915|66392|P4|Overall Study|Study termination|0
12692|NCT02163915|66393|P3|Overall Study|Study termination|0
12693|NCT02163915|66394|P2|Overall Study|Study termination|0
12694|NCT02163915|66395|P1|Overall Study|Study termination|1
12695|NCT02163915|66391|P5|Overall Study|Withdrawal by Subject|2
12696|NCT02163915|66392|P4|Overall Study|Withdrawal by Subject|2
12697|NCT02163915|66393|P3|Overall Study|Withdrawal by Subject|2
12698|NCT02163915|66394|P2|Overall Study|Withdrawal by Subject|0
12699|NCT02163915|66395|P1|Overall Study|Withdrawal by Subject|2
12700|NCT02163733|66450|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
12701|NCT02163733|66451|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
12702|NCT02163733|66452|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
12703|NCT02163733|66450|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
12704|NCT02163733|66451|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
12705|NCT02163733|66452|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
12706|NCT02163538|66489|P2|Overall Study|Physician Decision|1
12707|NCT02163538|66490|P1|Overall Study|Physician Decision|0
12708|NCT02163538|66489|P2|Overall Study|Protocol Violation|0
12709|NCT02163538|66490|P1|Overall Study|Protocol Violation|1
12710|NCT02163395|66520|P1|Overall Study|Adverse Event|1
12711|NCT02163395|66520|P1|Overall Study|Lost to Follow-up|3
12712|NCT02163395|66520|P1|Overall Study|Withdrawal by Subject|1
12713|NCT02163187|66529|P2|Overall Study|Progressive disease|0
12714|NCT02163187|66530|P1|Overall Study|Progressive disease|1
12715|NCT02163187|66529|P2|Overall Study|Device removed|0
12716|NCT02163187|66530|P1|Overall Study|Device removed|1
12717|NCT02162862|66554|P3|Overall Study|Subject did not feel the med was needed|4
12718|NCT02162862|66555|P2|Overall Study|Subject did not feel the med was needed|0
12719|NCT02162862|66556|P1|Overall Study|Subject did not feel the med was needed|0
12720|NCT02162862|66554|P3|Overall Study|Lost to Follow-up|0
12721|NCT02162862|66555|P2|Overall Study|Lost to Follow-up|11
12722|NCT02162862|66556|P1|Overall Study|Lost to Follow-up|0
12723|NCT02162758|66569|P2|Overall Study|Study termination|1
12724|NCT02162758|66570|P1|Overall Study|Study termination|0
12725|NCT02161757|66604|P3|Treatment Through Study Completion|Other|12
12726|NCT02161757|66605|P2|Treatment Through Study Completion|Other|7
12727|NCT02161757|66606|P1|Treatment Through Study Completion|Other|3
12728|NCT02161757|66604|P3|Treatment Through Study Completion|Lost to Follow-up|1
12729|NCT02161757|66605|P2|Treatment Through Study Completion|Lost to Follow-up|0
12730|NCT02161757|66606|P1|Treatment Through Study Completion|Lost to Follow-up|3
12731|NCT02161757|66604|P3|Treatment Through Study Completion|Withdrawal by Subject|21
12732|NCT02161757|66605|P2|Treatment Through Study Completion|Withdrawal by Subject|21
12733|NCT02161757|66606|P1|Treatment Through Study Completion|Withdrawal by Subject|28
12734|NCT02161757|66604|P3|Treatment Through Study Completion|Protocol Violation|1
12735|NCT02161757|66605|P2|Treatment Through Study Completion|Protocol Violation|5
12736|NCT02161757|66606|P1|Treatment Through Study Completion|Protocol Violation|2
12737|NCT02161757|66604|P3|Treatment Through Study Completion|Adverse Event|5
12738|NCT02161757|66605|P2|Treatment Through Study Completion|Adverse Event|16
12739|NCT02161757|66606|P1|Treatment Through Study Completion|Adverse Event|30
12740|NCT02161757|66604|P3|Randomised Through Start Treatment|Did not receive treatment|0
12741|NCT02161757|66605|P2|Randomised Through Start Treatment|Did not receive treatment|2
12742|NCT02161757|66606|P1|Randomised Through Start Treatment|Did not receive treatment|3
12743|NCT02161549|66663|P2|Overall Study|Physician Decision|2
12744|NCT02161549|66664|P1|Overall Study|Physician Decision|6
12745|NCT02161146|66700|P5|Overall Study|Other Miscellaneous Reasons|0
12746|NCT02161146|66701|P4|Overall Study|Other Miscellaneous Reasons|0
12747|NCT02161146|66702|P3|Overall Study|Other Miscellaneous Reasons|0
12748|NCT02161146|66703|P2|Overall Study|Other Miscellaneous Reasons|1
12749|NCT02161146|66704|P1|Overall Study|Other Miscellaneous Reasons|0
12750|NCT02161146|66700|P5|Overall Study|Personal Reasons|1
12751|NCT02161146|66701|P4|Overall Study|Personal Reasons|2
12752|NCT02161146|66702|P3|Overall Study|Personal Reasons|0
12753|NCT02161146|66703|P2|Overall Study|Personal Reasons|1
12754|NCT02161146|66704|P1|Overall Study|Personal Reasons|0
12756|NCT02161146|66701|P4|Overall Study|Lost to Follow-up|0
12757|NCT02161146|66702|P3|Overall Study|Lost to Follow-up|0
12758|NCT02161146|66703|P2|Overall Study|Lost to Follow-up|1
12759|NCT02161146|66704|P1|Overall Study|Lost to Follow-up|0
12760|NCT02161146|66700|P5|Overall Study|Adverse Event|0
12761|NCT02161146|66701|P4|Overall Study|Adverse Event|1
12762|NCT02161146|66702|P3|Overall Study|Adverse Event|0
12763|NCT02161146|66703|P2|Overall Study|Adverse Event|1
12764|NCT02161146|66704|P1|Overall Study|Adverse Event|1
12765|NCT02161016|66717|P1|Overall Study|withdrawn by IRB|1
12766|NCT02160977|66748|P2|Six Months After Surgery|Lost to Follow-up|1
12767|NCT02160977|66749|P1|Six Months After Surgery|Lost to Follow-up|2
12768|NCT02160977|66748|P2|Three Months After Surgery|Lost to Follow-up|2
12769|NCT02160977|66749|P1|Three Months After Surgery|Lost to Follow-up|0
12770|NCT02160977|66748|P2|Six Weeks After Surgery|Lost to Follow-up|0
12771|NCT02160977|66749|P1|Six Weeks After Surgery|Lost to Follow-up|1
12772|NCT02160314|66776|P2|Overall Study|Lost to Follow-up|1
12773|NCT02160314|66777|P1|Overall Study|Lost to Follow-up|0
12774|NCT02160314|66776|P2|Overall Study|Withdrawal by Subject|2
12775|NCT02160314|66777|P1|Overall Study|Withdrawal by Subject|1
12776|NCT02160314|66776|P2|Overall Study|Protocol Violation|4
12777|NCT02160314|66777|P1|Overall Study|Protocol Violation|0
12778|NCT02160314|66776|P2|Overall Study|Adverse Event|6
12779|NCT02160314|66777|P1|Overall Study|Adverse Event|0
12780|NCT02160002|66785|P2|Overall Study|Withdrawal by Subject|1
12781|NCT02160002|66786|P1|Overall Study|Withdrawal by Subject|2
12782|NCT02159950|66818|P2|Overall Study|Progression|1
12783|NCT02159950|66819|P1|Overall Study|Progression|0
12784|NCT02159950|66818|P2|Overall Study|Adverse Event|1
12785|NCT02159950|66819|P1|Overall Study|Adverse Event|0
12786|NCT02159482|66880|P1|Overall Study|Physician Decision|3
12787|NCT02159482|66880|P1|Overall Study|Withdrawal by Subject|2
12788|NCT02159469|66885|P1|Overall Study|Multiple|29
12789|NCT02159469|66885|P1|Overall Study|Other|1
12790|NCT02159469|66885|P1|Overall Study|Met Stopping Criteria|3
12791|NCT02159469|66885|P1|Overall Study|Sponsor's request|2
12792|NCT02159469|66885|P1|Overall Study|Lost to Follow-up|1
12793|NCT02159469|66885|P1|Overall Study|Withdrawal by Subject|9
12794|NCT02159469|66885|P1|Overall Study|Non-compliance|2
12795|NCT02159469|66885|P1|Overall Study|Adverse Event|5
12796|NCT02159469|66885|P1|Overall Study|Missing Completion status|1
12797|NCT02159365|66890|P1|Overall Study|Other|1
12798|NCT02159365|66890|P1|Overall Study|Subject Withdrew Consent|1
12799|NCT02159365|66890|P1|Overall Study|Subject Request to Discontinue Treatment|1
12800|NCT02159365|66890|P1|Overall Study|Study Drug Toxicity|1
12801|NCT02159365|66890|P1|Overall Study|Lost to Follow-up|1
12802|NCT02159365|66890|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
12803|NCT02159365|66890|P1|Overall Study|Disease Progression|11
12804|NCT02159352|66896|P2|Overall Study|Withdrawal by Subject|1
12805|NCT02159352|66897|P1|Overall Study|Withdrawal by Subject|0
12806|NCT02159352|66896|P2|Overall Study|Adverse Event|1
12807|NCT02159352|66897|P1|Overall Study|Adverse Event|3
12808|NCT02159040|66972|P1|Overall Study|Death|1
12809|NCT02158975|66985|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
12810|NCT02158936|66995|P2|Overall Study|Lost to Follow-up|1
12811|NCT02158936|66996|P1|Overall Study|Lost to Follow-up|0
12812|NCT02158936|66995|P2|Overall Study|Physician Decision|13
12813|NCT02158936|66996|P1|Overall Study|Physician Decision|15
12814|NCT02158936|66995|P2|Overall Study|Withdrawal by Subject|16
12815|NCT02158936|66996|P1|Overall Study|Withdrawal by Subject|15
12816|NCT02158936|66995|P2|Overall Study|Adverse Event|24
12817|NCT02158936|66996|P1|Overall Study|Adverse Event|39
12818|NCT02158936|66995|P2|Overall Study|Azacitidine tx discontinued|46
12819|NCT02158936|66996|P1|Overall Study|Azacitidine tx discontinued|53
12820|NCT02158936|66995|P2|Overall Study|Study closed/ terminated|77
12821|NCT02158936|66996|P1|Overall Study|Study closed/ terminated|57
12822|NCT02158728|67038|P1|Overall Study|no qualified dataset|24
12823|NCT02158728|67038|P1|Overall Study|no procedure according to CIP done|3
12824|NCT02158442|67055|P2|Overall Study|Perfusion staff not available|0
12825|NCT02158442|67056|P1|Overall Study|Perfusion staff not available|1
12826|NCT02158442|67055|P2|Overall Study|Withdrawal by Subject|0
12827|NCT02158442|67056|P1|Overall Study|Withdrawal by Subject|1
12828|NCT02158364|67062|P1|Overall Study|Protocol Deviation|50
12829|NCT02158364|67062|P1|Overall Study|Case report forms uncollected|10
12830|NCT02158247|67080|P1|Overall Study|Invisible vocal cords|5
12831|NCT02158039|67096|P1|Overall Study|Screen Failure|9
12832|NCT02158039|67096|P1|Overall Study|Withdrawal by Subject|1
12833|NCT02157948|67103|P2|Overall Study|Decision by Sponsor|1
12834|NCT02157948|67104|P1|Overall Study|Decision by Sponsor|0
12835|NCT02157948|67103|P2|Overall Study|Protocol Specified Criteria|1
12836|NCT02157948|67104|P1|Overall Study|Protocol Specified Criteria|2
12837|NCT02157948|67103|P2|Overall Study|Lost to Follow-up|2
12838|NCT02157948|67104|P1|Overall Study|Lost to Follow-up|3
12839|NCT02157948|67103|P2|Overall Study|Withdrawal by Subject|5
12840|NCT02157948|67104|P1|Overall Study|Withdrawal by Subject|4
12841|NCT02157935|67116|P2|Overall Study|Adverse Event|5
12842|NCT02157935|67117|P1|Overall Study|Adverse Event|3
12843|NCT02157935|67116|P2|Overall Study|Death|4
12844|NCT02157935|67117|P1|Overall Study|Death|4
12845|NCT02157935|67116|P2|Overall Study|Lack of Efficacy|1
12846|NCT02157935|67117|P1|Overall Study|Lack of Efficacy|0
12847|NCT02157935|67116|P2|Overall Study|Other|12
12848|NCT02157935|67117|P1|Overall Study|Other|5
12849|NCT02157935|67116|P2|Overall Study|Progressive disease|2
12850|NCT02157935|67117|P1|Overall Study|Progressive disease|0
12851|NCT02157935|67116|P2|Overall Study|Protocol Violation|0
12852|NCT02157935|67117|P1|Overall Study|Protocol Violation|1
12853|NCT02157935|67116|P2|Overall Study|Screen failure|2
12854|NCT02157935|67117|P1|Overall Study|Screen failure|1
12855|NCT02157935|67116|P2|Overall Study|Withdrawal by Subject|39
12856|NCT02157935|67117|P1|Overall Study|Withdrawal by Subject|25
12857|NCT02157883|67143|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
12858|NCT02157883|67143|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
12859|NCT02157883|67143|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
12860|NCT02157883|67143|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
12861|NCT02157883|67143|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
12862|NCT02157623|67174|P2|Overall Study|Physician Decision|3
12863|NCT02157623|67175|P1|Overall Study|Physician Decision|4
12864|NCT02157376|67183|P2|Overall Study|Investigator's misjudgement|2
12865|NCT02157376|67184|P1|Overall Study|Investigator's misjudgement|1
12866|NCT02157376|67183|P2|Overall Study|Not treated|3
12867|NCT02157376|67184|P1|Overall Study|Not treated|8
12868|NCT02157376|67183|P2|Overall Study|Withdrawal by Subject|8
12869|NCT02157376|67184|P1|Overall Study|Withdrawal by Subject|3
12870|NCT02157376|67183|P2|Overall Study|Eligibility criteria not fulfilled|1
12871|NCT02157376|67184|P1|Overall Study|Eligibility criteria not fulfilled|0
12872|NCT02157376|67183|P2|Overall Study|Death|4
12873|NCT02157376|67184|P1|Overall Study|Death|10
12874|NCT02157298|67194|P2|Overall Study|Withdrawal by Subject|0
12875|NCT02157298|67195|P1|Overall Study|Withdrawal by Subject|1
12876|NCT02157298|67194|P2|Overall Study|Poor/Non-compliance|0
12877|NCT02157298|67195|P1|Overall Study|Poor/Non-compliance|1
12878|NCT02157298|67194|P2|Overall Study|Subject no longer meets study criteria|2
12879|NCT02157298|67195|P1|Overall Study|Subject no longer meets study criteria|1
12880|NCT02157298|67194|P2|Overall Study|Adverse Event|0
12881|NCT02157298|67195|P1|Overall Study|Adverse Event|1
12882|NCT02157116|67234|P1|Overall Study|Failed Screening|2
12883|NCT02157116|67234|P1|Overall Study|Physician Decision|3
12884|NCT02157116|67234|P1|Overall Study|Withdrawal by Subject|4
12885|NCT02156466|67254|P5|Overall Study|Quantiferon Positivity|0
12886|NCT02156466|67255|P4|Overall Study|Quantiferon Positivity|1
12887|NCT02156466|67256|P3|Overall Study|Quantiferon Positivity|0
12888|NCT02156466|67257|P2|Overall Study|Quantiferon Positivity|0
12889|NCT02156466|67258|P1|Overall Study|Quantiferon Positivity|0
12890|NCT02156466|67254|P5|Overall Study|Adverse Event|0
12891|NCT02156466|67255|P4|Overall Study|Adverse Event|1
12892|NCT02156466|67256|P3|Overall Study|Adverse Event|1
12893|NCT02156466|67257|P2|Overall Study|Adverse Event|0
12894|NCT02156466|67258|P1|Overall Study|Adverse Event|0
12895|NCT02156271|67439|P2|Overall Study|Physician Decision|3
12896|NCT02156271|67440|P1|Overall Study|Physician Decision|4
12897|NCT02155985|67479|P3|Overall Study|Lost to Follow-up|0
12898|NCT02155985|67480|P2|Overall Study|Lost to Follow-up|0
12899|NCT02155985|67481|P1|Overall Study|Lost to Follow-up|1
12900|NCT02155985|67479|P3|Overall Study|Withdrawal by Subject|1
12901|NCT02155985|67480|P2|Overall Study|Withdrawal by Subject|0
12902|NCT02155985|67481|P1|Overall Study|Withdrawal by Subject|0
12903|NCT02155881|67548|P2|Overall Study|Inappropriately randomized|2
12904|NCT02155881|67549|P1|Overall Study|Inappropriately randomized|2
12905|NCT02155881|67548|P2|Overall Study|Withdrawal by Subject|2
12906|NCT02155881|67549|P1|Overall Study|Withdrawal by Subject|0
12907|NCT02155322|67601|P1|Overall Study|Withdrawal by Subject|4
12908|NCT02155322|67601|P1|Overall Study|Relapse/Recurrence|8
12909|NCT02155322|67601|P1|Overall Study|Physician Decision|1
12910|NCT02155322|67601|P1|Overall Study|Adverse Event|1
12911|NCT02155309|67608|P3|Overall Study|Protocol Violation|1
12912|NCT02155309|67609|P2|Overall Study|Protocol Violation|0
12913|NCT02155309|67610|P1|Overall Study|Protocol Violation|0
12914|NCT02155283|67617|P1|Overall Study|Protocol Violation|3
12915|NCT02155283|67617|P1|Overall Study|Withdrawal by Subject|1
12916|NCT02155283|67617|P1|Overall Study|Lost to Follow-up|3
12917|NCT02154425|67644|P1|Screening Period|Adverse Event|1
12918|NCT02154139|67703|P1|Overall Study|Investigator transferred|3
12919|NCT02154139|67703|P1|Overall Study|Other|2
12920|NCT02154139|67703|P1|Overall Study|Injection not administered|2
12921|NCT02154087|67711|P1|Overall Study|Study Termination|1
12922|NCT02153827|67730|P2|Overall Study|Lost to Follow-up|9
12923|NCT02153827|67731|P1|Overall Study|Lost to Follow-up|3
12924|NCT02153788|67747|P2|Overall Study|Physician Decision|1
12925|NCT02153788|67748|P1|Overall Study|Physician Decision|2
12926|NCT02153736|67768|P2|Overall Study|Withdrawal by Subject|1
12927|NCT02153736|67769|P1|Overall Study|Withdrawal by Subject|0
12928|NCT02153736|67768|P2|Overall Study|Death|1
12929|NCT02153736|67769|P1|Overall Study|Death|0
12930|NCT02153736|67768|P2|Overall Study|Medical status change made ineligible|0
12931|NCT02153736|67769|P1|Overall Study|Medical status change made ineligible|1
12932|NCT02153736|67768|P2|Overall Study|Lost to Follow-up|0
12933|NCT02153736|67769|P1|Overall Study|Lost to Follow-up|1
12934|NCT02153398|67829|P5|Overall Study|Adverse Event|0
12935|NCT02153398|67830|P4|Overall Study|Adverse Event|1
12936|NCT02153398|67831|P3|Overall Study|Adverse Event|1
12937|NCT02153398|67832|P2|Overall Study|Adverse Event|0
12938|NCT02153398|67833|P1|Overall Study|Adverse Event|0
12939|NCT02153398|67829|P5|Overall Study|Withdrawal by Subject|0
12940|NCT02153398|67830|P4|Overall Study|Withdrawal by Subject|0
12941|NCT02153398|67831|P3|Overall Study|Withdrawal by Subject|0
12942|NCT02153398|67832|P2|Overall Study|Withdrawal by Subject|0
12943|NCT02153398|67833|P1|Overall Study|Withdrawal by Subject|1
12944|NCT02153346|67955|P1|Overall Study|Lost to Follow-up|11
12945|NCT02153086|68029|P1|Overall Study|Other|2
12946|NCT02153086|68029|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
12947|NCT02152605|68045|P2|Overall Study|Withdrew consent|2
12948|NCT02152605|68046|P1|Overall Study|Withdrew consent|4
12949|NCT02152605|68045|P2|Overall Study|Lost to Follow-up|0
12950|NCT02152605|68046|P1|Overall Study|Lost to Follow-up|1
12951|NCT02152605|68045|P2|Overall Study|Protocol deviation|4
12952|NCT02152605|68046|P1|Overall Study|Protocol deviation|1
12953|NCT02152605|68045|P2|Overall Study|Lack of Efficacy|4
12954|NCT02152605|68046|P1|Overall Study|Lack of Efficacy|7
12955|NCT02152605|68045|P2|Overall Study|Adverse Event|8
12956|NCT02152605|68046|P1|Overall Study|Adverse Event|6
12957|NCT02152566|68056|P1|Overall Study|Withdrawal by Subject|2
12958|NCT02152566|68056|P1|Overall Study|Lost to Follow-up|1
12959|NCT02152371|68062|P2|Overall Study|Reason Not Given|1
12960|NCT02152371|68063|P1|Overall Study|Reason Not Given|0
12961|NCT02152371|68062|P2|Overall Study|Physician Decision|2
12962|NCT02152371|68063|P1|Overall Study|Physician Decision|0
12963|NCT02152371|68062|P2|Overall Study|Lack of Efficacy|1
12964|NCT02152371|68063|P1|Overall Study|Lack of Efficacy|0
12965|NCT02152371|68062|P2|Overall Study|Lost to Follow-up|0
12966|NCT02152371|68063|P1|Overall Study|Lost to Follow-up|1
12967|NCT02152371|68062|P2|Overall Study|Protocol Violation|3
12968|NCT02152371|68063|P1|Overall Study|Protocol Violation|2
12969|NCT02152371|68062|P2|Overall Study|Withdrawal by Subject|7
12970|NCT02152371|68063|P1|Overall Study|Withdrawal by Subject|3
12971|NCT02152371|68062|P2|Overall Study|Adverse Event|2
12972|NCT02152371|68063|P1|Overall Study|Adverse Event|6
12973|NCT02152007|68099|P1|Overall Study|Withdrawal by Subject|1
12974|NCT02151981|68160|P2|Overall Study|Eligibility criteria not fulfilled|1
12975|NCT02151981|68161|P1|Overall Study|Eligibility criteria not fulfilled|0
12976|NCT02151981|68160|P2|Overall Study|Ongoing Study at Data Cut-off|95
12977|NCT02151981|68161|P1|Overall Study|Ongoing Study at Data Cut-off|224
12978|NCT02151981|68160|P2|Overall Study|Withdrawal by Subject|18
12979|NCT02151981|68161|P1|Overall Study|Withdrawal by Subject|19
12980|NCT02151981|68160|P2|Overall Study|Lost to Follow-up|0
12981|NCT02151981|68161|P1|Overall Study|Lost to Follow-up|1
12982|NCT02151981|68160|P2|Overall Study|Death|26
12983|NCT02151981|68161|P1|Overall Study|Death|35
12984|NCT02151851|68179|P2|Overall Study|Adverse Event|28
12985|NCT02151851|68180|P1|Overall Study|Adverse Event|6
12986|NCT02151851|68179|P2|Overall Study|Subject entered into study in error|1
12987|NCT02151851|68180|P1|Overall Study|Subject entered into study in error|0
12988|NCT02151851|68179|P2|Overall Study|Low compliance to study visits|1
12989|NCT02151851|68180|P1|Overall Study|Low compliance to study visits|0
12990|NCT02151851|68179|P2|Overall Study|Medical impairment|0
12991|NCT02151851|68180|P1|Overall Study|Medical impairment|1
12992|NCT02151851|68179|P2|Overall Study|Withdrawal by Subject|5
12993|NCT02151851|68180|P1|Overall Study|Withdrawal by Subject|2
12994|NCT02151851|68179|P2|Overall Study|Protocol Violation|1
12995|NCT02151851|68180|P1|Overall Study|Protocol Violation|0
12996|NCT02151851|68179|P2|Overall Study|Lack of Efficacy|94
12997|NCT02151851|68180|P1|Overall Study|Lack of Efficacy|67
12998|NCT02151786|68192|P1|Overall Study|Unavailability of Information|8
12999|NCT02151786|68192|P1|Overall Study|Randomized, not Treated|1
13000|NCT02151786|68192|P1|Overall Study|Outside the Contract Period|1
13001|NCT02151786|68192|P1|Overall Study|Unavailability of Case Report Form|26
13002|NCT02151773|68203|P1|Overall Study|Protocol Deviation|64
13003|NCT02151643|68213|P5|Overall Study|High Ferritin levels|1
13004|NCT02151643|68214|P4|Overall Study|High Ferritin levels|2
13005|NCT02151643|68215|P3|Overall Study|High Ferritin levels|2
13006|NCT02151643|68216|P2|Overall Study|High Ferritin levels|3
13007|NCT02151643|68217|P1|Overall Study|High Ferritin levels|3
13008|NCT02151643|68213|P5|Overall Study|Hyperphosphataemia|1
13009|NCT02151643|68214|P4|Overall Study|Hyperphosphataemia|0
13010|NCT02151643|68215|P3|Overall Study|Hyperphosphataemia|0
13011|NCT02151643|68216|P2|Overall Study|Hyperphosphataemia|0
13012|NCT02151643|68217|P1|Overall Study|Hyperphosphataemia|1
13013|NCT02151643|68213|P5|Overall Study|Withdrawal by Subject|1
13014|NCT02151643|68214|P4|Overall Study|Withdrawal by Subject|1
13015|NCT02151643|68215|P3|Overall Study|Withdrawal by Subject|1
13016|NCT02151643|68216|P2|Overall Study|Withdrawal by Subject|1
13017|NCT02151643|68217|P1|Overall Study|Withdrawal by Subject|0
13018|NCT02151643|68213|P5|Overall Study|Adverse Event|0
13019|NCT02151643|68214|P4|Overall Study|Adverse Event|4
13020|NCT02151643|68215|P3|Overall Study|Adverse Event|1
13021|NCT02151643|68216|P2|Overall Study|Adverse Event|0
13022|NCT02151643|68217|P1|Overall Study|Adverse Event|2
13023|NCT02151461|68258|P4|Overall Study|Treatment discontinuation|0
13024|NCT02151461|68259|P3|Overall Study|Treatment discontinuation|1
13025|NCT02151461|68260|P2|Overall Study|Treatment discontinuation|0
13026|NCT02151461|68261|P1|Overall Study|Treatment discontinuation|0
13027|NCT02151461|68258|P4|Overall Study|Withdrawal by Subject|1
13028|NCT02151461|68259|P3|Overall Study|Withdrawal by Subject|1
13029|NCT02151461|68260|P2|Overall Study|Withdrawal by Subject|0
13030|NCT02151461|68261|P1|Overall Study|Withdrawal by Subject|1
13031|NCT02151461|68258|P4|Overall Study|Lost to Follow-up|1
13032|NCT02151461|68259|P3|Overall Study|Lost to Follow-up|1
13033|NCT02151461|68260|P2|Overall Study|Lost to Follow-up|0
13034|NCT02151461|68261|P1|Overall Study|Lost to Follow-up|0
13035|NCT02151461|68258|P4|Overall Study|Adverse Event|2
13036|NCT02151461|68259|P3|Overall Study|Adverse Event|0
13037|NCT02151461|68260|P2|Overall Study|Adverse Event|1
13038|NCT02151461|68261|P1|Overall Study|Adverse Event|5
13039|NCT02151058|68317|P3|Overall Study|Lost to Follow-up|2
13040|NCT02151058|68318|P2|Overall Study|Lost to Follow-up|0
13041|NCT02151058|68319|P1|Overall Study|Lost to Follow-up|1
13042|NCT02151058|68317|P3|Overall Study|Withdrawal by Subject|3
13043|NCT02151058|68318|P2|Overall Study|Withdrawal by Subject|1
13044|NCT02151058|68319|P1|Overall Study|Withdrawal by Subject|1
13045|NCT02150954|68353|P2|Overall Study|Protocol Violation|0
13046|NCT02150954|68354|P1|Overall Study|Protocol Violation|1
13047|NCT02150213|68426|P1|Overall Study|Withdrawal by Subject|1
13048|NCT02150213|68426|P1|Overall Study|Lost to Follow-up|1
13049|NCT02149875|68452|P3|Overall Study|Physician Decision|2
13050|NCT02149875|68453|P2|Overall Study|Physician Decision|2
13051|NCT02149875|68454|P1|Overall Study|Physician Decision|1
13052|NCT02149875|68452|P3|Overall Study|Withdrawal by Subject|2
13053|NCT02149875|68453|P2|Overall Study|Withdrawal by Subject|2
13054|NCT02149875|68454|P1|Overall Study|Withdrawal by Subject|3
13055|NCT02149875|68452|P3|Overall Study|Lost to Follow-up|5
13056|NCT02149875|68453|P2|Overall Study|Lost to Follow-up|4
13057|NCT02149875|68454|P1|Overall Study|Lost to Follow-up|3
13058|NCT02149264|68483|P1|Overall Study|Protocol Violation|1
13059|NCT02149264|68483|P1|Overall Study|Physician Decision|3
13060|NCT02149264|68483|P1|Overall Study|Adverse Event|7
13061|NCT02149264|68483|P1|Overall Study|Withdrawal by Subject|9
13062|NCT02149108|68498|P2|Overall Study|Lost to Follow-up|0
13063|NCT02149108|68499|P1|Overall Study|Lost to Follow-up|1
13064|NCT02149108|68498|P2|Overall Study|Refusal to continue trial medication|11
13065|NCT02149108|68499|P1|Overall Study|Refusal to continue trial medication|15
13066|NCT02149108|68498|P2|Overall Study|Other not defined above|2
13067|NCT02149108|68499|P1|Overall Study|Other not defined above|0
13068|NCT02149108|68498|P2|Overall Study|Other Adverse Event (AE)|18
13069|NCT02149108|68499|P1|Overall Study|Other Adverse Event (AE)|8
13070|NCT02149108|68498|P2|Overall Study|Worsening/adverse event cancer disease|32
13071|NCT02149108|68499|P1|Overall Study|Worsening/adverse event cancer disease|31
13072|NCT02149108|68498|P2|Overall Study|Progressive Disease (PD)|318
13073|NCT02149108|68499|P1|Overall Study|Progressive Disease (PD)|324
13074|NCT02149108|68498|P2|Overall Study|Not treated|2
13075|NCT02149108|68499|P1|Overall Study|Not treated|1
13076|NCT02148718|68516|P1|Overall Study|Discontinued Study Prematurely|5
13077|NCT02148718|68516|P1|Overall Study|Protocol Violation|26
13078|NCT02148445|68564|P2|Overall Study|Death|3
13079|NCT02148445|68565|P1|Overall Study|Death|1
13080|NCT02147691|68640|P2|Overall Study|Lost to Follow-up|1
13081|NCT02147691|68641|P1|Overall Study|Lost to Follow-up|0
13082|NCT02147691|68640|P2|Overall Study|Adverse Event|0
13083|NCT02147691|68641|P1|Overall Study|Adverse Event|2
13084|NCT02147691|68640|P2|Overall Study|Withdrawal by Subject|0
13085|NCT02147691|68641|P1|Overall Study|Withdrawal by Subject|2
13086|NCT02147587|68687|P2|Overall Study|Lack of Efficacy|1
13087|NCT02147587|68688|P1|Overall Study|Lack of Efficacy|2
13088|NCT02147587|68687|P2|Overall Study|Adverse Event|4
13089|NCT02147587|68688|P1|Overall Study|Adverse Event|9
13090|NCT02147561|68708|P1|Overall Study|Subjects who didn’t receive BOTOX|1
13091|NCT02147561|68708|P1|Overall Study|Lost to Follow-up|3
13092|NCT02147288|68729|P10|Overall Study|complications from concurrent hernia rep|0
13093|NCT02147288|68730|P9|Overall Study|complications from concurrent hernia rep|0
13094|NCT02147288|68731|P8|Overall Study|complications from concurrent hernia rep|0
13095|NCT02147288|68732|P7|Overall Study|complications from concurrent hernia rep|0
13096|NCT02147288|68733|P6|Overall Study|complications from concurrent hernia rep|0
13097|NCT02147288|68734|P5|Overall Study|complications from concurrent hernia rep|0
13098|NCT02147288|68735|P4|Overall Study|complications from concurrent hernia rep|0
13099|NCT02147288|68736|P3|Overall Study|complications from concurrent hernia rep|0
13100|NCT02147288|68737|P2|Overall Study|complications from concurrent hernia rep|1
13101|NCT02147288|68738|P1|Overall Study|complications from concurrent hernia rep|0
13102|NCT02147288|68729|P10|Overall Study|post-operative hematoma|0
13103|NCT02147288|68730|P9|Overall Study|post-operative hematoma|0
13104|NCT02147288|68731|P8|Overall Study|post-operative hematoma|0
13105|NCT02147288|68732|P7|Overall Study|post-operative hematoma|0
13106|NCT02147288|68733|P6|Overall Study|post-operative hematoma|0
13107|NCT02147288|68734|P5|Overall Study|post-operative hematoma|0
13108|NCT02147288|68735|P4|Overall Study|post-operative hematoma|0
13109|NCT02147288|68736|P3|Overall Study|post-operative hematoma|0
13110|NCT02147288|68737|P2|Overall Study|post-operative hematoma|1
13111|NCT02147288|68738|P1|Overall Study|post-operative hematoma|1
13112|NCT02147184|68746|P2|Overall Study|Other|0
13113|NCT02147184|68747|P1|Overall Study|Other|1
13114|NCT02147184|68746|P2|Overall Study|Physician Decision|2
13115|NCT02147184|68747|P1|Overall Study|Physician Decision|0
13116|NCT02147184|68746|P2|Overall Study|Moved out of state|3
13117|NCT02147184|68747|P1|Overall Study|Moved out of state|3
13118|NCT02147184|68746|P2|Overall Study|Pregnancy|0
13119|NCT02147184|68747|P1|Overall Study|Pregnancy|6
13120|NCT02147184|68746|P2|Overall Study|Study Burden|7
13121|NCT02147184|68747|P1|Overall Study|Study Burden|11
13122|NCT02147184|68746|P2|Overall Study|Lost to Follow-up|15
13123|NCT02147184|68747|P1|Overall Study|Lost to Follow-up|28
13124|NCT02147093|68767|P2|Period 2|Protocol Violation|0
13125|NCT02147093|68768|P1|Period 2|Protocol Violation|2
13126|NCT02147093|68767|P2|Period 1|Lost to Follow-up|1
13127|NCT02147093|68768|P1|Period 1|Lost to Follow-up|0
13128|NCT02146599|68776|P1|Overall Study|Failed to meet inclusion criteria|5
13129|NCT02146352|68789|P1|Overall Study|Patient entered hospice care|1
13130|NCT02146352|68789|P1|Overall Study|Death|1
13131|NCT02146326|68807|P4|Overall Study|Unable to complete interview|6
13132|NCT02146326|68808|P3|Overall Study|Unable to complete interview|10
13133|NCT02146326|68809|P2|Overall Study|Unable to complete interview|0
13134|NCT02146326|68810|P1|Overall Study|Unable to complete interview|0
13135|NCT02146326|68807|P4|Overall Study|Death|4
13136|NCT02146326|68808|P3|Overall Study|Death|4
13137|NCT02146326|68809|P2|Overall Study|Death|0
13138|NCT02146326|68810|P1|Overall Study|Death|0
13139|NCT02146326|68807|P4|Overall Study|Incarcerated|8
13140|NCT02146326|68808|P3|Overall Study|Incarcerated|3
13141|NCT02146326|68809|P2|Overall Study|Incarcerated|0
13142|NCT02146326|68810|P1|Overall Study|Incarcerated|0
13143|NCT02146326|68807|P4|Overall Study|Separated from mental health center|0
13144|NCT02146326|68808|P3|Overall Study|Separated from mental health center|0
13145|NCT02146326|68809|P2|Overall Study|Separated from mental health center|33
13146|NCT02146326|68810|P1|Overall Study|Separated from mental health center|23
13147|NCT02146326|68807|P4|Overall Study|Withdrawal by Subject|11
13148|NCT02146326|68808|P3|Overall Study|Withdrawal by Subject|15
13149|NCT02146326|68809|P2|Overall Study|Withdrawal by Subject|1
13150|NCT02146326|68810|P1|Overall Study|Withdrawal by Subject|2
13151|NCT02146326|68807|P4|Overall Study|Lost to Follow-up|19
13152|NCT02146326|68808|P3|Overall Study|Lost to Follow-up|11
13153|NCT02146326|68809|P2|Overall Study|Lost to Follow-up|3
13154|NCT02146326|68810|P1|Overall Study|Lost to Follow-up|3
13155|NCT02146248|68972|P1|Overall Study|Withdrawal by Subject|2
13156|NCT02146105|68980|P1|Overall Study|Withdrawal by Subject|5
13157|NCT02146105|68980|P1|Overall Study|Adverse Event|1
13158|NCT02145468|69031|P2|Overall Study|Withdrawal by Subject|8
13159|NCT02145468|69032|P1|Overall Study|Withdrawal by Subject|5
13160|NCT02145156|69120|P3|Overall Study|No match to vaccination records|41
13161|NCT02145156|69121|P2|Overall Study|No match to vaccination records|52
13162|NCT02145156|69122|P1|Overall Study|No match to vaccination records|60
13163|NCT02144337|69176|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
13164|NCT02144337|69177|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
13165|NCT02144337|69176|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
13166|NCT02144337|69177|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
13167|NCT02144337|69176|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
13168|NCT02144337|69177|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
13169|NCT02144337|69176|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
13170|NCT02144337|69177|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
13171|NCT02144337|69176|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
13172|NCT02144337|69177|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
13173|NCT02144220|69206|P1|Overall Study|Protocol Violation|1
13174|NCT02144220|69206|P1|Overall Study|Withdrawal by Subject|2
13175|NCT02144220|69206|P1|Overall Study|Physician Decision|3
13176|NCT02144220|69206|P1|Overall Study|Lack of Efficacy|4
13177|NCT02144220|69206|P1|Overall Study|technology incompatibility|9
13178|NCT02144012|69216|P2|Overall Study|Other|0
13179|NCT02144012|69217|P1|Overall Study|Other|3
13180|NCT02144012|69216|P2|Overall Study|Study Terminated by Sponsor|12
13181|NCT02144012|69217|P1|Overall Study|Study Terminated by Sponsor|18
13182|NCT02144012|69216|P2|Overall Study|Withdrawal by Subject|3
13183|NCT02144012|69217|P1|Overall Study|Withdrawal by Subject|11
13184|NCT02144012|69216|P2|Overall Study|Death|0
13185|NCT02144012|69217|P1|Overall Study|Death|1
13186|NCT02144012|69216|P2|Overall Study|Adverse Event|0
13187|NCT02144012|69217|P1|Overall Study|Adverse Event|1
13188|NCT02143947|69254|P2|Overall Study|Lost to Follow-up|2
13189|NCT02143947|69255|P1|Overall Study|Lost to Follow-up|4
13190|NCT02143583|69270|P3|Overall Study|husband illness|1
13191|NCT02143583|69271|P2|Overall Study|husband illness|0
13192|NCT02143583|69272|P1|Overall Study|husband illness|0
13193|NCT02143583|69270|P3|Overall Study|Withdrawal by Subject|1
13194|NCT02143583|69271|P2|Overall Study|Withdrawal by Subject|0
13195|NCT02143583|69272|P1|Overall Study|Withdrawal by Subject|1
13196|NCT02143141|69285|P2|Overall Study|pain scores at 24 hours not collected|0
13197|NCT02143141|69286|P1|Overall Study|pain scores at 24 hours not collected|1
13198|NCT02142738|69298|P2|Overall Study|Ongoing in Study|82
13199|NCT02142738|69299|P1|Overall Study|Ongoing in Study|107
13200|NCT02142738|69298|P2|Overall Study|Withdrawal by Subject|5
13201|NCT02142738|69299|P1|Overall Study|Withdrawal by Subject|5
13202|NCT02142738|69298|P2|Overall Study|Progressive Disease|1
13203|NCT02142738|69299|P1|Overall Study|Progressive Disease|0
13204|NCT02142738|69298|P2|Overall Study|Death|55
13205|NCT02142738|69299|P1|Overall Study|Death|33
13206|NCT02142738|69298|P2|Overall Study|Adverse Event|8
13207|NCT02142738|69299|P1|Overall Study|Adverse Event|9
13208|NCT02142712|69312|P4|Overall Study|Lost to Follow-up|0
13209|NCT02142712|69313|P3|Overall Study|Lost to Follow-up|1
13210|NCT02142712|69314|P2|Overall Study|Lost to Follow-up|1
13211|NCT02142712|69315|P1|Overall Study|Lost to Follow-up|1
13212|NCT02142504|69338|P3|Overall Study|Reason Not Specified|4
13213|NCT02142504|69339|P2|Overall Study|Reason Not Specified|5
13214|NCT02142504|69340|P1|Overall Study|Reason Not Specified|4
13215|NCT02142504|69338|P3|Overall Study|Physician Decision|3
13216|NCT02142504|69339|P2|Overall Study|Physician Decision|1
13217|NCT02142504|69340|P1|Overall Study|Physician Decision|0
13218|NCT02142504|69338|P3|Overall Study|Pregnancy|2
13219|NCT02142504|69339|P2|Overall Study|Pregnancy|4
13220|NCT02142504|69340|P1|Overall Study|Pregnancy|4
13221|NCT02142504|69338|P3|Overall Study|Withdrawal by Subject|11
13222|NCT02142504|69339|P2|Overall Study|Withdrawal by Subject|9
13223|NCT02142504|69340|P1|Overall Study|Withdrawal by Subject|7
13224|NCT02142504|69338|P3|Overall Study|Lost to Follow-up|17
13225|NCT02142504|69339|P2|Overall Study|Lost to Follow-up|19
13226|NCT02142504|69340|P1|Overall Study|Lost to Follow-up|12
13227|NCT02142504|69338|P3|Overall Study|Adverse Event|4
13228|NCT02142504|69339|P2|Overall Study|Adverse Event|3
13229|NCT02142504|69340|P1|Overall Study|Adverse Event|2
13230|NCT02142504|69338|P3|Overall Study|Protocol Violation|2
13231|NCT02142504|69339|P2|Overall Study|Protocol Violation|1
13232|NCT02142504|69340|P1|Overall Study|Protocol Violation|2
13233|NCT02141997|69582|P4|Overall Study|Not specified|0
13234|NCT02141997|69583|P3|Overall Study|Not specified|0
13235|NCT02141997|69584|P2|Overall Study|Not specified|4
13236|NCT02141997|69585|P1|Overall Study|Not specified|1
13237|NCT02141997|69582|P4|Overall Study|Withdrew consent|0
13238|NCT02141997|69583|P3|Overall Study|Withdrew consent|3
13239|NCT02141997|69584|P2|Overall Study|Withdrew consent|0
13240|NCT02141997|69585|P1|Overall Study|Withdrew consent|1
13241|NCT02141997|69582|P4|Overall Study|Participant noncompliance|0
13242|NCT02141997|69583|P3|Overall Study|Participant noncompliance|0
13243|NCT02141997|69584|P2|Overall Study|Participant noncompliance|0
13244|NCT02141997|69585|P1|Overall Study|Participant noncompliance|1
13245|NCT02141997|69582|P4|Overall Study|Adverse Event|1
13246|NCT02141997|69583|P3|Overall Study|Adverse Event|0
13247|NCT02141997|69584|P2|Overall Study|Adverse Event|2
13248|NCT02141997|69585|P1|Overall Study|Adverse Event|0
13249|NCT02141984|69623|P1|Overall Study|Lack of Efficacy|2
13250|NCT02141854|69642|P6|Treatment Period|Lost to Follow-up|1
13251|NCT02141854|69643|P5|Treatment Period|Lost to Follow-up|0
13252|NCT02141854|69644|P4|Treatment Period|Lost to Follow-up|1
13253|NCT02141854|69645|P3|Treatment Period|Lost to Follow-up|1
13254|NCT02141854|69646|P2|Treatment Period|Lost to Follow-up|1
13255|NCT02141854|69647|P1|Treatment Period|Lost to Follow-up|0
13256|NCT02141854|69642|P6|Treatment Period|Disease progression|18
13257|NCT02141854|69643|P5|Treatment Period|Disease progression|0
13258|NCT02141854|69644|P4|Treatment Period|Disease progression|3
13259|NCT02141854|69645|P3|Treatment Period|Disease progression|1
13260|NCT02141854|69646|P2|Treatment Period|Disease progression|2
13261|NCT02141854|69647|P1|Treatment Period|Disease progression|0
13262|NCT02141854|69642|P6|Treatment Period|Withdrawal by Subject|7
13263|NCT02141854|69643|P5|Treatment Period|Withdrawal by Subject|4
13264|NCT02141854|69644|P4|Treatment Period|Withdrawal by Subject|3
13265|NCT02141854|69645|P3|Treatment Period|Withdrawal by Subject|3
13266|NCT02141854|69646|P2|Treatment Period|Withdrawal by Subject|2
13267|NCT02141854|69647|P1|Treatment Period|Withdrawal by Subject|0
13268|NCT02141854|69642|P6|Treatment Period|Adverse Event|2
13269|NCT02141854|69643|P5|Treatment Period|Adverse Event|2
13270|NCT02141854|69644|P4|Treatment Period|Adverse Event|0
13271|NCT02141854|69645|P3|Treatment Period|Adverse Event|2
13272|NCT02141854|69646|P2|Treatment Period|Adverse Event|2
13273|NCT02141854|69647|P1|Treatment Period|Adverse Event|0
13274|NCT02141854|69642|P6|Treatment Period|Not specified|2
13275|NCT02141854|69643|P5|Treatment Period|Not specified|1
13276|NCT02141854|69644|P4|Treatment Period|Not specified|0
13277|NCT02141854|69645|P3|Treatment Period|Not specified|2
13278|NCT02141854|69646|P2|Treatment Period|Not specified|1
13279|NCT02141854|69647|P1|Treatment Period|Not specified|0
13280|NCT02141854|69642|P6|Treatment Period|Pregnancy|0
13281|NCT02141854|69643|P5|Treatment Period|Pregnancy|0
13282|NCT02141854|69644|P4|Treatment Period|Pregnancy|0
13283|NCT02141854|69645|P3|Treatment Period|Pregnancy|0
13284|NCT02141854|69646|P2|Treatment Period|Pregnancy|1
13285|NCT02141854|69647|P1|Treatment Period|Pregnancy|0
13286|NCT02141854|69642|P6|Treatment Period|Lack of Efficacy|7
13287|NCT02141854|69643|P5|Treatment Period|Lack of Efficacy|1
13288|NCT02141854|69644|P4|Treatment Period|Lack of Efficacy|1
13289|NCT02141854|69645|P3|Treatment Period|Lack of Efficacy|0
13290|NCT02141854|69646|P2|Treatment Period|Lack of Efficacy|0
13291|NCT02141854|69647|P1|Treatment Period|Lack of Efficacy|0
13292|NCT02141854|69642|P6|Treatment Period|Noncompliance|0
13293|NCT02141854|69643|P5|Treatment Period|Noncompliance|0
13294|NCT02141854|69644|P4|Treatment Period|Noncompliance|1
13295|NCT02141854|69645|P3|Treatment Period|Noncompliance|0
13296|NCT02141854|69646|P2|Treatment Period|Noncompliance|0
13297|NCT02141854|69647|P1|Treatment Period|Noncompliance|0
13298|NCT02141854|69642|P6|Treatment Period|Protocol Violation|1
13299|NCT02141854|69643|P5|Treatment Period|Protocol Violation|2
13300|NCT02141854|69644|P4|Treatment Period|Protocol Violation|2
13301|NCT02141854|69645|P3|Treatment Period|Protocol Violation|0
13302|NCT02141854|69646|P2|Treatment Period|Protocol Violation|1
13303|NCT02141854|69647|P1|Treatment Period|Protocol Violation|0
13304|NCT02141854|69642|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13305|NCT02141854|69643|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13306|NCT02141854|69644|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13307|NCT02141854|69645|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13308|NCT02141854|69646|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13309|NCT02141854|69647|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
13310|NCT02141854|69642|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13311|NCT02141854|69643|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13312|NCT02141854|69644|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13313|NCT02141854|69645|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13314|NCT02141854|69646|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13315|NCT02141854|69647|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
13316|NCT02141854|69642|P6|Run-In Period (Pre-assignment)|Adverse Event|0
13317|NCT02141854|69643|P5|Run-In Period (Pre-assignment)|Adverse Event|0
13318|NCT02141854|69644|P4|Run-In Period (Pre-assignment)|Adverse Event|0
13319|NCT02141854|69645|P3|Run-In Period (Pre-assignment)|Adverse Event|0
13320|NCT02141854|69646|P2|Run-In Period (Pre-assignment)|Adverse Event|0
13321|NCT02141854|69647|P1|Run-In Period (Pre-assignment)|Adverse Event|10
13322|NCT02141854|69642|P6|Run-In Period (Pre-assignment)|Not specified|0
13323|NCT02141854|69643|P5|Run-In Period (Pre-assignment)|Not specified|0
13324|NCT02141854|69644|P4|Run-In Period (Pre-assignment)|Not specified|0
13325|NCT02141854|69645|P3|Run-In Period (Pre-assignment)|Not specified|0
13326|NCT02141854|69646|P2|Run-In Period (Pre-assignment)|Not specified|0
13327|NCT02141854|69647|P1|Run-In Period (Pre-assignment)|Not specified|14
13328|NCT02141854|69642|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13329|NCT02141854|69643|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13330|NCT02141854|69644|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13331|NCT02141854|69645|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13332|NCT02141854|69646|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13333|NCT02141854|69647|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
13334|NCT02141854|69642|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13335|NCT02141854|69643|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13336|NCT02141854|69644|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13337|NCT02141854|69645|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13338|NCT02141854|69646|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13339|NCT02141854|69647|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
13340|NCT02141854|69642|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13341|NCT02141854|69643|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13342|NCT02141854|69644|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13343|NCT02141854|69645|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13344|NCT02141854|69646|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13345|NCT02141854|69647|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
13346|NCT02141633|69701|P2|Overall Study|Physician Decision|0
13347|NCT02141633|69702|P1|Overall Study|Physician Decision|1
13348|NCT02141620|69710|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
13349|NCT02141620|69711|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
13350|NCT02141516|69788|P3|Overall Study|Other|0
13351|NCT02141516|69789|P2|Overall Study|Other|3
13352|NCT02141516|69790|P1|Overall Study|Other|0
13353|NCT02141516|69788|P3|Overall Study|Lost to Follow-up|0
13354|NCT02141516|69789|P2|Overall Study|Lost to Follow-up|1
13355|NCT02141516|69790|P1|Overall Study|Lost to Follow-up|0
13356|NCT02141516|69788|P3|Overall Study|Adverse Event|0
13357|NCT02141516|69789|P2|Overall Study|Adverse Event|1
13358|NCT02141516|69790|P1|Overall Study|Adverse Event|0
13359|NCT02141360|69840|P3|Overall Study|Study Terminated before Visit|0
13360|NCT02141360|69841|P2|Overall Study|Study Terminated before Visit|0
13361|NCT02141360|69842|P1|Overall Study|Study Terminated before Visit|1
13362|NCT02141360|69840|P3|Overall Study|Withdrawal by Subject|0
13363|NCT02141360|69841|P2|Overall Study|Withdrawal by Subject|0
13364|NCT02141360|69842|P1|Overall Study|Withdrawal by Subject|6
13365|NCT02141217|69852|P2|Overall Study|Surgical Intervention|1
13366|NCT02141217|69853|P1|Overall Study|Surgical Intervention|1
13367|NCT02141217|69852|P2|Overall Study|Physician Decision|0
13368|NCT02141217|69853|P1|Overall Study|Physician Decision|1
13369|NCT02141217|69852|P2|Overall Study|Lost to Follow-up|1
13370|NCT02141217|69853|P1|Overall Study|Lost to Follow-up|1
13371|NCT02141217|69852|P2|Overall Study|Withdrawal by Subject|0
13372|NCT02141217|69853|P1|Overall Study|Withdrawal by Subject|6
13373|NCT02141217|69852|P2|Overall Study|Protocol Violation|4
13374|NCT02141217|69853|P1|Overall Study|Protocol Violation|1
13375|NCT02141217|69852|P2|Overall Study|Adverse Event|2
13376|NCT02141217|69853|P1|Overall Study|Adverse Event|1
13377|NCT02140645|69919|P6|Overall Study|Not linked|70896
13378|NCT02140645|69920|P5|Overall Study|Not linked|3286
13379|NCT02140645|69921|P4|Overall Study|Not linked|13833
13380|NCT02140645|69922|P3|Overall Study|Not linked|4236
13381|NCT02140645|69923|P2|Overall Study|Not linked|61654
13382|NCT02140645|69924|P1|Overall Study|Not linked|5489
13383|NCT02140164|70033|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
13384|NCT02140060|70054|P6|Overall Study|Lack of Efficacy|0
13385|NCT02140060|70055|P5|Overall Study|Lack of Efficacy|0
13386|NCT02140060|70056|P4|Overall Study|Lack of Efficacy|1
13387|NCT02140060|70057|P3|Overall Study|Lack of Efficacy|0
13388|NCT02140060|70058|P2|Overall Study|Lack of Efficacy|0
13389|NCT02140060|70059|P1|Overall Study|Lack of Efficacy|0
13390|NCT02140060|70054|P6|Overall Study|Adverse Event|1
13391|NCT02140060|70055|P5|Overall Study|Adverse Event|1
13392|NCT02140060|70056|P4|Overall Study|Adverse Event|1
13393|NCT02140060|70057|P3|Overall Study|Adverse Event|0
13394|NCT02140060|70058|P2|Overall Study|Adverse Event|0
13395|NCT02140060|70059|P1|Overall Study|Adverse Event|0
13396|NCT02139982|70084|P10|Overall Study|Lack of Efficacy|0
13397|NCT02139982|70085|P9|Overall Study|Lack of Efficacy|0
13398|NCT02139982|70086|P8|Overall Study|Lack of Efficacy|0
13399|NCT02139982|70087|P7|Overall Study|Lack of Efficacy|0
13400|NCT02139982|70088|P6|Overall Study|Lack of Efficacy|0
13401|NCT02139982|70089|P5|Overall Study|Lack of Efficacy|0
13402|NCT02139982|70090|P4|Overall Study|Lack of Efficacy|1
13403|NCT02139982|70091|P3|Overall Study|Lack of Efficacy|0
13404|NCT02139982|70092|P2|Overall Study|Lack of Efficacy|1
13405|NCT02139982|70093|P1|Overall Study|Lack of Efficacy|0
13406|NCT02139943|70138|P3|Overall Study|eGFR Withdrawal Criteria|1
13407|NCT02139943|70139|P2|Overall Study|eGFR Withdrawal Criteria|0
13408|NCT02139943|70140|P1|Overall Study|eGFR Withdrawal Criteria|0
13409|NCT02139943|70138|P3|Overall Study|Participant in Poor Compliance|1
13410|NCT02139943|70139|P2|Overall Study|Participant in Poor Compliance|0
13411|NCT02139943|70140|P1|Overall Study|Participant in Poor Compliance|1
13412|NCT02139943|70138|P3|Overall Study|Participant wishes to discontinue|0
13413|NCT02139943|70139|P2|Overall Study|Participant wishes to discontinue|0
13414|NCT02139943|70140|P1|Overall Study|Participant wishes to discontinue|2
13415|NCT02139943|70138|P3|Overall Study|Other|1
13416|NCT02139943|70139|P2|Overall Study|Other|0
13417|NCT02139943|70140|P1|Overall Study|Other|0
13418|NCT02139943|70138|P3|Overall Study|Withdrawal by Subject|0
13419|NCT02139943|70139|P2|Overall Study|Withdrawal by Subject|3
13420|NCT02139943|70140|P1|Overall Study|Withdrawal by Subject|4
13421|NCT02139943|70138|P3|Overall Study|Lost to Follow-up|2
13422|NCT02139943|70139|P2|Overall Study|Lost to Follow-up|2
13423|NCT02139943|70140|P1|Overall Study|Lost to Follow-up|3
13424|NCT02139943|70138|P3|Overall Study|Adverse Event|2
13425|NCT02139943|70139|P2|Overall Study|Adverse Event|1
13426|NCT02139943|70140|P1|Overall Study|Adverse Event|0
13427|NCT02139644|70165|P6|Treatment Period|Not specified|1
13428|NCT02139644|70166|P5|Treatment Period|Not specified|0
13429|NCT02139644|70167|P4|Treatment Period|Not specified|1
13430|NCT02139644|70168|P3|Treatment Period|Not specified|1
13431|NCT02139644|70169|P2|Treatment Period|Not specified|3
13432|NCT02139644|70170|P1|Treatment Period|Not specified|0
13433|NCT02139644|70165|P6|Treatment Period|Lack of Efficacy|4
13434|NCT02139644|70166|P5|Treatment Period|Lack of Efficacy|1
13435|NCT02139644|70167|P4|Treatment Period|Lack of Efficacy|0
13436|NCT02139644|70168|P3|Treatment Period|Lack of Efficacy|1
13437|NCT02139644|70169|P2|Treatment Period|Lack of Efficacy|0
13438|NCT02139644|70170|P1|Treatment Period|Lack of Efficacy|0
13439|NCT02139644|70165|P6|Treatment Period|Lost to Follow-up|1
13440|NCT02139644|70166|P5|Treatment Period|Lost to Follow-up|1
13441|NCT02139644|70167|P4|Treatment Period|Lost to Follow-up|1
13442|NCT02139644|70168|P3|Treatment Period|Lost to Follow-up|1
13443|NCT02139644|70169|P2|Treatment Period|Lost to Follow-up|0
13444|NCT02139644|70170|P1|Treatment Period|Lost to Follow-up|0
13445|NCT02139644|70165|P6|Treatment Period|Disease progression|2
13446|NCT02139644|70166|P5|Treatment Period|Disease progression|1
13447|NCT02139644|70167|P4|Treatment Period|Disease progression|1
13448|NCT02139644|70168|P3|Treatment Period|Disease progression|0
13449|NCT02139644|70169|P2|Treatment Period|Disease progression|0
13450|NCT02139644|70170|P1|Treatment Period|Disease progression|0
13451|NCT02139644|70165|P6|Treatment Period|Protocol Violation|1
13452|NCT02139644|70166|P5|Treatment Period|Protocol Violation|1
13453|NCT02139644|70167|P4|Treatment Period|Protocol Violation|1
13454|NCT02139644|70168|P3|Treatment Period|Protocol Violation|0
13455|NCT02139644|70169|P2|Treatment Period|Protocol Violation|0
13456|NCT02139644|70170|P1|Treatment Period|Protocol Violation|0
13457|NCT02139644|70165|P6|Treatment Period|Non-compliance|0
13458|NCT02139644|70166|P5|Treatment Period|Non-compliance|0
13459|NCT02139644|70167|P4|Treatment Period|Non-compliance|1
13460|NCT02139644|70168|P3|Treatment Period|Non-compliance|0
13461|NCT02139644|70169|P2|Treatment Period|Non-compliance|0
13462|NCT02139644|70170|P1|Treatment Period|Non-compliance|0
13463|NCT02139644|70165|P6|Treatment Period|Withdrawal by Subject|2
13464|NCT02139644|70166|P5|Treatment Period|Withdrawal by Subject|3
13465|NCT02139644|70167|P4|Treatment Period|Withdrawal by Subject|2
13466|NCT02139644|70168|P3|Treatment Period|Withdrawal by Subject|2
13467|NCT02139644|70169|P2|Treatment Period|Withdrawal by Subject|0
13468|NCT02139644|70170|P1|Treatment Period|Withdrawal by Subject|0
13469|NCT02139644|70165|P6|Treatment Period|Adverse Event|6
13470|NCT02139644|70166|P5|Treatment Period|Adverse Event|1
13471|NCT02139644|70167|P4|Treatment Period|Adverse Event|2
13472|NCT02139644|70168|P3|Treatment Period|Adverse Event|3
13473|NCT02139644|70169|P2|Treatment Period|Adverse Event|0
13474|NCT02139644|70170|P1|Treatment Period|Adverse Event|0
13475|NCT02139644|70165|P6|Run-In Period (Pre-assignment)|Not specified|0
13476|NCT02139644|70166|P5|Run-In Period (Pre-assignment)|Not specified|0
13477|NCT02139644|70167|P4|Run-In Period (Pre-assignment)|Not specified|0
13478|NCT02139644|70168|P3|Run-In Period (Pre-assignment)|Not specified|0
13479|NCT02139644|70169|P2|Run-In Period (Pre-assignment)|Not specified|0
13480|NCT02139644|70170|P1|Run-In Period (Pre-assignment)|Not specified|6
13481|NCT02139644|70165|P6|Run-In Period (Pre-assignment)|Adverse Event|0
13482|NCT02139644|70166|P5|Run-In Period (Pre-assignment)|Adverse Event|0
13483|NCT02139644|70167|P4|Run-In Period (Pre-assignment)|Adverse Event|0
13484|NCT02139644|70168|P3|Run-In Period (Pre-assignment)|Adverse Event|0
13485|NCT02139644|70169|P2|Run-In Period (Pre-assignment)|Adverse Event|0
13486|NCT02139644|70170|P1|Run-In Period (Pre-assignment)|Adverse Event|3
13487|NCT02139644|70165|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13488|NCT02139644|70166|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13489|NCT02139644|70167|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13490|NCT02139644|70168|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13491|NCT02139644|70169|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
13492|NCT02139644|70170|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
13493|NCT02139644|70165|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13494|NCT02139644|70166|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13495|NCT02139644|70167|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13496|NCT02139644|70168|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13497|NCT02139644|70169|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
13498|NCT02139644|70170|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
13499|NCT02139644|70165|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13500|NCT02139644|70166|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13501|NCT02139644|70167|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13502|NCT02139644|70168|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13503|NCT02139644|70169|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
13504|NCT02139644|70170|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
13505|NCT02139644|70165|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13506|NCT02139644|70166|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13507|NCT02139644|70167|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13508|NCT02139644|70168|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13509|NCT02139644|70169|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
13510|NCT02139644|70170|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
13511|NCT02139644|70165|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13512|NCT02139644|70166|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13513|NCT02139644|70167|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13514|NCT02139644|70168|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13515|NCT02139644|70169|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
13516|NCT02139644|70170|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
13517|NCT02139046|70268|P5|Overall Study|Other Miscellaneous Reasons|12
13518|NCT02139046|70269|P4|Overall Study|Other Miscellaneous Reasons|9
13519|NCT02139046|70270|P3|Overall Study|Other Miscellaneous Reasons|4
13520|NCT02139046|70271|P2|Overall Study|Other Miscellaneous Reasons|9
13521|NCT02139046|70272|P1|Overall Study|Other Miscellaneous Reasons|10
13522|NCT02139046|70268|P5|Overall Study|Withdrawal due to a Gout Flare|1
13523|NCT02139046|70269|P4|Overall Study|Withdrawal due to a Gout Flare|0
13524|NCT02139046|70270|P3|Overall Study|Withdrawal due to a Gout Flare|1
13525|NCT02139046|70271|P2|Overall Study|Withdrawal due to a Gout Flare|1
13526|NCT02139046|70272|P1|Overall Study|Withdrawal due to a Gout Flare|1
13527|NCT02139046|70268|P5|Overall Study|Lack of Efficacy|2
13528|NCT02139046|70269|P4|Overall Study|Lack of Efficacy|1
13529|NCT02139046|70270|P3|Overall Study|Lack of Efficacy|2
13530|NCT02139046|70271|P2|Overall Study|Lack of Efficacy|1
13531|NCT02139046|70272|P1|Overall Study|Lack of Efficacy|0
13532|NCT02139046|70268|P5|Overall Study|Voluntary Withdrawal|16
13533|NCT02139046|70269|P4|Overall Study|Voluntary Withdrawal|15
13534|NCT02139046|70270|P3|Overall Study|Voluntary Withdrawal|10
13535|NCT02139046|70271|P2|Overall Study|Voluntary Withdrawal|8
13536|NCT02139046|70272|P1|Overall Study|Voluntary Withdrawal|20
13537|NCT02139046|70268|P5|Overall Study|Lost to Follow-up|13
13538|NCT02139046|70269|P4|Overall Study|Lost to Follow-up|18
13539|NCT02139046|70270|P3|Overall Study|Lost to Follow-up|16
13540|NCT02139046|70271|P2|Overall Study|Lost to Follow-up|16
13541|NCT02139046|70272|P1|Overall Study|Lost to Follow-up|13
13542|NCT02139046|70268|P5|Overall Study|Major Protocol Deviation|6
13543|NCT02139046|70269|P4|Overall Study|Major Protocol Deviation|12
13544|NCT02139046|70270|P3|Overall Study|Major Protocol Deviation|16
13545|NCT02139046|70271|P2|Overall Study|Major Protocol Deviation|10
13546|NCT02139046|70272|P1|Overall Study|Major Protocol Deviation|9
13547|NCT02139046|70268|P5|Overall Study|Pretreatment Event/Adverse Event|7
13548|NCT02139046|70269|P4|Overall Study|Pretreatment Event/Adverse Event|13
13549|NCT02139046|70270|P3|Overall Study|Pretreatment Event/Adverse Event|10
13550|NCT02139046|70271|P2|Overall Study|Pretreatment Event/Adverse Event|9
13551|NCT02139046|70272|P1|Overall Study|Pretreatment Event/Adverse Event|9
13552|NCT02138838|70312|P2|Overall Study|Withdrawal by Subject|5
13553|NCT02138838|70313|P1|Overall Study|Withdrawal by Subject|1
13554|NCT02138838|70312|P2|Overall Study|Study Closure|6
13555|NCT02138838|70313|P1|Overall Study|Study Closure|7
13556|NCT02138825|70331|P2|Safety Follow-up|withdrawn due to lung transplant|1
13557|NCT02138825|70332|P1|Safety Follow-up|withdrawn due to lung transplant|0
13558|NCT02138825|70331|P2|Safety Follow-up|treatment unblinded|1
13559|NCT02138825|70332|P1|Safety Follow-up|treatment unblinded|0
13560|NCT02138825|70331|P2|Safety Follow-up|too unwell to attend the visit|1
13561|NCT02138825|70332|P1|Safety Follow-up|too unwell to attend the visit|0
13562|NCT02138825|70331|P2|Safety Follow-up|progressive disease|2
13563|NCT02138825|70332|P1|Safety Follow-up|progressive disease|0
13564|NCT02138825|70331|P2|Safety Follow-up|logistical difficulties|1
13565|NCT02138825|70332|P1|Safety Follow-up|logistical difficulties|0
13566|NCT02138825|70331|P2|Safety Follow-up|withdrawal by PI|0
13567|NCT02138825|70332|P1|Safety Follow-up|withdrawal by PI|1
13568|NCT02138825|70331|P2|Safety Follow-up|clinic worsening|0
13569|NCT02138825|70332|P1|Safety Follow-up|clinic worsening|1
13570|NCT02138825|70331|P2|Safety Follow-up|Withdrawal by Subject|3
13571|NCT02138825|70332|P1|Safety Follow-up|Withdrawal by Subject|5
13572|NCT02138825|70331|P2|Safety Follow-up|Death|5
13573|NCT02138825|70332|P1|Safety Follow-up|Death|11
13574|NCT02138825|70331|P2|Safety Follow-up|Adverse Event|3
13575|NCT02138825|70332|P1|Safety Follow-up|Adverse Event|4
13576|NCT02138825|70331|P2|Long-term Extension|Study termination by sponsor|38
13577|NCT02138825|70332|P1|Long-term Extension|Study termination by sponsor|32
13578|NCT02138825|70331|P2|Main Study Treatment|Medical decision|0
13579|NCT02138825|70332|P1|Main Study Treatment|Medical decision|1
13580|NCT02138825|70331|P2|Main Study Treatment|Withdrawal by Subject|1
13581|NCT02138825|70332|P1|Main Study Treatment|Withdrawal by Subject|3
13582|NCT02138825|70331|P2|Main Study Treatment|Study terminated by sponsor|9
13583|NCT02138825|70332|P1|Main Study Treatment|Study terminated by sponsor|10
13584|NCT02138825|70331|P2|Main Study Treatment|Sponsor decision|18
13585|NCT02138825|70332|P1|Main Study Treatment|Sponsor decision|12
13586|NCT02138825|70331|P2|Main Study Treatment|Protocol Violation|2
13587|NCT02138825|70332|P1|Main Study Treatment|Protocol Violation|2
13588|NCT02138825|70331|P2|Main Study Treatment|Death|2
13589|NCT02138825|70332|P1|Main Study Treatment|Death|1
13590|NCT02138825|70331|P2|Main Study Treatment|Adverse Event|3
13591|NCT02138825|70332|P1|Main Study Treatment|Adverse Event|11
13592|NCT02138747|70350|P4|Treatment Period 2|Other - Miscellaneous|0
13593|NCT02138747|70351|P3|Treatment Period 2|Other - Miscellaneous|0
13594|NCT02138747|70352|P2|Treatment Period 2|Other - Miscellaneous|0
13595|NCT02138747|70353|P1|Treatment Period 2|Other - Miscellaneous|3
13596|NCT02138747|70350|P4|Treatment Period 2|Withdrawal by Subject|2
13597|NCT02138747|70351|P3|Treatment Period 2|Withdrawal by Subject|1
13598|NCT02138747|70352|P2|Treatment Period 2|Withdrawal by Subject|4
13599|NCT02138747|70353|P1|Treatment Period 2|Withdrawal by Subject|5
13600|NCT02138747|70350|P4|Treatment Period 2|Protocol Violation|0
13601|NCT02138747|70351|P3|Treatment Period 2|Protocol Violation|0
13602|NCT02138747|70352|P2|Treatment Period 2|Protocol Violation|0
13603|NCT02138747|70353|P1|Treatment Period 2|Protocol Violation|1
13604|NCT02138747|70350|P4|Treatment Period 2|Lost to Follow-up|0
13605|NCT02138747|70351|P3|Treatment Period 2|Lost to Follow-up|0
13606|NCT02138747|70352|P2|Treatment Period 2|Lost to Follow-up|0
13607|NCT02138747|70353|P1|Treatment Period 2|Lost to Follow-up|2
13608|NCT02138747|70350|P4|Treatment Period 2|Adverse Event|1
13609|NCT02138747|70351|P3|Treatment Period 2|Adverse Event|1
13610|NCT02138747|70352|P2|Treatment Period 2|Adverse Event|3
13611|NCT02138747|70353|P1|Treatment Period 2|Adverse Event|6
13612|NCT02138747|70350|P4|Treatment Period 1|Other - Miscellaneous|0
13613|NCT02138747|70351|P3|Treatment Period 1|Other - Miscellaneous|0
13614|NCT02138747|70352|P2|Treatment Period 1|Other - Miscellaneous|4
13615|NCT02138747|70353|P1|Treatment Period 1|Other - Miscellaneous|2
13616|NCT02138747|70350|P4|Treatment Period 1|Withdrawal by Subject|3
13617|NCT02138747|70351|P3|Treatment Period 1|Withdrawal by Subject|1
13618|NCT02138747|70352|P2|Treatment Period 1|Withdrawal by Subject|4
13619|NCT02138747|70353|P1|Treatment Period 1|Withdrawal by Subject|8
13620|NCT02138747|70350|P4|Treatment Period 1|Protocol Violation|0
13621|NCT02138747|70351|P3|Treatment Period 1|Protocol Violation|0
13622|NCT02138747|70352|P2|Treatment Period 1|Protocol Violation|2
13623|NCT02138747|70353|P1|Treatment Period 1|Protocol Violation|0
13624|NCT02138747|70350|P4|Treatment Period 1|Lost to Follow-up|0
13625|NCT02138747|70351|P3|Treatment Period 1|Lost to Follow-up|1
13626|NCT02138747|70352|P2|Treatment Period 1|Lost to Follow-up|1
13627|NCT02138747|70353|P1|Treatment Period 1|Lost to Follow-up|0
13628|NCT02138747|70350|P4|Treatment Period 1|Adverse Event|1
13629|NCT02138747|70351|P3|Treatment Period 1|Adverse Event|2
13630|NCT02138747|70352|P2|Treatment Period 1|Adverse Event|14
13631|NCT02138747|70353|P1|Treatment Period 1|Adverse Event|10
13632|NCT02137785|70681|P2|Overall Study|subject moved out of state|0
13633|NCT02137785|70682|P1|Overall Study|subject moved out of state|1
13634|NCT02137785|70681|P2|Overall Study|Withdrawal by Subject|4
13635|NCT02137785|70682|P1|Overall Study|Withdrawal by Subject|1
13636|NCT02137785|70681|P2|Overall Study|Lost to Follow-up|0
13637|NCT02137785|70682|P1|Overall Study|Lost to Follow-up|1
13638|NCT02137772|70790|P2|Overall Study|Not treated|2
13639|NCT02137772|70791|P1|Overall Study|Not treated|3
13640|NCT02137772|70790|P2|Overall Study|Non-compliance with study drug|0
13641|NCT02137772|70791|P1|Overall Study|Non-compliance with study drug|1
13642|NCT02137772|70790|P2|Overall Study|Withdrawal by Subject|17
13643|NCT02137772|70791|P1|Overall Study|Withdrawal by Subject|28
13644|NCT02137772|70790|P2|Overall Study|Physician Decision|5
13645|NCT02137772|70791|P1|Overall Study|Physician Decision|15
13646|NCT02137772|70790|P2|Overall Study|Lost to Follow-up|4
13647|NCT02137772|70791|P1|Overall Study|Lost to Follow-up|8
13648|NCT02137772|70790|P2|Overall Study|Death|44
13649|NCT02137772|70791|P1|Overall Study|Death|71
13650|NCT02137772|70790|P2|Overall Study|Adverse Event|3
13651|NCT02137772|70791|P1|Overall Study|Adverse Event|6
13652|NCT02137226|70868|P5|Period 2 (Re - Randomization)|Other Reason|1
13653|NCT02137226|70869|P4|Period 2 (Re - Randomization)|Other Reason|1
13654|NCT02137226|70870|P3|Period 2 (Re - Randomization)|Other Reason|1
13655|NCT02137226|70871|P2|Period 2 (Re - Randomization)|Other Reason|0
13656|NCT02137226|70872|P1|Period 2 (Re - Randomization)|Other Reason|0
13657|NCT02137226|70868|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
13658|NCT02137226|70869|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
13659|NCT02137226|70870|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
13660|NCT02137226|70871|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
13661|NCT02137226|70872|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
13662|NCT02137226|70868|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
13663|NCT02137226|70869|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
13664|NCT02137226|70870|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
13665|NCT02137226|70871|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
13666|NCT02137226|70872|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
13667|NCT02137226|70868|P5|Period 2 (Re - Randomization)|Physician Decision|0
13668|NCT02137226|70869|P4|Period 2 (Re - Randomization)|Physician Decision|1
13669|NCT02137226|70870|P3|Period 2 (Re - Randomization)|Physician Decision|0
13670|NCT02137226|70871|P2|Period 2 (Re - Randomization)|Physician Decision|0
13671|NCT02137226|70872|P1|Period 2 (Re - Randomization)|Physician Decision|0
13672|NCT02137226|70868|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
13673|NCT02137226|70869|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
13674|NCT02137226|70870|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
13675|NCT02137226|70871|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
13676|NCT02137226|70872|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
13677|NCT02137226|70868|P5|Period 2 (Re - Randomization)|Adverse Event|4
13678|NCT02137226|70869|P4|Period 2 (Re - Randomization)|Adverse Event|1
13679|NCT02137226|70870|P3|Period 2 (Re - Randomization)|Adverse Event|3
13680|NCT02137226|70871|P2|Period 2 (Re - Randomization)|Adverse Event|0
13681|NCT02137226|70872|P1|Period 2 (Re - Randomization)|Adverse Event|0
13682|NCT02137226|70868|P5|Period 1 (Initial Randomization)|Other Reason|0
13683|NCT02137226|70869|P4|Period 1 (Initial Randomization)|Other Reason|0
13684|NCT02137226|70870|P3|Period 1 (Initial Randomization)|Other Reason|0
13685|NCT02137226|70871|P2|Period 1 (Initial Randomization)|Other Reason|3
13686|NCT02137226|70872|P1|Period 1 (Initial Randomization)|Other Reason|1
13687|NCT02137226|70868|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
13688|NCT02137226|70869|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
13689|NCT02137226|70870|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
13690|NCT02137226|70871|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
13691|NCT02137226|70872|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
13692|NCT02137226|70868|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
13693|NCT02137226|70869|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
13694|NCT02137226|70870|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
13695|NCT02137226|70871|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
13696|NCT02137226|70872|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
13697|NCT02137226|70868|P5|Period 1 (Initial Randomization)|Physician Decision|0
13698|NCT02137226|70869|P4|Period 1 (Initial Randomization)|Physician Decision|0
13699|NCT02137226|70870|P3|Period 1 (Initial Randomization)|Physician Decision|0
13700|NCT02137226|70871|P2|Period 1 (Initial Randomization)|Physician Decision|3
13701|NCT02137226|70872|P1|Period 1 (Initial Randomization)|Physician Decision|1
13702|NCT02137226|70868|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
13703|NCT02137226|70869|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
13704|NCT02137226|70870|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
13705|NCT02137226|70871|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
13706|NCT02137226|70872|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
13707|NCT02137226|70868|P5|Period 1 (Initial Randomization)|Adverse Event|0
13708|NCT02137226|70869|P4|Period 1 (Initial Randomization)|Adverse Event|0
13709|NCT02137226|70870|P3|Period 1 (Initial Randomization)|Adverse Event|0
13710|NCT02137226|70871|P2|Period 1 (Initial Randomization)|Adverse Event|3
13711|NCT02137226|70872|P1|Period 1 (Initial Randomization)|Adverse Event|3
13712|NCT02136914|70886|P2|Overall Study|Death|1
13713|NCT02136914|70887|P1|Overall Study|Death|0
13714|NCT02136914|70886|P2|Overall Study|Lack of Efficacy|0
13715|NCT02136914|70887|P1|Overall Study|Lack of Efficacy|1
13716|NCT02136914|70886|P2|Overall Study|Did Not Receive Study Drug|0
13717|NCT02136914|70887|P1|Overall Study|Did Not Receive Study Drug|2
13718|NCT02136914|70886|P2|Overall Study|Lost to Follow-up|1
13719|NCT02136914|70887|P1|Overall Study|Lost to Follow-up|1
13720|NCT02136914|70886|P2|Overall Study|Subject Unwilling to Proceed|2
13721|NCT02136914|70887|P1|Overall Study|Subject Unwilling to Proceed|7
13722|NCT02136914|70886|P2|Overall Study|Withdrawal by Subject|10
13723|NCT02136914|70887|P1|Overall Study|Withdrawal by Subject|3
13724|NCT02136914|70886|P2|Overall Study|Sponsor's Decision to Stop the Study|7
13725|NCT02136914|70887|P1|Overall Study|Sponsor's Decision to Stop the Study|7
13726|NCT02136134|70962|P2|Overall Study|Subjects randomized but not treated|8
13727|NCT02136134|70963|P1|Overall Study|Subjects randomized but not treated|10
13728|NCT02136134|70962|P2|Overall Study|Ongoing|207
13729|NCT02136134|70963|P1|Overall Study|Ongoing|185
13730|NCT02136134|70962|P2|Overall Study|Other|3
13731|NCT02136134|70963|P1|Overall Study|Other|3
13732|NCT02136134|70962|P2|Overall Study|Withdrawal by Subject|4
13733|NCT02136134|70963|P1|Overall Study|Withdrawal by Subject|14
13734|NCT02136134|70962|P2|Overall Study|Death|29
13735|NCT02136134|70963|P1|Overall Study|Death|35
13736|NCT02135848|71001|P2|Overall Study|Withdrawal by Subject|1
13737|NCT02135848|71002|P1|Overall Study|Withdrawal by Subject|1
13738|NCT02135848|71001|P2|Overall Study|Adverse Event|0
13739|NCT02135848|71002|P1|Overall Study|Adverse Event|2
13740|NCT02135692|71060|P1|Overall Study|Withdrawal by Subject|15
13741|NCT02135692|71060|P1|Overall Study|Lost to Follow-up|4
13742|NCT02135692|71060|P1|Overall Study|Study closed/terminated|153
13743|NCT02135692|71060|P1|Overall Study|Product commercially available|159
13744|NCT02135692|71060|P1|Overall Study|Subject met Liver Stopping Criteria|1
13745|NCT02135692|71060|P1|Overall Study|Protocol Violation|2
13746|NCT02135692|71060|P1|Overall Study|Lack of Efficacy|2
13747|NCT02135692|71060|P1|Overall Study|Adverse Event|3
13748|NCT02135614|71079|P2|Overall Study|Lost to Follow-up|0
13749|NCT02135614|71080|P1|Overall Study|Lost to Follow-up|3
13750|NCT02135614|71079|P2|Overall Study|Withdrew Consent|2
13751|NCT02135614|71080|P1|Overall Study|Withdrew Consent|2
13752|NCT02135614|71079|P2|Overall Study|Investigator's Discretion|1
13753|NCT02135614|71080|P1|Overall Study|Investigator's Discretion|0
13754|NCT02135614|71079|P2|Overall Study|Death|0
13755|NCT02135614|71080|P1|Overall Study|Death|1
13756|NCT02135614|71079|P2|Overall Study|Adverse Event|1
13757|NCT02135614|71080|P1|Overall Study|Adverse Event|0
13758|NCT02135614|71079|P2|Overall Study|Randomized but Not Treated|1
13759|NCT02135614|71080|P1|Overall Study|Randomized but Not Treated|2
13760|NCT02135445|71094|P2|Overall Study|Withdrawal by Subject|0
13761|NCT02135445|71095|P1|Overall Study|Withdrawal by Subject|1
13762|NCT02135445|71094|P2|Overall Study|Lost to Follow-up|0
13763|NCT02135445|71095|P1|Overall Study|Lost to Follow-up|1
13764|NCT02135029|71162|P3|Overall Study|Death|0
13765|NCT02135029|71163|P2|Overall Study|Death|1
13766|NCT02135029|71164|P1|Overall Study|Death|0
13767|NCT02135029|71162|P3|Overall Study|Other|0
13768|NCT02135029|71163|P2|Overall Study|Other|1
13769|NCT02135029|71164|P1|Overall Study|Other|0
13770|NCT02135029|71162|P3|Overall Study|Withdrawal by Subject|1
13771|NCT02135029|71163|P2|Overall Study|Withdrawal by Subject|0
13772|NCT02135029|71164|P1|Overall Study|Withdrawal by Subject|2
13773|NCT02135029|71162|P3|Overall Study|Lost to Follow-up|0
13774|NCT02135029|71163|P2|Overall Study|Lost to Follow-up|1
13775|NCT02135029|71164|P1|Overall Study|Lost to Follow-up|0
13776|NCT02135029|71162|P3|Overall Study|Adverse Event|2
13777|NCT02135029|71163|P2|Overall Study|Adverse Event|2
13778|NCT02135029|71164|P1|Overall Study|Adverse Event|2
13779|NCT02134977|71269|P1|Overall Study|Protocol Deviation|102
13780|NCT02134925|71303|P2|Overall Study|Cancel|6
13781|NCT02134925|71304|P1|Overall Study|Cancel|1
13782|NCT02134925|71303|P2|Overall Study|Withdrawal by Subject|0
13783|NCT02134925|71304|P1|Overall Study|Withdrawal by Subject|1
13784|NCT02134587|71318|P1|Overall Study|Did not completed all meetings|30
13785|NCT02134015|71386|P2|Overall Study|Withdrawal by Subject|7
13786|NCT02134015|71387|P1|Overall Study|Withdrawal by Subject|3
13787|NCT02134015|71386|P2|Overall Study|Adverse Event|10
13788|NCT02134015|71387|P1|Overall Study|Adverse Event|9
13789|NCT02134015|71386|P2|Overall Study|Study terminated by sponsor|3
13790|NCT02134015|71387|P1|Overall Study|Study terminated by sponsor|2
13791|NCT02134015|71386|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
13792|NCT02134015|71387|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
13793|NCT02134015|71386|P2|Overall Study|Clinical progression|7
13794|NCT02134015|71387|P1|Overall Study|Clinical progression|14
13795|NCT02134015|71386|P2|Overall Study|Reason not provided|2
13796|NCT02134015|71387|P1|Overall Study|Reason not provided|1
13797|NCT02134015|71386|P2|Overall Study|Death|1
13798|NCT02134015|71387|P1|Overall Study|Death|2
13799|NCT02134015|71386|P2|Overall Study|Protocol Violation|1
13800|NCT02134015|71387|P1|Overall Study|Protocol Violation|0
13801|NCT02133664|71425|P2|Overall Study|Adverse Event|6
13802|NCT02133664|71426|P1|Overall Study|Adverse Event|3
13803|NCT02133664|71425|P2|Overall Study|Lost to Follow-up|1
13804|NCT02133664|71426|P1|Overall Study|Lost to Follow-up|2
13805|NCT02133508|71442|P1|Overall Study|Lost to Follow-up|2
13806|NCT02133508|71442|P1|Overall Study|Death|12
13807|NCT02133508|71442|P1|Overall Study|Decision of Investigator or Sponsor|1
13808|NCT02133352|71450|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
13809|NCT02133131|71481|P7|Overall Study|Protocol Violation|1
13810|NCT02133131|71482|P6|Overall Study|Protocol Violation|0
13811|NCT02133131|71483|P5|Overall Study|Protocol Violation|0
13812|NCT02133131|71484|P4|Overall Study|Protocol Violation|0
13813|NCT02133131|71485|P3|Overall Study|Protocol Violation|0
13814|NCT02133131|71486|P2|Overall Study|Protocol Violation|0
13815|NCT02133131|71487|P1|Overall Study|Protocol Violation|0
13816|NCT02133131|71481|P7|Overall Study|Ongoing in study|11
13817|NCT02133131|71482|P6|Overall Study|Ongoing in study|14
13818|NCT02133131|71483|P5|Overall Study|Ongoing in study|15
13819|NCT02133131|71484|P4|Overall Study|Ongoing in study|0
13820|NCT02133131|71485|P3|Overall Study|Ongoing in study|0
13821|NCT02133131|71486|P2|Overall Study|Ongoing in study|0
13822|NCT02133131|71487|P1|Overall Study|Ongoing in study|0
13823|NCT02133131|71481|P7|Overall Study|Status not recorded|0
13824|NCT02133131|71482|P6|Overall Study|Status not recorded|0
13825|NCT02133131|71483|P5|Overall Study|Status not recorded|0
13826|NCT02133131|71484|P4|Overall Study|Status not recorded|4
13827|NCT02133131|71485|P3|Overall Study|Status not recorded|1
13828|NCT02133131|71486|P2|Overall Study|Status not recorded|5
13829|NCT02133131|71487|P1|Overall Study|Status not recorded|4
13830|NCT02133131|71481|P7|Overall Study|Lost to Follow-up|0
13831|NCT02133131|71482|P6|Overall Study|Lost to Follow-up|0
13832|NCT02133131|71483|P5|Overall Study|Lost to Follow-up|0
13833|NCT02133131|71484|P4|Overall Study|Lost to Follow-up|1
13834|NCT02133131|71485|P3|Overall Study|Lost to Follow-up|0
13835|NCT02133131|71486|P2|Overall Study|Lost to Follow-up|0
13836|NCT02133131|71487|P1|Overall Study|Lost to Follow-up|1
13837|NCT02133131|71481|P7|Overall Study|Adverse Event|0
13838|NCT02133131|71482|P6|Overall Study|Adverse Event|0
13839|NCT02133131|71483|P5|Overall Study|Adverse Event|0
13840|NCT02133131|71484|P4|Overall Study|Adverse Event|1
13841|NCT02133131|71485|P3|Overall Study|Adverse Event|0
13842|NCT02133131|71486|P2|Overall Study|Adverse Event|0
13843|NCT02133131|71487|P1|Overall Study|Adverse Event|0
13844|NCT02132949|71541|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
13845|NCT02132949|71542|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
13846|NCT02132949|71541|P2|Adjuvant Treatment Period|Protocol Deviation|0
13847|NCT02132949|71542|P1|Adjuvant Treatment Period|Protocol Deviation|1
13848|NCT02132949|71541|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
13849|NCT02132949|71542|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
13850|NCT02132949|71541|P2|Adjuvant Treatment Period|Physician Decision|0
13851|NCT02132949|71542|P1|Adjuvant Treatment Period|Physician Decision|1
13852|NCT02132949|71541|P2|Adjuvant Treatment Period|Disease Relapse|1
13853|NCT02132949|71542|P1|Adjuvant Treatment Period|Disease Relapse|0
13854|NCT02132949|71541|P2|Adjuvant Treatment Period|Disease Progression|1
13855|NCT02132949|71542|P1|Adjuvant Treatment Period|Disease Progression|0
13856|NCT02132949|71541|P2|Adjuvant Treatment Period|Reason unspecified|1
13857|NCT02132949|71542|P1|Adjuvant Treatment Period|Reason unspecified|0
13858|NCT02132949|71541|P2|Adjuvant Treatment Period|Adverse Event|6
13859|NCT02132949|71542|P1|Adjuvant Treatment Period|Adverse Event|4
13860|NCT02132949|71541|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
13861|NCT02132949|71542|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
13862|NCT02132949|71541|P2|Neoadjuvant Treatment Period|Adverse Event|3
13863|NCT02132949|71542|P1|Neoadjuvant Treatment Period|Adverse Event|6
13864|NCT02132949|71541|P2|Neoadjuvant Treatment Period|Disease Progression|1
13865|NCT02132949|71542|P1|Neoadjuvant Treatment Period|Disease Progression|1
13866|NCT02132949|71541|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
13867|NCT02132949|71542|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
13868|NCT02132949|71541|P2|Neoadjuvant Treatment Period|Physician Decision|0
13869|NCT02132949|71542|P1|Neoadjuvant Treatment Period|Physician Decision|2
13870|NCT02132949|71541|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
13871|NCT02132949|71542|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
13872|NCT02132949|71541|P2|Neoadjuvant Treatment Period|Reason unspecified|1
13873|NCT02132949|71542|P1|Neoadjuvant Treatment Period|Reason unspecified|3
13874|NCT02132949|71541|P2|Neoadjuvant Treatment Period|Early surgery|3
13875|NCT02132949|71542|P1|Neoadjuvant Treatment Period|Early surgery|4
13876|NCT02132767|71635|P2|Overall Study|Lost to Follow-up|4
13877|NCT02132767|71636|P1|Overall Study|Lost to Follow-up|4
13878|NCT02132767|71635|P2|Overall Study|Withdrawal by Subject|9
13879|NCT02132767|71636|P1|Overall Study|Withdrawal by Subject|10
13880|NCT02132767|71635|P2|Overall Study|Death|2
13881|NCT02132767|71636|P1|Overall Study|Death|3
13882|NCT02132637|71658|P2|Study Period 2 (Crossover)|Physician Decision|0
13883|NCT02132637|71659|P1|Study Period 2 (Crossover)|Physician Decision|2
13884|NCT02132637|71658|P2|Study Period 2 (Crossover)|Adverse Event|1
13885|NCT02132637|71659|P1|Study Period 2 (Crossover)|Adverse Event|0
13886|NCT02132637|71658|P2|Study Period 1|Physician Decision|0
13887|NCT02132637|71659|P1|Study Period 1|Physician Decision|1
13888|NCT02132637|71658|P2|Study Period 1|Withdrawal by Subject|4
13889|NCT02132637|71659|P1|Study Period 1|Withdrawal by Subject|0
13890|NCT02132611|71683|P1|Overall Study|Death|2
13891|NCT02132247|71701|P2|Overall Study|Protocol Violation|0
13892|NCT02132247|71702|P1|Overall Study|Protocol Violation|1
13893|NCT02132117|71731|P2|Overall Study|Other Miscellaneous Reasons|0
13894|NCT02132117|71732|P1|Overall Study|Other Miscellaneous Reasons|2
13895|NCT02132117|71731|P2|Overall Study|Personal Reasons|2
13896|NCT02132117|71732|P1|Overall Study|Personal Reasons|1
13897|NCT02132117|71731|P2|Overall Study|Lost to Follow-up|2
13898|NCT02132117|71732|P1|Overall Study|Lost to Follow-up|2
13899|NCT02132117|71731|P2|Overall Study|Adverse Event|1
13900|NCT02132117|71732|P1|Overall Study|Adverse Event|6
13901|NCT02131662|71753|P5|Overall Study|Not treated|3
13902|NCT02131662|71754|P4|Overall Study|Not treated|2
13903|NCT02131662|71755|P3|Overall Study|Not treated|2
13904|NCT02131662|71756|P2|Overall Study|Not treated|0
13905|NCT02131662|71757|P1|Overall Study|Not treated|2
13906|NCT02131662|71753|P5|Overall Study|Lost to Follow-up|0
13907|NCT02131662|71754|P4|Overall Study|Lost to Follow-up|9
13908|NCT02131662|71755|P3|Overall Study|Lost to Follow-up|0
13909|NCT02131662|71756|P2|Overall Study|Lost to Follow-up|3
13910|NCT02131662|71757|P1|Overall Study|Lost to Follow-up|1
13911|NCT02131662|71753|P5|Overall Study|Withdrawal by Subject|6
13912|NCT02131662|71754|P4|Overall Study|Withdrawal by Subject|5
13913|NCT02131662|71755|P3|Overall Study|Withdrawal by Subject|1
13914|NCT02131662|71756|P2|Overall Study|Withdrawal by Subject|5
13915|NCT02131662|71757|P1|Overall Study|Withdrawal by Subject|1
13916|NCT02131662|71753|P5|Overall Study|Lack of Efficacy|1
13917|NCT02131662|71754|P4|Overall Study|Lack of Efficacy|0
13918|NCT02131662|71755|P3|Overall Study|Lack of Efficacy|0
13919|NCT02131662|71756|P2|Overall Study|Lack of Efficacy|0
13920|NCT02131662|71757|P1|Overall Study|Lack of Efficacy|1
13921|NCT02131662|71753|P5|Overall Study|Wish for pregnancy|1
13922|NCT02131662|71754|P4|Overall Study|Wish for pregnancy|0
13923|NCT02131662|71755|P3|Overall Study|Wish for pregnancy|0
13924|NCT02131662|71756|P2|Overall Study|Wish for pregnancy|0
13925|NCT02131662|71757|P1|Overall Study|Wish for pregnancy|0
13926|NCT02131662|71753|P5|Overall Study|Pregnancy|0
13927|NCT02131662|71754|P4|Overall Study|Pregnancy|1
13928|NCT02131662|71755|P3|Overall Study|Pregnancy|0
13929|NCT02131662|71756|P2|Overall Study|Pregnancy|1
13930|NCT02131662|71757|P1|Overall Study|Pregnancy|0
13931|NCT02131662|71753|P5|Overall Study|Adverse Event|3
13932|NCT02131662|71754|P4|Overall Study|Adverse Event|1
13933|NCT02131662|71755|P3|Overall Study|Adverse Event|1
13934|NCT02131662|71756|P2|Overall Study|Adverse Event|1
13935|NCT02131662|71757|P1|Overall Study|Adverse Event|0
13936|NCT02131662|71753|P5|Overall Study|Other|4
13937|NCT02131662|71754|P4|Overall Study|Other|3
13938|NCT02131662|71755|P3|Overall Study|Other|3
13939|NCT02131662|71756|P2|Overall Study|Other|4
13940|NCT02131662|71757|P1|Overall Study|Other|2
13941|NCT02131662|71753|P5|Overall Study|Protocol Violation|0
13942|NCT02131662|71754|P4|Overall Study|Protocol Violation|0
13943|NCT02131662|71755|P3|Overall Study|Protocol Violation|0
13944|NCT02131662|71756|P2|Overall Study|Protocol Violation|0
13945|NCT02131662|71757|P1|Overall Study|Protocol Violation|1
13946|NCT02131636|71803|P2|Overall Study|Adverse Event|1
13947|NCT02131636|71804|P1|Overall Study|Adverse Event|4
13948|NCT02131636|71803|P2|Overall Study|Lost to Follow-up|0
13949|NCT02131636|71804|P1|Overall Study|Lost to Follow-up|4
13950|NCT02131636|71803|P2|Overall Study|Personal Reasons|4
13951|NCT02131636|71804|P1|Overall Study|Personal Reasons|4
13952|NCT02131532|71820|P1|Overall Study|Other health conditions|2
13953|NCT02131532|71820|P1|Overall Study|Physician Decision|1
13954|NCT02131532|71820|P1|Overall Study|Withdrawal by Subject|1
13955|NCT02131324|71912|P2|Overall Study|Lost to Follow-up|1
13956|NCT02131324|71913|P1|Overall Study|Lost to Follow-up|1
13957|NCT02131324|71912|P2|Overall Study|Withdrawal by Subject|2
13958|NCT02131324|71913|P1|Overall Study|Withdrawal by Subject|1
13959|NCT02131311|71919|P1|Overall Study|Lost to Follow-up|1
13960|NCT02131311|71919|P1|Overall Study|Protocol Violation|1
13961|NCT02131311|71919|P1|Overall Study|Adverse Event|2
13962|NCT02131272|71931|P2|Overall Study|Withdrawal Criteria|0
13963|NCT02131272|71932|P1|Overall Study|Withdrawal Criteria|1
13964|NCT02131272|71931|P2|Overall Study|Withdrawal by Subject|1
13965|NCT02131272|71932|P1|Overall Study|Withdrawal by Subject|0
13966|NCT02131272|71931|P2|Overall Study|Withdrawal by parent|1
13967|NCT02131272|71932|P1|Overall Study|Withdrawal by parent|0
13968|NCT02131233|71952|P2|Overall Study|Withdrawal by Subject|11
13969|NCT02131233|71953|P1|Overall Study|Withdrawal by Subject|18
13970|NCT02131233|71952|P2|Overall Study|Pregnancy|0
13971|NCT02131233|71953|P1|Overall Study|Pregnancy|4
13972|NCT02131233|71952|P2|Overall Study|Physician Decision|0
13973|NCT02131233|71953|P1|Overall Study|Physician Decision|7
13974|NCT02131233|71952|P2|Overall Study|Non-Compliance With Study Drug|5
13975|NCT02131233|71953|P1|Overall Study|Non-Compliance With Study Drug|8
13976|NCT02131233|71952|P2|Overall Study|Lost to Follow-up|13
13977|NCT02131233|71953|P1|Overall Study|Lost to Follow-up|14
13978|NCT02131233|71952|P2|Overall Study|Lack of Efficacy|3
13979|NCT02131233|71953|P1|Overall Study|Lack of Efficacy|6
13980|NCT02131233|71952|P2|Overall Study|Death|1
13981|NCT02131233|71953|P1|Overall Study|Death|0
13982|NCT02131233|71952|P2|Overall Study|Adverse Event|6
13983|NCT02131233|71953|P1|Overall Study|Adverse Event|7
13984|NCT02131233|71952|P2|Overall Study|Not Treated|3
13985|NCT02131233|71953|P1|Overall Study|Not Treated|2
13986|NCT02131064|71987|P2|Overall Study|Other|0
13987|NCT02131064|71988|P1|Overall Study|Other|1
13988|NCT02131064|71987|P2|Overall Study|Ongoing|207
13989|NCT02131064|71988|P1|Overall Study|Ongoing|214
13990|NCT02131064|71987|P2|Overall Study|Withdrawal by Subject|14
13991|NCT02131064|71988|P1|Overall Study|Withdrawal by Subject|6
13992|NCT02131064|71987|P2|Overall Study|Lost to Follow-up|1
13993|NCT02131064|71988|P1|Overall Study|Lost to Follow-up|0
13994|NCT02131064|71987|P2|Overall Study|Death|1
13995|NCT02131064|71988|P1|Overall Study|Death|0
13996|NCT02130284|72251|P1|Overall Study|Screen Failure|1
13997|NCT02130284|72251|P1|Overall Study|Subject was screened as backup for study|3
13998|NCT02130284|72251|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
13999|NCT02130284|72251|P1|Overall Study|Subject Withdrew Consent|1
14000|NCT02130284|72251|P1|Overall Study|Withdrawal by Subject|3
14001|NCT02130193|72277|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
14002|NCT02130193|72278|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
14003|NCT02130193|72279|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
14004|NCT02130193|72277|P3|Part B: 52-week Double-blind Period|Physician Decision|1
14005|NCT02130193|72278|P2|Part B: 52-week Double-blind Period|Physician Decision|0
14006|NCT02130193|72279|P1|Part B: 52-week Double-blind Period|Physician Decision|0
14007|NCT02130193|72277|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
14008|NCT02130193|72278|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
14009|NCT02130193|72279|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
14010|NCT02130193|72277|P3|Part B: 52-week Double-blind Period|Adverse Event|3
14011|NCT02130193|72278|P2|Part B: 52-week Double-blind Period|Adverse Event|5
14012|NCT02130193|72279|P1|Part B: 52-week Double-blind Period|Adverse Event|0
14013|NCT02129777|72363|P7|Open-Label Period|Study Termination|39
14014|NCT02129777|72364|P6|Open-Label Period|Study Termination|10
14015|NCT02129777|72365|P5|Open-Label Period|Study Termination|0
14016|NCT02129777|72366|P4|Open-Label Period|Study Termination|0
14017|NCT02129777|72367|P3|Open-Label Period|Study Termination|0
14018|NCT02129777|72368|P2|Open-Label Period|Study Termination|0
14019|NCT02129777|72369|P1|Open-Label Period|Study Termination|0
14020|NCT02129777|72363|P7|Open-Label Period|Withdrawal by Subject|3
14021|NCT02129777|72364|P6|Open-Label Period|Withdrawal by Subject|1
14022|NCT02129777|72365|P5|Open-Label Period|Withdrawal by Subject|0
14023|NCT02129777|72366|P4|Open-Label Period|Withdrawal by Subject|0
14024|NCT02129777|72367|P3|Open-Label Period|Withdrawal by Subject|0
14025|NCT02129777|72368|P2|Open-Label Period|Withdrawal by Subject|0
14026|NCT02129777|72369|P1|Open-Label Period|Withdrawal by Subject|0
14027|NCT02129777|72363|P7|Open-Label Period|Lost to Follow-up|1
14028|NCT02129777|72364|P6|Open-Label Period|Lost to Follow-up|1
14029|NCT02129777|72365|P5|Open-Label Period|Lost to Follow-up|0
14030|NCT02129777|72366|P4|Open-Label Period|Lost to Follow-up|0
14031|NCT02129777|72367|P3|Open-Label Period|Lost to Follow-up|0
14032|NCT02129777|72368|P2|Open-Label Period|Lost to Follow-up|0
14033|NCT02129777|72369|P1|Open-Label Period|Lost to Follow-up|0
14034|NCT02129777|72363|P7|Open-Label Period|Lack of Efficacy|5
14035|NCT02129777|72364|P6|Open-Label Period|Lack of Efficacy|0
14036|NCT02129777|72365|P5|Open-Label Period|Lack of Efficacy|0
14037|NCT02129777|72366|P4|Open-Label Period|Lack of Efficacy|0
14038|NCT02129777|72367|P3|Open-Label Period|Lack of Efficacy|0
14039|NCT02129777|72368|P2|Open-Label Period|Lack of Efficacy|0
14040|NCT02129777|72369|P1|Open-Label Period|Lack of Efficacy|0
14041|NCT02129777|72363|P7|Double-Blind Period|Other|0
14042|NCT02129777|72364|P6|Double-Blind Period|Other|0
14043|NCT02129777|72365|P5|Double-Blind Period|Other|0
14044|NCT02129777|72366|P4|Double-Blind Period|Other|0
14045|NCT02129777|72367|P3|Double-Blind Period|Other|0
14046|NCT02129777|72368|P2|Double-Blind Period|Other|2
14047|NCT02129777|72369|P1|Double-Blind Period|Other|1
14048|NCT02129777|72363|P7|Double-Blind Period|Lack of Efficacy|0
14049|NCT02129777|72364|P6|Double-Blind Period|Lack of Efficacy|0
14050|NCT02129777|72365|P5|Double-Blind Period|Lack of Efficacy|2
14051|NCT02129777|72366|P4|Double-Blind Period|Lack of Efficacy|3
14052|NCT02129777|72367|P3|Double-Blind Period|Lack of Efficacy|0
14053|NCT02129777|72368|P2|Double-Blind Period|Lack of Efficacy|1
14054|NCT02129777|72369|P1|Double-Blind Period|Lack of Efficacy|3
14055|NCT02129777|72363|P7|Double-Blind Period|Pregnancy|0
14056|NCT02129777|72364|P6|Double-Blind Period|Pregnancy|0
14057|NCT02129777|72365|P5|Double-Blind Period|Pregnancy|1
14058|NCT02129777|72366|P4|Double-Blind Period|Pregnancy|0
14059|NCT02129777|72367|P3|Double-Blind Period|Pregnancy|0
14060|NCT02129777|72368|P2|Double-Blind Period|Pregnancy|0
14061|NCT02129777|72369|P1|Double-Blind Period|Pregnancy|0
14062|NCT02129777|72363|P7|Double-Blind Period|Withdrawal by Subject|0
14063|NCT02129777|72364|P6|Double-Blind Period|Withdrawal by Subject|0
14064|NCT02129777|72365|P5|Double-Blind Period|Withdrawal by Subject|3
14065|NCT02129777|72366|P4|Double-Blind Period|Withdrawal by Subject|2
14066|NCT02129777|72367|P3|Double-Blind Period|Withdrawal by Subject|3
14067|NCT02129777|72368|P2|Double-Blind Period|Withdrawal by Subject|4
14068|NCT02129777|72369|P1|Double-Blind Period|Withdrawal by Subject|2
14069|NCT02129777|72363|P7|Double-Blind Period|Lost to Follow-up|0
14070|NCT02129777|72364|P6|Double-Blind Period|Lost to Follow-up|0
14071|NCT02129777|72365|P5|Double-Blind Period|Lost to Follow-up|0
14072|NCT02129777|72366|P4|Double-Blind Period|Lost to Follow-up|2
14073|NCT02129777|72367|P3|Double-Blind Period|Lost to Follow-up|1
14074|NCT02129777|72368|P2|Double-Blind Period|Lost to Follow-up|1
14075|NCT02129777|72369|P1|Double-Blind Period|Lost to Follow-up|1
14076|NCT02129777|72363|P7|Double-Blind Period|Adverse Event|0
14077|NCT02129777|72364|P6|Double-Blind Period|Adverse Event|0
14078|NCT02129777|72365|P5|Double-Blind Period|Adverse Event|1
14079|NCT02129777|72366|P4|Double-Blind Period|Adverse Event|0
14080|NCT02129777|72367|P3|Double-Blind Period|Adverse Event|0
14081|NCT02129777|72368|P2|Double-Blind Period|Adverse Event|0
14082|NCT02129777|72369|P1|Double-Blind Period|Adverse Event|0
14083|NCT02129608|72485|P3|Overall Study|Withdrawal by Subject|2
14084|NCT02129608|72486|P2|Overall Study|Withdrawal by Subject|0
14085|NCT02129608|72487|P1|Overall Study|Withdrawal by Subject|0
14086|NCT02129608|72485|P3|Overall Study|Lost to Follow-up|1
14087|NCT02129608|72486|P2|Overall Study|Lost to Follow-up|1
14088|NCT02129608|72487|P1|Overall Study|Lost to Follow-up|0
14089|NCT02129192|72500|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
14090|NCT02129192|72501|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
14091|NCT02129062|72518|P1|Overall Study|Disease Progression|2
14092|NCT02129062|72518|P1|Overall Study|Death|1
14093|NCT02128997|72525|P2|Overall Study|Lost to Follow-up|11
14094|NCT02128997|72526|P1|Overall Study|Lost to Follow-up|6
14095|NCT02128932|72541|P3|Overall Study|No reason for withdrawal|7
14096|NCT02128932|72542|P2|Overall Study|No reason for withdrawal|11
14097|NCT02128932|72543|P1|Overall Study|No reason for withdrawal|12
14098|NCT02128932|72541|P3|Overall Study|Lost to Follow-up|1
14099|NCT02128932|72542|P2|Overall Study|Lost to Follow-up|1
14100|NCT02128932|72543|P1|Overall Study|Lost to Follow-up|2
14101|NCT02128932|72541|P3|Overall Study|Death|2
14102|NCT02128932|72542|P2|Overall Study|Death|0
14103|NCT02128932|72543|P1|Overall Study|Death|2
14104|NCT02128932|72541|P3|Overall Study|Withdrawal by Subject|8
14105|NCT02128932|72542|P2|Overall Study|Withdrawal by Subject|7
14106|NCT02128932|72543|P1|Overall Study|Withdrawal by Subject|11
14107|NCT02128542|72600|P2|Overall Study|Withdrew Consent|0
14108|NCT02128542|72601|P1|Overall Study|Withdrew Consent|1
14109|NCT02128542|72600|P2|Overall Study|Lost to Follow-up|0
14110|NCT02128542|72601|P1|Overall Study|Lost to Follow-up|3
14111|NCT02128490|72619|P5|Overall Study|Other Miscellaneous Reasons|1
14112|NCT02128490|72620|P4|Overall Study|Other Miscellaneous Reasons|1
14113|NCT02128490|72621|P3|Overall Study|Other Miscellaneous Reasons|2
14114|NCT02128490|72622|P2|Overall Study|Other Miscellaneous Reasons|0
14115|NCT02128490|72623|P1|Overall Study|Other Miscellaneous Reasons|0
14116|NCT02128490|72619|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
14117|NCT02128490|72620|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
14118|NCT02128490|72621|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
14119|NCT02128490|72622|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
14120|NCT02128490|72623|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
14121|NCT02128490|72619|P5|Overall Study|Lack of Efficacy|0
14122|NCT02128490|72620|P4|Overall Study|Lack of Efficacy|0
14123|NCT02128490|72621|P3|Overall Study|Lack of Efficacy|0
14124|NCT02128490|72622|P2|Overall Study|Lack of Efficacy|1
14125|NCT02128490|72623|P1|Overall Study|Lack of Efficacy|0
14126|NCT02128490|72619|P5|Overall Study|Voluntary Withdrawal|2
14127|NCT02128490|72620|P4|Overall Study|Voluntary Withdrawal|1
14128|NCT02128490|72621|P3|Overall Study|Voluntary Withdrawal|1
14129|NCT02128490|72622|P2|Overall Study|Voluntary Withdrawal|3
14130|NCT02128490|72623|P1|Overall Study|Voluntary Withdrawal|3
14131|NCT02128490|72619|P5|Overall Study|Lost to Follow-up|1
14132|NCT02128490|72620|P4|Overall Study|Lost to Follow-up|1
14133|NCT02128490|72621|P3|Overall Study|Lost to Follow-up|1
14134|NCT02128490|72622|P2|Overall Study|Lost to Follow-up|0
14135|NCT02128490|72623|P1|Overall Study|Lost to Follow-up|0
14136|NCT02128490|72619|P5|Overall Study|Major Protocol Deviation|2
14137|NCT02128490|72620|P4|Overall Study|Major Protocol Deviation|2
14138|NCT02128490|72621|P3|Overall Study|Major Protocol Deviation|0
14139|NCT02128490|72622|P2|Overall Study|Major Protocol Deviation|2
14140|NCT02128490|72623|P1|Overall Study|Major Protocol Deviation|1
14141|NCT02128490|72619|P5|Overall Study|Pretreatment Event/Adverse Event|0
14142|NCT02128490|72620|P4|Overall Study|Pretreatment Event/Adverse Event|1
14143|NCT02128490|72621|P3|Overall Study|Pretreatment Event/Adverse Event|1
14144|NCT02128490|72622|P2|Overall Study|Pretreatment Event/Adverse Event|0
14145|NCT02128490|72623|P1|Overall Study|Pretreatment Event/Adverse Event|1
14146|NCT02128269|72645|P1|Treatment Period|Physician Decision|1
14147|NCT02128269|72645|P1|Treatment Period|Adverse Event|1
14148|NCT02128217|72651|P2|Overall Study|Lost to Follow-up|1
14149|NCT02128217|72652|P1|Overall Study|Lost to Follow-up|0
14150|NCT02127372|72788|P2|Overall Study|Withdrawal by Subject|0
14151|NCT02127372|72789|P1|Overall Study|Withdrawal by Subject|1
14152|NCT02127307|72799|P1|Overall Study|Other than specified above|169
14153|NCT02127307|72799|P1|Overall Study|Death|101
14154|NCT02127307|72799|P1|Overall Study|Lost to Follow-up|2
14155|NCT02127307|72799|P1|Overall Study|Protocol Violation|36
14156|NCT02127281|72805|P2|Overall Study|Lost to Follow-up|0
14157|NCT02127281|72806|P1|Overall Study|Lost to Follow-up|1
14158|NCT02126839|72834|P2|Overall Study|Not specified|5
14159|NCT02126839|72835|P1|Overall Study|Not specified|5
14160|NCT02126839|72834|P2|Overall Study|Lost to Follow-up|4
14161|NCT02126839|72835|P1|Overall Study|Lost to Follow-up|1
14162|NCT02126839|72834|P2|Overall Study|Sponsor request|1
14163|NCT02126839|72835|P1|Overall Study|Sponsor request|0
14164|NCT02126839|72834|P2|Overall Study|Protocol Violation|3
14165|NCT02126839|72835|P1|Overall Study|Protocol Violation|2
14166|NCT02126839|72834|P2|Overall Study|Withdrawal by parent/guardian|0
14167|NCT02126839|72835|P1|Overall Study|Withdrawal by parent/guardian|1
14168|NCT02126839|72834|P2|Overall Study|Withdrawal by Subject|0
14169|NCT02126839|72835|P1|Overall Study|Withdrawal by Subject|1
14170|NCT02126839|72834|P2|Overall Study|Adverse Event|1
14171|NCT02126839|72835|P1|Overall Study|Adverse Event|0
14172|NCT02126670|72862|P4|Overall Study|Withdrawal by Subject|1
14173|NCT02126670|72863|P3|Overall Study|Withdrawal by Subject|0
14174|NCT02126670|72864|P2|Overall Study|Withdrawal by Subject|0
14175|NCT02126670|72865|P1|Overall Study|Withdrawal by Subject|1
14176|NCT02125877|72917|P2|Overall Study|Adverse Event|4
14177|NCT02125877|72918|P1|Overall Study|Adverse Event|6
14178|NCT02125877|72917|P2|Overall Study|Protocol deviation|1
14179|NCT02125877|72918|P1|Overall Study|Protocol deviation|4
14180|NCT02125877|72917|P2|Overall Study|Withdrawal by Subject|1
14181|NCT02125877|72918|P1|Overall Study|Withdrawal by Subject|2
14182|NCT02125877|72917|P2|Overall Study|Participant/guardian decision|2
14183|NCT02125877|72918|P1|Overall Study|Participant/guardian decision|0
14184|NCT02125877|72917|P2|Overall Study|Administrative problems|1
14185|NCT02125877|72918|P1|Overall Study|Administrative problems|0
14186|NCT02125877|72917|P2|Overall Study|Death|1
14187|NCT02125877|72918|P1|Overall Study|Death|0
14188|NCT02125877|72917|P2|Overall Study|Physician Decision|0
14189|NCT02125877|72918|P1|Overall Study|Physician Decision|1
14190|NCT02125838|72948|P2|Overall Study|Lost to Follow-up|4
14191|NCT02125838|72949|P1|Overall Study|Lost to Follow-up|4
14192|NCT02125734|72967|P2|Period 2|Adverse Event|1
14193|NCT02125734|72968|P1|Period 2|Adverse Event|0
14194|NCT02125604|72978|P1|Overall Study|Adverse Event|20
14195|NCT02125604|72978|P1|Overall Study|Consent Withdrawn|4
14196|NCT02125604|72978|P1|Overall Study|Lost to Follow-up|2
14197|NCT02125604|72978|P1|Overall Study|Investigator Decision|1
14198|NCT02125604|72978|P1|Overall Study|Not Specified|4
14199|NCT02124798|73024|P1|Overall Study|Lost to Follow-up|1
14200|NCT02124798|73024|P1|Overall Study|Adverse Event|3
14201|NCT02124161|73082|P2|Overall Study|Lost to Follow-up|4
14202|NCT02124161|73083|P1|Overall Study|Lost to Follow-up|3
14203|NCT02124161|73082|P2|Overall Study|No longer meets eligibility criteria|4
14204|NCT02124161|73083|P1|Overall Study|No longer meets eligibility criteria|5
14205|NCT02124161|73082|P2|Overall Study|Does not meet entrance criteria|3
14206|NCT02124161|73083|P1|Overall Study|Does not meet entrance criteria|2
14207|NCT02124161|73082|P2|Overall Study|Adverse Event|0
14208|NCT02124161|73083|P1|Overall Study|Adverse Event|2
14209|NCT02124161|73082|P2|Overall Study|Withdrawal by Subject|2
14210|NCT02124161|73083|P1|Overall Study|Withdrawal by Subject|1
14211|NCT02124161|73082|P2|Overall Study|Protocol Violation|1
14212|NCT02124161|73083|P1|Overall Study|Protocol Violation|2
14213|NCT02124161|73082|P2|Overall Study|Death|0
14214|NCT02124161|73083|P1|Overall Study|Death|1
14215|NCT02124161|73082|P2|Overall Study|Other unspecified|1
14216|NCT02124161|73083|P1|Overall Study|Other unspecified|0
14217|NCT02123472|73150|P2|Period 2 (7 Days)|Withdrawal by Subject|1
14218|NCT02123472|73151|P1|Period 2 (7 Days)|Withdrawal by Subject|0
14219|NCT02123459|73161|P2|Washout Period (1 Day)|Adverse Event|0
14220|NCT02123459|73162|P1|Washout Period (1 Day)|Adverse Event|1
14221|NCT02123446|73172|P2|Washout Period (1 Day)|Physician Decision|0
14222|NCT02123446|73173|P1|Washout Period (1 Day)|Physician Decision|1
14223|NCT02122146|73271|P8|Part 1: Dose Escalation|Other|2
14224|NCT02122146|73272|P7|Part 1: Dose Escalation|Other|1
14225|NCT02122146|73273|P6|Part 1: Dose Escalation|Other|1
14226|NCT02122146|73274|P5|Part 1: Dose Escalation|Other|0
14227|NCT02122146|73275|P4|Part 1: Dose Escalation|Other|0
14228|NCT02122146|73276|P3|Part 1: Dose Escalation|Other|0
14229|NCT02122146|73277|P2|Part 1: Dose Escalation|Other|0
14230|NCT02122146|73278|P1|Part 1: Dose Escalation|Other|1
14231|NCT02122146|73271|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
14232|NCT02122146|73272|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
14233|NCT02122146|73273|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
14234|NCT02122146|73274|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
14235|NCT02122146|73275|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
14236|NCT02122146|73276|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
14237|NCT02122146|73277|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
14238|NCT02122146|73278|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
14239|NCT02122146|73271|P8|Part 1: Dose Escalation|Lost to Follow-up|0
14240|NCT02122146|73272|P7|Part 1: Dose Escalation|Lost to Follow-up|0
14241|NCT02122146|73273|P6|Part 1: Dose Escalation|Lost to Follow-up|0
14242|NCT02122146|73274|P5|Part 1: Dose Escalation|Lost to Follow-up|1
14243|NCT02122146|73275|P4|Part 1: Dose Escalation|Lost to Follow-up|0
14244|NCT02122146|73276|P3|Part 1: Dose Escalation|Lost to Follow-up|1
14245|NCT02122146|73277|P2|Part 1: Dose Escalation|Lost to Follow-up|0
14246|NCT02122146|73278|P1|Part 1: Dose Escalation|Lost to Follow-up|0
14247|NCT02122146|73271|P8|Part 1: Dose Escalation|Death|0
14248|NCT02122146|73272|P7|Part 1: Dose Escalation|Death|0
14249|NCT02122146|73273|P6|Part 1: Dose Escalation|Death|0
14250|NCT02122146|73274|P5|Part 1: Dose Escalation|Death|0
14251|NCT02122146|73275|P4|Part 1: Dose Escalation|Death|0
14252|NCT02122146|73276|P3|Part 1: Dose Escalation|Death|1
14253|NCT02122146|73277|P2|Part 1: Dose Escalation|Death|1
14254|NCT02122146|73278|P1|Part 1: Dose Escalation|Death|0
14255|NCT02121847|73539|P1|Overall Study|Adverse Event|2
14256|NCT02121847|73539|P1|Overall Study|Administrative Reasons|1
14257|NCT02121808|73558|P1|Overall Study|Technical problem|3
14258|NCT02121795|73569|P2|Overall Study|Still in Study up to the Data Cut Date|316
14259|NCT02121795|73570|P1|Overall Study|Still in Study up to the Data Cut Date|315
14260|NCT02121795|73569|P2|Overall Study|Lost to Follow-up|1
14261|NCT02121795|73570|P1|Overall Study|Lost to Follow-up|2
14262|NCT02121795|73569|P2|Overall Study|Withdrew Consent|10
14263|NCT02121795|73570|P1|Overall Study|Withdrew Consent|10
14264|NCT02121795|73569|P2|Overall Study|Protocol Violation|2
14265|NCT02121795|73570|P1|Overall Study|Protocol Violation|0
14266|NCT02121795|73569|P2|Overall Study|Non-Compliance with Study Drug|1
14267|NCT02121795|73570|P1|Overall Study|Non-Compliance with Study Drug|1
14268|NCT02121795|73569|P2|Overall Study|Investigator's Discretion|0
14269|NCT02121795|73570|P1|Overall Study|Investigator's Discretion|1
14270|NCT02121795|73569|P2|Overall Study|Adverse Event|0
14271|NCT02121795|73570|P1|Overall Study|Adverse Event|4
14272|NCT02121795|73569|P2|Overall Study|Randomized but Never Treated|4
14273|NCT02121795|73570|P1|Overall Study|Randomized but Never Treated|1
14274|NCT02121535|73586|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
14275|NCT02121535|73587|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
14276|NCT02121535|73586|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
14277|NCT02121535|73587|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
14278|NCT02121522|73610|P1|Overall Study|Adverse Event|1
14279|NCT02121509|73617|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
14280|NCT02121509|73618|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
14281|NCT02121509|73619|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
14282|NCT02121509|73620|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
14283|NCT02121509|73617|P4|Washout Period (35 Days)|Withdrawal by Subject|0
14284|NCT02121509|73618|P3|Washout Period (35 Days)|Withdrawal by Subject|0
14285|NCT02121509|73619|P2|Washout Period (35 Days)|Withdrawal by Subject|3
14286|NCT02121509|73620|P1|Washout Period (35 Days)|Withdrawal by Subject|0
14287|NCT02121509|73617|P4|Washout Period (35 Days)|Adverse Event|0
14288|NCT02121509|73618|P3|Washout Period (35 Days)|Adverse Event|0
14289|NCT02121509|73619|P2|Washout Period (35 Days)|Adverse Event|1
14290|NCT02121509|73620|P1|Washout Period (35 Days)|Adverse Event|1
14291|NCT02121210|73691|P2|Overall Study|Other than specified above|2
14292|NCT02121210|73692|P1|Overall Study|Other than specified above|0
14293|NCT02121210|73691|P2|Overall Study|Lack of Efficacy|0
14294|NCT02121210|73692|P1|Overall Study|Lack of Efficacy|2
14295|NCT02121210|73691|P2|Overall Study|Adverse Event|7
14296|NCT02121210|73692|P1|Overall Study|Adverse Event|5
14297|NCT02120833|73717|P2|Overall Study|Lost to Follow-up|1
14298|NCT02120833|73718|P1|Overall Study|Lost to Follow-up|1
14299|NCT02120833|73717|P2|Overall Study|Withdrawal by Subject|0
14300|NCT02120833|73718|P1|Overall Study|Withdrawal by Subject|2
14301|NCT02120833|73717|P2|Overall Study|Adverse Event|0
14302|NCT02120833|73718|P1|Overall Study|Adverse Event|1
14303|NCT02120664|73877|P5|Overall Study|Withdrawal by Subject|0
14304|NCT02120664|73878|P4|Overall Study|Withdrawal by Subject|1
14305|NCT02120664|73879|P3|Overall Study|Withdrawal by Subject|0
14306|NCT02120664|73880|P2|Overall Study|Withdrawal by Subject|0
14307|NCT02120664|73881|P1|Overall Study|Withdrawal by Subject|0
14308|NCT02120625|73899|P1|Overall Study|Physician Decision|2
14309|NCT02120417|73914|P2|Overall Study|Other unspecified|4
14310|NCT02120417|73915|P1|Overall Study|Other unspecified|5
14311|NCT02120417|73914|P2|Overall Study|Physician Decision|3
14312|NCT02120417|73915|P1|Overall Study|Physician Decision|2
14313|NCT02120417|73914|P2|Overall Study|Noncompliance with study treatment|2
14314|NCT02120417|73915|P1|Overall Study|Noncompliance with study treatment|0
14315|NCT02120417|73914|P2|Overall Study|Disease progression|45
14316|NCT02120417|73915|P1|Overall Study|Disease progression|41
14317|NCT02120417|73914|P2|Overall Study|Participant decision|4
14318|NCT02120417|73915|P1|Overall Study|Participant decision|4
14319|NCT02120417|73914|P2|Overall Study|Adverse Event|9
14320|NCT02120417|73915|P1|Overall Study|Adverse Event|3
14321|NCT02120417|73914|P2|Overall Study|Death|1
14322|NCT02120417|73915|P1|Overall Study|Death|5
14323|NCT02120300|73937|P4|Overall Study|Lost to Follow-up|0
14324|NCT02120300|73938|P3|Overall Study|Lost to Follow-up|0
14325|NCT02120300|73939|P2|Overall Study|Lost to Follow-up|0
14326|NCT02120300|73940|P1|Overall Study|Lost to Follow-up|1
14327|NCT02120300|73937|P4|Overall Study|Lack of Efficacy|1
14328|NCT02120300|73938|P3|Overall Study|Lack of Efficacy|0
14329|NCT02120300|73939|P2|Overall Study|Lack of Efficacy|0
14330|NCT02120300|73940|P1|Overall Study|Lack of Efficacy|0
14331|NCT02120300|73937|P4|Overall Study|Enrolled but Never Treated|0
14332|NCT02120300|73938|P3|Overall Study|Enrolled but Never Treated|0
14333|NCT02120300|73939|P2|Overall Study|Enrolled but Never Treated|0
14334|NCT02120300|73940|P1|Overall Study|Enrolled but Never Treated|2
14335|NCT02120027|73978|P2|Overall Study|Withdrawal by Subject|25
14336|NCT02120027|73979|P1|Overall Study|Withdrawal by Subject|33
14337|NCT02120027|73978|P2|Overall Study|Study terminated by Sponsor|47
14338|NCT02120027|73979|P1|Overall Study|Study terminated by Sponsor|45
14339|NCT02120027|73978|P2|Overall Study|Protocol Violation|21
14340|NCT02120027|73979|P1|Overall Study|Protocol Violation|18
14341|NCT02120027|73978|P2|Overall Study|Physician Decision|3
14342|NCT02120027|73979|P1|Overall Study|Physician Decision|4
14343|NCT02120027|73978|P2|Overall Study|Other|0
14344|NCT02120027|73979|P1|Overall Study|Other|4
14345|NCT02120027|73978|P2|Overall Study|Lost to Follow-up|13
14346|NCT02120027|73979|P1|Overall Study|Lost to Follow-up|5
14347|NCT02120027|73978|P2|Overall Study|Lack of Efficacy|5
14348|NCT02120027|73979|P1|Overall Study|Lack of Efficacy|3
14349|NCT02120027|73978|P2|Overall Study|Adverse Event|5
14350|NCT02120027|73979|P1|Overall Study|Adverse Event|4
14351|NCT02119936|74004|P1|Overall Study|Lost to Follow-up|10
14352|NCT02119676|74038|P4|Overall Study|Did not receive study med|5
14353|NCT02119676|74039|P3|Overall Study|Did not receive study med|4
14354|NCT02119676|74040|P2|Overall Study|Did not receive study med|2
14355|NCT02119676|74041|P1|Overall Study|Did not receive study med|2
14356|NCT02119676|74038|P4|Overall Study|Other, unspecified|4
14357|NCT02119676|74039|P3|Overall Study|Other, unspecified|3
14358|NCT02119676|74040|P2|Overall Study|Other, unspecified|1
14359|NCT02119676|74041|P1|Overall Study|Other, unspecified|2
14360|NCT02119676|74038|P4|Overall Study|Protocol deviation|0
14361|NCT02119676|74039|P3|Overall Study|Protocol deviation|1
14362|NCT02119676|74040|P2|Overall Study|Protocol deviation|0
14363|NCT02119676|74041|P1|Overall Study|Protocol deviation|0
14364|NCT02119676|74038|P4|Overall Study|Lost to Follow-up|0
14365|NCT02119676|74039|P3|Overall Study|Lost to Follow-up|1
14366|NCT02119676|74040|P2|Overall Study|Lost to Follow-up|0
14367|NCT02119676|74041|P1|Overall Study|Lost to Follow-up|0
14368|NCT02119676|74038|P4|Overall Study|Noncompliance|0
14369|NCT02119676|74039|P3|Overall Study|Noncompliance|0
14370|NCT02119676|74040|P2|Overall Study|Noncompliance|1
14371|NCT02119676|74041|P1|Overall Study|Noncompliance|0
14372|NCT02119676|74038|P4|Overall Study|Death|1
14373|NCT02119676|74039|P3|Overall Study|Death|2
14374|NCT02119676|74040|P2|Overall Study|Death|3
14375|NCT02119676|74041|P1|Overall Study|Death|9
14376|NCT02119676|74038|P4|Overall Study|Physician Decision|2
14377|NCT02119676|74039|P3|Overall Study|Physician Decision|3
14378|NCT02119676|74040|P2|Overall Study|Physician Decision|2
14379|NCT02119676|74041|P1|Overall Study|Physician Decision|4
14380|NCT02119676|74038|P4|Overall Study|Patient decision, inc. consent withdrawn|6
14381|NCT02119676|74039|P3|Overall Study|Patient decision, inc. consent withdrawn|5
14382|NCT02119676|74040|P2|Overall Study|Patient decision, inc. consent withdrawn|5
14383|NCT02119676|74041|P1|Overall Study|Patient decision, inc. consent withdrawn|4
14384|NCT02119676|74038|P4|Overall Study|Disease progression|73
14385|NCT02119676|74039|P3|Overall Study|Disease progression|68
14386|NCT02119676|74040|P2|Overall Study|Disease progression|55
14387|NCT02119676|74041|P1|Overall Study|Disease progression|53
14388|NCT02119676|74038|P4|Overall Study|Adverse Event|10
14389|NCT02119676|74039|P3|Overall Study|Adverse Event|10
14390|NCT02119676|74040|P2|Overall Study|Adverse Event|17
14391|NCT02119676|74041|P1|Overall Study|Adverse Event|9
14392|NCT02119663|74073|P2|Overall Study|Study Terminated by the Sponsor|4
14393|NCT02119663|74074|P1|Overall Study|Study Terminated by the Sponsor|3
14394|NCT02119663|74073|P2|Overall Study|Subject decision|1
14395|NCT02119663|74074|P1|Overall Study|Subject decision|0
14396|NCT02119663|74073|P2|Overall Study|Other unspecified|0
14397|NCT02119663|74074|P1|Overall Study|Other unspecified|2
14398|NCT02119663|74073|P2|Overall Study|Physician Decision|2
14399|NCT02119663|74074|P1|Overall Study|Physician Decision|1
14400|NCT02119663|74073|P2|Overall Study|Death|2
14401|NCT02119663|74074|P1|Overall Study|Death|3
14402|NCT02119663|74073|P2|Overall Study|Adverse Event|5
14403|NCT02119663|74074|P1|Overall Study|Adverse Event|5
14404|NCT02119663|74073|P2|Overall Study|Disease progression|27
14405|NCT02119663|74074|P1|Overall Study|Disease progression|26
14406|NCT02119650|74092|P2|Overall Study|Multiple reasons for termination|1
14407|NCT02119650|74093|P1|Overall Study|Multiple reasons for termination|2
14408|NCT02119650|74092|P2|Overall Study|Physician Decision|2
14409|NCT02119650|74093|P1|Overall Study|Physician Decision|0
14410|NCT02119650|74092|P2|Overall Study|Study terminated by the sponsor|0
14411|NCT02119650|74093|P1|Overall Study|Study terminated by the sponsor|1
14412|NCT02119650|74092|P2|Overall Study|Noncompliance with study treatment|1
14413|NCT02119650|74093|P1|Overall Study|Noncompliance with study treatment|1
14414|NCT02119650|74092|P2|Overall Study|Death|1
14415|NCT02119650|74093|P1|Overall Study|Death|5
14416|NCT02119650|74092|P2|Overall Study|Disease progression|14
14417|NCT02119650|74093|P1|Overall Study|Disease progression|11
14418|NCT02119650|74092|P2|Overall Study|Subject decision|3
14419|NCT02119650|74093|P1|Overall Study|Subject decision|2
14420|NCT02119650|74092|P2|Overall Study|Adverse Event|4
14421|NCT02119650|74093|P1|Overall Study|Adverse Event|3
14422|NCT02119325|74107|P2|Washout Period 1|Adverse Event|1
14423|NCT02119325|74108|P1|Washout Period 1|Adverse Event|0
14424|NCT02119299|74152|P1|Overall Study|Pregnancy|1
14425|NCT02119299|74152|P1|Overall Study|Lack of Efficacy|1
14426|NCT02119299|74152|P1|Overall Study|Withdrawal by Subject|7
14427|NCT02119286|74166|P3|Overall Study|Withdrawal by Subject|0
14428|NCT02119286|74167|P2|Overall Study|Withdrawal by Subject|1
14429|NCT02119286|74168|P1|Overall Study|Withdrawal by Subject|4
14430|NCT02119286|74166|P3|Overall Study|Lost to Follow-up|1
14431|NCT02119286|74167|P2|Overall Study|Lost to Follow-up|0
14432|NCT02119286|74168|P1|Overall Study|Lost to Follow-up|2
14433|NCT02119286|74166|P3|Overall Study|Lack of Efficacy|4
14434|NCT02119286|74167|P2|Overall Study|Lack of Efficacy|3
14435|NCT02119286|74168|P1|Overall Study|Lack of Efficacy|11
14436|NCT02119286|74166|P3|Overall Study|Adverse Event|2
14437|NCT02119286|74167|P2|Overall Study|Adverse Event|7
14438|NCT02119286|74168|P1|Overall Study|Adverse Event|9
14439|NCT02119104|74179|P1|Overall Study|Protocol Violation|16
14440|NCT02118961|74185|P2|Overall Study|Withdrawal by Subject|0
14441|NCT02118961|74186|P1|Overall Study|Withdrawal by Subject|1
14442|NCT02118896|74214|P10|Overall Study|Miscellaneous|0
14443|NCT02118896|74215|P9|Overall Study|Miscellaneous|0
14444|NCT02118896|74216|P8|Overall Study|Miscellaneous|0
14445|NCT02118896|74217|P7|Overall Study|Miscellaneous|0
14446|NCT02118896|74218|P6|Overall Study|Miscellaneous|4
14447|NCT02118896|74219|P5|Overall Study|Miscellaneous|0
14448|NCT02118896|74220|P4|Overall Study|Miscellaneous|2
14449|NCT02118896|74221|P3|Overall Study|Miscellaneous|0
14450|NCT02118896|74222|P2|Overall Study|Miscellaneous|2
14451|NCT02118896|74223|P1|Overall Study|Miscellaneous|1
14452|NCT02118896|74214|P10|Overall Study|Prohibited medication|0
14453|NCT02118896|74215|P9|Overall Study|Prohibited medication|0
14454|NCT02118896|74216|P8|Overall Study|Prohibited medication|0
14455|NCT02118896|74217|P7|Overall Study|Prohibited medication|0
14456|NCT02118896|74218|P6|Overall Study|Prohibited medication|3
14457|NCT02118896|74219|P5|Overall Study|Prohibited medication|1
14458|NCT02118896|74220|P4|Overall Study|Prohibited medication|0
14459|NCT02118896|74221|P3|Overall Study|Prohibited medication|0
14460|NCT02118896|74222|P2|Overall Study|Prohibited medication|0
14461|NCT02118896|74223|P1|Overall Study|Prohibited medication|0
14462|NCT02118896|74214|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
14463|NCT02118896|74215|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
14464|NCT02118896|74216|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
14465|NCT02118896|74217|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
14466|NCT02118896|74218|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
14467|NCT02118896|74219|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
14468|NCT02118896|74220|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
14469|NCT02118896|74221|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
14470|NCT02118896|74222|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
14471|NCT02118896|74223|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
14472|NCT02118896|74214|P10|Overall Study|Lost to Follow-up|0
14473|NCT02118896|74215|P9|Overall Study|Lost to Follow-up|0
14474|NCT02118896|74216|P8|Overall Study|Lost to Follow-up|0
14475|NCT02118896|74217|P7|Overall Study|Lost to Follow-up|0
14476|NCT02118896|74218|P6|Overall Study|Lost to Follow-up|1
14477|NCT02118896|74219|P5|Overall Study|Lost to Follow-up|2
14478|NCT02118896|74220|P4|Overall Study|Lost to Follow-up|0
14479|NCT02118896|74221|P3|Overall Study|Lost to Follow-up|1
14480|NCT02118896|74222|P2|Overall Study|Lost to Follow-up|2
14481|NCT02118896|74223|P1|Overall Study|Lost to Follow-up|1
14482|NCT02118896|74214|P10|Overall Study|Pregnancy|0
14483|NCT02118896|74215|P9|Overall Study|Pregnancy|0
14484|NCT02118896|74216|P8|Overall Study|Pregnancy|0
14485|NCT02118896|74217|P7|Overall Study|Pregnancy|1
14486|NCT02118896|74218|P6|Overall Study|Pregnancy|3
14487|NCT02118896|74219|P5|Overall Study|Pregnancy|1
14488|NCT02118896|74220|P4|Overall Study|Pregnancy|0
14489|NCT02118896|74221|P3|Overall Study|Pregnancy|0
14490|NCT02118896|74222|P2|Overall Study|Pregnancy|1
14491|NCT02118896|74223|P1|Overall Study|Pregnancy|1
14492|NCT02118896|74214|P10|Overall Study|Non-compliance|0
14493|NCT02118896|74215|P9|Overall Study|Non-compliance|0
14494|NCT02118896|74216|P8|Overall Study|Non-compliance|1
14495|NCT02118896|74217|P7|Overall Study|Non-compliance|0
14496|NCT02118896|74218|P6|Overall Study|Non-compliance|1
14497|NCT02118896|74219|P5|Overall Study|Non-compliance|0
14498|NCT02118896|74220|P4|Overall Study|Non-compliance|5
14499|NCT02118896|74221|P3|Overall Study|Non-compliance|1
14500|NCT02118896|74222|P2|Overall Study|Non-compliance|1
14501|NCT02118896|74223|P1|Overall Study|Non-compliance|2
14502|NCT02118896|74214|P10|Overall Study|Consent withdrawn|0
14503|NCT02118896|74215|P9|Overall Study|Consent withdrawn|0
14504|NCT02118896|74216|P8|Overall Study|Consent withdrawn|0
14505|NCT02118896|74217|P7|Overall Study|Consent withdrawn|0
14506|NCT02118896|74218|P6|Overall Study|Consent withdrawn|4
14507|NCT02118896|74219|P5|Overall Study|Consent withdrawn|1
14508|NCT02118896|74220|P4|Overall Study|Consent withdrawn|4
14509|NCT02118896|74221|P3|Overall Study|Consent withdrawn|3
14510|NCT02118896|74222|P2|Overall Study|Consent withdrawn|0
14511|NCT02118896|74223|P1|Overall Study|Consent withdrawn|2
14512|NCT02118896|74214|P10|Overall Study|Adverse Event|0
14513|NCT02118896|74215|P9|Overall Study|Adverse Event|4
14514|NCT02118896|74216|P8|Overall Study|Adverse Event|1
14515|NCT02118896|74217|P7|Overall Study|Adverse Event|1
14516|NCT02118896|74218|P6|Overall Study|Adverse Event|9
14517|NCT02118896|74219|P5|Overall Study|Adverse Event|5
14518|NCT02118896|74220|P4|Overall Study|Adverse Event|5
14519|NCT02118896|74221|P3|Overall Study|Adverse Event|4
14520|NCT02118896|74222|P2|Overall Study|Adverse Event|4
14521|NCT02118896|74223|P1|Overall Study|Adverse Event|5
14522|NCT02118896|74214|P10|Overall Study|Death|0
14523|NCT02118896|74215|P9|Overall Study|Death|0
14524|NCT02118896|74216|P8|Overall Study|Death|0
14525|NCT02118896|74217|P7|Overall Study|Death|0
14526|NCT02118896|74218|P6|Overall Study|Death|1
14527|NCT02118896|74219|P5|Overall Study|Death|3
14528|NCT02118896|74220|P4|Overall Study|Death|6
14529|NCT02118896|74221|P3|Overall Study|Death|4
14530|NCT02118896|74222|P2|Overall Study|Death|0
14531|NCT02118896|74223|P1|Overall Study|Death|4
14532|NCT02118792|74313|P2|Overall Study|Randomised but not treated|0
14533|NCT02118792|74314|P1|Overall Study|Randomised but not treated|1
14534|NCT02118792|74313|P2|Overall Study|Other|6
14535|NCT02118792|74314|P1|Overall Study|Other|1
14536|NCT02118792|74313|P2|Overall Study|Withdrawal by parent/guardian|20
14537|NCT02118792|74314|P1|Overall Study|Withdrawal by parent/guardian|14
14538|NCT02118792|74313|P2|Overall Study|Adverse Event|4
14539|NCT02118792|74314|P1|Overall Study|Adverse Event|5
14540|NCT02118792|74313|P2|Overall Study|Lost to Follow-up|4
14541|NCT02118792|74314|P1|Overall Study|Lost to Follow-up|4
14542|NCT02118792|74313|P2|Overall Study|Withdrawal by Subject|3
14543|NCT02118792|74314|P1|Overall Study|Withdrawal by Subject|6
14544|NCT02118766|74356|P2|Overall Study|Other|1
14545|NCT02118766|74357|P1|Overall Study|Other|3
14546|NCT02118766|74356|P2|Overall Study|Withdrawal by parent/guardian|18
14547|NCT02118766|74357|P1|Overall Study|Withdrawal by parent/guardian|12
14548|NCT02118766|74356|P2|Overall Study|Lost to Follow-up|4
14549|NCT02118766|74357|P1|Overall Study|Lost to Follow-up|5
14550|NCT02118766|74356|P2|Overall Study|Withdrawal by Subject|6
14551|NCT02118766|74357|P1|Overall Study|Withdrawal by Subject|3
14552|NCT02118766|74356|P2|Overall Study|Adverse Event|2
14553|NCT02118766|74357|P1|Overall Study|Adverse Event|7
14554|NCT02118597|74379|P1|Overall Study|Investigator's decision|1
14555|NCT02118597|74379|P1|Overall Study|Serious Adverse Event|1
14556|NCT02118597|74379|P1|Overall Study|Sponsor terminated the study|14
14557|NCT02117687|74421|P2|Overall Study|Other Reasons|1
14558|NCT02117687|74422|P1|Overall Study|Other Reasons|1
14559|NCT02117687|74421|P2|Overall Study|Adverse Event|2
14560|NCT02117687|74422|P1|Overall Study|Adverse Event|0
14561|NCT02117687|74421|P2|Overall Study|Lost to Follow-up|1
14562|NCT02117687|74422|P1|Overall Study|Lost to Follow-up|0
14563|NCT02117570|74457|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
14564|NCT02117570|74458|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
14565|NCT02117570|74459|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
14566|NCT02117570|74457|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
14567|NCT02117570|74458|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
14568|NCT02117570|74459|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
14569|NCT02117570|74457|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
14570|NCT02117570|74458|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
14571|NCT02117570|74459|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
14572|NCT02117570|74457|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
14573|NCT02117570|74458|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
14574|NCT02117570|74459|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
14575|NCT02117570|74457|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
14576|NCT02117570|74458|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
14577|NCT02117570|74459|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
14578|NCT02117570|74457|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
14579|NCT02117570|74458|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
14580|NCT02117570|74459|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
14581|NCT02117570|74457|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
14582|NCT02117570|74458|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
14583|NCT02117570|74459|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
14584|NCT02117544|74509|P2|Period 1|Lost to follow-up (prior to treatment)|0
14585|NCT02117544|74510|P1|Period 1|Lost to follow-up (prior to treatment)|2
14586|NCT02117479|74525|P2|Overall Study|Other unspecified|7
14587|NCT02117479|74526|P1|Overall Study|Other unspecified|11
14588|NCT02117479|74525|P2|Overall Study|Physician Decision|2
14589|NCT02117479|74526|P1|Overall Study|Physician Decision|7
14590|NCT02117479|74525|P2|Overall Study|Study terminated by the sponsor|6
14591|NCT02117479|74526|P1|Overall Study|Study terminated by the sponsor|4
14592|NCT02117479|74525|P2|Overall Study|Noncompliance with study treatment|0
14593|NCT02117479|74526|P1|Overall Study|Noncompliance with study treatment|1
14594|NCT02117479|74525|P2|Overall Study|Disease progression|108
14595|NCT02117479|74526|P1|Overall Study|Disease progression|104
14596|NCT02117479|74525|P2|Overall Study|Subject decision|9
14597|NCT02117479|74526|P1|Overall Study|Subject decision|8
14598|NCT02117479|74525|P2|Overall Study|Adverse Event|16
14599|NCT02117479|74526|P1|Overall Study|Adverse Event|8
14600|NCT02117479|74525|P2|Overall Study|Death|8
14601|NCT02117479|74526|P1|Overall Study|Death|13
14602|NCT02117414|74544|P2|Overall Study|Withdrawal by Subject|4
14603|NCT02117414|74545|P1|Overall Study|Withdrawal by Subject|10
14604|NCT02117414|74544|P2|Overall Study|Death|2
14605|NCT02117414|74545|P1|Overall Study|Death|5
14606|NCT02117050|74589|P1|Overall Study|Subject Enrolled but not Dosed|1
14607|NCT02116972|74604|P3|Overall Study|scheduling conflicts and relocation|6
14608|NCT02116972|74605|P2|Overall Study|scheduling conflicts and relocation|3
14609|NCT02116972|74606|P1|Overall Study|scheduling conflicts and relocation|3
14610|NCT02116972|74604|P3|Overall Study|Lack of Efficacy|5
14611|NCT02116972|74605|P2|Overall Study|Lack of Efficacy|6
14612|NCT02116972|74606|P1|Overall Study|Lack of Efficacy|6
14613|NCT02116972|74604|P3|Overall Study|Lost to Follow-up|1
14614|NCT02116972|74605|P2|Overall Study|Lost to Follow-up|3
14615|NCT02116972|74606|P1|Overall Study|Lost to Follow-up|4
14616|NCT02116972|74604|P3|Overall Study|Protocol Violation|1
14617|NCT02116972|74605|P2|Overall Study|Protocol Violation|0
14618|NCT02116972|74606|P1|Overall Study|Protocol Violation|1
14619|NCT02116972|74604|P3|Overall Study|Withdrawal by Subject|5
14620|NCT02116972|74605|P2|Overall Study|Withdrawal by Subject|1
14621|NCT02116972|74606|P1|Overall Study|Withdrawal by Subject|1
14622|NCT02116972|74604|P3|Overall Study|Adverse Event|1
14623|NCT02116972|74605|P2|Overall Study|Adverse Event|4
14624|NCT02116972|74606|P1|Overall Study|Adverse Event|4
14625|NCT02116803|74638|P2|Overall Study|Death|0
14626|NCT02116803|74639|P1|Overall Study|Death|1
14627|NCT02116803|74638|P2|Overall Study|Study terminated by sponsor|1
14628|NCT02116803|74639|P1|Overall Study|Study terminated by sponsor|2
14629|NCT02116803|74638|P2|Overall Study|Progressive disease|0
14630|NCT02116803|74639|P1|Overall Study|Progressive disease|4
14631|NCT02116803|74638|P2|Overall Study|Physician Decision|0
14632|NCT02116803|74639|P1|Overall Study|Physician Decision|1
14633|NCT02116803|74638|P2|Overall Study|Adverse Event|1
14634|NCT02116803|74639|P1|Overall Study|Adverse Event|2
14635|NCT02116621|74647|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
14636|NCT02116621|74648|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
14637|NCT02116621|74647|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
14638|NCT02116621|74648|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
14639|NCT02116621|74647|P2|Twelve Month Follow-up|Lost to Follow-up|1
14640|NCT02116621|74648|P1|Twelve Month Follow-up|Lost to Follow-up|0
14641|NCT02116621|74647|P2|Twelve Month Follow-up|Withdrawal by Subject|0
14642|NCT02116621|74648|P1|Twelve Month Follow-up|Withdrawal by Subject|1
14643|NCT02116621|74647|P2|Six Month Follow-up|Did not complete follow-up survey|1
14644|NCT02116621|74648|P1|Six Month Follow-up|Did not complete follow-up survey|1
14645|NCT02116621|74647|P2|Six Month Follow-up|Lost to Follow-up|1
14646|NCT02116621|74648|P1|Six Month Follow-up|Lost to Follow-up|2
14647|NCT02116621|74647|P2|Six Month Follow-up|Withdrawal by Subject|1
14648|NCT02116621|74648|P1|Six Month Follow-up|Withdrawal by Subject|1
14649|NCT02116621|74647|P2|Three Month Follow-up|Did not complete follow-up survey|4
14650|NCT02116621|74648|P1|Three Month Follow-up|Did not complete follow-up survey|14
14651|NCT02116621|74647|P2|Three Month Follow-up|Lost to Follow-up|1
14652|NCT02116621|74648|P1|Three Month Follow-up|Lost to Follow-up|0
14653|NCT02116621|74647|P2|Three Month Follow-up|Withdrawal by Subject|1
14654|NCT02116621|74648|P1|Three Month Follow-up|Withdrawal by Subject|4
14655|NCT02116621|74647|P2|Three Month Follow-up|Death|1
14656|NCT02116621|74648|P1|Three Month Follow-up|Death|1
14657|NCT02116621|74647|P2|Baseline|Withdrawal by Subject|4
14658|NCT02116621|74648|P1|Baseline|Withdrawal by Subject|0
14659|NCT02116582|74736|P1|Overall Study|Other: Miscellaneous|9
14660|NCT02116582|74736|P1|Overall Study|Withdrawal by Subject|8
14661|NCT02116582|74736|P1|Overall Study|Protocol Violation|3
14662|NCT02116582|74736|P1|Overall Study|Progressive Disease|140
14663|NCT02116582|74736|P1|Overall Study|Death|7
14664|NCT02116582|74736|P1|Overall Study|Adverse Event|17
14665|NCT02116582|74736|P1|Overall Study|Enrolled but Never Received Study Drug|1
14666|NCT02116530|74746|P2|Overall Study|Other Medical Problems|2
14667|NCT02116530|74747|P1|Overall Study|Other Medical Problems|2
14668|NCT02116530|74746|P2|Overall Study|Lost to Follow-up|0
14669|NCT02116530|74747|P1|Overall Study|Lost to Follow-up|1
14670|NCT02116530|74746|P2|Overall Study|Physician Decision|0
14671|NCT02116530|74747|P1|Overall Study|Physician Decision|1
14672|NCT02116530|74746|P2|Overall Study|Adverse Event|0
14673|NCT02116530|74747|P1|Overall Study|Adverse Event|4
14674|NCT02116530|74746|P2|Overall Study|Withdrawal by Subject|2
14675|NCT02116530|74747|P1|Overall Study|Withdrawal by Subject|1
14676|NCT02116361|74765|P4|Overall Study|Investigator Decision - Relapse|5
14677|NCT02116361|74766|P3|Overall Study|Investigator Decision - Relapse|8
14678|NCT02116361|74767|P2|Overall Study|Investigator Decision - Relapse|7
14679|NCT02116361|74768|P1|Overall Study|Investigator Decision - Relapse|9
14680|NCT02116361|74765|P4|Overall Study|Personal Reasons|9
14681|NCT02116361|74766|P3|Overall Study|Personal Reasons|4
14682|NCT02116361|74767|P2|Overall Study|Personal Reasons|6
14683|NCT02116361|74768|P1|Overall Study|Personal Reasons|6
14684|NCT02116361|74765|P4|Overall Study|Lost to Follow-up|5
14685|NCT02116361|74766|P3|Overall Study|Lost to Follow-up|7
14686|NCT02116361|74767|P2|Overall Study|Lost to Follow-up|5
14687|NCT02116361|74768|P1|Overall Study|Lost to Follow-up|4
14688|NCT02116361|74765|P4|Overall Study|Lack of Efficacy|3
14689|NCT02116361|74766|P3|Overall Study|Lack of Efficacy|4
14690|NCT02116361|74767|P2|Overall Study|Lack of Efficacy|7
14691|NCT02116361|74768|P1|Overall Study|Lack of Efficacy|5
14692|NCT02116361|74765|P4|Overall Study|Other Reasons|3
14693|NCT02116361|74766|P3|Overall Study|Other Reasons|3
14694|NCT02116361|74767|P2|Overall Study|Other Reasons|3
14695|NCT02116361|74768|P1|Overall Study|Other Reasons|3
14696|NCT02116361|74765|P4|Overall Study|Adverse Event|3
14697|NCT02116361|74766|P3|Overall Study|Adverse Event|0
14698|NCT02116361|74767|P2|Overall Study|Adverse Event|0
14699|NCT02116361|74768|P1|Overall Study|Adverse Event|1
14700|NCT02116361|74765|P4|Overall Study|Physician Decision|0
14701|NCT02116361|74766|P3|Overall Study|Physician Decision|0
14702|NCT02116361|74767|P2|Overall Study|Physician Decision|3
14703|NCT02116361|74768|P1|Overall Study|Physician Decision|2
14704|NCT02116361|74765|P4|Overall Study|Protocol Violation|2
14705|NCT02116361|74766|P3|Overall Study|Protocol Violation|0
14706|NCT02116361|74767|P2|Overall Study|Protocol Violation|0
14707|NCT02116361|74768|P1|Overall Study|Protocol Violation|1
14708|NCT02116361|74765|P4|Overall Study|Pregnancy|1
14709|NCT02116361|74766|P3|Overall Study|Pregnancy|0
14710|NCT02116361|74767|P2|Overall Study|Pregnancy|0
14711|NCT02116361|74768|P1|Overall Study|Pregnancy|0
14712|NCT02116309|74805|P2|Overall Study|Lost to Follow-up|1
14713|NCT02116309|74806|P1|Overall Study|Lost to Follow-up|0
14714|NCT02115815|74830|P7|Overall Study|Missed appointment, randomized in error|0
14715|NCT02115815|74831|P6|Overall Study|Missed appointment, randomized in error|1
14716|NCT02115815|74832|P5|Overall Study|Missed appointment, randomized in error|0
14717|NCT02115815|74833|P4|Overall Study|Missed appointment, randomized in error|0
14718|NCT02115815|74834|P3|Overall Study|Missed appointment, randomized in error|0
14719|NCT02115815|74835|P2|Overall Study|Missed appointment, randomized in error|0
14720|NCT02115815|74836|P1|Overall Study|Missed appointment, randomized in error|0
14721|NCT02115815|74830|P7|Overall Study|Not enough drug to dose participant|0
14722|NCT02115815|74831|P6|Overall Study|Not enough drug to dose participant|1
14723|NCT02115815|74832|P5|Overall Study|Not enough drug to dose participant|0
14724|NCT02115815|74833|P4|Overall Study|Not enough drug to dose participant|0
14725|NCT02115815|74834|P3|Overall Study|Not enough drug to dose participant|0
14726|NCT02115815|74835|P2|Overall Study|Not enough drug to dose participant|0
14727|NCT02115815|74836|P1|Overall Study|Not enough drug to dose participant|0
14728|NCT02115815|74830|P7|Overall Study|Withdrawal by Subject|0
14729|NCT02115815|74831|P6|Overall Study|Withdrawal by Subject|0
14730|NCT02115815|74832|P5|Overall Study|Withdrawal by Subject|0
14731|NCT02115815|74833|P4|Overall Study|Withdrawal by Subject|0
14732|NCT02115815|74834|P3|Overall Study|Withdrawal by Subject|0
14733|NCT02115815|74835|P2|Overall Study|Withdrawal by Subject|0
14734|NCT02115815|74836|P1|Overall Study|Withdrawal by Subject|2
14735|NCT02115321|74957|P2|Overall Study|Death|0
14736|NCT02115321|74958|P1|Overall Study|Death|1
14737|NCT02115269|74978|P1|Overall Study|Didn't take study drug|2
14738|NCT02115269|74978|P1|Overall Study|Withdrawal by Subject|2
14739|NCT02115269|74978|P1|Overall Study|Moved to another city|7
14740|NCT02115269|74978|P1|Overall Study|Did not complete patient diary|3
14741|NCT02115269|74978|P1|Overall Study|Lost to Follow-up|43
14742|NCT02115256|74998|P2|Overall Study|Withdrawal by Subject|1
14743|NCT02115256|74999|P1|Overall Study|Withdrawal by Subject|0
14744|NCT02114931|75013|P2|Overall Study|Other|1
14745|NCT02114931|75014|P1|Overall Study|Other|2
14746|NCT02114931|75013|P2|Overall Study|Physician Decision|2
14747|NCT02114931|75014|P1|Overall Study|Physician Decision|1
14748|NCT02114931|75013|P2|Overall Study|Lost to Follow-up|3
14749|NCT02114931|75014|P1|Overall Study|Lost to Follow-up|3
14750|NCT02114931|75013|P2|Overall Study|Adverse Event|6
14751|NCT02114931|75014|P1|Overall Study|Adverse Event|4
14752|NCT02114931|75013|P2|Overall Study|Withdrawal by Subject|18
14753|NCT02114931|75014|P1|Overall Study|Withdrawal by Subject|15
14754|NCT02114892|75030|P2|Overall Study|Lost to Follow-up|2
14755|NCT02114892|75031|P1|Overall Study|Lost to Follow-up|1
14756|NCT02114268|75071|P6|Overall Study|Withdrawn by site due to noncompliance|0
14757|NCT02114268|75072|P5|Overall Study|Withdrawn by site due to noncompliance|0
14758|NCT02114268|75073|P4|Overall Study|Withdrawn by site due to noncompliance|0
14759|NCT02114268|75074|P3|Overall Study|Withdrawn by site due to noncompliance|0
14760|NCT02114268|75075|P2|Overall Study|Withdrawn by site due to noncompliance|0
14761|NCT02114268|75076|P1|Overall Study|Withdrawn by site due to noncompliance|1
14762|NCT02114268|75071|P6|Overall Study|Withdrawal by Subject|1
14763|NCT02114268|75072|P5|Overall Study|Withdrawal by Subject|0
14764|NCT02114268|75073|P4|Overall Study|Withdrawal by Subject|0
14765|NCT02114268|75074|P3|Overall Study|Withdrawal by Subject|0
14766|NCT02114268|75075|P2|Overall Study|Withdrawal by Subject|0
14767|NCT02114268|75076|P1|Overall Study|Withdrawal by Subject|1
14768|NCT02114268|75071|P6|Overall Study|Lost to Follow-up|2
14769|NCT02114268|75072|P5|Overall Study|Lost to Follow-up|0
14770|NCT02114268|75073|P4|Overall Study|Lost to Follow-up|0
14771|NCT02114268|75074|P3|Overall Study|Lost to Follow-up|1
14772|NCT02114268|75075|P2|Overall Study|Lost to Follow-up|1
14773|NCT02114268|75076|P1|Overall Study|Lost to Follow-up|4
14774|NCT02114203|75145|P3|Overall Study|Withdrawal by Subject|0
14775|NCT02114203|75146|P2|Overall Study|Withdrawal by Subject|1
14776|NCT02114203|75147|P1|Overall Study|Withdrawal by Subject|0
14777|NCT02114203|75145|P3|Overall Study|Adverse Event|0
14778|NCT02114203|75146|P2|Overall Study|Adverse Event|1
14779|NCT02114203|75147|P1|Overall Study|Adverse Event|0
14780|NCT02114177|75181|P2|Overall Study|Other|1
14781|NCT02114177|75182|P1|Overall Study|Other|2
14782|NCT02114177|75181|P2|Overall Study|Withdrawal by Subject|1
14783|NCT02114177|75182|P1|Overall Study|Withdrawal by Subject|6
14784|NCT02114177|75181|P2|Overall Study|Lost to Follow-up|2
14785|NCT02114177|75182|P1|Overall Study|Lost to Follow-up|1
14786|NCT02114151|75206|P1|Overall Study|Withdrawal by Subject|5
14787|NCT02114151|75206|P1|Overall Study|Lost to Follow-up|1
14788|NCT02114151|75206|P1|Overall Study|Death|1
14789|NCT02113579|75223|P2|Overall Study|Lost to Follow-up|2
14790|NCT02113579|75224|P1|Overall Study|Lost to Follow-up|6
14791|NCT02113579|75223|P2|Overall Study|Withdrawal by Subject|2
14792|NCT02113579|75224|P1|Overall Study|Withdrawal by Subject|3
14793|NCT02113579|75223|P2|Overall Study|Adverse Event|0
14794|NCT02113579|75224|P1|Overall Study|Adverse Event|1
14795|NCT02113449|75248|P1|Overall Study|Adverse Event|4
14796|NCT02113436|75264|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
14797|NCT02113436|75265|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
14798|NCT02113436|75266|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
14799|NCT02113436|75267|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
14800|NCT02113436|75264|P4|Period 2: 16 Weeks|Physician Decision|0
14801|NCT02113436|75265|P3|Period 2: 16 Weeks|Physician Decision|2
14802|NCT02113436|75266|P2|Period 2: 16 Weeks|Physician Decision|0
14803|NCT02113436|75267|P1|Period 2: 16 Weeks|Physician Decision|0
14804|NCT02113436|75264|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
14805|NCT02113436|75265|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
14806|NCT02113436|75266|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
14807|NCT02113436|75267|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
14808|NCT02113436|75264|P4|Period 2: 16 Weeks|Adverse Event|5
14809|NCT02113436|75265|P3|Period 2: 16 Weeks|Adverse Event|4
14810|NCT02113436|75266|P2|Period 2: 16 Weeks|Adverse Event|0
14811|NCT02113436|75267|P1|Period 2: 16 Weeks|Adverse Event|0
14812|NCT02113436|75264|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
14813|NCT02113436|75265|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
14814|NCT02113436|75266|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
14815|NCT02113436|75267|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
14816|NCT02113436|75264|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
14817|NCT02113436|75265|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
14818|NCT02113436|75266|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
14819|NCT02113436|75267|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
14820|NCT02113436|75264|P4|Period 1: 8 Weeks|Protocol Violation|0
14821|NCT02113436|75265|P3|Period 1: 8 Weeks|Protocol Violation|0
14822|NCT02113436|75266|P2|Period 1: 8 Weeks|Protocol Violation|0
14823|NCT02113436|75267|P1|Period 1: 8 Weeks|Protocol Violation|1
14824|NCT02113436|75264|P4|Period 1: 8 Weeks|Adverse Event|0
14825|NCT02113436|75265|P3|Period 1: 8 Weeks|Adverse Event|0
14826|NCT02113436|75266|P2|Period 1: 8 Weeks|Adverse Event|0
14827|NCT02113436|75267|P1|Period 1: 8 Weeks|Adverse Event|1
14828|NCT02113124|75290|P2|Overall Study|Unable to retrieve blood sample|1
14829|NCT02113124|75291|P1|Overall Study|Unable to retrieve blood sample|1
14830|NCT02113007|75297|P1|Overall Study|Progressive disease|2
14831|NCT02112448|75305|P2|Overall Study|required heparin so could not use ketoro|0
14832|NCT02112448|75306|P1|Overall Study|required heparin so could not use ketoro|1
14833|NCT02112448|75305|P2|Overall Study|Physician Decision|6
14834|NCT02112448|75306|P1|Overall Study|Physician Decision|4
14835|NCT02112448|75305|P2|Overall Study|Protocol Violation|2
14836|NCT02112448|75306|P1|Overall Study|Protocol Violation|1
14837|NCT02112448|75305|P2|Overall Study|lab values precluding use of ketorolac|2
14838|NCT02112448|75306|P1|Overall Study|lab values precluding use of ketorolac|2
14839|NCT02111603|75354|P1|Overall Study|Withdrawal by Subject|1
14840|NCT02111369|75363|P1|Overall Study|Withdrawal by Subject|1
14841|NCT02111369|75363|P1|Overall Study|Lost to Follow-up|2
14842|NCT02111096|75409|P3|Overall Study|Withdrawal by Subject|8
14843|NCT02111096|75410|P2|Overall Study|Withdrawal by Subject|2
14844|NCT02111096|75411|P1|Overall Study|Withdrawal by Subject|4
14845|NCT02111096|75409|P3|Overall Study|Terminated by Sponsor|54
14846|NCT02111096|75410|P2|Overall Study|Terminated by Sponsor|35
14847|NCT02111096|75411|P1|Overall Study|Terminated by Sponsor|53
14848|NCT02111096|75409|P3|Overall Study|Protocol Violation|1
14849|NCT02111096|75410|P2|Overall Study|Protocol Violation|0
14850|NCT02111096|75411|P1|Overall Study|Protocol Violation|1
14851|NCT02111096|75409|P3|Overall Study|Physician Decision|0
14852|NCT02111096|75410|P2|Overall Study|Physician Decision|1
14853|NCT02111096|75411|P1|Overall Study|Physician Decision|0
14854|NCT02111096|75409|P3|Overall Study|Lost to Follow Up|1
14855|NCT02111096|75410|P2|Overall Study|Lost to Follow Up|1
14856|NCT02111096|75411|P1|Overall Study|Lost to Follow Up|1
14857|NCT02111096|75409|P3|Overall Study|Non-Compliance with Study Drug|0
14858|NCT02111096|75410|P2|Overall Study|Non-Compliance with Study Drug|1
14859|NCT02111096|75411|P1|Overall Study|Non-Compliance with Study Drug|1
14860|NCT02111096|75409|P3|Overall Study|Adverse Event|2
14861|NCT02111096|75410|P2|Overall Study|Adverse Event|1
14862|NCT02111096|75411|P1|Overall Study|Adverse Event|4
14863|NCT02111083|75459|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
14864|NCT02111083|75460|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
14865|NCT02110693|75478|P2|Overall Study|Other|0
14866|NCT02110693|75479|P1|Overall Study|Other|1
14867|NCT02110693|75478|P2|Overall Study|technical difficulties|4
14868|NCT02110693|75479|P1|Overall Study|technical difficulties|6
14869|NCT02110693|75478|P2|Overall Study|skipped assessment|18
14870|NCT02110693|75479|P1|Overall Study|skipped assessment|15
14871|NCT02110693|75478|P2|Overall Study|Withdrawal by Subject|7
14872|NCT02110693|75479|P1|Overall Study|Withdrawal by Subject|6
14873|NCT02110238|75525|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
14874|NCT02110238|75526|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
14875|NCT02110238|75525|P2|14 Week Blinded Extension Phase|Protocol Violation|3
14876|NCT02110238|75526|P1|14 Week Blinded Extension Phase|Protocol Violation|2
14877|NCT02110238|75525|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
14878|NCT02110238|75526|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
14879|NCT02110238|75525|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
14880|NCT02110238|75526|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
14881|NCT02110238|75525|P2|14 Week Blinded Extension Phase|Adverse Event|1
14882|NCT02110238|75526|P1|14 Week Blinded Extension Phase|Adverse Event|1
14883|NCT02110238|75525|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
14884|NCT02110238|75526|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
14885|NCT02110238|75525|P2|12 Week Pivotal Phase|Protocol Violation|1
14886|NCT02110238|75526|P1|12 Week Pivotal Phase|Protocol Violation|0
14887|NCT02110238|75525|P2|12 Week Pivotal Phase|Physician Decision|2
14888|NCT02110238|75526|P1|12 Week Pivotal Phase|Physician Decision|0
14889|NCT02110238|75525|P2|12 Week Pivotal Phase|Lost to Follow-up|0
14890|NCT02110238|75526|P1|12 Week Pivotal Phase|Lost to Follow-up|2
14891|NCT02110238|75525|P2|12 Week Pivotal Phase|Lack of Efficacy|3
14892|NCT02110238|75526|P1|12 Week Pivotal Phase|Lack of Efficacy|2
14893|NCT02110238|75525|P2|12 Week Pivotal Phase|Adverse Event|0
14894|NCT02110238|75526|P1|12 Week Pivotal Phase|Adverse Event|3
14895|NCT02109484|75568|P8|Overall Study|Moved away from study area|1
14896|NCT02109484|75569|P7|Overall Study|Moved away from study area|1
14897|NCT02109484|75570|P6|Overall Study|Moved away from study area|0
14898|NCT02109484|75571|P5|Overall Study|Moved away from study area|0
14899|NCT02109484|75572|P4|Overall Study|Moved away from study area|0
14900|NCT02109484|75573|P3|Overall Study|Moved away from study area|0
14901|NCT02109484|75574|P2|Overall Study|Moved away from study area|0
14902|NCT02109484|75575|P1|Overall Study|Moved away from study area|0
14903|NCT02109484|75568|P8|Overall Study|Death|2
14904|NCT02109484|75569|P7|Overall Study|Death|0
14905|NCT02109484|75570|P6|Overall Study|Death|0
14906|NCT02109484|75571|P5|Overall Study|Death|0
14907|NCT02109484|75572|P4|Overall Study|Death|0
14908|NCT02109484|75573|P3|Overall Study|Death|0
14909|NCT02109484|75574|P2|Overall Study|Death|0
14910|NCT02109484|75575|P1|Overall Study|Death|0
14911|NCT02109484|75568|P8|Overall Study|Physician Decision|0
14912|NCT02109484|75569|P7|Overall Study|Physician Decision|0
14913|NCT02109484|75570|P6|Overall Study|Physician Decision|0
14914|NCT02109484|75571|P5|Overall Study|Physician Decision|2
14915|NCT02109484|75572|P4|Overall Study|Physician Decision|0
14916|NCT02109484|75573|P3|Overall Study|Physician Decision|0
14917|NCT02109484|75574|P2|Overall Study|Physician Decision|0
14918|NCT02109484|75575|P1|Overall Study|Physician Decision|0
14919|NCT02109484|75568|P8|Overall Study|Withdrawal by Subject|0
14920|NCT02109484|75569|P7|Overall Study|Withdrawal by Subject|1
14921|NCT02109484|75570|P6|Overall Study|Withdrawal by Subject|1
14922|NCT02109484|75571|P5|Overall Study|Withdrawal by Subject|1
14923|NCT02109484|75572|P4|Overall Study|Withdrawal by Subject|0
14924|NCT02109484|75573|P3|Overall Study|Withdrawal by Subject|0
14925|NCT02109484|75574|P2|Overall Study|Withdrawal by Subject|0
14926|NCT02109484|75575|P1|Overall Study|Withdrawal by Subject|0
14927|NCT02109484|75568|P8|Overall Study|Lost to Follow-up|0
14928|NCT02109484|75569|P7|Overall Study|Lost to Follow-up|1
14929|NCT02109484|75570|P6|Overall Study|Lost to Follow-up|0
14930|NCT02109484|75571|P5|Overall Study|Lost to Follow-up|1
14931|NCT02109484|75572|P4|Overall Study|Lost to Follow-up|1
14932|NCT02109484|75573|P3|Overall Study|Lost to Follow-up|0
14933|NCT02109484|75574|P2|Overall Study|Lost to Follow-up|0
14934|NCT02109484|75575|P1|Overall Study|Lost to Follow-up|0
14935|NCT02109445|75631|P1|Overall Study|Adverse Event|1
14936|NCT02109445|75631|P1|Overall Study|Symptomatic deterioration|2
14937|NCT02109172|75664|P6|Overall Study|Death|0
14938|NCT02109172|75665|P5|Overall Study|Death|1
14939|NCT02109172|75666|P4|Overall Study|Death|0
14940|NCT02109172|75667|P3|Overall Study|Death|0
14941|NCT02109172|75668|P2|Overall Study|Death|0
14942|NCT02109172|75669|P1|Overall Study|Death|0
14943|NCT02109172|75664|P6|Overall Study|Adverse Event|1
14944|NCT02109172|75665|P5|Overall Study|Adverse Event|0
14945|NCT02109172|75666|P4|Overall Study|Adverse Event|0
14946|NCT02109172|75667|P3|Overall Study|Adverse Event|1
14947|NCT02109172|75668|P2|Overall Study|Adverse Event|0
14948|NCT02109172|75669|P1|Overall Study|Adverse Event|0
14949|NCT02109172|75664|P6|Overall Study|Withdrawal by Subject|0
14950|NCT02109172|75665|P5|Overall Study|Withdrawal by Subject|0
14951|NCT02109172|75666|P4|Overall Study|Withdrawal by Subject|1
14952|NCT02109172|75667|P3|Overall Study|Withdrawal by Subject|0
14953|NCT02109172|75668|P2|Overall Study|Withdrawal by Subject|0
14954|NCT02109172|75669|P1|Overall Study|Withdrawal by Subject|1
14955|NCT02109133|75690|P2|Overall Study|Lost to Follow-up|0
14956|NCT02109133|75691|P1|Overall Study|Lost to Follow-up|1
14957|NCT02109107|75703|P1|Overall Study|Lost to Follow-up|2
14958|NCT02108951|75725|P1|Overall Study|Study Terminated by Sponsor|14
14959|NCT02108951|75725|P1|Overall Study|Patient's/guardian's decision|1
14960|NCT02108951|75725|P1|Overall Study|Lost to Follow-up|1
14961|NCT02108652|75763|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
14962|NCT02108652|75763|P1|Overall Study|Withdrawal by Subject|8
14963|NCT02108652|75763|P1|Overall Study|Lost to Follow-up|2
14964|NCT02108652|75763|P1|Overall Study|Death|226
14965|NCT02107898|75932|P2|Overall Study|Randomized but not treated|1
14966|NCT02107898|75933|P1|Overall Study|Randomized but not treated|0
14967|NCT02107898|75932|P2|Overall Study|Consent withdrawn by participant|1
14968|NCT02107898|75933|P1|Overall Study|Consent withdrawn by participant|2
14969|NCT02107898|75932|P2|Overall Study|Participant moved|2
14970|NCT02107898|75933|P1|Overall Study|Participant moved|0
14971|NCT02107898|75932|P2|Overall Study|Poor compliance to protocol|1
14972|NCT02107898|75933|P1|Overall Study|Poor compliance to protocol|0
14973|NCT02107898|75932|P2|Overall Study|Adverse Event|7
14974|NCT02107898|75933|P1|Overall Study|Adverse Event|4
14975|NCT02107703|75987|P2|Overall Study|On study treatment/follow up|152
14976|NCT02107703|75988|P1|Overall Study|On study treatment/follow up|319
14977|NCT02107703|75987|P2|Overall Study|Lost to Follow-up|4
14978|NCT02107703|75988|P1|Overall Study|Lost to Follow-up|6
14979|NCT02107703|75987|P2|Overall Study|Withdrawal by Subject|19
14980|NCT02107703|75988|P1|Overall Study|Withdrawal by Subject|36
14981|NCT02107482|76020|P1|Overall Study|Lack of Efficacy|1
14982|NCT02107482|76020|P1|Overall Study|Lost to Follow-up|1
14983|NCT02107482|76020|P1|Overall Study|inconveinence|2
14984|NCT02107313|76057|P2|Overall Study|One participant did not do the FED cohor|1
14985|NCT02107313|76058|P1|Overall Study|One participant did not do the FED cohor|0
14986|NCT02107274|76068|P2|Control Phase|Adverse Event|1
14987|NCT02107274|76069|P1|Control Phase|Adverse Event|0
14988|NCT02107274|76068|P2|Control Phase|Death|0
14989|NCT02107274|76069|P1|Control Phase|Death|2
14990|NCT02107274|76068|P2|Control Phase|Lost to Follow-up|1
14991|NCT02107274|76069|P1|Control Phase|Lost to Follow-up|1
14992|NCT02107274|76068|P2|Treatment vs. Placebo|Lost to Follow-up|2
14993|NCT02107274|76069|P1|Treatment vs. Placebo|Lost to Follow-up|0
14994|NCT02107274|76068|P2|Treatment vs. Placebo|Adverse Event|0
14995|NCT02107274|76069|P1|Treatment vs. Placebo|Adverse Event|3
14996|NCT02107196|76083|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
14997|NCT02107196|76084|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
14998|NCT02107196|76083|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
14999|NCT02107196|76084|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
15000|NCT02107196|76083|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
15001|NCT02107196|76084|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
15002|NCT02107196|76083|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
15003|NCT02107196|76084|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
15004|NCT02107196|76083|P2|12-week Treatment Period|Reason Missing|8
15005|NCT02107196|76084|P1|12-week Treatment Period|Reason Missing|11
15006|NCT02107196|76083|P2|12-week Treatment Period|Protocol Violation|8
15007|NCT02107196|76084|P1|12-week Treatment Period|Protocol Violation|7
15008|NCT02107196|76083|P2|12-week Treatment Period|Withdrawal by Subject|12
15009|NCT02107196|76084|P1|12-week Treatment Period|Withdrawal by Subject|15
15010|NCT02107196|76083|P2|12-week Treatment Period|Physician Decision|1
15011|NCT02107196|76084|P1|12-week Treatment Period|Physician Decision|0
15012|NCT02107196|76083|P2|12-week Treatment Period|Lost to Follow-up|6
15013|NCT02107196|76084|P1|12-week Treatment Period|Lost to Follow-up|3
15014|NCT02107196|76083|P2|12-week Treatment Period|Lack of Efficacy|1
15015|NCT02107196|76084|P1|12-week Treatment Period|Lack of Efficacy|2
15016|NCT02107196|76083|P2|12-week Treatment Period|Adverse Event|3
15017|NCT02107196|76084|P1|12-week Treatment Period|Adverse Event|6
15018|NCT02107014|76097|P1|Overall Study|Withdrew before drug: moving interstate|1
15019|NCT02106923|76179|P6|Overall Study|Protocol Violation|1
15020|NCT02106923|76180|P5|Overall Study|Protocol Violation|0
15021|NCT02106923|76181|P4|Overall Study|Protocol Violation|0
15022|NCT02106923|76182|P3|Overall Study|Protocol Violation|0
15023|NCT02106923|76183|P2|Overall Study|Protocol Violation|0
15024|NCT02106923|76184|P1|Overall Study|Protocol Violation|0
15025|NCT02106832|76232|P4|Overall Study|Technical problems|0
15026|NCT02106832|76233|P3|Overall Study|Technical problems|0
15027|NCT02106832|76234|P2|Overall Study|Technical problems|1
15028|NCT02106832|76235|P1|Overall Study|Technical problems|0
15029|NCT02106832|76232|P4|Overall Study|Withdrawal by Subject|7
15030|NCT02106832|76233|P3|Overall Study|Withdrawal by Subject|10
15031|NCT02106832|76234|P2|Overall Study|Withdrawal by Subject|17
15032|NCT02106832|76235|P1|Overall Study|Withdrawal by Subject|17
15033|NCT02106832|76232|P4|Overall Study|Protocol Violation|1
15034|NCT02106832|76233|P3|Overall Study|Protocol Violation|0
15035|NCT02106832|76234|P2|Overall Study|Protocol Violation|0
15036|NCT02106832|76235|P1|Overall Study|Protocol Violation|0
15037|NCT02106832|76232|P4|Overall Study|Physician Decision|0
15038|NCT02106832|76233|P3|Overall Study|Physician Decision|0
15039|NCT02106832|76234|P2|Overall Study|Physician Decision|0
15040|NCT02106832|76235|P1|Overall Study|Physician Decision|1
15041|NCT02106832|76232|P4|Overall Study|Lost to Follow-up|3
15042|NCT02106832|76233|P3|Overall Study|Lost to Follow-up|1
15043|NCT02106832|76234|P2|Overall Study|Lost to Follow-up|1
15044|NCT02106832|76235|P1|Overall Study|Lost to Follow-up|0
15045|NCT02106832|76232|P4|Overall Study|Deterioration of general conditions|0
15046|NCT02106832|76233|P3|Overall Study|Deterioration of general conditions|1
15047|NCT02106832|76234|P2|Overall Study|Deterioration of general conditions|0
15048|NCT02106832|76235|P1|Overall Study|Deterioration of general conditions|0
15049|NCT02106832|76232|P4|Overall Study|Death|4
15050|NCT02106832|76233|P3|Overall Study|Death|1
15051|NCT02106832|76234|P2|Overall Study|Death|4
15052|NCT02106832|76235|P1|Overall Study|Death|4
15053|NCT02106832|76232|P4|Overall Study|Adverse Event|0
15054|NCT02106832|76233|P3|Overall Study|Adverse Event|3
15055|NCT02106832|76234|P2|Overall Study|Adverse Event|2
15056|NCT02106832|76235|P1|Overall Study|Adverse Event|1
15057|NCT02106403|76302|P6|Follow-Up Visit 3|Other Reason|1
15058|NCT02106403|76303|P5|Follow-Up Visit 3|Other Reason|0
15059|NCT02106403|76304|P4|Follow-Up Visit 3|Other Reason|0
15060|NCT02106403|76305|P3|Follow-Up Visit 3|Other Reason|0
15061|NCT02106403|76306|P2|Follow-Up Visit 3|Other Reason|0
15062|NCT02106403|76307|P1|Follow-Up Visit 3|Other Reason|0
15063|NCT02106156|76330|P3|Overall Study|Relocation/Change of Physician|0
15064|NCT02106156|76331|P2|Overall Study|Relocation/Change of Physician|1
15065|NCT02106156|76332|P1|Overall Study|Relocation/Change of Physician|40
15066|NCT02106156|76330|P3|Overall Study|Hospitalization/Surgical Intervention|0
15067|NCT02106156|76331|P2|Overall Study|Hospitalization/Surgical Intervention|0
15068|NCT02106156|76332|P1|Overall Study|Hospitalization/Surgical Intervention|6
15069|NCT02106156|76330|P3|Overall Study|Change of Laboratory Parameter|0
15070|NCT02106156|76331|P2|Overall Study|Change of Laboratory Parameter|0
15071|NCT02106156|76332|P1|Overall Study|Change of Laboratory Parameter|10
15072|NCT02106156|76330|P3|Overall Study|Unplanned Event|0
15073|NCT02106156|76331|P2|Overall Study|Unplanned Event|2
15074|NCT02106156|76332|P1|Overall Study|Unplanned Event|82
15075|NCT02106156|76330|P3|Overall Study|Lost to Follow-up|0
15076|NCT02106156|76331|P2|Overall Study|Lost to Follow-up|8
15077|NCT02106156|76332|P1|Overall Study|Lost to Follow-up|451
15078|NCT02106156|76330|P3|Overall Study|Patients Request|0
15079|NCT02106156|76331|P2|Overall Study|Patients Request|9
15080|NCT02106156|76332|P1|Overall Study|Patients Request|307
15081|NCT02106156|76330|P3|Overall Study|Lack of Compliance|0
15082|NCT02106156|76331|P2|Overall Study|Lack of Compliance|7
15083|NCT02106156|76332|P1|Overall Study|Lack of Compliance|211
15084|NCT02106156|76330|P3|Overall Study|Concomitant Disease|0
15085|NCT02106156|76331|P2|Overall Study|Concomitant Disease|2
15086|NCT02106156|76332|P1|Overall Study|Concomitant Disease|74
15087|NCT02106156|76330|P3|Overall Study|Lack of Virological Response|0
15088|NCT02106156|76331|P2|Overall Study|Lack of Virological Response|8
15089|NCT02106156|76332|P1|Overall Study|Lack of Virological Response|1044
15090|NCT02106156|76330|P3|Overall Study|Lack of Tolerability|0
15091|NCT02106156|76331|P2|Overall Study|Lack of Tolerability|3
15092|NCT02106156|76332|P1|Overall Study|Lack of Tolerability|305
15093|NCT02106156|76330|P3|Overall Study|Patient Died|0
15094|NCT02106156|76331|P2|Overall Study|Patient Died|0
15095|NCT02106156|76332|P1|Overall Study|Patient Died|19
15096|NCT02105987|76356|P6|Continuation Phase|Protocol Violation|0
15097|NCT02105987|76357|P5|Continuation Phase|Protocol Violation|1
15098|NCT02105987|76358|P4|Continuation Phase|Protocol Violation|0
15099|NCT02105987|76359|P3|Continuation Phase|Protocol Violation|0
15100|NCT02105987|76360|P2|Continuation Phase|Protocol Violation|0
15101|NCT02105987|76361|P1|Continuation Phase|Protocol Violation|0
15102|NCT02105987|76356|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
15103|NCT02105987|76357|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
15104|NCT02105987|76358|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
15105|NCT02105987|76359|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
15106|NCT02105987|76360|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
15107|NCT02105987|76361|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
15108|NCT02105987|76356|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
15109|NCT02105987|76357|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
15110|NCT02105987|76358|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
15111|NCT02105987|76359|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
15112|NCT02105987|76360|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
15113|NCT02105987|76361|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
15114|NCT02105987|76356|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
15115|NCT02105987|76357|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
15116|NCT02105987|76358|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
15117|NCT02105987|76359|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
15118|NCT02105987|76360|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
15119|NCT02105987|76361|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
15120|NCT02105987|76356|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
15121|NCT02105987|76357|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
15122|NCT02105987|76358|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
15123|NCT02105987|76359|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
15124|NCT02105987|76360|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
15125|NCT02105987|76361|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
15126|NCT02105987|76356|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
15127|NCT02105987|76357|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
15128|NCT02105987|76358|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
15129|NCT02105987|76359|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
15130|NCT02105987|76360|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
15131|NCT02105987|76361|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
15132|NCT02105987|76356|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
15133|NCT02105987|76357|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
15134|NCT02105987|76358|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
15135|NCT02105987|76359|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
15136|NCT02105987|76360|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
15137|NCT02105987|76361|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
15138|NCT02105987|76356|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
15139|NCT02105987|76357|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
15140|NCT02105987|76358|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
15141|NCT02105987|76359|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
15142|NCT02105987|76360|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
15143|NCT02105987|76361|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
15144|NCT02105987|76356|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
15145|NCT02105987|76357|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
15146|NCT02105987|76358|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
15147|NCT02105987|76359|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
15148|NCT02105987|76360|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
15149|NCT02105987|76361|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
15150|NCT02105987|76356|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
15151|NCT02105987|76357|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
15152|NCT02105987|76358|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
15153|NCT02105987|76359|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
15154|NCT02105987|76360|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
15155|NCT02105987|76361|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
15156|NCT02105987|76356|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
15157|NCT02105987|76357|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
15158|NCT02105987|76358|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
15159|NCT02105987|76359|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
15160|NCT02105987|76360|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
15161|NCT02105987|76361|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
15162|NCT02105987|76356|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
15163|NCT02105987|76357|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
15164|NCT02105987|76358|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
15165|NCT02105987|76359|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
15166|NCT02105987|76360|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
15167|NCT02105987|76361|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
15168|NCT02105987|76356|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
15169|NCT02105987|76357|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
15170|NCT02105987|76358|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
15171|NCT02105987|76359|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
15172|NCT02105987|76360|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
15173|NCT02105987|76361|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
15174|NCT02105987|76356|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
15175|NCT02105987|76357|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
15176|NCT02105987|76358|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
15177|NCT02105987|76359|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
15178|NCT02105987|76360|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
15179|NCT02105987|76361|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
15180|NCT02105974|76415|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
15181|NCT02105974|76416|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
15182|NCT02105974|76417|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
15183|NCT02105974|76415|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
15184|NCT02105974|76416|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
15185|NCT02105974|76417|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
15186|NCT02105974|76415|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
15187|NCT02105974|76416|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
15188|NCT02105974|76417|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
15189|NCT02105974|76415|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
15190|NCT02105974|76416|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
15191|NCT02105974|76417|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
15192|NCT02105974|76415|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
15193|NCT02105974|76416|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
15194|NCT02105974|76417|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
15195|NCT02105974|76415|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
15196|NCT02105974|76416|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
15197|NCT02105974|76417|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
15198|NCT02105974|76415|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
15199|NCT02105974|76416|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
15200|NCT02105974|76417|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
15201|NCT02105974|76415|P3|2 Week Run-in Period|Investigator discretion|0
15202|NCT02105974|76416|P2|2 Week Run-in Period|Investigator discretion|0
15203|NCT02105974|76417|P1|2 Week Run-in Period|Investigator discretion|8
15204|NCT02105974|76415|P3|2 Week Run-in Period|Withdrew consent|0
15205|NCT02105974|76416|P2|2 Week Run-in Period|Withdrew consent|0
15206|NCT02105974|76417|P1|2 Week Run-in Period|Withdrew consent|23
15207|NCT02105974|76415|P3|2 Week Run-in Period|Lost to Follow-up|0
15208|NCT02105974|76416|P2|2 Week Run-in Period|Lost to Follow-up|0
15209|NCT02105974|76417|P1|2 Week Run-in Period|Lost to Follow-up|2
15210|NCT02105974|76415|P3|2 Week Run-in Period|Study closed/terminated|0
15211|NCT02105974|76416|P2|2 Week Run-in Period|Study closed/terminated|0
15212|NCT02105974|76417|P1|2 Week Run-in Period|Study closed/terminated|1
15213|NCT02105974|76415|P3|2 Week Run-in Period|Adverse Event|0
15214|NCT02105974|76416|P2|2 Week Run-in Period|Adverse Event|0
15215|NCT02105974|76417|P1|2 Week Run-in Period|Adverse Event|6
15216|NCT02105974|76415|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
15217|NCT02105974|76416|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
15218|NCT02105974|76417|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
15219|NCT02105974|76415|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
15220|NCT02105974|76416|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
15221|NCT02105974|76417|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
15222|NCT02105961|76430|P3|Overall Study|Withdrawal by Subject|11
15223|NCT02105961|76431|P2|Overall Study|Withdrawal by Subject|7
15224|NCT02105961|76432|P1|Overall Study|Withdrawal by Subject|15
15225|NCT02105961|76430|P3|Overall Study|Physician Decision|2
15226|NCT02105961|76431|P2|Overall Study|Physician Decision|3
15227|NCT02105961|76432|P1|Overall Study|Physician Decision|3
15228|NCT02105961|76430|P3|Overall Study|Lost to Follow-up|1
15229|NCT02105961|76431|P2|Overall Study|Lost to Follow-up|0
15230|NCT02105961|76432|P1|Overall Study|Lost to Follow-up|2
15231|NCT02105961|76430|P3|Overall Study|Lack of Efficacy|3
15232|NCT02105961|76431|P2|Overall Study|Lack of Efficacy|0
15233|NCT02105961|76432|P1|Overall Study|Lack of Efficacy|3
15234|NCT02105961|76430|P3|Overall Study|Adverse Event|13
15235|NCT02105961|76431|P2|Overall Study|Adverse Event|7
15236|NCT02105961|76432|P1|Overall Study|Adverse Event|18
15237|NCT02105948|76456|P4|Overall Study|Withdrawal by Subject|11
15238|NCT02105948|76457|P3|Overall Study|Withdrawal by Subject|10
15239|NCT02105948|76458|P2|Overall Study|Withdrawal by Subject|10
15240|NCT02105948|76459|P1|Overall Study|Withdrawal by Subject|15
15241|NCT02105948|76456|P4|Overall Study|Physician Decision|2
15242|NCT02105948|76457|P3|Overall Study|Physician Decision|2
15243|NCT02105948|76458|P2|Overall Study|Physician Decision|2
15244|NCT02105948|76459|P1|Overall Study|Physician Decision|2
15245|NCT02105948|76456|P4|Overall Study|Lost to Follow-up|1
15246|NCT02105948|76457|P3|Overall Study|Lost to Follow-up|2
15247|NCT02105948|76458|P2|Overall Study|Lost to Follow-up|0
15248|NCT02105948|76459|P1|Overall Study|Lost to Follow-up|0
15249|NCT02105948|76456|P4|Overall Study|Lack of Efficacy|2
15250|NCT02105948|76457|P3|Overall Study|Lack of Efficacy|3
15251|NCT02105948|76458|P2|Overall Study|Lack of Efficacy|1
15252|NCT02105948|76459|P1|Overall Study|Lack of Efficacy|0
15253|NCT02105948|76456|P4|Overall Study|Adverse Event|11
15254|NCT02105948|76457|P3|Overall Study|Adverse Event|11
15255|NCT02105948|76458|P2|Overall Study|Adverse Event|7
15256|NCT02105948|76459|P1|Overall Study|Adverse Event|10
15257|NCT02105701|76500|P4|Overall Study|Death|0
15258|NCT02105701|76501|P3|Overall Study|Death|0
15259|NCT02105701|76502|P2|Overall Study|Death|0
15260|NCT02105701|76503|P1|Overall Study|Death|1
15261|NCT02105701|76500|P4|Overall Study|Withdrawal by Subject|1
15262|NCT02105701|76501|P3|Overall Study|Withdrawal by Subject|0
15263|NCT02105701|76502|P2|Overall Study|Withdrawal by Subject|1
15264|NCT02105701|76503|P1|Overall Study|Withdrawal by Subject|2
15265|NCT02105701|76500|P4|Overall Study|Protocol Violation|0
15266|NCT02105701|76501|P3|Overall Study|Protocol Violation|1
15267|NCT02105701|76502|P2|Overall Study|Protocol Violation|0
15268|NCT02105701|76503|P1|Overall Study|Protocol Violation|0
15269|NCT02105701|76500|P4|Overall Study|Lost to Follow-up|1
15270|NCT02105701|76501|P3|Overall Study|Lost to Follow-up|2
15271|NCT02105701|76502|P2|Overall Study|Lost to Follow-up|0
15272|NCT02105701|76503|P1|Overall Study|Lost to Follow-up|1
15273|NCT02105688|76527|P2|Overall Study|Withdrawal by Subject|2
15274|NCT02105688|76528|P1|Overall Study|Withdrawal by Subject|4
15275|NCT02105688|76527|P2|Overall Study|Protocol Violation|1
15276|NCT02105688|76528|P1|Overall Study|Protocol Violation|0
15277|NCT02105688|76527|P2|Overall Study|Physician Decision|1
15278|NCT02105688|76528|P1|Overall Study|Physician Decision|0
15279|NCT02105688|76527|P2|Overall Study|Lost to Follow-up|4
15280|NCT02105688|76528|P1|Overall Study|Lost to Follow-up|9
15281|NCT02105688|76527|P2|Overall Study|Adverse Event|1
15282|NCT02105688|76528|P1|Overall Study|Adverse Event|1
15283|NCT02105688|76527|P2|Overall Study|Ongoing|90
15284|NCT02105688|76528|P1|Overall Study|Ongoing|12
15285|NCT02105662|76538|P1|Overall Study|Withdrawal by Subject|1
15286|NCT02105662|76538|P1|Overall Study|Lost to Follow-up|5
15287|NCT02105636|76547|P2|Overall Study|Not Reported|0
15288|NCT02105636|76548|P1|Overall Study|Not Reported|3
15289|NCT02105636|76547|P2|Overall Study|Reason Not Specified|2
15290|NCT02105636|76548|P1|Overall Study|Reason Not Specified|0
15291|NCT02105636|76547|P2|Overall Study|Poor/Non-compliance|1
15292|NCT02105636|76548|P1|Overall Study|Poor/Non-compliance|0
15293|NCT02105636|76547|P2|Overall Study|Maximum Clinical Benefit|1
15294|NCT02105636|76548|P1|Overall Study|Maximum Clinical Benefit|1
15295|NCT02105636|76547|P2|Overall Study|Subject Withdrew Consent|1
15296|NCT02105636|76548|P1|Overall Study|Subject Withdrew Consent|4
15297|NCT02105636|76547|P2|Overall Study|Subject Request to Discontinue Treatment|6
15298|NCT02105636|76548|P1|Overall Study|Subject Request to Discontinue Treatment|4
15299|NCT02105636|76547|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
15300|NCT02105636|76548|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
15301|NCT02105636|76547|P2|Overall Study|Study Drug Toxicity|11
15302|NCT02105636|76548|P1|Overall Study|Study Drug Toxicity|9
15303|NCT02105636|76547|P2|Overall Study|Disease Progression|83
15304|NCT02105636|76548|P1|Overall Study|Disease Progression|162
15305|NCT02105467|76560|P2|Period 3|Lost to Follow-up|1
15306|NCT02105467|76561|P1|Period 3|Lost to Follow-up|0
15307|NCT02105467|76560|P2|Period 2|Withdrawal by Subject|2
15308|NCT02105467|76561|P1|Period 2|Withdrawal by Subject|0
15309|NCT02105467|76560|P2|Period 2|Death|0
15310|NCT02105467|76561|P1|Period 2|Death|1
15311|NCT02105467|76560|P2|Period 2|Lost to Follow-up|0
15312|NCT02105467|76561|P1|Period 2|Lost to Follow-up|1
15313|NCT02105467|76560|P2|Period 1|Death|0
15314|NCT02105467|76561|P1|Period 1|Death|1
15315|NCT02105467|76560|P2|Period 1|Lost to Follow-up|0
15316|NCT02105467|76561|P1|Period 1|Lost to Follow-up|1
15317|NCT02105454|76573|P1|Overall Study|Withdrawal by Subject|1
15318|NCT02105285|76660|P3|Overall Study|Withdrawal by Subject|0
15319|NCT02105285|76661|P2|Overall Study|Withdrawal by Subject|0
15320|NCT02105285|76662|P1|Overall Study|Withdrawal by Subject|1
15321|NCT02105285|76660|P3|Overall Study|Protocol Violation|0
15322|NCT02105285|76661|P2|Overall Study|Protocol Violation|1
15323|NCT02105285|76662|P1|Overall Study|Protocol Violation|0
15324|NCT02105285|76660|P3|Overall Study|Adverse Event|0
15325|NCT02105285|76661|P2|Overall Study|Adverse Event|1
15326|NCT02105285|76662|P1|Overall Study|Adverse Event|1
15327|NCT02105272|76681|P2|Overall Study|Withdrawal by Subject|0
15328|NCT02105272|76682|P1|Overall Study|Withdrawal by Subject|2
15329|NCT02105272|76681|P2|Overall Study|Protocol Violation|0
15330|NCT02105272|76682|P1|Overall Study|Protocol Violation|2
15331|NCT02105272|76681|P2|Overall Study|Physician Decision|1
15332|NCT02105272|76682|P1|Overall Study|Physician Decision|0
15333|NCT02105272|76681|P2|Overall Study|Adverse Event|2
15334|NCT02105272|76682|P1|Overall Study|Adverse Event|1
15335|NCT02105012|76698|P1|Overall Study|Lack of Efficacy|1
15336|NCT02105012|76698|P1|Overall Study|Adverse Event|1
15337|NCT02105012|76698|P1|Overall Study|Physician Decision|3
15338|NCT02105012|76698|P1|Overall Study|Protocol Violation|4
15339|NCT02105012|76698|P1|Overall Study|Lost to Follow-up|4
15340|NCT02105012|76698|P1|Overall Study|Protocol Specified Criteria|9
15341|NCT02105012|76698|P1|Overall Study|Withdrawal by Subject|11
15342|NCT02104947|76732|P2|Overall Study|Other than stated above|3
15343|NCT02104947|76733|P1|Overall Study|Other than stated above|2
15344|NCT02104947|76732|P2|Overall Study|Adverse Event|38
15345|NCT02104947|76733|P1|Overall Study|Adverse Event|57
15346|NCT02104947|76732|P2|Overall Study|Protocol Violation|8
15347|NCT02104947|76733|P1|Overall Study|Protocol Violation|6
15348|NCT02104947|76732|P2|Overall Study|Lost to Follow-up|4
15349|NCT02104947|76733|P1|Overall Study|Lost to Follow-up|4
15350|NCT02104947|76732|P2|Overall Study|Withdrawal by Subject|3
15351|NCT02104947|76733|P1|Overall Study|Withdrawal by Subject|10
15352|NCT02104895|76751|P2|Overall Study|Withdrawal by Subject|14
15353|NCT02104895|76752|P1|Overall Study|Withdrawal by Subject|0
15354|NCT02104804|76792|P2|Overall Study|Withdrawal by Subject|12
15355|NCT02104804|76793|P1|Overall Study|Withdrawal by Subject|4
15356|NCT02104804|76792|P2|Overall Study|Adverse Event|3
15357|NCT02104804|76793|P1|Overall Study|Adverse Event|4
15358|NCT02104804|76792|P2|Overall Study|Protocol Violation|1
15359|NCT02104804|76793|P1|Overall Study|Protocol Violation|0
15360|NCT02104804|76792|P2|Overall Study|Other listed|1
15361|NCT02104804|76793|P1|Overall Study|Other listed|2
15362|NCT02104804|76792|P2|Overall Study|Study specific discontinuation criteria|1
15363|NCT02104804|76793|P1|Overall Study|Study specific discontinuation criteria|6
15364|NCT02104804|76792|P2|Overall Study|Did not take study medication|1
15365|NCT02104804|76793|P1|Overall Study|Did not take study medication|0
15366|NCT02104505|76811|P2|Second Intervention (14 Days)|Adverse Event|0
15367|NCT02104505|76812|P1|Second Intervention (14 Days)|Adverse Event|2
15368|NCT02104505|76811|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
15369|NCT02104505|76812|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
15370|NCT02104505|76811|P2|First Intervention (14 Days)|exclusionary condition|1
15371|NCT02104505|76812|P1|First Intervention (14 Days)|exclusionary condition|0
15372|NCT02104505|76811|P2|First Intervention (14 Days)|Lost to Follow-up|1
15373|NCT02104505|76812|P1|First Intervention (14 Days)|Lost to Follow-up|0
15374|NCT02104505|76811|P2|First Intervention (14 Days)|Withdrawal by Subject|1
15375|NCT02104505|76812|P1|First Intervention (14 Days)|Withdrawal by Subject|0
15376|NCT02104505|76811|P2|First Intervention (14 Days)|Adverse Event|0
15377|NCT02104505|76812|P1|First Intervention (14 Days)|Adverse Event|2
15378|NCT02103439|76864|P2|Overall Study|Withdrawal by Subject|1
15379|NCT02103439|76865|P1|Overall Study|Withdrawal by Subject|3
15380|NCT02103439|76864|P2|Overall Study|Adverse Event|2
15381|NCT02103439|76865|P1|Overall Study|Adverse Event|0
15382|NCT02103062|76957|P2|Overall Study|Death|1
15383|NCT02103062|76958|P1|Overall Study|Death|0
15384|NCT02103062|76957|P2|Overall Study|Progressive Disease|20
15385|NCT02103062|76958|P1|Overall Study|Progressive Disease|17
15386|NCT02103062|76957|P2|Overall Study|Adverse Event|2
15387|NCT02103062|76958|P1|Overall Study|Adverse Event|1
15388|NCT02102490|77049|P1|Overall Study|Lost to Follow-up|1
15389|NCT02102490|77049|P1|Overall Study|Death|5
15390|NCT02102490|77049|P1|Overall Study|Adverse Event|3
15391|NCT02102464|77063|P3|Randomized Study|Withdrawal by Subject|0
15392|NCT02102464|77064|P2|Randomized Study|Withdrawal by Subject|1
15393|NCT02102464|77065|P1|Randomized Study|Withdrawal by Subject|0
15394|NCT02102399|77084|P2|Overall Study|Withdrawal by Subject|4
15395|NCT02102399|77085|P1|Overall Study|Withdrawal by Subject|6
15396|NCT02102204|77133|P1|Overall Study|Ongoing|5
15397|NCT02102204|77133|P1|Overall Study|Sponsor Decision|5
15398|NCT02102204|77133|P1|Overall Study|Lost to Follow-up|65
15399|NCT02102204|77133|P1|Overall Study|Death|92
15400|NCT02102204|77133|P1|Overall Study|Withdrawal by Subject|137
15401|NCT02101359|77144|P2|Overall Study|Protocol Violation|2
15402|NCT02101359|77145|P1|Overall Study|Protocol Violation|0
15403|NCT02101359|77144|P2|Overall Study|Lost to Follow-up|0
15404|NCT02101359|77145|P1|Overall Study|Lost to Follow-up|1
15405|NCT02101359|77144|P2|Overall Study|Withdrawal by Subject|4
15406|NCT02101359|77145|P1|Overall Study|Withdrawal by Subject|5
15407|NCT02101359|77144|P2|Overall Study|Not included|13
15408|NCT02101359|77145|P1|Overall Study|Not included|23
15409|NCT02101294|77151|P1|Overall Study|Lost to Follow-up|6
15410|NCT02101294|77151|P1|Overall Study|Withdrawal by Subject|5
15411|NCT02101112|77171|P6|Overall Study|Withdrawal by Subject|0
15412|NCT02101112|77172|P5|Overall Study|Withdrawal by Subject|1
15413|NCT02101112|77173|P4|Overall Study|Withdrawal by Subject|0
15414|NCT02101112|77174|P3|Overall Study|Withdrawal by Subject|0
15415|NCT02101112|77175|P2|Overall Study|Withdrawal by Subject|0
15416|NCT02101112|77176|P1|Overall Study|Withdrawal by Subject|0
15417|NCT02101112|77171|P6|Overall Study|Adverse Event|0
15418|NCT02101112|77172|P5|Overall Study|Adverse Event|0
15419|NCT02101112|77173|P4|Overall Study|Adverse Event|0
15420|NCT02101112|77174|P3|Overall Study|Adverse Event|1
15421|NCT02101112|77175|P2|Overall Study|Adverse Event|0
15422|NCT02101112|77176|P1|Overall Study|Adverse Event|0
15423|NCT02101021|77206|P5|Overall Study|Study Terminated by Sponsor|1
15424|NCT02101021|77207|P4|Overall Study|Study Terminated by Sponsor|1
15425|NCT02101021|77208|P3|Overall Study|Study Terminated by Sponsor|1
15426|NCT02101021|77209|P2|Overall Study|Study Terminated by Sponsor|0
15427|NCT02101021|77210|P1|Overall Study|Study Terminated by Sponsor|1
15428|NCT02101021|77206|P5|Overall Study|Lost to Follow-up|0
15429|NCT02101021|77207|P4|Overall Study|Lost to Follow-up|0
15430|NCT02101021|77208|P3|Overall Study|Lost to Follow-up|0
15431|NCT02101021|77209|P2|Overall Study|Lost to Follow-up|0
15432|NCT02101021|77210|P1|Overall Study|Lost to Follow-up|1
15433|NCT02101021|77206|P5|Overall Study|Withdrew Consent from study|0
15434|NCT02101021|77207|P4|Overall Study|Withdrew Consent from study|2
15435|NCT02101021|77208|P3|Overall Study|Withdrew Consent from study|0
15436|NCT02101021|77209|P2|Overall Study|Withdrew Consent from study|1
15437|NCT02101021|77210|P1|Overall Study|Withdrew Consent from study|1
15438|NCT02101021|77206|P5|Overall Study|Death|3
15439|NCT02101021|77207|P4|Overall Study|Death|0
15440|NCT02101021|77208|P3|Overall Study|Death|6
15441|NCT02101021|77209|P2|Overall Study|Death|3
15442|NCT02101021|77210|P1|Overall Study|Death|4
15443|NCT02100839|77259|P2|Multiple Ascending Dose|Withdrawal by Subject|0
15444|NCT02100839|77260|P1|Multiple Ascending Dose|Withdrawal by Subject|2
15445|NCT02100839|77259|P2|Multiple Ascending Dose|Adverse Event|0
15446|NCT02100839|77260|P1|Multiple Ascending Dose|Adverse Event|2
15447|NCT02100670|77287|P4|Overall Study|Withdrawal by Subject|0
15448|NCT02100670|77288|P3|Overall Study|Withdrawal by Subject|0
15449|NCT02100670|77289|P2|Overall Study|Withdrawal by Subject|0
15450|NCT02100670|77290|P1|Overall Study|Withdrawal by Subject|1
15451|NCT02100670|77287|P4|Overall Study|Physician Decision|0
15452|NCT02100670|77288|P3|Overall Study|Physician Decision|0
15453|NCT02100670|77289|P2|Overall Study|Physician Decision|1
15454|NCT02100670|77290|P1|Overall Study|Physician Decision|0
15455|NCT02100670|77287|P4|Overall Study|Poor Efficacy|0
15456|NCT02100670|77288|P3|Overall Study|Poor Efficacy|0
15457|NCT02100670|77289|P2|Overall Study|Poor Efficacy|1
15458|NCT02100670|77290|P1|Overall Study|Poor Efficacy|0
15459|NCT02100670|77287|P4|Overall Study|No swelling no pain|0
15460|NCT02100670|77288|P3|Overall Study|No swelling no pain|0
15461|NCT02100670|77289|P2|Overall Study|No swelling no pain|0
15462|NCT02100670|77290|P1|Overall Study|No swelling no pain|1
15463|NCT02100670|77287|P4|Overall Study|Withdrawal of Consent|0
15464|NCT02100670|77288|P3|Overall Study|Withdrawal of Consent|1
15465|NCT02100670|77289|P2|Overall Study|Withdrawal of Consent|1
15466|NCT02100670|77290|P1|Overall Study|Withdrawal of Consent|0
15467|NCT02100670|77287|P4|Overall Study|Protocol Violation|1
15468|NCT02100670|77288|P3|Overall Study|Protocol Violation|0
15469|NCT02100670|77289|P2|Overall Study|Protocol Violation|1
15470|NCT02100670|77290|P1|Overall Study|Protocol Violation|0
15471|NCT02100670|77287|P4|Overall Study|Lost to Follow-up|0
15472|NCT02100670|77288|P3|Overall Study|Lost to Follow-up|0
15473|NCT02100670|77289|P2|Overall Study|Lost to Follow-up|0
15474|NCT02100670|77290|P1|Overall Study|Lost to Follow-up|1
15475|NCT02100670|77287|P4|Overall Study|Adverse Event|0
15476|NCT02100670|77288|P3|Overall Study|Adverse Event|3
15477|NCT02100670|77289|P2|Overall Study|Adverse Event|3
15478|NCT02100670|77290|P1|Overall Study|Adverse Event|10
15479|NCT02100644|77350|P3|LTG Escalation Phase|Withdrawal by Subject|0
15480|NCT02100644|77351|P2|LTG Escalation Phase|Withdrawal by Subject|0
15481|NCT02100644|77352|P1|LTG Escalation Phase|Withdrawal by Subject|3
15482|NCT02100644|77350|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
15483|NCT02100644|77351|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
15484|NCT02100644|77352|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
15485|NCT02100644|77350|P3|LTG Escalation Phase|Adverse Event|0
15486|NCT02100644|77351|P2|LTG Escalation Phase|Adverse Event|0
15487|NCT02100644|77352|P1|LTG Escalation Phase|Adverse Event|9
15488|NCT02100514|77377|P2|Overall Study|Other|11
15489|NCT02100514|77378|P1|Overall Study|Other|9
15490|NCT02100514|77377|P2|Overall Study|Withdrawal by Subject|37
15491|NCT02100514|77378|P1|Overall Study|Withdrawal by Subject|12
15492|NCT02100514|77377|P2|Overall Study|Protocol Violation|1
15493|NCT02100514|77378|P1|Overall Study|Protocol Violation|1
15494|NCT02100514|77377|P2|Overall Study|Did Not Meet Entrance Criteria|1
15495|NCT02100514|77378|P1|Overall Study|Did Not Meet Entrance Criteria|0
15496|NCT02100514|77377|P2|Overall Study|Lost to Follow-up|17
15497|NCT02100514|77378|P1|Overall Study|Lost to Follow-up|5
15498|NCT02100514|77377|P2|Overall Study|Death|2
15499|NCT02100514|77378|P1|Overall Study|Death|2
15500|NCT02100514|77377|P2|Overall Study|Adverse Event|5
15501|NCT02100514|77378|P1|Overall Study|Adverse Event|0
15502|NCT02100475|77438|P2|Overall Study|Withdrawal criteria|0
15503|NCT02100475|77439|P1|Overall Study|Withdrawal criteria|1
15504|NCT02100475|77438|P2|Overall Study|Unclassified|2
15505|NCT02100475|77439|P1|Overall Study|Unclassified|1
15506|NCT02100228|77489|P2|Overall Study|Death|1
15507|NCT02100228|77490|P1|Overall Study|Death|1
15508|NCT02100228|77489|P2|Overall Study|Adverse Event|12
15509|NCT02100228|77490|P1|Overall Study|Adverse Event|16
15510|NCT02100228|77489|P2|Overall Study|Withdrawal by Subject|37
15511|NCT02100228|77490|P1|Overall Study|Withdrawal by Subject|27
15512|NCT02100228|77489|P2|Overall Study|Lost to Follow-up|1
15513|NCT02100228|77490|P1|Overall Study|Lost to Follow-up|0
15514|NCT02100228|77489|P2|Overall Study|Non-compliance|3
15515|NCT02100228|77490|P1|Overall Study|Non-compliance|0
15516|NCT02100228|77489|P2|Overall Study|Inclusion/Exclusion criteria not met|16
15517|NCT02100228|77490|P1|Overall Study|Inclusion/Exclusion criteria not met|12
15518|NCT02100228|77489|P2|Overall Study|Administrative reason|1
15519|NCT02100228|77490|P1|Overall Study|Administrative reason|0
15520|NCT02100228|77489|P2|Overall Study|Other|19
15521|NCT02100228|77490|P1|Overall Study|Other|19
15522|NCT02099838|77536|P2|Overall Study|Withdrawal by Subject|1
15523|NCT02099838|77537|P1|Overall Study|Withdrawal by Subject|0
15524|NCT02099838|77536|P2|Overall Study|Lost to Follow-up|1
15525|NCT02099838|77537|P1|Overall Study|Lost to Follow-up|3
15526|NCT02099838|77536|P2|Overall Study|Death|0
15527|NCT02099838|77537|P1|Overall Study|Death|1
15528|NCT02099708|77567|P1|Overall Study|Other|29
15529|NCT02099708|77567|P1|Overall Study|Lost to Follow-up|141
15530|NCT02099708|77567|P1|Overall Study|Data Not Available|30
15531|NCT02099682|77578|P1|Overall Study|Other|29
15532|NCT02099682|77578|P1|Overall Study|Lost to Follow-up|31
15533|NCT02099682|77578|P1|Overall Study|Data Not Available|51
15534|NCT02099344|77604|P2|Overall Study|Physician Decision|0
15535|NCT02099344|77605|P1|Overall Study|Physician Decision|1
15536|NCT02099110|77640|P5|Overall Study|Physician Decision|1
15537|NCT02099110|77641|P4|Overall Study|Physician Decision|2
15538|NCT02099110|77642|P3|Overall Study|Physician Decision|1
15539|NCT02099110|77643|P2|Overall Study|Physician Decision|0
15540|NCT02099110|77644|P1|Overall Study|Physician Decision|3
15541|NCT02099110|77640|P5|Overall Study|Non-compliance with study drug|1
15542|NCT02099110|77641|P4|Overall Study|Non-compliance with study drug|0
15543|NCT02099110|77642|P3|Overall Study|Non-compliance with study drug|0
15544|NCT02099110|77643|P2|Overall Study|Non-compliance with study drug|0
15545|NCT02099110|77644|P1|Overall Study|Non-compliance with study drug|2
15546|NCT02099110|77640|P5|Overall Study|Screen failure|1
15547|NCT02099110|77641|P4|Overall Study|Screen failure|0
15548|NCT02099110|77642|P3|Overall Study|Screen failure|0
15549|NCT02099110|77643|P2|Overall Study|Screen failure|0
15550|NCT02099110|77644|P1|Overall Study|Screen failure|0
15551|NCT02099110|77640|P5|Overall Study|Death|0
15552|NCT02099110|77641|P4|Overall Study|Death|0
15553|NCT02099110|77642|P3|Overall Study|Death|0
15554|NCT02099110|77643|P2|Overall Study|Death|1
15555|NCT02099110|77644|P1|Overall Study|Death|0
15556|NCT02099110|77640|P5|Overall Study|Lost to Follow-up|6
15557|NCT02099110|77641|P4|Overall Study|Lost to Follow-up|5
15558|NCT02099110|77642|P3|Overall Study|Lost to Follow-up|11
15559|NCT02099110|77643|P2|Overall Study|Lost to Follow-up|12
15560|NCT02099110|77644|P1|Overall Study|Lost to Follow-up|6
15561|NCT02099110|77640|P5|Overall Study|Adverse Event|2
15562|NCT02099110|77641|P4|Overall Study|Adverse Event|3
15563|NCT02099110|77642|P3|Overall Study|Adverse Event|2
15564|NCT02099110|77643|P2|Overall Study|Adverse Event|5
15565|NCT02099110|77644|P1|Overall Study|Adverse Event|3
15566|NCT02099110|77640|P5|Overall Study|Withdrawal by Subject|13
15567|NCT02099110|77641|P4|Overall Study|Withdrawal by Subject|9
15568|NCT02099110|77642|P3|Overall Study|Withdrawal by Subject|13
15569|NCT02099110|77643|P2|Overall Study|Withdrawal by Subject|11
15570|NCT02099110|77644|P1|Overall Study|Withdrawal by Subject|7
15571|NCT02099110|77640|P5|Overall Study|Participant moved|2
15572|NCT02099110|77641|P4|Overall Study|Participant moved|0
15573|NCT02099110|77642|P3|Overall Study|Participant moved|1
15574|NCT02099110|77643|P2|Overall Study|Participant moved|1
15575|NCT02099110|77644|P1|Overall Study|Participant moved|1
15576|NCT02099110|77640|P5|Overall Study|Protocol Violation|1
15577|NCT02099110|77641|P4|Overall Study|Protocol Violation|3
15578|NCT02099110|77642|P3|Overall Study|Protocol Violation|0
15579|NCT02099110|77643|P2|Overall Study|Protocol Violation|1
15580|NCT02099110|77644|P1|Overall Study|Protocol Violation|2
15581|NCT02098746|77718|P1|Overall Study|Data Not Available After Treatment|1
15582|NCT02098746|77718|P1|Overall Study|Enrolled 15 Days After the First Dose|1
15583|NCT02098746|77718|P1|Overall Study|Other Miscellaneous Reasons|1
15584|NCT02098746|77718|P1|Overall Study|Changes of Investigator|2
15585|NCT02098733|77726|P1|Overall Study|Lost to Follow-up|5
15586|NCT02098733|77726|P1|Overall Study|Data Not Available|5
15587|NCT02098395|77740|P4|Overall Study|Unclassified|2
15588|NCT02098395|77741|P3|Overall Study|Unclassified|3
15589|NCT02098395|77742|P2|Overall Study|Unclassified|0
15590|NCT02098395|77743|P1|Overall Study|Unclassified|0
15591|NCT02098395|77740|P4|Overall Study|Lost to Follow-up|3
15592|NCT02098395|77741|P3|Overall Study|Lost to Follow-up|0
15593|NCT02098395|77742|P2|Overall Study|Lost to Follow-up|1
15594|NCT02098395|77743|P1|Overall Study|Lost to Follow-up|2
15595|NCT02098395|77740|P4|Overall Study|Adverse Event|2
15596|NCT02098395|77741|P3|Overall Study|Adverse Event|34
15597|NCT02098395|77742|P2|Overall Study|Adverse Event|19
15598|NCT02098395|77743|P1|Overall Study|Adverse Event|12
15599|NCT02098395|77740|P4|Overall Study|Withdrawal by Subject|13
15600|NCT02098395|77741|P3|Overall Study|Withdrawal by Subject|5
15601|NCT02098395|77742|P2|Overall Study|Withdrawal by Subject|10
15602|NCT02098395|77743|P1|Overall Study|Withdrawal by Subject|10
15603|NCT02098395|77740|P4|Overall Study|Protocol Violation|7
15604|NCT02098395|77741|P3|Overall Study|Protocol Violation|0
15605|NCT02098395|77742|P2|Overall Study|Protocol Violation|2
15606|NCT02098395|77743|P1|Overall Study|Protocol Violation|2
15607|NCT02098109|77770|P2|Overall Study|Protocol Violation|0
15608|NCT02098109|77771|P1|Overall Study|Protocol Violation|3
15609|NCT02097823|77849|P2|Overall Study|Withdrawal by Subject|1
15610|NCT02097823|77850|P1|Overall Study|Withdrawal by Subject|1
15611|NCT02097745|77865|P1|Overall Study|Reason Not Specified|96
15612|NCT02097745|77865|P1|Overall Study|Administrative/Other|27
15613|NCT02097745|77865|P1|Overall Study|Failure to Return|14
15614|NCT02097745|77865|P1|Overall Study|Death|16
15615|NCT02097745|77865|P1|Overall Study|Adverse Event|25
15616|NCT02097719|77901|P2|Overall Study|Adverse Event|0
15617|NCT02097719|77902|P1|Overall Study|Adverse Event|2
15618|NCT02097719|77901|P2|Overall Study|Lost to Follow-up|1
15619|NCT02097719|77902|P1|Overall Study|Lost to Follow-up|0
15620|NCT02097719|77901|P2|Overall Study|Subject Withdrew Consent|0
15621|NCT02097719|77902|P1|Overall Study|Subject Withdrew Consent|1
15622|NCT02097290|77924|P1|Overall Study|Attempt|8
15623|NCT02097290|77924|P1|Overall Study|Total Withdrawals|3
15624|NCT02097290|77924|P1|Overall Study|Death|6
15625|NCT02097238|77934|P1|Overall Study|Progressive Disease|17
15626|NCT02097238|77934|P1|Overall Study|Physician Decision|1
15627|NCT02097238|77934|P1|Overall Study|Death|1
15628|NCT02097108|77940|P1|Overall Study|patient was abroad for 6 months|1
15629|NCT02097108|77940|P1|Overall Study|Adverse Event|1
15630|NCT02097056|77947|P1|Overall Study|Not specified|2
15631|NCT02097056|77947|P1|Overall Study|Adverse Event|37
15632|NCT02097056|77947|P1|Overall Study|Lost to Follow-up|2
15633|NCT02097056|77947|P1|Overall Study|Withdrawal by Subject|15
15634|NCT02097056|77947|P1|Overall Study|Protocol Violation|2
15635|NCT02097030|77955|P2|First Intervention (3 Days)|Visual Acuity|1
15636|NCT02097030|77956|P1|First Intervention (3 Days)|Visual Acuity|0
15637|NCT02097030|77955|P2|First Intervention (3 Days)|Lost to Follow-up|0
15638|NCT02097030|77956|P1|First Intervention (3 Days)|Lost to Follow-up|1
15639|NCT02096952|78017|P1|Overall Study|Adverse Event|1
15640|NCT02096900|78023|P2|Overall Study|Surgery cancelled- medication received|1
15641|NCT02096900|78024|P1|Overall Study|Surgery cancelled- medication received|1
15642|NCT02096900|78023|P2|Overall Study|Did not receive medication|1
15643|NCT02096900|78024|P1|Overall Study|Did not receive medication|3
15644|NCT02096835|78076|P3|Overall Study|Lost to Follow-up|1
15645|NCT02096835|78077|P2|Overall Study|Lost to Follow-up|0
15646|NCT02096835|78078|P1|Overall Study|Lost to Follow-up|1
15647|NCT02096835|78076|P3|Overall Study|converted to open procedures|0
15648|NCT02096835|78077|P2|Overall Study|converted to open procedures|0
15649|NCT02096835|78078|P1|Overall Study|converted to open procedures|1
15650|NCT02096835|78076|P3|Overall Study|Withdrawal by Subject|0
15651|NCT02096835|78077|P2|Overall Study|Withdrawal by Subject|0
15652|NCT02096835|78078|P1|Overall Study|Withdrawal by Subject|1
15653|NCT02096744|78095|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
15654|NCT02096744|78096|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
15655|NCT02096744|78095|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
15656|NCT02096744|78096|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
15657|NCT02096744|78095|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
15658|NCT02096744|78096|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
15659|NCT02096705|78150|P2|Follow-up|Subjects not reporting status|2
15660|NCT02096705|78151|P1|Follow-up|Subjects not reporting status|1
15661|NCT02096705|78150|P2|Follow-up|Adverse Event|2
15662|NCT02096705|78151|P1|Follow-up|Adverse Event|2
15663|NCT02096705|78150|P2|Follow-up|Withdrawal by Subject|0
15664|NCT02096705|78151|P1|Follow-up|Withdrawal by Subject|1
15665|NCT02096705|78150|P2|Treatment|Other|1
15666|NCT02096705|78151|P1|Treatment|Other|1
15667|NCT02096705|78150|P2|Treatment|Withdrawal by Subject|0
15668|NCT02096705|78151|P1|Treatment|Withdrawal by Subject|1
15669|NCT02096705|78150|P2|Treatment|Subject request to discontinue treatment|1
15670|NCT02096705|78151|P1|Treatment|Subject request to discontinue treatment|1
15671|NCT02096705|78150|P2|Treatment|Adverse Event|3
15672|NCT02096705|78151|P1|Treatment|Adverse Event|6
15673|NCT02096042|78249|P3|Overall Study|Disease Progression|0
15674|NCT02096042|78250|P2|Overall Study|Disease Progression|0
15675|NCT02096042|78251|P1|Overall Study|Disease Progression|1
15676|NCT02095873|78260|P2|Second Intervention (8 Weeks)|Protocol Violation|0
15677|NCT02095873|78261|P1|Second Intervention (8 Weeks)|Protocol Violation|1
15678|NCT02095873|78260|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
15679|NCT02095873|78261|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
15680|NCT02095873|78260|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
15681|NCT02095873|78261|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
15682|NCT02095691|78273|P1|Overall Study|Physician Decision|1
15683|NCT02095535|78305|P1|Recruitment|Protocol Violation|2
15684|NCT02095223|78311|P2|Overall Study|Withdrawal by Subject|0
15685|NCT02095223|78312|P1|Overall Study|Withdrawal by Subject|1
15686|NCT02095197|78322|P2|Overall Study|Lost to Follow-up|3
15687|NCT02095197|78323|P1|Overall Study|Lost to Follow-up|0
15688|NCT02095158|78335|P1|Overall Study|Other Miscellaneous Reasons|1
15689|NCT02095158|78335|P1|Overall Study|Protocol Violation|1
15690|NCT02095158|78335|P1|Overall Study|Personal Reasons|35
15691|NCT02095158|78335|P1|Overall Study|Lost to Follow-up|20
15692|NCT02095158|78335|P1|Overall Study|Pregnancy|1
15693|NCT02095158|78335|P1|Overall Study|Lack of Efficacy|3
15694|NCT02095158|78335|P1|Overall Study|Adverse Event|14
15695|NCT02095106|78342|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
15696|NCT02095106|78343|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
15697|NCT02094937|78359|P4|12 Weeks in Period 2|Randomized incorrectly|0
15698|NCT02094937|78360|P3|12 Weeks in Period 2|Randomized incorrectly|0
15699|NCT02094937|78361|P2|12 Weeks in Period 2|Randomized incorrectly|1
15700|NCT02094937|78362|P1|12 Weeks in Period 2|Randomized incorrectly|0
15701|NCT02094937|78359|P4|12 Weeks in Period 2|Withdrawal by Subject|0
15702|NCT02094937|78360|P3|12 Weeks in Period 2|Withdrawal by Subject|2
15703|NCT02094937|78361|P2|12 Weeks in Period 2|Withdrawal by Subject|2
15704|NCT02094937|78362|P1|12 Weeks in Period 2|Withdrawal by Subject|0
15705|NCT02094937|78359|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
15706|NCT02094937|78360|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
15707|NCT02094937|78361|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
15708|NCT02094937|78362|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
15709|NCT02094937|78359|P4|12 Weeks in Period 2|Lack of Efficacy|0
15710|NCT02094937|78360|P3|12 Weeks in Period 2|Lack of Efficacy|0
15711|NCT02094937|78361|P2|12 Weeks in Period 2|Lack of Efficacy|1
15712|NCT02094937|78362|P1|12 Weeks in Period 2|Lack of Efficacy|0
15713|NCT02094937|78359|P4|12 Weeks in Period 2|Adverse Event|1
15714|NCT02094937|78360|P3|12 Weeks in Period 2|Adverse Event|4
15715|NCT02094937|78361|P2|12 Weeks in Period 2|Adverse Event|2
15716|NCT02094937|78362|P1|12 Weeks in Period 2|Adverse Event|0
15717|NCT02094937|78359|P4|8 Weeks in Period 1|Withdrawal by Subject|0
15718|NCT02094937|78360|P3|8 Weeks in Period 1|Withdrawal by Subject|0
15719|NCT02094937|78361|P2|8 Weeks in Period 1|Withdrawal by Subject|0
15720|NCT02094937|78362|P1|8 Weeks in Period 1|Withdrawal by Subject|4
15721|NCT02094937|78359|P4|8 Weeks in Period 1|Physician Decision|0
15722|NCT02094937|78360|P3|8 Weeks in Period 1|Physician Decision|0
15723|NCT02094937|78361|P2|8 Weeks in Period 1|Physician Decision|0
15724|NCT02094937|78362|P1|8 Weeks in Period 1|Physician Decision|1
15725|NCT02094937|78359|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
15726|NCT02094937|78360|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
15727|NCT02094937|78361|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
15728|NCT02094937|78362|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
15729|NCT02094937|78359|P4|8 Weeks in Period 1|Protocol Violation|0
15730|NCT02094937|78360|P3|8 Weeks in Period 1|Protocol Violation|0
15731|NCT02094937|78361|P2|8 Weeks in Period 1|Protocol Violation|0
15732|NCT02094937|78362|P1|8 Weeks in Period 1|Protocol Violation|2
15733|NCT02094937|78359|P4|8 Weeks in Period 1|Lack of Efficacy|0
15734|NCT02094937|78360|P3|8 Weeks in Period 1|Lack of Efficacy|0
15735|NCT02094937|78361|P2|8 Weeks in Period 1|Lack of Efficacy|0
15736|NCT02094937|78362|P1|8 Weeks in Period 1|Lack of Efficacy|3
15737|NCT02094937|78359|P4|8 Weeks in Period 1|Adverse Event|0
15738|NCT02094937|78360|P3|8 Weeks in Period 1|Adverse Event|0
15739|NCT02094937|78361|P2|8 Weeks in Period 1|Adverse Event|0
15740|NCT02094937|78362|P1|8 Weeks in Period 1|Adverse Event|9
15741|NCT02094898|78392|P1|Overall Study|Lack of Efficacy|1
15742|NCT02094898|78392|P1|Overall Study|Adverse Event|2
15743|NCT02094898|78392|P1|Overall Study|Clinical Worsening|2
15744|NCT02094885|78439|P2|Overall Study|Withdrawn due to age|0
15745|NCT02094885|78440|P1|Overall Study|Withdrawn due to age|1
15746|NCT02094885|78439|P2|Overall Study|Death|5
15747|NCT02094885|78440|P1|Overall Study|Death|1
15748|NCT02094677|78454|P2|Overall Study|Screening|1
15749|NCT02094677|78455|P1|Overall Study|Screening|3
15750|NCT02094612|78534|P2|Overall Study|Never started ADHD medication|23
15751|NCT02094612|78535|P1|Overall Study|Never started ADHD medication|32
15752|NCT02094612|78534|P2|Overall Study|Lost to Follow-up|47
15753|NCT02094612|78535|P1|Overall Study|Lost to Follow-up|47
15754|NCT02094573|78555|P2|Overall Study|Ongoing|76
15755|NCT02094573|78556|P1|Overall Study|Ongoing|64
15756|NCT02094573|78555|P2|Overall Study|Randomized but not treated|0
15757|NCT02094573|78556|P1|Overall Study|Randomized but not treated|3
15758|NCT02094573|78555|P2|Overall Study|Withdrawal by Subject|4
15759|NCT02094573|78556|P1|Overall Study|Withdrawal by Subject|2
15760|NCT02094573|78555|P2|Overall Study|Non-compliance with study drug|1
15761|NCT02094573|78556|P1|Overall Study|Non-compliance with study drug|0
15762|NCT02094573|78555|P2|Overall Study|Death|1
15763|NCT02094573|78556|P1|Overall Study|Death|7
15764|NCT02094573|78555|P2|Overall Study|Adverse Event|9
15765|NCT02094573|78556|P1|Overall Study|Adverse Event|3
15766|NCT02094573|78555|P2|Overall Study|Clinical Progressive Disease|3
15767|NCT02094573|78556|P1|Overall Study|Clinical Progressive Disease|4
15768|NCT02094573|78555|P2|Overall Study|Documented Progressive Disease|16
15769|NCT02094573|78556|P1|Overall Study|Documented Progressive Disease|29
15770|NCT02094300|78638|P1|Overall Study|Still be eligible for follow-up|3
15771|NCT02094300|78638|P1|Overall Study|Lost to Follow-up|10
15772|NCT02094300|78638|P1|Overall Study|Death|7
15773|NCT02094261|78642|P1|Overall Study|Ongoing Study at Data Cut-off|181
15774|NCT02094261|78642|P1|Overall Study|Withdrawal by Subject|4
15775|NCT02094261|78642|P1|Overall Study|Lost to Follow-up|1
15776|NCT02094261|78642|P1|Overall Study|Death|24
15777|NCT02093923|78684|P5|Overall Study|Screen failure after randomization|0
15778|NCT02093923|78685|P4|Overall Study|Screen failure after randomization|1
15779|NCT02093923|78686|P3|Overall Study|Screen failure after randomization|0
15780|NCT02093923|78687|P2|Overall Study|Screen failure after randomization|0
15781|NCT02093923|78688|P1|Overall Study|Screen failure after randomization|0
15782|NCT02093923|78684|P5|Overall Study|Lost to Follow-up|0
15783|NCT02093923|78685|P4|Overall Study|Lost to Follow-up|1
15784|NCT02093923|78686|P3|Overall Study|Lost to Follow-up|0
15785|NCT02093923|78687|P2|Overall Study|Lost to Follow-up|0
15786|NCT02093923|78688|P1|Overall Study|Lost to Follow-up|0
15787|NCT02093897|78743|P1|Overall Study|Adverse event, non-fatal|1
15788|NCT02093897|78743|P1|Overall Study|Planned age group closure - no's reached|17
15789|NCT02093897|78743|P1|Overall Study|Physician Decision|1
15790|NCT02093689|78846|P3|Overall Study|Physician Decision|0
15791|NCT02093689|78847|P2|Overall Study|Physician Decision|0
15792|NCT02093689|78848|P1|Overall Study|Physician Decision|4
15793|NCT02093520|78856|P2|Overall Study|Not treated|22
15794|NCT02093520|78857|P1|Overall Study|Not treated|6
15795|NCT02093390|78869|P2|Overall Study|Withdrawal by Subject|1
15796|NCT02093390|78870|P1|Overall Study|Withdrawal by Subject|0
15797|NCT02093351|78909|P3|Overall Study|Death|0
15798|NCT02093351|78910|P2|Overall Study|Death|1
15799|NCT02093351|78911|P1|Overall Study|Death|0
15800|NCT02093351|78909|P3|Overall Study|Condition under investigation worsened|2
15801|NCT02093351|78910|P2|Overall Study|Condition under investigation worsened|0
15802|NCT02093351|78911|P1|Overall Study|Condition under investigation worsened|2
15803|NCT02093351|78909|P3|Overall Study|Adverse Event|1
15804|NCT02093351|78910|P2|Overall Study|Adverse Event|1
15805|NCT02093351|78911|P1|Overall Study|Adverse Event|0
15806|NCT02093221|78967|P5|Overall Study|Study termination|7
15807|NCT02093221|78968|P4|Overall Study|Study termination|6
15808|NCT02093221|78969|P3|Overall Study|Study termination|4
15809|NCT02093221|78970|P2|Overall Study|Study termination|5
15810|NCT02093221|78971|P1|Overall Study|Study termination|6
15811|NCT02093221|78967|P5|Overall Study|Protocol Violation|0
15812|NCT02093221|78968|P4|Overall Study|Protocol Violation|0
15813|NCT02093221|78969|P3|Overall Study|Protocol Violation|0
15814|NCT02093221|78970|P2|Overall Study|Protocol Violation|1
15815|NCT02093221|78971|P1|Overall Study|Protocol Violation|0
15816|NCT02093221|78967|P5|Overall Study|Death|0
15817|NCT02093221|78968|P4|Overall Study|Death|0
15818|NCT02093221|78969|P3|Overall Study|Death|0
15819|NCT02093221|78970|P2|Overall Study|Death|1
15820|NCT02093221|78971|P1|Overall Study|Death|0
15821|NCT02093221|78967|P5|Overall Study|Lost to Follow-up|0
15822|NCT02093221|78968|P4|Overall Study|Lost to Follow-up|1
15823|NCT02093221|78969|P3|Overall Study|Lost to Follow-up|1
15824|NCT02093221|78970|P2|Overall Study|Lost to Follow-up|0
15825|NCT02093221|78971|P1|Overall Study|Lost to Follow-up|2
15826|NCT02093221|78967|P5|Overall Study|Withdrawal by Subject|1
15827|NCT02093221|78968|P4|Overall Study|Withdrawal by Subject|1
15828|NCT02093221|78969|P3|Overall Study|Withdrawal by Subject|4
15829|NCT02093221|78970|P2|Overall Study|Withdrawal by Subject|1
15830|NCT02093221|78971|P1|Overall Study|Withdrawal by Subject|1
15831|NCT02093221|78967|P5|Overall Study|Adverse Event|0
15832|NCT02093221|78968|P4|Overall Study|Adverse Event|0
15833|NCT02093221|78969|P3|Overall Study|Adverse Event|0
15834|NCT02093221|78970|P2|Overall Study|Adverse Event|0
15835|NCT02093221|78971|P1|Overall Study|Adverse Event|1
15836|NCT02093026|79008|P1|Overall Study|Other|157
15837|NCT02093026|79008|P1|Overall Study|Death|10
15838|NCT02093026|79008|P1|Overall Study|Adverse Event|26
15839|NCT02092961|79030|P3|Overall Study|Adverse Event|0
15840|NCT02092961|79031|P2|Overall Study|Adverse Event|4
15841|NCT02092961|79032|P1|Overall Study|Adverse Event|2
15842|NCT02092961|79030|P3|Overall Study|Dev. of study specific discont. criteria|0
15843|NCT02092961|79031|P2|Overall Study|Dev. of study specific discont. criteria|0
15844|NCT02092961|79032|P1|Overall Study|Dev. of study specific discont. criteria|3
15845|NCT02092961|79030|P3|Overall Study|Lack of therapeutic response|3
15846|NCT02092961|79031|P2|Overall Study|Lack of therapeutic response|1
15847|NCT02092961|79032|P1|Overall Study|Lack of therapeutic response|2
15848|NCT02092961|79030|P3|Overall Study|Study stopped|12
15849|NCT02092961|79031|P2|Overall Study|Study stopped|9
15850|NCT02092961|79032|P1|Overall Study|Study stopped|13
15851|NCT02092961|79030|P3|Overall Study|Not reported|1
15852|NCT02092961|79031|P2|Overall Study|Not reported|0
15853|NCT02092961|79032|P1|Overall Study|Not reported|1
15854|NCT02092662|79068|P2|Overall Study|Lost to Follow-up|0
15855|NCT02092662|79069|P1|Overall Study|Lost to Follow-up|13
15856|NCT02092389|79128|P1|Overall Study|Not specified|5
15857|NCT02092389|79128|P1|Overall Study|Adverse Event|1
15858|NCT02092350|79140|P2|Overall Study|Withdrawal by Subject|2
15859|NCT02092350|79141|P1|Overall Study|Withdrawal by Subject|2
15860|NCT02092350|79140|P2|Overall Study|Screen Failure|0
15861|NCT02092350|79141|P1|Overall Study|Screen Failure|1
15862|NCT02092350|79140|P2|Overall Study|Physician Decision|1
15863|NCT02092350|79141|P1|Overall Study|Physician Decision|1
15864|NCT02092350|79140|P2|Overall Study|Protocol Violation|0
15865|NCT02092350|79141|P1|Overall Study|Protocol Violation|1
15866|NCT02092350|79140|P2|Overall Study|Lost to Follow-up|1
15867|NCT02092350|79141|P1|Overall Study|Lost to Follow-up|3
15868|NCT02092350|79140|P2|Overall Study|Death|5
15869|NCT02092350|79141|P1|Overall Study|Death|2
15870|NCT02092350|79140|P2|Overall Study|Adverse Event|3
15871|NCT02092350|79141|P1|Overall Study|Adverse Event|0
15872|NCT02092285|79169|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
15873|NCT02092285|79169|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
15874|NCT02092285|79169|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
15875|NCT02092285|79169|P1|Maintenance Phase & Follow-up|Protocol Violation|11
15876|NCT02092285|79169|P1|Maintenance Phase & Follow-up|Pregnancy|1
15877|NCT02092285|79169|P1|Maintenance Phase & Follow-up|Physician Decision|10
15878|NCT02092285|79169|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
15879|NCT02092285|79169|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
15880|NCT02092285|79169|P1|Maintenance Phase & Follow-up|Adverse Event|22
15881|NCT02092285|79169|P1|Induction Phase|Lack of Efficacy|14
15882|NCT02092285|79169|P1|Induction Phase|Withdrawal by Subject|2
15883|NCT02092285|79169|P1|Induction Phase|Relapse/Recurrence|7
15884|NCT02092285|79169|P1|Induction Phase|Pregnancy|1
15885|NCT02092285|79169|P1|Induction Phase|Physician Decision|4
15886|NCT02092285|79169|P1|Induction Phase|Adverse Event|7
15887|NCT02092220|79173|P2|Period 2|Nausea, Anxiety, Inconvenience|1
15888|NCT02092220|79174|P1|Period 2|Nausea, Anxiety, Inconvenience|0
15889|NCT02092220|79173|P2|Period 2|Severe Hypoglycaemia|0
15890|NCT02092220|79174|P1|Period 2|Severe Hypoglycaemia|1
15891|NCT02092220|79173|P2|Period 1|Unrelated Illness|2
15892|NCT02092220|79174|P1|Period 1|Unrelated Illness|0
15893|NCT02092116|79247|P2|Overall Study|Adverse Event|1
15894|NCT02092116|79248|P1|Overall Study|Adverse Event|0
15895|NCT02092116|79247|P2|Overall Study|Withdrawal by Subject|3
15896|NCT02092116|79248|P1|Overall Study|Withdrawal by Subject|0
15897|NCT02091986|79260|P3|Overall Study|Adverse Event|2
15898|NCT02091986|79261|P2|Overall Study|Adverse Event|0
15899|NCT02091986|79262|P1|Overall Study|Adverse Event|0
15900|NCT02091986|79260|P3|Overall Study|Withdrawal by Subject|3
15901|NCT02091986|79261|P2|Overall Study|Withdrawal by Subject|8
15902|NCT02091986|79262|P1|Overall Study|Withdrawal by Subject|4
15903|NCT02091986|79260|P3|Overall Study|Lost to Follow-up|0
15904|NCT02091986|79261|P2|Overall Study|Lost to Follow-up|0
15905|NCT02091986|79262|P1|Overall Study|Lost to Follow-up|1
15906|NCT02091986|79260|P3|Overall Study|7 rand in error 1 patient decision|3
15907|NCT02091986|79261|P2|Overall Study|7 rand in error 1 patient decision|3
15908|NCT02091986|79262|P1|Overall Study|7 rand in error 1 patient decision|2
15909|NCT02091960|79309|P1|Overall Study|On Study at Data Cut-off|12
15910|NCT02091960|79309|P1|Overall Study|Miscellaneous Reasons|31
15911|NCT02091960|79309|P1|Overall Study|Withdrawal by Subject|1
15912|NCT02091960|79309|P1|Overall Study|Death|7
15913|NCT02091869|79322|P2|Overall Study|Withdrawal by Subject|3
15914|NCT02091869|79323|P1|Overall Study|Withdrawal by Subject|0
15915|NCT02091752|79364|P1|Overall Study|Adverse Event|1
15916|NCT02091752|79364|P1|Overall Study|Study terminated by Sponsor|2
15917|NCT02091739|79378|P5|EP: 48 Weeks|Withdrawal by Subject|6
15918|NCT02091739|79379|P4|EP: 48 Weeks|Withdrawal by Subject|2
15919|NCT02091739|79380|P3|EP: 48 Weeks|Withdrawal by Subject|0
15920|NCT02091739|79381|P2|EP: 48 Weeks|Withdrawal by Subject|0
15921|NCT02091739|79382|P1|EP: 48 Weeks|Withdrawal by Subject|0
15922|NCT02091739|79378|P5|EP: 48 Weeks|Adverse Event|6
15923|NCT02091739|79379|P4|EP: 48 Weeks|Adverse Event|2
15924|NCT02091739|79380|P3|EP: 48 Weeks|Adverse Event|0
15925|NCT02091739|79381|P2|EP: 48 Weeks|Adverse Event|0
15926|NCT02091739|79382|P1|EP: 48 Weeks|Adverse Event|0
15927|NCT02091739|79378|P5|EP: 48 Weeks|Death|2
15928|NCT02091739|79379|P4|EP: 48 Weeks|Death|3
15929|NCT02091739|79380|P3|EP: 48 Weeks|Death|0
15930|NCT02091739|79381|P2|EP: 48 Weeks|Death|0
15931|NCT02091739|79382|P1|EP: 48 Weeks|Death|0
15932|NCT02091739|79378|P5|EP: 48 Weeks|Other|0
15933|NCT02091739|79379|P4|EP: 48 Weeks|Other|1
15934|NCT02091739|79380|P3|EP: 48 Weeks|Other|0
15935|NCT02091739|79381|P2|EP: 48 Weeks|Other|0
15936|NCT02091739|79382|P1|EP: 48 Weeks|Other|0
15937|NCT02091739|79378|P5|MP: 16 Weeks|Lost to Follow-up|0
15938|NCT02091739|79379|P4|MP: 16 Weeks|Lost to Follow-up|0
15939|NCT02091739|79380|P3|MP: 16 Weeks|Lost to Follow-up|1
15940|NCT02091739|79381|P2|MP: 16 Weeks|Lost to Follow-up|0
15941|NCT02091739|79382|P1|MP: 16 Weeks|Lost to Follow-up|0
15942|NCT02091739|79378|P5|MP: 16 Weeks|Withdrawal by Subject|0
15943|NCT02091739|79379|P4|MP: 16 Weeks|Withdrawal by Subject|0
15944|NCT02091739|79380|P3|MP: 16 Weeks|Withdrawal by Subject|0
15945|NCT02091739|79381|P2|MP: 16 Weeks|Withdrawal by Subject|4
15946|NCT02091739|79382|P1|MP: 16 Weeks|Withdrawal by Subject|3
15947|NCT02091739|79378|P5|MP: 16 Weeks|Adverse Event|0
15948|NCT02091739|79379|P4|MP: 16 Weeks|Adverse Event|0
15949|NCT02091739|79380|P3|MP: 16 Weeks|Adverse Event|1
15950|NCT02091739|79381|P2|MP: 16 Weeks|Adverse Event|1
15951|NCT02091739|79382|P1|MP: 16 Weeks|Adverse Event|1
15952|NCT02091726|79401|P1|Overall Study|Lost to Follow-up|6
15953|NCT02091414|79418|P1|Overall Study|Death|2
15954|NCT02091414|79418|P1|Overall Study|Withdrawal by Subject|2
15955|NCT02090855|79430|P1|Overall Study|no evaluable Standard of Truth results|2
15956|NCT02090764|79443|P2|Overall Study|Lost to Follow-up|2
15957|NCT02090764|79444|P1|Overall Study|Lost to Follow-up|2
15958|NCT02090764|79443|P2|Overall Study|Intercurrent illness and other|1
15959|NCT02090764|79444|P1|Overall Study|Intercurrent illness and other|1
15960|NCT02090764|79443|P2|Overall Study|Withdrawal by Subject|1
15961|NCT02090764|79444|P1|Overall Study|Withdrawal by Subject|2
15962|NCT02090764|79443|P2|Overall Study|Lack of Efficacy|13
15963|NCT02090764|79444|P1|Overall Study|Lack of Efficacy|0
15964|NCT02090764|79443|P2|Overall Study|Adverse Event|3
15965|NCT02090764|79444|P1|Overall Study|Adverse Event|1
15966|NCT02090413|79453|P3|Overall Study|Lost to Follow-up|0
15967|NCT02090413|79454|P2|Overall Study|Lost to Follow-up|1
15968|NCT02090413|79455|P1|Overall Study|Lost to Follow-up|1
15969|NCT02090413|79453|P3|Overall Study|Not Specified|0
15970|NCT02090413|79454|P2|Overall Study|Not Specified|1
15971|NCT02090413|79455|P1|Overall Study|Not Specified|2
15972|NCT02090413|79453|P3|Overall Study|Investigator Decision|0
15973|NCT02090413|79454|P2|Overall Study|Investigator Decision|1
15974|NCT02090413|79455|P1|Overall Study|Investigator Decision|1
15975|NCT02090413|79453|P3|Overall Study|Withdrawal by Subject|2
15976|NCT02090413|79454|P2|Overall Study|Withdrawal by Subject|2
15977|NCT02090413|79455|P1|Overall Study|Withdrawal by Subject|2
15978|NCT02090413|79453|P3|Overall Study|Flushing event|1
15979|NCT02090413|79454|P2|Overall Study|Flushing event|0
15980|NCT02090413|79455|P1|Overall Study|Flushing event|2
15981|NCT02090413|79453|P3|Overall Study|Adverse Event|20
15982|NCT02090413|79454|P2|Overall Study|Adverse Event|15
15983|NCT02090413|79455|P1|Overall Study|Adverse Event|11
15984|NCT02089737|79541|P1|Overall Study|Not treated|1
15985|NCT02089737|79541|P1|Overall Study|Survey form not completed|5
15986|NCT02089347|79550|P2|Overall Study|Protocol Violation|0
15987|NCT02089347|79551|P1|Overall Study|Protocol Violation|1
15988|NCT02088957|79591|P2|Overall Study|Lack of Efficacy|0
15989|NCT02088957|79592|P1|Overall Study|Lack of Efficacy|1
15990|NCT02088177|79608|P1|Overall Study|Lost to Follow-up|3
15991|NCT02087943|79620|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
15992|NCT02087943|79621|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
15993|NCT02087943|79622|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
15994|NCT02087943|79623|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
15995|NCT02087943|79624|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
15996|NCT02087943|79620|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
15997|NCT02087943|79621|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
15998|NCT02087943|79622|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
15999|NCT02087943|79623|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
16000|NCT02087943|79624|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
16001|NCT02087943|79620|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
16002|NCT02087943|79621|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
16003|NCT02087943|79622|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
16004|NCT02087943|79623|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
16005|NCT02087943|79624|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
16006|NCT02087943|79620|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
16007|NCT02087943|79621|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
16008|NCT02087943|79622|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
16009|NCT02087943|79623|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
16010|NCT02087943|79624|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
16011|NCT02087943|79620|P5|Active Treatment Phase Week 12-24|Adverse Event|1
16012|NCT02087943|79621|P4|Active Treatment Phase Week 12-24|Adverse Event|0
16013|NCT02087943|79622|P3|Active Treatment Phase Week 12-24|Adverse Event|2
16014|NCT02087943|79623|P2|Active Treatment Phase Week 12-24|Adverse Event|1
16015|NCT02087943|79624|P1|Active Treatment Phase Week 12-24|Adverse Event|0
16016|NCT02087943|79620|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
16017|NCT02087943|79621|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
16018|NCT02087943|79622|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
16019|NCT02087943|79623|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
16105|NCT02085161|79850|P2|Overall Study|Not Treated|0
16020|NCT02087943|79624|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
16021|NCT02087943|79620|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
16022|NCT02087943|79621|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
16023|NCT02087943|79622|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
16024|NCT02087943|79623|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
16025|NCT02087943|79624|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
16026|NCT02087943|79620|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
16027|NCT02087943|79621|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
16028|NCT02087943|79622|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
16029|NCT02087943|79623|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
16030|NCT02087943|79624|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
16031|NCT02087943|79620|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
16032|NCT02087943|79621|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
16033|NCT02087943|79622|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
16034|NCT02087943|79623|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
16035|NCT02087943|79624|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
16036|NCT02087943|79620|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
16037|NCT02087943|79621|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
16038|NCT02087943|79622|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
16039|NCT02087943|79623|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
16040|NCT02087943|79624|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
16041|NCT02087774|79650|P2|Overall Study|Were absent day of data collection|20
16042|NCT02087774|79651|P1|Overall Study|Were absent day of data collection|8
16043|NCT02087670|79671|P2|Overall Study|Withdrawal by Subject|2
16044|NCT02087670|79672|P1|Overall Study|Withdrawal by Subject|3
16045|NCT02087423|79708|P3|Overall Study|Ongoing treatment at data cutoff|18
16046|NCT02087423|79709|P2|Overall Study|Ongoing treatment at data cutoff|0
16047|NCT02087423|79710|P1|Overall Study|Ongoing treatment at data cutoff|10
16048|NCT02087423|79708|P3|Overall Study|Adverse Event|3
16049|NCT02087423|79709|P2|Overall Study|Adverse Event|24
16050|NCT02087423|79710|P1|Overall Study|Adverse Event|2
16051|NCT02087423|79708|P3|Overall Study|Withdrawal by Subject|2
16052|NCT02087423|79709|P2|Overall Study|Withdrawal by Subject|7
16053|NCT02087423|79710|P1|Overall Study|Withdrawal by Subject|5
16054|NCT02087423|79708|P3|Overall Study|Physician Decision|35
16055|NCT02087423|79709|P2|Overall Study|Physician Decision|174
16056|NCT02087423|79710|P1|Overall Study|Physician Decision|86
16057|NCT02087241|79734|P4|Overall Study|Study Terminated by Sponsor|4
16058|NCT02087241|79735|P3|Overall Study|Study Terminated by Sponsor|0
16059|NCT02087241|79736|P2|Overall Study|Study Terminated by Sponsor|2
16060|NCT02087241|79737|P1|Overall Study|Study Terminated by Sponsor|0
16061|NCT02087241|79734|P4|Overall Study|Progressive Disease|1
16062|NCT02087241|79735|P3|Overall Study|Progressive Disease|0
16063|NCT02087241|79736|P2|Overall Study|Progressive Disease|0
16064|NCT02087241|79737|P1|Overall Study|Progressive Disease|0
16065|NCT02087241|79734|P4|Overall Study|Withdrawal by Subject|1
16066|NCT02087241|79735|P3|Overall Study|Withdrawal by Subject|0
16067|NCT02087241|79736|P2|Overall Study|Withdrawal by Subject|0
16068|NCT02087241|79737|P1|Overall Study|Withdrawal by Subject|1
16069|NCT02087241|79734|P4|Overall Study|Death|1
16070|NCT02087241|79735|P3|Overall Study|Death|1
16071|NCT02087241|79736|P2|Overall Study|Death|1
16072|NCT02087241|79737|P1|Overall Study|Death|2
16073|NCT02087176|79763|P1|Overall Study|Study Terminated by Sponsor|2
16074|NCT02087176|79763|P1|Overall Study|Censored|19
16075|NCT02087176|79763|P1|Overall Study|Death|10
16076|NCT02087176|79763|P1|Overall Study|Withdrawal by Subject|1
16077|NCT02087059|79768|P1|Overall Study|Lost to Follow-up|1
16078|NCT02087059|79768|P1|Overall Study|Adverse Event|5
16079|NCT02087059|79768|P1|Overall Study|Disease Progression|1
16080|NCT02086591|79815|P1|Overall Study|protocol terminated|3
16081|NCT02086591|79815|P1|Overall Study|Withdrawal by Subject|1
16082|NCT02086591|79815|P1|Overall Study|Adverse Event|1
16083|NCT02085785|79823|P2|Overall Study|Lost to Follow-up|1
16084|NCT02085785|79824|P1|Overall Study|Lost to Follow-up|0
16085|NCT02085785|79823|P2|Overall Study|Withdrawal by Subject|1
16086|NCT02085785|79824|P1|Overall Study|Withdrawal by Subject|2
16087|NCT02085161|79848|P4|Overall Study|Other Reason|1
16088|NCT02085161|79849|P3|Overall Study|Other Reason|1
16089|NCT02085161|79850|P2|Overall Study|Other Reason|0
16090|NCT02085161|79851|P1|Overall Study|Other Reason|1
16091|NCT02085161|79848|P4|Overall Study|Withdrawal by Subject|3
16092|NCT02085161|79849|P3|Overall Study|Withdrawal by Subject|0
16093|NCT02085161|79850|P2|Overall Study|Withdrawal by Subject|4
16094|NCT02085161|79851|P1|Overall Study|Withdrawal by Subject|2
16095|NCT02085161|79848|P4|Overall Study|Protocol Violation|1
16096|NCT02085161|79849|P3|Overall Study|Protocol Violation|0
16097|NCT02085161|79850|P2|Overall Study|Protocol Violation|1
16098|NCT02085161|79851|P1|Overall Study|Protocol Violation|0
16099|NCT02085161|79848|P4|Overall Study|Adverse Event|5
16100|NCT02085161|79849|P3|Overall Study|Adverse Event|4
16101|NCT02085161|79850|P2|Overall Study|Adverse Event|5
16102|NCT02085161|79851|P1|Overall Study|Adverse Event|8
16103|NCT02085161|79848|P4|Overall Study|Not Treated|0
16104|NCT02085161|79849|P3|Overall Study|Not Treated|0
16106|NCT02085161|79851|P1|Overall Study|Not Treated|1
16107|NCT02084238|79919|P1|Overall Study|Lost to Follow-up|2
16108|NCT02084134|79932|P2|Overall Study|Death|1
16109|NCT02084134|79933|P1|Overall Study|Death|0
16110|NCT02084134|79932|P2|Overall Study|Protocol Violation|2
16111|NCT02084134|79933|P1|Overall Study|Protocol Violation|4
16112|NCT02084082|79943|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
16113|NCT02084082|79944|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
16114|NCT02084082|79945|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
16115|NCT02084082|79946|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
16116|NCT02084082|79943|P4|Washout Period 1 (35 Days)|Adverse Event|1
16117|NCT02084082|79944|P3|Washout Period 1 (35 Days)|Adverse Event|1
16118|NCT02084082|79945|P2|Washout Period 1 (35 Days)|Adverse Event|0
16119|NCT02084082|79946|P1|Washout Period 1 (35 Days)|Adverse Event|0
16120|NCT02084056|79987|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
16121|NCT02084056|79988|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
16122|NCT02084056|79989|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
16123|NCT02084056|79990|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
16124|NCT02084056|79987|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
16125|NCT02084056|79988|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
16126|NCT02084056|79989|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
16127|NCT02084056|79990|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
16128|NCT02083965|80022|P2|Treatment Period|Not Specified|0
16129|NCT02083965|80023|P1|Treatment Period|Not Specified|1
16130|NCT02083380|80140|P3|Overall Study|Other|6
16131|NCT02083380|80141|P2|Overall Study|Other|4
16132|NCT02083380|80142|P1|Overall Study|Other|8
16133|NCT02083380|80140|P3|Overall Study|Lost to Follow-up|3
16134|NCT02083380|80141|P2|Overall Study|Lost to Follow-up|3
16135|NCT02083380|80142|P1|Overall Study|Lost to Follow-up|5
16136|NCT02083380|80140|P3|Overall Study|Adverse Event|1
16137|NCT02083380|80141|P2|Overall Study|Adverse Event|0
16138|NCT02083380|80142|P1|Overall Study|Adverse Event|0
16139|NCT02083380|80140|P3|Overall Study|Physician Decision|3
16140|NCT02083380|80141|P2|Overall Study|Physician Decision|6
16141|NCT02083380|80142|P1|Overall Study|Physician Decision|1
16142|NCT02083380|80140|P3|Overall Study|Withdrawal by Subject|7
16143|NCT02083380|80141|P2|Overall Study|Withdrawal by Subject|3
16144|NCT02083380|80142|P1|Overall Study|Withdrawal by Subject|9
16145|NCT02083380|80140|P3|Overall Study|Lack of Efficacy|64
16146|NCT02083380|80141|P2|Overall Study|Lack of Efficacy|79
16147|NCT02083380|80142|P1|Overall Study|Lack of Efficacy|68
16148|NCT02083185|80247|P3|Overall Study|Did not Receive Study Drug|0
16149|NCT02083185|80248|P2|Overall Study|Did not Receive Study Drug|2
16150|NCT02083185|80249|P1|Overall Study|Did not Receive Study Drug|0
16151|NCT02083185|80247|P3|Overall Study|Study Terminated by Sponsor|0
16152|NCT02083185|80248|P2|Overall Study|Study Terminated by Sponsor|1
16153|NCT02083185|80249|P1|Overall Study|Study Terminated by Sponsor|0
16154|NCT02083185|80247|P3|Overall Study|Reason not Specified|5
16155|NCT02083185|80248|P2|Overall Study|Reason not Specified|6
16156|NCT02083185|80249|P1|Overall Study|Reason not Specified|9
16157|NCT02083185|80247|P3|Overall Study|Death|1
16158|NCT02083185|80248|P2|Overall Study|Death|2
16159|NCT02083185|80249|P1|Overall Study|Death|2
16160|NCT02083185|80247|P3|Overall Study|Withdrawal by Subject|1
16161|NCT02083185|80248|P2|Overall Study|Withdrawal by Subject|15
16162|NCT02083185|80249|P1|Overall Study|Withdrawal by Subject|9
16163|NCT02083185|80247|P3|Overall Study|Lost to Follow-up|0
16164|NCT02083185|80248|P2|Overall Study|Lost to Follow-up|3
16165|NCT02083185|80249|P1|Overall Study|Lost to Follow-up|0
16166|NCT02082912|80346|P2|Overall Study|Physician Decision|1
16167|NCT02082912|80347|P1|Overall Study|Physician Decision|0
16168|NCT02082262|80411|P1|Overall Study|Adverse Event|48
16169|NCT02082262|80411|P1|Overall Study|Withdrawal by Subject|3
16170|NCT02082184|80417|P2|Overall Study|Subject non-compliance|1
16171|NCT02082184|80418|P1|Overall Study|Subject non-compliance|0
16172|NCT02082184|80417|P2|Overall Study|Lost to Follow-up|2
16173|NCT02082184|80418|P1|Overall Study|Lost to Follow-up|0
16174|NCT02082184|80417|P2|Overall Study|Protocol Violation|6
16175|NCT02082184|80418|P1|Overall Study|Protocol Violation|0
16176|NCT02082184|80417|P2|Overall Study|Withdrawal by Subject|2
16177|NCT02082184|80418|P1|Overall Study|Withdrawal by Subject|3
16178|NCT02082184|80417|P2|Overall Study|Device associated symptoms|0
16179|NCT02082184|80418|P1|Overall Study|Device associated symptoms|5
16180|NCT02082184|80417|P2|Overall Study|Medical diagnosis|2
16181|NCT02082184|80418|P1|Overall Study|Medical diagnosis|1
16182|NCT02082184|80417|P2|Overall Study|Adverse Event|0
16183|NCT02082184|80418|P1|Overall Study|Adverse Event|1
16184|NCT02082158|80443|P6|Overall Study|Failed Fit-testing|7
16185|NCT02082158|80444|P5|Overall Study|Failed Fit-testing|3
16186|NCT02082158|80445|P4|Overall Study|Failed Fit-testing|4
16187|NCT02082158|80446|P3|Overall Study|Failed Fit-testing|14
16188|NCT02082158|80447|P2|Overall Study|Failed Fit-testing|8
16189|NCT02082158|80448|P1|Overall Study|Failed Fit-testing|8
16190|NCT02082158|80443|P6|Overall Study|Withdrawal by Subject|0
16191|NCT02082158|80444|P5|Overall Study|Withdrawal by Subject|1
16192|NCT02082158|80445|P4|Overall Study|Withdrawal by Subject|0
16193|NCT02082158|80446|P3|Overall Study|Withdrawal by Subject|0
16194|NCT02082158|80447|P2|Overall Study|Withdrawal by Subject|0
16195|NCT02082158|80448|P1|Overall Study|Withdrawal by Subject|0
16196|NCT02081859|80470|P2|Overall Study|Other reasons|0
16197|NCT02081859|80471|P1|Overall Study|Other reasons|2
16198|NCT02081859|80470|P2|Overall Study|< 4 embryos|23
16199|NCT02081859|80471|P1|Overall Study|< 4 embryos|27
16200|NCT02081859|80470|P2|Overall Study|Unanticipated freeze all cycle|6
16201|NCT02081859|80471|P1|Overall Study|Unanticipated freeze all cycle|2
16202|NCT02081859|80470|P2|Overall Study|No sperm|0
16203|NCT02081859|80471|P1|Overall Study|No sperm|1
16204|NCT02081859|80470|P2|Overall Study|No fertilization|2
16205|NCT02081859|80471|P1|Overall Study|No fertilization|2
16206|NCT02081690|80479|P1|Overall Study|Withdrawal by Subject|1
16207|NCT02081690|80479|P1|Overall Study|Physician Decision|3
16208|NCT02081690|80479|P1|Overall Study|Death|3
16209|NCT02081677|80490|P4|Overall Study|Unsatisfactory Lens Fitting|0
16210|NCT02081677|80491|P3|Overall Study|Unsatisfactory Lens Fitting|0
16211|NCT02081677|80492|P2|Overall Study|Unsatisfactory Lens Fitting|1
16212|NCT02081677|80493|P1|Overall Study|Unsatisfactory Lens Fitting|0
16213|NCT02081677|80490|P4|Overall Study|Not comfortable with lens care system|0
16214|NCT02081677|80491|P3|Overall Study|Not comfortable with lens care system|0
16215|NCT02081677|80492|P2|Overall Study|Not comfortable with lens care system|0
16216|NCT02081677|80493|P1|Overall Study|Not comfortable with lens care system|1
16217|NCT02081677|80490|P4|Overall Study|No Longer Meets Eligibility Criteria|0
16218|NCT02081677|80491|P3|Overall Study|No Longer Meets Eligibility Criteria|1
16219|NCT02081677|80492|P2|Overall Study|No Longer Meets Eligibility Criteria|0
16220|NCT02081677|80493|P1|Overall Study|No Longer Meets Eligibility Criteria|0
16221|NCT02081677|80490|P4|Overall Study|Adverse Event|0
16222|NCT02081677|80491|P3|Overall Study|Adverse Event|1
16223|NCT02081677|80492|P2|Overall Study|Adverse Event|0
16224|NCT02081677|80493|P1|Overall Study|Adverse Event|0
16225|NCT02081599|80585|P2|Period 2：Open-label Period|Withdrawal by Subject|0
16226|NCT02081599|80586|P1|Period 2：Open-label Period|Withdrawal by Subject|2
16227|NCT02081599|80585|P2|Period 2：Open-label Period|Physician Decision|0
16228|NCT02081599|80586|P1|Period 2：Open-label Period|Physician Decision|1
16229|NCT02081599|80585|P2|Period 2：Open-label Period|Lack of Efficacy|4
16230|NCT02081599|80586|P1|Period 2：Open-label Period|Lack of Efficacy|2
16231|NCT02081599|80585|P2|Period 2：Open-label Period|Adverse Event|0
16232|NCT02081599|80586|P1|Period 2：Open-label Period|Adverse Event|1
16233|NCT02081599|80585|P2|Period 1：Double-blind Period|stopping criteria|0
16234|NCT02081599|80586|P1|Period 1：Double-blind Period|stopping criteria|1
16235|NCT02081599|80585|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
16236|NCT02081599|80586|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
16237|NCT02081599|80585|P2|Period 1：Double-blind Period|Protocol Violation|1
16238|NCT02081599|80586|P1|Period 1：Double-blind Period|Protocol Violation|0
16239|NCT02081599|80585|P2|Period 1：Double-blind Period|Physician Decision|0
16240|NCT02081599|80586|P1|Period 1：Double-blind Period|Physician Decision|1
16241|NCT02081599|80585|P2|Period 1：Double-blind Period|Lack of Efficacy|1
16242|NCT02081599|80586|P1|Period 1：Double-blind Period|Lack of Efficacy|2
16243|NCT02081599|80585|P2|Period 1：Double-blind Period|Adverse Event|0
16244|NCT02081599|80586|P1|Period 1：Double-blind Period|Adverse Event|3
16245|NCT02081586|80604|P4|Overall Study|Head injury not related to study|0
16246|NCT02081586|80605|P3|Overall Study|Head injury not related to study|1
16247|NCT02081586|80606|P2|Overall Study|Head injury not related to study|0
16248|NCT02081586|80607|P1|Overall Study|Head injury not related to study|0
16249|NCT02081586|80604|P4|Overall Study|Lost to Follow-up|1
16250|NCT02081586|80605|P3|Overall Study|Lost to Follow-up|0
16251|NCT02081586|80606|P2|Overall Study|Lost to Follow-up|1
16252|NCT02081586|80607|P1|Overall Study|Lost to Follow-up|0
16253|NCT02081183|80673|P2|Overall Study|Not specified|3
16254|NCT02081183|80674|P1|Overall Study|Not specified|3
16255|NCT02081183|80673|P2|Overall Study|Protocol Violation|0
16256|NCT02081183|80674|P1|Overall Study|Protocol Violation|1
16257|NCT02081183|80673|P2|Overall Study|Lost to Follow-up|1
16258|NCT02081183|80674|P1|Overall Study|Lost to Follow-up|0
16259|NCT02081079|80690|P2|Overall Study|Lost to Follow-up|0
16260|NCT02081079|80691|P1|Overall Study|Lost to Follow-up|1
16261|NCT02081079|80690|P2|Overall Study|Lack of Efficacy|2
16262|NCT02081079|80691|P1|Overall Study|Lack of Efficacy|3
16263|NCT02081001|80764|P12|Overall Study|Adverse Event|0
16264|NCT02081001|80765|P11|Overall Study|Adverse Event|0
16265|NCT02081001|80766|P10|Overall Study|Adverse Event|0
16266|NCT02081001|80767|P9|Overall Study|Adverse Event|0
16267|NCT02081001|80768|P8|Overall Study|Adverse Event|0
16268|NCT02081001|80769|P7|Overall Study|Adverse Event|0
16269|NCT02081001|80770|P6|Overall Study|Adverse Event|0
16270|NCT02081001|80771|P5|Overall Study|Adverse Event|1
16271|NCT02081001|80772|P4|Overall Study|Adverse Event|0
16272|NCT02081001|80773|P3|Overall Study|Adverse Event|0
16273|NCT02081001|80774|P2|Overall Study|Adverse Event|0
16274|NCT02081001|80775|P1|Overall Study|Adverse Event|0
16275|NCT02080832|80842|P3|Overall Study|Lost to Follow-up|2
16276|NCT02080832|80843|P2|Overall Study|Lost to Follow-up|2
16277|NCT02080832|80844|P1|Overall Study|Lost to Follow-up|0
16278|NCT02080832|80842|P3|Overall Study|Excluded from analysis by MRI|14
16279|NCT02080832|80843|P2|Overall Study|Excluded from analysis by MRI|10
16280|NCT02080832|80844|P1|Overall Study|Excluded from analysis by MRI|9
16281|NCT02080481|80902|P2|Overall Study|Never received a block.|0
16282|NCT02080481|80903|P1|Overall Study|Never received a block.|1
16283|NCT02080091|80921|P1|Overall Study|Other|1
16284|NCT02080091|80921|P1|Overall Study|Withdrawal by Subject|1
16285|NCT02080091|80921|P1|Overall Study|Death|1
16286|NCT02080091|80921|P1|Overall Study|Study Terminated|22
16287|NCT02079844|80930|P3|Treatment Period 2|Voluntary Withdrawal|0
16288|NCT02079844|80931|P2|Treatment Period 2|Voluntary Withdrawal|1
16289|NCT02079844|80932|P1|Treatment Period 2|Voluntary Withdrawal|0
16290|NCT02079844|80930|P3|Treatment Period 1|Voluntary Withdrawal|2
16291|NCT02079844|80931|P2|Treatment Period 1|Voluntary Withdrawal|0
16292|NCT02079844|80932|P1|Treatment Period 1|Voluntary Withdrawal|0
16293|NCT02079805|80990|P2|Overall Study|Voluntary Withdrawal|1
16294|NCT02079805|80991|P1|Overall Study|Voluntary Withdrawal|0
16295|NCT02079805|80990|P2|Overall Study|Pretreatment Event/Adverse Event|1
16296|NCT02079805|80991|P1|Overall Study|Pretreatment Event/Adverse Event|0
16297|NCT02079649|81013|P4|Overall Study|Randomization error (prior to treatment)|0
16298|NCT02079649|81014|P3|Overall Study|Randomization error (prior to treatment)|1
16299|NCT02079649|81015|P2|Overall Study|Randomization error (prior to treatment)|0
16300|NCT02079649|81016|P1|Overall Study|Randomization error (prior to treatment)|1
16301|NCT02079649|81013|P4|Overall Study|Withdrawal by Subject|1
16302|NCT02079649|81014|P3|Overall Study|Withdrawal by Subject|0
16303|NCT02079649|81015|P2|Overall Study|Withdrawal by Subject|0
16304|NCT02079649|81016|P1|Overall Study|Withdrawal by Subject|0
16305|NCT02079649|81013|P4|Overall Study|Lost to Follow-up|1
16306|NCT02079649|81014|P3|Overall Study|Lost to Follow-up|0
16307|NCT02079649|81015|P2|Overall Study|Lost to Follow-up|0
16308|NCT02079649|81016|P1|Overall Study|Lost to Follow-up|0
16309|NCT02079610|81033|P2|Overall Study|Withdrawal by Subject|1
16310|NCT02079610|81034|P1|Overall Study|Withdrawal by Subject|1
16311|NCT02079532|81044|P1|Overall Study|Not specified|3
16312|NCT02079532|81044|P1|Overall Study|Inclusion into ReFIRST|3
16313|NCT02079532|81044|P1|Overall Study|Administrative problems|1
16314|NCT02079532|81044|P1|Overall Study|Withdrawal by Subject|1
16315|NCT02079532|81044|P1|Overall Study|Protocol Violation|3
16316|NCT02079532|81044|P1|Overall Study|Lack of Efficacy|9
16317|NCT02079532|81044|P1|Overall Study|Additional or changed therapy|2
16318|NCT02079532|81044|P1|Overall Study|Adverse Event|7
16319|NCT02079519|81066|P1|Overall Study|Adverse Event|1
16320|NCT02079519|81066|P1|Overall Study|Disease Progression|9
16321|NCT02077374|81124|P2|Overall Study|Protocol Violation|1
16322|NCT02077374|81125|P1|Overall Study|Protocol Violation|0
16323|NCT02077374|81124|P2|Overall Study|Withdrawal by Subject|1
16324|NCT02077374|81125|P1|Overall Study|Withdrawal by Subject|0
16325|NCT02077140|81146|P5|Overall Study|Withdrawal by Subject|2
16326|NCT02077140|81147|P4|Overall Study|Withdrawal by Subject|2
16327|NCT02077140|81148|P3|Overall Study|Withdrawal by Subject|0
16328|NCT02077140|81149|P2|Overall Study|Withdrawal by Subject|1
16329|NCT02077140|81150|P1|Overall Study|Withdrawal by Subject|0
16330|NCT02077140|81146|P5|Overall Study|Lost to Follow-up|3
16331|NCT02077140|81147|P4|Overall Study|Lost to Follow-up|2
16332|NCT02077140|81148|P3|Overall Study|Lost to Follow-up|2
16333|NCT02077140|81149|P2|Overall Study|Lost to Follow-up|1
16334|NCT02077140|81150|P1|Overall Study|Lost to Follow-up|4
16335|NCT02076334|81354|P4|Overall Study|muscle soreness|1
16336|NCT02076334|81355|P3|Overall Study|muscle soreness|0
16337|NCT02076334|81356|P2|Overall Study|muscle soreness|0
16338|NCT02076334|81357|P1|Overall Study|muscle soreness|0
16339|NCT02076334|81354|P4|Overall Study|Lost to Follow-up|0
16340|NCT02076334|81355|P3|Overall Study|Lost to Follow-up|1
16341|NCT02076334|81356|P2|Overall Study|Lost to Follow-up|1
16342|NCT02076334|81357|P1|Overall Study|Lost to Follow-up|0
16343|NCT02076334|81354|P4|Overall Study|Protocol Violation|0
16344|NCT02076334|81355|P3|Overall Study|Protocol Violation|0
16345|NCT02076334|81356|P2|Overall Study|Protocol Violation|0
16346|NCT02076334|81357|P1|Overall Study|Protocol Violation|1
16347|NCT02076178|81390|P2|Injection Phase|Lost to Follow-up|1
16348|NCT02076178|81391|P1|Injection Phase|Lost to Follow-up|0
16349|NCT02076178|81390|P2|Injection Phase|Physician Decision|3
16350|NCT02076178|81391|P1|Injection Phase|Physician Decision|0
16351|NCT02076178|81390|P2|Injection Phase|Withdrawal by Subject|3
16352|NCT02076178|81391|P1|Injection Phase|Withdrawal by Subject|0
16353|NCT02076178|81390|P2|Injection Phase|Protocol defined stopping criteria|0
16354|NCT02076178|81391|P1|Injection Phase|Protocol defined stopping criteria|1
16355|NCT02076178|81390|P2|Oral Phase|Physician Decision|1
16356|NCT02076178|81391|P1|Oral Phase|Physician Decision|0
16357|NCT02076178|81390|P2|Oral Phase|Withdrawal by Subject|4
16358|NCT02076178|81391|P1|Oral Phase|Withdrawal by Subject|0
16359|NCT02076178|81390|P2|Oral Phase|Adverse Event|7
16360|NCT02076178|81391|P1|Oral Phase|Adverse Event|0
16361|NCT02076009|81425|P2|Overall Study|Subjects randomized but not treated|3
16362|NCT02076009|81426|P1|Overall Study|Subjects randomized but not treated|2
16363|NCT02076009|81425|P2|Overall Study|Ongoing|249
16364|NCT02076009|81426|P1|Overall Study|Ongoing|226
16365|NCT02076009|81425|P2|Overall Study|Progressive disease|0
16366|NCT02076009|81426|P1|Overall Study|Progressive disease|1
16367|NCT02076009|81425|P2|Overall Study|Lost to Follow-up|1
16368|NCT02076009|81426|P1|Overall Study|Lost to Follow-up|1
16369|NCT02076009|81425|P2|Overall Study|Withdrawal by Subject|3
16370|NCT02076009|81426|P1|Overall Study|Withdrawal by Subject|9
16371|NCT02076009|81425|P2|Overall Study|Death|30
16372|NCT02076009|81426|P1|Overall Study|Death|44
16373|NCT02075840|81448|P2|Overall Study|Ongoing at CCOD|82
16374|NCT02075840|81449|P1|Overall Study|Ongoing at CCOD|99
16375|NCT02075840|81448|P2|Overall Study|Physician Decision|3
16376|NCT02075840|81449|P1|Overall Study|Physician Decision|1
16377|NCT02075840|81448|P2|Overall Study|Lost to Follow-up|2
16378|NCT02075840|81449|P1|Overall Study|Lost to Follow-up|3
16379|NCT02075840|81448|P2|Overall Study|Death|40
16380|NCT02075840|81449|P1|Overall Study|Death|35
16381|NCT02075840|81448|P2|Overall Study|Adverse Event|2
16382|NCT02075840|81449|P1|Overall Study|Adverse Event|0
16383|NCT02075840|81448|P2|Overall Study|Reason not specified|0
16384|NCT02075840|81449|P1|Overall Study|Reason not specified|1
16385|NCT02075840|81448|P2|Overall Study|Withdrawal by Subject|22
16386|NCT02075840|81449|P1|Overall Study|Withdrawal by Subject|13
16387|NCT02075658|81505|P2|Overall Study|Physician Decision|2
16388|NCT02075658|81506|P1|Overall Study|Physician Decision|2
16389|NCT02075632|81516|P2|Overall Study|Withdrawal by Subject|1
16390|NCT02075632|81517|P1|Overall Study|Withdrawal by Subject|0
16391|NCT02075632|81516|P2|Overall Study|Lost to Follow-up|3
16392|NCT02075632|81517|P1|Overall Study|Lost to Follow-up|0
16393|NCT02075632|81516|P2|Overall Study|Adverse Event|1
16394|NCT02075632|81517|P1|Overall Study|Adverse Event|1
16395|NCT02075515|81530|P3|Overall Study|Lost to Follow-up|6
16396|NCT02075515|81531|P2|Overall Study|Lost to Follow-up|3
16397|NCT02075515|81532|P1|Overall Study|Lost to Follow-up|1
16398|NCT02075515|81530|P3|Overall Study|Withdrawal by Subject|1
16399|NCT02075515|81531|P2|Overall Study|Withdrawal by Subject|0
16400|NCT02075515|81532|P1|Overall Study|Withdrawal by Subject|2
16401|NCT02075515|81530|P3|Overall Study|Non-Serious Adverse Event|0
16402|NCT02075515|81531|P2|Overall Study|Non-Serious Adverse Event|1
16403|NCT02075515|81532|P1|Overall Study|Non-Serious Adverse Event|0
16404|NCT02075515|81530|P3|Overall Study|Serious Adverse Event|1
16405|NCT02075515|81531|P2|Overall Study|Serious Adverse Event|1
16406|NCT02075515|81532|P1|Overall Study|Serious Adverse Event|1
16407|NCT02075463|81567|P1|Overall Study|Withdrawal by Subject|1
16408|NCT02075463|81567|P1|Overall Study|Par. reached stopping criteria|4
16409|NCT02075463|81567|P1|Overall Study|Adverse Event|3
16410|NCT02075320|81617|P1|Overall Study|Withdrawal by Subject|2
16411|NCT02075255|81627|P3|Overall Study|Death|0
16412|NCT02075255|81628|P2|Overall Study|Death|2
16413|NCT02075255|81629|P1|Overall Study|Death|0
16414|NCT02075255|81627|P3|Overall Study|Adverse Event|1
16415|NCT02075255|81628|P2|Overall Study|Adverse Event|0
16416|NCT02075255|81629|P1|Overall Study|Adverse Event|0
16417|NCT02075255|81627|P3|Overall Study|Lost to Follow-up|1
16418|NCT02075255|81628|P2|Overall Study|Lost to Follow-up|0
16419|NCT02075255|81629|P1|Overall Study|Lost to Follow-up|0
16420|NCT02075255|81627|P3|Overall Study|Withdrawal by Subject|0
16421|NCT02075255|81628|P2|Overall Study|Withdrawal by Subject|1
16422|NCT02075255|81629|P1|Overall Study|Withdrawal by Subject|4
16423|NCT02075255|81627|P3|Overall Study|Study specific withdrawal criteria|1
16424|NCT02075255|81628|P2|Overall Study|Study specific withdrawal criteria|1
16425|NCT02075255|81629|P1|Overall Study|Study specific withdrawal criteria|0
16426|NCT02075073|81760|P3|Overall Study|Withdrawal by Subject|0
16427|NCT02075073|81761|P2|Overall Study|Withdrawal by Subject|1
16428|NCT02075073|81762|P1|Overall Study|Withdrawal by Subject|0
16429|NCT02075008|81784|P1|Overall Study|Study terminated by Sponsor|159
16430|NCT02075008|81784|P1|Overall Study|Withdrawal by Subject|6
16431|NCT02075008|81784|P1|Overall Study|Adverse Event|5
16432|NCT02075008|81784|P1|Overall Study|Death|1
16433|NCT02075008|81784|P1|Overall Study|Lack of Efficacy|1
16434|NCT02075008|81784|P1|Overall Study|Lost to Follow-up|1
16435|NCT02075008|81784|P1|Overall Study|Physician Decision|1
16436|NCT02075008|81784|P1|Overall Study|Pregnancy|1
16437|NCT02075008|81784|P1|Overall Study|Technical problems|1
16438|NCT02074982|81807|P2|Overall Study|Death|2
16439|NCT02074982|81808|P1|Overall Study|Death|0
16440|NCT02074982|81807|P2|Overall Study|Subject/guardian decision|24
16441|NCT02074982|81808|P1|Overall Study|Subject/guardian decision|15
16442|NCT02074982|81807|P2|Overall Study|Technical problems|2
16443|NCT02074982|81808|P1|Overall Study|Technical problems|0
16444|NCT02074982|81807|P2|Overall Study|Protocol deviation|3
16445|NCT02074982|81808|P1|Overall Study|Protocol deviation|4
16446|NCT02074982|81807|P2|Overall Study|Pregnancy|2
16447|NCT02074982|81808|P1|Overall Study|Pregnancy|1
16448|NCT02074982|81807|P2|Overall Study|Physician Decision|1
16449|NCT02074982|81808|P1|Overall Study|Physician Decision|1
16450|NCT02074982|81807|P2|Overall Study|Non-compliance with study treatment|2
16451|NCT02074982|81808|P1|Overall Study|Non-compliance with study treatment|0
16452|NCT02074982|81807|P2|Overall Study|Lost to Follow-up|10
16453|NCT02074982|81808|P1|Overall Study|Lost to Follow-up|9
16454|NCT02074982|81807|P2|Overall Study|Lack of Efficacy|1
16455|NCT02074982|81808|P1|Overall Study|Lack of Efficacy|6
16456|NCT02074982|81807|P2|Overall Study|Adverse Event|7
16457|NCT02074982|81808|P1|Overall Study|Adverse Event|15
16458|NCT02074553|81846|P8|Washout Period 3|Physician Decision|1
16459|NCT02074553|81847|P7|Washout Period 3|Physician Decision|0
16460|NCT02074553|81848|P6|Washout Period 3|Physician Decision|0
16461|NCT02074553|81849|P5|Washout Period 3|Physician Decision|0
16462|NCT02074553|81850|P4|Washout Period 3|Physician Decision|0
16463|NCT02074553|81851|P3|Washout Period 3|Physician Decision|0
16464|NCT02074553|81852|P2|Washout Period 3|Physician Decision|0
16465|NCT02074553|81853|P1|Washout Period 3|Physician Decision|0
16466|NCT02074553|81846|P8|Washout Period 2|Lost to Follow-up|0
16467|NCT02074553|81847|P7|Washout Period 2|Lost to Follow-up|0
16468|NCT02074553|81848|P6|Washout Period 2|Lost to Follow-up|0
16469|NCT02074553|81849|P5|Washout Period 2|Lost to Follow-up|0
16470|NCT02074553|81850|P4|Washout Period 2|Lost to Follow-up|0
16471|NCT02074553|81851|P3|Washout Period 2|Lost to Follow-up|1
16472|NCT02074553|81852|P2|Washout Period 2|Lost to Follow-up|0
16473|NCT02074553|81853|P1|Washout Period 2|Lost to Follow-up|0
16474|NCT02074553|81846|P8|Washout Period 2|Physician Decision|0
16475|NCT02074553|81847|P7|Washout Period 2|Physician Decision|0
16476|NCT02074553|81848|P6|Washout Period 2|Physician Decision|1
16477|NCT02074553|81849|P5|Washout Period 2|Physician Decision|0
16478|NCT02074553|81850|P4|Washout Period 2|Physician Decision|0
16479|NCT02074553|81851|P3|Washout Period 2|Physician Decision|0
16480|NCT02074553|81852|P2|Washout Period 2|Physician Decision|0
16481|NCT02074553|81853|P1|Washout Period 2|Physician Decision|0
16482|NCT02074553|81846|P8|Washout Period 2|Adverse Event|0
16483|NCT02074553|81847|P7|Washout Period 2|Adverse Event|1
16484|NCT02074553|81848|P6|Washout Period 2|Adverse Event|0
16485|NCT02074553|81849|P5|Washout Period 2|Adverse Event|0
16486|NCT02074553|81850|P4|Washout Period 2|Adverse Event|0
16487|NCT02074553|81851|P3|Washout Period 2|Adverse Event|0
16488|NCT02074553|81852|P2|Washout Period 2|Adverse Event|0
16489|NCT02074553|81853|P1|Washout Period 2|Adverse Event|0
16490|NCT02074553|81846|P8|Washout Period 1|Other|0
16491|NCT02074553|81847|P7|Washout Period 1|Other|0
16492|NCT02074553|81848|P6|Washout Period 1|Other|1
16493|NCT02074553|81849|P5|Washout Period 1|Other|0
16494|NCT02074553|81850|P4|Washout Period 1|Other|0
16495|NCT02074553|81851|P3|Washout Period 1|Other|0
16496|NCT02074553|81852|P2|Washout Period 1|Other|0
16497|NCT02074553|81853|P1|Washout Period 1|Other|0
16498|NCT02074553|81846|P8|Washout Period 1|Physician Decision|0
16499|NCT02074553|81847|P7|Washout Period 1|Physician Decision|0
16500|NCT02074553|81848|P6|Washout Period 1|Physician Decision|0
16501|NCT02074553|81849|P5|Washout Period 1|Physician Decision|0
16502|NCT02074553|81850|P4|Washout Period 1|Physician Decision|1
16503|NCT02074553|81851|P3|Washout Period 1|Physician Decision|0
16504|NCT02074553|81852|P2|Washout Period 1|Physician Decision|0
16505|NCT02074553|81853|P1|Washout Period 1|Physician Decision|0
16506|NCT02074553|81846|P8|Washout Period 1|Adverse Event|0
16507|NCT02074553|81847|P7|Washout Period 1|Adverse Event|0
16508|NCT02074553|81848|P6|Washout Period 1|Adverse Event|0
16509|NCT02074553|81849|P5|Washout Period 1|Adverse Event|0
16510|NCT02074553|81850|P4|Washout Period 1|Adverse Event|0
16511|NCT02074553|81851|P3|Washout Period 1|Adverse Event|0
16512|NCT02074553|81852|P2|Washout Period 1|Adverse Event|0
16513|NCT02074553|81853|P1|Washout Period 1|Adverse Event|1
16514|NCT02074553|81846|P8|Intervention Period 1|Family Emergency|0
16515|NCT02074553|81847|P7|Intervention Period 1|Family Emergency|0
16516|NCT02074553|81848|P6|Intervention Period 1|Family Emergency|0
16517|NCT02074553|81849|P5|Intervention Period 1|Family Emergency|0
16518|NCT02074553|81850|P4|Intervention Period 1|Family Emergency|1
16519|NCT02074553|81851|P3|Intervention Period 1|Family Emergency|0
16520|NCT02074553|81852|P2|Intervention Period 1|Family Emergency|0
16521|NCT02074553|81853|P1|Intervention Period 1|Family Emergency|0
16522|NCT02074514|82035|P2|Overall Study|Withdrew Consent|1
16523|NCT02074514|82036|P1|Overall Study|Withdrew Consent|0
16524|NCT02074514|82035|P2|Overall Study|Lost to Follow-up|1
16525|NCT02074514|82036|P1|Overall Study|Lost to Follow-up|0
16526|NCT02074514|82035|P2|Overall Study|Lack of Efficacy|2
16527|NCT02074514|82036|P1|Overall Study|Lack of Efficacy|3
16528|NCT02074059|82177|P6|Overall Study|Death|1
16529|NCT02074059|82178|P5|Overall Study|Death|1
16530|NCT02074059|82179|P4|Overall Study|Death|0
16531|NCT02074059|82180|P3|Overall Study|Death|0
16532|NCT02074059|82181|P2|Overall Study|Death|0
16533|NCT02074059|82182|P1|Overall Study|Death|0
16534|NCT02073656|82229|P1|Primary Study|Withdrew Consent|1
16535|NCT02073656|82229|P1|Primary Study|Death|1
16536|NCT02073656|82229|P1|Primary Study|Lost to Follow-up|6
16537|NCT02072980|82307|P2|Period 2, Second Wear|Adverse Event|1
16538|NCT02072980|82308|P1|Period 2, Second Wear|Adverse Event|0
16539|NCT02072096|82334|P2|Overall Study|Lost to Follow-up|0
16540|NCT02072096|82335|P1|Overall Study|Lost to Follow-up|1
16541|NCT02072096|82334|P2|Overall Study|Study Terminated by Sponsor|30
16542|NCT02072096|82335|P1|Overall Study|Study Terminated by Sponsor|43
16543|NCT02072096|82334|P2|Overall Study|Physician Decision|1
16544|NCT02072096|82335|P1|Overall Study|Physician Decision|0
16545|NCT02072096|82334|P2|Overall Study|Death|0
16546|NCT02072096|82335|P1|Overall Study|Death|2
16547|NCT02072096|82334|P2|Overall Study|No Reason Provided|2
16548|NCT02072096|82335|P1|Overall Study|No Reason Provided|4
16549|NCT02072096|82334|P2|Overall Study|Adverse Event|2
16550|NCT02072096|82335|P1|Overall Study|Adverse Event|5
16551|NCT02072096|82334|P2|Overall Study|Withdrawal by Subject|7
16552|NCT02072096|82335|P1|Overall Study|Withdrawal by Subject|5
16553|NCT02072096|82334|P2|Overall Study|Protocol Violation|7
16554|NCT02072096|82335|P1|Overall Study|Protocol Violation|7
16555|NCT02072096|82334|P2|Overall Study|Lack of Efficacy|29
16556|NCT02072096|82335|P1|Overall Study|Lack of Efficacy|18
16557|NCT02071849|82357|P1|2-year Extended Follow-up|Adverse Event|1
16558|NCT02071849|82357|P1|6-month Primary Endpoint|Adverse Event|1
16559|NCT02071849|82357|P1|6-month Primary Endpoint|Did not receive device|4
16560|NCT02071771|82423|P2|Period 1: First 10 Days|Unavailable lens power|0
16561|NCT02071771|82424|P1|Period 1: First 10 Days|Unavailable lens power|1
16562|NCT02071771|82423|P2|Period 1: First 10 Days|Unacceptable lens fit|0
16563|NCT02071771|82424|P1|Period 1: First 10 Days|Unacceptable lens fit|1
16564|NCT02071082|82479|P2|Overall Study|Lost to Follow-up|1
16565|NCT02071082|82480|P1|Overall Study|Lost to Follow-up|1
16566|NCT02071082|82479|P2|Overall Study|Withdrew Consent|4
16567|NCT02071082|82480|P1|Overall Study|Withdrew Consent|0
16568|NCT02071082|82479|P2|Overall Study|Adverse Event|1
16569|NCT02071082|82480|P1|Overall Study|Adverse Event|0
16570|NCT02071082|82479|P2|Overall Study|Enrolled and Never Treated|1
16571|NCT02071082|82480|P1|Overall Study|Enrolled and Never Treated|1
16572|NCT02070965|82511|P3|Overall Study|Subject moved|0
16573|NCT02070965|82512|P2|Overall Study|Subject moved|0
16574|NCT02070965|82513|P1|Overall Study|Subject moved|1
16575|NCT02070965|82511|P3|Overall Study|Withdrawal by Subject|1
16576|NCT02070965|82512|P2|Overall Study|Withdrawal by Subject|1
16577|NCT02070965|82513|P1|Overall Study|Withdrawal by Subject|1
16578|NCT02070965|82511|P3|Overall Study|Lost to Follow-up|0
16579|NCT02070965|82512|P2|Overall Study|Lost to Follow-up|1
16580|NCT02070965|82513|P1|Overall Study|Lost to Follow-up|0
16581|NCT02070744|82525|P5|OLE Phase (48 Weeks)|Other|1
16582|NCT02070744|82526|P4|OLE Phase (48 Weeks)|Other|0
16583|NCT02070744|82527|P3|OLE Phase (48 Weeks)|Other|0
16584|NCT02070744|82528|P2|OLE Phase (48 Weeks)|Other|0
16585|NCT02070744|82529|P1|OLE Phase (48 Weeks)|Other|0
16586|NCT02070744|82525|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
16587|NCT02070744|82526|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
16588|NCT02070744|82527|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
16589|NCT02070744|82528|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
16590|NCT02070744|82529|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
16591|NCT02070744|82525|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
16592|NCT02070744|82526|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
16593|NCT02070744|82527|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
16594|NCT02070744|82528|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
16595|NCT02070744|82529|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
16596|NCT02070588|82612|P3|Overall Study|Adverse Event|0
16597|NCT02070588|82613|P2|Overall Study|Adverse Event|0
16598|NCT02070588|82614|P1|Overall Study|Adverse Event|1
16599|NCT02070588|82612|P3|Overall Study|Writhdrawal due to early termination|0
16600|NCT02070588|82613|P2|Overall Study|Writhdrawal due to early termination|0
16601|NCT02070588|82614|P1|Overall Study|Writhdrawal due to early termination|9
16602|NCT02070588|82612|P3|Overall Study|Withdrawal by Subject|0
16603|NCT02070588|82613|P2|Overall Study|Withdrawal by Subject|1
16604|NCT02070588|82614|P1|Overall Study|Withdrawal by Subject|29
16605|NCT02070380|82632|P4|Second Injection|Protocol Violation|5
16606|NCT02070380|82633|P3|Second Injection|Protocol Violation|1
16607|NCT02070380|82634|P2|Second Injection|Protocol Violation|1
16608|NCT02070380|82635|P1|Second Injection|Protocol Violation|0
16609|NCT02070380|82632|P4|Second Injection|Image sets missing or technically inadeq|0
16610|NCT02070380|82633|P3|Second Injection|Image sets missing or technically inadeq|0
16611|NCT02070380|82634|P2|Second Injection|Image sets missing or technically inadeq|1
16612|NCT02070380|82635|P1|Second Injection|Image sets missing or technically inadeq|0
16613|NCT02070380|82632|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
16614|NCT02070380|82633|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
16615|NCT02070380|82634|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
16616|NCT02070380|82635|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
16617|NCT02069093|82713|P1|Overall Study|Adverse Event|10
16618|NCT02069093|82713|P1|Overall Study|Abnormal laboratory values|1
16619|NCT02069093|82713|P1|Overall Study|Withdrawal by Subject|2
16620|NCT02069093|82713|P1|Overall Study|Administrative problems|1
16621|NCT02069093|82713|P1|Overall Study|Death|1
16622|NCT02069093|82713|P1|Overall Study|New cancer therapy|1
16623|NCT02069093|82713|P1|Overall Study|Disease progression|14
16624|NCT02068547|82724|P2|Overall Study|Physician Decision|0
16625|NCT02068547|82725|P1|Overall Study|Physician Decision|1
16626|NCT02068547|82724|P2|Overall Study|Lost to Follow-up|3
16627|NCT02068547|82725|P1|Overall Study|Lost to Follow-up|3
16628|NCT02068443|82738|P3|Overall Study|Other Reason Not Specified|0
16629|NCT02068443|82739|P2|Overall Study|Other Reason Not Specified|0
16630|NCT02068443|82740|P1|Overall Study|Other Reason Not Specified|1
16631|NCT02068443|82738|P3|Overall Study|Lack of Efficacy|0
16632|NCT02068443|82739|P2|Overall Study|Lack of Efficacy|1
16633|NCT02068443|82740|P1|Overall Study|Lack of Efficacy|2
16634|NCT02068443|82738|P3|Overall Study|Voluntary Withdrawal|1
16635|NCT02068443|82739|P2|Overall Study|Voluntary Withdrawal|0
16636|NCT02068443|82740|P1|Overall Study|Voluntary Withdrawal|4
16637|NCT02068443|82738|P3|Overall Study|Pretreatment Event/Adverse Event|2
16638|NCT02068443|82739|P2|Overall Study|Pretreatment Event/Adverse Event|5
16639|NCT02068443|82740|P1|Overall Study|Pretreatment Event/Adverse Event|0
16640|NCT02068222|82775|P1|Overall Study|Lost to Follow-up|1
16641|NCT02067728|82800|P2|6 Month Measurements|Unable to attend|97
16642|NCT02067728|82801|P1|6 Month Measurements|Unable to attend|114
16643|NCT02067728|82800|P2|6 Month Follow up Survey|Lost to Follow-up|60
16644|NCT02067728|82801|P1|6 Month Follow up Survey|Lost to Follow-up|48
16645|NCT02067728|82800|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
16646|NCT02067728|82801|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
16647|NCT02067676|82835|P6|Overall Study|Withdrawal by Subject|0
16648|NCT02067676|82836|P5|Overall Study|Withdrawal by Subject|0
16649|NCT02067676|82837|P4|Overall Study|Withdrawal by Subject|0
16650|NCT02067676|82838|P3|Overall Study|Withdrawal by Subject|0
16651|NCT02067676|82839|P2|Overall Study|Withdrawal by Subject|0
16652|NCT02067676|82840|P1|Overall Study|Withdrawal by Subject|1
16653|NCT02067533|82957|P2|Overall Study|Lost to Follow-up|2
16654|NCT02067533|82958|P1|Overall Study|Lost to Follow-up|4
16655|NCT02066922|82973|P1|Overall Study|Adverse Event|1
16656|NCT02066402|83027|P2|Overall Study|Protocol driven decision point|1
16657|NCT02066402|83028|P1|Overall Study|Protocol driven decision point|0
16658|NCT02066402|83027|P2|Overall Study|Progressive disease-clinical progression|1
16659|NCT02066402|83028|P1|Overall Study|Progressive disease-clinical progression|0
16660|NCT02066402|83027|P2|Overall Study|Withdrawal by Subject|11
16661|NCT02066402|83028|P1|Overall Study|Withdrawal by Subject|14
16662|NCT02066402|83027|P2|Overall Study|Lost to Follow-up|8
16663|NCT02066402|83028|P1|Overall Study|Lost to Follow-up|11
16664|NCT02066402|83027|P2|Overall Study|Adverse Event|2
16665|NCT02066402|83028|P1|Overall Study|Adverse Event|1
16666|NCT02066233|83056|P2|EG Scan II (Day 1)|difficulty intubating subject|6
16667|NCT02066233|83057|P1|EG Scan II (Day 1)|difficulty intubating subject|6
16668|NCT02066051|83065|P1|Overall Study|Subject developed active GVHD|1
16669|NCT02065895|83070|P6|Overall Study|Scheduling conflicts|0
16670|NCT02065895|83071|P5|Overall Study|Scheduling conflicts|0
16671|NCT02065895|83072|P4|Overall Study|Scheduling conflicts|0
16672|NCT02065895|83073|P3|Overall Study|Scheduling conflicts|0
16673|NCT02065895|83074|P2|Overall Study|Scheduling conflicts|1
16674|NCT02065895|83075|P1|Overall Study|Scheduling conflicts|0
16675|NCT02065895|83070|P6|Overall Study|Protocol Violation|0
16676|NCT02065895|83071|P5|Overall Study|Protocol Violation|0
16677|NCT02065895|83072|P4|Overall Study|Protocol Violation|1
16678|NCT02065895|83073|P3|Overall Study|Protocol Violation|0
16679|NCT02065895|83074|P2|Overall Study|Protocol Violation|0
16680|NCT02065895|83075|P1|Overall Study|Protocol Violation|1
16681|NCT02064920|83268|P2|Overall Study|Withdrawal by Subject|3
16682|NCT02064920|83269|P1|Overall Study|Withdrawal by Subject|1
16683|NCT02064920|83268|P2|Overall Study|Technical Problems|1
16684|NCT02064920|83269|P1|Overall Study|Technical Problems|0
16685|NCT02064920|83268|P2|Overall Study|Physician Decision|1
16686|NCT02064920|83269|P1|Overall Study|Physician Decision|0
16687|NCT02064920|83268|P2|Overall Study|Adverse Event|4
16688|NCT02064920|83269|P1|Overall Study|Adverse Event|0
16689|NCT02064894|83299|P3|Overall Study|Withdrawal by Subject|115
16690|NCT02064894|83300|P2|Overall Study|Withdrawal by Subject|102
16691|NCT02064894|83301|P1|Overall Study|Withdrawal by Subject|43
16692|NCT02064439|83315|P3|Overall Study|Other|7
16693|NCT02064439|83316|P2|Overall Study|Other|2
16694|NCT02064439|83317|P1|Overall Study|Other|2
16695|NCT02064439|83315|P3|Overall Study|Safety outcome reached|10
16696|NCT02064439|83316|P2|Overall Study|Safety outcome reached|20
16697|NCT02064439|83317|P1|Overall Study|Safety outcome reached|12
16698|NCT02064439|83315|P3|Overall Study|Efficacy outcome reached|57
16699|NCT02064439|83316|P2|Overall Study|Efficacy outcome reached|16
16700|NCT02064439|83317|P1|Overall Study|Efficacy outcome reached|18
16701|NCT02064439|83315|P3|Overall Study|Logistical difficulties|2
16702|NCT02064439|83316|P2|Overall Study|Logistical difficulties|5
16703|NCT02064439|83317|P1|Overall Study|Logistical difficulties|6
16704|NCT02064439|83315|P3|Overall Study|Physician Decision|1
16705|NCT02064439|83316|P2|Overall Study|Physician Decision|1
16706|NCT02064439|83317|P1|Overall Study|Physician Decision|0
16707|NCT02064439|83315|P3|Overall Study|Non-compliance with study medication|23
16708|NCT02064439|83316|P2|Overall Study|Non-compliance with study medication|19
16709|NCT02064439|83317|P1|Overall Study|Non-compliance with study medication|21
16710|NCT02064439|83315|P3|Overall Study|Lost to Follow-up|4
16711|NCT02064439|83316|P2|Overall Study|Lost to Follow-up|3
16712|NCT02064439|83317|P1|Overall Study|Lost to Follow-up|1
16713|NCT02064439|83315|P3|Overall Study|Protocol Violation|3
16714|NCT02064439|83316|P2|Overall Study|Protocol Violation|5
16715|NCT02064439|83317|P1|Overall Study|Protocol Violation|3
16716|NCT02064439|83315|P3|Overall Study|Withdrawal by Subject|26
16717|NCT02064439|83316|P2|Overall Study|Withdrawal by Subject|18
16718|NCT02064439|83317|P1|Overall Study|Withdrawal by Subject|29
16719|NCT02064439|83315|P3|Overall Study|Death|3
16720|NCT02064439|83316|P2|Overall Study|Death|2
16721|NCT02064439|83317|P1|Overall Study|Death|0
16722|NCT02064439|83315|P3|Overall Study|Adverse Event|46
16723|NCT02064439|83316|P2|Overall Study|Adverse Event|47
16724|NCT02064439|83317|P1|Overall Study|Adverse Event|51
16725|NCT02064231|83352|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
16726|NCT02064231|83353|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
16727|NCT02064231|83354|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
16728|NCT02064231|83355|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
16729|NCT02064231|83352|P4|First Test Period (Test A or Test C)|Adverse Event|0
16730|NCT02064231|83353|P3|First Test Period (Test A or Test C)|Adverse Event|1
16731|NCT02064231|83354|P2|First Test Period (Test A or Test C)|Adverse Event|0
16732|NCT02064231|83355|P1|First Test Period (Test A or Test C)|Adverse Event|1
16733|NCT02064231|83352|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
16734|NCT02064231|83353|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
16735|NCT02064231|83354|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
16736|NCT02064231|83355|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
16737|NCT02064231|83352|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
16738|NCT02064231|83353|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
16739|NCT02064231|83354|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
16740|NCT02064231|83355|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
16741|NCT02064205|83367|P1|Overall Study|Withdrawal by Subject|1
16742|NCT02063880|83385|P2|Overall Study|Ineligible|2
16743|NCT02063880|83386|P1|Overall Study|Ineligible|0
16744|NCT02063880|83385|P2|Overall Study|Lost to Follow-up|7
16745|NCT02063880|83386|P1|Overall Study|Lost to Follow-up|7
16746|NCT02063880|83385|P2|Overall Study|Death|18
16747|NCT02063880|83386|P1|Overall Study|Death|21
16748|NCT02063854|83403|P7|Overall Study|Did Not Receive Study Drug|0
16749|NCT02063854|83404|P6|Overall Study|Did Not Receive Study Drug|1
16750|NCT02063854|83405|P5|Overall Study|Did Not Receive Study Drug|0
16751|NCT02063854|83406|P4|Overall Study|Did Not Receive Study Drug|0
16752|NCT02063854|83407|P3|Overall Study|Did Not Receive Study Drug|0
16753|NCT02063854|83408|P2|Overall Study|Did Not Receive Study Drug|0
16754|NCT02063854|83409|P1|Overall Study|Did Not Receive Study Drug|0
16755|NCT02063854|83403|P7|Overall Study|Reason Not Specified|0
16756|NCT02063854|83404|P6|Overall Study|Reason Not Specified|0
16757|NCT02063854|83405|P5|Overall Study|Reason Not Specified|0
16758|NCT02063854|83406|P4|Overall Study|Reason Not Specified|0
16759|NCT02063854|83407|P3|Overall Study|Reason Not Specified|0
16760|NCT02063854|83408|P2|Overall Study|Reason Not Specified|0
16761|NCT02063854|83409|P1|Overall Study|Reason Not Specified|1
16762|NCT02063854|83403|P7|Overall Study|Surgical Dental Work Performed/Planned|1
16763|NCT02063854|83404|P6|Overall Study|Surgical Dental Work Performed/Planned|6
16764|NCT02063854|83405|P5|Overall Study|Surgical Dental Work Performed/Planned|1
16765|NCT02063854|83406|P4|Overall Study|Surgical Dental Work Performed/Planned|1
16766|NCT02063854|83407|P3|Overall Study|Surgical Dental Work Performed/Planned|6
16767|NCT02063854|83408|P2|Overall Study|Surgical Dental Work Performed/Planned|2
16768|NCT02063854|83409|P1|Overall Study|Surgical Dental Work Performed/Planned|5
16769|NCT02063854|83403|P7|Overall Study|Voluntary Withdrawal|1
16770|NCT02063854|83404|P6|Overall Study|Voluntary Withdrawal|6
16771|NCT02063854|83405|P5|Overall Study|Voluntary Withdrawal|3
16772|NCT02063854|83406|P4|Overall Study|Voluntary Withdrawal|1
16773|NCT02063854|83407|P3|Overall Study|Voluntary Withdrawal|8
16774|NCT02063854|83408|P2|Overall Study|Voluntary Withdrawal|0
16775|NCT02063854|83409|P1|Overall Study|Voluntary Withdrawal|2
16776|NCT02063854|83403|P7|Overall Study|Major Protocol Deviation|0
16777|NCT02063854|83404|P6|Overall Study|Major Protocol Deviation|0
16778|NCT02063854|83405|P5|Overall Study|Major Protocol Deviation|0
16779|NCT02063854|83406|P4|Overall Study|Major Protocol Deviation|0
16780|NCT02063854|83407|P3|Overall Study|Major Protocol Deviation|3
16781|NCT02063854|83408|P2|Overall Study|Major Protocol Deviation|0
16782|NCT02063854|83409|P1|Overall Study|Major Protocol Deviation|0
16783|NCT02063854|83403|P7|Overall Study|Pretreatment Event/Adverse Event|4
16784|NCT02063854|83404|P6|Overall Study|Pretreatment Event/Adverse Event|18
16785|NCT02063854|83405|P5|Overall Study|Pretreatment Event/Adverse Event|7
16786|NCT02063854|83406|P4|Overall Study|Pretreatment Event/Adverse Event|8
16787|NCT02063854|83407|P3|Overall Study|Pretreatment Event/Adverse Event|13
16788|NCT02063854|83408|P2|Overall Study|Pretreatment Event/Adverse Event|10
16789|NCT02063854|83409|P1|Overall Study|Pretreatment Event/Adverse Event|13
16790|NCT02063737|83493|P2|Overall Study|Lost to Follow-up|4
16791|NCT02063737|83494|P1|Overall Study|Lost to Follow-up|11
16792|NCT02063672|83528|P2|Overall Study|Withdrawal by Subject|2
16793|NCT02063672|83529|P1|Overall Study|Withdrawal by Subject|2
16794|NCT02063672|83528|P2|Overall Study|Lost to Follow-up|3
16795|NCT02063672|83529|P1|Overall Study|Lost to Follow-up|1
16796|NCT02063672|83528|P2|Overall Study|Death|3
16797|NCT02063672|83529|P1|Overall Study|Death|5
16798|NCT02063672|83528|P2|Overall Study|Ongoing Follow-up|14
16799|NCT02063672|83529|P1|Overall Study|Ongoing Follow-up|27
16800|NCT02063659|83576|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
16801|NCT02063659|83577|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
16802|NCT02063659|83578|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
16803|NCT02063659|83579|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
16804|NCT02063659|83576|P4|Open-Label Extension Period (OLE)|Adverse Event|7
16805|NCT02063659|83577|P3|Open-Label Extension Period (OLE)|Adverse Event|0
16806|NCT02063659|83578|P2|Open-Label Extension Period (OLE)|Adverse Event|0
16807|NCT02063659|83579|P1|Open-Label Extension Period (OLE)|Adverse Event|0
16808|NCT02063659|83576|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
16809|NCT02063659|83577|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
16810|NCT02063659|83578|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
16811|NCT02063659|83579|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
16812|NCT02063659|83576|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
16813|NCT02063659|83577|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
16814|NCT02063659|83578|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
16815|NCT02063659|83579|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
16816|NCT02063659|83576|P4|Open-Label Extension Period (OLE)|Physician Decision|1
16817|NCT02063659|83577|P3|Open-Label Extension Period (OLE)|Physician Decision|0
16818|NCT02063659|83578|P2|Open-Label Extension Period (OLE)|Physician Decision|0
16819|NCT02063659|83579|P1|Open-Label Extension Period (OLE)|Physician Decision|0
16820|NCT02063659|83576|P4|Double-Blind Treatment Period|Withdrawal of consent|0
16821|NCT02063659|83577|P3|Double-Blind Treatment Period|Withdrawal of consent|3
16822|NCT02063659|83578|P2|Double-Blind Treatment Period|Withdrawal of consent|1
16823|NCT02063659|83579|P1|Double-Blind Treatment Period|Withdrawal of consent|0
16824|NCT02063659|83576|P4|Double-Blind Treatment Period|Physician Decision|0
16825|NCT02063659|83577|P3|Double-Blind Treatment Period|Physician Decision|0
16826|NCT02063659|83578|P2|Double-Blind Treatment Period|Physician Decision|0
16827|NCT02063659|83579|P1|Double-Blind Treatment Period|Physician Decision|1
16828|NCT02063659|83576|P4|Double-Blind Treatment Period|Adverse Event|0
16829|NCT02063659|83577|P3|Double-Blind Treatment Period|Adverse Event|0
16830|NCT02063659|83578|P2|Double-Blind Treatment Period|Adverse Event|2
16831|NCT02063659|83579|P1|Double-Blind Treatment Period|Adverse Event|1
16832|NCT02063217|83662|P3|Overall Study|Withdrawal by Subject|0
16833|NCT02063217|83663|P2|Overall Study|Withdrawal by Subject|0
16834|NCT02063217|83664|P1|Overall Study|Withdrawal by Subject|1
16835|NCT02062879|83700|P2|Overall Study|Withdrawal by Subject|1
16836|NCT02062879|83701|P1|Overall Study|Withdrawal by Subject|4
16837|NCT02062658|83737|P1|Overall Study|Lack of Efficacy|1
16838|NCT02062658|83737|P1|Overall Study|Withdrawal by Subject|1
16839|NCT02062645|83741|P1|Overall Study|Lost to Follow-up|5
16840|NCT02062645|83741|P1|Overall Study|Protocol Violation|8
16841|NCT02062645|83741|P1|Overall Study|Adverse Event|2
16842|NCT02062450|83783|P1|Overall Study|No follow-up visit|124
16843|NCT02062437|83797|P1|Overall Study|Pt. couldn't come due to med. condition|1
16844|NCT02062437|83797|P1|Overall Study|Death|2
16845|NCT02062437|83797|P1|Overall Study|Patient not available for the 2y visit|18
16846|NCT02062437|83797|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
16847|NCT02062385|83810|P4|Overall Study|Lost to Follow-up|0
16848|NCT02062385|83811|P3|Overall Study|Lost to Follow-up|1
16849|NCT02062385|83812|P2|Overall Study|Lost to Follow-up|0
16850|NCT02062385|83813|P1|Overall Study|Lost to Follow-up|0
16851|NCT02062385|83810|P4|Overall Study|Death|1
16852|NCT02062385|83811|P3|Overall Study|Death|0
16853|NCT02062385|83812|P2|Overall Study|Death|0
16854|NCT02062385|83813|P1|Overall Study|Death|0
16855|NCT02062385|83810|P4|Overall Study|Withdrawn by parent/guardian|8
16856|NCT02062385|83811|P3|Overall Study|Withdrawn by parent/guardian|9
16857|NCT02062385|83812|P2|Overall Study|Withdrawn by parent/guardian|41
16858|NCT02062385|83813|P1|Overall Study|Withdrawn by parent/guardian|46
16859|NCT02062385|83810|P4|Overall Study|Moved|0
16860|NCT02062385|83811|P3|Overall Study|Moved|1
16861|NCT02062385|83812|P2|Overall Study|Moved|11
16862|NCT02062385|83813|P1|Overall Study|Moved|10
16863|NCT02062385|83810|P4|Overall Study|Incomplete EPI by database lock|0
16864|NCT02062385|83811|P3|Overall Study|Incomplete EPI by database lock|0
16865|NCT02062385|83812|P2|Overall Study|Incomplete EPI by database lock|0
16866|NCT02062385|83813|P1|Overall Study|Incomplete EPI by database lock|2
16867|NCT02062385|83810|P4|Overall Study|Protocol Violation|0
16868|NCT02062385|83811|P3|Overall Study|Protocol Violation|0
16869|NCT02062385|83812|P2|Overall Study|Protocol Violation|0
16870|NCT02062385|83813|P1|Overall Study|Protocol Violation|1
16871|NCT02062385|83810|P4|Overall Study|Adverse Event|0
16872|NCT02062385|83811|P3|Overall Study|Adverse Event|1
16873|NCT02062385|83812|P2|Overall Study|Adverse Event|13
16874|NCT02062385|83813|P1|Overall Study|Adverse Event|19
16875|NCT02061592|83966|P2|Period 2|Lost to Follow-up|1
16876|NCT02061592|83967|P1|Period 2|Lost to Follow-up|0
16877|NCT02061592|83966|P2|Period 1|Protocol Violation|0
16878|NCT02061592|83967|P1|Period 1|Protocol Violation|1
16879|NCT02061592|83966|P2|Period 1|Withdrawal by Subject|0
16880|NCT02061592|83967|P1|Period 1|Withdrawal by Subject|1
16881|NCT02061540|83979|P1|Overall Study|Withdrawal by Subject|2
16882|NCT02061540|83979|P1|Overall Study|Adverse Event|2
16883|NCT02061280|84147|P2|Overall Study|Lost to Follow-up|1
16884|NCT02061280|84148|P1|Overall Study|Lost to Follow-up|5
16885|NCT02061280|84147|P2|Overall Study|Withdrawal by Subject|2
16886|NCT02061280|84148|P1|Overall Study|Withdrawal by Subject|1
16887|NCT02061280|84147|P2|Overall Study|moved out of state|1
16888|NCT02061280|84148|P1|Overall Study|moved out of state|0
16889|NCT02061280|84147|P2|Overall Study|Protocol Violation|8
16890|NCT02061280|84148|P1|Overall Study|Protocol Violation|12
16891|NCT02059395|84324|P2|Overall Study|Lost to Follow-up|4
16892|NCT02059395|84325|P1|Overall Study|Lost to Follow-up|2
16893|NCT02059291|84340|P25|Epoch 4|Lack of Efficacy|0
16894|NCT02059291|84341|P24|Epoch 4|Lack of Efficacy|1
16895|NCT02059291|84342|P23|Epoch 4|Lack of Efficacy|0
16896|NCT02059291|84343|P22|Epoch 4|Lack of Efficacy|0
16897|NCT02059291|84344|P21|Epoch 4|Lack of Efficacy|0
16898|NCT02059291|84345|P20|Epoch 4|Lack of Efficacy|0
16899|NCT02059291|84346|P19|Epoch 4|Lack of Efficacy|0
16900|NCT02059291|84347|P18|Epoch 4|Lack of Efficacy|0
16901|NCT02059291|84348|P17|Epoch 4|Lack of Efficacy|0
16902|NCT02059291|84349|P16|Epoch 4|Lack of Efficacy|0
16903|NCT02059291|84350|P15|Epoch 4|Lack of Efficacy|0
16904|NCT02059291|84351|P14|Epoch 4|Lack of Efficacy|0
16905|NCT02059291|84352|P13|Epoch 4|Lack of Efficacy|0
16906|NCT02059291|84353|P12|Epoch 4|Lack of Efficacy|0
16907|NCT02059291|84354|P11|Epoch 4|Lack of Efficacy|0
16908|NCT02059291|84355|P10|Epoch 4|Lack of Efficacy|0
16909|NCT02059291|84356|P9|Epoch 4|Lack of Efficacy|0
16910|NCT02059291|84357|P8|Epoch 4|Lack of Efficacy|0
16911|NCT02059291|84358|P7|Epoch 4|Lack of Efficacy|0
16912|NCT02059291|84359|P6|Epoch 4|Lack of Efficacy|0
16913|NCT02059291|84360|P5|Epoch 4|Lack of Efficacy|0
16914|NCT02059291|84361|P4|Epoch 4|Lack of Efficacy|0
16915|NCT02059291|84362|P3|Epoch 4|Lack of Efficacy|0
16916|NCT02059291|84363|P2|Epoch 4|Lack of Efficacy|0
16917|NCT02059291|84364|P1|Epoch 4|Lack of Efficacy|0
16918|NCT02059291|84340|P25|Epoch 4|Withdrawal by Subject|0
16919|NCT02059291|84341|P24|Epoch 4|Withdrawal by Subject|0
16920|NCT02059291|84342|P23|Epoch 4|Withdrawal by Subject|0
16921|NCT02059291|84343|P22|Epoch 4|Withdrawal by Subject|0
16922|NCT02059291|84344|P21|Epoch 4|Withdrawal by Subject|1
16923|NCT02059291|84345|P20|Epoch 4|Withdrawal by Subject|0
16924|NCT02059291|84346|P19|Epoch 4|Withdrawal by Subject|0
16925|NCT02059291|84347|P18|Epoch 4|Withdrawal by Subject|0
16926|NCT02059291|84348|P17|Epoch 4|Withdrawal by Subject|0
16927|NCT02059291|84349|P16|Epoch 4|Withdrawal by Subject|0
16928|NCT02059291|84350|P15|Epoch 4|Withdrawal by Subject|0
16929|NCT02059291|84351|P14|Epoch 4|Withdrawal by Subject|0
16930|NCT02059291|84352|P13|Epoch 4|Withdrawal by Subject|0
16931|NCT02059291|84353|P12|Epoch 4|Withdrawal by Subject|0
16932|NCT02059291|84354|P11|Epoch 4|Withdrawal by Subject|0
16933|NCT02059291|84355|P10|Epoch 4|Withdrawal by Subject|0
16934|NCT02059291|84356|P9|Epoch 4|Withdrawal by Subject|0
16935|NCT02059291|84357|P8|Epoch 4|Withdrawal by Subject|0
16936|NCT02059291|84358|P7|Epoch 4|Withdrawal by Subject|0
16937|NCT02059291|84359|P6|Epoch 4|Withdrawal by Subject|0
16938|NCT02059291|84360|P5|Epoch 4|Withdrawal by Subject|0
16939|NCT02059291|84361|P4|Epoch 4|Withdrawal by Subject|0
16940|NCT02059291|84362|P3|Epoch 4|Withdrawal by Subject|0
16941|NCT02059291|84363|P2|Epoch 4|Withdrawal by Subject|0
16942|NCT02059291|84364|P1|Epoch 4|Withdrawal by Subject|0
16943|NCT02059291|84340|P25|Epoch 4|Pregnancy|0
16944|NCT02059291|84341|P24|Epoch 4|Pregnancy|0
16945|NCT02059291|84342|P23|Epoch 4|Pregnancy|0
16946|NCT02059291|84343|P22|Epoch 4|Pregnancy|0
16947|NCT02059291|84344|P21|Epoch 4|Pregnancy|0
16948|NCT02059291|84345|P20|Epoch 4|Pregnancy|0
16949|NCT02059291|84346|P19|Epoch 4|Pregnancy|0
16950|NCT02059291|84347|P18|Epoch 4|Pregnancy|0
16951|NCT02059291|84348|P17|Epoch 4|Pregnancy|1
16952|NCT02059291|84349|P16|Epoch 4|Pregnancy|0
16953|NCT02059291|84350|P15|Epoch 4|Pregnancy|0
16954|NCT02059291|84351|P14|Epoch 4|Pregnancy|0
16955|NCT02059291|84352|P13|Epoch 4|Pregnancy|0
16956|NCT02059291|84353|P12|Epoch 4|Pregnancy|0
16957|NCT02059291|84354|P11|Epoch 4|Pregnancy|0
16958|NCT02059291|84355|P10|Epoch 4|Pregnancy|0
16959|NCT02059291|84356|P9|Epoch 4|Pregnancy|0
16960|NCT02059291|84357|P8|Epoch 4|Pregnancy|0
16961|NCT02059291|84358|P7|Epoch 4|Pregnancy|0
16962|NCT02059291|84359|P6|Epoch 4|Pregnancy|0
16963|NCT02059291|84360|P5|Epoch 4|Pregnancy|0
16964|NCT02059291|84361|P4|Epoch 4|Pregnancy|0
16965|NCT02059291|84362|P3|Epoch 4|Pregnancy|0
16966|NCT02059291|84363|P2|Epoch 4|Pregnancy|0
16967|NCT02059291|84364|P1|Epoch 4|Pregnancy|0
16968|NCT02059291|84340|P25|Epoch 4|Adverse Event|0
16969|NCT02059291|84341|P24|Epoch 4|Adverse Event|0
16970|NCT02059291|84342|P23|Epoch 4|Adverse Event|1
16971|NCT02059291|84343|P22|Epoch 4|Adverse Event|0
16972|NCT02059291|84344|P21|Epoch 4|Adverse Event|0
16973|NCT02059291|84345|P20|Epoch 4|Adverse Event|0
16974|NCT02059291|84346|P19|Epoch 4|Adverse Event|0
16975|NCT02059291|84347|P18|Epoch 4|Adverse Event|0
16976|NCT02059291|84348|P17|Epoch 4|Adverse Event|1
16977|NCT02059291|84349|P16|Epoch 4|Adverse Event|0
16978|NCT02059291|84350|P15|Epoch 4|Adverse Event|0
16979|NCT02059291|84351|P14|Epoch 4|Adverse Event|0
16980|NCT02059291|84352|P13|Epoch 4|Adverse Event|0
16981|NCT02059291|84353|P12|Epoch 4|Adverse Event|0
16982|NCT02059291|84354|P11|Epoch 4|Adverse Event|0
16983|NCT02059291|84355|P10|Epoch 4|Adverse Event|0
16984|NCT02059291|84356|P9|Epoch 4|Adverse Event|0
16985|NCT02059291|84357|P8|Epoch 4|Adverse Event|0
16986|NCT02059291|84358|P7|Epoch 4|Adverse Event|0
16987|NCT02059291|84359|P6|Epoch 4|Adverse Event|0
16988|NCT02059291|84360|P5|Epoch 4|Adverse Event|0
16989|NCT02059291|84361|P4|Epoch 4|Adverse Event|0
16990|NCT02059291|84362|P3|Epoch 4|Adverse Event|0
16991|NCT02059291|84363|P2|Epoch 4|Adverse Event|0
16992|NCT02059291|84364|P1|Epoch 4|Adverse Event|0
16993|NCT02059291|84340|P25|Epoch 3|Withdrawal by Subject|0
16994|NCT02059291|84341|P24|Epoch 3|Withdrawal by Subject|0
16995|NCT02059291|84342|P23|Epoch 3|Withdrawal by Subject|0
16996|NCT02059291|84343|P22|Epoch 3|Withdrawal by Subject|0
16997|NCT02059291|84344|P21|Epoch 3|Withdrawal by Subject|0
16998|NCT02059291|84345|P20|Epoch 3|Withdrawal by Subject|0
16999|NCT02059291|84346|P19|Epoch 3|Withdrawal by Subject|0
17000|NCT02059291|84347|P18|Epoch 3|Withdrawal by Subject|0
17001|NCT02059291|84348|P17|Epoch 3|Withdrawal by Subject|0
17002|NCT02059291|84349|P16|Epoch 3|Withdrawal by Subject|1
17003|NCT02059291|84350|P15|Epoch 3|Withdrawal by Subject|0
17004|NCT02059291|84351|P14|Epoch 3|Withdrawal by Subject|0
17005|NCT02059291|84352|P13|Epoch 3|Withdrawal by Subject|0
17006|NCT02059291|84353|P12|Epoch 3|Withdrawal by Subject|0
17007|NCT02059291|84354|P11|Epoch 3|Withdrawal by Subject|0
17008|NCT02059291|84355|P10|Epoch 3|Withdrawal by Subject|0
17009|NCT02059291|84356|P9|Epoch 3|Withdrawal by Subject|0
17010|NCT02059291|84357|P8|Epoch 3|Withdrawal by Subject|0
17011|NCT02059291|84358|P7|Epoch 3|Withdrawal by Subject|0
17012|NCT02059291|84359|P6|Epoch 3|Withdrawal by Subject|0
17013|NCT02059291|84360|P5|Epoch 3|Withdrawal by Subject|0
17014|NCT02059291|84361|P4|Epoch 3|Withdrawal by Subject|0
17015|NCT02059291|84362|P3|Epoch 3|Withdrawal by Subject|0
17016|NCT02059291|84363|P2|Epoch 3|Withdrawal by Subject|0
17017|NCT02059291|84364|P1|Epoch 3|Withdrawal by Subject|0
17018|NCT02059291|84340|P25|Epoch 3|Lack of Efficacy|0
17019|NCT02059291|84341|P24|Epoch 3|Lack of Efficacy|0
17020|NCT02059291|84342|P23|Epoch 3|Lack of Efficacy|0
17021|NCT02059291|84343|P22|Epoch 3|Lack of Efficacy|0
17022|NCT02059291|84344|P21|Epoch 3|Lack of Efficacy|0
17023|NCT02059291|84345|P20|Epoch 3|Lack of Efficacy|0
17024|NCT02059291|84346|P19|Epoch 3|Lack of Efficacy|0
17025|NCT02059291|84347|P18|Epoch 3|Lack of Efficacy|0
17026|NCT02059291|84348|P17|Epoch 3|Lack of Efficacy|0
17027|NCT02059291|84349|P16|Epoch 3|Lack of Efficacy|3
17028|NCT02059291|84350|P15|Epoch 3|Lack of Efficacy|0
17029|NCT02059291|84351|P14|Epoch 3|Lack of Efficacy|0
17030|NCT02059291|84352|P13|Epoch 3|Lack of Efficacy|0
17031|NCT02059291|84353|P12|Epoch 3|Lack of Efficacy|0
17032|NCT02059291|84354|P11|Epoch 3|Lack of Efficacy|0
17033|NCT02059291|84355|P10|Epoch 3|Lack of Efficacy|0
17034|NCT02059291|84356|P9|Epoch 3|Lack of Efficacy|0
17035|NCT02059291|84357|P8|Epoch 3|Lack of Efficacy|0
17036|NCT02059291|84358|P7|Epoch 3|Lack of Efficacy|0
17037|NCT02059291|84359|P6|Epoch 3|Lack of Efficacy|0
17038|NCT02059291|84360|P5|Epoch 3|Lack of Efficacy|0
17039|NCT02059291|84361|P4|Epoch 3|Lack of Efficacy|0
17040|NCT02059291|84362|P3|Epoch 3|Lack of Efficacy|0
17041|NCT02059291|84363|P2|Epoch 3|Lack of Efficacy|0
17042|NCT02059291|84364|P1|Epoch 3|Lack of Efficacy|0
17043|NCT02059291|84340|P25|Epoch 3|Adverse Event|0
17044|NCT02059291|84341|P24|Epoch 3|Adverse Event|0
17045|NCT02059291|84342|P23|Epoch 3|Adverse Event|0
17046|NCT02059291|84343|P22|Epoch 3|Adverse Event|0
17047|NCT02059291|84344|P21|Epoch 3|Adverse Event|0
17048|NCT02059291|84345|P20|Epoch 3|Adverse Event|0
17049|NCT02059291|84346|P19|Epoch 3|Adverse Event|0
17050|NCT02059291|84347|P18|Epoch 3|Adverse Event|0
17051|NCT02059291|84348|P17|Epoch 3|Adverse Event|0
17052|NCT02059291|84349|P16|Epoch 3|Adverse Event|1
17053|NCT02059291|84350|P15|Epoch 3|Adverse Event|0
17054|NCT02059291|84351|P14|Epoch 3|Adverse Event|0
17055|NCT02059291|84352|P13|Epoch 3|Adverse Event|0
17056|NCT02059291|84353|P12|Epoch 3|Adverse Event|0
17057|NCT02059291|84354|P11|Epoch 3|Adverse Event|0
17058|NCT02059291|84355|P10|Epoch 3|Adverse Event|0
17059|NCT02059291|84356|P9|Epoch 3|Adverse Event|0
17060|NCT02059291|84357|P8|Epoch 3|Adverse Event|0
17061|NCT02059291|84358|P7|Epoch 3|Adverse Event|0
17062|NCT02059291|84359|P6|Epoch 3|Adverse Event|0
17063|NCT02059291|84360|P5|Epoch 3|Adverse Event|0
17064|NCT02059291|84361|P4|Epoch 3|Adverse Event|0
17065|NCT02059291|84362|P3|Epoch 3|Adverse Event|0
17066|NCT02059291|84363|P2|Epoch 3|Adverse Event|0
17067|NCT02059291|84364|P1|Epoch 3|Adverse Event|0
17068|NCT02059291|84340|P25|Epoch 3|Physician Decision|0
17069|NCT02059291|84341|P24|Epoch 3|Physician Decision|0
17070|NCT02059291|84342|P23|Epoch 3|Physician Decision|0
17071|NCT02059291|84343|P22|Epoch 3|Physician Decision|0
17072|NCT02059291|84344|P21|Epoch 3|Physician Decision|0
17073|NCT02059291|84345|P20|Epoch 3|Physician Decision|0
17074|NCT02059291|84346|P19|Epoch 3|Physician Decision|0
17075|NCT02059291|84347|P18|Epoch 3|Physician Decision|0
17076|NCT02059291|84348|P17|Epoch 3|Physician Decision|0
17077|NCT02059291|84349|P16|Epoch 3|Physician Decision|1
17078|NCT02059291|84350|P15|Epoch 3|Physician Decision|0
17079|NCT02059291|84351|P14|Epoch 3|Physician Decision|1
17080|NCT02059291|84352|P13|Epoch 3|Physician Decision|0
17081|NCT02059291|84353|P12|Epoch 3|Physician Decision|0
17082|NCT02059291|84354|P11|Epoch 3|Physician Decision|0
17083|NCT02059291|84355|P10|Epoch 3|Physician Decision|0
17084|NCT02059291|84356|P9|Epoch 3|Physician Decision|0
17085|NCT02059291|84357|P8|Epoch 3|Physician Decision|0
17086|NCT02059291|84358|P7|Epoch 3|Physician Decision|0
17087|NCT02059291|84359|P6|Epoch 3|Physician Decision|0
17088|NCT02059291|84360|P5|Epoch 3|Physician Decision|0
17089|NCT02059291|84361|P4|Epoch 3|Physician Decision|0
17090|NCT02059291|84362|P3|Epoch 3|Physician Decision|0
17091|NCT02059291|84363|P2|Epoch 3|Physician Decision|0
17092|NCT02059291|84364|P1|Epoch 3|Physician Decision|0
17093|NCT02059291|84340|P25|Epoch 2|Withdrawal by Subject|0
17094|NCT02059291|84341|P24|Epoch 2|Withdrawal by Subject|0
17095|NCT02059291|84342|P23|Epoch 2|Withdrawal by Subject|0
17096|NCT02059291|84343|P22|Epoch 2|Withdrawal by Subject|0
17097|NCT02059291|84344|P21|Epoch 2|Withdrawal by Subject|0
17098|NCT02059291|84345|P20|Epoch 2|Withdrawal by Subject|0
17099|NCT02059291|84346|P19|Epoch 2|Withdrawal by Subject|0
17100|NCT02059291|84347|P18|Epoch 2|Withdrawal by Subject|0
17101|NCT02059291|84348|P17|Epoch 2|Withdrawal by Subject|0
17102|NCT02059291|84349|P16|Epoch 2|Withdrawal by Subject|0
17103|NCT02059291|84350|P15|Epoch 2|Withdrawal by Subject|0
17104|NCT02059291|84351|P14|Epoch 2|Withdrawal by Subject|0
17105|NCT02059291|84352|P13|Epoch 2|Withdrawal by Subject|0
17106|NCT02059291|84353|P12|Epoch 2|Withdrawal by Subject|0
17107|NCT02059291|84354|P11|Epoch 2|Withdrawal by Subject|0
17108|NCT02059291|84355|P10|Epoch 2|Withdrawal by Subject|0
17109|NCT02059291|84356|P9|Epoch 2|Withdrawal by Subject|1
17110|NCT02059291|84357|P8|Epoch 2|Withdrawal by Subject|0
17111|NCT02059291|84358|P7|Epoch 2|Withdrawal by Subject|0
17112|NCT02059291|84359|P6|Epoch 2|Withdrawal by Subject|1
17113|NCT02059291|84360|P5|Epoch 2|Withdrawal by Subject|0
17114|NCT02059291|84361|P4|Epoch 2|Withdrawal by Subject|0
17115|NCT02059291|84362|P3|Epoch 2|Withdrawal by Subject|0
17116|NCT02059291|84363|P2|Epoch 2|Withdrawal by Subject|1
17117|NCT02059291|84364|P1|Epoch 2|Withdrawal by Subject|0
17118|NCT02059291|84340|P25|Epoch 2|Adverse Event|0
17119|NCT02059291|84341|P24|Epoch 2|Adverse Event|0
17120|NCT02059291|84342|P23|Epoch 2|Adverse Event|0
17121|NCT02059291|84343|P22|Epoch 2|Adverse Event|0
17122|NCT02059291|84344|P21|Epoch 2|Adverse Event|0
17123|NCT02059291|84345|P20|Epoch 2|Adverse Event|0
17124|NCT02059291|84346|P19|Epoch 2|Adverse Event|0
17125|NCT02059291|84347|P18|Epoch 2|Adverse Event|0
17126|NCT02059291|84348|P17|Epoch 2|Adverse Event|0
17127|NCT02059291|84349|P16|Epoch 2|Adverse Event|0
17128|NCT02059291|84350|P15|Epoch 2|Adverse Event|0
17129|NCT02059291|84351|P14|Epoch 2|Adverse Event|0
17130|NCT02059291|84352|P13|Epoch 2|Adverse Event|0
17131|NCT02059291|84353|P12|Epoch 2|Adverse Event|0
17132|NCT02059291|84354|P11|Epoch 2|Adverse Event|0
17133|NCT02059291|84355|P10|Epoch 2|Adverse Event|0
17134|NCT02059291|84356|P9|Epoch 2|Adverse Event|1
17135|NCT02059291|84357|P8|Epoch 2|Adverse Event|1
17136|NCT02059291|84358|P7|Epoch 2|Adverse Event|0
17137|NCT02059291|84359|P6|Epoch 2|Adverse Event|0
17138|NCT02059291|84360|P5|Epoch 2|Adverse Event|0
17139|NCT02059291|84361|P4|Epoch 2|Adverse Event|1
17140|NCT02059291|84362|P3|Epoch 2|Adverse Event|1
17141|NCT02059291|84363|P2|Epoch 2|Adverse Event|0
17142|NCT02059291|84364|P1|Epoch 2|Adverse Event|0
17143|NCT02059291|84340|P25|Epoch 2|Lack of Efficacy|0
17144|NCT02059291|84341|P24|Epoch 2|Lack of Efficacy|0
17145|NCT02059291|84342|P23|Epoch 2|Lack of Efficacy|0
17146|NCT02059291|84343|P22|Epoch 2|Lack of Efficacy|0
17147|NCT02059291|84344|P21|Epoch 2|Lack of Efficacy|0
17148|NCT02059291|84345|P20|Epoch 2|Lack of Efficacy|0
17149|NCT02059291|84346|P19|Epoch 2|Lack of Efficacy|0
17150|NCT02059291|84347|P18|Epoch 2|Lack of Efficacy|0
17151|NCT02059291|84348|P17|Epoch 2|Lack of Efficacy|0
17152|NCT02059291|84349|P16|Epoch 2|Lack of Efficacy|0
17153|NCT02059291|84350|P15|Epoch 2|Lack of Efficacy|0
17154|NCT02059291|84351|P14|Epoch 2|Lack of Efficacy|0
17155|NCT02059291|84352|P13|Epoch 2|Lack of Efficacy|0
17156|NCT02059291|84353|P12|Epoch 2|Lack of Efficacy|0
17157|NCT02059291|84354|P11|Epoch 2|Lack of Efficacy|0
17158|NCT02059291|84355|P10|Epoch 2|Lack of Efficacy|0
17159|NCT02059291|84356|P9|Epoch 2|Lack of Efficacy|0
17160|NCT02059291|84357|P8|Epoch 2|Lack of Efficacy|0
17161|NCT02059291|84358|P7|Epoch 2|Lack of Efficacy|0
17162|NCT02059291|84359|P6|Epoch 2|Lack of Efficacy|1
17163|NCT02059291|84360|P5|Epoch 2|Lack of Efficacy|0
17164|NCT02059291|84361|P4|Epoch 2|Lack of Efficacy|1
17165|NCT02059291|84362|P3|Epoch 2|Lack of Efficacy|0
17166|NCT02059291|84363|P2|Epoch 2|Lack of Efficacy|0
17167|NCT02059291|84364|P1|Epoch 2|Lack of Efficacy|0
17168|NCT02059187|84418|P2|Overall Study|Withdrawal by Subject|8
17169|NCT02059187|84419|P1|Overall Study|Withdrawal by Subject|12
17170|NCT02059187|84418|P2|Overall Study|Protocol Violation|0
17171|NCT02059187|84419|P1|Overall Study|Protocol Violation|1
17172|NCT02059187|84418|P2|Overall Study|Physician Decision|2
17173|NCT02059187|84419|P1|Overall Study|Physician Decision|1
17174|NCT02059187|84418|P2|Overall Study|Non-compliance with study drug|0
17175|NCT02059187|84419|P1|Overall Study|Non-compliance with study drug|1
17176|NCT02059187|84418|P2|Overall Study|Lost to Follow-up|8
17177|NCT02059187|84419|P1|Overall Study|Lost to Follow-up|9
17178|NCT02059187|84418|P2|Overall Study|Death|1
17179|NCT02059187|84419|P1|Overall Study|Death|1
17180|NCT02059187|84418|P2|Overall Study|Adverse Event|3
17181|NCT02059187|84419|P1|Overall Study|Adverse Event|0
17182|NCT02059174|84445|P2|Period 3|Physician Decision|0
17183|NCT02059174|84446|P1|Period 3|Physician Decision|1
17184|NCT02059174|84445|P2|Period 2|Protocol Violation|0
17185|NCT02059174|84446|P1|Period 2|Protocol Violation|1
17186|NCT02059174|84445|P2|Period 2|Withdrawal by Subject|2
17187|NCT02059174|84446|P1|Period 2|Withdrawal by Subject|0
17188|NCT02059174|84445|P2|Period 1|Withdrawal by Subject|2
17189|NCT02059174|84446|P1|Period 1|Withdrawal by Subject|0
17190|NCT02059161|84470|P2|Overall Study|Non-compliance with study drug|2
17191|NCT02059161|84471|P1|Overall Study|Non-compliance with study drug|6
17192|NCT02059161|84470|P2|Overall Study|Randomized in error, no study drug|1
17193|NCT02059161|84471|P1|Overall Study|Randomized in error, no study drug|0
17194|NCT02059161|84470|P2|Overall Study|Withdrawal by Subject|13
17195|NCT02059161|84471|P1|Overall Study|Withdrawal by Subject|16
17196|NCT02059161|84470|P2|Overall Study|Protocol Violation|1
17197|NCT02059161|84471|P1|Overall Study|Protocol Violation|1
17198|NCT02059161|84470|P2|Overall Study|Physician Decision|4
17199|NCT02059161|84471|P1|Overall Study|Physician Decision|4
17200|NCT02059161|84470|P2|Overall Study|Lost to Follow-up|12
17201|NCT02059161|84471|P1|Overall Study|Lost to Follow-up|20
17202|NCT02059161|84470|P2|Overall Study|Adverse Event|6
17203|NCT02059161|84471|P1|Overall Study|Adverse Event|2
17204|NCT02059161|84470|P2|Overall Study|Pregnancy|2
17205|NCT02059161|84471|P1|Overall Study|Pregnancy|0
17206|NCT02059135|84533|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
17207|NCT02059135|84534|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
17208|NCT02059135|84533|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
17209|NCT02059135|84534|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
17210|NCT02059135|84533|P2|Neonatal Follow-up (Safety Population)|Death|2
17211|NCT02059135|84534|P1|Neonatal Follow-up (Safety Population)|Death|3
17212|NCT02059135|84533|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
17213|NCT02059135|84534|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
17214|NCT02059135|84533|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
17215|NCT02059135|84534|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
17216|NCT02059135|84533|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
17217|NCT02059135|84534|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
17218|NCT02059135|84533|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
17219|NCT02059135|84534|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
17220|NCT02059135|84533|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
17221|NCT02059135|84534|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
17222|NCT02058992|84561|P1|Overall Study|CRF Uncollected|20
17223|NCT02058992|84561|P1|Overall Study|Protocol Violation|92
17224|NCT02058992|84561|P1|Overall Study|Lost to Follow-up|4
17225|NCT02058836|84572|P2|Overall Study|Withdrawal by Subject|1
17226|NCT02058836|84573|P1|Overall Study|Withdrawal by Subject|1
17227|NCT02058628|84603|P2|Overall Study|Non compliance|0
17228|NCT02058628|84604|P1|Overall Study|Non compliance|1
17229|NCT02058628|84603|P2|Overall Study|A lot of time for study for participant|0
17230|NCT02058628|84604|P1|Overall Study|A lot of time for study for participant|1
17231|NCT02058628|84603|P2|Overall Study|The visit date was not in timeline|1
17232|NCT02058628|84604|P1|Overall Study|The visit date was not in timeline|0
17233|NCT02058628|84603|P2|Overall Study|Not in time schedule|1
17234|NCT02058628|84604|P1|Overall Study|Not in time schedule|0
17235|NCT02058628|84603|P2|Overall Study|Lost to Follow-up|4
17236|NCT02058628|84604|P1|Overall Study|Lost to Follow-up|2
17237|NCT02058628|84603|P2|Overall Study|Withdrawal by Subject|2
17238|NCT02058628|84604|P1|Overall Study|Withdrawal by Subject|2
17239|NCT02058628|84603|P2|Overall Study|Adverse Event|0
17240|NCT02058628|84604|P1|Overall Study|Adverse Event|1
17241|NCT02058563|84636|P2|Overall Study|Other (patient incarcerated)|1
17242|NCT02058563|84637|P1|Overall Study|Other (patient incarcerated)|0
17243|NCT02058563|84636|P2|Overall Study|Consent Withdrawal|1
17244|NCT02058563|84637|P1|Overall Study|Consent Withdrawal|1
17245|NCT02058563|84636|P2|Overall Study|Other (vaccinated later as new subject)|0
17246|NCT02058563|84637|P1|Overall Study|Other (vaccinated later as new subject)|1
17247|NCT02058563|84636|P2|Overall Study|Lost to Follow-up|22
17248|NCT02058563|84637|P1|Overall Study|Lost to Follow-up|26
17249|NCT02058537|84673|P1|Overall Study|Withdrawal by Subject|1
17250|NCT02058498|84679|P1|Overall Study|Withdrawal by Subject|4
17251|NCT02058290|84687|P2|Overall Study|Withdrawal by Subject|1
17252|NCT02058290|84688|P1|Overall Study|Withdrawal by Subject|0
17253|NCT02058290|84687|P2|Overall Study|Didn't meet intraoperative criteria|7
17254|NCT02058290|84688|P1|Overall Study|Didn't meet intraoperative criteria|8
17255|NCT02058290|84687|P2|Overall Study|Physician Decision|0
17256|NCT02058290|84688|P1|Overall Study|Physician Decision|1
17257|NCT02058290|84687|P2|Overall Study|Protocol Violation|1
17258|NCT02058290|84688|P1|Overall Study|Protocol Violation|2
17259|NCT02058160|84704|P2|Overall Study|Other than specified above|6
17260|NCT02058160|84705|P1|Overall Study|Other than specified above|12
17261|NCT02058160|84704|P2|Overall Study|Lost to Follow-up|0
17262|NCT02058160|84705|P1|Overall Study|Lost to Follow-up|1
17263|NCT02058160|84704|P2|Overall Study|Adverse Event|3
17264|NCT02058160|84705|P1|Overall Study|Adverse Event|12
17265|NCT02058160|84704|P2|Overall Study|Poor compliance to protocol|1
17266|NCT02058160|84705|P1|Overall Study|Poor compliance to protocol|4
17267|NCT02058160|84704|P2|Overall Study|Randomized but not treated|4
17268|NCT02058160|84705|P1|Overall Study|Randomized but not treated|2
17269|NCT02058147|84742|P3|Overall Study|Other than specified|0
17270|NCT02058147|84743|P2|Overall Study|Other than specified|9
17271|NCT02058147|84744|P1|Overall Study|Other than specified|8
17272|NCT02058147|84742|P3|Overall Study|Poor compliance to protocol|4
17273|NCT02058147|84743|P2|Overall Study|Poor compliance to protocol|9
17274|NCT02058147|84744|P1|Overall Study|Poor compliance to protocol|8
17275|NCT02058147|84742|P3|Overall Study|Lack of Efficacy|3
17276|NCT02058147|84743|P2|Overall Study|Lack of Efficacy|0
17277|NCT02058147|84744|P1|Overall Study|Lack of Efficacy|1
17278|NCT02058147|84742|P3|Overall Study|Adverse Event|21
17279|NCT02058147|84743|P2|Overall Study|Adverse Event|9
17280|NCT02058147|84744|P1|Overall Study|Adverse Event|12
17281|NCT02058147|84742|P3|Overall Study|Randomized but not treated|1
17282|NCT02058147|84743|P2|Overall Study|Randomized but not treated|0
17283|NCT02058147|84744|P1|Overall Study|Randomized but not treated|0
17284|NCT02058069|84793|P1|Overall Study|Withdrawal by Subject|6
17285|NCT02058069|84793|P1|Overall Study|Exclusion due to implant size|5
17286|NCT02057835|84852|P10|Overall Study|Withdrawal by Subject|0
17287|NCT02057835|84853|P9|Overall Study|Withdrawal by Subject|0
17288|NCT02057835|84854|P8|Overall Study|Withdrawal by Subject|0
17289|NCT02057835|84855|P7|Overall Study|Withdrawal by Subject|0
17290|NCT02057835|84856|P6|Overall Study|Withdrawal by Subject|0
17291|NCT02057835|84857|P5|Overall Study|Withdrawal by Subject|0
17292|NCT02057835|84858|P4|Overall Study|Withdrawal by Subject|0
17293|NCT02057835|84859|P3|Overall Study|Withdrawal by Subject|0
17294|NCT02057835|84860|P2|Overall Study|Withdrawal by Subject|2
17295|NCT02057835|84861|P1|Overall Study|Withdrawal by Subject|0
17296|NCT02057692|84942|P4|Overall Study|Lost to Follow-up|1
17297|NCT02057692|84943|P3|Overall Study|Lost to Follow-up|0
17298|NCT02057692|84944|P2|Overall Study|Lost to Follow-up|0
17299|NCT02057692|84945|P1|Overall Study|Lost to Follow-up|0
17300|NCT02057692|84942|P4|Overall Study|Adverse Event|0
17301|NCT02057692|84943|P3|Overall Study|Adverse Event|0
17302|NCT02057692|84944|P2|Overall Study|Adverse Event|0
17303|NCT02057692|84945|P1|Overall Study|Adverse Event|1
17304|NCT02057549|84971|P2|Overall Study|Withdrawal by Subject|0
17305|NCT02057549|84972|P1|Overall Study|Withdrawal by Subject|1
17306|NCT02057549|84971|P2|Overall Study|Physician Decision|0
17307|NCT02057549|84972|P1|Overall Study|Physician Decision|1
17308|NCT02057549|84971|P2|Overall Study|Lost to Follow-up|0
17309|NCT02057549|84972|P1|Overall Study|Lost to Follow-up|1
17310|NCT02057406|84995|P3|Overall Study|Patient transportation issues|1
17311|NCT02057406|84996|P2|Overall Study|Patient transportation issues|0
17312|NCT02057406|84997|P1|Overall Study|Patient transportation issues|0
17313|NCT02057406|84995|P3|Overall Study|Protocol Violation|0
17314|NCT02057406|84996|P2|Overall Study|Protocol Violation|1
17315|NCT02057406|84997|P1|Overall Study|Protocol Violation|0
17316|NCT02057406|84995|P3|Overall Study|Death|0
17317|NCT02057406|84996|P2|Overall Study|Death|0
17318|NCT02057406|84997|P1|Overall Study|Death|1
17319|NCT02057406|84995|P3|Overall Study|Lost to Follow-up|1
17320|NCT02057406|84996|P2|Overall Study|Lost to Follow-up|0
17321|NCT02057406|84997|P1|Overall Study|Lost to Follow-up|0
17322|NCT02057406|84995|P3|Overall Study|Withdrawal by Subject|0
17323|NCT02057406|84996|P2|Overall Study|Withdrawal by Subject|2
17324|NCT02057406|84997|P1|Overall Study|Withdrawal by Subject|0
17325|NCT02057406|84995|P3|Overall Study|Physician Decision|2
17326|NCT02057406|84996|P2|Overall Study|Physician Decision|0
17327|NCT02057406|84997|P1|Overall Study|Physician Decision|0
17328|NCT02057393|85008|P1|Overall Study|Patient did not meet criteria|1
17329|NCT02057393|85008|P1|Overall Study|Withdrawal by Subject|1
17330|NCT02057250|85029|P5|Extension Phase|Other than specified above|7
17331|NCT02057250|85030|P4|Extension Phase|Other than specified above|0
17332|NCT02057250|85031|P3|Extension Phase|Other than specified above|0
17333|NCT02057250|85032|P2|Extension Phase|Other than specified above|0
17334|NCT02057250|85033|P1|Extension Phase|Other than specified above|0
17335|NCT02057250|85029|P5|Extension Phase|Entered in this period but not treated|4
17336|NCT02057250|85030|P4|Extension Phase|Entered in this period but not treated|0
17337|NCT02057250|85031|P3|Extension Phase|Entered in this period but not treated|0
17338|NCT02057250|85032|P2|Extension Phase|Entered in this period but not treated|0
17339|NCT02057250|85033|P1|Extension Phase|Entered in this period but not treated|0
17340|NCT02057250|85029|P5|Extension Phase|Lack of Efficacy|10
17341|NCT02057250|85030|P4|Extension Phase|Lack of Efficacy|0
17342|NCT02057250|85031|P3|Extension Phase|Lack of Efficacy|0
17343|NCT02057250|85032|P2|Extension Phase|Lack of Efficacy|0
17344|NCT02057250|85033|P1|Extension Phase|Lack of Efficacy|0
17345|NCT02057250|85029|P5|Extension Phase|Adverse Event|15
17346|NCT02057250|85030|P4|Extension Phase|Adverse Event|0
17347|NCT02057250|85031|P3|Extension Phase|Adverse Event|0
17348|NCT02057250|85032|P2|Extension Phase|Adverse Event|0
17349|NCT02057250|85033|P1|Extension Phase|Adverse Event|0
17350|NCT02057250|85029|P5|AID Assessment Phase|Other than specified above|0
17351|NCT02057250|85030|P4|AID Assessment Phase|Other than specified above|1
17352|NCT02057250|85031|P3|AID Assessment Phase|Other than specified above|1
17353|NCT02057250|85032|P2|AID Assessment Phase|Other than specified above|1
17354|NCT02057250|85033|P1|AID Assessment Phase|Other than specified above|1
17355|NCT02057250|85029|P5|AID Assessment Phase|Adverse Event|0
17356|NCT02057250|85030|P4|AID Assessment Phase|Adverse Event|1
17357|NCT02057250|85031|P3|AID Assessment Phase|Adverse Event|6
17358|NCT02057250|85032|P2|AID Assessment Phase|Adverse Event|2
17359|NCT02057250|85033|P1|AID Assessment Phase|Adverse Event|3
17360|NCT02057068|85053|P2|Overall Study|Lost to Follow-up|2
17361|NCT02057068|85054|P1|Overall Study|Lost to Follow-up|2
17362|NCT02057068|85053|P2|Overall Study|Carepartner (CP) Health|2
17363|NCT02057068|85054|P1|Overall Study|Carepartner (CP) Health|4
17364|NCT02057068|85053|P2|Overall Study|Caregiver (CG) Health|2
17365|NCT02057068|85054|P1|Overall Study|Caregiver (CG) Health|0
17366|NCT02057068|85053|P2|Overall Study|Withdrawal by Subject|2
17367|NCT02057068|85054|P1|Overall Study|Withdrawal by Subject|2
17368|NCT02056834|85064|P1|Overall Study|Lost to Follow-up|7
17369|NCT02056652|85085|P2|Overall Study|Lost to Follow-up|3
17370|NCT02056652|85086|P1|Overall Study|Lost to Follow-up|0
17371|NCT02056652|85085|P2|Overall Study|Withdrawal by Subject|0
17372|NCT02056652|85086|P1|Overall Study|Withdrawal by Subject|1
17373|NCT02056392|85136|P6|Overall Study|Withdrawal by Subject|0
17374|NCT02056392|85137|P5|Overall Study|Withdrawal by Subject|1
17375|NCT02056392|85138|P4|Overall Study|Withdrawal by Subject|0
17376|NCT02056392|85139|P3|Overall Study|Withdrawal by Subject|0
17377|NCT02056392|85140|P2|Overall Study|Withdrawal by Subject|0
17378|NCT02056392|85141|P1|Overall Study|Withdrawal by Subject|1
17379|NCT02056392|85136|P6|Overall Study|Protocol Violation|0
17380|NCT02056392|85137|P5|Overall Study|Protocol Violation|0
17381|NCT02056392|85138|P4|Overall Study|Protocol Violation|0
17382|NCT02056392|85139|P3|Overall Study|Protocol Violation|1
17383|NCT02056392|85140|P2|Overall Study|Protocol Violation|0
17384|NCT02056392|85141|P1|Overall Study|Protocol Violation|1
17385|NCT02056392|85136|P6|Overall Study|Lost to Follow-up|0
17386|NCT02056392|85137|P5|Overall Study|Lost to Follow-up|0
17387|NCT02056392|85138|P4|Overall Study|Lost to Follow-up|0
17388|NCT02056392|85139|P3|Overall Study|Lost to Follow-up|2
17389|NCT02056392|85140|P2|Overall Study|Lost to Follow-up|1
17390|NCT02056392|85141|P1|Overall Study|Lost to Follow-up|0
17391|NCT02055365|85211|P1|Overall Study|Prematurely Withdrawn|1
17392|NCT02055352|85224|P2|Overall Study|Reason unknown|5
17393|NCT02055352|85225|P1|Overall Study|Reason unknown|1
17394|NCT02055352|85224|P2|Overall Study|Withdrawal of informed consent|0
17395|NCT02055352|85225|P1|Overall Study|Withdrawal of informed consent|1
17396|NCT02055352|85224|P2|Overall Study|AE, study drug would be detrimental|3
17397|NCT02055352|85225|P1|Overall Study|AE, study drug would be detrimental|1
17398|NCT02055352|85224|P2|Overall Study|Use of prohibited treatment|3
17399|NCT02055352|85225|P1|Overall Study|Use of prohibited treatment|0
17400|NCT02055352|85224|P2|Overall Study|Patient decision|1
17401|NCT02055352|85225|P1|Overall Study|Patient decision|1
17402|NCT02055352|85224|P2|Overall Study|Death|2
17403|NCT02055352|85225|P1|Overall Study|Death|1
17404|NCT02055352|85224|P2|Overall Study|Poor compliance|1
17405|NCT02055352|85225|P1|Overall Study|Poor compliance|1
17406|NCT02055352|85224|P2|Overall Study|Non-eligible|1
17407|NCT02055352|85225|P1|Overall Study|Non-eligible|0
17408|NCT02055352|85224|P2|Overall Study|Adverse Event|1
17409|NCT02055352|85225|P1|Overall Study|Adverse Event|0
17410|NCT02054910|85241|P2|Overall Study|Lost to Follow-up|1
17411|NCT02054910|85242|P1|Overall Study|Lost to Follow-up|4
17412|NCT02054897|85261|P3|Overall Study|Randomized but not exposed|0
17413|NCT02054897|85262|P2|Overall Study|Randomized but not exposed|0
17414|NCT02054897|85263|P1|Overall Study|Randomized but not exposed|1
17415|NCT02054897|85261|P3|Overall Study|Lost to Follow-up|7
17416|NCT02054897|85262|P2|Overall Study|Lost to Follow-up|2
17417|NCT02054897|85263|P1|Overall Study|Lost to Follow-up|4
17418|NCT02054897|85261|P3|Overall Study|Missing follow-up information|3
17419|NCT02054897|85262|P2|Overall Study|Missing follow-up information|5
17420|NCT02054897|85263|P1|Overall Study|Missing follow-up information|3
17421|NCT02054897|85261|P3|Overall Study|Withdrawal by Subject|2
17422|NCT02054897|85262|P2|Overall Study|Withdrawal by Subject|0
17423|NCT02054897|85263|P1|Overall Study|Withdrawal by Subject|2
17424|NCT02054715|85310|P2|Follow-up 2|Treatment Change or Delay|0
17425|NCT02054715|85311|P1|Follow-up 2|Treatment Change or Delay|1
17426|NCT02054715|85310|P2|Follow-up 2|No Reason|0
17427|NCT02054715|85311|P1|Follow-up 2|No Reason|2
17428|NCT02054715|85310|P2|Follow-up 2|Changed Mind|1
17429|NCT02054715|85311|P1|Follow-up 2|Changed Mind|0
17430|NCT02054715|85310|P2|Follow-up 2|Changed MD/Facility|1
17431|NCT02054715|85311|P1|Follow-up 2|Changed MD/Facility|0
17432|NCT02054715|85310|P2|Follow-up 2|Hospitalization|2
17433|NCT02054715|85311|P1|Follow-up 2|Hospitalization|0
17434|NCT02054715|85310|P2|Follow-up 2|Death|3
17435|NCT02054715|85311|P1|Follow-up 2|Death|3
17436|NCT02054715|85310|P2|Follow-up 2|Ineligible|5
17437|NCT02054715|85311|P1|Follow-up 2|Ineligible|4
17438|NCT02054715|85310|P2|Follow-up 2|Followup Not Completed|4
17439|NCT02054715|85311|P1|Follow-up 2|Followup Not Completed|3
17440|NCT02054715|85310|P2|Follow-up 2|Refused|2
17441|NCT02054715|85311|P1|Follow-up 2|Refused|3
17442|NCT02054715|85310|P2|Follow-up 2|Lost to Followup|1
17443|NCT02054715|85311|P1|Follow-up 2|Lost to Followup|3
17444|NCT02054715|85310|P2|Baseline/Follow-up 1|Changed Mind|0
17445|NCT02054715|85311|P1|Baseline/Follow-up 1|Changed Mind|1
17446|NCT02054715|85310|P2|Baseline/Follow-up 1|Hospitalization|0
17447|NCT02054715|85311|P1|Baseline/Follow-up 1|Hospitalization|1
17448|NCT02054715|85310|P2|Baseline/Follow-up 1|Ineligible|0
17449|NCT02054715|85311|P1|Baseline/Follow-up 1|Ineligible|3
17450|NCT02054715|85310|P2|Baseline/Follow-up 1|Overwhelmed|0
17451|NCT02054715|85311|P1|Baseline/Follow-up 1|Overwhelmed|2
17452|NCT02054715|85310|P2|Baseline/Follow-up 1|No Reason|1
17453|NCT02054715|85311|P1|Baseline/Follow-up 1|No Reason|0
17454|NCT02054715|85310|P2|Baseline/Follow-up 1|Disliked Procedure|1
17455|NCT02054715|85311|P1|Baseline/Follow-up 1|Disliked Procedure|0
17456|NCT02054715|85310|P2|Baseline/Follow-up 1|Changed MD/Facility|1
17457|NCT02054715|85311|P1|Baseline/Follow-up 1|Changed MD/Facility|0
17458|NCT02054715|85310|P2|Baseline/Follow-up 1|Medical|1
17459|NCT02054715|85311|P1|Baseline/Follow-up 1|Medical|0
17460|NCT02054715|85310|P2|Baseline/Follow-up 1|Refused|3
17461|NCT02054715|85311|P1|Baseline/Follow-up 1|Refused|1
17462|NCT02054702|85325|P2|Overall Study|Withdrawal by Subject|4
17463|NCT02054702|85326|P1|Overall Study|Withdrawal by Subject|14
17464|NCT02054702|85325|P2|Overall Study|Physician Decision|1
17465|NCT02054702|85326|P1|Overall Study|Physician Decision|0
17466|NCT02054702|85325|P2|Overall Study|Met Withdrawal Criteria|1
17467|NCT02054702|85326|P1|Overall Study|Met Withdrawal Criteria|4
17468|NCT02054702|85325|P2|Overall Study|Adverse Event|1
17469|NCT02054702|85326|P1|Overall Study|Adverse Event|3
17470|NCT02054702|85325|P2|Overall Study|Lost to Follow-up|5
17471|NCT02054702|85326|P1|Overall Study|Lost to Follow-up|3
17472|NCT02054481|85381|P4|Overall Study|Other reason|0
17473|NCT02054481|85382|P3|Overall Study|Other reason|2
17474|NCT02054481|85383|P2|Overall Study|Other reason|1
17475|NCT02054481|85384|P1|Overall Study|Other reason|2
17476|NCT02054481|85381|P4|Overall Study|Lost to Follow-up|0
17477|NCT02054481|85382|P3|Overall Study|Lost to Follow-up|0
17478|NCT02054481|85383|P2|Overall Study|Lost to Follow-up|0
17479|NCT02054481|85384|P1|Overall Study|Lost to Follow-up|1
17480|NCT02054481|85381|P4|Overall Study|Adverse Event|1
17481|NCT02054481|85382|P3|Overall Study|Adverse Event|0
17482|NCT02054481|85383|P2|Overall Study|Adverse Event|1
17483|NCT02054481|85384|P1|Overall Study|Adverse Event|1
17484|NCT02054325|85432|P2|Overall Study|Lost to Follow-up|5
17485|NCT02054325|85433|P1|Overall Study|Lost to Follow-up|8
17486|NCT02053753|85443|P2|Overall Study|Lost to Follow-up|3
17487|NCT02053753|85444|P1|Overall Study|Lost to Follow-up|4
17488|NCT02053753|85443|P2|Overall Study|Decision by Sponsor|1
17489|NCT02053753|85444|P1|Overall Study|Decision by Sponsor|1
17490|NCT02053753|85443|P2|Overall Study|Withdrawal by Subject|4
17491|NCT02053753|85444|P1|Overall Study|Withdrawal by Subject|2
17492|NCT02053610|85468|P2|Overall Study|Failure to Return|3
17493|NCT02053610|85469|P1|Overall Study|Failure to Return|4
17494|NCT02053610|85468|P2|Overall Study|Did not Receive Treatment|2
17495|NCT02053610|85469|P1|Overall Study|Did not Receive Treatment|0
17496|NCT02053610|85468|P2|Overall Study|Refused treatment/Did not cooperate|0
17497|NCT02053610|85469|P1|Overall Study|Refused treatment/Did not cooperate|3
17498|NCT02053610|85468|P2|Overall Study|Disease Progression|94
17499|NCT02053610|85469|P1|Overall Study|Disease Progression|148
17500|NCT02053610|85468|P2|Overall Study|Administrative/Other|27
17501|NCT02053610|85469|P1|Overall Study|Administrative/Other|34
17502|NCT02053610|85468|P2|Overall Study|Death|25
17503|NCT02053610|85469|P1|Overall Study|Death|31
17504|NCT02053610|85468|P2|Overall Study|Withdrew Consent|14
17505|NCT02053610|85469|P1|Overall Study|Withdrew Consent|12
17506|NCT02053610|85468|P2|Overall Study|Adverse Event/Intercurrent Illness|9
17507|NCT02053610|85469|P1|Overall Study|Adverse Event/Intercurrent Illness|3
17508|NCT02053493|85501|P2|Overall Study|Withdrawal by Subject|1
17509|NCT02053493|85502|P1|Overall Study|Withdrawal by Subject|1
17510|NCT02053168|85540|P1|Overall Study|Lost to Follow-up|1
17511|NCT02053168|85540|P1|Overall Study|Physician Decision|1
17512|NCT02053168|85540|P1|Overall Study|Withdrawal by Subject|1
17513|NCT02052596|85619|P2|Safety Phase|Lost due to Crohn`s disease|1
17514|NCT02052596|85620|P1|Safety Phase|Lost due to Crohn`s disease|0
17515|NCT02052596|85619|P2|Safety Phase|Enrolled in error|0
17516|NCT02052596|85620|P1|Safety Phase|Enrolled in error|1
17517|NCT02052596|85619|P2|Safety Phase|Withdrawal by Subject|11
17518|NCT02052596|85620|P1|Safety Phase|Withdrawal by Subject|8
17519|NCT02052596|85619|P2|Safety Phase|Protocol Violation|2
17520|NCT02052596|85620|P1|Safety Phase|Protocol Violation|1
17521|NCT02052596|85619|P2|Safety Phase|Lost to Follow-up|18
17522|NCT02052596|85620|P1|Safety Phase|Lost to Follow-up|11
17523|NCT02052596|85619|P2|Safety Phase|Adverse Event|3
17524|NCT02052596|85620|P1|Safety Phase|Adverse Event|6
17525|NCT02052596|85619|P2|Active Phase|Lost due to Crohn`s disease|1
17526|NCT02052596|85620|P1|Active Phase|Lost due to Crohn`s disease|0
17527|NCT02052596|85619|P2|Active Phase|Enrolled in error|0
17528|NCT02052596|85620|P1|Active Phase|Enrolled in error|1
17529|NCT02052596|85619|P2|Active Phase|Withdrawal by Subject|4
17530|NCT02052596|85620|P1|Active Phase|Withdrawal by Subject|3
17531|NCT02052596|85619|P2|Active Phase|Protocol Violation|2
17532|NCT02052596|85620|P1|Active Phase|Protocol Violation|1
17533|NCT02052596|85619|P2|Active Phase|Lost to Follow-up|11
17534|NCT02052596|85620|P1|Active Phase|Lost to Follow-up|8
17535|NCT02052596|85619|P2|Active Phase|Adverse Event|2
17536|NCT02052596|85620|P1|Active Phase|Adverse Event|3
17537|NCT02052466|85650|P1|Overall Study|Acromial fracture|1
17538|NCT02052466|85650|P1|Overall Study|Withdrawal by Subject|1
17539|NCT02052440|85667|P2|Overall Study|Withdrawal by Subject|1
17540|NCT02052440|85668|P1|Overall Study|Withdrawal by Subject|0
17541|NCT02052414|85680|P1|Overall Study|Withdrawal by Subject|3
17542|NCT02052414|85680|P1|Overall Study|Lack of Efficacy|2
17543|NCT02052414|85680|P1|Overall Study|Adverse Event|12
17544|NCT02052011|85690|P2|Overall Study|Withdrawal by Subject|2
17545|NCT02052011|85691|P1|Overall Study|Withdrawal by Subject|1
17546|NCT02052011|85690|P2|Overall Study|Lost to Follow-up|0
17547|NCT02052011|85691|P1|Overall Study|Lost to Follow-up|3
17548|NCT02050321|85842|P1|Overall Study|Adverse Event|1
17549|NCT02050321|85842|P1|Overall Study|Withdrawal by Subject|1
17550|NCT02050048|85849|P2|Overall Study|Ineligible after ERCP|1
17551|NCT02050048|85850|P1|Overall Study|Ineligible after ERCP|4
17552|NCT02050048|85849|P2|Overall Study|Death|0
17553|NCT02050048|85850|P1|Overall Study|Death|1
17554|NCT02050048|85849|P2|Overall Study|Lost to Follow-up|1
17555|NCT02050048|85850|P1|Overall Study|Lost to Follow-up|0
17556|NCT02049450|85869|P1|Overall Study|Patients/guardian decision|1
17557|NCT02049450|85869|P1|Overall Study|Withdrawal by Subject|1
17558|NCT02049450|85869|P1|Overall Study|Adverse Event|2
17559|NCT02048904|85907|P1|Overall Study|Physician Decision|70
17560|NCT02048904|85907|P1|Overall Study|Withdrawal by Subject|7
17561|NCT02048241|85922|P2|Overall Study|Withdrawal by Subject|1
17562|NCT02048241|85923|P1|Overall Study|Withdrawal by Subject|0
17563|NCT02048072|85929|P1|Overall Study|Lost to Follow-up|1
17564|NCT02048072|85929|P1|Overall Study|Adverse Event|3
17565|NCT02047227|85944|P2|Overall Study|Other|9
17566|NCT02047227|85945|P1|Overall Study|Other|10
17567|NCT02047227|85944|P2|Overall Study|All embryos discarded|11
17568|NCT02047227|85945|P1|Overall Study|All embryos discarded|12
17569|NCT02047227|85944|P2|Overall Study|Intention to freeze all embryos|0
17570|NCT02047227|85945|P1|Overall Study|Intention to freeze all embryos|1
17571|NCT02047227|85944|P2|Overall Study|No fertilization|51
17572|NCT02047227|85945|P1|Overall Study|No fertilization|61
17573|NCT02047227|85944|P2|Overall Study|No oocytes retrieved|20
17574|NCT02047227|85945|P1|Overall Study|No oocytes retrieved|21
17575|NCT02047227|85944|P2|Overall Study|Lack of ovarian response to stimulation|32
17576|NCT02047227|85945|P1|Overall Study|Lack of ovarian response to stimulation|35
17577|NCT02047227|85944|P2|Overall Study|Spontaneous pregnancy|0
17578|NCT02047227|85945|P1|Overall Study|Spontaneous pregnancy|1
17579|NCT02047227|85944|P2|Overall Study|Protocol Violation|0
17580|NCT02047227|85945|P1|Overall Study|Protocol Violation|1
17581|NCT02047227|85944|P2|Overall Study|Lost to Follow-up|3
17582|NCT02047227|85945|P1|Overall Study|Lost to Follow-up|0
17583|NCT02047227|85944|P2|Overall Study|Adverse Event|4
17584|NCT02047227|85945|P1|Overall Study|Adverse Event|2
17585|NCT02046993|85963|P2|Overall Study|Lost to Follow-up|1
17586|NCT02046993|85964|P1|Overall Study|Lost to Follow-up|1
17587|NCT02046993|85963|P2|Overall Study|Withdrawal by Subject|10
17588|NCT02046993|85964|P1|Overall Study|Withdrawal by Subject|2
17589|NCT02046616|86014|P1|8-Week FU Period|Lost to Follow-up|1
17590|NCT02046616|86014|P1|24-Week Treatment Period|Not Specified|1
17591|NCT02046616|86014|P1|24-Week Treatment Period|Physician Decision|3
17592|NCT02046616|86014|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
17593|NCT02046616|86014|P1|24-Week Treatment Period|Any Other Adverse Event|13
17594|NCT02046616|86014|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
17595|NCT02046564|86036|P2|Overall Study|Subject met withdrawal criteria|5
17596|NCT02046564|86037|P1|Overall Study|Subject met withdrawal criteria|2
17597|NCT02046564|86036|P2|Overall Study|Withdrawal by Subject|10
17598|NCT02046564|86037|P1|Overall Study|Withdrawal by Subject|4
17599|NCT02046564|86036|P2|Overall Study|Protocol Violation|1
17600|NCT02046564|86037|P1|Overall Study|Protocol Violation|3
17601|NCT02046564|86036|P2|Overall Study|Physician Decision|1
17602|NCT02046564|86037|P1|Overall Study|Physician Decision|0
17603|NCT02046564|86036|P2|Overall Study|Adverse Event|3
17604|NCT02046564|86037|P1|Overall Study|Adverse Event|6
17605|NCT02046369|86076|P2|Overall Study|non compliance|0
17606|NCT02046369|86077|P1|Overall Study|non compliance|1
17607|NCT02046369|86076|P2|Overall Study|never received study drug|1
17608|NCT02046369|86077|P1|Overall Study|never received study drug|0
17609|NCT02046369|86076|P2|Overall Study|Withdrawal by Subject|6
17610|NCT02046369|86077|P1|Overall Study|Withdrawal by Subject|3
17611|NCT02046369|86076|P2|Overall Study|Protocol Violation|2
17612|NCT02046369|86077|P1|Overall Study|Protocol Violation|1
17613|NCT02046369|86076|P2|Overall Study|Lost to Follow-up|3
17614|NCT02046369|86077|P1|Overall Study|Lost to Follow-up|3
17615|NCT02046369|86076|P2|Overall Study|Lack of Efficacy|3
17616|NCT02046369|86077|P1|Overall Study|Lack of Efficacy|3
17617|NCT02046369|86076|P2|Overall Study|Adverse Event|3
17618|NCT02046369|86077|P1|Overall Study|Adverse Event|3
17619|NCT02046226|86110|P1|Overall Study|Lost to Follow-up|7
17620|NCT02046148|86158|P2|Overall Study|Withdrawal by Subject|2
17621|NCT02046148|86159|P1|Overall Study|Withdrawal by Subject|0
17622|NCT02046148|86158|P2|Overall Study|Lost to Follow-up|1
17623|NCT02046148|86159|P1|Overall Study|Lost to Follow-up|1
17624|NCT02045836|86205|P2|Overall Study|Migrated from study area|2
17625|NCT02045836|86206|P1|Overall Study|Migrated from study area|0
17626|NCT02045836|86205|P2|Overall Study|Lost to Follow-up|7
17627|NCT02045836|86206|P1|Overall Study|Lost to Follow-up|4
17628|NCT02045836|86205|P2|Overall Study|Withdrawal by Subject|1
17629|NCT02045836|86206|P1|Overall Study|Withdrawal by Subject|1
17630|NCT02045836|86205|P2|Overall Study|Adverse Event|4
17631|NCT02045836|86206|P1|Overall Study|Adverse Event|4
17632|NCT02045797|86238|P3|Overall Study|Withdrawal by Subject|0
17633|NCT02045797|86239|P2|Overall Study|Withdrawal by Subject|2
17634|NCT02045797|86240|P1|Overall Study|Withdrawal by Subject|1
17635|NCT02045797|86238|P3|Overall Study|Physician Decision|0
17636|NCT02045797|86239|P2|Overall Study|Physician Decision|1
17637|NCT02045797|86240|P1|Overall Study|Physician Decision|0
17638|NCT02045797|86238|P3|Overall Study|Lost to Follow-up|1
17639|NCT02045797|86239|P2|Overall Study|Lost to Follow-up|3
17640|NCT02045797|86240|P1|Overall Study|Lost to Follow-up|2
17641|NCT02045797|86238|P3|Overall Study|Lack of Efficacy|0
17642|NCT02045797|86239|P2|Overall Study|Lack of Efficacy|0
17643|NCT02045797|86240|P1|Overall Study|Lack of Efficacy|1
17644|NCT02045797|86238|P3|Overall Study|Adverse Event|0
17645|NCT02045797|86239|P2|Overall Study|Adverse Event|1
17646|NCT02045797|86240|P1|Overall Study|Adverse Event|3
17647|NCT02045732|86385|P2|Overall Study|At the discretion of the investigator|1
17648|NCT02045732|86386|P1|Overall Study|At the discretion of the investigator|1
17649|NCT02044848|86517|P2|Overall Study|Administrative Problems|3
17650|NCT02044848|86518|P1|Overall Study|Administrative Problems|2
17651|NCT02044822|86524|P1|Overall Study|Lost to Follow-up|1
17652|NCT02044822|86524|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
17653|NCT02044822|86524|P1|Overall Study|Withdrew Consent|3
17654|NCT02044822|86524|P1|Overall Study|Investigator's Discretion|10
17655|NCT02044822|86524|P1|Overall Study|Study Terminated by Sponsor|77
17656|NCT02044458|86536|P2|Overall Study|Protocol Violation|8
17657|NCT02044458|86537|P1|Overall Study|Protocol Violation|3
17658|NCT02044302|86623|P2|Overall Study|study terminated|0
17659|NCT02044302|86624|P1|Overall Study|study terminated|2
17660|NCT02044094|86630|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
17661|NCT02044094|86630|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
17662|NCT02044094|86630|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
17663|NCT02044094|86630|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
17664|NCT02044094|86630|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
17665|NCT02044094|86630|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
17666|NCT02044094|86630|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
17667|NCT02044094|86630|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
17668|NCT02043938|86687|P1|Overall Study|Investigator decision|1
17669|NCT02043938|86687|P1|Overall Study|No show by subject|1
17670|NCT02043938|86687|P1|Overall Study|Unable to place EEG sensors on patient|1
17671|NCT02043938|86687|P1|Overall Study|Withdrawal by Subject|7
17672|NCT02043782|86738|P6|Period 1|Adverse Event|0
17673|NCT02043782|86739|P5|Period 1|Adverse Event|0
17674|NCT02043782|86740|P4|Period 1|Adverse Event|0
17675|NCT02043782|86741|P3|Period 1|Adverse Event|1
17676|NCT02043782|86742|P2|Period 1|Adverse Event|0
17677|NCT02043782|86743|P1|Period 1|Adverse Event|0
17678|NCT02043366|86854|P6|Overall Study|Lost to Follow-up|2
17679|NCT02043366|86855|P5|Overall Study|Lost to Follow-up|2
17680|NCT02043366|86856|P4|Overall Study|Lost to Follow-up|2
17681|NCT02043366|86857|P3|Overall Study|Lost to Follow-up|2
17682|NCT02043366|86858|P2|Overall Study|Lost to Follow-up|2
17683|NCT02043366|86859|P1|Overall Study|Lost to Follow-up|2
17684|NCT02043132|86897|P2|Overall Study|screen failures|8
17685|NCT02043132|86898|P1|Overall Study|screen failures|4
17686|NCT02043132|86897|P2|Overall Study|Lost to Follow-up|1
17687|NCT02043132|86898|P1|Overall Study|Lost to Follow-up|1
17688|NCT02043015|86918|P1|Overall Study|Incarceration|1
17689|NCT02043015|86918|P1|Overall Study|Participant moved away from study city|4
17690|NCT02043015|86918|P1|Overall Study|Removed once target enrollment reached|15
17691|NCT02043015|86918|P1|Overall Study|Withdrawal by Subject|4
17692|NCT02043015|86918|P1|Overall Study|Lost to Follow-up|4
17693|NCT02042924|86931|P1|Overall Study|Early Death|1
17694|NCT02042443|86979|P2|Overall Study|Not eligible/not analyzable|6
17695|NCT02042443|86980|P1|Overall Study|Not eligible/not analyzable|3
17696|NCT02042443|86979|P2|Overall Study|not protocol specified|1
17697|NCT02042443|86980|P1|Overall Study|not protocol specified|1
17698|NCT02042443|86979|P2|Overall Study|Progression|17
17699|NCT02042443|86980|P1|Overall Study|Progression|21
17700|NCT02042443|86979|P2|Overall Study|Withdrawal by Subject|1
17701|NCT02042443|86980|P1|Overall Study|Withdrawal by Subject|0
17702|NCT02042443|86979|P2|Overall Study|Adverse Event|1
17703|NCT02042443|86980|P1|Overall Study|Adverse Event|2
17704|NCT02042404|86992|P2|Overall Study|Inability to meet time requirements|0
17705|NCT02042404|86993|P1|Overall Study|Inability to meet time requirements|1
17706|NCT02042404|86992|P2|Overall Study|Unrelated Adverse Event|0
17707|NCT02042404|86993|P1|Overall Study|Unrelated Adverse Event|3
17708|NCT02042404|86992|P2|Overall Study|Death|0
17709|NCT02042404|86993|P1|Overall Study|Death|1
17710|NCT02041533|87033|P2|Overall Study|Randomized, not treated|7
17711|NCT02041533|87034|P1|Overall Study|Randomized, not treated|4
17712|NCT02041533|87033|P2|Overall Study|Completed max number of chemo cycles|29
17713|NCT02041533|87034|P1|Overall Study|Completed max number of chemo cycles|0
17714|NCT02041533|87033|P2|Overall Study|Other reasons|1
17715|NCT02041533|87034|P1|Overall Study|Other reasons|0
17716|NCT02041533|87033|P2|Overall Study|Poor/non-compliance|0
17717|NCT02041533|87034|P1|Overall Study|Poor/non-compliance|1
17718|NCT02041533|87033|P2|Overall Study|Maximum clinical benefit|18
17719|NCT02041533|87034|P1|Overall Study|Maximum clinical benefit|0
17720|NCT02041533|87033|P2|Overall Study|Withdrawal by Subject|1
17721|NCT02041533|87034|P1|Overall Study|Withdrawal by Subject|2
17722|NCT02041533|87033|P2|Overall Study|Subject request to discontinue treatment|9
17723|NCT02041533|87034|P1|Overall Study|Subject request to discontinue treatment|5
17724|NCT02041533|87033|P2|Overall Study|Adverse Event unrelated to study drug|21
17725|NCT02041533|87034|P1|Overall Study|Adverse Event unrelated to study drug|20
17726|NCT02041533|87033|P2|Overall Study|Death|0
17727|NCT02041533|87034|P1|Overall Study|Death|1
17728|NCT02041533|87033|P2|Overall Study|Study drug toxicity|30
17729|NCT02041533|87034|P1|Overall Study|Study drug toxicity|27
17730|NCT02041533|87033|P2|Overall Study|Disease Progression|142
17731|NCT02041533|87034|P1|Overall Study|Disease Progression|168
17732|NCT02041520|87056|P2|Overall Study|Hypothiroidism identified during follow-|1
17733|NCT02041520|87057|P1|Overall Study|Hypothiroidism identified during follow-|0
17734|NCT02041520|87056|P2|Overall Study|Lost to Follow-up|1
17735|NCT02041520|87057|P1|Overall Study|Lost to Follow-up|0
17736|NCT02041520|87056|P2|Overall Study|Protocol Violation|0
17737|NCT02041520|87057|P1|Overall Study|Protocol Violation|1
17738|NCT02041520|87056|P2|Overall Study|Withdrawal by Subject|4
17739|NCT02041520|87057|P1|Overall Study|Withdrawal by Subject|3
17740|NCT02041520|87056|P2|Overall Study|Adverse Event|1
17741|NCT02041520|87057|P1|Overall Study|Adverse Event|2
17742|NCT02041286|87100|P1|Overall Study|Adverse Event|1
17743|NCT02040844|87136|P3|Overall Study|Concomitant medication|1
17744|NCT02040844|87137|P2|Overall Study|Concomitant medication|3
17745|NCT02040844|87138|P1|Overall Study|Concomitant medication|1
17746|NCT02040844|87136|P3|Overall Study|Non-specified|5
17747|NCT02040844|87137|P2|Overall Study|Non-specified|2
17748|NCT02040844|87138|P1|Overall Study|Non-specified|8
17749|NCT02040844|87136|P3|Overall Study|Missing|2
17750|NCT02040844|87137|P2|Overall Study|Missing|3
17751|NCT02040844|87138|P1|Overall Study|Missing|13
17752|NCT02040844|87136|P3|Overall Study|Lost to Follow-up|13
17753|NCT02040844|87137|P2|Overall Study|Lost to Follow-up|9
17754|NCT02040844|87138|P1|Overall Study|Lost to Follow-up|12
17755|NCT02040844|87136|P3|Overall Study|Withdrawal by Subject|25
17756|NCT02040844|87137|P2|Overall Study|Withdrawal by Subject|22
17757|NCT02040844|87138|P1|Overall Study|Withdrawal by Subject|16
17758|NCT02040844|87136|P3|Overall Study|Adverse Event|1
17759|NCT02040844|87137|P2|Overall Study|Adverse Event|0
17760|NCT02040844|87138|P1|Overall Study|Adverse Event|0
17761|NCT02040779|87185|P3|Overall Study|Lack of Efficacy|0
17762|NCT02040779|87186|P2|Overall Study|Lack of Efficacy|2
17763|NCT02040779|87187|P1|Overall Study|Lack of Efficacy|4
17764|NCT02040779|87185|P3|Overall Study|Lost to Follow-up|1
17765|NCT02040779|87186|P2|Overall Study|Lost to Follow-up|2
17766|NCT02040779|87187|P1|Overall Study|Lost to Follow-up|1
17767|NCT02040779|87185|P3|Overall Study|Protocol Violation|0
17768|NCT02040779|87186|P2|Overall Study|Protocol Violation|1
17769|NCT02040779|87187|P1|Overall Study|Protocol Violation|2
17770|NCT02040779|87185|P3|Overall Study|Non-compliance|0
17771|NCT02040779|87186|P2|Overall Study|Non-compliance|1
17772|NCT02040779|87187|P1|Overall Study|Non-compliance|0
17773|NCT02040779|87185|P3|Overall Study|Withdrawal by Subject|3
17774|NCT02040779|87186|P2|Overall Study|Withdrawal by Subject|1
17775|NCT02040779|87187|P1|Overall Study|Withdrawal by Subject|4
17776|NCT02040779|87185|P3|Overall Study|Adverse Event|0
17777|NCT02040779|87186|P2|Overall Study|Adverse Event|0
17778|NCT02040779|87187|P1|Overall Study|Adverse Event|1
17779|NCT02040766|87227|P5|Overall Study|Lack of Efficacy|5
17780|NCT02040766|87228|P4|Overall Study|Lack of Efficacy|6
17781|NCT02040766|87229|P3|Overall Study|Lack of Efficacy|4
17782|NCT02040766|87230|P2|Overall Study|Lack of Efficacy|3
17783|NCT02040766|87231|P1|Overall Study|Lack of Efficacy|6
17784|NCT02040766|87227|P5|Overall Study|Not reported|0
17785|NCT02040766|87228|P4|Overall Study|Not reported|0
17786|NCT02040766|87229|P3|Overall Study|Not reported|0
17787|NCT02040766|87230|P2|Overall Study|Not reported|0
17788|NCT02040766|87231|P1|Overall Study|Not reported|1
17789|NCT02040766|87227|P5|Overall Study|Lost to Follow-up|4
17790|NCT02040766|87228|P4|Overall Study|Lost to Follow-up|1
17791|NCT02040766|87229|P3|Overall Study|Lost to Follow-up|3
17792|NCT02040766|87230|P2|Overall Study|Lost to Follow-up|1
17793|NCT02040766|87231|P1|Overall Study|Lost to Follow-up|4
17794|NCT02040766|87227|P5|Overall Study|Protocol Violation|0
17795|NCT02040766|87228|P4|Overall Study|Protocol Violation|3
17796|NCT02040766|87229|P3|Overall Study|Protocol Violation|2
17797|NCT02040766|87230|P2|Overall Study|Protocol Violation|1
17798|NCT02040766|87231|P1|Overall Study|Protocol Violation|2
17799|NCT02040766|87227|P5|Overall Study|Non-compliance|0
17800|NCT02040766|87228|P4|Overall Study|Non-compliance|0
17801|NCT02040766|87229|P3|Overall Study|Non-compliance|0
17802|NCT02040766|87230|P2|Overall Study|Non-compliance|1
17803|NCT02040766|87231|P1|Overall Study|Non-compliance|0
17804|NCT02040766|87227|P5|Overall Study|Withdrawal by Subject|2
17805|NCT02040766|87228|P4|Overall Study|Withdrawal by Subject|3
17806|NCT02040766|87229|P3|Overall Study|Withdrawal by Subject|2
17807|NCT02040766|87230|P2|Overall Study|Withdrawal by Subject|3
17808|NCT02040766|87231|P1|Overall Study|Withdrawal by Subject|4
17809|NCT02040766|87227|P5|Overall Study|Adverse Event|2
17810|NCT02040766|87228|P4|Overall Study|Adverse Event|0
17811|NCT02040766|87229|P3|Overall Study|Adverse Event|1
17812|NCT02040766|87230|P2|Overall Study|Adverse Event|1
17813|NCT02040766|87231|P1|Overall Study|Adverse Event|1
17814|NCT02040532|87282|P1|Overall Study|Withdrawal by Subject|3
17815|NCT02040532|87282|P1|Overall Study|Adverse Event|4
17816|NCT02040532|87282|P1|Overall Study|Physician Decision|4
17817|NCT02040532|87282|P1|Overall Study|Lost to Follow-up|1
17818|NCT02040428|87295|P2|Overall Study|Withdrawal by Subject|1
17819|NCT02040428|87296|P1|Overall Study|Withdrawal by Subject|1
17820|NCT02040428|87295|P2|Overall Study|Death|3
17821|NCT02040428|87296|P1|Overall Study|Death|4
17822|NCT02039778|87344|P1|Overall Study|Never started the protocol treatment|1
17823|NCT02039778|87344|P1|Overall Study|Withdrawal by Subject|1
17824|NCT02039778|87344|P1|Overall Study|Death|2
17825|NCT02039687|87356|P4|Overall Study|treatment assignment could not be confir|0
17826|NCT02039687|87357|P3|Overall Study|treatment assignment could not be confir|2
17827|NCT02039687|87358|P2|Overall Study|treatment assignment could not be confir|0
17828|NCT02039687|87359|P1|Overall Study|treatment assignment could not be confir|0
17829|NCT02039687|87356|P4|Overall Study|Withdrawal by Subject|0
17830|NCT02039687|87357|P3|Overall Study|Withdrawal by Subject|0
17831|NCT02039687|87358|P2|Overall Study|Withdrawal by Subject|1
17832|NCT02039687|87359|P1|Overall Study|Withdrawal by Subject|0
17833|NCT02039687|87356|P4|Overall Study|Adverse Event|0
17834|NCT02039687|87357|P3|Overall Study|Adverse Event|1
17835|NCT02039687|87358|P2|Overall Study|Adverse Event|0
17836|NCT02039687|87359|P1|Overall Study|Adverse Event|0
17837|NCT02039674|87394|P9|Overall Study|Ongoing in Study|4
17838|NCT02039674|87395|P8|Overall Study|Ongoing in Study|33
17839|NCT02039674|87396|P7|Overall Study|Ongoing in Study|34
17840|NCT02039674|87397|P6|Overall Study|Ongoing in Study|1
17841|NCT02039674|87398|P5|Overall Study|Ongoing in Study|6
17842|NCT02039674|87399|P4|Overall Study|Ongoing in Study|2
17843|NCT02039674|87400|P3|Overall Study|Ongoing in Study|5
17844|NCT02039674|87401|P2|Overall Study|Ongoing in Study|5
17845|NCT02039674|87402|P1|Overall Study|Ongoing in Study|7
17846|NCT02039674|87394|P9|Overall Study|Withdrawal by Subject|2
17847|NCT02039674|87395|P8|Overall Study|Withdrawal by Subject|5
17848|NCT02039674|87396|P7|Overall Study|Withdrawal by Subject|3
17849|NCT02039674|87397|P6|Overall Study|Withdrawal by Subject|1
17850|NCT02039674|87398|P5|Overall Study|Withdrawal by Subject|2
17851|NCT02039674|87399|P4|Overall Study|Withdrawal by Subject|0
17852|NCT02039674|87400|P3|Overall Study|Withdrawal by Subject|1
17853|NCT02039674|87401|P2|Overall Study|Withdrawal by Subject|1
17854|NCT02039674|87402|P1|Overall Study|Withdrawal by Subject|2
17855|NCT02039674|87394|P9|Overall Study|Progressive Disease|23
17856|NCT02039674|87395|P8|Overall Study|Progressive Disease|18
17857|NCT02039674|87396|P7|Overall Study|Progressive Disease|17
17858|NCT02039674|87397|P6|Overall Study|Progressive Disease|0
17859|NCT02039674|87398|P5|Overall Study|Progressive Disease|2
17860|NCT02039674|87399|P4|Overall Study|Progressive Disease|4
17861|NCT02039674|87400|P3|Overall Study|Progressive Disease|15
17862|NCT02039674|87401|P2|Overall Study|Progressive Disease|13
17863|NCT02039674|87402|P1|Overall Study|Progressive Disease|13
17864|NCT02039674|87394|P9|Overall Study|Physician Decision|0
17865|NCT02039674|87395|P8|Overall Study|Physician Decision|0
17866|NCT02039674|87396|P7|Overall Study|Physician Decision|1
17867|NCT02039674|87397|P6|Overall Study|Physician Decision|0
17868|NCT02039674|87398|P5|Overall Study|Physician Decision|0
17869|NCT02039674|87399|P4|Overall Study|Physician Decision|0
17870|NCT02039674|87400|P3|Overall Study|Physician Decision|0
17871|NCT02039674|87401|P2|Overall Study|Physician Decision|0
17872|NCT02039674|87402|P1|Overall Study|Physician Decision|0
17873|NCT02039674|87394|P9|Overall Study|Lost to Follow-up|0
17874|NCT02039674|87395|P8|Overall Study|Lost to Follow-up|1
17875|NCT02039674|87396|P7|Overall Study|Lost to Follow-up|0
17876|NCT02039674|87397|P6|Overall Study|Lost to Follow-up|0
17877|NCT02039674|87398|P5|Overall Study|Lost to Follow-up|0
17878|NCT02039674|87399|P4|Overall Study|Lost to Follow-up|0
17879|NCT02039674|87400|P3|Overall Study|Lost to Follow-up|0
17880|NCT02039674|87401|P2|Overall Study|Lost to Follow-up|0
17881|NCT02039674|87402|P1|Overall Study|Lost to Follow-up|0
17882|NCT02039674|87394|P9|Overall Study|Excluded Medication|5
17883|NCT02039674|87395|P8|Overall Study|Excluded Medication|4
17884|NCT02039674|87396|P7|Overall Study|Excluded Medication|2
17885|NCT02039674|87397|P6|Overall Study|Excluded Medication|4
17886|NCT02039674|87398|P5|Overall Study|Excluded Medication|2
17887|NCT02039674|87399|P4|Overall Study|Excluded Medication|0
17888|NCT02039674|87400|P3|Overall Study|Excluded Medication|2
17889|NCT02039674|87401|P2|Overall Study|Excluded Medication|1
17890|NCT02039674|87402|P1|Overall Study|Excluded Medication|2
17891|NCT02039674|87394|P9|Overall Study|Death|8
17892|NCT02039674|87395|P8|Overall Study|Death|0
17893|NCT02039674|87396|P7|Overall Study|Death|1
17894|NCT02039674|87397|P6|Overall Study|Death|1
17895|NCT02039674|87398|P5|Overall Study|Death|0
17896|NCT02039674|87399|P4|Overall Study|Death|0
17897|NCT02039674|87400|P3|Overall Study|Death|0
17898|NCT02039674|87401|P2|Overall Study|Death|3
17899|NCT02039674|87402|P1|Overall Study|Death|0
17900|NCT02039674|87394|P9|Overall Study|Adverse Event|3
17901|NCT02039674|87395|P8|Overall Study|Adverse Event|2
17902|NCT02039674|87396|P7|Overall Study|Adverse Event|2
17903|NCT02039674|87397|P6|Overall Study|Adverse Event|0
17904|NCT02039674|87398|P5|Overall Study|Adverse Event|0
17905|NCT02039674|87399|P4|Overall Study|Adverse Event|0
17906|NCT02039674|87400|P3|Overall Study|Adverse Event|1
17907|NCT02039674|87401|P2|Overall Study|Adverse Event|2
17908|NCT02039674|87402|P1|Overall Study|Adverse Event|0
17909|NCT02039427|87438|P4|Overall Study|Steroid Use|0
17910|NCT02039427|87439|P3|Overall Study|Steroid Use|0
17911|NCT02039427|87440|P2|Overall Study|Steroid Use|0
17912|NCT02039427|87441|P1|Overall Study|Steroid Use|1
17913|NCT02039427|87438|P4|Overall Study|Loss of follow - up|4
17914|NCT02039427|87439|P3|Overall Study|Loss of follow - up|2
17915|NCT02039427|87440|P2|Overall Study|Loss of follow - up|0
17916|NCT02039427|87441|P1|Overall Study|Loss of follow - up|1
17917|NCT02039427|87438|P4|Overall Study|Cancellation of surgery|0
17918|NCT02039427|87439|P3|Overall Study|Cancellation of surgery|1
17919|NCT02039427|87440|P2|Overall Study|Cancellation of surgery|0
17920|NCT02039427|87441|P1|Overall Study|Cancellation of surgery|0
17921|NCT02039427|87438|P4|Overall Study|Withdrawal on concent|1
17922|NCT02039427|87439|P3|Overall Study|Withdrawal on concent|0
17923|NCT02039427|87440|P2|Overall Study|Withdrawal on concent|0
17924|NCT02039427|87441|P1|Overall Study|Withdrawal on concent|0
17925|NCT02039427|87438|P4|Overall Study|Duration of surgery > 3h|0
17926|NCT02039427|87439|P3|Overall Study|Duration of surgery > 3h|0
17927|NCT02039427|87440|P2|Overall Study|Duration of surgery > 3h|1
17928|NCT02039427|87441|P1|Overall Study|Duration of surgery > 3h|1
17929|NCT02039414|87461|P2|Overall Study|Protocol Violation|1
17930|NCT02039414|87462|P1|Overall Study|Protocol Violation|3
17931|NCT02039414|87461|P2|Overall Study|Lost to Follow-up|0
17932|NCT02039414|87462|P1|Overall Study|Lost to Follow-up|2
17933|NCT02039414|87461|P2|Overall Study|Delivered|1
17934|NCT02039414|87462|P1|Overall Study|Delivered|1
17935|NCT02038959|87485|P2|Overall Study|Withdrawal by Subject|8
17936|NCT02038959|87486|P1|Overall Study|Withdrawal by Subject|6
17937|NCT02038933|87514|P1|Follow-up|Disease Progression|2
17938|NCT02038933|87514|P1|Follow-up|Withdrawal by Subject|1
17939|NCT02038933|87514|P1|Follow-up|Lost to Follow-up|1
17940|NCT02038933|87514|P1|Follow-up|Adverse event unrelated to study drug|4
17941|NCT02038933|87514|P1|Follow-up|Death|11
17942|NCT02038933|87514|P1|Treatment|Withdrawal by Subject|1
17943|NCT02038933|87514|P1|Treatment|Disease Progression|101
17944|NCT02038933|87514|P1|Treatment|Study Drug Toxicity|4
17945|NCT02038933|87514|P1|Treatment|Adverse Event Unrelated to Study Drug|6
17946|NCT02038933|87514|P1|Treatment|Lost to Follow-up|1
17947|NCT02038933|87514|P1|Treatment|No longer meets study criteria|1
17948|NCT02038907|87547|P14|Overall Study|Withdrawal by Subject|0
17949|NCT02038907|87548|P13|Overall Study|Withdrawal by Subject|0
17950|NCT02038907|87549|P12|Overall Study|Withdrawal by Subject|0
17951|NCT02038907|87550|P11|Overall Study|Withdrawal by Subject|1
17952|NCT02038907|87551|P10|Overall Study|Withdrawal by Subject|0
17953|NCT02038907|87552|P9|Overall Study|Withdrawal by Subject|0
17954|NCT02038907|87553|P8|Overall Study|Withdrawal by Subject|0
17955|NCT02038907|87554|P7|Overall Study|Withdrawal by Subject|0
17956|NCT02038907|87555|P6|Overall Study|Withdrawal by Subject|0
17957|NCT02038907|87556|P5|Overall Study|Withdrawal by Subject|0
17958|NCT02038907|87557|P4|Overall Study|Withdrawal by Subject|0
17959|NCT02038907|87558|P3|Overall Study|Withdrawal by Subject|0
17960|NCT02038907|87559|P2|Overall Study|Withdrawal by Subject|0
17961|NCT02038907|87560|P1|Overall Study|Withdrawal by Subject|0
17962|NCT02038907|87547|P14|Overall Study|Protocol Violation|0
17963|NCT02038907|87548|P13|Overall Study|Protocol Violation|0
17964|NCT02038907|87549|P12|Overall Study|Protocol Violation|0
17965|NCT02038907|87550|P11|Overall Study|Protocol Violation|1
17966|NCT02038907|87551|P10|Overall Study|Protocol Violation|0
17967|NCT02038907|87552|P9|Overall Study|Protocol Violation|0
17968|NCT02038907|87553|P8|Overall Study|Protocol Violation|0
17969|NCT02038907|87554|P7|Overall Study|Protocol Violation|0
17970|NCT02038907|87555|P6|Overall Study|Protocol Violation|0
17971|NCT02038907|87556|P5|Overall Study|Protocol Violation|0
17972|NCT02038907|87557|P4|Overall Study|Protocol Violation|0
17973|NCT02038907|87558|P3|Overall Study|Protocol Violation|0
17974|NCT02038907|87559|P2|Overall Study|Protocol Violation|0
17975|NCT02038907|87560|P1|Overall Study|Protocol Violation|0
17976|NCT02038829|88088|P12|Treatment Period 6|Adverse Event|0
17977|NCT02038829|88089|P11|Treatment Period 6|Adverse Event|0
17978|NCT02038829|88090|P10|Treatment Period 6|Adverse Event|0
17979|NCT02038829|88091|P9|Treatment Period 6|Adverse Event|0
17980|NCT02038829|88092|P8|Treatment Period 6|Adverse Event|0
17981|NCT02038829|88093|P7|Treatment Period 6|Adverse Event|0
17982|NCT02038829|88094|P6|Treatment Period 6|Adverse Event|0
17983|NCT02038829|88095|P5|Treatment Period 6|Adverse Event|0
17984|NCT02038829|88096|P4|Treatment Period 6|Adverse Event|0
17985|NCT02038829|88097|P3|Treatment Period 6|Adverse Event|1
17986|NCT02038829|88098|P2|Treatment Period 6|Adverse Event|0
17987|NCT02038829|88099|P1|Treatment Period 6|Adverse Event|0
17988|NCT02038829|88088|P12|Washout Period 4|Adverse Event|0
17989|NCT02038829|88089|P11|Washout Period 4|Adverse Event|0
17990|NCT02038829|88090|P10|Washout Period 4|Adverse Event|0
17991|NCT02038829|88091|P9|Washout Period 4|Adverse Event|0
17992|NCT02038829|88092|P8|Washout Period 4|Adverse Event|0
17993|NCT02038829|88093|P7|Washout Period 4|Adverse Event|1
17994|NCT02038829|88094|P6|Washout Period 4|Adverse Event|0
17995|NCT02038829|88095|P5|Washout Period 4|Adverse Event|0
17996|NCT02038829|88096|P4|Washout Period 4|Adverse Event|0
17997|NCT02038829|88097|P3|Washout Period 4|Adverse Event|0
17998|NCT02038829|88098|P2|Washout Period 4|Adverse Event|0
17999|NCT02038829|88099|P1|Washout Period 4|Adverse Event|0
18000|NCT02038829|88088|P12|Treatment Period 4|Adverse Event|0
18001|NCT02038829|88089|P11|Treatment Period 4|Adverse Event|0
18002|NCT02038829|88090|P10|Treatment Period 4|Adverse Event|0
18003|NCT02038829|88091|P9|Treatment Period 4|Adverse Event|0
18004|NCT02038829|88092|P8|Treatment Period 4|Adverse Event|0
18005|NCT02038829|88093|P7|Treatment Period 4|Adverse Event|0
18006|NCT02038829|88094|P6|Treatment Period 4|Adverse Event|0
18007|NCT02038829|88095|P5|Treatment Period 4|Adverse Event|0
18008|NCT02038829|88096|P4|Treatment Period 4|Adverse Event|0
18009|NCT02038829|88097|P3|Treatment Period 4|Adverse Event|0
18010|NCT02038829|88098|P2|Treatment Period 4|Adverse Event|1
18011|NCT02038829|88099|P1|Treatment Period 4|Adverse Event|0
18012|NCT02038829|88088|P12|Washout Period 2|Withdrawal by Subject|0
18013|NCT02038829|88089|P11|Washout Period 2|Withdrawal by Subject|0
18014|NCT02038829|88090|P10|Washout Period 2|Withdrawal by Subject|0
18015|NCT02038829|88091|P9|Washout Period 2|Withdrawal by Subject|0
18016|NCT02038829|88092|P8|Washout Period 2|Withdrawal by Subject|0
18017|NCT02038829|88093|P7|Washout Period 2|Withdrawal by Subject|0
18018|NCT02038829|88094|P6|Washout Period 2|Withdrawal by Subject|1
18019|NCT02038829|88095|P5|Washout Period 2|Withdrawal by Subject|0
18020|NCT02038829|88096|P4|Washout Period 2|Withdrawal by Subject|0
18021|NCT02038829|88097|P3|Washout Period 2|Withdrawal by Subject|0
18022|NCT02038829|88098|P2|Washout Period 2|Withdrawal by Subject|0
18023|NCT02038829|88099|P1|Washout Period 2|Withdrawal by Subject|0
18024|NCT02038829|88088|P12|Washout Period 2|Adverse Event|0
18025|NCT02038829|88089|P11|Washout Period 2|Adverse Event|0
18026|NCT02038829|88090|P10|Washout Period 2|Adverse Event|0
18027|NCT02038829|88091|P9|Washout Period 2|Adverse Event|1
18028|NCT02038829|88092|P8|Washout Period 2|Adverse Event|0
18029|NCT02038829|88093|P7|Washout Period 2|Adverse Event|0
18030|NCT02038829|88094|P6|Washout Period 2|Adverse Event|0
18031|NCT02038829|88095|P5|Washout Period 2|Adverse Event|0
18032|NCT02038829|88096|P4|Washout Period 2|Adverse Event|0
18033|NCT02038829|88097|P3|Washout Period 2|Adverse Event|0
18034|NCT02038829|88098|P2|Washout Period 2|Adverse Event|0
18035|NCT02038829|88099|P1|Washout Period 2|Adverse Event|0
18036|NCT02038829|88088|P12|Treatment Period 2|Withdrawal by Subject|0
18037|NCT02038829|88089|P11|Treatment Period 2|Withdrawal by Subject|0
18038|NCT02038829|88090|P10|Treatment Period 2|Withdrawal by Subject|0
18039|NCT02038829|88091|P9|Treatment Period 2|Withdrawal by Subject|0
18040|NCT02038829|88092|P8|Treatment Period 2|Withdrawal by Subject|0
18041|NCT02038829|88093|P7|Treatment Period 2|Withdrawal by Subject|0
18042|NCT02038829|88094|P6|Treatment Period 2|Withdrawal by Subject|0
18043|NCT02038829|88095|P5|Treatment Period 2|Withdrawal by Subject|0
18044|NCT02038829|88096|P4|Treatment Period 2|Withdrawal by Subject|0
18045|NCT02038829|88097|P3|Treatment Period 2|Withdrawal by Subject|0
18046|NCT02038829|88098|P2|Treatment Period 2|Withdrawal by Subject|0
18047|NCT02038829|88099|P1|Treatment Period 2|Withdrawal by Subject|1
18048|NCT02038829|88088|P12|Treatment Period 2|Adverse Event|0
18049|NCT02038829|88089|P11|Treatment Period 2|Adverse Event|1
18050|NCT02038829|88090|P10|Treatment Period 2|Adverse Event|0
18051|NCT02038829|88091|P9|Treatment Period 2|Adverse Event|0
18052|NCT02038829|88092|P8|Treatment Period 2|Adverse Event|0
18053|NCT02038829|88093|P7|Treatment Period 2|Adverse Event|0
18054|NCT02038829|88094|P6|Treatment Period 2|Adverse Event|0
18055|NCT02038829|88095|P5|Treatment Period 2|Adverse Event|0
18056|NCT02038829|88096|P4|Treatment Period 2|Adverse Event|0
18057|NCT02038829|88097|P3|Treatment Period 2|Adverse Event|0
18058|NCT02038829|88098|P2|Treatment Period 2|Adverse Event|0
18059|NCT02038829|88099|P1|Treatment Period 2|Adverse Event|0
18060|NCT02038829|88088|P12|Washout Period 1|Death|0
18061|NCT02038829|88089|P11|Washout Period 1|Death|0
18062|NCT02038829|88090|P10|Washout Period 1|Death|0
18063|NCT02038829|88091|P9|Washout Period 1|Death|0
18064|NCT02038829|88092|P8|Washout Period 1|Death|0
18065|NCT02038829|88093|P7|Washout Period 1|Death|0
18066|NCT02038829|88094|P6|Washout Period 1|Death|0
18067|NCT02038829|88095|P5|Washout Period 1|Death|1
18068|NCT02038829|88096|P4|Washout Period 1|Death|0
18069|NCT02038829|88097|P3|Washout Period 1|Death|0
18070|NCT02038829|88098|P2|Washout Period 1|Death|0
18071|NCT02038829|88099|P1|Washout Period 1|Death|0
18072|NCT02038790|88133|P2|Day 0 - First Treatment|Withdrawal by Subject|1
18073|NCT02038790|88134|P1|Day 0 - First Treatment|Withdrawal by Subject|1
18074|NCT02038543|88169|P4|Overall Study|Withdrawal by Subject|1
18075|NCT02038543|88170|P3|Overall Study|Withdrawal by Subject|0
18076|NCT02038543|88171|P2|Overall Study|Withdrawal by Subject|0
18077|NCT02038543|88172|P1|Overall Study|Withdrawal by Subject|0
18078|NCT02038543|88169|P4|Overall Study|Screen Failure|1
18079|NCT02038543|88170|P3|Overall Study|Screen Failure|0
18080|NCT02038543|88171|P2|Overall Study|Screen Failure|0
18081|NCT02038543|88172|P1|Overall Study|Screen Failure|0
18082|NCT02038075|88188|P2|Overall Study|Withdrawal by Subject|0
18083|NCT02038075|88189|P1|Overall Study|Withdrawal by Subject|3
18084|NCT02037568|88220|P2|Overall Study|Patient did not receive transplant|1
18085|NCT02037568|88221|P1|Overall Study|Patient did not receive transplant|0
18086|NCT02037568|88220|P2|Overall Study|Screen Failure|1
18087|NCT02037568|88221|P1|Overall Study|Screen Failure|3
18088|NCT02037568|88220|P2|Overall Study|Lost to Follow-up|13
18089|NCT02037568|88221|P1|Overall Study|Lost to Follow-up|16
18090|NCT02037568|88220|P2|Overall Study|Withdrawal by Subject|24
18091|NCT02037568|88221|P1|Overall Study|Withdrawal by Subject|17
18092|NCT02037477|88247|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
18093|NCT02037477|88248|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
18094|NCT02037477|88249|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
18095|NCT02037477|88250|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
18096|NCT02036775|88328|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
18097|NCT02036775|88329|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
18098|NCT02036775|88330|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
18099|NCT02036775|88331|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
18100|NCT02036775|88332|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
18101|NCT02036775|88333|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
18102|NCT02036580|88374|P3|Overall Study|Adverse Event|0
18103|NCT02036580|88375|P2|Overall Study|Adverse Event|0
18104|NCT02036580|88376|P1|Overall Study|Adverse Event|1
18105|NCT02036580|88374|P3|Overall Study|Withdrawal by Subject|0
18106|NCT02036580|88375|P2|Overall Study|Withdrawal by Subject|1
18107|NCT02036580|88376|P1|Overall Study|Withdrawal by Subject|0
18108|NCT02036515|88397|P3|Overall Study|Hyperglycemia|1
18109|NCT02036515|88398|P2|Overall Study|Hyperglycemia|0
18110|NCT02036515|88399|P1|Overall Study|Hyperglycemia|0
18111|NCT02036515|88397|P3|Overall Study|Withdrawal by Subject|9
18112|NCT02036515|88398|P2|Overall Study|Withdrawal by Subject|7
18113|NCT02036515|88399|P1|Overall Study|Withdrawal by Subject|4
18114|NCT02036515|88397|P3|Overall Study|Screen failure|0
18115|NCT02036515|88398|P2|Overall Study|Screen failure|2
18116|NCT02036515|88399|P1|Overall Study|Screen failure|0
18117|NCT02036515|88397|P3|Overall Study|Non-compliance with study drug|2
18118|NCT02036515|88398|P2|Overall Study|Non-compliance with study drug|0
18119|NCT02036515|88399|P1|Overall Study|Non-compliance with study drug|0
18120|NCT02036515|88397|P3|Overall Study|Lost to Follow-up|0
18121|NCT02036515|88398|P2|Overall Study|Lost to Follow-up|2
18122|NCT02036515|88399|P1|Overall Study|Lost to Follow-up|0
18123|NCT02036515|88397|P3|Overall Study|Adverse Event|2
18124|NCT02036515|88398|P2|Overall Study|Adverse Event|1
18125|NCT02036515|88399|P1|Overall Study|Adverse Event|1
18126|NCT02035748|88498|P1|Overall Study|Progressive Disease|1
18127|NCT02035748|88498|P1|Overall Study|Withdrawal by Subject|6
18128|NCT02035748|88498|P1|Overall Study|Physician Decision|3
18129|NCT02035748|88498|P1|Overall Study|Lost to Follow-up|2
18130|NCT02035748|88498|P1|Overall Study|Death|3
18131|NCT02035748|88498|P1|Overall Study|Adverse Event|5
18132|NCT02035696|88512|P4|Overall Study|Withdrawal by Subject|1
18133|NCT02035696|88513|P3|Overall Study|Withdrawal by Subject|2
18134|NCT02035696|88514|P2|Overall Study|Withdrawal by Subject|0
18135|NCT02035696|88515|P1|Overall Study|Withdrawal by Subject|3
18136|NCT02035696|88512|P4|Overall Study|Lost to Follow-up|2
18137|NCT02035696|88513|P3|Overall Study|Lost to Follow-up|1
18138|NCT02035696|88514|P2|Overall Study|Lost to Follow-up|3
18139|NCT02035696|88515|P1|Overall Study|Lost to Follow-up|0
18140|NCT02035553|88571|P2|Overall Study|Other Reason|4
18141|NCT02035553|88572|P1|Overall Study|Other Reason|0
18142|NCT02035553|88571|P2|Overall Study|Lost to Follow-up|1
18143|NCT02035553|88572|P1|Overall Study|Lost to Follow-up|0
18144|NCT02035553|88571|P2|Overall Study|Non-compliance with Study Drug|1
18145|NCT02035553|88572|P1|Overall Study|Non-compliance with Study Drug|0
18146|NCT02035553|88571|P2|Overall Study|Withdrawal by Subject|7
18147|NCT02035553|88572|P1|Overall Study|Withdrawal by Subject|4
18148|NCT02035553|88571|P2|Overall Study|Lack of Efficacy|1
18149|NCT02035553|88572|P1|Overall Study|Lack of Efficacy|1
18150|NCT02035553|88571|P2|Overall Study|Physician Decision|2
18151|NCT02035553|88572|P1|Overall Study|Physician Decision|3
18152|NCT02035553|88571|P2|Overall Study|Adverse Event|6
18153|NCT02035553|88572|P1|Overall Study|Adverse Event|10
18154|NCT02035553|88571|P2|Overall Study|Death (See All-Cause Mortality Table)|1
18155|NCT02035553|88572|P1|Overall Study|Death (See All-Cause Mortality Table)|0
18156|NCT02035475|88578|P1|Overall Study|Equipment Error|1
18157|NCT02035475|88578|P1|Overall Study|Physician Decision|1
18158|NCT02035475|88578|P1|Overall Study|Withdrawal by Subject|4
18159|NCT02035332|88589|P1|Overall Study|Procedure Aborted due to Uterine Width|1
18160|NCT02034916|88597|P2|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|20
18161|NCT02034916|88598|P1|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|15
18162|NCT02034916|88597|P2|Overall Study|Lost to Follow-up|1
18163|NCT02034916|88598|P1|Overall Study|Lost to Follow-up|1
18164|NCT02034916|88597|P2|Overall Study|Withdrawal by Subject|1
18165|NCT02034916|88598|P1|Overall Study|Withdrawal by Subject|1
18166|NCT02034916|88597|P2|Overall Study|Death|13
18167|NCT02034916|88598|P1|Overall Study|Death|32
18168|NCT02034877|88633|P2|Overall Study|No Longer Willing to Participate|3
18169|NCT02034877|88634|P1|Overall Study|No Longer Willing to Participate|0
18170|NCT02034877|88633|P2|Overall Study|Lost to Follow-up|3
18171|NCT02034877|88634|P1|Overall Study|Lost to Follow-up|0
18172|NCT02034799|88652|P2|Overall Study|Death|1
18173|NCT02034799|88653|P1|Overall Study|Death|2
18174|NCT02034799|88652|P2|Overall Study|Lost to Follow-up|1
18175|NCT02034799|88653|P1|Overall Study|Lost to Follow-up|0
18176|NCT02034799|88652|P2|Overall Study|Withdrawal by Subject|2
18177|NCT02034799|88653|P1|Overall Study|Withdrawal by Subject|0
18178|NCT02034708|88667|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
18179|NCT02034708|88668|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
18180|NCT02034708|88667|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
18181|NCT02034708|88668|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
18182|NCT02034708|88667|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
18183|NCT02034708|88668|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
18184|NCT02034708|88667|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
18185|NCT02034708|88668|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
18186|NCT02034591|88679|P6|Overall Study|Withdrawal by Subject|0
18187|NCT02034591|88680|P5|Overall Study|Withdrawal by Subject|1
18188|NCT02034591|88681|P4|Overall Study|Withdrawal by Subject|0
18189|NCT02034591|88682|P3|Overall Study|Withdrawal by Subject|0
18190|NCT02034591|88683|P2|Overall Study|Withdrawal by Subject|0
18191|NCT02034591|88684|P1|Overall Study|Withdrawal by Subject|0
18192|NCT02034565|88739|P2|Overall Study|Adverse Event|0
18193|NCT02034565|88740|P1|Overall Study|Adverse Event|1
18194|NCT02034552|88757|P3|Overall Study|Non-compliance with study drug|1
18195|NCT02034552|88758|P2|Overall Study|Non-compliance with study drug|0
18196|NCT02034552|88759|P1|Overall Study|Non-compliance with study drug|0
18197|NCT02034552|88757|P3|Overall Study|Withdrawal by Subject|1
18198|NCT02034552|88758|P2|Overall Study|Withdrawal by Subject|0
18199|NCT02034552|88759|P1|Overall Study|Withdrawal by Subject|2
18200|NCT02034552|88757|P3|Overall Study|AE associated with disease progression|0
18201|NCT02034552|88758|P2|Overall Study|AE associated with disease progression|1
18202|NCT02034552|88759|P1|Overall Study|AE associated with disease progression|0
18203|NCT02034552|88757|P3|Overall Study|AE not assoc. with disease progression|2
18204|NCT02034552|88758|P2|Overall Study|AE not assoc. with disease progression|3
18205|NCT02034552|88759|P1|Overall Study|AE not assoc. with disease progression|1
18206|NCT02034552|88757|P3|Overall Study|Ongoing with treatment|11
18207|NCT02034552|88758|P2|Overall Study|Ongoing with treatment|11
18208|NCT02034552|88759|P1|Overall Study|Ongoing with treatment|0
18209|NCT02034552|88757|P3|Overall Study|Never treated|0
18210|NCT02034552|88758|P2|Overall Study|Never treated|2
18211|NCT02034552|88759|P1|Overall Study|Never treated|3
18212|NCT02034513|88784|P2|Overall Study|Unclassified|1
18213|NCT02034513|88785|P1|Overall Study|Unclassified|0
18214|NCT02034513|88784|P2|Overall Study|Withdrawal by Subject|25
18215|NCT02034513|88785|P1|Overall Study|Withdrawal by Subject|25
18216|NCT02034513|88784|P2|Overall Study|Protocol Violation|10
18217|NCT02034513|88785|P1|Overall Study|Protocol Violation|7
18218|NCT02034513|88784|P2|Overall Study|Pregnancy|3
18219|NCT02034513|88785|P1|Overall Study|Pregnancy|0
18220|NCT02034513|88784|P2|Overall Study|Lost to Follow-up|7
18221|NCT02034513|88785|P1|Overall Study|Lost to Follow-up|6
18222|NCT02034513|88784|P2|Overall Study|Lack of Efficacy|1
18223|NCT02034513|88785|P1|Overall Study|Lack of Efficacy|0
18224|NCT02034513|88784|P2|Overall Study|Adverse Event|10
18225|NCT02034513|88785|P1|Overall Study|Adverse Event|11
18226|NCT02034162|88803|P3|Double-blind|Withdrawal by Subject|0
18227|NCT02034162|88804|P2|Double-blind|Withdrawal by Subject|7
18228|NCT02034162|88805|P1|Double-blind|Withdrawal by Subject|5
18229|NCT02034162|88803|P3|Double-blind|Protocol Violation|0
18230|NCT02034162|88804|P2|Double-blind|Protocol Violation|1
18231|NCT02034162|88805|P1|Double-blind|Protocol Violation|0
18232|NCT02034162|88803|P3|Double-blind|Physician Decision|0
18233|NCT02034162|88804|P2|Double-blind|Physician Decision|0
18234|NCT02034162|88805|P1|Double-blind|Physician Decision|1
18235|NCT02034162|88803|P3|Double-blind|Lost to Follow-up|0
18236|NCT02034162|88804|P2|Double-blind|Lost to Follow-up|0
18237|NCT02034162|88805|P1|Double-blind|Lost to Follow-up|3
18238|NCT02033369|88878|P2|Overall Study|Protocol Violation|0
18239|NCT02033369|88879|P1|Overall Study|Protocol Violation|2
18240|NCT02033369|88878|P2|Overall Study|Lost to Follow-up|0
18241|NCT02033369|88879|P1|Overall Study|Lost to Follow-up|1
18242|NCT02033369|88878|P2|Overall Study|Withdrawal by Subject|1
18243|NCT02033369|88879|P1|Overall Study|Withdrawal by Subject|1
18244|NCT02033369|88878|P2|Overall Study|Not a good demographic match|2
18245|NCT02033369|88879|P1|Overall Study|Not a good demographic match|0
18246|NCT02033369|88878|P2|Overall Study|Physician Decision|2
18247|NCT02033369|88879|P1|Overall Study|Physician Decision|1
18248|NCT02032901|88945|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
18249|NCT02032901|88946|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
18250|NCT02032901|88945|P2|Treatment Period (12 Weeks)|Pregnancy|0
18251|NCT02032901|88946|P1|Treatment Period (12 Weeks)|Pregnancy|1
18252|NCT02032888|88970|P3|Follow-up Period|Not specified|0
18253|NCT02032888|88971|P2|Follow-up Period|Not specified|0
18254|NCT02032888|88972|P1|Follow-up Period|Not specified|1
18255|NCT02032888|88970|P3|Follow-up Period|Death|0
18256|NCT02032888|88971|P2|Follow-up Period|Death|1
18257|NCT02032888|88972|P1|Follow-up Period|Death|1
18258|NCT02032888|88970|P3|Follow-up Period|Lost to Follow-up|0
18259|NCT02032888|88971|P2|Follow-up Period|Lost to Follow-up|1
18260|NCT02032888|88972|P1|Follow-up Period|Lost to Follow-up|1
18261|NCT02032888|88970|P3|Treatment Period|Not specified|0
18262|NCT02032888|88971|P2|Treatment Period|Not specified|1
18263|NCT02032888|88972|P1|Treatment Period|Not specified|1
18264|NCT02032888|88970|P3|Treatment Period|Poor compliance/noncompliance|0
18265|NCT02032888|88971|P2|Treatment Period|Poor compliance/noncompliance|1
18266|NCT02032888|88972|P1|Treatment Period|Poor compliance/noncompliance|1
18267|NCT02032875|89003|P2|Follow-up Period|Virologic Relapse|10
18268|NCT02032875|89004|P1|Follow-up Period|Virologic Relapse|3
18269|NCT02032875|89003|P2|Follow-up Period|Death|1
18270|NCT02032875|89004|P1|Follow-up Period|Death|0
18271|NCT02032875|89003|P2|Treatment Period|Liver transplant, Treatment extension|3
18272|NCT02032875|89004|P1|Treatment Period|Liver transplant, Treatment extension|0
18273|NCT02032875|89003|P2|Treatment Period|Liver transplant, No extension needed|1
18274|NCT02032875|89004|P1|Treatment Period|Liver transplant, No extension needed|0
18275|NCT02032875|89003|P2|Treatment Period|Adverse Event|0
18276|NCT02032875|89004|P1|Treatment Period|Adverse Event|1
18277|NCT02032706|89033|P1|Overall Study|Protocol Violation|1
18278|NCT02032706|89033|P1|Overall Study|Did not qualify|5
18279|NCT02032407|89090|P1|Overall Study|Other Miscellaneous Reasons|2
18280|NCT02032407|89090|P1|Overall Study|Pregnancy|1
18281|NCT02032407|89090|P1|Overall Study|Lost to Follow-up|2
18282|NCT02032238|89103|P2|Overall Study|Lost to Follow-up|0
18283|NCT02032238|89104|P1|Overall Study|Lost to Follow-up|2
18284|NCT02031679|89145|P2|Overall Study|Lack of Efficacy|1
18285|NCT02031679|89146|P1|Overall Study|Lack of Efficacy|0
18286|NCT02031679|89145|P2|Overall Study|Protocol Violation|1
18287|NCT02031679|89146|P1|Overall Study|Protocol Violation|0
18288|NCT02031640|89161|P6|Double-blind Treatment Period|Lost to Follow-up|0
18289|NCT02031640|89162|P5|Double-blind Treatment Period|Lost to Follow-up|1
18290|NCT02031640|89163|P4|Double-blind Treatment Period|Lost to Follow-up|0
18291|NCT02031640|89164|P3|Double-blind Treatment Period|Lost to Follow-up|0
18292|NCT02031640|89165|P2|Double-blind Treatment Period|Lost to Follow-up|3
18293|NCT02031640|89166|P1|Double-blind Treatment Period|Lost to Follow-up|0
18294|NCT02031640|89161|P6|Double-blind Treatment Period|Withdrawal by Subject|1
18295|NCT02031640|89162|P5|Double-blind Treatment Period|Withdrawal by Subject|1
18296|NCT02031640|89163|P4|Double-blind Treatment Period|Withdrawal by Subject|1
18297|NCT02031640|89164|P3|Double-blind Treatment Period|Withdrawal by Subject|3
18298|NCT02031640|89165|P2|Double-blind Treatment Period|Withdrawal by Subject|2
18299|NCT02031640|89166|P1|Double-blind Treatment Period|Withdrawal by Subject|0
18300|NCT02031640|89161|P6|Double-blind Treatment Period|Adverse Event|0
18301|NCT02031640|89162|P5|Double-blind Treatment Period|Adverse Event|0
18302|NCT02031640|89163|P4|Double-blind Treatment Period|Adverse Event|2
18303|NCT02031640|89164|P3|Double-blind Treatment Period|Adverse Event|0
18304|NCT02031640|89165|P2|Double-blind Treatment Period|Adverse Event|0
18305|NCT02031640|89166|P1|Double-blind Treatment Period|Adverse Event|0
18306|NCT02031640|89161|P6|Double-blind Treatment Period|Non-compliance|0
18307|NCT02031640|89162|P5|Double-blind Treatment Period|Non-compliance|1
18308|NCT02031640|89163|P4|Double-blind Treatment Period|Non-compliance|1
18309|NCT02031640|89164|P3|Double-blind Treatment Period|Non-compliance|0
18310|NCT02031640|89165|P2|Double-blind Treatment Period|Non-compliance|1
18311|NCT02031640|89166|P1|Double-blind Treatment Period|Non-compliance|0
18312|NCT02031640|89161|P6|Double-blind Treatment Period|Lack of Efficacy|1
18313|NCT02031640|89162|P5|Double-blind Treatment Period|Lack of Efficacy|5
18314|NCT02031640|89163|P4|Double-blind Treatment Period|Lack of Efficacy|2
18315|NCT02031640|89164|P3|Double-blind Treatment Period|Lack of Efficacy|3
18316|NCT02031640|89165|P2|Double-blind Treatment Period|Lack of Efficacy|14
18317|NCT02031640|89166|P1|Double-blind Treatment Period|Lack of Efficacy|0
18318|NCT02031640|89161|P6|Double-blind Treatment Period|Protocol deviation|1
18319|NCT02031640|89162|P5|Double-blind Treatment Period|Protocol deviation|3
18320|NCT02031640|89163|P4|Double-blind Treatment Period|Protocol deviation|1
18321|NCT02031640|89164|P3|Double-blind Treatment Period|Protocol deviation|0
18322|NCT02031640|89165|P2|Double-blind Treatment Period|Protocol deviation|2
18323|NCT02031640|89166|P1|Double-blind Treatment Period|Protocol deviation|0
18324|NCT02031640|89161|P6|Run-In Period|Various administrative reasons|0
18325|NCT02031640|89162|P5|Run-In Period|Various administrative reasons|0
18326|NCT02031640|89163|P4|Run-In Period|Various administrative reasons|0
18327|NCT02031640|89164|P3|Run-In Period|Various administrative reasons|0
18328|NCT02031640|89165|P2|Run-In Period|Various administrative reasons|0
18329|NCT02031640|89166|P1|Run-In Period|Various administrative reasons|17
18330|NCT02031640|89161|P6|Run-In Period|Randomization criteria not met|0
18331|NCT02031640|89162|P5|Run-In Period|Randomization criteria not met|0
18332|NCT02031640|89163|P4|Run-In Period|Randomization criteria not met|0
18333|NCT02031640|89164|P3|Run-In Period|Randomization criteria not met|0
18334|NCT02031640|89165|P2|Run-In Period|Randomization criteria not met|0
18335|NCT02031640|89166|P1|Run-In Period|Randomization criteria not met|85
18336|NCT02031640|89161|P6|Run-In Period|Exclusion criteria met|0
18337|NCT02031640|89162|P5|Run-In Period|Exclusion criteria met|0
18338|NCT02031640|89163|P4|Run-In Period|Exclusion criteria met|0
18339|NCT02031640|89164|P3|Run-In Period|Exclusion criteria met|0
18340|NCT02031640|89165|P2|Run-In Period|Exclusion criteria met|0
18341|NCT02031640|89166|P1|Run-In Period|Exclusion criteria met|8
18342|NCT02031640|89161|P6|Run-In Period|Inclusion criteria not met|0
18343|NCT02031640|89162|P5|Run-In Period|Inclusion criteria not met|0
18344|NCT02031640|89163|P4|Run-In Period|Inclusion criteria not met|0
18345|NCT02031640|89164|P3|Run-In Period|Inclusion criteria not met|0
18346|NCT02031640|89165|P2|Run-In Period|Inclusion criteria not met|0
18347|NCT02031640|89166|P1|Run-In Period|Inclusion criteria not met|38
18348|NCT02031640|89161|P6|Run-In Period|Withdrawal by Subject|0
18349|NCT02031640|89162|P5|Run-In Period|Withdrawal by Subject|0
18350|NCT02031640|89163|P4|Run-In Period|Withdrawal by Subject|0
18351|NCT02031640|89164|P3|Run-In Period|Withdrawal by Subject|0
18352|NCT02031640|89165|P2|Run-In Period|Withdrawal by Subject|0
18353|NCT02031640|89166|P1|Run-In Period|Withdrawal by Subject|17
18354|NCT02031640|89161|P6|Run-In Period|Adverse Event|0
18355|NCT02031640|89162|P5|Run-In Period|Adverse Event|0
18356|NCT02031640|89163|P4|Run-In Period|Adverse Event|0
18357|NCT02031640|89164|P3|Run-In Period|Adverse Event|0
18358|NCT02031640|89165|P2|Run-In Period|Adverse Event|0
18359|NCT02031640|89166|P1|Run-In Period|Adverse Event|4
18360|NCT02031640|89161|P6|Screening Period|Enrollment closed|0
18361|NCT02031640|89162|P5|Screening Period|Enrollment closed|0
18362|NCT02031640|89163|P4|Screening Period|Enrollment closed|0
18363|NCT02031640|89164|P3|Screening Period|Enrollment closed|0
18364|NCT02031640|89165|P2|Screening Period|Enrollment closed|0
18365|NCT02031640|89166|P1|Screening Period|Enrollment closed|26
18366|NCT02031640|89161|P6|Screening Period|Lost to Follow-up|0
18367|NCT02031640|89162|P5|Screening Period|Lost to Follow-up|0
18368|NCT02031640|89163|P4|Screening Period|Lost to Follow-up|0
18369|NCT02031640|89164|P3|Screening Period|Lost to Follow-up|0
18370|NCT02031640|89165|P2|Screening Period|Lost to Follow-up|0
18371|NCT02031640|89166|P1|Screening Period|Lost to Follow-up|14
18372|NCT02031640|89161|P6|Screening Period|Exclusion criteria met|0
18373|NCT02031640|89162|P5|Screening Period|Exclusion criteria met|0
18374|NCT02031640|89163|P4|Screening Period|Exclusion criteria met|0
18375|NCT02031640|89164|P3|Screening Period|Exclusion criteria met|0
18376|NCT02031640|89165|P2|Screening Period|Exclusion criteria met|0
18377|NCT02031640|89166|P1|Screening Period|Exclusion criteria met|30
18378|NCT02031640|89161|P6|Screening Period|Inclusion criteria not met|0
18379|NCT02031640|89162|P5|Screening Period|Inclusion criteria not met|0
18380|NCT02031640|89163|P4|Screening Period|Inclusion criteria not met|0
18381|NCT02031640|89164|P3|Screening Period|Inclusion criteria not met|0
18382|NCT02031640|89165|P2|Screening Period|Inclusion criteria not met|0
18383|NCT02031640|89166|P1|Screening Period|Inclusion criteria not met|312
18384|NCT02031640|89161|P6|Screening Period|Withdrawal by Subject|0
18385|NCT02031640|89162|P5|Screening Period|Withdrawal by Subject|0
18386|NCT02031640|89163|P4|Screening Period|Withdrawal by Subject|0
18387|NCT02031640|89164|P3|Screening Period|Withdrawal by Subject|0
18388|NCT02031640|89165|P2|Screening Period|Withdrawal by Subject|0
18389|NCT02031640|89166|P1|Screening Period|Withdrawal by Subject|29
18390|NCT02031640|89161|P6|Screening Period|Adverse Event|0
18391|NCT02031640|89162|P5|Screening Period|Adverse Event|0
18392|NCT02031640|89163|P4|Screening Period|Adverse Event|0
18393|NCT02031640|89164|P3|Screening Period|Adverse Event|0
18394|NCT02031640|89165|P2|Screening Period|Adverse Event|0
18395|NCT02031640|89166|P1|Screening Period|Adverse Event|1
18396|NCT02031471|89209|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
18397|NCT02031471|89209|P1|Long Term Extension (LTE) Period|Adverse Event|1
18398|NCT02031471|89209|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
18399|NCT02031471|89209|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
18400|NCT02031471|89209|P1|24 Week Treatment Period|Protocol Violation|1
18401|NCT02031471|89209|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
18402|NCT02031471|89209|P1|24 Week Treatment Period|Adverse Event|6
18403|NCT02031458|89242|P3|Overall Study|Lost to Follow-up|2
18404|NCT02031458|89243|P2|Overall Study|Lost to Follow-up|1
18405|NCT02031458|89244|P1|Overall Study|Lost to Follow-up|1
18406|NCT02031458|89242|P3|Overall Study|On Treatment|73
18407|NCT02031458|89243|P2|Overall Study|On Treatment|81
18408|NCT02031458|89244|P1|Overall Study|On Treatment|43
18409|NCT02031458|89242|P3|Overall Study|On Survival Follow-Up|73
18410|NCT02031458|89243|P2|Overall Study|On Survival Follow-Up|83
18411|NCT02031458|89244|P1|Overall Study|On Survival Follow-Up|46
18412|NCT02031458|89242|P3|Overall Study|Withdrawal by Subject|3
18413|NCT02031458|89243|P2|Overall Study|Withdrawal by Subject|9
18414|NCT02031458|89244|P1|Overall Study|Withdrawal by Subject|6
18415|NCT02031458|89242|P3|Overall Study|Unknown Reason|2
18416|NCT02031458|89243|P2|Overall Study|Unknown Reason|1
18417|NCT02031458|89244|P1|Overall Study|Unknown Reason|0
18418|NCT02031458|89242|P3|Overall Study|Physician Decision|0
18419|NCT02031458|89243|P2|Overall Study|Physician Decision|1
18420|NCT02031458|89244|P1|Overall Study|Physician Decision|0
18421|NCT02031458|89242|P3|Overall Study|Protocol Violation|0
18422|NCT02031458|89243|P2|Overall Study|Protocol Violation|4
18423|NCT02031458|89244|P1|Overall Study|Protocol Violation|7
18424|NCT02031458|89242|P3|Overall Study|Death|100
18425|NCT02031458|89243|P2|Overall Study|Death|87
18426|NCT02031458|89244|P1|Overall Study|Death|36
18427|NCT02030600|89340|P2|Treatment Period 2|Unclassified|0
18428|NCT02030600|89341|P1|Treatment Period 2|Unclassified|1
18429|NCT02030600|89340|P2|Treatment Period 2|Withdrawal by Subject|9
18430|NCT02030600|89341|P1|Treatment Period 2|Withdrawal by Subject|13
18431|NCT02030600|89340|P2|Treatment Period 2|Protocol Violation|2
18432|NCT02030600|89341|P1|Treatment Period 2|Protocol Violation|1
18433|NCT02030600|89340|P2|Treatment Period 2|Lost to Follow-up|2
18434|NCT02030600|89341|P1|Treatment Period 2|Lost to Follow-up|4
18435|NCT02030600|89340|P2|Treatment Period 2|Lack of Efficacy|1
18436|NCT02030600|89341|P1|Treatment Period 2|Lack of Efficacy|2
18437|NCT02030600|89340|P2|Treatment Period 2|Adverse Event|4
18438|NCT02030600|89341|P1|Treatment Period 2|Adverse Event|4
18439|NCT02030600|89340|P2|Treatment Period 1|Unclassified|0
18440|NCT02030600|89341|P1|Treatment Period 1|Unclassified|1
18441|NCT02030600|89340|P2|Treatment Period 1|Casebook Unsigned|0
18442|NCT02030600|89341|P1|Treatment Period 1|Casebook Unsigned|1
18443|NCT02030600|89340|P2|Treatment Period 1|Withdrawal by Subject|17
18444|NCT02030600|89341|P1|Treatment Period 1|Withdrawal by Subject|13
18445|NCT02030600|89340|P2|Treatment Period 1|Protocol Violation|17
18446|NCT02030600|89341|P1|Treatment Period 1|Protocol Violation|22
18447|NCT02030600|89340|P2|Treatment Period 1|Lost to Follow-up|3
18448|NCT02030600|89341|P1|Treatment Period 1|Lost to Follow-up|11
18449|NCT02030600|89340|P2|Treatment Period 1|Lack of Efficacy|1
18450|NCT02030600|89341|P1|Treatment Period 1|Lack of Efficacy|0
18451|NCT02030600|89340|P2|Treatment Period 1|Adverse Event|7
18452|NCT02030600|89341|P1|Treatment Period 1|Adverse Event|5
18453|NCT02030535|89362|P1|Washout Period 1 (21 Days)|Adverse Event|1
18454|NCT02030405|89430|P1|Overall Study|Lost to Follow-up|1
18455|NCT02030405|89430|P1|Overall Study|Withdrawal by Subject|1
18456|NCT02030119|89439|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
18457|NCT02030119|89440|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
18458|NCT02030119|89441|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
18459|NCT02030119|89442|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
18460|NCT02030119|89439|P4|Overall Study|Withdrawal by Subject|3
18461|NCT02030119|89440|P3|Overall Study|Withdrawal by Subject|5
18462|NCT02030119|89441|P2|Overall Study|Withdrawal by Subject|1
18463|NCT02030119|89442|P1|Overall Study|Withdrawal by Subject|3
18464|NCT02030041|89480|P3|Overall Study|Withdrawal by Subject|1
18465|NCT02030041|89481|P2|Overall Study|Withdrawal by Subject|2
18466|NCT02030041|89482|P1|Overall Study|Withdrawal by Subject|2
18467|NCT02029989|89495|P2|Overall Study|Protocol Violation|0
18468|NCT02029989|89496|P1|Overall Study|Protocol Violation|1
18469|NCT02029989|89495|P2|Overall Study|Death|1
18470|NCT02029989|89496|P1|Overall Study|Death|0
18471|NCT02029989|89495|P2|Overall Study|Lost to Follow-up|7
18472|NCT02029989|89496|P1|Overall Study|Lost to Follow-up|9
18473|NCT02029989|89495|P2|Overall Study|Physician Decision|0
18474|NCT02029989|89496|P1|Overall Study|Physician Decision|2
18475|NCT02029989|89495|P2|Overall Study|Change of location|3
18476|NCT02029989|89496|P1|Overall Study|Change of location|2
18477|NCT02029989|89495|P2|Overall Study|Withdrawal: Fear of needles|0
18478|NCT02029989|89496|P1|Overall Study|Withdrawal: Fear of needles|1
18479|NCT02029989|89495|P2|Overall Study|Withdrawal by Subject|0
18480|NCT02029989|89496|P1|Overall Study|Withdrawal by Subject|1
18481|NCT02029846|89519|P2|Overall Study|n=1 each arm|1
18482|NCT02029846|89520|P1|Overall Study|n=1 each arm|1
18483|NCT02029521|89557|P2|Overall Study|Withdrawal by Subject|1
18484|NCT02029521|89558|P1|Overall Study|Withdrawal by Subject|1
18485|NCT02029521|89557|P2|Overall Study|Protocol Violation|0
18486|NCT02029521|89558|P1|Overall Study|Protocol Violation|1
18487|NCT02029417|89656|P1|Overall Study|Adverse Event|1
18488|NCT02029417|89656|P1|Overall Study|Death|1
18489|NCT02028767|89760|P2|Treatment Period 2|Reason other than those specified above|0
18490|NCT02028767|89761|P1|Treatment Period 2|Reason other than those specified above|1
18491|NCT02028767|89760|P2|Treatment Period 2|Non compliant with protocol|0
18492|NCT02028767|89761|P1|Treatment Period 2|Non compliant with protocol|1
18493|NCT02028169|89986|P1|Overall Study|Concomitant Medication Usage|1
18494|NCT02028169|89986|P1|Overall Study|Cessation of Drug|1
18495|NCT02028169|89986|P1|Overall Study|Adverse Event|1
18496|NCT02028169|89986|P1|Overall Study|Withdrawal by Subject|2
18497|NCT02028169|89986|P1|Overall Study|Lack of Efficacy|2
18498|NCT02028169|89986|P1|Overall Study|Lost to Follow-up|21
18499|NCT02028065|90012|P3|Treatment Through Study Completion|Adverse Event|5
18500|NCT02028065|90013|P2|Treatment Through Study Completion|Adverse Event|3
18501|NCT02028065|90014|P1|Treatment Through Study Completion|Adverse Event|3
18502|NCT02028065|90012|P3|Treatment Through Study Completion|Withdrawal by Subject|3
18503|NCT02028065|90013|P2|Treatment Through Study Completion|Withdrawal by Subject|4
18504|NCT02028065|90014|P1|Treatment Through Study Completion|Withdrawal by Subject|5
18505|NCT02028065|90012|P3|Treatment Through Study Completion|Protocol Violation|0
18506|NCT02028065|90013|P2|Treatment Through Study Completion|Protocol Violation|4
18507|NCT02028065|90014|P1|Treatment Through Study Completion|Protocol Violation|1
18508|NCT02028065|90012|P3|Treatment Through Study Completion|Physician Decision|0
18509|NCT02028065|90013|P2|Treatment Through Study Completion|Physician Decision|0
18510|NCT02028065|90014|P1|Treatment Through Study Completion|Physician Decision|1
18511|NCT02028065|90012|P3|Treatment Through Study Completion|Lost to Follow-up|6
18512|NCT02028065|90013|P2|Treatment Through Study Completion|Lost to Follow-up|4
18513|NCT02028065|90014|P1|Treatment Through Study Completion|Lost to Follow-up|2
18514|NCT02028065|90012|P3|Randomization Through Start Treatment|Not treated|3
18515|NCT02028065|90013|P2|Randomization Through Start Treatment|Not treated|3
18516|NCT02028065|90014|P1|Randomization Through Start Treatment|Not treated|1
18517|NCT02027844|90041|P3|Overall Study|Incomlete data|0
18518|NCT02027844|90042|P2|Overall Study|Incomlete data|0
18519|NCT02027844|90043|P1|Overall Study|Incomlete data|2
18520|NCT02027844|90041|P3|Overall Study|Protocol Violation|0
18521|NCT02027844|90042|P2|Overall Study|Protocol Violation|2
18522|NCT02027844|90043|P1|Overall Study|Protocol Violation|0
18523|NCT02027844|90041|P3|Overall Study|Lost to Follow-up|1
18524|NCT02027844|90042|P2|Overall Study|Lost to Follow-up|2
18525|NCT02027844|90043|P1|Overall Study|Lost to Follow-up|0
18526|NCT02027844|90041|P3|Overall Study|Withdrawal by Subject|1
18527|NCT02027844|90042|P2|Overall Study|Withdrawal by Subject|2
18528|NCT02027844|90043|P1|Overall Study|Withdrawal by Subject|3
18529|NCT02027402|90062|P2|Overall Study|Withdrawal by Subject|1
18530|NCT02027402|90063|P1|Overall Study|Withdrawal by Subject|4
18531|NCT02027311|90077|P2|Overall Study|Protocol Violation|2
18532|NCT02027311|90078|P1|Overall Study|Protocol Violation|3
18533|NCT02026258|90113|P2|Recieved Allocated Intervention|Lost to Follow-up|1
18534|NCT02026258|90114|P1|Recieved Allocated Intervention|Lost to Follow-up|0
18535|NCT02026258|90113|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
18536|NCT02026258|90114|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
18537|NCT02026258|90113|P2|Randomized|Presence of periodontal disease|1
18538|NCT02026258|90114|P1|Randomized|Presence of periodontal disease|1
18539|NCT02026258|90113|P2|Randomized|Change in treatment plan|0
18540|NCT02026258|90114|P1|Randomized|Change in treatment plan|1
18541|NCT02026258|90113|P2|Randomized|Did not start treatment|1
18542|NCT02026258|90114|P1|Randomized|Did not start treatment|2
18543|NCT02026141|90148|P2|Overall Study|Protocol Violation|1
18544|NCT02026141|90149|P1|Overall Study|Protocol Violation|0
18545|NCT02025907|90157|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
18546|NCT02025907|90158|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
18547|NCT02025907|90157|P2|Overall Study|Adverse Event|1
18548|NCT02025907|90158|P1|Overall Study|Adverse Event|3
18549|NCT02025907|90157|P2|Overall Study|Lost to Follow-up|2
18550|NCT02025907|90158|P1|Overall Study|Lost to Follow-up|2
18551|NCT02025907|90157|P2|Overall Study|Physician Decision|0
18552|NCT02025907|90158|P1|Overall Study|Physician Decision|2
18553|NCT02025907|90157|P2|Overall Study|Protocol Violation|0
18554|NCT02025907|90158|P1|Overall Study|Protocol Violation|2
18555|NCT02025907|90157|P2|Overall Study|Withdrawal by Subject|8
18556|NCT02025907|90158|P1|Overall Study|Withdrawal by Subject|15
18557|NCT02025907|90157|P2|Overall Study|Lack of Efficacy|0
18558|NCT02025907|90158|P1|Overall Study|Lack of Efficacy|1
18559|NCT02025621|90215|P2|Overall Study|Reason Not Completed|18
18560|NCT02025621|90216|P1|Overall Study|Reason Not Completed|12
18561|NCT02025621|90215|P2|Overall Study|Lost to Follow-up|1
18562|NCT02025621|90216|P1|Overall Study|Lost to Follow-up|0
18563|NCT02025621|90215|P2|Overall Study|Physician Decision|0
18564|NCT02025621|90216|P1|Overall Study|Physician Decision|1
18565|NCT02025621|90215|P2|Overall Study|Withdrawal by Subject|0
18566|NCT02025621|90216|P1|Overall Study|Withdrawal by Subject|1
18567|NCT02024971|90261|P1|Overall Study|Lost to Follow-up|6
18568|NCT02024971|90261|P1|Overall Study|Data Not Available|30
18569|NCT02024932|90274|P6|Overall Study|Abnormal laboratory value|0
18570|NCT02024932|90275|P5|Overall Study|Abnormal laboratory value|0
18571|NCT02024932|90276|P4|Overall Study|Abnormal laboratory value|2
18572|NCT02024932|90277|P3|Overall Study|Abnormal laboratory value|0
18573|NCT02024932|90278|P2|Overall Study|Abnormal laboratory value|0
18574|NCT02024932|90279|P1|Overall Study|Abnormal laboratory value|0
18575|NCT02024932|90274|P6|Overall Study|Adverse Event|0
18576|NCT02024932|90275|P5|Overall Study|Adverse Event|2
18577|NCT02024932|90276|P4|Overall Study|Adverse Event|0
18578|NCT02024932|90277|P3|Overall Study|Adverse Event|0
18579|NCT02024932|90278|P2|Overall Study|Adverse Event|3
18580|NCT02024932|90279|P1|Overall Study|Adverse Event|2
18581|NCT02024867|90338|P2|Overall Study|Lost to Follow-up|4
18582|NCT02024867|90339|P1|Overall Study|Lost to Follow-up|6
18583|NCT02024867|90338|P2|Overall Study|Protocol Violation|3
18584|NCT02024867|90339|P1|Overall Study|Protocol Violation|3
18585|NCT02024698|90364|P2|First Intervention (7 Days)|Withdrawal by Subject|1
18586|NCT02024698|90365|P1|First Intervention (7 Days)|Withdrawal by Subject|0
18587|NCT02023879|90443|P3|Overall Study|Other than specified above|1
18588|NCT02023879|90444|P2|Overall Study|Other than specified above|3
18589|NCT02023879|90445|P1|Overall Study|Other than specified above|1
18590|NCT02023879|90443|P3|Overall Study|Randomized but not treated|1
18591|NCT02023879|90444|P2|Overall Study|Randomized but not treated|1
18592|NCT02023879|90445|P1|Overall Study|Randomized but not treated|0
18593|NCT02023879|90443|P3|Overall Study|Consent withdrawn by participant|1
18594|NCT02023879|90444|P2|Overall Study|Consent withdrawn by participant|0
18595|NCT02023879|90445|P1|Overall Study|Consent withdrawn by participant|1
18596|NCT02023879|90443|P3|Overall Study|Physician Decision|0
18597|NCT02023879|90444|P2|Overall Study|Physician Decision|1
18598|NCT02023879|90445|P1|Overall Study|Physician Decision|0
18599|NCT02023879|90443|P3|Overall Study|Poor compliance to protocol|1
18600|NCT02023879|90444|P2|Overall Study|Poor compliance to protocol|2
18601|NCT02023879|90445|P1|Overall Study|Poor compliance to protocol|0
18602|NCT02023879|90443|P3|Overall Study|Adverse Event|5
18603|NCT02023879|90444|P2|Overall Study|Adverse Event|2
18604|NCT02023879|90445|P1|Overall Study|Adverse Event|2
18605|NCT02023866|90528|P1|Overall Study|Withdrawal by Subject|1
18606|NCT02023866|90528|P1|Overall Study|Adverse Event|3
18607|NCT02023866|90528|P1|Overall Study|Non-compliance|2
18608|NCT02023268|90560|P2|Overall Study|Withdrawal by Subject|1
18609|NCT02023268|90561|P1|Overall Study|Withdrawal by Subject|0
18610|NCT02023268|90560|P2|Overall Study|Adverse Event|2
18611|NCT02023268|90561|P1|Overall Study|Adverse Event|0
18612|NCT02023268|90560|P2|Overall Study|Lack of Efficacy|1
18613|NCT02023268|90561|P1|Overall Study|Lack of Efficacy|0
18614|NCT02023151|90567|P1|Overall Study|Lost to Follow-up|4
18615|NCT02023112|90637|P2|Overall Study|Withdrawal by Subject|1
18616|NCT02023112|90638|P1|Overall Study|Withdrawal by Subject|2
18617|NCT02023099|90659|P3|Overall Study|Non-treatment-emergent Fatal AE|1
18618|NCT02023099|90660|P2|Overall Study|Non-treatment-emergent Fatal AE|0
18619|NCT02023099|90661|P1|Overall Study|Non-treatment-emergent Fatal AE|0
18620|NCT02023099|90659|P3|Overall Study|Withdrawn Consent|1
18621|NCT02023099|90660|P2|Overall Study|Withdrawn Consent|0
18622|NCT02023099|90661|P1|Overall Study|Withdrawn Consent|3
18623|NCT02023099|90659|P3|Overall Study|Non-fatal Adverse Event (AE)|1
18624|NCT02023099|90660|P2|Overall Study|Non-fatal Adverse Event (AE)|0
18625|NCT02023099|90661|P1|Overall Study|Non-fatal Adverse Event (AE)|0
18626|NCT02022748|90684|P3|Overall Study|Withdrawal by Subject|0
18627|NCT02022748|90685|P2|Overall Study|Withdrawal by Subject|1
18628|NCT02022748|90686|P1|Overall Study|Withdrawal by Subject|0
18629|NCT02022748|90684|P3|Overall Study|Adverse Event|0
18630|NCT02022748|90685|P2|Overall Study|Adverse Event|1
18631|NCT02022748|90686|P1|Overall Study|Adverse Event|1
18632|NCT02022670|90712|P3|Overall Study|Adverse Event|1
18633|NCT02022670|90713|P2|Overall Study|Adverse Event|0
18634|NCT02022670|90714|P1|Overall Study|Adverse Event|1
18635|NCT02022007|90758|P3|Overall Study|Noncompliant|1
18636|NCT02022007|90759|P2|Overall Study|Noncompliant|0
18637|NCT02022007|90760|P1|Overall Study|Noncompliant|0
18638|NCT02022007|90758|P3|Overall Study|Withdrawal by Subject|1
18639|NCT02022007|90759|P2|Overall Study|Withdrawal by Subject|1
18640|NCT02022007|90760|P1|Overall Study|Withdrawal by Subject|1
18641|NCT02021643|90825|P4|Overall Study|Withdrew Consent|0
18642|NCT02021643|90826|P3|Overall Study|Withdrew Consent|0
18643|NCT02021643|90827|P2|Overall Study|Withdrew Consent|1
18644|NCT02021643|90828|P1|Overall Study|Withdrew Consent|0
18645|NCT02021643|90825|P4|Overall Study|Lost to Follow-up|0
18646|NCT02021643|90826|P3|Overall Study|Lost to Follow-up|0
18647|NCT02021643|90827|P2|Overall Study|Lost to Follow-up|1
18648|NCT02021643|90828|P1|Overall Study|Lost to Follow-up|0
18649|NCT02021643|90825|P4|Overall Study|Lack of Efficacy|12
18650|NCT02021643|90826|P3|Overall Study|Lack of Efficacy|0
18651|NCT02021643|90827|P2|Overall Study|Lack of Efficacy|6
18652|NCT02021643|90828|P1|Overall Study|Lack of Efficacy|7
18653|NCT02021643|90825|P4|Overall Study|Investigator's Discretion|0
18654|NCT02021643|90826|P3|Overall Study|Investigator's Discretion|0
18655|NCT02021643|90827|P2|Overall Study|Investigator's Discretion|0
18656|NCT02021643|90828|P1|Overall Study|Investigator's Discretion|1
18657|NCT02021643|90825|P4|Overall Study|Death|0
18658|NCT02021643|90826|P3|Overall Study|Death|0
18659|NCT02021643|90827|P2|Overall Study|Death|1
18660|NCT02021643|90828|P1|Overall Study|Death|0
18661|NCT02021643|90825|P4|Overall Study|Adverse Event|0
18662|NCT02021643|90826|P3|Overall Study|Adverse Event|0
18663|NCT02021643|90827|P2|Overall Study|Adverse Event|1
18664|NCT02021643|90828|P1|Overall Study|Adverse Event|0
18665|NCT02021643|90825|P4|Overall Study|Enrolled but Never Treated|0
18666|NCT02021643|90826|P3|Overall Study|Enrolled but Never Treated|0
18667|NCT02021643|90827|P2|Overall Study|Enrolled but Never Treated|0
18668|NCT02021643|90828|P1|Overall Study|Enrolled but Never Treated|1
18669|NCT02021565|90870|P2|3-month Follow-up|Protocol Violation|2
18670|NCT02021565|90871|P1|3-month Follow-up|Protocol Violation|3
18671|NCT02021565|90870|P2|3-month Follow-up|Withdrawal by Subject|0
18672|NCT02021565|90871|P1|3-month Follow-up|Withdrawal by Subject|4
18673|NCT02021565|90870|P2|3-month Follow-up|Death|0
18674|NCT02021565|90871|P1|3-month Follow-up|Death|3
18675|NCT02021565|90870|P2|Baseline Through Intervention|Lost to Follow-up|2
18676|NCT02021565|90871|P1|Baseline Through Intervention|Lost to Follow-up|4
18677|NCT02021565|90870|P2|Baseline Through Intervention|Protocol Violation|7
18678|NCT02021565|90871|P1|Baseline Through Intervention|Protocol Violation|0
18679|NCT02021565|90870|P2|Baseline Through Intervention|Withdrawal by Subject|8
18680|NCT02021565|90871|P1|Baseline Through Intervention|Withdrawal by Subject|8
18681|NCT02021565|90870|P2|Baseline Through Intervention|Death|1
18682|NCT02021565|90871|P1|Baseline Through Intervention|Death|0
18683|NCT02021331|90891|P2|Overall Study|Adverse Event|2
18684|NCT02021331|90892|P1|Overall Study|Adverse Event|0
18685|NCT02021292|90904|P2|Overall Study|Death|1
18686|NCT02021292|90905|P1|Overall Study|Death|0
18687|NCT02021292|90904|P2|Overall Study|Lost to Follow-up|1
18688|NCT02021292|90905|P1|Overall Study|Lost to Follow-up|0
18689|NCT02021292|90904|P2|Overall Study|Physician Decision|1
18690|NCT02021292|90905|P1|Overall Study|Physician Decision|0
18691|NCT02020941|90927|P1|Overall Study|Disease Progression|4
18692|NCT02020941|90927|P1|Overall Study|Withdrawal by Subject|1
18693|NCT02020941|90927|P1|Overall Study|Physician Decision|2
18694|NCT02020941|90927|P1|Overall Study|Adverse Event|1
18695|NCT02020889|90938|P2|Overall Study|Withdrawal by Subject|2
18696|NCT02020889|90939|P1|Overall Study|Withdrawal by Subject|3
18697|NCT02020889|90938|P2|Overall Study|Physician Decision|0
18698|NCT02020889|90939|P1|Overall Study|Physician Decision|2
18699|NCT02020889|90938|P2|Overall Study|Lost to Follow-up|0
18700|NCT02020889|90939|P1|Overall Study|Lost to Follow-up|1
18701|NCT02020889|90938|P2|Overall Study|Lack of Efficacy|0
18702|NCT02020889|90939|P1|Overall Study|Lack of Efficacy|1
18703|NCT02020889|90938|P2|Overall Study|Adverse Event|1
18704|NCT02020889|90939|P1|Overall Study|Adverse Event|0
18705|NCT02020863|90993|P1|Overall Study|Team chose not to place an a line|1
18706|NCT02020863|90993|P1|Overall Study|Discovery of Metastatic disease|4
18707|NCT02020616|91008|P7|Overall Study|Lack of Efficacy|0
18708|NCT02020616|91009|P6|Overall Study|Lack of Efficacy|0
18709|NCT02020616|91010|P5|Overall Study|Lack of Efficacy|1
18710|NCT02020616|91011|P4|Overall Study|Lack of Efficacy|0
18711|NCT02020616|91012|P3|Overall Study|Lack of Efficacy|0
18712|NCT02020616|91013|P2|Overall Study|Lack of Efficacy|0
18713|NCT02020616|91014|P1|Overall Study|Lack of Efficacy|0
18714|NCT02020616|91008|P7|Overall Study|Randomized in Error|0
18715|NCT02020616|91009|P6|Overall Study|Randomized in Error|0
18716|NCT02020616|91010|P5|Overall Study|Randomized in Error|0
18717|NCT02020616|91011|P4|Overall Study|Randomized in Error|1
18718|NCT02020616|91012|P3|Overall Study|Randomized in Error|0
18719|NCT02020616|91013|P2|Overall Study|Randomized in Error|0
18720|NCT02020616|91014|P1|Overall Study|Randomized in Error|0
18721|NCT02020616|91008|P7|Overall Study|Early Termination Criteria Met|0
18722|NCT02020616|91009|P6|Overall Study|Early Termination Criteria Met|1
18723|NCT02020616|91010|P5|Overall Study|Early Termination Criteria Met|0
18724|NCT02020616|91011|P4|Overall Study|Early Termination Criteria Met|0
18725|NCT02020616|91012|P3|Overall Study|Early Termination Criteria Met|1
18726|NCT02020616|91013|P2|Overall Study|Early Termination Criteria Met|0
18727|NCT02020616|91014|P1|Overall Study|Early Termination Criteria Met|0
18728|NCT02020616|91008|P7|Overall Study|Lost to Follow-up|0
18729|NCT02020616|91009|P6|Overall Study|Lost to Follow-up|1
18730|NCT02020616|91010|P5|Overall Study|Lost to Follow-up|1
18731|NCT02020616|91011|P4|Overall Study|Lost to Follow-up|1
18732|NCT02020616|91012|P3|Overall Study|Lost to Follow-up|0
18733|NCT02020616|91013|P2|Overall Study|Lost to Follow-up|1
18734|NCT02020616|91014|P1|Overall Study|Lost to Follow-up|0
18735|NCT02020616|91008|P7|Overall Study|Withdrawal by Subject|1
18736|NCT02020616|91009|P6|Overall Study|Withdrawal by Subject|1
18737|NCT02020616|91010|P5|Overall Study|Withdrawal by Subject|0
18738|NCT02020616|91011|P4|Overall Study|Withdrawal by Subject|0
18739|NCT02020616|91012|P3|Overall Study|Withdrawal by Subject|1
18740|NCT02020616|91013|P2|Overall Study|Withdrawal by Subject|0
18741|NCT02020616|91014|P1|Overall Study|Withdrawal by Subject|0
18742|NCT02020616|91008|P7|Overall Study|Physician Decision|2
18743|NCT02020616|91009|P6|Overall Study|Physician Decision|1
18744|NCT02020616|91010|P5|Overall Study|Physician Decision|0
18745|NCT02020616|91011|P4|Overall Study|Physician Decision|0
18746|NCT02020616|91012|P3|Overall Study|Physician Decision|0
18747|NCT02020616|91013|P2|Overall Study|Physician Decision|0
18748|NCT02020616|91014|P1|Overall Study|Physician Decision|0
18749|NCT02020616|91008|P7|Overall Study|Adverse Event|1
18750|NCT02020616|91009|P6|Overall Study|Adverse Event|1
18751|NCT02020616|91010|P5|Overall Study|Adverse Event|0
18752|NCT02020616|91011|P4|Overall Study|Adverse Event|0
18753|NCT02020616|91012|P3|Overall Study|Adverse Event|0
18754|NCT02020616|91013|P2|Overall Study|Adverse Event|0
18755|NCT02020616|91014|P1|Overall Study|Adverse Event|0
18756|NCT02020577|91107|P2|Overall Study|Other than stated above|1
18757|NCT02020577|91108|P1|Overall Study|Other than stated above|0
18758|NCT02020577|91107|P2|Overall Study|Withdrawal by Subject|1
18759|NCT02020577|91108|P1|Overall Study|Withdrawal by Subject|0
18760|NCT02020577|91107|P2|Overall Study|Other AE or clinical progression|15
18761|NCT02020577|91108|P1|Overall Study|Other AE or clinical progression|0
18762|NCT02020577|91107|P2|Overall Study|Progressive disease|38
18763|NCT02020577|91108|P1|Overall Study|Progressive disease|3
18764|NCT02020512|91135|P1|Overall Study|Protocol Violation|4
18765|NCT02020512|91135|P1|Overall Study|Lost to Follow-up|3
18766|NCT02020512|91135|P1|Overall Study|Adverse Event|1
18767|NCT02020031|91187|P2|Overall Study|Physician Decision|1
18768|NCT02020031|91188|P1|Overall Study|Physician Decision|1
18769|NCT02019979|91196|P1|Overall Study|study terminated|14
18770|NCT02019719|91207|P5|Overall Study|Physician Decision|0
18771|NCT02019719|91208|P4|Overall Study|Physician Decision|0
18772|NCT02019719|91209|P3|Overall Study|Physician Decision|0
18773|NCT02019719|91210|P2|Overall Study|Physician Decision|0
18774|NCT02019719|91211|P1|Overall Study|Physician Decision|2
18775|NCT02019719|91207|P5|Overall Study|Protocol defined stopping criteria|1
18776|NCT02019719|91208|P4|Overall Study|Protocol defined stopping criteria|1
18777|NCT02019719|91209|P3|Overall Study|Protocol defined stopping criteria|0
18778|NCT02019719|91210|P2|Overall Study|Protocol defined stopping criteria|0
18779|NCT02019719|91211|P1|Overall Study|Protocol defined stopping criteria|2
18780|NCT02019719|91207|P5|Overall Study|Protocol Violation|0
18781|NCT02019719|91208|P4|Overall Study|Protocol Violation|0
18782|NCT02019719|91209|P3|Overall Study|Protocol Violation|0
18783|NCT02019719|91210|P2|Overall Study|Protocol Violation|1
18784|NCT02019719|91211|P1|Overall Study|Protocol Violation|1
18785|NCT02019719|91207|P5|Overall Study|Adverse Event|1
18786|NCT02019719|91208|P4|Overall Study|Adverse Event|1
18787|NCT02019719|91209|P3|Overall Study|Adverse Event|0
18788|NCT02019719|91210|P2|Overall Study|Adverse Event|0
18789|NCT02019719|91211|P1|Overall Study|Adverse Event|1
18790|NCT02019550|91327|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
18791|NCT02019550|91328|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
18792|NCT02019472|91369|P3|Overall Study|Other|6
18793|NCT02019472|91370|P2|Overall Study|Other|8
18794|NCT02019472|91371|P1|Overall Study|Other|3
18795|NCT02019472|91369|P3|Overall Study|Withdrawal by Subject|11
18796|NCT02019472|91370|P2|Overall Study|Withdrawal by Subject|10
18797|NCT02019472|91371|P1|Overall Study|Withdrawal by Subject|11
18798|NCT02019472|91369|P3|Overall Study|Pregnancy|2
18799|NCT02019472|91370|P2|Overall Study|Pregnancy|2
18800|NCT02019472|91371|P1|Overall Study|Pregnancy|1
18801|NCT02019472|91369|P3|Overall Study|Physician Decision|0
18802|NCT02019472|91370|P2|Overall Study|Physician Decision|2
18803|NCT02019472|91371|P1|Overall Study|Physician Decision|1
18804|NCT02019472|91369|P3|Overall Study|Lost to Follow-up|1
18805|NCT02019472|91370|P2|Overall Study|Lost to Follow-up|2
18806|NCT02019472|91371|P1|Overall Study|Lost to Follow-up|0
18807|NCT02019472|91369|P3|Overall Study|Lack of Efficacy|4
18808|NCT02019472|91370|P2|Overall Study|Lack of Efficacy|4
18809|NCT02019472|91371|P1|Overall Study|Lack of Efficacy|7
18810|NCT02019472|91369|P3|Overall Study|Death|1
18811|NCT02019472|91370|P2|Overall Study|Death|1
18812|NCT02019472|91371|P1|Overall Study|Death|0
18813|NCT02019472|91369|P3|Overall Study|Adverse Event|17
18814|NCT02019472|91370|P2|Overall Study|Adverse Event|23
18815|NCT02019472|91371|P1|Overall Study|Adverse Event|14
18816|NCT02018562|91415|P2|Overall Study|Discharged prior to study completion|0
18817|NCT02018562|91416|P1|Overall Study|Discharged prior to study completion|1
18818|NCT02018562|91415|P2|Overall Study|Withdrawal by Subject|0
18819|NCT02018562|91416|P1|Overall Study|Withdrawal by Subject|2
18820|NCT02017015|91456|P1|Overall Study|Physician Decision|2
18821|NCT02017015|91456|P1|Overall Study|Non-compliance with study drug|2
18822|NCT02017015|91456|P1|Overall Study|Progressive Disease|31
18823|NCT02017015|91456|P1|Overall Study|Death|4
18824|NCT02017015|91456|P1|Overall Study|Withdrawal by Subject|21
18825|NCT02017015|91456|P1|Overall Study|Adverse Event|9
18826|NCT02016898|91481|P2|Overall Study|Lost to Follow-up|4
18827|NCT02016898|91482|P1|Overall Study|Lost to Follow-up|4
18828|NCT02016898|91481|P2|Overall Study|Death|1
18829|NCT02016898|91482|P1|Overall Study|Death|1
18830|NCT02016690|91490|P1|Overall Study|Hospitalized for RSV at study start|3
18831|NCT02016690|91490|P1|Overall Study|Did not meet inclusion criteria|13
18832|NCT02016690|91490|P1|Overall Study|Excluded from SAS: Ineligible for study|2
18833|NCT02016690|91490|P1|Overall Study|Excluded from SAS: Early treatment|2
18834|NCT02016690|91490|P1|Overall Study|Excluded from SAS: Duplication|2
18835|NCT02016690|91490|P1|Overall Study|Excluded from SAS: Enrollment violation|2
18836|NCT02016625|91503|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
18837|NCT02016625|91504|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
18838|NCT02016625|91503|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
18839|NCT02016625|91504|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
18840|NCT02016625|91503|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
18841|NCT02016625|91504|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
18842|NCT02016482|91559|P2|Period B|Required Alternative/Prohibited Therapy|2
18843|NCT02016482|91560|P1|Period B|Required Alternative/Prohibited Therapy|0
18844|NCT02016482|91559|P2|Period B|Not Specified|0
18845|NCT02016482|91560|P1|Period B|Not Specified|4
18846|NCT02016482|91559|P2|Period B|Lack of Efficacy|4
18847|NCT02016482|91560|P1|Period B|Lack of Efficacy|6
18848|NCT02016482|91559|P2|Period B|Lost to Follow-up|0
18849|NCT02016482|91560|P1|Period B|Lost to Follow-up|2
18850|NCT02016482|91559|P2|Period B|Withdrawal by Subject|1
18851|NCT02016482|91560|P1|Period B|Withdrawal by Subject|1
18852|NCT02016482|91559|P2|Period A|Required Alternative/Prohibited Therapy|1
18853|NCT02016482|91560|P1|Period A|Required Alternative/Prohibited Therapy|0
18854|NCT02016482|91559|P2|Period A|Protocol Violation|1
18855|NCT02016482|91560|P1|Period A|Protocol Violation|0
18856|NCT02016482|91559|P2|Period A|Not Specified|0
18857|NCT02016482|91560|P1|Period A|Not Specified|3
18858|NCT02016482|91559|P2|Period A|Lack of Efficacy|1
18859|NCT02016482|91560|P1|Period A|Lack of Efficacy|2
18860|NCT02016482|91559|P2|Period A|Lost to Follow-up|3
18861|NCT02016482|91560|P1|Period A|Lost to Follow-up|3
18862|NCT02016482|91559|P2|Period A|Withdrawal by Subject|4
18863|NCT02016482|91560|P1|Period A|Withdrawal by Subject|3
18864|NCT02016482|91559|P2|Period A|Adverse Event|5
18865|NCT02016482|91560|P1|Period A|Adverse Event|3
18866|NCT02016170|91651|P3|Overall Study|Protocol Violation|0
18867|NCT02016170|91652|P2|Overall Study|Protocol Violation|0
18868|NCT02016170|91653|P1|Overall Study|Protocol Violation|1
18869|NCT02016170|91651|P3|Overall Study|Adverse Event|0
18870|NCT02016170|91652|P2|Overall Study|Adverse Event|1
18871|NCT02016170|91653|P1|Overall Study|Adverse Event|1
18872|NCT02016105|91664|P6|EXTENSION PERIOD|Lost to Follow-up|2
18873|NCT02016105|91665|P5|EXTENSION PERIOD|Lost to Follow-up|0
18874|NCT02016105|91666|P4|EXTENSION PERIOD|Lost to Follow-up|0
18875|NCT02016105|91667|P3|EXTENSION PERIOD|Lost to Follow-up|0
18876|NCT02016105|91668|P2|EXTENSION PERIOD|Lost to Follow-up|0
18877|NCT02016105|91669|P1|EXTENSION PERIOD|Lost to Follow-up|0
18878|NCT02016105|91664|P6|EXTENSION PERIOD|Non-compliance with study indication|0
18879|NCT02016105|91665|P5|EXTENSION PERIOD|Non-compliance with study indication|1
18880|NCT02016105|91666|P4|EXTENSION PERIOD|Non-compliance with study indication|0
18881|NCT02016105|91667|P3|EXTENSION PERIOD|Non-compliance with study indication|0
18882|NCT02016105|91668|P2|EXTENSION PERIOD|Non-compliance with study indication|0
18883|NCT02016105|91669|P1|EXTENSION PERIOD|Non-compliance with study indication|0
18884|NCT02016105|91664|P6|EXTENSION PERIOD|Withdrawal by Subject|2
18885|NCT02016105|91665|P5|EXTENSION PERIOD|Withdrawal by Subject|2
18886|NCT02016105|91666|P4|EXTENSION PERIOD|Withdrawal by Subject|2
18887|NCT02016105|91667|P3|EXTENSION PERIOD|Withdrawal by Subject|2
18888|NCT02016105|91668|P2|EXTENSION PERIOD|Withdrawal by Subject|0
18889|NCT02016105|91669|P1|EXTENSION PERIOD|Withdrawal by Subject|0
18890|NCT02016105|91664|P6|EXTENSION PERIOD|Adverse Event|0
18891|NCT02016105|91665|P5|EXTENSION PERIOD|Adverse Event|1
18892|NCT02016105|91666|P4|EXTENSION PERIOD|Adverse Event|0
18893|NCT02016105|91667|P3|EXTENSION PERIOD|Adverse Event|2
18894|NCT02016105|91668|P2|EXTENSION PERIOD|Adverse Event|0
18895|NCT02016105|91669|P1|EXTENSION PERIOD|Adverse Event|0
18896|NCT02016105|91664|P6|EXTENSION PERIOD|Lack of Efficacy|1
18897|NCT02016105|91665|P5|EXTENSION PERIOD|Lack of Efficacy|1
18898|NCT02016105|91666|P4|EXTENSION PERIOD|Lack of Efficacy|3
18899|NCT02016105|91667|P3|EXTENSION PERIOD|Lack of Efficacy|1
18900|NCT02016105|91668|P2|EXTENSION PERIOD|Lack of Efficacy|0
18901|NCT02016105|91669|P1|EXTENSION PERIOD|Lack of Efficacy|0
18902|NCT02016105|91664|P6|EXTENSION PERIOD|New therapy for study indication|1
18903|NCT02016105|91665|P5|EXTENSION PERIOD|New therapy for study indication|1
18904|NCT02016105|91666|P4|EXTENSION PERIOD|New therapy for study indication|0
18905|NCT02016105|91667|P3|EXTENSION PERIOD|New therapy for study indication|0
18906|NCT02016105|91668|P2|EXTENSION PERIOD|New therapy for study indication|0
18907|NCT02016105|91669|P1|EXTENSION PERIOD|New therapy for study indication|0
18908|NCT02016105|91664|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
18909|NCT02016105|91665|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
18910|NCT02016105|91666|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
18911|NCT02016105|91667|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
18912|NCT02016105|91668|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
18913|NCT02016105|91669|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
18914|NCT02016105|91664|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
18915|NCT02016105|91665|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
18916|NCT02016105|91666|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
18917|NCT02016105|91667|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
18918|NCT02016105|91668|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
18919|NCT02016105|91669|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
18920|NCT02016105|91664|P6|TREATMENT PERIOD 2|Adverse Event|1
18921|NCT02016105|91665|P5|TREATMENT PERIOD 2|Adverse Event|0
18922|NCT02016105|91666|P4|TREATMENT PERIOD 2|Adverse Event|4
18923|NCT02016105|91667|P3|TREATMENT PERIOD 2|Adverse Event|0
18924|NCT02016105|91668|P2|TREATMENT PERIOD 2|Adverse Event|0
18925|NCT02016105|91669|P1|TREATMENT PERIOD 2|Adverse Event|0
18926|NCT02016105|91664|P6|TREATMENT PERIOD 2|Death|1
18927|NCT02016105|91665|P5|TREATMENT PERIOD 2|Death|0
18928|NCT02016105|91666|P4|TREATMENT PERIOD 2|Death|0
18929|NCT02016105|91667|P3|TREATMENT PERIOD 2|Death|0
18930|NCT02016105|91668|P2|TREATMENT PERIOD 2|Death|0
18931|NCT02016105|91669|P1|TREATMENT PERIOD 2|Death|0
18932|NCT02016105|91664|P6|TREATMENT PERIOD 2|Pregnancy|1
18933|NCT02016105|91665|P5|TREATMENT PERIOD 2|Pregnancy|0
18934|NCT02016105|91666|P4|TREATMENT PERIOD 2|Pregnancy|0
18935|NCT02016105|91667|P3|TREATMENT PERIOD 2|Pregnancy|0
18936|NCT02016105|91668|P2|TREATMENT PERIOD 2|Pregnancy|0
18937|NCT02016105|91669|P1|TREATMENT PERIOD 2|Pregnancy|0
18938|NCT02016105|91664|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
18939|NCT02016105|91665|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
18940|NCT02016105|91666|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
18941|NCT02016105|91667|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
18942|NCT02016105|91668|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
18943|NCT02016105|91669|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
18944|NCT02016105|91664|P6|TREATMENT PERIOD 2|Non compliance study medication|1
18945|NCT02016105|91665|P5|TREATMENT PERIOD 2|Non compliance study medication|0
18946|NCT02016105|91666|P4|TREATMENT PERIOD 2|Non compliance study medication|0
18947|NCT02016105|91667|P3|TREATMENT PERIOD 2|Non compliance study medication|0
18948|NCT02016105|91668|P2|TREATMENT PERIOD 2|Non compliance study medication|0
18949|NCT02016105|91669|P1|TREATMENT PERIOD 2|Non compliance study medication|0
18950|NCT02016105|91664|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
18951|NCT02016105|91665|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
18952|NCT02016105|91666|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
18953|NCT02016105|91667|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
18954|NCT02016105|91668|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
18955|NCT02016105|91669|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
18956|NCT02016105|91664|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
18957|NCT02016105|91665|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
18958|NCT02016105|91666|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
18959|NCT02016105|91667|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
18960|NCT02016105|91668|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
18961|NCT02016105|91669|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
18962|NCT02016105|91664|P6|TREATMENT PERIOD 1|Adverse Event|0
18963|NCT02016105|91665|P5|TREATMENT PERIOD 1|Adverse Event|0
18964|NCT02016105|91666|P4|TREATMENT PERIOD 1|Adverse Event|0
18965|NCT02016105|91667|P3|TREATMENT PERIOD 1|Adverse Event|0
18966|NCT02016105|91668|P2|TREATMENT PERIOD 1|Adverse Event|5
18967|NCT02016105|91669|P1|TREATMENT PERIOD 1|Adverse Event|3
18968|NCT02016105|91664|P6|TREATMENT PERIOD 1|Pregnancy|0
18969|NCT02016105|91665|P5|TREATMENT PERIOD 1|Pregnancy|0
18970|NCT02016105|91666|P4|TREATMENT PERIOD 1|Pregnancy|0
18971|NCT02016105|91667|P3|TREATMENT PERIOD 1|Pregnancy|0
18972|NCT02016105|91668|P2|TREATMENT PERIOD 1|Pregnancy|1
18973|NCT02016105|91669|P1|TREATMENT PERIOD 1|Pregnancy|0
18974|NCT02016105|91664|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
18975|NCT02016105|91665|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
18976|NCT02016105|91666|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
18977|NCT02016105|91667|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
18978|NCT02016105|91668|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
18979|NCT02016105|91669|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
18980|NCT02016105|91664|P6|TREATMENT PERIOD 1|Physician Decision|0
18981|NCT02016105|91665|P5|TREATMENT PERIOD 1|Physician Decision|0
18982|NCT02016105|91666|P4|TREATMENT PERIOD 1|Physician Decision|0
18983|NCT02016105|91667|P3|TREATMENT PERIOD 1|Physician Decision|0
18984|NCT02016105|91668|P2|TREATMENT PERIOD 1|Physician Decision|2
18985|NCT02016105|91669|P1|TREATMENT PERIOD 1|Physician Decision|0
18986|NCT02016105|91664|P6|TREATMENT PERIOD 1|Protocol Violation|0
18987|NCT02016105|91665|P5|TREATMENT PERIOD 1|Protocol Violation|0
18988|NCT02016105|91666|P4|TREATMENT PERIOD 1|Protocol Violation|0
18989|NCT02016105|91667|P3|TREATMENT PERIOD 1|Protocol Violation|0
18990|NCT02016105|91668|P2|TREATMENT PERIOD 1|Protocol Violation|8
18991|NCT02016105|91669|P1|TREATMENT PERIOD 1|Protocol Violation|2
18992|NCT02015793|91728|P2|Overall Study|Withdrawal by Subject|1
18993|NCT02015793|91729|P1|Overall Study|Withdrawal by Subject|1
18994|NCT02015793|91728|P2|Overall Study|Adverse Event|3
18995|NCT02015793|91729|P1|Overall Study|Adverse Event|3
18996|NCT02015754|91759|P1|Overall Study|Lost to Follow-up|1
18997|NCT02015754|91759|P1|Overall Study|Change in treatment modality|5
18998|NCT02015754|91759|P1|Overall Study|Disease progression|5
18999|NCT02015676|91779|P3|Overall Study|Disease progression|1
19000|NCT02015676|91780|P2|Overall Study|Disease progression|1
19001|NCT02015676|91781|P1|Overall Study|Disease progression|3
19002|NCT02015676|91779|P3|Overall Study|Death|0
19003|NCT02015676|91780|P2|Overall Study|Death|1
19004|NCT02015676|91781|P1|Overall Study|Death|0
19005|NCT02015676|91779|P3|Overall Study|Administrative reasons|1
19006|NCT02015676|91780|P2|Overall Study|Administrative reasons|3
19007|NCT02015676|91781|P1|Overall Study|Administrative reasons|0
19008|NCT02015676|91779|P3|Overall Study|Withdrawal by Subject|1
19009|NCT02015676|91780|P2|Overall Study|Withdrawal by Subject|7
19010|NCT02015676|91781|P1|Overall Study|Withdrawal by Subject|1
19011|NCT02015676|91779|P3|Overall Study|Protocol Violation|0
19012|NCT02015676|91780|P2|Overall Study|Protocol Violation|0
19013|NCT02015676|91781|P1|Overall Study|Protocol Violation|1
19014|NCT02015676|91779|P3|Overall Study|Lack of Efficacy|0
19015|NCT02015676|91780|P2|Overall Study|Lack of Efficacy|4
19016|NCT02015676|91781|P1|Overall Study|Lack of Efficacy|2
19017|NCT02015676|91779|P3|Overall Study|Adverse Event|0
19018|NCT02015676|91780|P2|Overall Study|Adverse Event|18
19019|NCT02015676|91781|P1|Overall Study|Adverse Event|2
19020|NCT02015663|91797|P2|Overall Study|Administrative problems|11
19021|NCT02015663|91798|P1|Overall Study|Administrative problems|10
19022|NCT02015663|91797|P2|Overall Study|Adverse Event|0
19023|NCT02015663|91798|P1|Overall Study|Adverse Event|3
19024|NCT02015663|91797|P2|Overall Study|Protocol Violation|1
19025|NCT02015663|91798|P1|Overall Study|Protocol Violation|0
19026|NCT02015663|91797|P2|Overall Study|Withdrawal by Subject|0
19027|NCT02015663|91798|P1|Overall Study|Withdrawal by Subject|1
19028|NCT02015663|91797|P2|Overall Study|unsatisfactory therapeutic effect|0
19029|NCT02015663|91798|P1|Overall Study|unsatisfactory therapeutic effect|1
19030|NCT02015637|91829|P2|Overall Study|Did not take study drug|0
19031|NCT02015637|91830|P1|Overall Study|Did not take study drug|2
19032|NCT02015637|91829|P2|Overall Study|Adverse Event|0
19033|NCT02015637|91830|P1|Overall Study|Adverse Event|3
19034|NCT02015637|91829|P2|Overall Study|Lost to Follow-up|5
19035|NCT02015637|91830|P1|Overall Study|Lost to Follow-up|3
19036|NCT02015546|91841|P3|Overall Study|Screem Failure|3
19037|NCT02015546|91842|P2|Overall Study|Screem Failure|1
19038|NCT02015546|91843|P1|Overall Study|Screem Failure|2
19039|NCT02015546|91841|P3|Overall Study|Withdrawal by Subject|1
19040|NCT02015546|91842|P2|Overall Study|Withdrawal by Subject|1
19041|NCT02015546|91843|P1|Overall Study|Withdrawal by Subject|1
19042|NCT02015481|91875|P1|Overall Study|Death|1
19043|NCT02015221|91899|P2|Overall Study|Lost to Follow-up|0
19044|NCT02015221|91900|P1|Overall Study|Lost to Follow-up|1
19045|NCT02015221|91899|P2|Overall Study|Withdrawal by Subject|6
19046|NCT02015221|91900|P1|Overall Study|Withdrawal by Subject|8
19047|NCT02015195|91913|P7|Overall Study|Adverse Event|0
19048|NCT02015195|91914|P6|Overall Study|Adverse Event|0
19049|NCT02015195|91915|P5|Overall Study|Adverse Event|0
19050|NCT02015195|91916|P4|Overall Study|Adverse Event|1
19051|NCT02015195|91917|P3|Overall Study|Adverse Event|0
19052|NCT02015195|91918|P2|Overall Study|Adverse Event|0
19053|NCT02015195|91919|P1|Overall Study|Adverse Event|0
19054|NCT02015039|91942|P2|Overall Study|Not eligible|1
19055|NCT02015039|91943|P1|Overall Study|Not eligible|0
19056|NCT02014740|91963|P2|Overall Study|Withdrawal by Subject|1
19057|NCT02014740|91964|P1|Overall Study|Withdrawal by Subject|2
19058|NCT02014740|91963|P2|Overall Study|Lost to Follow-up|4
19059|NCT02014740|91964|P1|Overall Study|Lost to Follow-up|4
19060|NCT02014584|91972|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
19061|NCT02014584|91973|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
19062|NCT02014584|91974|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
19063|NCT02014584|91975|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
19064|NCT02014584|91976|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
19065|NCT02014584|91977|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
19066|NCT02014584|91972|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
19067|NCT02014584|91973|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
19068|NCT02014584|91974|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
19069|NCT02014584|91975|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
19070|NCT02014584|91976|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
19071|NCT02014584|91977|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
19072|NCT02014584|91972|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
19073|NCT02014584|91973|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
19074|NCT02014584|91974|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
19075|NCT02014584|91975|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
19076|NCT02014584|91976|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
19077|NCT02014584|91977|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
19078|NCT02014584|91972|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
19079|NCT02014584|91973|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
19080|NCT02014584|91974|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
19081|NCT02014584|91975|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
19082|NCT02014584|91976|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
19083|NCT02014584|91977|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
19084|NCT02014584|91972|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
19085|NCT02014584|91973|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
19086|NCT02014584|91974|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
19087|NCT02014584|91975|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
19088|NCT02014584|91976|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
19089|NCT02014584|91977|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
19090|NCT02014480|92094|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
19091|NCT02014480|92095|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
19092|NCT02014480|92096|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
19093|NCT02014480|92097|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
19094|NCT02014480|92098|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
19095|NCT02014480|92099|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
19096|NCT02014480|92094|P6|Treatment Period 3 (14 Days)|Adverse Event|1
19097|NCT02014480|92095|P5|Treatment Period 3 (14 Days)|Adverse Event|0
19098|NCT02014480|92096|P4|Treatment Period 3 (14 Days)|Adverse Event|0
19099|NCT02014480|92097|P3|Treatment Period 3 (14 Days)|Adverse Event|1
19100|NCT02014480|92098|P2|Treatment Period 3 (14 Days)|Adverse Event|0
19101|NCT02014480|92099|P1|Treatment Period 3 (14 Days)|Adverse Event|0
19102|NCT02014480|92094|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
19103|NCT02014480|92095|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
19104|NCT02014480|92096|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
19105|NCT02014480|92097|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
19106|NCT02014480|92098|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
19107|NCT02014480|92099|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
19108|NCT02014480|92094|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
19109|NCT02014480|92095|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
19110|NCT02014480|92096|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
19111|NCT02014480|92097|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
19112|NCT02014480|92098|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
19113|NCT02014480|92099|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
19114|NCT02014480|92094|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
19115|NCT02014480|92095|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
19116|NCT02014480|92096|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
19117|NCT02014480|92097|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
19118|NCT02014480|92098|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
19119|NCT02014480|92099|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
19120|NCT02014480|92094|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
19121|NCT02014480|92095|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
19122|NCT02014480|92096|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
19123|NCT02014480|92097|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
19124|NCT02014480|92098|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
19125|NCT02014480|92099|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
19126|NCT02014480|92094|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
19127|NCT02014480|92095|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
19128|NCT02014480|92096|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
19129|NCT02014480|92097|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
19130|NCT02014480|92098|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
19131|NCT02014480|92099|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
19132|NCT02014467|92118|P2|Overall Study|Withdrawal by Subject|4
19133|NCT02014467|92119|P1|Overall Study|Withdrawal by Subject|16
19134|NCT02014467|92118|P2|Overall Study|Physician Decision|3
19135|NCT02014467|92119|P1|Overall Study|Physician Decision|2
19136|NCT02014467|92118|P2|Overall Study|Protocol Violation|0
19137|NCT02014467|92119|P1|Overall Study|Protocol Violation|3
19138|NCT02014467|92118|P2|Overall Study|Adverse Event|0
19139|NCT02014467|92119|P1|Overall Study|Adverse Event|4
19140|NCT02014441|92179|P1|Overall Study|Continuing in Study|21
19141|NCT02014441|92179|P1|Overall Study|Withdrawal by Subject|9
19142|NCT02014402|92275|P4|Overall Study|Lost to Follow-up|2
19143|NCT02014402|92276|P3|Overall Study|Lost to Follow-up|1
19144|NCT02014402|92277|P2|Overall Study|Lost to Follow-up|0
19145|NCT02014402|92278|P1|Overall Study|Lost to Follow-up|0
19146|NCT02014402|92275|P4|Overall Study|Subject did not have transportation|0
19147|NCT02014402|92276|P3|Overall Study|Subject did not have transportation|0
19148|NCT02014402|92277|P2|Overall Study|Subject did not have transportation|1
19149|NCT02014402|92278|P1|Overall Study|Subject did not have transportation|0
19150|NCT02014402|92275|P4|Overall Study|Withdrawal by Subject|1
19151|NCT02014402|92276|P3|Overall Study|Withdrawal by Subject|2
19152|NCT02014402|92277|P2|Overall Study|Withdrawal by Subject|2
19153|NCT02014402|92278|P1|Overall Study|Withdrawal by Subject|1
19154|NCT02014402|92275|P4|Overall Study|Adverse Event|0
19155|NCT02014402|92276|P3|Overall Study|Adverse Event|0
19156|NCT02014402|92277|P2|Overall Study|Adverse Event|0
19157|NCT02014402|92278|P1|Overall Study|Adverse Event|1
19158|NCT02014272|92318|P2|Intervention Period 1|Adverse Event|1
19159|NCT02014272|92319|P1|Intervention Period 1|Adverse Event|0
19160|NCT02014272|92318|P2|Intervention Period 1|Withdrawal by Subject|0
19161|NCT02014272|92319|P1|Intervention Period 1|Withdrawal by Subject|1
19162|NCT02013830|92351|P1|Overall Study|Refused treatment|1
19163|NCT02013830|92351|P1|Overall Study|Insufficient therapeutic response|25
19164|NCT02013830|92351|P1|Overall Study|Death|1
19165|NCT02013830|92351|P1|Overall Study|Adverse Event|3
19166|NCT02013817|92362|P1|Overall Study|Not specified|9
19167|NCT02013817|92362|P1|Overall Study|Death|2
19168|NCT02013817|92362|P1|Overall Study|Withdrawal by Subject|4
19169|NCT02013817|92362|P1|Overall Study|Adverse Event|12
19170|NCT02013791|92380|P9|Period 1|Other Miscellaneous Reasons|0
19171|NCT02013791|92381|P8|Period 1|Other Miscellaneous Reasons|0
19172|NCT02013791|92382|P7|Period 1|Other Miscellaneous Reasons|0
19173|NCT02013791|92383|P6|Period 1|Other Miscellaneous Reasons|0
19174|NCT02013791|92384|P5|Period 1|Other Miscellaneous Reasons|0
19175|NCT02013791|92385|P4|Period 1|Other Miscellaneous Reasons|0
19176|NCT02013791|92386|P3|Period 1|Other Miscellaneous Reasons|0
19177|NCT02013791|92387|P2|Period 1|Other Miscellaneous Reasons|2
19178|NCT02013791|92388|P1|Period 1|Other Miscellaneous Reasons|0
19179|NCT02013791|92380|P9|Period 1|Lost to Follow-up|0
19180|NCT02013791|92381|P8|Period 1|Lost to Follow-up|1
19181|NCT02013791|92382|P7|Period 1|Lost to Follow-up|1
19182|NCT02013791|92383|P6|Period 1|Lost to Follow-up|0
19183|NCT02013791|92384|P5|Period 1|Lost to Follow-up|0
19184|NCT02013791|92385|P4|Period 1|Lost to Follow-up|1
19185|NCT02013791|92386|P3|Period 1|Lost to Follow-up|0
19186|NCT02013791|92387|P2|Period 1|Lost to Follow-up|0
19187|NCT02013791|92388|P1|Period 1|Lost to Follow-up|0
19188|NCT02013765|92409|P1|Overall Study|Trial was terminated by sponsor|1
19189|NCT02013687|92423|P4|Overall Study|Missed visits due to patient travel|0
19190|NCT02013687|92424|P3|Overall Study|Missed visits due to patient travel|1
19191|NCT02013687|92425|P2|Overall Study|Missed visits due to patient travel|0
19192|NCT02013687|92426|P1|Overall Study|Missed visits due to patient travel|0
19193|NCT02013687|92423|P4|Overall Study|Withdrawal by Subject|1
19194|NCT02013687|92424|P3|Overall Study|Withdrawal by Subject|0
19195|NCT02013687|92425|P2|Overall Study|Withdrawal by Subject|0
19196|NCT02013687|92426|P1|Overall Study|Withdrawal by Subject|0
19197|NCT02013687|92423|P4|Overall Study|Protocol Violation|1
19198|NCT02013687|92424|P3|Overall Study|Protocol Violation|0
19199|NCT02013687|92425|P2|Overall Study|Protocol Violation|0
19200|NCT02013687|92426|P1|Overall Study|Protocol Violation|0
19201|NCT02013687|92423|P4|Overall Study|Lost to Follow-up|0
19202|NCT02013687|92424|P3|Overall Study|Lost to Follow-up|1
19203|NCT02013687|92425|P2|Overall Study|Lost to Follow-up|0
19204|NCT02013687|92426|P1|Overall Study|Lost to Follow-up|0
19205|NCT02013622|92456|P1|Overall Study|Lack of Efficacy|1
19206|NCT02013622|92456|P1|Overall Study|Protocol Deviation|1
19207|NCT02013622|92456|P1|Overall Study|Withdrawal by Subject|6
19208|NCT02013622|92456|P1|Overall Study|Met Withdrawal Criteria|3
19209|NCT02013622|92456|P1|Overall Study|Adverse Event|3
19210|NCT02013622|92456|P1|Overall Study|Lost to Follow-up|10
19211|NCT02013609|92476|P1|Overall Study|Met Withdrawal Criteria|3
19212|NCT02013609|92476|P1|Overall Study|Adverse Event|3
19213|NCT02013609|92476|P1|Overall Study|Lost to Follow-up|3
19214|NCT02013609|92476|P1|Overall Study|Withdrawal by Subject|9
19215|NCT02013544|92501|P2|Overall Study|Entry criteria not met/non-compliance|3
19216|NCT02013544|92502|P1|Overall Study|Entry criteria not met/non-compliance|2
19217|NCT02013544|92501|P2|Overall Study|Physician Decision|1
19218|NCT02013544|92502|P1|Overall Study|Physician Decision|0
19219|NCT02013544|92501|P2|Overall Study|Withdrawal by Subject|8
19220|NCT02013544|92502|P1|Overall Study|Withdrawal by Subject|2
19221|NCT02013544|92501|P2|Overall Study|Lost to Follow-up|3
19222|NCT02013544|92502|P1|Overall Study|Lost to Follow-up|2
19223|NCT02013544|92501|P2|Overall Study|Adverse Event|5
19224|NCT02013544|92502|P1|Overall Study|Adverse Event|5
19225|NCT02013531|92524|P1|Overall Study|Withdrawal by Subject|1
19226|NCT02013531|92524|P1|Overall Study|Met Withdrawal Criteria|1
19227|NCT02013531|92524|P1|Overall Study|Lost to Follow-up|3
19228|NCT02013388|92554|P8|Overall Study|work emergency|0
19229|NCT02013388|92555|P7|Overall Study|work emergency|0
19230|NCT02013388|92556|P6|Overall Study|work emergency|0
19231|NCT02013388|92557|P5|Overall Study|work emergency|1
19232|NCT02013388|92558|P4|Overall Study|work emergency|0
19233|NCT02013388|92559|P3|Overall Study|work emergency|0
19234|NCT02013388|92560|P2|Overall Study|work emergency|0
19235|NCT02013388|92561|P1|Overall Study|work emergency|1
19236|NCT02013206|92618|P2|Overall Study|Other reasons off treatment|2
19237|NCT02013206|92619|P1|Overall Study|Other reasons off treatment|5
19238|NCT02013206|92618|P2|Overall Study|Death|2
19239|NCT02013206|92619|P1|Overall Study|Death|1
19240|NCT02013206|92618|P2|Overall Study|Patient non-compliance|0
19241|NCT02013206|92619|P1|Overall Study|Patient non-compliance|1
19242|NCT02013206|92618|P2|Overall Study|Patient refusal|0
19243|NCT02013206|92619|P1|Overall Study|Patient refusal|2
19244|NCT02013206|92618|P2|Overall Study|Adverse Event|0
19245|NCT02013206|92619|P1|Overall Study|Adverse Event|1
19246|NCT02013206|92618|P2|Overall Study|Symptomatic deterioration|1
19247|NCT02013206|92619|P1|Overall Study|Symptomatic deterioration|3
19248|NCT02013206|92618|P2|Overall Study|Progressive disease (PD)|17
19249|NCT02013206|92619|P1|Overall Study|Progressive disease (PD)|14
19250|NCT02013167|92641|P2|Overall Study|Death|160
19251|NCT02013167|92642|P1|Overall Study|Death|85
19252|NCT02013167|92641|P2|Overall Study|Lost to Follow-up|1
19253|NCT02013167|92642|P1|Overall Study|Lost to Follow-up|0
19254|NCT02013167|92641|P2|Overall Study|Sponsor Decision|3
19255|NCT02013167|92642|P1|Overall Study|Sponsor Decision|1
19256|NCT02013167|92641|P2|Overall Study|Withdrawal by Subject|14
19257|NCT02013167|92642|P1|Overall Study|Withdrawal by Subject|15
19258|NCT02012686|92720|P2|Overall Study|electrocardiography monitoring noise|1
19259|NCT02012686|92721|P1|Overall Study|electrocardiography monitoring noise|0
19260|NCT02012686|92720|P2|Overall Study|muscle contraction|1
19261|NCT02012686|92721|P1|Overall Study|muscle contraction|0
19262|NCT02012452|92768|P2|Overall Study|Withdrawal by Subject|0
19263|NCT02012452|92769|P1|Overall Study|Withdrawal by Subject|4
19264|NCT02012452|92768|P2|Overall Study|Lost to Follow-up|1
19265|NCT02012452|92769|P1|Overall Study|Lost to Follow-up|2
19266|NCT02012218|92782|P5|Overall Study|Protocol Deviation|0
19267|NCT02012218|92783|P4|Overall Study|Protocol Deviation|0
19268|NCT02012218|92784|P3|Overall Study|Protocol Deviation|0
19269|NCT02012218|92785|P2|Overall Study|Protocol Deviation|0
19270|NCT02012218|92786|P1|Overall Study|Protocol Deviation|1
19271|NCT02012218|92782|P5|Overall Study|Protocol Specified|0
19272|NCT02012218|92783|P4|Overall Study|Protocol Specified|0
19273|NCT02012218|92784|P3|Overall Study|Protocol Specified|0
19274|NCT02012218|92785|P2|Overall Study|Protocol Specified|0
19275|NCT02012218|92786|P1|Overall Study|Protocol Specified|1
19276|NCT02012218|92782|P5|Overall Study|Lost to Follow-up|0
19277|NCT02012218|92783|P4|Overall Study|Lost to Follow-up|0
19278|NCT02012218|92784|P3|Overall Study|Lost to Follow-up|1
19279|NCT02012218|92785|P2|Overall Study|Lost to Follow-up|1
19280|NCT02012218|92786|P1|Overall Study|Lost to Follow-up|0
19281|NCT02012218|92782|P5|Overall Study|Adverse Event|0
19282|NCT02012218|92783|P4|Overall Study|Adverse Event|1
19283|NCT02012218|92784|P3|Overall Study|Adverse Event|0
19284|NCT02012218|92785|P2|Overall Study|Adverse Event|0
19285|NCT02012218|92786|P1|Overall Study|Adverse Event|1
19286|NCT02012218|92782|P5|Overall Study|Withdrawal by Subject|1
19287|NCT02012218|92783|P4|Overall Study|Withdrawal by Subject|1
19288|NCT02012218|92784|P3|Overall Study|Withdrawal by Subject|1
19289|NCT02012218|92785|P2|Overall Study|Withdrawal by Subject|0
19290|NCT02012218|92786|P1|Overall Study|Withdrawal by Subject|1
19291|NCT02011893|92798|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
19292|NCT02011893|92799|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
19293|NCT02011893|92800|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
19294|NCT02011893|92798|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
19295|NCT02011893|92799|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
19296|NCT02011893|92800|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
19297|NCT02011893|92798|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
19298|NCT02011893|92799|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
19299|NCT02011893|92800|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
19300|NCT02011893|92798|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
19301|NCT02011893|92799|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
19302|NCT02011893|92800|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
19303|NCT02011893|92798|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
19304|NCT02011893|92799|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
19305|NCT02011893|92800|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
19306|NCT02011893|92798|P3|Enrollment to Randomization|Screening Failure|0
19307|NCT02011893|92799|P2|Enrollment to Randomization|Screening Failure|0
19308|NCT02011893|92800|P1|Enrollment to Randomization|Screening Failure|29
19309|NCT02011893|92798|P3|Enrollment to Randomization|Withdrawal by Subject|0
19310|NCT02011893|92799|P2|Enrollment to Randomization|Withdrawal by Subject|0
19311|NCT02011893|92800|P1|Enrollment to Randomization|Withdrawal by Subject|21
19312|NCT02011893|92798|P3|Enrollment to Randomization|Physician Decision|0
19313|NCT02011893|92799|P2|Enrollment to Randomization|Physician Decision|0
19314|NCT02011893|92800|P1|Enrollment to Randomization|Physician Decision|10
19315|NCT02011893|92798|P3|Enrollment to Randomization|Adverse Event|0
19316|NCT02011893|92799|P2|Enrollment to Randomization|Adverse Event|0
19317|NCT02011893|92800|P1|Enrollment to Randomization|Adverse Event|2
19318|NCT02011542|92811|P1|Overall Study|Physician Decision|1
19319|NCT02011113|92942|P1|Overall Study|Study terminated by sponsor|11
19320|NCT02011113|92942|P1|Overall Study|Investigator's judgement- DP|3
19321|NCT02011113|92942|P1|Overall Study|Insufficient effect of Pomalidomide|1
19322|NCT02011113|92942|P1|Overall Study|Death|1
19323|NCT02011113|92942|P1|Overall Study|Disease Progression (DP)|16
19324|NCT02011113|92942|P1|Overall Study|Adverse Event|4
19325|NCT02010684|92971|P2|Overall Study|Withdrawal by Subject|5
19326|NCT02010684|92972|P1|Overall Study|Withdrawal by Subject|4
19327|NCT02010684|92971|P2|Overall Study|Lost to Follow-up|18
19328|NCT02010684|92972|P1|Overall Study|Lost to Follow-up|8
19329|NCT02010632|92990|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
19330|NCT02010632|92991|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
19331|NCT02010567|93002|P5|Overall Study|Adverse Event|1
19332|NCT02010567|93003|P4|Overall Study|Adverse Event|0
19333|NCT02010567|93004|P3|Overall Study|Adverse Event|1
19334|NCT02010567|93005|P2|Overall Study|Adverse Event|0
19335|NCT02010567|93006|P1|Overall Study|Adverse Event|0
19336|NCT02010255|93031|P14|Overall Study|Randomized but Not Treated|1
19337|NCT02010255|93032|P13|Overall Study|Randomized but Not Treated|0
19338|NCT02010255|93033|P12|Overall Study|Randomized but Not Treated|0
19339|NCT02010255|93034|P11|Overall Study|Randomized but Not Treated|0
19340|NCT02010255|93035|P10|Overall Study|Randomized but Not Treated|0
19341|NCT02010255|93036|P9|Overall Study|Randomized but Not Treated|0
19342|NCT02010255|93037|P8|Overall Study|Randomized but Not Treated|0
19343|NCT02010255|93038|P7|Overall Study|Randomized but Not Treated|0
19344|NCT02010255|93039|P6|Overall Study|Randomized but Not Treated|0
19345|NCT02010255|93040|P5|Overall Study|Randomized but Not Treated|0
19346|NCT02010255|93041|P4|Overall Study|Randomized but Not Treated|0
19347|NCT02010255|93042|P3|Overall Study|Randomized but Not Treated|0
19348|NCT02010255|93043|P2|Overall Study|Randomized but Not Treated|0
19349|NCT02010255|93044|P1|Overall Study|Randomized but Not Treated|0
19350|NCT02010255|93031|P14|Overall Study|Lost to Follow-up|0
19351|NCT02010255|93032|P13|Overall Study|Lost to Follow-up|0
19352|NCT02010255|93033|P12|Overall Study|Lost to Follow-up|0
19353|NCT02010255|93034|P11|Overall Study|Lost to Follow-up|0
19354|NCT02010255|93035|P10|Overall Study|Lost to Follow-up|0
19355|NCT02010255|93036|P9|Overall Study|Lost to Follow-up|0
19356|NCT02010255|93037|P8|Overall Study|Lost to Follow-up|0
19357|NCT02010255|93038|P7|Overall Study|Lost to Follow-up|0
19358|NCT02010255|93039|P6|Overall Study|Lost to Follow-up|0
19359|NCT02010255|93040|P5|Overall Study|Lost to Follow-up|1
19360|NCT02010255|93041|P4|Overall Study|Lost to Follow-up|0
19361|NCT02010255|93042|P3|Overall Study|Lost to Follow-up|1
19362|NCT02010255|93043|P2|Overall Study|Lost to Follow-up|0
19363|NCT02010255|93044|P1|Overall Study|Lost to Follow-up|0
19364|NCT02010255|93031|P14|Overall Study|Adverse Event|0
19365|NCT02010255|93032|P13|Overall Study|Adverse Event|0
19366|NCT02010255|93033|P12|Overall Study|Adverse Event|0
19367|NCT02010255|93034|P11|Overall Study|Adverse Event|0
19368|NCT02010255|93035|P10|Overall Study|Adverse Event|0
19369|NCT02010255|93036|P9|Overall Study|Adverse Event|0
19370|NCT02010255|93037|P8|Overall Study|Adverse Event|0
19371|NCT02010255|93038|P7|Overall Study|Adverse Event|0
19372|NCT02010255|93039|P6|Overall Study|Adverse Event|0
19373|NCT02010255|93040|P5|Overall Study|Adverse Event|0
19374|NCT02010255|93041|P4|Overall Study|Adverse Event|0
19375|NCT02010255|93042|P3|Overall Study|Adverse Event|0
19376|NCT02010255|93043|P2|Overall Study|Adverse Event|0
19377|NCT02010255|93044|P1|Overall Study|Adverse Event|1
19378|NCT02010255|93031|P14|Overall Study|Withdrew Consent|0
19379|NCT02010255|93032|P13|Overall Study|Withdrew Consent|0
19380|NCT02010255|93033|P12|Overall Study|Withdrew Consent|0
19381|NCT02010255|93034|P11|Overall Study|Withdrew Consent|0
19382|NCT02010255|93035|P10|Overall Study|Withdrew Consent|0
19383|NCT02010255|93036|P9|Overall Study|Withdrew Consent|0
19384|NCT02010255|93037|P8|Overall Study|Withdrew Consent|0
19385|NCT02010255|93038|P7|Overall Study|Withdrew Consent|0
19386|NCT02010255|93039|P6|Overall Study|Withdrew Consent|0
19387|NCT02010255|93040|P5|Overall Study|Withdrew Consent|0
19388|NCT02010255|93041|P4|Overall Study|Withdrew Consent|1
19389|NCT02010255|93042|P3|Overall Study|Withdrew Consent|0
19390|NCT02010255|93043|P2|Overall Study|Withdrew Consent|0
19391|NCT02010255|93044|P1|Overall Study|Withdrew Consent|1
19392|NCT02010255|93031|P14|Overall Study|Lack of Efficacy|0
19393|NCT02010255|93032|P13|Overall Study|Lack of Efficacy|0
19394|NCT02010255|93033|P12|Overall Study|Lack of Efficacy|0
19395|NCT02010255|93034|P11|Overall Study|Lack of Efficacy|1
19396|NCT02010255|93035|P10|Overall Study|Lack of Efficacy|0
19397|NCT02010255|93036|P9|Overall Study|Lack of Efficacy|0
19398|NCT02010255|93037|P8|Overall Study|Lack of Efficacy|0
19399|NCT02010255|93038|P7|Overall Study|Lack of Efficacy|0
19400|NCT02010255|93039|P6|Overall Study|Lack of Efficacy|0
19401|NCT02010255|93040|P5|Overall Study|Lack of Efficacy|1
19402|NCT02010255|93041|P4|Overall Study|Lack of Efficacy|1
19403|NCT02010255|93042|P3|Overall Study|Lack of Efficacy|2
19404|NCT02010255|93043|P2|Overall Study|Lack of Efficacy|1
19405|NCT02010255|93044|P1|Overall Study|Lack of Efficacy|4
19406|NCT02010255|93031|P14|Overall Study|Death|0
19407|NCT02010255|93032|P13|Overall Study|Death|0
19408|NCT02010255|93033|P12|Overall Study|Death|1
19409|NCT02010255|93034|P11|Overall Study|Death|1
19410|NCT02010255|93035|P10|Overall Study|Death|0
19411|NCT02010255|93036|P9|Overall Study|Death|1
19412|NCT02010255|93037|P8|Overall Study|Death|1
19413|NCT02010255|93038|P7|Overall Study|Death|1
19414|NCT02010255|93039|P6|Overall Study|Death|0
19415|NCT02010255|93040|P5|Overall Study|Death|2
19416|NCT02010255|93041|P4|Overall Study|Death|4
19417|NCT02010255|93042|P3|Overall Study|Death|4
19418|NCT02010255|93043|P2|Overall Study|Death|1
19419|NCT02010255|93044|P1|Overall Study|Death|0
19420|NCT02009878|93388|P3|Overall Study|Participant Met Withdrawal Criteria|0
19421|NCT02009878|93389|P2|Overall Study|Participant Met Withdrawal Criteria|1
19422|NCT02009878|93390|P1|Overall Study|Participant Met Withdrawal Criteria|0
19423|NCT02009865|93424|P2|Overall Study|Withdrawal by Subject|1
19424|NCT02009865|93425|P1|Overall Study|Withdrawal by Subject|1
19425|NCT02009865|93424|P2|Overall Study|Protocol Violation|2
19426|NCT02009865|93425|P1|Overall Study|Protocol Violation|0
19427|NCT02009865|93424|P2|Overall Study|Adverse Event|2
19428|NCT02009865|93425|P1|Overall Study|Adverse Event|0
19429|NCT02009722|93441|P2|Overall Study|Did not receive intervention|1
19430|NCT02009722|93442|P1|Overall Study|Did not receive intervention|0
19431|NCT02009722|93441|P2|Overall Study|Protocol Violation|2
19432|NCT02009722|93442|P1|Overall Study|Protocol Violation|1
19433|NCT02009696|93466|P1|Overall Study|Withdrawal by Subject|2
19434|NCT02009163|93474|P3|Randomized-withdrawal Period|Not specified|5
19435|NCT02009163|93475|P2|Randomized-withdrawal Period|Not specified|9
19436|NCT02009163|93476|P1|Randomized-withdrawal Period|Not specified|0
19437|NCT02009163|93474|P3|Randomized-withdrawal Period|Pregnancy|2
19438|NCT02009163|93475|P2|Randomized-withdrawal Period|Pregnancy|0
19439|NCT02009163|93476|P1|Randomized-withdrawal Period|Pregnancy|0
19440|NCT02009163|93474|P3|Randomized-withdrawal Period|Protocol Violation|2
19441|NCT02009163|93475|P2|Randomized-withdrawal Period|Protocol Violation|1
19442|NCT02009163|93476|P1|Randomized-withdrawal Period|Protocol Violation|0
19443|NCT02009163|93474|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
19444|NCT02009163|93475|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
19445|NCT02009163|93476|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
19446|NCT02009163|93474|P3|Randomized-withdrawal Period|Adverse Event|6
19447|NCT02009163|93475|P2|Randomized-withdrawal Period|Adverse Event|0
19448|NCT02009163|93476|P1|Randomized-withdrawal Period|Adverse Event|0
19449|NCT02009163|93474|P3|Randomized-withdrawal Period|Lost to Follow-up|6
19450|NCT02009163|93475|P2|Randomized-withdrawal Period|Lost to Follow-up|13
19451|NCT02009163|93476|P1|Randomized-withdrawal Period|Lost to Follow-up|0
19452|NCT02009163|93474|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
19453|NCT02009163|93475|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
19454|NCT02009163|93476|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
19455|NCT02009163|93474|P3|Open-label Period (Non-randomized)|Not specified|0
19456|NCT02009163|93475|P2|Open-label Period (Non-randomized)|Not specified|0
19457|NCT02009163|93476|P1|Open-label Period (Non-randomized)|Not specified|13
19458|NCT02009163|93474|P3|Open-label Period (Non-randomized)|Pregnancy|0
19459|NCT02009163|93475|P2|Open-label Period (Non-randomized)|Pregnancy|0
19460|NCT02009163|93476|P1|Open-label Period (Non-randomized)|Pregnancy|1
19461|NCT02009163|93474|P3|Open-label Period (Non-randomized)|Protocol Violation|0
19462|NCT02009163|93475|P2|Open-label Period (Non-randomized)|Protocol Violation|0
19463|NCT02009163|93476|P1|Open-label Period (Non-randomized)|Protocol Violation|10
19464|NCT02009163|93474|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
19465|NCT02009163|93475|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
19466|NCT02009163|93476|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
19467|NCT02009163|93474|P3|Open-label Period (Non-randomized)|Adverse Event|0
19468|NCT02009163|93475|P2|Open-label Period (Non-randomized)|Adverse Event|0
19469|NCT02009163|93476|P1|Open-label Period (Non-randomized)|Adverse Event|22
19470|NCT02009163|93474|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
19471|NCT02009163|93475|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
19472|NCT02009163|93476|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
19473|NCT02009163|93474|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
19474|NCT02009163|93475|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
19475|NCT02009163|93476|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
19476|NCT02008526|93553|P3|Overall Study|Lost to Follow-up|6
19477|NCT02008526|93554|P2|Overall Study|Lost to Follow-up|9
19478|NCT02008526|93555|P1|Overall Study|Lost to Follow-up|5
19479|NCT02008526|93553|P3|Overall Study|Withdrawal by Subject|2
19480|NCT02008526|93554|P2|Overall Study|Withdrawal by Subject|3
19481|NCT02008526|93555|P1|Overall Study|Withdrawal by Subject|3
19482|NCT02008526|93553|P3|Overall Study|Death|1
19483|NCT02008526|93554|P2|Overall Study|Death|2
19484|NCT02008526|93555|P1|Overall Study|Death|0
19485|NCT02008227|93568|P2|Overall Study|Ongoing Survival Follow-up|106
19486|NCT02008227|93569|P1|Overall Study|Ongoing Survival Follow-up|135
19487|NCT02008227|93568|P2|Overall Study|Ongoing on Study Treatment|85
19488|NCT02008227|93569|P1|Overall Study|Ongoing on Study Treatment|4
19489|NCT02008227|93568|P2|Overall Study|Withdrawal by Subject|34
19490|NCT02008227|93569|P1|Overall Study|Withdrawal by Subject|63
19491|NCT02008227|93568|P2|Overall Study|Death|383
19492|NCT02008227|93569|P1|Overall Study|Death|407
19493|NCT02008227|93568|P2|Overall Study|Lost to Follow-up|5
19494|NCT02008227|93569|P1|Overall Study|Lost to Follow-up|3
19495|NCT02007954|93630|P1|Overall Study|Death|1
19496|NCT02007954|93630|P1|Overall Study|Disease progression and unrelated AE|1
19497|NCT02007954|93630|P1|Overall Study|Switch in treatment modality|2
19498|NCT02007954|93630|P1|Overall Study|Received liver transplant|3
19499|NCT02007577|93649|P2|Overall Study|Withdrawal by Subject|1
19500|NCT02007577|93650|P1|Overall Study|Withdrawal by Subject|0
19501|NCT02007577|93649|P2|Overall Study|Adverse Event|0
19502|NCT02007577|93650|P1|Overall Study|Adverse Event|1
19503|NCT02007512|93662|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
19504|NCT02007512|93663|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
19505|NCT02007512|93664|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
19506|NCT02007512|93665|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
19507|NCT02007512|93662|P4|Open Label Treatment Period|Disease progression|11
19508|NCT02007512|93663|P3|Open Label Treatment Period|Disease progression|0
19509|NCT02007512|93664|P2|Open Label Treatment Period|Disease progression|17
19510|NCT02007512|93665|P1|Open Label Treatment Period|Disease progression|0
19511|NCT02007512|93662|P4|Open Label Treatment Period|Other|1
19512|NCT02007512|93663|P3|Open Label Treatment Period|Other|0
19513|NCT02007512|93664|P2|Open Label Treatment Period|Other|0
19514|NCT02007512|93665|P1|Open Label Treatment Period|Other|0
19515|NCT02007512|93662|P4|Open Label Treatment Period|Adverse Event|0
19516|NCT02007512|93663|P3|Open Label Treatment Period|Adverse Event|0
19517|NCT02007512|93664|P2|Open Label Treatment Period|Adverse Event|1
19518|NCT02007512|93665|P1|Open Label Treatment Period|Adverse Event|0
19519|NCT02007512|93662|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
19520|NCT02007512|93663|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
19521|NCT02007512|93664|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
19522|NCT02007512|93665|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
19523|NCT02007512|93662|P4|Double Blind Treatment Period|Other|2
19524|NCT02007512|93663|P3|Double Blind Treatment Period|Other|1
19525|NCT02007512|93664|P2|Double Blind Treatment Period|Other|0
19526|NCT02007512|93665|P1|Double Blind Treatment Period|Other|0
19527|NCT02007512|93662|P4|Double Blind Treatment Period|Protocol Violation|1
19528|NCT02007512|93663|P3|Double Blind Treatment Period|Protocol Violation|0
19529|NCT02007512|93664|P2|Double Blind Treatment Period|Protocol Violation|0
19530|NCT02007512|93665|P1|Double Blind Treatment Period|Protocol Violation|0
19531|NCT02007512|93662|P4|Double Blind Treatment Period|Withdrawal by Subject|3
19532|NCT02007512|93663|P3|Double Blind Treatment Period|Withdrawal by Subject|3
19533|NCT02007512|93664|P2|Double Blind Treatment Period|Withdrawal by Subject|2
19534|NCT02007512|93665|P1|Double Blind Treatment Period|Withdrawal by Subject|4
19535|NCT02007512|93662|P4|Double Blind Treatment Period|Disease progression|51
19536|NCT02007512|93663|P3|Double Blind Treatment Period|Disease progression|45
19537|NCT02007512|93664|P2|Double Blind Treatment Period|Disease progression|49
19538|NCT02007512|93665|P1|Double Blind Treatment Period|Disease progression|44
19539|NCT02007512|93662|P4|Double Blind Treatment Period|Death|0
19540|NCT02007512|93663|P3|Double Blind Treatment Period|Death|0
19541|NCT02007512|93664|P2|Double Blind Treatment Period|Death|0
19542|NCT02007512|93665|P1|Double Blind Treatment Period|Death|1
19543|NCT02007512|93662|P4|Double Blind Treatment Period|Adverse Event|2
19544|NCT02007512|93663|P3|Double Blind Treatment Period|Adverse Event|6
19545|NCT02007512|93664|P2|Double Blind Treatment Period|Adverse Event|2
19546|NCT02007512|93665|P1|Double Blind Treatment Period|Adverse Event|4
19547|NCT02007434|93735|P8|Overall Study|Non-compliance|0
19548|NCT02007434|93736|P7|Overall Study|Non-compliance|0
19549|NCT02007434|93737|P6|Overall Study|Non-compliance|0
19550|NCT02007434|93738|P5|Overall Study|Non-compliance|0
19551|NCT02007434|93739|P4|Overall Study|Non-compliance|0
19552|NCT02007434|93740|P3|Overall Study|Non-compliance|1
19553|NCT02007434|93741|P2|Overall Study|Non-compliance|0
19554|NCT02007434|93742|P1|Overall Study|Non-compliance|1
19555|NCT02007434|93735|P8|Overall Study|Lost to Follow-up|0
19556|NCT02007434|93736|P7|Overall Study|Lost to Follow-up|0
19557|NCT02007434|93737|P6|Overall Study|Lost to Follow-up|0
19558|NCT02007434|93738|P5|Overall Study|Lost to Follow-up|0
19559|NCT02007434|93739|P4|Overall Study|Lost to Follow-up|0
19560|NCT02007434|93740|P3|Overall Study|Lost to Follow-up|0
19561|NCT02007434|93741|P2|Overall Study|Lost to Follow-up|1
19562|NCT02007434|93742|P1|Overall Study|Lost to Follow-up|0
19563|NCT02007278|93864|P2|Overall Study|Mis-randomization|1
19564|NCT02007278|93865|P1|Overall Study|Mis-randomization|1
19565|NCT02007278|93864|P2|Overall Study|Incorrect medication administration|0
19566|NCT02007278|93865|P1|Overall Study|Incorrect medication administration|1
19567|NCT02007278|93864|P2|Overall Study|Ingestion of drugs not allowed in study|1
19568|NCT02007278|93865|P1|Overall Study|Ingestion of drugs not allowed in study|0
19569|NCT02007278|93864|P2|Overall Study|Failure to comply with an eligibility|1
19570|NCT02007278|93865|P1|Overall Study|Failure to comply with an eligibility|0
19571|NCT02007252|93887|P2|Overall Study|Adverse Event|4
19572|NCT02007252|93888|P1|Overall Study|Adverse Event|7
19573|NCT02007252|93887|P2|Overall Study|Abnormal laboratory value(s)|0
19574|NCT02007252|93888|P1|Overall Study|Abnormal laboratory value(s)|1
19575|NCT02007252|93887|P2|Overall Study|Administrative problems|7
19576|NCT02007252|93888|P1|Overall Study|Administrative problems|3
19577|NCT02007096|93903|P2|Overall Study|no mesh placed|1
19578|NCT02007096|93904|P1|Overall Study|no mesh placed|0
19579|NCT02007096|93903|P2|Overall Study|converted to open surgery|1
19580|NCT02007096|93904|P1|Overall Study|converted to open surgery|1
19581|NCT02007096|93903|P2|Overall Study|did not follow postoperative protocol|11
19582|NCT02007096|93904|P1|Overall Study|did not follow postoperative protocol|8
19583|NCT02007096|93903|P2|Overall Study|did not inject saline|3
19584|NCT02007096|93904|P1|Overall Study|did not inject saline|0
19585|NCT02007096|93903|P2|Overall Study|medication not available|0
19586|NCT02007096|93904|P1|Overall Study|medication not available|2
19587|NCT02007070|93916|P1|Overall Study|Progressive Disease|21
19588|NCT02007070|93916|P1|Overall Study|Physician Decision|1
19589|NCT02007070|93916|P1|Overall Study|Protocol Violation|2
19590|NCT02007070|93916|P1|Overall Study|Death|1
19591|NCT02007070|93916|P1|Overall Study|Clinical Progression|4
19592|NCT02007070|93916|P1|Overall Study|Adverse Event|4
19593|NCT02006732|93973|P4|Overall Study|Withdrawal by Subject|1
19594|NCT02006732|93974|P3|Overall Study|Withdrawal by Subject|4
19595|NCT02006732|93975|P2|Overall Study|Withdrawal by Subject|0
19596|NCT02006732|93976|P1|Overall Study|Withdrawal by Subject|3
19597|NCT02006732|93973|P4|Overall Study|Lost to Follow-up|0
19598|NCT02006732|93974|P3|Overall Study|Lost to Follow-up|0
19599|NCT02006732|93975|P2|Overall Study|Lost to Follow-up|1
19600|NCT02006732|93976|P1|Overall Study|Lost to Follow-up|0
19601|NCT02006732|93973|P4|Overall Study|Protocol Violation|0
19602|NCT02006732|93974|P3|Overall Study|Protocol Violation|0
19603|NCT02006732|93975|P2|Overall Study|Protocol Violation|1
19604|NCT02006732|93976|P1|Overall Study|Protocol Violation|1
19605|NCT02006732|93973|P4|Overall Study|Lack of Efficacy|1
19606|NCT02006732|93974|P3|Overall Study|Lack of Efficacy|1
19607|NCT02006732|93975|P2|Overall Study|Lack of Efficacy|3
19608|NCT02006732|93976|P1|Overall Study|Lack of Efficacy|6
19609|NCT02006732|93973|P4|Overall Study|Adverse Event|2
19610|NCT02006732|93974|P3|Overall Study|Adverse Event|4
19611|NCT02006732|93975|P2|Overall Study|Adverse Event|7
19612|NCT02006732|93976|P1|Overall Study|Adverse Event|10
19613|NCT02006719|94016|P2|Overall Study|Other/Unknown|1
19614|NCT02006719|94017|P1|Overall Study|Other/Unknown|0
19615|NCT02006719|94016|P2|Overall Study|Adverse Event|1
19616|NCT02006719|94017|P1|Overall Study|Adverse Event|1
19617|NCT02006719|94016|P2|Overall Study|Protocol Violation|0
19618|NCT02006719|94017|P1|Overall Study|Protocol Violation|2
19619|NCT02006719|94016|P2|Overall Study|Lost to Follow-up|1
19620|NCT02006719|94017|P1|Overall Study|Lost to Follow-up|5
19621|NCT02006719|94016|P2|Overall Study|Withdrawal by Subject|2
19622|NCT02006719|94017|P1|Overall Study|Withdrawal by Subject|10
19623|NCT02006706|94047|P1|Overall Study|Lost to Follow-up|1
19624|NCT02006667|94052|P1|Overall Study|Withdrawal by Subject|1
19625|NCT02006667|94052|P1|Overall Study|Death|2
19626|NCT02006667|94052|P1|Overall Study|Adverse Event|3
19627|NCT02006654|94064|P2|Overall Study|moving out of state|1
19628|NCT02006654|94065|P1|Overall Study|moving out of state|0
19629|NCT02006654|94064|P2|Overall Study|disallowed medication|0
19630|NCT02006654|94065|P1|Overall Study|disallowed medication|1
19631|NCT02006654|94064|P2|Overall Study|mood disorder|1
19632|NCT02006654|94065|P1|Overall Study|mood disorder|0
19633|NCT02006654|94064|P2|Overall Study|faecal incontinence|1
19634|NCT02006654|94065|P1|Overall Study|faecal incontinence|0
19635|NCT02006654|94064|P2|Overall Study|worsening cognitive condition|1
19636|NCT02006654|94065|P1|Overall Study|worsening cognitive condition|0
19637|NCT02006654|94064|P2|Overall Study|insufficient compliance|0
19638|NCT02006654|94065|P1|Overall Study|insufficient compliance|1
19639|NCT02006654|94064|P2|Overall Study|patient's will|1
19640|NCT02006654|94065|P1|Overall Study|patient's will|2
19641|NCT02006654|94064|P2|Overall Study|Lost to Follow-up|0
19642|NCT02006654|94065|P1|Overall Study|Lost to Follow-up|1
19643|NCT02006654|94064|P2|Overall Study|Protocol Violation|8
19644|NCT02006654|94065|P1|Overall Study|Protocol Violation|5
19645|NCT02006654|94064|P2|Overall Study|Withdrawal by Subject|12
19646|NCT02006654|94065|P1|Overall Study|Withdrawal by Subject|14
19647|NCT02006654|94064|P2|Overall Study|Death|0
19648|NCT02006654|94065|P1|Overall Study|Death|1
19649|NCT02006654|94064|P2|Overall Study|Adverse Event|17
19650|NCT02006654|94065|P1|Overall Study|Adverse Event|16
19651|NCT02006654|94064|P2|Overall Study|Withdrawal before treatment|2
19652|NCT02006654|94065|P1|Overall Study|Withdrawal before treatment|4
19653|NCT02006641|94094|P3|Overall Study|Other reason: protocol non-compliance|1
19654|NCT02006641|94095|P2|Overall Study|Other reason: protocol non-compliance|0
19655|NCT02006641|94096|P1|Overall Study|Other reason: protocol non-compliance|0
19656|NCT02006641|94094|P3|Overall Study|Other reason: caregiver impossibility|1
19657|NCT02006641|94095|P2|Overall Study|Other reason: caregiver impossibility|0
19658|NCT02006641|94096|P1|Overall Study|Other reason: caregiver impossibility|0
19659|NCT02006641|94094|P3|Overall Study|Other reason: hospitalisation|0
19660|NCT02006641|94095|P2|Overall Study|Other reason: hospitalisation|1
19661|NCT02006641|94096|P1|Overall Study|Other reason: hospitalisation|0
19662|NCT02006641|94094|P3|Overall Study|Other reason: patient's wife has died|1
19663|NCT02006641|94095|P2|Overall Study|Other reason: patient's wife has died|0
19664|NCT02006641|94096|P1|Overall Study|Other reason: patient's wife has died|0
19665|NCT02006641|94094|P3|Overall Study|Other reason: caregiver in hospital|0
19666|NCT02006641|94095|P2|Overall Study|Other reason: caregiver in hospital|1
19667|NCT02006641|94096|P1|Overall Study|Other reason: caregiver in hospital|0
19668|NCT02006641|94094|P3|Overall Study|Other reason: patient has moved|1
19669|NCT02006641|94095|P2|Overall Study|Other reason: patient has moved|0
19670|NCT02006641|94096|P1|Overall Study|Other reason: patient has moved|1
19671|NCT02006641|94094|P3|Overall Study|Other reason:patient didn't want to come|1
19672|NCT02006641|94095|P2|Overall Study|Other reason:patient didn't want to come|0
19673|NCT02006641|94096|P1|Overall Study|Other reason:patient didn't want to come|0
19674|NCT02006641|94094|P3|Overall Study|Other reason: patient didn't show up|0
19675|NCT02006641|94095|P2|Overall Study|Other reason: patient didn't show up|0
19676|NCT02006641|94096|P1|Overall Study|Other reason: patient didn't show up|1
19677|NCT02006641|94094|P3|Overall Study|Withdrawal by Subject|11
19678|NCT02006641|94095|P2|Overall Study|Withdrawal by Subject|12
19679|NCT02006641|94096|P1|Overall Study|Withdrawal by Subject|7
19680|NCT02006641|94094|P3|Overall Study|Lost to Follow-up|0
19681|NCT02006641|94095|P2|Overall Study|Lost to Follow-up|1
19682|NCT02006641|94096|P1|Overall Study|Lost to Follow-up|0
19683|NCT02006641|94094|P3|Overall Study|Protocol Violation|2
19684|NCT02006641|94095|P2|Overall Study|Protocol Violation|2
19685|NCT02006641|94096|P1|Overall Study|Protocol Violation|0
19686|NCT02006641|94094|P3|Overall Study|Adverse Event|15
19687|NCT02006641|94095|P2|Overall Study|Adverse Event|11
19688|NCT02006641|94096|P1|Overall Study|Adverse Event|15
19689|NCT02006641|94094|P3|Overall Study|Withdrawal before treatment|3
19690|NCT02006641|94095|P2|Overall Study|Withdrawal before treatment|5
19691|NCT02006641|94096|P1|Overall Study|Withdrawal before treatment|2
19692|NCT02005692|94162|P1|Overall Study|Discharged earlier than anticipated|5
19693|NCT02005692|94162|P1|Overall Study|Withdrawal by Subject|1
19694|NCT02005692|94162|P1|Overall Study|Protocol Violation|1
19695|NCT02005562|94182|P2|Overall Study|Physician Decision|1
19696|NCT02005562|94183|P1|Overall Study|Physician Decision|0
19697|NCT02005562|94182|P2|Overall Study|No transplant|4
19698|NCT02005562|94183|P1|Overall Study|No transplant|1
19699|NCT02005562|94182|P2|Overall Study|Withdrawal by Subject|2
19700|NCT02005562|94183|P1|Overall Study|Withdrawal by Subject|2
19701|NCT02005562|94182|P2|Overall Study|Graft loss|6
19702|NCT02005562|94183|P1|Overall Study|Graft loss|7
19703|NCT02005562|94182|P2|Overall Study|Death|2
19704|NCT02005562|94183|P1|Overall Study|Death|2
19705|NCT02005484|94225|P1|Overall Study|Sponsor decision|1
19706|NCT02005484|94225|P1|Overall Study|Changed to a Different Study|1
19707|NCT02005484|94225|P1|Overall Study|Disease progression|1
19708|NCT02005484|94225|P1|Overall Study|Death|1
19709|NCT02005211|94246|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
19710|NCT02005211|94247|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
19711|NCT02005211|94248|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
19712|NCT02005211|94249|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
19713|NCT02005211|94250|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
19714|NCT02005211|94251|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
19715|NCT02005211|94252|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
19716|NCT02005029|94287|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
19717|NCT02005029|94288|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
19718|NCT02004886|94340|P4|Overall Study|Unable to attend future visits|0
19719|NCT02004886|94341|P3|Overall Study|Unable to attend future visits|0
19720|NCT02004886|94342|P2|Overall Study|Unable to attend future visits|0
19721|NCT02004886|94343|P1|Overall Study|Unable to attend future visits|1
19722|NCT02004886|94340|P4|Overall Study|Adverse Event|0
19723|NCT02004886|94341|P3|Overall Study|Adverse Event|0
19724|NCT02004886|94342|P2|Overall Study|Adverse Event|1
19725|NCT02004886|94343|P1|Overall Study|Adverse Event|0
19726|NCT02004873|94393|P1|Overall Study|Withdrawal by Subject|1
19727|NCT02004873|94393|P1|Overall Study|Death|23
19728|NCT02004873|94393|P1|Overall Study|Missed 6-month visit|4
19729|NCT02004873|94393|P1|Overall Study|Awaiting 6-month visit|390
19730|NCT02004873|94393|P1|Overall Study|Implant unsuccessful|6
19731|NCT02004847|94402|P2|Overall Study|Protocol Violation|1
19732|NCT02004847|94403|P1|Overall Study|Protocol Violation|1
19733|NCT02004262|94453|P6|Overall Study|Study Terminated by Sponsor|5
19734|NCT02004262|94454|P5|Overall Study|Study Terminated by Sponsor|1
19735|NCT02004262|94455|P4|Overall Study|Study Terminated by Sponsor|1
19736|NCT02004262|94456|P3|Overall Study|Study Terminated by Sponsor|2
19737|NCT02004262|94457|P2|Overall Study|Study Terminated by Sponsor|3
19738|NCT02004262|94458|P1|Overall Study|Study Terminated by Sponsor|4
19739|NCT02004262|94453|P6|Overall Study|Lost to Follow-up|0
19740|NCT02004262|94454|P5|Overall Study|Lost to Follow-up|0
19741|NCT02004262|94455|P4|Overall Study|Lost to Follow-up|0
19742|NCT02004262|94456|P3|Overall Study|Lost to Follow-up|0
19743|NCT02004262|94457|P2|Overall Study|Lost to Follow-up|1
19744|NCT02004262|94458|P1|Overall Study|Lost to Follow-up|1
19745|NCT02004262|94453|P6|Overall Study|Withdrawal by Subject|3
19746|NCT02004262|94454|P5|Overall Study|Withdrawal by Subject|1
19747|NCT02004262|94455|P4|Overall Study|Withdrawal by Subject|0
19748|NCT02004262|94456|P3|Overall Study|Withdrawal by Subject|4
19749|NCT02004262|94457|P2|Overall Study|Withdrawal by Subject|0
19750|NCT02004262|94458|P1|Overall Study|Withdrawal by Subject|1
19751|NCT02004262|94453|P6|Overall Study|Death|22
19752|NCT02004262|94454|P5|Overall Study|Death|29
19753|NCT02004262|94455|P4|Overall Study|Death|28
19754|NCT02004262|94456|P3|Overall Study|Death|66
19755|NCT02004262|94457|P2|Overall Study|Death|64
19756|NCT02004262|94458|P1|Overall Study|Death|67
19757|NCT02004236|94478|P3|Overall Study|Lack of Efficacy|16
19758|NCT02004236|94479|P2|Overall Study|Lack of Efficacy|0
19759|NCT02004236|94480|P1|Overall Study|Lack of Efficacy|0
19760|NCT02004093|94540|P2|Overall Study|Not specified|1
19761|NCT02004093|94541|P1|Overall Study|Not specified|3
19762|NCT02004093|94540|P2|Overall Study|Withdrawal by Subject|7
19763|NCT02004093|94541|P1|Overall Study|Withdrawal by Subject|3
19764|NCT02004093|94540|P2|Overall Study|Lost to Follow-up|1
19765|NCT02004093|94541|P1|Overall Study|Lost to Follow-up|0
19766|NCT02004093|94540|P2|Overall Study|Protocol Violation|1
19767|NCT02004093|94541|P1|Overall Study|Protocol Violation|0
19768|NCT02004093|94540|P2|Overall Study|Lack of Efficacy|62
19769|NCT02004093|94541|P1|Overall Study|Lack of Efficacy|66
19770|NCT02004093|94540|P2|Overall Study|Death|1
19771|NCT02004093|94541|P1|Overall Study|Death|2
19772|NCT02003963|94573|P2|Overall Study|Lost to Follow-up|1
19773|NCT02003963|94574|P1|Overall Study|Lost to Follow-up|2
19774|NCT02003638|94596|P2|Overall Study|Withdrawal by Subject|0
19775|NCT02003638|94597|P1|Overall Study|Withdrawal by Subject|1
19776|NCT02003534|94603|P1|Overall Study|Lost to Follow-up|47
19777|NCT02003391|94615|P2|Overall Study|Adverse Event|0
19778|NCT02003391|94616|P1|Overall Study|Adverse Event|1
19779|NCT02003391|94615|P2|Overall Study|Protocol Violation|1
19780|NCT02003391|94616|P1|Overall Study|Protocol Violation|0
19781|NCT02003391|94615|P2|Overall Study|Withdrawal by Subject|1
19782|NCT02003391|94616|P1|Overall Study|Withdrawal by Subject|2
19783|NCT02003365|94629|P3|Overall Study|Lost to Follow-up|1
19784|NCT02003365|94630|P2|Overall Study|Lost to Follow-up|0
19785|NCT02003365|94631|P1|Overall Study|Lost to Follow-up|0
19786|NCT02003014|94655|P1|Overall Study|Investigator's transfer|4
19787|NCT02003014|94655|P1|Overall Study|Patient did not visit the study site|5
19788|NCT02003014|94655|P1|Overall Study|Treatment started after contract period|1
19789|NCT02003014|94655|P1|Overall Study|Case report forms uncollected|9
19790|NCT02002689|94737|P1|Overall Study|Adverse Event|3
19791|NCT02002689|94737|P1|Overall Study|Disease Progression|7
19792|NCT02002533|94756|P2|Overall Study|Lost to Follow-up|1
19793|NCT02002533|94757|P1|Overall Study|Lost to Follow-up|0
19794|NCT02002533|94756|P2|Overall Study|Adverse Event|3
19795|NCT02002533|94757|P1|Overall Study|Adverse Event|0
19796|NCT02002533|94756|P2|Overall Study|Protocol Violation|1
19797|NCT02002533|94757|P1|Overall Study|Protocol Violation|0
19798|NCT02002533|94756|P2|Overall Study|Withdrawal by Subject|13
19799|NCT02002533|94757|P1|Overall Study|Withdrawal by Subject|6
19800|NCT02002221|94782|P2|Overall Study|Patient withdrew consent|1
19801|NCT02002221|94783|P1|Overall Study|Patient withdrew consent|0
19802|NCT02002221|94782|P2|Overall Study|Unsatisfactory therapeutic effect|1
19803|NCT02002221|94783|P1|Overall Study|Unsatisfactory therapeutic effect|0
19804|NCT02002221|94782|P2|Overall Study|Adverse Event|1
19805|NCT02002221|94783|P1|Overall Study|Adverse Event|2
19806|NCT02001181|94819|P2|Overall Study|Withdrawal by Subject|1
19807|NCT02001181|94820|P1|Overall Study|Withdrawal by Subject|0
19808|NCT02001181|94819|P2|Overall Study|Lost to Follow-up|0
19809|NCT02001181|94820|P1|Overall Study|Lost to Follow-up|1
19810|NCT02001181|94819|P2|Overall Study|Adverse Event|2
19811|NCT02001181|94820|P1|Overall Study|Adverse Event|0
19812|NCT02001051|94836|P2|Overall Study|Deemed not eligible following enrollment|1
19813|NCT02001051|94837|P1|Overall Study|Deemed not eligible following enrollment|0
19814|NCT02000921|94889|P3|Overall Study|Physician Decision|0
19815|NCT02000921|94890|P2|Overall Study|Physician Decision|2
19816|NCT02000921|94891|P1|Overall Study|Physician Decision|0
19817|NCT02000921|94889|P3|Overall Study|Lost to Follow-up|5
19818|NCT02000921|94890|P2|Overall Study|Lost to Follow-up|4
19819|NCT02000921|94891|P1|Overall Study|Lost to Follow-up|2
19820|NCT02000921|94889|P3|Overall Study|Withdrawal by Subject|5
19821|NCT02000921|94890|P2|Overall Study|Withdrawal by Subject|10
19822|NCT02000921|94891|P1|Overall Study|Withdrawal by Subject|3
19823|NCT02000752|94910|P2|Overall Study|Shift Changes|5
19824|NCT02000752|94911|P1|Overall Study|Shift Changes|12
19825|NCT02000752|94910|P2|Overall Study|Dystocic delivery|8
19826|NCT02000752|94911|P1|Overall Study|Dystocic delivery|19
19827|NCT02000622|94925|P2|Overall Study|Withdrawal by Subject|7
19828|NCT02000622|94926|P1|Overall Study|Withdrawal by Subject|5
19829|NCT02000622|94925|P2|Overall Study|Death|46
19830|NCT02000622|94926|P1|Overall Study|Death|94
19831|NCT02000622|94925|P2|Overall Study|Lost to Follow-up|0
19832|NCT02000622|94926|P1|Overall Study|Lost to Follow-up|1
19833|NCT02000622|94925|P2|Overall Study|Withdrawn due to site closure|0
19834|NCT02000622|94926|P1|Overall Study|Withdrawn due to site closure|1
19835|NCT02000531|94948|P2|Overall Study|Discontinued due to data cut-off|8
19836|NCT02000531|94949|P1|Overall Study|Discontinued due to data cut-off|3
19837|NCT02000531|94948|P2|Overall Study|Lost to Follow-up|0
19838|NCT02000531|94949|P1|Overall Study|Lost to Follow-up|1
19839|NCT02000440|94957|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
19840|NCT02000440|94957|P1|Overall Study|Adverse Event|3
19841|NCT02000427|94977|P1|Overall Study|Death|22
19842|NCT01999894|95034|P1|Overall Study|Inclusion/exclusion criteria not met|1
19843|NCT01999894|95034|P1|Overall Study|Other Reason|3
19844|NCT01999894|95034|P1|Overall Study|Lost to Follow-up|10
19845|NCT01999894|95034|P1|Overall Study|Withdrawal by Subject|7
19846|NCT01999894|95034|P1|Overall Study|Protocol Violation|1
19847|NCT01999894|95034|P1|Overall Study|Lack of Efficacy|5
19848|NCT01999894|95034|P1|Overall Study|Adverse Event|9
19849|NCT01999322|95076|P2|Overall Study|Adverse Event|0
19850|NCT01999322|95077|P1|Overall Study|Adverse Event|1
19851|NCT01999218|95129|P3|Overall Study|Treated but excluded at 1 trial site|2
19852|NCT01999218|95130|P2|Overall Study|Treated but excluded at 1 trial site|5
19853|NCT01999218|95131|P1|Overall Study|Treated but excluded at 1 trial site|3
19854|NCT01999218|95129|P3|Overall Study|Adverse Event|7
19855|NCT01999218|95130|P2|Overall Study|Adverse Event|7
19856|NCT01999218|95131|P1|Overall Study|Adverse Event|9
19857|NCT01999218|95129|P3|Overall Study|Excluded Medication|2
19858|NCT01999218|95130|P2|Overall Study|Excluded Medication|1
19859|NCT01999218|95131|P1|Overall Study|Excluded Medication|1
19860|NCT01999218|95129|P3|Overall Study|Death|2
19861|NCT01999218|95130|P2|Overall Study|Death|1
19862|NCT01999218|95131|P1|Overall Study|Death|7
19863|NCT01999218|95129|P3|Overall Study|Creatinine/eGFR|1
19864|NCT01999218|95130|P2|Overall Study|Creatinine/eGFR|0
19865|NCT01999218|95131|P1|Overall Study|Creatinine/eGFR|0
19866|NCT01999218|95129|P3|Overall Study|Withdrawal by Subject|34
19867|NCT01999218|95130|P2|Overall Study|Withdrawal by Subject|29
19868|NCT01999218|95131|P1|Overall Study|Withdrawal by Subject|28
19869|NCT01999218|95129|P3|Overall Study|Participant moves|3
19870|NCT01999218|95130|P2|Overall Study|Participant moves|5
19871|NCT01999218|95131|P1|Overall Study|Participant moves|2
19872|NCT01999218|95129|P3|Overall Study|Study Terminated By Sponsor|12
19873|NCT01999218|95130|P2|Overall Study|Study Terminated By Sponsor|5
19874|NCT01999218|95131|P1|Overall Study|Study Terminated By Sponsor|7
19875|NCT01999218|95129|P3|Overall Study|Screen failure|0
19876|NCT01999218|95130|P2|Overall Study|Screen failure|1
19877|NCT01999218|95131|P1|Overall Study|Screen failure|0
19878|NCT01999218|95129|P3|Overall Study|Protocol Violation|4
19879|NCT01999218|95130|P2|Overall Study|Protocol Violation|5
19880|NCT01999218|95131|P1|Overall Study|Protocol Violation|4
19881|NCT01999218|95129|P3|Overall Study|Physician Decision|6
19882|NCT01999218|95130|P2|Overall Study|Physician Decision|4
19883|NCT01999218|95131|P1|Overall Study|Physician Decision|1
19884|NCT01999218|95129|P3|Overall Study|Non-Compliance With Study Drug|1
19885|NCT01999218|95130|P2|Overall Study|Non-Compliance With Study Drug|4
19886|NCT01999218|95131|P1|Overall Study|Non-Compliance With Study Drug|6
19887|NCT01999218|95129|P3|Overall Study|Lost to Follow-up|18
19888|NCT01999218|95130|P2|Overall Study|Lost to Follow-up|17
19889|NCT01999218|95131|P1|Overall Study|Lost to Follow-up|22
19890|NCT01999218|95129|P3|Overall Study|Lack of Efficacy|1
19891|NCT01999218|95130|P2|Overall Study|Lack of Efficacy|0
19892|NCT01999218|95131|P1|Overall Study|Lack of Efficacy|1
19893|NCT01999218|95129|P3|Overall Study|Hyperglycemia|17
19894|NCT01999218|95130|P2|Overall Study|Hyperglycemia|17
19895|NCT01999218|95131|P1|Overall Study|Hyperglycemia|18
19896|NCT01998919|95173|P2|Overall Study|Not specified|2
19897|NCT01998919|95174|P1|Overall Study|Not specified|5
19898|NCT01998919|95173|P2|Overall Study|Lost to Follow-up|0
19899|NCT01998919|95174|P1|Overall Study|Lost to Follow-up|2
19900|NCT01998919|95173|P2|Overall Study|Withdrawal by Subject|4
19901|NCT01998919|95174|P1|Overall Study|Withdrawal by Subject|2
19902|NCT01998919|95173|P2|Overall Study|Disease progression|22
19903|NCT01998919|95174|P1|Overall Study|Disease progression|31
19904|NCT01998919|95173|P2|Overall Study|Adverse Event|5
19905|NCT01998919|95174|P1|Overall Study|Adverse Event|0
19906|NCT01998919|95173|P2|Overall Study|Death|2
19907|NCT01998919|95174|P1|Overall Study|Death|2
19908|NCT01998906|95195|P3|Overall Study|Not specified|4
19909|NCT01998906|95196|P2|Overall Study|Not specified|8
19910|NCT01998906|95197|P1|Overall Study|Not specified|3
19911|NCT01998906|95195|P3|Overall Study|Administrative/Other|3
19912|NCT01998906|95196|P2|Overall Study|Administrative/Other|1
19913|NCT01998906|95197|P1|Overall Study|Administrative/Other|2
19914|NCT01998906|95195|P3|Overall Study|Withdrawal by Subject|3
19915|NCT01998906|95196|P2|Overall Study|Withdrawal by Subject|4
19916|NCT01998906|95197|P1|Overall Study|Withdrawal by Subject|1
19917|NCT01998906|95195|P3|Overall Study|Violation of Selection Criteria|1
19918|NCT01998906|95196|P2|Overall Study|Violation of Selection Criteria|0
19919|NCT01998906|95197|P1|Overall Study|Violation of Selection Criteria|0
19920|NCT01998906|95195|P3|Overall Study|Failure to return|4
19921|NCT01998906|95196|P2|Overall Study|Failure to return|2
19922|NCT01998906|95197|P1|Overall Study|Failure to return|0
19923|NCT01998906|95195|P3|Overall Study|Lack of Efficacy|8
19924|NCT01998906|95196|P2|Overall Study|Lack of Efficacy|9
19925|NCT01998906|95197|P1|Overall Study|Lack of Efficacy|10
19926|NCT01998906|95195|P3|Overall Study|Death|17
19927|NCT01998906|95196|P2|Overall Study|Death|30
19928|NCT01998906|95197|P1|Overall Study|Death|21
19929|NCT01998906|95195|P3|Overall Study|Participants ongoing in follow−up|58
19930|NCT01998906|95196|P2|Overall Study|Participants ongoing in follow−up|60
19931|NCT01998906|95197|P1|Overall Study|Participants ongoing in follow−up|77
19932|NCT01998893|95241|P1|Overall Study|Transformation to high-grade lymphoma|1
19933|NCT01998893|95241|P1|Overall Study|Withdrawal by Subject|1
19934|NCT01998893|95241|P1|Overall Study|Protocol Violation|2
19935|NCT01998893|95241|P1|Overall Study|Physician Decision|2
19936|NCT01998893|95241|P1|Overall Study|Lost to Follow-up|8
19937|NCT01998893|95241|P1|Overall Study|Death|1
19938|NCT01998893|95241|P1|Overall Study|Adverse Event|2
19939|NCT01998880|95253|P2|Overall Study|Violation of Selection Criteria at Entry|1
19940|NCT01998880|95254|P1|Overall Study|Violation of Selection Criteria at Entry|1
19941|NCT01998880|95253|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
19942|NCT01998880|95254|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
19943|NCT01998880|95253|P2|Overall Study|Other Protocol Violation|1
19944|NCT01998880|95254|P1|Overall Study|Other Protocol Violation|0
19945|NCT01998880|95253|P2|Overall Study|Administrative/Other|1
19946|NCT01998880|95254|P1|Overall Study|Administrative/Other|3
19947|NCT01998880|95253|P2|Overall Study|Insufficient Therapeutic Response|5
19948|NCT01998880|95254|P1|Overall Study|Insufficient Therapeutic Response|1
19949|NCT01998880|95253|P2|Overall Study|Death|6
19950|NCT01998880|95254|P1|Overall Study|Death|3
19951|NCT01998880|95253|P2|Overall Study|Withdrew Consent|2
19952|NCT01998880|95254|P1|Overall Study|Withdrew Consent|2
19953|NCT01998880|95253|P2|Overall Study|Progression of Disease|8
19954|NCT01998880|95254|P1|Overall Study|Progression of Disease|2
19955|NCT01998880|95253|P2|Overall Study|Adverse Events or Intercurrent Illness|16
19956|NCT01998880|95254|P1|Overall Study|Adverse Events or Intercurrent Illness|16
19957|NCT01998737|95272|P2|Overall Study|Corrupted database|0
19958|NCT01998737|95273|P1|Overall Study|Corrupted database|23
19959|NCT01998581|95285|P2|Overall Study|Randomized but withdrew before treatment|0
19960|NCT01998581|95286|P1|Overall Study|Randomized but withdrew before treatment|1
19961|NCT01998581|95285|P2|Overall Study|Other reasons|2
19962|NCT01998581|95286|P1|Overall Study|Other reasons|3
19963|NCT01998581|95285|P2|Overall Study|Adverse Event|1
19964|NCT01998581|95286|P1|Overall Study|Adverse Event|1
19965|NCT01998581|95285|P2|Overall Study|Lost to Follow-up|4
19966|NCT01998581|95286|P1|Overall Study|Lost to Follow-up|12
19967|NCT01998581|95285|P2|Overall Study|Withdrawal by Subject|1
19968|NCT01998581|95286|P1|Overall Study|Withdrawal by Subject|8
19969|NCT01998581|95285|P2|Overall Study|Protocol Violation|0
19970|NCT01998581|95286|P1|Overall Study|Protocol Violation|1
19971|NCT01998581|95285|P2|Overall Study|Refused repeat treatment|4
19972|NCT01998581|95286|P1|Overall Study|Refused repeat treatment|20
19973|NCT01998477|95298|P2|Overall Study|Withdrawal by Subject|0
19974|NCT01998477|95299|P1|Overall Study|Withdrawal by Subject|6
19975|NCT01998477|95298|P2|Overall Study|Lost to Follow-up|5
19976|NCT01998477|95299|P1|Overall Study|Lost to Follow-up|4
19977|NCT01998399|95345|P2|Overall Study|Withdrawal by Subject|1
19978|NCT01998399|95346|P1|Overall Study|Withdrawal by Subject|0
19979|NCT01998399|95345|P2|Overall Study|Study stopped before dosing completed|3
19980|NCT01998399|95346|P1|Overall Study|Study stopped before dosing completed|3
19981|NCT01998399|95345|P2|Overall Study|Death|2
19982|NCT01998399|95346|P1|Overall Study|Death|4
19983|NCT01998399|95345|P2|Overall Study|Lost to Follow-up|3
19984|NCT01998399|95346|P1|Overall Study|Lost to Follow-up|1
19985|NCT01997892|95408|P1|Overall Study|Study completion data not recorded|35
19986|NCT01997892|95408|P1|Overall Study|Other|3
19987|NCT01997892|95408|P1|Overall Study|Renal transplant|8
19988|NCT01997892|95408|P1|Overall Study|Death|14
19989|NCT01997892|95408|P1|Overall Study|Lost to Follow-up|6
19990|NCT01997892|95408|P1|Overall Study|Physician Decision|2
19991|NCT01996904|95575|P2|Overall Study|Lost to Follow-up|27
19992|NCT01996904|95576|P1|Overall Study|Lost to Follow-up|38
19993|NCT01996748|95589|P2|Overall Study|Lost to Follow-up|1
19994|NCT01996748|95590|P1|Overall Study|Lost to Follow-up|4
19995|NCT01996748|95589|P2|Overall Study|Withdrawal by Subject|1
19996|NCT01996748|95590|P1|Overall Study|Withdrawal by Subject|0
19997|NCT01996748|95589|P2|Overall Study|Adverse Event|4
19998|NCT01996748|95590|P1|Overall Study|Adverse Event|1
19999|NCT01996748|95589|P2|Overall Study|Physician Decision|0
20000|NCT01996748|95590|P1|Overall Study|Physician Decision|2
20001|NCT01996748|95589|P2|Overall Study|Personal reason|0
20002|NCT01996748|95590|P1|Overall Study|Personal reason|1
20003|NCT01996709|95604|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
20004|NCT01996709|95605|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
20005|NCT01996709|95604|P2|Overall Study|Subject Non-Compliant|0
20006|NCT01996709|95605|P1|Overall Study|Subject Non-Compliant|1
20007|NCT01996709|95604|P2|Overall Study|Lost to Follow-up|0
20008|NCT01996709|95605|P1|Overall Study|Lost to Follow-up|3
20009|NCT01996709|95604|P2|Overall Study|Withdrawal by Subject|0
20010|NCT01996709|95605|P1|Overall Study|Withdrawal by Subject|1
20011|NCT01996332|95679|P1|Overall Study|Lost to Follow-up|34
20012|NCT01996332|95679|P1|Overall Study|Physician Decision|17
20013|NCT01996332|95679|P1|Overall Study|Clinical Deterioration|28
20014|NCT01996332|95679|P1|Overall Study|Other|20
20015|NCT01996332|95679|P1|Overall Study|Withdrawal by Subject|71
20016|NCT01996332|95679|P1|Overall Study|Protocol Violation|9
20017|NCT01996332|95679|P1|Overall Study|Death|264
20018|NCT01996332|95679|P1|Overall Study|Lack of Efficacy|1245
20019|NCT01996332|95679|P1|Overall Study|Adverse Event|117
20020|NCT01996319|95687|P2|Overall Study|Adverse Event|2
20021|NCT01996319|95688|P1|Overall Study|Adverse Event|2
20022|NCT01996319|95687|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
20023|NCT01996319|95688|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
20024|NCT01996319|95687|P2|Overall Study|Protocol Violation|0
20025|NCT01996319|95688|P1|Overall Study|Protocol Violation|1
20026|NCT01995513|95708|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
20027|NCT01995513|95709|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
20028|NCT01995513|95710|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
20029|NCT01995513|95708|P3|Double Blind Treatment Period|Disease Progression|93
20030|NCT01995513|95709|P2|Double Blind Treatment Period|Disease Progression|82
20031|NCT01995513|95710|P1|Double Blind Treatment Period|Disease Progression|0
20032|NCT01995513|95708|P3|Double Blind Treatment Period|Death|1
20033|NCT01995513|95709|P2|Double Blind Treatment Period|Death|0
20034|NCT01995513|95710|P1|Double Blind Treatment Period|Death|0
20035|NCT01995513|95708|P3|Double Blind Treatment Period|Withdrawal by Subject|6
20036|NCT01995513|95709|P2|Double Blind Treatment Period|Withdrawal by Subject|4
20037|NCT01995513|95710|P1|Double Blind Treatment Period|Withdrawal by Subject|0
20038|NCT01995513|95708|P3|Double Blind Treatment Period|Other|2
20039|NCT01995513|95709|P2|Double Blind Treatment Period|Other|1
20040|NCT01995513|95710|P1|Double Blind Treatment Period|Other|0
20041|NCT01995513|95708|P3|Double Blind Treatment Period|Adverse Event|5
20042|NCT01995513|95709|P2|Double Blind Treatment Period|Adverse Event|12
20043|NCT01995513|95710|P1|Double Blind Treatment Period|Adverse Event|0
20044|NCT01995513|95708|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
20045|NCT01995513|95709|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
20046|NCT01995513|95710|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
20047|NCT01995513|95708|P3|Open Label Treatment Period|Death|0
20048|NCT01995513|95709|P2|Open Label Treatment Period|Death|0
20049|NCT01995513|95710|P1|Open Label Treatment Period|Death|8
20050|NCT01995513|95708|P3|Open Label Treatment Period|Adverse Event|0
20051|NCT01995513|95709|P2|Open Label Treatment Period|Adverse Event|0
20052|NCT01995513|95710|P1|Open Label Treatment Period|Adverse Event|35
20053|NCT01995513|95708|P3|Open Label Treatment Period|No PSA response at week 13|0
20054|NCT01995513|95709|P2|Open Label Treatment Period|No PSA response at week 13|0
20055|NCT01995513|95710|P1|Open Label Treatment Period|No PSA response at week 13|43
20056|NCT01995513|95708|P3|Open Label Treatment Period|Disease Progression|0
20057|NCT01995513|95709|P2|Open Label Treatment Period|Disease Progression|0
20058|NCT01995513|95710|P1|Open Label Treatment Period|Disease Progression|64
20059|NCT01995513|95708|P3|Open Label Treatment Period|Protocol Violation|0
20060|NCT01995513|95709|P2|Open Label Treatment Period|Protocol Violation|0
20061|NCT01995513|95710|P1|Open Label Treatment Period|Protocol Violation|1
20062|NCT01995513|95708|P3|Open Label Treatment Period|Withdrawal by Subject|0
20063|NCT01995513|95709|P2|Open Label Treatment Period|Withdrawal by Subject|0
20064|NCT01995513|95710|P1|Open Label Treatment Period|Withdrawal by Subject|14
20065|NCT01995513|95708|P3|Open Label Treatment Period|Other|0
20066|NCT01995513|95709|P2|Open Label Treatment Period|Other|0
20067|NCT01995513|95710|P1|Open Label Treatment Period|Other|9
20068|NCT01995461|95753|P1|Overall Study|Withdrawal by Subject|2
20069|NCT01995461|95753|P1|Overall Study|Lost to Follow-up|2
20070|NCT01995461|95753|P1|Overall Study|Death|1
20071|NCT01995357|95759|P6|Period 5|Adverse Event|0
20072|NCT01995357|95760|P5|Period 5|Adverse Event|0
20073|NCT01995357|95761|P4|Period 5|Adverse Event|0
20074|NCT01995357|95762|P3|Period 5|Adverse Event|1
20075|NCT01995357|95763|P2|Period 5|Adverse Event|0
20076|NCT01995357|95764|P1|Period 5|Adverse Event|1
20077|NCT01995357|95759|P6|Period 5|Lack of Efficacy|0
20078|NCT01995357|95760|P5|Period 5|Lack of Efficacy|0
20079|NCT01995357|95761|P4|Period 5|Lack of Efficacy|0
20080|NCT01995357|95762|P3|Period 5|Lack of Efficacy|0
20081|NCT01995357|95763|P2|Period 5|Lack of Efficacy|0
20082|NCT01995357|95764|P1|Period 5|Lack of Efficacy|1
20083|NCT01995201|95782|P7|From Week 24 Until Week 48|Protocol Violation|0
20084|NCT01995201|95783|P6|From Week 24 Until Week 48|Protocol Violation|0
20085|NCT01995201|95784|P5|From Week 24 Until Week 48|Protocol Violation|2
20086|NCT01995201|95785|P4|From Week 24 Until Week 48|Protocol Violation|0
20087|NCT01995201|95786|P3|From Week 24 Until Week 48|Protocol Violation|1
20088|NCT01995201|95787|P2|From Week 24 Until Week 48|Protocol Violation|0
20089|NCT01995201|95788|P1|From Week 24 Until Week 48|Protocol Violation|0
20090|NCT01995201|95782|P7|From Week 24 Until Week 48|Physician Decision|0
20091|NCT01995201|95783|P6|From Week 24 Until Week 48|Physician Decision|0
20092|NCT01995201|95784|P5|From Week 24 Until Week 48|Physician Decision|1
20093|NCT01995201|95785|P4|From Week 24 Until Week 48|Physician Decision|0
20094|NCT01995201|95786|P3|From Week 24 Until Week 48|Physician Decision|0
20095|NCT01995201|95787|P2|From Week 24 Until Week 48|Physician Decision|0
20096|NCT01995201|95788|P1|From Week 24 Until Week 48|Physician Decision|0
20097|NCT01995201|95782|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
20098|NCT01995201|95783|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
20099|NCT01995201|95784|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
20100|NCT01995201|95785|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
20101|NCT01995201|95786|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
20102|NCT01995201|95787|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
20103|NCT01995201|95788|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
20104|NCT01995201|95782|P7|From Week 24 Until Week 48|Lost to Follow-up|0
20105|NCT01995201|95783|P6|From Week 24 Until Week 48|Lost to Follow-up|1
20106|NCT01995201|95784|P5|From Week 24 Until Week 48|Lost to Follow-up|1
20107|NCT01995201|95785|P4|From Week 24 Until Week 48|Lost to Follow-up|0
20108|NCT01995201|95786|P3|From Week 24 Until Week 48|Lost to Follow-up|0
20109|NCT01995201|95787|P2|From Week 24 Until Week 48|Lost to Follow-up|0
20110|NCT01995201|95788|P1|From Week 24 Until Week 48|Lost to Follow-up|0
20111|NCT01995201|95782|P7|From Week 24 Until Week 48|Lack of Efficacy|1
20112|NCT01995201|95783|P6|From Week 24 Until Week 48|Lack of Efficacy|2
20113|NCT01995201|95784|P5|From Week 24 Until Week 48|Lack of Efficacy|0
20114|NCT01995201|95785|P4|From Week 24 Until Week 48|Lack of Efficacy|0
20115|NCT01995201|95786|P3|From Week 24 Until Week 48|Lack of Efficacy|1
20116|NCT01995201|95787|P2|From Week 24 Until Week 48|Lack of Efficacy|0
20117|NCT01995201|95788|P1|From Week 24 Until Week 48|Lack of Efficacy|0
20118|NCT01995201|95782|P7|From Week 24 Until Week 48|Death|0
20119|NCT01995201|95783|P6|From Week 24 Until Week 48|Death|2
20120|NCT01995201|95784|P5|From Week 24 Until Week 48|Death|0
20121|NCT01995201|95785|P4|From Week 24 Until Week 48|Death|0
20122|NCT01995201|95786|P3|From Week 24 Until Week 48|Death|0
20123|NCT01995201|95787|P2|From Week 24 Until Week 48|Death|0
20124|NCT01995201|95788|P1|From Week 24 Until Week 48|Death|0
20125|NCT01995201|95782|P7|From Week 24 Until Week 48|Adverse Event|1
20126|NCT01995201|95783|P6|From Week 24 Until Week 48|Adverse Event|3
20127|NCT01995201|95784|P5|From Week 24 Until Week 48|Adverse Event|1
20128|NCT01995201|95785|P4|From Week 24 Until Week 48|Adverse Event|1
20129|NCT01995201|95786|P3|From Week 24 Until Week 48|Adverse Event|2
20130|NCT01995201|95787|P2|From Week 24 Until Week 48|Adverse Event|0
20131|NCT01995201|95788|P1|From Week 24 Until Week 48|Adverse Event|0
20132|NCT01995201|95782|P7|From Baseline Until Week 24|Protocol Violation|0
20133|NCT01995201|95783|P6|From Baseline Until Week 24|Protocol Violation|0
20134|NCT01995201|95784|P5|From Baseline Until Week 24|Protocol Violation|0
20135|NCT01995201|95785|P4|From Baseline Until Week 24|Protocol Violation|0
20136|NCT01995201|95786|P3|From Baseline Until Week 24|Protocol Violation|0
20137|NCT01995201|95787|P2|From Baseline Until Week 24|Protocol Violation|9
20138|NCT01995201|95788|P1|From Baseline Until Week 24|Protocol Violation|0
20139|NCT01995201|95782|P7|From Baseline Until Week 24|Physician Decision|0
20140|NCT01995201|95783|P6|From Baseline Until Week 24|Physician Decision|0
20141|NCT01995201|95784|P5|From Baseline Until Week 24|Physician Decision|0
20142|NCT01995201|95785|P4|From Baseline Until Week 24|Physician Decision|0
20143|NCT01995201|95786|P3|From Baseline Until Week 24|Physician Decision|0
20144|NCT01995201|95787|P2|From Baseline Until Week 24|Physician Decision|2
20145|NCT01995201|95788|P1|From Baseline Until Week 24|Physician Decision|0
20146|NCT01995201|95782|P7|From Baseline Until Week 24|Withdrawal by Subject|0
20147|NCT01995201|95783|P6|From Baseline Until Week 24|Withdrawal by Subject|0
20148|NCT01995201|95784|P5|From Baseline Until Week 24|Withdrawal by Subject|0
20149|NCT01995201|95785|P4|From Baseline Until Week 24|Withdrawal by Subject|0
20150|NCT01995201|95786|P3|From Baseline Until Week 24|Withdrawal by Subject|0
20151|NCT01995201|95787|P2|From Baseline Until Week 24|Withdrawal by Subject|8
20152|NCT01995201|95788|P1|From Baseline Until Week 24|Withdrawal by Subject|2
20153|NCT01995201|95782|P7|From Baseline Until Week 24|Lost to Follow-up|0
20154|NCT01995201|95783|P6|From Baseline Until Week 24|Lost to Follow-up|0
20155|NCT01995201|95784|P5|From Baseline Until Week 24|Lost to Follow-up|0
20156|NCT01995201|95785|P4|From Baseline Until Week 24|Lost to Follow-up|0
20157|NCT01995201|95786|P3|From Baseline Until Week 24|Lost to Follow-up|0
20158|NCT01995201|95787|P2|From Baseline Until Week 24|Lost to Follow-up|3
20159|NCT01995201|95788|P1|From Baseline Until Week 24|Lost to Follow-up|2
20160|NCT01995201|95782|P7|From Baseline Until Week 24|Lack of Efficacy|0
20161|NCT01995201|95783|P6|From Baseline Until Week 24|Lack of Efficacy|0
20162|NCT01995201|95784|P5|From Baseline Until Week 24|Lack of Efficacy|0
20163|NCT01995201|95785|P4|From Baseline Until Week 24|Lack of Efficacy|0
20164|NCT01995201|95786|P3|From Baseline Until Week 24|Lack of Efficacy|0
20165|NCT01995201|95787|P2|From Baseline Until Week 24|Lack of Efficacy|5
20166|NCT01995201|95788|P1|From Baseline Until Week 24|Lack of Efficacy|2
20167|NCT01995201|95782|P7|From Baseline Until Week 24|Death|0
20168|NCT01995201|95783|P6|From Baseline Until Week 24|Death|0
20169|NCT01995201|95784|P5|From Baseline Until Week 24|Death|0
20170|NCT01995201|95785|P4|From Baseline Until Week 24|Death|0
20171|NCT01995201|95786|P3|From Baseline Until Week 24|Death|0
20172|NCT01995201|95787|P2|From Baseline Until Week 24|Death|1
20173|NCT01995201|95788|P1|From Baseline Until Week 24|Death|0
20174|NCT01995201|95782|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
20175|NCT01995201|95783|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
20176|NCT01995201|95784|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
20177|NCT01995201|95785|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
20178|NCT01995201|95786|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
20179|NCT01995201|95787|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
20180|NCT01995201|95788|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
20181|NCT01995201|95782|P7|From Baseline Until Week 24|Adverse Event|0
20182|NCT01995201|95783|P6|From Baseline Until Week 24|Adverse Event|0
20183|NCT01995201|95784|P5|From Baseline Until Week 24|Adverse Event|0
20184|NCT01995201|95785|P4|From Baseline Until Week 24|Adverse Event|0
20185|NCT01995201|95786|P3|From Baseline Until Week 24|Adverse Event|0
20186|NCT01995201|95787|P2|From Baseline Until Week 24|Adverse Event|15
20187|NCT01995201|95788|P1|From Baseline Until Week 24|Adverse Event|4
20188|NCT01995136|95897|P1|Overall Study|Change in residence|1
20189|NCT01995071|95913|P12|Overall Study|Incarcerated|0
20190|NCT01995071|95914|P11|Overall Study|Incarcerated|0
20191|NCT01995071|95915|P10|Overall Study|Incarcerated|0
20192|NCT01995071|95916|P9|Overall Study|Incarcerated|0
20193|NCT01995071|95917|P8|Overall Study|Incarcerated|1
20194|NCT01995071|95918|P7|Overall Study|Incarcerated|0
20195|NCT01995071|95919|P6|Overall Study|Incarcerated|0
20196|NCT01995071|95920|P5|Overall Study|Incarcerated|0
20197|NCT01995071|95921|P4|Overall Study|Incarcerated|0
20198|NCT01995071|95922|P3|Overall Study|Incarcerated|0
20199|NCT01995071|95923|P2|Overall Study|Incarcerated|0
20200|NCT01995071|95924|P1|Overall Study|Incarcerated|0
20201|NCT01995071|95913|P12|Overall Study|Lost to Follow-up|0
20202|NCT01995071|95914|P11|Overall Study|Lost to Follow-up|0
20203|NCT01995071|95915|P10|Overall Study|Lost to Follow-up|0
20204|NCT01995071|95916|P9|Overall Study|Lost to Follow-up|1
20205|NCT01995071|95917|P8|Overall Study|Lost to Follow-up|1
20206|NCT01995071|95918|P7|Overall Study|Lost to Follow-up|0
20207|NCT01995071|95919|P6|Overall Study|Lost to Follow-up|0
20208|NCT01995071|95920|P5|Overall Study|Lost to Follow-up|0
20209|NCT01995071|95921|P4|Overall Study|Lost to Follow-up|0
20210|NCT01995071|95922|P3|Overall Study|Lost to Follow-up|0
20211|NCT01995071|95923|P2|Overall Study|Lost to Follow-up|0
20212|NCT01995071|95924|P1|Overall Study|Lost to Follow-up|1
20213|NCT01995071|95913|P12|Overall Study|Moved|0
20214|NCT01995071|95914|P11|Overall Study|Moved|1
20215|NCT01995071|95915|P10|Overall Study|Moved|0
20216|NCT01995071|95916|P9|Overall Study|Moved|0
20217|NCT01995071|95917|P8|Overall Study|Moved|0
20218|NCT01995071|95918|P7|Overall Study|Moved|0
20219|NCT01995071|95919|P6|Overall Study|Moved|0
20220|NCT01995071|95920|P5|Overall Study|Moved|1
20221|NCT01995071|95921|P4|Overall Study|Moved|0
20222|NCT01995071|95922|P3|Overall Study|Moved|1
20223|NCT01995071|95923|P2|Overall Study|Moved|0
20224|NCT01995071|95924|P1|Overall Study|Moved|0
20225|NCT01995071|95913|P12|Overall Study|Adverse Event|0
20226|NCT01995071|95914|P11|Overall Study|Adverse Event|0
20227|NCT01995071|95915|P10|Overall Study|Adverse Event|0
20228|NCT01995071|95916|P9|Overall Study|Adverse Event|0
20229|NCT01995071|95917|P8|Overall Study|Adverse Event|0
20230|NCT01995071|95918|P7|Overall Study|Adverse Event|1
20231|NCT01995071|95919|P6|Overall Study|Adverse Event|0
20232|NCT01995071|95920|P5|Overall Study|Adverse Event|0
20233|NCT01995071|95921|P4|Overall Study|Adverse Event|0
20234|NCT01995071|95922|P3|Overall Study|Adverse Event|0
20235|NCT01995071|95923|P2|Overall Study|Adverse Event|0
20236|NCT01995071|95924|P1|Overall Study|Adverse Event|0
20237|NCT01994902|96059|P2|Test Period 2|Other|3
20238|NCT01994902|96060|P1|Test Period 2|Other|0
20239|NCT01994902|96059|P2|Test Period 2|Lack of Efficacy|1
20240|NCT01994902|96060|P1|Test Period 2|Lack of Efficacy|0
20241|NCT01994902|96059|P2|Test Period 2|Withdrawal by Subject|2
20242|NCT01994902|96060|P1|Test Period 2|Withdrawal by Subject|0
20243|NCT01994902|96059|P2|Test Period 1|bag too small|0
20244|NCT01994902|96060|P1|Test Period 1|bag too small|1
20245|NCT01994902|96059|P2|Test Period 1|Lack of Efficacy|1
20246|NCT01994902|96060|P1|Test Period 1|Lack of Efficacy|0
20247|NCT01994902|96059|P2|Test Period 1|Adverse Event|1
20248|NCT01994902|96060|P1|Test Period 1|Adverse Event|2
20249|NCT01994902|96059|P2|Test Period 1|device deficiency with adverse event|1
20250|NCT01994902|96060|P1|Test Period 1|device deficiency with adverse event|0
20251|NCT01994902|96059|P2|Test Period 1|Withdrawal by Subject|0
20252|NCT01994902|96060|P1|Test Period 1|Withdrawal by Subject|3
20253|NCT01994876|96066|P2|Test Period 2|Protocol Violation|1
20254|NCT01994876|96067|P1|Test Period 2|Protocol Violation|0
20255|NCT01994876|96066|P2|Test Period 2|Adverse Event|0
20256|NCT01994876|96067|P1|Test Period 2|Adverse Event|1
20257|NCT01994876|96066|P2|Test Period 1|Adverse Event|1
20258|NCT01994876|96067|P1|Test Period 1|Adverse Event|0
20259|NCT01994876|96066|P2|Test Period 1|Withdrawal by Subject|1
20260|NCT01994876|96067|P1|Test Period 1|Withdrawal by Subject|0
20261|NCT01994863|96075|P2|Period 2|Withdrawal by Subject|1
20262|NCT01994863|96076|P1|Period 2|Withdrawal by Subject|1
20263|NCT01994863|96075|P2|Period 2|Lack of Efficacy|2
20264|NCT01994863|96076|P1|Period 2|Lack of Efficacy|0
20265|NCT01994863|96075|P2|Period 2|Adverse Event|1
20266|NCT01994863|96076|P1|Period 2|Adverse Event|0
20267|NCT01994863|96075|P2|Period 1|Lack of Efficacy|0
20268|NCT01994863|96076|P1|Period 1|Lack of Efficacy|1
20269|NCT01994863|96075|P2|Period 1|Trial stopped by sponsor|3
20270|NCT01994863|96076|P1|Period 1|Trial stopped by sponsor|1
20271|NCT01994863|96075|P2|Period 1|Withdrawal by Subject|0
20272|NCT01994863|96076|P1|Period 1|Withdrawal by Subject|1
20273|NCT01994863|96075|P2|Period 1|Adverse Event|0
20274|NCT01994863|96076|P1|Period 1|Adverse Event|4
20275|NCT01994837|96082|P1|Overall Study|Removed from study due to no response|1
20276|NCT01994837|96082|P1|Overall Study|Proceeded to transplant|1
20277|NCT01994837|96082|P1|Overall Study|Chose palliative care|1
20278|NCT01994837|96082|P1|Overall Study|Adverse event not related to progression|1
20279|NCT01994837|96082|P1|Overall Study|Fatal progressive disease|2
20280|NCT01994837|96082|P1|Overall Study|Adv event related to progressive disease|3
20281|NCT01994837|96082|P1|Overall Study|Progressive disease per protocol|23
20282|NCT01994720|96121|P2|Overall Study|Withdrawal by Subject|56
20283|NCT01994720|96122|P1|Overall Study|Withdrawal by Subject|46
20284|NCT01994629|96164|P2|Overall Study|Lost to Follow-up|3
20285|NCT01994629|96165|P1|Overall Study|Lost to Follow-up|0
20286|NCT01994629|96164|P2|Overall Study|Withdrawal by Subject|0
20287|NCT01994629|96165|P1|Overall Study|Withdrawal by Subject|1
20288|NCT01994395|96200|P2|Overall Study|Withdrawal by Subject|2
20289|NCT01994395|96201|P1|Overall Study|Withdrawal by Subject|1
20290|NCT01994291|96226|P3|Overall Study|Other|0
20291|NCT01994291|96227|P2|Overall Study|Other|2
20292|NCT01994291|96228|P1|Overall Study|Other|1
20293|NCT01994291|96226|P3|Overall Study|Withdrawal by Subject|5
20294|NCT01994291|96227|P2|Overall Study|Withdrawal by Subject|3
20295|NCT01994291|96228|P1|Overall Study|Withdrawal by Subject|6
20296|NCT01994291|96226|P3|Overall Study|Protocol Violation|0
20297|NCT01994291|96227|P2|Overall Study|Protocol Violation|0
20298|NCT01994291|96228|P1|Overall Study|Protocol Violation|1
20299|NCT01994291|96226|P3|Overall Study|Medication error without associated AE|1
20300|NCT01994291|96227|P2|Overall Study|Medication error without associated AE|0
20301|NCT01994291|96228|P1|Overall Study|Medication error without associated AE|1
20302|NCT01994291|96226|P3|Overall Study|Does not meet entrance criteria|0
20303|NCT01994291|96227|P2|Overall Study|Does not meet entrance criteria|0
20304|NCT01994291|96228|P1|Overall Study|Does not meet entrance criteria|1
20305|NCT01994291|96226|P3|Overall Study|Lost to Follow-up|0
20306|NCT01994291|96227|P2|Overall Study|Lost to Follow-up|1
20307|NCT01994291|96228|P1|Overall Study|Lost to Follow-up|1
20308|NCT01994291|96226|P3|Overall Study|Adverse Event|3
20309|NCT01994291|96227|P2|Overall Study|Adverse Event|1
20310|NCT01994291|96228|P1|Overall Study|Adverse Event|4
20311|NCT01994226|96284|P2|Overall Study|Early Cessation of treatment|11
20312|NCT01994226|96285|P1|Overall Study|Early Cessation of treatment|6
20313|NCT01994226|96284|P2|Overall Study|Protocol Violation|10
20314|NCT01994226|96285|P1|Overall Study|Protocol Violation|13
20315|NCT01993940|96293|P2|Overall Study|Other - Miscellaneous|1
20316|NCT01993940|96294|P1|Overall Study|Other - Miscellaneous|1
20317|NCT01993940|96293|P2|Overall Study|Death|0
20318|NCT01993940|96294|P1|Overall Study|Death|1
20319|NCT01993940|96293|P2|Overall Study|Protocol Violation|8
20320|NCT01993940|96294|P1|Overall Study|Protocol Violation|5
20321|NCT01993940|96293|P2|Overall Study|Lost to Follow-up|5
20322|NCT01993940|96294|P1|Overall Study|Lost to Follow-up|2
20323|NCT01993940|96293|P2|Overall Study|Withdrawal by Subject|19
20324|NCT01993940|96294|P1|Overall Study|Withdrawal by Subject|15
20325|NCT01993940|96293|P2|Overall Study|Adverse Event|11
20326|NCT01993940|96294|P1|Overall Study|Adverse Event|16
20327|NCT01993888|96310|P2|Overall Study|Withdrawal by Subject|1
20328|NCT01993888|96311|P1|Overall Study|Withdrawal by Subject|0
20329|NCT01993888|96310|P2|Overall Study|Lost to Follow-up|1
20330|NCT01993888|96311|P1|Overall Study|Lost to Follow-up|1
20331|NCT01993888|96310|P2|Overall Study|Death|1
20332|NCT01993888|96311|P1|Overall Study|Death|1
20333|NCT01993823|96329|P2|Overall Study|Lost to Follow-up|4
20334|NCT01993823|96330|P1|Overall Study|Lost to Follow-up|1
20335|NCT01993823|96329|P2|Overall Study|Protocol Violation|1
20336|NCT01993823|96330|P1|Overall Study|Protocol Violation|0
20337|NCT01993823|96329|P2|Overall Study|Requested by the patient|11
20338|NCT01993823|96330|P1|Overall Study|Requested by the patient|6
20339|NCT01993030|96345|P2|Overall Study|Adverse Event|4
20340|NCT01993030|96346|P1|Overall Study|Adverse Event|0
20341|NCT01992536|96400|P10|Overall Study|Withdrawal by Subject|0
20342|NCT01992536|96401|P9|Overall Study|Withdrawal by Subject|0
20343|NCT01992536|96402|P8|Overall Study|Withdrawal by Subject|0
20344|NCT01992536|96403|P7|Overall Study|Withdrawal by Subject|0
20345|NCT01992536|96404|P6|Overall Study|Withdrawal by Subject|0
20346|NCT01992536|96405|P5|Overall Study|Withdrawal by Subject|0
20347|NCT01992536|96406|P4|Overall Study|Withdrawal by Subject|2
20348|NCT01992536|96407|P3|Overall Study|Withdrawal by Subject|0
20349|NCT01992536|96408|P2|Overall Study|Withdrawal by Subject|1
20350|NCT01992536|96409|P1|Overall Study|Withdrawal by Subject|0
20351|NCT01992536|96400|P10|Overall Study|Lost to Follow-up|1
20352|NCT01992536|96401|P9|Overall Study|Lost to Follow-up|1
20353|NCT01992536|96402|P8|Overall Study|Lost to Follow-up|0
20354|NCT01992536|96403|P7|Overall Study|Lost to Follow-up|0
20355|NCT01992536|96404|P6|Overall Study|Lost to Follow-up|1
20356|NCT01992536|96405|P5|Overall Study|Lost to Follow-up|0
20357|NCT01992536|96406|P4|Overall Study|Lost to Follow-up|0
20358|NCT01992536|96407|P3|Overall Study|Lost to Follow-up|1
20359|NCT01992536|96408|P2|Overall Study|Lost to Follow-up|2
20360|NCT01992536|96409|P1|Overall Study|Lost to Follow-up|4
20361|NCT01992536|96400|P10|Overall Study|Administrative Reason|0
20362|NCT01992536|96401|P9|Overall Study|Administrative Reason|0
20363|NCT01992536|96402|P8|Overall Study|Administrative Reason|0
20364|NCT01992536|96403|P7|Overall Study|Administrative Reason|7
20365|NCT01992536|96404|P6|Overall Study|Administrative Reason|0
20366|NCT01992536|96405|P5|Overall Study|Administrative Reason|0
20367|NCT01992536|96406|P4|Overall Study|Administrative Reason|0
20368|NCT01992536|96407|P3|Overall Study|Administrative Reason|0
20369|NCT01992536|96408|P2|Overall Study|Administrative Reason|0
20370|NCT01992536|96409|P1|Overall Study|Administrative Reason|0
20371|NCT01992107|96660|P3|Overall Study|Withdrawal by Subject|8
20372|NCT01992107|96661|P2|Overall Study|Withdrawal by Subject|7
20373|NCT01992107|96662|P1|Overall Study|Withdrawal by Subject|13
20374|NCT01992107|96660|P3|Overall Study|noncompliance and were unavailable|2
20375|NCT01992107|96661|P2|Overall Study|noncompliance and were unavailable|3
20376|NCT01992107|96662|P1|Overall Study|noncompliance and were unavailable|7
20377|NCT01992107|96660|P3|Overall Study|Lost to Follow-up|26
20378|NCT01992107|96661|P2|Overall Study|Lost to Follow-up|22
20379|NCT01992107|96662|P1|Overall Study|Lost to Follow-up|46
20380|NCT01992107|96660|P3|Overall Study|Adverse Event|0
20381|NCT01992107|96661|P2|Overall Study|Adverse Event|1
20382|NCT01992107|96662|P1|Overall Study|Adverse Event|0
20383|NCT01992107|96660|P3|Overall Study|Administrative reasons|0
20384|NCT01992107|96661|P2|Overall Study|Administrative reasons|0
20385|NCT01992107|96662|P1|Overall Study|Administrative reasons|2
20386|NCT01992094|96718|P3|Overall Study|Withdrawal by Subject|4
20387|NCT01992094|96719|P2|Overall Study|Withdrawal by Subject|3
20388|NCT01992094|96720|P1|Overall Study|Withdrawal by Subject|7
20389|NCT01992094|96718|P3|Overall Study|Protocol Violation|1
20390|NCT01992094|96719|P2|Overall Study|Protocol Violation|0
20391|NCT01992094|96720|P1|Overall Study|Protocol Violation|1
20392|NCT01992094|96718|P3|Overall Study|OTHER|0
20393|NCT01992094|96719|P2|Overall Study|OTHER|0
20394|NCT01992094|96720|P1|Overall Study|OTHER|4
20395|NCT01992094|96718|P3|Overall Study|Lost to Follow-up|13
20396|NCT01992094|96719|P2|Overall Study|Lost to Follow-up|9
20397|NCT01992094|96720|P1|Overall Study|Lost to Follow-up|26
20398|NCT01992094|96718|P3|Overall Study|Death|2
20399|NCT01992094|96719|P2|Overall Study|Death|5
20400|NCT01992094|96720|P1|Overall Study|Death|5
20401|NCT01992094|96718|P3|Overall Study|Adverse Event|0
20402|NCT01992094|96719|P2|Overall Study|Adverse Event|0
20403|NCT01992094|96720|P1|Overall Study|Adverse Event|1
20404|NCT01992094|96718|P3|Overall Study|ADMINISTRATIVE REASON|1
20405|NCT01992094|96719|P2|Overall Study|ADMINISTRATIVE REASON|7
20406|NCT01992094|96720|P1|Overall Study|ADMINISTRATIVE REASON|6
20407|NCT01991314|96825|P2|Overall Study|Lost to Follow-up|10
20408|NCT01991314|96826|P1|Overall Study|Lost to Follow-up|6
20409|NCT01991314|96825|P2|Overall Study|Adverse Event|1
20410|NCT01991314|96826|P1|Overall Study|Adverse Event|5
20411|NCT01990859|96848|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
20412|NCT01990859|96848|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
20413|NCT01990664|96997|P2|Overall Study|Unsatisfactory Visual Response|1
20414|NCT01990664|96998|P1|Overall Study|Unsatisfactory Visual Response|0
20415|NCT01990664|96997|P2|Overall Study|Lens Handling Difficulties|0
20416|NCT01990664|96998|P1|Overall Study|Lens Handling Difficulties|1
20417|NCT01990664|96997|P2|Overall Study|Lens Discomfort|1
20418|NCT01990664|96998|P1|Overall Study|Lens Discomfort|1
20419|NCT01990664|96997|P2|Overall Study|Protocol Violation|0
20420|NCT01990664|96998|P1|Overall Study|Protocol Violation|1
20421|NCT01990664|96997|P2|Overall Study|Withdrawal by Subject|3
20422|NCT01990664|96998|P1|Overall Study|Withdrawal by Subject|2
20423|NCT01990664|96997|P2|Overall Study|Lost to Follow-up|6
20424|NCT01990664|96998|P1|Overall Study|Lost to Follow-up|2
20425|NCT01990560|97004|P1|Overall Study|Withdrawal by Subject|1
20426|NCT01990534|97018|P1|Overall Study|Overall Survival Follow-up|25
20427|NCT01990534|97018|P1|Overall Study|Progression Free Survival Follow-up|11
20428|NCT01990534|97018|P1|Overall Study|Reason Not Specified|2
20429|NCT01990534|97018|P1|Overall Study|Withdrawal by Subject|3
20430|NCT01990534|97018|P1|Overall Study|Symptomatic Deterioration|1
20431|NCT01990534|97018|P1|Overall Study|Withdrawal of Informed Consent|2
20432|NCT01990534|97018|P1|Overall Study|Protocol Violation|1
20433|NCT01990534|97018|P1|Overall Study|Progressive disease|3
20434|NCT01990534|97018|P1|Overall Study|Death|12
20435|NCT01990339|97034|P1|Overall Study|Lost to Follow-up|861
20436|NCT01990339|97034|P1|Overall Study|Voluntary Withdrawal|1402
20437|NCT01990339|97034|P1|Overall Study|Data Not Available|49
20438|NCT01990313|97039|P1|Overall Study|Lost to Follow-up|1
20439|NCT01990261|97044|P1|Overall Study|Lost to Follow-up|2
20440|NCT01990261|97044|P1|Overall Study|Dossier not Approved|1
20441|NCT01990261|97044|P1|Overall Study|PD Before Treatment Start|1
20442|NCT01990261|97044|P1|Overall Study|Disease Progression (PD)|8
20443|NCT01990261|97044|P1|Overall Study|Death From other Causes|1
20444|NCT01990261|97044|P1|Overall Study|Death due to Disease Progression (PD)|10
20445|NCT01990261|97044|P1|Overall Study|Death Before Treatment Start|2
20446|NCT01989689|97056|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
20447|NCT01989689|97057|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
20448|NCT01989689|97056|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
20449|NCT01989689|97057|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
20450|NCT01989676|97069|P2|Overall Study|Discontinued|68
20451|NCT01989676|97070|P1|Overall Study|Discontinued|59
20452|NCT01989676|97069|P2|Overall Study|Ongoing at data cutoff|279
20453|NCT01989676|97070|P1|Overall Study|Ongoing at data cutoff|279
20454|NCT01989572|97096|P6|Overall Study|alternative therapy|3
20455|NCT01989572|97097|P5|Overall Study|alternative therapy|1
20456|NCT01989572|97098|P4|Overall Study|alternative therapy|0
20457|NCT01989572|97099|P3|Overall Study|alternative therapy|0
20458|NCT01989572|97100|P2|Overall Study|alternative therapy|0
20459|NCT01989572|97101|P1|Overall Study|alternative therapy|3
20460|NCT01989572|97096|P6|Overall Study|not start protocol therapy|18
20461|NCT01989572|97097|P5|Overall Study|not start protocol therapy|4
20462|NCT01989572|97098|P4|Overall Study|not start protocol therapy|3
20463|NCT01989572|97099|P3|Overall Study|not start protocol therapy|2
20464|NCT01989572|97100|P2|Overall Study|not start protocol therapy|1
20465|NCT01989572|97101|P1|Overall Study|not start protocol therapy|5
20466|NCT01989572|97096|P6|Overall Study|unknown/not specify|5
20467|NCT01989572|97097|P5|Overall Study|unknown/not specify|3
20468|NCT01989572|97098|P4|Overall Study|unknown/not specify|3
20469|NCT01989572|97099|P3|Overall Study|unknown/not specify|1
20470|NCT01989572|97100|P2|Overall Study|unknown/not specify|4
20471|NCT01989572|97101|P1|Overall Study|unknown/not specify|3
20472|NCT01989572|97096|P6|Overall Study|maximum dose reached|0
20473|NCT01989572|97097|P5|Overall Study|maximum dose reached|1
20474|NCT01989572|97098|P4|Overall Study|maximum dose reached|0
20475|NCT01989572|97099|P3|Overall Study|maximum dose reached|0
20476|NCT01989572|97100|P2|Overall Study|maximum dose reached|1
20477|NCT01989572|97101|P1|Overall Study|maximum dose reached|0
20478|NCT01989572|97096|P6|Overall Study|error|1
20479|NCT01989572|97097|P5|Overall Study|error|1
20480|NCT01989572|97098|P4|Overall Study|error|1
20481|NCT01989572|97099|P3|Overall Study|error|1
20482|NCT01989572|97100|P2|Overall Study|error|1
20483|NCT01989572|97101|P1|Overall Study|error|2
20484|NCT01989572|97096|P6|Overall Study|complicating disease|0
20485|NCT01989572|97097|P5|Overall Study|complicating disease|1
20486|NCT01989572|97098|P4|Overall Study|complicating disease|0
20487|NCT01989572|97099|P3|Overall Study|complicating disease|2
20488|NCT01989572|97100|P2|Overall Study|complicating disease|1
20489|NCT01989572|97101|P1|Overall Study|complicating disease|1
20490|NCT01989572|97096|P6|Overall Study|Withdrawal by Subject|4
20491|NCT01989572|97097|P5|Overall Study|Withdrawal by Subject|12
20492|NCT01989572|97098|P4|Overall Study|Withdrawal by Subject|1
20493|NCT01989572|97099|P3|Overall Study|Withdrawal by Subject|5
20494|NCT01989572|97100|P2|Overall Study|Withdrawal by Subject|1
20495|NCT01989572|97101|P1|Overall Study|Withdrawal by Subject|4
20496|NCT01989572|97096|P6|Overall Study|Death|0
20497|NCT01989572|97097|P5|Overall Study|Death|1
20498|NCT01989572|97098|P4|Overall Study|Death|0
20499|NCT01989572|97099|P3|Overall Study|Death|0
20500|NCT01989572|97100|P2|Overall Study|Death|0
20501|NCT01989572|97101|P1|Overall Study|Death|0
20502|NCT01989572|97096|P6|Overall Study|Adverse Event|0
20503|NCT01989572|97097|P5|Overall Study|Adverse Event|3
20504|NCT01989572|97098|P4|Overall Study|Adverse Event|0
20505|NCT01989572|97099|P3|Overall Study|Adverse Event|3
20506|NCT01989572|97100|P2|Overall Study|Adverse Event|1
20507|NCT01989572|97101|P1|Overall Study|Adverse Event|2
20508|NCT01989572|97096|P6|Overall Study|Lack of Efficacy|79
20509|NCT01989572|97097|P5|Overall Study|Lack of Efficacy|71
20510|NCT01989572|97098|P4|Overall Study|Lack of Efficacy|43
20511|NCT01989572|97099|P3|Overall Study|Lack of Efficacy|48
20512|NCT01989572|97100|P2|Overall Study|Lack of Efficacy|48
20513|NCT01989572|97101|P1|Overall Study|Lack of Efficacy|35
20514|NCT01989455|97134|P5|Overall Study|Technical problems with infusion|1
20515|NCT01989455|97135|P4|Overall Study|Technical problems with infusion|0
20516|NCT01989455|97136|P3|Overall Study|Technical problems with infusion|1
20517|NCT01989455|97137|P2|Overall Study|Technical problems with infusion|0
20518|NCT01989455|97138|P1|Overall Study|Technical problems with infusion|0
20519|NCT01989455|97134|P5|Overall Study|Withdrawal by Subject|0
20520|NCT01989455|97135|P4|Overall Study|Withdrawal by Subject|0
20521|NCT01989455|97136|P3|Overall Study|Withdrawal by Subject|0
20522|NCT01989455|97137|P2|Overall Study|Withdrawal by Subject|1
20523|NCT01989455|97138|P1|Overall Study|Withdrawal by Subject|0
20524|NCT01989455|97134|P5|Overall Study|Adverse Event|0
20525|NCT01989455|97135|P4|Overall Study|Adverse Event|0
20526|NCT01989455|97136|P3|Overall Study|Adverse Event|0
20527|NCT01989455|97137|P2|Overall Study|Adverse Event|1
20528|NCT01989455|97138|P1|Overall Study|Adverse Event|0
20529|NCT01989169|97182|P2|Period 2|Adverse Event|1
20530|NCT01989169|97183|P1|Period 2|Adverse Event|0
20531|NCT01989156|97196|P3|End of Study (Population at Day 90)|Employment Conflict|0
20532|NCT01989156|97197|P2|End of Study (Population at Day 90)|Employment Conflict|1
20533|NCT01989156|97198|P1|End of Study (Population at Day 90)|Employment Conflict|0
20534|NCT01989156|97196|P3|End of Study (Population at Day 90)|Moved out of state|0
20535|NCT01989156|97197|P2|End of Study (Population at Day 90)|Moved out of state|0
20536|NCT01989156|97198|P1|End of Study (Population at Day 90)|Moved out of state|1
20537|NCT01989156|97196|P3|End of Study (Population at Day 90)|Physician Decision|1
20538|NCT01989156|97197|P2|End of Study (Population at Day 90)|Physician Decision|0
20539|NCT01989156|97198|P1|End of Study (Population at Day 90)|Physician Decision|1
20540|NCT01989156|97196|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
20541|NCT01989156|97197|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
20542|NCT01989156|97198|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
20543|NCT01989156|97196|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
20544|NCT01989156|97197|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
20545|NCT01989156|97198|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
20546|NCT01989156|97196|P3|Confinement Period (Population at Day 5)|Adverse Event|1
20547|NCT01989156|97197|P2|Confinement Period (Population at Day 5)|Adverse Event|0
20548|NCT01989156|97198|P1|Confinement Period (Population at Day 5)|Adverse Event|0
20549|NCT01989156|97196|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
20550|NCT01989156|97197|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
20551|NCT01989156|97198|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
20552|NCT01989156|97196|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
20553|NCT01989156|97197|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
20554|NCT01989156|97198|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
20555|NCT01988662|97258|P2|Overall Study|Adverse Event|1
20556|NCT01988662|97259|P1|Overall Study|Adverse Event|3
20557|NCT01988662|97258|P2|Overall Study|Subject/guardian decision|1
20558|NCT01988662|97259|P1|Overall Study|Subject/guardian decision|1
20559|NCT01988402|97286|P2|Overall Study|Withdrawal by Subject|0
20560|NCT01988402|97287|P1|Overall Study|Withdrawal by Subject|1
20561|NCT01988402|97286|P2|Overall Study|Adverse Event|2
20562|NCT01988402|97287|P1|Overall Study|Adverse Event|1
20563|NCT01988012|97329|P1|Overall Study|Protocol Violation|1
20564|NCT01988012|97329|P1|Overall Study|Physician Decision|1
20565|NCT01988012|97329|P1|Overall Study|Lost to Follow-up|1
20566|NCT01988012|97329|P1|Overall Study|Patient Withdrawal of Consent|4
20567|NCT01988012|97329|P1|Overall Study|Insufficient Therapeutic Response|3
20568|NCT01988012|97329|P1|Overall Study|Adverse Event|5
20569|NCT01987986|97355|P4|Overall Study|Adverse Event|0
20570|NCT01987986|97356|P3|Overall Study|Adverse Event|2
20571|NCT01987986|97357|P2|Overall Study|Adverse Event|0
20572|NCT01987986|97358|P1|Overall Study|Adverse Event|1
20573|NCT01987986|97355|P4|Overall Study|Lost to Follow-up|0
20574|NCT01987986|97356|P3|Overall Study|Lost to Follow-up|0
20575|NCT01987986|97357|P2|Overall Study|Lost to Follow-up|0
20576|NCT01987986|97358|P1|Overall Study|Lost to Follow-up|1
20577|NCT01987960|97398|P4|Period 3|Administrative or other reason|43
20578|NCT01987960|97399|P3|Period 3|Administrative or other reason|0
20579|NCT01987960|97400|P2|Period 3|Administrative or other reason|0
20580|NCT01987960|97401|P1|Period 3|Administrative or other reason|0
20581|NCT01987960|97398|P4|Period 3|Lost to Follow-up|5
20582|NCT01987960|97399|P3|Period 3|Lost to Follow-up|0
20583|NCT01987960|97400|P2|Period 3|Lost to Follow-up|0
20584|NCT01987960|97401|P1|Period 3|Lost to Follow-up|0
20585|NCT01987960|97398|P4|Period 3|Withdrawal by Subject|9
20586|NCT01987960|97399|P3|Period 3|Withdrawal by Subject|0
20587|NCT01987960|97400|P2|Period 3|Withdrawal by Subject|0
20588|NCT01987960|97401|P1|Period 3|Withdrawal by Subject|0
20589|NCT01987960|97398|P4|Period 3|Protocol Violation|6
20590|NCT01987960|97399|P3|Period 3|Protocol Violation|0
20591|NCT01987960|97400|P2|Period 3|Protocol Violation|0
20592|NCT01987960|97401|P1|Period 3|Protocol Violation|0
20593|NCT01987960|97398|P4|Period 3|Non-compliance with IMP|1
20594|NCT01987960|97399|P3|Period 3|Non-compliance with IMP|0
20595|NCT01987960|97400|P2|Period 3|Non-compliance with IMP|0
20596|NCT01987960|97401|P1|Period 3|Non-compliance with IMP|0
20597|NCT01987960|97398|P4|Period 3|Adverse Event|7
20598|NCT01987960|97399|P3|Period 3|Adverse Event|0
20599|NCT01987960|97400|P2|Period 3|Adverse Event|0
20600|NCT01987960|97401|P1|Period 3|Adverse Event|0
20601|NCT01987960|97398|P4|Period 2|Administrative or other reason|0
20602|NCT01987960|97399|P3|Period 2|Administrative or other reason|7
20603|NCT01987960|97400|P2|Period 2|Administrative or other reason|5
20604|NCT01987960|97401|P1|Period 2|Administrative or other reason|0
20605|NCT01987960|97398|P4|Period 2|Withdrawal by Subject|0
20606|NCT01987960|97399|P3|Period 2|Withdrawal by Subject|1
20607|NCT01987960|97400|P2|Period 2|Withdrawal by Subject|0
20608|NCT01987960|97401|P1|Period 2|Withdrawal by Subject|0
20609|NCT01987960|97398|P4|Period 2|Adverse Event|0
20610|NCT01987960|97399|P3|Period 2|Adverse Event|1
20611|NCT01987960|97400|P2|Period 2|Adverse Event|0
20612|NCT01987960|97401|P1|Period 2|Adverse Event|0
20613|NCT01987960|97398|P4|Period 1|Withdrawal of consent before treatment|0
20614|NCT01987960|97399|P3|Period 1|Withdrawal of consent before treatment|0
20615|NCT01987960|97400|P2|Period 1|Withdrawal of consent before treatment|0
20616|NCT01987960|97401|P1|Period 1|Withdrawal of consent before treatment|4
20617|NCT01987960|97398|P4|Period 1|administrative or other reason|0
20618|NCT01987960|97399|P3|Period 1|administrative or other reason|0
20619|NCT01987960|97400|P2|Period 1|administrative or other reason|0
20620|NCT01987960|97401|P1|Period 1|administrative or other reason|75
20621|NCT01987960|97398|P4|Period 1|Lost to Follow-up|0
20622|NCT01987960|97399|P3|Period 1|Lost to Follow-up|0
20623|NCT01987960|97400|P2|Period 1|Lost to Follow-up|0
20624|NCT01987960|97401|P1|Period 1|Lost to Follow-up|40
20625|NCT01987960|97398|P4|Period 1|Withdrawal by Subject|0
20626|NCT01987960|97399|P3|Period 1|Withdrawal by Subject|0
20627|NCT01987960|97400|P2|Period 1|Withdrawal by Subject|0
20628|NCT01987960|97401|P1|Period 1|Withdrawal by Subject|21
20629|NCT01987960|97398|P4|Period 1|Protocol Violation|0
20630|NCT01987960|97399|P3|Period 1|Protocol Violation|0
20631|NCT01987960|97400|P2|Period 1|Protocol Violation|0
20632|NCT01987960|97401|P1|Period 1|Protocol Violation|12
20633|NCT01987960|97398|P4|Period 1|Non-compliance with IMP|0
20634|NCT01987960|97399|P3|Period 1|Non-compliance with IMP|0
20635|NCT01987960|97400|P2|Period 1|Non-compliance with IMP|0
20636|NCT01987960|97401|P1|Period 1|Non-compliance with IMP|6
20637|NCT01987960|97398|P4|Period 1|Lack of Efficacy|0
20638|NCT01987960|97399|P3|Period 1|Lack of Efficacy|0
20639|NCT01987960|97400|P2|Period 1|Lack of Efficacy|0
20640|NCT01987960|97401|P1|Period 1|Lack of Efficacy|4
20641|NCT01987960|97398|P4|Period 1|Adverse Event|0
20642|NCT01987960|97399|P3|Period 1|Adverse Event|0
20643|NCT01987960|97400|P2|Period 1|Adverse Event|0
20644|NCT01987960|97401|P1|Period 1|Adverse Event|24
20645|NCT01987908|97413|P3|Post-Treatment Observation Period|Other: Bad Veins|0
20646|NCT01987908|97414|P2|Post-Treatment Observation Period|Other: Bad Veins|1
20647|NCT01987908|97415|P1|Post-Treatment Observation Period|Other: Bad Veins|0
20648|NCT01987908|97413|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
20649|NCT01987908|97414|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
20650|NCT01987908|97415|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
20651|NCT01987908|97413|P3|Treatment Period|Adverse Event|1
20652|NCT01987908|97414|P2|Treatment Period|Adverse Event|1
20653|NCT01987908|97415|P1|Treatment Period|Adverse Event|0
20654|NCT01987908|97413|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
20655|NCT01987908|97414|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
20656|NCT01987908|97415|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
20657|NCT01987908|97413|P3|Placebo Lead-in Period|Withdrawal by Subject|0
20658|NCT01987908|97414|P2|Placebo Lead-in Period|Withdrawal by Subject|0
20659|NCT01987908|97415|P1|Placebo Lead-in Period|Withdrawal by Subject|1
20660|NCT01987908|97413|P3|Placebo Lead-in Period|Physician Decision|0
20661|NCT01987908|97414|P2|Placebo Lead-in Period|Physician Decision|0
20662|NCT01987908|97415|P1|Placebo Lead-in Period|Physician Decision|2
20663|NCT01987908|97413|P3|Placebo Lead-in Period|Adverse Event|0
20664|NCT01987908|97414|P2|Placebo Lead-in Period|Adverse Event|0
20665|NCT01987908|97415|P1|Placebo Lead-in Period|Adverse Event|2
20666|NCT01987895|97498|P2|Overall Study|randomized before giving IC|1
20667|NCT01987895|97499|P1|Overall Study|randomized before giving IC|0
20668|NCT01987895|97498|P2|Overall Study|Lost to Follow-up|5
20669|NCT01987895|97499|P1|Overall Study|Lost to Follow-up|3
20670|NCT01987895|97498|P2|Overall Study|Death|7
20671|NCT01987895|97499|P1|Overall Study|Death|7
20672|NCT01987895|97498|P2|Overall Study|Physician Decision|10
20673|NCT01987895|97499|P1|Overall Study|Physician Decision|8
20674|NCT01987895|97498|P2|Overall Study|Withdrawal by Subject|7
20675|NCT01987895|97499|P1|Overall Study|Withdrawal by Subject|12
20676|NCT01987765|97523|P1|Overall Study|Lost to Follow-up|37
20677|NCT01987765|97523|P1|Overall Study|Protocol Violation|65
20678|NCT01987557|97547|P3|Overall Study|Adverse Event|0
20679|NCT01987557|97548|P2|Overall Study|Adverse Event|2
20680|NCT01987557|97549|P1|Overall Study|Adverse Event|0
20681|NCT01987557|97547|P3|Overall Study|Withdrawal by Subject|2
20682|NCT01987557|97548|P2|Overall Study|Withdrawal by Subject|1
20683|NCT01987557|97549|P1|Overall Study|Withdrawal by Subject|2
20684|NCT01987557|97547|P3|Overall Study|Protocol Violation|1
20685|NCT01987557|97548|P2|Overall Study|Protocol Violation|0
20686|NCT01987557|97549|P1|Overall Study|Protocol Violation|1
20687|NCT01987479|97557|P1|Overall Study|Adverse Event|7
20688|NCT01987479|97557|P1|Overall Study|Lost to Follow-up|1
20689|NCT01987479|97557|P1|Overall Study|Other|5
20690|NCT01987479|97557|P1|Overall Study|Participant/legal guardian decision|1
20691|NCT01987479|97557|P1|Overall Study|Physician Decision|2
20692|NCT01987479|97557|P1|Overall Study|Protocol Violation|1
20693|NCT01987453|97585|P3|Overall Study|Lack of Efficacy|0
20694|NCT01987453|97586|P2|Overall Study|Lack of Efficacy|12
20695|NCT01987453|97587|P1|Overall Study|Lack of Efficacy|1
20696|NCT01987453|97585|P3|Overall Study|Death|1
20697|NCT01987453|97586|P2|Overall Study|Death|0
20698|NCT01987453|97587|P1|Overall Study|Death|0
20699|NCT01987232|97656|P5|Overall Study|Ongoing in Study|0
20700|NCT01987232|97657|P4|Overall Study|Ongoing in Study|1
20701|NCT01987232|97658|P3|Overall Study|Ongoing in Study|0
20702|NCT01987232|97659|P2|Overall Study|Ongoing in Study|0
20703|NCT01987232|97660|P1|Overall Study|Ongoing in Study|0
20704|NCT01986985|97747|P1|Overall Study|Scan not completed due to malfunction|3
20705|NCT01986985|97747|P1|Overall Study|Withdrawal by Subject|4
20706|NCT01986855|97787|P3|Overall Study|Withdrawal by Subject|5
20707|NCT01986855|97788|P2|Overall Study|Withdrawal by Subject|8
20708|NCT01986855|97789|P1|Overall Study|Withdrawal by Subject|7
20709|NCT01986855|97787|P3|Overall Study|Participant Moved|2
20710|NCT01986855|97788|P2|Overall Study|Participant Moved|0
20711|NCT01986855|97789|P1|Overall Study|Participant Moved|0
20712|NCT01986855|97787|P3|Overall Study|Screen Failure|0
20713|NCT01986855|97788|P2|Overall Study|Screen Failure|1
20714|NCT01986855|97789|P1|Overall Study|Screen Failure|0
20715|NCT01986855|97787|P3|Overall Study|Lost to Follow-up|0
20716|NCT01986855|97788|P2|Overall Study|Lost to Follow-up|1
20717|NCT01986855|97789|P1|Overall Study|Lost to Follow-up|2
20718|NCT01986855|97787|P3|Overall Study|Death|4
20719|NCT01986855|97788|P2|Overall Study|Death|4
20720|NCT01986855|97789|P1|Overall Study|Death|3
20721|NCT01986855|97787|P3|Overall Study|Adverse Event|0
20722|NCT01986855|97788|P2|Overall Study|Adverse Event|0
20723|NCT01986855|97789|P1|Overall Study|Adverse Event|1
20724|NCT01986751|97839|P2|Overall Study|improperly consented|2
20725|NCT01986751|97840|P1|Overall Study|improperly consented|10
20726|NCT01986231|97894|P1|Overall Study|Adverse Event|1
20727|NCT01986062|97901|P2|Overall Study|Lost to Follow-up|1
20728|NCT01986062|97902|P1|Overall Study|Lost to Follow-up|1
20729|NCT01985321|97975|P2|Overall Study|Subject treated wrong type of sore|0
20730|NCT01985321|97976|P1|Overall Study|Subject treated wrong type of sore|1
20731|NCT01985321|97975|P2|Overall Study|Lost to Follow-up|2
20732|NCT01985321|97976|P1|Overall Study|Lost to Follow-up|5
20733|NCT01985321|97975|P2|Overall Study|Withdrawal by Subject|0
20734|NCT01985321|97976|P1|Overall Study|Withdrawal by Subject|1
20735|NCT01985321|97975|P2|Overall Study|Protocol Violation|3
20736|NCT01985321|97976|P1|Overall Study|Protocol Violation|4
20737|NCT01985126|97986|P2|Overall Study|Ongoing|67
20738|NCT01985126|97987|P1|Overall Study|Ongoing|9
20739|NCT01985126|97986|P2|Overall Study|Lost to Follow-up|3
20740|NCT01985126|97987|P1|Overall Study|Lost to Follow-up|0
20741|NCT01985126|97986|P2|Overall Study|Withdrawal by Subject|5
20742|NCT01985126|97987|P1|Overall Study|Withdrawal by Subject|2
20743|NCT01985126|97986|P2|Overall Study|Death|31
20744|NCT01985126|97987|P1|Overall Study|Death|7
20745|NCT01984892|98005|P1|Overall Study|Progressive disease|7
20746|NCT01984697|98016|P5|Overall Study|Follow-up continues|308
20747|NCT01984697|98017|P4|Overall Study|Follow-up continues|290
20748|NCT01984697|98018|P3|Overall Study|Follow-up continues|292
20749|NCT01984697|98019|P2|Overall Study|Follow-up continues|294
20750|NCT01984697|98020|P1|Overall Study|Follow-up continues|290
20751|NCT01984697|98016|P5|Overall Study|Withdrawal by Subject|2
20752|NCT01984697|98017|P4|Overall Study|Withdrawal by Subject|7
20753|NCT01984697|98018|P3|Overall Study|Withdrawal by Subject|4
20754|NCT01984697|98019|P2|Overall Study|Withdrawal by Subject|5
20755|NCT01984697|98020|P1|Overall Study|Withdrawal by Subject|3
20756|NCT01984697|98016|P5|Overall Study|Protocol Violation|0
20757|NCT01984697|98017|P4|Overall Study|Protocol Violation|1
20758|NCT01984697|98018|P3|Overall Study|Protocol Violation|0
20759|NCT01984697|98019|P2|Overall Study|Protocol Violation|0
20760|NCT01984697|98020|P1|Overall Study|Protocol Violation|0
20761|NCT01984697|98016|P5|Overall Study|Physician Decision|0
20762|NCT01984697|98017|P4|Overall Study|Physician Decision|0
20763|NCT01984697|98018|P3|Overall Study|Physician Decision|0
20764|NCT01984697|98019|P2|Overall Study|Physician Decision|0
20765|NCT01984697|98020|P1|Overall Study|Physician Decision|1
20766|NCT01984697|98016|P5|Overall Study|Lost to Follow-up|4
20767|NCT01984697|98017|P4|Overall Study|Lost to Follow-up|3
20768|NCT01984697|98018|P3|Overall Study|Lost to Follow-up|4
20769|NCT01984697|98019|P2|Overall Study|Lost to Follow-up|2
20770|NCT01984697|98020|P1|Overall Study|Lost to Follow-up|7
20771|NCT01984697|98016|P5|Overall Study|Adverse Event|0
20772|NCT01984697|98017|P4|Overall Study|Adverse Event|0
20773|NCT01984697|98018|P3|Overall Study|Adverse Event|1
20774|NCT01984697|98019|P2|Overall Study|Adverse Event|0
20775|NCT01984697|98020|P1|Overall Study|Adverse Event|0
20776|NCT01984684|98119|P2|Overall Study|Subject had inadequate IV access|1
20777|NCT01984684|98120|P1|Overall Study|Subject had inadequate IV access|0
20778|NCT01984684|98119|P2|Overall Study|Study drug not available at site|1
20779|NCT01984684|98120|P1|Overall Study|Study drug not available at site|1
20780|NCT01984684|98119|P2|Overall Study|Subject incarcerated|0
20781|NCT01984684|98120|P1|Overall Study|Subject incarcerated|1
20782|NCT01984684|98119|P2|Overall Study|Noncompliance with study drug|1
20783|NCT01984684|98120|P1|Overall Study|Noncompliance with study drug|2
20784|NCT01984684|98119|P2|Overall Study|Death|1
20785|NCT01984684|98120|P1|Overall Study|Death|0
20786|NCT01984684|98119|P2|Overall Study|Protocol Violation|2
20787|NCT01984684|98120|P1|Overall Study|Protocol Violation|4
20788|NCT01984684|98119|P2|Overall Study|Physician Decision|2
20789|NCT01984684|98120|P1|Overall Study|Physician Decision|4
20790|NCT01984684|98119|P2|Overall Study|Lack of Efficacy|6
20791|NCT01984684|98120|P1|Overall Study|Lack of Efficacy|3
20792|NCT01984684|98119|P2|Overall Study|Withdrawal by Subject|9
20793|NCT01984684|98120|P1|Overall Study|Withdrawal by Subject|9
20794|NCT01984684|98119|P2|Overall Study|Adverse Event|12
20795|NCT01984684|98120|P1|Overall Study|Adverse Event|8
20796|NCT01984684|98119|P2|Overall Study|Lost to Follow-up|24
20797|NCT01984684|98120|P1|Overall Study|Lost to Follow-up|25
20798|NCT01984424|98138|P2|Overall Study|Lost to Follow-up|1
20799|NCT01984424|98139|P1|Overall Study|Lost to Follow-up|0
20800|NCT01984424|98138|P2|Overall Study|Sponsor Decision|1
20801|NCT01984424|98139|P1|Overall Study|Sponsor Decision|0
20802|NCT01984424|98138|P2|Overall Study|Withdrawal by Subject|5
20803|NCT01984424|98139|P1|Overall Study|Withdrawal by Subject|3
20804|NCT01984294|98194|P3|Overall Study|Adverse Event|0
20805|NCT01984294|98195|P2|Overall Study|Adverse Event|1
20806|NCT01984294|98196|P1|Overall Study|Adverse Event|0
20807|NCT01984294|98194|P3|Overall Study|Lack of Efficacy|6
20808|NCT01984294|98195|P2|Overall Study|Lack of Efficacy|2
20809|NCT01984294|98196|P1|Overall Study|Lack of Efficacy|4
20810|NCT01984294|98194|P3|Overall Study|Randomized but Never Treated|1
20811|NCT01984294|98195|P2|Overall Study|Randomized but Never Treated|0
20812|NCT01984294|98196|P1|Overall Study|Randomized but Never Treated|0
20813|NCT01984242|98219|P3|Overall Study|Ongoing in Study|61
20814|NCT01984242|98220|P2|Overall Study|Ongoing in Study|65
20815|NCT01984242|98221|P1|Overall Study|Ongoing in Study|60
20816|NCT01984242|98219|P3|Overall Study|Randomized, but not treated|1
20817|NCT01984242|98220|P2|Overall Study|Randomized, but not treated|0
20818|NCT01984242|98221|P1|Overall Study|Randomized, but not treated|0
20819|NCT01984242|98219|P3|Overall Study|Other|1
20820|NCT01984242|98220|P2|Overall Study|Other|0
20821|NCT01984242|98221|P1|Overall Study|Other|1
20822|NCT01984242|98219|P3|Overall Study|Lost to Follow-up|1
20823|NCT01984242|98220|P2|Overall Study|Lost to Follow-up|0
20824|NCT01984242|98221|P1|Overall Study|Lost to Follow-up|0
20825|NCT01984242|98219|P3|Overall Study|Physician Decision|2
20826|NCT01984242|98220|P2|Overall Study|Physician Decision|0
20827|NCT01984242|98221|P1|Overall Study|Physician Decision|1
20828|NCT01984242|98219|P3|Overall Study|Withdrawal by Subject|5
20829|NCT01984242|98220|P2|Overall Study|Withdrawal by Subject|2
20830|NCT01984242|98221|P1|Overall Study|Withdrawal by Subject|2
20831|NCT01984242|98219|P3|Overall Study|Death|30
20832|NCT01984242|98220|P2|Overall Study|Death|36
20833|NCT01984242|98221|P1|Overall Study|Death|37
20834|NCT01984229|98371|P2|Safety Follow-up Period|Lost to Follow-up|0
20835|NCT01984229|98372|P1|Safety Follow-up Period|Lost to Follow-up|1
20836|NCT01984229|98371|P2|Safety Follow-up Period|Adverse Event|1
20837|NCT01984229|98372|P1|Safety Follow-up Period|Adverse Event|1
20838|NCT01983683|98463|P2|Overall Study|Sponsor Decision|1
20839|NCT01983683|98464|P1|Overall Study|Sponsor Decision|1
20840|NCT01983683|98463|P2|Overall Study|Lost to Follow-up|8
20841|NCT01983683|98464|P1|Overall Study|Lost to Follow-up|4
20842|NCT01983683|98463|P2|Overall Study|Physician Decision|9
20843|NCT01983683|98464|P1|Overall Study|Physician Decision|8
20844|NCT01983683|98463|P2|Overall Study|Death|15
20845|NCT01983683|98464|P1|Overall Study|Death|11
20846|NCT01983683|98463|P2|Overall Study|Withdrawal by Subject|18
20847|NCT01983683|98464|P1|Overall Study|Withdrawal by Subject|14
20848|NCT01983254|98516|P2|Overall Study|too ill|8
20849|NCT01983254|98517|P1|Overall Study|too ill|11
20850|NCT01983254|98516|P2|Overall Study|Lost to Follow-up|16
20851|NCT01983254|98517|P1|Overall Study|Lost to Follow-up|17
20852|NCT01983254|98516|P2|Overall Study|Death|6
20853|NCT01983254|98517|P1|Overall Study|Death|6
20854|NCT01983111|98529|P2|Overall Study|Protocol Violation|1
20855|NCT01983111|98530|P1|Overall Study|Protocol Violation|0
20856|NCT01983111|98529|P2|Overall Study|Adverse Event|0
20857|NCT01983111|98530|P1|Overall Study|Adverse Event|4
20858|NCT01983111|98529|P2|Overall Study|Withdrawal by Subject|6
20859|NCT01983111|98530|P1|Overall Study|Withdrawal by Subject|8
20860|NCT01982812|98565|P2|Overall Study|Adverse Event|5
20861|NCT01982812|98566|P1|Overall Study|Adverse Event|0
20862|NCT01982812|98565|P2|Overall Study|Death|5
20863|NCT01982812|98566|P1|Overall Study|Death|1
20864|NCT01982773|98580|P2|Overall Study|Lost to Follow-up|1
20865|NCT01982773|98581|P1|Overall Study|Lost to Follow-up|7
20866|NCT01982773|98580|P2|Overall Study|Withdrawal by Subject|3
20867|NCT01982773|98581|P1|Overall Study|Withdrawal by Subject|1
20868|NCT01982435|98608|P2|Overall Study|Adverse Event|0
20869|NCT01982435|98609|P1|Overall Study|Adverse Event|1
20870|NCT01982292|98648|P2|Overall Study|Technical Problems|0
20871|NCT01982292|98649|P1|Overall Study|Technical Problems|2
20872|NCT01982292|98648|P2|Overall Study|Patient/Guardian Decision|1
20873|NCT01982292|98649|P1|Overall Study|Patient/Guardian Decision|3
20874|NCT01982292|98648|P2|Overall Study|Protocol Deviation|0
20875|NCT01982292|98649|P1|Overall Study|Protocol Deviation|1
20876|NCT01982292|98648|P2|Overall Study|Non-Compliance With Study Treatment|0
20877|NCT01982292|98649|P1|Overall Study|Non-Compliance With Study Treatment|1
20878|NCT01982292|98648|P2|Overall Study|Lost to Follow-up|0
20879|NCT01982292|98649|P1|Overall Study|Lost to Follow-up|2
20880|NCT01982292|98648|P2|Overall Study|Death|0
20881|NCT01982292|98649|P1|Overall Study|Death|1
20882|NCT01982292|98648|P2|Overall Study|Adverse Event|0
20883|NCT01982292|98649|P1|Overall Study|Adverse Event|2
20884|NCT01982253|98670|P3|Overall Study|Study terminated by sponsor|4
20885|NCT01982253|98671|P2|Overall Study|Study terminated by sponsor|4
20886|NCT01982253|98672|P1|Overall Study|Study terminated by sponsor|1
20887|NCT01982253|98670|P3|Overall Study|Withdrawal by Subject|0
20888|NCT01982253|98671|P2|Overall Study|Withdrawal by Subject|0
20889|NCT01982253|98672|P1|Overall Study|Withdrawal by Subject|1
20890|NCT01981616|98711|P2|Overall Study|Protocol Violation|0
20891|NCT01981616|98712|P1|Overall Study|Protocol Violation|1
20892|NCT01981616|98711|P2|Overall Study|Adverse Event|1
20893|NCT01981616|98712|P1|Overall Study|Adverse Event|0
20894|NCT01981473|98738|P3|Overall Study|Received treatment for >24 months|6
20895|NCT01981473|98739|P2|Overall Study|Received treatment for >24 months|0
20896|NCT01981473|98740|P1|Overall Study|Received treatment for >24 months|2
20897|NCT01981473|98738|P3|Overall Study|Received treatment for < 6 months|1
20898|NCT01981473|98739|P2|Overall Study|Received treatment for < 6 months|0
20899|NCT01981473|98740|P1|Overall Study|Received treatment for < 6 months|0
20900|NCT01981473|98738|P3|Overall Study|Incorrect diagnosis of RA|1
20901|NCT01981473|98739|P2|Overall Study|Incorrect diagnosis of RA|0
20902|NCT01981473|98740|P1|Overall Study|Incorrect diagnosis of RA|0
20903|NCT01981356|98781|P2|Overall Study|Protocol Violation|0
20904|NCT01981356|98782|P1|Overall Study|Protocol Violation|2
20905|NCT01981356|98781|P2|Overall Study|Withdrawal by Subject|1
20906|NCT01981356|98782|P1|Overall Study|Withdrawal by Subject|1
20907|NCT01981356|98781|P2|Overall Study|Lost to Follow-up|1
20908|NCT01981356|98782|P1|Overall Study|Lost to Follow-up|4
20909|NCT01980992|98818|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
20910|NCT01980992|98819|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
20911|NCT01980992|98818|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
20912|NCT01980992|98819|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
20913|NCT01980992|98818|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
20914|NCT01980992|98819|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
20915|NCT01980992|98818|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
20916|NCT01980992|98819|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
20917|NCT01980992|98818|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
20918|NCT01980992|98819|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
20919|NCT01980992|98818|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
20920|NCT01980992|98819|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
20921|NCT01980940|98844|P8|Overall Study|Protocol Violation|0
20922|NCT01980940|98845|P7|Overall Study|Protocol Violation|0
20923|NCT01980940|98846|P6|Overall Study|Protocol Violation|2
20924|NCT01980940|98847|P5|Overall Study|Protocol Violation|0
20925|NCT01980940|98848|P4|Overall Study|Protocol Violation|0
20926|NCT01980940|98849|P3|Overall Study|Protocol Violation|0
20927|NCT01980940|98850|P2|Overall Study|Protocol Violation|0
20928|NCT01980940|98851|P1|Overall Study|Protocol Violation|0
20929|NCT01980888|98905|P2|Overall Study|Non-Compliance with Study Drug|2
20930|NCT01980888|98906|P1|Overall Study|Non-Compliance with Study Drug|3
20931|NCT01980888|98905|P2|Overall Study|Investigator's Discretion|3
20932|NCT01980888|98906|P1|Overall Study|Investigator's Discretion|8
20933|NCT01980888|98905|P2|Overall Study|Withdrew Consent|6
20934|NCT01980888|98906|P1|Overall Study|Withdrew Consent|17
20935|NCT01980888|98905|P2|Overall Study|Study Terminated by Sponsor|122
20936|NCT01980888|98906|P1|Overall Study|Study Terminated by Sponsor|116
20937|NCT01980875|98925|P3|Overall Study|Lost to Follow-up|1
20938|NCT01980875|98926|P2|Overall Study|Lost to Follow-up|0
20939|NCT01980875|98927|P1|Overall Study|Lost to Follow-up|0
20940|NCT01980875|98925|P3|Overall Study|Study Terminated by Sponsor|22
20941|NCT01980875|98926|P2|Overall Study|Study Terminated by Sponsor|24
20942|NCT01980875|98927|P1|Overall Study|Study Terminated by Sponsor|7
20943|NCT01980875|98925|P3|Overall Study|Withdrew Consent|1
20944|NCT01980875|98926|P2|Overall Study|Withdrew Consent|1
20945|NCT01980875|98927|P1|Overall Study|Withdrew Consent|1
20946|NCT01980095|98998|P2|Overall Study|Study drug discontinued|0
20947|NCT01980095|98999|P1|Overall Study|Study drug discontinued|1
20948|NCT01980095|98998|P2|Overall Study|Safety issue|1
20949|NCT01980095|98999|P1|Overall Study|Safety issue|0
20950|NCT01980095|98998|P2|Overall Study|Poor compliance|0
20951|NCT01980095|98999|P1|Overall Study|Poor compliance|5
20952|NCT01980095|98998|P2|Overall Study|Withdrawal by Subject|3
20953|NCT01980095|98999|P1|Overall Study|Withdrawal by Subject|2
20954|NCT01980095|98998|P2|Overall Study|Lost to Follow-up|7
20955|NCT01980095|98999|P1|Overall Study|Lost to Follow-up|6
20956|NCT01979952|99009|P2|Overall Study|Other than specified above|0
20957|NCT01979952|99010|P1|Overall Study|Other than specified above|1
20958|NCT01979952|99009|P2|Overall Study|Withdrawal by Subject|1
20959|NCT01979952|99010|P1|Overall Study|Withdrawal by Subject|2
20960|NCT01979952|99009|P2|Overall Study|Protocol Violation|0
20961|NCT01979952|99010|P1|Overall Study|Protocol Violation|1
20962|NCT01979952|99009|P2|Overall Study|Adverse Event|5
20963|NCT01979952|99010|P1|Overall Study|Adverse Event|4
20964|NCT01979185|99077|P2|Period 2|Not specified|1
20965|NCT01979185|99078|P1|Period 2|Not specified|0
20966|NCT01978145|99243|P2|Treatment Period 2|Par. reached defined stopping criteria|5
20967|NCT01978145|99244|P1|Treatment Period 2|Par. reached defined stopping criteria|8
20968|NCT01978145|99243|P2|Treatment Period 2|Withdrawal by Subject|4
20969|NCT01978145|99244|P1|Treatment Period 2|Withdrawal by Subject|7
20970|NCT01978145|99243|P2|Treatment Period 2|Lost to Follow-up|1
20971|NCT01978145|99244|P1|Treatment Period 2|Lost to Follow-up|1
20972|NCT01978145|99243|P2|Treatment Period 2|Protocol Violation|1
20973|NCT01978145|99244|P1|Treatment Period 2|Protocol Violation|0
20974|NCT01978145|99243|P2|Treatment Period 2|Adverse Event|3
20975|NCT01978145|99244|P1|Treatment Period 2|Adverse Event|3
20976|NCT01978145|99243|P2|Washout Period 1|Par. reached defined stopping criteria|1
20977|NCT01978145|99244|P1|Washout Period 1|Par. reached defined stopping criteria|0
20978|NCT01978145|99243|P2|Washout Period 1|Withdrawal by Subject|1
20979|NCT01978145|99244|P1|Washout Period 1|Withdrawal by Subject|1
20980|NCT01978145|99243|P2|Washout Period 1|Adverse Event|1
20981|NCT01978145|99244|P1|Washout Period 1|Adverse Event|0
20982|NCT01978145|99243|P2|Treatment Period 1|Par. reached defined stopping criteria|3
20983|NCT01978145|99244|P1|Treatment Period 1|Par. reached defined stopping criteria|2
20984|NCT01978145|99243|P2|Treatment Period 1|Withdrawal by Subject|4
20985|NCT01978145|99244|P1|Treatment Period 1|Withdrawal by Subject|5
20986|NCT01978145|99243|P2|Treatment Period 1|Physician Decision|0
20987|NCT01978145|99244|P1|Treatment Period 1|Physician Decision|1
20988|NCT01978145|99243|P2|Treatment Period 1|Adverse Event|9
20989|NCT01978145|99244|P1|Treatment Period 1|Adverse Event|1
20990|NCT01978119|99260|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
20991|NCT01978119|99261|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
20992|NCT01978119|99260|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
20993|NCT01978119|99261|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
20994|NCT01978119|99260|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
20995|NCT01978119|99261|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
20996|NCT01977820|99287|P2|Overall Study|Sponsor terminated the study|1
20997|NCT01977820|99288|P1|Overall Study|Sponsor terminated the study|1
20998|NCT01977794|99296|P2|Overall Study|Other|1
20999|NCT01977794|99297|P1|Overall Study|Other|0
21000|NCT01977794|99296|P2|Overall Study|Withdrew consent|1
21001|NCT01977794|99297|P1|Overall Study|Withdrew consent|2
21002|NCT01977794|99296|P2|Overall Study|Death|1
21003|NCT01977794|99297|P1|Overall Study|Death|1
21004|NCT01977794|99296|P2|Overall Study|Protocol Violation|0
21005|NCT01977794|99297|P1|Overall Study|Protocol Violation|1
21006|NCT01977794|99296|P2|Overall Study|Lost to Follow-up|1
21007|NCT01977794|99297|P1|Overall Study|Lost to Follow-up|2
21008|NCT01977794|99296|P2|Overall Study|Adverse Event|2
21009|NCT01977794|99297|P1|Overall Study|Adverse Event|2
21010|NCT01977729|99332|P1|Overall Study|Study terminated|1
21011|NCT01977690|99344|P2|Overall Study|Withdrawal by Subject|4
21012|NCT01977690|99345|P1|Overall Study|Withdrawal by Subject|0
21013|NCT01977625|99351|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
21014|NCT01977625|99352|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
21015|NCT01977625|99351|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
21016|NCT01977625|99352|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
21017|NCT01977612|99362|P2|Overall Study|Lost to Follow-up|1
21018|NCT01977612|99363|P1|Overall Study|Lost to Follow-up|1
21019|NCT01977573|99385|P4|Overall Study|Withdrawal by Subject|1
21020|NCT01977573|99386|P3|Overall Study|Withdrawal by Subject|1
21021|NCT01977573|99387|P2|Overall Study|Withdrawal by Subject|1
21022|NCT01977573|99388|P1|Overall Study|Withdrawal by Subject|6
21023|NCT01977573|99385|P4|Overall Study|Reached Defined Stopping Criteria|0
21024|NCT01977573|99386|P3|Overall Study|Reached Defined Stopping Criteria|1
21025|NCT01977573|99387|P2|Overall Study|Reached Defined Stopping Criteria|1
21026|NCT01977573|99388|P1|Overall Study|Reached Defined Stopping Criteria|2
21027|NCT01977573|99385|P4|Overall Study|Protocol Violation|0
21028|NCT01977573|99386|P3|Overall Study|Protocol Violation|0
21029|NCT01977573|99387|P2|Overall Study|Protocol Violation|1
21030|NCT01977573|99388|P1|Overall Study|Protocol Violation|3
21031|NCT01977573|99385|P4|Overall Study|Physician Decision|0
21032|NCT01977573|99386|P3|Overall Study|Physician Decision|0
21033|NCT01977573|99387|P2|Overall Study|Physician Decision|0
21034|NCT01977573|99388|P1|Overall Study|Physician Decision|1
21035|NCT01977573|99385|P4|Overall Study|Lost to Follow-up|1
21036|NCT01977573|99386|P3|Overall Study|Lost to Follow-up|0
21037|NCT01977573|99387|P2|Overall Study|Lost to Follow-up|0
21038|NCT01977573|99388|P1|Overall Study|Lost to Follow-up|1
21039|NCT01977573|99385|P4|Overall Study|Adverse Event|1
21040|NCT01977573|99386|P3|Overall Study|Adverse Event|2
21041|NCT01977573|99387|P2|Overall Study|Adverse Event|0
21042|NCT01977573|99388|P1|Overall Study|Adverse Event|7
21043|NCT01977482|99502|P6|Overall Study|Withdrawal by Subject|5
21044|NCT01977482|99503|P5|Overall Study|Withdrawal by Subject|1
21045|NCT01977482|99504|P4|Overall Study|Withdrawal by Subject|3
21046|NCT01977482|99505|P3|Overall Study|Withdrawal by Subject|1
21047|NCT01977482|99506|P2|Overall Study|Withdrawal by Subject|4
21048|NCT01977482|99507|P1|Overall Study|Withdrawal by Subject|2
21049|NCT01977482|99502|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
21050|NCT01977482|99503|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
21051|NCT01977482|99504|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
21052|NCT01977482|99505|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
21053|NCT01977482|99506|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
21054|NCT01977482|99507|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
21055|NCT01977482|99502|P6|Overall Study|Protocol Violation|0
21056|NCT01977482|99503|P5|Overall Study|Protocol Violation|0
21057|NCT01977482|99504|P4|Overall Study|Protocol Violation|0
21058|NCT01977482|99505|P3|Overall Study|Protocol Violation|1
21059|NCT01977482|99506|P2|Overall Study|Protocol Violation|0
21060|NCT01977482|99507|P1|Overall Study|Protocol Violation|0
21061|NCT01977482|99502|P6|Overall Study|Physician Decision|0
21062|NCT01977482|99503|P5|Overall Study|Physician Decision|0
21063|NCT01977482|99504|P4|Overall Study|Physician Decision|0
21064|NCT01977482|99505|P3|Overall Study|Physician Decision|0
21065|NCT01977482|99506|P2|Overall Study|Physician Decision|1
21066|NCT01977482|99507|P1|Overall Study|Physician Decision|0
21067|NCT01977482|99502|P6|Overall Study|Lost to Follow-up|0
21068|NCT01977482|99503|P5|Overall Study|Lost to Follow-up|0
21069|NCT01977482|99504|P4|Overall Study|Lost to Follow-up|0
21070|NCT01977482|99505|P3|Overall Study|Lost to Follow-up|0
21071|NCT01977482|99506|P2|Overall Study|Lost to Follow-up|0
21072|NCT01977482|99507|P1|Overall Study|Lost to Follow-up|1
21073|NCT01977482|99502|P6|Overall Study|Adverse Event|0
21074|NCT01977482|99503|P5|Overall Study|Adverse Event|2
21075|NCT01977482|99504|P4|Overall Study|Adverse Event|0
21076|NCT01977482|99505|P3|Overall Study|Adverse Event|1
21077|NCT01977482|99506|P2|Overall Study|Adverse Event|1
21078|NCT01977482|99507|P1|Overall Study|Adverse Event|0
21079|NCT01977456|99622|P1|Overall Study|Death|5
21080|NCT01977352|99631|P2|Overall Study|Lost to Follow-up|2
21081|NCT01977352|99632|P1|Overall Study|Lost to Follow-up|1
21082|NCT01977222|99650|P1|Overall Study|Withdrawal by Subject|1
21083|NCT01976845|99692|P3|Overall Study|Physician Decision|3
21084|NCT01976845|99693|P2|Overall Study|Physician Decision|8
21085|NCT01976845|99694|P1|Overall Study|Physician Decision|8
21086|NCT01976806|99719|P2|Overall Study|Withdrawal by Subject|1
21087|NCT01976806|99720|P1|Overall Study|Withdrawal by Subject|1
21088|NCT01976806|99719|P2|Overall Study|Adverse Event|1
21089|NCT01976806|99720|P1|Overall Study|Adverse Event|1
21090|NCT01976806|99719|P2|Overall Study|Lost to Follow-up|4
21091|NCT01976806|99720|P1|Overall Study|Lost to Follow-up|1
21092|NCT01976663|99748|P1|Overall Study|Lost to Follow-up|3
21093|NCT01976663|99748|P1|Overall Study|Adverse Event|2
21094|NCT01976663|99748|P1|Overall Study|Screen Failure|3
21095|NCT01976663|99748|P1|Overall Study|Withdrawal by Subject|4
21096|NCT01976663|99748|P1|Overall Study|Personal Reasons|6
21097|NCT01976663|99748|P1|Overall Study|Completed 18 mos but no repeat treatment|24
21098|NCT01976624|99767|P1|Overall Study|Participants age less than 19 years|12
21099|NCT01976624|99767|P1|Overall Study|Participants contraindicated|2
21100|NCT01976507|99795|P1|Overall Study|ablation not done, drug not given|1
21101|NCT01976507|99795|P1|Overall Study|Adverse Event|6
21102|NCT01976338|99819|P2|Overall Study|Adverse Event|1
21103|NCT01976338|99820|P1|Overall Study|Adverse Event|5
21104|NCT01976338|99819|P2|Overall Study|Withdrawal by Subject|2
21105|NCT01976338|99820|P1|Overall Study|Withdrawal by Subject|5
21106|NCT01976338|99819|P2|Overall Study|Lost to Follow-up|0
21107|NCT01976338|99820|P1|Overall Study|Lost to Follow-up|3
21108|NCT01976338|99819|P2|Overall Study|Physician Decision|1
21109|NCT01976338|99820|P1|Overall Study|Physician Decision|0
21110|NCT01976312|99847|P2|Overall Study|Protocol Violation|0
21111|NCT01976312|99848|P1|Overall Study|Protocol Violation|2
21112|NCT01976312|99847|P2|Overall Study|Adverse Event|6
21113|NCT01976312|99848|P1|Overall Study|Adverse Event|6
21114|NCT01976312|99847|P2|Overall Study|Withdrawal by Subject|2
21115|NCT01976312|99848|P1|Overall Study|Withdrawal by Subject|7
21116|NCT01976312|99847|P2|Overall Study|Lost to Follow-up|0
21117|NCT01976312|99848|P1|Overall Study|Lost to Follow-up|2
21118|NCT01976312|99847|P2|Overall Study|Pregnancy|1
21119|NCT01976312|99848|P1|Overall Study|Pregnancy|0
21120|NCT01976299|99869|P2|Overall Study|See clarification above in comments|2
21121|NCT01976299|99870|P1|Overall Study|See clarification above in comments|9
21122|NCT01976299|99869|P2|Overall Study|Lost to Follow-up|1
21123|NCT01976299|99870|P1|Overall Study|Lost to Follow-up|7
21124|NCT01976299|99869|P2|Overall Study|Death|2
21125|NCT01976299|99870|P1|Overall Study|Death|4
21126|NCT01976299|99869|P2|Overall Study|Withdrawal by Subject|1
21127|NCT01976299|99870|P1|Overall Study|Withdrawal by Subject|3
21128|NCT01976104|99897|P4|Overall Study|Other|0
21129|NCT01976104|99898|P3|Overall Study|Other|0
21130|NCT01976104|99899|P2|Overall Study|Other|1
21131|NCT01976104|99900|P1|Overall Study|Other|0
21132|NCT01976104|99897|P4|Overall Study|Withdrawal by Subject|1
21133|NCT01976104|99898|P3|Overall Study|Withdrawal by Subject|0
21134|NCT01976104|99899|P2|Overall Study|Withdrawal by Subject|0
21135|NCT01976104|99900|P1|Overall Study|Withdrawal by Subject|3
21136|NCT01976104|99897|P4|Overall Study|Subject Choice|1
21137|NCT01976104|99898|P3|Overall Study|Subject Choice|0
21138|NCT01976104|99899|P2|Overall Study|Subject Choice|1
21139|NCT01976104|99900|P1|Overall Study|Subject Choice|0
21140|NCT01976104|99897|P4|Overall Study|Lost to Follow-up|1
21141|NCT01976104|99898|P3|Overall Study|Lost to Follow-up|1
21142|NCT01976104|99899|P2|Overall Study|Lost to Follow-up|0
21143|NCT01976104|99900|P1|Overall Study|Lost to Follow-up|3
21144|NCT01976104|99897|P4|Overall Study|Adverse Event|0
21145|NCT01976104|99898|P3|Overall Study|Adverse Event|1
21146|NCT01976104|99899|P2|Overall Study|Adverse Event|0
21147|NCT01976104|99900|P1|Overall Study|Adverse Event|0
21148|NCT01975948|99934|P4|Overall Study|Withdrawal by Subject|6
21149|NCT01975948|99935|P3|Overall Study|Withdrawal by Subject|7
21150|NCT01975948|99936|P2|Overall Study|Withdrawal by Subject|21
21151|NCT01975948|99937|P1|Overall Study|Withdrawal by Subject|17
21152|NCT01975675|100008|P4|Overall Study|Death|0
21153|NCT01975675|100009|P3|Overall Study|Death|0
21154|NCT01975675|100010|P2|Overall Study|Death|1
21155|NCT01975675|100011|P1|Overall Study|Death|0
21156|NCT01975285|100044|P2|Overall Study|Failed Block and follow up|2
21157|NCT01975285|100045|P1|Overall Study|Failed Block and follow up|2
21158|NCT01975246|100061|P2|Overall Study|Other than stated|1
21159|NCT01975246|100062|P1|Overall Study|Other than stated|0
21160|NCT01975246|100061|P2|Overall Study|Protocol Violation|0
21161|NCT01975246|100062|P1|Overall Study|Protocol Violation|1
21162|NCT01975246|100061|P2|Overall Study|Lack of Efficacy|0
21163|NCT01975246|100062|P1|Overall Study|Lack of Efficacy|1
21164|NCT01975246|100061|P2|Overall Study|Adverse Event|1
21165|NCT01975246|100062|P1|Overall Study|Adverse Event|2
21166|NCT01975220|100075|P6|Test Period 1|Not treated|0
21167|NCT01975220|100076|P5|Test Period 1|Not treated|0
21168|NCT01975220|100077|P4|Test Period 1|Not treated|0
21169|NCT01975220|100078|P3|Test Period 1|Not treated|0
21170|NCT01975220|100079|P2|Test Period 1|Not treated|1
21171|NCT01975220|100080|P1|Test Period 1|Not treated|0
21172|NCT01974895|100136|P2|Overall Study|Other (Reason unknown)|8
21173|NCT01974895|100137|P1|Overall Study|Other (Reason unknown)|9
21174|NCT01974895|100136|P2|Overall Study|Other (Missed Visit)|0
21175|NCT01974895|100137|P1|Overall Study|Other (Missed Visit)|1
21176|NCT01974895|100136|P2|Overall Study|Withdrawal by Subject|1
21177|NCT01974895|100137|P1|Overall Study|Withdrawal by Subject|0
21178|NCT01974895|100136|P2|Overall Study|Lost to Follow-up|6
21179|NCT01974895|100137|P1|Overall Study|Lost to Follow-up|4
21180|NCT01974895|100136|P2|Overall Study|Protocol Violation|0
21181|NCT01974895|100137|P1|Overall Study|Protocol Violation|1
21182|NCT01974817|100167|P1|Overall Study|Protocol Violation|2
21183|NCT01974817|100167|P1|Overall Study|Lost to Follow-up|2
21184|NCT01974817|100167|P1|Overall Study|Death|4
21185|NCT01974752|100173|P2|Overall Study|Other Eligibility Criteria|1
21186|NCT01974752|100174|P1|Overall Study|Other Eligibility Criteria|0
21187|NCT01974752|100173|P2|Overall Study|Withdrawal by Subject|3
21188|NCT01974752|100174|P1|Overall Study|Withdrawal by Subject|2
21189|NCT01974752|100173|P2|Overall Study|Lost to Follow-up|0
21190|NCT01974752|100174|P1|Overall Study|Lost to Follow-up|2
21191|NCT01974752|100173|P2|Overall Study|Death|11
21192|NCT01974752|100174|P1|Overall Study|Death|33
21193|NCT01974323|100201|P2|Overall Study|Adverse Event|2
21194|NCT01974323|100202|P1|Overall Study|Adverse Event|2
21195|NCT01974323|100201|P2|Overall Study|Lack of Efficacy|1
21196|NCT01974323|100202|P1|Overall Study|Lack of Efficacy|1
21197|NCT01974323|100201|P2|Overall Study|Pregnancy|1
21198|NCT01974323|100202|P1|Overall Study|Pregnancy|2
21199|NCT01974323|100201|P2|Overall Study|Lost to Follow-up|40
21200|NCT01974323|100202|P1|Overall Study|Lost to Follow-up|45
21201|NCT01974323|100201|P2|Overall Study|Personal Reasons|19
21202|NCT01974323|100202|P1|Overall Study|Personal Reasons|15
21203|NCT01974323|100201|P2|Overall Study|Protocol Violation|2
21204|NCT01974323|100202|P1|Overall Study|Protocol Violation|2
21205|NCT01974323|100201|P2|Overall Study|Other Reasons|28
21206|NCT01974323|100202|P1|Overall Study|Other Reasons|25
21207|NCT01974141|100235|P2|Overall Study|Adverse Event|5
21208|NCT01974141|100236|P1|Overall Study|Adverse Event|4
21209|NCT01974141|100235|P2|Overall Study|Lack of Efficacy|1
21210|NCT01974141|100236|P1|Overall Study|Lack of Efficacy|0
21211|NCT01974141|100235|P2|Overall Study|Pregnancy|3
21212|NCT01974141|100236|P1|Overall Study|Pregnancy|3
21213|NCT01974141|100235|P2|Overall Study|Lost to Follow-up|29
21214|NCT01974141|100236|P1|Overall Study|Lost to Follow-up|38
21215|NCT01974141|100235|P2|Overall Study|Personal Reasons|20
21216|NCT01974141|100236|P1|Overall Study|Personal Reasons|21
21217|NCT01974141|100235|P2|Overall Study|Protocol Violation|6
21218|NCT01974141|100236|P1|Overall Study|Protocol Violation|2
21219|NCT01974141|100235|P2|Overall Study|Other Reasons|18
21220|NCT01974141|100236|P1|Overall Study|Other Reasons|28
21221|NCT01973595|100300|P4|Washout|Withdrawal by Subject|0
21222|NCT01973595|100301|P3|Washout|Withdrawal by Subject|1
21223|NCT01973595|100302|P2|Washout|Withdrawal by Subject|0
21224|NCT01973595|100303|P1|Washout|Withdrawal by Subject|1
21225|NCT01973491|100317|P1|Treatment Period (16 Weeks)|Adverse Event|1
21226|NCT01973491|100317|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
21227|NCT01973491|100317|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
21228|NCT01973439|100333|P1|Overall Study|PK curve incomplete|2
21229|NCT01973439|100333|P1|Overall Study|Vomiting after commencing once daily|1
21230|NCT01973439|100333|P1|Overall Study|Lost samples from one PK Day|2
21231|NCT01973387|100355|P2|Overall Study|Did not receive study drug|2
21232|NCT01973387|100356|P1|Overall Study|Did not receive study drug|2
21233|NCT01973387|100355|P2|Overall Study|Ongoing|0
21234|NCT01973387|100356|P1|Overall Study|Ongoing|72
21235|NCT01973387|100355|P2|Overall Study|Adverse Event|4
21236|NCT01973387|100356|P1|Overall Study|Adverse Event|13
21237|NCT01973387|100355|P2|Overall Study|Progressive disease or relapse|5
21238|NCT01973387|100356|P1|Overall Study|Progressive disease or relapse|10
21239|NCT01973387|100355|P2|Overall Study|Death|3
21240|NCT01973387|100356|P1|Overall Study|Death|3
21241|NCT01973387|100355|P2|Overall Study|Withdrawal by Subject|4
21242|NCT01973387|100356|P1|Overall Study|Withdrawal by Subject|6
21243|NCT01973231|100393|P2|Overall Study|Withdrawal by Subject|9
21244|NCT01973231|100394|P1|Overall Study|Withdrawal by Subject|7
21245|NCT01973231|100393|P2|Overall Study|unclassified|1
21246|NCT01973231|100394|P1|Overall Study|unclassified|2
21247|NCT01973231|100393|P2|Overall Study|Lost to Follow-up|1
21248|NCT01973231|100394|P1|Overall Study|Lost to Follow-up|1
21249|NCT01973231|100393|P2|Overall Study|Protocol Violation|1
21250|NCT01973231|100394|P1|Overall Study|Protocol Violation|1
21251|NCT01973218|100414|P2|Overall Study|Withdrawal by Subject|0
21252|NCT01973218|100415|P1|Overall Study|Withdrawal by Subject|1
21253|NCT01973218|100414|P2|Overall Study|Adverse Event|0
21254|NCT01973218|100415|P1|Overall Study|Adverse Event|1
21255|NCT01972776|100457|P6|Part 2|Administrative problems|7
21256|NCT01972776|100458|P5|Part 2|Administrative problems|10
21257|NCT01972776|100459|P4|Part 2|Administrative problems|0
21258|NCT01972776|100460|P3|Part 2|Administrative problems|0
21259|NCT01972776|100461|P2|Part 2|Administrative problems|0
21260|NCT01972776|100462|P1|Part 2|Administrative problems|0
21261|NCT01972776|100457|P6|Part 2|Adverse Event|0
21262|NCT01972776|100458|P5|Part 2|Adverse Event|3
21263|NCT01972776|100459|P4|Part 2|Adverse Event|0
21264|NCT01972776|100460|P3|Part 2|Adverse Event|0
21265|NCT01972776|100461|P2|Part 2|Adverse Event|0
21266|NCT01972776|100462|P1|Part 2|Adverse Event|0
21267|NCT01972776|100457|P6|Part 1|Adverse Event|0
21268|NCT01972776|100458|P5|Part 1|Adverse Event|0
21269|NCT01972776|100459|P4|Part 1|Adverse Event|1
21270|NCT01972776|100460|P3|Part 1|Adverse Event|1
21271|NCT01972776|100461|P2|Part 1|Adverse Event|0
21272|NCT01972776|100462|P1|Part 1|Adverse Event|0
21273|NCT01972776|100457|P6|Part 1|Withdrawal by Subject|0
21274|NCT01972776|100458|P5|Part 1|Withdrawal by Subject|0
21275|NCT01972776|100459|P4|Part 1|Withdrawal by Subject|0
21276|NCT01972776|100460|P3|Part 1|Withdrawal by Subject|1
21277|NCT01972776|100461|P2|Part 1|Withdrawal by Subject|0
21278|NCT01972776|100462|P1|Part 1|Withdrawal by Subject|0
21279|NCT01972659|100532|P2|Overall Study|problems realted to acceleromyograph|1
21280|NCT01972659|100533|P1|Overall Study|problems realted to acceleromyograph|2
21281|NCT01972659|100532|P2|Overall Study|Protocol Violation|2
21282|NCT01972659|100533|P1|Overall Study|Protocol Violation|2
21283|NCT01972568|100542|P3|Overall Study|Adverse Event|5
21284|NCT01972568|100543|P2|Overall Study|Adverse Event|6
21285|NCT01972568|100544|P1|Overall Study|Adverse Event|5
21286|NCT01972568|100542|P3|Overall Study|Lost to Follow-up|0
21287|NCT01972568|100543|P2|Overall Study|Lost to Follow-up|0
21288|NCT01972568|100544|P1|Overall Study|Lost to Follow-up|1
21289|NCT01972568|100542|P3|Overall Study|Withdrawal by Subject|7
21290|NCT01972568|100543|P2|Overall Study|Withdrawal by Subject|3
21291|NCT01972568|100544|P1|Overall Study|Withdrawal by Subject|6
21292|NCT01972568|100542|P3|Overall Study|Protocol Violation|2
21293|NCT01972568|100543|P2|Overall Study|Protocol Violation|2
21294|NCT01972568|100544|P1|Overall Study|Protocol Violation|1
21295|NCT01972568|100542|P3|Overall Study|Lack of Efficacy|2
21296|NCT01972568|100543|P2|Overall Study|Lack of Efficacy|1
21297|NCT01972568|100544|P1|Overall Study|Lack of Efficacy|0
21298|NCT01972568|100542|P3|Overall Study|Other events|0
21299|NCT01972568|100543|P2|Overall Study|Other events|0
21300|NCT01972568|100544|P1|Overall Study|Other events|3
21301|NCT01972529|100583|P4|Overall Study|Not treated|1
21302|NCT01972529|100584|P3|Overall Study|Not treated|2
21303|NCT01972529|100585|P2|Overall Study|Not treated|1
21304|NCT01972529|100586|P1|Overall Study|Not treated|0
21305|NCT01972529|100583|P4|Overall Study|Not Specified|2
21306|NCT01972529|100584|P3|Overall Study|Not Specified|0
21307|NCT01972529|100585|P2|Overall Study|Not Specified|0
21308|NCT01972529|100586|P1|Overall Study|Not Specified|0
21309|NCT01972529|100583|P4|Overall Study|Withdrawl of Consent|1
21310|NCT01972529|100584|P3|Overall Study|Withdrawl of Consent|0
21311|NCT01972529|100585|P2|Overall Study|Withdrawl of Consent|2
21312|NCT01972529|100586|P1|Overall Study|Withdrawl of Consent|1
21313|NCT01972529|100583|P4|Overall Study|Participant Choice|0
21314|NCT01972529|100584|P3|Overall Study|Participant Choice|0
21315|NCT01972529|100585|P2|Overall Study|Participant Choice|1
21316|NCT01972529|100586|P1|Overall Study|Participant Choice|0
21317|NCT01972529|100583|P4|Overall Study|Lost to Follow-up|0
21318|NCT01972529|100584|P3|Overall Study|Lost to Follow-up|0
21319|NCT01972529|100585|P2|Overall Study|Lost to Follow-up|0
21320|NCT01972529|100586|P1|Overall Study|Lost to Follow-up|1
21321|NCT01972529|100583|P4|Overall Study|Adverse Event|0
21322|NCT01972529|100584|P3|Overall Study|Adverse Event|0
21323|NCT01972529|100585|P2|Overall Study|Adverse Event|1
21324|NCT01972529|100586|P1|Overall Study|Adverse Event|0
21325|NCT01972464|100631|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
21326|NCT01972464|100632|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
21327|NCT01972464|100631|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
21328|NCT01972464|100632|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
21329|NCT01972464|100631|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
21330|NCT01972464|100632|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
21331|NCT01972464|100631|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
21332|NCT01972464|100632|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
21333|NCT01972438|100648|P2|Post Month 12 Study Period|Early Study Closure|4
21334|NCT01972438|100649|P1|Post Month 12 Study Period|Early Study Closure|3
21335|NCT01972438|100648|P2|Months 6-12 Study Period|Early Study Closure|2
21336|NCT01972438|100649|P1|Months 6-12 Study Period|Early Study Closure|2
21337|NCT01972438|100648|P2|Months 6-12 Study Period|Death|0
21338|NCT01972438|100649|P1|Months 6-12 Study Period|Death|1
21339|NCT01972438|100648|P2|Months 3-6 Crossover Period|Early Study Closure|1
21340|NCT01972438|100649|P1|Months 3-6 Crossover Period|Early Study Closure|0
21341|NCT01972438|100648|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
21342|NCT01972438|100649|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
21343|NCT01972438|100648|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
21344|NCT01972438|100649|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
21345|NCT01972438|100648|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
21346|NCT01972438|100649|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
21347|NCT01972438|100648|P2|Baseline-Month 3 Crossover Period|Death|0
21348|NCT01972438|100649|P1|Baseline-Month 3 Crossover Period|Death|1
21349|NCT01972152|100701|P6|Second Treatment Visit|Protocol Violation|0
21350|NCT01972152|100702|P5|Second Treatment Visit|Protocol Violation|0
21351|NCT01972152|100703|P4|Second Treatment Visit|Protocol Violation|0
21352|NCT01972152|100704|P3|Second Treatment Visit|Protocol Violation|0
21353|NCT01972152|100705|P2|Second Treatment Visit|Protocol Violation|1
21354|NCT01972152|100706|P1|Second Treatment Visit|Protocol Violation|0
21355|NCT01972152|100701|P6|First Treatment Visit|Lost to Follow-up|0
21356|NCT01972152|100702|P5|First Treatment Visit|Lost to Follow-up|0
21357|NCT01972152|100703|P4|First Treatment Visit|Lost to Follow-up|0
21358|NCT01972152|100704|P3|First Treatment Visit|Lost to Follow-up|0
21359|NCT01972152|100705|P2|First Treatment Visit|Lost to Follow-up|1
21360|NCT01972152|100706|P1|First Treatment Visit|Lost to Follow-up|0
21361|NCT01971723|100743|P2|Overall Study|Protocol Violation|2
21362|NCT01971723|100744|P1|Overall Study|Protocol Violation|1
21363|NCT01971723|100743|P2|Overall Study|Withdrawal by Subject|1
21364|NCT01971723|100744|P1|Overall Study|Withdrawal by Subject|1
21365|NCT01971645|100777|P3|Overall Study|Protocol Violation|1
21366|NCT01971645|100778|P2|Overall Study|Protocol Violation|0
21367|NCT01971645|100779|P1|Overall Study|Protocol Violation|0
21368|NCT01971645|100777|P3|Overall Study|Lost to Follow-up|1
21369|NCT01971645|100778|P2|Overall Study|Lost to Follow-up|0
21370|NCT01971645|100779|P1|Overall Study|Lost to Follow-up|1
21371|NCT01971645|100777|P3|Overall Study|Adverse Event|0
21372|NCT01971645|100778|P2|Overall Study|Adverse Event|0
21373|NCT01971645|100779|P1|Overall Study|Adverse Event|1
21374|NCT01971567|100813|P2|Overall Study|Lost to Follow-up|0
21375|NCT01971567|100814|P1|Overall Study|Lost to Follow-up|1
21376|NCT01971567|100813|P2|Overall Study|Withdrawal by Subject|2
21377|NCT01971567|100814|P1|Overall Study|Withdrawal by Subject|3
21378|NCT01971554|100840|P4|Overall Study|Lost to Follow-up|0
21379|NCT01971554|100841|P3|Overall Study|Lost to Follow-up|0
21380|NCT01971554|100842|P2|Overall Study|Lost to Follow-up|0
21381|NCT01971554|100843|P1|Overall Study|Lost to Follow-up|1
21382|NCT01971203|100910|P2|Overall Study|Adverse Event|0
21383|NCT01971203|100911|P1|Overall Study|Adverse Event|1
21384|NCT01971203|100910|P2|Overall Study|Withdrawal by Subject|6
21385|NCT01971203|100911|P1|Overall Study|Withdrawal by Subject|5
21386|NCT01971203|100910|P2|Overall Study|Protocol Violation|2
21387|NCT01971203|100911|P1|Overall Study|Protocol Violation|3
21388|NCT01970995|100938|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
21389|NCT01970995|100939|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
21390|NCT01970995|100940|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
21391|NCT01970995|100938|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
21392|NCT01970995|100939|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
21393|NCT01970995|100940|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
21394|NCT01970982|100963|P3|Overall Study|Withdrawal by Subject|2
21395|NCT01970982|100964|P2|Overall Study|Withdrawal by Subject|0
21396|NCT01970982|100965|P1|Overall Study|Withdrawal by Subject|0
21397|NCT01970878|100987|P4|Overall Study|No Completion Status|0
21398|NCT01970878|100988|P3|Overall Study|No Completion Status|0
21399|NCT01970878|100989|P2|Overall Study|No Completion Status|1
21400|NCT01970878|100990|P1|Overall Study|No Completion Status|0
21401|NCT01970878|100987|P4|Overall Study|Physician Decision|0
21402|NCT01970878|100988|P3|Overall Study|Physician Decision|1
21403|NCT01970878|100989|P2|Overall Study|Physician Decision|1
21404|NCT01970878|100990|P1|Overall Study|Physician Decision|0
21405|NCT01970878|100987|P4|Overall Study|Protocol Specified Criteria|6
21406|NCT01970878|100988|P3|Overall Study|Protocol Specified Criteria|3
21407|NCT01970878|100989|P2|Overall Study|Protocol Specified Criteria|4
21408|NCT01970878|100990|P1|Overall Study|Protocol Specified Criteria|10
21409|NCT01970878|100987|P4|Overall Study|Adverse Event|3
21410|NCT01970878|100988|P3|Overall Study|Adverse Event|4
21411|NCT01970878|100989|P2|Overall Study|Adverse Event|7
21412|NCT01970878|100990|P1|Overall Study|Adverse Event|12
21413|NCT01970878|100987|P4|Overall Study|Lack of Efficacy|0
21414|NCT01970878|100988|P3|Overall Study|Lack of Efficacy|2
21415|NCT01970878|100989|P2|Overall Study|Lack of Efficacy|1
21416|NCT01970878|100990|P1|Overall Study|Lack of Efficacy|2
21417|NCT01970878|100987|P4|Overall Study|Administrative Reasons|4
21418|NCT01970878|100988|P3|Overall Study|Administrative Reasons|0
21419|NCT01970878|100989|P2|Overall Study|Administrative Reasons|0
21420|NCT01970878|100990|P1|Overall Study|Administrative Reasons|1
21421|NCT01970878|100987|P4|Overall Study|Lost to Follow-up|4
21422|NCT01970878|100988|P3|Overall Study|Lost to Follow-up|2
21423|NCT01970878|100989|P2|Overall Study|Lost to Follow-up|3
21424|NCT01970878|100990|P1|Overall Study|Lost to Follow-up|1
21425|NCT01970878|100987|P4|Overall Study|Withdrawal by Subject|7
21426|NCT01970878|100988|P3|Overall Study|Withdrawal by Subject|14
21427|NCT01970878|100989|P2|Overall Study|Withdrawal by Subject|10
21428|NCT01970878|100990|P1|Overall Study|Withdrawal by Subject|11
21429|NCT01970865|101033|P17|Overall Study|Study ongoing|2
21430|NCT01970865|101034|P16|Overall Study|Study ongoing|29
21431|NCT01970865|101035|P15|Overall Study|Study ongoing|29
21432|NCT01970865|101036|P14|Overall Study|Study ongoing|41
21433|NCT01970865|101037|P13|Overall Study|Study ongoing|43
21434|NCT01970865|101038|P12|Overall Study|Study ongoing|22
21435|NCT01970865|101039|P11|Overall Study|Study ongoing|29
21436|NCT01970865|101040|P10|Overall Study|Study ongoing|3
21437|NCT01970865|101041|P9|Overall Study|Study ongoing|1
21438|NCT01970865|101042|P8|Overall Study|Study ongoing|0
21439|NCT01970865|101043|P7|Overall Study|Study ongoing|2
21440|NCT01970865|101044|P6|Overall Study|Study ongoing|0
21441|NCT01970865|101045|P5|Overall Study|Study ongoing|8
21442|NCT01970865|101046|P4|Overall Study|Study ongoing|6
21443|NCT01970865|101047|P3|Overall Study|Study ongoing|0
21444|NCT01970865|101048|P2|Overall Study|Study ongoing|2
21445|NCT01970865|101049|P1|Overall Study|Study ongoing|0
21446|NCT01970865|101033|P17|Overall Study|Other|0
21447|NCT01970865|101034|P16|Overall Study|Other|1
21448|NCT01970865|101035|P15|Overall Study|Other|0
21449|NCT01970865|101036|P14|Overall Study|Other|1
21450|NCT01970865|101037|P13|Overall Study|Other|0
21451|NCT01970865|101038|P12|Overall Study|Other|0
21452|NCT01970865|101039|P11|Overall Study|Other|0
21453|NCT01970865|101040|P10|Overall Study|Other|0
21454|NCT01970865|101041|P9|Overall Study|Other|0
21455|NCT01970865|101042|P8|Overall Study|Other|0
21456|NCT01970865|101043|P7|Overall Study|Other|0
21457|NCT01970865|101044|P6|Overall Study|Other|0
21458|NCT01970865|101045|P5|Overall Study|Other|0
21459|NCT01970865|101046|P4|Overall Study|Other|1
21460|NCT01970865|101047|P3|Overall Study|Other|0
21461|NCT01970865|101048|P2|Overall Study|Other|0
21462|NCT01970865|101049|P1|Overall Study|Other|0
21463|NCT01970865|101033|P17|Overall Study|Withdrawal by Subject|0
21464|NCT01970865|101034|P16|Overall Study|Withdrawal by Subject|7
21465|NCT01970865|101035|P15|Overall Study|Withdrawal by Subject|2
21466|NCT01970865|101036|P14|Overall Study|Withdrawal by Subject|5
21467|NCT01970865|101037|P13|Overall Study|Withdrawal by Subject|2
21468|NCT01970865|101038|P12|Overall Study|Withdrawal by Subject|1
21469|NCT01970865|101039|P11|Overall Study|Withdrawal by Subject|0
21470|NCT01970865|101040|P10|Overall Study|Withdrawal by Subject|0
21471|NCT01970865|101041|P9|Overall Study|Withdrawal by Subject|0
21472|NCT01970865|101042|P8|Overall Study|Withdrawal by Subject|0
21473|NCT01970865|101043|P7|Overall Study|Withdrawal by Subject|0
21474|NCT01970865|101044|P6|Overall Study|Withdrawal by Subject|0
21475|NCT01970865|101045|P5|Overall Study|Withdrawal by Subject|2
21476|NCT01970865|101046|P4|Overall Study|Withdrawal by Subject|1
21477|NCT01970865|101047|P3|Overall Study|Withdrawal by Subject|0
21478|NCT01970865|101048|P2|Overall Study|Withdrawal by Subject|0
21479|NCT01970865|101049|P1|Overall Study|Withdrawal by Subject|0
21480|NCT01970865|101033|P17|Overall Study|Lost to Follow-up|0
21481|NCT01970865|101034|P16|Overall Study|Lost to Follow-up|0
21482|NCT01970865|101035|P15|Overall Study|Lost to Follow-up|0
21483|NCT01970865|101036|P14|Overall Study|Lost to Follow-up|0
21484|NCT01970865|101037|P13|Overall Study|Lost to Follow-up|1
21485|NCT01970865|101038|P12|Overall Study|Lost to Follow-up|0
21486|NCT01970865|101039|P11|Overall Study|Lost to Follow-up|0
21487|NCT01970865|101040|P10|Overall Study|Lost to Follow-up|0
21488|NCT01970865|101041|P9|Overall Study|Lost to Follow-up|0
21489|NCT01970865|101042|P8|Overall Study|Lost to Follow-up|0
21490|NCT01970865|101043|P7|Overall Study|Lost to Follow-up|0
21491|NCT01970865|101044|P6|Overall Study|Lost to Follow-up|0
21492|NCT01970865|101045|P5|Overall Study|Lost to Follow-up|1
21493|NCT01970865|101046|P4|Overall Study|Lost to Follow-up|1
21494|NCT01970865|101047|P3|Overall Study|Lost to Follow-up|0
21495|NCT01970865|101048|P2|Overall Study|Lost to Follow-up|0
21496|NCT01970865|101049|P1|Overall Study|Lost to Follow-up|0
21497|NCT01970865|101033|P17|Overall Study|Death|1
21498|NCT01970865|101034|P16|Overall Study|Death|10
21499|NCT01970865|101035|P15|Overall Study|Death|15
21500|NCT01970865|101036|P14|Overall Study|Death|19
21501|NCT01970865|101037|P13|Overall Study|Death|14
21502|NCT01970865|101038|P12|Overall Study|Death|4
21503|NCT01970865|101039|P11|Overall Study|Death|1
21504|NCT01970865|101040|P10|Overall Study|Death|1
21505|NCT01970865|101041|P9|Overall Study|Death|2
21506|NCT01970865|101042|P8|Overall Study|Death|3
21507|NCT01970865|101043|P7|Overall Study|Death|1
21508|NCT01970865|101044|P6|Overall Study|Death|3
21509|NCT01970865|101045|P5|Overall Study|Death|6
21510|NCT01970865|101046|P4|Overall Study|Death|4
21511|NCT01970865|101047|P3|Overall Study|Death|3
21512|NCT01970865|101048|P2|Overall Study|Death|1
21513|NCT01970865|101049|P1|Overall Study|Death|3
21514|NCT01970488|101483|P5|Part 2: Post Week 16|Lost to Follow-up|2
21515|NCT01970488|101484|P4|Part 2: Post Week 16|Lost to Follow-up|1
21516|NCT01970488|101485|P3|Part 2: Post Week 16|Lost to Follow-up|1
21517|NCT01970488|101486|P2|Part 2: Post Week 16|Lost to Follow-up|0
21518|NCT01970488|101487|P1|Part 2: Post Week 16|Lost to Follow-up|0
21519|NCT01970488|101483|P5|Part 2: Post Week 16|Withdrawal by Subject|3
21520|NCT01970488|101484|P4|Part 2: Post Week 16|Withdrawal by Subject|3
21521|NCT01970488|101485|P3|Part 2: Post Week 16|Withdrawal by Subject|8
21522|NCT01970488|101486|P2|Part 2: Post Week 16|Withdrawal by Subject|0
21523|NCT01970488|101487|P1|Part 2: Post Week 16|Withdrawal by Subject|0
21524|NCT01970488|101483|P5|Part 2: Post Week 16|Adverse Event|1
21525|NCT01970488|101484|P4|Part 2: Post Week 16|Adverse Event|1
21526|NCT01970488|101485|P3|Part 2: Post Week 16|Adverse Event|5
21527|NCT01970488|101486|P2|Part 2: Post Week 16|Adverse Event|0
21528|NCT01970488|101487|P1|Part 2: Post Week 16|Adverse Event|0
21529|NCT01970488|101483|P5|Part 2: Post Week 16|Lack of Efficacy|1
21530|NCT01970488|101484|P4|Part 2: Post Week 16|Lack of Efficacy|3
21531|NCT01970488|101485|P3|Part 2: Post Week 16|Lack of Efficacy|2
21532|NCT01970488|101486|P2|Part 2: Post Week 16|Lack of Efficacy|0
21533|NCT01970488|101487|P1|Part 2: Post Week 16|Lack of Efficacy|0
21534|NCT01970488|101483|P5|Part 2: Post Week 16|Non-compliance|0
21535|NCT01970488|101484|P4|Part 2: Post Week 16|Non-compliance|0
21536|NCT01970488|101485|P3|Part 2: Post Week 16|Non-compliance|1
21537|NCT01970488|101486|P2|Part 2: Post Week 16|Non-compliance|0
21538|NCT01970488|101487|P1|Part 2: Post Week 16|Non-compliance|0
21539|NCT01970488|101483|P5|Part 2: Post Week 16|Physician Decision|1
21540|NCT01970488|101484|P4|Part 2: Post Week 16|Physician Decision|0
21541|NCT01970488|101485|P3|Part 2: Post Week 16|Physician Decision|0
21542|NCT01970488|101486|P2|Part 2: Post Week 16|Physician Decision|0
21543|NCT01970488|101487|P1|Part 2: Post Week 16|Physician Decision|0
21544|NCT01970488|101483|P5|Part 1: Through Week 16|Lost to Follow-up|0
21545|NCT01970488|101484|P4|Part 1: Through Week 16|Lost to Follow-up|0
21546|NCT01970488|101485|P3|Part 1: Through Week 16|Lost to Follow-up|0
21547|NCT01970488|101486|P2|Part 1: Through Week 16|Lost to Follow-up|2
21548|NCT01970488|101487|P1|Part 1: Through Week 16|Lost to Follow-up|0
21549|NCT01970488|101483|P5|Part 1: Through Week 16|Withdrawal by Subject|0
21550|NCT01970488|101484|P4|Part 1: Through Week 16|Withdrawal by Subject|0
21551|NCT01970488|101485|P3|Part 1: Through Week 16|Withdrawal by Subject|0
21552|NCT01970488|101486|P2|Part 1: Through Week 16|Withdrawal by Subject|2
21553|NCT01970488|101487|P1|Part 1: Through Week 16|Withdrawal by Subject|3
21554|NCT01970488|101483|P5|Part 1: Through Week 16|Adverse Event|0
21555|NCT01970488|101484|P4|Part 1: Through Week 16|Adverse Event|0
21556|NCT01970488|101485|P3|Part 1: Through Week 16|Adverse Event|0
21557|NCT01970488|101486|P2|Part 1: Through Week 16|Adverse Event|5
21558|NCT01970488|101487|P1|Part 1: Through Week 16|Adverse Event|6
21559|NCT01970488|101483|P5|Part 1: Through Week 16|Protocol Violation|0
21560|NCT01970488|101484|P4|Part 1: Through Week 16|Protocol Violation|0
21561|NCT01970488|101485|P3|Part 1: Through Week 16|Protocol Violation|0
21562|NCT01970488|101486|P2|Part 1: Through Week 16|Protocol Violation|2
21563|NCT01970488|101487|P1|Part 1: Through Week 16|Protocol Violation|1
21564|NCT01970488|101483|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
21565|NCT01970488|101484|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
21566|NCT01970488|101485|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
21567|NCT01970488|101486|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
21568|NCT01970488|101487|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
21569|NCT01970475|101554|P2|Overall Study|Protocol Violation|0
21570|NCT01970475|101555|P1|Overall Study|Protocol Violation|1
21571|NCT01970475|101554|P2|Overall Study|Lost to Follow-up|2
21572|NCT01970475|101555|P1|Overall Study|Lost to Follow-up|2
21573|NCT01970475|101554|P2|Overall Study|Adverse Event|3
21574|NCT01970475|101555|P1|Overall Study|Adverse Event|7
21575|NCT01970475|101554|P2|Overall Study|Withdrawal by Subject|6
21576|NCT01970475|101555|P1|Overall Study|Withdrawal by Subject|11
21577|NCT01970462|101575|P2|Overall Study|Lost to Follow-up|2
21578|NCT01970462|101576|P1|Overall Study|Lost to Follow-up|0
21579|NCT01970397|101590|P2|Overall Study|Protocol Violation|1
21580|NCT01970397|101591|P1|Overall Study|Protocol Violation|1
21581|NCT01970397|101590|P2|Overall Study|Personal Reasons|2
21582|NCT01970397|101591|P1|Overall Study|Personal Reasons|1
21583|NCT01970397|101590|P2|Overall Study|Lost to Follow-up|1
21584|NCT01970397|101591|P1|Overall Study|Lost to Follow-up|0
21585|NCT01970397|101590|P2|Overall Study|Adverse Event|1
21586|NCT01970397|101591|P1|Overall Study|Adverse Event|0
21587|NCT01969799|101603|P2|Overall Study|Physician Decision|0
21588|NCT01969799|101604|P1|Overall Study|Physician Decision|1
21589|NCT01969799|101603|P2|Overall Study|Lost to Follow-up|2
21590|NCT01969799|101604|P1|Overall Study|Lost to Follow-up|0
21591|NCT01969799|101603|P2|Overall Study|Death|11
21592|NCT01969799|101604|P1|Overall Study|Death|16
21593|NCT01969799|101603|P2|Overall Study|Adverse Event|1
21594|NCT01969799|101604|P1|Overall Study|Adverse Event|0
21595|NCT01969721|101641|P4|Overall Study|Discontinued during washout periods.|2
21596|NCT01969721|101642|P3|Overall Study|Discontinued during washout periods.|1
21597|NCT01969721|101643|P2|Overall Study|Discontinued during washout periods.|1
21598|NCT01969721|101644|P1|Overall Study|Discontinued during washout periods.|0
21599|NCT01969721|101641|P4|Overall Study|Other not defined above|0
21600|NCT01969721|101642|P3|Overall Study|Other not defined above|0
21601|NCT01969721|101643|P2|Overall Study|Other not defined above|2
21602|NCT01969721|101644|P1|Overall Study|Other not defined above|0
21603|NCT01969721|101641|P4|Overall Study|Non compliant with protocol|2
21604|NCT01969721|101642|P3|Overall Study|Non compliant with protocol|0
21605|NCT01969721|101643|P2|Overall Study|Non compliant with protocol|1
21606|NCT01969721|101644|P1|Overall Study|Non compliant with protocol|1
21607|NCT01969721|101641|P4|Overall Study|Lack of Efficacy|0
21608|NCT01969721|101642|P3|Overall Study|Lack of Efficacy|1
21609|NCT01969721|101643|P2|Overall Study|Lack of Efficacy|0
21610|NCT01969721|101644|P1|Overall Study|Lack of Efficacy|0
21611|NCT01969721|101641|P4|Overall Study|Adverse Event|2
21612|NCT01969721|101642|P3|Overall Study|Adverse Event|3
21613|NCT01969721|101643|P2|Overall Study|Adverse Event|8
21614|NCT01969721|101644|P1|Overall Study|Adverse Event|3
21615|NCT01969565|101670|P1|Overall Study|Withdrawal by Subject|1
21616|NCT01969084|101730|P2|Overall Study|Adverse Event|1
21617|NCT01969084|101731|P1|Overall Study|Adverse Event|0
21618|NCT01969058|101747|P2|Overall Study|Adverse Event|0
21619|NCT01969058|101748|P1|Overall Study|Adverse Event|1
21620|NCT01969058|101747|P2|Overall Study|Withdrawal by Subject|0
21621|NCT01969058|101748|P1|Overall Study|Withdrawal by Subject|2
21622|NCT01968980|101784|P2|Overall Study|Other unspecified|2
21623|NCT01968980|101785|P1|Overall Study|Other unspecified|1
21624|NCT01968980|101784|P2|Overall Study|Withdrawal by Subject|5
21625|NCT01968980|101785|P1|Overall Study|Withdrawal by Subject|13
21626|NCT01968980|101784|P2|Overall Study|Does not meet entry criteria|3
21627|NCT01968980|101785|P1|Overall Study|Does not meet entry criteria|1
21628|NCT01968980|101784|P2|Overall Study|Adverse Event|3
21629|NCT01968980|101785|P1|Overall Study|Adverse Event|1
21630|NCT01968980|101784|P2|Overall Study|Death|1
21631|NCT01968980|101785|P1|Overall Study|Death|0
21632|NCT01968967|101847|P2|Overall Study|Randomized Not Treated|5
21633|NCT01968967|101848|P1|Overall Study|Randomized Not Treated|6
21634|NCT01968967|101847|P2|Overall Study|Death|2
21635|NCT01968967|101848|P1|Overall Study|Death|9
21636|NCT01968967|101847|P2|Overall Study|Adverse Event|8
21637|NCT01968967|101848|P1|Overall Study|Adverse Event|9
21638|NCT01968967|101847|P2|Overall Study|Protocol Violation|2
21639|NCT01968967|101848|P1|Overall Study|Protocol Violation|1
21640|NCT01968967|101847|P2|Overall Study|Lost to Follow-up|31
21641|NCT01968967|101848|P1|Overall Study|Lost to Follow-up|26
21642|NCT01968967|101847|P2|Overall Study|Did Not Meet Entrance Criteria|3
21643|NCT01968967|101848|P1|Overall Study|Did Not Meet Entrance Criteria|2
21644|NCT01968967|101847|P2|Overall Study|Withdrawal by Subject|61
21645|NCT01968967|101848|P1|Overall Study|Withdrawal by Subject|71
21646|NCT01968967|101847|P2|Overall Study|Other|22
21647|NCT01968967|101848|P1|Overall Study|Other|22
21648|NCT01968954|101909|P2|Overall Study|Did not met inclusion criteria|2
21649|NCT01968954|101910|P1|Overall Study|Did not met inclusion criteria|0
21650|NCT01968954|101909|P2|Overall Study|Protocol Violation|1
21651|NCT01968954|101910|P1|Overall Study|Protocol Violation|0
21652|NCT01968954|101909|P2|Overall Study|Other|8
21653|NCT01968954|101910|P1|Overall Study|Other|7
21654|NCT01968954|101909|P2|Overall Study|Withdrawal by Subject|23
21655|NCT01968954|101910|P1|Overall Study|Withdrawal by Subject|20
21656|NCT01968954|101909|P2|Overall Study|Lost to Follow-up|4
21657|NCT01968954|101910|P1|Overall Study|Lost to Follow-up|6
21658|NCT01968954|101909|P2|Overall Study|Death|2
21659|NCT01968954|101910|P1|Overall Study|Death|1
21660|NCT01968954|101909|P2|Overall Study|Adverse Event|3
21661|NCT01968954|101910|P1|Overall Study|Adverse Event|6
21662|NCT01968811|101974|P1|Overall Study|post op.ref. of subject to other hospita|1
21663|NCT01968811|101974|P1|Overall Study|Protocol Violation|4
21664|NCT01968694|101981|P2|Washout (1 Month)|Lost to Follow-up|1
21665|NCT01968694|101982|P1|Washout (1 Month)|Lost to Follow-up|0
21666|NCT01968551|101999|P3|Extension Phase|Lost to Follow-up|1
21667|NCT01968551|102000|P2|Extension Phase|Lost to Follow-up|0
21668|NCT01968551|102001|P1|Extension Phase|Lost to Follow-up|1
21669|NCT01968551|101999|P3|Extension Phase|Withdrew Consent|1
21670|NCT01968551|102000|P2|Extension Phase|Withdrew Consent|0
21671|NCT01968551|102001|P1|Extension Phase|Withdrew Consent|0
21672|NCT01968551|101999|P3|Extension Phase|Death|0
21673|NCT01968551|102000|P2|Extension Phase|Death|1
21674|NCT01968551|102001|P1|Extension Phase|Death|0
21675|NCT01968551|101999|P3|Extension Phase|Adverse Event|2
21676|NCT01968551|102000|P2|Extension Phase|Adverse Event|0
21677|NCT01968551|102001|P1|Extension Phase|Adverse Event|0
21678|NCT01968551|101999|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
21679|NCT01968551|102000|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
21680|NCT01968551|102001|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
21681|NCT01968551|101999|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
21682|NCT01968551|102000|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
21683|NCT01968551|102001|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
21684|NCT01968551|101999|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
21685|NCT01968551|102000|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
21686|NCT01968551|102001|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
21687|NCT01968551|101999|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
21688|NCT01968551|102000|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
21689|NCT01968551|102001|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
21690|NCT01968434|102017|P2|Overall Study|Lost to Follow-up|6
21691|NCT01968434|102018|P1|Overall Study|Lost to Follow-up|3
21692|NCT01968226|102028|P1|Overall Study|[F-18] RDG-K5 was not available|2
21693|NCT01967940|102060|P3|Part 2|Still on Study|14
21694|NCT01967940|102061|P2|Part 2|Still on Study|16
21695|NCT01967940|102062|P1|Part 2|Still on Study|8
21696|NCT01967732|102089|P4|First Intervention (Day 1)|Poor venous access|0
21697|NCT01967732|102090|P3|First Intervention (Day 1)|Poor venous access|0
21698|NCT01967732|102091|P2|First Intervention (Day 1)|Poor venous access|1
21699|NCT01967732|102092|P1|First Intervention (Day 1)|Poor venous access|0
21700|NCT01967732|102089|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
21701|NCT01967732|102090|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
21702|NCT01967732|102091|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
21703|NCT01967732|102092|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
21704|NCT01967719|102106|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
21705|NCT01967719|102107|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
21706|NCT01967719|102108|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
21707|NCT01967719|102109|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
21708|NCT01967719|102106|P4|First Intervention (Day 1)|Withdrawal by Subject|1
21709|NCT01967719|102107|P3|First Intervention (Day 1)|Withdrawal by Subject|0
21710|NCT01967719|102108|P2|First Intervention (Day 1)|Withdrawal by Subject|1
21711|NCT01967719|102109|P1|First Intervention (Day 1)|Withdrawal by Subject|0
21712|NCT01967706|102124|P4|First Intervention (Day 1)|Withdrawal by Subject|0
21713|NCT01967706|102125|P3|First Intervention (Day 1)|Withdrawal by Subject|0
21714|NCT01967706|102126|P2|First Intervention (Day 1)|Withdrawal by Subject|0
21715|NCT01967706|102127|P1|First Intervention (Day 1)|Withdrawal by Subject|1
21716|NCT01967628|102142|P2|Overall Study|Low protein concentration in sample|25
21717|NCT01967628|102143|P1|Overall Study|Low protein concentration in sample|20
21718|NCT01967628|102142|P2|Overall Study|Lost to Follow-up|0
21719|NCT01967628|102143|P1|Overall Study|Lost to Follow-up|1
21720|NCT01967628|102142|P2|Overall Study|Unable to complete bronchoscopy|6
21721|NCT01967628|102143|P1|Overall Study|Unable to complete bronchoscopy|4
21722|NCT01967628|102142|P2|Overall Study|Withdrawal by Subject|0
21723|NCT01967628|102143|P1|Overall Study|Withdrawal by Subject|2
21724|NCT01967550|102151|P2|Overall Study|Non Compliance|1
21725|NCT01967550|102152|P1|Overall Study|Non Compliance|0
21726|NCT01967550|102151|P2|Overall Study|Protocol Violation|1
21727|NCT01967550|102152|P1|Overall Study|Protocol Violation|2
21728|NCT01967550|102151|P2|Overall Study|Adverse Event|0
21729|NCT01967550|102152|P1|Overall Study|Adverse Event|2
21730|NCT01967550|102151|P2|Overall Study|Withdrawal by Subject|0
21731|NCT01967550|102152|P1|Overall Study|Withdrawal by Subject|1
21732|NCT01967277|102182|P2|Overall Study|Unrelated illness|1
21733|NCT01967277|102183|P1|Overall Study|Unrelated illness|0
21734|NCT01967277|102182|P2|Overall Study|Lost to Follow-up|2
21735|NCT01967277|102183|P1|Overall Study|Lost to Follow-up|1
21736|NCT01967147|102193|P2|Overall Study|Other|5
21737|NCT01967147|102194|P1|Overall Study|Other|4
21738|NCT01967147|102193|P2|Overall Study|Non-compliance with Study Drug|3
21739|NCT01967147|102194|P1|Overall Study|Non-compliance with Study Drug|0
21740|NCT01967147|102193|P2|Overall Study|Withdrawal by Subject|4
21741|NCT01967147|102194|P1|Overall Study|Withdrawal by Subject|2
21742|NCT01967147|102193|P2|Overall Study|Lost to Follow-up|2
21743|NCT01967147|102194|P1|Overall Study|Lost to Follow-up|1
21744|NCT01967147|102193|P2|Overall Study|Lack of Efficacy|4
21745|NCT01967147|102194|P1|Overall Study|Lack of Efficacy|1
21746|NCT01967147|102193|P2|Overall Study|Adverse Event|2
21747|NCT01967147|102194|P1|Overall Study|Adverse Event|5
21748|NCT01967069|102224|P2|Overall Study|Lack of Efficacy|1
21749|NCT01967069|102225|P1|Overall Study|Lack of Efficacy|0
21750|NCT01967069|102224|P2|Overall Study|Withdrawal by Subject|3
21751|NCT01967069|102225|P1|Overall Study|Withdrawal by Subject|1
21752|NCT01967069|102224|P2|Overall Study|Lost to Follow-up|2
21753|NCT01967069|102225|P1|Overall Study|Lost to Follow-up|5
21754|NCT01967069|102224|P2|Overall Study|Adverse Event|2
21755|NCT01967069|102225|P1|Overall Study|Adverse Event|2
21756|NCT01966432|102382|P3|Overall Study|SBIRT program ended|20
21757|NCT01966432|102383|P2|Overall Study|SBIRT program ended|8
21758|NCT01966432|102384|P1|Overall Study|SBIRT program ended|1
21759|NCT01966432|102382|P3|Overall Study|Subject Incarcerated|1
21760|NCT01966432|102383|P2|Overall Study|Subject Incarcerated|0
21761|NCT01966432|102384|P1|Overall Study|Subject Incarcerated|0
21762|NCT01966432|102382|P3|Overall Study|Withdrawal by Subject|0
21763|NCT01966432|102383|P2|Overall Study|Withdrawal by Subject|3
21764|NCT01966432|102384|P1|Overall Study|Withdrawal by Subject|1
21765|NCT01966432|102382|P3|Overall Study|Lost to Follow-up|5
21766|NCT01966432|102383|P2|Overall Study|Lost to Follow-up|2
21767|NCT01966432|102384|P1|Overall Study|Lost to Follow-up|3
21768|NCT01966120|102454|P2|Overall Study|Lost to Follow-up|1
21769|NCT01966120|102455|P1|Overall Study|Lost to Follow-up|1
21770|NCT01966120|102454|P2|Overall Study|Withdrawal by Subject|5
21771|NCT01966120|102455|P1|Overall Study|Withdrawal by Subject|0
21772|NCT01966068|102479|P1|Overall Study|Lost to Follow-up|81
21773|NCT01966068|102479|P1|Overall Study|Withdrawal by Subject|57
21774|NCT01966042|102484|P1|Overall Study|Death|2
21775|NCT01966003|102493|P2|Overall Study|Other|1
21776|NCT01966003|102494|P1|Overall Study|Other|1
21777|NCT01966003|102493|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
21778|NCT01966003|102494|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
21779|NCT01966003|102493|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
21780|NCT01966003|102494|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
21781|NCT01966003|102493|P2|Overall Study|Withdrawal by Subject|19
21782|NCT01966003|102494|P1|Overall Study|Withdrawal by Subject|29
21783|NCT01966003|102493|P2|Overall Study|Physician Decision|13
21784|NCT01966003|102494|P1|Overall Study|Physician Decision|12
21785|NCT01966003|102493|P2|Overall Study|Lost to Follow-up|3
21786|NCT01966003|102494|P1|Overall Study|Lost to Follow-up|4
21787|NCT01966003|102493|P2|Overall Study|Protocol Violation|4
21788|NCT01966003|102494|P1|Overall Study|Protocol Violation|6
21789|NCT01966003|102493|P2|Overall Study|Death|36
21790|NCT01966003|102494|P1|Overall Study|Death|43
21791|NCT01965938|102512|P2|Overall Study|Withdrawal by Subject|0
21792|NCT01965938|102513|P1|Overall Study|Withdrawal by Subject|1
21793|NCT01965834|102544|P1|Overall Study|Lack of Efficacy|4
21794|NCT01965652|102575|P2|Overall Study|Pregnancy|1
21795|NCT01965652|102576|P1|Overall Study|Pregnancy|0
21796|NCT01965652|102575|P2|Overall Study|Other - Miscellaneous|21
21797|NCT01965652|102576|P1|Overall Study|Other - Miscellaneous|18
21798|NCT01965652|102575|P2|Overall Study|Death|4
21799|NCT01965652|102576|P1|Overall Study|Death|3
21800|NCT01965652|102575|P2|Overall Study|Protocol Violation|38
21801|NCT01965652|102576|P1|Overall Study|Protocol Violation|34
21802|NCT01965652|102575|P2|Overall Study|Lost to Follow-up|40
21803|NCT01965652|102576|P1|Overall Study|Lost to Follow-up|53
21804|NCT01965652|102575|P2|Overall Study|Withdrawal by Subject|69
21805|NCT01965652|102576|P1|Overall Study|Withdrawal by Subject|62
21806|NCT01965652|102575|P2|Overall Study|Adverse Event|37
21807|NCT01965652|102576|P1|Overall Study|Adverse Event|40
21808|NCT01965600|102606|P4|Second Intervention|Study terminated by Sponsor|2
21809|NCT01965600|102607|P3|Second Intervention|Study terminated by Sponsor|2
21810|NCT01965600|102608|P2|Second Intervention|Study terminated by Sponsor|0
21811|NCT01965600|102609|P1|Second Intervention|Study terminated by Sponsor|0
21812|NCT01965600|102606|P4|Washout Period of Approximately 15 Days|Adverse Event|1
21813|NCT01965600|102607|P3|Washout Period of Approximately 15 Days|Adverse Event|0
21814|NCT01965600|102608|P2|Washout Period of Approximately 15 Days|Adverse Event|0
21815|NCT01965600|102609|P1|Washout Period of Approximately 15 Days|Adverse Event|0
21816|NCT01965600|102606|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
21817|NCT01965600|102607|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
21818|NCT01965600|102608|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
21819|NCT01965600|102609|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
21820|NCT01965600|102606|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
21821|NCT01965600|102607|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
21822|NCT01965600|102608|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
21823|NCT01965600|102609|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
21824|NCT01965600|102606|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
21825|NCT01965600|102607|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
21826|NCT01965600|102608|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
21827|NCT01965600|102609|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
21828|NCT01965535|102666|P2|Overall Study|Lack of Efficacy|1
21829|NCT01965535|102667|P1|Overall Study|Lack of Efficacy|2
21830|NCT01965431|102681|P6|Overall Study|Other than stated above|6
21831|NCT01965431|102682|P5|Overall Study|Other than stated above|6
21832|NCT01965431|102683|P4|Overall Study|Other than stated above|6
21833|NCT01965431|102684|P3|Overall Study|Other than stated above|6
21834|NCT01965431|102685|P2|Overall Study|Other than stated above|5
21835|NCT01965431|102686|P1|Overall Study|Other than stated above|6
21836|NCT01965431|102681|P6|Overall Study|Adverse Event|0
21837|NCT01965431|102682|P5|Overall Study|Adverse Event|0
21838|NCT01965431|102683|P4|Overall Study|Adverse Event|0
21839|NCT01965431|102684|P3|Overall Study|Adverse Event|0
21840|NCT01965431|102685|P2|Overall Study|Adverse Event|1
21841|NCT01965431|102686|P1|Overall Study|Adverse Event|0
21842|NCT01965327|102699|P1|Overall Study|Physician Decision|2
21843|NCT01965262|102913|P2|Second Intervention (7 Days)|Poor visual acuity|0
21844|NCT01965262|102914|P1|Second Intervention (7 Days)|Poor visual acuity|1
21845|NCT01965262|102913|P2|Second Intervention (7 Days)|Poor lens fit|9
21846|NCT01965262|102914|P1|Second Intervention (7 Days)|Poor lens fit|0
21847|NCT01965262|102913|P2|Second Intervention (7 Days)|Discontinued|1
21848|NCT01965262|102914|P1|Second Intervention (7 Days)|Discontinued|0
21849|NCT01965158|102978|P2|Overall Study|Other - Miscellaneous|0
21850|NCT01965158|102979|P1|Overall Study|Other - Miscellaneous|3
21851|NCT01965158|102978|P2|Overall Study|Protocol Violation|1
21852|NCT01965158|102979|P1|Overall Study|Protocol Violation|1
21853|NCT01965158|102978|P2|Overall Study|Lost to Follow-up|5
21854|NCT01965158|102979|P1|Overall Study|Lost to Follow-up|7
21855|NCT01965158|102978|P2|Overall Study|Withdrawal by Subject|24
21856|NCT01965158|102979|P1|Overall Study|Withdrawal by Subject|16
21857|NCT01965158|102978|P2|Overall Study|Adverse Event|5
21858|NCT01965158|102979|P1|Overall Study|Adverse Event|14
21859|NCT01964976|103020|P1|Overall Study|Protocol Violation|31
21860|NCT01964950|103034|P1|Overall Study|Protocol Violation|25
21861|NCT01964898|103048|P2|Overall Study|Withdrawal by Subject|0
21862|NCT01964898|103049|P1|Overall Study|Withdrawal by Subject|1
21863|NCT01964898|103048|P2|Overall Study|Lost to Follow-up|5
21864|NCT01964898|103049|P1|Overall Study|Lost to Follow-up|3
21865|NCT01964898|103048|P2|Overall Study|did not receive the allocated interventi|1
21866|NCT01964898|103049|P1|Overall Study|did not receive the allocated interventi|2
21867|NCT01964898|103048|P2|Overall Study|ineligible post-randomization|1
21868|NCT01964898|103049|P1|Overall Study|ineligible post-randomization|1
21869|NCT01964716|103071|P2|Overall Study|Death|0
21870|NCT01964716|103072|P1|Overall Study|Death|1
21871|NCT01964716|103071|P2|Overall Study|No longer met eligibility criteria|1
21872|NCT01964716|103072|P1|Overall Study|No longer met eligibility criteria|1
21873|NCT01964716|103071|P2|Overall Study|Lost to Follow-up|2
21874|NCT01964716|103072|P1|Overall Study|Lost to Follow-up|1
21875|NCT01964716|103071|P2|Overall Study|Withdrawal by Subject|3
21876|NCT01964716|103072|P1|Overall Study|Withdrawal by Subject|2
21877|NCT01964547|103110|P2|Overall Study|Withdrawal by Investigator|1
21878|NCT01964547|103111|P1|Overall Study|Withdrawal by Investigator|0
21879|NCT01964547|103110|P2|Overall Study|Lost to Follow-up|1
21880|NCT01964547|103111|P1|Overall Study|Lost to Follow-up|0
21881|NCT01964547|103110|P2|Overall Study|Withdrawal by Subject|7
21882|NCT01964547|103111|P1|Overall Study|Withdrawal by Subject|4
21883|NCT01964547|103110|P2|Overall Study|Adverse Event|2
21884|NCT01964547|103111|P1|Overall Study|Adverse Event|8
21885|NCT01964352|103139|P4|Overall Study|Other than stated above|2
21886|NCT01964352|103140|P3|Overall Study|Other than stated above|1
21887|NCT01964352|103141|P2|Overall Study|Other than stated above|2
21888|NCT01964352|103142|P1|Overall Study|Other than stated above|0
21889|NCT01964352|103139|P4|Overall Study|Withdrawal by Subject|0
21890|NCT01964352|103140|P3|Overall Study|Withdrawal by Subject|1
21891|NCT01964352|103141|P2|Overall Study|Withdrawal by Subject|2
21892|NCT01964352|103142|P1|Overall Study|Withdrawal by Subject|4
21893|NCT01964352|103139|P4|Overall Study|Lost to Follow-up|1
21894|NCT01964352|103140|P3|Overall Study|Lost to Follow-up|0
21895|NCT01964352|103141|P2|Overall Study|Lost to Follow-up|0
21896|NCT01964352|103142|P1|Overall Study|Lost to Follow-up|1
21897|NCT01964352|103139|P4|Overall Study|Protocol Violation|2
21898|NCT01964352|103140|P3|Overall Study|Protocol Violation|0
21899|NCT01964352|103141|P2|Overall Study|Protocol Violation|4
21900|NCT01964352|103142|P1|Overall Study|Protocol Violation|2
21901|NCT01964352|103139|P4|Overall Study|Lack of Efficacy|0
21902|NCT01964352|103140|P3|Overall Study|Lack of Efficacy|0
21903|NCT01964352|103141|P2|Overall Study|Lack of Efficacy|0
21904|NCT01964352|103142|P1|Overall Study|Lack of Efficacy|6
21905|NCT01964352|103139|P4|Overall Study|Adverse Event|3
21906|NCT01964352|103140|P3|Overall Study|Adverse Event|4
21907|NCT01964352|103141|P2|Overall Study|Adverse Event|3
21908|NCT01964352|103142|P1|Overall Study|Adverse Event|13
21909|NCT01964326|103172|P1|Overall Study|Did not meet eligibility criteria|1
21910|NCT01964326|103172|P1|Overall Study|Other|9
21911|NCT01964326|103172|P1|Overall Study|Investigator Discretion|1
21912|NCT01964326|103172|P1|Overall Study|Physician Decision|55
21913|NCT01964326|103172|P1|Overall Study|No Longer Meets Eligibility Criteria|1
21914|NCT01964326|103172|P1|Overall Study|Pregnancy|1
21915|NCT01964326|103172|P1|Overall Study|Withdrawal by Subject|87
21916|NCT01964326|103172|P1|Overall Study|Lost to Follow-up|88
21917|NCT01964326|103172|P1|Overall Study|Protocol Violation|4
21918|NCT01964326|103172|P1|Overall Study|Death|2
21919|NCT01964326|103172|P1|Overall Study|Adverse Event|48
21920|NCT01964222|103181|P2|Overall Study|Screening Failure|0
21921|NCT01964222|103182|P1|Overall Study|Screening Failure|2
21922|NCT01964222|103181|P2|Overall Study|Withdrawal by Subject|6
21923|NCT01964222|103182|P1|Overall Study|Withdrawal by Subject|6
21924|NCT01964222|103181|P2|Overall Study|Lost to Follow-up|5
21925|NCT01964222|103182|P1|Overall Study|Lost to Follow-up|7
21926|NCT01964105|103199|P3|Overall Study|Lost to Follow-up|0
21927|NCT01964105|103200|P2|Overall Study|Lost to Follow-up|13
21928|NCT01964105|103201|P1|Overall Study|Lost to Follow-up|2
21929|NCT01963767|103228|P2|Overall Study|Adverse Event|0
21930|NCT01963767|103229|P1|Overall Study|Adverse Event|2
21931|NCT01963767|103228|P2|Overall Study|Withdrawal by Subject|2
21932|NCT01963767|103229|P1|Overall Study|Withdrawal by Subject|4
21933|NCT01963676|103239|P2|Overall Study|Withdrawal by Subject|0
21934|NCT01963676|103240|P1|Overall Study|Withdrawal by Subject|1
21935|NCT01963611|103253|P5|Overall Study|Other|45
21936|NCT01963611|103254|P4|Overall Study|Other|45
21937|NCT01963611|103255|P3|Overall Study|Other|48
21938|NCT01963611|103256|P2|Overall Study|Other|46
21939|NCT01963611|103257|P1|Overall Study|Other|47
21940|NCT01963611|103253|P5|Overall Study|Withdrawal by Subject|3
21941|NCT01963611|103254|P4|Overall Study|Withdrawal by Subject|1
21942|NCT01963611|103255|P3|Overall Study|Withdrawal by Subject|1
21943|NCT01963611|103256|P2|Overall Study|Withdrawal by Subject|2
21944|NCT01963611|103257|P1|Overall Study|Withdrawal by Subject|3
21945|NCT01963611|103253|P5|Overall Study|Lack of Efficacy|0
21946|NCT01963611|103254|P4|Overall Study|Lack of Efficacy|1
21947|NCT01963611|103255|P3|Overall Study|Lack of Efficacy|0
21948|NCT01963611|103256|P2|Overall Study|Lack of Efficacy|0
21949|NCT01963611|103257|P1|Overall Study|Lack of Efficacy|0
21950|NCT01963611|103253|P5|Overall Study|Protocol Violation|0
21951|NCT01963611|103254|P4|Overall Study|Protocol Violation|1
21952|NCT01963611|103255|P3|Overall Study|Protocol Violation|0
21953|NCT01963611|103256|P2|Overall Study|Protocol Violation|0
21954|NCT01963611|103257|P1|Overall Study|Protocol Violation|0
21955|NCT01963611|103253|P5|Overall Study|Adverse Event|3
21956|NCT01963611|103254|P4|Overall Study|Adverse Event|4
21957|NCT01963611|103255|P3|Overall Study|Adverse Event|3
21958|NCT01963611|103256|P2|Overall Study|Adverse Event|1
21959|NCT01963611|103257|P1|Overall Study|Adverse Event|1
21960|NCT01963403|103316|P2|Overall Study|Implant removal|1
21961|NCT01963403|103317|P1|Overall Study|Implant removal|0
21962|NCT01963403|103316|P2|Overall Study|Lost to Follow-up|3
21963|NCT01963403|103317|P1|Overall Study|Lost to Follow-up|2
21964|NCT01963260|103339|P10|Overall Study|Withdrawal by Subject|0
21965|NCT01963260|103340|P9|Overall Study|Withdrawal by Subject|0
21966|NCT01963260|103341|P8|Overall Study|Withdrawal by Subject|0
21967|NCT01963260|103342|P7|Overall Study|Withdrawal by Subject|0
21968|NCT01963260|103343|P6|Overall Study|Withdrawal by Subject|0
21969|NCT01963260|103344|P5|Overall Study|Withdrawal by Subject|2
21970|NCT01963260|103345|P4|Overall Study|Withdrawal by Subject|1
21971|NCT01963260|103346|P3|Overall Study|Withdrawal by Subject|0
21972|NCT01963260|103347|P2|Overall Study|Withdrawal by Subject|0
21973|NCT01963260|103348|P1|Overall Study|Withdrawal by Subject|2
21974|NCT01962974|103428|P1|Overall Study|Study termination|7
21975|NCT01962922|103455|P2|Extendion Portion (up to Month 6)|Physician Decision|0
21976|NCT01962922|103456|P1|Extendion Portion (up to Month 6)|Physician Decision|1
21977|NCT01962922|103455|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
21978|NCT01962922|103456|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
21979|NCT01962922|103455|P2|PK Portion Day 7|non-compliance|0
21980|NCT01962922|103456|P1|PK Portion Day 7|non-compliance|1
21981|NCT01962922|103455|P2|PK Portion Day 7|Withdrawal by Subject|0
21982|NCT01962922|103456|P1|PK Portion Day 7|Withdrawal by Subject|3
21983|NCT01962493|103514|P2|Overall Study|Withdrawal by Subject|2
21984|NCT01962493|103515|P1|Overall Study|Withdrawal by Subject|4
21985|NCT01962493|103514|P2|Overall Study|Protocol Violation|1
21986|NCT01962493|103515|P1|Overall Study|Protocol Violation|0
21987|NCT01962493|103514|P2|Overall Study|Adverse Event|2
21988|NCT01962493|103515|P1|Overall Study|Adverse Event|1
21989|NCT01962441|103538|P3|Retreatment Substudy|Lost to Follow-up|0
21990|NCT01962441|103539|P2|Retreatment Substudy|Lost to Follow-up|0
21991|NCT01962441|103540|P1|Retreatment Substudy|Lost to Follow-up|1
21992|NCT01962441|103538|P3|Retreatment Substudy|Lack of Efficacy|0
21993|NCT01962441|103539|P2|Retreatment Substudy|Lack of Efficacy|0
21994|NCT01962441|103540|P1|Retreatment Substudy|Lack of Efficacy|1
21995|NCT01962441|103538|P3|Randomized Period|Protocol Violation|0
21996|NCT01962441|103539|P2|Randomized Period|Protocol Violation|1
21997|NCT01962441|103540|P1|Randomized Period|Protocol Violation|0
21998|NCT01962441|103538|P3|Randomized Period|Death|2
21999|NCT01962441|103539|P2|Randomized Period|Death|0
22000|NCT01962441|103540|P1|Randomized Period|Death|0
22001|NCT01962441|103538|P3|Randomized Period|Adverse Event|0
22002|NCT01962441|103539|P2|Randomized Period|Adverse Event|1
22003|NCT01962441|103540|P1|Randomized Period|Adverse Event|1
22004|NCT01962441|103538|P3|Randomized Period|Withdrew Consent|2
22005|NCT01962441|103539|P2|Randomized Period|Withdrew Consent|3
22006|NCT01962441|103540|P1|Randomized Period|Withdrew Consent|3
22007|NCT01962441|103538|P3|Randomized Period|Lost to Follow-up|4
22008|NCT01962441|103539|P2|Randomized Period|Lost to Follow-up|4
22009|NCT01962441|103540|P1|Randomized Period|Lost to Follow-up|2
22010|NCT01962441|103538|P3|Randomized Period|Randomized but Never Treated|3
22011|NCT01962441|103539|P2|Randomized Period|Randomized but Never Treated|2
22012|NCT01962441|103540|P1|Randomized Period|Randomized but Never Treated|4
22013|NCT01961544|103579|P1|Overall Study|Aggravation of Steral Pain|1
22014|NCT01961544|103579|P1|Overall Study|Poor Tolerance|1
22015|NCT01961544|103579|P1|Overall Study|Physician Decision|2
22016|NCT01961544|103579|P1|Overall Study|Adverse Event|1
22017|NCT01961544|103579|P1|Overall Study|Withdrawal by Subject|7
22018|NCT01961544|103579|P1|Overall Study|Protocol Violation|1
22019|NCT01961349|103587|P3|Overall Study|registration error, personal reason etc|1
22020|NCT01961349|103588|P2|Overall Study|registration error, personal reason etc|2
22021|NCT01961349|103589|P1|Overall Study|registration error, personal reason etc|2
22022|NCT01961349|103587|P3|Overall Study|Adverse Event|1
22023|NCT01961349|103588|P2|Overall Study|Adverse Event|0
22024|NCT01961349|103589|P1|Overall Study|Adverse Event|0
22025|NCT01961349|103587|P3|Overall Study|Withdrawal by Subject|0
22026|NCT01961349|103588|P2|Overall Study|Withdrawal by Subject|4
22027|NCT01961349|103589|P1|Overall Study|Withdrawal by Subject|1
22028|NCT01961323|103600|P1|Overall Study|screen failure|34
22029|NCT01961323|103600|P1|Overall Study|Lost to Follow-up|8
22030|NCT01961323|103600|P1|Overall Study|Withdrawal by Subject|7
22031|NCT01961297|103608|P2|Overall Study|unconfirmed diagnosis of SD|1
22032|NCT01961297|103609|P1|Overall Study|unconfirmed diagnosis of SD|2
22033|NCT01961115|103635|P3|Overall Study|Adverse Event|1
22034|NCT01961115|103636|P2|Overall Study|Adverse Event|0
22035|NCT01961115|103637|P1|Overall Study|Adverse Event|1
22036|NCT01961115|103635|P3|Overall Study|Disease Progression|3
22037|NCT01961115|103636|P2|Overall Study|Disease Progression|0
22038|NCT01961115|103637|P1|Overall Study|Disease Progression|1
22039|NCT01960907|103680|P2|Overall Study|Withdrawal by Subject|42
22040|NCT01960907|103681|P1|Overall Study|Withdrawal by Subject|32
22041|NCT01960907|103680|P2|Overall Study|Death|3
22042|NCT01960907|103681|P1|Overall Study|Death|4
22043|NCT01960842|103691|P1|Overall Study|Withdrawal by Subject|2
22044|NCT01960842|103691|P1|Overall Study|Adverse Event|1
22045|NCT01960816|103714|P1|Overall Study|Lost to Follow-up|1
22046|NCT01960725|103722|P2|Overall Study|unable to obtain blood sample|2
22047|NCT01960725|103723|P1|Overall Study|unable to obtain blood sample|1
22048|NCT01960725|103722|P2|Overall Study|Withdrawal by Subject|0
22049|NCT01960725|103723|P1|Overall Study|Withdrawal by Subject|1
22050|NCT01960725|103722|P2|Overall Study|Lost to Follow-up|3
22051|NCT01960725|103723|P1|Overall Study|Lost to Follow-up|4
22052|NCT01960296|103802|P2|Overall Study|Received different procedure|3
22053|NCT01960296|103803|P1|Overall Study|Received different procedure|1
22054|NCT01960296|103802|P2|Overall Study|Postponed surgery|0
22055|NCT01960296|103803|P1|Overall Study|Postponed surgery|1
22056|NCT01960140|103823|P1|Period 2 (Days 3-18)|Adverse Event|2
22057|NCT01960114|103834|P2|Overall Study|Could not swallow study medication|1
22058|NCT01960114|103835|P1|Overall Study|Could not swallow study medication|0
22059|NCT01960114|103834|P2|Overall Study|Adverse Event|0
22060|NCT01960114|103835|P1|Overall Study|Adverse Event|1
22061|NCT01959932|103881|P3|Overall Study|Withdrawal by Subject|0
22062|NCT01959932|103882|P2|Overall Study|Withdrawal by Subject|0
22063|NCT01959932|103883|P1|Overall Study|Withdrawal by Subject|1
22064|NCT01959880|103905|P4|Overall Study|Study completed early-FDA approved|152
22065|NCT01959880|103906|P3|Overall Study|Study completed early-FDA approved|179
22066|NCT01959880|103907|P2|Overall Study|Study completed early-FDA approved|311
22067|NCT01959880|103908|P1|Overall Study|Study completed early-FDA approved|1003
22068|NCT01959880|103905|P4|Overall Study|Explantation w/o study device reimplant.|12
22069|NCT01959880|103906|P3|Overall Study|Explantation w/o study device reimplant.|5
22070|NCT01959880|103907|P2|Overall Study|Explantation w/o study device reimplant.|17
22071|NCT01959880|103908|P1|Overall Study|Explantation w/o study device reimplant.|22
22072|NCT01959880|103905|P4|Overall Study|Lost to Follow-up|8
22073|NCT01959880|103906|P3|Overall Study|Lost to Follow-up|15
22074|NCT01959880|103907|P2|Overall Study|Lost to Follow-up|18
22075|NCT01959880|103908|P1|Overall Study|Lost to Follow-up|95
22076|NCT01959880|103905|P4|Overall Study|Death|2
22077|NCT01959880|103906|P3|Overall Study|Death|1
22078|NCT01959880|103907|P2|Overall Study|Death|10
22079|NCT01959880|103908|P1|Overall Study|Death|1
22080|NCT01959880|103905|P4|Overall Study|Withdrawal by Subject|7
22081|NCT01959880|103906|P3|Overall Study|Withdrawal by Subject|8
22082|NCT01959880|103907|P2|Overall Study|Withdrawal by Subject|13
22083|NCT01959880|103908|P1|Overall Study|Withdrawal by Subject|11
22084|NCT01959607|103937|P4|First Intervention (Day 1)|Withdrawal by Subject|0
22085|NCT01959607|103938|P3|First Intervention (Day 1)|Withdrawal by Subject|0
22086|NCT01959607|103939|P2|First Intervention (Day 1)|Withdrawal by Subject|1
22087|NCT01959607|103940|P1|First Intervention (Day 1)|Withdrawal by Subject|1
22088|NCT01959581|103953|P1|Overall Study|Lost to Follow-up|5
22089|NCT01959529|103959|P2|Overall Study|Lack of glycaemic control|1
22090|NCT01959529|103960|P1|Overall Study|Lack of glycaemic control|1
22091|NCT01959529|103959|P2|Overall Study|Hypoglycaemia|1
22092|NCT01959529|103960|P1|Overall Study|Hypoglycaemia|1
22093|NCT01959529|103959|P2|Overall Study|Other|68
22094|NCT01959529|103960|P1|Overall Study|Other|70
22095|NCT01959529|103959|P2|Overall Study|Lost to Follow-up|1
22096|NCT01959529|103960|P1|Overall Study|Lost to Follow-up|4
22097|NCT01959529|103959|P2|Overall Study|Adverse event (not hypoglycaemia)|1
22098|NCT01959529|103960|P1|Overall Study|Adverse event (not hypoglycaemia)|0
22099|NCT01959516|103972|P2|Epoch 2|Moderate or severe COPD exacerbation|1
22100|NCT01959516|103973|P1|Epoch 2|Moderate or severe COPD exacerbation|0
22101|NCT01959516|103972|P2|Epoch 2|Subject withdrew consent|0
22102|NCT01959516|103973|P1|Epoch 2|Subject withdrew consent|1
22103|NCT01959516|103972|P2|Epoch 2|unsatisfactory therapeutic effect|0
22104|NCT01959516|103973|P1|Epoch 2|unsatisfactory therapeutic effect|1
22105|NCT01959516|103972|P2|Epoch 1|Protocol deviation|1
22106|NCT01959516|103973|P1|Epoch 1|Protocol deviation|0
22107|NCT01959516|103972|P2|Epoch 1|Moderate or severe COPD exacerbation|1
22108|NCT01959516|103973|P1|Epoch 1|Moderate or severe COPD exacerbation|0
22109|NCT01959516|103972|P2|Epoch 1|Use of prohibited treatment|0
22110|NCT01959516|103973|P1|Epoch 1|Use of prohibited treatment|1
22111|NCT01959516|103972|P2|Epoch 1|Administrative problems|0
22112|NCT01959516|103973|P1|Epoch 1|Administrative problems|1
22113|NCT01959516|103972|P2|Epoch 1|Subject withdrew consent|2
22114|NCT01959516|103973|P1|Epoch 1|Subject withdrew consent|3
22115|NCT01959516|103972|P2|Epoch 1|unsatisfactory therapeutic effect|0
22116|NCT01959516|103973|P1|Epoch 1|unsatisfactory therapeutic effect|1
22117|NCT01959516|103972|P2|Epoch 1|Adverse Event|1
22118|NCT01959516|103973|P1|Epoch 1|Adverse Event|4
22119|NCT01959503|103983|P2|Overall Study|Randomized but not treated|1
22120|NCT01959503|103984|P1|Overall Study|Randomized but not treated|1
22121|NCT01959503|103983|P2|Overall Study|Death|1
22122|NCT01959503|103984|P1|Overall Study|Death|2
22123|NCT01959412|104004|P6|Overall Study|Adverse Event|0
22124|NCT01959412|104005|P5|Overall Study|Adverse Event|0
22125|NCT01959412|104006|P4|Overall Study|Adverse Event|1
22126|NCT01959412|104007|P3|Overall Study|Adverse Event|0
22127|NCT01959412|104008|P2|Overall Study|Adverse Event|0
22128|NCT01959412|104009|P1|Overall Study|Adverse Event|0
22129|NCT01959412|104004|P6|Overall Study|Protocol deviation|0
22130|NCT01959412|104005|P5|Overall Study|Protocol deviation|3
22131|NCT01959412|104006|P4|Overall Study|Protocol deviation|1
22132|NCT01959412|104007|P3|Overall Study|Protocol deviation|0
22133|NCT01959412|104008|P2|Overall Study|Protocol deviation|1
22134|NCT01959412|104009|P1|Overall Study|Protocol deviation|1
22135|NCT01959035|104047|P1|Overall Study|Other (no primary reason given)|1
22136|NCT01959035|104047|P1|Overall Study|Lost to Follow-up|1
22137|NCT01959035|104047|P1|Overall Study|Withdrawal by Subject|4
22138|NCT01959035|104047|P1|Overall Study|Adverse Event|5
22139|NCT01958827|104073|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
22140|NCT01958827|104073|P1|Overall Study|Lack of Efficacy|6
22141|NCT01958827|104073|P1|Overall Study|Adverse Event|3
22142|NCT01958671|104104|P3|Overall Study|Withdrawal by Subject|13
22143|NCT01958671|104105|P2|Overall Study|Withdrawal by Subject|10
22144|NCT01958671|104106|P1|Overall Study|Withdrawal by Subject|8
22145|NCT01958671|104104|P3|Overall Study|Participant moved|1
22146|NCT01958671|104105|P2|Overall Study|Participant moved|0
22147|NCT01958671|104106|P1|Overall Study|Participant moved|0
22148|NCT01958671|104104|P3|Overall Study|Study site terminated by sponsor|1
22149|NCT01958671|104105|P2|Overall Study|Study site terminated by sponsor|0
22150|NCT01958671|104106|P1|Overall Study|Study site terminated by sponsor|1
22151|NCT01958671|104104|P3|Overall Study|Protocol Violation|0
22152|NCT01958671|104105|P2|Overall Study|Protocol Violation|1
22153|NCT01958671|104106|P1|Overall Study|Protocol Violation|0
22154|NCT01958671|104104|P3|Overall Study|Pregnancy|1
22155|NCT01958671|104105|P2|Overall Study|Pregnancy|0
22156|NCT01958671|104106|P1|Overall Study|Pregnancy|0
22157|NCT01958671|104104|P3|Overall Study|Non-compliance with study drug|1
22158|NCT01958671|104105|P2|Overall Study|Non-compliance with study drug|1
22159|NCT01958671|104106|P1|Overall Study|Non-compliance with study drug|1
22160|NCT01958671|104104|P3|Overall Study|Lost to Follow-up|7
22161|NCT01958671|104105|P2|Overall Study|Lost to Follow-up|11
22162|NCT01958671|104106|P1|Overall Study|Lost to Follow-up|7
22163|NCT01958671|104104|P3|Overall Study|Hyperglycemia|2
22164|NCT01958671|104105|P2|Overall Study|Hyperglycemia|0
22165|NCT01958671|104106|P1|Overall Study|Hyperglycemia|0
22166|NCT01958671|104104|P3|Overall Study|Excluded medication|1
22167|NCT01958671|104105|P2|Overall Study|Excluded medication|0
22168|NCT01958671|104106|P1|Overall Study|Excluded medication|0
22169|NCT01958671|104104|P3|Overall Study|Death|0
22170|NCT01958671|104105|P2|Overall Study|Death|0
22171|NCT01958671|104106|P1|Overall Study|Death|1
22172|NCT01958671|104104|P3|Overall Study|Adverse Event|5
22173|NCT01958671|104105|P2|Overall Study|Adverse Event|1
22174|NCT01958671|104106|P1|Overall Study|Adverse Event|1
22175|NCT01958619|104180|P4|Overall Study|Protocol Violation|0
22176|NCT01958619|104181|P3|Overall Study|Protocol Violation|1
22177|NCT01958619|104182|P2|Overall Study|Protocol Violation|0
22178|NCT01958619|104183|P1|Overall Study|Protocol Violation|2
22179|NCT01958164|104257|P2|Overall Study|Lost to Follow-up|3
22180|NCT01958164|104258|P1|Overall Study|Lost to Follow-up|2
22181|NCT01958164|104257|P2|Overall Study|Adverse Event|2
22182|NCT01958164|104258|P1|Overall Study|Adverse Event|0
22183|NCT01958060|104277|P6|Overall Study|Not treated|0
22184|NCT01958060|104278|P5|Overall Study|Not treated|1
22185|NCT01958060|104279|P4|Overall Study|Not treated|0
22186|NCT01958060|104280|P3|Overall Study|Not treated|0
22187|NCT01958060|104281|P2|Overall Study|Not treated|0
22188|NCT01958060|104282|P1|Overall Study|Not treated|2
22189|NCT01958021|104307|P2|Overall Study|Death|0
22190|NCT01958021|104308|P1|Overall Study|Death|2
22191|NCT01958021|104307|P2|Overall Study|Protocol Violation|1
22192|NCT01958021|104308|P1|Overall Study|Protocol Violation|3
22193|NCT01958021|104307|P2|Overall Study|Physician Decision|13
22194|NCT01958021|104308|P1|Overall Study|Physician Decision|10
22195|NCT01958021|104307|P2|Overall Study|Subject/guardian decision|13
22196|NCT01958021|104308|P1|Overall Study|Subject/guardian decision|12
22197|NCT01958021|104307|P2|Overall Study|Adverse Event|7
22198|NCT01958021|104308|P1|Overall Study|Adverse Event|25
22199|NCT01958021|104307|P2|Overall Study|Progressive disease|146
22200|NCT01958021|104308|P1|Overall Study|Progressive disease|87
22201|NCT01958008|104320|P4|Overall Study|Other adverse event|0
22202|NCT01958008|104321|P3|Overall Study|Other adverse event|0
22203|NCT01958008|104322|P2|Overall Study|Other adverse event|0
22204|NCT01958008|104323|P1|Overall Study|Other adverse event|1
22205|NCT01958008|104320|P4|Overall Study|Worsening of disease under study|0
22206|NCT01958008|104321|P3|Overall Study|Worsening of disease under study|1
22207|NCT01958008|104322|P2|Overall Study|Worsening of disease under study|0
22208|NCT01958008|104323|P1|Overall Study|Worsening of disease under study|0
22209|NCT01957865|104363|P3|Overall Study|Lost to Follow-up|2
22210|NCT01957865|104364|P2|Overall Study|Lost to Follow-up|2
22211|NCT01957865|104365|P1|Overall Study|Lost to Follow-up|0
22212|NCT01957865|104363|P3|Overall Study|Found HIV negative|1
22213|NCT01957865|104364|P2|Overall Study|Found HIV negative|0
22214|NCT01957865|104365|P1|Overall Study|Found HIV negative|0
22215|NCT01957579|104398|P4|Overall Study|Death|0
22216|NCT01957579|104399|P3|Overall Study|Death|2
22217|NCT01957579|104400|P2|Overall Study|Death|0
22218|NCT01957579|104401|P1|Overall Study|Death|0
22219|NCT01957579|104398|P4|Overall Study|Withdrawal of concent|0
22220|NCT01957579|104399|P3|Overall Study|Withdrawal of concent|0
22221|NCT01957579|104400|P2|Overall Study|Withdrawal of concent|1
22222|NCT01957579|104401|P1|Overall Study|Withdrawal of concent|0
22223|NCT01957553|104468|P2|Test Period 2 (21 +- 1 Days)|Other|0
22224|NCT01957553|104469|P1|Test Period 2 (21 +- 1 Days)|Other|1
22225|NCT01957553|104468|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
22226|NCT01957553|104469|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
22227|NCT01957553|104468|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
22228|NCT01957553|104469|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
22229|NCT01957553|104468|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
22230|NCT01957553|104469|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
22231|NCT01957553|104468|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
22232|NCT01957553|104469|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
22233|NCT01957553|104468|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
22234|NCT01957553|104469|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
22235|NCT01957553|104468|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
22236|NCT01957553|104469|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
22237|NCT01957553|104468|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
22238|NCT01957553|104469|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
22239|NCT01957553|104468|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
22240|NCT01957553|104469|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
22241|NCT01957488|104475|P6|Test Period 3|Lack of Efficacy|0
22242|NCT01957488|104476|P5|Test Period 3|Lack of Efficacy|0
22243|NCT01957488|104477|P4|Test Period 3|Lack of Efficacy|0
22244|NCT01957488|104478|P3|Test Period 3|Lack of Efficacy|0
22245|NCT01957488|104479|P2|Test Period 3|Lack of Efficacy|1
22246|NCT01957488|104480|P1|Test Period 3|Lack of Efficacy|0
22247|NCT01957488|104475|P6|Test Period 3|Withdrawal by Subject|0
22248|NCT01957488|104476|P5|Test Period 3|Withdrawal by Subject|0
22249|NCT01957488|104477|P4|Test Period 3|Withdrawal by Subject|0
22250|NCT01957488|104478|P3|Test Period 3|Withdrawal by Subject|0
22251|NCT01957488|104479|P2|Test Period 3|Withdrawal by Subject|0
22252|NCT01957488|104480|P1|Test Period 3|Withdrawal by Subject|1
22253|NCT01957488|104475|P6|Test Period 2|Discontinue due to personal problems|1
22254|NCT01957488|104476|P5|Test Period 2|Discontinue due to personal problems|0
22255|NCT01957488|104477|P4|Test Period 2|Discontinue due to personal problems|0
22256|NCT01957488|104478|P3|Test Period 2|Discontinue due to personal problems|0
22257|NCT01957488|104479|P2|Test Period 2|Discontinue due to personal problems|0
22258|NCT01957488|104480|P1|Test Period 2|Discontinue due to personal problems|0
22259|NCT01957488|104475|P6|Test Period 2|Adverse Event|0
22260|NCT01957488|104476|P5|Test Period 2|Adverse Event|2
22261|NCT01957488|104477|P4|Test Period 2|Adverse Event|0
22262|NCT01957488|104478|P3|Test Period 2|Adverse Event|0
22263|NCT01957488|104479|P2|Test Period 2|Adverse Event|0
22264|NCT01957488|104480|P1|Test Period 2|Adverse Event|0
22265|NCT01957488|104475|P6|Test Period 2|Withdrawal by Subject|0
22266|NCT01957488|104476|P5|Test Period 2|Withdrawal by Subject|0
22267|NCT01957488|104477|P4|Test Period 2|Withdrawal by Subject|0
22268|NCT01957488|104478|P3|Test Period 2|Withdrawal by Subject|0
22269|NCT01957488|104479|P2|Test Period 2|Withdrawal by Subject|1
22270|NCT01957488|104480|P1|Test Period 2|Withdrawal by Subject|0
22271|NCT01957488|104475|P6|Test Period 2|Other|0
22272|NCT01957488|104476|P5|Test Period 2|Other|0
22273|NCT01957488|104477|P4|Test Period 2|Other|0
22274|NCT01957488|104478|P3|Test Period 2|Other|0
22275|NCT01957488|104479|P2|Test Period 2|Other|0
22276|NCT01957488|104480|P1|Test Period 2|Other|1
22277|NCT01957488|104475|P6|Test Period 2|Protocol Violation|0
22278|NCT01957488|104476|P5|Test Period 2|Protocol Violation|0
22279|NCT01957488|104477|P4|Test Period 2|Protocol Violation|1
22280|NCT01957488|104478|P3|Test Period 2|Protocol Violation|1
22281|NCT01957488|104479|P2|Test Period 2|Protocol Violation|0
22282|NCT01957488|104480|P1|Test Period 2|Protocol Violation|2
22283|NCT01957488|104475|P6|Test Period 1|screen failure|1
22284|NCT01957488|104476|P5|Test Period 1|screen failure|0
22285|NCT01957488|104477|P4|Test Period 1|screen failure|0
22286|NCT01957488|104478|P3|Test Period 1|screen failure|0
22287|NCT01957488|104479|P2|Test Period 1|screen failure|0
22288|NCT01957488|104480|P1|Test Period 1|screen failure|0
22289|NCT01957488|104475|P6|Test Period 1|subject did not want to wait for cut bag|0
22290|NCT01957488|104476|P5|Test Period 1|subject did not want to wait for cut bag|1
22291|NCT01957488|104477|P4|Test Period 1|subject did not want to wait for cut bag|0
22292|NCT01957488|104478|P3|Test Period 1|subject did not want to wait for cut bag|0
22293|NCT01957488|104479|P2|Test Period 1|subject did not want to wait for cut bag|0
22294|NCT01957488|104480|P1|Test Period 1|subject did not want to wait for cut bag|0
22295|NCT01957488|104475|P6|Test Period 1|Withdrawal by Subject|2
22296|NCT01957488|104476|P5|Test Period 1|Withdrawal by Subject|1
22297|NCT01957488|104477|P4|Test Period 1|Withdrawal by Subject|1
22298|NCT01957488|104478|P3|Test Period 1|Withdrawal by Subject|0
22299|NCT01957488|104479|P2|Test Period 1|Withdrawal by Subject|0
22300|NCT01957488|104480|P1|Test Period 1|Withdrawal by Subject|0
22301|NCT01957488|104475|P6|Test Period 1|Adverse Event|0
22302|NCT01957488|104476|P5|Test Period 1|Adverse Event|1
22303|NCT01957488|104477|P4|Test Period 1|Adverse Event|0
22304|NCT01957488|104478|P3|Test Period 1|Adverse Event|1
22305|NCT01957488|104479|P2|Test Period 1|Adverse Event|1
22306|NCT01957488|104480|P1|Test Period 1|Adverse Event|0
22307|NCT01957488|104475|P6|Test Period 1|Protocol Violation|3
22308|NCT01957488|104476|P5|Test Period 1|Protocol Violation|0
22309|NCT01957488|104477|P4|Test Period 1|Protocol Violation|1
22310|NCT01957488|104478|P3|Test Period 1|Protocol Violation|2
22311|NCT01957488|104479|P2|Test Period 1|Protocol Violation|2
22312|NCT01957488|104480|P1|Test Period 1|Protocol Violation|1
22313|NCT01957488|104475|P6|Test Period 1|Lost to Follow-up|0
22314|NCT01957488|104476|P5|Test Period 1|Lost to Follow-up|0
22315|NCT01957488|104477|P4|Test Period 1|Lost to Follow-up|1
22316|NCT01957488|104478|P3|Test Period 1|Lost to Follow-up|1
22317|NCT01957488|104479|P2|Test Period 1|Lost to Follow-up|0
22318|NCT01957488|104480|P1|Test Period 1|Lost to Follow-up|2
22319|NCT01957475|104488|P2|Test Period 2|Adverse Event|0
22320|NCT01957475|104489|P1|Test Period 2|Adverse Event|1
22321|NCT01957475|104488|P2|Test Period 1|Lack of Efficacy|1
22322|NCT01957475|104489|P1|Test Period 1|Lack of Efficacy|0
22323|NCT01957475|104488|P2|Test Period 1|Other|0
22324|NCT01957475|104489|P1|Test Period 1|Other|1
22325|NCT01957475|104488|P2|Test Period 1|Withdrawal by Subject|0
22326|NCT01957475|104489|P1|Test Period 1|Withdrawal by Subject|1
22327|NCT01957462|104495|P2|Test Period 1|Adverse Event|0
22328|NCT01957462|104496|P1|Test Period 1|Adverse Event|1
22329|NCT01957462|104495|P2|Test Period 1|Withdrawal by Subject|0
22330|NCT01957462|104496|P1|Test Period 1|Withdrawal by Subject|1
22331|NCT01957397|104507|P2|Test Period 3|the adhesive did not work|0
22332|NCT01957397|104508|P1|Test Period 3|the adhesive did not work|1
22333|NCT01957397|104507|P2|Test Period 3|Adverse Event|2
22334|NCT01957397|104508|P1|Test Period 3|Adverse Event|1
22335|NCT01957397|104507|P2|Test Period 2|Adverse Event|1
22336|NCT01957397|104508|P1|Test Period 2|Adverse Event|0
22337|NCT01957397|104507|P2|Test Period 1|Withdrawal by Subject|0
22338|NCT01957397|104508|P1|Test Period 1|Withdrawal by Subject|1
22339|NCT01957397|104507|P2|Test Period 1|sudden leakage/small bag|1
22340|NCT01957397|104508|P1|Test Period 1|sudden leakage/small bag|1
22341|NCT01957215|104533|P2|Overall Study|Withdrawal by Subject|5
22342|NCT01957215|104534|P1|Overall Study|Withdrawal by Subject|7
22343|NCT01957215|104533|P2|Overall Study|Protocol Violation|2
22344|NCT01957215|104534|P1|Overall Study|Protocol Violation|1
22345|NCT01957215|104533|P2|Overall Study|Lost to Follow-up|3
22346|NCT01957215|104534|P1|Overall Study|Lost to Follow-up|3
22347|NCT01957215|104533|P2|Overall Study|Adverse Event|2
22348|NCT01957215|104534|P1|Overall Study|Adverse Event|2
22349|NCT01957202|104562|P18|Treatment Period 3 (8 Days)|Adverse Event|0
22350|NCT01957202|104563|P17|Treatment Period 3 (8 Days)|Adverse Event|1
22351|NCT01957202|104564|P16|Treatment Period 3 (8 Days)|Adverse Event|0
22352|NCT01957202|104565|P15|Treatment Period 3 (8 Days)|Adverse Event|0
22353|NCT01957202|104566|P14|Treatment Period 3 (8 Days)|Adverse Event|0
22354|NCT01957202|104567|P13|Treatment Period 3 (8 Days)|Adverse Event|0
22355|NCT01957202|104568|P12|Treatment Period 3 (8 Days)|Adverse Event|0
22356|NCT01957202|104569|P11|Treatment Period 3 (8 Days)|Adverse Event|0
22357|NCT01957202|104570|P10|Treatment Period 3 (8 Days)|Adverse Event|0
22358|NCT01957202|104571|P9|Treatment Period 3 (8 Days)|Adverse Event|0
22359|NCT01957202|104572|P8|Treatment Period 3 (8 Days)|Adverse Event|0
22360|NCT01957202|104573|P7|Treatment Period 3 (8 Days)|Adverse Event|0
22361|NCT01957202|104574|P6|Treatment Period 3 (8 Days)|Adverse Event|0
22362|NCT01957202|104575|P5|Treatment Period 3 (8 Days)|Adverse Event|0
22363|NCT01957202|104576|P4|Treatment Period 3 (8 Days)|Adverse Event|0
22364|NCT01957202|104577|P3|Treatment Period 3 (8 Days)|Adverse Event|0
22365|NCT01957202|104578|P2|Treatment Period 3 (8 Days)|Adverse Event|0
22366|NCT01957202|104579|P1|Treatment Period 3 (8 Days)|Adverse Event|0
22367|NCT01957202|104562|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22368|NCT01957202|104563|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
22369|NCT01957202|104564|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22370|NCT01957202|104565|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22371|NCT01957202|104566|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22372|NCT01957202|104567|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22373|NCT01957202|104568|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22374|NCT01957202|104569|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22375|NCT01957202|104570|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22376|NCT01957202|104571|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22377|NCT01957202|104572|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22378|NCT01957202|104573|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22379|NCT01957202|104574|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22380|NCT01957202|104575|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22381|NCT01957202|104576|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22382|NCT01957202|104577|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22383|NCT01957202|104578|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
22384|NCT01957202|104579|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
22385|NCT01957163|104604|P3|Overall Study|Withdrawal by Subject|4
22386|NCT01957163|104605|P2|Overall Study|Withdrawal by Subject|2
22387|NCT01957163|104606|P1|Overall Study|Withdrawal by Subject|4
22388|NCT01957163|104604|P3|Overall Study|Lost to Follow-up|0
22389|NCT01957163|104605|P2|Overall Study|Lost to Follow-up|1
22390|NCT01957163|104606|P1|Overall Study|Lost to Follow-up|0
22391|NCT01957163|104604|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
22392|NCT01957163|104605|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
22393|NCT01957163|104606|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
22394|NCT01957163|104604|P3|Overall Study|Protocol Violation|0
22395|NCT01957163|104605|P2|Overall Study|Protocol Violation|2
22396|NCT01957163|104606|P1|Overall Study|Protocol Violation|1
22397|NCT01957163|104604|P3|Overall Study|Lack of Efficacy|9
22398|NCT01957163|104605|P2|Overall Study|Lack of Efficacy|4
22399|NCT01957163|104606|P1|Overall Study|Lack of Efficacy|5
22400|NCT01957163|104604|P3|Overall Study|Adverse Event|4
22401|NCT01957163|104605|P2|Overall Study|Adverse Event|2
22402|NCT01957163|104606|P1|Overall Study|Adverse Event|5
22403|NCT01957137|104617|P1|Randomized Portion|Withdrawal by Subject|1
22404|NCT01957137|104617|P1|Randomized Portion|Adverse Event|1
22405|NCT01957111|104647|P2|Overall Study|Withdrawal by Subject|1
22406|NCT01957111|104648|P1|Overall Study|Withdrawal by Subject|1
22407|NCT01956240|104666|P2|Overall Study|Adverse Event|4
22408|NCT01956240|104667|P1|Overall Study|Adverse Event|17
22409|NCT01956240|104666|P2|Overall Study|Lost to Follow-up|20
22410|NCT01956240|104667|P1|Overall Study|Lost to Follow-up|6
22411|NCT01955733|104756|P3|Period 2|Other not defined above|2
22412|NCT01955733|104757|P2|Period 2|Other not defined above|2
22413|NCT01955733|104758|P1|Period 2|Other not defined above|0
22414|NCT01955733|104756|P3|Period 2|Lost to Follow-up|0
22415|NCT01955733|104757|P2|Period 2|Lost to Follow-up|0
22416|NCT01955733|104758|P1|Period 2|Lost to Follow-up|2
22417|NCT01955733|104756|P3|Period 2|Study terminated by sponsor|16
22418|NCT01955733|104757|P2|Period 2|Study terminated by sponsor|14
22419|NCT01955733|104758|P1|Period 2|Study terminated by sponsor|8
22420|NCT01955733|104756|P3|Period 2|Withdrawal by Subject|2
22421|NCT01955733|104757|P2|Period 2|Withdrawal by Subject|3
22422|NCT01955733|104758|P1|Period 2|Withdrawal by Subject|1
22423|NCT01955733|104756|P3|Period 2|Physician Decision|1
22424|NCT01955733|104757|P2|Period 2|Physician Decision|0
22425|NCT01955733|104758|P1|Period 2|Physician Decision|0
22426|NCT01955733|104756|P3|Period 2|Adverse Event|0
22427|NCT01955733|104757|P2|Period 2|Adverse Event|0
22428|NCT01955733|104758|P1|Period 2|Adverse Event|1
22429|NCT01955733|104756|P3|Period 1|Lost to Follow-up|0
22430|NCT01955733|104757|P2|Period 1|Lost to Follow-up|0
22431|NCT01955733|104758|P1|Period 1|Lost to Follow-up|1
22432|NCT01955707|104851|P2|Overall Study|Not Specified|2
22433|NCT01955707|104852|P1|Overall Study|Not Specified|4
22434|NCT01955707|104851|P2|Overall Study|Death|14
22435|NCT01955707|104852|P1|Overall Study|Death|13
22436|NCT01955707|104851|P2|Overall Study|Withdrawal by Subject|3
22437|NCT01955707|104852|P1|Overall Study|Withdrawal by Subject|0
22438|NCT01955707|104851|P2|Overall Study|Lost to Follow-up|1
22439|NCT01955707|104852|P1|Overall Study|Lost to Follow-up|2
22440|NCT01955707|104851|P2|Overall Study|Adverse Event|2
22441|NCT01955707|104852|P1|Overall Study|Adverse Event|1
22442|NCT01955161|105120|P3|Overall Study|Other reason: patient's will|1
22443|NCT01955161|105121|P2|Overall Study|Other reason: patient's will|0
22444|NCT01955161|105122|P1|Overall Study|Other reason: patient's will|0
22445|NCT01955161|105120|P3|Overall Study|Other reason: primary biliary cirrhosis|0
22446|NCT01955161|105121|P2|Overall Study|Other reason: primary biliary cirrhosis|0
22447|NCT01955161|105122|P1|Overall Study|Other reason: primary biliary cirrhosis|1
22448|NCT01955161|105120|P3|Overall Study|Other reason: insufficient compliance|1
22449|NCT01955161|105121|P2|Overall Study|Other reason: insufficient compliance|0
22450|NCT01955161|105122|P1|Overall Study|Other reason: insufficient compliance|0
22451|NCT01955161|105120|P3|Overall Study|Other reason: moved to nursing home|0
22452|NCT01955161|105121|P2|Overall Study|Other reason: moved to nursing home|1
22453|NCT01955161|105122|P1|Overall Study|Other reason: moved to nursing home|0
22454|NCT01955161|105120|P3|Overall Study|Other reason: caregiver unavailable|0
22455|NCT01955161|105121|P2|Overall Study|Other reason: caregiver unavailable|0
22456|NCT01955161|105122|P1|Overall Study|Other reason: caregiver unavailable|1
22457|NCT01955161|105120|P3|Overall Study|Other reason: disallowed medication|1
22458|NCT01955161|105121|P2|Overall Study|Other reason: disallowed medication|0
22459|NCT01955161|105122|P1|Overall Study|Other reason: disallowed medication|1
22460|NCT01955161|105120|P3|Overall Study|Other reason: physician decision|1
22461|NCT01955161|105121|P2|Overall Study|Other reason: physician decision|1
22462|NCT01955161|105122|P1|Overall Study|Other reason: physician decision|0
22463|NCT01955161|105120|P3|Overall Study|Protocol Violation|0
22464|NCT01955161|105121|P2|Overall Study|Protocol Violation|0
22465|NCT01955161|105122|P1|Overall Study|Protocol Violation|2
22466|NCT01955161|105120|P3|Overall Study|Withdrawal by Subject|12
22467|NCT01955161|105121|P2|Overall Study|Withdrawal by Subject|8
22468|NCT01955161|105122|P1|Overall Study|Withdrawal by Subject|9
22469|NCT01955161|105120|P3|Overall Study|Death|3
22470|NCT01955161|105121|P2|Overall Study|Death|1
22471|NCT01955161|105122|P1|Overall Study|Death|1
22472|NCT01955161|105120|P3|Overall Study|Adverse Event|15
22473|NCT01955161|105121|P2|Overall Study|Adverse Event|14
22474|NCT01955161|105122|P1|Overall Study|Adverse Event|10
22475|NCT01955161|105120|P3|Overall Study|Withdrawal before treatment|1
22476|NCT01955161|105121|P2|Overall Study|Withdrawal before treatment|0
22477|NCT01955161|105122|P1|Overall Study|Withdrawal before treatment|2
22478|NCT01955122|105162|P2|Overall Study|Physician Decision|5
22479|NCT01955122|105163|P1|Overall Study|Physician Decision|5
22480|NCT01955083|105183|P2|Overall Study|Lost to Follow-up|1
22481|NCT01955083|105184|P1|Overall Study|Lost to Follow-up|1
22482|NCT01955044|105217|P3|Overall Study|Death|0
22483|NCT01955044|105218|P2|Overall Study|Death|1
22484|NCT01955044|105219|P1|Overall Study|Death|1
22485|NCT01955005|105232|P2|Overall Study|Withdrawal by Subject|5
22486|NCT01955005|105233|P1|Overall Study|Withdrawal by Subject|3
22487|NCT01954771|105246|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
22488|NCT01954771|105247|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
22489|NCT01954771|105248|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
22490|NCT01954771|105246|P3|Overall Study|Missing CGMS of end-point|0
22491|NCT01954771|105247|P2|Overall Study|Missing CGMS of end-point|1
22492|NCT01954771|105248|P1|Overall Study|Missing CGMS of end-point|1
22493|NCT01954771|105246|P3|Overall Study|Missing HbA1c of end-point|0
22494|NCT01954771|105247|P2|Overall Study|Missing HbA1c of end-point|1
22495|NCT01954771|105248|P1|Overall Study|Missing HbA1c of end-point|1
22496|NCT01954745|105265|P1|Overall Study|Death|1
22497|NCT01954745|105265|P1|Overall Study|Adverse Event|2
22498|NCT01954745|105265|P1|Overall Study|Clinical Progression|5
22499|NCT01954745|105265|P1|Overall Study|Radiological Progression|11
22500|NCT01954251|105296|P2|Overall Study|Withdrawal by Subject|6
22501|NCT01954251|105297|P1|Overall Study|Withdrawal by Subject|2
22502|NCT01954251|105296|P2|Overall Study|Lost to Follow-up|6
22503|NCT01954251|105297|P1|Overall Study|Lost to Follow-up|6
22504|NCT01954251|105296|P2|Overall Study|Adverse Event|7
22505|NCT01954251|105297|P1|Overall Study|Adverse Event|5
22506|NCT01954121|105394|P2|Overall Study|Subject did not follow instructions|2
22507|NCT01954121|105395|P1|Overall Study|Subject did not follow instructions|0
22508|NCT01954121|105394|P2|Overall Study|Non-compliant patient|1
22509|NCT01954121|105395|P1|Overall Study|Non-compliant patient|1
22510|NCT01954121|105394|P2|Overall Study|Non-compliant with study procedures|0
22511|NCT01954121|105395|P1|Overall Study|Non-compliant with study procedures|1
22512|NCT01954121|105394|P2|Overall Study|SAE, non-fatal|4
22513|NCT01954121|105395|P1|Overall Study|SAE, non-fatal|1
22514|NCT01954121|105394|P2|Overall Study|AE, non-serious non-fatal|22
22515|NCT01954121|105395|P1|Overall Study|AE, non-serious non-fatal|5
22516|NCT01954121|105394|P2|Overall Study|AE, serious fatal|0
22517|NCT01954121|105395|P1|Overall Study|AE, serious fatal|1
22518|NCT01954121|105394|P2|Overall Study|Pregnancy|1
22519|NCT01954121|105395|P1|Overall Study|Pregnancy|1
22520|NCT01954121|105394|P2|Overall Study|Withdrawal by Subject|12
22521|NCT01954121|105395|P1|Overall Study|Withdrawal by Subject|18
22522|NCT01954121|105394|P2|Overall Study|Lost to Follow-up|6
22523|NCT01954121|105395|P1|Overall Study|Lost to Follow-up|5
22524|NCT01954121|105394|P2|Overall Study|Protocol Violation|2
22525|NCT01954121|105395|P1|Overall Study|Protocol Violation|0
22526|NCT01954121|105394|P2|Overall Study|Lack of Efficacy|41
22527|NCT01954121|105395|P1|Overall Study|Lack of Efficacy|94
22528|NCT01953354|105457|P2|Overall Study|Disease Exacerbation|0
22529|NCT01953354|105458|P1|Overall Study|Disease Exacerbation|1
22530|NCT01953354|105457|P2|Overall Study|Decision of Sponsor|1
22531|NCT01953354|105458|P1|Overall Study|Decision of Sponsor|0
22532|NCT01953354|105457|P2|Overall Study|Withdrawal by Subject|1
22533|NCT01953354|105458|P1|Overall Study|Withdrawal by Subject|0
22534|NCT01953328|105486|P8|Overall Study|Lost to Follow-up|0
22535|NCT01953328|105487|P7|Overall Study|Lost to Follow-up|0
22536|NCT01953328|105488|P6|Overall Study|Lost to Follow-up|0
22537|NCT01953328|105489|P5|Overall Study|Lost to Follow-up|1
22538|NCT01953328|105490|P4|Overall Study|Lost to Follow-up|0
22539|NCT01953328|105491|P3|Overall Study|Lost to Follow-up|0
22540|NCT01953328|105492|P2|Overall Study|Lost to Follow-up|0
22541|NCT01953328|105493|P1|Overall Study|Lost to Follow-up|0
22542|NCT01953328|105486|P8|Overall Study|Withdrawal by Subject|0
22543|NCT01953328|105487|P7|Overall Study|Withdrawal by Subject|0
22544|NCT01953328|105488|P6|Overall Study|Withdrawal by Subject|0
22545|NCT01953328|105489|P5|Overall Study|Withdrawal by Subject|1
22546|NCT01953328|105490|P4|Overall Study|Withdrawal by Subject|0
22547|NCT01953328|105491|P3|Overall Study|Withdrawal by Subject|0
22548|NCT01953328|105492|P2|Overall Study|Withdrawal by Subject|0
22549|NCT01953328|105493|P1|Overall Study|Withdrawal by Subject|0
22550|NCT01952834|105723|P1|Overall Study|Adverse Event|1
22551|NCT01952691|105730|P1|Overall Study|Lost to Follow-up|2
22552|NCT01952665|105738|P2|Overall Study|Protocol Violation|1
22553|NCT01952665|105739|P1|Overall Study|Protocol Violation|0
22554|NCT01952665|105738|P2|Overall Study|Adverse Event|1
22555|NCT01952665|105739|P1|Overall Study|Adverse Event|2
22556|NCT01952665|105738|P2|Overall Study|Lost to Follow-up|2
22557|NCT01952665|105739|P1|Overall Study|Lost to Follow-up|1
22558|NCT01952665|105738|P2|Overall Study|Physician Decision|2
22559|NCT01952665|105739|P1|Overall Study|Physician Decision|3
22560|NCT01952366|105905|P1|Overall Study|Withdrawal by Subject|9
22561|NCT01952366|105905|P1|Overall Study|Death|22
22562|NCT01952145|105919|P2|Overall Study|Unclassified|1
22563|NCT01952145|105920|P1|Overall Study|Unclassified|1
22564|NCT01952145|105919|P2|Overall Study|Withdrawal Criteria|11
22565|NCT01952145|105920|P1|Overall Study|Withdrawal Criteria|16
22566|NCT01952145|105919|P2|Overall Study|Adverse Event|0
22567|NCT01952145|105920|P1|Overall Study|Adverse Event|9
22568|NCT01952145|105919|P2|Overall Study|Death|1
22569|NCT01952145|105920|P1|Overall Study|Death|0
22570|NCT01952145|105919|P2|Overall Study|Protocol Violation|1
22571|NCT01952145|105920|P1|Overall Study|Protocol Violation|2
22572|NCT01952080|105934|P4|Overall Study|Protocol Non-compliance|0
22573|NCT01952080|105935|P3|Overall Study|Protocol Non-compliance|0
22574|NCT01952080|105936|P2|Overall Study|Protocol Non-compliance|1
22575|NCT01952080|105937|P1|Overall Study|Protocol Non-compliance|0
22576|NCT01952080|105934|P4|Overall Study|Withdrawal by Subject|1
22577|NCT01952080|105935|P3|Overall Study|Withdrawal by Subject|0
22578|NCT01952080|105936|P2|Overall Study|Withdrawal by Subject|0
22579|NCT01952080|105937|P1|Overall Study|Withdrawal by Subject|0
22580|NCT01951703|106016|P2|Second Intervention|Unsatisfactory Lens fitting|1
22581|NCT01951703|106017|P1|Second Intervention|Unsatisfactory Lens fitting|0
22582|NCT01951703|106016|P2|Second Intervention|Protocol Violation|1
22583|NCT01951703|106017|P1|Second Intervention|Protocol Violation|0
22584|NCT01951703|106016|P2|First Intervention|Physician Decision|0
22585|NCT01951703|106017|P1|First Intervention|Physician Decision|1
22586|NCT01951703|106016|P2|First Intervention|Subject was not compliant|1
22587|NCT01951703|106017|P1|First Intervention|Subject was not compliant|1
22588|NCT01951703|106016|P2|First Intervention|Withdrawal by Subject|0
22589|NCT01951703|106017|P1|First Intervention|Withdrawal by Subject|1
22590|NCT01951586|106042|P2|Overall Study|Withdrawal by Subject|13
22591|NCT01951586|106043|P1|Overall Study|Withdrawal by Subject|7
22592|NCT01951586|106042|P2|Overall Study|Death|100
22593|NCT01951586|106043|P1|Overall Study|Death|52
22594|NCT01951573|106067|P2|Washout Period|Adverse Event|1
22595|NCT01951573|106068|P1|Washout Period|Adverse Event|0
22596|NCT01951417|106078|P1|Overall Study|Lost to Follow-up|6
22597|NCT01951417|106078|P1|Overall Study|Protocol Violation|2
22598|NCT01951417|106078|P1|Overall Study|Withdrawal by Subject|1
22599|NCT01951170|106101|P1|Overall Study|Investigator decision|1
22600|NCT01951092|106124|P1|Overall Study|Transfer of Care|1
22601|NCT01951092|106124|P1|Overall Study|Incarceration|1
22602|NCT01951092|106124|P1|Overall Study|Lost to Follow-up|10
22603|NCT01950741|106135|P1|Overall Study|Withdrawal by Subject|1
22604|NCT01950741|106135|P1|Overall Study|Death|1
22605|NCT01950741|106135|P1|Overall Study|Lost to Follow-up|1
22606|NCT01950364|106150|P2|Overall Study|Protocol Violation|1
22607|NCT01950364|106151|P1|Overall Study|Protocol Violation|0
22608|NCT01950364|106150|P2|Overall Study|Withdrawal by Subject|1
22609|NCT01950364|106151|P1|Overall Study|Withdrawal by Subject|0
22610|NCT01950364|106150|P2|Overall Study|Disease Progression|2
22611|NCT01950364|106151|P1|Overall Study|Disease Progression|5
22612|NCT01950364|106150|P2|Overall Study|Stem Cell Transplant|6
22613|NCT01950364|106151|P1|Overall Study|Stem Cell Transplant|2
22614|NCT01950364|106150|P2|Overall Study|Adverse Event|0
22615|NCT01950364|106151|P1|Overall Study|Adverse Event|3
22616|NCT01949870|106260|P1|Overall Study|Eligibility requirements not fulfilled|2
22617|NCT01949870|106260|P1|Overall Study|Study termination|1
22618|NCT01949870|106260|P1|Overall Study|Adverse Event|1
22619|NCT01949870|106260|P1|Overall Study|Lack of Efficacy|2
22620|NCT01949532|106419|P2|Overall Study|On-study at the Data Cut-off Date|3
22621|NCT01949532|106420|P1|Overall Study|On-study at the Data Cut-off Date|3
22622|NCT01949155|106495|P2|Overall Study|Protocol Violation|0
22623|NCT01949155|106496|P1|Overall Study|Protocol Violation|1
22624|NCT01949155|106495|P2|Overall Study|Lost to Follow-up|0
22625|NCT01949155|106496|P1|Overall Study|Lost to Follow-up|1
22626|NCT01949142|106508|P2|Overall Study|Parent changed their mind|0
22627|NCT01949142|106509|P1|Overall Study|Parent changed their mind|1
22628|NCT01949142|106508|P2|Overall Study|Lost to Follow-up|1
22629|NCT01949142|106509|P1|Overall Study|Lost to Follow-up|1
22630|NCT01949142|106508|P2|Overall Study|Withdrawal of consent|0
22631|NCT01949142|106509|P1|Overall Study|Withdrawal of consent|1
22632|NCT01949116|106521|P2|Overall Study|Withdrawal by Subject|3
22633|NCT01949116|106522|P1|Overall Study|Withdrawal by Subject|5
22634|NCT01949116|106521|P2|Overall Study|Lost to Follow-up|3
22635|NCT01949116|106522|P1|Overall Study|Lost to Follow-up|1
22636|NCT01949116|106521|P2|Overall Study|Death|0
22637|NCT01949116|106522|P1|Overall Study|Death|2
22638|NCT01949090|106559|P5|Overall Study|Lost to Follow-up|1
22639|NCT01949090|106560|P4|Overall Study|Lost to Follow-up|1
22640|NCT01949090|106561|P3|Overall Study|Lost to Follow-up|0
22641|NCT01949090|106562|P2|Overall Study|Lost to Follow-up|1
22642|NCT01949090|106563|P1|Overall Study|Lost to Follow-up|2
22643|NCT01949090|106559|P5|Overall Study|Protocol non-compliance|1
22644|NCT01949090|106560|P4|Overall Study|Protocol non-compliance|0
22645|NCT01949090|106561|P3|Overall Study|Protocol non-compliance|0
22646|NCT01949090|106562|P2|Overall Study|Protocol non-compliance|0
22647|NCT01949090|106563|P1|Overall Study|Protocol non-compliance|0
22648|NCT01949090|106559|P5|Overall Study|Withdrawal by Subject|1
22649|NCT01949090|106560|P4|Overall Study|Withdrawal by Subject|0
22650|NCT01949090|106561|P3|Overall Study|Withdrawal by Subject|0
22651|NCT01949090|106562|P2|Overall Study|Withdrawal by Subject|0
22652|NCT01949090|106563|P1|Overall Study|Withdrawal by Subject|2
22653|NCT01949090|106559|P5|Overall Study|Serious Adverse Event|1
22654|NCT01949090|106560|P4|Overall Study|Serious Adverse Event|0
22655|NCT01949090|106561|P3|Overall Study|Serious Adverse Event|2
22656|NCT01949090|106562|P2|Overall Study|Serious Adverse Event|1
22657|NCT01949090|106563|P1|Overall Study|Serious Adverse Event|0
22658|NCT01949051|106740|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
22659|NCT01949051|106741|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
22660|NCT01949051|106742|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
22661|NCT01949051|106743|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
22662|NCT01949051|106744|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
22663|NCT01949051|106745|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
22664|NCT01949051|106740|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
22665|NCT01949051|106741|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
22666|NCT01949051|106742|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
22667|NCT01949051|106743|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
22668|NCT01949051|106744|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
22669|NCT01949051|106745|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
22670|NCT01949051|106740|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
22671|NCT01949051|106741|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
22672|NCT01949051|106742|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
22673|NCT01949051|106743|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
22674|NCT01949051|106744|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
22675|NCT01949051|106745|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
22676|NCT01949051|106740|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
22677|NCT01949051|106741|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
22678|NCT01949051|106742|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
22679|NCT01949051|106743|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
22680|NCT01949051|106744|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
22681|NCT01949051|106745|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
22682|NCT01949051|106740|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
22683|NCT01949051|106741|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
22684|NCT01949051|106742|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
22685|NCT01949051|106743|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
22686|NCT01949051|106744|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
22687|NCT01949051|106745|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
22688|NCT01948908|106774|P3|Overall Study|Protocol Violation|2
22689|NCT01948908|106775|P2|Overall Study|Protocol Violation|0
22690|NCT01948908|106776|P1|Overall Study|Protocol Violation|1
22691|NCT01948830|106792|P2|Overall Study|Death|4
22692|NCT01948830|106793|P1|Overall Study|Death|3
22693|NCT01948830|106792|P2|Overall Study|Adverse Event|2
22694|NCT01948830|106793|P1|Overall Study|Adverse Event|9
22695|NCT01948830|106792|P2|Overall Study|Withdrawal by Subject|17
22696|NCT01948830|106793|P1|Overall Study|Withdrawal by Subject|14
22697|NCT01948830|106792|P2|Overall Study|Lost to Follow-up|4
22698|NCT01948830|106793|P1|Overall Study|Lost to Follow-up|5
22699|NCT01948830|106792|P2|Overall Study|Protocol deviation|2
22700|NCT01948830|106793|P1|Overall Study|Protocol deviation|1
22701|NCT01948830|106792|P2|Overall Study|Physician Decision|3
22702|NCT01948830|106793|P1|Overall Study|Physician Decision|1
22703|NCT01948791|106825|P1|Overall Study|Screening failure|35
22704|NCT01948791|106825|P1|Overall Study|Others|7
22705|NCT01948791|106825|P1|Overall Study|Management issues|1
22706|NCT01948791|106825|P1|Overall Study|Lost to Follow-up|6
22707|NCT01948791|106825|P1|Overall Study|Withdrawal by Subject|5
22708|NCT01948791|106825|P1|Overall Study|Protocol Violation|2
22709|NCT01948791|106825|P1|Overall Study|Lack of Efficacy|3
22710|NCT01948791|106825|P1|Overall Study|Adverse Event|12
22711|NCT01948193|106868|P1|Overall Study|Lost to Follow-up|7
22712|NCT01948193|106868|P1|Overall Study|Serious event|2
22713|NCT01948076|106890|P2|Overall Study|Withdrawal by Subject|1
22714|NCT01948076|106891|P1|Overall Study|Withdrawal by Subject|0
22715|NCT01948063|106901|P2|Overall Study|Blood samples were accidentally thawed|0
22716|NCT01948063|106902|P1|Overall Study|Blood samples were accidentally thawed|1
22717|NCT01948063|106901|P2|Overall Study|Discovered an enrollment in other study|1
22718|NCT01948063|106902|P1|Overall Study|Discovered an enrollment in other study|0
22719|NCT01948063|106901|P2|Overall Study|Boston MCI halted research protocol|1
22720|NCT01948063|106902|P1|Overall Study|Boston MCI halted research protocol|0
22721|NCT01948050|106910|P2|Overall Study|Withdrawal by Subject|1
22722|NCT01948050|106911|P1|Overall Study|Withdrawal by Subject|0
22723|NCT01947855|106979|P3|Overall Study|Withdrawal by Subject|0
22724|NCT01947855|106980|P2|Overall Study|Withdrawal by Subject|0
22725|NCT01947855|106981|P1|Overall Study|Withdrawal by Subject|1
22726|NCT01947582|106989|P1|Overall Study|Withdrawal by Subject|1
22727|NCT01947517|106998|P2|Overall Study|Withdrawal by Subject|1
22728|NCT01947517|106999|P1|Overall Study|Withdrawal by Subject|1
22729|NCT01947491|107017|P4|Overall Study|Adverse Event|2
22730|NCT01947491|107018|P3|Overall Study|Adverse Event|0
22731|NCT01947491|107019|P2|Overall Study|Adverse Event|1
22732|NCT01947491|107020|P1|Overall Study|Adverse Event|0
22733|NCT01947491|107017|P4|Overall Study|Worsening of condition|0
22734|NCT01947491|107018|P3|Overall Study|Worsening of condition|0
22735|NCT01947491|107019|P2|Overall Study|Worsening of condition|1
22736|NCT01947491|107020|P1|Overall Study|Worsening of condition|0
22737|NCT01947491|107017|P4|Overall Study|Withdrawal by Subject|0
22738|NCT01947491|107018|P3|Overall Study|Withdrawal by Subject|1
22739|NCT01947491|107019|P2|Overall Study|Withdrawal by Subject|1
22740|NCT01947491|107020|P1|Overall Study|Withdrawal by Subject|1
22741|NCT01947491|107017|P4|Overall Study|Protocol Violation|0
22742|NCT01947491|107018|P3|Overall Study|Protocol Violation|0
22743|NCT01947491|107019|P2|Overall Study|Protocol Violation|0
22744|NCT01947491|107020|P1|Overall Study|Protocol Violation|1
22745|NCT01947491|107017|P4|Overall Study|Lack of Efficacy|1
22746|NCT01947491|107018|P3|Overall Study|Lack of Efficacy|0
22747|NCT01947491|107019|P2|Overall Study|Lack of Efficacy|0
22748|NCT01947491|107020|P1|Overall Study|Lack of Efficacy|1
22749|NCT01947491|107017|P4|Overall Study|Lost to Follow-up|2
22750|NCT01947491|107018|P3|Overall Study|Lost to Follow-up|1
22751|NCT01947491|107019|P2|Overall Study|Lost to Follow-up|3
22752|NCT01947491|107020|P1|Overall Study|Lost to Follow-up|5
22753|NCT01947127|107064|P2|Overall Study|Data loss|4
22754|NCT01947127|107065|P1|Overall Study|Data loss|4
22755|NCT01947127|107064|P2|Overall Study|Withdrawal by Subject|1
22756|NCT01947127|107065|P1|Overall Study|Withdrawal by Subject|1
22757|NCT01947127|107064|P2|Overall Study|Protocol Violation|38
22758|NCT01947127|107065|P1|Overall Study|Protocol Violation|18
22759|NCT01946529|107089|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
22760|NCT01946529|107090|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
22761|NCT01946529|107091|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
22762|NCT01946529|107089|P3|End of Window Therapy (2 Courses)|Physician Decision|0
22763|NCT01946529|107090|P2|End of Window Therapy (2 Courses)|Physician Decision|1
22764|NCT01946529|107091|P1|End of Window Therapy (2 Courses)|Physician Decision|0
22765|NCT01946438|107102|P4|Overall Study|Withdrawal by Subject|0
22766|NCT01946438|107103|P3|Overall Study|Withdrawal by Subject|0
22767|NCT01946438|107104|P2|Overall Study|Withdrawal by Subject|0
22768|NCT01946438|107105|P1|Overall Study|Withdrawal by Subject|1
22769|NCT01946438|107102|P4|Overall Study|Protocol Violation|0
22770|NCT01946438|107103|P3|Overall Study|Protocol Violation|1
22771|NCT01946438|107104|P2|Overall Study|Protocol Violation|0
22772|NCT01946438|107105|P1|Overall Study|Protocol Violation|0
22773|NCT01946438|107102|P4|Overall Study|Serious Adverse event|0
22774|NCT01946438|107103|P3|Overall Study|Serious Adverse event|0
22775|NCT01946438|107104|P2|Overall Study|Serious Adverse event|0
22776|NCT01946438|107105|P1|Overall Study|Serious Adverse event|1
22777|NCT01946438|107102|P4|Overall Study|Adverse Event|1
22778|NCT01946438|107103|P3|Overall Study|Adverse Event|0
22779|NCT01946438|107104|P2|Overall Study|Adverse Event|0
22780|NCT01946438|107105|P1|Overall Study|Adverse Event|0
22781|NCT01946425|107133|P2|Overall Study|Withdrawal by Subject|0
22782|NCT01946425|107134|P1|Overall Study|Withdrawal by Subject|1
22783|NCT01946425|107133|P2|Overall Study|Protocol Violation|0
22784|NCT01946425|107134|P1|Overall Study|Protocol Violation|1
22785|NCT01946412|107148|P1|Overall Study|Difficulty in swallowing|1
22786|NCT01946412|107148|P1|Overall Study|Continued with commercial Kalydeco|2
22787|NCT01946412|107148|P1|Overall Study|Non-Compliance|1
22788|NCT01946412|107148|P1|Overall Study|Adverse Event|1
22789|NCT01946178|107191|P1|Overall Study|Lost to Follow-up|1
22790|NCT01946178|107191|P1|Overall Study|Pregnancy|1
22791|NCT01945944|107260|P2|Overall Study|Withdrawal by Subject|1
22792|NCT01945944|107261|P1|Overall Study|Withdrawal by Subject|0
22793|NCT01945944|107260|P2|Overall Study|Physician Decision|0
22794|NCT01945944|107261|P1|Overall Study|Physician Decision|1
22795|NCT01945944|107260|P2|Overall Study|Adverse Event|2
22796|NCT01945944|107261|P1|Overall Study|Adverse Event|0
22797|NCT01945489|107285|P2|Cycle 2|Lost to Follow-up|1
22798|NCT01945489|107286|P1|Cycle 2|Lost to Follow-up|0
22799|NCT01945489|107285|P2|Cycle 2|Adverse Event|0
22800|NCT01945489|107286|P1|Cycle 2|Adverse Event|1
22801|NCT01945489|107285|P2|Cycle 1|Other Miscellaneous Reasons|1
22802|NCT01945489|107286|P1|Cycle 1|Other Miscellaneous Reasons|3
22803|NCT01945489|107285|P2|Cycle 1|Protocol Violation|1
22804|NCT01945489|107286|P1|Cycle 1|Protocol Violation|0
22805|NCT01945489|107285|P2|Cycle 1|Personal Reasons|2
22806|NCT01945489|107286|P1|Cycle 1|Personal Reasons|4
22807|NCT01945489|107285|P2|Cycle 1|Lost to Follow-up|0
22808|NCT01945489|107286|P1|Cycle 1|Lost to Follow-up|4
22809|NCT01945489|107285|P2|Cycle 1|Adverse Event|0
22810|NCT01945489|107286|P1|Cycle 1|Adverse Event|2
22811|NCT01945242|107340|P2|Overall Study|Physician Decision|3
22812|NCT01945242|107341|P1|Overall Study|Physician Decision|3
22813|NCT01945086|107399|P3|Overall Study|Adverse Event|1
22814|NCT01945086|107400|P2|Overall Study|Adverse Event|0
22815|NCT01945086|107401|P1|Overall Study|Adverse Event|0
22816|NCT01945086|107399|P3|Overall Study|Withdrawal by Subject|1
22817|NCT01945086|107400|P2|Overall Study|Withdrawal by Subject|0
22818|NCT01945086|107401|P1|Overall Study|Withdrawal by Subject|1
22819|NCT01945034|107445|P3|Overall Study|Protocol Violation|1
22820|NCT01945034|107446|P2|Overall Study|Protocol Violation|0
22821|NCT01945034|107447|P1|Overall Study|Protocol Violation|1
22822|NCT01945034|107445|P3|Overall Study|Lost to Follow-up|2
22823|NCT01945034|107446|P2|Overall Study|Lost to Follow-up|0
22824|NCT01945034|107447|P1|Overall Study|Lost to Follow-up|0
22825|NCT01945034|107445|P3|Overall Study|Other|3
22826|NCT01945034|107446|P2|Overall Study|Other|1
22827|NCT01945034|107447|P1|Overall Study|Other|0
22828|NCT01945034|107445|P3|Overall Study|Withdrawal by Subject|1
22829|NCT01945034|107446|P2|Overall Study|Withdrawal by Subject|3
22830|NCT01945034|107447|P1|Overall Study|Withdrawal by Subject|0
22831|NCT01945034|107445|P3|Overall Study|Medication Error|0
22832|NCT01945034|107446|P2|Overall Study|Medication Error|1
22833|NCT01945034|107447|P1|Overall Study|Medication Error|0
22834|NCT01945021|107497|P1|Overall Study|Non-RECIST disease progression|1
22835|NCT01945021|107497|P1|Overall Study|Withdrawal of consent|3
22836|NCT01945021|107497|P1|Overall Study|Withdrawal by Subject|2
22837|NCT01945021|107497|P1|Overall Study|Global deterioration of health-related s|1
22838|NCT01945021|107497|P1|Overall Study|Disease progression by RECIST v1.1|30
22839|NCT01945021|107497|P1|Overall Study|Pregnancy|1
22840|NCT01945021|107497|P1|Overall Study|Death|1
22841|NCT01945021|107497|P1|Overall Study|Adverse Event|8
22842|NCT01944969|107511|P1|Overall Study|Administrative or other reasons|23
22843|NCT01944969|107511|P1|Overall Study|Non-compliance with IMP|1
22844|NCT01944969|107511|P1|Overall Study|Lack of Efficacy|1
22845|NCT01944969|107511|P1|Overall Study|Adverse Event|1
22846|NCT01944774|107536|P3|Overall Study|Lost to Follow-up|0
22847|NCT01944774|107537|P2|Overall Study|Lost to Follow-up|1
22848|NCT01944774|107538|P1|Overall Study|Lost to Follow-up|0
22849|NCT01944774|107536|P3|Overall Study|Lack of Efficacy|2
22850|NCT01944774|107537|P2|Overall Study|Lack of Efficacy|2
22851|NCT01944774|107538|P1|Overall Study|Lack of Efficacy|1
22852|NCT01944774|107536|P3|Overall Study|Adverse Event|3
22853|NCT01944774|107537|P2|Overall Study|Adverse Event|2
22854|NCT01944774|107538|P1|Overall Study|Adverse Event|3
22855|NCT01944774|107536|P3|Overall Study|Withdrawal by Subject|3
22856|NCT01944774|107537|P2|Overall Study|Withdrawal by Subject|3
22857|NCT01944774|107538|P1|Overall Study|Withdrawal by Subject|2
22858|NCT01944722|107581|P1|Overall Study|>ASCUS Cytology|1122
22859|NCT01944722|107581|P1|Overall Study|Unsatisfactory Cytology Result|63
22860|NCT01944722|107581|P1|Overall Study|NILM Subjects <30 years old|8106
22861|NCT01944722|107581|P1|Overall Study|Withdrawal by Subject|8
22862|NCT01944722|107581|P1|Overall Study|Specimens Mislabeled|2
22863|NCT01944722|107581|P1|Overall Study|Missing Specimens|3
22864|NCT01944722|107581|P1|Overall Study|Insufficient Volume for Test|1
22865|NCT01944722|107581|P1|Overall Study|Improper Storage/Transport|5
22866|NCT01944722|107581|P1|Overall Study|Specimen Shipping Issues|34
22867|NCT01944722|107581|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
22868|NCT01944670|107615|P1|Overall Study|Lost to Follow-up|2
22869|NCT01944631|107622|P2|Overall Study|Withdrawal by Subject|1
22870|NCT01944631|107623|P1|Overall Study|Withdrawal by Subject|0
22871|NCT01944631|107622|P2|Overall Study|Lost to Follow-up|1
22872|NCT01944631|107623|P1|Overall Study|Lost to Follow-up|3
22873|NCT01944631|107622|P2|Overall Study|Adverse Event|0
22874|NCT01944631|107623|P1|Overall Study|Adverse Event|1
22875|NCT01944462|107639|P1|PPPP Educational Program|Lost to Follow-up|60
22876|NCT01944098|107669|P2|Overall Study|Physician Decision|0
22877|NCT01944098|107670|P1|Overall Study|Physician Decision|1
22878|NCT01944059|107682|P1|Overall Study|Adverse Event|2
22879|NCT01944059|107682|P1|Overall Study|Withdrawal by Subject|1
22880|NCT01944059|107682|P1|Overall Study|Physician Decision|3
22881|NCT01944059|107682|P1|Overall Study|Lost to Follow-up|1
22882|NCT01943552|107755|P2|Overall Study|Other Reasons|17
22883|NCT01943552|107756|P1|Overall Study|Other Reasons|16
22884|NCT01943552|107755|P2|Overall Study|Withdrawal by Subject|6
22885|NCT01943552|107756|P1|Overall Study|Withdrawal by Subject|6
22886|NCT01943552|107755|P2|Overall Study|Adverse Event|2
22887|NCT01943552|107756|P1|Overall Study|Adverse Event|3
22888|NCT01943539|107772|P2|Overall Study|Non-compliance with at-home intervention|0
22889|NCT01943539|107773|P1|Overall Study|Non-compliance with at-home intervention|4
22890|NCT01943435|107809|P3|6 Month Follow up|Lost to Follow-up|15
22891|NCT01943435|107810|P2|6 Month Follow up|Lost to Follow-up|7
22892|NCT01943435|107811|P1|6 Month Follow up|Lost to Follow-up|12
22893|NCT01943435|107809|P3|2 Month Follow up|Lost to Follow-up|0
22894|NCT01943435|107810|P2|2 Month Follow up|Lost to Follow-up|3
22895|NCT01943435|107811|P1|2 Month Follow up|Lost to Follow-up|2
22896|NCT01943435|107809|P3|Intervention Period|Withdrawal by Subject|4
22897|NCT01943435|107810|P2|Intervention Period|Withdrawal by Subject|3
22898|NCT01943435|107811|P1|Intervention Period|Withdrawal by Subject|3
22899|NCT01943435|107809|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
22900|NCT01943435|107810|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
22901|NCT01943435|107811|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
22902|NCT01943292|107832|P3|Overall Study|Withdrawal by Subject|0
22903|NCT01943292|107833|P2|Overall Study|Withdrawal by Subject|0
22904|NCT01943292|107834|P1|Overall Study|Withdrawal by Subject|1
22905|NCT01942785|107861|P1|Overall Study|Protocol Violation|1
22906|NCT01942785|107861|P1|Overall Study|Withdrawal by Subject|1
22907|NCT01942785|107861|P1|Overall Study|Adverse Event|2
22908|NCT01942733|107890|P1|Overall Study|Administrative|1
22909|NCT01942733|107890|P1|Overall Study|Non-compliance with IMP|1
22910|NCT01942733|107890|P1|Overall Study|Lost to Follow-up|1
22911|NCT01942590|107942|P2|Overall Study|Adverse Event|0
22912|NCT01942590|107943|P1|Overall Study|Adverse Event|1
22913|NCT01942590|107942|P2|Overall Study|Withdrawal by Subject|1
22914|NCT01942590|107943|P1|Overall Study|Withdrawal by Subject|0
22915|NCT01942161|107976|P3|Overall Study|Withdrawal by Subject|1
22916|NCT01942161|107977|P2|Overall Study|Withdrawal by Subject|3
22917|NCT01942161|107978|P1|Overall Study|Withdrawal by Subject|3
22918|NCT01942161|107976|P3|Overall Study|Protocol Violation|0
22919|NCT01942161|107977|P2|Overall Study|Protocol Violation|0
22920|NCT01942161|107978|P1|Overall Study|Protocol Violation|1
22921|NCT01942161|107976|P3|Overall Study|Physician Decision|0
22922|NCT01942161|107977|P2|Overall Study|Physician Decision|1
22923|NCT01942161|107978|P1|Overall Study|Physician Decision|3
22924|NCT01942161|107976|P3|Overall Study|Adverse Event|5
22925|NCT01942161|107977|P2|Overall Study|Adverse Event|2
22926|NCT01942161|107978|P1|Overall Study|Adverse Event|1
22927|NCT01942148|107998|P1|Overall Study|Use of the prohibition medicine|1
22928|NCT01942148|107998|P1|Overall Study|Withdrawal by Subject|8
22929|NCT01942148|107998|P1|Overall Study|Protocol Violation|1
22930|NCT01942148|107998|P1|Overall Study|Physician Decision|11
22931|NCT01942148|107998|P1|Overall Study|Lack of Efficacy|2
22932|NCT01942148|107998|P1|Overall Study|Adverse Event|4
22933|NCT01942135|108006|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
22934|NCT01942135|108007|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
22935|NCT01942135|108006|P2|Overall Study|Withdrawal by Subject|2
22936|NCT01942135|108007|P1|Overall Study|Withdrawal by Subject|4
22937|NCT01942135|108006|P2|Overall Study|Participant Refused toContinue Treatment|1
22938|NCT01942135|108007|P1|Overall Study|Participant Refused toContinue Treatment|1
22939|NCT01942135|108006|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
22940|NCT01942135|108007|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
22941|NCT01942135|108006|P2|Overall Study|Death|1
22942|NCT01942135|108007|P1|Overall Study|Death|0
22943|NCT01942135|108006|P2|Overall Study|Randomized Not Treated|2
22944|NCT01942135|108007|P1|Overall Study|Randomized Not Treated|2
22945|NCT01942135|108006|P2|Overall Study|Global deterioration of health status|3
22946|NCT01942135|108007|P1|Overall Study|Global deterioration of health status|8
22947|NCT01942135|108006|P2|Overall Study|Adverse Event|3
22948|NCT01942135|108007|P1|Overall Study|Adverse Event|9
22949|NCT01941940|108044|P1|Overall Study|Other|1
22950|NCT01941940|108044|P1|Overall Study|Other|1
22951|NCT01941940|108044|P1|Overall Study|Death|1
22952|NCT01941940|108044|P1|Overall Study|Withdrawal by Subject|15
22953|NCT01941940|108044|P1|Overall Study|Physician Decision|2
22954|NCT01941940|108044|P1|Overall Study|Lost to Follow-up|2
22955|NCT01941940|108044|P1|Overall Study|Adverse Event|11
22956|NCT01941498|108093|P1|Overall Study|Relocated out of state|1
22957|NCT01941186|108211|P2|Follow-up|Lost to Follow-up|0
22958|NCT01941186|108212|P1|Follow-up|Lost to Follow-up|1
22959|NCT01940497|108282|P2|Overall Study|Ongoing at data cut-off|117
22960|NCT01940497|108283|P1|Overall Study|Ongoing at data cut-off|116
22961|NCT01940497|108282|P2|Overall Study|Withdrawal by Subject|0
22962|NCT01940497|108283|P1|Overall Study|Withdrawal by Subject|2
22963|NCT01940497|108282|P2|Overall Study|Protocol Violation|0
22964|NCT01940497|108283|P1|Overall Study|Protocol Violation|1
22965|NCT01940497|108282|P2|Overall Study|Failure to return|1
22966|NCT01940497|108283|P1|Overall Study|Failure to return|0
22967|NCT01940497|108282|P2|Overall Study|Adverse event/Intercurrent illness|0
22968|NCT01940497|108283|P1|Overall Study|Adverse event/Intercurrent illness|1
22969|NCT01940484|108322|P1|Overall Study|Adverse Event|1
22970|NCT01940484|108322|P1|Overall Study|Death|2
22971|NCT01940484|108322|P1|Overall Study|Underwent transplantation|4
22972|NCT01940484|108322|P1|Overall Study|Withdrawal by Subject|3
22973|NCT01940471|108342|P2|Open-Label Extension|Still on Open-Label Treatment|8
22974|NCT01940471|108343|P1|Open-Label Extension|Still on Open-Label Treatment|14
22975|NCT01940471|108342|P2|Double-Blind Phase|Still on Double-Blind Treatment|270
22976|NCT01940471|108343|P1|Double-Blind Phase|Still on Double-Blind Treatment|537
22977|NCT01940471|108342|P2|Double-Blind Phase|HBsAg Seroconversion|0
22978|NCT01940471|108343|P1|Double-Blind Phase|HBsAg Seroconversion|1
22979|NCT01940471|108342|P2|Double-Blind Phase|Protocol Violation|1
22980|NCT01940471|108343|P1|Double-Blind Phase|Protocol Violation|0
22981|NCT01940471|108342|P2|Double-Blind Phase|Lack of Efficacy|0
22982|NCT01940471|108343|P1|Double-Blind Phase|Lack of Efficacy|1
22983|NCT01940471|108342|P2|Double-Blind Phase|Death|0
22984|NCT01940471|108343|P1|Double-Blind Phase|Death|1
22985|NCT01940471|108342|P2|Double-Blind Phase|Protocol-Specified Criteria|0
22986|NCT01940471|108343|P1|Double-Blind Phase|Protocol-Specified Criteria|2
22987|NCT01940471|108342|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
22988|NCT01940471|108343|P1|Double-Blind Phase|Non-Compliance with Study Drug|2
22989|NCT01940471|108342|P2|Double-Blind Phase|Investigator's Discretion|1
22990|NCT01940471|108343|P1|Double-Blind Phase|Investigator's Discretion|2
22991|NCT01940471|108342|P2|Double-Blind Phase|Pregnancy|1
22992|NCT01940471|108343|P1|Double-Blind Phase|Pregnancy|2
22993|NCT01940471|108342|P2|Double-Blind Phase|Lost to Follow-up|2
22994|NCT01940471|108343|P1|Double-Blind Phase|Lost to Follow-up|2
22995|NCT01940471|108342|P2|Double-Blind Phase|Adverse Event|3
22996|NCT01940471|108343|P1|Double-Blind Phase|Adverse Event|6
22997|NCT01940471|108342|P2|Double-Blind Phase|Withdrew Consent|5
22998|NCT01940471|108343|P1|Double-Blind Phase|Withdrew Consent|11
22999|NCT01940471|108342|P2|Double-Blind Phase|Randomized but Never Treated|1
23000|NCT01940471|108343|P1|Double-Blind Phase|Randomized but Never Treated|1
23001|NCT01940354|108361|P2|Overall Study|Withdrawal by Subject|2
23002|NCT01940354|108362|P1|Overall Study|Withdrawal by Subject|4
23003|NCT01940341|108374|P2|Open-label Extension Phase|Still on Study|1
23004|NCT01940341|108375|P1|Open-label Extension Phase|Still on Study|4
23005|NCT01940341|108374|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
23006|NCT01940341|108375|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
23007|NCT01940341|108374|P2|Double-Blind Phase|Protocol Specified Criteria|0
23008|NCT01940341|108375|P1|Double-Blind Phase|Protocol Specified Criteria|1
23009|NCT01940341|108374|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
23010|NCT01940341|108375|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
23011|NCT01940341|108374|P2|Double-Blind Phase|Investigator's Discretion|0
23012|NCT01940341|108375|P1|Double-Blind Phase|Investigator's Discretion|1
23013|NCT01940341|108374|P2|Double-Blind Phase|Pregnancy|1
23014|NCT01940341|108375|P1|Double-Blind Phase|Pregnancy|0
23015|NCT01940341|108374|P2|Double-Blind Phase|Lost to Follow-up|1
23016|NCT01940341|108375|P1|Double-Blind Phase|Lost to Follow-up|4
23017|NCT01940341|108374|P2|Double-Blind Phase|Withdrew Consent|2
23018|NCT01940341|108375|P1|Double-Blind Phase|Withdrew Consent|3
23019|NCT01940341|108374|P2|Double-Blind Phase|Adverse Event|2
23020|NCT01940341|108375|P1|Double-Blind Phase|Adverse Event|3
23021|NCT01940341|108374|P2|Double-Blind Phase|Randomized but Never Treated|1
23022|NCT01940341|108375|P1|Double-Blind Phase|Randomized but Never Treated|0
23023|NCT01940120|108406|P1|Overall Study|Withdrawal by Subject|8
23024|NCT01940120|108406|P1|Overall Study|Death|40
23025|NCT01939548|108568|P3|Overall Study|Did not complete follow-up|0
23026|NCT01939548|108569|P2|Overall Study|Did not complete follow-up|1
23027|NCT01939548|108570|P1|Overall Study|Did not complete follow-up|0
23028|NCT01939548|108568|P3|Overall Study|Participant withdrew consent|0
23029|NCT01939548|108569|P2|Overall Study|Participant withdrew consent|2
23030|NCT01939548|108570|P1|Overall Study|Participant withdrew consent|0
23031|NCT01939548|108568|P3|Overall Study|Participant unwilling to continue|0
23032|NCT01939548|108569|P2|Overall Study|Participant unwilling to continue|1
23033|NCT01939548|108570|P1|Overall Study|Participant unwilling to continue|0
23034|NCT01939548|108568|P3|Overall Study|Participant dropped|1
23035|NCT01939548|108569|P2|Overall Study|Participant dropped|0
23036|NCT01939548|108570|P1|Overall Study|Participant dropped|0
23037|NCT01939548|108568|P3|Overall Study|Death|1
23038|NCT01939548|108569|P2|Overall Study|Death|0
23039|NCT01939548|108570|P1|Overall Study|Death|0
23040|NCT01939548|108568|P3|Overall Study|Adverse Event|7
23041|NCT01939548|108569|P2|Overall Study|Adverse Event|9
23042|NCT01939548|108570|P1|Overall Study|Adverse Event|2
23043|NCT01939548|108568|P3|Overall Study|Lost to Follow-up|3
23044|NCT01939548|108569|P2|Overall Study|Lost to Follow-up|5
23045|NCT01939548|108570|P1|Overall Study|Lost to Follow-up|5
23046|NCT01939548|108568|P3|Overall Study|Protocol Violation|5
23047|NCT01939548|108569|P2|Overall Study|Protocol Violation|6
23048|NCT01939548|108570|P1|Overall Study|Protocol Violation|7
23049|NCT01939548|108568|P3|Overall Study|Withdrawal by Subject|1
23050|NCT01939548|108569|P2|Overall Study|Withdrawal by Subject|4
23051|NCT01939548|108570|P1|Overall Study|Withdrawal by Subject|4
23052|NCT01939548|108568|P3|Overall Study|Did Not Meet Entrance Criteria|0
23053|NCT01939548|108569|P2|Overall Study|Did Not Meet Entrance Criteria|0
23054|NCT01939548|108570|P1|Overall Study|Did Not Meet Entrance Criteria|1
23055|NCT01939548|108568|P3|Overall Study|Insufficient Clinical Response|0
23056|NCT01939548|108569|P2|Overall Study|Insufficient Clinical Response|0
23057|NCT01939548|108570|P1|Overall Study|Insufficient Clinical Response|1
23058|NCT01939548|108568|P3|Overall Study|Study Terminated by Sponsor|12
23059|NCT01939548|108569|P2|Overall Study|Study Terminated by Sponsor|19
23060|NCT01939548|108570|P1|Overall Study|Study Terminated by Sponsor|17
23061|NCT01939548|108568|P3|Overall Study|Non compliance|0
23062|NCT01939548|108569|P2|Overall Study|Non compliance|2
23063|NCT01939548|108570|P1|Overall Study|Non compliance|0
23064|NCT01939496|108644|P3|Overall Study|Other|1
23065|NCT01939496|108645|P2|Overall Study|Other|0
23066|NCT01939496|108646|P1|Overall Study|Other|2
23067|NCT01939496|108644|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
23068|NCT01939496|108645|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
23069|NCT01939496|108646|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
23070|NCT01939496|108644|P3|Overall Study|Withdrawal by Subject|1
23071|NCT01939496|108645|P2|Overall Study|Withdrawal by Subject|1
23072|NCT01939496|108646|P1|Overall Study|Withdrawal by Subject|0
23073|NCT01939496|108644|P3|Overall Study|Protocol Violation|0
23074|NCT01939496|108645|P2|Overall Study|Protocol Violation|0
23075|NCT01939496|108646|P1|Overall Study|Protocol Violation|3
23076|NCT01939496|108644|P3|Overall Study|Physician Decision|0
23077|NCT01939496|108645|P2|Overall Study|Physician Decision|0
23078|NCT01939496|108646|P1|Overall Study|Physician Decision|1
23079|NCT01939496|108644|P3|Overall Study|Lost to Follow-up|0
23080|NCT01939496|108645|P2|Overall Study|Lost to Follow-up|1
23081|NCT01939496|108646|P1|Overall Study|Lost to Follow-up|1
23082|NCT01939496|108644|P3|Overall Study|Adverse Event|0
23083|NCT01939496|108645|P2|Overall Study|Adverse Event|0
23084|NCT01939496|108646|P1|Overall Study|Adverse Event|2
23085|NCT01939314|108713|P2|Overall Study|Lost to Follow-up|6
23086|NCT01939314|108714|P1|Overall Study|Lost to Follow-up|5
23087|NCT01939314|108713|P2|Overall Study|Pregnancy|1
23088|NCT01939314|108714|P1|Overall Study|Pregnancy|0
23089|NCT01939314|108713|P2|Overall Study|Protocol Violation|0
23090|NCT01939314|108714|P1|Overall Study|Protocol Violation|1
23091|NCT01939314|108713|P2|Overall Study|Withdrawal by Subject|1
23092|NCT01939314|108714|P1|Overall Study|Withdrawal by Subject|3
23093|NCT01939223|108735|P2|Overall Study|Withdrawal by Subject|0
23094|NCT01939223|108736|P1|Overall Study|Withdrawal by Subject|6
23095|NCT01939223|108735|P2|Overall Study|Study stopped by Sponsor|7
23096|NCT01939223|108736|P1|Overall Study|Study stopped by Sponsor|5
23097|NCT01939223|108735|P2|Overall Study|Disease recurrence (radiological)|3
23098|NCT01939223|108736|P1|Overall Study|Disease recurrence (radiological)|1
23099|NCT01939223|108735|P2|Overall Study|AE not assoc. with disease recurrence|1
23100|NCT01939223|108736|P1|Overall Study|AE not assoc. with disease recurrence|1
23101|NCT01939197|108751|P7|Overall Study|Lost to Follow-up|2
23102|NCT01939197|108752|P6|Overall Study|Lost to Follow-up|1
23103|NCT01939197|108753|P5|Overall Study|Lost to Follow-up|3
23104|NCT01939197|108754|P4|Overall Study|Lost to Follow-up|1
23105|NCT01939197|108755|P3|Overall Study|Lost to Follow-up|0
23106|NCT01939197|108756|P2|Overall Study|Lost to Follow-up|1
23107|NCT01939197|108757|P1|Overall Study|Lost to Follow-up|0
23108|NCT01939197|108751|P7|Overall Study|Withdrawal by Subject|0
23109|NCT01939197|108752|P6|Overall Study|Withdrawal by Subject|0
23110|NCT01939197|108753|P5|Overall Study|Withdrawal by Subject|1
23111|NCT01939197|108754|P4|Overall Study|Withdrawal by Subject|0
23112|NCT01939197|108755|P3|Overall Study|Withdrawal by Subject|0
23113|NCT01939197|108756|P2|Overall Study|Withdrawal by Subject|0
23114|NCT01939197|108757|P1|Overall Study|Withdrawal by Subject|1
23115|NCT01939002|108828|P2|Overall Study|Not Specified|2
23116|NCT01939002|108829|P1|Overall Study|Not Specified|1
23117|NCT01939002|108828|P2|Overall Study|Withdrawal by Subject|3
23118|NCT01939002|108829|P1|Overall Study|Withdrawal by Subject|5
23119|NCT01939002|108828|P2|Overall Study|Adverse Event|13
23120|NCT01939002|108829|P1|Overall Study|Adverse Event|13
23121|NCT01938573|108910|P2|Overall Study|Operation at other hospital|0
23122|NCT01938573|108911|P1|Overall Study|Operation at other hospital|1
23123|NCT01938573|108910|P2|Overall Study|Lack of Efficacy|0
23124|NCT01938573|108911|P1|Overall Study|Lack of Efficacy|1
23125|NCT01938430|108931|P14|Overall Study|Withdrew Consent|0
23126|NCT01938430|108932|P13|Overall Study|Withdrew Consent|0
23127|NCT01938430|108933|P12|Overall Study|Withdrew Consent|0
23128|NCT01938430|108934|P11|Overall Study|Withdrew Consent|0
23129|NCT01938430|108935|P10|Overall Study|Withdrew Consent|0
23130|NCT01938430|108936|P9|Overall Study|Withdrew Consent|1
23131|NCT01938430|108937|P8|Overall Study|Withdrew Consent|0
23132|NCT01938430|108938|P7|Overall Study|Withdrew Consent|0
23133|NCT01938430|108939|P6|Overall Study|Withdrew Consent|0
23134|NCT01938430|108940|P5|Overall Study|Withdrew Consent|0
23135|NCT01938430|108941|P4|Overall Study|Withdrew Consent|0
23136|NCT01938430|108942|P3|Overall Study|Withdrew Consent|0
23137|NCT01938430|108943|P2|Overall Study|Withdrew Consent|0
23138|NCT01938430|108944|P1|Overall Study|Withdrew Consent|0
23139|NCT01938430|108931|P14|Overall Study|Lost to Follow-up|0
23140|NCT01938430|108932|P13|Overall Study|Lost to Follow-up|0
23141|NCT01938430|108933|P12|Overall Study|Lost to Follow-up|0
23142|NCT01938430|108934|P11|Overall Study|Lost to Follow-up|0
23143|NCT01938430|108935|P10|Overall Study|Lost to Follow-up|0
23144|NCT01938430|108936|P9|Overall Study|Lost to Follow-up|0
23145|NCT01938430|108937|P8|Overall Study|Lost to Follow-up|0
23146|NCT01938430|108938|P7|Overall Study|Lost to Follow-up|0
23147|NCT01938430|108939|P6|Overall Study|Lost to Follow-up|1
23148|NCT01938430|108940|P5|Overall Study|Lost to Follow-up|0
23149|NCT01938430|108941|P4|Overall Study|Lost to Follow-up|0
23150|NCT01938430|108942|P3|Overall Study|Lost to Follow-up|1
23151|NCT01938430|108943|P2|Overall Study|Lost to Follow-up|0
23152|NCT01938430|108944|P1|Overall Study|Lost to Follow-up|0
23153|NCT01938430|108931|P14|Overall Study|Lack of Efficacy|0
23154|NCT01938430|108932|P13|Overall Study|Lack of Efficacy|0
23155|NCT01938430|108933|P12|Overall Study|Lack of Efficacy|1
23156|NCT01938430|108934|P11|Overall Study|Lack of Efficacy|2
23157|NCT01938430|108935|P10|Overall Study|Lack of Efficacy|0
23158|NCT01938430|108936|P9|Overall Study|Lack of Efficacy|1
23159|NCT01938430|108937|P8|Overall Study|Lack of Efficacy|0
23160|NCT01938430|108938|P7|Overall Study|Lack of Efficacy|0
23161|NCT01938430|108939|P6|Overall Study|Lack of Efficacy|0
23162|NCT01938430|108940|P5|Overall Study|Lack of Efficacy|0
23163|NCT01938430|108941|P4|Overall Study|Lack of Efficacy|1
23164|NCT01938430|108942|P3|Overall Study|Lack of Efficacy|1
23165|NCT01938430|108943|P2|Overall Study|Lack of Efficacy|1
23166|NCT01938430|108944|P1|Overall Study|Lack of Efficacy|3
23167|NCT01938430|108931|P14|Overall Study|Investigator's Discretion|0
23168|NCT01938430|108932|P13|Overall Study|Investigator's Discretion|0
23169|NCT01938430|108933|P12|Overall Study|Investigator's Discretion|0
23170|NCT01938430|108934|P11|Overall Study|Investigator's Discretion|0
23171|NCT01938430|108935|P10|Overall Study|Investigator's Discretion|0
23172|NCT01938430|108936|P9|Overall Study|Investigator's Discretion|0
23173|NCT01938430|108937|P8|Overall Study|Investigator's Discretion|0
23174|NCT01938430|108938|P7|Overall Study|Investigator's Discretion|0
23175|NCT01938430|108939|P6|Overall Study|Investigator's Discretion|0
23176|NCT01938430|108940|P5|Overall Study|Investigator's Discretion|0
23177|NCT01938430|108941|P4|Overall Study|Investigator's Discretion|0
23178|NCT01938430|108942|P3|Overall Study|Investigator's Discretion|1
23179|NCT01938430|108943|P2|Overall Study|Investigator's Discretion|0
23180|NCT01938430|108944|P1|Overall Study|Investigator's Discretion|0
23181|NCT01938430|108931|P14|Overall Study|Death|0
23182|NCT01938430|108932|P13|Overall Study|Death|0
23183|NCT01938430|108933|P12|Overall Study|Death|0
23184|NCT01938430|108934|P11|Overall Study|Death|0
23185|NCT01938430|108935|P10|Overall Study|Death|3
23186|NCT01938430|108936|P9|Overall Study|Death|2
23187|NCT01938430|108937|P8|Overall Study|Death|1
23188|NCT01938430|108938|P7|Overall Study|Death|1
23189|NCT01938430|108939|P6|Overall Study|Death|0
23190|NCT01938430|108940|P5|Overall Study|Death|0
23191|NCT01938430|108941|P4|Overall Study|Death|1
23192|NCT01938430|108942|P3|Overall Study|Death|2
23193|NCT01938430|108943|P2|Overall Study|Death|2
23194|NCT01938430|108944|P1|Overall Study|Death|1
23195|NCT01938430|108931|P14|Overall Study|Adverse Event|0
23196|NCT01938430|108932|P13|Overall Study|Adverse Event|0
23197|NCT01938430|108933|P12|Overall Study|Adverse Event|0
23198|NCT01938430|108934|P11|Overall Study|Adverse Event|0
23199|NCT01938430|108935|P10|Overall Study|Adverse Event|0
23200|NCT01938430|108936|P9|Overall Study|Adverse Event|0
23201|NCT01938430|108937|P8|Overall Study|Adverse Event|0
23202|NCT01938430|108938|P7|Overall Study|Adverse Event|1
23203|NCT01938430|108939|P6|Overall Study|Adverse Event|0
23204|NCT01938430|108940|P5|Overall Study|Adverse Event|0
23205|NCT01938430|108941|P4|Overall Study|Adverse Event|0
23206|NCT01938430|108942|P3|Overall Study|Adverse Event|0
23207|NCT01938430|108943|P2|Overall Study|Adverse Event|0
23208|NCT01938430|108944|P1|Overall Study|Adverse Event|0
23209|NCT01938430|108931|P14|Overall Study|Randomized but Not Treated|1
23210|NCT01938430|108932|P13|Overall Study|Randomized but Not Treated|0
23211|NCT01938430|108933|P12|Overall Study|Randomized but Not Treated|0
23212|NCT01938430|108934|P11|Overall Study|Randomized but Not Treated|1
23213|NCT01938430|108935|P10|Overall Study|Randomized but Not Treated|0
23214|NCT01938430|108936|P9|Overall Study|Randomized but Not Treated|0
23215|NCT01938430|108937|P8|Overall Study|Randomized but Not Treated|0
23216|NCT01938430|108938|P7|Overall Study|Randomized but Not Treated|0
23217|NCT01938430|108939|P6|Overall Study|Randomized but Not Treated|0
23218|NCT01938430|108940|P5|Overall Study|Randomized but Not Treated|0
23219|NCT01938430|108941|P4|Overall Study|Randomized but Not Treated|0
23220|NCT01938430|108942|P3|Overall Study|Randomized but Not Treated|0
23221|NCT01938430|108943|P2|Overall Study|Randomized but Not Treated|0
23222|NCT01938430|108944|P1|Overall Study|Randomized but Not Treated|0
23223|NCT01938391|109269|P1|12 Month Follow up|Withdrawal by Subject|1
23224|NCT01938391|109269|P1|12 Month Follow up|Physician Decision|1
23225|NCT01938391|109269|P1|6 Month Follow up|Withdrawal by Subject|1
23226|NCT01937871|109388|P3|Overall Study|Entry Criteria Not Met|1
23227|NCT01937871|109389|P2|Overall Study|Entry Criteria Not Met|2
23228|NCT01937871|109390|P1|Overall Study|Entry Criteria Not Met|1
23229|NCT01937871|109388|P3|Overall Study|Physician Decision|0
23230|NCT01937871|109389|P2|Overall Study|Physician Decision|1
23231|NCT01937871|109390|P1|Overall Study|Physician Decision|0
23232|NCT01937871|109388|P3|Overall Study|Withdrawal by Subject|4
23233|NCT01937871|109389|P2|Overall Study|Withdrawal by Subject|6
23234|NCT01937871|109390|P1|Overall Study|Withdrawal by Subject|9
23235|NCT01937871|109388|P3|Overall Study|Lost to Follow-up|4
23236|NCT01937871|109389|P2|Overall Study|Lost to Follow-up|2
23237|NCT01937871|109390|P1|Overall Study|Lost to Follow-up|8
23238|NCT01937871|109388|P3|Overall Study|Adverse Event|2
23239|NCT01937871|109389|P2|Overall Study|Adverse Event|6
23240|NCT01937871|109390|P1|Overall Study|Adverse Event|6
23241|NCT01937715|109466|P5|Overall Study|Other|0
23242|NCT01937715|109467|P4|Overall Study|Other|3
23243|NCT01937715|109468|P3|Overall Study|Other|0
23244|NCT01937715|109469|P2|Overall Study|Other|0
23245|NCT01937715|109470|P1|Overall Study|Other|0
23246|NCT01937715|109466|P5|Overall Study|Withdrawal by Subject|2
23247|NCT01937715|109467|P4|Overall Study|Withdrawal by Subject|0
23248|NCT01937715|109468|P3|Overall Study|Withdrawal by Subject|0
23249|NCT01937715|109469|P2|Overall Study|Withdrawal by Subject|1
23250|NCT01937715|109470|P1|Overall Study|Withdrawal by Subject|0
23251|NCT01937715|109466|P5|Overall Study|Death|0
23252|NCT01937715|109467|P4|Overall Study|Death|1
23253|NCT01937715|109468|P3|Overall Study|Death|0
23254|NCT01937715|109469|P2|Overall Study|Death|0
23255|NCT01937715|109470|P1|Overall Study|Death|0
23256|NCT01937364|109663|P2|Overall Study|Adverse Event|1
23257|NCT01937364|109664|P1|Overall Study|Adverse Event|2
23258|NCT01937351|109676|P2|Overall Study|Not treated w device, per protocol fail|0
23259|NCT01937351|109677|P1|Overall Study|Not treated w device, per protocol fail|4
23260|NCT01937351|109676|P2|Overall Study|Death|0
23261|NCT01937351|109677|P1|Overall Study|Death|1
23262|NCT01937351|109676|P2|Overall Study|Withdrawal by Subject|2
23263|NCT01937351|109677|P1|Overall Study|Withdrawal by Subject|4
23264|NCT01937312|109685|P2|Overall Study|Withdrawal of subject prior to treatment|1
23265|NCT01937312|109686|P1|Overall Study|Withdrawal of subject prior to treatment|1
23266|NCT01937312|109685|P2|Overall Study|Lack of Efficacy|1
23267|NCT01937312|109686|P1|Overall Study|Lack of Efficacy|0
23268|NCT01937312|109685|P2|Overall Study|Adverse Event|1
23269|NCT01937312|109686|P1|Overall Study|Adverse Event|10
23270|NCT01937299|109701|P2|Overall Study|Withdrawal by Subject|0
23271|NCT01937299|109702|P1|Overall Study|Withdrawal by Subject|1
23272|NCT01937299|109701|P2|Overall Study|Lack of Efficacy|4
23273|NCT01937299|109702|P1|Overall Study|Lack of Efficacy|0
23274|NCT01937299|109701|P2|Overall Study|Adverse Event|0
23275|NCT01937299|109702|P1|Overall Study|Adverse Event|13
23276|NCT01937130|109737|P4|Overall Study|Patient lost to FU due to death|0
23277|NCT01937130|109738|P3|Overall Study|Patient lost to FU due to death|0
23278|NCT01937130|109739|P2|Overall Study|Patient lost to FU due to death|0
23279|NCT01937130|109740|P1|Overall Study|Patient lost to FU due to death|2
23280|NCT01937130|109737|P4|Overall Study|Patients unable to swallow|0
23281|NCT01937130|109738|P3|Overall Study|Patients unable to swallow|0
23282|NCT01937130|109739|P2|Overall Study|Patients unable to swallow|1
23283|NCT01937130|109740|P1|Overall Study|Patients unable to swallow|0
23284|NCT01937130|109737|P4|Overall Study|Physician Decision|0
23285|NCT01937130|109738|P3|Overall Study|Physician Decision|0
23286|NCT01937130|109739|P2|Overall Study|Physician Decision|1
23287|NCT01937130|109740|P1|Overall Study|Physician Decision|0
23288|NCT01937130|109737|P4|Overall Study|Lost to Follow-up|0
23289|NCT01937130|109738|P3|Overall Study|Lost to Follow-up|2
23290|NCT01937130|109739|P2|Overall Study|Lost to Follow-up|0
23291|NCT01937130|109740|P1|Overall Study|Lost to Follow-up|2
23292|NCT01937130|109737|P4|Overall Study|Death|0
23293|NCT01937130|109738|P3|Overall Study|Death|1
23294|NCT01937130|109739|P2|Overall Study|Death|1
23295|NCT01937130|109740|P1|Overall Study|Death|1
23296|NCT01937130|109737|P4|Overall Study|Adverse Event|1
23297|NCT01937130|109738|P3|Overall Study|Adverse Event|0
23298|NCT01937130|109739|P2|Overall Study|Adverse Event|1
23299|NCT01937130|109740|P1|Overall Study|Adverse Event|0
23300|NCT01937130|109737|P4|Overall Study|Withdrawal by Subject|1
23301|NCT01937130|109738|P3|Overall Study|Withdrawal by Subject|0
23302|NCT01937130|109739|P2|Overall Study|Withdrawal by Subject|0
23303|NCT01937130|109740|P1|Overall Study|Withdrawal by Subject|0
23304|NCT01936974|109778|P2|Overall Study|Physician Decision|5
23305|NCT01936974|109779|P1|Overall Study|Physician Decision|2
23306|NCT01936870|109809|P1|Overall Study|No Drug Administration|1
23307|NCT01936870|109809|P1|Overall Study|Protocol Violation|12
23308|NCT01936870|109809|P1|Overall Study|No Visit After Treatment|176
23309|NCT01936649|109846|P1|Overall Study|Other than specified above|5
23310|NCT01936649|109846|P1|Overall Study|Protocol Violation|2
23311|NCT01936649|109846|P1|Overall Study|Physician Decision|2
23312|NCT01936649|109846|P1|Overall Study|Withdrawal by Subject|4
23313|NCT01936623|109853|P2|Overall Study|Lost to Follow-up|5
23314|NCT01936623|109854|P1|Overall Study|Lost to Follow-up|0
23315|NCT01936363|109898|P2|Overall Study|Ongoing|5
23316|NCT01936363|109899|P1|Overall Study|Ongoing|7
23317|NCT01936181|109925|P4|Transition-extension|Withdrawal by Subject|1
23318|NCT01936181|109926|P3|Transition-extension|Withdrawal by Subject|2
23319|NCT01936181|109927|P2|Transition-extension|Withdrawal by Subject|0
23320|NCT01936181|109928|P1|Transition-extension|Withdrawal by Subject|7
23321|NCT01936181|109925|P4|Transition-extension|Physician Decision|1
23322|NCT01936181|109926|P3|Transition-extension|Physician Decision|0
23323|NCT01936181|109927|P2|Transition-extension|Physician Decision|0
23324|NCT01936181|109928|P1|Transition-extension|Physician Decision|2
23325|NCT01936181|109925|P4|Transition-extension|Lost to Follow-up|2
23326|NCT01936181|109926|P3|Transition-extension|Lost to Follow-up|1
23327|NCT01936181|109927|P2|Transition-extension|Lost to Follow-up|0
23328|NCT01936181|109928|P1|Transition-extension|Lost to Follow-up|3
23329|NCT01936181|109925|P4|Transition-extension|Adverse Event|1
23330|NCT01936181|109926|P3|Transition-extension|Adverse Event|3
23331|NCT01936181|109927|P2|Transition-extension|Adverse Event|0
23332|NCT01936181|109928|P1|Transition-extension|Adverse Event|3
23333|NCT01936181|109925|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
23334|NCT01936181|109926|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
23335|NCT01936181|109927|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
23336|NCT01936181|109928|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
23337|NCT01936181|109925|P4|Randomised, Double-blind|Withdrawal by Subject|0
23338|NCT01936181|109926|P3|Randomised, Double-blind|Withdrawal by Subject|0
23339|NCT01936181|109927|P2|Randomised, Double-blind|Withdrawal by Subject|26
23340|NCT01936181|109928|P1|Randomised, Double-blind|Withdrawal by Subject|23
23341|NCT01936181|109925|P4|Randomised, Double-blind|Physician Decision|0
23342|NCT01936181|109926|P3|Randomised, Double-blind|Physician Decision|0
23343|NCT01936181|109927|P2|Randomised, Double-blind|Physician Decision|4
23344|NCT01936181|109928|P1|Randomised, Double-blind|Physician Decision|4
23345|NCT01936181|109925|P4|Randomised, Double-blind|Pregnancy|0
23346|NCT01936181|109926|P3|Randomised, Double-blind|Pregnancy|0
23347|NCT01936181|109927|P2|Randomised, Double-blind|Pregnancy|1
23348|NCT01936181|109928|P1|Randomised, Double-blind|Pregnancy|0
23349|NCT01936181|109925|P4|Randomised, Double-blind|Lost to Follow-up|0
23350|NCT01936181|109926|P3|Randomised, Double-blind|Lost to Follow-up|0
23351|NCT01936181|109927|P2|Randomised, Double-blind|Lost to Follow-up|1
23352|NCT01936181|109928|P1|Randomised, Double-blind|Lost to Follow-up|0
23353|NCT01936181|109925|P4|Randomised, Double-blind|Lack of Efficacy|0
23354|NCT01936181|109926|P3|Randomised, Double-blind|Lack of Efficacy|0
23355|NCT01936181|109927|P2|Randomised, Double-blind|Lack of Efficacy|6
23356|NCT01936181|109928|P1|Randomised, Double-blind|Lack of Efficacy|5
23357|NCT01936181|109925|P4|Randomised, Double-blind|Protocol Violation|0
23358|NCT01936181|109926|P3|Randomised, Double-blind|Protocol Violation|0
23359|NCT01936181|109927|P2|Randomised, Double-blind|Protocol Violation|5
23360|NCT01936181|109928|P1|Randomised, Double-blind|Protocol Violation|1
23361|NCT01936181|109925|P4|Randomised, Double-blind|Adverse Event|0
23362|NCT01936181|109926|P3|Randomised, Double-blind|Adverse Event|0
23363|NCT01936181|109927|P2|Randomised, Double-blind|Adverse Event|21
23364|NCT01936181|109928|P1|Randomised, Double-blind|Adverse Event|27
23365|NCT01934894|109975|P2|Overall Study|Progressive Disease|2
23366|NCT01934894|109976|P1|Overall Study|Progressive Disease|3
23367|NCT01934894|109975|P2|Overall Study|Withdrawal by Subject|1
23368|NCT01934894|109976|P1|Overall Study|Withdrawal by Subject|0
23369|NCT01934894|109975|P2|Overall Study|Death|0
23370|NCT01934894|109976|P1|Overall Study|Death|2
23371|NCT01934894|109975|P2|Overall Study|Adverse Event|2
23372|NCT01934894|109976|P1|Overall Study|Adverse Event|1
23373|NCT01934790|109991|P1|Active Follow up|Other reason|1
23374|NCT01934790|109991|P1|Active Follow up|Progressive disease|1
23375|NCT01934790|109991|P1|Active Follow up|Physician Decision|2
23376|NCT01934790|109991|P1|Active Follow up|Death|20
23377|NCT01934790|109991|P1|Treatment|Study drug never administered|1
23378|NCT01934790|109991|P1|Treatment|Withdrawal by Subject|2
23379|NCT01934790|109991|P1|Treatment|Radiological progression|4
23380|NCT01934790|109991|P1|Treatment|Clinical progression|6
23381|NCT01934790|109991|P1|Treatment|Adverse Event|3
23382|NCT01934504|110045|P4|Overall Study|Study Terminated by Sponsor|5
23383|NCT01934504|110046|P3|Overall Study|Study Terminated by Sponsor|5
23384|NCT01934504|110047|P2|Overall Study|Study Terminated by Sponsor|0
23385|NCT01934504|110048|P1|Overall Study|Study Terminated by Sponsor|1
23386|NCT01934504|110045|P4|Overall Study|Protocol Deviation|2
23387|NCT01934504|110046|P3|Overall Study|Protocol Deviation|0
23388|NCT01934504|110047|P2|Overall Study|Protocol Deviation|0
23389|NCT01934504|110048|P1|Overall Study|Protocol Deviation|0
23390|NCT01934218|110081|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
23391|NCT01934218|110082|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
23392|NCT01934218|110081|P2|Open-Label Phase|Noncompliance with Study Protocol|2
23393|NCT01934218|110082|P1|Open-Label Phase|Noncompliance with Study Protocol|4
23394|NCT01934218|110081|P2|Open-Label Phase|Withdrawal by Subject|11
23395|NCT01934218|110082|P1|Open-Label Phase|Withdrawal by Subject|13
23396|NCT01934218|110081|P2|Open-Label Phase|Protocol Violation|0
23397|NCT01934218|110082|P1|Open-Label Phase|Protocol Violation|1
23398|NCT01934218|110081|P2|Open-Label Phase|Physician Decision|0
23399|NCT01934218|110082|P1|Open-Label Phase|Physician Decision|1
23400|NCT01934218|110081|P2|Open-Label Phase|Lost to Follow-up|2
23401|NCT01934218|110082|P1|Open-Label Phase|Lost to Follow-up|4
23402|NCT01934218|110081|P2|Open-Label Phase|Lack of Efficacy|4
23403|NCT01934218|110082|P1|Open-Label Phase|Lack of Efficacy|1
23404|NCT01934218|110081|P2|Open-Label Phase|Adverse Event|4
23405|NCT01934218|110082|P1|Open-Label Phase|Adverse Event|2
23406|NCT01934218|110081|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
23407|NCT01934218|110082|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
23408|NCT01934218|110081|P2|Double-blind Phase|Noncompliance with Study Protocol|8
23409|NCT01934218|110082|P1|Double-blind Phase|Noncompliance with Study Protocol|5
23410|NCT01934218|110081|P2|Double-blind Phase|Withdrawal by Subject|13
23411|NCT01934218|110082|P1|Double-blind Phase|Withdrawal by Subject|16
23412|NCT01934218|110081|P2|Double-blind Phase|Protocol Violation|0
23413|NCT01934218|110082|P1|Double-blind Phase|Protocol Violation|4
23414|NCT01934218|110081|P2|Double-blind Phase|Physician Decision|2
23415|NCT01934218|110082|P1|Double-blind Phase|Physician Decision|1
23416|NCT01934218|110081|P2|Double-blind Phase|Lost to Follow-up|14
23417|NCT01934218|110082|P1|Double-blind Phase|Lost to Follow-up|7
23418|NCT01934218|110081|P2|Double-blind Phase|Lack of Efficacy|7
23419|NCT01934218|110082|P1|Double-blind Phase|Lack of Efficacy|6
23420|NCT01934218|110081|P2|Double-blind Phase|Adverse Event|8
23421|NCT01934218|110082|P1|Double-blind Phase|Adverse Event|8
23422|NCT01934192|110093|P4|Overall Study|Physician Decision|0
23423|NCT01934192|110094|P3|Overall Study|Physician Decision|0
23424|NCT01934192|110095|P2|Overall Study|Physician Decision|2
23425|NCT01934192|110096|P1|Overall Study|Physician Decision|3
23426|NCT01934192|110093|P4|Overall Study|Other: reached stopping criteria|0
23427|NCT01934192|110094|P3|Overall Study|Other: reached stopping criteria|1
23428|NCT01934192|110095|P2|Overall Study|Other: reached stopping criteria|5
23429|NCT01934192|110096|P1|Overall Study|Other: reached stopping criteria|6
23430|NCT01934192|110093|P4|Overall Study|Protocol Violation|1
23431|NCT01934192|110094|P3|Overall Study|Protocol Violation|0
23432|NCT01934192|110095|P2|Overall Study|Protocol Violation|0
23433|NCT01934192|110096|P1|Overall Study|Protocol Violation|0
23434|NCT01934010|110233|P3|Overall Study|Lost to Follow-up|0
23435|NCT01934010|110234|P2|Overall Study|Lost to Follow-up|4
23436|NCT01934010|110235|P1|Overall Study|Lost to Follow-up|7
23437|NCT01934010|110233|P3|Overall Study|Withdrawal by Subject|2
23438|NCT01934010|110234|P2|Overall Study|Withdrawal by Subject|6
23439|NCT01934010|110235|P1|Overall Study|Withdrawal by Subject|15
23440|NCT01934010|110233|P3|Overall Study|Adverse Event|0
23441|NCT01934010|110234|P2|Overall Study|Adverse Event|1
23442|NCT01934010|110235|P1|Overall Study|Adverse Event|1
23443|NCT01933932|110254|P2|Overall Study|Eligibility criteria not fulfilled|1
23444|NCT01933932|110255|P1|Overall Study|Eligibility criteria not fulfilled|0
23445|NCT01933932|110254|P2|Overall Study|Withdrawal by Subject|14
23446|NCT01933932|110255|P1|Overall Study|Withdrawal by Subject|11
23447|NCT01933932|110254|P2|Overall Study|Death|163
23448|NCT01933932|110255|P1|Overall Study|Death|173
23449|NCT01933919|110273|P2|Open-label Long-term Phase|Other|2
23450|NCT01933919|110274|P1|Open-label Long-term Phase|Other|1
23451|NCT01933919|110273|P2|Open-label Long-term Phase|Lost to Follow-up|0
23452|NCT01933919|110274|P1|Open-label Long-term Phase|Lost to Follow-up|1
23453|NCT01933919|110273|P2|Open-label Long-term Phase|Withdrawal by Subject|4
23454|NCT01933919|110274|P1|Open-label Long-term Phase|Withdrawal by Subject|3
23455|NCT01933919|110273|P2|Open-label Long-term Phase|Adverse Event|0
23456|NCT01933919|110274|P1|Open-label Long-term Phase|Adverse Event|2
23457|NCT01933919|110273|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
23458|NCT01933919|110274|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
23459|NCT01933919|110273|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
23460|NCT01933919|110274|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
23461|NCT01933919|110273|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
23462|NCT01933919|110274|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
23463|NCT01933880|110310|P2|Overall Study|Protocol Violation|0
23464|NCT01933880|110311|P1|Overall Study|Protocol Violation|1
23465|NCT01933880|110310|P2|Overall Study|Other|0
23466|NCT01933880|110311|P1|Overall Study|Other|4
23467|NCT01933880|110310|P2|Overall Study|Followup exceeded 4 days to visit window|0
23468|NCT01933880|110311|P1|Overall Study|Followup exceeded 4 days to visit window|19
23469|NCT01933880|110310|P2|Overall Study|Concomitant medication Interference|1
23470|NCT01933880|110311|P1|Overall Study|Concomitant medication Interference|0
23471|NCT01933880|110310|P2|Overall Study|Lack of Efficacy|0
23472|NCT01933880|110311|P1|Overall Study|Lack of Efficacy|1
23473|NCT01933880|110310|P2|Overall Study|Withdrawal by Subject|0
23474|NCT01933880|110311|P1|Overall Study|Withdrawal by Subject|5
23475|NCT01933672|110387|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
23476|NCT01933672|110388|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
23477|NCT01933672|110389|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
23478|NCT01933672|110390|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
23479|NCT01933672|110391|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
23480|NCT01933672|110392|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
23481|NCT01933672|110393|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
23482|NCT01933672|110387|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
23483|NCT01933672|110388|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
23484|NCT01933672|110389|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
23485|NCT01933672|110390|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
23486|NCT01933672|110391|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
23487|NCT01933672|110392|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
23488|NCT01933672|110393|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
23489|NCT01933672|110387|P7|Second Intervention Period (12-16 Days)|Other|0
23490|NCT01933672|110388|P6|Second Intervention Period (12-16 Days)|Other|0
23491|NCT01933672|110389|P5|Second Intervention Period (12-16 Days)|Other|0
23492|NCT01933672|110390|P4|Second Intervention Period (12-16 Days)|Other|0
23493|NCT01933672|110391|P3|Second Intervention Period (12-16 Days)|Other|1
23494|NCT01933672|110392|P2|Second Intervention Period (12-16 Days)|Other|1
23495|NCT01933672|110393|P1|Second Intervention Period (12-16 Days)|Other|0
23496|NCT01933672|110387|P7|First Intervention Period (12-16 Days)|Other|0
23497|NCT01933672|110388|P6|First Intervention Period (12-16 Days)|Other|1
23498|NCT01933672|110389|P5|First Intervention Period (12-16 Days)|Other|0
23499|NCT01933672|110390|P4|First Intervention Period (12-16 Days)|Other|0
23500|NCT01933672|110391|P3|First Intervention Period (12-16 Days)|Other|1
23501|NCT01933672|110392|P2|First Intervention Period (12-16 Days)|Other|0
23502|NCT01933672|110393|P1|First Intervention Period (12-16 Days)|Other|0
23503|NCT01933672|110387|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
23504|NCT01933672|110388|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
23505|NCT01933672|110389|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
23506|NCT01933672|110390|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
23507|NCT01933672|110391|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
23508|NCT01933672|110392|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
23509|NCT01933672|110393|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
23510|NCT01933672|110387|P7|Metformin Run-in Period|Other|0
23511|NCT01933672|110388|P6|Metformin Run-in Period|Other|0
23512|NCT01933672|110389|P5|Metformin Run-in Period|Other|0
23513|NCT01933672|110390|P4|Metformin Run-in Period|Other|0
23514|NCT01933672|110391|P3|Metformin Run-in Period|Other|0
23515|NCT01933672|110392|P2|Metformin Run-in Period|Other|0
23516|NCT01933672|110393|P1|Metformin Run-in Period|Other|5
23517|NCT01933672|110387|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
23518|NCT01933672|110388|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
23519|NCT01933672|110389|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
23520|NCT01933672|110390|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
23521|NCT01933672|110391|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
23522|NCT01933672|110392|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
23523|NCT01933672|110393|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
23524|NCT01933672|110387|P7|Metformin Run-in Period|Adverse Event|0
23525|NCT01933672|110388|P6|Metformin Run-in Period|Adverse Event|0
23526|NCT01933672|110389|P5|Metformin Run-in Period|Adverse Event|0
23527|NCT01933672|110390|P4|Metformin Run-in Period|Adverse Event|0
23528|NCT01933672|110391|P3|Metformin Run-in Period|Adverse Event|0
23529|NCT01933672|110392|P2|Metformin Run-in Period|Adverse Event|0
23530|NCT01933672|110393|P1|Metformin Run-in Period|Adverse Event|1
23531|NCT01933334|110468|P2|Overall Study|Withdrawal by Subject|1
23532|NCT01933334|110469|P1|Overall Study|Withdrawal by Subject|0
23533|NCT01933334|110468|P2|Overall Study|Adverse Event|1
23534|NCT01933334|110469|P1|Overall Study|Adverse Event|5
23535|NCT01933048|110498|P2|Overall Study|unknown reasons|1
23536|NCT01933048|110499|P1|Overall Study|unknown reasons|1
23537|NCT01933048|110498|P2|Overall Study|Physician Decision|0
23538|NCT01933048|110499|P1|Overall Study|Physician Decision|1
23539|NCT01933048|110498|P2|Overall Study|Protocol Violation|8
23540|NCT01933048|110499|P1|Overall Study|Protocol Violation|7
23541|NCT01933048|110498|P2|Overall Study|personal reasons|1
23542|NCT01933048|110499|P1|Overall Study|personal reasons|1
23543|NCT01933048|110498|P2|Overall Study|Lost to Follow-up|18
23544|NCT01933048|110499|P1|Overall Study|Lost to Follow-up|15
23545|NCT01932970|110512|P1|Overall Study|Protocol Specified Criteria|10
23546|NCT01932970|110512|P1|Overall Study|Lost to Follow-up|2
23547|NCT01932970|110512|P1|Overall Study|Death|1
23548|NCT01932970|110512|P1|Overall Study|Withdrawal by Subject|5
23549|NCT01932762|110524|P4|Overall Study|Physician Decision|0
23550|NCT01932762|110525|P3|Overall Study|Physician Decision|0
23551|NCT01932762|110526|P2|Overall Study|Physician Decision|0
23552|NCT01932762|110527|P1|Overall Study|Physician Decision|1
23553|NCT01932762|110524|P4|Overall Study|Lost to Follow-up|1
23554|NCT01932762|110525|P3|Overall Study|Lost to Follow-up|0
23555|NCT01932762|110526|P2|Overall Study|Lost to Follow-up|0
23556|NCT01932762|110527|P1|Overall Study|Lost to Follow-up|4
23557|NCT01932762|110524|P4|Overall Study|Withdrawal by Subject|0
23558|NCT01932762|110525|P3|Overall Study|Withdrawal by Subject|0
23559|NCT01932762|110526|P2|Overall Study|Withdrawal by Subject|2
23560|NCT01932762|110527|P1|Overall Study|Withdrawal by Subject|1
23561|NCT01931865|110774|P1|Overall Study|Withdrawal by Subject|2
23562|NCT01931865|110774|P1|Overall Study|Lost to Follow-up|2
23563|NCT01931839|110787|P7|Overall Study|Other|0
23564|NCT01931839|110788|P6|Overall Study|Other|0
23565|NCT01931839|110789|P5|Overall Study|Other|0
23566|NCT01931839|110790|P4|Overall Study|Other|0
23567|NCT01931839|110791|P3|Overall Study|Other|6
23568|NCT01931839|110792|P2|Overall Study|Other|2
23569|NCT01931839|110793|P1|Overall Study|Other|4
23570|NCT01931839|110787|P7|Overall Study|Lost to Follow-up|0
23571|NCT01931839|110788|P6|Overall Study|Lost to Follow-up|0
23572|NCT01931839|110789|P5|Overall Study|Lost to Follow-up|0
23573|NCT01931839|110790|P4|Overall Study|Lost to Follow-up|5
23574|NCT01931839|110791|P3|Overall Study|Lost to Follow-up|4
23575|NCT01931839|110792|P2|Overall Study|Lost to Follow-up|2
23576|NCT01931839|110793|P1|Overall Study|Lost to Follow-up|1
23577|NCT01931839|110787|P7|Overall Study|Other non-compliance|0
23578|NCT01931839|110788|P6|Overall Study|Other non-compliance|3
23579|NCT01931839|110789|P5|Overall Study|Other non-compliance|0
23580|NCT01931839|110790|P4|Overall Study|Other non-compliance|3
23581|NCT01931839|110791|P3|Overall Study|Other non-compliance|12
23582|NCT01931839|110792|P2|Overall Study|Other non-compliance|9
23583|NCT01931839|110793|P1|Overall Study|Other non-compliance|15
23584|NCT01931839|110787|P7|Overall Study|Withdrawal of consent (not due to AE)|2
23585|NCT01931839|110788|P6|Overall Study|Withdrawal of consent (not due to AE)|2
23586|NCT01931839|110789|P5|Overall Study|Withdrawal of consent (not due to AE)|0
23587|NCT01931839|110790|P4|Overall Study|Withdrawal of consent (not due to AE)|3
23588|NCT01931839|110791|P3|Overall Study|Withdrawal of consent (not due to AE)|13
23589|NCT01931839|110792|P2|Overall Study|Withdrawal of consent (not due to AE)|8
23590|NCT01931839|110793|P1|Overall Study|Withdrawal of consent (not due to AE)|11
23591|NCT01931839|110787|P7|Overall Study|Adverse Event|1
23592|NCT01931839|110788|P6|Overall Study|Adverse Event|0
23593|NCT01931839|110789|P5|Overall Study|Adverse Event|0
23594|NCT01931839|110790|P4|Overall Study|Adverse Event|3
23595|NCT01931839|110791|P3|Overall Study|Adverse Event|1
23596|NCT01931839|110792|P2|Overall Study|Adverse Event|4
23597|NCT01931839|110793|P1|Overall Study|Adverse Event|9
23598|NCT01931839|110787|P7|Overall Study|Withdrawal of consent|0
23599|NCT01931839|110788|P6|Overall Study|Withdrawal of consent|0
23600|NCT01931839|110789|P5|Overall Study|Withdrawal of consent|1
23601|NCT01931839|110790|P4|Overall Study|Withdrawal of consent|0
23602|NCT01931839|110791|P3|Overall Study|Withdrawal of consent|0
23603|NCT01931839|110792|P2|Overall Study|Withdrawal of consent|0
23604|NCT01931839|110793|P1|Overall Study|Withdrawal of consent|0
23605|NCT01931839|110787|P7|Overall Study|Physician Decision|1
23606|NCT01931839|110788|P6|Overall Study|Physician Decision|0
23607|NCT01931839|110789|P5|Overall Study|Physician Decision|0
23608|NCT01931839|110790|P4|Overall Study|Physician Decision|0
23609|NCT01931839|110791|P3|Overall Study|Physician Decision|1
23610|NCT01931839|110792|P2|Overall Study|Physician Decision|0
23611|NCT01931839|110793|P1|Overall Study|Physician Decision|1
23612|NCT01931839|110787|P7|Overall Study|Death|0
23613|NCT01931839|110788|P6|Overall Study|Death|0
23614|NCT01931839|110789|P5|Overall Study|Death|0
23615|NCT01931839|110790|P4|Overall Study|Death|0
23616|NCT01931839|110791|P3|Overall Study|Death|2
23617|NCT01931839|110792|P2|Overall Study|Death|1
23618|NCT01931839|110793|P1|Overall Study|Death|0
23619|NCT01931475|110884|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
23620|NCT01931475|110885|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
23621|NCT01931475|110884|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
23622|NCT01931475|110885|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
23623|NCT01931475|110884|P2|Period 2: Extension Treatment Phase|Physician Decision|1
23624|NCT01931475|110885|P1|Period 2: Extension Treatment Phase|Physician Decision|1
23625|NCT01931475|110884|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
23626|NCT01931475|110885|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
23627|NCT01931475|110884|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
23628|NCT01931475|110885|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
23629|NCT01931475|110884|P2|Period 2: Extension Treatment Phase|Adverse Event|8
23630|NCT01931475|110885|P1|Period 2: Extension Treatment Phase|Adverse Event|0
23631|NCT01931475|110884|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
23632|NCT01931475|110885|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
23633|NCT01931475|110884|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
23634|NCT01931475|110885|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
23635|NCT01931475|110884|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
23636|NCT01931475|110885|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
23637|NCT01931475|110884|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
23638|NCT01931475|110885|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
23639|NCT01931475|110884|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
23640|NCT01931475|110885|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
23641|NCT01931462|110912|P1|Overall Study|Withdrawal by Subject|1
23642|NCT01931397|110923|P1|Overall Study|moved out of state|1
23643|NCT01931397|110923|P1|Overall Study|Withdrawal by Subject|8
23644|NCT01931397|110923|P1|Overall Study|Physician Decision|2
23645|NCT01931150|110934|P2|Overall Study|Withdrawal by Subject|2
23646|NCT01931150|110935|P1|Overall Study|Withdrawal by Subject|1
23647|NCT01931059|110943|P2|Day3|Lost to Follow-up|0
23648|NCT01931059|110944|P1|Day3|Lost to Follow-up|1
23649|NCT01931059|110943|P2|Day 1|Pregnancy|1
23650|NCT01931059|110944|P1|Day 1|Pregnancy|0
23651|NCT01930890|110960|P4|Overall Study|Adverse Event|0
23652|NCT01930890|110961|P3|Overall Study|Adverse Event|0
23653|NCT01930890|110962|P2|Overall Study|Adverse Event|1
23654|NCT01930890|110963|P1|Overall Study|Adverse Event|0
23655|NCT01930890|110960|P4|Overall Study|Consent Withdrawn|1
23656|NCT01930890|110961|P3|Overall Study|Consent Withdrawn|0
23657|NCT01930890|110962|P2|Overall Study|Consent Withdrawn|3
23658|NCT01930890|110963|P1|Overall Study|Consent Withdrawn|0
23659|NCT01930890|110960|P4|Overall Study|Investigator Decision|0
23660|NCT01930890|110961|P3|Overall Study|Investigator Decision|0
23661|NCT01930890|110962|P2|Overall Study|Investigator Decision|1
23662|NCT01930890|110963|P1|Overall Study|Investigator Decision|0
23663|NCT01930890|110960|P4|Overall Study|Death|1
23664|NCT01930890|110961|P3|Overall Study|Death|0
23665|NCT01930890|110962|P2|Overall Study|Death|0
23666|NCT01930890|110963|P1|Overall Study|Death|0
23667|NCT01930890|110960|P4|Overall Study|Study Termination|25
23668|NCT01930890|110961|P3|Overall Study|Study Termination|13
23669|NCT01930890|110962|P2|Overall Study|Study Termination|28
23670|NCT01930890|110963|P1|Overall Study|Study Termination|14
23671|NCT01930799|110977|P1|Overall Study|Lost to Follow-up|5
23672|NCT01930799|110977|P1|Overall Study|Withdrawal by Subject|3
23673|NCT01930162|111085|P1|Overall Study|Death|1
23674|NCT01930162|111085|P1|Overall Study|Abnormal test procedure result(s)|4
23675|NCT01930045|111121|P6|Pause (up to 37 Days)|Protocol Violation|1
23676|NCT01930045|111122|P5|Pause (up to 37 Days)|Protocol Violation|0
23677|NCT01930045|111123|P4|Pause (up to 37 Days)|Protocol Violation|0
23678|NCT01930045|111124|P3|Pause (up to 37 Days)|Protocol Violation|0
23679|NCT01930045|111125|P2|Pause (up to 37 Days)|Protocol Violation|0
23680|NCT01930045|111126|P1|Pause (up to 37 Days)|Protocol Violation|0
23681|NCT01930045|111121|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
23682|NCT01930045|111122|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
23683|NCT01930045|111123|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
23684|NCT01930045|111124|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
23685|NCT01930045|111125|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
23686|NCT01930045|111126|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
23687|NCT01929993|111153|P2|Overall Study|Absent CIN, invasion present or artifact|22
23688|NCT01929993|111154|P1|Overall Study|Absent CIN, invasion present or artifact|26
23689|NCT01929993|111153|P2|Overall Study|Protocol Violation|6
23690|NCT01929993|111154|P1|Overall Study|Protocol Violation|4
23691|NCT01929980|111160|P1|Overall Study|Physician Decision|1
23692|NCT01929876|111168|P1|Period 2|Non-Compliance|1
23693|NCT01929863|111181|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
23694|NCT01929863|111182|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
23695|NCT01929863|111181|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
23696|NCT01929863|111182|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
23697|NCT01929863|111181|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
23698|NCT01929863|111182|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
23699|NCT01929681|111239|P2|Overall Study|Physician Decision|1
23700|NCT01929681|111240|P1|Overall Study|Physician Decision|1
23701|NCT01929681|111239|P2|Overall Study|Withdrawal by Subject|0
23702|NCT01929681|111240|P1|Overall Study|Withdrawal by Subject|1
23703|NCT01929317|111285|P2|Long-term Phase|Study Closed/Terminated|3
23704|NCT01929317|111286|P1|Long-term Phase|Study Closed/Terminated|5
23705|NCT01929317|111285|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
23706|NCT01929317|111286|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
23707|NCT01929317|111285|P2|Long-term Phase|Protocol Violation|0
23708|NCT01929317|111286|P1|Long-term Phase|Protocol Violation|1
23709|NCT01929317|111285|P2|Long-term Phase|Withdrawal by Subject|0
23710|NCT01929317|111286|P1|Long-term Phase|Withdrawal by Subject|4
23711|NCT01929317|111285|P2|Long-term Phase|Physician Decision|0
23712|NCT01929317|111286|P1|Long-term Phase|Physician Decision|3
23713|NCT01929317|111285|P2|Long-term Phase|Adverse Event|1
23714|NCT01929317|111286|P1|Long-term Phase|Adverse Event|5
23715|NCT01929317|111285|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
23716|NCT01929317|111286|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
23717|NCT01929317|111285|P2|Dose Increase Effect Verification Phase|Physician Decision|0
23718|NCT01929317|111286|P1|Dose Increase Effect Verification Phase|Physician Decision|1
23719|NCT01929317|111285|P2|Dose Increase Effect Verification Phase|Adverse Event|1
23720|NCT01929317|111286|P1|Dose Increase Effect Verification Phase|Adverse Event|5
23721|NCT01929135|111355|P2|Overall Study|Lost to Follow-up|1
23722|NCT01929135|111356|P1|Overall Study|Lost to Follow-up|1
23723|NCT01929083|111370|P2|Intervention 2|Adverse Event|1
23724|NCT01929083|111371|P1|Intervention 2|Adverse Event|0
23725|NCT01929083|111370|P2|Intervention 1|Nonadherent to study medications|0
23726|NCT01929083|111371|P1|Intervention 1|Nonadherent to study medications|1
23727|NCT01929083|111370|P2|Intervention 1|Lost to Follow-up|0
23728|NCT01929083|111371|P1|Intervention 1|Lost to Follow-up|2
23729|NCT01929044|111397|P2|Overall Study|Not Treated|3
23730|NCT01929044|111398|P1|Overall Study|Not Treated|1
23731|NCT01929044|111397|P2|Overall Study|Protocol Violation|14
23732|NCT01929044|111398|P1|Overall Study|Protocol Violation|9
23733|NCT01929044|111397|P2|Overall Study|Adverse Event|0
23734|NCT01929044|111398|P1|Overall Study|Adverse Event|1
23735|NCT01929031|111420|P6|Overall Study|Reason other than specified above|0
23736|NCT01929031|111421|P5|Overall Study|Reason other than specified above|1
23737|NCT01929031|111422|P4|Overall Study|Reason other than specified above|0
23738|NCT01929031|111423|P3|Overall Study|Reason other than specified above|0
23739|NCT01929031|111424|P2|Overall Study|Reason other than specified above|1
23740|NCT01929031|111425|P1|Overall Study|Reason other than specified above|0
23741|NCT01929031|111420|P6|Overall Study|Protocol Violation|1
23742|NCT01929031|111421|P5|Overall Study|Protocol Violation|0
23743|NCT01929031|111422|P4|Overall Study|Protocol Violation|0
23744|NCT01929031|111423|P3|Overall Study|Protocol Violation|0
23745|NCT01929031|111424|P2|Overall Study|Protocol Violation|0
23746|NCT01929031|111425|P1|Overall Study|Protocol Violation|1
23747|NCT01929031|111420|P6|Overall Study|Adverse Event|0
23748|NCT01929031|111421|P5|Overall Study|Adverse Event|0
23749|NCT01929031|111422|P4|Overall Study|Adverse Event|0
23750|NCT01929031|111423|P3|Overall Study|Adverse Event|1
23751|NCT01929031|111424|P2|Overall Study|Adverse Event|1
23752|NCT01929031|111425|P1|Overall Study|Adverse Event|3
23753|NCT01928940|111449|P2|Overall Study|Adverse Event|1
23754|NCT01928940|111450|P1|Overall Study|Adverse Event|0
23755|NCT01928927|111493|P2|Overall Study|Withdrawal by Subject|1
23756|NCT01928927|111494|P1|Overall Study|Withdrawal by Subject|1
23757|NCT01928927|111493|P2|Overall Study|Lost to Follow-up|0
23758|NCT01928927|111494|P1|Overall Study|Lost to Follow-up|1
23759|NCT01928862|111621|P5|Overall Study|Lost to Follow-up|1
23760|NCT01928862|111622|P4|Overall Study|Lost to Follow-up|0
23761|NCT01928862|111623|P3|Overall Study|Lost to Follow-up|0
23762|NCT01928862|111624|P2|Overall Study|Lost to Follow-up|0
23763|NCT01928862|111625|P1|Overall Study|Lost to Follow-up|1
23764|NCT01928771|111678|P3|Overall Study|Severe Non-Compliance to Protocol|2
23765|NCT01928771|111679|P2|Overall Study|Severe Non-Compliance to Protocol|2
23766|NCT01928771|111680|P1|Overall Study|Severe Non-Compliance to Protocol|4
23767|NCT01928771|111678|P3|Overall Study|Other Reasons|14
23768|NCT01928771|111679|P2|Overall Study|Other Reasons|9
23769|NCT01928771|111680|P1|Overall Study|Other Reasons|9
23770|NCT01928771|111678|P3|Overall Study|Study-Specific Withdrawal Criteria|1
23771|NCT01928771|111679|P2|Overall Study|Study-Specific Withdrawal Criteria|1
23772|NCT01928771|111680|P1|Overall Study|Study-Specific Withdrawal Criteria|0
23773|NCT01928771|111678|P3|Overall Study|Withdrawal by Subject|17
23774|NCT01928771|111679|P2|Overall Study|Withdrawal by Subject|15
23775|NCT01928771|111680|P1|Overall Study|Withdrawal by Subject|20
23776|NCT01928771|111678|P3|Overall Study|Lost to Follow-up|3
23777|NCT01928771|111679|P2|Overall Study|Lost to Follow-up|6
23778|NCT01928771|111680|P1|Overall Study|Lost to Follow-up|5
23779|NCT01928771|111678|P3|Overall Study|Death|2
23780|NCT01928771|111679|P2|Overall Study|Death|2
23781|NCT01928771|111680|P1|Overall Study|Death|2
23782|NCT01928771|111678|P3|Overall Study|Adverse Event|1
23783|NCT01928771|111679|P2|Overall Study|Adverse Event|5
23784|NCT01928771|111680|P1|Overall Study|Adverse Event|6
23785|NCT01928615|111792|P1|Overall Study|Study Terminated by Sponsor|2
23786|NCT01928472|111811|P4|Overall Study|Unclassified|0
23787|NCT01928472|111812|P3|Overall Study|Unclassified|1
23788|NCT01928472|111813|P2|Overall Study|Unclassified|0
23789|NCT01928472|111814|P1|Overall Study|Unclassified|0
23790|NCT01928472|111811|P4|Overall Study|Administrative Reason|0
23791|NCT01928472|111812|P3|Overall Study|Administrative Reason|0
23792|NCT01928472|111813|P2|Overall Study|Administrative Reason|1
23793|NCT01928472|111814|P1|Overall Study|Administrative Reason|2
23794|NCT01928472|111811|P4|Overall Study|Lost to Follow-up|0
23795|NCT01928472|111812|P3|Overall Study|Lost to Follow-up|4
23796|NCT01928472|111813|P2|Overall Study|Lost to Follow-up|3
23797|NCT01928472|111814|P1|Overall Study|Lost to Follow-up|2
23798|NCT01928472|111811|P4|Overall Study|Withdrawal by Subject|2
23799|NCT01928472|111812|P3|Overall Study|Withdrawal by Subject|1
23800|NCT01928472|111813|P2|Overall Study|Withdrawal by Subject|4
23801|NCT01928472|111814|P1|Overall Study|Withdrawal by Subject|4
23802|NCT01928472|111811|P4|Overall Study|Death|0
23803|NCT01928472|111812|P3|Overall Study|Death|1
23804|NCT01928472|111813|P2|Overall Study|Death|0
23805|NCT01928472|111814|P1|Overall Study|Death|0
23806|NCT01928433|111884|P3|Overall Study|Other reasons|4
23807|NCT01928433|111885|P2|Overall Study|Other reasons|3
23808|NCT01928433|111886|P1|Overall Study|Other reasons|3
23809|NCT01928433|111884|P3|Overall Study|Lost to Follow-up|3
23810|NCT01928433|111885|P2|Overall Study|Lost to Follow-up|2
23811|NCT01928433|111886|P1|Overall Study|Lost to Follow-up|0
23812|NCT01928433|111884|P3|Overall Study|Negative screening urine culture|10
23813|NCT01928433|111885|P2|Overall Study|Negative screening urine culture|6
23814|NCT01928433|111886|P1|Overall Study|Negative screening urine culture|7
23815|NCT01928433|111884|P3|Overall Study|Withdrawal by Subject|0
23816|NCT01928433|111885|P2|Overall Study|Withdrawal by Subject|4
23817|NCT01928433|111886|P1|Overall Study|Withdrawal by Subject|0
23818|NCT01928433|111884|P3|Overall Study|Lack of Efficacy|4
23819|NCT01928433|111885|P2|Overall Study|Lack of Efficacy|4
23820|NCT01928433|111886|P1|Overall Study|Lack of Efficacy|5
23821|NCT01928433|111884|P3|Overall Study|Protocol Violation|2
23822|NCT01928433|111885|P2|Overall Study|Protocol Violation|0
23823|NCT01928433|111886|P1|Overall Study|Protocol Violation|0
23824|NCT01928433|111884|P3|Overall Study|Adverse Event|5
23825|NCT01928433|111885|P2|Overall Study|Adverse Event|2
23826|NCT01928433|111886|P1|Overall Study|Adverse Event|5
23827|NCT01928381|111909|P7|Part 2 - Post Third Intervention|Protocol Violation|0
23828|NCT01928381|111910|P6|Part 2 - Post Third Intervention|Protocol Violation|0
23829|NCT01928381|111911|P5|Part 2 - Post Third Intervention|Protocol Violation|0
23830|NCT01928381|111912|P4|Part 2 - Post Third Intervention|Protocol Violation|0
23831|NCT01928381|111913|P3|Part 2 - Post Third Intervention|Protocol Violation|1
23832|NCT01928381|111914|P2|Part 2 - Post Third Intervention|Protocol Violation|0
23833|NCT01928381|111915|P1|Part 2 - Post Third Intervention|Protocol Violation|0
23834|NCT01928381|111909|P7|Part 2 - Second Intervention|Lost to Follow-up|0
23835|NCT01928381|111910|P6|Part 2 - Second Intervention|Lost to Follow-up|0
23836|NCT01928381|111911|P5|Part 2 - Second Intervention|Lost to Follow-up|0
23837|NCT01928381|111912|P4|Part 2 - Second Intervention|Lost to Follow-up|1
23838|NCT01928381|111913|P3|Part 2 - Second Intervention|Lost to Follow-up|0
23839|NCT01928381|111914|P2|Part 2 - Second Intervention|Lost to Follow-up|1
23840|NCT01928381|111915|P1|Part 2 - Second Intervention|Lost to Follow-up|0
23841|NCT01928381|111909|P7|Washout First Intervention|Protocol Violation|0
23842|NCT01928381|111910|P6|Washout First Intervention|Protocol Violation|0
23843|NCT01928381|111911|P5|Washout First Intervention|Protocol Violation|1
23844|NCT01928381|111912|P4|Washout First Intervention|Protocol Violation|0
23845|NCT01928381|111913|P3|Washout First Intervention|Protocol Violation|0
23846|NCT01928381|111914|P2|Washout First Intervention|Protocol Violation|0
23847|NCT01928381|111915|P1|Washout First Intervention|Protocol Violation|0
23848|NCT01928381|111909|P7|Part 2 - First Intervention|Lost to Follow-up|0
23849|NCT01928381|111910|P6|Part 2 - First Intervention|Lost to Follow-up|0
23850|NCT01928381|111911|P5|Part 2 - First Intervention|Lost to Follow-up|0
23851|NCT01928381|111912|P4|Part 2 - First Intervention|Lost to Follow-up|1
23852|NCT01928381|111913|P3|Part 2 - First Intervention|Lost to Follow-up|0
23853|NCT01928381|111914|P2|Part 2 - First Intervention|Lost to Follow-up|0
23854|NCT01928381|111915|P1|Part 2 - First Intervention|Lost to Follow-up|0
23855|NCT01928381|111909|P7|Part 2 - First Intervention|Eligibility criterion not met|1
23856|NCT01928381|111910|P6|Part 2 - First Intervention|Eligibility criterion not met|1
23857|NCT01928381|111911|P5|Part 2 - First Intervention|Eligibility criterion not met|0
23858|NCT01928381|111912|P4|Part 2 - First Intervention|Eligibility criterion not met|0
23859|NCT01928381|111913|P3|Part 2 - First Intervention|Eligibility criterion not met|0
23860|NCT01928381|111914|P2|Part 2 - First Intervention|Eligibility criterion not met|0
23861|NCT01928381|111915|P1|Part 2 - First Intervention|Eligibility criterion not met|0
23862|NCT01928381|111909|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
23863|NCT01928381|111910|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
23864|NCT01928381|111911|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
23865|NCT01928381|111912|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
23866|NCT01928381|111913|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
23867|NCT01928381|111914|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
23868|NCT01928381|111915|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
23869|NCT01928381|111909|P7|Part 2 - First Intervention|Withdrawal by Subject|0
23870|NCT01928381|111910|P6|Part 2 - First Intervention|Withdrawal by Subject|0
23871|NCT01928381|111911|P5|Part 2 - First Intervention|Withdrawal by Subject|0
23872|NCT01928381|111912|P4|Part 2 - First Intervention|Withdrawal by Subject|0
23873|NCT01928381|111913|P3|Part 2 - First Intervention|Withdrawal by Subject|1
23874|NCT01928381|111914|P2|Part 2 - First Intervention|Withdrawal by Subject|0
23875|NCT01928381|111915|P1|Part 2 - First Intervention|Withdrawal by Subject|0
23876|NCT01928381|111909|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
23877|NCT01928381|111910|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
23878|NCT01928381|111911|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
23879|NCT01928381|111912|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
23880|NCT01928381|111913|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
23881|NCT01928381|111914|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
23882|NCT01928381|111915|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
23883|NCT01928381|111909|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
23884|NCT01928381|111910|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
23885|NCT01928381|111911|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
23886|NCT01928381|111912|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
23887|NCT01928381|111913|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
23888|NCT01928381|111914|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
23889|NCT01928381|111915|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
23890|NCT01928381|111909|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
23971|NCT01927055|112023|P3|Double-Blind|Protocol Violation|1
23891|NCT01928381|111910|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
23892|NCT01928381|111911|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
23893|NCT01928381|111912|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
23894|NCT01928381|111913|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
23895|NCT01928381|111914|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
23896|NCT01928381|111915|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
23897|NCT01928381|111909|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
23898|NCT01928381|111910|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
23899|NCT01928381|111911|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
23900|NCT01928381|111912|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
23901|NCT01928381|111913|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
23902|NCT01928381|111914|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
23903|NCT01928381|111915|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
23904|NCT01928381|111909|P7|Part 1 - Pain Training|Protocol Violation|0
23905|NCT01928381|111910|P6|Part 1 - Pain Training|Protocol Violation|0
23906|NCT01928381|111911|P5|Part 1 - Pain Training|Protocol Violation|0
23907|NCT01928381|111912|P4|Part 1 - Pain Training|Protocol Violation|0
23908|NCT01928381|111913|P3|Part 1 - Pain Training|Protocol Violation|0
23909|NCT01928381|111914|P2|Part 1 - Pain Training|Protocol Violation|0
23910|NCT01928381|111915|P1|Part 1 - Pain Training|Protocol Violation|1
23911|NCT01928381|111909|P7|Part 1 - Pain Training|Lost to Follow-up|0
23912|NCT01928381|111910|P6|Part 1 - Pain Training|Lost to Follow-up|0
23913|NCT01928381|111911|P5|Part 1 - Pain Training|Lost to Follow-up|0
23914|NCT01928381|111912|P4|Part 1 - Pain Training|Lost to Follow-up|0
23915|NCT01928381|111913|P3|Part 1 - Pain Training|Lost to Follow-up|0
23916|NCT01928381|111914|P2|Part 1 - Pain Training|Lost to Follow-up|0
23917|NCT01928381|111915|P1|Part 1 - Pain Training|Lost to Follow-up|4
23918|NCT01928381|111909|P7|Part 1 - Pain Training|Withdrawal by Subject|0
23919|NCT01928381|111910|P6|Part 1 - Pain Training|Withdrawal by Subject|0
23920|NCT01928381|111911|P5|Part 1 - Pain Training|Withdrawal by Subject|0
23921|NCT01928381|111912|P4|Part 1 - Pain Training|Withdrawal by Subject|0
23922|NCT01928381|111913|P3|Part 1 - Pain Training|Withdrawal by Subject|0
23923|NCT01928381|111914|P2|Part 1 - Pain Training|Withdrawal by Subject|0
23924|NCT01928381|111915|P1|Part 1 - Pain Training|Withdrawal by Subject|1
23925|NCT01928381|111909|P7|Part 1 - Pain Training|Pain training criteria not met|0
23926|NCT01928381|111910|P6|Part 1 - Pain Training|Pain training criteria not met|0
23927|NCT01928381|111911|P5|Part 1 - Pain Training|Pain training criteria not met|0
23928|NCT01928381|111912|P4|Part 1 - Pain Training|Pain training criteria not met|0
23929|NCT01928381|111913|P3|Part 1 - Pain Training|Pain training criteria not met|0
23930|NCT01928381|111914|P2|Part 1 - Pain Training|Pain training criteria not met|0
23931|NCT01928381|111915|P1|Part 1 - Pain Training|Pain training criteria not met|29
23932|NCT01928381|111909|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
23933|NCT01928381|111910|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
23934|NCT01928381|111911|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
23935|NCT01928381|111912|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
23936|NCT01928381|111913|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
23937|NCT01928381|111914|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
23938|NCT01928381|111915|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
23939|NCT01928082|111942|P1|Overall Study|Study terminated.|1
23940|NCT01927757|111960|P1|Overall Study|Ethical Reasons|4
23941|NCT01927757|111960|P1|Overall Study|Other|1
23942|NCT01927757|111960|P1|Overall Study|Decision by Sponsor|2
23943|NCT01927757|111960|P1|Overall Study|Lost to Follow-up|2
23944|NCT01927757|111960|P1|Overall Study|Withdrawal by Subject|14
23945|NCT01927419|111988|P2|Overall Study|Not reported|0
23946|NCT01927419|111989|P1|Overall Study|Not reported|1
23947|NCT01927419|111988|P2|Overall Study|Not specified|1
23948|NCT01927419|111989|P1|Overall Study|Not specified|2
23949|NCT01927419|111988|P2|Overall Study|Withdrawal by Subject|1
23950|NCT01927419|111989|P1|Overall Study|Withdrawal by Subject|3
23951|NCT01927419|111988|P2|Overall Study|Adverse event unrelated to study drug|1
23952|NCT01927419|111989|P1|Overall Study|Adverse event unrelated to study drug|6
23953|NCT01927419|111988|P2|Overall Study|Death|1
23954|NCT01927419|111989|P1|Overall Study|Death|0
23955|NCT01927419|111988|P2|Overall Study|Study drug toxicity|7
23956|NCT01927419|111989|P1|Overall Study|Study drug toxicity|43
23957|NCT01927419|111988|P2|Overall Study|Disease progression|17
23958|NCT01927419|111989|P1|Overall Study|Disease progression|15
23959|NCT01927055|112023|P3|Double-Blind|Extended Vacation|0
23960|NCT01927055|112024|P2|Double-Blind|Extended Vacation|1
23961|NCT01927055|112025|P1|Double-Blind|Extended Vacation|0
23962|NCT01927055|112023|P3|Double-Blind|Supine Hypertension|1
23963|NCT01927055|112024|P2|Double-Blind|Supine Hypertension|0
23964|NCT01927055|112025|P1|Double-Blind|Supine Hypertension|0
23965|NCT01927055|112023|P3|Double-Blind|Study Stopped|7
23966|NCT01927055|112024|P2|Double-Blind|Study Stopped|7
23967|NCT01927055|112025|P1|Double-Blind|Study Stopped|0
23968|NCT01927055|112023|P3|Double-Blind|Withdrawal by Subject|3
23969|NCT01927055|112024|P2|Double-Blind|Withdrawal by Subject|2
23970|NCT01927055|112025|P1|Double-Blind|Withdrawal by Subject|0
23972|NCT01927055|112024|P2|Double-Blind|Protocol Violation|0
23973|NCT01927055|112025|P1|Double-Blind|Protocol Violation|0
23974|NCT01927055|112023|P3|Double-Blind|Adverse Event|1
23975|NCT01927055|112024|P2|Double-Blind|Adverse Event|1
23976|NCT01927055|112025|P1|Double-Blind|Adverse Event|0
23977|NCT01927055|112023|P3|Open-label|Difficulty attending study visits|0
23978|NCT01927055|112024|P2|Open-label|Difficulty attending study visits|0
23979|NCT01927055|112025|P1|Open-label|Difficulty attending study visits|1
23980|NCT01927055|112023|P3|Open-label|Supine Hypertension|0
23981|NCT01927055|112024|P2|Open-label|Supine Hypertension|0
23982|NCT01927055|112025|P1|Open-label|Supine Hypertension|4
23983|NCT01927055|112023|P3|Open-label|Study Stopped|0
23984|NCT01927055|112024|P2|Open-label|Study Stopped|0
23985|NCT01927055|112025|P1|Open-label|Study Stopped|4
23986|NCT01927055|112023|P3|Open-label|Withdrawal by Subject|0
23987|NCT01927055|112024|P2|Open-label|Withdrawal by Subject|0
23988|NCT01927055|112025|P1|Open-label|Withdrawal by Subject|1
23989|NCT01927055|112023|P3|Open-label|Adverse Event|0
23990|NCT01927055|112024|P2|Open-label|Adverse Event|0
23991|NCT01927055|112025|P1|Open-label|Adverse Event|6
23992|NCT01926782|112049|P6|Overall Study|Related to study drug administration|2
23993|NCT01926782|112050|P5|Overall Study|Related to study drug administration|0
23994|NCT01926782|112051|P4|Overall Study|Related to study drug administration|0
23995|NCT01926782|112052|P3|Overall Study|Related to study drug administration|0
23996|NCT01926782|112053|P2|Overall Study|Related to study drug administration|0
23997|NCT01926782|112054|P1|Overall Study|Related to study drug administration|0
23998|NCT01926782|112049|P6|Overall Study|Withdrawal by Subject|5
23999|NCT01926782|112050|P5|Overall Study|Withdrawal by Subject|0
24000|NCT01926782|112051|P4|Overall Study|Withdrawal by Subject|1
24001|NCT01926782|112052|P3|Overall Study|Withdrawal by Subject|8
24002|NCT01926782|112053|P2|Overall Study|Withdrawal by Subject|1
24003|NCT01926782|112054|P1|Overall Study|Withdrawal by Subject|6
24004|NCT01926782|112049|P6|Overall Study|Randomized and not treated|0
24005|NCT01926782|112050|P5|Overall Study|Randomized and not treated|0
24006|NCT01926782|112051|P4|Overall Study|Randomized and not treated|1
24007|NCT01926782|112052|P3|Overall Study|Randomized and not treated|0
24008|NCT01926782|112053|P2|Overall Study|Randomized and not treated|0
24009|NCT01926782|112054|P1|Overall Study|Randomized and not treated|0
24010|NCT01926782|112049|P6|Overall Study|Poor compliance to protocol|6
24011|NCT01926782|112050|P5|Overall Study|Poor compliance to protocol|1
24012|NCT01926782|112051|P4|Overall Study|Poor compliance to protocol|0
24013|NCT01926782|112052|P3|Overall Study|Poor compliance to protocol|8
24014|NCT01926782|112053|P2|Overall Study|Poor compliance to protocol|3
24015|NCT01926782|112054|P1|Overall Study|Poor compliance to protocol|5
24016|NCT01926782|112049|P6|Overall Study|Adverse Event|14
24017|NCT01926782|112050|P5|Overall Study|Adverse Event|3
24018|NCT01926782|112051|P4|Overall Study|Adverse Event|4
24019|NCT01926782|112052|P3|Overall Study|Adverse Event|17
24020|NCT01926782|112053|P2|Overall Study|Adverse Event|4
24021|NCT01926782|112054|P1|Overall Study|Adverse Event|13
24022|NCT01926782|112049|P6|Overall Study|Other than specified|11
24023|NCT01926782|112050|P5|Overall Study|Other than specified|4
24024|NCT01926782|112051|P4|Overall Study|Other than specified|12
24025|NCT01926782|112052|P3|Overall Study|Other than specified|5
24026|NCT01926782|112053|P2|Overall Study|Other than specified|3
24027|NCT01926782|112054|P1|Overall Study|Other than specified|2
24028|NCT01926782|112049|P6|Overall Study|Physician Decision|0
24029|NCT01926782|112050|P5|Overall Study|Physician Decision|0
24030|NCT01926782|112051|P4|Overall Study|Physician Decision|1
24031|NCT01926782|112052|P3|Overall Study|Physician Decision|1
24032|NCT01926782|112053|P2|Overall Study|Physician Decision|2
24033|NCT01926782|112054|P1|Overall Study|Physician Decision|0
24034|NCT01926782|112049|P6|Overall Study|Participant moved|3
24035|NCT01926782|112050|P5|Overall Study|Participant moved|0
24036|NCT01926782|112051|P4|Overall Study|Participant moved|1
24037|NCT01926782|112052|P3|Overall Study|Participant moved|1
24038|NCT01926782|112053|P2|Overall Study|Participant moved|0
24039|NCT01926782|112054|P1|Overall Study|Participant moved|2
24040|NCT01926626|112203|P1|Overall Study|Lost to Follow-up|7
24041|NCT01926626|112203|P1|Overall Study|Withdrawal by Subject|15
24042|NCT01926119|112213|P1|Overall Study|Withdrawal by Subject|1
24043|NCT01926015|112225|P2|Overall Study|Randomized not treated|0
24044|NCT01926015|112226|P1|Overall Study|Randomized not treated|2
24045|NCT01926015|112225|P2|Overall Study|Withdrawal by parent/guardian|1
24046|NCT01926015|112226|P1|Overall Study|Withdrawal by parent/guardian|0
24047|NCT01925768|112269|P2|Overall Study|Non-compliance with study drug|1
24048|NCT01925768|112270|P1|Overall Study|Non-compliance with study drug|0
24049|NCT01925768|112269|P2|Overall Study|Withdrawal by Subject|4
24050|NCT01925768|112270|P1|Overall Study|Withdrawal by Subject|1
24051|NCT01925768|112269|P2|Overall Study|Lack of Efficacy|6
24052|NCT01925768|112270|P1|Overall Study|Lack of Efficacy|3
24053|NCT01925768|112269|P2|Overall Study|Adverse Event|10
24054|NCT01925768|112270|P1|Overall Study|Adverse Event|5
24055|NCT01925768|112269|P2|Overall Study|Protocol Violation|2
24056|NCT01925768|112270|P1|Overall Study|Protocol Violation|1
24057|NCT01925768|112269|P2|Overall Study|Lost to Follow-up|0
24058|NCT01925768|112270|P1|Overall Study|Lost to Follow-up|1
24059|NCT01925703|112278|P1|Overall Study|Discharge prior to full iron repletion|1
24060|NCT01925703|112278|P1|Overall Study|Lost to Follow-up|2
24061|NCT01925703|112278|P1|Overall Study|Physician Decision|1
24062|NCT01925417|112297|P1|Overall Study|Death|1
24063|NCT01925417|112297|P1|Overall Study|Withdrawal by Subject|2
24064|NCT01925274|112307|P3|Overall Study|Protocol amendment|6
24065|NCT01925274|112308|P2|Overall Study|Protocol amendment|3
24066|NCT01925274|112309|P1|Overall Study|Protocol amendment|1
24067|NCT01925274|112307|P3|Overall Study|Study terminated by sponsor|0
24068|NCT01925274|112308|P2|Overall Study|Study terminated by sponsor|0
24069|NCT01925274|112309|P1|Overall Study|Study terminated by sponsor|4
24070|NCT01925274|112307|P3|Overall Study|Withdrawal by Subject|0
24071|NCT01925274|112308|P2|Overall Study|Withdrawal by Subject|2
24072|NCT01925274|112309|P1|Overall Study|Withdrawal by Subject|1
24073|NCT01925274|112307|P3|Overall Study|Lost to Follow-up|0
24074|NCT01925274|112308|P2|Overall Study|Lost to Follow-up|1
24075|NCT01925274|112309|P1|Overall Study|Lost to Follow-up|0
24076|NCT01925274|112307|P3|Overall Study|Death|0
24077|NCT01925274|112308|P2|Overall Study|Death|0
24078|NCT01925274|112309|P1|Overall Study|Death|1
24079|NCT01925209|112390|P4|Follow-up|Withdrawal by Subject|2
24080|NCT01925209|112391|P3|Follow-up|Withdrawal by Subject|0
24081|NCT01925209|112392|P2|Follow-up|Withdrawal by Subject|2
24082|NCT01925209|112393|P1|Follow-up|Withdrawal by Subject|0
24083|NCT01925209|112390|P4|Follow-up|Non-compliance with study treatment|1
24084|NCT01925209|112391|P3|Follow-up|Non-compliance with study treatment|0
24085|NCT01925209|112392|P2|Follow-up|Non-compliance with study treatment|0
24086|NCT01925209|112393|P1|Follow-up|Non-compliance with study treatment|0
24087|NCT01925209|112390|P4|Follow-up|Physician Decision|0
24088|NCT01925209|112391|P3|Follow-up|Physician Decision|1
24089|NCT01925209|112392|P2|Follow-up|Physician Decision|0
24090|NCT01925209|112393|P1|Follow-up|Physician Decision|0
24091|NCT01925209|112390|P4|Follow-up|Adverse Event|1
24092|NCT01925209|112391|P3|Follow-up|Adverse Event|0
24093|NCT01925209|112392|P2|Follow-up|Adverse Event|4
24094|NCT01925209|112393|P1|Follow-up|Adverse Event|1
24095|NCT01925209|112390|P4|Maintenance Treatment Epoch|Adverse Event|0
24096|NCT01925209|112391|P3|Maintenance Treatment Epoch|Adverse Event|1
24097|NCT01925209|112392|P2|Maintenance Treatment Epoch|Adverse Event|0
24098|NCT01925209|112393|P1|Maintenance Treatment Epoch|Adverse Event|0
24099|NCT01925209|112390|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
24100|NCT01925209|112391|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
24101|NCT01925209|112392|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
24102|NCT01925209|112393|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
24103|NCT01925209|112390|P4|Treatment Epoch|Adverse Event|1
24104|NCT01925209|112391|P3|Treatment Epoch|Adverse Event|3
24105|NCT01925209|112392|P2|Treatment Epoch|Adverse Event|5
24106|NCT01925209|112393|P1|Treatment Epoch|Adverse Event|3
24107|NCT01925209|112390|P4|Treatment Epoch|Withdrawal by Subject|2
24108|NCT01925209|112391|P3|Treatment Epoch|Withdrawal by Subject|3
24109|NCT01925209|112392|P2|Treatment Epoch|Withdrawal by Subject|3
24110|NCT01925209|112393|P1|Treatment Epoch|Withdrawal by Subject|4
24111|NCT01925209|112390|P4|Treatment Epoch|Protocol deviation|1
24112|NCT01925209|112391|P3|Treatment Epoch|Protocol deviation|1
24113|NCT01925209|112392|P2|Treatment Epoch|Protocol deviation|0
24114|NCT01925209|112393|P1|Treatment Epoch|Protocol deviation|0
24115|NCT01925209|112390|P4|Treatment Epoch|Death|0
24116|NCT01925209|112391|P3|Treatment Epoch|Death|0
24117|NCT01925209|112392|P2|Treatment Epoch|Death|0
24118|NCT01925209|112393|P1|Treatment Epoch|Death|1
24119|NCT01925209|112390|P4|Treatment Epoch|Non-compliance with study treatment|1
24120|NCT01925209|112391|P3|Treatment Epoch|Non-compliance with study treatment|0
24121|NCT01925209|112392|P2|Treatment Epoch|Non-compliance with study treatment|0
24122|NCT01925209|112393|P1|Treatment Epoch|Non-compliance with study treatment|0
24123|NCT01925209|112390|P4|Treatment Epoch|Physician Decision|0
24124|NCT01925209|112391|P3|Treatment Epoch|Physician Decision|0
24125|NCT01925209|112392|P2|Treatment Epoch|Physician Decision|0
24126|NCT01925209|112393|P1|Treatment Epoch|Physician Decision|1
24127|NCT01925183|112425|P2|Overall Study|Adverse Event|0
24128|NCT01925183|112426|P1|Overall Study|Adverse Event|1
24129|NCT01925170|112434|P1|Overall Study|Unverified cancer status|53
24130|NCT01924767|112499|P5|Overall Study|Adverse Event|0
24131|NCT01924767|112500|P4|Overall Study|Adverse Event|0
24132|NCT01924767|112501|P3|Overall Study|Adverse Event|1
24133|NCT01924767|112502|P2|Overall Study|Adverse Event|0
24134|NCT01924767|112503|P1|Overall Study|Adverse Event|1
24135|NCT01924364|112630|P1|Overall Study|Physician Decision|3
24136|NCT01924299|112647|P2|Period 2|Adverse Event|1
24137|NCT01924299|112648|P1|Period 2|Adverse Event|0
24138|NCT01924299|112647|P2|Period 2|Withdrawal by Subject|0
24139|NCT01924299|112648|P1|Period 2|Withdrawal by Subject|1
24140|NCT01924182|112670|P2|Overall Study|Withdrawal by Subject|0
24141|NCT01924182|112671|P1|Overall Study|Withdrawal by Subject|1
24142|NCT01923896|112690|P2|Overall Study|Adverse Event|0
24143|NCT01923896|112691|P1|Overall Study|Adverse Event|1
24144|NCT01923740|112714|P2|270-day Clinical Follow-up|Death|4
24145|NCT01923740|112715|P1|270-day Clinical Follow-up|Death|0
24146|NCT01923467|113040|P1|Overall Study|Subject non-interest|479
24147|NCT01923467|113040|P1|Overall Study|Lost to Follow-up|62
24148|NCT01923389|113046|P2|Overall Study|Protocol Violation|0
24149|NCT01923389|113047|P1|Overall Study|Protocol Violation|1
24150|NCT01922934|113084|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
24151|NCT01922934|113085|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
24152|NCT01922934|113084|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
24153|NCT01922934|113085|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
24154|NCT01922934|113084|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
24155|NCT01922934|113085|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
24156|NCT01922934|113084|P2|Eligible Patients|Did not meet inclusion criteria|81
24157|NCT01922934|113085|P1|Eligible Patients|Did not meet inclusion criteria|36
24158|NCT01922934|113084|P2|Eligible Patients|Physician Decision|0
24159|NCT01922934|113085|P1|Eligible Patients|Physician Decision|17
24160|NCT01922934|113084|P2|Eligible Patients|Death|7
24161|NCT01922934|113085|P1|Eligible Patients|Death|0
24162|NCT01922739|113097|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
24163|NCT01922739|113097|P1|Open-label Treatment Period|Physician Decision|1
24164|NCT01922739|113097|P1|Open-label Treatment Period|Lost to Follow-up|2
24165|NCT01922739|113097|P1|Open-label Treatment Period|Noncompliance to study procedures|1
24166|NCT01922739|113097|P1|Open-label Treatment Period|Pregnancy|1
24167|NCT01922739|113097|P1|Open-label Treatment Period|Protocol Violation|5
24168|NCT01922739|113097|P1|Open-label Treatment Period|Noncompliance to study medication|3
24169|NCT01922739|113097|P1|Open-label Treatment Period|Withdrawal by Subject|14
24170|NCT01922739|113097|P1|Open-label Treatment Period|Adverse Event|6
24171|NCT01922739|113097|P1|Titration/Adjustment Period|Lack of Efficacy|3
24172|NCT01922739|113097|P1|Titration/Adjustment Period|Lost to Follow-up|1
24173|NCT01922739|113097|P1|Titration/Adjustment Period|Withdrawal by Subject|5
24174|NCT01922739|113097|P1|Titration/Adjustment Period|Adverse Event|3
24175|NCT01922349|113126|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
24176|NCT01922349|113127|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
24177|NCT01922349|113128|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
24178|NCT01922349|113129|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
24179|NCT01922271|113236|P2|WASHOUT Period|Withdrawal by Subject|0
24180|NCT01922271|113237|P1|WASHOUT Period|Withdrawal by Subject|1
24181|NCT01922089|113278|P2|Overall Study|Lost to Follow-up|1
24182|NCT01922089|113279|P1|Overall Study|Lost to Follow-up|0
24183|NCT01922089|113278|P2|Overall Study|Death|1
24184|NCT01922089|113279|P1|Overall Study|Death|2
24185|NCT01922089|113278|P2|Overall Study|Physician Decision|3
24186|NCT01922089|113279|P1|Overall Study|Physician Decision|2
24187|NCT01922089|113278|P2|Overall Study|administrative problems|1
24188|NCT01922089|113279|P1|Overall Study|administrative problems|4
24189|NCT01922089|113278|P2|Overall Study|Withdrawal by Subject|4
24190|NCT01922089|113279|P1|Overall Study|Withdrawal by Subject|3
24191|NCT01922089|113278|P2|Overall Study|Protocol Deviation|7
24192|NCT01922089|113279|P1|Overall Study|Protocol Deviation|10
24193|NCT01922089|113278|P2|Overall Study|Adverse Event|13
24194|NCT01922089|113279|P1|Overall Study|Adverse Event|18
24195|NCT01922037|113291|P2|Overall Study|Other unspecified|66
24196|NCT01922037|113292|P1|Overall Study|Other unspecified|2
24197|NCT01922037|113291|P2|Overall Study|Investigator/Sponsor decision|4
24198|NCT01922037|113292|P1|Overall Study|Investigator/Sponsor decision|1
24199|NCT01922037|113291|P2|Overall Study|Participant non-compliance|46
24200|NCT01922037|113292|P1|Overall Study|Participant non-compliance|4
24201|NCT01922037|113291|P2|Overall Study|Pregnancy|2
24202|NCT01922037|113292|P1|Overall Study|Pregnancy|0
24203|NCT01922037|113291|P2|Overall Study|Death|5
24204|NCT01922037|113292|P1|Overall Study|Death|0
24205|NCT01922037|113291|P2|Overall Study|Adverse Event|7
24206|NCT01922037|113292|P1|Overall Study|Adverse Event|1
24207|NCT01922037|113291|P2|Overall Study|Withdrawal by Subject|44
24208|NCT01922037|113292|P1|Overall Study|Withdrawal by Subject|2
24209|NCT01922011|113386|P2|Overall Study|Randomized in error|0
24210|NCT01922011|113387|P1|Overall Study|Randomized in error|1
24211|NCT01922011|113386|P2|Overall Study|Lack of willing home health agency|0
24212|NCT01922011|113387|P1|Overall Study|Lack of willing home health agency|1
24213|NCT01922011|113386|P2|Overall Study|Not Treated|0
24214|NCT01922011|113387|P1|Overall Study|Not Treated|1
24215|NCT01922011|113386|P2|Overall Study|Missed Test-of-Cure Visit|2
24216|NCT01922011|113387|P1|Overall Study|Missed Test-of-Cure Visit|0
24217|NCT01922011|113386|P2|Overall Study|Lost to Follow-up|1
24218|NCT01922011|113387|P1|Overall Study|Lost to Follow-up|0
24219|NCT01922011|113386|P2|Overall Study|Parent/Guardian Decision|0
24220|NCT01922011|113387|P1|Overall Study|Parent/Guardian Decision|3
24221|NCT01922011|113386|P2|Overall Study|Physician Decision|1
24222|NCT01922011|113387|P1|Overall Study|Physician Decision|0
24223|NCT01922011|113386|P2|Overall Study|Protocol Violation|1
24224|NCT01922011|113387|P1|Overall Study|Protocol Violation|0
24225|NCT01921829|113454|P2|Overall Study|Withdrawal by Subject|1
24226|NCT01921829|113455|P1|Overall Study|Withdrawal by Subject|0
24227|NCT01921348|113531|P2|Overall Study|Lost to Follow-up|2
24228|NCT01921348|113532|P1|Overall Study|Lost to Follow-up|0
24229|NCT01921348|113531|P2|Overall Study|Withdrawal by Subject|0
24230|NCT01921348|113532|P1|Overall Study|Withdrawal by Subject|1
24231|NCT01921270|113561|P1|Overall Study|Withdrawal by Subject|1
24232|NCT01921257|113577|P1|Overall Study|Withdrawal by Subject|1
24233|NCT01921257|113577|P1|Overall Study|Protocol Violation|1
24234|NCT01921257|113577|P1|Overall Study|Adverse Event|1
24235|NCT01921205|113584|P2|Overall Study|Non Compliance Of Child|1
24236|NCT01921205|113585|P1|Overall Study|Non Compliance Of Child|0
24237|NCT01921205|113584|P2|Overall Study|Non Compliance Of The Parent|1
24238|NCT01921205|113585|P1|Overall Study|Non Compliance Of The Parent|0
24239|NCT01921205|113584|P2|Overall Study|The Excessive Use Of Rescue Medication|1
24240|NCT01921205|113585|P1|Overall Study|The Excessive Use Of Rescue Medication|0
24241|NCT01921205|113584|P2|Overall Study|Use Of Prohibited Medication|1
24242|NCT01921205|113585|P1|Overall Study|Use Of Prohibited Medication|0
24243|NCT01921205|113584|P2|Overall Study|Withdrawal by Subject|5
24244|NCT01921205|113585|P1|Overall Study|Withdrawal by Subject|6
24245|NCT01921205|113584|P2|Overall Study|Lost to Follow-up|1
24246|NCT01921205|113585|P1|Overall Study|Lost to Follow-up|1
24247|NCT01921205|113584|P2|Overall Study|Protocol Violation|3
24248|NCT01921205|113585|P1|Overall Study|Protocol Violation|1
24249|NCT01921205|113584|P2|Overall Study|Lack of Efficacy|0
24250|NCT01921205|113585|P1|Overall Study|Lack of Efficacy|1
24251|NCT01921205|113584|P2|Overall Study|Adverse Event|7
24252|NCT01921205|113585|P1|Overall Study|Adverse Event|12
24253|NCT01921101|113626|P2|Overall Study|Death|6
24254|NCT01921101|113627|P1|Overall Study|Death|16
24255|NCT01920958|113635|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
24256|NCT01920893|113653|P2|Overall Study|Lack of Efficacy|0
24257|NCT01920893|113654|P1|Overall Study|Lack of Efficacy|2
24258|NCT01920893|113653|P2|Overall Study|Adverse Event|2
24259|NCT01920893|113654|P1|Overall Study|Adverse Event|5
24260|NCT01920854|113687|P7|Overall Study|Withdrawal by Subject|1
24261|NCT01920854|113688|P6|Overall Study|Withdrawal by Subject|0
24262|NCT01920854|113689|P5|Overall Study|Withdrawal by Subject|1
24263|NCT01920854|113690|P4|Overall Study|Withdrawal by Subject|0
24264|NCT01920854|113691|P3|Overall Study|Withdrawal by Subject|0
24265|NCT01920854|113692|P2|Overall Study|Withdrawal by Subject|0
24266|NCT01920854|113693|P1|Overall Study|Withdrawal by Subject|1
24267|NCT01920594|113853|P2|Overall Study|Investigator discretion|1
24268|NCT01920594|113854|P1|Overall Study|Investigator discretion|0
24269|NCT01920594|113853|P2|Overall Study|Recovery|0
24270|NCT01920594|113854|P1|Overall Study|Recovery|2
24271|NCT01920594|113853|P2|Overall Study|Lost to Follow-up|0
24272|NCT01920594|113854|P1|Overall Study|Lost to Follow-up|1
24273|NCT01920594|113853|P2|Overall Study|Adverse Event|2
24274|NCT01920594|113854|P1|Overall Study|Adverse Event|4
24275|NCT01920568|113904|P2|Overall Study|Death due to disease progression|12
24276|NCT01920568|113905|P1|Overall Study|Death due to disease progression|25
24277|NCT01920568|113904|P2|Overall Study|Withdrawal by Subject|55
24278|NCT01920568|113905|P1|Overall Study|Withdrawal by Subject|79
24279|NCT01920568|113904|P2|Overall Study|Physician Decision|4
24280|NCT01920568|113905|P1|Overall Study|Physician Decision|13
24281|NCT01920568|113904|P2|Overall Study|Lost to Follow-up|2
24282|NCT01920568|113905|P1|Overall Study|Lost to Follow-up|2
24283|NCT01920568|113904|P2|Overall Study|Protocol Violation|3
24284|NCT01920568|113905|P1|Overall Study|Protocol Violation|5
24285|NCT01920568|113904|P2|Overall Study|Adverse Event|8
24286|NCT01920568|113905|P1|Overall Study|Adverse Event|27
24287|NCT01920555|113931|P5|Overall Study|Lost to Follow-up|0
24288|NCT01920555|113932|P4|Overall Study|Lost to Follow-up|1
24289|NCT01920555|113933|P3|Overall Study|Lost to Follow-up|0
24290|NCT01920555|113934|P2|Overall Study|Lost to Follow-up|1
24291|NCT01920555|113935|P1|Overall Study|Lost to Follow-up|0
24292|NCT01920555|113931|P5|Overall Study|Travel Difficulties|1
24293|NCT01920555|113932|P4|Overall Study|Travel Difficulties|0
24294|NCT01920555|113933|P3|Overall Study|Travel Difficulties|0
24295|NCT01920555|113934|P2|Overall Study|Travel Difficulties|1
24296|NCT01920555|113935|P1|Overall Study|Travel Difficulties|1
24297|NCT01920555|113931|P5|Overall Study|Lack of Efficacy|0
24298|NCT01920555|113932|P4|Overall Study|Lack of Efficacy|0
24299|NCT01920555|113933|P3|Overall Study|Lack of Efficacy|0
24300|NCT01920555|113934|P2|Overall Study|Lack of Efficacy|0
24301|NCT01920555|113935|P1|Overall Study|Lack of Efficacy|2
24302|NCT01920555|113931|P5|Overall Study|Physician Decision|0
24303|NCT01920555|113932|P4|Overall Study|Physician Decision|2
24304|NCT01920555|113933|P3|Overall Study|Physician Decision|1
24305|NCT01920555|113934|P2|Overall Study|Physician Decision|2
24306|NCT01920555|113935|P1|Overall Study|Physician Decision|1
24307|NCT01920178|114010|P2|Overall Study|Lost to Follow-up|1
24308|NCT01920178|114011|P1|Overall Study|Lost to Follow-up|2
24309|NCT01919801|114029|P2|Overall Study|Other|1
24310|NCT01919801|114030|P1|Overall Study|Other|0
24311|NCT01919801|114029|P2|Overall Study|Lost to Follow-up|1
24312|NCT01919801|114030|P1|Overall Study|Lost to Follow-up|0
24313|NCT01919801|114029|P2|Overall Study|Physician Decision|1
24314|NCT01919801|114030|P1|Overall Study|Physician Decision|0
24315|NCT01919801|114029|P2|Overall Study|Withdrawal by Subject|0
24316|NCT01919801|114030|P1|Overall Study|Withdrawal by Subject|1
24317|NCT01919723|114055|P2|Overall Study|Blood Samples Hemolyzed|2
24318|NCT01919723|114056|P1|Overall Study|Blood Samples Hemolyzed|2
24319|NCT01919307|114096|P1|Overall Study|Withdrawal by Subject|9
24320|NCT01919229|114106|P3|Overall Study|Subject/guardian decision|1
24321|NCT01919229|114107|P2|Overall Study|Subject/guardian decision|0
24322|NCT01919229|114108|P1|Overall Study|Subject/guardian decision|0
24323|NCT01918371|114173|P2|Overall Study|Missing Data|1
24324|NCT01918371|114174|P1|Overall Study|Missing Data|1
24325|NCT01918332|114252|P4|Overall Study|lipid result by central lab did not meet|0
24326|NCT01918332|114253|P3|Overall Study|lipid result by central lab did not meet|1
24327|NCT01918332|114254|P2|Overall Study|lipid result by central lab did not meet|0
24328|NCT01918332|114255|P1|Overall Study|lipid result by central lab did not meet|0
24329|NCT01918332|114252|P4|Overall Study|Protocol Violation|3
24330|NCT01918332|114253|P3|Overall Study|Protocol Violation|6
24331|NCT01918332|114254|P2|Overall Study|Protocol Violation|2
24332|NCT01918332|114255|P1|Overall Study|Protocol Violation|6
24333|NCT01918332|114252|P4|Overall Study|Withdrawal by Subject|3
24334|NCT01918332|114253|P3|Overall Study|Withdrawal by Subject|2
24335|NCT01918332|114254|P2|Overall Study|Withdrawal by Subject|3
24336|NCT01918332|114255|P1|Overall Study|Withdrawal by Subject|2
24337|NCT01918332|114252|P4|Overall Study|Adverse Event|1
24338|NCT01918332|114253|P3|Overall Study|Adverse Event|0
24339|NCT01918332|114254|P2|Overall Study|Adverse Event|0
24340|NCT01918332|114255|P1|Overall Study|Adverse Event|0
24341|NCT01918306|114267|P4|Overall Study|progress disease, crossover|0
24342|NCT01918306|114268|P3|Overall Study|progress disease, crossover|1
24343|NCT01918306|114269|P2|Overall Study|progress disease, crossover|0
24344|NCT01918306|114270|P1|Overall Study|progress disease, crossover|0
24345|NCT01918306|114267|P4|Overall Study|Lack of Efficacy|0
24346|NCT01918306|114268|P3|Overall Study|Lack of Efficacy|0
24347|NCT01918306|114269|P2|Overall Study|Lack of Efficacy|0
24348|NCT01918306|114270|P1|Overall Study|Lack of Efficacy|1
24349|NCT01918306|114267|P4|Overall Study|neutropenia|0
24350|NCT01918306|114268|P3|Overall Study|neutropenia|0
24351|NCT01918306|114269|P2|Overall Study|neutropenia|0
24352|NCT01918306|114270|P1|Overall Study|neutropenia|1
24353|NCT01918306|114267|P4|Overall Study|Withdrawal by Subject|2
24354|NCT01918306|114268|P3|Overall Study|Withdrawal by Subject|0
24355|NCT01918306|114269|P2|Overall Study|Withdrawal by Subject|0
24356|NCT01918306|114270|P1|Overall Study|Withdrawal by Subject|0
24357|NCT01918306|114267|P4|Overall Study|progresive disease|1
24358|NCT01918306|114268|P3|Overall Study|progresive disease|1
24359|NCT01918306|114269|P2|Overall Study|progresive disease|0
24360|NCT01918306|114270|P1|Overall Study|progresive disease|4
24361|NCT01918085|114292|P2|Test Period 1: Strata Strip|Adverse Event|1
24362|NCT01918085|114293|P1|Test Period 1: Strata Strip|Adverse Event|0
24363|NCT01918033|114304|P3|Overall Study|Withdrawal by Subject|0
24364|NCT01918033|114305|P2|Overall Study|Withdrawal by Subject|1
24365|NCT01918033|114306|P1|Overall Study|Withdrawal by Subject|2
24366|NCT01918033|114304|P3|Overall Study|Protocol Violation|1
24367|NCT01918033|114305|P2|Overall Study|Protocol Violation|0
24368|NCT01918033|114306|P1|Overall Study|Protocol Violation|2
24369|NCT01918033|114304|P3|Overall Study|Lost to Follow-up|0
24370|NCT01918033|114305|P2|Overall Study|Lost to Follow-up|1
24371|NCT01918033|114306|P1|Overall Study|Lost to Follow-up|0
24372|NCT01918033|114304|P3|Overall Study|Adverse Event|2
24373|NCT01918033|114305|P2|Overall Study|Adverse Event|0
24374|NCT01918033|114306|P1|Overall Study|Adverse Event|1
24375|NCT01917656|114377|P2|Overall Study|Lost to Follow-up|4
24376|NCT01917656|114378|P1|Overall Study|Lost to Follow-up|3
24377|NCT01917656|114377|P2|Overall Study|Withdrawal by Subject|3
24378|NCT01917656|114378|P1|Overall Study|Withdrawal by Subject|4
24379|NCT01917656|114377|P2|Overall Study|Unclassified|3
24380|NCT01917656|114378|P1|Overall Study|Unclassified|0
24381|NCT01917656|114377|P2|Overall Study|Withdrawal criteria|14
24382|NCT01917656|114378|P1|Overall Study|Withdrawal criteria|8
24383|NCT01917656|114377|P2|Overall Study|Adverse Event|0
24384|NCT01917656|114378|P1|Overall Study|Adverse Event|11
24385|NCT01917526|114404|P2|Overall Study|Protocol Violation|1
24386|NCT01917526|114405|P1|Overall Study|Protocol Violation|1
24387|NCT01917344|114422|P1|Overall Study|Withdrawal by Subject|1
24388|NCT01916980|114437|P2|Overall Study|Withdrawal by Subject|0
24389|NCT01916980|114438|P1|Overall Study|Withdrawal by Subject|1
24390|NCT01916980|114437|P2|Overall Study|Lack of Efficacy|2
24391|NCT01916980|114438|P1|Overall Study|Lack of Efficacy|2
24392|NCT01916980|114437|P2|Overall Study|Adverse Event|2
24393|NCT01916980|114438|P1|Overall Study|Adverse Event|4
24394|NCT01916967|114457|P3|Overall Study|Protocol Violation|0
24395|NCT01916967|114458|P2|Overall Study|Protocol Violation|1
24396|NCT01916967|114459|P1|Overall Study|Protocol Violation|0
24397|NCT01916967|114457|P3|Overall Study|Physician Decision|1
24398|NCT01916967|114458|P2|Overall Study|Physician Decision|0
24399|NCT01916967|114459|P1|Overall Study|Physician Decision|0
24400|NCT01916967|114457|P3|Overall Study|Lack of Efficacy|6
24401|NCT01916967|114458|P2|Overall Study|Lack of Efficacy|0
24402|NCT01916967|114459|P1|Overall Study|Lack of Efficacy|0
24403|NCT01916967|114457|P3|Overall Study|Adverse Event|2
24404|NCT01916967|114458|P2|Overall Study|Adverse Event|0
24405|NCT01916967|114459|P1|Overall Study|Adverse Event|0
24406|NCT01916824|114515|P2|Overall Study|Withdrawal by Subject|3
24407|NCT01916824|114516|P1|Overall Study|Withdrawal by Subject|2
24408|NCT01916824|114515|P2|Overall Study|Physician Decision|0
24409|NCT01916824|114516|P1|Overall Study|Physician Decision|2
24410|NCT01916824|114515|P2|Overall Study|Lost to Follow-up|6
24411|NCT01916824|114516|P1|Overall Study|Lost to Follow-up|3
24412|NCT01916304|114585|P1|Overall Study|Screening failure|17
24413|NCT01916226|114597|P4|Overall Study|Physician Decision|1
24414|NCT01916226|114598|P3|Overall Study|Physician Decision|0
24415|NCT01916226|114599|P2|Overall Study|Physician Decision|0
24416|NCT01916226|114600|P1|Overall Study|Physician Decision|0
24417|NCT01916226|114597|P4|Overall Study|Protocol Violation|1
24418|NCT01916226|114598|P3|Overall Study|Protocol Violation|0
24419|NCT01916226|114599|P2|Overall Study|Protocol Violation|1
24420|NCT01916226|114600|P1|Overall Study|Protocol Violation|0
24421|NCT01916226|114597|P4|Overall Study|Lack of Efficacy|1
24422|NCT01916226|114598|P3|Overall Study|Lack of Efficacy|2
24423|NCT01916226|114599|P2|Overall Study|Lack of Efficacy|0
24424|NCT01916226|114600|P1|Overall Study|Lack of Efficacy|0
24425|NCT01916226|114597|P4|Overall Study|Adverse Event|1
24426|NCT01916226|114598|P3|Overall Study|Adverse Event|1
24427|NCT01916226|114599|P2|Overall Study|Adverse Event|0
24428|NCT01916226|114600|P1|Overall Study|Adverse Event|1
24429|NCT01916109|114634|P1|Overall Study|Withdrawal by Subject|1
24430|NCT01915940|114640|P3|Treatment Period|Other Miscellaneous Reasons|0
24431|NCT01915940|114641|P2|Treatment Period|Other Miscellaneous Reasons|1
24432|NCT01915940|114642|P1|Treatment Period|Other Miscellaneous Reasons|0
24433|NCT01915940|114640|P3|Treatment Period|Adverse Event|1
24434|NCT01915940|114641|P2|Treatment Period|Adverse Event|9
24435|NCT01915940|114642|P1|Treatment Period|Adverse Event|0
24436|NCT01915940|114640|P3|Treatment Period|Decision of Participant|3
24437|NCT01915940|114641|P2|Treatment Period|Decision of Participant|1
24438|NCT01915940|114642|P1|Treatment Period|Decision of Participant|0
24439|NCT01915940|114640|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
24440|NCT01915940|114641|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
24441|NCT01915940|114642|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
24442|NCT01915914|114658|P4|Follow-up Phase|Physician Decision|1
24443|NCT01915914|114659|P3|Follow-up Phase|Physician Decision|0
24444|NCT01915914|114660|P2|Follow-up Phase|Physician Decision|0
24445|NCT01915914|114661|P1|Follow-up Phase|Physician Decision|0
24446|NCT01915914|114658|P4|Follow-up Phase|Withdrawal by Subject|1
24447|NCT01915914|114659|P3|Follow-up Phase|Withdrawal by Subject|0
24448|NCT01915914|114660|P2|Follow-up Phase|Withdrawal by Subject|0
24449|NCT01915914|114661|P1|Follow-up Phase|Withdrawal by Subject|0
24450|NCT01915914|114658|P4|Maintenance Phase|Missing|0
24451|NCT01915914|114659|P3|Maintenance Phase|Missing|0
24452|NCT01915914|114660|P2|Maintenance Phase|Missing|1
24453|NCT01915914|114661|P1|Maintenance Phase|Missing|0
24454|NCT01915914|114658|P4|Maintenance Phase|Lost to Follow-up|0
24455|NCT01915914|114659|P3|Maintenance Phase|Lost to Follow-up|1
24456|NCT01915914|114660|P2|Maintenance Phase|Lost to Follow-up|4
24457|NCT01915914|114661|P1|Maintenance Phase|Lost to Follow-up|0
24458|NCT01915914|114658|P4|Maintenance Phase|Withdrawal by Subject|0
24459|NCT01915914|114659|P3|Maintenance Phase|Withdrawal by Subject|1
24460|NCT01915914|114660|P2|Maintenance Phase|Withdrawal by Subject|1
24461|NCT01915914|114661|P1|Maintenance Phase|Withdrawal by Subject|0
24462|NCT01915914|114658|P4|Acute Phase|Missing|0
24463|NCT01915914|114659|P3|Acute Phase|Missing|0
24464|NCT01915914|114660|P2|Acute Phase|Missing|0
24465|NCT01915914|114661|P1|Acute Phase|Missing|1
24466|NCT01915914|114658|P4|Acute Phase|"Not Achieved treatment success"|0
24467|NCT01915914|114659|P3|Acute Phase|"Not Achieved treatment success"|0
24468|NCT01915914|114660|P2|Acute Phase|"Not Achieved treatment success"|0
24469|NCT01915914|114661|P1|Acute Phase|"Not Achieved treatment success"|1
24470|NCT01915914|114658|P4|Acute Phase|Accepted Other Topic Therapies|0
24471|NCT01915914|114659|P3|Acute Phase|Accepted Other Topic Therapies|0
24472|NCT01915914|114660|P2|Acute Phase|Accepted Other Topic Therapies|0
24473|NCT01915914|114661|P1|Acute Phase|Accepted Other Topic Therapies|1
24474|NCT01915914|114658|P4|Acute Phase|Physician Decision|0
24475|NCT01915914|114659|P3|Acute Phase|Physician Decision|0
24476|NCT01915914|114660|P2|Acute Phase|Physician Decision|0
24477|NCT01915914|114661|P1|Acute Phase|Physician Decision|1
24478|NCT01915914|114658|P4|Acute Phase|Lost to Follow-up|0
24479|NCT01915914|114659|P3|Acute Phase|Lost to Follow-up|0
24480|NCT01915914|114660|P2|Acute Phase|Lost to Follow-up|0
24481|NCT01915914|114661|P1|Acute Phase|Lost to Follow-up|4
24482|NCT01915914|114658|P4|Acute Phase|Withdrawal by Subject|0
24483|NCT01915914|114659|P3|Acute Phase|Withdrawal by Subject|0
24484|NCT01915914|114660|P2|Acute Phase|Withdrawal by Subject|0
24485|NCT01915914|114661|P1|Acute Phase|Withdrawal by Subject|4
24486|NCT01915849|114693|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
24487|NCT01915849|114694|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
24488|NCT01915849|114695|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
24489|NCT01915849|114696|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
24490|NCT01915849|114693|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
24491|NCT01915849|114694|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
24492|NCT01915849|114695|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
24493|NCT01915849|114696|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
24494|NCT01915732|114721|P2|Overall Study|Poor Conscious Effect|1
24495|NCT01915732|114722|P1|Overall Study|Poor Conscious Effect|0
24496|NCT01915732|114721|P2|Overall Study|Improper Facial Procedure|1
24497|NCT01915732|114722|P1|Overall Study|Improper Facial Procedure|0
24498|NCT01915732|114721|P2|Overall Study|Job Transfer|1
24499|NCT01915732|114722|P1|Overall Study|Job Transfer|0
24500|NCT01915732|114721|P2|Overall Study|Par. Refused to Hospital Visits|1
24501|NCT01915732|114722|P1|Overall Study|Par. Refused to Hospital Visits|0
24502|NCT01915732|114721|P2|Overall Study|Par. not Willing to Continue Treatment|1
24503|NCT01915732|114722|P1|Overall Study|Par. not Willing to Continue Treatment|0
24504|NCT01915732|114721|P2|Overall Study|Got Well|1
24505|NCT01915732|114722|P1|Overall Study|Got Well|0
24506|NCT01915732|114721|P2|Overall Study|Par. Unable to Come to the Hospital|1
24507|NCT01915732|114722|P1|Overall Study|Par. Unable to Come to the Hospital|0
24508|NCT01915732|114721|P2|Overall Study|Poor Perceived Efficacy|0
24509|NCT01915732|114722|P1|Overall Study|Poor Perceived Efficacy|1
24510|NCT01915732|114721|P2|Overall Study|Pregnancy|0
24511|NCT01915732|114722|P1|Overall Study|Pregnancy|1
24512|NCT01915732|114721|P2|Overall Study|Recovered|0
24513|NCT01915732|114722|P1|Overall Study|Recovered|1
24514|NCT01915732|114721|P2|Overall Study|Drug Release Error|0
24515|NCT01915732|114722|P1|Overall Study|Drug Release Error|1
24516|NCT01915732|114721|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
24517|NCT01915732|114722|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
24518|NCT01915732|114721|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
24519|NCT01915732|114722|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
24520|NCT01915732|114721|P2|Overall Study|Lost to Follow-up|26
24521|NCT01915732|114722|P1|Overall Study|Lost to Follow-up|22
24522|NCT01915732|114721|P2|Overall Study|Lack of Efficacy|11
24523|NCT01915732|114722|P1|Overall Study|Lack of Efficacy|6
24524|NCT01915732|114721|P2|Overall Study|Protocol Violation|5
24525|NCT01915732|114722|P1|Overall Study|Protocol Violation|5
24526|NCT01915732|114721|P2|Overall Study|Adverse Event|4
24527|NCT01915732|114722|P1|Overall Study|Adverse Event|12
24528|NCT01915732|114721|P2|Overall Study|Failure to Meet Randomization Criteria|0
24529|NCT01915732|114722|P1|Overall Study|Failure to Meet Randomization Criteria|1
24530|NCT01915732|114721|P2|Overall Study|Withdrawal by Subject|18
24531|NCT01915732|114722|P1|Overall Study|Withdrawal by Subject|18
24532|NCT01914926|114790|P2|Overall Study|uncooperative, agitated and removed|1
24533|NCT01914926|114791|P1|Overall Study|uncooperative, agitated and removed|0
24534|NCT01914926|114790|P2|Overall Study|Adverse Event|0
24535|NCT01914926|114791|P1|Overall Study|Adverse Event|1
24536|NCT01914757|114800|P3|Overall Study|Other reasons|4
24537|NCT01914757|114801|P2|Overall Study|Other reasons|9
24538|NCT01914757|114802|P1|Overall Study|Other reasons|5
24539|NCT01914757|114800|P3|Overall Study|Eligibility criteria not fulfilled|2
24540|NCT01914757|114801|P2|Overall Study|Eligibility criteria not fulfilled|0
24541|NCT01914757|114802|P1|Overall Study|Eligibility criteria not fulfilled|2
24542|NCT01914757|114800|P3|Overall Study|Study specific withdrawal criteria|0
24543|NCT01914757|114801|P2|Overall Study|Study specific withdrawal criteria|1
24544|NCT01914757|114802|P1|Overall Study|Study specific withdrawal criteria|0
24545|NCT01914757|114800|P3|Overall Study|Adverse Event|4
24546|NCT01914757|114801|P2|Overall Study|Adverse Event|3
24547|NCT01914757|114802|P1|Overall Study|Adverse Event|4
24548|NCT01914757|114800|P3|Overall Study|Death|1
24549|NCT01914757|114801|P2|Overall Study|Death|2
24550|NCT01914757|114802|P1|Overall Study|Death|2
24551|NCT01914757|114800|P3|Overall Study|Withdrawal by Subject|19
24552|NCT01914757|114801|P2|Overall Study|Withdrawal by Subject|27
24553|NCT01914757|114802|P1|Overall Study|Withdrawal by Subject|15
24554|NCT01914757|114800|P3|Overall Study|Lost to Follow-up|6
24555|NCT01914757|114801|P2|Overall Study|Lost to Follow-up|8
24556|NCT01914757|114802|P1|Overall Study|Lost to Follow-up|5
24557|NCT01914757|114800|P3|Overall Study|Severe non-compliance to protocol|2
24558|NCT01914757|114801|P2|Overall Study|Severe non-compliance to protocol|1
24559|NCT01914757|114802|P1|Overall Study|Severe non-compliance to protocol|3
24560|NCT01914679|114876|P1|Overall Study|Sponsor terminated study|4
24561|NCT01914679|114876|P1|Overall Study|Lack of Efficacy|1
24562|NCT01914666|114883|P3|Treatment Period|Physician Decision|2
24563|NCT01914666|114884|P2|Treatment Period|Physician Decision|0
24564|NCT01914666|114885|P1|Treatment Period|Physician Decision|0
24565|NCT01914666|114883|P3|Treatment Period|Withdrawal by Subject|2
24566|NCT01914666|114884|P2|Treatment Period|Withdrawal by Subject|2
24567|NCT01914666|114885|P1|Treatment Period|Withdrawal by Subject|3
24568|NCT01914666|114883|P3|Treatment Period|Adverse Event|2
24569|NCT01914666|114884|P2|Treatment Period|Adverse Event|4
24570|NCT01914666|114885|P1|Treatment Period|Adverse Event|10
24571|NCT01914666|114883|P3|Treatment Period|Lack of Efficacy|2
24572|NCT01914666|114884|P2|Treatment Period|Lack of Efficacy|0
24573|NCT01914666|114885|P1|Treatment Period|Lack of Efficacy|0
24574|NCT01913483|115011|P2|Overall Study|Death|17
24575|NCT01913483|115012|P1|Overall Study|Death|14
24576|NCT01913483|115011|P2|Overall Study|Lost to Follow-up|3
24577|NCT01913483|115012|P1|Overall Study|Lost to Follow-up|6
24578|NCT01913483|115011|P2|Overall Study|Withdrawal by Subject|2
24579|NCT01913483|115012|P1|Overall Study|Withdrawal by Subject|1
24580|NCT01913470|115024|P2|Overall Study|Withdrawal by Subject|1
24581|NCT01913470|115025|P1|Overall Study|Withdrawal by Subject|0
24582|NCT01913470|115024|P2|Overall Study|Physician Decision|1
24583|NCT01913470|115025|P1|Overall Study|Physician Decision|0
24584|NCT01913470|115024|P2|Overall Study|Lost to Follow-up|1
24585|NCT01913470|115025|P1|Overall Study|Lost to Follow-up|0
24586|NCT01913405|115043|P1|Overall Study|Adverse Event|1
24587|NCT01913405|115043|P1|Overall Study|Withdrawal by Subject|1
24588|NCT01913041|115097|P1|Overall Study|Physician Decision|1
24589|NCT01913041|115097|P1|Overall Study|Withdrawal by Subject|3
24590|NCT01913041|115097|P1|Overall Study|Protocol Violation|35
24591|NCT01912781|115103|P2|Overall Study|Withdrawal by Subject|0
24592|NCT01912781|115104|P1|Overall Study|Withdrawal by Subject|2
24593|NCT01912768|115135|P2|Overall Study|Randomized in error|0
24594|NCT01912768|115136|P1|Overall Study|Randomized in error|1
24595|NCT01912768|115135|P2|Overall Study|Withdrawal by Subject|3
24596|NCT01912768|115136|P1|Overall Study|Withdrawal by Subject|5
24597|NCT01912768|115135|P2|Overall Study|Lost to Follow-up|1
24598|NCT01912768|115136|P1|Overall Study|Lost to Follow-up|2
24599|NCT01912768|115135|P2|Overall Study|Adverse Event|0
24600|NCT01912768|115136|P1|Overall Study|Adverse Event|2
24601|NCT01912599|115167|P2|Overall Study|Withdrawal by Subject|1
24602|NCT01912599|115168|P1|Overall Study|Withdrawal by Subject|0
24603|NCT01912404|115193|P2|Overall Study|Due to personal reasons|0
24604|NCT01912404|115194|P1|Overall Study|Due to personal reasons|1
24605|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
24606|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
24607|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
24608|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
24609|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
24610|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
24611|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
24612|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
24613|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
24614|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
24615|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
24616|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
24617|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
24618|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
24619|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
24620|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
24621|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
24622|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
24623|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
24624|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
24625|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
24626|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
24627|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
24628|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
24629|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
24630|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
24631|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
24632|NCT01912339|115207|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
24633|NCT01912339|115208|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
24634|NCT01912339|115209|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
24635|NCT01912339|115207|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
24636|NCT01912339|115208|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
24637|NCT01912339|115209|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
24638|NCT01912339|115207|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
24639|NCT01912339|115208|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
24640|NCT01912339|115209|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
24641|NCT01912339|115207|P3|Blinded (0 to 3 Months)|Declined to participate|0
24642|NCT01912339|115208|P2|Blinded (0 to 3 Months)|Declined to participate|0
24643|NCT01912339|115209|P1|Blinded (0 to 3 Months)|Declined to participate|1
24644|NCT01912222|115226|P3|Part B: Treatment Period|Withdrawal by Subject|2
24645|NCT01912222|115227|P2|Part B: Treatment Period|Withdrawal by Subject|1
24646|NCT01912222|115228|P1|Part B: Treatment Period|Withdrawal by Subject|2
24647|NCT01912222|115226|P3|Part B: Treatment Period|Adverse Event|3
24648|NCT01912222|115227|P2|Part B: Treatment Period|Adverse Event|2
24649|NCT01912222|115228|P1|Part B: Treatment Period|Adverse Event|1
24650|NCT01912222|115226|P3|Part B: Treatment Period|Progressive disease|15
24651|NCT01912222|115227|P2|Part B: Treatment Period|Progressive disease|12
24652|NCT01912222|115228|P1|Part B: Treatment Period|Progressive disease|10
24653|NCT01912222|115226|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
24654|NCT01912222|115227|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
24655|NCT01912222|115228|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
24656|NCT01911845|115251|P1|Overall Study|Other (not specified)|3
24657|NCT01911845|115251|P1|Overall Study|Lost to Follow-up|1
24658|NCT01911845|115251|P1|Overall Study|Adverse Event|2
24659|NCT01911819|115268|P3|Overall Study|Withdrawal by Subject|0
24660|NCT01911819|115269|P2|Overall Study|Withdrawal by Subject|1
24661|NCT01911819|115270|P1|Overall Study|Withdrawal by Subject|1
24662|NCT01911819|115268|P3|Overall Study|Adverse Event|0
24663|NCT01911819|115269|P2|Overall Study|Adverse Event|1
24664|NCT01911819|115270|P1|Overall Study|Adverse Event|0
24665|NCT01911793|115283|P2|Overall Study|Physician Decision|5
24666|NCT01911793|115284|P1|Overall Study|Physician Decision|1
24667|NCT01911780|115308|P2|Extension Period (52 Weeks)|Personal reason|1
24668|NCT01911780|115309|P1|Extension Period (52 Weeks)|Personal reason|1
24669|NCT01911780|115308|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
24670|NCT01911780|115309|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
24671|NCT01911780|115308|P2|Extension Period (52 Weeks)|Adverse Event|0
24672|NCT01911780|115309|P1|Extension Period (52 Weeks)|Adverse Event|3
24673|NCT01911780|115308|P2|Double-blind Period (8 Weeks)|Personal reason|0
24674|NCT01911780|115309|P1|Double-blind Period (8 Weeks)|Personal reason|1
24675|NCT01911780|115308|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
24676|NCT01911780|115309|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
24677|NCT01911780|115308|P2|Double-blind Period (8 Weeks)|Adverse Event|2
24678|NCT01911780|115309|P1|Double-blind Period (8 Weeks)|Adverse Event|1
24679|NCT01911546|115343|P1|Overall Study|Everolimus was discontinued|5
24680|NCT01911546|115343|P1|Overall Study|Lost to Follow-up|1
24681|NCT01911442|115353|P3|Overall Study|Mother's Work Schedule|0
24682|NCT01911442|115354|P2|Overall Study|Mother's Work Schedule|1
24683|NCT01911442|115355|P1|Overall Study|Mother's Work Schedule|0
24684|NCT01911442|115353|P3|Overall Study|Withdrawal by Subject|6
24685|NCT01911442|115354|P2|Overall Study|Withdrawal by Subject|0
24686|NCT01911442|115355|P1|Overall Study|Withdrawal by Subject|1
24687|NCT01911442|115353|P3|Overall Study|Lost to Follow-up|1
24688|NCT01911442|115354|P2|Overall Study|Lost to Follow-up|0
24689|NCT01911442|115355|P1|Overall Study|Lost to Follow-up|2
24690|NCT01911442|115353|P3|Overall Study|Lack of Efficacy|1
24691|NCT01911442|115354|P2|Overall Study|Lack of Efficacy|1
24692|NCT01911442|115355|P1|Overall Study|Lack of Efficacy|1
24693|NCT01911442|115353|P3|Overall Study|Adverse Event|4
24694|NCT01911442|115354|P2|Overall Study|Adverse Event|2
24695|NCT01911442|115355|P1|Overall Study|Adverse Event|2
24696|NCT01911429|115384|P3|Overall Study|subject left study|0
24697|NCT01911429|115385|P2|Overall Study|subject left study|0
24698|NCT01911429|115386|P1|Overall Study|subject left study|1
24699|NCT01911429|115384|P3|Overall Study|Accidental randomization|1
24700|NCT01911429|115385|P2|Overall Study|Accidental randomization|0
24701|NCT01911429|115386|P1|Overall Study|Accidental randomization|0
24702|NCT01911429|115384|P3|Overall Study|Withdrawal by Subject|4
24703|NCT01911429|115385|P2|Overall Study|Withdrawal by Subject|5
24704|NCT01911429|115386|P1|Overall Study|Withdrawal by Subject|5
24705|NCT01911429|115384|P3|Overall Study|Protocol Violation|1
24706|NCT01911429|115385|P2|Overall Study|Protocol Violation|0
24707|NCT01911429|115386|P1|Overall Study|Protocol Violation|0
24708|NCT01911429|115384|P3|Overall Study|Lost to Follow-up|1
24709|NCT01911429|115385|P2|Overall Study|Lost to Follow-up|0
24710|NCT01911429|115386|P1|Overall Study|Lost to Follow-up|0
24711|NCT01911429|115384|P3|Overall Study|Lack of Efficacy|4
24712|NCT01911429|115385|P2|Overall Study|Lack of Efficacy|2
24713|NCT01911429|115386|P1|Overall Study|Lack of Efficacy|1
24714|NCT01911429|115384|P3|Overall Study|Adverse Event|9
24715|NCT01911429|115385|P2|Overall Study|Adverse Event|3
24716|NCT01911429|115386|P1|Overall Study|Adverse Event|5
24717|NCT01911273|115478|P2|Overall Study|Withdrawal by Subject|2
24718|NCT01911273|115479|P1|Overall Study|Withdrawal by Subject|0
24719|NCT01911273|115478|P2|Overall Study|Progression of Disease|0
24720|NCT01911273|115479|P1|Overall Study|Progression of Disease|1
24721|NCT01911260|115513|P4|Follow-up Period|transference or evasion of school|12
24722|NCT01911260|115514|P3|Follow-up Period|transference or evasion of school|15
24723|NCT01911260|115515|P2|Follow-up Period|transference or evasion of school|20
24724|NCT01911260|115516|P1|Follow-up Period|transference or evasion of school|13
24725|NCT01911260|115513|P4|Supplementation Period|less than 12 weeks supplementation|2
24726|NCT01911260|115514|P3|Supplementation Period|less than 12 weeks supplementation|1
24727|NCT01911260|115515|P2|Supplementation Period|less than 12 weeks supplementation|3
24728|NCT01911260|115516|P1|Supplementation Period|less than 12 weeks supplementation|0
24729|NCT01911260|115513|P4|Supplementation Period|refused to receive supplement|0
24730|NCT01911260|115514|P3|Supplementation Period|refused to receive supplement|1
24731|NCT01911260|115515|P2|Supplementation Period|refused to receive supplement|0
24732|NCT01911260|115516|P1|Supplementation Period|refused to receive supplement|1
24733|NCT01911260|115513|P4|Supplementation Period|Adverse Event|0
24734|NCT01911260|115514|P3|Supplementation Period|Adverse Event|1
24735|NCT01911260|115515|P2|Supplementation Period|Adverse Event|0
24736|NCT01911260|115516|P1|Supplementation Period|Adverse Event|2
24737|NCT01911260|115513|P4|Supplementation Period|transference or evasion of school|6
24738|NCT01911260|115514|P3|Supplementation Period|transference or evasion of school|7
24739|NCT01911260|115515|P2|Supplementation Period|transference or evasion of school|9
24740|NCT01911260|115516|P1|Supplementation Period|transference or evasion of school|7
24741|NCT01910441|115602|P2|Overall Study|Physician Decision|1
24742|NCT01910441|115603|P1|Overall Study|Physician Decision|0
24743|NCT01910441|115602|P2|Overall Study|Adverse Event|0
24744|NCT01910441|115603|P1|Overall Study|Adverse Event|1
24745|NCT01910441|115602|P2|Overall Study|Non-compliance|1
24746|NCT01910441|115603|P1|Overall Study|Non-compliance|0
24747|NCT01910441|115602|P2|Overall Study|Withdrawal by Subject|1
24748|NCT01910441|115603|P1|Overall Study|Withdrawal by Subject|0
24749|NCT01910441|115602|P2|Overall Study|Lost to Follow-up|5
24750|NCT01910441|115603|P1|Overall Study|Lost to Follow-up|6
24751|NCT01910441|115602|P2|Overall Study|Sponsor decision|2
24752|NCT01910441|115603|P1|Overall Study|Sponsor decision|0
24753|NCT01910402|115611|P2|Continuation Phase|Withdrawal by Subject|0
24754|NCT01910402|115612|P1|Continuation Phase|Withdrawal by Subject|2
24755|NCT01910402|115611|P2|Continuation Phase|Protocol Violation|0
24756|NCT01910402|115612|P1|Continuation Phase|Protocol Violation|3
24757|NCT01910402|115611|P2|Continuation Phase|Adverse Event|0
24758|NCT01910402|115612|P1|Continuation Phase|Adverse Event|1
24759|NCT01910402|115611|P2|Continuation Phase|Ongoing|0
24760|NCT01910402|115612|P1|Continuation Phase|Ongoing|84
24761|NCT01910402|115611|P2|Randomized Phase|Withdrawal by Subject|7
24762|NCT01910402|115612|P1|Randomized Phase|Withdrawal by Subject|5
24763|NCT01910402|115611|P2|Randomized Phase|Protocol Violation|13
24764|NCT01910402|115612|P1|Randomized Phase|Protocol Violation|10
24765|NCT01910402|115611|P2|Randomized Phase|Lost to Follow-up|13
24766|NCT01910402|115612|P1|Randomized Phase|Lost to Follow-up|11
24767|NCT01910402|115611|P2|Randomized Phase|Lack of Efficacy|4
24768|NCT01910402|115612|P1|Randomized Phase|Lack of Efficacy|5
24769|NCT01910402|115611|P2|Randomized Phase|Physician Decision|0
24770|NCT01910402|115612|P1|Randomized Phase|Physician Decision|1
24771|NCT01910402|115611|P2|Randomized Phase|Adverse Event|18
24772|NCT01910402|115612|P1|Randomized Phase|Adverse Event|10
24773|NCT01910389|115682|P2|Overall Study|Study Closed|8
24774|NCT01910389|115683|P1|Overall Study|Study Closed|13
24775|NCT01910389|115682|P2|Overall Study|Withdrawal by Subject|0
24776|NCT01910389|115683|P1|Overall Study|Withdrawal by Subject|2
24777|NCT01910181|115724|P1|Overall Study|Alive in Follow-Up|12
24778|NCT01910181|115724|P1|Overall Study|Alive on Treatment|14
24779|NCT01910181|115724|P1|Overall Study|Death|20
24780|NCT01910116|115751|P2|Overall Study|incomplete data|1
24781|NCT01910116|115752|P1|Overall Study|incomplete data|0
24782|NCT01910116|115751|P2|Overall Study|uncertain allocation|3
24783|NCT01910116|115752|P1|Overall Study|uncertain allocation|1
24784|NCT01910116|115751|P2|Overall Study|Withdrawal by Subject|3
24785|NCT01910116|115752|P1|Overall Study|Withdrawal by Subject|8
24786|NCT01910116|115751|P2|Overall Study|Protocol Violation|2
24787|NCT01910116|115752|P1|Overall Study|Protocol Violation|1
24788|NCT01910116|115751|P2|Overall Study|Lost to Follow-up|0
24789|NCT01910116|115752|P1|Overall Study|Lost to Follow-up|1
24790|NCT01910116|115751|P2|Overall Study|Lack of Efficacy|4
24791|NCT01910116|115752|P1|Overall Study|Lack of Efficacy|3
24792|NCT01910116|115751|P2|Overall Study|Adverse Event|3
24793|NCT01910116|115752|P1|Overall Study|Adverse Event|0
24794|NCT01909804|115849|P12|Overall Study|Protocol Violation|1
24795|NCT01909804|115850|P11|Overall Study|Protocol Violation|0
24796|NCT01909804|115851|P10|Overall Study|Protocol Violation|0
24797|NCT01909804|115852|P9|Overall Study|Protocol Violation|0
24798|NCT01909804|115853|P8|Overall Study|Protocol Violation|0
24799|NCT01909804|115854|P7|Overall Study|Protocol Violation|0
24800|NCT01909804|115855|P6|Overall Study|Protocol Violation|0
24801|NCT01909804|115856|P5|Overall Study|Protocol Violation|0
24802|NCT01909804|115857|P4|Overall Study|Protocol Violation|0
24803|NCT01909804|115858|P3|Overall Study|Protocol Violation|0
24804|NCT01909804|115859|P2|Overall Study|Protocol Violation|0
24805|NCT01909804|115860|P1|Overall Study|Protocol Violation|0
24806|NCT01909804|115849|P12|Overall Study|Withdrew Consent|0
24807|NCT01909804|115850|P11|Overall Study|Withdrew Consent|0
24808|NCT01909804|115851|P10|Overall Study|Withdrew Consent|0
24809|NCT01909804|115852|P9|Overall Study|Withdrew Consent|0
24810|NCT01909804|115853|P8|Overall Study|Withdrew Consent|0
24811|NCT01909804|115854|P7|Overall Study|Withdrew Consent|0
24812|NCT01909804|115855|P6|Overall Study|Withdrew Consent|1
24813|NCT01909804|115856|P5|Overall Study|Withdrew Consent|1
24814|NCT01909804|115857|P4|Overall Study|Withdrew Consent|0
24815|NCT01909804|115858|P3|Overall Study|Withdrew Consent|0
24816|NCT01909804|115859|P2|Overall Study|Withdrew Consent|0
24817|NCT01909804|115860|P1|Overall Study|Withdrew Consent|0
24818|NCT01909804|115849|P12|Overall Study|Lack of Efficacy|1
24819|NCT01909804|115850|P11|Overall Study|Lack of Efficacy|0
24820|NCT01909804|115851|P10|Overall Study|Lack of Efficacy|1
24821|NCT01909804|115852|P9|Overall Study|Lack of Efficacy|0
24822|NCT01909804|115853|P8|Overall Study|Lack of Efficacy|1
24823|NCT01909804|115854|P7|Overall Study|Lack of Efficacy|1
24824|NCT01909804|115855|P6|Overall Study|Lack of Efficacy|3
24825|NCT01909804|115856|P5|Overall Study|Lack of Efficacy|7
24826|NCT01909804|115857|P4|Overall Study|Lack of Efficacy|0
24827|NCT01909804|115858|P3|Overall Study|Lack of Efficacy|0
24828|NCT01909804|115859|P2|Overall Study|Lack of Efficacy|1
24829|NCT01909804|115860|P1|Overall Study|Lack of Efficacy|4
24830|NCT01909804|115849|P12|Overall Study|Death|0
24831|NCT01909804|115850|P11|Overall Study|Death|1
24832|NCT01909804|115851|P10|Overall Study|Death|0
24833|NCT01909804|115852|P9|Overall Study|Death|0
24834|NCT01909804|115853|P8|Overall Study|Death|0
24835|NCT01909804|115854|P7|Overall Study|Death|0
24836|NCT01909804|115855|P6|Overall Study|Death|0
24837|NCT01909804|115856|P5|Overall Study|Death|0
24838|NCT01909804|115857|P4|Overall Study|Death|0
24839|NCT01909804|115858|P3|Overall Study|Death|0
24840|NCT01909804|115859|P2|Overall Study|Death|0
24841|NCT01909804|115860|P1|Overall Study|Death|0
24842|NCT01909804|115849|P12|Overall Study|Randomized but Never Treated|1
24843|NCT01909804|115850|P11|Overall Study|Randomized but Never Treated|0
24844|NCT01909804|115851|P10|Overall Study|Randomized but Never Treated|0
24845|NCT01909804|115852|P9|Overall Study|Randomized but Never Treated|0
24846|NCT01909804|115853|P8|Overall Study|Randomized but Never Treated|0
24847|NCT01909804|115854|P7|Overall Study|Randomized but Never Treated|1
24848|NCT01909804|115855|P6|Overall Study|Randomized but Never Treated|0
24849|NCT01909804|115856|P5|Overall Study|Randomized but Never Treated|0
24850|NCT01909804|115857|P4|Overall Study|Randomized but Never Treated|0
24851|NCT01909804|115858|P3|Overall Study|Randomized but Never Treated|0
24852|NCT01909804|115859|P2|Overall Study|Randomized but Never Treated|0
24853|NCT01909804|115860|P1|Overall Study|Randomized but Never Treated|0
24854|NCT01909778|115906|P1|Overall Study|failed screening|1
24855|NCT01909674|115985|P2|Overall Study|Withdrawal by Subject|2
24856|NCT01909674|115986|P1|Overall Study|Withdrawal by Subject|5
24857|NCT01909466|116005|P2|Overall Study|Lack of Efficacy|0
24858|NCT01909466|116006|P1|Overall Study|Lack of Efficacy|1
24859|NCT01909466|116005|P2|Overall Study|Withdrawal by Subject|9
24860|NCT01909466|116006|P1|Overall Study|Withdrawal by Subject|11
24861|NCT01909466|116005|P2|Overall Study|Physician Decision|0
24862|NCT01909466|116006|P1|Overall Study|Physician Decision|2
24863|NCT01909466|116005|P2|Overall Study|Met Withdrawal Criteria|3
24864|NCT01909466|116006|P1|Overall Study|Met Withdrawal Criteria|0
24865|NCT01909466|116005|P2|Overall Study|Adverse Event|4
24866|NCT01909466|116006|P1|Overall Study|Adverse Event|3
24867|NCT01909466|116005|P2|Overall Study|Lost to Follow-up|7
24868|NCT01909466|116006|P1|Overall Study|Lost to Follow-up|5
24869|NCT01909336|116029|P3|Overall Study|Physician Decision|1
24870|NCT01909336|116030|P2|Overall Study|Physician Decision|1
24871|NCT01909336|116031|P1|Overall Study|Physician Decision|0
24872|NCT01909336|116029|P3|Overall Study|Lost to Follow-up|2
24873|NCT01909336|116030|P2|Overall Study|Lost to Follow-up|2
24874|NCT01909336|116031|P1|Overall Study|Lost to Follow-up|4
24875|NCT01908907|116083|P2|Overall Study|Protocol Violation|0
24876|NCT01908907|116084|P1|Overall Study|Protocol Violation|1
24877|NCT01908907|116083|P2|Overall Study|Physician Decision|0
24878|NCT01908907|116084|P1|Overall Study|Physician Decision|1
24879|NCT01908829|116128|P3|Overall Study|Withdrawal by Subject|22
24880|NCT01908829|116129|P2|Overall Study|Withdrawal by Subject|29
24881|NCT01908829|116130|P1|Overall Study|Withdrawal by Subject|26
24882|NCT01908829|116128|P3|Overall Study|Lack of Efficacy|2
24883|NCT01908829|116129|P2|Overall Study|Lack of Efficacy|3
24884|NCT01908829|116130|P1|Overall Study|Lack of Efficacy|1
24885|NCT01908829|116128|P3|Overall Study|Protocol Violation|0
24886|NCT01908829|116129|P2|Overall Study|Protocol Violation|2
24887|NCT01908829|116130|P1|Overall Study|Protocol Violation|2
24888|NCT01908829|116128|P3|Overall Study|Miscellaneous|0
24889|NCT01908829|116129|P2|Overall Study|Miscellaneous|2
24890|NCT01908829|116130|P1|Overall Study|Miscellaneous|0
24891|NCT01908829|116128|P3|Overall Study|Discontinued (no EoT page)|0
24892|NCT01908829|116129|P2|Overall Study|Discontinued (no EoT page)|0
24893|NCT01908829|116130|P1|Overall Study|Discontinued (no EoT page)|2
24894|NCT01908829|116128|P3|Overall Study|Randomized no double-blind drug received|1
24895|NCT01908829|116129|P2|Overall Study|Randomized no double-blind drug received|0
24896|NCT01908829|116130|P1|Overall Study|Randomized no double-blind drug received|1
24897|NCT01908829|116128|P3|Overall Study|Lost to Follow-up|1
24898|NCT01908829|116129|P2|Overall Study|Lost to Follow-up|2
24899|NCT01908829|116130|P1|Overall Study|Lost to Follow-up|4
24900|NCT01908829|116128|P3|Overall Study|Adverse Event|13
24901|NCT01908829|116129|P2|Overall Study|Adverse Event|11
24902|NCT01908829|116130|P1|Overall Study|Adverse Event|13
24903|NCT01908803|116245|P2|Overall Study|Adverse Event (pre-treatment)|0
24904|NCT01908803|116246|P1|Overall Study|Adverse Event (pre-treatment)|1
24905|NCT01908803|116245|P2|Overall Study|Randomization Error|0
24906|NCT01908803|116246|P1|Overall Study|Randomization Error|1
24907|NCT01908803|116245|P2|Overall Study|Withdrawal by Subject|0
24908|NCT01908803|116246|P1|Overall Study|Withdrawal by Subject|1
24909|NCT01908803|116245|P2|Overall Study|Physician Decision|1
24910|NCT01908803|116246|P1|Overall Study|Physician Decision|0
24911|NCT01908803|116245|P2|Overall Study|Adverse Event|0
24912|NCT01908803|116246|P1|Overall Study|Adverse Event|1
24913|NCT01908140|116259|P2|Overall Study|Adverse Event|23
24914|NCT01908140|116260|P1|Overall Study|Adverse Event|22
24915|NCT01908140|116259|P2|Overall Study|Protocol Violation|9
24916|NCT01908140|116260|P1|Overall Study|Protocol Violation|8
24917|NCT01908140|116259|P2|Overall Study|Lost to Follow-up|6
24918|NCT01908140|116260|P1|Overall Study|Lost to Follow-up|1
24919|NCT01908140|116259|P2|Overall Study|Withdrawal by Subject|24
24920|NCT01908140|116260|P1|Overall Study|Withdrawal by Subject|23
24921|NCT01908140|116259|P2|Overall Study|Lack of Efficacy|5
24922|NCT01908140|116260|P1|Overall Study|Lack of Efficacy|7
24923|NCT01908140|116259|P2|Overall Study|Other or Progressive Disease|12
24924|NCT01908140|116260|P1|Overall Study|Other or Progressive Disease|5
24925|NCT01907906|116281|P2|Overall Study|Physician Decision|1
24926|NCT01907906|116282|P1|Overall Study|Physician Decision|3
24927|NCT01907906|116281|P2|Overall Study|Withdrawal by Subject|0
24928|NCT01907906|116282|P1|Overall Study|Withdrawal by Subject|1
24929|NCT01907854|116362|P2|Overall Study|Unclassified|3
24930|NCT01907854|116363|P1|Overall Study|Unclassified|4
24931|NCT01907854|116362|P2|Overall Study|Lost to Follow-up|2
24932|NCT01907854|116363|P1|Overall Study|Lost to Follow-up|2
24933|NCT01907854|116362|P2|Overall Study|Withdrawal by Subject|7
24934|NCT01907854|116363|P1|Overall Study|Withdrawal by Subject|9
24935|NCT01907854|116362|P2|Overall Study|Protocol Violation|1
24936|NCT01907854|116363|P1|Overall Study|Protocol Violation|1
24937|NCT01907815|116383|P2|Overall Study|Withdrawal by Subject|0
24938|NCT01907815|116384|P1|Overall Study|Withdrawal by Subject|1
24939|NCT01907516|116400|P2|First Intervention (3 Weeks)|Developed DKA during study|0
24940|NCT01907516|116401|P1|First Intervention (3 Weeks)|Developed DKA during study|1
24941|NCT01907516|116400|P2|First Intervention (3 Weeks)|Delivered before second arm|4
24942|NCT01907516|116401|P1|First Intervention (3 Weeks)|Delivered before second arm|3
24943|NCT01907516|116400|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
24944|NCT01907516|116401|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
24945|NCT01907516|116400|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
24946|NCT01907516|116401|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
24947|NCT01906372|116559|P1|Overall Study|Withdrawal by Subject|2
24948|NCT01905683|116589|P1|Overall Study|Lost to Follow-up|4
24949|NCT01905683|116589|P1|Overall Study|Adverse Event|4
24950|NCT01905683|116589|P1|Overall Study|Withdrawal by Subject|20
24951|NCT01905683|116589|P1|Overall Study|Lack of Efficacy|8
24952|NCT01905683|116589|P1|Overall Study|Physician Decision|1
24953|NCT01905683|116589|P1|Overall Study|Re-injection criteria not met; others|13
24954|NCT01905683|116589|P1|Overall Study|Protocol Violation|1
24955|NCT01905657|116605|P3|Overall Study|Excluded from Efficacy Analysis|0
24956|NCT01905657|116606|P2|Overall Study|Excluded from Efficacy Analysis|0
24957|NCT01905657|116607|P1|Overall Study|Excluded from Efficacy Analysis|1
24958|NCT01905657|116605|P3|Overall Study|Continuing in Study|11
24959|NCT01905657|116606|P2|Overall Study|Continuing in Study|74
24960|NCT01905657|116607|P1|Overall Study|Continuing in Study|74
24961|NCT01905657|116605|P3|Overall Study|Withdrawal by Subject|45
24962|NCT01905657|116606|P2|Overall Study|Withdrawal by Subject|10
24963|NCT01905657|116607|P1|Overall Study|Withdrawal by Subject|5
24964|NCT01905657|116605|P3|Overall Study|Protocol Violation|1
24965|NCT01905657|116606|P2|Overall Study|Protocol Violation|1
24966|NCT01905657|116607|P1|Overall Study|Protocol Violation|2
24967|NCT01905657|116605|P3|Overall Study|Progressive Disease|89
24968|NCT01905657|116606|P2|Overall Study|Progressive Disease|126
24969|NCT01905657|116607|P1|Overall Study|Progressive Disease|124
24970|NCT01905657|116605|P3|Overall Study|Physician Decision|113
24971|NCT01905657|116606|P2|Overall Study|Physician Decision|74
24972|NCT01905657|116607|P1|Overall Study|Physician Decision|82
24973|NCT01905657|116605|P3|Overall Study|Other|1
24974|NCT01905657|116606|P2|Overall Study|Other|7
24975|NCT01905657|116607|P1|Overall Study|Other|3
24976|NCT01905657|116605|P3|Overall Study|Death|21
24977|NCT01905657|116606|P2|Overall Study|Death|21
24978|NCT01905657|116607|P1|Overall Study|Death|21
24979|NCT01905657|116605|P3|Overall Study|Adverse Event|47
24980|NCT01905657|116606|P2|Overall Study|Adverse Event|32
24981|NCT01905657|116607|P1|Overall Study|Adverse Event|33
24982|NCT01905657|116605|P3|Overall Study|Not Treated|0
24983|NCT01905657|116606|P2|Overall Study|Not Treated|1
24984|NCT01905657|116607|P1|Overall Study|Not Treated|0
24985|NCT01905553|116632|P2|Period 2|Adverse Event|0
24986|NCT01905553|116633|P1|Period 2|Adverse Event|1
24987|NCT01905540|116647|P4|Period 3|Not specified|1
24988|NCT01905540|116648|P3|Period 3|Not specified|1
24989|NCT01905540|116649|P2|Period 3|Not specified|0
24990|NCT01905540|116650|P1|Period 3|Not specified|1
24991|NCT01904773|116696|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
24992|NCT01904773|116697|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
24993|NCT01904773|116698|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
24994|NCT01904773|116699|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
24995|NCT01904773|116700|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
24996|NCT01904773|116701|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
24997|NCT01904773|116702|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
24998|NCT01904773|116703|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
24999|NCT01904773|116704|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
25000|NCT01904773|116696|P9|Fifth Intervention|Adverse Event|0
25001|NCT01904773|116697|P8|Fifth Intervention|Adverse Event|1
25002|NCT01904773|116698|P7|Fifth Intervention|Adverse Event|0
25003|NCT01904773|116699|P6|Fifth Intervention|Adverse Event|0
25004|NCT01904773|116700|P5|Fifth Intervention|Adverse Event|0
25005|NCT01904773|116701|P4|Fifth Intervention|Adverse Event|0
25006|NCT01904773|116702|P3|Fifth Intervention|Adverse Event|0
25007|NCT01904773|116703|P2|Fifth Intervention|Adverse Event|0
25008|NCT01904773|116704|P1|Fifth Intervention|Adverse Event|0
25009|NCT01904773|116696|P9|Placebo Washout First Intervention|Condition worsened|0
25010|NCT01904773|116697|P8|Placebo Washout First Intervention|Condition worsened|0
25011|NCT01904773|116698|P7|Placebo Washout First Intervention|Condition worsened|0
25012|NCT01904773|116699|P6|Placebo Washout First Intervention|Condition worsened|0
25013|NCT01904773|116700|P5|Placebo Washout First Intervention|Condition worsened|0
25014|NCT01904773|116701|P4|Placebo Washout First Intervention|Condition worsened|0
25015|NCT01904773|116702|P3|Placebo Washout First Intervention|Condition worsened|0
25016|NCT01904773|116703|P2|Placebo Washout First Intervention|Condition worsened|1
25017|NCT01904773|116704|P1|Placebo Washout First Intervention|Condition worsened|0
25018|NCT01904773|116696|P9|First Intervention|Adverse Event|0
25019|NCT01904773|116697|P8|First Intervention|Adverse Event|0
25020|NCT01904773|116698|P7|First Intervention|Adverse Event|1
25021|NCT01904773|116699|P6|First Intervention|Adverse Event|0
25022|NCT01904773|116700|P5|First Intervention|Adverse Event|0
25023|NCT01904773|116701|P4|First Intervention|Adverse Event|0
25024|NCT01904773|116702|P3|First Intervention|Adverse Event|0
25025|NCT01904773|116703|P2|First Intervention|Adverse Event|0
25026|NCT01904773|116704|P1|First Intervention|Adverse Event|0
25027|NCT01904773|116696|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
25028|NCT01904773|116697|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
25029|NCT01904773|116698|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
25030|NCT01904773|116699|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
25031|NCT01904773|116700|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
25032|NCT01904773|116701|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
25033|NCT01904773|116702|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
25034|NCT01904773|116703|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
25035|NCT01904773|116704|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
25036|NCT01904773|116696|P9|Screen|Withdrawal by Subject|0
25037|NCT01904773|116697|P8|Screen|Withdrawal by Subject|0
25038|NCT01904773|116698|P7|Screen|Withdrawal by Subject|0
25039|NCT01904773|116699|P6|Screen|Withdrawal by Subject|0
25040|NCT01904773|116700|P5|Screen|Withdrawal by Subject|0
25041|NCT01904773|116701|P4|Screen|Withdrawal by Subject|0
25042|NCT01904773|116702|P3|Screen|Withdrawal by Subject|0
25043|NCT01904773|116703|P2|Screen|Withdrawal by Subject|0
25044|NCT01904773|116704|P1|Screen|Withdrawal by Subject|1
25045|NCT01904773|116696|P9|Screen|Screen failure|0
25046|NCT01904773|116697|P8|Screen|Screen failure|0
25047|NCT01904773|116698|P7|Screen|Screen failure|0
25048|NCT01904773|116699|P6|Screen|Screen failure|0
25049|NCT01904773|116700|P5|Screen|Screen failure|0
25050|NCT01904773|116701|P4|Screen|Screen failure|0
25051|NCT01904773|116702|P3|Screen|Screen failure|0
25052|NCT01904773|116703|P2|Screen|Screen failure|0
25053|NCT01904773|116704|P1|Screen|Screen failure|3
25054|NCT01904760|116721|P2|Overall Study|Protocol Violation|0
25055|NCT01904760|116722|P1|Overall Study|Protocol Violation|1
25056|NCT01904721|116737|P7|Overall Study|Adverse Event|0
25057|NCT01904721|116738|P6|Overall Study|Adverse Event|1
25058|NCT01904721|116739|P5|Overall Study|Adverse Event|3
25059|NCT01904721|116740|P4|Overall Study|Adverse Event|0
25060|NCT01904721|116741|P3|Overall Study|Adverse Event|0
25061|NCT01904721|116742|P2|Overall Study|Adverse Event|0
25062|NCT01904721|116743|P1|Overall Study|Adverse Event|0
25063|NCT01904721|116737|P7|Overall Study|Lack of Efficacy|1
25064|NCT01904721|116738|P6|Overall Study|Lack of Efficacy|0
25065|NCT01904721|116739|P5|Overall Study|Lack of Efficacy|0
25066|NCT01904721|116740|P4|Overall Study|Lack of Efficacy|0
25067|NCT01904721|116741|P3|Overall Study|Lack of Efficacy|0
25068|NCT01904721|116742|P2|Overall Study|Lack of Efficacy|0
25069|NCT01904721|116743|P1|Overall Study|Lack of Efficacy|0
25070|NCT01904721|116737|P7|Overall Study|Lost to Follow-up|1
25071|NCT01904721|116738|P6|Overall Study|Lost to Follow-up|3
25072|NCT01904721|116739|P5|Overall Study|Lost to Follow-up|1
25073|NCT01904721|116740|P4|Overall Study|Lost to Follow-up|0
25074|NCT01904721|116741|P3|Overall Study|Lost to Follow-up|0
25075|NCT01904721|116742|P2|Overall Study|Lost to Follow-up|0
25076|NCT01904721|116743|P1|Overall Study|Lost to Follow-up|0
25077|NCT01904721|116737|P7|Overall Study|Personal Reasons|3
25078|NCT01904721|116738|P6|Overall Study|Personal Reasons|3
25079|NCT01904721|116739|P5|Overall Study|Personal Reasons|2
25080|NCT01904721|116740|P4|Overall Study|Personal Reasons|0
25081|NCT01904721|116741|P3|Overall Study|Personal Reasons|0
25082|NCT01904721|116742|P2|Overall Study|Personal Reasons|0
25083|NCT01904721|116743|P1|Overall Study|Personal Reasons|0
25084|NCT01904721|116737|P7|Overall Study|Other Reasons|2
25085|NCT01904721|116738|P6|Overall Study|Other Reasons|2
25086|NCT01904721|116739|P5|Overall Study|Other Reasons|2
25087|NCT01904721|116740|P4|Overall Study|Other Reasons|1
25088|NCT01904721|116741|P3|Overall Study|Other Reasons|1
25089|NCT01904721|116742|P2|Overall Study|Other Reasons|0
25090|NCT01904721|116743|P1|Overall Study|Other Reasons|0
25091|NCT01904604|116773|P3|Overall Study|Unrelated illness|0
25092|NCT01904604|116774|P2|Overall Study|Unrelated illness|1
25093|NCT01904604|116775|P1|Overall Study|Unrelated illness|0
25094|NCT01904604|116773|P3|Overall Study|Increased syncope|0
25095|NCT01904604|116774|P2|Overall Study|Increased syncope|1
25096|NCT01904604|116775|P1|Overall Study|Increased syncope|0
25097|NCT01904604|116773|P3|Overall Study|Patch site reactions|0
25098|NCT01904604|116774|P2|Overall Study|Patch site reactions|1
25099|NCT01904604|116775|P1|Overall Study|Patch site reactions|0
25100|NCT01904604|116773|P3|Overall Study|Anxiety about OFC/Refused OFC|0
25101|NCT01904604|116774|P2|Overall Study|Anxiety about OFC/Refused OFC|0
25102|NCT01904604|116775|P1|Overall Study|Anxiety about OFC/Refused OFC|2
25103|NCT01904604|116773|P3|Overall Study|Non-compliance|0
25104|NCT01904604|116774|P2|Overall Study|Non-compliance|0
25105|NCT01904604|116775|P1|Overall Study|Non-compliance|1
25106|NCT01904604|116773|P3|Overall Study|Withdrew before receiving dosing|0
25107|NCT01904604|116774|P2|Overall Study|Withdrew before receiving dosing|1
25108|NCT01904604|116775|P1|Overall Study|Withdrew before receiving dosing|0
25109|NCT01904279|116807|P2|Overall Study|Withdrawal by Subject|0
25110|NCT01904279|116808|P1|Overall Study|Withdrawal by Subject|1
25111|NCT01904279|116807|P2|Overall Study|Lack of Efficacy|3
25112|NCT01904279|116808|P1|Overall Study|Lack of Efficacy|2
25113|NCT01904149|116834|P6|Overall Study|non compliance with study drug|0
25114|NCT01904149|116835|P5|Overall Study|non compliance with study drug|0
25115|NCT01904149|116836|P4|Overall Study|non compliance with study drug|0
25116|NCT01904149|116837|P3|Overall Study|non compliance with study drug|0
25117|NCT01904149|116838|P2|Overall Study|non compliance with study drug|0
25118|NCT01904149|116839|P1|Overall Study|non compliance with study drug|1
25119|NCT01904149|116834|P6|Overall Study|Protocol Violation|0
25120|NCT01904149|116835|P5|Overall Study|Protocol Violation|0
25121|NCT01904149|116836|P4|Overall Study|Protocol Violation|0
25122|NCT01904149|116837|P3|Overall Study|Protocol Violation|0
25123|NCT01904149|116838|P2|Overall Study|Protocol Violation|1
25124|NCT01904149|116839|P1|Overall Study|Protocol Violation|0
25125|NCT01904149|116834|P6|Overall Study|Withdrawal by Subject|0
25126|NCT01904149|116835|P5|Overall Study|Withdrawal by Subject|1
25127|NCT01904149|116836|P4|Overall Study|Withdrawal by Subject|0
25128|NCT01904149|116837|P3|Overall Study|Withdrawal by Subject|1
25129|NCT01904149|116838|P2|Overall Study|Withdrawal by Subject|3
25130|NCT01904149|116839|P1|Overall Study|Withdrawal by Subject|1
25131|NCT01904149|116834|P6|Overall Study|Lack of Efficacy|1
25132|NCT01904149|116835|P5|Overall Study|Lack of Efficacy|3
25133|NCT01904149|116836|P4|Overall Study|Lack of Efficacy|3
25134|NCT01904149|116837|P3|Overall Study|Lack of Efficacy|1
25135|NCT01904149|116838|P2|Overall Study|Lack of Efficacy|3
25136|NCT01904149|116839|P1|Overall Study|Lack of Efficacy|0
25137|NCT01904149|116834|P6|Overall Study|Adverse Event|2
25138|NCT01904149|116835|P5|Overall Study|Adverse Event|1
25139|NCT01904149|116836|P4|Overall Study|Adverse Event|1
25140|NCT01904149|116837|P3|Overall Study|Adverse Event|0
25141|NCT01904149|116838|P2|Overall Study|Adverse Event|4
25142|NCT01904149|116839|P1|Overall Study|Adverse Event|3
25143|NCT01904058|116890|P4|Overall Study|Pregnancy|1
25144|NCT01904058|116891|P3|Overall Study|Pregnancy|0
25145|NCT01904058|116892|P2|Overall Study|Pregnancy|0
25146|NCT01904058|116893|P1|Overall Study|Pregnancy|0
25147|NCT01904058|116890|P4|Overall Study|Withdrawal by Subject|0
25148|NCT01904058|116891|P3|Overall Study|Withdrawal by Subject|1
25149|NCT01904058|116892|P2|Overall Study|Withdrawal by Subject|0
25150|NCT01904058|116893|P1|Overall Study|Withdrawal by Subject|1
25151|NCT01904058|116890|P4|Overall Study|Adverse Event|0
25152|NCT01904058|116891|P3|Overall Study|Adverse Event|0
25153|NCT01904058|116892|P2|Overall Study|Adverse Event|0
25154|NCT01904058|116893|P1|Overall Study|Adverse Event|2
25155|NCT01903993|116933|P2|Overall Study|Lost to Follow-up|1
25156|NCT01903993|116934|P1|Overall Study|Lost to Follow-up|2
25157|NCT01903993|116933|P2|Overall Study|Withdrawal by Subject|5
25158|NCT01903993|116934|P1|Overall Study|Withdrawal by Subject|13
25159|NCT01903993|116933|P2|Overall Study|Death|89
25160|NCT01903993|116934|P1|Overall Study|Death|108
25161|NCT01903876|116951|P2|Six-Month Follow-up Period|Lost to Follow-up|145
25162|NCT01903876|116952|P1|Six-Month Follow-up Period|Lost to Follow-up|91
25163|NCT01903876|116951|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
25164|NCT01903876|116952|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
25165|NCT01903863|116962|P2|Overall Study|Physician Decision|0
25166|NCT01903863|116963|P1|Overall Study|Physician Decision|2
25167|NCT01903720|116983|P1|Overall Study|Treatment with alternative drug|1
25168|NCT01903720|116983|P1|Overall Study|Lost to Follow-up|2
25169|NCT01903720|116983|P1|Overall Study|Rescinding of informed consent|2
25170|NCT01903720|116983|P1|Overall Study|Adverse Event|1
25171|NCT01903720|116983|P1|Overall Study|Inclusion / exclusion criteria not met|6
25172|NCT01903460|117021|P4|Overall Study|Adverse Event|1
25173|NCT01903460|117022|P3|Overall Study|Adverse Event|0
25174|NCT01903460|117023|P2|Overall Study|Adverse Event|0
25175|NCT01903460|117024|P1|Overall Study|Adverse Event|0
25176|NCT01903031|117094|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
25177|NCT01903031|117095|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
25178|NCT01903031|117096|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
25179|NCT01903031|117094|P3|Overall Study|Lost to Follow-up|1
25180|NCT01903031|117095|P2|Overall Study|Lost to Follow-up|0
25181|NCT01903031|117096|P1|Overall Study|Lost to Follow-up|0
25182|NCT01903031|117094|P3|Overall Study|Protocol Violation|2
25183|NCT01903031|117095|P2|Overall Study|Protocol Violation|0
25184|NCT01903031|117096|P1|Overall Study|Protocol Violation|0
25185|NCT01903031|117094|P3|Overall Study|Withdrawal by Subject|1
25186|NCT01903031|117095|P2|Overall Study|Withdrawal by Subject|1
25187|NCT01903031|117096|P1|Overall Study|Withdrawal by Subject|0
25188|NCT01903031|117094|P3|Overall Study|Adverse Event|0
25189|NCT01903031|117095|P2|Overall Study|Adverse Event|1
25190|NCT01903031|117096|P1|Overall Study|Adverse Event|0
25191|NCT01903031|117094|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
25192|NCT01903031|117095|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
25193|NCT01903031|117096|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
25194|NCT01903031|117094|P3|Overall Study|Not Able to Attend Clinic|0
25195|NCT01903031|117095|P2|Overall Study|Not Able to Attend Clinic|1
25196|NCT01903031|117096|P1|Overall Study|Not Able to Attend Clinic|1
25197|NCT01902888|117138|P1|Overall Study|Study Terminated|3
25198|NCT01902303|117173|P2|Overall Study|Did not develop a cold sore|19
25199|NCT01902303|117174|P1|Overall Study|Did not develop a cold sore|21
25200|NCT01902303|117173|P2|Overall Study|subject lost investigational product|1
25201|NCT01902303|117174|P1|Overall Study|subject lost investigational product|0
25202|NCT01902303|117173|P2|Overall Study|Protocol Violation|2
25203|NCT01902303|117174|P1|Overall Study|Protocol Violation|2
25204|NCT01902303|117173|P2|Overall Study|Lost to Follow-up|1
25205|NCT01902303|117174|P1|Overall Study|Lost to Follow-up|0
25206|NCT01902303|117173|P2|Overall Study|Adverse Event|1
25207|NCT01902303|117174|P1|Overall Study|Adverse Event|0
25208|NCT01902134|117188|P6|Overall Study|not specified|0
25209|NCT01902134|117189|P5|Overall Study|not specified|1
25210|NCT01902134|117190|P4|Overall Study|not specified|0
25211|NCT01902134|117191|P3|Overall Study|not specified|2
25212|NCT01902134|117192|P2|Overall Study|not specified|1
25213|NCT01902134|117193|P1|Overall Study|not specified|0
25214|NCT01902134|117188|P6|Overall Study|no compliance|0
25215|NCT01902134|117189|P5|Overall Study|no compliance|0
25216|NCT01902134|117190|P4|Overall Study|no compliance|0
25217|NCT01902134|117191|P3|Overall Study|no compliance|0
25218|NCT01902134|117192|P2|Overall Study|no compliance|0
25219|NCT01902134|117193|P1|Overall Study|no compliance|1
25220|NCT01902134|117188|P6|Overall Study|Withdrawal by Subject|4
25221|NCT01902134|117189|P5|Overall Study|Withdrawal by Subject|5
25222|NCT01902134|117190|P4|Overall Study|Withdrawal by Subject|1
25223|NCT01902134|117191|P3|Overall Study|Withdrawal by Subject|9
25224|NCT01902134|117192|P2|Overall Study|Withdrawal by Subject|8
25225|NCT01902134|117193|P1|Overall Study|Withdrawal by Subject|4
25226|NCT01902134|117188|P6|Overall Study|Protocol Violation|1
25227|NCT01902134|117189|P5|Overall Study|Protocol Violation|0
25228|NCT01902134|117190|P4|Overall Study|Protocol Violation|0
25229|NCT01902134|117191|P3|Overall Study|Protocol Violation|0
25230|NCT01902134|117192|P2|Overall Study|Protocol Violation|0
25231|NCT01902134|117193|P1|Overall Study|Protocol Violation|0
25232|NCT01902134|117188|P6|Overall Study|Physician Decision|0
25233|NCT01902134|117189|P5|Overall Study|Physician Decision|0
25234|NCT01902134|117190|P4|Overall Study|Physician Decision|0
25235|NCT01902134|117191|P3|Overall Study|Physician Decision|0
25236|NCT01902134|117192|P2|Overall Study|Physician Decision|1
25237|NCT01902134|117193|P1|Overall Study|Physician Decision|0
25238|NCT01902134|117188|P6|Overall Study|Lack of Efficacy|1
25239|NCT01902134|117189|P5|Overall Study|Lack of Efficacy|0
25240|NCT01902134|117190|P4|Overall Study|Lack of Efficacy|0
25241|NCT01902134|117191|P3|Overall Study|Lack of Efficacy|2
25242|NCT01902134|117192|P2|Overall Study|Lack of Efficacy|0
25243|NCT01902134|117193|P1|Overall Study|Lack of Efficacy|0
25244|NCT01902134|117188|P6|Overall Study|Adverse Event|3
25245|NCT01902134|117189|P5|Overall Study|Adverse Event|1
25246|NCT01902134|117190|P4|Overall Study|Adverse Event|1
25247|NCT01902134|117191|P3|Overall Study|Adverse Event|2
25248|NCT01902134|117192|P2|Overall Study|Adverse Event|1
25249|NCT01902134|117193|P1|Overall Study|Adverse Event|3
25250|NCT01901393|117262|P2|Overall Study|Adverse Event|0
25251|NCT01901393|117263|P1|Overall Study|Adverse Event|1
25252|NCT01901341|117281|P2|Overall Study|Withdrawal by Subject|1
25253|NCT01901341|117282|P1|Overall Study|Withdrawal by Subject|1
25254|NCT01901341|117281|P2|Overall Study|Study Terminated by Sponsor|15
25255|NCT01901341|117282|P1|Overall Study|Study Terminated by Sponsor|13
25256|NCT01901341|117281|P2|Overall Study|Protocol Violation|0
25257|NCT01901341|117282|P1|Overall Study|Protocol Violation|2
25258|NCT01901341|117281|P2|Overall Study|Lost to Follow-up|1
25259|NCT01901341|117282|P1|Overall Study|Lost to Follow-up|0
25260|NCT01901341|117281|P2|Overall Study|Lack of Efficacy|2
25261|NCT01901341|117282|P1|Overall Study|Lack of Efficacy|0
25262|NCT01901341|117281|P2|Overall Study|Adverse Event|2
25263|NCT01901341|117282|P1|Overall Study|Adverse Event|4
25264|NCT01901328|117296|P2|Overall Study|Lack of Efficacy|1
25265|NCT01901328|117297|P1|Overall Study|Lack of Efficacy|0
25266|NCT01901328|117296|P2|Overall Study|Withdrawal by Subject|2
25267|NCT01901328|117297|P1|Overall Study|Withdrawal by Subject|1
25268|NCT01901328|117296|P2|Overall Study|Study Terminated by Sponsor|16
25269|NCT01901328|117297|P1|Overall Study|Study Terminated by Sponsor|19
25270|NCT01901328|117296|P2|Overall Study|Protocol Violation|1
25271|NCT01901328|117297|P1|Overall Study|Protocol Violation|1
25272|NCT01901328|117296|P2|Overall Study|Physician Decision|1
25273|NCT01901328|117297|P1|Overall Study|Physician Decision|0
25274|NCT01901328|117296|P2|Overall Study|Lost to Follow-up|0
25275|NCT01901328|117297|P1|Overall Study|Lost to Follow-up|1
25276|NCT01901302|117311|P2|Overall Study|Withdrawal by Subject|0
25277|NCT01901302|117312|P1|Overall Study|Withdrawal by Subject|2
25278|NCT01901302|117311|P2|Overall Study|Study Terminated by Sponsor|20
25279|NCT01901302|117312|P1|Overall Study|Study Terminated by Sponsor|23
25280|NCT01901302|117311|P2|Overall Study|Lack of Efficacy|2
25281|NCT01901302|117312|P1|Overall Study|Lack of Efficacy|0
25282|NCT01901302|117311|P2|Overall Study|Adverse Event|1
25283|NCT01901302|117312|P1|Overall Study|Adverse Event|2
25284|NCT01901185|117359|P1|Overall Study|Withdrawal by Subject|2
25285|NCT01900665|117368|P2|Open Label Period|Withdrawal by Subject|28
25286|NCT01900665|117369|P1|Open Label Period|Withdrawal by Subject|20
25287|NCT01900665|117368|P2|Open Label Period|Sponsor Decision|765
25288|NCT01900665|117369|P1|Open Label Period|Sponsor Decision|802
25289|NCT01900665|117368|P2|Open Label Period|Protocol Violation|1
25290|NCT01900665|117369|P1|Open Label Period|Protocol Violation|0
25291|NCT01900665|117368|P2|Open Label Period|Physician Decision|4
25292|NCT01900665|117369|P1|Open Label Period|Physician Decision|4
25293|NCT01900665|117368|P2|Open Label Period|Parent/Caregiver Decision|34
25294|NCT01900665|117369|P1|Open Label Period|Parent/Caregiver Decision|33
25295|NCT01900665|117368|P2|Open Label Period|Lost to Follow-up|1
25296|NCT01900665|117369|P1|Open Label Period|Lost to Follow-up|1
25297|NCT01900665|117368|P2|Open Label Period|Death|6
25298|NCT01900665|117369|P1|Open Label Period|Death|5
25299|NCT01900665|117368|P2|Open Label Period|Adverse Event|20
25300|NCT01900665|117369|P1|Open Label Period|Adverse Event|16
25301|NCT01900665|117368|P2|Placebo Controlled Period|Entry Criteria Not Met|9
25302|NCT01900665|117369|P1|Placebo Controlled Period|Entry Criteria Not Met|5
25303|NCT01900665|117368|P2|Placebo Controlled Period|Caregiver Decision|41
25304|NCT01900665|117369|P1|Placebo Controlled Period|Caregiver Decision|33
25305|NCT01900665|117368|P2|Placebo Controlled Period|Lost to Follow-up|0
25306|NCT01900665|117369|P1|Placebo Controlled Period|Lost to Follow-up|3
25307|NCT01900665|117368|P2|Placebo Controlled Period|Physician Decision|7
25308|NCT01900665|117369|P1|Placebo Controlled Period|Physician Decision|11
25309|NCT01900665|117368|P2|Placebo Controlled Period|Withdrawal by Subject|45
25310|NCT01900665|117369|P1|Placebo Controlled Period|Withdrawal by Subject|33
25311|NCT01900665|117368|P2|Placebo Controlled Period|Protocol Violation|7
25312|NCT01900665|117369|P1|Placebo Controlled Period|Protocol Violation|1
25313|NCT01900665|117368|P2|Placebo Controlled Period|Adverse Event|39
25314|NCT01900665|117369|P1|Placebo Controlled Period|Adverse Event|48
25315|NCT01900665|117368|P2|Placebo Controlled Period|Death|16
25316|NCT01900665|117369|P1|Placebo Controlled Period|Death|9
25317|NCT01900444|117410|P1|Overall Study|Lost to Follow-up|1
25318|NCT01900444|117410|P1|Overall Study|Protocol Violation|2
25319|NCT01900431|117423|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
25320|NCT01900431|117424|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
25321|NCT01900431|117425|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
25322|NCT01900431|117423|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
25323|NCT01900431|117424|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
25324|NCT01900431|117425|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
25325|NCT01900431|117423|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
25326|NCT01900431|117424|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
25327|NCT01900431|117425|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
25328|NCT01900431|117423|P3|Extended Treatment Period (Part B)|Other than specified above|0
25329|NCT01900431|117424|P2|Extended Treatment Period (Part B)|Other than specified above|1
25330|NCT01900431|117425|P1|Extended Treatment Period (Part B)|Other than specified above|0
25331|NCT01900431|117423|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
25332|NCT01900431|117424|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
25333|NCT01900431|117425|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
25334|NCT01900431|117423|P3|Extended Treatment Period (Part B)|Adverse Event|0
25335|NCT01900431|117424|P2|Extended Treatment Period (Part B)|Adverse Event|2
25336|NCT01900431|117425|P1|Extended Treatment Period (Part B)|Adverse Event|0
25337|NCT01900431|117423|P3|Principal Treatment Period (Part A)|Other than specified above|0
25338|NCT01900431|117424|P2|Principal Treatment Period (Part A)|Other than specified above|1
25339|NCT01900431|117425|P1|Principal Treatment Period (Part A)|Other than specified above|0
25340|NCT01900431|117423|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
25341|NCT01900431|117424|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
25342|NCT01900431|117425|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
25343|NCT01900431|117423|P3|Principal Treatment Period (Part A)|Adverse Event|0
25344|NCT01900431|117424|P2|Principal Treatment Period (Part A)|Adverse Event|3
25345|NCT01900431|117425|P1|Principal Treatment Period (Part A)|Adverse Event|1
25346|NCT01900314|117451|P2|Overall Study|Withdrawal by Subject|3
25347|NCT01900314|117452|P1|Overall Study|Withdrawal by Subject|3
25348|NCT01900314|117451|P2|Overall Study|Protocol Violation|1
25349|NCT01900314|117452|P1|Overall Study|Protocol Violation|0
25350|NCT01900314|117451|P2|Overall Study|Lost to Follow-up|0
25351|NCT01900314|117452|P1|Overall Study|Lost to Follow-up|1
25352|NCT01900054|117482|P1|Overall Study|Withdrawal by Subject|1
25353|NCT01900054|117482|P1|Overall Study|Physician Decision|1
25354|NCT01899768|117491|P1|Part B|Withdrawal by Subject|1
25355|NCT01899768|117491|P1|Part B|Adverse Event|1
25356|NCT01899768|117491|P1|Part A|Withdrawal by Subject|1
25357|NCT01899768|117491|P1|Part A|Adverse Event|2
25358|NCT01899742|117565|P2|Overall Study|Withdrawal by Subject|5
25359|NCT01899742|117566|P1|Overall Study|Withdrawal by Subject|9
25360|NCT01899742|117565|P2|Overall Study|Protocol Violation|2
25361|NCT01899742|117566|P1|Overall Study|Protocol Violation|2
25362|NCT01899742|117565|P2|Overall Study|Lack of Efficacy|5
25363|NCT01899742|117566|P1|Overall Study|Lack of Efficacy|1
25364|NCT01899742|117565|P2|Overall Study|Adverse Event|4
25365|NCT01899742|117566|P1|Overall Study|Adverse Event|5
25366|NCT01899144|117605|P1|Treatment Period 5|Not specified|1
25367|NCT01899144|117605|P1|Treatment Period 3|Not specified|2
25368|NCT01899144|117605|P1|Treatment Period 2|Not specified|1
25369|NCT01898884|117632|P9|Multiple Dose Period|Randomized Not Treated|1
25370|NCT01898884|117633|P8|Multiple Dose Period|Randomized Not Treated|0
25371|NCT01898884|117634|P7|Multiple Dose Period|Randomized Not Treated|0
25372|NCT01898884|117635|P6|Multiple Dose Period|Randomized Not Treated|0
25373|NCT01898884|117636|P5|Multiple Dose Period|Randomized Not Treated|0
25374|NCT01898884|117637|P4|Multiple Dose Period|Randomized Not Treated|0
25375|NCT01898884|117638|P3|Multiple Dose Period|Randomized Not Treated|0
25376|NCT01898884|117639|P2|Multiple Dose Period|Randomized Not Treated|0
25377|NCT01898884|117640|P1|Multiple Dose Period|Randomized Not Treated|0
25378|NCT01898884|117632|P9|Multiple Dose Period|Adverse Event|0
25379|NCT01898884|117633|P8|Multiple Dose Period|Adverse Event|0
25380|NCT01898884|117634|P7|Multiple Dose Period|Adverse Event|1
25381|NCT01898884|117635|P6|Multiple Dose Period|Adverse Event|0
25382|NCT01898884|117636|P5|Multiple Dose Period|Adverse Event|0
25383|NCT01898884|117637|P4|Multiple Dose Period|Adverse Event|0
25384|NCT01898884|117638|P3|Multiple Dose Period|Adverse Event|0
25385|NCT01898884|117639|P2|Multiple Dose Period|Adverse Event|0
25386|NCT01898884|117640|P1|Multiple Dose Period|Adverse Event|0
25387|NCT01898598|117792|P2|Overall Study|Other|1
25388|NCT01898598|117793|P1|Overall Study|Other|0
25389|NCT01898598|117792|P2|Overall Study|Lost to Follow-up|1
25390|NCT01898598|117793|P1|Overall Study|Lost to Follow-up|0
25391|NCT01898598|117792|P2|Overall Study|Withdrawal by Subject|0
25392|NCT01898598|117793|P1|Overall Study|Withdrawal by Subject|3
25393|NCT01898598|117792|P2|Overall Study|Adverse Event|0
25394|NCT01898598|117793|P1|Overall Study|Adverse Event|1
25395|NCT01898442|117812|P3|Overall Study|Patient vomited pills|1
25396|NCT01898442|117813|P2|Overall Study|Patient vomited pills|0
25397|NCT01898442|117814|P1|Overall Study|Patient vomited pills|0
25398|NCT01898442|117812|P3|Overall Study|Hemolysis/technical problems|2
25399|NCT01898442|117813|P2|Overall Study|Hemolysis/technical problems|2
25400|NCT01898442|117814|P1|Overall Study|Hemolysis/technical problems|1
25401|NCT01898286|117843|P1|Overall Study|Lost to Follow-up|1
25402|NCT01898286|117843|P1|Overall Study|Protocol Violation|1
25403|NCT01898286|117843|P1|Overall Study|Withdrawal by Subject|1
25404|NCT01898208|117853|P3|Overall Study|Lost to Follow-up|1
25405|NCT01898208|117854|P2|Overall Study|Lost to Follow-up|1
25406|NCT01898208|117855|P1|Overall Study|Lost to Follow-up|3
25407|NCT01898208|117853|P3|Overall Study|System/Technical Error|3
25408|NCT01898208|117854|P2|Overall Study|System/Technical Error|2
25409|NCT01898208|117855|P1|Overall Study|System/Technical Error|1
25410|NCT01898208|117853|P3|Overall Study|Non-Blood Specimens in Bottles|4
25411|NCT01898208|117854|P2|Overall Study|Non-Blood Specimens in Bottles|5
25412|NCT01898208|117855|P1|Overall Study|Non-Blood Specimens in Bottles|3
25413|NCT01898208|117853|P3|Overall Study|Negative Gram Stain|6
25414|NCT01898208|117854|P2|Overall Study|Negative Gram Stain|9
25415|NCT01898208|117855|P1|Overall Study|Negative Gram Stain|6
25416|NCT01898208|117853|P3|Overall Study|Death/comfort care within 24 hours|8
25417|NCT01898208|117854|P2|Overall Study|Death/comfort care within 24 hours|9
25418|NCT01898208|117855|P1|Overall Study|Death/comfort care within 24 hours|10
25419|NCT01898208|117853|P3|Overall Study|Positive blood culture|15
25420|NCT01898208|117854|P2|Overall Study|Positive blood culture|23
25421|NCT01898208|117855|P1|Overall Study|Positive blood culture|17
25422|NCT01898195|117902|P3|Smoking Abstinence|Did not have good measurements|36
25423|NCT01898195|117903|P2|Smoking Abstinence|Did not have good measurements|38
25424|NCT01898195|117904|P1|Smoking Abstinence|Did not have good measurements|35
25425|NCT01898091|117917|P2|Overall Study|Withdrawal by Subject|5
25426|NCT01898091|117918|P1|Overall Study|Withdrawal by Subject|1
25427|NCT01898091|117917|P2|Overall Study|Lost to Follow-up|1
25428|NCT01898091|117918|P1|Overall Study|Lost to Follow-up|1
25429|NCT01897727|117953|P2|Overall Study|Exclusion: central sleep apnea|1
25430|NCT01897727|117954|P1|Overall Study|Exclusion: central sleep apnea|0
25431|NCT01897233|117983|P1|Part B (24 Weeks)|Physician Decision|1
25432|NCT01897233|117983|P1|Part B (24 Weeks)|Withdrawal by Subject|2
25433|NCT01897233|117983|P1|Part B (24 Weeks)|Adverse Event|1
25434|NCT01896986|118016|P2|Overall Study|samples lost|23
25435|NCT01896986|118017|P1|Overall Study|samples lost|14
25436|NCT01896934|118023|P1|Overall Study|Withdrawal by Subject|1
25437|NCT01896934|118023|P1|Overall Study|Adverse Event|1
25438|NCT01896895|118032|P4|Double-blind MP|Lost to Follow-up|0
25439|NCT01896895|118033|P3|Double-blind MP|Lost to Follow-up|1
25440|NCT01896895|118034|P2|Double-blind MP|Lost to Follow-up|0
25441|NCT01896895|118035|P1|Double-blind MP|Lost to Follow-up|1
25442|NCT01896895|118032|P4|Double-blind MP|Withdrawal by Subject|0
25443|NCT01896895|118033|P3|Double-blind MP|Withdrawal by Subject|1
25444|NCT01896895|118034|P2|Double-blind MP|Withdrawal by Subject|2
25445|NCT01896895|118035|P1|Double-blind MP|Withdrawal by Subject|0
25446|NCT01896895|118032|P4|Double-blind MP|Physician Decision|0
25447|NCT01896895|118033|P3|Double-blind MP|Physician Decision|1
25448|NCT01896895|118034|P2|Double-blind MP|Physician Decision|0
25449|NCT01896895|118035|P1|Double-blind MP|Physician Decision|0
25450|NCT01896726|118050|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
25451|NCT01896726|118050|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
25452|NCT01896700|118065|P2|Overall Study|Withdrawal by Subject|1
25453|NCT01896700|118066|P1|Overall Study|Withdrawal by Subject|0
25454|NCT01896700|118065|P2|Overall Study|Adverse Event|5
25455|NCT01896700|118066|P1|Overall Study|Adverse Event|4
25456|NCT01896557|118097|P2|Clopidogrel + GI Protector|Reading error|3
25457|NCT01896557|118098|P1|Clopidogrel + GI Protector|Reading error|1
25458|NCT01896557|118097|P2|Clopidogrel + GI Protector|low adherence|1
25459|NCT01896557|118098|P1|Clopidogrel + GI Protector|low adherence|1
25460|NCT01896557|118097|P2|Clopidogrel Alone|Adverse Event|0
25461|NCT01896557|118098|P1|Clopidogrel Alone|Adverse Event|1
25462|NCT01896297|118131|P1|Overall Study|Died in post treatment phase|1
25463|NCT01896232|118138|P2|Overall Study|Lost to Follow-up|12
25464|NCT01896232|118139|P1|Overall Study|Lost to Follow-up|9
25465|NCT01896232|118138|P2|Overall Study|Sponsor Decision|0
25466|NCT01896232|118139|P1|Overall Study|Sponsor Decision|2
25467|NCT01896232|118138|P2|Overall Study|Withdrawal by Subject|31
25468|NCT01896232|118139|P1|Overall Study|Withdrawal by Subject|32
25469|NCT01896232|118138|P2|Overall Study|Death|10
25470|NCT01896232|118139|P1|Overall Study|Death|6
25471|NCT01896193|118167|P2|Overall Study|Withdrew Consent|0
25472|NCT01896193|118168|P1|Overall Study|Withdrew Consent|1
25473|NCT01896193|118167|P2|Overall Study|Protocol Violation|1
25474|NCT01896193|118168|P1|Overall Study|Protocol Violation|0
25475|NCT01896193|118167|P2|Overall Study|Lack of Efficacy|11
25476|NCT01896193|118168|P1|Overall Study|Lack of Efficacy|20
25477|NCT01896050|118220|P2|Overall Study|Death|0
25478|NCT01896050|118221|P1|Overall Study|Death|1
25479|NCT01896050|118220|P2|Overall Study|Adverse Event|2
25480|NCT01896050|118221|P1|Overall Study|Adverse Event|37
25481|NCT01895608|118264|P4|Overall Study|Withdrawal by Subject|0
25482|NCT01895608|118265|P3|Overall Study|Withdrawal by Subject|2
25483|NCT01895608|118266|P2|Overall Study|Withdrawal by Subject|0
25484|NCT01895608|118267|P1|Overall Study|Withdrawal by Subject|0
25485|NCT01895608|118264|P4|Overall Study|change in health status|0
25486|NCT01895608|118265|P3|Overall Study|change in health status|1
25487|NCT01895608|118266|P2|Overall Study|change in health status|1
25488|NCT01895608|118267|P1|Overall Study|change in health status|0
25489|NCT01895543|118297|P1|Overall Study|Other (Not fulfilling above criteria)|24
25490|NCT01895543|118297|P1|Overall Study|Physician Decision|2
25491|NCT01895543|118297|P1|Overall Study|Protocol Violation|1
25492|NCT01895543|118297|P1|Overall Study|Subject's substantial non-compliance|6
25493|NCT01895543|118297|P1|Overall Study|Adverse Event|28
25494|NCT01895543|118297|P1|Overall Study|Lost to Follow-up|25
25495|NCT01895543|118297|P1|Overall Study|Withdrawal by Subject|43
25496|NCT01895452|118313|P2|Overall Study|Noncompliance with study drug|1
25497|NCT01895452|118314|P1|Overall Study|Noncompliance with study drug|0
25498|NCT01895452|118313|P2|Overall Study|Underlying disease|3
25499|NCT01895452|118314|P1|Overall Study|Underlying disease|0
25500|NCT01895452|118313|P2|Overall Study|Withdrawal by Subject|14
25501|NCT01895452|118314|P1|Overall Study|Withdrawal by Subject|2
25502|NCT01895452|118313|P2|Overall Study|Pregnancy|1
25503|NCT01895452|118314|P1|Overall Study|Pregnancy|0
25504|NCT01895452|118313|P2|Overall Study|Lost to Follow-up|5
25505|NCT01895452|118314|P1|Overall Study|Lost to Follow-up|1
25506|NCT01895452|118313|P2|Overall Study|Adverse Event|4
25507|NCT01895452|118314|P1|Overall Study|Adverse Event|1
25508|NCT01895335|118324|P1|Overall Study|Other than Specified Above|44
25509|NCT01895335|118324|P1|Overall Study|Included But Not treated|1
25510|NCT01895335|118324|P1|Overall Study|Poor Compliance to Protocol|11
25511|NCT01895335|118324|P1|Overall Study|Lack of Efficacy|53
25512|NCT01895335|118324|P1|Overall Study|Adverse Event|106
25513|NCT01895322|118341|P1|Overall Study|Protocol Violation|10
25514|NCT01895322|118341|P1|Overall Study|Withdrawal by Subject|2
25515|NCT01895322|118341|P1|Overall Study|Adverse Event|1
25516|NCT01895309|118350|P2|Overall Study|Withdrawal by Subject|18
25517|NCT01895309|118351|P1|Overall Study|Withdrawal by Subject|9
25518|NCT01895309|118350|P2|Overall Study|Physician Decision|10
25519|NCT01895309|118351|P1|Overall Study|Physician Decision|15
25520|NCT01895309|118350|P2|Overall Study|Lost to Follow-up|3
25521|NCT01895309|118351|P1|Overall Study|Lost to Follow-up|1
25522|NCT01895309|118350|P2|Overall Study|Lack of Efficacy|3
25523|NCT01895309|118351|P1|Overall Study|Lack of Efficacy|1
25524|NCT01895309|118350|P2|Overall Study|Protocol Violation|0
25525|NCT01895309|118351|P1|Overall Study|Protocol Violation|1
25526|NCT01895309|118350|P2|Overall Study|Adverse Event|17
25527|NCT01895309|118351|P1|Overall Study|Adverse Event|13
25528|NCT01895270|118365|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
25529|NCT01895270|118366|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
25530|NCT01895270|118365|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
25531|NCT01895270|118366|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
25532|NCT01895270|118365|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
25533|NCT01895270|118366|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
25534|NCT01895270|118365|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
25535|NCT01895270|118366|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
25536|NCT01895270|118365|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
25537|NCT01895270|118366|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
25538|NCT01895270|118365|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
25539|NCT01895270|118366|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
25540|NCT01895270|118365|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
25541|NCT01895270|118366|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
25542|NCT01895101|118385|P3|Overall Study|coagulation disorder|0
25543|NCT01895101|118386|P2|Overall Study|coagulation disorder|1
25544|NCT01895101|118387|P1|Overall Study|coagulation disorder|0
25545|NCT01895101|118385|P3|Overall Study|Death|0
25546|NCT01895101|118386|P2|Overall Study|Death|1
25547|NCT01895101|118387|P1|Overall Study|Death|0
25548|NCT01895101|118385|P3|Overall Study|another study, enrolled in other study|0
25549|NCT01895101|118386|P2|Overall Study|another study, enrolled in other study|1
25550|NCT01895101|118387|P1|Overall Study|another study, enrolled in other study|0
25551|NCT01895101|118385|P3|Overall Study|Withdrawal by Subject|2
25552|NCT01895101|118386|P2|Overall Study|Withdrawal by Subject|1
25553|NCT01895101|118387|P1|Overall Study|Withdrawal by Subject|0
25554|NCT01895101|118385|P3|Overall Study|OPCAB procedure|3
25555|NCT01895101|118386|P2|Overall Study|OPCAB procedure|1
25556|NCT01895101|118387|P1|Overall Study|OPCAB procedure|1
25557|NCT01894984|118422|P2|Overall Study|Other|175
25558|NCT01894984|118423|P1|Overall Study|Other|314
25559|NCT01894620|118480|P2|Overall Study|Withdrawal by Subject|1
25560|NCT01894620|118481|P1|Overall Study|Withdrawal by Subject|0
25561|NCT01894607|118489|P1|Overall Study|Ineligible|1
25562|NCT01894581|118496|P2|Overall Study|Screen Failure|4
25563|NCT01894581|118497|P1|Overall Study|Screen Failure|3
25564|NCT01894581|118496|P2|Overall Study|Withdrawal by Subject|3
25565|NCT01894581|118497|P1|Overall Study|Withdrawal by Subject|2
25566|NCT01894477|118509|P2|Overall Study|protocol changed due SC changed to cord|1
25567|NCT01894477|118510|P1|Overall Study|protocol changed due SC changed to cord|0
25568|NCT01894477|118509|P2|Overall Study|Protocol Violation|1
25569|NCT01894477|118510|P1|Overall Study|Protocol Violation|0
25570|NCT01894256|118521|P3|Part B|Lack of Efficacy|13
25571|NCT01894256|118522|P2|Part B|Lack of Efficacy|12
25572|NCT01894256|118523|P1|Part B|Lack of Efficacy|15
25573|NCT01894256|118521|P3|Part B|Withdrawal by Subject|0
25574|NCT01894256|118522|P2|Part B|Withdrawal by Subject|1
25575|NCT01894256|118523|P1|Part B|Withdrawal by Subject|0
25576|NCT01894256|118521|P3|Part B|Death|1
25577|NCT01894256|118522|P2|Part B|Death|1
25578|NCT01894256|118523|P1|Part B|Death|0
25579|NCT01894256|118521|P3|Part A|Adverse Event|0
25580|NCT01894256|118522|P2|Part A|Adverse Event|1
25581|NCT01894256|118523|P1|Part A|Adverse Event|0
25582|NCT01894230|118569|P2|Overall Study|Death|0
25583|NCT01894230|118570|P1|Overall Study|Death|1
25584|NCT01894230|118569|P2|Overall Study|Non-adherent|1
25585|NCT01894230|118570|P1|Overall Study|Non-adherent|0
25586|NCT01894230|118569|P2|Overall Study|Withdrawal by Subject|4
25587|NCT01894230|118570|P1|Overall Study|Withdrawal by Subject|4
25588|NCT01894230|118569|P2|Overall Study|Lost to Follow-up|2
25589|NCT01894230|118570|P1|Overall Study|Lost to Follow-up|2
25590|NCT01894100|118596|P2|Overall Study|Withdrawal by Subject|0
25591|NCT01894100|118597|P1|Overall Study|Withdrawal by Subject|3
25592|NCT01894100|118596|P2|Overall Study|Lost to Follow-up|1
25593|NCT01894100|118597|P1|Overall Study|Lost to Follow-up|0
25594|NCT01894022|118622|P2|Overall Study|Study Closed/terminated|10
25595|NCT01894022|118623|P1|Overall Study|Study Closed/terminated|7
25596|NCT01894022|118622|P2|Overall Study|Adverse Event, non-fatal|0
25597|NCT01894022|118623|P1|Overall Study|Adverse Event, non-fatal|1
25598|NCT01894022|118622|P2|Overall Study|Death|0
25599|NCT01894022|118623|P1|Overall Study|Death|1
25600|NCT01893905|118677|P2|Overall Study|Other reason|3
25601|NCT01893905|118678|P1|Overall Study|Other reason|1
25602|NCT01893905|118677|P2|Overall Study|Lack of adherence to treatment|0
25603|NCT01893905|118678|P1|Overall Study|Lack of adherence to treatment|2
25604|NCT01893905|118677|P2|Overall Study|Protocol Violation|1
25605|NCT01893905|118678|P1|Overall Study|Protocol Violation|6
25606|NCT01893905|118677|P2|Overall Study|Lost to Follow-up|0
25607|NCT01893905|118678|P1|Overall Study|Lost to Follow-up|1
25608|NCT01893905|118677|P2|Overall Study|Lack of Efficacy|7
25609|NCT01893905|118678|P1|Overall Study|Lack of Efficacy|5
25610|NCT01893905|118677|P2|Overall Study|Adverse Event|3
25611|NCT01893905|118678|P1|Overall Study|Adverse Event|9
25612|NCT01893905|118677|P2|Overall Study|Withdrawal by Subject|0
25613|NCT01893905|118678|P1|Overall Study|Withdrawal by Subject|1
25614|NCT01893411|118700|P3|Overall Study|Lost to Follow-up|1
25615|NCT01893411|118701|P2|Overall Study|Lost to Follow-up|0
25616|NCT01893411|118702|P1|Overall Study|Lost to Follow-up|2
25617|NCT01893411|118700|P3|Overall Study|Withdrawal by Subject|3
25618|NCT01893411|118701|P2|Overall Study|Withdrawal by Subject|4
25619|NCT01893411|118702|P1|Overall Study|Withdrawal by Subject|7
25620|NCT01893411|118700|P3|Overall Study|Adverse Event|0
25621|NCT01893411|118701|P2|Overall Study|Adverse Event|0
25622|NCT01893411|118702|P1|Overall Study|Adverse Event|1
25623|NCT01893411|118700|P3|Overall Study|Not Specified|3
25624|NCT01893411|118701|P2|Overall Study|Not Specified|1
25625|NCT01893411|118702|P1|Overall Study|Not Specified|3
25626|NCT01893411|118700|P3|Overall Study|Lack of Efficacy|0
25627|NCT01893411|118701|P2|Overall Study|Lack of Efficacy|1
25628|NCT01893411|118702|P1|Overall Study|Lack of Efficacy|2
25629|NCT01893411|118700|P3|Overall Study|Physician Decision|2
25630|NCT01893411|118701|P2|Overall Study|Physician Decision|1
25631|NCT01893411|118702|P1|Overall Study|Physician Decision|1
25632|NCT01893411|118700|P3|Overall Study|Protocol Violation|0
25633|NCT01893411|118701|P2|Overall Study|Protocol Violation|0
25634|NCT01893411|118702|P1|Overall Study|Protocol Violation|1
25635|NCT01893346|118784|P4|Overall Study|Withdrawal by Subject|0
25636|NCT01893346|118785|P3|Overall Study|Withdrawal by Subject|0
25637|NCT01893346|118786|P2|Overall Study|Withdrawal by Subject|0
25638|NCT01893346|118787|P1|Overall Study|Withdrawal by Subject|2
25639|NCT01893346|118784|P4|Overall Study|Protocol Violation|0
25640|NCT01893346|118785|P3|Overall Study|Protocol Violation|0
25641|NCT01893346|118786|P2|Overall Study|Protocol Violation|0
25642|NCT01893346|118787|P1|Overall Study|Protocol Violation|1
25643|NCT01893346|118784|P4|Overall Study|Lost to Follow-up|0
25644|NCT01893346|118785|P3|Overall Study|Lost to Follow-up|0
25645|NCT01893346|118786|P2|Overall Study|Lost to Follow-up|1
25646|NCT01893346|118787|P1|Overall Study|Lost to Follow-up|0
25647|NCT01893281|118801|P1|Overall Study|Withdrawal by Subject|1
25648|NCT01893281|118801|P1|Overall Study|Protocol Violation|1
25649|NCT01893281|118801|P1|Overall Study|Adverse Event|1
25650|NCT01893203|118808|P1|Overall Study|Withdrawal by Subject|1
25651|NCT01892657|118840|P1|Overall Study|Protocol Violation|12
25652|NCT01892657|118840|P1|Overall Study|Withdrawal by Subject|6
25653|NCT01892189|118917|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
25654|NCT01892189|118918|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
25655|NCT01892189|118919|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
25656|NCT01892189|118920|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
25657|NCT01892189|118921|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
25658|NCT01892189|118922|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
25659|NCT01892189|118923|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
25660|NCT01892189|118924|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
25661|NCT01892189|118925|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
25662|NCT01892189|118917|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
25663|NCT01892189|118918|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
25664|NCT01892189|118919|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
25665|NCT01892189|118920|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
25666|NCT01892189|118921|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
25667|NCT01892189|118922|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
25668|NCT01892189|118923|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
25669|NCT01892189|118924|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
25670|NCT01892189|118925|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
25671|NCT01892189|118917|P9|Washout Period 1 (7 Days)|Adverse Event|1
25672|NCT01892189|118918|P8|Washout Period 1 (7 Days)|Adverse Event|0
25673|NCT01892189|118919|P7|Washout Period 1 (7 Days)|Adverse Event|0
25674|NCT01892189|118920|P6|Washout Period 1 (7 Days)|Adverse Event|0
25675|NCT01892189|118921|P5|Washout Period 1 (7 Days)|Adverse Event|0
25676|NCT01892189|118922|P4|Washout Period 1 (7 Days)|Adverse Event|0
25677|NCT01892189|118923|P3|Washout Period 1 (7 Days)|Adverse Event|0
25678|NCT01892189|118924|P2|Washout Period 1 (7 Days)|Adverse Event|0
25679|NCT01892189|118925|P1|Washout Period 1 (7 Days)|Adverse Event|0
25680|NCT01892163|118967|P2|Overall Study|Lost to Follow-up|0
25681|NCT01892163|118968|P1|Overall Study|Lost to Follow-up|1
25682|NCT01892163|118967|P2|Overall Study|Death|1
25683|NCT01892163|118968|P1|Overall Study|Death|1
25684|NCT01892020|118980|P2|Period 2|Protocol Violation|0
25685|NCT01892020|118981|P1|Period 2|Protocol Violation|1
25686|NCT01892020|118980|P2|Period 1|Unclassified|1
25687|NCT01892020|118981|P1|Period 1|Unclassified|0
25688|NCT01892020|118980|P2|Period 1|Protocol Violation|4
25689|NCT01892020|118981|P1|Period 1|Protocol Violation|2
25690|NCT01892020|118980|P2|Period 1|Adverse Event|1
25691|NCT01892020|118981|P1|Period 1|Adverse Event|1
25692|NCT01891890|119006|P3|Overall Study|Study ended before endpoint reached|6
25693|NCT01891890|119007|P2|Overall Study|Study ended before endpoint reached|3
25694|NCT01891890|119008|P1|Overall Study|Study ended before endpoint reached|7
25695|NCT01891890|119006|P3|Overall Study|Lost to Follow-up|1
25696|NCT01891890|119007|P2|Overall Study|Lost to Follow-up|0
25697|NCT01891890|119008|P1|Overall Study|Lost to Follow-up|0
25698|NCT01891864|119051|P6|Extension Period|Lost to Follow-up|0
25699|NCT01891864|119052|P5|Extension Period|Lost to Follow-up|0
25700|NCT01891864|119053|P4|Extension Period|Lost to Follow-up|0
25701|NCT01891864|119054|P3|Extension Period|Lost to Follow-up|2
25702|NCT01891864|119055|P2|Extension Period|Lost to Follow-up|0
25703|NCT01891864|119056|P1|Extension Period|Lost to Follow-up|0
25704|NCT01891864|119051|P6|Extension Period|Withdrawal by Subject|0
25705|NCT01891864|119052|P5|Extension Period|Withdrawal by Subject|4
25706|NCT01891864|119053|P4|Extension Period|Withdrawal by Subject|2
25707|NCT01891864|119054|P3|Extension Period|Withdrawal by Subject|1
25708|NCT01891864|119055|P2|Extension Period|Withdrawal by Subject|0
25709|NCT01891864|119056|P1|Extension Period|Withdrawal by Subject|0
25710|NCT01891864|119051|P6|Extension Period|Adverse Event|0
25711|NCT01891864|119052|P5|Extension Period|Adverse Event|2
25712|NCT01891864|119053|P4|Extension Period|Adverse Event|2
25713|NCT01891864|119054|P3|Extension Period|Adverse Event|4
25714|NCT01891864|119055|P2|Extension Period|Adverse Event|0
25715|NCT01891864|119056|P1|Extension Period|Adverse Event|0
25716|NCT01891864|119051|P6|Extension Period|Pregnancy|0
25717|NCT01891864|119052|P5|Extension Period|Pregnancy|0
25718|NCT01891864|119053|P4|Extension Period|Pregnancy|0
25719|NCT01891864|119054|P3|Extension Period|Pregnancy|1
25720|NCT01891864|119055|P2|Extension Period|Pregnancy|0
25721|NCT01891864|119056|P1|Extension Period|Pregnancy|0
25722|NCT01891864|119051|P6|Extension Period|Lack of Efficacy|0
25723|NCT01891864|119052|P5|Extension Period|Lack of Efficacy|1
25724|NCT01891864|119053|P4|Extension Period|Lack of Efficacy|1
25725|NCT01891864|119054|P3|Extension Period|Lack of Efficacy|0
25726|NCT01891864|119055|P2|Extension Period|Lack of Efficacy|0
25727|NCT01891864|119056|P1|Extension Period|Lack of Efficacy|0
25728|NCT01891864|119051|P6|Treatment Period 2|Withdrawal by Subject|1
25729|NCT01891864|119052|P5|Treatment Period 2|Withdrawal by Subject|1
25730|NCT01891864|119053|P4|Treatment Period 2|Withdrawal by Subject|4
25731|NCT01891864|119054|P3|Treatment Period 2|Withdrawal by Subject|3
25732|NCT01891864|119055|P2|Treatment Period 2|Withdrawal by Subject|0
25733|NCT01891864|119056|P1|Treatment Period 2|Withdrawal by Subject|0
25734|NCT01891864|119051|P6|Treatment Period 2|Termination of Site|0
25735|NCT01891864|119052|P5|Treatment Period 2|Termination of Site|2
25736|NCT01891864|119053|P4|Treatment Period 2|Termination of Site|0
25737|NCT01891864|119054|P3|Treatment Period 2|Termination of Site|0
25738|NCT01891864|119055|P2|Treatment Period 2|Termination of Site|0
25739|NCT01891864|119056|P1|Treatment Period 2|Termination of Site|0
25740|NCT01891864|119051|P6|Treatment Period 2|Adverse Event|4
25741|NCT01891864|119052|P5|Treatment Period 2|Adverse Event|0
25742|NCT01891864|119053|P4|Treatment Period 2|Adverse Event|2
25743|NCT01891864|119054|P3|Treatment Period 2|Adverse Event|1
25744|NCT01891864|119055|P2|Treatment Period 2|Adverse Event|0
25745|NCT01891864|119056|P1|Treatment Period 2|Adverse Event|0
25746|NCT01891864|119051|P6|Treatment Period 2|Lack of Efficacy|0
25747|NCT01891864|119052|P5|Treatment Period 2|Lack of Efficacy|1
25748|NCT01891864|119053|P4|Treatment Period 2|Lack of Efficacy|0
25749|NCT01891864|119054|P3|Treatment Period 2|Lack of Efficacy|1
25750|NCT01891864|119055|P2|Treatment Period 2|Lack of Efficacy|0
25751|NCT01891864|119056|P1|Treatment Period 2|Lack of Efficacy|0
25752|NCT01891864|119051|P6|Treatment Period 2|Site Termination|0
25753|NCT01891864|119052|P5|Treatment Period 2|Site Termination|0
25754|NCT01891864|119053|P4|Treatment Period 2|Site Termination|2
25755|NCT01891864|119054|P3|Treatment Period 2|Site Termination|1
25756|NCT01891864|119055|P2|Treatment Period 2|Site Termination|0
25757|NCT01891864|119056|P1|Treatment Period 2|Site Termination|0
25758|NCT01891864|119051|P6|Treatment Period 2|Physician Decision|0
25759|NCT01891864|119052|P5|Treatment Period 2|Physician Decision|0
25760|NCT01891864|119053|P4|Treatment Period 2|Physician Decision|0
25761|NCT01891864|119054|P3|Treatment Period 2|Physician Decision|1
25762|NCT01891864|119055|P2|Treatment Period 2|Physician Decision|0
25763|NCT01891864|119056|P1|Treatment Period 2|Physician Decision|0
25764|NCT01891864|119051|P6|Treatment Period 2|Protocol Violation|0
25765|NCT01891864|119052|P5|Treatment Period 2|Protocol Violation|0
25766|NCT01891864|119053|P4|Treatment Period 2|Protocol Violation|1
25767|NCT01891864|119054|P3|Treatment Period 2|Protocol Violation|0
25768|NCT01891864|119055|P2|Treatment Period 2|Protocol Violation|0
25769|NCT01891864|119056|P1|Treatment Period 2|Protocol Violation|0
25770|NCT01891864|119051|P6|Treatment Period 1|Lost to Follow-up|0
25771|NCT01891864|119052|P5|Treatment Period 1|Lost to Follow-up|0
25772|NCT01891864|119053|P4|Treatment Period 1|Lost to Follow-up|0
25773|NCT01891864|119054|P3|Treatment Period 1|Lost to Follow-up|0
25774|NCT01891864|119055|P2|Treatment Period 1|Lost to Follow-up|0
25775|NCT01891864|119056|P1|Treatment Period 1|Lost to Follow-up|1
25776|NCT01891864|119051|P6|Treatment Period 1|Withdrawal by Subject|0
25777|NCT01891864|119052|P5|Treatment Period 1|Withdrawal by Subject|0
25778|NCT01891864|119053|P4|Treatment Period 1|Withdrawal by Subject|0
25779|NCT01891864|119054|P3|Treatment Period 1|Withdrawal by Subject|0
25780|NCT01891864|119055|P2|Treatment Period 1|Withdrawal by Subject|5
25781|NCT01891864|119056|P1|Treatment Period 1|Withdrawal by Subject|2
25782|NCT01891864|119051|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
25783|NCT01891864|119052|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
25784|NCT01891864|119053|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
25785|NCT01891864|119054|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
25786|NCT01891864|119055|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
25787|NCT01891864|119056|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
25788|NCT01891864|119051|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
25789|NCT01891864|119052|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
25790|NCT01891864|119053|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
25791|NCT01891864|119054|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
25792|NCT01891864|119055|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
25793|NCT01891864|119056|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
25794|NCT01891864|119051|P6|Treatment Period 1|Physician Decision|0
25795|NCT01891864|119052|P5|Treatment Period 1|Physician Decision|0
25796|NCT01891864|119053|P4|Treatment Period 1|Physician Decision|0
25797|NCT01891864|119054|P3|Treatment Period 1|Physician Decision|0
25798|NCT01891864|119055|P2|Treatment Period 1|Physician Decision|1
25799|NCT01891864|119056|P1|Treatment Period 1|Physician Decision|0
25800|NCT01891864|119051|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
25801|NCT01891864|119052|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
25802|NCT01891864|119053|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
25803|NCT01891864|119054|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
25804|NCT01891864|119055|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
25805|NCT01891864|119056|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
25806|NCT01891669|119099|P10|Overall Study|Other|0
25807|NCT01891669|119100|P9|Overall Study|Other|0
25808|NCT01891669|119101|P8|Overall Study|Other|1
25809|NCT01891669|119102|P7|Overall Study|Other|0
25810|NCT01891669|119103|P6|Overall Study|Other|0
25811|NCT01891669|119104|P5|Overall Study|Other|0
25812|NCT01891669|119105|P4|Overall Study|Other|0
25813|NCT01891669|119106|P3|Overall Study|Other|0
25814|NCT01891669|119107|P2|Overall Study|Other|0
25815|NCT01891669|119108|P1|Overall Study|Other|1
25816|NCT01891669|119099|P10|Overall Study|Withdrawal by Subject|1
25817|NCT01891669|119100|P9|Overall Study|Withdrawal by Subject|1
25818|NCT01891669|119101|P8|Overall Study|Withdrawal by Subject|2
25819|NCT01891669|119102|P7|Overall Study|Withdrawal by Subject|1
25820|NCT01891669|119103|P6|Overall Study|Withdrawal by Subject|0
25821|NCT01891669|119104|P5|Overall Study|Withdrawal by Subject|0
25822|NCT01891669|119105|P4|Overall Study|Withdrawal by Subject|0
25823|NCT01891669|119106|P3|Overall Study|Withdrawal by Subject|0
25824|NCT01891669|119107|P2|Overall Study|Withdrawal by Subject|1
25825|NCT01891669|119108|P1|Overall Study|Withdrawal by Subject|1
25826|NCT01891669|119099|P10|Overall Study|Death|1
25827|NCT01891669|119100|P9|Overall Study|Death|0
25828|NCT01891669|119101|P8|Overall Study|Death|1
25829|NCT01891669|119102|P7|Overall Study|Death|0
25830|NCT01891669|119103|P6|Overall Study|Death|0
25831|NCT01891669|119104|P5|Overall Study|Death|0
25832|NCT01891669|119105|P4|Overall Study|Death|0
25833|NCT01891669|119106|P3|Overall Study|Death|0
25834|NCT01891669|119107|P2|Overall Study|Death|0
25835|NCT01891669|119108|P1|Overall Study|Death|0
25836|NCT01890967|119265|P6|Overall Study|Withdrawal by Subject|1
25837|NCT01890967|119266|P5|Overall Study|Withdrawal by Subject|3
25838|NCT01890967|119267|P4|Overall Study|Withdrawal by Subject|3
25839|NCT01890967|119268|P3|Overall Study|Withdrawal by Subject|2
25840|NCT01890967|119269|P2|Overall Study|Withdrawal by Subject|4
25841|NCT01890967|119270|P1|Overall Study|Withdrawal by Subject|3
25842|NCT01890967|119265|P6|Overall Study|Sponsor Decision|3
25843|NCT01890967|119266|P5|Overall Study|Sponsor Decision|2
25844|NCT01890967|119267|P4|Overall Study|Sponsor Decision|3
25845|NCT01890967|119268|P3|Overall Study|Sponsor Decision|1
25846|NCT01890967|119269|P2|Overall Study|Sponsor Decision|0
25847|NCT01890967|119270|P1|Overall Study|Sponsor Decision|2
25848|NCT01890967|119265|P6|Overall Study|Protocol Violation|1
25849|NCT01890967|119266|P5|Overall Study|Protocol Violation|4
25850|NCT01890967|119267|P4|Overall Study|Protocol Violation|2
25851|NCT01890967|119268|P3|Overall Study|Protocol Violation|3
25852|NCT01890967|119269|P2|Overall Study|Protocol Violation|3
25853|NCT01890967|119270|P1|Overall Study|Protocol Violation|0
25854|NCT01890967|119265|P6|Overall Study|Lost to Follow-up|1
25855|NCT01890967|119266|P5|Overall Study|Lost to Follow-up|0
25856|NCT01890967|119267|P4|Overall Study|Lost to Follow-up|1
25857|NCT01890967|119268|P3|Overall Study|Lost to Follow-up|1
25858|NCT01890967|119269|P2|Overall Study|Lost to Follow-up|1
25859|NCT01890967|119270|P1|Overall Study|Lost to Follow-up|1
25860|NCT01890967|119265|P6|Overall Study|Death|0
25861|NCT01890967|119266|P5|Overall Study|Death|0
25862|NCT01890967|119267|P4|Overall Study|Death|0
25863|NCT01890967|119268|P3|Overall Study|Death|0
25864|NCT01890967|119269|P2|Overall Study|Death|0
25865|NCT01890967|119270|P1|Overall Study|Death|1
25866|NCT01890967|119265|P6|Overall Study|Adverse Event|7
25867|NCT01890967|119266|P5|Overall Study|Adverse Event|1
25868|NCT01890967|119267|P4|Overall Study|Adverse Event|2
25869|NCT01890967|119268|P3|Overall Study|Adverse Event|3
25870|NCT01890967|119269|P2|Overall Study|Adverse Event|3
25871|NCT01890967|119270|P1|Overall Study|Adverse Event|3
25872|NCT01890915|119348|P2|Overall Study|Equipment Malfunction|1
25873|NCT01890915|119349|P1|Overall Study|Equipment Malfunction|0
25874|NCT01890915|119348|P2|Overall Study|Protocol Violation|0
25875|NCT01890915|119349|P1|Overall Study|Protocol Violation|2
25876|NCT01890915|119348|P2|Overall Study|Adverse Event|0
25877|NCT01890915|119349|P1|Overall Study|Adverse Event|1
25878|NCT01890785|119365|P6|Third Intervention|Withdrawal by Subject|0
25879|NCT01890785|119366|P5|Third Intervention|Withdrawal by Subject|0
25880|NCT01890785|119367|P4|Third Intervention|Withdrawal by Subject|0
25881|NCT01890785|119368|P3|Third Intervention|Withdrawal by Subject|0
25882|NCT01890785|119369|P2|Third Intervention|Withdrawal by Subject|1
25883|NCT01890785|119370|P1|Third Intervention|Withdrawal by Subject|0
25884|NCT01890759|119389|P2|Overall Study|Withdrawal by Subject|8
25885|NCT01890759|119390|P1|Overall Study|Withdrawal by Subject|2
25886|NCT01890759|119389|P2|Overall Study|Lost to Follow-up|2
25887|NCT01890759|119390|P1|Overall Study|Lost to Follow-up|0
25888|NCT01890759|119389|P2|Overall Study|Protocol Violation|2
25889|NCT01890759|119390|P1|Overall Study|Protocol Violation|0
25890|NCT01890746|119424|P2|Overall Study|Ongoing|50
25891|NCT01890746|119425|P1|Overall Study|Ongoing|44
25892|NCT01890746|119424|P2|Overall Study|Death|14
25893|NCT01890746|119425|P1|Overall Study|Death|23
25894|NCT01890746|119424|P2|Overall Study|Withdrawal by Subject|8
25895|NCT01890746|119425|P1|Overall Study|Withdrawal by Subject|4
25896|NCT01890746|119424|P2|Overall Study|Physician Decision|2
25897|NCT01890746|119425|P1|Overall Study|Physician Decision|2
25898|NCT01890746|119424|P2|Overall Study|Adverse Event|0
25899|NCT01890746|119425|P1|Overall Study|Adverse Event|1
25900|NCT01890512|119522|P1|Overall Study|Protocol Violation|1
25901|NCT01890512|119522|P1|Overall Study|Withdrawal by Subject|1
25902|NCT01890512|119522|P1|Overall Study|Physician Decision|1
25903|NCT01890473|119528|P2|Overall Study|Poor/non-compliance|0
25904|NCT01890473|119529|P1|Overall Study|Poor/non-compliance|1
25905|NCT01890473|119528|P2|Overall Study|Lost to Follow-up|0
25906|NCT01890473|119529|P1|Overall Study|Lost to Follow-up|1
25907|NCT01890434|119555|P1|Overall Study|Withdrawal by PI for ICA not performed|2
25908|NCT01890434|119555|P1|Overall Study|Unable to contact|1
25909|NCT01890434|119555|P1|Overall Study|Moved out of position|1
25910|NCT01890434|119555|P1|Overall Study|Uncontactable by phone|1
25911|NCT01890434|119555|P1|Overall Study|Participant didn't complete MRI|1
25912|NCT01890434|119555|P1|Overall Study|GSPECT at rest was not done|1
25913|NCT01890434|119555|P1|Overall Study|Decline to return for GSPECT|1
25914|NCT01890434|119555|P1|Overall Study|Could not get whole set of images|1
25915|NCT01890434|119555|P1|Overall Study|CRC didn't contact participant for FU|1
25916|NCT01890434|119555|P1|Overall Study|Assessment discrepancy|1
25917|NCT01890434|119555|P1|Overall Study|PCI at external hospital|1
25918|NCT01890434|119555|P1|Overall Study|Adverse Event|8
25919|NCT01890421|119585|P1|Overall Study|Other reason|10
25920|NCT01890421|119585|P1|Overall Study|Adverse Event|1
25921|NCT01890148|119624|P1|Overall Study|Adverse Event|1
25922|NCT01890122|119644|P4|Overall Study|Randomized but not Treated|0
25923|NCT01890122|119645|P3|Overall Study|Randomized but not Treated|0
25924|NCT01890122|119646|P2|Overall Study|Randomized but not Treated|1
25925|NCT01890122|119647|P1|Overall Study|Randomized but not Treated|1
25926|NCT01890122|119644|P4|Overall Study|Reason not Specified|2
25927|NCT01890122|119645|P3|Overall Study|Reason not Specified|1
25928|NCT01890122|119646|P2|Overall Study|Reason not Specified|1
25929|NCT01890122|119647|P1|Overall Study|Reason not Specified|0
25930|NCT01890122|119644|P4|Overall Study|Lack of Efficacy|41
25931|NCT01890122|119645|P3|Overall Study|Lack of Efficacy|7
25932|NCT01890122|119646|P2|Overall Study|Lack of Efficacy|24
25933|NCT01890122|119647|P1|Overall Study|Lack of Efficacy|14
25934|NCT01890122|119644|P4|Overall Study|Voluntary Withdrawal|11
25935|NCT01890122|119645|P3|Overall Study|Voluntary Withdrawal|2
25936|NCT01890122|119646|P2|Overall Study|Voluntary Withdrawal|8
25937|NCT01890122|119647|P1|Overall Study|Voluntary Withdrawal|8
25938|NCT01890122|119644|P4|Overall Study|Lost to Follow-up|2
25939|NCT01890122|119645|P3|Overall Study|Lost to Follow-up|2
25940|NCT01890122|119646|P2|Overall Study|Lost to Follow-up|1
25941|NCT01890122|119647|P1|Overall Study|Lost to Follow-up|0
25942|NCT01890122|119644|P4|Overall Study|Major Protocol Deviation|1
25943|NCT01890122|119645|P3|Overall Study|Major Protocol Deviation|0
25944|NCT01890122|119646|P2|Overall Study|Major Protocol Deviation|1
25945|NCT01890122|119647|P1|Overall Study|Major Protocol Deviation|3
25946|NCT01890122|119644|P4|Overall Study|Adverse Event|2
25947|NCT01890122|119645|P3|Overall Study|Adverse Event|1
25948|NCT01890122|119646|P2|Overall Study|Adverse Event|1
25949|NCT01890122|119647|P1|Overall Study|Adverse Event|1
25950|NCT01889251|119794|P2|Overall Study|Adverse Event|0
25951|NCT01889251|119795|P1|Overall Study|Adverse Event|1
25952|NCT01888965|119801|P1|Overall Study|Lack of Efficacy|4
25953|NCT01888965|119801|P1|Overall Study|Adverse Event|5
25954|NCT01888900|119813|P2|Overall Study|failed treatment|2
25955|NCT01888900|119814|P1|Overall Study|failed treatment|0
25956|NCT01888367|119837|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
25957|NCT01888367|119838|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
25958|NCT01888367|119839|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
25959|NCT01888367|119837|P3|Overall Study|Protocol Violation|1
25960|NCT01888367|119838|P2|Overall Study|Protocol Violation|0
25961|NCT01888367|119839|P1|Overall Study|Protocol Violation|0
25962|NCT01888367|119837|P3|Overall Study|Lost to Follow-up|0
25963|NCT01888367|119838|P2|Overall Study|Lost to Follow-up|1
25964|NCT01888367|119839|P1|Overall Study|Lost to Follow-up|1
25965|NCT01888367|119837|P3|Overall Study|Withdrawal by Subject|1
25966|NCT01888367|119838|P2|Overall Study|Withdrawal by Subject|0
25967|NCT01888367|119839|P1|Overall Study|Withdrawal by Subject|1
25968|NCT01888367|119837|P3|Overall Study|Death|1
25969|NCT01888367|119838|P2|Overall Study|Death|0
25970|NCT01888367|119839|P1|Overall Study|Death|2
25971|NCT01888367|119837|P3|Overall Study|Physician Decision|2
25972|NCT01888367|119838|P2|Overall Study|Physician Decision|4
25973|NCT01888367|119839|P1|Overall Study|Physician Decision|3
25974|NCT01888003|119859|P3|Overall Study|Study Terminated|40
25975|NCT01888003|119860|P2|Overall Study|Study Terminated|6
25976|NCT01888003|119861|P1|Overall Study|Study Terminated|5
25977|NCT01887678|119901|P2|Overall Study|Specified|2
25978|NCT01887678|119902|P1|Overall Study|Specified|1
25979|NCT01887678|119901|P2|Overall Study|Non-compliance|3
25980|NCT01887678|119902|P1|Overall Study|Non-compliance|0
25981|NCT01887678|119901|P2|Overall Study|Lack of Efficacy|2
25982|NCT01887678|119902|P1|Overall Study|Lack of Efficacy|1
25983|NCT01887678|119901|P2|Overall Study|Deterioration of clinical condition|4
25984|NCT01887678|119902|P1|Overall Study|Deterioration of clinical condition|0
25985|NCT01887678|119901|P2|Overall Study|Lost to Follow-up|2
25986|NCT01887678|119902|P1|Overall Study|Lost to Follow-up|4
25987|NCT01887678|119901|P2|Overall Study|Withdrawal of consent|4
25988|NCT01887678|119902|P1|Overall Study|Withdrawal of consent|3
25989|NCT01887678|119901|P2|Overall Study|Exceeded rescue medication dosage|5
25990|NCT01887678|119902|P1|Overall Study|Exceeded rescue medication dosage|4
25991|NCT01887678|119901|P2|Overall Study|Adverse Event|6
25992|NCT01887678|119902|P1|Overall Study|Adverse Event|4
25993|NCT01887418|119970|P3|Overall Study|Travelling difficulties|1
25994|NCT01887418|119971|P2|Overall Study|Travelling difficulties|0
25995|NCT01887418|119972|P1|Overall Study|Travelling difficulties|0
25996|NCT01887353|119991|P2|Overall Study|Study stopped early|3
25997|NCT01887353|119992|P1|Overall Study|Study stopped early|4
25998|NCT01887288|119998|P1|Overall Study|The study was terminated and the PI has|16
25999|NCT01886781|120050|P2|Overall Study|Worsening of symptoms|1
26000|NCT01886781|120051|P1|Overall Study|Worsening of symptoms|1
26001|NCT01886781|120050|P2|Overall Study|Withdrawal by Subject|1
26002|NCT01886781|120051|P1|Overall Study|Withdrawal by Subject|2
26003|NCT01886781|120050|P2|Overall Study|Lost to Follow-up|0
26004|NCT01886781|120051|P1|Overall Study|Lost to Follow-up|5
26005|NCT01886781|120050|P2|Overall Study|Adverse Event|0
26006|NCT01886781|120051|P1|Overall Study|Adverse Event|1
26007|NCT01886781|120050|P2|Overall Study|Protocol Violation|0
26008|NCT01886781|120051|P1|Overall Study|Protocol Violation|5
26009|NCT01886716|120061|P4|Week 3|Lost to Follow-up|1
26010|NCT01886716|120062|P3|Week 3|Lost to Follow-up|0
26011|NCT01886716|120063|P2|Week 3|Lost to Follow-up|1
26012|NCT01886716|120064|P1|Week 3|Lost to Follow-up|1
26013|NCT01886716|120061|P4|Week 2|Lost to Follow-up|3
26014|NCT01886716|120062|P3|Week 2|Lost to Follow-up|1
26015|NCT01886716|120063|P2|Week 2|Lost to Follow-up|2
26016|NCT01886716|120064|P1|Week 2|Lost to Follow-up|3
26017|NCT01886716|120061|P4|Week 1|Lost to Follow-up|2
26018|NCT01886716|120062|P3|Week 1|Lost to Follow-up|2
26019|NCT01886716|120063|P2|Week 1|Lost to Follow-up|0
26020|NCT01886716|120064|P1|Week 1|Lost to Follow-up|0
26021|NCT01886690|120080|P2|Overall Study|Personal Reasons|1
26022|NCT01886690|120081|P1|Overall Study|Personal Reasons|0
26023|NCT01886690|120080|P2|Overall Study|Protocol Violation|1
26024|NCT01886690|120081|P1|Overall Study|Protocol Violation|0
26025|NCT01886313|120097|P2|Overall Study|Adverse Event|1
26026|NCT01886313|120098|P1|Overall Study|Adverse Event|1
26027|NCT01886300|120104|P1|Overall Study|Trial terminated by sponsor|16
26028|NCT01886287|120115|P1|Overall Study|Clinical progression due to disease|1
26029|NCT01886287|120115|P1|Overall Study|Radiographic disease progression|1
26030|NCT01885936|120133|P2|Overall Study|Withdrawal by Subject|0
26031|NCT01885936|120134|P1|Overall Study|Withdrawal by Subject|1
26032|NCT01885559|120168|P2|Overall Study|Protocol Violation|1
26033|NCT01885559|120169|P1|Overall Study|Protocol Violation|0
26034|NCT01885559|120168|P2|Overall Study|Less than full participation|19
26035|NCT01885559|120169|P1|Overall Study|Less than full participation|9
26036|NCT01885559|120168|P2|Overall Study|Lost to Follow-up|16
26037|NCT01885559|120169|P1|Overall Study|Lost to Follow-up|15
26038|NCT01885208|120191|P2|Overall Study|Unclassified|38
26039|NCT01885208|120192|P1|Overall Study|Unclassified|32
26040|NCT01885104|120233|P2|Overall Study|Physician Decision|0
26041|NCT01885104|120234|P1|Overall Study|Physician Decision|1
26042|NCT01885104|120233|P2|Overall Study|Lost to Follow-up|1
26043|NCT01885104|120234|P1|Overall Study|Lost to Follow-up|0
26044|NCT01885104|120233|P2|Overall Study|Withdrawal of Consent|0
26045|NCT01885104|120234|P1|Overall Study|Withdrawal of Consent|1
26046|NCT01885000|120244|P2|Overall Study|Protocol Violation|1
26047|NCT01885000|120245|P1|Overall Study|Protocol Violation|0
26048|NCT01885000|120244|P2|Overall Study|Withdrawal by Subject|1
26049|NCT01885000|120245|P1|Overall Study|Withdrawal by Subject|1
26050|NCT01885000|120244|P2|Overall Study|Adverse Event|0
26051|NCT01885000|120245|P1|Overall Study|Adverse Event|1
26052|NCT01884688|120257|P1|Overall Study|Screen Failure|2
26053|NCT01884675|120263|P2|Overall Study|Study closed/terminated|2
26054|NCT01884675|120264|P1|Overall Study|Study closed/terminated|3
26055|NCT01884597|120307|P3|Overall Study|Death|0
26056|NCT01884597|120308|P2|Overall Study|Death|1
26057|NCT01884597|120309|P1|Overall Study|Death|0
26058|NCT01884597|120307|P3|Overall Study|Lack of Efficacy|0
26059|NCT01884597|120308|P2|Overall Study|Lack of Efficacy|0
26060|NCT01884597|120309|P1|Overall Study|Lack of Efficacy|1
26061|NCT01884597|120307|P3|Overall Study|Adverse Event|1
26062|NCT01884597|120308|P2|Overall Study|Adverse Event|0
26063|NCT01884597|120309|P1|Overall Study|Adverse Event|0
26064|NCT01884571|120338|P1|Overall Study|Disease progression|3
26065|NCT01884571|120338|P1|Overall Study|Withdrawal by Subject|2
26066|NCT01884571|120338|P1|Overall Study|Death|2
26067|NCT01884571|120338|P1|Overall Study|Adverse Event|1
26068|NCT01884545|120353|P4|Overall Study|Non-adherence|0
26069|NCT01884545|120354|P3|Overall Study|Non-adherence|0
26070|NCT01884545|120355|P2|Overall Study|Non-adherence|2
26071|NCT01884545|120356|P1|Overall Study|Non-adherence|0
26072|NCT01884545|120353|P4|Overall Study|Patient withdrawn|5
26073|NCT01884545|120354|P3|Overall Study|Patient withdrawn|5
26074|NCT01884545|120355|P2|Overall Study|Patient withdrawn|12
26075|NCT01884545|120356|P1|Overall Study|Patient withdrawn|7
26076|NCT01884545|120353|P4|Overall Study|Lost to Follow-up|4
26077|NCT01884545|120354|P3|Overall Study|Lost to Follow-up|9
26078|NCT01884545|120355|P2|Overall Study|Lost to Follow-up|4
26079|NCT01884545|120356|P1|Overall Study|Lost to Follow-up|6
26080|NCT01883895|120548|P1|Overall Study|Lost to Follow-up|2
26081|NCT01883635|120562|P2|Overall Study|Withdrawal by Subject|0
26082|NCT01883635|120563|P1|Overall Study|Withdrawal by Subject|4
26083|NCT01883453|120577|P2|Overall Study|No episode of common cold|23
26084|NCT01883453|120578|P1|Overall Study|No episode of common cold|25
26085|NCT01882907|120606|P2|Overall Study|Withdrawal by Subject|6
26086|NCT01882907|120607|P1|Overall Study|Withdrawal by Subject|0
26087|NCT01882907|120606|P2|Overall Study|Protocol Violation|14
26088|NCT01882907|120607|P1|Overall Study|Protocol Violation|10
26089|NCT01882907|120606|P2|Overall Study|Lost to Follow-up|4
26090|NCT01882907|120607|P1|Overall Study|Lost to Follow-up|1
26091|NCT01882907|120606|P2|Overall Study|Lack of Efficacy|3
26092|NCT01882907|120607|P1|Overall Study|Lack of Efficacy|0
26093|NCT01882907|120606|P2|Overall Study|Adverse Event|1
26094|NCT01882907|120607|P1|Overall Study|Adverse Event|3
26095|NCT01882647|120650|P2|Overall Study|Withdrawal by Subject|4
26096|NCT01882647|120651|P1|Overall Study|Withdrawal by Subject|0
26097|NCT01882647|120650|P2|Overall Study|Lost to Follow-up|2
26098|NCT01882647|120651|P1|Overall Study|Lost to Follow-up|2
26099|NCT01882465|120691|P7|Period 2|Protocol Violation|0
26100|NCT01882465|120692|P6|Period 2|Protocol Violation|0
26101|NCT01882465|120693|P5|Period 2|Protocol Violation|1
26102|NCT01882465|120694|P4|Period 2|Protocol Violation|0
26103|NCT01882465|120695|P3|Period 2|Protocol Violation|0
26104|NCT01882465|120696|P2|Period 2|Protocol Violation|0
26105|NCT01882465|120697|P1|Period 2|Protocol Violation|0
26106|NCT01882465|120691|P7|Period 1|Withdrawal by Subject|1
26107|NCT01882465|120692|P6|Period 1|Withdrawal by Subject|0
26108|NCT01882465|120693|P5|Period 1|Withdrawal by Subject|0
26109|NCT01882465|120694|P4|Period 1|Withdrawal by Subject|0
26110|NCT01882465|120695|P3|Period 1|Withdrawal by Subject|0
26111|NCT01882465|120696|P2|Period 1|Withdrawal by Subject|0
26112|NCT01882465|120697|P1|Period 1|Withdrawal by Subject|0
26113|NCT01882465|120691|P7|Period 1|Lens Discomfort|0
26114|NCT01882465|120692|P6|Period 1|Lens Discomfort|0
26115|NCT01882465|120693|P5|Period 1|Lens Discomfort|0
26116|NCT01882465|120694|P4|Period 1|Lens Discomfort|1
26117|NCT01882465|120695|P3|Period 1|Lens Discomfort|0
26118|NCT01882465|120696|P2|Period 1|Lens Discomfort|0
26119|NCT01882465|120697|P1|Period 1|Lens Discomfort|0
26120|NCT01882439|120709|P4|Overall Study|Adverse event unrelated to study drug|1
26121|NCT01882439|120710|P3|Overall Study|Adverse event unrelated to study drug|1
26122|NCT01882439|120711|P2|Overall Study|Adverse event unrelated to study drug|2
26123|NCT01882439|120712|P1|Overall Study|Adverse event unrelated to study drug|2
26124|NCT01882439|120709|P4|Overall Study|Insufficient clinical response|2
26125|NCT01882439|120710|P3|Overall Study|Insufficient clinical response|4
26126|NCT01882439|120711|P2|Overall Study|Insufficient clinical response|4
26127|NCT01882439|120712|P1|Overall Study|Insufficient clinical response|1
26128|NCT01882439|120709|P4|Overall Study|Medication error with no associated AE|0
26129|NCT01882439|120710|P3|Overall Study|Medication error with no associated AE|2
26130|NCT01882439|120711|P2|Overall Study|Medication error with no associated AE|0
26131|NCT01882439|120712|P1|Overall Study|Medication error with no associated AE|0
26132|NCT01882439|120709|P4|Overall Study|No longer willing to participate|3
26133|NCT01882439|120710|P3|Overall Study|No longer willing to participate|2
26134|NCT01882439|120711|P2|Overall Study|No longer willing to participate|4
26135|NCT01882439|120712|P1|Overall Study|No longer willing to participate|1
26136|NCT01882439|120709|P4|Overall Study|Protocol Violation|1
26137|NCT01882439|120710|P3|Overall Study|Protocol Violation|0
26138|NCT01882439|120711|P2|Overall Study|Protocol Violation|2
26139|NCT01882439|120712|P1|Overall Study|Protocol Violation|2
26140|NCT01882439|120709|P4|Overall Study|Pregnancy|0
26141|NCT01882439|120710|P3|Overall Study|Pregnancy|0
26142|NCT01882439|120711|P2|Overall Study|Pregnancy|1
26143|NCT01882439|120712|P1|Overall Study|Pregnancy|0
26144|NCT01882439|120709|P4|Overall Study|Adverse event related to study drug|2
26145|NCT01882439|120710|P3|Overall Study|Adverse event related to study drug|1
26146|NCT01882439|120711|P2|Overall Study|Adverse event related to study drug|8
26147|NCT01882439|120712|P1|Overall Study|Adverse event related to study drug|3
26148|NCT01882257|120909|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
26149|NCT01882257|120910|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
26150|NCT01882257|120911|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
26151|NCT01882257|120909|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
26152|NCT01882257|120910|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
26153|NCT01882257|120911|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
26154|NCT01881776|120943|P3|Overall Study|Protocol Violation|1
26155|NCT01881776|120944|P2|Overall Study|Protocol Violation|2
26156|NCT01881776|120945|P1|Overall Study|Protocol Violation|0
26157|NCT01881776|120943|P3|Overall Study|Lost to Follow-up|1
26158|NCT01881776|120944|P2|Overall Study|Lost to Follow-up|2
26159|NCT01881776|120945|P1|Overall Study|Lost to Follow-up|1
26160|NCT01881737|120971|P1|Overall Study|Worsening of baseline behavior|1
26161|NCT01881737|120971|P1|Overall Study|Withdrawal by Subject|1
26162|NCT01881737|120971|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
26163|NCT01881230|120983|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
26164|NCT01881230|120984|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
26165|NCT01881230|120985|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
26166|NCT01881230|120983|P3|Overall Study|Untreated: Death|1
26167|NCT01881230|120984|P2|Overall Study|Untreated: Death|0
26168|NCT01881230|120985|P1|Overall Study|Untreated: Death|0
26169|NCT01881230|120983|P3|Overall Study|Untreated: Other|1
26170|NCT01881230|120984|P2|Overall Study|Untreated: Other|0
26171|NCT01881230|120985|P1|Overall Study|Untreated: Other|0
26172|NCT01881230|120983|P3|Overall Study|Miscellaneous|0
26173|NCT01881230|120984|P2|Overall Study|Miscellaneous|3
26174|NCT01881230|120985|P1|Overall Study|Miscellaneous|3
26175|NCT01881230|120983|P3|Overall Study|Protocol Violation|0
26176|NCT01881230|120984|P2|Overall Study|Protocol Violation|1
26177|NCT01881230|120985|P1|Overall Study|Protocol Violation|1
26178|NCT01881230|120983|P3|Overall Study|Given Commercially Available Drug|2
26179|NCT01881230|120984|P2|Overall Study|Given Commercially Available Drug|0
26180|NCT01881230|120985|P1|Overall Study|Given Commercially Available Drug|0
26181|NCT01881230|120983|P3|Overall Study|Non-Compliance with Study Drug|0
26182|NCT01881230|120984|P2|Overall Study|Non-Compliance with Study Drug|2
26183|NCT01881230|120985|P1|Overall Study|Non-Compliance with Study Drug|1
26184|NCT01881230|120983|P3|Overall Study|Physician Decision|6
26185|NCT01881230|120984|P2|Overall Study|Physician Decision|3
26186|NCT01881230|120985|P1|Overall Study|Physician Decision|4
26187|NCT01881230|120983|P3|Overall Study|Withdrawal by Subject|6
26188|NCT01881230|120984|P2|Overall Study|Withdrawal by Subject|4
26189|NCT01881230|120985|P1|Overall Study|Withdrawal by Subject|6
26190|NCT01881230|120983|P3|Overall Study|Symptomatic Deterioration|1
26191|NCT01881230|120984|P2|Overall Study|Symptomatic Deterioration|3
26192|NCT01881230|120985|P1|Overall Study|Symptomatic Deterioration|3
26193|NCT01881230|120983|P3|Overall Study|Progressive Disease|36
26194|NCT01881230|120984|P2|Overall Study|Progressive Disease|35
26195|NCT01881230|120985|P1|Overall Study|Progressive Disease|31
26196|NCT01881230|120983|P3|Overall Study|Adverse Event|12
26197|NCT01881230|120984|P2|Overall Study|Adverse Event|13
26198|NCT01881230|120985|P1|Overall Study|Adverse Event|9
26199|NCT01881230|120983|P3|Overall Study|Death|1
26200|NCT01881230|120984|P2|Overall Study|Death|0
26201|NCT01881230|120985|P1|Overall Study|Death|2
26202|NCT01881126|121013|P2|Overall Study|Adverse Event|1
26203|NCT01881126|121014|P1|Overall Study|Adverse Event|0
26204|NCT01881126|121013|P2|Overall Study|Non-compliance|1
26205|NCT01881126|121014|P1|Overall Study|Non-compliance|1
26206|NCT01880736|121106|P4|Overall Study|Withdrawal Criteria|5
26207|NCT01880736|121107|P3|Overall Study|Withdrawal Criteria|1
26208|NCT01880736|121108|P2|Overall Study|Withdrawal Criteria|2
26209|NCT01880736|121109|P1|Overall Study|Withdrawal Criteria|1
26210|NCT01880736|121106|P4|Overall Study|Adverse Event|1
26211|NCT01880736|121107|P3|Overall Study|Adverse Event|0
26212|NCT01880736|121108|P2|Overall Study|Adverse Event|0
26213|NCT01880736|121109|P1|Overall Study|Adverse Event|0
26214|NCT01880515|121193|P2|Overall Study|Disease Progression|7
26215|NCT01880515|121194|P1|Overall Study|Disease Progression|5
26216|NCT01880515|121193|P2|Overall Study|Lost to Follow-up|2
26217|NCT01880515|121194|P1|Overall Study|Lost to Follow-up|3
26218|NCT01880437|121205|P3|Overall Study|Study terminated by Sponsor|2
26219|NCT01880437|121206|P2|Overall Study|Study terminated by Sponsor|0
26220|NCT01880437|121207|P1|Overall Study|Study terminated by Sponsor|3
26221|NCT01880437|121205|P3|Overall Study|Death|17
26222|NCT01880437|121206|P2|Overall Study|Death|4
26223|NCT01880437|121207|P1|Overall Study|Death|12
26224|NCT01880424|121233|P2|Overall Study|Not specified|0
26225|NCT01880424|121234|P1|Overall Study|Not specified|1
26226|NCT01880424|121233|P2|Overall Study|Withdrawal by Subject|30
26227|NCT01880424|121234|P1|Overall Study|Withdrawal by Subject|10
26228|NCT01880424|121233|P2|Overall Study|Protocol Violation|13
26229|NCT01880424|121234|P1|Overall Study|Protocol Violation|11
26230|NCT01880424|121233|P2|Overall Study|Lost to Follow-up|2
26231|NCT01880424|121234|P1|Overall Study|Lost to Follow-up|3
26232|NCT01880424|121233|P2|Overall Study|Lack of Efficacy|4
26233|NCT01880424|121234|P1|Overall Study|Lack of Efficacy|1
26234|NCT01880424|121233|P2|Overall Study|Adverse Event|6
26235|NCT01880424|121234|P1|Overall Study|Adverse Event|7
26236|NCT01880086|121290|P2|Overall Study|Lost to Follow-up|1
26237|NCT01880086|121291|P1|Overall Study|Lost to Follow-up|1
26238|NCT01879852|121311|P2|Overall Study|Withdrawal by Subject|0
26239|NCT01879852|121312|P1|Overall Study|Withdrawal by Subject|2
26240|NCT01879722|121356|P10|Overall Study|Voluntary Withdrawal|0
26241|NCT01879722|121357|P9|Overall Study|Voluntary Withdrawal|1
26242|NCT01879722|121358|P8|Overall Study|Voluntary Withdrawal|0
26243|NCT01879722|121359|P7|Overall Study|Voluntary Withdrawal|0
26244|NCT01879722|121360|P6|Overall Study|Voluntary Withdrawal|0
26245|NCT01879722|121361|P5|Overall Study|Voluntary Withdrawal|0
26246|NCT01879722|121362|P4|Overall Study|Voluntary Withdrawal|0
26247|NCT01879722|121363|P3|Overall Study|Voluntary Withdrawal|0
26248|NCT01879722|121364|P2|Overall Study|Voluntary Withdrawal|0
26249|NCT01879722|121365|P1|Overall Study|Voluntary Withdrawal|0
26250|NCT01879722|121356|P10|Overall Study|Pretreatment Event/Adverse Event|0
26251|NCT01879722|121357|P9|Overall Study|Pretreatment Event/Adverse Event|1
26252|NCT01879722|121358|P8|Overall Study|Pretreatment Event/Adverse Event|1
26253|NCT01879722|121359|P7|Overall Study|Pretreatment Event/Adverse Event|0
26254|NCT01879722|121360|P6|Overall Study|Pretreatment Event/Adverse Event|0
26255|NCT01879722|121361|P5|Overall Study|Pretreatment Event/Adverse Event|1
26256|NCT01879722|121362|P4|Overall Study|Pretreatment Event/Adverse Event|1
26257|NCT01879722|121363|P3|Overall Study|Pretreatment Event/Adverse Event|0
26258|NCT01879722|121364|P2|Overall Study|Pretreatment Event/Adverse Event|1
26259|NCT01879722|121365|P1|Overall Study|Pretreatment Event/Adverse Event|0
26260|NCT01879683|121513|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
26261|NCT01879618|121520|P1|Overall Study|Adverse Event|5
26262|NCT01879618|121520|P1|Overall Study|Protocol Violation|6
26263|NCT01879618|121520|P1|Overall Study|Surgery;changed schedule; not available|8
26264|NCT01879618|121520|P1|Overall Study|Withdrawal by Subject|1
26265|NCT01879618|121520|P1|Overall Study|Does not meet entrance criteria|1
26266|NCT01879579|121527|P2|Overall Study|Discontinued insulin - possible allergy|1
26267|NCT01879579|121528|P1|Overall Study|Discontinued insulin - possible allergy|0
26268|NCT01879579|121527|P2|Overall Study|Phenotypic type 1 diabetes|1
26269|NCT01879579|121528|P1|Overall Study|Phenotypic type 1 diabetes|0
26270|NCT01879579|121527|P2|Overall Study|Did not initiate insulin treatment|0
26271|NCT01879579|121528|P1|Overall Study|Did not initiate insulin treatment|1
26272|NCT01879579|121527|P2|Overall Study|Did not enroll in texting platform|0
26273|NCT01879579|121528|P1|Overall Study|Did not enroll in texting platform|1
26274|NCT01879579|121527|P2|Overall Study|Phone incompatible with texting platform|0
26275|NCT01879579|121528|P1|Overall Study|Phone incompatible with texting platform|3
26276|NCT01879553|121558|P2|Overall Study|Withdrawal by Subject|0
26277|NCT01879553|121559|P1|Overall Study|Withdrawal by Subject|1
26278|NCT01879410|121593|P2|Overall Study|Randomised in Error|2
26279|NCT01879410|121594|P1|Overall Study|Randomised in Error|1
26280|NCT01879410|121593|P2|Overall Study|Withdrawal by Subject|8
26281|NCT01879410|121594|P1|Overall Study|Withdrawal by Subject|7
26282|NCT01879410|121593|P2|Overall Study|Lost to Follow-up|1
26283|NCT01879410|121594|P1|Overall Study|Lost to Follow-up|2
26284|NCT01879410|121593|P2|Overall Study|Protocol Violation|7
26285|NCT01879410|121594|P1|Overall Study|Protocol Violation|1
26286|NCT01879410|121593|P2|Overall Study|Lack of Efficacy|6
26287|NCT01879410|121594|P1|Overall Study|Lack of Efficacy|4
26288|NCT01879410|121593|P2|Overall Study|Adverse Event|14
26289|NCT01879410|121594|P1|Overall Study|Adverse Event|9
26290|NCT01879319|121661|P2|Overall Study|Lost to Follow-up|5
26291|NCT01879319|121662|P1|Overall Study|Lost to Follow-up|1
26292|NCT01879319|121661|P2|Overall Study|Withdrawal by Subject|0
26293|NCT01879319|121662|P1|Overall Study|Withdrawal by Subject|1
26294|NCT01879072|121679|P1|Overall Study|Withdrawal by Subject|48
26295|NCT01878214|121804|P2|Overall Study|Lost to Follow-up|36
26296|NCT01878214|121805|P1|Overall Study|Lost to Follow-up|35
26297|NCT01878214|121804|P2|Overall Study|Death|1
26298|NCT01878214|121805|P1|Overall Study|Death|0
26299|NCT01878214|121804|P2|Overall Study|Withdrawal by Subject|7
26300|NCT01878214|121805|P1|Overall Study|Withdrawal by Subject|18
26301|NCT01878175|121819|P1|Overall Study|Developed contraindicated health problem|2
26302|NCT01878149|121838|P2|Overall Study|Did Not Meet Eligibility Criteria|2
26303|NCT01878149|121839|P1|Overall Study|Did Not Meet Eligibility Criteria|2
26304|NCT01878097|121847|P2|Implementation Year 5|Surveys not fully completed|3007
26305|NCT01878097|121848|P1|Implementation Year 5|Surveys not fully completed|3604
26306|NCT01878097|121847|P2|Implementation Year 3|Surveys not fully completed|2980
26307|NCT01878097|121848|P1|Implementation Year 3|Surveys not fully completed|3494
26308|NCT01878097|121847|P2|Implementation Year 2|Surveys not fully completed|2841
26309|NCT01878097|121848|P1|Implementation Year 2|Surveys not fully completed|3281
26310|NCT01878097|121847|P2|Implementation Year 1|Surveys not fully completed|2549
26311|NCT01878097|121848|P1|Implementation Year 1|Surveys not fully completed|3202
26312|NCT01878097|121847|P2|Baseline|Surveys not fully completed|1800
26313|NCT01878097|121848|P1|Baseline|Surveys not fully completed|2497
26314|NCT01877720|121864|P2|Overall Study|Adverse Event|0
26315|NCT01877720|121865|P1|Overall Study|Adverse Event|1
26316|NCT01877668|121894|P5|Overall Study|Adverse event unrelated to study drug|1
26317|NCT01877668|121895|P4|Overall Study|Adverse event unrelated to study drug|0
26318|NCT01877668|121896|P3|Overall Study|Adverse event unrelated to study drug|2
26319|NCT01877668|121897|P2|Overall Study|Adverse event unrelated to study drug|1
26320|NCT01877668|121898|P1|Overall Study|Adverse event unrelated to study drug|4
26321|NCT01877668|121894|P5|Overall Study|Adverse event related to study drug|1
26322|NCT01877668|121895|P4|Overall Study|Adverse event related to study drug|2
26323|NCT01877668|121896|P3|Overall Study|Adverse event related to study drug|2
26324|NCT01877668|121897|P2|Overall Study|Adverse event related to study drug|2
26325|NCT01877668|121898|P1|Overall Study|Adverse event related to study drug|2
26326|NCT01877668|121894|P5|Overall Study|Protocol Violation|3
26327|NCT01877668|121895|P4|Overall Study|Protocol Violation|0
26328|NCT01877668|121896|P3|Overall Study|Protocol Violation|0
26329|NCT01877668|121897|P2|Overall Study|Protocol Violation|1
26330|NCT01877668|121898|P1|Overall Study|Protocol Violation|1
26331|NCT01877668|121894|P5|Overall Study|Not specified|3
26332|NCT01877668|121895|P4|Overall Study|Not specified|1
26333|NCT01877668|121896|P3|Overall Study|Not specified|1
26334|NCT01877668|121897|P2|Overall Study|Not specified|1
26335|NCT01877668|121898|P1|Overall Study|Not specified|1
26336|NCT01877668|121894|P5|Overall Study|Withdrawal by Subject|2
26337|NCT01877668|121895|P4|Overall Study|Withdrawal by Subject|2
26338|NCT01877668|121896|P3|Overall Study|Withdrawal by Subject|3
26339|NCT01877668|121897|P2|Overall Study|Withdrawal by Subject|0
26340|NCT01877668|121898|P1|Overall Study|Withdrawal by Subject|2
26341|NCT01877668|121894|P5|Overall Study|Lost to Follow-up|0
26342|NCT01877668|121895|P4|Overall Study|Lost to Follow-up|0
26343|NCT01877668|121896|P3|Overall Study|Lost to Follow-up|1
26344|NCT01877668|121897|P2|Overall Study|Lost to Follow-up|2
26345|NCT01877668|121898|P1|Overall Study|Lost to Follow-up|0
26346|NCT01877668|121894|P5|Overall Study|Insufficient clinical response|0
26347|NCT01877668|121895|P4|Overall Study|Insufficient clinical response|2
26348|NCT01877668|121896|P3|Overall Study|Insufficient clinical response|2
26349|NCT01877668|121897|P2|Overall Study|Insufficient clinical response|1
26350|NCT01877668|121898|P1|Overall Study|Insufficient clinical response|0
26351|NCT01877668|121894|P5|Overall Study|No longer met study criteria|0
26352|NCT01877668|121895|P4|Overall Study|No longer met study criteria|0
26353|NCT01877668|121896|P3|Overall Study|No longer met study criteria|1
26354|NCT01877668|121897|P2|Overall Study|No longer met study criteria|0
26355|NCT01877668|121898|P1|Overall Study|No longer met study criteria|1
26356|NCT01877668|121894|P5|Overall Study|Death|0
26357|NCT01877668|121895|P4|Overall Study|Death|1
26358|NCT01877668|121896|P3|Overall Study|Death|0
26359|NCT01877668|121897|P2|Overall Study|Death|0
26360|NCT01877668|121898|P1|Overall Study|Death|0
26361|NCT01877421|122202|P18|Phase 2|Protocol Violation|0
26362|NCT01877421|122203|P17|Phase 2|Protocol Violation|0
26363|NCT01877421|122204|P16|Phase 2|Protocol Violation|0
26364|NCT01877421|122205|P15|Phase 2|Protocol Violation|0
26365|NCT01877421|122206|P14|Phase 2|Protocol Violation|0
26366|NCT01877421|122207|P13|Phase 2|Protocol Violation|0
26367|NCT01877421|122208|P12|Phase 2|Protocol Violation|0
26368|NCT01877421|122209|P11|Phase 2|Protocol Violation|1
26369|NCT01877421|122210|P10|Phase 2|Protocol Violation|0
26370|NCT01877421|122211|P9|Phase 2|Protocol Violation|0
26371|NCT01877421|122212|P8|Phase 2|Protocol Violation|0
26372|NCT01877421|122213|P7|Phase 2|Protocol Violation|0
26373|NCT01877421|122214|P6|Phase 2|Protocol Violation|0
26374|NCT01877421|122215|P5|Phase 2|Protocol Violation|0
26375|NCT01877421|122216|P4|Phase 2|Protocol Violation|0
26376|NCT01877421|122217|P3|Phase 2|Protocol Violation|0
26377|NCT01877421|122218|P2|Phase 2|Protocol Violation|0
26378|NCT01877421|122219|P1|Phase 2|Protocol Violation|0
26379|NCT01877421|122202|P18|Phase 2|Withdrawal by Subject|0
26380|NCT01877421|122203|P17|Phase 2|Withdrawal by Subject|0
26381|NCT01877421|122204|P16|Phase 2|Withdrawal by Subject|1
26382|NCT01877421|122205|P15|Phase 2|Withdrawal by Subject|0
26383|NCT01877421|122206|P14|Phase 2|Withdrawal by Subject|0
26384|NCT01877421|122207|P13|Phase 2|Withdrawal by Subject|1
26385|NCT01877421|122208|P12|Phase 2|Withdrawal by Subject|0
26386|NCT01877421|122209|P11|Phase 2|Withdrawal by Subject|1
26387|NCT01877421|122210|P10|Phase 2|Withdrawal by Subject|0
26388|NCT01877421|122211|P9|Phase 2|Withdrawal by Subject|1
26389|NCT01877421|122212|P8|Phase 2|Withdrawal by Subject|0
26390|NCT01877421|122213|P7|Phase 2|Withdrawal by Subject|0
26391|NCT01877421|122214|P6|Phase 2|Withdrawal by Subject|0
26392|NCT01877421|122215|P5|Phase 2|Withdrawal by Subject|0
26393|NCT01877421|122216|P4|Phase 2|Withdrawal by Subject|0
26394|NCT01877421|122217|P3|Phase 2|Withdrawal by Subject|0
26395|NCT01877421|122218|P2|Phase 2|Withdrawal by Subject|0
26396|NCT01877421|122219|P1|Phase 2|Withdrawal by Subject|0
26397|NCT01877421|122202|P18|Phase 2|Lost to Follow-up|0
26398|NCT01877421|122203|P17|Phase 2|Lost to Follow-up|0
26399|NCT01877421|122204|P16|Phase 2|Lost to Follow-up|0
26400|NCT01877421|122205|P15|Phase 2|Lost to Follow-up|0
26401|NCT01877421|122206|P14|Phase 2|Lost to Follow-up|0
26402|NCT01877421|122207|P13|Phase 2|Lost to Follow-up|0
26403|NCT01877421|122208|P12|Phase 2|Lost to Follow-up|0
26404|NCT01877421|122209|P11|Phase 2|Lost to Follow-up|0
26405|NCT01877421|122210|P10|Phase 2|Lost to Follow-up|0
26406|NCT01877421|122211|P9|Phase 2|Lost to Follow-up|0
26407|NCT01877421|122212|P8|Phase 2|Lost to Follow-up|0
26408|NCT01877421|122213|P7|Phase 2|Lost to Follow-up|1
26409|NCT01877421|122214|P6|Phase 2|Lost to Follow-up|0
26410|NCT01877421|122215|P5|Phase 2|Lost to Follow-up|0
26411|NCT01877421|122216|P4|Phase 2|Lost to Follow-up|0
26412|NCT01877421|122217|P3|Phase 2|Lost to Follow-up|0
26413|NCT01877421|122218|P2|Phase 2|Lost to Follow-up|0
26414|NCT01877421|122219|P1|Phase 2|Lost to Follow-up|0
26415|NCT01877408|122329|P2|Overall Study|Lost to Follow-up|2
26416|NCT01877408|122330|P1|Overall Study|Lost to Follow-up|0
26417|NCT01877278|122363|P2|Overall Study|Lost to Follow-up|3
26418|NCT01877278|122364|P1|Overall Study|Lost to Follow-up|3
26419|NCT01876979|122412|P2|Overall Study|Physician Decision|3
26420|NCT01876979|122413|P1|Overall Study|Physician Decision|2
26421|NCT01876823|122419|P1|Overall Study|Patients moved|2
26422|NCT01876823|122419|P1|Overall Study|Physician Decision|2
26423|NCT01876823|122419|P1|Overall Study|Withdrawal by Subject|5
26424|NCT01876810|122432|P2|Overall Study|Physician Decision|1
26425|NCT01876810|122433|P1|Overall Study|Physician Decision|0
26426|NCT01876784|122445|P2|Overall Study|Ongoing|40
26427|NCT01876784|122446|P1|Overall Study|Ongoing|41
26428|NCT01876784|122445|P2|Overall Study|Other than specified above|6
26429|NCT01876784|122446|P1|Overall Study|Other than specified above|5
26430|NCT01876784|122445|P2|Overall Study|Randomized but not treated|1
26431|NCT01876784|122446|P1|Overall Study|Randomized but not treated|2
26432|NCT01876784|122445|P2|Overall Study|Death|0
26433|NCT01876784|122446|P1|Overall Study|Death|1
26434|NCT01876784|122445|P2|Overall Study|Lost to Follow-up|1
26435|NCT01876784|122446|P1|Overall Study|Lost to Follow-up|0
26436|NCT01876784|122445|P2|Overall Study|Disease progression|67
26437|NCT01876784|122446|P1|Overall Study|Disease progression|37
26438|NCT01876784|122445|P2|Overall Study|Protocol Violation|0
26439|NCT01876784|122446|P1|Overall Study|Protocol Violation|1
26440|NCT01876784|122445|P2|Overall Study|Adverse Event|2
26441|NCT01876784|122446|P1|Overall Study|Adverse Event|15
26442|NCT01876784|122445|P2|Overall Study|Withdrawal by Subject|2
26443|NCT01876784|122446|P1|Overall Study|Withdrawal by Subject|17
26444|NCT01876732|122452|P1|Overall Study|MMA was not over 800mg/dL|75
26445|NCT01876706|122457|P1|Overall Study|Lost to Follow-up|2
26446|NCT01876706|122457|P1|Overall Study|BPH Intervention|2
26447|NCT01876368|122476|P2|Overall Study|Subject/guardian decision|1
26448|NCT01876368|122477|P1|Overall Study|Subject/guardian decision|3
26449|NCT01876368|122476|P2|Overall Study|Protocol deviation|3
26450|NCT01876368|122477|P1|Overall Study|Protocol deviation|3
26451|NCT01876368|122476|P2|Overall Study|Physician Decision|2
26452|NCT01876368|122477|P1|Overall Study|Physician Decision|0
26453|NCT01876368|122476|P2|Overall Study|Non-compliance with study treatment|1
26454|NCT01876368|122477|P1|Overall Study|Non-compliance with study treatment|0
26455|NCT01876368|122476|P2|Overall Study|Lost to Follow-up|1
26456|NCT01876368|122477|P1|Overall Study|Lost to Follow-up|0
26457|NCT01876368|122476|P2|Overall Study|Lack of Efficacy|0
26458|NCT01876368|122477|P1|Overall Study|Lack of Efficacy|1
26459|NCT01876368|122476|P2|Overall Study|Adverse Event|5
26460|NCT01876368|122477|P1|Overall Study|Adverse Event|2
26461|NCT01875991|122521|P2|Overall Study|Sponsor Decision|0
26462|NCT01875991|122522|P1|Overall Study|Sponsor Decision|1
26463|NCT01875991|122521|P2|Overall Study|Withdrawal by Subject|6
26464|NCT01875991|122522|P1|Overall Study|Withdrawal by Subject|6
26465|NCT01875848|122560|P2|Overall Study|Withdrawal by Subject|0
26466|NCT01875848|122561|P1|Overall Study|Withdrawal by Subject|2
26467|NCT01875731|122578|P2|Overall Study|Fail to obtain lab sample|0
26468|NCT01875731|122579|P1|Overall Study|Fail to obtain lab sample|1
26469|NCT01875471|122598|P2|Overall Study|Unsatisfactory Lens Fitting|0
26470|NCT01875471|122599|P1|Overall Study|Unsatisfactory Lens Fitting|1
26471|NCT01875471|122598|P2|Overall Study|Adverse Event|1
26472|NCT01875471|122599|P1|Overall Study|Adverse Event|0
26473|NCT01875445|122607|P2|Overall Study|Withdrawal by Subject|0
26474|NCT01875445|122608|P1|Overall Study|Withdrawal by Subject|2
26475|NCT01875445|122607|P2|Overall Study|Lost to Follow-up|0
26476|NCT01875445|122608|P1|Overall Study|Lost to Follow-up|5
26477|NCT01875185|122618|P2|Overall Study|study was terminated|48
26478|NCT01875185|122619|P1|Overall Study|study was terminated|52
26479|NCT01874665|122667|P2|Overall Study|Other|0
26480|NCT01874665|122668|P1|Overall Study|Other|2
26481|NCT01874665|122667|P2|Overall Study|Documented Progressive Disease|7
26482|NCT01874665|122668|P1|Overall Study|Documented Progressive Disease|11
26483|NCT01874665|122667|P2|Overall Study|Study Terminated by Sponsor|2
26484|NCT01874665|122668|P1|Overall Study|Study Terminated by Sponsor|0
26485|NCT01874665|122667|P2|Overall Study|Clinical Progressive Disease|3
26486|NCT01874665|122668|P1|Overall Study|Clinical Progressive Disease|4
26487|NCT01874665|122667|P2|Overall Study|Physician Decision|0
26488|NCT01874665|122668|P1|Overall Study|Physician Decision|3
26489|NCT01874665|122667|P2|Overall Study|Withdrawal by Subject|1
26490|NCT01874665|122668|P1|Overall Study|Withdrawal by Subject|4
26491|NCT01874665|122667|P2|Overall Study|Adverse Event|2
26492|NCT01874665|122668|P1|Overall Study|Adverse Event|6
26493|NCT01874353|122696|P2|Overall Study|Withdrawal by Subject|9
26494|NCT01874353|122697|P1|Overall Study|Withdrawal by Subject|7
26495|NCT01874353|122696|P2|Overall Study|Death|27
26496|NCT01874353|122697|P1|Overall Study|Death|45
26497|NCT01874353|122696|P2|Overall Study|Lost to Follow-up|1
26498|NCT01874353|122697|P1|Overall Study|Lost to Follow-up|1
26499|NCT01874353|122696|P2|Overall Study|Other|0
26500|NCT01874353|122697|P1|Overall Study|Other|2
26501|NCT01874340|122724|P4|Overall Study|Withdrawal by Subject|1
26502|NCT01874340|122725|P3|Overall Study|Withdrawal by Subject|0
26503|NCT01874340|122726|P2|Overall Study|Withdrawal by Subject|0
26504|NCT01874340|122727|P1|Overall Study|Withdrawal by Subject|0
26505|NCT01874340|122724|P4|Overall Study|Study terminated by Sponsor|4
26506|NCT01874340|122725|P3|Overall Study|Study terminated by Sponsor|8
26507|NCT01874340|122726|P2|Overall Study|Study terminated by Sponsor|8
26508|NCT01874340|122727|P1|Overall Study|Study terminated by Sponsor|6
26509|NCT01874275|122755|P2|Overall Study|Lost to Follow-up|0
26510|NCT01874275|122756|P1|Overall Study|Lost to Follow-up|1
26511|NCT01874145|122779|P2|Extension Period|Lost to Follow-up|1
26512|NCT01874145|122780|P1|Extension Period|Lost to Follow-up|1
26513|NCT01874145|122779|P2|Extension Period|Withdrawal by Subject|1
26514|NCT01874145|122780|P1|Extension Period|Withdrawal by Subject|2
26515|NCT01874145|122779|P2|Extension Period|Adverse Event|2
26516|NCT01874145|122780|P1|Extension Period|Adverse Event|3
26517|NCT01874145|122779|P2|Core Period|Withdrawal by Subject|4
26518|NCT01874145|122780|P1|Core Period|Withdrawal by Subject|0
26519|NCT01874145|122779|P2|Core Period|Adverse Event|1
26520|NCT01874145|122780|P1|Core Period|Adverse Event|0
26521|NCT01874145|122779|P2|Core Period|Physician Decision|1
26522|NCT01874145|122780|P1|Core Period|Physician Decision|1
26523|NCT01874145|122779|P2|Core Period|Protocol Violation|1
26524|NCT01874145|122780|P1|Core Period|Protocol Violation|1
26525|NCT01874145|122779|P2|Core Period|Non-compliance|0
26526|NCT01874145|122780|P1|Core Period|Non-compliance|1
26527|NCT01874054|122839|P1|Follow-up Period|Continuing in Follow-up|48
26528|NCT01874054|122839|P1|Follow-up Period|Withdrawal by Subject|1
26529|NCT01874054|122839|P1|Treatment Period|Non-AE related|2
26530|NCT01874054|122839|P1|Treatment Period|Withdrawal by Subject|6
26531|NCT01874054|122839|P1|Treatment Period|Physician Decision|3
26532|NCT01874054|122839|P1|Treatment Period|Adverse Event|20
26533|NCT01874054|122839|P1|Treatment Period|Progressive Disease|7
26534|NCT01873950|122861|P5|Period 5|Withdrawal by Subject|0
26535|NCT01873950|122862|P4|Period 5|Withdrawal by Subject|1
26536|NCT01873950|122863|P3|Period 5|Withdrawal by Subject|0
26537|NCT01873950|122864|P2|Period 5|Withdrawal by Subject|0
26538|NCT01873950|122865|P1|Period 5|Withdrawal by Subject|0
26539|NCT01873859|122902|P2|Overall Study|Withdrawal by Subject|4
26540|NCT01873859|122903|P1|Overall Study|Withdrawal by Subject|0
26541|NCT01873729|122911|P1|Overall Study|Withdrawal by Subject|1
26542|NCT01873417|122916|P1|Overall Study|Physician Decision|3
26543|NCT01873417|122916|P1|Overall Study|Withdrawal by Subject|2
26544|NCT01873417|122916|P1|Overall Study|Lost to Follow-up|2
26545|NCT01873417|122916|P1|Overall Study|Adverse Event|24
26546|NCT01873417|122916|P1|Overall Study|Did Not Receive Any Study Drug|4
26547|NCT01872910|122933|P6|Overall Study|Lost to Follow-up|0
26548|NCT01872910|122934|P5|Overall Study|Lost to Follow-up|0
26549|NCT01872910|122935|P4|Overall Study|Lost to Follow-up|0
26550|NCT01872910|122936|P3|Overall Study|Lost to Follow-up|2
26551|NCT01872910|122937|P2|Overall Study|Lost to Follow-up|0
26552|NCT01872910|122938|P1|Overall Study|Lost to Follow-up|2
26553|NCT01872715|122983|P1|Overall Study|Withdrawal by Subject|2
26554|NCT01872715|122983|P1|Overall Study|Protocol Violation|1
26555|NCT01872715|122983|P1|Overall Study|Adverse Event|1
26556|NCT01872611|123000|P2|Overall Study|Reason not provided|6
26557|NCT01872611|123001|P1|Overall Study|Reason not provided|6
26558|NCT01872611|123000|P2|Overall Study|Withdrawal by Subject|1
26559|NCT01872611|123001|P1|Overall Study|Withdrawal by Subject|6
26560|NCT01872611|123000|P2|Overall Study|Physician Decision|0
26561|NCT01872611|123001|P1|Overall Study|Physician Decision|1
26562|NCT01872611|123000|P2|Overall Study|Lost to Follow-up|1
26563|NCT01872611|123001|P1|Overall Study|Lost to Follow-up|8
26564|NCT01872611|123000|P2|Overall Study|Death, prior to treatment|1
26565|NCT01872611|123001|P1|Overall Study|Death, prior to treatment|0
26566|NCT01872611|123000|P2|Overall Study|Death|1
26567|NCT01872611|123001|P1|Overall Study|Death|0
26568|NCT01872611|123000|P2|Overall Study|Adverse Event, prior to treatment|1
26569|NCT01872611|123001|P1|Overall Study|Adverse Event, prior to treatment|0
26570|NCT01872611|123000|P2|Overall Study|Adverse Event|1
26571|NCT01872611|123001|P1|Overall Study|Adverse Event|3
26572|NCT01872078|123023|P4|Overall Study|Patient met exclusion criterion 16.|1
26573|NCT01872078|123024|P3|Overall Study|Patient met exclusion criterion 16.|0
26574|NCT01872078|123025|P2|Overall Study|Patient met exclusion criterion 16.|0
26575|NCT01872078|123026|P1|Overall Study|Patient met exclusion criterion 16.|0
26576|NCT01872078|123023|P4|Overall Study|Withdrawal by Subject|0
26577|NCT01872078|123024|P3|Overall Study|Withdrawal by Subject|1
26578|NCT01872078|123025|P2|Overall Study|Withdrawal by Subject|0
26579|NCT01872078|123026|P1|Overall Study|Withdrawal by Subject|0
26580|NCT01872078|123023|P4|Overall Study|Protocol Violation|0
26581|NCT01872078|123024|P3|Overall Study|Protocol Violation|1
26582|NCT01872078|123025|P2|Overall Study|Protocol Violation|0
26583|NCT01872078|123026|P1|Overall Study|Protocol Violation|0
26584|NCT01872078|123023|P4|Overall Study|Dose administration non-compliance|1
26585|NCT01872078|123024|P3|Overall Study|Dose administration non-compliance|0
26586|NCT01872078|123025|P2|Overall Study|Dose administration non-compliance|0
26587|NCT01872078|123026|P1|Overall Study|Dose administration non-compliance|0
26588|NCT01872078|123023|P4|Overall Study|Adverse Event|0
26589|NCT01872078|123024|P3|Overall Study|Adverse Event|1
26590|NCT01872078|123025|P2|Overall Study|Adverse Event|0
26591|NCT01872078|123026|P1|Overall Study|Adverse Event|0
26592|NCT01871870|123036|P1|Overall Study|hyperglycemia|2
26593|NCT01871870|123036|P1|Overall Study|Hardware issues|7
26594|NCT01871805|123047|P6|Phase II|Lost to Follow-up|2
26595|NCT01871805|123048|P5|Phase II|Lost to Follow-up|0
26596|NCT01871805|123049|P4|Phase II|Lost to Follow-up|0
26597|NCT01871805|123050|P3|Phase II|Lost to Follow-up|0
26598|NCT01871805|123051|P2|Phase II|Lost to Follow-up|0
26599|NCT01871805|123052|P1|Phase II|Lost to Follow-up|0
26600|NCT01871805|123047|P6|Phase II|Alive in Survival Follow-up|17
26601|NCT01871805|123048|P5|Phase II|Alive in Survival Follow-up|0
26602|NCT01871805|123049|P4|Phase II|Alive in Survival Follow-up|0
26603|NCT01871805|123050|P3|Phase II|Alive in Survival Follow-up|0
26604|NCT01871805|123051|P2|Phase II|Alive in Survival Follow-up|0
26605|NCT01871805|123052|P1|Phase II|Alive in Survival Follow-up|0
26606|NCT01871805|123047|P6|Phase II|Alive on Treatment|56
26607|NCT01871805|123048|P5|Phase II|Alive on Treatment|0
26608|NCT01871805|123049|P4|Phase II|Alive on Treatment|0
26609|NCT01871805|123050|P3|Phase II|Alive on Treatment|0
26610|NCT01871805|123051|P2|Phase II|Alive on Treatment|0
26611|NCT01871805|123052|P1|Phase II|Alive on Treatment|0
26612|NCT01871805|123047|P6|Phase II|Death|12
26613|NCT01871805|123048|P5|Phase II|Death|0
26614|NCT01871805|123049|P4|Phase II|Death|0
26615|NCT01871805|123050|P3|Phase II|Death|0
26616|NCT01871805|123051|P2|Phase II|Death|0
26617|NCT01871805|123052|P1|Phase II|Death|0
26618|NCT01871805|123047|P6|Phase I|Lost to Follow-up|0
26619|NCT01871805|123048|P5|Phase I|Lost to Follow-up|0
26620|NCT01871805|123049|P4|Phase I|Lost to Follow-up|0
26621|NCT01871805|123050|P3|Phase I|Lost to Follow-up|0
26622|NCT01871805|123051|P2|Phase I|Lost to Follow-up|1
26623|NCT01871805|123052|P1|Phase I|Lost to Follow-up|0
26624|NCT01871805|123047|P6|Phase I|Alive in Survival Follow-up|0
26625|NCT01871805|123048|P5|Phase I|Alive in Survival Follow-up|4
26626|NCT01871805|123049|P4|Phase I|Alive in Survival Follow-up|1
26627|NCT01871805|123050|P3|Phase I|Alive in Survival Follow-up|3
26628|NCT01871805|123051|P2|Phase I|Alive in Survival Follow-up|0
26629|NCT01871805|123052|P1|Phase I|Alive in Survival Follow-up|1
26630|NCT01871805|123047|P6|Phase I|Alive on Treatment|0
26631|NCT01871805|123048|P5|Phase I|Alive on Treatment|3
26632|NCT01871805|123049|P4|Phase I|Alive on Treatment|4
26633|NCT01871805|123050|P3|Phase I|Alive on Treatment|5
26634|NCT01871805|123051|P2|Phase I|Alive on Treatment|3
26635|NCT01871805|123052|P1|Phase I|Alive on Treatment|0
26636|NCT01871805|123047|P6|Phase I|Death|0
26637|NCT01871805|123048|P5|Phase I|Death|6
26638|NCT01871805|123049|P4|Phase I|Death|2
26639|NCT01871805|123050|P3|Phase I|Death|5
26640|NCT01871805|123051|P2|Phase I|Death|3
26641|NCT01871805|123052|P1|Phase I|Death|6
26642|NCT01871558|123120|P2|Overall Study|Withdrawal by Subject|0
26643|NCT01871558|123121|P1|Overall Study|Withdrawal by Subject|2
26644|NCT01871558|123120|P2|Overall Study|antidiabetic drug prematurely stopped|1
26645|NCT01871558|123121|P1|Overall Study|antidiabetic drug prematurely stopped|1
26646|NCT01871558|123120|P2|Overall Study|Other reason|1
26647|NCT01871558|123121|P1|Overall Study|Other reason|0
26648|NCT01871532|123141|P2|Overall Study|Withdrawal by Subject|2
26649|NCT01871532|123142|P1|Overall Study|Withdrawal by Subject|1
26650|NCT01871519|123176|P1|Overall Study|Withdrawal by Subject|49
26651|NCT01871519|123176|P1|Overall Study|Lost to Follow-up|15
26652|NCT01871519|123176|P1|Overall Study|Death|26
26653|NCT01871402|123206|P2|Overall Study|Non-compliance|1
26654|NCT01871402|123207|P1|Overall Study|Non-compliance|0
26655|NCT01871402|123206|P2|Overall Study|Withdrawal by Subject|2
26656|NCT01871402|123207|P1|Overall Study|Withdrawal by Subject|0
26657|NCT01871402|123206|P2|Overall Study|Lost to Follow-up|0
26658|NCT01871402|123207|P1|Overall Study|Lost to Follow-up|1
26659|NCT01871285|123225|P4|First Intervention (1 Day)|Lost to Follow-up|0
26660|NCT01871285|123226|P3|First Intervention (1 Day)|Lost to Follow-up|1
26661|NCT01871285|123227|P2|First Intervention (1 Day)|Lost to Follow-up|1
26662|NCT01871285|123228|P1|First Intervention (1 Day)|Lost to Follow-up|0
26663|NCT01871285|123225|P4|First Intervention (1 Day)|Adverse Event|0
26664|NCT01871285|123226|P3|First Intervention (1 Day)|Adverse Event|0
26665|NCT01871285|123227|P2|First Intervention (1 Day)|Adverse Event|0
26666|NCT01871285|123228|P1|First Intervention (1 Day)|Adverse Event|1
26667|NCT01871142|123254|P1|Overall Study|Adverse Event|1
26668|NCT01871090|123270|P2|Overall Study|Subject Non-Compliance|1
26669|NCT01871090|123271|P1|Overall Study|Subject Non-Compliance|0
26670|NCT01871090|123270|P2|Overall Study|Interrogation not completed correctly|0
26671|NCT01871090|123271|P1|Overall Study|Interrogation not completed correctly|1
26672|NCT01871090|123270|P2|Overall Study|Interrogation not done in Emergency Room|22
26673|NCT01871090|123271|P1|Overall Study|Interrogation not done in Emergency Room|1
26674|NCT01870999|123284|P3|Overall Study|Protocol Violation|1
26675|NCT01870999|123285|P2|Overall Study|Protocol Violation|0
26676|NCT01870999|123286|P1|Overall Study|Protocol Violation|0
26677|NCT01870999|123284|P3|Overall Study|Withdrawal by Subject|5
26678|NCT01870999|123285|P2|Overall Study|Withdrawal by Subject|2
26679|NCT01870999|123286|P1|Overall Study|Withdrawal by Subject|0
26680|NCT01870999|123284|P3|Overall Study|Subject withdrawn by Investigator|0
26681|NCT01870999|123285|P2|Overall Study|Subject withdrawn by Investigator|0
26682|NCT01870999|123286|P1|Overall Study|Subject withdrawn by Investigator|1
26683|NCT01870999|123284|P3|Overall Study|Subject met withdrawal criteria|0
26684|NCT01870999|123285|P2|Overall Study|Subject met withdrawal criteria|2
26685|NCT01870999|123286|P1|Overall Study|Subject met withdrawal criteria|3
26686|NCT01870999|123284|P3|Overall Study|Adverse Event|1
26687|NCT01870999|123285|P2|Overall Study|Adverse Event|4
26688|NCT01870999|123286|P1|Overall Study|Adverse Event|0
26689|NCT01870973|123344|P2|Overall Study|Lost to Follow-up|3
26690|NCT01870973|123345|P1|Overall Study|Lost to Follow-up|10
26691|NCT01870921|123351|P1|Overall Study|Other|1
26692|NCT01870921|123351|P1|Overall Study|Subject Lost to Follow up|2
26693|NCT01870921|123351|P1|Overall Study|Severe non-compliance to protocol|7
26694|NCT01870921|123351|P1|Overall Study|Subject decision|80
26695|NCT01870843|123370|P1|Overall Study|Withdrawal by Subject|18
26696|NCT01870843|123370|P1|Overall Study|Death|1
26697|NCT01870843|123370|P1|Overall Study|Lost to Follow-up|24
26698|NCT01870843|123370|P1|Overall Study|Adverse Event|10
26699|NCT01870778|123385|P2|Overall Study|Lost to Follow-up|2
26700|NCT01870778|123386|P1|Overall Study|Lost to Follow-up|0
26701|NCT01870778|123385|P2|Overall Study|Withdrawal by Subject|7
26702|NCT01870778|123386|P1|Overall Study|Withdrawal by Subject|8
26703|NCT01870739|123412|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
26704|NCT01870739|123413|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
26705|NCT01870739|123412|P2|Add-on Period (40 Weeks)|Protocol deviation|1
26706|NCT01870739|123413|P1|Add-on Period (40 Weeks)|Protocol deviation|1
26707|NCT01870739|123412|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
26708|NCT01870739|123413|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
26709|NCT01870739|123412|P2|Add-on Period (40 Weeks)|Adverse Event|1
26710|NCT01870739|123413|P1|Add-on Period (40 Weeks)|Adverse Event|0
26711|NCT01870739|123412|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
26712|NCT01870739|123413|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
26713|NCT01870739|123412|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
26714|NCT01870739|123413|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
26715|NCT01870739|123412|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
26716|NCT01870739|123413|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
26717|NCT01870726|123452|P7|Overall Study|Progressive disease|10
26718|NCT01870726|123453|P6|Overall Study|Progressive disease|4
26719|NCT01870726|123454|P5|Overall Study|Progressive disease|6
26720|NCT01870726|123455|P4|Overall Study|Progressive disease|5
26721|NCT01870726|123456|P3|Overall Study|Progressive disease|4
26722|NCT01870726|123457|P2|Overall Study|Progressive disease|5
26723|NCT01870726|123458|P1|Overall Study|Progressive disease|5
26724|NCT01870726|123452|P7|Overall Study|Adverse Event|0
26725|NCT01870726|123453|P6|Overall Study|Adverse Event|1
26726|NCT01870726|123454|P5|Overall Study|Adverse Event|1
26727|NCT01870726|123455|P4|Overall Study|Adverse Event|0
26728|NCT01870726|123456|P3|Overall Study|Adverse Event|0
26729|NCT01870726|123457|P2|Overall Study|Adverse Event|0
26730|NCT01870726|123458|P1|Overall Study|Adverse Event|0
26731|NCT01870726|123452|P7|Overall Study|Withdrawal by Subject|0
26732|NCT01870726|123453|P6|Overall Study|Withdrawal by Subject|0
26733|NCT01870726|123454|P5|Overall Study|Withdrawal by Subject|0
26734|NCT01870726|123455|P4|Overall Study|Withdrawal by Subject|0
26735|NCT01870726|123456|P3|Overall Study|Withdrawal by Subject|0
26736|NCT01870726|123457|P2|Overall Study|Withdrawal by Subject|1
26737|NCT01870726|123458|P1|Overall Study|Withdrawal by Subject|0
26738|NCT01870726|123452|P7|Overall Study|Withdrawal of informed consent|0
26739|NCT01870726|123453|P6|Overall Study|Withdrawal of informed consent|0
26740|NCT01870726|123454|P5|Overall Study|Withdrawal of informed consent|0
26741|NCT01870726|123455|P4|Overall Study|Withdrawal of informed consent|1
26742|NCT01870726|123456|P3|Overall Study|Withdrawal of informed consent|0
26743|NCT01870726|123457|P2|Overall Study|Withdrawal of informed consent|0
26744|NCT01870726|123458|P1|Overall Study|Withdrawal of informed consent|0
26745|NCT01870583|123553|P3|Overall Study|Lost to Follow-up|5
26746|NCT01870583|123554|P2|Overall Study|Lost to Follow-up|13
26747|NCT01870583|123555|P1|Overall Study|Lost to Follow-up|11
26748|NCT01870583|123553|P3|Overall Study|Protocol Violation|3
26749|NCT01870583|123554|P2|Overall Study|Protocol Violation|5
26750|NCT01870583|123555|P1|Overall Study|Protocol Violation|0
26751|NCT01870076|123578|P4|Overall Study|Withdrawal by Subject|0
26752|NCT01870076|123579|P3|Overall Study|Withdrawal by Subject|1
26753|NCT01870076|123580|P2|Overall Study|Withdrawal by Subject|0
26754|NCT01870076|123581|P1|Overall Study|Withdrawal by Subject|1
26755|NCT01869959|123599|P5|Treatment Period|Withdrawal by Subject|0
26756|NCT01869959|123600|P4|Treatment Period|Withdrawal by Subject|0
26757|NCT01869959|123601|P3|Treatment Period|Withdrawal by Subject|0
26758|NCT01869959|123602|P2|Treatment Period|Withdrawal by Subject|1
26759|NCT01869959|123603|P1|Treatment Period|Withdrawal by Subject|0
26760|NCT01869959|123599|P5|Treatment Period|Sponsor decision|0
26761|NCT01869959|123600|P4|Treatment Period|Sponsor decision|1
26762|NCT01869959|123601|P3|Treatment Period|Sponsor decision|0
26763|NCT01869959|123602|P2|Treatment Period|Sponsor decision|1
26764|NCT01869959|123603|P1|Treatment Period|Sponsor decision|0
26765|NCT01869959|123599|P5|Treatment Period|Adverse Event|0
26766|NCT01869959|123600|P4|Treatment Period|Adverse Event|1
26767|NCT01869959|123601|P3|Treatment Period|Adverse Event|3
26768|NCT01869959|123602|P2|Treatment Period|Adverse Event|0
26769|NCT01869959|123603|P1|Treatment Period|Adverse Event|1
26770|NCT01869959|123599|P5|Randomization Period|Physician Decision|1
26771|NCT01869959|123600|P4|Randomization Period|Physician Decision|0
26772|NCT01869959|123601|P3|Randomization Period|Physician Decision|0
26773|NCT01869959|123602|P2|Randomization Period|Physician Decision|0
26774|NCT01869959|123603|P1|Randomization Period|Physician Decision|0
26775|NCT01869699|123673|P2|Overall Study|Withdrawal by Subject|0
26776|NCT01869699|123674|P1|Overall Study|Withdrawal by Subject|1
26777|NCT01869348|123737|P2|Overall Study|Withdrawal by Subject|1
26778|NCT01869348|123738|P1|Overall Study|Withdrawal by Subject|1
26779|NCT01868997|123771|P2|Overall Study|Not Specified|1
26780|NCT01868997|123772|P1|Overall Study|Not Specified|3
26781|NCT01868997|123771|P2|Overall Study|Lack of Efficacy|0
26782|NCT01868997|123772|P1|Overall Study|Lack of Efficacy|2
26783|NCT01868997|123771|P2|Overall Study|Adverse Event|5
26784|NCT01868997|123772|P1|Overall Study|Adverse Event|2
26785|NCT01868893|123788|P1|Overall Study|Neutropenia|1
26786|NCT01868893|123788|P1|Overall Study|Commercial availability of study drug|17
26787|NCT01868893|123788|P1|Overall Study|Adverse Event|2
26788|NCT01868542|123834|P2|Overall Study|Unclassified|1
26789|NCT01868542|123835|P1|Overall Study|Unclassified|0
26790|NCT01868542|123834|P2|Overall Study|Protocol Violation|1
26791|NCT01868542|123835|P1|Overall Study|Protocol Violation|0
26792|NCT01868503|123853|P1|Overall Study|Protocol Violation|1
26793|NCT01868503|123853|P1|Overall Study|Withdrawal by Subject|1
26794|NCT01868243|123908|P2|Overall Study|Death|1
26795|NCT01868243|123909|P1|Overall Study|Death|0
26796|NCT01868074|123919|P2|Overall Study|Withdrawal by Subject|2
26797|NCT01868074|123920|P1|Overall Study|Withdrawal by Subject|4
26798|NCT01868074|123919|P2|Overall Study|Lost to Follow-up|2
26799|NCT01868074|123920|P1|Overall Study|Lost to Follow-up|3
26800|NCT01868035|123930|P1|Overall Study|Non-compliance|1
26801|NCT01868035|123930|P1|Overall Study|Progressive Disease|2
26802|NCT01868035|123930|P1|Overall Study|Withdrawal by Subject|1
26803|NCT01868035|123930|P1|Overall Study|Lost to Follow-up|3
26804|NCT01868009|123946|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
26805|NCT01868009|123947|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
26806|NCT01868009|123946|P2|Period 2 (5-9 Days)|Adverse Event|0
26807|NCT01868009|123947|P1|Period 2 (5-9 Days)|Adverse Event|1
26808|NCT01868009|123946|P2|Period 1 (5-9 Days)|Adverse Event|2
26809|NCT01868009|123947|P1|Period 1 (5-9 Days)|Adverse Event|0
26810|NCT01867710|123961|P4|Overall Study|Other|0
26811|NCT01867710|123962|P3|Overall Study|Other|0
26812|NCT01867710|123963|P2|Overall Study|Other|1
26813|NCT01867710|123964|P1|Overall Study|Other|0
26814|NCT01867710|123961|P4|Overall Study|Eligible Criteria Not Met|0
26815|NCT01867710|123962|P3|Overall Study|Eligible Criteria Not Met|1
26816|NCT01867710|123963|P2|Overall Study|Eligible Criteria Not Met|0
26817|NCT01867710|123964|P1|Overall Study|Eligible Criteria Not Met|0
26818|NCT01867710|123961|P4|Overall Study|Withdrawal by Subject|0
26819|NCT01867710|123962|P3|Overall Study|Withdrawal by Subject|0
26820|NCT01867710|123963|P2|Overall Study|Withdrawal by Subject|1
26821|NCT01867710|123964|P1|Overall Study|Withdrawal by Subject|0
26822|NCT01867710|123961|P4|Overall Study|Protocol Violation|1
26823|NCT01867710|123962|P3|Overall Study|Protocol Violation|0
26824|NCT01867710|123963|P2|Overall Study|Protocol Violation|0
26825|NCT01867710|123964|P1|Overall Study|Protocol Violation|1
26826|NCT01867710|123961|P4|Overall Study|Physician Decision|0
26827|NCT01867710|123962|P3|Overall Study|Physician Decision|1
26828|NCT01867710|123963|P2|Overall Study|Physician Decision|0
26829|NCT01867710|123964|P1|Overall Study|Physician Decision|0
26830|NCT01867710|123961|P4|Overall Study|Death|0
26831|NCT01867710|123962|P3|Overall Study|Death|1
26832|NCT01867710|123963|P2|Overall Study|Death|1
26833|NCT01867710|123964|P1|Overall Study|Death|0
26834|NCT01867710|123961|P4|Overall Study|Other Adverse Events|3
26835|NCT01867710|123962|P3|Overall Study|Other Adverse Events|1
26836|NCT01867710|123963|P2|Overall Study|Other Adverse Events|0
26837|NCT01867710|123964|P1|Overall Study|Other Adverse Events|1
26838|NCT01867710|123961|P4|Overall Study|Palliative Radiation Required|1
26839|NCT01867710|123962|P3|Overall Study|Palliative Radiation Required|1
26840|NCT01867710|123963|P2|Overall Study|Palliative Radiation Required|0
26841|NCT01867710|123964|P1|Overall Study|Palliative Radiation Required|0
26842|NCT01867710|123961|P4|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
26843|NCT01867710|123962|P3|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
26844|NCT01867710|123963|P2|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
26845|NCT01867710|123964|P1|Overall Study|Adverse Event Sustained Toxicity>Grade 1|1
26846|NCT01867710|123961|P4|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
26847|NCT01867710|123962|P3|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
26848|NCT01867710|123963|P2|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|2
26849|NCT01867710|123964|P1|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
26850|NCT01867710|123961|P4|Overall Study|Disease Progression|2
26851|NCT01867710|123962|P3|Overall Study|Disease Progression|4
26852|NCT01867710|123963|P2|Overall Study|Disease Progression|2
26853|NCT01867710|123964|P1|Overall Study|Disease Progression|5
26854|NCT01867658|123978|P1|Overall Study|Subject could not be contacted|1
26855|NCT01867658|123978|P1|Overall Study|Death|2
26856|NCT01867658|123978|P1|Overall Study|Withdrawal by Subject|6
26857|NCT01867580|124002|P2|Overall Study|Wound recurrence|1
26858|NCT01867580|124003|P1|Overall Study|Wound recurrence|0
26859|NCT01867580|124002|P2|Overall Study|Continuation of therapy|1
26860|NCT01867580|124003|P1|Overall Study|Continuation of therapy|0
26861|NCT01867580|124002|P2|Overall Study|Osteomyelitis|1
26862|NCT01867580|124003|P1|Overall Study|Osteomyelitis|0
26863|NCT01867580|124002|P2|Overall Study|Interruption to therapy|0
26864|NCT01867580|124003|P1|Overall Study|Interruption to therapy|3
26865|NCT01867580|124002|P2|Overall Study|Missed follow-up assessment|1
26866|NCT01867580|124003|P1|Overall Study|Missed follow-up assessment|2
26867|NCT01867580|124002|P2|Overall Study|Sponsor terminated study|0
26868|NCT01867580|124003|P1|Overall Study|Sponsor terminated study|1
26869|NCT01867580|124002|P2|Overall Study|Lost to Follow-up|5
26870|NCT01867580|124003|P1|Overall Study|Lost to Follow-up|3
26871|NCT01867580|124002|P2|Overall Study|Physician Decision|12
26872|NCT01867580|124003|P1|Overall Study|Physician Decision|17
26873|NCT01867580|124002|P2|Overall Study|Withdrawal by Subject|3
26874|NCT01867580|124003|P1|Overall Study|Withdrawal by Subject|2
26875|NCT01867424|124028|P2|Overall Study|Patient noncompliance|1
26876|NCT01867424|124029|P1|Overall Study|Patient noncompliance|2
26877|NCT01867307|124043|P2|Overall Study|Other Adverse Event|3
26878|NCT01867307|124044|P1|Overall Study|Other Adverse Event|1
26879|NCT01867307|124043|P2|Overall Study|Protocol Violation|0
26880|NCT01867307|124044|P1|Overall Study|Protocol Violation|2
26881|NCT01867047|124076|P2|Overall Study|surgery not indicated in protocol|2
26882|NCT01867047|124077|P1|Overall Study|surgery not indicated in protocol|1
26883|NCT01867047|124076|P2|Overall Study|Physician Decision|0
26884|NCT01867047|124077|P1|Overall Study|Physician Decision|2
26885|NCT01867047|124076|P2|Overall Study|Withdrawal by Subject|0
26886|NCT01867047|124077|P1|Overall Study|Withdrawal by Subject|2
26887|NCT01867047|124076|P2|Overall Study|Lost to Follow-up|3
26888|NCT01867047|124077|P1|Overall Study|Lost to Follow-up|3
26889|NCT01867021|124097|P2|Overall Study|Withdrawal by Subject|6
26890|NCT01867021|124098|P1|Overall Study|Withdrawal by Subject|1
26891|NCT01867021|124097|P2|Overall Study|Lost to Follow-up|2
26892|NCT01867021|124098|P1|Overall Study|Lost to Follow-up|0
26893|NCT01867021|124097|P2|Overall Study|Death|0
26894|NCT01867021|124098|P1|Overall Study|Death|1
26895|NCT01867021|124097|P2|Overall Study|Not Eligible|1
26896|NCT01867021|124098|P1|Overall Study|Not Eligible|0
26897|NCT01867021|124097|P2|Overall Study|Adverse Event|1
26898|NCT01867021|124098|P1|Overall Study|Adverse Event|0
26899|NCT01866709|124129|P2|Overall Study|Adverse Event|0
26900|NCT01866709|124130|P1|Overall Study|Adverse Event|1
26901|NCT01866423|124171|P1|Overall Study|Sponsor Decision|1
26902|NCT01866423|124171|P1|Overall Study|Lack of Efficacy|3
26903|NCT01866319|124184|P3|Overall Study|Remain on study|176
26904|NCT01866319|124185|P2|Overall Study|Remain on study|190
26905|NCT01866319|124186|P1|Overall Study|Remain on study|131
26906|NCT01866319|124184|P3|Overall Study|Withdrawal by Subject|6
26907|NCT01866319|124185|P2|Overall Study|Withdrawal by Subject|9
26908|NCT01866319|124186|P1|Overall Study|Withdrawal by Subject|31
26909|NCT01866319|124184|P3|Overall Study|Physician Decision|0
26910|NCT01866319|124185|P2|Overall Study|Physician Decision|0
26911|NCT01866319|124186|P1|Overall Study|Physician Decision|1
26912|NCT01866319|124184|P3|Overall Study|Lost to Follow-up|6
26913|NCT01866319|124185|P2|Overall Study|Lost to Follow-up|0
26914|NCT01866319|124186|P1|Overall Study|Lost to Follow-up|3
26915|NCT01866319|124184|P3|Overall Study|Death|77
26916|NCT01866319|124185|P2|Overall Study|Death|74
26917|NCT01866319|124186|P1|Overall Study|Death|97
26918|NCT01866319|124184|P3|Overall Study|Clinical progression|0
26919|NCT01866319|124185|P2|Overall Study|Clinical progression|0
26920|NCT01866319|124186|P1|Overall Study|Clinical progression|1
26921|NCT01866319|124184|P3|Overall Study|Adverse Event|12
26922|NCT01866319|124185|P2|Overall Study|Adverse Event|6
26923|NCT01866319|124186|P1|Overall Study|Adverse Event|13
26924|NCT01866293|124285|P1|Overall Study|Adverse Event|2
26925|NCT01865812|124327|P1|Overall Study|Adverse Event|2
26926|NCT01865747|124335|P2|Primary Intent to Treat (PITT)|Other|1
26927|NCT01865747|124336|P1|Primary Intent to Treat (PITT)|Other|0
26928|NCT01865747|124335|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
26929|NCT01865747|124336|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
26930|NCT01865747|124335|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
26931|NCT01865747|124336|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
26932|NCT01865747|124335|P2|Primary Intent to Treat (PITT)|Physician Decision|2
26933|NCT01865747|124336|P1|Primary Intent to Treat (PITT)|Physician Decision|4
26934|NCT01865747|124335|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
26935|NCT01865747|124336|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
26936|NCT01865747|124335|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
26937|NCT01865747|124336|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
26938|NCT01865747|124335|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
26939|NCT01865747|124336|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
26940|NCT01865747|124335|P2|Primary Intent to Treat (PITT)|Adverse Event|20
26941|NCT01865747|124336|P1|Primary Intent to Treat (PITT)|Adverse Event|21
26942|NCT01865747|124335|P2|Overall Study (ITT)|Reason Not Provided|1
26943|NCT01865747|124336|P1|Overall Study (ITT)|Reason Not Provided|0
26944|NCT01865747|124335|P2|Overall Study (ITT)|Progressive Disease|158
26945|NCT01865747|124336|P1|Overall Study (ITT)|Progressive Disease|122
26946|NCT01865747|124335|P2|Overall Study (ITT)|Sponsor Decision|1
26947|NCT01865747|124336|P1|Overall Study (ITT)|Sponsor Decision|0
26948|NCT01865747|124335|P2|Overall Study (ITT)|Withdrawal by Subject|11
26949|NCT01865747|124336|P1|Overall Study (ITT)|Withdrawal by Subject|6
26950|NCT01865747|124335|P2|Overall Study (ITT)|Physician Decision|2
26951|NCT01865747|124336|P1|Overall Study (ITT)|Physician Decision|5
26952|NCT01865747|124335|P2|Overall Study (ITT)|Protocol Violation|1
26953|NCT01865747|124336|P1|Overall Study (ITT)|Protocol Violation|1
26954|NCT01865747|124335|P2|Overall Study (ITT)|Lack of Efficacy|0
26955|NCT01865747|124336|P1|Overall Study (ITT)|Lack of Efficacy|3
26956|NCT01865747|124335|P2|Overall Study (ITT)|Clinical Deterioration|50
26957|NCT01865747|124336|P1|Overall Study (ITT)|Clinical Deterioration|29
26958|NCT01865747|124335|P2|Overall Study (ITT)|Adverse Event|31
26959|NCT01865747|124336|P1|Overall Study (ITT)|Adverse Event|32
26960|NCT01865084|124354|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
26961|NCT01865084|124355|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
26962|NCT01865084|124356|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
26963|NCT01865084|124354|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
26964|NCT01865084|124355|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
26965|NCT01865084|124356|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
26966|NCT01865084|124354|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
26967|NCT01865084|124355|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
26968|NCT01865084|124356|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
26969|NCT01865084|124354|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
26970|NCT01865084|124355|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
26971|NCT01865084|124356|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
26972|NCT01865084|124354|P3|Open Label Extension (OLE) Period|Adverse Event|1
26973|NCT01865084|124355|P2|Open Label Extension (OLE) Period|Adverse Event|0
26974|NCT01865084|124356|P1|Open Label Extension (OLE) Period|Adverse Event|0
26975|NCT01865084|124354|P3|Double Blind Period (DB)|Withdrawal by Subject|0
26976|NCT01865084|124355|P2|Double Blind Period (DB)|Withdrawal by Subject|0
26977|NCT01865084|124356|P1|Double Blind Period (DB)|Withdrawal by Subject|1
26978|NCT01865084|124354|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
26979|NCT01865084|124355|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
26980|NCT01865084|124356|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
26981|NCT01865084|124354|P3|Double Blind Period (DB)|Protocol Violation|1
26982|NCT01865084|124355|P2|Double Blind Period (DB)|Protocol Violation|0
26983|NCT01865084|124356|P1|Double Blind Period (DB)|Protocol Violation|0
26984|NCT01865084|124354|P3|Double Blind Period (DB)|Adverse Event|1
26985|NCT01865084|124355|P2|Double Blind Period (DB)|Adverse Event|2
26986|NCT01865084|124356|P1|Double Blind Period (DB)|Adverse Event|2
26987|NCT01864200|124401|P2|Overall Study|Protocol Violation|0
26988|NCT01864200|124402|P1|Overall Study|Protocol Violation|1
26989|NCT01864200|124401|P2|Overall Study|Lost to Follow-up|3
26990|NCT01864200|124402|P1|Overall Study|Lost to Follow-up|1
26991|NCT01864174|124410|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
26992|NCT01864174|124411|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
26993|NCT01864174|124410|P2|Off Treatment Follow-Up|Other|0
26994|NCT01864174|124411|P1|Off Treatment Follow-Up|Other|2
26995|NCT01864174|124410|P2|Double Blind - Compliant Randomized|Other|10
26996|NCT01864174|124411|P1|Double Blind - Compliant Randomized|Other|6
26997|NCT01864174|124410|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
26998|NCT01864174|124411|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
26999|NCT01864174|124410|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
27000|NCT01864174|124411|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
27001|NCT01864174|124410|P2|Double Blind - Compliant Randomized|Death|0
27002|NCT01864174|124411|P1|Double Blind - Compliant Randomized|Death|1
27003|NCT01864174|124410|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
27004|NCT01864174|124411|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
27005|NCT01864174|124410|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
27006|NCT01864174|124411|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
27007|NCT01864174|124410|P2|Double Blind - Compliant Randomized|Adverse Event|1
27008|NCT01864174|124411|P1|Double Blind - Compliant Randomized|Adverse Event|6
27009|NCT01864174|124410|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
27010|NCT01864174|124411|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
27011|NCT01864148|124430|P5|Overall Study|Not Dosed|0
27012|NCT01864148|124431|P4|Overall Study|Not Dosed|1
27013|NCT01864148|124432|P3|Overall Study|Not Dosed|0
27014|NCT01864148|124433|P2|Overall Study|Not Dosed|0
27015|NCT01864148|124434|P1|Overall Study|Not Dosed|0
27016|NCT01864148|124430|P5|Overall Study|Adverse Event|7
27017|NCT01864148|124431|P4|Overall Study|Adverse Event|7
27018|NCT01864148|124432|P3|Overall Study|Adverse Event|4
27019|NCT01864148|124433|P2|Overall Study|Adverse Event|2
27020|NCT01864148|124434|P1|Overall Study|Adverse Event|4
27021|NCT01864148|124430|P5|Overall Study|Lost to Follow-up|1
27022|NCT01864148|124431|P4|Overall Study|Lost to Follow-up|2
27023|NCT01864148|124432|P3|Overall Study|Lost to Follow-up|0
27024|NCT01864148|124433|P2|Overall Study|Lost to Follow-up|0
27025|NCT01864148|124434|P1|Overall Study|Lost to Follow-up|0
27026|NCT01864148|124430|P5|Overall Study|Withdrawal by Subject|8
27027|NCT01864148|124431|P4|Overall Study|Withdrawal by Subject|8
27028|NCT01864148|124432|P3|Overall Study|Withdrawal by Subject|6
27029|NCT01864148|124433|P2|Overall Study|Withdrawal by Subject|2
27030|NCT01864148|124434|P1|Overall Study|Withdrawal by Subject|9
27031|NCT01864148|124430|P5|Overall Study|Investigator Decision|6
27032|NCT01864148|124431|P4|Overall Study|Investigator Decision|4
27033|NCT01864148|124432|P3|Overall Study|Investigator Decision|0
27034|NCT01864148|124433|P2|Overall Study|Investigator Decision|0
27035|NCT01864148|124434|P1|Overall Study|Investigator Decision|5
27036|NCT01864148|124430|P5|Overall Study|Death|0
27037|NCT01864148|124431|P4|Overall Study|Death|1
27038|NCT01864148|124432|P3|Overall Study|Death|0
27039|NCT01864148|124433|P2|Overall Study|Death|0
27040|NCT01864148|124434|P1|Overall Study|Death|0
27041|NCT01864148|124430|P5|Overall Study|Not Specified|1
27042|NCT01864148|124431|P4|Overall Study|Not Specified|3
27043|NCT01864148|124432|P3|Overall Study|Not Specified|1
27044|NCT01864148|124433|P2|Overall Study|Not Specified|1
27045|NCT01864148|124434|P1|Overall Study|Not Specified|2
27046|NCT01864005|124463|P2|Overall Study|Need GP IIb/IIIa|3
27047|NCT01864005|124464|P1|Overall Study|Need GP IIb/IIIa|1
27048|NCT01864005|124463|P2|Overall Study|Disease need|1
27049|NCT01864005|124464|P1|Overall Study|Disease need|1
27050|NCT01864005|124463|P2|Overall Study|Incorrect enrolment|0
27051|NCT01864005|124464|P1|Overall Study|Incorrect enrolment|1
27052|NCT01864005|124463|P2|Overall Study|Withdrawal by Subject|1
27053|NCT01864005|124464|P1|Overall Study|Withdrawal by Subject|0
27054|NCT01864005|124463|P2|Overall Study|Protocol Violation|1
27055|NCT01864005|124464|P1|Overall Study|Protocol Violation|0
27056|NCT01863953|124481|P3|Overall Study|Adverse Event|1
27057|NCT01863953|124482|P2|Overall Study|Adverse Event|0
27058|NCT01863953|124483|P1|Overall Study|Adverse Event|0
27059|NCT01863771|124497|P4|Maintenance Phase|Withdrawal by Subject|3
27060|NCT01863771|124498|P3|Maintenance Phase|Withdrawal by Subject|2
27061|NCT01863771|124499|P2|Maintenance Phase|Withdrawal by Subject|1
27062|NCT01863771|124500|P1|Maintenance Phase|Withdrawal by Subject|0
27063|NCT01863771|124497|P4|Maintenance Phase|Pregnancy|0
27064|NCT01863771|124498|P3|Maintenance Phase|Pregnancy|0
27065|NCT01863771|124499|P2|Maintenance Phase|Pregnancy|1
27066|NCT01863771|124500|P1|Maintenance Phase|Pregnancy|0
27067|NCT01863771|124497|P4|Maintenance Phase|Physician Decision|1
27068|NCT01863771|124498|P3|Maintenance Phase|Physician Decision|2
27069|NCT01863771|124499|P2|Maintenance Phase|Physician Decision|0
27070|NCT01863771|124500|P1|Maintenance Phase|Physician Decision|0
27071|NCT01863771|124497|P4|Maintenance Phase|Lack of Efficacy|38
27072|NCT01863771|124498|P3|Maintenance Phase|Lack of Efficacy|7
27073|NCT01863771|124499|P2|Maintenance Phase|Lack of Efficacy|3
27074|NCT01863771|124500|P1|Maintenance Phase|Lack of Efficacy|0
27075|NCT01863771|124497|P4|Maintenance Phase|Adverse Event|1
27076|NCT01863771|124498|P3|Maintenance Phase|Adverse Event|1
27077|NCT01863771|124499|P2|Maintenance Phase|Adverse Event|0
27078|NCT01863771|124500|P1|Maintenance Phase|Adverse Event|0
27079|NCT01863771|124497|P4|Induction Phase|Withdrawal by Subject|0
27080|NCT01863771|124498|P3|Induction Phase|Withdrawal by Subject|0
27081|NCT01863771|124499|P2|Induction Phase|Withdrawal by Subject|0
27082|NCT01863771|124500|P1|Induction Phase|Withdrawal by Subject|2
27083|NCT01863771|124497|P4|Induction Phase|Lack of Efficacy|0
27084|NCT01863771|124498|P3|Induction Phase|Lack of Efficacy|0
27085|NCT01863771|124499|P2|Induction Phase|Lack of Efficacy|0
27086|NCT01863771|124500|P1|Induction Phase|Lack of Efficacy|10
27087|NCT01863771|124497|P4|Induction Phase|Adverse Event|0
27088|NCT01863771|124498|P3|Induction Phase|Adverse Event|0
27089|NCT01863771|124499|P2|Induction Phase|Adverse Event|0
27090|NCT01863771|124500|P1|Induction Phase|Adverse Event|9
27091|NCT01863758|124512|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
27092|NCT01863758|124512|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
27093|NCT01863680|124520|P1|Overall Study|Other|6
27094|NCT01863680|124520|P1|Overall Study|Did not undergo IVF/ET|14
27095|NCT01863680|124520|P1|Overall Study|Withdrawal by Subject|1
27096|NCT01863680|124520|P1|Overall Study|Spontaneous pregnancy|2
27097|NCT01863680|124520|P1|Overall Study|Risk of OHSS|17
27098|NCT01863680|124520|P1|Overall Study|Adverse Event|17
27099|NCT01863667|124528|P2|Overall Study|Withdrawal by Subject|2
27100|NCT01863667|124529|P1|Overall Study|Withdrawal by Subject|2
27101|NCT01863667|124528|P2|Overall Study|Study terminated by Sponsor|30
27102|NCT01863667|124529|P1|Overall Study|Study terminated by Sponsor|30
27103|NCT01863667|124528|P2|Overall Study|Adverse Event|0
27104|NCT01863667|124529|P1|Overall Study|Adverse Event|1
27105|NCT01863433|124553|P1|Overall Study|Protocol Violation|1
27106|NCT01863368|124563|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
27107|NCT01863368|124564|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
27108|NCT01863368|124563|P2|Phase II, Day 35 to Day 90|Adverse Event|0
27109|NCT01863368|124564|P1|Phase II, Day 35 to Day 90|Adverse Event|1
27110|NCT01863368|124563|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
27111|NCT01863368|124564|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
27112|NCT01863368|124563|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
27113|NCT01863368|124564|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
27114|NCT01863368|124563|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
27115|NCT01863368|124564|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
27116|NCT01863368|124563|P2|Phase I, Day 0 to Day 35|Adverse Event|4
27117|NCT01863368|124564|P1|Phase I, Day 0 to Day 35|Adverse Event|2
27118|NCT01862991|124589|P3|Overall Study|Protocol Violation|0
27119|NCT01862991|124590|P2|Overall Study|Protocol Violation|0
27120|NCT01862991|124591|P1|Overall Study|Protocol Violation|1
27121|NCT01862991|124589|P3|Overall Study|Lost to Follow-up|1
27122|NCT01862991|124590|P2|Overall Study|Lost to Follow-up|1
27123|NCT01862991|124591|P1|Overall Study|Lost to Follow-up|2
27124|NCT01862484|124604|P2|Overall Study|Withdrawal by Subject|3
27125|NCT01862484|124605|P1|Overall Study|Withdrawal by Subject|0
27126|NCT01862484|124604|P2|Overall Study|Protocol Violation|2
27127|NCT01862484|124605|P1|Overall Study|Protocol Violation|0
27128|NCT01862484|124604|P2|Overall Study|Lost to Follow-up|2
27129|NCT01862484|124605|P1|Overall Study|Lost to Follow-up|1
27130|NCT01862484|124604|P2|Overall Study|Lack of Efficacy|1
27131|NCT01862484|124605|P1|Overall Study|Lack of Efficacy|1
27132|NCT01862250|124624|P1|Overall Study|Adverse Event|4
27133|NCT01861522|124700|P2|Overall Study|Withdrawal by Subject|0
27134|NCT01861522|124701|P1|Overall Study|Withdrawal by Subject|2
27135|NCT01861522|124700|P2|Overall Study|Adverse Event|0
27136|NCT01861522|124701|P1|Overall Study|Adverse Event|1
27137|NCT01860989|124725|P1|Overall Study|Unsatisfactory therapeutic|5
27138|NCT01860976|124731|P2|Long Term Extension|Ongoing treatment at time of analysis|100
27139|NCT01860976|124732|P1|Long Term Extension|Ongoing treatment at time of analysis|106
27140|NCT01860976|124731|P2|Long Term Extension|Withdrawal by Subject|0
27141|NCT01860976|124732|P1|Long Term Extension|Withdrawal by Subject|1
27142|NCT01860976|124731|P2|Long Term Extension|Subject request to discontinue treatment|0
27143|NCT01860976|124732|P1|Long Term Extension|Subject request to discontinue treatment|2
27144|NCT01860976|124731|P2|Long Term Extension|Lack of Efficacy|7
27145|NCT01860976|124732|P1|Long Term Extension|Lack of Efficacy|3
27146|NCT01860976|124731|P2|Long Term Extension|Adverse Event|0
27147|NCT01860976|124732|P1|Long Term Extension|Adverse Event|1
27148|NCT01860976|124731|P2|Open-Label|Ongoing OL treatment at time of analysis|45
27149|NCT01860976|124732|P1|Open-Label|Ongoing OL treatment at time of analysis|46
27150|NCT01860976|124731|P2|Open-Label|Other Reasons|1
27151|NCT01860976|124732|P1|Open-Label|Other Reasons|1
27152|NCT01860976|124731|P2|Open-Label|Withdrawal by Subject|1
27153|NCT01860976|124732|P1|Open-Label|Withdrawal by Subject|4
27154|NCT01860976|124731|P2|Open-Label|Subject request discontinue treatment|3
27155|NCT01860976|124732|P1|Open-Label|Subject request discontinue treatment|4
27156|NCT01860976|124731|P2|Open-Label|Lost to Follow-up|2
27157|NCT01860976|124732|P1|Open-Label|Lost to Follow-up|1
27158|NCT01860976|124731|P2|Open-Label|Lack of Efficacy|8
27159|NCT01860976|124732|P1|Open-Label|Lack of Efficacy|16
27160|NCT01860976|124731|P2|Open-Label|Adverse Event|4
27161|NCT01860976|124732|P1|Open-Label|Adverse Event|2
27162|NCT01860976|124731|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
27163|NCT01860976|124732|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
27164|NCT01860976|124731|P2|Blinded Treatment|Entered Open-Label in error|1
27165|NCT01860976|124732|P1|Blinded Treatment|Entered Open-Label in error|0
27166|NCT01860976|124731|P2|Blinded Treatment|Subject no longer met criteria|0
27167|NCT01860976|124732|P1|Blinded Treatment|Subject no longer met criteria|1
27168|NCT01860976|124731|P2|Blinded Treatment|Withdrawal by Subject|5
27169|NCT01860976|124732|P1|Blinded Treatment|Withdrawal by Subject|3
27170|NCT01860976|124731|P2|Blinded Treatment|Subject request to discontinue treatment|3
27171|NCT01860976|124732|P1|Blinded Treatment|Subject request to discontinue treatment|2
27172|NCT01860976|124731|P2|Blinded Treatment|Lack of Efficacy|12
27173|NCT01860976|124732|P1|Blinded Treatment|Lack of Efficacy|5
27174|NCT01860976|124731|P2|Blinded Treatment|Adverse Event|3
27175|NCT01860976|124732|P1|Blinded Treatment|Adverse Event|1
27176|NCT01860846|124754|P1|Overall Study|Lost to Follow-up|33
27177|NCT01860703|124765|P4|Overall Study|Personal reason|0
27178|NCT01860703|124766|P3|Overall Study|Personal reason|1
27179|NCT01860703|124767|P2|Overall Study|Personal reason|0
27180|NCT01860703|124768|P1|Overall Study|Personal reason|1
27181|NCT01860703|124765|P4|Overall Study|Withdrawal by Subject|0
27182|NCT01860703|124766|P3|Overall Study|Withdrawal by Subject|0
27183|NCT01860703|124767|P2|Overall Study|Withdrawal by Subject|1
27184|NCT01860703|124768|P1|Overall Study|Withdrawal by Subject|0
27185|NCT01860703|124765|P4|Overall Study|Adverse Event|2
27186|NCT01860703|124766|P3|Overall Study|Adverse Event|0
27187|NCT01860703|124767|P2|Overall Study|Adverse Event|4
27188|NCT01860703|124768|P1|Overall Study|Adverse Event|1
27189|NCT01860677|124800|P2|Second Intervention (1 Day)|Lost to Follow-up|0
27190|NCT01860677|124801|P1|Second Intervention (1 Day)|Lost to Follow-up|7
27191|NCT01860534|124839|P2|ROP #2|discharged prior to ROP #2|0
27192|NCT01860534|124840|P1|ROP #2|discharged prior to ROP #2|1
27193|NCT01860534|124839|P2|ROP #1|Needed treatment for ROP|1
27194|NCT01860534|124840|P1|ROP #1|Needed treatment for ROP|0
27195|NCT01860079|124888|P2|Overall Study|Physician Decision|22
27196|NCT01860079|124889|P1|Overall Study|Physician Decision|14
27197|NCT01860040|124897|P2|Overall Study|Withdrawal by Subject|0
27198|NCT01860040|124898|P1|Overall Study|Withdrawal by Subject|1
27199|NCT01859988|124909|P6|Overall Study|Other than specified above|3
27200|NCT01859988|124910|P5|Overall Study|Other than specified above|5
27201|NCT01859988|124911|P4|Overall Study|Other than specified above|3
27202|NCT01859988|124912|P3|Overall Study|Other than specified above|11
27203|NCT01859988|124913|P2|Overall Study|Other than specified above|2
27204|NCT01859988|124914|P1|Overall Study|Other than specified above|0
27205|NCT01859988|124909|P6|Overall Study|Protocol Violation|0
27206|NCT01859988|124910|P5|Overall Study|Protocol Violation|0
27207|NCT01859988|124911|P4|Overall Study|Protocol Violation|0
27208|NCT01859988|124912|P3|Overall Study|Protocol Violation|1
27209|NCT01859988|124913|P2|Overall Study|Protocol Violation|0
27210|NCT01859988|124914|P1|Overall Study|Protocol Violation|0
27211|NCT01859988|124909|P6|Overall Study|Lost to Follow-up|2
27212|NCT01859988|124910|P5|Overall Study|Lost to Follow-up|3
27213|NCT01859988|124911|P4|Overall Study|Lost to Follow-up|0
27214|NCT01859988|124912|P3|Overall Study|Lost to Follow-up|3
27215|NCT01859988|124913|P2|Overall Study|Lost to Follow-up|2
27216|NCT01859988|124914|P1|Overall Study|Lost to Follow-up|1
27217|NCT01859988|124909|P6|Overall Study|Adverse Event|2
27218|NCT01859988|124910|P5|Overall Study|Adverse Event|2
27219|NCT01859988|124911|P4|Overall Study|Adverse Event|1
27220|NCT01859988|124912|P3|Overall Study|Adverse Event|3
27221|NCT01859988|124913|P2|Overall Study|Adverse Event|1
27222|NCT01859988|124914|P1|Overall Study|Adverse Event|2
27223|NCT01859988|124909|P6|Overall Study|Physician Decision|1
27224|NCT01859988|124910|P5|Overall Study|Physician Decision|4
27225|NCT01859988|124911|P4|Overall Study|Physician Decision|3
27226|NCT01859988|124912|P3|Overall Study|Physician Decision|1
27227|NCT01859988|124913|P2|Overall Study|Physician Decision|3
27228|NCT01859988|124914|P1|Overall Study|Physician Decision|1
27229|NCT01859988|124909|P6|Overall Study|Lack of Efficacy|9
27230|NCT01859988|124910|P5|Overall Study|Lack of Efficacy|7
27231|NCT01859988|124911|P4|Overall Study|Lack of Efficacy|0
27232|NCT01859988|124912|P3|Overall Study|Lack of Efficacy|5
27233|NCT01859988|124913|P2|Overall Study|Lack of Efficacy|1
27234|NCT01859988|124914|P1|Overall Study|Lack of Efficacy|1
27235|NCT01859988|124909|P6|Overall Study|Withdrawal by Subject|2
27236|NCT01859988|124910|P5|Overall Study|Withdrawal by Subject|2
27237|NCT01859988|124911|P4|Overall Study|Withdrawal by Subject|3
27238|NCT01859988|124912|P3|Overall Study|Withdrawal by Subject|4
27239|NCT01859988|124913|P2|Overall Study|Withdrawal by Subject|3
27240|NCT01859988|124914|P1|Overall Study|Withdrawal by Subject|6
27241|NCT01859949|125008|P2|Overall Study|Adverse Event|1
27242|NCT01859949|125009|P1|Overall Study|Adverse Event|0
27243|NCT01859949|125008|P2|Overall Study|Protocol Violation|1
27244|NCT01859949|125009|P1|Overall Study|Protocol Violation|1
27245|NCT01859949|125008|P2|Overall Study|Withdrawal by Subject|10
27246|NCT01859949|125009|P1|Overall Study|Withdrawal by Subject|11
27247|NCT01859949|125008|P2|Overall Study|Physician Decision|4
27248|NCT01859949|125009|P1|Overall Study|Physician Decision|2
27249|NCT01859949|125008|P2|Overall Study|Family Matters|1
27250|NCT01859949|125009|P1|Overall Study|Family Matters|0
27251|NCT01859793|125027|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
27252|NCT01859793|125028|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
27253|NCT01859793|125027|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
27254|NCT01859793|125028|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
27255|NCT01859793|125027|P2|First Intervention (8 Weeks)|Adverse Event|0
27256|NCT01859793|125028|P1|First Intervention (8 Weeks)|Adverse Event|1
27257|NCT01859793|125027|P2|First Intervention (8 Weeks)|Protocol Violation|0
27258|NCT01859793|125028|P1|First Intervention (8 Weeks)|Protocol Violation|2
27259|NCT01859715|125041|P3|Overall Study|No 2nd VAS|23
27260|NCT01859715|125042|P2|Overall Study|No 2nd VAS|8
27261|NCT01859715|125043|P1|Overall Study|No 2nd VAS|16
27262|NCT01859702|125054|P1|Overall Study|Adverse Event|2
27263|NCT01859702|125054|P1|Overall Study|Protocol deviation|3
27264|NCT01859598|125068|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
27265|NCT01859507|125076|P1|Overall Study|left the country|4
27266|NCT01859494|125081|P1|Overall Study|Adverse Event|1
27267|NCT01859390|125092|P2|Overall Study|Shipment Error|1
27268|NCT01859390|125093|P1|Overall Study|Shipment Error|0
27269|NCT01859390|125092|P2|Overall Study|Tube Cracked|2
27270|NCT01859390|125093|P1|Overall Study|Tube Cracked|0
27271|NCT01859390|125092|P2|Overall Study|Sample Missing Collection Date|1
27272|NCT01859390|125093|P1|Overall Study|Sample Missing Collection Date|0
27273|NCT01859390|125092|P2|Overall Study|Insufficient Sputum Collected|3
27274|NCT01859390|125093|P1|Overall Study|Insufficient Sputum Collected|1
27275|NCT01859143|125227|P2|Overall Study|Lost to Follow-up|0
27276|NCT01859143|125228|P1|Overall Study|Lost to Follow-up|2
27277|NCT01858766|125284|P19|Overall Study|Withdrew Consent|0
27278|NCT01858766|125285|P18|Overall Study|Withdrew Consent|0
27279|NCT01858766|125286|P17|Overall Study|Withdrew Consent|0
27280|NCT01858766|125287|P16|Overall Study|Withdrew Consent|0
27281|NCT01858766|125288|P15|Overall Study|Withdrew Consent|0
27282|NCT01858766|125289|P14|Overall Study|Withdrew Consent|0
27283|NCT01858766|125290|P13|Overall Study|Withdrew Consent|0
27284|NCT01858766|125291|P12|Overall Study|Withdrew Consent|1
27285|NCT01858766|125292|P11|Overall Study|Withdrew Consent|0
27286|NCT01858766|125293|P10|Overall Study|Withdrew Consent|0
27287|NCT01858766|125294|P9|Overall Study|Withdrew Consent|0
27288|NCT01858766|125295|P8|Overall Study|Withdrew Consent|0
27289|NCT01858766|125296|P7|Overall Study|Withdrew Consent|0
27290|NCT01858766|125297|P6|Overall Study|Withdrew Consent|0
27291|NCT01858766|125298|P5|Overall Study|Withdrew Consent|0
27292|NCT01858766|125299|P4|Overall Study|Withdrew Consent|0
27293|NCT01858766|125300|P3|Overall Study|Withdrew Consent|0
27294|NCT01858766|125301|P2|Overall Study|Withdrew Consent|0
27295|NCT01858766|125302|P1|Overall Study|Withdrew Consent|0
27296|NCT01858766|125284|P19|Overall Study|Lost to Follow-up|1
27297|NCT01858766|125285|P18|Overall Study|Lost to Follow-up|0
27298|NCT01858766|125286|P17|Overall Study|Lost to Follow-up|1
27299|NCT01858766|125287|P16|Overall Study|Lost to Follow-up|1
27300|NCT01858766|125288|P15|Overall Study|Lost to Follow-up|3
27301|NCT01858766|125289|P14|Overall Study|Lost to Follow-up|0
27302|NCT01858766|125290|P13|Overall Study|Lost to Follow-up|0
27303|NCT01858766|125291|P12|Overall Study|Lost to Follow-up|1
27304|NCT01858766|125292|P11|Overall Study|Lost to Follow-up|0
27305|NCT01858766|125293|P10|Overall Study|Lost to Follow-up|0
27306|NCT01858766|125294|P9|Overall Study|Lost to Follow-up|0
27307|NCT01858766|125295|P8|Overall Study|Lost to Follow-up|2
27308|NCT01858766|125296|P7|Overall Study|Lost to Follow-up|0
27309|NCT01858766|125297|P6|Overall Study|Lost to Follow-up|1
27310|NCT01858766|125298|P5|Overall Study|Lost to Follow-up|0
27311|NCT01858766|125299|P4|Overall Study|Lost to Follow-up|0
27312|NCT01858766|125300|P3|Overall Study|Lost to Follow-up|0
27313|NCT01858766|125301|P2|Overall Study|Lost to Follow-up|0
27314|NCT01858766|125302|P1|Overall Study|Lost to Follow-up|0
27315|NCT01858766|125284|P19|Overall Study|Lack of Efficacy|3
27316|NCT01858766|125285|P18|Overall Study|Lack of Efficacy|3
27317|NCT01858766|125286|P17|Overall Study|Lack of Efficacy|2
27318|NCT01858766|125287|P16|Overall Study|Lack of Efficacy|5
27319|NCT01858766|125288|P15|Overall Study|Lack of Efficacy|5
27320|NCT01858766|125289|P14|Overall Study|Lack of Efficacy|3
27321|NCT01858766|125290|P13|Overall Study|Lack of Efficacy|5
27322|NCT01858766|125291|P12|Overall Study|Lack of Efficacy|3
27323|NCT01858766|125292|P11|Overall Study|Lack of Efficacy|0
27324|NCT01858766|125293|P10|Overall Study|Lack of Efficacy|0
27325|NCT01858766|125294|P9|Overall Study|Lack of Efficacy|0
27326|NCT01858766|125295|P8|Overall Study|Lack of Efficacy|0
27327|NCT01858766|125296|P7|Overall Study|Lack of Efficacy|0
27328|NCT01858766|125297|P6|Overall Study|Lack of Efficacy|2
27329|NCT01858766|125298|P5|Overall Study|Lack of Efficacy|1
27330|NCT01858766|125299|P4|Overall Study|Lack of Efficacy|0
27331|NCT01858766|125300|P3|Overall Study|Lack of Efficacy|0
27332|NCT01858766|125301|P2|Overall Study|Lack of Efficacy|0
27333|NCT01858766|125302|P1|Overall Study|Lack of Efficacy|1
27334|NCT01858766|125284|P19|Overall Study|Death|0
27335|NCT01858766|125285|P18|Overall Study|Death|0
27336|NCT01858766|125286|P17|Overall Study|Death|0
27337|NCT01858766|125287|P16|Overall Study|Death|0
27338|NCT01858766|125288|P15|Overall Study|Death|0
27339|NCT01858766|125289|P14|Overall Study|Death|0
27340|NCT01858766|125290|P13|Overall Study|Death|0
27341|NCT01858766|125291|P12|Overall Study|Death|0
27342|NCT01858766|125292|P11|Overall Study|Death|0
27343|NCT01858766|125293|P10|Overall Study|Death|0
27344|NCT01858766|125294|P9|Overall Study|Death|0
27345|NCT01858766|125295|P8|Overall Study|Death|0
27346|NCT01858766|125296|P7|Overall Study|Death|0
27347|NCT01858766|125297|P6|Overall Study|Death|0
27348|NCT01858766|125298|P5|Overall Study|Death|0
27349|NCT01858766|125299|P4|Overall Study|Death|0
27350|NCT01858766|125300|P3|Overall Study|Death|1
27351|NCT01858766|125301|P2|Overall Study|Death|0
27352|NCT01858766|125302|P1|Overall Study|Death|0
27353|NCT01858766|125284|P19|Overall Study|Randomized but Never Treated|0
27354|NCT01858766|125285|P18|Overall Study|Randomized but Never Treated|1
27355|NCT01858766|125286|P17|Overall Study|Randomized but Never Treated|0
27356|NCT01858766|125287|P16|Overall Study|Randomized but Never Treated|0
27357|NCT01858766|125288|P15|Overall Study|Randomized but Never Treated|0
27358|NCT01858766|125289|P14|Overall Study|Randomized but Never Treated|0
27359|NCT01858766|125290|P13|Overall Study|Randomized but Never Treated|0
27360|NCT01858766|125291|P12|Overall Study|Randomized but Never Treated|0
27361|NCT01858766|125292|P11|Overall Study|Randomized but Never Treated|0
27362|NCT01858766|125293|P10|Overall Study|Randomized but Never Treated|0
27363|NCT01858766|125294|P9|Overall Study|Randomized but Never Treated|0
27364|NCT01858766|125295|P8|Overall Study|Randomized but Never Treated|0
27365|NCT01858766|125296|P7|Overall Study|Randomized but Never Treated|0
27366|NCT01858766|125297|P6|Overall Study|Randomized but Never Treated|1
27367|NCT01858766|125298|P5|Overall Study|Randomized but Never Treated|0
27368|NCT01858766|125299|P4|Overall Study|Randomized but Never Treated|0
27369|NCT01858766|125300|P3|Overall Study|Randomized but Never Treated|0
27370|NCT01858766|125301|P2|Overall Study|Randomized but Never Treated|0
27371|NCT01858766|125302|P1|Overall Study|Randomized but Never Treated|0
27372|NCT01858701|125373|P2|Period 2, Second 30 Days of Wear|Comfort|1
27373|NCT01858701|125374|P1|Period 2, Second 30 Days of Wear|Comfort|0
27374|NCT01858701|125373|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
27375|NCT01858701|125374|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
27376|NCT01858701|125373|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
27377|NCT01858701|125374|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
27378|NCT01858701|125373|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
27379|NCT01858701|125374|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
27380|NCT01858636|125380|P1|Overall Study|Withdrawal by Subject|1
27381|NCT01858636|125380|P1|Overall Study|Lost to Follow-up|1
27382|NCT01858636|125380|P1|Overall Study|Death|1
27383|NCT01858636|125380|P1|Overall Study|Physician Decision|1
27384|NCT01858636|125380|P1|Overall Study|No Device Deployment Attempted|24
27385|NCT01858389|125433|P2|Overall Study|Did not receive treatment|3
27386|NCT01858389|125434|P1|Overall Study|Did not receive treatment|0
27387|NCT01858389|125433|P2|Overall Study|Adverse Event|1
27388|NCT01858389|125434|P1|Overall Study|Adverse Event|3
27389|NCT01858389|125433|P2|Overall Study|Not specified|4
27390|NCT01858389|125434|P1|Overall Study|Not specified|2
27391|NCT01858389|125433|P2|Overall Study|Progressive disease|11
27392|NCT01858389|125434|P1|Overall Study|Progressive disease|10
27393|NCT01858389|125433|P2|Overall Study|Withdrawal by Subject|1
27394|NCT01858389|125434|P1|Overall Study|Withdrawal by Subject|0
27395|NCT01858389|125433|P2|Overall Study|Study terminated by sponsor|2
27396|NCT01858389|125434|P1|Overall Study|Study terminated by sponsor|0
27397|NCT01858389|125433|P2|Overall Study|Death|3
27398|NCT01858389|125434|P1|Overall Study|Death|1
27399|NCT01858376|125449|P1|Overall Study|Dropped d/t lab work not fitting criter|4
27400|NCT01857622|125487|P3|Overall Study|Withdrawal by Subject|0
27401|NCT01857622|125488|P2|Overall Study|Withdrawal by Subject|0
27402|NCT01857622|125489|P1|Overall Study|Withdrawal by Subject|1
27403|NCT01857622|125487|P3|Overall Study|Protocol Violation|0
27404|NCT01857622|125488|P2|Overall Study|Protocol Violation|1
27405|NCT01857622|125489|P1|Overall Study|Protocol Violation|4
27406|NCT01857622|125487|P3|Overall Study|Physician Decision|0
27407|NCT01857622|125488|P2|Overall Study|Physician Decision|0
27408|NCT01857622|125489|P1|Overall Study|Physician Decision|1
27409|NCT01857622|125487|P3|Overall Study|Adverse Event|2
27410|NCT01857622|125488|P2|Overall Study|Adverse Event|0
27411|NCT01857622|125489|P1|Overall Study|Adverse Event|5
27412|NCT01857583|125501|P4|Overall Study|Withdrawal by Subject|2
27413|NCT01857583|125502|P3|Overall Study|Withdrawal by Subject|1
27414|NCT01857583|125503|P2|Overall Study|Withdrawal by Subject|0
27415|NCT01857583|125504|P1|Overall Study|Withdrawal by Subject|1
27416|NCT01857583|125501|P4|Overall Study|Physician Decision|1
27417|NCT01857583|125502|P3|Overall Study|Physician Decision|0
27418|NCT01857583|125503|P2|Overall Study|Physician Decision|0
27419|NCT01857583|125504|P1|Overall Study|Physician Decision|0
27420|NCT01857583|125501|P4|Overall Study|Death|0
27421|NCT01857583|125502|P3|Overall Study|Death|1
27422|NCT01857583|125503|P2|Overall Study|Death|1
27423|NCT01857583|125504|P1|Overall Study|Death|0
27424|NCT01857583|125501|P4|Overall Study|Adverse Event|1
27425|NCT01857583|125502|P3|Overall Study|Adverse Event|1
27426|NCT01857583|125503|P2|Overall Study|Adverse Event|0
27427|NCT01857583|125504|P1|Overall Study|Adverse Event|0
27428|NCT01857531|125514|P1|Overall Study|Withdrawal by Subject|4
27429|NCT01857323|125532|P1|Overall Study|Did not complete 180 doses|48
27430|NCT01857323|125532|P1|Overall Study|Not specified|4
27431|NCT01857323|125532|P1|Overall Study|Lost to Follow-up|1
27432|NCT01857323|125532|P1|Overall Study|Protocol Violation|6
27433|NCT01857323|125532|P1|Overall Study|Non-compliance|1
27434|NCT01857323|125532|P1|Overall Study|Withdrawal by Subject|3
27435|NCT01857323|125532|P1|Overall Study|Adverse Event|1
27436|NCT01857206|125581|P2|Overall Study|Withdrawal by Subject|0
27437|NCT01857206|125582|P1|Overall Study|Withdrawal by Subject|1
27438|NCT01857206|125581|P2|Overall Study|Unclassified|3
27439|NCT01857206|125582|P1|Overall Study|Unclassified|3
27440|NCT01857206|125581|P2|Overall Study|Lost to Follow-up|6
27441|NCT01857206|125582|P1|Overall Study|Lost to Follow-up|9
27442|NCT01857206|125581|P2|Overall Study|ADMINISTRATIVE REASON|1
27443|NCT01857206|125582|P1|Overall Study|ADMINISTRATIVE REASON|0
27444|NCT01857102|125600|P2|Period 2|Unsatisfactory Lens Fit|0
27445|NCT01857102|125601|P1|Period 2|Unsatisfactory Lens Fit|1
27446|NCT01857102|125600|P2|Period 2|Lens Discomfort|0
27447|NCT01857102|125601|P1|Period 2|Lens Discomfort|1
27448|NCT01857102|125600|P2|Period 1|Physician Decision|0
27449|NCT01857102|125601|P1|Period 1|Physician Decision|1
27450|NCT01857102|125600|P2|Period 1|Unsatisfactory Visual Response|0
27451|NCT01857102|125601|P1|Period 1|Unsatisfactory Visual Response|1
27452|NCT01857102|125600|P2|Period 1|Unsatisfactory Lens Fit|0
27453|NCT01857102|125601|P1|Period 1|Unsatisfactory Lens Fit|1
27454|NCT01857102|125600|P2|Period 1|Lost to Follow-up|3
27455|NCT01857102|125601|P1|Period 1|Lost to Follow-up|0
27456|NCT01857102|125600|P2|Period 1|No longer meets Eligibility Criteria|2
27457|NCT01857102|125601|P1|Period 1|No longer meets Eligibility Criteria|0
27458|NCT01857063|125611|P2|Period 2 (7 Days)|Withdrawal by Subject|0
27459|NCT01857063|125612|P1|Period 2 (7 Days)|Withdrawal by Subject|1
27460|NCT01857063|125611|P2|Period 2 (7 Days)|Physician Decision|1
27461|NCT01857063|125612|P1|Period 2 (7 Days)|Physician Decision|1
27462|NCT01857063|125611|P2|Period 2 (7 Days)|Adverse Event|1
27463|NCT01857063|125612|P1|Period 2 (7 Days)|Adverse Event|2
27464|NCT01857063|125611|P2|Period 1 (7 Days)|Withdrawal by Subject|3
27465|NCT01857063|125612|P1|Period 1 (7 Days)|Withdrawal by Subject|1
27466|NCT01857063|125611|P2|Period 1 (7 Days)|Physician Decision|0
27467|NCT01857063|125612|P1|Period 1 (7 Days)|Physician Decision|1
27468|NCT01857063|125611|P2|Period 1 (7 Days)|Adverse Event|1
27469|NCT01857063|125612|P1|Period 1 (7 Days)|Adverse Event|0
27470|NCT01856907|125645|P3|Overall Study|Withdrawal by Subject|0
27471|NCT01856907|125646|P2|Overall Study|Withdrawal by Subject|1
27472|NCT01856907|125647|P1|Overall Study|Withdrawal by Subject|0
27473|NCT01856907|125645|P3|Overall Study|Pregnancy|0
27474|NCT01856907|125646|P2|Overall Study|Pregnancy|1
27475|NCT01856907|125647|P1|Overall Study|Pregnancy|0
27476|NCT01856907|125645|P3|Overall Study|Pregnancy|0
27477|NCT01856907|125646|P2|Overall Study|Pregnancy|1
27478|NCT01856907|125647|P1|Overall Study|Pregnancy|0
27479|NCT01856686|125700|P2|Overall Study|Lost to Follow-up|11
27480|NCT01856686|125701|P1|Overall Study|Lost to Follow-up|5
27481|NCT01856673|125744|P3|Overall Study|Protocol Violation|1
27482|NCT01856673|125745|P2|Overall Study|Protocol Violation|0
27483|NCT01856673|125746|P1|Overall Study|Protocol Violation|1
27484|NCT01856673|125744|P3|Overall Study|Death|0
27485|NCT01856673|125745|P2|Overall Study|Death|1
27486|NCT01856673|125746|P1|Overall Study|Death|2
27487|NCT01856673|125744|P3|Overall Study|Paperwork errors|0
27488|NCT01856673|125745|P2|Overall Study|Paperwork errors|0
27489|NCT01856673|125746|P1|Overall Study|Paperwork errors|4
27490|NCT01856673|125744|P3|Overall Study|Psychologist decision|0
27491|NCT01856673|125745|P2|Overall Study|Psychologist decision|0
27492|NCT01856673|125746|P1|Overall Study|Psychologist decision|3
27493|NCT01856673|125744|P3|Overall Study|Unknown reasons|0
27494|NCT01856673|125745|P2|Overall Study|Unknown reasons|0
27495|NCT01856673|125746|P1|Overall Study|Unknown reasons|20
27496|NCT01856673|125744|P3|Overall Study|Lost to Follow-up|0
27497|NCT01856673|125745|P2|Overall Study|Lost to Follow-up|34
27498|NCT01856673|125746|P1|Overall Study|Lost to Follow-up|22
27499|NCT01856673|125744|P3|Overall Study|Withdrawal by Subject|33
27500|NCT01856673|125745|P2|Overall Study|Withdrawal by Subject|50
27501|NCT01856673|125746|P1|Overall Study|Withdrawal by Subject|46
27502|NCT01856569|125757|P1|Overall Study|Did not met inclusion criteria|8
27503|NCT01856569|125757|P1|Overall Study|Lost to Follow-up|3
27504|NCT01856569|125757|P1|Overall Study|Changed Site/Structure|1
27505|NCT01856569|125757|P1|Overall Study|Other|1
27506|NCT01856322|125812|P3|Overall Study|off study due to lack of accrual|3
27507|NCT01856322|125813|P2|Overall Study|off study due to lack of accrual|0
27508|NCT01856322|125814|P1|Overall Study|off study due to lack of accrual|0
27509|NCT01856257|125847|P4|Overall Study|Donor complication|1
27510|NCT01856257|125848|P3|Overall Study|Donor complication|0
27511|NCT01856257|125849|P2|Overall Study|Donor complication|0
27512|NCT01856257|125850|P1|Overall Study|Donor complication|0
27513|NCT01856257|125847|P4|Overall Study|Withdrawal by Subject|0
27514|NCT01856257|125848|P3|Overall Study|Withdrawal by Subject|0
27515|NCT01856257|125849|P2|Overall Study|Withdrawal by Subject|1
27516|NCT01856257|125850|P1|Overall Study|Withdrawal by Subject|1
27517|NCT01856257|125847|P4|Overall Study|Physician Decision|1
27518|NCT01856257|125848|P3|Overall Study|Physician Decision|0
27519|NCT01856257|125849|P2|Overall Study|Physician Decision|0
27520|NCT01856257|125850|P1|Overall Study|Physician Decision|0
27521|NCT01856257|125847|P4|Overall Study|Death|0
27522|NCT01856257|125848|P3|Overall Study|Death|0
27523|NCT01856257|125849|P2|Overall Study|Death|0
27524|NCT01856257|125850|P1|Overall Study|Death|2
27525|NCT01855958|126018|P2|Overall Study|Withdrawal by Subject|0
27526|NCT01855958|126019|P1|Overall Study|Withdrawal by Subject|1
27527|NCT01855945|126049|P12|Overall Study|Withdrawal by Subject|1
27528|NCT01855945|126050|P11|Overall Study|Withdrawal by Subject|4
27529|NCT01855945|126051|P10|Overall Study|Withdrawal by Subject|2
27530|NCT01855945|126052|P9|Overall Study|Withdrawal by Subject|0
27531|NCT01855945|126053|P8|Overall Study|Withdrawal by Subject|0
27532|NCT01855945|126054|P7|Overall Study|Withdrawal by Subject|1
27533|NCT01855945|126055|P6|Overall Study|Withdrawal by Subject|0
27534|NCT01855945|126056|P5|Overall Study|Withdrawal by Subject|1
27535|NCT01855945|126057|P4|Overall Study|Withdrawal by Subject|1
27536|NCT01855945|126058|P3|Overall Study|Withdrawal by Subject|4
27537|NCT01855945|126059|P2|Overall Study|Withdrawal by Subject|0
27538|NCT01855945|126060|P1|Overall Study|Withdrawal by Subject|4
27539|NCT01855945|126049|P12|Overall Study|Other - Unclassified|0
27540|NCT01855945|126050|P11|Overall Study|Other - Unclassified|1
27541|NCT01855945|126051|P10|Overall Study|Other - Unclassified|0
27542|NCT01855945|126052|P9|Overall Study|Other - Unclassified|0
27543|NCT01855945|126053|P8|Overall Study|Other - Unclassified|1
27544|NCT01855945|126054|P7|Overall Study|Other - Unclassified|2
27545|NCT01855945|126055|P6|Overall Study|Other - Unclassified|0
27546|NCT01855945|126056|P5|Overall Study|Other - Unclassified|0
27547|NCT01855945|126057|P4|Overall Study|Other - Unclassified|0
27548|NCT01855945|126058|P3|Overall Study|Other - Unclassified|1
27549|NCT01855945|126059|P2|Overall Study|Other - Unclassified|1
27550|NCT01855945|126060|P1|Overall Study|Other - Unclassified|1
27551|NCT01855945|126049|P12|Overall Study|Lost to Follow-up|2
27552|NCT01855945|126050|P11|Overall Study|Lost to Follow-up|0
27553|NCT01855945|126051|P10|Overall Study|Lost to Follow-up|0
27554|NCT01855945|126052|P9|Overall Study|Lost to Follow-up|2
27555|NCT01855945|126053|P8|Overall Study|Lost to Follow-up|7
27556|NCT01855945|126054|P7|Overall Study|Lost to Follow-up|4
27557|NCT01855945|126055|P6|Overall Study|Lost to Follow-up|3
27558|NCT01855945|126056|P5|Overall Study|Lost to Follow-up|0
27559|NCT01855945|126057|P4|Overall Study|Lost to Follow-up|3
27560|NCT01855945|126058|P3|Overall Study|Lost to Follow-up|7
27561|NCT01855945|126059|P2|Overall Study|Lost to Follow-up|10
27562|NCT01855945|126060|P1|Overall Study|Lost to Follow-up|11
27563|NCT01855945|126049|P12|Overall Study|Death|0
27564|NCT01855945|126050|P11|Overall Study|Death|0
27565|NCT01855945|126051|P10|Overall Study|Death|0
27566|NCT01855945|126052|P9|Overall Study|Death|0
27567|NCT01855945|126053|P8|Overall Study|Death|0
27568|NCT01855945|126054|P7|Overall Study|Death|2
27569|NCT01855945|126055|P6|Overall Study|Death|0
27570|NCT01855945|126056|P5|Overall Study|Death|0
27571|NCT01855945|126057|P4|Overall Study|Death|0
27572|NCT01855945|126058|P3|Overall Study|Death|0
27573|NCT01855945|126059|P2|Overall Study|Death|0
27574|NCT01855945|126060|P1|Overall Study|Death|0
27575|NCT01855945|126049|P12|Overall Study|Adverse Event|0
27576|NCT01855945|126050|P11|Overall Study|Adverse Event|0
27577|NCT01855945|126051|P10|Overall Study|Adverse Event|0
27578|NCT01855945|126052|P9|Overall Study|Adverse Event|0
27579|NCT01855945|126053|P8|Overall Study|Adverse Event|0
27580|NCT01855945|126054|P7|Overall Study|Adverse Event|1
27581|NCT01855945|126055|P6|Overall Study|Adverse Event|0
27582|NCT01855945|126056|P5|Overall Study|Adverse Event|0
27583|NCT01855945|126057|P4|Overall Study|Adverse Event|0
27584|NCT01855945|126058|P3|Overall Study|Adverse Event|0
27585|NCT01855945|126059|P2|Overall Study|Adverse Event|0
27586|NCT01855945|126060|P1|Overall Study|Adverse Event|0
27587|NCT01855919|126196|P2|Overall Study|Protocol Violation|4
27588|NCT01855919|126197|P1|Overall Study|Protocol Violation|1
27589|NCT01855919|126196|P2|Overall Study|Entry Criteria Not Met|1
27590|NCT01855919|126197|P1|Overall Study|Entry Criteria Not Met|1
27591|NCT01855919|126196|P2|Overall Study|Withdrawal by Subject|10
27592|NCT01855919|126197|P1|Overall Study|Withdrawal by Subject|4
27593|NCT01855919|126196|P2|Overall Study|Lack of Efficacy|3
27594|NCT01855919|126197|P1|Overall Study|Lack of Efficacy|1
27595|NCT01855919|126196|P2|Overall Study|Adverse Event|8
27596|NCT01855919|126197|P1|Overall Study|Adverse Event|16
27597|NCT01855789|126229|P4|2) Week 24 up to End of Study|Other|1
27598|NCT01855789|126230|P3|2) Week 24 up to End of Study|Other|0
27599|NCT01855789|126231|P2|2) Week 24 up to End of Study|Other|0
27600|NCT01855789|126232|P1|2) Week 24 up to End of Study|Other|0
27601|NCT01855789|126229|P4|2) Week 24 up to End of Study|Sponsor Decision|1
27602|NCT01855789|126230|P3|2) Week 24 up to End of Study|Sponsor Decision|0
27603|NCT01855789|126231|P2|2) Week 24 up to End of Study|Sponsor Decision|0
27604|NCT01855789|126232|P1|2) Week 24 up to End of Study|Sponsor Decision|0
27605|NCT01855789|126229|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
27606|NCT01855789|126230|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
27607|NCT01855789|126231|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
27608|NCT01855789|126232|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
27609|NCT01855789|126229|P4|2) Week 24 up to End of Study|Physician Decision|4
27610|NCT01855789|126230|P3|2) Week 24 up to End of Study|Physician Decision|2
27611|NCT01855789|126231|P2|2) Week 24 up to End of Study|Physician Decision|0
27612|NCT01855789|126232|P1|2) Week 24 up to End of Study|Physician Decision|0
27613|NCT01855789|126229|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
27614|NCT01855789|126230|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
27615|NCT01855789|126231|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
27616|NCT01855789|126232|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
27617|NCT01855789|126229|P4|2) Week 24 up to End of Study|Protocol Violation|1
27618|NCT01855789|126230|P3|2) Week 24 up to End of Study|Protocol Violation|0
27619|NCT01855789|126231|P2|2) Week 24 up to End of Study|Protocol Violation|0
27620|NCT01855789|126232|P1|2) Week 24 up to End of Study|Protocol Violation|0
27621|NCT01855789|126229|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
27622|NCT01855789|126230|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
27623|NCT01855789|126231|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
27624|NCT01855789|126232|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
27625|NCT01855789|126229|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
27626|NCT01855789|126230|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
27627|NCT01855789|126231|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
27628|NCT01855789|126232|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
27629|NCT01855789|126229|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
27630|NCT01855789|126230|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
27631|NCT01855789|126231|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
27632|NCT01855789|126232|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
27633|NCT01855789|126229|P4|2) Week 24 up to End of Study|Adverse Event|21
27634|NCT01855789|126230|P3|2) Week 24 up to End of Study|Adverse Event|5
27635|NCT01855789|126231|P2|2) Week 24 up to End of Study|Adverse Event|4
27636|NCT01855789|126232|P1|2) Week 24 up to End of Study|Adverse Event|0
27637|NCT01855789|126229|P4|1) Baseline up to Week 24|Other|0
27638|NCT01855789|126230|P3|1) Baseline up to Week 24|Other|0
27639|NCT01855789|126231|P2|1) Baseline up to Week 24|Other|0
27640|NCT01855789|126232|P1|1) Baseline up to Week 24|Other|4
27641|NCT01855789|126229|P4|1) Baseline up to Week 24|Sponsor Decision|0
27642|NCT01855789|126230|P3|1) Baseline up to Week 24|Sponsor Decision|0
27643|NCT01855789|126231|P2|1) Baseline up to Week 24|Sponsor Decision|0
27644|NCT01855789|126232|P1|1) Baseline up to Week 24|Sponsor Decision|3
27645|NCT01855789|126229|P4|1) Baseline up to Week 24|Participant Non-compliance|0
27646|NCT01855789|126230|P3|1) Baseline up to Week 24|Participant Non-compliance|0
27647|NCT01855789|126231|P2|1) Baseline up to Week 24|Participant Non-compliance|0
27648|NCT01855789|126232|P1|1) Baseline up to Week 24|Participant Non-compliance|3
27649|NCT01855789|126229|P4|1) Baseline up to Week 24|Pregnancy|0
27650|NCT01855789|126230|P3|1) Baseline up to Week 24|Pregnancy|0
27651|NCT01855789|126231|P2|1) Baseline up to Week 24|Pregnancy|0
27652|NCT01855789|126232|P1|1) Baseline up to Week 24|Pregnancy|1
27653|NCT01855789|126229|P4|1) Baseline up to Week 24|Physician Decision|0
27654|NCT01855789|126230|P3|1) Baseline up to Week 24|Physician Decision|0
27655|NCT01855789|126231|P2|1) Baseline up to Week 24|Physician Decision|0
27656|NCT01855789|126232|P1|1) Baseline up to Week 24|Physician Decision|4
27657|NCT01855789|126229|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
27658|NCT01855789|126230|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
27659|NCT01855789|126231|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
27660|NCT01855789|126232|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
27661|NCT01855789|126229|P4|1) Baseline up to Week 24|Protocol Violation|0
27662|NCT01855789|126230|P3|1) Baseline up to Week 24|Protocol Violation|0
27663|NCT01855789|126231|P2|1) Baseline up to Week 24|Protocol Violation|0
27664|NCT01855789|126232|P1|1) Baseline up to Week 24|Protocol Violation|4
27665|NCT01855789|126229|P4|1) Baseline up to Week 24|Lost to Follow-up|0
27666|NCT01855789|126230|P3|1) Baseline up to Week 24|Lost to Follow-up|0
27667|NCT01855789|126231|P2|1) Baseline up to Week 24|Lost to Follow-up|0
27668|NCT01855789|126232|P1|1) Baseline up to Week 24|Lost to Follow-up|11
27669|NCT01855789|126229|P4|1) Baseline up to Week 24|Lack of Efficacy|0
27670|NCT01855789|126230|P3|1) Baseline up to Week 24|Lack of Efficacy|0
27671|NCT01855789|126231|P2|1) Baseline up to Week 24|Lack of Efficacy|0
27672|NCT01855789|126232|P1|1) Baseline up to Week 24|Lack of Efficacy|16
27673|NCT01855789|126229|P4|1) Baseline up to Week 24|Death|0
27674|NCT01855789|126230|P3|1) Baseline up to Week 24|Death|0
27675|NCT01855789|126231|P2|1) Baseline up to Week 24|Death|0
27676|NCT01855789|126232|P1|1) Baseline up to Week 24|Death|2
27677|NCT01855789|126229|P4|1) Baseline up to Week 24|Adverse Event|0
27678|NCT01855789|126230|P3|1) Baseline up to Week 24|Adverse Event|0
27679|NCT01855789|126231|P2|1) Baseline up to Week 24|Adverse Event|0
27680|NCT01855789|126232|P1|1) Baseline up to Week 24|Adverse Event|37
27681|NCT01855074|126254|P1|Overall Study|Started but not treated|1
27682|NCT01855074|126254|P1|Overall Study|Withdrawal by Subject|8
27683|NCT01855074|126254|P1|Overall Study|Lost to Follow-up|4
27684|NCT01855074|126254|P1|Overall Study|Adverse Event|1
27685|NCT01854944|126266|P3|Overall Study|Withdrawal by Subject|1
27686|NCT01854944|126267|P2|Overall Study|Withdrawal by Subject|0
27687|NCT01854944|126268|P1|Overall Study|Withdrawal by Subject|0
27688|NCT01854827|126322|P1|Overall Study|Death|1
27689|NCT01854710|126334|P6|Overall Study|CRI procedural error|2
27690|NCT01854710|126335|P5|Overall Study|CRI procedural error|2
27691|NCT01854710|126336|P4|Overall Study|CRI procedural error|2
27692|NCT01854710|126337|P3|Overall Study|CRI procedural error|2
27693|NCT01854710|126338|P2|Overall Study|CRI procedural error|2
27694|NCT01854710|126339|P1|Overall Study|CRI procedural error|2
27695|NCT01854710|126334|P6|Overall Study|Withdrawal by Subject|0
27696|NCT01854710|126335|P5|Overall Study|Withdrawal by Subject|0
27697|NCT01854710|126336|P4|Overall Study|Withdrawal by Subject|0
27698|NCT01854710|126337|P3|Overall Study|Withdrawal by Subject|0
27699|NCT01854710|126338|P2|Overall Study|Withdrawal by Subject|1
27700|NCT01854710|126339|P1|Overall Study|Withdrawal by Subject|2
27701|NCT01854697|126360|P5|Overall Study|Not Specified|0
27702|NCT01854697|126361|P4|Overall Study|Not Specified|0
27703|NCT01854697|126362|P3|Overall Study|Not Specified|1
27704|NCT01854697|126363|P2|Overall Study|Not Specified|1
27705|NCT01854697|126364|P1|Overall Study|Not Specified|0
27706|NCT01854697|126360|P5|Overall Study|Withdrew Consent|0
27707|NCT01854697|126361|P4|Overall Study|Withdrew Consent|1
27708|NCT01854697|126362|P3|Overall Study|Withdrew Consent|0
27709|NCT01854697|126363|P2|Overall Study|Withdrew Consent|1
27710|NCT01854697|126364|P1|Overall Study|Withdrew Consent|0
27711|NCT01854697|126360|P5|Overall Study|To enter another AbbVie study|1
27712|NCT01854697|126361|P4|Overall Study|To enter another AbbVie study|0
27713|NCT01854697|126362|P3|Overall Study|To enter another AbbVie study|0
27714|NCT01854697|126363|P2|Overall Study|To enter another AbbVie study|0
27715|NCT01854697|126364|P1|Overall Study|To enter another AbbVie study|1
27716|NCT01854697|126360|P5|Overall Study|Lost to Follow-up|0
27717|NCT01854697|126361|P4|Overall Study|Lost to Follow-up|2
27718|NCT01854697|126362|P3|Overall Study|Lost to Follow-up|1
27719|NCT01854697|126363|P2|Overall Study|Lost to Follow-up|1
27720|NCT01854697|126364|P1|Overall Study|Lost to Follow-up|4
27721|NCT01854697|126360|P5|Overall Study|Adverse Event|1
27722|NCT01854697|126361|P4|Overall Study|Adverse Event|0
27723|NCT01854697|126362|P3|Overall Study|Adverse Event|0
27724|NCT01854697|126363|P2|Overall Study|Adverse Event|0
27725|NCT01854697|126364|P1|Overall Study|Adverse Event|1
27726|NCT01854658|126408|P4|Overall Study|Administrative reasons|2
27727|NCT01854658|126409|P3|Overall Study|Administrative reasons|2
27728|NCT01854658|126410|P2|Overall Study|Administrative reasons|1
27729|NCT01854658|126411|P1|Overall Study|Administrative reasons|5
27730|NCT01854658|126408|P4|Overall Study|Adverse Event|19
27731|NCT01854658|126409|P3|Overall Study|Adverse Event|23
27732|NCT01854658|126410|P2|Overall Study|Adverse Event|14
27733|NCT01854658|126411|P1|Overall Study|Adverse Event|21
27734|NCT01854658|126408|P4|Overall Study|Lack of Efficacy|7
27735|NCT01854658|126409|P3|Overall Study|Lack of Efficacy|4
27736|NCT01854658|126410|P2|Overall Study|Lack of Efficacy|8
27737|NCT01854658|126411|P1|Overall Study|Lack of Efficacy|3
27738|NCT01854658|126408|P4|Overall Study|Protocol-specified criteria|7
27739|NCT01854658|126409|P3|Overall Study|Protocol-specified criteria|10
27740|NCT01854658|126410|P2|Overall Study|Protocol-specified criteria|15
27741|NCT01854658|126411|P1|Overall Study|Protocol-specified criteria|15
27742|NCT01854658|126408|P4|Overall Study|Withdrawal by Subject|15
27743|NCT01854658|126409|P3|Overall Study|Withdrawal by Subject|29
27744|NCT01854658|126410|P2|Overall Study|Withdrawal by Subject|21
27745|NCT01854658|126411|P1|Overall Study|Withdrawal by Subject|28
27746|NCT01854658|126408|P4|Overall Study|Lost to Follow-up|4
27747|NCT01854658|126409|P3|Overall Study|Lost to Follow-up|8
27748|NCT01854658|126410|P2|Overall Study|Lost to Follow-up|9
27749|NCT01854658|126411|P1|Overall Study|Lost to Follow-up|8
27750|NCT01854658|126408|P4|Overall Study|Physician Decision|4
27751|NCT01854658|126409|P3|Overall Study|Physician Decision|2
27752|NCT01854658|126410|P2|Overall Study|Physician Decision|5
27753|NCT01854658|126411|P1|Overall Study|Physician Decision|7
27754|NCT01854658|126408|P4|Overall Study|Protocol Violation|1
27755|NCT01854658|126409|P3|Overall Study|Protocol Violation|2
27756|NCT01854658|126410|P2|Overall Study|Protocol Violation|2
27757|NCT01854658|126411|P1|Overall Study|Protocol Violation|6
27758|NCT01854645|126446|P5|Overall Study|Adverse Event|11
27759|NCT01854645|126447|P4|Overall Study|Adverse Event|20
27760|NCT01854645|126448|P3|Overall Study|Adverse Event|19
27761|NCT01854645|126449|P2|Overall Study|Adverse Event|31
27762|NCT01854645|126450|P1|Overall Study|Adverse Event|33
27763|NCT01854645|126446|P5|Overall Study|Lack of Efficacy|9
27764|NCT01854645|126447|P4|Overall Study|Lack of Efficacy|3
27765|NCT01854645|126448|P3|Overall Study|Lack of Efficacy|9
27766|NCT01854645|126449|P2|Overall Study|Lack of Efficacy|12
27767|NCT01854645|126450|P1|Overall Study|Lack of Efficacy|7
27768|NCT01854645|126446|P5|Overall Study|Withdrawal by Subject|24
27769|NCT01854645|126447|P4|Overall Study|Withdrawal by Subject|21
27770|NCT01854645|126448|P3|Overall Study|Withdrawal by Subject|30
27771|NCT01854645|126449|P2|Overall Study|Withdrawal by Subject|41
27772|NCT01854645|126450|P1|Overall Study|Withdrawal by Subject|31
27773|NCT01854645|126446|P5|Overall Study|Physician Decision|7
27774|NCT01854645|126447|P4|Overall Study|Physician Decision|3
27775|NCT01854645|126448|P3|Overall Study|Physician Decision|3
27776|NCT01854645|126449|P2|Overall Study|Physician Decision|5
27777|NCT01854645|126450|P1|Overall Study|Physician Decision|1
27778|NCT01854645|126446|P5|Overall Study|Lost to Follow-up|0
27779|NCT01854645|126447|P4|Overall Study|Lost to Follow-up|5
27780|NCT01854645|126448|P3|Overall Study|Lost to Follow-up|8
27781|NCT01854645|126449|P2|Overall Study|Lost to Follow-up|7
27782|NCT01854645|126450|P1|Overall Study|Lost to Follow-up|10
27783|NCT01854645|126446|P5|Overall Study|Protocol Violation|1
27784|NCT01854645|126447|P4|Overall Study|Protocol Violation|4
27785|NCT01854645|126448|P3|Overall Study|Protocol Violation|5
27786|NCT01854645|126449|P2|Overall Study|Protocol Violation|0
27787|NCT01854645|126450|P1|Overall Study|Protocol Violation|3
27788|NCT01854645|126446|P5|Overall Study|Administrative Reasons / Missing|1
27789|NCT01854645|126447|P4|Overall Study|Administrative Reasons / Missing|1
27790|NCT01854645|126448|P3|Overall Study|Administrative Reasons / Missing|0
27791|NCT01854645|126449|P2|Overall Study|Administrative Reasons / Missing|0
27792|NCT01854645|126450|P1|Overall Study|Administrative Reasons / Missing|0
27793|NCT01854645|126446|P5|Overall Study|Protocol-Specified Criteria|7
27794|NCT01854645|126447|P4|Overall Study|Protocol-Specified Criteria|5
27795|NCT01854645|126448|P3|Overall Study|Protocol-Specified Criteria|8
27796|NCT01854645|126449|P2|Overall Study|Protocol-Specified Criteria|10
27797|NCT01854645|126450|P1|Overall Study|Protocol-Specified Criteria|13
27798|NCT01854528|126531|P2|Overall Study|Virologic Failure|9
27799|NCT01854528|126532|P1|Overall Study|Virologic Failure|0
27800|NCT01854528|126531|P2|Overall Study|Withdrawal by Subject|2
27801|NCT01854528|126532|P1|Overall Study|Withdrawal by Subject|0
27802|NCT01854528|126531|P2|Overall Study|Adverse Event|4
27803|NCT01854528|126532|P1|Overall Study|Adverse Event|0
27804|NCT01854047|126580|P5|Overall Study|Other than specified above|8
27805|NCT01854047|126581|P4|Overall Study|Other than specified above|5
27806|NCT01854047|126582|P3|Overall Study|Other than specified above|3
27807|NCT01854047|126583|P2|Overall Study|Other than specified above|3
27808|NCT01854047|126584|P1|Overall Study|Other than specified above|3
27809|NCT01854047|126580|P5|Overall Study|Randomized but not treated|4
27810|NCT01854047|126581|P4|Overall Study|Randomized but not treated|0
27811|NCT01854047|126582|P3|Overall Study|Randomized but not treated|2
27812|NCT01854047|126583|P2|Overall Study|Randomized but not treated|1
27813|NCT01854047|126584|P1|Overall Study|Randomized but not treated|0
27814|NCT01854047|126580|P5|Overall Study|Adverse Event|7
27815|NCT01854047|126581|P4|Overall Study|Adverse Event|10
27816|NCT01854047|126582|P3|Overall Study|Adverse Event|6
27817|NCT01854047|126583|P2|Overall Study|Adverse Event|4
27818|NCT01854047|126584|P1|Overall Study|Adverse Event|5
27819|NCT01854047|126580|P5|Overall Study|Poor compliance to protocol|0
27820|NCT01854047|126581|P4|Overall Study|Poor compliance to protocol|0
27821|NCT01854047|126582|P3|Overall Study|Poor compliance to protocol|2
27822|NCT01854047|126583|P2|Overall Study|Poor compliance to protocol|0
27823|NCT01854047|126584|P1|Overall Study|Poor compliance to protocol|3
27824|NCT01854047|126580|P5|Overall Study|Lack of Efficacy|0
27825|NCT01854047|126581|P4|Overall Study|Lack of Efficacy|0
27826|NCT01854047|126582|P3|Overall Study|Lack of Efficacy|0
27827|NCT01854047|126583|P2|Overall Study|Lack of Efficacy|0
27828|NCT01854047|126584|P1|Overall Study|Lack of Efficacy|1
27829|NCT01853982|126715|P2|Overall Study|Lost to Follow-up|1
27830|NCT01853982|126716|P1|Overall Study|Lost to Follow-up|0
27831|NCT01853982|126715|P2|Overall Study|Death|0
27832|NCT01853982|126716|P1|Overall Study|Death|1
27833|NCT01853982|126715|P2|Overall Study|Withdrawal by Subject|0
27834|NCT01853982|126716|P1|Overall Study|Withdrawal by Subject|1
27835|NCT01853839|126722|P1|Overall Study|Lost to follow-up or no valid BP measure|336
27836|NCT01853839|126722|P1|Overall Study|End of treatment visit too early|33
27837|NCT01853839|126722|P1|Overall Study|Not meet ITT population definition|58
27838|NCT01853839|126722|P1|Overall Study|Violated inclusion criteria|2
27839|NCT01853696|126744|P2|Overall Study|Lost to Follow-up|4
27840|NCT01853696|126745|P1|Overall Study|Lost to Follow-up|5
27841|NCT01853696|126744|P2|Overall Study|Withdrawal by Subject|1
27842|NCT01853696|126745|P1|Overall Study|Withdrawal by Subject|1
27843|NCT01853475|126781|P3|Overall Study|Withdrawal by Subject|0
27844|NCT01853475|126782|P2|Overall Study|Withdrawal by Subject|1
27845|NCT01853475|126783|P1|Overall Study|Withdrawal by Subject|0
27846|NCT01853397|126804|P4|Overall Study|Subject Noncompliance|1
27847|NCT01853397|126805|P3|Overall Study|Subject Noncompliance|0
27848|NCT01853397|126806|P2|Overall Study|Subject Noncompliance|0
27849|NCT01853397|126807|P1|Overall Study|Subject Noncompliance|0
27850|NCT01853397|126804|P4|Overall Study|Withdrawal by Subject|1
27851|NCT01853397|126805|P3|Overall Study|Withdrawal by Subject|0
27852|NCT01853397|126806|P2|Overall Study|Withdrawal by Subject|0
27853|NCT01853397|126807|P1|Overall Study|Withdrawal by Subject|0
27854|NCT01853384|126835|P2|Completed Follow up Visit 2|Lost to Follow-up|1
27855|NCT01853384|126836|P1|Completed Follow up Visit 2|Lost to Follow-up|0
27856|NCT01853384|126835|P2|Completed Follow up Visit 2|Death|0
27857|NCT01853384|126836|P1|Completed Follow up Visit 2|Death|1
27858|NCT01853384|126835|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
27859|NCT01853384|126836|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
27860|NCT01853384|126835|P2|Completed Follow up Visit 2|Adverse Event|0
27861|NCT01853384|126836|P1|Completed Follow up Visit 2|Adverse Event|1
27862|NCT01853384|126835|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
27863|NCT01853384|126836|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
27864|NCT01853384|126835|P2|Completed Follow up Visit 1|Early Termination|9
27865|NCT01853384|126836|P1|Completed Follow up Visit 1|Early Termination|13
27866|NCT01853384|126835|P2|Randomized|Other|3
27867|NCT01853384|126836|P1|Randomized|Other|3
27868|NCT01853384|126835|P2|Randomized|Sponsor Decision|34
27869|NCT01853384|126836|P1|Randomized|Sponsor Decision|47
27870|NCT01853384|126835|P2|Randomized|Withdrawal by Subject|3
27871|NCT01853384|126836|P1|Randomized|Withdrawal by Subject|5
27872|NCT01853384|126835|P2|Randomized|Lost to Follow-up|1
27873|NCT01853384|126836|P1|Randomized|Lost to Follow-up|1
27874|NCT01853384|126835|P2|Randomized|Death|2
27875|NCT01853384|126836|P1|Randomized|Death|1
27876|NCT01853384|126835|P2|Randomized|Adverse Event|3
27877|NCT01853384|126836|P1|Randomized|Adverse Event|5
27878|NCT01853280|126876|P2|Overall Study|Ineligible|1
27879|NCT01853280|126877|P1|Overall Study|Ineligible|0
27880|NCT01853280|126876|P2|Overall Study|Withdrawal by Subject|1
27881|NCT01853280|126877|P1|Overall Study|Withdrawal by Subject|0
27882|NCT01853280|126876|P2|Overall Study|Physician Decision|1
27883|NCT01853280|126877|P1|Overall Study|Physician Decision|0
27884|NCT01853280|126876|P2|Overall Study|Lost to Follow-up|1
27885|NCT01853280|126877|P1|Overall Study|Lost to Follow-up|0
27886|NCT01853280|126876|P2|Overall Study|Lack of Efficacy|2
27887|NCT01853280|126877|P1|Overall Study|Lack of Efficacy|2
27888|NCT01853254|126883|P1|Overall Study|Administrative/Other|16
27889|NCT01853254|126883|P1|Overall Study|Withdrawal of Consent|16
27890|NCT01853254|126883|P1|Overall Study|Other Protocol Violation|1
27891|NCT01853254|126883|P1|Overall Study|Refusal of Treatment|1
27892|NCT01853254|126883|P1|Overall Study|Insufficient Therapeutic Response|22
27893|NCT01853254|126883|P1|Overall Study|Failure to Return|43
27894|NCT01853254|126883|P1|Overall Study|Death|1
27895|NCT01853254|126883|P1|Overall Study|Adverse Event/Intercurrent Illness|3
27896|NCT01853254|126883|P1|Overall Study|Abnormal Laboratory Test|1
27897|NCT01853176|126900|P2|Overall Study|Study terminated|0
27898|NCT01853176|126901|P1|Overall Study|Study terminated|4
27899|NCT01853072|126920|P2|Overall Study|Reason not specified|6
27900|NCT01853072|126921|P1|Overall Study|Reason not specified|9
27901|NCT01853072|126920|P2|Overall Study|Withdrawal by Subject|2
27902|NCT01853072|126921|P1|Overall Study|Withdrawal by Subject|1
27903|NCT01853072|126920|P2|Overall Study|Physician Decision|1
27904|NCT01853072|126921|P1|Overall Study|Physician Decision|1
27905|NCT01853072|126920|P2|Overall Study|Non-compliance with study drug|1
27906|NCT01853072|126921|P1|Overall Study|Non-compliance with study drug|0
27907|NCT01853072|126920|P2|Overall Study|Lost to Follow-up|3
27908|NCT01853072|126921|P1|Overall Study|Lost to Follow-up|0
27909|NCT01853072|126920|P2|Overall Study|Death|4
27910|NCT01853072|126921|P1|Overall Study|Death|1
27911|NCT01853072|126920|P2|Overall Study|Adverse Event|3
27912|NCT01853072|126921|P1|Overall Study|Adverse Event|0
27913|NCT01853072|126920|P2|Overall Study|Adverse event prior to treatment|1
27914|NCT01853072|126921|P1|Overall Study|Adverse event prior to treatment|0
27915|NCT01853046|126941|P2|Overall Study|Disease progression|3
27916|NCT01853046|126942|P1|Overall Study|Disease progression|13
27917|NCT01853046|126941|P2|Overall Study|Adverse Event|2
27918|NCT01853046|126942|P1|Overall Study|Adverse Event|4
27919|NCT01853046|126941|P2|Overall Study|Withdrawal by Subject|1
27920|NCT01853046|126942|P1|Overall Study|Withdrawal by Subject|1
27921|NCT01852825|127010|P3|Overall Study|Withdrawal by Subject|0
27922|NCT01852825|127011|P2|Overall Study|Withdrawal by Subject|0
27923|NCT01852825|127012|P1|Overall Study|Withdrawal by Subject|2
27924|NCT01852812|127038|P3|Overall Study|Non-compliance With Study Drug|0
27925|NCT01852812|127039|P2|Overall Study|Non-compliance With Study Drug|1
27926|NCT01852812|127040|P1|Overall Study|Non-compliance With Study Drug|0
27927|NCT01852812|127038|P3|Overall Study|Adverse Event|1
27928|NCT01852812|127039|P2|Overall Study|Adverse Event|0
27929|NCT01852812|127040|P1|Overall Study|Adverse Event|0
27930|NCT01852591|127069|P1|Overall Study|Not Evaluable at Time of Analysis|1
27931|NCT01852591|127069|P1|Overall Study|Withdrawal by Subject|2
27932|NCT01852214|127108|P2|Washout Period|Withdrawal by Subject|1
27933|NCT01852214|127109|P1|Washout Period|Withdrawal by Subject|0
27934|NCT01852214|127108|P2|Period 1|Withdrawal by Subject|1
27935|NCT01852214|127109|P1|Period 1|Withdrawal by Subject|0
27936|NCT01852214|127108|P2|Period 1|Adverse Event|2
27937|NCT01852214|127109|P1|Period 1|Adverse Event|1
27938|NCT01852162|127136|P2|Overall Study|Withdrawal by Subject|1
27939|NCT01852162|127137|P1|Overall Study|Withdrawal by Subject|3
27940|NCT01852162|127136|P2|Overall Study|Adverse Event|0
27941|NCT01852162|127137|P1|Overall Study|Adverse Event|1
27942|NCT01852110|127153|P6|Overall Study|Withdrawal by Subject|0
27943|NCT01852110|127154|P5|Overall Study|Withdrawal by Subject|0
27944|NCT01852110|127155|P4|Overall Study|Withdrawal by Subject|0
27945|NCT01852110|127156|P3|Overall Study|Withdrawal by Subject|0
27946|NCT01852110|127157|P2|Overall Study|Withdrawal by Subject|4
27947|NCT01852110|127158|P1|Overall Study|Withdrawal by Subject|4
27948|NCT01852110|127153|P6|Overall Study|Study Terminated by Sponsor|0
27949|NCT01852110|127154|P5|Overall Study|Study Terminated by Sponsor|0
27950|NCT01852110|127155|P4|Overall Study|Study Terminated by Sponsor|0
27951|NCT01852110|127156|P3|Overall Study|Study Terminated by Sponsor|0
27952|NCT01852110|127157|P2|Overall Study|Study Terminated by Sponsor|32
27953|NCT01852110|127158|P1|Overall Study|Study Terminated by Sponsor|30
27954|NCT01852110|127153|P6|Overall Study|Protocol Violation|0
27955|NCT01852110|127154|P5|Overall Study|Protocol Violation|0
27956|NCT01852110|127155|P4|Overall Study|Protocol Violation|0
27957|NCT01852110|127156|P3|Overall Study|Protocol Violation|0
27958|NCT01852110|127157|P2|Overall Study|Protocol Violation|1
27959|NCT01852110|127158|P1|Overall Study|Protocol Violation|0
27960|NCT01852110|127153|P6|Overall Study|Physician Decision|0
27961|NCT01852110|127154|P5|Overall Study|Physician Decision|0
27962|NCT01852110|127155|P4|Overall Study|Physician Decision|0
27963|NCT01852110|127156|P3|Overall Study|Physician Decision|0
27964|NCT01852110|127157|P2|Overall Study|Physician Decision|0
27965|NCT01852110|127158|P1|Overall Study|Physician Decision|1
27966|NCT01852110|127153|P6|Overall Study|Non-compliance with Study Drug|0
27967|NCT01852110|127154|P5|Overall Study|Non-compliance with Study Drug|0
27968|NCT01852110|127155|P4|Overall Study|Non-compliance with Study Drug|0
27969|NCT01852110|127156|P3|Overall Study|Non-compliance with Study Drug|0
27970|NCT01852110|127157|P2|Overall Study|Non-compliance with Study Drug|1
27971|NCT01852110|127158|P1|Overall Study|Non-compliance with Study Drug|2
27972|NCT01852110|127153|P6|Overall Study|Lost to Follow-up|0
27973|NCT01852110|127154|P5|Overall Study|Lost to Follow-up|0
27974|NCT01852110|127155|P4|Overall Study|Lost to Follow-up|0
27975|NCT01852110|127156|P3|Overall Study|Lost to Follow-up|0
27976|NCT01852110|127157|P2|Overall Study|Lost to Follow-up|3
27977|NCT01852110|127158|P1|Overall Study|Lost to Follow-up|1
27978|NCT01852110|127153|P6|Overall Study|Adverse Event|0
27979|NCT01852110|127154|P5|Overall Study|Adverse Event|0
27980|NCT01852110|127155|P4|Overall Study|Adverse Event|0
27981|NCT01852110|127156|P3|Overall Study|Adverse Event|0
27982|NCT01852110|127157|P2|Overall Study|Adverse Event|5
27983|NCT01852110|127158|P1|Overall Study|Adverse Event|12
27984|NCT01851863|127232|P4|Overall Study|Lost to Follow-up|3
27985|NCT01851863|127233|P3|Overall Study|Lost to Follow-up|2
27986|NCT01851863|127234|P2|Overall Study|Lost to Follow-up|4
27987|NCT01851863|127235|P1|Overall Study|Lost to Follow-up|3
27988|NCT01851863|127232|P4|Overall Study|Did not receive study medication|0
27989|NCT01851863|127233|P3|Overall Study|Did not receive study medication|3
27990|NCT01851863|127234|P2|Overall Study|Did not receive study medication|5
27991|NCT01851863|127235|P1|Overall Study|Did not receive study medication|2
27992|NCT01851720|127264|P2|Overall Study|Lost to Follow-up|1
27993|NCT01851720|127265|P1|Overall Study|Lost to Follow-up|0
27994|NCT01851590|127295|P3|Overall Study|Lack of Efficacy|0
27995|NCT01851590|127296|P2|Overall Study|Lack of Efficacy|1
27996|NCT01851590|127297|P1|Overall Study|Lack of Efficacy|0
27997|NCT01851590|127295|P3|Overall Study|Adverse Event|2
27998|NCT01851590|127296|P2|Overall Study|Adverse Event|0
27999|NCT01851590|127297|P1|Overall Study|Adverse Event|0
28000|NCT01851590|127295|P3|Overall Study|Withdrawal by Subject|1
28001|NCT01851590|127296|P2|Overall Study|Withdrawal by Subject|0
28002|NCT01851590|127297|P1|Overall Study|Withdrawal by Subject|0
28003|NCT01851330|127320|P3|Overall Study|Investigator’s Discretion|1
28004|NCT01851330|127321|P2|Overall Study|Investigator’s Discretion|0
28005|NCT01851330|127322|P1|Overall Study|Investigator’s Discretion|0
28006|NCT01851330|127320|P3|Overall Study|Withdrew Consent|0
28007|NCT01851330|127321|P2|Overall Study|Withdrew Consent|1
28008|NCT01851330|127322|P1|Overall Study|Withdrew Consent|2
28009|NCT01851330|127320|P3|Overall Study|Lost to Follow-up|9
28010|NCT01851330|127321|P2|Overall Study|Lost to Follow-up|6
28011|NCT01851330|127322|P1|Overall Study|Lost to Follow-up|1
28012|NCT01851330|127320|P3|Overall Study|Lack of Efficacy|2
28013|NCT01851330|127321|P2|Overall Study|Lack of Efficacy|9
28014|NCT01851330|127322|P1|Overall Study|Lack of Efficacy|10
28015|NCT01850615|127364|P2|Overall Study|Unclassified|1
28016|NCT01850615|127365|P1|Overall Study|Unclassified|0
28017|NCT01850615|127364|P2|Overall Study|Lost to Follow-up|1
28018|NCT01850615|127365|P1|Overall Study|Lost to Follow-up|0
28019|NCT01850615|127364|P2|Overall Study|Withdrawal by Subject|1
28020|NCT01850615|127365|P1|Overall Study|Withdrawal by Subject|3
28021|NCT01850615|127364|P2|Overall Study|Adverse Event|1
28022|NCT01850615|127365|P1|Overall Study|Adverse Event|2
28023|NCT01850615|127364|P2|Overall Study|Protocol Violation|1
28024|NCT01850615|127365|P1|Overall Study|Protocol Violation|4
28025|NCT01850589|127383|P2|Overall Study|Withdrawal by Subject|0
28026|NCT01850589|127384|P1|Overall Study|Withdrawal by Subject|8
28027|NCT01850030|127449|P2|Overall Study|pregnancy not confirmed at visit 4|249
28028|NCT01850030|127450|P1|Overall Study|pregnancy not confirmed at visit 4|248
28029|NCT01850030|127449|P2|Overall Study|Protocol Violation|28
28030|NCT01850030|127450|P1|Overall Study|Protocol Violation|24
28031|NCT01850030|127449|P2|Overall Study|Withdrawal by Subject|4
28032|NCT01850030|127450|P1|Overall Study|Withdrawal by Subject|3
28033|NCT01850030|127449|P2|Overall Study|Lost to Follow-up|5
28034|NCT01850030|127450|P1|Overall Study|Lost to Follow-up|5
28035|NCT01850030|127449|P2|Overall Study|Lack of Efficacy|1
28036|NCT01850030|127450|P1|Overall Study|Lack of Efficacy|3
28037|NCT01850030|127449|P2|Overall Study|Adverse Event|82
28038|NCT01850030|127450|P1|Overall Study|Adverse Event|64
28039|NCT01849848|127462|P1|Overall Study|Progression of the primary disease|3
28040|NCT01849848|127462|P1|Overall Study|Physician Decision|1
28041|NCT01849588|127560|P1|Overall Study|Lack of Efficacy|3
28042|NCT01849562|127570|P3|Overall Study|Non-compliance with Study Drug|0
28043|NCT01849562|127571|P2|Overall Study|Non-compliance with Study Drug|0
28044|NCT01849562|127572|P1|Overall Study|Non-compliance with Study Drug|1
28045|NCT01849562|127570|P3|Overall Study|Lost to Follow-up|0
28046|NCT01849562|127571|P2|Overall Study|Lost to Follow-up|0
28047|NCT01849562|127572|P1|Overall Study|Lost to Follow-up|1
28048|NCT01849497|127585|P2|Overall Study|Lost to Follow-up|1
28049|NCT01849497|127586|P1|Overall Study|Lost to Follow-up|0
28050|NCT01849497|127585|P2|Overall Study|Sponsor Decision|1
28051|NCT01849497|127586|P1|Overall Study|Sponsor Decision|0
28052|NCT01849497|127585|P2|Overall Study|Withdrawal by Subject|2
28053|NCT01849497|127586|P1|Overall Study|Withdrawal by Subject|1
28054|NCT01849458|127594|P1|Overall Study|Lost to Follow-up|4
28055|NCT01849289|127633|P2|Overall Study|Unclassified|18
28056|NCT01849289|127634|P1|Overall Study|Unclassified|25
28057|NCT01849289|127633|P2|Overall Study|Withdrawal criteria|0
28058|NCT01849289|127634|P1|Overall Study|Withdrawal criteria|1
28059|NCT01849289|127633|P2|Overall Study|Protocol Violation|3
28060|NCT01849289|127634|P1|Overall Study|Protocol Violation|3
28061|NCT01849289|127633|P2|Overall Study|Adverse Event|3
28062|NCT01849289|127634|P1|Overall Study|Adverse Event|3
28063|NCT01848990|127678|P3|Overall Study|Death|0
28064|NCT01848990|127679|P2|Overall Study|Death|0
28065|NCT01848990|127680|P1|Overall Study|Death|1
28066|NCT01848990|127678|P3|Overall Study|Non Compliance|0
28067|NCT01848990|127679|P2|Overall Study|Non Compliance|0
28068|NCT01848990|127680|P1|Overall Study|Non Compliance|1
28069|NCT01848990|127678|P3|Overall Study|Physician Decision|0
28070|NCT01848990|127679|P2|Overall Study|Physician Decision|0
28071|NCT01848990|127680|P1|Overall Study|Physician Decision|1
28072|NCT01848990|127678|P3|Overall Study|Withdrawal by Subject|9
28073|NCT01848990|127679|P2|Overall Study|Withdrawal by Subject|6
28074|NCT01848990|127680|P1|Overall Study|Withdrawal by Subject|20
28075|NCT01848990|127678|P3|Overall Study|Protocol Violation|0
28076|NCT01848990|127679|P2|Overall Study|Protocol Violation|1
28077|NCT01848990|127680|P1|Overall Study|Protocol Violation|0
28078|NCT01848990|127678|P3|Overall Study|Lost to Follow-up|2
28079|NCT01848990|127679|P2|Overall Study|Lost to Follow-up|1
28080|NCT01848990|127680|P1|Overall Study|Lost to Follow-up|6
28081|NCT01848990|127678|P3|Overall Study|Adverse Event|0
28082|NCT01848990|127679|P2|Overall Study|Adverse Event|1
28083|NCT01848990|127680|P1|Overall Study|Adverse Event|4
28084|NCT01848938|127706|P2|Overall Study|Lost to Follow-up|1
28085|NCT01848938|127707|P1|Overall Study|Lost to Follow-up|1
28086|NCT01848834|127756|P5|Overall Study|Not Treated|0
28087|NCT01848834|127757|P4|Overall Study|Not Treated|0
28088|NCT01848834|127758|P3|Overall Study|Not Treated|0
28089|NCT01848834|127759|P2|Overall Study|Not Treated|1
28090|NCT01848834|127760|P1|Overall Study|Not Treated|0
28091|NCT01848834|127756|P5|Overall Study|Withdrawal by Subject|7
28092|NCT01848834|127757|P4|Overall Study|Withdrawal by Subject|0
28093|NCT01848834|127758|P3|Overall Study|Withdrawal by Subject|3
28094|NCT01848834|127759|P2|Overall Study|Withdrawal by Subject|2
28095|NCT01848834|127760|P1|Overall Study|Withdrawal by Subject|0
28096|NCT01848834|127756|P5|Overall Study|Protocol Violation|2
28097|NCT01848834|127757|P4|Overall Study|Protocol Violation|0
28098|NCT01848834|127758|P3|Overall Study|Protocol Violation|1
28099|NCT01848834|127759|P2|Overall Study|Protocol Violation|0
28100|NCT01848834|127760|P1|Overall Study|Protocol Violation|0
28101|NCT01848834|127756|P5|Overall Study|Progressive Disease|78
28102|NCT01848834|127757|P4|Overall Study|Progressive Disease|36
28103|NCT01848834|127758|P3|Overall Study|Progressive Disease|21
28104|NCT01848834|127759|P2|Overall Study|Progressive Disease|41
28105|NCT01848834|127760|P1|Overall Study|Progressive Disease|27
28106|NCT01848834|127756|P5|Overall Study|Death|3
28107|NCT01848834|127757|P4|Overall Study|Death|0
28108|NCT01848834|127758|P3|Overall Study|Death|0
28109|NCT01848834|127759|P2|Overall Study|Death|1
28110|NCT01848834|127760|P1|Overall Study|Death|0
28111|NCT01848834|127756|P5|Overall Study|Complete Response|0
28112|NCT01848834|127757|P4|Overall Study|Complete Response|0
28113|NCT01848834|127758|P3|Overall Study|Complete Response|0
28114|NCT01848834|127759|P2|Overall Study|Complete Response|1
28115|NCT01848834|127760|P1|Overall Study|Complete Response|0
28116|NCT01848834|127756|P5|Overall Study|Adverse Event|15
28117|NCT01848834|127757|P4|Overall Study|Adverse Event|1
28118|NCT01848834|127758|P3|Overall Study|Adverse Event|6
28119|NCT01848834|127759|P2|Overall Study|Adverse Event|8
28120|NCT01848834|127760|P1|Overall Study|Adverse Event|3
28121|NCT01848834|127756|P5|Overall Study|Physician Decision|1
28122|NCT01848834|127757|P4|Overall Study|Physician Decision|0
28123|NCT01848834|127758|P3|Overall Study|Physician Decision|0
28124|NCT01848834|127759|P2|Overall Study|Physician Decision|0
28125|NCT01848834|127760|P1|Overall Study|Physician Decision|0
28126|NCT01848834|127756|P5|Overall Study|Ongoing in Study|26
28127|NCT01848834|127757|P4|Overall Study|Ongoing in Study|0
28128|NCT01848834|127758|P3|Overall Study|Ongoing in Study|1
28129|NCT01848834|127759|P2|Overall Study|Ongoing in Study|6
28130|NCT01848834|127760|P1|Overall Study|Ongoing in Study|0
28131|NCT01848756|127795|P1|Overall Study|Enrolled in Error|1
28132|NCT01848756|127795|P1|Overall Study|Withdrawal by Subject|1
28133|NCT01848756|127795|P1|Overall Study|Adverse Event|1
28134|NCT01848288|127809|P1|Overall Study|Withdrawal by Subject|1
28135|NCT01848288|127809|P1|Overall Study|Protocol Violation|1
28136|NCT01848288|127809|P1|Overall Study|Death|1
28137|NCT01848210|127820|P2|Overall Study|Administrative|0
28138|NCT01848210|127821|P1|Overall Study|Administrative|1
28139|NCT01848210|127820|P2|Overall Study|Chronic Venous Insufficiency Course|2
28140|NCT01848210|127821|P1|Overall Study|Chronic Venous Insufficiency Course|1
28141|NCT01848210|127820|P2|Overall Study|Hepatic Function Alteration|0
28142|NCT01848210|127821|P1|Overall Study|Hepatic Function Alteration|4
28143|NCT01848210|127820|P2|Overall Study|Hypesensitivity|0
28144|NCT01848210|127821|P1|Overall Study|Hypesensitivity|1
28145|NCT01848210|127820|P2|Overall Study|Discontinuation Criterion|7
28146|NCT01848210|127821|P1|Overall Study|Discontinuation Criterion|5
28147|NCT01848210|127820|P2|Overall Study|Adverse Event|9
28148|NCT01848210|127821|P1|Overall Study|Adverse Event|7
28149|NCT01848210|127820|P2|Overall Study|Impedition Condition|9
28150|NCT01848210|127821|P1|Overall Study|Impedition Condition|5
28151|NCT01848210|127820|P2|Overall Study|Use of Forbidden Drugs|10
28152|NCT01848210|127821|P1|Overall Study|Use of Forbidden Drugs|9
28153|NCT01848210|127820|P2|Overall Study|Protocol Violation|5
28154|NCT01848210|127821|P1|Overall Study|Protocol Violation|3
28155|NCT01848210|127820|P2|Overall Study|Lost to Follow-up|12
28156|NCT01848210|127821|P1|Overall Study|Lost to Follow-up|24
28157|NCT01848210|127820|P2|Overall Study|Informed Consent Form Withdrawal|24
28158|NCT01848210|127821|P1|Overall Study|Informed Consent Form Withdrawal|28
28159|NCT01848145|127833|P1|Subsequent Infusions: Weeks 3-8|Death|1
28160|NCT01848145|127833|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
28161|NCT01848145|127833|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
28162|NCT01848145|127833|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
28163|NCT01848145|127833|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
28164|NCT01848145|127833|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
28165|NCT01848145|127833|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
28166|NCT01847885|127873|P3|Randomization|Screen Failure|0
28167|NCT01847885|127874|P2|Randomization|Screen Failure|3
28168|NCT01847885|127875|P1|Randomization|Screen Failure|0
28169|NCT01847885|127873|P3|Randomization|Withdrawal by Subject|2
28170|NCT01847885|127874|P2|Randomization|Withdrawal by Subject|0
28171|NCT01847885|127875|P1|Randomization|Withdrawal by Subject|0
28172|NCT01847885|127873|P3|Randomization|Protocol Violation|0
28173|NCT01847885|127874|P2|Randomization|Protocol Violation|1
28174|NCT01847885|127875|P1|Randomization|Protocol Violation|0
28175|NCT01847885|127873|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
28176|NCT01847885|127874|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
28177|NCT01847885|127875|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
28178|NCT01847885|127873|P3|Initial Enrollment (Consented)|Screen failure|0
28179|NCT01847885|127874|P2|Initial Enrollment (Consented)|Screen failure|0
28180|NCT01847885|127875|P1|Initial Enrollment (Consented)|Screen failure|39
28181|NCT01847885|127873|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
28182|NCT01847885|127874|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
28183|NCT01847885|127875|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
28184|NCT01847885|127873|P3|Initial Enrollment (Consented)|Protocol Violation|0
28185|NCT01847885|127874|P2|Initial Enrollment (Consented)|Protocol Violation|0
28186|NCT01847885|127875|P1|Initial Enrollment (Consented)|Protocol Violation|1
28187|NCT01847443|127952|P4|Washout Period Before Study Period 4|Positive alcohol test|0
28188|NCT01847443|127953|P3|Washout Period Before Study Period 4|Positive alcohol test|0
28189|NCT01847443|127954|P2|Washout Period Before Study Period 4|Positive alcohol test|0
28190|NCT01847443|127955|P1|Washout Period Before Study Period 4|Positive alcohol test|1
28191|NCT01847443|127952|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
28192|NCT01847443|127953|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
28193|NCT01847443|127954|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
28194|NCT01847443|127955|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
28195|NCT01847443|127952|P4|Washout Period Before Study Period 3|Other reason|0
28196|NCT01847443|127953|P3|Washout Period Before Study Period 3|Other reason|0
28197|NCT01847443|127954|P2|Washout Period Before Study Period 3|Other reason|0
28198|NCT01847443|127955|P1|Washout Period Before Study Period 3|Other reason|1
28199|NCT01847443|127952|P4|Washout Period Before Study Period 2|Other reason|0
28200|NCT01847443|127953|P3|Washout Period Before Study Period 2|Other reason|0
28201|NCT01847443|127954|P2|Washout Period Before Study Period 2|Other reason|0
28202|NCT01847443|127955|P1|Washout Period Before Study Period 2|Other reason|1
28203|NCT01847443|127952|P4|Washout Period Before Study Period 2|Adverse Event|0
28204|NCT01847443|127953|P3|Washout Period Before Study Period 2|Adverse Event|0
28205|NCT01847443|127954|P2|Washout Period Before Study Period 2|Adverse Event|1
28206|NCT01847443|127955|P1|Washout Period Before Study Period 2|Adverse Event|1
28207|NCT01847443|127952|P4|Study Period 1|Withdrawal by Subject|0
28208|NCT01847443|127953|P3|Study Period 1|Withdrawal by Subject|0
28209|NCT01847443|127954|P2|Study Period 1|Withdrawal by Subject|1
28210|NCT01847443|127955|P1|Study Period 1|Withdrawal by Subject|0
28211|NCT01846741|128012|P1|Baseline Visit|Subject did not meet entry criteria|2
28212|NCT01846442|128138|P4|Overall Study|Left the city/Lost medication|1
28213|NCT01846442|128139|P3|Overall Study|Left the city/Lost medication|1
28214|NCT01846442|128140|P2|Overall Study|Left the city/Lost medication|0
28215|NCT01846442|128141|P1|Overall Study|Left the city/Lost medication|1
28216|NCT01846442|128138|P4|Overall Study|Withdrawal by Subject|1
28217|NCT01846442|128139|P3|Overall Study|Withdrawal by Subject|0
28218|NCT01846442|128140|P2|Overall Study|Withdrawal by Subject|2
28219|NCT01846442|128141|P1|Overall Study|Withdrawal by Subject|3
28220|NCT01846442|128138|P4|Overall Study|Lost to Follow-up|0
28221|NCT01846442|128139|P3|Overall Study|Lost to Follow-up|1
28222|NCT01846442|128140|P2|Overall Study|Lost to Follow-up|0
28223|NCT01846442|128141|P1|Overall Study|Lost to Follow-up|0
28224|NCT01846442|128138|P4|Overall Study|Adverse Event|1
28225|NCT01846442|128139|P3|Overall Study|Adverse Event|2
28226|NCT01846442|128140|P2|Overall Study|Adverse Event|4
28227|NCT01846442|128141|P1|Overall Study|Adverse Event|2
28228|NCT01846416|128182|P3|Overall Study|Lost to Follow-up|1
28229|NCT01846416|128183|P2|Overall Study|Lost to Follow-up|2
28230|NCT01846416|128184|P1|Overall Study|Lost to Follow-up|0
28231|NCT01846416|128182|P3|Overall Study|Ongoing as of 7 January 2015|3
28232|NCT01846416|128183|P2|Overall Study|Ongoing as of 7 January 2015|41
28233|NCT01846416|128184|P1|Overall Study|Ongoing as of 7 January 2015|21
28234|NCT01846416|128182|P3|Overall Study|Other|0
28235|NCT01846416|128183|P2|Overall Study|Other|0
28236|NCT01846416|128184|P1|Overall Study|Other|1
28237|NCT01846416|128182|P3|Overall Study|Withdrawal by Subject|0
28238|NCT01846416|128183|P2|Overall Study|Withdrawal by Subject|7
28239|NCT01846416|128184|P1|Overall Study|Withdrawal by Subject|1
28240|NCT01846416|128182|P3|Overall Study|Death|9
28241|NCT01846416|128183|P2|Overall Study|Death|43
28242|NCT01846416|128184|P1|Overall Study|Death|8
28243|NCT01846299|128229|P2|Overall Study|Adverse Event|0
28244|NCT01846299|128230|P1|Overall Study|Adverse Event|2
28245|NCT01846299|128229|P2|Overall Study|Withdrawal by Subject|6
28246|NCT01846299|128230|P1|Overall Study|Withdrawal by Subject|1
28247|NCT01846299|128229|P2|Overall Study|Lost to Follow-up|0
28248|NCT01846299|128230|P1|Overall Study|Lost to Follow-up|3
28249|NCT01846299|128229|P2|Overall Study|Death|2
28250|NCT01846299|128230|P1|Overall Study|Death|1
28251|NCT01846299|128229|P2|Overall Study|Protocol deviation|0
28252|NCT01846299|128230|P1|Overall Study|Protocol deviation|1
28253|NCT01846299|128229|P2|Overall Study|Physician Decision|2
28254|NCT01846299|128230|P1|Overall Study|Physician Decision|4
28255|NCT01846221|128268|P2|Overall Study|Age Exclusion|0
28256|NCT01846221|128269|P1|Overall Study|Age Exclusion|1
28257|NCT01846221|128268|P2|Overall Study|Catheter Failure|0
28258|NCT01846221|128269|P1|Overall Study|Catheter Failure|2
28259|NCT01846104|128283|P1|Overall Study|Withdrawal by Subject|1
28260|NCT01846039|128289|P1|Overall Study|Subject Withdrew Consent|1
28261|NCT01846039|128289|P1|Overall Study|Protocol Violation|1
28262|NCT01845974|128301|P2|Overall Study|screen failure|0
28263|NCT01845974|128302|P1|Overall Study|screen failure|1
28264|NCT01845831|128310|P5|Inpatient Phase|Withdrawal by Subject|0
28265|NCT01845831|128311|P4|Inpatient Phase|Withdrawal by Subject|0
28266|NCT01845831|128312|P3|Inpatient Phase|Withdrawal by Subject|0
28267|NCT01845831|128313|P2|Inpatient Phase|Withdrawal by Subject|1
28268|NCT01845831|128314|P1|Inpatient Phase|Withdrawal by Subject|1
28269|NCT01845077|128375|P6|Washout Period|Protocol Violation|0
28270|NCT01845077|128376|P5|Washout Period|Protocol Violation|1
28271|NCT01845077|128377|P4|Washout Period|Protocol Violation|1
28272|NCT01845077|128378|P3|Washout Period|Protocol Violation|0
28273|NCT01845077|128379|P2|Washout Period|Protocol Violation|0
28274|NCT01845077|128380|P1|Washout Period|Protocol Violation|0
28275|NCT01845077|128375|P6|Washout Period|elevated lab values (not clinic. sign.)|0
28276|NCT01845077|128376|P5|Washout Period|elevated lab values (not clinic. sign.)|0
28277|NCT01845077|128377|P4|Washout Period|elevated lab values (not clinic. sign.)|0
28278|NCT01845077|128378|P3|Washout Period|elevated lab values (not clinic. sign.)|1
28279|NCT01845077|128379|P2|Washout Period|elevated lab values (not clinic. sign.)|0
28280|NCT01845077|128380|P1|Washout Period|elevated lab values (not clinic. sign.)|0
28281|NCT01845077|128375|P6|Washout Period|Adverse Event|0
28282|NCT01845077|128376|P5|Washout Period|Adverse Event|0
28283|NCT01845077|128377|P4|Washout Period|Adverse Event|0
28284|NCT01845077|128378|P3|Washout Period|Adverse Event|0
28285|NCT01845077|128379|P2|Washout Period|Adverse Event|0
28286|NCT01845077|128380|P1|Washout Period|Adverse Event|1
28287|NCT01845077|128375|P6|Washout Period|Lost to Follow-up|1
28288|NCT01845077|128376|P5|Washout Period|Lost to Follow-up|0
28289|NCT01845077|128377|P4|Washout Period|Lost to Follow-up|1
28290|NCT01845077|128378|P3|Washout Period|Lost to Follow-up|0
28291|NCT01845077|128379|P2|Washout Period|Lost to Follow-up|1
28292|NCT01845077|128380|P1|Washout Period|Lost to Follow-up|0
28293|NCT01845025|128426|P2|Overall Study|Missing|1
28294|NCT01845025|128427|P1|Overall Study|Missing|1
28295|NCT01845025|128426|P2|Overall Study|Protocol deviation|6
28296|NCT01845025|128427|P1|Overall Study|Protocol deviation|3
28297|NCT01845025|128426|P2|Overall Study|Death|0
28298|NCT01845025|128427|P1|Overall Study|Death|2
28299|NCT01845025|128426|P2|Overall Study|Administrative problems|8
28300|NCT01845025|128427|P1|Overall Study|Administrative problems|8
28301|NCT01845025|128426|P2|Overall Study|Lost to Follow-up|13
28302|NCT01845025|128427|P1|Overall Study|Lost to Follow-up|13
28303|NCT01845025|128426|P2|Overall Study|Withdrawal by Subject|44
28304|NCT01845025|128427|P1|Overall Study|Withdrawal by Subject|48
28305|NCT01845025|128426|P2|Overall Study|Unsatisfactory therapeutic effect|2
28306|NCT01845025|128427|P1|Overall Study|Unsatisfactory therapeutic effect|4
28307|NCT01845025|128426|P2|Overall Study|Adverse Event|3
28308|NCT01845025|128427|P1|Overall Study|Adverse Event|6
28309|NCT01844895|128449|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
28310|NCT01844895|128449|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
28311|NCT01844895|128449|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
28312|NCT01844895|128449|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
28313|NCT01844895|128449|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
28314|NCT01844895|128449|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
28315|NCT01844895|128449|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
28316|NCT01844856|128467|P2|Overall Study|Randomized but was a Screen Failure|1
28317|NCT01844856|128468|P1|Overall Study|Randomized but was a Screen Failure|0
28318|NCT01844856|128467|P2|Overall Study|Inadvertently Not Scheduled|0
28319|NCT01844856|128468|P1|Overall Study|Inadvertently Not Scheduled|1
28320|NCT01844856|128467|P2|Overall Study|Enterococcus Resistant|1
28321|NCT01844856|128468|P1|Overall Study|Enterococcus Resistant|0
28322|NCT01844856|128467|P2|Overall Study|Noncompliance|3
28323|NCT01844856|128468|P1|Overall Study|Noncompliance|2
28324|NCT01844856|128467|P2|Overall Study|Withdrawal by Subject|2
28325|NCT01844856|128468|P1|Overall Study|Withdrawal by Subject|3
28326|NCT01844856|128467|P2|Overall Study|Adverse Event|6
28327|NCT01844856|128468|P1|Overall Study|Adverse Event|3
28328|NCT01844856|128467|P2|Overall Study|Lost to Follow-up|3
28329|NCT01844856|128468|P1|Overall Study|Lost to Follow-up|15
28330|NCT01844830|128480|P2|Overall Study|Withdrawal by Subject|0
28331|NCT01844830|128481|P1|Overall Study|Withdrawal by Subject|1
28332|NCT01844817|128511|P2|Treatment|Other|3
28333|NCT01844817|128512|P1|Treatment|Other|0
28334|NCT01844817|128511|P2|Treatment|Lost to Follow-up|1
28335|NCT01844817|128512|P1|Treatment|Lost to Follow-up|0
28336|NCT01844817|128511|P2|Treatment|Death|8
28337|NCT01844817|128512|P1|Treatment|Death|10
28338|NCT01844817|128511|P2|Treatment|Withdrawal by Subject|6
28339|NCT01844817|128512|P1|Treatment|Withdrawal by Subject|10
28340|NCT01844817|128511|P2|Treatment|Adverse Event|9
28341|NCT01844817|128512|P1|Treatment|Adverse Event|17
28342|NCT01844817|128511|P2|Treatment|Progressive Disease|36
28343|NCT01844817|128512|P1|Treatment|Progressive Disease|27
28344|NCT01844817|128511|P2|Enrolled and Randomized|Withdrawal by Subject|3
28345|NCT01844817|128512|P1|Enrolled and Randomized|Withdrawal by Subject|2
28346|NCT01844778|128525|P3|Overall Study|Adverse Event|2
28347|NCT01844778|128526|P2|Overall Study|Adverse Event|2
28348|NCT01844778|128527|P1|Overall Study|Adverse Event|0
28349|NCT01844778|128525|P3|Overall Study|Withdrawal by Subject|0
28350|NCT01844778|128526|P2|Overall Study|Withdrawal by Subject|0
28351|NCT01844778|128527|P1|Overall Study|Withdrawal by Subject|2
28352|NCT01844778|128525|P3|Overall Study|Protocol deviation|2
28353|NCT01844778|128526|P2|Overall Study|Protocol deviation|1
28354|NCT01844778|128527|P1|Overall Study|Protocol deviation|0
28355|NCT01844765|128553|P2|Overall Study|Untreated|0
28356|NCT01844765|128554|P1|Overall Study|Untreated|1
28357|NCT01844765|128553|P2|Overall Study|Protocol Violation|0
28358|NCT01844765|128554|P1|Overall Study|Protocol Violation|1
28359|NCT01844765|128553|P2|Overall Study|Disease progression|0
28360|NCT01844765|128554|P1|Overall Study|Disease progression|1
28361|NCT01844765|128553|P2|Overall Study|Administrative problems|1
28362|NCT01844765|128554|P1|Overall Study|Administrative problems|1
28363|NCT01844765|128553|P2|Overall Study|Withdrawal by Subject|1
28364|NCT01844765|128554|P1|Overall Study|Withdrawal by Subject|0
28365|NCT01844765|128553|P2|Overall Study|Adverse Event|4
28366|NCT01844765|128554|P1|Overall Study|Adverse Event|5
28367|NCT01844700|128574|P2|Overall Study|stopped taking meds|1
28368|NCT01844700|128575|P1|Overall Study|stopped taking meds|0
28369|NCT01844700|128574|P2|Overall Study|Withdrawal by Subject|0
28370|NCT01844700|128575|P1|Overall Study|Withdrawal by Subject|1
28371|NCT01844700|128574|P2|Overall Study|refused medication switch|0
28372|NCT01844700|128575|P1|Overall Study|refused medication switch|1
28373|NCT01844700|128574|P2|Overall Study|Lack of Efficacy|0
28374|NCT01844700|128575|P1|Overall Study|Lack of Efficacy|1
28375|NCT01844687|128587|P1|Visit 4|Withdrawal by Subject|2
28376|NCT01844687|128587|P1|Visit 4|Lost to Follow-up|1
28377|NCT01844687|128587|P1|Visit 4|Pregnancy|1
28378|NCT01844687|128587|P1|Visit 3|child care problems|1
28379|NCT01844687|128587|P1|Visit 3|Withdrawal by Subject|3
28380|NCT01844687|128587|P1|Visit 3|Lost to Follow-up|1
28381|NCT01844687|128587|P1|Visit 2|Protocol Violation|1
28382|NCT01844687|128587|P1|Visit 2|Withdrawal by Subject|1
28383|NCT01844687|128587|P1|Visit 1|Lost to Follow-up|5
28384|NCT01844687|128587|P1|Visit 1|Protocol Violation|3
28385|NCT01844531|128650|P4|Overall Study|Withdrawal by Subject|0
28386|NCT01844531|128651|P3|Overall Study|Withdrawal by Subject|0
28387|NCT01844531|128652|P2|Overall Study|Withdrawal by Subject|1
28388|NCT01844531|128653|P1|Overall Study|Withdrawal by Subject|0
28389|NCT01844518|128683|P1|Long-Term Extension|Still in On-Going Study|149
28390|NCT01844518|128683|P1|Long-Term Extension|No Longer Met Study Criteria|1
28391|NCT01844518|128683|P1|Long-Term Extension|Adverse Event|1
28392|NCT01844518|128683|P1|Long-Term Extension|Lack of Efficacy|6
28393|NCT01844518|128683|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
28394|NCT01844518|128683|P1|Short-Term (ST) Period|Withdrawal of Consent|2
28395|NCT01844518|128683|P1|Short-Term (ST) Period|Lack of Efficacy|3
28396|NCT01844518|128683|P1|Short-Term (ST) Period|Adverse Event|3
28397|NCT01844505|128700|P3|Overall Study|Not Reported|1
28398|NCT01844505|128701|P2|Overall Study|Not Reported|0
28399|NCT01844505|128702|P1|Overall Study|Not Reported|0
28400|NCT01844505|128700|P3|Overall Study|Other Reasons|2
28401|NCT01844505|128701|P2|Overall Study|Other Reasons|2
28402|NCT01844505|128702|P1|Overall Study|Other Reasons|4
28403|NCT01844505|128700|P3|Overall Study|Subject no longer meets criteria|0
28404|NCT01844505|128701|P2|Overall Study|Subject no longer meets criteria|1
28405|NCT01844505|128702|P1|Overall Study|Subject no longer meets criteria|0
28406|NCT01844505|128700|P3|Overall Study|Poor/non-compliance|1
28407|NCT01844505|128701|P2|Overall Study|Poor/non-compliance|1
28408|NCT01844505|128702|P1|Overall Study|Poor/non-compliance|1
28409|NCT01844505|128700|P3|Overall Study|Maximum clinical benefit|2
28410|NCT01844505|128701|P2|Overall Study|Maximum clinical benefit|11
28411|NCT01844505|128702|P1|Overall Study|Maximum clinical benefit|8
28412|NCT01844505|128700|P3|Overall Study|Lost to Follow-up|0
28413|NCT01844505|128701|P2|Overall Study|Lost to Follow-up|0
28414|NCT01844505|128702|P1|Overall Study|Lost to Follow-up|1
28415|NCT01844505|128700|P3|Overall Study|Withdrawal by Subject|0
28416|NCT01844505|128701|P2|Overall Study|Withdrawal by Subject|3
28417|NCT01844505|128702|P1|Overall Study|Withdrawal by Subject|0
28418|NCT01844505|128700|P3|Overall Study|Subject request discontinue treatment|8
28419|NCT01844505|128701|P2|Overall Study|Subject request discontinue treatment|14
28420|NCT01844505|128702|P1|Overall Study|Subject request discontinue treatment|17
28421|NCT01844505|128700|P3|Overall Study|Adverse event unrelated to study drug|6
28422|NCT01844505|128701|P2|Overall Study|Adverse event unrelated to study drug|15
28423|NCT01844505|128702|P1|Overall Study|Adverse event unrelated to study drug|7
28424|NCT01844505|128700|P3|Overall Study|Death|1
28425|NCT01844505|128701|P2|Overall Study|Death|3
28426|NCT01844505|128702|P1|Overall Study|Death|1
28427|NCT01844505|128700|P3|Overall Study|Study drug toxicity|50
28428|NCT01844505|128701|P2|Overall Study|Study drug toxicity|131
28429|NCT01844505|128702|P1|Overall Study|Study drug toxicity|40
28430|NCT01844505|128700|P3|Overall Study|Disease progression|224
28431|NCT01844505|128701|P2|Overall Study|Disease progression|88
28432|NCT01844505|128702|P1|Overall Study|Disease progression|170
28433|NCT01843972|128813|P10|Overall Study|Withdrawal by Subject|0
28434|NCT01843972|128814|P9|Overall Study|Withdrawal by Subject|0
28435|NCT01843972|128815|P8|Overall Study|Withdrawal by Subject|0
28436|NCT01843972|128816|P7|Overall Study|Withdrawal by Subject|0
28437|NCT01843972|128817|P6|Overall Study|Withdrawal by Subject|0
28438|NCT01843972|128818|P5|Overall Study|Withdrawal by Subject|1
28439|NCT01843972|128819|P4|Overall Study|Withdrawal by Subject|0
28440|NCT01843972|128820|P3|Overall Study|Withdrawal by Subject|0
28441|NCT01843972|128821|P2|Overall Study|Withdrawal by Subject|0
28442|NCT01843972|128822|P1|Overall Study|Withdrawal by Subject|0
28443|NCT01843933|128892|P2|Overall Study|Data lost|4
28444|NCT01843933|128893|P1|Overall Study|Data lost|6
28445|NCT01843777|128912|P2|Overall Study|Withdrawal by Subject|0
28446|NCT01843777|128913|P1|Overall Study|Withdrawal by Subject|1
28447|NCT01843673|128921|P1|Overall Study|Withdrawal by Subject|4
28448|NCT01843673|128921|P1|Overall Study|Lack of Efficacy|2
28449|NCT01843660|128933|P1|Overall Study|Other|30
28450|NCT01843374|128957|P2|Overall Study|Withdrawal by Subject|19
28451|NCT01843374|128958|P1|Overall Study|Withdrawal by Subject|14
28452|NCT01843374|128957|P2|Overall Study|Death|302
28453|NCT01843374|128958|P1|Overall Study|Death|150
28454|NCT01843348|128985|P3|Overall Study|Various reasons|6
28455|NCT01843348|128986|P2|Overall Study|Various reasons|9
28456|NCT01843348|128987|P1|Overall Study|Various reasons|4
28457|NCT01843348|128985|P3|Overall Study|Graft loss/retransplantation|11
28458|NCT01843348|128986|P2|Overall Study|Graft loss/retransplantation|8
28459|NCT01843348|128987|P1|Overall Study|Graft loss/retransplantation|5
28460|NCT01843348|128985|P3|Overall Study|Death|4
28461|NCT01843348|128986|P2|Overall Study|Death|3
28462|NCT01843348|128987|P1|Overall Study|Death|5
28463|NCT01843348|128985|P3|Overall Study|Lost to Follow-up|2
28464|NCT01843348|128986|P2|Overall Study|Lost to Follow-up|4
28465|NCT01843348|128987|P1|Overall Study|Lost to Follow-up|5
28466|NCT01843348|128985|P3|Overall Study|Withdrawal by Subject|18
28467|NCT01843348|128986|P2|Overall Study|Withdrawal by Subject|16
28468|NCT01843348|128987|P1|Overall Study|Withdrawal by Subject|4
28469|NCT01843205|129027|P2|First Treatment (11 Days)|Withdrawal by Subject|0
28470|NCT01843205|129028|P1|First Treatment (11 Days)|Withdrawal by Subject|1
28471|NCT01843192|129089|P3|Overall Study|Intra-operative exclusions per protocol|2
28472|NCT01843192|129090|P2|Overall Study|Intra-operative exclusions per protocol|6
28473|NCT01843192|129091|P1|Overall Study|Intra-operative exclusions per protocol|2
28474|NCT01842958|129122|P2|Overall Study|Lost to Follow-up|1
28475|NCT01842958|129123|P1|Overall Study|Lost to Follow-up|1
28476|NCT01842633|129196|P3|Overall Study|Technical issues|0
28477|NCT01842633|129197|P2|Overall Study|Technical issues|0
28478|NCT01842633|129198|P1|Overall Study|Technical issues|1
28479|NCT01842633|129196|P3|Overall Study|Withdrawal by Subject|0
28480|NCT01842633|129197|P2|Overall Study|Withdrawal by Subject|1
28481|NCT01842633|129198|P1|Overall Study|Withdrawal by Subject|0
28482|NCT01842633|129196|P3|Overall Study|Adverse Event|0
28483|NCT01842633|129197|P2|Overall Study|Adverse Event|1
28484|NCT01842633|129198|P1|Overall Study|Adverse Event|1
28485|NCT01842633|129196|P3|Overall Study|Screen Failure|0
28486|NCT01842633|129197|P2|Overall Study|Screen Failure|0
28487|NCT01842633|129198|P1|Overall Study|Screen Failure|1
28488|NCT01842620|129245|P2|Period 1|Withdrawal by Subject|0
28489|NCT01842620|129246|P1|Period 1|Withdrawal by Subject|1
28490|NCT01842607|129262|P1|Overall Study|Withdrawal by Subject|14
28491|NCT01842607|129262|P1|Overall Study|Physician Decision|9
28492|NCT01842607|129262|P1|Overall Study|Lost to Follow-up|3
28493|NCT01842607|129262|P1|Overall Study|Protocol defined stopping criteria|2
28494|NCT01842607|129262|P1|Overall Study|Protocol Violation|8
28495|NCT01842607|129262|P1|Overall Study|Lack of Efficacy|19
28496|NCT01842607|129262|P1|Overall Study|Adverse Event|11
28497|NCT01842438|129294|P2|T2: 6month Follow-up|Death|1
28498|NCT01842438|129295|P1|T2: 6month Follow-up|Death|0
28499|NCT01842438|129294|P2|T2: 6month Follow-up|Withdrawal by Subject|3
28500|NCT01842438|129295|P1|T2: 6month Follow-up|Withdrawal by Subject|4
28501|NCT01842438|129294|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
28502|NCT01842438|129295|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
28503|NCT01841970|129307|P1|Overall Study|Lost to Follow-up|8
28504|NCT01841970|129307|P1|Overall Study|Physician Decision|2
28505|NCT01841970|129307|P1|Overall Study|Withdrawal by Subject|1
28506|NCT01841697|129333|P2|Overall Study|Withdrawal by Subject|16
28507|NCT01841697|129334|P1|Overall Study|Withdrawal by Subject|16
28508|NCT01841697|129333|P2|Overall Study|Lost to Follow-up|1
28509|NCT01841697|129334|P1|Overall Study|Lost to Follow-up|4
28510|NCT01841697|129333|P2|Overall Study|Death|1
28511|NCT01841697|129334|P1|Overall Study|Death|0
28512|NCT01841593|129369|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
28513|NCT01841593|129370|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
28514|NCT01841593|129369|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
28515|NCT01841593|129370|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
28516|NCT01841567|129386|P1|Overall Study|Adverse Event|3
28517|NCT01840943|129414|P2|Overall Study|Lost to Follow-up|4
28518|NCT01840943|129415|P1|Overall Study|Lost to Follow-up|4
28519|NCT01840943|129414|P2|Overall Study|Physician Decision|2
28520|NCT01840943|129415|P1|Overall Study|Physician Decision|4
28521|NCT01840943|129414|P2|Overall Study|Withdrawal by Subject|6
28522|NCT01840943|129415|P1|Overall Study|Withdrawal by Subject|5
28523|NCT01840605|129451|P2|Overall Study|Physician Decision|1
28524|NCT01840605|129452|P1|Overall Study|Physician Decision|2
28525|NCT01840605|129451|P2|Overall Study|Adverse Event|1
28526|NCT01840605|129452|P1|Overall Study|Adverse Event|0
28527|NCT01840410|129466|P2|Overall Study|Adverse Event|1
28528|NCT01840410|129467|P1|Overall Study|Adverse Event|1
28529|NCT01840410|129466|P2|Overall Study|Withdrawal by Subject|1
28530|NCT01840410|129467|P1|Overall Study|Withdrawal by Subject|2
28531|NCT01840410|129466|P2|Overall Study|Lost to Follow-up|0
28532|NCT01840410|129467|P1|Overall Study|Lost to Follow-up|1
28533|NCT01840410|129466|P2|Overall Study|Protocol deviation|0
28534|NCT01840410|129467|P1|Overall Study|Protocol deviation|1
28535|NCT01840410|129466|P2|Overall Study|Pregnancy|0
28536|NCT01840410|129467|P1|Overall Study|Pregnancy|1
28537|NCT01840410|129466|P2|Overall Study|Physician Decision|2
28538|NCT01840410|129467|P1|Overall Study|Physician Decision|1
28539|NCT01839279|129634|P3|Overall Study|Classified as 'Other'|0
28540|NCT01839279|129635|P2|Overall Study|Classified as 'Other'|0
28541|NCT01839279|129636|P1|Overall Study|Classified as 'Other'|5
28542|NCT01839279|129634|P3|Overall Study|Withdrawal by Subject|1
28543|NCT01839279|129635|P2|Overall Study|Withdrawal by Subject|1
28544|NCT01839279|129636|P1|Overall Study|Withdrawal by Subject|4
28545|NCT01839279|129634|P3|Overall Study|Adverse Event|1
28546|NCT01839279|129635|P2|Overall Study|Adverse Event|1
28547|NCT01839279|129636|P1|Overall Study|Adverse Event|4
28548|NCT01838941|129668|P1|Overall Study|Withdrawal by Subject|1
28549|NCT01838941|129668|P1|Overall Study|Adverse Event|1
28550|NCT01838694|129680|P2|Overall Study|Adverse Event|1
28551|NCT01838694|129681|P1|Overall Study|Adverse Event|0
28552|NCT01838681|129690|P4|Period B/A+|Administrative or other reasons|28
28553|NCT01838681|129691|P3|Period B/A+|Administrative or other reasons|10
28554|NCT01838681|129692|P2|Period B/A+|Administrative or other reasons|6
28555|NCT01838681|129693|P1|Period B/A+|Administrative or other reasons|0
28556|NCT01838681|129690|P4|Period B/A+|Withdrawal before treatment|0
28557|NCT01838681|129691|P3|Period B/A+|Withdrawal before treatment|0
28558|NCT01838681|129692|P2|Period B/A+|Withdrawal before treatment|1
28559|NCT01838681|129693|P1|Period B/A+|Withdrawal before treatment|0
28560|NCT01838681|129690|P4|Period B/A+|Lost to Follow-up|11
28561|NCT01838681|129691|P3|Period B/A+|Lost to Follow-up|5
28562|NCT01838681|129692|P2|Period B/A+|Lost to Follow-up|2
28563|NCT01838681|129693|P1|Period B/A+|Lost to Follow-up|0
28564|NCT01838681|129690|P4|Period B/A+|Non-compliance with IMP|3
28565|NCT01838681|129691|P3|Period B/A+|Non-compliance with IMP|3
28566|NCT01838681|129692|P2|Period B/A+|Non-compliance with IMP|2
28567|NCT01838681|129693|P1|Period B/A+|Non-compliance with IMP|0
28568|NCT01838681|129690|P4|Period B/A+|Protocol Violation|6
28569|NCT01838681|129691|P3|Period B/A+|Protocol Violation|4
28570|NCT01838681|129692|P2|Period B/A+|Protocol Violation|1
28571|NCT01838681|129693|P1|Period B/A+|Protocol Violation|0
28572|NCT01838681|129690|P4|Period B/A+|Withdrawal by Subject|47
28573|NCT01838681|129691|P3|Period B/A+|Withdrawal by Subject|35
28574|NCT01838681|129692|P2|Period B/A+|Withdrawal by Subject|28
28575|NCT01838681|129693|P1|Period B/A+|Withdrawal by Subject|0
28576|NCT01838681|129690|P4|Period B/A+|Lack of Efficacy|6
28577|NCT01838681|129691|P3|Period B/A+|Lack of Efficacy|11
28578|NCT01838681|129692|P2|Period B/A+|Lack of Efficacy|9
28579|NCT01838681|129693|P1|Period B/A+|Lack of Efficacy|0
28580|NCT01838681|129690|P4|Period B/A+|Adverse Event|16
28581|NCT01838681|129691|P3|Period B/A+|Adverse Event|27
28582|NCT01838681|129692|P2|Period B/A+|Adverse Event|13
28583|NCT01838681|129693|P1|Period B/A+|Adverse Event|0
28584|NCT01838681|129690|P4|Period A|Administrative or other reasons|0
28585|NCT01838681|129691|P3|Period A|Administrative or other reasons|0
28586|NCT01838681|129692|P2|Period A|Administrative or other reasons|0
28587|NCT01838681|129693|P1|Period A|Administrative or other reasons|17
28588|NCT01838681|129690|P4|Period A|Withdrawal before treatment|0
28589|NCT01838681|129691|P3|Period A|Withdrawal before treatment|0
28590|NCT01838681|129692|P2|Period A|Withdrawal before treatment|0
28591|NCT01838681|129693|P1|Period A|Withdrawal before treatment|4
28592|NCT01838681|129690|P4|Period A|Lost to Follow-up|0
28593|NCT01838681|129691|P3|Period A|Lost to Follow-up|0
28594|NCT01838681|129692|P2|Period A|Lost to Follow-up|0
28595|NCT01838681|129693|P1|Period A|Lost to Follow-up|4
28596|NCT01838681|129690|P4|Period A|Non-compliance with IMP|0
28597|NCT01838681|129691|P3|Period A|Non-compliance with IMP|0
28598|NCT01838681|129692|P2|Period A|Non-compliance with IMP|0
28599|NCT01838681|129693|P1|Period A|Non-compliance with IMP|6
28600|NCT01838681|129690|P4|Period A|Protocol Violation|0
28601|NCT01838681|129691|P3|Period A|Protocol Violation|0
28602|NCT01838681|129692|P2|Period A|Protocol Violation|0
28603|NCT01838681|129693|P1|Period A|Protocol Violation|16
28604|NCT01838681|129690|P4|Period A|Withdrawal by Subject|0
28605|NCT01838681|129691|P3|Period A|Withdrawal by Subject|0
28606|NCT01838681|129692|P2|Period A|Withdrawal by Subject|0
28607|NCT01838681|129693|P1|Period A|Withdrawal by Subject|70
28608|NCT01838681|129690|P4|Period A|Early response|0
28609|NCT01838681|129691|P3|Period A|Early response|0
28610|NCT01838681|129692|P2|Period A|Early response|0
28611|NCT01838681|129693|P1|Period A|Early response|148
28612|NCT01838681|129690|P4|Period A|Lack of Efficacy|0
28613|NCT01838681|129691|P3|Period A|Lack of Efficacy|0
28614|NCT01838681|129692|P2|Period A|Lack of Efficacy|0
28615|NCT01838681|129693|P1|Period A|Lack of Efficacy|21
28616|NCT01838681|129690|P4|Period A|Adverse Event|0
28617|NCT01838681|129691|P3|Period A|Adverse Event|0
28618|NCT01838681|129692|P2|Period A|Adverse Event|0
28619|NCT01838681|129693|P1|Period A|Adverse Event|39
28620|NCT01838642|129801|P1|Overall Study|Died on study|1
28621|NCT01838616|129814|P2|Pick-up Arm|Technical problems|0
28622|NCT01838616|129815|P1|Pick-up Arm|Technical problems|1
28623|NCT01838616|129814|P2|Pick-up Arm|Withdrawal by Subject|0
28624|NCT01838616|129815|P1|Pick-up Arm|Withdrawal by Subject|1
28625|NCT01838616|129814|P2|Pick-up Arm|Adverse Event|0
28626|NCT01838616|129815|P1|Pick-up Arm|Adverse Event|9
28627|NCT01838616|129814|P2|Pick-up Arm|Lack of Efficacy|0
28628|NCT01838616|129815|P1|Pick-up Arm|Lack of Efficacy|4
28629|NCT01838616|129814|P2|Continuation Period|Technical problems|1
28630|NCT01838616|129815|P1|Continuation Period|Technical problems|0
28631|NCT01838616|129814|P2|Continuation Period|Withdrawal by Subject|4
28632|NCT01838616|129815|P1|Continuation Period|Withdrawal by Subject|0
28633|NCT01838616|129814|P2|Continuation Period|Lost to Follow-up|0
28634|NCT01838616|129815|P1|Continuation Period|Lost to Follow-up|1
28635|NCT01838616|129814|P2|Continuation Period|Protocol Violation|0
28636|NCT01838616|129815|P1|Continuation Period|Protocol Violation|2
28637|NCT01838616|129814|P2|Continuation Period|Adverse Event|4
28638|NCT01838616|129815|P1|Continuation Period|Adverse Event|8
28639|NCT01838616|129814|P2|Continuation Period|Lack of Efficacy|5
28640|NCT01838616|129815|P1|Continuation Period|Lack of Efficacy|3
28641|NCT01838616|129814|P2|Titration Period|Protocol Violation|1
28642|NCT01838616|129815|P1|Titration Period|Protocol Violation|0
28643|NCT01838616|129814|P2|Titration Period|Not specified|0
28644|NCT01838616|129815|P1|Titration Period|Not specified|1
28645|NCT01838616|129814|P2|Titration Period|Technical problems|0
28646|NCT01838616|129815|P1|Titration Period|Technical problems|1
28647|NCT01838616|129814|P2|Titration Period|Withdrawal by Subject|5
28648|NCT01838616|129815|P1|Titration Period|Withdrawal by Subject|5
28649|NCT01838616|129814|P2|Titration Period|Lack of Efficacy|12
28650|NCT01838616|129815|P1|Titration Period|Lack of Efficacy|5
28651|NCT01838616|129814|P2|Titration Period|Adverse Event|48
28652|NCT01838616|129815|P1|Titration Period|Adverse Event|18
28653|NCT01838590|129886|P2|Overall Study|Lost to Follow-up|1
28654|NCT01838590|129887|P1|Overall Study|Lost to Follow-up|0
28655|NCT01838590|129886|P2|Overall Study|Lack of Efficacy|4
28656|NCT01838590|129887|P1|Overall Study|Lack of Efficacy|12
28657|NCT01838499|129911|P2|Overall Study|Withdrawal by Subject|9
28658|NCT01838499|129912|P1|Overall Study|Withdrawal by Subject|19
28659|NCT01838499|129911|P2|Overall Study|Adverse Event|1
28660|NCT01838499|129912|P1|Overall Study|Adverse Event|2
28661|NCT01838499|129911|P2|Overall Study|Lack of Efficacy|2
28662|NCT01838499|129912|P1|Overall Study|Lack of Efficacy|1
28663|NCT01838499|129911|P2|Overall Study|Lost to Follow-up|4
28664|NCT01838499|129912|P1|Overall Study|Lost to Follow-up|2
28665|NCT01838499|129911|P2|Overall Study|Protocol Violation|1
28666|NCT01838499|129912|P1|Overall Study|Protocol Violation|0
28667|NCT01838213|129939|P2|Overall Study|Ineligible|191
28668|NCT01838213|129940|P1|Overall Study|Ineligible|166
28669|NCT01838044|129948|P2|Overall Study|Lost to Follow-up|2
28670|NCT01838044|129949|P1|Overall Study|Lost to Follow-up|0
28671|NCT01838044|129948|P2|Overall Study|Medication error without associated AE|1
28672|NCT01838044|129949|P1|Overall Study|Medication error without associated AE|0
28673|NCT01838044|129948|P2|Overall Study|Insufficient clinical response|2
28674|NCT01838044|129949|P1|Overall Study|Insufficient clinical response|1
28675|NCT01838044|129948|P2|Overall Study|Withdrawal by Subject|2
28676|NCT01838044|129949|P1|Overall Study|Withdrawal by Subject|0
28677|NCT01838044|129948|P2|Overall Study|Protocol Violation|3
28678|NCT01838044|129949|P1|Overall Study|Protocol Violation|3
28679|NCT01838044|129948|P2|Overall Study|Adverse Event|6
28680|NCT01838044|129949|P1|Overall Study|Adverse Event|4
28681|NCT01837966|129982|P2|Overall Study|Withdrawal by Subject|1
28682|NCT01837966|129983|P1|Overall Study|Withdrawal by Subject|2
28683|NCT01837823|129989|P1|Overall Study|Lost to Follow-up|6
28684|NCT01837797|130020|P5|Period 3|Other|2
28685|NCT01837797|130021|P4|Period 3|Other|0
28686|NCT01837797|130022|P3|Period 3|Other|0
28687|NCT01837797|130023|P2|Period 3|Other|0
28688|NCT01837797|130024|P1|Period 3|Other|0
28689|NCT01837797|130020|P5|Period 3|Administrative reasons|20
28690|NCT01837797|130021|P4|Period 3|Administrative reasons|0
28691|NCT01837797|130022|P3|Period 3|Administrative reasons|0
28692|NCT01837797|130023|P2|Period 3|Administrative reasons|0
28693|NCT01837797|130024|P1|Period 3|Administrative reasons|0
28694|NCT01837797|130020|P5|Period 3|Adverse Event|1
28695|NCT01837797|130021|P4|Period 3|Adverse Event|0
28696|NCT01837797|130022|P3|Period 3|Adverse Event|0
28697|NCT01837797|130023|P2|Period 3|Adverse Event|0
28698|NCT01837797|130024|P1|Period 3|Adverse Event|0
28699|NCT01837797|130020|P5|Period 2|Adverse Event|0
28700|NCT01837797|130021|P4|Period 2|Adverse Event|1
28701|NCT01837797|130022|P3|Period 2|Adverse Event|0
28702|NCT01837797|130023|P2|Period 2|Adverse Event|0
28703|NCT01837797|130024|P1|Period 2|Adverse Event|0
28704|NCT01837797|130020|P5|Period 2|Administrative or other reasons|0
28705|NCT01837797|130021|P4|Period 2|Administrative or other reasons|4
28706|NCT01837797|130022|P3|Period 2|Administrative or other reasons|2
28707|NCT01837797|130023|P2|Period 2|Administrative or other reasons|5
28708|NCT01837797|130024|P1|Period 2|Administrative or other reasons|0
28709|NCT01837797|130020|P5|Period 1|Other|0
28710|NCT01837797|130021|P4|Period 1|Other|0
28711|NCT01837797|130022|P3|Period 1|Other|0
28712|NCT01837797|130023|P2|Period 1|Other|0
28713|NCT01837797|130024|P1|Period 1|Other|10
28714|NCT01837797|130020|P5|Period 1|Withdrawal of consent before treatment|0
28715|NCT01837797|130021|P4|Period 1|Withdrawal of consent before treatment|0
28716|NCT01837797|130022|P3|Period 1|Withdrawal of consent before treatment|0
28717|NCT01837797|130023|P2|Period 1|Withdrawal of consent before treatment|0
28718|NCT01837797|130024|P1|Period 1|Withdrawal of consent before treatment|1
28719|NCT01837797|130020|P5|Period 1|Administrative reasons|0
28720|NCT01837797|130021|P4|Period 1|Administrative reasons|0
28721|NCT01837797|130022|P3|Period 1|Administrative reasons|0
28722|NCT01837797|130023|P2|Period 1|Administrative reasons|0
28723|NCT01837797|130024|P1|Period 1|Administrative reasons|76
28724|NCT01837797|130020|P5|Period 1|Withdrawal by Subject|0
28725|NCT01837797|130021|P4|Period 1|Withdrawal by Subject|0
28726|NCT01837797|130022|P3|Period 1|Withdrawal by Subject|0
28727|NCT01837797|130023|P2|Period 1|Withdrawal by Subject|0
28728|NCT01837797|130024|P1|Period 1|Withdrawal by Subject|6
28729|NCT01837797|130020|P5|Period 1|Adverse Event|0
28730|NCT01837797|130021|P4|Period 1|Adverse Event|0
28731|NCT01837797|130022|P3|Period 1|Adverse Event|0
28732|NCT01837797|130023|P2|Period 1|Adverse Event|0
28733|NCT01837797|130024|P1|Period 1|Adverse Event|9
28734|NCT01837719|130059|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
28735|NCT01837719|130059|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
28736|NCT01837680|130128|P2|Overall Study|switched to oral hypoglycemic or diet|4
28737|NCT01837680|130129|P1|Overall Study|switched to oral hypoglycemic or diet|2
28738|NCT01837680|130128|P2|Overall Study|allergic reaction|0
28739|NCT01837680|130129|P1|Overall Study|allergic reaction|6
28740|NCT01837680|130128|P2|Overall Study|lack of insurance|2
28741|NCT01837680|130129|P1|Overall Study|lack of insurance|0
28742|NCT01837680|130128|P2|Overall Study|Lost to Follow-up|2
28743|NCT01837680|130129|P1|Overall Study|Lost to Follow-up|2
28744|NCT01836523|130235|P4|Overall Study|Unclassified|29
28745|NCT01836523|130236|P3|Overall Study|Unclassified|19
28746|NCT01836523|130237|P2|Overall Study|Unclassified|28
28747|NCT01836523|130238|P1|Overall Study|Unclassified|17
28748|NCT01836523|130235|P4|Overall Study|Met Withdrawal Criteria|27
28749|NCT01836523|130236|P3|Overall Study|Met Withdrawal Criteria|21
28750|NCT01836523|130237|P2|Overall Study|Met Withdrawal Criteria|13
28751|NCT01836523|130238|P1|Overall Study|Met Withdrawal Criteria|13
28752|NCT01836523|130235|P4|Overall Study|Protocol Violation|4
28753|NCT01836523|130236|P3|Overall Study|Protocol Violation|2
28754|NCT01836523|130237|P2|Overall Study|Protocol Violation|3
28755|NCT01836523|130238|P1|Overall Study|Protocol Violation|6
28756|NCT01836523|130235|P4|Overall Study|Adverse Event|14
28757|NCT01836523|130236|P3|Overall Study|Adverse Event|49
28758|NCT01836523|130237|P2|Overall Study|Adverse Event|41
28759|NCT01836523|130238|P1|Overall Study|Adverse Event|15
28760|NCT01836471|130265|P5|Overall Study|Non compliance with tx|0
28761|NCT01836471|130266|P4|Overall Study|Non compliance with tx|0
28762|NCT01836471|130267|P3|Overall Study|Non compliance with tx|0
28763|NCT01836471|130268|P2|Overall Study|Non compliance with tx|1
28764|NCT01836471|130269|P1|Overall Study|Non compliance with tx|1
28765|NCT01836471|130265|P5|Overall Study|Adverse Event|2
28766|NCT01836471|130266|P4|Overall Study|Adverse Event|1
28767|NCT01836471|130267|P3|Overall Study|Adverse Event|1
28768|NCT01836471|130268|P2|Overall Study|Adverse Event|3
28769|NCT01836471|130269|P1|Overall Study|Adverse Event|6
28770|NCT01836471|130265|P5|Overall Study|Lost to Follow-up|1
28771|NCT01836471|130266|P4|Overall Study|Lost to Follow-up|1
28772|NCT01836471|130267|P3|Overall Study|Lost to Follow-up|0
28773|NCT01836471|130268|P2|Overall Study|Lost to Follow-up|0
28774|NCT01836471|130269|P1|Overall Study|Lost to Follow-up|0
28775|NCT01836471|130265|P5|Overall Study|Physician Decision|0
28776|NCT01836471|130266|P4|Overall Study|Physician Decision|0
28777|NCT01836471|130267|P3|Overall Study|Physician Decision|0
28778|NCT01836471|130268|P2|Overall Study|Physician Decision|1
28779|NCT01836471|130269|P1|Overall Study|Physician Decision|0
28780|NCT01836471|130265|P5|Overall Study|Withdrawal by Subject|2
28781|NCT01836471|130266|P4|Overall Study|Withdrawal by Subject|0
28782|NCT01836471|130267|P3|Overall Study|Withdrawal by Subject|1
28783|NCT01836471|130268|P2|Overall Study|Withdrawal by Subject|4
28784|NCT01836471|130269|P1|Overall Study|Withdrawal by Subject|3
28785|NCT01836471|130265|P5|Overall Study|Pregnancy|0
28786|NCT01836471|130266|P4|Overall Study|Pregnancy|0
28787|NCT01836471|130267|P3|Overall Study|Pregnancy|0
28788|NCT01836471|130268|P2|Overall Study|Pregnancy|0
28789|NCT01836471|130269|P1|Overall Study|Pregnancy|1
28790|NCT01836458|130298|P4|Overall Study|Unsatisfactory therapeutic effect|6
28791|NCT01836458|130299|P3|Overall Study|Unsatisfactory therapeutic effect|5
28792|NCT01836458|130300|P2|Overall Study|Unsatisfactory therapeutic effect|2
28793|NCT01836458|130301|P1|Overall Study|Unsatisfactory therapeutic effect|3
28794|NCT01835899|130363|P3|Overall Study|Other than stated above|0
28795|NCT01835899|130364|P2|Overall Study|Other than stated above|1
28796|NCT01835899|130365|P1|Overall Study|Other than stated above|0
28797|NCT01835899|130363|P3|Overall Study|Adverse Event|1
28798|NCT01835899|130364|P2|Overall Study|Adverse Event|0
28799|NCT01835899|130365|P1|Overall Study|Adverse Event|0
28800|NCT01835548|130409|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
28801|NCT01835548|130410|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
28802|NCT01835548|130411|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
28803|NCT01835548|130409|P3|Double-Blind Treatment Period|Adverse Event|0
28804|NCT01835548|130410|P2|Double-Blind Treatment Period|Adverse Event|1
28805|NCT01835548|130411|P1|Double-Blind Treatment Period|Adverse Event|0
28806|NCT01835548|130409|P3|Dose Optimization Period|Withdrawal by Subject|1
28807|NCT01835548|130410|P2|Dose Optimization Period|Withdrawal by Subject|0
28808|NCT01835548|130411|P1|Dose Optimization Period|Withdrawal by Subject|0
28809|NCT01835548|130409|P3|Dose Optimization Period|Adverse Event|1
28810|NCT01835548|130410|P2|Dose Optimization Period|Adverse Event|0
28811|NCT01835548|130411|P1|Dose Optimization Period|Adverse Event|0
28812|NCT01835470|130440|P1|Long Term Treatment Period|Lack of Efficacy|1
28813|NCT01835470|130440|P1|Long Term Treatment Period|Subject Request to Discontinue|1
28814|NCT01835431|130452|P2|Overall Study|Protocol Violation|0
28815|NCT01835431|130453|P1|Overall Study|Protocol Violation|1
28816|NCT01835431|130452|P2|Overall Study|Withdrawal by Subject|10
28817|NCT01835431|130453|P1|Overall Study|Withdrawal by Subject|6
28818|NCT01835431|130452|P2|Overall Study|other|2
28819|NCT01835431|130453|P1|Overall Study|other|0
28820|NCT01835431|130452|P2|Overall Study|Adverse Event|0
28821|NCT01835431|130453|P1|Overall Study|Adverse Event|1
28822|NCT01835132|130491|P1|Initial Phase|Insufficient Therapeutic Response|2
28823|NCT01835015|130536|P5|Overall Study|Adverse Event|0
28824|NCT01835015|130537|P4|Overall Study|Adverse Event|0
28825|NCT01835015|130538|P3|Overall Study|Adverse Event|1
28826|NCT01835015|130539|P2|Overall Study|Adverse Event|0
28827|NCT01835015|130540|P1|Overall Study|Adverse Event|0
28828|NCT01834586|130623|P1|Overall Study|Adverse Event|1
28829|NCT01834274|130663|P2|Overall Study|Other|1
28830|NCT01834274|130664|P1|Overall Study|Other|2
28831|NCT01834274|130663|P2|Overall Study|Lost to Follow-up|1
28832|NCT01834274|130664|P1|Overall Study|Lost to Follow-up|3
28833|NCT01834274|130663|P2|Overall Study|Withdrawal by Subject|1
28834|NCT01834274|130664|P1|Overall Study|Withdrawal by Subject|1
28835|NCT01834274|130663|P2|Overall Study|Study Termination|38
28836|NCT01834274|130664|P1|Overall Study|Study Termination|41
28837|NCT01834222|130687|P1|Overall Study|Not meet inclusion/exclusion criteria|1
28838|NCT01833897|130773|P1|Overall Study|Lack of Efficacy|1
28839|NCT01833533|130800|P2|Overall Study|Not Specified|7
28840|NCT01833533|130801|P1|Overall Study|Not Specified|2
28841|NCT01833533|130800|P2|Overall Study|To Enter an Extension Study|4
28842|NCT01833533|130801|P1|Overall Study|To Enter an Extension Study|0
28843|NCT01833533|130800|P2|Overall Study|Lost to Follow-up|9
28844|NCT01833533|130801|P1|Overall Study|Lost to Follow-up|4
28845|NCT01833533|130800|P2|Overall Study|Adverse Event|1
28846|NCT01833533|130801|P1|Overall Study|Adverse Event|0
28847|NCT01833169|130845|P1|Overall Study|Physician Decision|2
28848|NCT01833169|130845|P1|Overall Study|Death|3
28849|NCT01833169|130845|P1|Overall Study|Withdrawal by Subject|9
28850|NCT01833169|130845|P1|Overall Study|Adverse Event|33
28851|NCT01833169|130845|P1|Overall Study|Disease Progression|99
28852|NCT01833065|130914|P5|Overall Study|Others|4
28853|NCT01833065|130915|P4|Overall Study|Others|1
28854|NCT01833065|130916|P3|Overall Study|Others|1
28855|NCT01833065|130917|P2|Overall Study|Others|1
28856|NCT01833065|130918|P1|Overall Study|Others|2
28857|NCT01833065|130914|P5|Overall Study|Trial terminated by sponsor|13
28858|NCT01833065|130915|P4|Overall Study|Trial terminated by sponsor|3
28859|NCT01833065|130916|P3|Overall Study|Trial terminated by sponsor|7
28860|NCT01833065|130917|P2|Overall Study|Trial terminated by sponsor|8
28861|NCT01833065|130918|P1|Overall Study|Trial terminated by sponsor|8
28862|NCT01833065|130914|P5|Overall Study|Subject's substantial non-compliance|0
28863|NCT01833065|130915|P4|Overall Study|Subject's substantial non-compliance|0
28864|NCT01833065|130916|P3|Overall Study|Subject's substantial non-compliance|0
28865|NCT01833065|130917|P2|Overall Study|Subject's substantial non-compliance|1
28866|NCT01833065|130918|P1|Overall Study|Subject's substantial non-compliance|0
28867|NCT01833065|130914|P5|Overall Study|Withdrawal by Subject|11
28868|NCT01833065|130915|P4|Overall Study|Withdrawal by Subject|3
28869|NCT01833065|130916|P3|Overall Study|Withdrawal by Subject|4
28870|NCT01833065|130917|P2|Overall Study|Withdrawal by Subject|2
28871|NCT01833065|130918|P1|Overall Study|Withdrawal by Subject|6
28872|NCT01833065|130914|P5|Overall Study|Lost to Follow-up|3
28873|NCT01833065|130915|P4|Overall Study|Lost to Follow-up|0
28874|NCT01833065|130916|P3|Overall Study|Lost to Follow-up|0
28875|NCT01833065|130917|P2|Overall Study|Lost to Follow-up|0
28876|NCT01833065|130918|P1|Overall Study|Lost to Follow-up|1
28877|NCT01833065|130914|P5|Overall Study|Protocol Violation|2
28878|NCT01833065|130915|P4|Overall Study|Protocol Violation|0
28879|NCT01833065|130916|P3|Overall Study|Protocol Violation|0
28880|NCT01833065|130917|P2|Overall Study|Protocol Violation|0
28881|NCT01833065|130918|P1|Overall Study|Protocol Violation|1
28882|NCT01833065|130914|P5|Overall Study|Adverse Event|3
28883|NCT01833065|130915|P4|Overall Study|Adverse Event|2
28884|NCT01833065|130916|P3|Overall Study|Adverse Event|0
28885|NCT01833065|130917|P2|Overall Study|Adverse Event|1
28886|NCT01833065|130918|P1|Overall Study|Adverse Event|6
28887|NCT01832766|130949|P2|Washout|Lost to Follow-up|1
28888|NCT01832766|130950|P1|Washout|Lost to Follow-up|0
28889|NCT01832493|131016|P1|Overall Study|Unable to place LV lead|2
28890|NCT01832493|131016|P1|Overall Study|Protocol Violation|4
28891|NCT01832493|131016|P1|Overall Study|Physician Decision|2
28892|NCT01832155|131025|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
28893|NCT01832155|131026|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
28894|NCT01832155|131025|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
28895|NCT01832155|131026|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
28896|NCT01831817|131106|P4|Overall Study|Withdrawl of Consent|0
28897|NCT01831817|131107|P3|Overall Study|Withdrawl of Consent|0
28898|NCT01831817|131108|P2|Overall Study|Withdrawl of Consent|0
28899|NCT01831817|131109|P1|Overall Study|Withdrawl of Consent|3
28900|NCT01831817|131106|P4|Overall Study|Lost to Follow-up|0
28901|NCT01831817|131107|P3|Overall Study|Lost to Follow-up|0
28902|NCT01831817|131108|P2|Overall Study|Lost to Follow-up|0
28903|NCT01831817|131109|P1|Overall Study|Lost to Follow-up|1
28904|NCT01831791|131147|P1|Overall Study|Withdrawal by Subject|10
28905|NCT01831765|131176|P3|Overall Study|Lost to Follow-up|3
28906|NCT01831765|131177|P2|Overall Study|Lost to Follow-up|3
28907|NCT01831765|131178|P1|Overall Study|Lost to Follow-up|2
28908|NCT01831765|131176|P3|Overall Study|Withdrawal criteria|16
28909|NCT01831765|131177|P2|Overall Study|Withdrawal criteria|10
28910|NCT01831765|131178|P1|Overall Study|Withdrawal criteria|12
28911|NCT01831765|131176|P3|Overall Study|Withdrawal by Subject|17
28912|NCT01831765|131177|P2|Overall Study|Withdrawal by Subject|7
28913|NCT01831765|131178|P1|Overall Study|Withdrawal by Subject|22
28914|NCT01831765|131176|P3|Overall Study|Adverse Event|3
28915|NCT01831765|131177|P2|Overall Study|Adverse Event|3
28916|NCT01831765|131178|P1|Overall Study|Adverse Event|5
28917|NCT01831765|131176|P3|Overall Study|Other, site closed|0
28918|NCT01831765|131177|P2|Overall Study|Other, site closed|1
28919|NCT01831765|131178|P1|Overall Study|Other, site closed|1
28920|NCT01831765|131176|P3|Overall Study|Death|1
28921|NCT01831765|131177|P2|Overall Study|Death|1
28922|NCT01831765|131178|P1|Overall Study|Death|0
28923|NCT01831765|131176|P3|Overall Study|Pregnancy|2
28924|NCT01831765|131177|P2|Overall Study|Pregnancy|1
28925|NCT01831765|131178|P1|Overall Study|Pregnancy|1
28926|NCT01831765|131176|P3|Overall Study|Other, sponsor withdrew subject|0
28927|NCT01831765|131177|P2|Overall Study|Other, sponsor withdrew subject|1
28928|NCT01831765|131178|P1|Overall Study|Other, sponsor withdrew subject|0
28929|NCT01831765|131176|P3|Overall Study|Lack of Efficacy|0
28930|NCT01831765|131177|P2|Overall Study|Lack of Efficacy|0
28931|NCT01831765|131178|P1|Overall Study|Lack of Efficacy|1
28932|NCT01831726|131204|P1|Overall Study|Subject/guardian decision|7
28933|NCT01831726|131204|P1|Overall Study|Physician Decision|1
28934|NCT01831726|131204|P1|Overall Study|Disease Progression|49
28935|NCT01831726|131204|P1|Overall Study|Death|7
28936|NCT01831726|131204|P1|Overall Study|Adverse Event|16
28937|NCT01831466|131223|P12|Overall Study|Adverse Event|2
28938|NCT01831466|131224|P11|Overall Study|Adverse Event|0
28939|NCT01831466|131225|P10|Overall Study|Adverse Event|1
28940|NCT01831466|131226|P9|Overall Study|Adverse Event|1
28941|NCT01831466|131227|P8|Overall Study|Adverse Event|1
28942|NCT01831466|131228|P7|Overall Study|Adverse Event|0
28943|NCT01831466|131229|P6|Overall Study|Adverse Event|7
28944|NCT01831466|131230|P5|Overall Study|Adverse Event|3
28945|NCT01831466|131231|P4|Overall Study|Adverse Event|6
28946|NCT01831466|131232|P3|Overall Study|Adverse Event|4
28947|NCT01831466|131233|P2|Overall Study|Adverse Event|0
28948|NCT01831466|131234|P1|Overall Study|Adverse Event|0
28949|NCT01831466|131223|P12|Overall Study|Lack of Efficacy|0
28950|NCT01831466|131224|P11|Overall Study|Lack of Efficacy|2
28951|NCT01831466|131225|P10|Overall Study|Lack of Efficacy|2
28952|NCT01831466|131226|P9|Overall Study|Lack of Efficacy|2
28953|NCT01831466|131227|P8|Overall Study|Lack of Efficacy|1
28954|NCT01831466|131228|P7|Overall Study|Lack of Efficacy|1
28955|NCT01831466|131229|P6|Overall Study|Lack of Efficacy|8
28956|NCT01831466|131230|P5|Overall Study|Lack of Efficacy|9
28957|NCT01831466|131231|P4|Overall Study|Lack of Efficacy|6
28958|NCT01831466|131232|P3|Overall Study|Lack of Efficacy|7
28959|NCT01831466|131233|P2|Overall Study|Lack of Efficacy|8
28960|NCT01831466|131234|P1|Overall Study|Lack of Efficacy|5
28961|NCT01831466|131223|P12|Overall Study|Lost to Follow-up|1
28962|NCT01831466|131224|P11|Overall Study|Lost to Follow-up|0
28963|NCT01831466|131225|P10|Overall Study|Lost to Follow-up|1
28964|NCT01831466|131226|P9|Overall Study|Lost to Follow-up|0
28965|NCT01831466|131227|P8|Overall Study|Lost to Follow-up|0
28966|NCT01831466|131228|P7|Overall Study|Lost to Follow-up|0
28967|NCT01831466|131229|P6|Overall Study|Lost to Follow-up|3
28968|NCT01831466|131230|P5|Overall Study|Lost to Follow-up|0
28969|NCT01831466|131231|P4|Overall Study|Lost to Follow-up|2
28970|NCT01831466|131232|P3|Overall Study|Lost to Follow-up|4
28971|NCT01831466|131233|P2|Overall Study|Lost to Follow-up|1
28972|NCT01831466|131234|P1|Overall Study|Lost to Follow-up|0
28973|NCT01831466|131223|P12|Overall Study|Withdrawal by Subject|1
28974|NCT01831466|131224|P11|Overall Study|Withdrawal by Subject|0
28975|NCT01831466|131225|P10|Overall Study|Withdrawal by Subject|1
28976|NCT01831466|131226|P9|Overall Study|Withdrawal by Subject|0
28977|NCT01831466|131227|P8|Overall Study|Withdrawal by Subject|0
28978|NCT01831466|131228|P7|Overall Study|Withdrawal by Subject|0
28979|NCT01831466|131229|P6|Overall Study|Withdrawal by Subject|5
28980|NCT01831466|131230|P5|Overall Study|Withdrawal by Subject|3
28981|NCT01831466|131231|P4|Overall Study|Withdrawal by Subject|3
28982|NCT01831466|131232|P3|Overall Study|Withdrawal by Subject|3
28983|NCT01831466|131233|P2|Overall Study|Withdrawal by Subject|3
28984|NCT01831466|131234|P1|Overall Study|Withdrawal by Subject|6
28985|NCT01831466|131223|P12|Overall Study|Death|0
28986|NCT01831466|131224|P11|Overall Study|Death|0
28987|NCT01831466|131225|P10|Overall Study|Death|0
28988|NCT01831466|131226|P9|Overall Study|Death|0
28989|NCT01831466|131227|P8|Overall Study|Death|0
28990|NCT01831466|131228|P7|Overall Study|Death|0
28991|NCT01831466|131229|P6|Overall Study|Death|0
28992|NCT01831466|131230|P5|Overall Study|Death|0
28993|NCT01831466|131231|P4|Overall Study|Death|0
28994|NCT01831466|131232|P3|Overall Study|Death|0
28995|NCT01831466|131233|P2|Overall Study|Death|1
28996|NCT01831466|131234|P1|Overall Study|Death|0
28997|NCT01831466|131223|P12|Overall Study|Non-compliance with study treatment|0
28998|NCT01831466|131224|P11|Overall Study|Non-compliance with study treatment|0
28999|NCT01831466|131225|P10|Overall Study|Non-compliance with study treatment|0
29000|NCT01831466|131226|P9|Overall Study|Non-compliance with study treatment|0
29001|NCT01831466|131227|P8|Overall Study|Non-compliance with study treatment|0
29002|NCT01831466|131228|P7|Overall Study|Non-compliance with study treatment|0
29003|NCT01831466|131229|P6|Overall Study|Non-compliance with study treatment|1
29004|NCT01831466|131230|P5|Overall Study|Non-compliance with study treatment|0
29005|NCT01831466|131231|P4|Overall Study|Non-compliance with study treatment|0
29006|NCT01831466|131232|P3|Overall Study|Non-compliance with study treatment|1
29007|NCT01831466|131233|P2|Overall Study|Non-compliance with study treatment|1
29008|NCT01831466|131234|P1|Overall Study|Non-compliance with study treatment|2
29009|NCT01831466|131223|P12|Overall Study|Not specified|0
29010|NCT01831466|131224|P11|Overall Study|Not specified|0
29011|NCT01831466|131225|P10|Overall Study|Not specified|0
29012|NCT01831466|131226|P9|Overall Study|Not specified|0
29013|NCT01831466|131227|P8|Overall Study|Not specified|0
29014|NCT01831466|131228|P7|Overall Study|Not specified|0
29015|NCT01831466|131229|P6|Overall Study|Not specified|1
29016|NCT01831466|131230|P5|Overall Study|Not specified|2
29017|NCT01831466|131231|P4|Overall Study|Not specified|2
29018|NCT01831466|131232|P3|Overall Study|Not specified|2
29019|NCT01831466|131233|P2|Overall Study|Not specified|3
29020|NCT01831466|131234|P1|Overall Study|Not specified|2
29021|NCT01831466|131223|P12|Overall Study|Protocol Violation|0
29022|NCT01831466|131224|P11|Overall Study|Protocol Violation|0
29023|NCT01831466|131225|P10|Overall Study|Protocol Violation|0
29024|NCT01831466|131226|P9|Overall Study|Protocol Violation|0
29025|NCT01831466|131227|P8|Overall Study|Protocol Violation|0
29026|NCT01831466|131228|P7|Overall Study|Protocol Violation|0
29027|NCT01831466|131229|P6|Overall Study|Protocol Violation|1
29028|NCT01831466|131230|P5|Overall Study|Protocol Violation|0
29029|NCT01831466|131231|P4|Overall Study|Protocol Violation|0
29030|NCT01831466|131232|P3|Overall Study|Protocol Violation|2
29031|NCT01831466|131233|P2|Overall Study|Protocol Violation|1
29032|NCT01831466|131234|P1|Overall Study|Protocol Violation|1
29033|NCT01831258|131356|P2|Overall Study|Lost to Follow-up|2
29034|NCT01831258|131357|P1|Overall Study|Lost to Follow-up|3
29035|NCT01831258|131356|P2|Overall Study|Withdrawal by Subject|1
29036|NCT01831258|131357|P1|Overall Study|Withdrawal by Subject|2
29037|NCT01830972|131443|P2|Part IV|Non-Compliance|0
29038|NCT01830972|131444|P1|Part IV|Non-Compliance|1
29039|NCT01830972|131443|P2|Part IV|Withdrawal by Subject|1
29040|NCT01830972|131444|P1|Part IV|Withdrawal by Subject|2
29041|NCT01830972|131443|P2|Part III|Noncompliance|0
29042|NCT01830972|131444|P1|Part III|Noncompliance|1
29043|NCT01830972|131443|P2|Part III|Withdrawal by Subject|0
29044|NCT01830972|131444|P1|Part III|Withdrawal by Subject|1
29045|NCT01830972|131443|P2|Part II|Withdrawal by Subject|2
29046|NCT01830972|131444|P1|Part II|Withdrawal by Subject|2
29047|NCT01830920|131488|P5|Overall Study|Not specified|3
29048|NCT01830920|131489|P4|Overall Study|Not specified|5
29049|NCT01830920|131490|P3|Overall Study|Not specified|1
29050|NCT01830920|131491|P2|Overall Study|Not specified|1
29051|NCT01830920|131492|P1|Overall Study|Not specified|15
29052|NCT01830920|131488|P5|Overall Study|Death|4
29053|NCT01830920|131489|P4|Overall Study|Death|4
29054|NCT01830920|131490|P3|Overall Study|Death|5
29055|NCT01830920|131491|P2|Overall Study|Death|3
29056|NCT01830920|131492|P1|Overall Study|Death|3
29057|NCT01830920|131488|P5|Overall Study|Withdrawal by Subject|1
29058|NCT01830920|131489|P4|Overall Study|Withdrawal by Subject|7
29059|NCT01830920|131490|P3|Overall Study|Withdrawal by Subject|1
29060|NCT01830920|131491|P2|Overall Study|Withdrawal by Subject|2
29061|NCT01830920|131492|P1|Overall Study|Withdrawal by Subject|2
29062|NCT01830920|131488|P5|Overall Study|Adverse Event|0
29063|NCT01830920|131489|P4|Overall Study|Adverse Event|0
29064|NCT01830920|131490|P3|Overall Study|Adverse Event|1
29065|NCT01830920|131491|P2|Overall Study|Adverse Event|0
29066|NCT01830920|131492|P1|Overall Study|Adverse Event|1
29067|NCT01830881|131531|P2|Overall Study|Changed decision to have an abortion|1
29068|NCT01830881|131532|P1|Overall Study|Changed decision to have an abortion|0
29069|NCT01830855|131576|P4|Overall Study|Lost to Follow-up|33
29070|NCT01830855|131577|P3|Overall Study|Lost to Follow-up|23
29071|NCT01830855|131578|P2|Overall Study|Lost to Follow-up|20
29072|NCT01830855|131579|P1|Overall Study|Lost to Follow-up|47
29073|NCT01830855|131576|P4|Overall Study|No longer willing to participate|17
29074|NCT01830855|131577|P3|Overall Study|No longer willing to participate|12
29075|NCT01830855|131578|P2|Overall Study|No longer willing to participate|13
29076|NCT01830855|131579|P1|Overall Study|No longer willing to participate|32
29077|NCT01830855|131576|P4|Overall Study|Withdrawal by Subject|12
29078|NCT01830855|131577|P3|Overall Study|Withdrawal by Subject|10
29079|NCT01830855|131578|P2|Overall Study|Withdrawal by Subject|14
29080|NCT01830855|131579|P1|Overall Study|Withdrawal by Subject|33
29081|NCT01830855|131576|P4|Overall Study|Protocol deviation|6
29082|NCT01830855|131577|P3|Overall Study|Protocol deviation|6
29083|NCT01830855|131578|P2|Overall Study|Protocol deviation|5
29084|NCT01830855|131579|P1|Overall Study|Protocol deviation|10
29085|NCT01830855|131576|P4|Overall Study|Adverse Event|3
29086|NCT01830855|131577|P3|Overall Study|Adverse Event|6
29087|NCT01830855|131578|P2|Overall Study|Adverse Event|5
29088|NCT01830855|131579|P1|Overall Study|Adverse Event|11
29089|NCT01830855|131576|P4|Overall Study|No longer meets eligibility criteria|5
29090|NCT01830855|131577|P3|Overall Study|No longer meets eligibility criteria|3
29091|NCT01830855|131578|P2|Overall Study|No longer meets eligibility criteria|2
29092|NCT01830855|131579|P1|Overall Study|No longer meets eligibility criteria|11
29093|NCT01830855|131576|P4|Overall Study|Pregnancy|1
29094|NCT01830855|131577|P3|Overall Study|Pregnancy|2
29095|NCT01830855|131578|P2|Overall Study|Pregnancy|1
29096|NCT01830855|131579|P1|Overall Study|Pregnancy|3
29097|NCT01830855|131576|P4|Overall Study|Medication error without associated AE|1
29098|NCT01830855|131577|P3|Overall Study|Medication error without associated AE|0
29099|NCT01830855|131578|P2|Overall Study|Medication error without associated AE|0
29100|NCT01830855|131579|P1|Overall Study|Medication error without associated AE|1
29101|NCT01830855|131576|P4|Overall Study|Other|4
29102|NCT01830855|131577|P3|Overall Study|Other|4
29103|NCT01830855|131578|P2|Overall Study|Other|1
29104|NCT01830855|131579|P1|Overall Study|Other|7
29105|NCT01830543|131719|P3|Overall Study|Other|37
29106|NCT01830543|131720|P2|Overall Study|Other|17
29107|NCT01830543|131721|P1|Overall Study|Other|12
29108|NCT01830543|131719|P3|Overall Study|Withdrawal by consent|3
29109|NCT01830543|131720|P2|Overall Study|Withdrawal by consent|3
29110|NCT01830543|131721|P1|Overall Study|Withdrawal by consent|3
29111|NCT01830543|131719|P3|Overall Study|Physician Decision|12
29112|NCT01830543|131720|P2|Overall Study|Physician Decision|5
29113|NCT01830543|131721|P1|Overall Study|Physician Decision|11
29114|NCT01830543|131719|P3|Overall Study|Protocol Violation|7
29115|NCT01830543|131720|P2|Overall Study|Protocol Violation|7
29116|NCT01830543|131721|P1|Overall Study|Protocol Violation|3
29117|NCT01830543|131719|P3|Overall Study|Death|22
29118|NCT01830543|131720|P2|Overall Study|Death|22
29119|NCT01830543|131721|P1|Overall Study|Death|20
29120|NCT01830543|131719|P3|Overall Study|Adverse Event|76
29121|NCT01830543|131720|P2|Overall Study|Adverse Event|77
29122|NCT01830543|131721|P1|Overall Study|Adverse Event|91
29123|NCT01830543|131719|P3|Overall Study|Subject Decision|57
29124|NCT01830543|131720|P2|Overall Study|Subject Decision|21
29125|NCT01830543|131721|P1|Overall Study|Subject Decision|19
29126|NCT01830127|131853|P2|Overall Study|Other reason not defined above|2
29127|NCT01830127|131854|P1|Overall Study|Other reason not defined above|0
29128|NCT01830127|131853|P2|Overall Study|Withdrawal by Subject|1
29129|NCT01830127|131854|P1|Overall Study|Withdrawal by Subject|1
29130|NCT01830127|131853|P2|Overall Study|Lack of Efficacy|0
29131|NCT01830127|131854|P1|Overall Study|Lack of Efficacy|3
29132|NCT01830127|131853|P2|Overall Study|Adverse Event|6
29133|NCT01830127|131854|P1|Overall Study|Adverse Event|1
29134|NCT01829477|131903|P2|Overall Study|Withdrawal by Subject|0
29135|NCT01829477|131904|P1|Overall Study|Withdrawal by Subject|1
29136|NCT01829477|131903|P2|Overall Study|Study Terminated by Sponsor|15
29137|NCT01829477|131904|P1|Overall Study|Study Terminated by Sponsor|15
29138|NCT01829464|131917|P3|Overall Study|Lack of Efficacy|0
29139|NCT01829464|131918|P2|Overall Study|Lack of Efficacy|1
29140|NCT01829464|131919|P1|Overall Study|Lack of Efficacy|0
29141|NCT01829464|131917|P3|Overall Study|Study terminated by sponsor|25
29142|NCT01829464|131918|P2|Overall Study|Study terminated by sponsor|28
29143|NCT01829464|131919|P1|Overall Study|Study terminated by sponsor|25
29144|NCT01829464|131917|P3|Overall Study|Withdrawal by Subject|0
29145|NCT01829464|131918|P2|Overall Study|Withdrawal by Subject|0
29146|NCT01829464|131919|P1|Overall Study|Withdrawal by Subject|2
29147|NCT01829464|131917|P3|Overall Study|Lost to Follow-up|1
29148|NCT01829464|131918|P2|Overall Study|Lost to Follow-up|0
29149|NCT01829464|131919|P1|Overall Study|Lost to Follow-up|0
29150|NCT01829464|131917|P3|Overall Study|Adverse Event|0
29151|NCT01829464|131918|P2|Overall Study|Adverse Event|0
29152|NCT01829464|131919|P1|Overall Study|Adverse Event|1
29153|NCT01829243|131944|P2|First Intervention|Screen Failure|2
29154|NCT01829243|131945|P1|First Intervention|Screen Failure|4
29155|NCT01829230|131959|P2|Overall Study|Lost to Follow-up|1
29156|NCT01829230|131960|P1|Overall Study|Lost to Follow-up|1
29157|NCT01829230|131959|P2|Overall Study|Withdrawal by Subject|1
29158|NCT01829230|131960|P1|Overall Study|Withdrawal by Subject|0
29159|NCT01829230|131959|P2|Overall Study|Protocol Violation|2
29160|NCT01829230|131960|P1|Overall Study|Protocol Violation|0
29161|NCT01829191|131970|P2|Overall Study|Subject was fit for ortho - k|1
29162|NCT01829191|131971|P1|Overall Study|Subject was fit for ortho - k|0
29163|NCT01829191|131970|P2|Overall Study|Lost to Follow-up|1
29164|NCT01829191|131971|P1|Overall Study|Lost to Follow-up|0
29165|NCT01829191|131970|P2|Overall Study|Withdrawal by Subject|3
29166|NCT01829191|131971|P1|Overall Study|Withdrawal by Subject|2
29167|NCT01829191|131970|P2|Overall Study|Protocol Violation|1
29168|NCT01829191|131971|P1|Overall Study|Protocol Violation|4
29169|NCT01829191|131970|P2|Overall Study|Lens handling difficulty|4
29170|NCT01829191|131971|P1|Overall Study|Lens handling difficulty|1
29171|NCT01829191|131970|P2|Overall Study|Lens discomfort|3
29172|NCT01829191|131971|P1|Overall Study|Lens discomfort|0
29173|NCT01829191|131970|P2|Overall Study|Relocation|1
29174|NCT01829191|131971|P1|Overall Study|Relocation|0
29175|NCT01829165|131980|P2|Overall Study|Did not complete intervention|0
29176|NCT01829165|131981|P1|Overall Study|Did not complete intervention|2
29177|NCT01828281|132051|P2|Overall Study|Withdrawal by Subject|0
29178|NCT01828281|132052|P1|Overall Study|Withdrawal by Subject|1
29179|NCT01828112|132085|P2|Overall Study|Subject/guardian decision|8
29180|NCT01828112|132086|P1|Overall Study|Subject/guardian decision|6
29181|NCT01828112|132085|P2|Overall Study|Progressive disease|82
29182|NCT01828112|132086|P1|Overall Study|Progressive disease|56
29183|NCT01828112|132085|P2|Overall Study|Physician Decision|5
29184|NCT01828112|132086|P1|Overall Study|Physician Decision|5
29185|NCT01828112|132085|P2|Overall Study|Death|5
29186|NCT01828112|132086|P1|Overall Study|Death|9
29187|NCT01828112|132085|P2|Overall Study|Adverse Event|8
29188|NCT01828112|132086|P1|Overall Study|Adverse Event|6
29189|NCT01828099|132094|P2|Overall Study|Subject/guardian decision|23
29190|NCT01828099|132095|P1|Overall Study|Subject/guardian decision|7
29191|NCT01828099|132094|P2|Overall Study|Protocol Violation|0
29192|NCT01828099|132095|P1|Overall Study|Protocol Violation|1
29193|NCT01828099|132094|P2|Overall Study|Progressive disease|94
29194|NCT01828099|132095|P1|Overall Study|Progressive disease|51
29195|NCT01828099|132094|P2|Overall Study|Physician Decision|11
29196|NCT01828099|132095|P1|Overall Study|Physician Decision|7
29197|NCT01828099|132094|P2|Overall Study|Non-compliance with study treatment|0
29198|NCT01828099|132095|P1|Overall Study|Non-compliance with study treatment|2
29199|NCT01828099|132094|P2|Overall Study|Lost to Follow-up|0
29200|NCT01828099|132095|P1|Overall Study|Lost to Follow-up|2
29201|NCT01828099|132094|P2|Overall Study|Death|11
29202|NCT01828099|132095|P1|Overall Study|Death|9
29203|NCT01828099|132094|P2|Overall Study|Adverse Event|18
29204|NCT01828099|132095|P1|Overall Study|Adverse Event|15
29205|NCT01827839|132101|P1|Overall Study|Consent Withdrawal|2
29206|NCT01827839|132101|P1|Overall Study|Adverse Event|1
29207|NCT01827670|132125|P2|Overall Study|Lost to Follow-up|1
29208|NCT01827670|132126|P1|Overall Study|Lost to Follow-up|0
29209|NCT01827670|132125|P2|Overall Study|Withdrawal of Consent|2
29210|NCT01827670|132126|P1|Overall Study|Withdrawal of Consent|3
29211|NCT01827592|132145|P3|Overall Study|Others|3
29212|NCT01827592|132146|P2|Overall Study|Others|1
29213|NCT01827592|132147|P1|Overall Study|Others|0
29214|NCT01827592|132145|P3|Overall Study|Trial terminated by Sponsor|51
29215|NCT01827592|132146|P2|Overall Study|Trial terminated by Sponsor|53
29216|NCT01827592|132147|P1|Overall Study|Trial terminated by Sponsor|47
29217|NCT01827592|132145|P3|Overall Study|Patient's substantial non-compliance|6
29218|NCT01827592|132146|P2|Overall Study|Patient's substantial non-compliance|1
29219|NCT01827592|132147|P1|Overall Study|Patient's substantial non-compliance|1
29220|NCT01827592|132145|P3|Overall Study|Withdrawal by Subject|11
29221|NCT01827592|132146|P2|Overall Study|Withdrawal by Subject|11
29222|NCT01827592|132147|P1|Overall Study|Withdrawal by Subject|12
29223|NCT01827592|132145|P3|Overall Study|Lost to Follow-up|2
29224|NCT01827592|132146|P2|Overall Study|Lost to Follow-up|2
29225|NCT01827592|132147|P1|Overall Study|Lost to Follow-up|1
29226|NCT01827592|132145|P3|Overall Study|Protocol Violation|0
29227|NCT01827592|132146|P2|Overall Study|Protocol Violation|1
29228|NCT01827592|132147|P1|Overall Study|Protocol Violation|2
29229|NCT01827592|132145|P3|Overall Study|Physician Decision|1
29230|NCT01827592|132146|P2|Overall Study|Physician Decision|2
29231|NCT01827592|132147|P1|Overall Study|Physician Decision|0
29232|NCT01827592|132145|P3|Overall Study|Adverse Event|2
29233|NCT01827592|132146|P2|Overall Study|Adverse Event|9
29234|NCT01827592|132147|P1|Overall Study|Adverse Event|11
29235|NCT01827371|132212|P4|Overall Study|Temporary study halt to vaccinations|13
29236|NCT01827371|132213|P3|Overall Study|Temporary study halt to vaccinations|5
29237|NCT01827371|132214|P2|Overall Study|Temporary study halt to vaccinations|2
29238|NCT01827371|132215|P1|Overall Study|Temporary study halt to vaccinations|11
29239|NCT01827371|132212|P4|Overall Study|Physician Decision|1
29240|NCT01827371|132213|P3|Overall Study|Physician Decision|0
29241|NCT01827371|132214|P2|Overall Study|Physician Decision|1
29242|NCT01827371|132215|P1|Overall Study|Physician Decision|0
29243|NCT01827371|132212|P4|Overall Study|Withdrawal by Subject|3
29244|NCT01827371|132213|P3|Overall Study|Withdrawal by Subject|2
29245|NCT01827371|132214|P2|Overall Study|Withdrawal by Subject|2
29246|NCT01827371|132215|P1|Overall Study|Withdrawal by Subject|1
29247|NCT01827371|132212|P4|Overall Study|Protocol Violation|0
29248|NCT01827371|132213|P3|Overall Study|Protocol Violation|0
29249|NCT01827371|132214|P2|Overall Study|Protocol Violation|0
29250|NCT01827371|132215|P1|Overall Study|Protocol Violation|1
29251|NCT01827371|132212|P4|Overall Study|Lost to Follow-up|4
29252|NCT01827371|132213|P3|Overall Study|Lost to Follow-up|0
29253|NCT01827371|132214|P2|Overall Study|Lost to Follow-up|2
29254|NCT01827371|132215|P1|Overall Study|Lost to Follow-up|0
29255|NCT01827371|132212|P4|Overall Study|Adverse Event|2
29256|NCT01827371|132213|P3|Overall Study|Adverse Event|4
29257|NCT01827371|132214|P2|Overall Study|Adverse Event|0
29258|NCT01827371|132215|P1|Overall Study|Adverse Event|0
29259|NCT01827332|132274|P2|Overall Study|Lost to Follow-up|1
29260|NCT01827332|132275|P1|Overall Study|Lost to Follow-up|2
29261|NCT01827319|132283|P1|Overall Study|Lost to Follow-up|3
29262|NCT01827267|132306|P2|Overall Study|Still on study|2
29263|NCT01827267|132307|P1|Overall Study|Still on study|0
29264|NCT01827267|132306|P2|Overall Study|Sponsor Discontinued Study|8
29265|NCT01827267|132307|P1|Overall Study|Sponsor Discontinued Study|2
29266|NCT01827267|132306|P2|Overall Study|Disease Progression|1
29267|NCT01827267|132307|P1|Overall Study|Disease Progression|1
29268|NCT01827267|132306|P2|Overall Study|Physician Decision|0
29269|NCT01827267|132307|P1|Overall Study|Physician Decision|1
29270|NCT01827267|132306|P2|Overall Study|Did not receive study drug|1
29271|NCT01827267|132307|P1|Overall Study|Did not receive study drug|1
29272|NCT01827254|132322|P1|Overall Study|Intolerance to treatment|4
29273|NCT01827254|132322|P1|Overall Study|Disease progression|36
29274|NCT01827254|132322|P1|Overall Study|Did not complete re-challenge|1
29275|NCT01827254|132322|P1|Overall Study|Discontinued prior initiation: sunitinib|1
29276|NCT01827254|132322|P1|Overall Study|Invalidated centre|3
29277|NCT01827254|132322|P1|Overall Study|Case report form not completed|4
29278|NCT01827254|132322|P1|Overall Study|Death|10
29279|NCT01826981|132347|P15|Overall Study|Enrolled/Randomized but Not Treated|0
29280|NCT01826981|132348|P14|Overall Study|Enrolled/Randomized but Not Treated|0
29281|NCT01826981|132349|P13|Overall Study|Enrolled/Randomized but Not Treated|0
29282|NCT01826981|132350|P12|Overall Study|Enrolled/Randomized but Not Treated|0
29283|NCT01826981|132351|P11|Overall Study|Enrolled/Randomized but Not Treated|0
29284|NCT01826981|132352|P10|Overall Study|Enrolled/Randomized but Not Treated|0
29285|NCT01826981|132353|P9|Overall Study|Enrolled/Randomized but Not Treated|0
29286|NCT01826981|132354|P8|Overall Study|Enrolled/Randomized but Not Treated|1
29287|NCT01826981|132355|P7|Overall Study|Enrolled/Randomized but Not Treated|0
29288|NCT01826981|132356|P6|Overall Study|Enrolled/Randomized but Not Treated|0
29289|NCT01826981|132357|P5|Overall Study|Enrolled/Randomized but Not Treated|0
29290|NCT01826981|132358|P4|Overall Study|Enrolled/Randomized but Not Treated|0
29291|NCT01826981|132359|P3|Overall Study|Enrolled/Randomized but Not Treated|0
29292|NCT01826981|132360|P2|Overall Study|Enrolled/Randomized but Not Treated|0
29293|NCT01826981|132361|P1|Overall Study|Enrolled/Randomized but Not Treated|0
29294|NCT01826981|132347|P15|Overall Study|Upper G-I Haemorrhage|0
29295|NCT01826981|132348|P14|Overall Study|Upper G-I Haemorrhage|1
29296|NCT01826981|132349|P13|Overall Study|Upper G-I Haemorrhage|0
29297|NCT01826981|132350|P12|Overall Study|Upper G-I Haemorrhage|0
29298|NCT01826981|132351|P11|Overall Study|Upper G-I Haemorrhage|0
29299|NCT01826981|132352|P10|Overall Study|Upper G-I Haemorrhage|0
29300|NCT01826981|132353|P9|Overall Study|Upper G-I Haemorrhage|0
29301|NCT01826981|132354|P8|Overall Study|Upper G-I Haemorrhage|0
29302|NCT01826981|132355|P7|Overall Study|Upper G-I Haemorrhage|0
29303|NCT01826981|132356|P6|Overall Study|Upper G-I Haemorrhage|0
29304|NCT01826981|132357|P5|Overall Study|Upper G-I Haemorrhage|0
29305|NCT01826981|132358|P4|Overall Study|Upper G-I Haemorrhage|0
29306|NCT01826981|132359|P3|Overall Study|Upper G-I Haemorrhage|0
29307|NCT01826981|132360|P2|Overall Study|Upper G-I Haemorrhage|0
29308|NCT01826981|132361|P1|Overall Study|Upper G-I Haemorrhage|0
29309|NCT01826981|132347|P15|Overall Study|Adverse Event|0
29310|NCT01826981|132348|P14|Overall Study|Adverse Event|0
29311|NCT01826981|132349|P13|Overall Study|Adverse Event|0
29312|NCT01826981|132350|P12|Overall Study|Adverse Event|0
29313|NCT01826981|132351|P11|Overall Study|Adverse Event|0
29314|NCT01826981|132352|P10|Overall Study|Adverse Event|0
29315|NCT01826981|132353|P9|Overall Study|Adverse Event|0
29316|NCT01826981|132354|P8|Overall Study|Adverse Event|0
29317|NCT01826981|132355|P7|Overall Study|Adverse Event|0
29318|NCT01826981|132356|P6|Overall Study|Adverse Event|0
29319|NCT01826981|132357|P5|Overall Study|Adverse Event|1
29320|NCT01826981|132358|P4|Overall Study|Adverse Event|0
29321|NCT01826981|132359|P3|Overall Study|Adverse Event|0
29322|NCT01826981|132360|P2|Overall Study|Adverse Event|0
29323|NCT01826981|132361|P1|Overall Study|Adverse Event|0
29324|NCT01826981|132347|P15|Overall Study|Withdrew Consent|0
29325|NCT01826981|132348|P14|Overall Study|Withdrew Consent|1
29326|NCT01826981|132349|P13|Overall Study|Withdrew Consent|0
29327|NCT01826981|132350|P12|Overall Study|Withdrew Consent|1
29328|NCT01826981|132351|P11|Overall Study|Withdrew Consent|0
29329|NCT01826981|132352|P10|Overall Study|Withdrew Consent|0
29330|NCT01826981|132353|P9|Overall Study|Withdrew Consent|0
29331|NCT01826981|132354|P8|Overall Study|Withdrew Consent|1
29332|NCT01826981|132355|P7|Overall Study|Withdrew Consent|1
29333|NCT01826981|132356|P6|Overall Study|Withdrew Consent|0
29334|NCT01826981|132357|P5|Overall Study|Withdrew Consent|0
29335|NCT01826981|132358|P4|Overall Study|Withdrew Consent|0
29336|NCT01826981|132359|P3|Overall Study|Withdrew Consent|0
29337|NCT01826981|132360|P2|Overall Study|Withdrew Consent|0
29338|NCT01826981|132361|P1|Overall Study|Withdrew Consent|0
29339|NCT01826981|132347|P15|Overall Study|Lost to Follow-up|0
29340|NCT01826981|132348|P14|Overall Study|Lost to Follow-up|0
29341|NCT01826981|132349|P13|Overall Study|Lost to Follow-up|1
29342|NCT01826981|132350|P12|Overall Study|Lost to Follow-up|1
29343|NCT01826981|132351|P11|Overall Study|Lost to Follow-up|1
29344|NCT01826981|132352|P10|Overall Study|Lost to Follow-up|1
29345|NCT01826981|132353|P9|Overall Study|Lost to Follow-up|0
29346|NCT01826981|132354|P8|Overall Study|Lost to Follow-up|1
29347|NCT01826981|132355|P7|Overall Study|Lost to Follow-up|0
29348|NCT01826981|132356|P6|Overall Study|Lost to Follow-up|1
29349|NCT01826981|132357|P5|Overall Study|Lost to Follow-up|1
29350|NCT01826981|132358|P4|Overall Study|Lost to Follow-up|0
29351|NCT01826981|132359|P3|Overall Study|Lost to Follow-up|0
29352|NCT01826981|132360|P2|Overall Study|Lost to Follow-up|0
29353|NCT01826981|132361|P1|Overall Study|Lost to Follow-up|0
29354|NCT01826981|132347|P15|Overall Study|Lack of Efficacy|0
29355|NCT01826981|132348|P14|Overall Study|Lack of Efficacy|3
29356|NCT01826981|132349|P13|Overall Study|Lack of Efficacy|0
29357|NCT01826981|132350|P12|Overall Study|Lack of Efficacy|0
29358|NCT01826981|132351|P11|Overall Study|Lack of Efficacy|1
29359|NCT01826981|132352|P10|Overall Study|Lack of Efficacy|0
29360|NCT01826981|132353|P9|Overall Study|Lack of Efficacy|7
29361|NCT01826981|132354|P8|Overall Study|Lack of Efficacy|8
29362|NCT01826981|132355|P7|Overall Study|Lack of Efficacy|0
29363|NCT01826981|132356|P6|Overall Study|Lack of Efficacy|0
29364|NCT01826981|132357|P5|Overall Study|Lack of Efficacy|5
29365|NCT01826981|132358|P4|Overall Study|Lack of Efficacy|0
29366|NCT01826981|132359|P3|Overall Study|Lack of Efficacy|0
29367|NCT01826981|132360|P2|Overall Study|Lack of Efficacy|1
29368|NCT01826981|132361|P1|Overall Study|Lack of Efficacy|0
29369|NCT01826604|132526|P2|Overall Study|Lost to Follow-up|9
29370|NCT01826604|132527|P1|Overall Study|Lost to Follow-up|8
29371|NCT01826422|132571|P2|Overall Study|Withdrawal by Subject|3
29372|NCT01826422|132572|P1|Overall Study|Withdrawal by Subject|1
29373|NCT01826370|132616|P1|Overall Study|Other reason not defined above|2
29374|NCT01826370|132616|P1|Overall Study|Lost to Follow-up|12
29375|NCT01826370|132616|P1|Overall Study|Protocol Violation|6
29376|NCT01826214|132628|P2|Overall Study|Subject/guardian decision|3
29377|NCT01826214|132629|P1|Overall Study|Subject/guardian decision|2
29378|NCT01826214|132628|P2|Overall Study|Study terminated by Sponsor|1
29379|NCT01826214|132629|P1|Overall Study|Study terminated by Sponsor|0
29380|NCT01826214|132628|P2|Overall Study|Progressive disease|21
29381|NCT01826214|132629|P1|Overall Study|Progressive disease|22
29382|NCT01826214|132628|P2|Overall Study|Physician Decision|2
29383|NCT01826214|132629|P1|Overall Study|Physician Decision|0
29384|NCT01826214|132628|P2|Overall Study|Lost to Follow-up|0
29385|NCT01826214|132629|P1|Overall Study|Lost to Follow-up|1
29386|NCT01826214|132628|P2|Overall Study|Death|1
29387|NCT01826214|132629|P1|Overall Study|Death|3
29388|NCT01826214|132628|P2|Overall Study|Adverse Event|6
29389|NCT01826214|132629|P1|Overall Study|Adverse Event|7
29390|NCT01826201|132647|P1|Overall Study|Non compliance with protocol|4
29391|NCT01825837|132657|P4|PART II|reason unspecified|0
29392|NCT01825837|132658|P3|PART II|reason unspecified|2
29393|NCT01825837|132659|P2|PART II|reason unspecified|2
29394|NCT01825837|132660|P1|PART II|reason unspecified|2
29395|NCT01825837|132657|P4|PART II|Treatment failure|0
29396|NCT01825837|132658|P3|PART II|Treatment failure|5
29397|NCT01825837|132659|P2|PART II|Treatment failure|4
29398|NCT01825837|132660|P1|PART II|Treatment failure|6
29399|NCT01825837|132657|P4|PART II|Adverse Event|0
29400|NCT01825837|132658|P3|PART II|Adverse Event|1
29401|NCT01825837|132659|P2|PART II|Adverse Event|3
29402|NCT01825837|132660|P1|PART II|Adverse Event|3
29403|NCT01825837|132657|P4|PART II|Patient non-compliance|0
29404|NCT01825837|132658|P3|PART II|Patient non-compliance|4
29405|NCT01825837|132659|P2|PART II|Patient non-compliance|2
29406|NCT01825837|132660|P1|PART II|Patient non-compliance|5
29407|NCT01825837|132657|P4|PART II|Withdrawal by Subject|0
29408|NCT01825837|132658|P3|PART II|Withdrawal by Subject|7
29409|NCT01825837|132659|P2|PART II|Withdrawal by Subject|3
29410|NCT01825837|132660|P1|PART II|Withdrawal by Subject|3
29411|NCT01825837|132657|P4|PART I|reason unspecified|3
29412|NCT01825837|132658|P3|PART I|reason unspecified|0
29413|NCT01825837|132659|P2|PART I|reason unspecified|0
29414|NCT01825837|132660|P1|PART I|reason unspecified|0
29415|NCT01825837|132657|P4|PART I|Treatment failure|7
29416|NCT01825837|132658|P3|PART I|Treatment failure|0
29417|NCT01825837|132659|P2|PART I|Treatment failure|0
29418|NCT01825837|132660|P1|PART I|Treatment failure|0
29419|NCT01825837|132657|P4|PART I|Patient non-compliance|1
29420|NCT01825837|132658|P3|PART I|Patient non-compliance|0
29421|NCT01825837|132659|P2|PART I|Patient non-compliance|0
29422|NCT01825837|132660|P1|PART I|Patient non-compliance|0
29423|NCT01825837|132657|P4|PART I|Withdrawal by Subject|6
29424|NCT01825837|132658|P3|PART I|Withdrawal by Subject|0
29425|NCT01825837|132659|P2|PART I|Withdrawal by Subject|0
29426|NCT01825837|132660|P1|PART I|Withdrawal by Subject|0
29427|NCT01825798|132670|P2|Overall Study|Lost to Follow-up|0
29428|NCT01825798|132671|P1|Overall Study|Lost to Follow-up|1
29429|NCT01825798|132670|P2|Overall Study|Adverse Event|5
29430|NCT01825798|132671|P1|Overall Study|Adverse Event|1
29431|NCT01825577|132699|P1|Overall Study|Lack of Efficacy|3
29432|NCT01825577|132699|P1|Overall Study|Withdrawn by family members|2
29433|NCT01825577|132699|P1|Overall Study|Withdrawal by Subject|1
29434|NCT01825577|132699|P1|Overall Study|Physician Decision|2
29435|NCT01825200|132723|P2|Overall Study|Withdrawal by Subject|1
29436|NCT01825200|132724|P1|Overall Study|Withdrawal by Subject|0
29437|NCT01825200|132723|P2|Overall Study|Lost to Follow-up|6
29438|NCT01825200|132724|P1|Overall Study|Lost to Follow-up|5
29439|NCT01824979|132747|P2|Overall Study|Protocol Violation|13
29440|NCT01824979|132748|P1|Overall Study|Protocol Violation|6
29441|NCT01824979|132747|P2|Overall Study|Physician Decision|0
29442|NCT01824979|132748|P1|Overall Study|Physician Decision|2
29443|NCT01824979|132747|P2|Overall Study|Withdrawal by Subject|0
29444|NCT01824979|132748|P1|Overall Study|Withdrawal by Subject|5
29445|NCT01824823|132765|P2|Overall Study|Off-treatment reason not submitted|0
29446|NCT01824823|132766|P1|Overall Study|Off-treatment reason not submitted|1
29447|NCT01824823|132765|P2|Overall Study|Lack of Efficacy|1
29448|NCT01824823|132766|P1|Overall Study|Lack of Efficacy|1
29449|NCT01824602|132776|P4|Overall Study|Treatment failure|1
29450|NCT01824602|132777|P3|Overall Study|Treatment failure|0
29451|NCT01824602|132778|P2|Overall Study|Treatment failure|0
29452|NCT01824602|132779|P1|Overall Study|Treatment failure|0
29453|NCT01824602|132776|P4|Overall Study|Adverse Event|2
29454|NCT01824602|132777|P3|Overall Study|Adverse Event|2
29455|NCT01824602|132778|P2|Overall Study|Adverse Event|0
29456|NCT01824602|132779|P1|Overall Study|Adverse Event|1
29457|NCT01824602|132776|P4|Overall Study|Patient non-compliance|0
29458|NCT01824602|132777|P3|Overall Study|Patient non-compliance|1
29459|NCT01824602|132778|P2|Overall Study|Patient non-compliance|0
29460|NCT01824602|132779|P1|Overall Study|Patient non-compliance|0
29461|NCT01824602|132776|P4|Overall Study|Withdrawal by Subject|2
29462|NCT01824602|132777|P3|Overall Study|Withdrawal by Subject|1
29463|NCT01824602|132778|P2|Overall Study|Withdrawal by Subject|0
29464|NCT01824602|132779|P1|Overall Study|Withdrawal by Subject|0
29465|NCT01824576|132818|P1|Overall Study|Device deficiency|2
29466|NCT01824498|132836|P6|Washout (8 Weeks)|Withdrawal by Subject|0
29467|NCT01824498|132837|P5|Washout (8 Weeks)|Withdrawal by Subject|1
29468|NCT01824498|132838|P4|Washout (8 Weeks)|Withdrawal by Subject|1
29469|NCT01824498|132839|P3|Washout (8 Weeks)|Withdrawal by Subject|2
29470|NCT01824498|132840|P2|Washout (8 Weeks)|Withdrawal by Subject|0
29471|NCT01824498|132841|P1|Washout (8 Weeks)|Withdrawal by Subject|2
29472|NCT01824355|132872|P1|Overall Study|unevaluable reference method results per|1
29473|NCT01824355|132872|P1|Overall Study|Adverse Event|2
29474|NCT01824342|132883|P2|Overall Study|Death|0
29475|NCT01824342|132884|P1|Overall Study|Death|2
29476|NCT01824342|132883|P2|Overall Study|Physician Decision|0
29477|NCT01824342|132884|P1|Overall Study|Physician Decision|5
29478|NCT01824342|132883|P2|Overall Study|Disease Progression|1
29479|NCT01824342|132884|P1|Overall Study|Disease Progression|1
29480|NCT01824342|132883|P2|Overall Study|Adverse Event|1
29481|NCT01824342|132884|P1|Overall Study|Adverse Event|1
29482|NCT01824342|132883|P2|Overall Study|Withdrawal by Subject|3
29483|NCT01824342|132884|P1|Overall Study|Withdrawal by Subject|0
29484|NCT01824303|132898|P2|Randomized Study|Other Miscellaneous Reasons|0
29485|NCT01824303|132899|P1|Randomized Study|Other Miscellaneous Reasons|1
29486|NCT01824303|132898|P2|Randomized Study|Withdrawal by Subject|1
29487|NCT01824303|132899|P1|Randomized Study|Withdrawal by Subject|1
29488|NCT01823679|132927|P1|Overall Study|Death|1
29489|NCT01823536|132980|P6|Overall Study|Subject moved out of the state|0
29490|NCT01823536|132981|P5|Overall Study|Subject moved out of the state|1
29491|NCT01823536|132982|P4|Overall Study|Subject moved out of the state|0
29492|NCT01823536|132983|P3|Overall Study|Subject moved out of the state|0
29493|NCT01823536|132984|P2|Overall Study|Subject moved out of the state|0
29494|NCT01823536|132985|P1|Overall Study|Subject moved out of the state|0
29495|NCT01823536|132980|P6|Overall Study|Met exclusion criterion No 6|0
29496|NCT01823536|132981|P5|Overall Study|Met exclusion criterion No 6|0
29497|NCT01823536|132982|P4|Overall Study|Met exclusion criterion No 6|1
29498|NCT01823536|132983|P3|Overall Study|Met exclusion criterion No 6|0
29499|NCT01823536|132984|P2|Overall Study|Met exclusion criterion No 6|0
29500|NCT01823536|132985|P1|Overall Study|Met exclusion criterion No 6|0
29501|NCT01823536|132980|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
29502|NCT01823536|132981|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
29503|NCT01823536|132982|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
29504|NCT01823536|132983|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
29505|NCT01823536|132984|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
29506|NCT01823536|132985|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
29507|NCT01823536|132980|P6|Overall Study|Withdrawal by Subject|0
29508|NCT01823536|132981|P5|Overall Study|Withdrawal by Subject|0
29509|NCT01823536|132982|P4|Overall Study|Withdrawal by Subject|0
29510|NCT01823536|132983|P3|Overall Study|Withdrawal by Subject|0
29511|NCT01823536|132984|P2|Overall Study|Withdrawal by Subject|1
29512|NCT01823536|132985|P1|Overall Study|Withdrawal by Subject|1
29513|NCT01823536|132980|P6|Overall Study|Protocol Violation|0
29514|NCT01823536|132981|P5|Overall Study|Protocol Violation|0
29515|NCT01823536|132982|P4|Overall Study|Protocol Violation|0
29516|NCT01823536|132983|P3|Overall Study|Protocol Violation|0
29517|NCT01823536|132984|P2|Overall Study|Protocol Violation|1
29518|NCT01823536|132985|P1|Overall Study|Protocol Violation|0
29519|NCT01823536|132980|P6|Overall Study|Lost to Follow-up|0
29520|NCT01823536|132981|P5|Overall Study|Lost to Follow-up|1
29521|NCT01823536|132982|P4|Overall Study|Lost to Follow-up|1
29522|NCT01823536|132983|P3|Overall Study|Lost to Follow-up|0
29523|NCT01823536|132984|P2|Overall Study|Lost to Follow-up|0
29524|NCT01823536|132985|P1|Overall Study|Lost to Follow-up|1
29525|NCT01823341|133036|P1|Overall Study|Adverse Event|1
29526|NCT01823341|133036|P1|Overall Study|Withdrawal by Subject|7
29527|NCT01823341|133036|P1|Overall Study|Failed run-in|7
29528|NCT01823289|133079|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
29529|NCT01823289|133079|P1|Overall Study|Drug affected efficacy and safety|1
29530|NCT01823289|133079|P1|Overall Study|Transaminase increased more than 3 times|1
29531|NCT01823289|133079|P1|Overall Study|Administered contraindicated medicine|1
29532|NCT01823289|133079|P1|Overall Study|Physician Decision|9
29533|NCT01823289|133079|P1|Overall Study|Lack of Efficacy|1
29534|NCT01823289|133079|P1|Overall Study|Adverse Event|5
29535|NCT01823289|133079|P1|Overall Study|Lost to Follow-up|5
29536|NCT01823224|133087|P2|Overall Study|Withdrawal by Subject|1
29537|NCT01823224|133088|P1|Overall Study|Withdrawal by Subject|0
29538|NCT01823224|133087|P2|Overall Study|missed med dose|1
29539|NCT01823224|133088|P1|Overall Study|missed med dose|0
29540|NCT01823224|133087|P2|Overall Study|pharmacy error|1
29541|NCT01823224|133088|P1|Overall Study|pharmacy error|0
29542|NCT01823224|133087|P2|Overall Study|didn't qualify|2
29543|NCT01823224|133088|P1|Overall Study|didn't qualify|1
29544|NCT01823224|133087|P2|Overall Study|Lost to Follow-up|6
29545|NCT01823224|133088|P1|Overall Study|Lost to Follow-up|5
29546|NCT01823146|133098|P2|Overall Study|Lost to Follow-up|1
29547|NCT01823146|133099|P1|Overall Study|Lost to Follow-up|2
29548|NCT01823146|133098|P2|Overall Study|Withdrawal by Subject|1
29549|NCT01823146|133099|P1|Overall Study|Withdrawal by Subject|0
29550|NCT01822899|133111|P2|Overall Study|Withdrawal by Subject|7
29551|NCT01822899|133112|P1|Overall Study|Withdrawal by Subject|5
29552|NCT01822899|133111|P2|Overall Study|Lost to Follow-up|0
29553|NCT01822899|133112|P1|Overall Study|Lost to Follow-up|1
29554|NCT01822899|133111|P2|Overall Study|Protocol Violation|3
29555|NCT01822899|133112|P1|Overall Study|Protocol Violation|6
29556|NCT01822899|133111|P2|Overall Study|Lack of Efficacy|3
29557|NCT01822899|133112|P1|Overall Study|Lack of Efficacy|6
29558|NCT01822899|133111|P2|Overall Study|Adverse Event|5
29559|NCT01822899|133112|P1|Overall Study|Adverse Event|6
29560|NCT01822821|133122|P2|Overall Study|Other reasons|0
29561|NCT01822821|133123|P1|Overall Study|Other reasons|1
29562|NCT01822821|133122|P2|Overall Study|Eligible surgery cancelled|1
29563|NCT01822821|133123|P1|Overall Study|Eligible surgery cancelled|1
29564|NCT01822756|133152|P5|Overall Study|disease progression & patient preference|0
29565|NCT01822756|133153|P4|Overall Study|disease progression & patient preference|0
29566|NCT01822756|133154|P3|Overall Study|disease progression & patient preference|1
29567|NCT01822756|133155|P2|Overall Study|disease progression & patient preference|0
29568|NCT01822756|133156|P1|Overall Study|disease progression & patient preference|2
29569|NCT01822756|133152|P5|Overall Study|Physician Decision|0
29570|NCT01822756|133153|P4|Overall Study|Physician Decision|0
29571|NCT01822756|133154|P3|Overall Study|Physician Decision|0
29572|NCT01822756|133155|P2|Overall Study|Physician Decision|1
29573|NCT01822756|133156|P1|Overall Study|Physician Decision|0
29574|NCT01822756|133152|P5|Overall Study|Lost to Follow-up|1
29575|NCT01822756|133153|P4|Overall Study|Lost to Follow-up|0
29576|NCT01822756|133154|P3|Overall Study|Lost to Follow-up|1
29577|NCT01822756|133155|P2|Overall Study|Lost to Follow-up|0
29578|NCT01822756|133156|P1|Overall Study|Lost to Follow-up|1
29579|NCT01822756|133152|P5|Overall Study|Death|0
29580|NCT01822756|133153|P4|Overall Study|Death|0
29581|NCT01822756|133154|P3|Overall Study|Death|1
29582|NCT01822756|133155|P2|Overall Study|Death|2
29583|NCT01822756|133156|P1|Overall Study|Death|2
29584|NCT01822756|133152|P5|Overall Study|Disease progression|6
29585|NCT01822756|133153|P4|Overall Study|Disease progression|2
29586|NCT01822756|133154|P3|Overall Study|Disease progression|7
29587|NCT01822756|133155|P2|Overall Study|Disease progression|1
29588|NCT01822756|133156|P1|Overall Study|Disease progression|11
29589|NCT01822756|133152|P5|Overall Study|Adverse Event|0
29590|NCT01822756|133153|P4|Overall Study|Adverse Event|2
29591|NCT01822756|133154|P3|Overall Study|Adverse Event|0
29592|NCT01822756|133155|P2|Overall Study|Adverse Event|0
29593|NCT01822756|133156|P1|Overall Study|Adverse Event|0
29594|NCT01822691|133198|P1|Overall Study|Withdrawal by Subject|2
29595|NCT01822678|133209|P3|Overall Study|Lost to Follow-up|1
29596|NCT01822678|133210|P2|Overall Study|Lost to Follow-up|2
29597|NCT01822678|133211|P1|Overall Study|Lost to Follow-up|0
29598|NCT01822678|133209|P3|Overall Study|Lack of Efficacy|5
29599|NCT01822678|133210|P2|Overall Study|Lack of Efficacy|6
29600|NCT01822678|133211|P1|Overall Study|Lack of Efficacy|3
29601|NCT01822678|133209|P3|Overall Study|Adverse Event|1
29602|NCT01822678|133210|P2|Overall Study|Adverse Event|3
29603|NCT01822678|133211|P1|Overall Study|Adverse Event|4
29604|NCT01822678|133209|P3|Overall Study|Withdrawal by Subject|4
29605|NCT01822678|133210|P2|Overall Study|Withdrawal by Subject|4
29606|NCT01822678|133211|P1|Overall Study|Withdrawal by Subject|5
29607|NCT01822665|133219|P1|Overall Study|Other Reason|5
29608|NCT01822665|133219|P1|Overall Study|Adverse Event|3
29609|NCT01822561|133262|P1|Overall Study|Withdrawal by Subject|2
29610|NCT01822535|133283|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
29611|NCT01822535|133284|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
29612|NCT01822535|133283|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
29613|NCT01822535|133284|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
29614|NCT01822535|133283|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
29615|NCT01822535|133284|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
29616|NCT01822223|133308|P2|Overall Study|Death|1
29617|NCT01822223|133309|P1|Overall Study|Death|0
29618|NCT01821963|133354|P1|Overall Study|Adverse Event|1
29619|NCT01821937|133360|P2|Overall Study|Adverse Event|3
29620|NCT01821937|133361|P1|Overall Study|Adverse Event|0
29621|NCT01821807|133385|P2|Overall Study|Lost to Follow-up|1
29622|NCT01821807|133386|P1|Overall Study|Lost to Follow-up|3
29623|NCT01821118|133474|P2|Overall Study|Death|1
29624|NCT01821118|133475|P1|Overall Study|Death|0
29625|NCT01820585|133526|P4|Overall Study|Pregnancy|0
29626|NCT01820585|133527|P3|Overall Study|Pregnancy|0
29627|NCT01820585|133528|P2|Overall Study|Pregnancy|1
29628|NCT01820585|133529|P1|Overall Study|Pregnancy|0
29629|NCT01820585|133526|P4|Overall Study|at sponsor request|0
29630|NCT01820585|133527|P3|Overall Study|at sponsor request|1
29631|NCT01820585|133528|P2|Overall Study|at sponsor request|0
29632|NCT01820585|133529|P1|Overall Study|at sponsor request|0
29633|NCT01820585|133526|P4|Overall Study|Subject non-compliance|2
29634|NCT01820585|133527|P3|Overall Study|Subject non-compliance|1
29635|NCT01820585|133528|P2|Overall Study|Subject non-compliance|0
29636|NCT01820585|133529|P1|Overall Study|Subject non-compliance|0
29637|NCT01820585|133526|P4|Overall Study|Protocol Violation|1
29638|NCT01820585|133527|P3|Overall Study|Protocol Violation|1
29639|NCT01820585|133528|P2|Overall Study|Protocol Violation|1
29640|NCT01820585|133529|P1|Overall Study|Protocol Violation|3
29641|NCT01820585|133526|P4|Overall Study|Lost to Follow-up|3
29642|NCT01820585|133527|P3|Overall Study|Lost to Follow-up|0
29643|NCT01820585|133528|P2|Overall Study|Lost to Follow-up|3
29644|NCT01820585|133529|P1|Overall Study|Lost to Follow-up|3
29645|NCT01820585|133526|P4|Overall Study|Withdrawal by Subject|8
29646|NCT01820585|133527|P3|Overall Study|Withdrawal by Subject|3
29647|NCT01820585|133528|P2|Overall Study|Withdrawal by Subject|7
29648|NCT01820585|133529|P1|Overall Study|Withdrawal by Subject|3
29649|NCT01820585|133526|P4|Overall Study|Lack of Efficacy|1
29650|NCT01820585|133527|P3|Overall Study|Lack of Efficacy|5
29651|NCT01820585|133528|P2|Overall Study|Lack of Efficacy|7
29652|NCT01820585|133529|P1|Overall Study|Lack of Efficacy|9
29653|NCT01820585|133526|P4|Overall Study|Adverse Event|34
29654|NCT01820585|133527|P3|Overall Study|Adverse Event|23
29655|NCT01820585|133528|P2|Overall Study|Adverse Event|13
29656|NCT01820585|133529|P1|Overall Study|Adverse Event|9
29657|NCT01820559|133542|P3|Overall Study|Lack of Efficacy|3
29658|NCT01820559|133543|P2|Overall Study|Lack of Efficacy|2
29659|NCT01820559|133544|P1|Overall Study|Lack of Efficacy|3
29660|NCT01820559|133542|P3|Overall Study|At sponsor request|1
29661|NCT01820559|133543|P2|Overall Study|At sponsor request|0
29662|NCT01820559|133544|P1|Overall Study|At sponsor request|0
29663|NCT01820559|133542|P3|Overall Study|Lost to Follow-up|2
29664|NCT01820559|133543|P2|Overall Study|Lost to Follow-up|2
29665|NCT01820559|133544|P1|Overall Study|Lost to Follow-up|3
29666|NCT01820559|133542|P3|Overall Study|Subject's non-compliance|2
29667|NCT01820559|133543|P2|Overall Study|Subject's non-compliance|0
29668|NCT01820559|133544|P1|Overall Study|Subject's non-compliance|1
29669|NCT01820559|133542|P3|Overall Study|Protocol Violation|3
29670|NCT01820559|133543|P2|Overall Study|Protocol Violation|1
29671|NCT01820559|133544|P1|Overall Study|Protocol Violation|2
29672|NCT01820559|133542|P3|Overall Study|Withdrawal by Subject|5
29673|NCT01820559|133543|P2|Overall Study|Withdrawal by Subject|2
29674|NCT01820559|133544|P1|Overall Study|Withdrawal by Subject|1
29675|NCT01820559|133542|P3|Overall Study|Adverse Event|13
29676|NCT01820559|133543|P2|Overall Study|Adverse Event|6
29677|NCT01820559|133544|P1|Overall Study|Adverse Event|4
29678|NCT01820364|133565|P2|Part II: LGX818 + MEK162|Study Termination|1
29679|NCT01820364|133566|P1|Part II: LGX818 + MEK162|Study Termination|0
29680|NCT01820364|133565|P2|Part I: LGX818|Disease Progression|0
29681|NCT01820364|133566|P1|Part I: LGX818|Disease Progression|4
29682|NCT01820364|133565|P2|Part I: LGX818|Adverse Event|0
29683|NCT01820364|133566|P1|Part I: LGX818|Adverse Event|6
29684|NCT01820364|133565|P2|Part I: LGX818|Administrative Problems|0
29685|NCT01820364|133566|P1|Part I: LGX818|Administrative Problems|3
29686|NCT01820364|133565|P2|Part I: LGX818|Death|0
29687|NCT01820364|133566|P1|Part I: LGX818|Death|1
29688|NCT01819272|133741|P6|Overall Study|Loss of Glucose Control|0
29689|NCT01819272|133742|P5|Overall Study|Loss of Glucose Control|2
29690|NCT01819272|133743|P4|Overall Study|Loss of Glucose Control|1
29691|NCT01819272|133744|P3|Overall Study|Loss of Glucose Control|0
29692|NCT01819272|133745|P2|Overall Study|Loss of Glucose Control|1
29693|NCT01819272|133746|P1|Overall Study|Loss of Glucose Control|2
29694|NCT01819272|133741|P6|Overall Study|Withdrawal of Consent|1
29695|NCT01819272|133742|P5|Overall Study|Withdrawal of Consent|0
29696|NCT01819272|133743|P4|Overall Study|Withdrawal of Consent|1
29697|NCT01819272|133744|P3|Overall Study|Withdrawal of Consent|2
29698|NCT01819272|133745|P2|Overall Study|Withdrawal of Consent|1
29699|NCT01819272|133746|P1|Overall Study|Withdrawal of Consent|0
29700|NCT01819272|133741|P6|Overall Study|Physician Decision|0
29701|NCT01819272|133742|P5|Overall Study|Physician Decision|0
29702|NCT01819272|133743|P4|Overall Study|Physician Decision|0
29703|NCT01819272|133744|P3|Overall Study|Physician Decision|0
29704|NCT01819272|133745|P2|Overall Study|Physician Decision|1
29705|NCT01819272|133746|P1|Overall Study|Physician Decision|0
29706|NCT01819272|133741|P6|Overall Study|Protocol Violation|3
29707|NCT01819272|133742|P5|Overall Study|Protocol Violation|2
29708|NCT01819272|133743|P4|Overall Study|Protocol Violation|1
29709|NCT01819272|133744|P3|Overall Study|Protocol Violation|0
29710|NCT01819272|133745|P2|Overall Study|Protocol Violation|0
29711|NCT01819272|133746|P1|Overall Study|Protocol Violation|0
29712|NCT01819272|133741|P6|Overall Study|Lost to Follow-up|3
29713|NCT01819272|133742|P5|Overall Study|Lost to Follow-up|0
29714|NCT01819272|133743|P4|Overall Study|Lost to Follow-up|0
29715|NCT01819272|133744|P3|Overall Study|Lost to Follow-up|1
29716|NCT01819272|133745|P2|Overall Study|Lost to Follow-up|0
29717|NCT01819272|133746|P1|Overall Study|Lost to Follow-up|3
29718|NCT01819272|133741|P6|Overall Study|Adverse Event|0
29719|NCT01819272|133742|P5|Overall Study|Adverse Event|0
29720|NCT01819272|133743|P4|Overall Study|Adverse Event|2
29721|NCT01819272|133744|P3|Overall Study|Adverse Event|0
29722|NCT01819272|133745|P2|Overall Study|Adverse Event|0
29723|NCT01819272|133746|P1|Overall Study|Adverse Event|1
29724|NCT01819194|133772|P1|Overall Study|Loss of study articles|2
29725|NCT01819129|133779|P2|Overall Study|Withdrawal Criteria|15
29726|NCT01819129|133780|P1|Overall Study|Withdrawal Criteria|20
29727|NCT01819129|133779|P2|Overall Study|Death|1
29728|NCT01819129|133780|P1|Overall Study|Death|1
29729|NCT01819129|133779|P2|Overall Study|Adverse Event|4
29730|NCT01819129|133780|P1|Overall Study|Adverse Event|1
29731|NCT01819129|133779|P2|Overall Study|Lack of Efficacy|1
29732|NCT01819129|133780|P1|Overall Study|Lack of Efficacy|0
29733|NCT01819129|133779|P2|Overall Study|Lost to Follow-up|2
29734|NCT01819129|133780|P1|Overall Study|Lost to Follow-up|5
29735|NCT01819129|133779|P2|Overall Study|Withdrawal by Subject|15
29736|NCT01819129|133780|P1|Overall Study|Withdrawal by Subject|15
29737|NCT01819129|133779|P2|Overall Study|Other, Subject moved out of the country|1
29738|NCT01819129|133780|P1|Overall Study|Other, Subject moved out of the country|0
29739|NCT01819129|133779|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
29740|NCT01819129|133780|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
29741|NCT01819129|133779|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
29742|NCT01819129|133780|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
29743|NCT01818752|133794|P2|Overall Study|Randomized but not Dosed|4
29744|NCT01818752|133795|P1|Overall Study|Randomized but not Dosed|7
29745|NCT01818752|133794|P2|Overall Study|Continuing Treatment|4
29746|NCT01818752|133795|P1|Overall Study|Continuing Treatment|1
29747|NCT01818752|133794|P2|Overall Study|Other|8
29748|NCT01818752|133795|P1|Overall Study|Other|7
29749|NCT01818752|133794|P2|Overall Study|Disease Progression|48
29750|NCT01818752|133795|P1|Overall Study|Disease Progression|54
29751|NCT01818752|133794|P2|Overall Study|Physician Decision|8
29752|NCT01818752|133795|P1|Overall Study|Physician Decision|9
29753|NCT01818752|133794|P2|Overall Study|Withdrawal by Subject|14
29754|NCT01818752|133795|P1|Overall Study|Withdrawal by Subject|15
29755|NCT01818752|133794|P2|Overall Study|Non-compliance|20
29756|NCT01818752|133795|P1|Overall Study|Non-compliance|16
29757|NCT01818752|133794|P2|Overall Study|Death|18
29758|NCT01818752|133795|P1|Overall Study|Death|14
29759|NCT01818752|133794|P2|Overall Study|Adverse Event|74
29760|NCT01818752|133795|P1|Overall Study|Adverse Event|64
29761|NCT01818700|133813|P1|Overall Study|Other|1
29762|NCT01818700|133813|P1|Overall Study|Protocol Violation|2
29763|NCT01818700|133813|P1|Overall Study|Withdrawal by Subject|27
29764|NCT01818700|133813|P1|Overall Study|Lost to Follow-up|5
29765|NCT01818700|133813|P1|Overall Study|Lack of Efficacy|2
29766|NCT01818700|133813|P1|Overall Study|Adverse Event|67
29767|NCT01818596|133824|P2|Overall Study|Still on Study|6
29768|NCT01818596|133825|P1|Overall Study|Still on Study|232
29769|NCT01818596|133824|P2|Overall Study|Lost to Follow-up|0
29770|NCT01818596|133825|P1|Overall Study|Lost to Follow-up|2
29771|NCT01818596|133824|P2|Overall Study|Protocol Violation|0
29772|NCT01818596|133825|P1|Overall Study|Protocol Violation|1
29773|NCT01818596|133824|P2|Overall Study|Withdrew Consent|0
29774|NCT01818596|133825|P1|Overall Study|Withdrew Consent|3
29775|NCT01818596|133824|P2|Overall Study|Adverse Event|0
29776|NCT01818596|133825|P1|Overall Study|Adverse Event|4
29777|NCT01818596|133824|P2|Overall Study|Enrolled but Not Treated|0
29778|NCT01818596|133825|P1|Overall Study|Enrolled but Not Treated|4
29779|NCT01818336|133873|P2|Overall Study|Lost to Follow-up|1
29780|NCT01818336|133874|P1|Overall Study|Lost to Follow-up|0
29781|NCT01818336|133873|P2|Overall Study|Declined retest visit|11
29782|NCT01818336|133874|P1|Overall Study|Declined retest visit|0
29783|NCT01818297|133882|P2|Open Label Phase (3-12 Months)|Early study closure|10
29784|NCT01818297|133883|P1|Open Label Phase (3-12 Months)|Early study closure|17
29785|NCT01818297|133882|P2|Open Label Phase (3-12 Months)|Physician Decision|0
29786|NCT01818297|133883|P1|Open Label Phase (3-12 Months)|Physician Decision|1
29787|NCT01818297|133882|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
29788|NCT01818297|133883|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
29789|NCT01818141|133901|P2|Overall Study|Lost to Follow-up|2
29790|NCT01818141|133902|P1|Overall Study|Lost to Follow-up|0
29791|NCT01818141|133901|P2|Overall Study|No baseline C.diff colonies|1
29792|NCT01818141|133902|P1|Overall Study|No baseline C.diff colonies|1
29793|NCT01818141|133901|P2|Overall Study|Withdrawal by Subject|0
29794|NCT01818141|133902|P1|Overall Study|Withdrawal by Subject|2
29795|NCT01817790|133967|P2|Overall Study|Other: Could not attend appointment|1
29796|NCT01817790|133968|P1|Overall Study|Other: Could not attend appointment|1
29797|NCT01817790|133967|P2|Overall Study|Withdrawal by Subject|3
29798|NCT01817790|133968|P1|Overall Study|Withdrawal by Subject|1
29799|NCT01817790|133967|P2|Overall Study|Protocol Violation|1
29800|NCT01817790|133968|P1|Overall Study|Protocol Violation|2
29801|NCT01817790|133967|P2|Overall Study|Lost to Follow-up|1
29802|NCT01817790|133968|P1|Overall Study|Lost to Follow-up|0
29803|NCT01817790|133967|P2|Overall Study|Adverse Event|2
29804|NCT01817790|133968|P1|Overall Study|Adverse Event|0
29805|NCT01817777|134012|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
29806|NCT01817777|134013|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
29807|NCT01817777|134014|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
29808|NCT01817777|134012|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
29809|NCT01817777|134013|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
29810|NCT01817777|134014|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
29811|NCT01817777|134012|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
29812|NCT01817777|134013|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
29813|NCT01817777|134014|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
29814|NCT01817777|134012|P3|Observational Phase (8 Weeks)|Early Study Termination|0
29815|NCT01817777|134013|P2|Observational Phase (8 Weeks)|Early Study Termination|0
29816|NCT01817777|134014|P1|Observational Phase (8 Weeks)|Early Study Termination|2
29817|NCT01817777|134012|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
29818|NCT01817777|134013|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
29819|NCT01817777|134014|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
29820|NCT01817764|134038|P2|Overall Study|Withdrawal by Subject|12
29821|NCT01817764|134039|P1|Overall Study|Withdrawal by Subject|10
29822|NCT01817764|134038|P2|Overall Study|Lost to Follow-up|4
29823|NCT01817764|134039|P1|Overall Study|Lost to Follow-up|1
29824|NCT01817764|134038|P2|Overall Study|Protocol Violation|5
29825|NCT01817764|134039|P1|Overall Study|Protocol Violation|7
29826|NCT01817764|134038|P2|Overall Study|Lack of Efficacy|7
29827|NCT01817764|134039|P1|Overall Study|Lack of Efficacy|9
29828|NCT01817764|134038|P2|Overall Study|Adverse Event|10
29829|NCT01817764|134039|P1|Overall Study|Adverse Event|7
29830|NCT01817725|134047|P1|Overall Study|Withdrawal by Subject|1
29831|NCT01816893|134066|P2|Washout Period|Withdrawal by Subject|0
29832|NCT01816893|134067|P1|Washout Period|Withdrawal by Subject|2
29833|NCT01816685|134102|P2|Overall Study|Surgery Cancelled|2
29834|NCT01816685|134103|P1|Overall Study|Surgery Cancelled|3
29835|NCT01816685|134102|P2|Overall Study|Lost to Follow-up|9
29836|NCT01816685|134103|P1|Overall Study|Lost to Follow-up|7
29837|NCT01816477|134113|P2|Overall Study|Unable to tolerate catheter placement|0
29838|NCT01816477|134114|P1|Overall Study|Unable to tolerate catheter placement|3
29839|NCT01816477|134113|P2|Overall Study|Withdrawal by Subject|1
29840|NCT01816477|134114|P1|Overall Study|Withdrawal by Subject|13
29841|NCT01816295|134168|P2|OLE Phase|Lack of Efficacy|7
29842|NCT01816295|134169|P1|OLE Phase|Lack of Efficacy|3
29843|NCT01816295|134168|P2|OLE Phase|Withdrawal by Subject|10
29844|NCT01816295|134169|P1|OLE Phase|Withdrawal by Subject|10
29845|NCT01816295|134168|P2|OLE Phase|Sponsor Decision|9
29846|NCT01816295|134169|P1|OLE Phase|Sponsor Decision|7
29847|NCT01816295|134168|P2|OLE Phase|Protocol Violation|4
29848|NCT01816295|134169|P1|OLE Phase|Protocol Violation|4
29849|NCT01816295|134168|P2|OLE Phase|Physician Decision|1
29850|NCT01816295|134169|P1|OLE Phase|Physician Decision|3
29851|NCT01816295|134168|P2|OLE Phase|Lost to Follow-up|5
29852|NCT01816295|134169|P1|OLE Phase|Lost to Follow-up|5
29853|NCT01816295|134168|P2|OLE Phase|Entry Criteria Not Met|5
29854|NCT01816295|134169|P1|OLE Phase|Entry Criteria Not Met|3
29855|NCT01816295|134168|P2|OLE Phase|Death|0
29856|NCT01816295|134169|P1|OLE Phase|Death|1
29857|NCT01816295|134168|P2|OLE Phase|Adverse Event|15
29858|NCT01816295|134169|P1|OLE Phase|Adverse Event|17
29859|NCT01816295|134168|P2|Double Blind Phase|Withdrawal by Subject|20
29860|NCT01816295|134169|P1|Double Blind Phase|Withdrawal by Subject|22
29861|NCT01816295|134168|P2|Double Blind Phase|Sponsor Decision|8
29862|NCT01816295|134169|P1|Double Blind Phase|Sponsor Decision|8
29863|NCT01816295|134168|P2|Double Blind Phase|Protocol Violation|11
29864|NCT01816295|134169|P1|Double Blind Phase|Protocol Violation|17
29865|NCT01816295|134168|P2|Double Blind Phase|Physician Decision|2
29866|NCT01816295|134169|P1|Double Blind Phase|Physician Decision|2
29867|NCT01816295|134168|P2|Double Blind Phase|Lost to Follow-up|5
29868|NCT01816295|134169|P1|Double Blind Phase|Lost to Follow-up|3
29869|NCT01816295|134168|P2|Double Blind Phase|Entry Criteria Not Met|2
29870|NCT01816295|134169|P1|Double Blind Phase|Entry Criteria Not Met|0
29871|NCT01816295|134168|P2|Double Blind Phase|Adverse Event|8
29872|NCT01816295|134169|P1|Double Blind Phase|Adverse Event|11
29873|NCT01816243|134184|P1|Overall Study|Amputation|3
29874|NCT01816243|134184|P1|Overall Study|Not eligible for the study|1
29875|NCT01816243|134184|P1|Overall Study|Lack of Efficacy|1
29876|NCT01816243|134184|P1|Overall Study|Lost to Follow-up|1
29877|NCT01816243|134184|P1|Overall Study|Adverse Event|6
29878|NCT01816074|134195|P4|Phase 2|Withdrawal by Subject|0
29879|NCT01816074|134196|P3|Phase 2|Withdrawal by Subject|0
29880|NCT01816074|134197|P2|Phase 2|Withdrawal by Subject|0
29881|NCT01816074|134198|P1|Phase 2|Withdrawal by Subject|1
29882|NCT01816074|134195|P4|Phase 2|Physician Decision|1
29883|NCT01816074|134196|P3|Phase 2|Physician Decision|0
29884|NCT01816074|134197|P2|Phase 2|Physician Decision|0
29885|NCT01816074|134198|P1|Phase 2|Physician Decision|0
29886|NCT01816074|134195|P4|Phase 2|Unsatisfied with Randomization assignmen|0
29887|NCT01816074|134196|P3|Phase 2|Unsatisfied with Randomization assignmen|0
29888|NCT01816074|134197|P2|Phase 2|Unsatisfied with Randomization assignmen|0
29889|NCT01816074|134198|P1|Phase 2|Unsatisfied with Randomization assignmen|1
29890|NCT01816074|134195|P4|Phase 2|Time commitment Issues|0
29891|NCT01816074|134196|P3|Phase 2|Time commitment Issues|0
29892|NCT01816074|134197|P2|Phase 2|Time commitment Issues|2
29893|NCT01816074|134198|P1|Phase 2|Time commitment Issues|0
29894|NCT01816074|134195|P4|Phase 1|Time commitment issues|0
29895|NCT01816074|134196|P3|Phase 1|Time commitment issues|1
29896|NCT01816074|134197|P2|Phase 1|Time commitment issues|0
29897|NCT01816074|134198|P1|Phase 1|Time commitment issues|0
29898|NCT01816048|134226|P1|Overall Study|Disease Progression|3
29899|NCT01816048|134226|P1|Overall Study|Withdrawal by Subject|1
29900|NCT01816048|134226|P1|Overall Study|Death|1
29901|NCT01816048|134226|P1|Overall Study|Adverse Event|1
29902|NCT01815918|134241|P2|Overall Study|Lack of Efficacy|15
29903|NCT01815918|134242|P1|Overall Study|Lack of Efficacy|15
29904|NCT01815918|134241|P2|Overall Study|Patient samples not analyzable|4
29905|NCT01815918|134242|P1|Overall Study|Patient samples not analyzable|3
29906|NCT01815840|134258|P2|Overall Study|Sponsor Termination Treatment|0
29907|NCT01815840|134259|P1|Overall Study|Sponsor Termination Treatment|1
29908|NCT01815840|134258|P2|Overall Study|Refused Treatment|1
29909|NCT01815840|134259|P1|Overall Study|Refused Treatment|5
29910|NCT01815840|134258|P2|Overall Study|Lost to Follow-up|6
29911|NCT01815840|134259|P1|Overall Study|Lost to Follow-up|3
29912|NCT01815840|134258|P2|Overall Study|Investigators Decision|3
29913|NCT01815840|134259|P1|Overall Study|Investigators Decision|2
29914|NCT01815840|134258|P2|Overall Study|Disease progression|2
29915|NCT01815840|134259|P1|Overall Study|Disease progression|3
29916|NCT01815840|134258|P2|Overall Study|Death|2
29917|NCT01815840|134259|P1|Overall Study|Death|2
29918|NCT01815840|134258|P2|Overall Study|Adverse Event|16
29919|NCT01815840|134259|P1|Overall Study|Adverse Event|10
29920|NCT01815840|134258|P2|Overall Study|Administrative/Other|3
29921|NCT01815840|134259|P1|Overall Study|Administrative/Other|1
29922|NCT01815840|134258|P2|Overall Study|Withdrew Consent|30
29923|NCT01815840|134259|P1|Overall Study|Withdrew Consent|31
29924|NCT01815840|134258|P2|Overall Study|Missing|0
29925|NCT01815840|134259|P1|Overall Study|Missing|1
29926|NCT01815736|134289|P2|Overall Study|Still on Study|449
29927|NCT01815736|134290|P1|Overall Study|Still on Study|929
29928|NCT01815736|134289|P2|Overall Study|Lost to Follow-up|7
29929|NCT01815736|134290|P1|Overall Study|Lost to Follow-up|6
29930|NCT01815736|134289|P2|Overall Study|Withdrew Consent|15
29931|NCT01815736|134290|P1|Overall Study|Withdrew Consent|7
29932|NCT01815736|134289|P2|Overall Study|Investigator's Discretion|0
29933|NCT01815736|134290|P1|Overall Study|Investigator's Discretion|4
29934|NCT01815736|134289|P2|Overall Study|Death|0
29935|NCT01815736|134290|P1|Overall Study|Death|4
29936|NCT01815736|134289|P2|Overall Study|Adverse Event|4
29937|NCT01815736|134290|P1|Overall Study|Adverse Event|7
29938|NCT01815736|134289|P2|Overall Study|Randomized but Not Treated|3
29939|NCT01815736|134290|P1|Overall Study|Randomized but Not Treated|4
29940|NCT01815138|134338|P2|Overall Study|Physician Decision|5
29941|NCT01815138|134339|P1|Overall Study|Physician Decision|8
29942|NCT01815138|134338|P2|Overall Study|Withdrawal by Subject|1
29943|NCT01815138|134339|P1|Overall Study|Withdrawal by Subject|0
29944|NCT01815099|134351|P1|Overall Study|unable to attend study visits|1
29945|NCT01815099|134351|P1|Overall Study|Lack of Efficacy|1
29946|NCT01814878|134365|P2|Overall Study|Other|0
29947|NCT01814878|134366|P1|Overall Study|Other|2
29948|NCT01814878|134365|P2|Overall Study|Screening failure (drop-out)|3
29949|NCT01814878|134366|P1|Overall Study|Screening failure (drop-out)|0
29950|NCT01814878|134365|P2|Overall Study|Physician Decision|1
29951|NCT01814878|134366|P1|Overall Study|Physician Decision|3
29952|NCT01814878|134365|P2|Overall Study|Protocol Violation|5
29953|NCT01814878|134366|P1|Overall Study|Protocol Violation|5
29954|NCT01814878|134365|P2|Overall Study|Withdrawal by Subject|16
29955|NCT01814878|134366|P1|Overall Study|Withdrawal by Subject|20
29956|NCT01814878|134365|P2|Overall Study|Adverse Event|5
29957|NCT01814878|134366|P1|Overall Study|Adverse Event|16
29958|NCT01814800|134386|P1|Overall Study|Subject relocation|1
29959|NCT01814800|134386|P1|Overall Study|Sponsor decision|1
29960|NCT01814800|134386|P1|Overall Study|Pregnancy|1
29961|NCT01814800|134386|P1|Overall Study|Adverse Event|2
29962|NCT01814761|134446|P2|Overall Study|Lost to Follow-up|5
29963|NCT01814761|134447|P1|Overall Study|Lost to Follow-up|1
29964|NCT01814761|134446|P2|Overall Study|Ocular Adverse Event|15
29965|NCT01814761|134447|P1|Overall Study|Ocular Adverse Event|6
29966|NCT01814761|134446|P2|Overall Study|Other Reasons|10
29967|NCT01814761|134447|P1|Overall Study|Other Reasons|1
29968|NCT01814748|134461|P2|Overall Study|Withdrawal by Subject|4
29969|NCT01814748|134462|P1|Overall Study|Withdrawal by Subject|6
29970|NCT01814748|134461|P2|Overall Study|Study site terminated by sponsor|1
29971|NCT01814748|134462|P1|Overall Study|Study site terminated by sponsor|1
29972|NCT01814748|134461|P2|Overall Study|Lost to Follow-up|2
29973|NCT01814748|134462|P1|Overall Study|Lost to Follow-up|1
29974|NCT01814696|134506|P2|Overall Study|Randomized to wrong group|0
29975|NCT01814696|134507|P1|Overall Study|Randomized to wrong group|1
29976|NCT01814696|134506|P2|Overall Study|Withdrawal by Subject|0
29977|NCT01814696|134507|P1|Overall Study|Withdrawal by Subject|1
29978|NCT01814670|134525|P1|Overall Study|Protocol Violation|12
29979|NCT01814553|134535|P2|Overall Study|Other than stated|8
29980|NCT01814553|134536|P1|Overall Study|Other than stated|7
29981|NCT01814553|134535|P2|Overall Study|Withdrawal by Subject|1
29982|NCT01814553|134536|P1|Overall Study|Withdrawal by Subject|1
29983|NCT01814553|134535|P2|Overall Study|Other Adverse Event|5
29984|NCT01814553|134536|P1|Overall Study|Other Adverse Event|4
29985|NCT01814553|134535|P2|Overall Study|PD per clinical progression|8
29986|NCT01814553|134536|P1|Overall Study|PD per clinical progression|6
29987|NCT01814397|134550|P1|Overall Study|Withdrawal by Subject|7
29988|NCT01814397|134550|P1|Overall Study|Adverse Event|7
29989|NCT01814332|134559|P2|Overall Study|Lost to Follow-up|1
29990|NCT01814332|134560|P1|Overall Study|Lost to Follow-up|5
29991|NCT01814332|134559|P2|Overall Study|Protocol Violation|4
29992|NCT01814332|134560|P1|Overall Study|Protocol Violation|0
29993|NCT01814332|134559|P2|Overall Study|Withdrawal by Subject|8
29994|NCT01814332|134560|P1|Overall Study|Withdrawal by Subject|3
29995|NCT01814332|134559|P2|Overall Study|Adverse Event|3
29996|NCT01814332|134560|P1|Overall Study|Adverse Event|8
29997|NCT01814137|134582|P2|Overall Study|Unclassified|1
29998|NCT01814137|134583|P1|Overall Study|Unclassified|2
29999|NCT01814137|134582|P2|Overall Study|Physician Decision|1
30000|NCT01814137|134583|P1|Overall Study|Physician Decision|1
30001|NCT01814137|134582|P2|Overall Study|Withdrawal by Subject|2
30002|NCT01814137|134583|P1|Overall Study|Withdrawal by Subject|2
30003|NCT01814137|134582|P2|Overall Study|Adverse Event|1
30004|NCT01814137|134583|P1|Overall Study|Adverse Event|0
30005|NCT01814046|134599|P3|Drug Administration|Death due to complications of RSV|0
30006|NCT01814046|134600|P2|Drug Administration|Death due to complications of RSV|0
30007|NCT01814046|134601|P1|Drug Administration|Death due to complications of RSV|1
30008|NCT01813890|134615|P3|Overall Study|Lack of Efficacy|2
30009|NCT01813890|134616|P2|Overall Study|Lack of Efficacy|1
30010|NCT01813890|134617|P1|Overall Study|Lack of Efficacy|9
30011|NCT01813890|134615|P3|Overall Study|Adverse Event|4
30012|NCT01813890|134616|P2|Overall Study|Adverse Event|3
30013|NCT01813890|134617|P1|Overall Study|Adverse Event|0
30014|NCT01813721|134646|P1|Overall Study|Withdrawal by Subject|1
30015|NCT01813721|134646|P1|Overall Study|Ineligibility determined|63
30016|NCT01813474|134701|P3|Overall Study|Death|1
30017|NCT01813474|134702|P2|Overall Study|Death|0
30018|NCT01813474|134703|P1|Overall Study|Death|0
30019|NCT01813474|134701|P3|Overall Study|Lack of Efficacy|9
30020|NCT01813474|134702|P2|Overall Study|Lack of Efficacy|6
30021|NCT01813474|134703|P1|Overall Study|Lack of Efficacy|2
30022|NCT01813474|134701|P3|Overall Study|Adverse Event|0
30023|NCT01813474|134702|P2|Overall Study|Adverse Event|1
30024|NCT01813474|134703|P1|Overall Study|Adverse Event|1
30025|NCT01813474|134701|P3|Overall Study|Withdrawal by Subject|1
30026|NCT01813474|134702|P2|Overall Study|Withdrawal by Subject|0
30027|NCT01813474|134703|P1|Overall Study|Withdrawal by Subject|0
30028|NCT01813422|134727|P2|Overall Study|Lost to Follow-up|4
30029|NCT01813422|134728|P1|Overall Study|Lost to Follow-up|2
30030|NCT01813422|134727|P2|Overall Study|Sponsor Decision|1
30031|NCT01813422|134728|P1|Overall Study|Sponsor Decision|2
30032|NCT01813422|134727|P2|Overall Study|Death|3
30033|NCT01813422|134728|P1|Overall Study|Death|2
30034|NCT01813422|134727|P2|Overall Study|Withdrawal by Subject|8
30035|NCT01813422|134728|P1|Overall Study|Withdrawal by Subject|14
30036|NCT01813019|134753|P2|Overall Study|Protocol Deviation|1
30037|NCT01813019|134754|P1|Overall Study|Protocol Deviation|2
30038|NCT01813019|134753|P2|Overall Study|administrative problems|0
30039|NCT01813019|134754|P1|Overall Study|administrative problems|2
30040|NCT01813019|134753|P2|Overall Study|Withdrawal by Subject|2
30041|NCT01813019|134754|P1|Overall Study|Withdrawal by Subject|3
30042|NCT01813019|134753|P2|Overall Study|Adverse Event|3
30043|NCT01813019|134754|P1|Overall Study|Adverse Event|0
30044|NCT01812837|134765|P3|Overall Study|Protocol Violation|0
30045|NCT01812837|134766|P2|Overall Study|Protocol Violation|0
30046|NCT01812837|134767|P1|Overall Study|Protocol Violation|1
30047|NCT01812837|134765|P3|Overall Study|Lost to Follow-up|0
30048|NCT01812837|134766|P2|Overall Study|Lost to Follow-up|1
30049|NCT01812837|134767|P1|Overall Study|Lost to Follow-up|1
30050|NCT01812707|134779|P4|Overall Study|Consent withdrawn by participant|0
30051|NCT01812707|134780|P3|Overall Study|Consent withdrawn by participant|0
30052|NCT01812707|134781|P2|Overall Study|Consent withdrawn by participant|0
30053|NCT01812707|134782|P1|Overall Study|Consent withdrawn by participant|1
30054|NCT01812707|134779|P4|Overall Study|Poor compliance to protocol|0
30055|NCT01812707|134780|P3|Overall Study|Poor compliance to protocol|0
30056|NCT01812707|134781|P2|Overall Study|Poor compliance to protocol|0
30057|NCT01812707|134782|P1|Overall Study|Poor compliance to protocol|1
30058|NCT01812707|134779|P4|Overall Study|Adverse Event|2
30059|NCT01812707|134780|P3|Overall Study|Adverse Event|0
30060|NCT01812707|134781|P2|Overall Study|Adverse Event|0
30061|NCT01812707|134782|P1|Overall Study|Adverse Event|0
30062|NCT01812655|134830|P3|Overall Study|Protocol Violation|0
30063|NCT01812655|134831|P2|Overall Study|Protocol Violation|1
30064|NCT01812655|134832|P1|Overall Study|Protocol Violation|1
30065|NCT01812057|134857|P2|Overall Study|Physician Decision|0
30066|NCT01812057|134858|P1|Overall Study|Physician Decision|1
30067|NCT01812057|134857|P2|Overall Study|Protocol Violation|0
30068|NCT01812057|134858|P1|Overall Study|Protocol Violation|1
30069|NCT01811953|134936|P6|Overall Study|Protocol Violation|0
30070|NCT01811953|134937|P5|Overall Study|Protocol Violation|1
30071|NCT01811953|134938|P4|Overall Study|Protocol Violation|0
30072|NCT01811953|134939|P3|Overall Study|Protocol Violation|0
30073|NCT01811953|134940|P2|Overall Study|Protocol Violation|0
30074|NCT01811953|134941|P1|Overall Study|Protocol Violation|0
30075|NCT01811953|134936|P6|Overall Study|Adverse Event|1
30076|NCT01811953|134937|P5|Overall Study|Adverse Event|0
30077|NCT01811953|134938|P4|Overall Study|Adverse Event|1
30078|NCT01811953|134939|P3|Overall Study|Adverse Event|0
30079|NCT01811953|134940|P2|Overall Study|Adverse Event|0
30080|NCT01811953|134941|P1|Overall Study|Adverse Event|0
30081|NCT01811732|134987|P2|Overall Study|Correct study drug not available on site|0
30082|NCT01811732|134988|P1|Overall Study|Correct study drug not available on site|1
30083|NCT01811732|134987|P2|Overall Study|Admitted to another facility|0
30084|NCT01811732|134988|P1|Overall Study|Admitted to another facility|1
30085|NCT01811732|134987|P2|Overall Study|Subject incarcerated|2
30086|NCT01811732|134988|P1|Overall Study|Subject incarcerated|1
30087|NCT01811732|134987|P2|Overall Study|Protocol Violation|1
30088|NCT01811732|134988|P1|Overall Study|Protocol Violation|0
30089|NCT01811732|134987|P2|Overall Study|Insufficient venous access|1
30090|NCT01811732|134988|P1|Overall Study|Insufficient venous access|0
30091|NCT01811732|134987|P2|Overall Study|Death|1
30092|NCT01811732|134988|P1|Overall Study|Death|1
30093|NCT01811732|134987|P2|Overall Study|Physician Decision|0
30094|NCT01811732|134988|P1|Overall Study|Physician Decision|2
30095|NCT01811732|134987|P2|Overall Study|Non-compliance with study drug/procedure|3
30096|NCT01811732|134988|P1|Overall Study|Non-compliance with study drug/procedure|3
30097|NCT01811732|134987|P2|Overall Study|Lack of Efficacy|1
30098|NCT01811732|134988|P1|Overall Study|Lack of Efficacy|3
30099|NCT01811732|134987|P2|Overall Study|Adverse Event|9
30100|NCT01811732|134988|P1|Overall Study|Adverse Event|3
30101|NCT01811732|134987|P2|Overall Study|Withdrawal by Subject|10
30102|NCT01811732|134988|P1|Overall Study|Withdrawal by Subject|16
30103|NCT01811732|134987|P2|Overall Study|Lost to Follow-up|30
30104|NCT01811732|134988|P1|Overall Study|Lost to Follow-up|24
30105|NCT01811706|134998|P2|First Intervention ( 4 Weeks)|Adverse Event|0
30106|NCT01811706|134999|P1|First Intervention ( 4 Weeks)|Adverse Event|1
30107|NCT01811563|135016|P2|Overall Study|Incorrect Randomization procedure|1
30108|NCT01811563|135017|P1|Overall Study|Incorrect Randomization procedure|0
30109|NCT01811563|135016|P2|Overall Study|Lost to Follow-up|2
30110|NCT01811563|135017|P1|Overall Study|Lost to Follow-up|5
30111|NCT01811485|135046|P3|Overall Study|Protocol Deviation|0
30112|NCT01811485|135047|P2|Overall Study|Protocol Deviation|1
30113|NCT01811485|135048|P1|Overall Study|Protocol Deviation|0
30114|NCT01811485|135046|P3|Overall Study|Administrative problems|0
30115|NCT01811485|135047|P2|Overall Study|Administrative problems|0
30116|NCT01811485|135048|P1|Overall Study|Administrative problems|1
30117|NCT01811485|135046|P3|Overall Study|Unsatisfactory therapeutic effect|3
30118|NCT01811485|135047|P2|Overall Study|Unsatisfactory therapeutic effect|0
30119|NCT01811485|135048|P1|Overall Study|Unsatisfactory therapeutic effect|0
30120|NCT01811485|135046|P3|Overall Study|Adverse Event|2
30121|NCT01811485|135047|P2|Overall Study|Adverse Event|3
30122|NCT01811485|135048|P1|Overall Study|Adverse Event|1
30123|NCT01811472|135068|P3|Overall Study|Subject/guardian decision|0
30124|NCT01811472|135069|P2|Overall Study|Subject/guardian decision|0
30125|NCT01811472|135070|P1|Overall Study|Subject/guardian decision|1
30126|NCT01811472|135068|P3|Overall Study|Lost to Follow-up|1
30127|NCT01811472|135069|P2|Overall Study|Lost to Follow-up|0
30128|NCT01811472|135070|P1|Overall Study|Lost to Follow-up|0
30129|NCT01811472|135068|P3|Overall Study|Adverse Event|4
30130|NCT01811472|135069|P2|Overall Study|Adverse Event|0
30131|NCT01811472|135070|P1|Overall Study|Adverse Event|1
30132|NCT01811238|135157|P1|Overall Study|subject refused study medication|6
30133|NCT01811238|135157|P1|Overall Study|Lack of Efficacy|4
30134|NCT01811238|135157|P1|Overall Study|Protocol Violation|4
30135|NCT01811238|135157|P1|Overall Study|Adverse Event|25
30136|NCT01811238|135157|P1|Overall Study|Withdrawal by Subject|42
30137|NCT01811186|135181|P2|Overall Study|Lost to Follow-up|2
30138|NCT01811186|135182|P1|Overall Study|Lost to Follow-up|4
30139|NCT01811186|135181|P2|Overall Study|Lack of Efficacy|6
30140|NCT01811186|135182|P1|Overall Study|Lack of Efficacy|3
30141|NCT01811186|135181|P2|Overall Study|Withdrawal by Subject|10
30142|NCT01811186|135182|P1|Overall Study|Withdrawal by Subject|5
30143|NCT01811186|135181|P2|Overall Study|Protocol Violation|6
30144|NCT01811186|135182|P1|Overall Study|Protocol Violation|5
30145|NCT01811186|135181|P2|Overall Study|Adverse Event|38
30146|NCT01811186|135182|P1|Overall Study|Adverse Event|54
30147|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
30148|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
30149|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
30150|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
30151|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
30152|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
30153|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
30154|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
30155|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
30156|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
30157|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
30158|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
30159|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
30160|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
30161|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
30162|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
30163|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
30164|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
30165|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Death|1
30166|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Death|0
30167|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Death|0
30168|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
30169|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
30170|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
30171|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
30172|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
30173|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
30174|NCT01810939|135215|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
30175|NCT01810939|135216|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
30176|NCT01810939|135217|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
30177|NCT01810939|135215|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
30178|NCT01810939|135216|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
30179|NCT01810939|135217|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
30180|NCT01810939|135215|P3|Part A Treatment Period|Protocol-specified (High K+)|0
30181|NCT01810939|135216|P2|Part A Treatment Period|Protocol-specified (High K+)|0
30182|NCT01810939|135217|P1|Part A Treatment Period|Protocol-specified (High K+)|3
30183|NCT01810939|135215|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
30184|NCT01810939|135216|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
30185|NCT01810939|135217|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
30186|NCT01810939|135215|P3|Part A Treatment Period|Withdrawal by Subject|0
30187|NCT01810939|135216|P2|Part A Treatment Period|Withdrawal by Subject|0
30188|NCT01810939|135217|P1|Part A Treatment Period|Withdrawal by Subject|5
30189|NCT01810939|135215|P3|Part A Treatment Period|Adverse Event|0
30190|NCT01810939|135216|P2|Part A Treatment Period|Adverse Event|0
30191|NCT01810939|135217|P1|Part A Treatment Period|Adverse Event|10
30192|NCT01810939|135215|P3|Part A Treatment Period|Protocol Violation|0
30193|NCT01810939|135216|P2|Part A Treatment Period|Protocol Violation|0
30194|NCT01810939|135217|P1|Part A Treatment Period|Protocol Violation|2
30195|NCT01810939|135215|P3|Part A Treatment Period|Non-compliance with Study Drug|0
30196|NCT01810939|135216|P2|Part A Treatment Period|Non-compliance with Study Drug|0
30197|NCT01810939|135217|P1|Part A Treatment Period|Non-compliance with Study Drug|1
30198|NCT01810783|135230|P1|Overall Study|Enrolled, not treated|1
30199|NCT01810783|135230|P1|Overall Study|Adminstrative or other reason(s)|23
30200|NCT01810783|135230|P1|Overall Study|Non-compliance with IMP|4
30201|NCT01810783|135230|P1|Overall Study|Protocol Violation|5
30202|NCT01810783|135230|P1|Overall Study|Lost to Follow-up|10
30203|NCT01810783|135230|P1|Overall Study|Lack of Efficacy|12
30204|NCT01810783|135230|P1|Overall Study|Withdrawal by Subject|22
30205|NCT01810783|135230|P1|Overall Study|Adverse Event|32
30206|NCT01810380|135258|P3|Overall Study|Administrative or other reasons|9
30207|NCT01810380|135259|P2|Overall Study|Administrative or other reasons|13
30208|NCT01810380|135260|P1|Overall Study|Administrative or other reasons|11
30209|NCT01810380|135258|P3|Overall Study|Withdrawal by Subject|6
30210|NCT01810380|135259|P2|Overall Study|Withdrawal by Subject|0
30211|NCT01810380|135260|P1|Overall Study|Withdrawal by Subject|6
30212|NCT01810380|135258|P3|Overall Study|Protocol Violation|1
30213|NCT01810380|135259|P2|Overall Study|Protocol Violation|0
30214|NCT01810380|135260|P1|Overall Study|Protocol Violation|1
30215|NCT01810380|135258|P3|Overall Study|Lack of Efficacy|11
30216|NCT01810380|135259|P2|Overall Study|Lack of Efficacy|10
30217|NCT01810380|135260|P1|Overall Study|Lack of Efficacy|24
30218|NCT01810380|135258|P3|Overall Study|Adverse Event|4
30219|NCT01810380|135259|P2|Overall Study|Adverse Event|14
30220|NCT01810380|135260|P1|Overall Study|Adverse Event|11
30221|NCT01810380|135258|P3|Overall Study|Randomised not treated|1
30222|NCT01810380|135259|P2|Overall Study|Randomised not treated|1
30223|NCT01810380|135260|P1|Overall Study|Randomised not treated|2
30224|NCT01810302|135321|P2|Overall Study|Physician Decision|1
30225|NCT01810302|135322|P1|Overall Study|Physician Decision|0
30226|NCT01810302|135321|P2|Overall Study|Death|0
30227|NCT01810302|135322|P1|Overall Study|Death|1
30228|NCT01810263|135341|P2|Overall Study|Lost to Follow-up|7
30229|NCT01810263|135342|P1|Overall Study|Lost to Follow-up|8
30230|NCT01810042|135348|P1|Overall Study|Lost to Follow-up|10
30231|NCT01809327|135414|P5|Overall Study|Other|9
30232|NCT01809327|135415|P4|Overall Study|Other|4
30233|NCT01809327|135416|P3|Overall Study|Other|7
30234|NCT01809327|135417|P2|Overall Study|Other|15
30235|NCT01809327|135418|P1|Overall Study|Other|14
30236|NCT01809327|135414|P5|Overall Study|Pregnancy|0
30237|NCT01809327|135415|P4|Overall Study|Pregnancy|0
30238|NCT01809327|135416|P3|Overall Study|Pregnancy|0
30239|NCT01809327|135417|P2|Overall Study|Pregnancy|0
30240|NCT01809327|135418|P1|Overall Study|Pregnancy|1
30241|NCT01809327|135414|P5|Overall Study|Physician Decision|0
30242|NCT01809327|135415|P4|Overall Study|Physician Decision|0
30243|NCT01809327|135416|P3|Overall Study|Physician Decision|0
30244|NCT01809327|135417|P2|Overall Study|Physician Decision|1
30245|NCT01809327|135418|P1|Overall Study|Physician Decision|1
30246|NCT01809327|135414|P5|Overall Study|Protocol Violation|0
30247|NCT01809327|135415|P4|Overall Study|Protocol Violation|0
30248|NCT01809327|135416|P3|Overall Study|Protocol Violation|0
30249|NCT01809327|135417|P2|Overall Study|Protocol Violation|1
30250|NCT01809327|135418|P1|Overall Study|Protocol Violation|0
30251|NCT01809327|135414|P5|Overall Study|Death|0
30252|NCT01809327|135415|P4|Overall Study|Death|0
30253|NCT01809327|135416|P3|Overall Study|Death|0
30254|NCT01809327|135417|P2|Overall Study|Death|0
30255|NCT01809327|135418|P1|Overall Study|Death|1
30256|NCT01809327|135414|P5|Overall Study|Adverse Event|8
30257|NCT01809327|135415|P4|Overall Study|Adverse Event|4
30258|NCT01809327|135416|P3|Overall Study|Adverse Event|7
30259|NCT01809327|135417|P2|Overall Study|Adverse Event|3
30260|NCT01809327|135418|P1|Overall Study|Adverse Event|4
30261|NCT01809327|135414|P5|Overall Study|Withdrawal by Subject|5
30262|NCT01809327|135415|P4|Overall Study|Withdrawal by Subject|2
30263|NCT01809327|135416|P3|Overall Study|Withdrawal by Subject|4
30264|NCT01809327|135417|P2|Overall Study|Withdrawal by Subject|4
30265|NCT01809327|135418|P1|Overall Study|Withdrawal by Subject|6
30266|NCT01809327|135414|P5|Overall Study|Lost to Follow-up|3
30267|NCT01809327|135415|P4|Overall Study|Lost to Follow-up|2
30268|NCT01809327|135416|P3|Overall Study|Lost to Follow-up|4
30269|NCT01809327|135417|P2|Overall Study|Lost to Follow-up|2
30270|NCT01809327|135418|P1|Overall Study|Lost to Follow-up|5
30271|NCT01809314|135460|P1|Overall Study|Lost to Follow-up|724
30272|NCT01809314|135460|P1|Overall Study|Insufficient Therapeutic Response|14
30273|NCT01809314|135460|P1|Overall Study|Adverse Event|6
30274|NCT01809314|135460|P1|Overall Study|Withdrawal Prior to Treatment|1
30275|NCT01809262|135466|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
30276|NCT01809262|135467|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
30277|NCT01809262|135468|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
30278|NCT01809262|135469|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
30279|NCT01809262|135470|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
30280|NCT01809262|135471|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
30281|NCT01809262|135472|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
30282|NCT01809262|135473|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
30283|NCT01809262|135474|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
30284|NCT01809262|135475|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
30285|NCT01809262|135466|P10|Period 1 (First Dose + Washout)|Adverse Event|0
30286|NCT01809262|135467|P9|Period 1 (First Dose + Washout)|Adverse Event|0
30287|NCT01809262|135468|P8|Period 1 (First Dose + Washout)|Adverse Event|0
30288|NCT01809262|135469|P7|Period 1 (First Dose + Washout)|Adverse Event|0
30289|NCT01809262|135470|P6|Period 1 (First Dose + Washout)|Adverse Event|0
30290|NCT01809262|135471|P5|Period 1 (First Dose + Washout)|Adverse Event|1
30291|NCT01809262|135472|P4|Period 1 (First Dose + Washout)|Adverse Event|0
30292|NCT01809262|135473|P3|Period 1 (First Dose + Washout)|Adverse Event|0
30293|NCT01809262|135474|P2|Period 1 (First Dose + Washout)|Adverse Event|0
30294|NCT01809262|135475|P1|Period 1 (First Dose + Washout)|Adverse Event|0
30295|NCT01809210|135549|P7|Overall Study|Death|1
30296|NCT01809210|135550|P6|Overall Study|Death|3
30297|NCT01809210|135551|P5|Overall Study|Death|1
30298|NCT01809210|135552|P4|Overall Study|Death|0
30299|NCT01809210|135553|P3|Overall Study|Death|2
30300|NCT01809210|135554|P2|Overall Study|Death|1
30301|NCT01809210|135555|P1|Overall Study|Death|1
30302|NCT01809210|135549|P7|Overall Study|Withdrawal by Subject|4
30303|NCT01809210|135550|P6|Overall Study|Withdrawal by Subject|0
30304|NCT01809210|135551|P5|Overall Study|Withdrawal by Subject|1
30305|NCT01809210|135552|P4|Overall Study|Withdrawal by Subject|1
30306|NCT01809210|135553|P3|Overall Study|Withdrawal by Subject|1
30307|NCT01809210|135554|P2|Overall Study|Withdrawal by Subject|0
30308|NCT01809210|135555|P1|Overall Study|Withdrawal by Subject|0
30309|NCT01809197|135629|P2|Overall Study|Product not available|1
30310|NCT01809197|135630|P1|Overall Study|Product not available|0
30311|NCT01809197|135629|P2|Overall Study|Withdrawal by Subject|1
30312|NCT01809197|135630|P1|Overall Study|Withdrawal by Subject|1
30313|NCT01809197|135629|P2|Overall Study|Decision Unrelated to an Adverse Event|0
30314|NCT01809197|135630|P1|Overall Study|Decision Unrelated to an Adverse Event|1
30315|NCT01809197|135629|P2|Overall Study|Non-Compliance|1
30316|NCT01809197|135630|P1|Overall Study|Non-Compliance|1
30317|NCT01809197|135629|P2|Overall Study|Failed slit lamp exam|0
30318|NCT01809197|135630|P1|Overall Study|Failed slit lamp exam|1
30319|NCT01809197|135629|P2|Overall Study|Adverse Event|3
30320|NCT01809197|135630|P1|Overall Study|Adverse Event|2
30321|NCT01809197|135629|P2|Overall Study|Lost to Follow-up|2
30322|NCT01809197|135630|P1|Overall Study|Lost to Follow-up|4
30323|NCT01808651|135701|P3|Study Period 1|Participant Decision|3
30324|NCT01808651|135702|P2|Study Period 1|Participant Decision|7
30325|NCT01808651|135703|P1|Study Period 1|Participant Decision|9
30326|NCT01808651|135701|P3|Study Period 1|Adverse Event|1
30327|NCT01808651|135702|P2|Study Period 1|Adverse Event|4
30328|NCT01808651|135703|P1|Study Period 1|Adverse Event|10
30329|NCT01808651|135701|P3|Study Period 1|Lack of Efficacy|0
30330|NCT01808651|135702|P2|Study Period 1|Lack of Efficacy|1
30331|NCT01808651|135703|P1|Study Period 1|Lack of Efficacy|2
30332|NCT01808651|135701|P3|Study Period 1|Physician Decision|0
30333|NCT01808651|135702|P2|Study Period 1|Physician Decision|2
30334|NCT01808651|135703|P1|Study Period 1|Physician Decision|3
30335|NCT01808651|135701|P3|Study Period 1|Protocol Violation|1
30336|NCT01808651|135702|P2|Study Period 1|Protocol Violation|0
30337|NCT01808651|135703|P1|Study Period 1|Protocol Violation|1
30338|NCT01808651|135701|P3|Study Period 1|Lost to Follow-up|0
30339|NCT01808651|135702|P2|Study Period 1|Lost to Follow-up|3
30340|NCT01808651|135703|P1|Study Period 1|Lost to Follow-up|1
30341|NCT01808612|135738|P3|Discontinuation Period|Lost to Follow-up|0
30342|NCT01808612|135739|P2|Discontinuation Period|Lost to Follow-up|1
30343|NCT01808612|135740|P1|Discontinuation Period|Lost to Follow-up|0
30344|NCT01808612|135738|P3|Discontinuation Period|Physician Decision|0
30345|NCT01808612|135739|P2|Discontinuation Period|Physician Decision|0
30346|NCT01808612|135740|P1|Discontinuation Period|Physician Decision|1
30347|NCT01808612|135738|P3|Discontinuation Period|Adverse Event|0
30348|NCT01808612|135739|P2|Discontinuation Period|Adverse Event|0
30349|NCT01808612|135740|P1|Discontinuation Period|Adverse Event|1
30350|NCT01808612|135738|P3|Treatment Period|Lack of Efficacy|2
30351|NCT01808612|135739|P2|Treatment Period|Lack of Efficacy|1
30352|NCT01808612|135740|P1|Treatment Period|Lack of Efficacy|1
30353|NCT01808612|135738|P3|Treatment Period|Sponsor Decision|0
30354|NCT01808612|135739|P2|Treatment Period|Sponsor Decision|0
30355|NCT01808612|135740|P1|Treatment Period|Sponsor Decision|1
30356|NCT01808612|135738|P3|Treatment Period|Physician Decision|4
30357|NCT01808612|135739|P2|Treatment Period|Physician Decision|0
30358|NCT01808612|135740|P1|Treatment Period|Physician Decision|1
30359|NCT01808612|135738|P3|Treatment Period|Withdrawal by Subject|4
30360|NCT01808612|135739|P2|Treatment Period|Withdrawal by Subject|0
30361|NCT01808612|135740|P1|Treatment Period|Withdrawal by Subject|1
30362|NCT01808612|135738|P3|Treatment Period|Protocol Violation|0
30363|NCT01808612|135739|P2|Treatment Period|Protocol Violation|0
30364|NCT01808612|135740|P1|Treatment Period|Protocol Violation|1
30365|NCT01808612|135738|P3|Treatment Period|Lost to Follow-up|1
30366|NCT01808612|135739|P2|Treatment Period|Lost to Follow-up|2
30367|NCT01808612|135740|P1|Treatment Period|Lost to Follow-up|2
30368|NCT01808612|135738|P3|Treatment Period|Adverse Event|3
30369|NCT01808612|135739|P2|Treatment Period|Adverse Event|4
30370|NCT01808612|135740|P1|Treatment Period|Adverse Event|8
30371|NCT01808534|135806|P1|Overall Study|Physician Decision|1
30372|NCT01808534|135806|P1|Overall Study|Disease progression|3
30373|NCT01808508|135817|P3|Overall Study|Lost to Follow-up|0
30374|NCT01808508|135818|P2|Overall Study|Lost to Follow-up|0
30375|NCT01808508|135819|P1|Overall Study|Lost to Follow-up|1
30376|NCT01808339|135836|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
30377|NCT01808339|135837|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
30378|NCT01808339|135838|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
30379|NCT01808339|135839|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
30380|NCT01808339|135840|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
30381|NCT01808339|135841|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
30382|NCT01808339|135836|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
30383|NCT01808339|135837|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
30384|NCT01808339|135838|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
30385|NCT01808339|135839|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
30386|NCT01808339|135840|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
30387|NCT01808339|135841|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
30388|NCT01808339|135836|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
30389|NCT01808339|135837|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
30390|NCT01808339|135838|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
30391|NCT01808339|135839|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
30392|NCT01808339|135840|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
30393|NCT01808339|135841|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
30394|NCT01808313|135885|P1|Overall Study|Physician Decision|1
30395|NCT01808313|135885|P1|Overall Study|Lost to Follow-up|1
30396|NCT01808313|135885|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
30397|NCT01808313|135885|P1|Overall Study|Protocol Violation|2
30398|NCT01808313|135885|P1|Overall Study|Adverse Event|5
30399|NCT01808261|135915|P2|Overall Study|Lost to Follow-up|1
30400|NCT01808261|135916|P1|Overall Study|Lost to Follow-up|3
30401|NCT01808261|135915|P2|Overall Study|Consent withdrawn by subject|7
30402|NCT01808261|135916|P1|Overall Study|Consent withdrawn by subject|6
30403|NCT01808261|135915|P2|Overall Study|Adverse event, non-fatal|0
30404|NCT01808261|135916|P1|Overall Study|Adverse event, non-fatal|2
30405|NCT01808261|135915|P2|Overall Study|Study Closed/Terminated|23
30406|NCT01808261|135916|P1|Overall Study|Study Closed/Terminated|25
30407|NCT01808261|135915|P2|Overall Study|Physician Decision|2
30408|NCT01808261|135916|P1|Overall Study|Physician Decision|0
30409|NCT01808248|135972|P1|Overall Study|Lost to Follow-up|1
30410|NCT01808248|135972|P1|Overall Study|Withdrawal by Subject|1
30411|NCT01808248|135972|P1|Overall Study|Lack of Efficacy|3
30412|NCT01808209|135986|P2|Overall Study|Lost to Follow-up|1
30413|NCT01808209|135987|P1|Overall Study|Lost to Follow-up|0
30414|NCT01808144|136031|P2|Overall Study|Adverse Event|15
30415|NCT01808144|136032|P1|Overall Study|Adverse Event|11
30416|NCT01808144|136031|P2|Overall Study|Gout flare|1
30417|NCT01808144|136032|P1|Overall Study|Gout flare|0
30418|NCT01808144|136031|P2|Overall Study|Protocol Violation|6
30419|NCT01808144|136032|P1|Overall Study|Protocol Violation|6
30420|NCT01808144|136031|P2|Overall Study|Lost to Follow-up|3
30421|NCT01808144|136032|P1|Overall Study|Lost to Follow-up|6
30422|NCT01808144|136031|P2|Overall Study|Withdrawal by Subject|23
30423|NCT01808144|136032|P1|Overall Study|Withdrawal by Subject|16
30424|NCT01808144|136031|P2|Overall Study|Death|0
30425|NCT01808144|136032|P1|Overall Study|Death|1
30426|NCT01808118|136040|P3|Period 2|Switched to other therapy|0
30427|NCT01808118|136041|P2|Period 2|Switched to other therapy|1
30428|NCT01808118|136042|P1|Period 2|Switched to other therapy|0
30429|NCT01808118|136040|P3|Period 2|Investigator no longer conducting trials|0
30430|NCT01808118|136041|P2|Period 2|Investigator no longer conducting trials|1
30431|NCT01808118|136042|P1|Period 2|Investigator no longer conducting trials|0
30432|NCT01808118|136040|P3|Period 2|Lost to Follow-up|2
30433|NCT01808118|136041|P2|Period 2|Lost to Follow-up|0
30434|NCT01808118|136042|P1|Period 2|Lost to Follow-up|0
30435|NCT01808118|136040|P3|Period 2|Withdrew consent|6
30436|NCT01808118|136041|P2|Period 2|Withdrew consent|7
30437|NCT01808118|136042|P1|Period 2|Withdrew consent|0
30438|NCT01808118|136040|P3|Period 2|Adverse Event|0
30439|NCT01808118|136041|P2|Period 2|Adverse Event|4
30440|NCT01808118|136042|P1|Period 2|Adverse Event|0
30441|NCT01808118|136040|P3|Period 1|Lack of Efficacy|0
30442|NCT01808118|136041|P2|Period 1|Lack of Efficacy|0
30443|NCT01808118|136042|P1|Period 1|Lack of Efficacy|1
30444|NCT01808118|136040|P3|Period 1|Non-compliance per sponsor|0
30445|NCT01808118|136041|P2|Period 1|Non-compliance per sponsor|0
30446|NCT01808118|136042|P1|Period 1|Non-compliance per sponsor|1
30447|NCT01808118|136040|P3|Period 1|Investigator decision: site closure|0
30448|NCT01808118|136041|P2|Period 1|Investigator decision: site closure|0
30449|NCT01808118|136042|P1|Period 1|Investigator decision: site closure|2
30450|NCT01808118|136040|P3|Period 1|Non-conformance with inclusion criteria|0
30451|NCT01808118|136041|P2|Period 1|Non-conformance with inclusion criteria|0
30452|NCT01808118|136042|P1|Period 1|Non-conformance with inclusion criteria|3
30453|NCT01808118|136040|P3|Period 1|Did not meet inclusion criteria|0
30454|NCT01808118|136041|P2|Period 1|Did not meet inclusion criteria|0
30455|NCT01808118|136042|P1|Period 1|Did not meet inclusion criteria|3
30456|NCT01808118|136040|P3|Period 1|Enrolled in error|0
30457|NCT01808118|136041|P2|Period 1|Enrolled in error|0
30458|NCT01808118|136042|P1|Period 1|Enrolled in error|7
30459|NCT01808118|136040|P3|Period 1|Did not meet criteria for remission|0
30460|NCT01808118|136041|P2|Period 1|Did not meet criteria for remission|0
30461|NCT01808118|136042|P1|Period 1|Did not meet criteria for remission|303
30462|NCT01808118|136040|P3|Period 1|Lost to Follow-up|0
30463|NCT01808118|136041|P2|Period 1|Lost to Follow-up|0
30464|NCT01808118|136042|P1|Period 1|Lost to Follow-up|9
30465|NCT01808118|136040|P3|Period 1|Withdrew consent|0
30466|NCT01808118|136041|P2|Period 1|Withdrew consent|0
30467|NCT01808118|136042|P1|Period 1|Withdrew consent|24
30468|NCT01808118|136040|P3|Period 1|Adverse Event|0
30469|NCT01808118|136041|P2|Period 1|Adverse Event|0
30470|NCT01808118|136042|P1|Period 1|Adverse Event|15
30471|NCT01808092|136105|P2|Overall Study|Other Eligibility criteria|5
30472|NCT01808092|136106|P1|Overall Study|Other Eligibility criteria|3
30473|NCT01808092|136105|P2|Overall Study|Withdrawal by Subject|4
30474|NCT01808092|136106|P1|Overall Study|Withdrawal by Subject|9
30475|NCT01808092|136105|P2|Overall Study|Lost to Follow-up|7
30476|NCT01808092|136106|P1|Overall Study|Lost to Follow-up|3
30477|NCT01808092|136105|P2|Overall Study|Death|29
30478|NCT01808092|136106|P1|Overall Study|Death|39
30479|NCT01808066|136208|P1|Overall Study|Withdrawal by Subject|15
30480|NCT01807949|136215|P3|Overall Study|Randomized But Not Treated|2
30481|NCT01807949|136216|P2|Overall Study|Randomized But Not Treated|2
30482|NCT01807949|136217|P1|Overall Study|Randomized But Not Treated|0
30483|NCT01807949|136215|P3|Overall Study|Undefined|2
30484|NCT01807949|136216|P2|Overall Study|Undefined|1
30485|NCT01807949|136217|P1|Overall Study|Undefined|0
30486|NCT01807949|136215|P3|Overall Study|Non-Compliance|1
30487|NCT01807949|136216|P2|Overall Study|Non-Compliance|0
30488|NCT01807949|136217|P1|Overall Study|Non-Compliance|0
30489|NCT01807949|136215|P3|Overall Study|Withdrawal by Subject|2
30490|NCT01807949|136216|P2|Overall Study|Withdrawal by Subject|2
30491|NCT01807949|136217|P1|Overall Study|Withdrawal by Subject|1
30492|NCT01807949|136215|P3|Overall Study|Adverse Event|2
30493|NCT01807949|136216|P2|Overall Study|Adverse Event|2
30494|NCT01807949|136217|P1|Overall Study|Adverse Event|1
30495|NCT01807923|136269|P3|Overall Study|Randomized But Not Treated|5
30496|NCT01807923|136270|P2|Overall Study|Randomized But Not Treated|2
30497|NCT01807923|136271|P1|Overall Study|Randomized But Not Treated|3
30498|NCT01807923|136269|P3|Overall Study|Not Eligible (Genotype)|1
30499|NCT01807923|136270|P2|Overall Study|Not Eligible (Genotype)|0
30500|NCT01807923|136271|P1|Overall Study|Not Eligible (Genotype)|0
30501|NCT01807923|136269|P3|Overall Study|Physician Decision|1
30502|NCT01807923|136270|P2|Overall Study|Physician Decision|0
30503|NCT01807923|136271|P1|Overall Study|Physician Decision|0
30504|NCT01807923|136269|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
30505|NCT01807923|136270|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
30506|NCT01807923|136271|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
30507|NCT01807923|136269|P3|Overall Study|Adverse Event|2
30508|NCT01807923|136270|P2|Overall Study|Adverse Event|1
30509|NCT01807923|136271|P1|Overall Study|Adverse Event|2
30510|NCT01807520|136352|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
30511|NCT01807520|136353|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
30512|NCT01807520|136354|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
30513|NCT01807520|136355|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
30514|NCT01807520|136356|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
30515|NCT01807520|136357|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
30516|NCT01807520|136358|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
30517|NCT01807520|136352|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
30518|NCT01807520|136353|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
30519|NCT01807520|136354|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
30520|NCT01807520|136355|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
30521|NCT01807520|136356|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
30522|NCT01807520|136357|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
30523|NCT01807520|136358|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
30524|NCT01807520|136352|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
30525|NCT01807520|136353|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
30526|NCT01807520|136354|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
30527|NCT01807520|136355|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
30528|NCT01807520|136356|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
30529|NCT01807520|136357|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
30530|NCT01807520|136358|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
30531|NCT01807520|136352|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
30532|NCT01807520|136353|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
30533|NCT01807520|136354|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
30534|NCT01807520|136355|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
30535|NCT01807520|136356|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
30536|NCT01807520|136357|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
30537|NCT01807520|136358|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
30538|NCT01807520|136352|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
30539|NCT01807520|136353|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
30540|NCT01807520|136354|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
30541|NCT01807520|136355|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
30542|NCT01807520|136356|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
30543|NCT01807520|136357|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
30544|NCT01807520|136358|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
30545|NCT01807520|136352|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
30546|NCT01807520|136353|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
30547|NCT01807520|136354|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
30548|NCT01807520|136355|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
30549|NCT01807520|136356|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
30550|NCT01807520|136357|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
30551|NCT01807520|136358|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
30552|NCT01807520|136352|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
30553|NCT01807520|136353|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
30554|NCT01807520|136354|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
30555|NCT01807520|136355|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
30556|NCT01807520|136356|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
30557|NCT01807520|136357|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
30558|NCT01807520|136358|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
30559|NCT01807520|136352|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
30560|NCT01807520|136353|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
30561|NCT01807520|136354|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
30562|NCT01807520|136355|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
30563|NCT01807520|136356|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
30564|NCT01807520|136357|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
30565|NCT01807520|136358|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
30566|NCT01807520|136352|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
30567|NCT01807520|136353|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
30568|NCT01807520|136354|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
30569|NCT01807520|136355|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
30570|NCT01807520|136356|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
30571|NCT01807520|136357|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
30572|NCT01807520|136358|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
30573|NCT01807520|136352|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
30574|NCT01807520|136353|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
30575|NCT01807520|136354|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
30576|NCT01807520|136355|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
30577|NCT01807520|136356|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
30578|NCT01807520|136357|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
30579|NCT01807520|136358|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
30580|NCT01807520|136352|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
30581|NCT01807520|136353|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
30582|NCT01807520|136354|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
30583|NCT01807520|136355|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
30584|NCT01807520|136356|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
30585|NCT01807520|136357|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
30586|NCT01807520|136358|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
30587|NCT01807520|136352|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
30588|NCT01807520|136353|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
30589|NCT01807520|136354|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
30590|NCT01807520|136355|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
30591|NCT01807520|136356|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
30592|NCT01807520|136357|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
30593|NCT01807520|136358|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
30594|NCT01807520|136352|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
30595|NCT01807520|136353|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
30596|NCT01807520|136354|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
30597|NCT01807520|136355|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
30598|NCT01807520|136356|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
30599|NCT01807520|136357|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
30600|NCT01807520|136358|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
30601|NCT01807520|136352|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
30602|NCT01807520|136353|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
30603|NCT01807520|136354|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
30604|NCT01807520|136355|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
30605|NCT01807520|136356|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
30606|NCT01807520|136357|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
30607|NCT01807520|136358|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
30608|NCT01807520|136352|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
30609|NCT01807520|136353|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
30610|NCT01807520|136354|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
30611|NCT01807520|136355|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
30612|NCT01807520|136356|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
30613|NCT01807520|136357|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
30614|NCT01807520|136358|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
30615|NCT01807520|136352|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
30616|NCT01807520|136353|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
30617|NCT01807520|136354|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
30618|NCT01807520|136355|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
30619|NCT01807520|136356|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
30620|NCT01807520|136357|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
30621|NCT01807520|136358|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
30622|NCT01807520|136352|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
30623|NCT01807520|136353|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
30624|NCT01807520|136354|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
30625|NCT01807520|136355|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
30626|NCT01807520|136356|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
30627|NCT01807520|136357|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
30628|NCT01807520|136358|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
30629|NCT01807234|136391|P6|Overall Study|Lack of Efficacy|1
30630|NCT01807234|136392|P5|Overall Study|Lack of Efficacy|1
30631|NCT01807234|136393|P4|Overall Study|Lack of Efficacy|0
30632|NCT01807234|136394|P3|Overall Study|Lack of Efficacy|0
30633|NCT01807234|136395|P2|Overall Study|Lack of Efficacy|0
30634|NCT01807234|136396|P1|Overall Study|Lack of Efficacy|0
30635|NCT01807234|136391|P6|Overall Study|Withdrawal by Subject|1
30636|NCT01807234|136392|P5|Overall Study|Withdrawal by Subject|2
30637|NCT01807234|136393|P4|Overall Study|Withdrawal by Subject|1
30638|NCT01807234|136394|P3|Overall Study|Withdrawal by Subject|1
30639|NCT01807234|136395|P2|Overall Study|Withdrawal by Subject|1
30640|NCT01807234|136396|P1|Overall Study|Withdrawal by Subject|3
30641|NCT01807234|136391|P6|Overall Study|Lost to Follow-up|2
30642|NCT01807234|136392|P5|Overall Study|Lost to Follow-up|1
30643|NCT01807234|136393|P4|Overall Study|Lost to Follow-up|1
30644|NCT01807234|136394|P3|Overall Study|Lost to Follow-up|1
30645|NCT01807234|136395|P2|Overall Study|Lost to Follow-up|5
30646|NCT01807234|136396|P1|Overall Study|Lost to Follow-up|2
30647|NCT01807156|136431|P1|Overall Study|Physician Decision|1
30648|NCT01806961|136455|P1|Overall Study|sponsor decision|16
30649|NCT01806896|136461|P2|Overall Study|Other|0
30650|NCT01806896|136462|P1|Overall Study|Other|1
30651|NCT01806896|136461|P2|Overall Study|Adverse Event|0
30652|NCT01806896|136462|P1|Overall Study|Adverse Event|2
30653|NCT01806779|136529|P3|Overall Study|Withdrawal by Subject|22
30654|NCT01806779|136530|P2|Overall Study|Withdrawal by Subject|23
30655|NCT01806779|136531|P1|Overall Study|Withdrawal by Subject|20
30656|NCT01806779|136529|P3|Overall Study|Lost to Follow-up|0
30657|NCT01806779|136530|P2|Overall Study|Lost to Follow-up|20
30658|NCT01806779|136531|P1|Overall Study|Lost to Follow-up|19
30659|NCT01806779|136529|P3|Overall Study|Lack of Efficacy|0
30660|NCT01806779|136530|P2|Overall Study|Lack of Efficacy|1
30661|NCT01806779|136531|P1|Overall Study|Lack of Efficacy|1
30662|NCT01806779|136529|P3|Overall Study|Physician Decision|1
30663|NCT01806779|136530|P2|Overall Study|Physician Decision|0
30664|NCT01806779|136531|P1|Overall Study|Physician Decision|2
30665|NCT01806714|136546|P2|Overall Study|No functioning phone number|170
30666|NCT01806714|136547|P1|Overall Study|No functioning phone number|200
30667|NCT01806662|136557|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
30668|NCT01806662|136558|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
30669|NCT01806662|136557|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
30670|NCT01806662|136558|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
30671|NCT01806662|136557|P2|First Intervention (Weeks 0-16)|Adverse Event|1
30672|NCT01806662|136558|P1|First Intervention (Weeks 0-16)|Adverse Event|0
30673|NCT01806662|136557|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
30674|NCT01806662|136558|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
30675|NCT01806623|136564|P1|Overall Study|Did not meet the inclusion criteria|56
30676|NCT01806623|136564|P1|Overall Study|Adverse Event|1
30677|NCT01806623|136564|P1|Overall Study|Withdrawal by Subject|1
30678|NCT01806597|136584|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
30679|NCT01806597|136585|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
30680|NCT01806597|136586|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
30681|NCT01806597|136587|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
30682|NCT01806597|136588|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
30683|NCT01806597|136589|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
30684|NCT01806597|136584|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
30685|NCT01806597|136585|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
30686|NCT01806597|136586|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
30687|NCT01806597|136587|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
30688|NCT01806597|136588|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
30689|NCT01806597|136589|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
30690|NCT01806597|136584|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
30691|NCT01806597|136585|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
30692|NCT01806597|136586|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
30693|NCT01806597|136587|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
30694|NCT01806597|136588|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
30695|NCT01806597|136589|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
30696|NCT01806597|136584|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
30697|NCT01806597|136585|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
30698|NCT01806597|136586|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
30699|NCT01806597|136587|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
30700|NCT01806597|136588|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
30701|NCT01806597|136589|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
30702|NCT01806597|136584|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
30703|NCT01806597|136585|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
30704|NCT01806597|136586|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
30705|NCT01806597|136587|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
30706|NCT01806597|136588|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
30707|NCT01806597|136589|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
30708|NCT01806597|136584|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
30709|NCT01806597|136585|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
30710|NCT01806597|136586|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
30711|NCT01806597|136587|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
30712|NCT01806597|136588|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
30713|NCT01806597|136589|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
30714|NCT01806597|136584|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
30715|NCT01806597|136585|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
30716|NCT01806597|136586|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
30717|NCT01806597|136587|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
30718|NCT01806597|136588|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
30719|NCT01806597|136589|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
30720|NCT01806597|136584|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
30721|NCT01806597|136585|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
30722|NCT01806597|136586|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
30723|NCT01806597|136587|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
30724|NCT01806597|136588|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
30725|NCT01806597|136589|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
30726|NCT01806597|136584|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
30727|NCT01806597|136585|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
30728|NCT01806597|136586|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
30729|NCT01806597|136587|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
30730|NCT01806597|136588|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
30731|NCT01806597|136589|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
30732|NCT01806597|136584|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
30733|NCT01806597|136585|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
30734|NCT01806597|136586|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
30735|NCT01806597|136587|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
30736|NCT01806597|136588|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
30737|NCT01806597|136589|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
30738|NCT01806597|136584|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
30739|NCT01806597|136585|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
30740|NCT01806597|136586|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
30741|NCT01806597|136587|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
30742|NCT01806597|136588|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
30743|NCT01806597|136589|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
30744|NCT01806597|136584|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
30745|NCT01806597|136585|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
30746|NCT01806597|136586|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
30747|NCT01806597|136587|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
30748|NCT01806597|136588|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
30749|NCT01806597|136589|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
30750|NCT01806597|136584|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
30751|NCT01806597|136585|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
30752|NCT01806597|136586|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
30753|NCT01806597|136587|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
30754|NCT01806597|136588|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
30755|NCT01806597|136589|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
30756|NCT01806597|136584|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
30757|NCT01806597|136585|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
30758|NCT01806597|136586|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
30759|NCT01806597|136587|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
30760|NCT01806597|136588|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
30761|NCT01806597|136589|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
30762|NCT01806597|136584|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
30763|NCT01806597|136585|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
30764|NCT01806597|136586|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
30765|NCT01806597|136587|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
30766|NCT01806597|136588|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
30767|NCT01806597|136589|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
30768|NCT01806597|136584|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
30769|NCT01806597|136585|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
30770|NCT01806597|136586|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
30771|NCT01806597|136587|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
30772|NCT01806597|136588|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
30773|NCT01806597|136589|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
30774|NCT01806597|136584|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
30775|NCT01806597|136585|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
30776|NCT01806597|136586|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
30777|NCT01806597|136587|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
30778|NCT01806597|136588|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
30779|NCT01806597|136589|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
30780|NCT01806597|136584|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
30781|NCT01806597|136585|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
30782|NCT01806597|136586|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
30783|NCT01806597|136587|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
30784|NCT01806597|136588|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
30785|NCT01806597|136589|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
30786|NCT01806597|136584|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
30787|NCT01806597|136585|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
30788|NCT01806597|136586|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
30789|NCT01806597|136587|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
30790|NCT01806597|136588|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
30791|NCT01806597|136589|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
30792|NCT01806584|136625|P2|Overall Study|Other unspecified|0
30793|NCT01806584|136626|P1|Overall Study|Other unspecified|1
30794|NCT01806584|136625|P2|Overall Study|Withdrawal by Subject|1
30795|NCT01806584|136626|P1|Overall Study|Withdrawal by Subject|1
30796|NCT01806584|136625|P2|Overall Study|Study terminated by sponsor|14
30797|NCT01806584|136626|P1|Overall Study|Study terminated by sponsor|9
30798|NCT01806584|136625|P2|Overall Study|Lost to Follow-up|2
30799|NCT01806584|136626|P1|Overall Study|Lost to Follow-up|0
30800|NCT01806584|136625|P2|Overall Study|Death|0
30801|NCT01806584|136626|P1|Overall Study|Death|1
30802|NCT01806584|136625|P2|Overall Study|Adverse Event|1
30803|NCT01806584|136626|P1|Overall Study|Adverse Event|2
30804|NCT01806545|136640|P2|Overall Study|Withdrawal by Subject|2
30805|NCT01806545|136641|P1|Overall Study|Withdrawal by Subject|3
30806|NCT01806545|136640|P2|Overall Study|Lost to Follow-up|0
30807|NCT01806545|136641|P1|Overall Study|Lost to Follow-up|1
30808|NCT01806545|136640|P2|Overall Study|Adverse Event|3
30809|NCT01806545|136641|P1|Overall Study|Adverse Event|2
30810|NCT01806389|136663|P1|Overall Study|Withdrawal by Subject|4
30811|NCT01806298|136677|P1|Overall Study|Other|5
30812|NCT01806298|136677|P1|Overall Study|Withdrawal by Subject|1
30813|NCT01806298|136677|P1|Overall Study|Protocol Non-compliance|1
30814|NCT01806298|136677|P1|Overall Study|Adverse Event|3
30815|NCT01806051|136687|P1|Overall Study|Withdrawal by Subject|6
30816|NCT01805180|136785|P3|Lead-in Donor Phase|screen failure|0
30817|NCT01805180|136786|P2|Lead-in Donor Phase|screen failure|0
30818|NCT01805180|136787|P1|Lead-in Donor Phase|screen failure|1
30819|NCT01804946|136825|P2|Overall Study|Do not meet inclusion criteria|2
30820|NCT01804946|136826|P1|Overall Study|Do not meet inclusion criteria|1
30821|NCT01804946|136825|P2|Overall Study|Insufficient data available|1
30822|NCT01804946|136826|P1|Overall Study|Insufficient data available|0
30823|NCT01804946|136825|P2|Overall Study|Adverse Event|1
30824|NCT01804946|136826|P1|Overall Study|Adverse Event|0
30825|NCT01804946|136825|P2|Overall Study|Protocol Violation|0
30826|NCT01804946|136826|P1|Overall Study|Protocol Violation|1
30827|NCT01804842|136864|P3|Overall Study|Personal Reason|1
30828|NCT01804842|136865|P2|Overall Study|Personal Reason|0
30829|NCT01804842|136866|P1|Overall Study|Personal Reason|0
30830|NCT01804842|136864|P3|Overall Study|Non-Compliance|0
30831|NCT01804842|136865|P2|Overall Study|Non-Compliance|1
30832|NCT01804842|136866|P1|Overall Study|Non-Compliance|1
30833|NCT01804842|136864|P3|Overall Study|Lost to Follow-up|0
30834|NCT01804842|136865|P2|Overall Study|Lost to Follow-up|0
30835|NCT01804842|136866|P1|Overall Study|Lost to Follow-up|1
30836|NCT01804842|136864|P3|Overall Study|Adverse Event|0
30837|NCT01804842|136865|P2|Overall Study|Adverse Event|1
30838|NCT01804842|136866|P1|Overall Study|Adverse Event|1
30839|NCT01804673|136883|P1|Overall Study|Other|4
30840|NCT01804673|136883|P1|Overall Study|Use of Prohibited Medication|1
30841|NCT01804673|136883|P1|Overall Study|No Further Therapy Required|84
30842|NCT01804673|136883|P1|Overall Study|Change to Oral Therapy|37
30843|NCT01804673|136883|P1|Overall Study|Lack of Efficacy|9
30844|NCT01804673|136883|P1|Overall Study|Withdrawal by Subject|1
30845|NCT01804673|136883|P1|Overall Study|Adverse Event|4
30846|NCT01804140|136903|P1|Overall Study|No sampling or biopsy procedures done|114
30847|NCT01803737|136972|P2|Overall Study|Lost to Follow-up|2
30848|NCT01803737|136973|P1|Overall Study|Lost to Follow-up|0
30849|NCT01803737|136972|P2|Overall Study|Medical Reason|1
30850|NCT01803737|136973|P1|Overall Study|Medical Reason|0
30851|NCT01803737|136972|P2|Overall Study|Lack of Time|0
30852|NCT01803737|136973|P1|Overall Study|Lack of Time|1
30853|NCT01803711|136997|P2|Overall Study|Adverse Event|1
30854|NCT01803711|136998|P1|Overall Study|Adverse Event|1
30855|NCT01803646|137016|P2|Overall Study|Lost to Follow-up|1
30856|NCT01803646|137017|P1|Overall Study|Lost to Follow-up|5
30857|NCT01803646|137016|P2|Overall Study|Randomization error|2
30858|NCT01803646|137017|P1|Overall Study|Randomization error|1
30859|NCT01803646|137016|P2|Overall Study|Withdrawal by Subject|6
30860|NCT01803646|137017|P1|Overall Study|Withdrawal by Subject|9
30861|NCT01803646|137016|P2|Overall Study|Adverse Event|1
30862|NCT01803646|137017|P1|Overall Study|Adverse Event|1
30863|NCT01803646|137016|P2|Overall Study|Protocol Violation|0
30864|NCT01803646|137017|P1|Overall Study|Protocol Violation|1
30865|NCT01803607|137029|P2|Overall Study|Withdrawal by Subject|5
30866|NCT01803607|137030|P1|Overall Study|Withdrawal by Subject|6
30867|NCT01803607|137029|P2|Overall Study|Study terminated by sponsor|56
30868|NCT01803607|137030|P1|Overall Study|Study terminated by sponsor|54
30869|NCT01803607|137029|P2|Overall Study|Protocol Violation|2
30870|NCT01803607|137030|P1|Overall Study|Protocol Violation|3
30871|NCT01803607|137029|P2|Overall Study|Lack of Efficacy|1
30872|NCT01803607|137030|P1|Overall Study|Lack of Efficacy|0
30873|NCT01803607|137029|P2|Overall Study|Adverse Event|3
30874|NCT01803607|137030|P1|Overall Study|Adverse Event|5
30875|NCT01803464|137054|P4|Overall Study|Withdrawal by Subject|0
30876|NCT01803464|137055|P3|Overall Study|Withdrawal by Subject|0
30877|NCT01803464|137056|P2|Overall Study|Withdrawal by Subject|0
30878|NCT01803464|137057|P1|Overall Study|Withdrawal by Subject|1
30879|NCT01803464|137054|P4|Overall Study|Incomplete data|0
30880|NCT01803464|137055|P3|Overall Study|Incomplete data|4
30881|NCT01803464|137056|P2|Overall Study|Incomplete data|0
30882|NCT01803464|137057|P1|Overall Study|Incomplete data|0
30883|NCT01802775|137077|P2|Overall Study|Lost to Follow-up|2
30884|NCT01802775|137078|P1|Overall Study|Lost to Follow-up|1
30885|NCT01802775|137077|P2|Overall Study|Withdrawal by Subject|5
30886|NCT01802775|137078|P1|Overall Study|Withdrawal by Subject|3
30887|NCT01802775|137077|P2|Overall Study|Adverse Event|1
30888|NCT01802775|137078|P1|Overall Study|Adverse Event|1
30889|NCT01802775|137077|P2|Overall Study|Physician Decision|0
30890|NCT01802775|137078|P1|Overall Study|Physician Decision|1
30891|NCT01802775|137077|P2|Overall Study|Reason not provided|1
30892|NCT01802775|137078|P1|Overall Study|Reason not provided|0
30893|NCT01802775|137077|P2|Overall Study|Death|3
30894|NCT01802775|137078|P1|Overall Study|Death|0
30895|NCT01802632|137100|P6|Overall Study|Other (not specified)|1
30896|NCT01802632|137101|P5|Overall Study|Other (not specified)|0
30897|NCT01802632|137102|P4|Overall Study|Other (not specified)|1
30898|NCT01802632|137103|P3|Overall Study|Other (not specified)|7
30899|NCT01802632|137104|P2|Overall Study|Other (not specified)|0
30900|NCT01802632|137105|P1|Overall Study|Other (not specified)|0
30901|NCT01802632|137100|P6|Overall Study|Ongoing Study at Data Cut-off|22
30902|NCT01802632|137101|P5|Overall Study|Ongoing Study at Data Cut-off|6
30903|NCT01802632|137102|P4|Overall Study|Ongoing Study at Data Cut-off|50
30904|NCT01802632|137103|P3|Overall Study|Ongoing Study at Data Cut-off|115
30905|NCT01802632|137104|P2|Overall Study|Ongoing Study at Data Cut-off|16
30906|NCT01802632|137105|P1|Overall Study|Ongoing Study at Data Cut-off|168
30907|NCT01802632|137100|P6|Overall Study|Objective Disease Progression|4
30908|NCT01802632|137101|P5|Overall Study|Objective Disease Progression|4
30909|NCT01802632|137102|P4|Overall Study|Objective Disease Progression|6
30910|NCT01802632|137103|P3|Overall Study|Objective Disease Progression|104
30911|NCT01802632|137104|P2|Overall Study|Objective Disease Progression|12
30912|NCT01802632|137105|P1|Overall Study|Objective Disease Progression|1
30913|NCT01802632|137100|P6|Overall Study|Withdrawal by Subject|1
30914|NCT01802632|137101|P5|Overall Study|Withdrawal by Subject|0
30915|NCT01802632|137102|P4|Overall Study|Withdrawal by Subject|3
30916|NCT01802632|137103|P3|Overall Study|Withdrawal by Subject|7
30917|NCT01802632|137104|P2|Overall Study|Withdrawal by Subject|2
30918|NCT01802632|137105|P1|Overall Study|Withdrawal by Subject|4
30919|NCT01802632|137100|P6|Overall Study|Death|0
30920|NCT01802632|137101|P5|Overall Study|Death|2
30921|NCT01802632|137102|P4|Overall Study|Death|0
30922|NCT01802632|137103|P3|Overall Study|Death|38
30923|NCT01802632|137104|P2|Overall Study|Death|1
30924|NCT01802632|137105|P1|Overall Study|Death|28
30925|NCT01802515|137139|P3|Overall Study|Withdrawal by Subject|0
30926|NCT01802515|137140|P2|Overall Study|Withdrawal by Subject|0
30927|NCT01802515|137141|P1|Overall Study|Withdrawal by Subject|3
30928|NCT01802320|137152|P1|Overall Study|Withdrawal by Subject|1
30929|NCT01802320|137152|P1|Overall Study|Death|1
30930|NCT01801982|137226|P1|Overall Study|Lost to Follow-up|1
30931|NCT01801917|137240|P4|Period 1 - Randomized|Adverse Event|0
30932|NCT01801917|137241|P3|Period 1 - Randomized|Adverse Event|1
30933|NCT01801917|137242|P2|Period 1 - Randomized|Adverse Event|0
30934|NCT01801917|137243|P1|Period 1 - Randomized|Adverse Event|1
30935|NCT01801735|137263|P1|Overall Study|Other, including site closure|19
30936|NCT01801735|137263|P1|Overall Study|Death|1
30937|NCT01801735|137263|P1|Overall Study|Physician Decision|3
30938|NCT01801735|137263|P1|Overall Study|Non-compliance with Trial Drug|13
30939|NCT01801735|137263|P1|Overall Study|Lost to Follow-up|15
30940|NCT01801735|137263|P1|Overall Study|Protocol Violation|25
30941|NCT01801735|137263|P1|Overall Study|Withdrawal by Subject|27
30942|NCT01801735|137263|P1|Overall Study|Lack of Efficacy|28
30943|NCT01801735|137263|P1|Overall Study|Adverse Event|79
30944|NCT01801475|137270|P5|Overall Study|Withdrawal by Subject|1
30945|NCT01801475|137271|P4|Overall Study|Withdrawal by Subject|0
30946|NCT01801475|137272|P3|Overall Study|Withdrawal by Subject|0
30947|NCT01801475|137273|P2|Overall Study|Withdrawal by Subject|0
30948|NCT01801475|137274|P1|Overall Study|Withdrawal by Subject|0
30949|NCT01801436|137299|P1|Overall Study|Progressive disease|4
30950|NCT01801436|137299|P1|Overall Study|Adverse Event|2
30951|NCT01801436|137299|P1|Overall Study|Withdrawal by Subject|3
30952|NCT01801358|137337|P6|Overall Study|Withdrawal by Subject|2
30953|NCT01801358|137338|P5|Overall Study|Withdrawal by Subject|0
30954|NCT01801358|137339|P4|Overall Study|Withdrawal by Subject|1
30955|NCT01801358|137340|P3|Overall Study|Withdrawal by Subject|0
30956|NCT01801358|137341|P2|Overall Study|Withdrawal by Subject|0
30957|NCT01801358|137342|P1|Overall Study|Withdrawal by Subject|0
30958|NCT01801358|137337|P6|Overall Study|Progressive Disease|5
30959|NCT01801358|137338|P5|Overall Study|Progressive Disease|6
30960|NCT01801358|137339|P4|Overall Study|Progressive Disease|5
30961|NCT01801358|137340|P3|Overall Study|Progressive Disease|4
30962|NCT01801358|137341|P2|Overall Study|Progressive Disease|4
30963|NCT01801358|137342|P1|Overall Study|Progressive Disease|6
30964|NCT01801358|137337|P6|Overall Study|Physician Decision|0
30965|NCT01801358|137338|P5|Overall Study|Physician Decision|0
30966|NCT01801358|137339|P4|Overall Study|Physician Decision|0
30967|NCT01801358|137340|P3|Overall Study|Physician Decision|1
30968|NCT01801358|137341|P2|Overall Study|Physician Decision|0
30969|NCT01801358|137342|P1|Overall Study|Physician Decision|0
30970|NCT01801358|137337|P6|Overall Study|Adverse Event|1
30971|NCT01801358|137338|P5|Overall Study|Adverse Event|0
30972|NCT01801358|137339|P4|Overall Study|Adverse Event|0
30973|NCT01801358|137340|P3|Overall Study|Adverse Event|1
30974|NCT01801358|137341|P2|Overall Study|Adverse Event|2
30975|NCT01801358|137342|P1|Overall Study|Adverse Event|0
30976|NCT01801280|137464|P4|Period 4|Protocol Violation|0
30977|NCT01801280|137465|P3|Period 4|Protocol Violation|1
30978|NCT01801280|137466|P2|Period 4|Protocol Violation|0
30979|NCT01801280|137467|P1|Period 4|Protocol Violation|0
30980|NCT01801280|137464|P4|Period 2|Withdrawal by Subject|0
30981|NCT01801280|137465|P3|Period 2|Withdrawal by Subject|0
30982|NCT01801280|137466|P2|Period 2|Withdrawal by Subject|0
30983|NCT01801280|137467|P1|Period 2|Withdrawal by Subject|1
30984|NCT01801280|137464|P4|Period 1|Withdrawal by Subject|0
30985|NCT01801280|137465|P3|Period 1|Withdrawal by Subject|0
30986|NCT01801280|137466|P2|Period 1|Withdrawal by Subject|1
30987|NCT01801280|137467|P1|Period 1|Withdrawal by Subject|0
30988|NCT01801111|137482|P1|Overall Study|On-going Survival Follow up|25
30989|NCT01801111|137482|P1|Overall Study|Death|24
30990|NCT01801111|137482|P1|Overall Study|Treatment On-going|89
30991|NCT01800968|137507|P2|Overall Study|Physician Decision|0
30992|NCT01800968|137508|P1|Overall Study|Physician Decision|1
30993|NCT01800968|137507|P2|Overall Study|Withdrawal by Subject|9
30994|NCT01800968|137508|P1|Overall Study|Withdrawal by Subject|7
30995|NCT01800968|137507|P2|Overall Study|Lost to Follow-up|7
30996|NCT01800968|137508|P1|Overall Study|Lost to Follow-up|5
30997|NCT01800968|137507|P2|Overall Study|Death|16
30998|NCT01800968|137508|P1|Overall Study|Death|23
30999|NCT01800916|137550|P9|Test Period 1 (1 Week)|Adverse Event|0
31000|NCT01800916|137551|P8|Test Period 1 (1 Week)|Adverse Event|0
31001|NCT01800916|137552|P7|Test Period 1 (1 Week)|Adverse Event|0
31002|NCT01800916|137553|P6|Test Period 1 (1 Week)|Adverse Event|0
31003|NCT01800916|137554|P5|Test Period 1 (1 Week)|Adverse Event|1
31004|NCT01800916|137555|P4|Test Period 1 (1 Week)|Adverse Event|0
31005|NCT01800916|137556|P3|Test Period 1 (1 Week)|Adverse Event|0
31006|NCT01800916|137557|P2|Test Period 1 (1 Week)|Adverse Event|0
31007|NCT01800916|137558|P1|Test Period 1 (1 Week)|Adverse Event|0
31008|NCT01800916|137550|P9|Test Period 1 (1 Week)|Convex product user|0
31009|NCT01800916|137551|P8|Test Period 1 (1 Week)|Convex product user|0
31010|NCT01800916|137552|P7|Test Period 1 (1 Week)|Convex product user|0
31011|NCT01800916|137553|P6|Test Period 1 (1 Week)|Convex product user|0
31012|NCT01800916|137554|P5|Test Period 1 (1 Week)|Convex product user|0
31013|NCT01800916|137555|P4|Test Period 1 (1 Week)|Convex product user|1
31014|NCT01800916|137556|P3|Test Period 1 (1 Week)|Convex product user|0
31015|NCT01800916|137557|P2|Test Period 1 (1 Week)|Convex product user|0
31016|NCT01800916|137558|P1|Test Period 1 (1 Week)|Convex product user|0
31017|NCT01800903|137568|P6|Second Test Period|unable to catheterise|0
31018|NCT01800903|137569|P5|Second Test Period|unable to catheterise|0
31019|NCT01800903|137570|P4|Second Test Period|unable to catheterise|0
31020|NCT01800903|137571|P3|Second Test Period|unable to catheterise|0
31021|NCT01800903|137572|P2|Second Test Period|unable to catheterise|0
31022|NCT01800903|137573|P1|Second Test Period|unable to catheterise|1
31023|NCT01799941|137668|P1|Overall Study|Not Specified|15
31024|NCT01799941|137668|P1|Overall Study|Lost to Follow-up|17
31025|NCT01799941|137668|P1|Overall Study|Lack of Efficacy|3
31026|NCT01799941|137668|P1|Overall Study|Investigator Decision|4
31027|NCT01799941|137668|P1|Overall Study|Death|2
31028|NCT01799941|137668|P1|Overall Study|Withdrawal by Subject|21
31029|NCT01799941|137668|P1|Overall Study|Adverse Event|34
31030|NCT01799720|137725|P3|Overall Study|Pregnancy|1
31031|NCT01799720|137726|P2|Overall Study|Pregnancy|0
31032|NCT01799720|137727|P1|Overall Study|Pregnancy|0
31033|NCT01799720|137725|P3|Overall Study|Protocol Violation|0
31034|NCT01799720|137726|P2|Overall Study|Protocol Violation|1
31035|NCT01799720|137727|P1|Overall Study|Protocol Violation|0
31036|NCT01799720|137725|P3|Overall Study|Withdrawal by Subject|0
31037|NCT01799720|137726|P2|Overall Study|Withdrawal by Subject|0
31038|NCT01799720|137727|P1|Overall Study|Withdrawal by Subject|3
31039|NCT01799590|137765|P3|Overall Study|Other|1
31040|NCT01799590|137766|P2|Overall Study|Other|0
31041|NCT01799590|137767|P1|Overall Study|Other|3
31042|NCT01799590|137765|P3|Overall Study|Use of prohibited concomitant drugs|0
31043|NCT01799590|137766|P2|Overall Study|Use of prohibited concomitant drugs|0
31044|NCT01799590|137767|P1|Overall Study|Use of prohibited concomitant drugs|1
31045|NCT01799590|137765|P3|Overall Study|Using drugs with restricted days of use|2
31046|NCT01799590|137766|P2|Overall Study|Using drugs with restricted days of use|3
31047|NCT01799590|137767|P1|Overall Study|Using drugs with restricted days of use|0
31048|NCT01799590|137765|P3|Overall Study|Aggravation of complications|1
31049|NCT01799590|137766|P2|Overall Study|Aggravation of complications|1
31050|NCT01799590|137767|P1|Overall Study|Aggravation of complications|0
31051|NCT01799590|137765|P3|Overall Study|Participants convenience|2
31052|NCT01799590|137766|P2|Overall Study|Participants convenience|4
31053|NCT01799590|137767|P1|Overall Study|Participants convenience|4
31054|NCT01799590|137765|P3|Overall Study|Lack of Efficacy|3
31055|NCT01799590|137766|P2|Overall Study|Lack of Efficacy|1
31056|NCT01799590|137767|P1|Overall Study|Lack of Efficacy|3
31057|NCT01799590|137765|P3|Overall Study|Pregnancy|0
31058|NCT01799590|137766|P2|Overall Study|Pregnancy|0
31059|NCT01799590|137767|P1|Overall Study|Pregnancy|2
31060|NCT01799590|137765|P3|Overall Study|Adverse Event|5
31061|NCT01799590|137766|P2|Overall Study|Adverse Event|7
31062|NCT01799590|137767|P1|Overall Study|Adverse Event|13
31063|NCT01799239|137810|P2|Period 2 (7 Days)|Protocol Violation|0
31064|NCT01799239|137811|P1|Period 2 (7 Days)|Protocol Violation|1
31065|NCT01799239|137810|P2|Period 2 (7 Days)|Withdrawal by Subject|1
31066|NCT01799239|137811|P1|Period 2 (7 Days)|Withdrawal by Subject|1
31067|NCT01799239|137810|P2|Period 1 (7 Days)|Protocol Violation|1
31068|NCT01799239|137811|P1|Period 1 (7 Days)|Protocol Violation|0
31069|NCT01799239|137810|P2|Period 1 (7 Days)|Withdrawal by Subject|0
31070|NCT01799239|137811|P1|Period 1 (7 Days)|Withdrawal by Subject|2
31071|NCT01799239|137810|P2|Period 1 (7 Days)|Lack of Efficacy|0
31072|NCT01799239|137811|P1|Period 1 (7 Days)|Lack of Efficacy|1
31073|NCT01799226|137819|P2|Overall Study|Disqualified at Day 14|0
31074|NCT01799226|137820|P1|Overall Study|Disqualified at Day 14|1
31075|NCT01799226|137819|P2|Overall Study|Withdrawal by Subject|0
31076|NCT01799226|137820|P1|Overall Study|Withdrawal by Subject|1
31077|NCT01798992|137832|P4|Overall Study|Insufficient biopsy tissue|0
31078|NCT01798992|137833|P3|Overall Study|Insufficient biopsy tissue|1
31079|NCT01798992|137834|P2|Overall Study|Insufficient biopsy tissue|0
31080|NCT01798992|137835|P1|Overall Study|Insufficient biopsy tissue|0
31081|NCT01798992|137832|P4|Overall Study|Lost to Follow-up|0
31082|NCT01798992|137833|P3|Overall Study|Lost to Follow-up|1
31083|NCT01798992|137834|P2|Overall Study|Lost to Follow-up|1
31084|NCT01798992|137835|P1|Overall Study|Lost to Follow-up|0
31085|NCT01798992|137832|P4|Overall Study|Administrative withdrawal|1
31086|NCT01798992|137833|P3|Overall Study|Administrative withdrawal|0
31087|NCT01798992|137834|P2|Overall Study|Administrative withdrawal|1
31088|NCT01798992|137835|P1|Overall Study|Administrative withdrawal|0
31089|NCT01798927|137855|P1|Overall Study|Withdrawal by Subject|1
31090|NCT01798706|137863|P2|Overall Study|Other than specified above|9
31091|NCT01798706|137864|P1|Overall Study|Other than specified above|5
31092|NCT01798706|137863|P2|Overall Study|Poor compliance to protocol|0
31093|NCT01798706|137864|P1|Overall Study|Poor compliance to protocol|1
31094|NCT01798706|137863|P2|Overall Study|Lack of Efficacy|2
31095|NCT01798706|137864|P1|Overall Study|Lack of Efficacy|0
31096|NCT01798706|137863|P2|Overall Study|Adverse Event|10
31097|NCT01798706|137864|P1|Overall Study|Adverse Event|15
31098|NCT01798485|137909|P2|Overall Study|Clinical Progression|24
31099|NCT01798485|137910|P1|Overall Study|Clinical Progression|35
31100|NCT01798485|137909|P2|Overall Study|Sponsor Decision|54
31101|NCT01798485|137910|P1|Overall Study|Sponsor Decision|61
31102|NCT01798485|137909|P2|Overall Study|Death|22
31103|NCT01798485|137910|P1|Overall Study|Death|25
31104|NCT01798485|137909|P2|Overall Study|Objective Disease Progression|106
31105|NCT01798485|137910|P1|Overall Study|Objective Disease Progression|152
31106|NCT01798485|137909|P2|Overall Study|Physician Decision|10
31107|NCT01798485|137910|P1|Overall Study|Physician Decision|14
31108|NCT01798485|137909|P2|Overall Study|Lost to Follow-up|3
31109|NCT01798485|137910|P1|Overall Study|Lost to Follow-up|0
31110|NCT01798485|137909|P2|Overall Study|Withdrawal by Subject|31
31111|NCT01798485|137910|P1|Overall Study|Withdrawal by Subject|27
31112|NCT01798485|137909|P2|Overall Study|Adverse Event|40
31113|NCT01798485|137910|P1|Overall Study|Adverse Event|32
31114|NCT01798134|138036|P1|Overall Study|Liver transplant/surgery|4
31115|NCT01798134|138036|P1|Overall Study|Physician Decision|3
31116|NCT01798134|138036|P1|Overall Study|Adverse Event|3
31117|NCT01798134|138036|P1|Overall Study|Death|2
31118|NCT01798134|138036|P1|Overall Study|Withdrawal by Subject|3
31119|NCT01798134|138036|P1|Overall Study|Lost to Follow-up|1
31120|NCT01798004|138043|P1|Overall Study|Enrollment another COG therapeutic trial|32
31121|NCT01798004|138043|P1|Overall Study|Initiation of other non-protocol therapy|5
31122|NCT01798004|138043|P1|Overall Study|Patient/parent refusal|7
31123|NCT01798004|138043|P1|Overall Study|Ineligible|4
31124|NCT01798004|138043|P1|Overall Study|Withdrawal by Subject|4
31125|NCT01798004|138043|P1|Overall Study|Physician Decision|25
31126|NCT01798004|138043|P1|Overall Study|Lack of Efficacy|8
31127|NCT01798004|138043|P1|Overall Study|Death|2
31128|NCT01797783|138049|P2|Overall Study|Withdrawal by Subject|0
31129|NCT01797783|138050|P1|Overall Study|Withdrawal by Subject|1
31130|NCT01797783|138049|P2|Overall Study|Adverse Event|1
31131|NCT01797783|138050|P1|Overall Study|Adverse Event|1
31132|NCT01797731|138074|P2|Overall Study|Didn't have proper radiographs required|3
31133|NCT01797731|138075|P1|Overall Study|Didn't have proper radiographs required|3
31134|NCT01797705|138083|P1|Overall Study|Withdrawal by Subject|1
31135|NCT01797705|138083|P1|Overall Study|Equipment anomalies during sleep studies|4
31136|NCT01797536|138148|P4|Overall Study|Adverse Event|0
31137|NCT01797536|138149|P3|Overall Study|Adverse Event|0
31138|NCT01797536|138150|P2|Overall Study|Adverse Event|1
31139|NCT01797536|138151|P1|Overall Study|Adverse Event|0
31140|NCT01797445|138223|P2|Overall Study|Still on Study|383
31141|NCT01797445|138224|P1|Overall Study|Still on Study|381
31142|NCT01797445|138223|P2|Overall Study|Lost to Follow-up|15
31143|NCT01797445|138224|P1|Overall Study|Lost to Follow-up|22
31144|NCT01797445|138223|P2|Overall Study|Withdrew Consent|19
31145|NCT01797445|138224|P1|Overall Study|Withdrew Consent|12
31146|NCT01797445|138223|P2|Overall Study|Protocol Violation|1
31147|NCT01797445|138224|P1|Overall Study|Protocol Violation|0
31148|NCT01797445|138223|P2|Overall Study|Noncompliance with Study Drug|1
31149|NCT01797445|138224|P1|Overall Study|Noncompliance with Study Drug|3
31150|NCT01797445|138223|P2|Overall Study|Investigator's Discretion|12
31151|NCT01797445|138224|P1|Overall Study|Investigator's Discretion|8
31152|NCT01797445|138223|P2|Overall Study|Lack of Efficacy|2
31153|NCT01797445|138224|P1|Overall Study|Lack of Efficacy|1
31154|NCT01797445|138223|P2|Overall Study|Death|2
31155|NCT01797445|138224|P1|Overall Study|Death|1
31156|NCT01797445|138223|P2|Overall Study|Adverse Event|0
31157|NCT01797445|138224|P1|Overall Study|Adverse Event|3
31158|NCT01797445|138223|P2|Overall Study|Randomized but Not Treated|2
31159|NCT01797445|138224|P1|Overall Study|Randomized but Not Treated|4
31160|NCT01797120|138282|P2|Overall Study|never start protocol therapy|0
31161|NCT01797120|138283|P1|Overall Study|never start protocol therapy|2
31162|NCT01797120|138282|P2|Overall Study|still on treatment|4
31163|NCT01797120|138283|P1|Overall Study|still on treatment|2
31164|NCT01797120|138282|P2|Overall Study|Physician Decision|0
31165|NCT01797120|138283|P1|Overall Study|Physician Decision|3
31166|NCT01797120|138282|P2|Overall Study|Non-compliance|0
31167|NCT01797120|138283|P1|Overall Study|Non-compliance|1
31168|NCT01797120|138282|P2|Overall Study|Symptomatic progression|1
31169|NCT01797120|138283|P1|Overall Study|Symptomatic progression|2
31170|NCT01797120|138282|P2|Overall Study|Withdrawal by Subject|6
31171|NCT01797120|138283|P1|Overall Study|Withdrawal by Subject|6
31172|NCT01797120|138282|P2|Overall Study|Adverse Event|5
31173|NCT01797120|138283|P1|Overall Study|Adverse Event|13
31174|NCT01797120|138282|P2|Overall Study|Disesae progression|49
31175|NCT01797120|138283|P1|Overall Study|Disesae progression|37
31176|NCT01797094|138297|P2|Overall Study|Other Miscellaneous Reasons|0
31177|NCT01797094|138298|P1|Overall Study|Other Miscellaneous Reasons|1
31178|NCT01797094|138297|P2|Overall Study|Protocol Violation|1
31179|NCT01797094|138298|P1|Overall Study|Protocol Violation|0
31180|NCT01797094|138297|P2|Overall Study|Personal Reasons|0
31181|NCT01797094|138298|P1|Overall Study|Personal Reasons|4
31182|NCT01797094|138297|P2|Overall Study|Adverse Event|1
31183|NCT01797094|138298|P1|Overall Study|Adverse Event|1
31184|NCT01797081|138320|P4|Overall Study|Protocol Violation|1
31185|NCT01797081|138321|P3|Overall Study|Protocol Violation|0
31186|NCT01797081|138322|P2|Overall Study|Protocol Violation|0
31187|NCT01797081|138323|P1|Overall Study|Protocol Violation|0
31188|NCT01797081|138320|P4|Overall Study|Personal Reasons|8
31189|NCT01797081|138321|P3|Overall Study|Personal Reasons|4
31190|NCT01797081|138322|P2|Overall Study|Personal Reasons|4
31191|NCT01797081|138323|P1|Overall Study|Personal Reasons|12
31192|NCT01797081|138320|P4|Overall Study|Pregnancy|0
31193|NCT01797081|138321|P3|Overall Study|Pregnancy|0
31194|NCT01797081|138322|P2|Overall Study|Pregnancy|0
31195|NCT01797081|138323|P1|Overall Study|Pregnancy|1
31196|NCT01797081|138320|P4|Overall Study|Adverse Event|0
31197|NCT01797081|138321|P3|Overall Study|Adverse Event|1
31198|NCT01797081|138322|P2|Overall Study|Adverse Event|0
31199|NCT01797081|138323|P1|Overall Study|Adverse Event|1
31200|NCT01796964|138364|P2|Overall Study|Withdrawal by Subject|1
31201|NCT01796964|138365|P1|Overall Study|Withdrawal by Subject|1
31202|NCT01796964|138364|P2|Overall Study|Protocol Violation|1
31203|NCT01796964|138365|P1|Overall Study|Protocol Violation|0
31204|NCT01796964|138364|P2|Overall Study|Death|0
31205|NCT01796964|138365|P1|Overall Study|Death|1
31206|NCT01796964|138364|P2|Overall Study|Adverse Event|1
31207|NCT01796964|138365|P1|Overall Study|Adverse Event|1
31208|NCT01796860|138387|P1|Overall Study|Withdrawal by Subject|3
31209|NCT01796548|138393|P1|Overall Study|Other|2
31210|NCT01796548|138393|P1|Overall Study|Lost to Follow-up|1
31211|NCT01795937|138427|P3|Overall Study|Physician Decision|0
31212|NCT01795937|138428|P2|Overall Study|Physician Decision|1
31213|NCT01795937|138429|P1|Overall Study|Physician Decision|0
31214|NCT01795937|138427|P3|Overall Study|Withdrawal by Subject|0
31215|NCT01795937|138428|P2|Overall Study|Withdrawal by Subject|0
31216|NCT01795937|138429|P1|Overall Study|Withdrawal by Subject|1
31217|NCT01795898|138458|P1|Overall Study|Physician Decision|1
31218|NCT01795898|138458|P1|Overall Study|Withdrew consent & had adverse events|3
31219|NCT01795898|138458|P1|Overall Study|Death|1
31220|NCT01795898|138458|P1|Overall Study|No pain|1
31221|NCT01795898|138458|P1|Overall Study|Diagnosed with metastasis|1
31222|NCT01795898|138458|P1|Overall Study|Withdrawal of consent|6
31223|NCT01795898|138458|P1|Overall Study|Lost to Follow-up|20
31224|NCT01795898|138458|P1|Overall Study|Adverse Event|27
31225|NCT01795547|138494|P2|Overall Study|Not stated|1
31226|NCT01795547|138495|P1|Overall Study|Not stated|0
31227|NCT01795547|138494|P2|Overall Study|Others|1
31228|NCT01795547|138495|P1|Overall Study|Others|4
31229|NCT01795547|138494|P2|Overall Study|Non-compliance with IMP|1
31230|NCT01795547|138495|P1|Overall Study|Non-compliance with IMP|1
31231|NCT01795547|138494|P2|Overall Study|Not Treated|10
31232|NCT01795547|138495|P1|Overall Study|Not Treated|4
31233|NCT01795547|138494|P2|Overall Study|Withdrawal of consent|12
31234|NCT01795547|138495|P1|Overall Study|Withdrawal of consent|7
31235|NCT01795547|138494|P2|Overall Study|Lost to Follow-up|5
31236|NCT01795547|138495|P1|Overall Study|Lost to Follow-up|2
31237|NCT01795547|138494|P2|Overall Study|Protocol Violation|4
31238|NCT01795547|138495|P1|Overall Study|Protocol Violation|6
31239|NCT01795547|138494|P2|Overall Study|Lack of Efficacy|3
31240|NCT01795547|138495|P1|Overall Study|Lack of Efficacy|8
31241|NCT01795547|138494|P2|Overall Study|Adverse Event|27
31242|NCT01795547|138495|P1|Overall Study|Adverse Event|16
31243|NCT01795495|138527|P3|Overall Study|Physician Decision|1
31244|NCT01795495|138528|P2|Overall Study|Physician Decision|0
31245|NCT01795495|138529|P1|Overall Study|Physician Decision|0
31246|NCT01795495|138527|P3|Overall Study|Protocol Violation|1
31247|NCT01795495|138528|P2|Overall Study|Protocol Violation|0
31248|NCT01795495|138529|P1|Overall Study|Protocol Violation|1
31249|NCT01794949|138542|P2|Overall Study|Lost to Follow-up|0
31250|NCT01794949|138543|P1|Overall Study|Lost to Follow-up|1
31251|NCT01794845|138554|P1|Overall Study|Withdrawal by Subject|1
31252|NCT01794000|138604|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
31253|NCT01794000|138605|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
31254|NCT01794000|138604|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
31255|NCT01794000|138605|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
31256|NCT01794000|138604|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
31257|NCT01794000|138605|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
31258|NCT01794000|138604|P2|Double-Blind Phase (DBP)|Physician Decision|0
31259|NCT01794000|138605|P1|Double-Blind Phase (DBP)|Physician Decision|2
31260|NCT01794000|138604|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
31261|NCT01794000|138605|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
31262|NCT01794000|138604|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
31263|NCT01794000|138605|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
31264|NCT01794000|138604|P2|Double-Blind Phase (DBP)|Death|2
31265|NCT01794000|138605|P1|Double-Blind Phase (DBP)|Death|1
31266|NCT01794000|138604|P2|Double-Blind Phase (DBP)|Adverse Event|2
31267|NCT01794000|138605|P1|Double-Blind Phase (DBP)|Adverse Event|5
31268|NCT01793935|138638|P2|Overall Study|Lost to Follow-up|1
31269|NCT01793935|138639|P1|Overall Study|Lost to Follow-up|0
31270|NCT01793935|138638|P2|Overall Study|Patient did not take study medication|1
31271|NCT01793935|138639|P1|Overall Study|Patient did not take study medication|1
31272|NCT01793935|138638|P2|Overall Study|Adverse Event|0
31273|NCT01793935|138639|P1|Overall Study|Adverse Event|2
31274|NCT01793935|138638|P2|Overall Study|Protocol Violation|1
31275|NCT01793935|138639|P1|Overall Study|Protocol Violation|2
31276|NCT01793935|138638|P2|Overall Study|Pregnancy|0
31277|NCT01793935|138639|P1|Overall Study|Pregnancy|1
31278|NCT01793883|138676|P3|Overall Study|Respiratory distress during spirometry|1
31279|NCT01793883|138677|P2|Overall Study|Respiratory distress during spirometry|0
31280|NCT01793883|138678|P1|Overall Study|Respiratory distress during spirometry|0
31281|NCT01793883|138676|P3|Overall Study|Dosing error|0
31282|NCT01793883|138677|P2|Overall Study|Dosing error|1
31283|NCT01793883|138678|P1|Overall Study|Dosing error|0
31284|NCT01793883|138676|P3|Overall Study|Met exclusion criteria|0
31285|NCT01793883|138677|P2|Overall Study|Met exclusion criteria|0
31286|NCT01793883|138678|P1|Overall Study|Met exclusion criteria|1
31287|NCT01793883|138676|P3|Overall Study|Unable to complete measurements|0
31288|NCT01793883|138677|P2|Overall Study|Unable to complete measurements|0
31289|NCT01793883|138678|P1|Overall Study|Unable to complete measurements|1
31290|NCT01793883|138676|P3|Overall Study|Unable to complete spriometry|0
31291|NCT01793883|138677|P2|Overall Study|Unable to complete spriometry|0
31292|NCT01793883|138678|P1|Overall Study|Unable to complete spriometry|1
31293|NCT01793883|138676|P3|Overall Study|Randomized in error|0
31294|NCT01793883|138677|P2|Overall Study|Randomized in error|0
31295|NCT01793883|138678|P1|Overall Study|Randomized in error|1
31296|NCT01793883|138676|P3|Overall Study|Lost to Follow-up|3
31297|NCT01793883|138677|P2|Overall Study|Lost to Follow-up|1
31298|NCT01793883|138678|P1|Overall Study|Lost to Follow-up|5
31299|NCT01793883|138676|P3|Overall Study|Subject noncompliance|1
31300|NCT01793883|138677|P2|Overall Study|Subject noncompliance|1
31301|NCT01793883|138678|P1|Overall Study|Subject noncompliance|0
31302|NCT01793883|138676|P3|Overall Study|Withdrawal by Subject|3
31303|NCT01793883|138677|P2|Overall Study|Withdrawal by Subject|7
31304|NCT01793883|138678|P1|Overall Study|Withdrawal by Subject|3
31305|NCT01793688|138686|P1|Overall Study|Protocol Violation|2
31306|NCT01792830|138728|P7|Overall Study|Adverse Event|0
31307|NCT01792830|138729|P6|Overall Study|Adverse Event|0
31308|NCT01792830|138730|P5|Overall Study|Adverse Event|1
31309|NCT01792830|138731|P4|Overall Study|Adverse Event|0
31310|NCT01792830|138732|P3|Overall Study|Adverse Event|0
31311|NCT01792830|138733|P2|Overall Study|Adverse Event|0
31312|NCT01792830|138734|P1|Overall Study|Adverse Event|0
31313|NCT01792830|138728|P7|Overall Study|Death|1
31314|NCT01792830|138729|P6|Overall Study|Death|0
31315|NCT01792830|138730|P5|Overall Study|Death|2
31316|NCT01792830|138731|P4|Overall Study|Death|1
31317|NCT01792830|138732|P3|Overall Study|Death|0
31318|NCT01792830|138733|P2|Overall Study|Death|0
31319|NCT01792830|138734|P1|Overall Study|Death|3
31320|NCT01792830|138728|P7|Overall Study|Withdrawal by Subject|2
31321|NCT01792830|138729|P6|Overall Study|Withdrawal by Subject|0
31322|NCT01792830|138730|P5|Overall Study|Withdrawal by Subject|9
31323|NCT01792830|138731|P4|Overall Study|Withdrawal by Subject|4
31324|NCT01792830|138732|P3|Overall Study|Withdrawal by Subject|0
31325|NCT01792830|138733|P2|Overall Study|Withdrawal by Subject|0
31326|NCT01792830|138734|P1|Overall Study|Withdrawal by Subject|22
31327|NCT01792635|138782|P3|Part B|Study terminated|3
31328|NCT01792635|138783|P2|Part B|Study terminated|4
31329|NCT01792635|138784|P1|Part B|Study terminated|0
31330|NCT01792635|138782|P3|Part B|Adverse Event|1
31331|NCT01792635|138783|P2|Part B|Adverse Event|0
31332|NCT01792635|138784|P1|Part B|Adverse Event|0
31333|NCT01792518|138812|P2|Overall Study|Other Reason|1
31334|NCT01792518|138813|P1|Overall Study|Other Reason|0
31335|NCT01792518|138812|P2|Overall Study|Withdrawal by Subject|0
31336|NCT01792518|138813|P1|Overall Study|Withdrawal by Subject|2
31337|NCT01792518|138812|P2|Overall Study|Lost to Follow-up|1
31338|NCT01792518|138813|P1|Overall Study|Lost to Follow-up|3
31339|NCT01792518|138812|P2|Overall Study|Protocol Violation|1
31340|NCT01792518|138813|P1|Overall Study|Protocol Violation|0
31341|NCT01792518|138812|P2|Overall Study|Adverse Event|4
31342|NCT01792518|138813|P1|Overall Study|Adverse Event|3
31343|NCT01792284|138823|P3|Randomization Period 2|Withdrawal by Subject|0
31344|NCT01792284|138824|P2|Randomization Period 2|Withdrawal by Subject|2
31345|NCT01792284|138825|P1|Randomization Period 2|Withdrawal by Subject|0
31346|NCT01792284|138823|P3|Randomization Period 2|Protocol Violation|0
31347|NCT01792284|138824|P2|Randomization Period 2|Protocol Violation|1
31348|NCT01792284|138825|P1|Randomization Period 2|Protocol Violation|0
31349|NCT01792284|138823|P3|Randomization Period 1|Lost to Follow-up|1
31350|NCT01792284|138824|P2|Randomization Period 1|Lost to Follow-up|0
31351|NCT01792284|138825|P1|Randomization Period 1|Lost to Follow-up|0
31352|NCT01792284|138823|P3|Randomization Period 1|Adverse Event|2
31353|NCT01792284|138824|P2|Randomization Period 1|Adverse Event|0
31354|NCT01792284|138825|P1|Randomization Period 1|Adverse Event|0
31355|NCT01792284|138823|P3|Randomization Period 1|Physician Decision|1
31356|NCT01792284|138824|P2|Randomization Period 1|Physician Decision|1
31357|NCT01792284|138825|P1|Randomization Period 1|Physician Decision|0
31358|NCT01792284|138823|P3|Randomization Period 1|Withdrawal by Subject|1
31359|NCT01792284|138824|P2|Randomization Period 1|Withdrawal by Subject|1
31360|NCT01792284|138825|P1|Randomization Period 1|Withdrawal by Subject|0
31361|NCT01792284|138823|P3|Lead-in Period|Protocol Required Discontinuation|0
31362|NCT01792284|138824|P2|Lead-in Period|Protocol Required Discontinuation|0
31363|NCT01792284|138825|P1|Lead-in Period|Protocol Required Discontinuation|1
31364|NCT01792284|138823|P3|Lead-in Period|Physician Decision|0
31365|NCT01792284|138824|P2|Lead-in Period|Physician Decision|0
31366|NCT01792284|138825|P1|Lead-in Period|Physician Decision|1
31367|NCT01792284|138823|P3|Lead-in Period|Withdrawal by Subject|0
31368|NCT01792284|138824|P2|Lead-in Period|Withdrawal by Subject|0
31369|NCT01792284|138825|P1|Lead-in Period|Withdrawal by Subject|10
31370|NCT01792284|138823|P3|Lead-in Period|Protocol Violation|0
31371|NCT01792284|138824|P2|Lead-in Period|Protocol Violation|0
31372|NCT01792284|138825|P1|Lead-in Period|Protocol Violation|1
31373|NCT01792284|138823|P3|Lead-in Period|Lost to Follow-up|0
31374|NCT01792284|138824|P2|Lead-in Period|Lost to Follow-up|0
31375|NCT01792284|138825|P1|Lead-in Period|Lost to Follow-up|2
31376|NCT01792284|138823|P3|Lead-in Period|Adverse Event|0
31377|NCT01792284|138824|P2|Lead-in Period|Adverse Event|0
31378|NCT01792284|138825|P1|Lead-in Period|Adverse Event|15
31379|NCT01791894|138884|P1|Overall Study|Adverse Event|1
31380|NCT01791803|138895|P4|Overall Study|Death|2
31381|NCT01791803|138896|P3|Overall Study|Death|2
31382|NCT01791803|138897|P2|Overall Study|Death|0
31383|NCT01791803|138898|P1|Overall Study|Death|0
31384|NCT01791803|138895|P4|Overall Study|Physician Decision|1
31385|NCT01791803|138896|P3|Overall Study|Physician Decision|0
31386|NCT01791803|138897|P2|Overall Study|Physician Decision|2
31387|NCT01791803|138898|P1|Overall Study|Physician Decision|0
31388|NCT01791803|138895|P4|Overall Study|Withdrawal by Subject|2
31389|NCT01791803|138896|P3|Overall Study|Withdrawal by Subject|0
31390|NCT01791803|138897|P2|Overall Study|Withdrawal by Subject|0
31391|NCT01791803|138898|P1|Overall Study|Withdrawal by Subject|0
31392|NCT01791725|138916|P3|Overall Study|Withdrawal by Subject|0
31393|NCT01791725|138917|P2|Overall Study|Withdrawal by Subject|1
31394|NCT01791725|138918|P1|Overall Study|Withdrawal by Subject|0
31395|NCT01791517|138941|P12|Phase II|Pre-Existing Ocular Issue|1
31396|NCT01791517|138942|P11|Phase II|Pre-Existing Ocular Issue|0
31397|NCT01791517|138943|P10|Phase II|Pre-Existing Ocular Issue|0
31398|NCT01791517|138944|P9|Phase II|Pre-Existing Ocular Issue|0
31399|NCT01791517|138945|P8|Phase II|Pre-Existing Ocular Issue|0
31400|NCT01791517|138946|P7|Phase II|Pre-Existing Ocular Issue|0
31401|NCT01791517|138947|P6|Phase II|Pre-Existing Ocular Issue|0
31402|NCT01791517|138948|P5|Phase II|Pre-Existing Ocular Issue|0
31403|NCT01791517|138949|P4|Phase II|Pre-Existing Ocular Issue|0
31404|NCT01791517|138950|P3|Phase II|Pre-Existing Ocular Issue|0
31405|NCT01791517|138951|P2|Phase II|Pre-Existing Ocular Issue|0
31406|NCT01791517|138952|P1|Phase II|Pre-Existing Ocular Issue|0
31407|NCT01791517|138941|P12|Phase II|Unsatisfactory Lens Fitting|0
31408|NCT01791517|138942|P11|Phase II|Unsatisfactory Lens Fitting|0
31409|NCT01791517|138943|P10|Phase II|Unsatisfactory Lens Fitting|1
31410|NCT01791517|138944|P9|Phase II|Unsatisfactory Lens Fitting|0
31411|NCT01791517|138945|P8|Phase II|Unsatisfactory Lens Fitting|0
31412|NCT01791517|138946|P7|Phase II|Unsatisfactory Lens Fitting|0
31413|NCT01791517|138947|P6|Phase II|Unsatisfactory Lens Fitting|0
31414|NCT01791517|138948|P5|Phase II|Unsatisfactory Lens Fitting|0
31415|NCT01791517|138949|P4|Phase II|Unsatisfactory Lens Fitting|0
31416|NCT01791517|138950|P3|Phase II|Unsatisfactory Lens Fitting|0
31417|NCT01791517|138951|P2|Phase II|Unsatisfactory Lens Fitting|0
31418|NCT01791517|138952|P1|Phase II|Unsatisfactory Lens Fitting|0
31419|NCT01791517|138941|P12|Phase II|Lens Handling Difficulties|0
31420|NCT01791517|138942|P11|Phase II|Lens Handling Difficulties|0
31421|NCT01791517|138943|P10|Phase II|Lens Handling Difficulties|0
31422|NCT01791517|138944|P9|Phase II|Lens Handling Difficulties|1
31423|NCT01791517|138945|P8|Phase II|Lens Handling Difficulties|0
31424|NCT01791517|138946|P7|Phase II|Lens Handling Difficulties|0
31425|NCT01791517|138947|P6|Phase II|Lens Handling Difficulties|0
31426|NCT01791517|138948|P5|Phase II|Lens Handling Difficulties|0
31427|NCT01791517|138949|P4|Phase II|Lens Handling Difficulties|0
31428|NCT01791517|138950|P3|Phase II|Lens Handling Difficulties|0
31429|NCT01791517|138951|P2|Phase II|Lens Handling Difficulties|0
31430|NCT01791517|138952|P1|Phase II|Lens Handling Difficulties|0
31431|NCT01791517|138941|P12|Phase II|Adverse Event|0
31432|NCT01791517|138942|P11|Phase II|Adverse Event|0
31433|NCT01791517|138943|P10|Phase II|Adverse Event|1
31434|NCT01791517|138944|P9|Phase II|Adverse Event|0
31435|NCT01791517|138945|P8|Phase II|Adverse Event|1
31436|NCT01791517|138946|P7|Phase II|Adverse Event|2
31437|NCT01791517|138947|P6|Phase II|Adverse Event|0
31438|NCT01791517|138948|P5|Phase II|Adverse Event|0
31439|NCT01791517|138949|P4|Phase II|Adverse Event|0
31440|NCT01791517|138950|P3|Phase II|Adverse Event|0
31441|NCT01791517|138951|P2|Phase II|Adverse Event|0
31442|NCT01791517|138952|P1|Phase II|Adverse Event|0
31443|NCT01791517|138941|P12|Phase II|Lack of Efficacy|0
31444|NCT01791517|138942|P11|Phase II|Lack of Efficacy|0
31445|NCT01791517|138943|P10|Phase II|Lack of Efficacy|0
31446|NCT01791517|138944|P9|Phase II|Lack of Efficacy|0
31447|NCT01791517|138945|P8|Phase II|Lack of Efficacy|0
31448|NCT01791517|138946|P7|Phase II|Lack of Efficacy|0
31449|NCT01791517|138947|P6|Phase II|Lack of Efficacy|0
31450|NCT01791517|138948|P5|Phase II|Lack of Efficacy|1
31451|NCT01791517|138949|P4|Phase II|Lack of Efficacy|0
31452|NCT01791517|138950|P3|Phase II|Lack of Efficacy|0
31453|NCT01791517|138951|P2|Phase II|Lack of Efficacy|0
31454|NCT01791517|138952|P1|Phase II|Lack of Efficacy|0
31455|NCT01791517|138941|P12|Phase II|Withdrawal by Subject|0
31456|NCT01791517|138942|P11|Phase II|Withdrawal by Subject|1
31457|NCT01791517|138943|P10|Phase II|Withdrawal by Subject|0
31458|NCT01791517|138944|P9|Phase II|Withdrawal by Subject|0
31459|NCT01791517|138945|P8|Phase II|Withdrawal by Subject|1
31460|NCT01791517|138946|P7|Phase II|Withdrawal by Subject|0
31461|NCT01791517|138947|P6|Phase II|Withdrawal by Subject|2
31462|NCT01791517|138948|P5|Phase II|Withdrawal by Subject|0
31463|NCT01791517|138949|P4|Phase II|Withdrawal by Subject|0
31464|NCT01791517|138950|P3|Phase II|Withdrawal by Subject|0
31465|NCT01791517|138951|P2|Phase II|Withdrawal by Subject|0
31466|NCT01791517|138952|P1|Phase II|Withdrawal by Subject|1
31467|NCT01791517|138941|P12|Phase II|Lost to Follow-up|0
31468|NCT01791517|138942|P11|Phase II|Lost to Follow-up|0
31469|NCT01791517|138943|P10|Phase II|Lost to Follow-up|1
31470|NCT01791517|138944|P9|Phase II|Lost to Follow-up|1
31471|NCT01791517|138945|P8|Phase II|Lost to Follow-up|1
31472|NCT01791517|138946|P7|Phase II|Lost to Follow-up|0
31473|NCT01791517|138947|P6|Phase II|Lost to Follow-up|2
31474|NCT01791517|138948|P5|Phase II|Lost to Follow-up|1
31475|NCT01791517|138949|P4|Phase II|Lost to Follow-up|0
31476|NCT01791517|138950|P3|Phase II|Lost to Follow-up|1
31477|NCT01791517|138951|P2|Phase II|Lost to Follow-up|0
31478|NCT01791517|138952|P1|Phase II|Lost to Follow-up|1
31479|NCT01791517|138941|P12|Phase I: Period 3|Adverse Event|0
31480|NCT01791517|138942|P11|Phase I: Period 3|Adverse Event|0
31481|NCT01791517|138943|P10|Phase I: Period 3|Adverse Event|0
31482|NCT01791517|138944|P9|Phase I: Period 3|Adverse Event|0
31483|NCT01791517|138945|P8|Phase I: Period 3|Adverse Event|0
31484|NCT01791517|138946|P7|Phase I: Period 3|Adverse Event|0
31485|NCT01791517|138947|P6|Phase I: Period 3|Adverse Event|0
31486|NCT01791517|138948|P5|Phase I: Period 3|Adverse Event|0
31487|NCT01791517|138949|P4|Phase I: Period 3|Adverse Event|1
31488|NCT01791517|138950|P3|Phase I: Period 3|Adverse Event|0
31489|NCT01791517|138951|P2|Phase I: Period 3|Adverse Event|0
31490|NCT01791517|138952|P1|Phase I: Period 3|Adverse Event|0
31491|NCT01791517|138941|P12|Phase I: Period 3|Lost to Follow-up|0
31492|NCT01791517|138942|P11|Phase I: Period 3|Lost to Follow-up|0
31493|NCT01791517|138943|P10|Phase I: Period 3|Lost to Follow-up|0
31494|NCT01791517|138944|P9|Phase I: Period 3|Lost to Follow-up|0
31495|NCT01791517|138945|P8|Phase I: Period 3|Lost to Follow-up|0
31496|NCT01791517|138946|P7|Phase I: Period 3|Lost to Follow-up|0
31497|NCT01791517|138947|P6|Phase I: Period 3|Lost to Follow-up|0
31498|NCT01791517|138948|P5|Phase I: Period 3|Lost to Follow-up|1
31499|NCT01791517|138949|P4|Phase I: Period 3|Lost to Follow-up|0
31500|NCT01791517|138950|P3|Phase I: Period 3|Lost to Follow-up|0
31501|NCT01791517|138951|P2|Phase I: Period 3|Lost to Follow-up|1
31502|NCT01791517|138952|P1|Phase I: Period 3|Lost to Follow-up|0
31503|NCT01791517|138941|P12|Phase I: Period 3|Lens Discomfort|1
31504|NCT01791517|138942|P11|Phase I: Period 3|Lens Discomfort|0
31505|NCT01791517|138943|P10|Phase I: Period 3|Lens Discomfort|0
31506|NCT01791517|138944|P9|Phase I: Period 3|Lens Discomfort|0
31507|NCT01791517|138945|P8|Phase I: Period 3|Lens Discomfort|0
31508|NCT01791517|138946|P7|Phase I: Period 3|Lens Discomfort|0
31509|NCT01791517|138947|P6|Phase I: Period 3|Lens Discomfort|0
31510|NCT01791517|138948|P5|Phase I: Period 3|Lens Discomfort|0
31511|NCT01791517|138949|P4|Phase I: Period 3|Lens Discomfort|0
31512|NCT01791517|138950|P3|Phase I: Period 3|Lens Discomfort|0
31513|NCT01791517|138951|P2|Phase I: Period 3|Lens Discomfort|0
31514|NCT01791517|138952|P1|Phase I: Period 3|Lens Discomfort|0
31515|NCT01791517|138941|P12|Phase I: Period 2|Lost to Follow-up|0
31516|NCT01791517|138942|P11|Phase I: Period 2|Lost to Follow-up|0
31517|NCT01791517|138943|P10|Phase I: Period 2|Lost to Follow-up|0
31518|NCT01791517|138944|P9|Phase I: Period 2|Lost to Follow-up|0
31519|NCT01791517|138945|P8|Phase I: Period 2|Lost to Follow-up|0
31520|NCT01791517|138946|P7|Phase I: Period 2|Lost to Follow-up|0
31521|NCT01791517|138947|P6|Phase I: Period 2|Lost to Follow-up|0
31522|NCT01791517|138948|P5|Phase I: Period 2|Lost to Follow-up|0
31523|NCT01791517|138949|P4|Phase I: Period 2|Lost to Follow-up|0
31524|NCT01791517|138950|P3|Phase I: Period 2|Lost to Follow-up|2
31525|NCT01791517|138951|P2|Phase I: Period 2|Lost to Follow-up|3
31526|NCT01791517|138952|P1|Phase I: Period 2|Lost to Follow-up|0
31527|NCT01791517|138941|P12|Phase I: Period 2|Lens Discomfort|0
31528|NCT01791517|138942|P11|Phase I: Period 2|Lens Discomfort|0
31529|NCT01791517|138943|P10|Phase I: Period 2|Lens Discomfort|0
31530|NCT01791517|138944|P9|Phase I: Period 2|Lens Discomfort|0
31531|NCT01791517|138945|P8|Phase I: Period 2|Lens Discomfort|0
31532|NCT01791517|138946|P7|Phase I: Period 2|Lens Discomfort|0
31533|NCT01791517|138947|P6|Phase I: Period 2|Lens Discomfort|1
31534|NCT01791517|138948|P5|Phase I: Period 2|Lens Discomfort|0
31535|NCT01791517|138949|P4|Phase I: Period 2|Lens Discomfort|0
31536|NCT01791517|138950|P3|Phase I: Period 2|Lens Discomfort|0
31537|NCT01791517|138951|P2|Phase I: Period 2|Lens Discomfort|0
31538|NCT01791517|138952|P1|Phase I: Period 2|Lens Discomfort|0
31539|NCT01791517|138941|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
31540|NCT01791517|138942|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
31541|NCT01791517|138943|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
31542|NCT01791517|138944|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
31543|NCT01791517|138945|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
31544|NCT01791517|138946|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
31545|NCT01791517|138947|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
31546|NCT01791517|138948|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
31547|NCT01791517|138949|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
31548|NCT01791517|138950|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
31549|NCT01791517|138951|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
31550|NCT01791517|138952|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
31551|NCT01791517|138941|P12|Phase I: Period 2|Withdrawal by Subject|0
31552|NCT01791517|138942|P11|Phase I: Period 2|Withdrawal by Subject|1
31553|NCT01791517|138943|P10|Phase I: Period 2|Withdrawal by Subject|1
31554|NCT01791517|138944|P9|Phase I: Period 2|Withdrawal by Subject|0
31555|NCT01791517|138945|P8|Phase I: Period 2|Withdrawal by Subject|0
31556|NCT01791517|138946|P7|Phase I: Period 2|Withdrawal by Subject|0
31557|NCT01791517|138947|P6|Phase I: Period 2|Withdrawal by Subject|0
31558|NCT01791517|138948|P5|Phase I: Period 2|Withdrawal by Subject|0
31559|NCT01791517|138949|P4|Phase I: Period 2|Withdrawal by Subject|0
31560|NCT01791517|138950|P3|Phase I: Period 2|Withdrawal by Subject|0
31561|NCT01791517|138951|P2|Phase I: Period 2|Withdrawal by Subject|0
31562|NCT01791517|138952|P1|Phase I: Period 2|Withdrawal by Subject|0
31563|NCT01791517|138941|P12|Phase I: Period 2|Protocol Violation|0
31564|NCT01791517|138942|P11|Phase I: Period 2|Protocol Violation|0
31565|NCT01791517|138943|P10|Phase I: Period 2|Protocol Violation|0
31566|NCT01791517|138944|P9|Phase I: Period 2|Protocol Violation|0
31567|NCT01791517|138945|P8|Phase I: Period 2|Protocol Violation|0
31568|NCT01791517|138946|P7|Phase I: Period 2|Protocol Violation|0
31569|NCT01791517|138947|P6|Phase I: Period 2|Protocol Violation|0
31570|NCT01791517|138948|P5|Phase I: Period 2|Protocol Violation|0
31571|NCT01791517|138949|P4|Phase I: Period 2|Protocol Violation|1
31572|NCT01791517|138950|P3|Phase I: Period 2|Protocol Violation|0
31573|NCT01791517|138951|P2|Phase I: Period 2|Protocol Violation|0
31574|NCT01791517|138952|P1|Phase I: Period 2|Protocol Violation|0
31575|NCT01791517|138941|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
31576|NCT01791517|138942|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
31577|NCT01791517|138943|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
31578|NCT01791517|138944|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
31579|NCT01791517|138945|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
31580|NCT01791517|138946|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
31581|NCT01791517|138947|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
31582|NCT01791517|138948|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
31583|NCT01791517|138949|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
31584|NCT01791517|138950|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
31585|NCT01791517|138951|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
31586|NCT01791517|138952|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
31587|NCT01791517|138941|P12|Phase I: Period 1|Lens Handling DIfficulties|1
31588|NCT01791517|138942|P11|Phase I: Period 1|Lens Handling DIfficulties|0
31589|NCT01791517|138943|P10|Phase I: Period 1|Lens Handling DIfficulties|0
31590|NCT01791517|138944|P9|Phase I: Period 1|Lens Handling DIfficulties|0
31591|NCT01791517|138945|P8|Phase I: Period 1|Lens Handling DIfficulties|0
31592|NCT01791517|138946|P7|Phase I: Period 1|Lens Handling DIfficulties|0
31593|NCT01791517|138947|P6|Phase I: Period 1|Lens Handling DIfficulties|0
31594|NCT01791517|138948|P5|Phase I: Period 1|Lens Handling DIfficulties|0
31595|NCT01791517|138949|P4|Phase I: Period 1|Lens Handling DIfficulties|0
31596|NCT01791517|138950|P3|Phase I: Period 1|Lens Handling DIfficulties|0
31597|NCT01791517|138951|P2|Phase I: Period 1|Lens Handling DIfficulties|0
31598|NCT01791517|138952|P1|Phase I: Period 1|Lens Handling DIfficulties|0
31599|NCT01791517|138941|P12|Phase I: Period 1|Lost to Follow-up|0
31600|NCT01791517|138942|P11|Phase I: Period 1|Lost to Follow-up|0
31601|NCT01791517|138943|P10|Phase I: Period 1|Lost to Follow-up|1
31602|NCT01791517|138944|P9|Phase I: Period 1|Lost to Follow-up|1
31603|NCT01791517|138945|P8|Phase I: Period 1|Lost to Follow-up|0
31604|NCT01791517|138946|P7|Phase I: Period 1|Lost to Follow-up|1
31605|NCT01791517|138947|P6|Phase I: Period 1|Lost to Follow-up|0
31606|NCT01791517|138948|P5|Phase I: Period 1|Lost to Follow-up|0
31607|NCT01791517|138949|P4|Phase I: Period 1|Lost to Follow-up|1
31608|NCT01791517|138950|P3|Phase I: Period 1|Lost to Follow-up|0
31609|NCT01791517|138951|P2|Phase I: Period 1|Lost to Follow-up|0
31610|NCT01791517|138952|P1|Phase I: Period 1|Lost to Follow-up|0
31611|NCT01791517|138941|P12|Phase I: Period 1|Protocol Violation|0
31612|NCT01791517|138942|P11|Phase I: Period 1|Protocol Violation|0
31613|NCT01791517|138943|P10|Phase I: Period 1|Protocol Violation|0
31614|NCT01791517|138944|P9|Phase I: Period 1|Protocol Violation|0
31615|NCT01791517|138945|P8|Phase I: Period 1|Protocol Violation|0
31616|NCT01791517|138946|P7|Phase I: Period 1|Protocol Violation|0
31617|NCT01791517|138947|P6|Phase I: Period 1|Protocol Violation|0
31618|NCT01791517|138948|P5|Phase I: Period 1|Protocol Violation|0
31619|NCT01791517|138949|P4|Phase I: Period 1|Protocol Violation|0
31620|NCT01791517|138950|P3|Phase I: Period 1|Protocol Violation|0
31621|NCT01791517|138951|P2|Phase I: Period 1|Protocol Violation|1
31622|NCT01791517|138952|P1|Phase I: Period 1|Protocol Violation|0
31623|NCT01791517|138941|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31624|NCT01791517|138942|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31625|NCT01791517|138943|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31626|NCT01791517|138944|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31627|NCT01791517|138945|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31628|NCT01791517|138946|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31629|NCT01791517|138947|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31630|NCT01791517|138948|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31631|NCT01791517|138949|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31632|NCT01791517|138950|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31633|NCT01791517|138951|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
31634|NCT01791517|138952|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
31635|NCT01791517|138941|P12|Phase I: Period 1|Adverse Event|0
31636|NCT01791517|138942|P11|Phase I: Period 1|Adverse Event|0
31637|NCT01791517|138943|P10|Phase I: Period 1|Adverse Event|0
31638|NCT01791517|138944|P9|Phase I: Period 1|Adverse Event|0
31639|NCT01791517|138945|P8|Phase I: Period 1|Adverse Event|0
31640|NCT01791517|138946|P7|Phase I: Period 1|Adverse Event|0
31641|NCT01791517|138947|P6|Phase I: Period 1|Adverse Event|0
31642|NCT01791517|138948|P5|Phase I: Period 1|Adverse Event|0
31643|NCT01791517|138949|P4|Phase I: Period 1|Adverse Event|1
31644|NCT01791517|138950|P3|Phase I: Period 1|Adverse Event|1
31645|NCT01791517|138951|P2|Phase I: Period 1|Adverse Event|0
31646|NCT01791517|138952|P1|Phase I: Period 1|Adverse Event|0
31647|NCT01791517|138941|P12|Phase I: Period 1|Withdrawal by Subject|0
31648|NCT01791517|138942|P11|Phase I: Period 1|Withdrawal by Subject|0
31649|NCT01791517|138943|P10|Phase I: Period 1|Withdrawal by Subject|0
31650|NCT01791517|138944|P9|Phase I: Period 1|Withdrawal by Subject|0
31651|NCT01791517|138945|P8|Phase I: Period 1|Withdrawal by Subject|0
31652|NCT01791517|138946|P7|Phase I: Period 1|Withdrawal by Subject|0
31653|NCT01791517|138947|P6|Phase I: Period 1|Withdrawal by Subject|1
31654|NCT01791517|138948|P5|Phase I: Period 1|Withdrawal by Subject|1
31655|NCT01791517|138949|P4|Phase I: Period 1|Withdrawal by Subject|0
31656|NCT01791517|138950|P3|Phase I: Period 1|Withdrawal by Subject|1
31657|NCT01791517|138951|P2|Phase I: Period 1|Withdrawal by Subject|1
31658|NCT01791517|138952|P1|Phase I: Period 1|Withdrawal by Subject|0
31659|NCT01791413|139016|P2|Overall Study|Lost to Follow-up|1
31660|NCT01791413|139017|P1|Overall Study|Lost to Follow-up|5
31661|NCT01791244|139026|P2|Overall Study|Laboratory Abnormality|1
31662|NCT01791244|139027|P1|Overall Study|Laboratory Abnormality|0
31663|NCT01791244|139026|P2|Overall Study|Insufficient clinical response|10
31664|NCT01791244|139027|P1|Overall Study|Insufficient clinical response|10
31665|NCT01791244|139026|P2|Overall Study|Adverse Event|7
31666|NCT01791244|139027|P1|Overall Study|Adverse Event|5
31667|NCT01791205|139063|P2|Phase II|Physician’s decision|0
31668|NCT01791205|139064|P1|Phase II|Physician’s decision|1
31669|NCT01791205|139063|P2|Phase II|Remission of disease|0
31670|NCT01791205|139064|P1|Phase II|Remission of disease|1
31671|NCT01791205|139063|P2|Phase II|Lost to Follow-up|0
31672|NCT01791205|139064|P1|Phase II|Lost to Follow-up|1
31673|NCT01791205|139063|P2|Phase II|Safety|0
31674|NCT01791205|139064|P1|Phase II|Safety|1
31675|NCT01791205|139063|P2|Phase II|Adverse Event|0
31676|NCT01791205|139064|P1|Phase II|Adverse Event|2
31677|NCT01791205|139063|P2|Phase II|Lack of Efficacy|0
31678|NCT01791205|139064|P1|Phase II|Lack of Efficacy|6
31679|NCT01791153|139148|P4|Overall Study|Withdrawal by Subject|1
31680|NCT01791153|139149|P3|Overall Study|Withdrawal by Subject|2
31681|NCT01791153|139150|P2|Overall Study|Withdrawal by Subject|2
31682|NCT01791153|139151|P1|Overall Study|Withdrawal by Subject|6
31683|NCT01791153|139148|P4|Overall Study|Protocol Violation|1
31684|NCT01791153|139149|P3|Overall Study|Protocol Violation|0
31685|NCT01791153|139150|P2|Overall Study|Protocol Violation|0
31686|NCT01791153|139151|P1|Overall Study|Protocol Violation|0
31687|NCT01791153|139148|P4|Overall Study|Physician Decision|1
31688|NCT01791153|139149|P3|Overall Study|Physician Decision|0
31689|NCT01791153|139150|P2|Overall Study|Physician Decision|0
31690|NCT01791153|139151|P1|Overall Study|Physician Decision|0
31691|NCT01791153|139148|P4|Overall Study|Non-Compliance|0
31692|NCT01791153|139149|P3|Overall Study|Non-Compliance|0
31693|NCT01791153|139150|P2|Overall Study|Non-Compliance|0
31694|NCT01791153|139151|P1|Overall Study|Non-Compliance|1
31695|NCT01791153|139148|P4|Overall Study|Lack of Efficacy|2
31696|NCT01791153|139149|P3|Overall Study|Lack of Efficacy|2
31697|NCT01791153|139150|P2|Overall Study|Lack of Efficacy|3
31698|NCT01791153|139151|P1|Overall Study|Lack of Efficacy|1
31699|NCT01791153|139148|P4|Overall Study|Adverse Event|0
31700|NCT01791153|139149|P3|Overall Study|Adverse Event|2
31701|NCT01791153|139150|P2|Overall Study|Adverse Event|3
31702|NCT01791153|139151|P1|Overall Study|Adverse Event|7
31703|NCT01790828|139207|P1|Overall Study|Not specified|34
31704|NCT01790633|139265|P2|Overall Study|RT failure and no follow-up ELISA|3
31705|NCT01790633|139266|P1|Overall Study|RT failure and no follow-up ELISA|0
31706|NCT01790633|139265|P2|Overall Study|Did not have serology performed|0
31707|NCT01790633|139266|P1|Overall Study|Did not have serology performed|47
31708|NCT01790633|139265|P2|Overall Study|Protocol Violation|2
31709|NCT01790633|139266|P1|Overall Study|Protocol Violation|1
31710|NCT01790594|139279|P3|Overall Study|Terminated prior to week 76|0
31711|NCT01790594|139280|P2|Overall Study|Terminated prior to week 76|2
31712|NCT01790594|139281|P1|Overall Study|Terminated prior to week 76|0
31713|NCT01790594|139279|P3|Overall Study|Transplant was not done|3
31714|NCT01790594|139280|P2|Overall Study|Transplant was not done|0
31715|NCT01790594|139281|P1|Overall Study|Transplant was not done|0
31716|NCT01790594|139279|P3|Overall Study|Withdrawal by Subject|0
31717|NCT01790594|139280|P2|Overall Study|Withdrawal by Subject|0
31718|NCT01790594|139281|P1|Overall Study|Withdrawal by Subject|2
31719|NCT01790594|139279|P3|Overall Study|Physician Decision|0
31720|NCT01790594|139280|P2|Overall Study|Physician Decision|1
31721|NCT01790594|139281|P1|Overall Study|Physician Decision|2
31722|NCT01790594|139279|P3|Overall Study|Death|0
31723|NCT01790594|139280|P2|Overall Study|Death|0
31724|NCT01790594|139281|P1|Overall Study|Death|1
31725|NCT01790568|139358|P2|Overall Study|Progression prior to transplant|1
31726|NCT01790568|139359|P1|Overall Study|Progression prior to transplant|0
31727|NCT01790516|139367|P2|Overall Study|Physician Decision|0
31728|NCT01790516|139368|P1|Overall Study|Physician Decision|1
31729|NCT01790438|139392|P2|Overall Study|Protocol Required Discontinuation|1
31730|NCT01790438|139393|P1|Overall Study|Protocol Required Discontinuation|7
31731|NCT01790438|139392|P2|Overall Study|Sponsor Decision|3
31732|NCT01790438|139393|P1|Overall Study|Sponsor Decision|0
31733|NCT01790438|139392|P2|Overall Study|Physician Decision|1
31734|NCT01790438|139393|P1|Overall Study|Physician Decision|3
31735|NCT01790438|139392|P2|Overall Study|Withdrawal by Subject|2
31736|NCT01790438|139393|P1|Overall Study|Withdrawal by Subject|13
31737|NCT01790438|139392|P2|Overall Study|Lost to Follow-up|2
31738|NCT01790438|139393|P1|Overall Study|Lost to Follow-up|5
31739|NCT01790438|139392|P2|Overall Study|Death|0
31740|NCT01790438|139393|P1|Overall Study|Death|4
31741|NCT01790438|139392|P2|Overall Study|Adverse Event|2
31742|NCT01790438|139393|P1|Overall Study|Adverse Event|3
31743|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
31744|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
31745|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
31746|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Not specified|3
31747|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
31748|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
31749|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
31750|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
31751|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
31752|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
31753|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
31754|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
31755|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
31756|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
31757|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
31758|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
31759|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
31760|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
31761|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
31762|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
31763|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
31764|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
31765|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
31766|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
31767|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
31768|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
31769|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
31770|NCT01789970|139462|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
31771|NCT01789970|139463|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
31772|NCT01789970|139464|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
31773|NCT01789970|139462|P3|Open-label Titration Period|Dropped out prior to dosing|0
31774|NCT01789970|139463|P2|Open-label Titration Period|Dropped out prior to dosing|0
31775|NCT01789970|139464|P1|Open-label Titration Period|Dropped out prior to dosing|2
31776|NCT01789970|139462|P3|Open-label Titration Period|Not specified|0
31777|NCT01789970|139463|P2|Open-label Titration Period|Not specified|0
31778|NCT01789970|139464|P1|Open-label Titration Period|Not specified|76
31779|NCT01789970|139462|P3|Open-label Titration Period|Pregnancy|0
31780|NCT01789970|139463|P2|Open-label Titration Period|Pregnancy|0
31781|NCT01789970|139464|P1|Open-label Titration Period|Pregnancy|2
31782|NCT01789970|139462|P3|Open-label Titration Period|Noncompliance with study procedures|0
31783|NCT01789970|139463|P2|Open-label Titration Period|Noncompliance with study procedures|0
31784|NCT01789970|139464|P1|Open-label Titration Period|Noncompliance with study procedures|8
31785|NCT01789970|139462|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
31786|NCT01789970|139463|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
31787|NCT01789970|139464|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
31788|NCT01789970|139462|P3|Open-label Titration Period|Noncompliance to study drug admin|0
31789|NCT01789970|139463|P2|Open-label Titration Period|Noncompliance to study drug admin|0
31790|NCT01789970|139464|P1|Open-label Titration Period|Noncompliance to study drug admin|11
31791|NCT01789970|139462|P3|Open-label Titration Period|Lost to Follow-up|0
31792|NCT01789970|139463|P2|Open-label Titration Period|Lost to Follow-up|0
31793|NCT01789970|139464|P1|Open-label Titration Period|Lost to Follow-up|5
31794|NCT01789970|139462|P3|Open-label Titration Period|Protocol Violation|0
31795|NCT01789970|139463|P2|Open-label Titration Period|Protocol Violation|0
31796|NCT01789970|139464|P1|Open-label Titration Period|Protocol Violation|18
31797|NCT01789970|139462|P3|Open-label Titration Period|Withdrawal by Subject|0
31798|NCT01789970|139463|P2|Open-label Titration Period|Withdrawal by Subject|0
31799|NCT01789970|139464|P1|Open-label Titration Period|Withdrawal by Subject|31
31800|NCT01789970|139462|P3|Open-label Titration Period|Lack of Efficacy|0
31801|NCT01789970|139463|P2|Open-label Titration Period|Lack of Efficacy|0
31802|NCT01789970|139464|P1|Open-label Titration Period|Lack of Efficacy|31
31803|NCT01789970|139462|P3|Open-label Titration Period|Adverse Event|0
31804|NCT01789970|139463|P2|Open-label Titration Period|Adverse Event|0
31805|NCT01789970|139464|P1|Open-label Titration Period|Adverse Event|68
31806|NCT01789606|139516|P2|Overall Study|Ineligible or not Willing to Continue|348
31807|NCT01789606|139517|P1|Overall Study|Ineligible or not Willing to Continue|0
31808|NCT01789606|139516|P2|Overall Study|Lost to Follow-up|14
31809|NCT01789606|139517|P1|Overall Study|Lost to Follow-up|0
31810|NCT01789606|139516|P2|Overall Study|Adverse Event|3
31811|NCT01789606|139517|P1|Overall Study|Adverse Event|0
31812|NCT01789606|139516|P2|Overall Study|Protocol Violation|55
31813|NCT01789606|139517|P1|Overall Study|Protocol Violation|0
31814|NCT01789606|139516|P2|Overall Study|No Study Medication Taken|1
31815|NCT01789606|139517|P1|Overall Study|No Study Medication Taken|0
31816|NCT01789606|139516|P2|Overall Study|Administrative Reasons|6
31817|NCT01789606|139517|P1|Overall Study|Administrative Reasons|17
31818|NCT01789606|139516|P2|Overall Study|Ineligible|2
31819|NCT01789606|139517|P1|Overall Study|Ineligible|6
31820|NCT01789606|139516|P2|Overall Study|Withdrawal by Subject|1
31821|NCT01789606|139517|P1|Overall Study|Withdrawal by Subject|0
31822|NCT01789606|139516|P2|Overall Study|Participant not Purchased the Product|20
31823|NCT01789606|139517|P1|Overall Study|Participant not Purchased the Product|0
31824|NCT01789476|139537|P2|Overall Study|Unable to get IV access|0
31825|NCT01789476|139538|P1|Overall Study|Unable to get IV access|1
31826|NCT01789476|139537|P2|Overall Study|Adverse Event|0
31827|NCT01789476|139538|P1|Overall Study|Adverse Event|1
31828|NCT01789476|139537|P2|Overall Study|Lack of Efficacy|2
31829|NCT01789476|139538|P1|Overall Study|Lack of Efficacy|6
31830|NCT01788943|139566|P2|Overall Study|Withdrawal by Subject|0
31831|NCT01788943|139567|P1|Overall Study|Withdrawal by Subject|1
31832|NCT01788566|139596|P1|Overall Study|Clinical Progressive Disease|3
31833|NCT01788566|139596|P1|Overall Study|Adverse Event|1
31834|NCT01788566|139596|P1|Overall Study|Death|4
31835|NCT01788358|139606|P1|Overall Study|Adverse Event|51
31836|NCT01788358|139606|P1|Overall Study|Lack of Efficacy|1
31837|NCT01788358|139606|P1|Overall Study|Withdrawal by Subject|26
31838|NCT01788358|139606|P1|Overall Study|Protocol Violation|3
31839|NCT01788358|139606|P1|Overall Study|Lost to Follow-up|5
31840|NCT01788358|139606|P1|Overall Study|Logistical difficulties|1
31841|NCT01788358|139606|P1|Overall Study|Other|11
31842|NCT01788228|139620|P2|Overall Study|Migrated/moved from study area|0
31843|NCT01788228|139621|P1|Overall Study|Migrated/moved from study area|1
31844|NCT01788215|139640|P2|Overall Study|Lost to Follow-up|0
31845|NCT01788215|139641|P1|Overall Study|Lost to Follow-up|2
31846|NCT01788215|139640|P2|Overall Study|Withdrawal by Subject|1
31847|NCT01788215|139641|P1|Overall Study|Withdrawal by Subject|0
31848|NCT01788163|139670|P9|Overall Study|Withdrawal by Subject|1
31849|NCT01788163|139671|P8|Overall Study|Withdrawal by Subject|0
31850|NCT01788163|139672|P7|Overall Study|Withdrawal by Subject|0
31851|NCT01788163|139673|P6|Overall Study|Withdrawal by Subject|0
31852|NCT01788163|139674|P5|Overall Study|Withdrawal by Subject|0
31853|NCT01788163|139675|P4|Overall Study|Withdrawal by Subject|0
31854|NCT01788163|139676|P3|Overall Study|Withdrawal by Subject|0
31855|NCT01788163|139677|P2|Overall Study|Withdrawal by Subject|0
31856|NCT01788163|139678|P1|Overall Study|Withdrawal by Subject|2
31857|NCT01788163|139670|P9|Overall Study|Other|15
31858|NCT01788163|139671|P8|Overall Study|Other|48
31859|NCT01788163|139672|P7|Overall Study|Other|1
31860|NCT01788163|139673|P6|Overall Study|Other|7
31861|NCT01788163|139674|P5|Overall Study|Other|0
31862|NCT01788163|139675|P4|Overall Study|Other|0
31863|NCT01788163|139676|P3|Overall Study|Other|0
31864|NCT01788163|139677|P2|Overall Study|Other|0
31865|NCT01788163|139678|P1|Overall Study|Other|53
31866|NCT01788046|139841|P2|Overall Study|Protocol Specified Criteria|1
31867|NCT01788046|139842|P1|Overall Study|Protocol Specified Criteria|25
31868|NCT01788046|139841|P2|Overall Study|Death|5
31869|NCT01788046|139842|P1|Overall Study|Death|7
31870|NCT01788046|139841|P2|Overall Study|Lost to Follow-up|19
31871|NCT01788046|139842|P1|Overall Study|Lost to Follow-up|12
31872|NCT01788046|139841|P2|Overall Study|Withdrawal by Subject|12
31873|NCT01788046|139842|P1|Overall Study|Withdrawal by Subject|12
31874|NCT01787838|139865|P1|Overall Study|refused|1413
31875|NCT01787825|139869|P2|Overall Study|Data Not Analyzable|1
31876|NCT01787825|139870|P1|Overall Study|Data Not Analyzable|5
31877|NCT01787825|139869|P2|Overall Study|Subject Did Not Ingest Capsules|0
31878|NCT01787825|139870|P1|Overall Study|Subject Did Not Ingest Capsules|1
31879|NCT01787760|139888|P3|Overall Study|Near vision blur|0
31880|NCT01787760|139889|P2|Overall Study|Near vision blur|0
31881|NCT01787760|139890|P1|Overall Study|Near vision blur|1
31882|NCT01787760|139888|P3|Overall Study|Unsatisfactory visual response|0
31883|NCT01787760|139889|P2|Overall Study|Unsatisfactory visual response|1
31884|NCT01787760|139890|P1|Overall Study|Unsatisfactory visual response|1
31885|NCT01787760|139888|P3|Overall Study|Unsatisfactory physiological response|0
31886|NCT01787760|139889|P2|Overall Study|Unsatisfactory physiological response|4
31887|NCT01787760|139890|P1|Overall Study|Unsatisfactory physiological response|2
31888|NCT01787760|139888|P3|Overall Study|Unsatisfactory lens fitting performance|0
31889|NCT01787760|139889|P2|Overall Study|Unsatisfactory lens fitting performance|6
31890|NCT01787760|139890|P1|Overall Study|Unsatisfactory lens fitting performance|3
31891|NCT01787760|139888|P3|Overall Study|Stroke|0
31892|NCT01787760|139889|P2|Overall Study|Stroke|0
31893|NCT01787760|139890|P1|Overall Study|Stroke|1
31894|NCT01787760|139888|P3|Overall Study|Lost to Follow-up|1
31895|NCT01787760|139889|P2|Overall Study|Lost to Follow-up|0
31896|NCT01787760|139890|P1|Overall Study|Lost to Follow-up|1
31897|NCT01787760|139888|P3|Overall Study|Withdrawal by Subject|2
31898|NCT01787760|139889|P2|Overall Study|Withdrawal by Subject|1
31899|NCT01787760|139890|P1|Overall Study|Withdrawal by Subject|5
31900|NCT01787760|139888|P3|Overall Study|Protocol Violation|1
31901|NCT01787760|139889|P2|Overall Study|Protocol Violation|0
31902|NCT01787760|139890|P1|Overall Study|Protocol Violation|6
31903|NCT01787760|139888|P3|Overall Study|Lens handling difficulty|0
31904|NCT01787760|139889|P2|Overall Study|Lens handling difficulty|2
31905|NCT01787760|139890|P1|Overall Study|Lens handling difficulty|1
31906|NCT01787760|139888|P3|Overall Study|Lens discomfort|0
31907|NCT01787760|139889|P2|Overall Study|Lens discomfort|0
31908|NCT01787760|139890|P1|Overall Study|Lens discomfort|3
31909|NCT01787760|139888|P3|Overall Study|Relocation|0
31910|NCT01787760|139889|P2|Overall Study|Relocation|1
31911|NCT01787760|139890|P1|Overall Study|Relocation|1
31912|NCT01787760|139888|P3|Overall Study|Dryness|0
31913|NCT01787760|139889|P2|Overall Study|Dryness|1
31914|NCT01787760|139890|P1|Overall Study|Dryness|0
31915|NCT01787760|139888|P3|Overall Study|Decompensated on left exotropia|1
31916|NCT01787760|139889|P2|Overall Study|Decompensated on left exotropia|0
31917|NCT01787760|139890|P1|Overall Study|Decompensated on left exotropia|0
31918|NCT01787760|139888|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
31919|NCT01787760|139889|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
31920|NCT01787760|139890|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
31921|NCT01787591|139904|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
31922|NCT01787591|139905|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
31923|NCT01787591|139906|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
31924|NCT01787591|139907|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
31925|NCT01787461|139935|P2|Overall Study|Protocol Violation|0
31926|NCT01787461|139936|P1|Overall Study|Protocol Violation|3
31927|NCT01787461|139935|P2|Overall Study|Withdrawal by Subject|4
31928|NCT01787461|139936|P1|Overall Study|Withdrawal by Subject|3
31929|NCT01787461|139935|P2|Overall Study|No longer met eligibility criteria|0
31930|NCT01787461|139936|P1|Overall Study|No longer met eligibility criteria|1
31931|NCT01787461|139935|P2|Overall Study|Lost to Follow-up|2
31932|NCT01787461|139936|P1|Overall Study|Lost to Follow-up|3
31933|NCT01787461|139935|P2|Overall Study|Adverse Event|3
31934|NCT01787461|139936|P1|Overall Study|Adverse Event|4
31935|NCT01787279|139985|P1|Overall Study|Lack of Efficacy|1
31936|NCT01787279|139985|P1|Overall Study|Lost to Follow-up|2
31937|NCT01787188|140011|P3|Overall Study|Other, including patient moved|0
31938|NCT01787188|140012|P2|Overall Study|Other, including patient moved|3
31939|NCT01787188|140013|P1|Overall Study|Other, including patient moved|0
31940|NCT01787188|140011|P3|Overall Study|Lost to Follow-up|2
31941|NCT01787188|140012|P2|Overall Study|Lost to Follow-up|2
31942|NCT01787188|140013|P1|Overall Study|Lost to Follow-up|1
31943|NCT01787188|140011|P3|Overall Study|Protocol Violation|3
31944|NCT01787188|140012|P2|Overall Study|Protocol Violation|2
31945|NCT01787188|140013|P1|Overall Study|Protocol Violation|3
31946|NCT01787188|140011|P3|Overall Study|Withdrawal by Subject|2
31947|NCT01787188|140012|P2|Overall Study|Withdrawal by Subject|3
31948|NCT01787188|140013|P1|Overall Study|Withdrawal by Subject|4
31949|NCT01787188|140011|P3|Overall Study|Non-compliance with Study Drug|0
31950|NCT01787188|140012|P2|Overall Study|Non-compliance with Study Drug|1
31951|NCT01787188|140013|P1|Overall Study|Non-compliance with Study Drug|0
31952|NCT01787188|140011|P3|Overall Study|Lack of Efficacy|5
31953|NCT01787188|140012|P2|Overall Study|Lack of Efficacy|3
31954|NCT01787188|140013|P1|Overall Study|Lack of Efficacy|7
31955|NCT01787188|140011|P3|Overall Study|Adverse Event|6
31956|NCT01787188|140012|P2|Overall Study|Adverse Event|4
31957|NCT01787188|140013|P1|Overall Study|Adverse Event|2
31958|NCT01787032|140085|P6|Overall Study|Protocol Violation|1
31959|NCT01787032|140086|P5|Overall Study|Protocol Violation|1
31960|NCT01787032|140087|P4|Overall Study|Protocol Violation|0
31961|NCT01787032|140088|P3|Overall Study|Protocol Violation|0
31962|NCT01787032|140089|P2|Overall Study|Protocol Violation|0
31963|NCT01787032|140090|P1|Overall Study|Protocol Violation|0
31964|NCT01786993|140114|P2|Overall Study|Hospice Admission|0
31965|NCT01786993|140115|P1|Overall Study|Hospice Admission|1
31966|NCT01786993|140114|P2|Overall Study|System Explant|0
31967|NCT01786993|140115|P1|Overall Study|System Explant|1
31968|NCT01786993|140114|P2|Overall Study|Subject Non-Compliance|0
31969|NCT01786993|140115|P1|Overall Study|Subject Non-Compliance|1
31970|NCT01786993|140114|P2|Overall Study|Lost to Follow-up|1
31971|NCT01786993|140115|P1|Overall Study|Lost to Follow-up|0
31972|NCT01786993|140114|P2|Overall Study|Withdrawal by Subject|2
31973|NCT01786993|140115|P1|Overall Study|Withdrawal by Subject|3
31974|NCT01786993|140114|P2|Overall Study|Death|7
31975|NCT01786993|140115|P1|Overall Study|Death|6
31976|NCT01786707|140165|P2|Overall Study|Lost to Follow-up|1
31977|NCT01786707|140166|P1|Overall Study|Lost to Follow-up|1
31978|NCT01786668|140178|P4|Overall Study|Lost to Follow-up|0
31979|NCT01786668|140179|P3|Overall Study|Lost to Follow-up|1
31980|NCT01786668|140180|P2|Overall Study|Lost to Follow-up|0
31981|NCT01786668|140181|P1|Overall Study|Lost to Follow-up|1
31982|NCT01786668|140178|P4|Overall Study|Pregnancy|1
31983|NCT01786668|140179|P3|Overall Study|Pregnancy|0
31984|NCT01786668|140180|P2|Overall Study|Pregnancy|0
31985|NCT01786668|140181|P1|Overall Study|Pregnancy|0
31986|NCT01786668|140178|P4|Overall Study|Withdrawal by Subject|1
31987|NCT01786668|140179|P3|Overall Study|Withdrawal by Subject|3
31988|NCT01786668|140180|P2|Overall Study|Withdrawal by Subject|0
31989|NCT01786668|140181|P1|Overall Study|Withdrawal by Subject|0
31990|NCT01786668|140178|P4|Overall Study|Adverse Event|2
31991|NCT01786668|140179|P3|Overall Study|Adverse Event|1
31992|NCT01786668|140180|P2|Overall Study|Adverse Event|1
31993|NCT01786668|140181|P1|Overall Study|Adverse Event|0
31994|NCT01786629|140281|P2|Overall Study|Adverse Event|1
31995|NCT01786629|140282|P1|Overall Study|Adverse Event|0
31996|NCT01786629|140281|P2|Overall Study|Lack of Efficacy|4
31997|NCT01786629|140282|P1|Overall Study|Lack of Efficacy|0
31998|NCT01786551|140288|P1|Overall Study|Participant withdrew consent|2
31999|NCT01786330|140296|P2|Overall Study|Protocol Violation|0
32000|NCT01786330|140297|P1|Overall Study|Protocol Violation|1
32001|NCT01786330|140296|P2|Overall Study|Excluded intraoperatively|1
32002|NCT01786330|140297|P1|Overall Study|Excluded intraoperatively|0
32003|NCT01786330|140296|P2|Overall Study|Lost to Follow-up|1
32004|NCT01786330|140297|P1|Overall Study|Lost to Follow-up|0
32005|NCT01786330|140296|P2|Overall Study|Withdrawal by Subject|1
32006|NCT01786330|140297|P1|Overall Study|Withdrawal by Subject|0
32007|NCT01786174|140335|P2|Overall Study|Discontinued Study Drug|0
32008|NCT01786174|140336|P1|Overall Study|Discontinued Study Drug|2
32009|NCT01786109|140366|P3|Overall Study|adverse effects colon preparation|1
32010|NCT01786109|140367|P2|Overall Study|adverse effects colon preparation|0
32011|NCT01786109|140368|P1|Overall Study|adverse effects colon preparation|0
32012|NCT01786109|140366|P3|Overall Study|unrelated illness|1
32013|NCT01786109|140367|P2|Overall Study|unrelated illness|0
32014|NCT01786109|140368|P1|Overall Study|unrelated illness|0
32015|NCT01786109|140366|P3|Overall Study|fail manometry barostat tube placement|0
32016|NCT01786109|140367|P2|Overall Study|fail manometry barostat tube placement|0
32017|NCT01786109|140368|P1|Overall Study|fail manometry barostat tube placement|1
32018|NCT01785875|140397|P3|Overall Study|Missing|3
32019|NCT01785875|140398|P2|Overall Study|Missing|1
32020|NCT01785875|140399|P1|Overall Study|Missing|0
32021|NCT01785875|140397|P3|Overall Study|Protocol Specified Criteria|55
32022|NCT01785875|140398|P2|Overall Study|Protocol Specified Criteria|214
32023|NCT01785875|140399|P1|Overall Study|Protocol Specified Criteria|207
32024|NCT01785875|140397|P3|Overall Study|Sponsor Decision|0
32025|NCT01785875|140398|P2|Overall Study|Sponsor Decision|2
32026|NCT01785875|140399|P1|Overall Study|Sponsor Decision|0
32027|NCT01785875|140397|P3|Overall Study|Death|7
32028|NCT01785875|140398|P2|Overall Study|Death|16
32029|NCT01785875|140399|P1|Overall Study|Death|27
32030|NCT01785875|140397|P3|Overall Study|Lost to Follow-up|6
32031|NCT01785875|140398|P2|Overall Study|Lost to Follow-up|22
32032|NCT01785875|140399|P1|Overall Study|Lost to Follow-up|19
32033|NCT01785875|140397|P3|Overall Study|Withdrawal by Subject|36
32034|NCT01785875|140398|P2|Overall Study|Withdrawal by Subject|34
32035|NCT01785875|140399|P1|Overall Study|Withdrawal by Subject|41
32036|NCT01785849|140468|P2|Overall Study|Lost to Follow-up|11
32037|NCT01785849|140469|P1|Overall Study|Lost to Follow-up|10
32038|NCT01785849|140468|P2|Overall Study|Sponsor Decision|1
32039|NCT01785849|140469|P1|Overall Study|Sponsor Decision|0
32040|NCT01785849|140468|P2|Overall Study|Withdrawal by Subject|12
32041|NCT01785849|140469|P1|Overall Study|Withdrawal by Subject|15
32042|NCT01785849|140468|P2|Overall Study|Protocol Specified Criteria|1
32043|NCT01785849|140469|P1|Overall Study|Protocol Specified Criteria|29
32044|NCT01785849|140468|P2|Overall Study|Death|9
32045|NCT01785849|140469|P1|Overall Study|Death|7
32046|NCT01785628|140487|P2|Overall Study|Lost to Follow-up|3
32047|NCT01785628|140488|P1|Overall Study|Lost to Follow-up|2
32048|NCT01785615|140511|P4|Dietary Phase|Lost to Follow-up|24
32049|NCT01785615|140512|P3|Dietary Phase|Lost to Follow-up|0
32050|NCT01785615|140513|P2|Dietary Phase|Lost to Follow-up|0
32051|NCT01785615|140514|P1|Dietary Phase|Lost to Follow-up|0
32052|NCT01785602|140586|P2|Overall Study|Administrative problems|3
32053|NCT01785602|140587|P1|Overall Study|Administrative problems|7
32054|NCT01785602|140586|P2|Overall Study|Adverse Event|5
32055|NCT01785602|140587|P1|Overall Study|Adverse Event|3
32056|NCT01785602|140586|P2|Overall Study|Lost to Follow-up|1
32057|NCT01785602|140587|P1|Overall Study|Lost to Follow-up|1
32058|NCT01785602|140586|P2|Overall Study|Withdrawal by Subject|0
32059|NCT01785602|140587|P1|Overall Study|Withdrawal by Subject|2
32060|NCT01785524|140597|P2|Overall Study|Withdrawal by Subject|2
32061|NCT01785524|140598|P1|Overall Study|Withdrawal by Subject|2
32062|NCT01785472|140617|P3|Overall Study|Technical problems|1
32063|NCT01785472|140618|P2|Overall Study|Technical problems|0
32064|NCT01785472|140619|P1|Overall Study|Technical problems|0
32065|NCT01785472|140617|P3|Overall Study|Subject/guardian decision|11
32066|NCT01785472|140618|P2|Overall Study|Subject/guardian decision|10
32067|NCT01785472|140619|P1|Overall Study|Subject/guardian decision|15
32068|NCT01785472|140617|P3|Overall Study|Protocol deviation|2
32069|NCT01785472|140618|P2|Overall Study|Protocol deviation|2
32070|NCT01785472|140619|P1|Overall Study|Protocol deviation|0
32071|NCT01785472|140617|P3|Overall Study|Physician Decision|1
32072|NCT01785472|140618|P2|Overall Study|Physician Decision|1
32073|NCT01785472|140619|P1|Overall Study|Physician Decision|1
32074|NCT01785472|140617|P3|Overall Study|Lost to Follow-up|0
32075|NCT01785472|140618|P2|Overall Study|Lost to Follow-up|2
32076|NCT01785472|140619|P1|Overall Study|Lost to Follow-up|1
32077|NCT01785472|140617|P3|Overall Study|Lack of Efficacy|1
32078|NCT01785472|140618|P2|Overall Study|Lack of Efficacy|0
32079|NCT01785472|140619|P1|Overall Study|Lack of Efficacy|2
32080|NCT01785472|140617|P3|Overall Study|Adverse Event|6
32081|NCT01785472|140618|P2|Overall Study|Adverse Event|4
32082|NCT01785472|140619|P1|Overall Study|Adverse Event|5
32083|NCT01785160|140692|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
32084|NCT01785160|140692|P1|Treatment Period 1: Raltegravir|Not treated|1
32085|NCT01784965|140727|P2|Overall Study|Adverse Event|8
32086|NCT01784965|140728|P1|Overall Study|Adverse Event|0
32087|NCT01784965|140727|P2|Overall Study|Withdrawal by Subject|3
32088|NCT01784965|140728|P1|Overall Study|Withdrawal by Subject|6
32089|NCT01783938|140803|P2|Overall Study|Not Specified|0
32090|NCT01783938|140804|P1|Overall Study|Not Specified|1
32091|NCT01783938|140803|P2|Overall Study|Withdrew Consent|0
32092|NCT01783938|140804|P1|Overall Study|Withdrew Consent|3
32093|NCT01783938|140803|P2|Overall Study|Request to Discontinue Study Treatment|2
32094|NCT01783938|140804|P1|Overall Study|Request to Discontinue Study Treatment|1
32095|NCT01783938|140803|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
32096|NCT01783938|140804|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
32097|NCT01783938|140803|P2|Overall Study|Study Drug Toxicity|10
32098|NCT01783938|140804|P1|Overall Study|Study Drug Toxicity|22
32099|NCT01783938|140803|P2|Overall Study|Disease Progression|39
32100|NCT01783938|140804|P1|Overall Study|Disease Progression|18
32101|NCT01783886|140832|P3|Overall Study|Adverse Event|4
32102|NCT01783886|140833|P2|Overall Study|Adverse Event|5
32103|NCT01783886|140834|P1|Overall Study|Adverse Event|4
32104|NCT01783886|140832|P3|Overall Study|Withdrawal of consent by participant|4
32105|NCT01783886|140833|P2|Overall Study|Withdrawal of consent by participant|3
32106|NCT01783886|140834|P1|Overall Study|Withdrawal of consent by participant|1
32107|NCT01783886|140832|P3|Overall Study|Protocol deviation|2
32108|NCT01783886|140833|P2|Overall Study|Protocol deviation|0
32109|NCT01783886|140834|P1|Overall Study|Protocol deviation|0
32110|NCT01783886|140832|P3|Overall Study|Lost to Follow-up|0
32111|NCT01783886|140833|P2|Overall Study|Lost to Follow-up|3
32112|NCT01783886|140834|P1|Overall Study|Lost to Follow-up|0
32113|NCT01783821|140881|P2|Overall Study|Screen Failure|1
32114|NCT01783821|140882|P1|Overall Study|Screen Failure|1
32115|NCT01783743|140900|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
32116|NCT01783743|140901|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
32117|NCT01783743|140900|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
32118|NCT01783743|140901|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
32119|NCT01783743|140900|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
32120|NCT01783743|140901|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
32121|NCT01783730|140915|P1|Overall Study|Failed to meet inclusion criteria|6
32122|NCT01783678|140940|P6|Overall Study|Withdrew Consent|0
32123|NCT01783678|140941|P5|Overall Study|Withdrew Consent|0
32124|NCT01783678|140942|P4|Overall Study|Withdrew Consent|2
32125|NCT01783678|140943|P3|Overall Study|Withdrew Consent|0
32126|NCT01783678|140944|P2|Overall Study|Withdrew Consent|1
32127|NCT01783678|140945|P1|Overall Study|Withdrew Consent|1
32128|NCT01783678|140940|P6|Overall Study|Lost to Follow-up|0
32129|NCT01783678|140941|P5|Overall Study|Lost to Follow-up|1
32130|NCT01783678|140942|P4|Overall Study|Lost to Follow-up|2
32131|NCT01783678|140943|P3|Overall Study|Lost to Follow-up|0
32132|NCT01783678|140944|P2|Overall Study|Lost to Follow-up|4
32133|NCT01783678|140945|P1|Overall Study|Lost to Follow-up|0
32134|NCT01783678|140940|P6|Overall Study|Lack of Efficacy|5
32135|NCT01783678|140941|P5|Overall Study|Lack of Efficacy|6
32136|NCT01783678|140942|P4|Overall Study|Lack of Efficacy|3
32137|NCT01783678|140943|P3|Overall Study|Lack of Efficacy|1
32138|NCT01783678|140944|P2|Overall Study|Lack of Efficacy|13
32139|NCT01783678|140945|P1|Overall Study|Lack of Efficacy|1
32140|NCT01783678|140940|P6|Overall Study|Randomized but Not Treated|0
32141|NCT01783678|140941|P5|Overall Study|Randomized but Not Treated|0
32142|NCT01783678|140942|P4|Overall Study|Randomized but Not Treated|1
32143|NCT01783678|140943|P3|Overall Study|Randomized but Not Treated|0
32144|NCT01783678|140944|P2|Overall Study|Randomized but Not Treated|0
32145|NCT01783678|140945|P1|Overall Study|Randomized but Not Treated|0
32146|NCT01783548|141047|P2|Overall Study|Lack of Efficacy|1
32147|NCT01783548|141048|P1|Overall Study|Lack of Efficacy|1
32148|NCT01783548|141047|P2|Overall Study|Lost to Follow-up|3
32149|NCT01783548|141048|P1|Overall Study|Lost to Follow-up|8
32150|NCT01783548|141047|P2|Overall Study|Protocol Violation|2
32151|NCT01783548|141048|P1|Overall Study|Protocol Violation|2
32152|NCT01783548|141047|P2|Overall Study|Non-compliance|0
32153|NCT01783548|141048|P1|Overall Study|Non-compliance|4
32154|NCT01783548|141047|P2|Overall Study|Withdrawal by Subject|8
32155|NCT01783548|141048|P1|Overall Study|Withdrawal by Subject|11
32156|NCT01783548|141047|P2|Overall Study|Adverse Event|4
32157|NCT01783548|141048|P1|Overall Study|Adverse Event|8
32158|NCT01783496|141066|P6|Overall Study|Withdrawal by Subject|0
32159|NCT01783496|141067|P5|Overall Study|Withdrawal by Subject|0
32160|NCT01783496|141068|P4|Overall Study|Withdrawal by Subject|0
32161|NCT01783496|141069|P3|Overall Study|Withdrawal by Subject|0
32162|NCT01783496|141070|P2|Overall Study|Withdrawal by Subject|0
32163|NCT01783496|141071|P1|Overall Study|Withdrawal by Subject|1
32164|NCT01783496|141066|P6|Overall Study|Lost to Follow-up|1
32165|NCT01783496|141067|P5|Overall Study|Lost to Follow-up|0
32166|NCT01783496|141068|P4|Overall Study|Lost to Follow-up|2
32167|NCT01783496|141069|P3|Overall Study|Lost to Follow-up|0
32168|NCT01783496|141070|P2|Overall Study|Lost to Follow-up|0
32169|NCT01783496|141071|P1|Overall Study|Lost to Follow-up|0
32170|NCT01783483|141099|P2|Overall Study|Physician Decision|1
32171|NCT01783483|141100|P1|Overall Study|Physician Decision|1
32172|NCT01783483|141099|P2|Overall Study|Withdrawal by Subject|1
32173|NCT01783483|141100|P1|Overall Study|Withdrawal by Subject|2
32174|NCT01783483|141099|P2|Overall Study|Lost to Follow-up|10
32175|NCT01783483|141100|P1|Overall Study|Lost to Follow-up|14
32176|NCT01783483|141099|P2|Overall Study|Death|3
32177|NCT01783483|141100|P1|Overall Study|Death|3
32178|NCT01783418|141138|P2|Overall Study|Withdrawal by Subject|0
32179|NCT01783418|141139|P1|Overall Study|Withdrawal by Subject|1
32180|NCT01783015|141192|P3|Open Label Treatment|Study Terminated by Sponsor|6
32181|NCT01783015|141193|P2|Open Label Treatment|Study Terminated by Sponsor|0
32182|NCT01783015|141194|P1|Open Label Treatment|Study Terminated by Sponsor|0
32183|NCT01783015|141192|P3|Blinded Treatment|Study Terminated by Sponsor|0
32184|NCT01783015|141193|P2|Blinded Treatment|Study Terminated by Sponsor|0
32185|NCT01783015|141194|P1|Blinded Treatment|Study Terminated by Sponsor|2
32186|NCT01783015|141192|P3|Blinded Treatment|Withdrawal by Subject|0
32187|NCT01783015|141193|P2|Blinded Treatment|Withdrawal by Subject|1
32188|NCT01783015|141194|P1|Blinded Treatment|Withdrawal by Subject|0
32189|NCT01783015|141192|P3|Blinded Treatment|Protocol Violation|0
32190|NCT01783015|141193|P2|Blinded Treatment|Protocol Violation|1
32191|NCT01783015|141194|P1|Blinded Treatment|Protocol Violation|0
32192|NCT01783015|141192|P3|Blinded Treatment|Adverse Event|0
32193|NCT01783015|141193|P2|Blinded Treatment|Adverse Event|1
32194|NCT01783015|141194|P1|Blinded Treatment|Adverse Event|0
32195|NCT01782885|141303|P2|Overall Study|Lost to Follow-up|6
32196|NCT01782885|141304|P1|Overall Study|Lost to Follow-up|4
32197|NCT01782872|141330|P4|Overall Study|Withdrawal by Subject|0
32198|NCT01782872|141331|P3|Overall Study|Withdrawal by Subject|0
32199|NCT01782872|141332|P2|Overall Study|Withdrawal by Subject|1
32200|NCT01782872|141333|P1|Overall Study|Withdrawal by Subject|0
32201|NCT01782872|141330|P4|Overall Study|Protocol Violation|1
32202|NCT01782872|141331|P3|Overall Study|Protocol Violation|0
32203|NCT01782872|141332|P2|Overall Study|Protocol Violation|0
32204|NCT01782872|141333|P1|Overall Study|Protocol Violation|0
32205|NCT01782859|141357|P2|Overall Study|Withdrawal by Subject|1
32206|NCT01782859|141358|P1|Overall Study|Withdrawal by Subject|0
32207|NCT01782859|141357|P2|Overall Study|Protocol Violation|6
32208|NCT01782859|141358|P1|Overall Study|Protocol Violation|6
32209|NCT01782742|141374|P2|Double-blind Treatment Phase|Adverse Event|0
32210|NCT01782742|141375|P1|Double-blind Treatment Phase|Adverse Event|1
32211|NCT01782664|141414|P6|Overall Study|Withdrawal by Subject|0
32212|NCT01782664|141415|P5|Overall Study|Withdrawal by Subject|0
32213|NCT01782664|141416|P4|Overall Study|Withdrawal by Subject|0
32214|NCT01782664|141417|P3|Overall Study|Withdrawal by Subject|0
32215|NCT01782664|141418|P2|Overall Study|Withdrawal by Subject|2
32216|NCT01782664|141419|P1|Overall Study|Withdrawal by Subject|2
32217|NCT01782664|141414|P6|Overall Study|Protocol Violation|0
32218|NCT01782664|141415|P5|Overall Study|Protocol Violation|0
32219|NCT01782664|141416|P4|Overall Study|Protocol Violation|1
32220|NCT01782664|141417|P3|Overall Study|Protocol Violation|0
32221|NCT01782664|141418|P2|Overall Study|Protocol Violation|1
32222|NCT01782664|141419|P1|Overall Study|Protocol Violation|0
32223|NCT01782664|141414|P6|Overall Study|Lack of Efficacy|0
32224|NCT01782664|141415|P5|Overall Study|Lack of Efficacy|0
32225|NCT01782664|141416|P4|Overall Study|Lack of Efficacy|2
32226|NCT01782664|141417|P3|Overall Study|Lack of Efficacy|2
32227|NCT01782664|141418|P2|Overall Study|Lack of Efficacy|0
32228|NCT01782664|141419|P1|Overall Study|Lack of Efficacy|2
32229|NCT01782664|141414|P6|Overall Study|Adverse Event|0
32230|NCT01782664|141415|P5|Overall Study|Adverse Event|0
32231|NCT01782664|141416|P4|Overall Study|Adverse Event|2
32232|NCT01782664|141417|P3|Overall Study|Adverse Event|2
32233|NCT01782664|141418|P2|Overall Study|Adverse Event|2
32234|NCT01782664|141419|P1|Overall Study|Adverse Event|2
32235|NCT01782495|141576|P11|Overall Study|Withdrew Consent|0
32236|NCT01782495|141577|P10|Overall Study|Withdrew Consent|0
32237|NCT01782495|141578|P9|Overall Study|Withdrew Consent|0
32238|NCT01782495|141579|P8|Overall Study|Withdrew Consent|1
32239|NCT01782495|141580|P7|Overall Study|Withdrew Consent|0
32240|NCT01782495|141581|P6|Overall Study|Withdrew Consent|0
32241|NCT01782495|141582|P5|Overall Study|Withdrew Consent|0
32242|NCT01782495|141583|P4|Overall Study|Withdrew Consent|0
32243|NCT01782495|141584|P3|Overall Study|Withdrew Consent|0
32244|NCT01782495|141585|P2|Overall Study|Withdrew Consent|1
32245|NCT01782495|141586|P1|Overall Study|Withdrew Consent|0
32246|NCT01782495|141576|P11|Overall Study|Adverse Event|0
32247|NCT01782495|141577|P10|Overall Study|Adverse Event|0
32248|NCT01782495|141578|P9|Overall Study|Adverse Event|0
32249|NCT01782495|141579|P8|Overall Study|Adverse Event|2
32250|NCT01782495|141580|P7|Overall Study|Adverse Event|0
32251|NCT01782495|141581|P6|Overall Study|Adverse Event|0
32252|NCT01782495|141582|P5|Overall Study|Adverse Event|0
32253|NCT01782495|141583|P4|Overall Study|Adverse Event|0
32254|NCT01782495|141584|P3|Overall Study|Adverse Event|0
32255|NCT01782495|141585|P2|Overall Study|Adverse Event|0
32256|NCT01782495|141586|P1|Overall Study|Adverse Event|0
32257|NCT01782482|141645|P2|Overall Study|Habitually wearing toric lens OS|1
32258|NCT01782482|141646|P1|Overall Study|Habitually wearing toric lens OS|0
32259|NCT01782482|141645|P2|Overall Study|Randomized in Error|2
32260|NCT01782482|141646|P1|Overall Study|Randomized in Error|2
32261|NCT01782482|141645|P2|Overall Study|Withdrawal by Subject|3
32262|NCT01782482|141646|P1|Overall Study|Withdrawal by Subject|2
32263|NCT01782482|141645|P2|Overall Study|Protocol Violation|0
32264|NCT01782482|141646|P1|Overall Study|Protocol Violation|1
32265|NCT01782482|141645|P2|Overall Study|Physician Decision|0
32266|NCT01782482|141646|P1|Overall Study|Physician Decision|1
32267|NCT01782482|141645|P2|Overall Study|Lost to Follow-up|3
32268|NCT01782482|141646|P1|Overall Study|Lost to Follow-up|2
32269|NCT01782482|141645|P2|Overall Study|Adverse Event|1
32270|NCT01782482|141646|P1|Overall Study|Adverse Event|2
32271|NCT01782469|141654|P1|Overall Study|Lost to Follow-up|1
32272|NCT01782326|141664|P2|Double-blind Treatment|Technical problems|5
32273|NCT01782326|141665|P1|Double-blind Treatment|Technical problems|0
32274|NCT01782326|141664|P2|Double-blind Treatment|Protocol deviation|7
32275|NCT01782326|141665|P1|Double-blind Treatment|Protocol deviation|8
32276|NCT01782326|141664|P2|Double-blind Treatment|Physician Decision|16
32277|NCT01782326|141665|P1|Double-blind Treatment|Physician Decision|13
32278|NCT01782326|141664|P2|Double-blind Treatment|Lack of Efficacy|22
32279|NCT01782326|141665|P1|Double-blind Treatment|Lack of Efficacy|17
32280|NCT01782326|141664|P2|Double-blind Treatment|Subject/guardian decision|125
32281|NCT01782326|141665|P1|Double-blind Treatment|Subject/guardian decision|111
32282|NCT01782326|141664|P2|Double-blind Treatment|Adverse Event|145
32283|NCT01782326|141665|P1|Double-blind Treatment|Adverse Event|129
32284|NCT01782326|141664|P2|Planned Treatment Epoch|Technical problems|4
32285|NCT01782326|141665|P1|Planned Treatment Epoch|Technical problems|0
32286|NCT01782326|141664|P2|Planned Treatment Epoch|Lost to Follow-up|4
32287|NCT01782326|141665|P1|Planned Treatment Epoch|Lost to Follow-up|4
32288|NCT01782326|141664|P2|Planned Treatment Epoch|Protocol deviation|3
32289|NCT01782326|141665|P1|Planned Treatment Epoch|Protocol deviation|2
32290|NCT01782326|141664|P2|Planned Treatment Epoch|Physician Decision|16
32291|NCT01782326|141665|P1|Planned Treatment Epoch|Physician Decision|18
32292|NCT01782326|141664|P2|Planned Treatment Epoch|Death|30
32293|NCT01782326|141665|P1|Planned Treatment Epoch|Death|29
32294|NCT01782326|141664|P2|Planned Treatment Epoch|Subject/guardian decision|151
32295|NCT01782326|141665|P1|Planned Treatment Epoch|Subject/guardian decision|149
32296|NCT01782222|141728|P3|Overall Study|Moved to other state|0
32297|NCT01782222|141729|P2|Overall Study|Moved to other state|1
32298|NCT01782222|141730|P1|Overall Study|Moved to other state|0
32299|NCT01782222|141728|P3|Overall Study|Withdrawal by Subject|1
32300|NCT01782222|141729|P2|Overall Study|Withdrawal by Subject|4
32301|NCT01782222|141730|P1|Overall Study|Withdrawal by Subject|1
32302|NCT01782222|141728|P3|Overall Study|Protocol Violation|0
32303|NCT01782222|141729|P2|Overall Study|Protocol Violation|0
32304|NCT01782222|141730|P1|Overall Study|Protocol Violation|1
32305|NCT01782222|141728|P3|Overall Study|Lack of Efficacy|0
32306|NCT01782222|141729|P2|Overall Study|Lack of Efficacy|1
32307|NCT01782222|141730|P1|Overall Study|Lack of Efficacy|2
32308|NCT01782222|141728|P3|Overall Study|Adverse Event|3
32309|NCT01782222|141729|P2|Overall Study|Adverse Event|5
32310|NCT01782222|141730|P1|Overall Study|Adverse Event|4
32311|NCT01781962|141762|P1|Overall Study|Other Miscellaneous Reasons|5
32312|NCT01781832|141768|P1|Overall Study|Withdrawal by Subject|1
32313|NCT01781637|141788|P2|Overall Study|Withdrawal by Subject|0
32314|NCT01781637|141789|P1|Overall Study|Withdrawal by Subject|1
32315|NCT01781637|141788|P2|Overall Study|Lack of Efficacy|6
32316|NCT01781637|141789|P1|Overall Study|Lack of Efficacy|2
32317|NCT01781637|141788|P2|Overall Study|Adverse Event|0
32318|NCT01781637|141789|P1|Overall Study|Adverse Event|1
32319|NCT01781299|141876|P2|Overall Study|Withdrawal by Subject|1
32320|NCT01781299|141877|P1|Overall Study|Withdrawal by Subject|0
32321|NCT01781026|141913|P1|Overall Study|Lack of Efficacy|2
32322|NCT01780987|141919|P2|Overall Study|Not Receiving any Study Medication|1
32323|NCT01780987|141920|P1|Overall Study|Not Receiving any Study Medication|0
32324|NCT01780987|141919|P2|Overall Study|Changing Residence|0
32325|NCT01780987|141920|P1|Overall Study|Changing Residence|1
32326|NCT01780987|141919|P2|Overall Study|Request of Changing Hospital|1
32327|NCT01780987|141920|P1|Overall Study|Request of Changing Hospital|0
32328|NCT01780987|141919|P2|Overall Study|Withdrawal by Subject|0
32329|NCT01780987|141920|P1|Overall Study|Withdrawal by Subject|2
32330|NCT01780987|141919|P2|Overall Study|Adverse Event|4
32331|NCT01780987|141920|P1|Overall Study|Adverse Event|0
32332|NCT01780974|141938|P2|Overall Study|Adverse Event|3
32333|NCT01780974|141939|P1|Overall Study|Adverse Event|1
32334|NCT01780974|141938|P2|Overall Study|Death|0
32335|NCT01780974|141939|P1|Overall Study|Death|1
32336|NCT01780935|141949|P2|Overall Study|Patient withdrew consent|9
32337|NCT01780935|141950|P1|Overall Study|Patient withdrew consent|8
32338|NCT01780935|141949|P2|Overall Study|Protocol deviation|1
32339|NCT01780935|141950|P1|Overall Study|Protocol deviation|0
32340|NCT01780935|141949|P2|Overall Study|Physician Decision|1
32341|NCT01780935|141950|P1|Overall Study|Physician Decision|1
32342|NCT01780935|141949|P2|Overall Study|Lost to Follow-up|6
32343|NCT01780935|141950|P1|Overall Study|Lost to Follow-up|2
32344|NCT01780935|141949|P2|Overall Study|Death|6
32345|NCT01780935|141950|P1|Overall Study|Death|1
32346|NCT01780935|141949|P2|Overall Study|Adverse Event|4
32347|NCT01780935|141950|P1|Overall Study|Adverse Event|2
32348|NCT01780935|141949|P2|Overall Study|Admin problems due to early termination|309
32349|NCT01780935|141950|P1|Overall Study|Admin problems due to early termination|321
32350|NCT01780584|142054|P3|Overall Study|Protocol Violation|1
32351|NCT01780584|142055|P2|Overall Study|Protocol Violation|0
32352|NCT01780584|142056|P1|Overall Study|Protocol Violation|0
32353|NCT01780584|142054|P3|Overall Study|Adverse Event|0
32354|NCT01780584|142055|P2|Overall Study|Adverse Event|1
32355|NCT01780584|142056|P1|Overall Study|Adverse Event|0
32356|NCT01780584|142054|P3|Overall Study|Death|1
32357|NCT01780584|142055|P2|Overall Study|Death|0
32358|NCT01780584|142056|P1|Overall Study|Death|1
32359|NCT01780545|142078|P2|Overall Study|Lost to Follow-up|1
32360|NCT01780545|142079|P1|Overall Study|Lost to Follow-up|1
32361|NCT01780545|142078|P2|Overall Study|Withdrawal by Subject|1
32362|NCT01780545|142079|P1|Overall Study|Withdrawal by Subject|3
32363|NCT01780506|142097|P2|Overall Study|Still on Study|388
32364|NCT01780506|142098|P1|Overall Study|Still on Study|401
32365|NCT01780506|142097|P2|Overall Study|Lost to Follow-up|14
32366|NCT01780506|142098|P1|Overall Study|Lost to Follow-up|10
32367|NCT01780506|142097|P2|Overall Study|Withdrew Consent|15
32368|NCT01780506|142098|P1|Overall Study|Withdrew Consent|13
32369|NCT01780506|142097|P2|Overall Study|Protocol Violation|3
32370|NCT01780506|142098|P1|Overall Study|Protocol Violation|3
32371|NCT01780506|142097|P2|Overall Study|Non-Compliance with Study Drug|1
32372|NCT01780506|142098|P1|Overall Study|Non-Compliance with Study Drug|1
32373|NCT01780506|142097|P2|Overall Study|Investigator's Discretion|1
32374|NCT01780506|142098|P1|Overall Study|Investigator's Discretion|2
32375|NCT01780506|142097|P2|Overall Study|Lack of Efficacy|1
32376|NCT01780506|142098|P1|Overall Study|Lack of Efficacy|1
32377|NCT01780506|142097|P2|Overall Study|Pregnancy|0
32378|NCT01780506|142098|P1|Overall Study|Pregnancy|1
32379|NCT01780506|142097|P2|Overall Study|Death|1
32380|NCT01780506|142098|P1|Overall Study|Death|0
32381|NCT01780506|142097|P2|Overall Study|Adverse Event|8
32382|NCT01780506|142098|P1|Overall Study|Adverse Event|3
32383|NCT01780506|142097|P2|Overall Study|Randomized but not Treated|2
32384|NCT01780506|142098|P1|Overall Study|Randomized but not Treated|3
32385|NCT01780389|142136|P1|Overall Study|Adverse Event|1
32386|NCT01779648|142176|P2|Overall Study|Protocol Violation|0
32387|NCT01779648|142177|P1|Overall Study|Protocol Violation|1
32388|NCT01778985|142227|P2|Overall Study|Protocol Violation|1
32389|NCT01778985|142228|P1|Overall Study|Protocol Violation|4
32390|NCT01778985|142227|P2|Overall Study|Physician Decision|2
32391|NCT01778985|142228|P1|Overall Study|Physician Decision|2
32392|NCT01778985|142227|P2|Overall Study|Lost to Follow-up|0
32393|NCT01778985|142228|P1|Overall Study|Lost to Follow-up|1
32394|NCT01778855|142274|P2|Overall Study|Death|1
32395|NCT01778855|142275|P1|Overall Study|Death|0
32396|NCT01778751|142283|P2|Overall Study|Transfered care|0
32397|NCT01778751|142284|P1|Overall Study|Transfered care|1
32398|NCT01778751|142283|P2|Overall Study|Withdrawal by Subject|2
32399|NCT01778751|142284|P1|Overall Study|Withdrawal by Subject|0
32400|NCT01778751|142283|P2|Overall Study|Lost to Follow-up|0
32401|NCT01778751|142284|P1|Overall Study|Lost to Follow-up|1
32402|NCT01778530|142335|P1|Overall Study|Adverse event/side effect|1
32403|NCT01778530|142335|P1|Overall Study|Progression on study|1
32404|NCT01778127|142347|P3|Overall Study|Withdrawal by Subject|4
32405|NCT01778127|142348|P2|Overall Study|Withdrawal by Subject|1
32406|NCT01778127|142349|P1|Overall Study|Withdrawal by Subject|3
32407|NCT01778127|142347|P3|Overall Study|Lost to Follow-up|2
32408|NCT01778127|142348|P2|Overall Study|Lost to Follow-up|1
32409|NCT01778127|142349|P1|Overall Study|Lost to Follow-up|5
32410|NCT01778062|142392|P2|Overall Study|major protocol deviation|3
32411|NCT01778062|142393|P1|Overall Study|major protocol deviation|4
32412|NCT01778062|142392|P2|Overall Study|Consent Withdrawal|5
32413|NCT01778062|142393|P1|Overall Study|Consent Withdrawal|1
32414|NCT01778062|142392|P2|Overall Study|Adverse Event|3
32415|NCT01778062|142393|P1|Overall Study|Adverse Event|1
32416|NCT01778049|142407|P6|Double Blind Treatment Period|Other reason not defined above|1
32417|NCT01778049|142408|P5|Double Blind Treatment Period|Other reason not defined above|2
32418|NCT01778049|142409|P4|Double Blind Treatment Period|Other reason not defined above|2
32419|NCT01778049|142410|P3|Double Blind Treatment Period|Other reason not defined above|4
32420|NCT01778049|142411|P2|Double Blind Treatment Period|Other reason not defined above|0
32421|NCT01778049|142412|P1|Double Blind Treatment Period|Other reason not defined above|0
32422|NCT01778049|142407|P6|Double Blind Treatment Period|Not treated|0
32423|NCT01778049|142408|P5|Double Blind Treatment Period|Not treated|2
32424|NCT01778049|142409|P4|Double Blind Treatment Period|Not treated|2
32425|NCT01778049|142410|P3|Double Blind Treatment Period|Not treated|0
32426|NCT01778049|142411|P2|Double Blind Treatment Period|Not treated|0
32427|NCT01778049|142412|P1|Double Blind Treatment Period|Not treated|0
32428|NCT01778049|142407|P6|Double Blind Treatment Period|Withdrawal by Subject|1
32429|NCT01778049|142408|P5|Double Blind Treatment Period|Withdrawal by Subject|0
32430|NCT01778049|142409|P4|Double Blind Treatment Period|Withdrawal by Subject|2
32431|NCT01778049|142410|P3|Double Blind Treatment Period|Withdrawal by Subject|1
32432|NCT01778049|142411|P2|Double Blind Treatment Period|Withdrawal by Subject|0
32433|NCT01778049|142412|P1|Double Blind Treatment Period|Withdrawal by Subject|0
32434|NCT01778049|142407|P6|Double Blind Treatment Period|Lost to Follow-up|2
32435|NCT01778049|142408|P5|Double Blind Treatment Period|Lost to Follow-up|5
32436|NCT01778049|142409|P4|Double Blind Treatment Period|Lost to Follow-up|1
32437|NCT01778049|142410|P3|Double Blind Treatment Period|Lost to Follow-up|4
32438|NCT01778049|142411|P2|Double Blind Treatment Period|Lost to Follow-up|0
32439|NCT01778049|142412|P1|Double Blind Treatment Period|Lost to Follow-up|0
32440|NCT01778049|142407|P6|Double Blind Treatment Period|Protocol Violation|0
32441|NCT01778049|142408|P5|Double Blind Treatment Period|Protocol Violation|0
32442|NCT01778049|142409|P4|Double Blind Treatment Period|Protocol Violation|0
32443|NCT01778049|142410|P3|Double Blind Treatment Period|Protocol Violation|2
32444|NCT01778049|142411|P2|Double Blind Treatment Period|Protocol Violation|0
32445|NCT01778049|142412|P1|Double Blind Treatment Period|Protocol Violation|0
32446|NCT01778049|142407|P6|Double Blind Treatment Period|Lack of Efficacy|1
32447|NCT01778049|142408|P5|Double Blind Treatment Period|Lack of Efficacy|0
32448|NCT01778049|142409|P4|Double Blind Treatment Period|Lack of Efficacy|0
32449|NCT01778049|142410|P3|Double Blind Treatment Period|Lack of Efficacy|0
32450|NCT01778049|142411|P2|Double Blind Treatment Period|Lack of Efficacy|0
32451|NCT01778049|142412|P1|Double Blind Treatment Period|Lack of Efficacy|0
32452|NCT01778049|142407|P6|Double Blind Treatment Period|Adverse Event|2
32453|NCT01778049|142408|P5|Double Blind Treatment Period|Adverse Event|3
32454|NCT01778049|142409|P4|Double Blind Treatment Period|Adverse Event|5
32455|NCT01778049|142410|P3|Double Blind Treatment Period|Adverse Event|4
32456|NCT01778049|142411|P2|Double Blind Treatment Period|Adverse Event|0
32457|NCT01778049|142412|P1|Double Blind Treatment Period|Adverse Event|0
32458|NCT01778049|142407|P6|Open Label Treatment Period|Other reason not defined above|0
32459|NCT01778049|142408|P5|Open Label Treatment Period|Other reason not defined above|0
32460|NCT01778049|142409|P4|Open Label Treatment Period|Other reason not defined above|0
32461|NCT01778049|142410|P3|Open Label Treatment Period|Other reason not defined above|0
32462|NCT01778049|142411|P2|Open Label Treatment Period|Other reason not defined above|94
32463|NCT01778049|142412|P1|Open Label Treatment Period|Other reason not defined above|77
32464|NCT01778049|142407|P6|Open Label Treatment Period|Not treated|0
32465|NCT01778049|142408|P5|Open Label Treatment Period|Not treated|0
32466|NCT01778049|142409|P4|Open Label Treatment Period|Not treated|0
32467|NCT01778049|142410|P3|Open Label Treatment Period|Not treated|0
32468|NCT01778049|142411|P2|Open Label Treatment Period|Not treated|1
32469|NCT01778049|142412|P1|Open Label Treatment Period|Not treated|2
32470|NCT01778049|142407|P6|Open Label Treatment Period|Withdrawal by Subject|0
32471|NCT01778049|142408|P5|Open Label Treatment Period|Withdrawal by Subject|0
32472|NCT01778049|142409|P4|Open Label Treatment Period|Withdrawal by Subject|0
32473|NCT01778049|142410|P3|Open Label Treatment Period|Withdrawal by Subject|0
32474|NCT01778049|142411|P2|Open Label Treatment Period|Withdrawal by Subject|10
32475|NCT01778049|142412|P1|Open Label Treatment Period|Withdrawal by Subject|4
32476|NCT01778049|142407|P6|Open Label Treatment Period|Lost to Follow-up|0
32477|NCT01778049|142408|P5|Open Label Treatment Period|Lost to Follow-up|0
32478|NCT01778049|142409|P4|Open Label Treatment Period|Lost to Follow-up|0
32479|NCT01778049|142410|P3|Open Label Treatment Period|Lost to Follow-up|0
32480|NCT01778049|142411|P2|Open Label Treatment Period|Lost to Follow-up|3
32481|NCT01778049|142412|P1|Open Label Treatment Period|Lost to Follow-up|4
32482|NCT01778049|142407|P6|Open Label Treatment Period|Protocol Violation|0
32483|NCT01778049|142408|P5|Open Label Treatment Period|Protocol Violation|0
32484|NCT01778049|142409|P4|Open Label Treatment Period|Protocol Violation|0
32485|NCT01778049|142410|P3|Open Label Treatment Period|Protocol Violation|0
32486|NCT01778049|142411|P2|Open Label Treatment Period|Protocol Violation|5
32487|NCT01778049|142412|P1|Open Label Treatment Period|Protocol Violation|5
32488|NCT01778049|142407|P6|Open Label Treatment Period|Lack of Efficacy|0
32489|NCT01778049|142408|P5|Open Label Treatment Period|Lack of Efficacy|0
32490|NCT01778049|142409|P4|Open Label Treatment Period|Lack of Efficacy|0
32491|NCT01778049|142410|P3|Open Label Treatment Period|Lack of Efficacy|0
32492|NCT01778049|142411|P2|Open Label Treatment Period|Lack of Efficacy|1
32493|NCT01778049|142412|P1|Open Label Treatment Period|Lack of Efficacy|1
32494|NCT01778049|142407|P6|Open Label Treatment Period|Adverse Event|0
32495|NCT01778049|142408|P5|Open Label Treatment Period|Adverse Event|0
32496|NCT01778049|142409|P4|Open Label Treatment Period|Adverse Event|0
32497|NCT01778049|142410|P3|Open Label Treatment Period|Adverse Event|0
32498|NCT01778049|142411|P2|Open Label Treatment Period|Adverse Event|15
32499|NCT01778049|142412|P1|Open Label Treatment Period|Adverse Event|5
32500|NCT01778023|142430|P2|Overall Study|Withdrawal by Subject|3
32501|NCT01778023|142431|P1|Overall Study|Withdrawal by Subject|0
32502|NCT01778010|142448|P1|Overall Study|rash while on placebo|1
32503|NCT01778010|142448|P1|Overall Study|Arrested|1
32504|NCT01778010|142448|P1|Overall Study|abnormal ECG before meds|1
32505|NCT01778010|142448|P1|Overall Study|Withdrawal by Subject|2
32506|NCT01777997|142489|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
32507|NCT01777997|142489|P1|Weeks 48 to 72/96 on ART|Death|1
32508|NCT01777997|142489|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
32509|NCT01777997|142489|P1|12 Week lead-in of no ART|Severe debilitation|2
32510|NCT01777932|142511|P1|Overall Study|Patient refused further treatment|10
32511|NCT01777932|142511|P1|Overall Study|Reimbursement limit|9
32512|NCT01777932|142511|P1|Overall Study|Investigator decision|10
32513|NCT01777932|142511|P1|Overall Study|Lost to Follow-up|3
32514|NCT01777932|142511|P1|Overall Study|Adverse Event|34
32515|NCT01777932|142511|P1|Overall Study|Death|3
32516|NCT01777932|142511|P1|Overall Study|Disease progression|136
32517|NCT01777776|142529|P4|Overall Study|Withdrawal by Subject|1
32518|NCT01777776|142530|P3|Overall Study|Withdrawal by Subject|0
32519|NCT01777776|142531|P2|Overall Study|Withdrawal by Subject|0
32520|NCT01777776|142532|P1|Overall Study|Withdrawal by Subject|0
32521|NCT01777776|142529|P4|Overall Study|Disease Progression|3
32522|NCT01777776|142530|P3|Overall Study|Disease Progression|6
32523|NCT01777776|142531|P2|Overall Study|Disease Progression|8
32524|NCT01777776|142532|P1|Overall Study|Disease Progression|4
32525|NCT01777776|142529|P4|Overall Study|Adverse Event|0
32526|NCT01777776|142530|P3|Overall Study|Adverse Event|0
32527|NCT01777776|142531|P2|Overall Study|Adverse Event|4
32528|NCT01777776|142532|P1|Overall Study|Adverse Event|2
32529|NCT01777763|142591|P2|Overall Study|Treatment Failure|6
32530|NCT01777763|142592|P1|Overall Study|Treatment Failure|1
32531|NCT01777763|142591|P2|Overall Study|Withdrawal by Subject|2
32532|NCT01777763|142592|P1|Overall Study|Withdrawal by Subject|0
32533|NCT01777763|142591|P2|Overall Study|Protocol Violation|7
32534|NCT01777763|142592|P1|Overall Study|Protocol Violation|1
32535|NCT01777763|142591|P2|Overall Study|Adverse Event|32
32536|NCT01777763|142592|P1|Overall Study|Adverse Event|2
32537|NCT01777620|142616|P2|Overall Study|Subject Withdrawal|0
32538|NCT01777620|142617|P1|Overall Study|Subject Withdrawal|1
32539|NCT01777581|142643|P2|Overall Study|Lack of Efficacy|1
32540|NCT01777581|142644|P1|Overall Study|Lack of Efficacy|0
32541|NCT01777581|142643|P2|Overall Study|Adverse Event|0
32542|NCT01777581|142644|P1|Overall Study|Adverse Event|2
32543|NCT01777581|142643|P2|Overall Study|Lost to Follow-up|1
32544|NCT01777581|142644|P1|Overall Study|Lost to Follow-up|1
32545|NCT01777542|142662|P2|Second Intervention (20 Weeks)|Adverse Event|1
32546|NCT01777542|142663|P1|Second Intervention (20 Weeks)|Adverse Event|0
32547|NCT01777334|142731|P2|Overall Study|Withdrawal by Subject|11
32548|NCT01777334|142732|P1|Overall Study|Withdrawal by Subject|14
32549|NCT01777334|142731|P2|Overall Study|Lost to Follow-up|2
32550|NCT01777334|142732|P1|Overall Study|Lost to Follow-up|3
32551|NCT01777334|142731|P2|Overall Study|Protocol Violation|7
32552|NCT01777334|142732|P1|Overall Study|Protocol Violation|3
32553|NCT01777334|142731|P2|Overall Study|Lack of Efficacy|29
32554|NCT01777334|142732|P1|Overall Study|Lack of Efficacy|15
32555|NCT01777334|142731|P2|Overall Study|Adverse Event|14
32556|NCT01777334|142732|P1|Overall Study|Adverse Event|18
32557|NCT01777321|142742|P2|Overall Study|Withdrawal by Subject|1
32558|NCT01777321|142743|P1|Overall Study|Withdrawal by Subject|0
32559|NCT01777282|142784|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
32560|NCT01777282|142785|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
32561|NCT01777282|142786|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
32562|NCT01777282|142787|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
32563|NCT01777282|142788|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
32564|NCT01777282|142784|P5|Overall Study|Protocol Violation|2
32565|NCT01777282|142785|P4|Overall Study|Protocol Violation|0
32566|NCT01777282|142786|P3|Overall Study|Protocol Violation|1
32567|NCT01777282|142787|P2|Overall Study|Protocol Violation|0
32568|NCT01777282|142788|P1|Overall Study|Protocol Violation|2
32569|NCT01777282|142784|P5|Overall Study|Withdrawal by Subject|2
32570|NCT01777282|142785|P4|Overall Study|Withdrawal by Subject|1
32571|NCT01777282|142786|P3|Overall Study|Withdrawal by Subject|0
32572|NCT01777282|142787|P2|Overall Study|Withdrawal by Subject|0
32573|NCT01777282|142788|P1|Overall Study|Withdrawal by Subject|4
32574|NCT01777282|142784|P5|Overall Study|Adverse Event|3
32575|NCT01777282|142785|P4|Overall Study|Adverse Event|1
32576|NCT01777282|142786|P3|Overall Study|Adverse Event|2
32577|NCT01777282|142787|P2|Overall Study|Adverse Event|4
32578|NCT01777282|142788|P1|Overall Study|Adverse Event|4
32579|NCT01777282|142784|P5|Overall Study|New Antidiabetic Medication|0
32580|NCT01777282|142785|P4|Overall Study|New Antidiabetic Medication|0
32581|NCT01777282|142786|P3|Overall Study|New Antidiabetic Medication|1
32582|NCT01777282|142787|P2|Overall Study|New Antidiabetic Medication|0
32583|NCT01777282|142788|P1|Overall Study|New Antidiabetic Medication|0
32584|NCT01777282|142784|P5|Overall Study|Persistent Hyperglycemia|0
32585|NCT01777282|142785|P4|Overall Study|Persistent Hyperglycemia|0
32586|NCT01777282|142786|P3|Overall Study|Persistent Hyperglycemia|1
32587|NCT01777282|142787|P2|Overall Study|Persistent Hyperglycemia|0
32588|NCT01777282|142788|P1|Overall Study|Persistent Hyperglycemia|0
32589|NCT01777269|142832|P2|Overall Study|Withdrawal by Subject|9
32590|NCT01777269|142833|P1|Overall Study|Withdrawal by Subject|9
32591|NCT01777269|142832|P2|Overall Study|Physician Decision|2
32592|NCT01777269|142833|P1|Overall Study|Physician Decision|5
32593|NCT01777269|142832|P2|Overall Study|Lost to Follow-up|0
32594|NCT01777269|142833|P1|Overall Study|Lost to Follow-up|4
32595|NCT01777269|142832|P2|Overall Study|Participants reached stopping criteria|1
32596|NCT01777269|142833|P1|Overall Study|Participants reached stopping criteria|1
32597|NCT01777269|142832|P2|Overall Study|Protocol Violation|4
32598|NCT01777269|142833|P1|Overall Study|Protocol Violation|4
32599|NCT01777269|142832|P2|Overall Study|Lack of Efficacy|10
32600|NCT01777269|142833|P1|Overall Study|Lack of Efficacy|8
32601|NCT01777269|142832|P2|Overall Study|Adverse Event|33
32602|NCT01777269|142833|P1|Overall Study|Adverse Event|24
32603|NCT01777191|142870|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
32604|NCT01777191|142871|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
32605|NCT01777191|142870|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
32606|NCT01777191|142871|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
32607|NCT01777191|142870|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
32608|NCT01777191|142871|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
32609|NCT01777191|142870|P2|Safety Extension Per (Week 12-Week 48)|Death|1
32610|NCT01777191|142871|P1|Safety Extension Per (Week 12-Week 48)|Death|0
32611|NCT01777191|142870|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
32612|NCT01777191|142871|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
32613|NCT01777191|142870|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
32614|NCT01777191|142871|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
32615|NCT01777191|142870|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
32616|NCT01777191|142871|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
32617|NCT01777191|142870|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
32618|NCT01777191|142871|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
32619|NCT01777191|142870|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
32620|NCT01777191|142871|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
32621|NCT01777191|142870|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
32622|NCT01777191|142871|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
32623|NCT01777191|142870|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
32624|NCT01777191|142871|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
32625|NCT01776554|142934|P2|Overall Study|Unclassified|1
32626|NCT01776554|142935|P1|Overall Study|Unclassified|4
32627|NCT01776554|142934|P2|Overall Study|Protocol Violation|0
32628|NCT01776554|142935|P1|Overall Study|Protocol Violation|1
32629|NCT01776554|142934|P2|Overall Study|Administrative Reason|5
32630|NCT01776554|142935|P1|Overall Study|Administrative Reason|2
32631|NCT01776554|142934|P2|Overall Study|Lost to Follow-up|9
32632|NCT01776554|142935|P1|Overall Study|Lost to Follow-up|6
32633|NCT01776554|142934|P2|Overall Study|Withdrawal by Subject|8
32634|NCT01776554|142935|P1|Overall Study|Withdrawal by Subject|3
32635|NCT01776554|142934|P2|Overall Study|Adverse Event|0
32636|NCT01776554|142935|P1|Overall Study|Adverse Event|1
32637|NCT01776541|142978|P2|Overall Study|Withdrawal by Subject|20
32638|NCT01776541|142979|P1|Overall Study|Withdrawal by Subject|12
32639|NCT01776541|142978|P2|Overall Study|Protocol Violation|1
32640|NCT01776541|142979|P1|Overall Study|Protocol Violation|2
32641|NCT01776541|142978|P2|Overall Study|Unclassified|4
32642|NCT01776541|142979|P1|Overall Study|Unclassified|5
32643|NCT01776541|142978|P2|Overall Study|Lost to Follow-up|48
32644|NCT01776541|142979|P1|Overall Study|Lost to Follow-up|27
32645|NCT01776541|142978|P2|Overall Study|Death|0
32646|NCT01776541|142979|P1|Overall Study|Death|4
32647|NCT01776541|142978|P2|Overall Study|Administrative Reason|2
32648|NCT01776541|142979|P1|Overall Study|Administrative Reason|6
32649|NCT01776008|143009|P1|Overall Study|ineligible|2
32650|NCT01775995|143023|P2|Overall Study|Lost to Follow-up|1
32651|NCT01775995|143024|P1|Overall Study|Lost to Follow-up|1
32652|NCT01775787|143118|P2|Second 7-10 Days|concerns with using IV|1
32653|NCT01775787|143119|P1|Second 7-10 Days|concerns with using IV|0
32654|NCT01775787|143118|P2|Second 7-10 Days|time commitment|1
32655|NCT01775787|143119|P1|Second 7-10 Days|time commitment|0
32656|NCT01775787|143118|P2|First 7-10 Days|concerns with using IV|2
32657|NCT01775787|143119|P1|First 7-10 Days|concerns with using IV|1
32658|NCT01775787|143118|P2|First 7-10 Days|time commitment|2
32659|NCT01775787|143119|P1|First 7-10 Days|time commitment|0
32660|NCT01775787|143118|P2|First 7-10 Days|family emergency|1
32661|NCT01775787|143119|P1|First 7-10 Days|family emergency|0
32662|NCT01775787|143118|P2|First 7-10 Days|Adverse Event|1
32663|NCT01775787|143119|P1|First 7-10 Days|Adverse Event|0
32664|NCT01775670|143166|P2|Overall Study|Lost to Follow-up|1
32665|NCT01775670|143167|P1|Overall Study|Lost to Follow-up|1
32666|NCT01775553|143193|P1|Overall Study|Disease Progression|12
32667|NCT01775553|143193|P1|Overall Study|Adverse Event|1
32668|NCT01775189|143201|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
32669|NCT01775189|143202|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
32670|NCT01775189|143203|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
32671|NCT01775189|143204|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
32672|NCT01775189|143205|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
32673|NCT01775189|143206|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
32674|NCT01775189|143207|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
32675|NCT01775189|143201|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
32676|NCT01775189|143202|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
32677|NCT01775189|143203|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
32678|NCT01775189|143204|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
32679|NCT01775189|143205|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
32680|NCT01775189|143206|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
32681|NCT01775189|143207|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
32682|NCT01775189|143201|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
32683|NCT01775189|143202|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
32684|NCT01775189|143203|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
32685|NCT01775189|143204|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
32686|NCT01775189|143205|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
32687|NCT01775189|143206|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
32688|NCT01775189|143207|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
32689|NCT01775189|143201|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
32690|NCT01775189|143202|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
32691|NCT01775189|143203|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
32692|NCT01775189|143204|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
32693|NCT01775189|143205|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
32694|NCT01775189|143206|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
32695|NCT01775189|143207|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
32696|NCT01775189|143201|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
32697|NCT01775189|143202|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
32698|NCT01775189|143203|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
32699|NCT01775189|143204|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
32700|NCT01775189|143205|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
32701|NCT01775189|143206|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
32702|NCT01775189|143207|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
32703|NCT01775189|143201|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
32704|NCT01775189|143202|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
32705|NCT01775189|143203|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
32706|NCT01775189|143204|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
32707|NCT01775189|143205|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
32708|NCT01775189|143206|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
32709|NCT01775189|143207|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
32710|NCT01775137|143426|P1|Overall Study|Withdrawal by participants|5
32711|NCT01775137|143426|P1|Overall Study|Adverse Event|1
32712|NCT01775137|143426|P1|Overall Study|Unsatisfactory therapeutic effect|2
32713|NCT01775137|143426|P1|Overall Study|Protocol deviation|2
32714|NCT01775137|143426|P1|Overall Study|Death|1
32715|NCT01775124|143453|P2|Extension Period|Withdrawal by Subject|12
32716|NCT01775124|143454|P1|Extension Period|Withdrawal by Subject|9
32717|NCT01775124|143453|P2|Extension Period|Lost to Follow-up|1
32718|NCT01775124|143454|P1|Extension Period|Lost to Follow-up|0
32719|NCT01775124|143453|P2|Extension Period|Administrative problems|1
32720|NCT01775124|143454|P1|Extension Period|Administrative problems|0
32721|NCT01775124|143453|P2|Extension Period|Physician Decision|2
32722|NCT01775124|143454|P1|Extension Period|Physician Decision|0
32723|NCT01775124|143453|P2|Extension Period|Adverse Event|2
32724|NCT01775124|143454|P1|Extension Period|Adverse Event|3
32725|NCT01775124|143453|P2|Core Period|Adverse Event|5
32726|NCT01775124|143454|P1|Core Period|Adverse Event|5
32727|NCT01775124|143453|P2|Core Period|Withdrawal by Subject|2
32728|NCT01775124|143454|P1|Core Period|Withdrawal by Subject|4
32729|NCT01775124|143453|P2|Core Period|Administrative problems|0
32730|NCT01775124|143454|P1|Core Period|Administrative problems|1
32731|NCT01775124|143453|P2|Core Period|Death|1
32732|NCT01775124|143454|P1|Core Period|Death|0
32733|NCT01775124|143453|P2|Core Period|Physician Decision|1
32734|NCT01775124|143454|P1|Core Period|Physician Decision|1
32735|NCT01775124|143453|P2|Core Period|Disease Progression|1
32736|NCT01775124|143454|P1|Core Period|Disease Progression|0
32737|NCT01774981|143489|P8|Overall Study|Death|0
32738|NCT01774981|143490|P7|Overall Study|Death|0
32739|NCT01774981|143491|P6|Overall Study|Death|0
32740|NCT01774981|143492|P5|Overall Study|Death|1
32741|NCT01774981|143493|P4|Overall Study|Death|0
32742|NCT01774981|143494|P3|Overall Study|Death|0
32743|NCT01774981|143495|P2|Overall Study|Death|0
32744|NCT01774981|143496|P1|Overall Study|Death|0
32745|NCT01774981|143489|P8|Overall Study|Withdrawal by Subject|1
32746|NCT01774981|143490|P7|Overall Study|Withdrawal by Subject|0
32747|NCT01774981|143491|P6|Overall Study|Withdrawal by Subject|0
32748|NCT01774981|143492|P5|Overall Study|Withdrawal by Subject|0
32749|NCT01774981|143493|P4|Overall Study|Withdrawal by Subject|0
32750|NCT01774981|143494|P3|Overall Study|Withdrawal by Subject|0
32751|NCT01774981|143495|P2|Overall Study|Withdrawal by Subject|0
32752|NCT01774981|143496|P1|Overall Study|Withdrawal by Subject|0
32753|NCT01774981|143489|P8|Overall Study|Adverse Event|0
32754|NCT01774981|143490|P7|Overall Study|Adverse Event|0
32755|NCT01774981|143491|P6|Overall Study|Adverse Event|1
32756|NCT01774981|143492|P5|Overall Study|Adverse Event|0
32757|NCT01774981|143493|P4|Overall Study|Adverse Event|0
32758|NCT01774981|143494|P3|Overall Study|Adverse Event|0
32759|NCT01774981|143495|P2|Overall Study|Adverse Event|0
32760|NCT01774981|143496|P1|Overall Study|Adverse Event|0
32761|NCT01774968|143528|P2|Overall Study|Withdrawal by Subject|11
32762|NCT01774968|143529|P1|Overall Study|Withdrawal by Subject|6
32763|NCT01774968|143528|P2|Overall Study|Sponsor Decision|2
32764|NCT01774968|143529|P1|Overall Study|Sponsor Decision|0
32765|NCT01774968|143528|P2|Overall Study|Protocol Violation|13
32766|NCT01774968|143529|P1|Overall Study|Protocol Violation|14
32767|NCT01774968|143528|P2|Overall Study|Physician Decision|1
32768|NCT01774968|143529|P1|Overall Study|Physician Decision|5
32769|NCT01774968|143528|P2|Overall Study|Lost to Follow-up|3
32770|NCT01774968|143529|P1|Overall Study|Lost to Follow-up|1
32771|NCT01774968|143528|P2|Overall Study|Death|1
32772|NCT01774968|143529|P1|Overall Study|Death|0
32773|NCT01774968|143528|P2|Overall Study|Adverse Event|4
32774|NCT01774968|143529|P1|Overall Study|Adverse Event|4
32775|NCT01774929|143563|P1|Overall Study|Adverse Event|3
32776|NCT01774903|143569|P1|Overall Study|Ineligible to continue the trial|1
32777|NCT01774903|143569|P1|Overall Study|Lack of Efficacy|1
32778|NCT01774903|143569|P1|Overall Study|Withdrawal by Subject|2
32779|NCT01774903|143569|P1|Overall Study|Adverse Event|7
32780|NCT01774786|143587|P2|Overall Study|Ineligible for Study|3
32781|NCT01774786|143588|P1|Overall Study|Ineligible for Study|1
32782|NCT01774786|143587|P2|Overall Study|Physician Decision|0
32783|NCT01774786|143588|P1|Overall Study|Physician Decision|1
32784|NCT01774786|143587|P2|Overall Study|Withdrawal by Subject|12
32785|NCT01774786|143588|P1|Overall Study|Withdrawal by Subject|15
32786|NCT01774786|143587|P2|Overall Study|Lost to Follow-up|4
32787|NCT01774786|143588|P1|Overall Study|Lost to Follow-up|3
32788|NCT01774786|143587|P2|Overall Study|Death|262
32789|NCT01774786|143588|P1|Overall Study|Death|242
32790|NCT01774786|143587|P2|Overall Study|In Follow-up|62
32791|NCT01774786|143588|P1|Overall Study|In Follow-up|65
32792|NCT01774786|143587|P2|Overall Study|Between Treatment and Follow-up|2
32793|NCT01774786|143588|P1|Overall Study|Between Treatment and Follow-up|6
32794|NCT01774786|143587|P2|Overall Study|On Treatment|47
32795|NCT01774786|143588|P1|Overall Study|On Treatment|55
32796|NCT01774591|143639|P2|Overall Study|Adverse Event|2
32797|NCT01774591|143640|P1|Overall Study|Adverse Event|0
32798|NCT01774591|143639|P2|Overall Study|Withdrawal by Subject|1
32799|NCT01774591|143640|P1|Overall Study|Withdrawal by Subject|0
32800|NCT01774591|143639|P2|Overall Study|Physician Decision|1
32801|NCT01774591|143640|P1|Overall Study|Physician Decision|1
32802|NCT01774344|143652|P2|Overall Study|Non-compliance with study drug|2
32803|NCT01774344|143653|P1|Overall Study|Non-compliance with study drug|0
32804|NCT01774344|143652|P2|Overall Study|Physician Decision|1
32805|NCT01774344|143653|P1|Overall Study|Physician Decision|0
32806|NCT01774344|143652|P2|Overall Study|Adverse event (AE)|1
32807|NCT01774344|143653|P1|Overall Study|Adverse event (AE)|0
32808|NCT01774344|143652|P2|Overall Study|AE not related to disease progression|47
32809|NCT01774344|143653|P1|Overall Study|AE not related to disease progression|12
32810|NCT01774344|143652|P2|Overall Study|Ongoing with treatment|65
32811|NCT01774344|143653|P1|Overall Study|Ongoing with treatment|10
32812|NCT01774344|143652|P2|Overall Study|Other|0
32813|NCT01774344|143653|P1|Overall Study|Other|1
32814|NCT01774344|143652|P2|Overall Study|Study drug never administered|5
32815|NCT01774344|143653|P1|Overall Study|Study drug never administered|1
32816|NCT01774344|143652|P2|Overall Study|Withdrawal by Subject|26
32817|NCT01774344|143653|P1|Overall Study|Withdrawal by Subject|5
32818|NCT01774344|143652|P2|Overall Study|Protocol Violation|1
32819|NCT01774344|143653|P1|Overall Study|Protocol Violation|3
32820|NCT01774305|143669|P2|Overall Study|Physician Decision|0
32821|NCT01774305|143670|P1|Overall Study|Physician Decision|1
32822|NCT01774253|143678|P1|Overall Study|Death|1
32823|NCT01774253|143678|P1|Overall Study|Withdrawal by Subject|2
32824|NCT01774253|143678|P1|Overall Study|Physician Decision|2
32825|NCT01774253|143678|P1|Overall Study|Lack of Efficacy|4
32826|NCT01774110|143697|P1|Overall Study|Lost to Follow-up|7
32827|NCT01774097|143705|P2|Overall Study|Adverse Event|1
32828|NCT01774097|143706|P1|Overall Study|Adverse Event|1
32829|NCT01774097|143705|P2|Overall Study|Withdrawal by Subject|1
32830|NCT01774097|143706|P1|Overall Study|Withdrawal by Subject|1
32831|NCT01774084|143736|P2|Overall Study|Personal reasons|0
32832|NCT01774084|143737|P1|Overall Study|Personal reasons|1
32833|NCT01773889|143767|P1|Overall Study|lack of funding|2
32834|NCT01773473|143773|P2|Overall Study|Lost to Follow-up|0
32835|NCT01773473|143774|P1|Overall Study|Lost to Follow-up|2
32836|NCT01773473|143773|P2|Overall Study|Withdrawal by Subject|3
32837|NCT01773473|143774|P1|Overall Study|Withdrawal by Subject|5
32838|NCT01773473|143773|P2|Overall Study|Non-Compliance with study drug|4
32839|NCT01773473|143774|P1|Overall Study|Non-Compliance with study drug|1
32840|NCT01773473|143773|P2|Overall Study|Lack of Efficacy|1
32841|NCT01773473|143774|P1|Overall Study|Lack of Efficacy|0
32842|NCT01773473|143773|P2|Overall Study|Sponsor Decision|0
32843|NCT01773473|143774|P1|Overall Study|Sponsor Decision|2
32844|NCT01773473|143773|P2|Overall Study|Physician Decision|5
32845|NCT01773473|143774|P1|Overall Study|Physician Decision|3
32846|NCT01773473|143773|P2|Overall Study|Protocol Violation|4
32847|NCT01773473|143774|P1|Overall Study|Protocol Violation|0
32848|NCT01773473|143773|P2|Overall Study|Adverse Event|2
32849|NCT01773473|143774|P1|Overall Study|Adverse Event|3
32850|NCT01773291|143795|P3|Overall Study|Withdrawal by Subject|1
32851|NCT01773291|143796|P2|Overall Study|Withdrawal by Subject|0
32852|NCT01773291|143797|P1|Overall Study|Withdrawal by Subject|0
32853|NCT01773291|143795|P3|Overall Study|Protocol Violation|0
32854|NCT01773291|143796|P2|Overall Study|Protocol Violation|0
32855|NCT01773291|143797|P1|Overall Study|Protocol Violation|1
32856|NCT01773226|143808|P1|Overall Study|Withdrawal by Subject|1
32857|NCT01773122|143827|P4|Overall Study|Due to amended age eligibility criteria|1
32858|NCT01773122|143828|P3|Overall Study|Due to amended age eligibility criteria|0
32859|NCT01773122|143829|P2|Overall Study|Due to amended age eligibility criteria|1
32860|NCT01773122|143830|P1|Overall Study|Due to amended age eligibility criteria|3
32861|NCT01773070|143844|P1|Overall Study|Death (unrelated to study procedures)|3
32862|NCT01773070|143844|P1|Overall Study|Other|15
32863|NCT01773070|143844|P1|Overall Study|Lost to Follow-up|39
32864|NCT01773070|143844|P1|Overall Study|Withdrawal by Subject|24
32865|NCT01772823|143854|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
32866|NCT01772823|143855|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
32867|NCT01772823|143854|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
32868|NCT01772823|143855|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
32869|NCT01772823|143854|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
32870|NCT01772823|143855|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
32871|NCT01772823|143854|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
32872|NCT01772823|143855|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
32873|NCT01772823|143854|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
32874|NCT01772823|143855|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
32875|NCT01772823|143854|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
32876|NCT01772823|143855|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
32877|NCT01772823|143854|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
32878|NCT01772823|143855|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
32879|NCT01772823|143854|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
32880|NCT01772823|143855|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
32881|NCT01772823|143854|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
32882|NCT01772823|143855|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
32883|NCT01772823|143854|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
32884|NCT01772823|143855|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
32885|NCT01772823|143854|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
32886|NCT01772823|143855|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
32887|NCT01772823|143854|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
32888|NCT01772823|143855|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
32889|NCT01772823|143854|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
32890|NCT01772823|143855|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
32891|NCT01772823|143854|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
32892|NCT01772823|143855|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
32893|NCT01772823|143854|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
32894|NCT01772823|143855|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
32895|NCT01772823|143854|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
32896|NCT01772823|143855|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
32897|NCT01772576|143977|P1|Overall Study|Withdrawal by Subject|6
32898|NCT01772576|143977|P1|Overall Study|Adverse Event|6
32899|NCT01772576|143977|P1|Overall Study|Study device not used|3
32900|NCT01772576|143977|P1|Overall Study|Lost to Follow-up|3
32901|NCT01772576|143977|P1|Overall Study|Protocol Violation|1
32902|NCT01772576|143977|P1|Overall Study|Death|15
32903|NCT01772550|143989|P3|Overall Study|Adverse Event|1
32904|NCT01772550|143990|P2|Overall Study|Adverse Event|0
32905|NCT01772550|143991|P1|Overall Study|Adverse Event|0
32906|NCT01772550|143989|P3|Overall Study|Unable to insert IV in antecubital vein|5
32907|NCT01772550|143990|P2|Overall Study|Unable to insert IV in antecubital vein|1
32908|NCT01772550|143991|P1|Overall Study|Unable to insert IV in antecubital vein|1
32909|NCT01772537|144032|P3|Overall Study|unsuccessful lumbar drain placement|0
32910|NCT01772537|144033|P2|Overall Study|unsuccessful lumbar drain placement|0
32911|NCT01772537|144034|P1|Overall Study|unsuccessful lumbar drain placement|1
32912|NCT01772368|144048|P1|Overall Study|Not specified|1
32913|NCT01772368|144048|P1|Overall Study|Protocol Violation|2
32914|NCT01772368|144048|P1|Overall Study|Withdrawal by Subject|3
32915|NCT01772368|144048|P1|Overall Study|Adverse Event|1
32916|NCT01772316|144094|P1|Overall Study|Withdrawn by sponsor decision|5
32917|NCT01772316|144094|P1|Overall Study|Inform consent withdrawn|1
32918|NCT01772316|144094|P1|Overall Study|Serious adverse event|1
32919|NCT01772147|144115|P3|Overall Study|Lack of Efficacy|6
32920|NCT01772147|144116|P2|Overall Study|Lack of Efficacy|6
32921|NCT01772147|144117|P1|Overall Study|Lack of Efficacy|8
32922|NCT01772147|144115|P3|Overall Study|Protocol Deviation|1
32923|NCT01772147|144116|P2|Overall Study|Protocol Deviation|1
32924|NCT01772147|144117|P1|Overall Study|Protocol Deviation|2
32925|NCT01772147|144115|P3|Overall Study|Lost to Follow-up|1
32926|NCT01772147|144116|P2|Overall Study|Lost to Follow-up|0
32927|NCT01772147|144117|P1|Overall Study|Lost to Follow-up|1
32928|NCT01772147|144115|P3|Overall Study|Withdrew Consent|4
32929|NCT01772147|144116|P2|Overall Study|Withdrew Consent|8
32930|NCT01772147|144117|P1|Overall Study|Withdrew Consent|7
32931|NCT01772147|144115|P3|Overall Study|Adverse Event|6
32932|NCT01772147|144116|P2|Overall Study|Adverse Event|10
32933|NCT01772147|144117|P1|Overall Study|Adverse Event|13
32934|NCT01772134|144137|P3|Overall Study|Randomized Study Medication Not Received|1
32935|NCT01772134|144138|P2|Overall Study|Randomized Study Medication Not Received|0
32936|NCT01772134|144139|P1|Overall Study|Randomized Study Medication Not Received|2
32937|NCT01772134|144137|P3|Overall Study|Protocol-defined Stopping Criteria|0
32938|NCT01772134|144138|P2|Overall Study|Protocol-defined Stopping Criteria|0
32939|NCT01772134|144139|P1|Overall Study|Protocol-defined Stopping Criteria|1
32940|NCT01772134|144137|P3|Overall Study|Lack of Efficacy|3
32941|NCT01772134|144138|P2|Overall Study|Lack of Efficacy|5
32942|NCT01772134|144139|P1|Overall Study|Lack of Efficacy|11
32943|NCT01772134|144137|P3|Overall Study|Protocol Deviation|3
32944|NCT01772134|144138|P2|Overall Study|Protocol Deviation|3
32945|NCT01772134|144139|P1|Overall Study|Protocol Deviation|4
32946|NCT01772134|144137|P3|Overall Study|Lost to Follow-up|0
32947|NCT01772134|144138|P2|Overall Study|Lost to Follow-up|0
32948|NCT01772134|144139|P1|Overall Study|Lost to Follow-up|2
32949|NCT01772134|144137|P3|Overall Study|Withdrew Consent|5
32950|NCT01772134|144138|P2|Overall Study|Withdrew Consent|1
32951|NCT01772134|144139|P1|Overall Study|Withdrew Consent|3
32952|NCT01772134|144137|P3|Overall Study|Adverse Event|10
32953|NCT01772134|144138|P2|Overall Study|Adverse Event|5
32954|NCT01772134|144139|P1|Overall Study|Adverse Event|6
32955|NCT01771913|144176|P2|Overall Study|Withdrawal by Subject|0
32956|NCT01771913|144177|P1|Overall Study|Withdrawal by Subject|1
32957|NCT01770860|144196|P1|Overall Study|Administrative decision made by the PI|1
32958|NCT01770860|144196|P1|Overall Study|Lost to Follow-up|1
32959|NCT01770860|144196|P1|Overall Study|Withdrawal by Subject|4
32960|NCT01770743|144244|P5|Overall Study|Moving Out of State|0
32961|NCT01770743|144245|P4|Overall Study|Moving Out of State|0
32962|NCT01770743|144246|P3|Overall Study|Moving Out of State|0
32963|NCT01770743|144247|P2|Overall Study|Moving Out of State|1
32964|NCT01770743|144248|P1|Overall Study|Moving Out of State|0
32965|NCT01770743|144244|P5|Overall Study|Sponsor Terminated Subject|0
32966|NCT01770743|144245|P4|Overall Study|Sponsor Terminated Subject|1
32967|NCT01770743|144246|P3|Overall Study|Sponsor Terminated Subject|0
32968|NCT01770743|144247|P2|Overall Study|Sponsor Terminated Subject|0
32969|NCT01770743|144248|P1|Overall Study|Sponsor Terminated Subject|1
32970|NCT01770743|144244|P5|Overall Study|Lost to Follow-up|1
32971|NCT01770743|144245|P4|Overall Study|Lost to Follow-up|0
32972|NCT01770743|144246|P3|Overall Study|Lost to Follow-up|0
32973|NCT01770743|144247|P2|Overall Study|Lost to Follow-up|2
32974|NCT01770743|144248|P1|Overall Study|Lost to Follow-up|0
32975|NCT01770743|144244|P5|Overall Study|Withdrawal by Subject|1
32976|NCT01770743|144245|P4|Overall Study|Withdrawal by Subject|1
32977|NCT01770743|144246|P3|Overall Study|Withdrawal by Subject|1
32978|NCT01770743|144247|P2|Overall Study|Withdrawal by Subject|0
32979|NCT01770743|144248|P1|Overall Study|Withdrawal by Subject|0
32980|NCT01770743|144244|P5|Overall Study|Adverse Event|0
32981|NCT01770743|144245|P4|Overall Study|Adverse Event|0
32982|NCT01770743|144246|P3|Overall Study|Adverse Event|0
32983|NCT01770743|144247|P2|Overall Study|Adverse Event|0
32984|NCT01770743|144248|P1|Overall Study|Adverse Event|1
32985|NCT01770509|144350|P2|Overall Study|Lost to Follow-up|2
32986|NCT01770509|144351|P1|Overall Study|Lost to Follow-up|1
32987|NCT01770509|144350|P2|Overall Study|Injury|1
32988|NCT01770509|144351|P1|Overall Study|Injury|0
32989|NCT01770392|144387|P1|Washout Period of at Least 14 Days|Adverse Event|1
32990|NCT01770379|144402|P3|Overall Study|Adverse Event|2
32991|NCT01770379|144403|P2|Overall Study|Adverse Event|3
32992|NCT01770379|144404|P1|Overall Study|Adverse Event|1
32993|NCT01770379|144402|P3|Overall Study|Lack of Efficacy|6
32994|NCT01770379|144403|P2|Overall Study|Lack of Efficacy|6
32995|NCT01770379|144404|P1|Overall Study|Lack of Efficacy|8
32996|NCT01770379|144402|P3|Overall Study|Lost to Follow-up|2
32997|NCT01770379|144403|P2|Overall Study|Lost to Follow-up|0
32998|NCT01770379|144404|P1|Overall Study|Lost to Follow-up|0
32999|NCT01770379|144402|P3|Overall Study|Physician Decision|2
33000|NCT01770379|144403|P2|Overall Study|Physician Decision|1
33001|NCT01770379|144404|P1|Overall Study|Physician Decision|0
33002|NCT01770379|144402|P3|Overall Study|Protocol Violation|1
33003|NCT01770379|144403|P2|Overall Study|Protocol Violation|1
33004|NCT01770379|144404|P1|Overall Study|Protocol Violation|0
33005|NCT01770379|144402|P3|Overall Study|study terminated by sponsor|22
33006|NCT01770379|144403|P2|Overall Study|study terminated by sponsor|23
33007|NCT01770379|144404|P1|Overall Study|study terminated by sponsor|22
33008|NCT01770379|144402|P3|Overall Study|Withdrawal by Subject|7
33009|NCT01770379|144403|P2|Overall Study|Withdrawal by Subject|10
33010|NCT01770379|144404|P1|Overall Study|Withdrawal by Subject|7
33011|NCT01770379|144402|P3|Overall Study|Technical issues|0
33012|NCT01770379|144403|P2|Overall Study|Technical issues|0
33013|NCT01770379|144404|P1|Overall Study|Technical issues|1
33014|NCT01770145|144441|P1|Treatment|Withdrawal by Subject|1
33015|NCT01770145|144441|P1|Treatment|Adverse Event|3
33016|NCT01770145|144441|P1|Baseline|Unable to define optimal dose|4
33017|NCT01770145|144441|P1|Baseline|Lost to Follow-up|1
33018|NCT01770145|144441|P1|Baseline|Withdrawal by Subject|1
33019|NCT01770145|144441|P1|Baseline|Adverse Event|20
33020|NCT01769508|144461|P1|Overall Study|Lost to Follow-up|1
33021|NCT01769508|144461|P1|Overall Study|Adverse Event|1
33022|NCT01769508|144461|P1|Overall Study|Withdrawal by Subject|1
33023|NCT01769508|144461|P1|Overall Study|Death|3
33024|NCT01769456|144470|P1|Overall Study|Parental request to youth to withdraw|1
33025|NCT01769456|144470|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
33026|NCT01769456|144470|P1|Overall Study|Moved out of the area|3
33027|NCT01769456|144470|P1|Overall Study|Did not receive PCC intervention|6
33028|NCT01769456|144470|P1|Overall Study|Withdrawal by Subject|3
33029|NCT01769456|144470|P1|Overall Study|Lost to Follow-up|19
33030|NCT01769443|144491|P2|Overall Study|Study closure|0
33031|NCT01769443|144492|P1|Overall Study|Study closure|1
33032|NCT01769391|144536|P2|Overall Study|On Treatment at Study Conclusion|0
33033|NCT01769391|144537|P1|Overall Study|On Treatment at Study Conclusion|3
33034|NCT01769391|144536|P2|Overall Study|Investigator Decision|0
33035|NCT01769391|144537|P1|Overall Study|Investigator Decision|2
33036|NCT01769391|144536|P2|Overall Study|Withdrawal by Subject|3
33037|NCT01769391|144537|P1|Overall Study|Withdrawal by Subject|4
33038|NCT01769391|144536|P2|Overall Study|Progressive Disease|2
33039|NCT01769391|144537|P1|Overall Study|Progressive Disease|1
33040|NCT01769391|144536|P2|Overall Study|Adverse Event|3
33041|NCT01769391|144537|P1|Overall Study|Adverse Event|0
33042|NCT01769391|144536|P2|Overall Study|Death|1
33043|NCT01769391|144537|P1|Overall Study|Death|10
33044|NCT01769378|144556|P2|Overall Study|Lost to Follow-up|0
33045|NCT01769378|144557|P1|Overall Study|Lost to Follow-up|2
33046|NCT01769378|144556|P2|Overall Study|Sponsor Decision|0
33047|NCT01769378|144557|P1|Overall Study|Sponsor Decision|1
33048|NCT01769378|144556|P2|Overall Study|Withdrawal by Subject|3
33049|NCT01769378|144557|P1|Overall Study|Withdrawal by Subject|10
33050|NCT01769378|144556|P2|Overall Study|Protocol Violation|1
33051|NCT01769378|144557|P1|Overall Study|Protocol Violation|1
33052|NCT01769378|144556|P2|Overall Study|Entry criteria not met|0
33053|NCT01769378|144557|P1|Overall Study|Entry criteria not met|1
33054|NCT01769378|144556|P2|Overall Study|Adverse Event|0
33055|NCT01769378|144557|P1|Overall Study|Adverse Event|10
33056|NCT01769339|144637|P1|Overall Study|Adverse Event|1
33057|NCT01769339|144637|P1|Overall Study|Lost to Follow-up|42
33058|NCT01769326|144648|P4|Overall Study|Got sick and could not complete study|0
33059|NCT01769326|144649|P3|Overall Study|Got sick and could not complete study|1
33060|NCT01769326|144650|P2|Overall Study|Got sick and could not complete study|0
33061|NCT01769326|144651|P1|Overall Study|Got sick and could not complete study|0
33062|NCT01769326|144648|P4|Overall Study|got a job|0
33063|NCT01769326|144649|P3|Overall Study|got a job|0
33064|NCT01769326|144650|P2|Overall Study|got a job|1
33065|NCT01769326|144651|P1|Overall Study|got a job|0
33066|NCT01769326|144648|P4|Overall Study|unrelated injry|0
33067|NCT01769326|144649|P3|Overall Study|unrelated injry|0
33068|NCT01769326|144650|P2|Overall Study|unrelated injry|1
33069|NCT01769326|144651|P1|Overall Study|unrelated injry|1
33070|NCT01769326|144648|P4|Overall Study|Lost to Follow-up|0
33071|NCT01769326|144649|P3|Overall Study|Lost to Follow-up|0
33072|NCT01769326|144650|P2|Overall Study|Lost to Follow-up|2
33073|NCT01769326|144651|P1|Overall Study|Lost to Follow-up|1
33074|NCT01769196|144693|P2|Overall Study|Withdrew consent|40
33075|NCT01769196|144694|P1|Overall Study|Withdrew consent|36
33076|NCT01769196|144693|P2|Overall Study|Participant never dosed with study drug|0
33077|NCT01769196|144694|P1|Overall Study|Participant never dosed with study drug|1
33078|NCT01769196|144693|P2|Overall Study|Study terminated by sponsor|161
33079|NCT01769196|144694|P1|Overall Study|Study terminated by sponsor|160
33080|NCT01769196|144693|P2|Overall Study|Protocol Violation|3
33081|NCT01769196|144694|P1|Overall Study|Protocol Violation|0
33082|NCT01769196|144693|P2|Overall Study|Protocol defined criteria for withdrawal|11
33083|NCT01769196|144694|P1|Overall Study|Protocol defined criteria for withdrawal|9
33084|NCT01769196|144693|P2|Overall Study|Progressive disease|6
33085|NCT01769196|144694|P1|Overall Study|Progressive disease|11
33086|NCT01769196|144693|P2|Overall Study|Lack of Efficacy|2
33087|NCT01769196|144694|P1|Overall Study|Lack of Efficacy|3
33088|NCT01769196|144693|P2|Overall Study|Investigator Discretion|3
33089|NCT01769196|144694|P1|Overall Study|Investigator Discretion|7
33090|NCT01769196|144693|P2|Overall Study|Death|26
33091|NCT01769196|144694|P1|Overall Study|Death|21
33092|NCT01769196|144693|P2|Overall Study|Adverse Event|20
33093|NCT01769196|144694|P1|Overall Study|Adverse Event|24
33094|NCT01769105|144724|P2|Cross-over|Lost to Follow-up|0
33095|NCT01769105|144725|P1|Cross-over|Lost to Follow-up|5
33096|NCT01769105|144724|P2|First Intervention|Protocol Violation|2
33097|NCT01769105|144725|P1|First Intervention|Protocol Violation|2
33098|NCT01768676|144746|P2|Overall Study|Withdrawal by Subject|10
33099|NCT01768676|144747|P1|Overall Study|Withdrawal by Subject|3
33100|NCT01768676|144746|P2|Overall Study|Physician Decision|1
33101|NCT01768676|144747|P1|Overall Study|Physician Decision|4
33102|NCT01768676|144746|P2|Overall Study|Protocol Violation|1
33103|NCT01768676|144747|P1|Overall Study|Protocol Violation|1
33104|NCT01768676|144746|P2|Overall Study|Lost to Follow-up|16
33105|NCT01768676|144747|P1|Overall Study|Lost to Follow-up|13
33106|NCT01768676|144746|P2|Overall Study|Adverse Event|3
33107|NCT01768676|144747|P1|Overall Study|Adverse Event|3
33108|NCT01768572|144764|P3|Overall Study|Other, Not due to an adverse event|1
33109|NCT01768572|144765|P2|Overall Study|Other, Not due to an adverse event|1
33110|NCT01768572|144766|P1|Overall Study|Other, Not due to an adverse event|1
33111|NCT01768572|144764|P3|Overall Study|Lack of Efficacy|1
33112|NCT01768572|144765|P2|Overall Study|Lack of Efficacy|3
33113|NCT01768572|144766|P1|Overall Study|Lack of Efficacy|1
33114|NCT01768572|144764|P3|Overall Study|Adverse Event|4
33115|NCT01768572|144765|P2|Overall Study|Adverse Event|8
33116|NCT01768572|144766|P1|Overall Study|Adverse Event|7
33117|NCT01768559|144777|P3|Overall Study|Other than specified|5
33118|NCT01768559|144778|P2|Overall Study|Other than specified|8
33119|NCT01768559|144779|P1|Overall Study|Other than specified|9
33120|NCT01768559|144777|P3|Overall Study|Poor compliance to protocol|2
33121|NCT01768559|144778|P2|Overall Study|Poor compliance to protocol|3
33122|NCT01768559|144779|P1|Overall Study|Poor compliance to protocol|0
33123|NCT01768559|144777|P3|Overall Study|Lack of Efficacy|0
33124|NCT01768559|144778|P2|Overall Study|Lack of Efficacy|4
33125|NCT01768559|144779|P1|Overall Study|Lack of Efficacy|6
33126|NCT01768559|144777|P3|Overall Study|Adverse Event|5
33127|NCT01768559|144778|P2|Overall Study|Adverse Event|2
33128|NCT01768559|144779|P1|Overall Study|Adverse Event|15
33129|NCT01768559|144777|P3|Overall Study|Randomized but not treated|1
33130|NCT01768559|144778|P2|Overall Study|Randomized but not treated|0
33131|NCT01768559|144779|P1|Overall Study|Randomized but not treated|0
33132|NCT01768286|144844|P4|Overall Study|Withdrew Consent|0
33133|NCT01768286|144845|P3|Overall Study|Withdrew Consent|1
33134|NCT01768286|144846|P2|Overall Study|Withdrew Consent|0
33135|NCT01768286|144847|P1|Overall Study|Withdrew Consent|0
33136|NCT01768286|144844|P4|Overall Study|Lack of Efficacy|1
33137|NCT01768286|144845|P3|Overall Study|Lack of Efficacy|0
33138|NCT01768286|144846|P2|Overall Study|Lack of Efficacy|4
33139|NCT01768286|144847|P1|Overall Study|Lack of Efficacy|7
33140|NCT01768286|144844|P4|Overall Study|Randomized But Not Treated|0
33141|NCT01768286|144845|P3|Overall Study|Randomized But Not Treated|1
33142|NCT01768286|144846|P2|Overall Study|Randomized But Not Treated|0
33143|NCT01768286|144847|P1|Overall Study|Randomized But Not Treated|0
33144|NCT01768117|144909|P1|Overall Study|Protocol Violation|3
33145|NCT01768117|144909|P1|Overall Study|Withdrawal by Subject|2
33146|NCT01768117|144909|P1|Overall Study|Lost to Follow-up|1
33147|NCT01767987|144973|P2|Overall Study|Physician Decision|1
33148|NCT01767987|144974|P1|Overall Study|Physician Decision|4
33149|NCT01767597|145040|P2|Overall Study|Withdrawal by Subject|0
33150|NCT01767597|145041|P1|Overall Study|Withdrawal by Subject|1
33151|NCT01767597|145040|P2|Overall Study|Incomplete intervention|1
33152|NCT01767597|145041|P1|Overall Study|Incomplete intervention|3
33153|NCT01767519|145050|P3|Overall Study|Adverse Event|1
33154|NCT01767519|145051|P2|Overall Study|Adverse Event|5
33155|NCT01767519|145052|P1|Overall Study|Adverse Event|5
33156|NCT01767519|145050|P3|Overall Study|Lack of Efficacy|0
33157|NCT01767519|145051|P2|Overall Study|Lack of Efficacy|0
33158|NCT01767519|145052|P1|Overall Study|Lack of Efficacy|1
33159|NCT01767519|145050|P3|Overall Study|Lost to Follow-up|2
33160|NCT01767519|145051|P2|Overall Study|Lost to Follow-up|1
33161|NCT01767519|145052|P1|Overall Study|Lost to Follow-up|3
33162|NCT01767519|145050|P3|Overall Study|Personal Reasons|0
33163|NCT01767519|145051|P2|Overall Study|Personal Reasons|0
33164|NCT01767519|145052|P1|Overall Study|Personal Reasons|1
33165|NCT01767519|145050|P3|Overall Study|Protocol Violation|0
33166|NCT01767519|145051|P2|Overall Study|Protocol Violation|3
33167|NCT01767519|145052|P1|Overall Study|Protocol Violation|0
33168|NCT01767519|145050|P3|Overall Study|Other Reasons|2
33169|NCT01767519|145051|P2|Overall Study|Other Reasons|4
33170|NCT01767519|145052|P1|Overall Study|Other Reasons|4
33171|NCT01767467|145093|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
33172|NCT01767467|145094|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
33173|NCT01767467|145093|P2|End of Study Phase (up to Month 13)|Physician Decision|0
33174|NCT01767467|145094|P1|End of Study Phase (up to Month 13)|Physician Decision|1
33175|NCT01767467|145093|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
33176|NCT01767467|145094|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
33177|NCT01767467|145093|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
33178|NCT01767467|145094|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
33179|NCT01767467|145093|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
33180|NCT01767467|145094|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
33181|NCT01767467|145093|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
33182|NCT01767467|145094|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
33183|NCT01767467|145093|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
33184|NCT01767467|145094|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
33185|NCT01767467|145093|P2|End of Study Phase (up to Month 13)|Adverse Event|39
33186|NCT01767467|145094|P1|End of Study Phase (up to Month 13)|Adverse Event|29
33187|NCT01767467|145093|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
33188|NCT01767467|145094|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
33189|NCT01767467|145093|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
33190|NCT01767467|145094|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
33191|NCT01767467|145093|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
33192|NCT01767467|145094|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
33193|NCT01767467|145093|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
33194|NCT01767467|145094|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
33195|NCT01767467|145093|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
33196|NCT01767467|145094|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
33197|NCT01767467|145093|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
33198|NCT01767467|145094|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
33199|NCT01767376|145145|P3|Overall Study|Withdrawal by Subject|0
33200|NCT01767376|145146|P2|Overall Study|Withdrawal by Subject|1
33201|NCT01767376|145147|P1|Overall Study|Withdrawal by Subject|1
33202|NCT01767376|145145|P3|Overall Study|Lost to Follow-up|0
33203|NCT01767376|145146|P2|Overall Study|Lost to Follow-up|2
33204|NCT01767376|145147|P1|Overall Study|Lost to Follow-up|3
33205|NCT01767116|145213|P2|Overall Study|Lost to Follow-up|2
33206|NCT01767116|145214|P1|Overall Study|Lost to Follow-up|2
33207|NCT01766921|145272|P2|Overall Study|Withdrawal by Subject|5
33208|NCT01766921|145273|P1|Overall Study|Withdrawal by Subject|14
33209|NCT01766921|145272|P2|Overall Study|Protocol Violation|1
33210|NCT01766921|145273|P1|Overall Study|Protocol Violation|1
33211|NCT01766921|145272|P2|Overall Study|Unclassified|2
33212|NCT01766921|145273|P1|Overall Study|Unclassified|2
33213|NCT01766921|145272|P2|Overall Study|Lost to Follow-up|3
33214|NCT01766921|145273|P1|Overall Study|Lost to Follow-up|1
33215|NCT01766921|145272|P2|Overall Study|Death|1
33216|NCT01766921|145273|P1|Overall Study|Death|1
33217|NCT01766921|145272|P2|Overall Study|Administrative Reason|5
33218|NCT01766921|145273|P1|Overall Study|Administrative Reason|5
33219|NCT01766778|145294|P2|Overall Study|Withdrawal by Subject|0
33220|NCT01766778|145295|P1|Overall Study|Withdrawal by Subject|1
33221|NCT01766778|145294|P2|Overall Study|Adverse Event|4
33222|NCT01766778|145295|P1|Overall Study|Adverse Event|4
33223|NCT01766336|145349|P2|Overall Study|Withdrawal by Subject|15
33224|NCT01766336|145350|P1|Overall Study|Withdrawal by Subject|18
33225|NCT01766336|145349|P2|Overall Study|Sponsor Decision|43
33226|NCT01766336|145350|P1|Overall Study|Sponsor Decision|52
33227|NCT01766336|145349|P2|Overall Study|Protocol Violation|1
33228|NCT01766336|145350|P1|Overall Study|Protocol Violation|0
33229|NCT01766336|145349|P2|Overall Study|Physician Decision|2
33230|NCT01766336|145350|P1|Overall Study|Physician Decision|4
33231|NCT01766336|145349|P2|Overall Study|Lost to Follow-up|3
33232|NCT01766336|145350|P1|Overall Study|Lost to Follow-up|1
33233|NCT01766336|145349|P2|Overall Study|Death|3
33234|NCT01766336|145350|P1|Overall Study|Death|4
33235|NCT01766336|145349|P2|Overall Study|Adverse Event|8
33236|NCT01766336|145350|P1|Overall Study|Adverse Event|11
33237|NCT01766310|145358|P2|Overall Study|Lost to Follow-up|3
33238|NCT01766310|145359|P1|Overall Study|Lost to Follow-up|1
33239|NCT01766050|145387|P1|Overall Study|Withdrawal by Subject|2
33240|NCT01766050|145387|P1|Overall Study|Lost to Follow-up|1
33241|NCT01766050|145387|P1|Overall Study|Adverse Event|1
33242|NCT01766037|145522|P2|Overall Study|nausea / discomfort|0
33243|NCT01766037|145523|P1|Overall Study|nausea / discomfort|3
33244|NCT01766037|145522|P2|Overall Study|medical - unrelated|2
33245|NCT01766037|145523|P1|Overall Study|medical - unrelated|1
33246|NCT01766037|145522|P2|Overall Study|Moved from area|0
33247|NCT01766037|145523|P1|Overall Study|Moved from area|5
33248|NCT01766037|145522|P2|Overall Study|Withdrawal by Subject|16
33249|NCT01766037|145523|P1|Overall Study|Withdrawal by Subject|18
33250|NCT01766037|145522|P2|Overall Study|Physician Decision|1
33251|NCT01766037|145523|P1|Overall Study|Physician Decision|0
33252|NCT01766037|145522|P2|Overall Study|Lost to Follow-up|10
33253|NCT01766037|145523|P1|Overall Study|Lost to Follow-up|0
33254|NCT01766037|145522|P2|Overall Study|Lack of Efficacy|0
33255|NCT01766037|145523|P1|Overall Study|Lack of Efficacy|1
33256|NCT01766037|145522|P2|Overall Study|Adverse Event|0
33257|NCT01766037|145523|P1|Overall Study|Adverse Event|1
33258|NCT01765764|145592|P3|Treatment Period|Other Miscellaneous Reasons|2
33259|NCT01765764|145593|P2|Treatment Period|Other Miscellaneous Reasons|2
33260|NCT01765764|145594|P1|Treatment Period|Other Miscellaneous Reasons|1
33261|NCT01765764|145592|P3|Treatment Period|Personal Reasons|1
33262|NCT01765764|145593|P2|Treatment Period|Personal Reasons|2
33263|NCT01765764|145594|P1|Treatment Period|Personal Reasons|1
33264|NCT01765764|145592|P3|Treatment Period|Lost to Follow-up|2
33265|NCT01765764|145593|P2|Treatment Period|Lost to Follow-up|3
33266|NCT01765764|145594|P1|Treatment Period|Lost to Follow-up|0
33267|NCT01765764|145592|P3|Treatment Period|Adverse Event|1
33268|NCT01765764|145593|P2|Treatment Period|Adverse Event|2
33269|NCT01765764|145594|P1|Treatment Period|Adverse Event|1
33270|NCT01765751|145614|P3|Overall Study|Lost to Follow-up|1
33271|NCT01765751|145615|P2|Overall Study|Lost to Follow-up|2
33272|NCT01765751|145616|P1|Overall Study|Lost to Follow-up|0
33273|NCT01765673|145648|P1|Overall Study|No transportation for 2nd/3rd visits|1
33274|NCT01765582|145674|P3|Overall Study|Withdrawal of Consent|10
33275|NCT01765582|145675|P2|Overall Study|Withdrawal of Consent|6
33276|NCT01765582|145676|P1|Overall Study|Withdrawal of Consent|11
33277|NCT01765582|145674|P3|Overall Study|Sponsor Decision|42
33278|NCT01765582|145675|P2|Overall Study|Sponsor Decision|42
33279|NCT01765582|145676|P1|Overall Study|Sponsor Decision|46
33280|NCT01765582|145674|P3|Overall Study|Death|33
33281|NCT01765582|145675|P2|Overall Study|Death|36
33282|NCT01765582|145676|P1|Overall Study|Death|31
33283|NCT01765582|145674|P3|Overall Study|Lost to Follow-up|1
33284|NCT01765582|145675|P2|Overall Study|Lost to Follow-up|2
33285|NCT01765582|145676|P1|Overall Study|Lost to Follow-up|2
33286|NCT01765582|145674|P3|Overall Study|Other|9
33287|NCT01765582|145675|P2|Overall Study|Other|6
33288|NCT01765582|145676|P1|Overall Study|Other|3
33289|NCT01765569|145709|P1|Period C|Death|1
33290|NCT01765569|145709|P1|Period B|Withdrawal by Subject|1
33291|NCT01765543|145730|P1|Overall Study|Withdrawal by Subject|2
33292|NCT01765543|145730|P1|Overall Study|Death|1
33293|NCT01765426|145782|P4|Overall Study|Lost to Follow-up|0
33294|NCT01765426|145783|P3|Overall Study|Lost to Follow-up|0
33295|NCT01765426|145784|P2|Overall Study|Lost to Follow-up|1
33296|NCT01765426|145785|P1|Overall Study|Lost to Follow-up|0
33297|NCT01765270|145841|P2|Overall Study|Withdrawal by Subject|1
33298|NCT01765270|145842|P1|Overall Study|Withdrawal by Subject|0
33299|NCT01765270|145841|P2|Overall Study|Physician Decision|0
33300|NCT01765270|145842|P1|Overall Study|Physician Decision|1
33301|NCT01765192|145864|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
33302|NCT01765192|145865|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
33303|NCT01765192|145864|P2|Treatment Period 2|Reason not specified|2
33304|NCT01765192|145865|P1|Treatment Period 2|Reason not specified|0
33305|NCT01765192|145864|P2|Washout Period|Reason not specified|0
33306|NCT01765192|145865|P1|Washout Period|Reason not specified|1
33307|NCT01765192|145864|P2|Washout Period|Voluntary Withdrawal|1
33308|NCT01765192|145865|P1|Washout Period|Voluntary Withdrawal|1
33309|NCT01765192|145864|P2|Treatment Period 1|Adverse Event|1
33310|NCT01765192|145865|P1|Treatment Period 1|Adverse Event|0
33311|NCT01765179|145883|P1|Overall Study|Ca elevated 10.6|1
33312|NCT01765179|145883|P1|Overall Study|work conflict|1
33313|NCT01765179|145883|P1|Overall Study|lack of venous access|1
33314|NCT01765179|145883|P1|Overall Study|Out of country unable to finish study|1
33315|NCT01765179|145883|P1|Overall Study|prohibited med|1
33316|NCT01765179|145883|P1|Overall Study|Hematocrit >54%|3
33317|NCT01765179|145883|P1|Overall Study|Withdrawal by Subject|8
33318|NCT01765179|145883|P1|Overall Study|Protocol Violation|1
33319|NCT01765179|145883|P1|Overall Study|Non-compliance with study drug|2
33320|NCT01765179|145883|P1|Overall Study|Lost to Follow-up|5
33321|NCT01765179|145883|P1|Overall Study|Adverse Event|3
33322|NCT01765153|145890|P2|Rest Phase 2|Lost to Follow-up|1
33323|NCT01765153|145891|P1|Rest Phase 2|Lost to Follow-up|2
33324|NCT01765153|145890|P2|Training Phase 2|Withdrawal by Subject|1
33325|NCT01765153|145891|P1|Training Phase 2|Withdrawal by Subject|0
33326|NCT01765153|145890|P2|Rest Phase 1|Withdrawal by Subject|1
33327|NCT01765153|145891|P1|Rest Phase 1|Withdrawal by Subject|0
33328|NCT01765153|145890|P2|Training Phase 1|Poor participation in intervention|1
33329|NCT01765153|145891|P1|Training Phase 1|Poor participation in intervention|0
33330|NCT01765153|145890|P2|Training Phase 1|Format of intervention differed|0
33331|NCT01765153|145891|P1|Training Phase 1|Format of intervention differed|1
33332|NCT01764997|145998|P5|Study Drug Treatment Period|Other than specified above|10
33333|NCT01764997|145999|P4|Study Drug Treatment Period|Other than specified above|0
33334|NCT01764997|146000|P3|Study Drug Treatment Period|Other than specified above|0
33335|NCT01764997|146001|P2|Study Drug Treatment Period|Other than specified above|0
33336|NCT01764997|146002|P1|Study Drug Treatment Period|Other than specified above|0
33337|NCT01764997|145998|P5|Study Drug Treatment Period|Lack of Efficacy|2
33338|NCT01764997|145999|P4|Study Drug Treatment Period|Lack of Efficacy|0
33339|NCT01764997|146000|P3|Study Drug Treatment Period|Lack of Efficacy|0
33340|NCT01764997|146001|P2|Study Drug Treatment Period|Lack of Efficacy|0
33341|NCT01764997|146002|P1|Study Drug Treatment Period|Lack of Efficacy|0
33342|NCT01764997|145998|P5|Study Drug Treatment Period|Adverse Event|24
33343|NCT01764997|145999|P4|Study Drug Treatment Period|Adverse Event|0
33344|NCT01764997|146000|P3|Study Drug Treatment Period|Adverse Event|0
33345|NCT01764997|146001|P2|Study Drug Treatment Period|Adverse Event|1
33346|NCT01764997|146002|P1|Study Drug Treatment Period|Adverse Event|0
33347|NCT01764997|145998|P5|Run-in Period|Other than specified above|0
33348|NCT01764997|145999|P4|Run-in Period|Other than specified above|0
33349|NCT01764997|146000|P3|Run-in Period|Other than specified above|0
33350|NCT01764997|146001|P2|Run-in Period|Other than specified above|0
33351|NCT01764997|146002|P1|Run-in Period|Other than specified above|17
33352|NCT01764997|145998|P5|Run-in Period|Poor compliance to protocol|0
33353|NCT01764997|145999|P4|Run-in Period|Poor compliance to protocol|0
33354|NCT01764997|146000|P3|Run-in Period|Poor compliance to protocol|0
33355|NCT01764997|146001|P2|Run-in Period|Poor compliance to protocol|0
33356|NCT01764997|146002|P1|Run-in Period|Poor compliance to protocol|1
33357|NCT01764997|145998|P5|Run-in Period|Lack of Efficacy|0
33358|NCT01764997|145999|P4|Run-in Period|Lack of Efficacy|0
33359|NCT01764997|146000|P3|Run-in Period|Lack of Efficacy|0
33360|NCT01764997|146001|P2|Run-in Period|Lack of Efficacy|0
33361|NCT01764997|146002|P1|Run-in Period|Lack of Efficacy|5
33362|NCT01764997|145998|P5|Run-in Period|Adverse Event|0
33363|NCT01764997|145999|P4|Run-in Period|Adverse Event|0
33364|NCT01764997|146000|P3|Run-in Period|Adverse Event|0
33365|NCT01764997|146001|P2|Run-in Period|Adverse Event|0
33366|NCT01764997|146002|P1|Run-in Period|Adverse Event|15
33367|NCT01764945|146029|P8|Overall Study|Adverse Event|0
33368|NCT01764945|146030|P7|Overall Study|Adverse Event|1
33369|NCT01764945|146031|P6|Overall Study|Adverse Event|0
33370|NCT01764945|146032|P5|Overall Study|Adverse Event|0
33371|NCT01764945|146033|P4|Overall Study|Adverse Event|0
33372|NCT01764945|146034|P3|Overall Study|Adverse Event|0
33373|NCT01764945|146035|P2|Overall Study|Adverse Event|1
33374|NCT01764945|146036|P1|Overall Study|Adverse Event|0
33375|NCT01764841|146082|P4|Overall Study|Lost to Follow-up|0
33376|NCT01764841|146083|P3|Overall Study|Lost to Follow-up|1
33377|NCT01764841|146084|P2|Overall Study|Lost to Follow-up|0
33378|NCT01764841|146085|P1|Overall Study|Lost to Follow-up|3
33379|NCT01764841|146082|P4|Overall Study|Withdrawal by Subject|15
33380|NCT01764841|146083|P3|Overall Study|Withdrawal by Subject|11
33381|NCT01764841|146084|P2|Overall Study|Withdrawal by Subject|24
33382|NCT01764841|146085|P1|Overall Study|Withdrawal by Subject|16
33383|NCT01764841|146082|P4|Overall Study|Protocol Violation|0
33384|NCT01764841|146083|P3|Overall Study|Protocol Violation|0
33385|NCT01764841|146084|P2|Overall Study|Protocol Violation|1
33386|NCT01764841|146085|P1|Overall Study|Protocol Violation|0
33387|NCT01764841|146082|P4|Overall Study|No Follow Up|0
33388|NCT01764841|146083|P3|Overall Study|No Follow Up|1
33389|NCT01764841|146084|P2|Overall Study|No Follow Up|0
33390|NCT01764841|146085|P1|Overall Study|No Follow Up|1
33391|NCT01764841|146082|P4|Overall Study|Death|4
33392|NCT01764841|146083|P3|Overall Study|Death|1
33393|NCT01764841|146084|P2|Overall Study|Death|0
33394|NCT01764841|146085|P1|Overall Study|Death|3
33395|NCT01764841|146082|P4|Overall Study|Logistical Difficulties|0
33396|NCT01764841|146083|P3|Overall Study|Logistical Difficulties|0
33397|NCT01764841|146084|P2|Overall Study|Logistical Difficulties|1
33398|NCT01764841|146085|P1|Overall Study|Logistical Difficulties|0
33399|NCT01764633|146128|P2|Overall Study|Lost to Follow-up|5
33400|NCT01764633|146129|P1|Overall Study|Lost to Follow-up|13
33401|NCT01764633|146128|P2|Overall Study|Withdrawal by Subject|88
33402|NCT01764633|146129|P1|Overall Study|Withdrawal by Subject|105
33403|NCT01764386|146158|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
33404|NCT01764386|146159|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
33405|NCT01764386|146158|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
33406|NCT01764386|146159|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
33407|NCT01764386|146158|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
33408|NCT01764386|146159|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
33409|NCT01764386|146158|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
33410|NCT01764386|146159|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
33411|NCT01764386|146158|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
33412|NCT01764386|146159|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
33413|NCT01764386|146158|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
33414|NCT01764386|146159|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
33415|NCT01764386|146158|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
33416|NCT01764386|146159|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
33417|NCT01764386|146158|P2|Controlled Treatment Period (CTP)|Adverse Event|0
33418|NCT01764386|146159|P1|Controlled Treatment Period (CTP)|Adverse Event|35
33419|NCT01764022|146202|P2|Overall Study|Protocol Violation|0
33420|NCT01764022|146203|P1|Overall Study|Protocol Violation|1
33421|NCT01764022|146202|P2|Overall Study|Physician Decision|2
33422|NCT01764022|146203|P1|Overall Study|Physician Decision|2
33423|NCT01764022|146202|P2|Overall Study|Lack of Efficacy|5
33424|NCT01764022|146203|P1|Overall Study|Lack of Efficacy|10
33425|NCT01764022|146202|P2|Overall Study|Withdrawal by Subject|4
33426|NCT01764022|146203|P1|Overall Study|Withdrawal by Subject|5
33427|NCT01764022|146202|P2|Overall Study|Death|1
33428|NCT01764022|146203|P1|Overall Study|Death|3
33429|NCT01763996|146231|P2|Treatment Period 2|Adverse Event|1
33430|NCT01763996|146232|P1|Treatment Period 2|Adverse Event|0
33431|NCT01763918|146262|P4|Overall Study|Sponsor Decision|0
33432|NCT01763918|146263|P3|Overall Study|Sponsor Decision|9
33433|NCT01763918|146264|P2|Overall Study|Sponsor Decision|0
33434|NCT01763918|146265|P1|Overall Study|Sponsor Decision|4
33435|NCT01763918|146262|P4|Overall Study|Withdrawal by Subject|2
33436|NCT01763918|146263|P3|Overall Study|Withdrawal by Subject|1
33437|NCT01763918|146264|P2|Overall Study|Withdrawal by Subject|1
33438|NCT01763918|146265|P1|Overall Study|Withdrawal by Subject|2
33439|NCT01763905|146363|P4|Overall Study|Lost to Follow-up|0
33440|NCT01763905|146364|P3|Overall Study|Lost to Follow-up|1
33441|NCT01763905|146365|P2|Overall Study|Lost to Follow-up|0
33442|NCT01763905|146366|P1|Overall Study|Lost to Follow-up|0
33443|NCT01763905|146363|P4|Overall Study|Decision by sponsor|0
33444|NCT01763905|146364|P3|Overall Study|Decision by sponsor|8
33445|NCT01763905|146365|P2|Overall Study|Decision by sponsor|0
33446|NCT01763905|146366|P1|Overall Study|Decision by sponsor|5
33447|NCT01763905|146363|P4|Overall Study|Withdrawal by Subject|1
33448|NCT01763905|146364|P3|Overall Study|Withdrawal by Subject|0
33449|NCT01763905|146365|P2|Overall Study|Withdrawal by Subject|1
33450|NCT01763905|146366|P1|Overall Study|Withdrawal by Subject|1
33451|NCT01763866|146484|P24|Overall Study|Death|0
33452|NCT01763866|146485|P23|Overall Study|Death|0
33453|NCT01763866|146486|P22|Overall Study|Death|0
33454|NCT01763866|146487|P21|Overall Study|Death|0
33455|NCT01763866|146488|P20|Overall Study|Death|0
33456|NCT01763866|146489|P19|Overall Study|Death|0
33457|NCT01763866|146490|P18|Overall Study|Death|0
33458|NCT01763866|146491|P17|Overall Study|Death|1
33459|NCT01763866|146492|P16|Overall Study|Death|0
33460|NCT01763866|146493|P15|Overall Study|Death|0
33461|NCT01763866|146494|P14|Overall Study|Death|0
33462|NCT01763866|146495|P13|Overall Study|Death|0
33463|NCT01763866|146496|P12|Overall Study|Death|0
33464|NCT01763866|146497|P11|Overall Study|Death|0
33465|NCT01763866|146498|P10|Overall Study|Death|0
33466|NCT01763866|146499|P9|Overall Study|Death|0
33467|NCT01763866|146500|P8|Overall Study|Death|0
33468|NCT01763866|146501|P7|Overall Study|Death|0
33469|NCT01763866|146502|P6|Overall Study|Death|0
33470|NCT01763866|146503|P5|Overall Study|Death|0
33471|NCT01763866|146504|P4|Overall Study|Death|0
33472|NCT01763866|146505|P3|Overall Study|Death|0
33473|NCT01763866|146506|P2|Overall Study|Death|0
33474|NCT01763866|146507|P1|Overall Study|Death|0
33475|NCT01763866|146484|P24|Overall Study|Lost to Follow-up|1
33476|NCT01763866|146485|P23|Overall Study|Lost to Follow-up|0
33477|NCT01763866|146486|P22|Overall Study|Lost to Follow-up|0
33478|NCT01763866|146487|P21|Overall Study|Lost to Follow-up|0
33479|NCT01763866|146488|P20|Overall Study|Lost to Follow-up|1
33480|NCT01763866|146489|P19|Overall Study|Lost to Follow-up|1
33481|NCT01763866|146490|P18|Overall Study|Lost to Follow-up|0
33482|NCT01763866|146491|P17|Overall Study|Lost to Follow-up|0
33483|NCT01763866|146492|P16|Overall Study|Lost to Follow-up|0
33484|NCT01763866|146493|P15|Overall Study|Lost to Follow-up|1
33485|NCT01763866|146494|P14|Overall Study|Lost to Follow-up|0
33486|NCT01763866|146495|P13|Overall Study|Lost to Follow-up|1
33487|NCT01763866|146496|P12|Overall Study|Lost to Follow-up|0
33488|NCT01763866|146497|P11|Overall Study|Lost to Follow-up|0
33489|NCT01763866|146498|P10|Overall Study|Lost to Follow-up|0
33490|NCT01763866|146499|P9|Overall Study|Lost to Follow-up|0
33491|NCT01763866|146500|P8|Overall Study|Lost to Follow-up|0
33492|NCT01763866|146501|P7|Overall Study|Lost to Follow-up|1
33493|NCT01763866|146502|P6|Overall Study|Lost to Follow-up|0
33494|NCT01763866|146503|P5|Overall Study|Lost to Follow-up|0
33495|NCT01763866|146504|P4|Overall Study|Lost to Follow-up|0
33496|NCT01763866|146505|P3|Overall Study|Lost to Follow-up|0
33497|NCT01763866|146506|P2|Overall Study|Lost to Follow-up|0
33498|NCT01763866|146507|P1|Overall Study|Lost to Follow-up|0
33499|NCT01763866|146484|P24|Overall Study|Decision by sponsor|0
33500|NCT01763866|146485|P23|Overall Study|Decision by sponsor|1
33501|NCT01763866|146486|P22|Overall Study|Decision by sponsor|0
33502|NCT01763866|146487|P21|Overall Study|Decision by sponsor|2
33503|NCT01763866|146488|P20|Overall Study|Decision by sponsor|0
33504|NCT01763866|146489|P19|Overall Study|Decision by sponsor|4
33505|NCT01763866|146490|P18|Overall Study|Decision by sponsor|0
33506|NCT01763866|146491|P17|Overall Study|Decision by sponsor|0
33507|NCT01763866|146492|P16|Overall Study|Decision by sponsor|0
33508|NCT01763866|146493|P15|Overall Study|Decision by sponsor|5
33509|NCT01763866|146494|P14|Overall Study|Decision by sponsor|0
33510|NCT01763866|146495|P13|Overall Study|Decision by sponsor|1
33511|NCT01763866|146496|P12|Overall Study|Decision by sponsor|0
33512|NCT01763866|146497|P11|Overall Study|Decision by sponsor|6
33513|NCT01763866|146498|P10|Overall Study|Decision by sponsor|0
33514|NCT01763866|146499|P9|Overall Study|Decision by sponsor|2
33515|NCT01763866|146500|P8|Overall Study|Decision by sponsor|0
33516|NCT01763866|146501|P7|Overall Study|Decision by sponsor|2
33517|NCT01763866|146502|P6|Overall Study|Decision by sponsor|0
33518|NCT01763866|146503|P5|Overall Study|Decision by sponsor|2
33519|NCT01763866|146504|P4|Overall Study|Decision by sponsor|0
33520|NCT01763866|146505|P3|Overall Study|Decision by sponsor|1
33521|NCT01763866|146506|P2|Overall Study|Decision by sponsor|0
33522|NCT01763866|146507|P1|Overall Study|Decision by sponsor|0
33523|NCT01763866|146484|P24|Overall Study|Withdrawal by Subject|1
33524|NCT01763866|146485|P23|Overall Study|Withdrawal by Subject|2
33525|NCT01763866|146486|P22|Overall Study|Withdrawal by Subject|1
33526|NCT01763866|146487|P21|Overall Study|Withdrawal by Subject|2
33527|NCT01763866|146488|P20|Overall Study|Withdrawal by Subject|1
33528|NCT01763866|146489|P19|Overall Study|Withdrawal by Subject|1
33529|NCT01763866|146490|P18|Overall Study|Withdrawal by Subject|1
33530|NCT01763866|146491|P17|Overall Study|Withdrawal by Subject|0
33531|NCT01763866|146492|P16|Overall Study|Withdrawal by Subject|3
33532|NCT01763866|146493|P15|Overall Study|Withdrawal by Subject|6
33533|NCT01763866|146494|P14|Overall Study|Withdrawal by Subject|0
33534|NCT01763866|146495|P13|Overall Study|Withdrawal by Subject|2
33535|NCT01763866|146496|P12|Overall Study|Withdrawal by Subject|2
33536|NCT01763866|146497|P11|Overall Study|Withdrawal by Subject|2
33537|NCT01763866|146498|P10|Overall Study|Withdrawal by Subject|1
33538|NCT01763866|146499|P9|Overall Study|Withdrawal by Subject|1
33539|NCT01763866|146500|P8|Overall Study|Withdrawal by Subject|0
33540|NCT01763866|146501|P7|Overall Study|Withdrawal by Subject|4
33541|NCT01763866|146502|P6|Overall Study|Withdrawal by Subject|3
33542|NCT01763866|146503|P5|Overall Study|Withdrawal by Subject|0
33543|NCT01763866|146504|P4|Overall Study|Withdrawal by Subject|0
33544|NCT01763866|146505|P3|Overall Study|Withdrawal by Subject|4
33545|NCT01763866|146506|P2|Overall Study|Withdrawal by Subject|1
33546|NCT01763866|146507|P1|Overall Study|Withdrawal by Subject|2
33547|NCT01763827|147067|P6|Overall Study|Lost to Follow-up|1
33548|NCT01763827|147068|P5|Overall Study|Lost to Follow-up|2
33549|NCT01763827|147069|P4|Overall Study|Lost to Follow-up|1
33550|NCT01763827|147070|P3|Overall Study|Lost to Follow-up|1
33551|NCT01763827|147071|P2|Overall Study|Lost to Follow-up|1
33552|NCT01763827|147072|P1|Overall Study|Lost to Follow-up|0
33553|NCT01763827|147067|P6|Overall Study|Decision by sponsor|1
33554|NCT01763827|147068|P5|Overall Study|Decision by sponsor|2
33555|NCT01763827|147069|P4|Overall Study|Decision by sponsor|0
33556|NCT01763827|147070|P3|Overall Study|Decision by sponsor|3
33557|NCT01763827|147071|P2|Overall Study|Decision by sponsor|0
33558|NCT01763827|147072|P1|Overall Study|Decision by sponsor|2
33559|NCT01763827|147067|P6|Overall Study|Withdrawal by Subject|0
33560|NCT01763827|147068|P5|Overall Study|Withdrawal by Subject|2
33561|NCT01763827|147069|P4|Overall Study|Withdrawal by Subject|0
33562|NCT01763827|147070|P3|Overall Study|Withdrawal by Subject|0
33563|NCT01763827|147071|P2|Overall Study|Withdrawal by Subject|0
33564|NCT01763827|147072|P1|Overall Study|Withdrawal by Subject|1
33565|NCT01763047|147243|P2|Period 2|Unsatisfactory lens Fitting|1
33566|NCT01763047|147244|P1|Period 2|Unsatisfactory lens Fitting|0
33567|NCT01763047|147243|P2|Period 2|Protocol Violation|2
33568|NCT01763047|147244|P1|Period 2|Protocol Violation|0
33569|NCT01763047|147243|P2|Period 2|Unsatisfactory Visual Response|1
33570|NCT01763047|147244|P1|Period 2|Unsatisfactory Visual Response|1
33571|NCT01763047|147243|P2|Period 2|Study Site office Closed|1
33572|NCT01763047|147244|P1|Period 2|Study Site office Closed|1
33573|NCT01763047|147243|P2|Period 2|No longer meets Eligibility Criteria|0
33574|NCT01763047|147244|P1|Period 2|No longer meets Eligibility Criteria|1
33575|NCT01763047|147243|P2|Period 2|Lens Discomfort|0
33576|NCT01763047|147244|P1|Period 2|Lens Discomfort|1
33577|NCT01763047|147243|P2|Period 1|Study Site office Closed|1
33578|NCT01763047|147244|P1|Period 1|Study Site office Closed|0
33579|NCT01763047|147243|P2|Period 1|Lens Power Not Available|1
33580|NCT01763047|147244|P1|Period 1|Lens Power Not Available|0
33581|NCT01763047|147243|P2|Period 1|Unsatisfactory Visual Response|3
33582|NCT01763047|147244|P1|Period 1|Unsatisfactory Visual Response|0
33583|NCT01763047|147243|P2|Period 1|Adverse Event|1
33584|NCT01763047|147244|P1|Period 1|Adverse Event|0
33585|NCT01763047|147243|P2|Period 1|No Longer Meets Eligibility criteria|0
33586|NCT01763047|147244|P1|Period 1|No Longer Meets Eligibility criteria|1
33587|NCT01763047|147243|P2|Period 1|Protocol Violation|4
33588|NCT01763047|147244|P1|Period 1|Protocol Violation|4
33589|NCT01763047|147243|P2|Period 1|Test Article Not Available|1
33590|NCT01763047|147244|P1|Period 1|Test Article Not Available|4
33591|NCT01762943|147283|P2|Overall Study|Withdrawal by Subject|1
33592|NCT01762943|147284|P1|Overall Study|Withdrawal by Subject|2
33593|NCT01762943|147283|P2|Overall Study|Protocol Violation|0
33594|NCT01762943|147284|P1|Overall Study|Protocol Violation|1
33595|NCT01762943|147283|P2|Overall Study|Physician Decision|1
33596|NCT01762943|147284|P1|Overall Study|Physician Decision|1
33597|NCT01762800|147301|P2|Overall Study|Withdrawal by Subject|4
33598|NCT01762800|147302|P1|Overall Study|Withdrawal by Subject|7
33599|NCT01762800|147301|P2|Overall Study|Physician Decision|1
33600|NCT01762800|147302|P1|Overall Study|Physician Decision|1
33601|NCT01762800|147301|P2|Overall Study|Study Closed/Terminated|1
33602|NCT01762800|147302|P1|Overall Study|Study Closed/Terminated|0
33603|NCT01762800|147301|P2|Overall Study|Lack of Efficacy|2
33604|NCT01762800|147302|P1|Overall Study|Lack of Efficacy|3
33605|NCT01762800|147301|P2|Overall Study|Adverse Event|13
33606|NCT01762800|147302|P1|Overall Study|Adverse Event|8
33607|NCT01762761|147376|P2|Overall Study|Physician Decision|1
33608|NCT01762761|147377|P1|Overall Study|Physician Decision|0
33609|NCT01762761|147376|P2|Overall Study|Protocol Violation|1
33610|NCT01762761|147377|P1|Overall Study|Protocol Violation|0
33611|NCT01762761|147376|P2|Overall Study|Lack of Efficacy|0
33612|NCT01762761|147377|P1|Overall Study|Lack of Efficacy|1
33613|NCT01762761|147376|P2|Overall Study|Adverse Event|2
33614|NCT01762761|147377|P1|Overall Study|Adverse Event|1
33615|NCT01762345|147455|P1|Overall Study|Protocol Violation|2
33616|NCT01762345|147455|P1|Overall Study|Adverse Event|5
33617|NCT01761565|147503|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
33618|NCT01761162|147556|P1|Overall Study|Withdrawal by Subject|3
33619|NCT01760876|147648|P1|Overall Study|Very poor baseline OCT quality|2
33620|NCT01760876|147648|P1|Overall Study|Major depression|1
33621|NCT01760876|147648|P1|Overall Study|Impaired renal function|1
33622|NCT01760876|147648|P1|Overall Study|Carcinoma of prostate|1
33623|NCT01760876|147648|P1|Overall Study|Non-cardiac death (head injury)|1
33624|NCT01759511|147703|P1|Overall Study|Withdrawal by Subject|3
33625|NCT01759511|147703|P1|Overall Study|Study Terminated by Sponsor|13
33626|NCT01759511|147703|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
33627|NCT01759511|147703|P1|Overall Study|Progressive Disease|5
33628|NCT01759511|147703|P1|Overall Study|Physician Decision|1
33629|NCT01759511|147703|P1|Overall Study|Lack of Efficacy|2
33630|NCT01759511|147703|P1|Overall Study|Death|2
33631|NCT01759511|147703|P1|Overall Study|Adverse Event|4
33632|NCT01759420|147711|P1|Overall Study|Inaccurate EKG machine readings|1
33633|NCT01759420|147711|P1|Overall Study|Screen failure|5
33634|NCT01759407|147718|P2|Overall Study|Protocol Violation|2
33635|NCT01759407|147719|P1|Overall Study|Protocol Violation|0
33636|NCT01759381|147731|P2|Overall Study|Death|0
33637|NCT01759381|147732|P1|Overall Study|Death|1
33638|NCT01759368|147740|P2|Overall Study|Lost to Follow-up|0
33639|NCT01759368|147741|P1|Overall Study|Lost to Follow-up|1
33640|NCT01759290|147759|P1|Overall Study|Unknown reason|4
33641|NCT01759290|147759|P1|Overall Study|Lost to Follow-up|53
33642|NCT01759290|147759|P1|Overall Study|Death|17
33643|NCT01759290|147759|P1|Overall Study|Physician Decision|2
33644|NCT01759290|147759|P1|Overall Study|Subjects withdrawn consent|5
33645|NCT01759264|147819|P1|Overall Study|Discontinued Humira Due to Business Trip|1
33646|NCT01759264|147819|P1|Overall Study|Withdrawal by Subject|3
33647|NCT01759264|147819|P1|Overall Study|Lost to Follow-up|2
33648|NCT01759264|147819|P1|Overall Study|Not Specified|2
33649|NCT01759264|147819|P1|Overall Study|Adverse Event|1
33650|NCT01759264|147819|P1|Overall Study|Serious Adverse Events (SAEs)|1
33651|NCT01758900|147847|P2|Overall Study|difficulty for further intubation|8
33652|NCT01758900|147848|P1|Overall Study|difficulty for further intubation|7
33653|NCT01758289|147866|P1|Overall Study|Adverse Event|9
33654|NCT01758289|147866|P1|Overall Study|Premature Study Termination|44
33655|NCT01757847|147892|P2|Overall Study|Withdrawal by Subject|4
33656|NCT01757847|147893|P1|Overall Study|Withdrawal by Subject|3
33657|NCT01757821|147901|P1|Overall Study|Adverse Event|1
33658|NCT01757704|147916|P2|Overall Study|Protocol Violation|3
33659|NCT01757704|147917|P1|Overall Study|Protocol Violation|1
33660|NCT01757691|147935|P2|Overall Study|Administrative problems|0
33661|NCT01757691|147936|P1|Overall Study|Administrative problems|2
33662|NCT01757405|147984|P2|Overall Study|Withdrawal by Subject|1
33663|NCT01757405|147985|P1|Overall Study|Withdrawal by Subject|0
33664|NCT01757405|147984|P2|Overall Study|Lost to Follow-up|1
33665|NCT01757405|147985|P1|Overall Study|Lost to Follow-up|1
33666|NCT01757275|148003|P2|Overall Study|Not treated|4
33667|NCT01757275|148004|P1|Overall Study|Not treated|3
33668|NCT01757275|148003|P2|Overall Study|Withdrawal by Subject|4
33669|NCT01757275|148004|P1|Overall Study|Withdrawal by Subject|2
33670|NCT01757275|148003|P2|Overall Study|Adverse Event|3
33671|NCT01757275|148004|P1|Overall Study|Adverse Event|3
33672|NCT01757275|148003|P2|Overall Study|Lost to Follow-up|2
33673|NCT01757275|148004|P1|Overall Study|Lost to Follow-up|1
33674|NCT01757197|148026|P1|Overall Study|Death|2
33675|NCT01757184|148033|P2|Double-Blind Period|Adverse Event|0
33676|NCT01757184|148034|P1|Double-Blind Period|Adverse Event|1
33677|NCT01757171|148058|P2|Overall Study|ECOG decline|0
33678|NCT01757171|148059|P1|Overall Study|ECOG decline|1
33679|NCT01757171|148058|P2|Overall Study|Hospitalization|0
33680|NCT01757171|148059|P1|Overall Study|Hospitalization|1
33681|NCT01757171|148058|P2|Overall Study|Disease Progression|0
33682|NCT01757171|148059|P1|Overall Study|Disease Progression|1
33683|NCT01757171|148058|P2|Overall Study|Adverse Event|1
33684|NCT01757171|148059|P1|Overall Study|Adverse Event|5
33685|NCT01756300|148093|P1|Overall Study|Withdrawal by Subject|1
33686|NCT01756300|148093|P1|Overall Study|Death|1
33687|NCT01756274|148115|P1|Overall Study|Laboratory error|1
33688|NCT01756274|148115|P1|Overall Study|Protocol Violation|2
33689|NCT01756235|148122|P1|Overall Study|Adalimumab Treatment was not Documented|2
33690|NCT01756157|148143|P2|First Intervention Period|Lost to Follow-up|2
33691|NCT01756157|148144|P1|First Intervention Period|Lost to Follow-up|0
33692|NCT01756157|148143|P2|First Intervention Period|Withdrawal by Subject|0
33693|NCT01756157|148144|P1|First Intervention Period|Withdrawal by Subject|1
33694|NCT01756079|148158|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
33695|NCT01756079|148158|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
33696|NCT01756079|148158|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
33697|NCT01756079|148158|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
33698|NCT01756079|148158|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
33699|NCT01756053|148164|P2|Period 2 (10 Days)|Protocol Violation|2
33700|NCT01756053|148165|P1|Period 2 (10 Days)|Protocol Violation|0
33701|NCT01756053|148164|P2|Period 1 (10 Days)|Protocol Violation|1
33702|NCT01756053|148165|P1|Period 1 (10 Days)|Protocol Violation|1
33703|NCT01755702|148185|P1|Washout Period II|Other Reason|5
33704|NCT01755702|148185|P1|Wash Out Period I|Other Reason|3
33705|NCT01755637|148227|P2|Period 1|Adverse Event|1
33706|NCT01755637|148228|P1|Period 1|Adverse Event|0
33707|NCT01755234|148261|P2|Overall Study|unblinded|0
33708|NCT01755234|148262|P1|Overall Study|unblinded|1
33709|NCT01755234|148261|P2|Overall Study|Withdrawal by Subject|1
33710|NCT01755234|148262|P1|Overall Study|Withdrawal by Subject|0
33711|NCT01755234|148261|P2|Overall Study|case cancelled|0
33712|NCT01755234|148262|P1|Overall Study|case cancelled|1
33713|NCT01755234|148261|P2|Overall Study|Change in surgical case|1
33714|NCT01755234|148262|P1|Overall Study|Change in surgical case|2
33715|NCT01755234|148261|P2|Overall Study|Lost to Follow-up|6
33716|NCT01755234|148262|P1|Overall Study|Lost to Follow-up|11
33717|NCT01755156|148293|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
33718|NCT01755156|148294|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
33719|NCT01755156|148293|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
33720|NCT01755156|148294|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
33721|NCT01755156|148293|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
33722|NCT01755156|148294|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
33723|NCT01755156|148293|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
33724|NCT01755156|148294|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
33725|NCT01755156|148293|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
33726|NCT01755156|148294|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
33727|NCT01755156|148293|P2|Phase A (Weeks 0-24)|Protocol Violation|1
33728|NCT01755156|148294|P1|Phase A (Weeks 0-24)|Protocol Violation|1
33729|NCT01755156|148293|P2|Phase A (Weeks 0-24)|Physician Decision|1
33730|NCT01755156|148294|P1|Phase A (Weeks 0-24)|Physician Decision|0
33731|NCT01755156|148293|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
33732|NCT01755156|148294|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
33733|NCT01755156|148293|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
33734|NCT01755156|148294|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
33735|NCT01755156|148293|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
33736|NCT01755156|148294|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
33737|NCT01755156|148293|P2|Phase A (Weeks 0-24)|Adverse Event|3
33738|NCT01755156|148294|P1|Phase A (Weeks 0-24)|Adverse Event|2
33739|NCT01755091|148358|P3|Overall Study|Physician Decision|2
33740|NCT01755091|148359|P2|Overall Study|Physician Decision|1
33741|NCT01755091|148360|P1|Overall Study|Physician Decision|1
33742|NCT01755091|148358|P3|Overall Study|Lost to Follow-up|1
33743|NCT01755091|148359|P2|Overall Study|Lost to Follow-up|0
33744|NCT01755091|148360|P1|Overall Study|Lost to Follow-up|1
33745|NCT01755091|148358|P3|Overall Study|Adverse Event|1
33746|NCT01755091|148359|P2|Overall Study|Adverse Event|1
33747|NCT01755091|148360|P1|Overall Study|Adverse Event|1
33748|NCT01755091|148358|P3|Overall Study|Withdrawal by Subject|3
33749|NCT01755091|148359|P2|Overall Study|Withdrawal by Subject|1
33750|NCT01755091|148360|P1|Overall Study|Withdrawal by Subject|6
33751|NCT01755026|148385|P2|Overall Study|Withdrawal by Subject|1
33752|NCT01755026|148386|P1|Overall Study|Withdrawal by Subject|1
33753|NCT01755026|148385|P2|Overall Study|Adverse Event|0
33754|NCT01755026|148386|P1|Overall Study|Adverse Event|1
33755|NCT01754922|148394|P2|Overall Study|Adverse Event|1
33756|NCT01754922|148395|P1|Overall Study|Adverse Event|0
33757|NCT01754766|148408|P3|Overall Study|Personal reasons|0
33758|NCT01754766|148409|P2|Overall Study|Personal reasons|1
33759|NCT01754766|148410|P1|Overall Study|Personal reasons|1
33760|NCT01754727|148424|P1|Overall Study|Adalimumab Treatment was not Documented|2
33761|NCT01754493|148551|P1|Overall Study|Scheduling conflict|1
33762|NCT01754493|148551|P1|Overall Study|Moved out of town|1
33763|NCT01754493|148551|P1|Overall Study|Withdrawal by Subject|1
33764|NCT01754493|148551|P1|Overall Study|Lost to Follow-up|3
33765|NCT01754493|148551|P1|Overall Study|Adverse Event|1
33766|NCT01754467|148576|P1|Overall Study|Lost to Follow-up|1
33767|NCT01754402|148586|P3|Overall Study|Lack of Efficacy|1
33768|NCT01754402|148587|P2|Overall Study|Lack of Efficacy|0
33769|NCT01754402|148588|P1|Overall Study|Lack of Efficacy|0
33770|NCT01754402|148586|P3|Overall Study|Withdrawal by Subject|1
33771|NCT01754402|148587|P2|Overall Study|Withdrawal by Subject|0
33772|NCT01754402|148588|P1|Overall Study|Withdrawal by Subject|0
33773|NCT01754402|148586|P3|Overall Study|Adverse Event|1
33774|NCT01754402|148587|P2|Overall Study|Adverse Event|2
33775|NCT01754402|148588|P1|Overall Study|Adverse Event|2
33776|NCT01754402|148586|P3|Overall Study|Death|1
33777|NCT01754402|148587|P2|Overall Study|Death|0
33778|NCT01754402|148588|P1|Overall Study|Death|0
33779|NCT01754376|148622|P1|Overall Study|Lack of Efficacy|2
33780|NCT01754376|148622|P1|Overall Study|Adverse Event|1
33781|NCT01754259|148633|P2|Overall Study|Lost to Follow-up|1
33782|NCT01754259|148634|P1|Overall Study|Lost to Follow-up|0
33783|NCT01754259|148633|P2|Overall Study|Adverse Event|1
33784|NCT01754259|148634|P1|Overall Study|Adverse Event|3
33785|NCT01754259|148633|P2|Overall Study|Withdrawal by Subject|4
33786|NCT01754259|148634|P1|Overall Study|Withdrawal by Subject|2
33787|NCT01754194|148644|P2|Overall Study|Not Specified|8
33788|NCT01754194|148645|P1|Overall Study|Not Specified|9
33789|NCT01754194|148644|P2|Overall Study|Withdrawal by Subject|5
33790|NCT01754194|148645|P1|Overall Study|Withdrawal by Subject|4
33791|NCT01754194|148644|P2|Overall Study|Lost to Follow-up|14
33792|NCT01754194|148645|P1|Overall Study|Lost to Follow-up|39
33793|NCT01753856|148667|P2|Overall Study|Sponsor Decision|0
33794|NCT01753856|148668|P1|Overall Study|Sponsor Decision|2
33795|NCT01753856|148667|P2|Overall Study|Withdrawal by Subject|2
33796|NCT01753856|148668|P1|Overall Study|Withdrawal by Subject|0
33797|NCT01753856|148667|P2|Overall Study|Adverse Event|0
33798|NCT01753856|148668|P1|Overall Study|Adverse Event|1
33799|NCT01753518|148758|P2|Postpartum Follow-up|Lost to Follow-up|15
33800|NCT01753518|148759|P1|Postpartum Follow-up|Lost to Follow-up|22
33801|NCT01753518|148758|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
33802|NCT01753518|148759|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
33803|NCT01753518|148758|P2|Intention-to-Treat Analysis|Multifetal gestation|3
33804|NCT01753518|148759|P1|Intention-to-Treat Analysis|Multifetal gestation|2
33805|NCT01753518|148758|P2|Intention-to-Treat Analysis|Missing consent form|3
33806|NCT01753518|148759|P1|Intention-to-Treat Analysis|Missing consent form|5
33807|NCT01753336|148781|P1|Overall Study|Withdrawal by Subject|1
33808|NCT01753336|148781|P1|Overall Study|Sponsor's decision|2
33809|NCT01753336|148781|P1|Overall Study|Physician Decision|2
33810|NCT01753336|148781|P1|Overall Study|Lost to Follow-up|3
33811|NCT01753336|148781|P1|Overall Study|Patient decision|12
33812|NCT01753323|148793|P3|Overall Study|Adverse Event|1
33813|NCT01753323|148794|P2|Overall Study|Adverse Event|0
33814|NCT01753323|148795|P1|Overall Study|Adverse Event|0
33815|NCT01753323|148793|P3|Overall Study|Protocol deviation|0
33816|NCT01753323|148794|P2|Overall Study|Protocol deviation|0
33817|NCT01753323|148795|P1|Overall Study|Protocol deviation|1
33818|NCT01753323|148793|P3|Overall Study|Lack of Efficacy|8
33819|NCT01753323|148794|P2|Overall Study|Lack of Efficacy|0
33820|NCT01753323|148795|P1|Overall Study|Lack of Efficacy|0
33821|NCT01753310|148833|P2|Overall Study|Withdrawal by Subject|0
33822|NCT01753310|148834|P1|Overall Study|Withdrawal by Subject|1
33823|NCT01753310|148833|P2|Overall Study|Sponsor decision|0
33824|NCT01753310|148834|P1|Overall Study|Sponsor decision|1
33825|NCT01753310|148833|P2|Overall Study|Subject decision|2
33826|NCT01753310|148834|P1|Overall Study|Subject decision|2
33827|NCT01753310|148833|P2|Overall Study|Lost to Follow-up|0
33828|NCT01753310|148834|P1|Overall Study|Lost to Follow-up|2
33829|NCT01753310|148833|P2|Overall Study|Adverse Event|0
33830|NCT01753310|148834|P1|Overall Study|Adverse Event|1
33831|NCT01753310|148833|P2|Overall Study|Entered into open label extension study|22
33832|NCT01753310|148834|P1|Overall Study|Entered into open label extension study|25
33833|NCT01753115|148857|P3|Overall Study|Used excluded drug|0
33834|NCT01753115|148858|P2|Overall Study|Used excluded drug|1
33835|NCT01753115|148859|P1|Overall Study|Used excluded drug|0
33836|NCT01753115|148857|P3|Overall Study|Subject non-compliant|0
33837|NCT01753115|148858|P2|Overall Study|Subject non-compliant|3
33838|NCT01753115|148859|P1|Overall Study|Subject non-compliant|3
33839|NCT01753115|148857|P3|Overall Study|Withdrawal by Subject|6
33840|NCT01753115|148858|P2|Overall Study|Withdrawal by Subject|5
33841|NCT01753115|148859|P1|Overall Study|Withdrawal by Subject|6
33842|NCT01753115|148857|P3|Overall Study|Lost to Follow-up|8
33843|NCT01753115|148858|P2|Overall Study|Lost to Follow-up|6
33844|NCT01753115|148859|P1|Overall Study|Lost to Follow-up|3
33845|NCT01753076|148869|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
33846|NCT01753076|148870|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
33847|NCT01753076|148869|P2|Overall Study|Withdrawal by Subject|24
33848|NCT01753076|148870|P1|Overall Study|Withdrawal by Subject|14
33849|NCT01753076|148869|P2|Overall Study|Physician Decision|2
33850|NCT01753076|148870|P1|Overall Study|Physician Decision|4
33851|NCT01753076|148869|P2|Overall Study|Lost to Follow-up|1
33852|NCT01753076|148870|P1|Overall Study|Lost to Follow-up|2
33853|NCT01753076|148869|P2|Overall Study|Lack of Efficacy|1
33854|NCT01753076|148870|P1|Overall Study|Lack of Efficacy|3
33855|NCT01753076|148869|P2|Overall Study|Adverse Event|18
33856|NCT01753076|148870|P1|Overall Study|Adverse Event|17
33857|NCT01752907|148896|P2|Overall Study|Decision by Sponsor|9
33858|NCT01752907|148897|P1|Overall Study|Decision by Sponsor|6
33859|NCT01752907|148896|P2|Overall Study|Lost to Follow-up|1
33860|NCT01752907|148897|P1|Overall Study|Lost to Follow-up|2
33861|NCT01752907|148896|P2|Overall Study|Withdrawal by Subject|10
33862|NCT01752907|148897|P1|Overall Study|Withdrawal by Subject|4
33863|NCT01752855|148917|P2|Overall Study|Lack of Efficacy|2
33864|NCT01752855|148918|P1|Overall Study|Lack of Efficacy|0
33865|NCT01752855|148917|P2|Overall Study|Withdrew Consent|2
33866|NCT01752855|148918|P1|Overall Study|Withdrew Consent|0
33867|NCT01752855|148917|P2|Overall Study|Adverse Event|0
33868|NCT01752855|148918|P1|Overall Study|Adverse Event|1
33869|NCT01752023|148964|P2|Overall Study|Physician Decision|1
33870|NCT01752023|148965|P1|Overall Study|Physician Decision|2
33871|NCT01751867|149152|P2|Overall Study|Randomized but not treated.|1
33872|NCT01751867|149153|P1|Overall Study|Randomized but not treated.|2
33873|NCT01751867|149152|P2|Overall Study|Other|37
33874|NCT01751867|149153|P1|Overall Study|Other|11
33875|NCT01751867|149152|P2|Overall Study|Death|5
33876|NCT01751867|149153|P1|Overall Study|Death|0
33877|NCT01751867|149152|P2|Overall Study|Protocol Violation|2
33878|NCT01751867|149153|P1|Overall Study|Protocol Violation|0
33879|NCT01751867|149152|P2|Overall Study|Physician Decision|7
33880|NCT01751867|149153|P1|Overall Study|Physician Decision|4
33881|NCT01751867|149152|P2|Overall Study|Withdrawal by Subject|1
33882|NCT01751867|149153|P1|Overall Study|Withdrawal by Subject|3
33883|NCT01751867|149152|P2|Overall Study|Poor Compliance|5
33884|NCT01751867|149153|P1|Overall Study|Poor Compliance|0
33885|NCT01751867|149152|P2|Overall Study|Adverse Event|15
33886|NCT01751867|149153|P1|Overall Study|Adverse Event|8
33887|NCT01751867|149152|P2|Overall Study|Diease Progression|18
33888|NCT01751867|149153|P1|Overall Study|Diease Progression|4
33889|NCT01751867|149152|P2|Overall Study|Completed treatment,dropped in follow-up|8
33890|NCT01751867|149153|P1|Overall Study|Completed treatment,dropped in follow-up|4
33891|NCT01751802|149173|P2|Overall Study|Adverse Event|2
33892|NCT01751802|149174|P1|Overall Study|Adverse Event|4
33893|NCT01751724|149188|P2|Overall Study|withdrawn by parent|2
33894|NCT01751724|149189|P1|Overall Study|withdrawn by parent|0
33895|NCT01751724|149188|P2|Overall Study|extubated bef.start assigned treatment|0
33896|NCT01751724|149189|P1|Overall Study|extubated bef.start assigned treatment|1
33897|NCT01751412|149215|P1|Overall Study|Disease Progression Before Treatment|1
33898|NCT01751178|149283|P3|Overall Study|Other Reason (unknown)|2
33899|NCT01751178|149284|P2|Overall Study|Other Reason (unknown)|0
33900|NCT01751178|149285|P1|Overall Study|Other Reason (unknown)|1
33901|NCT01751178|149283|P3|Overall Study|Adverse Event|0
33902|NCT01751178|149284|P2|Overall Study|Adverse Event|0
33903|NCT01751178|149285|P1|Overall Study|Adverse Event|2
33904|NCT01751165|149305|P3|Overall Study|Lost to Follow-up|1
33905|NCT01751165|149306|P2|Overall Study|Lost to Follow-up|1
33906|NCT01751165|149307|P1|Overall Study|Lost to Follow-up|1
33907|NCT01751165|149305|P3|Overall Study|Serious adverse event|0
33908|NCT01751165|149306|P2|Overall Study|Serious adverse event|2
33909|NCT01751165|149307|P1|Overall Study|Serious adverse event|0
33910|NCT01751165|149305|P3|Overall Study|Withdrawal by Subject|1
33911|NCT01751165|149306|P2|Overall Study|Withdrawal by Subject|0
33912|NCT01751165|149307|P1|Overall Study|Withdrawal by Subject|0
33913|NCT01751165|149305|P3|Overall Study|Adverse event, serious fatal|1
33914|NCT01751165|149306|P2|Overall Study|Adverse event, serious fatal|0
33915|NCT01751165|149307|P1|Overall Study|Adverse event, serious fatal|1
33916|NCT01751113|149347|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
33917|NCT01751113|149348|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
33918|NCT01751113|149349|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
33919|NCT01751113|149350|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
33920|NCT01751113|149351|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
33921|NCT01751113|149352|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
33922|NCT01751113|149347|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
33923|NCT01751113|149348|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
33924|NCT01751113|149349|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
33925|NCT01751113|149350|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
33926|NCT01751113|149351|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
33927|NCT01751113|149352|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
33928|NCT01751087|149393|P3|Overall Study|Physician Decision|1
33929|NCT01751087|149394|P2|Overall Study|Physician Decision|0
33930|NCT01751087|149395|P1|Overall Study|Physician Decision|0
33931|NCT01751087|149393|P3|Overall Study|Withdrawal by Subject|0
33932|NCT01751087|149394|P2|Overall Study|Withdrawal by Subject|0
33933|NCT01751087|149395|P1|Overall Study|Withdrawal by Subject|1
33934|NCT01750840|149483|P1|Overall Study|Lost to Follow-up|4
33935|NCT01750684|149490|P2|Overall Study|Protocol Violation|0
33936|NCT01750684|149491|P1|Overall Study|Protocol Violation|1
33937|NCT01750684|149490|P2|Overall Study|Withdrawn by Sponsor|1
33938|NCT01750684|149491|P1|Overall Study|Withdrawn by Sponsor|0
33939|NCT01750684|149490|P2|Overall Study|Non-compliance with Study Drug|1
33940|NCT01750684|149491|P1|Overall Study|Non-compliance with Study Drug|0
33941|NCT01750684|149490|P2|Overall Study|Death|0
33942|NCT01750684|149491|P1|Overall Study|Death|1
33943|NCT01750346|149526|P3|Overall Study|Adverse Event|0
33944|NCT01750346|149527|P2|Overall Study|Adverse Event|0
33945|NCT01750346|149528|P1|Overall Study|Adverse Event|1
33946|NCT01750294|149554|P1|Overall Study|Safety Endpoint|1
33947|NCT01750294|149554|P1|Overall Study|Withdrawal by Subject|1
33948|NCT01750281|149561|P3|Overall Study|Did not receive treatment|0
33949|NCT01750281|149562|P2|Overall Study|Did not receive treatment|1
33950|NCT01750281|149563|P1|Overall Study|Did not receive treatment|0
33951|NCT01750281|149561|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
33952|NCT01750281|149562|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
33953|NCT01750281|149563|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
33954|NCT01750281|149561|P3|Overall Study|Discontinued Selumetinib/Placebo|75
33955|NCT01750281|149562|P2|Overall Study|Discontinued Selumetinib/Placebo|77
33956|NCT01750281|149563|P1|Overall Study|Discontinued Selumetinib/Placebo|37
33957|NCT01750242|149593|P1|Overall Study|Unreadable Images|3
33958|NCT01750229|149598|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
33959|NCT01750229|149598|P1|Long-term Follow-up Phase|Adverse Event|2
33960|NCT01750229|149598|P1|Randomized Crossover Phase|Withdrawal by Subject|1
33961|NCT01750229|149598|P1|Randomized Crossover Phase|Adverse Event|1
33962|NCT01749982|149621|P4|Overall Study|Withdrawal by Subject|1
33963|NCT01749982|149622|P3|Overall Study|Withdrawal by Subject|0
33964|NCT01749982|149623|P2|Overall Study|Withdrawal by Subject|0
33965|NCT01749982|149624|P1|Overall Study|Withdrawal by Subject|0
33966|NCT01749982|149621|P4|Overall Study|Lost to Follow-up|1
33967|NCT01749982|149622|P3|Overall Study|Lost to Follow-up|0
33968|NCT01749982|149623|P2|Overall Study|Lost to Follow-up|0
33969|NCT01749982|149624|P1|Overall Study|Lost to Follow-up|0
33970|NCT01749982|149621|P4|Overall Study|Physician Decision|1
33971|NCT01749982|149622|P3|Overall Study|Physician Decision|0
33972|NCT01749982|149623|P2|Overall Study|Physician Decision|0
33973|NCT01749982|149624|P1|Overall Study|Physician Decision|0
33974|NCT01749800|149655|P3|Overall Study|Withdrawal by Subject|0
33975|NCT01749800|149656|P2|Overall Study|Withdrawal by Subject|1
33976|NCT01749800|149657|P1|Overall Study|Withdrawal by Subject|0
33977|NCT01749800|149655|P3|Overall Study|not meeting inclusion criteria|0
33978|NCT01749800|149656|P2|Overall Study|not meeting inclusion criteria|0
33979|NCT01749800|149657|P1|Overall Study|not meeting inclusion criteria|3
33980|NCT01749735|149667|P2|Overall Study|Withdrawal by Subject|0
33981|NCT01749735|149668|P1|Overall Study|Withdrawal by Subject|1
33982|NCT01748890|149757|P1|Overall Study|Insufficient recruitment for analysis|4
33983|NCT01748760|149812|P2|Overall Study|Lost to Follow-up|1
33984|NCT01748760|149813|P1|Overall Study|Lost to Follow-up|5
33985|NCT01748760|149812|P2|Overall Study|Withdrawal by Subject|1
33986|NCT01748760|149813|P1|Overall Study|Withdrawal by Subject|1
33987|NCT01748292|149849|P2|Overall Study|Withdrawal by Subject|2
33988|NCT01748292|149850|P1|Overall Study|Withdrawal by Subject|0
33989|NCT01748292|149849|P2|Overall Study|Death|3
33990|NCT01748292|149850|P1|Overall Study|Death|0
33991|NCT01748292|149849|P2|Overall Study|Lost to Follow-up|3
33992|NCT01748292|149850|P1|Overall Study|Lost to Follow-up|0
33993|NCT01748292|149849|P2|Overall Study|Adverse Event|4
33994|NCT01748292|149850|P1|Overall Study|Adverse Event|2
33995|NCT01748162|149876|P2|Overall Study|reasons not available|2
33996|NCT01748162|149877|P1|Overall Study|reasons not available|3
33997|NCT01748162|149876|P2|Overall Study|participant consented but did not begin|1
33998|NCT01748162|149877|P1|Overall Study|participant consented but did not begin|0
33999|NCT01748162|149876|P2|Overall Study|no additional croup episodes to evaluate|2
34000|NCT01748162|149877|P1|Overall Study|no additional croup episodes to evaluate|2
34001|NCT01748071|149888|P3|Overall Study|Adverse Event|0
34002|NCT01748071|149889|P2|Overall Study|Adverse Event|2
34003|NCT01748071|149890|P1|Overall Study|Adverse Event|2
34004|NCT01747811|150177|P2|Overall Study|Lack of Efficacy|4
34005|NCT01747811|150178|P1|Overall Study|Lack of Efficacy|2
34006|NCT01747772|150194|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
34007|NCT01747655|150202|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
34008|NCT01747655|150203|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
34009|NCT01747655|150202|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
34010|NCT01747655|150203|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
34011|NCT01747655|150202|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
34012|NCT01747655|150203|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
34013|NCT01747629|150233|P2|Overall Study|Not specified|1
34014|NCT01747629|150234|P1|Overall Study|Not specified|2
34015|NCT01747629|150233|P2|Overall Study|Not treated|0
34016|NCT01747629|150234|P1|Overall Study|Not treated|1
34017|NCT01747629|150233|P2|Overall Study|Inclusion criteria not met|0
34018|NCT01747629|150234|P1|Overall Study|Inclusion criteria not met|1
34019|NCT01747629|150233|P2|Overall Study|Noncompliance|1
34020|NCT01747629|150234|P1|Overall Study|Noncompliance|1
34021|NCT01747629|150233|P2|Overall Study|Withdrawal by Subject|2
34022|NCT01747629|150234|P1|Overall Study|Withdrawal by Subject|2
34023|NCT01747629|150233|P2|Overall Study|Adverse Event|2
34024|NCT01747629|150234|P1|Overall Study|Adverse Event|1
34025|NCT01747551|150268|P2|Overall Study|Other|0
34026|NCT01747551|150269|P1|Overall Study|Other|2
34027|NCT01747551|150268|P2|Overall Study|Physician Decision|1
34028|NCT01747551|150269|P1|Overall Study|Physician Decision|2
34029|NCT01747551|150268|P2|Overall Study|Withdrawal by Subject|1
34030|NCT01747551|150269|P1|Overall Study|Withdrawal by Subject|3
34031|NCT01747551|150268|P2|Overall Study|Prolonged Treatment Delay|0
34032|NCT01747551|150269|P1|Overall Study|Prolonged Treatment Delay|2
34033|NCT01747551|150268|P2|Overall Study|Adverse Event|1
34034|NCT01747551|150269|P1|Overall Study|Adverse Event|7
34035|NCT01747551|150268|P2|Overall Study|Death|1
34036|NCT01747551|150269|P1|Overall Study|Death|3
34037|NCT01747551|150268|P2|Overall Study|Progressive Disease|17
34038|NCT01747551|150269|P1|Overall Study|Progressive Disease|24
34039|NCT01746862|150327|P2|Overall Study|Entered puberty during the study|0
34040|NCT01746862|150328|P1|Overall Study|Entered puberty during the study|1
34041|NCT01746862|150327|P2|Overall Study|Consent withdrawal by parent’s guardian|2
34042|NCT01746862|150328|P1|Overall Study|Consent withdrawal by parent’s guardian|5
34043|NCT01746862|150327|P2|Overall Study|Protocol Violation|0
34044|NCT01746862|150328|P1|Overall Study|Protocol Violation|1
34045|NCT01746862|150327|P2|Overall Study|Withdrawal by Subject|1
34046|NCT01746862|150328|P1|Overall Study|Withdrawal by Subject|1
34047|NCT01746368|150398|P2|Overall Study|Withdrawal by Subject|1
34048|NCT01746368|150399|P1|Overall Study|Withdrawal by Subject|0
34049|NCT01746368|150398|P2|Overall Study|Lost to Follow-up|0
34050|NCT01746368|150399|P1|Overall Study|Lost to Follow-up|2
34051|NCT01746173|150426|P1|Overall Study|Disease Progression|2
34052|NCT01746108|150434|P3|Overall Study|Lost to Follow-up|0
34053|NCT01746108|150435|P2|Overall Study|Lost to Follow-up|1
34054|NCT01746108|150436|P1|Overall Study|Lost to Follow-up|0
34055|NCT01746108|150434|P3|Overall Study|Withdrawal by Subject|0
34056|NCT01746108|150435|P2|Overall Study|Withdrawal by Subject|1
34057|NCT01746108|150436|P1|Overall Study|Withdrawal by Subject|0
34058|NCT01746108|150434|P3|Overall Study|Adverse event, non-fatal|0
34059|NCT01746108|150435|P2|Overall Study|Adverse event, non-fatal|1
34060|NCT01746108|150436|P1|Overall Study|Adverse event, non-fatal|0
34061|NCT01746108|150434|P3|Overall Study|Migrated /moved from study area|0
34062|NCT01746108|150435|P2|Overall Study|Migrated /moved from study area|1
34063|NCT01746108|150436|P1|Overall Study|Migrated /moved from study area|0
34064|NCT01745848|150509|P1|Overall Study|Adverse Event|6
34065|NCT01745380|150516|P2|Overall Study|Lack of Efficacy|1
34066|NCT01745380|150517|P1|Overall Study|Lack of Efficacy|0
34067|NCT01745380|150516|P2|Overall Study|Lost to Follow-up|0
34068|NCT01745380|150517|P1|Overall Study|Lost to Follow-up|1
34069|NCT01745094|150570|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
34070|NCT01745094|150571|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
34071|NCT01745094|150572|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
34072|NCT01745094|150573|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
34073|NCT01745094|150570|P4|Overall Study|Show no Stable Solifenacin Intake|0
34074|NCT01745094|150571|P3|Overall Study|Show no Stable Solifenacin Intake|1
34075|NCT01745094|150572|P2|Overall Study|Show no Stable Solifenacin Intake|0
34076|NCT01745094|150573|P1|Overall Study|Show no Stable Solifenacin Intake|0
34077|NCT01745094|150570|P4|Overall Study|Need Further Examinations Due to Biopsy|0
34078|NCT01745094|150571|P3|Overall Study|Need Further Examinations Due to Biopsy|1
34079|NCT01745094|150572|P2|Overall Study|Need Further Examinations Due to Biopsy|0
34080|NCT01745094|150573|P1|Overall Study|Need Further Examinations Due to Biopsy|0
34081|NCT01745094|150570|P4|Overall Study|Protocol Violation|1
34082|NCT01745094|150571|P3|Overall Study|Protocol Violation|3
34083|NCT01745094|150572|P2|Overall Study|Protocol Violation|0
34084|NCT01745094|150573|P1|Overall Study|Protocol Violation|1
34085|NCT01745094|150570|P4|Overall Study|Withdrawal by Subject|2
34086|NCT01745094|150571|P3|Overall Study|Withdrawal by Subject|1
34087|NCT01745094|150572|P2|Overall Study|Withdrawal by Subject|0
34088|NCT01745094|150573|P1|Overall Study|Withdrawal by Subject|2
34089|NCT01745094|150570|P4|Overall Study|Adverse Event|0
34090|NCT01745094|150571|P3|Overall Study|Adverse Event|3
34091|NCT01745094|150572|P2|Overall Study|Adverse Event|0
34092|NCT01745094|150573|P1|Overall Study|Adverse Event|0
34093|NCT01745094|150570|P4|Overall Study|Not Meeting the Eligibility Criteria|0
34094|NCT01745094|150571|P3|Overall Study|Not Meeting the Eligibility Criteria|3
34095|NCT01745094|150572|P2|Overall Study|Not Meeting the Eligibility Criteria|0
34096|NCT01745094|150573|P1|Overall Study|Not Meeting the Eligibility Criteria|1
34097|NCT01744977|150674|P2|Overall Study|No longer meets inclusion|0
34098|NCT01744977|150675|P1|Overall Study|No longer meets inclusion|6
34099|NCT01744977|150674|P2|Overall Study|Lost to Follow-up|0
34100|NCT01744977|150675|P1|Overall Study|Lost to Follow-up|2
34101|NCT01744977|150674|P2|Overall Study|Death|3
34102|NCT01744977|150675|P1|Overall Study|Death|2
34103|NCT01744977|150674|P2|Overall Study|Withdrawal by Subject|2
34104|NCT01744977|150675|P1|Overall Study|Withdrawal by Subject|1
34105|NCT01744782|150746|P1|Overall Study|Death|1
34106|NCT01744691|150806|P1|Overall Study|Physician Decision|4
34107|NCT01744691|150806|P1|Overall Study|Withdrawal of consent for treatment|3
34108|NCT01744691|150806|P1|Overall Study|Unacceptable toxicity, AE or death|18
34109|NCT01744691|150806|P1|Overall Study|Progressive Disease|18
34110|NCT01744496|150813|P2|Maintenance Period|Subject left town|0
34111|NCT01744496|150814|P1|Maintenance Period|Subject left town|1
34112|NCT01744496|150813|P2|Maintenance Period|Withdrawal by Subject|1
34113|NCT01744496|150814|P1|Maintenance Period|Withdrawal by Subject|1
34114|NCT01744496|150813|P2|Maintenance Period|Protocol Violation|0
34115|NCT01744496|150814|P1|Maintenance Period|Protocol Violation|1
34116|NCT01744496|150813|P2|Maintenance Period|Adverse Event|3
34117|NCT01744496|150814|P1|Maintenance Period|Adverse Event|1
34118|NCT01744496|150813|P2|Titration Period|Personal reasons|1
34119|NCT01744496|150814|P1|Titration Period|Personal reasons|0
34120|NCT01744496|150813|P2|Titration Period|Adverse Event|1
34121|NCT01744496|150814|P1|Titration Period|Adverse Event|2
34122|NCT01744483|150835|P3|Overall Study|Routed to OSH|1
34123|NCT01744483|150836|P2|Overall Study|Routed to OSH|0
34124|NCT01744483|150837|P1|Overall Study|Routed to OSH|2
34125|NCT01744483|150835|P3|Overall Study|No ICU Admit|2
34126|NCT01744483|150836|P2|Overall Study|No ICU Admit|1
34127|NCT01744483|150837|P1|Overall Study|No ICU Admit|5
34128|NCT01744483|150835|P3|Overall Study|Withdrawal by Subject|2
34129|NCT01744483|150836|P2|Overall Study|Withdrawal by Subject|6
34130|NCT01744483|150837|P1|Overall Study|Withdrawal by Subject|4
34131|NCT01744483|150835|P3|Overall Study|Protocol Violation|1
34132|NCT01744483|150836|P2|Overall Study|Protocol Violation|2
34133|NCT01744483|150837|P1|Overall Study|Protocol Violation|1
34134|NCT01744483|150835|P3|Overall Study|Lost to Follow-up|11
34135|NCT01744483|150836|P2|Overall Study|Lost to Follow-up|9
34136|NCT01744483|150837|P1|Overall Study|Lost to Follow-up|8
34137|NCT01744483|150835|P3|Overall Study|Death|11
34138|NCT01744483|150836|P2|Overall Study|Death|4
34139|NCT01744483|150837|P1|Overall Study|Death|9
34140|NCT01744392|150845|P1|Overall Study|Physician Decision|1
34141|NCT01744197|150885|P2|Overall Study|No patch received|2
34142|NCT01744197|150886|P1|Overall Study|No patch received|2
34143|NCT01744197|150885|P2|Overall Study|Received 1 patch|1
34144|NCT01744197|150886|P1|Overall Study|Received 1 patch|2
34145|NCT01743469|150977|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
34146|NCT01743469|150978|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
34147|NCT01743469|150979|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
34148|NCT01743469|150980|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
34149|NCT01743469|150977|P4|Follow-up Period - Post-Treatment|Death|16
34150|NCT01743469|150978|P3|Follow-up Period - Post-Treatment|Death|22
34151|NCT01743469|150979|P2|Follow-up Period - Post-Treatment|Death|47
34152|NCT01743469|150980|P1|Follow-up Period - Post-Treatment|Death|43
34153|NCT01743469|150977|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
34154|NCT01743469|150978|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
34155|NCT01743469|150979|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
34156|NCT01743469|150980|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
34157|NCT01743469|150977|P4|Active Treatment Phase|Missing|0
34158|NCT01743469|150978|P3|Active Treatment Phase|Missing|0
34159|NCT01743469|150979|P2|Active Treatment Phase|Missing|0
34160|NCT01743469|150980|P1|Active Treatment Phase|Missing|1
34161|NCT01743469|150977|P4|Active Treatment Phase|Withdrawal by Subject|0
34162|NCT01743469|150978|P3|Active Treatment Phase|Withdrawal by Subject|0
34163|NCT01743469|150979|P2|Active Treatment Phase|Withdrawal by Subject|3
34164|NCT01743469|150980|P1|Active Treatment Phase|Withdrawal by Subject|2
34165|NCT01743469|150977|P4|Active Treatment Phase|Disease Progression|20
34166|NCT01743469|150978|P3|Active Treatment Phase|Disease Progression|30
34167|NCT01743469|150979|P2|Active Treatment Phase|Disease Progression|47
34168|NCT01743469|150980|P1|Active Treatment Phase|Disease Progression|40
34169|NCT01743469|150977|P4|Active Treatment Phase|Adverse Event|1
34170|NCT01743469|150978|P3|Active Treatment Phase|Adverse Event|8
34171|NCT01743469|150979|P2|Active Treatment Phase|Adverse Event|5
34172|NCT01743469|150980|P1|Active Treatment Phase|Adverse Event|10
34173|NCT01743092|151020|P2|Overall Study|Lost to Follow-up|15
34174|NCT01743092|151021|P1|Overall Study|Lost to Follow-up|14
34175|NCT01743027|151033|P4|Overall Study|Withdrawal by Subject|1
34176|NCT01743027|151034|P3|Overall Study|Withdrawal by Subject|3
34177|NCT01743027|151035|P2|Overall Study|Withdrawal by Subject|0
34178|NCT01743027|151036|P1|Overall Study|Withdrawal by Subject|1
34179|NCT01743027|151033|P4|Overall Study|Protocol Violation|0
34180|NCT01743027|151034|P3|Overall Study|Protocol Violation|1
34181|NCT01743027|151035|P2|Overall Study|Protocol Violation|1
34182|NCT01743027|151036|P1|Overall Study|Protocol Violation|1
34183|NCT01743027|151033|P4|Overall Study|Progressive Disease|0
34184|NCT01743027|151034|P3|Overall Study|Progressive Disease|3
34185|NCT01743027|151035|P2|Overall Study|Progressive Disease|4
34186|NCT01743027|151036|P1|Overall Study|Progressive Disease|1
34187|NCT01743027|151033|P4|Overall Study|Lost to Follow-up|0
34188|NCT01743027|151034|P3|Overall Study|Lost to Follow-up|2
34189|NCT01743027|151035|P2|Overall Study|Lost to Follow-up|0
34190|NCT01743027|151036|P1|Overall Study|Lost to Follow-up|0
34191|NCT01743027|151033|P4|Overall Study|Adverse Event|0
34192|NCT01743027|151034|P3|Overall Study|Adverse Event|0
34193|NCT01743027|151035|P2|Overall Study|Adverse Event|0
34194|NCT01743027|151036|P1|Overall Study|Adverse Event|2
34195|NCT01743001|151076|P2|Overall Study|Death|0
34196|NCT01743001|151077|P1|Overall Study|Death|1
34197|NCT01743001|151076|P2|Overall Study|Pregnancy|0
34198|NCT01743001|151077|P1|Overall Study|Pregnancy|1
34199|NCT01743001|151076|P2|Overall Study|Physician Decision|0
34200|NCT01743001|151077|P1|Overall Study|Physician Decision|1
34201|NCT01742897|151100|P1|Overall Study|Other|1
34202|NCT01742897|151100|P1|Overall Study|Withdrawal by Subject|1
34203|NCT01742897|151100|P1|Overall Study|Adverse Event|3
34204|NCT01741792|151149|P3|Overall Study|Death|12
34205|NCT01741792|151150|P2|Overall Study|Death|1
34206|NCT01741792|151151|P1|Overall Study|Death|6
34207|NCT01741701|151218|P2|Overall Study|Withdrawal by Subject|1
34208|NCT01741701|151219|P1|Overall Study|Withdrawal by Subject|0
34209|NCT01741701|151218|P2|Overall Study|Adverse Event|1
34210|NCT01741701|151219|P1|Overall Study|Adverse Event|5
34211|NCT01741688|151235|P1|Overall Study|Withdrawal by Subject|1
34212|NCT01741688|151235|P1|Overall Study|Lack of insurance coverage|2
34213|NCT01741259|151408|P2|Overall Study|Withdrawal by Subject|2
34214|NCT01741259|151409|P1|Overall Study|Withdrawal by Subject|0
34215|NCT01741259|151408|P2|Overall Study|Protocol Violation|4
34216|NCT01741259|151409|P1|Overall Study|Protocol Violation|6
34217|NCT01740440|151528|P1|Overall Study|Lost to Follow-up|3
34218|NCT01740427|151536|P2|Overall Study|Study terminated by Sponsor|0
34219|NCT01740427|151537|P1|Overall Study|Study terminated by Sponsor|1
34220|NCT01740427|151536|P2|Overall Study|Lost to Follow-up|0
34221|NCT01740427|151537|P1|Overall Study|Lost to Follow-up|1
34222|NCT01740427|151536|P2|Overall Study|Protocol Violation|3
34223|NCT01740427|151537|P1|Overall Study|Protocol Violation|5
34224|NCT01740427|151536|P2|Overall Study|Death|2
34225|NCT01740427|151537|P1|Overall Study|Death|6
34226|NCT01740427|151536|P2|Overall Study|Unspecified reasons|4
34227|NCT01740427|151537|P1|Overall Study|Unspecified reasons|6
34228|NCT01740427|151536|P2|Overall Study|Subject refused continued treatment|9
34229|NCT01740427|151537|P1|Overall Study|Subject refused continued treatment|12
34230|NCT01740427|151536|P2|Overall Study|Global deterioration of health status|9
34231|NCT01740427|151537|P1|Overall Study|Global deterioration of health status|16
34232|NCT01740427|151536|P2|Overall Study|Adverse Event|9
34233|NCT01740427|151537|P1|Overall Study|Adverse Event|20
34234|NCT01740427|151536|P2|Overall Study|Objective progression or relapse|125
34235|NCT01740427|151537|P1|Overall Study|Objective progression or relapse|172
34236|NCT01740427|151536|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
34237|NCT01740427|151537|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
34238|NCT01740401|151589|P1|Overall Study|Did not reach primary endpoint|2
34239|NCT01740401|151589|P1|Overall Study|Adverse Event|2
34240|NCT01740401|151589|P1|Overall Study|Progression of disease|6
34241|NCT01740388|151598|P2|Overall Study|Subjects missing data, completed|36
34242|NCT01740388|151599|P1|Overall Study|Subjects missing data, completed|41
34243|NCT01740388|151598|P2|Overall Study|Physician Decision|6
34244|NCT01740388|151599|P1|Overall Study|Physician Decision|2
34245|NCT01740388|151598|P2|Overall Study|Lost to Follow-up|0
34246|NCT01740388|151599|P1|Overall Study|Lost to Follow-up|2
34247|NCT01740388|151598|P2|Overall Study|Withdrawal by Subject|2
34248|NCT01740388|151599|P1|Overall Study|Withdrawal by Subject|1
34249|NCT01740297|151651|P3|Overall Study|Sponsor Decision|0
34250|NCT01740297|151652|P2|Overall Study|Sponsor Decision|1
34251|NCT01740297|151653|P1|Overall Study|Sponsor Decision|0
34252|NCT01740297|151651|P3|Overall Study|Death|19
34253|NCT01740297|151652|P2|Overall Study|Death|23
34254|NCT01740297|151653|P1|Overall Study|Death|8
34255|NCT01740297|151651|P3|Overall Study|Withdrawal by Subject|11
34256|NCT01740297|151652|P2|Overall Study|Withdrawal by Subject|9
34257|NCT01740297|151653|P1|Overall Study|Withdrawal by Subject|1
34258|NCT01740297|151651|P3|Overall Study|Continuing Study|68
34259|NCT01740297|151652|P2|Overall Study|Continuing Study|67
34260|NCT01740297|151653|P1|Overall Study|Continuing Study|10
34261|NCT01740128|151704|P2|Overall Study|Insufficient protocol compliance|2
34262|NCT01740128|151705|P1|Overall Study|Insufficient protocol compliance|2
34263|NCT01740128|151704|P2|Overall Study|Withdrawal by Subject|0
34264|NCT01740128|151705|P1|Overall Study|Withdrawal by Subject|1
34265|NCT01740128|151704|P2|Overall Study|Lost to Follow-up|2
34266|NCT01740128|151705|P1|Overall Study|Lost to Follow-up|2
34267|NCT01740128|151704|P2|Overall Study|Protocol Violation|2
34268|NCT01740128|151705|P1|Overall Study|Protocol Violation|1
34269|NCT01740128|151704|P2|Overall Study|Pregnancy|1
34270|NCT01740128|151705|P1|Overall Study|Pregnancy|0
34271|NCT01740089|151734|P3|After 12 Weeks|Withdrawal by Subject|1
34272|NCT01740089|151735|P2|After 12 Weeks|Withdrawal by Subject|1
34273|NCT01740089|151736|P1|After 12 Weeks|Withdrawal by Subject|1
34274|NCT01740089|151734|P3|After 12 Weeks|Protocol Violation|1
34275|NCT01740089|151735|P2|After 12 Weeks|Protocol Violation|1
34276|NCT01740089|151736|P1|After 12 Weeks|Protocol Violation|1
34277|NCT01740089|151734|P3|After 12 Weeks|Adverse Event|5
34278|NCT01740089|151735|P2|After 12 Weeks|Adverse Event|0
34279|NCT01740089|151736|P1|After 12 Weeks|Adverse Event|2
34280|NCT01740089|151734|P3|After 12 Weeks|Lack of Efficacy|4
34281|NCT01740089|151735|P2|After 12 Weeks|Lack of Efficacy|1
34282|NCT01740089|151736|P1|After 12 Weeks|Lack of Efficacy|3
34283|NCT01740089|151734|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
34284|NCT01740089|151735|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
34285|NCT01740089|151736|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
34286|NCT01740089|151734|P3|First 12 Weeks of Treatment|Adverse Event|2
34287|NCT01740089|151735|P2|First 12 Weeks of Treatment|Adverse Event|1
34288|NCT01740089|151736|P1|First 12 Weeks of Treatment|Adverse Event|0
34289|NCT01739803|151754|P2|Overall Study|Lost to Follow-up|6
34290|NCT01739803|151755|P1|Overall Study|Lost to Follow-up|9
34291|NCT01739790|151767|P2|Overall Study|Early Trial Termination|4
34292|NCT01739790|151768|P1|Overall Study|Early Trial Termination|2
34293|NCT01739595|151777|P3|Overall Study|Drug discrepancy|0
34294|NCT01739595|151778|P2|Overall Study|Drug discrepancy|0
34295|NCT01739595|151779|P1|Overall Study|Drug discrepancy|1
34296|NCT01739595|151777|P3|Overall Study|Lab assessment|0
34297|NCT01739595|151778|P2|Overall Study|Lab assessment|0
34298|NCT01739595|151779|P1|Overall Study|Lab assessment|1
34299|NCT01739595|151777|P3|Overall Study|Protocol Violation|0
34300|NCT01739595|151778|P2|Overall Study|Protocol Violation|0
34301|NCT01739595|151779|P1|Overall Study|Protocol Violation|1
34302|NCT01739595|151777|P3|Overall Study|Eligibility issue|0
34303|NCT01739595|151778|P2|Overall Study|Eligibility issue|0
34304|NCT01739595|151779|P1|Overall Study|Eligibility issue|3
34305|NCT01739595|151777|P3|Overall Study|Withdrawal by Subject|2
34306|NCT01739595|151778|P2|Overall Study|Withdrawal by Subject|1
34307|NCT01739595|151779|P1|Overall Study|Withdrawal by Subject|2
34308|NCT01739595|151777|P3|Overall Study|Lost to Follow-up|0
34309|NCT01739595|151778|P2|Overall Study|Lost to Follow-up|0
34310|NCT01739595|151779|P1|Overall Study|Lost to Follow-up|2
34311|NCT01739595|151777|P3|Overall Study|Adverse Event|0
34312|NCT01739595|151778|P2|Overall Study|Adverse Event|0
34313|NCT01739595|151779|P1|Overall Study|Adverse Event|3
34314|NCT01739348|151804|P4|Part II (Extension Study)|Withdrawal by Subject|7
34315|NCT01739348|151805|P3|Part II (Extension Study)|Withdrawal by Subject|4
34316|NCT01739348|151806|P2|Part II (Extension Study)|Withdrawal by Subject|2
34317|NCT01739348|151807|P1|Part II (Extension Study)|Withdrawal by Subject|5
34318|NCT01739348|151804|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
34319|NCT01739348|151805|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
34320|NCT01739348|151806|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
34321|NCT01739348|151807|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
34322|NCT01739348|151804|P4|Part II (Extension Study)|Participant Moved|3
34323|NCT01739348|151805|P3|Part II (Extension Study)|Participant Moved|0
34324|NCT01739348|151806|P2|Part II (Extension Study)|Participant Moved|3
34325|NCT01739348|151807|P1|Part II (Extension Study)|Participant Moved|3
34326|NCT01739348|151804|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
34327|NCT01739348|151805|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
34328|NCT01739348|151806|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
34329|NCT01739348|151807|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
34330|NCT01739348|151804|P4|Part II (Extension Study)|Physician Decision|12
34331|NCT01739348|151805|P3|Part II (Extension Study)|Physician Decision|6
34332|NCT01739348|151806|P2|Part II (Extension Study)|Physician Decision|11
34333|NCT01739348|151807|P1|Part II (Extension Study)|Physician Decision|7
34334|NCT01739348|151804|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
34335|NCT01739348|151805|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
34336|NCT01739348|151806|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
34337|NCT01739348|151807|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
34338|NCT01739348|151804|P4|Part II (Extension Study)|Lost to Follow-up|1
34339|NCT01739348|151805|P3|Part II (Extension Study)|Lost to Follow-up|0
34340|NCT01739348|151806|P2|Part II (Extension Study)|Lost to Follow-up|4
34341|NCT01739348|151807|P1|Part II (Extension Study)|Lost to Follow-up|3
34342|NCT01739348|151804|P4|Part II (Extension Study)|Lack of Efficacy|1
34343|NCT01739348|151805|P3|Part II (Extension Study)|Lack of Efficacy|0
34344|NCT01739348|151806|P2|Part II (Extension Study)|Lack of Efficacy|5
34345|NCT01739348|151807|P1|Part II (Extension Study)|Lack of Efficacy|1
34346|NCT01739348|151804|P4|Part II (Extension Study)|Death|6
34347|NCT01739348|151805|P3|Part II (Extension Study)|Death|2
34348|NCT01739348|151806|P2|Part II (Extension Study)|Death|3
34349|NCT01739348|151807|P1|Part II (Extension Study)|Death|3
34350|NCT01739348|151804|P4|Part II (Extension Study)|Adverse Event|26
34351|NCT01739348|151805|P3|Part II (Extension Study)|Adverse Event|7
34352|NCT01739348|151806|P2|Part II (Extension Study)|Adverse Event|11
34353|NCT01739348|151807|P1|Part II (Extension Study)|Adverse Event|10
34354|NCT01739348|151804|P4|Part I (Base Study)|Withdrawal by Subject|20
34355|NCT01739348|151805|P3|Part I (Base Study)|Withdrawal by Subject|7
34356|NCT01739348|151806|P2|Part I (Base Study)|Withdrawal by Subject|21
34357|NCT01739348|151807|P1|Part I (Base Study)|Withdrawal by Subject|23
34358|NCT01739348|151804|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
34359|NCT01739348|151805|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
34360|NCT01739348|151806|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
34361|NCT01739348|151807|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
34362|NCT01739348|151804|P4|Part I (Base Study)|Participant Moved|7
34363|NCT01739348|151805|P3|Part I (Base Study)|Participant Moved|1
34364|NCT01739348|151806|P2|Part I (Base Study)|Participant Moved|3
34365|NCT01739348|151807|P1|Part I (Base Study)|Participant Moved|4
34366|NCT01739348|151804|P4|Part I (Base Study)|Study Terminated by Sponsor|86
34367|NCT01739348|151805|P3|Part I (Base Study)|Study Terminated by Sponsor|0
34368|NCT01739348|151806|P2|Part I (Base Study)|Study Terminated by Sponsor|73
34369|NCT01739348|151807|P1|Part I (Base Study)|Study Terminated by Sponsor|72
34370|NCT01739348|151804|P4|Part I (Base Study)|Site Discontinued Study Participation|0
34371|NCT01739348|151805|P3|Part I (Base Study)|Site Discontinued Study Participation|0
34372|NCT01739348|151806|P2|Part I (Base Study)|Site Discontinued Study Participation|3
34373|NCT01739348|151807|P1|Part I (Base Study)|Site Discontinued Study Participation|1
34374|NCT01739348|151804|P4|Part I (Base Study)|Screen Failure|0
34375|NCT01739348|151805|P3|Part I (Base Study)|Screen Failure|0
34376|NCT01739348|151806|P2|Part I (Base Study)|Screen Failure|0
34377|NCT01739348|151807|P1|Part I (Base Study)|Screen Failure|2
34378|NCT01739348|151804|P4|Part I (Base Study)|Protocol Violation|2
34379|NCT01739348|151805|P3|Part I (Base Study)|Protocol Violation|1
34380|NCT01739348|151806|P2|Part I (Base Study)|Protocol Violation|0
34381|NCT01739348|151807|P1|Part I (Base Study)|Protocol Violation|2
34382|NCT01739348|151804|P4|Part I (Base Study)|Physician Decision|4
34383|NCT01739348|151805|P3|Part I (Base Study)|Physician Decision|1
34384|NCT01739348|151806|P2|Part I (Base Study)|Physician Decision|7
34385|NCT01739348|151807|P1|Part I (Base Study)|Physician Decision|10
34386|NCT01739348|151804|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
34387|NCT01739348|151805|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
34388|NCT01739348|151806|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
34389|NCT01739348|151807|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
34390|NCT01739348|151804|P4|Part I (Base Study)|Lost to Follow-up|4
34391|NCT01739348|151805|P3|Part I (Base Study)|Lost to Follow-up|4
34392|NCT01739348|151806|P2|Part I (Base Study)|Lost to Follow-up|2
34393|NCT01739348|151807|P1|Part I (Base Study)|Lost to Follow-up|4
34394|NCT01739348|151804|P4|Part I (Base Study)|Lack of Efficacy|7
34395|NCT01739348|151805|P3|Part I (Base Study)|Lack of Efficacy|0
34396|NCT01739348|151806|P2|Part I (Base Study)|Lack of Efficacy|8
34397|NCT01739348|151807|P1|Part I (Base Study)|Lack of Efficacy|3
34398|NCT01739348|151804|P4|Part I (Base Study)|Death|8
34399|NCT01739348|151805|P3|Part I (Base Study)|Death|2
34400|NCT01739348|151806|P2|Part I (Base Study)|Death|7
34401|NCT01739348|151807|P1|Part I (Base Study)|Death|10
34402|NCT01739348|151804|P4|Part I (Base Study)|Adverse Event|33
34403|NCT01739348|151805|P3|Part I (Base Study)|Adverse Event|8
34404|NCT01739348|151806|P2|Part I (Base Study)|Adverse Event|52
34405|NCT01739348|151807|P1|Part I (Base Study)|Adverse Event|41
34406|NCT01739335|151879|P2|Overall Study|Ineligible patient randomized|1
34407|NCT01739335|151880|P1|Overall Study|Ineligible patient randomized|0
34408|NCT01739335|151879|P2|Overall Study|Lost to Follow-up|4
34409|NCT01739335|151880|P1|Overall Study|Lost to Follow-up|7
34410|NCT01738984|151914|P2|Overall Study|Lost to Follow-up|39
34411|NCT01738984|151915|P1|Overall Study|Lost to Follow-up|59
34412|NCT01738984|151914|P2|Overall Study|Withdrawal by Subject|0
34413|NCT01738984|151915|P1|Overall Study|Withdrawal by Subject|1
34414|NCT01738984|151914|P2|Overall Study|Pregnancy|0
34415|NCT01738984|151915|P1|Overall Study|Pregnancy|4
34416|NCT01738971|151928|P3|Overall Study|Lost to Follow-up|17
34417|NCT01738971|151929|P2|Overall Study|Lost to Follow-up|30
34418|NCT01738971|151930|P1|Overall Study|Lost to Follow-up|19
34419|NCT01738919|151946|P2|Overall Study|Not treated in accordance to guidelines|1
34420|NCT01738919|151947|P1|Overall Study|Not treated in accordance to guidelines|0
34421|NCT01738919|151946|P2|Overall Study|Withdrawal by Subject|1
34422|NCT01738919|151947|P1|Overall Study|Withdrawal by Subject|0
34423|NCT01738919|151946|P2|Overall Study|Immigrated|1
34424|NCT01738919|151947|P1|Overall Study|Immigrated|0
34425|NCT01738919|151946|P2|Overall Study|Lost to Follow-up|0
34426|NCT01738919|151947|P1|Overall Study|Lost to Follow-up|1
34427|NCT01738646|152097|P1|Overall Study|Still Receiving Treatment|2
34428|NCT01738581|152107|P2|Overall Study|Lost to Follow-up|0
34429|NCT01738581|152108|P1|Overall Study|Lost to Follow-up|1
34430|NCT01738503|152132|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
34431|NCT01738503|152133|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
34432|NCT01738503|152134|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
34433|NCT01738503|152135|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
34434|NCT01738503|152136|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
34435|NCT01738503|152137|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
34436|NCT01738503|152138|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
34437|NCT01738503|152132|P7|PET Imaging Sub-study|Adverse Event|0
34438|NCT01738503|152133|P6|PET Imaging Sub-study|Adverse Event|1
34439|NCT01738503|152134|P5|PET Imaging Sub-study|Adverse Event|0
34440|NCT01738503|152135|P4|PET Imaging Sub-study|Adverse Event|0
34441|NCT01738503|152136|P3|PET Imaging Sub-study|Adverse Event|0
34442|NCT01738503|152137|P2|PET Imaging Sub-study|Adverse Event|0
34443|NCT01738503|152138|P1|PET Imaging Sub-study|Adverse Event|0
34444|NCT01738503|152132|P7|Treatment Period|Not specified|0
34445|NCT01738503|152133|P6|Treatment Period|Not specified|0
34446|NCT01738503|152134|P5|Treatment Period|Not specified|0
34447|NCT01738503|152135|P4|Treatment Period|Not specified|0
34448|NCT01738503|152136|P3|Treatment Period|Not specified|1
34449|NCT01738503|152137|P2|Treatment Period|Not specified|0
34450|NCT01738503|152138|P1|Treatment Period|Not specified|0
34451|NCT01738503|152132|P7|Treatment Period|Protocol Violation|0
34452|NCT01738503|152133|P6|Treatment Period|Protocol Violation|2
34453|NCT01738503|152134|P5|Treatment Period|Protocol Violation|4
34454|NCT01738503|152135|P4|Treatment Period|Protocol Violation|0
34455|NCT01738503|152136|P3|Treatment Period|Protocol Violation|1
34456|NCT01738503|152137|P2|Treatment Period|Protocol Violation|3
34457|NCT01738503|152138|P1|Treatment Period|Protocol Violation|0
34458|NCT01738503|152132|P7|Treatment Period|Withdrawal by Subject|1
34459|NCT01738503|152133|P6|Treatment Period|Withdrawal by Subject|1
34460|NCT01738503|152134|P5|Treatment Period|Withdrawal by Subject|1
34461|NCT01738503|152135|P4|Treatment Period|Withdrawal by Subject|1
34462|NCT01738503|152136|P3|Treatment Period|Withdrawal by Subject|0
34463|NCT01738503|152137|P2|Treatment Period|Withdrawal by Subject|1
34464|NCT01738503|152138|P1|Treatment Period|Withdrawal by Subject|0
34465|NCT01738503|152132|P7|Treatment Period|Lost to Follow-up|5
34466|NCT01738503|152133|P6|Treatment Period|Lost to Follow-up|1
34467|NCT01738503|152134|P5|Treatment Period|Lost to Follow-up|1
34468|NCT01738503|152135|P4|Treatment Period|Lost to Follow-up|4
34469|NCT01738503|152136|P3|Treatment Period|Lost to Follow-up|3
34470|NCT01738503|152137|P2|Treatment Period|Lost to Follow-up|0
34471|NCT01738503|152138|P1|Treatment Period|Lost to Follow-up|0
34472|NCT01738503|152132|P7|Treatment Period|Adverse Event|2
34473|NCT01738503|152133|P6|Treatment Period|Adverse Event|2
34474|NCT01738503|152134|P5|Treatment Period|Adverse Event|2
34475|NCT01738503|152135|P4|Treatment Period|Adverse Event|1
34476|NCT01738503|152136|P3|Treatment Period|Adverse Event|0
34477|NCT01738503|152137|P2|Treatment Period|Adverse Event|1
34478|NCT01738503|152138|P1|Treatment Period|Adverse Event|0
34479|NCT01738503|152132|P7|Induction/Stabilization (Days -14 to -1)|Not specified|0
34480|NCT01738503|152133|P6|Induction/Stabilization (Days -14 to -1)|Not specified|0
34481|NCT01738503|152134|P5|Induction/Stabilization (Days -14 to -1)|Not specified|0
34482|NCT01738503|152135|P4|Induction/Stabilization (Days -14 to -1)|Not specified|0
34483|NCT01738503|152136|P3|Induction/Stabilization (Days -14 to -1)|Not specified|0
34484|NCT01738503|152137|P2|Induction/Stabilization (Days -14 to -1)|Not specified|0
34485|NCT01738503|152138|P1|Induction/Stabilization (Days -14 to -1)|Not specified|35
34486|NCT01738477|152336|P2|Overall Study|Lost to Follow-up|4
34487|NCT01738477|152337|P1|Overall Study|Lost to Follow-up|1
34488|NCT01738438|152365|P1|Overall Study|Adverse Event|3
34489|NCT01738438|152365|P1|Overall Study|Disease Progression|32
34490|NCT01737996|152383|P3|Overall Study|Withdrawal by Subject|1
34491|NCT01737996|152384|P2|Overall Study|Withdrawal by Subject|0
34492|NCT01737996|152385|P1|Overall Study|Withdrawal by Subject|0
34493|NCT01737996|152383|P3|Overall Study|Adverse Event|1
34494|NCT01737996|152384|P2|Overall Study|Adverse Event|1
34495|NCT01737996|152385|P1|Overall Study|Adverse Event|0
34496|NCT01737931|152447|P3|Overall Study|Physician Decision|0
34497|NCT01737931|152448|P2|Overall Study|Physician Decision|1
34498|NCT01737931|152449|P1|Overall Study|Physician Decision|0
34499|NCT01737931|152447|P3|Overall Study|Withdrawal by Subject|1
34500|NCT01737931|152448|P2|Overall Study|Withdrawal by Subject|1
34501|NCT01737931|152449|P1|Overall Study|Withdrawal by Subject|0
34502|NCT01737879|152464|P1|Overall Study|Sponsor decision|40
34503|NCT01737879|152464|P1|Overall Study|Death|1
34504|NCT01737840|152473|P2|Overall Study|Diagnosed with an other pathology|2
34505|NCT01737840|152474|P1|Overall Study|Diagnosed with an other pathology|2
34506|NCT01737762|152484|P2|Overall Study|Trial termination|9
34507|NCT01737762|152485|P1|Overall Study|Trial termination|11
34508|NCT01737762|152484|P2|Overall Study|Moved from area|1
34509|NCT01737762|152485|P1|Overall Study|Moved from area|2
34510|NCT01737762|152484|P2|Overall Study|Physician Decision|1
34511|NCT01737762|152485|P1|Overall Study|Physician Decision|1
34512|NCT01737762|152484|P2|Overall Study|Progressive disease|2
34513|NCT01737762|152485|P1|Overall Study|Progressive disease|1
34514|NCT01737762|152484|P2|Overall Study|Withdrawal by Subject|2
34515|NCT01737762|152485|P1|Overall Study|Withdrawal by Subject|2
34516|NCT01737762|152484|P2|Overall Study|Lost to Follow-up|0
34517|NCT01737762|152485|P1|Overall Study|Lost to Follow-up|1
34518|NCT01737762|152484|P2|Overall Study|Adverse Event|2
34519|NCT01737762|152485|P1|Overall Study|Adverse Event|2
34520|NCT01737710|152498|P5|Overall Study|Vaccinated in Error/Ineligible|0
34521|NCT01737710|152499|P4|Overall Study|Vaccinated in Error/Ineligible|0
34522|NCT01737710|152500|P3|Overall Study|Vaccinated in Error/Ineligible|0
34523|NCT01737710|152501|P2|Overall Study|Vaccinated in Error/Ineligible|1
34524|NCT01737710|152502|P1|Overall Study|Vaccinated in Error/Ineligible|1
34525|NCT01737710|152498|P5|Overall Study|Withdrawal by Subject|0
34526|NCT01737710|152499|P4|Overall Study|Withdrawal by Subject|0
34527|NCT01737710|152500|P3|Overall Study|Withdrawal by Subject|1
34528|NCT01737710|152501|P2|Overall Study|Withdrawal by Subject|1
34529|NCT01737710|152502|P1|Overall Study|Withdrawal by Subject|1
34530|NCT01737710|152498|P5|Overall Study|Lost to Follow-up|0
34531|NCT01737710|152499|P4|Overall Study|Lost to Follow-up|0
34532|NCT01737710|152500|P3|Overall Study|Lost to Follow-up|2
34533|NCT01737710|152501|P2|Overall Study|Lost to Follow-up|2
34534|NCT01737710|152502|P1|Overall Study|Lost to Follow-up|0
34535|NCT01737268|152593|P1|Overall Study|In consideration of the patient’s safety|1
34536|NCT01737268|152593|P1|Overall Study|Worsening of Target Disease|2
34537|NCT01737268|152593|P1|Overall Study|Adverse Event|6
34538|NCT01737021|152607|P2|Overall Study|Lost to Follow-up|3
34539|NCT01737021|152608|P1|Overall Study|Lost to Follow-up|5
34540|NCT01736917|152654|P1|Overall Study|Protocol Violation|10
34541|NCT01736917|152654|P1|Overall Study|Adverse Event|1
34542|NCT01736696|152668|P7|Overall Study|Withdrawal by Subject|0
34543|NCT01736696|152669|P6|Overall Study|Withdrawal by Subject|0
34544|NCT01736696|152670|P5|Overall Study|Withdrawal by Subject|0
34545|NCT01736696|152671|P4|Overall Study|Withdrawal by Subject|0
34546|NCT01736696|152672|P3|Overall Study|Withdrawal by Subject|1
34547|NCT01736696|152673|P2|Overall Study|Withdrawal by Subject|0
34548|NCT01736696|152674|P1|Overall Study|Withdrawal by Subject|0
34549|NCT01736657|152991|P1|Overall Study|insufficient vascular access|1
34550|NCT01736579|153000|P2|Overall Study|Termination of Study by Sponsor|2
34551|NCT01736579|153001|P1|Overall Study|Termination of Study by Sponsor|2
34552|NCT01736553|153037|P2|Overall Study|Lost to Follow-up|2
34553|NCT01736553|153038|P1|Overall Study|Lost to Follow-up|2
34554|NCT01736553|153037|P2|Overall Study|Withdrawal by Subject|2
34555|NCT01736553|153038|P1|Overall Study|Withdrawal by Subject|5
34556|NCT01736553|153037|P2|Overall Study|Death|0
34557|NCT01736553|153038|P1|Overall Study|Death|12
34558|NCT01736540|153089|P1|Overall Study|Unable to make MRI appointment|3
34559|NCT01736540|153089|P1|Overall Study|No show for MRI appointment|1
34560|NCT01736540|153089|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
34561|NCT01736540|153089|P1|Overall Study|Protocol Violation|1
34562|NCT01736540|153089|P1|Overall Study|Withdrawal by Subject|5
34563|NCT01736540|153089|P1|Overall Study|Abnormal test procedure|1
34564|NCT01736540|153089|P1|Overall Study|Death|1
34565|NCT01736540|153089|P1|Overall Study|Did not complete scan within 45 days|2
34566|NCT01736475|153155|P2|Overall Study|Other - Surgical procedure|0
34567|NCT01736475|153156|P1|Overall Study|Other - Surgical procedure|1
34568|NCT01736475|153155|P2|Overall Study|Other - Screen failure|0
34569|NCT01736475|153156|P1|Overall Study|Other - Screen failure|1
34570|NCT01736475|153155|P2|Overall Study|Protocol Violation|0
34571|NCT01736475|153156|P1|Overall Study|Protocol Violation|4
34572|NCT01736475|153155|P2|Overall Study|Withdrawal by Subject|0
34573|NCT01736475|153156|P1|Overall Study|Withdrawal by Subject|2
34574|NCT01736475|153155|P2|Overall Study|Adverse Event|0
34575|NCT01736475|153156|P1|Overall Study|Adverse Event|4
34576|NCT01736397|153211|P2|Overall Study|Not stated|4
34577|NCT01736397|153212|P1|Overall Study|Not stated|1
34578|NCT01736397|153211|P2|Overall Study|Adverse Event|3
34579|NCT01736397|153212|P1|Overall Study|Adverse Event|6
34580|NCT01736397|153211|P2|Overall Study|Lost to Follow-up|1
34581|NCT01736397|153212|P1|Overall Study|Lost to Follow-up|0
34582|NCT01736397|153211|P2|Overall Study|Withdrawal by Subject|5
34583|NCT01736397|153212|P1|Overall Study|Withdrawal by Subject|6
34584|NCT01736397|153211|P2|Overall Study|Lack of Efficacy|11
34585|NCT01736397|153212|P1|Overall Study|Lack of Efficacy|1
34586|NCT01736215|153224|P1|Overall Study|Insufficient data to perform analysis|8
34587|NCT01736215|153224|P1|Overall Study|Progressive disease stop chemotherapy|1
34588|NCT01736215|153224|P1|Overall Study|Adverse Event|4
34589|NCT01736215|153224|P1|Overall Study|Early termination of erythropoietin use|1
34590|NCT01736176|153236|P1|Overall Study|Unable to Complete PEG Placement|1
34591|NCT01736176|153236|P1|Overall Study|Lack of Efficacy|3
34592|NCT01736176|153236|P1|Overall Study|Withdrawal by Subject|4
34593|NCT01736176|153236|P1|Overall Study|Adverse Event|3
34594|NCT01735916|153283|P3|Overall Study|Withdrawal by Subject|0
34595|NCT01735916|153284|P2|Overall Study|Withdrawal by Subject|0
34596|NCT01735916|153285|P1|Overall Study|Withdrawal by Subject|3
34597|NCT01735916|153283|P3|Overall Study|Early termination of study by sponsor|7
34598|NCT01735916|153284|P2|Overall Study|Early termination of study by sponsor|19
34599|NCT01735916|153285|P1|Overall Study|Early termination of study by sponsor|4
34600|NCT01735916|153283|P3|Overall Study|Subject not eligible to be randomized|0
34601|NCT01735916|153284|P2|Overall Study|Subject not eligible to be randomized|0
34602|NCT01735916|153285|P1|Overall Study|Subject not eligible to be randomized|11
34603|NCT01735630|153323|P2|Overall Study|Withdrawal by Subject|9
34604|NCT01735630|153324|P1|Overall Study|Withdrawal by Subject|7
34605|NCT01735630|153323|P2|Overall Study|Sponsor Decision|1
34606|NCT01735630|153324|P1|Overall Study|Sponsor Decision|2
34607|NCT01735630|153323|P2|Overall Study|Physician Decision|1
34608|NCT01735630|153324|P1|Overall Study|Physician Decision|0
34609|NCT01735630|153323|P2|Overall Study|Lost to Follow-up|0
34610|NCT01735630|153324|P1|Overall Study|Lost to Follow-up|1
34611|NCT01735630|153323|P2|Overall Study|Adverse Event|7
34612|NCT01735630|153324|P1|Overall Study|Adverse Event|8
34613|NCT01735396|153351|P1|Overall Study|not evaluable|1
34614|NCT01735201|153380|P8|Overall Study|Other Miscellaneous Reasons|1
34615|NCT01735201|153381|P7|Overall Study|Other Miscellaneous Reasons|1
34616|NCT01735201|153382|P6|Overall Study|Other Miscellaneous Reasons|2
34617|NCT01735201|153383|P5|Overall Study|Other Miscellaneous Reasons|0
34618|NCT01735201|153384|P4|Overall Study|Other Miscellaneous Reasons|1
34619|NCT01735201|153385|P3|Overall Study|Other Miscellaneous Reasons|0
34620|NCT01735201|153386|P2|Overall Study|Other Miscellaneous Reasons|0
34621|NCT01735201|153387|P1|Overall Study|Other Miscellaneous Reasons|0
34622|NCT01735201|153380|P8|Overall Study|Protocol Violation|0
34623|NCT01735201|153381|P7|Overall Study|Protocol Violation|0
34624|NCT01735201|153382|P6|Overall Study|Protocol Violation|0
34625|NCT01735201|153383|P5|Overall Study|Protocol Violation|0
34626|NCT01735201|153384|P4|Overall Study|Protocol Violation|0
34627|NCT01735201|153385|P3|Overall Study|Protocol Violation|0
34628|NCT01735201|153386|P2|Overall Study|Protocol Violation|0
34629|NCT01735201|153387|P1|Overall Study|Protocol Violation|1
34630|NCT01735201|153380|P8|Overall Study|Personal Reasons|0
34631|NCT01735201|153381|P7|Overall Study|Personal Reasons|0
34632|NCT01735201|153382|P6|Overall Study|Personal Reasons|0
34633|NCT01735201|153383|P5|Overall Study|Personal Reasons|0
34634|NCT01735201|153384|P4|Overall Study|Personal Reasons|0
34635|NCT01735201|153385|P3|Overall Study|Personal Reasons|0
34636|NCT01735201|153386|P2|Overall Study|Personal Reasons|0
34637|NCT01735201|153387|P1|Overall Study|Personal Reasons|1
34638|NCT01735201|153380|P8|Overall Study|Adverse Event|1
34639|NCT01735201|153381|P7|Overall Study|Adverse Event|2
34640|NCT01735201|153382|P6|Overall Study|Adverse Event|3
34641|NCT01735201|153383|P5|Overall Study|Adverse Event|1
34642|NCT01735201|153384|P4|Overall Study|Adverse Event|1
34643|NCT01735201|153385|P3|Overall Study|Adverse Event|0
34644|NCT01735201|153386|P2|Overall Study|Adverse Event|1
34645|NCT01735201|153387|P1|Overall Study|Adverse Event|1
34646|NCT01735175|153423|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
34647|NCT01735175|153424|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
34648|NCT01735175|153423|P2|Overall Study|Death|2
34649|NCT01735175|153424|P1|Overall Study|Death|3
34650|NCT01735175|153423|P2|Overall Study|Lost to Follow-up|2
34651|NCT01735175|153424|P1|Overall Study|Lost to Follow-up|4
34652|NCT01735175|153423|P2|Overall Study|Withdrawal by Subject|2
34653|NCT01735175|153424|P1|Overall Study|Withdrawal by Subject|9
34654|NCT01734993|153444|P1|Overall Study|Lack of Efficacy|1
34655|NCT01734993|153444|P1|Overall Study|Adverse Event|1
34656|NCT01734785|153481|P4|Double−Blind Period|Not treated|0
34657|NCT01734785|153482|P3|Double−Blind Period|Not treated|0
34658|NCT01734785|153483|P2|Double−Blind Period|Not treated|0
34659|NCT01734785|153484|P1|Double−Blind Period|Not treated|1
34660|NCT01734785|153481|P4|Double−Blind Period|Withdrawal by Subject|0
34661|NCT01734785|153482|P3|Double−Blind Period|Withdrawal by Subject|0
34662|NCT01734785|153483|P2|Double−Blind Period|Withdrawal by Subject|0
34663|NCT01734785|153484|P1|Double−Blind Period|Withdrawal by Subject|2
34664|NCT01734785|153481|P4|Double−Blind Period|Lost to Follow-up|0
34665|NCT01734785|153482|P3|Double−Blind Period|Lost to Follow-up|2
34666|NCT01734785|153483|P2|Double−Blind Period|Lost to Follow-up|4
34667|NCT01734785|153484|P1|Double−Blind Period|Lost to Follow-up|2
34668|NCT01734785|153481|P4|Double−Blind Period|Protocol Violation|0
34669|NCT01734785|153482|P3|Double−Blind Period|Protocol Violation|1
34670|NCT01734785|153483|P2|Double−Blind Period|Protocol Violation|1
34671|NCT01734785|153484|P1|Double−Blind Period|Protocol Violation|0
34672|NCT01734785|153481|P4|Double−Blind Period|Lack of Efficacy|0
34673|NCT01734785|153482|P3|Double−Blind Period|Lack of Efficacy|0
34674|NCT01734785|153483|P2|Double−Blind Period|Lack of Efficacy|1
34675|NCT01734785|153484|P1|Double−Blind Period|Lack of Efficacy|0
34676|NCT01734785|153481|P4|Double−Blind Period|Adverse Event|0
34677|NCT01734785|153482|P3|Double−Blind Period|Adverse Event|2
34678|NCT01734785|153483|P2|Double−Blind Period|Adverse Event|3
34679|NCT01734785|153484|P1|Double−Blind Period|Adverse Event|0
34680|NCT01734785|153481|P4|Open−Label Period|Other Reasons|224
34681|NCT01734785|153482|P3|Open−Label Period|Other Reasons|0
34682|NCT01734785|153483|P2|Open−Label Period|Other Reasons|0
34683|NCT01734785|153484|P1|Open−Label Period|Other Reasons|0
34684|NCT01734785|153481|P4|Open−Label Period|Withdrawal by Subject|12
34685|NCT01734785|153482|P3|Open−Label Period|Withdrawal by Subject|0
34686|NCT01734785|153483|P2|Open−Label Period|Withdrawal by Subject|0
34687|NCT01734785|153484|P1|Open−Label Period|Withdrawal by Subject|0
34688|NCT01734785|153481|P4|Open−Label Period|Lost to Follow-up|14
34689|NCT01734785|153482|P3|Open−Label Period|Lost to Follow-up|0
34690|NCT01734785|153483|P2|Open−Label Period|Lost to Follow-up|0
34691|NCT01734785|153484|P1|Open−Label Period|Lost to Follow-up|0
34692|NCT01734785|153481|P4|Open−Label Period|Protocol Violation|13
34693|NCT01734785|153482|P3|Open−Label Period|Protocol Violation|0
34694|NCT01734785|153483|P2|Open−Label Period|Protocol Violation|0
34695|NCT01734785|153484|P1|Open−Label Period|Protocol Violation|0
34696|NCT01734785|153481|P4|Open−Label Period|Lack of Efficacy|1
34697|NCT01734785|153482|P3|Open−Label Period|Lack of Efficacy|0
34698|NCT01734785|153483|P2|Open−Label Period|Lack of Efficacy|0
34699|NCT01734785|153484|P1|Open−Label Period|Lack of Efficacy|0
34700|NCT01734785|153481|P4|Open−Label Period|Adverse Event|9
34701|NCT01734785|153482|P3|Open−Label Period|Adverse Event|0
34702|NCT01734785|153483|P2|Open−Label Period|Adverse Event|0
34703|NCT01734785|153484|P1|Open−Label Period|Adverse Event|0
34704|NCT01734772|153501|P2|Overall Study|Withdrawal by Subject|1
34705|NCT01734772|153502|P1|Overall Study|Withdrawal by Subject|0
34706|NCT01734772|153501|P2|Overall Study|Adverse Event|2
34707|NCT01734772|153502|P1|Overall Study|Adverse Event|1
34708|NCT01734395|153543|P1|Overall Study|Missing the reasons for not completed|3
34709|NCT01734395|153543|P1|Overall Study|Withdrawal by Subject|10
34710|NCT01734395|153543|P1|Overall Study|Adverse Event|40
34711|NCT01734395|153543|P1|Overall Study|Lack of Efficacy|5
34712|NCT01734395|153543|P1|Overall Study|Lost to Follow-up|287
34713|NCT01734395|153543|P1|Overall Study|Not specified|65
34714|NCT01733758|153601|P4|Overall Study|Inv Decision, HbA1c not controlled|1
34715|NCT01733758|153602|P3|Overall Study|Inv Decision, HbA1c not controlled|0
34716|NCT01733758|153603|P2|Overall Study|Inv Decision, HbA1c not controlled|1
34717|NCT01733758|153604|P1|Overall Study|Inv Decision, HbA1c not controlled|1
34718|NCT01733758|153601|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
34719|NCT01733758|153602|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
34720|NCT01733758|153603|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
34721|NCT01733758|153604|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
34722|NCT01733758|153601|P4|Overall Study|Non-compliance|0
34723|NCT01733758|153602|P3|Overall Study|Non-compliance|0
34724|NCT01733758|153603|P2|Overall Study|Non-compliance|0
34725|NCT01733758|153604|P1|Overall Study|Non-compliance|1
34726|NCT01733758|153601|P4|Overall Study|Protocol Violation|2
34727|NCT01733758|153602|P3|Overall Study|Protocol Violation|2
34728|NCT01733758|153603|P2|Overall Study|Protocol Violation|1
34729|NCT01733758|153604|P1|Overall Study|Protocol Violation|0
34730|NCT01733758|153601|P4|Overall Study|Persistent Hyperglycemia|0
34731|NCT01733758|153602|P3|Overall Study|Persistent Hyperglycemia|0
34732|NCT01733758|153603|P2|Overall Study|Persistent Hyperglycemia|2
34733|NCT01733758|153604|P1|Overall Study|Persistent Hyperglycemia|3
34734|NCT01733758|153601|P4|Overall Study|Withdrawal by Subject|3
34735|NCT01733758|153602|P3|Overall Study|Withdrawal by Subject|5
34736|NCT01733758|153603|P2|Overall Study|Withdrawal by Subject|1
34737|NCT01733758|153604|P1|Overall Study|Withdrawal by Subject|1
34738|NCT01733758|153601|P4|Overall Study|Adverse Event|1
34739|NCT01733758|153602|P3|Overall Study|Adverse Event|8
34740|NCT01733758|153603|P2|Overall Study|Adverse Event|7
34741|NCT01733758|153604|P1|Overall Study|Adverse Event|5
34742|NCT01733732|153670|P2|Overall Study|Did not attend all study visits|0
34743|NCT01733732|153671|P1|Overall Study|Did not attend all study visits|1
34744|NCT01733732|153670|P2|Overall Study|Adverse Event|0
34745|NCT01733732|153671|P1|Overall Study|Adverse Event|1
34746|NCT01733329|153715|P2|Overall Study|Uterine artery injury|0
34747|NCT01733329|153716|P1|Overall Study|Uterine artery injury|1
34748|NCT01733329|153715|P2|Overall Study|Protocol Violation|1
34749|NCT01733329|153716|P1|Overall Study|Protocol Violation|1
34750|NCT01733316|153728|P1|Overall Study|Withdrawal by Subject|1
34751|NCT01733316|153728|P1|Overall Study|Noncompliance|1
34752|NCT01733121|153774|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
34753|NCT01733121|153775|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
34754|NCT01733121|153774|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
34755|NCT01733121|153775|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
34756|NCT01733121|153774|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
34757|NCT01733121|153775|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
34758|NCT01733121|153774|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
34759|NCT01733121|153775|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
34760|NCT01732926|153817|P2|Overall Study|Blind Broken by Subject or Study Site|1
34761|NCT01732926|153818|P1|Overall Study|Blind Broken by Subject or Study Site|1
34762|NCT01732926|153817|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
34763|NCT01732926|153818|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
34764|NCT01732926|153817|P2|Overall Study|Other Reason|4
34765|NCT01732926|153818|P1|Overall Study|Other Reason|21
34766|NCT01732926|153817|P2|Overall Study|Physician Decision|11
34767|NCT01732926|153818|P1|Overall Study|Physician Decision|24
34768|NCT01732926|153817|P2|Overall Study|Withdrawal by Subject|8
34769|NCT01732926|153818|P1|Overall Study|Withdrawal by Subject|46
34770|NCT01732926|153817|P2|Overall Study|Study Terminated by Sponsor|80
34771|NCT01732926|153818|P1|Overall Study|Study Terminated by Sponsor|168
34772|NCT01732913|153834|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
34773|NCT01732913|153835|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
34774|NCT01732913|153834|P2|Overall Study|Other|1
34775|NCT01732913|153835|P1|Overall Study|Other|7
34776|NCT01732913|153834|P2|Overall Study|Physician Decision|7
34777|NCT01732913|153835|P1|Overall Study|Physician Decision|14
34778|NCT01732913|153834|P2|Overall Study|Withdrawal by Subject|4
34779|NCT01732913|153835|P1|Overall Study|Withdrawal by Subject|27
34780|NCT01732913|153834|P2|Overall Study|Study Terminated by Sponsor|55
34781|NCT01732913|153835|P1|Overall Study|Study Terminated by Sponsor|105
34782|NCT01732835|153849|P1|2-year Extended Follow-up|Death|1
34783|NCT01732835|153849|P1|2-year Extended Follow-up|Adverse Event|3
34784|NCT01732835|153849|P1|2-year Extended Follow-up|Withdrawal by Subject|1
34785|NCT01732835|153849|P1|6-month Primary Endpoint|Adverse Event|3
34786|NCT01732835|153849|P1|6-month Primary Endpoint|Withdrawal by Subject|2
34787|NCT01732835|153849|P1|6-month Primary Endpoint|Did not receive device|19
34788|NCT01732822|153882|P2|Overall Study|Withdrawal by Subject|113
34789|NCT01732822|153883|P1|Overall Study|Withdrawal by Subject|123
34790|NCT01732796|153956|P3|Overall Study|Other reason not defined above|2
34791|NCT01732796|153957|P2|Overall Study|Other reason not defined above|0
34792|NCT01732796|153958|P1|Overall Study|Other reason not defined above|1
34793|NCT01732796|153956|P3|Overall Study|Withdrawal by Subject|2
34794|NCT01732796|153957|P2|Overall Study|Withdrawal by Subject|8
34795|NCT01732796|153958|P1|Overall Study|Withdrawal by Subject|6
34796|NCT01732796|153956|P3|Overall Study|Lost to Follow-up|0
34797|NCT01732796|153957|P2|Overall Study|Lost to Follow-up|0
34798|NCT01732796|153958|P1|Overall Study|Lost to Follow-up|2
34799|NCT01732796|153956|P3|Overall Study|Lack of Efficacy|5
34800|NCT01732796|153957|P2|Overall Study|Lack of Efficacy|18
34801|NCT01732796|153958|P1|Overall Study|Lack of Efficacy|21
34802|NCT01732796|153956|P3|Overall Study|Adverse Event|4
34803|NCT01732796|153957|P2|Overall Study|Adverse Event|16
34804|NCT01732796|153958|P1|Overall Study|Adverse Event|16
34805|NCT01732770|153976|P2|Overall Study|Death|0
34806|NCT01732770|153977|P1|Overall Study|Death|1
34807|NCT01732770|153976|P2|Overall Study|Decision by Sponsor|2
34808|NCT01732770|153977|P1|Overall Study|Decision by Sponsor|2
34809|NCT01732770|153976|P2|Overall Study|Withdrawal by Subject|3
34810|NCT01732770|153977|P1|Overall Study|Withdrawal by Subject|5
34811|NCT01732770|153976|P2|Overall Study|Lost to Follow-up|3
34812|NCT01732770|153977|P1|Overall Study|Lost to Follow-up|2
34813|NCT01732757|153992|P3|Overall Study|Lost to Follow-up|0
34814|NCT01732757|153993|P2|Overall Study|Lost to Follow-up|0
34815|NCT01732757|153994|P1|Overall Study|Lost to Follow-up|1
34816|NCT01732692|154034|P2|Overall Study|Adverse Event|1
34817|NCT01732692|154035|P1|Overall Study|Adverse Event|0
34818|NCT01732588|154052|P3|First Intervention (7 Days)|Adverse Event|0
34819|NCT01732588|154053|P2|First Intervention (7 Days)|Adverse Event|1
34820|NCT01732588|154054|P1|First Intervention (7 Days)|Adverse Event|0
34821|NCT01732549|154070|P2|Overall Study|Not Specified|14
34822|NCT01732549|154071|P1|Overall Study|Not Specified|8
34823|NCT01732549|154070|P2|Overall Study|Disease progression|50
34824|NCT01732549|154071|P1|Overall Study|Disease progression|37
34825|NCT01732549|154070|P2|Overall Study|Consent withdrawn|6
34826|NCT01732549|154071|P1|Overall Study|Consent withdrawn|13
34827|NCT01732549|154070|P2|Overall Study|Adverse Event|3
34828|NCT01732549|154071|P1|Overall Study|Adverse Event|13
34829|NCT01732510|154098|P7|Overall Study|Study Terminated By Sponsor|6
34830|NCT01732510|154099|P6|Overall Study|Study Terminated By Sponsor|12
34831|NCT01732510|154100|P5|Overall Study|Study Terminated By Sponsor|0
34832|NCT01732510|154101|P4|Overall Study|Study Terminated By Sponsor|1
34833|NCT01732510|154102|P3|Overall Study|Study Terminated By Sponsor|0
34834|NCT01732510|154103|P2|Overall Study|Study Terminated By Sponsor|0
34835|NCT01732510|154104|P1|Overall Study|Study Terminated By Sponsor|0
34836|NCT01732510|154098|P7|Overall Study|Pregnancy|0
34837|NCT01732510|154099|P6|Overall Study|Pregnancy|0
34838|NCT01732510|154100|P5|Overall Study|Pregnancy|0
34839|NCT01732510|154101|P4|Overall Study|Pregnancy|1
34840|NCT01732510|154102|P3|Overall Study|Pregnancy|0
34841|NCT01732510|154103|P2|Overall Study|Pregnancy|0
34842|NCT01732510|154104|P1|Overall Study|Pregnancy|0
34843|NCT01732510|154098|P7|Overall Study|Physician Decision|0
34844|NCT01732510|154099|P6|Overall Study|Physician Decision|0
34845|NCT01732510|154100|P5|Overall Study|Physician Decision|0
34846|NCT01732510|154101|P4|Overall Study|Physician Decision|0
34847|NCT01732510|154102|P3|Overall Study|Physician Decision|0
34848|NCT01732510|154103|P2|Overall Study|Physician Decision|1
34849|NCT01732510|154104|P1|Overall Study|Physician Decision|0
34850|NCT01732510|154098|P7|Overall Study|Lost to Follow-up|0
34851|NCT01732510|154099|P6|Overall Study|Lost to Follow-up|1
34852|NCT01732510|154100|P5|Overall Study|Lost to Follow-up|0
34853|NCT01732510|154101|P4|Overall Study|Lost to Follow-up|1
34854|NCT01732510|154102|P3|Overall Study|Lost to Follow-up|1
34855|NCT01732510|154103|P2|Overall Study|Lost to Follow-up|0
34856|NCT01732510|154104|P1|Overall Study|Lost to Follow-up|0
34857|NCT01732510|154098|P7|Overall Study|Withdrawal by Subject|1
34858|NCT01732510|154099|P6|Overall Study|Withdrawal by Subject|0
34859|NCT01732510|154100|P5|Overall Study|Withdrawal by Subject|5
34860|NCT01732510|154101|P4|Overall Study|Withdrawal by Subject|1
34861|NCT01732510|154102|P3|Overall Study|Withdrawal by Subject|2
34862|NCT01732510|154103|P2|Overall Study|Withdrawal by Subject|3
34863|NCT01732510|154104|P1|Overall Study|Withdrawal by Subject|1
34864|NCT01732510|154098|P7|Overall Study|Protocol Violation|0
34865|NCT01732510|154099|P6|Overall Study|Protocol Violation|0
34866|NCT01732510|154100|P5|Overall Study|Protocol Violation|0
34867|NCT01732510|154101|P4|Overall Study|Protocol Violation|1
34868|NCT01732510|154102|P3|Overall Study|Protocol Violation|0
34869|NCT01732510|154103|P2|Overall Study|Protocol Violation|0
34870|NCT01732510|154104|P1|Overall Study|Protocol Violation|0
34871|NCT01732510|154098|P7|Overall Study|Adverse Event|1
34872|NCT01732510|154099|P6|Overall Study|Adverse Event|0
34873|NCT01732510|154100|P5|Overall Study|Adverse Event|0
34874|NCT01732510|154101|P4|Overall Study|Adverse Event|0
34875|NCT01732510|154102|P3|Overall Study|Adverse Event|1
34876|NCT01732510|154103|P2|Overall Study|Adverse Event|1
34877|NCT01732510|154104|P1|Overall Study|Adverse Event|0
34878|NCT01732484|154183|P1|Overall Study|chronical illness|5
34879|NCT01732484|154183|P1|Overall Study|Lost to Follow-up|14
34880|NCT01732484|154183|P1|Overall Study|Death|7
34881|NCT01732471|154191|P1|Overall Study|Withdrawal by Subject|1
34882|NCT01732458|154202|P4|Overall Study|Screen Failure|0
34883|NCT01732458|154203|P3|Overall Study|Screen Failure|0
34884|NCT01732458|154204|P2|Overall Study|Screen Failure|1
34885|NCT01732458|154205|P1|Overall Study|Screen Failure|0
34886|NCT01732458|154202|P4|Overall Study|Protocol Violation|2
34887|NCT01732458|154203|P3|Overall Study|Protocol Violation|0
34888|NCT01732458|154204|P2|Overall Study|Protocol Violation|0
34889|NCT01732458|154205|P1|Overall Study|Protocol Violation|2
34890|NCT01732458|154202|P4|Overall Study|Physician Decision|0
34891|NCT01732458|154203|P3|Overall Study|Physician Decision|2
34892|NCT01732458|154204|P2|Overall Study|Physician Decision|2
34893|NCT01732458|154205|P1|Overall Study|Physician Decision|1
34894|NCT01732458|154202|P4|Overall Study|Non-Compliance With Study Drug|0
34895|NCT01732458|154203|P3|Overall Study|Non-Compliance With Study Drug|1
34896|NCT01732458|154204|P2|Overall Study|Non-Compliance With Study Drug|0
34897|NCT01732458|154205|P1|Overall Study|Non-Compliance With Study Drug|0
34898|NCT01732458|154202|P4|Overall Study|Lost to Follow-up|0
34899|NCT01732458|154203|P3|Overall Study|Lost to Follow-up|0
34900|NCT01732458|154204|P2|Overall Study|Lost to Follow-up|2
34901|NCT01732458|154205|P1|Overall Study|Lost to Follow-up|0
34902|NCT01731990|154319|P2|Overall Study|Death|0
34903|NCT01731990|154320|P1|Overall Study|Death|1
34904|NCT01731990|154319|P2|Overall Study|Protocol deviation|2
34905|NCT01731990|154320|P1|Overall Study|Protocol deviation|1
34906|NCT01731990|154319|P2|Overall Study|Withdrawal by Subject|1
34907|NCT01731990|154320|P1|Overall Study|Withdrawal by Subject|1
34908|NCT01731990|154319|P2|Overall Study|Adverse Event|5
34909|NCT01731990|154320|P1|Overall Study|Adverse Event|1
34910|NCT01731938|154336|P2|Primary Part II|Missed Week 6 visit|3
34911|NCT01731938|154337|P1|Primary Part II|Missed Week 6 visit|2
34912|NCT01731938|154336|P2|Primary Part II|Death|1
34913|NCT01731938|154337|P1|Primary Part II|Death|2
34914|NCT01731938|154336|P2|Primary Part II|Lost to Follow-up|5
34915|NCT01731938|154337|P1|Primary Part II|Lost to Follow-up|4
34916|NCT01731938|154336|P2|Primary Part II|Withdrawal by Subject|4
34917|NCT01731938|154337|P1|Primary Part II|Withdrawal by Subject|5
34918|NCT01731938|154336|P2|Preliminary Part I|Missed Week 6 visit|3
34919|NCT01731938|154337|P1|Preliminary Part I|Missed Week 6 visit|0
34920|NCT01731938|154336|P2|Preliminary Part I|Lost to Follow-up|3
34921|NCT01731938|154337|P1|Preliminary Part I|Lost to Follow-up|0
34922|NCT01731938|154336|P2|Preliminary Part I|Physician Decision|0
34923|NCT01731938|154337|P1|Preliminary Part I|Physician Decision|1
34924|NCT01731938|154336|P2|Preliminary Part I|Withdrawal by Subject|2
34925|NCT01731938|154337|P1|Preliminary Part I|Withdrawal by Subject|2
34926|NCT01731470|154349|P1|Overall Study|Did not meet study criteria|1
34927|NCT01731470|154349|P1|Overall Study|Withdrawal by Subject|1
34928|NCT01731002|154376|P3|Overall Study|Inappropriate use of study medications|1
34929|NCT01731002|154377|P2|Overall Study|Inappropriate use of study medications|0
34930|NCT01731002|154378|P1|Overall Study|Inappropriate use of study medications|0
34931|NCT01731002|154376|P3|Overall Study|Elevated IOP|0
34932|NCT01731002|154377|P2|Overall Study|Elevated IOP|0
34933|NCT01731002|154378|P1|Overall Study|Elevated IOP|1
34934|NCT01731002|154376|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
34935|NCT01731002|154377|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
34936|NCT01731002|154378|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
34937|NCT01731002|154376|P3|Overall Study|Test Agent Discontinuation|0
34938|NCT01731002|154377|P2|Overall Study|Test Agent Discontinuation|1
34939|NCT01731002|154378|P1|Overall Study|Test Agent Discontinuation|0
34940|NCT01731002|154376|P3|Overall Study|Lost to Follow-up|0
34941|NCT01731002|154377|P2|Overall Study|Lost to Follow-up|0
34942|NCT01731002|154378|P1|Overall Study|Lost to Follow-up|1
34943|NCT01731002|154376|P3|Overall Study|Non-Compliant|0
34944|NCT01731002|154377|P2|Overall Study|Non-Compliant|1
34945|NCT01731002|154378|P1|Overall Study|Non-Compliant|0
34946|NCT01731002|154376|P3|Overall Study|Adverse Event|2
34947|NCT01731002|154377|P2|Overall Study|Adverse Event|2
34948|NCT01731002|154378|P1|Overall Study|Adverse Event|0
34949|NCT01730378|154407|P2|Overall Study|Lost to Follow-up|0
34950|NCT01730378|154408|P1|Overall Study|Lost to Follow-up|1
34951|NCT01730339|154439|P2|Overall Study|Un-specified|0
34952|NCT01730339|154440|P1|Overall Study|Un-specified|1
34953|NCT01730339|154439|P2|Overall Study|Lost to Follow-up|1
34954|NCT01730339|154440|P1|Overall Study|Lost to Follow-up|1
34955|NCT01730339|154439|P2|Overall Study|Withdrawal by Subject|2
34956|NCT01730339|154440|P1|Overall Study|Withdrawal by Subject|3
34957|NCT01730053|154480|P6|Overall Study|Other than specified|9
34958|NCT01730053|154481|P5|Overall Study|Other than specified|7
34959|NCT01730053|154482|P4|Overall Study|Other than specified|4
34960|NCT01730053|154483|P3|Overall Study|Other than specified|5
34961|NCT01730053|154484|P2|Overall Study|Other than specified|6
34962|NCT01730053|154485|P1|Overall Study|Other than specified|2
34963|NCT01730053|154480|P6|Overall Study|Poor compliance to protocol|2
34964|NCT01730053|154481|P5|Overall Study|Poor compliance to protocol|0
34965|NCT01730053|154482|P4|Overall Study|Poor compliance to protocol|0
34966|NCT01730053|154483|P3|Overall Study|Poor compliance to protocol|2
34967|NCT01730053|154484|P2|Overall Study|Poor compliance to protocol|2
34968|NCT01730053|154485|P1|Overall Study|Poor compliance to protocol|1
34969|NCT01730053|154480|P6|Overall Study|Adverse Event|2
34970|NCT01730053|154481|P5|Overall Study|Adverse Event|2
34971|NCT01730053|154482|P4|Overall Study|Adverse Event|3
34972|NCT01730053|154483|P3|Overall Study|Adverse Event|3
34973|NCT01730053|154484|P2|Overall Study|Adverse Event|6
34974|NCT01730053|154485|P1|Overall Study|Adverse Event|2
34975|NCT01730053|154480|P6|Overall Study|Physician Decision|0
34976|NCT01730053|154481|P5|Overall Study|Physician Decision|0
34977|NCT01730053|154482|P4|Overall Study|Physician Decision|1
34978|NCT01730053|154483|P3|Overall Study|Physician Decision|0
34979|NCT01730053|154484|P2|Overall Study|Physician Decision|0
34980|NCT01730053|154485|P1|Overall Study|Physician Decision|0
34981|NCT01730053|154480|P6|Overall Study|Participant moved|0
34982|NCT01730053|154481|P5|Overall Study|Participant moved|0
34983|NCT01730053|154482|P4|Overall Study|Participant moved|0
34984|NCT01730053|154483|P3|Overall Study|Participant moved|1
34985|NCT01730053|154484|P2|Overall Study|Participant moved|0
34986|NCT01730053|154485|P1|Overall Study|Participant moved|0
34987|NCT01730040|154644|P7|Overall Study|Poor compliance to protocol|1
34988|NCT01730040|154645|P6|Overall Study|Poor compliance to protocol|0
34989|NCT01730040|154646|P5|Overall Study|Poor compliance to protocol|0
34990|NCT01730040|154647|P4|Overall Study|Poor compliance to protocol|0
34991|NCT01730040|154648|P3|Overall Study|Poor compliance to protocol|0
34992|NCT01730040|154649|P2|Overall Study|Poor compliance to protocol|4
34993|NCT01730040|154650|P1|Overall Study|Poor compliance to protocol|2
34994|NCT01730040|154644|P7|Overall Study|Adverse Event|2
34995|NCT01730040|154645|P6|Overall Study|Adverse Event|1
34996|NCT01730040|154646|P5|Overall Study|Adverse Event|1
34997|NCT01730040|154647|P4|Overall Study|Adverse Event|3
34998|NCT01730040|154648|P3|Overall Study|Adverse Event|5
34999|NCT01730040|154649|P2|Overall Study|Adverse Event|3
35000|NCT01730040|154650|P1|Overall Study|Adverse Event|4
35001|NCT01730040|154644|P7|Overall Study|Other than specified|4
35002|NCT01730040|154645|P6|Overall Study|Other than specified|4
35003|NCT01730040|154646|P5|Overall Study|Other than specified|5
35004|NCT01730040|154647|P4|Overall Study|Other than specified|5
35005|NCT01730040|154648|P3|Overall Study|Other than specified|5
35006|NCT01730040|154649|P2|Overall Study|Other than specified|8
35007|NCT01730040|154650|P1|Overall Study|Other than specified|7
35008|NCT01730040|154644|P7|Overall Study|Physician Decision|1
35009|NCT01730040|154645|P6|Overall Study|Physician Decision|1
35010|NCT01730040|154646|P5|Overall Study|Physician Decision|0
35011|NCT01730040|154647|P4|Overall Study|Physician Decision|0
35012|NCT01730040|154648|P3|Overall Study|Physician Decision|0
35013|NCT01730040|154649|P2|Overall Study|Physician Decision|0
35014|NCT01730040|154650|P1|Overall Study|Physician Decision|0
35015|NCT01730040|154644|P7|Overall Study|Subject moved|1
35016|NCT01730040|154645|P6|Overall Study|Subject moved|0
35017|NCT01730040|154646|P5|Overall Study|Subject moved|0
35018|NCT01730040|154647|P4|Overall Study|Subject moved|0
35019|NCT01730040|154648|P3|Overall Study|Subject moved|1
35020|NCT01730040|154649|P2|Overall Study|Subject moved|0
35021|NCT01730040|154650|P1|Overall Study|Subject moved|0
35022|NCT01730040|154644|P7|Overall Study|Randomized but not treated|0
35023|NCT01730040|154645|P6|Overall Study|Randomized but not treated|1
35024|NCT01730040|154646|P5|Overall Study|Randomized but not treated|0
35025|NCT01730040|154647|P4|Overall Study|Randomized but not treated|0
35026|NCT01730040|154648|P3|Overall Study|Randomized but not treated|0
35027|NCT01730040|154649|P2|Overall Study|Randomized but not treated|0
35028|NCT01730040|154650|P1|Overall Study|Randomized but not treated|0
35029|NCT01729871|154839|P2|Overall Study|Other|9
35030|NCT01729871|154840|P1|Overall Study|Other|4
35031|NCT01729871|154839|P2|Overall Study|Withdrawal by Subject|3
35032|NCT01729871|154840|P1|Overall Study|Withdrawal by Subject|0
35033|NCT01729871|154839|P2|Overall Study|Protocol Violation|0
35034|NCT01729871|154840|P1|Overall Study|Protocol Violation|1
35035|NCT01729871|154839|P2|Overall Study|Physician Decision|2
35036|NCT01729871|154840|P1|Overall Study|Physician Decision|0
35037|NCT01729871|154839|P2|Overall Study|Lack of Efficacy|1
35038|NCT01729871|154840|P1|Overall Study|Lack of Efficacy|0
35039|NCT01729871|154839|P2|Overall Study|Death|1
35040|NCT01729871|154840|P1|Overall Study|Death|0
35041|NCT01729871|154839|P2|Overall Study|Adverse Event|7
35042|NCT01729871|154840|P1|Overall Study|Adverse Event|7
35043|NCT01729728|154875|P3|Overall Study|Protocol Violation|1
35044|NCT01729728|154876|P2|Overall Study|Protocol Violation|0
35045|NCT01729728|154877|P1|Overall Study|Protocol Violation|1
35046|NCT01729728|154875|P3|Overall Study|Adverse Event|0
35047|NCT01729728|154876|P2|Overall Study|Adverse Event|6
35048|NCT01729728|154877|P1|Overall Study|Adverse Event|0
35049|NCT01729559|155010|P2|Overall Study|Protocol Violation|28
35050|NCT01729559|155011|P1|Overall Study|Protocol Violation|31
35051|NCT01729026|155054|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
35052|NCT01729026|155055|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
35053|NCT01729026|155054|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
35054|NCT01729026|155055|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
35055|NCT01728792|155066|P5|Overall Study|Lost to Follow-up|0
35056|NCT01728792|155067|P4|Overall Study|Lost to Follow-up|2
35057|NCT01728792|155068|P3|Overall Study|Lost to Follow-up|4
35058|NCT01728792|155069|P2|Overall Study|Lost to Follow-up|1
35059|NCT01728792|155070|P1|Overall Study|Lost to Follow-up|2
35060|NCT01728792|155066|P5|Overall Study|Withdrawal of Consent|0
35061|NCT01728792|155067|P4|Overall Study|Withdrawal of Consent|1
35062|NCT01728792|155068|P3|Overall Study|Withdrawal of Consent|0
35063|NCT01728792|155069|P2|Overall Study|Withdrawal of Consent|1
35064|NCT01728792|155070|P1|Overall Study|Withdrawal of Consent|1
35065|NCT01728584|155121|P4|Overall Study|Other reason (not specified)|1
35066|NCT01728584|155122|P3|Overall Study|Other reason (not specified)|0
35067|NCT01728584|155123|P2|Overall Study|Other reason (not specified)|0
35068|NCT01728584|155124|P1|Overall Study|Other reason (not specified)|1
35069|NCT01728584|155121|P4|Overall Study|Screen failure|0
35070|NCT01728584|155122|P3|Overall Study|Screen failure|0
35071|NCT01728584|155123|P2|Overall Study|Screen failure|0
35072|NCT01728584|155124|P1|Overall Study|Screen failure|1
35073|NCT01728584|155121|P4|Overall Study|Withdrawal by Subject|0
35074|NCT01728584|155122|P3|Overall Study|Withdrawal by Subject|0
35075|NCT01728584|155123|P2|Overall Study|Withdrawal by Subject|0
35076|NCT01728584|155124|P1|Overall Study|Withdrawal by Subject|1
35077|NCT01728584|155121|P4|Overall Study|Physician Decision|0
35078|NCT01728584|155122|P3|Overall Study|Physician Decision|1
35079|NCT01728584|155123|P2|Overall Study|Physician Decision|0
35080|NCT01728584|155124|P1|Overall Study|Physician Decision|4
35081|NCT01728584|155121|P4|Overall Study|Adverse Event|0
35082|NCT01728584|155122|P3|Overall Study|Adverse Event|0
35083|NCT01728584|155123|P2|Overall Study|Adverse Event|0
35084|NCT01728584|155124|P1|Overall Study|Adverse Event|1
35085|NCT01728376|155182|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
35086|NCT01728376|155183|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
35087|NCT01728376|155184|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
35088|NCT01728376|155185|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
35089|NCT01728376|155186|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
35090|NCT01728376|155187|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
35091|NCT01728376|155182|P6|Overall Study|Did not receive treatment|0
35092|NCT01728376|155183|P5|Overall Study|Did not receive treatment|0
35093|NCT01728376|155184|P4|Overall Study|Did not receive treatment|0
35094|NCT01728376|155185|P3|Overall Study|Did not receive treatment|0
35095|NCT01728376|155186|P2|Overall Study|Did not receive treatment|1
35096|NCT01728376|155187|P1|Overall Study|Did not receive treatment|0
35097|NCT01728376|155182|P6|Overall Study|No relevant bacteria|1
35098|NCT01728376|155183|P5|Overall Study|No relevant bacteria|1
35099|NCT01728376|155184|P4|Overall Study|No relevant bacteria|0
35100|NCT01728376|155185|P3|Overall Study|No relevant bacteria|0
35101|NCT01728376|155186|P2|Overall Study|No relevant bacteria|0
35102|NCT01728376|155187|P1|Overall Study|No relevant bacteria|2
35103|NCT01728376|155182|P6|Overall Study|Persistent Positive Blood Cultures|0
35104|NCT01728376|155183|P5|Overall Study|Persistent Positive Blood Cultures|0
35105|NCT01728376|155184|P4|Overall Study|Persistent Positive Blood Cultures|0
35106|NCT01728376|155185|P3|Overall Study|Persistent Positive Blood Cultures|1
35107|NCT01728376|155186|P2|Overall Study|Persistent Positive Blood Cultures|0
35108|NCT01728376|155187|P1|Overall Study|Persistent Positive Blood Cultures|1
35109|NCT01728376|155182|P6|Overall Study|Adverse Event|0
35110|NCT01728376|155183|P5|Overall Study|Adverse Event|1
35111|NCT01728376|155184|P4|Overall Study|Adverse Event|1
35112|NCT01728376|155185|P3|Overall Study|Adverse Event|1
35113|NCT01728376|155186|P2|Overall Study|Adverse Event|1
35114|NCT01728376|155187|P1|Overall Study|Adverse Event|1
35115|NCT01728324|155260|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
35116|NCT01728324|155261|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
35117|NCT01728324|155262|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
35118|NCT01728324|155260|P3|Termination of RBV|Adverse Event (Placebo Period)|0
35119|NCT01728324|155261|P2|Termination of RBV|Adverse Event (Placebo Period)|1
35120|NCT01728324|155262|P1|Termination of RBV|Adverse Event (Placebo Period)|0
35121|NCT01728324|155260|P3|Termination of RBV|Other than stated|1
35122|NCT01728324|155261|P2|Termination of RBV|Other than stated|3
35123|NCT01728324|155262|P1|Termination of RBV|Other than stated|1
35124|NCT01728324|155260|P3|Termination of RBV|Withdrawal by Subject|2
35125|NCT01728324|155261|P2|Termination of RBV|Withdrawal by Subject|5
35126|NCT01728324|155262|P1|Termination of RBV|Withdrawal by Subject|9
35127|NCT01728324|155260|P3|Termination of RBV|Lack of Efficacy|7
35128|NCT01728324|155261|P2|Termination of RBV|Lack of Efficacy|11
35129|NCT01728324|155262|P1|Termination of RBV|Lack of Efficacy|14
35130|NCT01728324|155260|P3|Termination of RBV|Adverse Event|5
35131|NCT01728324|155261|P2|Termination of RBV|Adverse Event|16
35132|NCT01728324|155262|P1|Termination of RBV|Adverse Event|15
35133|NCT01728324|155260|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
35134|NCT01728324|155261|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
35135|NCT01728324|155262|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
35136|NCT01728324|155260|P3|Termination of FDV|Adverse Event (Placebo Period)|0
35137|NCT01728324|155261|P2|Termination of FDV|Adverse Event (Placebo Period)|1
35138|NCT01728324|155262|P1|Termination of FDV|Adverse Event (Placebo Period)|0
35139|NCT01728324|155260|P3|Termination of FDV|Other than stated|0
35140|NCT01728324|155261|P2|Termination of FDV|Other than stated|3
35141|NCT01728324|155262|P1|Termination of FDV|Other than stated|1
35142|NCT01728324|155260|P3|Termination of FDV|Withdrawal by Subject|2
35143|NCT01728324|155261|P2|Termination of FDV|Withdrawal by Subject|6
35144|NCT01728324|155262|P1|Termination of FDV|Withdrawal by Subject|9
35145|NCT01728324|155260|P3|Termination of FDV|Lack of Efficacy|8
35146|NCT01728324|155261|P2|Termination of FDV|Lack of Efficacy|12
35147|NCT01728324|155262|P1|Termination of FDV|Lack of Efficacy|14
35148|NCT01728324|155260|P3|Termination of FDV|Adverse Event|4
35149|NCT01728324|155261|P2|Termination of FDV|Adverse Event|13
35150|NCT01728324|155262|P1|Termination of FDV|Adverse Event|14
35151|NCT01728324|155260|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
35152|NCT01728324|155261|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
35153|NCT01728324|155262|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
35154|NCT01728324|155260|P3|Termination of DBV|Adverse Event (Placebo Period)|0
35155|NCT01728324|155261|P2|Termination of DBV|Adverse Event (Placebo Period)|1
35156|NCT01728324|155262|P1|Termination of DBV|Adverse Event (Placebo Period)|0
35157|NCT01728324|155260|P3|Termination of DBV|Other than stated|0
35158|NCT01728324|155261|P2|Termination of DBV|Other than stated|3
35159|NCT01728324|155262|P1|Termination of DBV|Other than stated|1
35160|NCT01728324|155260|P3|Termination of DBV|Withdrawal by Subject|2
35161|NCT01728324|155261|P2|Termination of DBV|Withdrawal by Subject|6
35162|NCT01728324|155262|P1|Termination of DBV|Withdrawal by Subject|9
35163|NCT01728324|155260|P3|Termination of DBV|Lack of Efficacy|8
35164|NCT01728324|155261|P2|Termination of DBV|Lack of Efficacy|12
35165|NCT01728324|155262|P1|Termination of DBV|Lack of Efficacy|14
35166|NCT01728324|155260|P3|Termination of DBV|Adverse Event|4
35167|NCT01728324|155261|P2|Termination of DBV|Adverse Event|13
35168|NCT01728324|155262|P1|Termination of DBV|Adverse Event|14
35169|NCT01728246|155283|P2|Overall Study|Adverse Event|5
35170|NCT01728246|155284|P1|Overall Study|Adverse Event|8
35171|NCT01728246|155283|P2|Overall Study|Lack of Efficacy|1
35172|NCT01728246|155284|P1|Overall Study|Lack of Efficacy|1
35173|NCT01728246|155283|P2|Overall Study|Lost to Follow-up|22
35174|NCT01728246|155284|P1|Overall Study|Lost to Follow-up|23
35175|NCT01728246|155283|P2|Overall Study|Withdrawal by Subject|3
35176|NCT01728246|155284|P1|Overall Study|Withdrawal by Subject|2
35177|NCT01728246|155283|P2|Overall Study|Protocol Violation|0
35178|NCT01728246|155284|P1|Overall Study|Protocol Violation|1
35179|NCT01728246|155283|P2|Overall Study|Participant needed rescue medication|5
35180|NCT01728246|155284|P1|Overall Study|Participant needed rescue medication|1
35181|NCT01728116|155302|P2|Overall Study|various not noted previously|0
35182|NCT01728116|155303|P1|Overall Study|various not noted previously|5
35183|NCT01728116|155302|P2|Overall Study|Incorrectly enrolled in Study|1
35184|NCT01728116|155303|P1|Overall Study|Incorrectly enrolled in Study|0
35185|NCT01728116|155302|P2|Overall Study|Inter-current finding at procedure|0
35186|NCT01728116|155303|P1|Overall Study|Inter-current finding at procedure|1
35187|NCT01728116|155302|P2|Overall Study|Subject Non-Compliance|0
35188|NCT01728116|155303|P1|Overall Study|Subject Non-Compliance|2
35189|NCT01728116|155302|P2|Overall Study|Physician Decision|0
35190|NCT01728116|155303|P1|Overall Study|Physician Decision|2
35191|NCT01728116|155302|P2|Overall Study|Lost to Follow-up|2
35192|NCT01728116|155303|P1|Overall Study|Lost to Follow-up|9
35193|NCT01728116|155302|P2|Overall Study|Procedure/device failure|0
35194|NCT01728116|155303|P1|Overall Study|Procedure/device failure|7
35195|NCT01728116|155302|P2|Overall Study|Adverse Event|0
35196|NCT01728116|155303|P1|Overall Study|Adverse Event|13
35197|NCT01728116|155302|P2|Overall Study|Withdrawal by Subject|9
35198|NCT01728116|155303|P1|Overall Study|Withdrawal by Subject|16
35199|NCT01728116|155302|P2|Overall Study|Sponsor Terminated Study|35
35200|NCT01728116|155303|P1|Overall Study|Sponsor Terminated Study|106
35201|NCT01728077|155328|P2|Overall Study|Non compliance|0
35202|NCT01728077|155329|P1|Overall Study|Non compliance|1
35203|NCT01728077|155328|P2|Overall Study|Patient moving|0
35204|NCT01728077|155329|P1|Overall Study|Patient moving|1
35205|NCT01728077|155328|P2|Overall Study|Death|1
35206|NCT01728077|155329|P1|Overall Study|Death|0
35207|NCT01728077|155328|P2|Overall Study|Subject choice|3
35208|NCT01728077|155329|P1|Overall Study|Subject choice|2
35209|NCT01728077|155328|P2|Overall Study|Lost to Follow-up|0
35210|NCT01728077|155329|P1|Overall Study|Lost to Follow-up|1
35211|NCT01728077|155328|P2|Overall Study|Lack of Efficacy|1
35212|NCT01728077|155329|P1|Overall Study|Lack of Efficacy|3
35213|NCT01727713|155381|P1|Overall Study|Protocol Deviation|2
35214|NCT01727713|155381|P1|Overall Study|Withdrawal by Subject|13
35215|NCT01727713|155381|P1|Overall Study|Participant Met Withdrawal Criteria|5
35216|NCT01727713|155381|P1|Overall Study|Adverse Event|10
35217|NCT01727713|155381|P1|Overall Study|Lost to Follow-up|5
35218|NCT01727700|155408|P3|Overall Study|Protocol Violation|0
35219|NCT01727700|155409|P2|Overall Study|Protocol Violation|0
35220|NCT01727700|155410|P1|Overall Study|Protocol Violation|2
35221|NCT01727700|155408|P3|Overall Study|Particpant withdrew consent|1
35222|NCT01727700|155409|P2|Overall Study|Particpant withdrew consent|3
35223|NCT01727700|155410|P1|Overall Study|Particpant withdrew consent|0
35224|NCT01727700|155408|P3|Overall Study|Adverse Event|1
35225|NCT01727700|155409|P2|Overall Study|Adverse Event|7
35226|NCT01727700|155410|P1|Overall Study|Adverse Event|0
35227|NCT01727505|155433|P2|Second 24 Hours|Missing data|1
35228|NCT01727505|155434|P1|Second 24 Hours|Missing data|0
35229|NCT01727505|155433|P2|First 24 Hours|Adverse Event|1
35230|NCT01727505|155434|P1|First 24 Hours|Adverse Event|0
35231|NCT01727297|155459|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
35232|NCT01727297|155460|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
35233|NCT01727297|155459|P2|Overall Study|Physician Decision|5
35234|NCT01727297|155460|P1|Overall Study|Physician Decision|19
35235|NCT01727297|155459|P2|Overall Study|Withdrawal by Subject|27
35236|NCT01727297|155460|P1|Overall Study|Withdrawal by Subject|26
35237|NCT01727297|155459|P2|Overall Study|Lost to Follow-up|0
35238|NCT01727297|155460|P1|Overall Study|Lost to Follow-up|11
35239|NCT01727297|155459|P2|Overall Study|Adverse Event|1
35240|NCT01727297|155460|P1|Overall Study|Adverse Event|3
35241|NCT01727297|155459|P2|Overall Study|Protocol Violation|10
35242|NCT01727297|155460|P1|Overall Study|Protocol Violation|1
35243|NCT01727297|155459|P2|Overall Study|Death|0
35244|NCT01727297|155460|P1|Overall Study|Death|13
35245|NCT01727258|155476|P3|Overall Study|Lost to Follow-up|0
35246|NCT01727258|155477|P2|Overall Study|Lost to Follow-up|0
35247|NCT01727258|155478|P1|Overall Study|Lost to Follow-up|1
35248|NCT01727258|155476|P3|Overall Study|Withdrawal by Subject|0
35249|NCT01727258|155477|P2|Overall Study|Withdrawal by Subject|1
35250|NCT01727258|155478|P1|Overall Study|Withdrawal by Subject|1
35251|NCT01727258|155476|P3|Overall Study|Noncompliance with Study Drug|1
35252|NCT01727258|155477|P2|Overall Study|Noncompliance with Study Drug|0
35253|NCT01727258|155478|P1|Overall Study|Noncompliance with Study Drug|0
35254|NCT01727258|155476|P3|Overall Study|Adverse Event|0
35255|NCT01727258|155477|P2|Overall Study|Adverse Event|2
35256|NCT01727258|155478|P1|Overall Study|Adverse Event|0
35257|NCT01727141|155520|P4|Overall Study|Withdrawal by Subject|11
35258|NCT01727141|155521|P3|Overall Study|Withdrawal by Subject|2
35259|NCT01727141|155522|P2|Overall Study|Withdrawal by Subject|4
35260|NCT01727141|155523|P1|Overall Study|Withdrawal by Subject|4
35261|NCT01727141|155520|P4|Overall Study|Protocol deviation|1
35262|NCT01727141|155521|P3|Overall Study|Protocol deviation|0
35263|NCT01727141|155522|P2|Overall Study|Protocol deviation|1
35264|NCT01727141|155523|P1|Overall Study|Protocol deviation|1
35265|NCT01727141|155520|P4|Overall Study|Death|1
35266|NCT01727141|155521|P3|Overall Study|Death|1
35267|NCT01727141|155522|P2|Overall Study|Death|1
35268|NCT01727141|155523|P1|Overall Study|Death|0
35269|NCT01727141|155520|P4|Overall Study|Lost to Follow-up|0
35270|NCT01727141|155521|P3|Overall Study|Lost to Follow-up|0
35271|NCT01727141|155522|P2|Overall Study|Lost to Follow-up|2
35272|NCT01727141|155523|P1|Overall Study|Lost to Follow-up|0
35273|NCT01727141|155520|P4|Overall Study|Physician Decision|2
35274|NCT01727141|155521|P3|Overall Study|Physician Decision|0
35275|NCT01727141|155522|P2|Overall Study|Physician Decision|1
35276|NCT01727141|155523|P1|Overall Study|Physician Decision|0
35277|NCT01727024|155573|P2|Period 1|Withdrawal by Subject|3
35278|NCT01727024|155574|P1|Period 1|Withdrawal by Subject|2
35279|NCT01727024|155573|P2|Period 1|Lost to Follow-up|1
35280|NCT01727024|155574|P1|Period 1|Lost to Follow-up|1
35281|NCT01726517|155596|P5|Overall Study|Withdrawal by Subject|0
35282|NCT01726517|155597|P4|Overall Study|Withdrawal by Subject|0
35283|NCT01726517|155598|P3|Overall Study|Withdrawal by Subject|1
35284|NCT01726517|155599|P2|Overall Study|Withdrawal by Subject|0
35285|NCT01726517|155600|P1|Overall Study|Withdrawal by Subject|0
35286|NCT01726335|155656|P1|Overall Study|Exacerbation of psychotic symptoms|1
35287|NCT01726335|155656|P1|Overall Study|Lost to Follow-up|2
35288|NCT01726335|155656|P1|Overall Study|Adverse Event|4
35289|NCT01726335|155656|P1|Overall Study|Withdrawal by Subject|15
35290|NCT01726335|155656|P1|Overall Study|Lost to Follow-up|2
35291|NCT01726049|155674|P2|Overall Study|refused second HC|2
35292|NCT01726049|155675|P1|Overall Study|refused second HC|0
35293|NCT01726049|155674|P2|Overall Study|Adverse Event|1
35294|NCT01726049|155675|P1|Overall Study|Adverse Event|4
35295|NCT01726049|155674|P2|Overall Study|Death|1
35296|NCT01726049|155675|P1|Overall Study|Death|1
35297|NCT01726023|155689|P2|Overall Study|Withdrawal by Subject|8
35298|NCT01726023|155690|P1|Overall Study|Withdrawal by Subject|16
35299|NCT01726023|155689|P2|Overall Study|Other Eligibility criteria|7
35300|NCT01726023|155690|P1|Overall Study|Other Eligibility criteria|7
35301|NCT01726023|155689|P2|Overall Study|Lost to Follow-up|10
35302|NCT01726023|155690|P1|Overall Study|Lost to Follow-up|5
35303|NCT01726023|155689|P2|Overall Study|Death|1
35304|NCT01726023|155690|P1|Overall Study|Death|1
35305|NCT01725529|155810|P3|Overall Study|Withdrawal by Subject|8
35306|NCT01725529|155811|P2|Overall Study|Withdrawal by Subject|14
35307|NCT01725529|155812|P1|Overall Study|Withdrawal by Subject|12
35308|NCT01725529|155810|P3|Overall Study|Protocol Violation|1
35309|NCT01725529|155811|P2|Overall Study|Protocol Violation|1
35310|NCT01725529|155812|P1|Overall Study|Protocol Violation|0
35311|NCT01725529|155810|P3|Overall Study|Lost to Follow-up|1
35312|NCT01725529|155811|P2|Overall Study|Lost to Follow-up|1
35313|NCT01725529|155812|P1|Overall Study|Lost to Follow-up|2
35314|NCT01725529|155810|P3|Overall Study|Adverse Event|0
35315|NCT01725529|155811|P2|Overall Study|Adverse Event|0
35316|NCT01725529|155812|P1|Overall Study|Adverse Event|1
35317|NCT01725451|155838|P4|Period 4|Adverse Event|0
35318|NCT01725451|155839|P3|Period 4|Adverse Event|1
35319|NCT01725451|155840|P2|Period 4|Adverse Event|0
35320|NCT01725451|155841|P1|Period 4|Adverse Event|0
35321|NCT01725451|155838|P4|Washout From Period 3|Adverse Event|0
35322|NCT01725451|155839|P3|Washout From Period 3|Adverse Event|0
35323|NCT01725451|155840|P2|Washout From Period 3|Adverse Event|1
35324|NCT01725451|155841|P1|Washout From Period 3|Adverse Event|0
35325|NCT01725451|155838|P4|Washout From Period 3|Protocol Violation|0
35326|NCT01725451|155839|P3|Washout From Period 3|Protocol Violation|1
35327|NCT01725451|155840|P2|Washout From Period 3|Protocol Violation|0
35328|NCT01725451|155841|P1|Washout From Period 3|Protocol Violation|0
35329|NCT01725451|155838|P4|Period 1|Withdrawal by Subject|0
35330|NCT01725451|155839|P3|Period 1|Withdrawal by Subject|0
35331|NCT01725451|155840|P2|Period 1|Withdrawal by Subject|0
35332|NCT01725451|155841|P1|Period 1|Withdrawal by Subject|1
35333|NCT01725386|155863|P2|Overall Study|Withdrawal by Subject|0
35334|NCT01725386|155864|P1|Overall Study|Withdrawal by Subject|10
35335|NCT01725386|155863|P2|Overall Study|Lost to Follow-up|6
35336|NCT01725386|155864|P1|Overall Study|Lost to Follow-up|81
35337|NCT01725386|155863|P2|Overall Study|Death|40
35338|NCT01725386|155864|P1|Overall Study|Death|84
35339|NCT01725308|155883|P3|Treatment Period II|Miscellaneous|7
35340|NCT01725308|155884|P2|Treatment Period II|Miscellaneous|3
35341|NCT01725308|155885|P1|Treatment Period II|Miscellaneous|5
35342|NCT01725308|155883|P3|Treatment Period II|Protocol Deviations|1
35343|NCT01725308|155884|P2|Treatment Period II|Protocol Deviations|0
35344|NCT01725308|155885|P1|Treatment Period II|Protocol Deviations|0
35345|NCT01725308|155883|P3|Treatment Period II|Lost to Follow-up|3
35346|NCT01725308|155884|P2|Treatment Period II|Lost to Follow-up|5
35347|NCT01725308|155885|P1|Treatment Period II|Lost to Follow-up|1
35348|NCT01725308|155883|P3|Treatment Period II|Withdrawal of Consent|16
35349|NCT01725308|155884|P2|Treatment Period II|Withdrawal of Consent|2
35350|NCT01725308|155885|P1|Treatment Period II|Withdrawal of Consent|28
35351|NCT01725308|155883|P3|Treatment Period II|Changes in the Episodes|5
35352|NCT01725308|155884|P2|Treatment Period II|Changes in the Episodes|0
35353|NCT01725308|155885|P1|Treatment Period II|Changes in the Episodes|1
35354|NCT01725308|155883|P3|Treatment Period II|Worsening of the Target Disease|2
35355|NCT01725308|155884|P2|Treatment Period II|Worsening of the Target Disease|4
35356|NCT01725308|155885|P1|Treatment Period II|Worsening of the Target Disease|1
35357|NCT01725308|155883|P3|Treatment Period II|Insufficient Response|6
35358|NCT01725308|155884|P2|Treatment Period II|Insufficient Response|4
35359|NCT01725308|155885|P1|Treatment Period II|Insufficient Response|2
35360|NCT01725308|155883|P3|Treatment Period II|Adverse Event|20
35361|NCT01725308|155884|P2|Treatment Period II|Adverse Event|8
35362|NCT01725308|155885|P1|Treatment Period II|Adverse Event|13
35363|NCT01725308|155883|P3|Treatment Period II|Did Not Receive Drug|0
35364|NCT01725308|155884|P2|Treatment Period II|Did Not Receive Drug|0
35365|NCT01725308|155885|P1|Treatment Period II|Did Not Receive Drug|4
35366|NCT01725308|155883|P3|Treatment Period II|Did Not Meet Transition Criteria|4
35367|NCT01725308|155884|P2|Treatment Period II|Did Not Meet Transition Criteria|3
35368|NCT01725308|155885|P1|Treatment Period II|Did Not Meet Transition Criteria|0
35369|NCT01725308|155883|P3|Treatment Period I|Miscellaneous|3
35370|NCT01725308|155884|P2|Treatment Period I|Miscellaneous|0
35371|NCT01725308|155885|P1|Treatment Period I|Miscellaneous|2
35372|NCT01725308|155883|P3|Treatment Period I|Protocol Deviations|1
35373|NCT01725308|155884|P2|Treatment Period I|Protocol Deviations|1
35374|NCT01725308|155885|P1|Treatment Period I|Protocol Deviations|3
35375|NCT01725308|155883|P3|Treatment Period I|Lost to Follow-up|2
35376|NCT01725308|155884|P2|Treatment Period I|Lost to Follow-up|2
35377|NCT01725308|155885|P1|Treatment Period I|Lost to Follow-up|3
35378|NCT01725308|155883|P3|Treatment Period I|Withdrawal of Consent|5
35379|NCT01725308|155884|P2|Treatment Period I|Withdrawal of Consent|7
35380|NCT01725308|155885|P1|Treatment Period I|Withdrawal of Consent|12
35381|NCT01725308|155883|P3|Treatment Period I|Changes in the Episodes|2
35382|NCT01725308|155884|P2|Treatment Period I|Changes in the Episodes|0
35383|NCT01725308|155885|P1|Treatment Period I|Changes in the Episodes|3
35384|NCT01725308|155883|P3|Treatment Period I|Worsening of the Target Disease|2
35385|NCT01725308|155884|P2|Treatment Period I|Worsening of the Target Disease|0
35386|NCT01725308|155885|P1|Treatment Period I|Worsening of the Target Disease|8
35387|NCT01725308|155883|P3|Treatment Period I|Insufficient Response|5
35388|NCT01725308|155884|P2|Treatment Period I|Insufficient Response|0
35389|NCT01725308|155885|P1|Treatment Period I|Insufficient Response|7
35390|NCT01725308|155883|P3|Treatment Period I|Adverse Event|21
35391|NCT01725308|155884|P2|Treatment Period I|Adverse Event|4
35392|NCT01725308|155885|P1|Treatment Period I|Adverse Event|5
35393|NCT01725308|155883|P3|Treatment Period I|Did Not Receive Drug|0
35394|NCT01725308|155884|P2|Treatment Period I|Did Not Receive Drug|0
35395|NCT01725308|155885|P1|Treatment Period I|Did Not Receive Drug|1
35396|NCT01725282|156032|P4|Overall Study|Lack of Efficacy|1
35397|NCT01725282|156033|P3|Overall Study|Lack of Efficacy|0
35398|NCT01725282|156034|P2|Overall Study|Lack of Efficacy|1
35399|NCT01725282|156035|P1|Overall Study|Lack of Efficacy|0
35400|NCT01725282|156032|P4|Overall Study|Withdrawal by Subject|1
35401|NCT01725282|156033|P3|Overall Study|Withdrawal by Subject|1
35402|NCT01725282|156034|P2|Overall Study|Withdrawal by Subject|0
35403|NCT01725282|156035|P1|Overall Study|Withdrawal by Subject|0
35404|NCT01725282|156032|P4|Overall Study|Study Site Withdrawal|0
35405|NCT01725282|156033|P3|Overall Study|Study Site Withdrawal|0
35406|NCT01725282|156034|P2|Overall Study|Study Site Withdrawal|1
35407|NCT01725282|156035|P1|Overall Study|Study Site Withdrawal|0
35408|NCT01725282|156032|P4|Overall Study|Met Exclusion Criteria|0
35409|NCT01725282|156033|P3|Overall Study|Met Exclusion Criteria|1
35410|NCT01725282|156034|P2|Overall Study|Met Exclusion Criteria|0
35411|NCT01725282|156035|P1|Overall Study|Met Exclusion Criteria|0
35412|NCT01725282|156032|P4|Overall Study|Exacerbation of Target Disease|1
35413|NCT01725282|156033|P3|Overall Study|Exacerbation of Target Disease|0
35414|NCT01725282|156034|P2|Overall Study|Exacerbation of Target Disease|0
35415|NCT01725282|156035|P1|Overall Study|Exacerbation of Target Disease|1
35416|NCT01725282|156032|P4|Overall Study|Adverse Event|4
35417|NCT01725282|156033|P3|Overall Study|Adverse Event|6
35418|NCT01725282|156034|P2|Overall Study|Adverse Event|3
35419|NCT01725282|156035|P1|Overall Study|Adverse Event|1
35420|NCT01725217|156068|P3|Overall Study|Withdrawal by Subject|0
35421|NCT01725217|156069|P2|Overall Study|Withdrawal by Subject|0
35422|NCT01725217|156070|P1|Overall Study|Withdrawal by Subject|1
35423|NCT01725126|156104|P6|Overall Study|Withdrawal by Subject|0
35424|NCT01725126|156105|P5|Overall Study|Withdrawal by Subject|0
35425|NCT01725126|156106|P4|Overall Study|Withdrawal by Subject|1
35426|NCT01725126|156107|P3|Overall Study|Withdrawal by Subject|0
35427|NCT01725126|156108|P2|Overall Study|Withdrawal by Subject|0
35428|NCT01725126|156109|P1|Overall Study|Withdrawal by Subject|0
35429|NCT01725126|156104|P6|Overall Study|Protocol Violation|0
35430|NCT01725126|156105|P5|Overall Study|Protocol Violation|0
35431|NCT01725126|156106|P4|Overall Study|Protocol Violation|0
35432|NCT01725126|156107|P3|Overall Study|Protocol Violation|0
35433|NCT01725126|156108|P2|Overall Study|Protocol Violation|1
35434|NCT01725126|156109|P1|Overall Study|Protocol Violation|0
35435|NCT01724528|156307|P2|Overall Study|Patient refused to attend last visit|0
35436|NCT01724528|156308|P1|Overall Study|Patient refused to attend last visit|1
35437|NCT01724528|156307|P2|Overall Study|Protocol Violation|1
35438|NCT01724528|156308|P1|Overall Study|Protocol Violation|0
35439|NCT01724528|156307|P2|Overall Study|Withdrawal by Subject|2
35440|NCT01724528|156308|P1|Overall Study|Withdrawal by Subject|0
35441|NCT01724528|156307|P2|Overall Study|Death|0
35442|NCT01724528|156308|P1|Overall Study|Death|3
35443|NCT01724359|156322|P1|Overall Study|Not specified|20
35444|NCT01724359|156322|P1|Overall Study|Death|1
35445|NCT01724359|156322|P1|Overall Study|Adverse Event|10
35446|NCT01724216|156335|P1|Overall Study|Scan was not completed|1
35447|NCT01724177|156339|P1|Overall Study|Serious Adverse Event Related|1
35448|NCT01724177|156339|P1|Overall Study|Nervous participant|1
35449|NCT01724177|156339|P1|Overall Study|Progressive disease or Relapsed Disease|16
35450|NCT01724177|156339|P1|Overall Study|Adverse Event|8
35451|NCT01724021|156352|P2|Overall Study|Missing|1
35452|NCT01724021|156353|P1|Overall Study|Missing|1
35453|NCT01724021|156352|P2|Overall Study|Reason Not Specified|39
35454|NCT01724021|156353|P1|Overall Study|Reason Not Specified|36
35455|NCT01724021|156352|P2|Overall Study|Lost to Follow-up|15
35456|NCT01724021|156353|P1|Overall Study|Lost to Follow-up|15
35457|NCT01724021|156352|P2|Overall Study|Participant request/ Withdrew consent|14
35458|NCT01724021|156353|P1|Overall Study|Participant request/ Withdrew consent|18
35459|NCT01724021|156352|P2|Overall Study|Death|58
35460|NCT01724021|156353|P1|Overall Study|Death|46
35461|NCT01724021|156352|P2|Overall Study|Adverse Event|6
35462|NCT01724021|156353|P1|Overall Study|Adverse Event|11
35463|NCT01723904|156385|P1|Overall Study|Unable to follow protocol/ judged by inv|3
35464|NCT01723904|156385|P1|Overall Study|Adverse Event|5
35465|NCT01723904|156385|P1|Overall Study|Noncompliant|3
35466|NCT01723397|156406|P2|Study Period 2|Protocol Violation|1
35467|NCT01723397|156407|P1|Study Period 2|Protocol Violation|0
35468|NCT01723397|156406|P2|Study Period 1|Protocol Violation|1
35469|NCT01723397|156407|P1|Study Period 1|Protocol Violation|0
35470|NCT01723254|156421|P8|Overall Study|Withdrawal by Subject|2
35471|NCT01723254|156422|P7|Overall Study|Withdrawal by Subject|1
35472|NCT01723254|156423|P6|Overall Study|Withdrawal by Subject|1
35473|NCT01723254|156424|P5|Overall Study|Withdrawal by Subject|1
35474|NCT01723254|156425|P4|Overall Study|Withdrawal by Subject|0
35475|NCT01723254|156426|P3|Overall Study|Withdrawal by Subject|1
35476|NCT01723254|156427|P2|Overall Study|Withdrawal by Subject|2
35477|NCT01723254|156428|P1|Overall Study|Withdrawal by Subject|1
35478|NCT01723254|156421|P8|Overall Study|Protocol Violation|0
35479|NCT01723254|156422|P7|Overall Study|Protocol Violation|0
35480|NCT01723254|156423|P6|Overall Study|Protocol Violation|0
35481|NCT01723254|156424|P5|Overall Study|Protocol Violation|0
35482|NCT01723254|156425|P4|Overall Study|Protocol Violation|0
35483|NCT01723254|156426|P3|Overall Study|Protocol Violation|0
35484|NCT01723254|156427|P2|Overall Study|Protocol Violation|1
35485|NCT01723254|156428|P1|Overall Study|Protocol Violation|0
35486|NCT01723254|156421|P8|Overall Study|Move/Left to another country/city|0
35487|NCT01723254|156422|P7|Overall Study|Move/Left to another country/city|0
35488|NCT01723254|156423|P6|Overall Study|Move/Left to another country/city|0
35489|NCT01723254|156424|P5|Overall Study|Move/Left to another country/city|1
35490|NCT01723254|156425|P4|Overall Study|Move/Left to another country/city|1
35491|NCT01723254|156426|P3|Overall Study|Move/Left to another country/city|2
35492|NCT01723254|156427|P2|Overall Study|Move/Left to another country/city|0
35493|NCT01723254|156428|P1|Overall Study|Move/Left to another country/city|0
35494|NCT01723254|156421|P8|Overall Study|No longer have time to participate|0
35495|NCT01723254|156422|P7|Overall Study|No longer have time to participate|0
35496|NCT01723254|156423|P6|Overall Study|No longer have time to participate|0
35497|NCT01723254|156424|P5|Overall Study|No longer have time to participate|0
35498|NCT01723254|156425|P4|Overall Study|No longer have time to participate|1
35499|NCT01723254|156426|P3|Overall Study|No longer have time to participate|0
35500|NCT01723254|156427|P2|Overall Study|No longer have time to participate|0
35501|NCT01723254|156428|P1|Overall Study|No longer have time to participate|0
35502|NCT01723254|156421|P8|Overall Study|Personal issues|0
35503|NCT01723254|156422|P7|Overall Study|Personal issues|0
35504|NCT01723254|156423|P6|Overall Study|Personal issues|1
35505|NCT01723254|156424|P5|Overall Study|Personal issues|0
35506|NCT01723254|156425|P4|Overall Study|Personal issues|0
35507|NCT01723254|156426|P3|Overall Study|Personal issues|0
35508|NCT01723254|156427|P2|Overall Study|Personal issues|0
35509|NCT01723254|156428|P1|Overall Study|Personal issues|0
35510|NCT01723254|156421|P8|Overall Study|Conflict with work schedule|1
35511|NCT01723254|156422|P7|Overall Study|Conflict with work schedule|0
35512|NCT01723254|156423|P6|Overall Study|Conflict with work schedule|0
35513|NCT01723254|156424|P5|Overall Study|Conflict with work schedule|0
35514|NCT01723254|156425|P4|Overall Study|Conflict with work schedule|0
35515|NCT01723254|156426|P3|Overall Study|Conflict with work schedule|0
35516|NCT01723254|156427|P2|Overall Study|Conflict with work schedule|0
35517|NCT01723254|156428|P1|Overall Study|Conflict with work schedule|0
35518|NCT01723228|156480|P2|Overall Study|Not Specified|1
35519|NCT01723228|156481|P1|Overall Study|Not Specified|2
35520|NCT01723228|156480|P2|Overall Study|Lost to Follow-up|1
35521|NCT01723228|156481|P1|Overall Study|Lost to Follow-up|2
35522|NCT01723228|156480|P2|Overall Study|Protocol Violation|2
35523|NCT01723228|156481|P1|Overall Study|Protocol Violation|0
35524|NCT01723228|156480|P2|Overall Study|Withdrawal by Subject|1
35525|NCT01723228|156481|P1|Overall Study|Withdrawal by Subject|2
35526|NCT01723228|156480|P2|Overall Study|Adverse Event|6
35527|NCT01723228|156481|P1|Overall Study|Adverse Event|2
35528|NCT01722994|156499|P2|Overall Study|Missing data|17
35529|NCT01722994|156500|P1|Overall Study|Missing data|25
35530|NCT01722877|156519|P1|Overall Study|Lost to Follow-up|1
35531|NCT01722877|156519|P1|Overall Study|Death|1
35532|NCT01722266|156580|P4|Overall Study|Dropped out due to Nausea|0
35533|NCT01722266|156581|P3|Overall Study|Dropped out due to Nausea|2
35534|NCT01722266|156582|P2|Overall Study|Dropped out due to Nausea|0
35535|NCT01722266|156583|P1|Overall Study|Dropped out due to Nausea|0
35536|NCT01722266|156580|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
35537|NCT01722266|156581|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
35538|NCT01722266|156582|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
35539|NCT01722266|156583|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
35540|NCT01722266|156580|P4|Overall Study|Withdrawal by Subject|0
35541|NCT01722266|156581|P3|Overall Study|Withdrawal by Subject|0
35542|NCT01722266|156582|P2|Overall Study|Withdrawal by Subject|2
35543|NCT01722266|156583|P1|Overall Study|Withdrawal by Subject|1
35544|NCT01722162|156611|P2|Overall Study|Noncompliance|1
35545|NCT01722162|156612|P1|Overall Study|Noncompliance|0
35546|NCT01722162|156611|P2|Overall Study|Insurance denial post enrollment|1
35547|NCT01722162|156612|P1|Overall Study|Insurance denial post enrollment|0
35548|NCT01722162|156611|P2|Overall Study|Adverse Event|1
35549|NCT01722162|156612|P1|Overall Study|Adverse Event|1
35550|NCT01722162|156611|P2|Overall Study|Unrelated to study adverse event|2
35551|NCT01722162|156612|P1|Overall Study|Unrelated to study adverse event|2
35552|NCT01722162|156611|P2|Overall Study|Found ineligible|0
35553|NCT01722162|156612|P1|Overall Study|Found ineligible|1
35554|NCT01722162|156611|P2|Overall Study|Withdrawal by Subject|1
35555|NCT01722162|156612|P1|Overall Study|Withdrawal by Subject|1
35556|NCT01722097|156622|P2|Overall Study|Patient sheets not returned|5
35557|NCT01722097|156623|P1|Overall Study|Patient sheets not returned|6
35558|NCT01722071|156631|P2|Overall Study|Protocol Violation|0
35559|NCT01722071|156632|P1|Overall Study|Protocol Violation|1
35560|NCT01722045|156638|P1|Overall Study|Relocation (did not wish to transfer)|1
35561|NCT01722045|156638|P1|Overall Study|Physician Decision|3
35562|NCT01722045|156638|P1|Overall Study|Protocol Deviation|1
35563|NCT01722045|156638|P1|Overall Study|Lost to Follow-up|4
35564|NCT01722045|156638|P1|Overall Study|Withdrawal by Subject|8
35565|NCT01722045|156638|P1|Overall Study|Death|3
35566|NCT01722045|156638|P1|Overall Study|Adverse Event|8
35567|NCT01721772|156663|P2|Overall Study|Not specified|1
35568|NCT01721772|156664|P1|Overall Study|Not specified|0
35569|NCT01721772|156663|P2|Overall Study|Maximum clinical benefit|1
35570|NCT01721772|156664|P1|Overall Study|Maximum clinical benefit|1
35571|NCT01721772|156663|P2|Overall Study|Withdrawal by Subject|5
35572|NCT01721772|156664|P1|Overall Study|Withdrawal by Subject|7
35573|NCT01721772|156663|P2|Overall Study|Unrelated adverse event|3
35574|NCT01721772|156664|P1|Overall Study|Unrelated adverse event|2
35575|NCT01721772|156663|P2|Overall Study|Study drug toxicity|7
35576|NCT01721772|156664|P1|Overall Study|Study drug toxicity|5
35577|NCT01721772|156663|P2|Overall Study|Disease progression|175
35578|NCT01721772|156664|P1|Overall Study|Disease progression|96
35579|NCT01721759|156684|P1|Overall Study|Withdrawal by Subject|1
35580|NCT01721759|156684|P1|Overall Study|Adverse event unrelated to study drug|9
35581|NCT01721759|156684|P1|Overall Study|Study drug toxicity|14
35582|NCT01721759|156684|P1|Overall Study|Disease progression|78
35583|NCT01721746|156692|P3|Treatment Period|Other|1
35584|NCT01721746|156693|P2|Treatment Period|Other|1
35585|NCT01721746|156694|P1|Treatment Period|Other|2
35586|NCT01721746|156692|P3|Treatment Period|Subject No Longer Met Study Criteria|0
35587|NCT01721746|156693|P2|Treatment Period|Subject No Longer Met Study Criteria|0
35588|NCT01721746|156694|P1|Treatment Period|Subject No Longer Met Study Criteria|4
35589|NCT01721746|156692|P3|Treatment Period|Poor/Non-compliance|0
35590|NCT01721746|156693|P2|Treatment Period|Poor/Non-compliance|0
35591|NCT01721746|156694|P1|Treatment Period|Poor/Non-compliance|1
35592|NCT01721746|156692|P3|Treatment Period|Maximum Clinical Benefit|3
35593|NCT01721746|156693|P2|Treatment Period|Maximum Clinical Benefit|0
35594|NCT01721746|156694|P1|Treatment Period|Maximum Clinical Benefit|1
35595|NCT01721746|156692|P3|Treatment Period|Subject Withdrew Consent|2
35596|NCT01721746|156693|P2|Treatment Period|Subject Withdrew Consent|0
35597|NCT01721746|156694|P1|Treatment Period|Subject Withdrew Consent|3
35598|NCT01721746|156692|P3|Treatment Period|Subject Request to Discontinue Treatment|6
35599|NCT01721746|156693|P2|Treatment Period|Subject Request to Discontinue Treatment|1
35600|NCT01721746|156694|P1|Treatment Period|Subject Request to Discontinue Treatment|19
35601|NCT01721746|156692|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
35602|NCT01721746|156693|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
35603|NCT01721746|156694|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
35604|NCT01721746|156692|P3|Treatment Period|Study Drug Toxicity|9
35605|NCT01721746|156693|P2|Treatment Period|Study Drug Toxicity|2
35606|NCT01721746|156694|P1|Treatment Period|Study Drug Toxicity|15
35607|NCT01721746|156692|P3|Treatment Period|Disease Progression|34
35608|NCT01721746|156693|P2|Treatment Period|Disease Progression|40
35609|NCT01721746|156694|P1|Treatment Period|Disease Progression|182
35610|NCT01721486|156734|P2|Overall Study|Physician Decision|1
35611|NCT01721486|156735|P1|Overall Study|Physician Decision|0
35612|NCT01721486|156734|P2|Overall Study|Protocol Violation|0
35613|NCT01721486|156735|P1|Overall Study|Protocol Violation|1
35614|NCT01721408|156756|P2|Overall Study|Does not meet entrance criteria|0
35615|NCT01721408|156757|P1|Overall Study|Does not meet entrance criteria|1
35616|NCT01721408|156756|P2|Overall Study|Lost to Follow-up|2
35617|NCT01721408|156757|P1|Overall Study|Lost to Follow-up|1
35618|NCT01721408|156756|P2|Overall Study|Other|3
35619|NCT01721408|156757|P1|Overall Study|Other|3
35620|NCT01721408|156756|P2|Overall Study|Protocol Violation|2
35621|NCT01721408|156757|P1|Overall Study|Protocol Violation|0
35622|NCT01721408|156756|P2|Overall Study|No longer willing to participate study|10
35623|NCT01721408|156757|P1|Overall Study|No longer willing to participate study|9
35624|NCT01721408|156756|P2|Overall Study|Insufficient clinical response|6
35625|NCT01721408|156757|P1|Overall Study|Insufficient clinical response|15
35626|NCT01721408|156756|P2|Overall Study|Death|0
35627|NCT01721408|156757|P1|Overall Study|Death|1
35628|NCT01721408|156756|P2|Overall Study|Adverse Event|1
35629|NCT01721408|156757|P1|Overall Study|Adverse Event|6
35630|NCT01721330|156773|P2|Overall Study|Withdrawal by Subject|1
35631|NCT01721330|156774|P1|Overall Study|Withdrawal by Subject|0
35632|NCT01721317|156782|P2|Overall Study|Withdrawal by Subject|1
35633|NCT01721317|156783|P1|Overall Study|Withdrawal by Subject|0
35634|NCT01721317|156782|P2|Overall Study|Physician Decision|1
35635|NCT01721317|156783|P1|Overall Study|Physician Decision|0
35636|NCT01721317|156782|P2|Overall Study|Study Closed / Terminated|2
35637|NCT01721317|156783|P1|Overall Study|Study Closed / Terminated|2
35638|NCT01721200|156862|P2|Overall Study|Lost to Follow-up|5
35639|NCT01721200|156863|P1|Overall Study|Lost to Follow-up|3
35640|NCT01721161|156888|P2|Overall Study|Not Specified|1
35641|NCT01721161|156889|P1|Overall Study|Not Specified|0
35642|NCT01721161|156888|P2|Overall Study|Withdrawal by Subject|1
35643|NCT01721161|156889|P1|Overall Study|Withdrawal by Subject|1
35644|NCT01721161|156888|P2|Overall Study|Lost to Follow-up|2
35645|NCT01721161|156889|P1|Overall Study|Lost to Follow-up|1
35646|NCT01721161|156888|P2|Overall Study|Adverse Event|3
35647|NCT01721161|156889|P1|Overall Study|Adverse Event|2
35648|NCT01721109|156912|P1|Extension Phase|Still on Study|35
35649|NCT01721109|156912|P1|Extension Phase|Non-Compliance with Study Drug|2
35650|NCT01721109|156912|P1|Main Phase|Non-Compliance with Study Drug|1
35651|NCT01721096|156927|P2|Overall Study|Other|0
35652|NCT01721096|156928|P1|Overall Study|Other|1
35653|NCT01721096|156927|P2|Overall Study|Lost to Follow-up|2
35654|NCT01721096|156928|P1|Overall Study|Lost to Follow-up|12
35655|NCT01721096|156927|P2|Overall Study|Physician Decision|0
35656|NCT01721096|156928|P1|Overall Study|Physician Decision|1
35657|NCT01721096|156927|P2|Overall Study|Withdrawal by Subject|0
35658|NCT01721096|156928|P1|Overall Study|Withdrawal by Subject|1
35659|NCT01721096|156927|P2|Overall Study|Death|8
35660|NCT01721096|156928|P1|Overall Study|Death|12
35661|NCT01721070|157077|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
35662|NCT01721057|157088|P7|Rescue Period|Lack of Efficacy|0
35663|NCT01721057|157089|P6|Rescue Period|Lack of Efficacy|0
35664|NCT01721057|157090|P5|Rescue Period|Lack of Efficacy|0
35665|NCT01721057|157091|P4|Rescue Period|Lack of Efficacy|2
35666|NCT01721057|157092|P3|Rescue Period|Lack of Efficacy|0
35667|NCT01721057|157093|P2|Rescue Period|Lack of Efficacy|0
35668|NCT01721057|157094|P1|Rescue Period|Lack of Efficacy|0
35669|NCT01721057|157088|P7|Rescue Period|Adverse Event|0
35670|NCT01721057|157089|P6|Rescue Period|Adverse Event|0
35671|NCT01721057|157090|P5|Rescue Period|Adverse Event|0
35672|NCT01721057|157091|P4|Rescue Period|Adverse Event|1
35673|NCT01721057|157092|P3|Rescue Period|Adverse Event|0
35674|NCT01721057|157093|P2|Rescue Period|Adverse Event|0
35675|NCT01721057|157094|P1|Rescue Period|Adverse Event|0
35676|NCT01721057|157088|P7|Treatment Period|Death|0
35677|NCT01721057|157089|P6|Treatment Period|Death|0
35678|NCT01721057|157090|P5|Treatment Period|Death|0
35679|NCT01721057|157091|P4|Treatment Period|Death|0
35680|NCT01721057|157092|P3|Treatment Period|Death|0
35681|NCT01721057|157093|P2|Treatment Period|Death|0
35682|NCT01721057|157094|P1|Treatment Period|Death|2
35683|NCT01721057|157088|P7|Treatment Period|Physician Decision|0
35684|NCT01721057|157089|P6|Treatment Period|Physician Decision|0
35685|NCT01721057|157090|P5|Treatment Period|Physician Decision|0
35686|NCT01721057|157091|P4|Treatment Period|Physician Decision|0
35687|NCT01721057|157092|P3|Treatment Period|Physician Decision|3
35688|NCT01721057|157093|P2|Treatment Period|Physician Decision|1
35689|NCT01721057|157094|P1|Treatment Period|Physician Decision|0
35690|NCT01721057|157088|P7|Treatment Period|Lost to Follow-up|0
35691|NCT01721057|157089|P6|Treatment Period|Lost to Follow-up|0
35692|NCT01721057|157090|P5|Treatment Period|Lost to Follow-up|0
35693|NCT01721057|157091|P4|Treatment Period|Lost to Follow-up|0
35694|NCT01721057|157092|P3|Treatment Period|Lost to Follow-up|0
35695|NCT01721057|157093|P2|Treatment Period|Lost to Follow-up|0
35696|NCT01721057|157094|P1|Treatment Period|Lost to Follow-up|1
35697|NCT01721057|157088|P7|Treatment Period|Lack of Efficacy|0
35698|NCT01721057|157089|P6|Treatment Period|Lack of Efficacy|0
35699|NCT01721057|157090|P5|Treatment Period|Lack of Efficacy|0
35700|NCT01721057|157091|P4|Treatment Period|Lack of Efficacy|0
35701|NCT01721057|157092|P3|Treatment Period|Lack of Efficacy|0
35702|NCT01721057|157093|P2|Treatment Period|Lack of Efficacy|3
35703|NCT01721057|157094|P1|Treatment Period|Lack of Efficacy|7
35704|NCT01721057|157088|P7|Treatment Period|Adverse Event|0
35705|NCT01721057|157089|P6|Treatment Period|Adverse Event|0
35706|NCT01721057|157090|P5|Treatment Period|Adverse Event|0
35707|NCT01721057|157091|P4|Treatment Period|Adverse Event|0
35708|NCT01721057|157092|P3|Treatment Period|Adverse Event|12
35709|NCT01721057|157093|P2|Treatment Period|Adverse Event|10
35710|NCT01721057|157094|P1|Treatment Period|Adverse Event|7
35711|NCT01721057|157088|P7|Treatment Period|Withdrawal by Subject|0
35712|NCT01721057|157089|P6|Treatment Period|Withdrawal by Subject|0
35713|NCT01721057|157090|P5|Treatment Period|Withdrawal by Subject|0
35714|NCT01721057|157091|P4|Treatment Period|Withdrawal by Subject|0
35715|NCT01721057|157092|P3|Treatment Period|Withdrawal by Subject|8
35716|NCT01721057|157093|P2|Treatment Period|Withdrawal by Subject|5
35717|NCT01721057|157094|P1|Treatment Period|Withdrawal by Subject|11
35718|NCT01721044|157167|P3|Treatment Period|Withdrawal by Subject|1
35719|NCT01721044|157168|P2|Treatment Period|Withdrawal by Subject|6
35720|NCT01721044|157169|P1|Treatment Period|Withdrawal by Subject|7
35721|NCT01721044|157167|P3|Treatment Period|Protocol Violation|0
35722|NCT01721044|157168|P2|Treatment Period|Protocol Violation|0
35723|NCT01721044|157169|P1|Treatment Period|Protocol Violation|1
35724|NCT01721044|157167|P3|Treatment Period|Physician Decision|2
35725|NCT01721044|157168|P2|Treatment Period|Physician Decision|0
35726|NCT01721044|157169|P1|Treatment Period|Physician Decision|1
35727|NCT01721044|157167|P3|Treatment Period|Lost to Follow-up|1
35728|NCT01721044|157168|P2|Treatment Period|Lost to Follow-up|0
35729|NCT01721044|157169|P1|Treatment Period|Lost to Follow-up|0
35730|NCT01721044|157167|P3|Treatment Period|Lack of Efficacy|4
35731|NCT01721044|157168|P2|Treatment Period|Lack of Efficacy|4
35732|NCT01721044|157169|P1|Treatment Period|Lack of Efficacy|16
35733|NCT01721044|157167|P3|Treatment Period|Death|1
35734|NCT01721044|157168|P2|Treatment Period|Death|0
35735|NCT01721044|157169|P1|Treatment Period|Death|0
35736|NCT01721044|157167|P3|Treatment Period|Adverse Event|10
35737|NCT01721044|157168|P2|Treatment Period|Adverse Event|7
35738|NCT01721044|157169|P1|Treatment Period|Adverse Event|7
35739|NCT01720797|157242|P2|Overall Study|Withdrawal by Subject|0
35740|NCT01720797|157243|P1|Overall Study|Withdrawal by Subject|3
35741|NCT01720602|157249|P1|Overall Study|Progressive disease on therapy|2
35742|NCT01720602|157249|P1|Overall Study|Adverse Event|3
35743|NCT01720446|157259|P4|Overall Study|Withdrawal by Subject|4
35744|NCT01720446|157260|P3|Overall Study|Withdrawal by Subject|4
35745|NCT01720446|157261|P2|Overall Study|Withdrawal by Subject|5
35746|NCT01720446|157262|P1|Overall Study|Withdrawal by Subject|2
35747|NCT01720446|157259|P4|Overall Study|Lost to Follow-up|16
35748|NCT01720446|157260|P3|Overall Study|Lost to Follow-up|16
35749|NCT01720446|157261|P2|Overall Study|Lost to Follow-up|6
35750|NCT01720446|157262|P1|Overall Study|Lost to Follow-up|12
35751|NCT01720043|157404|P1|Overall Study|Withdrawal by Subject|1
35752|NCT01719861|157408|P1|Cycle 2|Death|1
35753|NCT01719861|157408|P1|Cycle 1|Death|4
35754|NCT01719757|157416|P1|Overall Study|well controlled pain|27
35755|NCT01719757|157416|P1|Overall Study|Protocol Violation|1
35756|NCT01719757|157416|P1|Overall Study|Lost to Follow-up|20
35757|NCT01719757|157416|P1|Overall Study|Withdrawal by Subject|15
35758|NCT01719757|157416|P1|Overall Study|Adverse Event|38
35759|NCT01719224|157461|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
35760|NCT01719224|157462|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
35761|NCT01719172|157471|P1|Overall Study|Death|1
35762|NCT01719172|157471|P1|Overall Study|Lost to Follow-up|1
35763|NCT01719003|157485|P9|Overall Study|Lack of Efficacy|0
35764|NCT01719003|157486|P8|Overall Study|Lack of Efficacy|0
35765|NCT01719003|157487|P7|Overall Study|Lack of Efficacy|1
35766|NCT01719003|157488|P6|Overall Study|Lack of Efficacy|0
35767|NCT01719003|157489|P5|Overall Study|Lack of Efficacy|0
35768|NCT01719003|157490|P4|Overall Study|Lack of Efficacy|0
35769|NCT01719003|157491|P3|Overall Study|Lack of Efficacy|0
35770|NCT01719003|157492|P2|Overall Study|Lack of Efficacy|0
35771|NCT01719003|157493|P1|Overall Study|Lack of Efficacy|0
35772|NCT01719003|157485|P9|Overall Study|Reason other than those specified|1
35773|NCT01719003|157486|P8|Overall Study|Reason other than those specified|3
35774|NCT01719003|157487|P7|Overall Study|Reason other than those specified|0
35775|NCT01719003|157488|P6|Overall Study|Reason other than those specified|1
35776|NCT01719003|157489|P5|Overall Study|Reason other than those specified|4
35777|NCT01719003|157490|P4|Overall Study|Reason other than those specified|3
35778|NCT01719003|157491|P3|Overall Study|Reason other than those specified|2
35779|NCT01719003|157492|P2|Overall Study|Reason other than those specified|0
35780|NCT01719003|157493|P1|Overall Study|Reason other than those specified|0
35781|NCT01719003|157485|P9|Overall Study|Refusal to continue, not due to AE|1
35782|NCT01719003|157486|P8|Overall Study|Refusal to continue, not due to AE|7
35783|NCT01719003|157487|P7|Overall Study|Refusal to continue, not due to AE|8
35784|NCT01719003|157488|P6|Overall Study|Refusal to continue, not due to AE|3
35785|NCT01719003|157489|P5|Overall Study|Refusal to continue, not due to AE|4
35786|NCT01719003|157490|P4|Overall Study|Refusal to continue, not due to AE|4
35787|NCT01719003|157491|P3|Overall Study|Refusal to continue, not due to AE|4
35788|NCT01719003|157492|P2|Overall Study|Refusal to continue, not due to AE|5
35789|NCT01719003|157493|P1|Overall Study|Refusal to continue, not due to AE|2
35790|NCT01719003|157485|P9|Overall Study|Lost to Follow-up|2
35791|NCT01719003|157486|P8|Overall Study|Lost to Follow-up|2
35792|NCT01719003|157487|P7|Overall Study|Lost to Follow-up|3
35793|NCT01719003|157488|P6|Overall Study|Lost to Follow-up|4
35794|NCT01719003|157489|P5|Overall Study|Lost to Follow-up|3
35795|NCT01719003|157490|P4|Overall Study|Lost to Follow-up|2
35796|NCT01719003|157491|P3|Overall Study|Lost to Follow-up|7
35797|NCT01719003|157492|P2|Overall Study|Lost to Follow-up|6
35798|NCT01719003|157493|P1|Overall Study|Lost to Follow-up|0
35799|NCT01719003|157485|P9|Overall Study|Adverse Event|0
35800|NCT01719003|157486|P8|Overall Study|Adverse Event|5
35801|NCT01719003|157487|P7|Overall Study|Adverse Event|6
35802|NCT01719003|157488|P6|Overall Study|Adverse Event|3
35803|NCT01719003|157489|P5|Overall Study|Adverse Event|4
35804|NCT01719003|157490|P4|Overall Study|Adverse Event|3
35805|NCT01719003|157491|P3|Overall Study|Adverse Event|4
35806|NCT01719003|157492|P2|Overall Study|Adverse Event|5
35807|NCT01719003|157493|P1|Overall Study|Adverse Event|6
35808|NCT01719003|157485|P9|Overall Study|Non compliant with protocol|0
35809|NCT01719003|157486|P8|Overall Study|Non compliant with protocol|3
35810|NCT01719003|157487|P7|Overall Study|Non compliant with protocol|2
35811|NCT01719003|157488|P6|Overall Study|Non compliant with protocol|1
35812|NCT01719003|157489|P5|Overall Study|Non compliant with protocol|2
35813|NCT01719003|157490|P4|Overall Study|Non compliant with protocol|1
35814|NCT01719003|157491|P3|Overall Study|Non compliant with protocol|0
35815|NCT01719003|157492|P2|Overall Study|Non compliant with protocol|1
35816|NCT01719003|157493|P1|Overall Study|Non compliant with protocol|1
35817|NCT01718535|157574|P10|Overall Study|Bidirectional Sequencing not possible|0
35818|NCT01718535|157575|P9|Overall Study|Bidirectional Sequencing not possible|0
35819|NCT01718535|157576|P8|Overall Study|Bidirectional Sequencing not possible|0
35820|NCT01718535|157577|P7|Overall Study|Bidirectional Sequencing not possible|0
35821|NCT01718535|157578|P6|Overall Study|Bidirectional Sequencing not possible|0
35822|NCT01718535|157579|P5|Overall Study|Bidirectional Sequencing not possible|0
35823|NCT01718535|157580|P4|Overall Study|Bidirectional Sequencing not possible|1
35824|NCT01718535|157581|P3|Overall Study|Bidirectional Sequencing not possible|0
35825|NCT01718535|157582|P2|Overall Study|Bidirectional Sequencing not possible|0
35826|NCT01718535|157583|P1|Overall Study|Bidirectional Sequencing not possible|1
35827|NCT01718509|157607|P2|Overall Study|Lack of Efficacy|0
35828|NCT01718509|157608|P1|Overall Study|Lack of Efficacy|1
35829|NCT01718509|157607|P2|Overall Study|Protocol Violation|2
35830|NCT01718509|157608|P1|Overall Study|Protocol Violation|4
35831|NCT01718509|157607|P2|Overall Study|Not specified|11
35832|NCT01718509|157608|P1|Overall Study|Not specified|13
35833|NCT01718509|157607|P2|Overall Study|Adverse Event|7
35834|NCT01718509|157608|P1|Overall Study|Adverse Event|5
35835|NCT01718509|157607|P2|Overall Study|Withdrawal by Subject|13
35836|NCT01718509|157608|P1|Overall Study|Withdrawal by Subject|7
35837|NCT01718509|157607|P2|Overall Study|Lost to Follow-up|15
35838|NCT01718509|157608|P1|Overall Study|Lost to Follow-up|18
35839|NCT01718483|157654|P2|Overall Study|Lack of Efficacy|0
35840|NCT01718483|157655|P1|Overall Study|Lack of Efficacy|1
35841|NCT01718483|157654|P2|Overall Study|Pregnancy|1
35842|NCT01718483|157655|P1|Overall Study|Pregnancy|1
35843|NCT01718483|157654|P2|Overall Study|Not specified|4
35844|NCT01718483|157655|P1|Overall Study|Not specified|1
35845|NCT01718483|157654|P2|Overall Study|Protocol Violation|2
35846|NCT01718483|157655|P1|Overall Study|Protocol Violation|4
35847|NCT01718483|157654|P2|Overall Study|Lost to Follow-up|3
35848|NCT01718483|157655|P1|Overall Study|Lost to Follow-up|8
35849|NCT01718483|157654|P2|Overall Study|Adverse Event|12
35850|NCT01718483|157655|P1|Overall Study|Adverse Event|5
35851|NCT01718483|157654|P2|Overall Study|Withdrawal by Subject|12
35852|NCT01718483|157655|P1|Overall Study|Withdrawal by Subject|14
35853|NCT01718353|157701|P2|Overall Study|Randomized but not treated|0
35854|NCT01718353|157702|P1|Overall Study|Randomized but not treated|2
35855|NCT01718353|157701|P2|Overall Study|Principal Investigator's Decision|4
35856|NCT01718353|157702|P1|Overall Study|Principal Investigator's Decision|10
35857|NCT01718353|157701|P2|Overall Study|Lost to Follow-up|1
35858|NCT01718353|157702|P1|Overall Study|Lost to Follow-up|0
35859|NCT01717989|157733|P1|Overall Study|Other|40
35860|NCT01717989|157733|P1|Overall Study|Protocol-specified criteria|551
35861|NCT01717989|157733|P1|Overall Study|Death|439
35862|NCT01717989|157733|P1|Overall Study|Lost to Follow-up|11
35863|NCT01717989|157733|P1|Overall Study|Physician Decision|2
35864|NCT01717989|157733|P1|Overall Study|Withdrawal by Subject|11
35865|NCT01717989|157733|P1|Overall Study|Protocol deviation|6
35866|NCT01717989|157733|P1|Overall Study|Ineligibility determined|6
35867|NCT01717976|157801|P2|Overall Study|Protocol Violation|1
35868|NCT01717976|157802|P1|Overall Study|Protocol Violation|0
35869|NCT01717768|157867|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35870|NCT01717768|157868|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35871|NCT01717768|157869|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
35872|NCT01717768|157870|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35873|NCT01717768|157871|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35874|NCT01717768|157872|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35875|NCT01717768|157873|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35876|NCT01717768|157874|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35877|NCT01717768|157875|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35878|NCT01717768|157876|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35879|NCT01717768|157877|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35880|NCT01717768|157878|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
35881|NCT01717768|157867|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35882|NCT01717768|157868|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35883|NCT01717768|157869|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35884|NCT01717768|157870|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35885|NCT01717768|157871|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
35886|NCT01717768|157872|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35887|NCT01717768|157873|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35888|NCT01717768|157874|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35889|NCT01717768|157875|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35890|NCT01717768|157876|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35891|NCT01717768|157877|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35892|NCT01717768|157878|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
35893|NCT01717768|157867|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
35894|NCT01717768|157868|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35895|NCT01717768|157869|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35896|NCT01717768|157870|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35897|NCT01717768|157871|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35898|NCT01717768|157872|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35899|NCT01717768|157873|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35900|NCT01717768|157874|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35901|NCT01717768|157875|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35902|NCT01717768|157876|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35903|NCT01717768|157877|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35904|NCT01717768|157878|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
35905|NCT01717768|157867|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35906|NCT01717768|157868|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35907|NCT01717768|157869|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35908|NCT01717768|157870|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35909|NCT01717768|157871|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35910|NCT01717768|157872|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35911|NCT01717768|157873|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35912|NCT01717768|157874|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35913|NCT01717768|157875|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35914|NCT01717768|157876|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35915|NCT01717768|157877|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
35916|NCT01717768|157878|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
35917|NCT01717638|157929|P13|Overall Study|Withdrawal by Subject|18
35918|NCT01717638|157930|P12|Overall Study|Withdrawal by Subject|0
35919|NCT01717638|157931|P11|Overall Study|Withdrawal by Subject|0
35920|NCT01717638|157932|P10|Overall Study|Withdrawal by Subject|1
35921|NCT01717638|157933|P9|Overall Study|Withdrawal by Subject|2
35922|NCT01717638|157934|P8|Overall Study|Withdrawal by Subject|1
35923|NCT01717638|157935|P7|Overall Study|Withdrawal by Subject|2
35924|NCT01717638|157936|P6|Overall Study|Withdrawal by Subject|0
35925|NCT01717638|157937|P5|Overall Study|Withdrawal by Subject|1
35926|NCT01717638|157938|P4|Overall Study|Withdrawal by Subject|0
35927|NCT01717638|157939|P3|Overall Study|Withdrawal by Subject|1
35928|NCT01717638|157940|P2|Overall Study|Withdrawal by Subject|1
35929|NCT01717638|157941|P1|Overall Study|Withdrawal by Subject|0
35930|NCT01717638|157929|P13|Overall Study|Father in hospital|1
35931|NCT01717638|157930|P12|Overall Study|Father in hospital|0
35932|NCT01717638|157931|P11|Overall Study|Father in hospital|0
35933|NCT01717638|157932|P10|Overall Study|Father in hospital|0
35934|NCT01717638|157933|P9|Overall Study|Father in hospital|0
35935|NCT01717638|157934|P8|Overall Study|Father in hospital|0
35936|NCT01717638|157935|P7|Overall Study|Father in hospital|0
35937|NCT01717638|157936|P6|Overall Study|Father in hospital|0
35938|NCT01717638|157937|P5|Overall Study|Father in hospital|0
35939|NCT01717638|157938|P4|Overall Study|Father in hospital|0
35940|NCT01717638|157939|P3|Overall Study|Father in hospital|0
35941|NCT01717638|157940|P2|Overall Study|Father in hospital|0
35942|NCT01717638|157941|P1|Overall Study|Father in hospital|0
35943|NCT01717638|157929|P13|Overall Study|Lost to Follow-up|0
35944|NCT01717638|157930|P12|Overall Study|Lost to Follow-up|0
35945|NCT01717638|157931|P11|Overall Study|Lost to Follow-up|0
35946|NCT01717638|157932|P10|Overall Study|Lost to Follow-up|0
35947|NCT01717638|157933|P9|Overall Study|Lost to Follow-up|0
35948|NCT01717638|157934|P8|Overall Study|Lost to Follow-up|0
35949|NCT01717638|157935|P7|Overall Study|Lost to Follow-up|0
35950|NCT01717638|157936|P6|Overall Study|Lost to Follow-up|1
35951|NCT01717638|157937|P5|Overall Study|Lost to Follow-up|0
35952|NCT01717638|157938|P4|Overall Study|Lost to Follow-up|0
35953|NCT01717638|157939|P3|Overall Study|Lost to Follow-up|0
35954|NCT01717638|157940|P2|Overall Study|Lost to Follow-up|0
35955|NCT01717638|157941|P1|Overall Study|Lost to Follow-up|0
35956|NCT01717456|158085|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
35957|NCT01717456|158086|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
35958|NCT01717456|158085|P2|End of Treatment|Lost to Follow-up|1
35959|NCT01717456|158086|P1|End of Treatment|Lost to Follow-up|0
35960|NCT01717456|158085|P2|End of Treatment|Physician Decision|1
35961|NCT01717456|158086|P1|End of Treatment|Physician Decision|0
35962|NCT01717391|158154|P1|Overall Study|FLT technical failure|3
35963|NCT01717391|158154|P1|Overall Study|Physician Decision|1
35964|NCT01717391|158154|P1|Overall Study|Withdrawal by Subject|5
35965|NCT01717326|158183|P20|Overall Study|Withdrawal by Subject|3
35966|NCT01717326|158184|P19|Overall Study|Withdrawal by Subject|2
35967|NCT01717326|158185|P18|Overall Study|Withdrawal by Subject|0
35968|NCT01717326|158186|P17|Overall Study|Withdrawal by Subject|0
35969|NCT01717326|158187|P16|Overall Study|Withdrawal by Subject|1
35970|NCT01717326|158188|P15|Overall Study|Withdrawal by Subject|0
35971|NCT01717326|158189|P14|Overall Study|Withdrawal by Subject|0
35972|NCT01717326|158190|P13|Overall Study|Withdrawal by Subject|1
35973|NCT01717326|158191|P12|Overall Study|Withdrawal by Subject|0
35974|NCT01717326|158192|P11|Overall Study|Withdrawal by Subject|0
35975|NCT01717326|158193|P10|Overall Study|Withdrawal by Subject|1
35976|NCT01717326|158194|P9|Overall Study|Withdrawal by Subject|0
35977|NCT01717326|158195|P8|Overall Study|Withdrawal by Subject|0
35978|NCT01717326|158196|P7|Overall Study|Withdrawal by Subject|0
35979|NCT01717326|158197|P6|Overall Study|Withdrawal by Subject|0
35980|NCT01717326|158198|P5|Overall Study|Withdrawal by Subject|0
35981|NCT01717326|158199|P4|Overall Study|Withdrawal by Subject|0
35982|NCT01717326|158200|P3|Overall Study|Withdrawal by Subject|0
35983|NCT01717326|158201|P2|Overall Study|Withdrawal by Subject|1
35984|NCT01717326|158202|P1|Overall Study|Withdrawal by Subject|0
35985|NCT01717326|158183|P20|Overall Study|Protocol Violation|0
35986|NCT01717326|158184|P19|Overall Study|Protocol Violation|0
35987|NCT01717326|158185|P18|Overall Study|Protocol Violation|0
35988|NCT01717326|158186|P17|Overall Study|Protocol Violation|0
35989|NCT01717326|158187|P16|Overall Study|Protocol Violation|0
35990|NCT01717326|158188|P15|Overall Study|Protocol Violation|0
35991|NCT01717326|158189|P14|Overall Study|Protocol Violation|0
35992|NCT01717326|158190|P13|Overall Study|Protocol Violation|0
35993|NCT01717326|158191|P12|Overall Study|Protocol Violation|0
35994|NCT01717326|158192|P11|Overall Study|Protocol Violation|0
35995|NCT01717326|158193|P10|Overall Study|Protocol Violation|0
35996|NCT01717326|158194|P9|Overall Study|Protocol Violation|0
35997|NCT01717326|158195|P8|Overall Study|Protocol Violation|0
35998|NCT01717326|158196|P7|Overall Study|Protocol Violation|0
35999|NCT01717326|158197|P6|Overall Study|Protocol Violation|0
36000|NCT01717326|158198|P5|Overall Study|Protocol Violation|1
36001|NCT01717326|158199|P4|Overall Study|Protocol Violation|0
36002|NCT01717326|158200|P3|Overall Study|Protocol Violation|0
36003|NCT01717326|158201|P2|Overall Study|Protocol Violation|0
36004|NCT01717326|158202|P1|Overall Study|Protocol Violation|0
36005|NCT01717326|158183|P20|Overall Study|Physician Decision|0
36006|NCT01717326|158184|P19|Overall Study|Physician Decision|0
36007|NCT01717326|158185|P18|Overall Study|Physician Decision|0
36008|NCT01717326|158186|P17|Overall Study|Physician Decision|0
36009|NCT01717326|158187|P16|Overall Study|Physician Decision|0
36010|NCT01717326|158188|P15|Overall Study|Physician Decision|0
36011|NCT01717326|158189|P14|Overall Study|Physician Decision|0
36012|NCT01717326|158190|P13|Overall Study|Physician Decision|0
36013|NCT01717326|158191|P12|Overall Study|Physician Decision|0
36014|NCT01717326|158192|P11|Overall Study|Physician Decision|0
36015|NCT01717326|158193|P10|Overall Study|Physician Decision|1
36016|NCT01717326|158194|P9|Overall Study|Physician Decision|0
36017|NCT01717326|158195|P8|Overall Study|Physician Decision|0
36018|NCT01717326|158196|P7|Overall Study|Physician Decision|0
36019|NCT01717326|158197|P6|Overall Study|Physician Decision|0
36020|NCT01717326|158198|P5|Overall Study|Physician Decision|0
36021|NCT01717326|158199|P4|Overall Study|Physician Decision|0
36022|NCT01717326|158200|P3|Overall Study|Physician Decision|0
36023|NCT01717326|158201|P2|Overall Study|Physician Decision|0
36024|NCT01717326|158202|P1|Overall Study|Physician Decision|0
36025|NCT01717326|158183|P20|Overall Study|Lost to Follow-up|3
36026|NCT01717326|158184|P19|Overall Study|Lost to Follow-up|2
36027|NCT01717326|158185|P18|Overall Study|Lost to Follow-up|0
36028|NCT01717326|158186|P17|Overall Study|Lost to Follow-up|1
36029|NCT01717326|158187|P16|Overall Study|Lost to Follow-up|2
36030|NCT01717326|158188|P15|Overall Study|Lost to Follow-up|0
36031|NCT01717326|158189|P14|Overall Study|Lost to Follow-up|0
36032|NCT01717326|158190|P13|Overall Study|Lost to Follow-up|0
36033|NCT01717326|158191|P12|Overall Study|Lost to Follow-up|0
36034|NCT01717326|158192|P11|Overall Study|Lost to Follow-up|1
36035|NCT01717326|158193|P10|Overall Study|Lost to Follow-up|0
36036|NCT01717326|158194|P9|Overall Study|Lost to Follow-up|0
36037|NCT01717326|158195|P8|Overall Study|Lost to Follow-up|0
36038|NCT01717326|158196|P7|Overall Study|Lost to Follow-up|1
36039|NCT01717326|158197|P6|Overall Study|Lost to Follow-up|0
36040|NCT01717326|158198|P5|Overall Study|Lost to Follow-up|1
36041|NCT01717326|158199|P4|Overall Study|Lost to Follow-up|2
36042|NCT01717326|158200|P3|Overall Study|Lost to Follow-up|0
36043|NCT01717326|158201|P2|Overall Study|Lost to Follow-up|0
36044|NCT01717326|158202|P1|Overall Study|Lost to Follow-up|3
36045|NCT01717326|158183|P20|Overall Study|Death|0
36046|NCT01717326|158184|P19|Overall Study|Death|0
36047|NCT01717326|158185|P18|Overall Study|Death|0
36048|NCT01717326|158186|P17|Overall Study|Death|0
36049|NCT01717326|158187|P16|Overall Study|Death|0
36050|NCT01717326|158188|P15|Overall Study|Death|0
36051|NCT01717326|158189|P14|Overall Study|Death|0
36052|NCT01717326|158190|P13|Overall Study|Death|0
36053|NCT01717326|158191|P12|Overall Study|Death|0
36054|NCT01717326|158192|P11|Overall Study|Death|1
36055|NCT01717326|158193|P10|Overall Study|Death|0
36056|NCT01717326|158194|P9|Overall Study|Death|0
36057|NCT01717326|158195|P8|Overall Study|Death|0
36058|NCT01717326|158196|P7|Overall Study|Death|0
36059|NCT01717326|158197|P6|Overall Study|Death|0
36060|NCT01717326|158198|P5|Overall Study|Death|0
36061|NCT01717326|158199|P4|Overall Study|Death|0
36062|NCT01717326|158200|P3|Overall Study|Death|0
36063|NCT01717326|158201|P2|Overall Study|Death|0
36064|NCT01717326|158202|P1|Overall Study|Death|0
36065|NCT01717313|158466|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
36066|NCT01717313|158467|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
36067|NCT01717313|158466|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
36068|NCT01717313|158467|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
36069|NCT01717313|158466|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
36070|NCT01717313|158467|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
36071|NCT01717313|158466|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
36072|NCT01717313|158467|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
36073|NCT01717313|158466|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
36074|NCT01717313|158467|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
36075|NCT01717313|158466|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
36076|NCT01717313|158467|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
36077|NCT01717313|158466|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
36078|NCT01717313|158467|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
36079|NCT01717313|158466|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
36080|NCT01717313|158467|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
36081|NCT01717313|158466|P2|Phase A (Weeks 0 to 24)|Death|1
36082|NCT01717313|158467|P1|Phase A (Weeks 0 to 24)|Death|0
36083|NCT01717287|158505|P2|Overall Study|Protocol Violation|1
36084|NCT01717287|158506|P1|Overall Study|Protocol Violation|0
36085|NCT01717287|158505|P2|Overall Study|Lost to Follow-up|2
36086|NCT01717287|158506|P1|Overall Study|Lost to Follow-up|0
36087|NCT01717040|158539|P2|Overall Study|New Substance Use Disorder|0
36088|NCT01717040|158540|P1|Overall Study|New Substance Use Disorder|1
36089|NCT01717040|158539|P2|Overall Study|Required Medication Change|1
36090|NCT01717040|158540|P1|Overall Study|Required Medication Change|0
36091|NCT01717040|158539|P2|Overall Study|Adverse Event|0
36092|NCT01717040|158540|P1|Overall Study|Adverse Event|1
36093|NCT01717040|158539|P2|Overall Study|Lack of Efficacy|1
36094|NCT01717040|158540|P1|Overall Study|Lack of Efficacy|1
36095|NCT01717040|158539|P2|Overall Study|Lost to Follow-up|3
36096|NCT01717040|158540|P1|Overall Study|Lost to Follow-up|2
36097|NCT01716754|158558|P4|Overall Study|Withdrawal by Subject|3
36098|NCT01716754|158559|P3|Overall Study|Withdrawal by Subject|4
36099|NCT01716754|158560|P2|Overall Study|Withdrawal by Subject|0
36100|NCT01716754|158561|P1|Overall Study|Withdrawal by Subject|5
36101|NCT01716754|158558|P4|Overall Study|Adverse Event|1
36102|NCT01716754|158559|P3|Overall Study|Adverse Event|2
36103|NCT01716754|158560|P2|Overall Study|Adverse Event|2
36104|NCT01716754|158561|P1|Overall Study|Adverse Event|4
36105|NCT01716754|158558|P4|Overall Study|Lost to Follow-up|1
36106|NCT01716754|158559|P3|Overall Study|Lost to Follow-up|0
36107|NCT01716754|158560|P2|Overall Study|Lost to Follow-up|0
36108|NCT01716754|158561|P1|Overall Study|Lost to Follow-up|1
36109|NCT01716754|158558|P4|Overall Study|Physician Decision|0
36110|NCT01716754|158559|P3|Overall Study|Physician Decision|0
36111|NCT01716754|158560|P2|Overall Study|Physician Decision|0
36112|NCT01716754|158561|P1|Overall Study|Physician Decision|1
36113|NCT01716754|158558|P4|Overall Study|Non-compliance with study treatment|0
36114|NCT01716754|158559|P3|Overall Study|Non-compliance with study treatment|1
36115|NCT01716754|158560|P2|Overall Study|Non-compliance with study treatment|0
36116|NCT01716754|158561|P1|Overall Study|Non-compliance with study treatment|0
36117|NCT01716754|158558|P4|Overall Study|Protocol deviation|2
36118|NCT01716754|158559|P3|Overall Study|Protocol deviation|7
36119|NCT01716754|158560|P2|Overall Study|Protocol deviation|2
36120|NCT01716754|158561|P1|Overall Study|Protocol deviation|0
36121|NCT01716754|158558|P4|Overall Study|Death|1
36122|NCT01716754|158559|P3|Overall Study|Death|0
36123|NCT01716754|158560|P2|Overall Study|Death|0
36124|NCT01716754|158561|P1|Overall Study|Death|0
36125|NCT01716663|158582|P1|Overall Study|Treated with non-study catheter|2
36126|NCT01716663|158582|P1|Overall Study|Withdrawn prior to procedure|4
36127|NCT01716585|158592|P2|Open-label Treatment|Withdrawal by Subject|3
36128|NCT01716585|158593|P1|Open-label Treatment|Withdrawal by Subject|0
36129|NCT01716585|158592|P2|Open-label Treatment|Virologic Failure|2
36130|NCT01716585|158593|P1|Open-label Treatment|Virologic Failure|0
36131|NCT01716585|158592|P2|Open-label Treatment|Adverse Event|2
36132|NCT01716585|158593|P1|Open-label Treatment|Adverse Event|0
36133|NCT01716585|158592|P2|Double-blind Treatment|Not Specified|0
36134|NCT01716585|158593|P1|Double-blind Treatment|Not Specified|1
36135|NCT01716585|158592|P2|Double-blind Treatment|Subject Noncompliant|0
36136|NCT01716585|158593|P1|Double-blind Treatment|Subject Noncompliant|1
36137|NCT01716585|158592|P2|Double-blind Treatment|Lost to Follow-up|0
36138|NCT01716585|158593|P1|Double-blind Treatment|Lost to Follow-up|2
36139|NCT01716585|158592|P2|Double-blind Treatment|Withdrawal by Subject|0
36140|NCT01716585|158593|P1|Double-blind Treatment|Withdrawal by Subject|3
36141|NCT01716585|158592|P2|Double-blind Treatment|Adverse Event|1
36142|NCT01716585|158593|P1|Double-blind Treatment|Adverse Event|2
36143|NCT01716585|158592|P2|Double-blind Treatment|Did Not Receive Study Drug|1
36144|NCT01716585|158593|P1|Double-blind Treatment|Did Not Receive Study Drug|4
36145|NCT01716559|158605|P1|Overall Study|Other withdrawal reason|75
36146|NCT01716559|158605|P1|Overall Study|Withdrawal by Subject|4
36147|NCT01716559|158605|P1|Overall Study|Death|21
36148|NCT01716559|158605|P1|Overall Study|Adverse Event|11
36149|NCT01716520|158613|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
36150|NCT01716520|158614|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
36151|NCT01716520|158615|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
36152|NCT01716520|158616|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
36153|NCT01716520|158617|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
36154|NCT01716520|158618|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
36155|NCT01716520|158613|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
36156|NCT01716520|158614|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
36157|NCT01716520|158615|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
36158|NCT01716520|158616|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
36159|NCT01716520|158617|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
36160|NCT01716520|158618|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
36161|NCT01716520|158613|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
36162|NCT01716520|158614|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
36163|NCT01716520|158615|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
36164|NCT01716520|158616|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
36165|NCT01716520|158617|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
36166|NCT01716520|158618|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
36167|NCT01716520|158613|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
36168|NCT01716520|158614|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
36169|NCT01716520|158615|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
36170|NCT01716520|158616|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
36171|NCT01716520|158617|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
36172|NCT01716520|158618|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
36173|NCT01716520|158613|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
36174|NCT01716520|158614|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
36175|NCT01716520|158615|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
36176|NCT01716520|158616|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
36177|NCT01716520|158617|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
36178|NCT01716520|158618|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
36179|NCT01716520|158613|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
36180|NCT01716520|158614|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
36181|NCT01716520|158615|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
36182|NCT01716520|158616|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
36183|NCT01716520|158617|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
36184|NCT01716520|158618|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
36185|NCT01716520|158613|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
36186|NCT01716520|158614|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
36187|NCT01716520|158615|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
36188|NCT01716520|158616|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
36189|NCT01716520|158617|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
36190|NCT01716520|158618|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
36191|NCT01716520|158613|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
36192|NCT01716520|158614|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
36193|NCT01716520|158615|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
36194|NCT01716520|158616|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
36195|NCT01716520|158617|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
36196|NCT01716520|158618|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
36197|NCT01716520|158613|P6|Treatment Period 2 (14 Days)|Adverse Event|0
36198|NCT01716520|158614|P5|Treatment Period 2 (14 Days)|Adverse Event|1
36199|NCT01716520|158615|P4|Treatment Period 2 (14 Days)|Adverse Event|0
36200|NCT01716520|158616|P3|Treatment Period 2 (14 Days)|Adverse Event|0
36201|NCT01716520|158617|P2|Treatment Period 2 (14 Days)|Adverse Event|0
36202|NCT01716520|158618|P1|Treatment Period 2 (14 Days)|Adverse Event|0
36203|NCT01716520|158613|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
36204|NCT01716520|158614|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
36205|NCT01716520|158615|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
36206|NCT01716520|158616|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
36207|NCT01716520|158617|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
36208|NCT01716520|158618|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
36209|NCT01716520|158613|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
36210|NCT01716520|158614|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
36211|NCT01716520|158615|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
36212|NCT01716520|158616|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
36213|NCT01716520|158617|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
36214|NCT01716520|158618|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
36215|NCT01716520|158613|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
36216|NCT01716520|158614|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
36217|NCT01716520|158615|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
36218|NCT01716520|158616|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
36219|NCT01716520|158617|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
36220|NCT01716520|158618|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
36221|NCT01716520|158613|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
36222|NCT01716520|158614|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
36223|NCT01716520|158615|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
36224|NCT01716520|158616|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
36225|NCT01716520|158617|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
36226|NCT01716520|158618|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
36227|NCT01716520|158613|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
36228|NCT01716520|158614|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
36229|NCT01716520|158615|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
36230|NCT01716520|158616|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
36231|NCT01716520|158617|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
36232|NCT01716520|158618|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
36233|NCT01716520|158613|P6|Treatment Period 1 (14 Days)|Adverse Event|0
36234|NCT01716520|158614|P5|Treatment Period 1 (14 Days)|Adverse Event|0
36235|NCT01716520|158615|P4|Treatment Period 1 (14 Days)|Adverse Event|0
36236|NCT01716520|158616|P3|Treatment Period 1 (14 Days)|Adverse Event|0
36237|NCT01716520|158617|P2|Treatment Period 1 (14 Days)|Adverse Event|0
36238|NCT01716520|158618|P1|Treatment Period 1 (14 Days)|Adverse Event|1
36239|NCT01716234|158673|P7|Overall Study|Withdrawal by Subject|0
36240|NCT01716234|158674|P6|Overall Study|Withdrawal by Subject|3
36241|NCT01716234|158675|P5|Overall Study|Withdrawal by Subject|1
36242|NCT01716234|158676|P4|Overall Study|Withdrawal by Subject|2
36243|NCT01716234|158677|P3|Overall Study|Withdrawal by Subject|2
36244|NCT01716234|158678|P2|Overall Study|Withdrawal by Subject|0
36245|NCT01716234|158679|P1|Overall Study|Withdrawal by Subject|3
36246|NCT01716234|158673|P7|Overall Study|Adverse Event|0
36247|NCT01716234|158674|P6|Overall Study|Adverse Event|6
36248|NCT01716234|158675|P5|Overall Study|Adverse Event|3
36249|NCT01716234|158676|P4|Overall Study|Adverse Event|8
36250|NCT01716234|158677|P3|Overall Study|Adverse Event|2
36251|NCT01716234|158678|P2|Overall Study|Adverse Event|10
36252|NCT01716234|158679|P1|Overall Study|Adverse Event|7
36253|NCT01716234|158673|P7|Overall Study|Did not meet protocol eligibility|0
36254|NCT01716234|158674|P6|Overall Study|Did not meet protocol eligibility|4
36255|NCT01716234|158675|P5|Overall Study|Did not meet protocol eligibility|0
36256|NCT01716234|158676|P4|Overall Study|Did not meet protocol eligibility|0
36257|NCT01716234|158677|P3|Overall Study|Did not meet protocol eligibility|1
36258|NCT01716234|158678|P2|Overall Study|Did not meet protocol eligibility|0
36259|NCT01716234|158679|P1|Overall Study|Did not meet protocol eligibility|0
36260|NCT01716234|158673|P7|Overall Study|Lack of Efficacy|0
36261|NCT01716234|158674|P6|Overall Study|Lack of Efficacy|0
36262|NCT01716234|158675|P5|Overall Study|Lack of Efficacy|0
36263|NCT01716234|158676|P4|Overall Study|Lack of Efficacy|1
36264|NCT01716234|158677|P3|Overall Study|Lack of Efficacy|0
36265|NCT01716234|158678|P2|Overall Study|Lack of Efficacy|0
36266|NCT01716234|158679|P1|Overall Study|Lack of Efficacy|0
36267|NCT01716234|158673|P7|Overall Study|Protocol Violation|0
36268|NCT01716234|158674|P6|Overall Study|Protocol Violation|1
36269|NCT01716234|158675|P5|Overall Study|Protocol Violation|1
36270|NCT01716234|158676|P4|Overall Study|Protocol Violation|1
36271|NCT01716234|158677|P3|Overall Study|Protocol Violation|0
36272|NCT01716234|158678|P2|Overall Study|Protocol Violation|0
36273|NCT01716234|158679|P1|Overall Study|Protocol Violation|0
36274|NCT01716169|158742|P1|Overall Study|inconsistent dressing application|1
36275|NCT01716169|158742|P1|Overall Study|Withdrawal by Subject|1
36276|NCT01716169|158742|P1|Overall Study|Lost to Follow-up|1
36277|NCT01716169|158742|P1|Overall Study|Adverse Event|1
36278|NCT01716156|158751|P3|Overall Study|Lost to Follow-up|0
36279|NCT01716156|158752|P2|Overall Study|Lost to Follow-up|0
36280|NCT01716156|158753|P1|Overall Study|Lost to Follow-up|1
36281|NCT01716156|158751|P3|Overall Study|Withdrawal by Subject|2
36282|NCT01716156|158752|P2|Overall Study|Withdrawal by Subject|1
36283|NCT01716156|158753|P1|Overall Study|Withdrawal by Subject|0
36284|NCT01716156|158751|P3|Overall Study|Protocol Violation|0
36285|NCT01716156|158752|P2|Overall Study|Protocol Violation|0
36286|NCT01716156|158753|P1|Overall Study|Protocol Violation|1
36287|NCT01716052|158779|P2|Overall Study|Withdrawal of funding|1
36288|NCT01716052|158780|P1|Overall Study|Withdrawal of funding|1
36289|NCT01715896|158822|P2|Overall Study|Other|5
36290|NCT01715896|158823|P1|Overall Study|Other|2
36291|NCT01715896|158822|P2|Overall Study|Withdrawal by Subject|4
36292|NCT01715896|158823|P1|Overall Study|Withdrawal by Subject|1
36293|NCT01715896|158822|P2|Overall Study|Lost to Follow-up|2
36294|NCT01715896|158823|P1|Overall Study|Lost to Follow-up|0
36295|NCT01715857|158886|P1|Overall Study|Did Not Meet Eligibility Criteria|96
36296|NCT01715831|158896|P1|Overall Study|Adverse Event|1
36297|NCT01715415|158914|P2|Open-label Treatment|Subject Noncompliant|1
36298|NCT01715415|158915|P1|Open-label Treatment|Subject Noncompliant|0
36299|NCT01715415|158914|P2|Open-label Treatment|Adverse Event|1
36300|NCT01715415|158915|P1|Open-label Treatment|Adverse Event|0
36301|NCT01715415|158914|P2|Double-blind Treatment|Not Specified|0
36302|NCT01715415|158915|P1|Double-blind Treatment|Not Specified|1
36303|NCT01715415|158914|P2|Double-blind Treatment|Withdrawal by Subject|1
36304|NCT01715415|158915|P1|Double-blind Treatment|Withdrawal by Subject|1
36305|NCT01715415|158914|P2|Double-blind Treatment|Adverse Event|0
36306|NCT01715415|158915|P1|Double-blind Treatment|Adverse Event|3
36307|NCT01715415|158914|P2|Double-blind Treatment|Did Not Receive Study Drug|1
36308|NCT01715415|158915|P1|Double-blind Treatment|Did Not Receive Study Drug|0
36309|NCT01715298|158929|P2|Overall Study|Patient/guardian decision|9
36310|NCT01715298|158930|P1|Overall Study|Patient/guardian decision|7
36311|NCT01715298|158929|P2|Overall Study|Lost to Follow-up|2
36312|NCT01715298|158930|P1|Overall Study|Lost to Follow-up|0
36313|NCT01715129|158977|P1|Overall Study|Other|1
36314|NCT01715129|158977|P1|Overall Study|Lost to Follow-up|1
36315|NCT01715129|158977|P1|Overall Study|Consent Withdrawn|2
36316|NCT01715129|158977|P1|Overall Study|Protocol Violation|1
36317|NCT01715129|158977|P1|Overall Study|Lack of Efficacy|3
36318|NCT01715129|158977|P1|Overall Study|Adverse Event, fatal|1
36319|NCT01714817|159005|P2|Overall Study|Hypersensitivity to the medication|1
36320|NCT01714817|159006|P1|Overall Study|Hypersensitivity to the medication|0
36321|NCT01714817|159005|P2|Overall Study|Antiproteinuric changed/dose increased|1
36322|NCT01714817|159006|P1|Overall Study|Antiproteinuric changed/dose increased|0
36323|NCT01714817|159005|P2|Overall Study|Need of use of Prohibited Medications|0
36324|NCT01714817|159006|P1|Overall Study|Need of use of Prohibited Medications|1
36325|NCT01714817|159005|P2|Overall Study|Change in Concomitant Medication|1
36326|NCT01714817|159006|P1|Overall Study|Change in Concomitant Medication|0
36327|NCT01714817|159005|P2|Overall Study|Not treated- received ACE inhibition|0
36328|NCT01714817|159006|P1|Overall Study|Not treated- received ACE inhibition|1
36329|NCT01714817|159005|P2|Overall Study|Participant no longer meets criteria|2
36330|NCT01714817|159006|P1|Overall Study|Participant no longer meets criteria|6
36331|NCT01714817|159005|P2|Overall Study|Pregnancy|0
36332|NCT01714817|159006|P1|Overall Study|Pregnancy|2
36333|NCT01714817|159005|P2|Overall Study|Poor / non-compliance|1
36334|NCT01714817|159006|P1|Overall Study|Poor / non-compliance|0
36335|NCT01714817|159005|P2|Overall Study|Lost to Follow-up|2
36336|NCT01714817|159006|P1|Overall Study|Lost to Follow-up|0
36337|NCT01714817|159005|P2|Overall Study|Death|1
36338|NCT01714817|159006|P1|Overall Study|Death|1
36339|NCT01714817|159005|P2|Overall Study|Withdrawal by Subject|7
36340|NCT01714817|159006|P1|Overall Study|Withdrawal by Subject|6
36341|NCT01714817|159005|P2|Overall Study|Adverse Event|17
36342|NCT01714817|159006|P1|Overall Study|Adverse Event|20
36343|NCT01714817|159005|P2|Overall Study|Lack of Efficacy|9
36344|NCT01714817|159006|P1|Overall Study|Lack of Efficacy|11
36345|NCT01714635|159039|P3|Overall Study|Missed 6-month exam|0
36346|NCT01714635|159040|P2|Overall Study|Missed 6-month exam|0
36347|NCT01714635|159041|P1|Overall Study|Missed 6-month exam|1
36348|NCT01714635|159039|P3|Overall Study|Discontinued|2
36349|NCT01714635|159040|P2|Overall Study|Discontinued|0
36350|NCT01714635|159041|P1|Overall Study|Discontinued|1
36351|NCT01714609|159057|P2|Overall Study|Protocol Violation|0
36352|NCT01714609|159058|P1|Overall Study|Protocol Violation|1
36353|NCT01714544|159064|P1|Overall Study|Withdrawal by Subject|1
36354|NCT01714544|159064|P1|Overall Study|Physician Decision|1
36355|NCT01714544|159064|P1|Overall Study|Lost to Follow-up|1
36356|NCT01714310|159114|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
36357|NCT01714310|159115|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
36358|NCT01714310|159116|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
36359|NCT01714310|159114|P3|Double Blind Adjunctive Treatment|Adverse Event|0
36360|NCT01714310|159115|P2|Double Blind Adjunctive Treatment|Adverse Event|1
36361|NCT01714310|159116|P1|Double Blind Adjunctive Treatment|Adverse Event|1
36362|NCT01714310|159114|P3|Open Lisdexamfetamine Titration|Adverse Event|3
36363|NCT01714310|159115|P2|Open Lisdexamfetamine Titration|Adverse Event|0
36364|NCT01714310|159116|P1|Open Lisdexamfetamine Titration|Adverse Event|0
36365|NCT01714310|159114|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
36366|NCT01714310|159115|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
36367|NCT01714310|159116|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
36368|NCT01713998|159194|P3|Overall Study|Withdrawal by Subject|0
36369|NCT01713998|159195|P2|Overall Study|Withdrawal by Subject|0
36370|NCT01713998|159196|P1|Overall Study|Withdrawal by Subject|1
36371|NCT01713998|159194|P3|Overall Study|Lost to Follow-up|2
36372|NCT01713998|159195|P2|Overall Study|Lost to Follow-up|0
36373|NCT01713998|159196|P1|Overall Study|Lost to Follow-up|2
36374|NCT01713933|159214|P1|Overall Study|Excluded from analysis as a BMI outlier|1
36375|NCT01713933|159214|P1|Overall Study|Withdrawal by Subject|3
36376|NCT01713933|159214|P1|Overall Study|Lost to Follow-up|2
36377|NCT01713686|159226|P1|Overall Study|Withdrawal by Subject|6
36378|NCT01713686|159226|P1|Overall Study|Lost to Follow-up|9
36379|NCT01713530|159277|P2|Overall Study|Unclassified|2
36380|NCT01713530|159278|P1|Overall Study|Unclassified|4
36381|NCT01713530|159277|P2|Overall Study|Withdrawal criteria|12
36382|NCT01713530|159278|P1|Overall Study|Withdrawal criteria|21
36383|NCT01713530|159277|P2|Overall Study|Adverse Event|5
36384|NCT01713530|159278|P1|Overall Study|Adverse Event|0
36385|NCT01713348|159309|P4|Overall Study|Lost to Follow-up|0
36386|NCT01713348|159310|P3|Overall Study|Lost to Follow-up|0
36387|NCT01713348|159311|P2|Overall Study|Lost to Follow-up|0
36388|NCT01713348|159312|P1|Overall Study|Lost to Follow-up|1
36389|NCT01713348|159309|P4|Overall Study|Withdrawal by Subject|0
36390|NCT01713348|159310|P3|Overall Study|Withdrawal by Subject|2
36391|NCT01713348|159311|P2|Overall Study|Withdrawal by Subject|2
36392|NCT01713348|159312|P1|Overall Study|Withdrawal by Subject|3
36393|NCT01713283|159342|P2|Overall Study|Lost to Follow-up|1
36394|NCT01713283|159343|P1|Overall Study|Lost to Follow-up|1
36395|NCT01713283|159342|P2|Overall Study|Lack of Efficacy|2
36396|NCT01713283|159343|P1|Overall Study|Lack of Efficacy|10
36397|NCT01713036|159365|P1|Overall Study|Death|1
36398|NCT01712984|159405|P3|Overall Study|Withdrawal by Subject|7
36399|NCT01712984|159406|P2|Overall Study|Withdrawal by Subject|6
36400|NCT01712984|159407|P1|Overall Study|Withdrawal by Subject|6
36401|NCT01712984|159405|P3|Overall Study|Lost to Follow-up|1
36402|NCT01712984|159406|P2|Overall Study|Lost to Follow-up|10
36403|NCT01712984|159407|P1|Overall Study|Lost to Follow-up|8
36404|NCT01712984|159405|P3|Overall Study|Protocol Violation|1
36405|NCT01712984|159406|P2|Overall Study|Protocol Violation|0
36406|NCT01712984|159407|P1|Overall Study|Protocol Violation|2
36407|NCT01712984|159405|P3|Overall Study|Adverse Event|1
36408|NCT01712984|159406|P2|Overall Study|Adverse Event|0
36409|NCT01712984|159407|P1|Overall Study|Adverse Event|0
36410|NCT01712854|159427|P1|Overall Study|Physician Decision|1
36411|NCT01712685|159450|P1|Overall Study|pt declined to participate before trmt|1
36412|NCT01712516|159466|P4|Overall Study|Withdrawal by Subject|9
36413|NCT01712516|159467|P3|Overall Study|Withdrawal by Subject|3
36414|NCT01712516|159468|P2|Overall Study|Withdrawal by Subject|9
36415|NCT01712516|159469|P1|Overall Study|Withdrawal by Subject|3
36416|NCT01712516|159466|P4|Overall Study|Physician Decision|1
36417|NCT01712516|159467|P3|Overall Study|Physician Decision|0
36418|NCT01712516|159468|P2|Overall Study|Physician Decision|0
36419|NCT01712516|159469|P1|Overall Study|Physician Decision|2
36420|NCT01712516|159466|P4|Overall Study|Protocol deviation|0
36421|NCT01712516|159467|P3|Overall Study|Protocol deviation|1
36422|NCT01712516|159468|P2|Overall Study|Protocol deviation|0
36423|NCT01712516|159469|P1|Overall Study|Protocol deviation|1
36424|NCT01712516|159466|P4|Overall Study|Death|0
36425|NCT01712516|159467|P3|Overall Study|Death|0
36426|NCT01712516|159468|P2|Overall Study|Death|1
36427|NCT01712516|159469|P1|Overall Study|Death|0
36428|NCT01712516|159466|P4|Overall Study|Lost to Follow-up|1
36429|NCT01712516|159467|P3|Overall Study|Lost to Follow-up|2
36430|NCT01712516|159468|P2|Overall Study|Lost to Follow-up|0
36431|NCT01712516|159469|P1|Overall Study|Lost to Follow-up|0
36432|NCT01712516|159466|P4|Overall Study|Technical problems|2
36433|NCT01712516|159467|P3|Overall Study|Technical problems|0
36434|NCT01712516|159468|P2|Overall Study|Technical problems|0
36435|NCT01712516|159469|P1|Overall Study|Technical problems|0
36436|NCT01712399|159519|P1|Overall Study|Study closure|345
36437|NCT01712399|159519|P1|Overall Study|Adverse Event|11
36438|NCT01712399|159519|P1|Overall Study|Death|1
36439|NCT01712399|159519|P1|Overall Study|Withdrawal by Subject|39
36440|NCT01712399|159519|P1|Overall Study|Lost to Follow-up|1
36441|NCT01712334|159565|P2|Treatment Period 1|Randomized in Error|2
36442|NCT01712334|159566|P1|Treatment Period 1|Randomized in Error|0
36443|NCT01712256|159574|P1|Overall Study|Lost to Follow-up|1
36444|NCT01712204|159585|P2|Overall Study|Protocol Violation|1
36445|NCT01712204|159586|P1|Overall Study|Protocol Violation|1
36446|NCT01712204|159585|P2|Overall Study|Lost to Follow-up|0
36447|NCT01712204|159586|P1|Overall Study|Lost to Follow-up|1
36448|NCT01712204|159585|P2|Overall Study|Withdrawal by Subject|3
36449|NCT01712204|159586|P1|Overall Study|Withdrawal by Subject|3
36450|NCT01712204|159585|P2|Overall Study|Adverse Event|1
36451|NCT01712204|159586|P1|Overall Study|Adverse Event|3
36452|NCT01712178|159594|P2|Overall Study|Lost to Follow-up|1
36453|NCT01712178|159595|P1|Overall Study|Lost to Follow-up|0
36454|NCT01712178|159594|P2|Overall Study|Serious adverse event/withdrew consent|1
36455|NCT01712178|159595|P1|Overall Study|Serious adverse event/withdrew consent|0
36456|NCT01712178|159594|P2|Overall Study|Withdrew consent due to an adverse event|1
36457|NCT01712178|159595|P1|Overall Study|Withdrew consent due to an adverse event|1
36458|NCT01712074|159620|P3|Double Blind Period|No longer met eligibility criteria|0
36459|NCT01712074|159621|P2|Double Blind Period|No longer met eligibility criteria|3
36460|NCT01712074|159622|P1|Double Blind Period|No longer met eligibility criteria|0
36461|NCT01712074|159620|P3|Double Blind Period|Protocol Violation|1
36462|NCT01712074|159621|P2|Double Blind Period|Protocol Violation|0
36463|NCT01712074|159622|P1|Double Blind Period|Protocol Violation|0
36464|NCT01712074|159620|P3|Double Blind Period|Other|1
36465|NCT01712074|159621|P2|Double Blind Period|Other|4
36466|NCT01712074|159622|P1|Double Blind Period|Other|0
36467|NCT01712074|159620|P3|Double Blind Period|Lost to Follow-up|1
36468|NCT01712074|159621|P2|Double Blind Period|Lost to Follow-up|2
36469|NCT01712074|159622|P1|Double Blind Period|Lost to Follow-up|0
36470|NCT01712074|159620|P3|Double Blind Period|Death|0
36471|NCT01712074|159621|P2|Double Blind Period|Death|1
36472|NCT01712074|159622|P1|Double Blind Period|Death|0
36473|NCT01712074|159620|P3|Double Blind Period|No longer willing to participate|4
36474|NCT01712074|159621|P2|Double Blind Period|No longer willing to participate|2
36475|NCT01712074|159622|P1|Double Blind Period|No longer willing to participate|0
36476|NCT01712074|159620|P3|Double Blind Period|Adverse Event|1
36477|NCT01712074|159621|P2|Double Blind Period|Adverse Event|2
36478|NCT01712074|159622|P1|Double Blind Period|Adverse Event|0
36479|NCT01712074|159620|P3|Placebo Run-in Period|No longer willing to participate|0
36480|NCT01712074|159621|P2|Placebo Run-in Period|No longer willing to participate|0
36481|NCT01712074|159622|P1|Placebo Run-in Period|No longer willing to participate|1
36482|NCT01712074|159620|P3|Placebo Run-in Period|Other|0
36483|NCT01712074|159621|P2|Placebo Run-in Period|Other|0
36484|NCT01712074|159622|P1|Placebo Run-in Period|Other|1
36485|NCT01712074|159620|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
36486|NCT01712074|159621|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
36487|NCT01712074|159622|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
36488|NCT01712074|159620|P3|Placebo Run-in Period|Lost to Follow-up|0
36489|NCT01712074|159621|P2|Placebo Run-in Period|Lost to Follow-up|0
36490|NCT01712074|159622|P1|Placebo Run-in Period|Lost to Follow-up|1
36491|NCT01712074|159620|P3|Placebo Run-in Period|Adverse Event|0
36492|NCT01712074|159621|P2|Placebo Run-in Period|Adverse Event|0
36493|NCT01712074|159622|P1|Placebo Run-in Period|Adverse Event|2
36494|NCT01712061|159678|P3|Overall Study|Other|0
36495|NCT01712061|159679|P2|Overall Study|Other|3
36496|NCT01712061|159680|P1|Overall Study|Other|0
36497|NCT01712061|159678|P3|Overall Study|Withdrawal by Subject|1
36498|NCT01712061|159679|P2|Overall Study|Withdrawal by Subject|7
36499|NCT01712061|159680|P1|Overall Study|Withdrawal by Subject|1
36500|NCT01712061|159678|P3|Overall Study|Medication Error Without Associated AE|0
36501|NCT01712061|159679|P2|Overall Study|Medication Error Without Associated AE|1
36502|NCT01712061|159680|P1|Overall Study|Medication Error Without Associated AE|0
36503|NCT01712061|159678|P3|Overall Study|Did Not Meet Entrance Criteria|3
36504|NCT01712061|159679|P2|Overall Study|Did Not Meet Entrance Criteria|6
36505|NCT01712061|159680|P1|Overall Study|Did Not Meet Entrance Criteria|4
36506|NCT01712061|159678|P3|Overall Study|Lost to Follow-up|1
36507|NCT01712061|159679|P2|Overall Study|Lost to Follow-up|0
36508|NCT01712061|159680|P1|Overall Study|Lost to Follow-up|1
36509|NCT01712061|159678|P3|Overall Study|Death|1
36510|NCT01712061|159679|P2|Overall Study|Death|0
36511|NCT01712061|159680|P1|Overall Study|Death|0
36512|NCT01712061|159678|P3|Overall Study|Adverse Event|5
36513|NCT01712061|159679|P2|Overall Study|Adverse Event|9
36514|NCT01712061|159680|P1|Overall Study|Adverse Event|4
36515|NCT01712009|159720|P3|Overall Study|Decision by Sponsor|12
36516|NCT01712009|159721|P2|Overall Study|Decision by Sponsor|14
36517|NCT01712009|159722|P1|Overall Study|Decision by Sponsor|12
36518|NCT01712009|159720|P3|Overall Study|Lost to Follow-up|1
36519|NCT01712009|159721|P2|Overall Study|Lost to Follow-up|0
36520|NCT01712009|159722|P1|Overall Study|Lost to Follow-up|2
36521|NCT01712009|159720|P3|Overall Study|Withdrawal by Subject|8
36522|NCT01712009|159721|P2|Overall Study|Withdrawal by Subject|15
36523|NCT01712009|159722|P1|Overall Study|Withdrawal by Subject|24
36524|NCT01711866|159756|P1|Overall Study|Adverse Event|2
36525|NCT01711866|159756|P1|Overall Study|Withdrawal by Subject|3
36526|NCT01711866|159756|P1|Overall Study|Noncompliant|3
36527|NCT01711853|159761|P1|Overall Study|Not treated|3
36528|NCT01711736|159768|P2|Overall Study|Migrated/moved from study area|1
36529|NCT01711736|159769|P1|Overall Study|Migrated/moved from study area|2
36530|NCT01711736|159768|P2|Overall Study|Withdrawal by Subject|6
36531|NCT01711736|159769|P1|Overall Study|Withdrawal by Subject|6
36532|NCT01711736|159768|P2|Overall Study|Lost to Follow-up|1
36533|NCT01711736|159769|P1|Overall Study|Lost to Follow-up|4
36534|NCT01711645|159797|P1|Overall Study|Physician Decision|5
36535|NCT01711645|159797|P1|Overall Study|Lost to Follow-up|6
36536|NCT01711645|159797|P1|Overall Study|Withdrawal by Subject|8
36537|NCT01711359|159842|P3|Treatment Period|Randomized, Not Treated|0
36538|NCT01711359|159843|P2|Treatment Period|Randomized, Not Treated|1
36539|NCT01711359|159844|P1|Treatment Period|Randomized, Not Treated|3
36540|NCT01711359|159842|P3|Treatment Period|Lost to Follow-up|1
36541|NCT01711359|159843|P2|Treatment Period|Lost to Follow-up|1
36542|NCT01711359|159844|P1|Treatment Period|Lost to Follow-up|1
36543|NCT01711359|159842|P3|Treatment Period|Sponsor Decision|0
36544|NCT01711359|159843|P2|Treatment Period|Sponsor Decision|0
36545|NCT01711359|159844|P1|Treatment Period|Sponsor Decision|1
36546|NCT01711359|159842|P3|Treatment Period|Entry Criteria Not Met|0
36547|NCT01711359|159843|P2|Treatment Period|Entry Criteria Not Met|0
36548|NCT01711359|159844|P1|Treatment Period|Entry Criteria Not Met|1
36549|NCT01711359|159842|P3|Treatment Period|Death|0
36550|NCT01711359|159843|P2|Treatment Period|Death|0
36551|NCT01711359|159844|P1|Treatment Period|Death|3
36552|NCT01711359|159842|P3|Treatment Period|Physician Decision|2
36553|NCT01711359|159843|P2|Treatment Period|Physician Decision|3
36554|NCT01711359|159844|P1|Treatment Period|Physician Decision|4
36555|NCT01711359|159842|P3|Treatment Period|Adverse Event|24
36556|NCT01711359|159843|P2|Treatment Period|Adverse Event|10
36557|NCT01711359|159844|P1|Treatment Period|Adverse Event|8
36558|NCT01711359|159842|P3|Treatment Period|Lack of Efficacy|2
36559|NCT01711359|159843|P2|Treatment Period|Lack of Efficacy|2
36560|NCT01711359|159844|P1|Treatment Period|Lack of Efficacy|13
36561|NCT01711359|159842|P3|Treatment Period|Withdrawal by Subject|13
36562|NCT01711359|159843|P2|Treatment Period|Withdrawal by Subject|7
36563|NCT01711359|159844|P1|Treatment Period|Withdrawal by Subject|18
36564|NCT01711216|159915|P1|Overall Study|no reason specified|22
36565|NCT01711216|159915|P1|Overall Study|variety of other minor reasons|83
36566|NCT01711216|159915|P1|Overall Study|Lost to Follow-up|46
36567|NCT01711216|159915|P1|Overall Study|Withdrawal by Subject|6
36568|NCT01711216|159915|P1|Overall Study|Pregnancy|56
36569|NCT01711216|159915|P1|Overall Study|Adverse Event|4
36570|NCT01710800|159974|P1|Overall Study|Protocol Violation|1
36571|NCT01710800|159974|P1|Overall Study|Withdrawal by Subject|21
36572|NCT01710657|160041|P3|Overall Study|Lack of Efficacy|1
36573|NCT01710657|160042|P2|Overall Study|Lack of Efficacy|1
36574|NCT01710657|160043|P1|Overall Study|Lack of Efficacy|0
36575|NCT01710657|160041|P3|Overall Study|Withdrawal by Subject|2
36576|NCT01710657|160042|P2|Overall Study|Withdrawal by Subject|1
36577|NCT01710657|160043|P1|Overall Study|Withdrawal by Subject|0
36578|NCT01710657|160041|P3|Overall Study|Adverse Event|28
36579|NCT01710657|160042|P2|Overall Study|Adverse Event|8
36580|NCT01710657|160043|P1|Overall Study|Adverse Event|14
36581|NCT01710657|160041|P3|Overall Study|Protocol Violation|0
36582|NCT01710657|160042|P2|Overall Study|Protocol Violation|2
36583|NCT01710657|160043|P1|Overall Study|Protocol Violation|2
36584|NCT01710657|160041|P3|Overall Study|Lost to Follow-up|1
36585|NCT01710657|160042|P2|Overall Study|Lost to Follow-up|0
36586|NCT01710657|160043|P1|Overall Study|Lost to Follow-up|2
36587|NCT01710527|160060|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
36588|NCT01710527|160061|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
36589|NCT01710514|160087|P2|Overall Study|Withdrawal by Subject|0
36590|NCT01710514|160088|P1|Overall Study|Withdrawal by Subject|1
36591|NCT01710514|160087|P2|Overall Study|Adverse Event|7
36592|NCT01710514|160088|P1|Overall Study|Adverse Event|6
36593|NCT01710501|160109|P3|Overall Study|Lost to Follow-up|0
36594|NCT01710501|160110|P2|Overall Study|Lost to Follow-up|0
36595|NCT01710501|160111|P1|Overall Study|Lost to Follow-up|2
36596|NCT01710358|160143|P3|Rescue Period|Withdrawal by Subject|0
36597|NCT01710358|160144|P2|Rescue Period|Withdrawal by Subject|8
36598|NCT01710358|160145|P1|Rescue Period|Withdrawal by Subject|0
36599|NCT01710358|160143|P3|Rescue Period|Lack of Efficacy|0
36600|NCT01710358|160144|P2|Rescue Period|Lack of Efficacy|7
36601|NCT01710358|160145|P1|Rescue Period|Lack of Efficacy|0
36602|NCT01710358|160143|P3|Rescue Period|Death|0
36603|NCT01710358|160144|P2|Rescue Period|Death|1
36604|NCT01710358|160145|P1|Rescue Period|Death|0
36605|NCT01710358|160143|P3|Rescue Period|Adverse Event|0
36606|NCT01710358|160144|P2|Rescue Period|Adverse Event|15
36607|NCT01710358|160145|P1|Rescue Period|Adverse Event|0
36608|NCT01710358|160143|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
36609|NCT01710358|160144|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
36610|NCT01710358|160145|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
36611|NCT01710358|160143|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
36612|NCT01710358|160144|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
36613|NCT01710358|160145|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
36614|NCT01710358|160143|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
36615|NCT01710358|160144|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
36616|NCT01710358|160145|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
36617|NCT01710358|160143|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
36618|NCT01710358|160144|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
36619|NCT01710358|160145|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
36620|NCT01710358|160143|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
36621|NCT01710358|160144|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
36622|NCT01710358|160145|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
36623|NCT01710358|160143|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
36624|NCT01710358|160144|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
36625|NCT01710358|160145|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
36626|NCT01710358|160143|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
36627|NCT01710358|160144|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
36628|NCT01710358|160145|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
36629|NCT01710358|160143|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
36630|NCT01710358|160144|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
36631|NCT01710358|160145|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
36632|NCT01710358|160143|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
36633|NCT01710358|160144|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
36634|NCT01710358|160145|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
36635|NCT01710358|160143|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
36636|NCT01710358|160144|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
36637|NCT01710358|160145|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
36638|NCT01710358|160143|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
36639|NCT01710358|160144|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
36640|NCT01710358|160145|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
36641|NCT01710358|160143|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
36642|NCT01710358|160144|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
36643|NCT01710358|160145|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
36644|NCT01710358|160143|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
36645|NCT01710358|160144|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
36646|NCT01710358|160145|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
36647|NCT01710358|160143|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
36648|NCT01710358|160144|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
36649|NCT01710358|160145|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
36650|NCT01710358|160143|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
36651|NCT01710358|160144|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
36652|NCT01710358|160145|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
36653|NCT01710358|160143|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
36654|NCT01710358|160144|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
36655|NCT01710358|160145|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
36656|NCT01710345|160216|P3|Overall Study|Drug Dosing Error|0
36657|NCT01710345|160217|P2|Overall Study|Drug Dosing Error|0
36658|NCT01710345|160218|P1|Overall Study|Drug Dosing Error|1
36659|NCT01710345|160216|P3|Overall Study|Lack of Efficacy|1
36660|NCT01710345|160217|P2|Overall Study|Lack of Efficacy|3
36661|NCT01710345|160218|P1|Overall Study|Lack of Efficacy|2
36662|NCT01710345|160216|P3|Overall Study|Adverse Event|0
36663|NCT01710345|160217|P2|Overall Study|Adverse Event|2
36664|NCT01710345|160218|P1|Overall Study|Adverse Event|0
36665|NCT01710046|160245|P2|Overall Study|Lost to Follow-up|0
36666|NCT01710046|160246|P1|Overall Study|Lost to Follow-up|1
36667|NCT01710033|160286|P5|Stage 2|Adverse Event|1
36668|NCT01710033|160287|P4|Stage 2|Adverse Event|0
36669|NCT01710033|160288|P3|Stage 2|Adverse Event|0
36670|NCT01710033|160289|P2|Stage 2|Adverse Event|0
36671|NCT01710033|160290|P1|Stage 2|Adverse Event|0
36672|NCT01710020|160371|P1|Period 1|Protocol Violation|1
36673|NCT01709903|160390|P2|Overall Study|Adverse Event|18
36674|NCT01709903|160391|P1|Overall Study|Adverse Event|11
36675|NCT01709903|160390|P2|Overall Study|Withdrawal by Subject|6
36676|NCT01709903|160391|P1|Overall Study|Withdrawal by Subject|6
36677|NCT01709903|160390|P2|Overall Study|Lack of Efficacy|3
36678|NCT01709903|160391|P1|Overall Study|Lack of Efficacy|3
36679|NCT01709903|160390|P2|Overall Study|Protocol Violation|2
36680|NCT01709903|160391|P1|Overall Study|Protocol Violation|3
36681|NCT01709903|160390|P2|Overall Study|Death|0
36682|NCT01709903|160391|P1|Overall Study|Death|2
36683|NCT01709903|160390|P2|Overall Study|Lost to Follow-up|2
36684|NCT01709903|160391|P1|Overall Study|Lost to Follow-up|0
36685|NCT01709903|160390|P2|Overall Study|no longer needed study drug|1
36686|NCT01709903|160391|P1|Overall Study|no longer needed study drug|0
36687|NCT01709903|160390|P2|Overall Study|In ability to use device|1
36688|NCT01709903|160391|P1|Overall Study|In ability to use device|1
36689|NCT01709903|160390|P2|Overall Study|Abnormal test procedure results|0
36690|NCT01709903|160391|P1|Overall Study|Abnormal test procedure results|1
36691|NCT01709903|160390|P2|Overall Study|administrative problems|6
36692|NCT01709903|160391|P1|Overall Study|administrative problems|2
36693|NCT01709864|160415|P2|Overall Study|Death|1
36694|NCT01709864|160416|P1|Overall Study|Death|0
36695|NCT01709864|160415|P2|Overall Study|Adverse Event|2
36696|NCT01709864|160416|P1|Overall Study|Adverse Event|0
36697|NCT01709864|160415|P2|Overall Study|non-compliance with study treatment|1
36698|NCT01709864|160416|P1|Overall Study|non-compliance with study treatment|1
36699|NCT01709864|160415|P2|Overall Study|Lost to Follow-up|0
36700|NCT01709864|160416|P1|Overall Study|Lost to Follow-up|1
36701|NCT01709864|160415|P2|Overall Study|subject/guardian decision|6
36702|NCT01709864|160416|P1|Overall Study|subject/guardian decision|5
36703|NCT01709864|160415|P2|Overall Study|Physician Decision|1
36704|NCT01709864|160416|P1|Overall Study|Physician Decision|0
36705|NCT01709708|160487|P2|Overall Study|Protocol Violation|2
36706|NCT01709708|160488|P1|Overall Study|Protocol Violation|1
36707|NCT01709695|160512|P2|Overall Study|Withdrawal by Subject|1
36708|NCT01709695|160513|P1|Overall Study|Withdrawal by Subject|1
36709|NCT01709578|160538|P3|Overall Study|Other, not related to safety or efficacy|5
36710|NCT01709578|160539|P2|Overall Study|Other, not related to safety or efficacy|7
36711|NCT01709578|160540|P1|Overall Study|Other, not related to safety or efficacy|2
36712|NCT01709578|160538|P3|Overall Study|Poor compliance to protocol|1
36713|NCT01709578|160539|P2|Overall Study|Poor compliance to protocol|2
36714|NCT01709578|160540|P1|Overall Study|Poor compliance to protocol|1
36715|NCT01709578|160538|P3|Overall Study|Lack of Efficacy|2
36716|NCT01709578|160539|P2|Overall Study|Lack of Efficacy|4
36717|NCT01709578|160540|P1|Overall Study|Lack of Efficacy|5
36718|NCT01709578|160538|P3|Overall Study|Adverse Event|17
36719|NCT01709578|160539|P2|Overall Study|Adverse Event|18
36720|NCT01709578|160540|P1|Overall Study|Adverse Event|9
36721|NCT01709578|160538|P3|Overall Study|Rescued and entered in long term safety|26
36722|NCT01709578|160539|P2|Overall Study|Rescued and entered in long term safety|25
36723|NCT01709578|160540|P1|Overall Study|Rescued and entered in long term safety|63
36724|NCT01709513|160671|P3|Overall Study|Other|7
36725|NCT01709513|160672|P2|Overall Study|Other|11
36726|NCT01709513|160673|P1|Overall Study|Other|3
36727|NCT01709513|160671|P3|Overall Study|Poor compliance to protocol|0
36728|NCT01709513|160672|P2|Overall Study|Poor compliance to protocol|0
36729|NCT01709513|160673|P1|Overall Study|Poor compliance to protocol|2
36730|NCT01709513|160671|P3|Overall Study|Adverse Event|23
36731|NCT01709513|160672|P2|Overall Study|Adverse Event|31
36732|NCT01709513|160673|P1|Overall Study|Adverse Event|16
36733|NCT01709513|160671|P3|Overall Study|Randomized but not treated|0
36734|NCT01709513|160672|P2|Overall Study|Randomized but not treated|1
36735|NCT01709513|160673|P1|Overall Study|Randomized but not treated|0
36736|NCT01709500|160734|P2|Overall Study|Treatment ongoing|78
36737|NCT01709500|160735|P1|Overall Study|Treatment ongoing|156
36738|NCT01709500|160734|P2|Overall Study|Related to IMP administration|0
36739|NCT01709500|160735|P1|Overall Study|Related to IMP administration|1
36740|NCT01709500|160734|P2|Overall Study|Other|1
36741|NCT01709500|160735|P1|Overall Study|Other|3
36742|NCT01709500|160734|P2|Overall Study|Poor compliance to protocol|1
36743|NCT01709500|160735|P1|Overall Study|Poor compliance to protocol|2
36744|NCT01709500|160734|P2|Overall Study|Adverse Event|1
36745|NCT01709500|160735|P1|Overall Study|Adverse Event|5
36746|NCT01709500|160734|P2|Overall Study|Randomized but not treated|1
36747|NCT01709500|160735|P1|Overall Study|Randomized but not treated|0
36748|NCT01709409|160813|P2|Overall Study|Protocol Violation|0
36749|NCT01709409|160814|P1|Overall Study|Protocol Violation|1
36750|NCT01709383|160822|P2|Overall Study|Lost to Follow-up|0
36751|NCT01709383|160823|P1|Overall Study|Lost to Follow-up|1
36752|NCT01709331|160841|P1|Overall Study|Adverse Event|1
36753|NCT01709305|160847|P5|Phase 2|Withdrawal by Subject|12
36754|NCT01709305|160848|P4|Phase 2|Withdrawal by Subject|15
36755|NCT01709305|160849|P3|Phase 2|Withdrawal by Subject|6
36756|NCT01709305|160850|P2|Phase 2|Withdrawal by Subject|8
36757|NCT01709305|160851|P1|Phase 2|Withdrawal by Subject|0
36758|NCT01709305|160847|P5|Phase 2|Protocol Violation|9
36759|NCT01709305|160848|P4|Phase 2|Protocol Violation|13
36760|NCT01709305|160849|P3|Phase 2|Protocol Violation|19
36761|NCT01709305|160850|P2|Phase 2|Protocol Violation|19
36762|NCT01709305|160851|P1|Phase 2|Protocol Violation|0
36763|NCT01709305|160847|P5|Phase 2|Physician Decision|2
36764|NCT01709305|160848|P4|Phase 2|Physician Decision|1
36765|NCT01709305|160849|P3|Phase 2|Physician Decision|0
36766|NCT01709305|160850|P2|Phase 2|Physician Decision|2
36767|NCT01709305|160851|P1|Phase 2|Physician Decision|0
36768|NCT01709305|160847|P5|Phase 2|Travel, moving, etc.|5
36769|NCT01709305|160848|P4|Phase 2|Travel, moving, etc.|3
36770|NCT01709305|160849|P3|Phase 2|Travel, moving, etc.|3
36771|NCT01709305|160850|P2|Phase 2|Travel, moving, etc.|2
36772|NCT01709305|160851|P1|Phase 2|Travel, moving, etc.|0
36773|NCT01709305|160847|P5|Phase 2|Lost to Follow-up|5
36774|NCT01709305|160848|P4|Phase 2|Lost to Follow-up|9
36775|NCT01709305|160849|P3|Phase 2|Lost to Follow-up|6
36776|NCT01709305|160850|P2|Phase 2|Lost to Follow-up|10
36777|NCT01709305|160851|P1|Phase 2|Lost to Follow-up|0
36778|NCT01709305|160847|P5|Phase 2|Laboratory Adverse Event|1
36779|NCT01709305|160848|P4|Phase 2|Laboratory Adverse Event|1
36780|NCT01709305|160849|P3|Phase 2|Laboratory Adverse Event|0
36781|NCT01709305|160850|P2|Phase 2|Laboratory Adverse Event|1
36782|NCT01709305|160851|P1|Phase 2|Laboratory Adverse Event|0
36783|NCT01709305|160847|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
36784|NCT01709305|160848|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
36785|NCT01709305|160849|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
36786|NCT01709305|160850|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
36787|NCT01709305|160851|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
36788|NCT01709305|160847|P5|Phase 2|Death|0
36789|NCT01709305|160848|P4|Phase 2|Death|0
36790|NCT01709305|160849|P3|Phase 2|Death|1
36791|NCT01709305|160850|P2|Phase 2|Death|0
36792|NCT01709305|160851|P1|Phase 2|Death|0
36793|NCT01709305|160847|P5|Phase 2|Clinical Adverse Event|11
36794|NCT01709305|160848|P4|Phase 2|Clinical Adverse Event|6
36795|NCT01709305|160849|P3|Phase 2|Clinical Adverse Event|10
36796|NCT01709305|160850|P2|Phase 2|Clinical Adverse Event|10
36797|NCT01709305|160851|P1|Phase 2|Clinical Adverse Event|0
36798|NCT01709305|160847|P5|Phase 1|Withdrawal by Subject|0
36799|NCT01709305|160848|P4|Phase 1|Withdrawal by Subject|0
36800|NCT01709305|160849|P3|Phase 1|Withdrawal by Subject|0
36801|NCT01709305|160850|P2|Phase 1|Withdrawal by Subject|0
36802|NCT01709305|160851|P1|Phase 1|Withdrawal by Subject|218
36803|NCT01709305|160847|P5|Phase 1|Protocol Violation|0
36804|NCT01709305|160848|P4|Phase 1|Protocol Violation|0
36805|NCT01709305|160849|P3|Phase 1|Protocol Violation|0
36806|NCT01709305|160850|P2|Phase 1|Protocol Violation|0
36807|NCT01709305|160851|P1|Phase 1|Protocol Violation|118
36808|NCT01709305|160847|P5|Phase 1|Physician Decision|0
36809|NCT01709305|160848|P4|Phase 1|Physician Decision|0
36810|NCT01709305|160849|P3|Phase 1|Physician Decision|0
36811|NCT01709305|160850|P2|Phase 1|Physician Decision|0
36812|NCT01709305|160851|P1|Phase 1|Physician Decision|13
36813|NCT01709305|160847|P5|Phase 1|Travel, moving, etc.|0
36814|NCT01709305|160848|P4|Phase 1|Travel, moving, etc.|0
36815|NCT01709305|160849|P3|Phase 1|Travel, moving, etc.|0
36816|NCT01709305|160850|P2|Phase 1|Travel, moving, etc.|0
36817|NCT01709305|160851|P1|Phase 1|Travel, moving, etc.|30
36818|NCT01709305|160847|P5|Phase 1|Lost to Follow-up|0
36819|NCT01709305|160848|P4|Phase 1|Lost to Follow-up|0
36820|NCT01709305|160849|P3|Phase 1|Lost to Follow-up|0
36821|NCT01709305|160850|P2|Phase 1|Lost to Follow-up|0
36822|NCT01709305|160851|P1|Phase 1|Lost to Follow-up|147
36823|NCT01709305|160847|P5|Phase 1|Laboratory Adverse Event|0
36824|NCT01709305|160848|P4|Phase 1|Laboratory Adverse Event|0
36825|NCT01709305|160849|P3|Phase 1|Laboratory Adverse Event|0
36826|NCT01709305|160850|P2|Phase 1|Laboratory Adverse Event|0
36827|NCT01709305|160851|P1|Phase 1|Laboratory Adverse Event|16
36828|NCT01709305|160847|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
36829|NCT01709305|160848|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
36830|NCT01709305|160849|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
36831|NCT01709305|160850|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
36832|NCT01709305|160851|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
36833|NCT01709305|160847|P5|Phase 1|Death|0
36834|NCT01709305|160848|P4|Phase 1|Death|0
36835|NCT01709305|160849|P3|Phase 1|Death|0
36836|NCT01709305|160850|P2|Phase 1|Death|0
36837|NCT01709305|160851|P1|Phase 1|Death|2
36838|NCT01709305|160847|P5|Phase 1|Clinical Adverse Event|0
36839|NCT01709305|160848|P4|Phase 1|Clinical Adverse Event|0
36840|NCT01709305|160849|P3|Phase 1|Clinical Adverse Event|0
36841|NCT01709305|160850|P2|Phase 1|Clinical Adverse Event|0
36842|NCT01709305|160851|P1|Phase 1|Clinical Adverse Event|80
36843|NCT01709227|160888|P2|Overall Study|Pleural Peritoneal communication|9
36844|NCT01709227|160889|P1|Overall Study|Pleural Peritoneal communication|0
36845|NCT01709227|160888|P2|Overall Study|Physician Decision|0
36846|NCT01709227|160889|P1|Overall Study|Physician Decision|1
36847|NCT01709162|160915|P2|Overall Study|Withdrawal by Subject|1
36848|NCT01709162|160916|P1|Overall Study|Withdrawal by Subject|0
36849|NCT01709162|160915|P2|Overall Study|Not specified|0
36850|NCT01709162|160916|P1|Overall Study|Not specified|1
36851|NCT01709162|160915|P2|Overall Study|Administrative reason by sponsor|1
36852|NCT01709162|160916|P1|Overall Study|Administrative reason by sponsor|0
36853|NCT01709162|160915|P2|Overall Study|Study drug toxicity|0
36854|NCT01709162|160916|P1|Overall Study|Study drug toxicity|2
36855|NCT01709162|160915|P2|Overall Study|Disease progression|3
36856|NCT01709162|160916|P1|Overall Study|Disease progression|3
36857|NCT01709110|160937|P2|Overall Study|Caregiver Decision|1
36858|NCT01709110|160938|P1|Overall Study|Caregiver Decision|1
36859|NCT01709110|160937|P2|Overall Study|Lack of Efficacy|1
36860|NCT01709110|160938|P1|Overall Study|Lack of Efficacy|1
36861|NCT01709110|160937|P2|Overall Study|Sponsor Decision|2
36862|NCT01709110|160938|P1|Overall Study|Sponsor Decision|2
36863|NCT01709110|160937|P2|Overall Study|Physician Decision|10
36864|NCT01709110|160938|P1|Overall Study|Physician Decision|4
36865|NCT01709110|160937|P2|Overall Study|Withdrawal by Subject|89
36866|NCT01709110|160938|P1|Overall Study|Withdrawal by Subject|96
36867|NCT01709110|160937|P2|Overall Study|Protocol Violation|6
36868|NCT01709110|160938|P1|Overall Study|Protocol Violation|4
36869|NCT01709110|160937|P2|Overall Study|Lost to Follow-up|5
36870|NCT01709110|160938|P1|Overall Study|Lost to Follow-up|7
36871|NCT01709110|160937|P2|Overall Study|Death|6
36872|NCT01709110|160938|P1|Overall Study|Death|14
36873|NCT01709110|160937|P2|Overall Study|Adverse Event|48
36874|NCT01709110|160938|P1|Overall Study|Adverse Event|56
36875|NCT01709084|160968|P2|Overall Study|Not Treated|2
36876|NCT01709084|160969|P1|Overall Study|Not Treated|0
36877|NCT01709084|160968|P2|Overall Study|Participant Reached a Virologic Endpoint|1
36878|NCT01709084|160969|P1|Overall Study|Participant Reached a Virologic Endpoint|0
36879|NCT01709084|160968|P2|Overall Study|Other|3
36880|NCT01709084|160969|P1|Overall Study|Other|5
36881|NCT01709084|160968|P2|Overall Study|Adverse Event|0
36882|NCT01709084|160969|P1|Overall Study|Adverse Event|5
36883|NCT01709084|160968|P2|Overall Study|Withdrawal by Subject|2
36884|NCT01709084|160969|P1|Overall Study|Withdrawal by Subject|2
36885|NCT01709084|160968|P2|Overall Study|Lost to Follow-up|7
36886|NCT01709084|160969|P1|Overall Study|Lost to Follow-up|4
36887|NCT01708954|160997|P3|Step 2|Withdrawal by Subject|0
36888|NCT01708954|160998|P2|Step 2|Withdrawal by Subject|1
36889|NCT01708954|160999|P1|Step 2|Withdrawal by Subject|1
36890|NCT01708954|160997|P3|Step 2|Adverse Event|0
36891|NCT01708954|160998|P2|Step 2|Adverse Event|2
36892|NCT01708954|160999|P1|Step 2|Adverse Event|3
36893|NCT01708954|160997|P3|Step 2|Disease progression|0
36894|NCT01708954|160998|P2|Step 2|Disease progression|4
36895|NCT01708954|160999|P1|Step 2|Disease progression|9
36896|NCT01708954|160997|P3|Step 1|Ineligible or never received treatment|8
36897|NCT01708954|160998|P2|Step 1|Ineligible or never received treatment|2
36898|NCT01708954|160999|P1|Step 1|Ineligible or never received treatment|4
36899|NCT01708954|160997|P3|Step 1|Off-treatment reason not submitted|1
36900|NCT01708954|160998|P2|Step 1|Off-treatment reason not submitted|1
36901|NCT01708954|160999|P1|Step 1|Off-treatment reason not submitted|1
36902|NCT01708954|160997|P3|Step 1|Symptomatic deterioration|1
36903|NCT01708954|160998|P2|Step 1|Symptomatic deterioration|0
36904|NCT01708954|160999|P1|Step 1|Symptomatic deterioration|1
36905|NCT01708954|160997|P3|Step 1|Crossed over to Step 2|0
36906|NCT01708954|160998|P2|Step 1|Crossed over to Step 2|0
36907|NCT01708954|160999|P1|Step 1|Crossed over to Step 2|2
36908|NCT01708954|160997|P3|Step 1|Other complicating disease|0
36909|NCT01708954|160998|P2|Step 1|Other complicating disease|2
36910|NCT01708954|160999|P1|Step 1|Other complicating disease|0
36911|NCT01708954|160997|P3|Step 1|Withdrawal by Subject|3
36912|NCT01708954|160998|P2|Step 1|Withdrawal by Subject|5
36913|NCT01708954|160999|P1|Step 1|Withdrawal by Subject|2
36914|NCT01708954|160997|P3|Step 1|Death|3
36915|NCT01708954|160998|P2|Step 1|Death|2
36916|NCT01708954|160999|P1|Step 1|Death|3
36917|NCT01708954|160997|P3|Step 1|Adverse Event|13
36918|NCT01708954|160998|P2|Step 1|Adverse Event|11
36919|NCT01708954|160999|P1|Step 1|Adverse Event|3
36920|NCT01708954|160997|P3|Step 1|Disease progression|14
36921|NCT01708954|160998|P2|Step 1|Disease progression|17
36922|NCT01708954|160999|P1|Step 1|Disease progression|26
36923|NCT01708915|161024|P4|Overall Study|Other reasons than stated above|2
36924|NCT01708915|161025|P3|Overall Study|Other reasons than stated above|0
36925|NCT01708915|161026|P2|Overall Study|Other reasons than stated above|1
36926|NCT01708915|161027|P1|Overall Study|Other reasons than stated above|1
36927|NCT01708915|161024|P4|Overall Study|Withdrawal by Subject|2
36928|NCT01708915|161025|P3|Overall Study|Withdrawal by Subject|2
36929|NCT01708915|161026|P2|Overall Study|Withdrawal by Subject|1
36930|NCT01708915|161027|P1|Overall Study|Withdrawal by Subject|0
36931|NCT01708915|161024|P4|Overall Study|Protocol Violation|1
36932|NCT01708915|161025|P3|Overall Study|Protocol Violation|0
36933|NCT01708915|161026|P2|Overall Study|Protocol Violation|0
36934|NCT01708915|161027|P1|Overall Study|Protocol Violation|0
36935|NCT01708915|161024|P4|Overall Study|Lack of Efficacy|15
36936|NCT01708915|161025|P3|Overall Study|Lack of Efficacy|35
36937|NCT01708915|161026|P2|Overall Study|Lack of Efficacy|60
36938|NCT01708915|161027|P1|Overall Study|Lack of Efficacy|84
36939|NCT01708915|161024|P4|Overall Study|Adverse Event|13
36940|NCT01708915|161025|P3|Overall Study|Adverse Event|9
36941|NCT01708915|161026|P2|Overall Study|Adverse Event|0
36942|NCT01708915|161027|P1|Overall Study|Adverse Event|1
36943|NCT01708902|161056|P7|Overall Study|Other Reason|0
36944|NCT01708902|161057|P6|Overall Study|Other Reason|2
36945|NCT01708902|161058|P5|Overall Study|Other Reason|1
36946|NCT01708902|161059|P4|Overall Study|Other Reason|1
36947|NCT01708902|161060|P3|Overall Study|Other Reason|1
36948|NCT01708902|161061|P2|Overall Study|Other Reason|0
36949|NCT01708902|161062|P1|Overall Study|Other Reason|1
36950|NCT01708902|161056|P7|Overall Study|Refused to continue trial medication|1
36951|NCT01708902|161057|P6|Overall Study|Refused to continue trial medication|1
36952|NCT01708902|161058|P5|Overall Study|Refused to continue trial medication|8
36953|NCT01708902|161059|P4|Overall Study|Refused to continue trial medication|2
36954|NCT01708902|161060|P3|Overall Study|Refused to continue trial medication|4
36955|NCT01708902|161061|P2|Overall Study|Refused to continue trial medication|0
36956|NCT01708902|161062|P1|Overall Study|Refused to continue trial medication|8
36957|NCT01708902|161056|P7|Overall Study|Lost to Follow-up|1
36958|NCT01708902|161057|P6|Overall Study|Lost to Follow-up|0
36959|NCT01708902|161058|P5|Overall Study|Lost to Follow-up|0
36960|NCT01708902|161059|P4|Overall Study|Lost to Follow-up|2
36961|NCT01708902|161060|P3|Overall Study|Lost to Follow-up|2
36962|NCT01708902|161061|P2|Overall Study|Lost to Follow-up|1
36963|NCT01708902|161062|P1|Overall Study|Lost to Follow-up|2
36964|NCT01708902|161056|P7|Overall Study|Non compliance with protocol|0
36965|NCT01708902|161057|P6|Overall Study|Non compliance with protocol|0
36966|NCT01708902|161058|P5|Overall Study|Non compliance with protocol|0
36967|NCT01708902|161059|P4|Overall Study|Non compliance with protocol|3
36968|NCT01708902|161060|P3|Overall Study|Non compliance with protocol|1
36969|NCT01708902|161061|P2|Overall Study|Non compliance with protocol|2
36970|NCT01708902|161062|P1|Overall Study|Non compliance with protocol|0
36971|NCT01708902|161056|P7|Overall Study|Lack of Efficacy|0
36972|NCT01708902|161057|P6|Overall Study|Lack of Efficacy|1
36973|NCT01708902|161058|P5|Overall Study|Lack of Efficacy|0
36974|NCT01708902|161059|P4|Overall Study|Lack of Efficacy|0
36975|NCT01708902|161060|P3|Overall Study|Lack of Efficacy|0
36976|NCT01708902|161061|P2|Overall Study|Lack of Efficacy|1
36977|NCT01708902|161062|P1|Overall Study|Lack of Efficacy|3
36978|NCT01708902|161056|P7|Overall Study|Adverse Event|5
36979|NCT01708902|161057|P6|Overall Study|Adverse Event|3
36980|NCT01708902|161058|P5|Overall Study|Adverse Event|7
36981|NCT01708902|161059|P4|Overall Study|Adverse Event|2
36982|NCT01708902|161060|P3|Overall Study|Adverse Event|9
36983|NCT01708902|161061|P2|Overall Study|Adverse Event|4
36984|NCT01708902|161062|P1|Overall Study|Adverse Event|3
36985|NCT01708291|161135|P2|Overall Study|fighting|1
36986|NCT01708291|161136|P1|Overall Study|fighting|2
36987|NCT01708187|161175|P2|Overall Study|Lost to Follow-up|1
36988|NCT01708187|161176|P1|Overall Study|Lost to Follow-up|0
36989|NCT01708174|161185|P3|Treatment Period|Adverse Event|0
36990|NCT01708174|161186|P2|Treatment Period|Adverse Event|1
36991|NCT01708174|161187|P1|Treatment Period|Adverse Event|0
36992|NCT01708174|161185|P3|Treatment Period|Death|1
36993|NCT01708174|161186|P2|Treatment Period|Death|0
36994|NCT01708174|161187|P1|Treatment Period|Death|0
36995|NCT01708174|161185|P3|Treatment Period|Progressive disease|0
36996|NCT01708174|161186|P2|Treatment Period|Progressive disease|1
36997|NCT01708174|161187|P1|Treatment Period|Progressive disease|0
36998|NCT01708174|161185|P3|Treatment Period|Withdrawal by Subject|0
36999|NCT01708174|161186|P2|Treatment Period|Withdrawal by Subject|0
37000|NCT01708174|161187|P1|Treatment Period|Withdrawal by Subject|1
37001|NCT01708057|161224|P3|Overall Study|Withdrawal due to study termination.|1
37002|NCT01708057|161225|P2|Overall Study|Withdrawal due to study termination.|1
37003|NCT01708057|161226|P1|Overall Study|Withdrawal due to study termination.|1
37004|NCT01707667|161284|P2|Period 1|expulsion of colonic sensor catheter|0
37005|NCT01707667|161285|P1|Period 1|expulsion of colonic sensor catheter|1
37006|NCT01707290|161309|P2|Overall Study|Other unspecified|0
37007|NCT01707290|161310|P1|Overall Study|Other unspecified|17
37008|NCT01707290|161309|P2|Overall Study|Commercial drug available|1
37009|NCT01707290|161310|P1|Overall Study|Commercial drug available|60
37010|NCT01707290|161309|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
37011|NCT01707290|161310|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
37012|NCT01707290|161309|P2|Overall Study|Lost to Follow-up|0
37013|NCT01707290|161310|P1|Overall Study|Lost to Follow-up|3
37014|NCT01707290|161309|P2|Overall Study|Physician Decision|0
37015|NCT01707290|161310|P1|Overall Study|Physician Decision|1
37016|NCT01707290|161309|P2|Overall Study|Adverse event (AE)|0
37017|NCT01707290|161310|P1|Overall Study|Adverse event (AE)|1
37018|NCT01706926|161404|P4|Overall Study|Other|3
37019|NCT01706926|161405|P3|Overall Study|Other|4
37020|NCT01706926|161406|P2|Overall Study|Other|4
37021|NCT01706926|161407|P1|Overall Study|Other|4
37022|NCT01706926|161404|P4|Overall Study|Withdrawal by Subject|2
37023|NCT01706926|161405|P3|Overall Study|Withdrawal by Subject|1
37024|NCT01706926|161406|P2|Overall Study|Withdrawal by Subject|0
37025|NCT01706926|161407|P1|Overall Study|Withdrawal by Subject|2
37026|NCT01706926|161404|P4|Overall Study|Lost to Follow-up|0
37027|NCT01706926|161405|P3|Overall Study|Lost to Follow-up|1
37028|NCT01706926|161406|P2|Overall Study|Lost to Follow-up|0
37029|NCT01706926|161407|P1|Overall Study|Lost to Follow-up|0
37030|NCT01706770|161526|P2|Overall Study|Physician Decision|0
37031|NCT01706770|161527|P1|Overall Study|Physician Decision|1
37032|NCT01706770|161526|P2|Overall Study|Lost to Follow-up|0
37033|NCT01706770|161527|P1|Overall Study|Lost to Follow-up|1
37034|NCT01706575|161575|P1|Overall Study|Started but not Treated|6
37035|NCT01706575|161575|P1|Overall Study|Lost to Follow-up|2
37036|NCT01706575|161575|P1|Overall Study|Participant Withdrew Consent|4
37037|NCT01706536|161596|P5|Overall Study|non compliance|0
37038|NCT01706536|161597|P4|Overall Study|non compliance|0
37039|NCT01706536|161598|P3|Overall Study|non compliance|0
37040|NCT01706536|161599|P2|Overall Study|non compliance|1
37041|NCT01706536|161600|P1|Overall Study|non compliance|0
37042|NCT01706536|161596|P5|Overall Study|Lack of Efficacy|0
37043|NCT01706536|161597|P4|Overall Study|Lack of Efficacy|1
37044|NCT01706536|161598|P3|Overall Study|Lack of Efficacy|0
37045|NCT01706536|161599|P2|Overall Study|Lack of Efficacy|0
37046|NCT01706536|161600|P1|Overall Study|Lack of Efficacy|1
37047|NCT01706536|161596|P5|Overall Study|Adverse Event|2
37048|NCT01706536|161597|P4|Overall Study|Adverse Event|3
37049|NCT01706536|161598|P3|Overall Study|Adverse Event|4
37050|NCT01706536|161599|P2|Overall Study|Adverse Event|3
37051|NCT01706536|161600|P1|Overall Study|Adverse Event|2
37052|NCT01706536|161596|P5|Overall Study|Withdrawal by Subject|0
37053|NCT01706536|161597|P4|Overall Study|Withdrawal by Subject|0
37054|NCT01706536|161598|P3|Overall Study|Withdrawal by Subject|1
37055|NCT01706536|161599|P2|Overall Study|Withdrawal by Subject|0
37056|NCT01706536|161600|P1|Overall Study|Withdrawal by Subject|1
37057|NCT01706328|161659|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
37058|NCT01706328|161660|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
37059|NCT01706328|161661|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
37060|NCT01706328|161659|P3|12-week Double-blind Treatment Period|Physician Decision|2
37061|NCT01706328|161660|P2|12-week Double-blind Treatment Period|Physician Decision|2
37062|NCT01706328|161661|P1|12-week Double-blind Treatment Period|Physician Decision|0
37063|NCT01706328|161659|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
37064|NCT01706328|161660|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
37065|NCT01706328|161661|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
37066|NCT01706328|161659|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
37067|NCT01706328|161660|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
37068|NCT01706328|161661|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
37069|NCT01706328|161659|P3|12-week Double-blind Treatment Period|Protocol Violation|2
37070|NCT01706328|161660|P2|12-week Double-blind Treatment Period|Protocol Violation|4
37071|NCT01706328|161661|P1|12-week Double-blind Treatment Period|Protocol Violation|0
37072|NCT01706328|161659|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
37073|NCT01706328|161660|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
37074|NCT01706328|161661|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
37075|NCT01706328|161659|P3|12-week Double-blind Treatment Period|Adverse Event|16
37076|NCT01706328|161660|P2|12-week Double-blind Treatment Period|Adverse Event|14
37077|NCT01706328|161661|P1|12-week Double-blind Treatment Period|Adverse Event|0
37078|NCT01706328|161659|P3|2-week Run-in Period|Lost to Follow-up|0
37079|NCT01706328|161660|P2|2-week Run-in Period|Lost to Follow-up|0
37080|NCT01706328|161661|P1|2-week Run-in Period|Lost to Follow-up|2
37081|NCT01706328|161659|P3|2-week Run-in Period|Adverse Event|0
37082|NCT01706328|161660|P2|2-week Run-in Period|Adverse Event|0
37083|NCT01706328|161661|P1|2-week Run-in Period|Adverse Event|4
37084|NCT01706328|161659|P3|2-week Run-in Period|Physician Decision|0
37085|NCT01706328|161660|P2|2-week Run-in Period|Physician Decision|0
37086|NCT01706328|161661|P1|2-week Run-in Period|Physician Decision|4
37087|NCT01706328|161659|P3|2-week Run-in Period|Withdrawal by Subject|0
37088|NCT01706328|161660|P2|2-week Run-in Period|Withdrawal by Subject|0
37089|NCT01706328|161661|P1|2-week Run-in Period|Withdrawal by Subject|15
37090|NCT01706328|161659|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
37091|NCT01706328|161660|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
37092|NCT01706328|161661|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
37093|NCT01706250|161680|P1|Overall Study|Lost to Follow-up|2
37094|NCT01706159|161711|P2|Overall Study|Unclassified|1
37095|NCT01706159|161712|P1|Overall Study|Unclassified|6
37096|NCT01706159|161711|P2|Overall Study|Withdrawal Criteria|1
37097|NCT01706159|161712|P1|Overall Study|Withdrawal Criteria|2
37098|NCT01706146|161726|P1|Overall Study|Developed AF and need for antiplatelets|2
37099|NCT01706146|161726|P1|Overall Study|Adverse Event|3
37100|NCT01706146|161726|P1|Overall Study|Withdrawal by Subject|1
37101|NCT01705717|161733|P2|Overall Study|Not Specified|2
37102|NCT01705717|161734|P1|Overall Study|Not Specified|0
37103|NCT01705717|161733|P2|Overall Study|Lack of Efficacy|1
37104|NCT01705717|161734|P1|Overall Study|Lack of Efficacy|0
37105|NCT01705717|161733|P2|Overall Study|Adverse Event|2
37106|NCT01705717|161734|P1|Overall Study|Adverse Event|2
37107|NCT01705652|161751|P2|Overall Study|non-compliance|1
37108|NCT01705652|161752|P1|Overall Study|non-compliance|1
37109|NCT01705652|161751|P2|Overall Study|Withdrawal by Subject|2
37110|NCT01705652|161752|P1|Overall Study|Withdrawal by Subject|1
37111|NCT01705652|161751|P2|Overall Study|Adverse Event|0
37112|NCT01705652|161752|P1|Overall Study|Adverse Event|1
37113|NCT01705587|161760|P2|Overall Study|Withdrawal by Subject|1
37114|NCT01705587|161761|P1|Overall Study|Withdrawal by Subject|0
37115|NCT01705574|161779|P2|Overall Study|Still on Study|125
37116|NCT01705574|161780|P1|Overall Study|Still on Study|135
37117|NCT01705574|161779|P2|Overall Study|Lost to Follow-up|15
37118|NCT01705574|161780|P1|Overall Study|Lost to Follow-up|11
37119|NCT01705574|161779|P2|Overall Study|Withdrew Consent|5
37120|NCT01705574|161780|P1|Overall Study|Withdrew Consent|8
37121|NCT01705574|161779|P2|Overall Study|Protocol Violation|0
37122|NCT01705574|161780|P1|Overall Study|Protocol Violation|1
37123|NCT01705574|161779|P2|Overall Study|Non-Compliance with Study Drug|4
37124|NCT01705574|161780|P1|Overall Study|Non-Compliance with Study Drug|4
37125|NCT01705574|161779|P2|Overall Study|Pregnancy|1
37126|NCT01705574|161780|P1|Overall Study|Pregnancy|1
37127|NCT01705574|161779|P2|Overall Study|Adverse Event|9
37128|NCT01705574|161780|P1|Overall Study|Adverse Event|3
37129|NCT01705574|161779|P2|Overall Study|Randomized but Not Treated|4
37130|NCT01705574|161780|P1|Overall Study|Randomized but Not Treated|4
37131|NCT01705145|161798|P1|Part B|Adverse Event|1
37132|NCT01704846|161853|P2|Treatment Period 2|Withdrawal by Subject|1
37133|NCT01704846|161854|P1|Treatment Period 2|Withdrawal by Subject|0
37134|NCT01704755|161909|P2|Overall Study|Withdrew consent and personal issues|0
37135|NCT01704755|161910|P1|Overall Study|Withdrew consent and personal issues|1
37136|NCT01704755|161909|P2|Overall Study|Other (not specified)|1
37137|NCT01704755|161910|P1|Overall Study|Other (not specified)|3
37138|NCT01704755|161909|P2|Overall Study|Withdrew consent|1
37139|NCT01704755|161910|P1|Overall Study|Withdrew consent|1
37140|NCT01704755|161909|P2|Overall Study|Lost to Follow-up|4
37141|NCT01704755|161910|P1|Overall Study|Lost to Follow-up|3
37142|NCT01704755|161909|P2|Overall Study|Adverse Event|1
37143|NCT01704755|161910|P1|Overall Study|Adverse Event|4
37144|NCT01704651|161924|P2|Overall Study|Post-op did not have laparotomy|1
37145|NCT01704651|161925|P1|Overall Study|Post-op did not have laparotomy|2
37146|NCT01704651|161924|P2|Overall Study|Nasogastric tube placement in surgery|1
37147|NCT01704651|161925|P1|Overall Study|Nasogastric tube placement in surgery|1
37148|NCT01704651|161924|P2|Overall Study|Pre-op change in treatment plan|4
37149|NCT01704651|161925|P1|Overall Study|Pre-op change in treatment plan|1
37150|NCT01704651|161924|P2|Overall Study|Pre-op withdrawal by subject|1
37151|NCT01704651|161925|P1|Overall Study|Pre-op withdrawal by subject|1
37152|NCT01704599|161933|P1|Overall Study|Adverse Event|1
37153|NCT01704495|161973|P4|Optional Safety Extension|Withdrawal by Subject|2
37154|NCT01704495|161974|P3|Optional Safety Extension|Withdrawal by Subject|1
37155|NCT01704495|161975|P2|Optional Safety Extension|Withdrawal by Subject|0
37156|NCT01704495|161976|P1|Optional Safety Extension|Withdrawal by Subject|2
37157|NCT01704495|161973|P4|Optional Safety Extension|Other reason|28
37158|NCT01704495|161974|P3|Optional Safety Extension|Other reason|30
37159|NCT01704495|161975|P2|Optional Safety Extension|Other reason|29
37160|NCT01704495|161976|P1|Optional Safety Extension|Other reason|27
37161|NCT01704495|161973|P4|Optional Safety Extension|Adverse Event|1
37162|NCT01704495|161974|P3|Optional Safety Extension|Adverse Event|0
37163|NCT01704495|161975|P2|Optional Safety Extension|Adverse Event|4
37164|NCT01704495|161976|P1|Optional Safety Extension|Adverse Event|0
37165|NCT01704495|161973|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
37166|NCT01704495|161974|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
37167|NCT01704495|161975|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
37168|NCT01704495|161976|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
37169|NCT01704495|161973|P4|Subjects Randomized|Protocol Violation|0
37170|NCT01704495|161974|P3|Subjects Randomized|Protocol Violation|2
37171|NCT01704495|161975|P2|Subjects Randomized|Protocol Violation|1
37172|NCT01704495|161976|P1|Subjects Randomized|Protocol Violation|1
37173|NCT01704495|161973|P4|Subjects Randomized|Withdrawal by Subject|5
37174|NCT01704495|161974|P3|Subjects Randomized|Withdrawal by Subject|5
37175|NCT01704495|161975|P2|Subjects Randomized|Withdrawal by Subject|5
37176|NCT01704495|161976|P1|Subjects Randomized|Withdrawal by Subject|5
37177|NCT01704495|161973|P4|Subjects Randomized|Adverse Event|7
37178|NCT01704495|161974|P3|Subjects Randomized|Adverse Event|0
37179|NCT01704495|161975|P2|Subjects Randomized|Adverse Event|2
37180|NCT01704495|161976|P1|Subjects Randomized|Adverse Event|8
37181|NCT01704495|161973|P4|Subjects Randomized|Discontinuation criteria met|0
37182|NCT01704495|161974|P3|Subjects Randomized|Discontinuation criteria met|2
37183|NCT01704495|161975|P2|Subjects Randomized|Discontinuation criteria met|2
37184|NCT01704495|161976|P1|Subjects Randomized|Discontinuation criteria met|4
37185|NCT01704495|161973|P4|Subjects Randomized|Other Reason|2
37186|NCT01704495|161974|P3|Subjects Randomized|Other Reason|3
37187|NCT01704495|161975|P2|Subjects Randomized|Other Reason|2
37188|NCT01704495|161976|P1|Subjects Randomized|Other Reason|3
37189|NCT01704287|162192|P5|Switch to Pembrolizumab Treatment Period|Ongoing in Study|16
37190|NCT01704287|162193|P4|Switch to Pembrolizumab Treatment Period|Ongoing in Study|21
37191|NCT01704287|162194|P3|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
37192|NCT01704287|162195|P2|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
37193|NCT01704287|162196|P1|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
37194|NCT01704287|162192|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
37195|NCT01704287|162193|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
37196|NCT01704287|162194|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
37197|NCT01704287|162195|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
37198|NCT01704287|162196|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
37199|NCT01704287|162192|P5|Switch to Pembrolizumab Treatment Period|Death|28
37200|NCT01704287|162193|P4|Switch to Pembrolizumab Treatment Period|Death|29
37201|NCT01704287|162194|P3|Switch to Pembrolizumab Treatment Period|Death|0
37202|NCT01704287|162195|P2|Switch to Pembrolizumab Treatment Period|Death|0
37203|NCT01704287|162196|P1|Switch to Pembrolizumab Treatment Period|Death|0
37204|NCT01704287|162192|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
37205|NCT01704287|162193|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
37206|NCT01704287|162194|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
37207|NCT01704287|162195|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
37208|NCT01704287|162196|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
37209|NCT01704287|162192|P5|Initial Treatment Period|Switched to Pembrolizumab|0
37210|NCT01704287|162193|P4|Initial Treatment Period|Switched to Pembrolizumab|0
37211|NCT01704287|162194|P3|Initial Treatment Period|Switched to Pembrolizumab|98
37212|NCT01704287|162195|P2|Initial Treatment Period|Switched to Pembrolizumab|0
37213|NCT01704287|162196|P1|Initial Treatment Period|Switched to Pembrolizumab|0
37214|NCT01704287|162192|P5|Initial Treatment Period|Lost to Follow-up|0
37215|NCT01704287|162193|P4|Initial Treatment Period|Lost to Follow-up|0
37216|NCT01704287|162194|P3|Initial Treatment Period|Lost to Follow-up|3
37217|NCT01704287|162195|P2|Initial Treatment Period|Lost to Follow-up|1
37218|NCT01704287|162196|P1|Initial Treatment Period|Lost to Follow-up|3
37219|NCT01704287|162192|P5|Initial Treatment Period|Ongoing in Study|0
37220|NCT01704287|162193|P4|Initial Treatment Period|Ongoing in Study|0
37221|NCT01704287|162194|P3|Initial Treatment Period|Ongoing in Study|44
37222|NCT01704287|162195|P2|Initial Treatment Period|Ongoing in Study|62
37223|NCT01704287|162196|P1|Initial Treatment Period|Ongoing in Study|52
37224|NCT01704287|162192|P5|Initial Treatment Period|Other|0
37225|NCT01704287|162193|P4|Initial Treatment Period|Other|0
37226|NCT01704287|162194|P3|Initial Treatment Period|Other|0
37227|NCT01704287|162195|P2|Initial Treatment Period|Other|0
37228|NCT01704287|162196|P1|Initial Treatment Period|Other|1
37229|NCT01704287|162192|P5|Initial Treatment Period|Withdrawal by Subject|0
37230|NCT01704287|162193|P4|Initial Treatment Period|Withdrawal by Subject|0
37231|NCT01704287|162194|P3|Initial Treatment Period|Withdrawal by Subject|4
37232|NCT01704287|162195|P2|Initial Treatment Period|Withdrawal by Subject|1
37233|NCT01704287|162196|P1|Initial Treatment Period|Withdrawal by Subject|1
37234|NCT01704287|162192|P5|Initial Treatment Period|Death|0
37235|NCT01704287|162193|P4|Initial Treatment Period|Death|0
37236|NCT01704287|162194|P3|Initial Treatment Period|Death|30
37237|NCT01704287|162195|P2|Initial Treatment Period|Death|117
37238|NCT01704287|162196|P1|Initial Treatment Period|Death|123
37239|NCT01704261|162231|P2|Overall Study|Lost to Follow-up|0
37240|NCT01704261|162232|P1|Overall Study|Lost to Follow-up|1
37241|NCT01704261|162231|P2|Overall Study|Withdrawal by Subject|15
37242|NCT01704261|162232|P1|Overall Study|Withdrawal by Subject|12
37243|NCT01704079|162259|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
37244|NCT01704079|162260|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
37245|NCT01704079|162259|P2|Overall Study|Subject noncompliance|3
37246|NCT01704079|162260|P1|Overall Study|Subject noncompliance|2
37247|NCT01704079|162259|P2|Overall Study|Protocol Violation|0
37248|NCT01704079|162260|P1|Overall Study|Protocol Violation|1
37249|NCT01704079|162259|P2|Overall Study|Adverse Event|7
37250|NCT01704079|162260|P1|Overall Study|Adverse Event|4
37251|NCT01704079|162259|P2|Overall Study|Lost to Follow-up|5
37252|NCT01704079|162260|P1|Overall Study|Lost to Follow-up|2
37253|NCT01704079|162259|P2|Overall Study|Withdrawal by Subject|7
37254|NCT01704079|162260|P1|Overall Study|Withdrawal by Subject|5
37255|NCT01703988|162276|P4|Overall Study|Investigator Judgment|1
37256|NCT01703988|162277|P3|Overall Study|Investigator Judgment|0
37257|NCT01703988|162278|P2|Overall Study|Investigator Judgment|0
37258|NCT01703988|162279|P1|Overall Study|Investigator Judgment|0
37259|NCT01703858|162309|P3|Overall Study|Withdrawal by Subject|0
37260|NCT01703858|162310|P2|Overall Study|Withdrawal by Subject|1
37261|NCT01703858|162311|P1|Overall Study|Withdrawal by Subject|0
37262|NCT01703845|162336|P2|Overall Study|other than stated above|0
37263|NCT01703845|162337|P1|Overall Study|other than stated above|1
37264|NCT01703845|162336|P2|Overall Study|Protocol Violation|0
37265|NCT01703845|162337|P1|Overall Study|Protocol Violation|1
37266|NCT01703845|162336|P2|Overall Study|Adverse Event|0
37267|NCT01703845|162337|P1|Overall Study|Adverse Event|1
37268|NCT01703832|162374|P2|Overall Study|Withdrawal by Subject|0
37269|NCT01703832|162375|P1|Overall Study|Withdrawal by Subject|1
37270|NCT01703819|162407|P2|Overall Study|Withdrawal by Subject|1
37271|NCT01703819|162408|P1|Overall Study|Withdrawal by Subject|0
37272|NCT01703819|162407|P2|Overall Study|Adverse Event|1
37273|NCT01703819|162408|P1|Overall Study|Adverse Event|0
37274|NCT01703741|162438|P1|Overall Study|Subject started testosterone injections|1
37275|NCT01703741|162438|P1|Overall Study|Subject cannot comply with study visits|1
37276|NCT01703741|162438|P1|Overall Study|Subject did not want to continue|2
37277|NCT01703741|162438|P1|Overall Study|Lost to Follow-up|3
37278|NCT01703741|162438|P1|Overall Study|Protocol Violation|1
37279|NCT01703741|162438|P1|Overall Study|Physician Decision|2
37280|NCT01703741|162438|P1|Overall Study|Adverse Event|2
37281|NCT01703741|162438|P1|Overall Study|Withdrawal by Subject|6
37282|NCT01703286|162481|P6|Period 2 Including Washout|Adverse Event|0
37283|NCT01703286|162482|P5|Period 2 Including Washout|Adverse Event|0
37284|NCT01703286|162483|P4|Period 2 Including Washout|Adverse Event|1
37285|NCT01703286|162484|P3|Period 2 Including Washout|Adverse Event|0
37286|NCT01703286|162485|P2|Period 2 Including Washout|Adverse Event|0
37287|NCT01703286|162486|P1|Period 2 Including Washout|Adverse Event|0
37288|NCT01703286|162481|P6|Period 1 Including Washout|Withdrawal by Subject|1
37289|NCT01703286|162482|P5|Period 1 Including Washout|Withdrawal by Subject|0
37290|NCT01703286|162483|P4|Period 1 Including Washout|Withdrawal by Subject|1
37291|NCT01703286|162484|P3|Period 1 Including Washout|Withdrawal by Subject|0
37292|NCT01703286|162485|P2|Period 1 Including Washout|Withdrawal by Subject|0
37293|NCT01703286|162486|P1|Period 1 Including Washout|Withdrawal by Subject|0
37294|NCT01703260|162509|P3|Overall Study|Study Termination|0
37295|NCT01703260|162510|P2|Overall Study|Study Termination|2
37296|NCT01703260|162511|P1|Overall Study|Study Termination|1
37297|NCT01703260|162509|P3|Overall Study|Withdrawal by Subject|1
37298|NCT01703260|162510|P2|Overall Study|Withdrawal by Subject|0
37299|NCT01703260|162511|P1|Overall Study|Withdrawal by Subject|0
37300|NCT01703260|162509|P3|Overall Study|Lost to Follow-up|0
37301|NCT01703260|162510|P2|Overall Study|Lost to Follow-up|0
37302|NCT01703260|162511|P1|Overall Study|Lost to Follow-up|1
37303|NCT01703260|162509|P3|Overall Study|Adverse Event|2
37304|NCT01703260|162510|P2|Overall Study|Adverse Event|2
37305|NCT01703260|162511|P1|Overall Study|Adverse Event|1
37306|NCT01703221|162537|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
37307|NCT01703221|162538|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
37308|NCT01703221|162539|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
37309|NCT01703221|162537|P3|Phase B - (Week 25 to 52)|Adverse Event|2
37310|NCT01703221|162538|P2|Phase B - (Week 25 to 52)|Adverse Event|3
37311|NCT01703221|162539|P1|Phase B - (Week 25 to 52)|Adverse Event|2
37312|NCT01703221|162537|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
37313|NCT01703221|162538|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
37314|NCT01703221|162539|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
37315|NCT01703221|162537|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
37316|NCT01703221|162538|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
37317|NCT01703221|162539|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
37318|NCT01703221|162537|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
37319|NCT01703221|162538|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
37320|NCT01703221|162539|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
37321|NCT01703221|162537|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
37322|NCT01703221|162538|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
37323|NCT01703221|162539|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
37324|NCT01703221|162537|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
37325|NCT01703221|162538|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
37326|NCT01703221|162539|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
37327|NCT01703221|162537|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
37328|NCT01703221|162538|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
37329|NCT01703221|162539|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
37330|NCT01703208|162570|P2|Overall Study|Protocol Deviation|0
37331|NCT01703208|162571|P1|Overall Study|Protocol Deviation|2
37332|NCT01703208|162570|P2|Overall Study|Technical Problems|1
37333|NCT01703208|162571|P1|Overall Study|Technical Problems|0
37334|NCT01703208|162570|P2|Overall Study|Adverse Event|19
37335|NCT01703208|162571|P1|Overall Study|Adverse Event|14
37336|NCT01703208|162570|P2|Overall Study|Withdrawal by Subject|209
37337|NCT01703208|162571|P1|Overall Study|Withdrawal by Subject|205
37338|NCT01703208|162570|P2|Overall Study|Study Terminated by Sponsor|1716
37339|NCT01703208|162571|P1|Overall Study|Study Terminated by Sponsor|1710
37340|NCT01703208|162570|P2|Overall Study|Protocol Violation|1
37341|NCT01703208|162571|P1|Overall Study|Protocol Violation|1
37342|NCT01703208|162570|P2|Overall Study|Progressive disease|2
37343|NCT01703208|162571|P1|Overall Study|Progressive disease|2
37344|NCT01703208|162570|P2|Overall Study|Physician Decision|13
37345|NCT01703208|162571|P1|Overall Study|Physician Decision|11
37346|NCT01703208|162570|P2|Overall Study|Site Discontinued Study Participation|27
37347|NCT01703208|162571|P1|Overall Study|Site Discontinued Study Participation|23
37348|NCT01703208|162570|P2|Overall Study|Excluded Medication|2
37349|NCT01703208|162571|P1|Overall Study|Excluded Medication|1
37350|NCT01703208|162570|P2|Overall Study|Non-Compliance with Study Drug|0
37351|NCT01703208|162571|P1|Overall Study|Non-Compliance with Study Drug|1
37352|NCT01703208|162570|P2|Overall Study|Lost to Follow-up|62
37353|NCT01703208|162571|P1|Overall Study|Lost to Follow-up|68
37354|NCT01703208|162570|P2|Overall Study|Lack of Efficacy|2
37355|NCT01703208|162571|P1|Overall Study|Lack of Efficacy|1
37356|NCT01703208|162570|P2|Overall Study|Death|48
37357|NCT01703208|162571|P1|Overall Study|Death|61
37358|NCT01703091|162635|P2|Overall Study|Sponsor Decision|0
37359|NCT01703091|162636|P1|Overall Study|Sponsor Decision|1
37360|NCT01703091|162635|P2|Overall Study|Withdrawal by Subject|0
37361|NCT01703091|162636|P1|Overall Study|Withdrawal by Subject|1
37362|NCT01703091|162635|P2|Overall Study|Physician Decision|1
37363|NCT01703091|162636|P1|Overall Study|Physician Decision|2
37364|NCT01703091|162635|P2|Overall Study|Adverse Event|3
37365|NCT01703091|162636|P1|Overall Study|Adverse Event|5
37366|NCT01703000|162652|P1|Overall Study|Death|1
37367|NCT01702987|162685|P2|Overall Study|Withdrawal by Subject|0
37368|NCT01702987|162686|P1|Overall Study|Withdrawal by Subject|1
37369|NCT01702961|162692|P1|Overall Study|Ongoing|11
37370|NCT01702961|162692|P1|Overall Study|Lost to Follow-up|2
37371|NCT01702961|162692|P1|Overall Study|Death|6
37372|NCT01702961|162692|P1|Overall Study|Relapse|20
37373|NCT01702961|162692|P1|Overall Study|Progressive disease|5
37374|NCT01702961|162692|P1|Overall Study|Additional treatment|3
37375|NCT01702532|162712|P2|Overall Study|Adverse Event|1
37376|NCT01702532|162713|P1|Overall Study|Adverse Event|0
37377|NCT01702519|162723|P2|Washout Period|Withdrawal by Subject|2
37378|NCT01702519|162724|P1|Washout Period|Withdrawal by Subject|0
37379|NCT01702519|162723|P2|Washout Period|Lost to Follow-up|0
37380|NCT01702519|162724|P1|Washout Period|Lost to Follow-up|1
37381|NCT01702454|162742|P2|Overall Study|Lost to Follow-up|6
37382|NCT01702454|162743|P1|Overall Study|Lost to Follow-up|3
37383|NCT01702454|162742|P2|Overall Study|Migrated/moved from study area|1
37384|NCT01702454|162743|P1|Overall Study|Migrated/moved from study area|0
37385|NCT01702454|162742|P2|Overall Study|Consent withdrawal|1
37386|NCT01702454|162743|P1|Overall Study|Consent withdrawal|0
37387|NCT01702363|162821|P1|Overall Study|Withdrawal by Subject|2
37388|NCT01702363|162821|P1|Overall Study|Lack of Efficacy|4
37389|NCT01702363|162821|P1|Overall Study|Adverse Event|14
37390|NCT01702311|162838|P2|Overall Study|Physician Decision|4
37391|NCT01702311|162839|P1|Overall Study|Physician Decision|3
37392|NCT01702311|162838|P2|Overall Study|Discharge less than 24 hours|7
37393|NCT01702311|162839|P1|Overall Study|Discharge less than 24 hours|10
37394|NCT01702311|162838|P2|Overall Study|Withdrawal by Subject|2
37395|NCT01702311|162839|P1|Overall Study|Withdrawal by Subject|3
37396|NCT01702298|162869|P1|Overall Study|Withdrawal by Subject|1
37397|NCT01702246|162897|P1|Overall Study|Physician Decision|1
37398|NCT01702246|162897|P1|Overall Study|Withdrawal by Subject|2
37399|NCT01702246|162897|P1|Overall Study|Lost to Follow-up|2
37400|NCT01702025|162951|P4|Overall Study|Adverse Event|0
37401|NCT01702025|162952|P3|Overall Study|Adverse Event|1
37402|NCT01702025|162953|P2|Overall Study|Adverse Event|1
37403|NCT01702025|162954|P1|Overall Study|Adverse Event|1
37404|NCT01702025|162951|P4|Overall Study|Equipment failure|0
37405|NCT01702025|162952|P3|Overall Study|Equipment failure|0
37406|NCT01702025|162953|P2|Overall Study|Equipment failure|0
37407|NCT01702025|162954|P1|Overall Study|Equipment failure|1
37408|NCT01701973|162983|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
37409|NCT01701973|162984|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
37410|NCT01701973|162985|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
37411|NCT01701973|162986|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
37412|NCT01701973|162987|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
37413|NCT01701973|162988|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
37414|NCT01701973|162989|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
37415|NCT01701973|162990|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
37416|NCT01701674|163037|P1|Overall Study|Unable to safely complete treatment|1
37417|NCT01701401|163123|P4|Overall Study|Protocol Violation|0
37418|NCT01701401|163124|P3|Overall Study|Protocol Violation|1
37419|NCT01701401|163125|P2|Overall Study|Protocol Violation|0
37420|NCT01701401|163126|P1|Overall Study|Protocol Violation|0
37421|NCT01701401|163123|P4|Overall Study|Adverse Event|0
37422|NCT01701401|163124|P3|Overall Study|Adverse Event|0
37423|NCT01701401|163125|P2|Overall Study|Adverse Event|0
37424|NCT01701401|163126|P1|Overall Study|Adverse Event|1
37425|NCT01701401|163123|P4|Overall Study|Lack of Efficacy|0
37426|NCT01701401|163124|P3|Overall Study|Lack of Efficacy|2
37427|NCT01701401|163125|P2|Overall Study|Lack of Efficacy|0
37428|NCT01701401|163126|P1|Overall Study|Lack of Efficacy|1
37429|NCT01701401|163123|P4|Overall Study|Withdrew Consent|2
37430|NCT01701401|163124|P3|Overall Study|Withdrew Consent|1
37431|NCT01701401|163125|P2|Overall Study|Withdrew Consent|3
37432|NCT01701401|163126|P1|Overall Study|Withdrew Consent|0
37433|NCT01701401|163123|P4|Overall Study|Lost to Follow-up|3
37434|NCT01701401|163124|P3|Overall Study|Lost to Follow-up|1
37435|NCT01701401|163125|P2|Overall Study|Lost to Follow-up|5
37436|NCT01701401|163126|P1|Overall Study|Lost to Follow-up|5
37437|NCT01701401|163123|P4|Overall Study|Randomized But Not Treated|1
37438|NCT01701401|163124|P3|Overall Study|Randomized But Not Treated|0
37439|NCT01701401|163125|P2|Overall Study|Randomized But Not Treated|1
37440|NCT01701401|163126|P1|Overall Study|Randomized But Not Treated|3
37441|NCT01701362|163178|P2|Overall Study|Reasons other than those mentioned above|5
37442|NCT01701362|163179|P1|Overall Study|Reasons other than those mentioned above|3
37443|NCT01701362|163178|P2|Overall Study|Randomized but not treated|2
37444|NCT01701362|163179|P1|Overall Study|Randomized but not treated|1
37445|NCT01701362|163178|P2|Overall Study|Death|1
37446|NCT01701362|163179|P1|Overall Study|Death|0
37447|NCT01701362|163178|P2|Overall Study|Insufficient clinical response|6
37448|NCT01701362|163179|P1|Overall Study|Insufficient clinical response|6
37449|NCT01701362|163178|P2|Overall Study|Lost to Follow-up|9
37450|NCT01701362|163179|P1|Overall Study|Lost to Follow-up|6
37451|NCT01701362|163178|P2|Overall Study|No longer willing to participate|14
37452|NCT01701362|163179|P1|Overall Study|No longer willing to participate|8
37453|NCT01701362|163178|P2|Overall Study|Protocol Violation|3
37454|NCT01701362|163179|P1|Overall Study|Protocol Violation|5
37455|NCT01701362|163178|P2|Overall Study|Adverse events related to study drug|10
37456|NCT01701362|163179|P1|Overall Study|Adverse events related to study drug|12
37457|NCT01701362|163178|P2|Overall Study|Adverse events not related to study drug|6
37458|NCT01701362|163179|P1|Overall Study|Adverse events not related to study drug|1
37459|NCT01701258|163217|P13|Assessment and Scheduling|Investigator Terminated|0
37460|NCT01701258|163218|P12|Assessment and Scheduling|Investigator Terminated|0
37461|NCT01701258|163219|P11|Assessment and Scheduling|Investigator Terminated|0
37462|NCT01701258|163220|P10|Assessment and Scheduling|Investigator Terminated|0
37463|NCT01701258|163221|P9|Assessment and Scheduling|Investigator Terminated|0
37464|NCT01701258|163222|P8|Assessment and Scheduling|Investigator Terminated|0
37465|NCT01701258|163223|P7|Assessment and Scheduling|Investigator Terminated|0
37466|NCT01701258|163224|P6|Assessment and Scheduling|Investigator Terminated|0
37467|NCT01701258|163225|P5|Assessment and Scheduling|Investigator Terminated|0
37468|NCT01701258|163226|P4|Assessment and Scheduling|Investigator Terminated|0
37469|NCT01701258|163227|P3|Assessment and Scheduling|Investigator Terminated|0
37470|NCT01701258|163228|P2|Assessment and Scheduling|Investigator Terminated|0
37471|NCT01701258|163229|P1|Assessment and Scheduling|Investigator Terminated|2
37472|NCT01701258|163217|P13|Assessment and Scheduling|Withdrawal by Subject|0
37473|NCT01701258|163218|P12|Assessment and Scheduling|Withdrawal by Subject|0
37474|NCT01701258|163219|P11|Assessment and Scheduling|Withdrawal by Subject|0
37475|NCT01701258|163220|P10|Assessment and Scheduling|Withdrawal by Subject|0
37476|NCT01701258|163221|P9|Assessment and Scheduling|Withdrawal by Subject|0
37477|NCT01701258|163222|P8|Assessment and Scheduling|Withdrawal by Subject|0
37478|NCT01701258|163223|P7|Assessment and Scheduling|Withdrawal by Subject|0
37479|NCT01701258|163224|P6|Assessment and Scheduling|Withdrawal by Subject|0
37480|NCT01701258|163225|P5|Assessment and Scheduling|Withdrawal by Subject|0
37481|NCT01701258|163226|P4|Assessment and Scheduling|Withdrawal by Subject|0
37482|NCT01701258|163227|P3|Assessment and Scheduling|Withdrawal by Subject|0
37483|NCT01701258|163228|P2|Assessment and Scheduling|Withdrawal by Subject|0
37484|NCT01701258|163229|P1|Assessment and Scheduling|Withdrawal by Subject|14
37485|NCT01701258|163217|P13|Assessment and Scheduling|Lost to Follow-up|0
37486|NCT01701258|163218|P12|Assessment and Scheduling|Lost to Follow-up|0
37487|NCT01701258|163219|P11|Assessment and Scheduling|Lost to Follow-up|0
37488|NCT01701258|163220|P10|Assessment and Scheduling|Lost to Follow-up|0
37489|NCT01701258|163221|P9|Assessment and Scheduling|Lost to Follow-up|0
37490|NCT01701258|163222|P8|Assessment and Scheduling|Lost to Follow-up|0
37491|NCT01701258|163223|P7|Assessment and Scheduling|Lost to Follow-up|0
37492|NCT01701258|163224|P6|Assessment and Scheduling|Lost to Follow-up|0
37493|NCT01701258|163225|P5|Assessment and Scheduling|Lost to Follow-up|0
37494|NCT01701258|163226|P4|Assessment and Scheduling|Lost to Follow-up|0
37495|NCT01701258|163227|P3|Assessment and Scheduling|Lost to Follow-up|0
37496|NCT01701258|163228|P2|Assessment and Scheduling|Lost to Follow-up|0
37497|NCT01701258|163229|P1|Assessment and Scheduling|Lost to Follow-up|10
37498|NCT01701258|163217|P13|Assessment and Scheduling|Found to be Ineligible|0
37499|NCT01701258|163218|P12|Assessment and Scheduling|Found to be Ineligible|0
37500|NCT01701258|163219|P11|Assessment and Scheduling|Found to be Ineligible|0
37501|NCT01701258|163220|P10|Assessment and Scheduling|Found to be Ineligible|0
37502|NCT01701258|163221|P9|Assessment and Scheduling|Found to be Ineligible|0
37503|NCT01701258|163222|P8|Assessment and Scheduling|Found to be Ineligible|0
37504|NCT01701258|163223|P7|Assessment and Scheduling|Found to be Ineligible|0
37505|NCT01701258|163224|P6|Assessment and Scheduling|Found to be Ineligible|0
37506|NCT01701258|163225|P5|Assessment and Scheduling|Found to be Ineligible|0
37507|NCT01701258|163226|P4|Assessment and Scheduling|Found to be Ineligible|0
37508|NCT01701258|163227|P3|Assessment and Scheduling|Found to be Ineligible|0
37509|NCT01701258|163228|P2|Assessment and Scheduling|Found to be Ineligible|0
37510|NCT01701258|163229|P1|Assessment and Scheduling|Found to be Ineligible|57
37511|NCT01701245|163283|P2|Overall Study|Did not complete the open label period|12
37512|NCT01701245|163284|P1|Overall Study|Did not complete the open label period|11
37513|NCT01701245|163283|P2|Overall Study|Protocol Violation|3
37514|NCT01701245|163284|P1|Overall Study|Protocol Violation|1
37515|NCT01701063|163331|P3|Overall Study|Other|1
37516|NCT01701063|163332|P2|Overall Study|Other|0
37517|NCT01701063|163333|P1|Overall Study|Other|0
37518|NCT01701063|163331|P3|Overall Study|Withdrawal by Subject|1
37519|NCT01701063|163332|P2|Overall Study|Withdrawal by Subject|0
37520|NCT01701063|163333|P1|Overall Study|Withdrawal by Subject|0
37521|NCT01701063|163331|P3|Overall Study|Lost to Follow-up|0
37522|NCT01701063|163332|P2|Overall Study|Lost to Follow-up|1
37523|NCT01701063|163333|P1|Overall Study|Lost to Follow-up|0
37524|NCT01700530|163464|P3|Overall Study|Withdrawal by Subject|1
37525|NCT01700530|163465|P2|Overall Study|Withdrawal by Subject|3
37526|NCT01700530|163466|P1|Overall Study|Withdrawal by Subject|0
37527|NCT01700387|163515|P2|Overall Study|Lost to Follow-up|1
37528|NCT01700387|163516|P1|Overall Study|Lost to Follow-up|2
37529|NCT01700387|163515|P2|Overall Study|Adverse Event|1
37530|NCT01700387|163516|P1|Overall Study|Adverse Event|1
37531|NCT01700387|163515|P2|Overall Study|Withdrawal by Subject|2
37532|NCT01700387|163516|P1|Overall Study|Withdrawal by Subject|1
37533|NCT01700348|163526|P1|Overall Study|Lost to Follow-up|1
37534|NCT01700348|163526|P1|Overall Study|Withdrawal by Subject|22
37535|NCT01700192|163544|P2|Overall Study|Never received study drug|0
37536|NCT01700192|163545|P1|Overall Study|Never received study drug|1
37537|NCT01700192|163544|P2|Overall Study|Withdrawal by Subject|64
37538|NCT01700192|163545|P1|Overall Study|Withdrawal by Subject|56
37539|NCT01700192|163544|P2|Overall Study|Technical problems|1
37540|NCT01700192|163545|P1|Overall Study|Technical problems|0
37541|NCT01700192|163544|P2|Overall Study|Protocol Violation|4
37542|NCT01700192|163545|P1|Overall Study|Protocol Violation|3
37543|NCT01700192|163544|P2|Overall Study|Progressive disease|0
37544|NCT01700192|163545|P1|Overall Study|Progressive disease|1
37545|NCT01700192|163544|P2|Overall Study|Pregnancy|4
37546|NCT01700192|163545|P1|Overall Study|Pregnancy|1
37547|NCT01700192|163544|P2|Overall Study|Physician Decision|3
37548|NCT01700192|163545|P1|Overall Study|Physician Decision|2
37549|NCT01700192|163544|P2|Overall Study|Noncompliance with study drug|5
37550|NCT01700192|163545|P1|Overall Study|Noncompliance with study drug|0
37551|NCT01700192|163544|P2|Overall Study|Lost to Follow-up|29
37552|NCT01700192|163545|P1|Overall Study|Lost to Follow-up|42
37553|NCT01700192|163544|P2|Overall Study|Lack of Efficacy|0
37554|NCT01700192|163545|P1|Overall Study|Lack of Efficacy|1
37555|NCT01700192|163544|P2|Overall Study|Adverse Event|18
37556|NCT01700192|163545|P1|Overall Study|Adverse Event|73
37557|NCT01700179|163563|P1|Overall Study|Physician Decision|2
37558|NCT01700140|163570|P3|Overall Study|Inclusion/exclusion criteria deviation|0
37559|NCT01700140|163571|P2|Overall Study|Inclusion/exclusion criteria deviation|4
37560|NCT01700140|163572|P1|Overall Study|Inclusion/exclusion criteria deviation|1
37561|NCT01700140|163570|P3|Overall Study|Adverse Event|0
37562|NCT01700140|163571|P2|Overall Study|Adverse Event|1
37563|NCT01700140|163572|P1|Overall Study|Adverse Event|0
37564|NCT01700140|163570|P3|Overall Study|Aggravation of symptoms|0
37565|NCT01700140|163571|P2|Overall Study|Aggravation of symptoms|0
37566|NCT01700140|163572|P1|Overall Study|Aggravation of symptoms|1
37567|NCT01700140|163570|P3|Overall Study|Use of chemotherapy or surgical therapy|0
37568|NCT01700140|163571|P2|Overall Study|Use of chemotherapy or surgical therapy|1
37569|NCT01700140|163572|P1|Overall Study|Use of chemotherapy or surgical therapy|0
37570|NCT01700140|163570|P3|Overall Study|Discontinuation of radiotherapy|0
37571|NCT01700140|163571|P2|Overall Study|Discontinuation of radiotherapy|0
37572|NCT01700140|163572|P1|Overall Study|Discontinuation of radiotherapy|1
37573|NCT01700140|163570|P3|Overall Study|Use of rescue drugs|1
37574|NCT01700140|163571|P2|Overall Study|Use of rescue drugs|3
37575|NCT01700140|163572|P1|Overall Study|Use of rescue drugs|3
37576|NCT01699867|163613|P1|Overall Study|Screening Failure|3
37577|NCT01699815|163620|P2|Overall Study|Adverse Event|1
37578|NCT01699815|163621|P1|Overall Study|Adverse Event|0
37579|NCT01699815|163620|P2|Overall Study|record could not be located|0
37580|NCT01699815|163621|P1|Overall Study|record could not be located|1
37581|NCT01699815|163620|P2|Overall Study|Protocol Violation|7
37582|NCT01699815|163621|P1|Overall Study|Protocol Violation|4
37583|NCT01699789|163633|P2|Overall Study|Lost to Follow-up|101
37584|NCT01699789|163634|P1|Overall Study|Lost to Follow-up|83
37585|NCT01699789|163633|P2|Overall Study|Death|2
37586|NCT01699789|163634|P1|Overall Study|Death|1
37587|NCT01699789|163633|P2|Overall Study|Withdrawal by Subject|23
37588|NCT01699789|163634|P1|Overall Study|Withdrawal by Subject|18
37589|NCT01699750|163704|P2|Overall Study|Other|2
37590|NCT01699750|163705|P1|Overall Study|Other|0
37591|NCT01699750|163704|P2|Overall Study|Withdrew Consent|1
37592|NCT01699750|163705|P1|Overall Study|Withdrew Consent|0
37593|NCT01699685|163740|P2|Period 2|Lost to Follow-up|0
37594|NCT01699685|163741|P1|Period 2|Lost to Follow-up|1
37595|NCT01699685|163740|P2|Period 1|Patient request|1
37596|NCT01699685|163741|P1|Period 1|Patient request|0
37597|NCT01699685|163740|P2|Period 1|Other|1
37598|NCT01699685|163741|P1|Period 1|Other|0
37599|NCT01699685|163740|P2|Period 1|Medical or ethical, noncompliance|0
37600|NCT01699685|163741|P1|Period 1|Medical or ethical, noncompliance|2
37601|NCT01699685|163740|P2|Period 1|Adverse Event|1
37602|NCT01699685|163741|P1|Period 1|Adverse Event|1
37603|NCT01699087|163774|P1|Overall Study|Unable to make future visits|2
37604|NCT01699087|163774|P1|Overall Study|Screen failure (prior to treatment)|15
37605|NCT01699087|163774|P1|Overall Study|Lost to Follow-up|7
37606|NCT01699022|163788|P1|Overall Study|Early discontinuation from the study|3
37607|NCT01698814|163803|P2|Overall Study|Randomized in error|0
37608|NCT01698814|163804|P1|Overall Study|Randomized in error|1
37609|NCT01698814|163803|P2|Overall Study|Pregnancy|0
37610|NCT01698814|163804|P1|Overall Study|Pregnancy|1
37611|NCT01698814|163803|P2|Overall Study|Lost to Follow-up|1
37612|NCT01698814|163804|P1|Overall Study|Lost to Follow-up|0
37613|NCT01698814|163803|P2|Overall Study|Adverse Event|2
37614|NCT01698814|163804|P1|Overall Study|Adverse Event|0
37615|NCT01698801|163810|P1|Follow Up Phase|Death|4
37616|NCT01698801|163810|P1|Follow Up Phase|Withdrawal by Subject|1
37617|NCT01698801|163810|P1|Treatment Phase|Disease progression|1
37618|NCT01698801|163810|P1|Treatment Phase|Withdrawal by Subject|1
37619|NCT01698801|163810|P1|Treatment Phase|Not specified|4
37620|NCT01698801|163810|P1|Treatment Phase|Protocol Violation|1
37621|NCT01698801|163810|P1|Treatment Phase|Adverse Event|4
37622|NCT01698775|163821|P2|Phase B|Withdrawal by Subject|2
37623|NCT01698775|163822|P1|Phase B|Withdrawal by Subject|6
37624|NCT01698775|163821|P2|Phase B|Protocol Violation|1
37625|NCT01698775|163822|P1|Phase B|Protocol Violation|1
37626|NCT01698775|163821|P2|Phase B|Physician Decision|1
37627|NCT01698775|163822|P1|Phase B|Physician Decision|1
37628|NCT01698775|163821|P2|Phase B|Lost to Follow-up|1
37629|NCT01698775|163822|P1|Phase B|Lost to Follow-up|0
37630|NCT01698775|163821|P2|Phase B|Lack of Efficacy|1
37631|NCT01698775|163822|P1|Phase B|Lack of Efficacy|0
37632|NCT01698775|163821|P2|Phase B|Death|1
37633|NCT01698775|163822|P1|Phase B|Death|0
37634|NCT01698775|163821|P2|Phase B|Adverse Event|3
37635|NCT01698775|163822|P1|Phase B|Adverse Event|6
37636|NCT01698775|163821|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
37637|NCT01698775|163822|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
37638|NCT01698775|163821|P2|Phase A|Kidney [transplant]|1
37639|NCT01698775|163822|P1|Phase A|Kidney [transplant]|0
37640|NCT01698775|163821|P2|Phase A|Withdrawal by Subject|4
37641|NCT01698775|163822|P1|Phase A|Withdrawal by Subject|3
37642|NCT01698775|163821|P2|Phase A|Protocol Violation|0
37643|NCT01698775|163822|P1|Phase A|Protocol Violation|1
37644|NCT01698775|163821|P2|Phase A|Lost to Follow-up|2
37645|NCT01698775|163822|P1|Phase A|Lost to Follow-up|1
37646|NCT01698775|163821|P2|Phase A|Lack of Efficacy|0
37647|NCT01698775|163822|P1|Phase A|Lack of Efficacy|1
37648|NCT01698775|163821|P2|Phase A|Death|1
37649|NCT01698775|163822|P1|Phase A|Death|1
37650|NCT01698775|163821|P2|Phase A|Adverse Event|1
37651|NCT01698775|163822|P1|Phase A|Adverse Event|2
37652|NCT01698554|163871|P4|Overall Study|Other Miscellaneous Reasons|0
37653|NCT01698554|163872|P3|Overall Study|Other Miscellaneous Reasons|0
37654|NCT01698554|163873|P2|Overall Study|Other Miscellaneous Reasons|0
37655|NCT01698554|163874|P1|Overall Study|Other Miscellaneous Reasons|1
37656|NCT01698554|163871|P4|Overall Study|Protocol Violation|0
37657|NCT01698554|163872|P3|Overall Study|Protocol Violation|1
37658|NCT01698554|163873|P2|Overall Study|Protocol Violation|0
37659|NCT01698554|163874|P1|Overall Study|Protocol Violation|2
37660|NCT01698554|163871|P4|Overall Study|Personal Reasons|1
37661|NCT01698554|163872|P3|Overall Study|Personal Reasons|1
37662|NCT01698554|163873|P2|Overall Study|Personal Reasons|5
37663|NCT01698554|163874|P1|Overall Study|Personal Reasons|0
37664|NCT01698554|163871|P4|Overall Study|Lost to Follow-up|0
37665|NCT01698554|163872|P3|Overall Study|Lost to Follow-up|0
37666|NCT01698554|163873|P2|Overall Study|Lost to Follow-up|0
37667|NCT01698554|163874|P1|Overall Study|Lost to Follow-up|1
37668|NCT01698554|163871|P4|Overall Study|Adverse Event|1
37669|NCT01698554|163872|P3|Overall Study|Adverse Event|0
37670|NCT01698554|163873|P2|Overall Study|Adverse Event|5
37671|NCT01698554|163874|P1|Overall Study|Adverse Event|2
37672|NCT01698320|163930|P3|40-Week Open-Label Period|Lost to Follow-up|0
37673|NCT01698320|163931|P2|40-Week Open-Label Period|Lost to Follow-up|2
37674|NCT01698320|163932|P1|40-Week Open-Label Period|Lost to Follow-up|0
37675|NCT01698320|163930|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
37676|NCT01698320|163931|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
37677|NCT01698320|163932|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
37678|NCT01698320|163930|P3|40-Week Open-Label Period|Pregnancy|1
37679|NCT01698320|163931|P2|40-Week Open-Label Period|Pregnancy|2
37680|NCT01698320|163932|P1|40-Week Open-Label Period|Pregnancy|0
37681|NCT01698320|163930|P3|40-Week Open-Label Period|Withdrawal by Subject|7
37682|NCT01698320|163931|P2|40-Week Open-Label Period|Withdrawal by Subject|11
37683|NCT01698320|163932|P1|40-Week Open-Label Period|Withdrawal by Subject|0
37684|NCT01698320|163930|P3|40-Week Open-Label Period|Adverse Event|2
37685|NCT01698320|163931|P2|40-Week Open-Label Period|Adverse Event|3
37686|NCT01698320|163932|P1|40-Week Open-Label Period|Adverse Event|0
37687|NCT01698320|163930|P3|12-Week Double-Blind Period|Lost to Follow-up|4
37688|NCT01698320|163931|P2|12-Week Double-Blind Period|Lost to Follow-up|0
37689|NCT01698320|163932|P1|12-Week Double-Blind Period|Lost to Follow-up|0
37690|NCT01698320|163930|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
37691|NCT01698320|163931|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
37692|NCT01698320|163932|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
37693|NCT01698320|163930|P3|12-Week Double-Blind Period|Pregnancy|1
37694|NCT01698320|163931|P2|12-Week Double-Blind Period|Pregnancy|1
37695|NCT01698320|163932|P1|12-Week Double-Blind Period|Pregnancy|0
37696|NCT01698320|163930|P3|12-Week Double-Blind Period|Protocol Violation|2
37697|NCT01698320|163931|P2|12-Week Double-Blind Period|Protocol Violation|0
37698|NCT01698320|163932|P1|12-Week Double-Blind Period|Protocol Violation|0
37699|NCT01698320|163930|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
37700|NCT01698320|163931|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
37701|NCT01698320|163932|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
37702|NCT01698320|163930|P3|12-Week Double-Blind Period|Adverse Event|1
37703|NCT01698320|163931|P2|12-Week Double-Blind Period|Adverse Event|1
37704|NCT01698320|163932|P1|12-Week Double-Blind Period|Adverse Event|0
37705|NCT01698320|163930|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
37706|NCT01698320|163931|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
37707|NCT01698320|163932|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
37708|NCT01698320|163930|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
37709|NCT01698320|163931|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
37710|NCT01698320|163932|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
37711|NCT01698320|163930|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
37712|NCT01698320|163931|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
37713|NCT01698320|163932|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
37714|NCT01698320|163930|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
37715|NCT01698320|163931|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
37716|NCT01698320|163932|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
37717|NCT01698268|163952|P2|Overall Study|Physician Decision|1
37718|NCT01698268|163953|P1|Overall Study|Physician Decision|2
37719|NCT01697969|163959|P1|Overall Study|Did not meet inc/exc criteria|3
37720|NCT01697956|163966|P2|Overall Study|Protocol Violation|1
37721|NCT01697956|163967|P1|Overall Study|Protocol Violation|1
37722|NCT01697696|163997|P2|Overall Study|Subject/guardian decision|35
37723|NCT01697696|163998|P1|Overall Study|Subject/guardian decision|31
37724|NCT01697696|163997|P2|Overall Study|Lost to Follow-up|7
37725|NCT01697696|163998|P1|Overall Study|Lost to Follow-up|10
37726|NCT01697696|163997|P2|Overall Study|Death|2
37727|NCT01697696|163998|P1|Overall Study|Death|4
37728|NCT01697696|163997|P2|Overall Study|Physician Decision|0
37729|NCT01697696|163998|P1|Overall Study|Physician Decision|1
37730|NCT01697696|163997|P2|Overall Study|Protocol deviation|0
37731|NCT01697696|163998|P1|Overall Study|Protocol deviation|1
37732|NCT01697696|163997|P2|Overall Study|Study terminated by sponsor|3
37733|NCT01697696|163998|P1|Overall Study|Study terminated by sponsor|0
37734|NCT01697592|164030|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
37735|NCT01697592|164031|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
37736|NCT01697592|164032|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
37737|NCT01697592|164033|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
37738|NCT01697592|164034|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
37739|NCT01697592|164035|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
37740|NCT01697592|164036|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
37741|NCT01697592|164037|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
37742|NCT01697592|164038|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
37743|NCT01697592|164039|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
37744|NCT01697592|164030|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
37745|NCT01697592|164031|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
37746|NCT01697592|164032|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
37747|NCT01697592|164033|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
37748|NCT01697592|164034|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
37749|NCT01697592|164035|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
37750|NCT01697592|164036|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
37751|NCT01697592|164037|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
37752|NCT01697592|164038|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
37753|NCT01697592|164039|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
37754|NCT01697592|164030|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
37755|NCT01697592|164031|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
37756|NCT01697592|164032|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
37757|NCT01697592|164033|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
37758|NCT01697592|164034|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
37759|NCT01697592|164035|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
37760|NCT01697592|164036|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
37761|NCT01697592|164037|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
37762|NCT01697592|164038|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
37763|NCT01697592|164039|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
37764|NCT01697592|164030|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
37765|NCT01697592|164031|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
37766|NCT01697592|164032|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
37767|NCT01697592|164033|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
37768|NCT01697592|164034|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
37769|NCT01697592|164035|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
37770|NCT01697592|164036|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
37771|NCT01697592|164037|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
37772|NCT01697592|164038|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
37773|NCT01697592|164039|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
37774|NCT01697592|164030|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
37775|NCT01697592|164031|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
37776|NCT01697592|164032|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
37777|NCT01697592|164033|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
37778|NCT01697592|164034|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
37779|NCT01697592|164035|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
37780|NCT01697592|164036|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
37781|NCT01697592|164037|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
37782|NCT01697592|164038|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
37783|NCT01697592|164039|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
37784|NCT01697592|164030|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
37785|NCT01697592|164031|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
37786|NCT01697592|164032|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
37787|NCT01697592|164033|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
37788|NCT01697592|164034|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
37789|NCT01697592|164035|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
37790|NCT01697592|164036|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
37791|NCT01697592|164037|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
37792|NCT01697592|164038|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
37793|NCT01697592|164039|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
37794|NCT01697592|164030|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
37795|NCT01697592|164031|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
37796|NCT01697592|164032|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
37797|NCT01697592|164033|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
37798|NCT01697592|164034|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
37799|NCT01697592|164035|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
37800|NCT01697592|164036|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
37801|NCT01697592|164037|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
37802|NCT01697592|164038|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
37803|NCT01697592|164039|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
37804|NCT01697592|164030|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
37805|NCT01697592|164031|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
37806|NCT01697592|164032|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
37807|NCT01697592|164033|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
37808|NCT01697592|164034|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
37809|NCT01697592|164035|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
37810|NCT01697592|164036|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
37811|NCT01697592|164037|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
37812|NCT01697592|164038|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
37813|NCT01697592|164039|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
37814|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
37815|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
37816|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
37817|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
37818|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
37819|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
37820|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
37821|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
37822|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
37823|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
37824|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
37825|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
37826|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
37827|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
37828|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Participant Moved|2
37829|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Participant Moved|0
37830|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Participant Moved|0
37831|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Participant Moved|0
37832|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Participant Moved|0
37833|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Participant Moved|0
37834|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Participant Moved|0
37835|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Technical Problems|1
37836|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Technical Problems|0
37837|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Technical Problems|0
37838|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Technical Problems|0
37839|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Technical Problems|0
37840|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Technical Problems|0
37841|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Technical Problems|0
37842|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
37843|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
37844|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
37845|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
37846|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
37847|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
37848|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
37849|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
37850|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
37851|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
37852|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
37853|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
37854|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
37855|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
37856|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
37857|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
37858|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
37859|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
37860|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
37861|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
37862|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
37863|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
37864|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
37865|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
37866|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
37867|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
37868|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
37869|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
37870|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
37871|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
37872|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
37873|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
37874|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
37875|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
37876|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
38038|NCT01696643|164467|P2|Overall Study|Withdrawal by Subject|149
37877|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
37878|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
37879|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
37880|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
37881|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
37882|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
37883|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
37884|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Physician Decision|11
37885|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Physician Decision|7
37886|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Physician Decision|0
37887|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Physician Decision|0
37888|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Physician Decision|0
37889|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Physician Decision|0
37890|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Physician Decision|0
37891|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
37892|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
37893|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
37894|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
37895|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
37896|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
37897|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
37898|NCT01697579|164108|P7|Optional Extension-Cycles 2-6|Death|2
37899|NCT01697579|164109|P6|Optional Extension-Cycles 2-6|Death|0
37900|NCT01697579|164110|P5|Optional Extension-Cycles 2-6|Death|0
37901|NCT01697579|164111|P4|Optional Extension-Cycles 2-6|Death|0
37902|NCT01697579|164112|P3|Optional Extension-Cycles 2-6|Death|0
37903|NCT01697579|164113|P2|Optional Extension-Cycles 2-6|Death|0
37904|NCT01697579|164114|P1|Optional Extension-Cycles 2-6|Death|0
37905|NCT01697579|164108|P7|Base Study-Cycle 1|Technical Problems|0
37906|NCT01697579|164109|P6|Base Study-Cycle 1|Technical Problems|0
37907|NCT01697579|164110|P5|Base Study-Cycle 1|Technical Problems|0
37908|NCT01697579|164111|P4|Base Study-Cycle 1|Technical Problems|1
37909|NCT01697579|164112|P3|Base Study-Cycle 1|Technical Problems|1
37910|NCT01697579|164113|P2|Base Study-Cycle 1|Technical Problems|0
37911|NCT01697579|164114|P1|Base Study-Cycle 1|Technical Problems|0
37912|NCT01697579|164108|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
37913|NCT01697579|164109|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
37914|NCT01697579|164110|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
37915|NCT01697579|164111|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
37916|NCT01697579|164112|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
37917|NCT01697579|164113|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
37918|NCT01697579|164114|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
37919|NCT01697579|164108|P7|Base Study-Cycle 1|Protocol Violation|0
37920|NCT01697579|164109|P6|Base Study-Cycle 1|Protocol Violation|0
37921|NCT01697579|164110|P5|Base Study-Cycle 1|Protocol Violation|3
37922|NCT01697579|164111|P4|Base Study-Cycle 1|Protocol Violation|0
37923|NCT01697579|164112|P3|Base Study-Cycle 1|Protocol Violation|0
37924|NCT01697579|164113|P2|Base Study-Cycle 1|Protocol Violation|0
37925|NCT01697579|164114|P1|Base Study-Cycle 1|Protocol Violation|0
37926|NCT01697579|164108|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
37927|NCT01697579|164109|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
37928|NCT01697579|164110|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
37929|NCT01697579|164111|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
37930|NCT01697579|164112|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
37931|NCT01697579|164113|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
37932|NCT01697579|164114|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
37933|NCT01697579|164108|P7|Base Study-Cycle 1|Adverse Event|0
37934|NCT01697579|164109|P6|Base Study-Cycle 1|Adverse Event|0
37935|NCT01697579|164110|P5|Base Study-Cycle 1|Adverse Event|0
37936|NCT01697579|164111|P4|Base Study-Cycle 1|Adverse Event|0
37937|NCT01697579|164112|P3|Base Study-Cycle 1|Adverse Event|0
37938|NCT01697579|164113|P2|Base Study-Cycle 1|Adverse Event|0
37939|NCT01697579|164114|P1|Base Study-Cycle 1|Adverse Event|1
37940|NCT01697501|164226|P1|Overall Study|Protocol Violation|2
37941|NCT01697462|164269|P1|Overall Study|Missing|5
37942|NCT01697462|164269|P1|Overall Study|Other|10
37943|NCT01697462|164269|P1|Overall Study|Death|1
37944|NCT01697462|164269|P1|Overall Study|Investigator Decision|21
37945|NCT01697462|164269|P1|Overall Study|Withdrawal by Subject|12
37946|NCT01697462|164269|P1|Overall Study|Lost to Follow-up|21
37947|NCT01697462|164269|P1|Overall Study|Adverse Event|6
37948|NCT01697462|164269|P1|Overall Study|Disease Progression|1
37949|NCT01697449|164276|P1|Overall Study|Missing|25
37950|NCT01697449|164276|P1|Overall Study|Other|1
37951|NCT01697449|164276|P1|Overall Study|Death|2
37952|NCT01697449|164276|P1|Overall Study|Physician Decision|1
37953|NCT01697449|164276|P1|Overall Study|Withdrawal by Subject|2
37954|NCT01697449|164276|P1|Overall Study|Lost to Follow-up|5
37955|NCT01697449|164276|P1|Overall Study|Adverse Event|7
37956|NCT01697449|164276|P1|Overall Study|Disease progression|47
37957|NCT01697358|164287|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
37958|NCT01697358|164288|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
37959|NCT01697358|164287|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
37960|NCT01697358|164288|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
37961|NCT01697358|164287|P2|Period II: 6-24M Long-term Follow-up|Death|1
37962|NCT01697358|164288|P1|Period II: 6-24M Long-term Follow-up|Death|1
37963|NCT01697358|164287|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
37964|NCT01697358|164288|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
37965|NCT01697358|164287|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
37966|NCT01697358|164288|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
37967|NCT01697358|164287|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
37968|NCT01697358|164288|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
37969|NCT01697358|164287|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
37970|NCT01697358|164288|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
37971|NCT01697358|164287|P2|Period I: Randomization to 6 Months|Adverse Event|1
37972|NCT01697358|164288|P1|Period I: Randomization to 6 Months|Adverse Event|1
37973|NCT01697358|164287|P2|Period I: Randomization to 6 Months|Physician Decision|0
37974|NCT01697358|164288|P1|Period I: Randomization to 6 Months|Physician Decision|4
37975|NCT01697358|164287|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
37976|NCT01697358|164288|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
37977|NCT01697345|164304|P1|Overall Study|Withdrawal by Subject|1
37978|NCT01697319|164329|P1|Extension Phase|Terminated by Sponsor|15
37979|NCT01697319|164329|P1|Primary Phase|Withdrawal by Subject|1
37980|NCT01696994|164338|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
37981|NCT01696994|164339|P1|Overall Study|Refused Screen (Ovarian Screening)|0
37982|NCT01696994|164338|P2|Overall Study|Refused ASU (Control)|0
37983|NCT01696994|164339|P1|Overall Study|Refused ASU (Control)|311
37984|NCT01696994|164338|P2|Overall Study|No Ovaries at Baseline|4851
37985|NCT01696994|164339|P1|Overall Study|No Ovaries at Baseline|4807
37986|NCT01696994|164338|P2|Overall Study|Died Before ASU (Control)|0
37987|NCT01696994|164339|P1|Overall Study|Died Before ASU (Control)|73
37988|NCT01696994|164338|P2|Overall Study|Died Before Randomization|2
37989|NCT01696994|164339|P1|Overall Study|Died Before Randomization|1
37990|NCT01696994|164338|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
37991|NCT01696994|164339|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
37992|NCT01696981|164367|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
37993|NCT01696981|164368|P1|Overall Study|Refused Screen (Colorectal Screening)|0
37994|NCT01696981|164367|P2|Overall Study|Refused ASU (Control)|0
37995|NCT01696981|164368|P1|Overall Study|Refused ASU (Control)|920
37996|NCT01696981|164367|P2|Overall Study|Died Before ASU (Control)|0
37997|NCT01696981|164368|P1|Overall Study|Died Before ASU (Control)|278
37998|NCT01696981|164367|P2|Overall Study|Died Before Randomization|8
37999|NCT01696981|164368|P1|Overall Study|Died Before Randomization|3
38000|NCT01696981|164367|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
38001|NCT01696981|164368|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
38002|NCT01696968|164388|P2|Overall Study|Refused Screen (Lung Screening)|6796
38003|NCT01696968|164389|P1|Overall Study|Refused Screen (Lung Screening)|0
38004|NCT01696968|164388|P2|Overall Study|Refused ASU (Control)|0
38005|NCT01696968|164389|P1|Overall Study|Refused ASU (Control)|920
38006|NCT01696968|164388|P2|Overall Study|Died Before ASU (Control)|0
38007|NCT01696968|164389|P1|Overall Study|Died Before ASU (Control)|278
38008|NCT01696968|164388|P2|Overall Study|Died Before Randomization|8
38009|NCT01696968|164389|P1|Overall Study|Died Before Randomization|3
38010|NCT01696968|164388|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
38011|NCT01696968|164389|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
38012|NCT01696942|164411|P2|Overall Study|screen failure|1
38013|NCT01696942|164412|P1|Overall Study|screen failure|0
38014|NCT01696942|164411|P2|Overall Study|Protocol Violation|2
38015|NCT01696942|164412|P1|Overall Study|Protocol Violation|1
38016|NCT01696942|164411|P2|Overall Study|Withdrawal by Subject|0
38017|NCT01696942|164412|P1|Overall Study|Withdrawal by Subject|1
38018|NCT01696929|164420|P1|Overall Study|Physician Decision|1
38019|NCT01696773|164427|P2|Days 15-27, Washout|Adverse Event|0
38020|NCT01696773|164428|P1|Days 15-27, Washout|Adverse Event|1
38021|NCT01696695|164455|P1|Overall Study|Major Protocol Violation|192
38022|NCT01696695|164455|P1|Overall Study|Other|74
38023|NCT01696695|164455|P1|Overall Study|Lost to Follow-up|48
38024|NCT01696695|164455|P1|Overall Study|Withdrawal by Subject|92
38025|NCT01696695|164455|P1|Overall Study|Adverse Event|74
38026|NCT01696695|164455|P1|Overall Study|Death|29
38027|NCT01696695|164455|P1|Overall Study|Disease progression|373
38028|NCT01696643|164467|P2|Overall Study|Participant Did Not Receive Study Drug|2
38029|NCT01696643|164468|P1|Overall Study|Participant Did Not Receive Study Drug|2
38030|NCT01696643|164467|P2|Overall Study|Medical Monitor Decision|2
38031|NCT01696643|164468|P1|Overall Study|Medical Monitor Decision|0
38032|NCT01696643|164467|P2|Overall Study|Participant Incarcerated|1
38033|NCT01696643|164468|P1|Overall Study|Participant Incarcerated|0
38034|NCT01696643|164467|P2|Overall Study|Site Error|1
38035|NCT01696643|164468|P1|Overall Study|Site Error|2
38036|NCT01696643|164467|P2|Overall Study|Participant on Restricted Bed Rest|0
38037|NCT01696643|164468|P1|Overall Study|Participant on Restricted Bed Rest|1
38039|NCT01696643|164468|P1|Overall Study|Withdrawal by Subject|142
38040|NCT01696643|164467|P2|Overall Study|Study Terminated by Sponsor|294
38041|NCT01696643|164468|P1|Overall Study|Study Terminated by Sponsor|286
38042|NCT01696643|164467|P2|Overall Study|Protocol Violation|7
38043|NCT01696643|164468|P1|Overall Study|Protocol Violation|7
38044|NCT01696643|164467|P2|Overall Study|Pregnancy|1
38045|NCT01696643|164468|P1|Overall Study|Pregnancy|0
38046|NCT01696643|164467|P2|Overall Study|Physician Decision|2
38047|NCT01696643|164468|P1|Overall Study|Physician Decision|3
38048|NCT01696643|164467|P2|Overall Study|Lost to Follow-up|67
38049|NCT01696643|164468|P1|Overall Study|Lost to Follow-up|67
38050|NCT01696643|164467|P2|Overall Study|Lack of Efficacy|0
38051|NCT01696643|164468|P1|Overall Study|Lack of Efficacy|3
38052|NCT01696643|164467|P2|Overall Study|Death|2
38053|NCT01696643|164468|P1|Overall Study|Death|1
38054|NCT01696643|164467|P2|Overall Study|Adverse Event|7
38055|NCT01696643|164468|P1|Overall Study|Adverse Event|15
38056|NCT01696214|164496|P4|Overall Study|Lost to Follow-up|0
38057|NCT01696214|164497|P3|Overall Study|Lost to Follow-up|0
38058|NCT01696214|164498|P2|Overall Study|Lost to Follow-up|1
38059|NCT01696214|164499|P1|Overall Study|Lost to Follow-up|0
38060|NCT01696188|164511|P2|Overall Study|Protocol Violation|1
38061|NCT01696188|164512|P1|Overall Study|Protocol Violation|1
38062|NCT01696071|164543|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
38063|NCT01696071|164544|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
38064|NCT01696058|164572|P2|Overall Study|Other reason prematurely discontinued|3
38065|NCT01696058|164573|P1|Overall Study|Other reason prematurely discontinued|5
38066|NCT01696058|164572|P2|Overall Study|Withdrawal by Subject|6
38067|NCT01696058|164573|P1|Overall Study|Withdrawal by Subject|4
38068|NCT01696058|164572|P2|Overall Study|Lost to Follow-up|5
38069|NCT01696058|164573|P1|Overall Study|Lost to Follow-up|2
38070|NCT01696058|164572|P2|Overall Study|Protocol Violation|3
38071|NCT01696058|164573|P1|Overall Study|Protocol Violation|9
38072|NCT01696058|164572|P2|Overall Study|Lack of Efficacy|3
38073|NCT01696058|164573|P1|Overall Study|Lack of Efficacy|2
38074|NCT01696058|164572|P2|Overall Study|Adverse Event|11
38075|NCT01696058|164573|P1|Overall Study|Adverse Event|21
38076|NCT01696045|164601|P2|Overall Study|Disease progression|2
38077|NCT01696045|164602|P1|Overall Study|Disease progression|2
38078|NCT01696045|164601|P2|Overall Study|Study drug toxicity|5
38079|NCT01696045|164602|P1|Overall Study|Study drug toxicity|1
38080|NCT01695993|164621|P3|Overall Study|Changed Medical Facility|1
38081|NCT01695993|164622|P2|Overall Study|Changed Medical Facility|0
38082|NCT01695993|164623|P1|Overall Study|Changed Medical Facility|0
38083|NCT01695993|164621|P3|Overall Study|To ill to continue|0
38084|NCT01695993|164622|P2|Overall Study|To ill to continue|2
38085|NCT01695993|164623|P1|Overall Study|To ill to continue|1
38086|NCT01695993|164621|P3|Overall Study|Withdrawal by Subject|2
38087|NCT01695993|164622|P2|Overall Study|Withdrawal by Subject|2
38088|NCT01695993|164623|P1|Overall Study|Withdrawal by Subject|2
38089|NCT01695993|164621|P3|Overall Study|Lost to Follow-up|3
38090|NCT01695993|164622|P2|Overall Study|Lost to Follow-up|1
38091|NCT01695993|164623|P1|Overall Study|Lost to Follow-up|2
38092|NCT01695772|164631|P1|Overall Study|Unspecified Reason|1
38093|NCT01695772|164631|P1|Overall Study|Protocol Violation|2
38094|NCT01695772|164631|P1|Overall Study|Lost to Follow-up|4
38095|NCT01695772|164631|P1|Overall Study|Investigator Decision|5
38096|NCT01695772|164631|P1|Overall Study|Progressive Disease|8
38097|NCT01695772|164631|P1|Overall Study|Withdrawal by Subject|18
38098|NCT01695746|164643|P1|Overall Study|Participant not willing to participate|3
38099|NCT01695746|164643|P1|Overall Study|Protocol Violation|5
38100|NCT01695746|164643|P1|Overall Study|Non-compliance by the participant|3
38101|NCT01695746|164643|P1|Overall Study|Adverse Event|1
38102|NCT01695239|164692|P4|Overall Study|Protocol Violation|0
38103|NCT01695239|164693|P3|Overall Study|Protocol Violation|0
38104|NCT01695239|164694|P2|Overall Study|Protocol Violation|0
38105|NCT01695239|164695|P1|Overall Study|Protocol Violation|1
38106|NCT01695239|164692|P4|Overall Study|Lost to Follow-up|0
38107|NCT01695239|164693|P3|Overall Study|Lost to Follow-up|0
38108|NCT01695239|164694|P2|Overall Study|Lost to Follow-up|0
38109|NCT01695239|164695|P1|Overall Study|Lost to Follow-up|1
38110|NCT01695239|164692|P4|Overall Study|Sponsor Decision|0
38111|NCT01695239|164693|P3|Overall Study|Sponsor Decision|1
38112|NCT01695239|164694|P2|Overall Study|Sponsor Decision|0
38113|NCT01695239|164695|P1|Overall Study|Sponsor Decision|3
38114|NCT01695239|164692|P4|Overall Study|Withdrawal by Subject|0
38115|NCT01695239|164693|P3|Overall Study|Withdrawal by Subject|1
38116|NCT01695239|164694|P2|Overall Study|Withdrawal by Subject|1
38117|NCT01695239|164695|P1|Overall Study|Withdrawal by Subject|3
38118|NCT01695239|164692|P4|Overall Study|Lack of Efficacy|0
38119|NCT01695239|164693|P3|Overall Study|Lack of Efficacy|2
38120|NCT01695239|164694|P2|Overall Study|Lack of Efficacy|0
38121|NCT01695239|164695|P1|Overall Study|Lack of Efficacy|4
38122|NCT01695239|164692|P4|Overall Study|Adverse Event|3
38123|NCT01695239|164693|P3|Overall Study|Adverse Event|2
38124|NCT01695239|164694|P2|Overall Study|Adverse Event|2
38125|NCT01695239|164695|P1|Overall Study|Adverse Event|2
38126|NCT01695239|164692|P4|Overall Study|Entry Criteria Not Met|3
38127|NCT01695239|164693|P3|Overall Study|Entry Criteria Not Met|3
38128|NCT01695239|164694|P2|Overall Study|Entry Criteria Not Met|1
38129|NCT01695239|164695|P1|Overall Study|Entry Criteria Not Met|1
38130|NCT01695239|164692|P4|Overall Study|On Study Treatment|0
38131|NCT01695239|164693|P3|Overall Study|On Study Treatment|1
38132|NCT01695239|164694|P2|Overall Study|On Study Treatment|0
38133|NCT01695239|164695|P1|Overall Study|On Study Treatment|0
38134|NCT01694771|164811|P2|Overall Study|Other reasons|6
38135|NCT01694771|164812|P1|Overall Study|Other reasons|5
38136|NCT01694771|164811|P2|Overall Study|Consent withdrawn|9
38137|NCT01694771|164812|P1|Overall Study|Consent withdrawn|7
38138|NCT01694771|164811|P2|Overall Study|Lost to Follow-up|3
38139|NCT01694771|164812|P1|Overall Study|Lost to Follow-up|2
38140|NCT01694771|164811|P2|Overall Study|Non compliance protocol|6
38141|NCT01694771|164812|P1|Overall Study|Non compliance protocol|7
38142|NCT01694771|164811|P2|Overall Study|Lack of Efficacy|0
38143|NCT01694771|164812|P1|Overall Study|Lack of Efficacy|1
38144|NCT01694771|164811|P2|Overall Study|Adverse Event|16
38145|NCT01694771|164812|P1|Overall Study|Adverse Event|18
38146|NCT01694706|164836|P3|Overall Study|other reason not defined above|0
38147|NCT01694706|164837|P2|Overall Study|other reason not defined above|0
38148|NCT01694706|164838|P1|Overall Study|other reason not defined above|1
38149|NCT01694706|164836|P3|Overall Study|Adverse Event|0
38150|NCT01694706|164837|P2|Overall Study|Adverse Event|1
38151|NCT01694706|164838|P1|Overall Study|Adverse Event|0
38152|NCT01694420|164883|P1|Overall Study|Lost to Follow-up|3
38153|NCT01693367|165014|P2|Overall Study|Physician Decision|1
38154|NCT01693367|165015|P1|Overall Study|Physician Decision|0
38155|NCT01693367|165014|P2|Overall Study|Withdrawal by Subject|1
38156|NCT01693367|165015|P1|Overall Study|Withdrawal by Subject|1
38157|NCT01693185|165033|P2|Overall Study|diagnostic procedure after colonoscopy|6
38158|NCT01693185|165034|P1|Overall Study|diagnostic procedure after colonoscopy|0
38159|NCT01693120|165050|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
38160|NCT01693120|165050|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
38161|NCT01693120|165050|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
38162|NCT01693120|165050|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
38163|NCT01693120|165050|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
38164|NCT01693120|165050|P1|Enrollment|Not specified|1
38165|NCT01693120|165050|P1|Enrollment|Study closed|8
38166|NCT01693120|165050|P1|Enrollment|Adverse Event|1
38167|NCT01693120|165050|P1|Enrollment|Physician Decision|3
38168|NCT01693120|165050|P1|Enrollment|Protocol Violation|46
38169|NCT01693120|165050|P1|Enrollment|Withdrawal by Subject|10
38170|NCT01693120|165050|P1|Enrollment|Lost to Follow-up|1
38171|NCT01693068|165059|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
38172|NCT01693068|165060|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
38173|NCT01693068|165061|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
38174|NCT01693068|165059|P3|Randomization Period|On-study|0
38175|NCT01693068|165060|P2|Randomization Period|On-study|5
38176|NCT01693068|165061|P1|Randomization Period|On-study|2
38177|NCT01693029|165093|P2|Overall Study|Non-compliance|1
38178|NCT01693029|165094|P1|Overall Study|Non-compliance|2
38179|NCT01693029|165093|P2|Overall Study|Death|8
38180|NCT01693029|165094|P1|Overall Study|Death|5
38181|NCT01693029|165093|P2|Overall Study|Adverse Event|6
38182|NCT01693029|165094|P1|Overall Study|Adverse Event|1
38183|NCT01693029|165093|P2|Overall Study|Lost to Follow-up|1
38184|NCT01693029|165094|P1|Overall Study|Lost to Follow-up|0
38185|NCT01693029|165093|P2|Overall Study|Physician Decision|2
38186|NCT01693029|165094|P1|Overall Study|Physician Decision|0
38187|NCT01693029|165093|P2|Overall Study|Change in dialysis modality|1
38188|NCT01693029|165094|P1|Overall Study|Change in dialysis modality|2
38189|NCT01693029|165093|P2|Overall Study|Protocol Violation|7
38190|NCT01693029|165094|P1|Overall Study|Protocol Violation|6
38191|NCT01693029|165093|P2|Overall Study|Bindinging anti-EPO antibodies|2
38192|NCT01693029|165094|P1|Overall Study|Bindinging anti-EPO antibodies|6
38193|NCT01693029|165093|P2|Overall Study|Kidney transplantation|7
38194|NCT01693029|165094|P1|Overall Study|Kidney transplantation|7
38195|NCT01693029|165093|P2|Overall Study|Withdrawal by Subject|22
38196|NCT01693029|165094|P1|Overall Study|Withdrawal by Subject|15
38197|NCT01692938|165125|P2|Overall Study|Study completed prior to site completion|3
38198|NCT01692938|165126|P1|Overall Study|Study completed prior to site completion|3
38199|NCT01692938|165125|P2|Overall Study|Protocol Deviation|1
38200|NCT01692938|165126|P1|Overall Study|Protocol Deviation|1
38201|NCT01692782|165137|P3|Overall Study|Withdrawal by Subject|3
38202|NCT01692782|165138|P2|Overall Study|Withdrawal by Subject|10
38203|NCT01692782|165139|P1|Overall Study|Withdrawal by Subject|3
38204|NCT01692782|165137|P3|Overall Study|SAE not related to study drug|0
38205|NCT01692782|165138|P2|Overall Study|SAE not related to study drug|1
38206|NCT01692782|165139|P1|Overall Study|SAE not related to study drug|0
38207|NCT01692782|165137|P3|Overall Study|Non-compliant with study visits|1
38208|NCT01692782|165138|P2|Overall Study|Non-compliant with study visits|0
38209|NCT01692782|165139|P1|Overall Study|Non-compliant with study visits|0
38210|NCT01692782|165137|P3|Overall Study|Non-complance with study drug|1
38211|NCT01692782|165138|P2|Overall Study|Non-complance with study drug|4
38212|NCT01692782|165139|P1|Overall Study|Non-complance with study drug|0
38213|NCT01692782|165137|P3|Overall Study|Protocol Violation|2
38214|NCT01692782|165138|P2|Overall Study|Protocol Violation|0
38215|NCT01692782|165139|P1|Overall Study|Protocol Violation|1
38216|NCT01692782|165137|P3|Overall Study|Pregnancy|0
38217|NCT01692782|165138|P2|Overall Study|Pregnancy|0
38218|NCT01692782|165139|P1|Overall Study|Pregnancy|1
38219|NCT01692782|165137|P3|Overall Study|Lost to Follow-up|1
38220|NCT01692782|165138|P2|Overall Study|Lost to Follow-up|7
38221|NCT01692782|165139|P1|Overall Study|Lost to Follow-up|2
38222|NCT01692782|165137|P3|Overall Study|Lack of Efficacy|0
38223|NCT01692782|165138|P2|Overall Study|Lack of Efficacy|2
38224|NCT01692782|165139|P1|Overall Study|Lack of Efficacy|1
38225|NCT01692782|165137|P3|Overall Study|Adverse Event|2
38226|NCT01692782|165138|P2|Overall Study|Adverse Event|32
38227|NCT01692782|165139|P1|Overall Study|Adverse Event|12
38228|NCT01692730|165164|P2|Overall Study|Lost to Follow-up|227
38229|NCT01692730|165165|P1|Overall Study|Lost to Follow-up|225
38230|NCT01692626|165179|P2|Overall Study|Withdrawal by Subject|0
38231|NCT01692626|165180|P1|Overall Study|Withdrawal by Subject|1
38232|NCT01692626|165179|P2|Overall Study|Protocol Violation|2
38233|NCT01692626|165180|P1|Overall Study|Protocol Violation|1
38234|NCT01692626|165179|P2|Overall Study|Adverse Event|3
38235|NCT01692626|165180|P1|Overall Study|Adverse Event|2
38236|NCT01692626|165179|P2|Overall Study|Death|1
38237|NCT01692626|165180|P1|Overall Study|Death|0
38238|NCT01692301|165207|P2|Overall Study|Lost to Follow-up|1
38239|NCT01692301|165208|P1|Overall Study|Lost to Follow-up|1
38240|NCT01692301|165207|P2|Overall Study|Physician Decision|2
38241|NCT01692301|165208|P1|Overall Study|Physician Decision|2
38242|NCT01692301|165207|P2|Overall Study|Technical problems|1
38243|NCT01692301|165208|P1|Overall Study|Technical problems|0
38244|NCT01692301|165207|P2|Overall Study|Patient/guardian decision|15
38245|NCT01692301|165208|P1|Overall Study|Patient/guardian decision|16
38246|NCT01692301|165207|P2|Overall Study|Protocol deviation|2
38247|NCT01692301|165208|P1|Overall Study|Protocol deviation|9
38248|NCT01692301|165207|P2|Overall Study|Non-compliance with study treatment|2
38249|NCT01692301|165208|P1|Overall Study|Non-compliance with study treatment|1
38250|NCT01692301|165207|P2|Overall Study|Lack of Efficacy|5
38251|NCT01692301|165208|P1|Overall Study|Lack of Efficacy|0
38252|NCT01692301|165207|P2|Overall Study|Death|2
38253|NCT01692301|165208|P1|Overall Study|Death|1
38254|NCT01692301|165207|P2|Overall Study|Adverse Event|12
38255|NCT01692301|165208|P1|Overall Study|Adverse Event|15
38256|NCT01691898|165240|P6|Overall Study|Other|1
38257|NCT01691898|165241|P5|Overall Study|Other|0
38258|NCT01691898|165242|P4|Overall Study|Other|0
38259|NCT01691898|165243|P3|Overall Study|Other|1
38260|NCT01691898|165244|P2|Overall Study|Other|2
38261|NCT01691898|165245|P1|Overall Study|Other|0
38262|NCT01691898|165240|P6|Overall Study|Withdrawal by Subject|3
38263|NCT01691898|165241|P5|Overall Study|Withdrawal by Subject|2
38264|NCT01691898|165242|P4|Overall Study|Withdrawal by Subject|1
38265|NCT01691898|165243|P3|Overall Study|Withdrawal by Subject|1
38266|NCT01691898|165244|P2|Overall Study|Withdrawal by Subject|5
38267|NCT01691898|165245|P1|Overall Study|Withdrawal by Subject|8
38268|NCT01691898|165240|P6|Overall Study|Lost to Follow-up|0
38269|NCT01691898|165241|P5|Overall Study|Lost to Follow-up|0
38270|NCT01691898|165242|P4|Overall Study|Lost to Follow-up|0
38271|NCT01691898|165243|P3|Overall Study|Lost to Follow-up|0
38272|NCT01691898|165244|P2|Overall Study|Lost to Follow-up|0
38273|NCT01691898|165245|P1|Overall Study|Lost to Follow-up|1
38274|NCT01691898|165240|P6|Overall Study|Progression of Disease|2
38275|NCT01691898|165241|P5|Overall Study|Progression of Disease|1
38276|NCT01691898|165242|P4|Overall Study|Progression of Disease|0
38277|NCT01691898|165243|P3|Overall Study|Progression of Disease|1
38278|NCT01691898|165244|P2|Overall Study|Progression of Disease|3
38279|NCT01691898|165245|P1|Overall Study|Progression of Disease|2
38280|NCT01691898|165240|P6|Overall Study|Adverse Event|0
38281|NCT01691898|165241|P5|Overall Study|Adverse Event|0
38282|NCT01691898|165242|P4|Overall Study|Adverse Event|1
38283|NCT01691898|165243|P3|Overall Study|Adverse Event|0
38284|NCT01691898|165244|P2|Overall Study|Adverse Event|1
38285|NCT01691898|165245|P1|Overall Study|Adverse Event|0
38286|NCT01691898|165240|P6|Overall Study|Death|20
38287|NCT01691898|165241|P5|Overall Study|Death|5
38288|NCT01691898|165242|P4|Overall Study|Death|2
38289|NCT01691898|165243|P3|Overall Study|Death|4
38290|NCT01691898|165244|P2|Overall Study|Death|28
38291|NCT01691898|165245|P1|Overall Study|Death|31
38292|NCT01691898|165240|P6|Overall Study|Ongoing in Study|14
38293|NCT01691898|165241|P5|Overall Study|Ongoing in Study|31
38294|NCT01691898|165242|P4|Overall Study|Ongoing in Study|5
38295|NCT01691898|165243|P3|Overall Study|Ongoing in Study|11
38296|NCT01691898|165244|P2|Overall Study|Ongoing in Study|19
38297|NCT01691898|165245|P1|Overall Study|Ongoing in Study|18
38298|NCT01691885|165391|P2|Washout Period (7-9 Days)|Adverse Event|1
38299|NCT01691885|165392|P1|Washout Period (7-9 Days)|Adverse Event|0
38300|NCT01691885|165391|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
38301|NCT01691885|165392|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
38302|NCT01691859|165398|P1|Overall Study|Withdrawal by Subject|31
38303|NCT01691859|165398|P1|Overall Study|Physician Decision|6
38304|NCT01691859|165398|P1|Overall Study|Lost to Follow-up|5
38305|NCT01691859|165398|P1|Overall Study|Study closed/terminated|50
38306|NCT01691859|165398|P1|Overall Study|Product commercially available|221
38307|NCT01691859|165398|P1|Overall Study|Protocol Violation|4
38308|NCT01691859|165398|P1|Overall Study|Lack of Efficacy|11
38309|NCT01691859|165398|P1|Overall Study|Adverse Event|19
38310|NCT01691794|165420|P3|Overall Study|Did not complete first 24 weeks of study|3
38311|NCT01691794|165421|P2|Overall Study|Did not complete first 24 weeks of study|3
38312|NCT01691794|165422|P1|Overall Study|Did not complete first 24 weeks of study|0
38313|NCT01691794|165420|P3|Overall Study|Completed Only first 24 weeks of study|3
38314|NCT01691794|165421|P2|Overall Study|Completed Only first 24 weeks of study|2
38315|NCT01691794|165422|P1|Overall Study|Completed Only first 24 weeks of study|0
38316|NCT01691794|165420|P3|Overall Study|Adverse Event|1
38317|NCT01691794|165421|P2|Overall Study|Adverse Event|1
38318|NCT01691794|165422|P1|Overall Study|Adverse Event|0
38319|NCT01691794|165420|P3|Overall Study|Participant request to discontinue|0
38320|NCT01691794|165421|P2|Overall Study|Participant request to discontinue|1
38321|NCT01691794|165422|P1|Overall Study|Participant request to discontinue|0
38322|NCT01691794|165420|P3|Overall Study|Lack of Efficacy|1
38323|NCT01691794|165421|P2|Overall Study|Lack of Efficacy|7
38324|NCT01691794|165422|P1|Overall Study|Lack of Efficacy|0
38325|NCT01691794|165420|P3|Overall Study|Death|1
38326|NCT01691794|165421|P2|Overall Study|Death|0
38327|NCT01691794|165422|P1|Overall Study|Death|0
38328|NCT01691794|165420|P3|Overall Study|Poor/Non-Compliance|1
38329|NCT01691794|165421|P2|Overall Study|Poor/Non-Compliance|4
38330|NCT01691794|165422|P1|Overall Study|Poor/Non-Compliance|1
38331|NCT01691781|165438|P2|Overall Study|Adverse Event|1
38332|NCT01691781|165439|P1|Overall Study|Adverse Event|0
38333|NCT01691781|165438|P2|Overall Study|Protocol Violation|2
38334|NCT01691781|165439|P1|Overall Study|Protocol Violation|2
38335|NCT01691781|165438|P2|Overall Study|Physician Decision|1
38336|NCT01691781|165439|P1|Overall Study|Physician Decision|1
38337|NCT01691781|165438|P2|Overall Study|Withdrawal by Subject|3
38338|NCT01691781|165439|P1|Overall Study|Withdrawal by Subject|4
38339|NCT01691612|165462|P1|Overall Study|Adverse Event|1
38340|NCT01691612|165462|P1|Overall Study|deemed ineligible after 1st visit|6
38341|NCT01691521|165573|P3|Overall Study|Withdrawal by Subject|4
38342|NCT01691521|165574|P2|Overall Study|Withdrawal by Subject|9
38343|NCT01691521|165575|P1|Overall Study|Withdrawal by Subject|5
38344|NCT01691521|165573|P3|Overall Study|Physician Decision|0
38345|NCT01691521|165574|P2|Overall Study|Physician Decision|1
38346|NCT01691521|165575|P1|Overall Study|Physician Decision|2
38347|NCT01691521|165573|P3|Overall Study|Lost to Follow-up|2
38348|NCT01691521|165574|P2|Overall Study|Lost to Follow-up|2
38349|NCT01691521|165575|P1|Overall Study|Lost to Follow-up|0
38350|NCT01691521|165573|P3|Overall Study|Protocol Violation|0
38351|NCT01691521|165574|P2|Overall Study|Protocol Violation|3
38352|NCT01691521|165575|P1|Overall Study|Protocol Violation|0
38353|NCT01691521|165573|P3|Overall Study|Lack of Efficacy|2
38354|NCT01691521|165574|P2|Overall Study|Lack of Efficacy|1
38355|NCT01691521|165575|P1|Overall Study|Lack of Efficacy|1
38356|NCT01691521|165573|P3|Overall Study|Adverse Event|1
38357|NCT01691521|165574|P2|Overall Study|Adverse Event|0
38358|NCT01691521|165575|P1|Overall Study|Adverse Event|4
38359|NCT01691508|165597|P2|Overall Study|Withdrawal by Subject|0
38360|NCT01691508|165598|P1|Overall Study|Withdrawal by Subject|1
38361|NCT01691508|165597|P2|Overall Study|Adverse Event|3
38362|NCT01691508|165598|P1|Overall Study|Adverse Event|3
38363|NCT01691482|165612|P2|Treatment Period 2|Protocol Violation|1
38364|NCT01691482|165613|P1|Treatment Period 2|Protocol Violation|1
38365|NCT01691482|165612|P2|Treatment Period 2|Adverse Event|1
38366|NCT01691482|165613|P1|Treatment Period 2|Adverse Event|0
38367|NCT01691430|165631|P2|Overall Study|Lost to Follow-up|3
38368|NCT01691430|165632|P1|Overall Study|Lost to Follow-up|0
38369|NCT01691430|165631|P2|Overall Study|Withdrawal by Subject|1
38370|NCT01691430|165632|P1|Overall Study|Withdrawal by Subject|5
38371|NCT01691430|165631|P2|Overall Study|Death|16
38372|NCT01691430|165632|P1|Overall Study|Death|17
38373|NCT01691248|165729|P2|Overall Study|Not Treated|7
38374|NCT01691248|165730|P1|Overall Study|Not Treated|4
38375|NCT01691248|165729|P2|Overall Study|Reason not provided|4
38376|NCT01691248|165730|P1|Overall Study|Reason not provided|4
38377|NCT01691248|165729|P2|Overall Study|Lost to Follow-up|5
38378|NCT01691248|165730|P1|Overall Study|Lost to Follow-up|2
38379|NCT01691248|165729|P2|Overall Study|Confirmed CDAD|31
38380|NCT01691248|165730|P1|Overall Study|Confirmed CDAD|14
38381|NCT01691248|165729|P2|Overall Study|Withdrawal by Subject|18
38382|NCT01691248|165730|P1|Overall Study|Withdrawal by Subject|20
38383|NCT01691248|165729|P2|Overall Study|Adverse Event|22
38384|NCT01691248|165730|P1|Overall Study|Adverse Event|24
38385|NCT01691248|165729|P2|Overall Study|Protocol Violation|27
38386|NCT01691248|165730|P1|Overall Study|Protocol Violation|43
38387|NCT01691092|165740|P1|Overall Study|screen fail|19
38388|NCT01691092|165740|P1|Overall Study|used for different study|2
38389|NCT01691092|165740|P1|Overall Study|non-compliance|3
38390|NCT01691092|165740|P1|Overall Study|Withdrawal by Subject|3
38391|NCT01691092|165740|P1|Overall Study|Physician Decision|4
38392|NCT01691092|165740|P1|Overall Study|Lost to Follow-up|10
38393|NCT01691014|165753|P4|Overall Study|Lack of Efficacy|0
38394|NCT01691014|165754|P3|Overall Study|Lack of Efficacy|7
38395|NCT01691014|165755|P2|Overall Study|Lack of Efficacy|3
38396|NCT01691014|165756|P1|Overall Study|Lack of Efficacy|2
38397|NCT01691014|165753|P4|Overall Study|Adverse Event|1
38398|NCT01691014|165754|P3|Overall Study|Adverse Event|1
38399|NCT01691014|165755|P2|Overall Study|Adverse Event|5
38400|NCT01691014|165756|P1|Overall Study|Adverse Event|0
38401|NCT01691014|165753|P4|Overall Study|Withdrawal by Subject|1
38402|NCT01691014|165754|P3|Overall Study|Withdrawal by Subject|1
38403|NCT01691014|165755|P2|Overall Study|Withdrawal by Subject|1
38404|NCT01691014|165756|P1|Overall Study|Withdrawal by Subject|0
38405|NCT01691014|165753|P4|Overall Study|Other|0
38406|NCT01691014|165754|P3|Overall Study|Other|2
38407|NCT01691014|165755|P2|Overall Study|Other|0
38408|NCT01691014|165756|P1|Overall Study|Other|0
38409|NCT01691014|165753|P4|Overall Study|Premature Termination|3
38410|NCT01691014|165754|P3|Overall Study|Premature Termination|0
38411|NCT01691014|165755|P2|Overall Study|Premature Termination|6
38412|NCT01691014|165756|P1|Overall Study|Premature Termination|1
38413|NCT01690988|165801|P3|Overall Study|Sedated|2
38414|NCT01690988|165802|P2|Overall Study|Sedated|1
38415|NCT01690988|165803|P1|Overall Study|Sedated|1
38416|NCT01690988|165801|P3|Overall Study|Death|1
38417|NCT01690988|165802|P2|Overall Study|Death|1
38418|NCT01690988|165803|P1|Overall Study|Death|1
38419|NCT01690988|165801|P3|Overall Study|Determined ineligible|0
38420|NCT01690988|165802|P2|Overall Study|Determined ineligible|0
38421|NCT01690988|165803|P1|Overall Study|Determined ineligible|1
38422|NCT01690988|165801|P3|Overall Study|Operation Cancelled|0
38423|NCT01690988|165802|P2|Overall Study|Operation Cancelled|1
38424|NCT01690988|165803|P1|Overall Study|Operation Cancelled|1
38425|NCT01690988|165801|P3|Overall Study|Physician Decision|1
38426|NCT01690988|165802|P2|Overall Study|Physician Decision|0
38427|NCT01690988|165803|P1|Overall Study|Physician Decision|0
38428|NCT01690988|165801|P3|Overall Study|Withdrawal by Subject|3
38429|NCT01690988|165802|P2|Overall Study|Withdrawal by Subject|2
38430|NCT01690988|165803|P1|Overall Study|Withdrawal by Subject|2
38431|NCT01690299|165871|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
38432|NCT01690299|165872|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
38433|NCT01690299|165873|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
38434|NCT01690299|165874|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
38435|NCT01690299|165875|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
38436|NCT01690299|165876|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
38437|NCT01690299|165871|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
38438|NCT01690299|165872|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
38439|NCT01690299|165873|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
38440|NCT01690299|165874|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
38441|NCT01690299|165875|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
38442|NCT01690299|165876|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
38443|NCT01690299|165871|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
38444|NCT01690299|165872|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
38445|NCT01690299|165873|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
38446|NCT01690299|165874|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
38447|NCT01690299|165875|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
38448|NCT01690299|165876|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
38449|NCT01690299|165871|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
38450|NCT01690299|165872|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
38451|NCT01690299|165873|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
38452|NCT01690299|165874|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
38453|NCT01690299|165875|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
38454|NCT01690299|165876|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
38455|NCT01690299|165871|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
38456|NCT01690299|165872|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
38457|NCT01690299|165873|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
38458|NCT01690299|165874|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
38459|NCT01690299|165875|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
38460|NCT01690299|165876|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
38461|NCT01690299|165871|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
38462|NCT01690299|165872|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
38463|NCT01690299|165873|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
38464|NCT01690299|165874|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
38465|NCT01690299|165875|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
38466|NCT01690299|165876|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
38467|NCT01690299|165871|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
38468|NCT01690299|165872|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
38469|NCT01690299|165873|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
38470|NCT01690299|165874|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
38471|NCT01690299|165875|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
38472|NCT01690299|165876|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
38473|NCT01690299|165871|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
38474|NCT01690299|165872|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
38475|NCT01690299|165873|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
38476|NCT01690299|165874|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
38477|NCT01690299|165875|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
38478|NCT01690299|165876|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
38479|NCT01690299|165871|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
38480|NCT01690299|165872|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
38481|NCT01690299|165873|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
38482|NCT01690299|165874|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
38483|NCT01690299|165875|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
38484|NCT01690299|165876|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
38485|NCT01690299|165871|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
38486|NCT01690299|165872|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
38487|NCT01690299|165873|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
38488|NCT01690299|165874|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
38489|NCT01690299|165875|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
38490|NCT01690299|165876|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
38491|NCT01690052|166012|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
38492|NCT01690052|166013|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
38493|NCT01689974|166030|P2|Overall Study|Termination of Study|5
38494|NCT01689974|166031|P1|Overall Study|Termination of Study|5
38495|NCT01689857|166039|P2|Overall Study|Lost to Follow-up|2
38496|NCT01689857|166040|P1|Overall Study|Lost to Follow-up|5
38497|NCT01689649|166065|P1|Overall Study|Lost to Follow-up|5
38498|NCT01689649|166065|P1|Overall Study|Protocol Violation|3
38499|NCT01689649|166065|P1|Overall Study|Non-compliance|11
38500|NCT01689649|166065|P1|Overall Study|Lack of Efficacy|3
38501|NCT01689532|166077|P2|Overall Study|Physician Decision|0
38502|NCT01689532|166078|P1|Overall Study|Physician Decision|2
38503|NCT01689532|166077|P2|Overall Study|Withdrawal by Subject|2
38504|NCT01689532|166078|P1|Overall Study|Withdrawal by Subject|1
38505|NCT01689532|166077|P2|Overall Study|Lack of Efficacy|2
38506|NCT01689532|166078|P1|Overall Study|Lack of Efficacy|2
38507|NCT01689532|166077|P2|Overall Study|Adverse Event|5
38508|NCT01689532|166078|P1|Overall Study|Adverse Event|9
38509|NCT01689519|166142|P2|Overall Study|Physician Decision|3
38510|NCT01689519|166143|P1|Overall Study|Physician Decision|0
38511|NCT01689519|166142|P2|Overall Study|Withdrawal by Subject|17
38512|NCT01689519|166143|P1|Overall Study|Withdrawal by Subject|17
38513|NCT01689519|166142|P2|Overall Study|Lost to Follow-up|2
38514|NCT01689519|166143|P1|Overall Study|Lost to Follow-up|6
38515|NCT01689519|166142|P2|Overall Study|Death|116
38516|NCT01689519|166143|P1|Overall Study|Death|143
38517|NCT01689363|166170|P8|Overall Study|Protocol Violation|0
38518|NCT01689363|166171|P7|Overall Study|Protocol Violation|0
38519|NCT01689363|166172|P6|Overall Study|Protocol Violation|0
38520|NCT01689363|166173|P5|Overall Study|Protocol Violation|0
38521|NCT01689363|166174|P4|Overall Study|Protocol Violation|0
38522|NCT01689363|166175|P3|Overall Study|Protocol Violation|0
38523|NCT01689363|166176|P2|Overall Study|Protocol Violation|1
38524|NCT01689363|166177|P1|Overall Study|Protocol Violation|0
38525|NCT01689337|166232|P1|Overall Study|Study Discontinuation|1
38526|NCT01689207|166271|P11|Overall Study|Adverse Event|0
38527|NCT01689207|166272|P10|Overall Study|Adverse Event|0
38528|NCT01689207|166273|P9|Overall Study|Adverse Event|1
38529|NCT01689207|166274|P8|Overall Study|Adverse Event|0
38530|NCT01689207|166275|P7|Overall Study|Adverse Event|0
38531|NCT01689207|166276|P6|Overall Study|Adverse Event|1
38532|NCT01689207|166277|P5|Overall Study|Adverse Event|2
38533|NCT01689207|166278|P4|Overall Study|Adverse Event|0
38534|NCT01689207|166279|P3|Overall Study|Adverse Event|0
38535|NCT01689207|166280|P2|Overall Study|Adverse Event|1
38536|NCT01689207|166281|P1|Overall Study|Adverse Event|0
38537|NCT01688921|166388|P2|Overall Study|informed consent|0
38538|NCT01688921|166389|P1|Overall Study|informed consent|3
38539|NCT01688921|166388|P2|Overall Study|Protocol Violation|1
38540|NCT01688921|166389|P1|Overall Study|Protocol Violation|0
38541|NCT01688921|166388|P2|Overall Study|Physician Decision|1
38542|NCT01688921|166389|P1|Overall Study|Physician Decision|6
38543|NCT01688921|166388|P2|Overall Study|Lost to Follow-up|13
38544|NCT01688921|166389|P1|Overall Study|Lost to Follow-up|7
38545|NCT01688882|166414|P2|Overall Study|Administrative problems|0
38546|NCT01688882|166415|P1|Overall Study|Administrative problems|1
38547|NCT01688882|166414|P2|Overall Study|Unsatisfactory therapeutic effect|1
38548|NCT01688882|166415|P1|Overall Study|Unsatisfactory therapeutic effect|1
38549|NCT01688882|166414|P2|Overall Study|Adverse Event|0
38550|NCT01688882|166415|P1|Overall Study|Adverse Event|1
38551|NCT01688830|166460|P21|Overall Study|Lost to Follow-up|0
38552|NCT01688830|166461|P20|Overall Study|Lost to Follow-up|0
38553|NCT01688830|166462|P19|Overall Study|Lost to Follow-up|0
38554|NCT01688830|166463|P18|Overall Study|Lost to Follow-up|0
38555|NCT01688830|166464|P17|Overall Study|Lost to Follow-up|0
38556|NCT01688830|166465|P16|Overall Study|Lost to Follow-up|0
38557|NCT01688830|166466|P15|Overall Study|Lost to Follow-up|0
38558|NCT01688830|166467|P14|Overall Study|Lost to Follow-up|0
38559|NCT01688830|166468|P13|Overall Study|Lost to Follow-up|0
38560|NCT01688830|166469|P12|Overall Study|Lost to Follow-up|0
38561|NCT01688830|166470|P11|Overall Study|Lost to Follow-up|1
38562|NCT01688830|166471|P10|Overall Study|Lost to Follow-up|0
38563|NCT01688830|166472|P9|Overall Study|Lost to Follow-up|0
38564|NCT01688830|166473|P8|Overall Study|Lost to Follow-up|0
38565|NCT01688830|166474|P7|Overall Study|Lost to Follow-up|0
38566|NCT01688830|166475|P6|Overall Study|Lost to Follow-up|0
38567|NCT01688830|166476|P5|Overall Study|Lost to Follow-up|0
38568|NCT01688830|166477|P4|Overall Study|Lost to Follow-up|0
38569|NCT01688830|166478|P3|Overall Study|Lost to Follow-up|0
38570|NCT01688830|166479|P2|Overall Study|Lost to Follow-up|0
38571|NCT01688830|166480|P1|Overall Study|Lost to Follow-up|0
38572|NCT01688726|166626|P2|Overall Study|Relocated abroad|1
38573|NCT01688726|166627|P1|Overall Study|Relocated abroad|0
38574|NCT01688726|166626|P2|Overall Study|Adverse Event|0
38575|NCT01688726|166627|P1|Overall Study|Adverse Event|1
38576|NCT01688635|166639|P2|Washout 3|Withdrawal by Subject|0
38577|NCT01688635|166640|P1|Washout 3|Withdrawal by Subject|1
38578|NCT01688635|166639|P2|Washout 2|Sponsor Decision|2
38579|NCT01688635|166640|P1|Washout 2|Sponsor Decision|1
38580|NCT01688635|166639|P2|Washout 2|Withdrawal by Subject|0
38581|NCT01688635|166640|P1|Washout 2|Withdrawal by Subject|1
38582|NCT01688635|166639|P2|Washout 2|Physician Decision|0
38583|NCT01688635|166640|P1|Washout 2|Physician Decision|1
38584|NCT01688635|166639|P2|Washout 1|Physician Decision|1
38585|NCT01688635|166640|P1|Washout 1|Physician Decision|0
38586|NCT01688635|166639|P2|Washout 1|Adverse Event|1
38587|NCT01688635|166640|P1|Washout 1|Adverse Event|0
38588|NCT01688635|166639|P2|Washout 1|Withdrawal by Subject|0
38589|NCT01688635|166640|P1|Washout 1|Withdrawal by Subject|1
38590|NCT01688466|166662|P2|Overall Study|Not evaluable|1
38591|NCT01688466|166663|P1|Overall Study|Not evaluable|0
38592|NCT01688466|166662|P2|Overall Study|Adverse Event|4
38593|NCT01688466|166663|P1|Overall Study|Adverse Event|0
38594|NCT01688466|166662|P2|Overall Study|Death|1
38595|NCT01688466|166663|P1|Overall Study|Death|0
38596|NCT01688466|166662|P2|Overall Study|Withdrawal by Subject|1
38597|NCT01688466|166663|P1|Overall Study|Withdrawal by Subject|2
38598|NCT01688050|166733|P1|Overall Study|Still be eligible for follow-up|37
38599|NCT01688050|166733|P1|Overall Study|Withdrawal by Subject|2
38600|NCT01688050|166733|P1|Overall Study|Lost to Follow-up|5
38601|NCT01688050|166733|P1|Overall Study|Conversion to open repair|1
38602|NCT01688050|166733|P1|Overall Study|Death|5
38603|NCT01688037|166742|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
38604|NCT01688037|166743|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
38605|NCT01688037|166744|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
38606|NCT01688037|166742|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
38607|NCT01688037|166743|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
38608|NCT01688037|166744|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
38609|NCT01688037|166742|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
38610|NCT01688037|166743|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
38611|NCT01688037|166744|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
38612|NCT01688037|166742|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
38613|NCT01688037|166743|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
38614|NCT01688037|166744|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
38615|NCT01688037|166742|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
38616|NCT01688037|166743|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
38617|NCT01688037|166744|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
38618|NCT01688037|166742|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
38619|NCT01688037|166743|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
38620|NCT01688037|166744|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
38621|NCT01688037|166742|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
38622|NCT01688037|166743|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
38623|NCT01688037|166744|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
38624|NCT01688037|166742|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
38625|NCT01688037|166743|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
38626|NCT01688037|166744|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
38627|NCT01688037|166742|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
38628|NCT01688037|166743|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
38629|NCT01688037|166744|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
38630|NCT01688037|166742|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
38631|NCT01688037|166743|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
38632|NCT01688037|166744|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
38633|NCT01687998|166760|P2|Overall Study|Lost to Follow-up|7
38634|NCT01687998|166761|P1|Overall Study|Lost to Follow-up|9
38635|NCT01687998|166760|P2|Overall Study|Known to be Alive at Study End|62
38636|NCT01687998|166761|P1|Overall Study|Known to be Alive at Study End|54
38637|NCT01687998|166760|P2|Overall Study|Withdrawal by Subject|51
38638|NCT01687998|166761|P1|Overall Study|Withdrawal by Subject|49
38639|NCT01687712|166797|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
38640|NCT01687712|166798|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
38641|NCT01687712|166797|P2|Cycle 3|Ectopic Pregnancy|0
38642|NCT01687712|166798|P1|Cycle 3|Ectopic Pregnancy|1
38643|NCT01687712|166797|P2|Cycle 3|Early Pregnancy Loss|2
38644|NCT01687712|166798|P1|Cycle 3|Early Pregnancy Loss|1
38645|NCT01687712|166797|P2|Cycle 3|Not Biochemically Pregnant|22
38646|NCT01687712|166798|P1|Cycle 3|Not Biochemically Pregnant|21
38647|NCT01687712|166797|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
38648|NCT01687712|166798|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
38649|NCT01687712|166797|P2|Cycle 2|Still Birth|0
38650|NCT01687712|166798|P1|Cycle 2|Still Birth|1
38651|NCT01687712|166797|P2|Cycle 2|Ectopic Pregnancy|1
38652|NCT01687712|166798|P1|Cycle 2|Ectopic Pregnancy|0
38653|NCT01687712|166797|P2|Cycle 2|Early Pregnancy Loss|16
38654|NCT01687712|166798|P1|Cycle 2|Early Pregnancy Loss|18
38655|NCT01687712|166797|P2|Cycle 2|Not Biochemically Pregnant|77
38656|NCT01687712|166798|P1|Cycle 2|Not Biochemically Pregnant|74
38657|NCT01687712|166797|P2|Cycle 1|Lost to Follow-up|1
38658|NCT01687712|166798|P1|Cycle 1|Lost to Follow-up|1
38659|NCT01687712|166797|P2|Cycle 1|Intrauterine Fetal Death|1
38660|NCT01687712|166798|P1|Cycle 1|Intrauterine Fetal Death|0
38661|NCT01687712|166797|P2|Cycle 1|Abortion|0
38662|NCT01687712|166798|P1|Cycle 1|Abortion|3
38663|NCT01687712|166797|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
38664|NCT01687712|166798|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
38665|NCT01687712|166797|P2|Cycle 1|Heterotropic Pregnancy|0
38666|NCT01687712|166798|P1|Cycle 1|Heterotropic Pregnancy|1
38667|NCT01687712|166797|P2|Cycle 1|Ectopic Pregnancy|5
38668|NCT01687712|166798|P1|Cycle 1|Ectopic Pregnancy|5
38669|NCT01687712|166797|P2|Cycle 1|Early Pregnancy Loss|60
38670|NCT01687712|166798|P1|Cycle 1|Early Pregnancy Loss|43
38671|NCT01687712|166797|P2|Cycle 1|Not Biochemically Pregnant|348
38672|NCT01687712|166798|P1|Cycle 1|Not Biochemically Pregnant|386
38673|NCT01687478|166838|P2|Overall Study|Entry Criteria Not Met|2
38674|NCT01687478|166839|P1|Overall Study|Entry Criteria Not Met|6
38675|NCT01687478|166838|P2|Overall Study|Physician Decision|3
38676|NCT01687478|166839|P1|Overall Study|Physician Decision|1
38677|NCT01687478|166838|P2|Overall Study|Withdrawal by Subject|19
38678|NCT01687478|166839|P1|Overall Study|Withdrawal by Subject|21
38679|NCT01687478|166838|P2|Overall Study|Protocol Violation|2
38680|NCT01687478|166839|P1|Overall Study|Protocol Violation|0
38681|NCT01687478|166838|P2|Overall Study|Lost to Follow-up|3
38682|NCT01687478|166839|P1|Overall Study|Lost to Follow-up|1
38683|NCT01687478|166838|P2|Overall Study|Adverse Event|10
38684|NCT01687478|166839|P1|Overall Study|Adverse Event|3
38685|NCT01687296|166863|P2|Overall Study|Withdrawal by Subject|3
38686|NCT01687296|166864|P1|Overall Study|Withdrawal by Subject|6
38687|NCT01687296|166863|P2|Overall Study|Protocol Violation|1
38688|NCT01687296|166864|P1|Overall Study|Protocol Violation|0
38689|NCT01687296|166863|P2|Overall Study|Lack of Efficacy|1
38690|NCT01687296|166864|P1|Overall Study|Lack of Efficacy|1
38691|NCT01687283|166886|P2|Overall Study|Withdrawal by Subject|8
38692|NCT01687283|166887|P1|Overall Study|Withdrawal by Subject|9
38693|NCT01687283|166886|P2|Overall Study|Investigator discretion|0
38694|NCT01687283|166887|P1|Overall Study|Investigator discretion|2
38695|NCT01687283|166886|P2|Overall Study|Lost to Follow-up|1
38696|NCT01687283|166887|P1|Overall Study|Lost to Follow-up|1
38697|NCT01687283|166886|P2|Overall Study|protocol defined stopping criteria|10
38698|NCT01687283|166887|P1|Overall Study|protocol defined stopping criteria|8
38699|NCT01687283|166886|P2|Overall Study|Protocol Violation|3
38700|NCT01687283|166887|P1|Overall Study|Protocol Violation|1
38701|NCT01687283|166886|P2|Overall Study|Lack of Efficacy|1
38702|NCT01687283|166887|P1|Overall Study|Lack of Efficacy|3
38703|NCT01687283|166886|P2|Overall Study|Adverse Event|4
38704|NCT01687283|166887|P1|Overall Study|Adverse Event|11
38705|NCT01687270|166910|P1|Overall Study|Lost to Follow-up|1
38706|NCT01687270|166910|P1|Overall Study|Lack of Efficacy|11
38707|NCT01687257|166921|P3|Overall Study|Investigator's Discretion|0
38708|NCT01687257|166922|P2|Overall Study|Investigator's Discretion|3
38709|NCT01687257|166923|P1|Overall Study|Investigator's Discretion|0
38710|NCT01687257|166921|P3|Overall Study|Adverse Event|0
38711|NCT01687257|166922|P2|Overall Study|Adverse Event|0
38712|NCT01687257|166923|P1|Overall Study|Adverse Event|1
38713|NCT01687257|166921|P3|Overall Study|Subject Withdrew Consent|1
38714|NCT01687257|166922|P2|Overall Study|Subject Withdrew Consent|1
38715|NCT01687257|166923|P1|Overall Study|Subject Withdrew Consent|1
38716|NCT01687257|166921|P3|Overall Study|Efficacy Failure|5
38717|NCT01687257|166922|P2|Overall Study|Efficacy Failure|0
38718|NCT01687257|166923|P1|Overall Study|Efficacy Failure|6
38719|NCT01687218|166988|P6|Overall Study|Relocated, no follow-up planned|0
38720|NCT01687218|166989|P5|Overall Study|Relocated, no follow-up planned|0
38721|NCT01687218|166990|P4|Overall Study|Relocated, no follow-up planned|1
38722|NCT01687218|166991|P3|Overall Study|Relocated, no follow-up planned|1
38723|NCT01687218|166992|P2|Overall Study|Relocated, no follow-up planned|0
38724|NCT01687218|166993|P1|Overall Study|Relocated, no follow-up planned|1
38725|NCT01687218|166988|P6|Overall Study|Withdrawal by Subject|0
38726|NCT01687218|166989|P5|Overall Study|Withdrawal by Subject|1
38727|NCT01687218|166990|P4|Overall Study|Withdrawal by Subject|1
38728|NCT01687218|166991|P3|Overall Study|Withdrawal by Subject|0
38729|NCT01687218|166992|P2|Overall Study|Withdrawal by Subject|3
38730|NCT01687218|166993|P1|Overall Study|Withdrawal by Subject|2
38731|NCT01687101|167017|P1|Overall Study|Lost to Follow-up|7
38732|NCT01686932|167044|P2|Period 1|Adverse Event|1
38733|NCT01686932|167045|P1|Period 1|Adverse Event|1
38734|NCT01686828|167075|P4|Overall Study|Weight Loss|0
38735|NCT01686828|167076|P3|Overall Study|Weight Loss|1
38736|NCT01686828|167077|P2|Overall Study|Weight Loss|0
38737|NCT01686828|167078|P1|Overall Study|Weight Loss|0
38738|NCT01686828|167075|P4|Overall Study|New Job|0
38739|NCT01686828|167076|P3|Overall Study|New Job|0
38740|NCT01686828|167077|P2|Overall Study|New Job|1
38741|NCT01686828|167078|P1|Overall Study|New Job|0
38742|NCT01686828|167075|P4|Overall Study|Physician Decision|0
38743|NCT01686828|167076|P3|Overall Study|Physician Decision|0
38744|NCT01686828|167077|P2|Overall Study|Physician Decision|0
38745|NCT01686828|167078|P1|Overall Study|Physician Decision|1
38746|NCT01686633|167152|P3|Overall Study|Lost to Follow-up|1
38747|NCT01686633|167153|P2|Overall Study|Lost to Follow-up|1
38748|NCT01686633|167154|P1|Overall Study|Lost to Follow-up|0
38749|NCT01686633|167152|P3|Overall Study|Protocol-defined Stopping Criteria|1
38750|NCT01686633|167153|P2|Overall Study|Protocol-defined Stopping Criteria|0
38751|NCT01686633|167154|P1|Overall Study|Protocol-defined Stopping Criteria|1
38752|NCT01686633|167152|P3|Overall Study|Protocol Violation|0
38753|NCT01686633|167153|P2|Overall Study|Protocol Violation|3
38754|NCT01686633|167154|P1|Overall Study|Protocol Violation|2
38755|NCT01686633|167152|P3|Overall Study|Adverse Event|3
38756|NCT01686633|167153|P2|Overall Study|Adverse Event|3
38757|NCT01686633|167154|P1|Overall Study|Adverse Event|4
38758|NCT01686633|167152|P3|Overall Study|Physician Decision|4
38759|NCT01686633|167153|P2|Overall Study|Physician Decision|4
38760|NCT01686633|167154|P1|Overall Study|Physician Decision|3
38761|NCT01686633|167152|P3|Overall Study|Withdrawal by Subject|5
38762|NCT01686633|167153|P2|Overall Study|Withdrawal by Subject|8
38763|NCT01686633|167154|P1|Overall Study|Withdrawal by Subject|8
38764|NCT01686633|167152|P3|Overall Study|Lack of Efficacy|11
38765|NCT01686633|167153|P2|Overall Study|Lack of Efficacy|13
38766|NCT01686633|167154|P1|Overall Study|Lack of Efficacy|33
38767|NCT01686568|167179|P2|Sub-Study|Not consented for sub-study|2
38768|NCT01686568|167180|P1|Sub-Study|Not consented for sub-study|2
38769|NCT01686568|167179|P2|Main Study|Liver enzymes above range of exclusion|0
38770|NCT01686568|167180|P1|Main Study|Liver enzymes above range of exclusion|1
38771|NCT01686568|167179|P2|Main Study|Noncompliance with protocol|1
38772|NCT01686568|167180|P1|Main Study|Noncompliance with protocol|0
38773|NCT01686568|167179|P2|Main Study|Withdrawal by Subject|3
38774|NCT01686568|167180|P1|Main Study|Withdrawal by Subject|1
38775|NCT01685983|167265|P1|Overall Study|Other|7
38776|NCT01685983|167265|P1|Overall Study|Noncompliance with Study Drug|1
38777|NCT01685983|167265|P1|Overall Study|Physician Decision|13
38778|NCT01685983|167265|P1|Overall Study|Progressive Disease|32
38779|NCT01685983|167265|P1|Overall Study|Protocol Violation|2
38780|NCT01685983|167265|P1|Overall Study|Withdrawal by Subject|19
38781|NCT01685983|167265|P1|Overall Study|Death|1
38782|NCT01685983|167265|P1|Overall Study|Adverse Event|7
38783|NCT01685840|167277|P2|Overall Study|Had VAD, Dialysis or Transplant|17
38784|NCT01685840|167278|P1|Overall Study|Had VAD, Dialysis or Transplant|11
38785|NCT01685840|167277|P2|Overall Study|Futility|200
38786|NCT01685840|167278|P1|Overall Study|Futility|197
38787|NCT01685840|167277|P2|Overall Study|Withdrawal by Subject|17
38788|NCT01685840|167278|P1|Overall Study|Withdrawal by Subject|14
38789|NCT01685840|167277|P2|Overall Study|Physician Decision|7
38790|NCT01685840|167278|P1|Overall Study|Physician Decision|3
38791|NCT01685840|167277|P2|Overall Study|Lost to Follow-up|25
38792|NCT01685840|167278|P1|Overall Study|Lost to Follow-up|27
38793|NCT01685840|167277|P2|Overall Study|Death|66
38794|NCT01685840|167278|P1|Overall Study|Death|77
38795|NCT01685801|167322|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
38796|NCT01685801|167323|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
38797|NCT01685801|167324|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
38798|NCT01685801|167325|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
38799|NCT01685801|167322|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
38800|NCT01685801|167323|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
38801|NCT01685801|167324|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
38802|NCT01685801|167325|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
38803|NCT01685606|167373|P1|Overall Study|Withdrawal by Subject|1
38804|NCT01685437|167386|P1|Overall Study|Unable to make visits due to work|1
38805|NCT01685437|167386|P1|Overall Study|Protocol Violation|4
38806|NCT01685437|167386|P1|Overall Study|Adverse Event|1
38807|NCT01685437|167386|P1|Overall Study|Lost to Follow-up|3
38808|NCT01685437|167386|P1|Overall Study|Withdrawal by Subject|22
38809|NCT01685372|167400|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
38810|NCT01685372|167401|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
38811|NCT01685216|167489|P1|Overall Study|Did not receive study drug|1
38812|NCT01685203|167506|P7|Overall Study|Patient's decision|0
38813|NCT01685203|167507|P6|Overall Study|Patient's decision|1
38814|NCT01685203|167508|P5|Overall Study|Patient's decision|0
38815|NCT01685203|167509|P4|Overall Study|Patient's decision|0
38816|NCT01685203|167510|P3|Overall Study|Patient's decision|0
38817|NCT01685203|167511|P2|Overall Study|Patient's decision|0
38818|NCT01685203|167512|P1|Overall Study|Patient's decision|0
38819|NCT01685203|167506|P7|Overall Study|Adverse event and withdrew consent|0
38820|NCT01685203|167507|P6|Overall Study|Adverse event and withdrew consent|0
38821|NCT01685203|167508|P5|Overall Study|Adverse event and withdrew consent|0
38822|NCT01685203|167509|P4|Overall Study|Adverse event and withdrew consent|0
38823|NCT01685203|167510|P3|Overall Study|Adverse event and withdrew consent|0
38824|NCT01685203|167511|P2|Overall Study|Adverse event and withdrew consent|0
38825|NCT01685203|167512|P1|Overall Study|Adverse event and withdrew consent|1
38826|NCT01685203|167506|P7|Overall Study|Adverse Event|0
38827|NCT01685203|167507|P6|Overall Study|Adverse Event|2
38828|NCT01685203|167508|P5|Overall Study|Adverse Event|0
38829|NCT01685203|167509|P4|Overall Study|Adverse Event|0
38830|NCT01685203|167510|P3|Overall Study|Adverse Event|0
38831|NCT01685203|167511|P2|Overall Study|Adverse Event|0
38832|NCT01685203|167512|P1|Overall Study|Adverse Event|0
38833|NCT01685203|167506|P7|Overall Study|Lost to Follow-up|0
38834|NCT01685203|167507|P6|Overall Study|Lost to Follow-up|0
38835|NCT01685203|167508|P5|Overall Study|Lost to Follow-up|0
38836|NCT01685203|167509|P4|Overall Study|Lost to Follow-up|1
38837|NCT01685203|167510|P3|Overall Study|Lost to Follow-up|0
38838|NCT01685203|167511|P2|Overall Study|Lost to Follow-up|3
38839|NCT01685203|167512|P1|Overall Study|Lost to Follow-up|3
38840|NCT01685060|167556|P1|Overall Study|Death|8
38841|NCT01685060|167556|P1|Overall Study|Lost to Follow-up|1
38842|NCT01685060|167556|P1|Overall Study|Subject/guardian decision|20
38843|NCT01685060|167556|P1|Overall Study|Physician Decision|14
38844|NCT01685060|167556|P1|Overall Study|Progressive disease|69
38845|NCT01685060|167556|P1|Overall Study|Adverse Event|12
38846|NCT01685060|167556|P1|Overall Study|Rollover patients|16
38847|NCT01684930|167582|P2|Overall Study|Withdrawal by Subject|1
38848|NCT01684930|167583|P1|Overall Study|Withdrawal by Subject|3
38849|NCT01684878|167603|P4|Part 2: Randomized Phase|Participant noncompliance|1
38850|NCT01684878|167604|P3|Part 2: Randomized Phase|Participant noncompliance|0
38851|NCT01684878|167605|P2|Part 2: Randomized Phase|Participant noncompliance|0
38852|NCT01684878|167606|P1|Part 2: Randomized Phase|Participant noncompliance|0
38853|NCT01684878|167603|P4|Part 2: Randomized Phase|Alive at data-cut|7
38854|NCT01684878|167604|P3|Part 2: Randomized Phase|Alive at data-cut|13
38855|NCT01684878|167605|P2|Part 2: Randomized Phase|Alive at data-cut|0
38856|NCT01684878|167606|P1|Part 2: Randomized Phase|Alive at data-cut|0
38857|NCT01684878|167603|P4|Part 2: Randomized Phase|Death|68
38858|NCT01684878|167604|P3|Part 2: Randomized Phase|Death|62
38859|NCT01684878|167605|P2|Part 2: Randomized Phase|Death|0
38860|NCT01684878|167606|P1|Part 2: Randomized Phase|Death|0
38861|NCT01684878|167603|P4|Part 2: Randomized Phase|Lost to Follow-up|0
38862|NCT01684878|167604|P3|Part 2: Randomized Phase|Lost to Follow-up|2
38863|NCT01684878|167605|P2|Part 2: Randomized Phase|Lost to Follow-up|0
38864|NCT01684878|167606|P1|Part 2: Randomized Phase|Lost to Follow-up|0
38865|NCT01684878|167603|P4|Part 2: Randomized Phase|Participant withdrew consent|2
38866|NCT01684878|167604|P3|Part 2: Randomized Phase|Participant withdrew consent|1
38867|NCT01684878|167605|P2|Part 2: Randomized Phase|Participant withdrew consent|0
38868|NCT01684878|167606|P1|Part 2: Randomized Phase|Participant withdrew consent|0
38869|NCT01684878|167603|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
38870|NCT01684878|167604|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
38871|NCT01684878|167605|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
38872|NCT01684878|167606|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
38873|NCT01684878|167603|P4|Part 1: Safety Run in Phase|Death|0
38874|NCT01684878|167604|P3|Part 1: Safety Run in Phase|Death|0
38875|NCT01684878|167605|P2|Part 1: Safety Run in Phase|Death|20
38876|NCT01684878|167606|P1|Part 1: Safety Run in Phase|Death|15
38877|NCT01684878|167603|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
38878|NCT01684878|167604|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
38879|NCT01684878|167605|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
38880|NCT01684878|167606|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
38881|NCT01684423|167710|P5|Overall Study|Withdrawal by Subject|0
38882|NCT01684423|167711|P4|Overall Study|Withdrawal by Subject|0
38883|NCT01684423|167712|P3|Overall Study|Withdrawal by Subject|1
38884|NCT01684423|167713|P2|Overall Study|Withdrawal by Subject|0
38885|NCT01684423|167714|P1|Overall Study|Withdrawal by Subject|0
38886|NCT01684215|167771|P4|Overall Study|Ongoing at date of cut-off|38
38887|NCT01684215|167772|P3|Overall Study|Ongoing at date of cut-off|4
38888|NCT01684215|167773|P2|Overall Study|Ongoing at date of cut-off|0
38889|NCT01684215|167774|P1|Overall Study|Ongoing at date of cut-off|0
38890|NCT01684215|167771|P4|Overall Study|Death|1
38891|NCT01684215|167772|P3|Overall Study|Death|0
38892|NCT01684215|167773|P2|Overall Study|Death|0
38893|NCT01684215|167774|P1|Overall Study|Death|0
38894|NCT01684215|167771|P4|Overall Study|Other|0
38895|NCT01684215|167772|P3|Overall Study|Other|1
38896|NCT01684215|167773|P2|Overall Study|Other|0
38897|NCT01684215|167774|P1|Overall Study|Other|0
38898|NCT01684215|167771|P4|Overall Study|Objective progression or relapse|0
38899|NCT01684215|167772|P3|Overall Study|Objective progression or relapse|0
38900|NCT01684215|167773|P2|Overall Study|Objective progression or relapse|6
38901|NCT01684215|167774|P1|Overall Study|Objective progression or relapse|5
38902|NCT01684215|167771|P4|Overall Study|Adverse Event|4
38903|NCT01684215|167772|P3|Overall Study|Adverse Event|1
38904|NCT01684215|167773|P2|Overall Study|Adverse Event|0
38905|NCT01684215|167774|P1|Overall Study|Adverse Event|1
38906|NCT01684046|167848|P2|Period 1, First 30 Days|Adverse Event|2
38907|NCT01684046|167849|P1|Period 1, First 30 Days|Adverse Event|0
38908|NCT01684033|167855|P2|Period 2, Second 30 Days|Adverse Event|0
38909|NCT01684033|167856|P1|Period 2, Second 30 Days|Adverse Event|1
38910|NCT01684033|167855|P2|Period 1, First 30 Days|Lost to Follow-up|0
38911|NCT01684033|167856|P1|Period 1, First 30 Days|Lost to Follow-up|1
38912|NCT01684033|167855|P2|Period 1, First 30 Days|Withdrawal by Subject|0
38913|NCT01684033|167856|P1|Period 1, First 30 Days|Withdrawal by Subject|1
38914|NCT01684033|167855|P2|Period 1, First 30 Days|Noncompliance|0
38915|NCT01684033|167856|P1|Period 1, First 30 Days|Noncompliance|1
38916|NCT01684033|167855|P2|Period 1, First 30 Days|Adverse Event|1
38917|NCT01684033|167856|P1|Period 1, First 30 Days|Adverse Event|1
38918|NCT01683838|167890|P2|Overall Study|not specified|3
38919|NCT01683838|167891|P1|Overall Study|not specified|4
38920|NCT01683838|167890|P2|Overall Study|Lost to Follow-up|1
38921|NCT01683838|167891|P1|Overall Study|Lost to Follow-up|1
38922|NCT01683838|167890|P2|Overall Study|Withdrawal by Subject|5
38923|NCT01683838|167891|P1|Overall Study|Withdrawal by Subject|6
38924|NCT01683838|167890|P2|Overall Study|Protocol Violation|1
38925|NCT01683838|167891|P1|Overall Study|Protocol Violation|3
38926|NCT01683838|167890|P2|Overall Study|Adverse Event|2
38927|NCT01683838|167891|P1|Overall Study|Adverse Event|12
38928|NCT01683604|167931|P1|Overall Study|Other|2
38929|NCT01683604|167931|P1|Overall Study|Lack of Efficacy|1
38930|NCT01683604|167931|P1|Overall Study|Adverse Event|2
38931|NCT01683409|168116|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
38932|NCT01683409|168117|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
38933|NCT01683409|168118|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
38934|NCT01683409|168119|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
38935|NCT01683409|168120|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
38936|NCT01683409|168116|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
38937|NCT01683409|168117|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
38938|NCT01683409|168118|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
38939|NCT01683409|168119|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
38940|NCT01683409|168120|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
38941|NCT01683409|168116|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
38942|NCT01683409|168117|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
38943|NCT01683409|168118|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
38944|NCT01683409|168119|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
38945|NCT01683409|168120|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
38946|NCT01683409|168116|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
38947|NCT01683409|168117|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
38948|NCT01683409|168118|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
38949|NCT01683409|168119|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
38950|NCT01683409|168120|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
38951|NCT01683409|168116|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
38952|NCT01683409|168117|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
38953|NCT01683409|168118|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
38954|NCT01683409|168119|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
38955|NCT01683409|168120|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
38956|NCT01683409|168116|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
38957|NCT01683409|168117|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
38958|NCT01683409|168118|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
38959|NCT01683409|168119|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
38960|NCT01683409|168120|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
38961|NCT01683409|168116|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
38962|NCT01683409|168117|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
38963|NCT01683409|168118|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
38964|NCT01683409|168119|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
38965|NCT01683409|168120|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
38966|NCT01683409|168116|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
38967|NCT01683409|168117|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
38968|NCT01683409|168118|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
38969|NCT01683409|168119|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
38970|NCT01683409|168120|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
38971|NCT01683409|168116|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
38972|NCT01683409|168117|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
38973|NCT01683409|168118|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
38974|NCT01683409|168119|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
38975|NCT01683409|168120|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
38976|NCT01683409|168116|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
38977|NCT01683409|168117|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
38978|NCT01683409|168118|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
38979|NCT01683409|168119|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
38980|NCT01683409|168120|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
38981|NCT01683409|168116|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
38982|NCT01683409|168117|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
38983|NCT01683409|168118|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
38984|NCT01683409|168119|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
38985|NCT01683409|168120|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
38986|NCT01683383|168163|P2|Overall Study|Infant was not transported|0
38987|NCT01683383|168164|P1|Overall Study|Infant was not transported|1
38988|NCT01683266|168180|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
38989|NCT01683266|168181|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
38990|NCT01683266|168180|P2|Overall Study|Possibly Hypoglycemia|0
38991|NCT01683266|168181|P1|Overall Study|Possibly Hypoglycemia|1
38992|NCT01683266|168180|P2|Overall Study|Perceived Lack of Efficacy|1
38993|NCT01683266|168181|P1|Overall Study|Perceived Lack of Efficacy|1
38994|NCT01683266|168180|P2|Overall Study|Nonserious Hypoglycemia|3
38995|NCT01683266|168181|P1|Overall Study|Nonserious Hypoglycemia|0
38996|NCT01683266|168180|P2|Overall Study|Site Closure / Site Withdrawal|3
38997|NCT01683266|168181|P1|Overall Study|Site Closure / Site Withdrawal|1
38998|NCT01683266|168180|P2|Overall Study|Lost to Follow-up|0
38999|NCT01683266|168181|P1|Overall Study|Lost to Follow-up|5
39000|NCT01683266|168180|P2|Overall Study|Selection Criterion / Protocol Violation|5
39001|NCT01683266|168181|P1|Overall Study|Selection Criterion / Protocol Violation|7
39002|NCT01683266|168180|P2|Overall Study|Personal Reason|25
39003|NCT01683266|168181|P1|Overall Study|Personal Reason|17
39004|NCT01683266|168180|P2|Overall Study|Protocol Violation|6
39005|NCT01683266|168181|P1|Overall Study|Protocol Violation|13
39006|NCT01683266|168180|P2|Overall Study|Lack of Efficacy|2
39007|NCT01683266|168181|P1|Overall Study|Lack of Efficacy|5
39008|NCT01683266|168180|P2|Overall Study|Adverse Event|4
39009|NCT01683266|168181|P1|Overall Study|Adverse Event|5
39010|NCT01683058|168209|P1|Overall Study|Lack of Efficacy|2
39011|NCT01683058|168209|P1|Overall Study|Withdrawal by Subject|7
39012|NCT01683058|168209|P1|Overall Study|Subject Met Withdrawal Criteria|5
39013|NCT01683058|168209|P1|Overall Study|Adverse Event|6
39014|NCT01683058|168209|P1|Overall Study|Lost to Follow-up|9
39015|NCT01683019|168240|P3|Overall Study|Withdrawal by Subject|4
39016|NCT01683019|168241|P2|Overall Study|Withdrawal by Subject|1
39017|NCT01683019|168242|P1|Overall Study|Withdrawal by Subject|2
39018|NCT01682876|168265|P4|Overall Study|Other|1
39019|NCT01682876|168266|P3|Overall Study|Other|1
39020|NCT01682876|168267|P2|Overall Study|Other|0
39021|NCT01682876|168268|P1|Overall Study|Other|1
39022|NCT01682876|168265|P4|Overall Study|Withdrawal by Subject|2
39023|NCT01682876|168266|P3|Overall Study|Withdrawal by Subject|0
39024|NCT01682876|168267|P2|Overall Study|Withdrawal by Subject|0
39025|NCT01682876|168268|P1|Overall Study|Withdrawal by Subject|4
39026|NCT01682876|168265|P4|Overall Study|Protocol Violation|1
39027|NCT01682876|168266|P3|Overall Study|Protocol Violation|1
39028|NCT01682876|168267|P2|Overall Study|Protocol Violation|1
39029|NCT01682876|168268|P1|Overall Study|Protocol Violation|1
39030|NCT01682876|168265|P4|Overall Study|Lost to Follow-up|11
39031|NCT01682876|168266|P3|Overall Study|Lost to Follow-up|9
39032|NCT01682876|168267|P2|Overall Study|Lost to Follow-up|15
39033|NCT01682876|168268|P1|Overall Study|Lost to Follow-up|11
39034|NCT01682876|168265|P4|Overall Study|Adverse Event|1
39035|NCT01682876|168266|P3|Overall Study|Adverse Event|0
39036|NCT01682876|168267|P2|Overall Study|Adverse Event|0
39037|NCT01682876|168268|P1|Overall Study|Adverse Event|0
39038|NCT01682876|168265|P4|Overall Study|Administrative reason|3
39039|NCT01682876|168266|P3|Overall Study|Administrative reason|0
39040|NCT01682876|168267|P2|Overall Study|Administrative reason|4
39041|NCT01682876|168268|P1|Overall Study|Administrative reason|4
39042|NCT01682863|168314|P3|Overall Study|Physician Decision|1
39043|NCT01682863|168315|P2|Overall Study|Physician Decision|0
39044|NCT01682863|168316|P1|Overall Study|Physician Decision|0
39045|NCT01682863|168314|P3|Overall Study|Adverse Event|2
39046|NCT01682863|168315|P2|Overall Study|Adverse Event|1
39047|NCT01682863|168316|P1|Overall Study|Adverse Event|0
39048|NCT01682863|168314|P3|Overall Study|Technical problems|0
39049|NCT01682863|168315|P2|Overall Study|Technical problems|0
39050|NCT01682863|168316|P1|Overall Study|Technical problems|1
39051|NCT01682863|168314|P3|Overall Study|Protocol deviation|1
39052|NCT01682863|168315|P2|Overall Study|Protocol deviation|0
39053|NCT01682863|168316|P1|Overall Study|Protocol deviation|1
39054|NCT01682863|168314|P3|Overall Study|Death|4
39055|NCT01682863|168315|P2|Overall Study|Death|3
39056|NCT01682863|168316|P1|Overall Study|Death|1
39057|NCT01682863|168314|P3|Overall Study|Lost to Follow-up|6
39058|NCT01682863|168315|P2|Overall Study|Lost to Follow-up|1
39059|NCT01682863|168316|P1|Overall Study|Lost to Follow-up|5
39060|NCT01682863|168314|P3|Overall Study|Subject/guardian decision|10
39061|NCT01682863|168315|P2|Overall Study|Subject/guardian decision|12
39062|NCT01682863|168316|P1|Overall Study|Subject/guardian decision|19
39063|NCT01682837|168345|P1|Baseline|Withdrawal by Subject|5
39064|NCT01682759|168389|P2|Overall Study|Withdrawal by Subject|55
39065|NCT01682759|168390|P1|Overall Study|Withdrawal by Subject|56
39066|NCT01682759|168389|P2|Overall Study|Physician Decision|1
39067|NCT01682759|168390|P1|Overall Study|Physician Decision|1
39068|NCT01682759|168389|P2|Overall Study|Lost to Follow-up|13
39069|NCT01682759|168390|P1|Overall Study|Lost to Follow-up|10
39070|NCT01682759|168389|P2|Overall Study|Death|1
39071|NCT01682759|168390|P1|Overall Study|Death|2
39072|NCT01682720|168414|P4|Overall Study|Adverse Event|1
39073|NCT01682720|168415|P3|Overall Study|Adverse Event|1
39074|NCT01682720|168416|P2|Overall Study|Adverse Event|0
39075|NCT01682720|168417|P1|Overall Study|Adverse Event|1
39076|NCT01682720|168414|P4|Overall Study|Subject Withdrew Consent|2
39077|NCT01682720|168415|P3|Overall Study|Subject Withdrew Consent|2
39078|NCT01682720|168416|P2|Overall Study|Subject Withdrew Consent|0
39079|NCT01682720|168417|P1|Overall Study|Subject Withdrew Consent|0
39080|NCT01682720|168414|P4|Overall Study|Lost to Follow-up|6
39081|NCT01682720|168415|P3|Overall Study|Lost to Follow-up|0
39082|NCT01682720|168416|P2|Overall Study|Lost to Follow-up|1
39083|NCT01682720|168417|P1|Overall Study|Lost to Follow-up|1
39084|NCT01682720|168414|P4|Overall Study|Efficacy Failure|30
39085|NCT01682720|168415|P3|Overall Study|Efficacy Failure|3
39086|NCT01682720|168416|P2|Overall Study|Efficacy Failure|3
39087|NCT01682720|168417|P1|Overall Study|Efficacy Failure|0
39088|NCT01682720|168414|P4|Overall Study|Terminated by Sponsor|0
39089|NCT01682720|168415|P3|Overall Study|Terminated by Sponsor|0
39090|NCT01682720|168416|P2|Overall Study|Terminated by Sponsor|0
39091|NCT01682720|168417|P1|Overall Study|Terminated by Sponsor|83
39092|NCT01682720|168414|P4|Overall Study|Randomized but Not Treated|0
39093|NCT01682720|168415|P3|Overall Study|Randomized but Not Treated|1
39094|NCT01682720|168416|P2|Overall Study|Randomized but Not Treated|1
39095|NCT01682720|168417|P1|Overall Study|Randomized but Not Treated|0
39096|NCT01682681|168434|P1|Overall Study|Low compliance|13
39097|NCT01682681|168434|P1|Overall Study|Other|21
39098|NCT01682681|168434|P1|Overall Study|tapering of topiramate|5
39099|NCT01682681|168434|P1|Overall Study|Adverse Event|46
39100|NCT01682681|168434|P1|Overall Study|Lost to Follow-up|174
39101|NCT01682681|168434|P1|Overall Study|Moved to other hospital|10
39102|NCT01682681|168434|P1|Overall Study|Withdrawal by Subject|1
39103|NCT01682681|168434|P1|Overall Study|Lack of Efficacy|62
39104|NCT01682603|168463|P1|Overall Study|Lost to Follow-up|3
39105|NCT01682512|168508|P3|Overall Study|Other than stated above|2
39106|NCT01682512|168509|P2|Overall Study|Other than stated above|4
39107|NCT01682512|168510|P1|Overall Study|Other than stated above|2
39108|NCT01682512|168508|P3|Overall Study|Secondary lack of efficacy|0
39109|NCT01682512|168509|P2|Overall Study|Secondary lack of efficacy|1
39110|NCT01682512|168510|P1|Overall Study|Secondary lack of efficacy|1
39111|NCT01682512|168508|P3|Overall Study|Primary lack of efficacy|7
39112|NCT01682512|168509|P2|Overall Study|Primary lack of efficacy|7
39113|NCT01682512|168510|P1|Overall Study|Primary lack of efficacy|10
39114|NCT01682512|168508|P3|Overall Study|Protocol Violation|2
39115|NCT01682512|168509|P2|Overall Study|Protocol Violation|3
39116|NCT01682512|168510|P1|Overall Study|Protocol Violation|2
39117|NCT01682512|168508|P3|Overall Study|Lost to Follow-up|2
39118|NCT01682512|168509|P2|Overall Study|Lost to Follow-up|0
39119|NCT01682512|168510|P1|Overall Study|Lost to Follow-up|3
39120|NCT01682512|168508|P3|Overall Study|Study terminated by sponsor|0
39121|NCT01682512|168509|P2|Overall Study|Study terminated by sponsor|43
39122|NCT01682512|168510|P1|Overall Study|Study terminated by sponsor|46
39123|NCT01682512|168508|P3|Overall Study|Physician Decision|0
39124|NCT01682512|168509|P2|Overall Study|Physician Decision|2
39125|NCT01682512|168510|P1|Overall Study|Physician Decision|0
39126|NCT01682512|168508|P3|Overall Study|Withdrawal by Subject|3
39127|NCT01682512|168509|P2|Overall Study|Withdrawal by Subject|6
39128|NCT01682512|168510|P1|Overall Study|Withdrawal by Subject|2
39129|NCT01682512|168508|P3|Overall Study|Adverse Event|2
39130|NCT01682512|168509|P2|Overall Study|Adverse Event|5
39131|NCT01682512|168510|P1|Overall Study|Adverse Event|6
39132|NCT01682460|168535|P1|Overall Study|Did not meet inclusion criteria|2
39133|NCT01682460|168535|P1|Overall Study|Withdrawal by Subject|2
39134|NCT01682044|168587|P1|Overall Study|Progression|3
39135|NCT01682044|168587|P1|Overall Study|Death|1
39136|NCT01682031|168599|P2|Overall Study|Patient stopped selenium on his own|1
39137|NCT01682031|168600|P1|Overall Study|Patient stopped selenium on his own|0
39138|NCT01682031|168599|P2|Overall Study|Patient could not swallow tablets|0
39139|NCT01682031|168600|P1|Overall Study|Patient could not swallow tablets|1
39140|NCT01682031|168599|P2|Overall Study|MRI results indicate increased nodul|1
39141|NCT01682031|168600|P1|Overall Study|MRI results indicate increased nodul|0
39142|NCT01682031|168599|P2|Overall Study|Adverse Event|2
39143|NCT01682031|168600|P1|Overall Study|Adverse Event|0
39144|NCT01682031|168599|P2|Overall Study|Withdrawal by Subject|1
39145|NCT01682031|168600|P1|Overall Study|Withdrawal by Subject|0
39146|NCT01681849|168623|P3|Overall Study|Lost to Follow-up|6
39147|NCT01681849|168624|P2|Overall Study|Lost to Follow-up|2
39148|NCT01681849|168625|P1|Overall Study|Lost to Follow-up|3
39149|NCT01681849|168623|P3|Overall Study|Withdrawal by Subject|33
39150|NCT01681849|168624|P2|Overall Study|Withdrawal by Subject|5
39151|NCT01681849|168625|P1|Overall Study|Withdrawal by Subject|3
39152|NCT01681849|168623|P3|Overall Study|Protocol Violation|0
39153|NCT01681849|168624|P2|Overall Study|Protocol Violation|0
39154|NCT01681849|168625|P1|Overall Study|Protocol Violation|2
39155|NCT01681628|168636|P2|19 Months Follow-up|Lost to Follow-up|43
39156|NCT01681628|168637|P1|19 Months Follow-up|Lost to Follow-up|61
39157|NCT01681628|168636|P2|19 Months Follow-up|Death|0
39158|NCT01681628|168637|P1|19 Months Follow-up|Death|1
39159|NCT01681628|168636|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
39160|NCT01681628|168637|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
39161|NCT01681628|168636|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
39162|NCT01681628|168637|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
39163|NCT01681576|168650|P2|Period 2|Non-compliance with study treatment|0
39164|NCT01681576|168651|P1|Period 2|Non-compliance with study treatment|1
39165|NCT01681576|168650|P2|Period 2|subject/guardian decision|1
39166|NCT01681576|168651|P1|Period 2|subject/guardian decision|3
39167|NCT01681576|168650|P2|Period 1|Protocol Deviation|0
39168|NCT01681576|168651|P1|Period 1|Protocol Deviation|1
39169|NCT01681576|168650|P2|Period 1|Adverse Event|0
39170|NCT01681576|168651|P1|Period 1|Adverse Event|1
39171|NCT01681511|168667|P2|Overall Study|No post-catheter sample collected|4
39172|NCT01681511|168668|P1|Overall Study|No post-catheter sample collected|11
39173|NCT01681511|168667|P2|Overall Study|No Daily Urine Sample Collected|1
39174|NCT01681511|168668|P1|Overall Study|No Daily Urine Sample Collected|0
39175|NCT01681511|168667|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
39176|NCT01681511|168668|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
39177|NCT01681511|168667|P2|Overall Study|Failed Inclusion/Exclusion|0
39178|NCT01681511|168668|P1|Overall Study|Failed Inclusion/Exclusion|3
39179|NCT01681511|168667|P2|Overall Study|No Treatment Received|3
39180|NCT01681511|168668|P1|Overall Study|No Treatment Received|1
39181|NCT01681472|168686|P4|Overall Study|Adverse Event|0
39182|NCT01681472|168687|P3|Overall Study|Adverse Event|0
39183|NCT01681472|168688|P2|Overall Study|Adverse Event|1
39184|NCT01681472|168689|P1|Overall Study|Adverse Event|0
39185|NCT01681368|168699|P1|Overall Study|Refused further follow up|1
39186|NCT01681368|168699|P1|Overall Study|Refused further treatment|1
39187|NCT01681277|168716|P5|Overall Study|Adverse Event|0
39188|NCT01681277|168717|P4|Overall Study|Adverse Event|0
39189|NCT01681277|168718|P3|Overall Study|Adverse Event|0
39190|NCT01681277|168719|P2|Overall Study|Adverse Event|0
39191|NCT01681277|168720|P1|Overall Study|Adverse Event|1
39192|NCT01681212|168761|P1|Overall Study|Administrative reason by sponsor|1
39193|NCT01681212|168761|P1|Overall Study|No longer met study criteria|5
39194|NCT01681069|168819|P2|Overall Study|Adverse Event|1
39195|NCT01681069|168820|P1|Overall Study|Adverse Event|0
39196|NCT01681069|168819|P2|Overall Study|Protocol Violation|1
39197|NCT01681069|168820|P1|Overall Study|Protocol Violation|1
39198|NCT01681069|168819|P2|Overall Study|Withdrawal by Subject|5
39199|NCT01681069|168820|P1|Overall Study|Withdrawal by Subject|4
39200|NCT01681004|168857|P2|Study Completion|Death|1
39201|NCT01681004|168858|P1|Study Completion|Death|1
39202|NCT01681004|168857|P2|Study Completion|Site Termination|1
39203|NCT01681004|168858|P1|Study Completion|Site Termination|2
39204|NCT01681004|168857|P2|Study Completion|Physician Decision|3
39205|NCT01681004|168858|P1|Study Completion|Physician Decision|1
39206|NCT01681004|168857|P2|Study Completion|Lost to Follow-up|3
39207|NCT01681004|168858|P1|Study Completion|Lost to Follow-up|8
39208|NCT01681004|168857|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
39209|NCT01681004|168858|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
39210|NCT01680991|168915|P3|Overall Study|PD confirmed in other hospital|0
39211|NCT01680991|168916|P2|Overall Study|PD confirmed in other hospital|0
39212|NCT01680991|168917|P1|Overall Study|PD confirmed in other hospital|1
39213|NCT01680991|168915|P3|Overall Study|Bad physical condition|1
39214|NCT01680991|168916|P2|Overall Study|Bad physical condition|0
39215|NCT01680991|168917|P1|Overall Study|Bad physical condition|0
39216|NCT01680991|168915|P3|Overall Study|Physician Decision|2
39217|NCT01680991|168916|P2|Overall Study|Physician Decision|7
39218|NCT01680991|168917|P1|Overall Study|Physician Decision|0
39219|NCT01680991|168915|P3|Overall Study|Progressive disease (PD)|0
39220|NCT01680991|168916|P2|Overall Study|Progressive disease (PD)|10
39221|NCT01680991|168917|P1|Overall Study|Progressive disease (PD)|0
39222|NCT01680991|168915|P3|Overall Study|Withdrawal by Subject|0
39223|NCT01680991|168916|P2|Overall Study|Withdrawal by Subject|1
39224|NCT01680991|168917|P1|Overall Study|Withdrawal by Subject|5
39225|NCT01680991|168915|P3|Overall Study|Protocol Violation|0
39226|NCT01680991|168916|P2|Overall Study|Protocol Violation|1
39227|NCT01680991|168917|P1|Overall Study|Protocol Violation|0
39228|NCT01680991|168915|P3|Overall Study|Death|1
39229|NCT01680991|168916|P2|Overall Study|Death|0
39230|NCT01680991|168917|P1|Overall Study|Death|1
39231|NCT01680991|168915|P3|Overall Study|Adverse Event|0
39232|NCT01680991|168916|P2|Overall Study|Adverse Event|0
39233|NCT01680991|168917|P1|Overall Study|Adverse Event|1
39234|NCT01680861|168997|P2|Early Post-transplant Period|Protocol Violation|1
39235|NCT01680861|168998|P1|Early Post-transplant Period|Protocol Violation|1
39236|NCT01680497|169071|P1|Overall Study|Lost to Follow-up|2
39237|NCT01680458|169081|P1|Overall Study|Protocol Violation|3
39238|NCT01680341|169092|P2|Overall Study|Unclassified|15
39239|NCT01680341|169093|P1|Overall Study|Unclassified|18
39240|NCT01680341|169092|P2|Overall Study|Adverse Event|2
39241|NCT01680341|169093|P1|Overall Study|Adverse Event|3
39242|NCT01680159|169164|P1|Increased Dose Period|Withdrawal by Subject|2
39243|NCT01680159|169164|P1|Increased Dose Period|Adverse Event|6
39244|NCT01680159|169164|P1|Screening Period|Not meet criteria for dose-up period|7
39245|NCT01680016|169191|P4|Overall Study|Withdrawal by Subject|1
39246|NCT01680016|169192|P3|Overall Study|Withdrawal by Subject|1
39247|NCT01680016|169193|P2|Overall Study|Withdrawal by Subject|7
39248|NCT01680016|169194|P1|Overall Study|Withdrawal by Subject|5
39249|NCT01680016|169191|P4|Overall Study|Protocol Violation|0
39250|NCT01680016|169192|P3|Overall Study|Protocol Violation|0
39251|NCT01680016|169193|P2|Overall Study|Protocol Violation|1
39252|NCT01680016|169194|P1|Overall Study|Protocol Violation|0
39253|NCT01680016|169191|P4|Overall Study|The Subject went out of The Trial|0
39254|NCT01680016|169192|P3|Overall Study|The Subject went out of The Trial|3
39255|NCT01680016|169193|P2|Overall Study|The Subject went out of The Trial|0
39256|NCT01680016|169194|P1|Overall Study|The Subject went out of The Trial|1
39257|NCT01680016|169191|P4|Overall Study|Adverse Event|4
39258|NCT01680016|169192|P3|Overall Study|Adverse Event|1
39259|NCT01680016|169193|P2|Overall Study|Adverse Event|0
39260|NCT01680016|169194|P1|Overall Study|Adverse Event|0
39261|NCT01679613|169256|P4|Overall Study|other than stated above|2
39262|NCT01679613|169257|P3|Overall Study|other than stated above|2
39263|NCT01679613|169258|P2|Overall Study|other than stated above|1
39264|NCT01679613|169259|P1|Overall Study|other than stated above|0
39265|NCT01679236|169302|P2|Overall Study|Lost to Follow-up|15
39266|NCT01679236|169303|P1|Overall Study|Lost to Follow-up|15
39267|NCT01679002|169350|P3|Overall Study|Adverse Event|0
39268|NCT01679002|169351|P2|Overall Study|Adverse Event|1
39269|NCT01679002|169352|P1|Overall Study|Adverse Event|1
39270|NCT01678911|169379|P2|Second Intervention|Lost to Follow-up|0
39271|NCT01678911|169380|P1|Second Intervention|Lost to Follow-up|2
39272|NCT01678820|169426|P3|Overall Study|Not treated with double-blind study drug|2
39273|NCT01678820|169427|P2|Overall Study|Not treated with double-blind study drug|2
39274|NCT01678820|169428|P1|Overall Study|Not treated with double-blind study drug|0
39275|NCT01678820|169426|P3|Overall Study|Protocol Violation|4
39276|NCT01678820|169427|P2|Overall Study|Protocol Violation|5
39277|NCT01678820|169428|P1|Overall Study|Protocol Violation|4
39278|NCT01678820|169426|P3|Overall Study|Physician Decision|1
39279|NCT01678820|169427|P2|Overall Study|Physician Decision|0
39280|NCT01678820|169428|P1|Overall Study|Physician Decision|0
39281|NCT01678820|169426|P3|Overall Study|Non-compliance with study drug|0
39282|NCT01678820|169427|P2|Overall Study|Non-compliance with study drug|1
39283|NCT01678820|169428|P1|Overall Study|Non-compliance with study drug|0
39284|NCT01678820|169426|P3|Overall Study|Lost to Follow-up|2
39285|NCT01678820|169427|P2|Overall Study|Lost to Follow-up|2
39286|NCT01678820|169428|P1|Overall Study|Lost to Follow-up|7
39287|NCT01678820|169426|P3|Overall Study|Adverse Event|2
39288|NCT01678820|169427|P2|Overall Study|Adverse Event|2
39289|NCT01678820|169428|P1|Overall Study|Adverse Event|2
39290|NCT01678820|169426|P3|Overall Study|Protocol Specified Criteria|1
39291|NCT01678820|169427|P2|Overall Study|Protocol Specified Criteria|3
39292|NCT01678820|169428|P1|Overall Study|Protocol Specified Criteria|2
39293|NCT01678820|169426|P3|Overall Study|Withdrawal by Subject|2
39294|NCT01678820|169427|P2|Overall Study|Withdrawal by Subject|5
39295|NCT01678820|169428|P1|Overall Study|Withdrawal by Subject|2
39296|NCT01678820|169426|P3|Overall Study|Study Terminated by Sponsor|43
39297|NCT01678820|169427|P2|Overall Study|Study Terminated by Sponsor|43
39298|NCT01678820|169428|P1|Overall Study|Study Terminated by Sponsor|45
39299|NCT01678807|169473|P3|Overall Study|Withdrawn by Parent/Guardian|0
39300|NCT01678807|169474|P2|Overall Study|Withdrawn by Parent/Guardian|1
39301|NCT01678807|169475|P1|Overall Study|Withdrawn by Parent/Guardian|0
39302|NCT01678807|169473|P3|Overall Study|Adverse Event|0
39303|NCT01678807|169474|P2|Overall Study|Adverse Event|4
39304|NCT01678807|169475|P1|Overall Study|Adverse Event|4
39305|NCT01678313|169493|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
39306|NCT01678313|169494|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
39307|NCT01678313|169493|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
39308|NCT01678313|169494|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
39309|NCT01678313|169493|P2|Completed the 3-month Therapy|Physician Decision|4
39310|NCT01678313|169494|P1|Completed the 3-month Therapy|Physician Decision|3
39311|NCT01678313|169493|P2|Completed the 3-month Therapy|Lost to Follow-up|8
39312|NCT01678313|169494|P1|Completed the 3-month Therapy|Lost to Follow-up|3
39313|NCT01678131|169528|P3|Overall Study|Withdrawal by Subject|2
39314|NCT01678131|169529|P2|Overall Study|Withdrawal by Subject|0
39315|NCT01678131|169530|P1|Overall Study|Withdrawal by Subject|0
39316|NCT01678131|169528|P3|Overall Study|Adverse Event|0
39317|NCT01678131|169529|P2|Overall Study|Adverse Event|1
39318|NCT01678131|169530|P1|Overall Study|Adverse Event|0
39319|NCT01677988|169538|P1|Overall Study|Lack of Efficacy|2
39320|NCT01677936|169551|P2|Overall Study|Protocol Violation|4
39321|NCT01677936|169552|P1|Overall Study|Protocol Violation|0
39322|NCT01677936|169551|P2|Overall Study|Lost to Follow-up|0
39323|NCT01677936|169552|P1|Overall Study|Lost to Follow-up|1
39324|NCT01677936|169551|P2|Overall Study|Adverse Event|0
39325|NCT01677936|169552|P1|Overall Study|Adverse Event|1
39326|NCT01677936|169551|P2|Overall Study|Protocol Violation|0
39327|NCT01677936|169552|P1|Overall Study|Protocol Violation|3
39328|NCT01677936|169551|P2|Overall Study|Lost to Follow-up|1
39329|NCT01677936|169552|P1|Overall Study|Lost to Follow-up|4
39330|NCT01677910|169563|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
39331|NCT01677910|169564|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
39332|NCT01677910|169565|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
39333|NCT01677910|169566|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
39334|NCT01677910|169563|P4|Open-Label Extension Period (OLE)|Adverse Event|15
39335|NCT01677910|169564|P3|Open-Label Extension Period (OLE)|Adverse Event|0
39336|NCT01677910|169565|P2|Open-Label Extension Period (OLE)|Adverse Event|0
39337|NCT01677910|169566|P1|Open-Label Extension Period (OLE)|Adverse Event|0
39338|NCT01677910|169563|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
39339|NCT01677910|169564|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
39340|NCT01677910|169565|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
39341|NCT01677910|169566|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
39342|NCT01677910|169563|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
39343|NCT01677910|169564|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
39344|NCT01677910|169565|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
39345|NCT01677910|169566|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
39346|NCT01677910|169563|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
39347|NCT01677910|169564|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
39348|NCT01677910|169565|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
39349|NCT01677910|169566|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
39350|NCT01677910|169563|P4|Open-Label Extension Period (OLE)|Physician Decision|4
39351|NCT01677910|169564|P3|Open-Label Extension Period (OLE)|Physician Decision|0
39352|NCT01677910|169565|P2|Open-Label Extension Period (OLE)|Physician Decision|0
39353|NCT01677910|169566|P1|Open-Label Extension Period (OLE)|Physician Decision|0
39354|NCT01677910|169563|P4|Double-Blind Treatment Period|Reason Not Specified|0
39355|NCT01677910|169564|P3|Double-Blind Treatment Period|Reason Not Specified|0
39356|NCT01677910|169565|P2|Double-Blind Treatment Period|Reason Not Specified|1
39357|NCT01677910|169566|P1|Double-Blind Treatment Period|Reason Not Specified|0
39358|NCT01677910|169563|P4|Double-Blind Treatment Period|Withdrawal of consent|0
39359|NCT01677910|169564|P3|Double-Blind Treatment Period|Withdrawal of consent|3
39360|NCT01677910|169565|P2|Double-Blind Treatment Period|Withdrawal of consent|0
39361|NCT01677910|169566|P1|Double-Blind Treatment Period|Withdrawal of consent|1
39362|NCT01677910|169563|P4|Double-Blind Treatment Period|Physician Decision|0
39363|NCT01677910|169564|P3|Double-Blind Treatment Period|Physician Decision|1
39364|NCT01677910|169565|P2|Double-Blind Treatment Period|Physician Decision|0
39365|NCT01677910|169566|P1|Double-Blind Treatment Period|Physician Decision|0
39366|NCT01677910|169563|P4|Double-Blind Treatment Period|Adverse Event|0
39367|NCT01677910|169564|P3|Double-Blind Treatment Period|Adverse Event|3
39368|NCT01677910|169565|P2|Double-Blind Treatment Period|Adverse Event|2
39369|NCT01677910|169566|P1|Double-Blind Treatment Period|Adverse Event|6
39370|NCT01677858|169593|P5|Overall Study|Lost to Follow-up|1
39371|NCT01677858|169594|P4|Overall Study|Lost to Follow-up|0
39372|NCT01677858|169595|P3|Overall Study|Lost to Follow-up|0
39373|NCT01677858|169596|P2|Overall Study|Lost to Follow-up|0
39374|NCT01677858|169597|P1|Overall Study|Lost to Follow-up|0
39375|NCT01677858|169593|P5|Overall Study|Withdrawal by Subject|15
39376|NCT01677858|169594|P4|Overall Study|Withdrawal by Subject|0
39377|NCT01677858|169595|P3|Overall Study|Withdrawal by Subject|1
39378|NCT01677858|169596|P2|Overall Study|Withdrawal by Subject|1
39379|NCT01677858|169597|P1|Overall Study|Withdrawal by Subject|0
39380|NCT01677858|169593|P5|Overall Study|Progressive Disease|43
39381|NCT01677858|169594|P4|Overall Study|Progressive Disease|3
39382|NCT01677858|169595|P3|Overall Study|Progressive Disease|9
39383|NCT01677858|169596|P2|Overall Study|Progressive Disease|1
39384|NCT01677858|169597|P1|Overall Study|Progressive Disease|2
39385|NCT01677858|169593|P5|Overall Study|Physician Decision|12
39386|NCT01677858|169594|P4|Overall Study|Physician Decision|0
39387|NCT01677858|169595|P3|Overall Study|Physician Decision|2
39388|NCT01677858|169596|P2|Overall Study|Physician Decision|0
39389|NCT01677858|169597|P1|Overall Study|Physician Decision|1
39390|NCT01677858|169593|P5|Overall Study|Death|1
39391|NCT01677858|169594|P4|Overall Study|Death|0
39392|NCT01677858|169595|P3|Overall Study|Death|0
39393|NCT01677858|169596|P2|Overall Study|Death|0
39394|NCT01677858|169597|P1|Overall Study|Death|0
39395|NCT01677858|169593|P5|Overall Study|Adverse Event|13
39396|NCT01677858|169594|P4|Overall Study|Adverse Event|3
39397|NCT01677858|169595|P3|Overall Study|Adverse Event|2
39398|NCT01677858|169596|P2|Overall Study|Adverse Event|0
39399|NCT01677858|169597|P1|Overall Study|Adverse Event|0
39400|NCT01677767|169670|P1|Overall Study|Non-compliance by the participants|3
39401|NCT01677767|169670|P1|Overall Study|Withdrawal by Subject|10
39402|NCT01677767|169670|P1|Overall Study|Protocol Violation|4
39403|NCT01677767|169670|P1|Overall Study|Death|4
39404|NCT01677767|169670|P1|Overall Study|Adverse Event|1
39405|NCT01677624|169684|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
39406|NCT01677507|169689|P2|Second Assigment|Adverse Event|3
39407|NCT01677507|169690|P1|Second Assigment|Adverse Event|1
39408|NCT01677507|169689|P2|Second Assigment|Withdrawal by Subject|2
39409|NCT01677507|169690|P1|Second Assigment|Withdrawal by Subject|2
39410|NCT01677507|169689|P2|Initial Assignment|Protocol Violation|1
39411|NCT01677507|169690|P1|Initial Assignment|Protocol Violation|0
39412|NCT01677507|169689|P2|Initial Assignment|Adverse Event|1
39413|NCT01677507|169690|P1|Initial Assignment|Adverse Event|0
39414|NCT01677299|169704|P4|Overall Study|Withdrawal by Subject|1
39415|NCT01677299|169705|P3|Overall Study|Withdrawal by Subject|0
39416|NCT01677299|169706|P2|Overall Study|Withdrawal by Subject|1
39417|NCT01677299|169707|P1|Overall Study|Withdrawal by Subject|0
39418|NCT01677299|169704|P4|Overall Study|Adverse Event|0
39419|NCT01677299|169705|P3|Overall Study|Adverse Event|1
39420|NCT01677299|169706|P2|Overall Study|Adverse Event|2
39421|NCT01677299|169707|P1|Overall Study|Adverse Event|0
39422|NCT01677195|169739|P3|Overall Study|Protocol Violation|4
39423|NCT01677195|169740|P2|Overall Study|Protocol Violation|3
39424|NCT01677195|169741|P1|Overall Study|Protocol Violation|7
39425|NCT01677195|169739|P3|Overall Study|Pregnancy|0
39426|NCT01677195|169740|P2|Overall Study|Pregnancy|1
39427|NCT01677195|169741|P1|Overall Study|Pregnancy|0
39428|NCT01677195|169739|P3|Overall Study|Physician Decision|2
39429|NCT01677195|169740|P2|Overall Study|Physician Decision|2
39430|NCT01677195|169741|P1|Overall Study|Physician Decision|1
39431|NCT01677195|169739|P3|Overall Study|Adverse Event|1
39432|NCT01677195|169740|P2|Overall Study|Adverse Event|4
39433|NCT01677195|169741|P1|Overall Study|Adverse Event|6
39434|NCT01677195|169739|P3|Overall Study|Withdrawal by Subject|1
39435|NCT01677195|169740|P2|Overall Study|Withdrawal by Subject|0
39436|NCT01677195|169741|P1|Overall Study|Withdrawal by Subject|1
39437|NCT01677195|169739|P3|Overall Study|Lost to Follow-up|22
39438|NCT01677195|169740|P2|Overall Study|Lost to Follow-up|22
39439|NCT01677195|169741|P1|Overall Study|Lost to Follow-up|14
39440|NCT01677182|169752|P3|Overall Study|Other reasons|2
39441|NCT01677182|169753|P2|Overall Study|Other reasons|5
39442|NCT01677182|169754|P1|Overall Study|Other reasons|1
39443|NCT01677182|169752|P3|Overall Study|Lack of Efficacy|1
39444|NCT01677182|169753|P2|Overall Study|Lack of Efficacy|0
39445|NCT01677182|169754|P1|Overall Study|Lack of Efficacy|3
39446|NCT01677182|169752|P3|Overall Study|Study termination|11
39447|NCT01677182|169753|P2|Overall Study|Study termination|9
39448|NCT01677182|169754|P1|Overall Study|Study termination|12
39449|NCT01677182|169752|P3|Overall Study|Withdrawal by Subject|10
39450|NCT01677182|169753|P2|Overall Study|Withdrawal by Subject|12
39451|NCT01677182|169754|P1|Overall Study|Withdrawal by Subject|7
39452|NCT01677182|169752|P3|Overall Study|Lost to Follow-up|3
39453|NCT01677182|169753|P2|Overall Study|Lost to Follow-up|0
39454|NCT01677182|169754|P1|Overall Study|Lost to Follow-up|4
39455|NCT01677182|169752|P3|Overall Study|Protocol Violation|4
39456|NCT01677182|169753|P2|Overall Study|Protocol Violation|1
39457|NCT01677182|169754|P1|Overall Study|Protocol Violation|5
39458|NCT01677182|169752|P3|Overall Study|Adverse Event|8
39459|NCT01677182|169753|P2|Overall Study|Adverse Event|1
39460|NCT01677182|169754|P1|Overall Study|Adverse Event|2
39461|NCT01676961|169786|P1|Overall Study|Withdrawal by Subject|1
39462|NCT01676961|169786|P1|Overall Study|Lost to Follow-up|1
39463|NCT01676961|169786|P1|Overall Study|Death|3
39464|NCT01676896|169794|P3|Overall Study|Withdrawal by Subject|19
39465|NCT01676896|169795|P2|Overall Study|Withdrawal by Subject|7
39466|NCT01676896|169796|P1|Overall Study|Withdrawal by Subject|12
39467|NCT01676701|169900|P2|Overall Study|Sponsor Decision|4
39468|NCT01676701|169901|P1|Overall Study|Sponsor Decision|3
39469|NCT01676701|169900|P2|Overall Study|Protocol Violation|0
39470|NCT01676701|169901|P1|Overall Study|Protocol Violation|1
39471|NCT01676220|169986|P2|Overall Study|No More Need of Insulin|0
39472|NCT01676220|169987|P1|Overall Study|No More Need of Insulin|1
39473|NCT01676220|169986|P2|Overall Study|Non Serious Hypoglycemia|0
39474|NCT01676220|169987|P1|Overall Study|Non Serious Hypoglycemia|2
39475|NCT01676220|169986|P2|Overall Study|Perceived Lack of Efficacy|1
39476|NCT01676220|169987|P1|Overall Study|Perceived Lack of Efficacy|3
39477|NCT01676220|169986|P2|Overall Study|Site Closure/Site Withdrawal|4
39478|NCT01676220|169987|P1|Overall Study|Site Closure/Site Withdrawal|1
39479|NCT01676220|169986|P2|Overall Study|Selection Criterion/Protocol Violation|9
39480|NCT01676220|169987|P1|Overall Study|Selection Criterion/Protocol Violation|9
39481|NCT01676220|169986|P2|Overall Study|Lost to Follow-up|18
39482|NCT01676220|169987|P1|Overall Study|Lost to Follow-up|11
39483|NCT01676220|169986|P2|Overall Study|Personal Reason|45
39484|NCT01676220|169987|P1|Overall Study|Personal Reason|34
39485|NCT01676220|169986|P2|Overall Study|Received Rescue Therapy|22
39486|NCT01676220|169987|P1|Overall Study|Received Rescue Therapy|14
39487|NCT01676220|169986|P2|Overall Study|Protocol Violation|12
39488|NCT01676220|169987|P1|Overall Study|Protocol Violation|11
39489|NCT01676220|169986|P2|Overall Study|Lack of Efficacy|5
39490|NCT01676220|169987|P1|Overall Study|Lack of Efficacy|2
39491|NCT01676220|169986|P2|Overall Study|Adverse Event|8
39492|NCT01676220|169987|P1|Overall Study|Adverse Event|10
39493|NCT01676220|169986|P2|Overall Study|Randomized But Not Treated|1
39494|NCT01676220|169987|P1|Overall Study|Randomized But Not Treated|4
39495|NCT01676012|170017|P1|Overall Study|incomplete set of videos|1
39496|NCT01676012|170017|P1|Overall Study|Adverse Event|2
39497|NCT01675661|170028|P2|Overall Study|Other reason|2
39498|NCT01675661|170029|P1|Overall Study|Other reason|1
39499|NCT01675661|170028|P2|Overall Study|Death|1
39500|NCT01675661|170029|P1|Overall Study|Death|0
39501|NCT01675661|170028|P2|Overall Study|Physician Decision|2
39502|NCT01675661|170029|P1|Overall Study|Physician Decision|0
39503|NCT01675661|170028|P2|Overall Study|Withdrawal by Subject|7
39504|NCT01675661|170029|P1|Overall Study|Withdrawal by Subject|3
39505|NCT01675661|170028|P2|Overall Study|Moved away|6
39506|NCT01675661|170029|P1|Overall Study|Moved away|5
39507|NCT01675661|170028|P2|Overall Study|Practical problems|5
39508|NCT01675661|170029|P1|Overall Study|Practical problems|9
39509|NCT01675661|170028|P2|Overall Study|Lost to Follow-up|23
39510|NCT01675661|170029|P1|Overall Study|Lost to Follow-up|22
39511|NCT01675622|170058|P2|Overall Study|not specified|4
39512|NCT01675622|170059|P1|Overall Study|not specified|5
39513|NCT01675622|170058|P2|Overall Study|Lost to Follow-up|3
39514|NCT01675622|170059|P1|Overall Study|Lost to Follow-up|1
39515|NCT01675622|170058|P2|Overall Study|Lack of Efficacy|4
39516|NCT01675622|170059|P1|Overall Study|Lack of Efficacy|2
39517|NCT01675622|170058|P2|Overall Study|Protocol Violation|1
39518|NCT01675622|170059|P1|Overall Study|Protocol Violation|4
39519|NCT01675622|170058|P2|Overall Study|Adverse Event|10
39520|NCT01675622|170059|P1|Overall Study|Adverse Event|12
39521|NCT01675622|170058|P2|Overall Study|Withdrawal by Subject|2
39522|NCT01675622|170059|P1|Overall Study|Withdrawal by Subject|2
39523|NCT01675544|170083|P1|Overall Study|Withdrawal by Subject|2
39524|NCT01675531|170088|P1|Overall Study|Protocol Violation|8
39525|NCT01675531|170088|P1|Overall Study|Lack of Efficacy|1
39526|NCT01675531|170088|P1|Overall Study|Withdrawal by Subject|7
39527|NCT01675531|170088|P1|Overall Study|Adverse Event|9
39528|NCT01675492|170095|P1|Overall Study|study completed early - product approval|42
39529|NCT01675479|170100|P1|Overall Study|Lost to Follow-up|11
39530|NCT01675427|170114|P1|Overall Study|Not Specified|2
39531|NCT01675427|170114|P1|Overall Study|Lost to Follow-up|5
39532|NCT01675427|170114|P1|Overall Study|Sample not Collected by Mistake|2
39533|NCT01675427|170114|P1|Overall Study|Participant Refused Sample Collection|18
39534|NCT01675427|170114|P1|Overall Study|Withdrawal by Subject|7
39535|NCT01675167|170401|P3|Double-blind Treatment Phase|Not specified|5
39536|NCT01675167|170402|P2|Double-blind Treatment Phase|Not specified|7
39537|NCT01675167|170403|P1|Double-blind Treatment Phase|Not specified|0
39538|NCT01675167|170401|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
39539|NCT01675167|170402|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
39540|NCT01675167|170403|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
39541|NCT01675167|170401|P3|Double-blind Treatment Phase|Lost to Follow-up|5
39542|NCT01675167|170402|P2|Double-blind Treatment Phase|Lost to Follow-up|1
39543|NCT01675167|170403|P1|Double-blind Treatment Phase|Lost to Follow-up|0
39544|NCT01675167|170401|P3|Double-blind Treatment Phase|Protocol Violation|11
39545|NCT01675167|170402|P2|Double-blind Treatment Phase|Protocol Violation|4
39546|NCT01675167|170403|P1|Double-blind Treatment Phase|Protocol Violation|0
39547|NCT01675167|170401|P3|Double-blind Treatment Phase|Adverse Event|13
39548|NCT01675167|170402|P2|Double-blind Treatment Phase|Adverse Event|5
39549|NCT01675167|170403|P1|Double-blind Treatment Phase|Adverse Event|0
39550|NCT01675167|170401|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
39551|NCT01675167|170402|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
39552|NCT01675167|170403|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
39553|NCT01675167|170401|P3|Double-blind Treatment Phase|Lack of Efficacy|61
39554|NCT01675167|170402|P2|Double-blind Treatment Phase|Lack of Efficacy|19
39555|NCT01675167|170403|P1|Double-blind Treatment Phase|Lack of Efficacy|0
39556|NCT01675167|170401|P3|Open-label Titration Phase|Not specified|0
39557|NCT01675167|170402|P2|Open-label Titration Phase|Not specified|0
39558|NCT01675167|170403|P1|Open-label Titration Phase|Not specified|55
39559|NCT01675167|170401|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
39560|NCT01675167|170402|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
39561|NCT01675167|170403|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
39562|NCT01675167|170401|P3|Open-label Titration Phase|Lost to Follow-up|0
39563|NCT01675167|170402|P2|Open-label Titration Phase|Lost to Follow-up|0
39564|NCT01675167|170403|P1|Open-label Titration Phase|Lost to Follow-up|15
39565|NCT01675167|170401|P3|Open-label Titration Phase|Protocol Violation|0
39566|NCT01675167|170402|P2|Open-label Titration Phase|Protocol Violation|0
39567|NCT01675167|170403|P1|Open-label Titration Phase|Protocol Violation|43
39568|NCT01675167|170401|P3|Open-label Titration Phase|Withdrawal by Subject|0
39569|NCT01675167|170402|P2|Open-label Titration Phase|Withdrawal by Subject|0
39570|NCT01675167|170403|P1|Open-label Titration Phase|Withdrawal by Subject|46
39571|NCT01675167|170401|P3|Open-label Titration Phase|Lack of Efficacy|0
39572|NCT01675167|170402|P2|Open-label Titration Phase|Lack of Efficacy|0
39573|NCT01675167|170403|P1|Open-label Titration Phase|Lack of Efficacy|63
39574|NCT01675167|170401|P3|Open-label Titration Phase|Adverse Event|0
39575|NCT01675167|170402|P2|Open-label Titration Phase|Adverse Event|0
39576|NCT01675167|170403|P1|Open-label Titration Phase|Adverse Event|81
39577|NCT01675141|170425|P1|Overall Study|No treatment, per protocol|1
39578|NCT01675141|170425|P1|Overall Study|Physician Decision|4
39579|NCT01675141|170425|P1|Overall Study|Withdrawal by Subject|3
39580|NCT01675141|170425|P1|Overall Study|Lenalidomide outside NIH|3
39581|NCT01675128|170438|P3|Overall Study|Pulmonary complication; off study|0
39582|NCT01675128|170439|P2|Overall Study|Pulmonary complication; off study|1
39583|NCT01675128|170440|P1|Overall Study|Pulmonary complication; off study|0
39584|NCT01675128|170438|P3|Overall Study|Refused further treatment|0
39585|NCT01675128|170439|P2|Overall Study|Refused further treatment|0
39586|NCT01675128|170440|P1|Overall Study|Refused further treatment|1
39587|NCT01675128|170438|P3|Overall Study|Disease progression on study|1
39588|NCT01675128|170439|P2|Overall Study|Disease progression on study|1
39589|NCT01675128|170440|P1|Overall Study|Disease progression on study|1
39590|NCT01675050|170468|P2|Period One Treatment|Withdrawal by Subject|0
39591|NCT01675050|170469|P1|Period One Treatment|Withdrawal by Subject|1
39592|NCT01675011|170479|P2|Overall Study|Trial terminated by Sponsor|1
39593|NCT01675011|170480|P1|Overall Study|Trial terminated by Sponsor|3
39594|NCT01674725|170488|P2|Overall Study|Lost to Follow-up|1
39595|NCT01674725|170489|P1|Overall Study|Lost to Follow-up|0
39596|NCT01674725|170488|P2|Overall Study|Withdrawal by Subject|0
39597|NCT01674725|170489|P1|Overall Study|Withdrawal by Subject|1
39598|NCT01674725|170488|P2|Overall Study|Did not receive study drug|0
39599|NCT01674725|170489|P1|Overall Study|Did not receive study drug|1
39600|NCT01674725|170488|P2|Overall Study|Adverse Event|0
39601|NCT01674725|170489|P1|Overall Study|Adverse Event|1
39602|NCT01674712|170508|P5|Overall Study|Lack of Efficacy|1
39603|NCT01674712|170509|P4|Overall Study|Lack of Efficacy|0
39604|NCT01674712|170510|P3|Overall Study|Lack of Efficacy|1
39605|NCT01674712|170511|P2|Overall Study|Lack of Efficacy|0
39606|NCT01674712|170512|P1|Overall Study|Lack of Efficacy|0
39607|NCT01674712|170508|P5|Overall Study|Administrative|1
39608|NCT01674712|170509|P4|Overall Study|Administrative|0
39609|NCT01674712|170510|P3|Overall Study|Administrative|0
39610|NCT01674712|170511|P2|Overall Study|Administrative|1
39611|NCT01674712|170512|P1|Overall Study|Administrative|0
39612|NCT01674712|170508|P5|Overall Study|Withdrawal by Subject|3
39613|NCT01674712|170509|P4|Overall Study|Withdrawal by Subject|4
39614|NCT01674712|170510|P3|Overall Study|Withdrawal by Subject|5
39615|NCT01674712|170511|P2|Overall Study|Withdrawal by Subject|2
39616|NCT01674712|170512|P1|Overall Study|Withdrawal by Subject|2
39617|NCT01674712|170508|P5|Overall Study|Protocol Violation|0
39618|NCT01674712|170509|P4|Overall Study|Protocol Violation|0
39619|NCT01674712|170510|P3|Overall Study|Protocol Violation|0
39620|NCT01674712|170511|P2|Overall Study|Protocol Violation|0
39621|NCT01674712|170512|P1|Overall Study|Protocol Violation|2
39622|NCT01674712|170508|P5|Overall Study|Lost to Follow-up|0
39623|NCT01674712|170509|P4|Overall Study|Lost to Follow-up|0
39624|NCT01674712|170510|P3|Overall Study|Lost to Follow-up|0
39625|NCT01674712|170511|P2|Overall Study|Lost to Follow-up|0
39626|NCT01674712|170512|P1|Overall Study|Lost to Follow-up|1
39627|NCT01674712|170508|P5|Overall Study|Adverse Event|6
39628|NCT01674712|170509|P4|Overall Study|Adverse Event|4
39629|NCT01674712|170510|P3|Overall Study|Adverse Event|3
39630|NCT01674712|170511|P2|Overall Study|Adverse Event|6
39631|NCT01674712|170512|P1|Overall Study|Adverse Event|5
39632|NCT01674647|170536|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
39633|NCT01674647|170537|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
39634|NCT01674647|170536|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
39635|NCT01674647|170537|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
39636|NCT01674647|170536|P2|30-day Safety Follow-up Period|Logistical difficulties|3
39637|NCT01674647|170537|P1|30-day Safety Follow-up Period|Logistical difficulties|1
39638|NCT01674647|170536|P2|30-day Safety Follow-up Period|Protocol Violation|22
39639|NCT01674647|170537|P1|30-day Safety Follow-up Period|Protocol Violation|39
39640|NCT01674647|170536|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
39641|NCT01674647|170537|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
39642|NCT01674647|170536|P2|30-day Safety Follow-up Period|Death|2
39643|NCT01674647|170537|P1|30-day Safety Follow-up Period|Death|3
39644|NCT01674647|170536|P2|Treatment Period|Protocol Violation|36
39645|NCT01674647|170537|P1|Treatment Period|Protocol Violation|56
39646|NCT01674647|170536|P2|Treatment Period|Treatment failure|14
39647|NCT01674647|170537|P1|Treatment Period|Treatment failure|0
39648|NCT01674647|170536|P2|Treatment Period|Logistical difficulties|8
39649|NCT01674647|170537|P1|Treatment Period|Logistical difficulties|5
39650|NCT01674647|170536|P2|Treatment Period|Switching to other therapy|2
39651|NCT01674647|170537|P1|Treatment Period|Switching to other therapy|5
39652|NCT01674647|170536|P2|Treatment Period|Withdrawal by Subject|16
39653|NCT01674647|170537|P1|Treatment Period|Withdrawal by Subject|19
39654|NCT01674647|170536|P2|Treatment Period|Lost to Follow-up|1
39655|NCT01674647|170537|P1|Treatment Period|Lost to Follow-up|1
39656|NCT01674647|170536|P2|Treatment Period|Non-compliance with study drug|0
39657|NCT01674647|170537|P1|Treatment Period|Non-compliance with study drug|3
39658|NCT01674647|170536|P2|Treatment Period|Adverse Event|22
39659|NCT01674647|170537|P1|Treatment Period|Adverse Event|60
39660|NCT01674647|170536|P2|Treatment Period|Physician Decision|1
39661|NCT01674647|170537|P1|Treatment Period|Physician Decision|3
39662|NCT01674647|170536|P2|Treatment Period|Efficacy outcome reached|1
39663|NCT01674647|170537|P1|Treatment Period|Efficacy outcome reached|0
39664|NCT01674647|170536|P2|Treatment Period|Death|1
39665|NCT01674647|170537|P1|Treatment Period|Death|4
39666|NCT01674634|170563|P1|Overall Study|Lost to Follow-up|3
39667|NCT01674634|170563|P1|Overall Study|Withdrawal by Subject|3
39668|NCT01674062|170611|P2|Overall Study|Programming Error|0
39669|NCT01674062|170612|P1|Overall Study|Programming Error|1
39670|NCT01674062|170611|P2|Overall Study|Death|1
39671|NCT01674062|170612|P1|Overall Study|Death|0
39672|NCT01674062|170611|P2|Overall Study|Adverse Event|1
39673|NCT01674062|170612|P1|Overall Study|Adverse Event|1
39674|NCT01674062|170611|P2|Overall Study|Not Specified|1
39675|NCT01674062|170612|P1|Overall Study|Not Specified|8
39676|NCT01674062|170611|P2|Overall Study|Insufficient Therapeutic Response|26
39677|NCT01674062|170612|P1|Overall Study|Insufficient Therapeutic Response|56
39678|NCT01674010|170627|P3|Randomization Phase 2|Withdrawal by Subject|7
39679|NCT01674010|170628|P2|Randomization Phase 2|Withdrawal by Subject|8
39680|NCT01674010|170629|P1|Randomization Phase 2|Withdrawal by Subject|0
39681|NCT01674010|170627|P3|Randomization Phase 2|Sponsor Decision|45
39682|NCT01674010|170628|P2|Randomization Phase 2|Sponsor Decision|42
39683|NCT01674010|170629|P1|Randomization Phase 2|Sponsor Decision|0
39684|NCT01674010|170627|P3|Randomization Phase 2|Protocol Violation|1
39685|NCT01674010|170628|P2|Randomization Phase 2|Protocol Violation|1
39686|NCT01674010|170629|P1|Randomization Phase 2|Protocol Violation|0
39687|NCT01674010|170627|P3|Randomization Phase 2|Pregnancy|1
39688|NCT01674010|170628|P2|Randomization Phase 2|Pregnancy|1
39689|NCT01674010|170629|P1|Randomization Phase 2|Pregnancy|0
39690|NCT01674010|170627|P3|Randomization Phase 2|Physician Decision|2
39691|NCT01674010|170628|P2|Randomization Phase 2|Physician Decision|0
39692|NCT01674010|170629|P1|Randomization Phase 2|Physician Decision|0
39693|NCT01674010|170627|P3|Randomization Phase 2|Mood episode recurrence|2
39694|NCT01674010|170628|P2|Randomization Phase 2|Mood episode recurrence|8
39695|NCT01674010|170629|P1|Randomization Phase 2|Mood episode recurrence|0
39696|NCT01674010|170627|P3|Randomization Phase 2|Lost to Follow-up|2
39697|NCT01674010|170628|P2|Randomization Phase 2|Lost to Follow-up|1
39698|NCT01674010|170629|P1|Randomization Phase 2|Lost to Follow-up|0
39699|NCT01674010|170627|P3|Randomization Phase 2|Adverse Event|1
39700|NCT01674010|170628|P2|Randomization Phase 2|Adverse Event|1
39701|NCT01674010|170629|P1|Randomization Phase 2|Adverse Event|0
39702|NCT01674010|170627|P3|Open Treatment Phase 1|Withdrawal by Subject|0
39703|NCT01674010|170628|P2|Open Treatment Phase 1|Withdrawal by Subject|0
39704|NCT01674010|170629|P1|Open Treatment Phase 1|Withdrawal by Subject|25
39705|NCT01674010|170627|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
39706|NCT01674010|170628|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
39707|NCT01674010|170629|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
39708|NCT01674010|170627|P3|Open Treatment Phase 1|Sponsor Decision|0
39709|NCT01674010|170628|P2|Open Treatment Phase 1|Sponsor Decision|0
39710|NCT01674010|170629|P1|Open Treatment Phase 1|Sponsor Decision|79
39711|NCT01674010|170627|P3|Open Treatment Phase 1|Protocol Violation|0
39712|NCT01674010|170628|P2|Open Treatment Phase 1|Protocol Violation|0
39713|NCT01674010|170629|P1|Open Treatment Phase 1|Protocol Violation|7
39714|NCT01674010|170627|P3|Open Treatment Phase 1|Physician Decision|0
39715|NCT01674010|170628|P2|Open Treatment Phase 1|Physician Decision|0
39716|NCT01674010|170629|P1|Open Treatment Phase 1|Physician Decision|9
39717|NCT01674010|170627|P3|Open Treatment Phase 1|Lost to Follow-up|0
39718|NCT01674010|170628|P2|Open Treatment Phase 1|Lost to Follow-up|0
39719|NCT01674010|170629|P1|Open Treatment Phase 1|Lost to Follow-up|19
39720|NCT01674010|170627|P3|Open Treatment Phase 1|Death|0
39721|NCT01674010|170628|P2|Open Treatment Phase 1|Death|0
39722|NCT01674010|170629|P1|Open Treatment Phase 1|Death|1
39723|NCT01674010|170627|P3|Open Treatment Phase 1|Adverse Event|0
39724|NCT01674010|170628|P2|Open Treatment Phase 1|Adverse Event|0
39725|NCT01674010|170629|P1|Open Treatment Phase 1|Adverse Event|10
39726|NCT01673984|170648|P2|Overall Study|Study termination|6
39727|NCT01673984|170649|P1|Overall Study|Study termination|9
39728|NCT01673984|170648|P2|Overall Study|Adverse Event|0
39729|NCT01673984|170649|P1|Overall Study|Adverse Event|1
39730|NCT01673867|170691|P2|Treatment|Physician Decision|1
39731|NCT01673867|170692|P1|Treatment|Physician Decision|0
39732|NCT01673867|170691|P2|Treatment|Symptomatic deterioration|1
39733|NCT01673867|170692|P1|Treatment|Symptomatic deterioration|0
39734|NCT01673867|170691|P2|Treatment|Required prolonged hospitalization|1
39735|NCT01673867|170692|P1|Treatment|Required prolonged hospitalization|0
39736|NCT01673867|170691|P2|Treatment|Health status not improved|0
39737|NCT01673867|170692|P1|Treatment|Health status not improved|1
39738|NCT01673867|170691|P2|Treatment|Required steroid therapy|0
39739|NCT01673867|170692|P1|Treatment|Required steroid therapy|1
39740|NCT01673867|170691|P2|Treatment|No longer meets criteria|0
39741|NCT01673867|170692|P1|Treatment|No longer meets criteria|2
39742|NCT01673867|170691|P2|Treatment|Maximum clinical benefit|10
39743|NCT01673867|170692|P1|Treatment|Maximum clinical benefit|0
39744|NCT01673867|170691|P2|Treatment|Withdrawal by Subject|6
39745|NCT01673867|170692|P1|Treatment|Withdrawal by Subject|4
39746|NCT01673867|170691|P2|Treatment|Requested treatment discontinuation|16
39747|NCT01673867|170692|P1|Treatment|Requested treatment discontinuation|5
39748|NCT01673867|170691|P2|Treatment|AE unrelated to study drug|11
39749|NCT01673867|170692|P1|Treatment|AE unrelated to study drug|19
39750|NCT01673867|170691|P2|Treatment|Death|1
39751|NCT01673867|170692|P1|Treatment|Death|1
39752|NCT01673867|170691|P2|Treatment|Study Drug Toxicity|42
39753|NCT01673867|170692|P1|Treatment|Study Drug Toxicity|17
39754|NCT01673867|170691|P2|Treatment|Disease Progression|179
39755|NCT01673867|170692|P1|Treatment|Disease Progression|194
39756|NCT01673867|170691|P2|Randomization|No longer meets criteria|5
39757|NCT01673867|170692|P1|Randomization|No longer meets criteria|4
39758|NCT01673867|170691|P2|Randomization|Lost to Follow-up|1
39759|NCT01673867|170692|P1|Randomization|Lost to Follow-up|0
39760|NCT01673867|170691|P2|Randomization|Withdrawal by Subject|12
39761|NCT01673867|170692|P1|Randomization|Withdrawal by Subject|0
39762|NCT01673867|170691|P2|Randomization|Requested treatment discontinuation|4
39763|NCT01673867|170692|P1|Randomization|Requested treatment discontinuation|0
39764|NCT01673867|170691|P2|Randomization|AE unrelated to study drug|0
39765|NCT01673867|170692|P1|Randomization|AE unrelated to study drug|1
39766|NCT01673854|170718|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
39767|NCT01673854|170718|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
39768|NCT01673854|170718|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
39769|NCT01673854|170718|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
39770|NCT01673854|170718|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
39771|NCT01673854|170718|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
39772|NCT01673854|170718|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
39773|NCT01673854|170718|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
39774|NCT01673854|170718|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
39775|NCT01673854|170718|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
39776|NCT01673854|170718|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
39777|NCT01673854|170718|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
39778|NCT01673698|170741|P2|Overall Study|Lost to Follow-up|13
39779|NCT01673698|170742|P1|Overall Study|Lost to Follow-up|51
39780|NCT01673620|170752|P2|Overall Study|Adverse Event|0
39781|NCT01673620|170753|P1|Overall Study|Adverse Event|1
39782|NCT01673594|170763|P2|Overall Study|Withdrawal by Subject|1
39783|NCT01673594|170764|P1|Overall Study|Withdrawal by Subject|0
39784|NCT01673594|170763|P2|Overall Study|Physician Decision|4
39785|NCT01673594|170764|P1|Overall Study|Physician Decision|2
39786|NCT01673594|170763|P2|Overall Study|Lost to Follow-up|0
39787|NCT01673594|170764|P1|Overall Study|Lost to Follow-up|1
39788|NCT01673594|170763|P2|Overall Study|Adverse Event|1
39789|NCT01673594|170764|P1|Overall Study|Adverse Event|3
39790|NCT01673490|170783|P1|Overall Study|Withdrawal by Subject|3
39791|NCT01673490|170783|P1|Overall Study|Adverse Event|3
39792|NCT01673490|170783|P1|Overall Study|Lost to Follow-up|1
39793|NCT01673347|170800|P1|Overall Study|failure of allograft|7
39794|NCT01673282|170809|P2|Overall Study|Other|6
39795|NCT01673282|170810|P1|Overall Study|Other|1
39796|NCT01673282|170809|P2|Overall Study|Withdrawal by Subject|3
39797|NCT01673282|170810|P1|Overall Study|Withdrawal by Subject|3
39798|NCT01673282|170809|P2|Overall Study|Lost to Follow-up|10
39799|NCT01673282|170810|P1|Overall Study|Lost to Follow-up|11
39800|NCT01673282|170809|P2|Overall Study|Lack of Efficacy|2
39801|NCT01673282|170810|P1|Overall Study|Lack of Efficacy|9
39802|NCT01673282|170809|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
39803|NCT01673282|170810|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
39804|NCT01673178|170846|P5|Overall Study|Other|0
39805|NCT01673178|170847|P4|Overall Study|Other|1
39806|NCT01673178|170848|P3|Overall Study|Other|2
39807|NCT01673178|170849|P2|Overall Study|Other|0
39808|NCT01673178|170850|P1|Overall Study|Other|1
39809|NCT01673178|170846|P5|Overall Study|Adverse Event|0
39810|NCT01673178|170847|P4|Overall Study|Adverse Event|2
39811|NCT01673178|170848|P3|Overall Study|Adverse Event|0
39812|NCT01673178|170849|P2|Overall Study|Adverse Event|0
39813|NCT01673178|170850|P1|Overall Study|Adverse Event|1
39814|NCT01673178|170846|P5|Overall Study|Protocol Violation|0
39815|NCT01673178|170847|P4|Overall Study|Protocol Violation|1
39816|NCT01673178|170848|P3|Overall Study|Protocol Violation|0
39817|NCT01673178|170849|P2|Overall Study|Protocol Violation|1
39818|NCT01673178|170850|P1|Overall Study|Protocol Violation|1
39819|NCT01673178|170846|P5|Overall Study|Withdrawal by Subject|2
39820|NCT01673178|170847|P4|Overall Study|Withdrawal by Subject|4
39821|NCT01673178|170848|P3|Overall Study|Withdrawal by Subject|1
39822|NCT01673178|170849|P2|Overall Study|Withdrawal by Subject|0
39823|NCT01673178|170850|P1|Overall Study|Withdrawal by Subject|0
39824|NCT01673178|170846|P5|Overall Study|Lost to Follow-up|0
39825|NCT01673178|170847|P4|Overall Study|Lost to Follow-up|0
39826|NCT01673178|170848|P3|Overall Study|Lost to Follow-up|0
39827|NCT01673178|170849|P2|Overall Study|Lost to Follow-up|1
39828|NCT01673178|170850|P1|Overall Study|Lost to Follow-up|0
39829|NCT01673126|171089|P2|Overall Study|change of diagnosis|3
39830|NCT01673126|171090|P1|Overall Study|change of diagnosis|4
39831|NCT01673009|171106|P1|Overall Study|Withdrawal by Subject|8
39832|NCT01673009|171106|P1|Overall Study|Physician Decision|5
39833|NCT01672970|171191|P1|Overall Study|Enrolled but not treated|1
39834|NCT01672970|171191|P1|Overall Study|Other|9
39835|NCT01672970|171191|P1|Overall Study|Lost to Follow-up|5
39836|NCT01672970|171191|P1|Overall Study|Withdrawal by Subject|2
39837|NCT01672970|171191|P1|Overall Study|Adverse Event|18
39838|NCT01672970|171191|P1|Overall Study|Lack of Efficacy|12
39839|NCT01672957|171227|P1|Overall Study|ICF Signed After Transplantation|5
39840|NCT01672957|171227|P1|Overall Study|Death|2
39841|NCT01672957|171227|P1|Overall Study|Protocol Violation|48
39842|NCT01672892|171242|P2|Overall Study|Protocol Violation|3
39843|NCT01672892|171243|P1|Overall Study|Protocol Violation|8
39844|NCT01672788|171263|P4|Washout Period 2 (7 Days)|Adverse Event|1
39845|NCT01672788|171264|P3|Washout Period 2 (7 Days)|Adverse Event|0
39846|NCT01672788|171265|P2|Washout Period 2 (7 Days)|Adverse Event|0
39847|NCT01672788|171266|P1|Washout Period 2 (7 Days)|Adverse Event|0
39848|NCT01672723|171296|P2|First Intervention|Adverse Event|0
39849|NCT01672723|171297|P1|First Intervention|Adverse Event|3
39850|NCT01672294|171334|P4|Overall Study|Lost to Follow-up|9
39851|NCT01672294|171335|P3|Overall Study|Lost to Follow-up|7
39852|NCT01672294|171336|P2|Overall Study|Lost to Follow-up|16
39853|NCT01672294|171337|P1|Overall Study|Lost to Follow-up|1
39854|NCT01672294|171334|P4|Overall Study|Excluded by study|0
39855|NCT01672294|171335|P3|Overall Study|Excluded by study|0
39856|NCT01672294|171336|P2|Overall Study|Excluded by study|1
39857|NCT01672294|171337|P1|Overall Study|Excluded by study|1
39858|NCT01672294|171334|P4|Overall Study|Withdrawal by Subject|4
39859|NCT01672294|171335|P3|Overall Study|Withdrawal by Subject|4
39860|NCT01672294|171336|P2|Overall Study|Withdrawal by Subject|4
39861|NCT01672294|171337|P1|Overall Study|Withdrawal by Subject|4
39862|NCT01671748|171377|P2|4 Week run-in Phase|Not eligible|0
39863|NCT01671748|171378|P1|4 Week run-in Phase|Not eligible|9
39864|NCT01671748|171377|P2|4 Week run-in Phase|Adverse Event|0
39865|NCT01671748|171378|P1|4 Week run-in Phase|Adverse Event|1
39866|NCT01671748|171377|P2|4 Week run-in Phase|Withdrawal by Subject|0
39867|NCT01671748|171378|P1|4 Week run-in Phase|Withdrawal by Subject|1
39868|NCT01671488|171405|P1|Overall Study|Withdrawal by Subject|1
39869|NCT01671319|171411|P1|Overall Study|Withdrawal by Subject|1
39870|NCT01671280|171426|P1|Overall Study|Withdrawal by Subject|2
39871|NCT01671111|171437|P1|Overall Study|Other|24
39872|NCT01671111|171437|P1|Overall Study|Physician Decision|1
39873|NCT01671111|171437|P1|Overall Study|Withdrawal by Subject|2
39874|NCT01671111|171437|P1|Overall Study|Lack of Efficacy|1
39875|NCT01671111|171437|P1|Overall Study|Adverse Event|2
39876|NCT01671059|171447|P1|Overall Study|Lack of Efficacy|1
39877|NCT01671059|171447|P1|Overall Study|Adverse Event|4
39878|NCT01670721|171539|P1|Overall Study|Other than specified above|38
39879|NCT01670721|171539|P1|Overall Study|Participant's decision|15
39880|NCT01670656|171551|P5|Overall Study|Subject moved|0
39881|NCT01670656|171552|P4|Overall Study|Subject moved|1
39882|NCT01670656|171553|P3|Overall Study|Subject moved|0
39883|NCT01670656|171554|P2|Overall Study|Subject moved|0
39884|NCT01670656|171555|P1|Overall Study|Subject moved|0
39885|NCT01670656|171551|P5|Overall Study|Lost to Follow-up|3
39886|NCT01670656|171552|P4|Overall Study|Lost to Follow-up|0
39887|NCT01670656|171553|P3|Overall Study|Lost to Follow-up|0
39888|NCT01670656|171554|P2|Overall Study|Lost to Follow-up|0
39889|NCT01670656|171555|P1|Overall Study|Lost to Follow-up|0
39890|NCT01670656|171551|P5|Overall Study|Subject withdrew consent|1
39891|NCT01670656|171552|P4|Overall Study|Subject withdrew consent|1
39892|NCT01670656|171553|P3|Overall Study|Subject withdrew consent|2
39893|NCT01670656|171554|P2|Overall Study|Subject withdrew consent|1
39894|NCT01670656|171555|P1|Overall Study|Subject withdrew consent|0
39895|NCT01670656|171551|P5|Overall Study|Adverse Event|3
39896|NCT01670656|171552|P4|Overall Study|Adverse Event|3
39897|NCT01670656|171553|P3|Overall Study|Adverse Event|2
39898|NCT01670656|171554|P2|Overall Study|Adverse Event|2
39899|NCT01670656|171555|P1|Overall Study|Adverse Event|2
39900|NCT01670656|171551|P5|Overall Study|Non-compliance with protocol|2
39901|NCT01670656|171552|P4|Overall Study|Non-compliance with protocol|1
39902|NCT01670656|171553|P3|Overall Study|Non-compliance with protocol|1
39903|NCT01670656|171554|P2|Overall Study|Non-compliance with protocol|3
39904|NCT01670656|171555|P1|Overall Study|Non-compliance with protocol|0
39905|NCT01670656|171551|P5|Overall Study|Withdrawal by Subject|0
39906|NCT01670656|171552|P4|Overall Study|Withdrawal by Subject|0
39907|NCT01670656|171553|P3|Overall Study|Withdrawal by Subject|0
39908|NCT01670656|171554|P2|Overall Study|Withdrawal by Subject|1
39909|NCT01670656|171555|P1|Overall Study|Withdrawal by Subject|1
39910|NCT01670656|171551|P5|Overall Study|Pregnancy|1
39911|NCT01670656|171552|P4|Overall Study|Pregnancy|0
39912|NCT01670656|171553|P3|Overall Study|Pregnancy|0
39913|NCT01670656|171554|P2|Overall Study|Pregnancy|0
39914|NCT01670656|171555|P1|Overall Study|Pregnancy|0
39915|NCT01670656|171551|P5|Overall Study|Non-compliance with study drug|1
39916|NCT01670656|171552|P4|Overall Study|Non-compliance with study drug|0
39917|NCT01670656|171553|P3|Overall Study|Non-compliance with study drug|3
39918|NCT01670656|171554|P2|Overall Study|Non-compliance with study drug|0
39919|NCT01670656|171555|P1|Overall Study|Non-compliance with study drug|0
39920|NCT01670526|171584|P2|Overall Study|Lost to Follow-up|5
39921|NCT01670526|171585|P1|Overall Study|Lost to Follow-up|9
39922|NCT01670526|171584|P2|Overall Study|Withdrawal by Subject|1
39923|NCT01670526|171585|P1|Overall Study|Withdrawal by Subject|3
39924|NCT01670292|171606|P1|Overall Study|Lost to Follow-up|14
39925|NCT01670279|171647|P4|Overall Study|Participant met withdrawal criteria|1
39926|NCT01670279|171648|P3|Overall Study|Participant met withdrawal criteria|0
39927|NCT01670279|171649|P2|Overall Study|Participant met withdrawal criteria|0
39928|NCT01670279|171650|P1|Overall Study|Participant met withdrawal criteria|0
39929|NCT01670279|171647|P4|Overall Study|Physician Decision|0
39930|NCT01670279|171648|P3|Overall Study|Physician Decision|0
39931|NCT01670279|171649|P2|Overall Study|Physician Decision|1
39932|NCT01670279|171650|P1|Overall Study|Physician Decision|0
39933|NCT01670279|171647|P4|Overall Study|Adverse Event|0
39934|NCT01670279|171648|P3|Overall Study|Adverse Event|0
39935|NCT01670279|171649|P2|Overall Study|Adverse Event|1
39936|NCT01670279|171650|P1|Overall Study|Adverse Event|0
39937|NCT01670188|171692|P2|Overall Study|Death|1
39938|NCT01670188|171693|P1|Overall Study|Death|0
39939|NCT01670045|171699|P1|Overall Study|Lost to Follow-up|11
39940|NCT01670045|171699|P1|Overall Study|Death|1
39941|NCT01670045|171699|P1|Overall Study|Adverse Event|1
39942|NCT01670045|171699|P1|Overall Study|Withdrawal by Subject|3
39943|NCT01670019|171717|P2|Overall Study|Withdrawal by Subject|0
39944|NCT01670019|171718|P1|Overall Study|Withdrawal by Subject|6
39945|NCT01670019|171717|P2|Overall Study|Adverse Event|0
39946|NCT01670019|171718|P1|Overall Study|Adverse Event|3
39947|NCT01669902|171732|P1|Overall Study|Other|8
39948|NCT01669902|171732|P1|Overall Study|Lack of Efficacy|10
39949|NCT01669902|171732|P1|Overall Study|Adverse Event|11
39950|NCT01669811|171767|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
39951|NCT01669811|171768|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
39952|NCT01669811|171767|P2|Overall Study|Adverse Event|6
39953|NCT01669811|171768|P1|Overall Study|Adverse Event|2
39954|NCT01669811|171767|P2|Overall Study|Withdrawal by Subject|2
39955|NCT01669811|171768|P1|Overall Study|Withdrawal by Subject|1
39956|NCT01669811|171767|P2|Overall Study|Investigator decision|1
39957|NCT01669811|171768|P1|Overall Study|Investigator decision|0
39958|NCT01669629|171879|P2|Period 1|protocol deviation|2
39959|NCT01669629|171880|P1|Period 1|protocol deviation|1
39960|NCT01669577|171903|P1|Overall Study|Physician Decision|34
39961|NCT01669577|171903|P1|Overall Study|Lost to Follow-up|78
39962|NCT01669577|171903|P1|Overall Study|Death|22
39963|NCT01669174|171928|P2|Overall Study|Administrative problems|2
39964|NCT01669174|171929|P1|Overall Study|Administrative problems|1
39965|NCT01669174|171928|P2|Overall Study|Adverse Event|2
39966|NCT01669174|171929|P1|Overall Study|Adverse Event|2
39967|NCT01669174|171928|P2|Overall Study|Lost to Follow-up|0
39968|NCT01669174|171929|P1|Overall Study|Lost to Follow-up|1
39969|NCT01669174|171928|P2|Overall Study|Subject withdrew consent|2
39970|NCT01669174|171929|P1|Overall Study|Subject withdrew consent|2
39971|NCT01669122|171945|P1|Washout Period II|Protocol Violation|2
39972|NCT01669122|171945|P1|Period I|Lost to Follow-up|1
39973|NCT01668797|172038|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
39974|NCT01668797|172039|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
39975|NCT01668797|172040|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
39976|NCT01668797|172041|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
39977|NCT01668797|172038|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
39978|NCT01668797|172039|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
39979|NCT01668797|172040|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
39980|NCT01668797|172041|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
39981|NCT01668797|172038|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
39982|NCT01668797|172039|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
39983|NCT01668797|172040|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
39984|NCT01668797|172041|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
39985|NCT01668797|172038|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
39986|NCT01668797|172039|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
39987|NCT01668797|172040|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
39988|NCT01668797|172041|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
39989|NCT01668797|172038|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
39990|NCT01668797|172039|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
39991|NCT01668797|172040|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
39992|NCT01668797|172041|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
39993|NCT01668797|172038|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
39994|NCT01668797|172039|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
39995|NCT01668797|172040|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
39996|NCT01668797|172041|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
39997|NCT01668797|172038|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
39998|NCT01668797|172039|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
39999|NCT01668797|172040|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
40000|NCT01668797|172041|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
40001|NCT01668797|172038|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
40002|NCT01668797|172039|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
40003|NCT01668797|172040|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
40004|NCT01668797|172041|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
40005|NCT01668797|172038|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
40006|NCT01668797|172039|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
40007|NCT01668797|172040|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
40008|NCT01668797|172041|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
40009|NCT01668797|172038|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
40010|NCT01668797|172039|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
40011|NCT01668797|172040|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
40012|NCT01668797|172041|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
40013|NCT01668797|172038|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
40014|NCT01668797|172039|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
40015|NCT01668797|172040|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
40016|NCT01668797|172041|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
40017|NCT01668797|172038|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
40018|NCT01668797|172039|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
40019|NCT01668797|172040|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
40020|NCT01668797|172041|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
40021|NCT01668797|172038|P4|Phase B (Stabilization Phase)|Protocol Violation|0
40022|NCT01668797|172039|P3|Phase B (Stabilization Phase)|Protocol Violation|0
40023|NCT01668797|172040|P2|Phase B (Stabilization Phase)|Protocol Violation|3
40024|NCT01668797|172041|P1|Phase B (Stabilization Phase)|Protocol Violation|0
40025|NCT01668797|172038|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
40026|NCT01668797|172039|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
40027|NCT01668797|172040|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
40028|NCT01668797|172041|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
40029|NCT01668797|172038|P4|Phase B (Stabilization Phase)|Physician Decision|0
40030|NCT01668797|172039|P3|Phase B (Stabilization Phase)|Physician Decision|0
40031|NCT01668797|172040|P2|Phase B (Stabilization Phase)|Physician Decision|11
40032|NCT01668797|172041|P1|Phase B (Stabilization Phase)|Physician Decision|0
40033|NCT01668797|172038|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
40034|NCT01668797|172039|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
40035|NCT01668797|172040|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
40036|NCT01668797|172041|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
40037|NCT01668797|172038|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
40038|NCT01668797|172039|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
40039|NCT01668797|172040|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
40040|NCT01668797|172041|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
40041|NCT01668797|172038|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
40042|NCT01668797|172039|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
40043|NCT01668797|172040|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
40044|NCT01668797|172041|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
40045|NCT01668797|172038|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
40046|NCT01668797|172039|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
40047|NCT01668797|172040|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
40048|NCT01668797|172041|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
40049|NCT01668797|172038|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
40050|NCT01668797|172039|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
40051|NCT01668797|172040|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
40052|NCT01668797|172041|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
40053|NCT01668797|172038|P4|Phase A (Conversion Phase)|Protocol Violation|0
40054|NCT01668797|172039|P3|Phase A (Conversion Phase)|Protocol Violation|0
40055|NCT01668797|172040|P2|Phase A (Conversion Phase)|Protocol Violation|0
40056|NCT01668797|172041|P1|Phase A (Conversion Phase)|Protocol Violation|2
40057|NCT01668797|172038|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
40058|NCT01668797|172039|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
40059|NCT01668797|172040|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
40060|NCT01668797|172041|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
40061|NCT01668797|172038|P4|Phase A (Conversion Phase)|Physician Decision|0
40062|NCT01668797|172039|P3|Phase A (Conversion Phase)|Physician Decision|0
40063|NCT01668797|172040|P2|Phase A (Conversion Phase)|Physician Decision|0
40064|NCT01668797|172041|P1|Phase A (Conversion Phase)|Physician Decision|2
40065|NCT01668797|172038|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
40066|NCT01668797|172039|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
40067|NCT01668797|172040|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
40068|NCT01668797|172041|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
40069|NCT01668797|172038|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
40070|NCT01668797|172039|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
40071|NCT01668797|172040|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
40072|NCT01668797|172041|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
40073|NCT01668784|172106|P2|Treated (Overall)|Not Specified|4
40074|NCT01668784|172107|P1|Treated (Overall)|Not Specified|0
40075|NCT01668784|172106|P2|Treated (Overall)|Maximal Clinical Benefit|3
40076|NCT01668784|172107|P1|Treated (Overall)|Maximal Clinical Benefit|2
40077|NCT01668784|172106|P2|Treated (Overall)|Withdrawal by Subject|3
40078|NCT01668784|172107|P1|Treated (Overall)|Withdrawal by Subject|2
40079|NCT01668784|172106|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
40080|NCT01668784|172107|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
40081|NCT01668784|172106|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
40082|NCT01668784|172107|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
40083|NCT01668784|172106|P2|Treated (Overall)|Death|1
40084|NCT01668784|172107|P1|Treated (Overall)|Death|1
40085|NCT01668784|172106|P2|Treated (Overall)|Study Drug Toxicity|53
40086|NCT01668784|172107|P1|Treated (Overall)|Study Drug Toxicity|35
40087|NCT01668784|172106|P2|Treated (Overall)|Disease Progression|273
40088|NCT01668784|172107|P1|Treated (Overall)|Disease Progression|285
40089|NCT01668784|172106|P2|Randomized (Pre-treatment)|Not Specified|1
40090|NCT01668784|172107|P1|Randomized (Pre-treatment)|Not Specified|0
40091|NCT01668784|172106|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
40092|NCT01668784|172107|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
40093|NCT01668784|172106|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
40094|NCT01668784|172107|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
40095|NCT01668784|172106|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
40096|NCT01668784|172107|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
40097|NCT01668784|172106|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
40098|NCT01668784|172107|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
40099|NCT01668784|172106|P2|Randomized (Pre-treatment)|Disease Progression|1
40100|NCT01668784|172107|P1|Randomized (Pre-treatment)|Disease Progression|0
40101|NCT01668667|172135|P4|Overall Study|Withdrawal by Subject|5
40102|NCT01668667|172136|P3|Overall Study|Withdrawal by Subject|5
40103|NCT01668667|172137|P2|Overall Study|Withdrawal by Subject|4
40104|NCT01668667|172138|P1|Overall Study|Withdrawal by Subject|7
40105|NCT01668667|172135|P4|Overall Study|Physician Decision|0
40106|NCT01668667|172136|P3|Overall Study|Physician Decision|1
40107|NCT01668667|172137|P2|Overall Study|Physician Decision|0
40108|NCT01668667|172138|P1|Overall Study|Physician Decision|3
40109|NCT01668667|172135|P4|Overall Study|Lost to Follow-up|6
40110|NCT01668667|172136|P3|Overall Study|Lost to Follow-up|7
40111|NCT01668667|172137|P2|Overall Study|Lost to Follow-up|4
40112|NCT01668667|172138|P1|Overall Study|Lost to Follow-up|9
40113|NCT01668667|172135|P4|Overall Study|Protocol Violation|5
40114|NCT01668667|172136|P3|Overall Study|Protocol Violation|12
40115|NCT01668667|172137|P2|Overall Study|Protocol Violation|10
40116|NCT01668667|172138|P1|Overall Study|Protocol Violation|6
40117|NCT01668667|172135|P4|Overall Study|Lack of Efficacy|3
40118|NCT01668667|172136|P3|Overall Study|Lack of Efficacy|2
40119|NCT01668667|172137|P2|Overall Study|Lack of Efficacy|2
40120|NCT01668667|172138|P1|Overall Study|Lack of Efficacy|3
40121|NCT01668667|172135|P4|Overall Study|Adverse Event|4
40122|NCT01668667|172136|P3|Overall Study|Adverse Event|4
40123|NCT01668667|172137|P2|Overall Study|Adverse Event|6
40124|NCT01668667|172138|P1|Overall Study|Adverse Event|3
40125|NCT01668654|172160|P1|Overall Study|Withdrawal by Subject|1
40126|NCT01668654|172160|P1|Overall Study|Study Closed/Terminated|3
40127|NCT01668589|172221|P4|Overall Study|Other|15
40128|NCT01668589|172222|P3|Overall Study|Other|7
40129|NCT01668589|172223|P2|Overall Study|Other|10
40130|NCT01668589|172224|P1|Overall Study|Other|44
40131|NCT01668589|172221|P4|Overall Study|Death|11
40132|NCT01668589|172222|P3|Overall Study|Death|2
40133|NCT01668589|172223|P2|Overall Study|Death|3
40134|NCT01668589|172224|P1|Overall Study|Death|12
40135|NCT01668589|172221|P4|Overall Study|Full Consent/Agreement Withdrawn|4
40136|NCT01668589|172222|P3|Overall Study|Full Consent/Agreement Withdrawn|11
40137|NCT01668589|172223|P2|Overall Study|Full Consent/Agreement Withdrawn|8
40138|NCT01668589|172224|P1|Overall Study|Full Consent/Agreement Withdrawn|54
40139|NCT01668589|172221|P4|Overall Study|Lost to Follow-up|5
40140|NCT01668589|172222|P3|Overall Study|Lost to Follow-up|15
40141|NCT01668589|172223|P2|Overall Study|Lost to Follow-up|37
40142|NCT01668589|172224|P1|Overall Study|Lost to Follow-up|29
40143|NCT01668173|172262|P1|Overall Study|Trial suspension|4
40144|NCT01668173|172262|P1|Overall Study|Adverse Event|3
40145|NCT01668004|172388|P1|Overall Study|Non-compliance with treatment|2
40146|NCT01668004|172388|P1|Overall Study|Lack of Efficacy|9
40147|NCT01668004|172388|P1|Overall Study|Lost to Follow-up|5
40148|NCT01668004|172388|P1|Overall Study|Withdrawal by Subject|2
40149|NCT01668004|172388|P1|Overall Study|Adverse Event|7
40150|NCT01667926|172410|P3|Overall Study|Side effects|0
40151|NCT01667926|172411|P2|Overall Study|Side effects|0
40152|NCT01667926|172412|P1|Overall Study|Side effects|3
40153|NCT01667926|172410|P3|Overall Study|Lost to Follow-up|1
40154|NCT01667926|172411|P2|Overall Study|Lost to Follow-up|2
40155|NCT01667926|172412|P1|Overall Study|Lost to Follow-up|1
40156|NCT01667926|172410|P3|Overall Study|Inclusion/Exclusion Criteria|5
40157|NCT01667926|172411|P2|Overall Study|Inclusion/Exclusion Criteria|0
40158|NCT01667926|172412|P1|Overall Study|Inclusion/Exclusion Criteria|0
40159|NCT01667926|172410|P3|Overall Study|Time committment|2
40160|NCT01667926|172411|P2|Overall Study|Time committment|0
40161|NCT01667926|172412|P1|Overall Study|Time committment|0
40162|NCT01667926|172410|P3|Overall Study|Physician Decision|1
40163|NCT01667926|172411|P2|Overall Study|Physician Decision|0
40164|NCT01667926|172412|P1|Overall Study|Physician Decision|0
40165|NCT01667926|172410|P3|Overall Study|Withdrawal by Subject|2
40166|NCT01667926|172411|P2|Overall Study|Withdrawal by Subject|2
40167|NCT01667926|172412|P1|Overall Study|Withdrawal by Subject|1
40168|NCT01667900|172425|P20|Part B|Death|0
40169|NCT01667900|172426|P19|Part B|Death|0
40170|NCT01667900|172427|P18|Part B|Death|0
40171|NCT01667900|172428|P17|Part B|Death|1
40172|NCT01667900|172429|P16|Part B|Death|0
40173|NCT01667900|172430|P15|Part B|Death|0
40174|NCT01667900|172431|P14|Part B|Death|0
40175|NCT01667900|172432|P13|Part B|Death|0
40176|NCT01667900|172433|P12|Part B|Death|0
40177|NCT01667900|172434|P11|Part B|Death|0
40178|NCT01667900|172435|P10|Part B|Death|0
40179|NCT01667900|172436|P9|Part B|Death|0
40180|NCT01667900|172437|P8|Part B|Death|0
40181|NCT01667900|172438|P7|Part B|Death|0
40182|NCT01667900|172439|P6|Part B|Death|0
40183|NCT01667900|172440|P5|Part B|Death|0
40184|NCT01667900|172441|P4|Part B|Death|0
40185|NCT01667900|172442|P3|Part B|Death|0
40186|NCT01667900|172443|P2|Part B|Death|0
40187|NCT01667900|172444|P1|Part B|Death|0
40188|NCT01667731|172507|P5|Overall Study|Death|0
40189|NCT01667731|172508|P4|Overall Study|Death|0
40190|NCT01667731|172509|P3|Overall Study|Death|0
40191|NCT01667731|172510|P2|Overall Study|Death|1
40192|NCT01667731|172511|P1|Overall Study|Death|0
40193|NCT01667731|172507|P5|Overall Study|Subject Withdrew Consent|1
40194|NCT01667731|172508|P4|Overall Study|Subject Withdrew Consent|0
40195|NCT01667731|172509|P3|Overall Study|Subject Withdrew Consent|1
40196|NCT01667731|172510|P2|Overall Study|Subject Withdrew Consent|0
40197|NCT01667731|172511|P1|Overall Study|Subject Withdrew Consent|2
40198|NCT01667731|172507|P5|Overall Study|Lost to Follow-up|2
40199|NCT01667731|172508|P4|Overall Study|Lost to Follow-up|1
40200|NCT01667731|172509|P3|Overall Study|Lost to Follow-up|1
40201|NCT01667731|172510|P2|Overall Study|Lost to Follow-up|3
40202|NCT01667731|172511|P1|Overall Study|Lost to Follow-up|2
40203|NCT01667731|172507|P5|Overall Study|Efficacy Failure|24
40204|NCT01667731|172508|P4|Overall Study|Efficacy Failure|1
40205|NCT01667731|172509|P3|Overall Study|Efficacy Failure|0
40206|NCT01667731|172510|P2|Overall Study|Efficacy Failure|12
40207|NCT01667731|172511|P1|Overall Study|Efficacy Failure|1
40208|NCT01667731|172507|P5|Overall Study|Enrolled but not treated|1
40209|NCT01667731|172508|P4|Overall Study|Enrolled but not treated|0
40210|NCT01667731|172509|P3|Overall Study|Enrolled but not treated|0
40211|NCT01667731|172510|P2|Overall Study|Enrolled but not treated|0
40212|NCT01667731|172511|P1|Overall Study|Enrolled but not treated|0
40213|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
40214|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
40215|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
40216|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
40217|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
40218|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
40219|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
40220|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
40221|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
40222|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
40223|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
40224|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
40225|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
40226|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
40227|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
40228|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
40229|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
40230|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
40231|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
40232|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
40233|NCT01667679|172566|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
40234|NCT01667679|172567|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
40235|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
40236|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
40237|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
40238|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
40239|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
40240|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
40241|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
40242|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
40243|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
40244|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
40245|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
40246|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
40247|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
40248|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
40249|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
40250|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
40251|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
40252|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
40253|NCT01667679|172566|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
40254|NCT01667679|172567|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
40255|NCT01667432|172652|P1|Overall Study|Missing Information|4
40256|NCT01667432|172652|P1|Overall Study|Reason Not Specified|2
40257|NCT01667432|172652|P1|Overall Study|Principal Investigator Decision|1
40258|NCT01667432|172652|P1|Overall Study|Protocol Deviation|2
40259|NCT01667432|172652|P1|Overall Study|Adverse Event|1
40260|NCT01667432|172652|P1|Overall Study|Insufficient Therapeutic Response|4
40261|NCT01667432|172652|P1|Overall Study|Refused Treatment/Withdrew Consent|1
40262|NCT01667432|172652|P1|Overall Study|Lost to Follow-up|3
40263|NCT01667432|172652|P1|Overall Study|Moved to Another Center|3
40264|NCT01667432|172652|P1|Overall Study|Failure to Return|10
40265|NCT01667432|172652|P1|Overall Study|Premature Study Termination|26
40266|NCT01667224|172659|P2|Overall Study|Protocol Violation|1
40267|NCT01667224|172660|P1|Overall Study|Protocol Violation|1
40268|NCT01667224|172659|P2|Overall Study|Withdrawal by Subject|1
40269|NCT01667224|172660|P1|Overall Study|Withdrawal by Subject|3
40270|NCT01667107|172674|P2|Overall Study|Lack of Efficacy|1
40271|NCT01667107|172675|P1|Overall Study|Lack of Efficacy|0
40272|NCT01667107|172674|P2|Overall Study|Protocol Violation|1
40273|NCT01667107|172675|P1|Overall Study|Protocol Violation|0
40274|NCT01667107|172674|P2|Overall Study|Tolerability issues|2
40275|NCT01667107|172675|P1|Overall Study|Tolerability issues|0
40276|NCT01667107|172674|P2|Overall Study|Adverse Event|3
40277|NCT01667107|172675|P1|Overall Study|Adverse Event|4
40278|NCT01666951|172693|P2|Overall Study|Not dosed|1
40279|NCT01666951|172694|P1|Overall Study|Not dosed|1
40280|NCT01666782|172745|P2|Overall Study|Enrolled both years; year 1 data used|0
40281|NCT01666782|172746|P1|Overall Study|Enrolled both years; year 1 data used|4
40282|NCT01666782|172745|P2|Overall Study|Received 2 doses of vaccine|1
40283|NCT01666782|172746|P1|Overall Study|Received 2 doses of vaccine|0
40284|NCT01666314|172770|P4|Overall Study|Reason not Specified|5
40285|NCT01666314|172771|P3|Overall Study|Reason not Specified|5
40286|NCT01666314|172772|P2|Overall Study|Reason not Specified|7
40287|NCT01666314|172773|P1|Overall Study|Reason not Specified|10
40288|NCT01666314|172770|P4|Overall Study|Withdrawal by Subject|3
40289|NCT01666314|172771|P3|Overall Study|Withdrawal by Subject|2
40290|NCT01666314|172772|P2|Overall Study|Withdrawal by Subject|1
40291|NCT01666314|172773|P1|Overall Study|Withdrawal by Subject|1
40292|NCT01666314|172770|P4|Overall Study|Unsatisfactory Therapeutic Response|1
40293|NCT01666314|172771|P3|Overall Study|Unsatisfactory Therapeutic Response|1
40294|NCT01666314|172772|P2|Overall Study|Unsatisfactory Therapeutic Response|2
40295|NCT01666314|172773|P1|Overall Study|Unsatisfactory Therapeutic Response|7
40296|NCT01666314|172770|P4|Overall Study|Symptomatic Deterioration|0
40297|NCT01666314|172771|P3|Overall Study|Symptomatic Deterioration|2
40298|NCT01666314|172772|P2|Overall Study|Symptomatic Deterioration|0
40299|NCT01666314|172773|P1|Overall Study|Symptomatic Deterioration|1
40300|NCT01666314|172770|P4|Overall Study|Progressive Disease|20
40301|NCT01666314|172771|P3|Overall Study|Progressive Disease|19
40302|NCT01666314|172772|P2|Overall Study|Progressive Disease|9
40303|NCT01666314|172773|P1|Overall Study|Progressive Disease|11
40304|NCT01666314|172770|P4|Overall Study|Adverse Event|7
40305|NCT01666314|172771|P3|Overall Study|Adverse Event|7
40306|NCT01666314|172772|P2|Overall Study|Adverse Event|13
40307|NCT01666314|172773|P1|Overall Study|Adverse Event|3
40308|NCT01666119|172904|P1|Overall Study|Subject experiencing withdrawal symptoms|5
40309|NCT01666119|172904|P1|Overall Study|non compliance with study medication, pa|18
40310|NCT01666119|172904|P1|Overall Study|Lost to Follow-up|7
40311|NCT01666119|172904|P1|Overall Study|Withdrawal by Subject|16
40312|NCT01666119|172904|P1|Overall Study|Adverse Event|6
40313|NCT01666002|172911|P2|Overall Study|Lost to Follow-up|0
40314|NCT01666002|172912|P1|Overall Study|Lost to Follow-up|5
40315|NCT01665911|172933|P1|Overall Study|Adverse Event|1
40316|NCT01665911|172933|P1|Overall Study|Withdrawal by Subject|1
40317|NCT01665911|172933|P1|Overall Study|Protocol Violation|4
40318|NCT01665807|172942|P3|Overall Study|Withdrawal by Subject|1
40319|NCT01665807|172943|P2|Overall Study|Withdrawal by Subject|0
40320|NCT01665807|172944|P1|Overall Study|Withdrawal by Subject|2
40321|NCT01665599|172955|P1|Overall Study|Could Not Continue Due to Time Constrain|1
40322|NCT01665599|172955|P1|Overall Study|Participant Left for More Than 3 Months|1
40323|NCT01665599|172955|P1|Overall Study|Lost to Follow-up|2
40324|NCT01665599|172955|P1|Overall Study|Death|1
40325|NCT01665599|172955|P1|Overall Study|Investigator/Sponsor decision|1
40326|NCT01665599|172955|P1|Overall Study|Consent Withdrawn|1
40327|NCT01665599|172955|P1|Overall Study|Adverse Event|1
40328|NCT01665430|172991|P1|Overall Study|Other Unspecified|2
40329|NCT01665430|172991|P1|Overall Study|Withdrawal by Subject|6
40330|NCT01665430|172991|P1|Overall Study|Adverse Event|1
40331|NCT01664949|173139|P2|Overall Study|Other Miscellaneous Reasons|1
40332|NCT01664949|173140|P1|Overall Study|Other Miscellaneous Reasons|3
40333|NCT01664949|173139|P2|Overall Study|Protocol Violation|5
40334|NCT01664949|173140|P1|Overall Study|Protocol Violation|5
40335|NCT01664949|173139|P2|Overall Study|Personal Reasons|4
40336|NCT01664949|173140|P1|Overall Study|Personal Reasons|3
40337|NCT01664949|173139|P2|Overall Study|Lost to Follow-up|2
40338|NCT01664949|173140|P1|Overall Study|Lost to Follow-up|1
40339|NCT01664949|173139|P2|Overall Study|Lack of Efficacy|1
40340|NCT01664949|173140|P1|Overall Study|Lack of Efficacy|1
40341|NCT01664949|173139|P2|Overall Study|Adverse Event|12
40342|NCT01664949|173140|P1|Overall Study|Adverse Event|11
40343|NCT01664923|173156|P2|Overall Study|Miscellaneous|1
40344|NCT01664923|173157|P1|Overall Study|Miscellaneous|5
40345|NCT01664923|173156|P2|Overall Study|Adverse Event|12
40346|NCT01664923|173157|P1|Overall Study|Adverse Event|16
40347|NCT01664923|173156|P2|Overall Study|Disease Progression|139
40348|NCT01664923|173157|P1|Overall Study|Disease Progression|58
40349|NCT01664923|173156|P2|Overall Study|Withdrawal by Subject|5
40350|NCT01664923|173157|P1|Overall Study|Withdrawal by Subject|11
40351|NCT01664923|173156|P2|Overall Study|Protocol Violation|0
40352|NCT01664923|173157|P1|Overall Study|Protocol Violation|2
40353|NCT01664923|173156|P2|Overall Study|Lost to Follow-up|1
40354|NCT01664923|173157|P1|Overall Study|Lost to Follow-up|0
40355|NCT01664923|173156|P2|Overall Study|Death|0
40356|NCT01664923|173157|P1|Overall Study|Death|1
40357|NCT01664624|173201|P4|Overall Study|Adverse Event|0
40358|NCT01664624|173202|P3|Overall Study|Adverse Event|0
40359|NCT01664624|173203|P2|Overall Study|Adverse Event|1
40360|NCT01664624|173204|P1|Overall Study|Adverse Event|0
40361|NCT01664533|173251|P1|Overall Study|Protocol Violation|3
40362|NCT01664533|173251|P1|Overall Study|Study termination|9
40363|NCT01664533|173251|P1|Overall Study|Lost to Follow-up|3
40364|NCT01664533|173251|P1|Overall Study|Death|42
40365|NCT01664494|173259|P1|Overall Study|Lost to Follow-up|99
40366|NCT01664494|173259|P1|Overall Study|Not specified|49
40367|NCT01664494|173259|P1|Overall Study|Death|18
40368|NCT01664494|173259|P1|Overall Study|Withdrawal by Subject|27
40369|NCT01664247|173266|P2|Overall Study|Unclassified|29
40370|NCT01664247|173267|P1|Overall Study|Unclassified|5
40371|NCT01664247|173266|P2|Overall Study|Withdrawal Criteria|4
40372|NCT01664247|173267|P1|Overall Study|Withdrawal Criteria|1
40373|NCT01664247|173266|P2|Overall Study|Protocol Violation|5
40374|NCT01664247|173267|P1|Overall Study|Protocol Violation|3
40375|NCT01664247|173266|P2|Overall Study|Adverse Event|3
40376|NCT01664247|173267|P1|Overall Study|Adverse Event|5
40377|NCT01664104|173344|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
40378|NCT01664104|173344|P1|Overall Study|Other|1
40379|NCT01664104|173344|P1|Overall Study|Lost to Follow-up|4
40380|NCT01664104|173344|P1|Overall Study|Withdrawal by Subject|1
40381|NCT01664104|173344|P1|Overall Study|Lack of Efficacy|2
40382|NCT01664104|173344|P1|Overall Study|Adverse Event|6
40383|NCT01664052|173413|P2|Phase 2|No device placement|4
40384|NCT01664052|173414|P1|Phase 2|No device placement|0
40385|NCT01664052|173413|P2|Phase 1|No HSG 1 hr post placement|0
40386|NCT01664052|173414|P1|Phase 1|No HSG 1 hr post placement|1
40387|NCT01664052|173413|P2|Phase 1|No device placement|0
40388|NCT01664052|173414|P1|Phase 1|No device placement|6
40389|NCT01664039|173432|P2|Overall Study|Noncompliance|1
40390|NCT01664039|173433|P1|Overall Study|Noncompliance|1
40391|NCT01664039|173432|P2|Overall Study|Withdrawal by Subject|3
40392|NCT01664039|173433|P1|Overall Study|Withdrawal by Subject|1
40393|NCT01664039|173432|P2|Overall Study|Lost to Follow-up|1
40394|NCT01664039|173433|P1|Overall Study|Lost to Follow-up|1
40395|NCT01664039|173432|P2|Overall Study|Adverse Event|4
40396|NCT01664039|173433|P1|Overall Study|Adverse Event|3
40397|NCT01663987|173455|P2|Overall Study|Other reason not defined above|0
40398|NCT01663987|173456|P1|Overall Study|Other reason not defined above|3
40399|NCT01663987|173455|P2|Overall Study|Withdrawal by Subject|3
40400|NCT01663987|173456|P1|Overall Study|Withdrawal by Subject|2
40401|NCT01663987|173455|P2|Overall Study|Lost to Follow-up|1
40402|NCT01663987|173456|P1|Overall Study|Lost to Follow-up|1
40403|NCT01663987|173455|P2|Overall Study|Adverse Event|2
40404|NCT01663987|173456|P1|Overall Study|Adverse Event|7
40405|NCT01663727|173499|P2|Overall Study|Lost to Follow-up|3
40406|NCT01663727|173500|P1|Overall Study|Lost to Follow-up|8
40407|NCT01663727|173499|P2|Overall Study|Alive in Follow-Up|132
40408|NCT01663727|173500|P1|Overall Study|Alive in Follow-Up|143
40409|NCT01663727|173499|P2|Overall Study|Alive on Treatment|39
40410|NCT01663727|173500|P1|Overall Study|Alive on Treatment|31
40411|NCT01663727|173499|P2|Overall Study|Death|65
40412|NCT01663727|173500|P1|Overall Study|Death|60
40413|NCT01663714|173528|P1|Long-Term Follow-Up|Non-compliance|1
40414|NCT01663714|173528|P1|Long-Term Follow-Up|Death|4
40415|NCT01663714|173528|P1|Long-Term Follow-Up|Lost to Follow-up|1
40416|NCT01663714|173528|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
40417|NCT01663714|173528|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
40418|NCT01663714|173528|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
40419|NCT01663623|173557|P2|Overall Study|Withdrawal by Subject|1
40420|NCT01663623|173558|P1|Overall Study|Withdrawal by Subject|2
40421|NCT01663623|173557|P2|Overall Study|Physician Decision|4
40422|NCT01663623|173558|P1|Overall Study|Physician Decision|1
40423|NCT01663623|173557|P2|Overall Study|Other-Study closed/terminated|1
40424|NCT01663623|173558|P1|Overall Study|Other-Study closed/terminated|1
40425|NCT01663623|173557|P2|Overall Study|Protocol Violation|1
40426|NCT01663623|173558|P1|Overall Study|Protocol Violation|0
40427|NCT01663623|173557|P2|Overall Study|Lack of Efficacy|6
40428|NCT01663623|173558|P1|Overall Study|Lack of Efficacy|5
40429|NCT01663623|173557|P2|Overall Study|Adverse Event|7
40430|NCT01663623|173558|P1|Overall Study|Adverse Event|3
40431|NCT01663532|173568|P2|Overall Study|Lack of Efficacy|60
40432|NCT01663532|173569|P1|Overall Study|Lack of Efficacy|15
40433|NCT01663532|173568|P2|Overall Study|Withdrawal by Subject|17
40434|NCT01663532|173569|P1|Overall Study|Withdrawal by Subject|35
40435|NCT01663532|173568|P2|Overall Study|Physician Decision|1
40436|NCT01663532|173569|P1|Overall Study|Physician Decision|1
40437|NCT01663532|173568|P2|Overall Study|Met Withdrawal Criteria|6
40438|NCT01663532|173569|P1|Overall Study|Met Withdrawal Criteria|7
40439|NCT01663532|173568|P2|Overall Study|Adverse Event|13
40440|NCT01663532|173569|P1|Overall Study|Adverse Event|7
40441|NCT01663532|173568|P2|Overall Study|Lost to Follow-up|10
40442|NCT01663532|173569|P1|Overall Study|Lost to Follow-up|9
40443|NCT01663506|173587|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
40444|NCT01663506|173587|P1|Overall Study|Adverse Event|1
40445|NCT01663506|173587|P1|Overall Study|Lost to Follow-up|1
40446|NCT01663506|173587|P1|Overall Study|Consent Withdrawal by Subject|1
40447|NCT01663506|173587|P1|Overall Study|Lack of Efficacy|3
40448|NCT01663233|173629|P2|Overall Study|Lost to Follow-up|1
40449|NCT01663233|173630|P1|Overall Study|Lost to Follow-up|0
40450|NCT01663233|173629|P2|Overall Study|Protocol Deviation|4
40451|NCT01663233|173630|P1|Overall Study|Protocol Deviation|1
40452|NCT01663233|173629|P2|Overall Study|Withdrawal by Subject|2
40453|NCT01663233|173630|P1|Overall Study|Withdrawal by Subject|3
40454|NCT01663103|173654|P2|Overall Study|dog bite|0
40455|NCT01663103|173655|P1|Overall Study|dog bite|1
40456|NCT01663103|173654|P2|Overall Study|Adverse Event|0
40457|NCT01663103|173655|P1|Overall Study|Adverse Event|1
40458|NCT01663103|173654|P2|Overall Study|Withdrawal by Subject|2
40459|NCT01663103|173655|P1|Overall Study|Withdrawal by Subject|1
40460|NCT01662999|173683|P6|Period 3|Withdrawal by Subject|0
40461|NCT01662999|173684|P5|Period 3|Withdrawal by Subject|0
40462|NCT01662999|173685|P4|Period 3|Withdrawal by Subject|0
40463|NCT01662999|173686|P3|Period 3|Withdrawal by Subject|0
40464|NCT01662999|173687|P2|Period 3|Withdrawal by Subject|1
40465|NCT01662999|173688|P1|Period 3|Withdrawal by Subject|0
40466|NCT01662986|173759|P2|Overall Study|Other than stated above|0
40467|NCT01662986|173760|P1|Overall Study|Other than stated above|3
40468|NCT01662986|173759|P2|Overall Study|Not Treated|0
40469|NCT01662986|173760|P1|Overall Study|Not Treated|1
40470|NCT01662986|173759|P2|Overall Study|Withdrawal by Subject|2
40471|NCT01662986|173760|P1|Overall Study|Withdrawal by Subject|2
40472|NCT01662986|173759|P2|Overall Study|Lost to Follow-up|4
40473|NCT01662986|173760|P1|Overall Study|Lost to Follow-up|5
40474|NCT01662986|173759|P2|Overall Study|Protocol Violation|3
40475|NCT01662986|173760|P1|Overall Study|Protocol Violation|2
40476|NCT01662986|173759|P2|Overall Study|Adverse Event|4
40477|NCT01662986|173760|P1|Overall Study|Adverse Event|5
40478|NCT01662648|173880|P2|Overall Study|LOE and Participant non-compliant|1
40479|NCT01662648|173881|P1|Overall Study|LOE and Participant non-compliant|0
40480|NCT01662648|173880|P2|Overall Study|LOE and other reason unspecified|0
40481|NCT01662648|173881|P1|Overall Study|LOE and other reason unspecified|1
40482|NCT01662648|173880|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
40483|NCT01662648|173881|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
40484|NCT01662648|173880|P2|Overall Study|Other|11
40485|NCT01662648|173881|P1|Overall Study|Other|8
40486|NCT01662648|173880|P2|Overall Study|Participant non-compliant|20
40487|NCT01662648|173881|P1|Overall Study|Participant non-compliant|16
40488|NCT01662648|173880|P2|Overall Study|Withdrawal by Subject|53
40489|NCT01662648|173881|P1|Overall Study|Withdrawal by Subject|36
40490|NCT01662648|173880|P2|Overall Study|Lost to Follow-up|36
40491|NCT01662648|173881|P1|Overall Study|Lost to Follow-up|24
40492|NCT01662648|173880|P2|Overall Study|Participant ineligible to continue trial|1
40493|NCT01662648|173881|P1|Overall Study|Participant ineligible to continue trial|1
40494|NCT01662648|173880|P2|Overall Study|Lack of Efficacy|16
40495|NCT01662648|173881|P1|Overall Study|Lack of Efficacy|17
40496|NCT01662648|173880|P2|Overall Study|Adverse Event|37
40497|NCT01662648|173881|P1|Overall Study|Adverse Event|40
40498|NCT01662648|173880|P2|Overall Study|Death|3
40499|NCT01662648|173881|P1|Overall Study|Death|1
40500|NCT01662635|173903|P1|Overall Study|scarce samples for evaluation|30
40501|NCT01662492|173954|P3|Overall Study|Lack of Efficacy|2
40502|NCT01662492|173955|P2|Overall Study|Lack of Efficacy|1
40503|NCT01662492|173956|P1|Overall Study|Lack of Efficacy|1
40504|NCT01662492|173954|P3|Overall Study|Lost to Follow-up|2
40505|NCT01662492|173955|P2|Overall Study|Lost to Follow-up|0
40506|NCT01662492|173956|P1|Overall Study|Lost to Follow-up|0
40507|NCT01662492|173954|P3|Overall Study|Protocol Violation|0
40508|NCT01662492|173955|P2|Overall Study|Protocol Violation|0
40509|NCT01662492|173956|P1|Overall Study|Protocol Violation|1
40510|NCT01662492|173954|P3|Overall Study|Withdrawal by Subject|1
40511|NCT01662492|173955|P2|Overall Study|Withdrawal by Subject|0
40512|NCT01662492|173956|P1|Overall Study|Withdrawal by Subject|0
40513|NCT01662492|173954|P3|Overall Study|Other miscellaneous reasons.|1
40514|NCT01662492|173955|P2|Overall Study|Other miscellaneous reasons.|0
40515|NCT01662492|173956|P1|Overall Study|Other miscellaneous reasons.|1
40516|NCT01662440|173980|P4|Overall Study|Withdrawal by Subject|2
40517|NCT01662440|173981|P3|Overall Study|Withdrawal by Subject|2
40518|NCT01662440|173982|P2|Overall Study|Withdrawal by Subject|2
40519|NCT01662440|173983|P1|Overall Study|Withdrawal by Subject|5
40520|NCT01662440|173980|P4|Overall Study|Protocol Violation|0
40521|NCT01662440|173981|P3|Overall Study|Protocol Violation|0
40522|NCT01662440|173982|P2|Overall Study|Protocol Violation|0
40523|NCT01662440|173983|P1|Overall Study|Protocol Violation|1
40524|NCT01662440|173980|P4|Overall Study|Subject moved to another country.|0
40525|NCT01662440|173981|P3|Overall Study|Subject moved to another country.|0
40526|NCT01662440|173982|P2|Overall Study|Subject moved to another country.|1
40527|NCT01662440|173983|P1|Overall Study|Subject moved to another country.|0
40528|NCT01662440|173980|P4|Overall Study|Lost to Follow-up|1
40529|NCT01662440|173981|P3|Overall Study|Lost to Follow-up|4
40530|NCT01662440|173982|P2|Overall Study|Lost to Follow-up|2
40531|NCT01662440|173983|P1|Overall Study|Lost to Follow-up|2
40532|NCT01662440|173980|P4|Overall Study|Death|0
40533|NCT01662440|173981|P3|Overall Study|Death|0
40534|NCT01662440|173982|P2|Overall Study|Death|1
40535|NCT01662440|173983|P1|Overall Study|Death|0
40536|NCT01662440|173980|P4|Overall Study|Adverse Event|1
40537|NCT01662440|173981|P3|Overall Study|Adverse Event|0
40538|NCT01662440|173982|P2|Overall Study|Adverse Event|0
40539|NCT01662440|173983|P1|Overall Study|Adverse Event|1
40540|NCT01662362|174031|P1|Overall Study|Lost to Follow-up|38
40541|NCT01662336|174036|P1|Overall Study|Withdrawal by Subject|6
40542|NCT01662336|174036|P1|Overall Study|Other|29
40543|NCT01662336|174036|P1|Overall Study|No longer on LPV/r|30
40544|NCT01662336|174036|P1|Overall Study|Adverse Event|1
40545|NCT01662310|174062|P5|Open-Label Extension Phase|Withdrawal by Subject|7
40546|NCT01662310|174063|P4|Open-Label Extension Phase|Withdrawal by Subject|2
40547|NCT01662310|174064|P3|Open-Label Extension Phase|Withdrawal by Subject|0
40548|NCT01662310|174065|P2|Open-Label Extension Phase|Withdrawal by Subject|0
40549|NCT01662310|174066|P1|Open-Label Extension Phase|Withdrawal by Subject|0
40550|NCT01662310|174062|P5|Open-Label Extension Phase|Pregnancy|0
40551|NCT01662310|174063|P4|Open-Label Extension Phase|Pregnancy|1
40552|NCT01662310|174064|P3|Open-Label Extension Phase|Pregnancy|0
40553|NCT01662310|174065|P2|Open-Label Extension Phase|Pregnancy|0
40554|NCT01662310|174066|P1|Open-Label Extension Phase|Pregnancy|0
40555|NCT01662310|174062|P5|Open-Label Extension Phase|Lost to Follow-up|1
40556|NCT01662310|174063|P4|Open-Label Extension Phase|Lost to Follow-up|2
40557|NCT01662310|174064|P3|Open-Label Extension Phase|Lost to Follow-up|0
40558|NCT01662310|174065|P2|Open-Label Extension Phase|Lost to Follow-up|0
40559|NCT01662310|174066|P1|Open-Label Extension Phase|Lost to Follow-up|0
40560|NCT01662310|174062|P5|Open-Label Extension Phase|Lack of Efficacy|2
40561|NCT01662310|174063|P4|Open-Label Extension Phase|Lack of Efficacy|2
40562|NCT01662310|174064|P3|Open-Label Extension Phase|Lack of Efficacy|0
40563|NCT01662310|174065|P2|Open-Label Extension Phase|Lack of Efficacy|0
40564|NCT01662310|174066|P1|Open-Label Extension Phase|Lack of Efficacy|0
40565|NCT01662310|174062|P5|Open-Label Extension Phase|Death|0
40566|NCT01662310|174063|P4|Open-Label Extension Phase|Death|1
40567|NCT01662310|174064|P3|Open-Label Extension Phase|Death|0
40568|NCT01662310|174065|P2|Open-Label Extension Phase|Death|0
40569|NCT01662310|174066|P1|Open-Label Extension Phase|Death|0
40570|NCT01662310|174062|P5|Open-Label Extension Phase|Adverse Event|0
40571|NCT01662310|174063|P4|Open-Label Extension Phase|Adverse Event|3
40572|NCT01662310|174064|P3|Open-Label Extension Phase|Adverse Event|0
40573|NCT01662310|174065|P2|Open-Label Extension Phase|Adverse Event|0
40574|NCT01662310|174066|P1|Open-Label Extension Phase|Adverse Event|0
40575|NCT01662310|174062|P5|Double-Blind Phase|Randomized but not treated|0
40576|NCT01662310|174063|P4|Double-Blind Phase|Randomized but not treated|0
40577|NCT01662310|174064|P3|Double-Blind Phase|Randomized but not treated|0
40578|NCT01662310|174065|P2|Double-Blind Phase|Randomized but not treated|1
40579|NCT01662310|174066|P1|Double-Blind Phase|Randomized but not treated|0
40580|NCT01662310|174062|P5|Double-Blind Phase|Other|0
40581|NCT01662310|174063|P4|Double-Blind Phase|Other|0
40582|NCT01662310|174064|P3|Double-Blind Phase|Other|1
40583|NCT01662310|174065|P2|Double-Blind Phase|Other|0
40584|NCT01662310|174066|P1|Double-Blind Phase|Other|0
40585|NCT01662310|174062|P5|Double-Blind Phase|Withdrawal by Subject|0
40586|NCT01662310|174063|P4|Double-Blind Phase|Withdrawal by Subject|0
40587|NCT01662310|174064|P3|Double-Blind Phase|Withdrawal by Subject|3
40588|NCT01662310|174065|P2|Double-Blind Phase|Withdrawal by Subject|9
40589|NCT01662310|174066|P1|Double-Blind Phase|Withdrawal by Subject|0
40590|NCT01662310|174062|P5|Double-Blind Phase|Pregnancy|0
40591|NCT01662310|174063|P4|Double-Blind Phase|Pregnancy|0
40592|NCT01662310|174064|P3|Double-Blind Phase|Pregnancy|0
40593|NCT01662310|174065|P2|Double-Blind Phase|Pregnancy|2
40594|NCT01662310|174066|P1|Double-Blind Phase|Pregnancy|0
40595|NCT01662310|174062|P5|Double-Blind Phase|Lost to Follow-up|0
40596|NCT01662310|174063|P4|Double-Blind Phase|Lost to Follow-up|0
40597|NCT01662310|174064|P3|Double-Blind Phase|Lost to Follow-up|0
40598|NCT01662310|174065|P2|Double-Blind Phase|Lost to Follow-up|3
40599|NCT01662310|174066|P1|Double-Blind Phase|Lost to Follow-up|0
40600|NCT01662310|174062|P5|Double-Blind Phase|Adverse Event|0
40601|NCT01662310|174063|P4|Double-Blind Phase|Adverse Event|0
40602|NCT01662310|174064|P3|Double-Blind Phase|Adverse Event|1
40603|NCT01662310|174065|P2|Double-Blind Phase|Adverse Event|0
40604|NCT01662310|174066|P1|Double-Blind Phase|Adverse Event|0
40605|NCT01662310|174062|P5|Run-In or Stabilization Phase|Other|0
40606|NCT01662310|174063|P4|Run-In or Stabilization Phase|Other|0
40607|NCT01662310|174064|P3|Run-In or Stabilization Phase|Other|0
40608|NCT01662310|174065|P2|Run-In or Stabilization Phase|Other|0
40609|NCT01662310|174066|P1|Run-In or Stabilization Phase|Other|1
40610|NCT01662310|174062|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
40611|NCT01662310|174063|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
40612|NCT01662310|174064|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
40613|NCT01662310|174065|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
40614|NCT01662310|174066|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
40615|NCT01662310|174062|P5|Run-In or Stabilization Phase|Protocol Violation|0
40616|NCT01662310|174063|P4|Run-In or Stabilization Phase|Protocol Violation|0
40617|NCT01662310|174064|P3|Run-In or Stabilization Phase|Protocol Violation|0
40618|NCT01662310|174065|P2|Run-In or Stabilization Phase|Protocol Violation|0
40619|NCT01662310|174066|P1|Run-In or Stabilization Phase|Protocol Violation|15
40620|NCT01662310|174062|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
40621|NCT01662310|174063|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
40622|NCT01662310|174064|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
40623|NCT01662310|174065|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
40624|NCT01662310|174066|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
40625|NCT01662310|174062|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
40626|NCT01662310|174063|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
40627|NCT01662310|174064|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
40628|NCT01662310|174065|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
40629|NCT01662310|174066|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
40630|NCT01662310|174062|P5|Run-In or Stabilization Phase|Adverse Event|0
40631|NCT01662310|174063|P4|Run-In or Stabilization Phase|Adverse Event|0
40632|NCT01662310|174064|P3|Run-In or Stabilization Phase|Adverse Event|0
40633|NCT01662310|174065|P2|Run-In or Stabilization Phase|Adverse Event|0
40634|NCT01662310|174066|P1|Run-In or Stabilization Phase|Adverse Event|11
40635|NCT01662102|174122|P2|Overall Study|Sponsor's decision|0
40636|NCT01662102|174123|P1|Overall Study|Sponsor's decision|1
40637|NCT01662063|174131|P3|Overall Study|Not Specified|0
40638|NCT01662063|174132|P2|Overall Study|Not Specified|1
40639|NCT01662063|174133|P1|Overall Study|Not Specified|0
40640|NCT01662063|174131|P3|Overall Study|Physician Decision|0
40641|NCT01662063|174132|P2|Overall Study|Physician Decision|2
40642|NCT01662063|174133|P1|Overall Study|Physician Decision|0
40643|NCT01662063|174131|P3|Overall Study|Withdrawal by Subject|1
40644|NCT01662063|174132|P2|Overall Study|Withdrawal by Subject|4
40645|NCT01662063|174133|P1|Overall Study|Withdrawal by Subject|2
40646|NCT01662063|174131|P3|Overall Study|Protocol Violation|0
40647|NCT01662063|174132|P2|Overall Study|Protocol Violation|0
40648|NCT01662063|174133|P1|Overall Study|Protocol Violation|1
40649|NCT01662063|174131|P3|Overall Study|Lost to Follow-up|0
40650|NCT01662063|174132|P2|Overall Study|Lost to Follow-up|4
40651|NCT01662063|174133|P1|Overall Study|Lost to Follow-up|0
40652|NCT01662063|174131|P3|Overall Study|Lack of Efficacy|0
40653|NCT01662063|174132|P2|Overall Study|Lack of Efficacy|6
40654|NCT01662063|174133|P1|Overall Study|Lack of Efficacy|1
40655|NCT01662063|174131|P3|Overall Study|Adverse Event or Intercurrent Illness|0
40656|NCT01662063|174132|P2|Overall Study|Adverse Event or Intercurrent Illness|12
40657|NCT01662063|174133|P1|Overall Study|Adverse Event or Intercurrent Illness|1
40658|NCT01662024|174212|P1|Overall Study|Withdrawal by Subject|3
40659|NCT01662024|174212|P1|Overall Study|Pregnancy|2
40660|NCT01661972|174224|P2|Overall Study|Withdrawal by Subject|1
40661|NCT01661972|174225|P1|Overall Study|Withdrawal by Subject|0
40662|NCT01661972|174224|P2|Overall Study|Death during Treatment period|1
40663|NCT01661972|174225|P1|Overall Study|Death during Treatment period|1
40664|NCT01661972|174224|P2|Overall Study|Adverse Event|2
40665|NCT01661972|174225|P1|Overall Study|Adverse Event|1
40666|NCT01661933|174235|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
40667|NCT01661933|174235|P1|Low-dose Gluten Challenge|Physician Decision|2
40668|NCT01661790|174250|P2|Overall Study|Lost to Follow-up|2
40669|NCT01661790|174251|P1|Overall Study|Lost to Follow-up|0
40670|NCT01661205|174367|P1|Overall Study|Physician Decision|2
40671|NCT01661179|174378|P1|Overall Study|Other Eligibility criteria|4
40672|NCT01661179|174378|P1|Overall Study|Withdrawal by Subject|1
40673|NCT01661179|174378|P1|Overall Study|Death|1
40674|NCT01661140|174382|P3|Double-Blind Period|Administrative/Other|6
40675|NCT01661140|174383|P2|Double-Blind Period|Administrative/Other|7
40676|NCT01661140|174384|P1|Double-Blind Period|Administrative/Other|0
40677|NCT01661140|174382|P3|Double-Blind Period|Sponsor Termination|17
40678|NCT01661140|174383|P2|Double-Blind Period|Sponsor Termination|14
40679|NCT01661140|174384|P1|Double-Blind Period|Sponsor Termination|0
40680|NCT01661140|174382|P3|Double-Blind Period|Investigator's Decision|2
40681|NCT01661140|174383|P2|Double-Blind Period|Investigator's Decision|1
40682|NCT01661140|174384|P1|Double-Blind Period|Investigator's Decision|0
40683|NCT01661140|174382|P3|Double-Blind Period|Withdrawal by Subject|3
40684|NCT01661140|174383|P2|Double-Blind Period|Withdrawal by Subject|1
40685|NCT01661140|174384|P1|Double-Blind Period|Withdrawal by Subject|0
40686|NCT01661140|174382|P3|Double-Blind Period|Protocol Violation|3
40687|NCT01661140|174383|P2|Double-Blind Period|Protocol Violation|2
40688|NCT01661140|174384|P1|Double-Blind Period|Protocol Violation|0
40689|NCT01661140|174382|P3|Double-Blind Period|Adverse Event|18
40690|NCT01661140|174383|P2|Double-Blind Period|Adverse Event|16
40691|NCT01661140|174384|P1|Double-Blind Period|Adverse Event|0
40692|NCT01661140|174382|P3|Double-Blind Period|Refused Treatment|1
40693|NCT01661140|174383|P2|Double-Blind Period|Refused Treatment|0
40694|NCT01661140|174384|P1|Double-Blind Period|Refused Treatment|0
40695|NCT01661140|174382|P3|Open-Label Period|Lost to Follow-up|0
40696|NCT01661140|174383|P2|Open-Label Period|Lost to Follow-up|0
40697|NCT01661140|174384|P1|Open-Label Period|Lost to Follow-up|2
40698|NCT01661140|174382|P3|Open-Label Period|Did not meet EULAR criteria|0
40699|NCT01661140|174383|P2|Open-Label Period|Did not meet EULAR criteria|0
40700|NCT01661140|174384|P1|Open-Label Period|Did not meet EULAR criteria|1
40701|NCT01661140|174382|P3|Open-Label Period|Sponsor termination|0
40702|NCT01661140|174383|P2|Open-Label Period|Sponsor termination|0
40703|NCT01661140|174384|P1|Open-Label Period|Sponsor termination|16
40704|NCT01661140|174382|P3|Open-Label Period|Administrative/Other|0
40705|NCT01661140|174383|P2|Open-Label Period|Administrative/Other|0
40706|NCT01661140|174384|P1|Open-Label Period|Administrative/Other|1
40707|NCT01661140|174382|P3|Open-Label Period|Death|0
40708|NCT01661140|174383|P2|Open-Label Period|Death|0
40709|NCT01661140|174384|P1|Open-Label Period|Death|1
40710|NCT01661140|174382|P3|Open-Label Period|Investigator Decision|0
40711|NCT01661140|174383|P2|Open-Label Period|Investigator Decision|0
40712|NCT01661140|174384|P1|Open-Label Period|Investigator Decision|3
40713|NCT01661140|174382|P3|Open-Label Period|Withdrawal by Subject|0
40714|NCT01661140|174383|P2|Open-Label Period|Withdrawal by Subject|0
40715|NCT01661140|174384|P1|Open-Label Period|Withdrawal by Subject|5
40716|NCT01661140|174382|P3|Open-Label Period|Protocol Violation|0
40717|NCT01661140|174383|P2|Open-Label Period|Protocol Violation|0
40718|NCT01661140|174384|P1|Open-Label Period|Protocol Violation|3
40719|NCT01661140|174382|P3|Open-Label Period|Adverse Event|0
40720|NCT01661140|174383|P2|Open-Label Period|Adverse Event|0
40721|NCT01661140|174384|P1|Open-Label Period|Adverse Event|44
40722|NCT01661062|174430|P1|Overall Study|Withdrawal by Subject|2
40723|NCT01661062|174430|P1|Overall Study|Completed Treatment Off Study|3
40724|NCT01660906|174435|P1|Overall Study|Discontinued due to study drug toxicity|3
40725|NCT01660763|174518|P2|Overall Study|Patient ready for early discharge|4
40726|NCT01660763|174519|P1|Overall Study|Patient ready for early discharge|28
40727|NCT01660763|174518|P2|Overall Study|Withdrawal by Subject|0
40728|NCT01660763|174519|P1|Overall Study|Withdrawal by Subject|4
40729|NCT01660763|174518|P2|Overall Study|Protocol Violation|0
40730|NCT01660763|174519|P1|Overall Study|Protocol Violation|1
40731|NCT01660763|174518|P2|Overall Study|Adverse Event|7
40732|NCT01660763|174519|P1|Overall Study|Adverse Event|22
40733|NCT01660763|174518|P2|Overall Study|Lack of Efficacy|50
40734|NCT01660763|174519|P1|Overall Study|Lack of Efficacy|45
40735|NCT01660451|174567|P3|Overall Study|Ongoing with treatment|46
40736|NCT01660451|174568|P2|Overall Study|Ongoing with treatment|3
40737|NCT01660451|174569|P1|Overall Study|Ongoing with treatment|3
40738|NCT01660451|174567|P3|Overall Study|Withdrawal by Subject|16
40739|NCT01660451|174568|P2|Overall Study|Withdrawal by Subject|0
40740|NCT01660451|174569|P1|Overall Study|Withdrawal by Subject|1
40741|NCT01660451|174567|P3|Overall Study|Physician Decision|5
40742|NCT01660451|174568|P2|Overall Study|Physician Decision|2
40743|NCT01660451|174569|P1|Overall Study|Physician Decision|1
40744|NCT01660451|174567|P3|Overall Study|Protocol Deviation|1
40745|NCT01660451|174568|P2|Overall Study|Protocol Deviation|0
40746|NCT01660451|174569|P1|Overall Study|Protocol Deviation|0
40747|NCT01660451|174567|P3|Overall Study|Sponsor Decision|1
40748|NCT01660451|174568|P2|Overall Study|Sponsor Decision|0
40749|NCT01660451|174569|P1|Overall Study|Sponsor Decision|0
40750|NCT01660451|174567|P3|Overall Study|AE with Clinical PD|9
40751|NCT01660451|174568|P2|Overall Study|AE with Clinical PD|3
40752|NCT01660451|174569|P1|Overall Study|AE with Clinical PD|1
40753|NCT01660451|174567|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
40754|NCT01660451|174568|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
40755|NCT01660451|174569|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
40756|NCT01660451|174567|P3|Overall Study|Protocol Violation|1
40757|NCT01660451|174568|P2|Overall Study|Protocol Violation|1
40758|NCT01660451|174569|P1|Overall Study|Protocol Violation|0
40759|NCT01660412|174597|P2|Overall Study|Protocol Violation|3
40760|NCT01660412|174598|P1|Overall Study|Protocol Violation|0
40761|NCT01660334|174604|P1|Overall Study|Lost to Follow-up|1
40762|NCT01660022|174847|P6|First Sequence (7 Days)|Protocol Violation|1
40763|NCT01660022|174848|P5|First Sequence (7 Days)|Protocol Violation|0
40764|NCT01660022|174849|P4|First Sequence (7 Days)|Protocol Violation|0
40765|NCT01660022|174850|P3|First Sequence (7 Days)|Protocol Violation|0
40766|NCT01660022|174851|P2|First Sequence (7 Days)|Protocol Violation|0
40767|NCT01660022|174852|P1|First Sequence (7 Days)|Protocol Violation|0
40768|NCT01660022|174847|P6|First Sequence (7 Days)|Adverse Event|3
40769|NCT01660022|174848|P5|First Sequence (7 Days)|Adverse Event|1
40770|NCT01660022|174849|P4|First Sequence (7 Days)|Adverse Event|0
40771|NCT01660022|174850|P3|First Sequence (7 Days)|Adverse Event|0
40772|NCT01660022|174851|P2|First Sequence (7 Days)|Adverse Event|0
40773|NCT01660022|174852|P1|First Sequence (7 Days)|Adverse Event|0
40774|NCT01660022|174847|P6|First Sequence (7 Days)|Withdrawal by Subject|0
40775|NCT01660022|174848|P5|First Sequence (7 Days)|Withdrawal by Subject|0
40776|NCT01660022|174849|P4|First Sequence (7 Days)|Withdrawal by Subject|1
40777|NCT01660022|174850|P3|First Sequence (7 Days)|Withdrawal by Subject|0
40778|NCT01660022|174851|P2|First Sequence (7 Days)|Withdrawal by Subject|1
40779|NCT01660022|174852|P1|First Sequence (7 Days)|Withdrawal by Subject|0
40780|NCT01659996|174911|P3|Overall Study|Withdrawal by Subject|5
40781|NCT01659996|174912|P2|Overall Study|Withdrawal by Subject|1
40782|NCT01659996|174913|P1|Overall Study|Withdrawal by Subject|4
40783|NCT01659996|174911|P3|Overall Study|Adverse Event|1
40784|NCT01659996|174912|P2|Overall Study|Adverse Event|0
40785|NCT01659996|174913|P1|Overall Study|Adverse Event|0
40786|NCT01659996|174911|P3|Overall Study|Lost to Follow-up|2
40787|NCT01659996|174912|P2|Overall Study|Lost to Follow-up|3
40788|NCT01659996|174913|P1|Overall Study|Lost to Follow-up|1
40789|NCT01659996|174911|P3|Overall Study|Protocol Violation|3
40790|NCT01659996|174912|P2|Overall Study|Protocol Violation|3
40791|NCT01659996|174913|P1|Overall Study|Protocol Violation|3
40792|NCT01659853|174945|P2|Washout , 3 to 7 Days|Protocol Violation|0
40793|NCT01659853|174946|P1|Washout , 3 to 7 Days|Protocol Violation|1
40794|NCT01659853|174945|P2|Washout , 3 to 7 Days|Adverse Event|0
40795|NCT01659853|174946|P1|Washout , 3 to 7 Days|Adverse Event|1
40796|NCT01659736|174956|P2|3-month Follow-up|Lost to Follow-up|1
40797|NCT01659736|174957|P1|3-month Follow-up|Lost to Follow-up|0
40798|NCT01659736|174956|P2|Treatment Period|Withdrawal by Subject|0
40799|NCT01659736|174957|P1|Treatment Period|Withdrawal by Subject|1
40800|NCT01659736|174956|P2|Treatment Period|Protocol Violation|1
40801|NCT01659736|174957|P1|Treatment Period|Protocol Violation|3
40802|NCT01659736|174956|P2|Treatment Period|Adverse Event|1
40803|NCT01659736|174957|P1|Treatment Period|Adverse Event|1
40804|NCT01659567|174971|P1|Overall Study|Other|13
40805|NCT01659567|174971|P1|Overall Study|Progression of the main disease|1
40806|NCT01659567|174971|P1|Overall Study|Withdrawal by Subject|64
40807|NCT01659567|174971|P1|Overall Study|Good result at early stage of treatment|5
40808|NCT01659567|174971|P1|Overall Study|Adverse Event|12
40809|NCT01659567|174971|P1|Overall Study|Switched to Pegferon|6
40810|NCT01659567|174971|P1|Overall Study|Lack of Efficacy|22
40811|NCT01659554|174988|P1|Overall Study|Study Termination|4
40812|NCT01659320|174995|P1|Overall Study|Physician Decision|1
40813|NCT01659320|174995|P1|Overall Study|Withdrawal by Subject|2
40814|NCT01659125|175014|P1|Overall Study|Failed to Start Treatment|2
40815|NCT01659125|175014|P1|Overall Study|Time Constraints|2
40816|NCT01659125|175014|P1|Overall Study|Technical Problem|1
40817|NCT01659125|175014|P1|Overall Study|Lost to Follow-up|7
40818|NCT01659125|175014|P1|Overall Study|Withdrawal by Subject|2
40819|NCT01659021|175021|P2|Overall Study|Still on Study|1
40820|NCT01659021|175022|P1|Overall Study|Still on Study|34
40821|NCT01659021|175021|P2|Overall Study|Withdrawal by Subject|16
40822|NCT01659021|175022|P1|Overall Study|Withdrawal by Subject|18
40823|NCT01659021|175021|P2|Overall Study|Physician Decision|16
40824|NCT01659021|175022|P1|Overall Study|Physician Decision|32
40825|NCT01659021|175021|P2|Overall Study|Other?|1
40826|NCT01659021|175022|P1|Overall Study|Other?|1
40827|NCT01659021|175021|P2|Overall Study|Lost to Follow-up|0
40828|NCT01659021|175022|P1|Overall Study|Lost to Follow-up|1
40829|NCT01659021|175021|P2|Overall Study|Adverse Event|3
40830|NCT01659021|175022|P1|Overall Study|Adverse Event|2
40831|NCT01658943|175040|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
40832|NCT01658943|175041|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
40833|NCT01658943|175040|P2|Overall Study|Not eligible|9
40834|NCT01658943|175041|P1|Overall Study|Not eligible|7
40835|NCT01658943|175040|P2|Overall Study|not protocol specified|1
40836|NCT01658943|175041|P1|Overall Study|not protocol specified|4
40837|NCT01658943|175040|P2|Overall Study|Death|2
40838|NCT01658943|175041|P1|Overall Study|Death|4
40839|NCT01658943|175040|P2|Overall Study|Progression/Relapse|40
40840|NCT01658943|175041|P1|Overall Study|Progression/Relapse|39
40841|NCT01658943|175040|P2|Overall Study|Withdrawal by Subject|2
40842|NCT01658943|175041|P1|Overall Study|Withdrawal by Subject|9
40843|NCT01658943|175040|P2|Overall Study|Adverse Event|13
40844|NCT01658943|175041|P1|Overall Study|Adverse Event|6
40845|NCT01658904|175056|P3|Overall Study|Principal Investigator discretion|0
40846|NCT01658904|175057|P2|Overall Study|Principal Investigator discretion|0
40847|NCT01658904|175058|P1|Overall Study|Principal Investigator discretion|2
40848|NCT01658813|175084|P1|Overall Study|Disease progression|3
40849|NCT01658735|175095|P3|Overall Study|Withdrawal by Subject|3
40850|NCT01658735|175096|P2|Overall Study|Withdrawal by Subject|5
40851|NCT01658735|175097|P1|Overall Study|Withdrawal by Subject|3
40852|NCT01658735|175095|P3|Overall Study|Protocol Violation|0
40853|NCT01658735|175096|P2|Overall Study|Protocol Violation|1
40854|NCT01658735|175097|P1|Overall Study|Protocol Violation|0
40855|NCT01658735|175095|P3|Overall Study|Lost to Follow-up|0
40856|NCT01658735|175096|P2|Overall Study|Lost to Follow-up|1
40857|NCT01658735|175097|P1|Overall Study|Lost to Follow-up|1
40858|NCT01658735|175095|P3|Overall Study|Lack of Efficacy|1
40859|NCT01658735|175096|P2|Overall Study|Lack of Efficacy|0
40860|NCT01658735|175097|P1|Overall Study|Lack of Efficacy|1
40861|NCT01658579|175139|P4|Treatment Period B|Other|1
40862|NCT01658579|175140|P3|Treatment Period B|Other|0
40863|NCT01658579|175141|P2|Treatment Period B|Other|0
40864|NCT01658579|175142|P1|Treatment Period B|Other|0
40865|NCT01658579|175139|P4|Treatment Period A|Adverse Event|0
40866|NCT01658579|175140|P3|Treatment Period A|Adverse Event|0
40867|NCT01658579|175141|P2|Treatment Period A|Adverse Event|0
40868|NCT01658579|175142|P1|Treatment Period A|Adverse Event|1
40869|NCT01658579|175139|P4|Treatment Period A|Other|1
40870|NCT01658579|175140|P3|Treatment Period A|Other|1
40871|NCT01658579|175141|P2|Treatment Period A|Other|0
40872|NCT01658579|175142|P1|Treatment Period A|Other|0
40873|NCT01658514|175170|P3|Overall Study|Protocol Violation|2
40874|NCT01658514|175171|P2|Overall Study|Protocol Violation|0
40875|NCT01658514|175172|P1|Overall Study|Protocol Violation|1
40876|NCT01658436|175183|P2|Overall Study|Death|0
40877|NCT01658436|175184|P1|Overall Study|Death|1
40878|NCT01658436|175183|P2|Overall Study|Subject/guardian decision|1
40879|NCT01658436|175184|P1|Overall Study|Subject/guardian decision|0
40880|NCT01658436|175183|P2|Overall Study|Study terminated by sponsor|1
40881|NCT01658436|175184|P1|Overall Study|Study terminated by sponsor|0
40882|NCT01658436|175183|P2|Overall Study|Progressive disease|4
40883|NCT01658436|175184|P1|Overall Study|Progressive disease|12
40884|NCT01658436|175183|P2|Overall Study|Physician Decision|0
40885|NCT01658436|175184|P1|Overall Study|Physician Decision|1
40886|NCT01658436|175183|P2|Overall Study|Adverse Event|5
40887|NCT01658436|175184|P1|Overall Study|Adverse Event|6
40888|NCT01658072|175206|P2|Overall Study|Protocol Violation|2
40889|NCT01658072|175207|P1|Overall Study|Protocol Violation|4
40890|NCT01658020|175215|P2|Overall Study|Protocol Violation|1
40891|NCT01658020|175216|P1|Overall Study|Protocol Violation|0
40892|NCT01658020|175215|P2|Overall Study|Withdrawal by Subject|5
40893|NCT01658020|175216|P1|Overall Study|Withdrawal by Subject|4
40894|NCT01658020|175215|P2|Overall Study|Lost to Follow-up|0
40895|NCT01658020|175216|P1|Overall Study|Lost to Follow-up|1
40896|NCT01658020|175215|P2|Overall Study|Adverse Event|3
40897|NCT01658020|175216|P1|Overall Study|Adverse Event|3
40898|NCT01657903|175232|P1|Overall Study|Withdrawal by Subject|1
40899|NCT01657903|175232|P1|Overall Study|Lost to Follow-up|1
40900|NCT01657877|175254|P1|Overall Study|Other Reason|2
40901|NCT01657877|175254|P1|Overall Study|Adverse Event|2
40902|NCT01657877|175254|P1|Overall Study|Protocol Violation|6
40903|NCT01657877|175254|P1|Overall Study|Withdrawal by Subject|4
40904|NCT01657799|175274|P3|Overall Study|Other|49
40905|NCT01657799|175275|P2|Overall Study|Other|62
40906|NCT01657799|175276|P1|Overall Study|Other|52
40907|NCT01657799|175274|P3|Overall Study|Radiographic & Clinical Progression|15
40908|NCT01657799|175275|P2|Overall Study|Radiographic & Clinical Progression|11
40909|NCT01657799|175276|P1|Overall Study|Radiographic & Clinical Progression|16
40910|NCT01657799|175274|P3|Overall Study|Progressive Disease Clinical|7
40911|NCT01657799|175275|P2|Overall Study|Progressive Disease Clinical|4
40912|NCT01657799|175276|P1|Overall Study|Progressive Disease Clinical|7
40913|NCT01657799|175274|P3|Overall Study|Disease Progression|4
40914|NCT01657799|175275|P2|Overall Study|Disease Progression|4
40915|NCT01657799|175276|P1|Overall Study|Disease Progression|2
40916|NCT01657799|175274|P3|Overall Study|Lost to Follow-up|1
40917|NCT01657799|175275|P2|Overall Study|Lost to Follow-up|0
40918|NCT01657799|175276|P1|Overall Study|Lost to Follow-up|1
40919|NCT01657799|175274|P3|Overall Study|Withdrawal by Subject|10
40920|NCT01657799|175275|P2|Overall Study|Withdrawal by Subject|10
40921|NCT01657799|175276|P1|Overall Study|Withdrawal by Subject|13
40922|NCT01657799|175274|P3|Overall Study|Adverse Event Not Related to Progression|4
40923|NCT01657799|175275|P2|Overall Study|Adverse Event Not Related to Progression|4
40924|NCT01657799|175276|P1|Overall Study|Adverse Event Not Related to Progression|5
40925|NCT01657799|175274|P3|Overall Study|Adverse Event Related to progression|12
40926|NCT01657799|175275|P2|Overall Study|Adverse Event Related to progression|8
40927|NCT01657799|175276|P1|Overall Study|Adverse Event Related to progression|6
40928|NCT01657461|175295|P2|Overall Study|Withdrawal by Subject|3
40929|NCT01657461|175296|P1|Overall Study|Withdrawal by Subject|1
40930|NCT01657461|175295|P2|Overall Study|Physician Decision|2
40931|NCT01657461|175296|P1|Overall Study|Physician Decision|0
40932|NCT01657461|175295|P2|Overall Study|Lost to Follow-up|3
40933|NCT01657461|175296|P1|Overall Study|Lost to Follow-up|0
40934|NCT01657461|175295|P2|Overall Study|Death|12
40935|NCT01657461|175296|P1|Overall Study|Death|9
40936|NCT01657370|175326|P6|Overall Study|Lost to Follow-up|1
40937|NCT01657370|175327|P5|Overall Study|Lost to Follow-up|0
40938|NCT01657370|175328|P4|Overall Study|Lost to Follow-up|0
40939|NCT01657370|175329|P3|Overall Study|Lost to Follow-up|1
40940|NCT01657370|175330|P2|Overall Study|Lost to Follow-up|0
40941|NCT01657370|175331|P1|Overall Study|Lost to Follow-up|2
40942|NCT01657370|175326|P6|Overall Study|Protocol Violation|0
40943|NCT01657370|175327|P5|Overall Study|Protocol Violation|0
40944|NCT01657370|175328|P4|Overall Study|Protocol Violation|1
40945|NCT01657370|175329|P3|Overall Study|Protocol Violation|1
40946|NCT01657370|175330|P2|Overall Study|Protocol Violation|1
40947|NCT01657370|175331|P1|Overall Study|Protocol Violation|1
40948|NCT01657370|175326|P6|Overall Study|Adverse Event|0
40949|NCT01657370|175327|P5|Overall Study|Adverse Event|1
40950|NCT01657370|175328|P4|Overall Study|Adverse Event|0
40951|NCT01657370|175329|P3|Overall Study|Adverse Event|0
40952|NCT01657370|175330|P2|Overall Study|Adverse Event|0
40953|NCT01657370|175331|P1|Overall Study|Adverse Event|0
40954|NCT01657370|175326|P6|Overall Study|Lack of Qualifying Event|2
40955|NCT01657370|175327|P5|Overall Study|Lack of Qualifying Event|1
40956|NCT01657370|175328|P4|Overall Study|Lack of Qualifying Event|2
40957|NCT01657370|175329|P3|Overall Study|Lack of Qualifying Event|3
40958|NCT01657370|175330|P2|Overall Study|Lack of Qualifying Event|0
40959|NCT01657370|175331|P1|Overall Study|Lack of Qualifying Event|1
40960|NCT01657370|175326|P6|Overall Study|Physician Decision|0
40961|NCT01657370|175327|P5|Overall Study|Physician Decision|5
40962|NCT01657370|175328|P4|Overall Study|Physician Decision|2
40963|NCT01657370|175329|P3|Overall Study|Physician Decision|1
40964|NCT01657370|175330|P2|Overall Study|Physician Decision|3
40965|NCT01657370|175331|P1|Overall Study|Physician Decision|2
40966|NCT01657370|175326|P6|Overall Study|Withdrawal by Subject|1
40967|NCT01657370|175327|P5|Overall Study|Withdrawal by Subject|0
40968|NCT01657370|175328|P4|Overall Study|Withdrawal by Subject|0
40969|NCT01657370|175329|P3|Overall Study|Withdrawal by Subject|1
40970|NCT01657370|175330|P2|Overall Study|Withdrawal by Subject|0
40971|NCT01657370|175331|P1|Overall Study|Withdrawal by Subject|0
40972|NCT01657305|175413|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
40973|NCT01657305|175413|P1|Overall Study|Lost to Follow-up|1
40974|NCT01657305|175413|P1|Overall Study|Adverse Event|1
40975|NCT01657305|175413|P1|Overall Study|Withdrawal by Subject|4
40976|NCT01657305|175413|P1|Overall Study|Lack of Wound Closure at Day 28|15
40977|NCT01657292|175463|P1|Overall Study|Change of therapy|1
40978|NCT01657292|175463|P1|Overall Study|Violation of eligibility criteria|1
40979|NCT01657292|175463|P1|Overall Study|Withdrawal by Subject|2
40980|NCT01657292|175463|P1|Overall Study|Adverse Event|6
40981|NCT01657253|175472|P2|Overall Study|Adverse Event|1
40982|NCT01657253|175473|P1|Overall Study|Adverse Event|0
40983|NCT01657253|175472|P2|Overall Study|Withdrawal by Subject|12
40984|NCT01657253|175473|P1|Overall Study|Withdrawal by Subject|11
40985|NCT01657253|175472|P2|Overall Study|Lost to Follow-up|5
40986|NCT01657253|175473|P1|Overall Study|Lost to Follow-up|6
40987|NCT01657032|175485|P2|Overall Study|Lost to Follow-up|7
40988|NCT01657032|175486|P1|Overall Study|Lost to Follow-up|0
40989|NCT01657019|175512|P1|Overall Study|Not Specified|58
40990|NCT01657019|175512|P1|Overall Study|Lack of Efficacy|3
40991|NCT01657019|175512|P1|Overall Study|Protocol Violation|6
40992|NCT01657019|175512|P1|Overall Study|Lost to Follow-up|48
40993|NCT01657019|175512|P1|Overall Study|Adverse Event|55
40994|NCT01657019|175512|P1|Overall Study|Withdrawal by Subject|65
40995|NCT01656967|175526|P2|Overall Study|unsuccessful ETT insertion|2
40996|NCT01656967|175527|P1|Overall Study|unsuccessful ETT insertion|3
40997|NCT01656967|175526|P2|Overall Study|faulty monitor|0
40998|NCT01656967|175527|P1|Overall Study|faulty monitor|1
40999|NCT01656889|175549|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
41000|NCT01656889|175550|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
41001|NCT01656889|175549|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
41002|NCT01656889|175550|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
41003|NCT01656889|175549|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
41004|NCT01656889|175550|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
41005|NCT01656889|175549|P2|Post Treatment Follow-Up, 3 Months|Death|5
41006|NCT01656889|175550|P1|Post Treatment Follow-Up, 3 Months|Death|1
41007|NCT01656889|175549|P2|Treatment Period, 12 Weeks|Moved out of the area|2
41008|NCT01656889|175550|P1|Treatment Period, 12 Weeks|Moved out of the area|0
41009|NCT01656889|175549|P2|Treatment Period, 12 Weeks|Protocol Violation|1
41010|NCT01656889|175550|P1|Treatment Period, 12 Weeks|Protocol Violation|0
41011|NCT01656889|175549|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
41012|NCT01656889|175550|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
41013|NCT01656889|175549|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
41014|NCT01656889|175550|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
41015|NCT01656889|175549|P2|Treatment Period, 12 Weeks|Death|1
41016|NCT01656889|175550|P1|Treatment Period, 12 Weeks|Death|0
41017|NCT01656889|175549|P2|Treatment Period, 12 Weeks|Adverse Event|4
41018|NCT01656889|175550|P1|Treatment Period, 12 Weeks|Adverse Event|10
41019|NCT01656850|175570|P2|First Intervention (3 Months)|Withdrawal by Subject|4
41020|NCT01656850|175571|P1|First Intervention (3 Months)|Withdrawal by Subject|3
41021|NCT01656759|175662|P2|Overall Study|Protocol Violation|3
41022|NCT01656759|175663|P1|Overall Study|Protocol Violation|2
41023|NCT01656434|175694|P2|Overall Study|Withdrawal by Subject|7
41024|NCT01656434|175695|P1|Overall Study|Withdrawal by Subject|64
41025|NCT01656434|175694|P2|Overall Study|Participant withdrew consent|9
41026|NCT01656434|175695|P1|Overall Study|Participant withdrew consent|28
41027|NCT01656434|175694|P2|Overall Study|Participant moved|12
41028|NCT01656434|175695|P1|Overall Study|Participant moved|40
41029|NCT01656434|175694|P2|Overall Study|Non-compliance with protocol|15
41030|NCT01656434|175695|P1|Overall Study|Non-compliance with protocol|39
41031|NCT01656434|175694|P2|Overall Study|Part. discontinued; unrelated to drug|10
41032|NCT01656434|175695|P1|Overall Study|Part. discontinued; unrelated to drug|55
41033|NCT01656434|175694|P2|Overall Study|Participant discontinued; drug related|4
41034|NCT01656434|175695|P1|Overall Study|Participant discontinued; drug related|13
41035|NCT01656434|175694|P2|Overall Study|Study terminated by sponsor|348
41036|NCT01656434|175695|P1|Overall Study|Study terminated by sponsor|1501
41037|NCT01656434|175694|P2|Overall Study|Non-compliance with study drug|9
41038|NCT01656434|175695|P1|Overall Study|Non-compliance with study drug|48
41039|NCT01656434|175694|P2|Overall Study|Physician Decision|2
41040|NCT01656434|175695|P1|Overall Study|Physician Decision|7
41041|NCT01656434|175694|P2|Overall Study|Pregnancy|10
41042|NCT01656434|175695|P1|Overall Study|Pregnancy|45
41043|NCT01656434|175694|P2|Overall Study|Pregnancy wish|6
41044|NCT01656434|175695|P1|Overall Study|Pregnancy wish|18
41045|NCT01656434|175694|P2|Overall Study|Protocol Violation|0
41046|NCT01656434|175695|P1|Overall Study|Protocol Violation|7
41047|NCT01656434|175694|P2|Overall Study|Screen failure|0
41048|NCT01656434|175695|P1|Overall Study|Screen failure|2
41049|NCT01656434|175694|P2|Overall Study|Site discontinued study participation|9
41050|NCT01656434|175695|P1|Overall Study|Site discontinued study participation|24
41051|NCT01656434|175694|P2|Overall Study|Lost to Follow-up|76
41052|NCT01656434|175695|P1|Overall Study|Lost to Follow-up|309
41053|NCT01656434|175694|P2|Overall Study|Enrollment terminated at trial site|0
41054|NCT01656434|175695|P1|Overall Study|Enrollment terminated at trial site|2
41055|NCT01656434|175694|P2|Overall Study|Adverse Event|63
41056|NCT01656434|175695|P1|Overall Study|Adverse Event|199
41057|NCT01656408|175721|P10|Overall Study|Physician Decision|3
41058|NCT01656408|175722|P9|Overall Study|Physician Decision|1
41059|NCT01656408|175723|P8|Overall Study|Physician Decision|1
41060|NCT01656408|175724|P7|Overall Study|Physician Decision|0
41061|NCT01656408|175725|P6|Overall Study|Physician Decision|1
41062|NCT01656408|175726|P5|Overall Study|Physician Decision|1
41063|NCT01656408|175727|P4|Overall Study|Physician Decision|0
41064|NCT01656408|175728|P3|Overall Study|Physician Decision|1
41065|NCT01656408|175729|P2|Overall Study|Physician Decision|0
41066|NCT01656408|175730|P1|Overall Study|Physician Decision|1
41067|NCT01656408|175721|P10|Overall Study|Adverse Event|0
41068|NCT01656408|175722|P9|Overall Study|Adverse Event|1
41069|NCT01656408|175723|P8|Overall Study|Adverse Event|0
41070|NCT01656408|175724|P7|Overall Study|Adverse Event|1
41071|NCT01656408|175725|P6|Overall Study|Adverse Event|1
41072|NCT01656408|175726|P5|Overall Study|Adverse Event|0
41073|NCT01656408|175727|P4|Overall Study|Adverse Event|0
41074|NCT01656408|175728|P3|Overall Study|Adverse Event|1
41075|NCT01656408|175729|P2|Overall Study|Adverse Event|0
41076|NCT01656408|175730|P1|Overall Study|Adverse Event|0
41077|NCT01656304|175919|P1|Overall Study|Ineligible, uncontrolled hypertension|1
41078|NCT01656161|175957|P1|Overall Study|Withdrawal by Subject|1
41079|NCT01656161|175957|P1|Overall Study|Protocol Violation|1
41080|NCT01656161|175957|P1|Overall Study|Adverse Event|2
41081|NCT01656161|175957|P1|Overall Study|Death|3
41082|NCT01655498|175981|P1|Overall Study|Withdrawal by Subject|1
41083|NCT01655498|175981|P1|Overall Study|Protocol Violation|2
41084|NCT01655498|175981|P1|Overall Study|Unrelated health issue|2
41085|NCT01655381|175988|P1|Overall Study|Insufficient Treatment Response|1
41086|NCT01655381|175988|P1|Overall Study|Moved to Another City|1
41087|NCT01655381|175988|P1|Overall Study|Investigator Decision|1
41088|NCT01655069|176028|P4|Overall Study|Withdrawal by Subject|0
41089|NCT01655069|176029|P3|Overall Study|Withdrawal by Subject|0
41090|NCT01655069|176030|P2|Overall Study|Withdrawal by Subject|3
41091|NCT01655069|176031|P1|Overall Study|Withdrawal by Subject|2
41092|NCT01655069|176028|P4|Overall Study|No Treatment Needed|0
41093|NCT01655069|176029|P3|Overall Study|No Treatment Needed|0
41094|NCT01655069|176030|P2|Overall Study|No Treatment Needed|1
41095|NCT01655069|176031|P1|Overall Study|No Treatment Needed|0
41096|NCT01655069|176028|P4|Overall Study|Lack of Efficacy|0
41097|NCT01655069|176029|P3|Overall Study|Lack of Efficacy|0
41098|NCT01655069|176030|P2|Overall Study|Lack of Efficacy|1
41099|NCT01655069|176031|P1|Overall Study|Lack of Efficacy|0
41100|NCT01655069|176028|P4|Overall Study|Adverse Event|3
41101|NCT01655069|176029|P3|Overall Study|Adverse Event|2
41102|NCT01655069|176030|P2|Overall Study|Adverse Event|7
41103|NCT01655069|176031|P1|Overall Study|Adverse Event|6
41104|NCT01655069|176028|P4|Overall Study|Physician Decision|1
41105|NCT01655069|176029|P3|Overall Study|Physician Decision|0
41106|NCT01655069|176030|P2|Overall Study|Physician Decision|0
41107|NCT01655069|176031|P1|Overall Study|Physician Decision|0
41108|NCT01654666|176091|P3|Overall Study|Withdrawal by Subject|1
41109|NCT01654666|176092|P2|Overall Study|Withdrawal by Subject|4
41110|NCT01654666|176093|P1|Overall Study|Withdrawal by Subject|4
41111|NCT01654666|176091|P3|Overall Study|Lost to Follow-up|5
41112|NCT01654666|176092|P2|Overall Study|Lost to Follow-up|5
41113|NCT01654666|176093|P1|Overall Study|Lost to Follow-up|4
41114|NCT01654666|176091|P3|Overall Study|Protocol Violation|8
41115|NCT01654666|176092|P2|Overall Study|Protocol Violation|4
41116|NCT01654666|176093|P1|Overall Study|Protocol Violation|7
41117|NCT01654601|176118|P2|2nd Administration|Protocol Violation|1
41118|NCT01654601|176119|P1|2nd Administration|Protocol Violation|0
41119|NCT01654601|176118|P2|2nd Administration|Adverse Event|0
41120|NCT01654601|176119|P1|2nd Administration|Adverse Event|1
41121|NCT01654601|176118|P2|1st Administration|Protocol Violation|2
41122|NCT01654601|176119|P1|1st Administration|Protocol Violation|0
41123|NCT01654601|176118|P2|1st Administration|Withdrawal by Subject|0
41124|NCT01654601|176119|P1|1st Administration|Withdrawal by Subject|2
41125|NCT01654549|176133|P2|Overall Study|H.pylori eradication not successful|1
41126|NCT01654549|176134|P1|Overall Study|H.pylori eradication not successful|0
41127|NCT01654536|176146|P2|Overall Study|Withdrawal by Subject|25
41128|NCT01654536|176147|P1|Overall Study|Withdrawal by Subject|27
41129|NCT01654536|176146|P2|Overall Study|Physician Decision|8
41130|NCT01654536|176147|P1|Overall Study|Physician Decision|12
41131|NCT01654536|176146|P2|Overall Study|Lost to Follow-up|5
41132|NCT01654536|176147|P1|Overall Study|Lost to Follow-up|5
41133|NCT01654523|176183|P1|Overall Study|Withdrawal by Subject|1
41134|NCT01654302|176189|P2|Second Intervention (Day 7)|Lost to Follow-up|1
41135|NCT01654302|176190|P1|Second Intervention (Day 7)|Lost to Follow-up|1
41136|NCT01654276|176196|P1|Overall Study|Withdrawal by Subject|1
41137|NCT01654276|176196|P1|Overall Study|Lost to Follow-up|4
41138|NCT01654276|176196|P1|Overall Study|Lack of Efficacy|1
41139|NCT01654250|176250|P2|Overall Study|Lost to Follow-up|0
41140|NCT01654250|176251|P1|Overall Study|Lost to Follow-up|1
41141|NCT01654224|176268|P2|Overall Study|Insufficient blood sample|2
41142|NCT01654224|176269|P1|Overall Study|Insufficient blood sample|3
41143|NCT01654224|176268|P2|Overall Study|Did not receive allocation|8
41144|NCT01654224|176269|P1|Overall Study|Did not receive allocation|1
41145|NCT01654224|176268|P2|Overall Study|Lost to Follow-up|2
41146|NCT01654224|176269|P1|Overall Study|Lost to Follow-up|2
41147|NCT01653912|176294|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
41148|NCT01653912|176295|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
41149|NCT01653912|176296|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
41150|NCT01653912|176297|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
41151|NCT01653912|176298|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
41152|NCT01653912|176299|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
41153|NCT01653912|176294|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
41154|NCT01653912|176295|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
41155|NCT01653912|176296|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
41156|NCT01653912|176297|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
41157|NCT01653912|176298|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
41158|NCT01653912|176299|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
41159|NCT01653912|176294|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
41160|NCT01653912|176295|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
41161|NCT01653912|176296|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
41162|NCT01653912|176297|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
41163|NCT01653912|176298|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
41164|NCT01653912|176299|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
41165|NCT01653912|176294|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
41166|NCT01653912|176295|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
41167|NCT01653912|176296|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
41168|NCT01653912|176297|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
41169|NCT01653912|176298|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
41170|NCT01653912|176299|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
41171|NCT01653912|176294|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
41172|NCT01653912|176295|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
41173|NCT01653912|176296|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
41174|NCT01653912|176297|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
41175|NCT01653912|176298|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
41176|NCT01653912|176299|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
41177|NCT01653912|176294|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
41178|NCT01653912|176295|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
41179|NCT01653912|176296|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
41180|NCT01653912|176297|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
41181|NCT01653912|176298|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
41182|NCT01653912|176299|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
41183|NCT01653912|176294|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
41184|NCT01653912|176295|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
41185|NCT01653912|176296|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
41186|NCT01653912|176297|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
41187|NCT01653912|176298|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
41188|NCT01653912|176299|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
41189|NCT01653782|176317|P3|Overall Study|Lost to Follow-up|2
41190|NCT01653782|176318|P2|Overall Study|Lost to Follow-up|3
41191|NCT01653782|176319|P1|Overall Study|Lost to Follow-up|7
41192|NCT01653782|176317|P3|Overall Study|Withdrawal by Subject|4
41193|NCT01653782|176318|P2|Overall Study|Withdrawal by Subject|15
41194|NCT01653782|176319|P1|Overall Study|Withdrawal by Subject|9
41195|NCT01653743|176329|P2|Overall Study|Investigator discretion|0
41196|NCT01653743|176330|P1|Overall Study|Investigator discretion|3
41197|NCT01653743|176329|P2|Overall Study|Withdrawal by Subject|0
41198|NCT01653743|176330|P1|Overall Study|Withdrawal by Subject|1
41199|NCT01653262|176377|P1|Overall Study|AE, non-serious non-fatal|1
41200|NCT01653262|176377|P1|Overall Study|SAE, non-fatal|1
41201|NCT01653262|176377|P1|Overall Study|Lack of Efficacy|1
41202|NCT01653158|176390|P8|Overall Study|Withdrawal by Subject|0
41203|NCT01653158|176391|P7|Overall Study|Withdrawal by Subject|0
41204|NCT01653158|176392|P6|Overall Study|Withdrawal by Subject|0
41205|NCT01653158|176393|P5|Overall Study|Withdrawal by Subject|0
41206|NCT01653158|176394|P4|Overall Study|Withdrawal by Subject|0
41207|NCT01653158|176395|P3|Overall Study|Withdrawal by Subject|0
41208|NCT01653158|176396|P2|Overall Study|Withdrawal by Subject|0
41209|NCT01653158|176397|P1|Overall Study|Withdrawal by Subject|1
41210|NCT01653158|176390|P8|Overall Study|Progressive disease|9
41211|NCT01653158|176391|P7|Overall Study|Progressive disease|2
41212|NCT01653158|176392|P6|Overall Study|Progressive disease|1
41213|NCT01653158|176393|P5|Overall Study|Progressive disease|1
41214|NCT01653158|176394|P4|Overall Study|Progressive disease|0
41215|NCT01653158|176395|P3|Overall Study|Progressive disease|0
41216|NCT01653158|176396|P2|Overall Study|Progressive disease|0
41217|NCT01653158|176397|P1|Overall Study|Progressive disease|0
41218|NCT01653158|176390|P8|Overall Study|Other|1
41219|NCT01653158|176391|P7|Overall Study|Other|0
41220|NCT01653158|176392|P6|Overall Study|Other|0
41221|NCT01653158|176393|P5|Overall Study|Other|0
41222|NCT01653158|176394|P4|Overall Study|Other|0
41223|NCT01653158|176395|P3|Overall Study|Other|0
41224|NCT01653158|176396|P2|Overall Study|Other|0
41225|NCT01653158|176397|P1|Overall Study|Other|0
41226|NCT01653158|176390|P8|Overall Study|Adverse Event|3
41227|NCT01653158|176391|P7|Overall Study|Adverse Event|0
41228|NCT01653158|176392|P6|Overall Study|Adverse Event|0
41229|NCT01653158|176393|P5|Overall Study|Adverse Event|0
41230|NCT01653158|176394|P4|Overall Study|Adverse Event|1
41231|NCT01653158|176395|P3|Overall Study|Adverse Event|0
41232|NCT01653158|176396|P2|Overall Study|Adverse Event|0
41233|NCT01653158|176397|P1|Overall Study|Adverse Event|0
41234|NCT01653158|176390|P8|Overall Study|Death|2
41235|NCT01653158|176391|P7|Overall Study|Death|0
41236|NCT01653158|176392|P6|Overall Study|Death|0
41237|NCT01653158|176393|P5|Overall Study|Death|0
41238|NCT01653158|176394|P4|Overall Study|Death|1
41239|NCT01653158|176395|P3|Overall Study|Death|0
41240|NCT01653158|176396|P2|Overall Study|Death|0
41241|NCT01653158|176397|P1|Overall Study|Death|0
41242|NCT01653132|176669|P2|First Intervention|Protocol Violation|0
41243|NCT01653132|176670|P1|First Intervention|Protocol Violation|1
41244|NCT01652885|176720|P1|Overall Study|Adverse Event|1
41245|NCT01652729|176748|P3|Overall Study|Administrative|0
41246|NCT01652729|176749|P2|Overall Study|Administrative|0
41247|NCT01652729|176750|P1|Overall Study|Administrative|1
41248|NCT01652729|176748|P3|Overall Study|Lost to Follow-up|3
41249|NCT01652729|176749|P2|Overall Study|Lost to Follow-up|6
41250|NCT01652729|176750|P1|Overall Study|Lost to Follow-up|6
41251|NCT01652729|176748|P3|Overall Study|Protocol Violation|0
41252|NCT01652729|176749|P2|Overall Study|Protocol Violation|0
41253|NCT01652729|176750|P1|Overall Study|Protocol Violation|1
41254|NCT01652729|176748|P3|Overall Study|Physician Decision|1
41255|NCT01652729|176749|P2|Overall Study|Physician Decision|0
41256|NCT01652729|176750|P1|Overall Study|Physician Decision|1
41257|NCT01652729|176748|P3|Overall Study|Adverse Event|3
41258|NCT01652729|176749|P2|Overall Study|Adverse Event|0
41259|NCT01652729|176750|P1|Overall Study|Adverse Event|4
41260|NCT01652729|176748|P3|Overall Study|Withdrawal by Subject|7
41261|NCT01652729|176749|P2|Overall Study|Withdrawal by Subject|7
41262|NCT01652729|176750|P1|Overall Study|Withdrawal by Subject|14
41263|NCT01652716|176772|P2|Overall Study|Withdrawal by Subject|18
41264|NCT01652716|176773|P1|Overall Study|Withdrawal by Subject|33
41265|NCT01652716|176772|P2|Overall Study|Adverse Event|10
41266|NCT01652716|176773|P1|Overall Study|Adverse Event|7
41267|NCT01652716|176772|P2|Overall Study|Protocol Violation|1
41268|NCT01652716|176773|P1|Overall Study|Protocol Violation|2
41269|NCT01652716|176772|P2|Overall Study|Lost to Follow-up|11
41270|NCT01652716|176773|P1|Overall Study|Lost to Follow-up|12
41271|NCT01652716|176772|P2|Overall Study|Investigator decision|4
41272|NCT01652716|176773|P1|Overall Study|Investigator decision|1
41273|NCT01652716|176772|P2|Overall Study|Administrative|2
41274|NCT01652716|176773|P1|Overall Study|Administrative|0
41275|NCT01652716|176772|P2|Overall Study|Loss of glucose control|0
41276|NCT01652716|176773|P1|Overall Study|Loss of glucose control|1
41277|NCT01652703|176793|P6|Overall Study|Other|1
41278|NCT01652703|176794|P5|Overall Study|Other|1
41279|NCT01652703|176795|P4|Overall Study|Other|1
41280|NCT01652703|176796|P3|Overall Study|Other|0
41281|NCT01652703|176797|P2|Overall Study|Other|0
41282|NCT01652703|176798|P1|Overall Study|Other|0
41283|NCT01652703|176793|P6|Overall Study|Withdrawal by Subject|1
41284|NCT01652703|176794|P5|Overall Study|Withdrawal by Subject|0
41285|NCT01652703|176795|P4|Overall Study|Withdrawal by Subject|1
41286|NCT01652703|176796|P3|Overall Study|Withdrawal by Subject|3
41287|NCT01652703|176797|P2|Overall Study|Withdrawal by Subject|1
41288|NCT01652703|176798|P1|Overall Study|Withdrawal by Subject|0
41289|NCT01652690|176856|P2|Overall Study|Death|2
41290|NCT01652690|176857|P1|Overall Study|Death|5
41291|NCT01652690|176856|P2|Overall Study|Lost to Follow-up|6
41292|NCT01652690|176857|P1|Overall Study|Lost to Follow-up|6
41293|NCT01652690|176856|P2|Overall Study|Other|9
41294|NCT01652690|176857|P1|Overall Study|Other|8
41295|NCT01652690|176856|P2|Overall Study|Withdrawal by Subject|4
41296|NCT01652690|176857|P1|Overall Study|Withdrawal by Subject|16
41297|NCT01652664|176891|P2|Overall Study|Inadequate IOP control|0
41298|NCT01652664|176892|P1|Overall Study|Inadequate IOP control|1
41299|NCT01652664|176891|P2|Overall Study|Treatment Failure|1
41300|NCT01652664|176892|P1|Overall Study|Treatment Failure|5
41301|NCT01652573|176901|P2|Overall Study|Adverse Event|1
41302|NCT01652573|176902|P1|Overall Study|Adverse Event|0
41303|NCT01652287|176957|P2|Overall Study|Withdrawal by Subject|0
41304|NCT01652287|176958|P1|Overall Study|Withdrawal by Subject|2
41305|NCT01651949|176989|P3|Overall Study|Withdrawal by Subject|9
41306|NCT01651949|176990|P2|Overall Study|Withdrawal by Subject|18
41307|NCT01651949|176991|P1|Overall Study|Withdrawal by Subject|17
41308|NCT01651949|176989|P3|Overall Study|Screen failure|0
41309|NCT01651949|176990|P2|Overall Study|Screen failure|2
41310|NCT01651949|176991|P1|Overall Study|Screen failure|2
41311|NCT01651949|176989|P3|Overall Study|Adverse Event|1
41312|NCT01651949|176990|P2|Overall Study|Adverse Event|2
41313|NCT01651949|176991|P1|Overall Study|Adverse Event|0
41314|NCT01651949|176989|P3|Overall Study|Physician Decision|0
41315|NCT01651949|176990|P2|Overall Study|Physician Decision|2
41316|NCT01651949|176991|P1|Overall Study|Physician Decision|0
41317|NCT01651949|176989|P3|Overall Study|Protocol Violation|1
41318|NCT01651949|176990|P2|Overall Study|Protocol Violation|2
41319|NCT01651949|176991|P1|Overall Study|Protocol Violation|0
41320|NCT01651949|176989|P3|Overall Study|Lost to Follow-up|20
41321|NCT01651949|176990|P2|Overall Study|Lost to Follow-up|56
41322|NCT01651949|176991|P1|Overall Study|Lost to Follow-up|30
41323|NCT01651949|176989|P3|Overall Study|Unknown status|0
41324|NCT01651949|176990|P2|Overall Study|Unknown status|4
41325|NCT01651949|176991|P1|Overall Study|Unknown status|4
41326|NCT01651936|177011|P3|Extension Study|Study terminated by sponsor|13
41327|NCT01651936|177012|P2|Extension Study|Study terminated by sponsor|0
41328|NCT01651936|177013|P1|Extension Study|Study terminated by sponsor|0
41329|NCT01651936|177011|P3|Extension Study|Lack of Efficacy|1
41330|NCT01651936|177012|P2|Extension Study|Lack of Efficacy|0
41331|NCT01651936|177013|P1|Extension Study|Lack of Efficacy|0
41332|NCT01651936|177011|P3|Base Study|Study terminated by sponsor|0
41333|NCT01651936|177012|P2|Base Study|Study terminated by sponsor|16
41334|NCT01651936|177013|P1|Base Study|Study terminated by sponsor|21
41335|NCT01651936|177011|P3|Base Study|Early Escape|0
41336|NCT01651936|177012|P2|Base Study|Early Escape|8
41337|NCT01651936|177013|P1|Base Study|Early Escape|2
41338|NCT01651936|177011|P3|Base Study|Withdrawal by Subject|0
41339|NCT01651936|177012|P2|Base Study|Withdrawal by Subject|1
41340|NCT01651936|177013|P1|Base Study|Withdrawal by Subject|1
41341|NCT01651936|177011|P3|Base Study|Adverse Event|0
41342|NCT01651936|177012|P2|Base Study|Adverse Event|0
41343|NCT01651936|177013|P1|Base Study|Adverse Event|3
41344|NCT01651780|177062|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
41345|NCT01651780|177063|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
41346|NCT01651780|177062|P2|Overall Study|Lost to Follow-up|2
41347|NCT01651780|177063|P1|Overall Study|Lost to Follow-up|1
41348|NCT01651780|177062|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
41349|NCT01651780|177063|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
41350|NCT01651780|177062|P2|Overall Study|Withdrawal by Subject|0
41351|NCT01651780|177063|P1|Overall Study|Withdrawal by Subject|2
41352|NCT01651780|177062|P2|Overall Study|Reason Not Specified: No 30-day visit|2
41353|NCT01651780|177063|P1|Overall Study|Reason Not Specified: No 30-day visit|2
41354|NCT01651780|177062|P2|Overall Study|Physician decision: No 30-day visit|1
41355|NCT01651780|177063|P1|Overall Study|Physician decision: No 30-day visit|2
41356|NCT01651260|177113|P1|Overall Study|unable to apply product|3
41357|NCT01651208|177120|P2|Overall Study|Lost to Follow-up|16
41358|NCT01651208|177121|P1|Overall Study|Lost to Follow-up|14
41359|NCT01651039|177136|P1|Overall Study|Progressive Disease|22
41360|NCT01651039|177136|P1|Overall Study|Withdrawal by Subject|1
41361|NCT01651039|177136|P1|Overall Study|Physician Decision|2
41362|NCT01651039|177136|P1|Overall Study|Non-evaluables|5
41363|NCT01651000|177149|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
41364|NCT01651000|177150|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
41365|NCT01651000|177149|P2|Overall Study|Administrative reason|0
41366|NCT01651000|177150|P1|Overall Study|Administrative reason|1
41367|NCT01651000|177149|P2|Overall Study|Physician Decision|0
41368|NCT01651000|177150|P1|Overall Study|Physician Decision|1
41369|NCT01651000|177149|P2|Overall Study|Lack of Efficacy|1
41370|NCT01651000|177150|P1|Overall Study|Lack of Efficacy|1
41371|NCT01651000|177149|P2|Overall Study|Subject noncompliance|3
41372|NCT01651000|177150|P1|Overall Study|Subject noncompliance|0
41373|NCT01651000|177149|P2|Overall Study|Withdrawal by Subject|10
41374|NCT01651000|177150|P1|Overall Study|Withdrawal by Subject|2
41375|NCT01651000|177149|P2|Overall Study|Protocol Violation|3
41376|NCT01651000|177150|P1|Overall Study|Protocol Violation|0
41377|NCT01651000|177149|P2|Overall Study|Lost to Follow-up|2
41378|NCT01651000|177150|P1|Overall Study|Lost to Follow-up|3
41379|NCT01651000|177149|P2|Overall Study|Adverse Event|8
41380|NCT01651000|177150|P1|Overall Study|Adverse Event|2
41381|NCT01650831|177171|P1|Overall Study|Screen failure|1
41382|NCT01650805|177181|P2|Overall Study|Withdrawal by Subject|0
41383|NCT01650805|177182|P1|Overall Study|Withdrawal by Subject|1
41384|NCT01650779|177192|P1|Overall Study|Withdrawal by Subject|1
41385|NCT01650519|177214|P2|Overall Study|Withdrawal by Subject|0
41386|NCT01650519|177215|P1|Overall Study|Withdrawal by Subject|1
41387|NCT01650285|177276|P1|Overall Study|Adverse Event|1
41388|NCT01650246|177281|P1|Overall Study|Lack of Efficacy|30
41389|NCT01650246|177281|P1|Overall Study|Death|1
41390|NCT01650246|177281|P1|Overall Study|Withdrawal by Subject|26
41391|NCT01650246|177281|P1|Overall Study|Lost to Follow-up|5
41392|NCT01650246|177281|P1|Overall Study|Sponsor terminated study|53
41393|NCT01650246|177281|P1|Overall Study|Protocol Violation|5
41394|NCT01650246|177281|P1|Overall Study|Adverse Event|23
41395|NCT01649856|177288|P2|Overall Study|Not Specified|5
41396|NCT01649856|177289|P1|Overall Study|Not Specified|20
41397|NCT01649856|177288|P2|Overall Study|Lack of Compliance|1
41398|NCT01649856|177289|P1|Overall Study|Lack of Compliance|6
41399|NCT01649856|177288|P2|Overall Study|Lost to Follow-up|16
41400|NCT01649856|177289|P1|Overall Study|Lost to Follow-up|20
41401|NCT01649856|177288|P2|Overall Study|Stable or Progressed Disease|3
41402|NCT01649856|177289|P1|Overall Study|Stable or Progressed Disease|5
41403|NCT01649856|177288|P2|Overall Study|Death|34
41404|NCT01649856|177289|P1|Overall Study|Death|69
41405|NCT01649856|177288|P2|Overall Study|Treatment Failure|1
41406|NCT01649856|177289|P1|Overall Study|Treatment Failure|1
41407|NCT01649856|177288|P2|Overall Study|Protocol Violation|4
41408|NCT01649856|177289|P1|Overall Study|Protocol Violation|4
41409|NCT01649856|177288|P2|Overall Study|Withdrawal by Subject|14
41410|NCT01649856|177289|P1|Overall Study|Withdrawal by Subject|14
41411|NCT01649804|177321|P1|Overall Study|Administrative/Other|8
41412|NCT01649791|177333|P1|Overall Study|Adverse Event|1
41413|NCT01649791|177333|P1|Overall Study|Disease Progression|2
41414|NCT01649557|177365|P3|Overall Study|Lack of Efficacy|0
41415|NCT01649557|177366|P2|Overall Study|Lack of Efficacy|0
41416|NCT01649557|177367|P1|Overall Study|Lack of Efficacy|5
41417|NCT01649557|177365|P3|Overall Study|Protocol deviation|0
41418|NCT01649557|177366|P2|Overall Study|Protocol deviation|2
41419|NCT01649557|177367|P1|Overall Study|Protocol deviation|0
41420|NCT01649557|177365|P3|Overall Study|Withdrawal by Subject|4
41421|NCT01649557|177366|P2|Overall Study|Withdrawal by Subject|5
41422|NCT01649557|177367|P1|Overall Study|Withdrawal by Subject|15
41423|NCT01649557|177365|P3|Overall Study|Physician Decision|1
41424|NCT01649557|177366|P2|Overall Study|Physician Decision|2
41425|NCT01649557|177367|P1|Overall Study|Physician Decision|8
41426|NCT01649557|177365|P3|Overall Study|Met withdrawal criteria|0
41427|NCT01649557|177366|P2|Overall Study|Met withdrawal criteria|0
41428|NCT01649557|177367|P1|Overall Study|Met withdrawal criteria|4
41429|NCT01649557|177365|P3|Overall Study|Adverse Event|1
41430|NCT01649557|177366|P2|Overall Study|Adverse Event|5
41431|NCT01649557|177367|P1|Overall Study|Adverse Event|7
41432|NCT01649557|177365|P3|Overall Study|Lost to Follow-up|3
41433|NCT01649557|177366|P2|Overall Study|Lost to Follow-up|0
41434|NCT01649557|177367|P1|Overall Study|Lost to Follow-up|5
41435|NCT01649297|177429|P5|Overall Study|For other reason|0
41436|NCT01649297|177430|P4|Overall Study|For other reason|0
41437|NCT01649297|177431|P3|Overall Study|For other reason|2
41438|NCT01649297|177432|P2|Overall Study|For other reason|1
41439|NCT01649297|177433|P1|Overall Study|For other reason|4
41440|NCT01649297|177429|P5|Overall Study|Patient withdrawal (not due to AE)|1
41441|NCT01649297|177430|P4|Overall Study|Patient withdrawal (not due to AE)|1
41442|NCT01649297|177431|P3|Overall Study|Patient withdrawal (not due to AE)|4
41443|NCT01649297|177432|P2|Overall Study|Patient withdrawal (not due to AE)|6
41444|NCT01649297|177433|P1|Overall Study|Patient withdrawal (not due to AE)|3
41445|NCT01649297|177429|P5|Overall Study|Lost to Follow-up|0
41446|NCT01649297|177430|P4|Overall Study|Lost to Follow-up|3
41447|NCT01649297|177431|P3|Overall Study|Lost to Follow-up|4
41448|NCT01649297|177432|P2|Overall Study|Lost to Follow-up|1
41449|NCT01649297|177433|P1|Overall Study|Lost to Follow-up|1
41450|NCT01649297|177429|P5|Overall Study|Non compliant with Protocol|1
41451|NCT01649297|177430|P4|Overall Study|Non compliant with Protocol|2
41452|NCT01649297|177431|P3|Overall Study|Non compliant with Protocol|3
41453|NCT01649297|177432|P2|Overall Study|Non compliant with Protocol|0
41454|NCT01649297|177433|P1|Overall Study|Non compliant with Protocol|1
41455|NCT01649297|177429|P5|Overall Study|Lack of Efficacy|1
41456|NCT01649297|177430|P4|Overall Study|Lack of Efficacy|0
41457|NCT01649297|177431|P3|Overall Study|Lack of Efficacy|0
41458|NCT01649297|177432|P2|Overall Study|Lack of Efficacy|0
41459|NCT01649297|177433|P1|Overall Study|Lack of Efficacy|0
41460|NCT01649297|177429|P5|Overall Study|Adverse Event|1
41461|NCT01649297|177430|P4|Overall Study|Adverse Event|13
41462|NCT01649297|177431|P3|Overall Study|Adverse Event|4
41463|NCT01649297|177432|P2|Overall Study|Adverse Event|5
41464|NCT01649297|177433|P1|Overall Study|Adverse Event|5
41465|NCT01649271|177452|P2|Overall Study|Other than stated above|0
41466|NCT01649271|177453|P1|Overall Study|Other than stated above|1
41467|NCT01649271|177452|P2|Overall Study|Withdrawal by Subject|0
41468|NCT01649271|177453|P1|Overall Study|Withdrawal by Subject|1
41469|NCT01649271|177452|P2|Overall Study|Other Adverse Event|2
41470|NCT01649271|177453|P1|Overall Study|Other Adverse Event|0
41471|NCT01649271|177452|P2|Overall Study|Progressive disease|5
41472|NCT01649271|177453|P1|Overall Study|Progressive disease|4
41473|NCT01649232|177468|P2|Overall Study|Physician Decision|0
41474|NCT01649232|177469|P1|Overall Study|Physician Decision|2
41475|NCT01648790|177521|P5|Treatment 3|Withdrawal by Subject|0
41476|NCT01648790|177522|P4|Treatment 3|Withdrawal by Subject|1
41477|NCT01648790|177523|P3|Treatment 3|Withdrawal by Subject|0
41478|NCT01648790|177524|P2|Treatment 3|Withdrawal by Subject|0
41479|NCT01648790|177525|P1|Treatment 3|Withdrawal by Subject|0
41480|NCT01648699|177546|P1|Overall Study|Unspecified/unable to complete 4 visits|2
41481|NCT01648699|177546|P1|Overall Study|Lost to Follow-up|2
41482|NCT01648699|177546|P1|Overall Study|Death|1
41483|NCT01648582|177575|P3|Overall Study|Sponsor Decision|1
41484|NCT01648582|177576|P2|Overall Study|Sponsor Decision|1
41485|NCT01648582|177577|P1|Overall Study|Sponsor Decision|0
41486|NCT01648582|177575|P3|Overall Study|Death|0
41487|NCT01648582|177576|P2|Overall Study|Death|0
41488|NCT01648582|177577|P1|Overall Study|Death|1
41489|NCT01648582|177575|P3|Overall Study|Physician Decision|3
41490|NCT01648582|177576|P2|Overall Study|Physician Decision|1
41491|NCT01648582|177577|P1|Overall Study|Physician Decision|0
41492|NCT01648582|177575|P3|Overall Study|Withdrawal by Subject|17
41493|NCT01648582|177576|P2|Overall Study|Withdrawal by Subject|17
41494|NCT01648582|177577|P1|Overall Study|Withdrawal by Subject|15
41495|NCT01648582|177575|P3|Overall Study|Protocol Violation|1
41496|NCT01648582|177576|P2|Overall Study|Protocol Violation|2
41497|NCT01648582|177577|P1|Overall Study|Protocol Violation|1
41498|NCT01648582|177575|P3|Overall Study|Lost to Follow-up|8
41499|NCT01648582|177576|P2|Overall Study|Lost to Follow-up|6
41500|NCT01648582|177577|P1|Overall Study|Lost to Follow-up|9
41501|NCT01648582|177575|P3|Overall Study|Adverse Event|2
41502|NCT01648582|177576|P2|Overall Study|Adverse Event|11
41503|NCT01648582|177577|P1|Overall Study|Adverse Event|6
41504|NCT01648348|177680|P6|Overall Study|Replaced for MTD analysis|0
41505|NCT01648348|177681|P5|Overall Study|Replaced for MTD analysis|0
41506|NCT01648348|177682|P4|Overall Study|Replaced for MTD analysis|0
41507|NCT01648348|177683|P3|Overall Study|Replaced for MTD analysis|1
41508|NCT01648348|177684|P2|Overall Study|Replaced for MTD analysis|0
41509|NCT01648348|177685|P1|Overall Study|Replaced for MTD analysis|1
41510|NCT01648348|177680|P6|Overall Study|Cancel|6
41511|NCT01648348|177681|P5|Overall Study|Cancel|3
41512|NCT01648348|177682|P4|Overall Study|Cancel|0
41513|NCT01648348|177683|P3|Overall Study|Cancel|0
41514|NCT01648348|177684|P2|Overall Study|Cancel|0
41515|NCT01648348|177685|P1|Overall Study|Cancel|1
41516|NCT01648140|177734|P4|Overall Study|Lost to Follow-up|0
41517|NCT01648140|177735|P3|Overall Study|Lost to Follow-up|2
41518|NCT01648140|177736|P2|Overall Study|Lost to Follow-up|1
41519|NCT01648140|177737|P1|Overall Study|Lost to Follow-up|2
41520|NCT01648140|177734|P4|Overall Study|Withdrawal by Subject|2
41521|NCT01648140|177735|P3|Overall Study|Withdrawal by Subject|3
41522|NCT01648140|177736|P2|Overall Study|Withdrawal by Subject|3
41523|NCT01648140|177737|P1|Overall Study|Withdrawal by Subject|2
41524|NCT01648140|177734|P4|Overall Study|Adverse Event|0
41525|NCT01648140|177735|P3|Overall Study|Adverse Event|2
41526|NCT01648140|177736|P2|Overall Study|Adverse Event|1
41527|NCT01648140|177737|P1|Overall Study|Adverse Event|3
41528|NCT01648140|177734|P4|Overall Study|Lack of Efficacy|0
41529|NCT01648140|177735|P3|Overall Study|Lack of Efficacy|1
41530|NCT01648140|177736|P2|Overall Study|Lack of Efficacy|7
41531|NCT01648140|177737|P1|Overall Study|Lack of Efficacy|4
41532|NCT01648140|177734|P4|Overall Study|Physician Decision|0
41533|NCT01648140|177735|P3|Overall Study|Physician Decision|0
41534|NCT01648140|177736|P2|Overall Study|Physician Decision|0
41535|NCT01648140|177737|P1|Overall Study|Physician Decision|1
41536|NCT01648101|177902|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
41537|NCT01648101|177903|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
41538|NCT01648101|177904|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
41539|NCT01648101|177902|P3|Transition Phase (4 Weeks)|Study Terminated|0
41540|NCT01648101|177903|P2|Transition Phase (4 Weeks)|Study Terminated|0
41541|NCT01648101|177904|P1|Transition Phase (4 Weeks)|Study Terminated|1
41542|NCT01648101|177902|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
41543|NCT01648101|177903|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
41544|NCT01648101|177904|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
41545|NCT01648101|177902|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
41546|NCT01648101|177903|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
41547|NCT01648101|177904|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
41548|NCT01648101|177902|P3|Transition Phase (4 Weeks)|Adverse Event|2
41549|NCT01648101|177903|P2|Transition Phase (4 Weeks)|Adverse Event|3
41550|NCT01648101|177904|P1|Transition Phase (4 Weeks)|Adverse Event|4
41551|NCT01648101|177902|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
41552|NCT01648101|177903|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
41553|NCT01648101|177904|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
41554|NCT01648101|177902|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
41555|NCT01648101|177903|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
41556|NCT01648101|177904|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
41557|NCT01648101|177902|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
41558|NCT01648101|177903|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
41559|NCT01648101|177904|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
41560|NCT01648101|177902|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
41561|NCT01648101|177903|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
41562|NCT01648101|177904|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
41563|NCT01648101|177902|P3|Titration Phase (4 Weeks)|Adverse Event|3
41564|NCT01648101|177903|P2|Titration Phase (4 Weeks)|Adverse Event|2
41565|NCT01648101|177904|P1|Titration Phase (4 Weeks)|Adverse Event|0
41566|NCT01648101|177902|P3|Titration Phase (4 Weeks)|Protocol Violation|2
41567|NCT01648101|177903|P2|Titration Phase (4 Weeks)|Protocol Violation|1
41568|NCT01648101|177904|P1|Titration Phase (4 Weeks)|Protocol Violation|2
41569|NCT01647711|177991|P5|Overall Study|Other reason not defined|0
41570|NCT01647711|177992|P4|Overall Study|Other reason not defined|1
41571|NCT01647711|177993|P3|Overall Study|Other reason not defined|1
41572|NCT01647711|177994|P2|Overall Study|Other reason not defined|1
41573|NCT01647711|177995|P1|Overall Study|Other reason not defined|0
41574|NCT01647711|177991|P5|Overall Study|Refused to continue taking medication|1
41575|NCT01647711|177992|P4|Overall Study|Refused to continue taking medication|2
41576|NCT01647711|177993|P3|Overall Study|Refused to continue taking medication|0
41577|NCT01647711|177994|P2|Overall Study|Refused to continue taking medication|0
41578|NCT01647711|177995|P1|Overall Study|Refused to continue taking medication|0
41579|NCT01647711|177991|P5|Overall Study|Protocol Violation|1
41580|NCT01647711|177992|P4|Overall Study|Protocol Violation|0
41581|NCT01647711|177993|P3|Overall Study|Protocol Violation|0
41582|NCT01647711|177994|P2|Overall Study|Protocol Violation|0
41583|NCT01647711|177995|P1|Overall Study|Protocol Violation|0
41584|NCT01647711|177991|P5|Overall Study|Other adverse event|2
41585|NCT01647711|177992|P4|Overall Study|Other adverse event|0
41586|NCT01647711|177993|P3|Overall Study|Other adverse event|2
41587|NCT01647711|177994|P2|Overall Study|Other adverse event|0
41588|NCT01647711|177995|P1|Overall Study|Other adverse event|0
41589|NCT01647711|177991|P5|Overall Study|Progressive disease|2
41590|NCT01647711|177992|P4|Overall Study|Progressive disease|8
41591|NCT01647711|177993|P3|Overall Study|Progressive disease|6
41592|NCT01647711|177994|P2|Overall Study|Progressive disease|2
41593|NCT01647711|177995|P1|Overall Study|Progressive disease|6
41594|NCT01647542|178023|P3|Overall Study|Death|1
41595|NCT01647542|178024|P2|Overall Study|Death|0
41596|NCT01647542|178025|P1|Overall Study|Death|0
41597|NCT01647542|178023|P3|Overall Study|Lack of Efficacy|0
41598|NCT01647542|178024|P2|Overall Study|Lack of Efficacy|1
41599|NCT01647542|178025|P1|Overall Study|Lack of Efficacy|1
41600|NCT01647542|178023|P3|Overall Study|Study Termination|65
41601|NCT01647542|178024|P2|Overall Study|Study Termination|61
41602|NCT01647542|178025|P1|Overall Study|Study Termination|64
41603|NCT01647542|178023|P3|Overall Study|Withdrawal by Subject|0
41604|NCT01647542|178024|P2|Overall Study|Withdrawal by Subject|4
41605|NCT01647542|178025|P1|Overall Study|Withdrawal by Subject|6
41606|NCT01647542|178023|P3|Overall Study|Lost to Follow-up|2
41607|NCT01647542|178024|P2|Overall Study|Lost to Follow-up|2
41608|NCT01647542|178025|P1|Overall Study|Lost to Follow-up|0
41609|NCT01647542|178023|P3|Overall Study|Adverse Event|4
41610|NCT01647542|178024|P2|Overall Study|Adverse Event|5
41611|NCT01647542|178025|P1|Overall Study|Adverse Event|4
41612|NCT01647542|178023|P3|Overall Study|Major Protocol Deviation|0
41613|NCT01647542|178024|P2|Overall Study|Major Protocol Deviation|0
41614|NCT01647542|178025|P1|Overall Study|Major Protocol Deviation|1
41615|NCT01647282|178059|P2|Overall Study|Physician Decision|5
41616|NCT01647282|178060|P1|Overall Study|Physician Decision|7
41617|NCT01646827|178081|P2|Overall Study|Withdrawal by Subject|0
41618|NCT01646827|178082|P1|Overall Study|Withdrawal by Subject|1
41619|NCT01646827|178081|P2|Overall Study|Physician Decision|2
41620|NCT01646827|178082|P1|Overall Study|Physician Decision|1
41621|NCT01646827|178081|P2|Overall Study|Lost to Follow-up|3
41622|NCT01646827|178082|P1|Overall Study|Lost to Follow-up|0
41623|NCT01646398|178169|P2|Overall Study|Withdrawal by Subject|0
41624|NCT01646398|178170|P1|Overall Study|Withdrawal by Subject|1
41625|NCT01646385|178186|P2|Overall Study|Switched to alternate biologic|649
41626|NCT01646385|178187|P1|Overall Study|Switched to alternate biologic|636
41627|NCT01646385|178186|P2|Overall Study|Death|222
41628|NCT01646385|178187|P1|Overall Study|Death|202
41629|NCT01646320|178220|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
41630|NCT01646320|178221|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
41631|NCT01646320|178220|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
41632|NCT01646320|178221|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
41633|NCT01646320|178220|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
41634|NCT01646320|178221|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
41635|NCT01646320|178220|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
41636|NCT01646320|178221|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
41637|NCT01646320|178220|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
41638|NCT01646320|178221|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
41639|NCT01646320|178220|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
41640|NCT01646320|178221|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
41641|NCT01646320|178220|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
41642|NCT01646320|178221|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
41643|NCT01646320|178220|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
41644|NCT01646320|178221|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
41645|NCT01646320|178220|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
41646|NCT01646320|178221|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
41647|NCT01646320|178220|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
41648|NCT01646320|178221|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
41649|NCT01646320|178220|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
41650|NCT01646320|178221|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
41651|NCT01646268|178237|P2|Overall Study|Other|0
41652|NCT01646268|178238|P1|Overall Study|Other|2
41653|NCT01646268|178237|P2|Overall Study|Withdrawal by Subject|5
41654|NCT01646268|178238|P1|Overall Study|Withdrawal by Subject|2
41655|NCT01646268|178237|P2|Overall Study|Protocol Violation|1
41656|NCT01646268|178238|P1|Overall Study|Protocol Violation|0
41657|NCT01646268|178237|P2|Overall Study|Lack of Efficacy|3
41658|NCT01646268|178238|P1|Overall Study|Lack of Efficacy|1
41659|NCT01646268|178237|P2|Overall Study|Adverse Event|7
41660|NCT01646268|178238|P1|Overall Study|Adverse Event|6
41661|NCT01646255|178252|P2|Overall Study|Inclusion Criteria Deviation|0
41662|NCT01646255|178253|P1|Overall Study|Inclusion Criteria Deviation|1
41663|NCT01646255|178252|P2|Overall Study|Compliance is not well|0
41664|NCT01646255|178253|P1|Overall Study|Compliance is not well|1
41665|NCT01646255|178252|P2|Overall Study|Withdrawal by Subject|6
41666|NCT01646255|178253|P1|Overall Study|Withdrawal by Subject|10
41667|NCT01646255|178252|P2|Overall Study|Lack of Efficacy|0
41668|NCT01646255|178253|P1|Overall Study|Lack of Efficacy|2
41669|NCT01646255|178252|P2|Overall Study|Adverse Event|8
41670|NCT01646255|178253|P1|Overall Study|Adverse Event|7
41671|NCT01646216|178285|P2|Overall Study|Investigator decision|1
41672|NCT01646216|178286|P1|Overall Study|Investigator decision|1
41673|NCT01646216|178285|P2|Overall Study|Did not complete training|2
41674|NCT01646216|178286|P1|Overall Study|Did not complete training|0
41675|NCT01646216|178285|P2|Overall Study|Baseline step length difference (<5cm)|10
41676|NCT01646216|178286|P1|Overall Study|Baseline step length difference (<5cm)|10
41677|NCT01646177|178309|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
41678|NCT01646177|178310|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
41679|NCT01646177|178311|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
41680|NCT01646177|178312|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
41681|NCT01646177|178309|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
41682|NCT01646177|178310|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
41683|NCT01646177|178311|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
41684|NCT01646177|178312|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
41685|NCT01646177|178309|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
41686|NCT01646177|178310|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
41687|NCT01646177|178311|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
41688|NCT01646177|178312|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
41689|NCT01646177|178309|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
41690|NCT01646177|178310|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
41691|NCT01646177|178311|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
41692|NCT01646177|178312|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
41693|NCT01646177|178309|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
41694|NCT01646177|178310|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
41695|NCT01646177|178311|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
41696|NCT01646177|178312|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
41697|NCT01646177|178309|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
41698|NCT01646177|178310|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
41699|NCT01646177|178311|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
41700|NCT01646177|178312|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
41701|NCT01646138|178406|P5|Overall Study|Lost to Follow-up|2
41702|NCT01646138|178407|P4|Overall Study|Lost to Follow-up|0
41703|NCT01646138|178408|P3|Overall Study|Lost to Follow-up|0
41704|NCT01646138|178409|P2|Overall Study|Lost to Follow-up|0
41705|NCT01646138|178410|P1|Overall Study|Lost to Follow-up|0
41706|NCT01646125|178424|P2|Overall Study|Subject/Guardian decision|1
41707|NCT01646125|178425|P1|Overall Study|Subject/Guardian decision|1
41708|NCT01646125|178424|P2|Overall Study|Study terminated by sponsor|1
41709|NCT01646125|178425|P1|Overall Study|Study terminated by sponsor|2
41710|NCT01646125|178424|P2|Overall Study|Progressive disease|16
41711|NCT01646125|178425|P1|Overall Study|Progressive disease|22
41712|NCT01646125|178424|P2|Overall Study|Physician Decision|3
41713|NCT01646125|178425|P1|Overall Study|Physician Decision|1
41714|NCT01646125|178424|P2|Overall Study|Death|1
41715|NCT01646125|178425|P1|Overall Study|Death|1
41716|NCT01646125|178424|P2|Overall Study|Adverse Event|1
41717|NCT01646125|178425|P1|Overall Study|Adverse Event|2
41718|NCT01646125|178424|P2|Overall Study|Untreated|5
41719|NCT01646125|178425|P1|Overall Study|Untreated|2
41720|NCT01646073|178450|P2|Period B (12 Weeks)|Lost to Follow-up|1
41721|NCT01646073|178451|P1|Period B (12 Weeks)|Lost to Follow-up|0
41722|NCT01646073|178450|P2|Period B (12 Weeks)|Withdrawal by Subject|5
41723|NCT01646073|178451|P1|Period B (12 Weeks)|Withdrawal by Subject|1
41724|NCT01646073|178450|P2|Period B (12 Weeks)|Adverse Event|7
41725|NCT01646073|178451|P1|Period B (12 Weeks)|Adverse Event|0
41726|NCT01646073|178450|P2|Period A (12 Weeks)|Not Specified|1
41727|NCT01646073|178451|P1|Period A (12 Weeks)|Not Specified|0
41728|NCT01646073|178450|P2|Period A (12 Weeks)|Protocol Violation|1
41729|NCT01646073|178451|P1|Period A (12 Weeks)|Protocol Violation|0
41730|NCT01646073|178450|P2|Period A (12 Weeks)|Lack of Efficacy|0
41731|NCT01646073|178451|P1|Period A (12 Weeks)|Lack of Efficacy|1
41732|NCT01646073|178450|P2|Period A (12 Weeks)|Withdrawal by Subject|1
41733|NCT01646073|178451|P1|Period A (12 Weeks)|Withdrawal by Subject|1
41734|NCT01646073|178450|P2|Period A (12 Weeks)|Adverse Event|2
41735|NCT01646073|178451|P1|Period A (12 Weeks)|Adverse Event|0
41736|NCT01646021|178492|P2|Overall Study|Withdrawal by Subject|15
41737|NCT01646021|178493|P1|Overall Study|Withdrawal by Subject|10
41738|NCT01646021|178492|P2|Overall Study|Lost to Follow-up|2
41739|NCT01646021|178493|P1|Overall Study|Lost to Follow-up|2
41740|NCT01646021|178492|P2|Overall Study|Study Terminated by Sponsor|41
41741|NCT01646021|178493|P1|Overall Study|Study Terminated by Sponsor|50
41742|NCT01646021|178492|P2|Overall Study|Death|83
41743|NCT01646021|178493|P1|Overall Study|Death|77
41744|NCT01645735|178532|P2|Overall Study|Adverse Event|1
41745|NCT01645735|178533|P1|Overall Study|Adverse Event|0
41746|NCT01645735|178532|P2|Overall Study|Protocol Violation|0
41747|NCT01645735|178533|P1|Overall Study|Protocol Violation|1
41748|NCT01645735|178532|P2|Overall Study|Withdrawal by Subject|0
41749|NCT01645735|178533|P1|Overall Study|Withdrawal by Subject|1
41750|NCT01645735|178532|P2|Overall Study|Physician Decision|0
41751|NCT01645735|178533|P1|Overall Study|Physician Decision|2
41752|NCT01645280|178575|P5|Overall Study|Treatment not completed/Completed f/u|2
41753|NCT01645280|178576|P4|Overall Study|Treatment not completed/Completed f/u|0
41754|NCT01645280|178577|P3|Overall Study|Treatment not completed/Completed f/u|2
41755|NCT01645280|178578|P2|Overall Study|Treatment not completed/Completed f/u|1
41756|NCT01645280|178579|P1|Overall Study|Treatment not completed/Completed f/u|1
41757|NCT01645280|178575|P5|Overall Study|Other|0
41758|NCT01645280|178576|P4|Overall Study|Other|0
41759|NCT01645280|178577|P3|Overall Study|Other|2
41760|NCT01645280|178578|P2|Overall Study|Other|1
41761|NCT01645280|178579|P1|Overall Study|Other|1
41762|NCT01645280|178575|P5|Overall Study|Lost to Follow-up|1
41763|NCT01645280|178576|P4|Overall Study|Lost to Follow-up|2
41764|NCT01645280|178577|P3|Overall Study|Lost to Follow-up|0
41765|NCT01645280|178578|P2|Overall Study|Lost to Follow-up|0
41766|NCT01645280|178579|P1|Overall Study|Lost to Follow-up|0
41767|NCT01645280|178575|P5|Overall Study|Withdrawal by Subject|5
41768|NCT01645280|178576|P4|Overall Study|Withdrawal by Subject|4
41769|NCT01645280|178577|P3|Overall Study|Withdrawal by Subject|2
41770|NCT01645280|178578|P2|Overall Study|Withdrawal by Subject|0
41771|NCT01645280|178579|P1|Overall Study|Withdrawal by Subject|4
41772|NCT01645280|178575|P5|Overall Study|Death|0
41773|NCT01645280|178576|P4|Overall Study|Death|0
41774|NCT01645280|178577|P3|Overall Study|Death|0
41775|NCT01645280|178578|P2|Overall Study|Death|1
41776|NCT01645280|178579|P1|Overall Study|Death|0
41777|NCT01645176|178607|P1|Overall Study|did not complete final MRI|1
41778|NCT01645176|178607|P1|Overall Study|Lack of Efficacy|4
41779|NCT01645111|178611|P1|Overall Study|Did not require Clevidipine|15
41780|NCT01644734|178650|P1|Overall Study|Missing documentation|238
41781|NCT01644734|178650|P1|Overall Study|Reasons other than stated above|7
41782|NCT01644734|178650|P1|Overall Study|Lost to Follow-up|17
41783|NCT01644734|178650|P1|Overall Study|Adverse Event|4
41784|NCT01644643|178664|P4|Overall Study|Other Eligibility criteria|2
41785|NCT01644643|178665|P3|Overall Study|Other Eligibility criteria|0
41786|NCT01644643|178666|P2|Overall Study|Other Eligibility criteria|0
41787|NCT01644643|178667|P1|Overall Study|Other Eligibility criteria|0
41788|NCT01644643|178664|P4|Overall Study|Withdrawal by Subject|1
41789|NCT01644643|178665|P3|Overall Study|Withdrawal by Subject|2
41790|NCT01644643|178666|P2|Overall Study|Withdrawal by Subject|0
41791|NCT01644643|178667|P1|Overall Study|Withdrawal by Subject|1
41792|NCT01644643|178664|P4|Overall Study|Lost to Follow-up|4
41793|NCT01644643|178665|P3|Overall Study|Lost to Follow-up|0
41794|NCT01644643|178666|P2|Overall Study|Lost to Follow-up|0
41795|NCT01644643|178667|P1|Overall Study|Lost to Follow-up|0
41796|NCT01644643|178664|P4|Overall Study|Death|3
41797|NCT01644643|178665|P3|Overall Study|Death|3
41798|NCT01644643|178666|P2|Overall Study|Death|0
41799|NCT01644643|178667|P1|Overall Study|Death|1
41800|NCT01644617|178832|P3|Overall Study|Adverse Event|6
41801|NCT01644617|178833|P2|Overall Study|Adverse Event|0
41802|NCT01644617|178834|P1|Overall Study|Adverse Event|3
41803|NCT01644617|178832|P3|Overall Study|Lost to Follow-up|0
41804|NCT01644617|178833|P2|Overall Study|Lost to Follow-up|1
41805|NCT01644617|178834|P1|Overall Study|Lost to Follow-up|0
41806|NCT01644617|178832|P3|Overall Study|Withdrawal by Subject|1
41807|NCT01644617|178833|P2|Overall Study|Withdrawal by Subject|4
41808|NCT01644617|178834|P1|Overall Study|Withdrawal by Subject|3
41809|NCT01644500|178887|P3|Overall Study|Physician Decision|1
41810|NCT01644500|178888|P2|Overall Study|Physician Decision|1
41811|NCT01644500|178889|P1|Overall Study|Physician Decision|1
41812|NCT01644500|178887|P3|Overall Study|Withdrawal by Subject|12
41813|NCT01644500|178888|P2|Overall Study|Withdrawal by Subject|12
41814|NCT01644500|178889|P1|Overall Study|Withdrawal by Subject|11
41815|NCT01644500|178887|P3|Overall Study|Protocol Violation|0
41816|NCT01644500|178888|P2|Overall Study|Protocol Violation|1
41817|NCT01644500|178889|P1|Overall Study|Protocol Violation|1
41818|NCT01644500|178887|P3|Overall Study|Lost to Follow-up|0
41819|NCT01644500|178888|P2|Overall Study|Lost to Follow-up|8
41820|NCT01644500|178889|P1|Overall Study|Lost to Follow-up|3
41821|NCT01644500|178887|P3|Overall Study|Death|0
41822|NCT01644500|178888|P2|Overall Study|Death|1
41823|NCT01644500|178889|P1|Overall Study|Death|0
41824|NCT01644500|178887|P3|Overall Study|Adverse Event|2
41825|NCT01644500|178888|P2|Overall Study|Adverse Event|1
41826|NCT01644500|178889|P1|Overall Study|Adverse Event|6
41827|NCT01644474|178959|P2|Overall Study|Protocol Violation|0
41828|NCT01644474|178960|P1|Overall Study|Protocol Violation|1
41829|NCT01644474|178959|P2|Overall Study|Site scheduling error|1
41830|NCT01644474|178960|P1|Overall Study|Site scheduling error|1
41831|NCT01644474|178959|P2|Overall Study|Adverse Event|5
41832|NCT01644474|178960|P1|Overall Study|Adverse Event|4
41833|NCT01644474|178959|P2|Overall Study|Participant moved|1
41834|NCT01644474|178960|P1|Overall Study|Participant moved|0
41835|NCT01644474|178959|P2|Overall Study|Consent withdrawn by participant|1
41836|NCT01644474|178960|P1|Overall Study|Consent withdrawn by participant|0
41837|NCT01644474|178959|P2|Overall Study|Poor compliance to protocol|0
41838|NCT01644474|178960|P1|Overall Study|Poor compliance to protocol|1
41839|NCT01644188|179144|P2|Overall Study|Other than specified above|7
41840|NCT01644188|179145|P1|Overall Study|Other than specified above|6
41841|NCT01644188|179144|P2|Overall Study|Site closure|1
41842|NCT01644188|179145|P1|Overall Study|Site closure|1
41843|NCT01644188|179144|P2|Overall Study|Last visit outside protocol visit window|16
41844|NCT01644188|179145|P1|Overall Study|Last visit outside protocol visit window|14
41845|NCT01644188|179144|P2|Overall Study|Death|3
41846|NCT01644188|179145|P1|Overall Study|Death|4
41847|NCT01644188|179144|P2|Overall Study|Lost to Follow-up|0
41848|NCT01644188|179145|P1|Overall Study|Lost to Follow-up|1
41849|NCT01644188|179144|P2|Overall Study|Selection criteria finally not met|0
41850|NCT01644188|179145|P1|Overall Study|Selection criteria finally not met|2
41851|NCT01644188|179144|P2|Overall Study|Consent withdrawn by participant|7
41852|NCT01644188|179145|P1|Overall Study|Consent withdrawn by participant|14
41853|NCT01644188|179144|P2|Overall Study|Related to auto-injector administration|2
41854|NCT01644188|179145|P1|Overall Study|Related to auto-injector administration|2
41855|NCT01644188|179144|P2|Overall Study|Participant moved|2
41856|NCT01644188|179145|P1|Overall Study|Participant moved|7
41857|NCT01644188|179144|P2|Overall Study|Physician Decision|3
41858|NCT01644188|179145|P1|Overall Study|Physician Decision|1
41859|NCT01644188|179144|P2|Overall Study|Poor compliance to protocol|14
41860|NCT01644188|179145|P1|Overall Study|Poor compliance to protocol|26
41861|NCT01644188|179144|P2|Overall Study|Adverse Event|20
41862|NCT01644188|179145|P1|Overall Study|Adverse Event|44
41863|NCT01644175|179203|P2|Overall Study|Other than specified above|3
41864|NCT01644175|179204|P1|Overall Study|Other than specified above|0
41865|NCT01644175|179203|P2|Overall Study|Lost to Follow-up|0
41866|NCT01644175|179204|P1|Overall Study|Lost to Follow-up|1
41867|NCT01644175|179203|P2|Overall Study|Site closure|2
41868|NCT01644175|179204|P1|Overall Study|Site closure|2
41869|NCT01644175|179203|P2|Overall Study|Selection criteria finally not met|1
41870|NCT01644175|179204|P1|Overall Study|Selection criteria finally not met|0
41871|NCT01644175|179203|P2|Overall Study|Last visit outside protocol visit window|11
41872|NCT01644175|179204|P1|Overall Study|Last visit outside protocol visit window|4
41873|NCT01644175|179203|P2|Overall Study|Related to Autoinjector Administration|1
41874|NCT01644175|179204|P1|Overall Study|Related to Autoinjector Administration|2
41875|NCT01644175|179203|P2|Overall Study|Consent withdrawn by participant|4
41876|NCT01644175|179204|P1|Overall Study|Consent withdrawn by participant|3
41877|NCT01644175|179203|P2|Overall Study|Participant Moved|2
41878|NCT01644175|179204|P1|Overall Study|Participant Moved|1
41879|NCT01644175|179203|P2|Overall Study|Physician Decision|2
41880|NCT01644175|179204|P1|Overall Study|Physician Decision|1
41881|NCT01644175|179203|P2|Overall Study|Poor compliance to protocol|10
41882|NCT01644175|179204|P1|Overall Study|Poor compliance to protocol|9
41883|NCT01644175|179203|P2|Overall Study|Death|2
41884|NCT01644175|179204|P1|Overall Study|Death|1
41885|NCT01644175|179203|P2|Overall Study|Adverse Event|13
41886|NCT01644175|179204|P1|Overall Study|Adverse Event|8
41887|NCT01644175|179203|P2|Overall Study|Randomized But Not Treated|2
41888|NCT01644175|179204|P1|Overall Study|Randomized But Not Treated|0
41889|NCT01643928|179264|P5|Overall Study|Adverse Event|2
41890|NCT01643928|179265|P4|Overall Study|Adverse Event|1
41891|NCT01643928|179266|P3|Overall Study|Adverse Event|0
41892|NCT01643928|179267|P2|Overall Study|Adverse Event|1
41893|NCT01643928|179268|P1|Overall Study|Adverse Event|2
41894|NCT01643928|179264|P5|Overall Study|Other|0
41895|NCT01643928|179265|P4|Overall Study|Other|0
41896|NCT01643928|179266|P3|Overall Study|Other|1
41897|NCT01643928|179267|P2|Overall Study|Other|1
41898|NCT01643928|179268|P1|Overall Study|Other|5
41899|NCT01643928|179264|P5|Overall Study|Pregnancy|0
41900|NCT01643928|179265|P4|Overall Study|Pregnancy|1
41901|NCT01643928|179266|P3|Overall Study|Pregnancy|0
41902|NCT01643928|179267|P2|Overall Study|Pregnancy|0
41903|NCT01643928|179268|P1|Overall Study|Pregnancy|0
41904|NCT01643928|179264|P5|Overall Study|Withdrawal by Subject|0
41905|NCT01643928|179265|P4|Overall Study|Withdrawal by Subject|1
41906|NCT01643928|179266|P3|Overall Study|Withdrawal by Subject|0
41907|NCT01643928|179267|P2|Overall Study|Withdrawal by Subject|0
41908|NCT01643928|179268|P1|Overall Study|Withdrawal by Subject|2
41909|NCT01643928|179264|P5|Overall Study|Lost to Follow-up|0
41910|NCT01643928|179265|P4|Overall Study|Lost to Follow-up|0
41911|NCT01643928|179266|P3|Overall Study|Lost to Follow-up|2
41912|NCT01643928|179267|P2|Overall Study|Lost to Follow-up|0
41913|NCT01643928|179268|P1|Overall Study|Lost to Follow-up|1
41914|NCT01643798|179563|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
41915|NCT01643798|179564|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
41916|NCT01643668|179575|P1|Overall Study|Death|1
41917|NCT01643044|179615|P2|Overall Study|Delivered outside of hospital|2
41918|NCT01643044|179616|P1|Overall Study|Delivered outside of hospital|1
41919|NCT01643044|179615|P2|Overall Study|Miscarried baby|2
41920|NCT01643044|179616|P1|Overall Study|Miscarried baby|2
41921|NCT01643044|179615|P2|Overall Study|Lost to Follow-up|1
41922|NCT01643044|179616|P1|Overall Study|Lost to Follow-up|1
41923|NCT01642914|179625|P3|Overall Study|Other Reason|0
41924|NCT01642914|179626|P2|Overall Study|Other Reason|0
41925|NCT01642914|179627|P1|Overall Study|Other Reason|1
41926|NCT01642914|179625|P3|Overall Study|Lost to Follow-up|7
41927|NCT01642914|179626|P2|Overall Study|Lost to Follow-up|3
41928|NCT01642914|179627|P1|Overall Study|Lost to Follow-up|5
41929|NCT01642914|179625|P3|Overall Study|Withdrawal by Subject|10
41930|NCT01642914|179626|P2|Overall Study|Withdrawal by Subject|5
41931|NCT01642914|179627|P1|Overall Study|Withdrawal by Subject|5
41932|NCT01642914|179625|P3|Overall Study|Protocol Violation|6
41933|NCT01642914|179626|P2|Overall Study|Protocol Violation|13
41934|NCT01642914|179627|P1|Overall Study|Protocol Violation|15
41935|NCT01642914|179625|P3|Overall Study|Lack of Efficacy|2
41936|NCT01642914|179626|P2|Overall Study|Lack of Efficacy|4
41937|NCT01642914|179627|P1|Overall Study|Lack of Efficacy|9
41938|NCT01642914|179625|P3|Overall Study|Adverse Event|15
41939|NCT01642914|179626|P2|Overall Study|Adverse Event|7
41940|NCT01642914|179627|P1|Overall Study|Adverse Event|11
41941|NCT01642732|179702|P1|Overall Study|Withdrawal by Subject|1
41942|NCT01642615|179707|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
41943|NCT01642615|179708|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
41944|NCT01642615|179709|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
41945|NCT01642615|179707|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
41946|NCT01642615|179708|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
41947|NCT01642615|179709|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
41948|NCT01642615|179707|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
41949|NCT01642615|179708|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
41950|NCT01642615|179709|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
41951|NCT01642615|179707|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
41952|NCT01642615|179708|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
41953|NCT01642615|179709|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
41954|NCT01642615|179707|P3|Open Label Maintenance Phase|Did not receive treatment|0
41955|NCT01642615|179708|P2|Open Label Maintenance Phase|Did not receive treatment|0
41956|NCT01642615|179709|P1|Open Label Maintenance Phase|Did not receive treatment|1
41957|NCT01642615|179707|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
41958|NCT01642615|179708|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
41959|NCT01642615|179709|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
41960|NCT01642615|179707|P3|Open Label Maintenance Phase|Lost to Follow-up|0
41961|NCT01642615|179708|P2|Open Label Maintenance Phase|Lost to Follow-up|0
41962|NCT01642615|179709|P1|Open Label Maintenance Phase|Lost to Follow-up|1
41963|NCT01642615|179707|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
41964|NCT01642615|179708|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
41965|NCT01642615|179709|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
41966|NCT01642615|179707|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
41967|NCT01642615|179708|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
41968|NCT01642615|179709|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
41969|NCT01642602|179723|P1|Overall Study|Adverse Event|2
41970|NCT01642589|179730|P2|Overall Study|Withdrawal by Subject|1
41971|NCT01642589|179731|P1|Overall Study|Withdrawal by Subject|1
41972|NCT01642407|179770|P1|Overall Study|Insufficient clinical response|2
41973|NCT01642277|179814|P2|Overall Study|Withdrawal by Subject|0
41974|NCT01642277|179815|P1|Overall Study|Withdrawal by Subject|11
41975|NCT01642277|179814|P2|Overall Study|Protocol Violation|0
41976|NCT01642277|179815|P1|Overall Study|Protocol Violation|1
41977|NCT01642277|179814|P2|Overall Study|Physician Decision|0
41978|NCT01642277|179815|P1|Overall Study|Physician Decision|2
41979|NCT01642277|179814|P2|Overall Study|Adverse Event|0
41980|NCT01642277|179815|P1|Overall Study|Adverse Event|10
41981|NCT01642212|179847|P5|Open-label Extension|Not Specified|1
41982|NCT01642212|179848|P4|Open-label Extension|Not Specified|0
41983|NCT01642212|179849|P3|Open-label Extension|Not Specified|0
41984|NCT01642212|179850|P2|Open-label Extension|Not Specified|0
41985|NCT01642212|179851|P1|Open-label Extension|Not Specified|0
41986|NCT01642212|179847|P5|Open-label Extension|Lost to Follow-up|1
41987|NCT01642212|179848|P4|Open-label Extension|Lost to Follow-up|0
41988|NCT01642212|179849|P3|Open-label Extension|Lost to Follow-up|0
41989|NCT01642212|179850|P2|Open-label Extension|Lost to Follow-up|0
41990|NCT01642212|179851|P1|Open-label Extension|Lost to Follow-up|0
41991|NCT01642212|179847|P5|Open-label Extension|Consent Withdrawn|2
41992|NCT01642212|179848|P4|Open-label Extension|Consent Withdrawn|0
41993|NCT01642212|179849|P3|Open-label Extension|Consent Withdrawn|0
41994|NCT01642212|179850|P2|Open-label Extension|Consent Withdrawn|0
41995|NCT01642212|179851|P1|Open-label Extension|Consent Withdrawn|0
41996|NCT01642212|179847|P5|Open-label Extension|Sponsor Decision|4
41997|NCT01642212|179848|P4|Open-label Extension|Sponsor Decision|7
41998|NCT01642212|179849|P3|Open-label Extension|Sponsor Decision|0
41999|NCT01642212|179850|P2|Open-label Extension|Sponsor Decision|0
42000|NCT01642212|179851|P1|Open-label Extension|Sponsor Decision|0
42001|NCT01642212|179847|P5|Open-label Extension|Adverse Event|0
42002|NCT01642212|179848|P4|Open-label Extension|Adverse Event|3
42003|NCT01642212|179849|P3|Open-label Extension|Adverse Event|0
42004|NCT01642212|179850|P2|Open-label Extension|Adverse Event|0
42005|NCT01642212|179851|P1|Open-label Extension|Adverse Event|0
42006|NCT01642212|179847|P5|Double-blind Treatment|Adverse Event|0
42007|NCT01642212|179848|P4|Double-blind Treatment|Adverse Event|0
42008|NCT01642212|179849|P3|Double-blind Treatment|Adverse Event|1
42009|NCT01642212|179850|P2|Double-blind Treatment|Adverse Event|0
42010|NCT01642212|179851|P1|Double-blind Treatment|Adverse Event|0
42011|NCT01642212|179847|P5|Double-blind Treatment|Non-compliance|0
42012|NCT01642212|179848|P4|Double-blind Treatment|Non-compliance|0
42013|NCT01642212|179849|P3|Double-blind Treatment|Non-compliance|0
42014|NCT01642212|179850|P2|Double-blind Treatment|Non-compliance|1
42015|NCT01642212|179851|P1|Double-blind Treatment|Non-compliance|0
42016|NCT01642212|179847|P5|Double-blind Treatment|Not Specified|0
42017|NCT01642212|179848|P4|Double-blind Treatment|Not Specified|0
42018|NCT01642212|179849|P3|Double-blind Treatment|Not Specified|1
42019|NCT01642212|179850|P2|Double-blind Treatment|Not Specified|2
42020|NCT01642212|179851|P1|Double-blind Treatment|Not Specified|0
42021|NCT01642212|179847|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
42022|NCT01642212|179848|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
42023|NCT01642212|179849|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
42024|NCT01642212|179850|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
42025|NCT01642212|179851|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
42026|NCT01642004|179946|P2|Treatment|Missing from data|1
42027|NCT01642004|179947|P1|Treatment|Missing from data|0
42028|NCT01642004|179946|P2|Treatment|Other|2
42029|NCT01642004|179947|P1|Treatment|Other|1
42030|NCT01642004|179946|P2|Treatment|No longer meets study criteria|2
42031|NCT01642004|179947|P1|Treatment|No longer meets study criteria|1
42032|NCT01642004|179946|P2|Treatment|Poor/non-compliance|0
42033|NCT01642004|179947|P1|Treatment|Poor/non-compliance|1
42034|NCT01642004|179946|P2|Treatment|Maximum clinical benefit|7
42035|NCT01642004|179947|P1|Treatment|Maximum clinical benefit|2
42036|NCT01642004|179946|P2|Treatment|Withdrawal by Subject|9
42037|NCT01642004|179947|P1|Treatment|Withdrawal by Subject|5
42038|NCT01642004|179946|P2|Treatment|Adverse event unrelated to study drug|13
42039|NCT01642004|179947|P1|Treatment|Adverse event unrelated to study drug|6
42040|NCT01642004|179946|P2|Treatment|Death|0
42041|NCT01642004|179947|P1|Treatment|Death|1
42042|NCT01642004|179946|P2|Treatment|Study drug toxicity|13
42043|NCT01642004|179947|P1|Treatment|Study drug toxicity|5
42044|NCT01642004|179946|P2|Treatment|Disease progression|80
42045|NCT01642004|179947|P1|Treatment|Disease progression|88
42046|NCT01642004|179946|P2|Randomization|No longer meets study criteria|2
42047|NCT01642004|179947|P1|Randomization|No longer meets study criteria|2
42048|NCT01642004|179946|P2|Randomization|Withdrawal by Subject|6
42049|NCT01642004|179947|P1|Randomization|Withdrawal by Subject|1
42050|NCT01642004|179946|P2|Randomization|Adverse Event unrelated to study drug|0
42051|NCT01642004|179947|P1|Randomization|Adverse Event unrelated to study drug|1
42052|NCT01641991|179981|P4|Overall Study|no longer eligible|4
42053|NCT01641991|179982|P3|Overall Study|no longer eligible|0
42054|NCT01641991|179983|P2|Overall Study|no longer eligible|1
42055|NCT01641991|179984|P1|Overall Study|no longer eligible|2
42056|NCT01641991|179981|P4|Overall Study|Pregnancy|0
42057|NCT01641991|179982|P3|Overall Study|Pregnancy|1
42058|NCT01641991|179983|P2|Overall Study|Pregnancy|0
42059|NCT01641991|179984|P1|Overall Study|Pregnancy|0
42060|NCT01641991|179981|P4|Overall Study|Protocol Violation|0
42061|NCT01641991|179982|P3|Overall Study|Protocol Violation|3
42062|NCT01641991|179983|P2|Overall Study|Protocol Violation|1
42063|NCT01641991|179984|P1|Overall Study|Protocol Violation|1
42064|NCT01641991|179981|P4|Overall Study|Lost to Follow-up|1
42065|NCT01641991|179982|P3|Overall Study|Lost to Follow-up|3
42066|NCT01641991|179983|P2|Overall Study|Lost to Follow-up|2
42067|NCT01641991|179984|P1|Overall Study|Lost to Follow-up|0
42068|NCT01641991|179981|P4|Overall Study|Adverse Event|1
42069|NCT01641991|179982|P3|Overall Study|Adverse Event|2
42070|NCT01641991|179983|P2|Overall Study|Adverse Event|1
42071|NCT01641991|179984|P1|Overall Study|Adverse Event|2
42072|NCT01641991|179981|P4|Overall Study|Withdrawal by Subject|5
42073|NCT01641991|179982|P3|Overall Study|Withdrawal by Subject|1
42074|NCT01641991|179983|P2|Overall Study|Withdrawal by Subject|2
42075|NCT01641991|179984|P1|Overall Study|Withdrawal by Subject|4
42076|NCT01641991|179981|P4|Overall Study|Physician Decision|5
42077|NCT01641991|179982|P3|Overall Study|Physician Decision|7
42078|NCT01641991|179983|P2|Overall Study|Physician Decision|1
42079|NCT01641991|179984|P1|Overall Study|Physician Decision|0
42080|NCT01641952|180068|P1|Overall Study|Adverse Event|6
42081|NCT01641952|180068|P1|Overall Study|Lost to Follow-up|28
42082|NCT01641939|180084|P3|Overall Study|Study Terminated by Sponsor|3
42083|NCT01641939|180085|P2|Overall Study|Study Terminated by Sponsor|28
42084|NCT01641939|180086|P1|Overall Study|Study Terminated by Sponsor|10
42085|NCT01641939|180084|P3|Overall Study|Withdrawal by Subject|5
42086|NCT01641939|180085|P2|Overall Study|Withdrawal by Subject|11
42087|NCT01641939|180086|P1|Overall Study|Withdrawal by Subject|14
42088|NCT01641939|180084|P3|Overall Study|Lost to Follow-up|1
42089|NCT01641939|180085|P2|Overall Study|Lost to Follow-up|2
42090|NCT01641939|180086|P1|Overall Study|Lost to Follow-up|3
42091|NCT01641939|180084|P3|Overall Study|Death|61
42092|NCT01641939|180085|P2|Overall Study|Death|187
42093|NCT01641939|180086|P1|Overall Study|Death|90
42094|NCT01641926|180129|P4|Overall Study|Not Treated|0
42095|NCT01641926|180130|P3|Overall Study|Not Treated|1
42096|NCT01641926|180131|P2|Overall Study|Not Treated|1
42097|NCT01641926|180132|P1|Overall Study|Not Treated|1
42098|NCT01641926|180129|P4|Overall Study|Withdrawal by Subject|1
42099|NCT01641926|180130|P3|Overall Study|Withdrawal by Subject|6
42100|NCT01641926|180131|P2|Overall Study|Withdrawal by Subject|5
42101|NCT01641926|180132|P1|Overall Study|Withdrawal by Subject|13
42102|NCT01641926|180129|P4|Overall Study|Protocol Violation|1
42103|NCT01641926|180130|P3|Overall Study|Protocol Violation|0
42104|NCT01641926|180131|P2|Overall Study|Protocol Violation|0
42105|NCT01641926|180132|P1|Overall Study|Protocol Violation|1
42106|NCT01641926|180129|P4|Overall Study|Physician Decision|1
42107|NCT01641926|180130|P3|Overall Study|Physician Decision|0
42108|NCT01641926|180131|P2|Overall Study|Physician Decision|5
42109|NCT01641926|180132|P1|Overall Study|Physician Decision|6
42110|NCT01641926|180129|P4|Overall Study|Lost to Follow-up|0
42111|NCT01641926|180130|P3|Overall Study|Lost to Follow-up|1
42112|NCT01641926|180131|P2|Overall Study|Lost to Follow-up|2
42113|NCT01641926|180132|P1|Overall Study|Lost to Follow-up|2
42114|NCT01641926|180129|P4|Overall Study|Adverse Event|1
42115|NCT01641926|180130|P3|Overall Study|Adverse Event|3
42116|NCT01641926|180131|P2|Overall Study|Adverse Event|2
42117|NCT01641926|180132|P1|Overall Study|Adverse Event|5
42118|NCT01641900|180160|P2|Overall Study|Withdrawal by Subject|2
42119|NCT01641900|180161|P1|Overall Study|Withdrawal by Subject|2
42120|NCT01641861|180173|P2|Overall Study|Died due to drowning|1
42121|NCT01641861|180174|P1|Overall Study|Died due to drowning|0
42122|NCT01641861|180173|P2|Overall Study|Lost the tooth due to normal exfoliation|8
42123|NCT01641861|180174|P1|Overall Study|Lost the tooth due to normal exfoliation|14
42124|NCT01641861|180173|P2|Overall Study|Lost to Follow-up|16
42125|NCT01641861|180174|P1|Overall Study|Lost to Follow-up|21
42126|NCT01641822|180195|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
42127|NCT01641822|180196|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
42128|NCT01641822|180197|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
42129|NCT01641822|180195|P3|Comparative Phase|Withdrew consent|7
42130|NCT01641822|180196|P2|Comparative Phase|Withdrew consent|3
42131|NCT01641822|180197|P1|Comparative Phase|Withdrew consent|0
42132|NCT01641822|180195|P3|Comparative Phase|Adverse event, serious fatal|0
42133|NCT01641822|180196|P2|Comparative Phase|Adverse event, serious fatal|1
42134|NCT01641822|180197|P1|Comparative Phase|Adverse event, serious fatal|0
42135|NCT01641822|180195|P3|Comparative Phase|Pregnancy|1
42136|NCT01641822|180196|P2|Comparative Phase|Pregnancy|0
42137|NCT01641822|180197|P1|Comparative Phase|Pregnancy|0
42138|NCT01641822|180195|P3|Comparative Phase|Investigator's discretion|1
42139|NCT01641822|180196|P2|Comparative Phase|Investigator's discretion|0
42140|NCT01641822|180197|P1|Comparative Phase|Investigator's discretion|0
42141|NCT01641822|180195|P3|Comparative Phase|Noncompliance with study drug|0
42142|NCT01641822|180196|P2|Comparative Phase|Noncompliance with study drug|1
42143|NCT01641822|180197|P1|Comparative Phase|Noncompliance with study drug|0
42144|NCT01641822|180195|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
42145|NCT01641822|180196|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
42146|NCT01641822|180197|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
42147|NCT01641822|180195|P3|Run-in Phase|Withdrew consent|0
42148|NCT01641822|180196|P2|Run-in Phase|Withdrew consent|0
42149|NCT01641822|180197|P1|Run-in Phase|Withdrew consent|1
42150|NCT01641822|180195|P3|Run-in Phase|Adverse Event|0
42151|NCT01641822|180196|P2|Run-in Phase|Adverse Event|0
42152|NCT01641822|180197|P1|Run-in Phase|Adverse Event|3
42153|NCT01641822|180195|P3|Run-in Phase|Noncompliance with study drug|0
42154|NCT01641822|180196|P2|Run-in Phase|Noncompliance with study drug|0
42155|NCT01641822|180197|P1|Run-in Phase|Noncompliance with study drug|1
42156|NCT01641692|180214|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
42157|NCT01641692|180215|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
42158|NCT01641692|180216|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
42159|NCT01641692|180217|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
42160|NCT01641692|180218|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
42161|NCT01641692|180219|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
42162|NCT01641692|180220|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
42163|NCT01641692|180221|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
42164|NCT01641692|180214|P8|Washout Period 3 or Follow-up|Protocol Violation|0
42165|NCT01641692|180215|P7|Washout Period 3 or Follow-up|Protocol Violation|0
42166|NCT01641692|180216|P6|Washout Period 3 or Follow-up|Protocol Violation|1
42167|NCT01641692|180217|P5|Washout Period 3 or Follow-up|Protocol Violation|0
42168|NCT01641692|180218|P4|Washout Period 3 or Follow-up|Protocol Violation|0
42169|NCT01641692|180219|P3|Washout Period 3 or Follow-up|Protocol Violation|0
42170|NCT01641692|180220|P2|Washout Period 3 or Follow-up|Protocol Violation|0
42171|NCT01641692|180221|P1|Washout Period 3 or Follow-up|Protocol Violation|0
42172|NCT01641692|180214|P8|Treatment Period 3|Lost to Follow-up|0
42173|NCT01641692|180215|P7|Treatment Period 3|Lost to Follow-up|0
42174|NCT01641692|180216|P6|Treatment Period 3|Lost to Follow-up|0
42175|NCT01641692|180217|P5|Treatment Period 3|Lost to Follow-up|0
42176|NCT01641692|180218|P4|Treatment Period 3|Lost to Follow-up|0
42177|NCT01641692|180219|P3|Treatment Period 3|Lost to Follow-up|0
42178|NCT01641692|180220|P2|Treatment Period 3|Lost to Follow-up|1
42179|NCT01641692|180221|P1|Treatment Period 3|Lost to Follow-up|0
42180|NCT01641692|180214|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
42181|NCT01641692|180215|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
42182|NCT01641692|180216|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
42183|NCT01641692|180217|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
42184|NCT01641692|180218|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
42185|NCT01641692|180219|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
42186|NCT01641692|180220|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
42187|NCT01641692|180221|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
42188|NCT01641692|180214|P8|Treatment Period 3|Protocol Violation|0
42189|NCT01641692|180215|P7|Treatment Period 3|Protocol Violation|0
42190|NCT01641692|180216|P6|Treatment Period 3|Protocol Violation|0
42191|NCT01641692|180217|P5|Treatment Period 3|Protocol Violation|0
42192|NCT01641692|180218|P4|Treatment Period 3|Protocol Violation|0
42193|NCT01641692|180219|P3|Treatment Period 3|Protocol Violation|1
42194|NCT01641692|180220|P2|Treatment Period 3|Protocol Violation|0
42195|NCT01641692|180221|P1|Treatment Period 3|Protocol Violation|0
42196|NCT01641692|180214|P8|Treatment Period 3|Adverse Event|0
42197|NCT01641692|180215|P7|Treatment Period 3|Adverse Event|1
42198|NCT01641692|180216|P6|Treatment Period 3|Adverse Event|0
42199|NCT01641692|180217|P5|Treatment Period 3|Adverse Event|0
42200|NCT01641692|180218|P4|Treatment Period 3|Adverse Event|0
42201|NCT01641692|180219|P3|Treatment Period 3|Adverse Event|0
42202|NCT01641692|180220|P2|Treatment Period 3|Adverse Event|0
42203|NCT01641692|180221|P1|Treatment Period 3|Adverse Event|0
42204|NCT01641692|180214|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
42205|NCT01641692|180215|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
42206|NCT01641692|180216|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
42207|NCT01641692|180217|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
42208|NCT01641692|180218|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
42209|NCT01641692|180219|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
42210|NCT01641692|180220|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
42211|NCT01641692|180221|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
42212|NCT01641692|180214|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
42213|NCT01641692|180215|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
42214|NCT01641692|180216|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
42215|NCT01641692|180217|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
42216|NCT01641692|180218|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
42217|NCT01641692|180219|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
42218|NCT01641692|180220|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
42219|NCT01641692|180221|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
42220|NCT01641692|180214|P8|Treatment Period 2|Withdrawal by Subject|1
42221|NCT01641692|180215|P7|Treatment Period 2|Withdrawal by Subject|0
42222|NCT01641692|180216|P6|Treatment Period 2|Withdrawal by Subject|1
42223|NCT01641692|180217|P5|Treatment Period 2|Withdrawal by Subject|0
42224|NCT01641692|180218|P4|Treatment Period 2|Withdrawal by Subject|0
42225|NCT01641692|180219|P3|Treatment Period 2|Withdrawal by Subject|0
42226|NCT01641692|180220|P2|Treatment Period 2|Withdrawal by Subject|0
42227|NCT01641692|180221|P1|Treatment Period 2|Withdrawal by Subject|1
42228|NCT01641692|180214|P8|Treatment Period 2|Lost to Follow-up|0
42229|NCT01641692|180215|P7|Treatment Period 2|Lost to Follow-up|0
42230|NCT01641692|180216|P6|Treatment Period 2|Lost to Follow-up|1
42231|NCT01641692|180217|P5|Treatment Period 2|Lost to Follow-up|0
42232|NCT01641692|180218|P4|Treatment Period 2|Lost to Follow-up|0
42233|NCT01641692|180219|P3|Treatment Period 2|Lost to Follow-up|0
42234|NCT01641692|180220|P2|Treatment Period 2|Lost to Follow-up|0
42235|NCT01641692|180221|P1|Treatment Period 2|Lost to Follow-up|0
42236|NCT01641692|180214|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
42237|NCT01641692|180215|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
42238|NCT01641692|180216|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
42239|NCT01641692|180217|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
42240|NCT01641692|180218|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
42241|NCT01641692|180219|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
42242|NCT01641692|180220|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
42243|NCT01641692|180221|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
42244|NCT01641692|180214|P8|Treatment Period 2|Lack of Efficacy|0
42245|NCT01641692|180215|P7|Treatment Period 2|Lack of Efficacy|0
42246|NCT01641692|180216|P6|Treatment Period 2|Lack of Efficacy|0
42247|NCT01641692|180217|P5|Treatment Period 2|Lack of Efficacy|0
42248|NCT01641692|180218|P4|Treatment Period 2|Lack of Efficacy|0
42249|NCT01641692|180219|P3|Treatment Period 2|Lack of Efficacy|0
42250|NCT01641692|180220|P2|Treatment Period 2|Lack of Efficacy|0
42251|NCT01641692|180221|P1|Treatment Period 2|Lack of Efficacy|1
42252|NCT01641692|180214|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
42253|NCT01641692|180215|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
42254|NCT01641692|180216|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
42255|NCT01641692|180217|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
42256|NCT01641692|180218|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
42257|NCT01641692|180219|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
42258|NCT01641692|180220|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
42259|NCT01641692|180221|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
42260|NCT01641692|180214|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
42261|NCT01641692|180215|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
42262|NCT01641692|180216|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
42263|NCT01641692|180217|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
42264|NCT01641692|180218|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
42265|NCT01641692|180219|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
42266|NCT01641692|180220|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
42267|NCT01641692|180221|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
42268|NCT01641692|180214|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
42269|NCT01641692|180215|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
42270|NCT01641692|180216|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
42271|NCT01641692|180217|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
42272|NCT01641692|180218|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
42273|NCT01641692|180219|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
42274|NCT01641692|180220|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
42275|NCT01641692|180221|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
42276|NCT01641692|180214|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
42277|NCT01641692|180215|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
42278|NCT01641692|180216|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
42279|NCT01641692|180217|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
42280|NCT01641692|180218|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
42281|NCT01641692|180219|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
42282|NCT01641692|180220|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
42283|NCT01641692|180221|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
42284|NCT01641692|180214|P8|Treatment Period 1|Withdrawal by Subject|1
42285|NCT01641692|180215|P7|Treatment Period 1|Withdrawal by Subject|0
42286|NCT01641692|180216|P6|Treatment Period 1|Withdrawal by Subject|2
42287|NCT01641692|180217|P5|Treatment Period 1|Withdrawal by Subject|0
42288|NCT01641692|180218|P4|Treatment Period 1|Withdrawal by Subject|0
42289|NCT01641692|180219|P3|Treatment Period 1|Withdrawal by Subject|0
42290|NCT01641692|180220|P2|Treatment Period 1|Withdrawal by Subject|0
42291|NCT01641692|180221|P1|Treatment Period 1|Withdrawal by Subject|0
42292|NCT01641692|180214|P8|Treatment Period 1|Physician Decision|0
42293|NCT01641692|180215|P7|Treatment Period 1|Physician Decision|0
42294|NCT01641692|180216|P6|Treatment Period 1|Physician Decision|0
42295|NCT01641692|180217|P5|Treatment Period 1|Physician Decision|1
42296|NCT01641692|180218|P4|Treatment Period 1|Physician Decision|0
42297|NCT01641692|180219|P3|Treatment Period 1|Physician Decision|0
42298|NCT01641692|180220|P2|Treatment Period 1|Physician Decision|0
42299|NCT01641692|180221|P1|Treatment Period 1|Physician Decision|0
42300|NCT01641692|180214|P8|Treatment Period 1|Lost to Follow-up|0
42301|NCT01641692|180215|P7|Treatment Period 1|Lost to Follow-up|0
42302|NCT01641692|180216|P6|Treatment Period 1|Lost to Follow-up|0
42303|NCT01641692|180217|P5|Treatment Period 1|Lost to Follow-up|0
42304|NCT01641692|180218|P4|Treatment Period 1|Lost to Follow-up|0
42305|NCT01641692|180219|P3|Treatment Period 1|Lost to Follow-up|1
42306|NCT01641692|180220|P2|Treatment Period 1|Lost to Follow-up|0
42307|NCT01641692|180221|P1|Treatment Period 1|Lost to Follow-up|0
42308|NCT01641692|180214|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
42309|NCT01641692|180215|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
42310|NCT01641692|180216|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
42311|NCT01641692|180217|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
42312|NCT01641692|180218|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
42313|NCT01641692|180219|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
42314|NCT01641692|180220|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
42315|NCT01641692|180221|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
42316|NCT01641692|180214|P8|Treatment Period 1|Protocol Violation|0
42317|NCT01641692|180215|P7|Treatment Period 1|Protocol Violation|0
42318|NCT01641692|180216|P6|Treatment Period 1|Protocol Violation|0
42319|NCT01641692|180217|P5|Treatment Period 1|Protocol Violation|2
42320|NCT01641692|180218|P4|Treatment Period 1|Protocol Violation|0
42321|NCT01641692|180219|P3|Treatment Period 1|Protocol Violation|0
42322|NCT01641692|180220|P2|Treatment Period 1|Protocol Violation|0
42323|NCT01641692|180221|P1|Treatment Period 1|Protocol Violation|1
42324|NCT01641692|180214|P8|Treatment Period 1|Lack of Efficacy|1
42325|NCT01641692|180215|P7|Treatment Period 1|Lack of Efficacy|0
42326|NCT01641692|180216|P6|Treatment Period 1|Lack of Efficacy|0
42327|NCT01641692|180217|P5|Treatment Period 1|Lack of Efficacy|0
42328|NCT01641692|180218|P4|Treatment Period 1|Lack of Efficacy|0
42329|NCT01641692|180219|P3|Treatment Period 1|Lack of Efficacy|0
42330|NCT01641692|180220|P2|Treatment Period 1|Lack of Efficacy|0
42331|NCT01641692|180221|P1|Treatment Period 1|Lack of Efficacy|0
42332|NCT01641692|180214|P8|Treatment Period 1|Adverse Event|0
42333|NCT01641692|180215|P7|Treatment Period 1|Adverse Event|0
42334|NCT01641692|180216|P6|Treatment Period 1|Adverse Event|0
42335|NCT01641692|180217|P5|Treatment Period 1|Adverse Event|0
42336|NCT01641692|180218|P4|Treatment Period 1|Adverse Event|0
42337|NCT01641692|180219|P3|Treatment Period 1|Adverse Event|0
42338|NCT01641692|180220|P2|Treatment Period 1|Adverse Event|0
42339|NCT01641692|180221|P1|Treatment Period 1|Adverse Event|1
42340|NCT01641640|180421|P1|Overall Study|Adverse Event|1
42341|NCT01641640|180421|P1|Overall Study|Withdrawal by Subject|2
42342|NCT01641640|180421|P1|Overall Study|Lost to Follow-up|3
42343|NCT01641640|180421|P1|Overall Study|Efficacy failure|29
42344|NCT01641640|180421|P1|Overall Study|Enrolled but not treated|1
42345|NCT01641471|180432|P2|Overall Study|Protocol Violation|4
42346|NCT01641471|180433|P1|Overall Study|Protocol Violation|2
42347|NCT01641471|180432|P2|Overall Study|Lost to Follow-up|4
42348|NCT01641471|180433|P1|Overall Study|Lost to Follow-up|2
42349|NCT01641471|180432|P2|Overall Study|Withdrawal by Subject|19
42350|NCT01641471|180433|P1|Overall Study|Withdrawal by Subject|19
42351|NCT01641367|180451|P6|Overall Study|Lost to Follow-up|0
42352|NCT01641367|180452|P5|Overall Study|Lost to Follow-up|2
42353|NCT01641367|180453|P4|Overall Study|Lost to Follow-up|0
42354|NCT01641367|180454|P3|Overall Study|Lost to Follow-up|2
42355|NCT01641367|180455|P2|Overall Study|Lost to Follow-up|0
42356|NCT01641367|180456|P1|Overall Study|Lost to Follow-up|16
42357|NCT01641367|180451|P6|Overall Study|Death|1
42358|NCT01641367|180452|P5|Overall Study|Death|1
42359|NCT01641367|180453|P4|Overall Study|Death|0
42360|NCT01641367|180454|P3|Overall Study|Death|2
42361|NCT01641367|180455|P2|Overall Study|Death|1
42362|NCT01641367|180456|P1|Overall Study|Death|18
42363|NCT01641237|180471|P4|Period III|Lost to Follow-up|0
42364|NCT01641237|180472|P3|Period III|Lost to Follow-up|0
42365|NCT01641237|180473|P2|Period III|Lost to Follow-up|0
42366|NCT01641237|180474|P1|Period III|Lost to Follow-up|1
42367|NCT01641237|180471|P4|Period II|Withdrawal by Subject|0
42368|NCT01641237|180472|P3|Period II|Withdrawal by Subject|0
42369|NCT01641237|180473|P2|Period II|Withdrawal by Subject|0
42370|NCT01641237|180474|P1|Period II|Withdrawal by Subject|1
42371|NCT01641159|180498|P2|Overall Study|Withdrawal by Subject|1
42372|NCT01641159|180499|P1|Overall Study|Withdrawal by Subject|0
42373|NCT01641159|180498|P2|Overall Study|Lost to Follow-up|1
42374|NCT01641159|180499|P1|Overall Study|Lost to Follow-up|2
42375|NCT01641133|180510|P3|Overall Study|Lost to Follow-up|2
42376|NCT01641133|180511|P2|Overall Study|Lost to Follow-up|2
42377|NCT01641133|180512|P1|Overall Study|Lost to Follow-up|0
42378|NCT01641133|180510|P3|Overall Study|Withdrawal by Subject|3
42379|NCT01641133|180511|P2|Overall Study|Withdrawal by Subject|3
42380|NCT01641133|180512|P1|Overall Study|Withdrawal by Subject|5
42381|NCT01641133|180510|P3|Overall Study|Adverse Event|1
42382|NCT01641133|180511|P2|Overall Study|Adverse Event|0
42383|NCT01641133|180512|P1|Overall Study|Adverse Event|0
42384|NCT01641133|180510|P3|Overall Study|Migrated/moved from study area|1
42385|NCT01641133|180511|P2|Overall Study|Migrated/moved from study area|3
42386|NCT01641133|180512|P1|Overall Study|Migrated/moved from study area|5
42387|NCT01641133|180510|P3|Overall Study|Protocol Violation|1
42388|NCT01641133|180511|P2|Overall Study|Protocol Violation|1
42389|NCT01641133|180512|P1|Overall Study|Protocol Violation|0
42390|NCT01641081|180562|P10|Period 5|Adverse Event|0
42391|NCT01641081|180563|P9|Period 5|Adverse Event|0
42392|NCT01641081|180564|P8|Period 5|Adverse Event|0
42393|NCT01641081|180565|P7|Period 5|Adverse Event|0
42394|NCT01641081|180566|P6|Period 5|Adverse Event|0
42395|NCT01641081|180567|P5|Period 5|Adverse Event|0
42396|NCT01641081|180568|P4|Period 5|Adverse Event|0
42397|NCT01641081|180569|P3|Period 5|Adverse Event|2
42398|NCT01641081|180570|P2|Period 5|Adverse Event|0
42399|NCT01641081|180571|P1|Period 5|Adverse Event|0
42400|NCT01641081|180562|P10|Period 4|Adverse Event|0
42401|NCT01641081|180563|P9|Period 4|Adverse Event|0
42402|NCT01641081|180564|P8|Period 4|Adverse Event|0
42403|NCT01641081|180565|P7|Period 4|Adverse Event|0
42404|NCT01641081|180566|P6|Period 4|Adverse Event|0
42405|NCT01641081|180567|P5|Period 4|Adverse Event|0
42406|NCT01641081|180568|P4|Period 4|Adverse Event|1
42407|NCT01641081|180569|P3|Period 4|Adverse Event|0
42408|NCT01641081|180570|P2|Period 4|Adverse Event|1
42409|NCT01641081|180571|P1|Period 4|Adverse Event|0
42410|NCT01641081|180562|P10|Period 3|Withdrawal by Subject|0
42411|NCT01641081|180563|P9|Period 3|Withdrawal by Subject|1
42412|NCT01641081|180564|P8|Period 3|Withdrawal by Subject|0
42413|NCT01641081|180565|P7|Period 3|Withdrawal by Subject|0
42414|NCT01641081|180566|P6|Period 3|Withdrawal by Subject|0
42415|NCT01641081|180567|P5|Period 3|Withdrawal by Subject|0
42416|NCT01641081|180568|P4|Period 3|Withdrawal by Subject|0
42417|NCT01641081|180569|P3|Period 3|Withdrawal by Subject|0
42418|NCT01641081|180570|P2|Period 3|Withdrawal by Subject|0
42419|NCT01641081|180571|P1|Period 3|Withdrawal by Subject|0
42420|NCT01641081|180562|P10|Period 3|Adverse Event|0
42421|NCT01641081|180563|P9|Period 3|Adverse Event|0
42422|NCT01641081|180564|P8|Period 3|Adverse Event|0
42423|NCT01641081|180565|P7|Period 3|Adverse Event|0
42424|NCT01641081|180566|P6|Period 3|Adverse Event|0
42425|NCT01641081|180567|P5|Period 3|Adverse Event|0
42426|NCT01641081|180568|P4|Period 3|Adverse Event|0
42427|NCT01641081|180569|P3|Period 3|Adverse Event|1
42428|NCT01641081|180570|P2|Period 3|Adverse Event|0
42429|NCT01641081|180571|P1|Period 3|Adverse Event|0
42430|NCT01641081|180562|P10|Period 2|Protocol Violation|0
42431|NCT01641081|180563|P9|Period 2|Protocol Violation|0
42432|NCT01641081|180564|P8|Period 2|Protocol Violation|0
42433|NCT01641081|180565|P7|Period 2|Protocol Violation|0
42434|NCT01641081|180566|P6|Period 2|Protocol Violation|0
42435|NCT01641081|180567|P5|Period 2|Protocol Violation|0
42436|NCT01641081|180568|P4|Period 2|Protocol Violation|0
42437|NCT01641081|180569|P3|Period 2|Protocol Violation|0
42438|NCT01641081|180570|P2|Period 2|Protocol Violation|0
42439|NCT01641081|180571|P1|Period 2|Protocol Violation|1
42440|NCT01641081|180562|P10|Period 2|Withdrawal by Subject|0
42441|NCT01641081|180563|P9|Period 2|Withdrawal by Subject|0
42442|NCT01641081|180564|P8|Period 2|Withdrawal by Subject|0
42443|NCT01641081|180565|P7|Period 2|Withdrawal by Subject|2
42444|NCT01641081|180566|P6|Period 2|Withdrawal by Subject|0
42445|NCT01641081|180567|P5|Period 2|Withdrawal by Subject|0
42446|NCT01641081|180568|P4|Period 2|Withdrawal by Subject|1
42447|NCT01641081|180569|P3|Period 2|Withdrawal by Subject|0
42448|NCT01641081|180570|P2|Period 2|Withdrawal by Subject|0
42449|NCT01641081|180571|P1|Period 2|Withdrawal by Subject|0
42450|NCT01641081|180562|P10|Period 2|Adverse Event|0
42451|NCT01641081|180563|P9|Period 2|Adverse Event|0
42452|NCT01641081|180564|P8|Period 2|Adverse Event|0
42453|NCT01641081|180565|P7|Period 2|Adverse Event|0
42454|NCT01641081|180566|P6|Period 2|Adverse Event|1
42455|NCT01641081|180567|P5|Period 2|Adverse Event|0
42456|NCT01641081|180568|P4|Period 2|Adverse Event|0
42457|NCT01641081|180569|P3|Period 2|Adverse Event|0
42458|NCT01641081|180570|P2|Period 2|Adverse Event|0
42459|NCT01641081|180571|P1|Period 2|Adverse Event|0
42460|NCT01641081|180562|P10|Period 1|Adverse Event|0
42461|NCT01641081|180563|P9|Period 1|Adverse Event|0
42462|NCT01641081|180564|P8|Period 1|Adverse Event|2
42463|NCT01641081|180565|P7|Period 1|Adverse Event|0
42464|NCT01641081|180566|P6|Period 1|Adverse Event|0
42465|NCT01641081|180567|P5|Period 1|Adverse Event|0
42466|NCT01641081|180568|P4|Period 1|Adverse Event|0
42467|NCT01641081|180569|P3|Period 1|Adverse Event|0
42468|NCT01641081|180570|P2|Period 1|Adverse Event|0
42469|NCT01641081|180571|P1|Period 1|Adverse Event|1
42470|NCT01641081|180562|P10|Period 1|Protocol Violation|0
42471|NCT01641081|180563|P9|Period 1|Protocol Violation|0
42472|NCT01641081|180564|P8|Period 1|Protocol Violation|1
42473|NCT01641081|180565|P7|Period 1|Protocol Violation|0
42474|NCT01641081|180566|P6|Period 1|Protocol Violation|0
42475|NCT01641081|180567|P5|Period 1|Protocol Violation|1
42476|NCT01641081|180568|P4|Period 1|Protocol Violation|0
42477|NCT01641081|180569|P3|Period 1|Protocol Violation|0
42478|NCT01641081|180570|P2|Period 1|Protocol Violation|0
42479|NCT01641081|180571|P1|Period 1|Protocol Violation|0
42480|NCT01641081|180562|P10|Period 1|Sponsor request (potential unblinding)|0
42481|NCT01641081|180563|P9|Period 1|Sponsor request (potential unblinding)|0
42482|NCT01641081|180564|P8|Period 1|Sponsor request (potential unblinding)|0
42483|NCT01641081|180565|P7|Period 1|Sponsor request (potential unblinding)|1
42484|NCT01641081|180566|P6|Period 1|Sponsor request (potential unblinding)|0
42485|NCT01641081|180567|P5|Period 1|Sponsor request (potential unblinding)|0
42486|NCT01641081|180568|P4|Period 1|Sponsor request (potential unblinding)|0
42487|NCT01641081|180569|P3|Period 1|Sponsor request (potential unblinding)|0
42488|NCT01641081|180570|P2|Period 1|Sponsor request (potential unblinding)|0
42489|NCT01641081|180571|P1|Period 1|Sponsor request (potential unblinding)|0
42490|NCT01640964|180640|P3|Overall Study|Protocol Deviation|2
42491|NCT01640964|180641|P2|Overall Study|Protocol Deviation|1
42492|NCT01640964|180642|P1|Overall Study|Protocol Deviation|1
42493|NCT01640964|180640|P3|Overall Study|Lost to Follow-up|1
42494|NCT01640964|180641|P2|Overall Study|Lost to Follow-up|0
42495|NCT01640964|180642|P1|Overall Study|Lost to Follow-up|0
42496|NCT01640951|180665|P8|Overall Study|Death|2
42497|NCT01640951|180666|P7|Overall Study|Death|0
42498|NCT01640951|180667|P6|Overall Study|Death|0
42499|NCT01640951|180668|P5|Overall Study|Death|0
42500|NCT01640951|180669|P4|Overall Study|Death|0
42501|NCT01640951|180670|P3|Overall Study|Death|1
42502|NCT01640951|180671|P2|Overall Study|Death|1
42503|NCT01640951|180672|P1|Overall Study|Death|0
42504|NCT01640951|180665|P8|Overall Study|Subject/Guardian decision|4
42505|NCT01640951|180666|P7|Overall Study|Subject/Guardian decision|5
42506|NCT01640951|180667|P6|Overall Study|Subject/Guardian decision|19
42507|NCT01640951|180668|P5|Overall Study|Subject/Guardian decision|7
42508|NCT01640951|180669|P4|Overall Study|Subject/Guardian decision|15
42509|NCT01640951|180670|P3|Overall Study|Subject/Guardian decision|13
42510|NCT01640951|180671|P2|Overall Study|Subject/Guardian decision|4
42511|NCT01640951|180672|P1|Overall Study|Subject/Guardian decision|12
42512|NCT01640951|180665|P8|Overall Study|Protocol Deviation|0
42513|NCT01640951|180666|P7|Overall Study|Protocol Deviation|0
42514|NCT01640951|180667|P6|Overall Study|Protocol Deviation|1
42515|NCT01640951|180668|P5|Overall Study|Protocol Deviation|0
42516|NCT01640951|180669|P4|Overall Study|Protocol Deviation|1
42517|NCT01640951|180670|P3|Overall Study|Protocol Deviation|2
42518|NCT01640951|180671|P2|Overall Study|Protocol Deviation|1
42519|NCT01640951|180672|P1|Overall Study|Protocol Deviation|0
42520|NCT01640951|180665|P8|Overall Study|Pregnancy|0
42521|NCT01640951|180666|P7|Overall Study|Pregnancy|2
42522|NCT01640951|180667|P6|Overall Study|Pregnancy|0
42523|NCT01640951|180668|P5|Overall Study|Pregnancy|0
42524|NCT01640951|180669|P4|Overall Study|Pregnancy|4
42525|NCT01640951|180670|P3|Overall Study|Pregnancy|0
42526|NCT01640951|180671|P2|Overall Study|Pregnancy|0
42527|NCT01640951|180672|P1|Overall Study|Pregnancy|3
42528|NCT01640951|180665|P8|Overall Study|Physician Decision|0
42529|NCT01640951|180666|P7|Overall Study|Physician Decision|3
42530|NCT01640951|180667|P6|Overall Study|Physician Decision|3
42531|NCT01640951|180668|P5|Overall Study|Physician Decision|2
42532|NCT01640951|180669|P4|Overall Study|Physician Decision|2
42533|NCT01640951|180670|P3|Overall Study|Physician Decision|2
42534|NCT01640951|180671|P2|Overall Study|Physician Decision|5
42535|NCT01640951|180672|P1|Overall Study|Physician Decision|2
42536|NCT01640951|180665|P8|Overall Study|Non-compliance with study treatment|0
42537|NCT01640951|180666|P7|Overall Study|Non-compliance with study treatment|1
42538|NCT01640951|180667|P6|Overall Study|Non-compliance with study treatment|4
42539|NCT01640951|180668|P5|Overall Study|Non-compliance with study treatment|1
42540|NCT01640951|180669|P4|Overall Study|Non-compliance with study treatment|1
42541|NCT01640951|180670|P3|Overall Study|Non-compliance with study treatment|1
42542|NCT01640951|180671|P2|Overall Study|Non-compliance with study treatment|0
42543|NCT01640951|180672|P1|Overall Study|Non-compliance with study treatment|0
42544|NCT01640951|180665|P8|Overall Study|Lost to Follow-up|1
42545|NCT01640951|180666|P7|Overall Study|Lost to Follow-up|1
42546|NCT01640951|180667|P6|Overall Study|Lost to Follow-up|3
42547|NCT01640951|180668|P5|Overall Study|Lost to Follow-up|2
42548|NCT01640951|180669|P4|Overall Study|Lost to Follow-up|2
42549|NCT01640951|180670|P3|Overall Study|Lost to Follow-up|6
42550|NCT01640951|180671|P2|Overall Study|Lost to Follow-up|0
42551|NCT01640951|180672|P1|Overall Study|Lost to Follow-up|1
42552|NCT01640951|180665|P8|Overall Study|Lack of Efficacy|6
42553|NCT01640951|180666|P7|Overall Study|Lack of Efficacy|5
42554|NCT01640951|180667|P6|Overall Study|Lack of Efficacy|6
42555|NCT01640951|180668|P5|Overall Study|Lack of Efficacy|0
42556|NCT01640951|180669|P4|Overall Study|Lack of Efficacy|14
42557|NCT01640951|180670|P3|Overall Study|Lack of Efficacy|7
42558|NCT01640951|180671|P2|Overall Study|Lack of Efficacy|1
42559|NCT01640951|180672|P1|Overall Study|Lack of Efficacy|20
42560|NCT01640951|180665|P8|Overall Study|Adverse Event|3
42561|NCT01640951|180666|P7|Overall Study|Adverse Event|1
42562|NCT01640951|180667|P6|Overall Study|Adverse Event|11
42563|NCT01640951|180668|P5|Overall Study|Adverse Event|1
42564|NCT01640951|180669|P4|Overall Study|Adverse Event|6
42565|NCT01640951|180670|P3|Overall Study|Adverse Event|10
42566|NCT01640951|180671|P2|Overall Study|Adverse Event|3
42567|NCT01640951|180672|P1|Overall Study|Adverse Event|8
42568|NCT01640925|180774|P2|Overall Study|Previously enrolled in this trial|11
42569|NCT01640925|180775|P1|Overall Study|Previously enrolled in this trial|13
42570|NCT01640925|180774|P2|Overall Study|Withdrawal by Subject|0
42571|NCT01640925|180775|P1|Overall Study|Withdrawal by Subject|1
42572|NCT01640353|180812|P1|Overall Study|Physician Decision|1
42573|NCT01640353|180812|P1|Overall Study|Lost to Follow-up|12
42574|NCT01640353|180812|P1|Overall Study|Early site termination|3
42575|NCT01640353|180812|P1|Overall Study|Death|2
42576|NCT01640353|180812|P1|Overall Study|Withdrawal by Subject|5
42577|NCT01640353|180812|P1|Overall Study|Withdrawn from analysis at term site|12
42578|NCT01640353|180812|P1|Overall Study|Withdrew prior to treatment|10
42579|NCT01640314|180860|P2|Overall Study|Protocol Violation|1
42580|NCT01640314|180861|P1|Overall Study|Protocol Violation|0
42581|NCT01640184|180899|P3|Overall Study|Protocol Violation|1
42582|NCT01640184|180900|P2|Overall Study|Protocol Violation|0
42583|NCT01640184|180901|P1|Overall Study|Protocol Violation|0
42584|NCT01640184|180899|P3|Overall Study|Withdrawal by Subject|1
42585|NCT01640184|180900|P2|Overall Study|Withdrawal by Subject|1
42586|NCT01640184|180901|P1|Overall Study|Withdrawal by Subject|0
42587|NCT01640184|180899|P3|Overall Study|Physician Decision|0
42588|NCT01640184|180900|P2|Overall Study|Physician Decision|0
42589|NCT01640184|180901|P1|Overall Study|Physician Decision|3
42590|NCT01640184|180899|P3|Overall Study|Lost to Follow-up|0
42591|NCT01640184|180900|P2|Overall Study|Lost to Follow-up|1
42592|NCT01640184|180901|P1|Overall Study|Lost to Follow-up|4
42593|NCT01640184|180899|P3|Overall Study|Death|0
42594|NCT01640184|180900|P2|Overall Study|Death|0
42595|NCT01640184|180901|P1|Overall Study|Death|1
42596|NCT01640054|180930|P1|Overall Study|Adverse Event|2
42597|NCT01640054|180930|P1|Overall Study|Lack of Efficacy|3
42598|NCT01640054|180930|P1|Overall Study|Study-specific disc criteria|1
42599|NCT01639833|180940|P2|Overall Study|Withdrawal by Subject|2
42600|NCT01639833|180941|P1|Overall Study|Withdrawal by Subject|2
42601|NCT01639833|180940|P2|Overall Study|Death|2
42602|NCT01639833|180941|P1|Overall Study|Death|4
42603|NCT01639755|180949|P1|Overall Study|Patient had device explantation|4
42604|NCT01639755|180949|P1|Overall Study|Study Ongoing|15
42605|NCT01639742|180957|P1|Overall Study|Lost to Follow-up|1
42606|NCT01639742|180957|P1|Overall Study|Study Ongoing|17
42607|NCT01639729|180965|P6|Overall Study|Withdrawal by Subject|0
42608|NCT01639729|180966|P5|Overall Study|Withdrawal by Subject|0
42609|NCT01639729|180967|P4|Overall Study|Withdrawal by Subject|1
42610|NCT01639729|180968|P3|Overall Study|Withdrawal by Subject|1
42611|NCT01639729|180969|P2|Overall Study|Withdrawal by Subject|0
42612|NCT01639729|180970|P1|Overall Study|Withdrawal by Subject|1
42613|NCT01639703|180992|P1|Overall Study|Other reason|7
42614|NCT01639703|180992|P1|Overall Study|Withdrawal by Subject|5
42615|NCT01639560|181035|P2|Overall Study|Adverse Event|2
42616|NCT01639560|181036|P1|Overall Study|Adverse Event|0
42617|NCT01639560|181035|P2|Overall Study|Lost to Follow-up|11
42618|NCT01639560|181036|P1|Overall Study|Lost to Follow-up|9
42619|NCT01639560|181035|P2|Overall Study|Lack of Efficacy|2
42620|NCT01639560|181036|P1|Overall Study|Lack of Efficacy|1
42621|NCT01639560|181035|P2|Overall Study|Withdrawal by Subject|14
42622|NCT01639560|181036|P1|Overall Study|Withdrawal by Subject|9
42623|NCT01639495|181048|P1|Overall Study|No radiofrequency energy applied|2
42624|NCT01639495|181048|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
42625|NCT01639495|181048|P1|Overall Study|Consented but didn’t have study catheter|4
42626|NCT01639495|181048|P1|Overall Study|Lost to Follow-up|6
42627|NCT01639469|181058|P2|Overall Study|Lost to Follow-up|1
42628|NCT01639469|181059|P1|Overall Study|Lost to Follow-up|1
42629|NCT01639469|181058|P2|Overall Study|Death|2
42630|NCT01639469|181059|P1|Overall Study|Death|4
42631|NCT01639144|181164|P2|Overall Study|Met postoperative exclusion criteria|3
42632|NCT01639144|181165|P1|Overall Study|Met postoperative exclusion criteria|4
42633|NCT01639144|181164|P2|Overall Study|Physician Decision|0
42634|NCT01639144|181165|P1|Overall Study|Physician Decision|2
42635|NCT01639144|181164|P2|Overall Study|Withdrawal by Subject|2
42636|NCT01639144|181165|P1|Overall Study|Withdrawal by Subject|4
42637|NCT01639040|181173|P2|Overall Study|Adverse Event|0
42638|NCT01639040|181174|P1|Overall Study|Adverse Event|1
42639|NCT01639001|181192|P2|Overall Study|Death|35
42640|NCT01639001|181193|P1|Overall Study|Death|35
42641|NCT01639001|181192|P2|Overall Study|Lost to Follow-up|0
42642|NCT01639001|181193|P1|Overall Study|Lost to Follow-up|1
42643|NCT01639001|181192|P2|Overall Study|Refused further follow-up|6
42644|NCT01639001|181193|P1|Overall Study|Refused further follow-up|3
42645|NCT01639001|181192|P2|Overall Study|Ongoing at date of cutoff|60
42646|NCT01639001|181193|P1|Overall Study|Ongoing at date of cutoff|65
42647|NCT01639001|181192|P2|Overall Study|Randomized but not treated|2
42648|NCT01639001|181193|P1|Overall Study|Randomized but not treated|0
42649|NCT01638546|181243|P2|Overall Study|Adverse Event|3
42650|NCT01638546|181244|P1|Overall Study|Adverse Event|1
42651|NCT01638000|181290|P2|Overall Study|Miscellaneous|2
42652|NCT01638000|181291|P1|Overall Study|Miscellaneous|2
42653|NCT01638000|181290|P2|Overall Study|Withdrawal by Subject|24
42654|NCT01638000|181291|P1|Overall Study|Withdrawal by Subject|21
42655|NCT01638000|181290|P2|Overall Study|Protocol Violation|13
42656|NCT01638000|181291|P1|Overall Study|Protocol Violation|11
42657|NCT01638000|181290|P2|Overall Study|Lack of Efficacy|6
42658|NCT01638000|181291|P1|Overall Study|Lack of Efficacy|5
42659|NCT01638000|181290|P2|Overall Study|Adverse Event|16
42660|NCT01638000|181291|P1|Overall Study|Adverse Event|14
42661|NCT01638000|181290|P2|Overall Study|Randomized but Never Received Drug|10
42662|NCT01638000|181291|P1|Overall Study|Randomized but Never Received Drug|7
42663|NCT01637961|181389|P1|Overall Study|Ineligible: inadequate pathology|1
42664|NCT01637961|181389|P1|Overall Study|Ineligible: wrong primary|1
42665|NCT01637922|181421|P2|Overall Study|Lost to Follow-up|0
42666|NCT01637922|181422|P1|Overall Study|Lost to Follow-up|2
42667|NCT01637922|181421|P2|Overall Study|Withdrawal by Subject|3
42668|NCT01637922|181422|P1|Overall Study|Withdrawal by Subject|0
42669|NCT01637922|181421|P2|Overall Study|Protocol Violation|1
42670|NCT01637922|181422|P1|Overall Study|Protocol Violation|0
42671|NCT01637922|181421|P2|Overall Study|Adverse Event|1
42672|NCT01637922|181422|P1|Overall Study|Adverse Event|0
42673|NCT01637584|181451|P2|Overall Study|Withdrawal by Subject|3
42674|NCT01637584|181452|P1|Overall Study|Withdrawal by Subject|1
42675|NCT01637272|181459|P1|Overall Study|Protocol Violation|2
42676|NCT01637272|181459|P1|Overall Study|Administrative problems|1
42677|NCT01637272|181459|P1|Overall Study|completed core, did not enter ext. phase|4
42678|NCT01637272|181459|P1|Overall Study|Lost to Follow-up|2
42679|NCT01637272|181459|P1|Overall Study|Withdrawal by Subject|3
42680|NCT01637272|181459|P1|Overall Study|Unsatisfactory therapeutic effect|2
42681|NCT01637272|181459|P1|Overall Study|Adverse Event|6
42682|NCT01637077|181539|P2|Overall Study|No cycle 1 questionnaire data|0
42683|NCT01637077|181540|P1|Overall Study|No cycle 1 questionnaire data|2
42684|NCT01637077|181539|P2|Overall Study|Withdrawal by Subject|0
42685|NCT01637077|181540|P1|Overall Study|Withdrawal by Subject|1
42686|NCT01637077|181539|P2|Overall Study|Cancel|1
42687|NCT01637077|181540|P1|Overall Study|Cancel|1
42688|NCT01636986|181568|P2|Overall Study|Corneal Staining|1
42689|NCT01636986|181569|P1|Overall Study|Corneal Staining|0
42690|NCT01636986|181568|P2|Overall Study|Withdrawal by Subject|1
42691|NCT01636986|181569|P1|Overall Study|Withdrawal by Subject|0
42692|NCT01636960|181575|P1|Maintenance Phase|Progressive disease|1
42693|NCT01636960|181575|P1|Maintenance Phase|Adverse Event|3
42694|NCT01636960|181575|P1|Maintenance Phase|Continued drug after regulatory approval|3
42695|NCT01636960|181575|P1|Induction Phase|Adverse Event|2
42696|NCT01636947|181583|P2|Overall Study|Did Not Meet Eligibility Criteria|4
42697|NCT01636947|181584|P1|Overall Study|Did Not Meet Eligibility Criteria|1
42698|NCT01636947|181583|P2|Overall Study|Adverse Event|1
42699|NCT01636947|181584|P1|Overall Study|Adverse Event|1
42700|NCT01636947|181583|P2|Overall Study|Withdrawal by Subject|3
42701|NCT01636947|181584|P1|Overall Study|Withdrawal by Subject|3
42702|NCT01636947|181583|P2|Overall Study|Protocol Violation|1
42703|NCT01636947|181584|P1|Overall Study|Protocol Violation|1
42704|NCT01636947|181583|P2|Overall Study|Lost to Follow-up|0
42705|NCT01636947|181584|P1|Overall Study|Lost to Follow-up|4
42706|NCT01636947|181583|P2|Overall Study|Not Treated|2
42707|NCT01636947|181584|P1|Overall Study|Not Treated|2
42708|NCT01636778|181608|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
42709|NCT01636778|181609|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
42710|NCT01636778|181610|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
42711|NCT01636778|181608|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
42712|NCT01636778|181609|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
42713|NCT01636778|181610|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
42714|NCT01636778|181608|P3|Follow-up Period After Part 2|Other|1
42715|NCT01636778|181609|P2|Follow-up Period After Part 2|Other|0
42716|NCT01636778|181610|P1|Follow-up Period After Part 2|Other|0
42717|NCT01636778|181608|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
42718|NCT01636778|181609|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
42719|NCT01636778|181610|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
42720|NCT01636778|181608|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
42721|NCT01636778|181609|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
42722|NCT01636778|181610|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
42723|NCT01636778|181608|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
42724|NCT01636778|181609|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
42725|NCT01636778|181610|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
42726|NCT01636778|181608|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
42727|NCT01636778|181609|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
42728|NCT01636778|181610|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
42815|NCT01634360|182057|P2|Overall Study|Adverse Event|34
42729|NCT01636778|181608|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
42730|NCT01636778|181609|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
42731|NCT01636778|181610|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
42732|NCT01636713|181681|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
42733|NCT01636713|181682|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
42734|NCT01636713|181683|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
42735|NCT01636713|181681|P3|Overall Study|Withdrawal by Subject|8
42736|NCT01636713|181682|P2|Overall Study|Withdrawal by Subject|4
42737|NCT01636713|181683|P1|Overall Study|Withdrawal by Subject|5
42738|NCT01636713|181681|P3|Overall Study|Lost to Follow-up|1
42739|NCT01636713|181682|P2|Overall Study|Lost to Follow-up|0
42740|NCT01636713|181683|P1|Overall Study|Lost to Follow-up|0
42741|NCT01636713|181681|P3|Overall Study|Protocol Violation|1
42742|NCT01636713|181682|P2|Overall Study|Protocol Violation|0
42743|NCT01636713|181683|P1|Overall Study|Protocol Violation|3
42744|NCT01636713|181681|P3|Overall Study|Lack of Efficacy|2
42745|NCT01636713|181682|P2|Overall Study|Lack of Efficacy|6
42746|NCT01636713|181683|P1|Overall Study|Lack of Efficacy|6
42747|NCT01636713|181681|P3|Overall Study|Adverse Event|7
42748|NCT01636713|181682|P2|Overall Study|Adverse Event|16
42749|NCT01636713|181683|P1|Overall Study|Adverse Event|16
42750|NCT01636362|181735|P1|Overall Study|Withdrawal by Subject|1
42751|NCT01636362|181735|P1|Overall Study|Subject healed, not returning|1
42752|NCT01636362|181735|P1|Overall Study|Physician Decision|6
42753|NCT01636258|181743|P2|Overall Study|Lost to Follow-up|0
42754|NCT01636258|181744|P1|Overall Study|Lost to Follow-up|1
42755|NCT01636076|181784|P2|Overall Study|Withdrawal by Subject|10
42756|NCT01636076|181785|P1|Overall Study|Withdrawal by Subject|7
42757|NCT01636076|181784|P2|Overall Study|Adverse Event|11
42758|NCT01636076|181785|P1|Overall Study|Adverse Event|6
42759|NCT01636076|181784|P2|Overall Study|Non-compliance with study treatment|1
42760|NCT01636076|181785|P1|Overall Study|Non-compliance with study treatment|1
42761|NCT01636076|181784|P2|Overall Study|Physician Decision|1
42762|NCT01636076|181785|P1|Overall Study|Physician Decision|1
42763|NCT01636076|181784|P2|Overall Study|Lost to Follow-up|0
42764|NCT01636076|181785|P1|Overall Study|Lost to Follow-up|1
42765|NCT01636076|181784|P2|Overall Study|Lack of Efficacy|1
42766|NCT01636076|181785|P1|Overall Study|Lack of Efficacy|0
42767|NCT01636076|181784|P2|Overall Study|Terminated by sponsor|1
42768|NCT01636076|181785|P1|Overall Study|Terminated by sponsor|1
42769|NCT01635933|181856|P2|Overall Study|No longer had transportation|1
42770|NCT01635933|181857|P1|Overall Study|No longer had transportation|0
42771|NCT01635933|181856|P2|Overall Study|Noncompliance|1
42772|NCT01635933|181857|P1|Overall Study|Noncompliance|0
42773|NCT01635933|181856|P2|Overall Study|Subject decision|1
42774|NCT01635933|181857|P1|Overall Study|Subject decision|1
42775|NCT01635933|181856|P2|Overall Study|Lost to Follow-up|5
42776|NCT01635933|181857|P1|Overall Study|Lost to Follow-up|0
42777|NCT01635933|181856|P2|Overall Study|Adverse Event|0
42778|NCT01635933|181857|P1|Overall Study|Adverse Event|1
42779|NCT01635920|181869|P2|Overall Study|Subject decision|0
42780|NCT01635920|181870|P1|Overall Study|Subject decision|2
42781|NCT01635920|181869|P2|Overall Study|Lost to Follow-up|1
42782|NCT01635920|181870|P1|Overall Study|Lost to Follow-up|0
42783|NCT01635920|181869|P2|Overall Study|Adverse Event|0
42784|NCT01635920|181870|P1|Overall Study|Adverse Event|1
42785|NCT01635855|181883|P1|Overall Study|Withdrawal by Subject|4
42786|NCT01635764|181892|P1|Overall Study|Not Specified|28
42787|NCT01635764|181892|P1|Overall Study|Lost to Follow-up|53
42788|NCT01635764|181892|P1|Overall Study|Withdrew Consent|67
42789|NCT01635764|181892|P1|Overall Study|Protocol Deviation|1
42790|NCT01635764|181892|P1|Overall Study|Exceed Protocol-specified Interventions|2
42791|NCT01635764|181892|P1|Overall Study|Lack of Efficacy|76
42792|NCT01635764|181892|P1|Overall Study|Adverse Event|46
42793|NCT01635218|181958|P3|Overall Study|Lost to Follow-up|6
42794|NCT01635218|181959|P2|Overall Study|Lost to Follow-up|7
42795|NCT01635218|181960|P1|Overall Study|Lost to Follow-up|3
42796|NCT01634854|181995|P2|Overall Study|Cesarean delivery|7
42797|NCT01634854|181996|P1|Overall Study|Cesarean delivery|2
42798|NCT01634659|182016|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
42799|NCT01634659|182017|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
42800|NCT01634659|182016|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
42801|NCT01634659|182017|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
42802|NCT01634555|182047|P1|Overall Study|Ongoing receiving treatment|13
42803|NCT01634555|182047|P1|Overall Study|Physician Decision|1
42804|NCT01634555|182047|P1|Overall Study|Adverse Event|3
42805|NCT01634360|182057|P2|Overall Study|Study termination by sponsor|44
42806|NCT01634360|182058|P1|Overall Study|Study termination by sponsor|18
42807|NCT01634360|182057|P2|Overall Study|Not specified|20
42808|NCT01634360|182058|P1|Overall Study|Not specified|3
42809|NCT01634360|182057|P2|Overall Study|Lack of Efficacy|14
42810|NCT01634360|182058|P1|Overall Study|Lack of Efficacy|4
42811|NCT01634360|182057|P2|Overall Study|Protocol Violation|1
42812|NCT01634360|182058|P1|Overall Study|Protocol Violation|1
42813|NCT01634360|182057|P2|Overall Study|subject withdrew consent|23
42814|NCT01634360|182058|P1|Overall Study|subject withdrew consent|13
42816|NCT01634360|182058|P1|Overall Study|Adverse Event|10
42817|NCT01634243|182087|P2|Overall Study|Lack of Efficacy|0
42818|NCT01634243|182088|P1|Overall Study|Lack of Efficacy|1
42819|NCT01634243|182087|P2|Overall Study|Adverse Event|5
42820|NCT01634243|182088|P1|Overall Study|Adverse Event|5
42821|NCT01634165|182114|P4|Period 2|Adverse Event|0
42822|NCT01634165|182115|P3|Period 2|Adverse Event|0
42823|NCT01634165|182116|P2|Period 2|Adverse Event|1
42824|NCT01634165|182117|P1|Period 2|Adverse Event|0
42825|NCT01634152|182150|P3|Overall Study|Other reason not defined above|1
42826|NCT01634152|182151|P2|Overall Study|Other reason not defined above|0
42827|NCT01634152|182152|P1|Overall Study|Other reason not defined above|1
42828|NCT01634152|182150|P3|Overall Study|Not treated|0
42829|NCT01634152|182151|P2|Overall Study|Not treated|1
42830|NCT01634152|182152|P1|Overall Study|Not treated|0
42831|NCT01634152|182150|P3|Overall Study|Consent withdrawn not due to AE|1
42832|NCT01634152|182151|P2|Overall Study|Consent withdrawn not due to AE|0
42833|NCT01634152|182152|P1|Overall Study|Consent withdrawn not due to AE|1
42834|NCT01634152|182150|P3|Overall Study|Adverse Event|2
42835|NCT01634152|182151|P2|Overall Study|Adverse Event|0
42836|NCT01634152|182152|P1|Overall Study|Adverse Event|2
42837|NCT01634139|182235|P3|Overall Study|Not treated|0
42838|NCT01634139|182236|P2|Overall Study|Not treated|1
42839|NCT01634139|182237|P1|Overall Study|Not treated|1
42840|NCT01634139|182235|P3|Overall Study|Lost to Follow-up|0
42841|NCT01634139|182236|P2|Overall Study|Lost to Follow-up|2
42842|NCT01634139|182237|P1|Overall Study|Lost to Follow-up|0
42843|NCT01634139|182235|P3|Overall Study|Other|3
42844|NCT01634139|182236|P2|Overall Study|Other|0
42845|NCT01634139|182237|P1|Overall Study|Other|4
42846|NCT01634139|182235|P3|Overall Study|Consent withdrawn not due to AE|2
42847|NCT01634139|182236|P2|Overall Study|Consent withdrawn not due to AE|3
42848|NCT01634139|182237|P1|Overall Study|Consent withdrawn not due to AE|4
42849|NCT01634139|182235|P3|Overall Study|Non compliant with protocol|0
42850|NCT01634139|182236|P2|Overall Study|Non compliant with protocol|0
42851|NCT01634139|182237|P1|Overall Study|Non compliant with protocol|1
42852|NCT01634113|182338|P3|Overall Study|Not treated|1
42853|NCT01634113|182339|P2|Overall Study|Not treated|0
42854|NCT01634113|182340|P1|Overall Study|Not treated|0
42855|NCT01634100|182384|P6|Overall Study|Withdrawal by Subject|0
42856|NCT01634100|182385|P5|Overall Study|Withdrawal by Subject|0
42857|NCT01634100|182386|P4|Overall Study|Withdrawal by Subject|0
42858|NCT01634100|182387|P3|Overall Study|Withdrawal by Subject|1
42859|NCT01634100|182388|P2|Overall Study|Withdrawal by Subject|0
42860|NCT01634100|182389|P1|Overall Study|Withdrawal by Subject|1
42861|NCT01633944|182405|P3|Double-blind Treatment Phase|Not specified|0
42862|NCT01633944|182406|P2|Double-blind Treatment Phase|Not specified|7
42863|NCT01633944|182407|P1|Double-blind Treatment Phase|Not specified|0
42864|NCT01633944|182405|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
42865|NCT01633944|182406|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
42866|NCT01633944|182407|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
42867|NCT01633944|182405|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
42868|NCT01633944|182406|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
42869|NCT01633944|182407|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
42870|NCT01633944|182405|P3|Double-blind Treatment Phase|Lost to Follow-up|9
42871|NCT01633944|182406|P2|Double-blind Treatment Phase|Lost to Follow-up|4
42872|NCT01633944|182407|P1|Double-blind Treatment Phase|Lost to Follow-up|0
42873|NCT01633944|182405|P3|Double-blind Treatment Phase|Protocol Violation|10
42874|NCT01633944|182406|P2|Double-blind Treatment Phase|Protocol Violation|7
42875|NCT01633944|182407|P1|Double-blind Treatment Phase|Protocol Violation|0
42876|NCT01633944|182405|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
42877|NCT01633944|182406|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
42878|NCT01633944|182407|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
42879|NCT01633944|182405|P3|Double-blind Treatment Phase|Lack of Efficacy|23
42880|NCT01633944|182406|P2|Double-blind Treatment Phase|Lack of Efficacy|8
42881|NCT01633944|182407|P1|Double-blind Treatment Phase|Lack of Efficacy|0
42882|NCT01633944|182405|P3|Double-blind Treatment Phase|Adverse Event|7
42883|NCT01633944|182406|P2|Double-blind Treatment Phase|Adverse Event|13
42884|NCT01633944|182407|P1|Double-blind Treatment Phase|Adverse Event|0
42885|NCT01633944|182405|P3|Open-label Titration Phase|Not specified|0
42886|NCT01633944|182406|P2|Open-label Titration Phase|Not specified|0
42887|NCT01633944|182407|P1|Open-label Titration Phase|Not specified|68
42888|NCT01633944|182405|P3|Open-label Titration Phase|Lost to Follow-up|0
42889|NCT01633944|182406|P2|Open-label Titration Phase|Lost to Follow-up|0
42890|NCT01633944|182407|P1|Open-label Titration Phase|Lost to Follow-up|22
42891|NCT01633944|182405|P3|Open-label Titration Phase|Protocol Violation|0
42892|NCT01633944|182406|P2|Open-label Titration Phase|Protocol Violation|0
42893|NCT01633944|182407|P1|Open-label Titration Phase|Protocol Violation|24
42894|NCT01633944|182405|P3|Open-label Titration Phase|Withdrawal by Subject|0
42895|NCT01633944|182406|P2|Open-label Titration Phase|Withdrawal by Subject|0
42896|NCT01633944|182407|P1|Open-label Titration Phase|Withdrawal by Subject|34
42897|NCT01633944|182405|P3|Open-label Titration Phase|Lack of Efficacy|0
42898|NCT01633944|182406|P2|Open-label Titration Phase|Lack of Efficacy|0
42899|NCT01633944|182407|P1|Open-label Titration Phase|Lack of Efficacy|33
42900|NCT01633944|182405|P3|Open-label Titration Phase|Adverse Event|0
42901|NCT01633944|182406|P2|Open-label Titration Phase|Adverse Event|0
42902|NCT01633944|182407|P1|Open-label Titration Phase|Adverse Event|109
42903|NCT01633788|182475|P4|Overall Study|Other Reasons|7
42904|NCT01633788|182476|P3|Overall Study|Other Reasons|3
42905|NCT01633788|182477|P2|Overall Study|Other Reasons|2
42906|NCT01633788|182478|P1|Overall Study|Other Reasons|0
42907|NCT01633788|182475|P4|Overall Study|Protocol Violation|0
42908|NCT01633788|182476|P3|Overall Study|Protocol Violation|1
42909|NCT01633788|182477|P2|Overall Study|Protocol Violation|0
42910|NCT01633788|182478|P1|Overall Study|Protocol Violation|1
42911|NCT01633788|182475|P4|Overall Study|Personal Reasons|3
42912|NCT01633788|182476|P3|Overall Study|Personal Reasons|1
42913|NCT01633788|182477|P2|Overall Study|Personal Reasons|1
42914|NCT01633788|182478|P1|Overall Study|Personal Reasons|3
42915|NCT01633788|182475|P4|Overall Study|Lost to Follow-up|0
42916|NCT01633788|182476|P3|Overall Study|Lost to Follow-up|2
42917|NCT01633788|182477|P2|Overall Study|Lost to Follow-up|2
42918|NCT01633788|182478|P1|Overall Study|Lost to Follow-up|2
42919|NCT01633788|182475|P4|Overall Study|Adverse Event|3
42920|NCT01633788|182476|P3|Overall Study|Adverse Event|3
42921|NCT01633788|182477|P2|Overall Study|Adverse Event|3
42922|NCT01633788|182478|P1|Overall Study|Adverse Event|1
42923|NCT01632904|182522|P2|Overall Study|Reason for discontinuation not available|1
42924|NCT01632904|182523|P1|Overall Study|Reason for discontinuation not available|0
42925|NCT01632904|182522|P2|Overall Study|Disease Progression|1
42926|NCT01632904|182523|P1|Overall Study|Disease Progression|0
42927|NCT01632904|182522|P2|Overall Study|Subject decision|2
42928|NCT01632904|182523|P1|Overall Study|Subject decision|3
42929|NCT01632904|182522|P2|Overall Study|Physician Decision|1
42930|NCT01632904|182523|P1|Overall Study|Physician Decision|0
42931|NCT01632904|182522|P2|Overall Study|Adverse Event|1
42932|NCT01632904|182523|P1|Overall Study|Adverse Event|4
42933|NCT01632878|182534|P1|Treatment|no information on study completion|43
42934|NCT01632878|182534|P1|Treatment|missing information|4
42935|NCT01632878|182534|P1|Treatment|Physician Decision|34
42936|NCT01632878|182534|P1|Treatment|Withdrawal by Subject|36
42937|NCT01632878|182534|P1|Treatment|Lost to Follow-up|41
42938|NCT01632878|182534|P1|Screening|Physician Decision|268
42939|NCT01632800|182538|P1|Overall Study|Subject did not fit in apparatus|1
42940|NCT01632345|182618|P7|Treatment: Part II|Withdrawal by Subject|2
42941|NCT01632345|182619|P6|Treatment: Part II|Withdrawal by Subject|2
42942|NCT01632345|182620|P5|Treatment: Part II|Withdrawal by Subject|0
42943|NCT01632345|182621|P4|Treatment: Part II|Withdrawal by Subject|0
42944|NCT01632345|182622|P3|Treatment: Part II|Withdrawal by Subject|0
42945|NCT01632345|182623|P2|Treatment: Part II|Withdrawal by Subject|0
42946|NCT01632345|182624|P1|Treatment: Part II|Withdrawal by Subject|0
42947|NCT01632345|182618|P7|Treatment: Part II|Non-Compliance with Study Drug|0
42948|NCT01632345|182619|P6|Treatment: Part II|Non-Compliance with Study Drug|3
42949|NCT01632345|182620|P5|Treatment: Part II|Non-Compliance with Study Drug|0
42950|NCT01632345|182621|P4|Treatment: Part II|Non-Compliance with Study Drug|0
42951|NCT01632345|182622|P3|Treatment: Part II|Non-Compliance with Study Drug|0
42952|NCT01632345|182623|P2|Treatment: Part II|Non-Compliance with Study Drug|0
42953|NCT01632345|182624|P1|Treatment: Part II|Non-Compliance with Study Drug|0
42954|NCT01632345|182618|P7|Treatment: Part II|Lost to Follow-up|1
42955|NCT01632345|182619|P6|Treatment: Part II|Lost to Follow-up|3
42956|NCT01632345|182620|P5|Treatment: Part II|Lost to Follow-up|0
42957|NCT01632345|182621|P4|Treatment: Part II|Lost to Follow-up|0
42958|NCT01632345|182622|P3|Treatment: Part II|Lost to Follow-up|0
42959|NCT01632345|182623|P2|Treatment: Part II|Lost to Follow-up|0
42960|NCT01632345|182624|P1|Treatment: Part II|Lost to Follow-up|0
42961|NCT01632345|182618|P7|Treatment: Part II|Adverse Event|8
42962|NCT01632345|182619|P6|Treatment: Part II|Adverse Event|3
42963|NCT01632345|182620|P5|Treatment: Part II|Adverse Event|0
42964|NCT01632345|182621|P4|Treatment: Part II|Adverse Event|0
42965|NCT01632345|182622|P3|Treatment: Part II|Adverse Event|0
42966|NCT01632345|182623|P2|Treatment: Part II|Adverse Event|0
42967|NCT01632345|182624|P1|Treatment: Part II|Adverse Event|0
42968|NCT01632345|182618|P7|Treatment: Part I|Withdrawal by Subject|0
42969|NCT01632345|182619|P6|Treatment: Part I|Withdrawal by Subject|0
42970|NCT01632345|182620|P5|Treatment: Part I|Withdrawal by Subject|4
42971|NCT01632345|182621|P4|Treatment: Part I|Withdrawal by Subject|1
42972|NCT01632345|182622|P3|Treatment: Part I|Withdrawal by Subject|4
42973|NCT01632345|182623|P2|Treatment: Part I|Withdrawal by Subject|4
42974|NCT01632345|182624|P1|Treatment: Part I|Withdrawal by Subject|3
42975|NCT01632345|182618|P7|Treatment: Part I|Protocol Deviation|0
42976|NCT01632345|182619|P6|Treatment: Part I|Protocol Deviation|0
42977|NCT01632345|182620|P5|Treatment: Part I|Protocol Deviation|0
42978|NCT01632345|182621|P4|Treatment: Part I|Protocol Deviation|1
42979|NCT01632345|182622|P3|Treatment: Part I|Protocol Deviation|1
42980|NCT01632345|182623|P2|Treatment: Part I|Protocol Deviation|0
42981|NCT01632345|182624|P1|Treatment: Part I|Protocol Deviation|0
42982|NCT01632345|182618|P7|Treatment: Part I|Pregnancy|0
42983|NCT01632345|182619|P6|Treatment: Part I|Pregnancy|0
42984|NCT01632345|182620|P5|Treatment: Part I|Pregnancy|0
42985|NCT01632345|182621|P4|Treatment: Part I|Pregnancy|0
42986|NCT01632345|182622|P3|Treatment: Part I|Pregnancy|0
42987|NCT01632345|182623|P2|Treatment: Part I|Pregnancy|1
42988|NCT01632345|182624|P1|Treatment: Part I|Pregnancy|0
42989|NCT01632345|182618|P7|Treatment: Part I|Physician Decision|0
42990|NCT01632345|182619|P6|Treatment: Part I|Physician Decision|0
42991|NCT01632345|182620|P5|Treatment: Part I|Physician Decision|1
42992|NCT01632345|182621|P4|Treatment: Part I|Physician Decision|0
42993|NCT01632345|182622|P3|Treatment: Part I|Physician Decision|0
42994|NCT01632345|182623|P2|Treatment: Part I|Physician Decision|1
42995|NCT01632345|182624|P1|Treatment: Part I|Physician Decision|2
42996|NCT01632345|182618|P7|Treatment: Part I|Non-Compliance with Study Drug|0
42997|NCT01632345|182619|P6|Treatment: Part I|Non-Compliance with Study Drug|0
42998|NCT01632345|182620|P5|Treatment: Part I|Non-Compliance with Study Drug|0
42999|NCT01632345|182621|P4|Treatment: Part I|Non-Compliance with Study Drug|1
43000|NCT01632345|182622|P3|Treatment: Part I|Non-Compliance with Study Drug|2
43001|NCT01632345|182623|P2|Treatment: Part I|Non-Compliance with Study Drug|2
43002|NCT01632345|182624|P1|Treatment: Part I|Non-Compliance with Study Drug|3
43003|NCT01632345|182618|P7|Treatment: Part I|Lost to Follow-up|0
43004|NCT01632345|182619|P6|Treatment: Part I|Lost to Follow-up|0
43005|NCT01632345|182620|P5|Treatment: Part I|Lost to Follow-up|4
43006|NCT01632345|182621|P4|Treatment: Part I|Lost to Follow-up|3
43007|NCT01632345|182622|P3|Treatment: Part I|Lost to Follow-up|1
43008|NCT01632345|182623|P2|Treatment: Part I|Lost to Follow-up|2
43009|NCT01632345|182624|P1|Treatment: Part I|Lost to Follow-up|3
43010|NCT01632345|182618|P7|Treatment: Part I|Lack of Efficacy|0
43011|NCT01632345|182619|P6|Treatment: Part I|Lack of Efficacy|0
43012|NCT01632345|182620|P5|Treatment: Part I|Lack of Efficacy|1
43013|NCT01632345|182621|P4|Treatment: Part I|Lack of Efficacy|1
43014|NCT01632345|182622|P3|Treatment: Part I|Lack of Efficacy|0
43015|NCT01632345|182623|P2|Treatment: Part I|Lack of Efficacy|1
43016|NCT01632345|182624|P1|Treatment: Part I|Lack of Efficacy|0
43017|NCT01632345|182618|P7|Treatment: Part I|Adverse Event|0
43018|NCT01632345|182619|P6|Treatment: Part I|Adverse Event|0
43019|NCT01632345|182620|P5|Treatment: Part I|Adverse Event|3
43020|NCT01632345|182621|P4|Treatment: Part I|Adverse Event|1
43021|NCT01632345|182622|P3|Treatment: Part I|Adverse Event|2
43022|NCT01632345|182623|P2|Treatment: Part I|Adverse Event|4
43023|NCT01632345|182624|P1|Treatment: Part I|Adverse Event|1
43024|NCT01632280|182686|P2|Overall Study|Withdrawal by Subject|0
43025|NCT01632280|182687|P1|Overall Study|Withdrawal by Subject|1
43026|NCT01632150|182710|P1|Overall Study|Moved to compassionate program|2
43027|NCT01632150|182710|P1|Overall Study|Patient underwent autologous transplant|1
43028|NCT01632150|182710|P1|Overall Study|Withdrawal by Subject|2
43029|NCT01632150|182710|P1|Overall Study|Unrelated adverse event|7
43030|NCT01632150|182710|P1|Overall Study|Study drug toxicity|1
43031|NCT01632150|182710|P1|Overall Study|Disease progression|27
43032|NCT01632020|182719|P2|Overall Study|Adverse Event|0
43033|NCT01632020|182720|P1|Overall Study|Adverse Event|1
43034|NCT01632020|182719|P2|Overall Study|Withdrawal by Subject|0
43035|NCT01632020|182720|P1|Overall Study|Withdrawal by Subject|1
43036|NCT01631864|182739|P2|Overall Study|Adverse Event|3
43037|NCT01631864|182740|P1|Overall Study|Adverse Event|2
43038|NCT01631864|182739|P2|Overall Study|Withdrawal by Subject|1
43039|NCT01631864|182740|P1|Overall Study|Withdrawal by Subject|0
43040|NCT01631825|182752|P1|Overall Study|Physician Decision|2
43041|NCT01631825|182752|P1|Overall Study|Discontinuation criteria|1
43042|NCT01631825|182752|P1|Overall Study|Protocol Violation|4
43043|NCT01631825|182752|P1|Overall Study|Withdrawal by Subject|9
43044|NCT01631825|182752|P1|Overall Study|Lack of Efficacy|7
43045|NCT01631825|182752|P1|Overall Study|Adverse Event|42
43046|NCT01631812|182772|P1|Overall Study|Physician Decision|3
43047|NCT01631812|182772|P1|Overall Study|Withdrawal by Subject|4
43048|NCT01631812|182772|P1|Overall Study|Lack of Efficacy|5
43049|NCT01631812|182772|P1|Overall Study|Adverse Event|25
43050|NCT01631435|182919|P1|Overall Study|incomplete study procedure|5
43051|NCT01631435|182919|P1|Overall Study|Withdrawal by Subject|2
43052|NCT01631435|182919|P1|Overall Study|Adverse Event|2
43053|NCT01631227|182933|P2|Overall Study|administrative|1
43054|NCT01631227|182934|P1|Overall Study|administrative|2
43055|NCT01631227|182933|P2|Overall Study|Adverse Event|0
43056|NCT01631227|182934|P1|Overall Study|Adverse Event|1
43057|NCT01631227|182933|P2|Overall Study|withdrawn consent|21
43058|NCT01631227|182934|P1|Overall Study|withdrawn consent|27
43059|NCT01630811|182987|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
43060|NCT01630811|182988|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
43061|NCT01630616|183015|P6|Overall Study|Withdrawal by Subject|0
43062|NCT01630616|183016|P5|Overall Study|Withdrawal by Subject|0
43063|NCT01630616|183017|P4|Overall Study|Withdrawal by Subject|2
43064|NCT01630616|183018|P3|Overall Study|Withdrawal by Subject|0
43065|NCT01630616|183019|P2|Overall Study|Withdrawal by Subject|0
43066|NCT01630616|183020|P1|Overall Study|Withdrawal by Subject|0
43067|NCT01630616|183015|P6|Overall Study|Adverse Event|0
43068|NCT01630616|183016|P5|Overall Study|Adverse Event|0
43069|NCT01630616|183017|P4|Overall Study|Adverse Event|1
43070|NCT01630616|183018|P3|Overall Study|Adverse Event|0
43071|NCT01630616|183019|P2|Overall Study|Adverse Event|0
43072|NCT01630616|183020|P1|Overall Study|Adverse Event|0
43073|NCT01630135|183095|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
43074|NCT01630135|183096|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
43075|NCT01629953|183159|P2|Overall Study|Lost to Follow-up|14
43076|NCT01629953|183160|P1|Overall Study|Lost to Follow-up|10
43077|NCT01629953|183159|P2|Overall Study|Death|1
43078|NCT01629953|183160|P1|Overall Study|Death|3
43079|NCT01629823|183180|P3|Washout Period|Protocol Violation|0
43080|NCT01629823|183181|P2|Washout Period|Protocol Violation|1
43081|NCT01629823|183182|P1|Washout Period|Protocol Violation|0
43082|NCT01629823|183180|P3|Washout Period|Pregnancy|0
43083|NCT01629823|183181|P2|Washout Period|Pregnancy|0
43084|NCT01629823|183182|P1|Washout Period|Pregnancy|1
43085|NCT01629823|183180|P3|Washout Period|Safety|0
43086|NCT01629823|183181|P2|Washout Period|Safety|5
43087|NCT01629823|183182|P1|Washout Period|Safety|2
43088|NCT01629823|183180|P3|Trial Period|Failed to hold medication|1
43089|NCT01629823|183181|P2|Trial Period|Failed to hold medication|0
43090|NCT01629823|183182|P1|Trial Period|Failed to hold medication|0
43091|NCT01629823|183180|P3|Trial Period|Out-of-window visit|0
43092|NCT01629823|183181|P2|Trial Period|Out-of-window visit|2
43093|NCT01629823|183182|P1|Trial Period|Out-of-window visit|0
43094|NCT01629823|183180|P3|Trial Period|Adverse Event|0
43095|NCT01629823|183181|P2|Trial Period|Adverse Event|1
43096|NCT01629823|183182|P1|Trial Period|Adverse Event|0
43097|NCT01629823|183180|P3|Trial Period|Pregnancy|0
43098|NCT01629823|183181|P2|Trial Period|Pregnancy|0
43099|NCT01629823|183182|P1|Trial Period|Pregnancy|1
43100|NCT01629823|183180|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
43101|NCT01629823|183181|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
43102|NCT01629823|183182|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
43103|NCT01629823|183180|P3|Trial Period|Missed visit|8
43104|NCT01629823|183181|P2|Trial Period|Missed visit|9
43105|NCT01629823|183182|P1|Trial Period|Missed visit|11
43106|NCT01629706|183217|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
43107|NCT01629706|183217|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
43108|NCT01629706|183217|P1|Phase 2 Habitual|Relocation prior to Dispense|1
43109|NCT01629706|183217|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
43110|NCT01629706|183217|P1|Phase 2 Habitual|Screen Failure|6
43111|NCT01629706|183217|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
43112|NCT01629706|183217|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
43113|NCT01629706|183217|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
43114|NCT01629706|183217|P1|Phase 1 PureVision|Screen Failure|4
43115|NCT01629693|183245|P2|Overall Study|Subject decision unrelated to AE|1
43116|NCT01629693|183246|P1|Overall Study|Subject decision unrelated to AE|0
43117|NCT01629693|183245|P2|Overall Study|Poor comfort of study lenses|2
43118|NCT01629693|183246|P1|Overall Study|Poor comfort of study lenses|0
43119|NCT01629693|183245|P2|Overall Study|Investigator decision|1
43120|NCT01629693|183246|P1|Overall Study|Investigator decision|0
43121|NCT01629693|183245|P2|Overall Study|Adverse Event|0
43122|NCT01629693|183246|P1|Overall Study|Adverse Event|1
43123|NCT01629693|183245|P2|Overall Study|Withdrawal by Subject|2
43124|NCT01629693|183246|P1|Overall Study|Withdrawal by Subject|2
43125|NCT01629693|183245|P2|Overall Study|Lost to Follow-up|4
43126|NCT01629693|183246|P1|Overall Study|Lost to Follow-up|2
43127|NCT01629667|183255|P3|Overall Study|Code break|0
43128|NCT01629667|183256|P2|Overall Study|Code break|0
43129|NCT01629667|183257|P1|Overall Study|Code break|1
43130|NCT01629667|183255|P3|Overall Study|Enrolled in another clinical study|0
43131|NCT01629667|183256|P2|Overall Study|Enrolled in another clinical study|1
43132|NCT01629667|183257|P1|Overall Study|Enrolled in another clinical study|0
43133|NCT01629667|183255|P3|Overall Study|Site error in safety follow-up|1
43134|NCT01629667|183256|P2|Overall Study|Site error in safety follow-up|0
43135|NCT01629667|183257|P1|Overall Study|Site error in safety follow-up|0
43136|NCT01629667|183255|P3|Overall Study|Started other medicine|1
43137|NCT01629667|183256|P2|Overall Study|Started other medicine|0
43138|NCT01629667|183257|P1|Overall Study|Started other medicine|1
43139|NCT01629667|183255|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
43140|NCT01629667|183256|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
43141|NCT01629667|183257|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
43142|NCT01629667|183255|P3|Overall Study|Requiring lung transplant|3
43143|NCT01629667|183256|P2|Overall Study|Requiring lung transplant|1
43144|NCT01629667|183257|P1|Overall Study|Requiring lung transplant|2
43145|NCT01629667|183255|P3|Overall Study|Ongoing AE worsening right heart failure|0
43146|NCT01629667|183256|P2|Overall Study|Ongoing AE worsening right heart failure|1
43147|NCT01629667|183257|P1|Overall Study|Ongoing AE worsening right heart failure|0
43148|NCT01629667|183255|P3|Overall Study|Randomized, not treated|0
43149|NCT01629667|183256|P2|Overall Study|Randomized, not treated|1
43150|NCT01629667|183257|P1|Overall Study|Randomized, not treated|2
43151|NCT01629667|183255|P3|Overall Study|Death|3
43152|NCT01629667|183256|P2|Overall Study|Death|5
43153|NCT01629667|183257|P1|Overall Study|Death|1
43154|NCT01629667|183255|P3|Overall Study|Withdrawal by Subject|28
43155|NCT01629667|183256|P2|Overall Study|Withdrawal by Subject|20
43156|NCT01629667|183257|P1|Overall Study|Withdrawal by Subject|31
43157|NCT01629667|183255|P3|Overall Study|Lost to Follow-up|1
43158|NCT01629667|183256|P2|Overall Study|Lost to Follow-up|1
43159|NCT01629667|183257|P1|Overall Study|Lost to Follow-up|0
43160|NCT01629589|183341|P2|Overall Study|Did not receive study vaccine|1
43161|NCT01629589|183342|P1|Overall Study|Did not receive study vaccine|0
43162|NCT01629589|183341|P2|Overall Study|Withdrawal by Subject|3
43163|NCT01629589|183342|P1|Overall Study|Withdrawal by Subject|2
43164|NCT01629589|183341|P2|Overall Study|Lost to Follow-up|1
43165|NCT01629589|183342|P1|Overall Study|Lost to Follow-up|2
43166|NCT01629589|183341|P2|Overall Study|Protocol Violation|2
43167|NCT01629589|183342|P1|Overall Study|Protocol Violation|4
43168|NCT01628965|183381|P1|Overall Study|Discontinuation criteria|8
43169|NCT01628965|183381|P1|Overall Study|Lost to Follow-up|1
43170|NCT01628965|183381|P1|Overall Study|Withdrawal by Subject|3
43171|NCT01628965|183381|P1|Overall Study|Lack of Efficacy|7
43172|NCT01628965|183381|P1|Overall Study|Adverse Event|30
43173|NCT01628926|183390|P3|Overall Study|Physician Decision|1
43174|NCT01628926|183391|P2|Overall Study|Physician Decision|2
43175|NCT01628926|183392|P1|Overall Study|Physician Decision|2
43176|NCT01628926|183390|P3|Overall Study|Discontinuation criteria|0
43177|NCT01628926|183391|P2|Overall Study|Discontinuation criteria|4
43178|NCT01628926|183392|P1|Overall Study|Discontinuation criteria|3
43179|NCT01628926|183390|P3|Overall Study|Protocol Violation|0
43180|NCT01628926|183391|P2|Overall Study|Protocol Violation|1
43181|NCT01628926|183392|P1|Overall Study|Protocol Violation|0
43182|NCT01628926|183390|P3|Overall Study|Withdrawal by Subject|2
43183|NCT01628926|183391|P2|Overall Study|Withdrawal by Subject|4
43184|NCT01628926|183392|P1|Overall Study|Withdrawal by Subject|6
43185|NCT01628926|183390|P3|Overall Study|Lack of Efficacy|5
43186|NCT01628926|183391|P2|Overall Study|Lack of Efficacy|1
43187|NCT01628926|183392|P1|Overall Study|Lack of Efficacy|2
43188|NCT01628926|183390|P3|Overall Study|Adverse Event|9
43189|NCT01628926|183391|P2|Overall Study|Adverse Event|11
43190|NCT01628926|183392|P1|Overall Study|Adverse Event|13
43191|NCT01628913|183441|P2|Overall Study|Physician Decision|3
43192|NCT01628913|183442|P1|Overall Study|Physician Decision|1
43193|NCT01628913|183441|P2|Overall Study|Withdrawal by Subject|0
43194|NCT01628913|183442|P1|Overall Study|Withdrawal by Subject|1
43195|NCT01628913|183441|P2|Overall Study|study terminated by Sponsor|9
43196|NCT01628913|183442|P1|Overall Study|study terminated by Sponsor|4
43197|NCT01628913|183441|P2|Overall Study|Death|0
43198|NCT01628913|183442|P1|Overall Study|Death|1
43199|NCT01628913|183441|P2|Overall Study|Protocol Violation|0
43200|NCT01628913|183442|P1|Overall Study|Protocol Violation|1
43201|NCT01628913|183441|P2|Overall Study|Disease Progression|14
43202|NCT01628913|183442|P1|Overall Study|Disease Progression|11
43203|NCT01628913|183441|P2|Overall Study|Adverse Event|5
43204|NCT01628913|183442|P1|Overall Study|Adverse Event|12
43205|NCT01628848|183456|P2|Overall Study|Physician Decision|1
43206|NCT01628848|183457|P1|Overall Study|Physician Decision|3
43207|NCT01628848|183456|P2|Overall Study|Withdrawal by Subject|2
43208|NCT01628848|183457|P1|Overall Study|Withdrawal by Subject|0
43209|NCT01628848|183456|P2|Overall Study|Lack of Efficacy|4
43210|NCT01628848|183457|P1|Overall Study|Lack of Efficacy|0
43211|NCT01628848|183456|P2|Overall Study|Adverse Event|7
43212|NCT01628848|183457|P1|Overall Study|Adverse Event|9
43213|NCT01628692|183491|P6|Overall Study|Completed 12 Week only|1
43214|NCT01628692|183492|P5|Overall Study|Completed 12 Week only|0
43215|NCT01628692|183493|P4|Overall Study|Completed 12 Week only|0
43216|NCT01628692|183494|P3|Overall Study|Completed 12 Week only|0
43217|NCT01628692|183495|P2|Overall Study|Completed 12 Week only|0
43218|NCT01628692|183496|P1|Overall Study|Completed 12 Week only|0
43219|NCT01628692|183491|P6|Overall Study|Administrative reason by sponsor|1
43220|NCT01628692|183492|P5|Overall Study|Administrative reason by sponsor|0
43221|NCT01628692|183493|P4|Overall Study|Administrative reason by sponsor|0
43222|NCT01628692|183494|P3|Overall Study|Administrative reason by sponsor|0
43223|NCT01628692|183495|P2|Overall Study|Administrative reason by sponsor|0
43224|NCT01628692|183496|P1|Overall Study|Administrative reason by sponsor|0
43225|NCT01628692|183491|P6|Overall Study|Poor compliance/noncompliance|0
43226|NCT01628692|183492|P5|Overall Study|Poor compliance/noncompliance|0
43227|NCT01628692|183493|P4|Overall Study|Poor compliance/noncompliance|0
43228|NCT01628692|183494|P3|Overall Study|Poor compliance/noncompliance|0
43229|NCT01628692|183495|P2|Overall Study|Poor compliance/noncompliance|0
43230|NCT01628692|183496|P1|Overall Study|Poor compliance/noncompliance|1
43231|NCT01628692|183491|P6|Overall Study|Death|0
43232|NCT01628692|183492|P5|Overall Study|Death|0
43233|NCT01628692|183493|P4|Overall Study|Death|0
43234|NCT01628692|183494|P3|Overall Study|Death|0
43235|NCT01628692|183495|P2|Overall Study|Death|1
43236|NCT01628692|183496|P1|Overall Study|Death|0
43237|NCT01628692|183491|P6|Overall Study|Withdrawal by Subject|0
43238|NCT01628692|183492|P5|Overall Study|Withdrawal by Subject|0
43239|NCT01628692|183493|P4|Overall Study|Withdrawal by Subject|0
43240|NCT01628692|183494|P3|Overall Study|Withdrawal by Subject|1
43241|NCT01628692|183495|P2|Overall Study|Withdrawal by Subject|1
43242|NCT01628692|183496|P1|Overall Study|Withdrawal by Subject|0
43243|NCT01628692|183491|P6|Overall Study|Adverse Event|0
43244|NCT01628692|183492|P5|Overall Study|Adverse Event|0
43245|NCT01628692|183493|P4|Overall Study|Adverse Event|0
43246|NCT01628692|183494|P3|Overall Study|Adverse Event|2
43247|NCT01628692|183495|P2|Overall Study|Adverse Event|0
43248|NCT01628692|183496|P1|Overall Study|Adverse Event|2
43249|NCT01628692|183491|P6|Overall Study|Lack of Efficacy|7
43250|NCT01628692|183492|P5|Overall Study|Lack of Efficacy|4
43251|NCT01628692|183493|P4|Overall Study|Lack of Efficacy|1
43252|NCT01628692|183494|P3|Overall Study|Lack of Efficacy|5
43253|NCT01628692|183495|P2|Overall Study|Lack of Efficacy|4
43254|NCT01628692|183496|P1|Overall Study|Lack of Efficacy|4
43255|NCT01628510|183564|P2|Overall Study|Death|1
43256|NCT01628510|183565|P1|Overall Study|Death|3
43257|NCT01628510|183564|P2|Overall Study|Withdrawal by Subject|4
43258|NCT01628510|183565|P1|Overall Study|Withdrawal by Subject|0
43259|NCT01628367|183575|P2|Overall Study|Adverse Event|0
43260|NCT01628367|183576|P1|Overall Study|Adverse Event|1
43261|NCT01628198|183595|P1|Overall Study|Screen failure|1
43262|NCT01628198|183595|P1|Overall Study|Withdrawal by Subject|10
43263|NCT01628198|183595|P1|Overall Study|Lost to Follow-up|7
43264|NCT01627860|183635|P2|Overall Study|Protocol Violation|0
43265|NCT01627860|183636|P1|Overall Study|Protocol Violation|1
43266|NCT01627860|183635|P2|Overall Study|Seizure frequency doubled|1
43267|NCT01627860|183636|P1|Overall Study|Seizure frequency doubled|0
43268|NCT01627860|183635|P2|Overall Study|Withdrawal by Subject|1
43269|NCT01627860|183636|P1|Overall Study|Withdrawal by Subject|2
43270|NCT01627860|183635|P2|Overall Study|Adverse Event|4
43271|NCT01627860|183636|P1|Overall Study|Adverse Event|9
43272|NCT01627782|183650|P4|Overall Study|Randomized But Not Treated|0
43273|NCT01627782|183651|P3|Overall Study|Randomized But Not Treated|0
43274|NCT01627782|183652|P2|Overall Study|Randomized But Not Treated|0
43275|NCT01627782|183653|P1|Overall Study|Randomized But Not Treated|1
43276|NCT01627782|183650|P4|Overall Study|Other|3
43277|NCT01627782|183651|P3|Overall Study|Other|0
43278|NCT01627782|183652|P2|Overall Study|Other|2
43279|NCT01627782|183653|P1|Overall Study|Other|0
43280|NCT01627782|183650|P4|Overall Study|Withdrawal by Subject|0
43281|NCT01627782|183651|P3|Overall Study|Withdrawal by Subject|0
43282|NCT01627782|183652|P2|Overall Study|Withdrawal by Subject|1
43283|NCT01627782|183653|P1|Overall Study|Withdrawal by Subject|2
43284|NCT01627782|183650|P4|Overall Study|Protocol Violation|0
43285|NCT01627782|183651|P3|Overall Study|Protocol Violation|0
43286|NCT01627782|183652|P2|Overall Study|Protocol Violation|0
43287|NCT01627782|183653|P1|Overall Study|Protocol Violation|1
43288|NCT01627782|183650|P4|Overall Study|Lack of Efficacy|2
43289|NCT01627782|183651|P3|Overall Study|Lack of Efficacy|15
43290|NCT01627782|183652|P2|Overall Study|Lack of Efficacy|1
43291|NCT01627782|183653|P1|Overall Study|Lack of Efficacy|11
43292|NCT01627782|183650|P4|Overall Study|Adverse Event|1
43293|NCT01627782|183651|P3|Overall Study|Adverse Event|0
43294|NCT01627782|183652|P2|Overall Study|Adverse Event|2
43295|NCT01627782|183653|P1|Overall Study|Adverse Event|1
43296|NCT01627561|183711|P2|Overall Study|Withdrawal by Subject|2
43297|NCT01627561|183712|P1|Overall Study|Withdrawal by Subject|0
43298|NCT01627561|183711|P2|Overall Study|Migrated/moved from study area|1
43299|NCT01627561|183712|P1|Overall Study|Migrated/moved from study area|0
43300|NCT01627340|183760|P2|Overall Study|Withdrawal by Subject|0
43301|NCT01627340|183761|P1|Overall Study|Withdrawal by Subject|2
43302|NCT01627340|183760|P2|Overall Study|Pregnancy|0
43303|NCT01627340|183761|P1|Overall Study|Pregnancy|1
43304|NCT01627340|183760|P2|Overall Study|Lost to Follow-up|4
43305|NCT01627340|183761|P1|Overall Study|Lost to Follow-up|8
43306|NCT01627340|183760|P2|Overall Study|Adverse Event|0
43307|NCT01627340|183761|P1|Overall Study|Adverse Event|1
43308|NCT01627327|183779|P2|Overall Study|Withdrawal by Subject|3
43309|NCT01627327|183780|P1|Overall Study|Withdrawal by Subject|3
43310|NCT01627327|183779|P2|Overall Study|Physician Decision|0
43311|NCT01627327|183780|P1|Overall Study|Physician Decision|1
43312|NCT01627327|183779|P2|Overall Study|Lost to Follow-up|3
43313|NCT01627327|183780|P1|Overall Study|Lost to Follow-up|1
43314|NCT01627327|183779|P2|Overall Study|Protocol Violation|10
43315|NCT01627327|183780|P1|Overall Study|Protocol Violation|4
43316|NCT01627327|183779|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
43317|NCT01627327|183780|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
43318|NCT01627327|183779|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
43319|NCT01627327|183780|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
43320|NCT01627327|183779|P2|Overall Study|Adverse Event|12
43321|NCT01627327|183780|P1|Overall Study|Adverse Event|6
43322|NCT01627249|183793|P3|Overall Study|Missed Visit|0
43323|NCT01627249|183794|P2|Overall Study|Missed Visit|1
43324|NCT01627249|183795|P1|Overall Study|Missed Visit|1
43325|NCT01627249|183793|P3|Overall Study|Withdrawal by Subject|9
43326|NCT01627249|183794|P2|Overall Study|Withdrawal by Subject|6
43327|NCT01627249|183795|P1|Overall Study|Withdrawal by Subject|12
43328|NCT01627249|183793|P3|Overall Study|Death|3
43329|NCT01627249|183794|P2|Overall Study|Death|5
43330|NCT01627249|183795|P1|Overall Study|Death|3
43331|NCT01626690|183916|P2|Overall Study|Adverse Event|0
43332|NCT01626690|183917|P1|Overall Study|Adverse Event|1
43333|NCT01626690|183916|P2|Overall Study|Protocol Violation|0
43334|NCT01626690|183917|P1|Overall Study|Protocol Violation|1
43335|NCT01626456|183939|P2|Overall Study|Incarceration|2
43336|NCT01626456|183940|P1|Overall Study|Incarceration|0
43337|NCT01626456|183939|P2|Overall Study|Site Closure|3
43338|NCT01626456|183940|P1|Overall Study|Site Closure|2
43339|NCT01626456|183939|P2|Overall Study|Protocol Violation|1
43340|NCT01626456|183940|P1|Overall Study|Protocol Violation|1
43341|NCT01626456|183939|P2|Overall Study|Physician Decision|4
43342|NCT01626456|183940|P1|Overall Study|Physician Decision|1
43343|NCT01626456|183939|P2|Overall Study|Lack of Efficacy|7
43344|NCT01626456|183940|P1|Overall Study|Lack of Efficacy|6
43345|NCT01626456|183939|P2|Overall Study|Lost to Follow-up|27
43346|NCT01626456|183940|P1|Overall Study|Lost to Follow-up|2
43347|NCT01626456|183939|P2|Overall Study|Adverse Event|27
43348|NCT01626456|183940|P1|Overall Study|Adverse Event|2
43349|NCT01626456|183939|P2|Overall Study|Withdrawal by Subject|46
43350|NCT01626456|183940|P1|Overall Study|Withdrawal by Subject|21
43351|NCT01626391|183970|P2|Overall Study|Withdrawal by Subject|0
43352|NCT01626391|183971|P1|Overall Study|Withdrawal by Subject|1
43353|NCT01626391|183970|P2|Overall Study|Physician Decision|0
43354|NCT01626391|183971|P1|Overall Study|Physician Decision|1
43355|NCT01626352|183977|P1|Overall Study|Never Treated|1
43356|NCT01626352|183977|P1|Overall Study|Non-Compliance|1
43357|NCT01626352|183977|P1|Overall Study|Withdrawal by Subject|1
43358|NCT01626352|183977|P1|Overall Study|Death|2
43359|NCT01626352|183977|P1|Overall Study|Intercurrent Illness|2
43360|NCT01626352|183977|P1|Overall Study|Disease Progression|3
43361|NCT01626118|183991|P4|Overall Study|Investigator Decision|0
43362|NCT01626118|183992|P3|Overall Study|Investigator Decision|0
43363|NCT01626118|183993|P2|Overall Study|Investigator Decision|1
43364|NCT01626118|183994|P1|Overall Study|Investigator Decision|0
43365|NCT01626118|183991|P4|Overall Study|Adverse Event|0
43366|NCT01626118|183992|P3|Overall Study|Adverse Event|1
43367|NCT01626118|183993|P2|Overall Study|Adverse Event|1
43368|NCT01626118|183994|P1|Overall Study|Adverse Event|0
43369|NCT01626118|183991|P4|Overall Study|Lost to Follow-up|0
43370|NCT01626118|183992|P3|Overall Study|Lost to Follow-up|0
43371|NCT01626118|183993|P2|Overall Study|Lost to Follow-up|0
43372|NCT01626118|183994|P1|Overall Study|Lost to Follow-up|1
43373|NCT01626118|183991|P4|Overall Study|Lack of Efficacy|3
43374|NCT01626118|183992|P3|Overall Study|Lack of Efficacy|1
43375|NCT01626118|183993|P2|Overall Study|Lack of Efficacy|0
43376|NCT01626118|183994|P1|Overall Study|Lack of Efficacy|1
43377|NCT01625910|184040|P2|Overall Study|Lost to Follow-up|4
43378|NCT01625910|184041|P1|Overall Study|Lost to Follow-up|3
43379|NCT01625845|184051|P2|Overall Study|Withdrawal by Subject|0
43380|NCT01625845|184052|P1|Overall Study|Withdrawal by Subject|2
43381|NCT01625845|184051|P2|Overall Study|Lost to Follow-up|1
43382|NCT01625845|184052|P1|Overall Study|Lost to Follow-up|2
43383|NCT01625845|184051|P2|Overall Study|Adverse Event|2
43384|NCT01625845|184052|P1|Overall Study|Adverse Event|1
43385|NCT01625689|184072|P2|Overall Study|Migration|1
43386|NCT01625689|184073|P1|Overall Study|Migration|2
43387|NCT01625377|184128|P2|Overall Study|Abnormal laboratory values|0
43388|NCT01625377|184129|P1|Overall Study|Abnormal laboratory values|1
43389|NCT01625377|184128|P2|Overall Study|Unsatisfactory therapeutic effect|1
43390|NCT01625377|184129|P1|Overall Study|Unsatisfactory therapeutic effect|0
43391|NCT01625377|184128|P2|Overall Study|Graft loss|0
43392|NCT01625377|184129|P1|Overall Study|Graft loss|1
43393|NCT01625377|184128|P2|Overall Study|Adverse Event|16
43394|NCT01625377|184129|P1|Overall Study|Adverse Event|3
43395|NCT01625377|184128|P2|Overall Study|Protocol Violation|3
43396|NCT01625377|184129|P1|Overall Study|Protocol Violation|0
43397|NCT01625377|184128|P2|Overall Study|Administrative Problem|1
43398|NCT01625377|184129|P1|Overall Study|Administrative Problem|1
43399|NCT01625377|184128|P2|Overall Study|Death|1
43400|NCT01625377|184129|P1|Overall Study|Death|1
43401|NCT01625338|184162|P3|Overall Study|Study Discontinued by Sponsor|1
43402|NCT01625338|184163|P2|Overall Study|Study Discontinued by Sponsor|0
43403|NCT01625338|184164|P1|Overall Study|Study Discontinued by Sponsor|0
43404|NCT01625338|184162|P3|Overall Study|Adverse Event|1
43405|NCT01625338|184163|P2|Overall Study|Adverse Event|0
43406|NCT01625338|184164|P1|Overall Study|Adverse Event|1
43407|NCT01625338|184162|P3|Overall Study|Subject Withdrew Consent|2
43408|NCT01625338|184163|P2|Overall Study|Subject Withdrew Consent|0
43409|NCT01625338|184164|P1|Overall Study|Subject Withdrew Consent|1
43410|NCT01625338|184162|P3|Overall Study|Investigator Decision|1
43411|NCT01625338|184163|P2|Overall Study|Investigator Decision|2
43412|NCT01625338|184164|P1|Overall Study|Investigator Decision|0
43413|NCT01625338|184162|P3|Overall Study|Lost to Follow-up|2
43414|NCT01625338|184163|P2|Overall Study|Lost to Follow-up|3
43415|NCT01625338|184164|P1|Overall Study|Lost to Follow-up|3
43416|NCT01625338|184162|P3|Overall Study|Efficacy Failure|31
43417|NCT01625338|184163|P2|Overall Study|Efficacy Failure|39
43418|NCT01625338|184164|P1|Overall Study|Efficacy Failure|27
43419|NCT01625338|184162|P3|Overall Study|Enrolled but not Treated|1
43420|NCT01625338|184163|P2|Overall Study|Enrolled but not Treated|0
43421|NCT01625338|184164|P1|Overall Study|Enrolled but not Treated|0
43422|NCT01625182|184191|P2|Overall Study|Lack of Efficacy|8
43423|NCT01625182|184192|P1|Overall Study|Lack of Efficacy|12
43424|NCT01625182|184191|P2|Overall Study|Withdrawal by Subject|1
43425|NCT01625182|184192|P1|Overall Study|Withdrawal by Subject|5
43426|NCT01625182|184191|P2|Overall Study|Adverse Event|0
43427|NCT01625182|184192|P1|Overall Study|Adverse Event|2
43428|NCT01625182|184191|P2|Overall Study|Protocol deviation|2
43429|NCT01625182|184192|P1|Overall Study|Protocol deviation|0
43430|NCT01625182|184191|P2|Overall Study|Administrative problems|0
43431|NCT01625182|184192|P1|Overall Study|Administrative problems|1
43432|NCT01625091|184229|P2|Post-intervention|Study termination|1
43433|NCT01625091|184230|P1|Post-intervention|Study termination|2
43434|NCT01625091|184229|P2|Post-intervention|Lost to Follow-up|0
43435|NCT01625091|184230|P1|Post-intervention|Lost to Follow-up|2
43436|NCT01625091|184229|P2|Post-intervention|Death|1
43437|NCT01625091|184230|P1|Post-intervention|Death|0
43438|NCT01625091|184229|P2|Intervention|Study termination|3
43439|NCT01625091|184230|P1|Intervention|Study termination|2
43440|NCT01625091|184229|P2|Intervention|Lost to Follow-up|4
43441|NCT01625091|184230|P1|Intervention|Lost to Follow-up|4
43442|NCT01625091|184229|P2|Intervention|Adverse Event|2
43443|NCT01625091|184230|P1|Intervention|Adverse Event|0
43444|NCT01625091|184229|P2|Intervention|Withdrawal by Subject|1
43445|NCT01625091|184230|P1|Intervention|Withdrawal by Subject|4
43446|NCT01625091|184229|P2|Intervention|Death|1
43447|NCT01625091|184230|P1|Intervention|Death|1
43448|NCT01624467|184271|P1|Overall Study|Subject Withdrew from Treatment|1
43449|NCT01624467|184271|P1|Overall Study|Per Sponsor Requirement|1
43450|NCT01624467|184271|P1|Overall Study|Progressive Disease|19
43451|NCT01624467|184271|P1|Overall Study|Adverse Event|7
43452|NCT01624467|184271|P1|Overall Study|Lost to Follow-up|1
43453|NCT01624467|184271|P1|Overall Study|Withdrawal by Subject|2
43454|NCT01624259|184310|P2|Overall Study|Abnormal laboratory measure|0
43455|NCT01624259|184311|P1|Overall Study|Abnormal laboratory measure|3
43456|NCT01624259|184310|P2|Overall Study|Lost to Follow-up|3
43457|NCT01624259|184311|P1|Overall Study|Lost to Follow-up|2
43458|NCT01624259|184310|P2|Overall Study|Physician Decision|1
43459|NCT01624259|184311|P1|Overall Study|Physician Decision|1
43460|NCT01624259|184310|P2|Overall Study|Withdrawal by Subject|7
43461|NCT01624259|184311|P1|Overall Study|Withdrawal by Subject|5
43462|NCT01624259|184310|P2|Overall Study|Protocol Violation|2
43463|NCT01624259|184311|P1|Overall Study|Protocol Violation|1
43464|NCT01624259|184310|P2|Overall Study|Adverse Event|18
43465|NCT01624259|184311|P1|Overall Study|Adverse Event|18
43466|NCT01624233|184360|P1|Period 3 - Maintenance|Withdrawal by Subject|2
43467|NCT01624233|184360|P1|Period 3 - Maintenance|Physician Decision|2
43468|NCT01624233|184360|P1|Period 3 - Maintenance|Lack of Efficacy|1
43469|NCT01624233|184360|P1|Period 3 - Maintenance|Adverse Event|2
43470|NCT01624233|184360|P1|Period 2 - Induction|Adverse Event|1
43471|NCT01623830|184413|P2|Overall Study|Exclusion from Study|2
43472|NCT01623830|184414|P1|Overall Study|Exclusion from Study|1
43473|NCT01623830|184413|P2|Overall Study|Withdrawal by Subject|7
43474|NCT01623830|184414|P1|Overall Study|Withdrawal by Subject|6
43475|NCT01623596|184439|P2|Overall Study|Lack of Efficacy|3
43476|NCT01623596|184440|P1|Overall Study|Lack of Efficacy|5
43477|NCT01623596|184439|P2|Overall Study|Protocol Violation|6
43478|NCT01623596|184440|P1|Overall Study|Protocol Violation|0
43479|NCT01623596|184439|P2|Overall Study|Patient no longer requires study drug|0
43480|NCT01623596|184440|P1|Overall Study|Patient no longer requires study drug|1
43481|NCT01623596|184439|P2|Overall Study|Withdrawal by Subject|31
43482|NCT01623596|184440|P1|Overall Study|Withdrawal by Subject|13
43483|NCT01623596|184439|P2|Overall Study|Lost to Follow-up|16
43484|NCT01623596|184440|P1|Overall Study|Lost to Follow-up|12
43485|NCT01623596|184439|P2|Overall Study|Death|2
43486|NCT01623596|184440|P1|Overall Study|Death|0
43487|NCT01623596|184439|P2|Overall Study|Adverse Event|29
43488|NCT01623596|184440|P1|Overall Study|Adverse Event|20
43489|NCT01623596|184439|P2|Overall Study|Administrative problems|13
43490|NCT01623596|184440|P1|Overall Study|Administrative problems|9
43491|NCT01623596|184439|P2|Overall Study|Abnormal laboratory values|0
43492|NCT01623596|184440|P1|Overall Study|Abnormal laboratory values|2
43493|NCT01623310|184483|P1|Overall Study|Investigators Discretion-Noncompliant|1
43494|NCT01623310|184483|P1|Overall Study|Diagnoses of bilateral cateracts|1
43495|NCT01623310|184483|P1|Overall Study|Became potentially child-bearing|1
43496|NCT01623310|184483|P1|Overall Study|Withdrawal by Subject|25
43497|NCT01623310|184483|P1|Overall Study|Protocol Violation|6
43498|NCT01623310|184483|P1|Overall Study|Lack of Efficacy|6
43499|NCT01623310|184483|P1|Overall Study|Lost to Follow-up|18
43500|NCT01623310|184483|P1|Overall Study|Adverse Event|21
43501|NCT01623271|184492|P1|Overall Study|Withdrawal by Subject|2
43502|NCT01623154|184496|P1|Overall Study|Did not drink Pranactin Citric|4
43503|NCT01623115|184504|P2|Overall Study|Other than specified above|3
43504|NCT01623115|184505|P1|Overall Study|Other than specified above|0
43505|NCT01623115|184504|P2|Overall Study|Death|4
43506|NCT01623115|184505|P1|Overall Study|Death|0
43507|NCT01623115|184504|P2|Overall Study|Site closure|7
43508|NCT01623115|184505|P1|Overall Study|Site closure|1
43509|NCT01623115|184504|P2|Overall Study|Last visit outside protocol visit window|26
43510|NCT01623115|184505|P1|Overall Study|Last visit outside protocol visit window|14
43511|NCT01623115|184504|P2|Overall Study|Related to study drug administration|2
43512|NCT01623115|184505|P1|Overall Study|Related to study drug administration|0
43513|NCT01623115|184504|P2|Overall Study|Consent withdrawn by participant|6
43514|NCT01623115|184505|P1|Overall Study|Consent withdrawn by participant|2
43515|NCT01623115|184504|P2|Overall Study|Poor compliance to protocol|10
43516|NCT01623115|184505|P1|Overall Study|Poor compliance to protocol|4
43517|NCT01623115|184504|P2|Overall Study|Adverse Event|13
43518|NCT01623115|184505|P1|Overall Study|Adverse Event|10
43519|NCT01623115|184504|P2|Overall Study|Participants moved|5
43520|NCT01623115|184505|P1|Overall Study|Participants moved|1
43521|NCT01623115|184504|P2|Overall Study|Physician Decision|0
43522|NCT01623115|184505|P1|Overall Study|Physician Decision|1
43523|NCT01623115|184504|P2|Overall Study|Randomized but not treated|1
43524|NCT01623115|184505|P1|Overall Study|Randomized but not treated|0
43525|NCT01623050|184565|P1|Overall Study|Lost to Follow-up|9
43526|NCT01622673|184579|P6|Treatment Period 3|Protocol Violation|0
43527|NCT01622673|184580|P5|Treatment Period 3|Protocol Violation|0
43528|NCT01622673|184581|P4|Treatment Period 3|Protocol Violation|0
43529|NCT01622673|184582|P3|Treatment Period 3|Protocol Violation|0
43530|NCT01622673|184583|P2|Treatment Period 3|Protocol Violation|1
43531|NCT01622673|184584|P1|Treatment Period 3|Protocol Violation|0
43532|NCT01622673|184579|P6|Treatment Period 2|Withdrawal by Subject|0
43533|NCT01622673|184580|P5|Treatment Period 2|Withdrawal by Subject|0
43534|NCT01622673|184581|P4|Treatment Period 2|Withdrawal by Subject|1
43535|NCT01622673|184582|P3|Treatment Period 2|Withdrawal by Subject|0
43536|NCT01622673|184583|P2|Treatment Period 2|Withdrawal by Subject|0
43537|NCT01622673|184584|P1|Treatment Period 2|Withdrawal by Subject|0
43538|NCT01622673|184579|P6|Treatment Period 1|Protocol Violation|0
43539|NCT01622673|184580|P5|Treatment Period 1|Protocol Violation|0
43540|NCT01622673|184581|P4|Treatment Period 1|Protocol Violation|0
43541|NCT01622673|184582|P3|Treatment Period 1|Protocol Violation|0
43542|NCT01622673|184583|P2|Treatment Period 1|Protocol Violation|1
43543|NCT01622673|184584|P1|Treatment Period 1|Protocol Violation|0
43544|NCT01622673|184579|P6|Treatment Period 1|Withdrawal by Subject|0
43545|NCT01622673|184580|P5|Treatment Period 1|Withdrawal by Subject|0
43546|NCT01622673|184581|P4|Treatment Period 1|Withdrawal by Subject|1
43547|NCT01622673|184582|P3|Treatment Period 1|Withdrawal by Subject|0
43548|NCT01622673|184583|P2|Treatment Period 1|Withdrawal by Subject|0
43549|NCT01622673|184584|P1|Treatment Period 1|Withdrawal by Subject|0
43550|NCT01622660|184619|P1|Overall Study|Adverse Event|1
43551|NCT01622348|184626|P3|Overall Study|Withdrawal by Subject|1
43552|NCT01622348|184627|P2|Overall Study|Withdrawal by Subject|0
43553|NCT01622348|184628|P1|Overall Study|Withdrawal by Subject|1
43554|NCT01622231|184667|P1|Overall Study|Withdrawal by Subject|1
43555|NCT01622231|184667|P1|Overall Study|Physician Decision|1
43556|NCT01621802|184701|P6|Overall Study|Lost to Follow-up|11
43557|NCT01621802|184702|P5|Overall Study|Lost to Follow-up|31
43558|NCT01621802|184703|P4|Overall Study|Lost to Follow-up|7
43559|NCT01621802|184704|P3|Overall Study|Lost to Follow-up|24
43560|NCT01621802|184705|P2|Overall Study|Lost to Follow-up|16
43561|NCT01621802|184706|P1|Overall Study|Lost to Follow-up|36
43562|NCT01621802|184701|P6|Overall Study|Others|0
43563|NCT01621802|184702|P5|Overall Study|Others|1
43564|NCT01621802|184703|P4|Overall Study|Others|2
43565|NCT01621802|184704|P3|Overall Study|Others|3
43566|NCT01621802|184705|P2|Overall Study|Others|3
43567|NCT01621802|184706|P1|Overall Study|Others|3
43568|NCT01621802|184701|P6|Overall Study|Migrated/moved from study area|0
43569|NCT01621802|184702|P5|Overall Study|Migrated/moved from study area|1
43570|NCT01621802|184703|P4|Overall Study|Migrated/moved from study area|0
43571|NCT01621802|184704|P3|Overall Study|Migrated/moved from study area|2
43572|NCT01621802|184705|P2|Overall Study|Migrated/moved from study area|0
43573|NCT01621802|184706|P1|Overall Study|Migrated/moved from study area|0
43574|NCT01621802|184701|P6|Overall Study|Withdrawal by Subject|0
43575|NCT01621802|184702|P5|Overall Study|Withdrawal by Subject|2
43576|NCT01621802|184703|P4|Overall Study|Withdrawal by Subject|2
43577|NCT01621802|184704|P3|Overall Study|Withdrawal by Subject|4
43578|NCT01621802|184705|P2|Overall Study|Withdrawal by Subject|4
43579|NCT01621802|184706|P1|Overall Study|Withdrawal by Subject|8
43580|NCT01621802|184701|P6|Overall Study|Protocol Violation|1
43581|NCT01621802|184702|P5|Overall Study|Protocol Violation|0
43582|NCT01621802|184703|P4|Overall Study|Protocol Violation|0
43583|NCT01621802|184704|P3|Overall Study|Protocol Violation|0
43584|NCT01621802|184705|P2|Overall Study|Protocol Violation|0
43585|NCT01621802|184706|P1|Overall Study|Protocol Violation|0
43586|NCT01621191|184877|P1|Overall Study|Site Removed From Study|1
43587|NCT01621191|184877|P1|Overall Study|Lost to Follow-up|1
43588|NCT01621191|184877|P1|Overall Study|Lack of Efficacy|6
43589|NCT01621191|184877|P1|Overall Study|Withdrawal by Subject|8
43590|NCT01621191|184877|P1|Overall Study|Adverse Event|9
43591|NCT01621178|184891|P3|Overall Study|Physician Decision|7
43592|NCT01621178|184892|P2|Overall Study|Physician Decision|2
43593|NCT01621178|184893|P1|Overall Study|Physician Decision|5
43594|NCT01621178|184891|P3|Overall Study|Withdrawal by Subject|18
43595|NCT01621178|184892|P2|Overall Study|Withdrawal by Subject|17
43596|NCT01621178|184893|P1|Overall Study|Withdrawal by Subject|14
43597|NCT01621178|184891|P3|Overall Study|Lost to Follow-up|1
43598|NCT01621178|184892|P2|Overall Study|Lost to Follow-up|2
43599|NCT01621178|184893|P1|Overall Study|Lost to Follow-up|1
43600|NCT01621178|184891|P3|Overall Study|Death|2
43601|NCT01621178|184892|P2|Overall Study|Death|7
43602|NCT01621178|184893|P1|Overall Study|Death|6
43603|NCT01621178|184891|P3|Overall Study|Adverse Event|8
43604|NCT01621178|184892|P2|Overall Study|Adverse Event|2
43605|NCT01621178|184893|P1|Overall Study|Adverse Event|5
43606|NCT01621126|184985|P1|Overall Study|Physician Decision|6
43607|NCT01620762|185007|P3|Overall Study|Use of prohibted therapies|1
43608|NCT01620762|185008|P2|Overall Study|Use of prohibted therapies|1
43609|NCT01620762|185009|P1|Overall Study|Use of prohibted therapies|0
43610|NCT01620762|185007|P3|Overall Study|Non-specified|5
43611|NCT01620762|185008|P2|Overall Study|Non-specified|6
43612|NCT01620762|185009|P1|Overall Study|Non-specified|3
43613|NCT01620762|185007|P3|Overall Study|Subject deterioration|1
43614|NCT01620762|185008|P2|Overall Study|Subject deterioration|1
43615|NCT01620762|185009|P1|Overall Study|Subject deterioration|0
43616|NCT01620762|185007|P3|Overall Study|Protocol deviation|6
43617|NCT01620762|185008|P2|Overall Study|Protocol deviation|1
43618|NCT01620762|185009|P1|Overall Study|Protocol deviation|1
43619|NCT01620762|185007|P3|Overall Study|Lost to Follow-up|10
43620|NCT01620762|185008|P2|Overall Study|Lost to Follow-up|17
43621|NCT01620762|185009|P1|Overall Study|Lost to Follow-up|11
43622|NCT01620762|185007|P3|Overall Study|Withdrawal by Subject|27
43623|NCT01620762|185008|P2|Overall Study|Withdrawal by Subject|26
43624|NCT01620762|185009|P1|Overall Study|Withdrawal by Subject|23
43625|NCT01620762|185007|P3|Overall Study|Adverse Event|2
43626|NCT01620762|185008|P2|Overall Study|Adverse Event|5
43627|NCT01620762|185009|P1|Overall Study|Adverse Event|9
43628|NCT01620762|185007|P3|Overall Study|Protocol Violation|1
43629|NCT01620762|185008|P2|Overall Study|Protocol Violation|1
43630|NCT01620762|185009|P1|Overall Study|Protocol Violation|1
43631|NCT01620489|185054|P2|Overall Study|Unclassified|2
43632|NCT01620489|185055|P1|Overall Study|Unclassified|1
43633|NCT01620489|185054|P2|Overall Study|Withdrawal Criteria|25
43634|NCT01620489|185055|P1|Overall Study|Withdrawal Criteria|17
43635|NCT01620489|185054|P2|Overall Study|Protocol Violation|3
43636|NCT01620489|185055|P1|Overall Study|Protocol Violation|0
43637|NCT01620489|185054|P2|Overall Study|Adverse Event|4
43638|NCT01620489|185055|P1|Overall Study|Adverse Event|17
43639|NCT01620255|185076|P5|Overall Study|Withdrawn at discretion of investigator|1
43640|NCT01620255|185077|P4|Overall Study|Withdrawn at discretion of investigator|0
43641|NCT01620255|185078|P3|Overall Study|Withdrawn at discretion of investigator|0
43642|NCT01620255|185079|P2|Overall Study|Withdrawn at discretion of investigator|0
43643|NCT01620255|185080|P1|Overall Study|Withdrawn at discretion of investigator|0
43644|NCT01620255|185076|P5|Overall Study|Adverse Event|1
43645|NCT01620255|185077|P4|Overall Study|Adverse Event|1
43646|NCT01620255|185078|P3|Overall Study|Adverse Event|0
43647|NCT01620255|185079|P2|Overall Study|Adverse Event|4
43648|NCT01620255|185080|P1|Overall Study|Adverse Event|0
43649|NCT01620255|185076|P5|Overall Study|Non-compliance|0
43650|NCT01620255|185077|P4|Overall Study|Non-compliance|0
43651|NCT01620255|185078|P3|Overall Study|Non-compliance|0
43652|NCT01620255|185079|P2|Overall Study|Non-compliance|1
43653|NCT01620255|185080|P1|Overall Study|Non-compliance|0
43654|NCT01620255|185076|P5|Overall Study|Participant underwent fecal transplant|0
43655|NCT01620255|185077|P4|Overall Study|Participant underwent fecal transplant|0
43656|NCT01620255|185078|P3|Overall Study|Participant underwent fecal transplant|1
43657|NCT01620255|185079|P2|Overall Study|Participant underwent fecal transplant|0
43658|NCT01620255|185080|P1|Overall Study|Participant underwent fecal transplant|0
43659|NCT01620255|185076|P5|Overall Study|Withdrawal by Subject|4
43660|NCT01620255|185077|P4|Overall Study|Withdrawal by Subject|2
43661|NCT01620255|185078|P3|Overall Study|Withdrawal by Subject|1
43662|NCT01620255|185079|P2|Overall Study|Withdrawal by Subject|1
43663|NCT01620255|185080|P1|Overall Study|Withdrawal by Subject|4
43664|NCT01620177|185157|P1|Overall Study|Randomized, Not Active due to Scheduling|1
43665|NCT01620177|185157|P1|Overall Study|Physician Decision|2
43666|NCT01620177|185157|P1|Overall Study|Lost to Follow-up|7
43667|NCT01620177|185157|P1|Overall Study|Withdrawal by Subject|26
43668|NCT01620177|185157|P1|Overall Study|Failure at Screening Visit|43
43669|NCT01620138|185182|P2|Overall Study|Adverse Event|0
43670|NCT01620138|185183|P1|Overall Study|Adverse Event|2
43671|NCT01620138|185182|P2|Overall Study|Lack of Efficacy|0
43672|NCT01620138|185183|P1|Overall Study|Lack of Efficacy|1
43673|NCT01620138|185182|P2|Overall Study|Withdrawal by Subject|0
43674|NCT01620138|185183|P1|Overall Study|Withdrawal by Subject|3
43675|NCT01620086|185191|P3|Overall Study|Physician Decision|0
43676|NCT01620086|185192|P2|Overall Study|Physician Decision|0
43677|NCT01620086|185193|P1|Overall Study|Physician Decision|1
43678|NCT01620086|185191|P3|Overall Study|failed study criteria|0
43679|NCT01620086|185192|P2|Overall Study|failed study criteria|4
43680|NCT01620086|185193|P1|Overall Study|failed study criteria|1
43681|NCT01620086|185191|P3|Overall Study|Withdrawal by Subject|0
43682|NCT01620086|185192|P2|Overall Study|Withdrawal by Subject|3
43683|NCT01620086|185193|P1|Overall Study|Withdrawal by Subject|3
43684|NCT01620060|185212|P1|Overall Study|Per Sponsor Decision|2
43685|NCT01620060|185212|P1|Overall Study|Family emergency|1
43686|NCT01620060|185212|P1|Overall Study|Did not comply with Study Produre|1
43687|NCT01620060|185212|P1|Overall Study|Withdrawal by Subject|1
43688|NCT01620060|185212|P1|Overall Study|Protocol Violation|1
43689|NCT01620060|185212|P1|Overall Study|Adverse Event|9
43690|NCT01619878|185250|P1|Follow-up at 12 Months of Age|Death|2
43691|NCT01619878|185250|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
43692|NCT01619878|185250|P1|6 Week Follow-up Phase|Adverse Event|1
43693|NCT01619800|185264|P2|Overall Study|study terminated|0
43694|NCT01619800|185265|P1|Overall Study|study terminated|2
43695|NCT01619787|185273|P1|Overall Study|Lost to Follow-up|5
43696|NCT01619579|185290|P2|Overall Study|Withdrawal by Subject|3
43697|NCT01619579|185291|P1|Overall Study|Withdrawal by Subject|0
43698|NCT01619059|185303|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
43699|NCT01619059|185304|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
43700|NCT01619059|185303|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
43701|NCT01619059|185304|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
43702|NCT01619059|185303|P2|Long-Term (LT) Treatment Period|Death|0
43703|NCT01619059|185304|P1|Long-Term (LT) Treatment Period|Death|1
43704|NCT01619059|185303|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
43705|NCT01619059|185304|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
43706|NCT01619059|185303|P2|Long-Term (LT) Treatment Period|Adverse Event|3
43707|NCT01619059|185304|P1|Long-Term (LT) Treatment Period|Adverse Event|2
43708|NCT01619059|185303|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
43709|NCT01619059|185304|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
43710|NCT01619059|185303|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
43711|NCT01619059|185304|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
43712|NCT01619059|185303|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
43713|NCT01619059|185304|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
43714|NCT01619059|185303|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
43715|NCT01619059|185304|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
43716|NCT01619059|185303|P2|Short-Term (ST) Treatment Period|Adverse Event|0
43717|NCT01619059|185304|P1|Short-Term (ST) Treatment Period|Adverse Event|1
43718|NCT01618968|185320|P4|Overall Study|Death|1
43719|NCT01618968|185321|P3|Overall Study|Death|0
43720|NCT01618968|185322|P2|Overall Study|Death|0
43721|NCT01618968|185323|P1|Overall Study|Death|0
43722|NCT01618968|185320|P4|Overall Study|Adverse Event|0
43723|NCT01618968|185321|P3|Overall Study|Adverse Event|0
43724|NCT01618968|185322|P2|Overall Study|Adverse Event|0
43725|NCT01618968|185323|P1|Overall Study|Adverse Event|1
43726|NCT01618864|185390|P1|Overall Study|Lost to Follow-up|2
43727|NCT01618864|185390|P1|Overall Study|Withdrawal by Subject|2
43728|NCT01618838|185399|P1|Overall Study|slow accrual, trial closed prematurely.|4
43729|NCT01618708|185405|P2|Overall Study|Randomized but not treated|2
43730|NCT01618708|185406|P1|Overall Study|Randomized but not treated|3
43731|NCT01618708|185405|P2|Overall Study|Other than specified above|1
43732|NCT01618708|185406|P1|Overall Study|Other than specified above|1
43733|NCT01618708|185405|P2|Overall Study|Technical problems|0
43734|NCT01618708|185406|P1|Overall Study|Technical problems|2
43735|NCT01618708|185405|P2|Overall Study|Lack of Efficacy|8
43736|NCT01618708|185406|P1|Overall Study|Lack of Efficacy|8
43737|NCT01618708|185405|P2|Overall Study|Withdrawal by Subject|22
43738|NCT01618708|185406|P1|Overall Study|Withdrawal by Subject|17
43739|NCT01618708|185405|P2|Overall Study|Lost to Follow-up|3
43740|NCT01618708|185406|P1|Overall Study|Lost to Follow-up|3
43741|NCT01618708|185405|P2|Overall Study|Adverse Event|10
43742|NCT01618708|185406|P1|Overall Study|Adverse Event|10
43743|NCT01618669|185420|P2|Overall Study|Miscellaneous Reason|1
43744|NCT01618669|185421|P1|Overall Study|Miscellaneous Reason|0
43745|NCT01618669|185420|P2|Overall Study|Withdrawal by Subject|9
43746|NCT01618669|185421|P1|Overall Study|Withdrawal by Subject|9
43747|NCT01618669|185420|P2|Overall Study|Protocol Violation|3
43748|NCT01618669|185421|P1|Overall Study|Protocol Violation|5
43749|NCT01618669|185420|P2|Overall Study|Adverse Event|7
43750|NCT01618669|185421|P1|Overall Study|Adverse Event|16
43751|NCT01618669|185420|P2|Overall Study|Randomized but Never Received Study Drug|2
43752|NCT01618669|185421|P1|Overall Study|Randomized but Never Received Study Drug|3
43753|NCT01618669|185420|P2|Overall Study|Lost to Follow-up|1
43754|NCT01618669|185421|P1|Overall Study|Lost to Follow-up|1
43755|NCT01618266|185478|P1|Overall Study|Protocol Violation|43
43756|NCT01618266|185478|P1|Overall Study|Lack of Efficacy|23
43757|NCT01618266|185478|P1|Overall Study|Other reasons|11
43758|NCT01618266|185478|P1|Overall Study|Treatment satisfaction|10
43759|NCT01618266|185478|P1|Overall Study|Lost to Follow-up|9
43760|NCT01618214|185515|P2|Overall Study|Unclassified|5
43761|NCT01618214|185516|P1|Overall Study|Unclassified|4
43762|NCT01618214|185515|P2|Overall Study|Withdrawal Criteria|2
43763|NCT01618214|185516|P1|Overall Study|Withdrawal Criteria|1
43764|NCT01618214|185515|P2|Overall Study|Protocol Violation|4
43765|NCT01618214|185516|P1|Overall Study|Protocol Violation|1
43766|NCT01618214|185515|P2|Overall Study|Lack of Efficacy|1
43767|NCT01618214|185516|P1|Overall Study|Lack of Efficacy|1
43768|NCT01618214|185515|P2|Overall Study|Adverse Event|1
43769|NCT01618214|185516|P1|Overall Study|Adverse Event|3
43770|NCT01618162|185532|P2|Overall Study|Unclassified|13
43771|NCT01618162|185533|P1|Overall Study|Unclassified|14
43772|NCT01618162|185532|P2|Overall Study|Withdrawal Criteria|10
43773|NCT01618162|185533|P1|Overall Study|Withdrawal Criteria|2
43774|NCT01618162|185532|P2|Overall Study|Adverse Event|2
43775|NCT01618162|185533|P1|Overall Study|Adverse Event|9
43776|NCT01618162|185532|P2|Overall Study|Protocol Violation|10
43777|NCT01618162|185533|P1|Overall Study|Protocol Violation|13
43778|NCT01618019|185553|P2|Overall Study|Withdrawal by Subject|14
43779|NCT01618019|185554|P1|Overall Study|Withdrawal by Subject|14
43780|NCT01617681|185578|P5|Period 2 Open Label|Withdrawal by Subject|3
43781|NCT01617681|185579|P4|Period 2 Open Label|Withdrawal by Subject|0
43782|NCT01617681|185580|P3|Period 2 Open Label|Withdrawal by Subject|0
43783|NCT01617681|185581|P2|Period 2 Open Label|Withdrawal by Subject|0
43784|NCT01617681|185582|P1|Period 2 Open Label|Withdrawal by Subject|0
43785|NCT01617681|185578|P5|Period 2 Open Label|Adverse Event|3
43786|NCT01617681|185579|P4|Period 2 Open Label|Adverse Event|0
43787|NCT01617681|185580|P3|Period 2 Open Label|Adverse Event|0
43788|NCT01617681|185581|P2|Period 2 Open Label|Adverse Event|0
43789|NCT01617681|185582|P1|Period 2 Open Label|Adverse Event|0
43790|NCT01617681|185578|P5|Period 1 Double Blind|Withdrawal by Subject|0
43791|NCT01617681|185579|P4|Period 1 Double Blind|Withdrawal by Subject|0
43792|NCT01617681|185580|P3|Period 1 Double Blind|Withdrawal by Subject|1
43793|NCT01617681|185581|P2|Period 1 Double Blind|Withdrawal by Subject|1
43794|NCT01617681|185582|P1|Period 1 Double Blind|Withdrawal by Subject|1
43795|NCT01617681|185578|P5|Period 1 Double Blind|Adverse Event|0
43796|NCT01617681|185579|P4|Period 1 Double Blind|Adverse Event|2
43797|NCT01617681|185580|P3|Period 1 Double Blind|Adverse Event|0
43798|NCT01617681|185581|P2|Period 1 Double Blind|Adverse Event|0
43799|NCT01617681|185582|P1|Period 1 Double Blind|Adverse Event|2
43800|NCT01617668|185603|P4|Overall Study|Subject/guardian decision|1
43801|NCT01617668|185604|P3|Overall Study|Subject/guardian decision|2
43802|NCT01617668|185605|P2|Overall Study|Subject/guardian decision|3
43803|NCT01617668|185606|P1|Overall Study|Subject/guardian decision|1
43804|NCT01617668|185603|P4|Overall Study|Progressive Disease|9
43805|NCT01617668|185604|P3|Overall Study|Progressive Disease|6
43806|NCT01617668|185605|P2|Overall Study|Progressive Disease|4
43807|NCT01617668|185606|P1|Overall Study|Progressive Disease|4
43808|NCT01617668|185603|P4|Overall Study|Physician Decision|0
43809|NCT01617668|185604|P3|Overall Study|Physician Decision|3
43810|NCT01617668|185605|P2|Overall Study|Physician Decision|2
43811|NCT01617668|185606|P1|Overall Study|Physician Decision|1
43812|NCT01617668|185603|P4|Overall Study|Adverse Event|5
43813|NCT01617668|185604|P3|Overall Study|Adverse Event|12
43814|NCT01617668|185605|P2|Overall Study|Adverse Event|0
43815|NCT01617668|185606|P1|Overall Study|Adverse Event|7
43816|NCT01617655|185647|P2|Overall Study|Other than specified above|2
43817|NCT01617655|185648|P1|Overall Study|Other than specified above|1
43818|NCT01617655|185647|P2|Overall Study|Site closure|5
43819|NCT01617655|185648|P1|Overall Study|Site closure|3
43820|NCT01617655|185647|P2|Overall Study|Last visit outside protocol visit window|10
43821|NCT01617655|185648|P1|Overall Study|Last visit outside protocol visit window|1
43822|NCT01617655|185647|P2|Overall Study|Consent withdrawn by participant|1
43823|NCT01617655|185648|P1|Overall Study|Consent withdrawn by participant|1
43824|NCT01617655|185647|P2|Overall Study|Participants moved|4
43825|NCT01617655|185648|P1|Overall Study|Participants moved|0
43826|NCT01617655|185647|P2|Overall Study|Poor compliance to protocol|4
43827|NCT01617655|185648|P1|Overall Study|Poor compliance to protocol|1
43828|NCT01617655|185647|P2|Overall Study|Adverse Event|3
43829|NCT01617655|185648|P1|Overall Study|Adverse Event|2
43830|NCT01617629|185708|P1|Overall Study|Participant Withdrew Consent|2
43831|NCT01617629|185708|P1|Overall Study|Reason Not Specified|1
43832|NCT01617629|185708|P1|Overall Study|Investigator's Clinical Judgement|1
43833|NCT01617629|185708|P1|Overall Study|Death|2
43834|NCT01617460|185736|P1|Overall Study|Withdrawal by Subject|9
43835|NCT01617460|185736|P1|Overall Study|Protocol Violation|5
43836|NCT01617460|185736|P1|Overall Study|Physician Decision|16
43837|NCT01617460|185736|P1|Overall Study|Adverse Event|10
43838|NCT01617447|185742|P2|Overall Study|Physician Decision|2
43839|NCT01617447|185743|P1|Overall Study|Physician Decision|0
43840|NCT01617447|185742|P2|Overall Study|Adverse Event|1
43841|NCT01617447|185743|P1|Overall Study|Adverse Event|0
43842|NCT01617434|185751|P2|Overall Study|Unclassified|4
43843|NCT01617434|185752|P1|Overall Study|Unclassified|3
43844|NCT01617434|185751|P2|Overall Study|Withdrawal Criteria|37
43845|NCT01617434|185752|P1|Overall Study|Withdrawal Criteria|12
43846|NCT01617434|185751|P2|Overall Study|Protocol Violation|7
43847|NCT01617434|185752|P1|Overall Study|Protocol Violation|8
43848|NCT01617434|185751|P2|Overall Study|Adverse Event|3
43849|NCT01617434|185752|P1|Overall Study|Adverse Event|12
43850|NCT01617187|185784|P4|Treatment Through Study Completion|Protocol Violation|1
43851|NCT01617187|185785|P3|Treatment Through Study Completion|Protocol Violation|0
43852|NCT01617187|185786|P2|Treatment Through Study Completion|Protocol Violation|0
43853|NCT01617187|185787|P1|Treatment Through Study Completion|Protocol Violation|1
43854|NCT01617187|185784|P4|Treatment Through Study Completion|Withdrawal by Subject|6
43855|NCT01617187|185785|P3|Treatment Through Study Completion|Withdrawal by Subject|3
43856|NCT01617187|185786|P2|Treatment Through Study Completion|Withdrawal by Subject|8
43857|NCT01617187|185787|P1|Treatment Through Study Completion|Withdrawal by Subject|5
43858|NCT01617187|185784|P4|Treatment Through Study Completion|Lost to Follow-up|2
43859|NCT01617187|185785|P3|Treatment Through Study Completion|Lost to Follow-up|2
43860|NCT01617187|185786|P2|Treatment Through Study Completion|Lost to Follow-up|2
43861|NCT01617187|185787|P1|Treatment Through Study Completion|Lost to Follow-up|4
43862|NCT01617187|185784|P4|Treatment Through Study Completion|Adverse Event|1
43863|NCT01617187|185785|P3|Treatment Through Study Completion|Adverse Event|0
43864|NCT01617187|185786|P2|Treatment Through Study Completion|Adverse Event|1
43865|NCT01617187|185787|P1|Treatment Through Study Completion|Adverse Event|1
43866|NCT01617187|185784|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
43867|NCT01617187|185785|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
43868|NCT01617187|185786|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
43869|NCT01617187|185787|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
43870|NCT01617187|185784|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
43871|NCT01617187|185785|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
43872|NCT01617187|185786|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
43873|NCT01617187|185787|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
43874|NCT01617187|185784|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
43875|NCT01617187|185785|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
43876|NCT01617187|185786|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
43877|NCT01617187|185787|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
43878|NCT01617070|185873|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
43879|NCT01617005|185891|P1|Overall Study|Lack of motivation for treatment|1
43880|NCT01617005|185891|P1|Overall Study|Pregnancy|1
43881|NCT01616953|185900|P2|Overall Study|lack of bone and soft tissue|0
43882|NCT01616953|185901|P1|Overall Study|lack of bone and soft tissue|1
43883|NCT01616953|185900|P2|Overall Study|Lost to Follow-up|0
43884|NCT01616953|185901|P1|Overall Study|Lost to Follow-up|1
43885|NCT01616771|185909|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
43886|NCT01616459|185934|P4|Overall Study|Other reason|0
43887|NCT01616459|185935|P3|Overall Study|Other reason|1
43888|NCT01616459|185936|P2|Overall Study|Other reason|1
43889|NCT01616459|185937|P1|Overall Study|Other reason|0
43890|NCT01616459|185934|P4|Overall Study|Withdrawal by Subject|4
43891|NCT01616459|185935|P3|Overall Study|Withdrawal by Subject|4
43892|NCT01616459|185936|P2|Overall Study|Withdrawal by Subject|4
43893|NCT01616459|185937|P1|Overall Study|Withdrawal by Subject|2
43894|NCT01616459|185934|P4|Overall Study|Protocol Violation|2
43895|NCT01616459|185935|P3|Overall Study|Protocol Violation|0
43896|NCT01616459|185936|P2|Overall Study|Protocol Violation|0
43897|NCT01616459|185937|P1|Overall Study|Protocol Violation|0
43898|NCT01616459|185934|P4|Overall Study|Lost to Follow-up|2
43899|NCT01616459|185935|P3|Overall Study|Lost to Follow-up|3
43900|NCT01616459|185936|P2|Overall Study|Lost to Follow-up|11
43901|NCT01616459|185937|P1|Overall Study|Lost to Follow-up|1
43902|NCT01616459|185934|P4|Overall Study|Adverse Event|0
43903|NCT01616459|185935|P3|Overall Study|Adverse Event|2
43904|NCT01616459|185936|P2|Overall Study|Adverse Event|1
43905|NCT01616459|185937|P1|Overall Study|Adverse Event|1
43906|NCT01616173|186026|P3|Overall Study|Lost to Follow-up|0
43907|NCT01616173|186027|P2|Overall Study|Lost to Follow-up|2
43908|NCT01616173|186028|P1|Overall Study|Lost to Follow-up|0
43909|NCT01615939|186056|P2|Overall Study|Lost to Follow-up|0
43910|NCT01615939|186057|P1|Overall Study|Lost to Follow-up|5
43911|NCT01615822|186070|P3|Period 2|Lost to Follow-up|2
43912|NCT01615822|186071|P2|Period 2|Lost to Follow-up|1
43913|NCT01615822|186072|P1|Period 2|Lost to Follow-up|0
43914|NCT01615822|186070|P3|Period 1|Adverse Event|0
43915|NCT01615822|186071|P2|Period 1|Adverse Event|1
43916|NCT01615822|186072|P1|Period 1|Adverse Event|1
43917|NCT01615822|186070|P3|Period 1|Withdrawal by Subject|0
43918|NCT01615822|186071|P2|Period 1|Withdrawal by Subject|1
43919|NCT01615822|186072|P1|Period 1|Withdrawal by Subject|0
43920|NCT01615328|186160|P2|Overall Study|Lost to Follow-up|5
43921|NCT01615328|186161|P1|Overall Study|Lost to Follow-up|3
43922|NCT01615263|186173|P2|Overall Study|Post-randomization exclusion|2
43923|NCT01615263|186174|P1|Overall Study|Post-randomization exclusion|0
43924|NCT01615198|186188|P2|Overall Study|Adverse Event|5
43925|NCT01615198|186189|P1|Overall Study|Adverse Event|11
43926|NCT01615198|186188|P2|Overall Study|Lack of Efficacy|6
43927|NCT01615198|186189|P1|Overall Study|Lack of Efficacy|1
43928|NCT01615198|186188|P2|Overall Study|Lost to Follow-up|1
43929|NCT01615198|186189|P1|Overall Study|Lost to Follow-up|1
43930|NCT01615198|186188|P2|Overall Study|Physician Decision|1
43931|NCT01615198|186189|P1|Overall Study|Physician Decision|5
43932|NCT01615198|186188|P2|Overall Study|Protocol deviation|1
43933|NCT01615198|186189|P1|Overall Study|Protocol deviation|1
43934|NCT01615198|186188|P2|Overall Study|Withdrawal by Subject|5
43935|NCT01615198|186189|P1|Overall Study|Withdrawal by Subject|5
43936|NCT01615029|186222|P5|Overall Study|Ongoing|23
43937|NCT01615029|186223|P4|Overall Study|Ongoing|2
43938|NCT01615029|186224|P3|Overall Study|Ongoing|3
43939|NCT01615029|186225|P2|Overall Study|Ongoing|2
43940|NCT01615029|186226|P1|Overall Study|Ongoing|1
43941|NCT01615029|186222|P5|Overall Study|Physician Decision|1
43942|NCT01615029|186223|P4|Overall Study|Physician Decision|0
43943|NCT01615029|186224|P3|Overall Study|Physician Decision|0
43944|NCT01615029|186225|P2|Overall Study|Physician Decision|0
43945|NCT01615029|186226|P1|Overall Study|Physician Decision|0
43946|NCT01615029|186222|P5|Overall Study|Progressive disease|5
43947|NCT01615029|186223|P4|Overall Study|Progressive disease|1
43948|NCT01615029|186224|P3|Overall Study|Progressive disease|1
43949|NCT01615029|186225|P2|Overall Study|Progressive disease|1
43950|NCT01615029|186226|P1|Overall Study|Progressive disease|2
43951|NCT01615029|186222|P5|Overall Study|Lost to Follow-up|1
43952|NCT01615029|186223|P4|Overall Study|Lost to Follow-up|0
43953|NCT01615029|186224|P3|Overall Study|Lost to Follow-up|0
43954|NCT01615029|186225|P2|Overall Study|Lost to Follow-up|0
43955|NCT01615029|186226|P1|Overall Study|Lost to Follow-up|0
43956|NCT01615029|186222|P5|Overall Study|Death|1
43957|NCT01615029|186223|P4|Overall Study|Death|0
43958|NCT01615029|186224|P3|Overall Study|Death|0
43959|NCT01615029|186225|P2|Overall Study|Death|0
43960|NCT01615029|186226|P1|Overall Study|Death|0
43961|NCT01615029|186222|P5|Overall Study|Adverse Event|1
43962|NCT01615029|186223|P4|Overall Study|Adverse Event|0
43963|NCT01615029|186224|P3|Overall Study|Adverse Event|0
43964|NCT01615029|186225|P2|Overall Study|Adverse Event|0
43965|NCT01615029|186226|P1|Overall Study|Adverse Event|0
43966|NCT01614886|186249|P2|Overall Study|Protocol deviation|2
43967|NCT01614886|186250|P1|Overall Study|Protocol deviation|0
43968|NCT01614886|186249|P2|Overall Study|Death|0
43969|NCT01614886|186250|P1|Overall Study|Death|1
43970|NCT01614886|186249|P2|Overall Study|Withdrawal by Subject|4
43971|NCT01614886|186250|P1|Overall Study|Withdrawal by Subject|4
43972|NCT01614886|186249|P2|Overall Study|Adverse Event|20
43973|NCT01614886|186250|P1|Overall Study|Adverse Event|15
43974|NCT01614795|186268|P4|Overall Study|Ineligible|0
43975|NCT01614795|186269|P3|Overall Study|Ineligible|0
43976|NCT01614795|186270|P2|Overall Study|Ineligible|1
43977|NCT01614795|186271|P1|Overall Study|Ineligible|0
43978|NCT01614795|186268|P4|Overall Study|Withdrawal by Subject|2
43979|NCT01614795|186269|P3|Overall Study|Withdrawal by Subject|0
43980|NCT01614795|186270|P2|Overall Study|Withdrawal by Subject|1
43981|NCT01614795|186271|P1|Overall Study|Withdrawal by Subject|0
43982|NCT01614795|186268|P4|Overall Study|Physician Decision|1
43983|NCT01614795|186269|P3|Overall Study|Physician Decision|1
43984|NCT01614795|186270|P2|Overall Study|Physician Decision|0
43985|NCT01614795|186271|P1|Overall Study|Physician Decision|1
43986|NCT01614795|186268|P4|Overall Study|Lack of Efficacy|8
43987|NCT01614795|186269|P3|Overall Study|Lack of Efficacy|9
43988|NCT01614795|186270|P2|Overall Study|Lack of Efficacy|10
43989|NCT01614795|186271|P1|Overall Study|Lack of Efficacy|10
43990|NCT01614795|186268|P4|Overall Study|Adverse Event|1
43991|NCT01614795|186269|P3|Overall Study|Adverse Event|1
43992|NCT01614795|186270|P2|Overall Study|Adverse Event|0
43993|NCT01614795|186271|P1|Overall Study|Adverse Event|0
43994|NCT01614769|186281|P6|Period 3|Withdrawal by Subject|0
43995|NCT01614769|186282|P5|Period 3|Withdrawal by Subject|0
43996|NCT01614769|186283|P4|Period 3|Withdrawal by Subject|0
43997|NCT01614769|186284|P3|Period 3|Withdrawal by Subject|1
43998|NCT01614769|186285|P2|Period 3|Withdrawal by Subject|0
43999|NCT01614769|186286|P1|Period 3|Withdrawal by Subject|0
44000|NCT01614769|186281|P6|Period 1|Withdrawal by Subject|0
44001|NCT01614769|186282|P5|Period 1|Withdrawal by Subject|0
44002|NCT01614769|186283|P4|Period 1|Withdrawal by Subject|0
44003|NCT01614769|186284|P3|Period 1|Withdrawal by Subject|0
44004|NCT01614769|186285|P2|Period 1|Withdrawal by Subject|0
44005|NCT01614769|186286|P1|Period 1|Withdrawal by Subject|1
44006|NCT01614769|186281|P6|Period 1|Protocol Violation|0
44007|NCT01614769|186282|P5|Period 1|Protocol Violation|0
44008|NCT01614769|186283|P4|Period 1|Protocol Violation|1
44009|NCT01614769|186284|P3|Period 1|Protocol Violation|0
44010|NCT01614769|186285|P2|Period 1|Protocol Violation|0
44011|NCT01614769|186286|P1|Period 1|Protocol Violation|0
44012|NCT01614769|186281|P6|Period 1|Discontinued due to Hypoglycemia|1
44013|NCT01614769|186282|P5|Period 1|Discontinued due to Hypoglycemia|0
44014|NCT01614769|186283|P4|Period 1|Discontinued due to Hypoglycemia|1
44015|NCT01614769|186284|P3|Period 1|Discontinued due to Hypoglycemia|0
44016|NCT01614769|186285|P2|Period 1|Discontinued due to Hypoglycemia|0
44017|NCT01614769|186286|P1|Period 1|Discontinued due to Hypoglycemia|0
44018|NCT01614600|186308|P1|Overall Study|Protocol deviation|1
44019|NCT01614600|186308|P1|Overall Study|Unable to remove lens at the end of day|1
44020|NCT01614600|186308|P1|Overall Study|Discomfort|1
44021|NCT01614600|186308|P1|Overall Study|Unacceptable fit|1
44022|NCT01614470|186339|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
44023|NCT01614470|186340|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
44024|NCT01614470|186341|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
44025|NCT01614470|186339|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
44026|NCT01614470|186340|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
44027|NCT01614470|186341|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
44028|NCT01614457|186363|P2|Overall Study|Pregnancy (Self or Partner)|0
44029|NCT01614457|186364|P1|Overall Study|Pregnancy (Self or Partner)|1
44030|NCT01614457|186363|P2|Overall Study|Non-Compliance|0
44031|NCT01614457|186364|P1|Overall Study|Non-Compliance|1
44032|NCT01614249|186382|P2|Overall Study|Lost to Follow-up|23
44033|NCT01614249|186383|P1|Overall Study|Lost to Follow-up|11
44034|NCT01614093|186395|P1|Overall Study|Withdrawal by Subject|1
44035|NCT01613716|186400|P1|Overall Study|Lost to Follow-up|4
44036|NCT01613716|186400|P1|Overall Study|screen failures|3
44037|NCT01613599|186405|P1|Overall Study|Ongoing|81
44038|NCT01613599|186405|P1|Overall Study|Reason not specified|2
44039|NCT01613599|186405|P1|Overall Study|Withdrawal by Subject|6
44040|NCT01613599|186405|P1|Overall Study|Lost to Follow-up|2
44041|NCT01613599|186405|P1|Overall Study|Death|6
44042|NCT01613417|186420|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
44043|NCT01613417|186421|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
44044|NCT01613378|186458|P1|Overall Study|Other Reason|4
44045|NCT01613378|186458|P1|Overall Study|Lost to Follow-up|1
44046|NCT01613378|186458|P1|Overall Study|Death|2
44047|NCT01613378|186458|P1|Overall Study|Withdrawal by Subject|8
44048|NCT01613378|186458|P1|Overall Study|Adverse Event|11
44049|NCT01613378|186458|P1|Overall Study|Lack of Efficacy|13
44050|NCT01613326|186488|P2|Overall Study|Protocol Violation|1
44051|NCT01613326|186489|P1|Overall Study|Protocol Violation|0
44052|NCT01613326|186488|P2|Overall Study|Administrative|2
44053|NCT01613326|186489|P1|Overall Study|Administrative|0
44054|NCT01613326|186488|P2|Overall Study|Lost to Follow-up|1
44055|NCT01613326|186489|P1|Overall Study|Lost to Follow-up|0
44056|NCT01613326|186488|P2|Overall Study|Lack of Efficacy|1
44057|NCT01613326|186489|P1|Overall Study|Lack of Efficacy|0
44058|NCT01613326|186488|P2|Overall Study|inability to use device|0
44059|NCT01613326|186489|P1|Overall Study|inability to use device|1
44060|NCT01613326|186488|P2|Overall Study|Abnormal test procedure result(s)|0
44061|NCT01613326|186489|P1|Overall Study|Abnormal test procedure result(s)|2
44062|NCT01613326|186488|P2|Overall Study|Withdrawal by Subject|4
44063|NCT01613326|186489|P1|Overall Study|Withdrawal by Subject|3
44064|NCT01613326|186488|P2|Overall Study|Adverse Event|5
44065|NCT01613326|186489|P1|Overall Study|Adverse Event|7
44066|NCT01613248|186546|P6|Overall Study|Pregnancy|0
44067|NCT01613248|186547|P5|Overall Study|Pregnancy|0
44068|NCT01613248|186548|P4|Overall Study|Pregnancy|1
44069|NCT01613248|186549|P3|Overall Study|Pregnancy|0
44070|NCT01613248|186550|P2|Overall Study|Pregnancy|0
44071|NCT01613248|186551|P1|Overall Study|Pregnancy|0
44072|NCT01613248|186546|P6|Overall Study|Lack of Qualifying Event|18
44073|NCT01613248|186547|P5|Overall Study|Lack of Qualifying Event|15
44074|NCT01613248|186548|P4|Overall Study|Lack of Qualifying Event|11
44075|NCT01613248|186549|P3|Overall Study|Lack of Qualifying Event|10
44076|NCT01613248|186550|P2|Overall Study|Lack of Qualifying Event|11
44077|NCT01613248|186551|P1|Overall Study|Lack of Qualifying Event|9
44078|NCT01613248|186546|P6|Overall Study|Physician Decision|6
44079|NCT01613248|186547|P5|Overall Study|Physician Decision|7
44080|NCT01613248|186548|P4|Overall Study|Physician Decision|4
44081|NCT01613248|186549|P3|Overall Study|Physician Decision|9
44082|NCT01613248|186550|P2|Overall Study|Physician Decision|8
44083|NCT01613248|186551|P1|Overall Study|Physician Decision|8
44084|NCT01613248|186546|P6|Overall Study|Study Terminated by Sponsor|11
44085|NCT01613248|186547|P5|Overall Study|Study Terminated by Sponsor|9
44086|NCT01613248|186548|P4|Overall Study|Study Terminated by Sponsor|8
44087|NCT01613248|186549|P3|Overall Study|Study Terminated by Sponsor|8
44088|NCT01613248|186550|P2|Overall Study|Study Terminated by Sponsor|6
44089|NCT01613248|186551|P1|Overall Study|Study Terminated by Sponsor|4
44090|NCT01613248|186546|P6|Overall Study|Lost to Follow-up|2
44091|NCT01613248|186547|P5|Overall Study|Lost to Follow-up|4
44092|NCT01613248|186548|P4|Overall Study|Lost to Follow-up|8
44093|NCT01613248|186549|P3|Overall Study|Lost to Follow-up|4
44094|NCT01613248|186550|P2|Overall Study|Lost to Follow-up|7
44095|NCT01613248|186551|P1|Overall Study|Lost to Follow-up|5
44096|NCT01613248|186546|P6|Overall Study|Withdrawal by Subject|1
44097|NCT01613248|186547|P5|Overall Study|Withdrawal by Subject|0
44098|NCT01613248|186548|P4|Overall Study|Withdrawal by Subject|5
44099|NCT01613248|186549|P3|Overall Study|Withdrawal by Subject|2
44100|NCT01613248|186550|P2|Overall Study|Withdrawal by Subject|2
44101|NCT01613248|186551|P1|Overall Study|Withdrawal by Subject|3
44102|NCT01613248|186546|P6|Overall Study|Adverse Event|0
44103|NCT01613248|186547|P5|Overall Study|Adverse Event|0
44104|NCT01613248|186548|P4|Overall Study|Adverse Event|1
44105|NCT01613248|186549|P3|Overall Study|Adverse Event|0
44106|NCT01613248|186550|P2|Overall Study|Adverse Event|0
44107|NCT01613248|186551|P1|Overall Study|Adverse Event|0
44108|NCT01613131|186651|P2|Overall Study|Withdrawal by Subject|5
44109|NCT01613131|186652|P1|Overall Study|Withdrawal by Subject|3
44110|NCT01613027|186680|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
44111|NCT01613027|186680|P1|Overall Study|Lack of Efficacy|1
44112|NCT01613027|186680|P1|Overall Study|Switched Physician|1
44113|NCT01613027|186680|P1|Overall Study|Lost to Follow-up|5
44114|NCT01612858|186723|P2|Overall Study|Withdrawal by Subject|1
44115|NCT01612858|186724|P1|Overall Study|Withdrawal by Subject|5
44116|NCT01612702|186761|P2|Overall Study|Protocol Violation|11
44117|NCT01612702|186762|P1|Overall Study|Protocol Violation|11
44118|NCT01612676|186776|P4|Overall Study|Protocol Violation|0
44119|NCT01612676|186777|P3|Overall Study|Protocol Violation|0
44120|NCT01612676|186778|P2|Overall Study|Protocol Violation|1
44121|NCT01612676|186779|P1|Overall Study|Protocol Violation|0
44122|NCT01612676|186776|P4|Overall Study|Adverse Event|3
44123|NCT01612676|186777|P3|Overall Study|Adverse Event|1
44124|NCT01612676|186778|P2|Overall Study|Adverse Event|3
44125|NCT01612676|186779|P1|Overall Study|Adverse Event|2
44126|NCT01612156|186877|P2|Overall Study|Protocol Violation|0
44127|NCT01612156|186878|P1|Overall Study|Protocol Violation|2
44128|NCT01612000|186890|P4|Overall Study|Withdrawal by Subject|2
44129|NCT01612000|186891|P3|Overall Study|Withdrawal by Subject|2
44130|NCT01612000|186892|P2|Overall Study|Withdrawal by Subject|1
44131|NCT01612000|186893|P1|Overall Study|Withdrawal by Subject|3
44132|NCT01612000|186890|P4|Overall Study|Physician Decision|0
44133|NCT01612000|186891|P3|Overall Study|Physician Decision|1
44134|NCT01612000|186892|P2|Overall Study|Physician Decision|0
44135|NCT01612000|186893|P1|Overall Study|Physician Decision|0
44136|NCT01612000|186890|P4|Overall Study|Lost to Follow-up|8
44137|NCT01612000|186891|P3|Overall Study|Lost to Follow-up|4
44138|NCT01612000|186892|P2|Overall Study|Lost to Follow-up|4
44139|NCT01612000|186893|P1|Overall Study|Lost to Follow-up|6
44140|NCT01611974|186918|P3|Overall Study|Withdrawal by Subject|4
44141|NCT01611974|186919|P2|Overall Study|Withdrawal by Subject|1
44142|NCT01611974|186920|P1|Overall Study|Withdrawal by Subject|0
44143|NCT01611974|186918|P3|Overall Study|Physician Decision|2
44144|NCT01611974|186919|P2|Overall Study|Physician Decision|1
44145|NCT01611974|186920|P1|Overall Study|Physician Decision|5
44146|NCT01611974|186918|P3|Overall Study|Lost to Follow-up|0
44147|NCT01611974|186919|P2|Overall Study|Lost to Follow-up|1
44148|NCT01611974|186920|P1|Overall Study|Lost to Follow-up|0
44149|NCT01611974|186918|P3|Overall Study|Death|10
44150|NCT01611974|186919|P2|Overall Study|Death|12
44151|NCT01611974|186920|P1|Overall Study|Death|10
44152|NCT01611883|186966|P2|Overall Study|Adverse Event|1
44153|NCT01611883|186967|P1|Overall Study|Adverse Event|1
44154|NCT01611857|186993|P2|Overall Study|Withdrawal by Subject|2
44155|NCT01611857|186994|P1|Overall Study|Withdrawal by Subject|0
44156|NCT01611792|187006|P2|Followup: at 6 Months|Lost to Follow-up|13
44157|NCT01611792|187007|P1|Followup: at 6 Months|Lost to Follow-up|6
44158|NCT01611792|187006|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
44159|NCT01611792|187007|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
44160|NCT01611558|187061|P1|Maintenance Phase|Study drug toxicity|1
44161|NCT01611558|187061|P1|Maintenance Phase|Withdrawal by Subject|1
44162|NCT01611558|187061|P1|Induction Phase|Death|1
44163|NCT01611558|187061|P1|Induction Phase|Adverse event unrelated to study drug|1
44164|NCT01611558|187061|P1|Induction Phase|Not reported|5
44165|NCT01611558|187061|P1|Induction Phase|Disease progression|14
44166|NCT01611558|187061|P1|Induction Phase|Study drug toxicity|17
44167|NCT01611259|187067|P1|Overall Study|Withdrawal by Subject|7
44168|NCT01611259|187067|P1|Overall Study|Adverse Event|4
44169|NCT01611259|187067|P1|Overall Study|Lack of Efficacy|2
44170|NCT01611259|187067|P1|Overall Study|Physician Decision|1
44171|NCT01610791|187071|P1|Overall Study|Not determined|5
44172|NCT01610791|187071|P1|Overall Study|Death|1
44173|NCT01610791|187071|P1|Overall Study|Adverse event and Investigator decision|1
44174|NCT01610791|187071|P1|Overall Study|Physician Decision|1
44175|NCT01610791|187071|P1|Overall Study|Adverse Event|6
44176|NCT01610791|187071|P1|Overall Study|Lost to Follow-up|7
44177|NCT01610713|187094|P2|Overall Study|Lost to Follow-up|1
44178|NCT01610713|187095|P1|Overall Study|Lost to Follow-up|0
44179|NCT01610713|187094|P2|Overall Study|adv. to use original dose/amitriptyline|0
44180|NCT01610713|187095|P1|Overall Study|adv. to use original dose/amitriptyline|1
44181|NCT01610713|187094|P2|Overall Study|low mood and poor motivation|0
44182|NCT01610713|187095|P1|Overall Study|low mood and poor motivation|1
44183|NCT01610713|187094|P2|Overall Study|Lack of Efficacy|0
44184|NCT01610713|187095|P1|Overall Study|Lack of Efficacy|1
44185|NCT01610713|187094|P2|Overall Study|Adverse Event|0
44186|NCT01610713|187095|P1|Overall Study|Adverse Event|3
44187|NCT01610700|187153|P2|Overall Study|subject took one dose of street cannabis|1
44188|NCT01610700|187154|P1|Overall Study|subject took one dose of street cannabis|0
44189|NCT01610700|187153|P2|Overall Study|Withdrawal by Subject|1
44190|NCT01610700|187154|P1|Overall Study|Withdrawal by Subject|0
44191|NCT01610700|187153|P2|Overall Study|Adverse Event|1
44192|NCT01610700|187154|P1|Overall Study|Adverse Event|3
44193|NCT01610687|187208|P1|Overall Study|Felt more alter without study medication|1
44194|NCT01610687|187208|P1|Overall Study|Cannabis affecting job|1
44195|NCT01610687|187208|P1|Overall Study|Death|1
44196|NCT01610687|187208|P1|Overall Study|Unable to make journey|1
44197|NCT01610687|187208|P1|Overall Study|Symptom control without study medication|2
44198|NCT01610687|187208|P1|Overall Study|Lost to Follow-up|4
44199|NCT01610687|187208|P1|Overall Study|Withdrawal by Subject|7
44200|NCT01610687|187208|P1|Overall Study|Moved out of area|6
44201|NCT01610687|187208|P1|Overall Study|Adverse Event|18
44202|NCT01610687|187208|P1|Overall Study|Lack of Efficacy|26
44203|NCT01610596|187221|P2|Overall Study|Lost to Follow-up|1
44204|NCT01610596|187222|P1|Overall Study|Lost to Follow-up|0
44205|NCT01610557|187280|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
44206|NCT01610557|187281|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
44207|NCT01610557|187282|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
44208|NCT01610557|187283|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
44209|NCT01610557|187284|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
44210|NCT01610557|187280|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
44211|NCT01610557|187281|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
44212|NCT01610557|187282|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
44213|NCT01610557|187283|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
44214|NCT01610557|187284|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
44215|NCT01610492|187297|P1|Overall Study|Other:Treatment stopped due to remission|1
44216|NCT01610492|187297|P1|Overall Study|Other: Reached stopping criteria|1
44217|NCT01610492|187297|P1|Overall Study|Lack of Efficacy|3
44218|NCT01610492|187297|P1|Overall Study|Adverse Event|1
44219|NCT01610414|187348|P2|After Month 25|Study end not reached|53
44220|NCT01610414|187349|P1|After Month 25|Study end not reached|48
44221|NCT01610414|187348|P2|Month 13 - Month 25|Other reasons for withdrawal|7
44222|NCT01610414|187349|P1|Month 13 - Month 25|Other reasons for withdrawal|6
44223|NCT01610414|187348|P2|Month 13 - Month 25|Lost to Follow-up|9
44224|NCT01610414|187349|P1|Month 13 - Month 25|Lost to Follow-up|5
44225|NCT01610414|187348|P2|Month 13 - Month 25|Protocol Violation|2
44226|NCT01610414|187349|P1|Month 13 - Month 25|Protocol Violation|0
44227|NCT01610414|187348|P2|Month 13 - Month 25|Migrated/moved from study area|2
44228|NCT01610414|187349|P1|Month 13 - Month 25|Migrated/moved from study area|4
44229|NCT01610414|187348|P2|Month 13 - Month 25|Withdrawal by Subject|8
44230|NCT01610414|187349|P1|Month 13 - Month 25|Withdrawal by Subject|7
44231|NCT01610414|187348|P2|Month 13 - Month 25|Adverse Event|4
44232|NCT01610414|187349|P1|Month 13 - Month 25|Adverse Event|8
44233|NCT01610414|187348|P2|Month 13 - Month 25|Serious Adverse Event|38
44234|NCT01610414|187349|P1|Month 13 - Month 25|Serious Adverse Event|35
44235|NCT01610414|187348|P2|Study Start - Month 13|Other reasons for withdrawal|4
44236|NCT01610414|187349|P1|Study Start - Month 13|Other reasons for withdrawal|3
44237|NCT01610414|187348|P2|Study Start - Month 13|Suspected HZ episode|3
44238|NCT01610414|187349|P1|Study Start - Month 13|Suspected HZ episode|1
44239|NCT01610414|187348|P2|Study Start - Month 13|Lost to Follow-up|6
44240|NCT01610414|187349|P1|Study Start - Month 13|Lost to Follow-up|4
44241|NCT01610414|187348|P2|Study Start - Month 13|Migrated/moved from study area|4
44242|NCT01610414|187349|P1|Study Start - Month 13|Migrated/moved from study area|2
44243|NCT01610414|187348|P2|Study Start - Month 13|Withdrawal by Subject|30
44244|NCT01610414|187349|P1|Study Start - Month 13|Withdrawal by Subject|23
44245|NCT01610414|187348|P2|Study Start - Month 13|Protocol Violation|1
44246|NCT01610414|187349|P1|Study Start - Month 13|Protocol Violation|3
44247|NCT01610414|187348|P2|Study Start - Month 13|Adverse Event|14
44248|NCT01610414|187349|P1|Study Start - Month 13|Adverse Event|14
44249|NCT01610414|187348|P2|Study Start - Month 13|Serious Adverse Event|67
44250|NCT01610414|187349|P1|Study Start - Month 13|Serious Adverse Event|65
44251|NCT01610297|187378|P1|Overall Study|Lost to Follow-up|1
44252|NCT01610167|187389|P3|Overall Study|Scheduling conflict.|2
44253|NCT01610167|187390|P2|Overall Study|Scheduling conflict.|0
44254|NCT01610167|187391|P1|Overall Study|Scheduling conflict.|0
44255|NCT01610076|187428|P2|Overall Study|Lost to Follow-up|4
44256|NCT01610076|187429|P1|Overall Study|Lost to Follow-up|3
44257|NCT01610076|187428|P2|Overall Study|Technical issue with video|1
44258|NCT01610076|187429|P1|Overall Study|Technical issue with video|0
44259|NCT01610063|187440|P2|Overall Study|Lost to Follow-up|20
44260|NCT01610063|187441|P1|Overall Study|Lost to Follow-up|42
44261|NCT01610037|187464|P3|Treatment and Follow up Period|Lost to Follow-up|4
44262|NCT01610037|187465|P2|Treatment and Follow up Period|Lost to Follow-up|6
44263|NCT01610037|187466|P1|Treatment and Follow up Period|Lost to Follow-up|1
44264|NCT01610037|187464|P3|Treatment and Follow up Period|Administrative problems|2
44265|NCT01610037|187465|P2|Treatment and Follow up Period|Administrative problems|3
44266|NCT01610037|187466|P1|Treatment and Follow up Period|Administrative problems|1
44267|NCT01610037|187464|P3|Treatment and Follow up Period|Death|4
44268|NCT01610037|187465|P2|Treatment and Follow up Period|Death|5
44269|NCT01610037|187466|P1|Treatment and Follow up Period|Death|10
44270|NCT01610037|187464|P3|Treatment and Follow up Period|Subject withdrew consent|16
44271|NCT01610037|187465|P2|Treatment and Follow up Period|Subject withdrew consent|14
44272|NCT01610037|187466|P1|Treatment and Follow up Period|Subject withdrew consent|13
44273|NCT01610037|187464|P3|All Patients|Abnormal test procedure result(s)|3
44274|NCT01610037|187465|P2|All Patients|Abnormal test procedure result(s)|1
44275|NCT01610037|187466|P1|All Patients|Abnormal test procedure result(s)|0
44276|NCT01610037|187464|P3|All Patients|Lost to Follow-up|0
44277|NCT01610037|187465|P2|All Patients|Lost to Follow-up|0
44278|NCT01610037|187466|P1|All Patients|Lost to Follow-up|1
44279|NCT01610037|187464|P3|All Patients|Administrative problems|4
44280|NCT01610037|187465|P2|All Patients|Administrative problems|4
44281|NCT01610037|187466|P1|All Patients|Administrative problems|1
44282|NCT01610037|187464|P3|All Patients|Abnormal laboratory value|0
44283|NCT01610037|187465|P2|All Patients|Abnormal laboratory value|1
44284|NCT01610037|187466|P1|All Patients|Abnormal laboratory value|1
44285|NCT01610037|187464|P3|All Patients|Protocol deviation|3
44286|NCT01610037|187465|P2|All Patients|Protocol deviation|3
44287|NCT01610037|187466|P1|All Patients|Protocol deviation|4
44288|NCT01610037|187464|P3|All Patients|Death|1
44289|NCT01610037|187465|P2|All Patients|Death|2
44290|NCT01610037|187466|P1|All Patients|Death|4
44291|NCT01610037|187464|P3|All Patients|Unsatisfactory therapeutic effect|27
44292|NCT01610037|187465|P2|All Patients|Unsatisfactory therapeutic effect|8
44293|NCT01610037|187466|P1|All Patients|Unsatisfactory therapeutic effect|9
44294|NCT01610037|187464|P3|All Patients|Withdrawal by Subject|20
44295|NCT01610037|187465|P2|All Patients|Withdrawal by Subject|10
44296|NCT01610037|187466|P1|All Patients|Withdrawal by Subject|12
44297|NCT01610037|187464|P3|All Patients|Adverse Event|26
44298|NCT01610037|187465|P2|All Patients|Adverse Event|22
44299|NCT01610037|187466|P1|All Patients|Adverse Event|27
44300|NCT01609790|187519|P3|Overall Study|Protocol Violation|8
44301|NCT01609790|187520|P2|Overall Study|Protocol Violation|7
44302|NCT01609790|187521|P1|Overall Study|Protocol Violation|1
44303|NCT01609582|187540|P2|Overall Study|Randomized, but not treated|3
44304|NCT01609582|187541|P1|Overall Study|Randomized, but not treated|0
44305|NCT01609582|187540|P2|Overall Study|Other|10
44306|NCT01609582|187541|P1|Overall Study|Other|9
44307|NCT01609582|187540|P2|Overall Study|Study Terminated by Sponsor|1548
44308|NCT01609582|187541|P1|Overall Study|Study Terminated by Sponsor|1543
44309|NCT01609582|187540|P2|Overall Study|Withdrawal by Subject|15
44310|NCT01609582|187541|P1|Overall Study|Withdrawal by Subject|21
44311|NCT01609582|187540|P2|Overall Study|Lost to Follow-up|10
44312|NCT01609582|187541|P1|Overall Study|Lost to Follow-up|10
44313|NCT01609582|187540|P2|Overall Study|Adverse Event|18
44314|NCT01609582|187541|P1|Overall Study|Adverse Event|20
44315|NCT01609543|187549|P1|Overall Study|Death|7
44316|NCT01609543|187549|P1|Overall Study|Protocol Violation|1
44317|NCT01609543|187549|P1|Overall Study|Withdrawal by Subject|1
44318|NCT01609543|187549|P1|Overall Study|Adverse Event|5
44319|NCT01609543|187549|P1|Overall Study|Disease Progression|28
44320|NCT01609478|187558|P3|Overall Study|Withdrawal by Subject|2
44321|NCT01609478|187559|P2|Overall Study|Withdrawal by Subject|0
44322|NCT01609478|187560|P1|Overall Study|Withdrawal by Subject|2
44323|NCT01609478|187558|P3|Overall Study|Physician Decision|1
44324|NCT01609478|187559|P2|Overall Study|Physician Decision|0
44325|NCT01609478|187560|P1|Overall Study|Physician Decision|1
44326|NCT01609478|187558|P3|Overall Study|Non-Compliance with study treatment|0
44327|NCT01609478|187559|P2|Overall Study|Non-Compliance with study treatment|0
44328|NCT01609478|187560|P1|Overall Study|Non-Compliance with study treatment|1
44329|NCT01609478|187558|P3|Overall Study|Protocol Deviation|1
44330|NCT01609478|187559|P2|Overall Study|Protocol Deviation|1
44331|NCT01609478|187560|P1|Overall Study|Protocol Deviation|0
44332|NCT01609478|187558|P3|Overall Study|Adverse Event|5
44333|NCT01609478|187559|P2|Overall Study|Adverse Event|1
44334|NCT01609478|187560|P1|Overall Study|Adverse Event|3
44335|NCT01609257|187635|P2|Overall Study|Non-compliance/Protocol deviation|6
44336|NCT01609257|187636|P1|Overall Study|Non-compliance/Protocol deviation|4
44337|NCT01609257|187635|P2|Overall Study|Voluntary Withdrawal by Subject|1
44338|NCT01609257|187636|P1|Overall Study|Voluntary Withdrawal by Subject|0
44339|NCT01609257|187635|P2|Overall Study|Lost to Follow-up|1
44340|NCT01609257|187636|P1|Overall Study|Lost to Follow-up|2
44341|NCT01609062|187708|P2|Extension Phase|Anticipated surgery & transition to EAP|1
44342|NCT01609062|187709|P1|Extension Phase|Anticipated surgery & transition to EAP|0
44343|NCT01609062|187708|P2|Extension Phase|Discontinued drug and then was pregnant|0
44344|NCT01609062|187709|P1|Extension Phase|Discontinued drug and then was pregnant|1
44345|NCT01609062|187708|P2|Extension Phase|Terminated by Sponsor|9
44346|NCT01609062|187709|P1|Extension Phase|Terminated by Sponsor|14
44347|NCT01609023|187752|P1|Overall Study|Personal reasons|1
44348|NCT01609023|187752|P1|Overall Study|Death|2
44349|NCT01609023|187752|P1|Overall Study|Physician Decision|2
44350|NCT01609023|187752|P1|Overall Study|Disease progression|10
44351|NCT01609023|187752|P1|Overall Study|Toxicity|3
44352|NCT01609023|187752|P1|Overall Study|Lost to Follow-up|8
44353|NCT01609023|187752|P1|Overall Study|Withdrawal by Subject|4
44354|NCT01609023|187752|P1|Overall Study|Lack of Efficacy|3
44355|NCT01609010|187764|P2|Overall Study|Lost to Follow-up|1
44356|NCT01609010|187765|P1|Overall Study|Lost to Follow-up|1
44357|NCT01609010|187764|P2|Overall Study|New cancer|0
44358|NCT01609010|187765|P1|Overall Study|New cancer|1
44359|NCT01609010|187764|P2|Overall Study|Protocol Violation|1
44360|NCT01609010|187765|P1|Overall Study|Protocol Violation|1
44361|NCT01609010|187764|P2|Overall Study|Pathology review|1
44362|NCT01609010|187765|P1|Overall Study|Pathology review|2
44363|NCT01609010|187764|P2|Overall Study|Other malignancy|0
44364|NCT01609010|187765|P1|Overall Study|Other malignancy|1
44365|NCT01609010|187764|P2|Overall Study|Not specified|0
44366|NCT01609010|187765|P1|Overall Study|Not specified|2
44367|NCT01609010|187764|P2|Overall Study|Withdrawal by Subject|2
44368|NCT01609010|187765|P1|Overall Study|Withdrawal by Subject|2
44369|NCT01609010|187764|P2|Overall Study|Adverse Event|6
44370|NCT01609010|187765|P1|Overall Study|Adverse Event|3
44371|NCT01609010|187764|P2|Overall Study|Progressive disease (PD)|10
44372|NCT01609010|187765|P1|Overall Study|Progressive disease (PD)|8
44373|NCT01609010|187764|P2|Overall Study|Stable disease (SD)|16
44374|NCT01609010|187765|P1|Overall Study|Stable disease (SD)|22
44375|NCT01608724|187826|P1|Overall Study|Safety reasons|1
44376|NCT01608724|187826|P1|Overall Study|bood sugar too high, etc.|3
44377|NCT01608724|187826|P1|Overall Study|Protocol Violation|6
44378|NCT01608724|187826|P1|Overall Study|Adverse Event|29
44379|NCT01608724|187826|P1|Overall Study|Study-specific discontinuation criteria|32
44380|NCT01608724|187826|P1|Overall Study|Lost to Follow-up|41
44381|NCT01608724|187826|P1|Overall Study|Withdrawal by Subject|131
44382|NCT01608321|187858|P2|Overall Study|Withdrawal by Subject|0
44383|NCT01608321|187859|P1|Overall Study|Withdrawal by Subject|1
44384|NCT01608308|187867|P2|Overall Study|pretreatment medical and billing reasons|2
44385|NCT01608308|187868|P1|Overall Study|pretreatment medical and billing reasons|0
44386|NCT01607593|188068|P1|Overall Study|Other|4
44387|NCT01607593|188068|P1|Overall Study|Continuation|33
44388|NCT01607593|188068|P1|Overall Study|Lost to Follow-up|25
44389|NCT01607593|188068|P1|Overall Study|Lack of Efficacy|16
44390|NCT01607593|188068|P1|Overall Study|Adverse Event|15
44391|NCT01607554|188074|P1|Overall Study|Disease progression|2
44392|NCT01607476|188087|P3|Overall Study|Lost to Follow-up|2
44393|NCT01607476|188088|P2|Overall Study|Lost to Follow-up|0
44394|NCT01607476|188089|P1|Overall Study|Lost to Follow-up|0
44395|NCT01607476|188087|P3|Overall Study|Withdrawal by Subject|1
44396|NCT01607476|188088|P2|Overall Study|Withdrawal by Subject|0
44397|NCT01607476|188089|P1|Overall Study|Withdrawal by Subject|1
44398|NCT01607398|188183|P2|Overall Study|Severe COPD|0
44399|NCT01607398|188184|P1|Overall Study|Severe COPD|2
44400|NCT01607398|188183|P2|Overall Study|Adverse Event|2
44401|NCT01607398|188184|P1|Overall Study|Adverse Event|0
44402|NCT01607346|188228|P1|Overall Study|Adverse Event|3
44403|NCT01606800|188312|P2|Overall Study|Missing completion status|0
44404|NCT01606800|188313|P1|Overall Study|Missing completion status|2
44405|NCT01606800|188312|P2|Overall Study|Participant withdrew consent|1
44406|NCT01606800|188313|P1|Overall Study|Participant withdrew consent|0
44407|NCT01606800|188312|P2|Overall Study|Adverse Event|1
44408|NCT01606800|188313|P1|Overall Study|Adverse Event|3
44409|NCT01606761|188322|P5|Safety Follow-up Period (Week 52-68)|Other|3
44410|NCT01606761|188323|P4|Safety Follow-up Period (Week 52-68)|Other|1
44411|NCT01606761|188324|P3|Safety Follow-up Period (Week 52-68)|Other|9
44412|NCT01606761|188325|P2|Safety Follow-up Period (Week 52-68)|Other|3
44413|NCT01606761|188326|P1|Safety Follow-up Period (Week 52-68)|Other|0
44414|NCT01606761|188322|P5|Safety Follow-up Period (Week 52-68)|Death|1
44415|NCT01606761|188323|P4|Safety Follow-up Period (Week 52-68)|Death|0
44416|NCT01606761|188324|P3|Safety Follow-up Period (Week 52-68)|Death|0
44417|NCT01606761|188325|P2|Safety Follow-up Period (Week 52-68)|Death|0
44418|NCT01606761|188326|P1|Safety Follow-up Period (Week 52-68)|Death|0
44419|NCT01606761|188322|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
44420|NCT01606761|188323|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
44421|NCT01606761|188324|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
44422|NCT01606761|188325|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
44423|NCT01606761|188326|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
44424|NCT01606761|188322|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
44425|NCT01606761|188323|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
44426|NCT01606761|188324|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
44427|NCT01606761|188325|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
44428|NCT01606761|188326|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
44429|NCT01606761|188322|P5|Week 24 to Week 52|Other|2
44430|NCT01606761|188323|P4|Week 24 to Week 52|Other|2
44431|NCT01606761|188324|P3|Week 24 to Week 52|Other|5
44432|NCT01606761|188325|P2|Week 24 to Week 52|Other|1
44433|NCT01606761|188326|P1|Week 24 to Week 52|Other|0
44434|NCT01606761|188322|P5|Week 24 to Week 52|Physician Decision|0
44435|NCT01606761|188323|P4|Week 24 to Week 52|Physician Decision|0
44436|NCT01606761|188324|P3|Week 24 to Week 52|Physician Decision|1
44437|NCT01606761|188325|P2|Week 24 to Week 52|Physician Decision|1
44438|NCT01606761|188326|P1|Week 24 to Week 52|Physician Decision|0
44439|NCT01606761|188322|P5|Week 24 to Week 52|Lack of Efficacy|3
44440|NCT01606761|188323|P4|Week 24 to Week 52|Lack of Efficacy|10
44441|NCT01606761|188324|P3|Week 24 to Week 52|Lack of Efficacy|7
44442|NCT01606761|188325|P2|Week 24 to Week 52|Lack of Efficacy|13
44443|NCT01606761|188326|P1|Week 24 to Week 52|Lack of Efficacy|0
44444|NCT01606761|188322|P5|Week 24 to Week 52|Death|0
44445|NCT01606761|188323|P4|Week 24 to Week 52|Death|1
44446|NCT01606761|188324|P3|Week 24 to Week 52|Death|2
44447|NCT01606761|188325|P2|Week 24 to Week 52|Death|0
44448|NCT01606761|188326|P1|Week 24 to Week 52|Death|0
44449|NCT01606761|188322|P5|Week 24 to Week 52|Adverse Event|15
44450|NCT01606761|188323|P4|Week 24 to Week 52|Adverse Event|3
44451|NCT01606761|188324|P3|Week 24 to Week 52|Adverse Event|14
44452|NCT01606761|188325|P2|Week 24 to Week 52|Adverse Event|11
44453|NCT01606761|188326|P1|Week 24 to Week 52|Adverse Event|0
44454|NCT01606761|188322|P5|Week 24 to Week 52|Withdrawal by Subject|0
44455|NCT01606761|188323|P4|Week 24 to Week 52|Withdrawal by Subject|0
44456|NCT01606761|188324|P3|Week 24 to Week 52|Withdrawal by Subject|3
44457|NCT01606761|188325|P2|Week 24 to Week 52|Withdrawal by Subject|6
44458|NCT01606761|188326|P1|Week 24 to Week 52|Withdrawal by Subject|0
44459|NCT01606761|188322|P5|Week 24 to Week 52|Lost to Follow-up|0
44460|NCT01606761|188323|P4|Week 24 to Week 52|Lost to Follow-up|1
44461|NCT01606761|188324|P3|Week 24 to Week 52|Lost to Follow-up|1
44462|NCT01606761|188325|P2|Week 24 to Week 52|Lost to Follow-up|1
44463|NCT01606761|188326|P1|Week 24 to Week 52|Lost to Follow-up|0
44464|NCT01606761|188322|P5|Prior to Week 24|Other|0
44465|NCT01606761|188323|P4|Prior to Week 24|Other|0
44466|NCT01606761|188324|P3|Prior to Week 24|Other|5
44467|NCT01606761|188325|P2|Prior to Week 24|Other|7
44468|NCT01606761|188326|P1|Prior to Week 24|Other|4
44469|NCT01606761|188322|P5|Prior to Week 24|Physician Decision|0
44470|NCT01606761|188323|P4|Prior to Week 24|Physician Decision|0
44471|NCT01606761|188324|P3|Prior to Week 24|Physician Decision|1
44472|NCT01606761|188325|P2|Prior to Week 24|Physician Decision|3
44473|NCT01606761|188326|P1|Prior to Week 24|Physician Decision|0
44474|NCT01606761|188322|P5|Prior to Week 24|Lack of Efficacy|0
44475|NCT01606761|188323|P4|Prior to Week 24|Lack of Efficacy|0
44476|NCT01606761|188324|P3|Prior to Week 24|Lack of Efficacy|8
44477|NCT01606761|188325|P2|Prior to Week 24|Lack of Efficacy|14
44478|NCT01606761|188326|P1|Prior to Week 24|Lack of Efficacy|15
44479|NCT01606761|188322|P5|Prior to Week 24|Adverse Event|0
44480|NCT01606761|188323|P4|Prior to Week 24|Adverse Event|0
44481|NCT01606761|188324|P3|Prior to Week 24|Adverse Event|22
44482|NCT01606761|188325|P2|Prior to Week 24|Adverse Event|18
44483|NCT01606761|188326|P1|Prior to Week 24|Adverse Event|11
44484|NCT01606761|188322|P5|Prior to Week 24|Withdrawal by Subject|0
44485|NCT01606761|188323|P4|Prior to Week 24|Withdrawal by Subject|0
44486|NCT01606761|188324|P3|Prior to Week 24|Withdrawal by Subject|9
44487|NCT01606761|188325|P2|Prior to Week 24|Withdrawal by Subject|10
44488|NCT01606761|188326|P1|Prior to Week 24|Withdrawal by Subject|12
44489|NCT01606761|188322|P5|Prior to Week 24|Lost to Follow-up|0
44490|NCT01606761|188323|P4|Prior to Week 24|Lost to Follow-up|0
44491|NCT01606761|188324|P3|Prior to Week 24|Lost to Follow-up|2
44492|NCT01606761|188325|P2|Prior to Week 24|Lost to Follow-up|3
44493|NCT01606761|188326|P1|Prior to Week 24|Lost to Follow-up|0
44494|NCT01606748|188352|P2|Overall Study|Withdrawal by Subject|0
44495|NCT01606748|188353|P1|Overall Study|Withdrawal by Subject|1
44496|NCT01606748|188352|P2|Overall Study|Progressive Disease|0
44497|NCT01606748|188353|P1|Overall Study|Progressive Disease|1
44498|NCT01606748|188352|P2|Overall Study|Adverse Event|0
44499|NCT01606748|188353|P1|Overall Study|Adverse Event|1
44500|NCT01606670|188394|P1|Overall Study|Other Reason|2
44501|NCT01606670|188394|P1|Overall Study|Withdrawal by Subject|3
44502|NCT01606670|188394|P1|Overall Study|Lost to Follow-up|3
44503|NCT01606670|188394|P1|Overall Study|Lack of Efficacy|2
44504|NCT01606670|188394|P1|Overall Study|Adverse Event|6
44505|NCT01606319|188404|P2|Overall Study|Adverse Event|4
44506|NCT01606319|188405|P1|Overall Study|Adverse Event|1
44507|NCT01606319|188404|P2|Overall Study|Lack of Efficacy|8
44508|NCT01606319|188405|P1|Overall Study|Lack of Efficacy|6
44509|NCT01606319|188404|P2|Overall Study|Physician Decision|2
44510|NCT01606319|188405|P1|Overall Study|Physician Decision|1
44511|NCT01606319|188404|P2|Overall Study|Withdrawal by Subject|12
44512|NCT01606319|188405|P1|Overall Study|Withdrawal by Subject|9
44513|NCT01606319|188404|P2|Overall Study|Lost to Follow-up|14
44514|NCT01606319|188405|P1|Overall Study|Lost to Follow-up|17
44515|NCT01606306|188423|P6|Overall Study|Physician Decision|0
44516|NCT01606306|188424|P5|Overall Study|Physician Decision|0
44517|NCT01606306|188425|P4|Overall Study|Physician Decision|0
44518|NCT01606306|188426|P3|Overall Study|Physician Decision|0
44519|NCT01606306|188427|P2|Overall Study|Physician Decision|2
44520|NCT01606306|188428|P1|Overall Study|Physician Decision|1
44521|NCT01606306|188423|P6|Overall Study|Withdrawal by Subject|4
44522|NCT01606306|188424|P5|Overall Study|Withdrawal by Subject|5
44523|NCT01606306|188425|P4|Overall Study|Withdrawal by Subject|4
44524|NCT01606306|188426|P3|Overall Study|Withdrawal by Subject|4
44525|NCT01606306|188427|P2|Overall Study|Withdrawal by Subject|3
44526|NCT01606306|188428|P1|Overall Study|Withdrawal by Subject|4
44527|NCT01606306|188423|P6|Overall Study|Lost to Follow-up|5
44528|NCT01606306|188424|P5|Overall Study|Lost to Follow-up|3
44529|NCT01606306|188425|P4|Overall Study|Lost to Follow-up|4
44530|NCT01606306|188426|P3|Overall Study|Lost to Follow-up|5
44531|NCT01606306|188427|P2|Overall Study|Lost to Follow-up|4
44532|NCT01606306|188428|P1|Overall Study|Lost to Follow-up|7
44533|NCT01606306|188423|P6|Overall Study|Adverse Event|0
44534|NCT01606306|188424|P5|Overall Study|Adverse Event|2
44535|NCT01606306|188425|P4|Overall Study|Adverse Event|1
44536|NCT01606306|188426|P3|Overall Study|Adverse Event|1
44537|NCT01606306|188427|P2|Overall Study|Adverse Event|0
44538|NCT01606306|188428|P1|Overall Study|Adverse Event|1
44539|NCT01606306|188423|P6|Overall Study|Lack of Efficacy|2
44540|NCT01606306|188424|P5|Overall Study|Lack of Efficacy|1
44541|NCT01606306|188425|P4|Overall Study|Lack of Efficacy|4
44542|NCT01606306|188426|P3|Overall Study|Lack of Efficacy|4
44543|NCT01606306|188427|P2|Overall Study|Lack of Efficacy|1
44544|NCT01606306|188428|P1|Overall Study|Lack of Efficacy|2
44545|NCT01606254|188438|P4|Overall Study|Adverse Event|1
44546|NCT01606254|188439|P3|Overall Study|Adverse Event|0
44547|NCT01606254|188440|P2|Overall Study|Adverse Event|1
44548|NCT01606254|188441|P1|Overall Study|Adverse Event|1
44549|NCT01606254|188438|P4|Overall Study|Withdrawal by Subject|2
44550|NCT01606254|188439|P3|Overall Study|Withdrawal by Subject|0
44551|NCT01606254|188440|P2|Overall Study|Withdrawal by Subject|3
44552|NCT01606254|188441|P1|Overall Study|Withdrawal by Subject|1
44553|NCT01606228|188523|P1|Overall Study|Adverse Event|1
44554|NCT01606228|188523|P1|Overall Study|Lack of Efficacy|2
44555|NCT01606228|188523|P1|Overall Study|Non-compliant|3
44556|NCT01606228|188523|P1|Overall Study|Withdrawal by Subject|3
44557|NCT01606228|188523|P1|Overall Study|Lost to Follow-up|20
44558|NCT01606202|188540|P2|Overall Study|Problems with administration|1
44559|NCT01606202|188541|P1|Overall Study|Problems with administration|0
44560|NCT01606202|188540|P2|Overall Study|Personal problems|1
44561|NCT01606202|188541|P1|Overall Study|Personal problems|0
44562|NCT01606202|188540|P2|Overall Study|Withdrawal by Subject|1
44563|NCT01606202|188541|P1|Overall Study|Withdrawal by Subject|2
44564|NCT01606202|188540|P2|Overall Study|Adverse Event|0
44565|NCT01606202|188541|P1|Overall Study|Adverse Event|5
44566|NCT01606189|188573|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
44567|NCT01606189|188574|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
44568|NCT01606189|188575|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
44569|NCT01606189|188576|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
44570|NCT01606189|188577|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
44571|NCT01606189|188578|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
44572|NCT01606189|188573|P6|Second Intenvention (14-20 Days)|Adverse Event|1
44573|NCT01606189|188574|P5|Second Intenvention (14-20 Days)|Adverse Event|0
44574|NCT01606189|188575|P4|Second Intenvention (14-20 Days)|Adverse Event|0
44575|NCT01606189|188576|P3|Second Intenvention (14-20 Days)|Adverse Event|0
44576|NCT01606189|188577|P2|Second Intenvention (14-20 Days)|Adverse Event|0
44577|NCT01606189|188578|P1|Second Intenvention (14-20 Days)|Adverse Event|0
44578|NCT01606176|188612|P2|Overall Study|Withdrawal by Subject|0
44579|NCT01606176|188613|P1|Overall Study|Withdrawal by Subject|1
44580|NCT01606176|188612|P2|Overall Study|Disease progression|0
44581|NCT01606176|188613|P1|Overall Study|Disease progression|1
44582|NCT01606176|188612|P2|Overall Study|Adverse Event|3
44583|NCT01606176|188613|P1|Overall Study|Adverse Event|2
44584|NCT01606137|188658|P1|Overall Study|Unable to collect consistent data|1
44585|NCT01606137|188658|P1|Overall Study|Patient moving|1
44586|NCT01606137|188658|P1|Overall Study|Unable to tolerate study med. taste|1
44587|NCT01606137|188658|P1|Overall Study|Personal reasons|1
44588|NCT01606137|188658|P1|Overall Study|Patient leaving country|1
44589|NCT01606137|188658|P1|Overall Study|Wanted to try another treatment|1
44590|NCT01606137|188658|P1|Overall Study|Not enough improvement|4
44591|NCT01606137|188658|P1|Overall Study|Spray causes nausea|1
44592|NCT01606137|188658|P1|Overall Study|Increased bilirubin|1
44593|NCT01606137|188658|P1|Overall Study|multiple sclerosis less stable|1
44594|NCT01606137|188658|P1|Overall Study|Issues with driving|4
44595|NCT01606137|188658|P1|Overall Study|Decreased/no pain|4
44596|NCT01606137|188658|P1|Overall Study|Death|1
44597|NCT01606137|188658|P1|Overall Study|Patient non-compliance|9
44598|NCT01606137|188658|P1|Overall Study|Protocol Violation|1
44599|NCT01606137|188658|P1|Overall Study|Lost to Follow-up|15
44600|NCT01606137|188658|P1|Overall Study|Lack of Efficacy|56
44601|NCT01606137|188658|P1|Overall Study|Withdrawal by Subject|74
44602|NCT01606137|188658|P1|Overall Study|Adverse Event|85
44603|NCT01606007|188692|P3|Overall Study|Poor/Non-compliance|0
44604|NCT01606007|188693|P2|Overall Study|Poor/Non-compliance|0
44605|NCT01606007|188694|P1|Overall Study|Poor/Non-compliance|1
44606|NCT01606007|188692|P3|Overall Study|Lost to Follow-up|5
44607|NCT01606007|188693|P2|Overall Study|Lost to Follow-up|8
44608|NCT01606007|188694|P1|Overall Study|Lost to Follow-up|6
44609|NCT01606007|188692|P3|Overall Study|discontinue study treatment|1
44610|NCT01606007|188693|P2|Overall Study|discontinue study treatment|2
44611|NCT01606007|188694|P1|Overall Study|discontinue study treatment|0
44612|NCT01606007|188692|P3|Overall Study|Adverse Event|1
44613|NCT01606007|188693|P2|Overall Study|Adverse Event|1
44614|NCT01606007|188694|P1|Overall Study|Adverse Event|0
44615|NCT01606007|188692|P3|Overall Study|Withdrawal by Subject|1
44616|NCT01606007|188693|P2|Overall Study|Withdrawal by Subject|6
44617|NCT01606007|188694|P1|Overall Study|Withdrawal by Subject|8
44618|NCT01606007|188692|P3|Overall Study|Pregnancy|1
44619|NCT01606007|188693|P2|Overall Study|Pregnancy|1
44620|NCT01606007|188694|P1|Overall Study|Pregnancy|0
44621|NCT01606007|188692|P3|Overall Study|Reason 'Other' in the protocol|1
44622|NCT01606007|188693|P2|Overall Study|Reason 'Other' in the protocol|1
44623|NCT01606007|188694|P1|Overall Study|Reason 'Other' in the protocol|0
44624|NCT01605916|188729|P5|Overall Study|Withdrawal by Subject|2
44625|NCT01605916|188730|P4|Overall Study|Withdrawal by Subject|0
44626|NCT01605916|188731|P3|Overall Study|Withdrawal by Subject|0
44627|NCT01605916|188732|P2|Overall Study|Withdrawal by Subject|1
44628|NCT01605916|188733|P1|Overall Study|Withdrawal by Subject|1
44629|NCT01605916|188729|P5|Overall Study|Lack of Efficacy|4
44630|NCT01605916|188730|P4|Overall Study|Lack of Efficacy|5
44631|NCT01605916|188731|P3|Overall Study|Lack of Efficacy|3
44632|NCT01605916|188732|P2|Overall Study|Lack of Efficacy|3
44633|NCT01605916|188733|P1|Overall Study|Lack of Efficacy|2
44634|NCT01605916|188729|P5|Overall Study|Adverse Event|0
44635|NCT01605916|188730|P4|Overall Study|Adverse Event|1
44636|NCT01605916|188731|P3|Overall Study|Adverse Event|0
44637|NCT01605916|188732|P2|Overall Study|Adverse Event|0
44638|NCT01605916|188733|P1|Overall Study|Adverse Event|1
44639|NCT01605877|188815|P1|Overall Study|Withdrawal by Subject|1
44640|NCT01605825|188879|P2|Overall Study|Non-Compliance with Protocol|0
44641|NCT01605825|188880|P1|Overall Study|Non-Compliance with Protocol|3
44642|NCT01605825|188879|P2|Overall Study|Non-Compliance -Investigational Drug|0
44643|NCT01605825|188880|P1|Overall Study|Non-Compliance -Investigational Drug|3
44644|NCT01605825|188879|P2|Overall Study|Withdrawal by Subject|1
44645|NCT01605825|188880|P1|Overall Study|Withdrawal by Subject|0
44646|NCT01605825|188879|P2|Overall Study|Adverse Event|2
44647|NCT01605825|188880|P1|Overall Study|Adverse Event|4
44648|NCT01605799|188888|P2|Overall Study|Withdrawal by Subject|1
44649|NCT01605799|188889|P1|Overall Study|Withdrawal by Subject|2
44650|NCT01605617|188904|P2|Washout Period of 4 Weeks|Study Terminated|1
44651|NCT01605617|188905|P1|Washout Period of 4 Weeks|Study Terminated|2
44652|NCT01605617|188904|P2|First Intervention|Adverse Event|1
44653|NCT01605617|188905|P1|First Intervention|Adverse Event|0
44654|NCT01605461|188964|P1|Overall Study|Withdrawal by Subject|1
44655|NCT01605461|188964|P1|Overall Study|Lost to Follow-up|3
44656|NCT01605370|188975|P2|Overall Study|Adverse Event|0
44657|NCT01605370|188976|P1|Overall Study|Adverse Event|1
44658|NCT01605227|189011|P2|Overall Study|Dose Held >6 weeks|1
44659|NCT01605227|189012|P1|Overall Study|Dose Held >6 weeks|0
44660|NCT01605227|189011|P2|Overall Study|Subject Decision|1
44661|NCT01605227|189012|P1|Overall Study|Subject Decision|0
44662|NCT01605227|189011|P2|Overall Study|Started New Therapy|0
44663|NCT01605227|189012|P1|Overall Study|Started New Therapy|1
44664|NCT01605227|189011|P2|Overall Study|Sponsor Decision|0
44665|NCT01605227|189012|P1|Overall Study|Sponsor Decision|2
44666|NCT01605227|189011|P2|Overall Study|Withdrawal by Subject|14
44667|NCT01605227|189012|P1|Overall Study|Withdrawal by Subject|18
44668|NCT01605227|189011|P2|Overall Study|Physician Decision|7
44669|NCT01605227|189012|P1|Overall Study|Physician Decision|9
44670|NCT01605227|189011|P2|Overall Study|Protocol Violation|0
44671|NCT01605227|189012|P1|Overall Study|Protocol Violation|1
44672|NCT01605227|189011|P2|Overall Study|Lost to Follow-up|0
44673|NCT01605227|189012|P1|Overall Study|Lost to Follow-up|1
44674|NCT01605227|189011|P2|Overall Study|Clinical Deterioration|133
44675|NCT01605227|189012|P1|Overall Study|Clinical Deterioration|227
44676|NCT01605227|189011|P2|Overall Study|Progressive Disease|128
44677|NCT01605227|189012|P1|Overall Study|Progressive Disease|132
44678|NCT01605227|189011|P2|Overall Study|Adverse Event|42
44679|NCT01605227|189012|P1|Overall Study|Adverse Event|228
44680|NCT01605227|189011|P2|Overall Study|Did not receive study treatment|3
44681|NCT01605227|189012|P1|Overall Study|Did not receive study treatment|2
44682|NCT01604941|189024|P6|Overall Study|Early Study Termination|0
44683|NCT01604941|189025|P5|Overall Study|Early Study Termination|0
44684|NCT01604941|189026|P4|Overall Study|Early Study Termination|3
44685|NCT01604941|189027|P3|Overall Study|Early Study Termination|3
44686|NCT01604941|189028|P2|Overall Study|Early Study Termination|2
44687|NCT01604941|189029|P1|Overall Study|Early Study Termination|9
44688|NCT01604941|189024|P6|Overall Study|Participant Decision|2
44689|NCT01604941|189025|P5|Overall Study|Participant Decision|0
44690|NCT01604941|189026|P4|Overall Study|Participant Decision|0
44691|NCT01604941|189027|P3|Overall Study|Participant Decision|0
44692|NCT01604941|189028|P2|Overall Study|Participant Decision|0
44693|NCT01604941|189029|P1|Overall Study|Participant Decision|0
44694|NCT01604941|189024|P6|Overall Study|Non-compliance|0
44695|NCT01604941|189025|P5|Overall Study|Non-compliance|0
44696|NCT01604941|189026|P4|Overall Study|Non-compliance|0
44697|NCT01604941|189027|P3|Overall Study|Non-compliance|0
44698|NCT01604941|189028|P2|Overall Study|Non-compliance|0
44699|NCT01604941|189029|P1|Overall Study|Non-compliance|1
44700|NCT01604941|189024|P6|Overall Study|Adverse Event|5
44701|NCT01604941|189025|P5|Overall Study|Adverse Event|1
44702|NCT01604941|189026|P4|Overall Study|Adverse Event|0
44703|NCT01604941|189027|P3|Overall Study|Adverse Event|0
44704|NCT01604941|189028|P2|Overall Study|Adverse Event|2
44705|NCT01604941|189029|P1|Overall Study|Adverse Event|1
44706|NCT01604850|189057|P2|Overall Study|Subject withdrew consent|0
44707|NCT01604850|189058|P1|Overall Study|Subject withdrew consent|1
44708|NCT01604850|189057|P2|Overall Study|Lost to Follow-up|0
44709|NCT01604850|189058|P1|Overall Study|Lost to Follow-up|1
44710|NCT01604850|189057|P2|Overall Study|Efficacy Failure|29
44711|NCT01604850|189058|P1|Overall Study|Efficacy Failure|50
44712|NCT01604850|189057|P2|Overall Study|Enrolled but never treated|1
44713|NCT01604850|189058|P1|Overall Study|Enrolled but never treated|0
44714|NCT01604408|189082|P2|Observation Period|Withdrawal by Subject|2
44715|NCT01604408|189083|P1|Observation Period|Withdrawal by Subject|0
44716|NCT01604408|189082|P2|Observation Period|Adverse Event|1
44717|NCT01604408|189083|P1|Observation Period|Adverse Event|1
44718|NCT01604408|189082|P2|Treatment Period 6|Sponsor decision|1
44719|NCT01604408|189083|P1|Treatment Period 6|Sponsor decision|0
44720|NCT01604408|189082|P2|Treatment Period 6|Adverse Event|0
44721|NCT01604408|189083|P1|Treatment Period 6|Adverse Event|2
44722|NCT01604408|189082|P2|Treatment Period 6|Lost to Follow-up|1
44723|NCT01604408|189083|P1|Treatment Period 6|Lost to Follow-up|0
44724|NCT01604408|189082|P2|Treatment Period 5|Adverse Event|0
44725|NCT01604408|189083|P1|Treatment Period 5|Adverse Event|4
44726|NCT01604408|189082|P2|Treatment Period 4|Adverse Event|1
44727|NCT01604408|189083|P1|Treatment Period 4|Adverse Event|0
44728|NCT01604408|189082|P2|Treatment Period 4|Withdrawal by Subject|1
44729|NCT01604408|189083|P1|Treatment Period 4|Withdrawal by Subject|2
44730|NCT01604408|189082|P2|Treatment Period 4|Death|0
44731|NCT01604408|189083|P1|Treatment Period 4|Death|1
44732|NCT01604408|189082|P2|Treatment Period 3|Sponsor Decision|0
44733|NCT01604408|189083|P1|Treatment Period 3|Sponsor Decision|1
44734|NCT01604408|189082|P2|Treatment Period 3|Withdrawal by Subject|1
44735|NCT01604408|189083|P1|Treatment Period 3|Withdrawal by Subject|3
44736|NCT01604408|189082|P2|Treatment Period 3|Adverse Event|3
44737|NCT01604408|189083|P1|Treatment Period 3|Adverse Event|0
44738|NCT01604408|189082|P2|Treatment Period 3|Protocol Violation|1
44739|NCT01604408|189083|P1|Treatment Period 3|Protocol Violation|1
44740|NCT01604408|189082|P2|Treatment Period 2|Adverse Event|1
44741|NCT01604408|189083|P1|Treatment Period 2|Adverse Event|0
44742|NCT01604408|189082|P2|Treatment Period 2|Protocol Violation|0
44743|NCT01604408|189083|P1|Treatment Period 2|Protocol Violation|1
44744|NCT01604408|189082|P2|Treatment Period 2|Withdrawal by Subject|1
44745|NCT01604408|189083|P1|Treatment Period 2|Withdrawal by Subject|1
44746|NCT01604408|189082|P2|Treatment Period 1|Protocol Violation|1
44747|NCT01604408|189083|P1|Treatment Period 1|Protocol Violation|0
44748|NCT01604343|189098|P5|Safety Follow-up Period (Week 104-120)|Other|14
44749|NCT01604343|189099|P4|Safety Follow-up Period (Week 104-120)|Other|6
44750|NCT01604343|189100|P3|Safety Follow-up Period (Week 104-120)|Other|20
44751|NCT01604343|189101|P2|Safety Follow-up Period (Week 104-120)|Other|2
44752|NCT01604343|189102|P1|Safety Follow-up Period (Week 104-120)|Other|15
44753|NCT01604343|189098|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
44754|NCT01604343|189099|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
44755|NCT01604343|189100|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
44756|NCT01604343|189101|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
44757|NCT01604343|189102|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
44758|NCT01604343|189098|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
44759|NCT01604343|189099|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
44760|NCT01604343|189100|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
44761|NCT01604343|189101|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
44762|NCT01604343|189102|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
44763|NCT01604343|189098|P5|Week 52 to Week 104|Other|3
44764|NCT01604343|189099|P4|Week 52 to Week 104|Other|6
44765|NCT01604343|189100|P3|Week 52 to Week 104|Other|11
44766|NCT01604343|189101|P2|Week 52 to Week 104|Other|11
44767|NCT01604343|189102|P1|Week 52 to Week 104|Other|0
44768|NCT01604343|189098|P5|Week 52 to Week 104|Pregnancy|1
44769|NCT01604343|189099|P4|Week 52 to Week 104|Pregnancy|2
44770|NCT01604343|189100|P3|Week 52 to Week 104|Pregnancy|1
44771|NCT01604343|189101|P2|Week 52 to Week 104|Pregnancy|0
44772|NCT01604343|189102|P1|Week 52 to Week 104|Pregnancy|0
44773|NCT01604343|189098|P5|Week 52 to Week 104|Physician Decision|2
44774|NCT01604343|189099|P4|Week 52 to Week 104|Physician Decision|0
44775|NCT01604343|189100|P3|Week 52 to Week 104|Physician Decision|0
44776|NCT01604343|189101|P2|Week 52 to Week 104|Physician Decision|1
44777|NCT01604343|189102|P1|Week 52 to Week 104|Physician Decision|0
44778|NCT01604343|189098|P5|Week 52 to Week 104|Lack of Efficacy|3
44779|NCT01604343|189099|P4|Week 52 to Week 104|Lack of Efficacy|2
44780|NCT01604343|189100|P3|Week 52 to Week 104|Lack of Efficacy|11
44781|NCT01604343|189101|P2|Week 52 to Week 104|Lack of Efficacy|6
44782|NCT01604343|189102|P1|Week 52 to Week 104|Lack of Efficacy|0
44783|NCT01604343|189098|P5|Week 52 to Week 104|Death|0
44784|NCT01604343|189099|P4|Week 52 to Week 104|Death|5
44785|NCT01604343|189100|P3|Week 52 to Week 104|Death|2
44786|NCT01604343|189101|P2|Week 52 to Week 104|Death|4
44787|NCT01604343|189102|P1|Week 52 to Week 104|Death|0
44788|NCT01604343|189098|P5|Week 52 to Week 104|Adverse Event|27
44789|NCT01604343|189099|P4|Week 52 to Week 104|Adverse Event|21
44790|NCT01604343|189100|P3|Week 52 to Week 104|Adverse Event|26
44791|NCT01604343|189101|P2|Week 52 to Week 104|Adverse Event|12
44792|NCT01604343|189102|P1|Week 52 to Week 104|Adverse Event|0
44793|NCT01604343|189098|P5|Week 52 to Week 104|Withdrawal by Subject|4
44794|NCT01604343|189099|P4|Week 52 to Week 104|Withdrawal by Subject|8
44795|NCT01604343|189100|P3|Week 52 to Week 104|Withdrawal by Subject|12
44796|NCT01604343|189101|P2|Week 52 to Week 104|Withdrawal by Subject|7
44797|NCT01604343|189102|P1|Week 52 to Week 104|Withdrawal by Subject|0
44798|NCT01604343|189098|P5|Week 52 to Week 104|Lost to Follow-up|1
44799|NCT01604343|189099|P4|Week 52 to Week 104|Lost to Follow-up|2
44800|NCT01604343|189100|P3|Week 52 to Week 104|Lost to Follow-up|4
44801|NCT01604343|189101|P2|Week 52 to Week 104|Lost to Follow-up|2
44802|NCT01604343|189102|P1|Week 52 to Week 104|Lost to Follow-up|0
44803|NCT01604343|189098|P5|Prior to W52 Administration(Through W52)|Other|6
44804|NCT01604343|189099|P4|Prior to W52 Administration(Through W52)|Other|0
44805|NCT01604343|189100|P3|Prior to W52 Administration(Through W52)|Other|10
44806|NCT01604343|189101|P2|Prior to W52 Administration(Through W52)|Other|0
44807|NCT01604343|189102|P1|Prior to W52 Administration(Through W52)|Other|15
44808|NCT01604343|189098|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
44809|NCT01604343|189099|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
44810|NCT01604343|189100|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
44811|NCT01604343|189101|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
44812|NCT01604343|189102|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
44813|NCT01604343|189098|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
44814|NCT01604343|189099|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
44815|NCT01604343|189100|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
44816|NCT01604343|189101|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
44817|NCT01604343|189102|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
44818|NCT01604343|189098|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
44819|NCT01604343|189099|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
44820|NCT01604343|189100|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
44821|NCT01604343|189101|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
44822|NCT01604343|189102|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
44823|NCT01604343|189098|P5|Prior to W52 Administration(Through W52)|Death|4
44824|NCT01604343|189099|P4|Prior to W52 Administration(Through W52)|Death|0
44825|NCT01604343|189100|P3|Prior to W52 Administration(Through W52)|Death|2
44826|NCT01604343|189101|P2|Prior to W52 Administration(Through W52)|Death|0
44827|NCT01604343|189102|P1|Prior to W52 Administration(Through W52)|Death|5
44828|NCT01604343|189098|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
44829|NCT01604343|189099|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
44830|NCT01604343|189100|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
44831|NCT01604343|189101|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
44832|NCT01604343|189102|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
44833|NCT01604343|189098|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
44834|NCT01604343|189099|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
44835|NCT01604343|189100|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
44836|NCT01604343|189101|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
44837|NCT01604343|189102|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
44838|NCT01604343|189098|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
44839|NCT01604343|189099|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
44840|NCT01604343|189100|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
44841|NCT01604343|189101|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
44842|NCT01604343|189102|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
44843|NCT01604278|189213|P2|Overall Study|Protocol Deviation|3
44844|NCT01604278|189214|P1|Overall Study|Protocol Deviation|5
44845|NCT01604278|189213|P2|Overall Study|Adverse Event|5
44846|NCT01604278|189214|P1|Overall Study|Adverse Event|3
44847|NCT01604278|189213|P2|Overall Study|Withdrawal by Subject|3
44848|NCT01604278|189214|P1|Overall Study|Withdrawal by Subject|3
44849|NCT01604278|189213|P2|Overall Study|Administrative problems|1
44850|NCT01604278|189214|P1|Overall Study|Administrative problems|2
44851|NCT01604278|189213|P2|Overall Study|Lost to Follow-up|0
44852|NCT01604278|189214|P1|Overall Study|Lost to Follow-up|1
44853|NCT01604278|189213|P2|Overall Study|Lack of Efficacy|1
44854|NCT01604278|189214|P1|Overall Study|Lack of Efficacy|0
44855|NCT01604265|189240|P2|Overall Study|Withdrawal by Subject|0
44856|NCT01604265|189241|P1|Overall Study|Withdrawal by Subject|1
44857|NCT01604265|189240|P2|Overall Study|Adverse Event|0
44858|NCT01604265|189241|P1|Overall Study|Adverse Event|1
44859|NCT01603875|189352|P3|Overall Study|Protocol Violation|0
44860|NCT01603875|189353|P2|Overall Study|Protocol Violation|1
44861|NCT01603875|189354|P1|Overall Study|Protocol Violation|0
44862|NCT01603875|189352|P3|Overall Study|Lost to Follow-up|6
44863|NCT01603875|189353|P2|Overall Study|Lost to Follow-up|3
44864|NCT01603875|189354|P1|Overall Study|Lost to Follow-up|4
44865|NCT01603875|189352|P3|Overall Study|Preexisting rabies antibody|3
44866|NCT01603875|189353|P2|Overall Study|Preexisting rabies antibody|4
44867|NCT01603875|189354|P1|Overall Study|Preexisting rabies antibody|3
44868|NCT01603459|189374|P1|Overall Study|Administrative reason|1
44869|NCT01603459|189374|P1|Overall Study|Non-compliance|1
44870|NCT01603459|189374|P1|Overall Study|Predefined discontinuation criteria|3
44871|NCT01603459|189374|P1|Overall Study|Lost to Follow-up|3
44872|NCT01603459|189374|P1|Overall Study|Withdrawal by Subject|5
44873|NCT01603459|189374|P1|Overall Study|Adverse Event|5
44874|NCT01603394|189525|P1|Overall Study|Adverse Event|1
44875|NCT01603277|189542|P2|Overall Study|Non-Compliance|1
44876|NCT01603277|189543|P1|Overall Study|Non-Compliance|2
44877|NCT01603277|189542|P2|Overall Study|Withdrawal by Subject|4
44878|NCT01603277|189543|P1|Overall Study|Withdrawal by Subject|5
44879|NCT01603277|189542|P2|Overall Study|Protocol Violation|10
44880|NCT01603277|189543|P1|Overall Study|Protocol Violation|6
44881|NCT01603277|189542|P2|Overall Study|Physician Decision|1
44882|NCT01603277|189543|P1|Overall Study|Physician Decision|0
44883|NCT01603277|189542|P2|Overall Study|Adverse Event|2
44884|NCT01603277|189543|P1|Overall Study|Adverse Event|1
44885|NCT01603121|189549|P2|Second Intervention, 10 Hours|Adverse Event|0
44886|NCT01603121|189550|P1|Second Intervention, 10 Hours|Adverse Event|1
44887|NCT01603082|189562|P2|Overall Study|Failed inclusion criterion after dosed|0
44888|NCT01603082|189563|P1|Overall Study|Failed inclusion criterion after dosed|1
44889|NCT01603082|189562|P2|Overall Study|Withdrawal by Subject|0
44890|NCT01603082|189563|P1|Overall Study|Withdrawal by Subject|1
44891|NCT01603082|189562|P2|Overall Study|Adverse Event|1
44892|NCT01603082|189563|P1|Overall Study|Adverse Event|0
44893|NCT01603043|189604|P2|Overall Study|Study Futility|3
44894|NCT01603043|189605|P1|Overall Study|Study Futility|7
44895|NCT01602965|189617|P2|Overall Study|Lost to Follow-up|2
44896|NCT01602965|189618|P1|Overall Study|Lost to Follow-up|4
44897|NCT01602744|189626|P2|Overall Study|Lost to Follow-up|8
44898|NCT01602744|189627|P1|Overall Study|Lost to Follow-up|13
44899|NCT01602744|189626|P2|Overall Study|Death|15
44900|NCT01602744|189627|P1|Overall Study|Death|17
44901|NCT01602562|189651|P2|Overall Study|Withdrawal by Subject|1
44902|NCT01602562|189652|P1|Overall Study|Withdrawal by Subject|1
44903|NCT01602562|189651|P2|Overall Study|Physician Decision|1
44904|NCT01602562|189652|P1|Overall Study|Physician Decision|1
44905|NCT01602562|189651|P2|Overall Study|Adverse Event|1
44906|NCT01602562|189652|P1|Overall Study|Adverse Event|3
44907|NCT01602549|189688|P2|Overall Study|Withdrawal by Subject|0
44908|NCT01602549|189689|P1|Overall Study|Withdrawal by Subject|1
44909|NCT01602549|189688|P2|Overall Study|Protocol Violation|1
44910|NCT01602549|189689|P1|Overall Study|Protocol Violation|0
44911|NCT01602510|189768|P3|Randomized Phase|Withdrawal by Subject|7
44912|NCT01602510|189769|P2|Randomized Phase|Withdrawal by Subject|6
44913|NCT01602510|189770|P1|Randomized Phase|Withdrawal by Subject|0
44914|NCT01602510|189768|P3|Randomized Phase|Physician Decision|2
44915|NCT01602510|189769|P2|Randomized Phase|Physician Decision|0
44916|NCT01602510|189770|P1|Randomized Phase|Physician Decision|0
44917|NCT01602510|189768|P3|Randomized Phase|Lost to Follow-up|3
44918|NCT01602510|189769|P2|Randomized Phase|Lost to Follow-up|1
44919|NCT01602510|189770|P1|Randomized Phase|Lost to Follow-up|0
44920|NCT01602510|189768|P3|Randomized Phase|Met protocol-defined stopping criteria|48
44921|NCT01602510|189769|P2|Randomized Phase|Met protocol-defined stopping criteria|58
44922|NCT01602510|189770|P1|Randomized Phase|Met protocol-defined stopping criteria|0
44923|NCT01602510|189768|P3|Randomized Phase|Protocol Violation|3
44924|NCT01602510|189769|P2|Randomized Phase|Protocol Violation|3
44925|NCT01602510|189770|P1|Randomized Phase|Protocol Violation|0
44926|NCT01602510|189768|P3|Randomized Phase|Lack of Efficacy|4
44927|NCT01602510|189769|P2|Randomized Phase|Lack of Efficacy|4
44928|NCT01602510|189770|P1|Randomized Phase|Lack of Efficacy|0
44929|NCT01602510|189768|P3|Randomized Phase|Adverse Event|6
44930|NCT01602510|189769|P2|Randomized Phase|Adverse Event|2
44931|NCT01602510|189770|P1|Randomized Phase|Adverse Event|0
44932|NCT01602510|189768|P3|Open Label Phase|Withdrawal by Subject|0
44933|NCT01602510|189769|P2|Open Label Phase|Withdrawal by Subject|0
44934|NCT01602510|189770|P1|Open Label Phase|Withdrawal by Subject|57
44935|NCT01602510|189768|P3|Open Label Phase|Physician Decision|0
44936|NCT01602510|189769|P2|Open Label Phase|Physician Decision|0
44937|NCT01602510|189770|P1|Open Label Phase|Physician Decision|19
44938|NCT01602510|189768|P3|Open Label Phase|Lost to Follow-up|0
44939|NCT01602510|189769|P2|Open Label Phase|Lost to Follow-up|0
44940|NCT01602510|189770|P1|Open Label Phase|Lost to Follow-up|22
44941|NCT01602510|189768|P3|Open Label Phase|Met protocol-defined stopping criteria|0
44942|NCT01602510|189769|P2|Open Label Phase|Met protocol-defined stopping criteria|0
44943|NCT01602510|189770|P1|Open Label Phase|Met protocol-defined stopping criteria|122
44944|NCT01602510|189768|P3|Open Label Phase|Protocol Violation|0
44945|NCT01602510|189769|P2|Open Label Phase|Protocol Violation|0
44946|NCT01602510|189770|P1|Open Label Phase|Protocol Violation|15
44947|NCT01602510|189768|P3|Open Label Phase|Lack of Efficacy|0
44948|NCT01602510|189769|P2|Open Label Phase|Lack of Efficacy|0
44949|NCT01602510|189770|P1|Open Label Phase|Lack of Efficacy|22
44950|NCT01602510|189768|P3|Open Label Phase|Adverse Event|0
44951|NCT01602510|189769|P2|Open Label Phase|Adverse Event|0
44952|NCT01602510|189770|P1|Open Label Phase|Adverse Event|46
44953|NCT01602484|189796|P2|Overall Study|Airway issues unrelated to study|1
44954|NCT01602484|189797|P1|Overall Study|Airway issues unrelated to study|0
44955|NCT01602380|189815|P2|Overall Study|Eligibility criteria not fulfilled|3
44956|NCT01602380|189816|P1|Overall Study|Eligibility criteria not fulfilled|2
44957|NCT01602380|189815|P2|Overall Study|Lost to Follow-up|1
44958|NCT01602380|189816|P1|Overall Study|Lost to Follow-up|6
44959|NCT01602380|189815|P2|Overall Study|Withdrawal by Subject|29
44960|NCT01602380|189816|P1|Overall Study|Withdrawal by Subject|22
44961|NCT01602380|189815|P2|Overall Study|Death|68
44962|NCT01602380|189816|P1|Overall Study|Death|63
44963|NCT01602341|189840|P2|Overall Study|Adverse Event|1
44964|NCT01602341|189841|P1|Overall Study|Adverse Event|0
44965|NCT01602315|189882|P7|Overall Study|Cross-over patients to combo treatment|0
44966|NCT01602315|189883|P6|Overall Study|Cross-over patients to combo treatment|16
44967|NCT01602315|189884|P5|Overall Study|Cross-over patients to combo treatment|0
44968|NCT01602315|189885|P4|Overall Study|Cross-over patients to combo treatment|0
44969|NCT01602315|189886|P3|Overall Study|Cross-over patients to combo treatment|0
44970|NCT01602315|189887|P2|Overall Study|Cross-over patients to combo treatment|0
44971|NCT01602315|189888|P1|Overall Study|Cross-over patients to combo treatment|0
44972|NCT01602315|189882|P7|Overall Study|Subject/guardian decision|1
44973|NCT01602315|189883|P6|Overall Study|Subject/guardian decision|0
44974|NCT01602315|189884|P5|Overall Study|Subject/guardian decision|0
44975|NCT01602315|189885|P4|Overall Study|Subject/guardian decision|0
44976|NCT01602315|189886|P3|Overall Study|Subject/guardian decision|0
44977|NCT01602315|189887|P2|Overall Study|Subject/guardian decision|0
44978|NCT01602315|189888|P1|Overall Study|Subject/guardian decision|0
44979|NCT01602315|189882|P7|Overall Study|Adverse Event|9
44980|NCT01602315|189883|P6|Overall Study|Adverse Event|3
44981|NCT01602315|189884|P5|Overall Study|Adverse Event|15
44982|NCT01602315|189885|P4|Overall Study|Adverse Event|4
44983|NCT01602315|189886|P3|Overall Study|Adverse Event|5
44984|NCT01602315|189887|P2|Overall Study|Adverse Event|1
44985|NCT01602315|189888|P1|Overall Study|Adverse Event|5
44986|NCT01602315|189882|P7|Overall Study|Withdrawal by Subject|1
44987|NCT01602315|189883|P6|Overall Study|Withdrawal by Subject|0
44988|NCT01602315|189884|P5|Overall Study|Withdrawal by Subject|6
44989|NCT01602315|189885|P4|Overall Study|Withdrawal by Subject|0
44990|NCT01602315|189886|P3|Overall Study|Withdrawal by Subject|2
44991|NCT01602315|189887|P2|Overall Study|Withdrawal by Subject|0
44992|NCT01602315|189888|P1|Overall Study|Withdrawal by Subject|2
44993|NCT01602315|189882|P7|Overall Study|Death|2
44994|NCT01602315|189883|P6|Overall Study|Death|2
44995|NCT01602315|189884|P5|Overall Study|Death|7
44996|NCT01602315|189885|P4|Overall Study|Death|1
44997|NCT01602315|189886|P3|Overall Study|Death|1
44998|NCT01602315|189887|P2|Overall Study|Death|1
44999|NCT01602315|189888|P1|Overall Study|Death|1
45000|NCT01602315|189882|P7|Overall Study|Disease progression|15
45001|NCT01602315|189883|P6|Overall Study|Disease progression|12
45002|NCT01602315|189884|P5|Overall Study|Disease progression|41
45003|NCT01602315|189885|P4|Overall Study|Disease progression|1
45004|NCT01602315|189886|P3|Overall Study|Disease progression|10
45005|NCT01602315|189887|P2|Overall Study|Disease progression|3
45006|NCT01602315|189888|P1|Overall Study|Disease progression|6
45007|NCT01602315|189882|P7|Overall Study|Physician Decision|1
45008|NCT01602315|189883|P6|Overall Study|Physician Decision|1
45009|NCT01602315|189884|P5|Overall Study|Physician Decision|2
45010|NCT01602315|189885|P4|Overall Study|Physician Decision|0
45011|NCT01602315|189886|P3|Overall Study|Physician Decision|0
45012|NCT01602315|189887|P2|Overall Study|Physician Decision|0
45013|NCT01602315|189888|P1|Overall Study|Physician Decision|2
45014|NCT01602315|189882|P7|Overall Study|Protocol Violation|0
45015|NCT01602315|189883|P6|Overall Study|Protocol Violation|1
45016|NCT01602315|189884|P5|Overall Study|Protocol Violation|0
45017|NCT01602315|189885|P4|Overall Study|Protocol Violation|0
45018|NCT01602315|189886|P3|Overall Study|Protocol Violation|0
45019|NCT01602315|189887|P2|Overall Study|Protocol Violation|0
45020|NCT01602315|189888|P1|Overall Study|Protocol Violation|0
45021|NCT01601821|190019|P2|Overall Study|Other|1
45022|NCT01601821|190020|P1|Overall Study|Other|5
45023|NCT01601821|190019|P2|Overall Study|Study Events|1
45024|NCT01601821|190020|P1|Overall Study|Study Events|7
45025|NCT01601821|190019|P2|Overall Study|Graft Loss|6
45026|NCT01601821|190020|P1|Overall Study|Graft Loss|6
45027|NCT01601821|190019|P2|Overall Study|Withdrawal by Subject|0
45028|NCT01601821|190020|P1|Overall Study|Withdrawal by Subject|1
45029|NCT01601821|190019|P2|Overall Study|Lost to Follow-up|14
45030|NCT01601821|190020|P1|Overall Study|Lost to Follow-up|6
45031|NCT01601821|190019|P2|Overall Study|Protocol Violation|2
45032|NCT01601821|190020|P1|Overall Study|Protocol Violation|2
45033|NCT01601821|190019|P2|Overall Study|Death|5
45034|NCT01601821|190020|P1|Overall Study|Death|2
45035|NCT01601704|190056|P2|Overall Study|Randomized but not dispensed study med|4
45036|NCT01601704|190057|P1|Overall Study|Randomized but not dispensed study med|1
45037|NCT01601626|190078|P3|Overall Study|Not Willing to Adhere to Requirements|0
45038|NCT01601626|190079|P2|Overall Study|Not Willing to Adhere to Requirements|0
45039|NCT01601626|190080|P1|Overall Study|Not Willing to Adhere to Requirements|1
45040|NCT01601626|190078|P3|Overall Study|Withdrawal by Subject|1
45041|NCT01601626|190079|P2|Overall Study|Withdrawal by Subject|1
45042|NCT01601626|190080|P1|Overall Study|Withdrawal by Subject|0
45043|NCT01601626|190078|P3|Overall Study|Unable to Get to Clinic|0
45044|NCT01601626|190079|P2|Overall Study|Unable to Get to Clinic|1
45045|NCT01601626|190080|P1|Overall Study|Unable to Get to Clinic|0
45046|NCT01601626|190078|P3|Overall Study|Lost to Follow-up|0
45047|NCT01601626|190079|P2|Overall Study|Lost to Follow-up|2
45048|NCT01601626|190080|P1|Overall Study|Lost to Follow-up|1
45049|NCT01601626|190078|P3|Overall Study|Death|1
45050|NCT01601626|190079|P2|Overall Study|Death|1
45051|NCT01601626|190080|P1|Overall Study|Death|1
45052|NCT01601470|190163|P1|Period 2 - LCZ696|Physician Decision|1
45053|NCT01601132|190225|P1|Overall Study|Protocol deviation|1
45054|NCT01601132|190225|P1|Overall Study|Patient withdrew consent|1
45055|NCT01600885|190259|P2|First Period|moved out of area|0
45056|NCT01600885|190260|P1|First Period|moved out of area|1
45057|NCT01600885|190259|P2|First Period|Adverse Event|1
45058|NCT01600885|190260|P1|First Period|Adverse Event|1
45059|NCT01600716|190277|P2|Overall Study|Adverse Event|1
45060|NCT01600716|190278|P1|Overall Study|Adverse Event|1
45061|NCT01600716|190277|P2|Overall Study|Lack of Efficacy|1
45062|NCT01600716|190278|P1|Overall Study|Lack of Efficacy|2
45063|NCT01600716|190277|P2|Overall Study|Pregnancy|0
45064|NCT01600716|190278|P1|Overall Study|Pregnancy|1
45065|NCT01600716|190277|P2|Overall Study|Lost to Follow-up|2
45066|NCT01600716|190278|P1|Overall Study|Lost to Follow-up|0
45067|NCT01600716|190277|P2|Overall Study|Personal Reasons|2
45068|NCT01600716|190278|P1|Overall Study|Personal Reasons|0
45069|NCT01600716|190277|P2|Overall Study|Other Reasons|1
45070|NCT01600716|190278|P1|Overall Study|Other Reasons|3
45071|NCT01600586|190318|P2|Overall Study|Physician Decision|3
45072|NCT01600586|190319|P1|Overall Study|Physician Decision|3
45073|NCT01600326|190371|P2|Overall Study|Lost to Follow-up|1
45074|NCT01600326|190372|P1|Overall Study|Lost to Follow-up|1
45075|NCT01600092|190448|P2|Overall Study|Randomized but not vaccinated|3
45076|NCT01600092|190449|P1|Overall Study|Randomized but not vaccinated|3
45077|NCT01600092|190448|P2|Overall Study|Physician Decision|1
45078|NCT01600092|190449|P1|Overall Study|Physician Decision|1
45079|NCT01600092|190448|P2|Overall Study|Withdrawal by parent/guardian|6
45080|NCT01600092|190449|P1|Overall Study|Withdrawal by parent/guardian|8
45081|NCT01600092|190448|P2|Overall Study|Lost to Follow-up|6
45082|NCT01600092|190449|P1|Overall Study|Lost to Follow-up|4
45083|NCT01600092|190448|P2|Overall Study|Adverse Event|0
45084|NCT01600092|190449|P1|Overall Study|Adverse Event|2
45085|NCT01600053|190463|P1|Overall Study|trial will not meet the interim endpoint|9
45086|NCT01600053|190463|P1|Overall Study|Adverse Event|2
45087|NCT01600014|190468|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
45088|NCT01600014|190469|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
45089|NCT01600014|190468|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
45090|NCT01600014|190469|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
45091|NCT01600014|190468|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
45092|NCT01600014|190469|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
45093|NCT01600014|190468|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
45094|NCT01600014|190469|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
45095|NCT01600014|190468|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
45096|NCT01600014|190469|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
45097|NCT01600014|190468|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
45098|NCT01600014|190469|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
45099|NCT01600014|190468|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
45100|NCT01600014|190469|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
45101|NCT01600014|190468|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
45102|NCT01600014|190469|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
45103|NCT01600014|190468|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
45104|NCT01600014|190469|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
45105|NCT01600014|190468|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
45106|NCT01600014|190469|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
45107|NCT01600014|190468|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
45108|NCT01600014|190469|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
45109|NCT01600014|190468|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
45110|NCT01600014|190469|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
45111|NCT01600014|190468|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
45112|NCT01600014|190469|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
45113|NCT01600014|190468|P2|1. Cycle & Observation Period D1 to W52|Other|0
45114|NCT01600014|190469|P1|1. Cycle & Observation Period D1 to W52|Other|27
45115|NCT01600014|190468|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
45116|NCT01600014|190469|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
45117|NCT01600014|190468|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
45118|NCT01600014|190469|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
45119|NCT01600014|190468|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
45120|NCT01600014|190469|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
45121|NCT01599806|190497|P2|Overall Study|Other Eligibility criteria|9
45122|NCT01599806|190498|P1|Overall Study|Other Eligibility criteria|11
45123|NCT01599806|190497|P2|Overall Study|Withdrawal by Subject|12
45124|NCT01599806|190498|P1|Overall Study|Withdrawal by Subject|12
45125|NCT01599806|190497|P2|Overall Study|Lost to Follow-up|20
45126|NCT01599806|190498|P1|Overall Study|Lost to Follow-up|20
45127|NCT01599650|190631|P3|Overall Study|Adverse Event|4
45128|NCT01599650|190632|P2|Overall Study|Adverse Event|8
45129|NCT01599650|190633|P1|Overall Study|Adverse Event|3
45130|NCT01599650|190631|P3|Overall Study|Withdrawal by Subject|10
45131|NCT01599650|190632|P2|Overall Study|Withdrawal by Subject|11
45132|NCT01599650|190633|P1|Overall Study|Withdrawal by Subject|11
45133|NCT01599650|190631|P3|Overall Study|Lost to Follow-up|3
45134|NCT01599650|190632|P2|Overall Study|Lost to Follow-up|3
45135|NCT01599650|190633|P1|Overall Study|Lost to Follow-up|3
45136|NCT01599650|190631|P3|Overall Study|Death|2
45137|NCT01599650|190632|P2|Overall Study|Death|1
45138|NCT01599650|190633|P1|Overall Study|Death|2
45139|NCT01599650|190631|P3|Overall Study|Protocol Violation|0
45140|NCT01599650|190632|P2|Overall Study|Protocol Violation|3
45141|NCT01599650|190633|P1|Overall Study|Protocol Violation|0
45142|NCT01599650|190631|P3|Overall Study|Physician Decision|7
45143|NCT01599650|190632|P2|Overall Study|Physician Decision|0
45144|NCT01599650|190633|P1|Overall Study|Physician Decision|2
45145|NCT01599650|190631|P3|Overall Study|Administrative issue|1
45146|NCT01599650|190632|P2|Overall Study|Administrative issue|0
45147|NCT01599650|190633|P1|Overall Study|Administrative issue|1
45148|NCT01599637|190672|P3|Overall Study|Adverse Event|0
45149|NCT01599637|190673|P2|Overall Study|Adverse Event|0
45150|NCT01599637|190674|P1|Overall Study|Adverse Event|1
45151|NCT01599637|190672|P3|Overall Study|administrative problems|0
45152|NCT01599637|190673|P2|Overall Study|administrative problems|2
45153|NCT01599637|190674|P1|Overall Study|administrative problems|0
45154|NCT01599585|190721|P2|Overall Study|randomized did not start treatment|3
45155|NCT01599585|190722|P1|Overall Study|randomized did not start treatment|3
45156|NCT01599585|190721|P2|Overall Study|Lost to Follow-up|5
45157|NCT01599585|190722|P1|Overall Study|Lost to Follow-up|3
45158|NCT01599585|190721|P2|Overall Study|Withdrawal by Subject|9
45159|NCT01599585|190722|P1|Overall Study|Withdrawal by Subject|16
45160|NCT01599325|190760|P1|Overall Study|Other|2
45161|NCT01599325|190760|P1|Overall Study|Lack of Therapeutic Effect|9
45162|NCT01599325|190760|P1|Overall Study|Protocol Violation|1
45163|NCT01599325|190760|P1|Overall Study|Death|13
45164|NCT01599325|190760|P1|Overall Study|Withdrawal by Subject|20
45165|NCT01599325|190760|P1|Overall Study|Disease Progression|7
45166|NCT01599325|190760|P1|Overall Study|Adverse Event|5
45167|NCT01599234|190782|P2|Overall Study|Pregnancy|1
45168|NCT01599234|190783|P1|Overall Study|Pregnancy|0
45169|NCT01599234|190782|P2|Overall Study|Contra-indication discovered|1
45170|NCT01599234|190783|P1|Overall Study|Contra-indication discovered|0
45171|NCT01599234|190782|P2|Overall Study|Patient would not stop driving|0
45172|NCT01599234|190783|P1|Overall Study|Patient would not stop driving|1
45173|NCT01599234|190782|P2|Overall Study|Death|0
45174|NCT01599234|190783|P1|Overall Study|Death|1
45175|NCT01599234|190782|P2|Overall Study|Sponsor request as creatinine levels <50|1
45176|NCT01599234|190783|P1|Overall Study|Sponsor request as creatinine levels <50|0
45177|NCT01599234|190782|P2|Overall Study|Unable to operate spray|0
45178|NCT01599234|190783|P1|Overall Study|Unable to operate spray|1
45179|NCT01599234|190782|P2|Overall Study|Lack of Efficacy|4
45180|NCT01599234|190783|P1|Overall Study|Lack of Efficacy|2
45181|NCT01599234|190782|P2|Overall Study|Lost to Follow-up|2
45182|NCT01599234|190783|P1|Overall Study|Lost to Follow-up|1
45183|NCT01599234|190782|P2|Overall Study|Withdrawal by Subject|1
45184|NCT01599234|190783|P1|Overall Study|Withdrawal by Subject|2
45185|NCT01599234|190782|P2|Overall Study|Adverse Event|5
45186|NCT01599234|190783|P1|Overall Study|Adverse Event|9
45187|NCT01599104|190808|P3|Overall Study|Adverse Event|12
45188|NCT01599104|190809|P2|Overall Study|Adverse Event|6
45189|NCT01599104|190810|P1|Overall Study|Adverse Event|7
45190|NCT01599104|190808|P3|Overall Study|Lack of Efficacy|10
45191|NCT01599104|190809|P2|Overall Study|Lack of Efficacy|4
45192|NCT01599104|190810|P1|Overall Study|Lack of Efficacy|4
45193|NCT01599104|190808|P3|Overall Study|Non-compliance with study treatment|0
45194|NCT01599104|190809|P2|Overall Study|Non-compliance with study treatment|1
45195|NCT01599104|190810|P1|Overall Study|Non-compliance with study treatment|0
45196|NCT01599104|190808|P3|Overall Study|Physician Decision|2
45197|NCT01599104|190809|P2|Overall Study|Physician Decision|2
45198|NCT01599104|190810|P1|Overall Study|Physician Decision|3
45199|NCT01599104|190808|P3|Overall Study|Technical Problems|0
45200|NCT01599104|190809|P2|Overall Study|Technical Problems|0
45201|NCT01599104|190810|P1|Overall Study|Technical Problems|1
45202|NCT01599104|190808|P3|Overall Study|Withdrawal by Subject|2
45203|NCT01599104|190809|P2|Overall Study|Withdrawal by Subject|1
45204|NCT01599104|190810|P1|Overall Study|Withdrawal by Subject|1
45205|NCT01598987|190848|P1|Baseline to 24 Month|Lost to Follow-up|1
45206|NCT01598987|190848|P1|Baseline to 24 Month|Administrative problems|2
45207|NCT01598987|190848|P1|Baseline to 24 Month|Withdrawal by Subject|5
45208|NCT01598987|190848|P1|Baseline to Month 12|Withdrawal by Subject|4
45209|NCT01598987|190848|P1|Baseline to Month 12|Administrative problems|2
45210|NCT01598610|190897|P1|Overall Study|Adverse Event|1
45211|NCT01598532|190914|P1|Overall Study|Did not meet inclusion criteria|8
45212|NCT01598532|190914|P1|Overall Study|Lost to Follow-up|3
45213|NCT01598506|190923|P1|Overall Study|Withdrawal by Subject|2
45214|NCT01598311|190943|P2|Overall Study|Assigned to CB but received vancomycin|0
45215|NCT01598311|190944|P1|Overall Study|Assigned to CB but received vancomycin|1
45216|NCT01598311|190943|P2|Overall Study|Treated but no confirmed CDAD|8
45217|NCT01598311|190944|P1|Overall Study|Treated but no confirmed CDAD|9
45218|NCT01598311|190943|P2|Overall Study|Randomized but never treated|5
45219|NCT01598311|190944|P1|Overall Study|Randomized but never treated|8
45220|NCT01598311|190943|P2|Overall Study|No reason provided.|5
45221|NCT01598311|190944|P1|Overall Study|No reason provided.|0
45222|NCT01598311|190943|P2|Overall Study|Withdrawal by Subject|13
45223|NCT01598311|190944|P1|Overall Study|Withdrawal by Subject|9
45224|NCT01598311|190943|P2|Overall Study|Lost to Follow-up|12
45225|NCT01598311|190944|P1|Overall Study|Lost to Follow-up|7
45226|NCT01598311|190943|P2|Overall Study|Adverse Event|13
45227|NCT01598311|190944|P1|Overall Study|Adverse Event|9
45228|NCT01598311|190943|P2|Overall Study|Physician Decision|5
45229|NCT01598311|190944|P1|Overall Study|Physician Decision|4
45230|NCT01598298|190960|P2|Overall Study|Other reason (not protocol specified)|0
45231|NCT01598298|190961|P1|Overall Study|Other reason (not protocol specified)|4
45232|NCT01598298|190960|P2|Overall Study|Withdrawal by Subject|15
45233|NCT01598298|190961|P1|Overall Study|Withdrawal by Subject|10
45234|NCT01598298|190960|P2|Overall Study|Progression/relapse|2
45235|NCT01598298|190961|P1|Overall Study|Progression/relapse|0
45236|NCT01598298|190960|P2|Overall Study|Adverse Event|19
45237|NCT01598298|190961|P1|Overall Study|Adverse Event|21
45238|NCT01598298|190960|P2|Overall Study|Not eligible|5
45239|NCT01598298|190961|P1|Overall Study|Not eligible|5
45240|NCT01598129|190992|P1|Overall Study|Withdrawal by Subject|1
45241|NCT01598129|190992|P1|Overall Study|Deterioration of WHO status to WHO 4|2
45242|NCT01598129|190992|P1|Overall Study|Disease progression|6
45243|NCT01597908|191025|P2|Overall Study|Ongoing|202
45244|NCT01597908|191026|P1|Overall Study|Ongoing|236
45245|NCT01597908|191025|P2|Overall Study|Withdrawal by Subject|18
45246|NCT01597908|191026|P1|Overall Study|Withdrawal by Subject|10
45247|NCT01597908|191025|P2|Overall Study|Physician Decision|1
45248|NCT01597908|191026|P1|Overall Study|Physician Decision|2
45249|NCT01597908|191025|P2|Overall Study|Lost to Follow-up|9
45250|NCT01597908|191026|P1|Overall Study|Lost to Follow-up|4
45251|NCT01597908|191025|P2|Overall Study|Death|122
45252|NCT01597908|191026|P1|Overall Study|Death|100
45253|NCT01597791|191053|P2|Overall Study|Protocol Violation|1
45254|NCT01597791|191054|P1|Overall Study|Protocol Violation|0
45255|NCT01597791|191053|P2|Overall Study|Subject withdrawal|1
45256|NCT01597791|191054|P1|Overall Study|Subject withdrawal|0
45257|NCT01597791|191053|P2|Overall Study|Cesarean Section|7
45258|NCT01597791|191054|P1|Overall Study|Cesarean Section|6
45259|NCT01597791|191053|P2|Overall Study|Physician Decision|1
45260|NCT01597791|191054|P1|Overall Study|Physician Decision|2
45261|NCT01597635|191063|P3|Part B|Withdrawal by Subject|0
45262|NCT01597635|191064|P2|Part B|Withdrawal by Subject|1
45263|NCT01597635|191065|P1|Part B|Withdrawal by Subject|0
45264|NCT01597635|191063|P3|Part B|Protocol-defined stopping criteria|3
45265|NCT01597635|191064|P2|Part B|Protocol-defined stopping criteria|4
45266|NCT01597635|191065|P1|Part B|Protocol-defined stopping criteria|0
45267|NCT01597635|191063|P3|Part B|Protocol Violation|0
45268|NCT01597635|191064|P2|Part B|Protocol Violation|1
45269|NCT01597635|191065|P1|Part B|Protocol Violation|0
45270|NCT01597635|191063|P3|Part B|Adverse Event|1
45271|NCT01597635|191064|P2|Part B|Adverse Event|0
45272|NCT01597635|191065|P1|Part B|Adverse Event|0
45273|NCT01597635|191063|P3|Part A|Adverse Event|0
45274|NCT01597635|191064|P2|Part A|Adverse Event|0
45275|NCT01597635|191065|P1|Part A|Adverse Event|3
45276|NCT01597596|191130|P2|Overall Study|Physician Decision|1
45277|NCT01597596|191131|P1|Overall Study|Physician Decision|0
45278|NCT01597596|191130|P2|Overall Study|Study terminated by sponsor|0
45279|NCT01597596|191131|P1|Overall Study|Study terminated by sponsor|1
45280|NCT01597505|191145|P2|Overall Study|Missing|0
45281|NCT01597505|191146|P1|Overall Study|Missing|1
45282|NCT01597505|191145|P2|Overall Study|Other|6
45283|NCT01597505|191146|P1|Overall Study|Other|5
45284|NCT01597505|191145|P2|Overall Study|Withdrawal by Subject|18
45285|NCT01597505|191146|P1|Overall Study|Withdrawal by Subject|10
45286|NCT01597505|191145|P2|Overall Study|Lost to Follow-up|2
45287|NCT01597505|191146|P1|Overall Study|Lost to Follow-up|4
45288|NCT01597505|191145|P2|Overall Study|Adverse Event|7
45289|NCT01597505|191146|P1|Overall Study|Adverse Event|19
45290|NCT01597505|191145|P2|Overall Study|Physician Decision|0
45291|NCT01597505|191146|P1|Overall Study|Physician Decision|5
45292|NCT01597492|191180|P2|Overall Study|Other Reason|0
45293|NCT01597492|191181|P1|Overall Study|Other Reason|2
45294|NCT01597492|191180|P2|Overall Study|Lost to Follow-up|2
45295|NCT01597492|191181|P1|Overall Study|Lost to Follow-up|0
45296|NCT01597492|191180|P2|Overall Study|Adverse Event|0
45297|NCT01597492|191181|P1|Overall Study|Adverse Event|3
45298|NCT01597492|191180|P2|Overall Study|Withdrawal by Subject|2
45299|NCT01597492|191181|P1|Overall Study|Withdrawal by Subject|1
45300|NCT01597479|191189|P2|Overall Study|Lost to Follow-up|0
45301|NCT01597479|191190|P1|Overall Study|Lost to Follow-up|1
45302|NCT01597479|191189|P2|Overall Study|Protocol Violation|0
45303|NCT01597479|191190|P1|Overall Study|Protocol Violation|1
45304|NCT01597245|191212|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45305|NCT01597245|191213|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45306|NCT01597245|191214|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
45307|NCT01597245|191215|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45308|NCT01597245|191216|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45309|NCT01597245|191217|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45310|NCT01597245|191218|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45311|NCT01597245|191219|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45312|NCT01597245|191220|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45313|NCT01597245|191221|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45314|NCT01597245|191222|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45315|NCT01597245|191223|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45316|NCT01597245|191224|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
45317|NCT01597245|191212|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
45318|NCT01597245|191213|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
45319|NCT01597245|191214|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
45320|NCT01597245|191215|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
45321|NCT01597245|191216|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
45322|NCT01597245|191217|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
45323|NCT01597245|191218|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
45324|NCT01597245|191219|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
45325|NCT01597245|191220|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
45326|NCT01597245|191221|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
45327|NCT01597245|191222|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
45328|NCT01597245|191223|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
45329|NCT01597245|191224|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
45330|NCT01597245|191212|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
45331|NCT01597245|191213|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
45332|NCT01597245|191214|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
45333|NCT01597245|191215|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
45334|NCT01597245|191216|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
45335|NCT01597245|191217|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
45336|NCT01597245|191218|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
45337|NCT01597245|191219|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
45338|NCT01597245|191220|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
45339|NCT01597245|191221|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
45340|NCT01597245|191222|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
45341|NCT01597245|191223|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
45342|NCT01597245|191224|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
45343|NCT01597245|191212|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
45344|NCT01597245|191213|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
45345|NCT01597245|191214|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
45346|NCT01597245|191215|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
45347|NCT01597245|191216|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
45348|NCT01597245|191217|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
45349|NCT01597245|191218|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
45350|NCT01597245|191219|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
45351|NCT01597245|191220|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
45352|NCT01597245|191221|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
45353|NCT01597245|191222|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
45354|NCT01597245|191223|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
45355|NCT01597245|191224|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
45356|NCT01597245|191212|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
45357|NCT01597245|191213|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
45358|NCT01597245|191214|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
45359|NCT01597245|191215|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
45360|NCT01597245|191216|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
45361|NCT01597245|191217|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
45362|NCT01597245|191218|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
45363|NCT01597245|191219|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
45364|NCT01597245|191220|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
45365|NCT01597245|191221|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
45366|NCT01597245|191222|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
45367|NCT01597245|191223|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
45368|NCT01597245|191224|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
45369|NCT01597245|191212|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
45370|NCT01597245|191213|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
45371|NCT01597245|191214|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
45372|NCT01597245|191215|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
45373|NCT01597245|191216|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
45374|NCT01597245|191217|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
45375|NCT01597245|191218|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
45376|NCT01597245|191219|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
45377|NCT01597245|191220|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
45378|NCT01597245|191221|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
45379|NCT01597245|191222|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
45380|NCT01597245|191223|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
45381|NCT01597245|191224|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
45382|NCT01597245|191212|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
45383|NCT01597245|191213|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
45384|NCT01597245|191214|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
45385|NCT01597245|191215|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
45386|NCT01597245|191216|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
45387|NCT01597245|191217|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
45388|NCT01597245|191218|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
45389|NCT01597245|191219|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
45390|NCT01597245|191220|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
45391|NCT01597245|191221|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
45392|NCT01597245|191222|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
45393|NCT01597245|191223|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
45394|NCT01597245|191224|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
45395|NCT01597245|191212|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
45396|NCT01597245|191213|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
45397|NCT01597245|191214|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
45398|NCT01597245|191215|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
45399|NCT01597245|191216|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
45400|NCT01597245|191217|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
45401|NCT01597245|191218|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
45402|NCT01597245|191219|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
45403|NCT01597245|191220|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
45404|NCT01597245|191221|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
45405|NCT01597245|191222|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
45406|NCT01597245|191223|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
45407|NCT01597245|191224|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
45408|NCT01597245|191212|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45409|NCT01597245|191213|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45410|NCT01597245|191214|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45411|NCT01597245|191215|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45412|NCT01597245|191216|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45413|NCT01597245|191217|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45414|NCT01597245|191218|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
45415|NCT01597245|191219|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
45416|NCT01597245|191220|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45417|NCT01597245|191221|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45418|NCT01597245|191222|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45419|NCT01597245|191223|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45420|NCT01597245|191224|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
45421|NCT01597245|191212|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45422|NCT01597245|191213|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45423|NCT01597245|191214|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45424|NCT01597245|191215|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45425|NCT01597245|191216|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45426|NCT01597245|191217|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45427|NCT01597245|191218|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45428|NCT01597245|191219|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45429|NCT01597245|191220|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45430|NCT01597245|191221|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
45431|NCT01597245|191222|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
45432|NCT01597245|191223|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
45433|NCT01597245|191224|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
45434|NCT01597245|191212|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
45435|NCT01597245|191213|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
45436|NCT01597245|191214|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
45437|NCT01597245|191215|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
45438|NCT01597245|191216|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
45439|NCT01597245|191217|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
45440|NCT01597245|191218|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
45441|NCT01597245|191219|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
45442|NCT01597245|191220|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
45443|NCT01597245|191221|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
45444|NCT01597245|191222|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
45445|NCT01597245|191223|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
45446|NCT01597245|191224|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
45447|NCT01597245|191212|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45448|NCT01597245|191213|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45449|NCT01597245|191214|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45526|NCT01596062|191506|P1|Overall Study|Adverse Event|1
45450|NCT01597245|191215|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45451|NCT01597245|191216|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45452|NCT01597245|191217|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45453|NCT01597245|191218|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45454|NCT01597245|191219|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45455|NCT01597245|191220|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45456|NCT01597245|191221|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
45457|NCT01597245|191222|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
45458|NCT01597245|191223|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
45459|NCT01597245|191224|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
45460|NCT01597245|191212|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
45461|NCT01597245|191213|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
45462|NCT01597245|191214|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
45463|NCT01597245|191215|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
45464|NCT01597245|191216|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
45465|NCT01597245|191217|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
45466|NCT01597245|191218|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
45467|NCT01597245|191219|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
45468|NCT01597245|191220|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
45469|NCT01597245|191221|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
45470|NCT01597245|191222|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
45471|NCT01597245|191223|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
45472|NCT01597245|191224|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
45473|NCT01597245|191212|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
45474|NCT01597245|191213|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
45475|NCT01597245|191214|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
45476|NCT01597245|191215|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
45477|NCT01597245|191216|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
45478|NCT01597245|191217|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
45479|NCT01597245|191218|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
45480|NCT01597245|191219|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
45481|NCT01597245|191220|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
45482|NCT01597245|191221|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
45483|NCT01597245|191222|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
45484|NCT01597245|191223|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
45485|NCT01597245|191224|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
45486|NCT01597245|191212|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
45487|NCT01597245|191213|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
45488|NCT01597245|191214|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
45489|NCT01597245|191215|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
45490|NCT01597245|191216|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
45491|NCT01597245|191217|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
45492|NCT01597245|191218|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
45493|NCT01597245|191219|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
45494|NCT01597245|191220|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
45495|NCT01597245|191221|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
45496|NCT01597245|191222|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
45497|NCT01597245|191223|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
45498|NCT01597245|191224|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
45499|NCT01597050|191347|P2|Overall Study|Withdrawal by Subject|0
45500|NCT01597050|191348|P1|Overall Study|Withdrawal by Subject|1
45501|NCT01596972|191356|P2|Overall Study|Withdrawal by Subject|1
45502|NCT01596972|191357|P1|Overall Study|Withdrawal by Subject|0
45503|NCT01596972|191356|P2|Overall Study|Lost to Follow-up|4
45504|NCT01596972|191357|P1|Overall Study|Lost to Follow-up|0
45505|NCT01596972|191356|P2|Overall Study|Physician Decision|9
45506|NCT01596972|191357|P1|Overall Study|Physician Decision|1
45507|NCT01596582|191380|P2|Overall Study|Missing all outcome data|1
45508|NCT01596582|191381|P1|Overall Study|Missing all outcome data|1
45509|NCT01596582|191380|P2|Overall Study|Deemed ineligible after study visit|6
45510|NCT01596582|191381|P1|Overall Study|Deemed ineligible after study visit|3
45511|NCT01596504|191408|P3|Overall Study|Withdrawal by Subject|0
45512|NCT01596504|191409|P2|Overall Study|Withdrawal by Subject|0
45513|NCT01596504|191410|P1|Overall Study|Withdrawal by Subject|1
45514|NCT01596504|191408|P3|Overall Study|Adverse Event|1
45515|NCT01596504|191409|P2|Overall Study|Adverse Event|2
45516|NCT01596504|191410|P1|Overall Study|Adverse Event|1
45517|NCT01596504|191408|P3|Overall Study|Participant's Private Reason|0
45518|NCT01596504|191409|P2|Overall Study|Participant's Private Reason|1
45519|NCT01596504|191410|P1|Overall Study|Participant's Private Reason|0
45520|NCT01596127|191492|P1|Overall Study|Patient Ineligible|1
45521|NCT01596062|191504|P3|Overall Study|Lack of Efficacy|1
45522|NCT01596062|191505|P2|Overall Study|Lack of Efficacy|0
45523|NCT01596062|191506|P1|Overall Study|Lack of Efficacy|0
45524|NCT01596062|191504|P3|Overall Study|Adverse Event|2
45525|NCT01596062|191505|P2|Overall Study|Adverse Event|0
45527|NCT01595646|191570|P3|Overall Study|Withdrawal by Subject|0
45528|NCT01595646|191571|P2|Overall Study|Withdrawal by Subject|0
45529|NCT01595646|191572|P1|Overall Study|Withdrawal by Subject|1
45530|NCT01595438|191594|P2|Overall Study|Other Eligibility criteria|9
45531|NCT01595438|191595|P1|Overall Study|Other Eligibility criteria|11
45532|NCT01595438|191594|P2|Overall Study|Withdrawal by Subject|12
45533|NCT01595438|191595|P1|Overall Study|Withdrawal by Subject|12
45534|NCT01595438|191594|P2|Overall Study|Lost to Follow-up|20
45535|NCT01595438|191595|P1|Overall Study|Lost to Follow-up|20
45536|NCT01594970|191764|P3|Overall Study|Lost to Follow-up|37
45537|NCT01594970|191765|P2|Overall Study|Lost to Follow-up|54
45538|NCT01594970|191766|P1|Overall Study|Lost to Follow-up|54
45539|NCT01594970|191764|P3|Overall Study|Adverse Event|23
45540|NCT01594970|191765|P2|Overall Study|Adverse Event|23
45541|NCT01594970|191766|P1|Overall Study|Adverse Event|17
45542|NCT01594970|191764|P3|Overall Study|Non-Adverse Event Related|6
45543|NCT01594970|191765|P2|Overall Study|Non-Adverse Event Related|5
45544|NCT01594970|191766|P1|Overall Study|Non-Adverse Event Related|4
45545|NCT01594762|191785|P2|Overall Study|Lost to Follow-up|10
45546|NCT01594762|191786|P1|Overall Study|Lost to Follow-up|10
45547|NCT01594762|191785|P2|Overall Study|Withdrawal by Subject|0
45548|NCT01594762|191786|P1|Overall Study|Withdrawal by Subject|1
45549|NCT01594749|191798|P2|Overall Study|Lost Source Documentation|0
45550|NCT01594749|191799|P1|Overall Study|Lost Source Documentation|1
45551|NCT01594749|191798|P2|Overall Study|Not Treated|10
45552|NCT01594749|191799|P1|Overall Study|Not Treated|4
45553|NCT01594749|191798|P2|Overall Study|Death|3
45554|NCT01594749|191799|P1|Overall Study|Death|9
45555|NCT01594749|191798|P2|Overall Study|Lost to Follow-up|0
45556|NCT01594749|191799|P1|Overall Study|Lost to Follow-up|1
45557|NCT01594749|191798|P2|Overall Study|Non-compliance with Protocol|1
45558|NCT01594749|191799|P1|Overall Study|Non-compliance with Protocol|0
45559|NCT01594749|191798|P2|Overall Study|Physician Decision|1
45560|NCT01594749|191799|P1|Overall Study|Physician Decision|1
45561|NCT01594749|191798|P2|Overall Study|Protocol Violation|0
45562|NCT01594749|191799|P1|Overall Study|Protocol Violation|2
45563|NCT01594749|191798|P2|Overall Study|Withdrawal by Subject|2
45564|NCT01594749|191799|P1|Overall Study|Withdrawal by Subject|2
45565|NCT01594749|191798|P2|Overall Study|Adverse Event|1
45566|NCT01594749|191799|P1|Overall Study|Adverse Event|2
45567|NCT01594411|191928|P1|Overall Study|Lost to Follow-up|2
45568|NCT01594125|191982|P5|Overall Study|Progressive Disease|7
45569|NCT01594125|191983|P4|Overall Study|Progressive Disease|3
45570|NCT01594125|191984|P3|Overall Study|Progressive Disease|3
45571|NCT01594125|191985|P2|Overall Study|Progressive Disease|12
45572|NCT01594125|191986|P1|Overall Study|Progressive Disease|3
45573|NCT01594125|191982|P5|Overall Study|Withdrawal by Subject|0
45574|NCT01594125|191983|P4|Overall Study|Withdrawal by Subject|1
45575|NCT01594125|191984|P3|Overall Study|Withdrawal by Subject|0
45576|NCT01594125|191985|P2|Overall Study|Withdrawal by Subject|0
45577|NCT01594125|191986|P1|Overall Study|Withdrawal by Subject|1
45578|NCT01593787|192046|P3|Overall Study|Adverse Event|0
45579|NCT01593787|192047|P2|Overall Study|Adverse Event|0
45580|NCT01593787|192048|P1|Overall Study|Adverse Event|1
45581|NCT01592864|192135|P2|Overall Study|Withdrawal by Subject|1
45582|NCT01592864|192136|P1|Overall Study|Withdrawal by Subject|0
45583|NCT01592786|192167|P1|Overall Study|Other|3
45584|NCT01592786|192167|P1|Overall Study|Lost to Follow-up|19
45585|NCT01592786|192167|P1|Overall Study|Withdrawal by Subject|23
45586|NCT01592786|192167|P1|Overall Study|Protocol Violation|14
45587|NCT01592786|192167|P1|Overall Study|Lack of Efficacy|19
45588|NCT01592786|192167|P1|Overall Study|Adverse Event|60
45589|NCT01592773|192171|P1|Overall Study|Other Reason|1
45590|NCT01592773|192171|P1|Overall Study|Inclusion/exclusion not meet|1
45591|NCT01592773|192171|P1|Overall Study|Protocol Violation|2
45592|NCT01592773|192171|P1|Overall Study|Lack of Efficacy|9
45593|NCT01592773|192171|P1|Overall Study|Adverse Event|17
45594|NCT01592773|192171|P1|Overall Study|Lost to Follow-up|19
45595|NCT01592773|192171|P1|Overall Study|Withdrawal by Subject|35
45596|NCT01592773|192171|P1|Overall Study|Study Terminated by Sponsor|582
45597|NCT01592760|192178|P3|24-hour Follow-Up|Lost to Follow-up|2
45598|NCT01592760|192179|P2|24-hour Follow-Up|Lost to Follow-up|3
45599|NCT01592760|192180|P1|24-hour Follow-Up|Lost to Follow-up|4
45600|NCT01592708|192223|P2|Overall Study|Protocol Violation|0
45601|NCT01592708|192224|P1|Overall Study|Protocol Violation|3
45602|NCT01592695|192240|P2|Overall Study|Lost to Follow-up|4
45603|NCT01592695|192241|P1|Overall Study|Lost to Follow-up|8
45604|NCT01592344|192285|P2|Overall Study|not available at primary outcome visit|4
45605|NCT01592344|192286|P1|Overall Study|not available at primary outcome visit|2
45606|NCT01592344|192285|P2|Overall Study|Lack of Efficacy|0
45607|NCT01592344|192286|P1|Overall Study|Lack of Efficacy|1
45608|NCT01592344|192285|P2|Overall Study|Adverse Event|1
45609|NCT01592344|192286|P1|Overall Study|Adverse Event|1
45610|NCT01592292|192300|P4|Overall Study|Not specified|1
45611|NCT01592292|192301|P3|Overall Study|Not specified|2
45612|NCT01592292|192302|P2|Overall Study|Not specified|1
45613|NCT01592292|192303|P1|Overall Study|Not specified|1
45614|NCT01592292|192300|P4|Overall Study|Withdrew consent|0
45615|NCT01592292|192301|P3|Overall Study|Withdrew consent|0
45616|NCT01592292|192302|P2|Overall Study|Withdrew consent|1
45617|NCT01592292|192303|P1|Overall Study|Withdrew consent|2
45618|NCT01592292|192300|P4|Overall Study|Follow-up loss|0
45619|NCT01592292|192301|P3|Overall Study|Follow-up loss|1
45620|NCT01592292|192302|P2|Overall Study|Follow-up loss|3
45621|NCT01592292|192303|P1|Overall Study|Follow-up loss|3
45622|NCT01592240|192342|P7|Overall Study|Did Not Meet Entrance Criteria|0
45623|NCT01592240|192343|P6|Overall Study|Did Not Meet Entrance Criteria|0
45624|NCT01592240|192344|P5|Overall Study|Did Not Meet Entrance Criteria|0
45625|NCT01592240|192345|P4|Overall Study|Did Not Meet Entrance Criteria|0
45626|NCT01592240|192346|P3|Overall Study|Did Not Meet Entrance Criteria|1
45627|NCT01592240|192347|P2|Overall Study|Did Not Meet Entrance Criteria|0
45628|NCT01592240|192348|P1|Overall Study|Did Not Meet Entrance Criteria|1
45629|NCT01592240|192342|P7|Overall Study|Other|1
45630|NCT01592240|192343|P6|Overall Study|Other|0
45631|NCT01592240|192344|P5|Overall Study|Other|0
45632|NCT01592240|192345|P4|Overall Study|Other|1
45633|NCT01592240|192346|P3|Overall Study|Other|1
45634|NCT01592240|192347|P2|Overall Study|Other|3
45635|NCT01592240|192348|P1|Overall Study|Other|0
45636|NCT01592240|192342|P7|Overall Study|Withdrawal by Subject|2
45637|NCT01592240|192343|P6|Overall Study|Withdrawal by Subject|0
45638|NCT01592240|192344|P5|Overall Study|Withdrawal by Subject|3
45639|NCT01592240|192345|P4|Overall Study|Withdrawal by Subject|1
45640|NCT01592240|192346|P3|Overall Study|Withdrawal by Subject|4
45641|NCT01592240|192347|P2|Overall Study|Withdrawal by Subject|4
45642|NCT01592240|192348|P1|Overall Study|Withdrawal by Subject|0
45643|NCT01592240|192342|P7|Overall Study|Protocol Violation|0
45644|NCT01592240|192343|P6|Overall Study|Protocol Violation|1
45645|NCT01592240|192344|P5|Overall Study|Protocol Violation|0
45646|NCT01592240|192345|P4|Overall Study|Protocol Violation|0
45647|NCT01592240|192346|P3|Overall Study|Protocol Violation|0
45648|NCT01592240|192347|P2|Overall Study|Protocol Violation|0
45649|NCT01592240|192348|P1|Overall Study|Protocol Violation|0
45650|NCT01592240|192342|P7|Overall Study|Lost to Follow-up|0
45651|NCT01592240|192343|P6|Overall Study|Lost to Follow-up|2
45652|NCT01592240|192344|P5|Overall Study|Lost to Follow-up|3
45653|NCT01592240|192345|P4|Overall Study|Lost to Follow-up|0
45654|NCT01592240|192346|P3|Overall Study|Lost to Follow-up|1
45655|NCT01592240|192347|P2|Overall Study|Lost to Follow-up|3
45656|NCT01592240|192348|P1|Overall Study|Lost to Follow-up|1
45657|NCT01592240|192342|P7|Overall Study|Death|0
45658|NCT01592240|192343|P6|Overall Study|Death|0
45659|NCT01592240|192344|P5|Overall Study|Death|0
45660|NCT01592240|192345|P4|Overall Study|Death|0
45661|NCT01592240|192346|P3|Overall Study|Death|0
45662|NCT01592240|192347|P2|Overall Study|Death|1
45663|NCT01592240|192348|P1|Overall Study|Death|0
45664|NCT01592240|192342|P7|Overall Study|Adverse Event|0
45665|NCT01592240|192343|P6|Overall Study|Adverse Event|0
45666|NCT01592240|192344|P5|Overall Study|Adverse Event|1
45667|NCT01592240|192345|P4|Overall Study|Adverse Event|1
45668|NCT01592240|192346|P3|Overall Study|Adverse Event|0
45669|NCT01592240|192347|P2|Overall Study|Adverse Event|0
45670|NCT01592240|192348|P1|Overall Study|Adverse Event|1
45671|NCT01592045|192541|P2|Overall Study|Moved out of country|0
45672|NCT01592045|192542|P1|Overall Study|Moved out of country|2
45673|NCT01592045|192541|P2|Overall Study|Withdrawal by Subject|0
45674|NCT01592045|192542|P1|Overall Study|Withdrawal by Subject|1
45675|NCT01592045|192541|P2|Overall Study|Adverse Event|1
45676|NCT01592045|192542|P1|Overall Study|Adverse Event|1
45677|NCT01592045|192541|P2|Overall Study|Disease Progression|1
45678|NCT01592045|192542|P1|Overall Study|Disease Progression|1
45679|NCT01591863|192560|P1|Overall Study|Lack of Efficacy|1
45680|NCT01591863|192560|P1|Overall Study|recurrence|9
45681|NCT01591863|192560|P1|Overall Study|Withdrawal by Subject|1
45682|NCT01591863|192560|P1|Overall Study|Adverse Event|3
45683|NCT01591681|192598|P1|Overall Study|Failed to use system during run-in|1
45684|NCT01591681|192598|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
45685|NCT01591616|192624|P1|Overall Study|Withdrawal by Subject|1
45686|NCT01591499|192765|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
45687|NCT01591499|192766|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
45688|NCT01591499|192767|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
45689|NCT01591499|192768|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
45690|NCT01591499|192765|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
45691|NCT01591499|192766|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
45692|NCT01591499|192767|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
45693|NCT01591499|192768|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
45694|NCT01591499|192765|P4|Baseline Visit|Withdrawal by Subject|2
45695|NCT01591499|192766|P3|Baseline Visit|Withdrawal by Subject|0
45696|NCT01591499|192767|P2|Baseline Visit|Withdrawal by Subject|2
45697|NCT01591499|192768|P1|Baseline Visit|Withdrawal by Subject|0
45698|NCT01591460|192834|P1|Overall Study|Protocol Violation|1
45699|NCT01591460|192834|P1|Overall Study|Withdrawal by Subject|1
45700|NCT01591460|192834|P1|Overall Study|Participant Refusal|3
45701|NCT01591460|192834|P1|Overall Study|Noncompliance|1
45702|NCT01591460|192834|P1|Overall Study|Lost to Follow-up|1
45703|NCT01591460|192834|P1|Overall Study|Treatment Discontinued by Error|1
45704|NCT01591460|192834|P1|Overall Study|Rebound or Breakthrough|3
45705|NCT01591460|192834|P1|Overall Study|Futility Rule (Week 24)|3
45706|NCT01591460|192834|P1|Overall Study|Futility Rule (Week 12)|7
45707|NCT01591460|192834|P1|Overall Study|Adverse Event or Intercurrent Illness|5
45708|NCT01591382|192925|P2|Overall Study|Participant Opted for Morphine PCA|1
45709|NCT01591382|192926|P1|Overall Study|Participant Opted for Morphine PCA|1
45710|NCT01591382|192925|P2|Overall Study|Discharged Prior to Study Completion|1
45711|NCT01591382|192926|P1|Overall Study|Discharged Prior to Study Completion|2
45712|NCT01591096|192971|P1|Overall Study|Adverse Event|1
45713|NCT01590888|193056|P3|Overall Study|Lost to Follow-up|0
45714|NCT01590888|193057|P2|Overall Study|Lost to Follow-up|0
45715|NCT01590888|193058|P1|Overall Study|Lost to Follow-up|1
45716|NCT01590888|193056|P3|Overall Study|Adverse Event|1
45717|NCT01590888|193057|P2|Overall Study|Adverse Event|0
45718|NCT01590888|193058|P1|Overall Study|Adverse Event|3
45719|NCT01590810|193118|P5|Overall Study|Physician Decision|0
45720|NCT01590810|193119|P4|Overall Study|Physician Decision|0
45721|NCT01590810|193120|P3|Overall Study|Physician Decision|1
45722|NCT01590810|193121|P2|Overall Study|Physician Decision|1
45723|NCT01590810|193122|P1|Overall Study|Physician Decision|0
45724|NCT01590797|193267|P2|Overall Study|Other Protocol Specified Criteria|4
45725|NCT01590797|193268|P1|Overall Study|Other Protocol Specified Criteria|2
45726|NCT01590797|193267|P2|Overall Study|Withdrawal by Subject|5
45727|NCT01590797|193268|P1|Overall Study|Withdrawal by Subject|7
45728|NCT01590797|193267|P2|Overall Study|Protocol Violation|1
45729|NCT01590797|193268|P1|Overall Study|Protocol Violation|4
45730|NCT01590797|193267|P2|Overall Study|Lost to Follow-up|1
45731|NCT01590797|193268|P1|Overall Study|Lost to Follow-up|0
45732|NCT01590797|193267|P2|Overall Study|Lack of Efficacy|2
45733|NCT01590797|193268|P1|Overall Study|Lack of Efficacy|0
45734|NCT01590797|193267|P2|Overall Study|Adverse Event|3
45735|NCT01590797|193268|P1|Overall Study|Adverse Event|4
45736|NCT01590771|193284|P2|Overall Study|Adverse Event|7
45737|NCT01590771|193285|P1|Overall Study|Adverse Event|3
45738|NCT01590771|193284|P2|Overall Study|Lack of Efficacy|0
45739|NCT01590771|193285|P1|Overall Study|Lack of Efficacy|1
45740|NCT01590771|193284|P2|Overall Study|Lost to Follow-up|1
45741|NCT01590771|193285|P1|Overall Study|Lost to Follow-up|1
45742|NCT01590771|193284|P2|Overall Study|Protocol Violation|2
45743|NCT01590771|193285|P1|Overall Study|Protocol Violation|1
45744|NCT01590771|193284|P2|Overall Study|Withdrawal by Subject|15
45745|NCT01590771|193285|P1|Overall Study|Withdrawal by Subject|8
45746|NCT01590771|193284|P2|Overall Study|Other Protocol Specified Criteria|14
45747|NCT01590771|193285|P1|Overall Study|Other Protocol Specified Criteria|5
45748|NCT01590758|193313|P2|Overall Study|Lost to Follow-up|2
45749|NCT01590758|193314|P1|Overall Study|Lost to Follow-up|4
45750|NCT01590758|193313|P2|Overall Study|Physician Decision|2
45751|NCT01590758|193314|P1|Overall Study|Physician Decision|1
45752|NCT01590758|193313|P2|Overall Study|Withdrawal by Subject|3
45753|NCT01590758|193314|P1|Overall Study|Withdrawal by Subject|0
45754|NCT01590563|193324|P1|Overall Study|simple uterine hyperplasia - not related|1
45755|NCT01590212|193352|P3|Overall Study|Lost to Follow-up|3
45756|NCT01590212|193353|P2|Overall Study|Lost to Follow-up|2
45757|NCT01590212|193354|P1|Overall Study|Lost to Follow-up|1
45758|NCT01590212|193352|P3|Overall Study|Withdrawal by Subject|2
45759|NCT01590212|193353|P2|Overall Study|Withdrawal by Subject|2
45760|NCT01590212|193354|P1|Overall Study|Withdrawal by Subject|2
45761|NCT01589822|193398|P3|Overall Study|Missed 90 day visit|1
45762|NCT01589822|193399|P2|Overall Study|Missed 90 day visit|1
45763|NCT01589822|193400|P1|Overall Study|Missed 90 day visit|2
45764|NCT01589822|193398|P3|Overall Study|Death|0
45765|NCT01589822|193399|P2|Overall Study|Death|0
45766|NCT01589822|193400|P1|Overall Study|Death|1
45767|NCT01589822|193398|P3|Overall Study|Withdrawal by Subject|0
45768|NCT01589822|193399|P2|Overall Study|Withdrawal by Subject|2
45769|NCT01589822|193400|P1|Overall Study|Withdrawal by Subject|1
45770|NCT01589653|193419|P2|Overall Study|Unclassified|3
45771|NCT01589653|193420|P1|Overall Study|Unclassified|0
45772|NCT01589653|193419|P2|Overall Study|Withdrawal criteria|7
45773|NCT01589653|193420|P1|Overall Study|Withdrawal criteria|4
45774|NCT01589653|193419|P2|Overall Study|Protocol Violation|1
45775|NCT01589653|193420|P1|Overall Study|Protocol Violation|3
45776|NCT01589497|193468|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
45777|NCT01589497|193469|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
45778|NCT01589497|193470|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
45779|NCT01589497|193471|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
45780|NCT01589497|193468|P4|Overall Study|Death|0
45781|NCT01589497|193469|P3|Overall Study|Death|0
45782|NCT01589497|193470|P2|Overall Study|Death|0
45783|NCT01589497|193471|P1|Overall Study|Death|1
45784|NCT01589497|193468|P4|Overall Study|Withdrawal by Subject|1
45785|NCT01589497|193469|P3|Overall Study|Withdrawal by Subject|0
45786|NCT01589497|193470|P2|Overall Study|Withdrawal by Subject|1
45787|NCT01589497|193471|P1|Overall Study|Withdrawal by Subject|0
45788|NCT01589445|193577|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
45789|NCT01589445|193577|P1|002 (Metformin)-3 Months|Adverse Event|2
45790|NCT01589445|193577|P1|002 (Metformin)-3 Months|Protocol Violation|2
45791|NCT01589445|193577|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
45792|NCT01589445|193577|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
45793|NCT01589445|193577|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
45794|NCT01589445|193577|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
45795|NCT01589445|193577|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
45796|NCT01589445|193577|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
45797|NCT01589445|193577|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
45798|NCT01589237|193597|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
45799|NCT01589237|193598|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
45800|NCT01589237|193599|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
45801|NCT01589237|193600|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
45802|NCT01589237|193597|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
45803|NCT01589237|193598|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
45804|NCT01589237|193599|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
45805|NCT01589237|193600|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
45806|NCT01589237|193597|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
45807|NCT01589237|193598|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
45808|NCT01589237|193599|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
45809|NCT01589237|193600|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
45810|NCT01589237|193597|P4|Part A (52 Weeks)|Subject/guardian decision|0
45811|NCT01589237|193598|P3|Part A (52 Weeks)|Subject/guardian decision|2
45812|NCT01589237|193599|P2|Part A (52 Weeks)|Subject/guardian decision|3
45813|NCT01589237|193600|P1|Part A (52 Weeks)|Subject/guardian decision|2
45814|NCT01588951|193649|P3|Overall Study|Ineligible in retrospect|1
45815|NCT01588951|193650|P2|Overall Study|Ineligible in retrospect|0
45816|NCT01588951|193651|P1|Overall Study|Ineligible in retrospect|0
45817|NCT01588548|193682|P6|Overall Study|Condition Under Investigation Worsened|3
45818|NCT01588548|193683|P5|Overall Study|Condition Under Investigation Worsened|3
45819|NCT01588548|193684|P4|Overall Study|Condition Under Investigation Worsened|4
45820|NCT01588548|193685|P3|Overall Study|Condition Under Investigation Worsened|4
45821|NCT01588548|193686|P2|Overall Study|Condition Under Investigation Worsened|6
45822|NCT01588548|193687|P1|Overall Study|Condition Under Investigation Worsened|3
45823|NCT01588548|193682|P6|Overall Study|Adverse Event|0
45824|NCT01588548|193683|P5|Overall Study|Adverse Event|1
45825|NCT01588548|193684|P4|Overall Study|Adverse Event|2
45826|NCT01588548|193685|P3|Overall Study|Adverse Event|1
45827|NCT01588548|193686|P2|Overall Study|Adverse Event|0
45828|NCT01588548|193687|P1|Overall Study|Adverse Event|0
45829|NCT01588548|193682|P6|Overall Study|Withdrawal by Subject|3
45830|NCT01588548|193683|P5|Overall Study|Withdrawal by Subject|2
45831|NCT01588548|193684|P4|Overall Study|Withdrawal by Subject|1
45832|NCT01588548|193685|P3|Overall Study|Withdrawal by Subject|1
45833|NCT01588548|193686|P2|Overall Study|Withdrawal by Subject|1
45834|NCT01588548|193687|P1|Overall Study|Withdrawal by Subject|0
45835|NCT01588496|193704|P3|Overall Study|Withdrawal by Subject|0
45836|NCT01588496|193705|P2|Overall Study|Withdrawal by Subject|1
45837|NCT01588496|193706|P1|Overall Study|Withdrawal by Subject|0
45838|NCT01588405|193756|P1|Overall Study|Clinical Worsening|1
45839|NCT01588405|193756|P1|Overall Study|Adverse Event|1
45840|NCT01588353|193783|P3|Step3|Adverse Event|2
45841|NCT01588353|193784|P2|Step3|Adverse Event|0
45842|NCT01588353|193785|P1|Step3|Adverse Event|0
45843|NCT01588353|193783|P3|Step2|Withdrawal by Subject|0
45844|NCT01588353|193784|P2|Step2|Withdrawal by Subject|1
45845|NCT01588353|193785|P1|Step2|Withdrawal by Subject|0
45846|NCT01588106|193828|P2|Overall Study|Withdrawal by Subject|4
45847|NCT01588106|193829|P1|Overall Study|Withdrawal by Subject|5
45848|NCT01587989|193837|P3|Randomized Study Treatment|Physician Decision|1
45849|NCT01587989|193838|P2|Randomized Study Treatment|Physician Decision|0
45850|NCT01587989|193839|P1|Randomized Study Treatment|Physician Decision|0
45851|NCT01587989|193837|P3|Randomized Study Treatment|Screening failure|0
45852|NCT01587989|193838|P2|Randomized Study Treatment|Screening failure|1
45853|NCT01587989|193839|P1|Randomized Study Treatment|Screening failure|0
45854|NCT01587989|193837|P3|Randomized Study Treatment|Withdrawal by Subject|0
45855|NCT01587989|193838|P2|Randomized Study Treatment|Withdrawal by Subject|1
45856|NCT01587989|193839|P1|Randomized Study Treatment|Withdrawal by Subject|0
45857|NCT01587989|193837|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
45858|NCT01587989|193838|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
45859|NCT01587989|193839|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
45860|NCT01587989|193837|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
45861|NCT01587989|193838|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
45862|NCT01587989|193839|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
45863|NCT01587989|193837|P3|12-Week Open-Label Run-In Period|Physician Decision|0
45864|NCT01587989|193838|P2|12-Week Open-Label Run-In Period|Physician Decision|0
45865|NCT01587989|193839|P1|12-Week Open-Label Run-In Period|Physician Decision|7
45866|NCT01587924|193904|P4|Overall Study|Withdrawal by Subject|0
45867|NCT01587924|193905|P3|Overall Study|Withdrawal by Subject|1
45868|NCT01587924|193906|P2|Overall Study|Withdrawal by Subject|1
45869|NCT01587924|193907|P1|Overall Study|Withdrawal by Subject|0
45870|NCT01587924|193904|P4|Overall Study|Met Hemoglobin stopping criteria|0
45871|NCT01587924|193905|P3|Overall Study|Met Hemoglobin stopping criteria|1
45872|NCT01587924|193906|P2|Overall Study|Met Hemoglobin stopping criteria|0
45873|NCT01587924|193907|P1|Overall Study|Met Hemoglobin stopping criteria|2
45874|NCT01587924|193904|P4|Overall Study|Protocol Violation|1
45875|NCT01587924|193905|P3|Overall Study|Protocol Violation|2
45876|NCT01587924|193906|P2|Overall Study|Protocol Violation|1
45877|NCT01587924|193907|P1|Overall Study|Protocol Violation|2
45878|NCT01587924|193904|P4|Overall Study|Adverse Event|0
45879|NCT01587924|193905|P3|Overall Study|Adverse Event|0
45880|NCT01587924|193906|P2|Overall Study|Adverse Event|2
45881|NCT01587924|193907|P1|Overall Study|Adverse Event|0
45882|NCT01587898|194008|P4|Overall Study|Met haemoglobin stopping criteria|0
45883|NCT01587898|194009|P3|Overall Study|Met haemoglobin stopping criteria|1
45884|NCT01587898|194010|P2|Overall Study|Met haemoglobin stopping criteria|1
45885|NCT01587898|194011|P1|Overall Study|Met haemoglobin stopping criteria|1
45886|NCT01587898|194008|P4|Overall Study|Withdrawal by Subject|0
45887|NCT01587898|194009|P3|Overall Study|Withdrawal by Subject|0
45888|NCT01587898|194010|P2|Overall Study|Withdrawal by Subject|1
45889|NCT01587898|194011|P1|Overall Study|Withdrawal by Subject|2
45890|NCT01587898|194008|P4|Overall Study|Lost to Follow-up|1
45891|NCT01587898|194009|P3|Overall Study|Lost to Follow-up|0
45892|NCT01587898|194010|P2|Overall Study|Lost to Follow-up|0
45893|NCT01587898|194011|P1|Overall Study|Lost to Follow-up|0
45894|NCT01587898|194008|P4|Overall Study|Protocol Violation|1
45895|NCT01587898|194009|P3|Overall Study|Protocol Violation|1
45896|NCT01587898|194010|P2|Overall Study|Protocol Violation|2
45897|NCT01587898|194011|P1|Overall Study|Protocol Violation|0
45898|NCT01587898|194008|P4|Overall Study|Adverse Event|0
45899|NCT01587898|194009|P3|Overall Study|Adverse Event|0
45900|NCT01587898|194010|P2|Overall Study|Adverse Event|1
45901|NCT01587898|194011|P1|Overall Study|Adverse Event|1
45902|NCT01587885|194187|P2|Treatment Period 1|Protocol Violation|2
45903|NCT01587885|194188|P1|Treatment Period 1|Protocol Violation|0
45904|NCT01587885|194187|P2|Treatment Period 1|Failure to Return|1
45905|NCT01587885|194188|P1|Treatment Period 1|Failure to Return|0
45906|NCT01587651|194204|P3|Overall Study|Withdrawal by Subject|0
45907|NCT01587651|194205|P2|Overall Study|Withdrawal by Subject|1
45908|NCT01587651|194206|P1|Overall Study|Withdrawal by Subject|0
45909|NCT01587651|194204|P3|Overall Study|Protocol Violation|1
45910|NCT01587651|194205|P2|Overall Study|Protocol Violation|1
45911|NCT01587651|194206|P1|Overall Study|Protocol Violation|0
45912|NCT01587651|194204|P3|Overall Study|Adverse Event|0
45913|NCT01587651|194205|P2|Overall Study|Adverse Event|1
45914|NCT01587651|194206|P1|Overall Study|Adverse Event|0
45915|NCT01587118|194233|P1|Overall Study|nonresponse|1
45916|NCT01587118|194233|P1|Overall Study|Relocation|1
45917|NCT01587118|194233|P1|Overall Study|Lost to Follow-up|2
45918|NCT01587118|194233|P1|Overall Study|Adverse Event|3
45919|NCT01587079|194257|P1|Overall Study|Adverse Event|14
45920|NCT01587079|194257|P1|Overall Study|Withdrawal by Subject|7
45921|NCT01587079|194257|P1|Overall Study|Physician Decision|2
45922|NCT01587079|194257|P1|Overall Study|Lost to Follow-up|2
45923|NCT01587079|194257|P1|Overall Study|Protocol Violation|5
45924|NCT01587079|194257|P1|Overall Study|Protocol-specified criteria|9
45925|NCT01587014|194388|P1|Overall Study|Death|2
45926|NCT01587001|194395|P2|Overall Study|Insufficient samples to complete testing|1
45927|NCT01587001|194396|P1|Overall Study|Insufficient samples to complete testing|4
45928|NCT01587001|194395|P2|Overall Study|Lost to Follow-up|0
45929|NCT01587001|194396|P1|Overall Study|Lost to Follow-up|2
45930|NCT01586819|194444|P2|Overall Study|Withdrawal by Subject|0
45931|NCT01586819|194445|P1|Overall Study|Withdrawal by Subject|1
45932|NCT01586806|194456|P3|Overall Study|Lost to Follow-up|2
45933|NCT01586806|194457|P2|Overall Study|Lost to Follow-up|3
45934|NCT01586806|194458|P1|Overall Study|Lost to Follow-up|2
45935|NCT01586806|194456|P3|Overall Study|Withdrawal by Subject|0
45936|NCT01586806|194457|P2|Overall Study|Withdrawal by Subject|0
45937|NCT01586806|194458|P1|Overall Study|Withdrawal by Subject|1
45938|NCT01586806|194456|P3|Overall Study|Protocol Violation|0
45939|NCT01586806|194457|P2|Overall Study|Protocol Violation|1
45940|NCT01586806|194458|P1|Overall Study|Protocol Violation|0
45941|NCT01586364|194478|P1|Overall Study|Other-Not specified|1
45942|NCT01586364|194478|P1|Overall Study|Other-PI discretion, site closing|2
45943|NCT01586364|194478|P1|Overall Study|Other-Site closure due to PI illness|1
45944|NCT01586364|194478|P1|Overall Study|Other-Subject wasn't getting much relief|1
45945|NCT01586364|194478|P1|Overall Study|Other-Did not feel better post-treatment|1
45946|NCT01586364|194478|P1|Overall Study|Lack of Efficacy|1
45947|NCT01586364|194478|P1|Overall Study|Protocol Violation|16
45948|NCT01586364|194478|P1|Overall Study|Lost to Follow-up|17
45949|NCT01586364|194478|P1|Overall Study|Adverse Event|37
45950|NCT01586364|194478|P1|Overall Study|Withdrawal by Subject|40
45951|NCT01586338|194531|P1|Overall Study|Other|1
45952|NCT01586338|194531|P1|Overall Study|Withdrawal by participant|3
45953|NCT01586338|194531|P1|Overall Study|Lost to Follow-up|1
45954|NCT01586338|194531|P1|Overall Study|Adverse Event|3
45955|NCT01586195|194554|P1|Overall Study|Reason not specified|9
45956|NCT01586195|194554|P1|Overall Study|Started new anti-melanoma therapy|1
45957|NCT01586195|194554|P1|Overall Study|Withdrawal of Consent|5
45958|NCT01586195|194554|P1|Overall Study|Death|11
45959|NCT01586156|194568|P3|Overall Study|Pregnancy|0
45960|NCT01586156|194569|P2|Overall Study|Pregnancy|1
45961|NCT01586156|194570|P1|Overall Study|Pregnancy|0
45962|NCT01585987|194608|P2|Treated|Poor/Non-Compliance|1
45963|NCT01585987|194609|P1|Treated|Poor/Non-Compliance|0
45964|NCT01585987|194608|P2|Treated|Subject Request|1
45965|NCT01585987|194609|P1|Treated|Subject Request|0
45966|NCT01585987|194608|P2|Treated|Non-Specified|2
45967|NCT01585987|194609|P1|Treated|Non-Specified|1
45968|NCT01585987|194608|P2|Treated|Maximum Clinical Benefit|1
45969|NCT01585987|194609|P1|Treated|Maximum Clinical Benefit|0
45970|NCT01585987|194608|P2|Treated|Lost to Follow-up|1
45971|NCT01585987|194609|P1|Treated|Lost to Follow-up|0
45972|NCT01585987|194608|P2|Treated|Death|0
45973|NCT01585987|194609|P1|Treated|Death|1
45974|NCT01585987|194608|P2|Treated|Withdrawal by Subject|2
45975|NCT01585987|194609|P1|Treated|Withdrawal by Subject|1
45976|NCT01585987|194608|P2|Treated|Adverse Event|0
45977|NCT01585987|194609|P1|Treated|Adverse Event|3
45978|NCT01585987|194608|P2|Treated|Study Drug Toxicity|5
45979|NCT01585987|194609|P1|Treated|Study Drug Toxicity|9
45980|NCT01585987|194608|P2|Treated|Disease Progression|36
45981|NCT01585987|194609|P1|Treated|Disease Progression|39
45982|NCT01585987|194608|P2|Randomized|No longer met criteria|2
45983|NCT01585987|194609|P1|Randomized|No longer met criteria|0
45984|NCT01585987|194608|P2|Randomized|Withdrawal by Subject|4
45985|NCT01585987|194609|P1|Randomized|Withdrawal by Subject|0
45986|NCT01585961|194624|P1|Overall Study|Ablation cancelled for slow-heal wound|1
45987|NCT01585961|194624|P1|Overall Study|Lost to Follow-up|23
45988|NCT01585961|194624|P1|Overall Study|Withdrawal by Subject|1
45989|NCT01585961|194624|P1|Overall Study|Decision to use non-study catheter|1
45990|NCT01585961|194624|P1|Overall Study|Physician Decision|1
45991|NCT01585961|194624|P1|Overall Study|Death|6
45992|NCT01585584|194701|P1|Overall Study|Physician Decision|2
45993|NCT01585584|194701|P1|Overall Study|Withdrawal by Subject|1
45994|NCT01585584|194701|P1|Overall Study|Lack of Efficacy|1
45995|NCT01585558|194708|P3|Overall Study|Lack of Efficacy|1
45996|NCT01585558|194709|P2|Overall Study|Lack of Efficacy|0
45997|NCT01585558|194710|P1|Overall Study|Lack of Efficacy|0
45998|NCT01585558|194708|P3|Overall Study|Protocol Violation|2
45999|NCT01585558|194709|P2|Overall Study|Protocol Violation|3
46000|NCT01585558|194710|P1|Overall Study|Protocol Violation|4
46001|NCT01585558|194708|P3|Overall Study|Adverse Event|1
46002|NCT01585558|194709|P2|Overall Study|Adverse Event|4
46003|NCT01585558|194710|P1|Overall Study|Adverse Event|3
46004|NCT01585558|194708|P3|Overall Study|Lost to Follow-up|3
46005|NCT01585558|194709|P2|Overall Study|Lost to Follow-up|0
46006|NCT01585558|194710|P1|Overall Study|Lost to Follow-up|2
46007|NCT01585558|194708|P3|Overall Study|Withdrawal by Subject|8
46008|NCT01585558|194709|P2|Overall Study|Withdrawal by Subject|5
46009|NCT01585558|194710|P1|Overall Study|Withdrawal by Subject|4
46010|NCT01585428|194944|P2|Overall Study|Death during treatment|0
46011|NCT01585428|194945|P1|Overall Study|Death during treatment|1
46012|NCT01585272|194969|P1|Overall Study|Withdrawal by Subject|10
46013|NCT01585272|194969|P1|Overall Study|Protocol Violation|7
46014|NCT01585272|194969|P1|Overall Study|Adverse Event|22
46015|NCT01585246|194982|P5|Overall Study|Other|0
46016|NCT01585246|194983|P4|Overall Study|Other|1
46017|NCT01585246|194984|P3|Overall Study|Other|1
46018|NCT01585246|194985|P2|Overall Study|Other|1
46019|NCT01585246|194986|P1|Overall Study|Other|0
46020|NCT01585246|194982|P5|Overall Study|Withdrawal by Subject|1
46021|NCT01585246|194983|P4|Overall Study|Withdrawal by Subject|2
46022|NCT01585246|194984|P3|Overall Study|Withdrawal by Subject|1
46023|NCT01585246|194985|P2|Overall Study|Withdrawal by Subject|0
46024|NCT01585246|194986|P1|Overall Study|Withdrawal by Subject|0
46025|NCT01585246|194982|P5|Overall Study|Protocol Violation|1
46026|NCT01585246|194983|P4|Overall Study|Protocol Violation|0
46027|NCT01585246|194984|P3|Overall Study|Protocol Violation|0
46028|NCT01585246|194985|P2|Overall Study|Protocol Violation|0
46029|NCT01585246|194986|P1|Overall Study|Protocol Violation|0
46030|NCT01585246|194982|P5|Overall Study|Lost to Follow-up|0
46031|NCT01585246|194983|P4|Overall Study|Lost to Follow-up|1
46032|NCT01585246|194984|P3|Overall Study|Lost to Follow-up|2
46033|NCT01585246|194985|P2|Overall Study|Lost to Follow-up|0
46034|NCT01585246|194986|P1|Overall Study|Lost to Follow-up|0
46035|NCT01585168|195007|P4|Overall Study|Lost to Follow-up|1
46036|NCT01585168|195008|P3|Overall Study|Lost to Follow-up|1
46037|NCT01585168|195009|P2|Overall Study|Lost to Follow-up|1
46038|NCT01585168|195010|P1|Overall Study|Lost to Follow-up|3
46039|NCT01585038|195045|P2|Overall Study|Adverse Event|2
46040|NCT01585038|195046|P1|Overall Study|Adverse Event|2
46041|NCT01584843|195062|P6|Second Treatment Period|Withdrawal by Subject|1
46042|NCT01584843|195063|P5|Second Treatment Period|Withdrawal by Subject|0
46043|NCT01584843|195064|P4|Second Treatment Period|Withdrawal by Subject|0
46044|NCT01584843|195065|P3|Second Treatment Period|Withdrawal by Subject|0
46045|NCT01584843|195066|P2|Second Treatment Period|Withdrawal by Subject|0
46046|NCT01584843|195067|P1|Second Treatment Period|Withdrawal by Subject|0
46047|NCT01584843|195062|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
46048|NCT01584843|195063|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
46049|NCT01584843|195064|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
46050|NCT01584843|195065|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
46051|NCT01584843|195066|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
46052|NCT01584843|195067|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
46053|NCT01584843|195062|P6|First Treatment Period|Protocol Violation|1
46054|NCT01584843|195063|P5|First Treatment Period|Protocol Violation|0
46055|NCT01584843|195064|P4|First Treatment Period|Protocol Violation|0
46056|NCT01584843|195065|P3|First Treatment Period|Protocol Violation|0
46057|NCT01584843|195066|P2|First Treatment Period|Protocol Violation|0
46058|NCT01584843|195067|P1|First Treatment Period|Protocol Violation|0
46059|NCT01584843|195062|P6|First Treatment Period|Adverse Event|0
46060|NCT01584843|195063|P5|First Treatment Period|Adverse Event|0
46061|NCT01584843|195064|P4|First Treatment Period|Adverse Event|0
46062|NCT01584843|195065|P3|First Treatment Period|Adverse Event|1
46063|NCT01584843|195066|P2|First Treatment Period|Adverse Event|0
46064|NCT01584843|195067|P1|First Treatment Period|Adverse Event|0
46065|NCT01584648|195178|P2|Overall Study|Ongoing|147
46066|NCT01584648|195179|P1|Overall Study|Ongoing|154
46067|NCT01584648|195178|P2|Overall Study|Death|55
46068|NCT01584648|195179|P1|Overall Study|Death|40
46069|NCT01584648|195178|P2|Overall Study|Withdrawal by Subject|5
46070|NCT01584648|195179|P1|Overall Study|Withdrawal by Subject|11
46071|NCT01584648|195178|P2|Overall Study|Physician Decision|2
46072|NCT01584648|195179|P1|Overall Study|Physician Decision|2
46073|NCT01584648|195178|P2|Overall Study|Lost to Follow-up|3
46074|NCT01584648|195179|P1|Overall Study|Lost to Follow-up|4
46075|NCT01584232|195284|P2|Overall Study|Lost to Follow-up|0
46076|NCT01584232|195285|P1|Overall Study|Lost to Follow-up|1
46077|NCT01584232|195284|P2|Overall Study|Physician Decision|1
46078|NCT01584232|195285|P1|Overall Study|Physician Decision|2
46079|NCT01584232|195284|P2|Overall Study|Withdrawal by Subject|1
46080|NCT01584232|195285|P1|Overall Study|Withdrawal by Subject|2
46081|NCT01584232|195284|P2|Overall Study|Adverse Event|1
46082|NCT01584232|195285|P1|Overall Study|Adverse Event|3
46083|NCT01583530|195331|P6|Overall Study|Lack of compliance|0
46084|NCT01583530|195332|P5|Overall Study|Lack of compliance|1
46085|NCT01583530|195333|P4|Overall Study|Lack of compliance|0
46086|NCT01583530|195334|P3|Overall Study|Lack of compliance|0
46087|NCT01583530|195335|P2|Overall Study|Lack of compliance|0
46088|NCT01583530|195336|P1|Overall Study|Lack of compliance|0
46089|NCT01583530|195331|P6|Overall Study|Lost to Follow-up|0
46090|NCT01583530|195332|P5|Overall Study|Lost to Follow-up|3
46091|NCT01583530|195333|P4|Overall Study|Lost to Follow-up|0
46092|NCT01583530|195334|P3|Overall Study|Lost to Follow-up|0
46093|NCT01583530|195335|P2|Overall Study|Lost to Follow-up|0
46094|NCT01583530|195336|P1|Overall Study|Lost to Follow-up|0
46095|NCT01583530|195331|P6|Overall Study|Withdrawal by Subject|2
46096|NCT01583530|195332|P5|Overall Study|Withdrawal by Subject|1
46097|NCT01583530|195333|P4|Overall Study|Withdrawal by Subject|1
46098|NCT01583530|195334|P3|Overall Study|Withdrawal by Subject|0
46099|NCT01583530|195335|P2|Overall Study|Withdrawal by Subject|3
46100|NCT01583530|195336|P1|Overall Study|Withdrawal by Subject|0
46101|NCT01583530|195331|P6|Overall Study|Adverse Event|1
46102|NCT01583530|195332|P5|Overall Study|Adverse Event|0
46103|NCT01583530|195333|P4|Overall Study|Adverse Event|0
46104|NCT01583530|195334|P3|Overall Study|Adverse Event|0
46105|NCT01583530|195335|P2|Overall Study|Adverse Event|0
46106|NCT01583530|195336|P1|Overall Study|Adverse Event|0
46107|NCT01583374|195398|P3|Overall Study|Other|0
46108|NCT01583374|195399|P2|Overall Study|Other|1
46109|NCT01583374|195400|P1|Overall Study|Other|0
46110|NCT01583374|195398|P3|Overall Study|Protocol Violation|3
46111|NCT01583374|195399|P2|Overall Study|Protocol Violation|0
46112|NCT01583374|195400|P1|Overall Study|Protocol Violation|0
46113|NCT01583374|195398|P3|Overall Study|Lost to Follow-up|0
46114|NCT01583374|195399|P2|Overall Study|Lost to Follow-up|2
46115|NCT01583374|195400|P1|Overall Study|Lost to Follow-up|1
46116|NCT01583374|195398|P3|Overall Study|Withdrawal by Subject|5
46117|NCT01583374|195399|P2|Overall Study|Withdrawal by Subject|3
46118|NCT01583374|195400|P1|Overall Study|Withdrawal by Subject|8
46119|NCT01583374|195398|P3|Overall Study|Non-compliance with study drug|0
46120|NCT01583374|195399|P2|Overall Study|Non-compliance with study drug|1
46121|NCT01583374|195400|P1|Overall Study|Non-compliance with study drug|1
46122|NCT01583374|195398|P3|Overall Study|Lack of Efficacy|5
46123|NCT01583374|195399|P2|Overall Study|Lack of Efficacy|2
46124|NCT01583374|195400|P1|Overall Study|Lack of Efficacy|3
46125|NCT01583374|195398|P3|Overall Study|Adverse Event|12
46126|NCT01583374|195399|P2|Overall Study|Adverse Event|7
46127|NCT01583374|195400|P1|Overall Study|Adverse Event|6
46128|NCT01583218|195412|P2|Overall Study|Withdraw of consent on day of random|0
46129|NCT01583218|195413|P1|Overall Study|Withdraw of consent on day of random|1
46130|NCT01583218|195412|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
46131|NCT01583218|195413|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
46132|NCT01583218|195412|P2|Overall Study|Patient was randomized due to mistake|0
46133|NCT01583218|195413|P1|Overall Study|Patient was randomized due to mistake|1
46134|NCT01583218|195412|P2|Overall Study|Patient was early terminated from study|1
46135|NCT01583218|195413|P1|Overall Study|Patient was early terminated from study|0
46136|NCT01583218|195412|P2|Overall Study|Patient deemed ineligible after random|0
46137|NCT01583218|195413|P1|Overall Study|Patient deemed ineligible after random|2
46138|NCT01583218|195412|P2|Overall Study|Patient was assessed via phone in person|0
46139|NCT01583218|195413|P1|Overall Study|Patient was assessed via phone in person|1
46140|NCT01583218|195412|P2|Overall Study|Patient randomized but not dosed|16
46141|NCT01583218|195413|P1|Overall Study|Patient randomized but not dosed|17
46142|NCT01583218|195412|P2|Overall Study|Patient did not wish to attend visits|1
46143|NCT01583218|195413|P1|Overall Study|Patient did not wish to attend visits|0
46144|NCT01583218|195412|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
46145|NCT01583218|195413|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
46146|NCT01583218|195412|P2|Overall Study|Cannot contact patient directly|2
46147|NCT01583218|195413|P1|Overall Study|Cannot contact patient directly|1
46148|NCT01583218|195412|P2|Overall Study|Patient /Family decision|0
46149|NCT01583218|195413|P1|Overall Study|Patient /Family decision|3
46150|NCT01583218|195412|P2|Overall Study|Adverse event or serious adverse event|3
46151|NCT01583218|195413|P1|Overall Study|Adverse event or serious adverse event|3
46152|NCT01583218|195412|P2|Overall Study|Lost to Follow-up|17
46153|NCT01583218|195413|P1|Overall Study|Lost to Follow-up|11
46154|NCT01583218|195412|P2|Overall Study|Death|211
46155|NCT01583218|195413|P1|Overall Study|Death|206
46156|NCT01583218|195412|P2|Overall Study|Withdrawal by Subject|29
46157|NCT01583218|195413|P1|Overall Study|Withdrawal by Subject|43
46158|NCT01582971|195442|P2|Overall Study|Other|13
46159|NCT01582971|195443|P1|Overall Study|Other|15
46160|NCT01582971|195442|P2|Overall Study|Withdrawal by Subject|2
46161|NCT01582971|195443|P1|Overall Study|Withdrawal by Subject|4
46162|NCT01582971|195442|P2|Overall Study|Lost to Follow-up|21
46163|NCT01582971|195443|P1|Overall Study|Lost to Follow-up|18
46164|NCT01582971|195442|P2|Overall Study|Death|1
46165|NCT01582971|195443|P1|Overall Study|Death|2
46166|NCT01582945|195461|P1|Overall Study|Scheduling conflicts|1
46167|NCT01582945|195461|P1|Overall Study|Intolerable side-effects|1
46168|NCT01582854|195475|P2|Overall Study|Other Miscellaneous Reason|0
46169|NCT01582854|195476|P1|Overall Study|Other Miscellaneous Reason|1
46170|NCT01582854|195475|P2|Overall Study|General Anaesthesia|1
46171|NCT01582854|195476|P1|Overall Study|General Anaesthesia|0
46172|NCT01582854|195475|P2|Overall Study|Carotid or Neurosurgery|1
46173|NCT01582854|195476|P1|Overall Study|Carotid or Neurosurgery|0
46174|NCT01582854|195475|P2|Overall Study|Disallowed Concomitant Medication|2
46175|NCT01582854|195476|P1|Overall Study|Disallowed Concomitant Medication|3
46176|NCT01582854|195475|P2|Overall Study|Recurrent Stroke|8
46177|NCT01582854|195476|P1|Overall Study|Recurrent Stroke|13
46178|NCT01582854|195475|P2|Overall Study|Physician Decision|1
46179|NCT01582854|195476|P1|Overall Study|Physician Decision|0
46180|NCT01582854|195475|P2|Overall Study|Lost to Follow-up|2
46181|NCT01582854|195476|P1|Overall Study|Lost to Follow-up|1
46182|NCT01582854|195475|P2|Overall Study|Withdrawal by Participant|11
46183|NCT01582854|195476|P1|Overall Study|Withdrawal by Participant|8
46184|NCT01582854|195475|P2|Overall Study|Adverse Event|3
46185|NCT01582854|195476|P1|Overall Study|Adverse Event|2
46186|NCT01582854|195475|P2|Overall Study|Death|5
46187|NCT01582854|195476|P1|Overall Study|Death|8
46188|NCT01582789|195504|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
46189|NCT01582789|195505|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
46190|NCT01582451|195565|P2|Overall Study|Sponsor Decision|0
46191|NCT01582451|195566|P1|Overall Study|Sponsor Decision|1
46192|NCT01582451|195565|P2|Overall Study|Physician Decision|0
46193|NCT01582451|195566|P1|Overall Study|Physician Decision|3
46194|NCT01582451|195565|P2|Overall Study|Withdrawal by Subject|9
46195|NCT01582451|195566|P1|Overall Study|Withdrawal by Subject|13
46196|NCT01582451|195565|P2|Overall Study|Protocol Violation|3
46197|NCT01582451|195566|P1|Overall Study|Protocol Violation|11
46198|NCT01582451|195565|P2|Overall Study|Lost to Follow-up|2
46199|NCT01582451|195566|P1|Overall Study|Lost to Follow-up|0
46200|NCT01582451|195565|P2|Overall Study|Death|3
46201|NCT01582451|195566|P1|Overall Study|Death|3
46202|NCT01582451|195565|P2|Overall Study|Adverse Event|3
46203|NCT01582451|195566|P1|Overall Study|Adverse Event|1
46204|NCT01582308|195608|P10|Period 4|Physician Decision|1
46205|NCT01582308|195609|P9|Period 4|Physician Decision|0
46206|NCT01582308|195610|P8|Period 4|Physician Decision|0
46207|NCT01582308|195611|P7|Period 4|Physician Decision|0
46208|NCT01582308|195612|P6|Period 4|Physician Decision|1
46209|NCT01582308|195613|P5|Period 4|Physician Decision|0
46210|NCT01582308|195614|P4|Period 4|Physician Decision|0
46211|NCT01582308|195615|P3|Period 4|Physician Decision|0
46212|NCT01582308|195616|P2|Period 4|Physician Decision|0
46213|NCT01582308|195617|P1|Period 4|Physician Decision|1
46214|NCT01582308|195608|P10|10-day Washout Following Period 1|Physician Decision|0
46215|NCT01582308|195609|P9|10-day Washout Following Period 1|Physician Decision|0
46216|NCT01582308|195610|P8|10-day Washout Following Period 1|Physician Decision|0
46217|NCT01582308|195611|P7|10-day Washout Following Period 1|Physician Decision|0
46218|NCT01582308|195612|P6|10-day Washout Following Period 1|Physician Decision|0
46219|NCT01582308|195613|P5|10-day Washout Following Period 1|Physician Decision|1
46220|NCT01582308|195614|P4|10-day Washout Following Period 1|Physician Decision|0
46221|NCT01582308|195615|P3|10-day Washout Following Period 1|Physician Decision|0
46222|NCT01582308|195616|P2|10-day Washout Following Period 1|Physician Decision|0
46223|NCT01582308|195617|P1|10-day Washout Following Period 1|Physician Decision|0
46224|NCT01582308|195608|P10|Period 1|Withdrawal by Subject|0
46225|NCT01582308|195609|P9|Period 1|Withdrawal by Subject|0
46226|NCT01582308|195610|P8|Period 1|Withdrawal by Subject|0
46227|NCT01582308|195611|P7|Period 1|Withdrawal by Subject|1
46228|NCT01582308|195612|P6|Period 1|Withdrawal by Subject|0
46229|NCT01582308|195613|P5|Period 1|Withdrawal by Subject|0
46230|NCT01582308|195614|P4|Period 1|Withdrawal by Subject|0
46231|NCT01582308|195615|P3|Period 1|Withdrawal by Subject|0
46232|NCT01582308|195616|P2|Period 1|Withdrawal by Subject|0
46233|NCT01582308|195617|P1|Period 1|Withdrawal by Subject|0
46234|NCT01582282|195645|P3|Overall Study|fasting blood glucose outside Protocol|0
46235|NCT01582282|195646|P2|Overall Study|fasting blood glucose outside Protocol|1
46236|NCT01582282|195647|P1|Overall Study|fasting blood glucose outside Protocol|0
46237|NCT01582282|195645|P3|Overall Study|Lost to Follow-up|0
46238|NCT01582282|195646|P2|Overall Study|Lost to Follow-up|0
46239|NCT01582282|195647|P1|Overall Study|Lost to Follow-up|1
46240|NCT01582282|195645|P3|Overall Study|Adverse Event|0
46241|NCT01582282|195646|P2|Overall Study|Adverse Event|1
46242|NCT01582282|195647|P1|Overall Study|Adverse Event|1
46243|NCT01582243|195670|P1|Overall Study|Lost to Follow-up|1
46244|NCT01582243|195670|P1|Overall Study|Adverse Event|1
46245|NCT01582243|195670|P1|Overall Study|Withdrawal by Subject|1
46246|NCT01582178|195681|P2|Overall Study|Physician Decision|5
46247|NCT01582178|195682|P1|Overall Study|Physician Decision|6
46248|NCT01582100|195703|P1|Overall Study|Withdrawal by Subject|1
46249|NCT01582100|195703|P1|Overall Study|Adverse Event|1
46250|NCT01582009|195707|P1|Overall Study|Physician Decision|1
46251|NCT01582009|195707|P1|Overall Study|Withdrawal by Subject|1
46252|NCT01581931|195715|P2|Washout|Adverse Event|1
46253|NCT01581931|195716|P1|Washout|Adverse Event|0
46254|NCT01581684|195769|P10|Overall Study|Other reason not defined|0
46255|NCT01581684|195770|P9|Overall Study|Other reason not defined|1
46256|NCT01581684|195771|P8|Overall Study|Other reason not defined|0
46257|NCT01581684|195772|P7|Overall Study|Other reason not defined|0
46258|NCT01581684|195773|P6|Overall Study|Other reason not defined|0
46259|NCT01581684|195774|P5|Overall Study|Other reason not defined|0
46260|NCT01581684|195775|P4|Overall Study|Other reason not defined|0
46261|NCT01581684|195776|P3|Overall Study|Other reason not defined|0
46262|NCT01581684|195777|P2|Overall Study|Other reason not defined|0
46263|NCT01581684|195778|P1|Overall Study|Other reason not defined|0
46264|NCT01581619|195874|P1|Overall Study|Lost to Follow-up|1
46265|NCT01581619|195874|P1|Overall Study|Withdrawal by Subject|1
46266|NCT01581307|196027|P1|Overall Study|Withdrawal by Subject|1
46267|NCT01581281|196036|P3|Overall Study|Early Study Closure|12
46268|NCT01581281|196037|P2|Overall Study|Early Study Closure|6
46269|NCT01581281|196038|P1|Overall Study|Early Study Closure|15
46270|NCT01581021|196060|P2|Overall Study|Lack of Efficacy|1
46271|NCT01581021|196061|P1|Overall Study|Lack of Efficacy|0
46272|NCT01581021|196060|P2|Overall Study|Lenke 6 Classification|1
46273|NCT01581021|196061|P1|Overall Study|Lenke 6 Classification|0
46274|NCT01581021|196060|P2|Overall Study|Not Randomized|2
46275|NCT01581021|196061|P1|Overall Study|Not Randomized|1
46276|NCT01581021|196060|P2|Overall Study|Neuromuscular|1
46277|NCT01581021|196061|P1|Overall Study|Neuromuscular|2
46278|NCT01581021|196060|P2|Overall Study|More than 2 hooks in thoracic|0
46279|NCT01581021|196061|P1|Overall Study|More than 2 hooks in thoracic|3
46280|NCT01581021|196060|P2|Overall Study|Lost to Follow-up|6
46281|NCT01581021|196061|P1|Overall Study|Lost to Follow-up|4
46282|NCT01580995|196087|P2|Overall Study|Lost to Follow-up|2
46283|NCT01580995|196088|P1|Overall Study|Lost to Follow-up|2
46284|NCT01580488|196141|P1|Overall Study|Withdrawal by Subject|1
46285|NCT01580020|196297|P4|Overall Study|Lost to Follow-up|0
46286|NCT01580020|196298|P3|Overall Study|Lost to Follow-up|1
46287|NCT01580020|196299|P2|Overall Study|Lost to Follow-up|0
46288|NCT01580020|196300|P1|Overall Study|Lost to Follow-up|0
46289|NCT01580020|196297|P4|Overall Study|Administrative Problems|0
46290|NCT01580020|196298|P3|Overall Study|Administrative Problems|1
46291|NCT01580020|196299|P2|Overall Study|Administrative Problems|0
46292|NCT01580020|196300|P1|Overall Study|Administrative Problems|0
46293|NCT01580020|196297|P4|Overall Study|Adverse Event|1
46294|NCT01580020|196298|P3|Overall Study|Adverse Event|1
46295|NCT01580020|196299|P2|Overall Study|Adverse Event|1
46296|NCT01580020|196300|P1|Overall Study|Adverse Event|1
46297|NCT01580020|196297|P4|Overall Study|Withdrawal by Subject|0
46298|NCT01580020|196298|P3|Overall Study|Withdrawal by Subject|1
46299|NCT01580020|196299|P2|Overall Study|Withdrawal by Subject|1
46300|NCT01580020|196300|P1|Overall Study|Withdrawal by Subject|0
46301|NCT01580020|196297|P4|Overall Study|Lack of Efficacy|1
46302|NCT01580020|196298|P3|Overall Study|Lack of Efficacy|0
46303|NCT01580020|196299|P2|Overall Study|Lack of Efficacy|5
46304|NCT01580020|196300|P1|Overall Study|Lack of Efficacy|0
46305|NCT01579916|196344|P2|Overall Study|Death|0
46306|NCT01579916|196345|P1|Overall Study|Death|1
46307|NCT01579916|196344|P2|Overall Study|Withdrawal by Subject|1
46308|NCT01579916|196345|P1|Overall Study|Withdrawal by Subject|1
46309|NCT01579916|196344|P2|Overall Study|Lost to Follow-up|1
46310|NCT01579916|196345|P1|Overall Study|Lost to Follow-up|6
46311|NCT01579812|196371|P1|Overall Study|Withdrawal by Subject|6
46312|NCT01579812|196371|P1|Overall Study|Noncompliance|3
46313|NCT01579812|196371|P1|Overall Study|Patient choice|3
46314|NCT01579812|196371|P1|Overall Study|Ineligible after treatment start|40
46315|NCT01579578|196405|P2|Overall Study|Ongoing|0
46316|NCT01579578|196406|P1|Overall Study|Ongoing|3
46317|NCT01579578|196405|P2|Overall Study|Eligibility criteria|9
46318|NCT01579578|196406|P1|Overall Study|Eligibility criteria|3
46319|NCT01579578|196405|P2|Overall Study|Withdrawal by Subject|1
46320|NCT01579578|196406|P1|Overall Study|Withdrawal by Subject|2
46321|NCT01579578|196405|P2|Overall Study|Lost to Follow-up|1
46322|NCT01579578|196406|P1|Overall Study|Lost to Follow-up|1
46323|NCT01579578|196405|P2|Overall Study|Death|1
46324|NCT01579578|196406|P1|Overall Study|Death|4
46325|NCT01579565|196418|P2|Treated|declined to return for final visit|1
46326|NCT01579565|196419|P1|Treated|declined to return for final visit|0
46327|NCT01579565|196418|P2|Treated|Lost to Follow-up|1
46328|NCT01579565|196419|P1|Treated|Lost to Follow-up|2
46329|NCT01579565|196418|P2|Treated|Physician Decision|1
46330|NCT01579565|196419|P1|Treated|Physician Decision|0
46331|NCT01579565|196418|P2|Randomized|prohibited preoperative medication|1
46332|NCT01579565|196419|P1|Randomized|prohibited preoperative medication|0
46333|NCT01579565|196418|P2|Randomized|prohibited preoperative eating|0
46334|NCT01579565|196419|P1|Randomized|prohibited preoperative eating|1
46335|NCT01579565|196418|P2|Randomized|inadequate preoperative pupil dilation|1
46336|NCT01579565|196419|P1|Randomized|inadequate preoperative pupil dilation|0
46337|NCT01579565|196418|P2|Randomized|Withdrawal by Subject|0
46338|NCT01579565|196419|P1|Randomized|Withdrawal by Subject|3
46339|NCT01579565|196418|P2|Randomized|Adverse Event|3
46340|NCT01579565|196419|P1|Randomized|Adverse Event|1
46341|NCT01579474|196453|P6|Overall Study|Withdrawal by Subject|0
46342|NCT01579474|196454|P5|Overall Study|Withdrawal by Subject|0
46343|NCT01579474|196455|P4|Overall Study|Withdrawal by Subject|0
46344|NCT01579474|196456|P3|Overall Study|Withdrawal by Subject|0
46345|NCT01579474|196457|P2|Overall Study|Withdrawal by Subject|0
46346|NCT01579474|196458|P1|Overall Study|Withdrawal by Subject|1
46347|NCT01579474|196453|P6|Overall Study|Lack of Efficacy|0
46348|NCT01579474|196454|P5|Overall Study|Lack of Efficacy|1
46349|NCT01579474|196455|P4|Overall Study|Lack of Efficacy|0
46350|NCT01579474|196456|P3|Overall Study|Lack of Efficacy|0
46351|NCT01579474|196457|P2|Overall Study|Lack of Efficacy|0
46352|NCT01579474|196458|P1|Overall Study|Lack of Efficacy|1
46353|NCT01579474|196453|P6|Overall Study|Adverse Event|1
46354|NCT01579474|196454|P5|Overall Study|Adverse Event|0
46355|NCT01579474|196455|P4|Overall Study|Adverse Event|0
46356|NCT01579474|196456|P3|Overall Study|Adverse Event|2
46357|NCT01579474|196457|P2|Overall Study|Adverse Event|13
46358|NCT01579474|196458|P1|Overall Study|Adverse Event|1
46359|NCT01579318|196532|P1|Overall Study|Disease Progression|1
46360|NCT01579006|196627|P1|Overall Study|Scheduled surgery|1
46361|NCT01579006|196627|P1|Overall Study|Due to participant's health fund|1
46362|NCT01579006|196627|P1|Overall Study|Non-compliance|3
46363|NCT01579006|196627|P1|Overall Study|Withdrawal by Subject|5
46364|NCT01579006|196627|P1|Overall Study|Adverse Event|13
46365|NCT01579006|196627|P1|Overall Study|Lack of Efficacy|10
46366|NCT01578850|196686|P3|Period 2|Unspecified Reasons|0
46367|NCT01578850|196687|P2|Period 2|Unspecified Reasons|1
46368|NCT01578850|196688|P1|Period 2|Unspecified Reasons|0
46369|NCT01578850|196686|P3|Period 2|Study Terminated by Sponsor|4
46370|NCT01578850|196687|P2|Period 2|Study Terminated by Sponsor|5
46371|NCT01578850|196688|P1|Period 2|Study Terminated by Sponsor|0
46372|NCT01578850|196686|P3|Period 2|Withdrawal by Subject|2
46373|NCT01578850|196687|P2|Period 2|Withdrawal by Subject|2
46374|NCT01578850|196688|P1|Period 2|Withdrawal by Subject|0
46375|NCT01578850|196686|P3|Period 2|Lost to Follow-up|2
46376|NCT01578850|196687|P2|Period 2|Lost to Follow-up|1
46377|NCT01578850|196688|P1|Period 2|Lost to Follow-up|0
46378|NCT01578850|196686|P3|Period 2|Adverse Event|6
46379|NCT01578850|196687|P2|Period 2|Adverse Event|3
46380|NCT01578850|196688|P1|Period 2|Adverse Event|0
46381|NCT01578850|196686|P3|Period 2|Insufficient Clinical Response|0
46382|NCT01578850|196687|P2|Period 2|Insufficient Clinical Response|1
46383|NCT01578850|196688|P1|Period 2|Insufficient Clinical Response|0
46384|NCT01578850|196686|P3|Period 1|Study Terminated by Sponsor|0
46385|NCT01578850|196687|P2|Period 1|Study Terminated by Sponsor|0
46386|NCT01578850|196688|P1|Period 1|Study Terminated by Sponsor|3
46387|NCT01578850|196686|P3|Period 1|Withdrawal by Subject|0
46388|NCT01578850|196687|P2|Period 1|Withdrawal by Subject|0
46389|NCT01578850|196688|P1|Period 1|Withdrawal by Subject|9
46390|NCT01578850|196686|P3|Period 1|Does Not Meet Entrance Criteria|0
46391|NCT01578850|196687|P2|Period 1|Does Not Meet Entrance Criteria|0
46392|NCT01578850|196688|P1|Period 1|Does Not Meet Entrance Criteria|12
46393|NCT01578850|196686|P3|Period 1|Death|0
46394|NCT01578850|196687|P2|Period 1|Death|0
46395|NCT01578850|196688|P1|Period 1|Death|1
46396|NCT01578850|196686|P3|Period 1|Adverse Event|0
46397|NCT01578850|196687|P2|Period 1|Adverse Event|0
46398|NCT01578850|196688|P1|Period 1|Adverse Event|11
46399|NCT01578850|196686|P3|Period 1|Insufficient Clinical Response|0
46400|NCT01578850|196687|P2|Period 1|Insufficient Clinical Response|0
46401|NCT01578850|196688|P1|Period 1|Insufficient Clinical Response|1
46402|NCT01578785|196740|P2|Overall Study|Study terminated by sponsor|118
46403|NCT01578785|196741|P1|Overall Study|Study terminated by sponsor|59
46404|NCT01578785|196740|P2|Overall Study|Withdrawal by Subject|1
46405|NCT01578785|196741|P1|Overall Study|Withdrawal by Subject|0
46406|NCT01578499|196773|P2|Overall Study|Participants on Study Treatment|0
46407|NCT01578499|196774|P1|Overall Study|Participants on Study Treatment|3
46408|NCT01578499|196773|P2|Overall Study|Participants in Follow-up|39
46409|NCT01578499|196774|P1|Overall Study|Participants in Follow-up|42
46410|NCT01578499|196773|P2|Overall Study|Reason not Specified|1
46411|NCT01578499|196774|P1|Overall Study|Reason not Specified|0
46412|NCT01578499|196773|P2|Overall Study|Lost to Follow-up|1
46413|NCT01578499|196774|P1|Overall Study|Lost to Follow-up|2
46414|NCT01578499|196773|P2|Overall Study|Withdrawal by Participant|10
46415|NCT01578499|196774|P1|Overall Study|Withdrawal by Participant|8
46416|NCT01578499|196773|P2|Overall Study|Death|14
46417|NCT01578499|196774|P1|Overall Study|Death|11
46418|NCT01578486|196808|P1|Overall Study|Withdrawal by Subject|2
46419|NCT01578486|196808|P1|Overall Study|Physician Decision|3
46420|NCT01578330|196819|P1|Overall Study|Protocol Violation|5
46421|NCT01578330|196819|P1|Overall Study|Adverse Event|2
46422|NCT01578187|196835|P1|Usability Phase|Withdrawal by Subject|1
46423|NCT01577758|196869|P8|mCRC Expansion Phase|Progression Disease|19
46424|NCT01577758|196870|P7|mCRC Expansion Phase|Progression Disease|0
46425|NCT01577758|196871|P6|mCRC Expansion Phase|Progression Disease|0
46426|NCT01577758|196872|P5|mCRC Expansion Phase|Progression Disease|0
46427|NCT01577758|196873|P4|mCRC Expansion Phase|Progression Disease|0
46428|NCT01577758|196874|P3|mCRC Expansion Phase|Progression Disease|0
46429|NCT01577758|196875|P2|mCRC Expansion Phase|Progression Disease|0
46430|NCT01577758|196876|P1|mCRC Expansion Phase|Progression Disease|0
46431|NCT01577758|196869|P8|mCRC Expansion Phase|Withdrawal by Subject|2
46432|NCT01577758|196870|P7|mCRC Expansion Phase|Withdrawal by Subject|0
46433|NCT01577758|196871|P6|mCRC Expansion Phase|Withdrawal by Subject|0
46434|NCT01577758|196872|P5|mCRC Expansion Phase|Withdrawal by Subject|0
46435|NCT01577758|196873|P4|mCRC Expansion Phase|Withdrawal by Subject|0
46436|NCT01577758|196874|P3|mCRC Expansion Phase|Withdrawal by Subject|0
46437|NCT01577758|196875|P2|mCRC Expansion Phase|Withdrawal by Subject|0
46438|NCT01577758|196876|P1|mCRC Expansion Phase|Withdrawal by Subject|0
46439|NCT01577758|196869|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
46440|NCT01577758|196870|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
46441|NCT01577758|196871|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
46442|NCT01577758|196872|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
46443|NCT01577758|196873|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
46444|NCT01577758|196874|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
46445|NCT01577758|196875|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
46446|NCT01577758|196876|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
46447|NCT01577758|196869|P8|Dose Escalation Phase|Progression Disease|0
46448|NCT01577758|196870|P7|Dose Escalation Phase|Progression Disease|0
46449|NCT01577758|196871|P6|Dose Escalation Phase|Progression Disease|0
46450|NCT01577758|196872|P5|Dose Escalation Phase|Progression Disease|5
46451|NCT01577758|196873|P4|Dose Escalation Phase|Progression Disease|2
46452|NCT01577758|196874|P3|Dose Escalation Phase|Progression Disease|1
46453|NCT01577758|196875|P2|Dose Escalation Phase|Progression Disease|2
46454|NCT01577758|196876|P1|Dose Escalation Phase|Progression Disease|2
46455|NCT01577758|196869|P8|Dose Escalation Phase|Withdrawal by Subject|0
46456|NCT01577758|196870|P7|Dose Escalation Phase|Withdrawal by Subject|0
46457|NCT01577758|196871|P6|Dose Escalation Phase|Withdrawal by Subject|1
46458|NCT01577758|196872|P5|Dose Escalation Phase|Withdrawal by Subject|0
46459|NCT01577758|196873|P4|Dose Escalation Phase|Withdrawal by Subject|0
46460|NCT01577758|196874|P3|Dose Escalation Phase|Withdrawal by Subject|0
46461|NCT01577758|196875|P2|Dose Escalation Phase|Withdrawal by Subject|0
46462|NCT01577758|196876|P1|Dose Escalation Phase|Withdrawal by Subject|0
46463|NCT01577758|196869|P8|Dose Escalation Phase|Symptomatic Deterioration|0
46464|NCT01577758|196870|P7|Dose Escalation Phase|Symptomatic Deterioration|0
46465|NCT01577758|196871|P6|Dose Escalation Phase|Symptomatic Deterioration|1
46466|NCT01577758|196872|P5|Dose Escalation Phase|Symptomatic Deterioration|1
46467|NCT01577758|196873|P4|Dose Escalation Phase|Symptomatic Deterioration|0
46468|NCT01577758|196874|P3|Dose Escalation Phase|Symptomatic Deterioration|1
46469|NCT01577758|196875|P2|Dose Escalation Phase|Symptomatic Deterioration|0
46470|NCT01577758|196876|P1|Dose Escalation Phase|Symptomatic Deterioration|0
46471|NCT01577758|196869|P8|Dose Escalation Phase|Adverse Event|0
46472|NCT01577758|196870|P7|Dose Escalation Phase|Adverse Event|1
46473|NCT01577758|196871|P6|Dose Escalation Phase|Adverse Event|2
46474|NCT01577758|196872|P5|Dose Escalation Phase|Adverse Event|0
46475|NCT01577758|196873|P4|Dose Escalation Phase|Adverse Event|0
46476|NCT01577758|196874|P3|Dose Escalation Phase|Adverse Event|0
46477|NCT01577758|196875|P2|Dose Escalation Phase|Adverse Event|0
46478|NCT01577758|196876|P1|Dose Escalation Phase|Adverse Event|0
46479|NCT01577745|196915|P6|Overall Study|Alternative Therapy|0
46480|NCT01577745|196916|P5|Overall Study|Alternative Therapy|1
46481|NCT01577745|196917|P4|Overall Study|Alternative Therapy|1
46482|NCT01577745|196918|P3|Overall Study|Alternative Therapy|0
46483|NCT01577745|196919|P2|Overall Study|Alternative Therapy|0
46484|NCT01577745|196920|P1|Overall Study|Alternative Therapy|0
46485|NCT01577745|196915|P6|Overall Study|Lost to Follow-up|1
46486|NCT01577745|196916|P5|Overall Study|Lost to Follow-up|0
46487|NCT01577745|196917|P4|Overall Study|Lost to Follow-up|0
46488|NCT01577745|196918|P3|Overall Study|Lost to Follow-up|0
46489|NCT01577745|196919|P2|Overall Study|Lost to Follow-up|0
46490|NCT01577745|196920|P1|Overall Study|Lost to Follow-up|0
46491|NCT01577745|196915|P6|Overall Study|Physician Decision|0
46492|NCT01577745|196916|P5|Overall Study|Physician Decision|1
46493|NCT01577745|196917|P4|Overall Study|Physician Decision|1
46494|NCT01577745|196918|P3|Overall Study|Physician Decision|0
46495|NCT01577745|196919|P2|Overall Study|Physician Decision|0
46496|NCT01577745|196920|P1|Overall Study|Physician Decision|0
46497|NCT01577745|196915|P6|Overall Study|Death|3
46498|NCT01577745|196916|P5|Overall Study|Death|1
46499|NCT01577745|196917|P4|Overall Study|Death|1
46500|NCT01577745|196918|P3|Overall Study|Death|2
46501|NCT01577745|196919|P2|Overall Study|Death|2
46502|NCT01577745|196920|P1|Overall Study|Death|3
46503|NCT01577745|196915|P6|Overall Study|Withdrawal by Subject|0
46504|NCT01577745|196916|P5|Overall Study|Withdrawal by Subject|2
46505|NCT01577745|196917|P4|Overall Study|Withdrawal by Subject|3
46506|NCT01577745|196918|P3|Overall Study|Withdrawal by Subject|0
46507|NCT01577745|196919|P2|Overall Study|Withdrawal by Subject|1
46508|NCT01577745|196920|P1|Overall Study|Withdrawal by Subject|0
46509|NCT01577381|197104|P4|Overall Study|Ongoing at Date of Cut-Off|0
46510|NCT01577381|197105|P3|Overall Study|Ongoing at Date of Cut-Off|1
46511|NCT01577381|197106|P2|Overall Study|Ongoing at Date of Cut-Off|2
46512|NCT01577381|197107|P1|Overall Study|Ongoing at Date of Cut-Off|0
46513|NCT01577381|197104|P4|Overall Study|Discontinued|2
46514|NCT01577381|197105|P3|Overall Study|Discontinued|2
46515|NCT01577381|197106|P2|Overall Study|Discontinued|1
46516|NCT01577381|197107|P1|Overall Study|Discontinued|2
46517|NCT01577186|197245|P1|Overall Study|Other|2
46518|NCT01577186|197245|P1|Overall Study|Non-Compliant|8
46519|NCT01577186|197245|P1|Overall Study|Ineligible to Continue|15
46520|NCT01577186|197245|P1|Overall Study|Insufficient Response|18
46521|NCT01577186|197245|P1|Overall Study|Withdrawal by Subject|35
46522|NCT01577186|197245|P1|Overall Study|Lost to Follow-up|28
46523|NCT01577186|197245|P1|Overall Study|Death|1
46524|NCT01577186|197245|P1|Overall Study|Adverse Event|23
46525|NCT01577160|197253|P1|Overall Study|Other|9
46526|NCT01577160|197253|P1|Overall Study|Subject Uncooperative|7
46527|NCT01577160|197253|P1|Overall Study|Withdrawal by Subject|18
46528|NCT01577160|197253|P1|Overall Study|Lost to Follow-up|40
46529|NCT01577160|197253|P1|Overall Study|Lack of Efficacy|15
46530|NCT01577160|197253|P1|Overall Study|Adverse Event|9
46531|NCT01576718|197299|P7|Treatment Period|Noncompliance to study medication|1
46532|NCT01576718|197300|P6|Treatment Period|Noncompliance to study medication|1
46533|NCT01576718|197301|P5|Treatment Period|Noncompliance to study medication|0
46534|NCT01576718|197302|P4|Treatment Period|Noncompliance to study medication|0
46535|NCT01576718|197303|P3|Treatment Period|Noncompliance to study medication|0
46536|NCT01576718|197304|P2|Treatment Period|Noncompliance to study medication|0
46537|NCT01576718|197305|P1|Treatment Period|Noncompliance to study medication|0
46538|NCT01576718|197299|P7|Treatment Period|Lost to Follow-up|0
46539|NCT01576718|197300|P6|Treatment Period|Lost to Follow-up|0
46540|NCT01576718|197301|P5|Treatment Period|Lost to Follow-up|1
46541|NCT01576718|197302|P4|Treatment Period|Lost to Follow-up|0
46542|NCT01576718|197303|P3|Treatment Period|Lost to Follow-up|0
46543|NCT01576718|197304|P2|Treatment Period|Lost to Follow-up|0
46544|NCT01576718|197305|P1|Treatment Period|Lost to Follow-up|0
46545|NCT01576718|197299|P7|Treatment Period|Met stopping criteria|15
46546|NCT01576718|197300|P6|Treatment Period|Met stopping criteria|33
46547|NCT01576718|197301|P5|Treatment Period|Met stopping criteria|16
46548|NCT01576718|197302|P4|Treatment Period|Met stopping criteria|19
46549|NCT01576718|197303|P3|Treatment Period|Met stopping criteria|13
46550|NCT01576718|197304|P2|Treatment Period|Met stopping criteria|16
46551|NCT01576718|197305|P1|Treatment Period|Met stopping criteria|0
46552|NCT01576718|197299|P7|Treatment Period|Sponsor request|0
46553|NCT01576718|197300|P6|Treatment Period|Sponsor request|1
46554|NCT01576718|197301|P5|Treatment Period|Sponsor request|0
46555|NCT01576718|197302|P4|Treatment Period|Sponsor request|0
46556|NCT01576718|197303|P3|Treatment Period|Sponsor request|0
46557|NCT01576718|197304|P2|Treatment Period|Sponsor request|1
46558|NCT01576718|197305|P1|Treatment Period|Sponsor request|0
46559|NCT01576718|197299|P7|Treatment Period|Protocol Violation|12
46560|NCT01576718|197300|P6|Treatment Period|Protocol Violation|8
46561|NCT01576718|197301|P5|Treatment Period|Protocol Violation|6
46562|NCT01576718|197302|P4|Treatment Period|Protocol Violation|10
46563|NCT01576718|197303|P3|Treatment Period|Protocol Violation|4
46564|NCT01576718|197304|P2|Treatment Period|Protocol Violation|5
46565|NCT01576718|197305|P1|Treatment Period|Protocol Violation|0
46566|NCT01576718|197299|P7|Treatment Period|Physician Decision|0
46567|NCT01576718|197300|P6|Treatment Period|Physician Decision|0
46568|NCT01576718|197301|P5|Treatment Period|Physician Decision|1
46569|NCT01576718|197302|P4|Treatment Period|Physician Decision|1
46570|NCT01576718|197303|P3|Treatment Period|Physician Decision|1
46571|NCT01576718|197304|P2|Treatment Period|Physician Decision|1
46572|NCT01576718|197305|P1|Treatment Period|Physician Decision|0
46573|NCT01576718|197299|P7|Treatment Period|Withdrawal by Subject|2
46574|NCT01576718|197300|P6|Treatment Period|Withdrawal by Subject|4
46575|NCT01576718|197301|P5|Treatment Period|Withdrawal by Subject|2
46576|NCT01576718|197302|P4|Treatment Period|Withdrawal by Subject|0
46577|NCT01576718|197303|P3|Treatment Period|Withdrawal by Subject|1
46578|NCT01576718|197304|P2|Treatment Period|Withdrawal by Subject|1
46579|NCT01576718|197305|P1|Treatment Period|Withdrawal by Subject|0
46580|NCT01576718|197299|P7|Treatment Period|Adverse Event|0
46581|NCT01576718|197300|P6|Treatment Period|Adverse Event|1
46582|NCT01576718|197301|P5|Treatment Period|Adverse Event|1
46583|NCT01576718|197302|P4|Treatment Period|Adverse Event|1
46584|NCT01576718|197303|P3|Treatment Period|Adverse Event|1
46585|NCT01576718|197304|P2|Treatment Period|Adverse Event|1
46586|NCT01576718|197305|P1|Treatment Period|Adverse Event|0
46587|NCT01576718|197299|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
46588|NCT01576718|197300|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
46589|NCT01576718|197301|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
46590|NCT01576718|197302|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
46591|NCT01576718|197303|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
46592|NCT01576718|197304|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
46593|NCT01576718|197305|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
46594|NCT01576718|197299|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
46595|NCT01576718|197300|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
46596|NCT01576718|197301|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
46597|NCT01576718|197302|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
46598|NCT01576718|197303|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
46599|NCT01576718|197304|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
46600|NCT01576718|197305|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
46601|NCT01576718|197299|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
46602|NCT01576718|197300|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
46603|NCT01576718|197301|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
46604|NCT01576718|197302|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
46605|NCT01576718|197303|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
46606|NCT01576718|197304|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
46607|NCT01576718|197305|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
46608|NCT01576718|197299|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
46609|NCT01576718|197300|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
46610|NCT01576718|197301|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
46611|NCT01576718|197302|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
46612|NCT01576718|197303|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
46613|NCT01576718|197304|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
46614|NCT01576718|197305|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
46615|NCT01576718|197299|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
46616|NCT01576718|197300|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
46617|NCT01576718|197301|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
46618|NCT01576718|197302|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
46619|NCT01576718|197303|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
46620|NCT01576718|197304|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
46621|NCT01576718|197305|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
46622|NCT01576549|197397|P1|Overall Study|Sponsor Decision|2
46623|NCT01576367|197414|P1|Overall Study|Moved to commercial use after 6 months|1
46624|NCT01576367|197414|P1|Overall Study|Unsatisfactory therapeutic effect|2
46625|NCT01576341|197422|P1|Overall Study|Other|12
46626|NCT01576341|197422|P1|Overall Study|Protocol Violation|12
46627|NCT01576341|197422|P1|Overall Study|Kidney transplantation|10
46628|NCT01576341|197422|P1|Overall Study|Lost to Follow-up|2
46629|NCT01576341|197422|P1|Overall Study|Physician Decision|2
46630|NCT01576341|197422|P1|Overall Study|Death|21
46631|NCT01576341|197422|P1|Overall Study|Adverse Event|10
46632|NCT01576341|197422|P1|Overall Study|Withdrawal by Subject|24
46633|NCT01576159|197443|P4|Overall Study|Protocol Violation|0
46634|NCT01576159|197444|P3|Overall Study|Protocol Violation|0
46635|NCT01576159|197445|P2|Overall Study|Protocol Violation|0
46636|NCT01576159|197446|P1|Overall Study|Protocol Violation|1
46637|NCT01576159|197443|P4|Overall Study|Lost to Follow-up|1
46638|NCT01576159|197444|P3|Overall Study|Lost to Follow-up|0
46639|NCT01576159|197445|P2|Overall Study|Lost to Follow-up|0
46640|NCT01576159|197446|P1|Overall Study|Lost to Follow-up|0
46641|NCT01576159|197443|P4|Overall Study|Physician Decision|0
46642|NCT01576159|197444|P3|Overall Study|Physician Decision|1
46643|NCT01576159|197445|P2|Overall Study|Physician Decision|0
46644|NCT01576159|197446|P1|Overall Study|Physician Decision|0
46645|NCT01576159|197443|P4|Overall Study|Withdrawal by Subject|0
46646|NCT01576159|197444|P3|Overall Study|Withdrawal by Subject|0
46647|NCT01576159|197445|P2|Overall Study|Withdrawal by Subject|1
46648|NCT01576159|197446|P1|Overall Study|Withdrawal by Subject|0
46649|NCT01576146|197464|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
46650|NCT01576146|197464|P1|Extension Period 2|Renal Transplant|1
46651|NCT01576146|197464|P1|Extension Period 2|Adverse Event|1
46652|NCT01576146|197464|P1|Extension Period 2|Death|1
46653|NCT01576146|197464|P1|Extension Period 2|Sponsor Decision|13
46654|NCT01576146|197464|P1|Extension Period 1|Renal Transplant|1
46655|NCT01576146|197464|P1|Extension Period 1|Parathyroidectomy|1
46656|NCT01576146|197464|P1|Extension Period 1|Lost to Follow-up|1
46657|NCT01576146|197464|P1|Extension Period 1|Withdrawal by Subject|1
46658|NCT01576146|197464|P1|Extension Period 1|Physician Decision|2
46659|NCT01576146|197464|P1|Extension Period 1|Death|2
46660|NCT01576146|197464|P1|Extension Period 1|Adverse Event|2
46661|NCT01576042|197497|P2|Overall Study|Physician Decision|0
46662|NCT01576042|197498|P1|Overall Study|Physician Decision|2
46663|NCT01575899|197534|P3|Overall Study|Protocol Violation|0
46664|NCT01575899|197535|P2|Overall Study|Protocol Violation|1
46665|NCT01575899|197536|P1|Overall Study|Protocol Violation|2
46666|NCT01575899|197534|P3|Overall Study|Lost to Follow-up|2
46667|NCT01575899|197535|P2|Overall Study|Lost to Follow-up|4
46668|NCT01575899|197536|P1|Overall Study|Lost to Follow-up|3
46669|NCT01575808|197548|P2|Overall Study|Withdrawal by Subject|0
46670|NCT01575808|197549|P1|Overall Study|Withdrawal by Subject|1
46671|NCT01575808|197548|P2|Overall Study|Death|0
46672|NCT01575808|197549|P1|Overall Study|Death|2
46673|NCT01575769|197596|P1|Overall Study|Study terminated by sponsor|40
46674|NCT01575769|197596|P1|Overall Study|Adverse Event|1
46675|NCT01575561|197654|P1|Overall Study|administration|1
46676|NCT01575561|197654|P1|Overall Study|Withdrawal by Subject|11
46677|NCT01575561|197654|P1|Overall Study|Protocol Violation|4
46678|NCT01575561|197654|P1|Overall Study|Lost to Follow-up|6
46679|NCT01575561|197654|P1|Overall Study|Lack of Efficacy|8
46680|NCT01575561|197654|P1|Overall Study|Adverse Event|9
46681|NCT01575197|197677|P3|Overall Study|Protocol Violation|1
46682|NCT01575197|197678|P2|Overall Study|Protocol Violation|1
46683|NCT01575197|197679|P1|Overall Study|Protocol Violation|2
46684|NCT01575197|197677|P3|Overall Study|Withdrawal by Subject|1
46685|NCT01575197|197678|P2|Overall Study|Withdrawal by Subject|1
46686|NCT01575197|197679|P1|Overall Study|Withdrawal by Subject|0
46687|NCT01575197|197677|P3|Overall Study|Lost to Follow-up|0
46688|NCT01575197|197678|P2|Overall Study|Lost to Follow-up|1
46689|NCT01575197|197679|P1|Overall Study|Lost to Follow-up|0
46690|NCT01575197|197677|P3|Overall Study|SAE|0
46691|NCT01575197|197678|P2|Overall Study|SAE|1
46692|NCT01575197|197679|P1|Overall Study|SAE|0
46693|NCT01575197|197677|P3|Overall Study|Migration out of study area|4
46694|NCT01575197|197678|P2|Overall Study|Migration out of study area|5
46695|NCT01575197|197679|P1|Overall Study|Migration out of study area|1
46696|NCT01575054|197707|P2|Overall Study|Adverse Event|8
46697|NCT01575054|197708|P1|Overall Study|Adverse Event|9
46698|NCT01575054|197707|P2|Overall Study|Lost to Follow-up|3
46699|NCT01575054|197708|P1|Overall Study|Lost to Follow-up|3
46700|NCT01575054|197707|P2|Overall Study|Personal Reasons|11
46701|NCT01575054|197708|P1|Overall Study|Personal Reasons|10
46702|NCT01575054|197707|P2|Overall Study|Protocol Violation|1
46703|NCT01575054|197708|P1|Overall Study|Protocol Violation|2
46704|NCT01575054|197707|P2|Overall Study|Other Reasons|3
46705|NCT01575054|197708|P1|Overall Study|Other Reasons|5
46706|NCT01575028|197724|P2|Overall Study|Physician Decision|1
46707|NCT01575028|197725|P1|Overall Study|Physician Decision|0
46708|NCT01574703|197735|P4|Overall Study|Death|0
46709|NCT01574703|197736|P3|Overall Study|Death|1
46710|NCT01574703|197737|P2|Overall Study|Death|1
46711|NCT01574703|197738|P1|Overall Study|Death|2
46712|NCT01574703|197735|P4|Overall Study|Lost to Follow-up|35
46713|NCT01574703|197736|P3|Overall Study|Lost to Follow-up|46
46714|NCT01574703|197737|P2|Overall Study|Lost to Follow-up|41
46715|NCT01574703|197738|P1|Overall Study|Lost to Follow-up|43
46716|NCT01574703|197735|P4|Overall Study|Met Withdrawal Criteria|0
46717|NCT01574703|197736|P3|Overall Study|Met Withdrawal Criteria|1
46718|NCT01574703|197737|P2|Overall Study|Met Withdrawal Criteria|1
46719|NCT01574703|197738|P1|Overall Study|Met Withdrawal Criteria|0
46720|NCT01574703|197735|P4|Overall Study|Withdrawal by Subject|61
46721|NCT01574703|197736|P3|Overall Study|Withdrawal by Subject|36
46722|NCT01574703|197737|P2|Overall Study|Withdrawal by Subject|52
46723|NCT01574703|197738|P1|Overall Study|Withdrawal by Subject|53
46724|NCT01574703|197735|P4|Overall Study|Unspecified Reason|16
46725|NCT01574703|197736|P3|Overall Study|Unspecified Reason|20
46726|NCT01574703|197737|P2|Overall Study|Unspecified Reason|15
46727|NCT01574703|197738|P1|Overall Study|Unspecified Reason|27
46728|NCT01574703|197735|P4|Overall Study|Protocol Violation|1
46729|NCT01574703|197736|P3|Overall Study|Protocol Violation|0
46730|NCT01574703|197737|P2|Overall Study|Protocol Violation|0
46731|NCT01574703|197738|P1|Overall Study|Protocol Violation|0
46732|NCT01574703|197735|P4|Overall Study|Adverse Event|1
46733|NCT01574703|197736|P3|Overall Study|Adverse Event|1
46734|NCT01574703|197737|P2|Overall Study|Adverse Event|2
46735|NCT01574703|197738|P1|Overall Study|Adverse Event|0
46736|NCT01574651|197782|P2|Overall Study|Withdrawal by Subject|10
46737|NCT01574651|197783|P1|Overall Study|Withdrawal by Subject|9
46738|NCT01574651|197782|P2|Overall Study|Protocol Violation|5
46739|NCT01574651|197783|P1|Overall Study|Protocol Violation|3
46740|NCT01574651|197782|P2|Overall Study|Unsatisfactory therapeutic effect|0
46741|NCT01574651|197783|P1|Overall Study|Unsatisfactory therapeutic effect|6
46742|NCT01574651|197782|P2|Overall Study|Abnormal test procedure result(s)|1
46743|NCT01574651|197783|P1|Overall Study|Abnormal test procedure result(s)|1
46744|NCT01574651|197782|P2|Overall Study|Abnormal laboratory value(s)|0
46745|NCT01574651|197783|P1|Overall Study|Abnormal laboratory value(s)|1
46746|NCT01574651|197782|P2|Overall Study|Adverse Event|27
46747|NCT01574651|197783|P1|Overall Study|Adverse Event|36
46748|NCT01574651|197782|P2|Overall Study|Patient's inability to use the device|1
46749|NCT01574651|197783|P1|Overall Study|Patient's inability to use the device|0
46750|NCT01574651|197782|P2|Overall Study|Death|3
46751|NCT01574651|197783|P1|Overall Study|Death|3
46752|NCT01574651|197782|P2|Overall Study|Administrative problems|1
46753|NCT01574651|197783|P1|Overall Study|Administrative problems|0
46754|NCT01574651|197782|P2|Overall Study|Lost to Follow-up|4
46755|NCT01574651|197783|P1|Overall Study|Lost to Follow-up|2
46756|NCT01574612|197805|P1|Overall Study|Lost to Follow-up|2
46757|NCT01574612|197805|P1|Overall Study|Withdrawal by Subject|1
46758|NCT01574612|197805|P1|Overall Study|non compliant with drug|2
46759|NCT01574612|197805|P1|Overall Study|Adverse Event|3
46760|NCT01574326|197811|P2|Overall Study|Other: Mainly kidney transplant|8
46761|NCT01574326|197812|P1|Overall Study|Other: Mainly kidney transplant|8
46762|NCT01574326|197811|P2|Overall Study|Adverse Event|3
46763|NCT01574326|197812|P1|Overall Study|Adverse Event|1
46764|NCT01574326|197811|P2|Overall Study|Physician Decision|3
46765|NCT01574326|197812|P1|Overall Study|Physician Decision|5
46766|NCT01574326|197811|P2|Overall Study|Withdrawal by Participant|4
46767|NCT01574326|197812|P1|Overall Study|Withdrawal by Participant|2
46768|NCT01574326|197811|P2|Overall Study|Randomized but not treated|1
46769|NCT01574326|197812|P1|Overall Study|Randomized but not treated|0
46770|NCT01574248|197825|P2|Overall Study|Missing primary endpoint data|0
46771|NCT01574248|197826|P1|Overall Study|Missing primary endpoint data|1
46772|NCT01574248|197825|P2|Overall Study|Withdrawal by Subject|0
46773|NCT01574248|197826|P1|Overall Study|Withdrawal by Subject|2
46774|NCT01574079|197870|P2|Overall Study|Lost to Follow-up|0
46775|NCT01574079|197871|P1|Overall Study|Lost to Follow-up|1
46776|NCT01574079|197870|P2|Overall Study|Physician Decision|2
46777|NCT01574079|197871|P1|Overall Study|Physician Decision|0
46778|NCT01573910|197883|P2|Overall Study|Patient decision unrelated to Advs Event|11
46779|NCT01573910|197884|P1|Overall Study|Patient decision unrelated to Advs Event|11
46780|NCT01573910|197883|P2|Overall Study|Protocol Violation|0
46781|NCT01573910|197884|P1|Overall Study|Protocol Violation|3
46782|NCT01573910|197883|P2|Overall Study|Withdrawal by Subject|1
46783|NCT01573910|197884|P1|Overall Study|Withdrawal by Subject|0
46784|NCT01573910|197883|P2|Overall Study|Lost to Follow-up|1
46785|NCT01573910|197884|P1|Overall Study|Lost to Follow-up|2
46786|NCT01573910|197883|P2|Overall Study|Adverse Event|4
46787|NCT01573910|197884|P1|Overall Study|Adverse Event|4
46788|NCT01573767|197896|P4|Overall Study|Withdrawal by Subject|0
46789|NCT01573767|197897|P3|Overall Study|Withdrawal by Subject|0
46790|NCT01573767|197898|P2|Overall Study|Withdrawal by Subject|1
46791|NCT01573767|197899|P1|Overall Study|Withdrawal by Subject|0
46792|NCT01573767|197896|P4|Overall Study|Physician Decision|2
46793|NCT01573767|197897|P3|Overall Study|Physician Decision|0
46794|NCT01573767|197898|P2|Overall Study|Physician Decision|2
46795|NCT01573767|197899|P1|Overall Study|Physician Decision|1
46796|NCT01573767|197896|P4|Overall Study|Lost to Follow-up|1
46797|NCT01573767|197897|P3|Overall Study|Lost to Follow-up|1
46798|NCT01573767|197898|P2|Overall Study|Lost to Follow-up|1
46799|NCT01573767|197899|P1|Overall Study|Lost to Follow-up|0
46800|NCT01573767|197896|P4|Overall Study|Protocol Violation|3
46801|NCT01573767|197897|P3|Overall Study|Protocol Violation|1
46802|NCT01573767|197898|P2|Overall Study|Protocol Violation|1
46803|NCT01573767|197899|P1|Overall Study|Protocol Violation|3
46804|NCT01573767|197896|P4|Overall Study|Lack of Efficacy|17
46805|NCT01573767|197897|P3|Overall Study|Lack of Efficacy|12
46806|NCT01573767|197898|P2|Overall Study|Lack of Efficacy|15
46807|NCT01573767|197899|P1|Overall Study|Lack of Efficacy|18
46808|NCT01573767|197896|P4|Overall Study|Adverse Event|1
46809|NCT01573767|197897|P3|Overall Study|Adverse Event|0
46810|NCT01573767|197898|P2|Overall Study|Adverse Event|1
46811|NCT01573767|197899|P1|Overall Study|Adverse Event|0
46812|NCT01573624|197933|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
46813|NCT01573624|197934|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
46814|NCT01573624|197935|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
46815|NCT01573624|197936|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
46816|NCT01573624|197937|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
46817|NCT01573624|197938|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
46818|NCT01573624|197939|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
46819|NCT01573624|197933|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
46820|NCT01573624|197934|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
46821|NCT01573624|197935|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
46822|NCT01573624|197936|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
46823|NCT01573624|197937|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
46824|NCT01573624|197938|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
46825|NCT01573624|197939|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
46826|NCT01573624|197933|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
46827|NCT01573624|197934|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
46828|NCT01573624|197935|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
46829|NCT01573624|197936|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
46830|NCT01573624|197937|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
46831|NCT01573624|197938|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
46832|NCT01573624|197939|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
46833|NCT01573624|197933|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
46834|NCT01573624|197934|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
46835|NCT01573624|197935|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
46836|NCT01573624|197936|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
46837|NCT01573624|197937|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
46838|NCT01573624|197938|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
46839|NCT01573624|197939|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
46840|NCT01573624|197933|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
46841|NCT01573624|197934|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
46842|NCT01573624|197935|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
46843|NCT01573624|197936|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
46844|NCT01573624|197937|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
46845|NCT01573624|197938|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
46846|NCT01573624|197939|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
46847|NCT01573624|197933|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
46848|NCT01573624|197934|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
46849|NCT01573624|197935|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
46850|NCT01573624|197936|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
46851|NCT01573624|197937|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
46852|NCT01573624|197938|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
46853|NCT01573624|197939|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
46854|NCT01573624|197933|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
46855|NCT01573624|197934|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
46856|NCT01573624|197935|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
46857|NCT01573624|197936|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
46858|NCT01573624|197937|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
46859|NCT01573624|197938|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
46860|NCT01573624|197939|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
46861|NCT01573624|197933|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
46862|NCT01573624|197934|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
46863|NCT01573624|197935|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
46864|NCT01573624|197936|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
46865|NCT01573624|197937|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
46866|NCT01573624|197938|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
46867|NCT01573624|197939|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
46868|NCT01573624|197933|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
46869|NCT01573624|197934|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
46870|NCT01573624|197935|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
46871|NCT01573624|197936|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
46872|NCT01573624|197937|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
46873|NCT01573624|197938|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
46874|NCT01573624|197939|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
46875|NCT01573624|197933|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
46876|NCT01573624|197934|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
46877|NCT01573624|197935|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
46878|NCT01573624|197936|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
46879|NCT01573624|197937|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
46880|NCT01573624|197938|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
46881|NCT01573624|197939|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
46882|NCT01573624|197933|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
46883|NCT01573624|197934|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
46884|NCT01573624|197935|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
46885|NCT01573624|197936|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
46886|NCT01573624|197937|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
46887|NCT01573624|197938|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
46888|NCT01573624|197939|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
46889|NCT01573624|197933|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
46890|NCT01573624|197934|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
46891|NCT01573624|197935|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
46892|NCT01573624|197936|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
46893|NCT01573624|197937|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
46894|NCT01573624|197938|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
46895|NCT01573624|197939|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
46896|NCT01573624|197933|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
46897|NCT01573624|197934|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
46898|NCT01573624|197935|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
46899|NCT01573624|197936|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
46900|NCT01573624|197937|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
46901|NCT01573624|197938|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
46902|NCT01573624|197939|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
46903|NCT01573624|197933|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
46904|NCT01573624|197934|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
46905|NCT01573624|197935|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
46906|NCT01573624|197936|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
46907|NCT01573624|197937|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
46908|NCT01573624|197938|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
46909|NCT01573624|197939|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
46910|NCT01573624|197933|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
46911|NCT01573624|197934|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
46912|NCT01573624|197935|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
46913|NCT01573624|197936|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
46914|NCT01573624|197937|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
46915|NCT01573624|197938|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
46916|NCT01573624|197939|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
46917|NCT01573624|197933|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
46918|NCT01573624|197934|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
46919|NCT01573624|197935|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
46920|NCT01573624|197936|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
46921|NCT01573624|197937|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
46922|NCT01573624|197938|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
46923|NCT01573624|197939|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
46924|NCT01573624|197933|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
46925|NCT01573624|197934|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
46926|NCT01573624|197935|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
46927|NCT01573624|197936|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
46928|NCT01573624|197937|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
46929|NCT01573624|197938|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
46930|NCT01573624|197939|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
46931|NCT01573624|197933|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
46932|NCT01573624|197934|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
46933|NCT01573624|197935|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
46934|NCT01573624|197936|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
46935|NCT01573624|197937|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
46936|NCT01573624|197938|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
46937|NCT01573624|197939|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
46938|NCT01573624|197933|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
46939|NCT01573624|197934|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
46940|NCT01573624|197935|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
46941|NCT01573624|197936|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
46942|NCT01573624|197937|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
46943|NCT01573624|197938|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
46944|NCT01573624|197939|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
46945|NCT01573624|197933|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
46946|NCT01573624|197934|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
46947|NCT01573624|197935|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
46948|NCT01573624|197936|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
46949|NCT01573624|197937|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
46950|NCT01573624|197938|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
46951|NCT01573624|197939|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
46952|NCT01573624|197933|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
46953|NCT01573624|197934|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
46954|NCT01573624|197935|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
46955|NCT01573624|197936|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
46956|NCT01573624|197937|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
46957|NCT01573624|197938|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
46958|NCT01573624|197939|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
46959|NCT01573624|197933|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
46960|NCT01573624|197934|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
46961|NCT01573624|197935|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
46962|NCT01573624|197936|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
46963|NCT01573624|197937|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
46964|NCT01573624|197938|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
46965|NCT01573624|197939|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
46966|NCT01573624|197933|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
46967|NCT01573624|197934|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
46968|NCT01573624|197935|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
46969|NCT01573624|197936|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
46970|NCT01573624|197937|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
46971|NCT01573624|197938|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
46972|NCT01573624|197939|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
46973|NCT01573624|197933|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
46974|NCT01573624|197934|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
46975|NCT01573624|197935|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
46976|NCT01573624|197936|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
46977|NCT01573624|197937|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
46978|NCT01573624|197938|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
46979|NCT01573624|197939|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
46980|NCT01573624|197933|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
46981|NCT01573624|197934|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
46982|NCT01573624|197935|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
46983|NCT01573624|197936|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
46984|NCT01573624|197937|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
46985|NCT01573624|197938|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
46986|NCT01573624|197939|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
46987|NCT01573624|197933|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
46988|NCT01573624|197934|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
46989|NCT01573624|197935|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
46990|NCT01573624|197936|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
46991|NCT01573624|197937|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
46992|NCT01573624|197938|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
46993|NCT01573624|197939|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
46994|NCT01573624|197933|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
46995|NCT01573624|197934|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
46996|NCT01573624|197935|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
46997|NCT01573624|197936|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
46998|NCT01573624|197937|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
46999|NCT01573624|197938|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
47000|NCT01573624|197939|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
47001|NCT01573000|198028|P2|Long-Term Follow-Up|Lost to Follow-up|1
47002|NCT01573000|198029|P1|Long-Term Follow-Up|Lost to Follow-up|0
47003|NCT01573000|198028|P2|Long-Term Follow-Up|Death|0
47004|NCT01573000|198029|P1|Long-Term Follow-Up|Death|3
47005|NCT01573000|198028|P2|Crossover Phase|Death|3
47006|NCT01573000|198029|P1|Crossover Phase|Death|0
47007|NCT01573000|198028|P2|Crossover Phase|Lost to Follow-up|2
47008|NCT01573000|198029|P1|Crossover Phase|Lost to Follow-up|0
47009|NCT01573000|198028|P2|Crossover Phase|Lack of Efficacy|13
47010|NCT01573000|198029|P1|Crossover Phase|Lack of Efficacy|0
47011|NCT01573000|198028|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
47012|NCT01573000|198029|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
47013|NCT01573000|198028|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
47014|NCT01573000|198029|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
47015|NCT01573000|198028|P2|Dosimetric and Therapeutic Treatment|Death|1
47016|NCT01573000|198029|P1|Dosimetric and Therapeutic Treatment|Death|0
47017|NCT01573000|198028|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
47018|NCT01573000|198029|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
47019|NCT01573000|198028|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
47020|NCT01573000|198029|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
47021|NCT01572948|198125|P2|Overall Study|unable to contact|1
47022|NCT01572948|198126|P1|Overall Study|unable to contact|0
47023|NCT01572948|198125|P2|Overall Study|Lost to Follow-up|0
47024|NCT01572948|198126|P1|Overall Study|Lost to Follow-up|1
47025|NCT01572844|198142|P2|Overall Study|Physician Decision|1
47026|NCT01572844|198143|P1|Overall Study|Physician Decision|1
47027|NCT01572792|198161|P5|Extension Study|Site termination/COPD exacerbation/other|6
47028|NCT01572792|198162|P4|Extension Study|Site termination/COPD exacerbation/other|6
47029|NCT01572792|198163|P3|Extension Study|Site termination/COPD exacerbation/other|4
47030|NCT01572792|198164|P2|Extension Study|Site termination/COPD exacerbation/other|8
47031|NCT01572792|198165|P1|Extension Study|Site termination/COPD exacerbation/other|3
47032|NCT01572792|198161|P5|Extension Study|Adverse Event|4
47033|NCT01572792|198162|P4|Extension Study|Adverse Event|6
47034|NCT01572792|198163|P3|Extension Study|Adverse Event|5
47035|NCT01572792|198164|P2|Extension Study|Adverse Event|6
47036|NCT01572792|198165|P1|Extension Study|Adverse Event|7
47037|NCT01572792|198161|P5|Extension Study|Lack of Efficacy|2
47038|NCT01572792|198162|P4|Extension Study|Lack of Efficacy|2
47039|NCT01572792|198163|P3|Extension Study|Lack of Efficacy|3
47040|NCT01572792|198164|P2|Extension Study|Lack of Efficacy|3
47041|NCT01572792|198165|P1|Extension Study|Lack of Efficacy|2
47042|NCT01572792|198161|P5|Extension Study|Protocol Violation|3
47043|NCT01572792|198162|P4|Extension Study|Protocol Violation|4
47044|NCT01572792|198163|P3|Extension Study|Protocol Violation|3
47045|NCT01572792|198164|P2|Extension Study|Protocol Violation|4
47046|NCT01572792|198165|P1|Extension Study|Protocol Violation|0
47047|NCT01572792|198161|P5|Extension Study|Withdrawal by Subject|14
47048|NCT01572792|198162|P4|Extension Study|Withdrawal by Subject|8
47049|NCT01572792|198163|P3|Extension Study|Withdrawal by Subject|11
47050|NCT01572792|198164|P2|Extension Study|Withdrawal by Subject|6
47051|NCT01572792|198165|P1|Extension Study|Withdrawal by Subject|7
47052|NCT01572792|198161|P5|Extension Study|Lost to Follow-up|3
47053|NCT01572792|198162|P4|Extension Study|Lost to Follow-up|3
47054|NCT01572792|198163|P3|Extension Study|Lost to Follow-up|0
47055|NCT01572792|198164|P2|Extension Study|Lost to Follow-up|2
47056|NCT01572792|198165|P1|Extension Study|Lost to Follow-up|6
47057|NCT01572792|198161|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
47058|NCT01572792|198162|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
47059|NCT01572792|198163|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
47060|NCT01572792|198164|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
47061|NCT01572792|198165|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
47062|NCT01572792|198161|P5|Lead-in Study|Adverse Event|14
47063|NCT01572792|198162|P4|Lead-in Study|Adverse Event|16
47064|NCT01572792|198163|P3|Lead-in Study|Adverse Event|22
47065|NCT01572792|198164|P2|Lead-in Study|Adverse Event|21
47066|NCT01572792|198165|P1|Lead-in Study|Adverse Event|21
47067|NCT01572792|198161|P5|Lead-in Study|Lack of Efficacy|10
47068|NCT01572792|198162|P4|Lead-in Study|Lack of Efficacy|8
47069|NCT01572792|198163|P3|Lead-in Study|Lack of Efficacy|4
47070|NCT01572792|198164|P2|Lead-in Study|Lack of Efficacy|5
47071|NCT01572792|198165|P1|Lead-in Study|Lack of Efficacy|20
47072|NCT01572792|198161|P5|Lead-in Study|Protocol Violation|21
47073|NCT01572792|198162|P4|Lead-in Study|Protocol Violation|13
47074|NCT01572792|198163|P3|Lead-in Study|Protocol Violation|12
47075|NCT01572792|198164|P2|Lead-in Study|Protocol Violation|10
47076|NCT01572792|198165|P1|Lead-in Study|Protocol Violation|19
47077|NCT01572792|198161|P5|Lead-in Study|Withdrawal by Subject|11
47078|NCT01572792|198162|P4|Lead-in Study|Withdrawal by Subject|24
47079|NCT01572792|198163|P3|Lead-in Study|Withdrawal by Subject|12
47080|NCT01572792|198164|P2|Lead-in Study|Withdrawal by Subject|11
47081|NCT01572792|198165|P1|Lead-in Study|Withdrawal by Subject|22
47082|NCT01572792|198161|P5|Lead-in Study|Lost to Follow-up|4
47083|NCT01572792|198162|P4|Lead-in Study|Lost to Follow-up|2
47084|NCT01572792|198163|P3|Lead-in Study|Lost to Follow-up|4
47085|NCT01572792|198164|P2|Lead-in Study|Lost to Follow-up|9
47086|NCT01572792|198165|P1|Lead-in Study|Lost to Follow-up|5
47087|NCT01572740|198214|P2|Overall Study|unclassified|3
47088|NCT01572740|198215|P1|Overall Study|unclassified|4
47089|NCT01572740|198214|P2|Overall Study|Withdrawal by Subject|1
47090|NCT01572740|198215|P1|Overall Study|Withdrawal by Subject|1
47091|NCT01572740|198214|P2|Overall Study|Adverse Event|1
47092|NCT01572740|198215|P1|Overall Study|Adverse Event|1
47093|NCT01572727|198245|P2|Overall Study|Untreated|7
47094|NCT01572727|198246|P1|Overall Study|Untreated|4
47095|NCT01572727|198245|P2|Overall Study|Death|2
47096|NCT01572727|198246|P1|Overall Study|Death|2
47097|NCT01572727|198245|P2|Overall Study|Parent/guardian decision|9
47098|NCT01572727|198246|P1|Overall Study|Parent/guardian decision|14
47099|NCT01572727|198245|P2|Overall Study|Study terminated by sponsor|83
47100|NCT01572727|198246|P1|Overall Study|Study terminated by sponsor|61
47101|NCT01572727|198245|P2|Overall Study|Protocol Violation|1
47102|NCT01572727|198246|P1|Overall Study|Protocol Violation|0
47103|NCT01572727|198245|P2|Overall Study|Progressive disease|82
47104|NCT01572727|198246|P1|Overall Study|Progressive disease|59
47105|NCT01572727|198245|P2|Overall Study|Physician Decision|9
47106|NCT01572727|198246|P1|Overall Study|Physician Decision|23
47107|NCT01572727|198245|P2|Overall Study|Lost to Follow-up|1
47108|NCT01572727|198246|P1|Overall Study|Lost to Follow-up|1
47109|NCT01572727|198245|P2|Overall Study|Adverse Event|15
47110|NCT01572727|198246|P1|Overall Study|Adverse Event|43
47111|NCT01572675|198268|P2|Overall Study|Lost to Follow-up|27
47112|NCT01572675|198269|P1|Overall Study|Lost to Follow-up|22
47113|NCT01572675|198268|P2|Overall Study|Missing data|4
47114|NCT01572675|198269|P1|Overall Study|Missing data|1
47115|NCT01572675|198268|P2|Overall Study|Rheumatologist new evaluation|1
47116|NCT01572675|198269|P1|Overall Study|Rheumatologist new evaluation|0
47117|NCT01572675|198268|P2|Overall Study|Unknown reason|1
47118|NCT01572675|198269|P1|Overall Study|Unknown reason|1
47119|NCT01572675|198268|P2|Overall Study|Other disease detected|1
47120|NCT01572675|198269|P1|Overall Study|Other disease detected|1
47121|NCT01572675|198268|P2|Overall Study|Death unrelated to coxibs|1
47122|NCT01572675|198269|P1|Overall Study|Death unrelated to coxibs|1
47123|NCT01572675|198268|P2|Overall Study|Physician Decision|2
47124|NCT01572675|198269|P1|Overall Study|Physician Decision|2
47125|NCT01572675|198268|P2|Overall Study|Withdrawal by Subject|1
47126|NCT01572675|198269|P1|Overall Study|Withdrawal by Subject|5
47127|NCT01572675|198268|P2|Overall Study|Surgical intervention|6
47128|NCT01572675|198269|P1|Overall Study|Surgical intervention|3
47129|NCT01572675|198268|P2|Overall Study|Improved symptoms|2
47130|NCT01572675|198269|P1|Overall Study|Improved symptoms|8
47131|NCT01572675|198268|P2|Overall Study|Intolerance|5
47132|NCT01572675|198269|P1|Overall Study|Intolerance|6
47133|NCT01572675|198268|P2|Overall Study|Lack of Efficacy|31
47134|NCT01572675|198269|P1|Overall Study|Lack of Efficacy|31
47135|NCT01572675|198268|P2|Overall Study|Recovery|23
47136|NCT01572675|198269|P1|Overall Study|Recovery|16
47137|NCT01572675|198268|P2|Overall Study|End of prescribed treatment|118
47138|NCT01572675|198269|P1|Overall Study|End of prescribed treatment|140
47139|NCT01572389|198368|P2|Overall Study|Only A1C or Assessment was Collected|2
47140|NCT01572389|198369|P1|Overall Study|Only A1C or Assessment was Collected|6
47141|NCT01572389|198368|P2|Overall Study|Lost to Follow-up|14
47142|NCT01572389|198369|P1|Overall Study|Lost to Follow-up|25
47143|NCT01572389|198368|P2|Overall Study|Withdrawal by Subject|2
47144|NCT01572389|198369|P1|Overall Study|Withdrawal by Subject|14
47145|NCT01572389|198368|P2|Overall Study|Death|3
47146|NCT01572389|198369|P1|Overall Study|Death|1
47147|NCT01571453|198410|P2|Overall Study|Administrative or other reason(s)|3
47148|NCT01571453|198411|P1|Overall Study|Administrative or other reason(s)|4
47149|NCT01571453|198410|P2|Overall Study|Lost to Follow-up|2
47150|NCT01571453|198411|P1|Overall Study|Lost to Follow-up|4
47151|NCT01571453|198410|P2|Overall Study|Withdrawal of consent|13
47152|NCT01571453|198411|P1|Overall Study|Withdrawal of consent|5
47153|NCT01571453|198410|P2|Overall Study|Protocol Violation|5
47154|NCT01571453|198411|P1|Overall Study|Protocol Violation|1
47155|NCT01571453|198410|P2|Overall Study|Non-compliance|4
47156|NCT01571453|198411|P1|Overall Study|Non-compliance|2
47157|NCT01571453|198410|P2|Overall Study|Lack of Efficacy|3
47158|NCT01571453|198411|P1|Overall Study|Lack of Efficacy|8
47159|NCT01571453|198410|P2|Overall Study|Adverse Event|32
47160|NCT01571453|198411|P1|Overall Study|Adverse Event|14
47161|NCT01571362|198427|P3|Double-Blind Treatment Period|Other - unspecified|1
47162|NCT01571362|198428|P2|Double-Blind Treatment Period|Other - unspecified|6
47163|NCT01571362|198429|P1|Double-Blind Treatment Period|Other - unspecified|0
47164|NCT01571362|198427|P3|Double-Blind Treatment Period|Insufficient clinical response|4
47165|NCT01571362|198428|P2|Double-Blind Treatment Period|Insufficient clinical response|16
47166|NCT01571362|198429|P1|Double-Blind Treatment Period|Insufficient clinical response|0
47167|NCT01571362|198427|P3|Double-Blind Treatment Period|Lost to Follow-up|6
47168|NCT01571362|198428|P2|Double-Blind Treatment Period|Lost to Follow-up|3
47169|NCT01571362|198429|P1|Double-Blind Treatment Period|Lost to Follow-up|0
47170|NCT01571362|198427|P3|Double-Blind Treatment Period|Adverse Event|14
47171|NCT01571362|198428|P2|Double-Blind Treatment Period|Adverse Event|9
47172|NCT01571362|198429|P1|Double-Blind Treatment Period|Adverse Event|0
47173|NCT01571362|198427|P3|Double-Blind Treatment Period|Protocol Violation|9
47174|NCT01571362|198428|P2|Double-Blind Treatment Period|Protocol Violation|8
47175|NCT01571362|198429|P1|Double-Blind Treatment Period|Protocol Violation|0
47176|NCT01571362|198427|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
47177|NCT01571362|198428|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
47178|NCT01571362|198429|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
47179|NCT01571362|198427|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
47180|NCT01571362|198428|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
47181|NCT01571362|198429|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
47182|NCT01571362|198427|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
47183|NCT01571362|198428|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
47184|NCT01571362|198429|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
47185|NCT01571362|198427|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
47186|NCT01571362|198428|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
47187|NCT01571362|198429|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
47188|NCT01571362|198427|P3|Open-Label Conversion + Titration Period|Adverse Event|0
47189|NCT01571362|198428|P2|Open-Label Conversion + Titration Period|Adverse Event|0
47190|NCT01571362|198429|P1|Open-Label Conversion + Titration Period|Adverse Event|57
47191|NCT01571362|198427|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
47192|NCT01571362|198428|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
47193|NCT01571362|198429|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
47194|NCT01571362|198427|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
47195|NCT01571362|198428|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
47196|NCT01571362|198429|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
47197|NCT01571284|198599|P1|Overall Study|Other than specified above|80
47198|NCT01571284|198599|P1|Overall Study|Enrolled but not treated|2
47199|NCT01571284|198599|P1|Overall Study|Lost to Follow-up|3
47200|NCT01571284|198599|P1|Overall Study|Participant's decision|84
47201|NCT01571232|198622|P2|Overall Study|Withdrawal by Subject|0
47202|NCT01571232|198623|P1|Overall Study|Withdrawal by Subject|1
47203|NCT01571232|198622|P2|Overall Study|Lost to Follow-up|1
47204|NCT01571232|198623|P1|Overall Study|Lost to Follow-up|0
47205|NCT01570751|198635|P2|Period B (16 Weeks)|Protocol Violation|1
47206|NCT01570751|198636|P1|Period B (16 Weeks)|Protocol Violation|0
47207|NCT01570751|198635|P2|Period B (16 Weeks)|Adverse Event|0
47208|NCT01570751|198636|P1|Period B (16 Weeks)|Adverse Event|1
47209|NCT01570751|198635|P2|Period A (16 Weeks)|Unclassified|3
47210|NCT01570751|198636|P1|Period A (16 Weeks)|Unclassified|2
47211|NCT01570751|198635|P2|Period A (16 Weeks)|Withdrawal criteria|1
47212|NCT01570751|198636|P1|Period A (16 Weeks)|Withdrawal criteria|0
47213|NCT01570751|198635|P2|Period A (16 Weeks)|Protocol Violation|1
47214|NCT01570751|198636|P1|Period A (16 Weeks)|Protocol Violation|1
47215|NCT01570686|198654|P2|Overall Study|Unsatisfactory therapeutic effect|1
47216|NCT01570686|198655|P1|Overall Study|Unsatisfactory therapeutic effect|2
47217|NCT01570686|198654|P2|Overall Study|Withdrawal by Subject|4
47218|NCT01570686|198655|P1|Overall Study|Withdrawal by Subject|4
47219|NCT01570686|198654|P2|Overall Study|Protocol Deviation|0
47220|NCT01570686|198655|P1|Overall Study|Protocol Deviation|3
47221|NCT01570686|198654|P2|Overall Study|Lost to Follow-up|3
47222|NCT01570686|198655|P1|Overall Study|Lost to Follow-up|4
47223|NCT01570686|198654|P2|Overall Study|Adverse Event|6
47224|NCT01570686|198655|P1|Overall Study|Adverse Event|8
47225|NCT01570686|198654|P2|Overall Study|Administrative problems|1
47226|NCT01570686|198655|P1|Overall Study|Administrative problems|0
47227|NCT01570686|198654|P2|Overall Study|Abnormal test procedure result(s)|1
47228|NCT01570686|198655|P1|Overall Study|Abnormal test procedure result(s)|1
47229|NCT01570309|198691|P2|Overall Study|Withdrawal by Subject|3
47230|NCT01570309|198692|P1|Overall Study|Withdrawal by Subject|3
47231|NCT01570244|198706|P1|Microgynon+Faldaprevir|Adverse Event|1
47232|NCT01570192|198728|P2|Overall Study|Physician Decision|1
47233|NCT01570192|198729|P1|Overall Study|Physician Decision|0
47234|NCT01570192|198728|P2|Overall Study|changed to palliative care|0
47235|NCT01570192|198729|P1|Overall Study|changed to palliative care|1
47236|NCT01570192|198728|P2|Overall Study|no qualifying organism|12
47237|NCT01570192|198729|P1|Overall Study|no qualifying organism|6
47238|NCT01569841|198767|P2|Period A (6 Weeks)|Withdrawal by Subject|1
47239|NCT01569841|198768|P1|Period A (6 Weeks)|Withdrawal by Subject|0
47240|NCT01569763|198857|P2|Overall Study|Adverse Event|0
47241|NCT01569763|198858|P1|Overall Study|Adverse Event|1
47242|NCT01569763|198857|P2|Overall Study|Lack of Efficacy|7
47243|NCT01569763|198858|P1|Overall Study|Lack of Efficacy|2
47244|NCT01569568|198895|P2|Overall Study|Physician Decision|2
47245|NCT01569568|198896|P1|Overall Study|Physician Decision|0
47246|NCT01569464|198919|P2|Overall Study|Other|1
47247|NCT01569464|198920|P1|Overall Study|Other|1
47248|NCT01569464|198919|P2|Overall Study|Withdrawal by Subject|1
47249|NCT01569464|198920|P1|Overall Study|Withdrawal by Subject|1
47250|NCT01569464|198919|P2|Overall Study|Lost to Follow-up|3
47251|NCT01569464|198920|P1|Overall Study|Lost to Follow-up|2
47252|NCT01569464|198919|P2|Overall Study|Protocol Violation|0
47253|NCT01569464|198920|P1|Overall Study|Protocol Violation|1
47254|NCT01569464|198919|P2|Overall Study|Lack of Efficacy|0
47255|NCT01569464|198920|P1|Overall Study|Lack of Efficacy|1
47256|NCT01569464|198919|P2|Overall Study|Adverse Event|0
47257|NCT01569464|198920|P1|Overall Study|Adverse Event|4
47258|NCT01569438|198958|P2|Overall Study|Protocol Violation|0
47259|NCT01569438|198959|P1|Overall Study|Protocol Violation|1
47260|NCT01569438|198958|P2|Overall Study|Withdrawal by Subject|1
47261|NCT01569438|198959|P1|Overall Study|Withdrawal by Subject|0
47262|NCT01569438|198958|P2|Overall Study|Lack of Efficacy|1
47263|NCT01569438|198959|P1|Overall Study|Lack of Efficacy|1
47264|NCT01569438|198958|P2|Overall Study|Adverse Event|7
47265|NCT01569438|198959|P1|Overall Study|Adverse Event|0
47266|NCT01569295|198973|P2|Overall Study|Lost to Follow-up|0
47267|NCT01569295|198974|P1|Overall Study|Lost to Follow-up|1
47268|NCT01569295|198973|P2|Overall Study|Other Anticancer/Experimental Therapy|1
47269|NCT01569295|198974|P1|Overall Study|Other Anticancer/Experimental Therapy|2
47270|NCT01569295|198973|P2|Overall Study|Noncompliance with Study Drug|0
47271|NCT01569295|198974|P1|Overall Study|Noncompliance with Study Drug|3
47272|NCT01569295|198973|P2|Overall Study|Other|3
47273|NCT01569295|198974|P1|Overall Study|Other|4
47274|NCT01569295|198973|P2|Overall Study|Physician Decision|19
47275|NCT01569295|198974|P1|Overall Study|Physician Decision|7
47276|NCT01569295|198973|P2|Overall Study|Withdrawal by Subject|8
47277|NCT01569295|198974|P1|Overall Study|Withdrawal by Subject|20
47278|NCT01569295|198973|P2|Overall Study|Adverse Event|13
47279|NCT01569295|198974|P1|Overall Study|Adverse Event|27
47280|NCT01569295|198973|P2|Overall Study|Ongoing in Study|23
47281|NCT01569295|198974|P1|Overall Study|Ongoing in Study|70
47282|NCT01569152|199011|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
47283|NCT01569152|199012|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
47284|NCT01569152|199013|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
47285|NCT01569152|199011|P3|Safety Extension, Period 3|Physician Decision|2
47286|NCT01569152|199012|P2|Safety Extension, Period 3|Physician Decision|0
47287|NCT01569152|199013|P1|Safety Extension, Period 3|Physician Decision|0
47288|NCT01569152|199011|P3|Safety Extension, Period 3|Withdrawal by Subject|2
47289|NCT01569152|199012|P2|Safety Extension, Period 3|Withdrawal by Subject|0
47290|NCT01569152|199013|P1|Safety Extension, Period 3|Withdrawal by Subject|0
47291|NCT01569152|199011|P3|Safety Extension, Period 3|Adverse Event|4
47292|NCT01569152|199012|P2|Safety Extension, Period 3|Adverse Event|0
47293|NCT01569152|199013|P1|Safety Extension, Period 3|Adverse Event|0
47294|NCT01569152|199011|P3|Phase IIa, Period 1|Withdrawal by Subject|0
47295|NCT01569152|199012|P2|Phase IIa, Period 1|Withdrawal by Subject|1
47296|NCT01569152|199013|P1|Phase IIa, Period 1|Withdrawal by Subject|2
47297|NCT01569152|199011|P3|Phase IIa, Period 1|Protocol Violation|0
47298|NCT01569152|199012|P2|Phase IIa, Period 1|Protocol Violation|1
47299|NCT01569152|199013|P1|Phase IIa, Period 1|Protocol Violation|0
47300|NCT01569152|199011|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
47301|NCT01569152|199012|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
47302|NCT01569152|199013|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
47303|NCT01569152|199011|P3|Phase IIa, Period 1|Lost to Follow-up|0
47304|NCT01569152|199012|P2|Phase IIa, Period 1|Lost to Follow-up|0
47305|NCT01569152|199013|P1|Phase IIa, Period 1|Lost to Follow-up|1
47306|NCT01569152|199011|P3|Phase IIa, Period 1|Adverse Event|0
47307|NCT01569152|199012|P2|Phase IIa, Period 1|Adverse Event|0
47308|NCT01569152|199013|P1|Phase IIa, Period 1|Adverse Event|4
47309|NCT01569152|199011|P3|Phase IIa, Period 1|Early Escape|0
47310|NCT01569152|199012|P2|Phase IIa, Period 1|Early Escape|22
47311|NCT01569152|199013|P1|Phase IIa, Period 1|Early Escape|5
47312|NCT01569074|199149|P5|Overall Study|Adverse Event|0
47313|NCT01569074|199150|P4|Overall Study|Adverse Event|0
47314|NCT01569074|199151|P3|Overall Study|Adverse Event|3
47315|NCT01569074|199152|P2|Overall Study|Adverse Event|0
47316|NCT01569074|199153|P1|Overall Study|Adverse Event|1
47317|NCT01569074|199149|P5|Overall Study|eg change in circumstances|1
47318|NCT01569074|199150|P4|Overall Study|eg change in circumstances|1
47319|NCT01569074|199151|P3|Overall Study|eg change in circumstances|0
47320|NCT01569074|199152|P2|Overall Study|eg change in circumstances|2
47321|NCT01569074|199153|P1|Overall Study|eg change in circumstances|0
47322|NCT01569074|199149|P5|Overall Study|Severe non-compliance to protocol|0
47323|NCT01569074|199150|P4|Overall Study|Severe non-compliance to protocol|0
47324|NCT01569074|199151|P3|Overall Study|Severe non-compliance to protocol|1
47325|NCT01569074|199152|P2|Overall Study|Severe non-compliance to protocol|0
47326|NCT01569074|199153|P1|Overall Study|Severe non-compliance to protocol|0
47327|NCT01569074|199149|P5|Overall Study|Study-specific discontinuation criteria|0
47328|NCT01569074|199150|P4|Overall Study|Study-specific discontinuation criteria|0
47329|NCT01569074|199151|P3|Overall Study|Study-specific discontinuation criteria|0
47330|NCT01569074|199152|P2|Overall Study|Study-specific discontinuation criteria|1
47331|NCT01569074|199153|P1|Overall Study|Study-specific discontinuation criteria|0
47332|NCT01569074|199149|P5|Overall Study|Study stopped|7
47333|NCT01569074|199150|P4|Overall Study|Study stopped|7
47334|NCT01569074|199151|P3|Overall Study|Study stopped|8
47335|NCT01569074|199152|P2|Overall Study|Study stopped|6
47336|NCT01569074|199153|P1|Overall Study|Study stopped|6
47337|NCT01569022|199209|P2|Second Intervention|Lost to Follow-up|2
47338|NCT01569022|199210|P1|Second Intervention|Lost to Follow-up|2
47339|NCT01569022|199209|P2|First Intervention|Lost to Follow-up|1
47340|NCT01569022|199210|P1|First Intervention|Lost to Follow-up|2
47341|NCT01568892|199246|P2|Open-label Phase|Ongoing|15
47342|NCT01568892|199247|P1|Open-label Phase|Ongoing|12
47343|NCT01568892|199246|P2|Open-label Phase|Lack of Efficacy|1
47344|NCT01568892|199247|P1|Open-label Phase|Lack of Efficacy|0
47345|NCT01568892|199246|P2|Open-label Phase|Adverse Event|0
47346|NCT01568892|199247|P1|Open-label Phase|Adverse Event|1
47347|NCT01568866|199285|P2|Overall Study|Randomized but Not Dosed|1
47348|NCT01568866|199286|P1|Overall Study|Randomized but Not Dosed|9
47349|NCT01568866|199285|P2|Overall Study|Lost to Follow-up|0
47350|NCT01568866|199286|P1|Overall Study|Lost to Follow-up|1
47351|NCT01568866|199285|P2|Overall Study|Protocol Non-compliance|4
47352|NCT01568866|199286|P1|Overall Study|Protocol Non-compliance|1
47353|NCT01568866|199285|P2|Overall Study|Death|13
47354|NCT01568866|199286|P1|Overall Study|Death|9
47355|NCT01568866|199285|P2|Overall Study|Withdrawal by Subject|6
47356|NCT01568866|199286|P1|Overall Study|Withdrawal by Subject|19
47357|NCT01568866|199285|P2|Overall Study|Physician Decision|18
47358|NCT01568866|199286|P1|Overall Study|Physician Decision|35
47359|NCT01568866|199285|P2|Overall Study|Patient Request|40
47360|NCT01568866|199286|P1|Overall Study|Patient Request|45
47361|NCT01568866|199285|P2|Overall Study|Adverse Event|65
47362|NCT01568866|199286|P1|Overall Study|Adverse Event|73
47363|NCT01568866|199285|P2|Overall Study|Disease Progression|117
47364|NCT01568866|199286|P1|Overall Study|Disease Progression|168
47365|NCT01568593|199317|P2|Overall Study|Adverse Event|2
47366|NCT01568593|199318|P1|Overall Study|Adverse Event|3
47367|NCT01568593|199317|P2|Overall Study|Lack of Efficacy|1
47368|NCT01568593|199318|P1|Overall Study|Lack of Efficacy|4
47369|NCT01568112|199338|P4|Overall Study|Withdrawal by Physician|1
47370|NCT01568112|199339|P3|Overall Study|Withdrawal by Physician|1
47371|NCT01568112|199340|P2|Overall Study|Withdrawal by Physician|0
47372|NCT01568112|199341|P1|Overall Study|Withdrawal by Physician|1
47373|NCT01568112|199338|P4|Overall Study|Withdrawal by Subject|7
47374|NCT01568112|199339|P3|Overall Study|Withdrawal by Subject|0
47375|NCT01568112|199340|P2|Overall Study|Withdrawal by Subject|3
47376|NCT01568112|199341|P1|Overall Study|Withdrawal by Subject|2
47377|NCT01568112|199338|P4|Overall Study|Lost to Follow-up|1
47378|NCT01568112|199339|P3|Overall Study|Lost to Follow-up|0
47379|NCT01568112|199340|P2|Overall Study|Lost to Follow-up|0
47380|NCT01568112|199341|P1|Overall Study|Lost to Follow-up|0
47381|NCT01568112|199338|P4|Overall Study|Withdrew due to Adverse Event|3
47382|NCT01568112|199339|P3|Overall Study|Withdrew due to Adverse Event|6
47383|NCT01568112|199340|P2|Overall Study|Withdrew due to Adverse Event|4
47384|NCT01568112|199341|P1|Overall Study|Withdrew due to Adverse Event|2
47385|NCT01568112|199338|P4|Overall Study|Randomized But Not Treated|0
47386|NCT01568112|199339|P3|Overall Study|Randomized But Not Treated|0
47387|NCT01568112|199340|P2|Overall Study|Randomized But Not Treated|1
47388|NCT01568112|199341|P1|Overall Study|Randomized But Not Treated|0
47389|NCT01568047|199499|P4|Overall Study|Adverse Event|1
47390|NCT01568047|199500|P3|Overall Study|Adverse Event|1
47391|NCT01568047|199501|P2|Overall Study|Adverse Event|0
47392|NCT01568047|199502|P1|Overall Study|Adverse Event|0
47393|NCT01568047|199499|P4|Overall Study|Withdrawal by Subject|0
47394|NCT01568047|199500|P3|Overall Study|Withdrawal by Subject|0
47395|NCT01568047|199501|P2|Overall Study|Withdrawal by Subject|1
47396|NCT01568047|199502|P1|Overall Study|Withdrawal by Subject|0
47397|NCT01568047|199499|P4|Overall Study|Ineligibility|0
47398|NCT01568047|199500|P3|Overall Study|Ineligibility|0
47399|NCT01568047|199501|P2|Overall Study|Ineligibility|0
47400|NCT01568047|199502|P1|Overall Study|Ineligibility|1
47401|NCT01568034|199520|P4|Overall Study|Withdrawal by Subject|0
47402|NCT01568034|199521|P3|Overall Study|Withdrawal by Subject|0
47403|NCT01568034|199522|P2|Overall Study|Withdrawal by Subject|0
47404|NCT01568034|199523|P1|Overall Study|Withdrawal by Subject|1
47405|NCT01567852|199570|P2|Overall Study|ECT discontinued|1
47406|NCT01567852|199571|P1|Overall Study|ECT discontinued|1
47407|NCT01567852|199570|P2|Overall Study|Withdrawal by Subject|6
47408|NCT01567852|199571|P1|Overall Study|Withdrawal by Subject|3
47409|NCT01567826|199589|P2|Overall Study|Lost to Follow-up|2
47410|NCT01567826|199590|P1|Overall Study|Lost to Follow-up|3
47411|NCT01567462|199616|P2|Overall Study|Withdrawal by Subject|7
47412|NCT01567462|199617|P1|Overall Study|Withdrawal by Subject|4
47413|NCT01567163|199634|P1|Overall Study|Lost to Follow-up|2
47414|NCT01567163|199634|P1|Overall Study|Progressive Disease|2
47415|NCT01566981|199674|P2|Overall Study|Lost to Follow-up|8
47416|NCT01566981|199675|P1|Overall Study|Lost to Follow-up|5
47417|NCT01566773|199704|P1|Overall Study|Physician Decision|2
47418|NCT01566773|199704|P1|Overall Study|Adverse Event|10
47419|NCT01566773|199704|P1|Overall Study|Administrative reason|1
47420|NCT01566773|199704|P1|Overall Study|Withdrawal by Subject|9
47421|NCT01566773|199704|P1|Overall Study|Protocol Violation|4
47422|NCT01566773|199704|P1|Overall Study|Protocol specified criteria|4
47423|NCT01566721|199913|P2|Overall Study|Withdrew Prior to Treatment|1
47424|NCT01566721|199914|P1|Overall Study|Withdrew Prior to Treatment|3
47425|NCT01566721|199913|P2|Overall Study|Not Specified|4
47426|NCT01566721|199914|P1|Overall Study|Not Specified|10
47427|NCT01566721|199913|P2|Overall Study|Death|3
47428|NCT01566721|199914|P1|Overall Study|Death|6
47429|NCT01566721|199913|P2|Overall Study|Lost to Follow-up|0
47430|NCT01566721|199914|P1|Overall Study|Lost to Follow-up|18
47431|NCT01566721|199913|P2|Overall Study|Disease Progression/Recurrence|28
47432|NCT01566721|199914|P1|Overall Study|Disease Progression/Recurrence|123
47433|NCT01566721|199913|P2|Overall Study|Withdrawal by Subject|15
47434|NCT01566721|199914|P1|Overall Study|Withdrawal by Subject|58
47435|NCT01566721|199913|P2|Overall Study|Ongoing Study|659
47436|NCT01566721|199914|P1|Overall Study|Ongoing Study|1649
47437|NCT01566604|199996|P2|Overall Study|Withdrawal by Subject|6
47438|NCT01566604|199997|P1|Overall Study|Withdrawal by Subject|9
47439|NCT01566604|199996|P2|Overall Study|Adverse Event|2
47440|NCT01566604|199997|P1|Overall Study|Adverse Event|4
47441|NCT01566604|199996|P2|Overall Study|Death|1
47442|NCT01566604|199997|P1|Overall Study|Death|4
47443|NCT01566604|199996|P2|Overall Study|Abnormal laboratory value|0
47444|NCT01566604|199997|P1|Overall Study|Abnormal laboratory value|2
47445|NCT01566604|199996|P2|Overall Study|Protocol deviation|0
47446|NCT01566604|199997|P1|Overall Study|Protocol deviation|2
47447|NCT01566604|199996|P2|Overall Study|Lack of Efficacy|2
47448|NCT01566604|199997|P1|Overall Study|Lack of Efficacy|1
47449|NCT01566604|199996|P2|Overall Study|Administrative problems|0
47450|NCT01566604|199997|P1|Overall Study|Administrative problems|1
47451|NCT01566604|199996|P2|Overall Study|Patient's inability to use the device|0
47452|NCT01566604|199997|P1|Overall Study|Patient's inability to use the device|1
47453|NCT01566435|200153|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
47454|NCT01566149|200226|P2|Overall Study|Withdrawal by Subject|0
47455|NCT01566149|200227|P1|Overall Study|Withdrawal by Subject|1
47456|NCT01566149|200226|P2|Overall Study|Protocol Violation|1
47457|NCT01566149|200227|P1|Overall Study|Protocol Violation|0
47458|NCT01566149|200226|P2|Overall Study|Non-compliance with study medication|0
47459|NCT01566149|200227|P1|Overall Study|Non-compliance with study medication|2
47460|NCT01566149|200226|P2|Overall Study|Adverse Event|1
47461|NCT01566149|200227|P1|Overall Study|Adverse Event|0
47462|NCT01565993|200260|P2|Overall Study|Physician Decision|3
47463|NCT01565993|200261|P1|Overall Study|Physician Decision|0
47464|NCT01565980|200269|P2|Overall Study|Withdrawal by Subject|3
47465|NCT01565980|200270|P1|Overall Study|Withdrawal by Subject|0
47466|NCT01565980|200269|P2|Overall Study|stopped medical treatment|0
47467|NCT01565980|200270|P1|Overall Study|stopped medical treatment|1
47468|NCT01565980|200269|P2|Overall Study|health complications|1
47469|NCT01565980|200270|P1|Overall Study|health complications|1
47470|NCT01565980|200269|P2|Overall Study|Lost to Follow-up|0
47471|NCT01565980|200270|P1|Overall Study|Lost to Follow-up|1
47472|NCT01565980|200269|P2|Overall Study|Death|0
47473|NCT01565980|200270|P1|Overall Study|Death|1
47474|NCT01565941|200290|P2|Overall Study|Randomized; did not receive intevention|2
47475|NCT01565941|200291|P1|Overall Study|Randomized; did not receive intevention|8
47476|NCT01565941|200290|P2|Overall Study|Withdrawn by parent/guardian|2
47477|NCT01565941|200291|P1|Overall Study|Withdrawn by parent/guardian|3
47478|NCT01565889|200370|P6|Part B|Lost to Follow-up|1
47479|NCT01565889|200371|P5|Part B|Lost to Follow-up|0
47480|NCT01565889|200372|P4|Part B|Lost to Follow-up|0
47481|NCT01565889|200373|P3|Part B|Lost to Follow-up|0
47482|NCT01565889|200374|P2|Part B|Lost to Follow-up|0
47483|NCT01565889|200375|P1|Part B|Lost to Follow-up|0
47484|NCT01565889|200370|P6|Part B|Lack of Efficacy|2
47485|NCT01565889|200371|P5|Part B|Lack of Efficacy|0
47486|NCT01565889|200372|P4|Part B|Lack of Efficacy|0
47487|NCT01565889|200373|P3|Part B|Lack of Efficacy|0
47488|NCT01565889|200374|P2|Part B|Lack of Efficacy|0
47489|NCT01565889|200375|P1|Part B|Lack of Efficacy|0
47490|NCT01565889|200370|P6|Part B|Withdrawal by Subject|1
47491|NCT01565889|200371|P5|Part B|Withdrawal by Subject|0
47492|NCT01565889|200372|P4|Part B|Withdrawal by Subject|0
47493|NCT01565889|200373|P3|Part B|Withdrawal by Subject|0
47494|NCT01565889|200374|P2|Part B|Withdrawal by Subject|0
47495|NCT01565889|200375|P1|Part B|Withdrawal by Subject|0
47496|NCT01565889|200370|P6|Part A|Withdrawal by Subject|0
47497|NCT01565889|200371|P5|Part A|Withdrawal by Subject|0
47498|NCT01565889|200372|P4|Part A|Withdrawal by Subject|0
47499|NCT01565889|200373|P3|Part A|Withdrawal by Subject|0
47500|NCT01565889|200374|P2|Part A|Withdrawal by Subject|0
47501|NCT01565889|200375|P1|Part A|Withdrawal by Subject|1
47502|NCT01565850|200406|P2|Overall Study|Withdrew Consent|2
47503|NCT01565850|200407|P1|Overall Study|Withdrew Consent|4
47504|NCT01565850|200406|P2|Overall Study|Participant noncompliance|0
47505|NCT01565850|200407|P1|Overall Study|Participant noncompliance|2
47506|NCT01565850|200406|P2|Overall Study|Investigator’s Discretion|1
47507|NCT01565850|200407|P1|Overall Study|Investigator’s Discretion|2
47508|NCT01565850|200406|P2|Overall Study|Lost to Follow-up|4
47509|NCT01565850|200407|P1|Overall Study|Lost to Follow-up|12
47510|NCT01565850|200406|P2|Overall Study|Adverse Event|1
47511|NCT01565850|200407|P1|Overall Study|Adverse Event|0
47512|NCT01565707|200427|P4|Overall Study|Miscellaneous|2
47513|NCT01565707|200428|P3|Overall Study|Miscellaneous|0
47514|NCT01565707|200429|P2|Overall Study|Miscellaneous|1
47515|NCT01565707|200430|P1|Overall Study|Miscellaneous|1
47516|NCT01565707|200427|P4|Overall Study|Randomized but not evaluable|0
47517|NCT01565707|200428|P3|Overall Study|Randomized but not evaluable|0
47518|NCT01565707|200429|P2|Overall Study|Randomized but not evaluable|0
47519|NCT01565707|200430|P1|Overall Study|Randomized but not evaluable|2
47520|NCT01565707|200427|P4|Overall Study|Withdrawal by Subject|1
47521|NCT01565707|200428|P3|Overall Study|Withdrawal by Subject|1
47522|NCT01565707|200429|P2|Overall Study|Withdrawal by Subject|1
47523|NCT01565707|200430|P1|Overall Study|Withdrawal by Subject|3
47524|NCT01565707|200427|P4|Overall Study|Protocol Violation|1
47525|NCT01565707|200428|P3|Overall Study|Protocol Violation|0
47526|NCT01565707|200429|P2|Overall Study|Protocol Violation|0
47527|NCT01565707|200430|P1|Overall Study|Protocol Violation|1
47528|NCT01565707|200427|P4|Overall Study|Lost to Follow-up|0
47529|NCT01565707|200428|P3|Overall Study|Lost to Follow-up|0
47530|NCT01565707|200429|P2|Overall Study|Lost to Follow-up|0
47531|NCT01565707|200430|P1|Overall Study|Lost to Follow-up|1
47532|NCT01565707|200427|P4|Overall Study|Adverse Event|1
47533|NCT01565707|200428|P3|Overall Study|Adverse Event|2
47534|NCT01565707|200429|P2|Overall Study|Adverse Event|6
47535|NCT01565707|200430|P1|Overall Study|Adverse Event|1
47536|NCT01565564|200534|P2|Overall Study|Lost to Follow-up|1
47537|NCT01565564|200535|P1|Overall Study|Lost to Follow-up|5
47538|NCT01565343|200585|P3|Overall Study|Administrative decision/technical issues|0
47539|NCT01565343|200586|P2|Overall Study|Administrative decision/technical issues|0
47540|NCT01565343|200587|P1|Overall Study|Administrative decision/technical issues|1
47541|NCT01565291|200617|P2|Overall Study|Withdrawal by Subject|0
47542|NCT01565291|200618|P1|Overall Study|Withdrawal by Subject|1
47543|NCT01565148|200630|P4|Overall Study|Physician Decision|0
47544|NCT01565148|200631|P3|Overall Study|Physician Decision|0
47545|NCT01565148|200632|P2|Overall Study|Physician Decision|5
47546|NCT01565148|200633|P1|Overall Study|Physician Decision|2
47547|NCT01565148|200630|P4|Overall Study|Death|0
47548|NCT01565148|200631|P3|Overall Study|Death|1
47549|NCT01565148|200632|P2|Overall Study|Death|0
47550|NCT01565148|200633|P1|Overall Study|Death|0
47551|NCT01565148|200630|P4|Overall Study|Rescue Therapy|8
47552|NCT01565148|200631|P3|Overall Study|Rescue Therapy|5
47553|NCT01565148|200632|P2|Overall Study|Rescue Therapy|5
47554|NCT01565148|200633|P1|Overall Study|Rescue Therapy|8
47555|NCT01565148|200630|P4|Overall Study|Lost to Follow-up|3
47556|NCT01565148|200631|P3|Overall Study|Lost to Follow-up|0
47557|NCT01565148|200632|P2|Overall Study|Lost to Follow-up|4
47558|NCT01565148|200633|P1|Overall Study|Lost to Follow-up|4
47559|NCT01565148|200630|P4|Overall Study|Withdrawal by Subject|2
47560|NCT01565148|200631|P3|Overall Study|Withdrawal by Subject|1
47561|NCT01565148|200632|P2|Overall Study|Withdrawal by Subject|1
47562|NCT01565148|200633|P1|Overall Study|Withdrawal by Subject|1
47563|NCT01565083|200669|P2|Overall Study|Other|5
47564|NCT01565083|200670|P1|Overall Study|Other|3
47565|NCT01565083|200669|P2|Overall Study|Death|23
47566|NCT01565083|200670|P1|Overall Study|Death|22
47567|NCT01565083|200669|P2|Overall Study|Lost to Follow-up|7
47568|NCT01565083|200670|P1|Overall Study|Lost to Follow-up|2
47569|NCT01565083|200669|P2|Overall Study|Withdrawal by Subject|4
47570|NCT01565083|200670|P1|Overall Study|Withdrawal by Subject|6
47571|NCT01564862|200707|P3|Overall Study|Other reason(s)|0
47572|NCT01564862|200708|P2|Overall Study|Other reason(s)|0
47573|NCT01564862|200709|P1|Overall Study|Other reason(s)|1
47574|NCT01564862|200707|P3|Overall Study|Lack of Efficacy|6
47575|NCT01564862|200708|P2|Overall Study|Lack of Efficacy|5
47576|NCT01564862|200709|P1|Overall Study|Lack of Efficacy|1
47577|NCT01564862|200707|P3|Overall Study|Voluntary Withdrawal|8
47578|NCT01564862|200708|P2|Overall Study|Voluntary Withdrawal|6
47579|NCT01564862|200709|P1|Overall Study|Voluntary Withdrawal|9
47580|NCT01564862|200707|P3|Overall Study|Lost to Follow-up|6
47581|NCT01564862|200708|P2|Overall Study|Lost to Follow-up|8
47582|NCT01564862|200709|P1|Overall Study|Lost to Follow-up|10
47583|NCT01564862|200707|P3|Overall Study|Major Protocol Deviation|4
47584|NCT01564862|200708|P2|Overall Study|Major Protocol Deviation|3
47585|NCT01564862|200709|P1|Overall Study|Major Protocol Deviation|3
47586|NCT01564862|200707|P3|Overall Study|Pretreatment Event or Adverse Event|6
47587|NCT01564862|200708|P2|Overall Study|Pretreatment Event or Adverse Event|12
47588|NCT01564862|200709|P1|Overall Study|Pretreatment Event or Adverse Event|6
47589|NCT01564784|200760|P2|Overall Study|Death|126
47590|NCT01564784|200761|P1|Overall Study|Death|131
47591|NCT01564784|200760|P2|Overall Study|Lost to Follow-up|1
47592|NCT01564784|200761|P1|Overall Study|Lost to Follow-up|1
47593|NCT01564784|200760|P2|Overall Study|Subject refused further follow-up|6
47594|NCT01564784|200761|P1|Overall Study|Subject refused further follow-up|1
47595|NCT01564784|200760|P2|Overall Study|Other|0
47596|NCT01564784|200761|P1|Overall Study|Other|1
47597|NCT01564758|200788|P1|Overall Study|Other|3
47598|NCT01564758|200788|P1|Overall Study|Adverse Event|3
47599|NCT01564758|200788|P1|Overall Study|Death|8
47600|NCT01564732|200795|P2|Overall Study|Early termination by the study sponsor|5
47601|NCT01564732|200796|P1|Overall Study|Early termination by the study sponsor|6
47602|NCT01564537|200831|P2|Overall Study|Other Miscellaneous Reasons|2
47603|NCT01564537|200832|P1|Overall Study|Other Miscellaneous Reasons|1
47604|NCT01564537|200831|P2|Overall Study|Lost to Follow-up|0
47605|NCT01564537|200832|P1|Overall Study|Lost to Follow-up|1
47606|NCT01564537|200831|P2|Overall Study|Withdrawal by Participant|4
47607|NCT01564537|200832|P1|Overall Study|Withdrawal by Participant|4
47608|NCT01564459|200855|P3|Double-blind Treatment|Adverse Event|1
47609|NCT01564459|200856|P2|Double-blind Treatment|Adverse Event|0
47610|NCT01564459|200857|P1|Double-blind Treatment|Adverse Event|0
47611|NCT01564459|200855|P3|Run-In|Withdrawal by Subject|0
47612|NCT01564459|200856|P2|Run-In|Withdrawal by Subject|0
47613|NCT01564459|200857|P1|Run-In|Withdrawal by Subject|1
47614|NCT01564459|200855|P3|Run-In|Protocol Violation|0
47615|NCT01564459|200856|P2|Run-In|Protocol Violation|0
47616|NCT01564459|200857|P1|Run-In|Protocol Violation|1
47617|NCT01564459|200855|P3|Run-In|Non-compliance with study drug|0
47618|NCT01564459|200856|P2|Run-In|Non-compliance with study drug|0
47619|NCT01564459|200857|P1|Run-In|Non-compliance with study drug|2
47620|NCT01564459|200855|P3|Run-In|Lost to Follow-up|0
47621|NCT01564459|200856|P2|Run-In|Lost to Follow-up|0
47622|NCT01564459|200857|P1|Run-In|Lost to Follow-up|1
47623|NCT01564459|200855|P3|Run-In|Adverse Event|0
47624|NCT01564459|200856|P2|Run-In|Adverse Event|0
47625|NCT01564459|200857|P1|Run-In|Adverse Event|7
47626|NCT01564407|200881|P5|Overall Study|funding lost, study ended|0
47627|NCT01564407|200882|P4|Overall Study|funding lost, study ended|1
47628|NCT01564407|200883|P3|Overall Study|funding lost, study ended|0
47629|NCT01564407|200884|P2|Overall Study|funding lost, study ended|0
47630|NCT01564407|200885|P1|Overall Study|funding lost, study ended|0
47631|NCT01564407|200881|P5|Overall Study|Withdrawal by Subject|0
47632|NCT01564407|200882|P4|Overall Study|Withdrawal by Subject|0
47633|NCT01564407|200883|P3|Overall Study|Withdrawal by Subject|0
47634|NCT01564407|200884|P2|Overall Study|Withdrawal by Subject|1
47635|NCT01564407|200885|P1|Overall Study|Withdrawal by Subject|0
47636|NCT01564407|200881|P5|Overall Study|Lost to Follow-up|0
47637|NCT01564407|200882|P4|Overall Study|Lost to Follow-up|0
47638|NCT01564407|200883|P3|Overall Study|Lost to Follow-up|0
47639|NCT01564407|200884|P2|Overall Study|Lost to Follow-up|1
47640|NCT01564407|200885|P1|Overall Study|Lost to Follow-up|0
47641|NCT01564394|200926|P2|Overall Study|Withdrawal by Subject|10
47642|NCT01564394|200927|P1|Overall Study|Withdrawal by Subject|6
47643|NCT01564277|200941|P2|Overall Study|Physician Decision|0
47644|NCT01564277|200942|P1|Overall Study|Physician Decision|1
47645|NCT01564277|200941|P2|Overall Study|Protocol Violation|1
47646|NCT01564277|200942|P1|Overall Study|Protocol Violation|0
47647|NCT01563978|200960|P2|Overall Study|Adverse Event|2
47648|NCT01563978|200961|P1|Overall Study|Adverse Event|1
47649|NCT01563978|200960|P2|Overall Study|Dev. of study specific discont. criteria|0
47650|NCT01563978|200961|P1|Overall Study|Dev. of study specific discont. criteria|1
47651|NCT01563978|200960|P2|Overall Study|Lost to Follow-up|0
47652|NCT01563978|200961|P1|Overall Study|Lost to Follow-up|1
47653|NCT01563978|200960|P2|Overall Study|Physician Decision|0
47654|NCT01563978|200961|P1|Overall Study|Physician Decision|1
47655|NCT01563913|200987|P2|Overall Study|Spouse Passed Away|0
47656|NCT01563913|200988|P1|Overall Study|Spouse Passed Away|1
47657|NCT01563913|200987|P2|Overall Study|Physician Decision|0
47658|NCT01563913|200988|P1|Overall Study|Physician Decision|1
47659|NCT01563536|201000|P2|Overall Study|Lost to Follow-up|0
47660|NCT01563536|201001|P1|Overall Study|Lost to Follow-up|1
47661|NCT01563536|201000|P2|Overall Study|Withdrawal by Subject|2
47662|NCT01563536|201001|P1|Overall Study|Withdrawal by Subject|0
47663|NCT01563185|201060|P1|Overall Study|Non-Compliance with study drug|1
47664|NCT01563185|201060|P1|Overall Study|Withdrawal by Subject|1
47665|NCT01563172|201074|P1|Overall Study|Other (Not specified)|1
47666|NCT01563172|201074|P1|Overall Study|Other (Protocol deviation)|5
47667|NCT01563172|201074|P1|Overall Study|Lost to Follow-up|2
47668|NCT01563172|201074|P1|Overall Study|Adverse Event|5
47669|NCT01563029|201180|P5|Overall Study|Withdrawal by Subject|3
47670|NCT01563029|201181|P4|Overall Study|Withdrawal by Subject|4
47671|NCT01563029|201182|P3|Overall Study|Withdrawal by Subject|3
47672|NCT01563029|201183|P2|Overall Study|Withdrawal by Subject|1
47673|NCT01563029|201184|P1|Overall Study|Withdrawal by Subject|4
47674|NCT01563029|201180|P5|Overall Study|Physician Decision|2
47675|NCT01563029|201181|P4|Overall Study|Physician Decision|4
47676|NCT01563029|201182|P3|Overall Study|Physician Decision|2
47677|NCT01563029|201183|P2|Overall Study|Physician Decision|5
47678|NCT01563029|201184|P1|Overall Study|Physician Decision|3
47679|NCT01563029|201180|P5|Overall Study|Lost to Follow-up|1
47680|NCT01563029|201181|P4|Overall Study|Lost to Follow-up|1
47681|NCT01563029|201182|P3|Overall Study|Lost to Follow-up|1
47682|NCT01563029|201183|P2|Overall Study|Lost to Follow-up|0
47683|NCT01563029|201184|P1|Overall Study|Lost to Follow-up|1
47684|NCT01563029|201180|P5|Overall Study|Protocol defined stopping criteria|0
47685|NCT01563029|201181|P4|Overall Study|Protocol defined stopping criteria|0
47686|NCT01563029|201182|P3|Overall Study|Protocol defined stopping criteria|0
47687|NCT01563029|201183|P2|Overall Study|Protocol defined stopping criteria|0
47688|NCT01563029|201184|P1|Overall Study|Protocol defined stopping criteria|1
47689|NCT01563029|201180|P5|Overall Study|Protocol Violation|3
47690|NCT01563029|201181|P4|Overall Study|Protocol Violation|1
47691|NCT01563029|201182|P3|Overall Study|Protocol Violation|3
47692|NCT01563029|201183|P2|Overall Study|Protocol Violation|2
47693|NCT01563029|201184|P1|Overall Study|Protocol Violation|1
47694|NCT01563029|201180|P5|Overall Study|Lack of Efficacy|19
47695|NCT01563029|201181|P4|Overall Study|Lack of Efficacy|21
47696|NCT01563029|201182|P3|Overall Study|Lack of Efficacy|23
47697|NCT01563029|201183|P2|Overall Study|Lack of Efficacy|16
47698|NCT01563029|201184|P1|Overall Study|Lack of Efficacy|42
47699|NCT01563029|201180|P5|Overall Study|Adverse Event|1
47700|NCT01563029|201181|P4|Overall Study|Adverse Event|2
47701|NCT01563029|201182|P3|Overall Study|Adverse Event|1
47702|NCT01563029|201183|P2|Overall Study|Adverse Event|0
47703|NCT01563029|201184|P1|Overall Study|Adverse Event|1
47704|NCT01562873|201250|P2|Overall Study|Clinical PD and adverse event|0
47705|NCT01562873|201251|P1|Overall Study|Clinical PD and adverse event|1
47706|NCT01562873|201250|P2|Overall Study|Clinical Disease Progression|0
47707|NCT01562873|201251|P1|Overall Study|Clinical Disease Progression|9
47708|NCT01562873|201250|P2|Overall Study|Adverse Event|0
47709|NCT01562873|201251|P1|Overall Study|Adverse Event|1
47710|NCT01562873|201250|P2|Overall Study|Disease Progression per RECIST|0
47711|NCT01562873|201251|P1|Overall Study|Disease Progression per RECIST|10
47712|NCT01562743|201263|P1|Overall Study|Physician Decision|2
47713|NCT01562743|201263|P1|Overall Study|Lost to Follow-up|2
47714|NCT01562743|201263|P1|Overall Study|Discontinuation criteria|2
47715|NCT01562743|201263|P1|Overall Study|Protocol Violation|1
47716|NCT01562743|201263|P1|Overall Study|Withdrawal by Subject|13
47717|NCT01562743|201263|P1|Overall Study|Lack of Efficacy|3
47718|NCT01562743|201263|P1|Overall Study|Adverse Event|29
47719|NCT01562613|201282|P1|Overall Study|Withdrawal by Subject|2
47720|NCT01562613|201282|P1|Overall Study|Lost to Follow-up|2
47721|NCT01562548|201292|P4|Overall Study|Lost to Follow-up|0
47722|NCT01562548|201293|P3|Overall Study|Lost to Follow-up|1
47723|NCT01562548|201294|P2|Overall Study|Lost to Follow-up|0
47724|NCT01562548|201295|P1|Overall Study|Lost to Follow-up|0
47725|NCT01562327|201345|P1|Overall Study|Infusion not received at 6 month window|4
47726|NCT01562327|201345|P1|Overall Study|Participant drop-out|1
47727|NCT01562327|201345|P1|Overall Study|Lack of Efficacy|1
47728|NCT01562327|201345|P1|Overall Study|Adverse Event|2
47729|NCT01562314|201375|P2|Overall Study|Withdrawal by Subject|1
47730|NCT01562314|201376|P1|Overall Study|Withdrawal by Subject|0
47731|NCT01562314|201375|P2|Overall Study|Met Withdrawal Criteria|2
47732|NCT01562314|201376|P1|Overall Study|Met Withdrawal Criteria|3
47733|NCT01562314|201375|P2|Overall Study|Adverse Event|5
47734|NCT01562314|201376|P1|Overall Study|Adverse Event|10
47735|NCT01562275|201463|P13|Stage 2|Progression of Disease|4
47736|NCT01562275|201464|P12|Stage 2|Progression of Disease|12
47737|NCT01562275|201465|P11|Stage 2|Progression of Disease|0
47738|NCT01562275|201466|P10|Stage 2|Progression of Disease|0
47739|NCT01562275|201467|P9|Stage 2|Progression of Disease|0
47740|NCT01562275|201468|P8|Stage 2|Progression of Disease|0
47741|NCT01562275|201469|P7|Stage 2|Progression of Disease|0
47742|NCT01562275|201470|P6|Stage 2|Progression of Disease|0
47743|NCT01562275|201471|P5|Stage 2|Progression of Disease|0
47744|NCT01562275|201472|P4|Stage 2|Progression of Disease|0
47745|NCT01562275|201473|P3|Stage 2|Progression of Disease|0
47746|NCT01562275|201474|P2|Stage 2|Progression of Disease|0
47747|NCT01562275|201475|P1|Stage 2|Progression of Disease|0
47748|NCT01562275|201463|P13|Stage 2|Death|1
47749|NCT01562275|201464|P12|Stage 2|Death|2
47750|NCT01562275|201465|P11|Stage 2|Death|0
47751|NCT01562275|201466|P10|Stage 2|Death|0
47752|NCT01562275|201467|P9|Stage 2|Death|0
47753|NCT01562275|201468|P8|Stage 2|Death|0
47754|NCT01562275|201469|P7|Stage 2|Death|0
47755|NCT01562275|201470|P6|Stage 2|Death|0
47756|NCT01562275|201471|P5|Stage 2|Death|0
47757|NCT01562275|201472|P4|Stage 2|Death|0
47758|NCT01562275|201473|P3|Stage 2|Death|0
47759|NCT01562275|201474|P2|Stage 2|Death|0
47760|NCT01562275|201475|P1|Stage 2|Death|0
47761|NCT01562275|201463|P13|Stage 1|Withdrawal by Subject|0
47762|NCT01562275|201464|P12|Stage 1|Withdrawal by Subject|0
47763|NCT01562275|201465|P11|Stage 1|Withdrawal by Subject|0
47764|NCT01562275|201466|P10|Stage 1|Withdrawal by Subject|1
47765|NCT01562275|201467|P9|Stage 1|Withdrawal by Subject|0
47766|NCT01562275|201468|P8|Stage 1|Withdrawal by Subject|0
47767|NCT01562275|201469|P7|Stage 1|Withdrawal by Subject|1
47768|NCT01562275|201470|P6|Stage 1|Withdrawal by Subject|0
47769|NCT01562275|201471|P5|Stage 1|Withdrawal by Subject|0
47770|NCT01562275|201472|P4|Stage 1|Withdrawal by Subject|2
47771|NCT01562275|201473|P3|Stage 1|Withdrawal by Subject|0
47772|NCT01562275|201474|P2|Stage 1|Withdrawal by Subject|1
47773|NCT01562275|201475|P1|Stage 1|Withdrawal by Subject|0
47774|NCT01562275|201463|P13|Stage 1|Progression of Disease|0
47775|NCT01562275|201464|P12|Stage 1|Progression of Disease|0
47776|NCT01562275|201465|P11|Stage 1|Progression of Disease|3
47777|NCT01562275|201466|P10|Stage 1|Progression of Disease|5
47778|NCT01562275|201467|P9|Stage 1|Progression of Disease|2
47779|NCT01562275|201468|P8|Stage 1|Progression of Disease|7
47780|NCT01562275|201469|P7|Stage 1|Progression of Disease|1
47781|NCT01562275|201470|P6|Stage 1|Progression of Disease|4
47782|NCT01562275|201471|P5|Stage 1|Progression of Disease|2
47783|NCT01562275|201472|P4|Stage 1|Progression of Disease|1
47784|NCT01562275|201473|P3|Stage 1|Progression of Disease|2
47785|NCT01562275|201474|P2|Stage 1|Progression of Disease|6
47786|NCT01562275|201475|P1|Stage 1|Progression of Disease|2
47787|NCT01562275|201463|P13|Stage 1|Physician Decision|0
47788|NCT01562275|201464|P12|Stage 1|Physician Decision|0
47789|NCT01562275|201465|P11|Stage 1|Physician Decision|0
47790|NCT01562275|201466|P10|Stage 1|Physician Decision|0
47791|NCT01562275|201467|P9|Stage 1|Physician Decision|1
47792|NCT01562275|201468|P8|Stage 1|Physician Decision|0
47793|NCT01562275|201469|P7|Stage 1|Physician Decision|1
47794|NCT01562275|201470|P6|Stage 1|Physician Decision|0
47795|NCT01562275|201471|P5|Stage 1|Physician Decision|1
47796|NCT01562275|201472|P4|Stage 1|Physician Decision|0
47797|NCT01562275|201473|P3|Stage 1|Physician Decision|0
47798|NCT01562275|201474|P2|Stage 1|Physician Decision|0
47799|NCT01562275|201475|P1|Stage 1|Physician Decision|0
47800|NCT01562275|201463|P13|Stage 1|Non Compliance|0
47801|NCT01562275|201464|P12|Stage 1|Non Compliance|0
47802|NCT01562275|201465|P11|Stage 1|Non Compliance|0
47803|NCT01562275|201466|P10|Stage 1|Non Compliance|0
47804|NCT01562275|201467|P9|Stage 1|Non Compliance|0
47805|NCT01562275|201468|P8|Stage 1|Non Compliance|0
47806|NCT01562275|201469|P7|Stage 1|Non Compliance|0
47807|NCT01562275|201470|P6|Stage 1|Non Compliance|0
47808|NCT01562275|201471|P5|Stage 1|Non Compliance|0
47809|NCT01562275|201472|P4|Stage 1|Non Compliance|0
47810|NCT01562275|201473|P3|Stage 1|Non Compliance|1
47811|NCT01562275|201474|P2|Stage 1|Non Compliance|0
47812|NCT01562275|201475|P1|Stage 1|Non Compliance|0
47813|NCT01562275|201463|P13|Stage 1|Death|0
47814|NCT01562275|201464|P12|Stage 1|Death|0
47815|NCT01562275|201465|P11|Stage 1|Death|0
47816|NCT01562275|201466|P10|Stage 1|Death|0
47817|NCT01562275|201467|P9|Stage 1|Death|0
47818|NCT01562275|201468|P8|Stage 1|Death|0
47819|NCT01562275|201469|P7|Stage 1|Death|0
47820|NCT01562275|201470|P6|Stage 1|Death|0
47821|NCT01562275|201471|P5|Stage 1|Death|0
47822|NCT01562275|201472|P4|Stage 1|Death|0
47823|NCT01562275|201473|P3|Stage 1|Death|0
47824|NCT01562275|201474|P2|Stage 1|Death|0
47825|NCT01562275|201475|P1|Stage 1|Death|1
47826|NCT01562275|201463|P13|Stage 1|Adverse Event|0
47827|NCT01562275|201464|P12|Stage 1|Adverse Event|0
47828|NCT01562275|201465|P11|Stage 1|Adverse Event|0
47829|NCT01562275|201466|P10|Stage 1|Adverse Event|1
47830|NCT01562275|201467|P9|Stage 1|Adverse Event|0
47831|NCT01562275|201468|P8|Stage 1|Adverse Event|0
47832|NCT01562275|201469|P7|Stage 1|Adverse Event|0
47833|NCT01562275|201470|P6|Stage 1|Adverse Event|0
47834|NCT01562275|201471|P5|Stage 1|Adverse Event|1
47835|NCT01562275|201472|P4|Stage 1|Adverse Event|1
47836|NCT01562275|201473|P3|Stage 1|Adverse Event|0
47837|NCT01562275|201474|P2|Stage 1|Adverse Event|0
47838|NCT01562275|201475|P1|Stage 1|Adverse Event|0
47839|NCT01561976|201620|P6|Washout Period 2 (7 Days)|Non-compliance|0
47840|NCT01561976|201621|P5|Washout Period 2 (7 Days)|Non-compliance|0
47841|NCT01561976|201622|P4|Washout Period 2 (7 Days)|Non-compliance|0
47842|NCT01561976|201623|P3|Washout Period 2 (7 Days)|Non-compliance|1
47843|NCT01561976|201624|P2|Washout Period 2 (7 Days)|Non-compliance|0
47844|NCT01561976|201625|P1|Washout Period 2 (7 Days)|Non-compliance|1
47845|NCT01561976|201620|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
47846|NCT01561976|201621|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
47847|NCT01561976|201622|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
47848|NCT01561976|201623|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
47849|NCT01561976|201624|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
47850|NCT01561976|201625|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
47851|NCT01561976|201620|P6|Washout Period 1 (7 Days)|Adverse Event|0
47852|NCT01561976|201621|P5|Washout Period 1 (7 Days)|Adverse Event|0
47853|NCT01561976|201622|P4|Washout Period 1 (7 Days)|Adverse Event|1
47854|NCT01561976|201623|P3|Washout Period 1 (7 Days)|Adverse Event|0
47855|NCT01561976|201624|P2|Washout Period 1 (7 Days)|Adverse Event|0
47856|NCT01561976|201625|P1|Washout Period 1 (7 Days)|Adverse Event|0
47857|NCT01561976|201620|P6|Period 1|Adverse Event|0
47858|NCT01561976|201621|P5|Period 1|Adverse Event|0
47859|NCT01561976|201622|P4|Period 1|Adverse Event|0
47860|NCT01561976|201623|P3|Period 1|Adverse Event|1
47861|NCT01561976|201624|P2|Period 1|Adverse Event|0
47862|NCT01561976|201625|P1|Period 1|Adverse Event|0
47863|NCT01561898|201658|P4|Overall Study|Physician Decision|1
47864|NCT01561898|201659|P3|Overall Study|Physician Decision|7
47865|NCT01561898|201660|P2|Overall Study|Physician Decision|5
47866|NCT01561898|201661|P1|Overall Study|Physician Decision|1
47867|NCT01561898|201658|P4|Overall Study|Adverse Event|9
47868|NCT01561898|201659|P3|Overall Study|Adverse Event|14
47869|NCT01561898|201660|P2|Overall Study|Adverse Event|19
47870|NCT01561898|201661|P1|Overall Study|Adverse Event|1
47871|NCT01561898|201658|P4|Overall Study|Lost to Follow-up|0
47872|NCT01561898|201659|P3|Overall Study|Lost to Follow-up|1
47873|NCT01561898|201660|P2|Overall Study|Lost to Follow-up|0
47874|NCT01561898|201661|P1|Overall Study|Lost to Follow-up|0
47875|NCT01561898|201658|P4|Overall Study|Worsening of complications|0
47876|NCT01561898|201659|P3|Overall Study|Worsening of complications|0
47877|NCT01561898|201660|P2|Overall Study|Worsening of complications|1
47878|NCT01561898|201661|P1|Overall Study|Worsening of complications|0
47879|NCT01561898|201658|P4|Overall Study|Lack of Efficacy|5
47880|NCT01561898|201659|P3|Overall Study|Lack of Efficacy|10
47881|NCT01561898|201660|P2|Overall Study|Lack of Efficacy|8
47882|NCT01561898|201661|P1|Overall Study|Lack of Efficacy|0
47883|NCT01561898|201658|P4|Overall Study|Withdrawal by Subject|5
47884|NCT01561898|201659|P3|Overall Study|Withdrawal by Subject|12
47885|NCT01561898|201660|P2|Overall Study|Withdrawal by Subject|8
47886|NCT01561898|201661|P1|Overall Study|Withdrawal by Subject|0
47887|NCT01561755|201675|P2|Overall Study|Lost to Follow-up|1
47888|NCT01561755|201676|P1|Overall Study|Lost to Follow-up|0
47889|NCT01561560|201728|P2|Second Two Weeks of Wear|Adverse Event|1
47890|NCT01561560|201729|P1|Second Two Weeks of Wear|Adverse Event|0
47891|NCT01561560|201728|P2|First Two Weeks of Wear|Adverse Event|1
47892|NCT01561560|201729|P1|First Two Weeks of Wear|Adverse Event|0
47893|NCT01561560|201728|P2|First Two Weeks of Wear|Time/job conflict|1
47894|NCT01561560|201729|P1|First Two Weeks of Wear|Time/job conflict|0
47895|NCT01561430|201760|P4|Overall Study|Sponsor Decision|12
47896|NCT01561430|201761|P3|Overall Study|Sponsor Decision|13
47897|NCT01561430|201762|P2|Overall Study|Sponsor Decision|14
47898|NCT01561430|201763|P1|Overall Study|Sponsor Decision|1
47899|NCT01561430|201760|P4|Overall Study|Physician Decision|0
47900|NCT01561430|201761|P3|Overall Study|Physician Decision|0
47901|NCT01561430|201762|P2|Overall Study|Physician Decision|1
47902|NCT01561430|201763|P1|Overall Study|Physician Decision|0
47903|NCT01561430|201760|P4|Overall Study|Withdrawal by Subject|0
47904|NCT01561430|201761|P3|Overall Study|Withdrawal by Subject|1
47905|NCT01561430|201762|P2|Overall Study|Withdrawal by Subject|0
47906|NCT01561430|201763|P1|Overall Study|Withdrawal by Subject|0
47907|NCT01561430|201760|P4|Overall Study|Adverse Event|1
47908|NCT01561430|201761|P3|Overall Study|Adverse Event|3
47909|NCT01561430|201762|P2|Overall Study|Adverse Event|0
47910|NCT01561430|201763|P1|Overall Study|Adverse Event|0
47911|NCT01561313|201803|P2|Overall Study|Adverse event and withdrawal by subject|0
47912|NCT01561313|201804|P1|Overall Study|Adverse event and withdrawal by subject|1
47913|NCT01561313|201803|P2|Overall Study|Withdrawal by Subject|0
47914|NCT01561313|201804|P1|Overall Study|Withdrawal by Subject|1
47915|NCT01561300|201822|P2|Run in on Placebo|Adverse Event|0
47916|NCT01561300|201823|P1|Run in on Placebo|Adverse Event|1
47917|NCT01561079|201834|P1|Overall Study|Protocol Violation|2
47918|NCT01561079|201834|P1|Overall Study|Withdrawal by Subject|59
47919|NCT01561079|201834|P1|Overall Study|Physician Decision|17
47920|NCT01560988|201877|P2|Washout (Six Weeks)|Lost to Follow-up|2
47921|NCT01560988|201878|P1|Washout (Six Weeks)|Lost to Follow-up|2
47922|NCT01560988|201877|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
47923|NCT01560988|201878|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
47924|NCT01560988|201877|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
47925|NCT01560988|201878|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
47926|NCT01560819|201916|P2|Overall Study|Physician Decision|0
47927|NCT01560819|201917|P1|Overall Study|Physician Decision|1
47928|NCT01560507|201924|P3|Overall Study|Withdrawal by Subject|0
47929|NCT01560507|201925|P2|Overall Study|Withdrawal by Subject|1
47930|NCT01560507|201926|P1|Overall Study|Withdrawal by Subject|1
47931|NCT01560507|201924|P3|Overall Study|Lost to Follow-up|2
47932|NCT01560507|201925|P2|Overall Study|Lost to Follow-up|1
47933|NCT01560507|201926|P1|Overall Study|Lost to Follow-up|3
47934|NCT01560429|201939|P2|Overall Study|Protocol Violation|6
47935|NCT01560429|201940|P1|Overall Study|Protocol Violation|3
47936|NCT01560403|201950|P2|Overall Study|Lost to Follow-up|1
47937|NCT01560403|201951|P1|Overall Study|Lost to Follow-up|0
47938|NCT01560234|201969|P8|Overall Study|Lost to Follow-up|2
47939|NCT01560234|201970|P7|Overall Study|Lost to Follow-up|0
47940|NCT01560234|201971|P6|Overall Study|Lost to Follow-up|2
47941|NCT01560234|201972|P5|Overall Study|Lost to Follow-up|0
47942|NCT01560234|201973|P4|Overall Study|Lost to Follow-up|0
47943|NCT01560234|201974|P3|Overall Study|Lost to Follow-up|1
47944|NCT01560234|201975|P2|Overall Study|Lost to Follow-up|0
47945|NCT01560234|201976|P1|Overall Study|Lost to Follow-up|3
47946|NCT01559935|202054|P1|Maintenance Phase|Non-compliance|2
47947|NCT01559935|202054|P1|Maintenance Phase|Withdrawal by Subject|5
47948|NCT01559935|202054|P1|Maintenance Phase|Lack of Efficacy|18
47949|NCT01559935|202054|P1|Maintenance Phase|Toxicity|1
47950|NCT01559935|202054|P1|Maintenance Phase|Remains on study|28
47951|NCT01559935|202054|P1|BiRD Phase|Withdrawal by Subject|2
47952|NCT01559935|202054|P1|BiRD Phase|Lack of Efficacy|1
47953|NCT01559935|202054|P1|BiRD Phase|Toxicity|1
47954|NCT01559935|202054|P1|Car Phase|non-compliance|1
47955|NCT01559935|202054|P1|Car Phase|Insurance|1
47956|NCT01559935|202054|P1|Car Phase|Per protocol|1
47957|NCT01559935|202054|P1|Car Phase|Withdrawal by Subject|2
47958|NCT01559935|202054|P1|Car Phase|Physician Decision|1
47959|NCT01559935|202054|P1|Car Phase|Lost to Follow-up|1
47960|NCT01559935|202054|P1|Car Phase|Lack of Efficacy|2
47961|NCT01559935|202054|P1|Car Phase|Death|1
47962|NCT01559935|202054|P1|Car Phase|Toxicity|4
47963|NCT01559844|202090|P1|Overall Study|No Longer A Transplant Candidate|3
47964|NCT01559844|202090|P1|Overall Study|Efficacy Failure|10
47965|NCT01559844|202090|P1|Overall Study|Death|5
47966|NCT01559844|202090|P1|Overall Study|Consent Withdrawn|7
47967|NCT01559675|202103|P2|Overall Study|2nd operation on same patient excluded|12
47968|NCT01559675|202104|P1|Overall Study|2nd operation on same patient excluded|14
47969|NCT01559675|202103|P2|Overall Study|Protocol Violation|2
47970|NCT01559675|202104|P1|Overall Study|Protocol Violation|1
47971|NCT01559454|202135|P2|Overall Study|Lack of Efficacy|1
47972|NCT01559454|202136|P1|Overall Study|Lack of Efficacy|0
47973|NCT01559454|202135|P2|Overall Study|Protocol Violation|1
47974|NCT01559454|202136|P1|Overall Study|Protocol Violation|0
47975|NCT01559454|202135|P2|Overall Study|Physician Decision|1
47976|NCT01559454|202136|P1|Overall Study|Physician Decision|0
47977|NCT01559454|202135|P2|Overall Study|Withdrawal by Subject|1
47978|NCT01559454|202136|P1|Overall Study|Withdrawal by Subject|0
47979|NCT01559454|202135|P2|Overall Study|Lost to Follow-up|2
47980|NCT01559454|202136|P1|Overall Study|Lost to Follow-up|3
47981|NCT01559311|202155|P3|Overall Study|Adverse Event|1
47982|NCT01559311|202156|P2|Overall Study|Adverse Event|0
47983|NCT01559311|202157|P1|Overall Study|Adverse Event|0
47984|NCT01559311|202155|P3|Overall Study|Lost to Follow-up|2
47985|NCT01559311|202156|P2|Overall Study|Lost to Follow-up|3
47986|NCT01559311|202157|P1|Overall Study|Lost to Follow-up|0
47987|NCT01559311|202155|P3|Overall Study|Death|3
47988|NCT01559311|202156|P2|Overall Study|Death|2
47989|NCT01559311|202157|P1|Overall Study|Death|0
47990|NCT01559311|202155|P3|Overall Study|Withdrawal by Subject|0
47991|NCT01559311|202156|P2|Overall Study|Withdrawal by Subject|1
47992|NCT01559311|202157|P1|Overall Study|Withdrawal by Subject|2
47993|NCT01559311|202155|P3|Overall Study|Difficulty in cannulating the lateral ve|0
47994|NCT01559311|202156|P2|Overall Study|Difficulty in cannulating the lateral ve|0
47995|NCT01559311|202157|P1|Overall Study|Difficulty in cannulating the lateral ve|1
47996|NCT01559311|202155|P3|Overall Study|Protocol Violation|2
47997|NCT01559311|202156|P2|Overall Study|Protocol Violation|0
47998|NCT01559311|202157|P1|Overall Study|Protocol Violation|0
47999|NCT01559116|202168|P1|Overall Study|other than stated above|9
48000|NCT01559116|202168|P1|Overall Study|Withdrawal by Subject|4
48001|NCT01559116|202168|P1|Overall Study|Protocol Violation|1
48002|NCT01559116|202168|P1|Overall Study|Lost to Follow-up|1
48003|NCT01559116|202168|P1|Overall Study|Lack of Efficacy|1
48004|NCT01559116|202168|P1|Overall Study|Adverse Event|10
48005|NCT01559012|202251|P2|Overall Study|Withdrawal by Subject|1
48006|NCT01559012|202252|P1|Overall Study|Withdrawal by Subject|0
48007|NCT01558739|202288|P1|Overall Study|Protocol Violation|1
48008|NCT01558739|202288|P1|Overall Study|Disease Progression|4
48009|NCT01558739|202288|P1|Overall Study|Death|3
48010|NCT01558739|202288|P1|Overall Study|Withdrawal by Subject|2
48011|NCT01558739|202288|P1|Overall Study|Adverse Event|7
48012|NCT01558674|202313|P2|Part 1|Withdrawal by Subject|0
48013|NCT01558674|202314|P1|Part 1|Withdrawal by Subject|1
48014|NCT01558674|202313|P2|Part 1|Study Terminated by Sponsor|0
48015|NCT01558674|202314|P1|Part 1|Study Terminated by Sponsor|10
48016|NCT01558596|202367|P2|Overall Study|Protocol Violation|0
48017|NCT01558596|202368|P1|Overall Study|Protocol Violation|1
48018|NCT01558596|202367|P2|Overall Study|surgery elsewhere or cancelled|1
48019|NCT01558596|202368|P1|Overall Study|surgery elsewhere or cancelled|1
48020|NCT01558596|202367|P2|Overall Study|Withdrawal by Subject|0
48021|NCT01558596|202368|P1|Overall Study|Withdrawal by Subject|1
48022|NCT01558297|202383|P3|Overall Study|Withdrawal by Subject|1
48023|NCT01558297|202384|P2|Overall Study|Withdrawal by Subject|2
48024|NCT01558297|202385|P1|Overall Study|Withdrawal by Subject|2
48025|NCT01558271|202402|P3|Overall Study|Physician Decision|1
48026|NCT01558271|202403|P2|Overall Study|Physician Decision|2
48027|NCT01558271|202404|P1|Overall Study|Physician Decision|0
48028|NCT01558271|202402|P3|Overall Study|Withdrawal by Subject|12
48029|NCT01558271|202403|P2|Overall Study|Withdrawal by Subject|6
48030|NCT01558271|202404|P1|Overall Study|Withdrawal by Subject|10
48031|NCT01558271|202402|P3|Overall Study|Protocol Violation|0
48032|NCT01558271|202403|P2|Overall Study|Protocol Violation|0
48033|NCT01558271|202404|P1|Overall Study|Protocol Violation|1
48034|NCT01558271|202402|P3|Overall Study|Lost to Follow-up|0
48035|NCT01558271|202403|P2|Overall Study|Lost to Follow-up|0
48036|NCT01558271|202404|P1|Overall Study|Lost to Follow-up|1
48037|NCT01558271|202402|P3|Overall Study|Adverse Event|4
48038|NCT01558271|202403|P2|Overall Study|Adverse Event|3
48039|NCT01558271|202404|P1|Overall Study|Adverse Event|6
48040|NCT01558089|202470|P1|Overall Study|Withdrawal by Subject|6
48041|NCT01558089|202470|P1|Overall Study|Lost to Follow-up|5
48042|NCT01558089|202470|P1|Overall Study|Lack of Efficacy|1
48043|NCT01558089|202470|P1|Overall Study|Adverse Event|1
48044|NCT01557946|202491|P2|Overall Study|Adverse Event|0
48045|NCT01557946|202492|P1|Overall Study|Adverse Event|3
48046|NCT01557920|202498|P2|Overall Study|Lack of Efficacy|0
48047|NCT01557920|202499|P1|Overall Study|Lack of Efficacy|1
48048|NCT01557920|202498|P2|Overall Study|Withdrawal by Subject|3
48049|NCT01557920|202499|P1|Overall Study|Withdrawal by Subject|2
48050|NCT01557842|202562|P2|Overall Study|Not Ablated|0
48051|NCT01557842|202563|P1|Overall Study|Not Ablated|2
48052|NCT01557842|202562|P2|Overall Study|Study Terminated by Sponsor|4
48053|NCT01557842|202563|P1|Overall Study|Study Terminated by Sponsor|3
48054|NCT01557842|202562|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
48055|NCT01557842|202563|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
48056|NCT01557842|202562|P2|Overall Study|Lack of Efficacy|1
48057|NCT01557842|202563|P1|Overall Study|Lack of Efficacy|0
48058|NCT01557842|202562|P2|Overall Study|Death|0
48059|NCT01557842|202563|P1|Overall Study|Death|1
48060|NCT01557842|202562|P2|Overall Study|Lost to Follow-up|1
48061|NCT01557842|202563|P1|Overall Study|Lost to Follow-up|0
48062|NCT01557751|202571|P1|Overall Study|Physician Decision|3
48063|NCT01557582|202616|P1|Overall Study|Operator error|2
48064|NCT01557582|202616|P1|Overall Study|Protocol Violation|4
48065|NCT01557569|202624|P2|Overall Study|noncompliance with rules of residential|1
48066|NCT01557569|202625|P1|Overall Study|noncompliance with rules of residential|0
48067|NCT01557569|202624|P2|Overall Study|Withdrawal by Subject|5
48068|NCT01557569|202625|P1|Overall Study|Withdrawal by Subject|3
48069|NCT01557569|202624|P2|Overall Study|high blood pressure|1
48070|NCT01557569|202625|P1|Overall Study|high blood pressure|0
48071|NCT01557569|202624|P2|Overall Study|Adverse Event|0
48072|NCT01557569|202625|P1|Overall Study|Adverse Event|2
48073|NCT01557504|202633|P2|Overall Study|Physician Decision|0
48074|NCT01557504|202634|P1|Overall Study|Physician Decision|1
48075|NCT01557348|202659|P2|Overall Study|Administrative|11
48076|NCT01557348|202660|P1|Overall Study|Administrative|18
48077|NCT01557348|202659|P2|Overall Study|Lost to Follow-up|22
48078|NCT01557348|202660|P1|Overall Study|Lost to Follow-up|26
48079|NCT01557348|202659|P2|Overall Study|Withdrawal by Subject|4
48080|NCT01557348|202660|P1|Overall Study|Withdrawal by Subject|5
48081|NCT01557348|202659|P2|Overall Study|Insufficient Therapeutic Response|28
48082|NCT01557348|202660|P1|Overall Study|Insufficient Therapeutic Response|13
48083|NCT01557348|202659|P2|Overall Study|Death|4
48084|NCT01557348|202660|P1|Overall Study|Death|7
48085|NCT01557348|202659|P2|Overall Study|Infusion reaction event|5
48086|NCT01557348|202660|P1|Overall Study|Infusion reaction event|5
48087|NCT01557348|202659|P2|Overall Study|Adverse Event|16
48088|NCT01557348|202660|P1|Overall Study|Adverse Event|6
48089|NCT01557283|202777|P1|Overall Study|Other|6
48090|NCT01557283|202777|P1|Overall Study|Worsening of psoriasis|1
48091|NCT01557283|202777|P1|Overall Study|Participant’s weight too high for dose|1
48092|NCT01557283|202777|P1|Overall Study|Withdrawal by Subject|1
48093|NCT01557283|202777|P1|Overall Study|Non-compliance|1
48094|NCT01557283|202777|P1|Overall Study|Lack of Efficacy|1
48095|NCT01557283|202777|P1|Overall Study|Adverse Event|7
48096|NCT01557283|202777|P1|Overall Study|Non-responder|19
48097|NCT01557283|202777|P1|Overall Study|Lost to Follow-up|7
48098|NCT01557166|202789|P2|Overall Study|Unclassified|5
48099|NCT01557166|202790|P1|Overall Study|Unclassified|2
48100|NCT01557166|202789|P2|Overall Study|Psychiatric disorder|0
48101|NCT01557166|202790|P1|Overall Study|Psychiatric disorder|1
48102|NCT01557166|202789|P2|Overall Study|Target dose not tolerated|0
48103|NCT01557166|202790|P1|Overall Study|Target dose not tolerated|1
48104|NCT01557166|202789|P2|Overall Study|Withdrawn consent|20
48105|NCT01557166|202790|P1|Overall Study|Withdrawn consent|12
48106|NCT01557166|202789|P2|Overall Study|Protocol Violation|5
48107|NCT01557166|202790|P1|Overall Study|Protocol Violation|8
48108|NCT01557166|202789|P2|Overall Study|Lack of Efficacy|1
48109|NCT01557166|202790|P1|Overall Study|Lack of Efficacy|2
48110|NCT01557166|202789|P2|Overall Study|Adverse Event|6
48111|NCT01557166|202790|P1|Overall Study|Adverse Event|20
48112|NCT01556997|202805|P3|Overall Study|Not specified|7
48113|NCT01556997|202806|P2|Overall Study|Not specified|3
48114|NCT01556997|202807|P1|Overall Study|Not specified|2
48115|NCT01556997|202805|P3|Overall Study|Withdrawal by Subject|8
48116|NCT01556997|202806|P2|Overall Study|Withdrawal by Subject|6
48117|NCT01556997|202807|P1|Overall Study|Withdrawal by Subject|7
48118|NCT01556997|202805|P3|Overall Study|Physician Decision|1
48119|NCT01556997|202806|P2|Overall Study|Physician Decision|1
48120|NCT01556997|202807|P1|Overall Study|Physician Decision|1
48121|NCT01556997|202805|P3|Overall Study|Lost to Follow-up|4
48122|NCT01556997|202806|P2|Overall Study|Lost to Follow-up|6
48123|NCT01556997|202807|P1|Overall Study|Lost to Follow-up|6
48124|NCT01556997|202805|P3|Overall Study|Adverse Event|12
48125|NCT01556997|202806|P2|Overall Study|Adverse Event|12
48126|NCT01556997|202807|P1|Overall Study|Adverse Event|10
48127|NCT01556932|202818|P2|Time Point 60 Minutes|Withdrawal by Subject|1
48128|NCT01556932|202819|P1|Time Point 60 Minutes|Withdrawal by Subject|1
48129|NCT01556763|202845|P3|Overall Study|Withdrawal by Subject|0
48130|NCT01556763|202846|P2|Overall Study|Withdrawal by Subject|1
48131|NCT01556763|202847|P1|Overall Study|Withdrawal by Subject|0
48132|NCT01556165|202989|P2|Overall Study|Withdrawal of Consent|1
48133|NCT01556165|202990|P1|Overall Study|Withdrawal of Consent|7
48134|NCT01556165|202989|P2|Overall Study|Protocol Violation|3
48135|NCT01556165|202990|P1|Overall Study|Protocol Violation|0
48136|NCT01556165|202989|P2|Overall Study|Adverse Event|3
48137|NCT01556165|202990|P1|Overall Study|Adverse Event|5
48138|NCT01555983|203020|P6|Overall Study|Withdrawal by Subject|1
48139|NCT01555983|203021|P5|Overall Study|Withdrawal by Subject|1
48140|NCT01555983|203022|P4|Overall Study|Withdrawal by Subject|0
48141|NCT01555983|203023|P3|Overall Study|Withdrawal by Subject|0
48142|NCT01555983|203024|P2|Overall Study|Withdrawal by Subject|0
48143|NCT01555983|203025|P1|Overall Study|Withdrawal by Subject|1
48144|NCT01555931|203035|P2|Overall Study|Lost to Follow-up|5
48145|NCT01555931|203036|P1|Overall Study|Lost to Follow-up|2
48146|NCT01555463|203067|P2|Follow up|Other reason|3
48147|NCT01555463|203068|P1|Follow up|Other reason|3
48148|NCT01555463|203067|P2|Follow up|Protocol Violation|4
48149|NCT01555463|203068|P1|Follow up|Protocol Violation|2
48150|NCT01555463|203067|P2|Follow up|Lost to Follow-up|10
48151|NCT01555463|203068|P1|Follow up|Lost to Follow-up|9
48152|NCT01555463|203067|P2|Follow up|Withdrawal by Subject|22
48153|NCT01555463|203068|P1|Follow up|Withdrawal by Subject|22
48154|NCT01555463|203067|P2|Follow up|Death|1
48155|NCT01555463|203068|P1|Follow up|Death|0
48156|NCT01555463|203067|P2|Follow up|Adverse Event|5
48157|NCT01555463|203068|P1|Follow up|Adverse Event|2
48158|NCT01555463|203067|P2|Treatment|Other reason|3
48159|NCT01555463|203068|P1|Treatment|Other reason|2
48160|NCT01555463|203067|P2|Treatment|Protocol Violation|5
48161|NCT01555463|203068|P1|Treatment|Protocol Violation|4
48162|NCT01555463|203067|P2|Treatment|Lost to Follow-up|23
48163|NCT01555463|203068|P1|Treatment|Lost to Follow-up|28
48164|NCT01555463|203067|P2|Treatment|Withdrawal by Subject|36
48165|NCT01555463|203068|P1|Treatment|Withdrawal by Subject|24
48166|NCT01555463|203067|P2|Treatment|Adverse Event|12
48167|NCT01555463|203068|P1|Treatment|Adverse Event|6
48168|NCT01555164|203110|P2|Overall Study|Subject Withdrew Consent|11
48169|NCT01555164|203111|P1|Overall Study|Subject Withdrew Consent|6
48170|NCT01555164|203110|P2|Overall Study|Subject Non-compliance|6
48171|NCT01555164|203111|P1|Overall Study|Subject Non-compliance|14
48172|NCT01555164|203110|P2|Overall Study|Protocol Violation|5
48173|NCT01555164|203111|P1|Overall Study|Protocol Violation|9
48174|NCT01555164|203110|P2|Overall Study|Lost to Follow-up|3
48175|NCT01555164|203111|P1|Overall Study|Lost to Follow-up|4
48176|NCT01555164|203110|P2|Overall Study|Investigator's Discretion|2
48177|NCT01555164|203111|P1|Overall Study|Investigator's Discretion|2
48178|NCT01555164|203110|P2|Overall Study|Hyperglycemia|1
48179|NCT01555164|203111|P1|Overall Study|Hyperglycemia|0
48180|NCT01555164|203110|P2|Overall Study|Adverse Event|7
48181|NCT01555164|203111|P1|Overall Study|Adverse Event|5
48182|NCT01555151|203125|P4|Overall Study|Lost to Follow-up|1
48183|NCT01555151|203126|P3|Overall Study|Lost to Follow-up|0
48184|NCT01555151|203127|P2|Overall Study|Lost to Follow-up|0
48185|NCT01555151|203128|P1|Overall Study|Lost to Follow-up|0
48186|NCT01555151|203125|P4|Overall Study|Adverse Event|2
48187|NCT01555151|203126|P3|Overall Study|Adverse Event|1
48188|NCT01555151|203127|P2|Overall Study|Adverse Event|2
48189|NCT01555151|203128|P1|Overall Study|Adverse Event|1
48190|NCT01555151|203125|P4|Overall Study|Protocol Violation|5
48191|NCT01555151|203126|P3|Overall Study|Protocol Violation|3
48192|NCT01555151|203127|P2|Overall Study|Protocol Violation|3
48193|NCT01555151|203128|P1|Overall Study|Protocol Violation|3
48194|NCT01555151|203125|P4|Overall Study|Administrative|0
48195|NCT01555151|203126|P3|Overall Study|Administrative|2
48196|NCT01555151|203127|P2|Overall Study|Administrative|1
48197|NCT01555151|203128|P1|Overall Study|Administrative|3
48198|NCT01555151|203125|P4|Overall Study|Withdrawal by Subject|2
48199|NCT01555151|203126|P3|Overall Study|Withdrawal by Subject|0
48200|NCT01555151|203127|P2|Overall Study|Withdrawal by Subject|2
48201|NCT01555151|203128|P1|Overall Study|Withdrawal by Subject|6
48202|NCT01555138|203181|P2|Overall Study|Adverse Event|14
48203|NCT01555138|203182|P1|Overall Study|Adverse Event|14
48204|NCT01555138|203181|P2|Overall Study|Withdrawal by Subject|15
48205|NCT01555138|203182|P1|Overall Study|Withdrawal by Subject|16
48206|NCT01555138|203181|P2|Overall Study|Administrative problems|0
48207|NCT01555138|203182|P1|Overall Study|Administrative problems|8
48208|NCT01555138|203181|P2|Overall Study|Protocol Violation|3
48209|NCT01555138|203182|P1|Overall Study|Protocol Violation|5
48210|NCT01555138|203181|P2|Overall Study|Lack of Efficacy|2
48211|NCT01555138|203182|P1|Overall Study|Lack of Efficacy|2
48212|NCT01555138|203181|P2|Overall Study|Abnormal Lab reults|3
48213|NCT01555138|203182|P1|Overall Study|Abnormal Lab reults|1
48214|NCT01555138|203181|P2|Overall Study|Lost to Follow-up|0
48215|NCT01555138|203182|P1|Overall Study|Lost to Follow-up|1
48216|NCT01555138|203181|P2|Overall Study|Death|1
48217|NCT01555138|203182|P1|Overall Study|Death|0
48218|NCT01555073|203212|P4|Overall Study|Lost to Follow-up|5
48219|NCT01555073|203213|P3|Overall Study|Lost to Follow-up|0
48220|NCT01555073|203214|P2|Overall Study|Lost to Follow-up|2
48221|NCT01555073|203215|P1|Overall Study|Lost to Follow-up|1
48222|NCT01554904|203242|P1|Overall Study|Had sleep apnea on Home Study 1|1
48223|NCT01554904|203242|P1|Overall Study|Withdrawal by Subject|3
48224|NCT01554579|203262|P2|Overall Study|Withdrawal by Subject|1
48225|NCT01554579|203263|P1|Overall Study|Withdrawal by Subject|2
48226|NCT01554579|203262|P2|Overall Study|Lack of Efficacy|1
48227|NCT01554579|203263|P1|Overall Study|Lack of Efficacy|2
48228|NCT01554579|203262|P2|Overall Study|Adverse Event|25
48229|NCT01554579|203263|P1|Overall Study|Adverse Event|6
48230|NCT01554241|203277|P4|Overall Study|Withdrawal by Subject|0
48231|NCT01554241|203278|P3|Overall Study|Withdrawal by Subject|2
48232|NCT01554241|203279|P2|Overall Study|Withdrawal by Subject|0
48233|NCT01554241|203280|P1|Overall Study|Withdrawal by Subject|0
48234|NCT01554241|203277|P4|Overall Study|protocol specified change in eGFR|0
48235|NCT01554241|203278|P3|Overall Study|protocol specified change in eGFR|1
48236|NCT01554241|203279|P2|Overall Study|protocol specified change in eGFR|0
48237|NCT01554241|203280|P1|Overall Study|protocol specified change in eGFR|0
48238|NCT01554241|203277|P4|Overall Study|protocol specified renal stone|1
48239|NCT01554241|203278|P3|Overall Study|protocol specified renal stone|0
48240|NCT01554241|203279|P2|Overall Study|protocol specified renal stone|0
48241|NCT01554241|203280|P1|Overall Study|protocol specified renal stone|0
48242|NCT01554241|203277|P4|Overall Study|Death|0
48243|NCT01554241|203278|P3|Overall Study|Death|1
48244|NCT01554241|203279|P2|Overall Study|Death|1
48245|NCT01554241|203280|P1|Overall Study|Death|3
48246|NCT01554176|203296|P5|Run-out Phase|Protocol Violation|0
48247|NCT01554176|203297|P4|Run-out Phase|Protocol Violation|1
48248|NCT01554176|203298|P3|Run-out Phase|Protocol Violation|0
48249|NCT01554176|203299|P2|Run-out Phase|Protocol Violation|0
48250|NCT01554176|203300|P1|Run-out Phase|Protocol Violation|0
48251|NCT01554176|203296|P5|Treatment Phase|Lost to Follow-up|0
48252|NCT01554176|203297|P4|Treatment Phase|Lost to Follow-up|0
48253|NCT01554176|203298|P3|Treatment Phase|Lost to Follow-up|0
48254|NCT01554176|203299|P2|Treatment Phase|Lost to Follow-up|0
48255|NCT01554176|203300|P1|Treatment Phase|Lost to Follow-up|3
48256|NCT01554176|203296|P5|Treatment Phase|Withdrawal by Subject|0
48257|NCT01554176|203297|P4|Treatment Phase|Withdrawal by Subject|0
48258|NCT01554176|203298|P3|Treatment Phase|Withdrawal by Subject|0
48259|NCT01554176|203299|P2|Treatment Phase|Withdrawal by Subject|0
48260|NCT01554176|203300|P1|Treatment Phase|Withdrawal by Subject|1
48261|NCT01554176|203296|P5|Treatment Phase|Non-compliance with study drug|0
48262|NCT01554176|203297|P4|Treatment Phase|Non-compliance with study drug|0
48263|NCT01554176|203298|P3|Treatment Phase|Non-compliance with study drug|0
48264|NCT01554176|203299|P2|Treatment Phase|Non-compliance with study drug|0
48265|NCT01554176|203300|P1|Treatment Phase|Non-compliance with study drug|1
48266|NCT01554176|203296|P5|Treatment Phase|Adverse event, non-fatal|0
48267|NCT01554176|203297|P4|Treatment Phase|Adverse event, non-fatal|0
48268|NCT01554176|203298|P3|Treatment Phase|Adverse event, non-fatal|0
48269|NCT01554176|203299|P2|Treatment Phase|Adverse event, non-fatal|1
48270|NCT01554176|203300|P1|Treatment Phase|Adverse event, non-fatal|1
48271|NCT01554176|203296|P5|Treatment Phase|Lack of Efficacy|0
48272|NCT01554176|203297|P4|Treatment Phase|Lack of Efficacy|0
48273|NCT01554176|203298|P3|Treatment Phase|Lack of Efficacy|0
48274|NCT01554176|203299|P2|Treatment Phase|Lack of Efficacy|1
48275|NCT01554176|203300|P1|Treatment Phase|Lack of Efficacy|0
48276|NCT01554176|203296|P5|Treatment Phase|Physician Decision|0
48277|NCT01554176|203297|P4|Treatment Phase|Physician Decision|0
48278|NCT01554176|203298|P3|Treatment Phase|Physician Decision|0
48279|NCT01554176|203299|P2|Treatment Phase|Physician Decision|1
48280|NCT01554176|203300|P1|Treatment Phase|Physician Decision|1
48281|NCT01554176|203296|P5|Treatment Phase|Protocol Violation|0
48282|NCT01554176|203297|P4|Treatment Phase|Protocol Violation|0
48283|NCT01554176|203298|P3|Treatment Phase|Protocol Violation|0
48284|NCT01554176|203299|P2|Treatment Phase|Protocol Violation|2
48285|NCT01554176|203300|P1|Treatment Phase|Protocol Violation|1
48286|NCT01554163|203327|P2|Overall Study|Not Treated|0
48287|NCT01554163|203328|P1|Overall Study|Not Treated|1
48288|NCT01554163|203327|P2|Overall Study|Withdrawal by Subject|5
48289|NCT01554163|203328|P1|Overall Study|Withdrawal by Subject|1
48290|NCT01554163|203327|P2|Overall Study|Protocol Violation|4
48291|NCT01554163|203328|P1|Overall Study|Protocol Violation|0
48292|NCT01554163|203327|P2|Overall Study|Non-Compliance With Study Drug|1
48293|NCT01554163|203328|P1|Overall Study|Non-Compliance With Study Drug|1
48294|NCT01554163|203327|P2|Overall Study|Lost to Follow-up|0
48295|NCT01554163|203328|P1|Overall Study|Lost to Follow-up|1
48296|NCT01554163|203327|P2|Overall Study|Lack of Efficacy|0
48297|NCT01554163|203328|P1|Overall Study|Lack of Efficacy|1
48298|NCT01554163|203327|P2|Overall Study|Adverse Event|0
48299|NCT01554163|203328|P1|Overall Study|Adverse Event|3
48300|NCT01553916|203346|P1|Overall Study|Pre-treatment MRI metastatic disease|1
48301|NCT01553916|203346|P1|Overall Study|Withdrawal by Subject|2
48302|NCT01553851|203359|P1|Overall Study|constipation|1
48303|NCT01553851|203359|P1|Overall Study|Adverse Event|2
48304|NCT01553318|203390|P2|Overall Study|Protocol Violation|2
48305|NCT01553318|203391|P1|Overall Study|Protocol Violation|3
48306|NCT01553136|203426|P2|Overall Study|Scheduling Difficulties|4
48307|NCT01553136|203427|P1|Overall Study|Scheduling Difficulties|5
48308|NCT01553136|203426|P2|Overall Study|Physician Decision|3
48309|NCT01553136|203427|P1|Overall Study|Physician Decision|2
48310|NCT01553136|203426|P2|Overall Study|Lost to Follow-up|10
48311|NCT01553136|203427|P1|Overall Study|Lost to Follow-up|4
48312|NCT01553136|203426|P2|Overall Study|Withdrawal by Subject|3
48313|NCT01553136|203427|P1|Overall Study|Withdrawal by Subject|2
48314|NCT01553136|203426|P2|Overall Study|Adverse Event|2
48315|NCT01553136|203427|P1|Overall Study|Adverse Event|3
48316|NCT01552954|203507|P2|Overall Study|diagnosed DM|0
48317|NCT01552954|203508|P1|Overall Study|diagnosed DM|1
48318|NCT01552954|203507|P2|Overall Study|Protocol Violation|2
48319|NCT01552954|203508|P1|Overall Study|Protocol Violation|1
48320|NCT01552954|203507|P2|Overall Study|Withdrawal by Subject|1
48321|NCT01552954|203508|P1|Overall Study|Withdrawal by Subject|1
48322|NCT01552954|203507|P2|Overall Study|Lost to Follow-up|1
48323|NCT01552954|203508|P1|Overall Study|Lost to Follow-up|1
48324|NCT01552954|203507|P2|Overall Study|Adverse Event|2
48325|NCT01552954|203508|P1|Overall Study|Adverse Event|1
48326|NCT01552928|203524|P4|Period 3|Adverse Event|0
48327|NCT01552928|203525|P3|Period 3|Adverse Event|1
48328|NCT01552928|203526|P2|Period 3|Adverse Event|0
48329|NCT01552928|203527|P1|Period 3|Adverse Event|0
48330|NCT01552915|203574|P3|Overall Study|Not specified|6
48331|NCT01552915|203575|P2|Overall Study|Not specified|0
48332|NCT01552915|203576|P1|Overall Study|Not specified|2
48333|NCT01552915|203574|P3|Overall Study|Lack of Efficacy|4
48334|NCT01552915|203575|P2|Overall Study|Lack of Efficacy|1
48335|NCT01552915|203576|P1|Overall Study|Lack of Efficacy|8
48336|NCT01552915|203574|P3|Overall Study|Protocol Violation|4
48337|NCT01552915|203575|P2|Overall Study|Protocol Violation|4
48338|NCT01552915|203576|P1|Overall Study|Protocol Violation|0
48339|NCT01552915|203574|P3|Overall Study|Withdrawal by Subject|5
48340|NCT01552915|203575|P2|Overall Study|Withdrawal by Subject|4
48341|NCT01552915|203576|P1|Overall Study|Withdrawal by Subject|6
48342|NCT01552915|203574|P3|Overall Study|Lost to Follow-up|5
48343|NCT01552915|203575|P2|Overall Study|Lost to Follow-up|6
48344|NCT01552915|203576|P1|Overall Study|Lost to Follow-up|4
48345|NCT01552915|203574|P3|Overall Study|Adverse Event|3
48346|NCT01552915|203575|P2|Overall Study|Adverse Event|14
48347|NCT01552915|203576|P1|Overall Study|Adverse Event|3
48348|NCT01552902|203599|P3|Overall Study|Other|3
48349|NCT01552902|203600|P2|Overall Study|Other|4
48350|NCT01552902|203601|P1|Overall Study|Other|3
48351|NCT01552902|203599|P3|Overall Study|Lost to Follow-up|6
48352|NCT01552902|203600|P2|Overall Study|Lost to Follow-up|3
48353|NCT01552902|203601|P1|Overall Study|Lost to Follow-up|1
48354|NCT01552902|203599|P3|Overall Study|Withdrawal by Subject|6
48355|NCT01552902|203600|P2|Overall Study|Withdrawal by Subject|9
48356|NCT01552902|203601|P1|Overall Study|Withdrawal by Subject|1
48357|NCT01552902|203599|P3|Overall Study|Lack of Efficacy|1
48358|NCT01552902|203600|P2|Overall Study|Lack of Efficacy|3
48359|NCT01552902|203601|P1|Overall Study|Lack of Efficacy|4
48360|NCT01552902|203599|P3|Overall Study|Protocol Violation|3
48361|NCT01552902|203600|P2|Overall Study|Protocol Violation|3
48362|NCT01552902|203601|P1|Overall Study|Protocol Violation|3
48363|NCT01552902|203599|P3|Overall Study|Adverse Event|14
48364|NCT01552902|203600|P2|Overall Study|Adverse Event|15
48365|NCT01552902|203601|P1|Overall Study|Adverse Event|1
48366|NCT01552772|203651|P1|Overall Study|Protocol Deviation|1
48367|NCT01552772|203651|P1|Overall Study|Adverse Event|1
48368|NCT01552772|203651|P1|Overall Study|Lost to Follow-up|2
48369|NCT01552694|203667|P2|Overall Study|Protocol Violation|1
48370|NCT01552694|203668|P1|Overall Study|Protocol Violation|0
48371|NCT01552694|203667|P2|Overall Study|Lost to Follow-up|1
48372|NCT01552694|203668|P1|Overall Study|Lost to Follow-up|0
48373|NCT01552681|203684|P2|Overall Study|Subject moved away|1
48374|NCT01552681|203685|P1|Overall Study|Subject moved away|0
48375|NCT01552681|203684|P2|Overall Study|Physician Decision|0
48376|NCT01552681|203685|P1|Overall Study|Physician Decision|1
48377|NCT01552681|203684|P2|Overall Study|Withdrawal by Subject|0
48378|NCT01552681|203685|P1|Overall Study|Withdrawal by Subject|4
48379|NCT01552603|203733|P1|Overall Study|Physician Decision|1
48380|NCT01552057|203764|P2|Overall Study|Physician Decision|0
48381|NCT01552057|203765|P1|Overall Study|Physician Decision|1
48382|NCT01552057|203764|P2|Overall Study|Entry Criteria Not Met|2
48383|NCT01552057|203765|P1|Overall Study|Entry Criteria Not Met|2
48384|NCT01552057|203764|P2|Overall Study|Withdrawal by Subject|8
48385|NCT01552057|203765|P1|Overall Study|Withdrawal by Subject|5
48386|NCT01552057|203764|P2|Overall Study|Lack of Efficacy|23
48387|NCT01552057|203765|P1|Overall Study|Lack of Efficacy|8
48388|NCT01552057|203764|P2|Overall Study|Adverse Event|15
48389|NCT01552057|203765|P1|Overall Study|Adverse Event|14
48390|NCT01551758|203831|P2|Overall Study|Withdrawal by Subject|17
48391|NCT01551758|203832|P1|Overall Study|Withdrawal by Subject|14
48392|NCT01551758|203831|P2|Overall Study|Physician Decision|3
48393|NCT01551758|203832|P1|Overall Study|Physician Decision|9
48394|NCT01551758|203831|P2|Overall Study|Lost to Follow-up|25
48395|NCT01551758|203832|P1|Overall Study|Lost to Follow-up|29
48396|NCT01551758|203831|P2|Overall Study|Met Protocol-defined stopping criteria|10
48397|NCT01551758|203832|P1|Overall Study|Met Protocol-defined stopping criteria|8
48398|NCT01551758|203831|P2|Overall Study|Protocol Violation|6
48399|NCT01551758|203832|P1|Overall Study|Protocol Violation|5
48400|NCT01551758|203831|P2|Overall Study|Lack of Efficacy|1
48401|NCT01551758|203832|P1|Overall Study|Lack of Efficacy|0
48402|NCT01551758|203831|P2|Overall Study|Adverse Event|43
48403|NCT01551758|203832|P1|Overall Study|Adverse Event|29
48404|NCT01551745|203870|P1|Overall Study|Disease Progression|2
48405|NCT01551745|203870|P1|Overall Study|Withdrawal by Subject|1
48406|NCT01551693|203879|P2|Overall Study|Withdrawal by Subject|1
48407|NCT01551693|203880|P1|Overall Study|Withdrawal by Subject|0
48408|NCT01551693|203879|P2|Overall Study|Adverse Event|1
48409|NCT01551693|203880|P1|Overall Study|Adverse Event|0
48410|NCT01551693|203879|P2|Overall Study|Disease Progression|0
48411|NCT01551693|203880|P1|Overall Study|Disease Progression|1
48412|NCT01551355|203896|P6|Overall Study|Lost to Follow-up|6
48413|NCT01551355|203897|P5|Overall Study|Lost to Follow-up|9
48414|NCT01551355|203898|P4|Overall Study|Lost to Follow-up|24
48415|NCT01551355|203899|P3|Overall Study|Lost to Follow-up|34
48416|NCT01551355|203900|P2|Overall Study|Lost to Follow-up|49
48417|NCT01551355|203901|P1|Overall Study|Lost to Follow-up|51
48418|NCT01551303|203915|P2|Overall Study|failed awareness check on vision test|7
48419|NCT01551303|203916|P1|Overall Study|failed awareness check on vision test|4
48420|NCT01551173|203930|P2|Overall Study|Not specified|3
48421|NCT01551173|203931|P1|Overall Study|Not specified|5
48422|NCT01551173|203930|P2|Overall Study|Lost to Follow-up|7
48423|NCT01551173|203931|P1|Overall Study|Lost to Follow-up|5
48424|NCT01551173|203930|P2|Overall Study|Adverse Event|6
48425|NCT01551173|203931|P1|Overall Study|Adverse Event|7
48426|NCT01551173|203930|P2|Overall Study|Withdrawal by Subject|16
48427|NCT01551173|203931|P1|Overall Study|Withdrawal by Subject|11
48428|NCT01550965|204008|P1|Overall Study|Not Specified|13
48429|NCT01550965|204008|P1|Overall Study|Lack of Efficacy|59
48430|NCT01550965|204008|P1|Overall Study|Lost to Follow-up|2
48431|NCT01550965|204008|P1|Overall Study|Withdrawal by Subject|10
48432|NCT01550965|204008|P1|Overall Study|Adverse Event|26
48433|NCT01550757|204052|P4|Overall Study|Withdrawal by Subject|1
48434|NCT01550757|204053|P3|Overall Study|Withdrawal by Subject|3
48435|NCT01550757|204054|P2|Overall Study|Withdrawal by Subject|0
48436|NCT01550757|204055|P1|Overall Study|Withdrawal by Subject|2
48437|NCT01550757|204052|P4|Overall Study|Lost to Follow-up|53
48438|NCT01550757|204053|P3|Overall Study|Lost to Follow-up|42
48439|NCT01550757|204054|P2|Overall Study|Lost to Follow-up|14
48440|NCT01550757|204055|P1|Overall Study|Lost to Follow-up|21
48441|NCT01550744|204065|P3|Double-Blind|Other|10
48442|NCT01550744|204066|P2|Double-Blind|Other|2
48443|NCT01550744|204067|P1|Double-Blind|Other|0
48444|NCT01550744|204065|P3|Double-Blind|Pregnancy|3
48445|NCT01550744|204066|P2|Double-Blind|Pregnancy|0
48446|NCT01550744|204067|P1|Double-Blind|Pregnancy|0
48447|NCT01550744|204065|P3|Double-Blind|Protocol Violation|4
48448|NCT01550744|204066|P2|Double-Blind|Protocol Violation|0
48449|NCT01550744|204067|P1|Double-Blind|Protocol Violation|0
48450|NCT01550744|204065|P3|Double-Blind|Lack of Efficacy|8
48451|NCT01550744|204066|P2|Double-Blind|Lack of Efficacy|2
48452|NCT01550744|204067|P1|Double-Blind|Lack of Efficacy|0
48453|NCT01550744|204065|P3|Double-Blind|Death|0
48454|NCT01550744|204066|P2|Double-Blind|Death|1
48455|NCT01550744|204067|P1|Double-Blind|Death|0
48456|NCT01550744|204065|P3|Double-Blind|Adverse Event|15
48457|NCT01550744|204066|P2|Double-Blind|Adverse Event|4
48458|NCT01550744|204067|P1|Double-Blind|Adverse Event|0
48459|NCT01550744|204065|P3|Double-Blind|Withdrawal by Subject|15
48460|NCT01550744|204066|P2|Double-Blind|Withdrawal by Subject|2
48461|NCT01550744|204067|P1|Double-Blind|Withdrawal by Subject|0
48462|NCT01550744|204065|P3|Double-Blind|Lost to Follow-up|12
48463|NCT01550744|204066|P2|Double-Blind|Lost to Follow-up|6
48464|NCT01550744|204067|P1|Double-Blind|Lost to Follow-up|0
48465|NCT01550744|204065|P3|Open-Label|Other|0
48466|NCT01550744|204066|P2|Open-Label|Other|0
48467|NCT01550744|204067|P1|Open-Label|Other|1
48468|NCT01550744|204065|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
48469|NCT01550744|204066|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
48470|NCT01550744|204067|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
48471|NCT01550744|204065|P3|Open-Label|Not all 3 study drug injections received|0
48472|NCT01550744|204066|P2|Open-Label|Not all 3 study drug injections received|0
48473|NCT01550744|204067|P1|Open-Label|Not all 3 study drug injections received|2
48474|NCT01550744|204065|P3|Open-Label|Protocol Violation|0
48475|NCT01550744|204066|P2|Open-Label|Protocol Violation|0
48476|NCT01550744|204067|P1|Open-Label|Protocol Violation|4
48477|NCT01550744|204065|P3|Open-Label|Lack of Efficacy|0
48478|NCT01550744|204066|P2|Open-Label|Lack of Efficacy|0
48479|NCT01550744|204067|P1|Open-Label|Lack of Efficacy|4
48480|NCT01550744|204065|P3|Open-Label|Adverse Event|0
48481|NCT01550744|204066|P2|Open-Label|Adverse Event|0
48482|NCT01550744|204067|P1|Open-Label|Adverse Event|11
48483|NCT01550744|204065|P3|Open-Label|Withdrawal by Subject|0
48484|NCT01550744|204066|P2|Open-Label|Withdrawal by Subject|0
48485|NCT01550744|204067|P1|Open-Label|Withdrawal by Subject|13
48486|NCT01550744|204065|P3|Open-Label|Lost to Follow-up|0
48487|NCT01550744|204066|P2|Open-Label|Lost to Follow-up|0
48488|NCT01550744|204067|P1|Open-Label|Lost to Follow-up|7
48489|NCT01550289|204120|P2|Overall Study|Withdrawal by Subject|3
48490|NCT01550289|204121|P1|Overall Study|Withdrawal by Subject|11
48491|NCT01550289|204120|P2|Overall Study|Lost to Follow-up|1
48492|NCT01550289|204121|P1|Overall Study|Lost to Follow-up|1
48493|NCT01550289|204120|P2|Overall Study|Protocol Violation|0
48494|NCT01550289|204121|P1|Overall Study|Protocol Violation|1
48495|NCT01549964|204172|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
48496|NCT01549964|204173|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
48497|NCT01549964|204174|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
48498|NCT01549964|204175|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
48499|NCT01549964|204172|P4|80-Week Extension Period|Lost to Follow-up|1
48500|NCT01549964|204173|P3|80-Week Extension Period|Lost to Follow-up|2
48501|NCT01549964|204174|P2|80-Week Extension Period|Lost to Follow-up|0
48502|NCT01549964|204175|P1|80-Week Extension Period|Lost to Follow-up|1
48503|NCT01549964|204172|P4|80-Week Extension Period|Voluntary Withdrawal|2
48504|NCT01549964|204173|P3|80-Week Extension Period|Voluntary Withdrawal|4
48505|NCT01549964|204174|P2|80-Week Extension Period|Voluntary Withdrawal|1
48506|NCT01549964|204175|P1|80-Week Extension Period|Voluntary Withdrawal|0
48507|NCT01549964|204172|P4|80-Week Extension Period|Study Terminated by Sponsor|132
48508|NCT01549964|204173|P3|80-Week Extension Period|Study Terminated by Sponsor|132
48509|NCT01549964|204174|P2|80-Week Extension Period|Study Terminated by Sponsor|137
48510|NCT01549964|204175|P1|80-Week Extension Period|Study Terminated by Sponsor|65
48511|NCT01549964|204172|P4|80-Week Extension Period|Pregnancy|0
48512|NCT01549964|204173|P3|80-Week Extension Period|Pregnancy|1
48513|NCT01549964|204174|P2|80-Week Extension Period|Pregnancy|0
48514|NCT01549964|204175|P1|80-Week Extension Period|Pregnancy|0
48515|NCT01549964|204172|P4|24-Week Treatment Period|Completion Status Unknown|0
48516|NCT01549964|204173|P3|24-Week Treatment Period|Completion Status Unknown|1
48517|NCT01549964|204174|P2|24-Week Treatment Period|Completion Status Unknown|0
48518|NCT01549964|204175|P1|24-Week Treatment Period|Completion Status Unknown|1
48519|NCT01549964|204172|P4|24-Week Treatment Period|Randomized but Not Treated|1
48520|NCT01549964|204173|P3|24-Week Treatment Period|Randomized but Not Treated|0
48521|NCT01549964|204174|P2|24-Week Treatment Period|Randomized but Not Treated|0
48522|NCT01549964|204175|P1|24-Week Treatment Period|Randomized but Not Treated|0
48523|NCT01549964|204172|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
48524|NCT01549964|204173|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
48525|NCT01549964|204174|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
48526|NCT01549964|204175|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
48527|NCT01549964|204172|P4|24-Week Treatment Period|Other|0
48528|NCT01549964|204173|P3|24-Week Treatment Period|Other|1
48529|NCT01549964|204174|P2|24-Week Treatment Period|Other|0
48530|NCT01549964|204175|P1|24-Week Treatment Period|Other|1
48531|NCT01549964|204172|P4|24-Week Treatment Period|Lack of Efficacy|1
48532|NCT01549964|204173|P3|24-Week Treatment Period|Lack of Efficacy|1
48533|NCT01549964|204174|P2|24-Week Treatment Period|Lack of Efficacy|0
48534|NCT01549964|204175|P1|24-Week Treatment Period|Lack of Efficacy|1
48535|NCT01549964|204172|P4|24-Week Treatment Period|Lost to Follow-up|2
48536|NCT01549964|204173|P3|24-Week Treatment Period|Lost to Follow-up|1
48537|NCT01549964|204174|P2|24-Week Treatment Period|Lost to Follow-up|0
48538|NCT01549964|204175|P1|24-Week Treatment Period|Lost to Follow-up|1
48539|NCT01549964|204172|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
48540|NCT01549964|204173|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
48541|NCT01549964|204174|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
48542|NCT01549964|204175|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
48543|NCT01549964|204172|P4|24-Week Treatment Period|Voluntary Withdrawal|8
48544|NCT01549964|204173|P3|24-Week Treatment Period|Voluntary Withdrawal|3
48545|NCT01549964|204174|P2|24-Week Treatment Period|Voluntary Withdrawal|3
48546|NCT01549964|204175|P1|24-Week Treatment Period|Voluntary Withdrawal|6
48547|NCT01549964|204172|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
48548|NCT01549964|204173|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
48549|NCT01549964|204174|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
48550|NCT01549964|204175|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
48551|NCT01549951|204193|P1|Overall Study|Other|2
48552|NCT01549951|204193|P1|Overall Study|Symptomatic deterioration|1
48553|NCT01549951|204193|P1|Overall Study|Progressive disease|29
48554|NCT01549951|204193|P1|Overall Study|Unsatisfactory therapeutic response|1
48555|NCT01549951|204193|P1|Overall Study|Withdrawal by Subject|2
48556|NCT01549951|204193|P1|Overall Study|Adverse Event|15
48557|NCT01549873|204220|P2|Overall Study|Physician Decision|1
48558|NCT01549873|204221|P1|Overall Study|Physician Decision|0
48559|NCT01549860|204233|P2|Overall Study|Physician Decision|1
48560|NCT01549860|204234|P1|Overall Study|Physician Decision|1
48561|NCT01549860|204233|P2|Overall Study|Withdrawal by Subject|0
48562|NCT01549860|204234|P1|Overall Study|Withdrawal by Subject|1
48563|NCT01549613|204246|P2|Overall Study|Lost to Follow-up|11
48564|NCT01549613|204247|P1|Overall Study|Lost to Follow-up|11
48565|NCT01549392|204266|P2|Overall Study|Withdrawal by Subject|0
48566|NCT01549392|204267|P1|Overall Study|Withdrawal by Subject|1
48567|NCT01549275|204286|P2|Overall Study|Lost to Follow-up|0
48568|NCT01549275|204287|P1|Overall Study|Lost to Follow-up|1
48569|NCT01549041|204310|P2|Overall Study|Adverse Event|4
48570|NCT01549041|204311|P1|Overall Study|Adverse Event|0
48571|NCT01549041|204310|P2|Overall Study|Lack of Efficacy|4
48572|NCT01549041|204311|P1|Overall Study|Lack of Efficacy|2
48573|NCT01548638|204358|P1|Overall Study|Withdrawal by Subject|1
48574|NCT01548638|204358|P1|Overall Study|Protocol Violation|3
48575|NCT01548573|204368|P1|Overall Study|Withdrawal by Subject|2
48576|NCT01548573|204368|P1|Overall Study|Death|3
48577|NCT01548417|204377|P2|Overall Study|Withdrawal by Subject|2
48578|NCT01548417|204378|P1|Overall Study|Withdrawal by Subject|0
48579|NCT01548287|204390|P5|Randomized Period|Adverse Event|0
48580|NCT01548287|204391|P4|Randomized Period|Adverse Event|0
48581|NCT01548287|204392|P3|Randomized Period|Adverse Event|5
48582|NCT01548287|204393|P2|Randomized Period|Adverse Event|2
48583|NCT01548287|204394|P1|Randomized Period|Adverse Event|0
48584|NCT01548287|204390|P5|Randomized Period|Did not meet inclusion criteria|0
48585|NCT01548287|204391|P4|Randomized Period|Did not meet inclusion criteria|0
48586|NCT01548287|204392|P3|Randomized Period|Did not meet inclusion criteria|2
48587|NCT01548287|204393|P2|Randomized Period|Did not meet inclusion criteria|0
48588|NCT01548287|204394|P1|Randomized Period|Did not meet inclusion criteria|0
48589|NCT01548287|204390|P5|Screening|Did not meet eligibility criteria|74
48590|NCT01548287|204391|P4|Screening|Did not meet eligibility criteria|0
48591|NCT01548287|204392|P3|Screening|Did not meet eligibility criteria|0
48592|NCT01548287|204393|P2|Screening|Did not meet eligibility criteria|0
48593|NCT01548287|204394|P1|Screening|Did not meet eligibility criteria|0
48594|NCT01548287|204390|P5|Screening|No reason provided|9
48595|NCT01548287|204391|P4|Screening|No reason provided|0
48596|NCT01548287|204392|P3|Screening|No reason provided|0
48597|NCT01548287|204393|P2|Screening|No reason provided|0
48598|NCT01548287|204394|P1|Screening|No reason provided|0
48599|NCT01547728|204451|P1|Overall Study|Screen failure|39
48600|NCT01547728|204451|P1|Overall Study|Drug not ready for subject|1
48601|NCT01547728|204451|P1|Overall Study|Change in procedure and equipment|1
48602|NCT01547598|204560|P2|Overall Study|Other Miscellaneous Reasons|1
48603|NCT01547598|204561|P1|Overall Study|Other Miscellaneous Reasons|2
48604|NCT01547598|204560|P2|Overall Study|Protocol Violation|1
48605|NCT01547598|204561|P1|Overall Study|Protocol Violation|1
48606|NCT01547598|204560|P2|Overall Study|Adverse Event|1
48607|NCT01547598|204561|P1|Overall Study|Adverse Event|1
48608|NCT01547598|204560|P2|Overall Study|Lost to Follow-up|1
48609|NCT01547598|204561|P1|Overall Study|Lost to Follow-up|1
48610|NCT01547598|204560|P2|Overall Study|Withdrew consent|1
48611|NCT01547598|204561|P1|Overall Study|Withdrew consent|1
48612|NCT01547390|204578|P2|Overall Study|Adverse Event|0
48613|NCT01547390|204579|P1|Overall Study|Adverse Event|3
48614|NCT01547390|204578|P2|Overall Study|Lost to Follow-up|2
48615|NCT01547390|204579|P1|Overall Study|Lost to Follow-up|0
48616|NCT01547390|204578|P2|Overall Study|termination of pregnancy|1
48617|NCT01547390|204579|P1|Overall Study|termination of pregnancy|0
48618|NCT01547390|204578|P2|Overall Study|Withdrawal by Subject|7
48619|NCT01547390|204579|P1|Overall Study|Withdrawal by Subject|10
48620|NCT01547299|204589|P2|Overall Study|Withdrawal by Subject|2
48621|NCT01547299|204590|P1|Overall Study|Withdrawal by Subject|2
48622|NCT01547286|204656|P1|Overall Study|Physician Decision|1
48623|NCT01547286|204656|P1|Overall Study|Did not meet all eligibility criteria|1
48624|NCT01547130|204676|P2|Overall Study|Lost to Follow-up|5
48625|NCT01547130|204677|P1|Overall Study|Lost to Follow-up|9
48626|NCT01546922|204691|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
48627|NCT01546922|204692|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
48628|NCT01546922|204691|P2|Second Period of 10 Weeks|Protocol Violation|1
48629|NCT01546922|204692|P1|Second Period of 10 Weeks|Protocol Violation|3
48630|NCT01546922|204691|P2|First Period of 10 Weeks|Investigator's judgment|0
48631|NCT01546922|204692|P1|First Period of 10 Weeks|Investigator's judgment|1
48632|NCT01546922|204691|P2|First Period of 10 Weeks|Withdrawal by Subject|1
48633|NCT01546922|204692|P1|First Period of 10 Weeks|Withdrawal by Subject|1
48634|NCT01546922|204691|P2|First Period of 10 Weeks|Protocol Violation|1
48635|NCT01546922|204692|P1|First Period of 10 Weeks|Protocol Violation|3
48636|NCT01546883|204698|P1|Overall Study|other unrelated illness|1
48637|NCT01546883|204698|P1|Overall Study|early closure of study|2
48638|NCT01546883|204698|P1|Overall Study|Lost to Follow-up|2
48639|NCT01546883|204698|P1|Overall Study|Adverse Event|4
48640|NCT01546883|204698|P1|Overall Study|Withdrawal by Subject|3
48641|NCT01546688|204704|P2|Overall Study|Lack of Efficacy|0
48642|NCT01546688|204705|P1|Overall Study|Lack of Efficacy|1
48643|NCT01546688|204704|P2|Overall Study|Withdrawal by Subject|1
48644|NCT01546688|204705|P1|Overall Study|Withdrawal by Subject|2
48645|NCT01546688|204704|P2|Overall Study|Adverse Event|4
48646|NCT01546688|204705|P1|Overall Study|Adverse Event|0
48647|NCT01546649|204737|P2|Overall Study|Withdrawal by Subject|2
48648|NCT01546649|204738|P1|Overall Study|Withdrawal by Subject|1
48649|NCT01546649|204737|P2|Overall Study|Discovery of secondary cancer|1
48650|NCT01546649|204738|P1|Overall Study|Discovery of secondary cancer|0
48651|NCT01546649|204737|P2|Overall Study|Recurrence|1
48652|NCT01546649|204738|P1|Overall Study|Recurrence|1
48653|NCT01546649|204737|P2|Overall Study|Lack of Efficacy|0
48654|NCT01546649|204738|P1|Overall Study|Lack of Efficacy|1
48655|NCT01546649|204737|P2|Overall Study|Protocol Violation|0
48656|NCT01546649|204738|P1|Overall Study|Protocol Violation|1
48657|NCT01546649|204737|P2|Overall Study|Adverse Event|5
48658|NCT01546649|204738|P1|Overall Study|Adverse Event|4
48659|NCT01546623|204773|P2|Overall Study|Did Not Receive Study Drug|1
48660|NCT01546623|204774|P1|Overall Study|Did Not Receive Study Drug|1
48661|NCT01546623|204773|P2|Overall Study|High Prostate specific antigen|1
48662|NCT01546623|204774|P1|Overall Study|High Prostate specific antigen|2
48663|NCT01546623|204773|P2|Overall Study|Major Protocol Deviation|1
48664|NCT01546623|204774|P1|Overall Study|Major Protocol Deviation|1
48665|NCT01546623|204773|P2|Overall Study|Adverse Event|3
48666|NCT01546623|204774|P1|Overall Study|Adverse Event|2
48667|NCT01546519|204804|P4|Overall Study|Withdrawal by Subject|0
48668|NCT01546519|204805|P3|Overall Study|Withdrawal by Subject|0
48669|NCT01546519|204806|P2|Overall Study|Withdrawal by Subject|0
48670|NCT01546519|204807|P1|Overall Study|Withdrawal by Subject|1
48671|NCT01546519|204804|P4|Overall Study|Physician Decision|3
48672|NCT01546519|204805|P3|Overall Study|Physician Decision|2
48673|NCT01546519|204806|P2|Overall Study|Physician Decision|5
48674|NCT01546519|204807|P1|Overall Study|Physician Decision|6
48675|NCT01546519|204804|P4|Overall Study|related to disease progression|1
48676|NCT01546519|204805|P3|Overall Study|related to disease progression|2
48677|NCT01546519|204806|P2|Overall Study|related to disease progression|2
48678|NCT01546519|204807|P1|Overall Study|related to disease progression|2
48679|NCT01546519|204804|P4|Overall Study|Death|1
48680|NCT01546519|204805|P3|Overall Study|Death|3
48681|NCT01546519|204806|P2|Overall Study|Death|1
48682|NCT01546519|204807|P1|Overall Study|Death|0
48683|NCT01546519|204804|P4|Overall Study|Adverse Event|1
48684|NCT01546519|204805|P3|Overall Study|Adverse Event|1
48685|NCT01546519|204806|P2|Overall Study|Adverse Event|0
48686|NCT01546519|204807|P1|Overall Study|Adverse Event|0
48687|NCT01546207|204872|P1|Overall Study|Death|1
48688|NCT01546168|204887|P2|Overall Study|ineligible after signing consent|0
48689|NCT01546168|204888|P1|Overall Study|ineligible after signing consent|2
48690|NCT01546168|204887|P2|Overall Study|Withdrawal by Subject|0
48691|NCT01546168|204888|P1|Overall Study|Withdrawal by Subject|1
48692|NCT01546168|204887|P2|Overall Study|Lost to Follow-up|0
48693|NCT01546168|204888|P1|Overall Study|Lost to Follow-up|1
48694|NCT01546155|204900|P1|Overall Study|could not tolerate long scan duration|3
48695|NCT01546142|204906|P2|Overall Study|Subject Randomized but Not Treated|0
48696|NCT01546142|204907|P1|Overall Study|Subject Randomized but Not Treated|1
48697|NCT01546142|204906|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
48698|NCT01546142|204907|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
48699|NCT01546142|204906|P2|Overall Study|Lost to Follow-up|15
48700|NCT01546142|204907|P1|Overall Study|Lost to Follow-up|20
48701|NCT01546142|204906|P2|Overall Study|Adverse Event|3
48702|NCT01546142|204907|P1|Overall Study|Adverse Event|6
48703|NCT01546142|204906|P2|Overall Study|Subject Noncompliance|1
48704|NCT01546142|204907|P1|Overall Study|Subject Noncompliance|1
48705|NCT01546142|204906|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
48706|NCT01546142|204907|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
48707|NCT01546038|204925|P9|Overall Study|: Randomized, not treated|3
48708|NCT01546038|204926|P8|Overall Study|: Randomized, not treated|4
48709|NCT01546038|204927|P7|Overall Study|: Randomized, not treated|2
48710|NCT01546038|204928|P6|Overall Study|: Randomized, not treated|0
48711|NCT01546038|204929|P5|Overall Study|: Randomized, not treated|0
48712|NCT01546038|204930|P4|Overall Study|: Randomized, not treated|0
48713|NCT01546038|204931|P3|Overall Study|: Randomized, not treated|0
48714|NCT01546038|204932|P2|Overall Study|: Randomized, not treated|0
48715|NCT01546038|204933|P1|Overall Study|: Randomized, not treated|0
48716|NCT01546038|204925|P9|Overall Study|: Study ongoing at cutoff date|1
48717|NCT01546038|204926|P8|Overall Study|: Study ongoing at cutoff date|16
48718|NCT01546038|204927|P7|Overall Study|: Study ongoing at cutoff date|24
48719|NCT01546038|204928|P6|Overall Study|: Study ongoing at cutoff date|2
48720|NCT01546038|204929|P5|Overall Study|: Study ongoing at cutoff date|8
48721|NCT01546038|204930|P4|Overall Study|: Study ongoing at cutoff date|0
48722|NCT01546038|204931|P3|Overall Study|: Study ongoing at cutoff date|0
48723|NCT01546038|204932|P2|Overall Study|: Study ongoing at cutoff date|0
48724|NCT01546038|204933|P1|Overall Study|: Study ongoing at cutoff date|1
48725|NCT01546038|204925|P9|Overall Study|Withdrawal by Subject|0
48726|NCT01546038|204926|P8|Overall Study|Withdrawal by Subject|3
48727|NCT01546038|204927|P7|Overall Study|Withdrawal by Subject|3
48728|NCT01546038|204928|P6|Overall Study|Withdrawal by Subject|1
48729|NCT01546038|204929|P5|Overall Study|Withdrawal by Subject|0
48730|NCT01546038|204930|P4|Overall Study|Withdrawal by Subject|1
48731|NCT01546038|204931|P3|Overall Study|Withdrawal by Subject|0
48732|NCT01546038|204932|P2|Overall Study|Withdrawal by Subject|0
48733|NCT01546038|204933|P1|Overall Study|Withdrawal by Subject|1
48734|NCT01546038|204925|P9|Overall Study|Lost to Follow-up|0
48735|NCT01546038|204926|P8|Overall Study|Lost to Follow-up|1
48736|NCT01546038|204927|P7|Overall Study|Lost to Follow-up|1
48737|NCT01546038|204928|P6|Overall Study|Lost to Follow-up|0
48738|NCT01546038|204929|P5|Overall Study|Lost to Follow-up|1
48739|NCT01546038|204930|P4|Overall Study|Lost to Follow-up|0
48740|NCT01546038|204931|P3|Overall Study|Lost to Follow-up|0
48741|NCT01546038|204932|P2|Overall Study|Lost to Follow-up|0
48742|NCT01546038|204933|P1|Overall Study|Lost to Follow-up|0
48743|NCT01546038|204925|P9|Overall Study|Death|40
48744|NCT01546038|204926|P8|Overall Study|Death|64
48745|NCT01546038|204927|P7|Overall Study|Death|41
48746|NCT01546038|204928|P6|Overall Study|Death|3
48747|NCT01546038|204929|P5|Overall Study|Death|7
48748|NCT01546038|204930|P4|Overall Study|Death|2
48749|NCT01546038|204931|P3|Overall Study|Death|4
48750|NCT01546038|204932|P2|Overall Study|Death|6
48751|NCT01546038|204933|P1|Overall Study|Death|15
48752|NCT01545388|205190|P3|Overall Study|Not specified|0
48753|NCT01545388|205191|P2|Overall Study|Not specified|1
48754|NCT01545388|205192|P1|Overall Study|Not specified|1
48755|NCT01545388|205190|P3|Overall Study|Withdrawal by Subject|2
48756|NCT01545388|205191|P2|Overall Study|Withdrawal by Subject|4
48757|NCT01545388|205192|P1|Overall Study|Withdrawal by Subject|1
48758|NCT01545388|205190|P3|Overall Study|Participant moved or relocated|0
48759|NCT01545388|205191|P2|Overall Study|Participant moved or relocated|0
48760|NCT01545388|205192|P1|Overall Study|Participant moved or relocated|1
48761|NCT01545388|205190|P3|Overall Study|Lack of Efficacy|5
48762|NCT01545388|205191|P2|Overall Study|Lack of Efficacy|2
48763|NCT01545388|205192|P1|Overall Study|Lack of Efficacy|3
48764|NCT01545388|205190|P3|Overall Study|Adverse Event|1
48765|NCT01545388|205191|P2|Overall Study|Adverse Event|4
48766|NCT01545388|205192|P1|Overall Study|Adverse Event|2
48767|NCT01545375|205211|P2|Overall Study|Withdrawal by Subject|55
48768|NCT01545375|205212|P1|Overall Study|Withdrawal by Subject|58
48769|NCT01545375|205211|P2|Overall Study|Protocol Violation|3
48770|NCT01545375|205212|P1|Overall Study|Protocol Violation|3
48771|NCT01545375|205211|P2|Overall Study|Lost to Follow-up|31
48772|NCT01545375|205212|P1|Overall Study|Lost to Follow-up|34
48773|NCT01545375|205211|P2|Overall Study|Adverse Event|1
48774|NCT01545375|205212|P1|Overall Study|Adverse Event|2
48775|NCT01544920|205340|P2|Overall Study|Withdrawal by Subject|4
48776|NCT01544920|205341|P1|Overall Study|Withdrawal by Subject|4
48777|NCT01544920|205340|P2|Overall Study|Physician Decision|1
48778|NCT01544920|205341|P1|Overall Study|Physician Decision|4
48779|NCT01544920|205340|P2|Overall Study|Protocol Violation|2
48780|NCT01544920|205341|P1|Overall Study|Protocol Violation|0
48781|NCT01544920|205340|P2|Overall Study|Lost to Follow-up|12
48782|NCT01544920|205341|P1|Overall Study|Lost to Follow-up|11
48783|NCT01544920|205340|P2|Overall Study|Death|1
48784|NCT01544920|205341|P1|Overall Study|Death|0
48785|NCT01544920|205340|P2|Overall Study|Adverse Event|3
48786|NCT01544920|205341|P1|Overall Study|Adverse Event|0
48787|NCT01544582|205352|P4|Analysis Population|Participant in Jail|0
48788|NCT01544582|205353|P3|Analysis Population|Participant in Jail|1
48789|NCT01544582|205354|P2|Analysis Population|Participant in Jail|0
48790|NCT01544582|205355|P1|Analysis Population|Participant in Jail|0
48791|NCT01544582|205352|P4|Analysis Population|Programmed Surgery|0
48792|NCT01544582|205353|P3|Analysis Population|Programmed Surgery|0
48793|NCT01544582|205354|P2|Analysis Population|Programmed Surgery|1
48794|NCT01544582|205355|P1|Analysis Population|Programmed Surgery|0
48795|NCT01544582|205352|P4|Analysis Population|Poor Participant Compliance|0
48796|NCT01544582|205353|P3|Analysis Population|Poor Participant Compliance|0
48797|NCT01544582|205354|P2|Analysis Population|Poor Participant Compliance|1
48798|NCT01544582|205355|P1|Analysis Population|Poor Participant Compliance|0
48799|NCT01544582|205352|P4|Analysis Population|Poor Adherence|0
48800|NCT01544582|205353|P3|Analysis Population|Poor Adherence|1
48801|NCT01544582|205354|P2|Analysis Population|Poor Adherence|0
48802|NCT01544582|205355|P1|Analysis Population|Poor Adherence|0
48803|NCT01544582|205352|P4|Analysis Population|No Social Insurance|0
48804|NCT01544582|205353|P3|Analysis Population|No Social Insurance|1
48805|NCT01544582|205354|P2|Analysis Population|No Social Insurance|0
48806|NCT01544582|205355|P1|Analysis Population|No Social Insurance|0
48807|NCT01544582|205352|P4|Analysis Population|Liver Transplantation|0
48808|NCT01544582|205353|P3|Analysis Population|Liver Transplantation|1
48809|NCT01544582|205354|P2|Analysis Population|Liver Transplantation|0
48810|NCT01544582|205355|P1|Analysis Population|Liver Transplantation|0
48811|NCT01544582|205352|P4|Analysis Population|Intolerance|0
48812|NCT01544582|205353|P3|Analysis Population|Intolerance|0
48813|NCT01544582|205354|P2|Analysis Population|Intolerance|1
48814|NCT01544582|205355|P1|Analysis Population|Intolerance|0
48815|NCT01544582|205352|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
48816|NCT01544582|205353|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
48817|NCT01544582|205354|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
48818|NCT01544582|205355|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
48819|NCT01544582|205352|P4|Analysis Population|Bad Tolerance to Treatment|0
48820|NCT01544582|205353|P3|Analysis Population|Bad Tolerance to Treatment|2
48821|NCT01544582|205354|P2|Analysis Population|Bad Tolerance to Treatment|0
48822|NCT01544582|205355|P1|Analysis Population|Bad Tolerance to Treatment|0
48823|NCT01544582|205352|P4|Analysis Population|Lost to Follow-up|5
48824|NCT01544582|205353|P3|Analysis Population|Lost to Follow-up|6
48825|NCT01544582|205354|P2|Analysis Population|Lost to Follow-up|6
48826|NCT01544582|205355|P1|Analysis Population|Lost to Follow-up|0
48827|NCT01544582|205352|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
48828|NCT01544582|205353|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
48829|NCT01544582|205354|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
48830|NCT01544582|205355|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
48831|NCT01544582|205352|P4|Analysis Population|Effectiveness Reason|12
48832|NCT01544582|205353|P3|Analysis Population|Effectiveness Reason|29
48833|NCT01544582|205354|P2|Analysis Population|Effectiveness Reason|48
48834|NCT01544582|205355|P1|Analysis Population|Effectiveness Reason|0
48835|NCT01544582|205352|P4|Analysis Population|Safety Reason|8
48836|NCT01544582|205353|P3|Analysis Population|Safety Reason|31
48837|NCT01544582|205354|P2|Analysis Population|Safety Reason|33
48838|NCT01544582|205355|P1|Analysis Population|Safety Reason|0
48839|NCT01544582|205352|P4|Analysis Population|Physician Decision|9
48840|NCT01544582|205353|P3|Analysis Population|Physician Decision|10
48841|NCT01544582|205354|P2|Analysis Population|Physician Decision|13
48842|NCT01544582|205355|P1|Analysis Population|Physician Decision|0
48843|NCT01544582|205352|P4|Analysis Population|Participant Refuses to Continue Study|4
48844|NCT01544582|205353|P3|Analysis Population|Participant Refuses to Continue Study|17
48845|NCT01544582|205354|P2|Analysis Population|Participant Refuses to Continue Study|15
48846|NCT01544582|205355|P1|Analysis Population|Participant Refuses to Continue Study|0
48847|NCT01544582|205352|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
48848|NCT01544582|205353|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
48849|NCT01544582|205354|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
48850|NCT01544582|205355|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
48851|NCT01544582|205352|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
48852|NCT01544582|205353|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
48853|NCT01544582|205354|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
48854|NCT01544582|205355|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
48855|NCT01544478|205413|P1|Overall Study|Withdrawal by Subject|52
48856|NCT01544478|205413|P1|Overall Study|Pregnancy|1
48857|NCT01544478|205413|P1|Overall Study|Physician Decision|15
48858|NCT01544478|205413|P1|Overall Study|Lost to Follow-up|48
48859|NCT01544478|205413|P1|Overall Study|Death|1
48860|NCT01544478|205413|P1|Overall Study|Adverse Event|1
48861|NCT01544348|205456|P8|Overall Study|Physician Decision|0
48862|NCT01544348|205457|P7|Overall Study|Physician Decision|0
48863|NCT01544348|205458|P6|Overall Study|Physician Decision|1
48864|NCT01544348|205459|P5|Overall Study|Physician Decision|0
48865|NCT01544348|205460|P4|Overall Study|Physician Decision|0
48866|NCT01544348|205461|P3|Overall Study|Physician Decision|0
48867|NCT01544348|205462|P2|Overall Study|Physician Decision|0
48868|NCT01544348|205463|P1|Overall Study|Physician Decision|0
48869|NCT01544348|205456|P8|Overall Study|Withdrawal by Subject|0
48870|NCT01544348|205457|P7|Overall Study|Withdrawal by Subject|1
48871|NCT01544348|205458|P6|Overall Study|Withdrawal by Subject|2
48872|NCT01544348|205459|P5|Overall Study|Withdrawal by Subject|1
48873|NCT01544348|205460|P4|Overall Study|Withdrawal by Subject|0
48874|NCT01544348|205461|P3|Overall Study|Withdrawal by Subject|0
48875|NCT01544348|205462|P2|Overall Study|Withdrawal by Subject|0
48876|NCT01544348|205463|P1|Overall Study|Withdrawal by Subject|1
48877|NCT01544348|205456|P8|Overall Study|Lost to Follow-up|0
48878|NCT01544348|205457|P7|Overall Study|Lost to Follow-up|1
48879|NCT01544348|205458|P6|Overall Study|Lost to Follow-up|0
48880|NCT01544348|205459|P5|Overall Study|Lost to Follow-up|0
48881|NCT01544348|205460|P4|Overall Study|Lost to Follow-up|0
48882|NCT01544348|205461|P3|Overall Study|Lost to Follow-up|0
48883|NCT01544348|205462|P2|Overall Study|Lost to Follow-up|0
48884|NCT01544348|205463|P1|Overall Study|Lost to Follow-up|1
48885|NCT01544309|205505|P2|Overall Study|Administered prohibit prior medication|0
48886|NCT01544309|205506|P1|Overall Study|Administered prohibit prior medication|1
48887|NCT01544309|205505|P2|Overall Study|Not performed pre-dose examination|2
48888|NCT01544309|205506|P1|Overall Study|Not performed pre-dose examination|1
48889|NCT01544309|205505|P2|Overall Study|Physician Decision|1
48890|NCT01544309|205506|P1|Overall Study|Physician Decision|4
48891|NCT01544309|205505|P2|Overall Study|Protocol Violation|1
48892|NCT01544309|205506|P1|Overall Study|Protocol Violation|2
48893|NCT01544309|205505|P2|Overall Study|Withdrawal by Subject|7
48894|NCT01544309|205506|P1|Overall Study|Withdrawal by Subject|12
48895|NCT01544179|205544|P2|Overall Study|Eligibility criteria not fulfilled|0
48896|NCT01544179|205545|P1|Overall Study|Eligibility criteria not fulfilled|1
48897|NCT01544179|205544|P2|Overall Study|Withdrawal by Subject|7
48898|NCT01544179|205545|P1|Overall Study|Withdrawal by Subject|12
48899|NCT01544179|205544|P2|Overall Study|Adverse Event|1
48900|NCT01544179|205545|P1|Overall Study|Adverse Event|0
48901|NCT01544179|205544|P2|Overall Study|Lost to Follow-up|1
48902|NCT01544179|205545|P1|Overall Study|Lost to Follow-up|0
48903|NCT01544179|205544|P2|Overall Study|Death|37
48904|NCT01544179|205545|P1|Overall Study|Death|50
48905|NCT01544153|205638|P4|Overall Study|Non-smoker|0
48906|NCT01544153|205639|P3|Overall Study|Non-smoker|1
48907|NCT01544153|205640|P2|Overall Study|Non-smoker|0
48908|NCT01544153|205641|P1|Overall Study|Non-smoker|0
48909|NCT01544153|205638|P4|Overall Study|Under 18|0
48910|NCT01544153|205639|P3|Overall Study|Under 18|0
48911|NCT01544153|205640|P2|Overall Study|Under 18|1
48912|NCT01544153|205641|P1|Overall Study|Under 18|0
48913|NCT01544114|205658|P3|Overall Study|Protocol Violation|0
48914|NCT01544114|205659|P2|Overall Study|Protocol Violation|1
48915|NCT01544114|205660|P1|Overall Study|Protocol Violation|0
48916|NCT01544114|205658|P3|Overall Study|Adverse Event|2
48917|NCT01544114|205659|P2|Overall Study|Adverse Event|1
48918|NCT01544114|205660|P1|Overall Study|Adverse Event|1
48919|NCT01544114|205658|P3|Overall Study|Lost to Follow-up|0
48920|NCT01544114|205659|P2|Overall Study|Lost to Follow-up|2
48921|NCT01544114|205660|P1|Overall Study|Lost to Follow-up|0
48922|NCT01544114|205658|P3|Overall Study|Withdrawal by Subject|3
48923|NCT01544114|205659|P2|Overall Study|Withdrawal by Subject|0
48924|NCT01544114|205660|P1|Overall Study|Withdrawal by Subject|0
48925|NCT01543958|205743|P1|Overall Study|ART initiation|1
48926|NCT01543958|205743|P1|Overall Study|Loss to follow-up|3
48927|NCT01543828|205798|P2|Treatment 2|Lost to Follow-up|0
48928|NCT01543828|205799|P1|Treatment 2|Lost to Follow-up|1
48929|NCT01543685|205812|P5|Overall Study|Adverse Event|2
48930|NCT01543685|205813|P4|Overall Study|Adverse Event|0
48931|NCT01543685|205814|P3|Overall Study|Adverse Event|0
48932|NCT01543685|205815|P2|Overall Study|Adverse Event|1
48933|NCT01543685|205816|P1|Overall Study|Adverse Event|2
48934|NCT01543685|205812|P5|Overall Study|Lack of Efficacy|2
48935|NCT01543685|205813|P4|Overall Study|Lack of Efficacy|0
48936|NCT01543685|205814|P3|Overall Study|Lack of Efficacy|2
48937|NCT01543685|205815|P2|Overall Study|Lack of Efficacy|2
48938|NCT01543685|205816|P1|Overall Study|Lack of Efficacy|1
48939|NCT01543503|205888|P2|Overall Study|Screen failure|0
48940|NCT01543503|205889|P1|Overall Study|Screen failure|1
48941|NCT01543503|205888|P2|Overall Study|Participant went to United States|0
48942|NCT01543503|205889|P1|Overall Study|Participant went to United States|1
48943|NCT01543503|205888|P2|Overall Study|Participant consented to another study|2
48944|NCT01543503|205889|P1|Overall Study|Participant consented to another study|0
48945|NCT01543503|205888|P2|Overall Study|Moved to other rheumatologic site|1
48946|NCT01543503|205889|P1|Overall Study|Moved to other rheumatologic site|0
48947|NCT01543503|205888|P2|Overall Study|Participant did not attend a visit|0
48948|NCT01543503|205889|P1|Overall Study|Participant did not attend a visit|1
48949|NCT01543503|205888|P2|Overall Study|Site stopped participation|1
48950|NCT01543503|205889|P1|Overall Study|Site stopped participation|5
48951|NCT01543503|205888|P2|Overall Study|Participant recruited after closing date|1
48952|NCT01543503|205889|P1|Overall Study|Participant recruited after closing date|0
48953|NCT01543503|205888|P2|Overall Study|Investigator did not wish to participate|1
48954|NCT01543503|205889|P1|Overall Study|Investigator did not wish to participate|1
48955|NCT01543503|205888|P2|Overall Study|Participant decision to stop treatment|0
48956|NCT01543503|205889|P1|Overall Study|Participant decision to stop treatment|1
48957|NCT01543503|205888|P2|Overall Study|Participant moved to Scotland|0
48958|NCT01543503|205889|P1|Overall Study|Participant moved to Scotland|1
48959|NCT01543503|205888|P2|Overall Study|Participant transferred to another city|0
48960|NCT01543503|205889|P1|Overall Study|Participant transferred to another city|1
48961|NCT01543503|205888|P2|Overall Study|Participant will not return for visits|2
48962|NCT01543503|205889|P1|Overall Study|Participant will not return for visits|0
48963|NCT01543503|205888|P2|Overall Study|Participant moved to another city|0
48964|NCT01543503|205889|P1|Overall Study|Participant moved to another city|2
48965|NCT01543503|205888|P2|Overall Study|Incorrect medication received|0
48966|NCT01543503|205889|P1|Overall Study|Incorrect medication received|1
48967|NCT01543503|205888|P2|Overall Study|Refused to continue treatment|0
48968|NCT01543503|205889|P1|Overall Study|Refused to continue treatment|7
48969|NCT01543503|205888|P2|Overall Study|Participant did not complete last visit|2
48970|NCT01543503|205889|P1|Overall Study|Participant did not complete last visit|0
48971|NCT01543503|205888|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
48972|NCT01543503|205889|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
48973|NCT01543503|205888|P2|Overall Study|Intolerance to the biologic treatment|1
48974|NCT01543503|205889|P1|Overall Study|Intolerance to the biologic treatment|0
48975|NCT01543503|205888|P2|Overall Study|Change of jobs|1
48976|NCT01543503|205889|P1|Overall Study|Change of jobs|0
48977|NCT01543503|205888|P2|Overall Study|Participant withdrew informed consent|10
48978|NCT01543503|205889|P1|Overall Study|Participant withdrew informed consent|8
48979|NCT01543503|205888|P2|Overall Study|Lack of Efficacy|16
48980|NCT01543503|205889|P1|Overall Study|Lack of Efficacy|4
48981|NCT01543503|205888|P2|Overall Study|Adverse Event|13
48982|NCT01543503|205889|P1|Overall Study|Adverse Event|9
48983|NCT01543503|205888|P2|Overall Study|Lost to Follow-up|36
48984|NCT01543503|205889|P1|Overall Study|Lost to Follow-up|32
48985|NCT01543204|205933|P1|Overall Study|Lost to Follow-up|1
48986|NCT01543204|205933|P1|Overall Study|Requirement for Alternative Therapy|1
48987|NCT01543204|205933|P1|Overall Study|Withdrawal by Subject|4
48988|NCT01543204|205933|P1|Overall Study|Adverse Event|1
48989|NCT01543204|205933|P1|Overall Study|Non-compliance|1
48990|NCT01542788|206025|P2|Overall Study|Withdrawal by Subject|0
48991|NCT01542788|206026|P1|Overall Study|Withdrawal by Subject|1
48992|NCT01542788|206025|P2|Overall Study|Physician Decision|0
48993|NCT01542788|206026|P1|Overall Study|Physician Decision|1
48994|NCT01542788|206025|P2|Overall Study|Protocol Violation|0
48995|NCT01542788|206026|P1|Overall Study|Protocol Violation|2
48996|NCT01542788|206025|P2|Overall Study|Death|0
48997|NCT01542788|206026|P1|Overall Study|Death|3
48998|NCT01542788|206025|P2|Overall Study|Lost to Follow-up|0
48999|NCT01542788|206026|P1|Overall Study|Lost to Follow-up|5
49000|NCT01542788|206025|P2|Overall Study|Lack of Efficacy|71
49001|NCT01542788|206026|P1|Overall Study|Lack of Efficacy|41
49002|NCT01542788|206025|P2|Overall Study|Randomized but Not Treated|0
49003|NCT01542788|206026|P1|Overall Study|Randomized but Not Treated|2
49004|NCT01542632|206065|P6|Overall Study|Sponsor/Investigator Decision|0
49005|NCT01542632|206066|P5|Overall Study|Sponsor/Investigator Decision|1
49006|NCT01542632|206067|P4|Overall Study|Sponsor/Investigator Decision|0
49007|NCT01542632|206068|P3|Overall Study|Sponsor/Investigator Decision|0
49008|NCT01542632|206069|P2|Overall Study|Sponsor/Investigator Decision|0
49009|NCT01542632|206070|P1|Overall Study|Sponsor/Investigator Decision|0
49010|NCT01542632|206065|P6|Overall Study|Lost to Follow-up|0
49011|NCT01542632|206066|P5|Overall Study|Lost to Follow-up|0
49012|NCT01542632|206067|P4|Overall Study|Lost to Follow-up|0
49013|NCT01542632|206068|P3|Overall Study|Lost to Follow-up|0
49014|NCT01542632|206069|P2|Overall Study|Lost to Follow-up|1
49015|NCT01542632|206070|P1|Overall Study|Lost to Follow-up|0
49016|NCT01542632|206065|P6|Overall Study|Adverse Event|0
49017|NCT01542632|206066|P5|Overall Study|Adverse Event|0
49018|NCT01542632|206067|P4|Overall Study|Adverse Event|0
49019|NCT01542632|206068|P3|Overall Study|Adverse Event|1
49020|NCT01542632|206069|P2|Overall Study|Adverse Event|0
49021|NCT01542632|206070|P1|Overall Study|Adverse Event|0
49022|NCT01542632|206065|P6|Overall Study|Withdrawal of Consent|0
49023|NCT01542632|206066|P5|Overall Study|Withdrawal of Consent|3
49024|NCT01542632|206067|P4|Overall Study|Withdrawal of Consent|2
49025|NCT01542632|206068|P3|Overall Study|Withdrawal of Consent|0
49026|NCT01542632|206069|P2|Overall Study|Withdrawal of Consent|0
49027|NCT01542632|206070|P1|Overall Study|Withdrawal of Consent|0
49028|NCT01542528|206127|P2|Overall Study|Withdrawal by Subject|6
49029|NCT01542528|206128|P1|Overall Study|Withdrawal by Subject|9
49030|NCT01542528|206127|P2|Overall Study|Physician Decision|0
49031|NCT01542528|206128|P1|Overall Study|Physician Decision|1
49032|NCT01542528|206127|P2|Overall Study|Lost to Follow-up|1
49033|NCT01542528|206128|P1|Overall Study|Lost to Follow-up|2
49034|NCT01542034|206197|P2|Overall Study|Lost to Follow-up|6
49035|NCT01542034|206198|P1|Overall Study|Lost to Follow-up|7
49036|NCT01542034|206197|P2|Overall Study|Adverse Event|2
49037|NCT01542034|206198|P1|Overall Study|Adverse Event|2
49038|NCT01542034|206197|P2|Overall Study|Subject Noncompliance|0
49039|NCT01542034|206198|P1|Overall Study|Subject Noncompliance|1
49040|NCT01542034|206197|P2|Overall Study|Administrative decision|3
49041|NCT01542034|206198|P1|Overall Study|Administrative decision|0
49042|NCT01542034|206197|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
49043|NCT01542034|206198|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
49044|NCT01541969|206212|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
49045|NCT01541969|206213|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
49046|NCT01541969|206212|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
49047|NCT01541969|206213|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
49048|NCT01541969|206212|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
49049|NCT01541969|206213|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
49050|NCT01541969|206212|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
49051|NCT01541969|206213|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
49052|NCT01541969|206212|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
49053|NCT01541969|206213|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
49054|NCT01541969|206212|P2|Double-blind (0-12 Weeks)|Adverse Event|0
49055|NCT01541969|206213|P1|Double-blind (0-12 Weeks)|Adverse Event|2
49056|NCT01541969|206212|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
49057|NCT01541969|206213|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
49058|NCT01541969|206212|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
49059|NCT01541969|206213|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
49060|NCT01541969|206212|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
49061|NCT01541969|206213|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
49062|NCT01541969|206212|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
49063|NCT01541969|206213|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
49064|NCT01541930|206229|P1|Overall Study|Withdrawal by Subject|1
49065|NCT01541917|206251|P2|Overall Study|Withdrawal by Subject|7
49066|NCT01541917|206252|P1|Overall Study|Withdrawal by Subject|13
49067|NCT01541917|206251|P2|Overall Study|Lost to Follow-up|2
49068|NCT01541917|206252|P1|Overall Study|Lost to Follow-up|2
49069|NCT01541865|206268|P1|Overall Study|Protocol Violation|1
49070|NCT01541865|206268|P1|Overall Study|Adverse Event|1
49071|NCT01541865|206268|P1|Overall Study|Withdrawal by Subject|9
49072|NCT01541865|206268|P1|Overall Study|Lost to Follow-up|11
49073|NCT01541826|206286|P3|Overall Study|Withdrawal by Subject|0
49074|NCT01541826|206287|P2|Overall Study|Withdrawal by Subject|0
49075|NCT01541826|206288|P1|Overall Study|Withdrawal by Subject|2
49076|NCT01541826|206286|P3|Overall Study|Lost to Follow-up|0
49077|NCT01541826|206287|P2|Overall Study|Lost to Follow-up|3
49078|NCT01541826|206288|P1|Overall Study|Lost to Follow-up|2
49079|NCT01541644|206370|P1|Overall Study|Withdrawal by Subject|3
49080|NCT01541397|206389|P2|Overall Study|Study ended prior to data collection|2
49081|NCT01541397|206390|P1|Overall Study|Study ended prior to data collection|4
49082|NCT01541371|206415|P1|Overall Study|Other|6
49083|NCT01541371|206415|P1|Overall Study|Study medication non-compliance|3
49084|NCT01541371|206415|P1|Overall Study|Protocol Violation|6
49085|NCT01541371|206415|P1|Overall Study|Lack of Efficacy|12
49086|NCT01541371|206415|P1|Overall Study|Adverse Event|15
49087|NCT01541371|206415|P1|Overall Study|Lost to Follow-up|21
49088|NCT01541371|206415|P1|Overall Study|Withdrawal by Subject|14
49089|NCT01541254|206444|P1|Overall Study|alternate stent used|1
49090|NCT01541254|206444|P1|Overall Study|stent not required|1
49091|NCT01541254|206444|P1|Overall Study|GI bleed prior to procedure|1
49092|NCT01541254|206444|P1|Overall Study|enrolled after study closed|1
49093|NCT01541254|206444|P1|Overall Study|excluded - metal allergy|1
49094|NCT01541254|206444|P1|Overall Study|Withdrawal by Subject|1
49095|NCT01540981|206451|P2|Overall Study|Withdrawal by Subject|0
49096|NCT01540981|206452|P1|Overall Study|Withdrawal by Subject|1
49097|NCT01540851|206462|P2|Overall Study|Withdrawal by Subject|3
49098|NCT01540851|206463|P1|Overall Study|Withdrawal by Subject|7
49099|NCT01540851|206462|P2|Overall Study|Lost to Follow-up|15
49100|NCT01540851|206463|P1|Overall Study|Lost to Follow-up|14
49101|NCT01540487|206608|P2|Overall Study|Protocol Violation|0
49102|NCT01540487|206609|P1|Overall Study|Protocol Violation|1
49103|NCT01539759|206744|P2|Overall Study|Lost to Follow-up|8
49104|NCT01539759|206745|P1|Overall Study|Lost to Follow-up|6
49105|NCT01539642|206757|P2|Overall Study|Withdrawal by Subject|2
49106|NCT01539642|206758|P1|Overall Study|Withdrawal by Subject|2
49107|NCT01539642|206757|P2|Overall Study|Adverse Event|4
49108|NCT01539642|206758|P1|Overall Study|Adverse Event|6
49109|NCT01539642|206757|P2|Overall Study|Patient ready for early discharge|7
49110|NCT01539642|206758|P1|Overall Study|Patient ready for early discharge|8
49111|NCT01539642|206757|P2|Overall Study|Lack of Efficacy|18
49112|NCT01539642|206758|P1|Overall Study|Lack of Efficacy|20
49113|NCT01539538|206775|P2|Overall Study|PCA no longer required or PCA problem|7
49114|NCT01539538|206776|P1|Overall Study|PCA no longer required or PCA problem|3
49115|NCT01539538|206775|P2|Overall Study|Withdrawal by Subject|3
49116|NCT01539538|206776|P1|Overall Study|Withdrawal by Subject|2
49117|NCT01539538|206775|P2|Overall Study|Lack of Efficacy|16
49118|NCT01539538|206776|P1|Overall Study|Lack of Efficacy|13
49119|NCT01539538|206775|P2|Overall Study|Adverse Event|18
49120|NCT01539538|206776|P1|Overall Study|Adverse Event|13
49121|NCT01539525|206785|P3|Overall Study|Protocol Violation|4
49122|NCT01539525|206786|P2|Overall Study|Protocol Violation|1
49123|NCT01539525|206787|P1|Overall Study|Protocol Violation|1
49124|NCT01539525|206785|P3|Overall Study|Withdrawal by Subject|2
49125|NCT01539525|206786|P2|Overall Study|Withdrawal by Subject|3
49126|NCT01539525|206787|P1|Overall Study|Withdrawal by Subject|0
49127|NCT01539525|206785|P3|Overall Study|Lost to Follow-up|11
49128|NCT01539525|206786|P2|Overall Study|Lost to Follow-up|12
49129|NCT01539525|206787|P1|Overall Study|Lost to Follow-up|19
49130|NCT01539512|206806|P2|Overall Study|Richter's Transformation|0
49131|NCT01539512|206807|P1|Overall Study|Richter's Transformation|1
49132|NCT01539512|206806|P2|Overall Study|Withdrawal by Subject|5
49133|NCT01539512|206807|P1|Overall Study|Withdrawal by Subject|12
49134|NCT01539512|206806|P2|Overall Study|Physician Decision|1
49135|NCT01539512|206807|P1|Overall Study|Physician Decision|1
49136|NCT01539512|206806|P2|Overall Study|Adverse Event|7
49137|NCT01539512|206807|P1|Overall Study|Adverse Event|9
49138|NCT01539317|206823|P2|Overall Study|Screening Error. Deleted from analysis.|0
49139|NCT01539317|206824|P1|Overall Study|Screening Error. Deleted from analysis.|1
49140|NCT01539083|206854|P3|After Randomization (TP and VTP)|Progressive Disease|2
49141|NCT01539083|206855|P2|After Randomization (TP and VTP)|Progressive Disease|3
49142|NCT01539083|206856|P1|After Randomization (TP and VTP)|Progressive Disease|0
49143|NCT01539083|206854|P3|After Randomization (TP and VTP)|Death|6
49144|NCT01539083|206855|P2|After Randomization (TP and VTP)|Death|4
49145|NCT01539083|206856|P1|After Randomization (TP and VTP)|Death|0
49146|NCT01539083|206854|P3|After Randomization (TP and VTP)|Adverse Event|0
49147|NCT01539083|206855|P2|After Randomization (TP and VTP)|Adverse Event|1
49148|NCT01539083|206856|P1|After Randomization (TP and VTP)|Adverse Event|0
49149|NCT01539083|206854|P3|After Randomization (TP and VTP)|Withdrawal by Subject|1
49150|NCT01539083|206855|P2|After Randomization (TP and VTP)|Withdrawal by Subject|3
49151|NCT01539083|206856|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
49152|NCT01539083|206854|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
49153|NCT01539083|206855|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
49154|NCT01539083|206856|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
49155|NCT01539083|206854|P3|Before Randomization (VCD Induction)|Other|0
49156|NCT01539083|206855|P2|Before Randomization (VCD Induction)|Other|0
49157|NCT01539083|206856|P1|Before Randomization (VCD Induction)|Other|5
49158|NCT01539083|206854|P3|Before Randomization (VCD Induction)|Progressive Disease|0
49159|NCT01539083|206855|P2|Before Randomization (VCD Induction)|Progressive Disease|0
49160|NCT01539083|206856|P1|Before Randomization (VCD Induction)|Progressive Disease|8
49161|NCT01539083|206854|P3|Before Randomization (VCD Induction)|Physician Decision|0
49162|NCT01539083|206855|P2|Before Randomization (VCD Induction)|Physician Decision|0
49163|NCT01539083|206856|P1|Before Randomization (VCD Induction)|Physician Decision|14
49164|NCT01539083|206854|P3|Before Randomization (VCD Induction)|Protocol Violation|0
49165|NCT01539083|206855|P2|Before Randomization (VCD Induction)|Protocol Violation|0
49166|NCT01539083|206856|P1|Before Randomization (VCD Induction)|Protocol Violation|2
49167|NCT01539083|206854|P3|Before Randomization (VCD Induction)|Death|0
49168|NCT01539083|206855|P2|Before Randomization (VCD Induction)|Death|0
49169|NCT01539083|206856|P1|Before Randomization (VCD Induction)|Death|6
49170|NCT01539083|206854|P3|Before Randomization (VCD Induction)|Adverse Event|0
49171|NCT01539083|206855|P2|Before Randomization (VCD Induction)|Adverse Event|0
49172|NCT01539083|206856|P1|Before Randomization (VCD Induction)|Adverse Event|14
49173|NCT01539083|206854|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
49174|NCT01539083|206855|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
49175|NCT01539083|206856|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
49176|NCT01538719|206900|P2|Overall Study|Lost to Follow-up|0
49177|NCT01538719|206901|P1|Overall Study|Lost to Follow-up|2
49178|NCT01538472|206924|P1|Overall Study|Death|1
49179|NCT01538472|206924|P1|Overall Study|Disease Progression|3
49180|NCT01538199|206935|P4|Overall Study|Lack of Efficacy|0
49181|NCT01538199|206936|P3|Overall Study|Lack of Efficacy|0
49182|NCT01538199|206937|P2|Overall Study|Lack of Efficacy|1
49183|NCT01538199|206938|P1|Overall Study|Lack of Efficacy|0
49184|NCT01538199|206935|P4|Overall Study|participant did not have time|2
49185|NCT01538199|206936|P3|Overall Study|participant did not have time|0
49186|NCT01538199|206937|P2|Overall Study|participant did not have time|0
49187|NCT01538199|206938|P1|Overall Study|participant did not have time|1
49188|NCT01538199|206935|P4|Overall Study|Lost to Follow-up|0
49189|NCT01538199|206936|P3|Overall Study|Lost to Follow-up|1
49190|NCT01538199|206937|P2|Overall Study|Lost to Follow-up|2
49191|NCT01538199|206938|P1|Overall Study|Lost to Follow-up|1
49192|NCT01537783|206990|P2|Overall Study|Lost to Follow-up|2
49193|NCT01537783|206991|P1|Overall Study|Lost to Follow-up|11
49194|NCT01537549|207042|P1|Overall Study|Withdrawal by Subject|2
49195|NCT01537549|207042|P1|Overall Study|Lost to Follow-up|1
49196|NCT01537432|207050|P2|Overall Study|Unsatisfactory therapeutic effect|0
49197|NCT01537432|207051|P1|Overall Study|Unsatisfactory therapeutic effect|1
49198|NCT01537432|207050|P2|Overall Study|Adverse Event|0
49199|NCT01537432|207051|P1|Overall Study|Adverse Event|1
49200|NCT01537432|207050|P2|Overall Study|Administrative problems|0
49201|NCT01537432|207051|P1|Overall Study|Administrative problems|1
49202|NCT01537432|207050|P2|Overall Study|Withdrawal by Subject|1
49203|NCT01537432|207051|P1|Overall Study|Withdrawal by Subject|0
49204|NCT01537432|207050|P2|Overall Study|Lost to Follow-up|1
49205|NCT01537432|207051|P1|Overall Study|Lost to Follow-up|3
49206|NCT01537393|207074|P2|Overall Study|Censored (severe event unrelated to PT)|1
49207|NCT01537393|207075|P1|Overall Study|Censored (severe event unrelated to PT)|1
49208|NCT01537393|207074|P2|Overall Study|Failure - Not regrafted|6
49209|NCT01537393|207075|P1|Overall Study|Failure - Not regrafted|2
49210|NCT01537393|207074|P2|Overall Study|Failure - Regrafted|43
49211|NCT01537393|207075|P1|Overall Study|Failure - Regrafted|28
49212|NCT01537393|207074|P2|Overall Study|Lost to Follow-up|48
49213|NCT01537393|207075|P1|Overall Study|Lost to Follow-up|53
49214|NCT01537393|207074|P2|Overall Study|Withdrawal by Subject|17
49215|NCT01537393|207075|P1|Overall Study|Withdrawal by Subject|18
49216|NCT01537393|207074|P2|Overall Study|Death|32
49217|NCT01537393|207075|P1|Overall Study|Death|20
49218|NCT01537393|207074|P2|Overall Study|Exclude prior to study|44
49219|NCT01537393|207075|P1|Overall Study|Exclude prior to study|32
49220|NCT01537302|207111|P1|Overall Study|Withdrawal by Subject|1
49221|NCT01537302|207111|P1|Overall Study|Lost to Follow-up|1
49222|NCT01537198|207118|P1|Overall Study|Not Specified|111
49223|NCT01537198|207118|P1|Overall Study|No Further Visits to the Clinic|37
49224|NCT01537198|207118|P1|Overall Study|Adverse Event|4
49225|NCT01537198|207118|P1|Overall Study|RSV infection|2
49226|NCT01537133|207147|P4|Overall Study|Lost to Follow-up|0
49227|NCT01537133|207148|P3|Overall Study|Lost to Follow-up|0
49228|NCT01537133|207149|P2|Overall Study|Lost to Follow-up|0
49229|NCT01537133|207150|P1|Overall Study|Lost to Follow-up|1
49230|NCT01537133|207147|P4|Overall Study|Withdrawal by Subject|0
49231|NCT01537133|207148|P3|Overall Study|Withdrawal by Subject|0
49232|NCT01537133|207149|P2|Overall Study|Withdrawal by Subject|0
49233|NCT01537133|207150|P1|Overall Study|Withdrawal by Subject|2
49234|NCT01537120|207166|P1|3 Weeks Placebo|Withdrawal by Subject|1
49235|NCT01537120|207166|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
49236|NCT01537081|207179|P3|Overall Study|Assigned but never dosed|0
49237|NCT01537081|207180|P2|Overall Study|Assigned but never dosed|0
49238|NCT01537081|207181|P1|Overall Study|Assigned but never dosed|1
49239|NCT01537081|207179|P3|Overall Study|Sponsor decision|0
49240|NCT01537081|207180|P2|Overall Study|Sponsor decision|1
49241|NCT01537081|207181|P1|Overall Study|Sponsor decision|0
49242|NCT01537081|207179|P3|Overall Study|Physician Decision|0
49243|NCT01537081|207180|P2|Overall Study|Physician Decision|6
49244|NCT01537081|207181|P1|Overall Study|Physician Decision|5
49245|NCT01537081|207179|P3|Overall Study|Withdrawal by Subject|3
49246|NCT01537081|207180|P2|Overall Study|Withdrawal by Subject|11
49247|NCT01537081|207181|P1|Overall Study|Withdrawal by Subject|6
49248|NCT01537081|207179|P3|Overall Study|Protocol Violation|2
49249|NCT01537081|207180|P2|Overall Study|Protocol Violation|2
49250|NCT01537081|207181|P1|Overall Study|Protocol Violation|3
49251|NCT01537081|207179|P3|Overall Study|Lost to Follow-up|9
49252|NCT01537081|207180|P2|Overall Study|Lost to Follow-up|15
49253|NCT01537081|207181|P1|Overall Study|Lost to Follow-up|17
49254|NCT01537081|207179|P3|Overall Study|Lack of Efficacy|0
49255|NCT01537081|207180|P2|Overall Study|Lack of Efficacy|1
49256|NCT01537081|207181|P1|Overall Study|Lack of Efficacy|2
49257|NCT01537081|207179|P3|Overall Study|Adverse Event|2
49258|NCT01537081|207180|P2|Overall Study|Adverse Event|2
49259|NCT01537081|207181|P1|Overall Study|Adverse Event|5
49260|NCT01537068|207194|P2|Overall Study|Lack of Efficacy|0
49261|NCT01537068|207195|P1|Overall Study|Lack of Efficacy|1
49262|NCT01537068|207194|P2|Overall Study|Withdrawal by Subject|1
49263|NCT01537068|207195|P1|Overall Study|Withdrawal by Subject|1
49264|NCT01537068|207194|P2|Overall Study|Adverse Event|1
49265|NCT01537068|207195|P1|Overall Study|Adverse Event|0
49266|NCT01537068|207194|P2|Overall Study|Lost to Follow-up|1
49267|NCT01537068|207195|P1|Overall Study|Lost to Follow-up|2
49268|NCT01537042|207207|P2|Overall Study|Other|1
49269|NCT01537042|207208|P1|Overall Study|Other|0
49270|NCT01537042|207207|P2|Overall Study|Protocol Violation|1
49271|NCT01537042|207208|P1|Overall Study|Protocol Violation|0
49272|NCT01537042|207207|P2|Overall Study|Lack of Efficacy|1
49273|NCT01537042|207208|P1|Overall Study|Lack of Efficacy|0
49274|NCT01537042|207207|P2|Overall Study|Adverse Event|2
49275|NCT01537042|207208|P1|Overall Study|Adverse Event|0
49276|NCT01536951|207246|P9|Second Intervention and Washout Period 2|Adverse Event|0
49277|NCT01536951|207247|P8|Second Intervention and Washout Period 2|Adverse Event|1
49278|NCT01536951|207248|P7|Second Intervention and Washout Period 2|Adverse Event|0
49279|NCT01536951|207249|P6|Second Intervention and Washout Period 2|Adverse Event|0
49280|NCT01536951|207250|P5|Second Intervention and Washout Period 2|Adverse Event|0
49281|NCT01536951|207251|P4|Second Intervention and Washout Period 2|Adverse Event|0
49282|NCT01536951|207252|P3|Second Intervention and Washout Period 2|Adverse Event|0
49283|NCT01536951|207253|P2|Second Intervention and Washout Period 2|Adverse Event|0
49284|NCT01536951|207254|P1|Second Intervention and Washout Period 2|Adverse Event|0
49285|NCT01536951|207246|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
49286|NCT01536951|207247|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
49287|NCT01536951|207248|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
49288|NCT01536951|207249|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
49289|NCT01536951|207250|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
49290|NCT01536951|207251|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
49291|NCT01536951|207252|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
49292|NCT01536951|207253|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
49293|NCT01536951|207254|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
49294|NCT01536860|207311|P3|Washout Period (3 Days)|Lost to Follow-up|0
49295|NCT01536860|207312|P2|Washout Period (3 Days)|Lost to Follow-up|0
49296|NCT01536860|207313|P1|Washout Period (3 Days)|Lost to Follow-up|1
49297|NCT01536704|207321|P4|Washout Period 3|Adverse Event|0
49298|NCT01536704|207322|P3|Washout Period 3|Adverse Event|1
49299|NCT01536704|207323|P2|Washout Period 3|Adverse Event|0
49300|NCT01536704|207324|P1|Washout Period 3|Adverse Event|0
49301|NCT01536704|207321|P4|Period 3|Adverse Event|1
49302|NCT01536704|207322|P3|Period 3|Adverse Event|0
49303|NCT01536704|207323|P2|Period 3|Adverse Event|0
49304|NCT01536704|207324|P1|Period 3|Adverse Event|0
49305|NCT01536704|207321|P4|Washout Period 2|Withdrawal by Subject|1
49306|NCT01536704|207322|P3|Washout Period 2|Withdrawal by Subject|0
49307|NCT01536704|207323|P2|Washout Period 2|Withdrawal by Subject|0
49308|NCT01536704|207324|P1|Washout Period 2|Withdrawal by Subject|0
49309|NCT01536704|207321|P4|Washout Period 2|Adverse Event|0
49310|NCT01536704|207322|P3|Washout Period 2|Adverse Event|0
49311|NCT01536704|207323|P2|Washout Period 2|Adverse Event|0
49312|NCT01536704|207324|P1|Washout Period 2|Adverse Event|1
49313|NCT01536704|207321|P4|Washout Period 1|Withdrawal by Subject|0
49314|NCT01536704|207322|P3|Washout Period 1|Withdrawal by Subject|0
49315|NCT01536704|207323|P2|Washout Period 1|Withdrawal by Subject|2
49316|NCT01536704|207324|P1|Washout Period 1|Withdrawal by Subject|1
49317|NCT01536587|207354|P1|Overall Study|Adverse Event|2
49318|NCT01536574|207393|P2|Overall Study|Lack of Efficacy|0
49319|NCT01536574|207394|P1|Overall Study|Lack of Efficacy|1
49320|NCT01536574|207393|P2|Overall Study|Withdrawal by Subject|2
49321|NCT01536574|207394|P1|Overall Study|Withdrawal by Subject|1
49322|NCT01536574|207393|P2|Overall Study|Adverse Event|5
49323|NCT01536574|207394|P1|Overall Study|Adverse Event|4
49324|NCT01536561|207412|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
49325|NCT01536561|207412|P1|Dosimetric and Therapeutic Treatment|Death|2
49326|NCT01536561|207412|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
49327|NCT01536561|207412|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
49328|NCT01536561|207412|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
49329|NCT01536561|207412|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
49330|NCT01536418|207489|P2|Overall Study|Withdrawal by Subject|3
49331|NCT01536418|207490|P1|Overall Study|Withdrawal by Subject|5
49332|NCT01536418|207489|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
49333|NCT01536418|207490|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
49334|NCT01536418|207489|P2|Overall Study|Adverse Event|4
49335|NCT01536418|207490|P1|Overall Study|Adverse Event|9
49336|NCT01536418|207489|P2|Overall Study|Lack of Efficacy|16
49337|NCT01536418|207490|P1|Overall Study|Lack of Efficacy|10
49338|NCT01536418|207489|P2|Overall Study|Study closed/terminated|37
49339|NCT01536418|207490|P1|Overall Study|Study closed/terminated|41
49340|NCT01536418|207489|P2|Overall Study|Physician Decision|3
49341|NCT01536418|207490|P1|Overall Study|Physician Decision|1
49342|NCT01536418|207489|P2|Overall Study|Protocol Violation|3
49343|NCT01536418|207490|P1|Overall Study|Protocol Violation|2
49344|NCT01536405|207510|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
49345|NCT01536405|207511|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
49346|NCT01536405|207510|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
49347|NCT01536405|207511|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
49348|NCT01536405|207510|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
49349|NCT01536405|207511|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
49350|NCT01536405|207510|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
49351|NCT01536405|207511|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
49352|NCT01536405|207510|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
49353|NCT01536405|207511|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
49354|NCT01536405|207510|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
49355|NCT01536405|207511|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
49356|NCT01536405|207510|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
49357|NCT01536405|207511|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
49358|NCT01536405|207510|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
49359|NCT01536405|207511|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
49360|NCT01536405|207510|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
49361|NCT01536405|207511|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
49362|NCT01536405|207510|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
49363|NCT01536405|207511|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
49364|NCT01536405|207510|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
49365|NCT01536405|207511|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
49366|NCT01536405|207510|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
49367|NCT01536405|207511|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
49368|NCT01536405|207510|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
49369|NCT01536405|207511|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
49370|NCT01536379|207549|P2|Overall Study|Withdrawal by Subject|1
49371|NCT01536379|207550|P1|Overall Study|Withdrawal by Subject|1
49372|NCT01536379|207549|P2|Overall Study|Adverse Event|2
49373|NCT01536379|207550|P1|Overall Study|Adverse Event|1
49374|NCT01536262|207642|P3|Overall Study|Other than stated above|0
49375|NCT01536262|207643|P2|Overall Study|Other than stated above|0
49376|NCT01536262|207644|P1|Overall Study|Other than stated above|1
49377|NCT01536262|207642|P3|Overall Study|Withdrawal by Subject|0
49378|NCT01536262|207643|P2|Overall Study|Withdrawal by Subject|1
49379|NCT01536262|207644|P1|Overall Study|Withdrawal by Subject|1
49380|NCT01536262|207642|P3|Overall Study|Adverse Event|2
49381|NCT01536262|207643|P2|Overall Study|Adverse Event|1
49382|NCT01536262|207644|P1|Overall Study|Adverse Event|6
49383|NCT01536171|207686|P1|Overall Study|Withdrawal by Subject|1
49384|NCT01536145|207691|P11|Overall Study|Adverse Event|3
49385|NCT01536145|207692|P10|Overall Study|Adverse Event|0
49386|NCT01536145|207693|P9|Overall Study|Adverse Event|0
49387|NCT01536145|207694|P8|Overall Study|Adverse Event|2
49388|NCT01536145|207695|P7|Overall Study|Adverse Event|0
49389|NCT01536145|207696|P6|Overall Study|Adverse Event|0
49390|NCT01536145|207697|P5|Overall Study|Adverse Event|0
49391|NCT01536145|207698|P4|Overall Study|Adverse Event|0
49392|NCT01536145|207699|P3|Overall Study|Adverse Event|0
49393|NCT01536145|207700|P2|Overall Study|Adverse Event|0
49394|NCT01536145|207701|P1|Overall Study|Adverse Event|0
49395|NCT01536145|207691|P11|Overall Study|Death|0
49396|NCT01536145|207692|P10|Overall Study|Death|0
49397|NCT01536145|207693|P9|Overall Study|Death|0
49398|NCT01536145|207694|P8|Overall Study|Death|0
49399|NCT01536145|207695|P7|Overall Study|Death|1
49400|NCT01536145|207696|P6|Overall Study|Death|0
49401|NCT01536145|207697|P5|Overall Study|Death|0
49402|NCT01536145|207698|P4|Overall Study|Death|0
49403|NCT01536145|207699|P3|Overall Study|Death|0
49404|NCT01536145|207700|P2|Overall Study|Death|0
49405|NCT01536145|207701|P1|Overall Study|Death|0
49406|NCT01536145|207691|P11|Overall Study|Other|2
49407|NCT01536145|207692|P10|Overall Study|Other|3
49408|NCT01536145|207693|P9|Overall Study|Other|0
49409|NCT01536145|207694|P8|Overall Study|Other|0
49410|NCT01536145|207695|P7|Overall Study|Other|0
49411|NCT01536145|207696|P6|Overall Study|Other|0
49412|NCT01536145|207697|P5|Overall Study|Other|1
49413|NCT01536145|207698|P4|Overall Study|Other|0
49414|NCT01536145|207699|P3|Overall Study|Other|0
49415|NCT01536145|207700|P2|Overall Study|Other|0
49416|NCT01536145|207701|P1|Overall Study|Other|0
49417|NCT01536145|207691|P11|Overall Study|Withdrawal by Subject|2
49418|NCT01536145|207692|P10|Overall Study|Withdrawal by Subject|0
49419|NCT01536145|207693|P9|Overall Study|Withdrawal by Subject|2
49420|NCT01536145|207694|P8|Overall Study|Withdrawal by Subject|0
49421|NCT01536145|207695|P7|Overall Study|Withdrawal by Subject|0
49422|NCT01536145|207696|P6|Overall Study|Withdrawal by Subject|1
49423|NCT01536145|207697|P5|Overall Study|Withdrawal by Subject|0
49424|NCT01536145|207698|P4|Overall Study|Withdrawal by Subject|0
49425|NCT01536145|207699|P3|Overall Study|Withdrawal by Subject|1
49426|NCT01536145|207700|P2|Overall Study|Withdrawal by Subject|0
49427|NCT01536145|207701|P1|Overall Study|Withdrawal by Subject|0
49428|NCT01536145|207691|P11|Overall Study|Progressive disease|3
49429|NCT01536145|207692|P10|Overall Study|Progressive disease|3
49430|NCT01536145|207693|P9|Overall Study|Progressive disease|1
49431|NCT01536145|207694|P8|Overall Study|Progressive disease|2
49432|NCT01536145|207695|P7|Overall Study|Progressive disease|1
49433|NCT01536145|207696|P6|Overall Study|Progressive disease|2
49434|NCT01536145|207697|P5|Overall Study|Progressive disease|1
49435|NCT01536145|207698|P4|Overall Study|Progressive disease|2
49436|NCT01536145|207699|P3|Overall Study|Progressive disease|1
49437|NCT01536145|207700|P2|Overall Study|Progressive disease|4
49438|NCT01536145|207701|P1|Overall Study|Progressive disease|3
49439|NCT01536119|207808|P2|Overall Study|Lost to Follow-up|14
49440|NCT01536119|207809|P1|Overall Study|Lost to Follow-up|17
49441|NCT01536093|207835|P2|Overall Study|Withdrawal by Subject|1
49442|NCT01536093|207836|P1|Overall Study|Withdrawal by Subject|0
49443|NCT01536093|207835|P2|Overall Study|absence of maternal colostrum|0
49444|NCT01536093|207836|P1|Overall Study|absence of maternal colostrum|2
49445|NCT01536093|207835|P2|Overall Study|Death|2
49446|NCT01536093|207836|P1|Overall Study|Death|1
49447|NCT01536067|207852|P1|Overall Study|Disease Progression|1
49448|NCT01536015|207865|P2|Overall Study|Study closure|5
49449|NCT01536015|207866|P1|Overall Study|Study closure|5
49450|NCT01536015|207865|P2|Overall Study|Inclusion Criterion not met|0
49451|NCT01536015|207866|P1|Overall Study|Inclusion Criterion not met|2
49452|NCT01536015|207865|P2|Overall Study|Lost to Follow-up|1
49453|NCT01536015|207866|P1|Overall Study|Lost to Follow-up|0
49454|NCT01536015|207865|P2|Overall Study|Adverse Event|4
49455|NCT01536015|207866|P1|Overall Study|Adverse Event|1
49456|NCT01535807|207893|P2|Overall Study|Data collection error|1
49457|NCT01535807|207894|P1|Overall Study|Data collection error|1
49458|NCT01535807|207893|P2|Overall Study|Withdrawal by Subject|1
49459|NCT01535807|207894|P1|Overall Study|Withdrawal by Subject|1
49460|NCT01535729|207900|P1|Overall Study|No participant record available|5
49461|NCT01535729|207900|P1|Overall Study|Not treated|9
49462|NCT01535729|207900|P1|Overall Study|Screening failure|1
49463|NCT01535729|207900|P1|Overall Study|Protocol Violation|11
49464|NCT01535729|207900|P1|Overall Study|NSCLC grade IV histology not confirmed|20
49465|NCT01535729|207900|P1|Overall Study|No previous chemotherapy|33
49466|NCT01535729|207900|P1|Overall Study|Did not sign informed consent|1
49467|NCT01535729|207900|P1|Overall Study|Other|19
49468|NCT01535729|207900|P1|Overall Study|Death|52
49469|NCT01535729|207900|P1|Overall Study|Lost to Follow-up|8
49470|NCT01535729|207900|P1|Overall Study|Discontinued treatment|25
49471|NCT01535729|207900|P1|Overall Study|Disease progression|230
49472|NCT01535729|207900|P1|Overall Study|Withdrawal by Subject|2
49473|NCT01535638|207941|P6|Treatment 3 (Single Dose)|Protocol Violation|0
49474|NCT01535638|207942|P5|Treatment 3 (Single Dose)|Protocol Violation|0
49475|NCT01535638|207943|P4|Treatment 3 (Single Dose)|Protocol Violation|1
49476|NCT01535638|207944|P3|Treatment 3 (Single Dose)|Protocol Violation|0
49477|NCT01535638|207945|P2|Treatment 3 (Single Dose)|Protocol Violation|0
49478|NCT01535638|207946|P1|Treatment 3 (Single Dose)|Protocol Violation|0
49479|NCT01535638|207941|P6|Treatment 1 (Single Dose)|Protocol Violation|1
49480|NCT01535638|207942|P5|Treatment 1 (Single Dose)|Protocol Violation|0
49481|NCT01535638|207943|P4|Treatment 1 (Single Dose)|Protocol Violation|0
49482|NCT01535638|207944|P3|Treatment 1 (Single Dose)|Protocol Violation|0
49483|NCT01535638|207945|P2|Treatment 1 (Single Dose)|Protocol Violation|0
49484|NCT01535638|207946|P1|Treatment 1 (Single Dose)|Protocol Violation|0
49485|NCT01535599|207960|P2|Overall Study|Noncompliance|1
49486|NCT01535599|207961|P1|Overall Study|Noncompliance|0
49487|NCT01535599|207960|P2|Overall Study|Stopped medication|1
49488|NCT01535599|207961|P1|Overall Study|Stopped medication|0
49489|NCT01535599|207960|P2|Overall Study|Other|0
49490|NCT01535599|207961|P1|Overall Study|Other|1
49491|NCT01535599|207960|P2|Overall Study|Did not use product|0
49492|NCT01535599|207961|P1|Overall Study|Did not use product|1
49493|NCT01535599|207960|P2|Overall Study|Randomized in Error|4
49494|NCT01535599|207961|P1|Overall Study|Randomized in Error|2
49495|NCT01535599|207960|P2|Overall Study|BL Culture + for Yeast//Fungi|1
49496|NCT01535599|207961|P1|Overall Study|BL Culture + for Yeast//Fungi|0
49497|NCT01535599|207960|P2|Overall Study|BL Culture + for Group A Strep|1
49498|NCT01535599|207961|P1|Overall Study|BL Culture + for Group A Strep|0
49499|NCT01535599|207960|P2|Overall Study|Treatment Failure|66
49500|NCT01535599|207961|P1|Overall Study|Treatment Failure|33
49501|NCT01535599|207960|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
49502|NCT01535599|207961|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
49503|NCT01535599|207960|P2|Overall Study|Lost to Follow-up|4
49504|NCT01535599|207961|P1|Overall Study|Lost to Follow-up|3
49505|NCT01535599|207960|P2|Overall Study|Adverse Event|15
49506|NCT01535599|207961|P1|Overall Study|Adverse Event|6
49507|NCT01535560|207973|P2|Overall Study|Randomized in Error|1
49508|NCT01535560|207974|P1|Overall Study|Randomized in Error|0
49509|NCT01535560|207973|P2|Overall Study|Other|1
49510|NCT01535560|207974|P1|Overall Study|Other|0
49511|NCT01535560|207973|P2|Overall Study|Treatment Failure|83
49512|NCT01535560|207974|P1|Overall Study|Treatment Failure|21
49513|NCT01535560|207973|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
49514|NCT01535560|207974|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
49515|NCT01535560|207973|P2|Overall Study|Lost to Follow-up|3
49516|NCT01535560|207974|P1|Overall Study|Lost to Follow-up|1
49517|NCT01535560|207973|P2|Overall Study|Adverse Event|7
49518|NCT01535560|207974|P1|Overall Study|Adverse Event|12
49519|NCT01535261|208017|P1|Overall Study|Adverse Event|12
49520|NCT01535261|208017|P1|Overall Study|Withdrawal by Subject|14
49521|NCT01535261|208017|P1|Overall Study|Lost to Follow-up|8
49522|NCT01535261|208017|P1|Overall Study|Death|5
49523|NCT01535261|208017|P1|Overall Study|Protocol Violation|3
49524|NCT01535261|208017|P1|Overall Study|Physician Decision|8
49525|NCT01535235|208030|P2|Overall Study|Adverse Event|0
49526|NCT01535235|208031|P1|Overall Study|Adverse Event|1
49527|NCT01535222|208045|P6|Overall Study|Inclusion/exclusion|0
49528|NCT01535222|208046|P5|Overall Study|Inclusion/exclusion|0
49529|NCT01535222|208047|P4|Overall Study|Inclusion/exclusion|0
49530|NCT01535222|208048|P3|Overall Study|Inclusion/exclusion|1
49531|NCT01535222|208049|P2|Overall Study|Inclusion/exclusion|0
49532|NCT01535222|208050|P1|Overall Study|Inclusion/exclusion|0
49533|NCT01535040|208081|P2|Overall Study|Multiple Reasons|1
49534|NCT01535040|208082|P1|Overall Study|Multiple Reasons|1
49535|NCT01535040|208081|P2|Overall Study|Toxicity|5
49536|NCT01535040|208082|P1|Overall Study|Toxicity|7
49537|NCT01535040|208081|P2|Overall Study|Never Started|4
49538|NCT01535040|208082|P1|Overall Study|Never Started|9
49539|NCT01535040|208081|P2|Overall Study|Withdrawal by Subject|10
49540|NCT01535040|208082|P1|Overall Study|Withdrawal by Subject|13
49541|NCT01535040|208081|P2|Overall Study|Physician Decision|1
49542|NCT01535040|208082|P1|Overall Study|Physician Decision|0
49543|NCT01534962|208140|P4|Overall Study|Discontinued at AF recurrence|31
49544|NCT01534962|208141|P3|Overall Study|Discontinued at AF recurrence|24
49545|NCT01534962|208142|P2|Overall Study|Discontinued at AF recurrence|26
49546|NCT01534962|208143|P1|Overall Study|Discontinued at AF recurrence|35
49547|NCT01534962|208140|P4|Overall Study|Randomized but did not start treatment|1
49548|NCT01534962|208141|P3|Overall Study|Randomized but did not start treatment|0
49549|NCT01534962|208142|P2|Overall Study|Randomized but did not start treatment|0
49550|NCT01534962|208143|P1|Overall Study|Randomized but did not start treatment|2
49551|NCT01534676|208200|P2|Overall Study|Study closed due to poor enrollment|1
49552|NCT01534676|208201|P1|Overall Study|Study closed due to poor enrollment|2
49553|NCT01534637|208207|P1|Overall Study|Liver Mets before treatment|1
49554|NCT01534637|208207|P1|Overall Study|Adverse Event|1
49555|NCT01534637|208207|P1|Overall Study|Withdrawal by Subject|1
49556|NCT01534637|208207|P1|Overall Study|Lack of Efficacy|3
49557|NCT01534637|208207|P1|Overall Study|Physician Decision|3
49558|NCT01534533|208217|P4|Overall Study|Withdrawal by Subject|1
49559|NCT01534533|208218|P3|Overall Study|Withdrawal by Subject|4
49560|NCT01534533|208219|P2|Overall Study|Withdrawal by Subject|3
49561|NCT01534533|208220|P1|Overall Study|Withdrawal by Subject|5
49562|NCT01534533|208217|P4|Overall Study|Lost to Follow-up|3
49563|NCT01534533|208218|P3|Overall Study|Lost to Follow-up|4
49564|NCT01534533|208219|P2|Overall Study|Lost to Follow-up|0
49565|NCT01534533|208220|P1|Overall Study|Lost to Follow-up|3
49566|NCT01534520|208248|P2|Overall Study|Adverse Event|1
49567|NCT01534520|208249|P1|Overall Study|Adverse Event|0
49568|NCT01534351|208283|P3|Overall Study|Study Terminated Early|0
49569|NCT01534351|208284|P2|Overall Study|Study Terminated Early|0
49570|NCT01534351|208285|P1|Overall Study|Study Terminated Early|1
49571|NCT01534208|208304|P2|Overall Study|Needed prohibited meds|0
49572|NCT01534208|208305|P1|Overall Study|Needed prohibited meds|1
49573|NCT01534208|208304|P2|Overall Study|PCP decision|0
49574|NCT01534208|208305|P1|Overall Study|PCP decision|1
49575|NCT01534208|208304|P2|Overall Study|Eligibility error|0
49576|NCT01534208|208305|P1|Overall Study|Eligibility error|3
49577|NCT01534208|208304|P2|Overall Study|Lab assessment|1
49578|NCT01534208|208305|P1|Overall Study|Lab assessment|2
49579|NCT01534208|208304|P2|Overall Study|Subject relocation|0
49580|NCT01534208|208305|P1|Overall Study|Subject relocation|2
49581|NCT01534208|208304|P2|Overall Study|Sponsor decision|1
49582|NCT01534208|208305|P1|Overall Study|Sponsor decision|4
49583|NCT01534208|208304|P2|Overall Study|Protocol Violation|2
49584|NCT01534208|208305|P1|Overall Study|Protocol Violation|2
49585|NCT01534208|208304|P2|Overall Study|Lack of Efficacy|3
49586|NCT01534208|208305|P1|Overall Study|Lack of Efficacy|0
49587|NCT01534208|208304|P2|Overall Study|Physician Decision|0
49588|NCT01534208|208305|P1|Overall Study|Physician Decision|2
49589|NCT01534208|208304|P2|Overall Study|Adverse Event|8
49590|NCT01534208|208305|P1|Overall Study|Adverse Event|15
49591|NCT01534208|208304|P2|Overall Study|Withdrawal by Subject|20
49592|NCT01534208|208305|P1|Overall Study|Withdrawal by Subject|6
49593|NCT01534208|208304|P2|Overall Study|Lost to Follow-up|14
49594|NCT01534208|208305|P1|Overall Study|Lost to Follow-up|19
49595|NCT01534182|208323|P2|Overall Study|Adverse Event|3
49596|NCT01534182|208324|P1|Overall Study|Adverse Event|7
49597|NCT01534182|208323|P2|Overall Study|Withdrawal by Subject|7
49598|NCT01534182|208324|P1|Overall Study|Withdrawal by Subject|4
49599|NCT01534182|208323|P2|Overall Study|Administrative problems|0
49600|NCT01534182|208324|P1|Overall Study|Administrative problems|1
49601|NCT01534078|208355|P1|Overall Study|Withdrawal by Subject|1
49602|NCT01534078|208355|P1|Overall Study|Death|1
49603|NCT01533935|208383|P5|Overall Study|Other reason not defined above|1
49604|NCT01533935|208384|P4|Overall Study|Other reason not defined above|0
49605|NCT01533935|208385|P3|Overall Study|Other reason not defined above|1
49606|NCT01533935|208386|P2|Overall Study|Other reason not defined above|0
49607|NCT01533935|208387|P1|Overall Study|Other reason not defined above|1
49608|NCT01533935|208383|P5|Overall Study|Withdrawal by Subject|4
49609|NCT01533935|208384|P4|Overall Study|Withdrawal by Subject|2
49610|NCT01533935|208385|P3|Overall Study|Withdrawal by Subject|5
49611|NCT01533935|208386|P2|Overall Study|Withdrawal by Subject|4
49612|NCT01533935|208387|P1|Overall Study|Withdrawal by Subject|0
49613|NCT01533935|208383|P5|Overall Study|Lost to Follow-up|0
49614|NCT01533935|208384|P4|Overall Study|Lost to Follow-up|0
49615|NCT01533935|208385|P3|Overall Study|Lost to Follow-up|1
49616|NCT01533935|208386|P2|Overall Study|Lost to Follow-up|0
49617|NCT01533935|208387|P1|Overall Study|Lost to Follow-up|0
49618|NCT01533935|208383|P5|Overall Study|Protocol Violation|0
49619|NCT01533935|208384|P4|Overall Study|Protocol Violation|0
49620|NCT01533935|208385|P3|Overall Study|Protocol Violation|0
49621|NCT01533935|208386|P2|Overall Study|Protocol Violation|2
49622|NCT01533935|208387|P1|Overall Study|Protocol Violation|0
49623|NCT01533935|208383|P5|Overall Study|Adverse Event|3
49624|NCT01533935|208384|P4|Overall Study|Adverse Event|5
49625|NCT01533935|208385|P3|Overall Study|Adverse Event|1
49626|NCT01533935|208386|P2|Overall Study|Adverse Event|7
49627|NCT01533935|208387|P1|Overall Study|Adverse Event|5
49628|NCT01533922|208414|P5|Overall Study|Other reason not defined above|0
49629|NCT01533922|208415|P4|Overall Study|Other reason not defined above|0
49630|NCT01533922|208416|P3|Overall Study|Other reason not defined above|1
49631|NCT01533922|208417|P2|Overall Study|Other reason not defined above|0
49632|NCT01533922|208418|P1|Overall Study|Other reason not defined above|2
49633|NCT01533922|208414|P5|Overall Study|Withdrawal by Subject|1
49634|NCT01533922|208415|P4|Overall Study|Withdrawal by Subject|2
49635|NCT01533922|208416|P3|Overall Study|Withdrawal by Subject|2
49636|NCT01533922|208417|P2|Overall Study|Withdrawal by Subject|1
49637|NCT01533922|208418|P1|Overall Study|Withdrawal by Subject|3
49638|NCT01533922|208414|P5|Overall Study|Protocol Violation|1
49639|NCT01533922|208415|P4|Overall Study|Protocol Violation|0
49640|NCT01533922|208416|P3|Overall Study|Protocol Violation|0
49641|NCT01533922|208417|P2|Overall Study|Protocol Violation|3
49642|NCT01533922|208418|P1|Overall Study|Protocol Violation|0
49643|NCT01533922|208414|P5|Overall Study|Lack of Efficacy|0
49644|NCT01533922|208415|P4|Overall Study|Lack of Efficacy|0
49645|NCT01533922|208416|P3|Overall Study|Lack of Efficacy|1
49646|NCT01533922|208417|P2|Overall Study|Lack of Efficacy|0
49647|NCT01533922|208418|P1|Overall Study|Lack of Efficacy|0
49648|NCT01533922|208414|P5|Overall Study|Adverse Event|4
49649|NCT01533922|208415|P4|Overall Study|Adverse Event|3
49650|NCT01533922|208416|P3|Overall Study|Adverse Event|6
49651|NCT01533922|208417|P2|Overall Study|Adverse Event|8
49652|NCT01533922|208418|P1|Overall Study|Adverse Event|5
49653|NCT01533493|208481|P2|Overall Study|Lost to Follow-up|0
49654|NCT01533493|208482|P1|Overall Study|Lost to Follow-up|2
49655|NCT01533493|208481|P2|Overall Study|Withdrawal by Subject|2
49656|NCT01533493|208482|P1|Overall Study|Withdrawal by Subject|1
49657|NCT01533493|208481|P2|Overall Study|Adverse Event|1
49658|NCT01533493|208482|P1|Overall Study|Adverse Event|2
49659|NCT01533428|208490|P2|Overall Study|Withdrawal by Subject|6
49660|NCT01533428|208491|P1|Overall Study|Withdrawal by Subject|7
49661|NCT01533428|208490|P2|Overall Study|Lost to Follow-up|1
49662|NCT01533428|208491|P1|Overall Study|Lost to Follow-up|2
49663|NCT01533428|208490|P2|Overall Study|Adverse Event|1
49664|NCT01533428|208491|P1|Overall Study|Adverse Event|0
49665|NCT01533246|208537|P1|Overall Study|Withdrawal by Subject|1
49666|NCT01533246|208537|P1|Overall Study|Adverse Event|1
49667|NCT01533181|208548|P2|Overall Study|Patient withdrawal pre-active treatment|0
49668|NCT01533181|208549|P1|Overall Study|Patient withdrawal pre-active treatment|1
49669|NCT01533181|208548|P2|Overall Study|Disease progression pre-active treatment|1
49670|NCT01533181|208549|P1|Overall Study|Disease progression pre-active treatment|0
49671|NCT01532999|208666|P2|Overall Study|New job|2
49672|NCT01532999|208667|P1|Overall Study|New job|0
49673|NCT01532999|208666|P2|Overall Study|incarcerated|1
49674|NCT01532999|208667|P1|Overall Study|incarcerated|0
49675|NCT01532999|208666|P2|Overall Study|Adverse Event|1
49676|NCT01532999|208667|P1|Overall Study|Adverse Event|0
49677|NCT01532999|208666|P2|Overall Study|no show for week 9 assessments|4
49678|NCT01532999|208667|P1|Overall Study|no show for week 9 assessments|6
49679|NCT01532999|208666|P2|Overall Study|substantial noncompliance|0
49680|NCT01532999|208667|P1|Overall Study|substantial noncompliance|2
49681|NCT01532999|208666|P2|Overall Study|should not have been randomized|0
49682|NCT01532999|208667|P1|Overall Study|should not have been randomized|1
49683|NCT01532999|208666|P2|Overall Study|Relocated|0
49684|NCT01532999|208667|P1|Overall Study|Relocated|2
49685|NCT01532999|208666|P2|Overall Study|Withdrawal by Subject|0
49686|NCT01532999|208667|P1|Overall Study|Withdrawal by Subject|5
49687|NCT01532999|208666|P2|Overall Study|Physician Decision|2
49688|NCT01532999|208667|P1|Overall Study|Physician Decision|1
49689|NCT01532999|208666|P2|Overall Study|Lost to Follow-up|8
49690|NCT01532999|208667|P1|Overall Study|Lost to Follow-up|14
49691|NCT01532934|208749|P2|Overall Study|In controlled environment|2
49692|NCT01532934|208750|P1|Overall Study|In controlled environment|3
49693|NCT01532934|208749|P2|Overall Study|Lost to Follow-up|11
49694|NCT01532934|208750|P1|Overall Study|Lost to Follow-up|11
49695|NCT01532869|208762|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
49696|NCT01532869|208763|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
49697|NCT01532869|208762|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
49698|NCT01532869|208763|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
49699|NCT01532869|208762|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
49700|NCT01532869|208763|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
49701|NCT01532869|208762|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
49702|NCT01532869|208763|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
49703|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
49704|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
49705|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
49706|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
49707|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
49708|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
49709|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
49710|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
49711|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
49712|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
49713|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
49714|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
49715|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
49716|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
49717|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
49718|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
49719|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
49720|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
49721|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
49722|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
49723|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
49724|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
49725|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
49726|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
49727|NCT01532869|208762|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
49728|NCT01532869|208763|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
49729|NCT01532570|208829|P4|Overall Study|Withdrawal by Subject|0
49730|NCT01532570|208830|P3|Overall Study|Withdrawal by Subject|0
49731|NCT01532570|208831|P2|Overall Study|Withdrawal by Subject|1
49732|NCT01532570|208832|P1|Overall Study|Withdrawal by Subject|0
49733|NCT01532570|208829|P4|Overall Study|Lack of Efficacy|0
49734|NCT01532570|208830|P3|Overall Study|Lack of Efficacy|0
49735|NCT01532570|208831|P2|Overall Study|Lack of Efficacy|0
49736|NCT01532570|208832|P1|Overall Study|Lack of Efficacy|1
49737|NCT01532414|208877|P3|Overall Study|Withdrawn by sponsor|0
49738|NCT01532414|208878|P2|Overall Study|Withdrawn by sponsor|0
49739|NCT01532414|208879|P1|Overall Study|Withdrawn by sponsor|1
49740|NCT01532414|208877|P3|Overall Study|Unable to complete 24 hour PK|1
49741|NCT01532414|208878|P2|Overall Study|Unable to complete 24 hour PK|0
49742|NCT01532414|208879|P1|Overall Study|Unable to complete 24 hour PK|0
49743|NCT01532414|208877|P3|Overall Study|Adverse Event|1
49744|NCT01532414|208878|P2|Overall Study|Adverse Event|1
49745|NCT01532414|208879|P1|Overall Study|Adverse Event|0
49746|NCT01532414|208877|P3|Overall Study|No V6 semen sample|0
49747|NCT01532414|208878|P2|Overall Study|No V6 semen sample|1
49748|NCT01532414|208879|P1|Overall Study|No V6 semen sample|0
49749|NCT01532414|208877|P3|Overall Study|Withdrawal by Subject|0
49750|NCT01532414|208878|P2|Overall Study|Withdrawal by Subject|0
49751|NCT01532414|208879|P1|Overall Study|Withdrawal by Subject|3
49752|NCT01532414|208877|P3|Overall Study|Lost to Follow-up|1
49753|NCT01532414|208878|P2|Overall Study|Lost to Follow-up|0
49754|NCT01532414|208879|P1|Overall Study|Lost to Follow-up|3
49755|NCT01531998|208945|P1|Overall Study|Withdrawal by Subject|3
49756|NCT01531725|208950|P1|Overall Study|Protocol Violation|5
49757|NCT01531673|208968|P13|Overall Study|Other|0
49758|NCT01531673|208969|P12|Overall Study|Other|0
49759|NCT01531673|208970|P11|Overall Study|Other|0
49760|NCT01531673|208971|P10|Overall Study|Other|1
49761|NCT01531673|208972|P9|Overall Study|Other|0
49762|NCT01531673|208973|P8|Overall Study|Other|0
49763|NCT01531673|208974|P7|Overall Study|Other|0
49764|NCT01531673|208975|P6|Overall Study|Other|0
49765|NCT01531673|208976|P5|Overall Study|Other|0
49766|NCT01531673|208977|P4|Overall Study|Other|1
49767|NCT01531673|208978|P3|Overall Study|Other|0
49768|NCT01531673|208979|P2|Overall Study|Other|0
49769|NCT01531673|208980|P1|Overall Study|Other|0
49770|NCT01531673|208968|P13|Overall Study|Lost to Follow-up|0
49771|NCT01531673|208969|P12|Overall Study|Lost to Follow-up|0
49772|NCT01531673|208970|P11|Overall Study|Lost to Follow-up|0
49773|NCT01531673|208971|P10|Overall Study|Lost to Follow-up|0
49774|NCT01531673|208972|P9|Overall Study|Lost to Follow-up|0
49775|NCT01531673|208973|P8|Overall Study|Lost to Follow-up|0
49776|NCT01531673|208974|P7|Overall Study|Lost to Follow-up|0
49777|NCT01531673|208975|P6|Overall Study|Lost to Follow-up|0
49778|NCT01531673|208976|P5|Overall Study|Lost to Follow-up|1
49779|NCT01531673|208977|P4|Overall Study|Lost to Follow-up|0
49780|NCT01531673|208978|P3|Overall Study|Lost to Follow-up|0
49781|NCT01531673|208979|P2|Overall Study|Lost to Follow-up|0
49782|NCT01531673|208980|P1|Overall Study|Lost to Follow-up|0
49783|NCT01531673|208968|P13|Overall Study|Adverse Event|0
49784|NCT01531673|208969|P12|Overall Study|Adverse Event|0
49785|NCT01531673|208970|P11|Overall Study|Adverse Event|0
49786|NCT01531673|208971|P10|Overall Study|Adverse Event|0
49787|NCT01531673|208972|P9|Overall Study|Adverse Event|0
49788|NCT01531673|208973|P8|Overall Study|Adverse Event|0
49789|NCT01531673|208974|P7|Overall Study|Adverse Event|0
49790|NCT01531673|208975|P6|Overall Study|Adverse Event|0
49791|NCT01531673|208976|P5|Overall Study|Adverse Event|0
49792|NCT01531673|208977|P4|Overall Study|Adverse Event|0
49793|NCT01531673|208978|P3|Overall Study|Adverse Event|0
49794|NCT01531673|208979|P2|Overall Study|Adverse Event|1
49795|NCT01531673|208980|P1|Overall Study|Adverse Event|0
49796|NCT01531673|208968|P13|Overall Study|Non-Compliance|0
49797|NCT01531673|208969|P12|Overall Study|Non-Compliance|0
49798|NCT01531673|208970|P11|Overall Study|Non-Compliance|0
49799|NCT01531673|208971|P10|Overall Study|Non-Compliance|0
49800|NCT01531673|208972|P9|Overall Study|Non-Compliance|0
49801|NCT01531673|208973|P8|Overall Study|Non-Compliance|0
49802|NCT01531673|208974|P7|Overall Study|Non-Compliance|0
49803|NCT01531673|208975|P6|Overall Study|Non-Compliance|1
49804|NCT01531673|208976|P5|Overall Study|Non-Compliance|0
49805|NCT01531673|208977|P4|Overall Study|Non-Compliance|0
49806|NCT01531673|208978|P3|Overall Study|Non-Compliance|0
49807|NCT01531673|208979|P2|Overall Study|Non-Compliance|0
49808|NCT01531673|208980|P1|Overall Study|Non-Compliance|0
49809|NCT01531387|209091|P2|Overall Study|Early termination of study|11
49810|NCT01531387|209092|P1|Overall Study|Early termination of study|11
49811|NCT01531205|209184|P1|Overall Study|Did not proceed to surgery|1
49812|NCT01530997|209193|P1|Overall Study|Withdrawal by Subject|1
49813|NCT01530997|209193|P1|Overall Study|Physician Decision|1
49814|NCT01530464|209237|P2|Washout (24h)|Withdrawal by Subject|1
49815|NCT01530464|209238|P1|Washout (24h)|Withdrawal by Subject|0
49816|NCT01530464|209237|P2|Washout (24h)|Withdrawal by Subject|0
49817|NCT01530464|209238|P1|Washout (24h)|Withdrawal by Subject|1
49818|NCT01530334|209290|P1|Overall Study|Progressive disease|47
49819|NCT01530334|209290|P1|Overall Study|unknown reason|1
49820|NCT01530334|209290|P1|Overall Study|Adverse Event|3
49821|NCT01530087|209324|P1|Overall Study|Physician Decision|2
49822|NCT01529645|209346|P10|Overall Study|Withdrawal by Subject|0
49823|NCT01529645|209347|P9|Overall Study|Withdrawal by Subject|0
49824|NCT01529645|209348|P8|Overall Study|Withdrawal by Subject|0
49825|NCT01529645|209349|P7|Overall Study|Withdrawal by Subject|0
49826|NCT01529645|209350|P6|Overall Study|Withdrawal by Subject|1
49827|NCT01529645|209351|P5|Overall Study|Withdrawal by Subject|1
49828|NCT01529645|209352|P4|Overall Study|Withdrawal by Subject|1
49829|NCT01529645|209353|P3|Overall Study|Withdrawal by Subject|0
49830|NCT01529645|209354|P2|Overall Study|Withdrawal by Subject|0
49831|NCT01529645|209355|P1|Overall Study|Withdrawal by Subject|2
49832|NCT01529645|209346|P10|Overall Study|SAE - Premature contractions|0
49833|NCT01529645|209347|P9|Overall Study|SAE - Premature contractions|0
49834|NCT01529645|209348|P8|Overall Study|SAE - Premature contractions|0
49835|NCT01529645|209349|P7|Overall Study|SAE - Premature contractions|0
49836|NCT01529645|209350|P6|Overall Study|SAE - Premature contractions|0
49837|NCT01529645|209351|P5|Overall Study|SAE - Premature contractions|0
49838|NCT01529645|209352|P4|Overall Study|SAE - Premature contractions|0
49839|NCT01529645|209353|P3|Overall Study|SAE - Premature contractions|1
49840|NCT01529645|209354|P2|Overall Study|SAE - Premature contractions|0
49841|NCT01529645|209355|P1|Overall Study|SAE - Premature contractions|0
49842|NCT01529645|209346|P10|Overall Study|Lost to Follow-up|0
49843|NCT01529645|209347|P9|Overall Study|Lost to Follow-up|1
49844|NCT01529645|209348|P8|Overall Study|Lost to Follow-up|0
49845|NCT01529645|209349|P7|Overall Study|Lost to Follow-up|2
49846|NCT01529645|209350|P6|Overall Study|Lost to Follow-up|0
49847|NCT01529645|209351|P5|Overall Study|Lost to Follow-up|1
49848|NCT01529645|209352|P4|Overall Study|Lost to Follow-up|1
49849|NCT01529645|209353|P3|Overall Study|Lost to Follow-up|1
49850|NCT01529645|209354|P2|Overall Study|Lost to Follow-up|1
49851|NCT01529645|209355|P1|Overall Study|Lost to Follow-up|0
49852|NCT01529632|209453|P2|Overall Study|Adverse Event|1
49853|NCT01529632|209454|P1|Overall Study|Adverse Event|1
49854|NCT01529632|209453|P2|Overall Study|Protocol Violation|1
49855|NCT01529632|209454|P1|Overall Study|Protocol Violation|0
49856|NCT01529632|209453|P2|Overall Study|Administrative problem|1
49857|NCT01529632|209454|P1|Overall Study|Administrative problem|2
49858|NCT01529515|209474|P4|DOUBLE BLIND PHASE|Other|2
49859|NCT01529515|209475|P3|DOUBLE BLIND PHASE|Other|9
49860|NCT01529515|209476|P2|DOUBLE BLIND PHASE|Other|0
49861|NCT01529515|209477|P1|DOUBLE BLIND PHASE|Other|0
49862|NCT01529515|209474|P4|DOUBLE BLIND PHASE|Protocol Violation|0
49863|NCT01529515|209475|P3|DOUBLE BLIND PHASE|Protocol Violation|1
49864|NCT01529515|209476|P2|DOUBLE BLIND PHASE|Protocol Violation|0
49865|NCT01529515|209477|P1|DOUBLE BLIND PHASE|Protocol Violation|0
49866|NCT01529515|209474|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
49867|NCT01529515|209475|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
49868|NCT01529515|209476|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
49869|NCT01529515|209477|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
49870|NCT01529515|209474|P4|DOUBLE BLIND PHASE|Pregnancy|0
49871|NCT01529515|209475|P3|DOUBLE BLIND PHASE|Pregnancy|1
49872|NCT01529515|209476|P2|DOUBLE BLIND PHASE|Pregnancy|0
49873|NCT01529515|209477|P1|DOUBLE BLIND PHASE|Pregnancy|0
49874|NCT01529515|209474|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
49875|NCT01529515|209475|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
49876|NCT01529515|209476|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
49877|NCT01529515|209477|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
49878|NCT01529515|209474|P4|DOUBLE BLIND PHASE|Adverse Event|0
49879|NCT01529515|209475|P3|DOUBLE BLIND PHASE|Adverse Event|1
49880|NCT01529515|209476|P2|DOUBLE BLIND PHASE|Adverse Event|0
49881|NCT01529515|209477|P1|DOUBLE BLIND PHASE|Adverse Event|0
49882|NCT01529515|209474|P4|MAINTENANCE PHASE|Other|0
49883|NCT01529515|209475|P3|MAINTENANCE PHASE|Other|0
49884|NCT01529515|209476|P2|MAINTENANCE PHASE|Other|10
49885|NCT01529515|209477|P1|MAINTENANCE PHASE|Other|0
49886|NCT01529515|209474|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
49887|NCT01529515|209475|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
49888|NCT01529515|209476|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
49889|NCT01529515|209477|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
49890|NCT01529515|209474|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
49891|NCT01529515|209475|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
49892|NCT01529515|209476|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
49893|NCT01529515|209477|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
49894|NCT01529515|209474|P4|MAINTENANCE PHASE|Protocol Violation|0
49895|NCT01529515|209475|P3|MAINTENANCE PHASE|Protocol Violation|0
49896|NCT01529515|209476|P2|MAINTENANCE PHASE|Protocol Violation|12
49897|NCT01529515|209477|P1|MAINTENANCE PHASE|Protocol Violation|0
49898|NCT01529515|209474|P4|MAINTENANCE PHASE|Lost to Follow-up|0
49899|NCT01529515|209475|P3|MAINTENANCE PHASE|Lost to Follow-up|0
49900|NCT01529515|209476|P2|MAINTENANCE PHASE|Lost to Follow-up|5
49901|NCT01529515|209477|P1|MAINTENANCE PHASE|Lost to Follow-up|0
49902|NCT01529515|209474|P4|MAINTENANCE PHASE|Lack of Efficacy|0
49903|NCT01529515|209475|P3|MAINTENANCE PHASE|Lack of Efficacy|0
49904|NCT01529515|209476|P2|MAINTENANCE PHASE|Lack of Efficacy|9
49905|NCT01529515|209477|P1|MAINTENANCE PHASE|Lack of Efficacy|0
49906|NCT01529515|209474|P4|MAINTENANCE PHASE|Adverse Event|0
49907|NCT01529515|209475|P3|MAINTENANCE PHASE|Adverse Event|0
49908|NCT01529515|209476|P2|MAINTENANCE PHASE|Adverse Event|10
49909|NCT01529515|209477|P1|MAINTENANCE PHASE|Adverse Event|0
49910|NCT01529515|209474|P4|TRANSITION PHASE|Other|0
49911|NCT01529515|209475|P3|TRANSITION PHASE|Other|0
49912|NCT01529515|209476|P2|TRANSITION PHASE|Other|0
49913|NCT01529515|209477|P1|TRANSITION PHASE|Other|9
49914|NCT01529515|209474|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
49915|NCT01529515|209475|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
49916|NCT01529515|209476|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
49917|NCT01529515|209477|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
49918|NCT01529515|209474|P4|TRANSITION PHASE|Withdrawal by Subject|0
49919|NCT01529515|209475|P3|TRANSITION PHASE|Withdrawal by Subject|0
49920|NCT01529515|209476|P2|TRANSITION PHASE|Withdrawal by Subject|0
49921|NCT01529515|209477|P1|TRANSITION PHASE|Withdrawal by Subject|51
49922|NCT01529515|209474|P4|TRANSITION PHASE|Protocol Violation|0
49923|NCT01529515|209475|P3|TRANSITION PHASE|Protocol Violation|0
49924|NCT01529515|209476|P2|TRANSITION PHASE|Protocol Violation|0
49925|NCT01529515|209477|P1|TRANSITION PHASE|Protocol Violation|4
49926|NCT01529515|209474|P4|TRANSITION PHASE|Lost to Follow-up|0
49927|NCT01529515|209475|P3|TRANSITION PHASE|Lost to Follow-up|0
49928|NCT01529515|209476|P2|TRANSITION PHASE|Lost to Follow-up|0
49929|NCT01529515|209477|P1|TRANSITION PHASE|Lost to Follow-up|19
49930|NCT01529515|209474|P4|TRANSITION PHASE|Lack of Efficacy|0
49931|NCT01529515|209475|P3|TRANSITION PHASE|Lack of Efficacy|0
49932|NCT01529515|209476|P2|TRANSITION PHASE|Lack of Efficacy|0
49933|NCT01529515|209477|P1|TRANSITION PHASE|Lack of Efficacy|19
49934|NCT01529515|209474|P4|TRANSITION PHASE|Death|0
49935|NCT01529515|209475|P3|TRANSITION PHASE|Death|0
49936|NCT01529515|209476|P2|TRANSITION PHASE|Death|0
49937|NCT01529515|209477|P1|TRANSITION PHASE|Death|1
49938|NCT01529515|209474|P4|TRANSITION PHASE|Adverse Event|0
49939|NCT01529515|209475|P3|TRANSITION PHASE|Adverse Event|0
49940|NCT01529515|209476|P2|TRANSITION PHASE|Adverse Event|0
49941|NCT01529515|209477|P1|TRANSITION PHASE|Adverse Event|16
49942|NCT01529385|209524|P2|Overall Study|Lost to Follow-up|1
49943|NCT01529385|209525|P1|Overall Study|Lost to Follow-up|2
49944|NCT01529268|209551|P2|Overall Study|Moved|0
49945|NCT01529268|209552|P1|Overall Study|Moved|3
49946|NCT01529268|209551|P2|Overall Study|Lost to Follow-up|3
49947|NCT01529268|209552|P1|Overall Study|Lost to Follow-up|9
49948|NCT01529112|209614|P2|Overall Study|Withdrawal by Subject|3
49949|NCT01529112|209615|P1|Overall Study|Withdrawal by Subject|7
49950|NCT01529112|209614|P2|Overall Study|Protocol Violation|0
49951|NCT01529112|209615|P1|Overall Study|Protocol Violation|1
49952|NCT01529112|209614|P2|Overall Study|Death|38
49953|NCT01529112|209615|P1|Overall Study|Death|59
49954|NCT01529112|209614|P2|Overall Study|Adverse Event|0
49955|NCT01529112|209615|P1|Overall Study|Adverse Event|2
49956|NCT01528969|209642|P2|Overall Study|absent from the school at baseline|0
49957|NCT01528969|209643|P1|Overall Study|absent from the school at baseline|2
49958|NCT01528787|209679|P4|Overall Study|Family Emergency|0
49959|NCT01528787|209680|P3|Overall Study|Family Emergency|1
49960|NCT01528787|209681|P2|Overall Study|Family Emergency|0
49961|NCT01528787|209682|P1|Overall Study|Family Emergency|0
49962|NCT01528787|209679|P4|Overall Study|Withdrawal by Subject|1
49963|NCT01528787|209680|P3|Overall Study|Withdrawal by Subject|0
49964|NCT01528787|209681|P2|Overall Study|Withdrawal by Subject|0
49965|NCT01528787|209682|P1|Overall Study|Withdrawal by Subject|0
49966|NCT01528735|209694|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
49967|NCT01528735|209695|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
49968|NCT01528735|209694|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
49969|NCT01528735|209695|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
49970|NCT01528696|209797|P2|Overall Study|See detailed description|19
49971|NCT01528696|209798|P1|Overall Study|See detailed description|18
49972|NCT01528605|209814|P6|Overall Study|Death|0
49973|NCT01528605|209815|P5|Overall Study|Death|0
49974|NCT01528605|209816|P4|Overall Study|Death|0
49975|NCT01528605|209817|P3|Overall Study|Death|0
49976|NCT01528605|209818|P2|Overall Study|Death|0
49977|NCT01528605|209819|P1|Overall Study|Death|1
49978|NCT01528605|209814|P6|Overall Study|Lost to Follow-up|0
49979|NCT01528605|209815|P5|Overall Study|Lost to Follow-up|0
49980|NCT01528605|209816|P4|Overall Study|Lost to Follow-up|1
49981|NCT01528605|209817|P3|Overall Study|Lost to Follow-up|1
49982|NCT01528605|209818|P2|Overall Study|Lost to Follow-up|0
49983|NCT01528605|209819|P1|Overall Study|Lost to Follow-up|1
49984|NCT01528345|209849|P2|Overall Study|Subject/Guardian Decision|0
49985|NCT01528345|209850|P1|Overall Study|Subject/Guardian Decision|5
49986|NCT01528345|209849|P2|Overall Study|Study Terminated by Sponsor|8
49987|NCT01528345|209850|P1|Overall Study|Study Terminated by Sponsor|4
49988|NCT01528345|209849|P2|Overall Study|Progressive Disease|40
49989|NCT01528345|209850|P1|Overall Study|Progressive Disease|26
49990|NCT01528345|209849|P2|Overall Study|Non-compliance with study treatment|0
49991|NCT01528345|209850|P1|Overall Study|Non-compliance with study treatment|1
49992|NCT01528345|209849|P2|Overall Study|Death|1
49993|NCT01528345|209850|P1|Overall Study|Death|1
49994|NCT01528345|209849|P2|Overall Study|Adverse Event|1
49995|NCT01528345|209850|P1|Overall Study|Adverse Event|10
49996|NCT01527487|209940|P2|Overall Study|Death|1
49997|NCT01527487|209941|P1|Overall Study|Death|0
49998|NCT01527487|209940|P2|Overall Study|Adverse Event|1
49999|NCT01527487|209941|P1|Overall Study|Adverse Event|1
50000|NCT01527487|209940|P2|Overall Study|Disease Progression|1
50001|NCT01527487|209941|P1|Overall Study|Disease Progression|4
50002|NCT01527487|209940|P2|Overall Study|MD Discretion/Lack of Efficacy|4
50003|NCT01527487|209941|P1|Overall Study|MD Discretion/Lack of Efficacy|3
50004|NCT01527370|209953|P1|Overall Study|Death|1
50005|NCT01527370|209953|P1|Overall Study|Physician Decision|1
50006|NCT01527370|209953|P1|Overall Study|Withdrawal by Subject|4
50007|NCT01527110|209970|P1|Overall Study|Adverse Event|1
50008|NCT01527006|210017|P2|Extension Phase|Not Specified|3
50009|NCT01527006|210018|P1|Extension Phase|Not Specified|0
50010|NCT01527006|210017|P2|Extension Phase|Inadequate therapeutic effect|1
50011|NCT01527006|210018|P1|Extension Phase|Inadequate therapeutic effect|1
50012|NCT01527006|210017|P2|Extension Phase|Subject Choice|1
50013|NCT01527006|210018|P1|Extension Phase|Subject Choice|1
50014|NCT01527006|210017|P2|Extension Phase|Lost to Follow-up|1
50015|NCT01527006|210018|P1|Extension Phase|Lost to Follow-up|0
50016|NCT01527006|210017|P2|Extension Phase|Adverse Event|2
50017|NCT01527006|210018|P1|Extension Phase|Adverse Event|4
50018|NCT01527006|210017|P2|Core Study|Not Specified|2
50019|NCT01527006|210018|P1|Core Study|Not Specified|0
50020|NCT01527006|210017|P2|Core Study|Withdrawal by Subject|1
50021|NCT01527006|210018|P1|Core Study|Withdrawal by Subject|0
50022|NCT01527006|210017|P2|Core Study|Inadequate Therapeutic Effect|0
50023|NCT01527006|210018|P1|Core Study|Inadequate Therapeutic Effect|1
50024|NCT01527006|210017|P2|Core Study|Subject Choice|0
50025|NCT01527006|210018|P1|Core Study|Subject Choice|1
50026|NCT01527006|210017|P2|Core Study|Lost to Follow-up|1
50027|NCT01527006|210018|P1|Core Study|Lost to Follow-up|0
50028|NCT01527006|210017|P2|Core Study|Adverse Event|2
50029|NCT01527006|210018|P1|Core Study|Adverse Event|0
50030|NCT01526785|210085|P1|Overall Study|Withdrawal by Subject|2
50031|NCT01526785|210085|P1|Overall Study|Physician Decision|1
50032|NCT01526785|210085|P1|Overall Study|Death|2
50033|NCT01526785|210085|P1|Overall Study|Study Terminated by Sponsor|8
50034|NCT01526733|210095|P2|Phase 1|Withdrawal by Subject|1
50035|NCT01526733|210096|P1|Phase 1|Withdrawal by Subject|1
50036|NCT01526733|210095|P2|Phase 1|Protocol Violation|0
50037|NCT01526733|210096|P1|Phase 1|Protocol Violation|1
50038|NCT01526551|210118|P1|Overall Study|Lack of returned parental consent form|424
50039|NCT01526148|210165|P2|Overall Study|Incarcerated|2
50040|NCT01526148|210166|P1|Overall Study|Incarcerated|0
50041|NCT01526148|210165|P2|Overall Study|Moved out of state|0
50042|NCT01526148|210166|P1|Overall Study|Moved out of state|1
50043|NCT01526148|210165|P2|Overall Study|Unable to discontinue concomitant med|0
50044|NCT01526148|210166|P1|Overall Study|Unable to discontinue concomitant med|1
50045|NCT01526148|210165|P2|Overall Study|Unstable Medical Condition|0
50046|NCT01526148|210166|P1|Overall Study|Unstable Medical Condition|1
50047|NCT01526148|210165|P2|Overall Study|Withdrawal by Subject|0
50048|NCT01526148|210166|P1|Overall Study|Withdrawal by Subject|2
50049|NCT01526148|210165|P2|Overall Study|Lost to Follow-up|6
50050|NCT01526148|210166|P1|Overall Study|Lost to Follow-up|3
50051|NCT01526148|210165|P2|Overall Study|Adverse Event|5
50052|NCT01526148|210166|P1|Overall Study|Adverse Event|6
50053|NCT01525849|210190|P2|Overall Study|Anatomic exclusion criteria identified|3
50054|NCT01525849|210191|P1|Overall Study|Anatomic exclusion criteria identified|0
50055|NCT01525849|210190|P2|Overall Study|Unrelated medical issue (not treated)|2
50056|NCT01525849|210191|P1|Overall Study|Unrelated medical issue (not treated)|1
50057|NCT01525849|210190|P2|Overall Study|Withdrawal by Subject|9
50058|NCT01525849|210191|P1|Overall Study|Withdrawal by Subject|1
50059|NCT01525849|210190|P2|Overall Study|Lost to Follow-up|2
50060|NCT01525849|210191|P1|Overall Study|Lost to Follow-up|3
50061|NCT01525641|210247|P1|Overall Study|Other than stated above|7
50062|NCT01525641|210247|P1|Overall Study|Lost to follow-up (Changing hospital)|19
50063|NCT01525641|210247|P1|Overall Study|Lost to follow-up (Unknown reason)|10
50064|NCT01525641|210247|P1|Overall Study|Lost to follow-up (relocation)|1
50065|NCT01525641|210247|P1|Overall Study|Improvement|5
50066|NCT01525641|210247|P1|Overall Study|Lack of Efficacy|24
50067|NCT01525641|210247|P1|Overall Study|Adverse Event|73
50068|NCT01525641|210247|P1|Overall Study|No visit since the first visit|16
50069|NCT01525641|210247|P1|Overall Study|Case report form not collected|25
50070|NCT01525628|210261|P5|Overall Study|Other reason not defined above|0
50071|NCT01525628|210262|P4|Overall Study|Other reason not defined above|3
50072|NCT01525628|210263|P3|Overall Study|Other reason not defined above|0
50073|NCT01525628|210264|P2|Overall Study|Other reason not defined above|0
50074|NCT01525628|210265|P1|Overall Study|Other reason not defined above|0
50075|NCT01525628|210261|P5|Overall Study|Withdrawal by Subject|0
50076|NCT01525628|210262|P4|Overall Study|Withdrawal by Subject|0
50077|NCT01525628|210263|P3|Overall Study|Withdrawal by Subject|0
50078|NCT01525628|210264|P2|Overall Study|Withdrawal by Subject|1
50079|NCT01525628|210265|P1|Overall Study|Withdrawal by Subject|0
50080|NCT01525628|210261|P5|Overall Study|Lost to Follow-up|0
50081|NCT01525628|210262|P4|Overall Study|Lost to Follow-up|0
50082|NCT01525628|210263|P3|Overall Study|Lost to Follow-up|0
50083|NCT01525628|210264|P2|Overall Study|Lost to Follow-up|1
50084|NCT01525628|210265|P1|Overall Study|Lost to Follow-up|1
50085|NCT01525628|210261|P5|Overall Study|Protocol Violation|0
50086|NCT01525628|210262|P4|Overall Study|Protocol Violation|0
50087|NCT01525628|210263|P3|Overall Study|Protocol Violation|1
50088|NCT01525628|210264|P2|Overall Study|Protocol Violation|0
50089|NCT01525628|210265|P1|Overall Study|Protocol Violation|0
50090|NCT01525628|210261|P5|Overall Study|Lack of Efficacy|2
50091|NCT01525628|210262|P4|Overall Study|Lack of Efficacy|1
50092|NCT01525628|210263|P3|Overall Study|Lack of Efficacy|2
50093|NCT01525628|210264|P2|Overall Study|Lack of Efficacy|2
50094|NCT01525628|210265|P1|Overall Study|Lack of Efficacy|0
50095|NCT01525628|210261|P5|Overall Study|Adverse Event|1
50096|NCT01525628|210262|P4|Overall Study|Adverse Event|0
50097|NCT01525628|210263|P3|Overall Study|Adverse Event|2
50098|NCT01525628|210264|P2|Overall Study|Adverse Event|1
50099|NCT01525628|210265|P1|Overall Study|Adverse Event|1
50100|NCT01525615|210332|P3|Overall Study|Other reason not described above|1
50101|NCT01525615|210333|P2|Overall Study|Other reason not described above|0
50102|NCT01525615|210334|P1|Overall Study|Other reason not described above|1
50103|NCT01525615|210332|P3|Overall Study|Withdrawal by Subject|0
50104|NCT01525615|210333|P2|Overall Study|Withdrawal by Subject|0
50105|NCT01525615|210334|P1|Overall Study|Withdrawal by Subject|1
50106|NCT01525615|210332|P3|Overall Study|Lost to Follow-up|0
50107|NCT01525615|210333|P2|Overall Study|Lost to Follow-up|0
50108|NCT01525615|210334|P1|Overall Study|Lost to Follow-up|1
50109|NCT01525615|210332|P3|Overall Study|Adverse Event|5
50110|NCT01525615|210333|P2|Overall Study|Adverse Event|7
50111|NCT01525615|210334|P1|Overall Study|Adverse Event|11
50112|NCT01525550|210390|P2|Overall Study|Ongoing|23
50113|NCT01525550|210391|P1|Overall Study|Ongoing|45
50114|NCT01525550|210390|P2|Overall Study|Other Unspecified|2
50115|NCT01525550|210391|P1|Overall Study|Other Unspecified|0
50116|NCT01525550|210390|P2|Overall Study|Death|19
50117|NCT01525550|210391|P1|Overall Study|Death|10
50118|NCT01525550|210390|P2|Overall Study|Lost to Follow-up|1
50119|NCT01525550|210391|P1|Overall Study|Lost to Follow-up|4
50120|NCT01525550|210390|P2|Overall Study|Withdrawal by Subject|0
50121|NCT01525550|210391|P1|Overall Study|Withdrawal by Subject|2
50122|NCT01525407|210462|P2|Overall Study|Delay in Transplant|0
50123|NCT01525407|210463|P1|Overall Study|Delay in Transplant|1
50124|NCT01525407|210462|P2|Overall Study|Transplant was delayed|1
50125|NCT01525407|210463|P1|Overall Study|Transplant was delayed|0
50126|NCT01525407|210462|P2|Overall Study|Withdrawal by Subject|1
50127|NCT01525407|210463|P1|Overall Study|Withdrawal by Subject|0
50128|NCT01525407|210462|P2|Overall Study|Change in recipient treatment plan|2
50129|NCT01525407|210463|P1|Overall Study|Change in recipient treatment plan|2
50130|NCT01525238|210480|P3|Overall Study|Withdrawal by Subject|0
50131|NCT01525238|210481|P2|Overall Study|Withdrawal by Subject|0
50132|NCT01525238|210482|P1|Overall Study|Withdrawal by Subject|1
50133|NCT01525225|210547|P1|Enrollment|Not Specified|1
50134|NCT01525225|210547|P1|Enrollment|No longer met study criteria|1
50135|NCT01524978|210572|P11|Overall Study|Death|17
50136|NCT01524978|210573|P10|Overall Study|Death|6
50137|NCT01524978|210574|P9|Overall Study|Death|5
50138|NCT01524978|210575|P8|Overall Study|Death|9
50139|NCT01524978|210576|P7|Overall Study|Death|1
50140|NCT01524978|210577|P6|Overall Study|Death|4
50141|NCT01524978|210578|P5|Overall Study|Death|4
50142|NCT01524978|210579|P4|Overall Study|Death|24
50143|NCT01524978|210580|P3|Overall Study|Death|5
50144|NCT01524978|210581|P2|Overall Study|Death|2
50145|NCT01524978|210582|P1|Overall Study|Death|34
50146|NCT01524978|210572|P11|Overall Study|Lost to Follow-up|1
50147|NCT01524978|210573|P10|Overall Study|Lost to Follow-up|1
50148|NCT01524978|210574|P9|Overall Study|Lost to Follow-up|1
50149|NCT01524978|210575|P8|Overall Study|Lost to Follow-up|0
50150|NCT01524978|210576|P7|Overall Study|Lost to Follow-up|2
50151|NCT01524978|210577|P6|Overall Study|Lost to Follow-up|1
50152|NCT01524978|210578|P5|Overall Study|Lost to Follow-up|1
50153|NCT01524978|210579|P4|Overall Study|Lost to Follow-up|0
50154|NCT01524978|210580|P3|Overall Study|Lost to Follow-up|3
50155|NCT01524978|210581|P2|Overall Study|Lost to Follow-up|0
50156|NCT01524978|210582|P1|Overall Study|Lost to Follow-up|0
50157|NCT01524978|210572|P11|Overall Study|Withdrawal by Subject|5
50158|NCT01524978|210573|P10|Overall Study|Withdrawal by Subject|0
50159|NCT01524978|210574|P9|Overall Study|Withdrawal by Subject|4
50160|NCT01524978|210575|P8|Overall Study|Withdrawal by Subject|2
50161|NCT01524978|210576|P7|Overall Study|Withdrawal by Subject|6
50162|NCT01524978|210577|P6|Overall Study|Withdrawal by Subject|1
50163|NCT01524978|210578|P5|Overall Study|Withdrawal by Subject|3
50164|NCT01524978|210579|P4|Overall Study|Withdrawal by Subject|1
50165|NCT01524978|210580|P3|Overall Study|Withdrawal by Subject|1
50166|NCT01524978|210581|P2|Overall Study|Withdrawal by Subject|0
50167|NCT01524978|210582|P1|Overall Study|Withdrawal by Subject|12
50168|NCT01524978|210572|P11|Overall Study|Other|5
50169|NCT01524978|210573|P10|Overall Study|Other|2
50170|NCT01524978|210574|P9|Overall Study|Other|2
50171|NCT01524978|210575|P8|Overall Study|Other|1
50172|NCT01524978|210576|P7|Overall Study|Other|17
50173|NCT01524978|210577|P6|Overall Study|Other|3
50174|NCT01524978|210578|P5|Overall Study|Other|1
50175|NCT01524978|210579|P4|Overall Study|Other|2
50176|NCT01524978|210580|P3|Overall Study|Other|1
50177|NCT01524978|210581|P2|Overall Study|Other|2
50178|NCT01524978|210582|P1|Overall Study|Other|16
50179|NCT01524913|210710|P3|Overall Study|Lost to Follow-up|0
50180|NCT01524913|210711|P2|Overall Study|Lost to Follow-up|0
50181|NCT01524913|210712|P1|Overall Study|Lost to Follow-up|4
50182|NCT01524900|210734|P5|Overall Study|No reason documented|0
50183|NCT01524900|210735|P4|Overall Study|No reason documented|1
50184|NCT01524900|210736|P3|Overall Study|No reason documented|0
50185|NCT01524900|210737|P2|Overall Study|No reason documented|1
50186|NCT01524900|210738|P1|Overall Study|No reason documented|2
50187|NCT01524900|210734|P5|Overall Study|Other reason than stated above|0
50188|NCT01524900|210735|P4|Overall Study|Other reason than stated above|0
50189|NCT01524900|210736|P3|Overall Study|Other reason than stated above|0
50190|NCT01524900|210737|P2|Overall Study|Other reason than stated above|1
50191|NCT01524900|210738|P1|Overall Study|Other reason than stated above|1
50192|NCT01524900|210734|P5|Overall Study|Lost to Follow-up|0
50193|NCT01524900|210735|P4|Overall Study|Lost to Follow-up|0
50194|NCT01524900|210736|P3|Overall Study|Lost to Follow-up|1
50195|NCT01524900|210737|P2|Overall Study|Lost to Follow-up|12
50196|NCT01524900|210738|P1|Overall Study|Lost to Follow-up|3
50197|NCT01524887|210783|P3|Overall Study|Use of prohibited medication|0
50198|NCT01524887|210784|P2|Overall Study|Use of prohibited medication|0
50199|NCT01524887|210785|P1|Overall Study|Use of prohibited medication|1
50200|NCT01524887|210783|P3|Overall Study|Withdrawal by Caregiver|2
50201|NCT01524887|210784|P2|Overall Study|Withdrawal by Caregiver|0
50202|NCT01524887|210785|P1|Overall Study|Withdrawal by Caregiver|0
50203|NCT01524887|210783|P3|Overall Study|Study termination|79
50204|NCT01524887|210784|P2|Overall Study|Study termination|87
50205|NCT01524887|210785|P1|Overall Study|Study termination|73
50206|NCT01524887|210783|P3|Overall Study|Protocol Violation|1
50207|NCT01524887|210784|P2|Overall Study|Protocol Violation|0
50208|NCT01524887|210785|P1|Overall Study|Protocol Violation|0
50209|NCT01524887|210783|P3|Overall Study|Adverse Event|1
50210|NCT01524887|210784|P2|Overall Study|Adverse Event|1
50211|NCT01524887|210785|P1|Overall Study|Adverse Event|5
50212|NCT01524887|210783|P3|Overall Study|Withdrawal by Subject|3
50213|NCT01524887|210784|P2|Overall Study|Withdrawal by Subject|2
50214|NCT01524887|210785|P1|Overall Study|Withdrawal by Subject|6
50215|NCT01524796|210829|P1|Overall Study|Adverse Event and Lack of Efficacy|1
50216|NCT01524796|210829|P1|Overall Study|Switch to carbamazapine|1
50217|NCT01524796|210829|P1|Overall Study|Nervous about confidentiality|1
50218|NCT01524796|210829|P1|Overall Study|Gall stone surgery|1
50219|NCT01524796|210829|P1|Overall Study|Deterioration of pains|1
50220|NCT01524796|210829|P1|Overall Study|Move|1
50221|NCT01524796|210829|P1|Overall Study|Withdrawal by Subject|4
50222|NCT01524796|210829|P1|Overall Study|The price|1
50223|NCT01524796|210829|P1|Overall Study|Lost to Follow-up|1
50224|NCT01524796|210829|P1|Overall Study|Lack of Efficacy|3
50225|NCT01524796|210829|P1|Overall Study|Adverse Event|13
50226|NCT01524783|210844|P2|Randomized and Treated|Death|1
50227|NCT01524783|210845|P1|Randomized and Treated|Death|4
50228|NCT01524783|210844|P2|Randomized and Treated|Protocol Violation|1
50229|NCT01524783|210845|P1|Randomized and Treated|Protocol Violation|1
50230|NCT01524783|210844|P2|Randomized and Treated|Withdrawal by Subject|5
50231|NCT01524783|210845|P1|Randomized and Treated|Withdrawal by Subject|15
50232|NCT01524783|210844|P2|Randomized and Treated|Disease Progression|70
50233|NCT01524783|210845|P1|Randomized and Treated|Disease Progression|76
50234|NCT01524783|210844|P2|Randomized and Treated|Adverse Event|7
50235|NCT01524783|210845|P1|Randomized and Treated|Adverse Event|59
50236|NCT01524783|210844|P2|Randomized But Not Treated|Randomized, did not receive drug|0
50237|NCT01524783|210845|P1|Randomized But Not Treated|Randomized, did not receive drug|2
50238|NCT01524770|210867|P2|First Intervention|Protocol Violation|0
50239|NCT01524770|210868|P1|First Intervention|Protocol Violation|1
50240|NCT01524770|210867|P2|First Intervention|Adverse Event|1
50241|NCT01524770|210868|P1|First Intervention|Adverse Event|1
50242|NCT01524770|210867|P2|First Intervention|Withdrawal by Subject|0
50243|NCT01524770|210868|P1|First Intervention|Withdrawal by Subject|1
50244|NCT01524692|210878|P1|Overall Study|Withdrawal by Subject|3
50245|NCT01524627|210888|P2|Overall Study|Lost to Follow-up|1
50246|NCT01524627|210889|P1|Overall Study|Lost to Follow-up|1
50247|NCT01524627|210888|P2|Overall Study|Physician Decision|1
50248|NCT01524627|210889|P1|Overall Study|Physician Decision|0
50249|NCT01524198|210916|P2|Overall Study|Withdrawal by Subject|10
50250|NCT01524198|210917|P1|Overall Study|Withdrawal by Subject|15
50251|NCT01524198|210916|P2|Overall Study|Protocol Violation|6
50252|NCT01524198|210917|P1|Overall Study|Protocol Violation|8
50253|NCT01524133|210928|P3|Overall Study 52 Weeks|Lost to Follow-up|15
50254|NCT01524133|210929|P2|Overall Study 52 Weeks|Lost to Follow-up|15
50255|NCT01524133|210930|P1|Overall Study 52 Weeks|Lost to Follow-up|16
50256|NCT01524133|210928|P3|Overall Study 52 Weeks|Physician Decision|2
50257|NCT01524133|210929|P2|Overall Study 52 Weeks|Physician Decision|0
50258|NCT01524133|210930|P1|Overall Study 52 Weeks|Physician Decision|1
50259|NCT01524133|210928|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
50260|NCT01524133|210929|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
50261|NCT01524133|210930|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
50262|NCT01524133|210928|P3|Treatment Phase|Lost to Follow-up|2
50263|NCT01524133|210929|P2|Treatment Phase|Lost to Follow-up|1
50264|NCT01524133|210930|P1|Treatment Phase|Lost to Follow-up|0
50265|NCT01524133|210928|P3|Treatment Phase|Physician Decision|3
50266|NCT01524133|210929|P2|Treatment Phase|Physician Decision|3
50267|NCT01524133|210930|P1|Treatment Phase|Physician Decision|6
50268|NCT01524133|210928|P3|Treatment Phase|Withdrawal by Subject|31
50269|NCT01524133|210929|P2|Treatment Phase|Withdrawal by Subject|28
50270|NCT01524133|210930|P1|Treatment Phase|Withdrawal by Subject|13
50271|NCT01523886|210973|P2|Overall Study|surgery cancelled|1
50272|NCT01523886|210974|P1|Overall Study|surgery cancelled|0
50273|NCT01523873|210980|P1|Overall Study|Protocol Violation|422
50274|NCT01523756|210987|P2|Test Period 2|Withdrawal by Subject|1
50275|NCT01523756|210988|P1|Test Period 2|Withdrawal by Subject|0
50276|NCT01523756|210987|P2|Test Period 1|Adverse Event|0
50277|NCT01523756|210988|P1|Test Period 1|Adverse Event|1
50278|NCT01523756|210987|P2|Baseline Period|Adverse Event|1
50279|NCT01523756|210988|P1|Baseline Period|Adverse Event|0
50280|NCT01523743|210996|P2|Period 2|Adverse Event|0
50281|NCT01523743|210997|P1|Period 2|Adverse Event|1
50282|NCT01523743|210996|P2|Period 2|Withdrawal by Subject|2
50283|NCT01523743|210997|P1|Period 2|Withdrawal by Subject|0
50284|NCT01523743|210996|P2|Period 1|Felt unable to empty bladder|0
50285|NCT01523743|210997|P1|Period 1|Felt unable to empty bladder|1
50286|NCT01523743|210996|P2|Period 1|Lack of Efficacy|0
50287|NCT01523743|210997|P1|Period 1|Lack of Efficacy|1
50288|NCT01523743|210996|P2|Period 1|Lost to Follow-up|0
50289|NCT01523743|210997|P1|Period 1|Lost to Follow-up|1
50290|NCT01523743|210996|P2|Period 1|Withdrawal by Subject|2
50291|NCT01523743|210997|P1|Period 1|Withdrawal by Subject|6
50292|NCT01523743|210996|P2|Period 1|Adverse Event|0
50293|NCT01523743|210997|P1|Period 1|Adverse Event|1
50294|NCT01523587|211020|P2|Overall Study|Randomised but not treated|2
50295|NCT01523587|211021|P1|Overall Study|Randomised but not treated|6
50296|NCT01523587|211020|P2|Overall Study|no reason given|3
50297|NCT01523587|211021|P1|Overall Study|no reason given|2
50298|NCT01523587|211020|P2|Overall Study|Withdrawal by Subject|12
50299|NCT01523587|211021|P1|Overall Study|Withdrawal by Subject|23
50300|NCT01523587|211020|P2|Overall Study|Lost to Follow-up|2
50301|NCT01523587|211021|P1|Overall Study|Lost to Follow-up|2
50302|NCT01523587|211020|P2|Overall Study|Non Compliance with protocol|1
50303|NCT01523587|211021|P1|Overall Study|Non Compliance with protocol|2
50304|NCT01523587|211020|P2|Overall Study|Adverse Event|34
50305|NCT01523587|211021|P1|Overall Study|Adverse Event|52
50306|NCT01523457|211062|P2|Overall Study|Withdrawal by Subject|2
50307|NCT01523457|211063|P1|Overall Study|Withdrawal by Subject|7
50308|NCT01523392|211081|P2|Washout Period - 10 to 14 Days|Adverse Event|0
50309|NCT01523392|211082|P1|Washout Period - 10 to 14 Days|Adverse Event|1
50310|NCT01523392|211081|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
50311|NCT01523392|211082|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
50312|NCT01523392|211081|P2|Treatment Period 1|Withdrawal by Subject|0
50313|NCT01523392|211082|P1|Treatment Period 1|Withdrawal by Subject|2
50314|NCT01523366|211098|P2|Treatment Period 2|Not completed at least 7 days treatment|0
50315|NCT01523366|211099|P1|Treatment Period 2|Not completed at least 7 days treatment|1
50316|NCT01523366|211098|P2|Treatment Period 1|Withdrawal by Subject|0
50317|NCT01523366|211099|P1|Treatment Period 1|Withdrawal by Subject|1
50318|NCT01523301|211115|P2|Overall Study|Other Reason|2
50319|NCT01523301|211116|P1|Overall Study|Other Reason|0
50320|NCT01523301|211115|P2|Overall Study|Withdrawal by Subject|8
50321|NCT01523301|211116|P1|Overall Study|Withdrawal by Subject|6
50322|NCT01523301|211115|P2|Overall Study|Lost to Follow-up|0
50323|NCT01523301|211116|P1|Overall Study|Lost to Follow-up|1
50324|NCT01523301|211115|P2|Overall Study|Protocol Violation|4
50325|NCT01523301|211116|P1|Overall Study|Protocol Violation|3
50326|NCT01523301|211115|P2|Overall Study|Lack of Efficacy|2
50327|NCT01523301|211116|P1|Overall Study|Lack of Efficacy|0
50328|NCT01523301|211115|P2|Overall Study|Adverse Event|16
50329|NCT01523301|211116|P1|Overall Study|Adverse Event|25
50330|NCT01522976|211137|P3|Overall Study|Not protocol specified|27
50331|NCT01522976|211138|P2|Overall Study|Not protocol specified|27
50332|NCT01522976|211139|P1|Overall Study|Not protocol specified|22
50333|NCT01522976|211137|P3|Overall Study|Refusal unrelated to adverse event|14
50334|NCT01522976|211138|P2|Overall Study|Refusal unrelated to adverse event|13
50335|NCT01522976|211139|P1|Overall Study|Refusal unrelated to adverse event|10
50336|NCT01522976|211137|P3|Overall Study|Adverse Event|18
50337|NCT01522976|211138|P2|Overall Study|Adverse Event|7
50338|NCT01522976|211139|P1|Overall Study|Adverse Event|17
50339|NCT01522976|211137|P3|Overall Study|Disease progression|25
50340|NCT01522976|211138|P2|Overall Study|Disease progression|30
50341|NCT01522976|211139|P1|Overall Study|Disease progression|28
50342|NCT01522976|211137|P3|Overall Study|Still on treatment|6
50343|NCT01522976|211138|P2|Overall Study|Still on treatment|9
50344|NCT01522976|211139|P1|Overall Study|Still on treatment|9
50345|NCT01522976|211137|P3|Overall Study|Death|2
50346|NCT01522976|211138|P2|Overall Study|Death|6
50347|NCT01522976|211139|P1|Overall Study|Death|7
50348|NCT01522976|211137|P3|Overall Study|Ineligible|1
50349|NCT01522976|211138|P2|Overall Study|Ineligible|0
50350|NCT01522976|211139|P1|Overall Study|Ineligible|4
50351|NCT01522456|211219|P1|Overall Study|Tolerability Assessment|1
50352|NCT01522456|211219|P1|Overall Study|Pregnancy|1
50353|NCT01522456|211219|P1|Overall Study|Withdrawal by Subject|2
50354|NCT01522456|211219|P1|Overall Study|Lost to Follow-up|2
50355|NCT01522456|211219|P1|Overall Study|Adverse Event|2
50356|NCT01522443|211282|P2|Overall Study|Other|3
50357|NCT01522443|211283|P1|Overall Study|Other|1
50358|NCT01522443|211282|P2|Overall Study|No study treatment given|1
50359|NCT01522443|211283|P1|Overall Study|No study treatment given|1
50360|NCT01522443|211282|P2|Overall Study|Withdrawal by Subject|8
50361|NCT01522443|211283|P1|Overall Study|Withdrawal by Subject|5
50362|NCT01522443|211282|P2|Overall Study|Adverse Event|15
50363|NCT01522443|211283|P1|Overall Study|Adverse Event|10
50364|NCT01522443|211282|P2|Overall Study|No longer receiving clinical benefit|28
50365|NCT01522443|211283|P1|Overall Study|No longer receiving clinical benefit|36
50366|NCT01522235|211300|P2|Overall Study|Physician Decision|1
50367|NCT01522235|211301|P1|Overall Study|Physician Decision|1
50368|NCT01521923|211332|P4|Overall Study|AE, captured in Period 1|1
50369|NCT01521923|211333|P3|Overall Study|AE, captured in Period 1|0
50370|NCT01521923|211334|P2|Overall Study|AE, captured in Period 1|1
50371|NCT01521923|211335|P1|Overall Study|AE, captured in Period 1|0
50372|NCT01521923|211332|P4|Overall Study|Other|6
50373|NCT01521923|211333|P3|Overall Study|Other|3
50374|NCT01521923|211334|P2|Overall Study|Other|1
50375|NCT01521923|211335|P1|Overall Study|Other|2
50376|NCT01521923|211332|P4|Overall Study|Withdrawal by Subject|2
50377|NCT01521923|211333|P3|Overall Study|Withdrawal by Subject|1
50378|NCT01521923|211334|P2|Overall Study|Withdrawal by Subject|1
50379|NCT01521923|211335|P1|Overall Study|Withdrawal by Subject|1
50380|NCT01521923|211332|P4|Overall Study|Lost to Follow-up|1
50381|NCT01521923|211333|P3|Overall Study|Lost to Follow-up|2
50382|NCT01521923|211334|P2|Overall Study|Lost to Follow-up|0
50383|NCT01521923|211335|P1|Overall Study|Lost to Follow-up|1
50384|NCT01521923|211332|P4|Overall Study|Protocol Violation|0
50385|NCT01521923|211333|P3|Overall Study|Protocol Violation|1
50386|NCT01521923|211334|P2|Overall Study|Protocol Violation|0
50387|NCT01521923|211335|P1|Overall Study|Protocol Violation|0
50388|NCT01521923|211332|P4|Overall Study|Lack of Efficacy|0
50389|NCT01521923|211333|P3|Overall Study|Lack of Efficacy|0
50390|NCT01521923|211334|P2|Overall Study|Lack of Efficacy|1
50391|NCT01521923|211335|P1|Overall Study|Lack of Efficacy|1
50392|NCT01521923|211332|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
50393|NCT01521923|211333|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
50394|NCT01521923|211334|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
50395|NCT01521923|211335|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
50396|NCT01521923|211332|P4|Overall Study|AE, non-serious, non-fatal|2
50397|NCT01521923|211333|P3|Overall Study|AE, non-serious, non-fatal|6
50398|NCT01521923|211334|P2|Overall Study|AE, non-serious, non-fatal|3
50399|NCT01521923|211335|P1|Overall Study|AE, non-serious, non-fatal|1
50400|NCT01521923|211332|P4|Overall Study|SAE, non-fatal|0
50401|NCT01521923|211333|P3|Overall Study|SAE, non-fatal|2
50402|NCT01521923|211334|P2|Overall Study|SAE, non-fatal|2
50403|NCT01521923|211335|P1|Overall Study|SAE, non-fatal|0
50404|NCT01521923|211332|P4|Overall Study|AE, serious fatal|0
50405|NCT01521923|211333|P3|Overall Study|AE, serious fatal|0
50406|NCT01521923|211334|P2|Overall Study|AE, serious fatal|0
50407|NCT01521923|211335|P1|Overall Study|AE, serious fatal|1
50408|NCT01521897|211455|P1|Overall Study|Lost to Follow-up|5
50409|NCT01521897|211455|P1|Overall Study|Protocol Violation|18
50410|NCT01521884|211467|P1|Overall Study|Lost to Follow-up|4
50411|NCT01521884|211467|P1|Overall Study|Participant non-eligible|1
50412|NCT01521884|211467|P1|Overall Study|Protocol Violation|3
50413|NCT01521884|211467|P1|Overall Study|Physician Decision|2
50414|NCT01521884|211467|P1|Overall Study|Withdrawal by Subject|1
50415|NCT01521884|211467|P1|Overall Study|Pregnancy|1
50416|NCT01521884|211467|P1|Overall Study|Adverse Event|5
50417|NCT01521884|211467|P1|Overall Study|Non Responders|10
50418|NCT01521559|211564|P2|Overall Study|Other|2
50419|NCT01521559|211565|P1|Overall Study|Other|1
50420|NCT01521559|211564|P2|Overall Study|Protocol Violation|0
50421|NCT01521559|211565|P1|Overall Study|Protocol Violation|1
50422|NCT01521559|211564|P2|Overall Study|Lost to Follow-up|1
50423|NCT01521559|211565|P1|Overall Study|Lost to Follow-up|3
50424|NCT01521559|211564|P2|Overall Study|Withdrawal by Subject|11
50425|NCT01521559|211565|P1|Overall Study|Withdrawal by Subject|9
50426|NCT01521559|211564|P2|Overall Study|Death|0
50427|NCT01521559|211565|P1|Overall Study|Death|1
50428|NCT01521559|211564|P2|Overall Study|Adverse Event|4
50429|NCT01521559|211565|P1|Overall Study|Adverse Event|0
50430|NCT01521507|211588|P2|Stage 2: Observational Design|Physician Decision|0
50431|NCT01521507|211589|P1|Stage 2: Observational Design|Physician Decision|1
50432|NCT01521507|211588|P2|Stage 2: Observational Design|Withdrawal by Subject|1
50433|NCT01521507|211589|P1|Stage 2: Observational Design|Withdrawal by Subject|3
50434|NCT01521507|211588|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
50435|NCT01521507|211589|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
50436|NCT01521507|211588|P2|Stage 1: Randomized Design|Lost to Follow-up|2
50437|NCT01521507|211589|P1|Stage 1: Randomized Design|Lost to Follow-up|0
50438|NCT01521507|211588|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
50439|NCT01521507|211589|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
50440|NCT01521507|211588|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
50441|NCT01521507|211589|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
50442|NCT01521364|211606|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
50443|NCT01521364|211606|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
50444|NCT01520987|211682|P8|Overall Study|Withdrawal by Subject|0
50445|NCT01520987|211683|P7|Overall Study|Withdrawal by Subject|0
50446|NCT01520987|211684|P6|Overall Study|Withdrawal by Subject|1
50447|NCT01520987|211685|P5|Overall Study|Withdrawal by Subject|0
50448|NCT01520987|211686|P4|Overall Study|Withdrawal by Subject|0
50449|NCT01520987|211687|P3|Overall Study|Withdrawal by Subject|0
50450|NCT01520987|211688|P2|Overall Study|Withdrawal by Subject|0
50451|NCT01520987|211689|P1|Overall Study|Withdrawal by Subject|1
50452|NCT01520922|211749|P2|Survival Follow-up|Withdrawal by Subject|0
50453|NCT01520922|211750|P1|Survival Follow-up|Withdrawal by Subject|1
50454|NCT01520922|211749|P2|Follow up|Lost to Follow-up|1
50455|NCT01520922|211750|P1|Follow up|Lost to Follow-up|0
50456|NCT01520922|211749|P2|Treatment Phase|Adverse Event|5
50457|NCT01520922|211750|P1|Treatment Phase|Adverse Event|3
50458|NCT01520922|211749|P2|Treatment Phase|Progression|2
50459|NCT01520922|211750|P1|Treatment Phase|Progression|0
50460|NCT01520922|211749|P2|Treatment Phase|Physician Decision|1
50461|NCT01520922|211750|P1|Treatment Phase|Physician Decision|2
50462|NCT01520909|211812|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
50463|NCT01520909|211813|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
50464|NCT01520909|211814|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
50465|NCT01520909|211812|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
50466|NCT01520909|211813|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
50467|NCT01520909|211814|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
50468|NCT01520909|211812|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
50469|NCT01520909|211813|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
50470|NCT01520909|211814|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
50471|NCT01520909|211812|P3|Part 1 (Randomized Period)|Adverse Event|0
50472|NCT01520909|211813|P2|Part 1 (Randomized Period)|Adverse Event|2
50473|NCT01520909|211814|P1|Part 1 (Randomized Period)|Adverse Event|1
50474|NCT01520714|211931|P2|Overall Study|Lack of Efficacy|1
50475|NCT01520714|211932|P1|Overall Study|Lack of Efficacy|0
50476|NCT01520714|211931|P2|Overall Study|Adverse Event|2
50477|NCT01520714|211932|P1|Overall Study|Adverse Event|0
50478|NCT01520714|211931|P2|Overall Study|Protocol Violation|3
50479|NCT01520714|211932|P1|Overall Study|Protocol Violation|0
50480|NCT01520506|211957|P1|Overall Study|Withdrawal by Subject|1
50481|NCT01520506|211957|P1|Overall Study|Lost to Follow-up|1
50482|NCT01520506|211957|P1|Overall Study|Missed Visit|4
50483|NCT01520402|212012|P1|Overall Study|Physician Decision|3
50484|NCT01520402|212012|P1|Overall Study|Withdrawal by Subject|2
50485|NCT01519960|212035|P3|Overall Study|Lost to Follow-up|0
50486|NCT01519960|212036|P2|Overall Study|Lost to Follow-up|1
50487|NCT01519960|212037|P1|Overall Study|Lost to Follow-up|0
50488|NCT01519960|212035|P3|Overall Study|Withdrawal by Subject|0
50489|NCT01519960|212036|P2|Overall Study|Withdrawal by Subject|4
50490|NCT01519960|212037|P1|Overall Study|Withdrawal by Subject|0
50491|NCT01519960|212035|P3|Overall Study|Adverse Event|0
50492|NCT01519960|212036|P2|Overall Study|Adverse Event|1
50493|NCT01519960|212037|P1|Overall Study|Adverse Event|0
50494|NCT01519960|212035|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
50495|NCT01519960|212036|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
50496|NCT01519960|212037|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
50497|NCT01519960|212035|P3|Overall Study|Ongoing in Follow-Up|10
50498|NCT01519960|212036|P2|Overall Study|Ongoing in Follow-Up|11
50499|NCT01519960|212037|P1|Overall Study|Ongoing in Follow-Up|101
50500|NCT01519934|212143|P1|Overall Study|Lost to Follow-up|3
50501|NCT01519921|212152|P2|Overall Study|High alanine aminotransferase (ALT)|1
50502|NCT01519921|212153|P1|Overall Study|High alanine aminotransferase (ALT)|0
50503|NCT01519921|212152|P2|Overall Study|Treatment refusal|1
50504|NCT01519921|212153|P1|Overall Study|Treatment refusal|2
50505|NCT01519921|212152|P2|Overall Study|Lost to Follow-up|1
50506|NCT01519921|212153|P1|Overall Study|Lost to Follow-up|2
50507|NCT01519921|212152|P2|Overall Study|Withdrawal by Subject|0
50508|NCT01519921|212153|P1|Overall Study|Withdrawal by Subject|3
50509|NCT01519921|212152|P2|Overall Study|Lack of Efficacy|3
50510|NCT01519921|212153|P1|Overall Study|Lack of Efficacy|4
50511|NCT01519921|212152|P2|Overall Study|Adverse Event|9
50512|NCT01519921|212153|P1|Overall Study|Adverse Event|10
50513|NCT01519817|212202|P4|Overall Study|Off study due to infection|1
50514|NCT01519817|212203|P3|Overall Study|Off study due to infection|0
50515|NCT01519817|212204|P2|Overall Study|Off study due to infection|0
50516|NCT01519817|212205|P1|Overall Study|Off study due to infection|0
50517|NCT01519817|212202|P4|Overall Study|Withdrawal by Subject|0
50518|NCT01519817|212203|P3|Overall Study|Withdrawal by Subject|0
50519|NCT01519817|212204|P2|Overall Study|Withdrawal by Subject|0
50520|NCT01519817|212205|P1|Overall Study|Withdrawal by Subject|1
50521|NCT01519791|212245|P2|Overall Study|Lost to Follow-up|14
50522|NCT01519791|212246|P1|Overall Study|Lost to Follow-up|6
50523|NCT01519791|212245|P2|Overall Study|Withdrawal by Subject|37
50524|NCT01519791|212246|P1|Overall Study|Withdrawal by Subject|15
50525|NCT01519791|212245|P2|Overall Study|AE, non-serious non-fatal|31
50526|NCT01519791|212246|P1|Overall Study|AE, non-serious non-fatal|12
50527|NCT01519791|212245|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
50528|NCT01519791|212246|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
50529|NCT01519791|212245|P2|Overall Study|AE, serious fatal|1
50530|NCT01519791|212246|P1|Overall Study|AE, serious fatal|0
50531|NCT01519791|212245|P2|Overall Study|SAE, non-fatal|22
50532|NCT01519791|212246|P1|Overall Study|SAE, non-fatal|6
50533|NCT01519791|212245|P2|Overall Study|Lack of Efficacy|20
50534|NCT01519791|212246|P1|Overall Study|Lack of Efficacy|16
50535|NCT01519791|212245|P2|Overall Study|subjects randomized in error|0
50536|NCT01519791|212246|P1|Overall Study|subjects randomized in error|2
50537|NCT01519791|212245|P2|Overall Study|Other Reason|222
50538|NCT01519791|212246|P1|Overall Study|Other Reason|87
50539|NCT01519791|212245|P2|Overall Study|Protocol Violation|19
50540|NCT01519791|212246|P1|Overall Study|Protocol Violation|6
50541|NCT01519791|212245|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
50542|NCT01519791|212246|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
50543|NCT01519778|212310|P1|Overall Study|Physician Decision|1
50544|NCT01519778|212310|P1|Overall Study|Lost to Follow-up|10
50545|NCT01519778|212310|P1|Overall Study|Withdrawal by Subject|3
50546|NCT01519765|212316|P2|Overall Study|Withdrawal by Subject|1
50547|NCT01519765|212317|P1|Overall Study|Withdrawal by Subject|0
50548|NCT01519765|212316|P2|Overall Study|Protocol Violation|0
50549|NCT01519765|212317|P1|Overall Study|Protocol Violation|1
50550|NCT01519765|212316|P2|Overall Study|Lack of Efficacy|0
50551|NCT01519765|212317|P1|Overall Study|Lack of Efficacy|2
50552|NCT01519765|212316|P2|Overall Study|Adverse Event|1
50553|NCT01519765|212317|P1|Overall Study|Adverse Event|0
50554|NCT01519700|212395|P4|Overall Study|Other Reason|4
50555|NCT01519700|212396|P3|Overall Study|Other Reason|0
50556|NCT01519700|212397|P2|Overall Study|Other Reason|2
50557|NCT01519700|212398|P1|Overall Study|Other Reason|2
50558|NCT01519700|212395|P4|Overall Study|Withdrawal by Subject|2
50559|NCT01519700|212396|P3|Overall Study|Withdrawal by Subject|3
50560|NCT01519700|212397|P2|Overall Study|Withdrawal by Subject|3
50561|NCT01519700|212398|P1|Overall Study|Withdrawal by Subject|5
50562|NCT01519700|212395|P4|Overall Study|Physician Decision|0
50563|NCT01519700|212396|P3|Overall Study|Physician Decision|3
50564|NCT01519700|212397|P2|Overall Study|Physician Decision|1
50565|NCT01519700|212398|P1|Overall Study|Physician Decision|1
50566|NCT01519700|212395|P4|Overall Study|Lost to Follow-up|1
50567|NCT01519700|212396|P3|Overall Study|Lost to Follow-up|1
50568|NCT01519700|212397|P2|Overall Study|Lost to Follow-up|0
50569|NCT01519700|212398|P1|Overall Study|Lost to Follow-up|0
50570|NCT01519700|212395|P4|Overall Study|Death|0
50571|NCT01519700|212396|P3|Overall Study|Death|0
50572|NCT01519700|212397|P2|Overall Study|Death|0
50573|NCT01519700|212398|P1|Overall Study|Death|1
50574|NCT01519674|212433|P3|Overall Study|Unsclassified|3
50575|NCT01519674|212434|P2|Overall Study|Unsclassified|4
50576|NCT01519674|212435|P1|Overall Study|Unsclassified|10
50577|NCT01519674|212433|P3|Overall Study|Withdrawal Criteria|7
50578|NCT01519674|212434|P2|Overall Study|Withdrawal Criteria|2
50579|NCT01519674|212435|P1|Overall Study|Withdrawal Criteria|7
50580|NCT01519674|212433|P3|Overall Study|Protocol Violation|1
50581|NCT01519674|212434|P2|Overall Study|Protocol Violation|3
50582|NCT01519674|212435|P1|Overall Study|Protocol Violation|0
50583|NCT01519674|212433|P3|Overall Study|Lack of Efficacy|1
50584|NCT01519674|212434|P2|Overall Study|Lack of Efficacy|1
50585|NCT01519674|212435|P1|Overall Study|Lack of Efficacy|1
50586|NCT01519674|212433|P3|Overall Study|Adverse Event|0
50587|NCT01519674|212434|P2|Overall Study|Adverse Event|3
50588|NCT01519674|212435|P1|Overall Study|Adverse Event|3
50589|NCT01519661|212473|P1|Overall Study|Adverse Event|29
50590|NCT01519661|212473|P1|Overall Study|Lack of Efficacy|6
50591|NCT01519661|212473|P1|Overall Study|Withdrawal by Subject|17
50592|NCT01519661|212473|P1|Overall Study|Lost to Follow-up|3
50593|NCT01519661|212473|P1|Overall Study|Protocol deviation|6
50594|NCT01519518|212499|P2|Overall Study|Consent not available|10
50595|NCT01519518|212500|P1|Overall Study|Consent not available|7
50596|NCT01519427|212525|P1|Overall Study|disease progression|2
50597|NCT01519323|212532|P2|Overall Study|Study terminated by sponsor|1
50598|NCT01519323|212533|P1|Overall Study|Study terminated by sponsor|0
50599|NCT01519323|212532|P2|Overall Study|Death|2
50600|NCT01519323|212533|P1|Overall Study|Death|3
50601|NCT01519245|212593|P2|Overall Study|Met exclusion criteria, not analysed|2
50602|NCT01519245|212594|P1|Overall Study|Met exclusion criteria, not analysed|1
50603|NCT01519206|212606|P1|Overall Study|Missed Visit|2
50604|NCT01519206|212606|P1|Overall Study|Lost to Follow-up|3
50605|NCT01519167|212620|P2|Overall Study|Physician Decision|1
50606|NCT01519167|212621|P1|Overall Study|Physician Decision|0
50607|NCT01519167|212620|P2|Overall Study|Medical condition changes&deep sedation|2
50608|NCT01519167|212621|P1|Overall Study|Medical condition changes&deep sedation|0
50609|NCT01519167|212620|P2|Overall Study|Lack of Efficacy|1
50610|NCT01519167|212621|P1|Overall Study|Lack of Efficacy|0
50611|NCT01519167|212620|P2|Overall Study|Adverse Event|1
50612|NCT01519167|212621|P1|Overall Study|Adverse Event|0
50613|NCT01519167|212620|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
50614|NCT01519167|212621|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
50615|NCT01519089|212647|P2|Overall Study|Not received study drug|1
50616|NCT01519089|212648|P1|Overall Study|Not received study drug|0
50617|NCT01519089|212647|P2|Overall Study|Other|6
50618|NCT01519089|212648|P1|Overall Study|Other|2
50619|NCT01519089|212647|P2|Overall Study|Withdrawal by Subject|2
50620|NCT01519089|212648|P1|Overall Study|Withdrawal by Subject|0
50621|NCT01519089|212647|P2|Overall Study|Lost to Follow-up|0
50622|NCT01519089|212648|P1|Overall Study|Lost to Follow-up|1
50623|NCT01519089|212647|P2|Overall Study|Lack of Efficacy|2
50624|NCT01519089|212648|P1|Overall Study|Lack of Efficacy|0
50625|NCT01519089|212647|P2|Overall Study|Adverse Event|4
50626|NCT01519089|212648|P1|Overall Study|Adverse Event|4
50627|NCT01518946|212769|P3|Randomized Phase (First Intervention)|Not specified|0
50628|NCT01518946|212770|P2|Randomized Phase (First Intervention)|Not specified|1
50629|NCT01518946|212771|P1|Randomized Phase (First Intervention)|Not specified|0
50630|NCT01518946|212769|P3|Open-label Phase|Not specified|0
50631|NCT01518946|212770|P2|Open-label Phase|Not specified|0
50632|NCT01518946|212771|P1|Open-label Phase|Not specified|4
50633|NCT01518322|212782|P1|Overall Study|FeNO measurement was missing|13
50634|NCT01518257|212803|P2|Overall Study|Other Miscellaneous Reason|0
50635|NCT01518257|212804|P1|Overall Study|Other Miscellaneous Reason|1
50636|NCT01518257|212803|P2|Overall Study|Lost to Follow-up|0
50637|NCT01518257|212804|P1|Overall Study|Lost to Follow-up|1
50638|NCT01518244|212826|P1|Overall Study|Adverse Event|3
50639|NCT01518192|212834|P3|Overall Study|Lost to Follow-up|35
50640|NCT01518192|212835|P2|Overall Study|Lost to Follow-up|26
50641|NCT01518192|212836|P1|Overall Study|Lost to Follow-up|29
50642|NCT01518153|212857|P3|Donor Lymphocyte Infusion|Death|1
50643|NCT01518153|212858|P2|Donor Lymphocyte Infusion|Death|2
50644|NCT01518153|212859|P1|Donor Lymphocyte Infusion|Death|0
50645|NCT01518153|212857|P3|Stem Cell Transplant|Adverse Event|0
50646|NCT01518153|212858|P2|Stem Cell Transplant|Adverse Event|0
50647|NCT01518153|212859|P1|Stem Cell Transplant|Adverse Event|1
50648|NCT01518153|212857|P3|Stem Cell Transplant|Secondary graft failure|0
50649|NCT01518153|212858|P2|Stem Cell Transplant|Secondary graft failure|0
50650|NCT01518153|212859|P1|Stem Cell Transplant|Secondary graft failure|1
50651|NCT01518153|212857|P3|Stem Cell Transplant|Death|0
50652|NCT01518153|212858|P2|Stem Cell Transplant|Death|0
50653|NCT01518153|212859|P1|Stem Cell Transplant|Death|2
50654|NCT01518153|212857|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
50655|NCT01518153|212858|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
50656|NCT01518153|212859|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
50657|NCT01517984|212870|P4|Overall Study|Ineligible for randomization|0
50658|NCT01517984|212871|P3|Overall Study|Ineligible for randomization|0
50659|NCT01517984|212872|P2|Overall Study|Ineligible for randomization|14
50660|NCT01517984|212873|P1|Overall Study|Ineligible for randomization|0
50661|NCT01517984|212870|P4|Overall Study|Screen Failure|0
50662|NCT01517984|212871|P3|Overall Study|Screen Failure|0
50663|NCT01517984|212872|P2|Overall Study|Screen Failure|0
50664|NCT01517984|212873|P1|Overall Study|Screen Failure|4
50665|NCT01517984|212870|P4|Overall Study|Withdrawal by Subject|1
50666|NCT01517984|212871|P3|Overall Study|Withdrawal by Subject|4
50667|NCT01517984|212872|P2|Overall Study|Withdrawal by Subject|8
50668|NCT01517984|212873|P1|Overall Study|Withdrawal by Subject|1
50669|NCT01517984|212870|P4|Overall Study|Lost to Follow-up|0
50670|NCT01517984|212871|P3|Overall Study|Lost to Follow-up|0
50671|NCT01517984|212872|P2|Overall Study|Lost to Follow-up|1
50672|NCT01517984|212873|P1|Overall Study|Lost to Follow-up|0
50673|NCT01517867|212908|P2|Overall Study|Still in treatment at study end|3
50674|NCT01517867|212909|P1|Overall Study|Still in treatment at study end|0
50675|NCT01517867|212908|P2|Overall Study|Withdrawal by Subject|30
50676|NCT01517867|212909|P1|Overall Study|Withdrawal by Subject|34
50677|NCT01517867|212908|P2|Overall Study|never started treatment|32
50678|NCT01517867|212909|P1|Overall Study|never started treatment|29
50679|NCT01517750|212921|P4|Overall Study|Lost to Follow-up|1
50680|NCT01517750|212922|P3|Overall Study|Lost to Follow-up|4
50681|NCT01517750|212923|P2|Overall Study|Lost to Follow-up|2
50682|NCT01517750|212924|P1|Overall Study|Lost to Follow-up|1
50683|NCT01517412|212961|P2|Overall Study|Other than specified above|5
50684|NCT01517412|212962|P1|Overall Study|Other than specified above|8
50685|NCT01517412|212961|P2|Overall Study|Poor compliance to protocol|3
50686|NCT01517412|212962|P1|Overall Study|Poor compliance to protocol|8
50687|NCT01517412|212961|P2|Overall Study|Lack of Efficacy|5
50688|NCT01517412|212962|P1|Overall Study|Lack of Efficacy|10
50689|NCT01517412|212961|P2|Overall Study|Adverse Event|11
50690|NCT01517412|212962|P1|Overall Study|Adverse Event|10
50691|NCT01517373|212991|P6|Treatment Period|Medication error without AEs|2
50692|NCT01517373|212992|P5|Treatment Period|Medication error without AEs|0
50693|NCT01517373|212993|P4|Treatment Period|Medication error without AEs|1
50694|NCT01517373|212994|P3|Treatment Period|Medication error without AEs|2
50695|NCT01517373|212995|P2|Treatment Period|Medication error without AEs|0
50696|NCT01517373|212996|P1|Treatment Period|Medication error without AEs|0
50697|NCT01517373|212991|P6|Treatment Period|Lack of Efficacy|0
50698|NCT01517373|212992|P5|Treatment Period|Lack of Efficacy|2
50699|NCT01517373|212993|P4|Treatment Period|Lack of Efficacy|3
50700|NCT01517373|212994|P3|Treatment Period|Lack of Efficacy|1
50701|NCT01517373|212995|P2|Treatment Period|Lack of Efficacy|1
50702|NCT01517373|212996|P1|Treatment Period|Lack of Efficacy|0
50703|NCT01517373|212991|P6|Treatment Period|Protocol Violation|0
50704|NCT01517373|212992|P5|Treatment Period|Protocol Violation|1
50705|NCT01517373|212993|P4|Treatment Period|Protocol Violation|0
50706|NCT01517373|212994|P3|Treatment Period|Protocol Violation|0
50707|NCT01517373|212995|P2|Treatment Period|Protocol Violation|0
50708|NCT01517373|212996|P1|Treatment Period|Protocol Violation|0
50709|NCT01517373|212991|P6|Treatment Period|Other|0
50710|NCT01517373|212992|P5|Treatment Period|Other|1
50711|NCT01517373|212993|P4|Treatment Period|Other|0
50712|NCT01517373|212994|P3|Treatment Period|Other|0
50713|NCT01517373|212995|P2|Treatment Period|Other|0
50714|NCT01517373|212996|P1|Treatment Period|Other|0
50715|NCT01517373|212991|P6|Treatment Period|Withdrawal by Subject|3
50716|NCT01517373|212992|P5|Treatment Period|Withdrawal by Subject|2
50717|NCT01517373|212993|P4|Treatment Period|Withdrawal by Subject|2
50718|NCT01517373|212994|P3|Treatment Period|Withdrawal by Subject|2
50719|NCT01517373|212995|P2|Treatment Period|Withdrawal by Subject|3
50720|NCT01517373|212996|P1|Treatment Period|Withdrawal by Subject|0
50721|NCT01517373|212991|P6|Treatment Period|Lost to Follow-up|0
50722|NCT01517373|212992|P5|Treatment Period|Lost to Follow-up|0
50723|NCT01517373|212993|P4|Treatment Period|Lost to Follow-up|1
50724|NCT01517373|212994|P3|Treatment Period|Lost to Follow-up|1
50725|NCT01517373|212995|P2|Treatment Period|Lost to Follow-up|0
50726|NCT01517373|212996|P1|Treatment Period|Lost to Follow-up|0
50727|NCT01517373|212991|P6|Treatment Period|Adverse Event|2
50728|NCT01517373|212992|P5|Treatment Period|Adverse Event|0
50729|NCT01517373|212993|P4|Treatment Period|Adverse Event|0
50730|NCT01517373|212994|P3|Treatment Period|Adverse Event|0
50731|NCT01517373|212995|P2|Treatment Period|Adverse Event|0
50732|NCT01517373|212996|P1|Treatment Period|Adverse Event|0
50733|NCT01517373|212991|P6|Run-in Period|Other|0
50734|NCT01517373|212992|P5|Run-in Period|Other|0
50735|NCT01517373|212993|P4|Run-in Period|Other|0
50736|NCT01517373|212994|P3|Run-in Period|Other|0
50737|NCT01517373|212995|P2|Run-in Period|Other|0
50738|NCT01517373|212996|P1|Run-in Period|Other|1
50739|NCT01517373|212991|P6|Run-in Period|Sponsor Decision|0
50740|NCT01517373|212992|P5|Run-in Period|Sponsor Decision|0
50741|NCT01517373|212993|P4|Run-in Period|Sponsor Decision|0
50742|NCT01517373|212994|P3|Run-in Period|Sponsor Decision|0
50743|NCT01517373|212995|P2|Run-in Period|Sponsor Decision|0
50744|NCT01517373|212996|P1|Run-in Period|Sponsor Decision|3
50745|NCT01517373|212991|P6|Run-in Period|Withdrawal by Subject|0
50746|NCT01517373|212992|P5|Run-in Period|Withdrawal by Subject|0
50747|NCT01517373|212993|P4|Run-in Period|Withdrawal by Subject|0
50748|NCT01517373|212994|P3|Run-in Period|Withdrawal by Subject|0
50749|NCT01517373|212995|P2|Run-in Period|Withdrawal by Subject|0
50750|NCT01517373|212996|P1|Run-in Period|Withdrawal by Subject|12
50751|NCT01517373|212991|P6|Run-in Period|Lost to Follow-up|0
50752|NCT01517373|212992|P5|Run-in Period|Lost to Follow-up|0
50753|NCT01517373|212993|P4|Run-in Period|Lost to Follow-up|0
50754|NCT01517373|212994|P3|Run-in Period|Lost to Follow-up|0
50755|NCT01517373|212995|P2|Run-in Period|Lost to Follow-up|0
50756|NCT01517373|212996|P1|Run-in Period|Lost to Follow-up|1
50757|NCT01517373|212991|P6|Run-in Period|Did not meet eligibility criteria|0
50758|NCT01517373|212992|P5|Run-in Period|Did not meet eligibility criteria|0
50759|NCT01517373|212993|P4|Run-in Period|Did not meet eligibility criteria|0
50760|NCT01517373|212994|P3|Run-in Period|Did not meet eligibility criteria|0
50761|NCT01517373|212995|P2|Run-in Period|Did not meet eligibility criteria|0
50762|NCT01517373|212996|P1|Run-in Period|Did not meet eligibility criteria|34
50763|NCT01517373|212991|P6|Run-in Period|Adverse Event|0
50764|NCT01517373|212992|P5|Run-in Period|Adverse Event|0
50765|NCT01517373|212993|P4|Run-in Period|Adverse Event|0
50766|NCT01517373|212994|P3|Run-in Period|Adverse Event|0
50767|NCT01517373|212995|P2|Run-in Period|Adverse Event|0
50768|NCT01517373|212996|P1|Run-in Period|Adverse Event|5
50769|NCT01517373|212991|P6|Run-in Period|Death|0
50770|NCT01517373|212992|P5|Run-in Period|Death|0
50771|NCT01517373|212993|P4|Run-in Period|Death|0
50772|NCT01517373|212994|P3|Run-in Period|Death|0
50773|NCT01517373|212995|P2|Run-in Period|Death|0
50774|NCT01517373|212996|P1|Run-in Period|Death|1
50775|NCT01517295|213066|P2|Overall Study|Physician Decision|0
50776|NCT01517295|213067|P1|Overall Study|Physician Decision|1
50777|NCT01517282|213081|P4|Overall Study|Physician Decision|0
50778|NCT01517282|213082|P3|Overall Study|Physician Decision|0
50779|NCT01517282|213083|P2|Overall Study|Physician Decision|0
50780|NCT01517282|213084|P1|Overall Study|Physician Decision|1
50781|NCT01517282|213081|P4|Overall Study|Consent withdrawn|1
50782|NCT01517282|213082|P3|Overall Study|Consent withdrawn|1
50783|NCT01517282|213083|P2|Overall Study|Consent withdrawn|1
50784|NCT01517282|213084|P1|Overall Study|Consent withdrawn|0
50785|NCT01517178|213118|P2|Period 2|E.g. study termination|2
50786|NCT01517178|213119|P1|Period 2|E.g. study termination|2
50787|NCT01517178|213118|P2|Period 2|Withdrawal by Subject|0
50788|NCT01517178|213119|P1|Period 2|Withdrawal by Subject|3
50789|NCT01517178|213118|P2|Period 2|Adverse Event|0
50790|NCT01517178|213119|P1|Period 2|Adverse Event|1
50791|NCT01517178|213118|P2|Period 1|Withdrawal by Subject|1
50792|NCT01517178|213119|P1|Period 1|Withdrawal by Subject|0
50793|NCT01517178|213118|P2|Period 1|E.g. study termination|1
50794|NCT01517178|213119|P1|Period 1|E.g. study termination|3
50795|NCT01517178|213118|P2|Period 1|Lack of Efficacy|1
50796|NCT01517178|213119|P1|Period 1|Lack of Efficacy|0
50797|NCT01517178|213118|P2|Period 1|Adverse Event|2
50798|NCT01517178|213119|P1|Period 1|Adverse Event|1
50799|NCT01516970|213138|P2|Overall Study|Other|7
50800|NCT01516970|213139|P1|Overall Study|Other|9
50801|NCT01516970|213138|P2|Overall Study|Withdrawal by Subject|1
50802|NCT01516970|213139|P1|Overall Study|Withdrawal by Subject|1
50803|NCT01516970|213138|P2|Overall Study|Adverse Event|5
50804|NCT01516970|213139|P1|Overall Study|Adverse Event|1
50805|NCT01516970|213138|P2|Overall Study|Lost to Follow-up|8
50806|NCT01516970|213139|P1|Overall Study|Lost to Follow-up|7
50807|NCT01516892|213151|P1|Overall Study|Missing|1
50808|NCT01516892|213151|P1|Overall Study|Other Miscellaneous Reasons|43
50809|NCT01516892|213151|P1|Overall Study|Protocol Violation|60
50810|NCT01516892|213151|P1|Overall Study|Subject Withdrew Consent|92
50811|NCT01516892|213151|P1|Overall Study|Lost to Follow-up|82
50812|NCT01516892|213151|P1|Overall Study|Pregnancy|5
50813|NCT01516892|213151|P1|Overall Study|Lack of Efficacy|35
50814|NCT01516892|213151|P1|Overall Study|Adverse Event|25
50815|NCT01516879|213159|P2|Overall Study|Other|10
50816|NCT01516879|213160|P1|Overall Study|Other|5
50817|NCT01516879|213159|P2|Overall Study|Lost to Follow-up|11
50818|NCT01516879|213160|P1|Overall Study|Lost to Follow-up|2
50819|NCT01516879|213159|P2|Overall Study|Death|2
50820|NCT01516879|213160|P1|Overall Study|Death|0
50821|NCT01516879|213159|P2|Overall Study|Withdrawal by Subject|11
50822|NCT01516879|213160|P1|Overall Study|Withdrawal by Subject|9
50823|NCT01516749|213194|P1|Follow-up Off Therapy|Lost to Follow-up|1
50824|NCT01516749|213194|P1|Active Therapy|Lost to Follow-up|1
50825|NCT01516736|213203|P2|Overall Study|Other (not specified)|1
50826|NCT01516736|213204|P1|Overall Study|Other (not specified)|0
50827|NCT01516736|213203|P2|Overall Study|Protocol Violation|1
50828|NCT01516736|213204|P1|Overall Study|Protocol Violation|0
50829|NCT01516736|213203|P2|Overall Study|Lack of Efficacy|0
50830|NCT01516736|213204|P1|Overall Study|Lack of Efficacy|1
50831|NCT01516736|213203|P2|Overall Study|Physician Decision|1
50832|NCT01516736|213204|P1|Overall Study|Physician Decision|2
50833|NCT01516736|213203|P2|Overall Study|Death|1
50834|NCT01516736|213204|P1|Overall Study|Death|3
50835|NCT01516736|213203|P2|Overall Study|Adverse Event|5
50836|NCT01516736|213204|P1|Overall Study|Adverse Event|4
50837|NCT01516736|213203|P2|Overall Study|Withdrawal by Subject|4
50838|NCT01516736|213204|P1|Overall Study|Withdrawal by Subject|10
50839|NCT01516437|213241|P4|Overall Study|Reason not specified|1
50840|NCT01516437|213242|P3|Overall Study|Reason not specified|1
50841|NCT01516437|213243|P2|Overall Study|Reason not specified|0
50842|NCT01516437|213244|P1|Overall Study|Reason not specified|0
50843|NCT01516034|213307|P1|Overall Study|Lack of Efficacy|7
50844|NCT01516034|213307|P1|Overall Study|Physician Decision|1
50845|NCT01516008|213314|P3|Overall Study|Reason not specified|1
50846|NCT01516008|213315|P2|Overall Study|Reason not specified|0
50847|NCT01516008|213316|P1|Overall Study|Reason not specified|0
50848|NCT01516008|213314|P3|Overall Study|Protocol Violation|0
50849|NCT01516008|213315|P2|Overall Study|Protocol Violation|0
50850|NCT01516008|213316|P1|Overall Study|Protocol Violation|1
50851|NCT01516008|213314|P3|Overall Study|Lack of Efficacy|10
50852|NCT01516008|213315|P2|Overall Study|Lack of Efficacy|14
50853|NCT01516008|213316|P1|Overall Study|Lack of Efficacy|44
50854|NCT01516008|213314|P3|Overall Study|Adverse Event|7
50855|NCT01516008|213315|P2|Overall Study|Adverse Event|2
50856|NCT01516008|213316|P1|Overall Study|Adverse Event|0
50857|NCT01515865|213412|P3|Part B (Open-label)|Not Specified|0
50858|NCT01515865|213413|P2|Part B (Open-label)|Not Specified|0
50859|NCT01515865|213414|P1|Part B (Open-label)|Not Specified|1
50860|NCT01515865|213412|P3|Part B (Open-label)|Withdrawal by Subject|0
50861|NCT01515865|213413|P2|Part B (Open-label)|Withdrawal by Subject|0
50862|NCT01515865|213414|P1|Part B (Open-label)|Withdrawal by Subject|1
50863|NCT01515865|213412|P3|Part A (Open-label)|Not Specified|0
50864|NCT01515865|213413|P2|Part A (Open-label)|Not Specified|0
50865|NCT01515865|213414|P1|Part A (Open-label)|Not Specified|3
50866|NCT01515423|213482|P3|DOUBLE BLIND|Blind broken by investigator|0
50867|NCT01515423|213483|P2|DOUBLE BLIND|Blind broken by investigator|1
50868|NCT01515423|213484|P1|DOUBLE BLIND|Blind broken by investigator|0
50869|NCT01515423|213482|P3|DOUBLE BLIND|Other|12
50870|NCT01515423|213483|P2|DOUBLE BLIND|Other|6
50871|NCT01515423|213484|P1|DOUBLE BLIND|Other|0
50872|NCT01515423|213482|P3|DOUBLE BLIND|Withdrawal by Subject|53
50873|NCT01515423|213483|P2|DOUBLE BLIND|Withdrawal by Subject|50
50874|NCT01515423|213484|P1|DOUBLE BLIND|Withdrawal by Subject|0
50875|NCT01515423|213482|P3|DOUBLE BLIND|Pregnancy|0
50876|NCT01515423|213483|P2|DOUBLE BLIND|Pregnancy|2
50877|NCT01515423|213484|P1|DOUBLE BLIND|Pregnancy|0
50878|NCT01515423|213482|P3|DOUBLE BLIND|Lost to Follow-up|12
50879|NCT01515423|213483|P2|DOUBLE BLIND|Lost to Follow-up|7
50880|NCT01515423|213484|P1|DOUBLE BLIND|Lost to Follow-up|0
50881|NCT01515423|213482|P3|DOUBLE BLIND|Death|2
50882|NCT01515423|213483|P2|DOUBLE BLIND|Death|1
50883|NCT01515423|213484|P1|DOUBLE BLIND|Death|0
50884|NCT01515423|213482|P3|DOUBLE BLIND|Adverse Event|13
50885|NCT01515423|213483|P2|DOUBLE BLIND|Adverse Event|15
50886|NCT01515423|213484|P1|DOUBLE BLIND|Adverse Event|0
50887|NCT01515423|213482|P3|Open Label Phase|Other|0
50888|NCT01515423|213483|P2|Open Label Phase|Other|0
50889|NCT01515423|213484|P1|Open Label Phase|Other|28
50890|NCT01515423|213482|P3|Open Label Phase|excluded from DB Phase|0
50891|NCT01515423|213483|P2|Open Label Phase|excluded from DB Phase|0
50892|NCT01515423|213484|P1|Open Label Phase|excluded from DB Phase|70
50893|NCT01515423|213482|P3|Open Label Phase|Withdrawal by Subject|0
50894|NCT01515423|213483|P2|Open Label Phase|Withdrawal by Subject|0
50895|NCT01515423|213484|P1|Open Label Phase|Withdrawal by Subject|118
50896|NCT01515423|213482|P3|Open Label Phase|Lost to Follow-up|0
50897|NCT01515423|213483|P2|Open Label Phase|Lost to Follow-up|0
50898|NCT01515423|213484|P1|Open Label Phase|Lost to Follow-up|21
50899|NCT01515423|213482|P3|Open Label Phase|Lack of Efficacy|0
50900|NCT01515423|213483|P2|Open Label Phase|Lack of Efficacy|0
50901|NCT01515423|213484|P1|Open Label Phase|Lack of Efficacy|117
50902|NCT01515423|213482|P3|Open Label Phase|Death|0
50903|NCT01515423|213483|P2|Open Label Phase|Death|0
50904|NCT01515423|213484|P1|Open Label Phase|Death|2
50905|NCT01515423|213482|P3|Open Label Phase|Adverse Event|0
50906|NCT01515423|213483|P2|Open Label Phase|Adverse Event|0
50907|NCT01515423|213484|P1|Open Label Phase|Adverse Event|57
50908|NCT01515306|213525|P2|Overall Study|Ongoing receiving treatment|14
50909|NCT01515306|213526|P1|Overall Study|Ongoing receiving treatment|9
50910|NCT01515306|213525|P2|Overall Study|Progressive Disease|0
50911|NCT01515306|213526|P1|Overall Study|Progressive Disease|1
50912|NCT01515306|213525|P2|Overall Study|Adverse Event|0
50913|NCT01515306|213526|P1|Overall Study|Adverse Event|2
50914|NCT01515189|213539|P2|First Re-Induction Phase|Other|0
50915|NCT01515189|213540|P1|First Re-Induction Phase|Other|1
50916|NCT01515189|213539|P2|First Re-Induction Phase|No longer meets study criteria|0
50917|NCT01515189|213540|P1|First Re-Induction Phase|No longer meets study criteria|1
50918|NCT01515189|213539|P2|First Re-Induction Phase|Withdrawal by Subject|1
50919|NCT01515189|213540|P1|First Re-Induction Phase|Withdrawal by Subject|1
50920|NCT01515189|213539|P2|First Re-Induction Phase|Study drug toxicity|0
50921|NCT01515189|213540|P1|First Re-Induction Phase|Study drug toxicity|5
50922|NCT01515189|213539|P2|First Re-Induction Phase|Disease progression|14
50923|NCT01515189|213540|P1|First Re-Induction Phase|Disease progression|6
50924|NCT01515189|213539|P2|Induction|Other|4
50925|NCT01515189|213540|P1|Induction|Other|0
50926|NCT01515189|213539|P2|Induction|Lost to Follow-up|0
50927|NCT01515189|213540|P1|Induction|Lost to Follow-up|1
50928|NCT01515189|213539|P2|Induction|No longer meets study criteria|2
50929|NCT01515189|213540|P1|Induction|No longer meets study criteria|0
50930|NCT01515189|213539|P2|Induction|Withdrawal by Subject|9
50931|NCT01515189|213540|P1|Induction|Withdrawal by Subject|3
50932|NCT01515189|213539|P2|Induction|Adverse Event|9
50933|NCT01515189|213540|P1|Induction|Adverse Event|14
50934|NCT01515189|213539|P2|Induction|Death|17
50935|NCT01515189|213540|P1|Induction|Death|24
50936|NCT01515189|213539|P2|Induction|Study drug toxicity|36
50937|NCT01515189|213540|P1|Induction|Study drug toxicity|86
50938|NCT01515189|213539|P2|Induction|Disease Progression|155
50939|NCT01515189|213540|P1|Induction|Disease Progression|109
50940|NCT01514864|213628|P2|Overall Study|Study drug toxicity|0
50941|NCT01514864|213629|P1|Overall Study|Study drug toxicity|2
50942|NCT01514864|213628|P2|Overall Study|Disease progression|5
50943|NCT01514864|213629|P1|Overall Study|Disease progression|7
50944|NCT01514760|213654|P1|Overall Study|Lost to Follow-up|2
50945|NCT01514682|213667|P2|Overall Study|Physician Decision|3
50946|NCT01514682|213668|P1|Overall Study|Physician Decision|4
50947|NCT01514682|213667|P2|Overall Study|Withdrawal by Subject|3
50948|NCT01514682|213668|P1|Overall Study|Withdrawal by Subject|2
50949|NCT01514461|213702|P3|Overall Study|Death|0
50950|NCT01514461|213703|P2|Overall Study|Death|0
50951|NCT01514461|213704|P1|Overall Study|Death|1
50952|NCT01514461|213702|P3|Overall Study|Patient/guardian decision|1
50953|NCT01514461|213703|P2|Overall Study|Patient/guardian decision|1
50954|NCT01514461|213704|P1|Overall Study|Patient/guardian decision|1
50955|NCT01514461|213702|P3|Overall Study|Physician Decision|0
50956|NCT01514461|213703|P2|Overall Study|Physician Decision|1
50957|NCT01514461|213704|P1|Overall Study|Physician Decision|1
50958|NCT01514461|213702|P3|Overall Study|Adverse Event|3
50959|NCT01514461|213703|P2|Overall Study|Adverse Event|1
50960|NCT01514461|213704|P1|Overall Study|Adverse Event|2
50961|NCT01514448|213743|P2|Overall Study|New Cancer Therapy|0
50962|NCT01514448|213744|P1|Overall Study|New Cancer Therapy|1
50963|NCT01514448|213743|P2|Overall Study|Lost to Follow-up|0
50964|NCT01514448|213744|P1|Overall Study|Lost to Follow-up|2
50965|NCT01514448|213743|P2|Overall Study|Withdrawal by Subject|0
50966|NCT01514448|213744|P1|Overall Study|Withdrawal by Subject|2
50967|NCT01514448|213743|P2|Overall Study|Death|8
50968|NCT01514448|213744|P1|Overall Study|Death|7
50969|NCT01514422|213759|P1|Overall Study|Lost to Follow-up|1
50970|NCT01514357|213767|P2|Overall Study|Withdrawal by Subject|0
50971|NCT01514357|213768|P1|Overall Study|Withdrawal by Subject|2
50972|NCT01514357|213767|P2|Overall Study|Screen failure|0
50973|NCT01514357|213768|P1|Overall Study|Screen failure|2
50974|NCT01514240|213786|P2|Overall Study|Subject Decision|7
50975|NCT01514240|213787|P1|Overall Study|Subject Decision|2
50976|NCT01514240|213786|P2|Overall Study|Adverse Event|4
50977|NCT01514240|213787|P1|Overall Study|Adverse Event|4
50978|NCT01514136|213900|P8|Test Period 2; Test C*|Protocol Violation|0
50979|NCT01514136|213901|P7|Test Period 2; Test C*|Protocol Violation|1
50980|NCT01514136|213902|P6|Test Period 2; Test C*|Protocol Violation|0
50981|NCT01514136|213903|P5|Test Period 2; Test C*|Protocol Violation|0
50982|NCT01514136|213904|P4|Test Period 2; Test C*|Protocol Violation|0
50983|NCT01514136|213905|P3|Test Period 2; Test C*|Protocol Violation|0
50984|NCT01514136|213906|P2|Test Period 2; Test C*|Protocol Violation|0
50985|NCT01514136|213907|P1|Test Period 2; Test C*|Protocol Violation|0
50986|NCT01514136|213900|P8|Test Period 2; Test C*|holiday|0
50987|NCT01514136|213901|P7|Test Period 2; Test C*|holiday|1
50988|NCT01514136|213902|P6|Test Period 2; Test C*|holiday|0
50989|NCT01514136|213903|P5|Test Period 2; Test C*|holiday|0
50990|NCT01514136|213904|P4|Test Period 2; Test C*|holiday|0
50991|NCT01514136|213905|P3|Test Period 2; Test C*|holiday|0
50992|NCT01514136|213906|P2|Test Period 2; Test C*|holiday|0
50993|NCT01514136|213907|P1|Test Period 2; Test C*|holiday|0
50994|NCT01514136|213900|P8|Test Period 2; Test C*|Withdrawal by Subject|0
50995|NCT01514136|213901|P7|Test Period 2; Test C*|Withdrawal by Subject|1
50996|NCT01514136|213902|P6|Test Period 2; Test C*|Withdrawal by Subject|0
50997|NCT01514136|213903|P5|Test Period 2; Test C*|Withdrawal by Subject|0
50998|NCT01514136|213904|P4|Test Period 2; Test C*|Withdrawal by Subject|0
50999|NCT01514136|213905|P3|Test Period 2; Test C*|Withdrawal by Subject|0
51000|NCT01514136|213906|P2|Test Period 2; Test C*|Withdrawal by Subject|0
51001|NCT01514136|213907|P1|Test Period 2; Test C*|Withdrawal by Subject|0
51002|NCT01514136|213900|P8|Test Period 2; Test B*|Withdrawal by Subject|0
51003|NCT01514136|213901|P7|Test Period 2; Test B*|Withdrawal by Subject|0
51004|NCT01514136|213902|P6|Test Period 2; Test B*|Withdrawal by Subject|2
51005|NCT01514136|213903|P5|Test Period 2; Test B*|Withdrawal by Subject|0
51006|NCT01514136|213904|P4|Test Period 2; Test B*|Withdrawal by Subject|0
51007|NCT01514136|213905|P3|Test Period 2; Test B*|Withdrawal by Subject|0
51008|NCT01514136|213906|P2|Test Period 2; Test B*|Withdrawal by Subject|0
51009|NCT01514136|213907|P1|Test Period 2; Test B*|Withdrawal by Subject|0
51010|NCT01514136|213900|P8|Test Period 2; Test A*|Holiday|0
51011|NCT01514136|213901|P7|Test Period 2; Test A*|Holiday|0
51012|NCT01514136|213902|P6|Test Period 2; Test A*|Holiday|0
51013|NCT01514136|213903|P5|Test Period 2; Test A*|Holiday|1
51014|NCT01514136|213904|P4|Test Period 2; Test A*|Holiday|0
51015|NCT01514136|213905|P3|Test Period 2; Test A*|Holiday|0
51016|NCT01514136|213906|P2|Test Period 2; Test A*|Holiday|0
51017|NCT01514136|213907|P1|Test Period 2; Test A*|Holiday|0
51018|NCT01514136|213900|P8|Test Period 2; Test A*|Adverse Event|0
51019|NCT01514136|213901|P7|Test Period 2; Test A*|Adverse Event|0
51020|NCT01514136|213902|P6|Test Period 2; Test A*|Adverse Event|0
51021|NCT01514136|213903|P5|Test Period 2; Test A*|Adverse Event|1
51022|NCT01514136|213904|P4|Test Period 2; Test A*|Adverse Event|0
51023|NCT01514136|213905|P3|Test Period 2; Test A*|Adverse Event|0
51024|NCT01514136|213906|P2|Test Period 2; Test A*|Adverse Event|0
51025|NCT01514136|213907|P1|Test Period 2; Test A*|Adverse Event|0
51026|NCT01514136|213900|P8|Test Period 1; Test D|Subject took a break due to holiday|0
51027|NCT01514136|213901|P7|Test Period 1; Test D|Subject took a break due to holiday|0
51028|NCT01514136|213902|P6|Test Period 1; Test D|Subject took a break due to holiday|0
51029|NCT01514136|213903|P5|Test Period 1; Test D|Subject took a break due to holiday|0
51030|NCT01514136|213904|P4|Test Period 1; Test D|Subject took a break due to holiday|2
51031|NCT01514136|213905|P3|Test Period 1; Test D|Subject took a break due to holiday|0
51032|NCT01514136|213906|P2|Test Period 1; Test D|Subject took a break due to holiday|0
51033|NCT01514136|213907|P1|Test Period 1; Test D|Subject took a break due to holiday|0
51034|NCT01514136|213900|P8|Test Period 1; Test B|Withdrawal by Subject|0
51035|NCT01514136|213901|P7|Test Period 1; Test B|Withdrawal by Subject|0
51036|NCT01514136|213902|P6|Test Period 1; Test B|Withdrawal by Subject|0
51037|NCT01514136|213903|P5|Test Period 1; Test B|Withdrawal by Subject|0
51038|NCT01514136|213904|P4|Test Period 1; Test B|Withdrawal by Subject|0
51039|NCT01514136|213905|P3|Test Period 1; Test B|Withdrawal by Subject|0
51040|NCT01514136|213906|P2|Test Period 1; Test B|Withdrawal by Subject|1
51041|NCT01514136|213907|P1|Test Period 1; Test B|Withdrawal by Subject|0
51042|NCT01514136|213900|P8|Test Period 1; Test A|Break from study holiday|0
51043|NCT01514136|213901|P7|Test Period 1; Test A|Break from study holiday|0
51044|NCT01514136|213902|P6|Test Period 1; Test A|Break from study holiday|0
51045|NCT01514136|213903|P5|Test Period 1; Test A|Break from study holiday|0
51046|NCT01514136|213904|P4|Test Period 1; Test A|Break from study holiday|0
51047|NCT01514136|213905|P3|Test Period 1; Test A|Break from study holiday|0
51048|NCT01514136|213906|P2|Test Period 1; Test A|Break from study holiday|0
51049|NCT01514136|213907|P1|Test Period 1; Test A|Break from study holiday|2
51050|NCT01514136|213900|P8|Test Period 1; Test A|Protocol Violation|0
51051|NCT01514136|213901|P7|Test Period 1; Test A|Protocol Violation|0
51052|NCT01514136|213902|P6|Test Period 1; Test A|Protocol Violation|0
51053|NCT01514136|213903|P5|Test Period 1; Test A|Protocol Violation|0
51054|NCT01514136|213904|P4|Test Period 1; Test A|Protocol Violation|0
51055|NCT01514136|213905|P3|Test Period 1; Test A|Protocol Violation|0
51056|NCT01514136|213906|P2|Test Period 1; Test A|Protocol Violation|0
51057|NCT01514136|213907|P1|Test Period 1; Test A|Protocol Violation|1
51058|NCT01513590|213975|P2|Overall Study|Unclassified|10
51059|NCT01513590|213976|P1|Overall Study|Unclassified|5
51060|NCT01513590|213975|P2|Overall Study|Withdrawal Criteria|0
51061|NCT01513590|213976|P1|Overall Study|Withdrawal Criteria|3
51062|NCT01513590|213975|P2|Overall Study|Adverse Event|3
51063|NCT01513590|213976|P1|Overall Study|Adverse Event|2
51064|NCT01513473|214000|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
51065|NCT01513473|214001|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
51066|NCT01513473|214000|P2|Extension Trial (26 Weeks)|Adverse Event|1
51067|NCT01513473|214001|P1|Extension Trial (26 Weeks)|Adverse Event|0
51068|NCT01513473|214000|P2|Main Trial (26 Weeks)|Unclassified|2
51069|NCT01513473|214001|P1|Main Trial (26 Weeks)|Unclassified|0
51070|NCT01513473|214000|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
51071|NCT01513473|214001|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
51072|NCT01513473|214000|P2|Main Trial (26 Weeks)|Adverse Event|2
51073|NCT01513473|214001|P1|Main Trial (26 Weeks)|Adverse Event|0
51074|NCT01513460|214028|P3|Overall Study|Abnormal test procedure|0
51075|NCT01513460|214029|P2|Overall Study|Abnormal test procedure|0
51076|NCT01513460|214030|P1|Overall Study|Abnormal test procedure|1
51077|NCT01513460|214028|P3|Overall Study|Adverse Event|23
51078|NCT01513460|214029|P2|Overall Study|Adverse Event|18
51079|NCT01513460|214030|P1|Overall Study|Adverse Event|16
51080|NCT01513460|214028|P3|Overall Study|Withdrawal by Subject|21
51081|NCT01513460|214029|P2|Overall Study|Withdrawal by Subject|8
51082|NCT01513460|214030|P1|Overall Study|Withdrawal by Subject|7
51083|NCT01513460|214028|P3|Overall Study|Protocol deviations|3
51084|NCT01513460|214029|P2|Overall Study|Protocol deviations|4
51085|NCT01513460|214030|P1|Overall Study|Protocol deviations|3
51086|NCT01513460|214028|P3|Overall Study|Lack of Efficacy|5
51087|NCT01513460|214029|P2|Overall Study|Lack of Efficacy|2
51088|NCT01513460|214030|P1|Overall Study|Lack of Efficacy|1
51089|NCT01513460|214028|P3|Overall Study|Abnormal laboratory value|1
51090|NCT01513460|214029|P2|Overall Study|Abnormal laboratory value|0
51091|NCT01513460|214030|P1|Overall Study|Abnormal laboratory value|1
51092|NCT01513460|214028|P3|Overall Study|Lost to Follow-up|2
51093|NCT01513460|214029|P2|Overall Study|Lost to Follow-up|0
51094|NCT01513460|214030|P1|Overall Study|Lost to Follow-up|0
51095|NCT01513460|214028|P3|Overall Study|Death|1
51096|NCT01513460|214029|P2|Overall Study|Death|0
51097|NCT01513460|214030|P1|Overall Study|Death|0
51098|NCT01513330|214065|P2|Standard Care First,|Other|0
51099|NCT01513330|214066|P1|Standard Care First,|Other|1
51100|NCT01513330|214065|P2|Standard Care First,|Withdrawal by Subject|2
51101|NCT01513330|214066|P1|Standard Care First,|Withdrawal by Subject|1
51102|NCT01513330|214065|P2|Standard Care First,|Lack of Efficacy|2
51103|NCT01513330|214066|P1|Standard Care First,|Lack of Efficacy|2
51104|NCT01513330|214065|P2|SenSura Mio First,|Other|0
51105|NCT01513330|214066|P1|SenSura Mio First,|Other|1
51106|NCT01513330|214065|P2|SenSura Mio First,|Withdrawal by Subject|1
51107|NCT01513330|214066|P1|SenSura Mio First,|Withdrawal by Subject|1
51108|NCT01513330|214065|P2|SenSura Mio First,|Lack of Efficacy|1
51109|NCT01513330|214066|P1|SenSura Mio First,|Lack of Efficacy|0
51110|NCT01513330|214065|P2|SenSura Mio First,|Adverse Event|0
51111|NCT01513330|214066|P1|SenSura Mio First,|Adverse Event|2
51112|NCT01513317|214074|P2|Overall Study|Not specified|1
51113|NCT01513317|214075|P1|Overall Study|Not specified|0
51114|NCT01513317|214074|P2|Overall Study|Study terminated by sponsor|18
51115|NCT01513317|214075|P1|Overall Study|Study terminated by sponsor|18
51116|NCT01513317|214074|P2|Overall Study|Death|1
51117|NCT01513317|214075|P1|Overall Study|Death|1
51118|NCT01513317|214074|P2|Overall Study|Withdrawal by Subject|4
51119|NCT01513317|214075|P1|Overall Study|Withdrawal by Subject|15
51120|NCT01513291|214093|P5|Run-out Period|Withdrawal by Subject|0
51121|NCT01513291|214094|P4|Run-out Period|Withdrawal by Subject|1
51122|NCT01513291|214095|P3|Run-out Period|Withdrawal by Subject|0
51123|NCT01513291|214096|P2|Run-out Period|Withdrawal by Subject|0
51124|NCT01513291|214097|P1|Run-out Period|Withdrawal by Subject|0
51125|NCT01513291|214093|P5|Run-out Period|Lost to Follow-up|0
51126|NCT01513291|214094|P4|Run-out Period|Lost to Follow-up|1
51127|NCT01513291|214095|P3|Run-out Period|Lost to Follow-up|0
51128|NCT01513291|214096|P2|Run-out Period|Lost to Follow-up|0
51129|NCT01513291|214097|P1|Run-out Period|Lost to Follow-up|0
51130|NCT01513291|214093|P5|Treatment Period|Randomized not treated|0
51131|NCT01513291|214094|P4|Treatment Period|Randomized not treated|0
51132|NCT01513291|214095|P3|Treatment Period|Randomized not treated|0
51133|NCT01513291|214096|P2|Treatment Period|Randomized not treated|2
51134|NCT01513291|214097|P1|Treatment Period|Randomized not treated|0
51135|NCT01513291|214093|P5|Treatment Period|Withdrawal by Subject|0
51136|NCT01513291|214094|P4|Treatment Period|Withdrawal by Subject|0
51137|NCT01513291|214095|P3|Treatment Period|Withdrawal by Subject|0
51138|NCT01513291|214096|P2|Treatment Period|Withdrawal by Subject|5
51139|NCT01513291|214097|P1|Treatment Period|Withdrawal by Subject|8
51140|NCT01513291|214093|P5|Treatment Period|Protocol Violation|0
51141|NCT01513291|214094|P4|Treatment Period|Protocol Violation|0
51142|NCT01513291|214095|P3|Treatment Period|Protocol Violation|0
51143|NCT01513291|214096|P2|Treatment Period|Protocol Violation|2
51144|NCT01513291|214097|P1|Treatment Period|Protocol Violation|1
51145|NCT01513291|214093|P5|Treatment Period|Physician Decision|0
51146|NCT01513291|214094|P4|Treatment Period|Physician Decision|0
51147|NCT01513291|214095|P3|Treatment Period|Physician Decision|0
51148|NCT01513291|214096|P2|Treatment Period|Physician Decision|0
51149|NCT01513291|214097|P1|Treatment Period|Physician Decision|1
51150|NCT01513291|214093|P5|Treatment Period|Lost to Follow-up|0
51151|NCT01513291|214094|P4|Treatment Period|Lost to Follow-up|0
51152|NCT01513291|214095|P3|Treatment Period|Lost to Follow-up|0
51153|NCT01513291|214096|P2|Treatment Period|Lost to Follow-up|3
51154|NCT01513291|214097|P1|Treatment Period|Lost to Follow-up|2
51155|NCT01513291|214093|P5|Treatment Period|Lack of Efficacy|0
51156|NCT01513291|214094|P4|Treatment Period|Lack of Efficacy|0
51157|NCT01513291|214095|P3|Treatment Period|Lack of Efficacy|0
51158|NCT01513291|214096|P2|Treatment Period|Lack of Efficacy|0
51159|NCT01513291|214097|P1|Treatment Period|Lack of Efficacy|3
51160|NCT01513291|214093|P5|Treatment Period|Adverse Event|0
51161|NCT01513291|214094|P4|Treatment Period|Adverse Event|0
51162|NCT01513291|214095|P3|Treatment Period|Adverse Event|0
51163|NCT01513291|214096|P2|Treatment Period|Adverse Event|4
51164|NCT01513291|214097|P1|Treatment Period|Adverse Event|8
51165|NCT01513239|214125|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
51166|NCT01513239|214126|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
51167|NCT01513239|214127|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
51168|NCT01513239|214128|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
51169|NCT01513239|214129|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
51170|NCT01513239|214130|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
51171|NCT01513239|214125|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
51172|NCT01513239|214126|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
51173|NCT01513239|214127|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
51174|NCT01513239|214128|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
51175|NCT01513239|214129|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
51176|NCT01513239|214130|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
51177|NCT01513239|214125|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
51178|NCT01513239|214126|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
51179|NCT01513239|214127|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
51180|NCT01513239|214128|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
51181|NCT01513239|214129|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
51182|NCT01513239|214130|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
51183|NCT01513239|214125|P6|Period 2: 9 Month Extension Phase|Death|2
51184|NCT01513239|214126|P5|Period 2: 9 Month Extension Phase|Death|5
51185|NCT01513239|214127|P4|Period 2: 9 Month Extension Phase|Death|2
51186|NCT01513239|214128|P3|Period 2: 9 Month Extension Phase|Death|0
51187|NCT01513239|214129|P2|Period 2: 9 Month Extension Phase|Death|0
51188|NCT01513239|214130|P1|Period 2: 9 Month Extension Phase|Death|0
51189|NCT01513239|214125|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
51190|NCT01513239|214126|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
51191|NCT01513239|214127|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
51192|NCT01513239|214128|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
51193|NCT01513239|214129|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
51194|NCT01513239|214130|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
51195|NCT01513239|214125|P6|Period 1: Main Phase|Withdrawal by Subject|0
51196|NCT01513239|214126|P5|Period 1: Main Phase|Withdrawal by Subject|0
51197|NCT01513239|214127|P4|Period 1: Main Phase|Withdrawal by Subject|0
51198|NCT01513239|214128|P3|Period 1: Main Phase|Withdrawal by Subject|42
51199|NCT01513239|214129|P2|Period 1: Main Phase|Withdrawal by Subject|29
51200|NCT01513239|214130|P1|Period 1: Main Phase|Withdrawal by Subject|27
51201|NCT01513239|214125|P6|Period 1: Main Phase|Technical Problems|0
51202|NCT01513239|214126|P5|Period 1: Main Phase|Technical Problems|0
51203|NCT01513239|214127|P4|Period 1: Main Phase|Technical Problems|0
51204|NCT01513239|214128|P3|Period 1: Main Phase|Technical Problems|0
51205|NCT01513239|214129|P2|Period 1: Main Phase|Technical Problems|2
51206|NCT01513239|214130|P1|Period 1: Main Phase|Technical Problems|1
51207|NCT01513239|214125|P6|Period 1: Main Phase|Protocol Violation|0
51208|NCT01513239|214126|P5|Period 1: Main Phase|Protocol Violation|0
51209|NCT01513239|214127|P4|Period 1: Main Phase|Protocol Violation|0
51210|NCT01513239|214128|P3|Period 1: Main Phase|Protocol Violation|2
51211|NCT01513239|214129|P2|Period 1: Main Phase|Protocol Violation|2
51212|NCT01513239|214130|P1|Period 1: Main Phase|Protocol Violation|2
51213|NCT01513239|214125|P6|Period 1: Main Phase|Physician Decision|0
51214|NCT01513239|214126|P5|Period 1: Main Phase|Physician Decision|0
51215|NCT01513239|214127|P4|Period 1: Main Phase|Physician Decision|0
51216|NCT01513239|214128|P3|Period 1: Main Phase|Physician Decision|4
51217|NCT01513239|214129|P2|Period 1: Main Phase|Physician Decision|4
51218|NCT01513239|214130|P1|Period 1: Main Phase|Physician Decision|4
51219|NCT01513239|214125|P6|Period 1: Main Phase|Lost to Follow-up|0
51220|NCT01513239|214126|P5|Period 1: Main Phase|Lost to Follow-up|0
51221|NCT01513239|214127|P4|Period 1: Main Phase|Lost to Follow-up|0
51222|NCT01513239|214128|P3|Period 1: Main Phase|Lost to Follow-up|6
51223|NCT01513239|214129|P2|Period 1: Main Phase|Lost to Follow-up|10
51224|NCT01513239|214130|P1|Period 1: Main Phase|Lost to Follow-up|11
51225|NCT01513239|214125|P6|Period 1: Main Phase|Death|0
51226|NCT01513239|214126|P5|Period 1: Main Phase|Death|0
51227|NCT01513239|214127|P4|Period 1: Main Phase|Death|0
51228|NCT01513239|214128|P3|Period 1: Main Phase|Death|32
51229|NCT01513239|214129|P2|Period 1: Main Phase|Death|22
51230|NCT01513239|214130|P1|Period 1: Main Phase|Death|29
51231|NCT01513239|214125|P6|Period 1: Main Phase|Adverse Event|0
51232|NCT01513239|214126|P5|Period 1: Main Phase|Adverse Event|0
51233|NCT01513239|214127|P4|Period 1: Main Phase|Adverse Event|0
51234|NCT01513239|214128|P3|Period 1: Main Phase|Adverse Event|2
51235|NCT01513239|214129|P2|Period 1: Main Phase|Adverse Event|1
51236|NCT01513239|214130|P1|Period 1: Main Phase|Adverse Event|1
51237|NCT01513148|214183|P2|Overall Study|Protocol Violation|2
51238|NCT01513148|214184|P1|Overall Study|Protocol Violation|2
51239|NCT01512979|214251|P2|Overall Study|Reason other than stated above|9
51240|NCT01512979|214252|P1|Overall Study|Reason other than stated above|13
51241|NCT01512979|214251|P2|Overall Study|Withdrawal by Subject|2
51242|NCT01512979|214252|P1|Overall Study|Withdrawal by Subject|1
51243|NCT01512979|214251|P2|Overall Study|Lost to Follow-up|5
51244|NCT01512979|214252|P1|Overall Study|Lost to Follow-up|2
51245|NCT01512979|214251|P2|Overall Study|Protocol Violation|4
51246|NCT01512979|214252|P1|Overall Study|Protocol Violation|1
51247|NCT01512979|214251|P2|Overall Study|Adverse Event|2
51248|NCT01512979|214252|P1|Overall Study|Adverse Event|2
51249|NCT01512745|214316|P2|Overall Study|Protocol Violation|0
51250|NCT01512745|214317|P1|Overall Study|Protocol Violation|1
51251|NCT01512745|214316|P2|Overall Study|Lack of Efficacy|2
51252|NCT01512745|214317|P1|Overall Study|Lack of Efficacy|2
51253|NCT01512745|214316|P2|Overall Study|Lost to Follow-up|0
51254|NCT01512745|214317|P1|Overall Study|Lost to Follow-up|4
51255|NCT01512745|214316|P2|Overall Study|Withdrawal by Subject|2
51256|NCT01512745|214317|P1|Overall Study|Withdrawal by Subject|2
51257|NCT01512745|214316|P2|Overall Study|Death|13
51258|NCT01512745|214317|P1|Overall Study|Death|9
51259|NCT01512745|214316|P2|Overall Study|Adverse Event|3
51260|NCT01512745|214317|P1|Overall Study|Adverse Event|22
51261|NCT01512693|214333|P2|Overall Study|Withdrawal by Subject|1
51262|NCT01512693|214334|P1|Overall Study|Withdrawal by Subject|0
51263|NCT01512368|214361|P1|Overall Study|Protocol Violation|3
51264|NCT01512160|214419|P4|Overall Study|Withdrawal by Subject|1
51265|NCT01512160|214420|P3|Overall Study|Withdrawal by Subject|0
51266|NCT01512160|214421|P2|Overall Study|Withdrawal by Subject|0
51267|NCT01512160|214422|P1|Overall Study|Withdrawal by Subject|1
51268|NCT01512160|214419|P4|Overall Study|Lost to Follow-up|0
51269|NCT01512160|214420|P3|Overall Study|Lost to Follow-up|0
51270|NCT01512160|214421|P2|Overall Study|Lost to Follow-up|0
51271|NCT01512160|214422|P1|Overall Study|Lost to Follow-up|1
51272|NCT01512108|214514|P2|Overall Study|Unclassified|3
51273|NCT01512108|214515|P1|Overall Study|Unclassified|11
51274|NCT01512108|214514|P2|Overall Study|Withdrawal Criteria|0
51275|NCT01512108|214515|P1|Overall Study|Withdrawal Criteria|1
51276|NCT01512108|214514|P2|Overall Study|Protocol Violation|2
51277|NCT01512108|214515|P1|Overall Study|Protocol Violation|1
51278|NCT01512108|214514|P2|Overall Study|Adverse Event|4
51279|NCT01512108|214515|P1|Overall Study|Adverse Event|9
51280|NCT01511939|214541|P3|Overall Study|Withdrawal by Subject|0
51281|NCT01511939|214542|P2|Overall Study|Withdrawal by Subject|1
51282|NCT01511939|214543|P1|Overall Study|Withdrawal by Subject|2
51283|NCT01511536|214572|P3|Phase 2|Other|9
51284|NCT01511536|214573|P2|Phase 2|Other|0
51285|NCT01511536|214574|P1|Phase 2|Other|0
51286|NCT01511536|214572|P3|Phase 1|Other|0
51287|NCT01511536|214573|P2|Phase 1|Other|1
51288|NCT01511536|214574|P1|Phase 1|Other|0
51289|NCT01511445|214596|P2|Overall Study|Protocol Violation|0
51290|NCT01511445|214597|P1|Overall Study|Protocol Violation|1
51291|NCT01511445|214596|P2|Overall Study|Protocol Violation|3
51292|NCT01511445|214597|P1|Overall Study|Protocol Violation|1
51293|NCT01511445|214596|P2|Overall Study|Lost to Follow-up|1
51294|NCT01511445|214597|P1|Overall Study|Lost to Follow-up|3
51295|NCT01511250|214625|P10|Overall Study|Protocol Violation|0
51296|NCT01511250|214626|P9|Overall Study|Protocol Violation|0
51297|NCT01511250|214627|P8|Overall Study|Protocol Violation|0
51298|NCT01511250|214628|P7|Overall Study|Protocol Violation|0
51299|NCT01511250|214629|P6|Overall Study|Protocol Violation|0
51300|NCT01511250|214630|P5|Overall Study|Protocol Violation|0
51301|NCT01511250|214631|P4|Overall Study|Protocol Violation|0
51302|NCT01511250|214632|P3|Overall Study|Protocol Violation|1
51303|NCT01511250|214633|P2|Overall Study|Protocol Violation|2
51304|NCT01511250|214634|P1|Overall Study|Protocol Violation|0
51305|NCT01511250|214625|P10|Overall Study|Lost to Follow-up|5
51306|NCT01511250|214626|P9|Overall Study|Lost to Follow-up|13
51307|NCT01511250|214627|P8|Overall Study|Lost to Follow-up|3
51308|NCT01511250|214628|P7|Overall Study|Lost to Follow-up|2
51309|NCT01511250|214629|P6|Overall Study|Lost to Follow-up|0
51310|NCT01511250|214630|P5|Overall Study|Lost to Follow-up|0
51311|NCT01511250|214631|P4|Overall Study|Lost to Follow-up|3
51312|NCT01511250|214632|P3|Overall Study|Lost to Follow-up|3
51313|NCT01511250|214633|P2|Overall Study|Lost to Follow-up|3
51314|NCT01511250|214634|P1|Overall Study|Lost to Follow-up|7
51315|NCT01511250|214625|P10|Overall Study|Sponsor/Investigator Decision|0
51316|NCT01511250|214626|P9|Overall Study|Sponsor/Investigator Decision|0
51317|NCT01511250|214627|P8|Overall Study|Sponsor/Investigator Decision|0
51318|NCT01511250|214628|P7|Overall Study|Sponsor/Investigator Decision|0
51319|NCT01511250|214629|P6|Overall Study|Sponsor/Investigator Decision|0
51320|NCT01511250|214630|P5|Overall Study|Sponsor/Investigator Decision|0
51321|NCT01511250|214631|P4|Overall Study|Sponsor/Investigator Decision|0
51322|NCT01511250|214632|P3|Overall Study|Sponsor/Investigator Decision|0
51323|NCT01511250|214633|P2|Overall Study|Sponsor/Investigator Decision|0
51324|NCT01511250|214634|P1|Overall Study|Sponsor/Investigator Decision|1
51325|NCT01511250|214625|P10|Overall Study|Withdrawal of Consent|0
51326|NCT01511250|214626|P9|Overall Study|Withdrawal of Consent|1
51327|NCT01511250|214627|P8|Overall Study|Withdrawal of Consent|1
51328|NCT01511250|214628|P7|Overall Study|Withdrawal of Consent|0
51329|NCT01511250|214629|P6|Overall Study|Withdrawal of Consent|0
51330|NCT01511250|214630|P5|Overall Study|Withdrawal of Consent|0
51331|NCT01511250|214631|P4|Overall Study|Withdrawal of Consent|0
51332|NCT01511250|214632|P3|Overall Study|Withdrawal of Consent|0
51333|NCT01511250|214633|P2|Overall Study|Withdrawal of Consent|0
51334|NCT01511250|214634|P1|Overall Study|Withdrawal of Consent|1
51335|NCT01511107|214782|P2|Overall Study|Withdrawal by Subject|20
51336|NCT01511107|214783|P1|Overall Study|Withdrawal by Subject|9
51337|NCT01511107|214782|P2|Overall Study|Lost to Follow-up|19
51338|NCT01511107|214783|P1|Overall Study|Lost to Follow-up|10
51339|NCT01511107|214782|P2|Overall Study|Ineligible|2
51340|NCT01511107|214783|P1|Overall Study|Ineligible|3
51341|NCT01510912|214861|P1|Overall Study|Other, including joint replacement|5
51342|NCT01510912|214861|P1|Overall Study|Lost to Follow-up|26
51343|NCT01510912|214861|P1|Overall Study|Protocol Violation|27
51344|NCT01510912|214861|P1|Overall Study|Physician Decision|1
51345|NCT01510912|214861|P1|Overall Study|Withdrawal by Subject|49
51346|NCT01510912|214861|P1|Overall Study|Non-compliance with trial drug|23
51347|NCT01510912|214861|P1|Overall Study|Lack of Efficacy|12
51348|NCT01510912|214861|P1|Overall Study|Adverse Event|99
51349|NCT01510769|214877|P3|Overall Study|Death|0
51350|NCT01510769|214878|P2|Overall Study|Death|1
51351|NCT01510769|214879|P1|Overall Study|Death|1
51352|NCT01510769|214877|P3|Overall Study|Withdrawal by Subject|3
51353|NCT01510769|214878|P2|Overall Study|Withdrawal by Subject|4
51354|NCT01510769|214879|P1|Overall Study|Withdrawal by Subject|3
51355|NCT01510769|214877|P3|Overall Study|Lost to Follow-up|5
51356|NCT01510769|214878|P2|Overall Study|Lost to Follow-up|1
51357|NCT01510769|214879|P1|Overall Study|Lost to Follow-up|5
51358|NCT01510769|214877|P3|Overall Study|Protocol Violation|9
51359|NCT01510769|214878|P2|Overall Study|Protocol Violation|10
51360|NCT01510769|214879|P1|Overall Study|Protocol Violation|11
51361|NCT01510769|214877|P3|Overall Study|Gout Flare|1
51362|NCT01510769|214878|P2|Overall Study|Gout Flare|3
51363|NCT01510769|214879|P1|Overall Study|Gout Flare|0
51364|NCT01510769|214877|P3|Overall Study|Adverse Event|4
51365|NCT01510769|214878|P2|Overall Study|Adverse Event|6
51366|NCT01510769|214879|P1|Overall Study|Adverse Event|7
51367|NCT01510756|214896|P1|Overall Study|Physician Decision|1
51368|NCT01510756|214896|P1|Overall Study|Lack of Efficacy|2
51369|NCT01510756|214896|P1|Overall Study|Death|1
51370|NCT01510717|214904|P2|Overall Study|Withdrawal by Subject|2
51371|NCT01510717|214905|P1|Overall Study|Withdrawal by Subject|0
51372|NCT01510717|214904|P2|Overall Study|Lost to Follow-up|1
51373|NCT01510717|214905|P1|Overall Study|Lost to Follow-up|0
51374|NCT01510717|214904|P2|Overall Study|Death|0
51375|NCT01510717|214905|P1|Overall Study|Death|1
51376|NCT01510717|214904|P2|Overall Study|Adverse Event|2
51377|NCT01510717|214905|P1|Overall Study|Adverse Event|1
51378|NCT01510158|215025|P3|Overall Study|Death|0
51379|NCT01510158|215026|P2|Overall Study|Death|0
51380|NCT01510158|215027|P1|Overall Study|Death|1
51381|NCT01510158|215025|P3|Overall Study|Withdrawal by Subject|10
51382|NCT01510158|215026|P2|Overall Study|Withdrawal by Subject|13
51383|NCT01510158|215027|P1|Overall Study|Withdrawal by Subject|10
51384|NCT01510158|215025|P3|Overall Study|Lost to Follow-up|9
51385|NCT01510158|215026|P2|Overall Study|Lost to Follow-up|16
51386|NCT01510158|215027|P1|Overall Study|Lost to Follow-up|13
51387|NCT01510158|215025|P3|Overall Study|Sponsor terminated study.|2
51388|NCT01510158|215026|P2|Overall Study|Sponsor terminated study.|0
51389|NCT01510158|215027|P1|Overall Study|Sponsor terminated study.|2
51390|NCT01510158|215025|P3|Overall Study|Protocol Violation|24
51391|NCT01510158|215026|P2|Overall Study|Protocol Violation|16
51392|NCT01510158|215027|P1|Overall Study|Protocol Violation|17
51393|NCT01510158|215025|P3|Overall Study|Gout flare|0
51394|NCT01510158|215026|P2|Overall Study|Gout flare|0
51395|NCT01510158|215027|P1|Overall Study|Gout flare|1
51396|NCT01510158|215025|P3|Overall Study|Adverse Event|5
51397|NCT01510158|215026|P2|Overall Study|Adverse Event|8
51398|NCT01510158|215027|P1|Overall Study|Adverse Event|7
51399|NCT01510145|215041|P1|Overall Study|Relative reported subject withdrew|1
51400|NCT01510145|215041|P1|Overall Study|Withdrawal by Subject|6
51401|NCT01510145|215041|P1|Overall Study|Lost to Follow-up|5
51402|NCT01510145|215041|P1|Overall Study|Adverse Event|6
51403|NCT01509664|215075|P2|Overall Study|Lost to Follow-up|21
51404|NCT01509664|215076|P1|Overall Study|Lost to Follow-up|15
51405|NCT01509079|215162|P2|Overall Study|started an excluded medication|1
51406|NCT01509079|215163|P1|Overall Study|started an excluded medication|0
51407|NCT01509079|215162|P2|Overall Study|Lack of Efficacy|2
51408|NCT01509079|215163|P1|Overall Study|Lack of Efficacy|0
51409|NCT01509053|215179|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
51410|NCT01509053|215179|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
51411|NCT01509053|215179|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
51412|NCT01509053|215179|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
51413|NCT01509053|215179|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
51414|NCT01509053|215179|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
51415|NCT01508936|215241|P2|Overall Study|Data from 2 sites deemed invalid|11
51416|NCT01508936|215242|P1|Overall Study|Data from 2 sites deemed invalid|4
51417|NCT01508936|215241|P2|Overall Study|Not specified|5
51418|NCT01508936|215242|P1|Overall Study|Not specified|0
51419|NCT01508936|215241|P2|Overall Study|Lost to Follow-up|9
51420|NCT01508936|215242|P1|Overall Study|Lost to Follow-up|2
51421|NCT01508936|215241|P2|Overall Study|Protocol Violation|3
51422|NCT01508936|215242|P1|Overall Study|Protocol Violation|2
51423|NCT01508936|215241|P2|Overall Study|Withdrawal by Subject|18
51424|NCT01508936|215242|P1|Overall Study|Withdrawal by Subject|4
51425|NCT01508936|215241|P2|Overall Study|Lack of Efficacy|1
51426|NCT01508936|215242|P1|Overall Study|Lack of Efficacy|0
51427|NCT01508936|215241|P2|Overall Study|Adverse Event|32
51428|NCT01508936|215242|P1|Overall Study|Adverse Event|11
51429|NCT01508910|215281|P4|Treatment|Sponsor Decision|1
51430|NCT01508910|215282|P3|Treatment|Sponsor Decision|0
51431|NCT01508910|215283|P2|Treatment|Sponsor Decision|0
51432|NCT01508910|215284|P1|Treatment|Sponsor Decision|0
51433|NCT01508910|215281|P4|Treatment|Withdrawal by Subject|1
51434|NCT01508910|215282|P3|Treatment|Withdrawal by Subject|6
51435|NCT01508910|215283|P2|Treatment|Withdrawal by Subject|1
51436|NCT01508910|215284|P1|Treatment|Withdrawal by Subject|0
51437|NCT01508910|215281|P4|Treatment|Lost to Follow-up|1
51438|NCT01508910|215282|P3|Treatment|Lost to Follow-up|2
51439|NCT01508910|215283|P2|Treatment|Lost to Follow-up|0
51440|NCT01508910|215284|P1|Treatment|Lost to Follow-up|0
51441|NCT01508910|215281|P4|Treatment|Death|0
51442|NCT01508910|215282|P3|Treatment|Death|2
51443|NCT01508910|215283|P2|Treatment|Death|3
51444|NCT01508910|215284|P1|Treatment|Death|2
51445|NCT01508702|215317|P2|Overall Study|Withdrawal by Subject|7
51446|NCT01508702|215318|P1|Overall Study|Withdrawal by Subject|11
51447|NCT01508702|215317|P2|Overall Study|Lost to Follow-up|2
51448|NCT01508702|215318|P1|Overall Study|Lost to Follow-up|1
51449|NCT01508702|215317|P2|Overall Study|Protocol Violation|1
51450|NCT01508702|215318|P1|Overall Study|Protocol Violation|2
51451|NCT01508702|215317|P2|Overall Study|Gout flare|0
51452|NCT01508702|215318|P1|Overall Study|Gout flare|2
51453|NCT01508702|215317|P2|Overall Study|Adverse Event|3
51454|NCT01508702|215318|P1|Overall Study|Adverse Event|7
51455|NCT01508676|215326|P2|Phase II (2 Weeks)|Medication Exclusion|0
51456|NCT01508676|215327|P1|Phase II (2 Weeks)|Medication Exclusion|1
51457|NCT01508676|215326|P2|Phase II (2 Weeks)|Skin Sensitivity|1
51458|NCT01508676|215327|P1|Phase II (2 Weeks)|Skin Sensitivity|0
51459|NCT01508676|215326|P2|Phase I (2 Weeks)|Positive Drug Screen|2
51460|NCT01508676|215327|P1|Phase I (2 Weeks)|Positive Drug Screen|0
51461|NCT01508676|215326|P2|Phase I (2 Weeks)|Wrong Pain Type|0
51462|NCT01508676|215327|P1|Phase I (2 Weeks)|Wrong Pain Type|1
51463|NCT01508676|215326|P2|Phase I (2 Weeks)|Medication Exclusion|1
51464|NCT01508676|215327|P1|Phase I (2 Weeks)|Medication Exclusion|1
51465|NCT01508325|215348|P2|Overall Study|Other|2
51466|NCT01508325|215349|P1|Overall Study|Other|2
51467|NCT01508325|215348|P2|Overall Study|Lost to Follow-up|6
51468|NCT01508325|215349|P1|Overall Study|Lost to Follow-up|5
51469|NCT01508325|215348|P2|Overall Study|Adverse Event|0
51470|NCT01508325|215349|P1|Overall Study|Adverse Event|1
51471|NCT01508325|215348|P2|Overall Study|Physician Decision|1
51472|NCT01508325|215349|P1|Overall Study|Physician Decision|2
51473|NCT01508325|215348|P2|Overall Study|Protocol Violation|3
51474|NCT01508325|215349|P1|Overall Study|Protocol Violation|0
51475|NCT01508325|215348|P2|Overall Study|Withdrawal by Subject|9
51476|NCT01508325|215349|P1|Overall Study|Withdrawal by Subject|8
51477|NCT01508169|215379|P2|Overall Study|Lost to Follow-up|2
51478|NCT01508169|215380|P1|Overall Study|Lost to Follow-up|1
51479|NCT01508169|215379|P2|Overall Study|Withdrawal by Subject|0
51480|NCT01508169|215380|P1|Overall Study|Withdrawal by Subject|1
51481|NCT01508169|215379|P2|Overall Study|Adverse Event|0
51482|NCT01508169|215380|P1|Overall Study|Adverse Event|1
51483|NCT01508130|215394|P2|Overall Study|Administrative|3
51484|NCT01508130|215395|P1|Overall Study|Administrative|14
51485|NCT01508130|215394|P2|Overall Study|Insufficient therapeutic response|23
51486|NCT01508130|215395|P1|Overall Study|Insufficient therapeutic response|74
51487|NCT01508130|215394|P2|Overall Study|Subject’s substantial non-compliance|9
51488|NCT01508130|215395|P1|Overall Study|Subject’s substantial non-compliance|25
51489|NCT01508130|215394|P2|Overall Study|Withdrawal by Subject|3
51490|NCT01508130|215395|P1|Overall Study|Withdrawal by Subject|3
51491|NCT01508130|215394|P2|Overall Study|Lost to Follow-up|2
51492|NCT01508130|215395|P1|Overall Study|Lost to Follow-up|25
51493|NCT01508130|215394|P2|Overall Study|Protocol Violation|0
51494|NCT01508130|215395|P1|Overall Study|Protocol Violation|2
51495|NCT01508130|215394|P2|Overall Study|Death|1
51496|NCT01508130|215395|P1|Overall Study|Death|3
51497|NCT01508130|215394|P2|Overall Study|Adverse Event|28
51498|NCT01508130|215395|P1|Overall Study|Adverse Event|81
51499|NCT01507896|215463|P1|Overall Study|The surgery was denied by the sponsor.|1
51500|NCT01507896|215463|P1|Overall Study|Withdrawal by Subject|1
51501|NCT01507831|215506|P2|Overall Study|Other|6
51502|NCT01507831|215507|P1|Overall Study|Other|3
51503|NCT01507831|215506|P2|Overall Study|Potential lost to follow-up|0
51504|NCT01507831|215507|P1|Overall Study|Potential lost to follow-up|3
51505|NCT01507831|215506|P2|Overall Study|Site closure|3
51506|NCT01507831|215507|P1|Overall Study|Site closure|0
51507|NCT01507831|215506|P2|Overall Study|Selection criteria finally not met|1
51508|NCT01507831|215507|P1|Overall Study|Selection criteria finally not met|0
51509|NCT01507831|215506|P2|Overall Study|Last visit outside protocol visit window|143
51510|NCT01507831|215507|P1|Overall Study|Last visit outside protocol visit window|51
51511|NCT01507831|215506|P2|Overall Study|Related to study drug administration|14
51512|NCT01507831|215507|P1|Overall Study|Related to study drug administration|5
51513|NCT01507831|215506|P2|Overall Study|Consent withdrawn by participant|72
51514|NCT01507831|215507|P1|Overall Study|Consent withdrawn by participant|34
51515|NCT01507831|215506|P2|Overall Study|Participant moved|19
51516|NCT01507831|215507|P1|Overall Study|Participant moved|5
51517|NCT01507831|215506|P2|Overall Study|Physician Decision|4
51518|NCT01507831|215507|P1|Overall Study|Physician Decision|0
51519|NCT01507831|215506|P2|Overall Study|Poor compliance to protocol|60
51520|NCT01507831|215507|P1|Overall Study|Poor compliance to protocol|38
51521|NCT01507831|215506|P2|Overall Study|Death|2
51522|NCT01507831|215507|P1|Overall Study|Death|6
51523|NCT01507831|215506|P2|Overall Study|Adverse Event|113
51524|NCT01507831|215507|P1|Overall Study|Adverse Event|48
51525|NCT01507831|215506|P2|Overall Study|Randomized but not treated|3
51526|NCT01507831|215507|P1|Overall Study|Randomized but not treated|0
51527|NCT01507662|215577|P2|Overall Study|Proxy interview done|3
51528|NCT01507662|215578|P1|Overall Study|Proxy interview done|2
51529|NCT01507662|215577|P2|Overall Study|Lost to Follow-up|523
51530|NCT01507662|215578|P1|Overall Study|Lost to Follow-up|498
51531|NCT01507662|215577|P2|Overall Study|Withdrawal by Subject|287
51532|NCT01507662|215578|P1|Overall Study|Withdrawal by Subject|290
51533|NCT01507662|215577|P2|Overall Study|Death|18
51534|NCT01507662|215578|P1|Overall Study|Death|26
51535|NCT01507246|215603|P2|Overall Study|Required different surgical procedures|1
51536|NCT01507246|215604|P1|Overall Study|Required different surgical procedures|2
51537|NCT01507090|215702|P1|Overall Study|incomplete dataset|18
51538|NCT01507051|215741|P4|Overall Study|Adverse Event|0
51539|NCT01507051|215742|P3|Overall Study|Adverse Event|0
51540|NCT01507051|215743|P2|Overall Study|Adverse Event|0
51541|NCT01507051|215744|P1|Overall Study|Adverse Event|1
51542|NCT01507051|215741|P4|Overall Study|Physician Decision|1
51543|NCT01507051|215742|P3|Overall Study|Physician Decision|0
51544|NCT01507051|215743|P2|Overall Study|Physician Decision|0
51545|NCT01507051|215744|P1|Overall Study|Physician Decision|0
51546|NCT01507051|215741|P4|Overall Study|Withdrawal by Subject|6
51547|NCT01507051|215742|P3|Overall Study|Withdrawal by Subject|1
51548|NCT01507051|215743|P2|Overall Study|Withdrawal by Subject|3
51549|NCT01507051|215744|P1|Overall Study|Withdrawal by Subject|1
51550|NCT01506960|215862|P1|Overall Study|Did not meet angiographic criteria|47
51551|NCT01506947|215868|P1|Overall Study|Did Not Meet Eligibility Criteria|3
51552|NCT01506947|215868|P1|Overall Study|Death|1
51553|NCT01506947|215868|P1|Overall Study|Adverse Event|5
51554|NCT01506947|215868|P1|Overall Study|Lost to Follow-up|7
51555|NCT01506908|215886|P2|Overall Study|Adverse Event|0
51556|NCT01506908|215887|P1|Overall Study|Adverse Event|1
51557|NCT01506882|215905|P2|Overall Study|Other Reason|0
51558|NCT01506882|215906|P1|Overall Study|Other Reason|2
51559|NCT01506882|215905|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
51560|NCT01506882|215906|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
51561|NCT01506882|215905|P2|Overall Study|AE, non-serious non-fatal|1
51562|NCT01506882|215906|P1|Overall Study|AE, non-serious non-fatal|3
51563|NCT01506882|215905|P2|Overall Study|SAE, non-fatal|0
51564|NCT01506882|215906|P1|Overall Study|SAE, non-fatal|2
51565|NCT01506882|215905|P2|Overall Study|Withdrawal by Subject|3
51566|NCT01506882|215906|P1|Overall Study|Withdrawal by Subject|9
51567|NCT01506882|215905|P2|Overall Study|Lost to Follow-up|0
51568|NCT01506882|215906|P1|Overall Study|Lost to Follow-up|1
51569|NCT01506882|215905|P2|Overall Study|Lack of Efficacy|3
51570|NCT01506882|215906|P1|Overall Study|Lack of Efficacy|4
51571|NCT01506726|215920|P2|Overall Study|Adverse Event|2
51572|NCT01506726|215921|P1|Overall Study|Adverse Event|1
51573|NCT01506596|215961|P1|Overall Study|ineligible pathology|1
51574|NCT01506479|215972|P3|Overall Study|Adverse Event|0
51575|NCT01506479|215973|P2|Overall Study|Adverse Event|1
51576|NCT01506479|215974|P1|Overall Study|Adverse Event|0
51577|NCT01506479|215972|P3|Overall Study|Missing assessment|0
51578|NCT01506479|215973|P2|Overall Study|Missing assessment|0
51579|NCT01506479|215974|P1|Overall Study|Missing assessment|1
51580|NCT01506479|215972|P3|Overall Study|Withdrawal by Subject|1
51581|NCT01506479|215973|P2|Overall Study|Withdrawal by Subject|2
51582|NCT01506479|215974|P1|Overall Study|Withdrawal by Subject|1
51583|NCT01506479|215972|P3|Overall Study|Lost to Follow-up|2
51584|NCT01506479|215973|P2|Overall Study|Lost to Follow-up|2
51585|NCT01506479|215974|P1|Overall Study|Lost to Follow-up|1
51586|NCT01506323|215992|P2|Overall Study|Started another treatment|0
51587|NCT01506323|215993|P1|Overall Study|Started another treatment|1
51588|NCT01506323|215992|P2|Overall Study|Schedule or Transportation conflict|0
51589|NCT01506323|215993|P1|Overall Study|Schedule or Transportation conflict|8
51590|NCT01506323|215992|P2|Overall Study|Moved out of area|2
51591|NCT01506323|215993|P1|Overall Study|Moved out of area|5
51592|NCT01506323|215992|P2|Overall Study|Lack of Efficacy|3
51593|NCT01506323|215993|P1|Overall Study|Lack of Efficacy|1
51594|NCT01506323|215992|P2|Overall Study|Withdrawal by Subject|4
51595|NCT01506323|215993|P1|Overall Study|Withdrawal by Subject|4
51596|NCT01506323|215992|P2|Overall Study|Lost to Follow-up|4
51597|NCT01506323|215993|P1|Overall Study|Lost to Follow-up|5
51598|NCT01506193|216022|P3|Overall Study|Lost to Follow-up|3
51599|NCT01506193|216023|P2|Overall Study|Lost to Follow-up|3
51600|NCT01506193|216024|P1|Overall Study|Lost to Follow-up|8
51601|NCT01506193|216022|P3|Overall Study|Withdrawal by Subject|8
51602|NCT01506193|216023|P2|Overall Study|Withdrawal by Subject|1
51603|NCT01506193|216024|P1|Overall Study|Withdrawal by Subject|5
51604|NCT01506193|216022|P3|Overall Study|Adverse event, non-fatal|1
51605|NCT01506193|216023|P2|Overall Study|Adverse event, non-fatal|0
51606|NCT01506193|216024|P1|Overall Study|Adverse event, non-fatal|0
51607|NCT01506193|216022|P3|Overall Study|Migrated/moved from study area|1
51608|NCT01506193|216023|P2|Overall Study|Migrated/moved from study area|0
51609|NCT01506193|216024|P1|Overall Study|Migrated/moved from study area|0
51610|NCT01506193|216022|P3|Overall Study|Protocol Violation|1
51611|NCT01506193|216023|P2|Overall Study|Protocol Violation|0
51612|NCT01506193|216024|P1|Overall Study|Protocol Violation|1
51613|NCT01505881|216057|P2|Overall Study|Withdrawal by Subject|0
51614|NCT01505881|216058|P1|Overall Study|Withdrawal by Subject|2
51615|NCT01505881|216057|P2|Overall Study|Lost to Follow-up|0
51616|NCT01505881|216058|P1|Overall Study|Lost to Follow-up|2
51617|NCT01505881|216057|P2|Overall Study|Adverse Event|1
51618|NCT01505881|216058|P1|Overall Study|Adverse Event|0
51619|NCT01505647|216142|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
51620|NCT01505647|216143|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
51621|NCT01505647|216142|P2|Day 43 Through Day 182 Follow-up|Death|1
51622|NCT01505647|216143|P1|Day 43 Through Day 182 Follow-up|Death|0
51623|NCT01505647|216142|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
51624|NCT01505647|216143|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
51625|NCT01505647|216142|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
51626|NCT01505647|216143|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
51627|NCT01505647|216142|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
51628|NCT01505647|216143|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
51629|NCT01505608|216159|P2|Phase II|Protocol Violation|1
51630|NCT01505608|216160|P1|Phase II|Protocol Violation|0
51631|NCT01505608|216159|P2|Phase II|Lack of Efficacy|1
51632|NCT01505608|216160|P1|Phase II|Lack of Efficacy|2
51633|NCT01505608|216159|P2|Phase I|Withdrawal by Subject|1
51634|NCT01505608|216160|P1|Phase I|Withdrawal by Subject|0
51635|NCT01505608|216159|P2|Phase I|Adverse Event|1
51636|NCT01505608|216160|P1|Phase I|Adverse Event|0
51637|NCT01505608|216159|P2|Phase I|Lack of Efficacy|4
51638|NCT01505608|216160|P1|Phase I|Lack of Efficacy|0
51639|NCT01505387|216195|P2|Overall Study|Withdrawal by Subject|1
51640|NCT01505387|216196|P1|Overall Study|Withdrawal by Subject|1
51641|NCT01505387|216195|P2|Overall Study|Protocol Violation|0
51642|NCT01505387|216196|P1|Overall Study|Protocol Violation|1
51643|NCT01505374|216202|P2|Overall Study|Lost to Follow-up|0
51644|NCT01505374|216203|P1|Overall Study|Lost to Follow-up|1
51645|NCT01505114|216249|P4|Overall Study|investigator decision|0
51646|NCT01505114|216250|P3|Overall Study|investigator decision|1
51647|NCT01505114|216251|P2|Overall Study|investigator decision|0
51648|NCT01505114|216252|P1|Overall Study|investigator decision|1
51649|NCT01505114|216249|P4|Overall Study|staff safety concerns|1
51650|NCT01505114|216250|P3|Overall Study|staff safety concerns|0
51651|NCT01505114|216251|P2|Overall Study|staff safety concerns|0
51652|NCT01505114|216252|P1|Overall Study|staff safety concerns|0
51653|NCT01505114|216249|P4|Overall Study|inadvertent enrollment due to peanut all|1
51654|NCT01505114|216250|P3|Overall Study|inadvertent enrollment due to peanut all|0
51655|NCT01505114|216251|P2|Overall Study|inadvertent enrollment due to peanut all|0
51656|NCT01505114|216252|P1|Overall Study|inadvertent enrollment due to peanut all|0
51657|NCT01505114|216249|P4|Overall Study|relocated|3
51658|NCT01505114|216250|P3|Overall Study|relocated|2
51659|NCT01505114|216251|P2|Overall Study|relocated|2
51660|NCT01505114|216252|P1|Overall Study|relocated|4
51661|NCT01505114|216249|P4|Overall Study|Lost to Follow-up|7
51662|NCT01505114|216250|P3|Overall Study|Lost to Follow-up|8
51663|NCT01505114|216251|P2|Overall Study|Lost to Follow-up|5
51664|NCT01505114|216252|P1|Overall Study|Lost to Follow-up|11
51665|NCT01505114|216249|P4|Overall Study|unable to adhere to visit schedule|3
51666|NCT01505114|216250|P3|Overall Study|unable to adhere to visit schedule|3
51667|NCT01505114|216251|P2|Overall Study|unable to adhere to visit schedule|2
51668|NCT01505114|216252|P1|Overall Study|unable to adhere to visit schedule|3
51669|NCT01505114|216249|P4|Overall Study|Death|1
51670|NCT01505114|216250|P3|Overall Study|Death|0
51671|NCT01505114|216251|P2|Overall Study|Death|0
51672|NCT01505114|216252|P1|Overall Study|Death|1
51673|NCT01505114|216249|P4|Overall Study|Withdrawal by Subject|7
51674|NCT01505114|216250|P3|Overall Study|Withdrawal by Subject|4
51675|NCT01505114|216251|P2|Overall Study|Withdrawal by Subject|4
51676|NCT01505114|216252|P1|Overall Study|Withdrawal by Subject|5
51677|NCT01504971|216266|P1|Overall Study|Physician Decision|13
51678|NCT01504867|216295|P2|Overall Study|Consent revoked|1
51679|NCT01504867|216296|P1|Overall Study|Consent revoked|5
51680|NCT01504867|216295|P2|Overall Study|Inclusion criteria not met|2
51681|NCT01504867|216296|P1|Overall Study|Inclusion criteria not met|2
51682|NCT01504204|216333|P2|Overall Study|Lost to Follow-up|1
51683|NCT01504204|216334|P1|Overall Study|Lost to Follow-up|1
51684|NCT01503164|216362|P2|Overall Study|Withdrawal by Subject|1
51685|NCT01503164|216363|P1|Overall Study|Withdrawal by Subject|2
51686|NCT01503021|216393|P2|Overall Study|Moved, received transplant, etc.|7
51687|NCT01503021|216394|P1|Overall Study|Moved, received transplant, etc.|5
51688|NCT01503021|216393|P2|Overall Study|Withdrawal by Subject|8
51689|NCT01503021|216394|P1|Overall Study|Withdrawal by Subject|9
51690|NCT01503021|216393|P2|Overall Study|Protocol Violation|3
51691|NCT01503021|216394|P1|Overall Study|Protocol Violation|1
51692|NCT01503021|216393|P2|Overall Study|Physician Decision|0
51693|NCT01503021|216394|P1|Overall Study|Physician Decision|3
51694|NCT01503021|216393|P2|Overall Study|Lost to Follow-up|0
51695|NCT01503021|216394|P1|Overall Study|Lost to Follow-up|2
51696|NCT01503021|216393|P2|Overall Study|Death|2
51697|NCT01503021|216394|P1|Overall Study|Death|0
51698|NCT01503021|216393|P2|Overall Study|Adverse Event|6
51699|NCT01503021|216394|P1|Overall Study|Adverse Event|7
51700|NCT01502956|216443|P2|Overall Study|Withdrawal by Subject|10
51701|NCT01502956|216444|P1|Overall Study|Withdrawal by Subject|8
51702|NCT01502956|216443|P2|Overall Study|Physician Decision|3
51703|NCT01502956|216444|P1|Overall Study|Physician Decision|2
51704|NCT01502956|216443|P2|Overall Study|Lost to Follow-up|11
51705|NCT01502956|216444|P1|Overall Study|Lost to Follow-up|14
51706|NCT01502956|216443|P2|Overall Study|Death|2
51707|NCT01502956|216444|P1|Overall Study|Death|0
51708|NCT01502709|216498|P2|Overall Study|Lost to Follow-up|0
51709|NCT01502709|216499|P1|Overall Study|Lost to Follow-up|4
51710|NCT01502644|216512|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
51711|NCT01502644|216513|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
51712|NCT01502644|216514|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
51713|NCT01502644|216515|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
51714|NCT01502644|216512|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
51715|NCT01502644|216513|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
51716|NCT01502644|216514|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
51717|NCT01502644|216515|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
51718|NCT01502644|216512|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
51719|NCT01502644|216513|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
51720|NCT01502644|216514|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
51721|NCT01502644|216515|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
51722|NCT01502644|216512|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
51723|NCT01502644|216513|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
51724|NCT01502644|216514|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
51725|NCT01502644|216515|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
51726|NCT01502644|216512|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
51727|NCT01502644|216513|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
51728|NCT01502644|216514|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
51729|NCT01502644|216515|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
51730|NCT01502423|216525|P2|Overall Study|Withdrawal by Subject|1
51731|NCT01502423|216526|P1|Overall Study|Withdrawal by Subject|0
51732|NCT01502410|216548|P4|Overall Study|Withdrawal by Subject|0
51733|NCT01502410|216549|P3|Overall Study|Withdrawal by Subject|0
51734|NCT01502410|216550|P2|Overall Study|Withdrawal by Subject|0
51735|NCT01502410|216551|P1|Overall Study|Withdrawal by Subject|2
51736|NCT01502410|216548|P4|Overall Study|Physician Decision|0
51737|NCT01502410|216549|P3|Overall Study|Physician Decision|0
51738|NCT01502410|216550|P2|Overall Study|Physician Decision|1
51739|NCT01502410|216551|P1|Overall Study|Physician Decision|0
51740|NCT01502410|216548|P4|Overall Study|Lack of Efficacy|0
51741|NCT01502410|216549|P3|Overall Study|Lack of Efficacy|0
51742|NCT01502410|216550|P2|Overall Study|Lack of Efficacy|7
51743|NCT01502410|216551|P1|Overall Study|Lack of Efficacy|7
51744|NCT01502410|216548|P4|Overall Study|Adverse Event|0
51745|NCT01502410|216549|P3|Overall Study|Adverse Event|0
51746|NCT01502410|216550|P2|Overall Study|Adverse Event|2
51747|NCT01502410|216551|P1|Overall Study|Adverse Event|1
51748|NCT01502371|216564|P5|Overall Study|Excluded Medication|1
51749|NCT01502371|216565|P4|Overall Study|Excluded Medication|0
51750|NCT01502371|216566|P3|Overall Study|Excluded Medication|1
51751|NCT01502371|216567|P2|Overall Study|Excluded Medication|1
51752|NCT01502371|216568|P1|Overall Study|Excluded Medication|0
51753|NCT01502371|216564|P5|Overall Study|Protocol Violation|10
51754|NCT01502371|216565|P4|Overall Study|Protocol Violation|5
51755|NCT01502371|216566|P3|Overall Study|Protocol Violation|6
51756|NCT01502371|216567|P2|Overall Study|Protocol Violation|5
51757|NCT01502371|216568|P1|Overall Study|Protocol Violation|9
51758|NCT01502371|216564|P5|Overall Study|Technical Problems|1
51759|NCT01502371|216565|P4|Overall Study|Technical Problems|4
51760|NCT01502371|216566|P3|Overall Study|Technical Problems|2
51761|NCT01502371|216567|P2|Overall Study|Technical Problems|0
51762|NCT01502371|216568|P1|Overall Study|Technical Problems|1
51763|NCT01502371|216564|P5|Overall Study|Noncompliance with Study Drug|1
51764|NCT01502371|216565|P4|Overall Study|Noncompliance with Study Drug|2
51765|NCT01502371|216566|P3|Overall Study|Noncompliance with Study Drug|1
51766|NCT01502371|216567|P2|Overall Study|Noncompliance with Study Drug|0
51767|NCT01502371|216568|P1|Overall Study|Noncompliance with Study Drug|0
51768|NCT01502371|216564|P5|Overall Study|Physician Decision|1
51769|NCT01502371|216565|P4|Overall Study|Physician Decision|0
51770|NCT01502371|216566|P3|Overall Study|Physician Decision|0
51771|NCT01502371|216567|P2|Overall Study|Physician Decision|0
51772|NCT01502371|216568|P1|Overall Study|Physician Decision|3
51773|NCT01502371|216564|P5|Overall Study|Lack of Efficacy|4
51774|NCT01502371|216565|P4|Overall Study|Lack of Efficacy|2
51775|NCT01502371|216566|P3|Overall Study|Lack of Efficacy|2
51776|NCT01502371|216567|P2|Overall Study|Lack of Efficacy|3
51777|NCT01502371|216568|P1|Overall Study|Lack of Efficacy|3
51778|NCT01502371|216564|P5|Overall Study|Treatment Failure|30
51779|NCT01502371|216565|P4|Overall Study|Treatment Failure|19
51780|NCT01502371|216566|P3|Overall Study|Treatment Failure|12
51781|NCT01502371|216567|P2|Overall Study|Treatment Failure|20
51782|NCT01502371|216568|P1|Overall Study|Treatment Failure|22
51783|NCT01502371|216564|P5|Overall Study|Adverse Event|3
51784|NCT01502371|216565|P4|Overall Study|Adverse Event|4
51785|NCT01502371|216566|P3|Overall Study|Adverse Event|0
51786|NCT01502371|216567|P2|Overall Study|Adverse Event|1
51787|NCT01502371|216568|P1|Overall Study|Adverse Event|2
51788|NCT01502371|216564|P5|Overall Study|Withdrawal by Subject|1
51789|NCT01502371|216565|P4|Overall Study|Withdrawal by Subject|1
51790|NCT01502371|216566|P3|Overall Study|Withdrawal by Subject|1
51791|NCT01502371|216567|P2|Overall Study|Withdrawal by Subject|2
51792|NCT01502371|216568|P1|Overall Study|Withdrawal by Subject|1
51793|NCT01502228|216608|P1|Overall Study|Death|1
51794|NCT01502033|216613|P1|Overall Study|1 participant went back to school|1
51795|NCT01502033|216613|P1|Overall Study|1 participant had worsening depression|1
51796|NCT01502033|216613|P1|Overall Study|1 participant had scalp discomfort|1
51797|NCT01501110|216632|P2|Overall Study|Death|1
51798|NCT01501110|216633|P1|Overall Study|Death|0
51799|NCT01500720|216657|P2|Overall Study|Other|8
51800|NCT01500720|216658|P1|Overall Study|Other|4
51801|NCT01500720|216657|P2|Overall Study|Randomized But Not Treated|1
51802|NCT01500720|216658|P1|Overall Study|Randomized But Not Treated|1
51803|NCT01500694|216672|P2|Overall Study|Other|3
51804|NCT01500694|216673|P1|Overall Study|Other|9
51805|NCT01500694|216672|P2|Overall Study|Lack of Efficacy|5
51806|NCT01500694|216673|P1|Overall Study|Lack of Efficacy|14
51807|NCT01500694|216672|P2|Overall Study|Lost to Follow-up|3
51808|NCT01500694|216673|P1|Overall Study|Lost to Follow-up|2
51809|NCT01500694|216672|P2|Overall Study|Withdrawal by Subject|14
51810|NCT01500694|216673|P1|Overall Study|Withdrawal by Subject|23
51811|NCT01500694|216672|P2|Overall Study|Protocol Violation|1
51812|NCT01500694|216673|P1|Overall Study|Protocol Violation|0
51813|NCT01500694|216672|P2|Overall Study|Adverse Event|3
51814|NCT01500694|216673|P1|Overall Study|Adverse Event|4
51815|NCT01500629|216699|P2|Washout Period of 14 to 30 Days|Pregnancy|0
51816|NCT01500629|216700|P1|Washout Period of 14 to 30 Days|Pregnancy|1
51817|NCT01500434|216784|P1|Overall Study|Missed 12-month follow-up|5
51818|NCT01500434|216784|P1|Overall Study|Withdrawal by Subject|1
51819|NCT01500434|216784|P1|Overall Study|Death|1
51820|NCT01500382|216817|P4|Washout Period|Study site went out of business|0
51821|NCT01500382|216818|P3|Washout Period|Study site went out of business|1
51822|NCT01500382|216819|P2|Washout Period|Study site went out of business|0
51823|NCT01500382|216820|P1|Washout Period|Study site went out of business|0
51824|NCT01500317|216845|P3|Overall Study|Withdrawal by Subject|0
51825|NCT01500317|216846|P2|Overall Study|Withdrawal by Subject|2
51826|NCT01500317|216847|P1|Overall Study|Withdrawal by Subject|3
51827|NCT01500278|216869|P2|Week 13 - Week 104|Adverse Event|54
51828|NCT01500278|216870|P1|Week 13 - Week 104|Adverse Event|54
51829|NCT01500278|216869|P2|Week 13 - Week 104|Death|4
51830|NCT01500278|216870|P1|Week 13 - Week 104|Death|2
51831|NCT01500278|216869|P2|Week 13 - Week 104|Not completed|1
51832|NCT01500278|216870|P1|Week 13 - Week 104|Not completed|0
51833|NCT01500278|216869|P2|Week 13 - Week 104|Personal reason|1
51834|NCT01500278|216870|P1|Week 13 - Week 104|Personal reason|0
51835|NCT01500278|216869|P2|Week 13 - Week 104|Medical monitor decision|2
51836|NCT01500278|216870|P1|Week 13 - Week 104|Medical monitor decision|0
51837|NCT01500278|216869|P2|Week 13 - Week 104|Sponsor decision|2
51838|NCT01500278|216870|P1|Week 13 - Week 104|Sponsor decision|0
51839|NCT01500278|216869|P2|Week 13 - Week 104|Relocation|1
51840|NCT01500278|216870|P1|Week 13 - Week 104|Relocation|0
51841|NCT01500278|216869|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
51842|NCT01500278|216870|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
51843|NCT01500278|216869|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
51844|NCT01500278|216870|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
51845|NCT01500278|216869|P2|Week 13 - Week 104|Principal investigator retiring|0
51846|NCT01500278|216870|P1|Week 13 - Week 104|Principal investigator retiring|1
51847|NCT01500278|216869|P2|Week 13 - Week 104|Protocol deviation|0
51848|NCT01500278|216870|P1|Week 13 - Week 104|Protocol deviation|1
51849|NCT01500278|216869|P2|Week 13 - Week 104|Exclusion criteria not met|0
51850|NCT01500278|216870|P1|Week 13 - Week 104|Exclusion criteria not met|1
51851|NCT01500278|216869|P2|Week 13 - Week 104|Withdrawn in error|0
51852|NCT01500278|216870|P1|Week 13 - Week 104|Withdrawn in error|1
51853|NCT01500278|216869|P2|Week 13 - Week 104|Sponsor request|0
51854|NCT01500278|216870|P1|Week 13 - Week 104|Sponsor request|4
51855|NCT01500278|216869|P2|Week 13 - Week 104|False positive test|2
51856|NCT01500278|216870|P1|Week 13 - Week 104|False positive test|1
51857|NCT01500278|216869|P2|Week 13 - Week 104|Recurrent infections|0
51858|NCT01500278|216870|P1|Week 13 - Week 104|Recurrent infections|1
51859|NCT01500278|216869|P2|Week 13 - Week 104|Non/bad compliance|5
51860|NCT01500278|216870|P1|Week 13 - Week 104|Non/bad compliance|7
51861|NCT01500278|216869|P2|Week 13 - Week 104|Week 24 Non-Responder|16
51862|NCT01500278|216870|P1|Week 13 - Week 104|Week 24 Non-Responder|20
51863|NCT01500278|216869|P2|Week 13 - Week 104|Withdrawal by Subject|13
51864|NCT01500278|216870|P1|Week 13 - Week 104|Withdrawal by Subject|22
51865|NCT01500278|216869|P2|Week 13 - Week 104|Lost to Follow-up|5
51866|NCT01500278|216870|P1|Week 13 - Week 104|Lost to Follow-up|6
51867|NCT01500278|216869|P2|Week 13 - Week 104|Protocol Violation|6
51868|NCT01500278|216870|P1|Week 13 - Week 104|Protocol Violation|6
51869|NCT01500278|216869|P2|Week 13 - Week 104|Lack of Efficacy|12
51870|NCT01500278|216870|P1|Week 13 - Week 104|Lack of Efficacy|11
51871|NCT01500278|216869|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
51872|NCT01500278|216870|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
51873|NCT01500278|216869|P2|Week 0 - Week 12|Other serious disease|1
51874|NCT01500278|216870|P1|Week 0 - Week 12|Other serious disease|0
51875|NCT01500278|216869|P2|Week 0 - Week 12|Personal reason|1
51876|NCT01500278|216870|P1|Week 0 - Week 12|Personal reason|0
51877|NCT01500278|216869|P2|Week 0 - Week 12|Sponsor decision|0
51878|NCT01500278|216870|P1|Week 0 - Week 12|Sponsor decision|1
51879|NCT01500278|216869|P2|Week 0 - Week 12|Prior history of serious disease|0
51880|NCT01500278|216870|P1|Week 0 - Week 12|Prior history of serious disease|1
51881|NCT01500278|216869|P2|Week 0 - Week 12|Investigator decision|0
51882|NCT01500278|216870|P1|Week 0 - Week 12|Investigator decision|1
51883|NCT01500278|216869|P2|Week 0 - Week 12|Exclusion criteria not met|0
51884|NCT01500278|216870|P1|Week 0 - Week 12|Exclusion criteria not met|1
51885|NCT01500278|216869|P2|Week 0 - Week 12|Patient decision|0
51886|NCT01500278|216870|P1|Week 0 - Week 12|Patient decision|1
51887|NCT01500278|216869|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
51888|NCT01500278|216870|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
51889|NCT01500278|216869|P2|Week 0 - Week 12|Withdrawal by Subject|2
51890|NCT01500278|216870|P1|Week 0 - Week 12|Withdrawal by Subject|7
51891|NCT01500278|216869|P2|Week 0 - Week 12|Lost to Follow-up|1
51892|NCT01500278|216870|P1|Week 0 - Week 12|Lost to Follow-up|1
51893|NCT01500278|216869|P2|Week 0 - Week 12|Protocol Violation|16
51894|NCT01500278|216870|P1|Week 0 - Week 12|Protocol Violation|10
51895|NCT01500278|216869|P2|Week 0 - Week 12|Lack of Efficacy|1
51896|NCT01500278|216870|P1|Week 0 - Week 12|Lack of Efficacy|0
51897|NCT01500252|216894|P2|Overall Study|Lost to Follow-up|4
51898|NCT01500252|216895|P1|Overall Study|Lost to Follow-up|5
51899|NCT01500252|216894|P2|Overall Study|Death|2
51900|NCT01500252|216895|P1|Overall Study|Death|4
51901|NCT01500226|216921|P2|Overall Study|Other Reasons|16
51902|NCT01500226|216922|P1|Overall Study|Other Reasons|19
51903|NCT01500226|216921|P2|Overall Study|Lost to Follow-up|5
51904|NCT01500226|216922|P1|Overall Study|Lost to Follow-up|9
51905|NCT01500226|216921|P2|Overall Study|Lack of Efficacy|30
51906|NCT01500226|216922|P1|Overall Study|Lack of Efficacy|14
51907|NCT01500226|216921|P2|Overall Study|Physician Decision|15
51908|NCT01500226|216922|P1|Overall Study|Physician Decision|17
51909|NCT01500226|216921|P2|Overall Study|Protocol Violation|39
51910|NCT01500226|216922|P1|Overall Study|Protocol Violation|53
51911|NCT01500226|216921|P2|Overall Study|Disease Progression|14
51912|NCT01500226|216922|P1|Overall Study|Disease Progression|16
51913|NCT01500226|216921|P2|Overall Study|Death|4
51914|NCT01500226|216922|P1|Overall Study|Death|12
51915|NCT01500226|216921|P2|Overall Study|Withdrawal by Subject|96
51916|NCT01500226|216922|P1|Overall Study|Withdrawal by Subject|93
51917|NCT01500226|216921|P2|Overall Study|Chemo Completed or Change in Therapy|237
51918|NCT01500226|216922|P1|Overall Study|Chemo Completed or Change in Therapy|235
51919|NCT01500226|216921|P2|Overall Study|Adverse Event|38
51920|NCT01500226|216922|P1|Overall Study|Adverse Event|31
51921|NCT01500213|216934|P2|Overall Study|Other Reasons|5
51922|NCT01500213|216935|P1|Overall Study|Other Reasons|7
51923|NCT01500213|216934|P2|Overall Study|Lost to Follow-up|6
51924|NCT01500213|216935|P1|Overall Study|Lost to Follow-up|3
51925|NCT01500213|216934|P2|Overall Study|Lack of Efficacy|7
51926|NCT01500213|216935|P1|Overall Study|Lack of Efficacy|9
51927|NCT01500213|216934|P2|Overall Study|Physician Decision|10
51928|NCT01500213|216935|P1|Overall Study|Physician Decision|12
51929|NCT01500213|216934|P2|Overall Study|Protocol Violation|19
51930|NCT01500213|216935|P1|Overall Study|Protocol Violation|19
51931|NCT01500213|216934|P2|Overall Study|Disease Progression|21
51932|NCT01500213|216935|P1|Overall Study|Disease Progression|13
51933|NCT01500213|216934|P2|Overall Study|Death|3
51934|NCT01500213|216935|P1|Overall Study|Death|7
51935|NCT01500213|216934|P2|Overall Study|Withdrawal by Subject|37
51936|NCT01500213|216935|P1|Overall Study|Withdrawal by Subject|28
51937|NCT01500213|216934|P2|Overall Study|Chemo Completed or Change in Therapy|81
51938|NCT01500213|216935|P1|Overall Study|Chemo Completed or Change in Therapy|84
51939|NCT01500213|216934|P2|Overall Study|Adverse Event|35
51940|NCT01500213|216935|P1|Overall Study|Adverse Event|35
51941|NCT01500135|216947|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
51942|NCT01500135|216948|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
51943|NCT01500135|216947|P2|Overall Study|Participant was a Safety Concern|0
51944|NCT01500135|216948|P1|Overall Study|Participant was a Safety Concern|1
51945|NCT01500135|216947|P2|Overall Study|Patient Missed Scheduled Appointments|1
51946|NCT01500135|216948|P1|Overall Study|Patient Missed Scheduled Appointments|0
51947|NCT01500135|216947|P2|Overall Study|Principal Investigator (PI) Discretion|0
51948|NCT01500135|216948|P1|Overall Study|Principal Investigator (PI) Discretion|1
51949|NCT01500135|216947|P2|Overall Study|Fatal Adverse Event (AE)|5
51950|NCT01500135|216948|P1|Overall Study|Fatal Adverse Event (AE)|5
51951|NCT01500135|216947|P2|Overall Study|Lost to Follow-up|4
51952|NCT01500135|216948|P1|Overall Study|Lost to Follow-up|6
51953|NCT01500135|216947|P2|Overall Study|Withdrawal of Consent|0
51954|NCT01500135|216948|P1|Overall Study|Withdrawal of Consent|4
51955|NCT01500083|216973|P2|Overall Study|Other Reasons|5
51956|NCT01500083|216974|P1|Overall Study|Other Reasons|2
51957|NCT01500083|216973|P2|Overall Study|Investigator Discretion|8
51958|NCT01500083|216974|P1|Overall Study|Investigator Discretion|3
51959|NCT01500083|216973|P2|Overall Study|Disease Progression|10
51960|NCT01500083|216974|P1|Overall Study|Disease Progression|2
51961|NCT01500083|216973|P2|Overall Study|Withdrawal of Consent|1
51962|NCT01500083|216974|P1|Overall Study|Withdrawal of Consent|0
51963|NCT01500083|216973|P2|Overall Study|Lost to Follow-up|0
51964|NCT01500083|216974|P1|Overall Study|Lost to Follow-up|1
51965|NCT01500083|216973|P2|Overall Study|Death|2
51966|NCT01500083|216974|P1|Overall Study|Death|0
51967|NCT01500083|216973|P2|Overall Study|Adverse Event|17
51968|NCT01500083|216974|P1|Overall Study|Adverse Event|4
51969|NCT01500057|216982|P2|Overall Study|Lost to Follow-up|4
51970|NCT01500057|216983|P1|Overall Study|Lost to Follow-up|6
51971|NCT01500031|216993|P1|Overall Study|Withdrawal by Subject|4
51972|NCT01500031|216993|P1|Overall Study|Death|1
51973|NCT01499849|217028|P2|Overall Study|Other Reasons|30
51974|NCT01499849|217029|P1|Overall Study|Other Reasons|27
51975|NCT01499849|217028|P2|Overall Study|Lost to Follow-up|3
51976|NCT01499849|217029|P1|Overall Study|Lost to Follow-up|6
51977|NCT01499849|217028|P2|Overall Study|Lack of Efficacy|4
51978|NCT01499849|217029|P1|Overall Study|Lack of Efficacy|3
51979|NCT01499849|217028|P2|Overall Study|Physician Decision|19
51980|NCT01499849|217029|P1|Overall Study|Physician Decision|20
51981|NCT01499849|217028|P2|Overall Study|Protocol Violation|11
51982|NCT01499849|217029|P1|Overall Study|Protocol Violation|11
51983|NCT01499849|217028|P2|Overall Study|Disease Progression|10
51984|NCT01499849|217029|P1|Overall Study|Disease Progression|11
51985|NCT01499849|217028|P2|Overall Study|Death|7
51986|NCT01499849|217029|P1|Overall Study|Death|5
51987|NCT01499849|217028|P2|Overall Study|Withdrawal by Subject|43
51988|NCT01499849|217029|P1|Overall Study|Withdrawal by Subject|43
51989|NCT01499849|217028|P2|Overall Study|Chemo completed or Change in Therapy|67
51990|NCT01499849|217029|P1|Overall Study|Chemo completed or Change in Therapy|70
51991|NCT01499849|217028|P2|Overall Study|Adverse Event|32
51992|NCT01499849|217029|P1|Overall Study|Adverse Event|28
51993|NCT01499810|217039|P1|Overall Study|Withdrawal by Subject|1
51994|NCT01499810|217039|P1|Overall Study|Protocol Violation|1
51995|NCT01499810|217039|P1|Overall Study|Lost to Follow-up|10
51996|NCT01499667|217089|P3|Overall Study|Lack of Efficacy|0
51997|NCT01499667|217090|P2|Overall Study|Lack of Efficacy|0
51998|NCT01499667|217091|P1|Overall Study|Lack of Efficacy|2
51999|NCT01499667|217089|P3|Overall Study|Withdrawal by Subject|1
52000|NCT01499667|217090|P2|Overall Study|Withdrawal by Subject|1
52001|NCT01499667|217091|P1|Overall Study|Withdrawal by Subject|2
52002|NCT01499667|217089|P3|Overall Study|Adverse Event|2
52003|NCT01499667|217090|P2|Overall Study|Adverse Event|2
52004|NCT01499667|217091|P1|Overall Study|Adverse Event|0
52005|NCT01499667|217089|P3|Overall Study|Protocol Violation|2
52006|NCT01499667|217090|P2|Overall Study|Protocol Violation|3
52007|NCT01499667|217091|P1|Overall Study|Protocol Violation|1
52008|NCT01499667|217089|P3|Overall Study|administrative problems|5
52009|NCT01499667|217090|P2|Overall Study|administrative problems|5
52010|NCT01499667|217091|P1|Overall Study|administrative problems|4
52011|NCT01499576|217139|P1|Overall Study|Withdrawal by Subject|9
52012|NCT01499576|217139|P1|Overall Study|Physician Decision|12
52013|NCT01499355|217153|P4|Double-Blind Period|Lost to Follow-up|0
52014|NCT01499355|217154|P3|Double-Blind Period|Lost to Follow-up|0
52015|NCT01499355|217155|P2|Double-Blind Period|Lost to Follow-up|1
52016|NCT01499355|217156|P1|Double-Blind Period|Lost to Follow-up|0
52017|NCT01499355|217153|P4|Double-Blind Period|Consent Withdrawn|2
52018|NCT01499355|217154|P3|Double-Blind Period|Consent Withdrawn|1
52019|NCT01499355|217155|P2|Double-Blind Period|Consent Withdrawn|0
52020|NCT01499355|217156|P1|Double-Blind Period|Consent Withdrawn|0
52021|NCT01499355|217153|P4|Double-Blind Period|Investigator Decision|3
52022|NCT01499355|217154|P3|Double-Blind Period|Investigator Decision|3
52023|NCT01499355|217155|P2|Double-Blind Period|Investigator Decision|0
52024|NCT01499355|217156|P1|Double-Blind Period|Investigator Decision|0
52025|NCT01499355|217153|P4|Double-Blind Period|Death|0
52026|NCT01499355|217154|P3|Double-Blind Period|Death|0
52027|NCT01499355|217155|P2|Double-Blind Period|Death|1
52028|NCT01499355|217156|P1|Double-Blind Period|Death|0
52029|NCT01499355|217153|P4|Double-Blind Period|Not Specified|2
52030|NCT01499355|217154|P3|Double-Blind Period|Not Specified|2
52031|NCT01499355|217155|P2|Double-Blind Period|Not Specified|1
52032|NCT01499355|217156|P1|Double-Blind Period|Not Specified|0
52033|NCT01499355|217153|P4|Double-Blind Period|Study Termination|14
52034|NCT01499355|217154|P3|Double-Blind Period|Study Termination|16
52035|NCT01499355|217155|P2|Double-Blind Period|Study Termination|18
52036|NCT01499355|217156|P1|Double-Blind Period|Study Termination|0
52037|NCT01499355|217153|P4|Double-Blind Period|Adverse Event|2
52038|NCT01499355|217154|P3|Double-Blind Period|Adverse Event|3
52039|NCT01499355|217155|P2|Double-Blind Period|Adverse Event|2
52040|NCT01499355|217156|P1|Double-Blind Period|Adverse Event|0
52041|NCT01499355|217153|P4|Run-In Period|Adverse Event|0
52042|NCT01499355|217154|P3|Run-In Period|Adverse Event|0
52043|NCT01499355|217155|P2|Run-In Period|Adverse Event|0
52044|NCT01499355|217156|P1|Run-In Period|Adverse Event|8
52045|NCT01499355|217153|P4|Run-In Period|Consent Withdrawn|0
52046|NCT01499355|217154|P3|Run-In Period|Consent Withdrawn|0
52047|NCT01499355|217155|P2|Run-In Period|Consent Withdrawn|0
52048|NCT01499355|217156|P1|Run-In Period|Consent Withdrawn|1
52049|NCT01499355|217153|P4|Run-In Period|Investigator Decision|0
52050|NCT01499355|217154|P3|Run-In Period|Investigator Decision|0
52051|NCT01499355|217155|P2|Run-In Period|Investigator Decision|0
52052|NCT01499355|217156|P1|Run-In Period|Investigator Decision|2
52053|NCT01499355|217153|P4|Run-In Period|Death|0
52054|NCT01499355|217154|P3|Run-In Period|Death|0
52055|NCT01499355|217155|P2|Run-In Period|Death|0
52056|NCT01499355|217156|P1|Run-In Period|Death|2
52057|NCT01499355|217153|P4|Run-In Period|Not Specified|0
52058|NCT01499355|217154|P3|Run-In Period|Not Specified|0
52059|NCT01499355|217155|P2|Run-In Period|Not Specified|0
52060|NCT01499355|217156|P1|Run-In Period|Not Specified|3
52061|NCT01499355|217153|P4|Run-In Period|Study Termination|0
52062|NCT01499355|217154|P3|Run-In Period|Study Termination|0
52063|NCT01499355|217155|P2|Run-In Period|Study Termination|0
52064|NCT01499355|217156|P1|Run-In Period|Study Termination|15
52065|NCT01499303|217189|P2|Overall Study|Other|1
52066|NCT01499303|217190|P1|Overall Study|Other|0
52067|NCT01499303|217189|P2|Overall Study|Adverse Event|4
52068|NCT01499303|217190|P1|Overall Study|Adverse Event|1
52069|NCT01499303|217189|P2|Overall Study|Withdrawal by Subject|1
52070|NCT01499303|217190|P1|Overall Study|Withdrawal by Subject|0
52071|NCT01499303|217189|P2|Overall Study|Ongoing|1
52072|NCT01499303|217190|P1|Overall Study|Ongoing|2
52073|NCT01499290|217198|P2|Overall Study|Adverse Event|7
52074|NCT01499290|217199|P1|Overall Study|Adverse Event|14
52075|NCT01499290|217198|P2|Overall Study|Lack of Efficacy|8
52076|NCT01499290|217199|P1|Overall Study|Lack of Efficacy|7
52077|NCT01499290|217198|P2|Overall Study|Condition improved/subject recovered|0
52078|NCT01499290|217199|P1|Overall Study|Condition improved/subject recovered|1
52079|NCT01499290|217198|P2|Overall Study|Not specified in study report|5
52080|NCT01499290|217199|P1|Overall Study|Not specified in study report|11
52081|NCT01499290|217198|P2|Overall Study|Withdrawal by Subject|15
52082|NCT01499290|217199|P1|Overall Study|Withdrawal by Subject|22
52083|NCT01499277|217249|P2|Overall Study|Lack of therapeutic response and other|7
52084|NCT01499277|217250|P1|Overall Study|Lack of therapeutic response and other|8
52085|NCT01499277|217249|P2|Overall Study|Withdrawal by Subject|6
52086|NCT01499277|217250|P1|Overall Study|Withdrawal by Subject|16
52087|NCT01499277|217249|P2|Overall Study|Protocol Violation|3
52088|NCT01499277|217250|P1|Overall Study|Protocol Violation|2
52089|NCT01499277|217249|P2|Overall Study|Lost to Follow-up|8
52090|NCT01499277|217250|P1|Overall Study|Lost to Follow-up|15
52091|NCT01499277|217249|P2|Overall Study|Death|2
52092|NCT01499277|217250|P1|Overall Study|Death|3
52093|NCT01499277|217249|P2|Overall Study|Adverse Event|6
52094|NCT01499277|217250|P1|Overall Study|Adverse Event|3
52095|NCT01499199|217272|P1|Overall Study|Lack of Efficacy|1
52096|NCT01499199|217272|P1|Overall Study|Adverse Event|1
52097|NCT01499160|217301|P1|Overall Study|Withdrawal by Subject|1
52098|NCT01499160|217301|P1|Overall Study|Adverse Event|1
52099|NCT01499134|217324|P2|Overall Study|Withdrawal by Subject|1
52100|NCT01499134|217325|P1|Overall Study|Withdrawal by Subject|0
52101|NCT01499095|217347|P2|Overall Study|Perceived Lack of Efficacy|1
52102|NCT01499095|217348|P1|Overall Study|Perceived Lack of Efficacy|1
52103|NCT01499095|217347|P2|Overall Study|Change in Injection Schedule|0
52104|NCT01499095|217348|P1|Overall Study|Change in Injection Schedule|2
52105|NCT01499095|217347|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
52106|NCT01499095|217348|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
52107|NCT01499095|217347|P2|Overall Study|Hypoglycemia|1
52108|NCT01499095|217348|P1|Overall Study|Hypoglycemia|3
52109|NCT01499095|217347|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
52110|NCT01499095|217348|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
52111|NCT01499095|217347|P2|Overall Study|Lost to Follow-up|4
52112|NCT01499095|217348|P1|Overall Study|Lost to Follow-up|6
52113|NCT01499095|217347|P2|Overall Study|Diverse Reasons|25
52114|NCT01499095|217348|P1|Overall Study|Diverse Reasons|22
52115|NCT01499095|217347|P2|Overall Study|Received Rescue Therapy|40
52116|NCT01499095|217348|P1|Overall Study|Received Rescue Therapy|32
52117|NCT01499095|217347|P2|Overall Study|Protocol Violation|7
52118|NCT01499095|217348|P1|Overall Study|Protocol Violation|6
52119|NCT01499095|217347|P2|Overall Study|Lack of Efficacy|1
52120|NCT01499095|217348|P1|Overall Study|Lack of Efficacy|2
52121|NCT01499095|217347|P2|Overall Study|Adverse Event|7
52122|NCT01499095|217348|P1|Overall Study|Adverse Event|12
52123|NCT01499095|217347|P2|Overall Study|Randomized But Not Treated|1
52124|NCT01499095|217348|P1|Overall Study|Randomized But Not Treated|1
52125|NCT01499082|217378|P2|Overall Study|Lost to Follow-up|3
52126|NCT01499082|217379|P1|Overall Study|Lost to Follow-up|1
52127|NCT01499082|217378|P2|Overall Study|Hypoglycemia|3
52128|NCT01499082|217379|P1|Overall Study|Hypoglycemia|2
52129|NCT01499082|217378|P2|Overall Study|Site Closure for Noncompliance|2
52130|NCT01499082|217379|P1|Overall Study|Site Closure for Noncompliance|5
52131|NCT01499082|217378|P2|Overall Study|Diverse Reasons|14
52132|NCT01499082|217379|P1|Overall Study|Diverse Reasons|18
52133|NCT01499082|217378|P2|Overall Study|Protocol Violation|8
52134|NCT01499082|217379|P1|Overall Study|Protocol Violation|6
52135|NCT01499082|217378|P2|Overall Study|Lack of Efficacy|1
52136|NCT01499082|217379|P1|Overall Study|Lack of Efficacy|1
52137|NCT01499082|217378|P2|Overall Study|Adverse Event|16
52138|NCT01499082|217379|P1|Overall Study|Adverse Event|12
52139|NCT01499082|217378|P2|Overall Study|Randomized but not Treated|1
52140|NCT01499082|217379|P1|Overall Study|Randomized but not Treated|0
52141|NCT01498822|217429|P2|Overall Study|Lost to Follow-up|3
52142|NCT01498822|217430|P1|Overall Study|Lost to Follow-up|8
52143|NCT01498822|217429|P2|Overall Study|Withdrawal by Subject|25
52144|NCT01498822|217430|P1|Overall Study|Withdrawal by Subject|15
52145|NCT01498822|217429|P2|Overall Study|Adverse Event, serious fatal|1
52146|NCT01498822|217430|P1|Overall Study|Adverse Event, serious fatal|1
52147|NCT01498822|217429|P2|Overall Study|SAE, non-fatal|2
52148|NCT01498822|217430|P1|Overall Study|SAE, non-fatal|2
52149|NCT01498822|217429|P2|Overall Study|AE, non-serious non-fatal|17
52150|NCT01498822|217430|P1|Overall Study|AE, non-serious non-fatal|8
52151|NCT01498822|217429|P2|Overall Study|Lack of Efficacy|2
52152|NCT01498822|217430|P1|Overall Study|Lack of Efficacy|7
52153|NCT01498822|217429|P2|Overall Study|Other Reason|2
52154|NCT01498822|217430|P1|Overall Study|Other Reason|5
52155|NCT01498822|217429|P2|Overall Study|Protocol Violation|4
52156|NCT01498822|217430|P1|Overall Study|Protocol Violation|8
52157|NCT01498692|217457|P1|Overall Study|Missed 12-month visit|3
52158|NCT01498692|217457|P1|Overall Study|Withdrawal by Subject|1
52159|NCT01498692|217457|P1|Overall Study|Death|4
52160|NCT01498679|217488|P2|Overall Study|Withdrawal by Subject|4
52161|NCT01498679|217489|P1|Overall Study|Withdrawal by Subject|12
52162|NCT01498679|217488|P2|Overall Study|Physician Decision|2
52163|NCT01498679|217489|P1|Overall Study|Physician Decision|0
52164|NCT01498679|217488|P2|Overall Study|Protocol Violation|0
52165|NCT01498679|217489|P1|Overall Study|Protocol Violation|4
52166|NCT01498679|217488|P2|Overall Study|Lack of Efficacy|12
52167|NCT01498679|217489|P1|Overall Study|Lack of Efficacy|72
52168|NCT01498679|217488|P2|Overall Study|Adverse Event|4
52169|NCT01498679|217489|P1|Overall Study|Adverse Event|1
52170|NCT01498653|217505|P2|Overall Study|Withdrawal by Subject|3
52171|NCT01498653|217506|P1|Overall Study|Withdrawal by Subject|2
52172|NCT01498653|217505|P2|Overall Study|Physician Decision|0
52173|NCT01498653|217506|P1|Overall Study|Physician Decision|2
52174|NCT01498653|217505|P2|Overall Study|Lost to Follow-up|0
52175|NCT01498653|217506|P1|Overall Study|Lost to Follow-up|1
52176|NCT01498653|217505|P2|Overall Study|Protocol Violation|4
52177|NCT01498653|217506|P1|Overall Study|Protocol Violation|0
52178|NCT01498653|217505|P2|Overall Study|Lack of Efficacy|26
52179|NCT01498653|217506|P1|Overall Study|Lack of Efficacy|12
52180|NCT01498653|217505|P2|Overall Study|Adverse Event|2
52181|NCT01498653|217506|P1|Overall Study|Adverse Event|2
52182|NCT01498640|217520|P1|Overall Study|not specified|3
52183|NCT01498640|217520|P1|Overall Study|Death|1
52184|NCT01498640|217520|P1|Overall Study|Lost to Follow-up|1
52185|NCT01498575|217550|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
52186|NCT01498575|217551|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
52187|NCT01498575|217550|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
52188|NCT01498575|217551|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
52189|NCT01498575|217550|P2|Overall Sample|Withdrawal by Subject|14
52190|NCT01498575|217551|P1|Overall Sample|Withdrawal by Subject|60
52191|NCT01498458|217568|P1|Overall Study|Physician Decision|3
52192|NCT01498458|217568|P1|Overall Study|Adverse Event|4
52193|NCT01498185|217623|P5|Overall Study|No longer met criteria, etc|2
52194|NCT01498185|217624|P4|Overall Study|No longer met criteria, etc|0
52195|NCT01498185|217625|P3|Overall Study|No longer met criteria, etc|0
52196|NCT01498185|217626|P2|Overall Study|No longer met criteria, etc|0
52197|NCT01498185|217627|P1|Overall Study|No longer met criteria, etc|0
52198|NCT01498185|217623|P5|Overall Study|Withdrawal by Subject|1
52199|NCT01498185|217624|P4|Overall Study|Withdrawal by Subject|2
52200|NCT01498185|217625|P3|Overall Study|Withdrawal by Subject|0
52201|NCT01498185|217626|P2|Overall Study|Withdrawal by Subject|1
52202|NCT01498185|217627|P1|Overall Study|Withdrawal by Subject|1
52203|NCT01498185|217623|P5|Overall Study|Adverse Event|0
52204|NCT01498185|217624|P4|Overall Study|Adverse Event|1
52205|NCT01498185|217625|P3|Overall Study|Adverse Event|0
52206|NCT01498185|217626|P2|Overall Study|Adverse Event|0
52207|NCT01498185|217627|P1|Overall Study|Adverse Event|0
52208|NCT01498120|217667|P1|Overall Study|Other|4
52209|NCT01498120|217667|P1|Overall Study|AE, non-serious non-fatal|3
52210|NCT01498120|217667|P1|Overall Study|Withdrawal by Subject|5
52211|NCT01498120|217667|P1|Overall Study|Lost to Follow-up|1
52212|NCT01498068|217674|P2|Overall Study|Withdrawal by Subject|1
52213|NCT01498068|217675|P1|Overall Study|Withdrawal by Subject|1
52214|NCT01497938|217693|P2|Overall Study|Device Violation|0
52215|NCT01497938|217694|P1|Overall Study|Device Violation|1
52216|NCT01497938|217693|P2|Overall Study|Withdrawal by Subject|0
52217|NCT01497938|217694|P1|Overall Study|Withdrawal by Subject|4
52218|NCT01497938|217693|P2|Overall Study|Physician Decision|1
52219|NCT01497938|217694|P1|Overall Study|Physician Decision|0
52220|NCT01497938|217693|P2|Overall Study|Adverse Event|1
52221|NCT01497938|217694|P1|Overall Study|Adverse Event|0
52222|NCT01497899|217706|P4|Open-Label Extension Phase|Lost to Follow-up|5
52223|NCT01497899|217707|P3|Open-Label Extension Phase|Lost to Follow-up|5
52224|NCT01497899|217708|P2|Open-Label Extension Phase|Lost to Follow-up|3
52225|NCT01497899|217709|P1|Open-Label Extension Phase|Lost to Follow-up|9
52226|NCT01497899|217706|P4|Open-Label Extension Phase|Protocol Violation|0
52227|NCT01497899|217707|P3|Open-Label Extension Phase|Protocol Violation|1
52228|NCT01497899|217708|P2|Open-Label Extension Phase|Protocol Violation|0
52229|NCT01497899|217709|P1|Open-Label Extension Phase|Protocol Violation|0
52230|NCT01497899|217706|P4|Open-Label Extension Phase|Pregnancy|0
52231|NCT01497899|217707|P3|Open-Label Extension Phase|Pregnancy|1
52232|NCT01497899|217708|P2|Open-Label Extension Phase|Pregnancy|1
52233|NCT01497899|217709|P1|Open-Label Extension Phase|Pregnancy|0
52234|NCT01497899|217706|P4|Open-Label Extension Phase|Withdrew Consent|0
52235|NCT01497899|217707|P3|Open-Label Extension Phase|Withdrew Consent|2
52236|NCT01497899|217708|P2|Open-Label Extension Phase|Withdrew Consent|3
52237|NCT01497899|217709|P1|Open-Label Extension Phase|Withdrew Consent|8
52238|NCT01497899|217706|P4|Open-Label Extension Phase|Death|0
52239|NCT01497899|217707|P3|Open-Label Extension Phase|Death|0
52240|NCT01497899|217708|P2|Open-Label Extension Phase|Death|0
52241|NCT01497899|217709|P1|Open-Label Extension Phase|Death|1
52242|NCT01497899|217706|P4|Open-Label Extension Phase|Adverse Event|0
52243|NCT01497899|217707|P3|Open-Label Extension Phase|Adverse Event|0
52244|NCT01497899|217708|P2|Open-Label Extension Phase|Adverse Event|0
52245|NCT01497899|217709|P1|Open-Label Extension Phase|Adverse Event|1
52246|NCT01497899|217706|P4|Double-Blind Phase|Subject Non-Compliance|0
52247|NCT01497899|217707|P3|Double-Blind Phase|Subject Non-Compliance|0
52248|NCT01497899|217708|P2|Double-Blind Phase|Subject Non-Compliance|1
52249|NCT01497899|217709|P1|Double-Blind Phase|Subject Non-Compliance|0
52250|NCT01497899|217706|P4|Double-Blind Phase|Lost to Follow-up|0
52251|NCT01497899|217707|P3|Double-Blind Phase|Lost to Follow-up|0
52252|NCT01497899|217708|P2|Double-Blind Phase|Lost to Follow-up|2
52253|NCT01497899|217709|P1|Double-Blind Phase|Lost to Follow-up|3
52254|NCT01497899|217706|P4|Double-Blind Phase|Withdrew Consent|0
52255|NCT01497899|217707|P3|Double-Blind Phase|Withdrew Consent|0
52256|NCT01497899|217708|P2|Double-Blind Phase|Withdrew Consent|1
52257|NCT01497899|217709|P1|Double-Blind Phase|Withdrew Consent|0
52258|NCT01497899|217706|P4|Double-Blind Phase|Investigator's Discretion|0
52259|NCT01497899|217707|P3|Double-Blind Phase|Investigator's Discretion|0
52260|NCT01497899|217708|P2|Double-Blind Phase|Investigator's Discretion|0
52261|NCT01497899|217709|P1|Double-Blind Phase|Investigator's Discretion|1
52262|NCT01497899|217706|P4|Double-Blind Phase|Lack of Efficacy|0
52263|NCT01497899|217707|P3|Double-Blind Phase|Lack of Efficacy|0
52264|NCT01497899|217708|P2|Double-Blind Phase|Lack of Efficacy|1
52265|NCT01497899|217709|P1|Double-Blind Phase|Lack of Efficacy|0
52266|NCT01497899|217706|P4|Double-Blind Phase|Adverse Event|0
52267|NCT01497899|217707|P3|Double-Blind Phase|Adverse Event|0
52268|NCT01497899|217708|P2|Double-Blind Phase|Adverse Event|0
52269|NCT01497899|217709|P1|Double-Blind Phase|Adverse Event|1
52270|NCT01497899|217706|P4|Double-Blind Phase|Randomized but not Treated|0
52271|NCT01497899|217707|P3|Double-Blind Phase|Randomized but not Treated|0
52272|NCT01497899|217708|P2|Double-Blind Phase|Randomized but not Treated|0
52273|NCT01497899|217709|P1|Double-Blind Phase|Randomized but not Treated|1
52274|NCT01497366|217772|P2|Overall Study|Randomized but not treated|21
52275|NCT01497366|217773|P1|Overall Study|Randomized but not treated|7
52276|NCT01497366|217772|P2|Overall Study|Death|1
52277|NCT01497366|217773|P1|Overall Study|Death|1
52278|NCT01497366|217772|P2|Overall Study|Other|0
52279|NCT01497366|217773|P1|Overall Study|Other|5
52280|NCT01497366|217772|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
52281|NCT01497366|217773|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
52282|NCT01497366|217772|P2|Overall Study|Withdrawal by Subject|6
52283|NCT01497366|217773|P1|Overall Study|Withdrawal by Subject|6
52284|NCT01497366|217772|P2|Overall Study|Lost to Follow-up|10
52285|NCT01497366|217773|P1|Overall Study|Lost to Follow-up|11
52286|NCT01497366|217772|P2|Overall Study|Virologic failure|50
52287|NCT01497366|217773|P1|Overall Study|Virologic failure|2
52288|NCT01497275|217791|P1|Overall Study|Adverse Event|1
52289|NCT01497275|217791|P1|Overall Study|Death|1
52290|NCT01497262|217798|P1|Overall Study|Protocol Violation|1
52291|NCT01497262|217798|P1|Overall Study|Adverse Event|2
52292|NCT01497262|217798|P1|Overall Study|Withdrawal by Subject|2
52293|NCT01497262|217798|P1|Overall Study|Physician Decision|1
52294|NCT01497262|217798|P1|Overall Study|Abnormal Test Procedure Result|1
52295|NCT01497262|217798|P1|Overall Study|Abnormal Lab Values|4
52296|NCT01497197|217805|P2|Overall Study|Other|1
52297|NCT01497197|217806|P1|Overall Study|Other|3
52298|NCT01497197|217805|P2|Overall Study|All embryos discarded|3
52299|NCT01497197|217806|P1|Overall Study|All embryos discarded|0
52300|NCT01497197|217805|P2|Overall Study|Intention to freeze all embryos|1
52301|NCT01497197|217806|P1|Overall Study|Intention to freeze all embryos|0
52302|NCT01497197|217805|P2|Overall Study|No fertilisation|5
52303|NCT01497197|217806|P1|Overall Study|No fertilisation|6
52304|NCT01497197|217805|P2|Overall Study|No oocytes retrieved|2
52305|NCT01497197|217806|P1|Overall Study|No oocytes retrieved|3
52306|NCT01497197|217805|P2|Overall Study|Risk of OHSS|0
52307|NCT01497197|217806|P1|Overall Study|Risk of OHSS|1
52308|NCT01497197|217805|P2|Overall Study|Excessive/lack of response to treatment|0
52309|NCT01497197|217806|P1|Overall Study|Excessive/lack of response to treatment|1
52310|NCT01497197|217805|P2|Overall Study|Withdrawal by Subject|1
52311|NCT01497197|217806|P1|Overall Study|Withdrawal by Subject|2
52312|NCT01497197|217805|P2|Overall Study|Protocol Violation|2
52313|NCT01497197|217806|P1|Overall Study|Protocol Violation|0
52314|NCT01497197|217805|P2|Overall Study|Lost to Follow-up|0
52315|NCT01497197|217806|P1|Overall Study|Lost to Follow-up|1
52316|NCT01496846|217847|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
52317|NCT01496846|217848|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
52318|NCT01496846|217849|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
52319|NCT01496846|217850|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
52320|NCT01496846|217851|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
52321|NCT01496846|217852|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
52322|NCT01496807|217863|P1|Overall Study|Change in diagnosis|1
52323|NCT01496807|217863|P1|Overall Study|Participant preference/toxicity|8
52324|NCT01496807|217863|P1|Overall Study|Progressive Disease|21
52325|NCT01496469|217875|P2|Overall Study|Other|1
52326|NCT01496469|217876|P1|Overall Study|Other|1
52327|NCT01496469|217875|P2|Overall Study|BP exceeds protocol limits|2
52328|NCT01496469|217876|P1|Overall Study|BP exceeds protocol limits|1
52329|NCT01496469|217875|P2|Overall Study|Withdrawal by Subject|4
52330|NCT01496469|217876|P1|Overall Study|Withdrawal by Subject|4
52331|NCT01496469|217875|P2|Overall Study|Lost to Follow-up|1
52332|NCT01496469|217876|P1|Overall Study|Lost to Follow-up|1
52333|NCT01496469|217875|P2|Overall Study|Protocol Violation|0
52334|NCT01496469|217876|P1|Overall Study|Protocol Violation|2
52335|NCT01496469|217875|P2|Overall Study|Adverse Event|0
52336|NCT01496469|217876|P1|Overall Study|Adverse Event|1
52337|NCT01496456|217886|P1|Overall Study|Lost to Follow-up|7
52338|NCT01496456|217886|P1|Overall Study|Protocol Violation|1
52339|NCT01496430|217899|P3|Overall Study|Other|0
52340|NCT01496430|217900|P2|Overall Study|Other|0
52341|NCT01496430|217901|P1|Overall Study|Other|2
52342|NCT01496430|217899|P3|Overall Study|Principal Investigator Discretion|1
52343|NCT01496430|217900|P2|Overall Study|Principal Investigator Discretion|1
52344|NCT01496430|217901|P1|Overall Study|Principal Investigator Discretion|0
52345|NCT01496430|217899|P3|Overall Study|Voluntary Withdrawal|6
52346|NCT01496430|217900|P2|Overall Study|Voluntary Withdrawal|1
52347|NCT01496430|217901|P1|Overall Study|Voluntary Withdrawal|2
52348|NCT01496430|217899|P3|Overall Study|Lost to Follow-up|1
52349|NCT01496430|217900|P2|Overall Study|Lost to Follow-up|3
52350|NCT01496430|217901|P1|Overall Study|Lost to Follow-up|2
52351|NCT01496430|217899|P3|Overall Study|Major Protocol Deviation|1
52352|NCT01496430|217900|P2|Overall Study|Major Protocol Deviation|0
52353|NCT01496430|217901|P1|Overall Study|Major Protocol Deviation|0
52354|NCT01496430|217899|P3|Overall Study|Adverse Event|1
52355|NCT01496430|217900|P2|Overall Study|Adverse Event|0
52356|NCT01496430|217901|P1|Overall Study|Adverse Event|0
52357|NCT01496287|218013|P1|Overall Study|Incomplete anesthesia|5
52358|NCT01496287|218013|P1|Overall Study|Lost to Follow-up|1
52359|NCT01496274|218023|P2|Overall Study|Lost to Follow-up|3
52360|NCT01496274|218024|P1|Overall Study|Lost to Follow-up|0
52361|NCT01496274|218023|P2|Overall Study|Withdrawal by Subject|0
52362|NCT01496274|218024|P1|Overall Study|Withdrawal by Subject|2
52363|NCT01496274|218023|P2|Overall Study|Adverse Event|1
52364|NCT01496274|218024|P1|Overall Study|Adverse Event|1
52365|NCT01496274|218023|P2|Overall Study|Protocol Violation|1
52366|NCT01496274|218024|P1|Overall Study|Protocol Violation|0
52367|NCT01496183|218069|P2|Overall Study|Withdrawal by Subject|1
52368|NCT01496183|218070|P1|Overall Study|Withdrawal by Subject|0
52369|NCT01496183|218069|P2|Overall Study|Physician Decision|1
52370|NCT01496183|218070|P1|Overall Study|Physician Decision|3
52371|NCT01496066|218093|P2|Overall Study|Death|4
52372|NCT01496066|218094|P1|Overall Study|Death|1
52373|NCT01496066|218093|P2|Overall Study|Explant|0
52374|NCT01496066|218094|P1|Overall Study|Explant|3
52375|NCT01496066|218093|P2|Overall Study|Lost to Follow-up|5
52376|NCT01496066|218094|P1|Overall Study|Lost to Follow-up|8
52377|NCT01495975|218156|P2|Overall Study|Lost to Follow-up|0
52378|NCT01495975|218157|P1|Overall Study|Lost to Follow-up|1
52379|NCT01495793|218281|P1|Overall Study|Violation of inclusion criteria|1
52380|NCT01495793|218281|P1|Overall Study|Lost to Follow-up|1
52381|NCT01495702|218294|P2|Randomized Phase|Protocol Violation|1
52382|NCT01495702|218295|P1|Randomized Phase|Protocol Violation|3
52383|NCT01495702|218294|P2|Randomized Phase|Participant Noncompliance|0
52384|NCT01495702|218295|P1|Randomized Phase|Participant Noncompliance|1
52385|NCT01495702|218294|P2|Randomized Phase|Lost to Follow-up|3
52386|NCT01495702|218295|P1|Randomized Phase|Lost to Follow-up|4
52387|NCT01495702|218294|P2|Randomized Phase|Withdrew Consent|18
52388|NCT01495702|218295|P1|Randomized Phase|Withdrew Consent|10
52389|NCT01495702|218294|P2|Randomized Phase|Investigators Discretion|0
52390|NCT01495702|218295|P1|Randomized Phase|Investigators Discretion|2
52391|NCT01495702|218294|P2|Randomized Phase|Lack of Efficacy|0
52392|NCT01495702|218295|P1|Randomized Phase|Lack of Efficacy|2
52393|NCT01495702|218294|P2|Randomized Phase|Death|0
52394|NCT01495702|218295|P1|Randomized Phase|Death|1
52395|NCT01495702|218294|P2|Randomized Phase|Adverse Event|2
52396|NCT01495702|218295|P1|Randomized Phase|Adverse Event|2
52397|NCT01495702|218294|P2|Randomized Phase|Randomized But Not Treated|4
52398|NCT01495702|218295|P1|Randomized Phase|Randomized But Not Treated|1
52399|NCT01495000|218366|P2|Overall Study|Withdrawal by Subject|10
52400|NCT01495000|218367|P1|Overall Study|Withdrawal by Subject|10
52401|NCT01495000|218366|P2|Overall Study|Protocol Violation|0
52402|NCT01495000|218367|P1|Overall Study|Protocol Violation|1
52403|NCT01495000|218366|P2|Overall Study|Lost to Follow-up|2
52404|NCT01495000|218367|P1|Overall Study|Lost to Follow-up|2
52405|NCT01494987|218409|P2|Overall Study|Subject Withdrew Consent|3
52406|NCT01494987|218410|P1|Overall Study|Subject Withdrew Consent|2
52407|NCT01494987|218409|P2|Overall Study|Subject Non-Compliance|10
52408|NCT01494987|218410|P1|Overall Study|Subject Non-Compliance|9
52409|NCT01494987|218409|P2|Overall Study|Protocol Violation|3
52410|NCT01494987|218410|P1|Overall Study|Protocol Violation|3
52411|NCT01494987|218409|P2|Overall Study|Lost to Follow-up|1
52412|NCT01494987|218410|P1|Overall Study|Lost to Follow-up|1
52413|NCT01494987|218409|P2|Overall Study|Investigator's Discretion|2
52414|NCT01494987|218410|P1|Overall Study|Investigator's Discretion|1
52415|NCT01494987|218409|P2|Overall Study|Hyperglycemia|4
52416|NCT01494987|218410|P1|Overall Study|Hyperglycemia|6
52417|NCT01494987|218409|P2|Overall Study|Adverse Event|5
52418|NCT01494987|218410|P1|Overall Study|Adverse Event|6
52419|NCT01494818|218424|P2|Overall Study|Lost to Follow-up|0
52420|NCT01494818|218425|P1|Overall Study|Lost to Follow-up|1
52421|NCT01494818|218424|P2|Overall Study|Relocation|2
52422|NCT01494818|218425|P1|Overall Study|Relocation|1
52423|NCT01494649|218456|P2|Overall Study|Lost to Follow-up|1
52424|NCT01494649|218457|P1|Overall Study|Lost to Follow-up|0
52425|NCT01494610|218473|P2|Period 4|Protocol Violation|0
52426|NCT01494610|218474|P1|Period 4|Protocol Violation|1
52427|NCT01494610|218473|P2|Period 3|Withdrawal by Subject|0
52428|NCT01494610|218474|P1|Period 3|Withdrawal by Subject|1
52429|NCT01494610|218473|P2|Period 3|Adverse Event|0
52430|NCT01494610|218474|P1|Period 3|Adverse Event|1
52431|NCT01494610|218473|P2|Period 1|Withdrawal by Subject|1
52432|NCT01494610|218474|P1|Period 1|Withdrawal by Subject|1
52433|NCT01494584|218542|P1|Overall Study|Study Closed/Terminated|1
52434|NCT01494532|218674|P6|Overall Study|Withdrawal by Subject|0
52435|NCT01494532|218675|P5|Overall Study|Withdrawal by Subject|2
52436|NCT01494532|218676|P4|Overall Study|Withdrawal by Subject|3
52437|NCT01494532|218677|P3|Overall Study|Withdrawal by Subject|4
52438|NCT01494532|218678|P2|Overall Study|Withdrawal by Subject|1
52439|NCT01494532|218679|P1|Overall Study|Withdrawal by Subject|3
52440|NCT01494532|218674|P6|Overall Study|Physician Decision|0
52441|NCT01494532|218675|P5|Overall Study|Physician Decision|0
52442|NCT01494532|218676|P4|Overall Study|Physician Decision|2
52443|NCT01494532|218677|P3|Overall Study|Physician Decision|1
52444|NCT01494532|218678|P2|Overall Study|Physician Decision|1
52445|NCT01494532|218679|P1|Overall Study|Physician Decision|0
52446|NCT01494532|218674|P6|Overall Study|Lost to Follow-up|0
52447|NCT01494532|218675|P5|Overall Study|Lost to Follow-up|0
52448|NCT01494532|218676|P4|Overall Study|Lost to Follow-up|2
52449|NCT01494532|218677|P3|Overall Study|Lost to Follow-up|0
52450|NCT01494532|218678|P2|Overall Study|Lost to Follow-up|0
52451|NCT01494532|218679|P1|Overall Study|Lost to Follow-up|1
52452|NCT01494532|218674|P6|Overall Study|Protocol-defined stopping criteria|0
52453|NCT01494532|218675|P5|Overall Study|Protocol-defined stopping criteria|0
52454|NCT01494532|218676|P4|Overall Study|Protocol-defined stopping criteria|0
52455|NCT01494532|218677|P3|Overall Study|Protocol-defined stopping criteria|1
52456|NCT01494532|218678|P2|Overall Study|Protocol-defined stopping criteria|0
52457|NCT01494532|218679|P1|Overall Study|Protocol-defined stopping criteria|0
52458|NCT01494532|218674|P6|Overall Study|Protocol deviation|0
52459|NCT01494532|218675|P5|Overall Study|Protocol deviation|3
52460|NCT01494532|218676|P4|Overall Study|Protocol deviation|2
52461|NCT01494532|218677|P3|Overall Study|Protocol deviation|3
52462|NCT01494532|218678|P2|Overall Study|Protocol deviation|1
52463|NCT01494532|218679|P1|Overall Study|Protocol deviation|2
52464|NCT01494532|218674|P6|Overall Study|Lack of Efficacy|0
52465|NCT01494532|218675|P5|Overall Study|Lack of Efficacy|2
52466|NCT01494532|218676|P4|Overall Study|Lack of Efficacy|0
52467|NCT01494532|218677|P3|Overall Study|Lack of Efficacy|0
52468|NCT01494532|218678|P2|Overall Study|Lack of Efficacy|0
52469|NCT01494532|218679|P1|Overall Study|Lack of Efficacy|0
52470|NCT01494532|218674|P6|Overall Study|Adverse Event|0
52471|NCT01494532|218675|P5|Overall Study|Adverse Event|5
52472|NCT01494532|218676|P4|Overall Study|Adverse Event|6
52473|NCT01494532|218677|P3|Overall Study|Adverse Event|8
52474|NCT01494532|218678|P2|Overall Study|Adverse Event|1
52475|NCT01494532|218679|P1|Overall Study|Adverse Event|4
52476|NCT01494506|218834|P3|Overall Study|Other|1
52477|NCT01494506|218835|P2|Overall Study|Other|3
52478|NCT01494506|218836|P1|Overall Study|Other|0
52479|NCT01494506|218834|P3|Overall Study|Sponsor Decision|1
52480|NCT01494506|218835|P2|Overall Study|Sponsor Decision|0
52481|NCT01494506|218836|P1|Overall Study|Sponsor Decision|0
52482|NCT01494506|218834|P3|Overall Study|Clinical Deterioration|13
52483|NCT01494506|218835|P2|Overall Study|Clinical Deterioration|17
52484|NCT01494506|218836|P1|Overall Study|Clinical Deterioration|21
52485|NCT01494506|218834|P3|Overall Study|Withdrawal by Subject|14
52486|NCT01494506|218835|P2|Overall Study|Withdrawal by Subject|20
52487|NCT01494506|218836|P1|Overall Study|Withdrawal by Subject|17
52488|NCT01494506|218834|P3|Overall Study|Physician Decision|4
52489|NCT01494506|218835|P2|Overall Study|Physician Decision|5
52490|NCT01494506|218836|P1|Overall Study|Physician Decision|7
52491|NCT01494506|218834|P3|Overall Study|Death|2
52492|NCT01494506|218835|P2|Overall Study|Death|5
52493|NCT01494506|218836|P1|Overall Study|Death|9
52494|NCT01494506|218834|P3|Overall Study|Adverse Event|11
52495|NCT01494506|218835|P2|Overall Study|Adverse Event|10
52496|NCT01494506|218836|P1|Overall Study|Adverse Event|17
52497|NCT01494506|218834|P3|Overall Study|Lack of Efficacy|57
52498|NCT01494506|218835|P2|Overall Study|Lack of Efficacy|83
52499|NCT01494506|218836|P1|Overall Study|Lack of Efficacy|77
52500|NCT01494467|218873|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
52501|NCT01494467|218874|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
52502|NCT01494467|218873|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
52503|NCT01494467|218874|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
52504|NCT01494467|218873|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
52505|NCT01494467|218874|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
52506|NCT01494467|218873|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
52507|NCT01494467|218874|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
52508|NCT01494467|218873|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
52509|NCT01494467|218874|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
52510|NCT01494467|218873|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
52511|NCT01494467|218874|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
52512|NCT01494467|218873|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
52513|NCT01494467|218874|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
52514|NCT01494467|218873|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
52515|NCT01494467|218874|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
52516|NCT01494467|218873|P2|Part A Vehicle Control (12 Weeks)|Other|1
52517|NCT01494467|218874|P1|Part A Vehicle Control (12 Weeks)|Other|1
52518|NCT01494467|218873|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
52519|NCT01494467|218874|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
52520|NCT01494467|218873|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
52521|NCT01494467|218874|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
52522|NCT01494467|218873|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
52523|NCT01494467|218874|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
52524|NCT01494467|218873|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
52525|NCT01494467|218874|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
52526|NCT01494467|218873|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
52527|NCT01494467|218874|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
52528|NCT01494350|218890|P1|Overall Study|Worsening of lesion|1
52529|NCT01494298|218900|P2|Overall Study|Protocol Violation|8
52530|NCT01494298|218901|P1|Overall Study|Protocol Violation|2
52531|NCT01493960|218913|P2|Overall Study|Non-specified|4
52532|NCT01493960|218914|P1|Overall Study|Non-specified|4
52533|NCT01493960|218913|P2|Overall Study|Withdrawal by Subject|4
52534|NCT01493960|218914|P1|Overall Study|Withdrawal by Subject|10
52535|NCT01493960|218913|P2|Overall Study|Protocol Violation|0
52536|NCT01493960|218914|P1|Overall Study|Protocol Violation|3
52537|NCT01493960|218913|P2|Overall Study|Lack of Efficacy|9
52538|NCT01493960|218914|P1|Overall Study|Lack of Efficacy|15
52539|NCT01493960|218913|P2|Overall Study|Adverse Event|1
52540|NCT01493960|218914|P1|Overall Study|Adverse Event|0
52541|NCT01493687|218947|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
52542|NCT01493687|218948|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
52543|NCT01493687|218947|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
52544|NCT01493687|218948|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
52545|NCT01493687|218947|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
52546|NCT01493687|218948|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
52547|NCT01493687|218947|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
52548|NCT01493687|218948|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
52549|NCT01493687|218947|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
52550|NCT01493687|218948|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
52551|NCT01493687|218947|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
52552|NCT01493687|218948|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
52553|NCT01493687|218947|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
52554|NCT01493687|218948|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
52555|NCT01493687|218947|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
52556|NCT01493687|218948|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
52557|NCT01493687|218947|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
52558|NCT01493687|218948|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
52559|NCT01493687|218947|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
52560|NCT01493687|218948|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
52561|NCT01493687|218947|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
52562|NCT01493687|218948|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
52563|NCT01493687|218947|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
52564|NCT01493687|218948|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
52565|NCT01493687|218947|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
52566|NCT01493687|218948|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
52567|NCT01493687|218947|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
52568|NCT01493687|218948|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
52569|NCT01493687|218947|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
52570|NCT01493687|218948|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
52571|NCT01493557|218967|P3|Adding the Second Strategy|Withdrawal by Subject|0
52572|NCT01493557|218968|P2|Adding the Second Strategy|Withdrawal by Subject|1
52573|NCT01493557|218969|P1|Adding the Second Strategy|Withdrawal by Subject|0
52574|NCT01493557|218967|P3|Adding the Second Strategy|Other adverse event|0
52575|NCT01493557|218968|P2|Adding the Second Strategy|Other adverse event|2
52576|NCT01493557|218969|P1|Adding the Second Strategy|Other adverse event|1
52577|NCT01493557|218967|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
52578|NCT01493557|218968|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
52579|NCT01493557|218969|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
52580|NCT01493557|218967|P3|Randomized to Management Strategies|Other than stated above|0
52581|NCT01493557|218968|P2|Randomized to Management Strategies|Other than stated above|3
52582|NCT01493557|218969|P1|Randomized to Management Strategies|Other than stated above|1
52583|NCT01493557|218967|P3|Randomized to Management Strategies|Withdrawal by Subject|0
52584|NCT01493557|218968|P2|Randomized to Management Strategies|Withdrawal by Subject|1
52585|NCT01493557|218969|P1|Randomized to Management Strategies|Withdrawal by Subject|0
52586|NCT01493557|218967|P3|Randomized to Management Strategies|Protocol Violation|0
52587|NCT01493557|218968|P2|Randomized to Management Strategies|Protocol Violation|0
52588|NCT01493557|218969|P1|Randomized to Management Strategies|Protocol Violation|3
52589|NCT01493557|218967|P3|Randomized to Management Strategies|Other adverse event|0
52590|NCT01493557|218968|P2|Randomized to Management Strategies|Other adverse event|5
52591|NCT01493557|218969|P1|Randomized to Management Strategies|Other adverse event|8
52592|NCT01493557|218967|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
52593|NCT01493557|218968|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
52594|NCT01493557|218969|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
52595|NCT01493557|218967|P3|Not Randomized to Management Strategies|Other than stated above|21
52596|NCT01493557|218968|P2|Not Randomized to Management Strategies|Other than stated above|0
52597|NCT01493557|218969|P1|Not Randomized to Management Strategies|Other than stated above|0
52598|NCT01493557|218967|P3|Not Randomized to Management Strategies|Early termination|34
52599|NCT01493557|218968|P2|Not Randomized to Management Strategies|Early termination|0
52600|NCT01493557|218969|P1|Not Randomized to Management Strategies|Early termination|0
52601|NCT01493557|218967|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
52602|NCT01493557|218968|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
52603|NCT01493557|218969|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
52604|NCT01493557|218967|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
52605|NCT01493557|218968|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
52606|NCT01493557|218969|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
52607|NCT01493557|218967|P3|Not Randomized to Management Strategies|Protocol Violation|1
52608|NCT01493557|218968|P2|Not Randomized to Management Strategies|Protocol Violation|0
52609|NCT01493557|218969|P1|Not Randomized to Management Strategies|Protocol Violation|0
52610|NCT01493557|218967|P3|Not Randomized to Management Strategies|Other adverse event|54
52611|NCT01493557|218968|P2|Not Randomized to Management Strategies|Other adverse event|0
52612|NCT01493557|218969|P1|Not Randomized to Management Strategies|Other adverse event|0
52613|NCT01493557|218967|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
52614|NCT01493557|218968|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
52615|NCT01493557|218969|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
52616|NCT01493557|218967|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
52617|NCT01493557|218968|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
52618|NCT01493557|218969|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
52619|NCT01493531|218997|P3|Overall Study|Death|0
52620|NCT01493531|218998|P2|Overall Study|Death|1
52621|NCT01493531|218999|P1|Overall Study|Death|0
52622|NCT01493531|218997|P3|Overall Study|Withdrawal by Subject|11
52623|NCT01493531|218998|P2|Overall Study|Withdrawal by Subject|13
52624|NCT01493531|218999|P1|Overall Study|Withdrawal by Subject|16
52625|NCT01493531|218997|P3|Overall Study|Lost to Follow-up|11
52626|NCT01493531|218998|P2|Overall Study|Lost to Follow-up|7
52627|NCT01493531|218999|P1|Overall Study|Lost to Follow-up|5
52628|NCT01493531|218997|P3|Overall Study|Sponsor terminated study|3
52629|NCT01493531|218998|P2|Overall Study|Sponsor terminated study|2
52630|NCT01493531|218999|P1|Overall Study|Sponsor terminated study|5
52631|NCT01493531|218997|P3|Overall Study|Protocol Violation|12
52632|NCT01493531|218998|P2|Overall Study|Protocol Violation|15
52633|NCT01493531|218999|P1|Overall Study|Protocol Violation|8
52634|NCT01493531|218997|P3|Overall Study|Gout flare|2
52635|NCT01493531|218998|P2|Overall Study|Gout flare|0
52636|NCT01493531|218999|P1|Overall Study|Gout flare|3
52637|NCT01493531|218997|P3|Overall Study|Adverse Event|9
52638|NCT01493531|218998|P2|Overall Study|Adverse Event|12
52639|NCT01493531|218999|P1|Overall Study|Adverse Event|4
52640|NCT01493427|219013|P1|Overall Study|Other|2
52641|NCT01493427|219013|P1|Overall Study|Inability to Follow Instructions|2
52642|NCT01493427|219013|P1|Overall Study|Lost to Follow-up|2
52643|NCT01493427|219013|P1|Overall Study|Personal Reasons|4
52644|NCT01493427|219013|P1|Overall Study|Adverse Event|10
52645|NCT01493284|219018|P1|Overall Study|Withdrawal by Subject|32
52646|NCT01493284|219018|P1|Overall Study|Death|29
52647|NCT01493089|219040|P2|Overall Study|Physician Decision|1
52648|NCT01493089|219041|P1|Overall Study|Physician Decision|0
52649|NCT01493089|219040|P2|Overall Study|Withdrawal by Subject|0
52650|NCT01493089|219041|P1|Overall Study|Withdrawal by Subject|1
52651|NCT01493089|219040|P2|Overall Study|Protocol Violation|2
52652|NCT01493089|219041|P1|Overall Study|Protocol Violation|2
52653|NCT01492439|219059|P2|Overall Study|Withdrew from RTE|9
52654|NCT01492439|219060|P1|Overall Study|Withdrew from RTE|4
52655|NCT01492426|219108|P2|Follow-Up|Lost to Follow-up|6
52656|NCT01492426|219109|P1|Follow-Up|Lost to Follow-up|12
52657|NCT01492426|219108|P2|Follow-Up|Participant Withdrew Consent|1
52658|NCT01492426|219109|P1|Follow-Up|Participant Withdrew Consent|6
52659|NCT01492426|219108|P2|Follow-Up|Other|2
52660|NCT01492426|219109|P1|Follow-Up|Other|4
52661|NCT01492426|219108|P2|Follow-Up|Death|0
52662|NCT01492426|219109|P1|Follow-Up|Death|1
52663|NCT01492426|219108|P2|Follow-Up|Protocol Requires no Follow-Up|1
52664|NCT01492426|219109|P1|Follow-Up|Protocol Requires no Follow-Up|2
52665|NCT01492426|219108|P2|Treatment|Participant does not meet study criteria|0
52666|NCT01492426|219109|P1|Treatment|Participant does not meet study criteria|1
52667|NCT01492426|219108|P2|Treatment|Lost to Follow-up|4
52668|NCT01492426|219109|P1|Treatment|Lost to Follow-up|9
52669|NCT01492426|219108|P2|Treatment|Subject requested discontinue study drug|3
52670|NCT01492426|219109|P1|Treatment|Subject requested discontinue study drug|7
52671|NCT01492426|219108|P2|Treatment|Poor compliance/noncompliance|0
52672|NCT01492426|219109|P1|Treatment|Poor compliance/noncompliance|1
52673|NCT01492426|219108|P2|Treatment|Participant withdrew consent|2
52674|NCT01492426|219109|P1|Treatment|Participant withdrew consent|1
52675|NCT01492426|219108|P2|Treatment|Lack of Efficacy|5
52676|NCT01492426|219109|P1|Treatment|Lack of Efficacy|38
52677|NCT01492426|219108|P2|Treatment|Adverse Event|25
52678|NCT01492426|219109|P1|Treatment|Adverse Event|25
52679|NCT01492426|219108|P2|Treatment|Other|0
52680|NCT01492426|219109|P1|Treatment|Other|1
52681|NCT01492426|219108|P2|Treatment|Death|1
52682|NCT01492426|219109|P1|Treatment|Death|0
52683|NCT01492400|219127|P2|Overall Study|Adverse Event|5
52684|NCT01492400|219128|P1|Overall Study|Adverse Event|10
52685|NCT01492400|219127|P2|Overall Study|Lack of Efficacy|1
52686|NCT01492400|219128|P1|Overall Study|Lack of Efficacy|1
52687|NCT01492400|219127|P2|Overall Study|Pregnancy|1
52688|NCT01492400|219128|P1|Overall Study|Pregnancy|0
52689|NCT01492400|219127|P2|Overall Study|Lost to Follow-up|1
52690|NCT01492400|219128|P1|Overall Study|Lost to Follow-up|3
52691|NCT01492400|219127|P2|Overall Study|Personal Reasons|5
52692|NCT01492400|219128|P1|Overall Study|Personal Reasons|0
52693|NCT01492400|219127|P2|Overall Study|Miscellaneous Reasons|3
52694|NCT01492400|219128|P1|Overall Study|Miscellaneous Reasons|2
52695|NCT01492088|219152|P3|Overall Study|Reason Not Specified|12
52696|NCT01492088|219153|P2|Overall Study|Reason Not Specified|6
52697|NCT01492088|219154|P1|Overall Study|Reason Not Specified|2
52698|NCT01492088|219152|P3|Overall Study|Death|1
52699|NCT01492088|219153|P2|Overall Study|Death|6
52700|NCT01492088|219154|P1|Overall Study|Death|1
52701|NCT01492088|219152|P3|Overall Study|Withdrawal by Patient|0
52702|NCT01492088|219153|P2|Overall Study|Withdrawal by Patient|2
52703|NCT01492088|219154|P1|Overall Study|Withdrawal by Patient|0
52704|NCT01491919|219235|P3|Overall Study|Insufficient PK sampling|1
52705|NCT01491919|219236|P2|Overall Study|Insufficient PK sampling|2
52706|NCT01491919|219237|P1|Overall Study|Insufficient PK sampling|1
52707|NCT01491802|219283|P2|Overall Study|Withdrawal by Subject|1
52708|NCT01491802|219284|P1|Overall Study|Withdrawal by Subject|0
52709|NCT01491802|219283|P2|Overall Study|Adverse Event|1
52710|NCT01491802|219284|P1|Overall Study|Adverse Event|1
52711|NCT01491737|219311|P2|Overall Study|Reason not specified|3
52712|NCT01491737|219312|P1|Overall Study|Reason not specified|2
52713|NCT01491737|219311|P2|Overall Study|Death|28
52714|NCT01491737|219312|P1|Overall Study|Death|33
52715|NCT01491737|219311|P2|Overall Study|Lost to Follow-up|6
52716|NCT01491737|219312|P1|Overall Study|Lost to Follow-up|1
52717|NCT01491737|219311|P2|Overall Study|Withdrawal of consent|13
52718|NCT01491737|219312|P1|Overall Study|Withdrawal of consent|13
52719|NCT01491672|219335|P3|Overall Study|Death|0
52720|NCT01491672|219336|P2|Overall Study|Death|4
52721|NCT01491672|219337|P1|Overall Study|Death|0
52722|NCT01491672|219335|P3|Overall Study|Protocol deviation|0
52723|NCT01491672|219336|P2|Overall Study|Protocol deviation|1
52724|NCT01491672|219337|P1|Overall Study|Protocol deviation|0
52725|NCT01491672|219335|P3|Overall Study|Disease progression|6
52726|NCT01491672|219336|P2|Overall Study|Disease progression|34
52727|NCT01491672|219337|P1|Overall Study|Disease progression|42
52728|NCT01491672|219335|P3|Overall Study|Adverse Event|4
52729|NCT01491672|219336|P2|Overall Study|Adverse Event|10
52730|NCT01491672|219337|P1|Overall Study|Adverse Event|8
52731|NCT01491672|219335|P3|Overall Study|Withdrawal by Subject|0
52732|NCT01491672|219336|P2|Overall Study|Withdrawal by Subject|7
52733|NCT01491672|219337|P1|Overall Study|Withdrawal by Subject|6
52734|NCT01491672|219335|P3|Overall Study|Lost to Follow-up|1
52735|NCT01491672|219336|P2|Overall Study|Lost to Follow-up|4
52736|NCT01491672|219337|P1|Overall Study|Lost to Follow-up|0
52737|NCT01491607|219374|P1|Overall Study|Withdrawal by Subject|3
52738|NCT01491607|219374|P1|Overall Study|Lost to Follow-up|7
52739|NCT01491178|219479|P1|Overall Study|Other than specified above|657
52740|NCT01491178|219479|P1|Overall Study|To take a contraindication|20
52741|NCT01491178|219479|P1|Overall Study|Lost to follow−up (changing hospital)|545
52742|NCT01491178|219479|P1|Overall Study|Lost to follow−up (unknown reason)|287
52743|NCT01491178|219479|P1|Overall Study|To conduct invasive treatment|59
52744|NCT01491178|219479|P1|Overall Study|Improvement of NVAF|210
52745|NCT01491178|219479|P1|Overall Study|Adverse Event|1016
52746|NCT01491035|219588|P8|Overall Study|Lost to Follow-up|0
52747|NCT01491035|219589|P7|Overall Study|Lost to Follow-up|0
52748|NCT01491035|219590|P6|Overall Study|Lost to Follow-up|0
52749|NCT01491035|219591|P5|Overall Study|Lost to Follow-up|1
52750|NCT01491035|219592|P4|Overall Study|Lost to Follow-up|0
52751|NCT01491035|219593|P3|Overall Study|Lost to Follow-up|0
52752|NCT01491035|219594|P2|Overall Study|Lost to Follow-up|0
52753|NCT01491035|219595|P1|Overall Study|Lost to Follow-up|0
52754|NCT01490866|219696|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
52755|NCT01490866|219696|P1|Axitinib Maintenance Therapy|Protocol Violation|2
52756|NCT01490866|219696|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
52757|NCT01490866|219696|P1|Axitinib Maintenance Therapy|Adverse Event|12
52758|NCT01490866|219696|P1|Axitinib Maintenance Therapy|Disease Progression|30
52759|NCT01490866|219696|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
52760|NCT01490866|219696|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
52761|NCT01490866|219696|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
52762|NCT01490866|219696|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
52763|NCT01490866|219696|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
52764|NCT01490866|219696|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
52765|NCT01490840|219707|P2|Phase 2|Adverse Event|1
52766|NCT01490840|219708|P1|Phase 2|Adverse Event|1
52767|NCT01490840|219707|P2|Phase 2|Lost to Follow-up|1
52768|NCT01490840|219708|P1|Phase 2|Lost to Follow-up|1
52769|NCT01490840|219707|P2|Phase 2|Permanent interruption of fingolimod|1
52770|NCT01490840|219708|P1|Phase 2|Permanent interruption of fingolimod|0
52771|NCT01490840|219707|P2|Phase 2|Withdrawal by Subject|3
52772|NCT01490840|219708|P1|Phase 2|Withdrawal by Subject|4
52773|NCT01490840|219707|P2|Phase 1|Visit 6a omitted|0
52774|NCT01490840|219708|P1|Phase 1|Visit 6a omitted|1
52775|NCT01490840|219707|P2|Phase 1|Withdrawal by Subject|5
52776|NCT01490840|219708|P1|Phase 1|Withdrawal by Subject|6
52777|NCT01490840|219707|P2|Phase 1|Adverse Event|1
52778|NCT01490840|219708|P1|Phase 1|Adverse Event|2
52779|NCT01490840|219707|P2|Phase 1|Lost to Follow-up|0
52780|NCT01490840|219708|P1|Phase 1|Lost to Follow-up|1
52781|NCT01490697|219732|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
52782|NCT01490697|219733|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
52783|NCT01490632|219746|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
52784|NCT01490632|219747|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
52785|NCT01490632|219748|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
52786|NCT01490632|219749|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
52787|NCT01490632|219750|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
52788|NCT01490632|219751|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
52789|NCT01490632|219752|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
52790|NCT01490632|219753|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
52791|NCT01490632|219754|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
52792|NCT01490632|219755|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
52793|NCT01490632|219756|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
52794|NCT01490632|219757|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
52795|NCT01490632|219758|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
52796|NCT01490632|219759|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
52797|NCT01490632|219760|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
52798|NCT01490632|219761|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
52799|NCT01490632|219762|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
52800|NCT01490632|219763|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
52801|NCT01490632|219764|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
52802|NCT01490632|219765|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
52803|NCT01490632|219746|P20|Part D: Re-Treatment Period|Protocol Violation|0
52804|NCT01490632|219747|P19|Part D: Re-Treatment Period|Protocol Violation|1
52805|NCT01490632|219748|P18|Part D: Re-Treatment Period|Protocol Violation|0
52806|NCT01490632|219749|P17|Part D: Re-Treatment Period|Protocol Violation|0
52807|NCT01490632|219750|P16|Part D: Re-Treatment Period|Protocol Violation|0
52808|NCT01490632|219751|P15|Part D: Re-Treatment Period|Protocol Violation|0
52809|NCT01490632|219752|P14|Part D: Re-Treatment Period|Protocol Violation|0
52810|NCT01490632|219753|P13|Part D: Re-Treatment Period|Protocol Violation|0
52811|NCT01490632|219754|P12|Part D: Re-Treatment Period|Protocol Violation|0
52812|NCT01490632|219755|P11|Part D: Re-Treatment Period|Protocol Violation|0
52813|NCT01490632|219756|P10|Part D: Re-Treatment Period|Protocol Violation|0
52814|NCT01490632|219757|P9|Part D: Re-Treatment Period|Protocol Violation|0
52815|NCT01490632|219758|P8|Part D: Re-Treatment Period|Protocol Violation|0
52816|NCT01490632|219759|P7|Part D: Re-Treatment Period|Protocol Violation|0
52817|NCT01490632|219760|P6|Part D: Re-Treatment Period|Protocol Violation|0
52818|NCT01490632|219761|P5|Part D: Re-Treatment Period|Protocol Violation|0
52819|NCT01490632|219762|P4|Part D: Re-Treatment Period|Protocol Violation|0
52820|NCT01490632|219763|P3|Part D: Re-Treatment Period|Protocol Violation|0
52821|NCT01490632|219764|P2|Part D: Re-Treatment Period|Protocol Violation|0
52822|NCT01490632|219765|P1|Part D: Re-Treatment Period|Protocol Violation|0
52823|NCT01490632|219746|P20|Part D: Re-Treatment Period|Physician Decision|1
52824|NCT01490632|219747|P19|Part D: Re-Treatment Period|Physician Decision|1
52825|NCT01490632|219748|P18|Part D: Re-Treatment Period|Physician Decision|0
52826|NCT01490632|219749|P17|Part D: Re-Treatment Period|Physician Decision|0
52827|NCT01490632|219750|P16|Part D: Re-Treatment Period|Physician Decision|0
52828|NCT01490632|219751|P15|Part D: Re-Treatment Period|Physician Decision|0
52829|NCT01490632|219752|P14|Part D: Re-Treatment Period|Physician Decision|0
52830|NCT01490632|219753|P13|Part D: Re-Treatment Period|Physician Decision|0
52831|NCT01490632|219754|P12|Part D: Re-Treatment Period|Physician Decision|0
52832|NCT01490632|219755|P11|Part D: Re-Treatment Period|Physician Decision|0
52833|NCT01490632|219756|P10|Part D: Re-Treatment Period|Physician Decision|0
52834|NCT01490632|219757|P9|Part D: Re-Treatment Period|Physician Decision|0
52835|NCT01490632|219758|P8|Part D: Re-Treatment Period|Physician Decision|0
52836|NCT01490632|219759|P7|Part D: Re-Treatment Period|Physician Decision|0
52837|NCT01490632|219760|P6|Part D: Re-Treatment Period|Physician Decision|0
52838|NCT01490632|219761|P5|Part D: Re-Treatment Period|Physician Decision|0
52839|NCT01490632|219762|P4|Part D: Re-Treatment Period|Physician Decision|0
52840|NCT01490632|219763|P3|Part D: Re-Treatment Period|Physician Decision|0
52841|NCT01490632|219764|P2|Part D: Re-Treatment Period|Physician Decision|0
52842|NCT01490632|219765|P1|Part D: Re-Treatment Period|Physician Decision|0
52843|NCT01490632|219746|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
52844|NCT01490632|219747|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
52845|NCT01490632|219748|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
52846|NCT01490632|219749|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
52847|NCT01490632|219750|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
52848|NCT01490632|219751|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
52849|NCT01490632|219752|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
52850|NCT01490632|219753|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
52851|NCT01490632|219754|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
52852|NCT01490632|219755|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
52853|NCT01490632|219756|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
52854|NCT01490632|219757|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
52855|NCT01490632|219758|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
52856|NCT01490632|219759|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
52857|NCT01490632|219760|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
52858|NCT01490632|219761|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
52859|NCT01490632|219762|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
52860|NCT01490632|219763|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
52861|NCT01490632|219764|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
52862|NCT01490632|219765|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
52863|NCT01490632|219746|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
52864|NCT01490632|219747|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
52865|NCT01490632|219748|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
52866|NCT01490632|219749|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
52867|NCT01490632|219750|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
52868|NCT01490632|219751|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
52869|NCT01490632|219752|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
52870|NCT01490632|219753|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
52871|NCT01490632|219754|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
52872|NCT01490632|219755|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
52873|NCT01490632|219756|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
52874|NCT01490632|219757|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
52875|NCT01490632|219758|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
52876|NCT01490632|219759|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
52877|NCT01490632|219760|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
52878|NCT01490632|219761|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
52879|NCT01490632|219762|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
52880|NCT01490632|219763|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
52881|NCT01490632|219764|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
52882|NCT01490632|219765|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
52883|NCT01490632|219746|P20|Part D: Re-Treatment Period|Death|0
52884|NCT01490632|219747|P19|Part D: Re-Treatment Period|Death|1
52885|NCT01490632|219748|P18|Part D: Re-Treatment Period|Death|0
52886|NCT01490632|219749|P17|Part D: Re-Treatment Period|Death|0
52887|NCT01490632|219750|P16|Part D: Re-Treatment Period|Death|0
52888|NCT01490632|219751|P15|Part D: Re-Treatment Period|Death|0
52889|NCT01490632|219752|P14|Part D: Re-Treatment Period|Death|0
52890|NCT01490632|219753|P13|Part D: Re-Treatment Period|Death|0
52891|NCT01490632|219754|P12|Part D: Re-Treatment Period|Death|0
52892|NCT01490632|219755|P11|Part D: Re-Treatment Period|Death|0
52893|NCT01490632|219756|P10|Part D: Re-Treatment Period|Death|0
52894|NCT01490632|219757|P9|Part D: Re-Treatment Period|Death|0
52895|NCT01490632|219758|P8|Part D: Re-Treatment Period|Death|0
52896|NCT01490632|219759|P7|Part D: Re-Treatment Period|Death|0
52897|NCT01490632|219760|P6|Part D: Re-Treatment Period|Death|0
52898|NCT01490632|219761|P5|Part D: Re-Treatment Period|Death|0
52899|NCT01490632|219762|P4|Part D: Re-Treatment Period|Death|0
52900|NCT01490632|219763|P3|Part D: Re-Treatment Period|Death|0
52901|NCT01490632|219764|P2|Part D: Re-Treatment Period|Death|0
52902|NCT01490632|219765|P1|Part D: Re-Treatment Period|Death|0
52903|NCT01490632|219746|P20|Part D: Re-Treatment Period|Adverse Event|3
52904|NCT01490632|219747|P19|Part D: Re-Treatment Period|Adverse Event|1
52905|NCT01490632|219748|P18|Part D: Re-Treatment Period|Adverse Event|1
52906|NCT01490632|219749|P17|Part D: Re-Treatment Period|Adverse Event|0
52907|NCT01490632|219750|P16|Part D: Re-Treatment Period|Adverse Event|0
52908|NCT01490632|219751|P15|Part D: Re-Treatment Period|Adverse Event|0
52909|NCT01490632|219752|P14|Part D: Re-Treatment Period|Adverse Event|0
52910|NCT01490632|219753|P13|Part D: Re-Treatment Period|Adverse Event|0
52911|NCT01490632|219754|P12|Part D: Re-Treatment Period|Adverse Event|0
52912|NCT01490632|219755|P11|Part D: Re-Treatment Period|Adverse Event|0
52913|NCT01490632|219756|P10|Part D: Re-Treatment Period|Adverse Event|0
52914|NCT01490632|219757|P9|Part D: Re-Treatment Period|Adverse Event|0
52915|NCT01490632|219758|P8|Part D: Re-Treatment Period|Adverse Event|0
52916|NCT01490632|219759|P7|Part D: Re-Treatment Period|Adverse Event|0
52917|NCT01490632|219760|P6|Part D: Re-Treatment Period|Adverse Event|0
52918|NCT01490632|219761|P5|Part D: Re-Treatment Period|Adverse Event|0
52919|NCT01490632|219762|P4|Part D: Re-Treatment Period|Adverse Event|0
52920|NCT01490632|219763|P3|Part D: Re-Treatment Period|Adverse Event|0
52921|NCT01490632|219764|P2|Part D: Re-Treatment Period|Adverse Event|0
52922|NCT01490632|219765|P1|Part D: Re-Treatment Period|Adverse Event|0
52923|NCT01490632|219746|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52924|NCT01490632|219747|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52925|NCT01490632|219748|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52926|NCT01490632|219749|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52927|NCT01490632|219750|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
52928|NCT01490632|219751|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
52929|NCT01490632|219752|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
52930|NCT01490632|219753|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
52931|NCT01490632|219754|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52932|NCT01490632|219755|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52933|NCT01490632|219756|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52934|NCT01490632|219757|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52935|NCT01490632|219758|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52936|NCT01490632|219759|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52937|NCT01490632|219760|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52938|NCT01490632|219761|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52939|NCT01490632|219762|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52940|NCT01490632|219763|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52941|NCT01490632|219764|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52942|NCT01490632|219765|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
52943|NCT01490632|219746|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52944|NCT01490632|219747|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52945|NCT01490632|219748|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52946|NCT01490632|219749|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52947|NCT01490632|219750|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
52948|NCT01490632|219751|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
52949|NCT01490632|219752|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52950|NCT01490632|219753|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52951|NCT01490632|219754|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52952|NCT01490632|219755|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52953|NCT01490632|219756|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52954|NCT01490632|219757|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52955|NCT01490632|219758|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52956|NCT01490632|219759|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52957|NCT01490632|219760|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52958|NCT01490632|219761|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52959|NCT01490632|219762|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52960|NCT01490632|219763|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52961|NCT01490632|219764|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52962|NCT01490632|219765|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
52963|NCT01490632|219746|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52964|NCT01490632|219747|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52965|NCT01490632|219748|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52966|NCT01490632|219749|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52967|NCT01490632|219750|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52968|NCT01490632|219751|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52969|NCT01490632|219752|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
52970|NCT01490632|219753|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52971|NCT01490632|219754|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52972|NCT01490632|219755|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52973|NCT01490632|219756|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52974|NCT01490632|219757|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52975|NCT01490632|219758|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52976|NCT01490632|219759|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52977|NCT01490632|219760|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52978|NCT01490632|219761|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52979|NCT01490632|219762|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52980|NCT01490632|219763|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52981|NCT01490632|219764|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52982|NCT01490632|219765|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
52983|NCT01490632|219746|P20|Part C: Washout or Step-Down Period|Adverse Event|0
52984|NCT01490632|219747|P19|Part C: Washout or Step-Down Period|Adverse Event|0
52985|NCT01490632|219748|P18|Part C: Washout or Step-Down Period|Adverse Event|0
52986|NCT01490632|219749|P17|Part C: Washout or Step-Down Period|Adverse Event|0
52987|NCT01490632|219750|P16|Part C: Washout or Step-Down Period|Adverse Event|2
52988|NCT01490632|219751|P15|Part C: Washout or Step-Down Period|Adverse Event|2
52989|NCT01490632|219752|P14|Part C: Washout or Step-Down Period|Adverse Event|0
52990|NCT01490632|219753|P13|Part C: Washout or Step-Down Period|Adverse Event|0
52991|NCT01490632|219754|P12|Part C: Washout or Step-Down Period|Adverse Event|0
52992|NCT01490632|219755|P11|Part C: Washout or Step-Down Period|Adverse Event|0
52993|NCT01490632|219756|P10|Part C: Washout or Step-Down Period|Adverse Event|0
52994|NCT01490632|219757|P9|Part C: Washout or Step-Down Period|Adverse Event|0
52995|NCT01490632|219758|P8|Part C: Washout or Step-Down Period|Adverse Event|0
52996|NCT01490632|219759|P7|Part C: Washout or Step-Down Period|Adverse Event|0
52997|NCT01490632|219760|P6|Part C: Washout or Step-Down Period|Adverse Event|0
52998|NCT01490632|219761|P5|Part C: Washout or Step-Down Period|Adverse Event|0
52999|NCT01490632|219762|P4|Part C: Washout or Step-Down Period|Adverse Event|0
53000|NCT01490632|219763|P3|Part C: Washout or Step-Down Period|Adverse Event|0
53001|NCT01490632|219764|P2|Part C: Washout or Step-Down Period|Adverse Event|0
53002|NCT01490632|219765|P1|Part C: Washout or Step-Down Period|Adverse Event|0
53003|NCT01490632|219746|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53004|NCT01490632|219747|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53005|NCT01490632|219748|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53006|NCT01490632|219749|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53007|NCT01490632|219750|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53008|NCT01490632|219751|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53009|NCT01490632|219752|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53010|NCT01490632|219753|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53011|NCT01490632|219754|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
53012|NCT01490632|219755|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
53013|NCT01490632|219756|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
53014|NCT01490632|219757|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
53015|NCT01490632|219758|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
53016|NCT01490632|219759|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
53017|NCT01490632|219760|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
53018|NCT01490632|219761|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53019|NCT01490632|219762|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53020|NCT01490632|219763|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53021|NCT01490632|219764|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53022|NCT01490632|219765|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
53023|NCT01490632|219746|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53024|NCT01490632|219747|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53025|NCT01490632|219748|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53026|NCT01490632|219749|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53027|NCT01490632|219750|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53028|NCT01490632|219751|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53029|NCT01490632|219752|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53030|NCT01490632|219753|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53031|NCT01490632|219754|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
53032|NCT01490632|219755|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
53033|NCT01490632|219756|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53034|NCT01490632|219757|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
53035|NCT01490632|219758|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53036|NCT01490632|219759|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
53037|NCT01490632|219760|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53038|NCT01490632|219761|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53039|NCT01490632|219762|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53040|NCT01490632|219763|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53041|NCT01490632|219764|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53042|NCT01490632|219765|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
53043|NCT01490632|219746|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
53044|NCT01490632|219747|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
53045|NCT01490632|219748|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
53046|NCT01490632|219749|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
53047|NCT01490632|219750|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
53048|NCT01490632|219751|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
53049|NCT01490632|219752|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
53050|NCT01490632|219753|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
53051|NCT01490632|219754|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
53052|NCT01490632|219755|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
53053|NCT01490632|219756|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
53054|NCT01490632|219757|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
53055|NCT01490632|219758|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
53056|NCT01490632|219759|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
53057|NCT01490632|219760|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
53058|NCT01490632|219761|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
53059|NCT01490632|219762|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
53060|NCT01490632|219763|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
53061|NCT01490632|219764|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
53062|NCT01490632|219765|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
53063|NCT01490632|219746|P20|Part B: Extension or Step-Up Period|Physician Decision|0
53064|NCT01490632|219747|P19|Part B: Extension or Step-Up Period|Physician Decision|0
53065|NCT01490632|219748|P18|Part B: Extension or Step-Up Period|Physician Decision|0
53066|NCT01490632|219749|P17|Part B: Extension or Step-Up Period|Physician Decision|0
53067|NCT01490632|219750|P16|Part B: Extension or Step-Up Period|Physician Decision|0
53068|NCT01490632|219751|P15|Part B: Extension or Step-Up Period|Physician Decision|0
53069|NCT01490632|219752|P14|Part B: Extension or Step-Up Period|Physician Decision|0
53070|NCT01490632|219753|P13|Part B: Extension or Step-Up Period|Physician Decision|0
53071|NCT01490632|219754|P12|Part B: Extension or Step-Up Period|Physician Decision|0
53072|NCT01490632|219755|P11|Part B: Extension or Step-Up Period|Physician Decision|0
53073|NCT01490632|219756|P10|Part B: Extension or Step-Up Period|Physician Decision|0
53074|NCT01490632|219757|P9|Part B: Extension or Step-Up Period|Physician Decision|0
53075|NCT01490632|219758|P8|Part B: Extension or Step-Up Period|Physician Decision|0
53076|NCT01490632|219759|P7|Part B: Extension or Step-Up Period|Physician Decision|1
53077|NCT01490632|219760|P6|Part B: Extension or Step-Up Period|Physician Decision|0
53078|NCT01490632|219761|P5|Part B: Extension or Step-Up Period|Physician Decision|0
53079|NCT01490632|219762|P4|Part B: Extension or Step-Up Period|Physician Decision|0
53080|NCT01490632|219763|P3|Part B: Extension or Step-Up Period|Physician Decision|0
53081|NCT01490632|219764|P2|Part B: Extension or Step-Up Period|Physician Decision|0
53082|NCT01490632|219765|P1|Part B: Extension or Step-Up Period|Physician Decision|0
53083|NCT01490632|219746|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53084|NCT01490632|219747|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53085|NCT01490632|219748|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53086|NCT01490632|219749|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53087|NCT01490632|219750|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53088|NCT01490632|219751|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53089|NCT01490632|219752|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53090|NCT01490632|219753|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53091|NCT01490632|219754|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53092|NCT01490632|219755|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53093|NCT01490632|219756|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
53094|NCT01490632|219757|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53095|NCT01490632|219758|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53096|NCT01490632|219759|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
53097|NCT01490632|219760|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53098|NCT01490632|219761|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53099|NCT01490632|219762|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53100|NCT01490632|219763|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53101|NCT01490632|219764|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53102|NCT01490632|219765|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
53103|NCT01490632|219746|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53104|NCT01490632|219747|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53105|NCT01490632|219748|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53106|NCT01490632|219749|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53107|NCT01490632|219750|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53108|NCT01490632|219751|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53109|NCT01490632|219752|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53110|NCT01490632|219753|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53111|NCT01490632|219754|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53112|NCT01490632|219755|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
53113|NCT01490632|219756|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
53114|NCT01490632|219757|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
53115|NCT01490632|219758|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53116|NCT01490632|219759|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
53117|NCT01490632|219760|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53118|NCT01490632|219761|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53119|NCT01490632|219762|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53120|NCT01490632|219763|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53121|NCT01490632|219764|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53122|NCT01490632|219765|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
53123|NCT01490632|219746|P20|Part B: Extension or Step-Up Period|Adverse Event|0
53124|NCT01490632|219747|P19|Part B: Extension or Step-Up Period|Adverse Event|0
53125|NCT01490632|219748|P18|Part B: Extension or Step-Up Period|Adverse Event|0
53126|NCT01490632|219749|P17|Part B: Extension or Step-Up Period|Adverse Event|0
53127|NCT01490632|219750|P16|Part B: Extension or Step-Up Period|Adverse Event|0
53128|NCT01490632|219751|P15|Part B: Extension or Step-Up Period|Adverse Event|0
53129|NCT01490632|219752|P14|Part B: Extension or Step-Up Period|Adverse Event|0
53130|NCT01490632|219753|P13|Part B: Extension or Step-Up Period|Adverse Event|0
53131|NCT01490632|219754|P12|Part B: Extension or Step-Up Period|Adverse Event|1
53132|NCT01490632|219755|P11|Part B: Extension or Step-Up Period|Adverse Event|3
53133|NCT01490632|219756|P10|Part B: Extension or Step-Up Period|Adverse Event|2
53134|NCT01490632|219757|P9|Part B: Extension or Step-Up Period|Adverse Event|0
53135|NCT01490632|219758|P8|Part B: Extension or Step-Up Period|Adverse Event|0
53136|NCT01490632|219759|P7|Part B: Extension or Step-Up Period|Adverse Event|2
53137|NCT01490632|219760|P6|Part B: Extension or Step-Up Period|Adverse Event|2
53138|NCT01490632|219761|P5|Part B: Extension or Step-Up Period|Adverse Event|0
53139|NCT01490632|219762|P4|Part B: Extension or Step-Up Period|Adverse Event|0
53140|NCT01490632|219763|P3|Part B: Extension or Step-Up Period|Adverse Event|0
53141|NCT01490632|219764|P2|Part B: Extension or Step-Up Period|Adverse Event|0
53142|NCT01490632|219765|P1|Part B: Extension or Step-Up Period|Adverse Event|0
53143|NCT01490632|219746|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53144|NCT01490632|219747|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53145|NCT01490632|219748|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53146|NCT01490632|219749|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53147|NCT01490632|219750|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53148|NCT01490632|219751|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53149|NCT01490632|219752|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53150|NCT01490632|219753|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53151|NCT01490632|219754|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53152|NCT01490632|219755|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53153|NCT01490632|219756|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53154|NCT01490632|219757|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53155|NCT01490632|219758|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53156|NCT01490632|219759|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53157|NCT01490632|219760|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53158|NCT01490632|219761|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
53159|NCT01490632|219762|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53160|NCT01490632|219763|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53161|NCT01490632|219764|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53162|NCT01490632|219765|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
53163|NCT01490632|219746|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
53164|NCT01490632|219747|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
53165|NCT01490632|219748|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
53166|NCT01490632|219749|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
53167|NCT01490632|219750|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
53168|NCT01490632|219751|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
53169|NCT01490632|219752|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
53170|NCT01490632|219753|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
53171|NCT01490632|219754|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
53172|NCT01490632|219755|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
53173|NCT01490632|219756|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
53174|NCT01490632|219757|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
53175|NCT01490632|219758|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
53176|NCT01490632|219759|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
53177|NCT01490632|219760|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
53178|NCT01490632|219761|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
53179|NCT01490632|219762|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
53180|NCT01490632|219763|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
53181|NCT01490632|219764|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
53182|NCT01490632|219765|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
53183|NCT01490632|219746|P20|Part A: Initial Treatment Period|Sponsor Decision|0
53184|NCT01490632|219747|P19|Part A: Initial Treatment Period|Sponsor Decision|0
53185|NCT01490632|219748|P18|Part A: Initial Treatment Period|Sponsor Decision|0
53186|NCT01490632|219749|P17|Part A: Initial Treatment Period|Sponsor Decision|0
53187|NCT01490632|219750|P16|Part A: Initial Treatment Period|Sponsor Decision|0
53188|NCT01490632|219751|P15|Part A: Initial Treatment Period|Sponsor Decision|0
53189|NCT01490632|219752|P14|Part A: Initial Treatment Period|Sponsor Decision|0
53190|NCT01490632|219753|P13|Part A: Initial Treatment Period|Sponsor Decision|0
53191|NCT01490632|219754|P12|Part A: Initial Treatment Period|Sponsor Decision|0
53192|NCT01490632|219755|P11|Part A: Initial Treatment Period|Sponsor Decision|0
53193|NCT01490632|219756|P10|Part A: Initial Treatment Period|Sponsor Decision|0
53194|NCT01490632|219757|P9|Part A: Initial Treatment Period|Sponsor Decision|0
53195|NCT01490632|219758|P8|Part A: Initial Treatment Period|Sponsor Decision|0
53196|NCT01490632|219759|P7|Part A: Initial Treatment Period|Sponsor Decision|0
53197|NCT01490632|219760|P6|Part A: Initial Treatment Period|Sponsor Decision|0
53198|NCT01490632|219761|P5|Part A: Initial Treatment Period|Sponsor Decision|0
53199|NCT01490632|219762|P4|Part A: Initial Treatment Period|Sponsor Decision|0
53200|NCT01490632|219763|P3|Part A: Initial Treatment Period|Sponsor Decision|0
53201|NCT01490632|219764|P2|Part A: Initial Treatment Period|Sponsor Decision|0
53202|NCT01490632|219765|P1|Part A: Initial Treatment Period|Sponsor Decision|2
53203|NCT01490632|219746|P20|Part A: Initial Treatment Period|Physician Decision|0
53204|NCT01490632|219747|P19|Part A: Initial Treatment Period|Physician Decision|0
53205|NCT01490632|219748|P18|Part A: Initial Treatment Period|Physician Decision|0
53206|NCT01490632|219749|P17|Part A: Initial Treatment Period|Physician Decision|0
53207|NCT01490632|219750|P16|Part A: Initial Treatment Period|Physician Decision|0
53208|NCT01490632|219751|P15|Part A: Initial Treatment Period|Physician Decision|0
53209|NCT01490632|219752|P14|Part A: Initial Treatment Period|Physician Decision|0
53210|NCT01490632|219753|P13|Part A: Initial Treatment Period|Physician Decision|0
53211|NCT01490632|219754|P12|Part A: Initial Treatment Period|Physician Decision|0
53212|NCT01490632|219755|P11|Part A: Initial Treatment Period|Physician Decision|0
53213|NCT01490632|219756|P10|Part A: Initial Treatment Period|Physician Decision|0
53214|NCT01490632|219757|P9|Part A: Initial Treatment Period|Physician Decision|0
53215|NCT01490632|219758|P8|Part A: Initial Treatment Period|Physician Decision|0
53216|NCT01490632|219759|P7|Part A: Initial Treatment Period|Physician Decision|0
53217|NCT01490632|219760|P6|Part A: Initial Treatment Period|Physician Decision|0
53218|NCT01490632|219761|P5|Part A: Initial Treatment Period|Physician Decision|0
53219|NCT01490632|219762|P4|Part A: Initial Treatment Period|Physician Decision|1
53220|NCT01490632|219763|P3|Part A: Initial Treatment Period|Physician Decision|0
53221|NCT01490632|219764|P2|Part A: Initial Treatment Period|Physician Decision|1
53222|NCT01490632|219765|P1|Part A: Initial Treatment Period|Physician Decision|0
53223|NCT01490632|219746|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
53224|NCT01490632|219747|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
53225|NCT01490632|219748|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
53226|NCT01490632|219749|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
53227|NCT01490632|219750|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
53228|NCT01490632|219751|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
53229|NCT01490632|219752|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
53230|NCT01490632|219753|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
53231|NCT01490632|219754|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
53232|NCT01490632|219755|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
53233|NCT01490632|219756|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
53234|NCT01490632|219757|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
53235|NCT01490632|219758|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
53236|NCT01490632|219759|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
53237|NCT01490632|219760|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
53238|NCT01490632|219761|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
53239|NCT01490632|219762|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
53240|NCT01490632|219763|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
53241|NCT01490632|219764|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
53242|NCT01490632|219765|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
53243|NCT01490632|219746|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
53244|NCT01490632|219747|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
53245|NCT01490632|219748|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
53246|NCT01490632|219749|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
53247|NCT01490632|219750|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
53248|NCT01490632|219751|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
53249|NCT01490632|219752|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
53250|NCT01490632|219753|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
53251|NCT01490632|219754|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
53252|NCT01490632|219755|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
53253|NCT01490632|219756|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
53254|NCT01490632|219757|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
53255|NCT01490632|219758|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
53256|NCT01490632|219759|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
53257|NCT01490632|219760|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
53258|NCT01490632|219761|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
53259|NCT01490632|219762|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
53260|NCT01490632|219763|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
53261|NCT01490632|219764|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
53262|NCT01490632|219765|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
53263|NCT01490632|219746|P20|Part A: Initial Treatment Period|Adverse Event|0
53264|NCT01490632|219747|P19|Part A: Initial Treatment Period|Adverse Event|0
53265|NCT01490632|219748|P18|Part A: Initial Treatment Period|Adverse Event|0
53266|NCT01490632|219749|P17|Part A: Initial Treatment Period|Adverse Event|0
53267|NCT01490632|219750|P16|Part A: Initial Treatment Period|Adverse Event|0
53268|NCT01490632|219751|P15|Part A: Initial Treatment Period|Adverse Event|0
53269|NCT01490632|219752|P14|Part A: Initial Treatment Period|Adverse Event|0
53270|NCT01490632|219753|P13|Part A: Initial Treatment Period|Adverse Event|0
53271|NCT01490632|219754|P12|Part A: Initial Treatment Period|Adverse Event|0
53272|NCT01490632|219755|P11|Part A: Initial Treatment Period|Adverse Event|0
53273|NCT01490632|219756|P10|Part A: Initial Treatment Period|Adverse Event|0
53274|NCT01490632|219757|P9|Part A: Initial Treatment Period|Adverse Event|0
53275|NCT01490632|219758|P8|Part A: Initial Treatment Period|Adverse Event|0
53276|NCT01490632|219759|P7|Part A: Initial Treatment Period|Adverse Event|0
53277|NCT01490632|219760|P6|Part A: Initial Treatment Period|Adverse Event|0
53278|NCT01490632|219761|P5|Part A: Initial Treatment Period|Adverse Event|4
53279|NCT01490632|219762|P4|Part A: Initial Treatment Period|Adverse Event|4
53280|NCT01490632|219763|P3|Part A: Initial Treatment Period|Adverse Event|2
53281|NCT01490632|219764|P2|Part A: Initial Treatment Period|Adverse Event|0
53282|NCT01490632|219765|P1|Part A: Initial Treatment Period|Adverse Event|0
53283|NCT01490294|219920|P4|Overall Study|Adverse Event|0
53284|NCT01490294|219921|P3|Overall Study|Adverse Event|0
53285|NCT01490294|219922|P2|Overall Study|Adverse Event|0
53286|NCT01490294|219923|P1|Overall Study|Adverse Event|1
53287|NCT01490294|219920|P4|Overall Study|Prematurely discontinuation|1
53288|NCT01490294|219921|P3|Overall Study|Prematurely discontinuation|1
53289|NCT01490294|219922|P2|Overall Study|Prematurely discontinuation|0
53290|NCT01490294|219923|P1|Overall Study|Prematurely discontinuation|4
53291|NCT01490190|220157|P1|Overall Study|Ring expulsion|2
53292|NCT01490190|220157|P1|Overall Study|Inconvenience|1
53293|NCT01490190|220157|P1|Overall Study|Relocation|1
53294|NCT01490190|220157|P1|Overall Study|Lost to Follow-up|13
53295|NCT01490190|220157|P1|Overall Study|Protocol Violation|5
53296|NCT01490190|220157|P1|Overall Study|Adverse Event|17
53297|NCT01490190|220157|P1|Overall Study|Withdrawal by Subject|9
53298|NCT01490125|220184|P6|Period III|Lack of Efficacy|0
53299|NCT01490125|220185|P5|Period III|Lack of Efficacy|1
53300|NCT01490125|220186|P4|Period III|Lack of Efficacy|0
53301|NCT01490125|220187|P3|Period III|Lack of Efficacy|0
53302|NCT01490125|220188|P2|Period III|Lack of Efficacy|0
53303|NCT01490125|220189|P1|Period III|Lack of Efficacy|0
53304|NCT01490125|220184|P6|Period III|Death|0
53305|NCT01490125|220185|P5|Period III|Death|0
53306|NCT01490125|220186|P4|Period III|Death|1
53307|NCT01490125|220187|P3|Period III|Death|0
53308|NCT01490125|220188|P2|Period III|Death|0
53309|NCT01490125|220189|P1|Period III|Death|0
53310|NCT01490125|220184|P6|Period III|Adverse Event|0
53311|NCT01490125|220185|P5|Period III|Adverse Event|0
53312|NCT01490125|220186|P4|Period III|Adverse Event|1
53313|NCT01490125|220187|P3|Period III|Adverse Event|0
53314|NCT01490125|220188|P2|Period III|Adverse Event|1
53315|NCT01490125|220189|P1|Period III|Adverse Event|3
53316|NCT01490125|220184|P6|Period II|Withdrawal by Subject|0
53317|NCT01490125|220185|P5|Period II|Withdrawal by Subject|0
53318|NCT01490125|220186|P4|Period II|Withdrawal by Subject|0
53319|NCT01490125|220187|P3|Period II|Withdrawal by Subject|0
53320|NCT01490125|220188|P2|Period II|Withdrawal by Subject|0
53321|NCT01490125|220189|P1|Period II|Withdrawal by Subject|1
53322|NCT01490125|220184|P6|Period II|Lost to Follow-up|0
53323|NCT01490125|220185|P5|Period II|Lost to Follow-up|0
53324|NCT01490125|220186|P4|Period II|Lost to Follow-up|0
53325|NCT01490125|220187|P3|Period II|Lost to Follow-up|0
53326|NCT01490125|220188|P2|Period II|Lost to Follow-up|1
53327|NCT01490125|220189|P1|Period II|Lost to Follow-up|0
53328|NCT01490125|220184|P6|Period II|Protocol Violation|0
53329|NCT01490125|220185|P5|Period II|Protocol Violation|0
53330|NCT01490125|220186|P4|Period II|Protocol Violation|1
53331|NCT01490125|220187|P3|Period II|Protocol Violation|1
53332|NCT01490125|220188|P2|Period II|Protocol Violation|0
53333|NCT01490125|220189|P1|Period II|Protocol Violation|0
53334|NCT01490125|220184|P6|Period II|Adverse Event|2
53335|NCT01490125|220185|P5|Period II|Adverse Event|4
53336|NCT01490125|220186|P4|Period II|Adverse Event|2
53337|NCT01490125|220187|P3|Period II|Adverse Event|2
53338|NCT01490125|220188|P2|Period II|Adverse Event|3
53339|NCT01490125|220189|P1|Period II|Adverse Event|2
53340|NCT01490125|220184|P6|Period I|Withdrawal by Subject|1
53341|NCT01490125|220185|P5|Period I|Withdrawal by Subject|2
53342|NCT01490125|220186|P4|Period I|Withdrawal by Subject|1
53343|NCT01490125|220187|P3|Period I|Withdrawal by Subject|2
53344|NCT01490125|220188|P2|Period I|Withdrawal by Subject|3
53345|NCT01490125|220189|P1|Period I|Withdrawal by Subject|1
53346|NCT01490125|220184|P6|Period I|Protocol Violation|0
53347|NCT01490125|220185|P5|Period I|Protocol Violation|0
53348|NCT01490125|220186|P4|Period I|Protocol Violation|1
53349|NCT01490125|220187|P3|Period I|Protocol Violation|1
53350|NCT01490125|220188|P2|Period I|Protocol Violation|1
53351|NCT01490125|220189|P1|Period I|Protocol Violation|1
53352|NCT01490125|220184|P6|Period I|Adverse Event|4
53353|NCT01490125|220185|P5|Period I|Adverse Event|2
53354|NCT01490125|220186|P4|Period I|Adverse Event|3
53355|NCT01490125|220187|P3|Period I|Adverse Event|1
53356|NCT01490125|220188|P2|Period I|Adverse Event|1
53357|NCT01490125|220189|P1|Period I|Adverse Event|4
53358|NCT01490086|220217|P5|Overall Study|Subject left hospital|0
53359|NCT01490086|220218|P4|Overall Study|Subject left hospital|1
53360|NCT01490086|220219|P3|Overall Study|Subject left hospital|0
53361|NCT01490086|220220|P2|Overall Study|Subject left hospital|1
53362|NCT01490086|220221|P1|Overall Study|Subject left hospital|0
53363|NCT01490086|220217|P5|Overall Study|Subject uncontrollable and abusive|0
53364|NCT01490086|220218|P4|Overall Study|Subject uncontrollable and abusive|0
53365|NCT01490086|220219|P3|Overall Study|Subject uncontrollable and abusive|0
53366|NCT01490086|220220|P2|Overall Study|Subject uncontrollable and abusive|1
53367|NCT01490086|220221|P1|Overall Study|Subject uncontrollable and abusive|0
53368|NCT01490086|220217|P5|Overall Study|Worsening of symptoms|0
53369|NCT01490086|220218|P4|Overall Study|Worsening of symptoms|1
53370|NCT01490086|220219|P3|Overall Study|Worsening of symptoms|0
53371|NCT01490086|220220|P2|Overall Study|Worsening of symptoms|1
53372|NCT01490086|220221|P1|Overall Study|Worsening of symptoms|0
53373|NCT01490086|220217|P5|Overall Study|Lack of Efficacy|8
53374|NCT01490086|220218|P4|Overall Study|Lack of Efficacy|0
53375|NCT01490086|220219|P3|Overall Study|Lack of Efficacy|1
53376|NCT01490086|220220|P2|Overall Study|Lack of Efficacy|3
53377|NCT01490086|220221|P1|Overall Study|Lack of Efficacy|0
53378|NCT01490086|220217|P5|Overall Study|Adverse Event|0
53379|NCT01490086|220218|P4|Overall Study|Adverse Event|2
53380|NCT01490086|220219|P3|Overall Study|Adverse Event|1
53381|NCT01490086|220220|P2|Overall Study|Adverse Event|0
53382|NCT01490086|220221|P1|Overall Study|Adverse Event|0
53383|NCT01490086|220217|P5|Overall Study|Physician Decision|1
53384|NCT01490086|220218|P4|Overall Study|Physician Decision|3
53385|NCT01490086|220219|P3|Overall Study|Physician Decision|2
53386|NCT01490086|220220|P2|Overall Study|Physician Decision|4
53387|NCT01490086|220221|P1|Overall Study|Physician Decision|3
53388|NCT01490086|220217|P5|Overall Study|Lost to Follow-up|1
53389|NCT01490086|220218|P4|Overall Study|Lost to Follow-up|0
53390|NCT01490086|220219|P3|Overall Study|Lost to Follow-up|0
53391|NCT01490086|220220|P2|Overall Study|Lost to Follow-up|0
53392|NCT01490086|220221|P1|Overall Study|Lost to Follow-up|0
53393|NCT01490086|220217|P5|Overall Study|Abnormal laboratory findings|0
53394|NCT01490086|220218|P4|Overall Study|Abnormal laboratory findings|0
53395|NCT01490086|220219|P3|Overall Study|Abnormal laboratory findings|0
53396|NCT01490086|220220|P2|Overall Study|Abnormal laboratory findings|0
53397|NCT01490086|220221|P1|Overall Study|Abnormal laboratory findings|1
53398|NCT01490086|220217|P5|Overall Study|Non-compliance|0
53399|NCT01490086|220218|P4|Overall Study|Non-compliance|0
53400|NCT01490086|220219|P3|Overall Study|Non-compliance|0
53401|NCT01490086|220220|P2|Overall Study|Non-compliance|1
53402|NCT01490086|220221|P1|Overall Study|Non-compliance|0
53403|NCT01490086|220217|P5|Overall Study|Consent withdrawn|1
53404|NCT01490086|220218|P4|Overall Study|Consent withdrawn|0
53405|NCT01490086|220219|P3|Overall Study|Consent withdrawn|3
53406|NCT01490086|220220|P2|Overall Study|Consent withdrawn|4
53407|NCT01490086|220221|P1|Overall Study|Consent withdrawn|4
53408|NCT01490060|220255|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
53409|NCT01490060|220256|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
53410|NCT01490060|220257|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
53411|NCT01490060|220258|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
53412|NCT01490060|220255|P4|Cycle 2|Non-Compliance|0
53413|NCT01490060|220256|P3|Cycle 2|Non-Compliance|1
53414|NCT01490060|220257|P2|Cycle 2|Non-Compliance|0
53415|NCT01490060|220258|P1|Cycle 2|Non-Compliance|0
53416|NCT01490060|220255|P4|Cycle 2|Change of Treatment|0
53417|NCT01490060|220256|P3|Cycle 2|Change of Treatment|0
53418|NCT01490060|220257|P2|Cycle 2|Change of Treatment|1
53419|NCT01490060|220258|P1|Cycle 2|Change of Treatment|1
53420|NCT01490060|220255|P4|Cycle 1|Treatment at Another Facility|1
53421|NCT01490060|220256|P3|Cycle 1|Treatment at Another Facility|0
53422|NCT01490060|220257|P2|Cycle 1|Treatment at Another Facility|0
53423|NCT01490060|220258|P1|Cycle 1|Treatment at Another Facility|0
53424|NCT01490060|220255|P4|Cycle 1|Withdrawal by Subject|1
53425|NCT01490060|220256|P3|Cycle 1|Withdrawal by Subject|0
53426|NCT01490060|220257|P2|Cycle 1|Withdrawal by Subject|0
53427|NCT01490060|220258|P1|Cycle 1|Withdrawal by Subject|0
53428|NCT01490060|220255|P4|Cycle 1|Insurance Denied|0
53429|NCT01490060|220256|P3|Cycle 1|Insurance Denied|2
53430|NCT01490060|220257|P2|Cycle 1|Insurance Denied|0
53431|NCT01490060|220258|P1|Cycle 1|Insurance Denied|0
53432|NCT01490060|220255|P4|Cycle 1|Change of Treatment|1
53433|NCT01490060|220256|P3|Cycle 1|Change of Treatment|1
53434|NCT01490060|220257|P2|Cycle 1|Change of Treatment|1
53435|NCT01490060|220258|P1|Cycle 1|Change of Treatment|0
53436|NCT01489956|220268|P3|Overall Study|Withdrawal by Subject|1
53437|NCT01489956|220269|P2|Overall Study|Withdrawal by Subject|0
53438|NCT01489956|220270|P1|Overall Study|Withdrawal by Subject|0
53439|NCT01489956|220268|P3|Overall Study|Lost to Follow-up|0
53440|NCT01489956|220269|P2|Overall Study|Lost to Follow-up|0
53441|NCT01489956|220270|P1|Overall Study|Lost to Follow-up|1
53442|NCT01489891|220307|P2|Overall Study|Endoscopy failure|0
53443|NCT01489891|220308|P1|Overall Study|Endoscopy failure|1
53444|NCT01489527|220446|P2|Overall Study|Not compliant|0
53445|NCT01489527|220447|P1|Overall Study|Not compliant|1
53446|NCT01489527|220446|P2|Overall Study|Procedures|0
53447|NCT01489527|220447|P1|Overall Study|Procedures|1
53448|NCT01489527|220446|P2|Overall Study|Lost to Follow-up|1
53449|NCT01489527|220447|P1|Overall Study|Lost to Follow-up|5
53450|NCT01489527|220446|P2|Overall Study|Withdrawal by Subject|4
53451|NCT01489527|220447|P1|Overall Study|Withdrawal by Subject|0
53452|NCT01489527|220446|P2|Overall Study|Participant moved|7
53453|NCT01489527|220447|P1|Overall Study|Participant moved|6
53454|NCT01489527|220446|P2|Overall Study|Pregnancy|14
53455|NCT01489527|220447|P1|Overall Study|Pregnancy|9
53456|NCT01489358|220464|P3|Overall Study|Lost to Follow-up|2
53457|NCT01489358|220465|P2|Overall Study|Lost to Follow-up|0
53458|NCT01489358|220466|P1|Overall Study|Lost to Follow-up|0
53459|NCT01489254|220516|P4|Open-label Extension Part|Other reasons for not completing study|5
53460|NCT01489254|220517|P3|Open-label Extension Part|Other reasons for not completing study|0
53461|NCT01489254|220518|P2|Open-label Extension Part|Other reasons for not completing study|0
53462|NCT01489254|220519|P1|Open-label Extension Part|Other reasons for not completing study|0
53463|NCT01489254|220516|P4|Open-label Extension Part|Lost to Follow-up|9
53464|NCT01489254|220517|P3|Open-label Extension Part|Lost to Follow-up|0
53465|NCT01489254|220518|P2|Open-label Extension Part|Lost to Follow-up|0
53466|NCT01489254|220519|P1|Open-label Extension Part|Lost to Follow-up|0
53467|NCT01489254|220516|P4|Open-label Extension Part|Protocol Violation|1
53468|NCT01489254|220517|P3|Open-label Extension Part|Protocol Violation|0
53469|NCT01489254|220518|P2|Open-label Extension Part|Protocol Violation|0
53470|NCT01489254|220519|P1|Open-label Extension Part|Protocol Violation|0
53471|NCT01489254|220516|P4|Open-label Extension Part|Withdrawal by Subject|30
53472|NCT01489254|220517|P3|Open-label Extension Part|Withdrawal by Subject|0
53473|NCT01489254|220518|P2|Open-label Extension Part|Withdrawal by Subject|0
53474|NCT01489254|220519|P1|Open-label Extension Part|Withdrawal by Subject|0
53475|NCT01489254|220516|P4|Open-label Extension Part|Pregnancy|3
53476|NCT01489254|220517|P3|Open-label Extension Part|Pregnancy|0
53477|NCT01489254|220518|P2|Open-label Extension Part|Pregnancy|0
53478|NCT01489254|220519|P1|Open-label Extension Part|Pregnancy|0
53479|NCT01489254|220516|P4|Open-label Extension Part|Adverse Event|10
53480|NCT01489254|220517|P3|Open-label Extension Part|Adverse Event|0
53481|NCT01489254|220518|P2|Open-label Extension Part|Adverse Event|0
53482|NCT01489254|220519|P1|Open-label Extension Part|Adverse Event|0
53483|NCT01489254|220516|P4|Double-blind Part|Other reasons for not completing study|0
53484|NCT01489254|220517|P3|Double-blind Part|Other reasons for not completing study|0
53485|NCT01489254|220518|P2|Double-blind Part|Other reasons for not completing study|6
53486|NCT01489254|220519|P1|Double-blind Part|Other reasons for not completing study|4
53487|NCT01489254|220516|P4|Double-blind Part|Lost to Follow-up|0
53488|NCT01489254|220517|P3|Double-blind Part|Lost to Follow-up|0
53489|NCT01489254|220518|P2|Double-blind Part|Lost to Follow-up|2
53490|NCT01489254|220519|P1|Double-blind Part|Lost to Follow-up|1
53491|NCT01489254|220516|P4|Double-blind Part|Withdrawal by Subject|0
53492|NCT01489254|220517|P3|Double-blind Part|Withdrawal by Subject|1
53493|NCT01489254|220518|P2|Double-blind Part|Withdrawal by Subject|20
53494|NCT01489254|220519|P1|Double-blind Part|Withdrawal by Subject|12
53495|NCT01489254|220516|P4|Double-blind Part|Pregnancy|0
53496|NCT01489254|220517|P3|Double-blind Part|Pregnancy|0
53497|NCT01489254|220518|P2|Double-blind Part|Pregnancy|3
53498|NCT01489254|220519|P1|Double-blind Part|Pregnancy|1
53499|NCT01489254|220516|P4|Double-blind Part|Adverse Event|0
53500|NCT01489254|220517|P3|Double-blind Part|Adverse Event|2
53501|NCT01489254|220518|P2|Double-blind Part|Adverse Event|2
53502|NCT01489254|220519|P1|Double-blind Part|Adverse Event|7
53503|NCT01489189|220530|P2|Overall Study|Missed Visit|4
53504|NCT01489189|220531|P1|Overall Study|Missed Visit|1
53505|NCT01489189|220530|P2|Overall Study|Death|8
53506|NCT01489189|220531|P1|Overall Study|Death|10
53507|NCT01489189|220530|P2|Overall Study|Withdrawal by Subject|23
53508|NCT01489189|220531|P1|Overall Study|Withdrawal by Subject|20
53509|NCT01488994|220558|P2|Overall Study|Withdrawal by Subject|1
53510|NCT01488994|220559|P1|Overall Study|Withdrawal by Subject|0
53511|NCT01488578|220686|P1|Overall Study|Protocol Violation|1836
53512|NCT01488487|220720|P1|Overall Study|Withdrawal by Subject|2
53513|NCT01488487|220720|P1|Overall Study|Death|1
53514|NCT01488487|220720|P1|Overall Study|Adverse Event|6
53515|NCT01488448|220729|P2|Overall Study|Protocol Violation|3
53516|NCT01488448|220730|P1|Overall Study|Protocol Violation|4
53517|NCT01488448|220729|P2|Overall Study|Physician Decision|9
53518|NCT01488448|220730|P1|Overall Study|Physician Decision|4
53519|NCT01488448|220729|P2|Overall Study|Adverse Event|4
53520|NCT01488448|220730|P1|Overall Study|Adverse Event|9
53521|NCT01488448|220729|P2|Overall Study|Withdrawal by Subject|1
53522|NCT01488448|220730|P1|Overall Study|Withdrawal by Subject|3
53523|NCT01488370|220772|P3|Overall Study|Protocol Violation|1
53524|NCT01488370|220773|P2|Overall Study|Protocol Violation|1
53525|NCT01488370|220774|P1|Overall Study|Protocol Violation|0
53526|NCT01488071|220845|P2|Overall Study|Administrative or Other Reason(s)|4
53527|NCT01488071|220846|P1|Overall Study|Administrative or Other Reason(s)|5
53528|NCT01488071|220845|P2|Overall Study|Lost to Follow-up|0
53529|NCT01488071|220846|P1|Overall Study|Lost to Follow-up|1
53530|NCT01488071|220845|P2|Overall Study|Withdrawal of Consent|12
53531|NCT01488071|220846|P1|Overall Study|Withdrawal of Consent|14
53532|NCT01488071|220845|P2|Overall Study|Protocol Violation|7
53533|NCT01488071|220846|P1|Overall Study|Protocol Violation|5
53534|NCT01488071|220845|P2|Overall Study|Non-compliance with study drug|0
53535|NCT01488071|220846|P1|Overall Study|Non-compliance with study drug|2
53536|NCT01488071|220845|P2|Overall Study|Lack of Efficacy|17
53537|NCT01488071|220846|P1|Overall Study|Lack of Efficacy|11
53538|NCT01488071|220845|P2|Overall Study|Adverse Event|23
53539|NCT01488071|220846|P1|Overall Study|Adverse Event|15
53540|NCT01487863|220926|P2|Overall Study|Death|19
53541|NCT01487863|220927|P1|Overall Study|Death|19
53542|NCT01487577|220944|P1|Overall Study|Became ineligible after signing consent|1
53543|NCT01487525|220958|P2|Overall Study|Withdrawal by Subject|1
53544|NCT01487525|220959|P1|Overall Study|Withdrawal by Subject|0
53545|NCT01487265|220975|P1|Overall Study|Still on Treatment|1
53546|NCT01487265|220975|P1|Overall Study|Death|2
53547|NCT01487265|220975|P1|Overall Study|Disease Progression|21
53548|NCT01487265|220975|P1|Overall Study|Withdrawal by Subject|5
53549|NCT01487265|220975|P1|Overall Study|Adverse Event|8
53550|NCT01487161|220987|P4|Overall Study|missing data|0
53551|NCT01487161|220988|P3|Overall Study|missing data|0
53552|NCT01487161|220989|P2|Overall Study|missing data|1
53553|NCT01487161|220990|P1|Overall Study|missing data|0
53554|NCT01487161|220987|P4|Overall Study|Withdrawal by Subject|2
53555|NCT01487161|220988|P3|Overall Study|Withdrawal by Subject|1
53556|NCT01487161|220989|P2|Overall Study|Withdrawal by Subject|1
53557|NCT01487161|220990|P1|Overall Study|Withdrawal by Subject|1
53558|NCT01487161|220987|P4|Overall Study|Adverse Event|0
53559|NCT01487161|220988|P3|Overall Study|Adverse Event|0
53560|NCT01487161|220989|P2|Overall Study|Adverse Event|0
53561|NCT01487161|220990|P1|Overall Study|Adverse Event|1
53562|NCT01486966|221055|P2|Overall Study|Withdrawal by Subject|1
53563|NCT01486966|221056|P1|Overall Study|Withdrawal by Subject|0
53564|NCT01486966|221055|P2|Overall Study|Adverse Event|1
53565|NCT01486966|221056|P1|Overall Study|Adverse Event|0
53566|NCT01486927|221080|P1|Overall Study|Subject did not reach 6 mo of treatment|1
53567|NCT01486927|221080|P1|Overall Study|Withdrawal by Subject|8
53568|NCT01486927|221080|P1|Overall Study|50 Exposure days not reached|2
53569|NCT01486927|221080|P1|Overall Study|Physician Decision|1
53570|NCT01486927|221080|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
53571|NCT01486758|221113|P2|Overall Study|Lost to Follow-up|1
53572|NCT01486758|221114|P1|Overall Study|Lost to Follow-up|0
53573|NCT01486446|221181|P2|Overall Study|Adverse Event|0
53574|NCT01486446|221182|P1|Overall Study|Adverse Event|1
53575|NCT01486238|221204|P2|Overall Study|Lost to Follow-up|3
53576|NCT01486238|221205|P1|Overall Study|Lost to Follow-up|0
53577|NCT01486238|221204|P2|Overall Study|Withdrawal by Subject|1
53578|NCT01486238|221205|P1|Overall Study|Withdrawal by Subject|2
53579|NCT01486238|221204|P2|Overall Study|Death|2
53580|NCT01486238|221205|P1|Overall Study|Death|0
53581|NCT01486199|221213|P2|Two Year Period Between Study Days|Physician Decision|0
53582|NCT01486199|221214|P1|Two Year Period Between Study Days|Physician Decision|1
53583|NCT01485991|221234|P2|Overall Study|randomized but not treated|2
53584|NCT01485991|221235|P1|Overall Study|randomized but not treated|6
53585|NCT01485991|221234|P2|Overall Study|Withdrawal by Subject|20
53586|NCT01485991|221235|P1|Overall Study|Withdrawal by Subject|13
53587|NCT01485991|221234|P2|Overall Study|Lost to Follow-up|10
53588|NCT01485991|221235|P1|Overall Study|Lost to Follow-up|13
53589|NCT01485991|221234|P2|Overall Study|Adverse Event|4
53590|NCT01485991|221235|P1|Overall Study|Adverse Event|0
53591|NCT01485887|221245|P1|Overall Study|Primary disease markedly improved|1
53592|NCT01485887|221245|P1|Overall Study|Deterioration of primary disease|1
53593|NCT01485887|221245|P1|Overall Study|Adverse Event|8
53594|NCT01485887|221245|P1|Overall Study|Withdrawal by Subject|2
53595|NCT01485796|221257|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
53596|NCT01485796|221257|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
53597|NCT01485796|221257|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
53598|NCT01485796|221257|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
53599|NCT01485796|221257|P1|Period 2: Epoch 2|Switch to safety follow-up|26
53600|NCT01485796|221257|P1|Period 2: Epoch 2|Adverse Event|3
53601|NCT01485796|221257|P1|Period 2: Epoch 2|Withdrawal by Subject|6
53602|NCT01485796|221257|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
53603|NCT01485640|221279|P1|Overall Study|Terminated by Sponsor|95
53604|NCT01485640|221279|P1|Overall Study|Withdrawal by Subject|14
53605|NCT01485640|221279|P1|Overall Study|Protocol Violation|1
53606|NCT01485640|221279|P1|Overall Study|Lack of Efficacy|2
53607|NCT01485640|221279|P1|Overall Study|Adverse Event|10
53608|NCT01485536|221284|P1|Overall Study|Adverse Event|1
53609|NCT01485536|221284|P1|Overall Study|Withdrawal by Subject|3
53610|NCT01485354|221293|P1|Overall Study|Withdrawal by Subject|5
53611|NCT01485172|221307|P6|Overall Study|Withdrawal by Subject|1
53612|NCT01485172|221308|P5|Overall Study|Withdrawal by Subject|1
53613|NCT01485172|221309|P4|Overall Study|Withdrawal by Subject|1
53614|NCT01485172|221310|P3|Overall Study|Withdrawal by Subject|0
53615|NCT01485172|221311|P2|Overall Study|Withdrawal by Subject|0
53616|NCT01485172|221312|P1|Overall Study|Withdrawal by Subject|2
53617|NCT01485172|221307|P6|Overall Study|Physician Decision|0
53618|NCT01485172|221308|P5|Overall Study|Physician Decision|1
53619|NCT01485172|221309|P4|Overall Study|Physician Decision|0
53620|NCT01485172|221310|P3|Overall Study|Physician Decision|0
53621|NCT01485172|221311|P2|Overall Study|Physician Decision|0
53622|NCT01485172|221312|P1|Overall Study|Physician Decision|0
53623|NCT01485172|221307|P6|Overall Study|Lost to Follow-up|1
53624|NCT01485172|221308|P5|Overall Study|Lost to Follow-up|0
53625|NCT01485172|221309|P4|Overall Study|Lost to Follow-up|0
53626|NCT01485172|221310|P3|Overall Study|Lost to Follow-up|1
53627|NCT01485172|221311|P2|Overall Study|Lost to Follow-up|0
53628|NCT01485172|221312|P1|Overall Study|Lost to Follow-up|0
53629|NCT01485172|221307|P6|Overall Study|Protocol defined stopping criteria|0
53630|NCT01485172|221308|P5|Overall Study|Protocol defined stopping criteria|1
53631|NCT01485172|221309|P4|Overall Study|Protocol defined stopping criteria|0
53632|NCT01485172|221310|P3|Overall Study|Protocol defined stopping criteria|0
53633|NCT01485172|221311|P2|Overall Study|Protocol defined stopping criteria|0
53634|NCT01485172|221312|P1|Overall Study|Protocol defined stopping criteria|1
53635|NCT01485172|221307|P6|Overall Study|Protocol Violation|0
53636|NCT01485172|221308|P5|Overall Study|Protocol Violation|1
53637|NCT01485172|221309|P4|Overall Study|Protocol Violation|5
53638|NCT01485172|221310|P3|Overall Study|Protocol Violation|4
53639|NCT01485172|221311|P2|Overall Study|Protocol Violation|0
53640|NCT01485172|221312|P1|Overall Study|Protocol Violation|0
53641|NCT01485172|221307|P6|Overall Study|Lack of Efficacy|0
53642|NCT01485172|221308|P5|Overall Study|Lack of Efficacy|0
53643|NCT01485172|221309|P4|Overall Study|Lack of Efficacy|0
53644|NCT01485172|221310|P3|Overall Study|Lack of Efficacy|0
53645|NCT01485172|221311|P2|Overall Study|Lack of Efficacy|0
53646|NCT01485172|221312|P1|Overall Study|Lack of Efficacy|2
53647|NCT01485172|221307|P6|Overall Study|Adverse Event|2
53648|NCT01485172|221308|P5|Overall Study|Adverse Event|1
53649|NCT01485172|221309|P4|Overall Study|Adverse Event|2
53650|NCT01485172|221310|P3|Overall Study|Adverse Event|2
53651|NCT01485172|221311|P2|Overall Study|Adverse Event|1
53652|NCT01485172|221312|P1|Overall Study|Adverse Event|2
53653|NCT01485094|221389|P3|Overall Study|Withdrawal by Subject|0
53654|NCT01485094|221390|P2|Overall Study|Withdrawal by Subject|1
53655|NCT01485094|221391|P1|Overall Study|Withdrawal by Subject|1
53656|NCT01485094|221389|P3|Overall Study|Lost to Follow-up|0
53657|NCT01485094|221390|P2|Overall Study|Lost to Follow-up|0
53658|NCT01485094|221391|P1|Overall Study|Lost to Follow-up|1
53659|NCT01485094|221389|P3|Overall Study|Adverse Event|1
53660|NCT01485094|221390|P2|Overall Study|Adverse Event|1
53661|NCT01485094|221391|P1|Overall Study|Adverse Event|1
53662|NCT01484977|221432|P1|Overall Study|Lack of Compliance|1
53663|NCT01484977|221432|P1|Overall Study|Low White Blood Cell Count|1
53664|NCT01484977|221432|P1|Overall Study|Moving Overseas|1
53665|NCT01484977|221432|P1|Overall Study|Subject Protocol Non-compliant|1
53666|NCT01484977|221432|P1|Overall Study|Withdrawal by Subject|4
53667|NCT01484977|221432|P1|Overall Study|Lost to Follow-up|1
53668|NCT01484977|221432|P1|Overall Study|Protocol Violation|6
53669|NCT01484977|221432|P1|Overall Study|Lack of Efficacy|4
53670|NCT01484977|221432|P1|Overall Study|Adverse Event|8
53671|NCT01484951|221436|P1|Overall Study|Non-Compliance|1
53672|NCT01484951|221436|P1|Overall Study|Personal Reasons|1
53673|NCT01484951|221436|P1|Overall Study|Adverse Event|3
53674|NCT01484938|221441|P1|Overall Study|Noncompliance|1
53675|NCT01484938|221441|P1|Overall Study|Lost to Follow-up|1
53676|NCT01484938|221441|P1|Overall Study|Adverse Event|2
53677|NCT01484912|221448|P2|Overall Study|Physician Decision|1
53678|NCT01484912|221449|P1|Overall Study|Physician Decision|0
53679|NCT01484912|221448|P2|Overall Study|Withdrawal by Subject|0
53680|NCT01484912|221449|P1|Overall Study|Withdrawal by Subject|1
53681|NCT01484873|221459|P1|Overall Study|Withdrawal by Subject|2
53682|NCT01484834|221471|P4|Overall Study|Lost to Follow-up|4
53683|NCT01484834|221472|P3|Overall Study|Lost to Follow-up|1
53684|NCT01484834|221473|P2|Overall Study|Lost to Follow-up|8
53685|NCT01484834|221474|P1|Overall Study|Lost to Follow-up|5
53686|NCT01484561|221511|P2|Overall Study|Adverse Event|4
53687|NCT01484561|221512|P1|Overall Study|Adverse Event|1
53688|NCT01484561|221511|P2|Overall Study|Not specified|1
53689|NCT01484561|221512|P1|Overall Study|Not specified|1
53690|NCT01484561|221511|P2|Overall Study|Withdrawal by Subject|0
53691|NCT01484561|221512|P1|Overall Study|Withdrawal by Subject|3
53692|NCT01484561|221511|P2|Overall Study|Lost to Follow-up|0
53693|NCT01484561|221512|P1|Overall Study|Lost to Follow-up|1
53694|NCT01484561|221511|P2|Overall Study|Lack of Efficacy|1
53695|NCT01484561|221512|P1|Overall Study|Lack of Efficacy|3
53696|NCT01484496|221602|P4|Period 2|Other|6
53697|NCT01484496|221603|P3|Period 2|Other|9
53698|NCT01484496|221604|P2|Period 2|Other|0
53699|NCT01484496|221605|P1|Period 2|Other|0
53700|NCT01484496|221602|P4|Period 2|Adverse Event|13
53701|NCT01484496|221603|P3|Period 2|Adverse Event|5
53702|NCT01484496|221604|P2|Period 2|Adverse Event|0
53703|NCT01484496|221605|P1|Period 2|Adverse Event|0
53704|NCT01484496|221602|P4|Period 2|Lack of Efficacy|3
53705|NCT01484496|221603|P3|Period 2|Lack of Efficacy|1
53706|NCT01484496|221604|P2|Period 2|Lack of Efficacy|0
53707|NCT01484496|221605|P1|Period 2|Lack of Efficacy|0
53708|NCT01484496|221602|P4|Period 1|Unable to Visit Site|0
53709|NCT01484496|221603|P3|Period 1|Unable to Visit Site|0
53710|NCT01484496|221604|P2|Period 1|Unable to Visit Site|2
53711|NCT01484496|221605|P1|Period 1|Unable to Visit Site|0
53712|NCT01484496|221602|P4|Period 1|Lack of Compliance|0
53713|NCT01484496|221603|P3|Period 1|Lack of Compliance|0
53714|NCT01484496|221604|P2|Period 1|Lack of Compliance|1
53715|NCT01484496|221605|P1|Period 1|Lack of Compliance|2
53716|NCT01484496|221602|P4|Period 1|Treatment Failure|0
53717|NCT01484496|221603|P3|Period 1|Treatment Failure|0
53718|NCT01484496|221604|P2|Period 1|Treatment Failure|6
53719|NCT01484496|221605|P1|Period 1|Treatment Failure|3
53720|NCT01484496|221602|P4|Period 1|Positive Pregnancy|0
53721|NCT01484496|221603|P3|Period 1|Positive Pregnancy|0
53722|NCT01484496|221604|P2|Period 1|Positive Pregnancy|6
53723|NCT01484496|221605|P1|Period 1|Positive Pregnancy|1
53724|NCT01484496|221602|P4|Period 1|Lost to Follow-up|0
53725|NCT01484496|221603|P3|Period 1|Lost to Follow-up|0
53726|NCT01484496|221604|P2|Period 1|Lost to Follow-up|6
53727|NCT01484496|221605|P1|Period 1|Lost to Follow-up|2
53728|NCT01484496|221602|P4|Period 1|Withdrawal by Subject|0
53729|NCT01484496|221603|P3|Period 1|Withdrawal by Subject|0
53730|NCT01484496|221604|P2|Period 1|Withdrawal by Subject|12
53731|NCT01484496|221605|P1|Period 1|Withdrawal by Subject|15
53732|NCT01484496|221602|P4|Period 1|Adverse Event|0
53733|NCT01484496|221603|P3|Period 1|Adverse Event|0
53734|NCT01484496|221604|P2|Period 1|Adverse Event|40
53735|NCT01484496|221605|P1|Period 1|Adverse Event|25
53736|NCT01484496|221602|P4|Period 1|Lack of Efficacy|0
53737|NCT01484496|221603|P3|Period 1|Lack of Efficacy|0
53738|NCT01484496|221604|P2|Period 1|Lack of Efficacy|15
53739|NCT01484496|221605|P1|Period 1|Lack of Efficacy|10
53740|NCT01484496|221602|P4|Period 1|Physician Decision|0
53741|NCT01484496|221603|P3|Period 1|Physician Decision|0
53742|NCT01484496|221604|P2|Period 1|Physician Decision|1
53743|NCT01484496|221605|P1|Period 1|Physician Decision|5
53744|NCT01484496|221602|P4|Period 1|Protocol Violation|0
53745|NCT01484496|221603|P3|Period 1|Protocol Violation|0
53746|NCT01484496|221604|P2|Period 1|Protocol Violation|4
53747|NCT01484496|221605|P1|Period 1|Protocol Violation|3
53748|NCT01484197|221623|P4|Treatment Period 2|Subject withdrew consent|1
53749|NCT01484197|221624|P3|Treatment Period 2|Subject withdrew consent|0
53750|NCT01484197|221625|P2|Treatment Period 2|Subject withdrew consent|0
53751|NCT01484197|221626|P1|Treatment Period 2|Subject withdrew consent|0
53752|NCT01484197|221623|P4|Treatment Period 1|Adverse Event|0
53753|NCT01484197|221624|P3|Treatment Period 1|Adverse Event|0
53754|NCT01484197|221625|P2|Treatment Period 1|Adverse Event|0
53755|NCT01484197|221626|P1|Treatment Period 1|Adverse Event|1
53756|NCT01484132|221709|P1|Overall Study|No post-treatment urine sample collected|10
53757|NCT01484132|221709|P1|Overall Study|No pre-treatment urine sample collected|1
53758|NCT01484132|221709|P1|Overall Study|Ineligible|1
53759|NCT01484132|221709|P1|Overall Study|Difficulty with time commitment|2
53760|NCT01484132|221709|P1|Overall Study|Lost to Follow-up|8
53761|NCT01484054|221717|P2|Period 1|Withdrawal by Subject|1
53762|NCT01484054|221718|P1|Period 1|Withdrawal by Subject|0
53763|NCT01484028|221736|P4|Period 1|Lens Discomfort|0
53764|NCT01484028|221737|P3|Period 1|Lens Discomfort|0
53765|NCT01484028|221738|P2|Period 1|Lens Discomfort|1
53766|NCT01484028|221739|P1|Period 1|Lens Discomfort|0
53767|NCT01484028|221736|P4|Period 1|Non-Compliance to Protocol|1
53768|NCT01484028|221737|P3|Period 1|Non-Compliance to Protocol|0
53769|NCT01484028|221738|P2|Period 1|Non-Compliance to Protocol|1
53770|NCT01484028|221739|P1|Period 1|Non-Compliance to Protocol|0
53771|NCT01484028|221736|P4|Period 1|Lost to Follow-up|0
53772|NCT01484028|221737|P3|Period 1|Lost to Follow-up|0
53773|NCT01484028|221738|P2|Period 1|Lost to Follow-up|1
53774|NCT01484028|221739|P1|Period 1|Lost to Follow-up|0
53775|NCT01483937|221832|P2|Overall Study|Withdrawal by Subject|3
53776|NCT01483937|221833|P1|Overall Study|Withdrawal by Subject|4
53777|NCT01483924|221860|P5|Overall Study|Sponsor concern over ECG result|0
53778|NCT01483924|221861|P4|Overall Study|Sponsor concern over ECG result|1
53779|NCT01483924|221862|P3|Overall Study|Sponsor concern over ECG result|0
53780|NCT01483924|221863|P2|Overall Study|Sponsor concern over ECG result|0
53781|NCT01483924|221864|P1|Overall Study|Sponsor concern over ECG result|0
53782|NCT01483924|221860|P5|Overall Study|Non-compliance|1
53783|NCT01483924|221861|P4|Overall Study|Non-compliance|1
53784|NCT01483924|221862|P3|Overall Study|Non-compliance|0
53785|NCT01483924|221863|P2|Overall Study|Non-compliance|0
53786|NCT01483924|221864|P1|Overall Study|Non-compliance|0
53787|NCT01483924|221860|P5|Overall Study|Adverse Event|0
53788|NCT01483924|221861|P4|Overall Study|Adverse Event|1
53789|NCT01483924|221862|P3|Overall Study|Adverse Event|1
53790|NCT01483924|221863|P2|Overall Study|Adverse Event|0
53791|NCT01483924|221864|P1|Overall Study|Adverse Event|0
53792|NCT01483924|221860|P5|Overall Study|Withdrawal by Subject|1
53793|NCT01483924|221861|P4|Overall Study|Withdrawal by Subject|1
53794|NCT01483924|221862|P3|Overall Study|Withdrawal by Subject|0
53795|NCT01483924|221863|P2|Overall Study|Withdrawal by Subject|0
53796|NCT01483924|221864|P1|Overall Study|Withdrawal by Subject|2
53797|NCT01483820|221912|P1|Overall Study|Death|1
53798|NCT01483820|221912|P1|Overall Study|Adverse Event|1
53799|NCT01483820|221912|P1|Overall Study|Lack of Efficacy|6
53800|NCT01483651|221921|P6|Overall Study|Withdrawal by Subject|1
53801|NCT01483651|221922|P5|Overall Study|Withdrawal by Subject|0
53802|NCT01483651|221923|P4|Overall Study|Withdrawal by Subject|0
53803|NCT01483651|221924|P3|Overall Study|Withdrawal by Subject|1
53804|NCT01483651|221925|P2|Overall Study|Withdrawal by Subject|1
53805|NCT01483651|221926|P1|Overall Study|Withdrawal by Subject|0
53806|NCT01483625|221936|P2|Overall Study|Due to other reason|0
53807|NCT01483625|221937|P1|Overall Study|Due to other reason|1
53808|NCT01483625|221936|P2|Overall Study|Refused to continue medication|1
53809|NCT01483625|221937|P1|Overall Study|Refused to continue medication|2
53810|NCT01483625|221936|P2|Overall Study|Adverse Event|1
53811|NCT01483625|221937|P1|Overall Study|Adverse Event|1
53812|NCT01483599|221960|P14|After Controlled Period(Week 16-Week 40)|Other|0
53813|NCT01483599|221961|P13|After Controlled Period(Week 16-Week 40)|Other|1
53814|NCT01483599|221962|P12|After Controlled Period(Week 16-Week 40)|Other|0
53815|NCT01483599|221963|P11|After Controlled Period(Week 16-Week 40)|Other|0
53816|NCT01483599|221964|P10|After Controlled Period(Week 16-Week 40)|Other|4
53817|NCT01483599|221965|P9|After Controlled Period(Week 16-Week 40)|Other|0
53818|NCT01483599|221966|P8|After Controlled Period(Week 16-Week 40)|Other|1
53819|NCT01483599|221967|P7|After Controlled Period(Week 16-Week 40)|Other|0
53820|NCT01483599|221968|P6|After Controlled Period(Week 16-Week 40)|Other|0
53821|NCT01483599|221969|P5|After Controlled Period(Week 16-Week 40)|Other|0
53822|NCT01483599|221970|P4|After Controlled Period(Week 16-Week 40)|Other|0
53823|NCT01483599|221971|P3|After Controlled Period(Week 16-Week 40)|Other|0
53824|NCT01483599|221972|P2|After Controlled Period(Week 16-Week 40)|Other|0
53825|NCT01483599|221973|P1|After Controlled Period(Week 16-Week 40)|Other|0
53826|NCT01483599|221960|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
53827|NCT01483599|221961|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
53828|NCT01483599|221962|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53829|NCT01483599|221963|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53830|NCT01483599|221964|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53831|NCT01483599|221965|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
53832|NCT01483599|221966|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53833|NCT01483599|221967|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53834|NCT01483599|221968|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53835|NCT01483599|221969|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53836|NCT01483599|221970|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53837|NCT01483599|221971|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53838|NCT01483599|221972|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53839|NCT01483599|221973|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
53840|NCT01483599|221960|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
53841|NCT01483599|221961|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53842|NCT01483599|221962|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53843|NCT01483599|221963|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
53844|NCT01483599|221964|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53845|NCT01483599|221965|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
53846|NCT01483599|221966|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53847|NCT01483599|221967|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53848|NCT01483599|221968|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53849|NCT01483599|221969|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53850|NCT01483599|221970|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53851|NCT01483599|221971|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53852|NCT01483599|221972|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53853|NCT01483599|221973|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
53854|NCT01483599|221960|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
53855|NCT01483599|221961|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53856|NCT01483599|221962|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
53857|NCT01483599|221963|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53858|NCT01483599|221964|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53859|NCT01483599|221965|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
53860|NCT01483599|221966|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53861|NCT01483599|221967|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53862|NCT01483599|221968|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53863|NCT01483599|221969|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53864|NCT01483599|221970|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53865|NCT01483599|221971|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53866|NCT01483599|221972|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53867|NCT01483599|221973|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
53868|NCT01483599|221960|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
53869|NCT01483599|221961|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
53870|NCT01483599|221962|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53871|NCT01483599|221963|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53872|NCT01483599|221964|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53873|NCT01483599|221965|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
53874|NCT01483599|221966|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
53875|NCT01483599|221967|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53876|NCT01483599|221968|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53877|NCT01483599|221969|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53878|NCT01483599|221970|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53879|NCT01483599|221971|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53880|NCT01483599|221972|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53881|NCT01483599|221973|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
53882|NCT01483599|221960|P14|After Controlled Period(Week 16-Week 40)|Death|0
53883|NCT01483599|221961|P13|After Controlled Period(Week 16-Week 40)|Death|0
53884|NCT01483599|221962|P12|After Controlled Period(Week 16-Week 40)|Death|0
53885|NCT01483599|221963|P11|After Controlled Period(Week 16-Week 40)|Death|0
53886|NCT01483599|221964|P10|After Controlled Period(Week 16-Week 40)|Death|0
53887|NCT01483599|221965|P9|After Controlled Period(Week 16-Week 40)|Death|1
53888|NCT01483599|221966|P8|After Controlled Period(Week 16-Week 40)|Death|0
53889|NCT01483599|221967|P7|After Controlled Period(Week 16-Week 40)|Death|0
53890|NCT01483599|221968|P6|After Controlled Period(Week 16-Week 40)|Death|0
53891|NCT01483599|221969|P5|After Controlled Period(Week 16-Week 40)|Death|0
53892|NCT01483599|221970|P4|After Controlled Period(Week 16-Week 40)|Death|0
53893|NCT01483599|221971|P3|After Controlled Period(Week 16-Week 40)|Death|0
53894|NCT01483599|221972|P2|After Controlled Period(Week 16-Week 40)|Death|0
53895|NCT01483599|221973|P1|After Controlled Period(Week 16-Week 40)|Death|0
53896|NCT01483599|221960|P14|Controlled Period (CP) (up to Week 16)|Other|0
53897|NCT01483599|221961|P13|Controlled Period (CP) (up to Week 16)|Other|0
53898|NCT01483599|221962|P12|Controlled Period (CP) (up to Week 16)|Other|0
53899|NCT01483599|221963|P11|Controlled Period (CP) (up to Week 16)|Other|0
53900|NCT01483599|221964|P10|Controlled Period (CP) (up to Week 16)|Other|0
53901|NCT01483599|221965|P9|Controlled Period (CP) (up to Week 16)|Other|0
53902|NCT01483599|221966|P8|Controlled Period (CP) (up to Week 16)|Other|0
53903|NCT01483599|221967|P7|Controlled Period (CP) (up to Week 16)|Other|0
53904|NCT01483599|221968|P6|Controlled Period (CP) (up to Week 16)|Other|0
53905|NCT01483599|221969|P5|Controlled Period (CP) (up to Week 16)|Other|1
53906|NCT01483599|221970|P4|Controlled Period (CP) (up to Week 16)|Other|1
53907|NCT01483599|221971|P3|Controlled Period (CP) (up to Week 16)|Other|0
53908|NCT01483599|221972|P2|Controlled Period (CP) (up to Week 16)|Other|2
53909|NCT01483599|221973|P1|Controlled Period (CP) (up to Week 16)|Other|0
53910|NCT01483599|221960|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53911|NCT01483599|221961|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53912|NCT01483599|221962|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53913|NCT01483599|221963|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53914|NCT01483599|221964|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53915|NCT01483599|221965|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53916|NCT01483599|221966|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53917|NCT01483599|221967|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53918|NCT01483599|221968|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53919|NCT01483599|221969|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53920|NCT01483599|221970|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53921|NCT01483599|221971|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53922|NCT01483599|221972|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
53923|NCT01483599|221973|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
53924|NCT01483599|221960|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53925|NCT01483599|221961|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53926|NCT01483599|221962|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53927|NCT01483599|221963|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53928|NCT01483599|221964|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53929|NCT01483599|221965|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53930|NCT01483599|221966|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53931|NCT01483599|221967|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
53932|NCT01483599|221968|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53933|NCT01483599|221969|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53934|NCT01483599|221970|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
54021|NCT01482312|222251|P3|Period 2, 90 Minutes of Wear|Other|0
53935|NCT01483599|221971|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53936|NCT01483599|221972|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
53937|NCT01483599|221973|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
53938|NCT01483599|221960|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
53939|NCT01483599|221961|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
53940|NCT01483599|221962|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
53941|NCT01483599|221963|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
53942|NCT01483599|221964|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
53943|NCT01483599|221965|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
53944|NCT01483599|221966|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
53945|NCT01483599|221967|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
53946|NCT01483599|221968|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
53947|NCT01483599|221969|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
53948|NCT01483599|221970|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
53949|NCT01483599|221971|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
53950|NCT01483599|221972|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
53951|NCT01483599|221973|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
53952|NCT01483183|222063|P10|Overall Study|Withdrawal by Subject|1
53953|NCT01483183|222064|P9|Overall Study|Withdrawal by Subject|0
53954|NCT01483183|222065|P8|Overall Study|Withdrawal by Subject|0
53955|NCT01483183|222066|P7|Overall Study|Withdrawal by Subject|0
53956|NCT01483183|222067|P6|Overall Study|Withdrawal by Subject|0
53957|NCT01483183|222068|P5|Overall Study|Withdrawal by Subject|0
53958|NCT01483183|222069|P4|Overall Study|Withdrawal by Subject|0
53959|NCT01483183|222070|P3|Overall Study|Withdrawal by Subject|0
53960|NCT01483183|222071|P2|Overall Study|Withdrawal by Subject|0
53961|NCT01483183|222072|P1|Overall Study|Withdrawal by Subject|0
53962|NCT01483183|222063|P10|Overall Study|Physician Decision|0
53963|NCT01483183|222064|P9|Overall Study|Physician Decision|0
53964|NCT01483183|222065|P8|Overall Study|Physician Decision|0
53965|NCT01483183|222066|P7|Overall Study|Physician Decision|2
53966|NCT01483183|222067|P6|Overall Study|Physician Decision|0
53967|NCT01483183|222068|P5|Overall Study|Physician Decision|0
53968|NCT01483183|222069|P4|Overall Study|Physician Decision|0
53969|NCT01483183|222070|P3|Overall Study|Physician Decision|0
53970|NCT01483183|222071|P2|Overall Study|Physician Decision|0
53971|NCT01483183|222072|P1|Overall Study|Physician Decision|0
53972|NCT01483118|222142|P2|Overall Study|Lost to Follow-up|16
53973|NCT01483118|222143|P1|Overall Study|Lost to Follow-up|12
53974|NCT01482910|222155|P2|Overall Study|Death|0
53975|NCT01482910|222156|P1|Overall Study|Death|1
53976|NCT01482910|222155|P2|Overall Study|Withdrawal by Subject|2
53977|NCT01482910|222156|P1|Overall Study|Withdrawal by Subject|7
53978|NCT01482910|222155|P2|Overall Study|Protocol Violation|1
53979|NCT01482910|222156|P1|Overall Study|Protocol Violation|1
53980|NCT01482910|222155|P2|Overall Study|Lost to Follow-up|1
53981|NCT01482910|222156|P1|Overall Study|Lost to Follow-up|0
53982|NCT01482910|222155|P2|Overall Study|Adverse Event|5
53983|NCT01482910|222156|P1|Overall Study|Adverse Event|6
53984|NCT01482884|222168|P2|Overall Study|Withdrawal by Subject|13
53985|NCT01482884|222169|P1|Overall Study|Withdrawal by Subject|8
53986|NCT01482884|222168|P2|Overall Study|Adverse Event|1
53987|NCT01482884|222169|P1|Overall Study|Adverse Event|2
53988|NCT01482884|222168|P2|Overall Study|Lack of Efficacy|1
53989|NCT01482884|222169|P1|Overall Study|Lack of Efficacy|0
53990|NCT01482884|222168|P2|Overall Study|Lost to Follow-up|2
53991|NCT01482884|222169|P1|Overall Study|Lost to Follow-up|2
53992|NCT01482884|222168|P2|Overall Study|Protocol Violation|0
53993|NCT01482884|222169|P1|Overall Study|Protocol Violation|1
53994|NCT01482884|222168|P2|Overall Study|Medical decision due to lack of efficacy|1
53995|NCT01482884|222169|P1|Overall Study|Medical decision due to lack of efficacy|0
53996|NCT01482819|222195|P1|Overall Study|Lost to Follow-up|2
53997|NCT01482767|222215|P2|Overall Study|Nurse error|0
53998|NCT01482767|222216|P1|Overall Study|Nurse error|1
53999|NCT01482767|222215|P2|Overall Study|Ineligible|5
54000|NCT01482767|222216|P1|Overall Study|Ineligible|0
54001|NCT01482767|222215|P2|Overall Study|Alternate HCV treatment|8
54002|NCT01482767|222216|P1|Overall Study|Alternate HCV treatment|7
54003|NCT01482767|222215|P2|Overall Study|Non-adherence to study requirements|7
54004|NCT01482767|222216|P1|Overall Study|Non-adherence to study requirements|4
54005|NCT01482767|222215|P2|Overall Study|Site closure|14
54006|NCT01482767|222216|P1|Overall Study|Site closure|22
54007|NCT01482767|222215|P2|Overall Study|Adverse Event|3
54008|NCT01482767|222216|P1|Overall Study|Adverse Event|0
54009|NCT01482767|222215|P2|Overall Study|Lost to Follow-up|6
54010|NCT01482767|222216|P1|Overall Study|Lost to Follow-up|12
54011|NCT01482767|222215|P2|Overall Study|Withdrawal by Subject|5
54012|NCT01482767|222216|P1|Overall Study|Withdrawal by Subject|7
54013|NCT01482767|222215|P2|Overall Study|Death|1
54014|NCT01482767|222216|P1|Overall Study|Death|1
54015|NCT01482429|222238|P2|Protocol|Protocol Violation|0
54016|NCT01482429|222239|P1|Protocol|Protocol Violation|275
54017|NCT01482429|222238|P2|Care Usual|Lost to Follow-up|1
54018|NCT01482429|222239|P1|Care Usual|Lost to Follow-up|0
54019|NCT01482429|222238|P2|Care Usual|Protocol Violation|172
54020|NCT01482429|222239|P1|Care Usual|Protocol Violation|0
54022|NCT01482312|222252|P2|Period 2, 90 Minutes of Wear|Other|0
54023|NCT01482312|222253|P1|Period 2, 90 Minutes of Wear|Other|1
54024|NCT01482312|222251|P3|Period 1, 90 Minutes of Wear|Other|0
54025|NCT01482312|222252|P2|Period 1, 90 Minutes of Wear|Other|0
54026|NCT01482312|222253|P1|Period 1, 90 Minutes of Wear|Other|1
54027|NCT01482221|222267|P3|Overall Study|Physician Decision|0
54028|NCT01482221|222268|P2|Overall Study|Physician Decision|1
54029|NCT01482221|222269|P1|Overall Study|Physician Decision|0
54030|NCT01482221|222267|P3|Overall Study|Incorrect randomization|0
54031|NCT01482221|222268|P2|Overall Study|Incorrect randomization|1
54032|NCT01482221|222269|P1|Overall Study|Incorrect randomization|0
54033|NCT01482221|222267|P3|Overall Study|Withdrawal by Subject|12
54034|NCT01482221|222268|P2|Overall Study|Withdrawal by Subject|7
54035|NCT01482221|222269|P1|Overall Study|Withdrawal by Subject|10
54036|NCT01482221|222267|P3|Overall Study|Adverse Event|3
54037|NCT01482221|222268|P2|Overall Study|Adverse Event|7
54038|NCT01482221|222269|P1|Overall Study|Adverse Event|1
54039|NCT01482221|222267|P3|Overall Study|Severe Non-Compliance to Protocol|1
54040|NCT01482221|222268|P2|Overall Study|Severe Non-Compliance to Protocol|0
54041|NCT01482221|222269|P1|Overall Study|Severe Non-Compliance to Protocol|1
54042|NCT01482221|222267|P3|Overall Study|Condition under Investigation Worsened|4
54043|NCT01482221|222268|P2|Overall Study|Condition under Investigation Worsened|2
54044|NCT01482221|222269|P1|Overall Study|Condition under Investigation Worsened|3
54045|NCT01482221|222267|P3|Overall Study|Study-Specific Withdrawal Criteria|1
54046|NCT01482221|222268|P2|Overall Study|Study-Specific Withdrawal Criteria|0
54047|NCT01482221|222269|P1|Overall Study|Study-Specific Withdrawal Criteria|2
54048|NCT01482221|222267|P3|Overall Study|Lost to Follow-up|1
54049|NCT01482221|222268|P2|Overall Study|Lost to Follow-up|2
54050|NCT01482221|222269|P1|Overall Study|Lost to Follow-up|3
54051|NCT01482221|222267|P3|Overall Study|Lack of Efficacy|1
54052|NCT01482221|222268|P2|Overall Study|Lack of Efficacy|0
54053|NCT01482221|222269|P1|Overall Study|Lack of Efficacy|1
54054|NCT01482169|222310|P1|Overall Study|Physician Decision|2
54055|NCT01482065|222352|P2|Overall Study|Withdrawal by Subject|1
54056|NCT01482065|222353|P1|Overall Study|Withdrawal by Subject|0
54057|NCT01481896|222374|P1|Overall Study|Lost to Follow-up|12
54058|NCT01481779|222390|P2|Overall Study|Sponsor Decision|1
54059|NCT01481779|222391|P1|Overall Study|Sponsor Decision|3
54060|NCT01481779|222390|P2|Overall Study|Physician Decision|4
54061|NCT01481779|222391|P1|Overall Study|Physician Decision|13
54062|NCT01481779|222390|P2|Overall Study|Withdrawal by Subject|13
54063|NCT01481779|222391|P1|Overall Study|Withdrawal by Subject|26
54064|NCT01481779|222390|P2|Overall Study|Protocol Violation|3
54065|NCT01481779|222391|P1|Overall Study|Protocol Violation|2
54066|NCT01481779|222390|P2|Overall Study|Lost to Follow-up|2
54067|NCT01481779|222391|P1|Overall Study|Lost to Follow-up|3
54068|NCT01481779|222390|P2|Overall Study|Adverse Event|5
54069|NCT01481779|222391|P1|Overall Study|Adverse Event|23
54070|NCT01481324|222476|P3|Overall Study|Missing Data|2
54071|NCT01481324|222477|P2|Overall Study|Missing Data|2
54072|NCT01481324|222478|P1|Overall Study|Missing Data|0
54073|NCT01481116|222497|P3|Overall Study|Hypoglycemic Event|0
54074|NCT01481116|222498|P2|Overall Study|Hypoglycemic Event|0
54075|NCT01481116|222499|P1|Overall Study|Hypoglycemic Event|4
54076|NCT01481116|222497|P3|Overall Study|Death|0
54077|NCT01481116|222498|P2|Overall Study|Death|1
54078|NCT01481116|222499|P1|Overall Study|Death|2
54079|NCT01481116|222497|P3|Overall Study|Investigator's Discretion|0
54080|NCT01481116|222498|P2|Overall Study|Investigator's Discretion|0
54081|NCT01481116|222499|P1|Overall Study|Investigator's Discretion|2
54082|NCT01481116|222497|P3|Overall Study|Non-Compliant With Study Drug|1
54083|NCT01481116|222498|P2|Overall Study|Non-Compliant With Study Drug|1
54084|NCT01481116|222499|P1|Overall Study|Non-Compliant With Study Drug|0
54085|NCT01481116|222497|P3|Overall Study|Sponsor Decision|3
54086|NCT01481116|222498|P2|Overall Study|Sponsor Decision|1
54087|NCT01481116|222499|P1|Overall Study|Sponsor Decision|0
54088|NCT01481116|222497|P3|Overall Study|Investigator Decision|1
54089|NCT01481116|222498|P2|Overall Study|Investigator Decision|2
54090|NCT01481116|222499|P1|Overall Study|Investigator Decision|3
54091|NCT01481116|222497|P3|Overall Study|Participant Moved Out of Country|1
54092|NCT01481116|222498|P2|Overall Study|Participant Moved Out of Country|0
54093|NCT01481116|222499|P1|Overall Study|Participant Moved Out of Country|1
54094|NCT01481116|222497|P3|Overall Study|Participant Moved Out of Area|1
54095|NCT01481116|222498|P2|Overall Study|Participant Moved Out of Area|0
54096|NCT01481116|222499|P1|Overall Study|Participant Moved Out of Area|2
54097|NCT01481116|222497|P3|Overall Study|Participant Started Taking Glipizide|0
54098|NCT01481116|222498|P2|Overall Study|Participant Started Taking Glipizide|0
54099|NCT01481116|222499|P1|Overall Study|Participant Started Taking Glipizide|1
54100|NCT01481116|222497|P3|Overall Study|Other|0
54101|NCT01481116|222498|P2|Overall Study|Other|1
54102|NCT01481116|222499|P1|Overall Study|Other|1
54103|NCT01481116|222497|P3|Overall Study|Contraindications|0
54104|NCT01481116|222498|P2|Overall Study|Contraindications|1
54105|NCT01481116|222499|P1|Overall Study|Contraindications|1
54106|NCT01481116|222497|P3|Overall Study|Lack of Efficacy|1
54107|NCT01481116|222498|P2|Overall Study|Lack of Efficacy|3
54108|NCT01481116|222499|P1|Overall Study|Lack of Efficacy|3
54109|NCT01481116|222497|P3|Overall Study|Pregnancy|1
54110|NCT01481116|222498|P2|Overall Study|Pregnancy|0
54111|NCT01481116|222499|P1|Overall Study|Pregnancy|0
54112|NCT01481116|222497|P3|Overall Study|Study Termination|713
54113|NCT01481116|222498|P2|Overall Study|Study Termination|729
54114|NCT01481116|222499|P1|Overall Study|Study Termination|730
54115|NCT01481116|222497|P3|Overall Study|Withdrawal by Subject|37
54116|NCT01481116|222498|P2|Overall Study|Withdrawal by Subject|33
54117|NCT01481116|222499|P1|Overall Study|Withdrawal by Subject|37
54118|NCT01481116|222497|P3|Overall Study|Lost to Follow-up|11
54119|NCT01481116|222498|P2|Overall Study|Lost to Follow-up|12
54120|NCT01481116|222499|P1|Overall Study|Lost to Follow-up|8
54121|NCT01481116|222497|P3|Overall Study|Major Protocol Deviation|1
54122|NCT01481116|222498|P2|Overall Study|Major Protocol Deviation|7
54123|NCT01481116|222499|P1|Overall Study|Major Protocol Deviation|3
54124|NCT01481116|222497|P3|Overall Study|Adverse Event|42
54125|NCT01481116|222498|P2|Overall Study|Adverse Event|26
54126|NCT01481116|222499|P1|Overall Study|Adverse Event|26
54127|NCT01480674|222530|P1|Overall Study|visit not done|10
54128|NCT01480674|222530|P1|Overall Study|Lost to Follow-up|2
54129|NCT01480674|222530|P1|Overall Study|Death|23
54130|NCT01480596|222544|P2|Overall Study|MG exacerbation or change in medication|2
54131|NCT01480596|222545|P1|Overall Study|MG exacerbation or change in medication|2
54132|NCT01480596|222544|P2|Overall Study|Adverse Event|0
54133|NCT01480596|222545|P1|Overall Study|Adverse Event|3
54134|NCT01480284|222593|P2|Overall Study|Physician Decision|0
54135|NCT01480284|222594|P1|Overall Study|Physician Decision|1
54136|NCT01480284|222593|P2|Overall Study|Lost to Follow-up|0
54137|NCT01480284|222594|P1|Overall Study|Lost to Follow-up|1
54138|NCT01480284|222593|P2|Overall Study|Study closed/terminated|0
54139|NCT01480284|222594|P1|Overall Study|Study closed/terminated|3
54140|NCT01480284|222593|P2|Overall Study|Adverse Event|0
54141|NCT01480284|222594|P1|Overall Study|Adverse Event|1
54142|NCT01480284|222593|P2|Overall Study|Withdrawal by Subject|0
54143|NCT01480284|222594|P1|Overall Study|Withdrawal by Subject|2
54144|NCT01480076|222677|P1|Overall Study|Not Specified|52
54145|NCT01480076|222677|P1|Overall Study|Investigator Decision|13
54146|NCT01480076|222677|P1|Overall Study|Lost to Follow-up|7
54147|NCT01480076|222677|P1|Overall Study|Withdrawal by Subject|105
54148|NCT01480076|222677|P1|Overall Study|Non-compliance With Study Protocol|15
54149|NCT01480076|222677|P1|Overall Study|Disease Progression|5
54150|NCT01480076|222677|P1|Overall Study|Death|2
54151|NCT01480076|222677|P1|Overall Study|Adverse Event|39
54152|NCT01480076|222677|P1|Overall Study|Run-in Failure|52
54153|NCT01479868|222796|P1|Overall Study|Initiation of new HCV Therapy|1
54154|NCT01479868|222796|P1|Overall Study|Sponsor's Decision|1
54155|NCT01479868|222796|P1|Overall Study|Withdrawal by Subject|1
54156|NCT01479868|222796|P1|Overall Study|Protocol Violation|1
54157|NCT01479868|222796|P1|Overall Study|Lost to Follow-up|4
54158|NCT01479868|222796|P1|Overall Study|Adverse Event|1
54159|NCT01479777|222811|P1|Overall Study|Physician Decision|2
54160|NCT01479764|222823|P2|Treated|Lost to Follow-up|2
54161|NCT01479764|222824|P1|Treated|Lost to Follow-up|0
54162|NCT01479764|222823|P2|Randomized|Withdrawal by Subject|0
54163|NCT01479764|222824|P1|Randomized|Withdrawal by Subject|1
54164|NCT01479764|222823|P2|Randomized|Adverse Event|1
54165|NCT01479764|222824|P1|Randomized|Adverse Event|1
54166|NCT01479621|222847|P7|Treatment Period|Met stopping criteria|6
54167|NCT01479621|222848|P6|Treatment Period|Met stopping criteria|20
54168|NCT01479621|222849|P5|Treatment Period|Met stopping criteria|9
54169|NCT01479621|222850|P4|Treatment Period|Met stopping criteria|4
54170|NCT01479621|222851|P3|Treatment Period|Met stopping criteria|7
54171|NCT01479621|222852|P2|Treatment Period|Met stopping criteria|8
54172|NCT01479621|222853|P1|Treatment Period|Met stopping criteria|0
54173|NCT01479621|222847|P7|Treatment Period|Lost to Follow-up|1
54174|NCT01479621|222848|P6|Treatment Period|Lost to Follow-up|2
54175|NCT01479621|222849|P5|Treatment Period|Lost to Follow-up|2
54176|NCT01479621|222850|P4|Treatment Period|Lost to Follow-up|0
54177|NCT01479621|222851|P3|Treatment Period|Lost to Follow-up|1
54178|NCT01479621|222852|P2|Treatment Period|Lost to Follow-up|0
54179|NCT01479621|222853|P1|Treatment Period|Lost to Follow-up|0
54180|NCT01479621|222847|P7|Treatment Period|Sponsor request subject to be withdrawn|3
54181|NCT01479621|222848|P6|Treatment Period|Sponsor request subject to be withdrawn|1
54182|NCT01479621|222849|P5|Treatment Period|Sponsor request subject to be withdrawn|1
54183|NCT01479621|222850|P4|Treatment Period|Sponsor request subject to be withdrawn|1
54184|NCT01479621|222851|P3|Treatment Period|Sponsor request subject to be withdrawn|3
54185|NCT01479621|222852|P2|Treatment Period|Sponsor request subject to be withdrawn|2
54186|NCT01479621|222853|P1|Treatment Period|Sponsor request subject to be withdrawn|0
54187|NCT01479621|222847|P7|Treatment Period|Pregnancy|0
54188|NCT01479621|222848|P6|Treatment Period|Pregnancy|0
54189|NCT01479621|222849|P5|Treatment Period|Pregnancy|0
54190|NCT01479621|222850|P4|Treatment Period|Pregnancy|0
54191|NCT01479621|222851|P3|Treatment Period|Pregnancy|2
54192|NCT01479621|222852|P2|Treatment Period|Pregnancy|0
54193|NCT01479621|222853|P1|Treatment Period|Pregnancy|0
54194|NCT01479621|222847|P7|Treatment Period|Protocol Violation|6
54195|NCT01479621|222848|P6|Treatment Period|Protocol Violation|10
54196|NCT01479621|222849|P5|Treatment Period|Protocol Violation|2
54197|NCT01479621|222850|P4|Treatment Period|Protocol Violation|5
54198|NCT01479621|222851|P3|Treatment Period|Protocol Violation|6
54199|NCT01479621|222852|P2|Treatment Period|Protocol Violation|9
54200|NCT01479621|222853|P1|Treatment Period|Protocol Violation|0
54201|NCT01479621|222847|P7|Treatment Period|Non-compliance to study drug|1
54202|NCT01479621|222848|P6|Treatment Period|Non-compliance to study drug|0
54203|NCT01479621|222849|P5|Treatment Period|Non-compliance to study drug|0
54204|NCT01479621|222850|P4|Treatment Period|Non-compliance to study drug|0
54205|NCT01479621|222851|P3|Treatment Period|Non-compliance to study drug|0
54206|NCT01479621|222852|P2|Treatment Period|Non-compliance to study drug|1
54207|NCT01479621|222853|P1|Treatment Period|Non-compliance to study drug|0
54208|NCT01479621|222847|P7|Treatment Period|Physician Decision|0
54209|NCT01479621|222848|P6|Treatment Period|Physician Decision|1
54210|NCT01479621|222849|P5|Treatment Period|Physician Decision|1
54211|NCT01479621|222850|P4|Treatment Period|Physician Decision|0
54212|NCT01479621|222851|P3|Treatment Period|Physician Decision|0
54213|NCT01479621|222852|P2|Treatment Period|Physician Decision|0
54214|NCT01479621|222853|P1|Treatment Period|Physician Decision|0
54215|NCT01479621|222847|P7|Treatment Period|Withdrawal by Subject|1
54216|NCT01479621|222848|P6|Treatment Period|Withdrawal by Subject|5
54217|NCT01479621|222849|P5|Treatment Period|Withdrawal by Subject|5
54218|NCT01479621|222850|P4|Treatment Period|Withdrawal by Subject|2
54219|NCT01479621|222851|P3|Treatment Period|Withdrawal by Subject|2
54220|NCT01479621|222852|P2|Treatment Period|Withdrawal by Subject|4
54221|NCT01479621|222853|P1|Treatment Period|Withdrawal by Subject|0
54222|NCT01479621|222847|P7|Treatment Period|Adverse Event|2
54223|NCT01479621|222848|P6|Treatment Period|Adverse Event|2
54224|NCT01479621|222849|P5|Treatment Period|Adverse Event|1
54225|NCT01479621|222850|P4|Treatment Period|Adverse Event|0
54226|NCT01479621|222851|P3|Treatment Period|Adverse Event|0
54227|NCT01479621|222852|P2|Treatment Period|Adverse Event|0
54228|NCT01479621|222853|P1|Treatment Period|Adverse Event|0
54229|NCT01479621|222847|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
54230|NCT01479621|222848|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
54231|NCT01479621|222849|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
54232|NCT01479621|222850|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
54233|NCT01479621|222851|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
54234|NCT01479621|222852|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
54235|NCT01479621|222853|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
54236|NCT01479621|222847|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
54237|NCT01479621|222848|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
54238|NCT01479621|222849|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
54239|NCT01479621|222850|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
54240|NCT01479621|222851|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
54241|NCT01479621|222852|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
54242|NCT01479621|222853|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
54243|NCT01479621|222847|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
54244|NCT01479621|222848|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
54245|NCT01479621|222849|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
54246|NCT01479621|222850|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
54247|NCT01479621|222851|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
54248|NCT01479621|222852|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
54249|NCT01479621|222853|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
54250|NCT01479621|222847|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
54251|NCT01479621|222848|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
54252|NCT01479621|222849|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
54253|NCT01479621|222850|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
54254|NCT01479621|222851|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
54255|NCT01479621|222852|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
54256|NCT01479621|222853|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
54257|NCT01479621|222847|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
54258|NCT01479621|222848|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
54259|NCT01479621|222849|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
54260|NCT01479621|222850|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
54261|NCT01479621|222851|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
54262|NCT01479621|222852|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
54263|NCT01479621|222853|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
54264|NCT01479595|222941|P2|Overall Study|Adverse Event|1
54265|NCT01479595|222942|P1|Overall Study|Adverse Event|2
54266|NCT01479595|222941|P2|Overall Study|Protocol deviation|1
54267|NCT01479595|222942|P1|Overall Study|Protocol deviation|0
54268|NCT01479530|222987|P2|Overall Study|Withdrawal of Consent|2
54269|NCT01479530|222988|P1|Overall Study|Withdrawal of Consent|3
54270|NCT01479530|222987|P2|Overall Study|Protocol Violation|3
54271|NCT01479530|222988|P1|Overall Study|Protocol Violation|2
54272|NCT01479530|222987|P2|Overall Study|Lack of Efficacy|1
54273|NCT01479530|222988|P1|Overall Study|Lack of Efficacy|0
54274|NCT01479530|222987|P2|Overall Study|Adverse Event|6
54275|NCT01479530|222988|P1|Overall Study|Adverse Event|5
54276|NCT01479374|223025|P3|Overall Study|Other|5
54277|NCT01479374|223026|P2|Overall Study|Other|4
54278|NCT01479374|223027|P1|Overall Study|Other|0
54279|NCT01479374|223025|P3|Overall Study|Decision Unrelated to Adverse Event|0
54280|NCT01479374|223026|P2|Overall Study|Decision Unrelated to Adverse Event|1
54281|NCT01479374|223027|P1|Overall Study|Decision Unrelated to Adverse Event|0
54282|NCT01479374|223025|P3|Overall Study|Lost to Follow-up|0
54283|NCT01479374|223026|P2|Overall Study|Lost to Follow-up|2
54284|NCT01479374|223027|P1|Overall Study|Lost to Follow-up|1
54285|NCT01479374|223025|P3|Overall Study|Adverse Event|0
54286|NCT01479374|223026|P2|Overall Study|Adverse Event|1
54287|NCT01479374|223027|P1|Overall Study|Adverse Event|2
54288|NCT01478971|223098|P1|Peginesatide Treatment Period|Other|4
54289|NCT01478971|223098|P1|Peginesatide Treatment Period|Lost to Follow-up|4
54290|NCT01478971|223098|P1|Peginesatide Treatment Period|Death|4
54291|NCT01478971|223098|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
54292|NCT01478971|223098|P1|Peginesatide Treatment Period|Adverse Event|1
54293|NCT01478971|223098|P1|Standard of Care Period|Other|4
54294|NCT01478971|223098|P1|Standard of Care Period|Lost to Follow-up|9
54295|NCT01478971|223098|P1|Standard of Care Period|Death|8
54296|NCT01478971|223098|P1|Standard of Care Period|Withdrawal by Subject|3
54297|NCT01478971|223098|P1|Standard of Care Period|Adverse Event|1
54298|NCT01478958|223115|P3|Overall Study|Unable to comply|2
54299|NCT01478958|223116|P2|Overall Study|Unable to comply|0
54300|NCT01478958|223117|P1|Overall Study|Unable to comply|0
54301|NCT01478958|223115|P3|Overall Study|Re-located|0
54302|NCT01478958|223116|P2|Overall Study|Re-located|1
54303|NCT01478958|223117|P1|Overall Study|Re-located|0
54304|NCT01478958|223115|P3|Overall Study|Weight loss|0
54305|NCT01478958|223116|P2|Overall Study|Weight loss|0
54306|NCT01478958|223117|P1|Overall Study|Weight loss|1
54307|NCT01478958|223115|P3|Overall Study|Withdrawal by Subject|1
54308|NCT01478958|223116|P2|Overall Study|Withdrawal by Subject|1
54309|NCT01478958|223117|P1|Overall Study|Withdrawal by Subject|1
54310|NCT01478828|223125|P1|Overall Study|Adverse Event|1
54311|NCT01478620|223130|P1|Overall Study|Lost to Follow-up|6
54312|NCT01478594|223136|P2|Overall Study|Study Closed by Sponsor|5
54313|NCT01478594|223137|P1|Overall Study|Study Closed by Sponsor|8
54314|NCT01478594|223136|P2|Overall Study|Withdrawal by Subject|3
54315|NCT01478594|223137|P1|Overall Study|Withdrawal by Subject|9
54316|NCT01478594|223136|P2|Overall Study|Lost to Follow-up|1
54317|NCT01478594|223137|P1|Overall Study|Lost to Follow-up|3
54318|NCT01478594|223136|P2|Overall Study|Death|18
54319|NCT01478594|223137|P1|Overall Study|Death|45
54320|NCT01478594|223136|P2|Overall Study|Randomized but Never Received Study Drug|1
54321|NCT01478594|223137|P1|Overall Study|Randomized but Never Received Study Drug|0
54322|NCT01478373|223209|P1|Survival Phase|Progressive Disease|27
54323|NCT01478373|223209|P1|Survival Phase|crossover to another study|2
54324|NCT01478373|223209|P1|Survival Phase|Protocol Violation|1
54325|NCT01478373|223209|P1|Survival Phase|Adverse Event|8
54326|NCT01478373|223209|P1|Treatment Phase|Protocol Violation|1
54327|NCT01478360|223222|P2|Overall Study|Administrative problems|2
54328|NCT01478360|223223|P1|Overall Study|Administrative problems|1
54329|NCT01478360|223222|P2|Overall Study|Adverse Event|1
54330|NCT01478360|223223|P1|Overall Study|Adverse Event|0
54331|NCT01478360|223222|P2|Overall Study|Lost to Follow-up|0
54332|NCT01478360|223223|P1|Overall Study|Lost to Follow-up|1
54333|NCT01478347|223229|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
54334|NCT01478347|223229|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
54335|NCT01478347|223229|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
54336|NCT01478113|223247|P2|Overall Study|Physician Decision|0
54337|NCT01478113|223248|P1|Overall Study|Physician Decision|1
54338|NCT01478113|223247|P2|Overall Study|Withdrawal by Subject|1
54339|NCT01478113|223248|P1|Overall Study|Withdrawal by Subject|0
54340|NCT01478087|223266|P1|Overall Study|due to sponsor closing study|1
54341|NCT01478048|223273|P2|Overall Study|no longer meets study criteria|0
54342|NCT01478048|223274|P1|Overall Study|no longer meets study criteria|1
54343|NCT01478048|223273|P2|Overall Study|poor/non-compliance|1
54344|NCT01478048|223274|P1|Overall Study|poor/non-compliance|0
54345|NCT01478048|223273|P2|Overall Study|non-specified|4
54346|NCT01478048|223274|P1|Overall Study|non-specified|6
54347|NCT01478048|223273|P2|Overall Study|Withdrawal by Subject|5
54348|NCT01478048|223274|P1|Overall Study|Withdrawal by Subject|2
54349|NCT01478048|223273|P2|Overall Study|subject request to discontinue treatment|5
54350|NCT01478048|223274|P1|Overall Study|subject request to discontinue treatment|3
54351|NCT01478048|223273|P2|Overall Study|Adverse Event|11
54352|NCT01478048|223274|P1|Overall Study|Adverse Event|2
54353|NCT01478048|223273|P2|Overall Study|study drug toxicity|14
54354|NCT01478048|223274|P1|Overall Study|study drug toxicity|11
54355|NCT01478048|223273|P2|Overall Study|Disease Progression|35
54356|NCT01478048|223274|P1|Overall Study|Disease Progression|52
54357|NCT01477892|223303|P2|Overall Study|Withdrawal by Subject|2
54358|NCT01477892|223304|P1|Overall Study|Withdrawal by Subject|0
54359|NCT01477853|223315|P3|Phase B|Study terminated by sponsor|11
54360|NCT01477853|223316|P2|Phase B|Study terminated by sponsor|10
54361|NCT01477853|223317|P1|Phase B|Study terminated by sponsor|12
54362|NCT01477853|223315|P3|Phase B|Lost to Follow-up|0
54363|NCT01477853|223316|P2|Phase B|Lost to Follow-up|1
54364|NCT01477853|223317|P1|Phase B|Lost to Follow-up|0
54365|NCT01477853|223315|P3|Phase A|Study terminated by sponsor|39
54366|NCT01477853|223316|P2|Phase A|Study terminated by sponsor|40
54367|NCT01477853|223317|P1|Phase A|Study terminated by sponsor|37
54368|NCT01477853|223315|P3|Phase A|Physician Decision|1
54369|NCT01477853|223316|P2|Phase A|Physician Decision|0
54370|NCT01477853|223317|P1|Phase A|Physician Decision|1
54371|NCT01477853|223315|P3|Phase A|Lost to Follow-up|2
54372|NCT01477853|223316|P2|Phase A|Lost to Follow-up|3
54373|NCT01477853|223317|P1|Phase A|Lost to Follow-up|4
54374|NCT01477853|223315|P3|Phase A|Adverse Event|2
54375|NCT01477853|223316|P2|Phase A|Adverse Event|2
54376|NCT01477853|223317|P1|Phase A|Adverse Event|1
54377|NCT01477749|223384|P1|Overall Study|Physician Decision|4
54378|NCT01477333|223492|P1|Overall Study|Clinical Deterioration|1
54379|NCT01477333|223492|P1|Overall Study|Withdrawal by Subject|1
54380|NCT01477333|223492|P1|Overall Study|Adverse Event|1
54381|NCT01476722|223535|P1|Overall Study|Adverse Event|1
54382|NCT01476696|223542|P3|Overall Study|Withdrawal by Subject|0
54383|NCT01476696|223543|P2|Overall Study|Withdrawal by Subject|0
54384|NCT01476696|223544|P1|Overall Study|Withdrawal by Subject|1
54385|NCT01476696|223542|P3|Overall Study|Sponsor decision|0
54386|NCT01476696|223543|P2|Overall Study|Sponsor decision|1
54387|NCT01476696|223544|P1|Overall Study|Sponsor decision|2
54388|NCT01476475|223560|P2|Overall Study|Other reasons|2
54389|NCT01476475|223561|P1|Overall Study|Other reasons|4
54390|NCT01476475|223560|P2|Overall Study|Poor compliance to protocol|1
54391|NCT01476475|223561|P1|Overall Study|Poor compliance to protocol|1
54392|NCT01476475|223560|P2|Overall Study|Adverse Event|0
54393|NCT01476475|223561|P1|Overall Study|Adverse Event|6
54394|NCT01475851|223990|P2|Overall Study|Protocol defined stopping criteria|0
54395|NCT01475851|223991|P1|Overall Study|Protocol defined stopping criteria|1
54396|NCT01475838|224019|P2|Extension Phase|Participant Noncompliance|0
54397|NCT01475838|224020|P1|Extension Phase|Participant Noncompliance|1
54398|NCT01475838|224019|P2|Randomized Phase|Protocol Violation|4
54399|NCT01475838|224020|P1|Randomized Phase|Protocol Violation|9
54400|NCT01475838|224019|P2|Randomized Phase|Participant Noncompliance|5
54401|NCT01475838|224020|P1|Randomized Phase|Participant Noncompliance|1
54402|NCT01475838|224019|P2|Randomized Phase|Lost to Follow-up|4
54403|NCT01475838|224020|P1|Randomized Phase|Lost to Follow-up|3
54404|NCT01475838|224019|P2|Randomized Phase|Withdrew Consent|14
54405|NCT01475838|224020|P1|Randomized Phase|Withdrew Consent|10
54406|NCT01475838|224019|P2|Randomized Phase|Investigators Discretion|2
54407|NCT01475838|224020|P1|Randomized Phase|Investigators Discretion|1
54408|NCT01475838|224019|P2|Randomized Phase|Pregnancy|1
54409|NCT01475838|224020|P1|Randomized Phase|Pregnancy|0
54410|NCT01475838|224019|P2|Randomized Phase|Adverse Event|1
54411|NCT01475838|224020|P1|Randomized Phase|Adverse Event|6
54412|NCT01475838|224019|P2|Randomized Phase|Randomized but Not Treated|5
54413|NCT01475838|224020|P1|Randomized Phase|Randomized but Not Treated|0
54414|NCT01475734|224035|P2|Overall Study|Physician Decision|1
54415|NCT01475734|224036|P1|Overall Study|Physician Decision|0
54416|NCT01475734|224035|P2|Overall Study|Protocol Violation|0
54417|NCT01475734|224036|P1|Overall Study|Protocol Violation|1
54418|NCT01475734|224035|P2|Overall Study|Withdrawal by Subject|0
54419|NCT01475734|224036|P1|Overall Study|Withdrawal by Subject|1
54420|NCT01475721|224064|P2|Overall Study|Withdrawal by Subject|8
54421|NCT01475721|224065|P1|Overall Study|Withdrawal by Subject|8
54422|NCT01475721|224064|P2|Overall Study|Death|6
54423|NCT01475721|224065|P1|Overall Study|Death|3
54424|NCT01475487|224081|P2|Overall Study|had to leave early for personal reasons|1
54425|NCT01475487|224082|P1|Overall Study|had to leave early for personal reasons|2
54426|NCT01475474|224094|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
54427|NCT01475474|224094|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
54428|NCT01475461|224105|P7|Treatment Period|Adverse Event|0
54429|NCT01475461|224106|P6|Treatment Period|Adverse Event|0
54430|NCT01475461|224107|P5|Treatment Period|Adverse Event|0
54431|NCT01475461|224108|P4|Treatment Period|Adverse Event|1
54432|NCT01475461|224109|P3|Treatment Period|Adverse Event|0
54433|NCT01475461|224110|P2|Treatment Period|Adverse Event|0
54434|NCT01475461|224111|P1|Treatment Period|Adverse Event|0
54435|NCT01475461|224105|P7|Treatment Period|Medication Error|0
54436|NCT01475461|224106|P6|Treatment Period|Medication Error|0
54437|NCT01475461|224107|P5|Treatment Period|Medication Error|0
54438|NCT01475461|224108|P4|Treatment Period|Medication Error|1
54439|NCT01475461|224109|P3|Treatment Period|Medication Error|0
54440|NCT01475461|224110|P2|Treatment Period|Medication Error|0
54441|NCT01475461|224111|P1|Treatment Period|Medication Error|0
54442|NCT01475461|224105|P7|Treatment Period|Lack of Efficacy|0
54443|NCT01475461|224106|P6|Treatment Period|Lack of Efficacy|1
54444|NCT01475461|224107|P5|Treatment Period|Lack of Efficacy|1
54445|NCT01475461|224108|P4|Treatment Period|Lack of Efficacy|2
54446|NCT01475461|224109|P3|Treatment Period|Lack of Efficacy|0
54447|NCT01475461|224110|P2|Treatment Period|Lack of Efficacy|2
54448|NCT01475461|224111|P1|Treatment Period|Lack of Efficacy|0
54449|NCT01475461|224105|P7|Treatment Period|Protocol Violation|1
54450|NCT01475461|224106|P6|Treatment Period|Protocol Violation|0
54451|NCT01475461|224107|P5|Treatment Period|Protocol Violation|0
54452|NCT01475461|224108|P4|Treatment Period|Protocol Violation|0
54453|NCT01475461|224109|P3|Treatment Period|Protocol Violation|0
54454|NCT01475461|224110|P2|Treatment Period|Protocol Violation|1
54455|NCT01475461|224111|P1|Treatment Period|Protocol Violation|0
54456|NCT01475461|224105|P7|Treatment Period|Other|0
54457|NCT01475461|224106|P6|Treatment Period|Other|0
54458|NCT01475461|224107|P5|Treatment Period|Other|0
54459|NCT01475461|224108|P4|Treatment Period|Other|0
54460|NCT01475461|224109|P3|Treatment Period|Other|0
54461|NCT01475461|224110|P2|Treatment Period|Other|1
54462|NCT01475461|224111|P1|Treatment Period|Other|0
54463|NCT01475461|224105|P7|Treatment Period|Withdrawal by Subject|0
54464|NCT01475461|224106|P6|Treatment Period|Withdrawal by Subject|2
54465|NCT01475461|224107|P5|Treatment Period|Withdrawal by Subject|2
54466|NCT01475461|224108|P4|Treatment Period|Withdrawal by Subject|0
54467|NCT01475461|224109|P3|Treatment Period|Withdrawal by Subject|2
54468|NCT01475461|224110|P2|Treatment Period|Withdrawal by Subject|2
54469|NCT01475461|224111|P1|Treatment Period|Withdrawal by Subject|0
54470|NCT01475461|224105|P7|Treatment Period|Lost to Follow-up|1
54471|NCT01475461|224106|P6|Treatment Period|Lost to Follow-up|2
54472|NCT01475461|224107|P5|Treatment Period|Lost to Follow-up|1
54473|NCT01475461|224108|P4|Treatment Period|Lost to Follow-up|3
54474|NCT01475461|224109|P3|Treatment Period|Lost to Follow-up|2
54475|NCT01475461|224110|P2|Treatment Period|Lost to Follow-up|3
54476|NCT01475461|224111|P1|Treatment Period|Lost to Follow-up|0
54477|NCT01475461|224105|P7|Treatment Period|Death|0
54478|NCT01475461|224106|P6|Treatment Period|Death|0
54479|NCT01475461|224107|P5|Treatment Period|Death|0
54480|NCT01475461|224108|P4|Treatment Period|Death|1
54481|NCT01475461|224109|P3|Treatment Period|Death|0
54482|NCT01475461|224110|P2|Treatment Period|Death|0
54483|NCT01475461|224111|P1|Treatment Period|Death|0
54484|NCT01475461|224105|P7|Run-in Period|Protocol Violation|0
54485|NCT01475461|224106|P6|Run-in Period|Protocol Violation|0
54486|NCT01475461|224107|P5|Run-in Period|Protocol Violation|0
54487|NCT01475461|224108|P4|Run-in Period|Protocol Violation|0
54488|NCT01475461|224109|P3|Run-in Period|Protocol Violation|0
54489|NCT01475461|224110|P2|Run-in Period|Protocol Violation|0
54490|NCT01475461|224111|P1|Run-in Period|Protocol Violation|4
54491|NCT01475461|224105|P7|Run-in Period|Other|0
54492|NCT01475461|224106|P6|Run-in Period|Other|0
54493|NCT01475461|224107|P5|Run-in Period|Other|0
54494|NCT01475461|224108|P4|Run-in Period|Other|0
54495|NCT01475461|224109|P3|Run-in Period|Other|0
54496|NCT01475461|224110|P2|Run-in Period|Other|0
54497|NCT01475461|224111|P1|Run-in Period|Other|3
54498|NCT01475461|224105|P7|Run-in Period|Withdrawal by Subject|0
54499|NCT01475461|224106|P6|Run-in Period|Withdrawal by Subject|0
54500|NCT01475461|224107|P5|Run-in Period|Withdrawal by Subject|0
54501|NCT01475461|224108|P4|Run-in Period|Withdrawal by Subject|0
54502|NCT01475461|224109|P3|Run-in Period|Withdrawal by Subject|0
54503|NCT01475461|224110|P2|Run-in Period|Withdrawal by Subject|0
54504|NCT01475461|224111|P1|Run-in Period|Withdrawal by Subject|11
54505|NCT01475461|224105|P7|Run-in Period|Lost to Follow-up|0
54506|NCT01475461|224106|P6|Run-in Period|Lost to Follow-up|0
54507|NCT01475461|224107|P5|Run-in Period|Lost to Follow-up|0
54508|NCT01475461|224108|P4|Run-in Period|Lost to Follow-up|0
54509|NCT01475461|224109|P3|Run-in Period|Lost to Follow-up|0
54510|NCT01475461|224110|P2|Run-in Period|Lost to Follow-up|0
54511|NCT01475461|224111|P1|Run-in Period|Lost to Follow-up|7
54512|NCT01475461|224105|P7|Run-in Period|Not meet eligibility criteria|0
54513|NCT01475461|224106|P6|Run-in Period|Not meet eligibility criteria|0
54514|NCT01475461|224107|P5|Run-in Period|Not meet eligibility criteria|0
54515|NCT01475461|224108|P4|Run-in Period|Not meet eligibility criteria|0
54516|NCT01475461|224109|P3|Run-in Period|Not meet eligibility criteria|0
54517|NCT01475461|224110|P2|Run-in Period|Not meet eligibility criteria|0
54518|NCT01475461|224111|P1|Run-in Period|Not meet eligibility criteria|16
54519|NCT01475331|224191|P2|Overall Study|cyst found to be prohibitively small|1
54520|NCT01475331|224192|P1|Overall Study|cyst found to be prohibitively small|0
54521|NCT01475331|224191|P2|Overall Study|Sign of malignancy during the procedure|0
54522|NCT01475331|224192|P1|Overall Study|Sign of malignancy during the procedure|2
54523|NCT01475331|224191|P2|Overall Study|Loss of needle positioning due pt. cough|0
54524|NCT01475331|224192|P1|Overall Study|Loss of needle positioning due pt. cough|1
54525|NCT01475331|224191|P2|Overall Study|excessive main duct communication|1
54526|NCT01475331|224192|P1|Overall Study|excessive main duct communication|1
54527|NCT01475331|224191|P2|Overall Study|Osteophyte obstruction of the proximal|0
54528|NCT01475331|224192|P1|Overall Study|Osteophyte obstruction of the proximal|1
54529|NCT01475253|224244|P4|Randomized, Blinded Study|Lost to Follow-up|0
54530|NCT01475253|224245|P3|Randomized, Blinded Study|Lost to Follow-up|0
54531|NCT01475253|224246|P2|Randomized, Blinded Study|Lost to Follow-up|0
54532|NCT01475253|224247|P1|Randomized, Blinded Study|Lost to Follow-up|1
54533|NCT01475253|224244|P4|Randomized, Blinded Study|Withdrawal by Subject|0
54534|NCT01475253|224245|P3|Randomized, Blinded Study|Withdrawal by Subject|0
54535|NCT01475253|224246|P2|Randomized, Blinded Study|Withdrawal by Subject|1
54536|NCT01475253|224247|P1|Randomized, Blinded Study|Withdrawal by Subject|1
54537|NCT01475214|224276|P3|Overall Study|Withdrawal by Subject|1
54538|NCT01475214|224277|P2|Overall Study|Withdrawal by Subject|4
54539|NCT01475214|224278|P1|Overall Study|Withdrawal by Subject|2
54540|NCT01475214|224276|P3|Overall Study|Physician Decision|0
54541|NCT01475214|224277|P2|Overall Study|Physician Decision|0
54542|NCT01475214|224278|P1|Overall Study|Physician Decision|2
54543|NCT01475214|224276|P3|Overall Study|Lost to Follow-up|1
54544|NCT01475214|224277|P2|Overall Study|Lost to Follow-up|0
54545|NCT01475214|224278|P1|Overall Study|Lost to Follow-up|1
54546|NCT01475097|224303|P2|Overall Study|Protocol Violation|1
54547|NCT01475097|224304|P1|Overall Study|Protocol Violation|1
54548|NCT01475071|224312|P1|Overall Study|Lost to Follow-up|1
54549|NCT01475071|224312|P1|Overall Study|Withdrawal by Subject|6
54550|NCT01475071|224312|P1|Overall Study|Physician Decision|1
54551|NCT01474993|224322|P2|Overall Study|Adverse Event|1
54552|NCT01474993|224323|P1|Overall Study|Adverse Event|0
54553|NCT01474993|224322|P2|Overall Study|Lost to Follow-up|2
54554|NCT01474993|224323|P1|Overall Study|Lost to Follow-up|1
54555|NCT01474876|224361|P3|Overall Study|Investigator's decision and pt request|0
54556|NCT01474876|224362|P2|Overall Study|Investigator's decision and pt request|0
54557|NCT01474876|224363|P1|Overall Study|Investigator's decision and pt request|1
54558|NCT01474876|224361|P3|Overall Study|Patient's request|0
54559|NCT01474876|224362|P2|Overall Study|Patient's request|5
54560|NCT01474876|224363|P1|Overall Study|Patient's request|19
54561|NCT01474876|224361|P3|Overall Study|Investigator's decision|0
54562|NCT01474876|224362|P2|Overall Study|Investigator's decision|6
54563|NCT01474876|224363|P1|Overall Study|Investigator's decision|28
54564|NCT01474876|224361|P3|Overall Study|Lost to Follow-up|0
54565|NCT01474876|224362|P2|Overall Study|Lost to Follow-up|4
54566|NCT01474876|224363|P1|Overall Study|Lost to Follow-up|5
54567|NCT01474876|224361|P3|Overall Study|Serious Adverse Event|0
54568|NCT01474876|224362|P2|Overall Study|Serious Adverse Event|3
54569|NCT01474876|224363|P1|Overall Study|Serious Adverse Event|2
54570|NCT01474876|224361|P3|Overall Study|Adverse Event|0
54571|NCT01474876|224362|P2|Overall Study|Adverse Event|5
54572|NCT01474876|224363|P1|Overall Study|Adverse Event|11
54573|NCT01474772|224409|P2|Follow-up|AE not Related to Study Drug|1
54574|NCT01474772|224410|P1|Follow-up|AE not Related to Study Drug|0
54575|NCT01474772|224409|P2|Period 2|Reason not Specified|2
54576|NCT01474772|224410|P1|Period 2|Reason not Specified|0
54577|NCT01474772|224409|P2|Period 2|Lost to Follow-up|1
54578|NCT01474772|224410|P1|Period 2|Lost to Follow-up|1
54579|NCT01474772|224409|P2|Period 2|Withdrawal by Subject|4
54580|NCT01474772|224410|P1|Period 2|Withdrawal by Subject|3
54581|NCT01474772|224409|P2|Period 2|Lack of Efficacy|0
54582|NCT01474772|224410|P1|Period 2|Lack of Efficacy|1
54583|NCT01474772|224409|P2|Period 2|AE not Related to Study Drug|1
54584|NCT01474772|224410|P1|Period 2|AE not Related to Study Drug|4
54585|NCT01474772|224409|P2|Period 2|AE Related to Study Drug|1
54586|NCT01474772|224410|P1|Period 2|AE Related to Study Drug|0
54587|NCT01474772|224409|P2|Period 2|Death|1
54588|NCT01474772|224410|P1|Period 2|Death|0
54589|NCT01474772|224409|P2|Washout|Reason not Specified|1
54590|NCT01474772|224410|P1|Washout|Reason not Specified|0
54591|NCT01474772|224409|P2|Washout|Lost to Follow-up|1
54592|NCT01474772|224410|P1|Washout|Lost to Follow-up|0
54593|NCT01474772|224409|P2|Washout|Withdrawal by Subject|0
54594|NCT01474772|224410|P1|Washout|Withdrawal by Subject|1
54595|NCT01474772|224409|P2|Washout|AE not Related to Study Drug|0
54596|NCT01474772|224410|P1|Washout|AE not Related to Study Drug|2
54597|NCT01474772|224409|P2|Period 1|Reason not Specified|1
54598|NCT01474772|224410|P1|Period 1|Reason not Specified|1
54599|NCT01474772|224409|P2|Period 1|Lost to Follow-up|0
54600|NCT01474772|224410|P1|Period 1|Lost to Follow-up|1
54601|NCT01474772|224409|P2|Period 1|Withdrawal by Subject|1
54602|NCT01474772|224410|P1|Period 1|Withdrawal by Subject|3
54603|NCT01474772|224409|P2|Period 1|AE not Related to Study Drug|0
54604|NCT01474772|224410|P1|Period 1|AE not Related to Study Drug|1
54605|NCT01474772|224409|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
54606|NCT01474772|224410|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
54607|NCT01474746|224460|P2|Overall Study|Withdrawal by Subject|1
54608|NCT01474746|224461|P1|Overall Study|Withdrawal by Subject|2
54609|NCT01474746|224460|P2|Overall Study|Lost to Follow-up|1
54610|NCT01474746|224461|P1|Overall Study|Lost to Follow-up|1
54611|NCT01474681|224525|P4|Overall Study|Death|6
54612|NCT01474681|224526|P3|Overall Study|Death|2
54613|NCT01474681|224527|P2|Overall Study|Death|3
54614|NCT01474681|224528|P1|Overall Study|Death|0
54615|NCT01474551|224579|P1|Overall Study|Death|1
54616|NCT01474538|224585|P2|Treatment Period 2|Protocol Violation|0
54617|NCT01474538|224586|P1|Treatment Period 2|Protocol Violation|1
54618|NCT01474538|224585|P2|Treatment Period 2|Physician Decision|1
54619|NCT01474538|224586|P1|Treatment Period 2|Physician Decision|0
54620|NCT01474538|224585|P2|Treatment Period 2|Sponsor decision|0
54621|NCT01474538|224586|P1|Treatment Period 2|Sponsor decision|1
54622|NCT01474538|224585|P2|Treatment Period 2|Withdrawal by Subject|0
54623|NCT01474538|224586|P1|Treatment Period 2|Withdrawal by Subject|2
54624|NCT01474538|224585|P2|Treatment Period 2|Adverse Event|1
54625|NCT01474538|224586|P1|Treatment Period 2|Adverse Event|1
54626|NCT01474538|224585|P2|Treatment Period 2|Death|0
54627|NCT01474538|224586|P1|Treatment Period 2|Death|1
54628|NCT01474538|224585|P2|Treatment Period 1|Protocol Violation|1
54629|NCT01474538|224586|P1|Treatment Period 1|Protocol Violation|0
54630|NCT01474538|224585|P2|Treatment Period 1|Withdrawal by Subject|3
54631|NCT01474538|224586|P1|Treatment Period 1|Withdrawal by Subject|1
54632|NCT01474538|224585|P2|Treatment Period 1|Physician Decision|0
54633|NCT01474538|224586|P1|Treatment Period 1|Physician Decision|1
54634|NCT01474538|224585|P2|Treatment Period 1|Death|0
54635|NCT01474538|224586|P1|Treatment Period 1|Death|1
54636|NCT01474512|224603|P10|Maintenance Period|Treated but Discontinued in Induction|0
54637|NCT01474512|224604|P9|Maintenance Period|Treated but Discontinued in Induction|0
54638|NCT01474512|224605|P8|Maintenance Period|Treated but Discontinued in Induction|0
54639|NCT01474512|224606|P7|Maintenance Period|Treated but Discontinued in Induction|0
54640|NCT01474512|224607|P6|Maintenance Period|Treated but Discontinued in Induction|0
54641|NCT01474512|224608|P5|Maintenance Period|Treated but Discontinued in Induction|1
54642|NCT01474512|224609|P4|Maintenance Period|Treated but Discontinued in Induction|0
54643|NCT01474512|224610|P3|Maintenance Period|Treated but Discontinued in Induction|0
54644|NCT01474512|224611|P2|Maintenance Period|Treated but Discontinued in Induction|0
54645|NCT01474512|224612|P1|Maintenance Period|Treated but Discontinued in Induction|0
54646|NCT01474512|224603|P10|Maintenance Period|Protocol Violation|1
54647|NCT01474512|224604|P9|Maintenance Period|Protocol Violation|0
54648|NCT01474512|224605|P8|Maintenance Period|Protocol Violation|1
54649|NCT01474512|224606|P7|Maintenance Period|Protocol Violation|0
54650|NCT01474512|224607|P6|Maintenance Period|Protocol Violation|0
54651|NCT01474512|224608|P5|Maintenance Period|Protocol Violation|0
54652|NCT01474512|224609|P4|Maintenance Period|Protocol Violation|1
54653|NCT01474512|224610|P3|Maintenance Period|Protocol Violation|0
54654|NCT01474512|224611|P2|Maintenance Period|Protocol Violation|0
54655|NCT01474512|224612|P1|Maintenance Period|Protocol Violation|0
54656|NCT01474512|224603|P10|Maintenance Period|Lack of Efficacy|12
54657|NCT01474512|224604|P9|Maintenance Period|Lack of Efficacy|11
54658|NCT01474512|224605|P8|Maintenance Period|Lack of Efficacy|11
54659|NCT01474512|224606|P7|Maintenance Period|Lack of Efficacy|0
54660|NCT01474512|224607|P6|Maintenance Period|Lack of Efficacy|0
54661|NCT01474512|224608|P5|Maintenance Period|Lack of Efficacy|0
54662|NCT01474512|224609|P4|Maintenance Period|Lack of Efficacy|1
54663|NCT01474512|224610|P3|Maintenance Period|Lack of Efficacy|0
54664|NCT01474512|224611|P2|Maintenance Period|Lack of Efficacy|0
54665|NCT01474512|224612|P1|Maintenance Period|Lack of Efficacy|0
54666|NCT01474512|224603|P10|Maintenance Period|Clinical Relapse|0
54667|NCT01474512|224604|P9|Maintenance Period|Clinical Relapse|0
54668|NCT01474512|224605|P8|Maintenance Period|Clinical Relapse|0
54669|NCT01474512|224606|P7|Maintenance Period|Clinical Relapse|0
54670|NCT01474512|224607|P6|Maintenance Period|Clinical Relapse|0
54671|NCT01474512|224608|P5|Maintenance Period|Clinical Relapse|0
54672|NCT01474512|224609|P4|Maintenance Period|Clinical Relapse|1
54673|NCT01474512|224610|P3|Maintenance Period|Clinical Relapse|0
54674|NCT01474512|224611|P2|Maintenance Period|Clinical Relapse|0
54675|NCT01474512|224612|P1|Maintenance Period|Clinical Relapse|0
54676|NCT01474512|224603|P10|Maintenance Period|Investigator Decision|0
54677|NCT01474512|224604|P9|Maintenance Period|Investigator Decision|0
54678|NCT01474512|224605|P8|Maintenance Period|Investigator Decision|2
54679|NCT01474512|224606|P7|Maintenance Period|Investigator Decision|0
54680|NCT01474512|224607|P6|Maintenance Period|Investigator Decision|1
54681|NCT01474512|224608|P5|Maintenance Period|Investigator Decision|0
54682|NCT01474512|224609|P4|Maintenance Period|Investigator Decision|0
54683|NCT01474512|224610|P3|Maintenance Period|Investigator Decision|0
54684|NCT01474512|224611|P2|Maintenance Period|Investigator Decision|0
54685|NCT01474512|224612|P1|Maintenance Period|Investigator Decision|0
54686|NCT01474512|224603|P10|Maintenance Period|Death|0
54687|NCT01474512|224604|P9|Maintenance Period|Death|0
54688|NCT01474512|224605|P8|Maintenance Period|Death|0
54689|NCT01474512|224606|P7|Maintenance Period|Death|0
54690|NCT01474512|224607|P6|Maintenance Period|Death|2
54691|NCT01474512|224608|P5|Maintenance Period|Death|0
54692|NCT01474512|224609|P4|Maintenance Period|Death|0
54693|NCT01474512|224610|P3|Maintenance Period|Death|0
54694|NCT01474512|224611|P2|Maintenance Period|Death|0
54695|NCT01474512|224612|P1|Maintenance Period|Death|0
54696|NCT01474512|224603|P10|Maintenance Period|Lost to Follow-up|1
54697|NCT01474512|224604|P9|Maintenance Period|Lost to Follow-up|1
54698|NCT01474512|224605|P8|Maintenance Period|Lost to Follow-up|2
54699|NCT01474512|224606|P7|Maintenance Period|Lost to Follow-up|0
54700|NCT01474512|224607|P6|Maintenance Period|Lost to Follow-up|0
54701|NCT01474512|224608|P5|Maintenance Period|Lost to Follow-up|3
54702|NCT01474512|224609|P4|Maintenance Period|Lost to Follow-up|3
54703|NCT01474512|224610|P3|Maintenance Period|Lost to Follow-up|0
54704|NCT01474512|224611|P2|Maintenance Period|Lost to Follow-up|0
54705|NCT01474512|224612|P1|Maintenance Period|Lost to Follow-up|0
54706|NCT01474512|224603|P10|Maintenance Period|Withdrawal by Subject|1
54707|NCT01474512|224604|P9|Maintenance Period|Withdrawal by Subject|3
54708|NCT01474512|224605|P8|Maintenance Period|Withdrawal by Subject|6
54709|NCT01474512|224606|P7|Maintenance Period|Withdrawal by Subject|1
54710|NCT01474512|224607|P6|Maintenance Period|Withdrawal by Subject|3
54711|NCT01474512|224608|P5|Maintenance Period|Withdrawal by Subject|2
54712|NCT01474512|224609|P4|Maintenance Period|Withdrawal by Subject|6
54713|NCT01474512|224610|P3|Maintenance Period|Withdrawal by Subject|0
54714|NCT01474512|224611|P2|Maintenance Period|Withdrawal by Subject|0
54715|NCT01474512|224612|P1|Maintenance Period|Withdrawal by Subject|0
54716|NCT01474512|224603|P10|Maintenance Period|Adverse Event|3
54717|NCT01474512|224604|P9|Maintenance Period|Adverse Event|1
54718|NCT01474512|224605|P8|Maintenance Period|Adverse Event|19
54719|NCT01474512|224606|P7|Maintenance Period|Adverse Event|0
54720|NCT01474512|224607|P6|Maintenance Period|Adverse Event|7
54721|NCT01474512|224608|P5|Maintenance Period|Adverse Event|2
54722|NCT01474512|224609|P4|Maintenance Period|Adverse Event|4
54723|NCT01474512|224610|P3|Maintenance Period|Adverse Event|0
54724|NCT01474512|224611|P2|Maintenance Period|Adverse Event|0
54725|NCT01474512|224612|P1|Maintenance Period|Adverse Event|0
54726|NCT01474512|224603|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
54727|NCT01474512|224604|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
54728|NCT01474512|224605|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
54729|NCT01474512|224606|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
54730|NCT01474512|224607|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
54731|NCT01474512|224608|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
54732|NCT01474512|224609|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
54733|NCT01474512|224610|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
54734|NCT01474512|224611|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
54735|NCT01474512|224612|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
54736|NCT01474512|224603|P10|Induction Period|Lost to Follow-up|0
54737|NCT01474512|224604|P9|Induction Period|Lost to Follow-up|0
54738|NCT01474512|224605|P8|Induction Period|Lost to Follow-up|0
54739|NCT01474512|224606|P7|Induction Period|Lost to Follow-up|0
54740|NCT01474512|224607|P6|Induction Period|Lost to Follow-up|0
54741|NCT01474512|224608|P5|Induction Period|Lost to Follow-up|0
54742|NCT01474512|224609|P4|Induction Period|Lost to Follow-up|0
54743|NCT01474512|224610|P3|Induction Period|Lost to Follow-up|2
54744|NCT01474512|224611|P2|Induction Period|Lost to Follow-up|0
54745|NCT01474512|224612|P1|Induction Period|Lost to Follow-up|1
54746|NCT01474512|224603|P10|Induction Period|Sponsor Decision|0
54747|NCT01474512|224604|P9|Induction Period|Sponsor Decision|0
54748|NCT01474512|224605|P8|Induction Period|Sponsor Decision|0
54749|NCT01474512|224606|P7|Induction Period|Sponsor Decision|0
54750|NCT01474512|224607|P6|Induction Period|Sponsor Decision|0
54751|NCT01474512|224608|P5|Induction Period|Sponsor Decision|0
54752|NCT01474512|224609|P4|Induction Period|Sponsor Decision|0
54753|NCT01474512|224610|P3|Induction Period|Sponsor Decision|1
54754|NCT01474512|224611|P2|Induction Period|Sponsor Decision|1
54755|NCT01474512|224612|P1|Induction Period|Sponsor Decision|1
54756|NCT01474512|224603|P10|Induction Period|Protocol Violation|0
54757|NCT01474512|224604|P9|Induction Period|Protocol Violation|0
54758|NCT01474512|224605|P8|Induction Period|Protocol Violation|0
54759|NCT01474512|224606|P7|Induction Period|Protocol Violation|0
54760|NCT01474512|224607|P6|Induction Period|Protocol Violation|0
54761|NCT01474512|224608|P5|Induction Period|Protocol Violation|0
54762|NCT01474512|224609|P4|Induction Period|Protocol Violation|0
54763|NCT01474512|224610|P3|Induction Period|Protocol Violation|0
54764|NCT01474512|224611|P2|Induction Period|Protocol Violation|6
54765|NCT01474512|224612|P1|Induction Period|Protocol Violation|3
54766|NCT01474512|224603|P10|Induction Period|Withdrawal by Subject|0
54767|NCT01474512|224604|P9|Induction Period|Withdrawal by Subject|0
54768|NCT01474512|224605|P8|Induction Period|Withdrawal by Subject|0
54769|NCT01474512|224606|P7|Induction Period|Withdrawal by Subject|0
54770|NCT01474512|224607|P6|Induction Period|Withdrawal by Subject|0
54771|NCT01474512|224608|P5|Induction Period|Withdrawal by Subject|0
54772|NCT01474512|224609|P4|Induction Period|Withdrawal by Subject|0
54773|NCT01474512|224610|P3|Induction Period|Withdrawal by Subject|5
54774|NCT01474512|224611|P2|Induction Period|Withdrawal by Subject|6
54775|NCT01474512|224612|P1|Induction Period|Withdrawal by Subject|6
54776|NCT01474512|224603|P10|Induction Period|Lack of Efficacy|0
54777|NCT01474512|224604|P9|Induction Period|Lack of Efficacy|0
54778|NCT01474512|224605|P8|Induction Period|Lack of Efficacy|0
54779|NCT01474512|224606|P7|Induction Period|Lack of Efficacy|0
54780|NCT01474512|224607|P6|Induction Period|Lack of Efficacy|0
54781|NCT01474512|224608|P5|Induction Period|Lack of Efficacy|0
54782|NCT01474512|224609|P4|Induction Period|Lack of Efficacy|0
54783|NCT01474512|224610|P3|Induction Period|Lack of Efficacy|0
54784|NCT01474512|224611|P2|Induction Period|Lack of Efficacy|1
54785|NCT01474512|224612|P1|Induction Period|Lack of Efficacy|7
54786|NCT01474512|224603|P10|Induction Period|Adverse Event|0
54787|NCT01474512|224604|P9|Induction Period|Adverse Event|0
54788|NCT01474512|224605|P8|Induction Period|Adverse Event|0
54789|NCT01474512|224606|P7|Induction Period|Adverse Event|0
54790|NCT01474512|224607|P6|Induction Period|Adverse Event|0
54791|NCT01474512|224608|P5|Induction Period|Adverse Event|0
54792|NCT01474512|224609|P4|Induction Period|Adverse Event|0
54793|NCT01474512|224610|P3|Induction Period|Adverse Event|10
54794|NCT01474512|224611|P2|Induction Period|Adverse Event|10
54795|NCT01474512|224612|P1|Induction Period|Adverse Event|6
54796|NCT01474434|224681|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
54797|NCT01474434|224682|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
54798|NCT01474434|224683|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
54799|NCT01474434|224684|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
54800|NCT01474434|224681|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
54801|NCT01474434|224682|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
54802|NCT01474434|224683|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
54803|NCT01474434|224684|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
54804|NCT01474434|224681|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
54805|NCT01474434|224682|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
54806|NCT01474434|224683|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
54807|NCT01474434|224684|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
54808|NCT01474317|224726|P1|Overall Study|Subject ineligible for study|1
54809|NCT01474317|224726|P1|Overall Study|Adverse Event|1
54810|NCT01474291|224735|P1|Overall Study|Death|2
54811|NCT01474291|224735|P1|Overall Study|No Reason Reported|10
54812|NCT01474291|224735|P1|Overall Study|Patient No Longer Wanted to Participate|12
54813|NCT01474291|224735|P1|Overall Study|Lost to Follow-up|29
54814|NCT01474291|224735|P1|Overall Study|Adverse Event|53
54815|NCT01474291|224735|P1|Overall Study|Lack of Treatment Efficacy|88
54816|NCT01474291|224735|P1|Overall Study|Not Evaluable for Efficacy|26
54817|NCT01474239|224779|P2|Overall Study|Withdrawal for Economic Reason|0
54818|NCT01474239|224780|P1|Overall Study|Withdrawal for Economic Reason|1
54819|NCT01474239|224779|P2|Overall Study|Clinical Disease Progression|1
54820|NCT01474239|224780|P1|Overall Study|Clinical Disease Progression|7
54821|NCT01474239|224779|P2|Overall Study|Death|1
54822|NCT01474239|224780|P1|Overall Study|Death|1
54823|NCT01474239|224779|P2|Overall Study|Withdrawal by Subject|2
54824|NCT01474239|224780|P1|Overall Study|Withdrawal by Subject|1
54825|NCT01474239|224779|P2|Overall Study|Adverse Event|3
54826|NCT01474239|224780|P1|Overall Study|Adverse Event|12
54827|NCT01474239|224779|P2|Overall Study|Disease Progression|25
54828|NCT01474239|224780|P1|Overall Study|Disease Progression|37
54829|NCT01473953|224974|P5|Overall Study|Other|0
54830|NCT01473953|224975|P4|Overall Study|Other|0
54831|NCT01473953|224976|P3|Overall Study|Other|0
54832|NCT01473953|224977|P2|Overall Study|Other|0
54833|NCT01473953|224978|P1|Overall Study|Other|1
54834|NCT01473836|225020|P1|Overall Study|Does not meet entrance criteria|1
54835|NCT01473836|225020|P1|Overall Study|Lack of Efficacy|1
54836|NCT01473836|225020|P1|Overall Study|Adverse Event|4
54837|NCT01473758|225031|P4|Cycle 2|Adverse Event|0
54838|NCT01473758|225032|P3|Cycle 2|Adverse Event|5
54839|NCT01473758|225033|P2|Cycle 2|Adverse Event|0
54840|NCT01473758|225034|P1|Cycle 2|Adverse Event|0
54841|NCT01473758|225031|P4|Cycle 1|Withdrawal by Subject|0
54842|NCT01473758|225032|P3|Cycle 1|Withdrawal by Subject|0
54843|NCT01473758|225033|P2|Cycle 1|Withdrawal by Subject|1
54844|NCT01473758|225034|P1|Cycle 1|Withdrawal by Subject|1
54845|NCT01473758|225031|P4|Cycle 1|Adverse Event|0
54846|NCT01473758|225032|P3|Cycle 1|Adverse Event|0
54847|NCT01473758|225033|P2|Cycle 1|Adverse Event|2
54848|NCT01473758|225034|P1|Cycle 1|Adverse Event|10
54849|NCT01473602|225171|P2|Overall Study|Physician Decision|0
54850|NCT01473602|225172|P1|Overall Study|Physician Decision|1
54851|NCT01473602|225171|P2|Overall Study|Withdrawal by Subject|4
54852|NCT01473602|225172|P1|Overall Study|Withdrawal by Subject|5
54853|NCT01473602|225171|P2|Overall Study|Lost to Follow-up|1
54854|NCT01473602|225172|P1|Overall Study|Lost to Follow-up|1
54855|NCT01473602|225171|P2|Overall Study|Death|1
54856|NCT01473602|225172|P1|Overall Study|Death|0
54857|NCT01473602|225171|P2|Overall Study|Adverse Event|2
54858|NCT01473602|225172|P1|Overall Study|Adverse Event|1
54859|NCT01473589|225208|P2|Overall Study|Entry criteria not met|1
54860|NCT01473589|225209|P1|Overall Study|Entry criteria not met|0
54861|NCT01473589|225208|P2|Overall Study|Physician Decision|1
54862|NCT01473589|225209|P1|Overall Study|Physician Decision|0
54863|NCT01473589|225208|P2|Overall Study|Withdrawal by Subject|11
54864|NCT01473589|225209|P1|Overall Study|Withdrawal by Subject|5
54865|NCT01473589|225208|P2|Overall Study|Protocol Violation|0
54866|NCT01473589|225209|P1|Overall Study|Protocol Violation|1
54867|NCT01473589|225208|P2|Overall Study|Lost to Follow-up|2
54868|NCT01473589|225209|P1|Overall Study|Lost to Follow-up|2
54869|NCT01473589|225208|P2|Overall Study|Death|0
54870|NCT01473589|225209|P1|Overall Study|Death|2
54871|NCT01473589|225208|P2|Overall Study|Adverse Event|1
54872|NCT01473589|225209|P1|Overall Study|Adverse Event|1
54873|NCT01473563|225243|P1|Overall Study|Lost to FU post tx discontinuation|1
54874|NCT01473524|225265|P3|Overall Study|Withdrawal by Subject|1
54875|NCT01473524|225266|P2|Overall Study|Withdrawal by Subject|1
54876|NCT01473524|225267|P1|Overall Study|Withdrawal by Subject|2
54877|NCT01473524|225265|P3|Overall Study|Death|0
54878|NCT01473524|225266|P2|Overall Study|Death|0
54879|NCT01473524|225267|P1|Overall Study|Death|1
54880|NCT01473524|225265|P3|Overall Study|Adverse Event|2
54881|NCT01473524|225266|P2|Overall Study|Adverse Event|8
54882|NCT01473524|225267|P1|Overall Study|Adverse Event|4
54883|NCT01473394|225300|P2|Overall Study|Lost to Follow-up|11
54884|NCT01473394|225301|P1|Overall Study|Lost to Follow-up|9
54885|NCT01473394|225300|P2|Overall Study|Withdrew Consent|10
54886|NCT01473394|225301|P1|Overall Study|Withdrew Consent|12
54887|NCT01473394|225300|P2|Overall Study|Protocol Violation|5
54888|NCT01473394|225301|P1|Overall Study|Protocol Violation|7
54889|NCT01473394|225300|P2|Overall Study|Insufficient Therapeutic Response|1
54890|NCT01473394|225301|P1|Overall Study|Insufficient Therapeutic Response|4
54891|NCT01473394|225300|P2|Overall Study|Adverse Event|16
54892|NCT01473394|225301|P1|Overall Study|Adverse Event|13
54893|NCT01473381|225315|P4|Overall Study|Other Reasons|3
54894|NCT01473381|225316|P3|Overall Study|Other Reasons|1
54895|NCT01473381|225317|P2|Overall Study|Other Reasons|0
54896|NCT01473381|225318|P1|Overall Study|Other Reasons|0
54897|NCT01473381|225315|P4|Overall Study|Lost to Follow-up|23
54898|NCT01473381|225316|P3|Overall Study|Lost to Follow-up|35
54899|NCT01473381|225317|P2|Overall Study|Lost to Follow-up|28
54900|NCT01473381|225318|P1|Overall Study|Lost to Follow-up|25
54901|NCT01473381|225315|P4|Overall Study|Withdrawal of Consent|26
54902|NCT01473381|225316|P3|Overall Study|Withdrawal of Consent|20
54903|NCT01473381|225317|P2|Overall Study|Withdrawal of Consent|21
54904|NCT01473381|225318|P1|Overall Study|Withdrawal of Consent|20
54905|NCT01473381|225315|P4|Overall Study|Protocol Violation|17
54906|NCT01473381|225316|P3|Overall Study|Protocol Violation|19
54907|NCT01473381|225317|P2|Overall Study|Protocol Violation|23
54908|NCT01473381|225318|P1|Overall Study|Protocol Violation|17
54909|NCT01473381|225315|P4|Overall Study|Insufficient Therapeutic Response|3
54910|NCT01473381|225316|P3|Overall Study|Insufficient Therapeutic Response|2
54911|NCT01473381|225317|P2|Overall Study|Insufficient Therapeutic Response|1
54912|NCT01473381|225318|P1|Overall Study|Insufficient Therapeutic Response|10
54913|NCT01473381|225315|P4|Overall Study|Adverse Event|17
54914|NCT01473381|225316|P3|Overall Study|Adverse Event|25
54915|NCT01473381|225317|P2|Overall Study|Adverse Event|20
54916|NCT01473381|225318|P1|Overall Study|Adverse Event|8
54917|NCT01472965|225400|P2|Overall Study|Withdrawal by Subject|0
54918|NCT01472965|225401|P1|Overall Study|Withdrawal by Subject|1
54919|NCT01472939|225421|P4|Overall Study|Withdrawal by Subject|4
54920|NCT01472939|225422|P3|Overall Study|Withdrawal by Subject|1
54921|NCT01472939|225423|P2|Overall Study|Withdrawal by Subject|3
54922|NCT01472939|225424|P1|Overall Study|Withdrawal by Subject|9
54923|NCT01472939|225421|P4|Overall Study|Protocol Violation|1
54924|NCT01472939|225422|P3|Overall Study|Protocol Violation|0
54925|NCT01472939|225423|P2|Overall Study|Protocol Violation|3
54926|NCT01472939|225424|P1|Overall Study|Protocol Violation|3
54927|NCT01472939|225421|P4|Overall Study|Withdrawal By PI|0
54928|NCT01472939|225422|P3|Overall Study|Withdrawal By PI|0
54929|NCT01472939|225423|P2|Overall Study|Withdrawal By PI|0
54930|NCT01472939|225424|P1|Overall Study|Withdrawal By PI|1
54931|NCT01472939|225421|P4|Overall Study|Prohibited Medication|0
54932|NCT01472939|225422|P3|Overall Study|Prohibited Medication|0
54933|NCT01472939|225423|P2|Overall Study|Prohibited Medication|1
54934|NCT01472939|225424|P1|Overall Study|Prohibited Medication|0
54935|NCT01472939|225421|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
54936|NCT01472939|225422|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
54937|NCT01472939|225423|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
54938|NCT01472939|225424|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
54939|NCT01472939|225421|P4|Overall Study|Lost to Follow-up|0
54940|NCT01472939|225422|P3|Overall Study|Lost to Follow-up|2
54941|NCT01472939|225423|P2|Overall Study|Lost to Follow-up|0
54942|NCT01472939|225424|P1|Overall Study|Lost to Follow-up|3
54943|NCT01472939|225421|P4|Overall Study|Lack of Efficacy|1
54944|NCT01472939|225422|P3|Overall Study|Lack of Efficacy|0
54945|NCT01472939|225423|P2|Overall Study|Lack of Efficacy|0
54946|NCT01472939|225424|P1|Overall Study|Lack of Efficacy|1
54947|NCT01472939|225421|P4|Overall Study|Adverse Event|14
54948|NCT01472939|225422|P3|Overall Study|Adverse Event|7
54949|NCT01472939|225423|P2|Overall Study|Adverse Event|7
54950|NCT01472939|225424|P1|Overall Study|Adverse Event|3
54951|NCT01472835|225468|P2|Overall Study|Lost to Follow-up|0
54952|NCT01472835|225469|P1|Overall Study|Lost to Follow-up|2
54953|NCT01472380|225524|P1|1 Day Period Between Dosing|Protocol Violation|1
54954|NCT01472380|225524|P1|Efavirenz Alone|Withdrawal by Subject|1
54955|NCT01472341|225535|P1|Overall Study|Death|9
54956|NCT01472341|225535|P1|Overall Study|Laboratory parameters unavailable|25
54957|NCT01472341|225535|P1|Overall Study|Lost to Follow-up|52
54958|NCT01472341|225535|P1|Overall Study|Withdrawal by Subject|39
54959|NCT01472341|225535|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
54960|NCT01472341|225535|P1|Overall Study|Started insulin therapy|55
54961|NCT01472289|225541|P1|Overall Study|Death|2
54962|NCT01472185|225553|P2|Overall Study|Subject Withdrew Consent|3
54963|NCT01472185|225554|P1|Overall Study|Subject Withdrew Consent|6
54964|NCT01472185|225553|P2|Overall Study|Subject Noncompliance|15
54965|NCT01472185|225554|P1|Overall Study|Subject Noncompliance|8
54966|NCT01472185|225553|P2|Overall Study|Protocol Violation|1
54967|NCT01472185|225554|P1|Overall Study|Protocol Violation|5
54968|NCT01472185|225553|P2|Overall Study|Lost to Follow-up|1
54969|NCT01472185|225554|P1|Overall Study|Lost to Follow-up|4
54970|NCT01472185|225553|P2|Overall Study|Investigator’s Discretion|1
54971|NCT01472185|225554|P1|Overall Study|Investigator’s Discretion|3
54972|NCT01472185|225553|P2|Overall Study|Hyperglycemia|2
54973|NCT01472185|225554|P1|Overall Study|Hyperglycemia|5
54974|NCT01472185|225553|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
54975|NCT01472185|225554|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
54976|NCT01472185|225553|P2|Overall Study|Randomized but Not Treated|1
54977|NCT01472185|225554|P1|Overall Study|Randomized but Not Treated|0
54978|NCT01471782|225574|P6|Overall Study|Death|1
54979|NCT01471782|225575|P5|Overall Study|Death|0
54980|NCT01471782|225576|P4|Overall Study|Death|0
54981|NCT01471782|225577|P3|Overall Study|Death|0
54982|NCT01471782|225578|P2|Overall Study|Death|0
54983|NCT01471782|225579|P1|Overall Study|Death|0
54984|NCT01471782|225574|P6|Overall Study|Withdrawal by Parent/Guardian|0
54985|NCT01471782|225575|P5|Overall Study|Withdrawal by Parent/Guardian|1
54986|NCT01471782|225576|P4|Overall Study|Withdrawal by Parent/Guardian|0
54987|NCT01471782|225577|P3|Overall Study|Withdrawal by Parent/Guardian|0
54988|NCT01471782|225578|P2|Overall Study|Withdrawal by Parent/Guardian|0
54989|NCT01471782|225579|P1|Overall Study|Withdrawal by Parent/Guardian|0
54990|NCT01471782|225574|P6|Overall Study|Physician Decision|8
54991|NCT01471782|225575|P5|Overall Study|Physician Decision|3
54992|NCT01471782|225576|P4|Overall Study|Physician Decision|0
54993|NCT01471782|225577|P3|Overall Study|Physician Decision|0
54994|NCT01471782|225578|P2|Overall Study|Physician Decision|0
54995|NCT01471782|225579|P1|Overall Study|Physician Decision|0
54996|NCT01471782|225574|P6|Overall Study|Disease Relapse|1
54997|NCT01471782|225575|P5|Overall Study|Disease Relapse|2
54998|NCT01471782|225576|P4|Overall Study|Disease Relapse|1
54999|NCT01471782|225577|P3|Overall Study|Disease Relapse|0
55000|NCT01471782|225578|P2|Overall Study|Disease Relapse|0
55001|NCT01471782|225579|P1|Overall Study|Disease Relapse|0
55002|NCT01471782|225574|P6|Overall Study|Change of Chemotherapy|4
55003|NCT01471782|225575|P5|Overall Study|Change of Chemotherapy|1
55004|NCT01471782|225576|P4|Overall Study|Change of Chemotherapy|0
55005|NCT01471782|225577|P3|Overall Study|Change of Chemotherapy|0
55006|NCT01471782|225578|P2|Overall Study|Change of Chemotherapy|1
55007|NCT01471782|225579|P1|Overall Study|Change of Chemotherapy|1
55008|NCT01471782|225574|P6|Overall Study|Other|5
55009|NCT01471782|225575|P5|Overall Study|Other|6
55010|NCT01471782|225576|P4|Overall Study|Other|1
55011|NCT01471782|225577|P3|Overall Study|Other|1
55012|NCT01471782|225578|P2|Overall Study|Other|0
55013|NCT01471782|225579|P1|Overall Study|Other|0
55014|NCT01471782|225574|P6|Overall Study|Adverse Event|1
55015|NCT01471782|225575|P5|Overall Study|Adverse Event|3
55016|NCT01471782|225576|P4|Overall Study|Adverse Event|2
55017|NCT01471782|225577|P3|Overall Study|Adverse Event|2
55018|NCT01471782|225578|P2|Overall Study|Adverse Event|1
55019|NCT01471782|225579|P1|Overall Study|Adverse Event|1
55020|NCT01471782|225574|P6|Overall Study|Lack of Efficacy|18
55021|NCT01471782|225575|P5|Overall Study|Lack of Efficacy|5
55022|NCT01471782|225576|P4|Overall Study|Lack of Efficacy|1
55023|NCT01471782|225577|P3|Overall Study|Lack of Efficacy|1
55024|NCT01471782|225578|P2|Overall Study|Lack of Efficacy|2
55025|NCT01471782|225579|P1|Overall Study|Lack of Efficacy|1
55026|NCT01471782|225574|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
55027|NCT01471782|225575|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
55028|NCT01471782|225576|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
55029|NCT01471782|225577|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
55030|NCT01471782|225578|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
55031|NCT01471782|225579|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
55032|NCT01471691|225633|P2|Overall Study|Lack of Efficacy|1
55033|NCT01471691|225634|P1|Overall Study|Lack of Efficacy|0
55034|NCT01471379|225643|P3|Overall Study|Study terminated|0
55035|NCT01471379|225644|P2|Overall Study|Study terminated|1
55036|NCT01471379|225645|P1|Overall Study|Study terminated|0
55037|NCT01471379|225643|P3|Overall Study|Adverse Event|0
55038|NCT01471379|225644|P2|Overall Study|Adverse Event|0
55039|NCT01471379|225645|P1|Overall Study|Adverse Event|1
55040|NCT01471353|225665|P1|Overall Study|remain on study|3
55041|NCT01471340|225673|P2|Overall Study|Invalid informed consent|0
55042|NCT01471340|225674|P1|Overall Study|Invalid informed consent|1
55043|NCT01471340|225673|P2|Overall Study|Investigational site closure|1
55044|NCT01471340|225674|P1|Overall Study|Investigational site closure|0
55045|NCT01471340|225673|P2|Overall Study|Lost to Follow-up|1
55046|NCT01471340|225674|P1|Overall Study|Lost to Follow-up|0
55047|NCT01471340|225673|P2|Overall Study|Death|4
55048|NCT01471340|225674|P1|Overall Study|Death|5
55049|NCT01471574|225697|P4|Follow-up Period|Follow-up no longer required|0
55050|NCT01471574|225698|P3|Follow-up Period|Follow-up no longer required|0
55051|NCT01471574|225699|P2|Follow-up Period|Follow-up no longer required|1
55052|NCT01471574|225700|P1|Follow-up Period|Follow-up no longer required|0
55053|NCT01471574|225697|P4|Follow-up Period|Death|0
55054|NCT01471574|225698|P3|Follow-up Period|Death|1
55055|NCT01471574|225699|P2|Follow-up Period|Death|0
55056|NCT01471574|225700|P1|Follow-up Period|Death|0
55057|NCT01471574|225697|P4|Follow-up Period|Lost to Follow-up|2
55058|NCT01471574|225698|P3|Follow-up Period|Lost to Follow-up|3
55059|NCT01471574|225699|P2|Follow-up Period|Lost to Follow-up|1
55060|NCT01471574|225700|P1|Follow-up Period|Lost to Follow-up|4
55061|NCT01471574|225697|P4|Follow-up Period|Withdrawal by Subject|1
55062|NCT01471574|225698|P3|Follow-up Period|Withdrawal by Subject|3
55063|NCT01471574|225699|P2|Follow-up Period|Withdrawal by Subject|0
55064|NCT01471574|225700|P1|Follow-up Period|Withdrawal by Subject|3
55065|NCT01471574|225697|P4|Treatment Period|Not specified|0
55066|NCT01471574|225698|P3|Treatment Period|Not specified|0
55067|NCT01471574|225699|P2|Treatment Period|Not specified|0
55068|NCT01471574|225700|P1|Treatment Period|Not specified|1
55069|NCT01471574|225697|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
55070|NCT01471574|225698|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
55071|NCT01471574|225699|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
55072|NCT01471574|225700|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
55073|NCT01471574|225697|P4|Treatment Period|Lost to Follow-up|0
55074|NCT01471574|225698|P3|Treatment Period|Lost to Follow-up|2
55075|NCT01471574|225699|P2|Treatment Period|Lost to Follow-up|2
55076|NCT01471574|225700|P1|Treatment Period|Lost to Follow-up|1
55077|NCT01471574|225697|P4|Treatment Period|Patient Requested Discontinue Study drug|1
55078|NCT01471574|225698|P3|Treatment Period|Patient Requested Discontinue Study drug|1
55079|NCT01471574|225699|P2|Treatment Period|Patient Requested Discontinue Study drug|0
55080|NCT01471574|225700|P1|Treatment Period|Patient Requested Discontinue Study drug|4
55081|NCT01471574|225697|P4|Treatment Period|Withdrawal by Subject|0
55082|NCT01471574|225698|P3|Treatment Period|Withdrawal by Subject|1
55083|NCT01471574|225699|P2|Treatment Period|Withdrawal by Subject|1
55084|NCT01471574|225700|P1|Treatment Period|Withdrawal by Subject|5
55085|NCT01471574|225697|P4|Treatment Period|Adverse Event|1
55086|NCT01471574|225698|P3|Treatment Period|Adverse Event|6
55087|NCT01471574|225699|P2|Treatment Period|Adverse Event|3
55088|NCT01471574|225700|P1|Treatment Period|Adverse Event|7
55089|NCT01471574|225697|P4|Treatment Period|Lack of Efficacy|1
55090|NCT01471574|225698|P3|Treatment Period|Lack of Efficacy|14
55091|NCT01471574|225699|P2|Treatment Period|Lack of Efficacy|4
55092|NCT01471574|225700|P1|Treatment Period|Lack of Efficacy|12
55093|NCT01471197|225731|P2|Overall Study|Study Drug Toxicity|0
55094|NCT01471197|225732|P1|Overall Study|Study Drug Toxicity|1
55095|NCT01471197|225731|P2|Overall Study|Death|0
55096|NCT01471197|225732|P1|Overall Study|Death|1
55097|NCT01471197|225731|P2|Overall Study|Disease Progression|2
55098|NCT01471197|225732|P1|Overall Study|Disease Progression|4
55099|NCT01471171|225742|P2|Treatment Period 2|Adverse Event|0
55100|NCT01471171|225743|P1|Treatment Period 2|Adverse Event|1
55101|NCT01471171|225742|P2|Treatment Period 1|Adverse Event|1
55102|NCT01471171|225743|P1|Treatment Period 1|Adverse Event|4
55103|NCT01471015|225761|P3|Overall Study|Death|1
55104|NCT01471015|225762|P2|Overall Study|Death|1
55105|NCT01471015|225763|P1|Overall Study|Death|0
55106|NCT01470599|225805|P2|Overall Study|Adverse event not related to study drug|5
55107|NCT01470599|225806|P1|Overall Study|Adverse event not related to study drug|1
55108|NCT01470599|225805|P2|Overall Study|Insufficient clinical response|27
55109|NCT01470599|225806|P1|Overall Study|Insufficient clinical response|6
55110|NCT01470599|225805|P2|Overall Study|Adverse event related to study drug|5
55111|NCT01470599|225806|P1|Overall Study|Adverse event related to study drug|2
55112|NCT01470599|225805|P2|Overall Study|Protocol Violation|1
55113|NCT01470599|225806|P1|Overall Study|Protocol Violation|3
55114|NCT01470599|225805|P2|Overall Study|Other|0
55115|NCT01470599|225806|P1|Overall Study|Other|1
55116|NCT01470599|225805|P2|Overall Study|Withdrawal by Subject|4
55117|NCT01470599|225806|P1|Overall Study|Withdrawal by Subject|3
55118|NCT01470599|225805|P2|Overall Study|Lost to Follow-up|1
55119|NCT01470599|225806|P1|Overall Study|Lost to Follow-up|2
55120|NCT01470599|225805|P2|Overall Study|Did not meet entrance criteria|0
55121|NCT01470599|225806|P1|Overall Study|Did not meet entrance criteria|1
55122|NCT01470469|225870|P2|Overall Study|Not specified|1
55123|NCT01470469|225871|P1|Overall Study|Not specified|2
55124|NCT01470469|225870|P2|Overall Study|Protocol Violation|1
55125|NCT01470469|225871|P1|Overall Study|Protocol Violation|1
55126|NCT01470469|225870|P2|Overall Study|Lost to Follow-up|2
55127|NCT01470469|225871|P1|Overall Study|Lost to Follow-up|2
55128|NCT01470469|225870|P2|Overall Study|Adverse Event|7
55129|NCT01470469|225871|P1|Overall Study|Adverse Event|0
55130|NCT01470469|225870|P2|Overall Study|Lack of Efficacy|7
55131|NCT01470469|225871|P1|Overall Study|Lack of Efficacy|1
55132|NCT01470469|225870|P2|Overall Study|Withdrawal by Subject|6
55133|NCT01470469|225871|P1|Overall Study|Withdrawal by Subject|4
55134|NCT01470417|225891|P2|Overall Study|Disease progression|2
55135|NCT01470417|225892|P1|Overall Study|Disease progression|0
55136|NCT01470248|225904|P1|Overall Study|Withdrawal by Subject|1
55137|NCT01470144|225960|P1|Overall Study|Patient’s and investigator’s decision|1
55138|NCT01470144|225960|P1|Overall Study|Lung transplant|6
55139|NCT01470144|225960|P1|Overall Study|Death|1
55140|NCT01470144|225960|P1|Overall Study|Adverse Event|2
55141|NCT01470001|226065|P2|Overall Study|Withdrawal by Subject|1
55142|NCT01470001|226066|P1|Overall Study|Withdrawal by Subject|2
55143|NCT01470001|226065|P2|Overall Study|Physician Decision|0
55144|NCT01470001|226066|P1|Overall Study|Physician Decision|2
55145|NCT01470001|226065|P2|Overall Study|Lost to Follow-up|1
55146|NCT01470001|226066|P1|Overall Study|Lost to Follow-up|1
55147|NCT01469819|226076|P1|Overall Study|Technical malfunction of SmartPill data|3
55148|NCT01469819|226076|P1|Overall Study|Could not swallow SmartPill|2
55149|NCT01469819|226076|P1|Overall Study|Did not meet inclusionary criteria|2
55150|NCT01469819|226076|P1|Overall Study|Withdrawal by Subject|1
55151|NCT01469637|226100|P2|Second Intervention|Incarcerated|0
55152|NCT01469637|226101|P1|Second Intervention|Incarcerated|1
55153|NCT01469637|226100|P2|First Intervention|Unacceptable behavior|1
55154|NCT01469637|226101|P1|First Intervention|Unacceptable behavior|0
55155|NCT01469546|226109|P1|Received 5 mg Dose|Physician Decision|3
55156|NCT01469546|226109|P1|Received 5 mg Dose|Progressive Disease|3
55157|NCT01469546|226109|P1|Received 5 mg Dose|Protocol Violation|2
55158|NCT01469546|226109|P1|Received 5 mg Dose|Death|2
55159|NCT01469546|226109|P1|Received 5 mg Dose|Adverse Event|13
55160|NCT01469377|226119|P3|Overall Study|Other Miscellaneous Reasons|0
55161|NCT01469377|226120|P2|Overall Study|Other Miscellaneous Reasons|0
55162|NCT01469377|226121|P1|Overall Study|Other Miscellaneous Reasons|2
55163|NCT01469377|226119|P3|Overall Study|Insufficient Therapeutic Response|0
55164|NCT01469377|226120|P2|Overall Study|Insufficient Therapeutic Response|4
55165|NCT01469377|226121|P1|Overall Study|Insufficient Therapeutic Response|3
55166|NCT01469377|226119|P3|Overall Study|Adverse Event|36
55167|NCT01469377|226120|P2|Overall Study|Adverse Event|18
55168|NCT01469377|226121|P1|Overall Study|Adverse Event|8
55169|NCT01469377|226119|P3|Overall Study|Withdrawal of Consent|15
55170|NCT01469377|226120|P2|Overall Study|Withdrawal of Consent|14
55171|NCT01469377|226121|P1|Overall Study|Withdrawal of Consent|12
55172|NCT01469377|226119|P3|Overall Study|Lost to Follow-up|5
55173|NCT01469377|226120|P2|Overall Study|Lost to Follow-up|2
55174|NCT01469377|226121|P1|Overall Study|Lost to Follow-up|3
55175|NCT01469377|226119|P3|Overall Study|Protocol Deviation|10
55176|NCT01469377|226120|P2|Overall Study|Protocol Deviation|10
55177|NCT01469377|226121|P1|Overall Study|Protocol Deviation|7
55178|NCT01469364|226132|P1|Overall Study|Withdrawal by Subject|1
55179|NCT01469364|226132|P1|Overall Study|Adverse Event|1
55180|NCT01469221|226183|P3|Double Blind Phase|Sponsor Terminate Study|0
55181|NCT01469221|226184|P2|Double Blind Phase|Sponsor Terminate Study|16
55182|NCT01469221|226185|P1|Double Blind Phase|Sponsor Terminate Study|12
55183|NCT01469221|226183|P3|Double Blind Phase|Physician Decision|0
55184|NCT01469221|226184|P2|Double Blind Phase|Physician Decision|1
55185|NCT01469221|226185|P1|Double Blind Phase|Physician Decision|1
55186|NCT01469221|226183|P3|Double Blind Phase|Protocol Violation|0
55187|NCT01469221|226184|P2|Double Blind Phase|Protocol Violation|0
55188|NCT01469221|226185|P1|Double Blind Phase|Protocol Violation|1
55189|NCT01469182|226196|P2|Overall Study|Did not meet Protocol Eligibility|0
55190|NCT01469182|226197|P1|Overall Study|Did not meet Protocol Eligibility|3
55191|NCT01469182|226196|P2|Overall Study|Protocol Violation|2
55192|NCT01469182|226197|P1|Overall Study|Protocol Violation|4
55193|NCT01469182|226196|P2|Overall Study|Withdrawal by Subject|1
55194|NCT01469182|226197|P1|Overall Study|Withdrawal by Subject|4
55195|NCT01469182|226196|P2|Overall Study|Lost to Follow-up|0
55196|NCT01469182|226197|P1|Overall Study|Lost to Follow-up|3
55197|NCT01469182|226196|P2|Overall Study|Adverse Event|3
55198|NCT01469182|226197|P1|Overall Study|Adverse Event|21
55199|NCT01469065|226224|P5|Overall Study|Not specified|0
55200|NCT01469065|226225|P4|Overall Study|Not specified|0
55201|NCT01469065|226226|P3|Overall Study|Not specified|0
55202|NCT01469065|226227|P2|Overall Study|Not specified|1
55203|NCT01469065|226228|P1|Overall Study|Not specified|0
55204|NCT01469065|226224|P5|Overall Study|Lack of Efficacy|1
55205|NCT01469065|226225|P4|Overall Study|Lack of Efficacy|0
55206|NCT01469065|226226|P3|Overall Study|Lack of Efficacy|0
55207|NCT01469065|226227|P2|Overall Study|Lack of Efficacy|0
55208|NCT01469065|226228|P1|Overall Study|Lack of Efficacy|0
55209|NCT01469052|226324|P6|Overall Study|Other|0
55210|NCT01469052|226325|P5|Overall Study|Other|1
55211|NCT01469052|226326|P4|Overall Study|Other|0
55212|NCT01469052|226327|P3|Overall Study|Other|0
55213|NCT01469052|226328|P2|Overall Study|Other|1
55214|NCT01469052|226329|P1|Overall Study|Other|0
55215|NCT01469052|226324|P6|Overall Study|Moved to rollover protocol|1
55216|NCT01469052|226325|P5|Overall Study|Moved to rollover protocol|0
55217|NCT01469052|226326|P4|Overall Study|Moved to rollover protocol|0
55218|NCT01469052|226327|P3|Overall Study|Moved to rollover protocol|1
55219|NCT01469052|226328|P2|Overall Study|Moved to rollover protocol|0
55220|NCT01469052|226329|P1|Overall Study|Moved to rollover protocol|1
55221|NCT01469052|226324|P6|Overall Study|Lack of Efficacy|2
55222|NCT01469052|226325|P5|Overall Study|Lack of Efficacy|0
55223|NCT01469052|226326|P4|Overall Study|Lack of Efficacy|0
55224|NCT01469052|226327|P3|Overall Study|Lack of Efficacy|0
55225|NCT01469052|226328|P2|Overall Study|Lack of Efficacy|0
55226|NCT01469052|226329|P1|Overall Study|Lack of Efficacy|0
55227|NCT01469052|226324|P6|Overall Study|Progressive disease|2
55228|NCT01469052|226325|P5|Overall Study|Progressive disease|7
55229|NCT01469052|226326|P4|Overall Study|Progressive disease|3
55230|NCT01469052|226327|P3|Overall Study|Progressive disease|5
55231|NCT01469052|226328|P2|Overall Study|Progressive disease|0
55232|NCT01469052|226329|P1|Overall Study|Progressive disease|3
55233|NCT01469052|226324|P6|Overall Study|Adverse Event|1
55234|NCT01469052|226325|P5|Overall Study|Adverse Event|0
55235|NCT01469052|226326|P4|Overall Study|Adverse Event|2
55236|NCT01469052|226327|P3|Overall Study|Adverse Event|0
55237|NCT01469052|226328|P2|Overall Study|Adverse Event|3
55238|NCT01469052|226329|P1|Overall Study|Adverse Event|2
55239|NCT01469000|226391|P2|Overall Study|On treatment, not yet died or PD|7
55240|NCT01469000|226392|P1|Overall Study|On treatment, not yet died or PD|23
55241|NCT01469000|226391|P2|Overall Study|Entry Criteria Not Met|0
55242|NCT01469000|226392|P1|Overall Study|Entry Criteria Not Met|1
55243|NCT01469000|226391|P2|Overall Study|Physician Decision|1
55244|NCT01469000|226392|P1|Overall Study|Physician Decision|0
55245|NCT01469000|226391|P2|Overall Study|Withdrawal by Subject|1
55246|NCT01469000|226392|P1|Overall Study|Withdrawal by Subject|9
55247|NCT01468987|226408|P2|Overall Study|Sponsor Decision|0
55248|NCT01468987|226409|P1|Overall Study|Sponsor Decision|1
55249|NCT01468987|226408|P2|Overall Study|Physician Decision|15
55250|NCT01468987|226409|P1|Overall Study|Physician Decision|8
55251|NCT01468987|226408|P2|Overall Study|Withdrawal by Subject|28
55252|NCT01468987|226409|P1|Overall Study|Withdrawal by Subject|28
55253|NCT01468987|226408|P2|Overall Study|Protocol Violation|2
55254|NCT01468987|226409|P1|Overall Study|Protocol Violation|8
55255|NCT01468987|226408|P2|Overall Study|Lost to Follow-up|5
55256|NCT01468987|226409|P1|Overall Study|Lost to Follow-up|10
55257|NCT01468987|226408|P2|Overall Study|Death|1
55258|NCT01468987|226409|P1|Overall Study|Death|4
55259|NCT01468987|226408|P2|Overall Study|Adverse Event|9
55260|NCT01468987|226409|P1|Overall Study|Adverse Event|12
55261|NCT01468818|226472|P1|Overall Study|Death during treatment|2
55262|NCT01468311|226530|P1|Overall Study|Withdrawal by Subject|1
55263|NCT01468311|226530|P1|Overall Study|mobilization failure|1
55264|NCT01468233|226542|P6|Treatment Period 2|Not specified|0
55265|NCT01468233|226543|P5|Treatment Period 2|Not specified|1
55266|NCT01468233|226544|P4|Treatment Period 2|Not specified|0
55267|NCT01468233|226545|P3|Treatment Period 2|Not specified|3
55268|NCT01468233|226546|P2|Treatment Period 2|Not specified|0
55269|NCT01468233|226547|P1|Treatment Period 2|Not specified|0
55270|NCT01468233|226542|P6|Treatment Period 2|Lost to Follow-up|0
55271|NCT01468233|226543|P5|Treatment Period 2|Lost to Follow-up|2
55272|NCT01468233|226544|P4|Treatment Period 2|Lost to Follow-up|0
55273|NCT01468233|226545|P3|Treatment Period 2|Lost to Follow-up|3
55274|NCT01468233|226546|P2|Treatment Period 2|Lost to Follow-up|0
55275|NCT01468233|226547|P1|Treatment Period 2|Lost to Follow-up|0
55276|NCT01468233|226542|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
55277|NCT01468233|226543|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
55278|NCT01468233|226544|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
55279|NCT01468233|226545|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
55280|NCT01468233|226546|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
55281|NCT01468233|226547|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
55282|NCT01468233|226542|P6|Treatment Period 2|Withdrawal by Subject|1
55283|NCT01468233|226543|P5|Treatment Period 2|Withdrawal by Subject|1
55284|NCT01468233|226544|P4|Treatment Period 2|Withdrawal by Subject|1
55285|NCT01468233|226545|P3|Treatment Period 2|Withdrawal by Subject|9
55286|NCT01468233|226546|P2|Treatment Period 2|Withdrawal by Subject|0
55287|NCT01468233|226547|P1|Treatment Period 2|Withdrawal by Subject|0
55288|NCT01468233|226542|P6|Treatment Period 2|Lack of Efficacy|1
55289|NCT01468233|226543|P5|Treatment Period 2|Lack of Efficacy|0
55290|NCT01468233|226544|P4|Treatment Period 2|Lack of Efficacy|2
55291|NCT01468233|226545|P3|Treatment Period 2|Lack of Efficacy|9
55292|NCT01468233|226546|P2|Treatment Period 2|Lack of Efficacy|0
55293|NCT01468233|226547|P1|Treatment Period 2|Lack of Efficacy|0
55294|NCT01468233|226542|P6|Treatment Period 2|Adverse Event|1
55295|NCT01468233|226543|P5|Treatment Period 2|Adverse Event|2
55296|NCT01468233|226544|P4|Treatment Period 2|Adverse Event|0
55297|NCT01468233|226545|P3|Treatment Period 2|Adverse Event|3
55298|NCT01468233|226546|P2|Treatment Period 2|Adverse Event|0
55299|NCT01468233|226547|P1|Treatment Period 2|Adverse Event|0
55300|NCT01468233|226542|P6|Treatment Period 1|Not specified|0
55301|NCT01468233|226543|P5|Treatment Period 1|Not specified|0
55302|NCT01468233|226544|P4|Treatment Period 1|Not specified|0
55303|NCT01468233|226545|P3|Treatment Period 1|Not specified|0
55304|NCT01468233|226546|P2|Treatment Period 1|Not specified|1
55305|NCT01468233|226547|P1|Treatment Period 1|Not specified|1
55306|NCT01468233|226542|P6|Treatment Period 1|Lost to Follow-up|0
55307|NCT01468233|226543|P5|Treatment Period 1|Lost to Follow-up|0
55308|NCT01468233|226544|P4|Treatment Period 1|Lost to Follow-up|0
55309|NCT01468233|226545|P3|Treatment Period 1|Lost to Follow-up|0
55310|NCT01468233|226546|P2|Treatment Period 1|Lost to Follow-up|0
55311|NCT01468233|226547|P1|Treatment Period 1|Lost to Follow-up|3
55312|NCT01468233|226542|P6|Treatment Period 1|Withdrawal by Subject|0
55313|NCT01468233|226543|P5|Treatment Period 1|Withdrawal by Subject|0
55314|NCT01468233|226544|P4|Treatment Period 1|Withdrawal by Subject|0
55315|NCT01468233|226545|P3|Treatment Period 1|Withdrawal by Subject|0
55316|NCT01468233|226546|P2|Treatment Period 1|Withdrawal by Subject|4
55317|NCT01468233|226547|P1|Treatment Period 1|Withdrawal by Subject|3
55318|NCT01468233|226542|P6|Treatment Period 1|Adverse Event|0
55319|NCT01468233|226543|P5|Treatment Period 1|Adverse Event|0
55320|NCT01468233|226544|P4|Treatment Period 1|Adverse Event|0
55321|NCT01468233|226545|P3|Treatment Period 1|Adverse Event|0
55322|NCT01468233|226546|P2|Treatment Period 1|Adverse Event|3
55323|NCT01468233|226547|P1|Treatment Period 1|Adverse Event|5
55324|NCT01468207|226569|P6|Treatment Period 2|Not specified|2
55325|NCT01468207|226570|P5|Treatment Period 2|Not specified|1
55326|NCT01468207|226571|P4|Treatment Period 2|Not specified|1
55327|NCT01468207|226572|P3|Treatment Period 2|Not specified|5
55328|NCT01468207|226573|P2|Treatment Period 2|Not specified|0
55329|NCT01468207|226574|P1|Treatment Period 2|Not specified|0
55330|NCT01468207|226569|P6|Treatment Period 2|Lost to Follow-up|0
55331|NCT01468207|226570|P5|Treatment Period 2|Lost to Follow-up|0
55332|NCT01468207|226571|P4|Treatment Period 2|Lost to Follow-up|1
55333|NCT01468207|226572|P3|Treatment Period 2|Lost to Follow-up|5
55334|NCT01468207|226573|P2|Treatment Period 2|Lost to Follow-up|0
55335|NCT01468207|226574|P1|Treatment Period 2|Lost to Follow-up|0
55336|NCT01468207|226569|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
55337|NCT01468207|226570|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
55338|NCT01468207|226571|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
55339|NCT01468207|226572|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
55340|NCT01468207|226573|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
55341|NCT01468207|226574|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
55342|NCT01468207|226569|P6|Treatment Period 2|Withdrawal by Subject|2
55343|NCT01468207|226570|P5|Treatment Period 2|Withdrawal by Subject|0
55344|NCT01468207|226571|P4|Treatment Period 2|Withdrawal by Subject|0
55345|NCT01468207|226572|P3|Treatment Period 2|Withdrawal by Subject|5
55346|NCT01468207|226573|P2|Treatment Period 2|Withdrawal by Subject|0
55347|NCT01468207|226574|P1|Treatment Period 2|Withdrawal by Subject|0
55348|NCT01468207|226569|P6|Treatment Period 2|Lack of Efficacy|2
55349|NCT01468207|226570|P5|Treatment Period 2|Lack of Efficacy|0
55350|NCT01468207|226571|P4|Treatment Period 2|Lack of Efficacy|1
55351|NCT01468207|226572|P3|Treatment Period 2|Lack of Efficacy|1
55352|NCT01468207|226573|P2|Treatment Period 2|Lack of Efficacy|0
55353|NCT01468207|226574|P1|Treatment Period 2|Lack of Efficacy|0
55354|NCT01468207|226569|P6|Treatment Period 2|Adverse Event|1
55355|NCT01468207|226570|P5|Treatment Period 2|Adverse Event|2
55356|NCT01468207|226571|P4|Treatment Period 2|Adverse Event|1
55357|NCT01468207|226572|P3|Treatment Period 2|Adverse Event|6
55358|NCT01468207|226573|P2|Treatment Period 2|Adverse Event|0
55359|NCT01468207|226574|P1|Treatment Period 2|Adverse Event|0
55360|NCT01468207|226569|P6|Treatment Period 1|Not specified|0
55361|NCT01468207|226570|P5|Treatment Period 1|Not specified|0
55362|NCT01468207|226571|P4|Treatment Period 1|Not specified|0
55363|NCT01468207|226572|P3|Treatment Period 1|Not specified|0
55364|NCT01468207|226573|P2|Treatment Period 1|Not specified|2
55365|NCT01468207|226574|P1|Treatment Period 1|Not specified|0
55366|NCT01468207|226569|P6|Treatment Period 1|Lost to Follow-up|0
55367|NCT01468207|226570|P5|Treatment Period 1|Lost to Follow-up|0
55368|NCT01468207|226571|P4|Treatment Period 1|Lost to Follow-up|0
55369|NCT01468207|226572|P3|Treatment Period 1|Lost to Follow-up|0
55370|NCT01468207|226573|P2|Treatment Period 1|Lost to Follow-up|1
55371|NCT01468207|226574|P1|Treatment Period 1|Lost to Follow-up|2
55372|NCT01468207|226569|P6|Treatment Period 1|Withdrawal by Subject|0
55373|NCT01468207|226570|P5|Treatment Period 1|Withdrawal by Subject|0
55374|NCT01468207|226571|P4|Treatment Period 1|Withdrawal by Subject|0
55375|NCT01468207|226572|P3|Treatment Period 1|Withdrawal by Subject|0
55376|NCT01468207|226573|P2|Treatment Period 1|Withdrawal by Subject|4
55377|NCT01468207|226574|P1|Treatment Period 1|Withdrawal by Subject|5
55378|NCT01468207|226569|P6|Treatment Period 1|Protocol Violation|0
55379|NCT01468207|226570|P5|Treatment Period 1|Protocol Violation|0
55380|NCT01468207|226571|P4|Treatment Period 1|Protocol Violation|0
55381|NCT01468207|226572|P3|Treatment Period 1|Protocol Violation|0
55382|NCT01468207|226573|P2|Treatment Period 1|Protocol Violation|1
55383|NCT01468207|226574|P1|Treatment Period 1|Protocol Violation|1
55384|NCT01468207|226569|P6|Treatment Period 1|Adverse Event|0
55385|NCT01468207|226570|P5|Treatment Period 1|Adverse Event|0
55386|NCT01468207|226571|P4|Treatment Period 1|Adverse Event|0
55387|NCT01468207|226572|P3|Treatment Period 1|Adverse Event|0
55388|NCT01468207|226573|P2|Treatment Period 1|Adverse Event|0
55389|NCT01468207|226574|P1|Treatment Period 1|Adverse Event|1
55390|NCT01468181|226599|P5|Overall Study|Withdrawal by Subject|0
55391|NCT01468181|226600|P4|Overall Study|Withdrawal by Subject|0
55392|NCT01468181|226601|P3|Overall Study|Withdrawal by Subject|0
55393|NCT01468181|226602|P2|Overall Study|Withdrawal by Subject|1
55394|NCT01468181|226603|P1|Overall Study|Withdrawal by Subject|0
55395|NCT01468181|226599|P5|Overall Study|Lost to Follow-up|1
55396|NCT01468181|226600|P4|Overall Study|Lost to Follow-up|0
55397|NCT01468181|226601|P3|Overall Study|Lost to Follow-up|1
55398|NCT01468181|226602|P2|Overall Study|Lost to Follow-up|0
55399|NCT01468181|226603|P1|Overall Study|Lost to Follow-up|0
55400|NCT01468181|226599|P5|Overall Study|Physician Decision|1
55401|NCT01468181|226600|P4|Overall Study|Physician Decision|1
55402|NCT01468181|226601|P3|Overall Study|Physician Decision|0
55403|NCT01468181|226602|P2|Overall Study|Physician Decision|0
55404|NCT01468181|226603|P1|Overall Study|Physician Decision|0
55405|NCT01468181|226599|P5|Overall Study|Protocol Violation|1
55406|NCT01468181|226600|P4|Overall Study|Protocol Violation|0
55407|NCT01468181|226601|P3|Overall Study|Protocol Violation|1
55408|NCT01468181|226602|P2|Overall Study|Protocol Violation|0
55409|NCT01468181|226603|P1|Overall Study|Protocol Violation|2
55410|NCT01468181|226599|P5|Overall Study|Adverse Event|2
55411|NCT01468181|226600|P4|Overall Study|Adverse Event|2
55412|NCT01468181|226601|P3|Overall Study|Adverse Event|6
55413|NCT01468181|226602|P2|Overall Study|Adverse Event|1
55414|NCT01468181|226603|P1|Overall Study|Adverse Event|8
55415|NCT01468077|226652|P2|Overall Study|Physician Decision|0
55416|NCT01468077|226653|P1|Overall Study|Physician Decision|1
55417|NCT01468077|226652|P2|Overall Study|Lack of Efficacy|1
55418|NCT01468077|226653|P1|Overall Study|Lack of Efficacy|1
55419|NCT01468077|226652|P2|Overall Study|Adverse Event|2
55420|NCT01468077|226653|P1|Overall Study|Adverse Event|2
55421|NCT01467960|226711|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
55422|NCT01467960|226712|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
55423|NCT01467960|226713|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
55424|NCT01467960|226714|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
55425|NCT01467960|226715|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
55426|NCT01467960|226716|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
55427|NCT01467713|226775|P4|Overall Study|Reason not Specified|7
55428|NCT01467713|226776|P3|Overall Study|Reason not Specified|8
55429|NCT01467713|226777|P2|Overall Study|Reason not Specified|11
55430|NCT01467713|226778|P1|Overall Study|Reason not Specified|6
55431|NCT01467713|226775|P4|Overall Study|Relapse|35
55432|NCT01467713|226776|P3|Overall Study|Relapse|28
55433|NCT01467713|226777|P2|Overall Study|Relapse|25
55434|NCT01467713|226778|P1|Overall Study|Relapse|35
55435|NCT01467713|226775|P4|Overall Study|Pregnancy|3
55436|NCT01467713|226776|P3|Overall Study|Pregnancy|1
55437|NCT01467713|226777|P2|Overall Study|Pregnancy|1
55438|NCT01467713|226778|P1|Overall Study|Pregnancy|0
55439|NCT01467713|226775|P4|Overall Study|Study Termination|29
55440|NCT01467713|226776|P3|Overall Study|Study Termination|28
55441|NCT01467713|226777|P2|Overall Study|Study Termination|33
55442|NCT01467713|226778|P1|Overall Study|Study Termination|23
55443|NCT01467713|226775|P4|Overall Study|Voluntary Withdrawal|20
55444|NCT01467713|226776|P3|Overall Study|Voluntary Withdrawal|21
55445|NCT01467713|226777|P2|Overall Study|Voluntary Withdrawal|14
55446|NCT01467713|226778|P1|Overall Study|Voluntary Withdrawal|18
55447|NCT01467713|226775|P4|Overall Study|Lost to Follow-up|9
55448|NCT01467713|226776|P3|Overall Study|Lost to Follow-up|6
55449|NCT01467713|226777|P2|Overall Study|Lost to Follow-up|12
55450|NCT01467713|226778|P1|Overall Study|Lost to Follow-up|9
55451|NCT01467713|226775|P4|Overall Study|Major Protocol Deviation|1
55452|NCT01467713|226776|P3|Overall Study|Major Protocol Deviation|4
55453|NCT01467713|226777|P2|Overall Study|Major Protocol Deviation|4
55454|NCT01467713|226778|P1|Overall Study|Major Protocol Deviation|2
55455|NCT01467713|226775|P4|Overall Study|Pretreatment Event or Adverse Event|5
55456|NCT01467713|226776|P3|Overall Study|Pretreatment Event or Adverse Event|6
55457|NCT01467713|226777|P2|Overall Study|Pretreatment Event or Adverse Event|4
55458|NCT01467713|226778|P1|Overall Study|Pretreatment Event or Adverse Event|9
55459|NCT01467700|226832|P4|Overall Study|Reason not Specified|8
55460|NCT01467700|226833|P3|Overall Study|Reason not Specified|2
55461|NCT01467700|226834|P2|Overall Study|Reason not Specified|3
55462|NCT01467700|226835|P1|Overall Study|Reason not Specified|1
55463|NCT01467700|226832|P4|Overall Study|Lack of Efficacy|1
55464|NCT01467700|226833|P3|Overall Study|Lack of Efficacy|2
55465|NCT01467700|226834|P2|Overall Study|Lack of Efficacy|0
55466|NCT01467700|226835|P1|Overall Study|Lack of Efficacy|2
55467|NCT01467700|226832|P4|Overall Study|Pregnancy|0
55468|NCT01467700|226833|P3|Overall Study|Pregnancy|1
55469|NCT01467700|226834|P2|Overall Study|Pregnancy|1
55470|NCT01467700|226835|P1|Overall Study|Pregnancy|0
55471|NCT01467700|226832|P4|Overall Study|Study Termination|7
55472|NCT01467700|226833|P3|Overall Study|Study Termination|10
55473|NCT01467700|226834|P2|Overall Study|Study Termination|5
55474|NCT01467700|226835|P1|Overall Study|Study Termination|6
55475|NCT01467700|226832|P4|Overall Study|Voluntary Withdrawal|2
55476|NCT01467700|226833|P3|Overall Study|Voluntary Withdrawal|6
55477|NCT01467700|226834|P2|Overall Study|Voluntary Withdrawal|7
55478|NCT01467700|226835|P1|Overall Study|Voluntary Withdrawal|5
55479|NCT01467700|226832|P4|Overall Study|Lost to Follow-up|3
55480|NCT01467700|226833|P3|Overall Study|Lost to Follow-up|2
55481|NCT01467700|226834|P2|Overall Study|Lost to Follow-up|5
55482|NCT01467700|226835|P1|Overall Study|Lost to Follow-up|6
55483|NCT01467700|226832|P4|Overall Study|Major Protocol Deviation|3
55484|NCT01467700|226833|P3|Overall Study|Major Protocol Deviation|2
55485|NCT01467700|226834|P2|Overall Study|Major Protocol Deviation|3
55486|NCT01467700|226835|P1|Overall Study|Major Protocol Deviation|3
55487|NCT01467700|226832|P4|Overall Study|Pretreatment Event or Adverse Event|3
55488|NCT01467700|226833|P3|Overall Study|Pretreatment Event or Adverse Event|2
55489|NCT01467700|226834|P2|Overall Study|Pretreatment Event or Adverse Event|4
55490|NCT01467700|226835|P1|Overall Study|Pretreatment Event or Adverse Event|6
55491|NCT01467661|226877|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
55492|NCT01467661|226877|P1|Overall Study|Lack of Efficacy|3
55493|NCT01467661|226877|P1|Overall Study|Withdrawal by Subject|1
55494|NCT01467661|226877|P1|Overall Study|Adverse Event|16
55495|NCT01467583|226897|P3|Overall Study|Protocol Violation|2
55496|NCT01467583|226898|P2|Overall Study|Protocol Violation|0
55497|NCT01467583|226899|P1|Overall Study|Protocol Violation|0
55498|NCT01467583|226897|P3|Overall Study|Withdrawal by Subject|0
55499|NCT01467583|226898|P2|Overall Study|Withdrawal by Subject|0
55500|NCT01467583|226899|P1|Overall Study|Withdrawal by Subject|1
55501|NCT01467583|226897|P3|Overall Study|Death|0
55502|NCT01467583|226898|P2|Overall Study|Death|1
55503|NCT01467583|226899|P1|Overall Study|Death|1
55504|NCT01467570|226912|P2|Overall Study|Lost to Follow-up|9
55505|NCT01467570|226913|P1|Overall Study|Lost to Follow-up|8
55506|NCT01467505|226950|P2|Overall Study|Study Terminated by Sponsor|3
55507|NCT01467505|226951|P1|Overall Study|Study Terminated by Sponsor|28
55508|NCT01467505|226950|P2|Overall Study|Withdrawal by Subject|0
55509|NCT01467505|226951|P1|Overall Study|Withdrawal by Subject|4
55510|NCT01467505|226950|P2|Overall Study|Adverse Event|0
55511|NCT01467505|226951|P1|Overall Study|Adverse Event|1
55512|NCT01467492|226983|P2|Overall Study|Enrolled But Not Treated|0
55513|NCT01467492|226984|P1|Overall Study|Enrolled But Not Treated|1
55514|NCT01467492|226983|P2|Overall Study|Undefined|0
55515|NCT01467492|226984|P1|Overall Study|Undefined|2
55516|NCT01467492|226983|P2|Overall Study|Lost to Follow-up|2
55517|NCT01467492|226984|P1|Overall Study|Lost to Follow-up|3
55518|NCT01467492|226983|P2|Overall Study|Adverse Event|3
55519|NCT01467492|226984|P1|Overall Study|Adverse Event|4
55520|NCT01467492|226983|P2|Overall Study|Study Terminated by Sponsor|4
55521|NCT01467492|226984|P1|Overall Study|Study Terminated by Sponsor|6
55522|NCT01467492|226983|P2|Overall Study|Withdrawal by Subject|4
55523|NCT01467492|226984|P1|Overall Study|Withdrawal by Subject|6
55524|NCT01467479|227008|P3|Overall Study|Other|0
55525|NCT01467479|227009|P2|Overall Study|Other|0
55526|NCT01467479|227010|P1|Overall Study|Other|1
55527|NCT01467479|227008|P3|Overall Study|Study Terminated by Sponsor|3
55528|NCT01467479|227009|P2|Overall Study|Study Terminated by Sponsor|3
55529|NCT01467479|227010|P1|Overall Study|Study Terminated by Sponsor|1
55530|NCT01467479|227008|P3|Overall Study|Withdrawal of Consent|7
55531|NCT01467479|227009|P2|Overall Study|Withdrawal of Consent|7
55532|NCT01467479|227010|P1|Overall Study|Withdrawal of Consent|3
55533|NCT01467479|227008|P3|Overall Study|Lost to Follow-up|3
55534|NCT01467479|227009|P2|Overall Study|Lost to Follow-up|5
55535|NCT01467479|227010|P1|Overall Study|Lost to Follow-up|2
55536|NCT01467479|227008|P3|Overall Study|Death|1
55537|NCT01467479|227009|P2|Overall Study|Death|0
55538|NCT01467479|227010|P1|Overall Study|Death|0
55539|NCT01467479|227008|P3|Overall Study|Adverse Event|0
55540|NCT01467479|227009|P2|Overall Study|Adverse Event|2
55541|NCT01467479|227010|P1|Overall Study|Adverse Event|1
55542|NCT01467479|227008|P3|Overall Study|No Study Medication|2
55543|NCT01467479|227009|P2|Overall Study|No Study Medication|0
55544|NCT01467479|227010|P1|Overall Study|No Study Medication|1
55545|NCT01467427|227039|P2|Overall Study|Not continuing in extension phase|2
55546|NCT01467427|227040|P1|Overall Study|Not continuing in extension phase|0
55547|NCT01467427|227039|P2|Overall Study|Entered extension phase|11
55548|NCT01467427|227040|P1|Overall Study|Entered extension phase|11
55549|NCT01467427|227039|P2|Overall Study|Withdrawal by Subject|0
55550|NCT01467427|227040|P1|Overall Study|Withdrawal by Subject|1
55551|NCT01467076|227061|P3|Overall Study|Lost to Follow-up|0
55552|NCT01467076|227062|P2|Overall Study|Lost to Follow-up|0
55553|NCT01467076|227063|P1|Overall Study|Lost to Follow-up|1
55554|NCT01466881|227080|P1|Overall Study|Other reason not protocol specified|5
55555|NCT01466881|227080|P1|Overall Study|Death|4
55556|NCT01466881|227080|P1|Overall Study|Progression/relapse|20
55557|NCT01466881|227080|P1|Overall Study|Adverse Event|6
55558|NCT01466881|227080|P1|Overall Study|Ineligible|5
55559|NCT01466790|227097|P8|Overall Study|Withdrawal by Subject|1
55560|NCT01466790|227098|P7|Overall Study|Withdrawal by Subject|1
55561|NCT01466790|227099|P6|Overall Study|Withdrawal by Subject|0
55562|NCT01466790|227100|P5|Overall Study|Withdrawal by Subject|1
55563|NCT01466790|227101|P4|Overall Study|Withdrawal by Subject|0
55564|NCT01466790|227102|P3|Overall Study|Withdrawal by Subject|0
55565|NCT01466790|227103|P2|Overall Study|Withdrawal by Subject|1
55566|NCT01466790|227104|P1|Overall Study|Withdrawal by Subject|1
55567|NCT01466790|227097|P8|Overall Study|Lost to Follow-up|0
55568|NCT01466790|227098|P7|Overall Study|Lost to Follow-up|0
55569|NCT01466790|227099|P6|Overall Study|Lost to Follow-up|0
55570|NCT01466790|227100|P5|Overall Study|Lost to Follow-up|0
55571|NCT01466790|227101|P4|Overall Study|Lost to Follow-up|0
55572|NCT01466790|227102|P3|Overall Study|Lost to Follow-up|0
55573|NCT01466790|227103|P2|Overall Study|Lost to Follow-up|0
55574|NCT01466790|227104|P1|Overall Study|Lost to Follow-up|2
55575|NCT01466790|227097|P8|Overall Study|Adverse Event|0
55576|NCT01466790|227098|P7|Overall Study|Adverse Event|0
55577|NCT01466790|227099|P6|Overall Study|Adverse Event|0
55578|NCT01466790|227100|P5|Overall Study|Adverse Event|2
55579|NCT01466790|227101|P4|Overall Study|Adverse Event|0
55580|NCT01466790|227102|P3|Overall Study|Adverse Event|0
55581|NCT01466790|227103|P2|Overall Study|Adverse Event|0
55582|NCT01466790|227104|P1|Overall Study|Adverse Event|1
55583|NCT01466673|227189|P2|Overall Study|Adverse Event|1
55584|NCT01466673|227190|P1|Overall Study|Adverse Event|2
55585|NCT01466673|227189|P2|Overall Study|Lost to Follow-up|5
55586|NCT01466673|227190|P1|Overall Study|Lost to Follow-up|3
55587|NCT01466673|227189|P2|Overall Study|Non-compliance with study treatment|0
55588|NCT01466673|227190|P1|Overall Study|Non-compliance with study treatment|2
55589|NCT01466660|227216|P2|Overall Study|Other reason not defined above|6
55590|NCT01466660|227217|P1|Overall Study|Other reason not defined above|3
55591|NCT01466660|227216|P2|Overall Study|Refused continuation of trial medication|3
55592|NCT01466660|227217|P1|Overall Study|Refused continuation of trial medication|4
55593|NCT01466660|227216|P2|Overall Study|Protocol Violation|1
55594|NCT01466660|227217|P1|Overall Study|Protocol Violation|1
55595|NCT01466660|227216|P2|Overall Study|Other adverse event|17
55596|NCT01466660|227217|P1|Overall Study|Other adverse event|18
55597|NCT01466660|227216|P2|Overall Study|Worsening of underlying cancer disease|2
55598|NCT01466660|227217|P1|Overall Study|Worsening of underlying cancer disease|5
55599|NCT01466660|227216|P2|Overall Study|Progressive Disease (RECIST 1.1)|122
55600|NCT01466660|227217|P1|Overall Study|Progressive Disease (RECIST 1.1)|115
55601|NCT01466595|227243|P2|Overall Study|Withdrawal by Subject|1
55602|NCT01466595|227244|P1|Overall Study|Withdrawal by Subject|0
55603|NCT01466491|227338|P4|Overall Study|Missing Data|0
55604|NCT01466491|227339|P3|Overall Study|Missing Data|1
55605|NCT01466491|227340|P2|Overall Study|Missing Data|0
55606|NCT01466491|227341|P1|Overall Study|Missing Data|0
55607|NCT01466491|227338|P4|Overall Study|Protocol Violation|0
55608|NCT01466491|227339|P3|Overall Study|Protocol Violation|2
55609|NCT01466491|227340|P2|Overall Study|Protocol Violation|3
55610|NCT01466491|227341|P1|Overall Study|Protocol Violation|0
55611|NCT01466387|227361|P6|Overall Study|Protocol Violation|0
55612|NCT01466387|227362|P5|Overall Study|Protocol Violation|0
55613|NCT01466387|227363|P4|Overall Study|Protocol Violation|1
55614|NCT01466387|227364|P3|Overall Study|Protocol Violation|0
55615|NCT01466387|227365|P2|Overall Study|Protocol Violation|0
55616|NCT01466387|227366|P1|Overall Study|Protocol Violation|1
55617|NCT01466387|227361|P6|Overall Study|Lost to Follow-up|1
55618|NCT01466387|227362|P5|Overall Study|Lost to Follow-up|0
55619|NCT01466387|227363|P4|Overall Study|Lost to Follow-up|0
55620|NCT01466387|227364|P3|Overall Study|Lost to Follow-up|0
55621|NCT01466387|227365|P2|Overall Study|Lost to Follow-up|0
55622|NCT01466387|227366|P1|Overall Study|Lost to Follow-up|0
55623|NCT01466387|227361|P6|Overall Study|Adverse Event|0
55624|NCT01466387|227362|P5|Overall Study|Adverse Event|0
55625|NCT01466387|227363|P4|Overall Study|Adverse Event|1
55626|NCT01466387|227364|P3|Overall Study|Adverse Event|1
55627|NCT01466387|227365|P2|Overall Study|Adverse Event|0
55628|NCT01466387|227366|P1|Overall Study|Adverse Event|0
55629|NCT01466348|227427|P2|Period I - First Intervention|Withdrawal by Subject|1
55630|NCT01466348|227428|P1|Period I - First Intervention|Withdrawal by Subject|0
55631|NCT01466270|227456|P2|Overall Study|Multiple|1
55632|NCT01466270|227457|P1|Overall Study|Multiple|1
55633|NCT01466270|227456|P2|Overall Study|Toxicity|1
55634|NCT01466270|227457|P1|Overall Study|Toxicity|4
55635|NCT01466270|227456|P2|Overall Study|Progression|0
55636|NCT01466270|227457|P1|Overall Study|Progression|1
55637|NCT01466270|227456|P2|Overall Study|Lost to Follow-up|3
55638|NCT01466270|227457|P1|Overall Study|Lost to Follow-up|1
55639|NCT01466270|227456|P2|Overall Study|Physician Decision|0
55640|NCT01466270|227457|P1|Overall Study|Physician Decision|1
55641|NCT01466270|227456|P2|Overall Study|Withdrawal by Subject|1
55642|NCT01466270|227457|P1|Overall Study|Withdrawal by Subject|4
55643|NCT01466192|227469|P1|Overall Study|Withdrawal by Subject|3
55644|NCT01466192|227469|P1|Overall Study|Physician Decision|1
55645|NCT01466179|227473|P1|Overall Study|Other|3
55646|NCT01466179|227473|P1|Overall Study|Protocol Violation|2
55647|NCT01466179|227473|P1|Overall Study|Withdrawal by Subject|7
55648|NCT01466179|227473|P1|Overall Study|Death|7
55649|NCT01466179|227473|P1|Overall Study|Lack of Efficacy|14
55650|NCT01466179|227473|P1|Overall Study|Disease relapse|23
55651|NCT01466179|227473|P1|Overall Study|Adverse Event|32
55652|NCT01466179|227473|P1|Overall Study|Progressive disease|43
55653|NCT01466179|227473|P1|Overall Study|Physician Decision|46
55654|NCT01466179|227473|P1|Overall Study|Ongoing in core study|2
55655|NCT01466153|227496|P3|Overall Study|Other-Unspecified|2
55656|NCT01466153|227497|P2|Overall Study|Other-Unspecified|4
55657|NCT01466153|227498|P1|Overall Study|Other-Unspecified|6
55658|NCT01466153|227496|P3|Overall Study|Randomized-Not Treated|4
55659|NCT01466153|227497|P2|Overall Study|Randomized-Not Treated|3
55660|NCT01466153|227498|P1|Overall Study|Randomized-Not Treated|2
55661|NCT01466153|227496|P3|Overall Study|Investigator Discretion|2
55662|NCT01466153|227497|P2|Overall Study|Investigator Discretion|2
55663|NCT01466153|227498|P1|Overall Study|Investigator Discretion|3
55664|NCT01466153|227496|P3|Overall Study|Withdrawal of Consent|0
55665|NCT01466153|227497|P2|Overall Study|Withdrawal of Consent|0
55666|NCT01466153|227498|P1|Overall Study|Withdrawal of Consent|2
55667|NCT01466153|227496|P3|Overall Study|Adverse Event|17
55668|NCT01466153|227497|P2|Overall Study|Adverse Event|13
55669|NCT01466153|227498|P1|Overall Study|Adverse Event|14
55670|NCT01466153|227496|P3|Overall Study|Disease Progression|0
55671|NCT01466153|227497|P2|Overall Study|Disease Progression|2
55672|NCT01466153|227498|P1|Overall Study|Disease Progression|2
55673|NCT01466062|227553|P1|Overall Study|Withdrawal by Subject|1
55674|NCT01466062|227553|P1|Overall Study|Adverse Event|1
55675|NCT01465997|227576|P2|Overall Study|subject left participation SP0993|1
55676|NCT01465997|227577|P1|Overall Study|subject left participation SP0993|0
55677|NCT01465997|227576|P2|Overall Study|decision by site staff|1
55678|NCT01465997|227577|P1|Overall Study|decision by site staff|0
55679|NCT01465997|227576|P2|Overall Study|withdrew before follow-up|13
55680|NCT01465997|227577|P1|Overall Study|withdrew before follow-up|0
55681|NCT01465997|227576|P2|Overall Study|local lab unblinded site|0
55682|NCT01465997|227577|P1|Overall Study|local lab unblinded site|1
55683|NCT01465997|227576|P2|Overall Study|subject withdrew consent|0
55684|NCT01465997|227577|P1|Overall Study|subject withdrew consent|1
55685|NCT01465997|227576|P2|Overall Study|sponsor's decision|1
55686|NCT01465997|227577|P1|Overall Study|sponsor's decision|1
55687|NCT01465997|227576|P2|Overall Study|Death|1
55688|NCT01465997|227577|P1|Overall Study|Death|0
55689|NCT01465997|227576|P2|Overall Study|investigator's decision|1
55690|NCT01465997|227577|P1|Overall Study|investigator's decision|1
55691|NCT01465997|227576|P2|Overall Study|Withdrawal by Subject|35
55692|NCT01465997|227577|P1|Overall Study|Withdrawal by Subject|32
55693|NCT01465997|227576|P2|Overall Study|Lost to Follow-up|9
55694|NCT01465997|227577|P1|Overall Study|Lost to Follow-up|6
55695|NCT01465997|227576|P2|Overall Study|Protocol Violation|4
55696|NCT01465997|227577|P1|Overall Study|Protocol Violation|1
55697|NCT01465997|227576|P2|Overall Study|Lack of Efficacy|1
55698|NCT01465997|227577|P1|Overall Study|Lack of Efficacy|13
55699|NCT01465997|227576|P2|Overall Study|Adverse Event|22
55700|NCT01465997|227577|P1|Overall Study|Adverse Event|12
55701|NCT01465958|227587|P2|Subcutaneous (SC) Phase|Adverse Event|1
55702|NCT01465958|227588|P1|Subcutaneous (SC) Phase|Adverse Event|0
55703|NCT01465958|227587|P2|Run-in Phase|Protocol Violation|0
55704|NCT01465958|227588|P1|Run-in Phase|Protocol Violation|1
55705|NCT01465802|227601|P5|Overall Study|Death|2
55706|NCT01465802|227602|P4|Overall Study|Death|10
55707|NCT01465802|227603|P3|Overall Study|Death|0
55708|NCT01465802|227604|P2|Overall Study|Death|12
55709|NCT01465802|227605|P1|Overall Study|Death|15
55710|NCT01465802|227601|P5|Overall Study|Reason not specified|2
55711|NCT01465802|227602|P4|Overall Study|Reason not specified|10
55712|NCT01465802|227603|P3|Overall Study|Reason not specified|0
55713|NCT01465802|227604|P2|Overall Study|Reason not specified|4
55714|NCT01465802|227605|P1|Overall Study|Reason not specified|9
55715|NCT01465802|227601|P5|Overall Study|Lost to Follow-up|0
55716|NCT01465802|227602|P4|Overall Study|Lost to Follow-up|0
55717|NCT01465802|227603|P3|Overall Study|Lost to Follow-up|0
55718|NCT01465802|227604|P2|Overall Study|Lost to Follow-up|1
55719|NCT01465802|227605|P1|Overall Study|Lost to Follow-up|1
55720|NCT01465802|227601|P5|Overall Study|Withdrawal by Subject|1
55721|NCT01465802|227602|P4|Overall Study|Withdrawal by Subject|8
55722|NCT01465802|227603|P3|Overall Study|Withdrawal by Subject|0
55723|NCT01465802|227604|P2|Overall Study|Withdrawal by Subject|7
55724|NCT01465802|227605|P1|Overall Study|Withdrawal by Subject|7
55725|NCT01465802|227601|P5|Overall Study|Study terminated by sponsor|7
55726|NCT01465802|227602|P4|Overall Study|Study terminated by sponsor|1
55727|NCT01465802|227603|P3|Overall Study|Study terminated by sponsor|0
55728|NCT01465802|227604|P2|Overall Study|Study terminated by sponsor|0
55729|NCT01465802|227605|P1|Overall Study|Study terminated by sponsor|1
55730|NCT01465763|227657|P3|Overall Study|Death|0
55731|NCT01465763|227658|P2|Overall Study|Death|0
55732|NCT01465763|227659|P1|Overall Study|Death|1
55733|NCT01465763|227657|P3|Overall Study|Protocol Violation|1
55734|NCT01465763|227658|P2|Overall Study|Protocol Violation|1
55735|NCT01465763|227659|P1|Overall Study|Protocol Violation|4
55736|NCT01465763|227657|P3|Overall Study|Other|0
55737|NCT01465763|227658|P2|Overall Study|Other|0
55738|NCT01465763|227659|P1|Overall Study|Other|2
55739|NCT01465763|227657|P3|Overall Study|Adverse Event|1
55740|NCT01465763|227658|P2|Overall Study|Adverse Event|0
55741|NCT01465763|227659|P1|Overall Study|Adverse Event|9
55742|NCT01465763|227657|P3|Overall Study|Insufficient Clinical Response|1
55743|NCT01465763|227658|P2|Overall Study|Insufficient Clinical Response|0
55744|NCT01465763|227659|P1|Overall Study|Insufficient Clinical Response|11
55745|NCT01465763|227657|P3|Overall Study|Withdrawal by Subject|1
55746|NCT01465763|227658|P2|Overall Study|Withdrawal by Subject|0
55747|NCT01465763|227659|P1|Overall Study|Withdrawal by Subject|4
55748|NCT01465386|227729|P1|Overall Study|Adverse Event|1
55749|NCT01465386|227729|P1|Overall Study|Lack of Efficacy|3
55750|NCT01465347|227733|P2|Overall Study|Admitted to hospice|1
55751|NCT01465347|227734|P1|Overall Study|Admitted to hospice|0
55752|NCT01465347|227733|P2|Overall Study|Physician Decision|1
55753|NCT01465347|227734|P1|Overall Study|Physician Decision|0
55754|NCT01465347|227733|P2|Overall Study|Withdrawal by Subject|1
55755|NCT01465347|227734|P1|Overall Study|Withdrawal by Subject|1
55756|NCT01465230|227744|P1|Overall Study|Withdrawal by Subject|2
55757|NCT01465178|227750|P2|Overall Study|Withdrawal by Subject|0
55758|NCT01465178|227751|P1|Overall Study|Withdrawal by Subject|1
55759|NCT01465022|227775|P3|Overall Study|Not Randomized|70
55760|NCT01465022|227776|P2|Overall Study|Not Randomized|0
55761|NCT01465022|227777|P1|Overall Study|Not Randomized|0
55762|NCT01465022|227775|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
55763|NCT01465022|227776|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
55764|NCT01465022|227777|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
55765|NCT01465022|227775|P3|Overall Study|Lost to Follow-up|0
55766|NCT01465022|227776|P2|Overall Study|Lost to Follow-up|14
55767|NCT01465022|227777|P1|Overall Study|Lost to Follow-up|15
55768|NCT01464931|227811|P2|Overall Study|Withdrawal by Subject|0
55769|NCT01464931|227812|P1|Overall Study|Withdrawal by Subject|1
55770|NCT01464879|227849|P1|Overall Study|Non-compliance|1
55771|NCT01464879|227849|P1|Overall Study|Physician Decision|1
55772|NCT01464827|227910|P14|Overall Study|Not Treated|2
55773|NCT01464827|227911|P13|Overall Study|Not Treated|0
55774|NCT01464827|227912|P12|Overall Study|Not Treated|1
55775|NCT01464827|227913|P11|Overall Study|Not Treated|0
55776|NCT01464827|227914|P10|Overall Study|Not Treated|2
55777|NCT01464827|227915|P9|Overall Study|Not Treated|0
55778|NCT01464827|227916|P8|Overall Study|Not Treated|0
55779|NCT01464827|227917|P7|Overall Study|Not Treated|1
55780|NCT01464827|227918|P6|Overall Study|Not Treated|0
55781|NCT01464827|227919|P5|Overall Study|Not Treated|1
55782|NCT01464827|227920|P4|Overall Study|Not Treated|0
55783|NCT01464827|227921|P3|Overall Study|Not Treated|0
55784|NCT01464827|227922|P2|Overall Study|Not Treated|2
55785|NCT01464827|227923|P1|Overall Study|Not Treated|0
55786|NCT01464827|227910|P14|Overall Study|Other|0
55787|NCT01464827|227911|P13|Overall Study|Other|1
55788|NCT01464827|227912|P12|Overall Study|Other|0
55789|NCT01464827|227913|P11|Overall Study|Other|2
55790|NCT01464827|227914|P10|Overall Study|Other|1
55791|NCT01464827|227915|P9|Overall Study|Other|3
55792|NCT01464827|227916|P8|Overall Study|Other|0
55793|NCT01464827|227917|P7|Overall Study|Other|1
55794|NCT01464827|227918|P6|Overall Study|Other|0
55795|NCT01464827|227919|P5|Overall Study|Other|3
55796|NCT01464827|227920|P4|Overall Study|Other|2
55797|NCT01464827|227921|P3|Overall Study|Other|0
55798|NCT01464827|227922|P2|Overall Study|Other|3
55799|NCT01464827|227923|P1|Overall Study|Other|2
55800|NCT01464827|227910|P14|Overall Study|Lost to Follow-up|1
55801|NCT01464827|227911|P13|Overall Study|Lost to Follow-up|0
55802|NCT01464827|227912|P12|Overall Study|Lost to Follow-up|1
55803|NCT01464827|227913|P11|Overall Study|Lost to Follow-up|0
55804|NCT01464827|227914|P10|Overall Study|Lost to Follow-up|0
55805|NCT01464827|227915|P9|Overall Study|Lost to Follow-up|0
55806|NCT01464827|227916|P8|Overall Study|Lost to Follow-up|2
55807|NCT01464827|227917|P7|Overall Study|Lost to Follow-up|2
55808|NCT01464827|227918|P6|Overall Study|Lost to Follow-up|1
55809|NCT01464827|227919|P5|Overall Study|Lost to Follow-up|3
55810|NCT01464827|227920|P4|Overall Study|Lost to Follow-up|2
55811|NCT01464827|227921|P3|Overall Study|Lost to Follow-up|0
55812|NCT01464827|227922|P2|Overall Study|Lost to Follow-up|2
55813|NCT01464827|227923|P1|Overall Study|Lost to Follow-up|0
55814|NCT01464827|227910|P14|Overall Study|Withdrawal by Subject|0
55815|NCT01464827|227911|P13|Overall Study|Withdrawal by Subject|0
55816|NCT01464827|227912|P12|Overall Study|Withdrawal by Subject|0
55817|NCT01464827|227913|P11|Overall Study|Withdrawal by Subject|0
55818|NCT01464827|227914|P10|Overall Study|Withdrawal by Subject|0
55819|NCT01464827|227915|P9|Overall Study|Withdrawal by Subject|0
55820|NCT01464827|227916|P8|Overall Study|Withdrawal by Subject|1
55821|NCT01464827|227917|P7|Overall Study|Withdrawal by Subject|0
55822|NCT01464827|227918|P6|Overall Study|Withdrawal by Subject|0
55823|NCT01464827|227919|P5|Overall Study|Withdrawal by Subject|1
55824|NCT01464827|227920|P4|Overall Study|Withdrawal by Subject|0
55825|NCT01464827|227921|P3|Overall Study|Withdrawal by Subject|0
55826|NCT01464827|227922|P2|Overall Study|Withdrawal by Subject|0
55827|NCT01464827|227923|P1|Overall Study|Withdrawal by Subject|1
55828|NCT01464827|227910|P14|Overall Study|Adverse Event|0
55829|NCT01464827|227911|P13|Overall Study|Adverse Event|1
55830|NCT01464827|227912|P12|Overall Study|Adverse Event|0
55831|NCT01464827|227913|P11|Overall Study|Adverse Event|0
55832|NCT01464827|227914|P10|Overall Study|Adverse Event|0
55833|NCT01464827|227915|P9|Overall Study|Adverse Event|0
55834|NCT01464827|227916|P8|Overall Study|Adverse Event|0
55835|NCT01464827|227917|P7|Overall Study|Adverse Event|0
55836|NCT01464827|227918|P6|Overall Study|Adverse Event|0
55837|NCT01464827|227919|P5|Overall Study|Adverse Event|0
55838|NCT01464827|227920|P4|Overall Study|Adverse Event|0
55839|NCT01464827|227921|P3|Overall Study|Adverse Event|0
55840|NCT01464827|227922|P2|Overall Study|Adverse Event|0
55841|NCT01464827|227923|P1|Overall Study|Adverse Event|0
55842|NCT01464788|227970|P3|Overall Study|Patient had hemorrhage after tPA started|0
55843|NCT01464788|227971|P2|Overall Study|Patient had hemorrhage after tPA started|1
55844|NCT01464788|227972|P1|Overall Study|Patient had hemorrhage after tPA started|0
55845|NCT01464788|227970|P3|Overall Study|Lost to Follow-up|0
55846|NCT01464788|227971|P2|Overall Study|Lost to Follow-up|1
55847|NCT01464788|227972|P1|Overall Study|Lost to Follow-up|0
55848|NCT01464619|227985|P2|Overall Study|Lost to Follow-up|4
55849|NCT01464619|227986|P1|Overall Study|Lost to Follow-up|3
55850|NCT01464424|228006|P2|Period 1, First 6 Weeks|Adverse Event|1
55851|NCT01464424|228007|P1|Period 1, First 6 Weeks|Adverse Event|0
55852|NCT01464346|228027|P3|Overall Study|Withdrawal by Subject|1
55853|NCT01464346|228028|P2|Overall Study|Withdrawal by Subject|0
55854|NCT01464346|228029|P1|Overall Study|Withdrawal by Subject|0
55855|NCT01464307|228040|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
55856|NCT01464307|228041|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
55857|NCT01464307|228040|P2|Open-Label Extension Period|Non-compliance|0
55858|NCT01464307|228041|P1|Open-Label Extension Period|Non-compliance|9
55859|NCT01464307|228040|P2|Open-Label Extension Period|Lost to Follow-up|0
55860|NCT01464307|228041|P1|Open-Label Extension Period|Lost to Follow-up|1
55861|NCT01464307|228040|P2|Open-Label Extension Period|Death|0
55862|NCT01464307|228041|P1|Open-Label Extension Period|Death|1
55863|NCT01464307|228040|P2|Open-Label Extension Period|Lack of Efficacy|0
55864|NCT01464307|228041|P1|Open-Label Extension Period|Lack of Efficacy|5
55865|NCT01464307|228040|P2|Open-Label Extension Period|Withdrawal by Subject|0
55866|NCT01464307|228041|P1|Open-Label Extension Period|Withdrawal by Subject|14
55867|NCT01464307|228040|P2|Open-Label Extension Period|Adverse Event|0
55868|NCT01464307|228041|P1|Open-Label Extension Period|Adverse Event|15
55869|NCT01464307|228040|P2|Main Period|Predefined discontinuation criteria|1
55870|NCT01464307|228041|P1|Main Period|Predefined discontinuation criteria|2
55871|NCT01464307|228040|P2|Main Period|Withdrawal by Subject|2
55872|NCT01464307|228041|P1|Main Period|Withdrawal by Subject|5
55873|NCT01464307|228040|P2|Main Period|Lack of Efficacy|0
55874|NCT01464307|228041|P1|Main Period|Lack of Efficacy|2
55875|NCT01464307|228040|P2|Main Period|Adverse Event|1
55876|NCT01464307|228041|P1|Main Period|Adverse Event|6
55877|NCT01464307|228040|P2|Main Period|Death|1
55878|NCT01464307|228041|P1|Main Period|Death|0
55879|NCT01464255|228056|P2|Overall Study|unresolve corneal staining|1
55880|NCT01464255|228057|P1|Overall Study|unresolve corneal staining|0
55881|NCT01464021|228102|P1|Overall Study|various|11
55882|NCT01464021|228102|P1|Overall Study|Lack of Efficacy|1
55883|NCT01464021|228102|P1|Overall Study|Lost to Follow-up|1
55884|NCT01464021|228102|P1|Overall Study|Withdrawal by Subject|13
55885|NCT01463982|228118|P4|Overall Study|Treatment delay over 5 week|0
55886|NCT01463982|228119|P3|Overall Study|Treatment delay over 5 week|1
55887|NCT01463982|228120|P2|Overall Study|Treatment delay over 5 week|0
55888|NCT01463982|228121|P1|Overall Study|Treatment delay over 5 week|0
55889|NCT01463982|228118|P4|Overall Study|Withdrawal by Subject|0
55890|NCT01463982|228119|P3|Overall Study|Withdrawal by Subject|1
55891|NCT01463982|228120|P2|Overall Study|Withdrawal by Subject|1
55892|NCT01463982|228121|P1|Overall Study|Withdrawal by Subject|0
55893|NCT01463878|228137|P2|Overall Study|no longer met criteria for tube feed|2
55894|NCT01463878|228138|P1|Overall Study|no longer met criteria for tube feed|2
55895|NCT01463696|228152|P8|Overall Study|Not Treated|0
55896|NCT01463696|228153|P7|Overall Study|Not Treated|1
55897|NCT01463696|228154|P6|Overall Study|Not Treated|0
55898|NCT01463696|228155|P5|Overall Study|Not Treated|0
55899|NCT01463696|228156|P4|Overall Study|Not Treated|0
55900|NCT01463696|228157|P3|Overall Study|Not Treated|0
55901|NCT01463696|228158|P2|Overall Study|Not Treated|0
55902|NCT01463696|228159|P1|Overall Study|Not Treated|0
55903|NCT01463696|228152|P8|Overall Study|Withdrawal by Subject|0
55904|NCT01463696|228153|P7|Overall Study|Withdrawal by Subject|2
55905|NCT01463696|228154|P6|Overall Study|Withdrawal by Subject|1
55906|NCT01463696|228155|P5|Overall Study|Withdrawal by Subject|1
55907|NCT01463696|228156|P4|Overall Study|Withdrawal by Subject|1
55908|NCT01463696|228157|P3|Overall Study|Withdrawal by Subject|0
55909|NCT01463696|228158|P2|Overall Study|Withdrawal by Subject|0
55910|NCT01463696|228159|P1|Overall Study|Withdrawal by Subject|0
55911|NCT01463696|228152|P8|Overall Study|Progressive Disease|2
55912|NCT01463696|228153|P7|Overall Study|Progressive Disease|4
55913|NCT01463696|228154|P6|Overall Study|Progressive Disease|1
55914|NCT01463696|228155|P5|Overall Study|Progressive Disease|0
55915|NCT01463696|228156|P4|Overall Study|Progressive Disease|1
55916|NCT01463696|228157|P3|Overall Study|Progressive Disease|0
55917|NCT01463696|228158|P2|Overall Study|Progressive Disease|1
55918|NCT01463696|228159|P1|Overall Study|Progressive Disease|0
55919|NCT01463696|228152|P8|Overall Study|Lost to Follow-up|0
55920|NCT01463696|228153|P7|Overall Study|Lost to Follow-up|0
55921|NCT01463696|228154|P6|Overall Study|Lost to Follow-up|0
55922|NCT01463696|228155|P5|Overall Study|Lost to Follow-up|0
55923|NCT01463696|228156|P4|Overall Study|Lost to Follow-up|0
55924|NCT01463696|228157|P3|Overall Study|Lost to Follow-up|1
55925|NCT01463696|228158|P2|Overall Study|Lost to Follow-up|0
55926|NCT01463696|228159|P1|Overall Study|Lost to Follow-up|0
55927|NCT01463696|228152|P8|Overall Study|Adverse Event|2
55928|NCT01463696|228153|P7|Overall Study|Adverse Event|3
55929|NCT01463696|228154|P6|Overall Study|Adverse Event|1
55930|NCT01463696|228155|P5|Overall Study|Adverse Event|0
55931|NCT01463696|228156|P4|Overall Study|Adverse Event|2
55932|NCT01463696|228157|P3|Overall Study|Adverse Event|0
55933|NCT01463696|228158|P2|Overall Study|Adverse Event|1
55934|NCT01463696|228159|P1|Overall Study|Adverse Event|0
55935|NCT01463683|228212|P3|Overall Study|Withdrawal by Subject|2
55936|NCT01463683|228213|P2|Overall Study|Withdrawal by Subject|17
55937|NCT01463683|228214|P1|Overall Study|Withdrawal by Subject|5
55938|NCT01463683|228212|P3|Overall Study|Pregnancy|1
55939|NCT01463683|228213|P2|Overall Study|Pregnancy|2
55940|NCT01463683|228214|P1|Overall Study|Pregnancy|2
55941|NCT01463683|228212|P3|Overall Study|Physician Decision|1
55942|NCT01463683|228213|P2|Overall Study|Physician Decision|3
55943|NCT01463683|228214|P1|Overall Study|Physician Decision|0
55944|NCT01463683|228212|P3|Overall Study|Lost to Follow-up|7
55945|NCT01463683|228213|P2|Overall Study|Lost to Follow-up|9
55946|NCT01463683|228214|P1|Overall Study|Lost to Follow-up|10
55947|NCT01463683|228212|P3|Overall Study|Adverse Event|0
55948|NCT01463683|228213|P2|Overall Study|Adverse Event|0
55949|NCT01463683|228214|P1|Overall Study|Adverse Event|2
55950|NCT01463527|228229|P2|Overall Study|Crying >20% of sedation|6
55951|NCT01463527|228230|P1|Overall Study|Crying >20% of sedation|5
55952|NCT01463527|228229|P2|Overall Study|Protocol Violation|1
55953|NCT01463527|228230|P1|Overall Study|Protocol Violation|1
55954|NCT01463293|228253|P3|Overall Study|Other|2
55955|NCT01463293|228254|P2|Overall Study|Other|0
55956|NCT01463293|228255|P1|Overall Study|Other|0
55957|NCT01463293|228253|P3|Overall Study|Withdrawal by Subject|5
55958|NCT01463293|228254|P2|Overall Study|Withdrawal by Subject|10
55959|NCT01463293|228255|P1|Overall Study|Withdrawal by Subject|4
55960|NCT01463293|228253|P3|Overall Study|Adverse Event|0
55961|NCT01463293|228254|P2|Overall Study|Adverse Event|2
55962|NCT01463293|228255|P1|Overall Study|Adverse Event|1
55963|NCT01463293|228253|P3|Overall Study|Lost to Follow-up|5
55964|NCT01463293|228254|P2|Overall Study|Lost to Follow-up|4
55965|NCT01463293|228255|P1|Overall Study|Lost to Follow-up|1
55966|NCT01463111|228274|P1|Overall Study|Physician Decision|2
55967|NCT01463111|228274|P1|Overall Study|Lost to Follow-up|5
55968|NCT01463111|228274|P1|Overall Study|Withdrawal by Subject|2
55969|NCT01463033|228284|P2|Overall Study|Death|2
55970|NCT01463033|228285|P1|Overall Study|Death|3
55971|NCT01463033|228284|P2|Overall Study|Lost to Follow-up|4
55972|NCT01463033|228285|P1|Overall Study|Lost to Follow-up|4
55973|NCT01463007|228292|P1|Overall Study|Physician Decision|1
55974|NCT01462942|228303|P5|Overall Study|Protocol Violation|6
55975|NCT01462942|228304|P4|Overall Study|Protocol Violation|9
55976|NCT01462942|228305|P3|Overall Study|Protocol Violation|9
55977|NCT01462942|228306|P2|Overall Study|Protocol Violation|6
55978|NCT01462942|228307|P1|Overall Study|Protocol Violation|4
55979|NCT01462942|228303|P5|Overall Study|Lost to Follow-up|1
55980|NCT01462942|228304|P4|Overall Study|Lost to Follow-up|1
55981|NCT01462942|228305|P3|Overall Study|Lost to Follow-up|1
55982|NCT01462942|228306|P2|Overall Study|Lost to Follow-up|1
55983|NCT01462942|228307|P1|Overall Study|Lost to Follow-up|0
55984|NCT01462942|228303|P5|Overall Study|Lack of Efficacy|3
55985|NCT01462942|228304|P4|Overall Study|Lack of Efficacy|5
55986|NCT01462942|228305|P3|Overall Study|Lack of Efficacy|4
55987|NCT01462942|228306|P2|Overall Study|Lack of Efficacy|0
55988|NCT01462942|228307|P1|Overall Study|Lack of Efficacy|6
55989|NCT01462942|228303|P5|Overall Study|Withdrawal by Subject|19
55990|NCT01462942|228304|P4|Overall Study|Withdrawal by Subject|16
55991|NCT01462942|228305|P3|Overall Study|Withdrawal by Subject|14
55992|NCT01462942|228306|P2|Overall Study|Withdrawal by Subject|10
55993|NCT01462942|228307|P1|Overall Study|Withdrawal by Subject|14
55994|NCT01462942|228303|P5|Overall Study|Other, including COPD exacerbation|5
55995|NCT01462942|228304|P4|Overall Study|Other, including COPD exacerbation|8
55996|NCT01462942|228305|P3|Overall Study|Other, including COPD exacerbation|2
55997|NCT01462942|228306|P2|Overall Study|Other, including COPD exacerbation|5
55998|NCT01462942|228307|P1|Overall Study|Other, including COPD exacerbation|3
55999|NCT01462942|228303|P5|Overall Study|Adverse Event|11
56000|NCT01462942|228304|P4|Overall Study|Adverse Event|11
56001|NCT01462942|228305|P3|Overall Study|Adverse Event|10
56002|NCT01462942|228306|P2|Overall Study|Adverse Event|12
56003|NCT01462942|228307|P1|Overall Study|Adverse Event|7
56004|NCT01462929|228337|P3|Overall Study|Lack of Efficacy|1
56005|NCT01462929|228338|P2|Overall Study|Lack of Efficacy|0
56006|NCT01462929|228339|P1|Overall Study|Lack of Efficacy|0
56007|NCT01462929|228337|P3|Overall Study|Withdrawal by Subject|0
56008|NCT01462929|228338|P2|Overall Study|Withdrawal by Subject|1
56009|NCT01462929|228339|P1|Overall Study|Withdrawal by Subject|2
56010|NCT01462929|228337|P3|Overall Study|Adverse Event|4
56011|NCT01462929|228338|P2|Overall Study|Adverse Event|3
56012|NCT01462929|228339|P1|Overall Study|Adverse Event|3
56013|NCT01462695|228380|P2|Overall Study|Inevaluable (did not receive study drug)|0
56014|NCT01462695|228381|P1|Overall Study|Inevaluable (did not receive study drug)|1
56015|NCT01462695|228380|P2|Overall Study|Withdrawal by Subject|0
56016|NCT01462695|228381|P1|Overall Study|Withdrawal by Subject|2
56017|NCT01462695|228380|P2|Overall Study|Physician Decision|0
56018|NCT01462695|228381|P1|Overall Study|Physician Decision|5
56019|NCT01462695|228380|P2|Overall Study|Lack of Efficacy|12
56020|NCT01462695|228381|P1|Overall Study|Lack of Efficacy|6
56021|NCT01462695|228380|P2|Overall Study|Death|0
56022|NCT01462695|228381|P1|Overall Study|Death|2
56023|NCT01462695|228380|P2|Overall Study|Adverse Event|1
56024|NCT01462695|228381|P1|Overall Study|Adverse Event|1
56025|NCT01462435|228409|P4|Overall Study|Lost to Follow-up|1
56026|NCT01462435|228410|P3|Overall Study|Lost to Follow-up|0
56027|NCT01462435|228411|P2|Overall Study|Lost to Follow-up|0
56028|NCT01462435|228412|P1|Overall Study|Lost to Follow-up|0
56029|NCT01462435|228409|P4|Overall Study|Withdrawal by Subject|1
56030|NCT01462435|228410|P3|Overall Study|Withdrawal by Subject|0
56031|NCT01462435|228411|P2|Overall Study|Withdrawal by Subject|0
56032|NCT01462435|228412|P1|Overall Study|Withdrawal by Subject|0
56033|NCT01462435|228409|P4|Overall Study|Physician Decision|0
56034|NCT01462435|228410|P3|Overall Study|Physician Decision|1
56035|NCT01462435|228411|P2|Overall Study|Physician Decision|0
56036|NCT01462435|228412|P1|Overall Study|Physician Decision|0
56037|NCT01462435|228409|P4|Overall Study|Lack of Efficacy|3
56038|NCT01462435|228410|P3|Overall Study|Lack of Efficacy|0
56039|NCT01462435|228411|P2|Overall Study|Lack of Efficacy|0
56040|NCT01462435|228412|P1|Overall Study|Lack of Efficacy|1
56041|NCT01462370|228450|P2|Overall Study|Withdrawal by Subject|3
56042|NCT01462370|228451|P1|Overall Study|Withdrawal by Subject|0
56043|NCT01462370|228450|P2|Overall Study|Physician Decision|1
56044|NCT01462370|228451|P1|Overall Study|Physician Decision|0
56045|NCT01462370|228450|P2|Overall Study|Lack of Qualifying Event|1
56046|NCT01462370|228451|P1|Overall Study|Lack of Qualifying Event|1
56047|NCT01462357|228486|P3|Month 24|Migrated/moved from study area|0
56048|NCT01462357|228487|P2|Month 24|Migrated/moved from study area|2
56049|NCT01462357|228488|P1|Month 24|Migrated/moved from study area|0
56050|NCT01462357|228486|P3|Month 24|Lost to Follow-up|6
56051|NCT01462357|228487|P2|Month 24|Lost to Follow-up|4
56052|NCT01462357|228488|P1|Month 24|Lost to Follow-up|2
56053|NCT01462357|228486|P3|Month 24|Withdrawal by Subject|3
56054|NCT01462357|228487|P2|Month 24|Withdrawal by Subject|8
56055|NCT01462357|228488|P1|Month 24|Withdrawal by Subject|2
56056|NCT01462357|228486|P3|Month 18|Other|1
56057|NCT01462357|228487|P2|Month 18|Other|1
56058|NCT01462357|228488|P1|Month 18|Other|0
56059|NCT01462357|228486|P3|Month 18|Lost to Follow-up|5
56060|NCT01462357|228487|P2|Month 18|Lost to Follow-up|4
56061|NCT01462357|228488|P1|Month 18|Lost to Follow-up|1
56062|NCT01462357|228486|P3|Month 18|Withdrawal by Subject|3
56063|NCT01462357|228487|P2|Month 18|Withdrawal by Subject|6
56064|NCT01462357|228488|P1|Month 18|Withdrawal by Subject|2
56065|NCT01462357|228486|P3|Month 12|Lost to Follow-up|5
56066|NCT01462357|228487|P2|Month 12|Lost to Follow-up|4
56067|NCT01462357|228488|P1|Month 12|Lost to Follow-up|1
56068|NCT01462357|228486|P3|Month 12|Withdrawal by Subject|3
56069|NCT01462357|228487|P2|Month 12|Withdrawal by Subject|6
56070|NCT01462357|228488|P1|Month 12|Withdrawal by Subject|2
56071|NCT01462357|228486|P3|Month 7|Withdrawal by Subject|6
56072|NCT01462357|228487|P2|Month 7|Withdrawal by Subject|5
56073|NCT01462357|228488|P1|Month 7|Withdrawal by Subject|1
56074|NCT01462344|228561|P2|Overall Study|Lost to Follow-up|7
56075|NCT01462344|228562|P1|Overall Study|Lost to Follow-up|7
56076|NCT01462344|228561|P2|Overall Study|Protocol Violation|53
56077|NCT01462344|228562|P1|Overall Study|Protocol Violation|68
56078|NCT01462344|228561|P2|Overall Study|Lack of Efficacy|6
56079|NCT01462344|228562|P1|Overall Study|Lack of Efficacy|5
56080|NCT01462344|228561|P2|Overall Study|Asthma Exacerbation|35
56081|NCT01462344|228562|P1|Overall Study|Asthma Exacerbation|34
56082|NCT01462344|228561|P2|Overall Study|Adverse Event|23
56083|NCT01462344|228562|P1|Overall Study|Adverse Event|24
56084|NCT01462344|228561|P2|Overall Study|Withdrawal by Subject|226
56085|NCT01462344|228562|P1|Overall Study|Withdrawal by Subject|245
56086|NCT01462318|228584|P3|Extension Phase|Adverse Event|22
56087|NCT01462318|228585|P2|Extension Phase|Adverse Event|0
56088|NCT01462318|228586|P1|Extension Phase|Adverse Event|0
56089|NCT01462318|228584|P3|Extension Phase|Investigator Decision|5
56090|NCT01462318|228585|P2|Extension Phase|Investigator Decision|0
56091|NCT01462318|228586|P1|Extension Phase|Investigator Decision|0
56092|NCT01462318|228584|P3|Extension Phase|Withdrawal by Subject|15
56093|NCT01462318|228585|P2|Extension Phase|Withdrawal by Subject|0
56094|NCT01462318|228586|P1|Extension Phase|Withdrawal by Subject|0
56095|NCT01462318|228584|P3|Extension Phase|Disease Progression|1
56096|NCT01462318|228585|P2|Extension Phase|Disease Progression|0
56097|NCT01462318|228586|P1|Extension Phase|Disease Progression|0
56098|NCT01462318|228584|P3|Extension Phase|Not Specified|1
56099|NCT01462318|228585|P2|Extension Phase|Not Specified|0
56100|NCT01462318|228586|P1|Extension Phase|Not Specified|0
56101|NCT01462318|228584|P3|Extension Phase|Lost to Follow-up|1
56102|NCT01462318|228585|P2|Extension Phase|Lost to Follow-up|0
56103|NCT01462318|228586|P1|Extension Phase|Lost to Follow-up|0
56104|NCT01462318|228584|P3|Main Study / TP-DI Study|Adverse Event|0
56105|NCT01462318|228585|P2|Main Study / TP-DI Study|Adverse Event|0
56106|NCT01462318|228586|P1|Main Study / TP-DI Study|Adverse Event|4
56107|NCT01462318|228584|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
56108|NCT01462318|228585|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
56109|NCT01462318|228586|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
56110|NCT01462318|228584|P3|Main Study / TP-DI Study|Not Specified|0
56111|NCT01462318|228585|P2|Main Study / TP-DI Study|Not Specified|0
56112|NCT01462318|228586|P1|Main Study / TP-DI Study|Not Specified|2
56113|NCT01462266|228674|P2|Overall Study|Screen failure|1
56114|NCT01462266|228675|P1|Overall Study|Screen failure|1
56115|NCT01462266|228674|P2|Overall Study|Withdrawal by Subject|2
56116|NCT01462266|228675|P1|Overall Study|Withdrawal by Subject|7
56117|NCT01462266|228674|P2|Overall Study|Protocol Violation|3
56118|NCT01462266|228675|P1|Overall Study|Protocol Violation|1
56119|NCT01462266|228674|P2|Overall Study|Physician Decision|5
56120|NCT01462266|228675|P1|Overall Study|Physician Decision|2
56121|NCT01462266|228674|P2|Overall Study|Creatinine and eGFR, excluded medication|4
56122|NCT01462266|228675|P1|Overall Study|Creatinine and eGFR, excluded medication|8
56123|NCT01462266|228674|P2|Overall Study|Non-compliance with study drug|0
56124|NCT01462266|228675|P1|Overall Study|Non-compliance with study drug|3
56125|NCT01462266|228674|P2|Overall Study|Lost to Follow-up|3
56126|NCT01462266|228675|P1|Overall Study|Lost to Follow-up|4
56127|NCT01462266|228674|P2|Overall Study|Lack of Efficacy|2
56128|NCT01462266|228675|P1|Overall Study|Lack of Efficacy|0
56129|NCT01462266|228674|P2|Overall Study|Death|1
56130|NCT01462266|228675|P1|Overall Study|Death|2
56131|NCT01462266|228674|P2|Overall Study|Adverse Event|6
56132|NCT01462266|228675|P1|Overall Study|Adverse Event|7
56133|NCT01462227|228691|P4|Second Assignment|Protocol Violation|0
56134|NCT01462227|228692|P3|Second Assignment|Protocol Violation|1
56135|NCT01462227|228693|P2|Second Assignment|Protocol Violation|1
56136|NCT01462227|228694|P1|Second Assignment|Protocol Violation|0
56137|NCT01462227|228691|P4|Second Assignment|Lost to Follow-up|0
56138|NCT01462227|228692|P3|Second Assignment|Lost to Follow-up|0
56139|NCT01462227|228693|P2|Second Assignment|Lost to Follow-up|0
56140|NCT01462227|228694|P1|Second Assignment|Lost to Follow-up|1
56141|NCT01462162|228712|P1|Overall Study|Other|2
56142|NCT01462162|228712|P1|Overall Study|Abnormal laboratory parameters|1
56143|NCT01462162|228712|P1|Overall Study|Lack of Efficacy|4
56144|NCT01462162|228712|P1|Overall Study|Adverse Event|5
56145|NCT01462084|228737|P2|Overall Study|Protocol Violation|1
56146|NCT01462084|228738|P1|Overall Study|Protocol Violation|1
56147|NCT01462084|228737|P2|Overall Study|Withdrawal by Subject|0
56148|NCT01462084|228738|P1|Overall Study|Withdrawal by Subject|1
56149|NCT01462045|228749|P3|Overall Study|Family matter|0
56150|NCT01462045|228750|P2|Overall Study|Family matter|1
56151|NCT01462045|228751|P1|Overall Study|Family matter|0
56152|NCT01461993|228765|P3|Overall Study|Other|6
56153|NCT01461993|228766|P2|Overall Study|Other|15
56154|NCT01461993|228767|P1|Overall Study|Other|13
56155|NCT01461993|228765|P3|Overall Study|Did not meet entrance criteria|0
56156|NCT01461993|228766|P2|Overall Study|Did not meet entrance criteria|3
56157|NCT01461993|228767|P1|Overall Study|Did not meet entrance criteria|2
56158|NCT01461993|228765|P3|Overall Study|No longer met eligibility criteria|10
56159|NCT01461993|228766|P2|Overall Study|No longer met eligibility criteria|18
56160|NCT01461993|228767|P1|Overall Study|No longer met eligibility criteria|13
56161|NCT01461993|228765|P3|Overall Study|Adverse Event|3
56162|NCT01461993|228766|P2|Overall Study|Adverse Event|11
56163|NCT01461993|228767|P1|Overall Study|Adverse Event|9
56164|NCT01461993|228765|P3|Overall Study|Protocol Violation|7
56165|NCT01461993|228766|P2|Overall Study|Protocol Violation|9
56166|NCT01461993|228767|P1|Overall Study|Protocol Violation|10
56167|NCT01461993|228765|P3|Overall Study|Lost to Follow-up|22
56168|NCT01461993|228766|P2|Overall Study|Lost to Follow-up|48
56169|NCT01461993|228767|P1|Overall Study|Lost to Follow-up|44
56170|NCT01461993|228765|P3|Overall Study|Withdrawal by Subject|16
56171|NCT01461993|228766|P2|Overall Study|Withdrawal by Subject|53
56172|NCT01461993|228767|P1|Overall Study|Withdrawal by Subject|60
56173|NCT01461980|228792|P3|Overall Study|Randomized but not vaccinated|7
56174|NCT01461980|228793|P2|Overall Study|Randomized but not vaccinated|8
56175|NCT01461980|228794|P1|Overall Study|Randomized but not vaccinated|4
56176|NCT01461980|228792|P3|Overall Study|No longer willing to participate|54
56177|NCT01461980|228793|P2|Overall Study|No longer willing to participate|38
56178|NCT01461980|228794|P1|Overall Study|No longer willing to participate|52
56179|NCT01461980|228792|P3|Overall Study|Lost to Follow-up|51
56180|NCT01461980|228793|P2|Overall Study|Lost to Follow-up|53
56181|NCT01461980|228794|P1|Overall Study|Lost to Follow-up|52
56182|NCT01461980|228792|P3|Overall Study|No longer meets eligibility criteria|19
56183|NCT01461980|228793|P2|Overall Study|No longer meets eligibility criteria|9
56184|NCT01461980|228794|P1|Overall Study|No longer meets eligibility criteria|18
56185|NCT01461980|228792|P3|Overall Study|Protocol Violation|16
56186|NCT01461980|228793|P2|Overall Study|Protocol Violation|19
56187|NCT01461980|228794|P1|Overall Study|Protocol Violation|12
56188|NCT01461980|228792|P3|Overall Study|Adverse Event|6
56189|NCT01461980|228793|P2|Overall Study|Adverse Event|5
56190|NCT01461980|228794|P1|Overall Study|Adverse Event|12
56191|NCT01461980|228792|P3|Overall Study|Medication error|6
56192|NCT01461980|228793|P2|Overall Study|Medication error|5
56193|NCT01461980|228794|P1|Overall Study|Medication error|7
56194|NCT01461980|228792|P3|Overall Study|Other|6
56195|NCT01461980|228793|P2|Overall Study|Other|8
56196|NCT01461980|228794|P1|Overall Study|Other|9
56197|NCT01461811|228845|P2|Overall Study|Noncompliance|1
56198|NCT01461811|228846|P1|Overall Study|Noncompliance|1
56199|NCT01461811|228845|P2|Overall Study|Subject decision unrelated to an AE|1
56200|NCT01461811|228846|P1|Overall Study|Subject decision unrelated to an AE|1
56201|NCT01461811|228845|P2|Overall Study|Adverse Event|1
56202|NCT01461811|228846|P1|Overall Study|Adverse Event|2
56203|NCT01461707|228885|P2|Overall Study|Withdrawal by Subject|0
56204|NCT01461707|228886|P1|Overall Study|Withdrawal by Subject|1
56205|NCT01461551|228923|P3|Overall Study|Physician Decision|2
56206|NCT01461551|228924|P2|Overall Study|Physician Decision|1
56207|NCT01461551|228925|P1|Overall Study|Physician Decision|2
56208|NCT01461538|228936|P3|Overall Study|Withdrawal by Subject|0
56209|NCT01461538|228937|P2|Overall Study|Withdrawal by Subject|1
56210|NCT01461538|228938|P1|Overall Study|Withdrawal by Subject|1
56211|NCT01461538|228936|P3|Overall Study|Study Stopped by Sponsor|0
56212|NCT01461538|228937|P2|Overall Study|Study Stopped by Sponsor|1
56213|NCT01461538|228938|P1|Overall Study|Study Stopped by Sponsor|2
56214|NCT01461538|228936|P3|Overall Study|Death|2
56215|NCT01461538|228937|P2|Overall Study|Death|6
56216|NCT01461538|228938|P1|Overall Study|Death|15
56217|NCT01461369|229007|P3|Overall Study|Withdrawal by Subject|2
56218|NCT01461369|229008|P2|Overall Study|Withdrawal by Subject|3
56219|NCT01461369|229009|P1|Overall Study|Withdrawal by Subject|1
56220|NCT01461369|229007|P3|Overall Study|Protocol Violation|2
56221|NCT01461369|229008|P2|Overall Study|Protocol Violation|2
56222|NCT01461369|229009|P1|Overall Study|Protocol Violation|1
56223|NCT01461369|229007|P3|Overall Study|Adverse Event|4
56224|NCT01461369|229008|P2|Overall Study|Adverse Event|12
56225|NCT01461369|229009|P1|Overall Study|Adverse Event|9
56226|NCT01461369|229007|P3|Overall Study|Lost to Follow-up|3
56227|NCT01461369|229008|P2|Overall Study|Lost to Follow-up|0
56228|NCT01461369|229009|P1|Overall Study|Lost to Follow-up|0
56229|NCT01461369|229007|P3|Overall Study|Lack of Efficacy|6
56230|NCT01461369|229008|P2|Overall Study|Lack of Efficacy|0
56231|NCT01461369|229009|P1|Overall Study|Lack of Efficacy|2
56232|NCT01461096|229034|P2|Overall Study|Lost to Follow-up|4
56233|NCT01461096|229035|P1|Overall Study|Lost to Follow-up|8
56234|NCT01461096|229034|P2|Overall Study|Subj not willing to adhere to reqs|4
56235|NCT01461096|229035|P1|Overall Study|Subj not willing to adhere to reqs|3
56236|NCT01461096|229034|P2|Overall Study|Withdrawal by Subject|3
56237|NCT01461096|229035|P1|Overall Study|Withdrawal by Subject|5
56238|NCT01461096|229034|P2|Overall Study|Site is closing|30
56239|NCT01461096|229035|P1|Overall Study|Site is closing|27
56240|NCT01461096|229034|P2|Overall Study|Subj not able to get to clinic|13
56241|NCT01461096|229035|P1|Overall Study|Subj not able to get to clinic|15
56242|NCT01461096|229034|P2|Overall Study|Severe debilitation, unable to continue|1
56243|NCT01461096|229035|P1|Overall Study|Severe debilitation, unable to continue|1
56244|NCT01461096|229034|P2|Overall Study|Death|6
56245|NCT01461096|229035|P1|Overall Study|Death|3
56246|NCT01461057|229051|P2|Overall Study|Physician Decision|1
56247|NCT01461057|229052|P1|Overall Study|Physician Decision|0
56248|NCT01461057|229051|P2|Overall Study|Withdrawal by Subject|3
56249|NCT01461057|229052|P1|Overall Study|Withdrawal by Subject|2
56250|NCT01461057|229051|P2|Overall Study|Death|8
56251|NCT01461057|229052|P1|Overall Study|Death|7
56252|NCT01461057|229051|P2|Overall Study|Currently in safety follow up|3
56253|NCT01461057|229052|P1|Overall Study|Currently in safety follow up|4
56254|NCT01461057|229051|P2|Overall Study|Currently in treatment|0
56255|NCT01461057|229052|P1|Overall Study|Currently in treatment|2
56256|NCT01461044|229062|P2|Overall Study|Lost to Follow-up|5
56257|NCT01461044|229063|P1|Overall Study|Lost to Follow-up|12
56258|NCT01461044|229062|P2|Overall Study|Death|35
56259|NCT01461044|229063|P1|Overall Study|Death|58
56260|NCT01460628|229163|P1|Overall Study|Withdrawal by Subject|2
56261|NCT01460628|229163|P1|Overall Study|Adverse Event|3
56262|NCT01460446|229175|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
56263|NCT01460446|229176|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
56264|NCT01460446|229175|P2|Overall Study|Pregnancy|0
56265|NCT01460446|229176|P1|Overall Study|Pregnancy|1
56266|NCT01460446|229175|P2|Overall Study|Surgery/Illness|1
56267|NCT01460446|229176|P1|Overall Study|Surgery/Illness|1
56268|NCT01460446|229175|P2|Overall Study|Non-compliance & Consent Withdrawn|3
56269|NCT01460446|229176|P1|Overall Study|Non-compliance & Consent Withdrawn|1
56270|NCT01460446|229175|P2|Overall Study|Consent Withdrawn|4
56271|NCT01460446|229176|P1|Overall Study|Consent Withdrawn|0
56272|NCT01460446|229175|P2|Overall Study|Non-compliance|9
56273|NCT01460446|229176|P1|Overall Study|Non-compliance|2
56274|NCT01460342|229205|P2|Overall Study|Lack of Efficacy|0
56275|NCT01460342|229206|P1|Overall Study|Lack of Efficacy|1
56276|NCT01460342|229205|P2|Overall Study|Physician Decision|3
56277|NCT01460342|229206|P1|Overall Study|Physician Decision|1
56278|NCT01460342|229205|P2|Overall Study|Withdrawal by Subject|4
56279|NCT01460342|229206|P1|Overall Study|Withdrawal by Subject|3
56280|NCT01460342|229205|P2|Overall Study|Protocol Violation|1
56281|NCT01460342|229206|P1|Overall Study|Protocol Violation|0
56282|NCT01460342|229205|P2|Overall Study|Lost to Follow-up|2
56283|NCT01460342|229206|P1|Overall Study|Lost to Follow-up|1
56284|NCT01460342|229205|P2|Overall Study|Adverse Event|4
56285|NCT01460342|229206|P1|Overall Study|Adverse Event|5
56286|NCT01460290|229237|P1|Overall Study|Elevated liver function|1
56287|NCT01460290|229237|P1|Overall Study|Adverse Event|3
56288|NCT01459913|229261|P4|Overall Study|Did Not Meet Inclusion Criteria|1
56289|NCT01459913|229262|P3|Overall Study|Did Not Meet Inclusion Criteria|0
56290|NCT01459913|229263|P2|Overall Study|Did Not Meet Inclusion Criteria|0
56291|NCT01459913|229264|P1|Overall Study|Did Not Meet Inclusion Criteria|0
56292|NCT01459913|229261|P4|Overall Study|Other|1
56293|NCT01459913|229262|P3|Overall Study|Other|3
56294|NCT01459913|229263|P2|Overall Study|Other|0
56295|NCT01459913|229264|P1|Overall Study|Other|0
56296|NCT01459913|229261|P4|Overall Study|Study Terminated by Sponsor|11
56297|NCT01459913|229262|P3|Overall Study|Study Terminated by Sponsor|9
56298|NCT01459913|229263|P2|Overall Study|Study Terminated by Sponsor|15
56299|NCT01459913|229264|P1|Overall Study|Study Terminated by Sponsor|30
56300|NCT01459913|229261|P4|Overall Study|Physician Decision|0
56301|NCT01459913|229262|P3|Overall Study|Physician Decision|0
56302|NCT01459913|229263|P2|Overall Study|Physician Decision|1
56303|NCT01459913|229264|P1|Overall Study|Physician Decision|0
56304|NCT01459913|229261|P4|Overall Study|Non- Compliance|3
56305|NCT01459913|229262|P3|Overall Study|Non- Compliance|0
56306|NCT01459913|229263|P2|Overall Study|Non- Compliance|0
56307|NCT01459913|229264|P1|Overall Study|Non- Compliance|0
56308|NCT01459913|229261|P4|Overall Study|Death|1
56309|NCT01459913|229262|P3|Overall Study|Death|0
56310|NCT01459913|229263|P2|Overall Study|Death|0
56311|NCT01459913|229264|P1|Overall Study|Death|0
56312|NCT01459913|229261|P4|Overall Study|Lost to Follow-up|8
56313|NCT01459913|229262|P3|Overall Study|Lost to Follow-up|1
56314|NCT01459913|229263|P2|Overall Study|Lost to Follow-up|4
56315|NCT01459913|229264|P1|Overall Study|Lost to Follow-up|7
56316|NCT01459913|229261|P4|Overall Study|Withdrawal by Subject|5
56317|NCT01459913|229262|P3|Overall Study|Withdrawal by Subject|0
56318|NCT01459913|229263|P2|Overall Study|Withdrawal by Subject|0
56319|NCT01459913|229264|P1|Overall Study|Withdrawal by Subject|4
56320|NCT01459913|229261|P4|Overall Study|Adverse Event|3
56321|NCT01459913|229262|P3|Overall Study|Adverse Event|0
56322|NCT01459913|229263|P2|Overall Study|Adverse Event|0
56323|NCT01459913|229264|P1|Overall Study|Adverse Event|0
56324|NCT01459796|229295|P2|Overall Study|Decision by the sponsor|108
56325|NCT01459796|229296|P1|Overall Study|Decision by the sponsor|75
56326|NCT01459796|229295|P2|Overall Study|Reason unspecified|2
56327|NCT01459796|229296|P1|Overall Study|Reason unspecified|1
56328|NCT01459796|229295|P2|Overall Study|Lost to Follow-up|4
56329|NCT01459796|229296|P1|Overall Study|Lost to Follow-up|5
56330|NCT01459796|229295|P2|Overall Study|Withdrawal by Subject|3
56331|NCT01459796|229296|P1|Overall Study|Withdrawal by Subject|6
56332|NCT01459796|229295|P2|Overall Study|Adverse Event|5
56333|NCT01459796|229296|P1|Overall Study|Adverse Event|5
56334|NCT01459796|229295|P2|Overall Study|Non compliance with protocol|4
56335|NCT01459796|229296|P1|Overall Study|Non compliance with protocol|2
56336|NCT01459783|229314|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
56337|NCT01459783|229315|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
56338|NCT01459783|229314|P2|6 Months to 12 Months|Lost to Follow-up|7
56339|NCT01459783|229315|P1|6 Months to 12 Months|Lost to Follow-up|2
56340|NCT01459783|229314|P2|6 Months to 12 Months|Withdrawal by Subject|5
56341|NCT01459783|229315|P1|6 Months to 12 Months|Withdrawal by Subject|6
56342|NCT01459783|229314|P2|6 Months to 12 Months|Death|1
56343|NCT01459783|229315|P1|6 Months to 12 Months|Death|0
56344|NCT01459783|229314|P2|Baseline to 6 Months|Lost to Follow-up|14
56345|NCT01459783|229315|P1|Baseline to 6 Months|Lost to Follow-up|19
56346|NCT01459783|229314|P2|Baseline to 6 Months|Withdrawal by Subject|6
56347|NCT01459783|229315|P1|Baseline to 6 Months|Withdrawal by Subject|12
56348|NCT01459783|229314|P2|Baseline to 6 Months|Death|0
56349|NCT01459783|229315|P1|Baseline to 6 Months|Death|1
56350|NCT01459068|229527|P2|Overall Study|Death|1
56351|NCT01459068|229528|P1|Overall Study|Death|0
56352|NCT01459068|229527|P2|Overall Study|Lost to Follow-up|15
56353|NCT01459068|229528|P1|Overall Study|Lost to Follow-up|31
56354|NCT01459068|229527|P2|Overall Study|Withdrawal by Subject|18
56355|NCT01459068|229528|P1|Overall Study|Withdrawal by Subject|8
56356|NCT01459016|229544|P1|Overall Study|Amendment Discontinuation Criteria|4
56357|NCT01459016|229544|P1|Overall Study|Withdrawal by Subject|11
56358|NCT01458951|229572|P3|Overall Study|Insufficient Clinical Response|11
56359|NCT01458951|229573|P2|Overall Study|Insufficient Clinical Response|0
56360|NCT01458951|229574|P1|Overall Study|Insufficient Clinical Response|17
56361|NCT01458951|229572|P3|Overall Study|Adverse Event|2
56362|NCT01458951|229573|P2|Overall Study|Adverse Event|0
56363|NCT01458951|229574|P1|Overall Study|Adverse Event|7
56364|NCT01458951|229572|P3|Overall Study|Withdrawal by Subject|2
56365|NCT01458951|229573|P2|Overall Study|Withdrawal by Subject|0
56366|NCT01458951|229574|P1|Overall Study|Withdrawal by Subject|2
56367|NCT01458951|229572|P3|Overall Study|Protocol Violation|0
56368|NCT01458951|229573|P2|Overall Study|Protocol Violation|1
56369|NCT01458951|229574|P1|Overall Study|Protocol Violation|5
56370|NCT01458951|229572|P3|Overall Study|Other|0
56371|NCT01458951|229573|P2|Overall Study|Other|0
56372|NCT01458951|229574|P1|Overall Study|Other|1
56373|NCT01458639|229599|P1|Overall Study|Inability to obtain subject blood sample|1
56374|NCT01458639|229599|P1|Overall Study|Equipment issue|1
56375|NCT01458639|229599|P1|Overall Study|Physician Decision|4
56376|NCT01458587|229611|P2|Overall Study|Withdrawal by Subject|0
56377|NCT01458587|229612|P1|Overall Study|Withdrawal by Subject|1
56378|NCT01458574|229775|P3|Overall Study|Randomized but not treated|0
56379|NCT01458574|229776|P2|Overall Study|Randomized but not treated|1
56380|NCT01458574|229777|P1|Overall Study|Randomized but not treated|0
56381|NCT01458574|229775|P3|Overall Study|Other|0
56382|NCT01458574|229776|P2|Overall Study|Other|1
56383|NCT01458574|229777|P1|Overall Study|Other|2
56384|NCT01458574|229775|P3|Overall Study|Withdrawal by Subject|5
56385|NCT01458574|229776|P2|Overall Study|Withdrawal by Subject|3
56386|NCT01458574|229777|P1|Overall Study|Withdrawal by Subject|6
56387|NCT01458574|229775|P3|Overall Study|Protocol Violation|0
56388|NCT01458574|229776|P2|Overall Study|Protocol Violation|1
56389|NCT01458574|229777|P1|Overall Study|Protocol Violation|0
56390|NCT01458574|229775|P3|Overall Study|Pregnancy|0
56391|NCT01458574|229776|P2|Overall Study|Pregnancy|1
56392|NCT01458574|229777|P1|Overall Study|Pregnancy|1
56393|NCT01458574|229775|P3|Overall Study|Lost to Follow-up|1
56394|NCT01458574|229776|P2|Overall Study|Lost to Follow-up|2
56395|NCT01458574|229777|P1|Overall Study|Lost to Follow-up|3
56396|NCT01458574|229775|P3|Overall Study|Lack of Efficacy|132
56397|NCT01458574|229776|P2|Overall Study|Lack of Efficacy|53
56398|NCT01458574|229777|P1|Overall Study|Lack of Efficacy|70
56399|NCT01458574|229775|P3|Overall Study|Adverse Event|7
56400|NCT01458574|229776|P2|Overall Study|Adverse Event|9
56401|NCT01458574|229777|P1|Overall Study|Adverse Event|5
56402|NCT01458535|229907|P6|Overall Study|Adverse Event|0
56403|NCT01458535|229908|P5|Overall Study|Adverse Event|0
56404|NCT01458535|229909|P4|Overall Study|Adverse Event|1
56405|NCT01458535|229910|P3|Overall Study|Adverse Event|0
56406|NCT01458535|229911|P2|Overall Study|Adverse Event|0
56407|NCT01458535|229912|P1|Overall Study|Adverse Event|0
56408|NCT01458535|229907|P6|Overall Study|Lost to Follow-up|2
56409|NCT01458535|229908|P5|Overall Study|Lost to Follow-up|2
56410|NCT01458535|229909|P4|Overall Study|Lost to Follow-up|3
56411|NCT01458535|229910|P3|Overall Study|Lost to Follow-up|0
56412|NCT01458535|229911|P2|Overall Study|Lost to Follow-up|2
56413|NCT01458535|229912|P1|Overall Study|Lost to Follow-up|0
56414|NCT01458535|229907|P6|Overall Study|Withdrawal by Subject|1
56415|NCT01458535|229908|P5|Overall Study|Withdrawal by Subject|1
56416|NCT01458535|229909|P4|Overall Study|Withdrawal by Subject|0
56417|NCT01458535|229910|P3|Overall Study|Withdrawal by Subject|2
56418|NCT01458535|229911|P2|Overall Study|Withdrawal by Subject|0
56419|NCT01458535|229912|P1|Overall Study|Withdrawal by Subject|0
56420|NCT01458535|229907|P6|Overall Study|Other|1
56421|NCT01458535|229908|P5|Overall Study|Other|1
56422|NCT01458535|229909|P4|Overall Study|Other|0
56423|NCT01458535|229910|P3|Overall Study|Other|0
56424|NCT01458535|229911|P2|Overall Study|Other|0
56425|NCT01458535|229912|P1|Overall Study|Other|0
56426|NCT01458392|229965|P3|Overall Study|Patient unwilling to comply with protoco|2
56427|NCT01458392|229966|P2|Overall Study|Patient unwilling to comply with protoco|0
56428|NCT01458392|229967|P1|Overall Study|Patient unwilling to comply with protoco|0
56429|NCT01458392|229965|P3|Overall Study|At the discretion of the sponsor|7
56430|NCT01458392|229966|P2|Overall Study|At the discretion of the sponsor|2
56431|NCT01458392|229967|P1|Overall Study|At the discretion of the sponsor|0
56432|NCT01458392|229965|P3|Overall Study|Death|22
56433|NCT01458392|229966|P2|Overall Study|Death|11
56434|NCT01458392|229967|P1|Overall Study|Death|2
56435|NCT01458275|229999|P3|Overall Study|Withdrawal by Subject|1
56436|NCT01458275|230000|P2|Overall Study|Withdrawal by Subject|2
56437|NCT01458275|230001|P1|Overall Study|Withdrawal by Subject|3
56438|NCT01458275|229999|P3|Overall Study|Protocol Violation|2
56439|NCT01458275|230000|P2|Overall Study|Protocol Violation|5
56440|NCT01458275|230001|P1|Overall Study|Protocol Violation|5
56441|NCT01458275|229999|P3|Overall Study|Lost to Follow-up|5
56442|NCT01458275|230000|P2|Overall Study|Lost to Follow-up|2
56443|NCT01458275|230001|P1|Overall Study|Lost to Follow-up|3
56444|NCT01458275|229999|P3|Overall Study|Adverse Event|1
56445|NCT01458275|230000|P2|Overall Study|Adverse Event|4
56446|NCT01458275|230001|P1|Overall Study|Adverse Event|3
56447|NCT01458249|230043|P1|Overall Study|Ongoing|1
56448|NCT01458249|230043|P1|Overall Study|Not specified|2
56449|NCT01458249|230043|P1|Overall Study|Adverse Event|4
56450|NCT01458249|230043|P1|Overall Study|Not treated|1
56451|NCT01458210|230062|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
56452|NCT01458210|230062|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
56453|NCT01458210|230062|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
56454|NCT01458210|230062|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
56455|NCT01458171|230079|P1|Overall Study|Adverse Event|1
56456|NCT01458106|230102|P2|Overall Study|Withdrawn Per Protocol|1
56457|NCT01458106|230103|P1|Overall Study|Withdrawn Per Protocol|0
56458|NCT01458106|230102|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
56459|NCT01458106|230103|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
56460|NCT01458106|230102|P2|Overall Study|Withdrawal by Subject|0
56461|NCT01458106|230103|P1|Overall Study|Withdrawal by Subject|2
56462|NCT01457950|230180|P4|Open-Label Phase|Withdrawal by Subject|0
56463|NCT01457950|230181|P3|Open-Label Phase|Withdrawal by Subject|2
56464|NCT01457950|230182|P2|Open-Label Phase|Withdrawal by Subject|0
56465|NCT01457950|230183|P1|Open-Label Phase|Withdrawal by Subject|0
56466|NCT01457950|230180|P4|Open-Label Phase|Protocol Violation|1
56467|NCT01457950|230181|P3|Open-Label Phase|Protocol Violation|0
56468|NCT01457950|230182|P2|Open-Label Phase|Protocol Violation|0
56469|NCT01457950|230183|P1|Open-Label Phase|Protocol Violation|0
56470|NCT01457950|230180|P4|Open-Label Phase|Adverse Event|1
56471|NCT01457950|230181|P3|Open-Label Phase|Adverse Event|0
56472|NCT01457950|230182|P2|Open-Label Phase|Adverse Event|0
56473|NCT01457950|230183|P1|Open-Label Phase|Adverse Event|0
56474|NCT01457950|230180|P4|Double-Blind Phase|Withdrawal by Subject|0
56475|NCT01457950|230181|P3|Double-Blind Phase|Withdrawal by Subject|0
56476|NCT01457950|230182|P2|Double-Blind Phase|Withdrawal by Subject|2
56477|NCT01457950|230183|P1|Double-Blind Phase|Withdrawal by Subject|6
56478|NCT01457950|230180|P4|Double-Blind Phase|Protocol Violation|0
56479|NCT01457950|230181|P3|Double-Blind Phase|Protocol Violation|0
56480|NCT01457950|230182|P2|Double-Blind Phase|Protocol Violation|1
56481|NCT01457950|230183|P1|Double-Blind Phase|Protocol Violation|2
56482|NCT01457950|230180|P4|Double-Blind Phase|Continuation Criteria Not Met|0
56483|NCT01457950|230181|P3|Double-Blind Phase|Continuation Criteria Not Met|0
56484|NCT01457950|230182|P2|Double-Blind Phase|Continuation Criteria Not Met|0
56485|NCT01457950|230183|P1|Double-Blind Phase|Continuation Criteria Not Met|1
56486|NCT01457924|230262|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
56487|NCT01457924|230263|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
56488|NCT01457924|230264|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
56489|NCT01457924|230265|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
56490|NCT01457924|230266|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
56491|NCT01457924|230262|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
56492|NCT01457924|230263|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
56493|NCT01457924|230264|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
56494|NCT01457924|230265|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
56495|NCT01457924|230266|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
56496|NCT01457924|230262|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
56497|NCT01457924|230263|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
56498|NCT01457924|230264|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
56499|NCT01457924|230265|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
56500|NCT01457924|230266|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
56501|NCT01457924|230262|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
56502|NCT01457924|230263|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
56503|NCT01457924|230264|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
56504|NCT01457924|230265|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
56505|NCT01457924|230266|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
56506|NCT01457924|230262|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
56507|NCT01457924|230263|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
56508|NCT01457924|230264|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
56509|NCT01457924|230265|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
56510|NCT01457924|230266|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
56511|NCT01457924|230262|P5|FUP (Weeks 24-48)|Physician Decision|0
56512|NCT01457924|230263|P4|FUP (Weeks 24-48)|Physician Decision|0
56513|NCT01457924|230264|P3|FUP (Weeks 24-48)|Physician Decision|1
56514|NCT01457924|230265|P2|FUP (Weeks 24-48)|Physician Decision|0
56515|NCT01457924|230266|P1|FUP (Weeks 24-48)|Physician Decision|1
56516|NCT01457924|230262|P5|FUP (Weeks 24-48)|Adverse Event|0
56517|NCT01457924|230263|P4|FUP (Weeks 24-48)|Adverse Event|0
56518|NCT01457924|230264|P3|FUP (Weeks 24-48)|Adverse Event|1
56519|NCT01457924|230265|P2|FUP (Weeks 24-48)|Adverse Event|0
56520|NCT01457924|230266|P1|FUP (Weeks 24-48)|Adverse Event|0
56521|NCT01457924|230262|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
56522|NCT01457924|230263|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
56523|NCT01457924|230264|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
56524|NCT01457924|230265|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
56525|NCT01457924|230266|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
56526|NCT01457924|230262|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
56527|NCT01457924|230263|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
56528|NCT01457924|230264|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
56529|NCT01457924|230265|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
56530|NCT01457924|230266|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
56531|NCT01457924|230262|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
56532|NCT01457924|230263|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
56533|NCT01457924|230264|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
56534|NCT01457924|230265|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
56535|NCT01457924|230266|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
56536|NCT01457924|230262|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
56537|NCT01457924|230263|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
56538|NCT01457924|230264|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
56539|NCT01457924|230265|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
56540|NCT01457924|230266|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
56541|NCT01457924|230262|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
56542|NCT01457924|230263|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
56543|NCT01457924|230264|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
56544|NCT01457924|230265|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
56545|NCT01457924|230266|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
56546|NCT01457924|230262|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
56547|NCT01457924|230263|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
56548|NCT01457924|230264|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
56549|NCT01457924|230265|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
56550|NCT01457924|230266|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
56551|NCT01457846|230336|P2|Overall Study|Lost to Follow-up|0
56552|NCT01457846|230337|P1|Overall Study|Lost to Follow-up|1
56553|NCT01457846|230336|P2|Overall Study|Withdrawal by Subject|1
56554|NCT01457846|230337|P1|Overall Study|Withdrawal by Subject|1
56555|NCT01457846|230336|P2|Overall Study|Unclassified reason for not completed|10
56556|NCT01457846|230337|P1|Overall Study|Unclassified reason for not completed|11
56557|NCT01457846|230336|P2|Overall Study|Death|16
56558|NCT01457846|230337|P1|Overall Study|Death|27
56559|NCT01457846|230336|P2|Overall Study|Did not receive treatment|1
56560|NCT01457846|230337|P1|Overall Study|Did not receive treatment|0
56561|NCT01457846|230336|P2|Overall Study|Death before treatment|2
56562|NCT01457846|230337|P1|Overall Study|Death before treatment|1
56563|NCT01457703|230353|P2|Overall Study|Withdrawal by Subject|4
56564|NCT01457703|230354|P1|Overall Study|Withdrawal by Subject|1
56565|NCT01457703|230353|P2|Overall Study|Screen Failure|7
56566|NCT01457703|230354|P1|Overall Study|Screen Failure|5
56567|NCT01457339|230465|P2|Period 6 (250 mg)|Personal appointment|1
56568|NCT01457339|230466|P1|Period 6 (250 mg)|Personal appointment|0
56569|NCT01457339|230465|P2|Period 6 (250 mg)|Family Emergency|0
56570|NCT01457339|230466|P1|Period 6 (250 mg)|Family Emergency|1
56571|NCT01457339|230465|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
56572|NCT01457339|230466|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
56573|NCT01457339|230465|P2|Period 3 (100 mg)|Adverse Event|1
56574|NCT01457339|230466|P1|Period 3 (100 mg)|Adverse Event|0
56575|NCT01457053|230632|P2|Overall Study|Unable to undergo selected treatment|1
56576|NCT01457053|230633|P1|Overall Study|Unable to undergo selected treatment|1
56577|NCT01457014|230639|P4|First Night|Withdrawal by Subject|0
56578|NCT01457014|230640|P3|First Night|Withdrawal by Subject|0
56579|NCT01457014|230641|P2|First Night|Withdrawal by Subject|0
56580|NCT01457014|230642|P1|First Night|Withdrawal by Subject|3
56581|NCT01457014|230639|P4|First Night|Didn't meet inclusion/exclusion criteria|0
56582|NCT01457014|230640|P3|First Night|Didn't meet inclusion/exclusion criteria|0
56583|NCT01457014|230641|P2|First Night|Didn't meet inclusion/exclusion criteria|0
56584|NCT01457014|230642|P1|First Night|Didn't meet inclusion/exclusion criteria|37
56585|NCT01456962|230659|P2|Overall Study|Lost to Follow-up|1
56586|NCT01456962|230660|P1|Overall Study|Lost to Follow-up|2
56587|NCT01456936|230670|P4|Overall Study|Randomized but not treated|21
56588|NCT01456936|230671|P3|Overall Study|Randomized but not treated|16
56589|NCT01456936|230672|P2|Overall Study|Randomized but not treated|28
56590|NCT01456936|230673|P1|Overall Study|Randomized but not treated|21
56591|NCT01456936|230670|P4|Overall Study|Death|3
56592|NCT01456936|230671|P3|Overall Study|Death|1
56593|NCT01456936|230672|P2|Overall Study|Death|3
56594|NCT01456936|230673|P1|Overall Study|Death|0
56595|NCT01456936|230670|P4|Overall Study|Adverse event (study drug unrelated)|9
56596|NCT01456936|230671|P3|Overall Study|Adverse event (study drug unrelated)|9
56597|NCT01456936|230672|P2|Overall Study|Adverse event (study drug unrelated)|7
56598|NCT01456936|230673|P1|Overall Study|Adverse event (study drug unrelated)|9
56599|NCT01456936|230670|P4|Overall Study|Adverse event (study drug)|17
56600|NCT01456936|230671|P3|Overall Study|Adverse event (study drug)|26
56601|NCT01456936|230672|P2|Overall Study|Adverse event (study drug)|21
56602|NCT01456936|230673|P1|Overall Study|Adverse event (study drug)|25
56603|NCT01456936|230670|P4|Overall Study|Medication error|1
56604|NCT01456936|230671|P3|Overall Study|Medication error|0
56605|NCT01456936|230672|P2|Overall Study|Medication error|1
56606|NCT01456936|230673|P1|Overall Study|Medication error|0
56607|NCT01456936|230670|P4|Overall Study|Lost to Follow-up|127
56608|NCT01456936|230671|P3|Overall Study|Lost to Follow-up|144
56609|NCT01456936|230672|P2|Overall Study|Lost to Follow-up|126
56610|NCT01456936|230673|P1|Overall Study|Lost to Follow-up|135
56611|NCT01456936|230670|P4|Overall Study|No longer willing to participate|248
56612|NCT01456936|230671|P3|Overall Study|No longer willing to participate|224
56613|NCT01456936|230672|P2|Overall Study|No longer willing to participate|218
56614|NCT01456936|230673|P1|Overall Study|No longer willing to participate|195
56615|NCT01456936|230670|P4|Overall Study|Insufficient clinical response|13
56616|NCT01456936|230671|P3|Overall Study|Insufficient clinical response|14
56617|NCT01456936|230672|P2|Overall Study|Insufficient clinical response|4
56618|NCT01456936|230673|P1|Overall Study|Insufficient clinical response|4
56619|NCT01456936|230670|P4|Overall Study|Pregnancy|1
56620|NCT01456936|230671|P3|Overall Study|Pregnancy|0
56621|NCT01456936|230672|P2|Overall Study|Pregnancy|0
56622|NCT01456936|230673|P1|Overall Study|Pregnancy|1
56623|NCT01456936|230670|P4|Overall Study|Protocol Violation|5
56624|NCT01456936|230671|P3|Overall Study|Protocol Violation|5
56625|NCT01456936|230672|P2|Overall Study|Protocol Violation|2
56626|NCT01456936|230673|P1|Overall Study|Protocol Violation|4
56627|NCT01456936|230670|P4|Overall Study|No longer meets eligibility criteria|5
56628|NCT01456936|230671|P3|Overall Study|No longer meets eligibility criteria|6
56629|NCT01456936|230672|P2|Overall Study|No longer meets eligibility criteria|8
56630|NCT01456936|230673|P1|Overall Study|No longer meets eligibility criteria|4
56631|NCT01456936|230670|P4|Overall Study|Other reason|33
56632|NCT01456936|230671|P3|Overall Study|Other reason|36
56633|NCT01456936|230672|P2|Overall Study|Other reason|30
56634|NCT01456936|230673|P1|Overall Study|Other reason|41
56635|NCT01456780|230782|P3|Overall Study|Lost to Follow-up|0
56636|NCT01456780|230783|P2|Overall Study|Lost to Follow-up|3
56637|NCT01456780|230784|P1|Overall Study|Lost to Follow-up|3
56638|NCT01456195|230817|P3|Overall Study|Other Reasons|3
56639|NCT01456195|230818|P2|Overall Study|Other Reasons|1
56640|NCT01456195|230819|P1|Overall Study|Other Reasons|2
56641|NCT01456195|230817|P3|Overall Study|Lack of Efficacy|0
56642|NCT01456195|230818|P2|Overall Study|Lack of Efficacy|1
56643|NCT01456195|230819|P1|Overall Study|Lack of Efficacy|0
56644|NCT01456195|230817|P3|Overall Study|Voluntary Withdrawal|7
56645|NCT01456195|230818|P2|Overall Study|Voluntary Withdrawal|3
56646|NCT01456195|230819|P1|Overall Study|Voluntary Withdrawal|5
56647|NCT01456195|230817|P3|Overall Study|Lost to Follow-up|3
56648|NCT01456195|230818|P2|Overall Study|Lost to Follow-up|1
56649|NCT01456195|230819|P1|Overall Study|Lost to Follow-up|3
56650|NCT01456195|230817|P3|Overall Study|Pretreatment Event/Adverse Event|1
56651|NCT01456195|230818|P2|Overall Study|Pretreatment Event/Adverse Event|4
56652|NCT01456195|230819|P1|Overall Study|Pretreatment Event/Adverse Event|1
56653|NCT01456169|230839|P3|Overall Study|Other|0
56654|NCT01456169|230840|P2|Overall Study|Other|1
56655|NCT01456169|230841|P1|Overall Study|Other|1
56656|NCT01456169|230839|P3|Overall Study|Lack of Efficacy|0
56657|NCT01456169|230840|P2|Overall Study|Lack of Efficacy|0
56658|NCT01456169|230841|P1|Overall Study|Lack of Efficacy|2
56659|NCT01456169|230839|P3|Overall Study|Voluntary Withdrawal|2
56660|NCT01456169|230840|P2|Overall Study|Voluntary Withdrawal|0
56661|NCT01456169|230841|P1|Overall Study|Voluntary Withdrawal|3
56662|NCT01456169|230839|P3|Overall Study|Major Protocol Deviation|3
56663|NCT01456169|230840|P2|Overall Study|Major Protocol Deviation|2
56664|NCT01456169|230841|P1|Overall Study|Major Protocol Deviation|3
56665|NCT01456169|230839|P3|Overall Study|Adverse Event|7
56666|NCT01456169|230840|P2|Overall Study|Adverse Event|2
56667|NCT01456169|230841|P1|Overall Study|Adverse Event|1
56668|NCT01456130|230901|P1|Overall Study|Other|1
56669|NCT01456130|230901|P1|Overall Study|Lack of Efficacy|4
56670|NCT01456130|230901|P1|Overall Study|Voluntary Withdrawal|1
56671|NCT01456130|230901|P1|Overall Study|Adverse Event|4
56672|NCT01456052|230911|P3|Overall Study|Treatment Failure|1
56673|NCT01456052|230912|P2|Overall Study|Treatment Failure|1
56674|NCT01456052|230913|P1|Overall Study|Treatment Failure|0
56675|NCT01456052|230911|P3|Overall Study|Physician Decision|1
56676|NCT01456052|230912|P2|Overall Study|Physician Decision|0
56677|NCT01456052|230913|P1|Overall Study|Physician Decision|1
56678|NCT01456052|230911|P3|Overall Study|Protocol Violation|0
56679|NCT01456052|230912|P2|Overall Study|Protocol Violation|1
56680|NCT01456052|230913|P1|Overall Study|Protocol Violation|0
56681|NCT01456052|230911|P3|Overall Study|Consent withdrawn|1
56682|NCT01456052|230912|P2|Overall Study|Consent withdrawn|2
56683|NCT01456052|230913|P1|Overall Study|Consent withdrawn|0
56684|NCT01456052|230911|P3|Overall Study|Adverse Event|2
56685|NCT01456052|230912|P2|Overall Study|Adverse Event|1
56686|NCT01456052|230913|P1|Overall Study|Adverse Event|1
56687|NCT01456039|230933|P3|Phase 2 (Second Step)|Other|1
56688|NCT01456039|230934|P2|Phase 2 (Second Step)|Other|0
56689|NCT01456039|230935|P1|Phase 2 (Second Step)|Other|0
56690|NCT01456039|230933|P3|Phase 2 (Second Step)|Protocol Violation|1
56691|NCT01456039|230934|P2|Phase 2 (Second Step)|Protocol Violation|0
56692|NCT01456039|230935|P1|Phase 2 (Second Step)|Protocol Violation|0
56693|NCT01456039|230933|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
56694|NCT01456039|230934|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
56695|NCT01456039|230935|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
56696|NCT01456039|230933|P3|Phase 2 (Second Step)|Adverse Event|10
56697|NCT01456039|230934|P2|Phase 2 (Second Step)|Adverse Event|0
56698|NCT01456039|230935|P1|Phase 2 (Second Step)|Adverse Event|0
56699|NCT01456039|230933|P3|Phase 2 (Second Step)|Disease Progression|17
56700|NCT01456039|230934|P2|Phase 2 (Second Step)|Disease Progression|0
56701|NCT01456039|230935|P1|Phase 2 (Second Step)|Disease Progression|0
56702|NCT01456039|230933|P3|Phase 1 (First Step)|Not specified|0
56703|NCT01456039|230934|P2|Phase 1 (First Step)|Not specified|1
56704|NCT01456039|230935|P1|Phase 1 (First Step)|Not specified|0
56705|NCT01456039|230933|P3|Phase 1 (First Step)|Adverse Event|0
56706|NCT01456039|230934|P2|Phase 1 (First Step)|Adverse Event|3
56707|NCT01456039|230935|P1|Phase 1 (First Step)|Adverse Event|0
56708|NCT01456039|230933|P3|Phase 1 (First Step)|Withdrawal by Subject|0
56709|NCT01456039|230934|P2|Phase 1 (First Step)|Withdrawal by Subject|2
56710|NCT01456039|230935|P1|Phase 1 (First Step)|Withdrawal by Subject|1
56711|NCT01456039|230933|P3|Phase 1 (First Step)|Disease Progression|0
56712|NCT01456039|230934|P2|Phase 1 (First Step)|Disease Progression|1
56713|NCT01456039|230935|P1|Phase 1 (First Step)|Disease Progression|1
56714|NCT01455428|231078|P2|Overall Study|Other|4
56715|NCT01455428|231079|P1|Overall Study|Other|2
56716|NCT01455428|231078|P2|Overall Study|Did not receive treatment|1
56717|NCT01455428|231079|P1|Overall Study|Did not receive treatment|1
56718|NCT01455428|231078|P2|Overall Study|Insufficient clinical response|2
56719|NCT01455428|231079|P1|Overall Study|Insufficient clinical response|0
56720|NCT01455428|231078|P2|Overall Study|Did not meet entrance criteria|2
56721|NCT01455428|231079|P1|Overall Study|Did not meet entrance criteria|0
56722|NCT01455428|231078|P2|Overall Study|Withdrawal by Subject|5
56723|NCT01455428|231079|P1|Overall Study|Withdrawal by Subject|2
56724|NCT01455428|231078|P2|Overall Study|Lost to Follow-up|1
56725|NCT01455428|231079|P1|Overall Study|Lost to Follow-up|1
56726|NCT01455428|231078|P2|Overall Study|Adverse Event|2
56727|NCT01455428|231079|P1|Overall Study|Adverse Event|6
56728|NCT01455428|231078|P2|Overall Study|Protocol Violation|1
56729|NCT01455428|231079|P1|Overall Study|Protocol Violation|2
56730|NCT01455415|231135|P2|Follow-up|Unspecified Reason|0
56731|NCT01455415|231136|P1|Follow-up|Unspecified Reason|1
56732|NCT01455415|231135|P2|Follow-up|Withdrawal by Subject|0
56733|NCT01455415|231136|P1|Follow-up|Withdrawal by Subject|2
56734|NCT01455415|231135|P2|Follow-up|Lack of Efficacy|1
56735|NCT01455415|231136|P1|Follow-up|Lack of Efficacy|0
56736|NCT01455415|231135|P2|Follow-up|AE Related to Study Drug|1
56737|NCT01455415|231136|P1|Follow-up|AE Related to Study Drug|0
56738|NCT01455415|231135|P2|Period 2|Protocol Violation|0
56739|NCT01455415|231136|P1|Period 2|Protocol Violation|2
56740|NCT01455415|231135|P2|Period 2|Unspecified Reason|3
56741|NCT01455415|231136|P1|Period 2|Unspecified Reason|2
56742|NCT01455415|231135|P2|Period 2|Withdrawal by Subject|3
56743|NCT01455415|231136|P1|Period 2|Withdrawal by Subject|2
56744|NCT01455415|231135|P2|Period 2|Lack of Efficacy|0
56745|NCT01455415|231136|P1|Period 2|Lack of Efficacy|2
56746|NCT01455415|231135|P2|Period 2|AE Not Related to Study Drug|1
56747|NCT01455415|231136|P1|Period 2|AE Not Related to Study Drug|2
56748|NCT01455415|231135|P2|Period 2|Lost to Follow-up|1
56749|NCT01455415|231136|P1|Period 2|Lost to Follow-up|2
56750|NCT01455415|231135|P2|Period 2|AE Related to Study Drug|2
56751|NCT01455415|231136|P1|Period 2|AE Related to Study Drug|1
56752|NCT01455415|231135|P2|Washout|Protocol Violation|1
56753|NCT01455415|231136|P1|Washout|Protocol Violation|0
56754|NCT01455415|231135|P2|Washout|Unspecified Reason|2
56755|NCT01455415|231136|P1|Washout|Unspecified Reason|1
56756|NCT01455415|231135|P2|Washout|AE Not Related to Study Drug|3
56757|NCT01455415|231136|P1|Washout|AE Not Related to Study Drug|2
56758|NCT01455415|231135|P2|Washout|Drug Error not Associated to AE|1
56759|NCT01455415|231136|P1|Washout|Drug Error not Associated to AE|2
56760|NCT01455415|231135|P2|Washout|Lost to Follow-up|0
56761|NCT01455415|231136|P1|Washout|Lost to Follow-up|1
56762|NCT01455415|231135|P2|Washout|AE Related to Study Drug|0
56763|NCT01455415|231136|P1|Washout|AE Related to Study Drug|2
56764|NCT01455415|231135|P2|Period 1|Protocol Violation|2
56765|NCT01455415|231136|P1|Period 1|Protocol Violation|0
56766|NCT01455415|231135|P2|Period 1|Unspecified Reason|1
56767|NCT01455415|231136|P1|Period 1|Unspecified Reason|1
56768|NCT01455415|231135|P2|Period 1|Withdrawal by Subject|5
56769|NCT01455415|231136|P1|Period 1|Withdrawal by Subject|4
56770|NCT01455415|231135|P2|Period 1|AE Not Related to Study Drug|6
56771|NCT01455415|231136|P1|Period 1|AE Not Related to Study Drug|2
56772|NCT01455415|231135|P2|Period 1|Drug Error not Associated to AE|1
56773|NCT01455415|231136|P1|Period 1|Drug Error not Associated to AE|0
56774|NCT01455415|231135|P2|Period 1|Lost To Follow-up Related to Study Drug|3
56775|NCT01455415|231136|P1|Period 1|Lost To Follow-up Related to Study Drug|3
56776|NCT01455415|231135|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
56777|NCT01455415|231136|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
56778|NCT01455220|231186|P1|Overall Study|screen fail|30
56779|NCT01455194|231196|P4|Overall Study|Miscellaneous|4
56780|NCT01455194|231197|P3|Overall Study|Miscellaneous|1
56781|NCT01455194|231198|P2|Overall Study|Miscellaneous|5
56782|NCT01455194|231199|P1|Overall Study|Miscellaneous|4
56783|NCT01455194|231196|P4|Overall Study|Discontinuation criterion fulfilled|2
56784|NCT01455194|231197|P3|Overall Study|Discontinuation criterion fulfilled|0
56785|NCT01455194|231198|P2|Overall Study|Discontinuation criterion fulfilled|2
56786|NCT01455194|231199|P1|Overall Study|Discontinuation criterion fulfilled|3
56787|NCT01455194|231196|P4|Overall Study|Pregnancy|0
56788|NCT01455194|231197|P3|Overall Study|Pregnancy|1
56789|NCT01455194|231198|P2|Overall Study|Pregnancy|1
56790|NCT01455194|231199|P1|Overall Study|Pregnancy|0
56791|NCT01455194|231196|P4|Overall Study|Lost to Follow-up|1
56792|NCT01455194|231197|P3|Overall Study|Lost to Follow-up|1
56793|NCT01455194|231198|P2|Overall Study|Lost to Follow-up|0
56794|NCT01455194|231199|P1|Overall Study|Lost to Follow-up|2
56795|NCT01455194|231196|P4|Overall Study|Withdrawal by Subject|9
56796|NCT01455194|231197|P3|Overall Study|Withdrawal by Subject|12
56797|NCT01455194|231198|P2|Overall Study|Withdrawal by Subject|16
56798|NCT01455194|231199|P1|Overall Study|Withdrawal by Subject|21
56799|NCT01455194|231196|P4|Overall Study|Adverse Event|3
56800|NCT01455194|231197|P3|Overall Study|Adverse Event|1
56801|NCT01455194|231198|P2|Overall Study|Adverse Event|1
56802|NCT01455194|231199|P1|Overall Study|Adverse Event|1
56803|NCT01455194|231196|P4|Overall Study|Deterioration in asthma|9
56804|NCT01455194|231197|P3|Overall Study|Deterioration in asthma|14
56805|NCT01455194|231198|P2|Overall Study|Deterioration in asthma|6
56806|NCT01455194|231199|P1|Overall Study|Deterioration in asthma|12
56807|NCT01455194|231196|P4|Overall Study|Randomisation Failure|0
56808|NCT01455194|231197|P3|Overall Study|Randomisation Failure|0
56809|NCT01455194|231198|P2|Overall Study|Randomisation Failure|0
56810|NCT01455194|231199|P1|Overall Study|Randomisation Failure|90
56811|NCT01455194|231196|P4|Overall Study|Screen Failure|0
56812|NCT01455194|231197|P3|Overall Study|Screen Failure|0
56813|NCT01455194|231198|P2|Overall Study|Screen Failure|0
56814|NCT01455194|231199|P1|Overall Study|Screen Failure|20
56815|NCT01455012|231262|P2|Overall Study|Unknown reason|0
56816|NCT01455012|231263|P1|Overall Study|Unknown reason|2
56817|NCT01455012|231262|P2|Overall Study|Withdrawal by Subject|1
56818|NCT01455012|231263|P1|Overall Study|Withdrawal by Subject|3
56819|NCT01455012|231262|P2|Overall Study|Lack of Efficacy|1
56820|NCT01455012|231263|P1|Overall Study|Lack of Efficacy|6
56821|NCT01455012|231262|P2|Overall Study|Adverse Event|2
56822|NCT01455012|231263|P1|Overall Study|Adverse Event|0
56823|NCT01454934|231330|P2|Overall Study|Ongoing, survival follow-up|2
56824|NCT01454934|231331|P1|Overall Study|Ongoing, survival follow-up|1
56825|NCT01454934|231330|P2|Overall Study|Not treated|2
56826|NCT01454934|231331|P1|Overall Study|Not treated|1
56827|NCT01454934|231330|P2|Overall Study|Not specified|16
56828|NCT01454934|231331|P1|Overall Study|Not specified|5
56829|NCT01454934|231330|P2|Overall Study|Clinical progression|25
56830|NCT01454934|231331|P1|Overall Study|Clinical progression|28
56831|NCT01454934|231330|P2|Overall Study|Withdrawn consent|5
56832|NCT01454934|231331|P1|Overall Study|Withdrawn consent|2
56833|NCT01454934|231330|P2|Overall Study|Lost to Follow-up|1
56834|NCT01454934|231331|P1|Overall Study|Lost to Follow-up|0
56835|NCT01454934|231330|P2|Overall Study|Withdrawal by Subject|15
56836|NCT01454934|231331|P1|Overall Study|Withdrawal by Subject|11
56837|NCT01454934|231330|P2|Overall Study|Adverse Event|24
56838|NCT01454934|231331|P1|Overall Study|Adverse Event|28
56839|NCT01454934|231330|P2|Overall Study|Disease progression|180
56840|NCT01454934|231331|P1|Overall Study|Disease progression|194
56841|NCT01454830|231343|P2|Overall Study|Withdrawal - no polysomnography|2
56842|NCT01454830|231344|P1|Overall Study|Withdrawal - no polysomnography|3
56843|NCT01454830|231343|P2|Overall Study|Post-allocation Exclude-other treatment|7
56844|NCT01454830|231344|P1|Overall Study|Post-allocation Exclude-other treatment|6
56845|NCT01454830|231343|P2|Overall Study|Post-allocation Exclude-refused PAP|2
56846|NCT01454830|231344|P1|Overall Study|Post-allocation Exclude-refused PAP|0
56847|NCT01454830|231343|P2|Overall Study|Post-allocation Exclude- AHI<10|12
56848|NCT01454830|231344|P1|Overall Study|Post-allocation Exclude- AHI<10|18
56849|NCT01454830|231343|P2|Overall Study|Withdrawal by Subject|4
56850|NCT01454830|231344|P1|Overall Study|Withdrawal by Subject|4
56851|NCT01454778|231375|P1|Overall Study|Death|1
56852|NCT01454778|231375|P1|Overall Study|Lost to Follow-up|2
56853|NCT01454726|231386|P2|Overall Study|Withdrawal by Subject|1
56854|NCT01454726|231387|P1|Overall Study|Withdrawal by Subject|0
56855|NCT01454583|231396|P3|3rd Year|Lost to Follow-up|297
56856|NCT01454583|231397|P2|3rd Year|Lost to Follow-up|512
56857|NCT01454583|231398|P1|3rd Year|Lost to Follow-up|1959
56858|NCT01454583|231396|P3|2nd Year|Lost to Follow-up|737
56859|NCT01454583|231397|P2|2nd Year|Lost to Follow-up|1049
56860|NCT01454583|231398|P1|2nd Year|Lost to Follow-up|3965
56861|NCT01454583|231396|P3|1st Year|Lost to Follow-up|180
56862|NCT01454583|231397|P2|1st Year|Lost to Follow-up|318
56863|NCT01454583|231398|P1|1st Year|Lost to Follow-up|1057
56864|NCT01454531|231466|P1|Overall Study|Other|1
56865|NCT01454531|231466|P1|Overall Study|Delay in IMP administration|1
56866|NCT01454531|231466|P1|Overall Study|Physician Decision|1
56867|NCT01454531|231466|P1|Overall Study|Lost to Follow-up|1
56868|NCT01454531|231466|P1|Overall Study|Withdrawal by Subject|5
56869|NCT01454531|231466|P1|Overall Study|Adverse Event|14
56870|NCT01454401|231502|P1|Overall Study|non-adherence|1
56871|NCT01454401|231502|P1|Overall Study|osteomyelitis|2
56872|NCT01454401|231502|P1|Overall Study|hospitalised|1
56873|NCT01454401|231502|P1|Overall Study|Death|1
56874|NCT01454284|231509|P2|Overall Study|Sponsor Decision|2
56875|NCT01454284|231510|P1|Overall Study|Sponsor Decision|0
56876|NCT01454284|231509|P2|Overall Study|Physician Decision|11
56877|NCT01454284|231510|P1|Overall Study|Physician Decision|16
56878|NCT01454284|231509|P2|Overall Study|Withdrawal by Subject|36
56879|NCT01454284|231510|P1|Overall Study|Withdrawal by Subject|58
56880|NCT01454284|231509|P2|Overall Study|Protocol Violation|6
56881|NCT01454284|231510|P1|Overall Study|Protocol Violation|9
56882|NCT01454284|231509|P2|Overall Study|Lost to Follow-up|8
56883|NCT01454284|231510|P1|Overall Study|Lost to Follow-up|13
56884|NCT01454284|231509|P2|Overall Study|Death|3
56885|NCT01454284|231510|P1|Overall Study|Death|0
56886|NCT01454284|231509|P2|Overall Study|Adverse Event|7
56887|NCT01454284|231510|P1|Overall Study|Adverse Event|20
56888|NCT01454076|231569|P5|Overall Study|Adverse Event|2
56889|NCT01454076|231570|P4|Overall Study|Adverse Event|0
56890|NCT01454076|231571|P3|Overall Study|Adverse Event|7
56891|NCT01454076|231572|P2|Overall Study|Adverse Event|2
56892|NCT01454076|231573|P1|Overall Study|Adverse Event|8
56893|NCT01454076|231569|P5|Overall Study|Withdrawal by Subject|2
56894|NCT01454076|231570|P4|Overall Study|Withdrawal by Subject|1
56895|NCT01454076|231571|P3|Overall Study|Withdrawal by Subject|2
56896|NCT01454076|231572|P2|Overall Study|Withdrawal by Subject|4
56897|NCT01454076|231573|P1|Overall Study|Withdrawal by Subject|3
56898|NCT01454076|231569|P5|Overall Study|Other|2
56899|NCT01454076|231570|P4|Overall Study|Other|1
56900|NCT01454076|231571|P3|Overall Study|Other|0
56901|NCT01454076|231572|P2|Overall Study|Other|0
56902|NCT01454076|231573|P1|Overall Study|Other|2
56903|NCT01454063|231626|P2|Randomized|Protocol Violation|1
56904|NCT01454063|231627|P1|Randomized|Protocol Violation|0
56905|NCT01454063|231626|P2|Randomized|Adverse Event|1
56906|NCT01454063|231627|P1|Randomized|Adverse Event|1
56907|NCT01453998|231648|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
56908|NCT01453998|231649|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
56909|NCT01453998|231650|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
56910|NCT01453946|231715|P1|Overall Study|Adverse Event|3
56911|NCT01453946|231715|P1|Overall Study|Lack of Efficacy|3
56912|NCT01453946|231715|P1|Overall Study|Protocol Violation|2
56913|NCT01453946|231715|P1|Overall Study|Did not receive drug for the taper phase|1
56914|NCT01453855|231732|P2|Overall Study|Other|1
56915|NCT01453855|231733|P1|Overall Study|Other|0
56916|NCT01453855|231732|P2|Overall Study|Inadequate Control of IOP|5
56917|NCT01453855|231733|P1|Overall Study|Inadequate Control of IOP|1
56918|NCT01453855|231732|P2|Overall Study|Noncompliance|0
56919|NCT01453855|231733|P1|Overall Study|Noncompliance|1
56920|NCT01453855|231732|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
56921|NCT01453855|231733|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
56922|NCT01453855|231732|P2|Overall Study|Lost to Follow-up|1
56923|NCT01453855|231733|P1|Overall Study|Lost to Follow-up|2
56924|NCT01453855|231732|P2|Overall Study|Adverse Event|4
56925|NCT01453855|231733|P1|Overall Study|Adverse Event|3
56926|NCT01453725|231741|P2|Overall Study|Physician Decision|1
56927|NCT01453725|231742|P1|Overall Study|Physician Decision|1
56928|NCT01453725|231741|P2|Overall Study|Pregnancy|0
56929|NCT01453725|231742|P1|Overall Study|Pregnancy|1
56930|NCT01453725|231741|P2|Overall Study|Pregnancy Wish|2
56931|NCT01453725|231742|P1|Overall Study|Pregnancy Wish|0
56932|NCT01453725|231741|P2|Overall Study|Withdrawal by Subject|3
56933|NCT01453725|231742|P1|Overall Study|Withdrawal by Subject|2
56934|NCT01453725|231741|P2|Overall Study|Protocol Violation|0
56935|NCT01453725|231742|P1|Overall Study|Protocol Violation|1
56936|NCT01453725|231741|P2|Overall Study|Non-compliance With Protocol|2
56937|NCT01453725|231742|P1|Overall Study|Non-compliance With Protocol|1
56938|NCT01453725|231741|P2|Overall Study|Lost to Follow-up|0
56939|NCT01453725|231742|P1|Overall Study|Lost to Follow-up|4
56940|NCT01453725|231741|P2|Overall Study|Adverse Event|3
56941|NCT01453725|231742|P1|Overall Study|Adverse Event|3
56942|NCT01453595|231765|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
56943|NCT01453595|231766|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
56944|NCT01453595|231767|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
56945|NCT01453374|231886|P1|Overall Study|Incarcerated|2
56946|NCT01453374|231886|P1|Overall Study|Withdrawal by Subject|5
56947|NCT01453374|231886|P1|Overall Study|Lost to Follow-up|3
56948|NCT01453374|231886|P1|Overall Study|Lack of Efficacy|1
56949|NCT01453374|231886|P1|Overall Study|Adverse Event|7
56950|NCT01453361|231902|P1|Overall Study|Screen-Failures|10
56951|NCT01453361|231902|P1|Overall Study|Disease Progression|6
56952|NCT01453348|231910|P3|Overall Study|Protocol Violation|0
56953|NCT01453348|231911|P2|Overall Study|Protocol Violation|0
56954|NCT01453348|231912|P1|Overall Study|Protocol Violation|1
56955|NCT01453348|231910|P3|Overall Study|Withdrawal by Subject|0
56956|NCT01453348|231911|P2|Overall Study|Withdrawal by Subject|1
56957|NCT01453348|231912|P1|Overall Study|Withdrawal by Subject|0
56958|NCT01453348|231910|P3|Overall Study|Death|1
56959|NCT01453348|231911|P2|Overall Study|Death|0
56960|NCT01453348|231912|P1|Overall Study|Death|0
56961|NCT01453296|231928|P2|Treatment Period 2|Withdrawal by Subject|0
56962|NCT01453296|231929|P1|Treatment Period 2|Withdrawal by Subject|1
56963|NCT01453296|231928|P2|Treatment Period 2|Adverse Event|0
56964|NCT01453296|231929|P1|Treatment Period 2|Adverse Event|1
56965|NCT01453296|231928|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
56966|NCT01453296|231929|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
56967|NCT01453296|231928|P2|Treatment Period 1|Adverse Event|1
56968|NCT01453296|231929|P1|Treatment Period 1|Adverse Event|0
56969|NCT01453205|231996|P3|Overall Study|Other|35
56970|NCT01453205|231997|P2|Overall Study|Other|27
56971|NCT01453205|231998|P1|Overall Study|Other|45
56972|NCT01453205|231996|P3|Overall Study|Death|18
56973|NCT01453205|231997|P2|Overall Study|Death|22
56974|NCT01453205|231998|P1|Overall Study|Death|24
56975|NCT01453205|231996|P3|Overall Study|Withdrawal by Subject|0
56976|NCT01453205|231997|P2|Overall Study|Withdrawal by Subject|3
56977|NCT01453205|231998|P1|Overall Study|Withdrawal by Subject|8
56978|NCT01453205|231996|P3|Overall Study|Lost to Follow-up|1
56979|NCT01453205|231997|P2|Overall Study|Lost to Follow-up|0
56980|NCT01453205|231998|P1|Overall Study|Lost to Follow-up|3
56981|NCT01453049|232082|P2|Overall Study|Randomized in Error|0
56982|NCT01453049|232083|P1|Overall Study|Randomized in Error|1
56983|NCT01453049|232082|P2|Overall Study|Withdrawal by Subject|0
56984|NCT01453049|232083|P1|Overall Study|Withdrawal by Subject|1
56985|NCT01453049|232082|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
56986|NCT01453049|232083|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
56987|NCT01453049|232082|P2|Overall Study|Lost to Follow-up|1
56988|NCT01453049|232083|P1|Overall Study|Lost to Follow-up|2
56989|NCT01453049|232082|P2|Overall Study|Protocol Violation|5
56990|NCT01453049|232083|P1|Overall Study|Protocol Violation|2
56991|NCT01453036|232156|P3|Overall Study|Lost to Follow-up|31
56992|NCT01453036|232157|P2|Overall Study|Lost to Follow-up|115
56993|NCT01453036|232158|P1|Overall Study|Lost to Follow-up|26
56994|NCT01453023|232166|P2|Treatment Period 2|Protocol Violation|1
56995|NCT01453023|232167|P1|Treatment Period 2|Protocol Violation|0
56996|NCT01453023|232166|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
56997|NCT01453023|232167|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
56998|NCT01453023|232166|P2|Treatment Period (TP) 1|Protocol Violation|0
56999|NCT01453023|232167|P1|Treatment Period (TP) 1|Protocol Violation|1
57000|NCT01452529|232241|P3|Double-blind (DB) Period|Administrative|7
57001|NCT01452529|232242|P2|Double-blind (DB) Period|Administrative|11
57002|NCT01452529|232243|P1|Double-blind (DB) Period|Administrative|0
57003|NCT01452529|232241|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
57004|NCT01452529|232242|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
57005|NCT01452529|232243|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
57006|NCT01452529|232241|P3|Double-blind (DB) Period|Lack of Efficacy|44
57007|NCT01452529|232242|P2|Double-blind (DB) Period|Lack of Efficacy|16
57008|NCT01452529|232243|P1|Double-blind (DB) Period|Lack of Efficacy|0
57009|NCT01452529|232241|P3|Double-blind (DB) Period|Lost to Follow-up|3
57010|NCT01452529|232242|P2|Double-blind (DB) Period|Lost to Follow-up|5
57011|NCT01452529|232243|P1|Double-blind (DB) Period|Lost to Follow-up|0
57012|NCT01452529|232241|P3|Double-blind (DB) Period|Withdrawal by Subject|14
57013|NCT01452529|232242|P2|Double-blind (DB) Period|Withdrawal by Subject|15
57014|NCT01452529|232243|P1|Double-blind (DB) Period|Withdrawal by Subject|0
57015|NCT01452529|232241|P3|Double-blind (DB) Period|Adverse Event|11
57016|NCT01452529|232242|P2|Double-blind (DB) Period|Adverse Event|18
57017|NCT01452529|232243|P1|Double-blind (DB) Period|Adverse Event|0
57018|NCT01452529|232241|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
57019|NCT01452529|232242|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
57020|NCT01452529|232243|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
57021|NCT01452529|232241|P3|Run-in Period|Administrative|0
57022|NCT01452529|232242|P2|Run-in Period|Administrative|0
57023|NCT01452529|232243|P1|Run-in Period|Administrative|21
57024|NCT01452529|232241|P3|Run-in Period|Confirmed or suspected diversion|0
57025|NCT01452529|232242|P2|Run-in Period|Confirmed or suspected diversion|0
57026|NCT01452529|232243|P1|Run-in Period|Confirmed or suspected diversion|23
57027|NCT01452529|232241|P3|Run-in Period|Lack of Efficacy|0
57028|NCT01452529|232242|P2|Run-in Period|Lack of Efficacy|0
57029|NCT01452529|232243|P1|Run-in Period|Lack of Efficacy|46
57030|NCT01452529|232241|P3|Run-in Period|Lost to Follow-up|0
57031|NCT01452529|232242|P2|Run-in Period|Lost to Follow-up|0
57032|NCT01452529|232243|P1|Run-in Period|Lost to Follow-up|19
57033|NCT01452529|232241|P3|Run-in Period|Withdrawal by Subject|0
57034|NCT01452529|232242|P2|Run-in Period|Withdrawal by Subject|0
57035|NCT01452529|232243|P1|Run-in Period|Withdrawal by Subject|49
57036|NCT01452529|232241|P3|Run-in Period|Adverse Event|0
57037|NCT01452529|232242|P2|Run-in Period|Adverse Event|0
57038|NCT01452529|232243|P1|Run-in Period|Adverse Event|96
57039|NCT01452347|232265|P2|Overall Study|Other reason not defined above|0
57040|NCT01452347|232266|P1|Overall Study|Other reason not defined above|2
57041|NCT01452347|232265|P2|Overall Study|Not treated|3
57042|NCT01452347|232266|P1|Overall Study|Not treated|6
57043|NCT01452347|232265|P2|Overall Study|Withdrawal by Subject|3
57044|NCT01452347|232266|P1|Overall Study|Withdrawal by Subject|3
57045|NCT01452347|232265|P2|Overall Study|Lost to Follow-up|0
57046|NCT01452347|232266|P1|Overall Study|Lost to Follow-up|2
57047|NCT01452347|232265|P2|Overall Study|Non compliance protocol|0
57048|NCT01452347|232266|P1|Overall Study|Non compliance protocol|2
57049|NCT01452347|232265|P2|Overall Study|Adverse Event|1
57050|NCT01452347|232266|P1|Overall Study|Adverse Event|2
57051|NCT01452152|232298|P3|Overall Study|Study termination by sponsor|4
57052|NCT01452152|232299|P2|Overall Study|Study termination by sponsor|0
57053|NCT01452152|232300|P1|Overall Study|Study termination by sponsor|5
57054|NCT01451931|232372|P3|Overall Study|Withdrawal by Subject|22
57055|NCT01451931|232373|P2|Overall Study|Withdrawal by Subject|22
57056|NCT01451931|232374|P1|Overall Study|Withdrawal by Subject|16
57057|NCT01451931|232372|P3|Overall Study|Lost to Follow-up|21
57058|NCT01451931|232373|P2|Overall Study|Lost to Follow-up|36
57059|NCT01451931|232374|P1|Overall Study|Lost to Follow-up|17
57060|NCT01451814|232396|P2|Overall Study|Lost to Follow-up|4
57061|NCT01451814|232397|P1|Overall Study|Lost to Follow-up|5
57062|NCT01451814|232396|P2|Overall Study|Withdrawal by Subject|1
57063|NCT01451814|232397|P1|Overall Study|Withdrawal by Subject|1
57064|NCT01451762|232429|P3|Overall Study|Lost to Follow-up|6
57065|NCT01451762|232430|P2|Overall Study|Lost to Follow-up|6
57066|NCT01451762|232431|P1|Overall Study|Lost to Follow-up|3
57067|NCT01451749|232441|P2|Overall Study|Withdrawal by Subject|1
57068|NCT01451749|232442|P1|Overall Study|Withdrawal by Subject|0
57069|NCT01451749|232441|P2|Overall Study|Adverse Event|0
57070|NCT01451749|232442|P1|Overall Study|Adverse Event|2
57071|NCT01451749|232441|P2|Overall Study|Meet the exclusion criteria,and|1
57072|NCT01451749|232442|P1|Overall Study|Meet the exclusion criteria,and|1
57073|NCT01451749|232441|P2|Overall Study|Lost to Follow-up|5
57074|NCT01451749|232442|P1|Overall Study|Lost to Follow-up|15
57075|NCT01451749|232441|P2|Overall Study|Protocol Violation|7
57076|NCT01451749|232442|P1|Overall Study|Protocol Violation|14
57077|NCT01451723|232454|P2|Overall Study|study halted|5
57078|NCT01451723|232455|P1|Overall Study|study halted|6
57079|NCT01451645|232465|P2|Overall Study|Lost to Follow-up|3
57080|NCT01451645|232466|P1|Overall Study|Lost to Follow-up|4
57081|NCT01451645|232465|P2|Overall Study|Withdrawal by Subject|2
57082|NCT01451645|232466|P1|Overall Study|Withdrawal by Subject|4
57083|NCT01451645|232465|P2|Overall Study|Adverse Event|3
57084|NCT01451645|232466|P1|Overall Study|Adverse Event|0
57085|NCT01451645|232465|P2|Overall Study|Protocol Violation|0
57086|NCT01451645|232466|P1|Overall Study|Protocol Violation|1
57087|NCT01451606|232537|P2|Overall Study|Withdrawal by Subject|3
57088|NCT01451606|232538|P1|Overall Study|Withdrawal by Subject|4
57089|NCT01451554|232548|P2|Overall Study|Withdrawal by Subject|9
57090|NCT01451554|232549|P1|Overall Study|Withdrawal by Subject|14
57091|NCT01451541|232560|P3|Overall Study|randomization error, noncompliance|8
57092|NCT01451541|232561|P2|Overall Study|randomization error, noncompliance|10
57093|NCT01451541|232562|P1|Overall Study|randomization error, noncompliance|11
57094|NCT01451541|232560|P3|Overall Study|Withdrawal by Subject|6
57095|NCT01451541|232561|P2|Overall Study|Withdrawal by Subject|8
57096|NCT01451541|232562|P1|Overall Study|Withdrawal by Subject|15
57097|NCT01451541|232560|P3|Overall Study|Lost to Follow-up|7
57098|NCT01451541|232561|P2|Overall Study|Lost to Follow-up|4
57099|NCT01451541|232562|P1|Overall Study|Lost to Follow-up|4
57100|NCT01451541|232560|P3|Overall Study|Lack of Efficacy|0
57101|NCT01451541|232561|P2|Overall Study|Lack of Efficacy|0
57102|NCT01451541|232562|P1|Overall Study|Lack of Efficacy|2
57103|NCT01451541|232560|P3|Overall Study|Adverse Event|6
57104|NCT01451541|232561|P2|Overall Study|Adverse Event|3
57105|NCT01451541|232562|P1|Overall Study|Adverse Event|4
57106|NCT01451437|232620|P9|Overall Study|Withdrawal by Subject|0
57107|NCT01451437|232621|P8|Overall Study|Withdrawal by Subject|0
57108|NCT01451437|232622|P7|Overall Study|Withdrawal by Subject|1
57109|NCT01451437|232623|P6|Overall Study|Withdrawal by Subject|0
57110|NCT01451437|232624|P5|Overall Study|Withdrawal by Subject|1
57111|NCT01451437|232625|P4|Overall Study|Withdrawal by Subject|0
57112|NCT01451437|232626|P3|Overall Study|Withdrawal by Subject|0
57113|NCT01451437|232627|P2|Overall Study|Withdrawal by Subject|0
57114|NCT01451437|232628|P1|Overall Study|Withdrawal by Subject|0
57115|NCT01451437|232620|P9|Overall Study|Protocol Violation|0
57116|NCT01451437|232621|P8|Overall Study|Protocol Violation|0
57117|NCT01451437|232622|P7|Overall Study|Protocol Violation|1
57118|NCT01451437|232623|P6|Overall Study|Protocol Violation|0
57119|NCT01451437|232624|P5|Overall Study|Protocol Violation|0
57120|NCT01451437|232625|P4|Overall Study|Protocol Violation|0
57121|NCT01451437|232626|P3|Overall Study|Protocol Violation|0
57122|NCT01451437|232627|P2|Overall Study|Protocol Violation|0
57123|NCT01451437|232628|P1|Overall Study|Protocol Violation|0
57124|NCT01451437|232620|P9|Overall Study|Disease Progression|3
57125|NCT01451437|232621|P8|Overall Study|Disease Progression|1
57126|NCT01451437|232622|P7|Overall Study|Disease Progression|3
57127|NCT01451437|232623|P6|Overall Study|Disease Progression|2
57128|NCT01451437|232624|P5|Overall Study|Disease Progression|3
57129|NCT01451437|232625|P4|Overall Study|Disease Progression|1
57130|NCT01451437|232626|P3|Overall Study|Disease Progression|1
57131|NCT01451437|232627|P2|Overall Study|Disease Progression|0
57132|NCT01451437|232628|P1|Overall Study|Disease Progression|0
57133|NCT01451437|232620|P9|Overall Study|Physician Decision|0
57134|NCT01451437|232621|P8|Overall Study|Physician Decision|0
57135|NCT01451437|232622|P7|Overall Study|Physician Decision|0
57136|NCT01451437|232623|P6|Overall Study|Physician Decision|0
57137|NCT01451437|232624|P5|Overall Study|Physician Decision|0
57138|NCT01451437|232625|P4|Overall Study|Physician Decision|0
57139|NCT01451437|232626|P3|Overall Study|Physician Decision|2
57140|NCT01451437|232627|P2|Overall Study|Physician Decision|1
57141|NCT01451437|232628|P1|Overall Study|Physician Decision|1
57142|NCT01451437|232620|P9|Overall Study|Adverse Event|1
57143|NCT01451437|232621|P8|Overall Study|Adverse Event|2
57144|NCT01451437|232622|P7|Overall Study|Adverse Event|1
57145|NCT01451437|232623|P6|Overall Study|Adverse Event|1
57146|NCT01451437|232624|P5|Overall Study|Adverse Event|0
57147|NCT01451437|232625|P4|Overall Study|Adverse Event|0
57148|NCT01451437|232626|P3|Overall Study|Adverse Event|0
57149|NCT01451437|232627|P2|Overall Study|Adverse Event|0
57150|NCT01451437|232628|P1|Overall Study|Adverse Event|0
57151|NCT01451424|232760|P4|Overall Study|Adverse Event|1
57152|NCT01451424|232761|P3|Overall Study|Adverse Event|0
57153|NCT01451424|232762|P2|Overall Study|Adverse Event|0
57154|NCT01451424|232763|P1|Overall Study|Adverse Event|0
57155|NCT01451424|232760|P4|Overall Study|Physician Decision|1
57156|NCT01451424|232761|P3|Overall Study|Physician Decision|1
57157|NCT01451424|232762|P2|Overall Study|Physician Decision|0
57158|NCT01451424|232763|P1|Overall Study|Physician Decision|0
57159|NCT01451424|232760|P4|Overall Study|Lost to Follow-up|1
57160|NCT01451424|232761|P3|Overall Study|Lost to Follow-up|0
57161|NCT01451424|232762|P2|Overall Study|Lost to Follow-up|1
57162|NCT01451424|232763|P1|Overall Study|Lost to Follow-up|0
57163|NCT01451424|232760|P4|Overall Study|Withdrawal by Subject|2
57164|NCT01451424|232761|P3|Overall Study|Withdrawal by Subject|0
57165|NCT01451424|232762|P2|Overall Study|Withdrawal by Subject|1
57166|NCT01451424|232763|P1|Overall Study|Withdrawal by Subject|1
57167|NCT01451398|232821|P2|Overall Study|Lack of Efficacy|1
57168|NCT01451398|232822|P1|Overall Study|Lack of Efficacy|0
57169|NCT01451398|232821|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
57170|NCT01451398|232822|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
57171|NCT01451398|232821|P2|Overall Study|Moved out of country|1
57172|NCT01451398|232822|P1|Overall Study|Moved out of country|0
57173|NCT01451398|232821|P2|Overall Study|Non-compliance with protocol|1
57174|NCT01451398|232822|P1|Overall Study|Non-compliance with protocol|1
57175|NCT01451398|232821|P2|Overall Study|Non-compliance with study drug|3
57176|NCT01451398|232822|P1|Overall Study|Non-compliance with study drug|1
57177|NCT01451398|232821|P2|Overall Study|Lost to Follow-up|4
57178|NCT01451398|232822|P1|Overall Study|Lost to Follow-up|6
57179|NCT01451398|232821|P2|Overall Study|Withdrawal by Subject|14
57180|NCT01451398|232822|P1|Overall Study|Withdrawal by Subject|10
57181|NCT01451398|232821|P2|Overall Study|Physician Decision|1
57182|NCT01451398|232822|P1|Overall Study|Physician Decision|1
57183|NCT01451398|232821|P2|Overall Study|Protocol Violation|2
57184|NCT01451398|232822|P1|Overall Study|Protocol Violation|1
57185|NCT01451398|232821|P2|Overall Study|Adverse Event|9
57186|NCT01451398|232822|P1|Overall Study|Adverse Event|7
57187|NCT01451203|232856|P2|Post-treatment Period|Investigator decision|1
57188|NCT01451203|232857|P1|Post-treatment Period|Investigator decision|0
57189|NCT01451203|232856|P2|Post-treatment Period|Adverse Event|1
57190|NCT01451203|232857|P1|Post-treatment Period|Adverse Event|0
57191|NCT01451203|232856|P2|Post-treatment Period|Lack of Efficacy|28
57192|NCT01451203|232857|P1|Post-treatment Period|Lack of Efficacy|12
57193|NCT01451203|232856|P2|Post-treatment Period|Consent withdrawn|4
57194|NCT01451203|232857|P1|Post-treatment Period|Consent withdrawn|2
57195|NCT01451203|232856|P2|Double-blind Treatment Period|Investigator decision|0
57196|NCT01451203|232857|P1|Double-blind Treatment Period|Investigator decision|2
57197|NCT01451203|232856|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
57198|NCT01451203|232857|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
57199|NCT01451203|232856|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
57200|NCT01451203|232857|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
57201|NCT01451203|232856|P2|Double-blind Treatment Period|Adverse Event|9
57202|NCT01451203|232857|P1|Double-blind Treatment Period|Adverse Event|6
57203|NCT01451203|232856|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
57204|NCT01451203|232857|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
57205|NCT01451203|232856|P2|Double-blind Treatment Period|Lack of Efficacy|36
57206|NCT01451203|232857|P1|Double-blind Treatment Period|Lack of Efficacy|71
57207|NCT01451203|232856|P2|Double-blind Treatment Period|Consent Withdrawn|2
57208|NCT01451203|232857|P1|Double-blind Treatment Period|Consent Withdrawn|3
57209|NCT01451203|232856|P2|Double-blind Treatment Period|Did not receive treatment|2
57210|NCT01451203|232857|P1|Double-blind Treatment Period|Did not receive treatment|1
57211|NCT01450813|232875|P4|Overall Study|Physician Decision|3
57212|NCT01450813|232876|P3|Overall Study|Physician Decision|0
57213|NCT01450813|232877|P2|Overall Study|Physician Decision|1
57214|NCT01450813|232878|P1|Overall Study|Physician Decision|1
57215|NCT01450800|232892|P2|Overall Study|Protocol Violation|3
57216|NCT01450800|232893|P1|Overall Study|Protocol Violation|1
57217|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
57218|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
57219|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Not reported|1
57220|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Not reported|0
57221|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
57222|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
57223|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
57224|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
57225|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
57226|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
57227|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
57228|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
57229|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Death|6
57230|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Death|5
57231|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
57232|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|11
57233|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
57234|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|14
57235|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
57236|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|25
57237|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
57238|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Study drug toxicity|85
57239|NCT01450761|232928|P2|Treatment With Blinded Study Therapy|Disease progression|409
57240|NCT01450761|232929|P1|Treatment With Blinded Study Therapy|Disease progression|314
57241|NCT01450761|232928|P2|Lead-in Chemotherapy|Lost to Follow-up|0
57242|NCT01450761|232929|P1|Lead-in Chemotherapy|Lost to Follow-up|2
57243|NCT01450761|232928|P2|Lead-in Chemotherapy|Other|2
57244|NCT01450761|232929|P1|Lead-in Chemotherapy|Other|2
57245|NCT01450761|232928|P2|Lead-in Chemotherapy|Death|3
57246|NCT01450761|232929|P1|Lead-in Chemotherapy|Death|3
57247|NCT01450761|232928|P2|Lead-in Chemotherapy|No longer meets study criteria|7
57248|NCT01450761|232929|P1|Lead-in Chemotherapy|No longer meets study criteria|3
57249|NCT01450761|232928|P2|Lead-in Chemotherapy|Study drug toxicity|10
57250|NCT01450761|232929|P1|Lead-in Chemotherapy|Study drug toxicity|6
57251|NCT01450761|232928|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
57252|NCT01450761|232929|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
57253|NCT01450761|232928|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
57254|NCT01450761|232929|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
57255|NCT01450761|232928|P2|Lead-in Chemotherapy|Disease progression|32
57256|NCT01450761|232929|P1|Lead-in Chemotherapy|Disease progression|33
57257|NCT01450761|232928|P2|Randomization|Other|1
57258|NCT01450761|232929|P1|Randomization|Other|0
57259|NCT01450761|232928|P2|Randomization|Adverse Event unrelated to study drug|0
57260|NCT01450761|232929|P1|Randomization|Adverse Event unrelated to study drug|1
57261|NCT01450761|232928|P2|Randomization|Disease progression|2
57262|NCT01450761|232929|P1|Randomization|Disease progression|0
57263|NCT01450761|232928|P2|Randomization|Withdrawal by Subject|0
57264|NCT01450761|232929|P1|Randomization|Withdrawal by Subject|2
57265|NCT01450761|232928|P2|Randomization|Subject no longer meets study criteria|2
57266|NCT01450761|232929|P1|Randomization|Subject no longer meets study criteria|1
57267|NCT01450696|232941|P2|Overall Study|Study Terminated by Sponsor|58
57268|NCT01450696|232942|P1|Overall Study|Study Terminated by Sponsor|53
57269|NCT01450696|232941|P2|Overall Study|Withdrawal by Subject|2
57270|NCT01450696|232942|P1|Overall Study|Withdrawal by Subject|13
57271|NCT01450696|232941|P2|Overall Study|Non-Compliance|0
57272|NCT01450696|232942|P1|Overall Study|Non-Compliance|1
57273|NCT01450696|232941|P2|Overall Study|Lost to Follow-up|3
57274|NCT01450696|232942|P1|Overall Study|Lost to Follow-up|3
57275|NCT01450696|232941|P2|Overall Study|Death|84
57276|NCT01450696|232942|P1|Overall Study|Death|77
57277|NCT01450696|232941|P2|Overall Study|Never Treated|1
57278|NCT01450696|232942|P1|Overall Study|Never Treated|1
57279|NCT01450683|232964|P1|Overall Study|Adverse Event|2
57280|NCT01450631|232970|P2|Overall Study|Withdrawal by Subject|0
57281|NCT01450631|232971|P1|Overall Study|Withdrawal by Subject|1
57282|NCT01450631|232970|P2|Overall Study|Lost to Follow-up|4
57283|NCT01450631|232971|P1|Overall Study|Lost to Follow-up|2
57284|NCT01450007|233102|P3|Overall Study|Adverse Event|0
57285|NCT01450007|233103|P2|Overall Study|Adverse Event|1
57286|NCT01450007|233104|P1|Overall Study|Adverse Event|0
57287|NCT01450007|233102|P3|Overall Study|Protocol Violation|1
57288|NCT01450007|233103|P2|Overall Study|Protocol Violation|1
57289|NCT01450007|233104|P1|Overall Study|Protocol Violation|0
57290|NCT01450007|233102|P3|Overall Study|Late exclusion before treatment|2
57291|NCT01450007|233103|P2|Overall Study|Late exclusion before treatment|3
57292|NCT01450007|233104|P1|Overall Study|Late exclusion before treatment|2
57293|NCT01449955|233123|P2|Overall Study|Withdrawal by Subject|2
57294|NCT01449955|233124|P1|Overall Study|Withdrawal by Subject|1
57295|NCT01449929|233132|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
57296|NCT01449929|233133|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
57297|NCT01449929|233134|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
57298|NCT01449929|233132|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
57299|NCT01449929|233133|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
57300|NCT01449929|233134|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
57301|NCT01449929|233132|P3|Extension Phase Approximately 3 Years|Adverse Event|2
57302|NCT01449929|233133|P2|Extension Phase Approximately 3 Years|Adverse Event|0
57303|NCT01449929|233134|P1|Extension Phase Approximately 3 Years|Adverse Event|0
57304|NCT01449929|233132|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
57305|NCT01449929|233133|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
57306|NCT01449929|233134|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
57307|NCT01449929|233132|P3|Randomization Phase 96 Week|Physician Decision|0
57308|NCT01449929|233133|P2|Randomization Phase 96 Week|Physician Decision|3
57309|NCT01449929|233134|P1|Randomization Phase 96 Week|Physician Decision|2
57310|NCT01449929|233132|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
57311|NCT01449929|233133|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
57312|NCT01449929|233134|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
57313|NCT01449929|233132|P3|Randomization Phase 96 Week|Lost to Follow-up|0
57314|NCT01449929|233133|P2|Randomization Phase 96 Week|Lost to Follow-up|18
57315|NCT01449929|233134|P1|Randomization Phase 96 Week|Lost to Follow-up|15
57316|NCT01449929|233132|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
57317|NCT01449929|233133|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
57318|NCT01449929|233134|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
57319|NCT01449929|233132|P3|Randomization Phase 96 Week|Protocol Violation|0
57320|NCT01449929|233133|P2|Randomization Phase 96 Week|Protocol Violation|6
57321|NCT01449929|233134|P1|Randomization Phase 96 Week|Protocol Violation|5
57322|NCT01449929|233132|P3|Randomization Phase 96 Week|Lack of Efficacy|0
57323|NCT01449929|233133|P2|Randomization Phase 96 Week|Lack of Efficacy|4
57324|NCT01449929|233134|P1|Randomization Phase 96 Week|Lack of Efficacy|3
57325|NCT01449929|233132|P3|Randomization Phase 96 Week|Adverse Event|0
57326|NCT01449929|233133|P2|Randomization Phase 96 Week|Adverse Event|13
57327|NCT01449929|233134|P1|Randomization Phase 96 Week|Adverse Event|5
57328|NCT01449812|233174|P3|Overall Study|Lost to Follow-up|0
57329|NCT01449812|233175|P2|Overall Study|Lost to Follow-up|0
57330|NCT01449812|233176|P1|Overall Study|Lost to Follow-up|1
57331|NCT01449812|233174|P3|Overall Study|Withdrawal by Subject|1
57332|NCT01449812|233175|P2|Overall Study|Withdrawal by Subject|0
57333|NCT01449812|233176|P1|Overall Study|Withdrawal by Subject|0
57334|NCT01449812|233174|P3|Overall Study|Migrated/moved from study area|0
57335|NCT01449812|233175|P2|Overall Study|Migrated/moved from study area|0
57336|NCT01449812|233176|P1|Overall Study|Migrated/moved from study area|1
57337|NCT01449721|233291|P2|Overall Study|Physician Decision|1
57338|NCT01449721|233292|P1|Overall Study|Physician Decision|0
57339|NCT01449721|233291|P2|Overall Study|Physician Decision|1
57340|NCT01449721|233292|P1|Overall Study|Physician Decision|0
57341|NCT01449708|233304|P2|Overall Study|respiratory failure|0
57342|NCT01449708|233305|P1|Overall Study|respiratory failure|1
57343|NCT01449708|233304|P2|Overall Study|surgical complication|2
57344|NCT01449708|233305|P1|Overall Study|surgical complication|1
57345|NCT01449708|233304|P2|Overall Study|Protocol Violation|1
57346|NCT01449708|233305|P1|Overall Study|Protocol Violation|0
57347|NCT01449682|233316|P2|Overall Study|Adverse Event|0
57348|NCT01449682|233317|P1|Overall Study|Adverse Event|1
57349|NCT01449682|233316|P2|Overall Study|Death|1
57350|NCT01449682|233317|P1|Overall Study|Death|0
57351|NCT01449539|233329|P1|Overall Study|Toxicity not study related|1
57352|NCT01449539|233329|P1|Overall Study|Withdrawal by Subject|3
57353|NCT01449526|233335|P2|Overall Study|Cannot maintain visits|1
57354|NCT01449526|233336|P1|Overall Study|Cannot maintain visits|0
57355|NCT01449526|233335|P2|Overall Study|Lack of Motivation|1
57356|NCT01449526|233336|P1|Overall Study|Lack of Motivation|0
57357|NCT01449526|233335|P2|Overall Study|Symptoms/complaints|1
57358|NCT01449526|233336|P1|Overall Study|Symptoms/complaints|0
57359|NCT01449526|233335|P2|Overall Study|Withdrawal by Subject|1
57360|NCT01449526|233336|P1|Overall Study|Withdrawal by Subject|1
57361|NCT01449526|233335|P2|Overall Study|Lost to Follow-up|2
57362|NCT01449526|233336|P1|Overall Study|Lost to Follow-up|1
57363|NCT01449461|233405|P6|Overall Study|Reason not specified|1
57364|NCT01449461|233406|P5|Overall Study|Reason not specified|0
57365|NCT01449461|233407|P4|Overall Study|Reason not specified|3
57366|NCT01449461|233408|P3|Overall Study|Reason not specified|0
57367|NCT01449461|233409|P2|Overall Study|Reason not specified|1
57368|NCT01449461|233410|P1|Overall Study|Reason not specified|0
57369|NCT01449461|233405|P6|Overall Study|Clinical progressive disease|3
57370|NCT01449461|233406|P5|Overall Study|Clinical progressive disease|3
57371|NCT01449461|233407|P4|Overall Study|Clinical progressive disease|0
57372|NCT01449461|233408|P3|Overall Study|Clinical progressive disease|0
57373|NCT01449461|233409|P2|Overall Study|Clinical progressive disease|1
57374|NCT01449461|233410|P1|Overall Study|Clinical progressive disease|2
57375|NCT01449461|233405|P6|Overall Study|Documented progressive disease|5
57376|NCT01449461|233406|P5|Overall Study|Documented progressive disease|21
57377|NCT01449461|233407|P4|Overall Study|Documented progressive disease|11
57378|NCT01449461|233408|P3|Overall Study|Documented progressive disease|14
57379|NCT01449461|233409|P2|Overall Study|Documented progressive disease|6
57380|NCT01449461|233410|P1|Overall Study|Documented progressive disease|4
57381|NCT01449461|233405|P6|Overall Study|Death|1
57382|NCT01449461|233406|P5|Overall Study|Death|4
57383|NCT01449461|233407|P4|Overall Study|Death|0
57384|NCT01449461|233408|P3|Overall Study|Death|0
57385|NCT01449461|233409|P2|Overall Study|Death|1
57386|NCT01449461|233410|P1|Overall Study|Death|0
57387|NCT01449461|233405|P6|Overall Study|Adverse Event|3
57388|NCT01449461|233406|P5|Overall Study|Adverse Event|3
57389|NCT01449461|233407|P4|Overall Study|Adverse Event|3
57390|NCT01449461|233408|P3|Overall Study|Adverse Event|2
57391|NCT01449461|233409|P2|Overall Study|Adverse Event|3
57392|NCT01449461|233410|P1|Overall Study|Adverse Event|0
57393|NCT01449461|233405|P6|Overall Study|Ongoing|2
57394|NCT01449461|233406|P5|Overall Study|Ongoing|17
57395|NCT01449461|233407|P4|Overall Study|Ongoing|15
57396|NCT01449461|233408|P3|Overall Study|Ongoing|2
57397|NCT01449461|233409|P2|Overall Study|Ongoing|6
57398|NCT01449461|233410|P1|Overall Study|Ongoing|0
57399|NCT01449370|233547|P25|Overall Study|Death|1
57400|NCT01449370|233548|P24|Overall Study|Death|0
57401|NCT01449370|233549|P23|Overall Study|Death|0
57402|NCT01449370|233550|P22|Overall Study|Death|0
57403|NCT01449370|233551|P21|Overall Study|Death|0
57404|NCT01449370|233552|P20|Overall Study|Death|0
57405|NCT01449370|233553|P19|Overall Study|Death|0
57406|NCT01449370|233554|P18|Overall Study|Death|0
57407|NCT01449370|233555|P17|Overall Study|Death|0
57408|NCT01449370|233556|P16|Overall Study|Death|0
57409|NCT01449370|233557|P15|Overall Study|Death|0
57410|NCT01449370|233558|P14|Overall Study|Death|0
57411|NCT01449370|233559|P13|Overall Study|Death|0
57412|NCT01449370|233560|P12|Overall Study|Death|0
57413|NCT01449370|233561|P11|Overall Study|Death|0
57414|NCT01449370|233562|P10|Overall Study|Death|0
57415|NCT01449370|233563|P9|Overall Study|Death|0
57416|NCT01449370|233564|P8|Overall Study|Death|0
57417|NCT01449370|233565|P7|Overall Study|Death|0
57418|NCT01449370|233566|P6|Overall Study|Death|0
57419|NCT01449370|233567|P5|Overall Study|Death|0
57420|NCT01449370|233568|P4|Overall Study|Death|0
57421|NCT01449370|233569|P3|Overall Study|Death|0
57422|NCT01449370|233570|P2|Overall Study|Death|0
57423|NCT01449370|233571|P1|Overall Study|Death|0
57424|NCT01449370|233547|P25|Overall Study|Medication Prohibited by Protocol|0
57425|NCT01449370|233548|P24|Overall Study|Medication Prohibited by Protocol|1
57426|NCT01449370|233549|P23|Overall Study|Medication Prohibited by Protocol|0
57427|NCT01449370|233550|P22|Overall Study|Medication Prohibited by Protocol|0
57428|NCT01449370|233551|P21|Overall Study|Medication Prohibited by Protocol|0
57429|NCT01449370|233552|P20|Overall Study|Medication Prohibited by Protocol|0
57430|NCT01449370|233553|P19|Overall Study|Medication Prohibited by Protocol|0
57431|NCT01449370|233554|P18|Overall Study|Medication Prohibited by Protocol|0
57432|NCT01449370|233555|P17|Overall Study|Medication Prohibited by Protocol|0
57433|NCT01449370|233556|P16|Overall Study|Medication Prohibited by Protocol|0
57434|NCT01449370|233557|P15|Overall Study|Medication Prohibited by Protocol|0
57435|NCT01449370|233558|P14|Overall Study|Medication Prohibited by Protocol|0
57436|NCT01449370|233559|P13|Overall Study|Medication Prohibited by Protocol|0
57437|NCT01449370|233560|P12|Overall Study|Medication Prohibited by Protocol|0
57438|NCT01449370|233561|P11|Overall Study|Medication Prohibited by Protocol|0
57439|NCT01449370|233562|P10|Overall Study|Medication Prohibited by Protocol|0
57440|NCT01449370|233563|P9|Overall Study|Medication Prohibited by Protocol|0
57441|NCT01449370|233564|P8|Overall Study|Medication Prohibited by Protocol|0
57442|NCT01449370|233565|P7|Overall Study|Medication Prohibited by Protocol|0
57443|NCT01449370|233566|P6|Overall Study|Medication Prohibited by Protocol|0
57444|NCT01449370|233567|P5|Overall Study|Medication Prohibited by Protocol|0
57445|NCT01449370|233568|P4|Overall Study|Medication Prohibited by Protocol|0
57446|NCT01449370|233569|P3|Overall Study|Medication Prohibited by Protocol|0
57447|NCT01449370|233570|P2|Overall Study|Medication Prohibited by Protocol|0
57448|NCT01449370|233571|P1|Overall Study|Medication Prohibited by Protocol|0
57449|NCT01449370|233547|P25|Overall Study|Other|0
57450|NCT01449370|233548|P24|Overall Study|Other|1
57451|NCT01449370|233549|P23|Overall Study|Other|1
57452|NCT01449370|233550|P22|Overall Study|Other|0
57453|NCT01449370|233551|P21|Overall Study|Other|0
57454|NCT01449370|233552|P20|Overall Study|Other|0
57455|NCT01449370|233553|P19|Overall Study|Other|0
57456|NCT01449370|233554|P18|Overall Study|Other|0
57457|NCT01449370|233555|P17|Overall Study|Other|0
57458|NCT01449370|233556|P16|Overall Study|Other|0
57459|NCT01449370|233557|P15|Overall Study|Other|0
57460|NCT01449370|233558|P14|Overall Study|Other|0
57461|NCT01449370|233559|P13|Overall Study|Other|0
57462|NCT01449370|233560|P12|Overall Study|Other|0
57463|NCT01449370|233561|P11|Overall Study|Other|0
57464|NCT01449370|233562|P10|Overall Study|Other|1
57465|NCT01449370|233563|P9|Overall Study|Other|1
57466|NCT01449370|233564|P8|Overall Study|Other|0
57467|NCT01449370|233565|P7|Overall Study|Other|0
57468|NCT01449370|233566|P6|Overall Study|Other|0
57469|NCT01449370|233567|P5|Overall Study|Other|0
57470|NCT01449370|233568|P4|Overall Study|Other|0
57471|NCT01449370|233569|P3|Overall Study|Other|0
57472|NCT01449370|233570|P2|Overall Study|Other|0
57473|NCT01449370|233571|P1|Overall Study|Other|0
57474|NCT01449370|233547|P25|Overall Study|Lost to Follow-up|0
57475|NCT01449370|233548|P24|Overall Study|Lost to Follow-up|0
57476|NCT01449370|233549|P23|Overall Study|Lost to Follow-up|0
57477|NCT01449370|233550|P22|Overall Study|Lost to Follow-up|0
57478|NCT01449370|233551|P21|Overall Study|Lost to Follow-up|1
57479|NCT01449370|233552|P20|Overall Study|Lost to Follow-up|0
57480|NCT01449370|233553|P19|Overall Study|Lost to Follow-up|0
57481|NCT01449370|233554|P18|Overall Study|Lost to Follow-up|0
57482|NCT01449370|233555|P17|Overall Study|Lost to Follow-up|0
57483|NCT01449370|233556|P16|Overall Study|Lost to Follow-up|0
57484|NCT01449370|233557|P15|Overall Study|Lost to Follow-up|0
57485|NCT01449370|233558|P14|Overall Study|Lost to Follow-up|0
57486|NCT01449370|233559|P13|Overall Study|Lost to Follow-up|0
57487|NCT01449370|233560|P12|Overall Study|Lost to Follow-up|0
57488|NCT01449370|233561|P11|Overall Study|Lost to Follow-up|0
57489|NCT01449370|233562|P10|Overall Study|Lost to Follow-up|0
57490|NCT01449370|233563|P9|Overall Study|Lost to Follow-up|0
57491|NCT01449370|233564|P8|Overall Study|Lost to Follow-up|0
57492|NCT01449370|233565|P7|Overall Study|Lost to Follow-up|0
57493|NCT01449370|233566|P6|Overall Study|Lost to Follow-up|0
57494|NCT01449370|233567|P5|Overall Study|Lost to Follow-up|0
57495|NCT01449370|233568|P4|Overall Study|Lost to Follow-up|0
57496|NCT01449370|233569|P3|Overall Study|Lost to Follow-up|0
57497|NCT01449370|233570|P2|Overall Study|Lost to Follow-up|0
57498|NCT01449370|233571|P1|Overall Study|Lost to Follow-up|0
57499|NCT01449370|233547|P25|Overall Study|Participant Decision|1
57500|NCT01449370|233548|P24|Overall Study|Participant Decision|0
57501|NCT01449370|233549|P23|Overall Study|Participant Decision|0
57502|NCT01449370|233550|P22|Overall Study|Participant Decision|1
57503|NCT01449370|233551|P21|Overall Study|Participant Decision|0
57504|NCT01449370|233552|P20|Overall Study|Participant Decision|0
57505|NCT01449370|233553|P19|Overall Study|Participant Decision|1
57506|NCT01449370|233554|P18|Overall Study|Participant Decision|0
57507|NCT01449370|233555|P17|Overall Study|Participant Decision|3
57508|NCT01449370|233556|P16|Overall Study|Participant Decision|1
57509|NCT01449370|233557|P15|Overall Study|Participant Decision|0
57510|NCT01449370|233558|P14|Overall Study|Participant Decision|1
57511|NCT01449370|233559|P13|Overall Study|Participant Decision|1
57512|NCT01449370|233560|P12|Overall Study|Participant Decision|0
57513|NCT01449370|233561|P11|Overall Study|Participant Decision|0
57514|NCT01449370|233562|P10|Overall Study|Participant Decision|0
57515|NCT01449370|233563|P9|Overall Study|Participant Decision|1
57516|NCT01449370|233564|P8|Overall Study|Participant Decision|1
57517|NCT01449370|233565|P7|Overall Study|Participant Decision|0
57518|NCT01449370|233566|P6|Overall Study|Participant Decision|0
57519|NCT01449370|233567|P5|Overall Study|Participant Decision|0
57520|NCT01449370|233568|P4|Overall Study|Participant Decision|0
57521|NCT01449370|233569|P3|Overall Study|Participant Decision|0
57522|NCT01449370|233570|P2|Overall Study|Participant Decision|0
57523|NCT01449370|233571|P1|Overall Study|Participant Decision|0
57524|NCT01449370|233547|P25|Overall Study|Adverse Event|3
57525|NCT01449370|233548|P24|Overall Study|Adverse Event|1
57526|NCT01449370|233549|P23|Overall Study|Adverse Event|0
57527|NCT01449370|233550|P22|Overall Study|Adverse Event|1
57528|NCT01449370|233551|P21|Overall Study|Adverse Event|0
57529|NCT01449370|233552|P20|Overall Study|Adverse Event|1
57530|NCT01449370|233553|P19|Overall Study|Adverse Event|1
57531|NCT01449370|233554|P18|Overall Study|Adverse Event|0
57532|NCT01449370|233555|P17|Overall Study|Adverse Event|0
57533|NCT01449370|233556|P16|Overall Study|Adverse Event|1
57534|NCT01449370|233557|P15|Overall Study|Adverse Event|0
57535|NCT01449370|233558|P14|Overall Study|Adverse Event|2
57536|NCT01449370|233559|P13|Overall Study|Adverse Event|0
57537|NCT01449370|233560|P12|Overall Study|Adverse Event|0
57538|NCT01449370|233561|P11|Overall Study|Adverse Event|0
57539|NCT01449370|233562|P10|Overall Study|Adverse Event|1
57540|NCT01449370|233563|P9|Overall Study|Adverse Event|1
57541|NCT01449370|233564|P8|Overall Study|Adverse Event|0
57542|NCT01449370|233565|P7|Overall Study|Adverse Event|0
57543|NCT01449370|233566|P6|Overall Study|Adverse Event|0
57544|NCT01449370|233567|P5|Overall Study|Adverse Event|0
57545|NCT01449370|233568|P4|Overall Study|Adverse Event|1
57546|NCT01449370|233569|P3|Overall Study|Adverse Event|0
57547|NCT01449370|233570|P2|Overall Study|Adverse Event|2
57548|NCT01449370|233571|P1|Overall Study|Adverse Event|1
57549|NCT01449370|233547|P25|Overall Study|Disease Progression|3
57550|NCT01449370|233548|P24|Overall Study|Disease Progression|7
57551|NCT01449370|233549|P23|Overall Study|Disease Progression|3
57552|NCT01449370|233550|P22|Overall Study|Disease Progression|2
57553|NCT01449370|233551|P21|Overall Study|Disease Progression|5
57554|NCT01449370|233552|P20|Overall Study|Disease Progression|2
57555|NCT01449370|233553|P19|Overall Study|Disease Progression|1
57556|NCT01449370|233554|P18|Overall Study|Disease Progression|3
57557|NCT01449370|233555|P17|Overall Study|Disease Progression|4
57558|NCT01449370|233556|P16|Overall Study|Disease Progression|1
57559|NCT01449370|233557|P15|Overall Study|Disease Progression|3
57560|NCT01449370|233558|P14|Overall Study|Disease Progression|8
57561|NCT01449370|233559|P13|Overall Study|Disease Progression|2
57562|NCT01449370|233560|P12|Overall Study|Disease Progression|3
57563|NCT01449370|233561|P11|Overall Study|Disease Progression|3
57564|NCT01449370|233562|P10|Overall Study|Disease Progression|1
57565|NCT01449370|233563|P9|Overall Study|Disease Progression|9
57566|NCT01449370|233564|P8|Overall Study|Disease Progression|2
57567|NCT01449370|233565|P7|Overall Study|Disease Progression|3
57568|NCT01449370|233566|P6|Overall Study|Disease Progression|3
57569|NCT01449370|233567|P5|Overall Study|Disease Progression|3
57570|NCT01449370|233568|P4|Overall Study|Disease Progression|3
57571|NCT01449370|233569|P3|Overall Study|Disease Progression|8
57572|NCT01449370|233570|P2|Overall Study|Disease Progression|4
57573|NCT01449370|233571|P1|Overall Study|Disease Progression|5
57574|NCT01449279|233949|P1|Overall Study|Toxicity|2
57575|NCT01449279|233949|P1|Overall Study|Lack of Efficacy|5
57576|NCT01449006|233974|P2|Overall Study|Protocol Violation|0
57577|NCT01449006|233975|P1|Overall Study|Protocol Violation|1
57578|NCT01449006|233974|P2|Overall Study|Withdrawal by Subject|0
57579|NCT01449006|233975|P1|Overall Study|Withdrawal by Subject|1
57580|NCT01449006|233974|P2|Overall Study|Lost to Follow-up|0
57581|NCT01449006|233975|P1|Overall Study|Lost to Follow-up|1
57582|NCT01448850|233989|P2|Overall Study|Other|12
57583|NCT01448850|233990|P1|Overall Study|Other|15
57584|NCT01448850|233989|P2|Overall Study|Lost to Follow-up|1
57585|NCT01448850|233990|P1|Overall Study|Lost to Follow-up|3
57586|NCT01448850|233989|P2|Overall Study|Withdrawal by Subject|21
57587|NCT01448850|233990|P1|Overall Study|Withdrawal by Subject|13
57588|NCT01448850|233989|P2|Overall Study|Death|6
57589|NCT01448850|233990|P1|Overall Study|Death|3
57590|NCT01448707|234015|P2|Overall Study|Other|4
57591|NCT01448707|234016|P1|Overall Study|Other|7
57592|NCT01448707|234015|P2|Overall Study|Withdrawal by Subject|7
57593|NCT01448707|234016|P1|Overall Study|Withdrawal by Subject|6
57594|NCT01448707|234015|P2|Overall Study|Lost to Follow-up|6
57595|NCT01448707|234016|P1|Overall Study|Lost to Follow-up|2
57596|NCT01448707|234015|P2|Overall Study|Adverse Event|1
57597|NCT01448707|234016|P1|Overall Study|Adverse Event|3
57598|NCT01448616|234037|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
57599|NCT01448616|234038|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
57600|NCT01448616|234039|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
57601|NCT01448616|234040|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
57602|NCT01448616|234037|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
57603|NCT01448616|234038|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
57604|NCT01448616|234039|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
57605|NCT01448616|234040|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
57606|NCT01448616|234037|P4|Study Drug (Treatment Phase)|Adverse Event|0
57607|NCT01448616|234038|P3|Study Drug (Treatment Phase)|Adverse Event|1
57608|NCT01448616|234039|P2|Study Drug (Treatment Phase)|Adverse Event|1
57609|NCT01448616|234040|P1|Study Drug (Treatment Phase)|Adverse Event|0
57610|NCT01448616|234037|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
57611|NCT01448616|234038|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
57612|NCT01448616|234039|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
57613|NCT01448616|234040|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
57614|NCT01448616|234037|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
57615|NCT01448616|234038|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
57616|NCT01448616|234039|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
57617|NCT01448616|234040|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
57618|NCT01448213|234087|P2|Overall Study|Protocol Violation|2
57619|NCT01448213|234088|P1|Overall Study|Protocol Violation|1
57620|NCT01448213|234087|P2|Overall Study|Adverse Event|10
57621|NCT01448213|234088|P1|Overall Study|Adverse Event|4
57622|NCT01448213|234087|P2|Overall Study|Lost to Follow-up|10
57623|NCT01448213|234088|P1|Overall Study|Lost to Follow-up|12
57624|NCT01448057|234098|P2|Overall Study|Withdrawal by Subject|0
57625|NCT01448057|234099|P1|Overall Study|Withdrawal by Subject|2
57626|NCT01448057|234098|P2|Overall Study|Adverse Event|2
57627|NCT01448057|234099|P1|Overall Study|Adverse Event|0
57628|NCT01448057|234098|P2|Overall Study|Lost to Follow-up|0
57629|NCT01448057|234099|P1|Overall Study|Lost to Follow-up|3
57630|NCT01448057|234098|P2|Overall Study|Protocol Violation|2
57631|NCT01448057|234099|P1|Overall Study|Protocol Violation|3
57632|NCT01448044|234109|P2|Follow Up Period|not specified|11
57633|NCT01448044|234110|P1|Follow Up Period|not specified|5
57634|NCT01448044|234109|P2|Follow Up Period|Lost to Follow-up|2
57635|NCT01448044|234110|P1|Follow Up Period|Lost to Follow-up|6
57636|NCT01448044|234109|P2|Follow Up Period|Withdrawal by Subject|1
57637|NCT01448044|234110|P1|Follow Up Period|Withdrawal by Subject|1
57638|NCT01448044|234109|P2|Treatment Period|Other reason|0
57639|NCT01448044|234110|P1|Treatment Period|Other reason|2
57640|NCT01448044|234109|P2|Treatment Period|Lost to Follow-up|1
57641|NCT01448044|234110|P1|Treatment Period|Lost to Follow-up|2
57642|NCT01448044|234109|P2|Treatment Period|Participant does not meet study criteria|0
57643|NCT01448044|234110|P1|Treatment Period|Participant does not meet study criteria|1
57644|NCT01448044|234109|P2|Treatment Period|Completed 24 weeks treatment period only|0
57645|NCT01448044|234110|P1|Treatment Period|Completed 24 weeks treatment period only|8
57646|NCT01448044|234109|P2|Treatment Period|Subject requested discontinue study drug|0
57647|NCT01448044|234110|P1|Treatment Period|Subject requested discontinue study drug|1
57648|NCT01448044|234109|P2|Treatment Period|Lack of Efficacy|12
57649|NCT01448044|234110|P1|Treatment Period|Lack of Efficacy|5
57650|NCT01448044|234109|P2|Treatment Period|Adverse Event|3
57651|NCT01448044|234110|P1|Treatment Period|Adverse Event|4
57652|NCT01447927|234126|P2|Overall Study|Withdrawal by Subject|0
57653|NCT01447927|234127|P1|Overall Study|Withdrawal by Subject|1
57654|NCT01447927|234126|P2|Overall Study|Adverse Event|3
57655|NCT01447927|234127|P1|Overall Study|Adverse Event|4
57656|NCT01447719|234157|P1|Overall Study|Family withdrew autopsy consent|7
57657|NCT01447719|234157|P1|Overall Study|Withdrawal by Subject|2
57658|NCT01447719|234157|P1|Overall Study|Subject still living at end of study|79
57659|NCT01447719|234157|P1|Overall Study|Invalid image or not imaged|3
57660|NCT01447719|234157|P1|Overall Study|Image acquisition failure|2
57661|NCT01447576|234183|P1|Overall Study|Physician Decision|6
57662|NCT01447576|234183|P1|Overall Study|Lack of Efficacy|68
57663|NCT01447576|234183|P1|Overall Study|Protocol deviation|83
57664|NCT01447576|234183|P1|Overall Study|Withdrawal by Subject|100
57665|NCT01447576|234183|P1|Overall Study|Participant met withdrawal criteria|40
57666|NCT01447576|234183|P1|Overall Study|Adverse Event|127
57667|NCT01447576|234183|P1|Overall Study|Lost to Follow-up|52
57668|NCT01447446|234216|P6|Overall Study|Reason not Specified|0
57669|NCT01447446|234217|P5|Overall Study|Reason not Specified|1
57670|NCT01447446|234218|P4|Overall Study|Reason not Specified|1
57671|NCT01447446|234219|P3|Overall Study|Reason not Specified|1
57672|NCT01447446|234220|P2|Overall Study|Reason not Specified|1
57673|NCT01447446|234221|P1|Overall Study|Reason not Specified|1
57674|NCT01447446|234216|P6|Overall Study|New Treatment Started|0
57675|NCT01447446|234217|P5|Overall Study|New Treatment Started|2
57676|NCT01447446|234218|P4|Overall Study|New Treatment Started|0
57677|NCT01447446|234219|P3|Overall Study|New Treatment Started|1
57678|NCT01447446|234220|P2|Overall Study|New Treatment Started|2
57679|NCT01447446|234221|P1|Overall Study|New Treatment Started|8
57680|NCT01447446|234216|P6|Overall Study|SVR12 Assessment|5
57681|NCT01447446|234217|P5|Overall Study|SVR12 Assessment|5
57682|NCT01447446|234218|P4|Overall Study|SVR12 Assessment|1
57683|NCT01447446|234219|P3|Overall Study|SVR12 Assessment|2
57684|NCT01447446|234220|P2|Overall Study|SVR12 Assessment|1
57685|NCT01447446|234221|P1|Overall Study|SVR12 Assessment|13
57686|NCT01447446|234216|P6|Overall Study|Administrative/Other|4
57687|NCT01447446|234217|P5|Overall Study|Administrative/Other|33
57688|NCT01447446|234218|P4|Overall Study|Administrative/Other|2
57689|NCT01447446|234219|P3|Overall Study|Administrative/Other|10
57690|NCT01447446|234220|P2|Overall Study|Administrative/Other|9
57691|NCT01447446|234221|P1|Overall Study|Administrative/Other|34
57692|NCT01447446|234216|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
57693|NCT01447446|234217|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
57694|NCT01447446|234218|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
57695|NCT01447446|234219|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
57696|NCT01447446|234220|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
57697|NCT01447446|234221|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
57698|NCT01447446|234216|P6|Overall Study|Failure to Return/Consent Withdrawn|9
57699|NCT01447446|234217|P5|Overall Study|Failure to Return/Consent Withdrawn|69
57700|NCT01447446|234218|P4|Overall Study|Failure to Return/Consent Withdrawn|7
57701|NCT01447446|234219|P3|Overall Study|Failure to Return/Consent Withdrawn|31
57702|NCT01447446|234220|P2|Overall Study|Failure to Return/Consent Withdrawn|78
57703|NCT01447446|234221|P1|Overall Study|Failure to Return/Consent Withdrawn|357
57704|NCT01447446|234216|P6|Overall Study|Adverse Event|0
57705|NCT01447446|234217|P5|Overall Study|Adverse Event|2
57706|NCT01447446|234218|P4|Overall Study|Adverse Event|0
57707|NCT01447446|234219|P3|Overall Study|Adverse Event|1
57708|NCT01447446|234220|P2|Overall Study|Adverse Event|0
57709|NCT01447446|234221|P1|Overall Study|Adverse Event|3
57710|NCT01447446|234216|P6|Overall Study|Death|0
57711|NCT01447446|234217|P5|Overall Study|Death|7
57712|NCT01447446|234218|P4|Overall Study|Death|1
57713|NCT01447446|234219|P3|Overall Study|Death|2
57714|NCT01447446|234220|P2|Overall Study|Death|3
57715|NCT01447446|234221|P1|Overall Study|Death|6
57716|NCT01447433|234311|P2|Overall Study|Protocol Violation|1
57717|NCT01447433|234312|P1|Overall Study|Protocol Violation|1
57718|NCT01447433|234311|P2|Overall Study|Withdrawal by Subject|3
57719|NCT01447433|234312|P1|Overall Study|Withdrawal by Subject|3
57720|NCT01447433|234311|P2|Overall Study|Lost to Follow-up|2
57721|NCT01447433|234312|P1|Overall Study|Lost to Follow-up|0
57722|NCT01447420|234339|P3|Overall Study|Lack of Efficacy|8
57723|NCT01447420|234340|P2|Overall Study|Lack of Efficacy|19
57724|NCT01447420|234341|P1|Overall Study|Lack of Efficacy|1
57725|NCT01447420|234339|P3|Overall Study|Withdrawal by Subject|0
57726|NCT01447420|234340|P2|Overall Study|Withdrawal by Subject|1
57727|NCT01447420|234341|P1|Overall Study|Withdrawal by Subject|4
57728|NCT01447420|234339|P3|Overall Study|Protocol Violation|0
57729|NCT01447420|234340|P2|Overall Study|Protocol Violation|3
57730|NCT01447420|234341|P1|Overall Study|Protocol Violation|3
57731|NCT01447420|234339|P3|Overall Study|Adverse Event|2
57732|NCT01447420|234340|P2|Overall Study|Adverse Event|4
57733|NCT01447420|234341|P1|Overall Study|Adverse Event|2
57734|NCT01446796|234454|P2|Overall Study|Withdrawal by Subject|0
57735|NCT01446796|234455|P1|Overall Study|Withdrawal by Subject|1
57736|NCT01446419|234480|P2|Overall Study|Terminated per protocol|0
57737|NCT01446419|234481|P1|Overall Study|Terminated per protocol|3
57738|NCT01446419|234480|P2|Overall Study|Withdrawal by Subject|1
57739|NCT01446419|234481|P1|Overall Study|Withdrawal by Subject|1
57740|NCT01446419|234480|P2|Overall Study|Death|0
57741|NCT01446419|234481|P1|Overall Study|Death|1
57742|NCT01446289|234495|P4|Overall Study|Withdrawal by Subject|0
57743|NCT01446289|234496|P3|Overall Study|Withdrawal by Subject|1
57744|NCT01446289|234497|P2|Overall Study|Withdrawal by Subject|0
57745|NCT01446289|234498|P1|Overall Study|Withdrawal by Subject|1
57746|NCT01446237|234541|P1|Overall Study|Withdrawal by Subject|7
57747|NCT01446237|234541|P1|Overall Study|Lost to Follow-up|2
57748|NCT01446237|234541|P1|Overall Study|Adverse Event|1
57749|NCT01446003|234549|P2|Period 2|Adverse Event|0
57750|NCT01446003|234550|P1|Period 2|Adverse Event|1
57751|NCT01446003|234549|P2|Period 1|Protocol Violation|0
57752|NCT01446003|234550|P1|Period 1|Protocol Violation|2
57753|NCT01445951|234571|P3|Overall Study|Cough|0
57754|NCT01445951|234572|P2|Overall Study|Cough|1
57755|NCT01445951|234573|P1|Overall Study|Cough|0
57756|NCT01445951|234571|P3|Overall Study|Sponsor decision - subject travel|0
57757|NCT01445951|234572|P2|Overall Study|Sponsor decision - subject travel|1
57758|NCT01445951|234573|P1|Overall Study|Sponsor decision - subject travel|0
57759|NCT01445951|234571|P3|Overall Study|Non-compliance with protocol|0
57760|NCT01445951|234572|P2|Overall Study|Non-compliance with protocol|1
57761|NCT01445951|234573|P1|Overall Study|Non-compliance with protocol|0
57762|NCT01445951|234571|P3|Overall Study|Non-compliance with study drug|0
57763|NCT01445951|234572|P2|Overall Study|Non-compliance with study drug|2
57764|NCT01445951|234573|P1|Overall Study|Non-compliance with study drug|1
57765|NCT01445951|234571|P3|Overall Study|Death|1
57766|NCT01445951|234572|P2|Overall Study|Death|0
57767|NCT01445951|234573|P1|Overall Study|Death|0
57768|NCT01445951|234571|P3|Overall Study|Pregnancy|4
57769|NCT01445951|234572|P2|Overall Study|Pregnancy|1
57770|NCT01445951|234573|P1|Overall Study|Pregnancy|0
57771|NCT01445951|234571|P3|Overall Study|Lost to Follow-up|4
57772|NCT01445951|234572|P2|Overall Study|Lost to Follow-up|2
57773|NCT01445951|234573|P1|Overall Study|Lost to Follow-up|1
57774|NCT01445951|234571|P3|Overall Study|Physician Decision|0
57775|NCT01445951|234572|P2|Overall Study|Physician Decision|1
57776|NCT01445951|234573|P1|Overall Study|Physician Decision|3
57777|NCT01445951|234571|P3|Overall Study|Withdrawal by Subject|8
57778|NCT01445951|234572|P2|Overall Study|Withdrawal by Subject|16
57779|NCT01445951|234573|P1|Overall Study|Withdrawal by Subject|21
57780|NCT01445951|234571|P3|Overall Study|Protocol Violation|2
57781|NCT01445951|234572|P2|Overall Study|Protocol Violation|2
57782|NCT01445951|234573|P1|Overall Study|Protocol Violation|2
57783|NCT01445951|234571|P3|Overall Study|Adverse Event|0
57784|NCT01445951|234572|P2|Overall Study|Adverse Event|9
57785|NCT01445951|234573|P1|Overall Study|Adverse Event|16
57786|NCT01445847|234641|P2|Overall Study|Missed Data|0
57787|NCT01445847|234642|P1|Overall Study|Missed Data|1
57788|NCT01445847|234641|P2|Overall Study|Protocol Violation|14
57789|NCT01445847|234642|P1|Overall Study|Protocol Violation|13
57790|NCT01445769|234648|P1|Overall Study|Lost to Follow-up|5
57791|NCT01445769|234648|P1|Overall Study|Disease Progression|1
57792|NCT01445769|234648|P1|Overall Study|Consent Withdrawn|2
57793|NCT01445678|234668|P2|Overall Study|Withdrawal by Subject|5
57794|NCT01445678|234669|P1|Overall Study|Withdrawal by Subject|9
57795|NCT01445678|234668|P2|Overall Study|Protocol Violation|1
57796|NCT01445678|234669|P1|Overall Study|Protocol Violation|1
57797|NCT01445678|234668|P2|Overall Study|Lost to Follow-up|5
57798|NCT01445678|234669|P1|Overall Study|Lost to Follow-up|8
57799|NCT01445678|234668|P2|Overall Study|Lack of Efficacy|2
57800|NCT01445678|234669|P1|Overall Study|Lack of Efficacy|0
57801|NCT01445678|234668|P2|Overall Study|Adverse Event|8
57802|NCT01445678|234669|P1|Overall Study|Adverse Event|12
57803|NCT01445652|234687|P2|Overall Study|Adverse Event|0
57804|NCT01445652|234688|P1|Overall Study|Adverse Event|1
57805|NCT01445652|234687|P2|Overall Study|Failed teach session|0
57806|NCT01445652|234688|P1|Overall Study|Failed teach session|2
57807|NCT01445652|234687|P2|Overall Study|Failed to attend scheduled visit|3
57808|NCT01445652|234688|P1|Overall Study|Failed to attend scheduled visit|2
57809|NCT01445652|234687|P2|Overall Study|Not comfortable in lenses|0
57810|NCT01445652|234688|P1|Overall Study|Not comfortable in lenses|5
57811|NCT01445613|234706|P1|1-year Follow-up|Received a non-study stent|2
57812|NCT01445613|234706|P1|1-year Follow-up|Physician Decision|2
57813|NCT01445613|234706|P1|1-year Follow-up|Death|30
57814|NCT01445613|234706|P1|1-year Follow-up|Lost to Follow-up|2
57815|NCT01445613|234706|P1|1-year Follow-up|Missed visit|29
57816|NCT01445613|234706|P1|1-year Follow-up|Withdrawal by Subject|12
57817|NCT01445613|234706|P1|30-day Follow-up|Death|3
57818|NCT01445613|234706|P1|30-day Follow-up|Missed visit|23
57819|NCT01445613|234706|P1|30-day Follow-up|Physician Decision|3
57820|NCT01445613|234706|P1|30-day Follow-up|Withdrawal by Subject|6
57821|NCT01445548|234724|P1|Overall Study|Adverse Event|1
57822|NCT01445301|234748|P3|Overall Study|Withdrawal by Subject|4
57823|NCT01445301|234749|P2|Overall Study|Withdrawal by Subject|6
57824|NCT01445301|234750|P1|Overall Study|Withdrawal by Subject|5
57825|NCT01445301|234748|P3|Overall Study|Physician Decision|0
57826|NCT01445301|234749|P2|Overall Study|Physician Decision|2
57827|NCT01445301|234750|P1|Overall Study|Physician Decision|0
57828|NCT01445301|234748|P3|Overall Study|Protocol-Defined Stopping Criteria|1
57829|NCT01445301|234749|P2|Overall Study|Protocol-Defined Stopping Criteria|1
57830|NCT01445301|234750|P1|Overall Study|Protocol-Defined Stopping Criteria|0
57831|NCT01445301|234748|P3|Overall Study|Protocol Violation|0
57832|NCT01445301|234749|P2|Overall Study|Protocol Violation|0
57833|NCT01445301|234750|P1|Overall Study|Protocol Violation|1
57834|NCT01445301|234748|P3|Overall Study|Lack of Efficacy|0
57835|NCT01445301|234749|P2|Overall Study|Lack of Efficacy|1
57836|NCT01445301|234750|P1|Overall Study|Lack of Efficacy|0
57837|NCT01445301|234748|P3|Overall Study|Adverse Event|4
57838|NCT01445301|234749|P2|Overall Study|Adverse Event|25
57839|NCT01445301|234750|P1|Overall Study|Adverse Event|15
57840|NCT01444898|234820|P1|Overall Study|Withdrawal by Subject|1
57841|NCT01444781|234835|P3|Overall Study|Withdrawal by Subject|2
57842|NCT01444781|234836|P2|Overall Study|Withdrawal by Subject|1
57843|NCT01444781|234837|P1|Overall Study|Withdrawal by Subject|3
57844|NCT01444781|234835|P3|Overall Study|Lost to Follow-up|1
57845|NCT01444781|234836|P2|Overall Study|Lost to Follow-up|3
57846|NCT01444781|234837|P1|Overall Study|Lost to Follow-up|0
57847|NCT01444742|234875|P1|Overall Study|Death|1
57848|NCT01444651|234882|P2|Overall Study|Missing data|1
57849|NCT01444651|234883|P1|Overall Study|Missing data|1
57850|NCT01444651|234882|P2|Overall Study|Non-fasting|1
57851|NCT01444651|234883|P1|Overall Study|Non-fasting|2
57852|NCT01444651|234882|P2|Overall Study|Lost to Follow-up|5
57853|NCT01444651|234883|P1|Overall Study|Lost to Follow-up|5
57854|NCT01444651|234882|P2|Overall Study|Adverse Event|2
57855|NCT01444651|234883|P1|Overall Study|Adverse Event|3
57856|NCT01444456|234899|P1|Overall Study|Not treated|104
57857|NCT01444456|234899|P1|Overall Study|Other|18
57858|NCT01444456|234899|P1|Overall Study|Ineligibility determined|23
57859|NCT01444456|234899|P1|Overall Study|Death|73
57860|NCT01444456|234899|P1|Overall Study|Lost to Follow-up|37
57861|NCT01444456|234899|P1|Overall Study|Physician Decision|9
57862|NCT01444456|234899|P1|Overall Study|Withdrawal by Subject|21
57863|NCT01444430|234910|P2|Overall Study|CRF termination module not completed.|1
57864|NCT01444430|234911|P1|Overall Study|CRF termination module not completed.|0
57865|NCT01444430|234910|P2|Overall Study|Lost to Follow-up|0
57866|NCT01444430|234911|P1|Overall Study|Lost to Follow-up|2
57867|NCT01444430|234910|P2|Overall Study|Death|8
57868|NCT01444430|234911|P1|Overall Study|Death|6
57869|NCT01444430|234910|P2|Overall Study|Withdrawal by Subject|72
57870|NCT01444430|234911|P1|Overall Study|Withdrawal by Subject|53
57871|NCT01444417|234933|P2|Overall Study|Withdrawal by Subject|0
57872|NCT01444417|234934|P1|Overall Study|Withdrawal by Subject|2
57873|NCT01444417|234933|P2|Overall Study|Ineligibility Determined|1
57874|NCT01444417|234934|P1|Overall Study|Ineligibility Determined|0
57875|NCT01444391|234950|P1|Overall Study|Death|1
57876|NCT01444378|234958|P1|Overall Study|Missed Visits|10
57877|NCT01444378|234958|P1|Overall Study|Administrative Closure Of The Study|2
57878|NCT01444378|234958|P1|Overall Study|Death|3
57879|NCT01444378|234958|P1|Overall Study|Withdrawal by Subject|1
57880|NCT01444378|234958|P1|Overall Study|Lost to Follow-up|1
57881|NCT01444300|235070|P2|Overall Study|Adverse Event|0
57882|NCT01444300|235071|P1|Overall Study|Adverse Event|4
57883|NCT01444092|235103|P1|Overall Study|Other Eligibility criteria|7
57884|NCT01444092|235103|P1|Overall Study|Withdrawal by Subject|1
57885|NCT01444092|235103|P1|Overall Study|Protocol Violation|1
57886|NCT01444092|235103|P1|Overall Study|Adverse Event|8
57887|NCT01444027|235112|P3|Overall Study|Lost to Follow-up|14
57888|NCT01444027|235113|P2|Overall Study|Lost to Follow-up|20
57889|NCT01444027|235114|P1|Overall Study|Lost to Follow-up|26
57890|NCT01444027|235112|P3|Overall Study|Withdrawal by Subject|24
57891|NCT01444027|235113|P2|Overall Study|Withdrawal by Subject|10
57892|NCT01444027|235114|P1|Overall Study|Withdrawal by Subject|4
57893|NCT01443923|235136|P2|Overall Study|Adverse Event|0
57894|NCT01443923|235137|P1|Overall Study|Adverse Event|1
57895|NCT01443858|235154|P3|Overall Study|Lost to Follow-up|2
57896|NCT01443858|235155|P2|Overall Study|Lost to Follow-up|5
57897|NCT01443858|235156|P1|Overall Study|Lost to Follow-up|5
57898|NCT01443858|235154|P3|Overall Study|Lack of Efficacy|0
57899|NCT01443858|235155|P2|Overall Study|Lack of Efficacy|0
57900|NCT01443858|235156|P1|Overall Study|Lack of Efficacy|1
57901|NCT01443858|235154|P3|Overall Study|Withdrawal by Subject|5
57902|NCT01443858|235155|P2|Overall Study|Withdrawal by Subject|8
57903|NCT01443858|235156|P1|Overall Study|Withdrawal by Subject|9
57904|NCT01443845|235178|P2|Overall Study|Lost to Follow-up|13
57905|NCT01443845|235179|P1|Overall Study|Lost to Follow-up|9
57906|NCT01443845|235178|P2|Overall Study|Military Conflict - Site Terminated|21
57907|NCT01443845|235179|P1|Overall Study|Military Conflict - Site Terminated|20
57908|NCT01443845|235178|P2|Overall Study|Withdrawal by Subject|67
57909|NCT01443845|235179|P1|Overall Study|Withdrawal by Subject|63
57910|NCT01443845|235178|P2|Overall Study|Adverse Event|138
57911|NCT01443845|235179|P1|Overall Study|Adverse Event|64
57912|NCT01443845|235178|P2|Overall Study|Lack of Efficacy|5
57913|NCT01443845|235179|P1|Overall Study|Lack of Efficacy|10
57914|NCT01443845|235178|P2|Overall Study|Deterioration in pulmonary function|4
57915|NCT01443845|235179|P1|Overall Study|Deterioration in pulmonary function|1
57916|NCT01443845|235178|P2|Overall Study|Other reasons, such as COPD exacerbation|44
57917|NCT01443845|235179|P1|Overall Study|Other reasons, such as COPD exacerbation|44
57918|NCT01443845|235178|P2|Overall Study|Protocol Violation|45
57919|NCT01443845|235179|P1|Overall Study|Protocol Violation|43
57920|NCT01443403|235200|P4|Overall Study|Other - Miscellaneous|1
57921|NCT01443403|235201|P3|Overall Study|Other - Miscellaneous|0
57922|NCT01443403|235202|P2|Overall Study|Other - Miscellaneous|0
57923|NCT01443403|235203|P1|Overall Study|Other - Miscellaneous|1
57924|NCT01443403|235200|P4|Overall Study|Use of Prohibited Treatment|0
57925|NCT01443403|235201|P3|Overall Study|Use of Prohibited Treatment|0
57926|NCT01443403|235202|P2|Overall Study|Use of Prohibited Treatment|3
57927|NCT01443403|235203|P1|Overall Study|Use of Prohibited Treatment|2
57928|NCT01443403|235200|P4|Overall Study|Protocol Violation|1
57929|NCT01443403|235201|P3|Overall Study|Protocol Violation|1
57930|NCT01443403|235202|P2|Overall Study|Protocol Violation|1
57931|NCT01443403|235203|P1|Overall Study|Protocol Violation|2
57932|NCT01443403|235200|P4|Overall Study|Lost to Follow-up|1
57933|NCT01443403|235201|P3|Overall Study|Lost to Follow-up|0
57934|NCT01443403|235202|P2|Overall Study|Lost to Follow-up|0
57935|NCT01443403|235203|P1|Overall Study|Lost to Follow-up|0
57936|NCT01443403|235200|P4|Overall Study|Withdrawal by Subject|1
57937|NCT01443403|235201|P3|Overall Study|Withdrawal by Subject|2
57938|NCT01443403|235202|P2|Overall Study|Withdrawal by Subject|1
57939|NCT01443403|235203|P1|Overall Study|Withdrawal by Subject|0
57940|NCT01443403|235200|P4|Overall Study|Adverse Event|5
57941|NCT01443403|235201|P3|Overall Study|Adverse Event|4
57942|NCT01443403|235202|P2|Overall Study|Adverse Event|1
57943|NCT01443403|235203|P1|Overall Study|Adverse Event|1
57944|NCT01443364|235350|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
57945|NCT01443364|235350|P1|Overall Study|AE, non-serious non-fatal|8
57946|NCT01443364|235350|P1|Overall Study|SAE, non-fatal|6
57947|NCT01443364|235350|P1|Overall Study|Other Reason|4
57948|NCT01443364|235350|P1|Overall Study|Withdrawal by Subject|5
57949|NCT01443364|235350|P1|Overall Study|Lost to Follow-up|3
57950|NCT01443364|235350|P1|Overall Study|Lack of Efficacy|14
57951|NCT01443130|235479|P6|Overall Study|Death of Subject's Infant|0
57952|NCT01443130|235480|P5|Overall Study|Death of Subject's Infant|0
57953|NCT01443130|235481|P4|Overall Study|Death of Subject's Infant|0
57954|NCT01443130|235482|P3|Overall Study|Death of Subject's Infant|11
57955|NCT01443130|235483|P2|Overall Study|Death of Subject's Infant|10
57956|NCT01443130|235484|P1|Overall Study|Death of Subject's Infant|5
57957|NCT01443130|235479|P6|Overall Study|Withdrawal by Subject|2
57958|NCT01443130|235480|P5|Overall Study|Withdrawal by Subject|7
57959|NCT01443130|235481|P4|Overall Study|Withdrawal by Subject|7
57960|NCT01443130|235482|P3|Overall Study|Withdrawal by Subject|12
57961|NCT01443130|235483|P2|Overall Study|Withdrawal by Subject|14
57962|NCT01443130|235484|P1|Overall Study|Withdrawal by Subject|15
57963|NCT01443130|235479|P6|Overall Study|Protocol Violation|3
57964|NCT01443130|235480|P5|Overall Study|Protocol Violation|2
57965|NCT01443130|235481|P4|Overall Study|Protocol Violation|2
57966|NCT01443130|235482|P3|Overall Study|Protocol Violation|3
57967|NCT01443130|235483|P2|Overall Study|Protocol Violation|1
57968|NCT01443130|235484|P1|Overall Study|Protocol Violation|2
57969|NCT01443130|235479|P6|Overall Study|Adverse Event|0
57970|NCT01443130|235480|P5|Overall Study|Adverse Event|0
57971|NCT01443130|235481|P4|Overall Study|Adverse Event|0
57972|NCT01443130|235482|P3|Overall Study|Adverse Event|1
57973|NCT01443130|235483|P2|Overall Study|Adverse Event|1
57974|NCT01443130|235484|P1|Overall Study|Adverse Event|2
57975|NCT01443130|235479|P6|Overall Study|Death|8
57976|NCT01443130|235480|P5|Overall Study|Death|10
57977|NCT01443130|235481|P4|Overall Study|Death|7
57978|NCT01443130|235482|P3|Overall Study|Death|0
57979|NCT01443130|235483|P2|Overall Study|Death|1
57980|NCT01443130|235484|P1|Overall Study|Death|0
57981|NCT01443130|235479|P6|Overall Study|Lost to Follow-up|21
57982|NCT01443130|235480|P5|Overall Study|Lost to Follow-up|25
57983|NCT01443130|235481|P4|Overall Study|Lost to Follow-up|23
57984|NCT01443130|235482|P3|Overall Study|Lost to Follow-up|50
57985|NCT01443130|235483|P2|Overall Study|Lost to Follow-up|42
57986|NCT01443130|235484|P1|Overall Study|Lost to Follow-up|44
57987|NCT01443078|235534|P1|Overall Study|Patient had brain mets|1
57988|NCT01443078|235534|P1|Overall Study|Withdrawal by Subject|1
57989|NCT01443078|235534|P1|Overall Study|Responded to neoadjuvant platinum txt|27
57990|NCT01443026|235540|P2|Overall Study|Lost to Follow-up|1
57991|NCT01443026|235541|P1|Overall Study|Lost to Follow-up|2
57992|NCT01443026|235540|P2|Overall Study|Withdrawal by Subject|3
57993|NCT01443026|235541|P1|Overall Study|Withdrawal by Subject|0
57994|NCT01443026|235540|P2|Overall Study|Death|1
57995|NCT01443026|235541|P1|Overall Study|Death|0
57996|NCT01443026|235540|P2|Overall Study|Physician Decision|0
57997|NCT01443026|235541|P1|Overall Study|Physician Decision|1
57998|NCT01442779|235556|P1|Overall Study|Non-compliance|1
57999|NCT01442779|235556|P1|Overall Study|Death|3
58000|NCT01442779|235556|P1|Overall Study|Withdrawal by Subject|3
58001|NCT01442714|235562|P1|Overall Study|Withdrawal by Subject|1
58002|NCT01442714|235562|P1|Overall Study|Death|11
58003|NCT01442688|235570|P2|Second Intervention|Adverse Event|0
58004|NCT01442688|235571|P1|Second Intervention|Adverse Event|1
58005|NCT01442688|235570|P2|First Intervention|subject incarcerated|0
58006|NCT01442688|235571|P1|First Intervention|subject incarcerated|1
58007|NCT01442688|235570|P2|First Intervention|Withdrawal by Subject|0
58008|NCT01442688|235571|P1|First Intervention|Withdrawal by Subject|1
58009|NCT01442675|235579|P1|Overall Study|Withdrawal by Subject|4
58010|NCT01442675|235579|P1|Overall Study|Lost to Follow-up|2
58011|NCT01442675|235579|P1|Overall Study|Protocol Violation|6
58012|NCT01442493|235591|P2|Overall Study|withdrawn from study|2
58013|NCT01442493|235592|P1|Overall Study|withdrawn from study|3
58014|NCT01442376|235613|P3|Overall Study|Not eligible for subsequent cycles|0
58015|NCT01442376|235614|P2|Overall Study|Not eligible for subsequent cycles|2
58016|NCT01442376|235615|P1|Overall Study|Not eligible for subsequent cycles|1
58017|NCT01442376|235613|P3|Overall Study|Patients not treated|1
58018|NCT01442376|235614|P2|Overall Study|Patients not treated|3
58019|NCT01442376|235615|P1|Overall Study|Patients not treated|2
58020|NCT01442376|235613|P3|Overall Study|Withdrawal of consent|1
58021|NCT01442376|235614|P2|Overall Study|Withdrawal of consent|0
58022|NCT01442376|235615|P1|Overall Study|Withdrawal of consent|0
58023|NCT01442376|235613|P3|Overall Study|Death|1
58024|NCT01442376|235614|P2|Overall Study|Death|1
58025|NCT01442376|235615|P1|Overall Study|Death|0
58026|NCT01442376|235613|P3|Overall Study|Adverse Event|2
58027|NCT01442376|235614|P2|Overall Study|Adverse Event|3
58028|NCT01442376|235615|P1|Overall Study|Adverse Event|0
58029|NCT01442181|235628|P2|Overall Study|atrial fibrillation not noted|1
58030|NCT01442181|235629|P1|Overall Study|atrial fibrillation not noted|0
58031|NCT01442181|235628|P2|Overall Study|patient in an additional study|0
58032|NCT01442181|235629|P1|Overall Study|patient in an additional study|1
58033|NCT01442181|235628|P2|Overall Study|Lost to Follow-up|1
58034|NCT01442181|235629|P1|Overall Study|Lost to Follow-up|1
58035|NCT01442181|235628|P2|Overall Study|low ejection factor|1
58036|NCT01442181|235629|P1|Overall Study|low ejection factor|0
58037|NCT01442181|235628|P2|Overall Study|no insurance for surgery|0
58038|NCT01442181|235629|P1|Overall Study|no insurance for surgery|1
58039|NCT01442181|235628|P2|Overall Study|patient refused surgery|0
58040|NCT01442181|235629|P1|Overall Study|patient refused surgery|1
58041|NCT01442155|235653|P1|Overall Study|Lost to Follow-up|2
58042|NCT01442155|235653|P1|Overall Study|Adverse Event|2
58043|NCT01442155|235653|P1|Overall Study|Recurrence|26
58044|NCT01442155|235653|P1|Overall Study|Complete remission|35
58045|NCT01442103|235669|P1|Overall Study|Lost to Follow-up|2
58046|NCT01442064|235679|P6|Overall Study|Condition mandated other intervention|2
58047|NCT01442064|235680|P5|Overall Study|Condition mandated other intervention|0
58048|NCT01442064|235681|P4|Overall Study|Condition mandated other intervention|0
58049|NCT01442064|235682|P3|Overall Study|Condition mandated other intervention|2
58050|NCT01442064|235683|P2|Overall Study|Condition mandated other intervention|1
58051|NCT01442064|235684|P1|Overall Study|Condition mandated other intervention|1
58052|NCT01442064|235679|P6|Overall Study|Subject non-compliance|2
58053|NCT01442064|235680|P5|Overall Study|Subject non-compliance|0
58054|NCT01442064|235681|P4|Overall Study|Subject non-compliance|0
58055|NCT01442064|235682|P3|Overall Study|Subject non-compliance|0
58056|NCT01442064|235683|P2|Overall Study|Subject non-compliance|0
58057|NCT01442064|235684|P1|Overall Study|Subject non-compliance|0
58058|NCT01442064|235679|P6|Overall Study|Sponsor decision|87
58059|NCT01442064|235680|P5|Overall Study|Sponsor decision|95
58060|NCT01442064|235681|P4|Overall Study|Sponsor decision|88
58061|NCT01442064|235682|P3|Overall Study|Sponsor decision|92
58062|NCT01442064|235683|P2|Overall Study|Sponsor decision|88
58063|NCT01442064|235684|P1|Overall Study|Sponsor decision|82
58064|NCT01442064|235679|P6|Overall Study|Withdrawal by Subject|1
58065|NCT01442064|235680|P5|Overall Study|Withdrawal by Subject|2
58066|NCT01442064|235681|P4|Overall Study|Withdrawal by Subject|2
58067|NCT01442064|235682|P3|Overall Study|Withdrawal by Subject|2
58068|NCT01442064|235683|P2|Overall Study|Withdrawal by Subject|3
58069|NCT01442064|235684|P1|Overall Study|Withdrawal by Subject|6
58070|NCT01442064|235679|P6|Overall Study|Physician Decision|1
58071|NCT01442064|235680|P5|Overall Study|Physician Decision|3
58072|NCT01442064|235681|P4|Overall Study|Physician Decision|3
58073|NCT01442064|235682|P3|Overall Study|Physician Decision|2
58074|NCT01442064|235683|P2|Overall Study|Physician Decision|1
58075|NCT01442064|235684|P1|Overall Study|Physician Decision|1
58076|NCT01442064|235679|P6|Overall Study|Lost to Follow-up|3
58077|NCT01442064|235680|P5|Overall Study|Lost to Follow-up|3
58078|NCT01442064|235681|P4|Overall Study|Lost to Follow-up|1
58079|NCT01442064|235682|P3|Overall Study|Lost to Follow-up|1
58080|NCT01442064|235683|P2|Overall Study|Lost to Follow-up|5
58081|NCT01442064|235684|P1|Overall Study|Lost to Follow-up|5
58082|NCT01442064|235679|P6|Overall Study|Death|3
58083|NCT01442064|235680|P5|Overall Study|Death|1
58084|NCT01442064|235681|P4|Overall Study|Death|3
58085|NCT01442064|235682|P3|Overall Study|Death|3
58086|NCT01442064|235683|P2|Overall Study|Death|1
58087|NCT01442064|235684|P1|Overall Study|Death|0
58088|NCT01442064|235679|P6|Overall Study|Adverse Event|0
58089|NCT01442064|235680|P5|Overall Study|Adverse Event|2
58090|NCT01442064|235681|P4|Overall Study|Adverse Event|1
58091|NCT01442064|235682|P3|Overall Study|Adverse Event|2
58092|NCT01442064|235683|P2|Overall Study|Adverse Event|2
58093|NCT01442064|235684|P1|Overall Study|Adverse Event|2
58094|NCT01442038|235721|P2|Overall Study|Study Terminated By Sponsor|3
58095|NCT01442038|235722|P1|Overall Study|Study Terminated By Sponsor|2
58096|NCT01442038|235721|P2|Overall Study|Investigator's Discretion|16
58097|NCT01442038|235722|P1|Overall Study|Investigator's Discretion|13
58098|NCT01442038|235721|P2|Overall Study|Protocol Deviation|20
58099|NCT01442038|235722|P1|Overall Study|Protocol Deviation|9
58100|NCT01442038|235721|P2|Overall Study|Adverse Event|15
58101|NCT01442038|235722|P1|Overall Study|Adverse Event|26
58102|NCT01442038|235721|P2|Overall Study|Lost to Follow-up|51
58103|NCT01442038|235722|P1|Overall Study|Lost to Follow-up|37
58104|NCT01442038|235721|P2|Overall Study|Participant Withdrew Consent|102
58105|NCT01442038|235722|P1|Overall Study|Participant Withdrew Consent|137
58106|NCT01442038|235721|P2|Overall Study|Investigator-Initiated Early Closure|43
58107|NCT01442038|235722|P1|Overall Study|Investigator-Initiated Early Closure|44
58108|NCT01442038|235721|P2|Overall Study|Death|29
58109|NCT01442038|235722|P1|Overall Study|Death|35
58110|NCT01441973|235736|P2|Overall Study|Participant withdrew consent|1
58111|NCT01441973|235737|P1|Overall Study|Participant withdrew consent|0
58112|NCT01441973|235736|P2|Overall Study|Administrative reason by sponsor|5
58113|NCT01441973|235737|P1|Overall Study|Administrative reason by sponsor|3
58114|NCT01441973|235736|P2|Overall Study|Poor compliance/noncompliance|1
58115|NCT01441973|235737|P1|Overall Study|Poor compliance/noncompliance|0
58116|NCT01441973|235736|P2|Overall Study|Participant request to discontinue|1
58117|NCT01441973|235737|P1|Overall Study|Participant request to discontinue|1
58118|NCT01441973|235736|P2|Overall Study|Adverse event unrelated to study drug|2
58119|NCT01441973|235737|P1|Overall Study|Adverse event unrelated to study drug|3
58120|NCT01441973|235736|P2|Overall Study|Disease progression|6
58121|NCT01441973|235737|P1|Overall Study|Disease progression|8
58122|NCT01441960|235759|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
58123|NCT01441960|235760|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
58124|NCT01441960|235759|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
58125|NCT01441960|235760|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
58126|NCT01441960|235759|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
58127|NCT01441960|235760|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
58128|NCT01441765|235785|P2|Overall Study|Death|0
58129|NCT01441765|235786|P1|Overall Study|Death|1
58130|NCT01441596|235803|P3|Overall Study|Not treated|1
58131|NCT01441596|235804|P2|Overall Study|Not treated|1
58132|NCT01441596|235805|P1|Overall Study|Not treated|0
58133|NCT01441596|235803|P3|Overall Study|Withdrawal by Subject|2
58134|NCT01441596|235804|P2|Overall Study|Withdrawal by Subject|0
58135|NCT01441596|235805|P1|Overall Study|Withdrawal by Subject|4
58136|NCT01441596|235803|P3|Overall Study|Other reason not defined below|1
58137|NCT01441596|235804|P2|Overall Study|Other reason not defined below|2
58138|NCT01441596|235805|P1|Overall Study|Other reason not defined below|0
58139|NCT01441440|235852|P3|Overall Study|Difficllty in keeping the schedule|0
58140|NCT01441440|235853|P2|Overall Study|Difficllty in keeping the schedule|1
58141|NCT01441440|235854|P1|Overall Study|Difficllty in keeping the schedule|1
58142|NCT01441440|235852|P3|Overall Study|Work-related matter|0
58143|NCT01441440|235853|P2|Overall Study|Work-related matter|1
58144|NCT01441440|235854|P1|Overall Study|Work-related matter|0
58145|NCT01441440|235852|P3|Overall Study|Moving|1
58146|NCT01441440|235853|P2|Overall Study|Moving|1
58147|NCT01441440|235854|P1|Overall Study|Moving|0
58148|NCT01441440|235852|P3|Overall Study|Lack of Efficacy|1
58149|NCT01441440|235853|P2|Overall Study|Lack of Efficacy|0
58150|NCT01441440|235854|P1|Overall Study|Lack of Efficacy|1
58151|NCT01441440|235852|P3|Overall Study|Pregnancy|0
58152|NCT01441440|235853|P2|Overall Study|Pregnancy|0
58153|NCT01441440|235854|P1|Overall Study|Pregnancy|1
58154|NCT01441440|235852|P3|Overall Study|Withdrawal by Subject|9
58155|NCT01441440|235853|P2|Overall Study|Withdrawal by Subject|9
58156|NCT01441440|235854|P1|Overall Study|Withdrawal by Subject|11
58157|NCT01441440|235852|P3|Overall Study|Lost to Follow-up|1
58158|NCT01441440|235853|P2|Overall Study|Lost to Follow-up|2
58159|NCT01441440|235854|P1|Overall Study|Lost to Follow-up|0
58160|NCT01441440|235852|P3|Overall Study|Adverse Event|9
58161|NCT01441440|235853|P2|Overall Study|Adverse Event|9
58162|NCT01441440|235854|P1|Overall Study|Adverse Event|2
58163|NCT01441440|235852|P3|Overall Study|Death|1
58164|NCT01441440|235853|P2|Overall Study|Death|0
58165|NCT01441440|235854|P1|Overall Study|Death|1
58166|NCT01441414|235877|P1|Overall Study|Subject refused further follow-up|1
58167|NCT01441414|235877|P1|Overall Study|Study terminated by sponsor|2
58168|NCT01441414|235877|P1|Overall Study|Other reasons|3
58169|NCT01441414|235877|P1|Overall Study|Participant died|9
58170|NCT01441180|235956|P3|Overall Study|Discontinued|2
58171|NCT01441180|235957|P2|Overall Study|Discontinued|0
58172|NCT01441180|235958|P1|Overall Study|Discontinued|0
58173|NCT01441180|235956|P3|Overall Study|Lost to Follow-up|1
58174|NCT01441180|235957|P2|Overall Study|Lost to Follow-up|1
58175|NCT01441180|235958|P1|Overall Study|Lost to Follow-up|1
58176|NCT01441102|235969|P1|Overall Study|Withdrawal by Subject|2
58177|NCT01441102|235969|P1|Overall Study|Adverse Event|1
58178|NCT01440972|236009|P2|Overall Study|Withdrawal by Subject|2
58179|NCT01440972|236010|P1|Overall Study|Withdrawal by Subject|3
58180|NCT01440946|236034|P2|Overall Study|Physician Decision|0
58181|NCT01440946|236035|P1|Overall Study|Physician Decision|1
58182|NCT01440946|236034|P2|Overall Study|Lost to Follow-up|1
58183|NCT01440946|236035|P1|Overall Study|Lost to Follow-up|1
58184|NCT01440881|236074|P2|Overall Study|Death|1
58185|NCT01440881|236075|P1|Overall Study|Death|0
58186|NCT01440816|236089|P2|Overall Study|To Be Seen By Local Oncologist|2
58187|NCT01440816|236090|P1|Overall Study|To Be Seen By Local Oncologist|1
58188|NCT01440816|236089|P2|Overall Study|Disease Progression|9
58189|NCT01440816|236090|P1|Overall Study|Disease Progression|0
58190|NCT01440647|236133|P2|Overall Study|Death|3
58191|NCT01440647|236134|P1|Overall Study|Death|2
58192|NCT01440595|236153|P3|Overall Study|Study terminated by sponsor.|1
58193|NCT01440595|236154|P2|Overall Study|Study terminated by sponsor.|2
58194|NCT01440595|236155|P1|Overall Study|Study terminated by sponsor.|1
58195|NCT01440595|236153|P3|Overall Study|Lost to Follow-up|0
58196|NCT01440595|236154|P2|Overall Study|Lost to Follow-up|1
58197|NCT01440595|236155|P1|Overall Study|Lost to Follow-up|0
58198|NCT01440569|236175|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
58199|NCT01440569|236176|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
58200|NCT01440569|236175|P2|Open-Label Rollover Phase|Lost to Follow-up|3
58201|NCT01440569|236176|P1|Open-Label Rollover Phase|Lost to Follow-up|26
58202|NCT01440569|236175|P2|Open-Label Rollover Phase|Withdrew Consent|1
58203|NCT01440569|236176|P1|Open-Label Rollover Phase|Withdrew Consent|11
58204|NCT01440569|236175|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
58205|NCT01440569|236176|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
58206|NCT01440569|236175|P2|Open-Label Rollover Phase|Lack of Efficacy|0
58207|NCT01440569|236176|P1|Open-Label Rollover Phase|Lack of Efficacy|2
58208|NCT01440569|236175|P2|Open-Label Rollover Phase|Pregnancy|0
58209|NCT01440569|236176|P1|Open-Label Rollover Phase|Pregnancy|1
58210|NCT01440569|236175|P2|Open-Label Rollover Phase|Adverse Event|0
58211|NCT01440569|236176|P1|Open-Label Rollover Phase|Adverse Event|3
58212|NCT01440569|236175|P2|Main Study|Protocol Violation|0
58213|NCT01440569|236176|P1|Main Study|Protocol Violation|1
58214|NCT01440569|236175|P2|Main Study|Subject Non-Compliance|0
58215|NCT01440569|236176|P1|Main Study|Subject Non-Compliance|3
58216|NCT01440569|236175|P2|Main Study|Lost to Follow-up|2
58217|NCT01440569|236176|P1|Main Study|Lost to Follow-up|13
58218|NCT01440569|236175|P2|Main Study|Withdrew Consent|1
58219|NCT01440569|236176|P1|Main Study|Withdrew Consent|7
58220|NCT01440569|236175|P2|Main Study|Investigator's Discretion|1
58221|NCT01440569|236176|P1|Main Study|Investigator's Discretion|1
58222|NCT01440569|236175|P2|Main Study|Pregnancy|0
58223|NCT01440569|236176|P1|Main Study|Pregnancy|1
58224|NCT01440569|236175|P2|Main Study|Adverse Event|0
58225|NCT01440569|236176|P1|Main Study|Adverse Event|9
58226|NCT01440569|236175|P2|Main Study|Enrolled but not treated|0
58227|NCT01440569|236176|P1|Main Study|Enrolled but not treated|1
58228|NCT01440517|236211|P1|Overall Study|Subject withdrawn prior to dosing|1
58229|NCT01440374|236242|P4|Part 3: Extension|Physician Decision|14
58230|NCT01440374|236243|P3|Part 3: Extension|Physician Decision|0
58231|NCT01440374|236244|P2|Part 3: Extension|Physician Decision|0
58232|NCT01440374|236245|P1|Part 3: Extension|Physician Decision|0
58233|NCT01440374|236242|P4|Part 3: Extension|Adverse Event|13
58234|NCT01440374|236243|P3|Part 3: Extension|Adverse Event|0
58235|NCT01440374|236244|P2|Part 3: Extension|Adverse Event|0
58236|NCT01440374|236245|P1|Part 3: Extension|Adverse Event|0
58237|NCT01440374|236242|P4|Part 3: Extension|Withdrawal by Subject|5
58238|NCT01440374|236243|P3|Part 3: Extension|Withdrawal by Subject|0
58239|NCT01440374|236244|P2|Part 3: Extension|Withdrawal by Subject|0
58240|NCT01440374|236245|P1|Part 3: Extension|Withdrawal by Subject|0
58241|NCT01440374|236242|P4|Part 2; Double-blind Phase|Not treated|0
58242|NCT01440374|236243|P3|Part 2; Double-blind Phase|Not treated|1
58243|NCT01440374|236244|P2|Part 2; Double-blind Phase|Not treated|0
58244|NCT01440374|236245|P1|Part 2; Double-blind Phase|Not treated|0
58245|NCT01440374|236242|P4|Part 2; Double-blind Phase|Adverse Event|0
58246|NCT01440374|236243|P3|Part 2; Double-blind Phase|Adverse Event|31
58247|NCT01440374|236244|P2|Part 2; Double-blind Phase|Adverse Event|7
58248|NCT01440374|236245|P1|Part 2; Double-blind Phase|Adverse Event|0
58249|NCT01440374|236242|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
58250|NCT01440374|236243|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
58251|NCT01440374|236244|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
58252|NCT01440374|236245|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
58253|NCT01440374|236242|P4|Part 2; Double-blind Phase|Protocol Violation|0
58254|NCT01440374|236243|P3|Part 2; Double-blind Phase|Protocol Violation|1
58255|NCT01440374|236244|P2|Part 2; Double-blind Phase|Protocol Violation|0
58256|NCT01440374|236245|P1|Part 2; Double-blind Phase|Protocol Violation|0
58257|NCT01440374|236242|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
58258|NCT01440374|236243|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
58259|NCT01440374|236244|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
58260|NCT01440374|236245|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
58261|NCT01440374|236242|P4|Part 2; Double-blind Phase|Physician Decision|0
58262|NCT01440374|236243|P3|Part 2; Double-blind Phase|Physician Decision|17
58263|NCT01440374|236244|P2|Part 2; Double-blind Phase|Physician Decision|8
58264|NCT01440374|236245|P1|Part 2; Double-blind Phase|Physician Decision|0
58265|NCT01440374|236242|P4|Part 1: Open-label Phase|Physician Decision|0
58266|NCT01440374|236243|P3|Part 1: Open-label Phase|Physician Decision|0
58267|NCT01440374|236244|P2|Part 1: Open-label Phase|Physician Decision|0
58268|NCT01440374|236245|P1|Part 1: Open-label Phase|Physician Decision|1
58269|NCT01440374|236242|P4|Part 1: Open-label Phase|Adverse Event|0
58270|NCT01440374|236243|P3|Part 1: Open-label Phase|Adverse Event|0
58271|NCT01440374|236244|P2|Part 1: Open-label Phase|Adverse Event|0
58272|NCT01440374|236245|P1|Part 1: Open-label Phase|Adverse Event|5
58273|NCT01440322|236280|P2|Overall Study|Other Non-Product Related|0
58274|NCT01440322|236281|P1|Overall Study|Other Non-Product Related|1
58275|NCT01440322|236280|P2|Overall Study|Unrelated Medical Problem|1
58276|NCT01440322|236281|P1|Overall Study|Unrelated Medical Problem|0
58277|NCT01440322|236280|P2|Overall Study|Other Product Related|0
58278|NCT01440322|236281|P1|Overall Study|Other Product Related|1
58279|NCT01440322|236280|P2|Overall Study|Unacceptable Subjective Vision|0
58280|NCT01440322|236281|P1|Overall Study|Unacceptable Subjective Vision|1
58281|NCT01440322|236280|P2|Overall Study|Symptoms and Problems|0
58282|NCT01440322|236281|P1|Overall Study|Symptoms and Problems|1
58283|NCT01440322|236280|P2|Overall Study|Biomicroscopy|0
58284|NCT01440322|236281|P1|Overall Study|Biomicroscopy|1
58285|NCT01440322|236280|P2|Overall Study|Discomfort|0
58286|NCT01440322|236281|P1|Overall Study|Discomfort|2
58287|NCT01440283|236303|P1|Overall Study|Physician Decision|3
58288|NCT01440283|236303|P1|Overall Study|Withdrawal by Subject|4
58289|NCT01440283|236303|P1|Overall Study|Death|3
58290|NCT01440101|236318|P3|Overall Study|Not Specified|0
58291|NCT01440101|236319|P2|Overall Study|Not Specified|1
58292|NCT01440101|236320|P1|Overall Study|Not Specified|0
58293|NCT01440101|236318|P3|Overall Study|Withdrawal by Subject|1
58294|NCT01440101|236319|P2|Overall Study|Withdrawal by Subject|3
58295|NCT01440101|236320|P1|Overall Study|Withdrawal by Subject|0
58296|NCT01440101|236318|P3|Overall Study|Adverse Event|0
58297|NCT01440101|236319|P2|Overall Study|Adverse Event|0
58298|NCT01440101|236320|P1|Overall Study|Adverse Event|2
58299|NCT01440049|236353|P1|Overall Study|Adverse Event|5
58300|NCT01439971|236385|P5|Overall Study|Required number in cohort dosed|1
58301|NCT01439971|236386|P4|Overall Study|Required number in cohort dosed|0
58302|NCT01439971|236387|P3|Overall Study|Required number in cohort dosed|2
58303|NCT01439971|236388|P2|Overall Study|Required number in cohort dosed|1
58304|NCT01439971|236389|P1|Overall Study|Required number in cohort dosed|0
58305|NCT01439945|236569|P4|Double-Blind Treatment Phase|Ineligible|1
58306|NCT01439945|236570|P3|Double-Blind Treatment Phase|Ineligible|0
58307|NCT01439945|236571|P2|Double-Blind Treatment Phase|Ineligible|2
58308|NCT01439945|236572|P1|Double-Blind Treatment Phase|Ineligible|1
58309|NCT01439945|236569|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
58310|NCT01439945|236570|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
58311|NCT01439945|236571|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
58312|NCT01439945|236572|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
58313|NCT01439867|236597|P2|Overall Study|Protocol-specified Criteria|0
58314|NCT01439867|236598|P1|Overall Study|Protocol-specified Criteria|1
58315|NCT01439867|236597|P2|Overall Study|Administrative Decision|5
58316|NCT01439867|236598|P1|Overall Study|Administrative Decision|4
58317|NCT01439867|236597|P2|Overall Study|Withdrawal by Subject|2
58318|NCT01439867|236598|P1|Overall Study|Withdrawal by Subject|1
58319|NCT01439867|236597|P2|Overall Study|Non-compliance|1
58320|NCT01439867|236598|P1|Overall Study|Non-compliance|0
58321|NCT01439724|236639|P2|Overall Study|missing consultation|8
58322|NCT01439724|236640|P1|Overall Study|missing consultation|9
58323|NCT01439711|236646|P1|Overall Study|No MRI|9
58324|NCT01439711|236646|P1|Overall Study|Noncompliance|3
58325|NCT01439711|236646|P1|Overall Study|Progression During Active Tx|3
58326|NCT01439711|236646|P1|Overall Study|Withdrawal by Subject|3
58327|NCT01439711|236646|P1|Overall Study|Adverse Event|5
58328|NCT01439711|236646|P1|Overall Study|Progression Prior to Beginning Tx|1
58329|NCT01439711|236646|P1|Overall Study|Cancel|3
58330|NCT01439711|236646|P1|Overall Study|Ineligible|13
58331|NCT01439373|236663|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
58332|NCT01439373|236664|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
58333|NCT01439373|236663|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
58334|NCT01439373|236664|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
58335|NCT01439360|236707|P2|Overall Study|Withdrawal by Subject|129
58336|NCT01439360|236708|P1|Overall Study|Withdrawal by Subject|140
58337|NCT01439360|236707|P2|Overall Study|Protocol Violation|0
58338|NCT01439360|236708|P1|Overall Study|Protocol Violation|1
58339|NCT01439360|236707|P2|Overall Study|Others|5
58340|NCT01439360|236708|P1|Overall Study|Others|10
58341|NCT01439360|236707|P2|Overall Study|Lost to Follow-up|58
58342|NCT01439360|236708|P1|Overall Study|Lost to Follow-up|43
58343|NCT01439360|236707|P2|Overall Study|Adverse Event|16
58344|NCT01439360|236708|P1|Overall Study|Adverse Event|4
58345|NCT01439282|236758|P2|Overall Study|Not specified|1
58346|NCT01439282|236759|P1|Overall Study|Not specified|1
58347|NCT01439282|236758|P2|Overall Study|Withdrawal by Subject|0
58348|NCT01439282|236759|P1|Overall Study|Withdrawal by Subject|2
58349|NCT01439282|236758|P2|Overall Study|Adverse Event|0
58350|NCT01439282|236759|P1|Overall Study|Adverse Event|5
58351|NCT01439204|236769|P2|Overall Study|poor/non-compliance|0
58352|NCT01439204|236770|P1|Overall Study|poor/non-compliance|3
58353|NCT01439204|236769|P2|Overall Study|No longer meets study criteria|0
58354|NCT01439204|236770|P1|Overall Study|No longer meets study criteria|1
58355|NCT01439204|236769|P2|Overall Study|Lost to Follow-up|2
58356|NCT01439204|236770|P1|Overall Study|Lost to Follow-up|0
58357|NCT01439204|236769|P2|Overall Study|Withdrawal by Subject|1
58358|NCT01439204|236770|P1|Overall Study|Withdrawal by Subject|0
58359|NCT01439165|236804|P2|Overall Study|Withdrawal by Subject|1
58360|NCT01439165|236805|P1|Overall Study|Withdrawal by Subject|7
58361|NCT01439165|236804|P2|Overall Study|Lost to Follow-up|1
58362|NCT01439165|236805|P1|Overall Study|Lost to Follow-up|11
58363|NCT01439165|236804|P2|Overall Study|Protocol Violation|0
58364|NCT01439165|236805|P1|Overall Study|Protocol Violation|3
58365|NCT01439126|236819|P2|Overall Study|Other-Miscellaneous|12
58366|NCT01439126|236820|P1|Overall Study|Other-Miscellaneous|12
58367|NCT01439126|236819|P2|Overall Study|Other-Use of prohibited treatment|2
58368|NCT01439126|236820|P1|Overall Study|Other-Use of prohibited treatment|0
58369|NCT01439126|236819|P2|Overall Study|Lost to Follow-up|3
58370|NCT01439126|236820|P1|Overall Study|Lost to Follow-up|6
58371|NCT01439126|236819|P2|Overall Study|Protocol Violation|4
58372|NCT01439126|236820|P1|Overall Study|Protocol Violation|6
58373|NCT01439126|236819|P2|Overall Study|Withdrawal by Subject|21
58374|NCT01439126|236820|P1|Overall Study|Withdrawal by Subject|5
58375|NCT01439126|236819|P2|Overall Study|Adverse Event|0
58376|NCT01439126|236820|P1|Overall Study|Adverse Event|2
58377|NCT01439074|236842|P2|Overall Study|Other|4
58378|NCT01439074|236843|P1|Overall Study|Other|4
58379|NCT01439074|236842|P2|Overall Study|Withdrawal by Subject|5
58380|NCT01439074|236843|P1|Overall Study|Withdrawal by Subject|1
58381|NCT01439074|236842|P2|Overall Study|Subject shedding|0
58382|NCT01439074|236843|P1|Overall Study|Subject shedding|1
58383|NCT01439074|236842|P2|Overall Study|Lost to Follow-up|4
58384|NCT01439074|236843|P1|Overall Study|Lost to Follow-up|3
58385|NCT01438996|236858|P3|Overall Study|Not meeting Inclusion Criteria|0
58386|NCT01438996|236859|P2|Overall Study|Not meeting Inclusion Criteria|1
58387|NCT01438996|236860|P1|Overall Study|Not meeting Inclusion Criteria|4
58388|NCT01438840|236894|P3|Extension Phase|Not specified|1
58389|NCT01438840|236895|P2|Extension Phase|Not specified|0
58390|NCT01438840|236896|P1|Extension Phase|Not specified|0
58391|NCT01438840|236894|P3|Extension Phase|Lack of Efficacy|2
58392|NCT01438840|236895|P2|Extension Phase|Lack of Efficacy|0
58393|NCT01438840|236896|P1|Extension Phase|Lack of Efficacy|0
58394|NCT01438840|236894|P3|Extension Phase|Withdrawal by Subject|3
58395|NCT01438840|236895|P2|Extension Phase|Withdrawal by Subject|0
58396|NCT01438840|236896|P1|Extension Phase|Withdrawal by Subject|0
58397|NCT01438840|236894|P3|Extension Phase|Lost to Follow-up|1
58398|NCT01438840|236895|P2|Extension Phase|Lost to Follow-up|0
58399|NCT01438840|236896|P1|Extension Phase|Lost to Follow-up|0
58400|NCT01438840|236894|P3|Extension Phase|Adverse Event|3
58401|NCT01438840|236895|P2|Extension Phase|Adverse Event|0
58402|NCT01438840|236896|P1|Extension Phase|Adverse Event|0
58403|NCT01438840|236894|P3|Core Study|Withdrawal of consent|0
58404|NCT01438840|236895|P2|Core Study|Withdrawal of consent|0
58405|NCT01438840|236896|P1|Core Study|Withdrawal of consent|1
58406|NCT01438840|236894|P3|Core Study|Lack of Efficacy|0
58407|NCT01438840|236895|P2|Core Study|Lack of Efficacy|7
58408|NCT01438840|236896|P1|Core Study|Lack of Efficacy|15
58409|NCT01438840|236894|P3|Core Study|Adverse Event|0
58410|NCT01438840|236895|P2|Core Study|Adverse Event|3
58411|NCT01438840|236896|P1|Core Study|Adverse Event|0
58412|NCT01438814|236909|P2|Overall Study|Not specified|4
58413|NCT01438814|236910|P1|Overall Study|Not specified|2
58414|NCT01438814|236909|P2|Overall Study|Withdrawal by Subject|2
58415|NCT01438814|236910|P1|Overall Study|Withdrawal by Subject|4
58416|NCT01438814|236909|P2|Overall Study|Lost to Follow-up|3
58417|NCT01438814|236910|P1|Overall Study|Lost to Follow-up|4
58418|NCT01438814|236909|P2|Overall Study|Protocol Violation|2
58419|NCT01438814|236910|P1|Overall Study|Protocol Violation|1
58420|NCT01438814|236909|P2|Overall Study|Adverse Event|3
58421|NCT01438814|236910|P1|Overall Study|Adverse Event|3
58422|NCT01438541|236946|P1|Overall Study|discharge from the hospital|5
58423|NCT01438541|236946|P1|Overall Study|Withdrawal by Subject|1
58424|NCT01438541|236946|P1|Overall Study|Physician Decision|1
58425|NCT01438489|236955|P3|Overall Study|Inadequate venous access|0
58426|NCT01438489|236956|P2|Overall Study|Inadequate venous access|2
58427|NCT01438489|236957|P1|Overall Study|Inadequate venous access|0
58428|NCT01438489|236955|P3|Overall Study|Did not complete all 3 follow-up visits|2
58429|NCT01438489|236956|P2|Overall Study|Did not complete all 3 follow-up visits|5
58430|NCT01438489|236957|P1|Overall Study|Did not complete all 3 follow-up visits|2
58431|NCT01438489|236955|P3|Overall Study|Received prohibited medication|0
58432|NCT01438489|236956|P2|Overall Study|Received prohibited medication|0
58433|NCT01438489|236957|P1|Overall Study|Received prohibited medication|1
58434|NCT01438489|236955|P3|Overall Study|AE/SAEs|1
58435|NCT01438489|236956|P2|Overall Study|AE/SAEs|1
58436|NCT01438489|236957|P1|Overall Study|AE/SAEs|2
58437|NCT01438489|236955|P3|Overall Study|Investigator decision|0
58438|NCT01438489|236956|P2|Overall Study|Investigator decision|1
58439|NCT01438489|236957|P1|Overall Study|Investigator decision|0
58440|NCT01438489|236955|P3|Overall Study|Subject choice/Subject moved|1
58441|NCT01438489|236956|P2|Overall Study|Subject choice/Subject moved|1
58442|NCT01438489|236957|P1|Overall Study|Subject choice/Subject moved|2
58443|NCT01438489|236955|P3|Overall Study|Sponsor decision|4
58444|NCT01438489|236956|P2|Overall Study|Sponsor decision|1
58445|NCT01438489|236957|P1|Overall Study|Sponsor decision|4
58446|NCT01438489|236955|P3|Overall Study|Death|1
58447|NCT01438489|236956|P2|Overall Study|Death|0
58448|NCT01438489|236957|P1|Overall Study|Death|0
58449|NCT01438489|236955|P3|Overall Study|Withdrawal by Subject|8
58450|NCT01438489|236956|P2|Overall Study|Withdrawal by Subject|3
58451|NCT01438489|236957|P1|Overall Study|Withdrawal by Subject|11
58452|NCT01438489|236955|P3|Overall Study|Lost to Follow-up|2
58453|NCT01438489|236956|P2|Overall Study|Lost to Follow-up|2
58454|NCT01438489|236957|P1|Overall Study|Lost to Follow-up|4
58455|NCT01438424|237000|P1|Overall Study|Participant noncompliance|20
58456|NCT01438424|237000|P1|Overall Study|No longer met inclusion criteria|1
58457|NCT01438424|237000|P1|Overall Study|Pregnancy|7
58458|NCT01438424|237000|P1|Overall Study|Need for drug prohibited by protocol|14
58459|NCT01438424|237000|P1|Overall Study|Abnormal laboratory test result|14
58460|NCT01438424|237000|P1|Overall Study|Lost to Follow-up|17
58461|NCT01438424|237000|P1|Overall Study|Adverse Event|17
58462|NCT01438424|237000|P1|Overall Study|Death|22
58463|NCT01438424|237000|P1|Overall Study|Progression of chronic hepatitis B|22
58464|NCT01438424|237000|P1|Overall Study|Withdrawal by Subject|104
58465|NCT01438424|237000|P1|Overall Study|Not identified|55
58466|NCT01438424|237000|P1|Overall Study|Minimal virologic response|95
58467|NCT01438424|237000|P1|Overall Study|Continuing treatment|29
58468|NCT01438307|237038|P2|Overall Study|Death|1
58469|NCT01438307|237039|P1|Overall Study|Death|1
58470|NCT01438294|237053|P2|Overall Study|Lost to Follow-up|7
58471|NCT01438294|237054|P1|Overall Study|Lost to Follow-up|3
58472|NCT01438177|237097|P1|Overall Study|Initiation of new therapy|1
58473|NCT01438177|237097|P1|Overall Study|Withdrawal by Subject|1
58474|NCT01438151|237103|P1|Overall Study|study terminated|8
58475|NCT01438060|237109|P2|On Study Beyond Week 140|Other Reason|3
58476|NCT01438060|237110|P1|On Study Beyond Week 140|Other Reason|0
58477|NCT01438060|237109|P2|On Study Beyond Week 140|Death|1
58478|NCT01438060|237110|P1|On Study Beyond Week 140|Death|0
58479|NCT01438060|237109|P2|On Study Beyond Week 140|Withdrawal by Subject|1
58480|NCT01438060|237110|P1|On Study Beyond Week 140|Withdrawal by Subject|0
58481|NCT01438060|237109|P2|On Study Beyond Week 140|Lack of Efficacy|1
58482|NCT01438060|237110|P1|On Study Beyond Week 140|Lack of Efficacy|0
58483|NCT01438060|237109|P2|On Study Beyond Week 140|Adverse Event|2
58484|NCT01438060|237110|P1|On Study Beyond Week 140|Adverse Event|0
58485|NCT01438060|237109|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
58486|NCT01438060|237110|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
58487|NCT01438060|237109|P2|Extension Phase: Week 10 to Week 130|Death|12
58488|NCT01438060|237110|P1|Extension Phase: Week 10 to Week 130|Death|22
58489|NCT01438060|237109|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
58490|NCT01438060|237110|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
58491|NCT01438060|237109|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
58492|NCT01438060|237110|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
58493|NCT01438060|237109|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
58494|NCT01438060|237110|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
58495|NCT01438060|237109|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
58496|NCT01438060|237110|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
58497|NCT01438060|237109|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
58498|NCT01438060|237110|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
58499|NCT01438060|237109|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
58500|NCT01438060|237110|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
58501|NCT01438060|237109|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
58502|NCT01438060|237110|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
58503|NCT01438060|237109|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
58504|NCT01438060|237110|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
58505|NCT01438060|237109|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
58506|NCT01438060|237110|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
58507|NCT01438060|237109|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
58508|NCT01438060|237110|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
58509|NCT01438060|237109|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
58510|NCT01438060|237110|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
58511|NCT01437995|237191|P3|Overall Study|Lost to Follow-up|20
58512|NCT01437995|237192|P2|Overall Study|Lost to Follow-up|18
58513|NCT01437995|237193|P1|Overall Study|Lost to Follow-up|11
58514|NCT01437943|237215|P2|Overall Study|Adverse Event|0
58515|NCT01437943|237216|P1|Overall Study|Adverse Event|2
58516|NCT01437943|237215|P2|Overall Study|Subject expressed pregnancy plans|0
58517|NCT01437943|237216|P1|Overall Study|Subject expressed pregnancy plans|1
58518|NCT01437943|237215|P2|Overall Study|Aliskiren trials terminated by Novartis|2
58519|NCT01437943|237216|P1|Overall Study|Aliskiren trials terminated by Novartis|4
58520|NCT01437878|237224|P2|Overall Study|Withdrawal by Subject|0
58521|NCT01437878|237225|P1|Overall Study|Withdrawal by Subject|1
58522|NCT01437540|237267|P2|Overall Study|Withdrawal by Subject|15
58523|NCT01437540|237268|P1|Overall Study|Withdrawal by Subject|31
58524|NCT01437540|237267|P2|Overall Study|Adverse Event|13
58525|NCT01437540|237268|P1|Overall Study|Adverse Event|26
58526|NCT01437540|237267|P2|Overall Study|Protocol Violation|12
58527|NCT01437540|237268|P1|Overall Study|Protocol Violation|24
58528|NCT01437540|237267|P2|Overall Study|Lack of Efficacy|11
58529|NCT01437540|237268|P1|Overall Study|Lack of Efficacy|23
58530|NCT01437540|237267|P2|Overall Study|Lost to Follow-up|5
58531|NCT01437540|237268|P1|Overall Study|Lost to Follow-up|3
58532|NCT01437540|237267|P2|Overall Study|COPD exacerbation|3
58533|NCT01437540|237268|P1|Overall Study|COPD exacerbation|13
58534|NCT01437540|237267|P2|Overall Study|Not listed below|6
58535|NCT01437540|237268|P1|Overall Study|Not listed below|7
58536|NCT01437423|237298|P1|Overall Study|Off label usage|3
58537|NCT01437423|237298|P1|Overall Study|Lost to Follow-up|12
58538|NCT01437397|237310|P5|Overall Study|Site termination/COPD exacerbation/other|14
58539|NCT01437397|237311|P4|Overall Study|Site termination/COPD exacerbation/other|9
58540|NCT01437397|237312|P3|Overall Study|Site termination/COPD exacerbation/other|9
58541|NCT01437397|237313|P2|Overall Study|Site termination/COPD exacerbation/other|8
58542|NCT01437397|237314|P1|Overall Study|Site termination/COPD exacerbation/other|10
58543|NCT01437397|237310|P5|Overall Study|Adverse Event|21
58544|NCT01437397|237311|P4|Overall Study|Adverse Event|14
58545|NCT01437397|237312|P3|Overall Study|Adverse Event|16
58546|NCT01437397|237313|P2|Overall Study|Adverse Event|22
58547|NCT01437397|237314|P1|Overall Study|Adverse Event|21
58548|NCT01437397|237310|P5|Overall Study|Lack of Efficacy|20
58549|NCT01437397|237311|P4|Overall Study|Lack of Efficacy|10
58550|NCT01437397|237312|P3|Overall Study|Lack of Efficacy|8
58551|NCT01437397|237313|P2|Overall Study|Lack of Efficacy|4
58552|NCT01437397|237314|P1|Overall Study|Lack of Efficacy|5
58553|NCT01437397|237310|P5|Overall Study|Protocol Violation|19
58554|NCT01437397|237311|P4|Overall Study|Protocol Violation|21
58555|NCT01437397|237312|P3|Overall Study|Protocol Violation|13
58556|NCT01437397|237313|P2|Overall Study|Protocol Violation|12
58557|NCT01437397|237314|P1|Overall Study|Protocol Violation|10
58558|NCT01437397|237310|P5|Overall Study|Withdrawal by Subject|22
58559|NCT01437397|237311|P4|Overall Study|Withdrawal by Subject|11
58560|NCT01437397|237312|P3|Overall Study|Withdrawal by Subject|24
58561|NCT01437397|237313|P2|Overall Study|Withdrawal by Subject|12
58562|NCT01437397|237314|P1|Overall Study|Withdrawal by Subject|11
58563|NCT01437397|237310|P5|Overall Study|Lost to Follow-up|5
58564|NCT01437397|237311|P4|Overall Study|Lost to Follow-up|4
58565|NCT01437397|237312|P3|Overall Study|Lost to Follow-up|2
58566|NCT01437397|237313|P2|Overall Study|Lost to Follow-up|4
58567|NCT01437397|237314|P1|Overall Study|Lost to Follow-up|9
58568|NCT01437319|237341|P3|Phase II|Protocol Violation|0
58569|NCT01437319|237342|P2|Phase II|Protocol Violation|1
58570|NCT01437319|237343|P1|Phase II|Protocol Violation|0
58571|NCT01437319|237341|P3|Phase II|Study related symptoms/complaints|19
58572|NCT01437319|237342|P2|Phase II|Study related symptoms/complaints|28
58573|NCT01437319|237343|P1|Phase II|Study related symptoms/complaints|0
58574|NCT01437319|237341|P3|Phase II|Lost to Follow-up|2
58575|NCT01437319|237342|P2|Phase II|Lost to Follow-up|7
58576|NCT01437319|237343|P1|Phase II|Lost to Follow-up|0
58577|NCT01437319|237341|P3|Phase II|Withdrawal by Subject|16
58578|NCT01437319|237342|P2|Phase II|Withdrawal by Subject|8
58579|NCT01437319|237343|P1|Phase II|Withdrawal by Subject|0
58580|NCT01437319|237341|P3|Phase I|Withdrawal by Subject|0
58581|NCT01437319|237342|P2|Phase I|Withdrawal by Subject|0
58582|NCT01437319|237343|P1|Phase I|Withdrawal by Subject|25
58583|NCT01437319|237341|P3|Phase I|Study related symptoms/complaints|0
58584|NCT01437319|237342|P2|Phase I|Study related symptoms/complaints|0
58585|NCT01437319|237343|P1|Phase I|Study related symptoms/complaints|27
58586|NCT01437319|237341|P3|Phase I|Protocol Violation|0
58587|NCT01437319|237342|P2|Phase I|Protocol Violation|0
58588|NCT01437319|237343|P1|Phase I|Protocol Violation|1
58589|NCT01437319|237341|P3|Phase I|Lost to Follow-up|0
58590|NCT01437319|237342|P2|Phase I|Lost to Follow-up|0
58591|NCT01437319|237343|P1|Phase I|Lost to Follow-up|2
58592|NCT01437267|237358|P6|Overall Study|Protocol Violation|0
58593|NCT01437267|237359|P5|Overall Study|Protocol Violation|0
58594|NCT01437267|237360|P4|Overall Study|Protocol Violation|0
58595|NCT01437267|237361|P3|Overall Study|Protocol Violation|0
58596|NCT01437267|237362|P2|Overall Study|Protocol Violation|1
58597|NCT01437267|237363|P1|Overall Study|Protocol Violation|0
58598|NCT01437267|237358|P6|Overall Study|Withdrawal by Subject|0
58599|NCT01437267|237359|P5|Overall Study|Withdrawal by Subject|0
58600|NCT01437267|237360|P4|Overall Study|Withdrawal by Subject|1
58601|NCT01437267|237361|P3|Overall Study|Withdrawal by Subject|0
58602|NCT01437267|237362|P2|Overall Study|Withdrawal by Subject|0
58603|NCT01437267|237363|P1|Overall Study|Withdrawal by Subject|0
58604|NCT01437111|237406|P1|Overall Study|Protocol Violation|1
58605|NCT01437111|237406|P1|Overall Study|Lost to Follow-up|5
58606|NCT01437111|237406|P1|Overall Study|Physician Decision|1
58607|NCT01437111|237406|P1|Overall Study|Not reported|5
58608|NCT01437111|237406|P1|Overall Study|Withdrawal by Subject|4
58609|NCT01437111|237406|P1|Overall Study|Adverse Event|2
58610|NCT01436643|237484|P4|Core Phase (16 Weeks)|Protocol Violation|0
58611|NCT01436643|237485|P3|Core Phase (16 Weeks)|Protocol Violation|1
58612|NCT01436643|237486|P2|Core Phase (16 Weeks)|Protocol Violation|1
58613|NCT01436643|237487|P1|Core Phase (16 Weeks)|Protocol Violation|1
58614|NCT01436643|237484|P4|Core Phase (16 Weeks)|Abnormal Test result|0
58615|NCT01436643|237485|P3|Core Phase (16 Weeks)|Abnormal Test result|1
58616|NCT01436643|237486|P2|Core Phase (16 Weeks)|Abnormal Test result|0
58617|NCT01436643|237487|P1|Core Phase (16 Weeks)|Abnormal Test result|0
58618|NCT01436643|237484|P4|Core Phase (16 Weeks)|Adverse Event|0
58619|NCT01436643|237485|P3|Core Phase (16 Weeks)|Adverse Event|1
58620|NCT01436643|237486|P2|Core Phase (16 Weeks)|Adverse Event|3
58621|NCT01436643|237487|P1|Core Phase (16 Weeks)|Adverse Event|0
58622|NCT01436643|237484|P4|2-week Pre-treatment|Protocol Violation|4
58623|NCT01436643|237485|P3|2-week Pre-treatment|Protocol Violation|0
58624|NCT01436643|237486|P2|2-week Pre-treatment|Protocol Violation|0
58625|NCT01436643|237487|P1|2-week Pre-treatment|Protocol Violation|0
58626|NCT01436643|237484|P4|2-week Pre-treatment|Adverse Event|5
58627|NCT01436643|237485|P3|2-week Pre-treatment|Adverse Event|0
58628|NCT01436643|237486|P2|2-week Pre-treatment|Adverse Event|0
58629|NCT01436643|237487|P1|2-week Pre-treatment|Adverse Event|0
58630|NCT01436643|237484|P4|2-week Pre-treatment|Abnormal test result|1
58631|NCT01436643|237485|P3|2-week Pre-treatment|Abnormal test result|0
58632|NCT01436643|237486|P2|2-week Pre-treatment|Abnormal test result|0
58633|NCT01436643|237487|P1|2-week Pre-treatment|Abnormal test result|0
58634|NCT01436500|237522|P5|Overall Study|not specified|0
58635|NCT01436500|237523|P4|Overall Study|not specified|1
58636|NCT01436500|237524|P3|Overall Study|not specified|0
58637|NCT01436500|237525|P2|Overall Study|not specified|1
58638|NCT01436500|237526|P1|Overall Study|not specified|0
58639|NCT01436500|237522|P5|Overall Study|discontinued study drug|0
58640|NCT01436500|237523|P4|Overall Study|discontinued study drug|0
58641|NCT01436500|237524|P3|Overall Study|discontinued study drug|0
58642|NCT01436500|237525|P2|Overall Study|discontinued study drug|0
58643|NCT01436500|237526|P1|Overall Study|discontinued study drug|1
58644|NCT01436500|237522|P5|Overall Study|initiation of dialysis|1
58645|NCT01436500|237523|P4|Overall Study|initiation of dialysis|0
58646|NCT01436500|237524|P3|Overall Study|initiation of dialysis|0
58647|NCT01436500|237525|P2|Overall Study|initiation of dialysis|0
58648|NCT01436500|237526|P1|Overall Study|initiation of dialysis|0
58649|NCT01436500|237522|P5|Overall Study|liver transplant|0
58650|NCT01436500|237523|P4|Overall Study|liver transplant|0
58651|NCT01436500|237524|P3|Overall Study|liver transplant|0
58652|NCT01436500|237525|P2|Overall Study|liver transplant|0
58653|NCT01436500|237526|P1|Overall Study|liver transplant|1
58654|NCT01436500|237522|P5|Overall Study|Physician Decision|0
58655|NCT01436500|237523|P4|Overall Study|Physician Decision|0
58656|NCT01436500|237524|P3|Overall Study|Physician Decision|1
58657|NCT01436500|237525|P2|Overall Study|Physician Decision|0
58658|NCT01436500|237526|P1|Overall Study|Physician Decision|0
58659|NCT01436500|237522|P5|Overall Study|Withdrawal by Subject|2
58660|NCT01436500|237523|P4|Overall Study|Withdrawal by Subject|0
58661|NCT01436500|237524|P3|Overall Study|Withdrawal by Subject|2
58662|NCT01436500|237525|P2|Overall Study|Withdrawal by Subject|0
58663|NCT01436500|237526|P1|Overall Study|Withdrawal by Subject|0
58664|NCT01436500|237522|P5|Overall Study|Adverse Event|1
58665|NCT01436500|237523|P4|Overall Study|Adverse Event|0
58666|NCT01436500|237524|P3|Overall Study|Adverse Event|2
58667|NCT01436500|237525|P2|Overall Study|Adverse Event|2
58668|NCT01436500|237526|P1|Overall Study|Adverse Event|0
58669|NCT01436500|237522|P5|Overall Study|Death|0
58670|NCT01436500|237523|P4|Overall Study|Death|0
58671|NCT01436500|237524|P3|Overall Study|Death|0
58672|NCT01436500|237525|P2|Overall Study|Death|0
58673|NCT01436500|237526|P1|Overall Study|Death|1
58674|NCT01436370|237576|P8|Overall Study|Lost to Follow-up|0
58675|NCT01436370|237577|P7|Overall Study|Lost to Follow-up|0
58676|NCT01436370|237578|P6|Overall Study|Lost to Follow-up|0
58677|NCT01436370|237579|P5|Overall Study|Lost to Follow-up|1
58678|NCT01436370|237580|P4|Overall Study|Lost to Follow-up|0
58679|NCT01436370|237581|P3|Overall Study|Lost to Follow-up|0
58680|NCT01436370|237582|P2|Overall Study|Lost to Follow-up|0
58681|NCT01436370|237583|P1|Overall Study|Lost to Follow-up|0
58682|NCT01436305|237664|P3|Overall Study|Withdrawal by Subject|0
58683|NCT01436305|237665|P2|Overall Study|Withdrawal by Subject|3
58684|NCT01436305|237666|P1|Overall Study|Withdrawal by Subject|1
58685|NCT01436305|237664|P3|Overall Study|Lost to Follow-up|0
58686|NCT01436305|237665|P2|Overall Study|Lost to Follow-up|1
58687|NCT01436305|237666|P1|Overall Study|Lost to Follow-up|0
58688|NCT01436305|237664|P3|Overall Study|Death|0
58689|NCT01436305|237665|P2|Overall Study|Death|0
58690|NCT01436305|237666|P1|Overall Study|Death|1
58691|NCT01436253|237793|P1|Overall Study|Not meeting all eligibility criteria|117
58692|NCT01436253|237793|P1|Overall Study|Lost to Follow-up|182
58693|NCT01436201|237798|P1|Overall Study|Protocol Violation|1
58694|NCT01436201|237798|P1|Overall Study|Withdrawal by Subject|1
58695|NCT01436201|237798|P1|Overall Study|Adverse Event|2
58696|NCT01436175|237808|P1|Overall Study|Other|826
58697|NCT01436175|237808|P1|Overall Study|Met blood pressure or pulse withdrawal|63
58698|NCT01436175|237808|P1|Overall Study|Lack of Efficacy|24
58699|NCT01436175|237808|P1|Overall Study|Lost to Follow-up|89
58700|NCT01436175|237808|P1|Overall Study|Withdrawal by Subject|108
58701|NCT01436175|237808|P1|Overall Study|Protocol Violation|49
58702|NCT01436175|237808|P1|Overall Study|Adverse Event|111
58703|NCT01436162|237835|P3|Randomized Phase|Not Specified|4
58704|NCT01436162|237836|P2|Randomized Phase|Not Specified|5
58705|NCT01436162|237837|P1|Randomized Phase|Not Specified|2
58706|NCT01436162|237835|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
58707|NCT01436162|237836|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
58708|NCT01436162|237837|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
58709|NCT01436162|237835|P3|Randomized Phase|Lack of Efficacy|1
58710|NCT01436162|237836|P2|Randomized Phase|Lack of Efficacy|1
58711|NCT01436162|237837|P1|Randomized Phase|Lack of Efficacy|0
58712|NCT01436162|237835|P3|Randomized Phase|Lost to Follow-up|4
58713|NCT01436162|237836|P2|Randomized Phase|Lost to Follow-up|5
58714|NCT01436162|237837|P1|Randomized Phase|Lost to Follow-up|17
58715|NCT01436162|237835|P3|Randomized Phase|Withdrawal by Subject|8
58716|NCT01436162|237836|P2|Randomized Phase|Withdrawal by Subject|9
58717|NCT01436162|237837|P1|Randomized Phase|Withdrawal by Subject|16
58718|NCT01436162|237835|P3|Randomized Phase|Protocol Violation|2
58719|NCT01436162|237836|P2|Randomized Phase|Protocol Violation|4
58720|NCT01436162|237837|P1|Randomized Phase|Protocol Violation|4
58721|NCT01436162|237835|P3|Randomized Phase|Adverse Event|6
58722|NCT01436162|237836|P2|Randomized Phase|Adverse Event|5
58723|NCT01436162|237837|P1|Randomized Phase|Adverse Event|1
58724|NCT01436162|237835|P3|Single-blind Lead-in Phase|Not Specified|0
58725|NCT01436162|237836|P2|Single-blind Lead-in Phase|Not Specified|0
58726|NCT01436162|237837|P1|Single-blind Lead-in Phase|Not Specified|107
58727|NCT01436162|237835|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
58728|NCT01436162|237836|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
58729|NCT01436162|237837|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
58730|NCT01436162|237835|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
58731|NCT01436162|237836|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
58732|NCT01436162|237837|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
58733|NCT01436162|237835|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
58734|NCT01436162|237836|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
58735|NCT01436162|237837|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
58736|NCT01436162|237835|P3|Single-blind Lead-in Phase|Protocol Violation|0
58737|NCT01436162|237836|P2|Single-blind Lead-in Phase|Protocol Violation|0
58738|NCT01436162|237837|P1|Single-blind Lead-in Phase|Protocol Violation|24
58739|NCT01436162|237835|P3|Single-blind Lead-in Phase|Adverse Event|0
58740|NCT01436162|237836|P2|Single-blind Lead-in Phase|Adverse Event|0
58741|NCT01436162|237837|P1|Single-blind Lead-in Phase|Adverse Event|26
58742|NCT01436149|237871|P3|Randomized Phase|Not Specified|11
58743|NCT01436149|237872|P2|Randomized Phase|Not Specified|5
58744|NCT01436149|237873|P1|Randomized Phase|Not Specified|12
58745|NCT01436149|237871|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
58746|NCT01436149|237872|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
58747|NCT01436149|237873|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
58748|NCT01436149|237871|P3|Randomized Phase|Lack of Efficacy|1
58749|NCT01436149|237872|P2|Randomized Phase|Lack of Efficacy|0
58750|NCT01436149|237873|P1|Randomized Phase|Lack of Efficacy|0
58751|NCT01436149|237871|P3|Randomized Phase|Lost to Follow-up|6
58752|NCT01436149|237872|P2|Randomized Phase|Lost to Follow-up|5
58753|NCT01436149|237873|P1|Randomized Phase|Lost to Follow-up|34
58754|NCT01436149|237871|P3|Randomized Phase|Withdrawal by Subject|10
58755|NCT01436149|237872|P2|Randomized Phase|Withdrawal by Subject|10
58756|NCT01436149|237873|P1|Randomized Phase|Withdrawal by Subject|16
58757|NCT01436149|237871|P3|Randomized Phase|Protocol Violation|0
58758|NCT01436149|237872|P2|Randomized Phase|Protocol Violation|5
58759|NCT01436149|237873|P1|Randomized Phase|Protocol Violation|4
58760|NCT01436149|237871|P3|Randomized Phase|Adverse Event|11
58761|NCT01436149|237872|P2|Randomized Phase|Adverse Event|10
58762|NCT01436149|237873|P1|Randomized Phase|Adverse Event|9
58763|NCT01436149|237871|P3|Antidepressant Lead-in Phase|Not Specified|0
58764|NCT01436149|237872|P2|Antidepressant Lead-in Phase|Not Specified|0
58765|NCT01436149|237873|P1|Antidepressant Lead-in Phase|Not Specified|119
58766|NCT01436149|237871|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
58767|NCT01436149|237872|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
58768|NCT01436149|237873|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
58769|NCT01436149|237871|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
58770|NCT01436149|237872|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
58771|NCT01436149|237873|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
58772|NCT01436149|237871|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
58773|NCT01436149|237872|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
58774|NCT01436149|237873|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
58775|NCT01436149|237871|P3|Antidepressant Lead-in Phase|Protocol Violation|0
58776|NCT01436149|237872|P2|Antidepressant Lead-in Phase|Protocol Violation|0
58777|NCT01436149|237873|P1|Antidepressant Lead-in Phase|Protocol Violation|29
58778|NCT01436149|237871|P3|Antidepressant Lead-in Phase|Adverse Event|0
58779|NCT01436149|237872|P2|Antidepressant Lead-in Phase|Adverse Event|0
58780|NCT01436149|237873|P1|Antidepressant Lead-in Phase|Adverse Event|39
58781|NCT01436110|237904|P3|Overall Study|Did Not Receive Trial Medication|3
58782|NCT01436110|237905|P2|Overall Study|Did Not Receive Trial Medication|0
58783|NCT01436110|237906|P1|Overall Study|Did Not Receive Trial Medication|1
58784|NCT01436110|237904|P3|Overall Study|Protocol Violation|1
58785|NCT01436110|237905|P2|Overall Study|Protocol Violation|1
58786|NCT01436110|237906|P1|Overall Study|Protocol Violation|3
58787|NCT01436110|237904|P3|Overall Study|Lost to Follow-up|3
58788|NCT01436110|237905|P2|Overall Study|Lost to Follow-up|1
58789|NCT01436110|237906|P1|Overall Study|Lost to Follow-up|1
58790|NCT01436110|237904|P3|Overall Study|Physician Decision|1
58791|NCT01436110|237905|P2|Overall Study|Physician Decision|1
58792|NCT01436110|237906|P1|Overall Study|Physician Decision|3
58793|NCT01436110|237904|P3|Overall Study|Adverse Event|2
58794|NCT01436110|237905|P2|Overall Study|Adverse Event|1
58795|NCT01436110|237906|P1|Overall Study|Adverse Event|2
58796|NCT01436110|237904|P3|Overall Study|Withdrawal by Subject|4
58797|NCT01436110|237905|P2|Overall Study|Withdrawal by Subject|8
58798|NCT01436110|237906|P1|Overall Study|Withdrawal by Subject|6
58799|NCT01436110|237904|P3|Overall Study|Lack of Efficacy|9
58800|NCT01436110|237905|P2|Overall Study|Lack of Efficacy|14
58801|NCT01436110|237906|P1|Overall Study|Lack of Efficacy|23
58802|NCT01436084|237929|P1|Overall Study|Early Closure of Study|1
58803|NCT01436084|237929|P1|Overall Study|Withdrawal by Subject|1
58804|NCT01436084|237929|P1|Overall Study|Disease Progression|2
58805|NCT01436071|237935|P2|Overall Study|Did Not Receive Trial Medication|3
58806|NCT01436071|237936|P1|Overall Study|Did Not Receive Trial Medication|3
58807|NCT01436071|237935|P2|Overall Study|Withdrawal by Subject|2
58808|NCT01436071|237936|P1|Overall Study|Withdrawal by Subject|2
58809|NCT01436071|237935|P2|Overall Study|Physician Decision|0
58810|NCT01436071|237936|P1|Overall Study|Physician Decision|1
58811|NCT01436071|237935|P2|Overall Study|Lost to Follow-up|1
58812|NCT01436071|237936|P1|Overall Study|Lost to Follow-up|3
58813|NCT01436071|237935|P2|Overall Study|Protocol Violation|1
58814|NCT01436071|237936|P1|Overall Study|Protocol Violation|0
58815|NCT01436071|237935|P2|Overall Study|Lack of Efficacy|7
58816|NCT01436071|237936|P1|Overall Study|Lack of Efficacy|16
58817|NCT01436071|237935|P2|Overall Study|Adverse Event|0
58818|NCT01436071|237936|P1|Overall Study|Adverse Event|1
58819|NCT01435928|237978|P3|Double Blind Phase - 28 Weeks|Administrative|2
58820|NCT01435928|237979|P2|Double Blind Phase - 28 Weeks|Administrative|5
58821|NCT01435928|237980|P1|Double Blind Phase - 28 Weeks|Administrative|0
58822|NCT01435928|237978|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
58823|NCT01435928|237979|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
58824|NCT01435928|237980|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
58825|NCT01435928|237978|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
58826|NCT01435928|237979|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
58827|NCT01435928|237980|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
58828|NCT01435928|237978|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
58829|NCT01435928|237979|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
58830|NCT01435928|237980|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
58831|NCT01435928|237978|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
58832|NCT01435928|237979|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
58833|NCT01435928|237980|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
58834|NCT01435928|237978|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
58835|NCT01435928|237979|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
58836|NCT01435928|237980|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
58837|NCT01435928|237978|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
58838|NCT01435928|237979|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
58839|NCT01435928|237980|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
58840|NCT01435928|237978|P3|Open Label Phase - up to 24 Weeks|Administrative|0
58841|NCT01435928|237979|P2|Open Label Phase - up to 24 Weeks|Administrative|0
58842|NCT01435928|237980|P1|Open Label Phase - up to 24 Weeks|Administrative|14
58843|NCT01435928|237978|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
58844|NCT01435928|237979|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
58845|NCT01435928|237980|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
58846|NCT01435928|237978|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
58847|NCT01435928|237979|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
58848|NCT01435928|237980|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
58849|NCT01435928|237978|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
58850|NCT01435928|237979|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
58851|NCT01435928|237980|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
58852|NCT01435928|237978|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
58853|NCT01435928|237979|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
58854|NCT01435928|237980|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
58855|NCT01435928|237978|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
58856|NCT01435928|237979|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
58857|NCT01435928|237980|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
58858|NCT01435928|237978|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
58859|NCT01435928|237979|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
58860|NCT01435928|237980|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
58861|NCT01435928|237978|P3|Open Label Phase - up to 24 Weeks|Death|0
58862|NCT01435928|237979|P2|Open Label Phase - up to 24 Weeks|Death|0
58863|NCT01435928|237980|P1|Open Label Phase - up to 24 Weeks|Death|1
58864|NCT01435928|237978|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
58865|NCT01435928|237979|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
58866|NCT01435928|237980|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
58867|NCT01435798|238007|P1|Overall Study|Withdrawal by Subject|1
58868|NCT01435772|238024|P3|Overall Study|Other - study termination|10
58869|NCT01435772|238025|P2|Overall Study|Other - study termination|2
58870|NCT01435772|238026|P1|Overall Study|Other - study termination|2
58871|NCT01435772|238024|P3|Overall Study|Withdrawal by Subject|3
58872|NCT01435772|238025|P2|Overall Study|Withdrawal by Subject|1
58873|NCT01435772|238026|P1|Overall Study|Withdrawal by Subject|0
58874|NCT01435772|238024|P3|Overall Study|Adverse Event|2
58875|NCT01435772|238025|P2|Overall Study|Adverse Event|0
58876|NCT01435772|238026|P1|Overall Study|Adverse Event|1
58877|NCT01435759|238076|P6|Double-blind Phase|Not Specified|0
58878|NCT01435759|238077|P5|Double-blind Phase|Not Specified|0
58879|NCT01435759|238078|P4|Double-blind Phase|Not Specified|2
58880|NCT01435759|238079|P3|Double-blind Phase|Not Specified|0
58881|NCT01435759|238080|P2|Double-blind Phase|Not Specified|2
58882|NCT01435759|238081|P1|Double-blind Phase|Not Specified|8
58883|NCT01435759|238076|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
58884|NCT01435759|238077|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
58885|NCT01435759|238078|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
58886|NCT01435759|238079|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
58887|NCT01435759|238080|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
58888|NCT01435759|238081|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
58889|NCT01435759|238076|P6|Double-blind Phase|Lost to Follow-up|3
58890|NCT01435759|238077|P5|Double-blind Phase|Lost to Follow-up|3
58891|NCT01435759|238078|P4|Double-blind Phase|Lost to Follow-up|0
58892|NCT01435759|238079|P3|Double-blind Phase|Lost to Follow-up|2
58893|NCT01435759|238080|P2|Double-blind Phase|Lost to Follow-up|1
58894|NCT01435759|238081|P1|Double-blind Phase|Lost to Follow-up|31
58895|NCT01435759|238076|P6|Double-blind Phase|Withdrawal by Subject|2
58896|NCT01435759|238077|P5|Double-blind Phase|Withdrawal by Subject|2
58897|NCT01435759|238078|P4|Double-blind Phase|Withdrawal by Subject|4
58898|NCT01435759|238079|P3|Double-blind Phase|Withdrawal by Subject|3
58899|NCT01435759|238080|P2|Double-blind Phase|Withdrawal by Subject|4
58900|NCT01435759|238081|P1|Double-blind Phase|Withdrawal by Subject|17
58901|NCT01435759|238076|P6|Double-blind Phase|Protocol Violation|1
58902|NCT01435759|238077|P5|Double-blind Phase|Protocol Violation|0
58903|NCT01435759|238078|P4|Double-blind Phase|Protocol Violation|2
58904|NCT01435759|238079|P3|Double-blind Phase|Protocol Violation|1
58905|NCT01435759|238080|P2|Double-blind Phase|Protocol Violation|0
58906|NCT01435759|238081|P1|Double-blind Phase|Protocol Violation|2
58907|NCT01435759|238076|P6|Double-blind Phase|Adverse Event|3
58908|NCT01435759|238077|P5|Double-blind Phase|Adverse Event|1
58909|NCT01435759|238078|P4|Double-blind Phase|Adverse Event|1
58910|NCT01435759|238079|P3|Double-blind Phase|Adverse Event|1
58911|NCT01435759|238080|P2|Double-blind Phase|Adverse Event|0
58912|NCT01435759|238081|P1|Double-blind Phase|Adverse Event|7
58913|NCT01435759|238076|P6|Antidepressant Lead-in Phase|Not Specified|0
58914|NCT01435759|238077|P5|Antidepressant Lead-in Phase|Not Specified|0
58915|NCT01435759|238078|P4|Antidepressant Lead-in Phase|Not Specified|0
58916|NCT01435759|238079|P3|Antidepressant Lead-in Phase|Not Specified|0
58917|NCT01435759|238080|P2|Antidepressant Lead-in Phase|Not Specified|0
58918|NCT01435759|238081|P1|Antidepressant Lead-in Phase|Not Specified|119
58919|NCT01435759|238076|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
58920|NCT01435759|238077|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
58921|NCT01435759|238078|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
58922|NCT01435759|238079|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
58923|NCT01435759|238080|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
58924|NCT01435759|238081|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
58925|NCT01435759|238076|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
58926|NCT01435759|238077|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
58927|NCT01435759|238078|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
58928|NCT01435759|238079|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
58929|NCT01435759|238080|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
58930|NCT01435759|238081|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
58931|NCT01435759|238076|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
58932|NCT01435759|238077|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
58933|NCT01435759|238078|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
58934|NCT01435759|238079|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
58935|NCT01435759|238080|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
58936|NCT01435759|238081|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
58937|NCT01435759|238076|P6|Antidepressant Lead-in Phase|Protocol Violation|0
58938|NCT01435759|238077|P5|Antidepressant Lead-in Phase|Protocol Violation|0
58939|NCT01435759|238078|P4|Antidepressant Lead-in Phase|Protocol Violation|0
58940|NCT01435759|238079|P3|Antidepressant Lead-in Phase|Protocol Violation|0
58941|NCT01435759|238080|P2|Antidepressant Lead-in Phase|Protocol Violation|0
58942|NCT01435759|238081|P1|Antidepressant Lead-in Phase|Protocol Violation|16
58943|NCT01435759|238076|P6|Antidepressant Lead-in Phase|Adverse Event|0
58944|NCT01435759|238077|P5|Antidepressant Lead-in Phase|Adverse Event|0
58945|NCT01435759|238078|P4|Antidepressant Lead-in Phase|Adverse Event|0
58946|NCT01435759|238079|P3|Antidepressant Lead-in Phase|Adverse Event|0
58947|NCT01435759|238080|P2|Antidepressant Lead-in Phase|Adverse Event|0
58948|NCT01435759|238081|P1|Antidepressant Lead-in Phase|Adverse Event|40
58949|NCT01435655|238108|P1|Overall Study|Other|1
58950|NCT01435655|238108|P1|Overall Study|Death|2
58951|NCT01435616|238122|P2|Overall Study|Sponsor Decision|0
58952|NCT01435616|238123|P1|Overall Study|Sponsor Decision|1
58953|NCT01435616|238122|P2|Overall Study|Physician Decision|7
58954|NCT01435616|238123|P1|Overall Study|Physician Decision|20
58955|NCT01435616|238122|P2|Overall Study|Withdrawal by Subject|24
58956|NCT01435616|238123|P1|Overall Study|Withdrawal by Subject|66
58957|NCT01435616|238122|P2|Overall Study|Protocol Violation|13
58958|NCT01435616|238123|P1|Overall Study|Protocol Violation|16
58959|NCT01435616|238122|P2|Overall Study|Lost to Follow-up|13
58960|NCT01435616|238123|P1|Overall Study|Lost to Follow-up|22
58961|NCT01435616|238122|P2|Overall Study|Death|2
58962|NCT01435616|238123|P1|Overall Study|Death|7
58963|NCT01435616|238122|P2|Overall Study|Adverse Event|21
58964|NCT01435616|238123|P1|Overall Study|Adverse Event|39
58965|NCT01435577|238178|P2|Overall Study|Alternative treatment started|1
58966|NCT01435577|238179|P1|Overall Study|Alternative treatment started|0
58967|NCT01435577|238178|P2|Overall Study|Lack of Efficacy|51
58968|NCT01435577|238179|P1|Overall Study|Lack of Efficacy|7
58969|NCT01435577|238178|P2|Overall Study|Adverse Event|0
58970|NCT01435577|238179|P1|Overall Study|Adverse Event|10
58971|NCT01435460|238229|P2|Overall Study|Did not meet eligibility criteria|0
58972|NCT01435460|238230|P1|Overall Study|Did not meet eligibility criteria|2
58973|NCT01435460|238229|P2|Overall Study|Protocol Violation|1
58974|NCT01435460|238230|P1|Overall Study|Protocol Violation|0
58975|NCT01435460|238229|P2|Overall Study|Withdrawal by Subject|3
58976|NCT01435460|238230|P1|Overall Study|Withdrawal by Subject|1
58977|NCT01435460|238229|P2|Overall Study|Lost to Follow-up|1
58978|NCT01435460|238230|P1|Overall Study|Lost to Follow-up|6
58979|NCT01435460|238229|P2|Overall Study|Adverse Event|1
58980|NCT01435460|238230|P1|Overall Study|Adverse Event|2
58981|NCT01435265|238263|P2|Overall Study|Lost to Follow-up|1
58982|NCT01435265|238264|P1|Overall Study|Lost to Follow-up|0
58983|NCT01435122|238278|P1|Overall Study|Early withdrawal due to toxicity|8
58984|NCT01435031|238287|P1|ITT at 4 Years|Lost to Follow-up|1
58985|NCT01435031|238287|P1|ITT at 4 Years|Withdrawal by Subject|2
58986|NCT01435031|238287|P1|ITT at 4 Years|Death|4
58987|NCT01435031|238287|P1|ITT at 3 Years|Lost to Follow-up|4
58988|NCT01435031|238287|P1|ITT at 3 Years|Withdrawal by Subject|2
58989|NCT01435031|238287|P1|ITT at 3 Years|Death|5
58990|NCT01435031|238287|P1|ITT at 2 Years|Lost to Follow-up|4
58991|NCT01435031|238287|P1|ITT at 2 Years|Withdrawal by Subject|2
58992|NCT01435031|238287|P1|ITT at 2 Years|Death|7
58993|NCT01435031|238287|P1|ITT at 1 Year|Lost to Follow-up|6
58994|NCT01435031|238287|P1|ITT at 1 Year|Withdrawal by Subject|2
58995|NCT01435031|238287|P1|ITT at 1 Year|Death|1
58996|NCT01435031|238287|P1|ITT at 6 Months|Lost to Follow-up|3
58997|NCT01435031|238287|P1|ITT at 6 Months|Death|2
58998|NCT01435031|238287|P1|ITT at 1 Month|Lost to Follow-up|4
58999|NCT01435031|238287|P1|ITT at 1 Month|Death|1
59000|NCT01435031|238287|P1|ITT at 1 Month|Withdrawal by Subject|1
59001|NCT01434823|238387|P2|Overall Study|Incomplete data in medical record|7
59002|NCT01434823|238388|P1|Overall Study|Incomplete data in medical record|4
59003|NCT01434693|238408|P4|Overall Study|Lost to Follow-up|0
59004|NCT01434693|238409|P3|Overall Study|Lost to Follow-up|0
59005|NCT01434693|238410|P2|Overall Study|Lost to Follow-up|0
59006|NCT01434693|238411|P1|Overall Study|Lost to Follow-up|1
59007|NCT01434693|238408|P4|Overall Study|Withdrawal by Subject|1
59008|NCT01434693|238409|P3|Overall Study|Withdrawal by Subject|1
59009|NCT01434693|238410|P2|Overall Study|Withdrawal by Subject|0
59010|NCT01434693|238411|P1|Overall Study|Withdrawal by Subject|1
59011|NCT01434693|238408|P4|Overall Study|Adverse Event|0
59012|NCT01434693|238409|P3|Overall Study|Adverse Event|0
59013|NCT01434693|238410|P2|Overall Study|Adverse Event|0
59014|NCT01434693|238411|P1|Overall Study|Adverse Event|1
59015|NCT01434680|238425|P4|Overall Study|Protocol Violation|0
59016|NCT01434680|238426|P3|Overall Study|Protocol Violation|0
59017|NCT01434680|238427|P2|Overall Study|Protocol Violation|1
59018|NCT01434680|238428|P1|Overall Study|Protocol Violation|1
59019|NCT01434680|238425|P4|Overall Study|Lost to Follow-up|0
59020|NCT01434680|238426|P3|Overall Study|Lost to Follow-up|0
59021|NCT01434680|238427|P2|Overall Study|Lost to Follow-up|1
59022|NCT01434680|238428|P1|Overall Study|Lost to Follow-up|1
59023|NCT01434680|238425|P4|Overall Study|Withdrawal by Subject|0
59024|NCT01434680|238426|P3|Overall Study|Withdrawal by Subject|2
59025|NCT01434680|238427|P2|Overall Study|Withdrawal by Subject|0
59026|NCT01434680|238428|P1|Overall Study|Withdrawal by Subject|1
59027|NCT01434654|238445|P2|Overall Study|Lost to Follow-up|0
59028|NCT01434654|238446|P1|Overall Study|Lost to Follow-up|1
59029|NCT01434654|238445|P2|Overall Study|Withdrawal by Subject|0
59030|NCT01434654|238446|P1|Overall Study|Withdrawal by Subject|1
59031|NCT01434290|238493|P2|Overall Study|No protocol treatment|4
59032|NCT01434290|238494|P1|Overall Study|No protocol treatment|2
59033|NCT01434290|238493|P2|Overall Study|Protocol Violation|3
59034|NCT01434290|238494|P1|Overall Study|Protocol Violation|6
59035|NCT01433978|238567|P3|Extension Phase|Study Terminated by Sponsor|4
59036|NCT01433978|238568|P2|Extension Phase|Study Terminated by Sponsor|0
59037|NCT01433978|238569|P1|Extension Phase|Study Terminated by Sponsor|0
59038|NCT01433978|238567|P3|Extension Phase|Lack of Efficacy|1
59039|NCT01433978|238568|P2|Extension Phase|Lack of Efficacy|0
59040|NCT01433978|238569|P1|Extension Phase|Lack of Efficacy|0
59041|NCT01433978|238567|P3|Extension Phase|Adverse Event, Non-Fatal|1
59042|NCT01433978|238568|P2|Extension Phase|Adverse Event, Non-Fatal|0
59043|NCT01433978|238569|P1|Extension Phase|Adverse Event, Non-Fatal|0
59044|NCT01433978|238567|P3|Core Study|Study Terminated by Sponsor|0
59045|NCT01433978|238568|P2|Core Study|Study Terminated by Sponsor|9
59046|NCT01433978|238569|P1|Core Study|Study Terminated by Sponsor|6
59047|NCT01433978|238567|P3|Core Study|Lack of Efficacy|0
59048|NCT01433978|238568|P2|Core Study|Lack of Efficacy|1
59049|NCT01433978|238569|P1|Core Study|Lack of Efficacy|5
59050|NCT01433978|238567|P3|Core Study|Adverse Event, Non-Fatal|0
59051|NCT01433978|238568|P2|Core Study|Adverse Event, Non-Fatal|1
59052|NCT01433978|238569|P1|Core Study|Adverse Event, Non-Fatal|0
59053|NCT01433549|238626|P2|Phase 2: Second Study Product|Adverse Event|1
59054|NCT01433549|238627|P1|Phase 2: Second Study Product|Adverse Event|0
59055|NCT01433471|238637|P2|Overall Study|Withdrawal by Subject|1
59056|NCT01433471|238638|P1|Overall Study|Withdrawal by Subject|0
59057|NCT01433354|238654|P1|Overall Study|Subject Withdrew Consent|3
59058|NCT01433354|238654|P1|Overall Study|Lack of Efficacy|17
59059|NCT01433354|238654|P1|Overall Study|Protocol Violation|2
59060|NCT01433354|238654|P1|Overall Study|Administrative problems|90
59061|NCT01433354|238654|P1|Overall Study|Lost to Follow-up|1
59062|NCT01433354|238654|P1|Overall Study|Adverse Event|6
59063|NCT01433263|238670|P2|Overall Study|Withdrawal by Subject|7
59064|NCT01433263|238671|P1|Overall Study|Withdrawal by Subject|10
59065|NCT01433263|238670|P2|Overall Study|Protocol Deviation|0
59066|NCT01433263|238671|P1|Overall Study|Protocol Deviation|1
59067|NCT01433263|238670|P2|Overall Study|Lost to Follow-up|1
59068|NCT01433263|238671|P1|Overall Study|Lost to Follow-up|0
59069|NCT01433263|238670|P2|Overall Study|Death|3
59070|NCT01433263|238671|P1|Overall Study|Death|5
59071|NCT01433263|238670|P2|Overall Study|Adverse Event|1
59072|NCT01433263|238671|P1|Overall Study|Adverse Event|3
59073|NCT01433250|238700|P2|Overall Study|Withdrawal by Subject|2
59074|NCT01433250|238701|P1|Overall Study|Withdrawal by Subject|3
59075|NCT01433250|238700|P2|Overall Study|Protocol Violation|1
59076|NCT01433250|238701|P1|Overall Study|Protocol Violation|0
59077|NCT01433172|238720|P3|Overall Study|Death|0
59078|NCT01433172|238721|P2|Overall Study|Death|2
59079|NCT01433172|238722|P1|Overall Study|Death|0
59080|NCT01433172|238720|P3|Overall Study|Disease Progression|1
59081|NCT01433172|238721|P2|Overall Study|Disease Progression|0
59082|NCT01433172|238722|P1|Overall Study|Disease Progression|0
59083|NCT01433172|238720|P3|Overall Study|Withdrawal by Subject|0
59084|NCT01433172|238721|P2|Overall Study|Withdrawal by Subject|1
59085|NCT01433172|238722|P1|Overall Study|Withdrawal by Subject|0
59086|NCT01433159|238734|P2|Overall Study|Protocol Violation|1
59087|NCT01433159|238735|P1|Overall Study|Protocol Violation|0
59088|NCT01433159|238734|P2|Overall Study|Physician Decision|0
59089|NCT01433159|238735|P1|Overall Study|Physician Decision|1
59090|NCT01433159|238734|P2|Overall Study|Adverse Event|0
59091|NCT01433159|238735|P1|Overall Study|Adverse Event|1
59092|NCT01433055|238767|P2|Overall Study|Severely elevated triglycerides at entry|0
59093|NCT01433055|238768|P1|Overall Study|Severely elevated triglycerides at entry|1
59094|NCT01433055|238767|P2|Overall Study|Diagnosed with cancer unrelated to study|0
59095|NCT01433055|238768|P1|Overall Study|Diagnosed with cancer unrelated to study|1
59096|NCT01432938|238790|P2|Second Intervention|Adverse Event|0
59097|NCT01432938|238791|P1|Second Intervention|Adverse Event|1
59098|NCT01432938|238790|P2|First Intervention|Physician Decision|0
59099|NCT01432938|238791|P1|First Intervention|Physician Decision|1
59100|NCT01432938|238790|P2|First Intervention|Protocol Violation|0
59101|NCT01432938|238791|P1|First Intervention|Protocol Violation|1
59102|NCT01432756|238821|P4|Overall Study|Lost to Follow-up|1
59103|NCT01432756|238822|P3|Overall Study|Lost to Follow-up|2
59104|NCT01432756|238823|P2|Overall Study|Lost to Follow-up|0
59105|NCT01432756|238824|P1|Overall Study|Lost to Follow-up|1
59106|NCT01432626|238832|P1|Overall Study|Imaging agent not available|1
59107|NCT01432626|238832|P1|Overall Study|Only 1 image competed|2
59108|NCT01432626|238832|P1|Overall Study|Withdrawal by Subject|2
59109|NCT01432626|238832|P1|Overall Study|LV function recovered|2
59110|NCT01432600|238839|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
59111|NCT01432600|238840|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
59112|NCT01432600|238841|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
59113|NCT01432574|238857|P1|Overall Study|Not interested|1
59114|NCT01432574|238857|P1|Overall Study|Moved|2
59115|NCT01432457|238903|P3|Overall Study|Did not take study drug|3
59116|NCT01432457|238904|P2|Overall Study|Did not take study drug|6
59117|NCT01432457|238905|P1|Overall Study|Did not take study drug|6
59118|NCT01432457|238903|P3|Overall Study|Reasons not defined|4
59119|NCT01432457|238904|P2|Overall Study|Reasons not defined|3
59120|NCT01432457|238905|P1|Overall Study|Reasons not defined|2
59121|NCT01432457|238903|P3|Overall Study|Withdrawal by Subject|9
59122|NCT01432457|238904|P2|Overall Study|Withdrawal by Subject|11
59123|NCT01432457|238905|P1|Overall Study|Withdrawal by Subject|6
59124|NCT01432457|238903|P3|Overall Study|Protocol Violation|6
59125|NCT01432457|238904|P2|Overall Study|Protocol Violation|2
59126|NCT01432457|238905|P1|Overall Study|Protocol Violation|3
59127|NCT01432457|238903|P3|Overall Study|Lost to Follow-up|20
59128|NCT01432457|238904|P2|Overall Study|Lost to Follow-up|15
59129|NCT01432457|238905|P1|Overall Study|Lost to Follow-up|11
59130|NCT01432457|238903|P3|Overall Study|Lack of Efficacy|1
59131|NCT01432457|238904|P2|Overall Study|Lack of Efficacy|1
59132|NCT01432457|238905|P1|Overall Study|Lack of Efficacy|2
59133|NCT01432457|238903|P3|Overall Study|Adverse Event|16
59134|NCT01432457|238904|P2|Overall Study|Adverse Event|10
59135|NCT01432457|238905|P1|Overall Study|Adverse Event|7
59136|NCT01432444|238934|P3|Extension Phase|Withdrawal by Subject|13
59137|NCT01432444|238935|P2|Extension Phase|Withdrawal by Subject|0
59138|NCT01432444|238936|P1|Extension Phase|Withdrawal by Subject|0
59139|NCT01432444|238934|P3|Extension Phase|Physician Decision|1
59140|NCT01432444|238935|P2|Extension Phase|Physician Decision|0
59141|NCT01432444|238936|P1|Extension Phase|Physician Decision|0
59142|NCT01432444|238934|P3|Extension Phase|Met Withdrawal Criteria|144
59143|NCT01432444|238935|P2|Extension Phase|Met Withdrawal Criteria|0
59144|NCT01432444|238936|P1|Extension Phase|Met Withdrawal Criteria|0
59145|NCT01432444|238934|P3|Extension Phase|Sponsor Discontinued Trial|7
59146|NCT01432444|238935|P2|Extension Phase|Sponsor Discontinued Trial|0
59147|NCT01432444|238936|P1|Extension Phase|Sponsor Discontinued Trial|0
59148|NCT01432444|238934|P3|Extension Phase|Adverse Event|10
59149|NCT01432444|238935|P2|Extension Phase|Adverse Event|0
59150|NCT01432444|238936|P1|Extension Phase|Adverse Event|0
59151|NCT01432444|238934|P3|Extension Phase|Lost to Follow-up|17
59152|NCT01432444|238935|P2|Extension Phase|Lost to Follow-up|0
59153|NCT01432444|238936|P1|Extension Phase|Lost to Follow-up|0
59154|NCT01432444|238934|P3|Treatment Phase|Lack of Efficacy|0
59155|NCT01432444|238935|P2|Treatment Phase|Lack of Efficacy|10
59156|NCT01432444|238936|P1|Treatment Phase|Lack of Efficacy|0
59157|NCT01432444|238934|P3|Treatment Phase|Protocol Deviation|0
59158|NCT01432444|238935|P2|Treatment Phase|Protocol Deviation|3
59159|NCT01432444|238936|P1|Treatment Phase|Protocol Deviation|0
59160|NCT01432444|238934|P3|Treatment Phase|Withdrawal by Subject|0
59161|NCT01432444|238935|P2|Treatment Phase|Withdrawal by Subject|41
59162|NCT01432444|238936|P1|Treatment Phase|Withdrawal by Subject|0
59163|NCT01432444|238934|P3|Treatment Phase|Physician Decision|0
59164|NCT01432444|238935|P2|Treatment Phase|Physician Decision|5
59165|NCT01432444|238936|P1|Treatment Phase|Physician Decision|0
59166|NCT01432444|238934|P3|Treatment Phase|Met Withdrawal Criteria|0
59167|NCT01432444|238935|P2|Treatment Phase|Met Withdrawal Criteria|11
59168|NCT01432444|238936|P1|Treatment Phase|Met Withdrawal Criteria|0
59169|NCT01432444|238934|P3|Treatment Phase|Adverse Event|0
59170|NCT01432444|238935|P2|Treatment Phase|Adverse Event|37
59171|NCT01432444|238936|P1|Treatment Phase|Adverse Event|0
59172|NCT01432444|238934|P3|Treatment Phase|Lost to Follow-up|0
59173|NCT01432444|238935|P2|Treatment Phase|Lost to Follow-up|33
59174|NCT01432444|238936|P1|Treatment Phase|Lost to Follow-up|0
59175|NCT01432444|238934|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
59176|NCT01432444|238935|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
59177|NCT01432444|238936|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
59178|NCT01432444|238934|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
59179|NCT01432444|238935|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
59180|NCT01432444|238936|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
59181|NCT01432444|238934|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
59182|NCT01432444|238935|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
59183|NCT01432444|238936|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
59184|NCT01432444|238934|P3|Tolerability/Cross-titration Phase|Physician Decision|0
59185|NCT01432444|238935|P2|Tolerability/Cross-titration Phase|Physician Decision|0
59186|NCT01432444|238936|P1|Tolerability/Cross-titration Phase|Physician Decision|8
59187|NCT01432444|238934|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
59188|NCT01432444|238935|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
59189|NCT01432444|238936|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
59190|NCT01432444|238934|P3|Tolerability/Cross-titration Phase|Adverse Event|0
59191|NCT01432444|238935|P2|Tolerability/Cross-titration Phase|Adverse Event|0
59192|NCT01432444|238936|P1|Tolerability/Cross-titration Phase|Adverse Event|16
59193|NCT01432444|238934|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
59194|NCT01432444|238935|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
59195|NCT01432444|238936|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
59196|NCT01432366|238962|P1|Overall Study|Other|14
59197|NCT01432366|238962|P1|Overall Study|Investigator Forget to Complete Visits|1
59198|NCT01432366|238962|P1|Overall Study|Site Closed|20
59199|NCT01432366|238962|P1|Overall Study|Lack of Efficacy|1
59200|NCT01432366|238962|P1|Overall Study|Lost to Follow-up|13
59201|NCT01432366|238962|P1|Overall Study|Pregnancy|1
59202|NCT01432366|238962|P1|Overall Study|Withdrawal Due to Non-Compliance|3
59203|NCT01432366|238962|P1|Overall Study|Adverse Event|8
59204|NCT01432366|238962|P1|Overall Study|Non-Responder|7
59205|NCT01432327|238984|P4|Posttest 1 Year|Allergic reaction|1
59206|NCT01432327|238985|P3|Posttest 1 Year|Allergic reaction|1
59207|NCT01432327|238986|P2|Posttest 1 Year|Allergic reaction|0
59208|NCT01432327|238987|P1|Posttest 1 Year|Allergic reaction|0
59209|NCT01432327|238984|P4|Posttest 1 Year|Lost to Follow-up|2
59210|NCT01432327|238985|P3|Posttest 1 Year|Lost to Follow-up|4
59211|NCT01432327|238986|P2|Posttest 1 Year|Lost to Follow-up|0
59212|NCT01432327|238987|P1|Posttest 1 Year|Lost to Follow-up|0
59213|NCT01432327|238984|P4|Posttest 1 Year|Measurement have to take place in future|20
59214|NCT01432327|238985|P3|Posttest 1 Year|Measurement have to take place in future|15
59215|NCT01432327|238986|P2|Posttest 1 Year|Measurement have to take place in future|28
59216|NCT01432327|238987|P1|Posttest 1 Year|Measurement have to take place in future|24
59217|NCT01432327|238984|P4|Posttest 6 Months|Withdrawal by Subject|0
59218|NCT01432327|238985|P3|Posttest 6 Months|Withdrawal by Subject|1
59219|NCT01432327|238986|P2|Posttest 6 Months|Withdrawal by Subject|0
59220|NCT01432327|238987|P1|Posttest 6 Months|Withdrawal by Subject|0
59221|NCT01432327|238984|P4|Posttest 6 Months|Allergic reaction|0
59222|NCT01432327|238985|P3|Posttest 6 Months|Allergic reaction|1
59223|NCT01432327|238986|P2|Posttest 6 Months|Allergic reaction|0
59224|NCT01432327|238987|P1|Posttest 6 Months|Allergic reaction|0
59225|NCT01432327|238984|P4|Posttest 6 Months|Lost to Follow-up|2
59226|NCT01432327|238985|P3|Posttest 6 Months|Lost to Follow-up|3
59227|NCT01432327|238986|P2|Posttest 6 Months|Lost to Follow-up|0
59228|NCT01432327|238987|P1|Posttest 6 Months|Lost to Follow-up|0
59229|NCT01432327|238984|P4|Posttest 3 Months|Allergic reaction|0
59230|NCT01432327|238985|P3|Posttest 3 Months|Allergic reaction|0
59231|NCT01432327|238986|P2|Posttest 3 Months|Allergic reaction|2
59232|NCT01432327|238987|P1|Posttest 3 Months|Allergic reaction|0
59233|NCT01432327|238984|P4|Posttest 3 Months|Lost to Follow-up|1
59234|NCT01432327|238985|P3|Posttest 3 Months|Lost to Follow-up|2
59235|NCT01432327|238986|P2|Posttest 3 Months|Lost to Follow-up|0
59236|NCT01432327|238987|P1|Posttest 3 Months|Lost to Follow-up|1
59237|NCT01432327|238984|P4|Posttest 3 Months|depression|0
59238|NCT01432327|238985|P3|Posttest 3 Months|depression|0
59239|NCT01432327|238986|P2|Posttest 3 Months|depression|0
59240|NCT01432327|238987|P1|Posttest 3 Months|depression|3
59241|NCT01432275|238997|P2|ADC With Calculator (10 Days)|Protocol Violation|1
59242|NCT01432275|238998|P1|ADC With Calculator (10 Days)|Protocol Violation|0
59243|NCT01432275|238997|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
59244|NCT01432275|238998|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
59245|NCT01432275|238997|P2|ADC With Calculator (10 Days)|Physician Decision|1
59246|NCT01432275|238998|P1|ADC With Calculator (10 Days)|Physician Decision|1
59247|NCT01432275|238997|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
59248|NCT01432275|238998|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
59249|NCT01432275|238997|P2|Second BG Meter System (7 Days)|Physician Decision|1
59250|NCT01432275|238998|P1|Second BG Meter System (7 Days)|Physician Decision|0
59251|NCT01432275|238997|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
59252|NCT01432275|238998|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
59253|NCT01432275|238997|P2|Second BG Meter System (7 Days)|Adverse Event|1
59254|NCT01432275|238998|P1|Second BG Meter System (7 Days)|Adverse Event|1
59255|NCT01432275|238997|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
59256|NCT01432275|238998|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
59257|NCT01432275|238997|P2|First BG Meter System (7 Days)|Adverse Event|2
59258|NCT01432275|238998|P1|First BG Meter System (7 Days)|Adverse Event|0
59259|NCT01432262|239007|P2|Overall Study|Withdrawal by Subject|1
59260|NCT01432262|239008|P1|Overall Study|Withdrawal by Subject|2
59261|NCT01431976|239102|P1|Overall Study|Withdrawal by Subject|1
59262|NCT01431976|239102|P1|Overall Study|Physician Decision|1
59263|NCT01431976|239102|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
59264|NCT01431976|239102|P1|Overall Study|Lack of Efficacy|2
59265|NCT01431976|239102|P1|Overall Study|Adverse Event|6
59266|NCT01431963|239113|P1|Overall Study|Withdrawal by Subject|3
59267|NCT01431963|239113|P1|Overall Study|Physician Decision|4
59268|NCT01431963|239113|P1|Overall Study|Protocol-defined Stopping Criteria|2
59269|NCT01431963|239113|P1|Overall Study|Protocol Violation|1
59270|NCT01431963|239113|P1|Overall Study|Lack of Efficacy|7
59271|NCT01431963|239113|P1|Overall Study|Adverse Event|18
59272|NCT01431950|239121|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
59273|NCT01431950|239122|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
59274|NCT01431950|239121|P2|Overall Study|Lost to Follow-up|1
59275|NCT01431950|239122|P1|Overall Study|Lost to Follow-up|0
59276|NCT01431950|239121|P2|Overall Study|Lack of Efficacy|1
59277|NCT01431950|239122|P1|Overall Study|Lack of Efficacy|2
59278|NCT01431950|239121|P2|Overall Study|Physician Decision|1
59279|NCT01431950|239122|P1|Overall Study|Physician Decision|2
59280|NCT01431950|239121|P2|Overall Study|Adverse Event|2
59281|NCT01431950|239122|P1|Overall Study|Adverse Event|2
59282|NCT01431950|239121|P2|Overall Study|Protocol Violation|3
59283|NCT01431950|239122|P1|Overall Study|Protocol Violation|2
59284|NCT01431950|239121|P2|Overall Study|Withdrawal by Subject|3
59285|NCT01431950|239122|P1|Overall Study|Withdrawal by Subject|4
59286|NCT01431950|239121|P2|Overall Study|Study Site Closed/Terminated|3
59287|NCT01431950|239122|P1|Overall Study|Study Site Closed/Terminated|7
59288|NCT01431716|239160|P1|Overall Study|Withdrawal of consent|1
59289|NCT01431521|239185|P4|Overall Study|Withdrawal by Subject|0
59290|NCT01431521|239186|P3|Overall Study|Withdrawal by Subject|1
59291|NCT01431521|239187|P2|Overall Study|Withdrawal by Subject|0
59292|NCT01431521|239188|P1|Overall Study|Withdrawal by Subject|0
59293|NCT01431508|239209|P1|Overall Study|Unable to Follow Protocol Procedures|1
59294|NCT01431508|239209|P1|Overall Study|Lack of Efficacy|1
59295|NCT01431287|239260|P5|Overall Study|not stated above|1
59296|NCT01431287|239261|P4|Overall Study|not stated above|2
59297|NCT01431287|239262|P3|Overall Study|not stated above|2
59298|NCT01431287|239263|P2|Overall Study|not stated above|2
59299|NCT01431287|239264|P1|Overall Study|not stated above|4
59300|NCT01431287|239260|P5|Overall Study|Consent withdrawn not due to AE|29
59301|NCT01431287|239261|P4|Overall Study|Consent withdrawn not due to AE|19
59302|NCT01431287|239262|P3|Overall Study|Consent withdrawn not due to AE|34
59303|NCT01431287|239263|P2|Overall Study|Consent withdrawn not due to AE|30
59304|NCT01431287|239264|P1|Overall Study|Consent withdrawn not due to AE|29
59305|NCT01431287|239260|P5|Overall Study|Lost to Follow-up|1
59306|NCT01431287|239261|P4|Overall Study|Lost to Follow-up|3
59307|NCT01431287|239262|P3|Overall Study|Lost to Follow-up|2
59308|NCT01431287|239263|P2|Overall Study|Lost to Follow-up|3
59309|NCT01431287|239264|P1|Overall Study|Lost to Follow-up|0
59310|NCT01431287|239260|P5|Overall Study|Non compliant with protocol|5
59311|NCT01431287|239261|P4|Overall Study|Non compliant with protocol|6
59312|NCT01431287|239262|P3|Overall Study|Non compliant with protocol|5
59313|NCT01431287|239263|P2|Overall Study|Non compliant with protocol|6
59314|NCT01431287|239264|P1|Overall Study|Non compliant with protocol|6
59315|NCT01431287|239260|P5|Overall Study|Adverse Event|41
59316|NCT01431287|239261|P4|Overall Study|Adverse Event|33
59317|NCT01431287|239262|P3|Overall Study|Adverse Event|53
59318|NCT01431287|239263|P2|Overall Study|Adverse Event|57
59319|NCT01431287|239264|P1|Overall Study|Adverse Event|59
59320|NCT01431287|239260|P5|Overall Study|not treated|0
59321|NCT01431287|239261|P4|Overall Study|not treated|0
59322|NCT01431287|239262|P3|Overall Study|not treated|1
59323|NCT01431287|239263|P2|Overall Study|not treated|0
59324|NCT01431287|239264|P1|Overall Study|not treated|0
59325|NCT01431274|239426|P5|Overall Study|Other reason not stated above|4
59326|NCT01431274|239427|P4|Overall Study|Other reason not stated above|2
59327|NCT01431274|239428|P3|Overall Study|Other reason not stated above|7
59328|NCT01431274|239429|P2|Overall Study|Other reason not stated above|5
59329|NCT01431274|239430|P1|Overall Study|Other reason not stated above|6
59330|NCT01431274|239426|P5|Overall Study|Lost to Follow-up|0
59331|NCT01431274|239427|P4|Overall Study|Lost to Follow-up|4
59332|NCT01431274|239428|P3|Overall Study|Lost to Follow-up|1
59333|NCT01431274|239429|P2|Overall Study|Lost to Follow-up|7
59334|NCT01431274|239430|P1|Overall Study|Lost to Follow-up|6
59335|NCT01431274|239426|P5|Overall Study|Non compliant with protocol|4
59336|NCT01431274|239427|P4|Overall Study|Non compliant with protocol|4
59337|NCT01431274|239428|P3|Overall Study|Non compliant with protocol|4
59338|NCT01431274|239429|P2|Overall Study|Non compliant with protocol|8
59339|NCT01431274|239430|P1|Overall Study|Non compliant with protocol|5
59340|NCT01431274|239426|P5|Overall Study|Consent withdrawn not due to AE|11
59341|NCT01431274|239427|P4|Overall Study|Consent withdrawn not due to AE|20
59342|NCT01431274|239428|P3|Overall Study|Consent withdrawn not due to AE|17
59343|NCT01431274|239429|P2|Overall Study|Consent withdrawn not due to AE|20
59344|NCT01431274|239430|P1|Overall Study|Consent withdrawn not due to AE|29
59345|NCT01431274|239426|P5|Overall Study|Adverse Event|37
59346|NCT01431274|239427|P4|Overall Study|Adverse Event|30
59347|NCT01431274|239428|P3|Overall Study|Adverse Event|43
59348|NCT01431274|239429|P2|Overall Study|Adverse Event|37
59349|NCT01431274|239430|P1|Overall Study|Adverse Event|51
59350|NCT01431144|239608|P2|Overall Study|Implant mobility and removal|0
59351|NCT01431144|239609|P1|Overall Study|Implant mobility and removal|2
59352|NCT01431079|239628|P2|Overall Study|Lost to Follow-up|39
59353|NCT01431079|239629|P1|Overall Study|Lost to Follow-up|35
59354|NCT01430754|239708|P2|Run-In Phase|Lost to Follow-up|0
59355|NCT01430754|239709|P1|Run-In Phase|Lost to Follow-up|1
59356|NCT01430754|239708|P2|Run-In Phase|Withdrawal by Subject|0
59357|NCT01430754|239709|P1|Run-In Phase|Withdrawal by Subject|2
59358|NCT01430754|239708|P2|Run-In Phase|Other|0
59359|NCT01430754|239709|P1|Run-In Phase|Other|2
59360|NCT01430754|239708|P2|Run-In Phase|Adverse Event|0
59361|NCT01430754|239709|P1|Run-In Phase|Adverse Event|2
59362|NCT01430754|239708|P2|Run-In Phase|Protocol Violation|0
59363|NCT01430754|239709|P1|Run-In Phase|Protocol Violation|6
59364|NCT01430754|239708|P2|Run-In Phase|Circadian Period Ineligible|0
59365|NCT01430754|239709|P1|Run-In Phase|Circadian Period Ineligible|24
59366|NCT01430624|239767|P3|Overall Study|technical or eligibility|2
59367|NCT01430624|239768|P2|Overall Study|technical or eligibility|5
59368|NCT01430624|239769|P1|Overall Study|technical or eligibility|5
59369|NCT01430624|239767|P3|Overall Study|Lost to Follow-up|27
59370|NCT01430624|239768|P2|Overall Study|Lost to Follow-up|29
59371|NCT01430624|239769|P1|Overall Study|Lost to Follow-up|23
59372|NCT01430611|239800|P2|Overall Study|Withdrawal by Subject|14
59373|NCT01430611|239801|P1|Overall Study|Withdrawal by Subject|15
59374|NCT01430611|239800|P2|Overall Study|Lost to Follow-up|0
59375|NCT01430611|239801|P1|Overall Study|Lost to Follow-up|1
59376|NCT01430611|239800|P2|Overall Study|Protocol Violation|0
59377|NCT01430611|239801|P1|Overall Study|Protocol Violation|1
59378|NCT01430611|239800|P2|Overall Study|Adverse Event|1
59379|NCT01430611|239801|P1|Overall Study|Adverse Event|0
59380|NCT01430585|239819|P1|Overall Study|Other|7
59381|NCT01430585|239819|P1|Overall Study|Study Terminated by Sponsor|3
59382|NCT01430585|239819|P1|Overall Study|Objective Progression or Relapse|3
59383|NCT01430585|239819|P1|Overall Study|Death|1
59384|NCT01430468|239854|P2|Overall Study|Withdrawal by Subject|1
59385|NCT01430468|239855|P1|Overall Study|Withdrawal by Subject|1
59386|NCT01430468|239854|P2|Overall Study|Physician Decision|1
59387|NCT01430468|239855|P1|Overall Study|Physician Decision|2
59388|NCT01430455|239861|P1|Overall Study|Switched to follow-up phase|1
59389|NCT01430455|239861|P1|Overall Study|Withdrawal by Subject|1
59390|NCT01430403|239868|P3|Overall Study|Withdrawal by Subject|3
59391|NCT01430403|239869|P2|Overall Study|Withdrawal by Subject|1
59392|NCT01430403|239870|P1|Overall Study|Withdrawal by Subject|9
59393|NCT01430403|239868|P3|Overall Study|Protocol Violation|2
59394|NCT01430403|239869|P2|Overall Study|Protocol Violation|3
59395|NCT01430403|239870|P1|Overall Study|Protocol Violation|2
59396|NCT01430403|239868|P3|Overall Study|Physician Decision|0
59397|NCT01430403|239869|P2|Overall Study|Physician Decision|0
59398|NCT01430403|239870|P1|Overall Study|Physician Decision|1
59399|NCT01430403|239868|P3|Overall Study|Lost to Follow-up|3
59400|NCT01430403|239869|P2|Overall Study|Lost to Follow-up|5
59401|NCT01430403|239870|P1|Overall Study|Lost to Follow-up|5
59402|NCT01430130|239977|P1|Overall Study|Infection on Control Side of Incision|1
59403|NCT01430130|239977|P1|Overall Study|Lost to Follow-up|1
59404|NCT01430104|239983|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
59405|NCT01429623|240036|P2|Overall Study|No post baseline data|4
59406|NCT01429623|240037|P1|Overall Study|No post baseline data|4
59407|NCT01429623|240036|P2|Overall Study|Conversion to Alzheimer's disease|21
59408|NCT01429623|240037|P1|Overall Study|Conversion to Alzheimer's disease|14
59409|NCT01429623|240036|P2|Overall Study|Assorted|2
59410|NCT01429623|240037|P1|Overall Study|Assorted|1
59411|NCT01429623|240036|P2|Overall Study|Protocol Violation|2
59412|NCT01429623|240037|P1|Overall Study|Protocol Violation|3
59413|NCT01429623|240036|P2|Overall Study|Physician Decision|3
59414|NCT01429623|240037|P1|Overall Study|Physician Decision|2
59415|NCT01429623|240036|P2|Overall Study|Withdrawal by Subject|13
59416|NCT01429623|240037|P1|Overall Study|Withdrawal by Subject|19
59417|NCT01429623|240036|P2|Overall Study|Adverse Event|14
59418|NCT01429623|240037|P1|Overall Study|Adverse Event|7
59419|NCT01429623|240036|P2|Overall Study|Death|0
59420|NCT01429623|240037|P1|Overall Study|Death|1
59421|NCT01429584|240051|P2|Overall Study|Protocol Violation|1
59422|NCT01429584|240052|P1|Overall Study|Protocol Violation|0
59423|NCT01429584|240051|P2|Overall Study|Withdrawal by Subject|0
59424|NCT01429584|240052|P1|Overall Study|Withdrawal by Subject|1
59425|NCT01429441|240083|P2|Overall Study|Withdrawal by Subject|18
59426|NCT01429441|240084|P1|Overall Study|Withdrawal by Subject|27
59427|NCT01429441|240083|P2|Overall Study|Physician Decision|0
59428|NCT01429441|240084|P1|Overall Study|Physician Decision|1
59429|NCT01429441|240083|P2|Overall Study|Lost to Follow-up|2
59430|NCT01429441|240084|P1|Overall Study|Lost to Follow-up|5
59431|NCT01429441|240083|P2|Overall Study|Death|2
59432|NCT01429441|240084|P1|Overall Study|Death|0
59433|NCT01429441|240083|P2|Overall Study|Adverse Event|1
59434|NCT01429441|240084|P1|Overall Study|Adverse Event|5
59435|NCT01429298|240094|P2|Overall Study|Protocol Violation|6
59436|NCT01429298|240095|P1|Overall Study|Protocol Violation|4
59437|NCT01429285|240111|P2|Overall Study|Erroneously Enrolled Twice|2
59438|NCT01429285|240112|P1|Overall Study|Erroneously Enrolled Twice|8
59439|NCT01429285|240111|P2|Overall Study|Missing Data|3
59440|NCT01429285|240112|P1|Overall Study|Missing Data|5
59441|NCT01429285|240111|P2|Overall Study|Protocol Violation|4
59442|NCT01429285|240112|P1|Overall Study|Protocol Violation|9
59443|NCT01429077|240158|P2|Overall Study|Lost to Follow-up|3
59444|NCT01429077|240159|P1|Overall Study|Lost to Follow-up|0
59445|NCT01429051|240182|P1|Tolerability Phase|Other|2
59446|NCT01429051|240182|P1|Tolerability Phase|Physician Decision|1
59447|NCT01429051|240182|P1|Tolerability Phase|Withdrawal by Subject|5
59448|NCT01429051|240182|P1|Tolerability Phase|Adverse Event|2
59449|NCT01429051|240182|P1|Tolerability Phase|Death|5
59450|NCT01429051|240182|P1|Efficacy Phase|Death|1
59451|NCT01429051|240182|P1|Efficacy Phase|Adverse Event|1
59452|NCT01429051|240182|P1|Titration Phase|Less than 3 BTP episodes per week|2
59453|NCT01429051|240182|P1|Titration Phase|Unsuccessful titration at any dose|1
59454|NCT01429051|240182|P1|Titration Phase|Physician Decision|1
59455|NCT01429051|240182|P1|Titration Phase|Withdrawal by Subject|7
59456|NCT01429051|240182|P1|Titration Phase|Death|1
59457|NCT01428882|240205|P2|Overall Study|Protocol Violation|3
59458|NCT01428882|240206|P1|Overall Study|Protocol Violation|4
59459|NCT01428882|240205|P2|Overall Study|Lack of Efficacy|7
59460|NCT01428882|240206|P1|Overall Study|Lack of Efficacy|2
59461|NCT01428713|240229|P2|Overall Study|Adverse Event|2
59462|NCT01428713|240230|P1|Overall Study|Adverse Event|0
59463|NCT01428713|240229|P2|Overall Study|Withdrawal by Subject|1
59464|NCT01428713|240230|P1|Overall Study|Withdrawal by Subject|1
59465|NCT01428713|240229|P2|Overall Study|Non-compliance|2
59466|NCT01428713|240230|P1|Overall Study|Non-compliance|2
59467|NCT01428661|240239|P3|Open Label Extension|**Various|185
59468|NCT01428661|240240|P2|Open Label Extension|**Various|0
59469|NCT01428661|240241|P1|Open Label Extension|**Various|0
59470|NCT01428661|240239|P3|Open Label Extension|Lack of Efficacy|24
59471|NCT01428661|240240|P2|Open Label Extension|Lack of Efficacy|0
59472|NCT01428661|240241|P1|Open Label Extension|Lack of Efficacy|0
59473|NCT01428661|240239|P3|Open Label Extension|Withdrawal by Subject|49
59474|NCT01428661|240240|P2|Open Label Extension|Withdrawal by Subject|0
59475|NCT01428661|240241|P1|Open Label Extension|Withdrawal by Subject|0
59476|NCT01428661|240239|P3|Open Label Extension|Lost to Follow-up|38
59477|NCT01428661|240240|P2|Open Label Extension|Lost to Follow-up|0
59478|NCT01428661|240241|P1|Open Label Extension|Lost to Follow-up|0
59479|NCT01428661|240239|P3|Open Label Extension|Adverse Event|15
59480|NCT01428661|240240|P2|Open Label Extension|Adverse Event|0
59481|NCT01428661|240241|P1|Open Label Extension|Adverse Event|0
59482|NCT01428661|240239|P3|Open Label Extension|Protocol Violation|9
59483|NCT01428661|240240|P2|Open Label Extension|Protocol Violation|0
59484|NCT01428661|240241|P1|Open Label Extension|Protocol Violation|0
59485|NCT01428661|240239|P3|Double-Masked Phase|*Various|0
59486|NCT01428661|240240|P2|Double-Masked Phase|*Various|6
59487|NCT01428661|240241|P1|Double-Masked Phase|*Various|1
59488|NCT01428661|240239|P3|Double-Masked Phase|Lack of Efficacy|0
59489|NCT01428661|240240|P2|Double-Masked Phase|Lack of Efficacy|1
59490|NCT01428661|240241|P1|Double-Masked Phase|Lack of Efficacy|2
59491|NCT01428661|240239|P3|Double-Masked Phase|Withdrawal by Subject|0
59492|NCT01428661|240240|P2|Double-Masked Phase|Withdrawal by Subject|20
59493|NCT01428661|240241|P1|Double-Masked Phase|Withdrawal by Subject|18
59494|NCT01428661|240239|P3|Double-Masked Phase|Lost to Follow-up|0
59495|NCT01428661|240240|P2|Double-Masked Phase|Lost to Follow-up|14
59496|NCT01428661|240241|P1|Double-Masked Phase|Lost to Follow-up|14
59497|NCT01428661|240239|P3|Double-Masked Phase|Adverse Event|0
59498|NCT01428661|240240|P2|Double-Masked Phase|Adverse Event|4
59499|NCT01428661|240241|P1|Double-Masked Phase|Adverse Event|13
59500|NCT01428661|240239|P3|Double-Masked Phase|Protocol Violation|0
59501|NCT01428661|240240|P2|Double-Masked Phase|Protocol Violation|4
59502|NCT01428661|240241|P1|Double-Masked Phase|Protocol Violation|9
59503|NCT01428583|240249|P1|Overall Study|Other|6
59504|NCT01428583|240249|P1|Overall Study|Sponsor’s request|3
59505|NCT01428583|240249|P1|Overall Study|Confirmed positive urine drug test|8
59506|NCT01428583|240249|P1|Overall Study|Non-compliant|25
59507|NCT01428583|240249|P1|Overall Study|Physician Decision|12
59508|NCT01428583|240249|P1|Overall Study|Protocol Violation|1
59509|NCT01428583|240249|P1|Overall Study|Pregnancy|1
59510|NCT01428583|240249|P1|Overall Study|Death|1
59511|NCT01428583|240249|P1|Overall Study|Lost to Follow-up|17
59512|NCT01428583|240249|P1|Overall Study|Lack of Efficacy|37
59513|NCT01428583|240249|P1|Overall Study|Withdrawal by Subject|51
59514|NCT01428583|240249|P1|Overall Study|Adverse Event|75
59515|NCT01428258|240286|P2|Intervention 1|Withdrawal by Subject|0
59516|NCT01428258|240287|P1|Intervention 1|Withdrawal by Subject|2
59517|NCT01428219|240305|P1|Overall Study|25 patients enrolled, 3 were not treated|3
59518|NCT01428128|240316|P1|Overall Study|Adverse Event|1
59519|NCT01428128|240316|P1|Overall Study|Received Neulasta in one cycle|2
59520|NCT01428128|240316|P1|Overall Study|Screen failure by p53|10
59521|NCT01428128|240316|P1|Overall Study|Withdrawal by Subject|4
59522|NCT01428115|240321|P1|Overall Study|Withdrawal by Subject|4
59523|NCT01428115|240321|P1|Overall Study|Protocol Violation|3
59524|NCT01428115|240321|P1|Overall Study|Pregnancy|1
59525|NCT01428115|240321|P1|Overall Study|Lost to Follow-up|10
59526|NCT01428115|240321|P1|Overall Study|Lack of Efficacy|3
59527|NCT01428076|240336|P2|Overall Study|Adverse Event|1
59528|NCT01428076|240337|P1|Overall Study|Adverse Event|0
59529|NCT01428063|240348|P3|Overall Study|No longer meets study criteria|0
59530|NCT01428063|240349|P2|Overall Study|No longer meets study criteria|1
59531|NCT01428063|240350|P1|Overall Study|No longer meets study criteria|0
59532|NCT01428063|240348|P3|Overall Study|Lost to Follow-up|0
59533|NCT01428063|240349|P2|Overall Study|Lost to Follow-up|2
59534|NCT01428063|240350|P1|Overall Study|Lost to Follow-up|0
59535|NCT01428063|240348|P3|Overall Study|Adverse Event|0
59536|NCT01428063|240349|P2|Overall Study|Adverse Event|3
59537|NCT01428063|240350|P1|Overall Study|Adverse Event|2
59538|NCT01428063|240348|P3|Overall Study|Lack of Efficacy|1
59539|NCT01428063|240349|P2|Overall Study|Lack of Efficacy|4
59540|NCT01428063|240350|P1|Overall Study|Lack of Efficacy|8
59541|NCT01427933|240421|P2|Overall Study|Investigator's Decision|0
59542|NCT01427933|240422|P1|Overall Study|Investigator's Decision|1
59543|NCT01427933|240421|P2|Overall Study|Not Specified|0
59544|NCT01427933|240422|P1|Overall Study|Not Specified|1
59545|NCT01427933|240421|P2|Overall Study|Lost to Follow-up|5
59546|NCT01427933|240422|P1|Overall Study|Lost to Follow-up|1
59547|NCT01427933|240421|P2|Overall Study|Withdrawal by Subject|8
59548|NCT01427933|240422|P1|Overall Study|Withdrawal by Subject|5
59549|NCT01427920|240442|P2|Overall Study|Unclassified|8
59550|NCT01427920|240443|P1|Overall Study|Unclassified|2
59551|NCT01427920|240442|P2|Overall Study|Withdrawal Criteria|4
59552|NCT01427920|240443|P1|Overall Study|Withdrawal Criteria|4
59553|NCT01427920|240442|P2|Overall Study|Protocol Violation|3
59554|NCT01427920|240443|P1|Overall Study|Protocol Violation|1
59555|NCT01427920|240442|P2|Overall Study|Lack of Efficacy|0
59556|NCT01427920|240443|P1|Overall Study|Lack of Efficacy|1
59557|NCT01427920|240442|P2|Overall Study|Adverse Event|2
59558|NCT01427920|240443|P1|Overall Study|Adverse Event|1
59559|NCT01427907|240463|P2|Overall Study|Withdrawal by Subject|4
59560|NCT01427907|240464|P1|Overall Study|Withdrawal by Subject|3
59561|NCT01427803|240485|P2|Overall Study|did not take product|0
59562|NCT01427803|240486|P1|Overall Study|did not take product|1
59563|NCT01427803|240485|P2|Overall Study|Physician Decision|0
59564|NCT01427803|240486|P1|Overall Study|Physician Decision|3
59565|NCT01427803|240485|P2|Overall Study|Protocol Violation|0
59566|NCT01427803|240486|P1|Overall Study|Protocol Violation|1
59567|NCT01427803|240485|P2|Overall Study|Unable to complete full treatment period|0
59568|NCT01427803|240486|P1|Overall Study|Unable to complete full treatment period|6
59569|NCT01427803|240485|P2|Overall Study|Withdrawal by Subject|0
59570|NCT01427803|240486|P1|Overall Study|Withdrawal by Subject|20
59571|NCT01427803|240485|P2|Overall Study|Lost to Follow-up|26
59572|NCT01427803|240486|P1|Overall Study|Lost to Follow-up|32
59573|NCT01427751|240500|P2|Overall Study|Other miscellaneous reasons|4
59574|NCT01427751|240501|P1|Overall Study|Other miscellaneous reasons|6
59575|NCT01427751|240500|P2|Overall Study|Death|0
59576|NCT01427751|240501|P1|Overall Study|Death|2
59577|NCT01427751|240500|P2|Overall Study|Protocol Violation|4
59578|NCT01427751|240501|P1|Overall Study|Protocol Violation|6
59579|NCT01427751|240500|P2|Overall Study|Withdrawal of consent|2
59580|NCT01427751|240501|P1|Overall Study|Withdrawal of consent|2
59581|NCT01427751|240500|P2|Overall Study|Lost to Follow-up|1
59582|NCT01427751|240501|P1|Overall Study|Lost to Follow-up|3
59583|NCT01427751|240500|P2|Overall Study|No further treatment benefit expected|1
59584|NCT01427751|240501|P1|Overall Study|No further treatment benefit expected|5
59585|NCT01427751|240500|P2|Overall Study|Adverse Event|2
59586|NCT01427751|240501|P1|Overall Study|Adverse Event|18
59587|NCT01427738|240521|P2|Overall Study|Lost to Follow-up|5
59588|NCT01427738|240522|P1|Overall Study|Lost to Follow-up|1
59589|NCT01427738|240521|P2|Overall Study|Subject not willing to adhere to reqs|2
59590|NCT01427738|240522|P1|Overall Study|Subject not willing to adhere to reqs|1
59591|NCT01427738|240521|P2|Overall Study|Withdrawal by Subject|2
59592|NCT01427738|240522|P1|Overall Study|Withdrawal by Subject|0
59593|NCT01427738|240521|P2|Overall Study|Subject unable to get to clinic|2
59594|NCT01427738|240522|P1|Overall Study|Subject unable to get to clinic|5
59595|NCT01427738|240521|P2|Overall Study|Severe debilitation, unable to continue|1
59596|NCT01427738|240522|P1|Overall Study|Severe debilitation, unable to continue|0
59597|NCT01427738|240521|P2|Overall Study|Death|9
59598|NCT01427738|240522|P1|Overall Study|Death|12
59599|NCT01427309|240585|P4|Overall Study|Withdrawal by Subject|55
59600|NCT01427309|240586|P3|Overall Study|Withdrawal by Subject|61
59601|NCT01427309|240587|P2|Overall Study|Withdrawal by Subject|148
59602|NCT01427309|240588|P1|Overall Study|Withdrawal by Subject|148
59603|NCT01427309|240585|P4|Overall Study|Serious adverse event|61
59604|NCT01427309|240586|P3|Overall Study|Serious adverse event|50
59605|NCT01427309|240587|P2|Overall Study|Serious adverse event|45
59606|NCT01427309|240588|P1|Overall Study|Serious adverse event|52
59607|NCT01427309|240585|P4|Overall Study|Adverse Event|1
59608|NCT01427309|240586|P3|Overall Study|Adverse Event|3
59609|NCT01427309|240587|P2|Overall Study|Adverse Event|0
59610|NCT01427309|240588|P1|Overall Study|Adverse Event|0
59611|NCT01427309|240585|P4|Overall Study|Protocol Violation|124
59612|NCT01427309|240586|P3|Overall Study|Protocol Violation|125
59613|NCT01427309|240587|P2|Overall Study|Protocol Violation|69
59614|NCT01427309|240588|P1|Overall Study|Protocol Violation|42
59615|NCT01427309|240585|P4|Overall Study|Lost to Follow-up|135
59616|NCT01427309|240586|P3|Overall Study|Lost to Follow-up|122
59617|NCT01427309|240587|P2|Overall Study|Lost to Follow-up|145
59618|NCT01427309|240588|P1|Overall Study|Lost to Follow-up|130
59619|NCT01426958|240635|P1|Overall Study|Adverse Event|2
59620|NCT01426854|240664|P2|Overall Study|Other|2
59621|NCT01426854|240665|P1|Overall Study|Other|3
59622|NCT01426854|240664|P2|Overall Study|Protocol Deviation|1
59623|NCT01426854|240665|P1|Overall Study|Protocol Deviation|0
59624|NCT01426854|240664|P2|Overall Study|Treatment Failure|16
59625|NCT01426854|240665|P1|Overall Study|Treatment Failure|0
59626|NCT01426854|240664|P2|Overall Study|Noncompliance|1
59627|NCT01426854|240665|P1|Overall Study|Noncompliance|0
59628|NCT01426854|240664|P2|Overall Study|Lost to Follow-up|0
59629|NCT01426854|240665|P1|Overall Study|Lost to Follow-up|3
59630|NCT01426854|240664|P2|Overall Study|Subject Decision Unrelated to AE|6
59631|NCT01426854|240665|P1|Overall Study|Subject Decision Unrelated to AE|5
59632|NCT01426854|240664|P2|Overall Study|Adverse Event|5
59633|NCT01426854|240665|P1|Overall Study|Adverse Event|1
59634|NCT01426789|240675|P6|Part 2|Adverse Event|0
59635|NCT01426789|240676|P5|Part 2|Adverse Event|1
59636|NCT01426789|240677|P4|Part 2|Adverse Event|0
59637|NCT01426789|240678|P3|Part 2|Adverse Event|2
59638|NCT01426789|240679|P2|Part 2|Adverse Event|0
59639|NCT01426789|240680|P1|Part 2|Adverse Event|0
59640|NCT01426789|240675|P6|Part 2|Lack of Efficacy|0
59641|NCT01426789|240676|P5|Part 2|Lack of Efficacy|2
59642|NCT01426789|240677|P4|Part 2|Lack of Efficacy|0
59643|NCT01426789|240678|P3|Part 2|Lack of Efficacy|5
59644|NCT01426789|240679|P2|Part 2|Lack of Efficacy|0
59645|NCT01426789|240680|P1|Part 2|Lack of Efficacy|0
59646|NCT01426789|240675|P6|Part 2|Withdrawal by Subject|0
59647|NCT01426789|240676|P5|Part 2|Withdrawal by Subject|2
59648|NCT01426789|240677|P4|Part 2|Withdrawal by Subject|1
59649|NCT01426789|240678|P3|Part 2|Withdrawal by Subject|0
59650|NCT01426789|240679|P2|Part 2|Withdrawal by Subject|0
59651|NCT01426789|240680|P1|Part 2|Withdrawal by Subject|0
59652|NCT01426789|240675|P6|Part 2|Lost to Follow-up|0
59653|NCT01426789|240676|P5|Part 2|Lost to Follow-up|1
59654|NCT01426789|240677|P4|Part 2|Lost to Follow-up|0
59655|NCT01426789|240678|P3|Part 2|Lost to Follow-up|4
59656|NCT01426789|240679|P2|Part 2|Lost to Follow-up|0
59657|NCT01426789|240680|P1|Part 2|Lost to Follow-up|0
59658|NCT01426789|240675|P6|Part 2|Administrative problems|0
59659|NCT01426789|240676|P5|Part 2|Administrative problems|1
59660|NCT01426789|240677|P4|Part 2|Administrative problems|0
59661|NCT01426789|240678|P3|Part 2|Administrative problems|2
59662|NCT01426789|240679|P2|Part 2|Administrative problems|0
59663|NCT01426789|240680|P1|Part 2|Administrative problems|0
59664|NCT01426789|240675|P6|Part 2|Death|0
59665|NCT01426789|240676|P5|Part 2|Death|1
59666|NCT01426789|240677|P4|Part 2|Death|0
59667|NCT01426789|240678|P3|Part 2|Death|1
59668|NCT01426789|240679|P2|Part 2|Death|0
59669|NCT01426789|240680|P1|Part 2|Death|0
59670|NCT01426789|240675|P6|Part 2|Protocol deviation|0
59671|NCT01426789|240676|P5|Part 2|Protocol deviation|0
59672|NCT01426789|240677|P4|Part 2|Protocol deviation|0
59673|NCT01426789|240678|P3|Part 2|Protocol deviation|1
59674|NCT01426789|240679|P2|Part 2|Protocol deviation|0
59675|NCT01426789|240680|P1|Part 2|Protocol deviation|0
59676|NCT01426789|240675|P6|Part 1|Adverse Event|0
59677|NCT01426789|240676|P5|Part 1|Adverse Event|0
59678|NCT01426789|240677|P4|Part 1|Adverse Event|0
59679|NCT01426789|240678|P3|Part 1|Adverse Event|0
59680|NCT01426789|240679|P2|Part 1|Adverse Event|0
59681|NCT01426789|240680|P1|Part 1|Adverse Event|3
59682|NCT01426789|240675|P6|Part 1|Lack of Efficacy|0
59683|NCT01426789|240676|P5|Part 1|Lack of Efficacy|0
59684|NCT01426789|240677|P4|Part 1|Lack of Efficacy|0
59685|NCT01426789|240678|P3|Part 1|Lack of Efficacy|0
59686|NCT01426789|240679|P2|Part 1|Lack of Efficacy|1
59687|NCT01426789|240680|P1|Part 1|Lack of Efficacy|2
59688|NCT01426789|240675|P6|Part 1|Lost to Follow-up|0
59689|NCT01426789|240676|P5|Part 1|Lost to Follow-up|0
59690|NCT01426789|240677|P4|Part 1|Lost to Follow-up|0
59691|NCT01426789|240678|P3|Part 1|Lost to Follow-up|0
59692|NCT01426789|240679|P2|Part 1|Lost to Follow-up|2
59693|NCT01426789|240680|P1|Part 1|Lost to Follow-up|1
59694|NCT01426789|240675|P6|Part 1|Protocol deviation|0
59695|NCT01426789|240676|P5|Part 1|Protocol deviation|0
59696|NCT01426789|240677|P4|Part 1|Protocol deviation|0
59697|NCT01426789|240678|P3|Part 1|Protocol deviation|0
59698|NCT01426789|240679|P2|Part 1|Protocol deviation|1
59699|NCT01426789|240680|P1|Part 1|Protocol deviation|0
59700|NCT01426438|240725|P2|Overall Study|Missed Scan|2
59701|NCT01426438|240726|P1|Overall Study|Missed Scan|2
59702|NCT01426438|240725|P2|Overall Study|Poor scan quality|2
59703|NCT01426438|240726|P1|Overall Study|Poor scan quality|3
59704|NCT01426438|240725|P2|Overall Study|Off study Treatment|3
59705|NCT01426438|240726|P1|Overall Study|Off study Treatment|9
59706|NCT01426438|240725|P2|Overall Study|Lost to Follow-up|3
59707|NCT01426438|240726|P1|Overall Study|Lost to Follow-up|1
59708|NCT01426425|240758|P1|Overall Study|Met inclusion/exclusion, not treated|2
59709|NCT01426425|240758|P1|Overall Study|Inclusion/exclusion criteria not met|151
59710|NCT01426425|240758|P1|Overall Study|Exited prior to EP study|22
59711|NCT01426373|240764|P1|Overall Study|Miscellaneous Reasons|4
59712|NCT01426373|240764|P1|Overall Study|Participant Convenience|10
59713|NCT01426373|240764|P1|Overall Study|Lost to Follow-up|14
59714|NCT01426373|240764|P1|Overall Study|Adverse Event|6
59715|NCT01426347|240797|P2|Overall Study|Withdrawal by Subject|0
59716|NCT01426347|240798|P1|Overall Study|Withdrawal by Subject|5
59717|NCT01426347|240797|P2|Overall Study|Protocol Violation|0
59718|NCT01426347|240798|P1|Overall Study|Protocol Violation|2
59719|NCT01426347|240797|P2|Overall Study|Lost to Follow-up|3
59720|NCT01426347|240798|P1|Overall Study|Lost to Follow-up|0
59721|NCT01426269|240806|P3|Period 2: 40 Weeks|Relapsed|18
59722|NCT01426269|240807|P2|Period 2: 40 Weeks|Relapsed|9
59723|NCT01426269|240808|P1|Period 2: 40 Weeks|Relapsed|0
59724|NCT01426269|240806|P3|Period 2: 40 Weeks|Site closed|5
59725|NCT01426269|240807|P2|Period 2: 40 Weeks|Site closed|6
59726|NCT01426269|240808|P1|Period 2: 40 Weeks|Site closed|0
59727|NCT01426269|240806|P3|Period 2: 40 Weeks|Lost to Follow-up|6
59728|NCT01426269|240807|P2|Period 2: 40 Weeks|Lost to Follow-up|8
59729|NCT01426269|240808|P1|Period 2: 40 Weeks|Lost to Follow-up|0
59730|NCT01426269|240806|P3|Period 2: 40 Weeks|Protocol Violation|5
59731|NCT01426269|240807|P2|Period 2: 40 Weeks|Protocol Violation|5
59732|NCT01426269|240808|P1|Period 2: 40 Weeks|Protocol Violation|0
59733|NCT01426269|240806|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
59734|NCT01426269|240807|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
59735|NCT01426269|240808|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
59736|NCT01426269|240806|P3|Period 2: 40 Weeks|Adverse Event|2
59737|NCT01426269|240807|P2|Period 2: 40 Weeks|Adverse Event|1
59738|NCT01426269|240808|P1|Period 2: 40 Weeks|Adverse Event|0
59739|NCT01426269|240806|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
59740|NCT01426269|240807|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
59826|NCT01425801|241047|P2|Period 1|Withdrawal by Subject|0
59741|NCT01426269|240808|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
59742|NCT01426269|240806|P3|Eligibility for Period 2, Randomization|Did not qualify|0
59743|NCT01426269|240807|P2|Eligibility for Period 2, Randomization|Did not qualify|0
59744|NCT01426269|240808|P1|Eligibility for Period 2, Randomization|Did not qualify|42
59745|NCT01426269|240806|P3|Period 1: 12 Weeks|Pregnancy|0
59746|NCT01426269|240807|P2|Period 1: 12 Weeks|Pregnancy|0
59747|NCT01426269|240808|P1|Period 1: 12 Weeks|Pregnancy|1
59748|NCT01426269|240806|P3|Period 1: 12 Weeks|Lost to Follow-up|0
59749|NCT01426269|240807|P2|Period 1: 12 Weeks|Lost to Follow-up|0
59750|NCT01426269|240808|P1|Period 1: 12 Weeks|Lost to Follow-up|22
59751|NCT01426269|240806|P3|Period 1: 12 Weeks|Protocol Violation|0
59752|NCT01426269|240807|P2|Period 1: 12 Weeks|Protocol Violation|0
59753|NCT01426269|240808|P1|Period 1: 12 Weeks|Protocol Violation|5
59754|NCT01426269|240806|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
59755|NCT01426269|240807|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
59756|NCT01426269|240808|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
59757|NCT01426269|240806|P3|Period 1: 12 Weeks|Adverse Event|0
59758|NCT01426269|240807|P2|Period 1: 12 Weeks|Adverse Event|0
59759|NCT01426269|240808|P1|Period 1: 12 Weeks|Adverse Event|5
59760|NCT01426113|240843|P2|Overall Study|Adverse Event|1
59761|NCT01426113|240844|P1|Overall Study|Adverse Event|0
59762|NCT01426113|240843|P2|Overall Study|Study Discontinued|1
59763|NCT01426113|240844|P1|Overall Study|Study Discontinued|1
59764|NCT01426009|240850|P1|Washout 4|Lost to Follow-up|1
59765|NCT01426009|240850|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
59766|NCT01426009|240850|P1|Washout 3|personal reasons|1
59767|NCT01426009|240850|P1|Washout 2|electrive surgery|1
59768|NCT01426009|240850|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
59769|NCT01426009|240850|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
59770|NCT01426009|240850|P1|Washout 1|Personal Reasons|1
59771|NCT01426009|240850|P1|Washout 1|Withdrawal by Subject|1
59772|NCT01426009|240850|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
59773|NCT01426009|240850|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
59774|NCT01425814|240946|P6|Period 5|Stability criteria not fulfilled|1
59775|NCT01425814|240947|P5|Period 5|Stability criteria not fulfilled|0
59776|NCT01425814|240948|P4|Period 5|Stability criteria not fulfilled|0
59777|NCT01425814|240949|P3|Period 5|Stability criteria not fulfilled|1
59778|NCT01425814|240950|P2|Period 5|Stability criteria not fulfilled|0
59779|NCT01425814|240951|P1|Period 5|Stability criteria not fulfilled|0
59780|NCT01425814|240946|P6|Period 4|Adverse Event|0
59781|NCT01425814|240947|P5|Period 4|Adverse Event|0
59782|NCT01425814|240948|P4|Period 4|Adverse Event|0
59783|NCT01425814|240949|P3|Period 4|Adverse Event|1
59784|NCT01425814|240950|P2|Period 4|Adverse Event|0
59785|NCT01425814|240951|P1|Period 4|Adverse Event|1
59786|NCT01425814|240946|P6|Period 3|Adverse Event|1
59787|NCT01425814|240947|P5|Period 3|Adverse Event|0
59788|NCT01425814|240948|P4|Period 3|Adverse Event|0
59789|NCT01425814|240949|P3|Period 3|Adverse Event|0
59790|NCT01425814|240950|P2|Period 3|Adverse Event|0
59791|NCT01425814|240951|P1|Period 3|Adverse Event|0
59792|NCT01425814|240946|P6|Period 2|Stability criteria not fulfilled|0
59793|NCT01425814|240947|P5|Period 2|Stability criteria not fulfilled|0
59794|NCT01425814|240948|P4|Period 2|Stability criteria not fulfilled|0
59795|NCT01425814|240949|P3|Period 2|Stability criteria not fulfilled|0
59796|NCT01425814|240950|P2|Period 2|Stability criteria not fulfilled|1
59797|NCT01425814|240951|P1|Period 2|Stability criteria not fulfilled|0
59798|NCT01425814|240946|P6|Period 1|Stability criteria not fulfilled|0
59799|NCT01425814|240947|P5|Period 1|Stability criteria not fulfilled|0
59800|NCT01425814|240948|P4|Period 1|Stability criteria not fulfilled|0
59801|NCT01425814|240949|P3|Period 1|Stability criteria not fulfilled|0
59802|NCT01425814|240950|P2|Period 1|Stability criteria not fulfilled|1
59803|NCT01425814|240951|P1|Period 1|Stability criteria not fulfilled|0
59804|NCT01425801|241043|P6|Period 4|Not able to maintain visit schedule|0
59805|NCT01425801|241044|P5|Period 4|Not able to maintain visit schedule|0
59806|NCT01425801|241045|P4|Period 4|Not able to maintain visit schedule|0
59807|NCT01425801|241046|P3|Period 4|Not able to maintain visit schedule|1
59808|NCT01425801|241047|P2|Period 4|Not able to maintain visit schedule|0
59809|NCT01425801|241048|P1|Period 4|Not able to maintain visit schedule|0
59810|NCT01425801|241043|P6|Period 3|Stability criteria not fullfilled|0
59811|NCT01425801|241044|P5|Period 3|Stability criteria not fullfilled|0
59812|NCT01425801|241045|P4|Period 3|Stability criteria not fullfilled|0
59813|NCT01425801|241046|P3|Period 3|Stability criteria not fullfilled|1
59814|NCT01425801|241047|P2|Period 3|Stability criteria not fullfilled|0
59815|NCT01425801|241048|P1|Period 3|Stability criteria not fullfilled|0
59816|NCT01425801|241043|P6|Period 2|Withdrawal by Subject|0
59817|NCT01425801|241044|P5|Period 2|Withdrawal by Subject|1
59818|NCT01425801|241045|P4|Period 2|Withdrawal by Subject|0
59819|NCT01425801|241046|P3|Period 2|Withdrawal by Subject|0
59820|NCT01425801|241047|P2|Period 2|Withdrawal by Subject|0
59821|NCT01425801|241048|P1|Period 2|Withdrawal by Subject|0
59822|NCT01425801|241043|P6|Period 1|Withdrawal by Subject|0
59823|NCT01425801|241044|P5|Period 1|Withdrawal by Subject|1
59824|NCT01425801|241045|P4|Period 1|Withdrawal by Subject|0
59825|NCT01425801|241046|P3|Period 1|Withdrawal by Subject|0
59827|NCT01425801|241048|P1|Period 1|Withdrawal by Subject|0
59828|NCT01425749|241154|P2|Overall Study|progression of melanoma|1
59829|NCT01425749|241155|P1|Overall Study|progression of melanoma|0
59830|NCT01425632|241173|P3|Overall Study|Withdrawal by Subject|1
59831|NCT01425632|241174|P2|Overall Study|Withdrawal by Subject|0
59832|NCT01425632|241175|P1|Overall Study|Withdrawal by Subject|0
59833|NCT01425632|241173|P3|Overall Study|Protocol Violation|2
59834|NCT01425632|241174|P2|Overall Study|Protocol Violation|0
59835|NCT01425632|241175|P1|Overall Study|Protocol Violation|0
59836|NCT01425632|241173|P3|Overall Study|Physician Decision|0
59837|NCT01425632|241174|P2|Overall Study|Physician Decision|0
59838|NCT01425632|241175|P1|Overall Study|Physician Decision|1
59839|NCT01425632|241173|P3|Overall Study|Adverse Event|1
59840|NCT01425632|241174|P2|Overall Study|Adverse Event|1
59841|NCT01425632|241175|P1|Overall Study|Adverse Event|0
59842|NCT01425528|241185|P2|Overall Study|Withdrawal by Subject|1
59843|NCT01425528|241186|P1|Overall Study|Withdrawal by Subject|1
59844|NCT01425463|241194|P2|Overall Study|Unknown Reason|7
59845|NCT01425463|241195|P1|Overall Study|Unknown Reason|4
59846|NCT01425463|241194|P2|Overall Study|Withdrawal by Subject|5
59847|NCT01425463|241195|P1|Overall Study|Withdrawal by Subject|7
59848|NCT01425463|241194|P2|Overall Study|Lost to Follow-up|2
59849|NCT01425463|241195|P1|Overall Study|Lost to Follow-up|5
59850|NCT01425463|241194|P2|Overall Study|Protocol Violation|2
59851|NCT01425463|241195|P1|Overall Study|Protocol Violation|2
59852|NCT01425463|241194|P2|Overall Study|Lack of Efficacy|1
59853|NCT01425463|241195|P1|Overall Study|Lack of Efficacy|1
59854|NCT01425463|241194|P2|Overall Study|Adverse Event|7
59855|NCT01425463|241195|P1|Overall Study|Adverse Event|5
59856|NCT01425359|241211|P2|Overall Study|Did Not Meet Qualifying Criteria|5
59857|NCT01425359|241212|P1|Overall Study|Did Not Meet Qualifying Criteria|3
59858|NCT01425359|241211|P2|Overall Study|Investigator’s Discretion|0
59859|NCT01425359|241212|P1|Overall Study|Investigator’s Discretion|2
59860|NCT01425359|241211|P2|Overall Study|Subject Withdrew Consent|2
59861|NCT01425359|241212|P1|Overall Study|Subject Withdrew Consent|1
59862|NCT01425359|241211|P2|Overall Study|Protocol Violation|2
59863|NCT01425359|241212|P1|Overall Study|Protocol Violation|1
59864|NCT01425359|241211|P2|Overall Study|Unsatisfactory Response|0
59865|NCT01425359|241212|P1|Overall Study|Unsatisfactory Response|1
59866|NCT01425359|241211|P2|Overall Study|Death|1
59867|NCT01425359|241212|P1|Overall Study|Death|0
59868|NCT01425359|241211|P2|Overall Study|Revascularization|1
59869|NCT01425359|241212|P1|Overall Study|Revascularization|0
59870|NCT01425359|241211|P2|Overall Study|Adverse Event|8
59871|NCT01425359|241212|P1|Overall Study|Adverse Event|9
59872|NCT01425359|241211|P2|Overall Study|Randomized but Not Treated|3
59873|NCT01425359|241212|P1|Overall Study|Randomized but Not Treated|2
59874|NCT01425268|241243|P2|Overall Study|Physician Decision|0
59875|NCT01425268|241244|P1|Overall Study|Physician Decision|1
59876|NCT01425268|241243|P2|Overall Study|Sponsor Decision|0
59877|NCT01425268|241244|P1|Overall Study|Sponsor Decision|5
59878|NCT01425268|241243|P2|Overall Study|Withdrawal by Subject|0
59879|NCT01425268|241244|P1|Overall Study|Withdrawal by Subject|2
59880|NCT01425203|241265|P3|Crossover Phase|Other virologic failure criteria|3
59881|NCT01425203|241266|P2|Crossover Phase|Other virologic failure criteria|0
59882|NCT01425203|241267|P1|Crossover Phase|Other virologic failure criteria|0
59883|NCT01425203|241265|P3|Crossover Phase|Failure at futility timepoint|3
59884|NCT01425203|241266|P2|Crossover Phase|Failure at futility timepoint|0
59885|NCT01425203|241267|P1|Crossover Phase|Failure at futility timepoint|0
59886|NCT01425203|241265|P3|Treatment Phase|Did not receive treatment|0
59887|NCT01425203|241266|P2|Treatment Phase|Did not receive treatment|1
59888|NCT01425203|241267|P1|Treatment Phase|Did not receive treatment|0
59889|NCT01425203|241265|P3|Treatment Phase|Unidentified reasons|0
59890|NCT01425203|241266|P2|Treatment Phase|Unidentified reasons|5
59891|NCT01425203|241267|P1|Treatment Phase|Unidentified reasons|11
59892|NCT01425203|241265|P3|Treatment Phase|Other virologic failure criteria|0
59893|NCT01425203|241266|P2|Treatment Phase|Other virologic failure criteria|3
59894|NCT01425203|241267|P1|Treatment Phase|Other virologic failure criteria|5
59895|NCT01425203|241265|P3|Treatment Phase|Failure at futility timepoint|0
59896|NCT01425203|241266|P2|Treatment Phase|Failure at futility timepoint|27
59897|NCT01425203|241267|P1|Treatment Phase|Failure at futility timepoint|8
59898|NCT01425203|241265|P3|Treatment Phase|DC during PR Lead-in Phase|0
59899|NCT01425203|241266|P2|Treatment Phase|DC during PR Lead-in Phase|1
59900|NCT01425203|241267|P1|Treatment Phase|DC during PR Lead-in Phase|3
59901|NCT01425190|241284|P3|Overall Study|Full dose not consumed.|0
59902|NCT01425190|241285|P2|Overall Study|Full dose not consumed.|0
59903|NCT01425190|241286|P1|Overall Study|Full dose not consumed.|1
59904|NCT01424930|241322|P2|Overall Study|Reason not specified|6
59905|NCT01424930|241323|P1|Overall Study|Reason not specified|0
59906|NCT01424930|241322|P2|Overall Study|Screen Failure|1
59907|NCT01424930|241323|P1|Overall Study|Screen Failure|0
59908|NCT01424930|241322|P2|Overall Study|Progressive Disease|6
59909|NCT01424930|241323|P1|Overall Study|Progressive Disease|3
59910|NCT01424930|241322|P2|Overall Study|Death|0
59911|NCT01424930|241323|P1|Overall Study|Death|1
59912|NCT01424930|241322|P2|Overall Study|Adverse Event|1
59913|NCT01424930|241323|P1|Overall Study|Adverse Event|0
59914|NCT01424813|241337|P2|Overall Study|not specified|2
59915|NCT01424813|241338|P1|Overall Study|not specified|1
59916|NCT01424813|241337|P2|Overall Study|Protocol Violation|0
59917|NCT01424813|241338|P1|Overall Study|Protocol Violation|1
59918|NCT01424813|241337|P2|Overall Study|Withdrawal by Subject|0
59919|NCT01424813|241338|P1|Overall Study|Withdrawal by Subject|3
59920|NCT01424644|241358|P2|Overall Study|Unable to Classify|0
59921|NCT01424644|241359|P1|Overall Study|Unable to Classify|1
59922|NCT01424644|241358|P2|Overall Study|Administrative Reason|0
59923|NCT01424644|241359|P1|Overall Study|Administrative Reason|1
59924|NCT01424644|241358|P2|Overall Study|Protocol Violation|3
59925|NCT01424644|241359|P1|Overall Study|Protocol Violation|4
59926|NCT01424644|241358|P2|Overall Study|Lost to Follow-up|12
59927|NCT01424644|241359|P1|Overall Study|Lost to Follow-up|16
59928|NCT01424644|241358|P2|Overall Study|Withdrawal by Subject|12
59929|NCT01424644|241359|P1|Overall Study|Withdrawal by Subject|9
59930|NCT01424644|241358|P2|Overall Study|Adverse Event|0
59931|NCT01424644|241359|P1|Overall Study|Adverse Event|2
59932|NCT01424566|241373|P3|Double-blind Treatment|Lack of Efficacy|1
59933|NCT01424566|241374|P2|Double-blind Treatment|Lack of Efficacy|1
59934|NCT01424566|241375|P1|Double-blind Treatment|Lack of Efficacy|0
59935|NCT01424566|241373|P3|Double-blind Treatment|Withdrawal by Investigator|1
59936|NCT01424566|241374|P2|Double-blind Treatment|Withdrawal by Investigator|1
59937|NCT01424566|241375|P1|Double-blind Treatment|Withdrawal by Investigator|0
59938|NCT01424566|241373|P3|Double-blind Treatment|Withdrawal by Subject|0
59939|NCT01424566|241374|P2|Double-blind Treatment|Withdrawal by Subject|2
59940|NCT01424566|241375|P1|Double-blind Treatment|Withdrawal by Subject|0
59941|NCT01424566|241373|P3|Double-blind Treatment|Adverse Event|13
59942|NCT01424566|241374|P2|Double-blind Treatment|Adverse Event|21
59943|NCT01424566|241375|P1|Double-blind Treatment|Adverse Event|0
59944|NCT01424566|241373|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
59945|NCT01424566|241374|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
59946|NCT01424566|241375|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
59947|NCT01424566|241373|P3|Single-blind Treatment|Met Exclusion Criteria|0
59948|NCT01424566|241374|P2|Single-blind Treatment|Met Exclusion Criteria|0
59949|NCT01424566|241375|P1|Single-blind Treatment|Met Exclusion Criteria|1
59950|NCT01424566|241373|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
59951|NCT01424566|241374|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
59952|NCT01424566|241375|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
59953|NCT01424566|241373|P3|Single-blind Treatment|Withdrawal by Investigator|0
59954|NCT01424566|241374|P2|Single-blind Treatment|Withdrawal by Investigator|0
59955|NCT01424566|241375|P1|Single-blind Treatment|Withdrawal by Investigator|2
59956|NCT01424566|241373|P3|Single-blind Treatment|Withdrawal by Subject|0
59957|NCT01424566|241374|P2|Single-blind Treatment|Withdrawal by Subject|0
59958|NCT01424566|241375|P1|Single-blind Treatment|Withdrawal by Subject|16
59959|NCT01424566|241373|P3|Single-blind Treatment|Adverse Event|0
59960|NCT01424566|241374|P2|Single-blind Treatment|Adverse Event|0
59961|NCT01424566|241375|P1|Single-blind Treatment|Adverse Event|71
59962|NCT01424514|241402|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
59963|NCT01424514|241403|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
59964|NCT01424514|241402|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
59965|NCT01424514|241403|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
59966|NCT01424501|241448|P6|Overall Study|Lost to Follow-up|0
59967|NCT01424501|241449|P5|Overall Study|Lost to Follow-up|0
59968|NCT01424501|241450|P4|Overall Study|Lost to Follow-up|0
59969|NCT01424501|241451|P3|Overall Study|Lost to Follow-up|1
59970|NCT01424501|241452|P2|Overall Study|Lost to Follow-up|0
59971|NCT01424501|241453|P1|Overall Study|Lost to Follow-up|0
59972|NCT01424501|241448|P6|Overall Study|Withdrawal by Subject|0
59973|NCT01424501|241449|P5|Overall Study|Withdrawal by Subject|0
59974|NCT01424501|241450|P4|Overall Study|Withdrawal by Subject|0
59975|NCT01424501|241451|P3|Overall Study|Withdrawal by Subject|1
59976|NCT01424501|241452|P2|Overall Study|Withdrawal by Subject|1
59977|NCT01424501|241453|P1|Overall Study|Withdrawal by Subject|1
59978|NCT01424306|241617|P6|Overall Study|Protocol Violation|0
59979|NCT01424306|241618|P5|Overall Study|Protocol Violation|1
59980|NCT01424306|241619|P4|Overall Study|Protocol Violation|0
59981|NCT01424306|241620|P3|Overall Study|Protocol Violation|0
59982|NCT01424306|241621|P2|Overall Study|Protocol Violation|0
59983|NCT01424306|241622|P1|Overall Study|Protocol Violation|0
59984|NCT01424228|241671|P2|Overall Study|Unplanned journey|1
59985|NCT01424228|241672|P1|Overall Study|Unplanned journey|0
59986|NCT01424228|241671|P2|Overall Study|Worsening of symptoms|0
59987|NCT01424228|241672|P1|Overall Study|Worsening of symptoms|1
59988|NCT01424228|241671|P2|Overall Study|Non-compliance|0
59989|NCT01424228|241672|P1|Overall Study|Non-compliance|2
59990|NCT01424228|241671|P2|Overall Study|inclusion/exclusion criteria not met|2
59991|NCT01424228|241672|P1|Overall Study|inclusion/exclusion criteria not met|2
59992|NCT01424228|241671|P2|Overall Study|Lack of Efficacy|7
59993|NCT01424228|241672|P1|Overall Study|Lack of Efficacy|5
59994|NCT01424228|241671|P2|Overall Study|Sponsor's decision|12
59995|NCT01424228|241672|P1|Overall Study|Sponsor's decision|9
59996|NCT01424228|241671|P2|Overall Study|Adverse Event|14
59997|NCT01424228|241672|P1|Overall Study|Adverse Event|10
59998|NCT01424228|241671|P2|Overall Study|Withdrawal by Subject|11
59999|NCT01424228|241672|P1|Overall Study|Withdrawal by Subject|27
60000|NCT01424189|241712|P2|Overall Study|Death|1
60001|NCT01424189|241713|P1|Overall Study|Death|3
60002|NCT01424189|241712|P2|Overall Study|Subject moved|0
60003|NCT01424189|241713|P1|Overall Study|Subject moved|1
60004|NCT01424189|241712|P2|Overall Study|Withdrawal by Subject|4
60005|NCT01424189|241713|P1|Overall Study|Withdrawal by Subject|4
60006|NCT01424189|241712|P2|Overall Study|Lost to Follow-up|1
60007|NCT01424189|241713|P1|Overall Study|Lost to Follow-up|4
60008|NCT01424189|241712|P2|Overall Study|Adverse Event|0
60009|NCT01424189|241713|P1|Overall Study|Adverse Event|1
60010|NCT01423916|241754|P3|Overall Study|Protocol Deviation|0
60011|NCT01423916|241755|P2|Overall Study|Protocol Deviation|0
60012|NCT01423916|241756|P1|Overall Study|Protocol Deviation|1
60013|NCT01423916|241754|P3|Overall Study|Withdrawal by Subject|3
60014|NCT01423916|241755|P2|Overall Study|Withdrawal by Subject|10
60015|NCT01423916|241756|P1|Overall Study|Withdrawal by Subject|3
60016|NCT01423916|241754|P3|Overall Study|Physician Decision|1
60017|NCT01423916|241755|P2|Overall Study|Physician Decision|0
60018|NCT01423916|241756|P1|Overall Study|Physician Decision|1
60019|NCT01423916|241754|P3|Overall Study|Met Withdrawal Criteria|1
60020|NCT01423916|241755|P2|Overall Study|Met Withdrawal Criteria|1
60021|NCT01423916|241756|P1|Overall Study|Met Withdrawal Criteria|1
60022|NCT01423916|241754|P3|Overall Study|Adverse Event|2
60023|NCT01423916|241755|P2|Overall Study|Adverse Event|9
60024|NCT01423916|241756|P1|Overall Study|Adverse Event|5
60025|NCT01423812|241812|P2|Overall Study|Withdrawal by Subject|2
60026|NCT01423812|241813|P1|Overall Study|Withdrawal by Subject|1
60027|NCT01423812|241812|P2|Overall Study|Lost to Follow-up|2
60028|NCT01423812|241813|P1|Overall Study|Lost to Follow-up|2
60029|NCT01423617|241841|P2|Overall Study|Lost to Follow-up|1
60030|NCT01423617|241842|P1|Overall Study|Lost to Follow-up|0
60031|NCT01423604|241859|P2|Randomized|Patient decision|9
60032|NCT01423604|241860|P1|Randomized|Patient decision|5
60033|NCT01423604|241859|P2|Randomized|Other - unspecified|31
60034|NCT01423604|241860|P1|Randomized|Other - unspecified|37
60035|NCT01423604|241859|P2|Randomized|Physician Decision|13
60036|NCT01423604|241860|P1|Randomized|Physician Decision|16
60037|NCT01423604|241859|P2|Randomized|Death|0
60038|NCT01423604|241860|P1|Randomized|Death|1
60039|NCT01423604|241859|P2|Randomized|Adverse Event|10
60040|NCT01423604|241860|P1|Randomized|Adverse Event|4
60041|NCT01423604|241859|P2|Safety Run-In|Patient decision|0
60042|NCT01423604|241860|P1|Safety Run-In|Patient decision|1
60043|NCT01423604|241859|P2|Safety Run-In|Disease progression|0
60044|NCT01423604|241860|P1|Safety Run-In|Disease progression|3
60045|NCT01423604|241859|P2|Safety Run-In|Physician Decision|0
60046|NCT01423604|241860|P1|Safety Run-In|Physician Decision|1
60047|NCT01423604|241859|P2|Safety Run-In|Death|0
60048|NCT01423604|241860|P1|Safety Run-In|Death|1
60049|NCT01423604|241859|P2|Safety Run-In|Adverse Event|0
60050|NCT01423604|241860|P1|Safety Run-In|Adverse Event|3
60051|NCT01423253|241875|P1|Overall Study|Withdrawal by Subject|2
60052|NCT01423253|241875|P1|Overall Study|Protocol Violation|2
60053|NCT01423253|241875|P1|Overall Study|Lost to Follow-up|1
60054|NCT01423253|241875|P1|Overall Study|Lack of Efficacy|2
60055|NCT01423253|241875|P1|Overall Study|Adverse Event|2
60056|NCT01423084|241897|P2|Overall Study|Withdrawal by Subject|3
60057|NCT01423084|241898|P1|Overall Study|Withdrawal by Subject|2
60058|NCT01423084|241897|P2|Overall Study|Adverse Event|1
60059|NCT01423084|241898|P1|Overall Study|Adverse Event|0
60060|NCT01422915|241928|P1|Overall Study|Adverse Event|1
60061|NCT01422889|241933|P1|Overall Study|No Data Entered for Study Stent|9
60062|NCT01422876|241948|P10|Week 52|Death|0
60063|NCT01422876|241949|P9|Week 52|Death|1
60064|NCT01422876|241950|P8|Week 52|Death|3
60065|NCT01422876|241951|P7|Week 52|Death|1
60066|NCT01422876|241952|P6|Week 52|Death|0
60067|NCT01422876|241953|P5|Week 52|Death|0
60068|NCT01422876|241954|P4|Week 52|Death|1
60069|NCT01422876|241955|P3|Week 52|Death|0
60070|NCT01422876|241956|P2|Week 52|Death|1
60071|NCT01422876|241957|P1|Week 52|Death|0
60072|NCT01422876|241948|P10|Week 52|Consent withdrawn|9
60073|NCT01422876|241949|P9|Week 52|Consent withdrawn|13
60074|NCT01422876|241950|P8|Week 52|Consent withdrawn|12
60075|NCT01422876|241951|P7|Week 52|Consent withdrawn|10
60076|NCT01422876|241952|P6|Week 52|Consent withdrawn|12
60077|NCT01422876|241953|P5|Week 52|Consent withdrawn|7
60078|NCT01422876|241954|P4|Week 52|Consent withdrawn|12
60079|NCT01422876|241955|P3|Week 52|Consent withdrawn|6
60080|NCT01422876|241956|P2|Week 52|Consent withdrawn|4
60081|NCT01422876|241957|P1|Week 52|Consent withdrawn|9
60082|NCT01422876|241948|P10|Week 52|Lost to Follow-up|8
60083|NCT01422876|241949|P9|Week 52|Lost to Follow-up|7
60084|NCT01422876|241950|P8|Week 52|Lost to Follow-up|8
60085|NCT01422876|241951|P7|Week 52|Lost to Follow-up|5
60086|NCT01422876|241952|P6|Week 52|Lost to Follow-up|5
60087|NCT01422876|241953|P5|Week 52|Lost to Follow-up|8
60088|NCT01422876|241954|P4|Week 52|Lost to Follow-up|5
60089|NCT01422876|241955|P3|Week 52|Lost to Follow-up|7
60090|NCT01422876|241956|P2|Week 52|Lost to Follow-up|5
60091|NCT01422876|241957|P1|Week 52|Lost to Follow-up|3
60092|NCT01422876|241948|P10|Week 24|Death|0
60093|NCT01422876|241949|P9|Week 24|Death|0
60094|NCT01422876|241950|P8|Week 24|Death|0
60095|NCT01422876|241951|P7|Week 24|Death|0
60096|NCT01422876|241952|P6|Week 24|Death|0
60097|NCT01422876|241953|P5|Week 24|Death|0
60098|NCT01422876|241954|P4|Week 24|Death|0
60099|NCT01422876|241955|P3|Week 24|Death|0
60100|NCT01422876|241956|P2|Week 24|Death|1
60101|NCT01422876|241957|P1|Week 24|Death|0
60102|NCT01422876|241948|P10|Week 24|Consent withdrawn|6
60103|NCT01422876|241949|P9|Week 24|Consent withdrawn|3
60104|NCT01422876|241950|P8|Week 24|Consent withdrawn|4
60105|NCT01422876|241951|P7|Week 24|Consent withdrawn|5
60106|NCT01422876|241952|P6|Week 24|Consent withdrawn|6
60107|NCT01422876|241953|P5|Week 24|Consent withdrawn|5
60108|NCT01422876|241954|P4|Week 24|Consent withdrawn|4
60109|NCT01422876|241955|P3|Week 24|Consent withdrawn|3
60110|NCT01422876|241956|P2|Week 24|Consent withdrawn|1
60111|NCT01422876|241957|P1|Week 24|Consent withdrawn|5
60112|NCT01422876|241948|P10|Week 24|Lost to Follow-up|4
60113|NCT01422876|241949|P9|Week 24|Lost to Follow-up|3
60114|NCT01422876|241950|P8|Week 24|Lost to Follow-up|3
60115|NCT01422876|241951|P7|Week 24|Lost to Follow-up|1
60116|NCT01422876|241952|P6|Week 24|Lost to Follow-up|0
60117|NCT01422876|241953|P5|Week 24|Lost to Follow-up|2
60118|NCT01422876|241954|P4|Week 24|Lost to Follow-up|4
60119|NCT01422876|241955|P3|Week 24|Lost to Follow-up|2
60120|NCT01422876|241956|P2|Week 24|Lost to Follow-up|1
60121|NCT01422876|241957|P1|Week 24|Lost to Follow-up|1
60122|NCT01422850|242004|P1|Overall Study|Physician Decision|3
60123|NCT01422824|242010|P1|Overall Study|Lost to Follow-up|37
60124|NCT01422824|242010|P1|Overall Study|Case record form not evaluated|1
60125|NCT01422720|242015|P1|Overall Study|Ineligibility|1
60126|NCT01422720|242015|P1|Overall Study|Withdrawal by Subject|4
60127|NCT01422720|242015|P1|Overall Study|Lack of Efficacy|1
60128|NCT01422720|242015|P1|Overall Study|Adverse Event|16
60129|NCT01422538|242026|P3|Overall Study|Missed visit|1
60130|NCT01422538|242027|P2|Overall Study|Missed visit|1
60131|NCT01422538|242028|P1|Overall Study|Missed visit|0
60132|NCT01422538|242026|P3|Overall Study|Lost to Follow-up|1
60133|NCT01422538|242027|P2|Overall Study|Lost to Follow-up|1
60134|NCT01422538|242028|P1|Overall Study|Lost to Follow-up|0
60135|NCT01422408|242072|P1|Overall Study|Withdrawal by Subject|3
60136|NCT01422408|242072|P1|Overall Study|Adverse Event|1
60137|NCT01422382|242101|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
60138|NCT01422304|242117|P2|Overall Study|Not Treated|11
60139|NCT01422304|242118|P1|Overall Study|Not Treated|3
60140|NCT01422304|242117|P2|Overall Study|Did Not Meet Protocol Eligibility|2
60141|NCT01422304|242118|P1|Overall Study|Did Not Meet Protocol Eligibility|0
60142|NCT01422304|242117|P2|Overall Study|Withdrawal by Subject|2
60143|NCT01422304|242118|P1|Overall Study|Withdrawal by Subject|4
60144|NCT01422304|242117|P2|Overall Study|Protocol Violation|0
60145|NCT01422304|242118|P1|Overall Study|Protocol Violation|1
60146|NCT01422304|242117|P2|Overall Study|Never Entered Follow-up|1
60147|NCT01422304|242118|P1|Overall Study|Never Entered Follow-up|2
60148|NCT01422304|242117|P2|Overall Study|Lost to Follow-up|20
60149|NCT01422304|242118|P1|Overall Study|Lost to Follow-up|14
60150|NCT01422304|242117|P2|Overall Study|Adverse Event|1
60151|NCT01422304|242118|P1|Overall Study|Adverse Event|0
60152|NCT01422239|242150|P2|Overall Study|Lost to Follow-up|3
60153|NCT01422239|242151|P1|Overall Study|Lost to Follow-up|4
60154|NCT01422213|242173|P3|Overall Study|Administrative or Other Reason(s)|2
60155|NCT01422213|242174|P2|Overall Study|Administrative or Other Reason(s)|4
60156|NCT01422213|242175|P1|Overall Study|Administrative or Other Reason(s)|5
60157|NCT01422213|242173|P3|Overall Study|Lost to Follow-up|5
60158|NCT01422213|242174|P2|Overall Study|Lost to Follow-up|3
60159|NCT01422213|242175|P1|Overall Study|Lost to Follow-up|3
60160|NCT01422213|242173|P3|Overall Study|Withdrawal of Consent|5
60161|NCT01422213|242174|P2|Overall Study|Withdrawal of Consent|3
60162|NCT01422213|242175|P1|Overall Study|Withdrawal of Consent|7
60163|NCT01422213|242173|P3|Overall Study|Protocol Violation|4
60164|NCT01422213|242174|P2|Overall Study|Protocol Violation|2
60165|NCT01422213|242175|P1|Overall Study|Protocol Violation|0
60166|NCT01422213|242173|P3|Overall Study|Non-compliance with study drug|0
60167|NCT01422213|242174|P2|Overall Study|Non-compliance with study drug|1
60168|NCT01422213|242175|P1|Overall Study|Non-compliance with study drug|0
60169|NCT01422213|242173|P3|Overall Study|Lack of Efficacy|2
60170|NCT01422213|242174|P2|Overall Study|Lack of Efficacy|2
60171|NCT01422213|242175|P1|Overall Study|Lack of Efficacy|10
60172|NCT01422213|242173|P3|Overall Study|Adverse Event|11
60173|NCT01422213|242174|P2|Overall Study|Adverse Event|7
60174|NCT01422213|242175|P1|Overall Study|Adverse Event|8
60175|NCT01422187|242236|P3|Overall Study|Lost to Follow-up|0
60176|NCT01422187|242237|P2|Overall Study|Lost to Follow-up|1
60177|NCT01422187|242238|P1|Overall Study|Lost to Follow-up|0
60178|NCT01422187|242236|P3|Overall Study|Personal reason|0
60179|NCT01422187|242237|P2|Overall Study|Personal reason|0
60180|NCT01422187|242238|P1|Overall Study|Personal reason|1
60181|NCT01421719|242269|P1|Overall Study|Withdrawal by Subject|4
60182|NCT01421667|242278|P4|Overall Study|Lost to Follow-up|0
60183|NCT01421667|242279|P3|Overall Study|Lost to Follow-up|0
60184|NCT01421667|242280|P2|Overall Study|Lost to Follow-up|1
60185|NCT01421667|242281|P1|Overall Study|Lost to Follow-up|0
60186|NCT01421667|242278|P4|Overall Study|Withdrawal by Subject|1
60187|NCT01421667|242279|P3|Overall Study|Withdrawal by Subject|2
60188|NCT01421667|242280|P2|Overall Study|Withdrawal by Subject|1
60189|NCT01421667|242281|P1|Overall Study|Withdrawal by Subject|0
60190|NCT01421641|242342|P2|Overall Study|Protocol Violation|2
60191|NCT01421641|242343|P1|Overall Study|Protocol Violation|2
60192|NCT01421511|242365|P2|Overall Study|Death|1
60193|NCT01421511|242366|P1|Overall Study|Death|1
60194|NCT01421511|242365|P2|Overall Study|Withdrawal by Subject|5
60195|NCT01421511|242366|P1|Overall Study|Withdrawal by Subject|6
60196|NCT01421511|242365|P2|Overall Study|Physician Decision|1
60197|NCT01421511|242366|P1|Overall Study|Physician Decision|0
60198|NCT01421511|242365|P2|Overall Study|Randomized but didn't receive study drug|7
60199|NCT01421511|242366|P1|Overall Study|Randomized but didn't receive study drug|1
60200|NCT01421511|242365|P2|Overall Study|Lost to Follow-up|14
60201|NCT01421511|242366|P1|Overall Study|Lost to Follow-up|11
60202|NCT01421459|242416|P2|Overall Study|Withdrawal by Subject|16
60203|NCT01421459|242417|P1|Overall Study|Withdrawal by Subject|12
60204|NCT01421459|242416|P2|Overall Study|Protocol Violation|5
60205|NCT01421459|242417|P1|Overall Study|Protocol Violation|8
60206|NCT01421459|242416|P2|Overall Study|Physician Decision|9
60207|NCT01421459|242417|P1|Overall Study|Physician Decision|9
60208|NCT01421459|242416|P2|Overall Study|Lost to Follow-up|9
60209|NCT01421459|242417|P1|Overall Study|Lost to Follow-up|8
60210|NCT01421459|242416|P2|Overall Study|Lack of Efficacy|2
60211|NCT01421459|242417|P1|Overall Study|Lack of Efficacy|1
60212|NCT01421459|242416|P2|Overall Study|Death|1
60213|NCT01421459|242417|P1|Overall Study|Death|1
60214|NCT01421459|242416|P2|Overall Study|Adverse Event|10
60215|NCT01421459|242417|P1|Overall Study|Adverse Event|6
60216|NCT01421342|242458|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
60217|NCT01421342|242459|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
60218|NCT01421342|242460|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
60219|NCT01421342|242458|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
60220|NCT01421342|242459|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
60221|NCT01421342|242460|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
60222|NCT01421342|242458|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
60223|NCT01421342|242459|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
60224|NCT01421342|242460|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
60225|NCT01421342|242458|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
60226|NCT01421342|242459|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
60227|NCT01421342|242460|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
60228|NCT01421342|242458|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
60229|NCT01421342|242459|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
60230|NCT01421342|242460|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
60231|NCT01421342|242458|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
60232|NCT01421342|242459|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
60233|NCT01421342|242460|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
60234|NCT01421342|242458|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
60235|NCT01421342|242459|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
60236|NCT01421342|242460|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
60237|NCT01421342|242458|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
60238|NCT01421342|242459|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
60239|NCT01421342|242460|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
60240|NCT01421342|242458|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
60241|NCT01421342|242459|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
60242|NCT01421342|242460|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
60243|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
60244|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
60245|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
60246|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
60247|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
60248|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
60249|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
60250|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
60251|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
60252|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
60253|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
60254|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
60255|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
60256|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
60257|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
60258|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
60259|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
60260|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
60261|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
60262|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
60263|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
60264|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
60265|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
60266|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
60267|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
60268|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
60269|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
60270|NCT01421342|242458|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
60271|NCT01421342|242459|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
60272|NCT01421342|242460|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
60273|NCT01421342|242458|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
60274|NCT01421342|242459|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
60275|NCT01421342|242460|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
60276|NCT01421342|242458|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
60277|NCT01421342|242459|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
60278|NCT01421342|242460|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
60279|NCT01421342|242458|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
60280|NCT01421342|242459|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
60281|NCT01421342|242460|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
60282|NCT01421342|242458|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
60283|NCT01421342|242459|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
60284|NCT01421342|242460|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
60285|NCT01421342|242458|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
60286|NCT01421342|242459|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
60287|NCT01421342|242460|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
60288|NCT01421342|242458|P3|Acute Treatment Phase (12 Weeks)|Death|3
60289|NCT01421342|242459|P2|Acute Treatment Phase (12 Weeks)|Death|0
60290|NCT01421342|242460|P1|Acute Treatment Phase (12 Weeks)|Death|0
60291|NCT01421342|242458|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
60292|NCT01421342|242459|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
60293|NCT01421342|242460|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
60294|NCT01421342|242458|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
60295|NCT01421342|242459|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
60296|NCT01421342|242460|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
60297|NCT01421342|242458|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
60298|NCT01421342|242459|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
60299|NCT01421342|242460|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
60300|NCT01421303|242477|P1|Overall Study|Withdrawal by Subject|1
60301|NCT01421303|242477|P1|Overall Study|Other|7
60302|NCT01421303|242477|P1|Overall Study|Non compliance with study procedure|1
60303|NCT01421303|242477|P1|Overall Study|Lost to Follow-up|13
60304|NCT01421277|242504|P2|Overall Study|Incomplete baseline data|31
60305|NCT01421277|242505|P1|Overall Study|Incomplete baseline data|0
60306|NCT01421277|242504|P2|Overall Study|Lack of qualifying event|61
60307|NCT01421277|242505|P1|Overall Study|Lack of qualifying event|0
60308|NCT01421147|242517|P2|Extension Period|Withdrawal by Subject|3
60309|NCT01421147|242518|P1|Extension Period|Withdrawal by Subject|5
60310|NCT01421147|242517|P2|Extension Period|Physician Decision|0
60311|NCT01421147|242518|P1|Extension Period|Physician Decision|1
60312|NCT01421147|242517|P2|Extension Period|Lost to Follow-up|5
60313|NCT01421147|242518|P1|Extension Period|Lost to Follow-up|2
60314|NCT01421147|242517|P2|Extension Period|Death|1
60315|NCT01421147|242518|P1|Extension Period|Death|0
60316|NCT01421147|242517|P2|Extension Period|Adverse Event|2
60317|NCT01421147|242518|P1|Extension Period|Adverse Event|0
60318|NCT01421147|242517|P2|Treatment Period|Withdrawal by Subject|5
60319|NCT01421147|242518|P1|Treatment Period|Withdrawal by Subject|10
60320|NCT01421147|242517|P2|Treatment Period|Physician Decision|2
60321|NCT01421147|242518|P1|Treatment Period|Physician Decision|2
60322|NCT01421147|242517|P2|Treatment Period|Lost to Follow-up|1
60323|NCT01421147|242518|P1|Treatment Period|Lost to Follow-up|2
60324|NCT01421147|242517|P2|Treatment Period|Adverse Event|3
60325|NCT01421147|242518|P1|Treatment Period|Adverse Event|2
60326|NCT01421134|242550|P2|Overall Study|Lost to Follow-up|1
60327|NCT01421134|242551|P1|Overall Study|Lost to Follow-up|1
60328|NCT01421134|242550|P2|Overall Study|Administrative|1
60329|NCT01421134|242551|P1|Overall Study|Administrative|0
60330|NCT01421134|242550|P2|Overall Study|Withdrawal by Subject|1
60331|NCT01421134|242551|P1|Overall Study|Withdrawal by Subject|1
60332|NCT01421134|242550|P2|Overall Study|Protocol Violation|3
60333|NCT01421134|242551|P1|Overall Study|Protocol Violation|0
60334|NCT01421134|242550|P2|Overall Study|Lack of Efficacy|4
60335|NCT01421134|242551|P1|Overall Study|Lack of Efficacy|2
60336|NCT01421134|242550|P2|Overall Study|Adverse Event|5
60337|NCT01421134|242551|P1|Overall Study|Adverse Event|3
60338|NCT01420926|242571|P2|Overall Study|Continues on active treatment|3
60339|NCT01420926|242572|P1|Overall Study|Continues on active treatment|1
60340|NCT01420926|242571|P2|Overall Study|Physician Decision|5
60341|NCT01420926|242572|P1|Overall Study|Physician Decision|7
60342|NCT01420926|242571|P2|Overall Study|Non-protocol treatment|20
60343|NCT01420926|242572|P1|Overall Study|Non-protocol treatment|17
60344|NCT01420926|242571|P2|Overall Study|Withdrawal by Subject|16
60345|NCT01420926|242572|P1|Overall Study|Withdrawal by Subject|11
60346|NCT01420926|242571|P2|Overall Study|Death|17
60347|NCT01420926|242572|P1|Overall Study|Death|18
60348|NCT01420926|242571|P2|Overall Study|Adverse Event|4
60349|NCT01420926|242572|P1|Overall Study|Adverse Event|6
60350|NCT01420081|242630|P9|Overall Study|Other Reasons|0
60351|NCT01420081|242631|P8|Overall Study|Other Reasons|0
60352|NCT01420081|242632|P7|Overall Study|Other Reasons|0
60353|NCT01420081|242633|P6|Overall Study|Other Reasons|0
60354|NCT01420081|242634|P5|Overall Study|Other Reasons|0
60355|NCT01420081|242635|P4|Overall Study|Other Reasons|0
60356|NCT01420081|242636|P3|Overall Study|Other Reasons|1
60357|NCT01420081|242637|P2|Overall Study|Other Reasons|0
60358|NCT01420081|242638|P1|Overall Study|Other Reasons|0
60359|NCT01420081|242630|P9|Overall Study|Subject Refused Futher Follow-up|0
60360|NCT01420081|242631|P8|Overall Study|Subject Refused Futher Follow-up|0
60361|NCT01420081|242632|P7|Overall Study|Subject Refused Futher Follow-up|0
60362|NCT01420081|242633|P6|Overall Study|Subject Refused Futher Follow-up|0
60363|NCT01420081|242634|P5|Overall Study|Subject Refused Futher Follow-up|1
60364|NCT01420081|242635|P4|Overall Study|Subject Refused Futher Follow-up|0
60365|NCT01420081|242636|P3|Overall Study|Subject Refused Futher Follow-up|1
60366|NCT01420081|242637|P2|Overall Study|Subject Refused Futher Follow-up|0
60367|NCT01420081|242638|P1|Overall Study|Subject Refused Futher Follow-up|0
60368|NCT01420081|242630|P9|Overall Study|Study Terminated by Sponsor|2
60369|NCT01420081|242631|P8|Overall Study|Study Terminated by Sponsor|2
60370|NCT01420081|242632|P7|Overall Study|Study Terminated by Sponsor|3
60371|NCT01420081|242633|P6|Overall Study|Study Terminated by Sponsor|7
60372|NCT01420081|242634|P5|Overall Study|Study Terminated by Sponsor|11
60373|NCT01420081|242635|P4|Overall Study|Study Terminated by Sponsor|3
60374|NCT01420081|242636|P3|Overall Study|Study Terminated by Sponsor|1
60375|NCT01420081|242637|P2|Overall Study|Study Terminated by Sponsor|1
60376|NCT01420081|242638|P1|Overall Study|Study Terminated by Sponsor|2
60377|NCT01420081|242630|P9|Overall Study|Lost to Follow-up|0
60378|NCT01420081|242631|P8|Overall Study|Lost to Follow-up|0
60379|NCT01420081|242632|P7|Overall Study|Lost to Follow-up|0
60380|NCT01420081|242633|P6|Overall Study|Lost to Follow-up|1
60381|NCT01420081|242634|P5|Overall Study|Lost to Follow-up|1
60382|NCT01420081|242635|P4|Overall Study|Lost to Follow-up|0
60383|NCT01420081|242636|P3|Overall Study|Lost to Follow-up|0
60384|NCT01420081|242637|P2|Overall Study|Lost to Follow-up|0
60385|NCT01420081|242638|P1|Overall Study|Lost to Follow-up|0
60386|NCT01420081|242630|P9|Overall Study|Death|1
60387|NCT01420081|242631|P8|Overall Study|Death|1
60388|NCT01420081|242632|P7|Overall Study|Death|0
60389|NCT01420081|242633|P6|Overall Study|Death|12
60390|NCT01420081|242634|P5|Overall Study|Death|7
60391|NCT01420081|242635|P4|Overall Study|Death|0
60392|NCT01420081|242636|P3|Overall Study|Death|8
60393|NCT01420081|242637|P2|Overall Study|Death|0
60394|NCT01420081|242638|P1|Overall Study|Death|1
60395|NCT01419769|242757|P1|Overall Study|Not evaluable due to pigtail stents|1
60396|NCT01419769|242757|P1|Overall Study|Did not receive the AXIOS stent|3
60397|NCT01419314|242778|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
60398|NCT01419314|242779|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
60399|NCT01419314|242778|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
60400|NCT01419314|242779|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
60401|NCT01419314|242778|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
60402|NCT01419314|242779|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
60403|NCT01419236|242820|P2|Overall Study|Entry Criteria Not Met|0
60404|NCT01419236|242821|P1|Overall Study|Entry Criteria Not Met|1
60405|NCT01419236|242820|P2|Overall Study|Withdrawal by Subject|4
60406|NCT01419236|242821|P1|Overall Study|Withdrawal by Subject|1
60407|NCT01419236|242820|P2|Overall Study|Physician Decision|0
60408|NCT01419236|242821|P1|Overall Study|Physician Decision|1
60409|NCT01419236|242820|P2|Overall Study|Lost to Follow-up|0
60410|NCT01419236|242821|P1|Overall Study|Lost to Follow-up|1
60411|NCT01419236|242820|P2|Overall Study|Lack of Efficacy|1
60412|NCT01419236|242821|P1|Overall Study|Lack of Efficacy|0
60413|NCT01419236|242820|P2|Overall Study|Adverse Event|0
60414|NCT01419236|242821|P1|Overall Study|Adverse Event|1
60415|NCT01419197|242845|P2|Overall Study|Lost to Follow-up|4
60416|NCT01419197|242846|P1|Overall Study|Lost to Follow-up|14
60417|NCT01419197|242845|P2|Overall Study|Reason Not Specified|1
60418|NCT01419197|242846|P1|Overall Study|Reason Not Specified|0
60419|NCT01419197|242845|P2|Overall Study|Study Completed by Sponsor|34
60420|NCT01419197|242846|P1|Overall Study|Study Completed by Sponsor|103
60421|NCT01419197|242845|P2|Overall Study|Withdrawal by Subject|32
60422|NCT01419197|242846|P1|Overall Study|Withdrawal by Subject|33
60423|NCT01419197|242845|P2|Overall Study|Non-compliance|1
60424|NCT01419197|242846|P1|Overall Study|Non-compliance|3
60425|NCT01419197|242845|P2|Overall Study|Physician Decision|4
60426|NCT01419197|242846|P1|Overall Study|Physician Decision|4
60427|NCT01419197|242845|P2|Overall Study|Death|122
60428|NCT01419197|242846|P1|Overall Study|Death|247
60429|NCT01419184|242871|P2|Overall Study|Participant randomized, not treated|0
60430|NCT01419184|242872|P1|Overall Study|Participant randomized, not treated|1
60431|NCT01419184|242871|P2|Overall Study|No IRLOS-No adverse event treatment date|1
60432|NCT01419184|242872|P1|Overall Study|No IRLOS-No adverse event treatment date|0
60433|NCT01419184|242871|P2|Overall Study|No IRLOS-non trial antibiotic used|2
60434|NCT01419184|242872|P1|Overall Study|No IRLOS-non trial antibiotic used|1
60435|NCT01419184|242871|P2|Overall Study|No IRLOS-randomized, not treated|4
60436|NCT01419184|242872|P1|Overall Study|No IRLOS-randomized, not treated|2
60437|NCT01419184|242871|P2|Overall Study|No IRLOS-No in-patient end date reported|6
60438|NCT01419184|242872|P1|Overall Study|No IRLOS-No in-patient end date reported|3
60439|NCT01419184|242871|P2|Overall Study|Site data not available|2
60440|NCT01419184|242872|P1|Overall Study|Site data not available|3
60441|NCT01418937|242910|P1|Overall Study|Withdrawal by Subject|1
60442|NCT01418937|242910|P1|Overall Study|Pregnancy|1
60443|NCT01418937|242910|P1|Overall Study|Protocol Violation|1
60444|NCT01418937|242910|P1|Overall Study|Lost to Follow-up|5
60445|NCT01418365|242941|P2|Second Intervention|Withdrawal by Subject|1
60446|NCT01418365|242942|P1|Second Intervention|Withdrawal by Subject|0
60447|NCT01418365|242941|P2|First Intervention|Non-compliance|0
60448|NCT01418365|242942|P1|First Intervention|Non-compliance|1
60449|NCT01418365|242941|P2|First Intervention|Withdrawal by Subject|1
60450|NCT01418365|242942|P1|First Intervention|Withdrawal by Subject|0
60451|NCT01418209|242953|P3|Overall Study|Did not provide hot flash diary data|3
60452|NCT01418209|242954|P2|Overall Study|Did not provide hot flash diary data|3
60453|NCT01418209|242955|P1|Overall Study|Did not provide hot flash diary data|1
60454|NCT01418209|242953|P3|Overall Study|Withdrawal by Subject|1
60455|NCT01418209|242954|P2|Overall Study|Withdrawal by Subject|0
60456|NCT01418209|242955|P1|Overall Study|Withdrawal by Subject|1
60457|NCT01417481|243010|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
60458|NCT01417481|243011|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
60459|NCT01417377|243076|P1|Overall Study|Enrolled, but not treated|1
60460|NCT01417377|243076|P1|Overall Study|Lost to Follow-up|12
60461|NCT01417195|243085|P2|Overall Study|No transfer due to elevated progesterone|0
60462|NCT01417195|243086|P1|Overall Study|No transfer due to elevated progesterone|1
60463|NCT01417195|243085|P2|Overall Study|No transfer due to risk of OHSS|0
60464|NCT01417195|243086|P1|Overall Study|No transfer due to risk of OHSS|1
60465|NCT01417195|243085|P2|Overall Study|No embryos for transfer|1
60466|NCT01417195|243086|P1|Overall Study|No embryos for transfer|0
60467|NCT01417195|243085|P2|Overall Study|Stimulation failure|0
60468|NCT01417195|243086|P1|Overall Study|Stimulation failure|1
60469|NCT01417156|243102|P1|Overall Study|Protocol Violation|2
60470|NCT01417156|243102|P1|Overall Study|Adverse Event|12
60471|NCT01417104|243112|P2|Overall Study|Adverse Event|0
60472|NCT01417104|243113|P1|Overall Study|Adverse Event|1
60473|NCT01417104|243112|P2|Overall Study|Failure to make contact|1
60474|NCT01417104|243113|P1|Overall Study|Failure to make contact|0
60475|NCT01417104|243112|P2|Overall Study|Withdrawal by Subject|1
60476|NCT01417104|243113|P1|Overall Study|Withdrawal by Subject|5
60477|NCT01417078|243123|P1|Overall Study|Withdrawal by Subject|1
60478|NCT01417000|243148|P2|Overall Study|Study Terminated by Sponsor|1
60479|NCT01417000|243149|P1|Overall Study|Study Terminated by Sponsor|1
60480|NCT01417000|243148|P2|Overall Study|Lost to Follow-up|0
60481|NCT01417000|243149|P1|Overall Study|Lost to Follow-up|1
60482|NCT01417000|243148|P2|Overall Study|Death|28
60483|NCT01417000|243149|P1|Overall Study|Death|59
60484|NCT01416610|243157|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
60485|NCT01416610|243157|P1|Overall Study|Lost to Follow-up|7
60486|NCT01416610|243157|P1|Overall Study|Withdrawal by Subject|13
60487|NCT01416610|243157|P1|Overall Study|No reason given|5
60488|NCT01416610|243157|P1|Overall Study|Lack of Efficacy|4
60489|NCT01416610|243157|P1|Overall Study|Adverse Event -Patient decision|3
60490|NCT01416610|243157|P1|Overall Study|Adverse Event|4
60491|NCT01416571|243211|P1|Overall Study|Lost to Follow-up|2
60492|NCT01416389|243240|P2|Overall Study|Started New Therapy|0
60493|NCT01416389|243241|P1|Overall Study|Started New Therapy|2
60494|NCT01416389|243240|P2|Overall Study|Lost to Follow-up|0
60495|NCT01416389|243241|P1|Overall Study|Lost to Follow-up|1
60496|NCT01416272|243258|P1|Overall Study|Study related complaints|1
60497|NCT01416272|243258|P1|Overall Study|Lost to Follow-up|1
60498|NCT01416272|243258|P1|Overall Study|Unacceptable distance visual acuity|2
60499|NCT01416181|243266|P2|Part 2|Lost to Follow-up|2
60500|NCT01416181|243267|P1|Part 2|Lost to Follow-up|2
60501|NCT01416181|243266|P2|Part 2|Lack of Efficacy|1
60502|NCT01416181|243267|P1|Part 2|Lack of Efficacy|4
60503|NCT01416181|243266|P2|Part 2|Withdrawal by Subject|5
60504|NCT01416181|243267|P1|Part 2|Withdrawal by Subject|14
60505|NCT01416181|243266|P2|Part 2|Investigator Decision|7
60506|NCT01416181|243267|P1|Part 2|Investigator Decision|6
60507|NCT01416181|243266|P2|Part 2|Not Specified|267
60508|NCT01416181|243267|P1|Part 2|Not Specified|234
60509|NCT01416181|243266|P2|Part 2|Adverse Event|4
60510|NCT01416181|243267|P1|Part 2|Adverse Event|11
60511|NCT01416181|243266|P2|Part 1|Ongoing in Follow-Up|8
60512|NCT01416181|243267|P1|Part 1|Ongoing in Follow-Up|14
60513|NCT01416181|243266|P2|Part 1|Adverse Event|18
60514|NCT01416181|243267|P1|Part 1|Adverse Event|15
60515|NCT01416181|243266|P2|Part 1|Lost to Follow-up|1
60516|NCT01416181|243267|P1|Part 1|Lost to Follow-up|1
60517|NCT01416181|243266|P2|Part 1|Lack of Efficacy|8
60518|NCT01416181|243267|P1|Part 1|Lack of Efficacy|16
60519|NCT01416181|243266|P2|Part 1|Withdrawal by Subject|48
60520|NCT01416181|243267|P1|Part 1|Withdrawal by Subject|74
60521|NCT01416181|243266|P2|Part 1|Investigator Decision|6
60522|NCT01416181|243267|P1|Part 1|Investigator Decision|7
60523|NCT01416181|243266|P2|Part 1|Death|1
60524|NCT01416181|243267|P1|Part 1|Death|0
60525|NCT01416181|243266|P2|Part 1|Not Specified|24
60526|NCT01416181|243267|P1|Part 1|Not Specified|10
60527|NCT01416155|243329|P1|Overall Study|Not specified|7
60528|NCT01416155|243329|P1|Overall Study|Investigator decision|8
60529|NCT01416155|243329|P1|Overall Study|Withdrawal by Subject|33
60530|NCT01416155|243329|P1|Overall Study|Positive for anti-BG00002 antibodies|2
60531|NCT01416155|243329|P1|Overall Study|Adverse Event|8
60532|NCT01416142|243336|P3|PureVision2 HD|Inability to maintain lens wear|1
60533|NCT01416142|243337|P2|PureVision2 HD|Inability to maintain lens wear|0
60534|NCT01416142|243338|P1|PureVision2 HD|Inability to maintain lens wear|0
60535|NCT01415986|243365|P1|Overall Study|Lost to Follow-up|1
60536|NCT01415921|243382|P2|Overall Study|Other|0
60537|NCT01415921|243383|P1|Overall Study|Other|2
60538|NCT01415921|243382|P2|Overall Study|Withdrawal by Subject|1
60539|NCT01415921|243383|P1|Overall Study|Withdrawal by Subject|0
60540|NCT01415921|243382|P2|Overall Study|Physician Decision|1
60541|NCT01415921|243383|P1|Overall Study|Physician Decision|1
60542|NCT01415921|243382|P2|Overall Study|Adverse Event|1
60543|NCT01415921|243383|P1|Overall Study|Adverse Event|0
60544|NCT01415908|243393|P2|Overall Study|Withdrawal by Subject|0
60545|NCT01415908|243394|P1|Overall Study|Withdrawal by Subject|1
60546|NCT01415531|243431|P2|Overall Study|Other Reasons|2
60547|NCT01415531|243432|P1|Overall Study|Other Reasons|3
60548|NCT01415531|243431|P2|Overall Study|Lack of Compliance|4
60549|NCT01415531|243432|P1|Overall Study|Lack of Compliance|1
60550|NCT01415531|243431|P2|Overall Study|Lost to Follow-up|14
60551|NCT01415531|243432|P1|Overall Study|Lost to Follow-up|6
60552|NCT01415531|243431|P2|Overall Study|Withdrawal by Subject|4
60553|NCT01415531|243432|P1|Overall Study|Withdrawal by Subject|5
60554|NCT01415531|243431|P2|Overall Study|Protocol Violation|1
60555|NCT01415531|243432|P1|Overall Study|Protocol Violation|0
60556|NCT01415531|243431|P2|Overall Study|Lack of Efficacy|2
60557|NCT01415531|243432|P1|Overall Study|Lack of Efficacy|3
60558|NCT01415531|243431|P2|Overall Study|Adverse Event|10
60559|NCT01415531|243432|P1|Overall Study|Adverse Event|7
60560|NCT01415518|243442|P2|Overall Study|Condition under Investigation Worsened|1
60561|NCT01415518|243443|P1|Overall Study|Condition under Investigation Worsened|1
60562|NCT01415518|243442|P2|Overall Study|Death|1
60563|NCT01415518|243443|P1|Overall Study|Death|1
60564|NCT01415518|243442|P2|Overall Study|Adverse Event|4
60565|NCT01415518|243443|P1|Overall Study|Adverse Event|3
60566|NCT01415518|243442|P2|Overall Study|Lost to Follow-up|5
60567|NCT01415518|243443|P1|Overall Study|Lost to Follow-up|3
60568|NCT01415518|243442|P2|Overall Study|Protocol Violation|8
60569|NCT01415518|243443|P1|Overall Study|Protocol Violation|6
60570|NCT01415518|243442|P2|Overall Study|Withdrawal by Subject|12
60571|NCT01415518|243443|P1|Overall Study|Withdrawal by Subject|2
60572|NCT01415401|243543|P1|Overall Study|Terminated by Sponsor|1
60573|NCT01415401|243543|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
60574|NCT01415401|243543|P1|Overall Study|Adverse Event|5
60575|NCT01415349|243548|P2|Treatment Period 1|Withdrawal by Subject|1
60576|NCT01415349|243549|P1|Treatment Period 1|Withdrawal by Subject|0
60577|NCT01415349|243548|P2|Treatment Period 1|Adverse Event|1
60578|NCT01415349|243549|P1|Treatment Period 1|Adverse Event|0
60579|NCT01414855|243561|P1|Overall Study|Withdrawal by Subject|7
60580|NCT01414855|243561|P1|Overall Study|Lost to Follow-up|5
60581|NCT01414855|243561|P1|Overall Study|Death|17
60582|NCT01414205|243627|P2|Overall Study|Randomized but not Treated|1
60583|NCT01414205|243628|P1|Overall Study|Randomized but not Treated|1
60584|NCT01414205|243627|P2|Overall Study|Physician Decision|1
60585|NCT01414205|243628|P1|Overall Study|Physician Decision|0
60586|NCT01414205|243627|P2|Overall Study|Lost to Follow-up|4
60587|NCT01414205|243628|P1|Overall Study|Lost to Follow-up|1
60588|NCT01414205|243627|P2|Overall Study|Death|1
60589|NCT01414205|243628|P1|Overall Study|Death|5
60590|NCT01414166|243697|P2|Overall Study|Withdrawal by Subject|5
60591|NCT01414166|243698|P1|Overall Study|Withdrawal by Subject|3
60592|NCT01414166|243697|P2|Overall Study|Study terminated by Sponsor|75
60593|NCT01414166|243698|P1|Overall Study|Study terminated by Sponsor|68
60594|NCT01414166|243697|P2|Overall Study|Protocol Violation|0
60595|NCT01414166|243698|P1|Overall Study|Protocol Violation|2
60596|NCT01414166|243697|P2|Overall Study|Physician Decision|0
60597|NCT01414166|243698|P1|Overall Study|Physician Decision|2
60598|NCT01414166|243697|P2|Overall Study|Non-compliance with study drug|0
60599|NCT01414166|243698|P1|Overall Study|Non-compliance with study drug|2
60600|NCT01414166|243697|P2|Overall Study|Lost to Follow-up|1
60601|NCT01414166|243698|P1|Overall Study|Lost to Follow-up|4
60602|NCT01414166|243697|P2|Overall Study|Adverse Event|2
60603|NCT01414166|243698|P1|Overall Study|Adverse Event|10
60604|NCT01414114|243761|P1|Overall Study|Other|2
60605|NCT01414114|243761|P1|Overall Study|Withdrawal by Subject|1
60606|NCT01414114|243761|P1|Overall Study|Adverse Event|2
60607|NCT01413958|243817|P2|Overall Study|Lost to Follow-up|1
60608|NCT01413958|243818|P1|Overall Study|Lost to Follow-up|0
60609|NCT01413542|243869|P4|Overall Study|Adverse Event|1
60610|NCT01413542|243870|P3|Overall Study|Adverse Event|0
60611|NCT01413542|243871|P2|Overall Study|Adverse Event|0
60612|NCT01413542|243872|P1|Overall Study|Adverse Event|0
60613|NCT01413542|243869|P4|Overall Study|Physician Decision|0
60614|NCT01413542|243870|P3|Overall Study|Physician Decision|3
60615|NCT01413542|243871|P2|Overall Study|Physician Decision|0
60616|NCT01413542|243872|P1|Overall Study|Physician Decision|1
60617|NCT01413360|243894|P1|Overall Study|Adverse Event|1
60618|NCT01413360|243894|P1|Overall Study|Lost to Follow-up|2
60619|NCT01413204|243902|P3|Overall Study|Fasting plasma glucose level increased|10
60620|NCT01413204|243903|P2|Overall Study|Fasting plasma glucose level increased|0
60621|NCT01413204|243904|P1|Overall Study|Fasting plasma glucose level increased|1
60622|NCT01413204|243902|P3|Overall Study|Clearly not eligible for the study|1
60623|NCT01413204|243903|P2|Overall Study|Clearly not eligible for the study|0
60624|NCT01413204|243904|P1|Overall Study|Clearly not eligible for the study|0
60625|NCT01413204|243902|P3|Overall Study|Withdrawal by Subject|4
60626|NCT01413204|243903|P2|Overall Study|Withdrawal by Subject|4
60627|NCT01413204|243904|P1|Overall Study|Withdrawal by Subject|1
60628|NCT01413204|243902|P3|Overall Study|Physician Decision|2
60629|NCT01413204|243903|P2|Overall Study|Physician Decision|0
60630|NCT01413204|243904|P1|Overall Study|Physician Decision|3
60631|NCT01413204|243902|P3|Overall Study|Adverse Event|2
60632|NCT01413204|243903|P2|Overall Study|Adverse Event|2
60633|NCT01413204|243904|P1|Overall Study|Adverse Event|1
60634|NCT01413191|243912|P1|Overall Study|Death|1
60635|NCT01413191|243912|P1|Overall Study|Disease Progression|5
60636|NCT01413191|243912|P1|Overall Study|Lost to Follow-up|5
60637|NCT01412983|243916|P2|1st Period|Inability to maintain wear|1
60638|NCT01412983|243917|P1|1st Period|Inability to maintain wear|0
60639|NCT01412983|243916|P2|1st Period|Unacceptable lens movement|1
60640|NCT01412983|243917|P1|1st Period|Unacceptable lens movement|0
60641|NCT01412983|243916|P2|1st Period|Positive slit lamp finding|1
60642|NCT01412983|243917|P1|1st Period|Positive slit lamp finding|0
60643|NCT01412983|243916|P2|1st Period|Ineligible|1
60644|NCT01412983|243917|P1|1st Period|Ineligible|0
60645|NCT01412957|243927|P2|Overall Study|Death|133
60646|NCT01412957|243928|P1|Overall Study|Death|136
60647|NCT01412957|243927|P2|Overall Study|Lost to Follow-up|2
60648|NCT01412957|243928|P1|Overall Study|Lost to Follow-up|7
60649|NCT01412957|243927|P2|Overall Study|Withdrawal by Subject|22
60650|NCT01412957|243928|P1|Overall Study|Withdrawal by Subject|6
60651|NCT01412944|243950|P6|Entire: IV + Maintenance|Adverse Event|0
60652|NCT01412944|243951|P5|Entire: IV + Maintenance|Adverse Event|0
60653|NCT01412944|243952|P4|Entire: IV + Maintenance|Adverse Event|0
60654|NCT01412944|243953|P3|Entire: IV + Maintenance|Adverse Event|0
60655|NCT01412944|243954|P2|Entire: IV + Maintenance|Adverse Event|1
60656|NCT01412944|243955|P1|Entire: IV + Maintenance|Adverse Event|0
60657|NCT01412944|243950|P6|Entire: IV + Maintenance|Lack of Efficacy|0
60658|NCT01412944|243951|P5|Entire: IV + Maintenance|Lack of Efficacy|0
60659|NCT01412944|243952|P4|Entire: IV + Maintenance|Lack of Efficacy|0
60660|NCT01412944|243953|P3|Entire: IV + Maintenance|Lack of Efficacy|0
60661|NCT01412944|243954|P2|Entire: IV + Maintenance|Lack of Efficacy|1
60662|NCT01412944|243955|P1|Entire: IV + Maintenance|Lack of Efficacy|0
60663|NCT01412944|243950|P6|Entire: IV + Maintenance|Lost to Follow-up|0
60664|NCT01412944|243951|P5|Entire: IV + Maintenance|Lost to Follow-up|0
60665|NCT01412944|243952|P4|Entire: IV + Maintenance|Lost to Follow-up|0
60666|NCT01412944|243953|P3|Entire: IV + Maintenance|Lost to Follow-up|0
60667|NCT01412944|243954|P2|Entire: IV + Maintenance|Lost to Follow-up|1
60668|NCT01412944|243955|P1|Entire: IV + Maintenance|Lost to Follow-up|0
60669|NCT01412944|243950|P6|Entire: IV + Maintenance|Protocol deviation|0
60670|NCT01412944|243951|P5|Entire: IV + Maintenance|Protocol deviation|0
60671|NCT01412944|243952|P4|Entire: IV + Maintenance|Protocol deviation|0
60672|NCT01412944|243953|P3|Entire: IV + Maintenance|Protocol deviation|0
60673|NCT01412944|243954|P2|Entire: IV + Maintenance|Protocol deviation|1
60674|NCT01412944|243955|P1|Entire: IV + Maintenance|Protocol deviation|0
60675|NCT01412944|243950|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
60676|NCT01412944|243951|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
60677|NCT01412944|243952|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
60678|NCT01412944|243953|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
60679|NCT01412944|243954|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
60680|NCT01412944|243955|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
60681|NCT01412944|243950|P6|Entire: IV + Maintenance|Lack of Efficacy|0
60682|NCT01412944|243951|P5|Entire: IV + Maintenance|Lack of Efficacy|1
60683|NCT01412944|243952|P4|Entire: IV + Maintenance|Lack of Efficacy|0
60684|NCT01412944|243953|P3|Entire: IV + Maintenance|Lack of Efficacy|0
60685|NCT01412944|243954|P2|Entire: IV + Maintenance|Lack of Efficacy|0
60686|NCT01412944|243955|P1|Entire: IV + Maintenance|Lack of Efficacy|0
60687|NCT01412944|243950|P6|Entire: IV + Maintenance|Lost to Follow-up|1
60688|NCT01412944|243951|P5|Entire: IV + Maintenance|Lost to Follow-up|0
60689|NCT01412944|243952|P4|Entire: IV + Maintenance|Lost to Follow-up|0
60690|NCT01412944|243953|P3|Entire: IV + Maintenance|Lost to Follow-up|0
60691|NCT01412944|243954|P2|Entire: IV + Maintenance|Lost to Follow-up|0
60692|NCT01412944|243955|P1|Entire: IV + Maintenance|Lost to Follow-up|0
60693|NCT01412944|243950|P6|Entire: IV + Maintenance|Protocol deviation|1
60694|NCT01412944|243951|P5|Entire: IV + Maintenance|Protocol deviation|0
60695|NCT01412944|243952|P4|Entire: IV + Maintenance|Protocol deviation|0
60696|NCT01412944|243953|P3|Entire: IV + Maintenance|Protocol deviation|0
60697|NCT01412944|243954|P2|Entire: IV + Maintenance|Protocol deviation|0
60698|NCT01412944|243955|P1|Entire: IV + Maintenance|Protocol deviation|0
60699|NCT01412944|243950|P6|Entire: IV + Maintenance|Adverse Event|0
60700|NCT01412944|243951|P5|Entire: IV + Maintenance|Adverse Event|1
60701|NCT01412944|243952|P4|Entire: IV + Maintenance|Adverse Event|0
60702|NCT01412944|243953|P3|Entire: IV + Maintenance|Adverse Event|0
60703|NCT01412944|243954|P2|Entire: IV + Maintenance|Adverse Event|0
60704|NCT01412944|243955|P1|Entire: IV + Maintenance|Adverse Event|0
60705|NCT01412944|243950|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
60706|NCT01412944|243951|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
60707|NCT01412944|243952|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
60708|NCT01412944|243953|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
60709|NCT01412944|243954|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
60710|NCT01412944|243955|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
60711|NCT01412944|243950|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
60712|NCT01412944|243951|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
60713|NCT01412944|243952|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
60714|NCT01412944|243953|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
60715|NCT01412944|243954|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
60716|NCT01412944|243955|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
60717|NCT01412944|243950|P6|IV: Per CAIN457A2307|Protocol deviation|0
60718|NCT01412944|243951|P5|IV: Per CAIN457A2307|Protocol deviation|0
60719|NCT01412944|243952|P4|IV: Per CAIN457A2307|Protocol deviation|0
60720|NCT01412944|243953|P3|IV: Per CAIN457A2307|Protocol deviation|0
60721|NCT01412944|243954|P2|IV: Per CAIN457A2307|Protocol deviation|1
60722|NCT01412944|243955|P1|IV: Per CAIN457A2307|Protocol deviation|0
60723|NCT01412944|243950|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
60724|NCT01412944|243951|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
60725|NCT01412944|243952|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
60726|NCT01412944|243953|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
60727|NCT01412944|243954|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
60728|NCT01412944|243955|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
60729|NCT01412944|243950|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
60730|NCT01412944|243951|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
60731|NCT01412944|243952|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
60732|NCT01412944|243953|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
60733|NCT01412944|243954|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
60734|NCT01412944|243955|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
60735|NCT01412944|243950|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
60736|NCT01412944|243951|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
60737|NCT01412944|243952|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
60738|NCT01412944|243953|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
60739|NCT01412944|243954|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
60740|NCT01412944|243955|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
60741|NCT01412944|243950|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
60742|NCT01412944|243951|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
60743|NCT01412944|243952|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
60744|NCT01412944|243953|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
60745|NCT01412944|243954|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
60746|NCT01412944|243955|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
60747|NCT01412879|244001|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
60748|NCT01412879|244002|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
60749|NCT01412879|244003|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
60750|NCT01412879|244001|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
60751|NCT01412879|244002|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
60752|NCT01412879|244003|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
60753|NCT01412879|244001|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
60754|NCT01412879|244002|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
60755|NCT01412879|244003|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
60756|NCT01412879|244001|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
60757|NCT01412879|244002|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
60841|NCT01411852|244313|P2|Hospital Intervention Phase|CPR administered|1
60758|NCT01412879|244003|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
60759|NCT01412879|244001|P3|Initial Registration (Induction Therapy)|Adverse Event|0
60760|NCT01412879|244002|P2|Initial Registration (Induction Therapy)|Adverse Event|3
60761|NCT01412879|244003|P1|Initial Registration (Induction Therapy)|Adverse Event|5
60762|NCT01412801|244023|P6|Overall Study|Relocated to another area|0
60763|NCT01412801|244024|P5|Overall Study|Relocated to another area|0
60764|NCT01412801|244025|P4|Overall Study|Relocated to another area|0
60765|NCT01412801|244026|P3|Overall Study|Relocated to another area|2
60766|NCT01412801|244027|P2|Overall Study|Relocated to another area|0
60767|NCT01412801|244028|P1|Overall Study|Relocated to another area|0
60768|NCT01412801|244023|P6|Overall Study|Withdrawal by Subject|0
60769|NCT01412801|244024|P5|Overall Study|Withdrawal by Subject|0
60770|NCT01412801|244025|P4|Overall Study|Withdrawal by Subject|0
60771|NCT01412801|244026|P3|Overall Study|Withdrawal by Subject|1
60772|NCT01412801|244027|P2|Overall Study|Withdrawal by Subject|2
60773|NCT01412801|244028|P1|Overall Study|Withdrawal by Subject|3
60774|NCT01412801|244023|P6|Overall Study|Lost to Follow-up|1
60775|NCT01412801|244024|P5|Overall Study|Lost to Follow-up|1
60776|NCT01412801|244025|P4|Overall Study|Lost to Follow-up|0
60777|NCT01412801|244026|P3|Overall Study|Lost to Follow-up|4
60778|NCT01412801|244027|P2|Overall Study|Lost to Follow-up|2
60779|NCT01412801|244028|P1|Overall Study|Lost to Follow-up|1
60780|NCT01412801|244023|P6|Overall Study|Death|2
60781|NCT01412801|244024|P5|Overall Study|Death|2
60782|NCT01412801|244025|P4|Overall Study|Death|4
60783|NCT01412801|244026|P3|Overall Study|Death|0
60784|NCT01412801|244027|P2|Overall Study|Death|1
60785|NCT01412801|244028|P1|Overall Study|Death|0
60786|NCT01412424|244187|P1|Extension Treatment Period|Patient Request|2
60787|NCT01412424|244187|P1|Extension Treatment Period|Treatment Failure|2
60788|NCT01412424|244187|P1|Extension Treatment Period|Adverse Event|2
60789|NCT01412424|244187|P1|Core Treatment Period|Sponsor Request|1
60790|NCT01412424|244187|P1|Core Treatment Period|Lost to Follow-up|2
60791|NCT01412424|244187|P1|Core Treatment Period|Patient Request|5
60792|NCT01412424|244187|P1|Core Treatment Period|Adverse Event|21
60793|NCT01412424|244187|P1|Core Treatment Period|Treatment Failure|24
60794|NCT01412333|244205|P2|Overall Study|Lost to Follow-up|6
60795|NCT01412333|244206|P1|Overall Study|Lost to Follow-up|10
60796|NCT01412333|244205|P2|Overall Study|Adverse Event|16
60797|NCT01412333|244206|P1|Overall Study|Adverse Event|25
60798|NCT01412333|244205|P2|Overall Study|Consent withdrawn by participant|12
60799|NCT01412333|244206|P1|Overall Study|Consent withdrawn by participant|25
60800|NCT01412333|244205|P2|Overall Study|Pregnancy|0
60801|NCT01412333|244206|P1|Overall Study|Pregnancy|3
60802|NCT01412333|244205|P2|Overall Study|Lack of Efficacy|6
60803|NCT01412333|244206|P1|Overall Study|Lack of Efficacy|15
60804|NCT01412333|244205|P2|Overall Study|Non-compliance|3
60805|NCT01412333|244206|P1|Overall Study|Non-compliance|1
60806|NCT01412333|244205|P2|Overall Study|Protocol Violation|1
60807|NCT01412333|244206|P1|Overall Study|Protocol Violation|1
60808|NCT01412333|244205|P2|Overall Study|Non-compliance with study drug|1
60809|NCT01412333|244206|P1|Overall Study|Non-compliance with study drug|1
60810|NCT01412333|244205|P2|Overall Study|Reason not specified|10
60811|NCT01412333|244206|P1|Overall Study|Reason not specified|16
60812|NCT01412333|244205|P2|Overall Study|Physician Decision|1
60813|NCT01412333|244206|P1|Overall Study|Physician Decision|0
60814|NCT01412333|244205|P2|Overall Study|Death|1
60815|NCT01412333|244206|P1|Overall Study|Death|1
60816|NCT01412229|244266|P1|Overall Study|Physician Decision|1
60817|NCT01412151|244282|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
60818|NCT01412151|244282|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
60819|NCT01412151|244282|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
60820|NCT01412151|244282|P1|Week 0 - 306 - Treatment Period|Death|1
60821|NCT01411995|244295|P2|Overall Study|Failed IUD insertion|1
60822|NCT01411995|244296|P1|Overall Study|Failed IUD insertion|0
60823|NCT01411891|244304|P2|Overall Study|Catheter dislodgement or loss to follow-|2
60824|NCT01411891|244305|P1|Overall Study|Catheter dislodgement or loss to follow-|3
60825|NCT01411852|244313|P2|Hospital Intervention Phase|Vascular access failed|0
60826|NCT01411852|244314|P1|Hospital Intervention Phase|Vascular access failed|1
60827|NCT01411852|244313|P2|Hospital Intervention Phase|Withdrawal by Subject|0
60828|NCT01411852|244314|P1|Hospital Intervention Phase|Withdrawal by Subject|1
60829|NCT01411852|244313|P2|Hospital Intervention Phase|Spinal cord injury|0
60830|NCT01411852|244314|P1|Hospital Intervention Phase|Spinal cord injury|2
60831|NCT01411852|244313|P2|Hospital Intervention Phase|Other ineligible|2
60832|NCT01411852|244314|P1|Hospital Intervention Phase|Other ineligible|2
60833|NCT01411852|244313|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
60834|NCT01411852|244314|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
60835|NCT01411852|244313|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
60836|NCT01411852|244314|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
60837|NCT01411852|244313|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
60838|NCT01411852|244314|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
60839|NCT01411852|244313|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
60840|NCT01411852|244314|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
60842|NCT01411852|244314|P1|Hospital Intervention Phase|CPR administered|3
60843|NCT01411852|244313|P2|Hospital Intervention Phase|Miscommunication error|2
60844|NCT01411852|244314|P1|Hospital Intervention Phase|Miscommunication error|1
60845|NCT01411852|244313|P2|Hospital Intervention Phase|No qualifying SBP|1
60846|NCT01411852|244314|P1|Hospital Intervention Phase|No qualifying SBP|5
60847|NCT01411852|244313|P2|Hospital Intervention Phase|Severe head injury|4
60848|NCT01411852|244314|P1|Hospital Intervention Phase|Severe head injury|5
60849|NCT01411852|244313|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
60850|NCT01411852|244314|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
60851|NCT01411852|244313|P2|Prehospital Intervention Phase|Found to be under age|1
60852|NCT01411852|244314|P1|Prehospital Intervention Phase|Found to be under age|0
60853|NCT01411852|244313|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
60854|NCT01411852|244314|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
60855|NCT01411852|244313|P2|Prehospital Intervention Phase|No qualifying SBP|4
60856|NCT01411852|244314|P1|Prehospital Intervention Phase|No qualifying SBP|5
60857|NCT01411839|244359|P2|Overall Study|Lost to Follow-up|3
60858|NCT01411839|244360|P1|Overall Study|Lost to Follow-up|4
60859|NCT01411774|244372|P2|Overall Study|Withdrawal by Subject|3
60860|NCT01411774|244373|P1|Overall Study|Withdrawal by Subject|0
60861|NCT01411228|244448|P3|Overall Study|Withdrawal by Subject|0
60862|NCT01411228|244449|P2|Overall Study|Withdrawal by Subject|0
60863|NCT01411228|244450|P1|Overall Study|Withdrawal by Subject|1
60864|NCT01411228|244448|P3|Overall Study|Lost to Follow-up|1
60865|NCT01411228|244449|P2|Overall Study|Lost to Follow-up|0
60866|NCT01411228|244450|P1|Overall Study|Lost to Follow-up|0
60867|NCT01411215|244472|P2|Overall Study|Screen failure|1
60868|NCT01411215|244473|P1|Overall Study|Screen failure|0
60869|NCT01411215|244472|P2|Overall Study|Other|17
60870|NCT01411215|244473|P1|Overall Study|Other|12
60871|NCT01411215|244472|P2|Overall Study|Withdrawal by Subject|21
60872|NCT01411215|244473|P1|Overall Study|Withdrawal by Subject|34
60873|NCT01411215|244472|P2|Overall Study|Protocol Violation|5
60874|NCT01411215|244473|P1|Overall Study|Protocol Violation|3
60875|NCT01411215|244472|P2|Overall Study|Study terminated by sponsor|15
60876|NCT01411215|244473|P1|Overall Study|Study terminated by sponsor|2
60877|NCT01411215|244472|P2|Overall Study|Did not meet entrance criteria|1
60878|NCT01411215|244473|P1|Overall Study|Did not meet entrance criteria|0
60879|NCT01411215|244472|P2|Overall Study|Lost to Follow-up|18
60880|NCT01411215|244473|P1|Overall Study|Lost to Follow-up|12
60881|NCT01411215|244472|P2|Overall Study|Lack of Efficacy|4
60882|NCT01411215|244473|P1|Overall Study|Lack of Efficacy|2
60883|NCT01411215|244472|P2|Overall Study|Adverse Event|2
60884|NCT01411215|244473|P1|Overall Study|Adverse Event|1
60885|NCT01411085|244525|P1|Overall Study|Adverse Event|1
60886|NCT01411085|244525|P1|Overall Study|Protocol Violation|1
60887|NCT01411085|244525|P1|Overall Study|Physician Decision|1
60888|NCT01410604|244536|P2|Overall Study|Physician Decision|1
60889|NCT01410604|244537|P1|Overall Study|Physician Decision|0
60890|NCT01410604|244536|P2|Overall Study|Lost to Follow-up|0
60891|NCT01410604|244537|P1|Overall Study|Lost to Follow-up|1
60892|NCT01410604|244536|P2|Overall Study|Adverse Event|1
60893|NCT01410604|244537|P1|Overall Study|Adverse Event|2
60894|NCT01410474|244578|P2|Overall Study|Withdrawal by Subject|1
60895|NCT01410474|244579|P1|Overall Study|Withdrawal by Subject|0
60896|NCT01410448|244602|P2|Overall Study|Death|3
60897|NCT01410448|244603|P1|Overall Study|Death|2
60898|NCT01410448|244602|P2|Overall Study|Protocol Violation|4
60899|NCT01410448|244603|P1|Overall Study|Protocol Violation|0
60900|NCT01410448|244602|P2|Overall Study|Withdrawal by Subject|2
60901|NCT01410448|244603|P1|Overall Study|Withdrawal by Subject|3
60902|NCT01410448|244602|P2|Overall Study|Lost to Follow-up|0
60903|NCT01410448|244603|P1|Overall Study|Lost to Follow-up|1
60904|NCT01410448|244602|P2|Overall Study|Administrative issues|1
60905|NCT01410448|244603|P1|Overall Study|Administrative issues|2
60906|NCT01410448|244602|P2|Overall Study|Graft loss|1
60907|NCT01410448|244603|P1|Overall Study|Graft loss|4
60908|NCT01410448|244602|P2|Overall Study|No conversion to everolimus|24
60909|NCT01410448|244603|P1|Overall Study|No conversion to everolimus|0
60910|NCT01410357|244668|P2|Overall Study|Lost to Follow-up|21
60911|NCT01410357|244669|P1|Overall Study|Lost to Follow-up|23
60912|NCT01410357|244668|P2|Overall Study|Withdrawal by Subject|2
60913|NCT01410357|244669|P1|Overall Study|Withdrawal by Subject|1
60914|NCT01410357|244668|P2|Overall Study|Death|1
60915|NCT01410357|244669|P1|Overall Study|Death|2
60916|NCT01410240|244730|P3|Overall Study|Missed week 6 assessments|1
60917|NCT01410240|244731|P2|Overall Study|Missed week 6 assessments|1
60918|NCT01410240|244732|P1|Overall Study|Missed week 6 assessments|1
60919|NCT01410240|244730|P3|Overall Study|Physician Decision|1
60920|NCT01410240|244731|P2|Overall Study|Physician Decision|0
60921|NCT01410240|244732|P1|Overall Study|Physician Decision|0
60922|NCT01410227|244803|P4|Overall Study|Met Excl. Criteria After Starting Study|0
60923|NCT01410227|244804|P3|Overall Study|Met Excl. Criteria After Starting Study|1
60924|NCT01410227|244805|P2|Overall Study|Met Excl. Criteria After Starting Study|0
60925|NCT01410227|244806|P1|Overall Study|Met Excl. Criteria After Starting Study|0
60926|NCT01410227|244803|P4|Overall Study|Pregnancy|1
60927|NCT01410227|244804|P3|Overall Study|Pregnancy|0
60928|NCT01410227|244805|P2|Overall Study|Pregnancy|0
60929|NCT01410227|244806|P1|Overall Study|Pregnancy|0
60930|NCT01410227|244803|P4|Overall Study|Withdrawal by Subject|0
60931|NCT01410227|244804|P3|Overall Study|Withdrawal by Subject|1
60932|NCT01410227|244805|P2|Overall Study|Withdrawal by Subject|0
60933|NCT01410227|244806|P1|Overall Study|Withdrawal by Subject|3
60934|NCT01410227|244803|P4|Overall Study|Adverse Event|0
60935|NCT01410227|244804|P3|Overall Study|Adverse Event|0
60936|NCT01410227|244805|P2|Overall Study|Adverse Event|0
60937|NCT01410227|244806|P1|Overall Study|Adverse Event|1
60938|NCT01410110|244878|P2|Overall Study|Withdrawal by Subject|2
60939|NCT01410110|244879|P1|Overall Study|Withdrawal by Subject|4
60940|NCT01409993|244928|P4|Overall Study|Lost to Follow-up|0
60941|NCT01409993|244929|P3|Overall Study|Lost to Follow-up|0
60942|NCT01409993|244930|P2|Overall Study|Lost to Follow-up|1
60943|NCT01409993|244931|P1|Overall Study|Lost to Follow-up|0
60944|NCT01409993|244928|P4|Overall Study|Withdrawal by Subject|4
60945|NCT01409993|244929|P3|Overall Study|Withdrawal by Subject|0
60946|NCT01409993|244930|P2|Overall Study|Withdrawal by Subject|0
60947|NCT01409993|244931|P1|Overall Study|Withdrawal by Subject|0
60948|NCT01409993|244928|P4|Overall Study|Adverse Event|1
60949|NCT01409993|244929|P3|Overall Study|Adverse Event|3
60950|NCT01409993|244930|P2|Overall Study|Adverse Event|4
60951|NCT01409993|244931|P1|Overall Study|Adverse Event|4
60952|NCT01409837|244951|P2|Overall Study|Physician Decision|1
60953|NCT01409837|244952|P1|Overall Study|Physician Decision|0
60954|NCT01409837|244951|P2|Overall Study|Lost to Follow-up|0
60955|NCT01409837|244952|P1|Overall Study|Lost to Follow-up|1
60956|NCT01409837|244951|P2|Overall Study|Withdrawal by Subject|1
60957|NCT01409837|244952|P1|Overall Study|Withdrawal by Subject|2
60958|NCT01409707|244977|P3|Overall Study|Withdrawal by Subject|16
60959|NCT01409707|244978|P2|Overall Study|Withdrawal by Subject|17
60960|NCT01409707|244979|P1|Overall Study|Withdrawal by Subject|5
60961|NCT01409564|244991|P2|Overall Study|brain abnormalities found in T1 MR|2
60962|NCT01409564|244992|P1|Overall Study|brain abnormalities found in T1 MR|1
60963|NCT01409564|244991|P2|Overall Study|low medication compliance|3
60964|NCT01409564|244992|P1|Overall Study|low medication compliance|4
60965|NCT01409434|245010|P1|Overall Study|Protocol Violation|4
60966|NCT01409382|245020|P2|Overall Study|Had a 2nd trimester loss after accident|0
60967|NCT01409382|245021|P1|Overall Study|Had a 2nd trimester loss after accident|1
60968|NCT01409382|245020|P2|Overall Study|Did not manage to get pregnant|70
60969|NCT01409382|245021|P1|Overall Study|Did not manage to get pregnant|64
60970|NCT01409382|245020|P2|Overall Study|Still pregnant when study ended|2
60971|NCT01409382|245021|P1|Overall Study|Still pregnant when study ended|13
60972|NCT01409382|245020|P2|Overall Study|Multiple pregnancy|4
60973|NCT01409382|245021|P1|Overall Study|Multiple pregnancy|2
60974|NCT01409382|245020|P2|Overall Study|Protocol Violation|3
60975|NCT01409382|245021|P1|Overall Study|Protocol Violation|0
60976|NCT01409382|245020|P2|Overall Study|Lost to Follow-up|1
60977|NCT01409382|245021|P1|Overall Study|Lost to Follow-up|1
60978|NCT01408914|245088|P3|Overall Study|Change in local TB/HIV norms|1
60979|NCT01408914|245089|P2|Overall Study|Change in local TB/HIV norms|1
60980|NCT01408914|245090|P1|Overall Study|Change in local TB/HIV norms|0
60981|NCT01408914|245088|P3|Overall Study|Late exclusion|3
60982|NCT01408914|245089|P2|Overall Study|Late exclusion|3
60983|NCT01408914|245090|P1|Overall Study|Late exclusion|0
60984|NCT01408914|245088|P3|Overall Study|Moved out of study jurisdiction|0
60985|NCT01408914|245089|P2|Overall Study|Moved out of study jurisdiction|1
60986|NCT01408914|245090|P1|Overall Study|Moved out of study jurisdiction|1
60987|NCT01408914|245088|P3|Overall Study|Withdrawal by Subject|1
60988|NCT01408914|245089|P2|Overall Study|Withdrawal by Subject|0
60989|NCT01408914|245090|P1|Overall Study|Withdrawal by Subject|1
60990|NCT01408914|245088|P3|Overall Study|Physician Decision|0
60991|NCT01408914|245089|P2|Overall Study|Physician Decision|1
60992|NCT01408914|245090|P1|Overall Study|Physician Decision|1
60993|NCT01408914|245088|P3|Overall Study|Lost to Follow-up|2
60994|NCT01408914|245089|P2|Overall Study|Lost to Follow-up|1
60995|NCT01408914|245090|P1|Overall Study|Lost to Follow-up|4
60996|NCT01408914|245088|P3|Overall Study|Could not complete tx in protocol period|6
60997|NCT01408914|245089|P2|Overall Study|Could not complete tx in protocol period|5
60998|NCT01408914|245090|P1|Overall Study|Could not complete tx in protocol period|5
60999|NCT01408888|245104|P2|Second Intervention|Adverse Event|0
61000|NCT01408888|245105|P1|Second Intervention|Adverse Event|1
61001|NCT01408888|245104|P2|Second Intervention|Withdrawal by Subject|0
61002|NCT01408888|245105|P1|Second Intervention|Withdrawal by Subject|1
61003|NCT01408888|245104|P2|First Intervention|Withdrawal by Subject|2
61004|NCT01408888|245105|P1|First Intervention|Withdrawal by Subject|0
61005|NCT01408888|245104|P2|First Intervention|Adverse Event|1
61006|NCT01408888|245105|P1|First Intervention|Adverse Event|0
61007|NCT01408732|245133|P2|Overall Study|Withdrawal by Subject|2
61008|NCT01408732|245134|P1|Overall Study|Withdrawal by Subject|2
61009|NCT01408706|245191|P2|Overall Study|Physician Decision|0
61010|NCT01408706|245192|P1|Overall Study|Physician Decision|1
61011|NCT01408641|245204|P2|Overall Study|Physician Decision|0
61012|NCT01408641|245205|P1|Overall Study|Physician Decision|1
61013|NCT01408628|245213|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
61014|NCT01408628|245213|P1|Completed 6 Month Follow-Up|Protocol Violation|6
61015|NCT01408628|245213|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
61016|NCT01408628|245213|P1|Consented|Withdrawal by Subject|12
61017|NCT01408537|245219|P1|Overall Study|Lost to Follow-up|3
61018|NCT01408537|245219|P1|Overall Study|Protocol Violation|3
61019|NCT01408537|245219|P1|Overall Study|Withdrawal by Subject|2
61020|NCT01408485|245235|P1|Overall Study|Withdrawal by Subject|21
61021|NCT01408303|245253|P3|Overall Study|Noncompliance|1
61022|NCT01408303|245254|P2|Overall Study|Noncompliance|0
61023|NCT01408303|245255|P1|Overall Study|Noncompliance|1
61024|NCT01408303|245253|P3|Overall Study|Protocol Violation|0
61025|NCT01408303|245254|P2|Overall Study|Protocol Violation|1
61026|NCT01408303|245255|P1|Overall Study|Protocol Violation|0
61027|NCT01408303|245253|P3|Overall Study|Withdrawal by Subject|1
61028|NCT01408303|245254|P2|Overall Study|Withdrawal by Subject|3
61029|NCT01408303|245255|P1|Overall Study|Withdrawal by Subject|2
61030|NCT01408303|245253|P3|Overall Study|Lost to Follow-up|2
61031|NCT01408303|245254|P2|Overall Study|Lost to Follow-up|1
61032|NCT01408303|245255|P1|Overall Study|Lost to Follow-up|0
61033|NCT01408303|245253|P3|Overall Study|Adverse Event|2
61034|NCT01408303|245254|P2|Overall Study|Adverse Event|7
61035|NCT01408303|245255|P1|Overall Study|Adverse Event|3
61036|NCT01408277|245265|P2|Overall Study|Protocol Violation|0
61037|NCT01408277|245266|P1|Overall Study|Protocol Violation|2
61038|NCT01408277|245265|P2|Overall Study|Withdrawal by Subject|0
61039|NCT01408277|245266|P1|Overall Study|Withdrawal by Subject|2
61040|NCT01408277|245265|P2|Overall Study|Lost to Follow-up|0
61041|NCT01408277|245266|P1|Overall Study|Lost to Follow-up|1
61042|NCT01408277|245265|P2|Overall Study|Adverse Event|4
61043|NCT01408277|245266|P1|Overall Study|Adverse Event|3
61044|NCT01407354|245303|P2|First Intervention|Physician Decision|0
61045|NCT01407354|245304|P1|First Intervention|Physician Decision|1
61046|NCT01407354|245303|P2|First Intervention|Adverse Event|0
61047|NCT01407354|245304|P1|First Intervention|Adverse Event|1
61048|NCT01407354|245303|P2|First Intervention|Withdrawal by Subject|2
61049|NCT01407354|245304|P1|First Intervention|Withdrawal by Subject|0
61050|NCT01407276|245320|P8|Overall Study|Withdrawal by Subject|1
61051|NCT01407276|245321|P7|Overall Study|Withdrawal by Subject|0
61052|NCT01407276|245322|P6|Overall Study|Withdrawal by Subject|0
61053|NCT01407276|245323|P5|Overall Study|Withdrawal by Subject|0
61054|NCT01407276|245324|P4|Overall Study|Withdrawal by Subject|0
61055|NCT01407276|245325|P3|Overall Study|Withdrawal by Subject|0
61056|NCT01407276|245326|P2|Overall Study|Withdrawal by Subject|0
61057|NCT01407276|245327|P1|Overall Study|Withdrawal by Subject|0
61058|NCT01406938|245466|P6|Follow up|Lost to Follow-up|1
61059|NCT01406938|245467|P5|Follow up|Lost to Follow-up|2
61060|NCT01406938|245468|P4|Follow up|Lost to Follow-up|1
61061|NCT01406938|245469|P3|Follow up|Lost to Follow-up|0
61062|NCT01406938|245470|P2|Follow up|Lost to Follow-up|1
61063|NCT01406938|245471|P1|Follow up|Lost to Follow-up|1
61064|NCT01406938|245466|P6|Follow up|Physician Decision|1
61065|NCT01406938|245467|P5|Follow up|Physician Decision|3
61066|NCT01406938|245468|P4|Follow up|Physician Decision|0
61067|NCT01406938|245469|P3|Follow up|Physician Decision|2
61068|NCT01406938|245470|P2|Follow up|Physician Decision|0
61069|NCT01406938|245471|P1|Follow up|Physician Decision|0
61070|NCT01406938|245466|P6|Follow up|Protocol Violation|0
61071|NCT01406938|245467|P5|Follow up|Protocol Violation|0
61072|NCT01406938|245468|P4|Follow up|Protocol Violation|0
61073|NCT01406938|245469|P3|Follow up|Protocol Violation|1
61074|NCT01406938|245470|P2|Follow up|Protocol Violation|0
61075|NCT01406938|245471|P1|Follow up|Protocol Violation|0
61076|NCT01406938|245466|P6|Follow up|Patient/guardian decision|1
61077|NCT01406938|245467|P5|Follow up|Patient/guardian decision|4
61078|NCT01406938|245468|P4|Follow up|Patient/guardian decision|2
61079|NCT01406938|245469|P3|Follow up|Patient/guardian decision|4
61080|NCT01406938|245470|P2|Follow up|Patient/guardian decision|2
61081|NCT01406938|245471|P1|Follow up|Patient/guardian decision|4
61082|NCT01406938|245466|P6|Follow up|Lack of Efficacy|0
61083|NCT01406938|245467|P5|Follow up|Lack of Efficacy|0
61084|NCT01406938|245468|P4|Follow up|Lack of Efficacy|0
61085|NCT01406938|245469|P3|Follow up|Lack of Efficacy|1
61086|NCT01406938|245470|P2|Follow up|Lack of Efficacy|2
61087|NCT01406938|245471|P1|Follow up|Lack of Efficacy|3
61088|NCT01406938|245466|P6|Maintenance Period|Lack of Efficacy|5
61089|NCT01406938|245467|P5|Maintenance Period|Lack of Efficacy|3
61090|NCT01406938|245468|P4|Maintenance Period|Lack of Efficacy|1
61091|NCT01406938|245469|P3|Maintenance Period|Lack of Efficacy|2
61092|NCT01406938|245470|P2|Maintenance Period|Lack of Efficacy|0
61093|NCT01406938|245471|P1|Maintenance Period|Lack of Efficacy|0
61094|NCT01406938|245466|P6|Maintenance Period|Lost to Follow-up|0
61095|NCT01406938|245467|P5|Maintenance Period|Lost to Follow-up|4
61096|NCT01406938|245468|P4|Maintenance Period|Lost to Follow-up|0
61097|NCT01406938|245469|P3|Maintenance Period|Lost to Follow-up|0
61098|NCT01406938|245470|P2|Maintenance Period|Lost to Follow-up|0
61099|NCT01406938|245471|P1|Maintenance Period|Lost to Follow-up|0
61100|NCT01406938|245466|P6|Maintenance Period|Pregnancy|0
61101|NCT01406938|245467|P5|Maintenance Period|Pregnancy|1
61102|NCT01406938|245468|P4|Maintenance Period|Pregnancy|0
61103|NCT01406938|245469|P3|Maintenance Period|Pregnancy|0
61104|NCT01406938|245470|P2|Maintenance Period|Pregnancy|0
61105|NCT01406938|245471|P1|Maintenance Period|Pregnancy|0
61106|NCT01406938|245466|P6|Maintenance Period|Protocol Violation|2
61107|NCT01406938|245467|P5|Maintenance Period|Protocol Violation|2
61108|NCT01406938|245468|P4|Maintenance Period|Protocol Violation|2
61109|NCT01406938|245469|P3|Maintenance Period|Protocol Violation|2
61110|NCT01406938|245470|P2|Maintenance Period|Protocol Violation|0
61111|NCT01406938|245471|P1|Maintenance Period|Protocol Violation|0
61112|NCT01406938|245466|P6|Maintenance Period|Subject/guardian decision|7
61113|NCT01406938|245467|P5|Maintenance Period|Subject/guardian decision|10
61114|NCT01406938|245468|P4|Maintenance Period|Subject/guardian decision|7
61115|NCT01406938|245469|P3|Maintenance Period|Subject/guardian decision|11
61116|NCT01406938|245470|P2|Maintenance Period|Subject/guardian decision|0
61117|NCT01406938|245471|P1|Maintenance Period|Subject/guardian decision|0
61118|NCT01406938|245466|P6|Maintenance Period|Death|0
61119|NCT01406938|245467|P5|Maintenance Period|Death|1
61120|NCT01406938|245468|P4|Maintenance Period|Death|0
61121|NCT01406938|245469|P3|Maintenance Period|Death|0
61122|NCT01406938|245470|P2|Maintenance Period|Death|0
61123|NCT01406938|245471|P1|Maintenance Period|Death|0
61124|NCT01406938|245466|P6|Maintenance Period|Adverse Event|2
61125|NCT01406938|245467|P5|Maintenance Period|Adverse Event|4
61126|NCT01406938|245468|P4|Maintenance Period|Adverse Event|8
61127|NCT01406938|245469|P3|Maintenance Period|Adverse Event|2
61128|NCT01406938|245470|P2|Maintenance Period|Adverse Event|0
61129|NCT01406938|245471|P1|Maintenance Period|Adverse Event|0
61130|NCT01406938|245466|P6|Induction Period|Lost to Follow-up|0
61131|NCT01406938|245467|P5|Induction Period|Lost to Follow-up|0
61132|NCT01406938|245468|P4|Induction Period|Lost to Follow-up|0
61133|NCT01406938|245469|P3|Induction Period|Lost to Follow-up|0
61134|NCT01406938|245470|P2|Induction Period|Lost to Follow-up|3
61135|NCT01406938|245471|P1|Induction Period|Lost to Follow-up|2
61136|NCT01406938|245466|P6|Induction Period|Lack of Efficacy|0
61137|NCT01406938|245467|P5|Induction Period|Lack of Efficacy|0
61138|NCT01406938|245468|P4|Induction Period|Lack of Efficacy|0
61139|NCT01406938|245469|P3|Induction Period|Lack of Efficacy|0
61140|NCT01406938|245470|P2|Induction Period|Lack of Efficacy|0
61141|NCT01406938|245471|P1|Induction Period|Lack of Efficacy|1
61142|NCT01406938|245466|P6|Induction Period|Adverse Event|0
61143|NCT01406938|245467|P5|Induction Period|Adverse Event|0
61144|NCT01406938|245468|P4|Induction Period|Adverse Event|0
61145|NCT01406938|245469|P3|Induction Period|Adverse Event|0
61146|NCT01406938|245470|P2|Induction Period|Adverse Event|9
61147|NCT01406938|245471|P1|Induction Period|Adverse Event|8
61148|NCT01406938|245466|P6|Induction Period|Protocol deviation|0
61149|NCT01406938|245467|P5|Induction Period|Protocol deviation|0
61150|NCT01406938|245468|P4|Induction Period|Protocol deviation|0
61151|NCT01406938|245469|P3|Induction Period|Protocol deviation|0
61152|NCT01406938|245470|P2|Induction Period|Protocol deviation|0
61153|NCT01406938|245471|P1|Induction Period|Protocol deviation|1
61154|NCT01406938|245466|P6|Induction Period|Subject/guardian decision|0
61155|NCT01406938|245467|P5|Induction Period|Subject/guardian decision|0
61156|NCT01406938|245468|P4|Induction Period|Subject/guardian decision|0
61157|NCT01406938|245469|P3|Induction Period|Subject/guardian decision|0
61158|NCT01406938|245470|P2|Induction Period|Subject/guardian decision|8
61159|NCT01406938|245471|P1|Induction Period|Subject/guardian decision|6
61160|NCT01406873|245589|P2|Overall Study|Withdrawal by Subject|1
61161|NCT01406873|245590|P1|Overall Study|Withdrawal by Subject|1
61162|NCT01406795|245621|P1|Overall Study|Withdrawal by Subject|1
61163|NCT01406574|245635|P4|Overall Study|Definite progression of primary disease|0
61164|NCT01406574|245636|P3|Overall Study|Definite progression of primary disease|0
61165|NCT01406574|245637|P2|Overall Study|Definite progression of primary disease|0
61166|NCT01406574|245638|P1|Overall Study|Definite progression of primary disease|1
61167|NCT01406574|245635|P4|Overall Study|Withdrawal by Subject|0
61168|NCT01406574|245636|P3|Overall Study|Withdrawal by Subject|0
61169|NCT01406574|245637|P2|Overall Study|Withdrawal by Subject|1
61170|NCT01406574|245638|P1|Overall Study|Withdrawal by Subject|0
61171|NCT01406574|245635|P4|Overall Study|Physician Decision|1
61172|NCT01406574|245636|P3|Overall Study|Physician Decision|0
61173|NCT01406574|245637|P2|Overall Study|Physician Decision|0
61174|NCT01406574|245638|P1|Overall Study|Physician Decision|0
61175|NCT01406574|245635|P4|Overall Study|Adverse Event|3
61176|NCT01406574|245636|P3|Overall Study|Adverse Event|1
61177|NCT01406574|245637|P2|Overall Study|Adverse Event|0
61178|NCT01406574|245638|P1|Overall Study|Adverse Event|0
61179|NCT01406015|245673|P2|Overall Study|Withdrawal by Subject|3
61180|NCT01406015|245674|P1|Overall Study|Withdrawal by Subject|3
61181|NCT01405950|245690|P4|Overall Study|Withdrawal by Subject|0
61182|NCT01405950|245691|P3|Overall Study|Withdrawal by Subject|0
61183|NCT01405950|245692|P2|Overall Study|Withdrawal by Subject|0
61184|NCT01405950|245693|P1|Overall Study|Withdrawal by Subject|1
61185|NCT01405924|245728|P1|Overall Study|Missing/Incomplete Data|2
61186|NCT01405924|245728|P1|Overall Study|Protocol Violation|8
61187|NCT01405898|245740|P2|Overall Study|Withdrawal by Subject|2
61188|NCT01405898|245741|P1|Overall Study|Withdrawal by Subject|2
61189|NCT01405820|245765|P6|Open-Label Treatment Period|Adverse Event|0
61190|NCT01405820|245766|P5|Open-Label Treatment Period|Adverse Event|0
61191|NCT01405820|245767|P4|Open-Label Treatment Period|Adverse Event|1
61192|NCT01405820|245768|P3|Open-Label Treatment Period|Adverse Event|0
61193|NCT01405820|245769|P2|Open-Label Treatment Period|Adverse Event|0
61194|NCT01405820|245770|P1|Open-Label Treatment Period|Adverse Event|0
61195|NCT01405820|245765|P6|Open-Label Treatment Period|Physician Decision|0
61196|NCT01405820|245766|P5|Open-Label Treatment Period|Physician Decision|1
61197|NCT01405820|245767|P4|Open-Label Treatment Period|Physician Decision|2
61198|NCT01405820|245768|P3|Open-Label Treatment Period|Physician Decision|1
61199|NCT01405820|245769|P2|Open-Label Treatment Period|Physician Decision|0
61200|NCT01405820|245770|P1|Open-Label Treatment Period|Physician Decision|0
61201|NCT01405820|245765|P6|Open-Label Treatment Period|Not Specified|1
61202|NCT01405820|245766|P5|Open-Label Treatment Period|Not Specified|1
61203|NCT01405820|245767|P4|Open-Label Treatment Period|Not Specified|1
61204|NCT01405820|245768|P3|Open-Label Treatment Period|Not Specified|1
61205|NCT01405820|245769|P2|Open-Label Treatment Period|Not Specified|1
61206|NCT01405820|245770|P1|Open-Label Treatment Period|Not Specified|1
61207|NCT01405820|245765|P6|Open-Label Treatment Period|Withdrawal by Subject|1
61208|NCT01405820|245766|P5|Open-Label Treatment Period|Withdrawal by Subject|0
61209|NCT01405820|245767|P4|Open-Label Treatment Period|Withdrawal by Subject|1
61210|NCT01405820|245768|P3|Open-Label Treatment Period|Withdrawal by Subject|1
61211|NCT01405820|245769|P2|Open-Label Treatment Period|Withdrawal by Subject|1
61212|NCT01405820|245770|P1|Open-Label Treatment Period|Withdrawal by Subject|3
61213|NCT01405820|245765|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
61214|NCT01405820|245766|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
61215|NCT01405820|245767|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
61216|NCT01405820|245768|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
61217|NCT01405820|245769|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
61218|NCT01405820|245770|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
61219|NCT01405820|245765|P6|Randomized Treatment Period|Death|0
61220|NCT01405820|245766|P5|Randomized Treatment Period|Death|0
61221|NCT01405820|245767|P4|Randomized Treatment Period|Death|1
61222|NCT01405820|245768|P3|Randomized Treatment Period|Death|0
61223|NCT01405820|245769|P2|Randomized Treatment Period|Death|0
61224|NCT01405820|245770|P1|Randomized Treatment Period|Death|0
61225|NCT01405820|245765|P6|Randomized Treatment Period|Treatment Arm Closed|28
61226|NCT01405820|245766|P5|Randomized Treatment Period|Treatment Arm Closed|33
61227|NCT01405820|245767|P4|Randomized Treatment Period|Treatment Arm Closed|36
61228|NCT01405820|245768|P3|Randomized Treatment Period|Treatment Arm Closed|20
61229|NCT01405820|245769|P2|Randomized Treatment Period|Treatment Arm Closed|0
61230|NCT01405820|245770|P1|Randomized Treatment Period|Treatment Arm Closed|0
61231|NCT01405820|245765|P6|Randomized Treatment Period|Incorrect Study Treatment|0
61232|NCT01405820|245766|P5|Randomized Treatment Period|Incorrect Study Treatment|2
61233|NCT01405820|245767|P4|Randomized Treatment Period|Incorrect Study Treatment|0
61234|NCT01405820|245768|P3|Randomized Treatment Period|Incorrect Study Treatment|3
61235|NCT01405820|245769|P2|Randomized Treatment Period|Incorrect Study Treatment|0
61236|NCT01405820|245770|P1|Randomized Treatment Period|Incorrect Study Treatment|0
61237|NCT01405820|245765|P6|Randomized Treatment Period|Rescue|8
61238|NCT01405820|245766|P5|Randomized Treatment Period|Rescue|8
61239|NCT01405820|245767|P4|Randomized Treatment Period|Rescue|10
61240|NCT01405820|245768|P3|Randomized Treatment Period|Rescue|13
61241|NCT01405820|245769|P2|Randomized Treatment Period|Rescue|1
61242|NCT01405820|245770|P1|Randomized Treatment Period|Rescue|0
61243|NCT01405820|245765|P6|Randomized Treatment Period|Physician Decision|0
61244|NCT01405820|245766|P5|Randomized Treatment Period|Physician Decision|0
61245|NCT01405820|245767|P4|Randomized Treatment Period|Physician Decision|0
61246|NCT01405820|245768|P3|Randomized Treatment Period|Physician Decision|1
61247|NCT01405820|245769|P2|Randomized Treatment Period|Physician Decision|2
61248|NCT01405820|245770|P1|Randomized Treatment Period|Physician Decision|0
61249|NCT01405820|245765|P6|Randomized Treatment Period|Not Specified|0
61250|NCT01405820|245766|P5|Randomized Treatment Period|Not Specified|0
61251|NCT01405820|245767|P4|Randomized Treatment Period|Not Specified|1
61252|NCT01405820|245768|P3|Randomized Treatment Period|Not Specified|1
61253|NCT01405820|245769|P2|Randomized Treatment Period|Not Specified|2
61254|NCT01405820|245770|P1|Randomized Treatment Period|Not Specified|2
61255|NCT01405820|245765|P6|Randomized Treatment Period|Withdrawal by Subject|0
61256|NCT01405820|245766|P5|Randomized Treatment Period|Withdrawal by Subject|0
61257|NCT01405820|245767|P4|Randomized Treatment Period|Withdrawal by Subject|2
61258|NCT01405820|245768|P3|Randomized Treatment Period|Withdrawal by Subject|2
61259|NCT01405820|245769|P2|Randomized Treatment Period|Withdrawal by Subject|2
61260|NCT01405820|245770|P1|Randomized Treatment Period|Withdrawal by Subject|6
61261|NCT01405820|245765|P6|Randomized Treatment Period|Adverse Event|1
61262|NCT01405820|245766|P5|Randomized Treatment Period|Adverse Event|2
61263|NCT01405820|245767|P4|Randomized Treatment Period|Adverse Event|0
61264|NCT01405820|245768|P3|Randomized Treatment Period|Adverse Event|3
61265|NCT01405820|245769|P2|Randomized Treatment Period|Adverse Event|3
61266|NCT01405820|245770|P1|Randomized Treatment Period|Adverse Event|3
61267|NCT01405768|245866|P2|Overall Study|Didn't complete questionnaire correctly|0
61268|NCT01405768|245867|P1|Overall Study|Didn't complete questionnaire correctly|4
61269|NCT01405742|245879|P2|Overall Study|Lost to Follow-up|0
61270|NCT01405742|245880|P1|Overall Study|Lost to Follow-up|1
61271|NCT01405560|245890|P1|Overall Study|Physician Decision|1
61272|NCT01405508|245905|P4|Overall Study|AE, non-serious non-fatal|0
61273|NCT01405508|245906|P3|Overall Study|AE, non-serious non-fatal|0
61274|NCT01405508|245907|P2|Overall Study|AE, non-serious non-fatal|1
61275|NCT01405508|245908|P1|Overall Study|AE, non-serious non-fatal|1
61276|NCT01405456|245940|P2|Overall Study|Physician Decision|0
61277|NCT01405456|245941|P1|Overall Study|Physician Decision|1
61278|NCT01405456|245940|P2|Overall Study|Lost to Follow-up|1
61279|NCT01405456|245941|P1|Overall Study|Lost to Follow-up|2
61280|NCT01405196|245981|P4|Overall Study|Lost to Follow-up|1
61281|NCT01405196|245982|P3|Overall Study|Lost to Follow-up|3
61282|NCT01405196|245983|P2|Overall Study|Lost to Follow-up|2
61283|NCT01405196|245984|P1|Overall Study|Lost to Follow-up|2
61284|NCT01405196|245981|P4|Overall Study|Death|0
61285|NCT01405196|245982|P3|Overall Study|Death|3
61286|NCT01405196|245983|P2|Overall Study|Death|0
61287|NCT01405196|245984|P1|Overall Study|Death|1
61288|NCT01405196|245981|P4|Overall Study|Adverse Event|2
61289|NCT01405196|245982|P3|Overall Study|Adverse Event|0
61290|NCT01405196|245983|P2|Overall Study|Adverse Event|2
61291|NCT01405196|245984|P1|Overall Study|Adverse Event|2
61292|NCT01405196|245981|P4|Overall Study|Withdrawal by Subject|6
61293|NCT01405196|245982|P3|Overall Study|Withdrawal by Subject|3
61294|NCT01405196|245983|P2|Overall Study|Withdrawal by Subject|6
61295|NCT01405196|245984|P1|Overall Study|Withdrawal by Subject|4
61296|NCT01405196|245981|P4|Overall Study|Other|0
61297|NCT01405196|245982|P3|Overall Study|Other|5
61298|NCT01405196|245983|P2|Overall Study|Other|2
61299|NCT01405196|245984|P1|Overall Study|Other|2
61300|NCT01405196|245981|P4|Overall Study|Study Terminated by Sponsor|0
61301|NCT01405196|245982|P3|Overall Study|Study Terminated by Sponsor|9
61302|NCT01405196|245983|P2|Overall Study|Study Terminated by Sponsor|0
61303|NCT01405196|245984|P1|Overall Study|Study Terminated by Sponsor|0
61304|NCT01405027|246071|P2|Overall Study|Other or Unknown|25
61305|NCT01405027|246072|P1|Overall Study|Other or Unknown|12
61306|NCT01405027|246071|P2|Overall Study|Death|0
61307|NCT01405027|246072|P1|Overall Study|Death|1
61308|NCT01405027|246071|P2|Overall Study|Investigator judgement|2
61309|NCT01405027|246072|P1|Overall Study|Investigator judgement|0
61310|NCT01405027|246071|P2|Overall Study|Lost to Follow-up|24
61311|NCT01405027|246072|P1|Overall Study|Lost to Follow-up|16
61312|NCT01405027|246071|P2|Overall Study|Withdrawn consent|0
61313|NCT01405027|246072|P1|Overall Study|Withdrawn consent|3
61314|NCT01404988|246089|P3|Overall Study|Lost to Follow-up|1
61315|NCT01404988|246090|P2|Overall Study|Lost to Follow-up|2
61316|NCT01404988|246091|P1|Overall Study|Lost to Follow-up|1
61317|NCT01404988|246089|P3|Overall Study|Withdrawal by Subject|0
61318|NCT01404988|246090|P2|Overall Study|Withdrawal by Subject|2
61319|NCT01404988|246091|P1|Overall Study|Withdrawal by Subject|2
61320|NCT01404988|246089|P3|Overall Study|Adverse Event|0
61321|NCT01404988|246090|P2|Overall Study|Adverse Event|0
61322|NCT01404988|246091|P1|Overall Study|Adverse Event|1
61323|NCT01404988|246089|P3|Overall Study|Death|2
61324|NCT01404988|246090|P2|Overall Study|Death|0
61325|NCT01404988|246091|P1|Overall Study|Death|2
61326|NCT01404234|246219|P1|Overall Study|Withdrawal by Subject|2
61327|NCT01404208|246235|P2|Overall Study|Discontinued|0
61328|NCT01404208|246236|P1|Overall Study|Discontinued|3
61329|NCT01403987|246301|P3|Overall Study|Residents forgot their secret PIN|18
61330|NCT01403987|246302|P2|Overall Study|Residents forgot their secret PIN|17
61331|NCT01403987|246303|P1|Overall Study|Residents forgot their secret PIN|18
61332|NCT01403805|246319|P2|Overall Study|Death|1
61333|NCT01403805|246320|P1|Overall Study|Death|0
61334|NCT01403805|246319|P2|Overall Study|Lost to Follow-up|2
61335|NCT01403805|246320|P1|Overall Study|Lost to Follow-up|0
61336|NCT01403805|246319|P2|Overall Study|Withdrawal by Subject|4
61337|NCT01403805|246320|P1|Overall Study|Withdrawal by Subject|0
61338|NCT01403194|246364|P1|Overall Study|Lost to Follow-up|8
61339|NCT01403194|246364|P1|Overall Study|Screen Failure|2
61340|NCT01403051|246376|P2|Overall Study|Lost to Follow-up|5
61341|NCT01403051|246377|P1|Overall Study|Lost to Follow-up|5
61342|NCT01403051|246376|P2|Overall Study|Withdrawal by Subject|1
61343|NCT01403051|246377|P1|Overall Study|Withdrawal by Subject|2
61344|NCT01403051|246376|P2|Overall Study|Death|0
61345|NCT01403051|246377|P1|Overall Study|Death|1
61346|NCT01403051|246376|P2|Overall Study|Protocol Violation|0
61347|NCT01403051|246377|P1|Overall Study|Protocol Violation|2
61348|NCT01402986|246413|P4|Overall Study|Other|6
61349|NCT01402986|246414|P3|Overall Study|Other|1
61350|NCT01402986|246415|P2|Overall Study|Other|5
61351|NCT01402986|246416|P1|Overall Study|Other|2
61352|NCT01402986|246413|P4|Overall Study|Lost to Follow-up|1
61353|NCT01402986|246414|P3|Overall Study|Lost to Follow-up|0
61354|NCT01402986|246415|P2|Overall Study|Lost to Follow-up|0
61355|NCT01402986|246416|P1|Overall Study|Lost to Follow-up|0
61356|NCT01402986|246413|P4|Overall Study|Death|2
61357|NCT01402986|246414|P3|Overall Study|Death|0
61358|NCT01402986|246415|P2|Overall Study|Death|0
61359|NCT01402986|246416|P1|Overall Study|Death|0
61360|NCT01402986|246413|P4|Overall Study|Withdrawal by Subject|13
61361|NCT01402986|246414|P3|Overall Study|Withdrawal by Subject|7
61362|NCT01402986|246415|P2|Overall Study|Withdrawal by Subject|10
61363|NCT01402986|246416|P1|Overall Study|Withdrawal by Subject|7
61364|NCT01402947|246551|P2|First Intervention|Adverse Event|1
61365|NCT01402947|246552|P1|First Intervention|Adverse Event|0
61366|NCT01402869|246563|P3|Overall Study|Required Tooth Extraction|1
61367|NCT01402869|246564|P2|Overall Study|Required Tooth Extraction|0
61368|NCT01402869|246565|P1|Overall Study|Required Tooth Extraction|0
61369|NCT01402817|246579|P1|Overall Study|Study Suspended by FDA|8
61370|NCT01402817|246579|P1|Overall Study|Withdrawal by Subject|3
61371|NCT01402700|246584|P1|Overall Study|Missed Visit|1
61372|NCT01402700|246584|P1|Overall Study|Withdrawal by Subject|3
61373|NCT01402700|246584|P1|Overall Study|Death|3
61374|NCT01402570|246588|P1|Overall Study|Adverse Event|1
61375|NCT01402284|246659|P1|Overall Study|Non compliance|2
61376|NCT01402284|246659|P1|Overall Study|Disease progression on study|9
61377|NCT01402284|246659|P1|Overall Study|Physician Decision|1
61378|NCT01402284|246659|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
61379|NCT01402284|246659|P1|Overall Study|Withdrawal consent|1
61380|NCT01402102|246741|P2|Overall Study|Withdrawal by Subject|2
61381|NCT01402102|246742|P1|Overall Study|Withdrawal by Subject|0
61382|NCT01402102|246741|P2|Overall Study|Insufficiency of compliance|1
61383|NCT01402102|246742|P1|Overall Study|Insufficiency of compliance|1
61384|NCT01402102|246741|P2|Overall Study|Protocol Violation|0
61385|NCT01402102|246742|P1|Overall Study|Protocol Violation|1
61386|NCT01402063|246762|P2|Overall Study|Withdrawal by Subject|3
61387|NCT01402063|246763|P1|Overall Study|Withdrawal by Subject|3
61388|NCT01401959|246772|P3|Treated|Protocol Violation|0
61389|NCT01401959|246773|P2|Treated|Protocol Violation|1
61390|NCT01401959|246774|P1|Treated|Protocol Violation|0
61391|NCT01401959|246772|P3|Treated|Withdrawal by Subject|2
61392|NCT01401959|246773|P2|Treated|Withdrawal by Subject|2
61393|NCT01401959|246774|P1|Treated|Withdrawal by Subject|1
61394|NCT01401959|246772|P3|Treated|Adverse Event|2
61395|NCT01401959|246773|P2|Treated|Adverse Event|3
61396|NCT01401959|246774|P1|Treated|Adverse Event|4
61397|NCT01401959|246772|P3|Treated|Disease Progression|1
61398|NCT01401959|246773|P2|Treated|Disease Progression|2
61399|NCT01401959|246774|P1|Treated|Disease Progression|2
61400|NCT01401959|246772|P3|Enrolled|Withdrawal by Subject|0
61401|NCT01401959|246773|P2|Enrolled|Withdrawal by Subject|0
61402|NCT01401959|246774|P1|Enrolled|Withdrawal by Subject|1
61403|NCT01401842|246811|P2|Overall Study|other/unknown|17
61404|NCT01401842|246812|P1|Overall Study|other/unknown|28
61405|NCT01401842|246811|P2|Overall Study|on profile|5
61406|NCT01401842|246812|P1|Overall Study|on profile|9
61407|NCT01401842|246811|P2|Overall Study|invalid follow-up strength data|4
61408|NCT01401842|246812|P1|Overall Study|invalid follow-up strength data|1
61409|NCT01401842|246811|P2|Overall Study|discharged from US Army|4
61410|NCT01401842|246812|P1|Overall Study|discharged from US Army|3
61411|NCT01401842|246811|P2|Overall Study|changed companies|34
61412|NCT01401842|246812|P1|Overall Study|changed companies|20
61413|NCT01401842|246811|P2|Overall Study|academic reason|1
61414|NCT01401842|246812|P1|Overall Study|academic reason|4
61415|NCT01401842|246811|P2|Overall Study|Withdrawal by Subject|2
61416|NCT01401842|246812|P1|Overall Study|Withdrawal by Subject|3
61417|NCT01401647|246825|P3|Overall Study|Lost to Follow-up|1
61418|NCT01401647|246826|P2|Overall Study|Lost to Follow-up|3
61419|NCT01401647|246827|P1|Overall Study|Lost to Follow-up|3
61420|NCT01401647|246825|P3|Overall Study|Withdrawal by Subject|2
61421|NCT01401647|246826|P2|Overall Study|Withdrawal by Subject|5
61422|NCT01401647|246827|P1|Overall Study|Withdrawal by Subject|1
61423|NCT01401478|246882|P1|Overall Study|Serious adverse event|1
61424|NCT01401478|246882|P1|Overall Study|Low intact parathyroid hormone|1
61425|NCT01401478|246882|P1|Overall Study|Hyperphosphatemia and adverse event|1
61426|NCT01401478|246882|P1|Overall Study|Blood samples not available|1
61427|NCT01401478|246882|P1|Overall Study|Withdrawal by Subject|3
61428|NCT01401478|246882|P1|Overall Study|Kidney transplantation|3
61429|NCT01401478|246882|P1|Overall Study|Lost to Follow-up|5
61430|NCT01401478|246882|P1|Overall Study|Hyperphosphatemia|5
61431|NCT01401478|246882|P1|Overall Study|Adverse Event|5
61432|NCT01401478|246882|P1|Overall Study|Study drug not available|6
61433|NCT01401465|246895|P2|Treatment Period 2|Withdrawal by Subject|1
61434|NCT01401465|246896|P1|Treatment Period 2|Withdrawal by Subject|0
61435|NCT01401465|246895|P2|Treatment Period 2|Lost to Follow-up|1
61436|NCT01401465|246896|P1|Treatment Period 2|Lost to Follow-up|0
61437|NCT01401465|246895|P2|Treatment Period 1|Scheduling Difficulties|1
61438|NCT01401465|246896|P1|Treatment Period 1|Scheduling Difficulties|1
61439|NCT01401465|246895|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
61440|NCT01401465|246896|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
61441|NCT01401465|246895|P2|Treatment Period 1|Non-Compliance to Study Drug|0
61442|NCT01401465|246896|P1|Treatment Period 1|Non-Compliance to Study Drug|1
61443|NCT01401465|246895|P2|Treatment Period 1|Withdrawal by Subject|4
61444|NCT01401465|246896|P1|Treatment Period 1|Withdrawal by Subject|1
61445|NCT01401465|246895|P2|Treatment Period 1|Protocol Violation|0
61446|NCT01401465|246896|P1|Treatment Period 1|Protocol Violation|5
61447|NCT01401465|246895|P2|Treatment Period 1|Pregnancy|1
61448|NCT01401465|246896|P1|Treatment Period 1|Pregnancy|0
61449|NCT01401465|246895|P2|Treatment Period 1|Adverse Event|1
61450|NCT01401465|246896|P1|Treatment Period 1|Adverse Event|4
61451|NCT01401452|246959|P1|Overall Study|Participant withdrew consent|1
61452|NCT01401452|246959|P1|Overall Study|Subject chose to discontinue treatment|1
61453|NCT01401452|246959|P1|Overall Study|Subject withdrew because of Tx success|1
61454|NCT01401452|246959|P1|Overall Study|Unsatisfactory output|1
61455|NCT01401452|246959|P1|Overall Study|Treatment failure|1
61456|NCT01401452|246959|P1|Overall Study|Discontinuation for personal reasons|1
61457|NCT01401452|246959|P1|Overall Study|Participant stopped Tx|2
61458|NCT01401452|246959|P1|Overall Study|Psoriatic arthritis|1
61459|NCT01401452|246959|P1|Overall Study|Subject's wife wants to get pregnant|1
61460|NCT01401452|246959|P1|Overall Study|Subject moved to another city|1
61461|NCT01401452|246959|P1|Overall Study|Subject didn't return for routine visits|1
61462|NCT01401452|246959|P1|Overall Study|Subject did not come to follow up visits|2
61463|NCT01401452|246959|P1|Overall Study|No more visits within the 36 wk followup|4
61464|NCT01401452|246959|P1|Overall Study|Tx stopped by psychiatrist|1
61465|NCT01401452|246959|P1|Overall Study|Tx stopped due to financial reasons|1
61466|NCT01401452|246959|P1|Overall Study|Participant developed breast cancer|1
61467|NCT01401452|246959|P1|Overall Study|Lack of Efficacy|30
61468|NCT01401452|246959|P1|Overall Study|Lost to Follow-up|12
61469|NCT01401452|246959|P1|Overall Study|Adverse reaction|9
61470|NCT01401361|246971|P1|Overall Study|Subject/family decision post procedure|2
61471|NCT01401361|246971|P1|Overall Study|Lost to Follow-up|3
61472|NCT01401361|246971|P1|Overall Study|Physician Decision|1
61473|NCT01401361|246971|P1|Overall Study|Lack of Efficacy|6
61474|NCT01401361|246971|P1|Overall Study|Withdrawal by Subject|16
61475|NCT01401322|246977|P1|Overall Study|Physician Decision|1
61476|NCT01401322|246977|P1|Overall Study|Withdrawal by Subject|1
61477|NCT01401283|246983|P2|Overall Study|suspicion of malignant hyperthermia|1
61478|NCT01401283|246984|P1|Overall Study|suspicion of malignant hyperthermia|0
61479|NCT01401283|246983|P2|Overall Study|no central venous access|1
61480|NCT01401283|246984|P1|Overall Study|no central venous access|0
61481|NCT01401283|246983|P2|Overall Study|preoperative arrhythmia|0
61482|NCT01401283|246984|P1|Overall Study|preoperative arrhythmia|5
61483|NCT01401283|246983|P2|Overall Study|surgery cancelled|8
61484|NCT01401283|246984|P1|Overall Study|surgery cancelled|5
61485|NCT01401153|247050|P2|Second Test Day|illness|5
61486|NCT01401153|247051|P1|Second Test Day|illness|0
61487|NCT01401153|247050|P2|First Test Day|Learning disabilities; illness|10
61488|NCT01401153|247051|P1|First Test Day|Learning disabilities; illness|1
61489|NCT01401062|247098|P2|Overall Study|Withdrawal by Subject|1
61490|NCT01401062|247099|P1|Overall Study|Withdrawal by Subject|1
61491|NCT01401062|247098|P2|Overall Study|Physician Decision|0
61492|NCT01401062|247099|P1|Overall Study|Physician Decision|1
61493|NCT01401062|247098|P2|Overall Study|Death|7
61494|NCT01401062|247099|P1|Overall Study|Death|9
61495|NCT01401010|247124|P2|Overall Study|Could not interpret assay results|0
61496|NCT01401010|247125|P1|Overall Study|Could not interpret assay results|1
61497|NCT01400958|247150|P2|Overall Study|Adverse Event|0
61498|NCT01400958|247151|P1|Overall Study|Adverse Event|1
61499|NCT01400958|247150|P2|Overall Study|Withdrawal by Subject|1
61500|NCT01400958|247151|P1|Overall Study|Withdrawal by Subject|0
61501|NCT01400958|247150|P2|Overall Study|Physician Decision|1
61502|NCT01400958|247151|P1|Overall Study|Physician Decision|0
61503|NCT01400932|247161|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
61504|NCT01400932|247162|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
61505|NCT01400932|247161|P2|Overall Study|Protocol Deviation|1
61506|NCT01400932|247162|P1|Overall Study|Protocol Deviation|0
61507|NCT01400932|247161|P2|Overall Study|Lost to Follow-up|0
61508|NCT01400932|247162|P1|Overall Study|Lost to Follow-up|1
61509|NCT01400932|247161|P2|Overall Study|Withdrawal by Subject|6
61510|NCT01400932|247162|P1|Overall Study|Withdrawal by Subject|2
61511|NCT01400932|247161|P2|Overall Study|Lack of Efficacy|3
61512|NCT01400932|247162|P1|Overall Study|Lack of Efficacy|0
61513|NCT01400932|247161|P2|Overall Study|Adverse Event|5
61514|NCT01400932|247162|P1|Overall Study|Adverse Event|10
61515|NCT01400919|247184|P1|Overall Study|Missed visit|2
61516|NCT01400919|247184|P1|Overall Study|Lost to Follow-up|2
61517|NCT01400919|247184|P1|Overall Study|Withdrawal by Subject|4
61518|NCT01400893|247227|P2|Overall Study|Lost to Follow-up|6
61519|NCT01400893|247228|P1|Overall Study|Lost to Follow-up|0
61520|NCT01400893|247227|P2|Overall Study|Death|21
61521|NCT01400893|247228|P1|Overall Study|Death|27
61522|NCT01400841|247240|P1|Extended Study Phase (2 Years)|Adverse Event|2
61523|NCT01400841|247240|P1|Initial Study Phase (6 Months)|Death|1
61524|NCT01400698|247278|P6|Overall Study|Other|0
61525|NCT01400698|247279|P5|Overall Study|Other|1
61526|NCT01400698|247280|P4|Overall Study|Other|2
61527|NCT01400698|247281|P3|Overall Study|Other|0
61528|NCT01400698|247282|P2|Overall Study|Other|2
61529|NCT01400698|247283|P1|Overall Study|Other|4
61530|NCT01400698|247278|P6|Overall Study|Adverse Event|0
61531|NCT01400698|247279|P5|Overall Study|Adverse Event|0
61532|NCT01400698|247280|P4|Overall Study|Adverse Event|0
61533|NCT01400698|247281|P3|Overall Study|Adverse Event|0
61534|NCT01400698|247282|P2|Overall Study|Adverse Event|0
61535|NCT01400698|247283|P1|Overall Study|Adverse Event|1
61536|NCT01400698|247278|P6|Overall Study|Non-compliance|0
61537|NCT01400698|247279|P5|Overall Study|Non-compliance|0
61538|NCT01400698|247280|P4|Overall Study|Non-compliance|1
61539|NCT01400698|247281|P3|Overall Study|Non-compliance|0
61540|NCT01400698|247282|P2|Overall Study|Non-compliance|1
61541|NCT01400698|247283|P1|Overall Study|Non-compliance|0
61542|NCT01400698|247278|P6|Overall Study|Protocol Violation|0
61543|NCT01400698|247279|P5|Overall Study|Protocol Violation|1
61544|NCT01400698|247280|P4|Overall Study|Protocol Violation|0
61545|NCT01400698|247281|P3|Overall Study|Protocol Violation|0
61546|NCT01400698|247282|P2|Overall Study|Protocol Violation|1
61547|NCT01400698|247283|P1|Overall Study|Protocol Violation|0
61548|NCT01400698|247278|P6|Overall Study|Withdrawal by Subject|3
61549|NCT01400698|247279|P5|Overall Study|Withdrawal by Subject|1
61550|NCT01400698|247280|P4|Overall Study|Withdrawal by Subject|4
61551|NCT01400698|247281|P3|Overall Study|Withdrawal by Subject|0
61552|NCT01400698|247282|P2|Overall Study|Withdrawal by Subject|2
61553|NCT01400698|247283|P1|Overall Study|Withdrawal by Subject|8
61554|NCT01400698|247278|P6|Overall Study|Lost to Follow-up|3
61555|NCT01400698|247279|P5|Overall Study|Lost to Follow-up|4
61556|NCT01400698|247280|P4|Overall Study|Lost to Follow-up|1
61557|NCT01400698|247281|P3|Overall Study|Lost to Follow-up|2
61558|NCT01400698|247282|P2|Overall Study|Lost to Follow-up|5
61559|NCT01400698|247283|P1|Overall Study|Lost to Follow-up|2
61560|NCT01400516|247307|P2|Primary Trial|Withdrawal by Subject|2
61561|NCT01400516|247308|P1|Primary Trial|Withdrawal by Subject|0
61562|NCT01400503|247318|P1|Overall Study|Other|1
61563|NCT01400503|247318|P1|Overall Study|Study Terminated by Sponsor|58
61564|NCT01400503|247318|P1|Overall Study|Withdrawal by Subject|1
61565|NCT01400451|247330|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
61566|NCT01400451|247331|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
61567|NCT01400451|247332|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
61568|NCT01400451|247330|P3|Combination Treatment (or Intended)|Disease Progression|1
61569|NCT01400451|247331|P2|Combination Treatment (or Intended)|Disease Progression|1
61570|NCT01400451|247332|P1|Combination Treatment (or Intended)|Disease Progression|3
61571|NCT01400451|247330|P3|Combination Treatment (or Intended)|Adverse Event|0
61572|NCT01400451|247331|P2|Combination Treatment (or Intended)|Adverse Event|0
61573|NCT01400451|247332|P1|Combination Treatment (or Intended)|Adverse Event|1
61574|NCT01400451|247330|P3|Combination Treatment (or Intended)|Drug Toxicity|0
61575|NCT01400451|247331|P2|Combination Treatment (or Intended)|Drug Toxicity|1
61576|NCT01400451|247332|P1|Combination Treatment (or Intended)|Drug Toxicity|0
61577|NCT01400451|247330|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
61578|NCT01400451|247331|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
61579|NCT01400451|247332|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
61580|NCT01400425|247346|P1|Overall Study|Withdrawal by Subject|10
61581|NCT01400412|247359|P2|Overall Study|Never started study treatment|3
61582|NCT01400412|247360|P1|Overall Study|Never started study treatment|0
61583|NCT01400412|247359|P2|Overall Study|Unable to complete|3
61584|NCT01400412|247360|P1|Overall Study|Unable to complete|3
61585|NCT01400412|247359|P2|Overall Study|Withdrawal by Subject|4
61586|NCT01400412|247360|P1|Overall Study|Withdrawal by Subject|3
61587|NCT01400412|247359|P2|Overall Study|Lost to Follow-up|7
61588|NCT01400412|247360|P1|Overall Study|Lost to Follow-up|4
61589|NCT01400243|247406|P2|Overall Study|Protocol Violation|11
61590|NCT01400243|247407|P1|Overall Study|Protocol Violation|8
61591|NCT01400139|247429|P1|HYD Extension Period|Administrative|10
61592|NCT01400139|247429|P1|HYD Extension Period|Withdrawal by Subject|5
61593|NCT01400139|247429|P1|HYD Extension Period|Adverse Event|8
61594|NCT01400139|247429|P1|HYD Core Study|Did not qualify for Maintenance Period|14
61595|NCT01400139|247429|P1|HYD Core Study|Administrative|56
61596|NCT01400139|247429|P1|HYD Core Study|Confirmed or suspected diversion|20
61597|NCT01400139|247429|P1|HYD Core Study|Lost to Follow-up|39
61598|NCT01400139|247429|P1|HYD Core Study|Withdrawal by Subject|114
61599|NCT01400139|247429|P1|HYD Core Study|Lack of Efficacy|59
61600|NCT01400139|247429|P1|HYD Core Study|Adverse Event|210
61601|NCT01400113|247439|P2|Overall Study|Withdrawal by Subject|1
61602|NCT01400113|247440|P1|Overall Study|Withdrawal by Subject|1
61603|NCT01399788|247465|P2|First Intervention Period|Adverse Event|0
61604|NCT01399788|247466|P1|First Intervention Period|Adverse Event|1
61605|NCT01399723|247488|P2|Overall Study|Lost to Follow-up|1
61606|NCT01399723|247489|P1|Overall Study|Lost to Follow-up|0
61607|NCT01399697|247502|P3|Overall Study|Sponsor Decision|0
61608|NCT01399697|247503|P2|Overall Study|Sponsor Decision|0
61609|NCT01399697|247504|P1|Overall Study|Sponsor Decision|1
61610|NCT01399697|247502|P3|Overall Study|Clinical RA remission|0
61611|NCT01399697|247503|P2|Overall Study|Clinical RA remission|0
61612|NCT01399697|247504|P1|Overall Study|Clinical RA remission|1
61613|NCT01399697|247502|P3|Overall Study|Positive result for hepatitis B|0
61614|NCT01399697|247503|P2|Overall Study|Positive result for hepatitis B|0
61615|NCT01399697|247504|P1|Overall Study|Positive result for hepatitis B|1
61616|NCT01399697|247502|P3|Overall Study|Inclusion Error|0
61617|NCT01399697|247503|P2|Overall Study|Inclusion Error|0
61618|NCT01399697|247504|P1|Overall Study|Inclusion Error|2
61619|NCT01399697|247502|P3|Overall Study|Non-Compliant|0
61620|NCT01399697|247503|P2|Overall Study|Non-Compliant|0
61621|NCT01399697|247504|P1|Overall Study|Non-Compliant|1
61622|NCT01399697|247502|P3|Overall Study|Protocol Violation|0
61623|NCT01399697|247503|P2|Overall Study|Protocol Violation|0
61624|NCT01399697|247504|P1|Overall Study|Protocol Violation|2
61625|NCT01399697|247502|P3|Overall Study|Lack of Efficacy|1
61626|NCT01399697|247503|P2|Overall Study|Lack of Efficacy|0
61627|NCT01399697|247504|P1|Overall Study|Lack of Efficacy|9
61628|NCT01399697|247502|P3|Overall Study|Investigator Decisión|2
61629|NCT01399697|247503|P2|Overall Study|Investigator Decisión|0
61630|NCT01399697|247504|P1|Overall Study|Investigator Decisión|1
61631|NCT01399697|247502|P3|Overall Study|Withdrawal by Subject|0
61632|NCT01399697|247503|P2|Overall Study|Withdrawal by Subject|0
61633|NCT01399697|247504|P1|Overall Study|Withdrawal by Subject|8
61634|NCT01399697|247502|P3|Overall Study|Lost to Follow-up|0
61635|NCT01399697|247503|P2|Overall Study|Lost to Follow-up|0
61636|NCT01399697|247504|P1|Overall Study|Lost to Follow-up|2
61637|NCT01399697|247502|P3|Overall Study|Adverse Event|1
61638|NCT01399697|247503|P2|Overall Study|Adverse Event|3
61639|NCT01399697|247504|P1|Overall Study|Adverse Event|13
61640|NCT01399619|247531|P4|Overall Study|Not treated|2
61641|NCT01399619|247532|P3|Overall Study|Not treated|0
61642|NCT01399619|247533|P2|Overall Study|Not treated|0
61643|NCT01399619|247534|P1|Overall Study|Not treated|0
61644|NCT01399619|247531|P4|Overall Study|Protocol Violation|1
61645|NCT01399619|247532|P3|Overall Study|Protocol Violation|0
61646|NCT01399619|247533|P2|Overall Study|Protocol Violation|0
61647|NCT01399619|247534|P1|Overall Study|Protocol Violation|0
61648|NCT01399619|247531|P4|Overall Study|Withdrawal by Subject|4
61649|NCT01399619|247532|P3|Overall Study|Withdrawal by Subject|3
61650|NCT01399619|247533|P2|Overall Study|Withdrawal by Subject|0
61651|NCT01399619|247534|P1|Overall Study|Withdrawal by Subject|6
61652|NCT01399619|247531|P4|Overall Study|Lack of Efficacy|0
61653|NCT01399619|247532|P3|Overall Study|Lack of Efficacy|5
61654|NCT01399619|247533|P2|Overall Study|Lack of Efficacy|0
61655|NCT01399619|247534|P1|Overall Study|Lack of Efficacy|9
61656|NCT01399619|247531|P4|Overall Study|Adverse Event|10
61657|NCT01399619|247532|P3|Overall Study|Adverse Event|4
61658|NCT01399619|247533|P2|Overall Study|Adverse Event|0
61659|NCT01399619|247534|P1|Overall Study|Adverse Event|10
61660|NCT01399593|247597|P2|Overall Study|Transplantectomy|1
61661|NCT01399593|247598|P1|Overall Study|Transplantectomy|0
61662|NCT01399593|247597|P2|Overall Study|Death|1
61663|NCT01399593|247598|P1|Overall Study|Death|1
61664|NCT01399593|247597|P2|Overall Study|Adverse Event|0
61665|NCT01399593|247598|P1|Overall Study|Adverse Event|1
61666|NCT01399593|247597|P2|Overall Study|Physician Decision|0
61667|NCT01399593|247598|P1|Overall Study|Physician Decision|1
61668|NCT01399190|247631|P1|Overall Study|Physician Decision|2
61669|NCT01399190|247631|P1|Overall Study|Participant's Request|5
61670|NCT01399190|247631|P1|Overall Study|Adverse Event|8
61671|NCT01399190|247631|P1|Overall Study|Not Eligible for Final Analysis|5
61672|NCT01399125|247639|P2|Overall Study|Protocol Deviation|2
61673|NCT01399125|247640|P1|Overall Study|Protocol Deviation|5
61674|NCT01399125|247639|P2|Overall Study|Death|1
61675|NCT01399125|247640|P1|Overall Study|Death|0
61676|NCT01399125|247639|P2|Overall Study|Administrative Problems|11
61677|NCT01399125|247640|P1|Overall Study|Administrative Problems|7
61678|NCT01399125|247639|P2|Overall Study|Lost to Follow-up|3
61679|NCT01399125|247640|P1|Overall Study|Lost to Follow-up|2
61680|NCT01399125|247639|P2|Overall Study|Withdrawal by Subject|8
61681|NCT01399125|247640|P1|Overall Study|Withdrawal by Subject|5
61682|NCT01399125|247639|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
61683|NCT01399125|247640|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
61684|NCT01399125|247639|P2|Overall Study|Abnormal Lab values|1
61685|NCT01399125|247640|P1|Overall Study|Abnormal Lab values|0
61686|NCT01399125|247639|P2|Overall Study|Adverse Event|30
61687|NCT01399125|247640|P1|Overall Study|Adverse Event|32
61688|NCT01399099|247654|P1|Overall Study|Miscellaneous|4
61689|NCT01399099|247654|P1|Overall Study|Infection|1
61690|NCT01399099|247654|P1|Overall Study|Skin Irritation|13
61691|NCT01399099|247654|P1|Overall Study|Protocol Violation|1
61692|NCT01399099|247654|P1|Overall Study|Physician Decision|1
61693|NCT01399099|247654|P1|Overall Study|Lost to Follow-up|11
61694|NCT01399047|247661|P2|Overall Study|Withdrawal by Subject|1
61695|NCT01399047|247662|P1|Overall Study|Withdrawal by Subject|0
61696|NCT01398956|247690|P1|Overall Study|Subject moved a long distance|1
61697|NCT01398956|247690|P1|Overall Study|Withdrawal Criteria No.3|1
61698|NCT01398956|247690|P1|Overall Study|AE, non-serious non-fatal|4
61699|NCT01398956|247690|P1|Overall Study|Withdrawal by Subject|4
61700|NCT01398787|247722|P1|Overall Study|Adverse Event|1
61701|NCT01398514|247740|P2|Overall Study|Failure to show a conditioned response|3
61702|NCT01398514|247741|P1|Overall Study|Failure to show a conditioned response|4
61703|NCT01398514|247740|P2|Overall Study|Physiologic non-responsiveness|3
61704|NCT01398514|247741|P1|Overall Study|Physiologic non-responsiveness|1
61705|NCT01398514|247740|P2|Overall Study|Non-compliance with study procedures|0
61706|NCT01398514|247741|P1|Overall Study|Non-compliance with study procedures|2
61707|NCT01398514|247740|P2|Overall Study|Adverse Event|0
61708|NCT01398514|247741|P1|Overall Study|Adverse Event|1
61709|NCT01398410|247776|P2|Overall Study|Not Specified|29
61710|NCT01398410|247777|P1|Overall Study|Not Specified|36
61711|NCT01398410|247776|P2|Overall Study|Inadequate Therapeutic Effect|0
61712|NCT01398410|247777|P1|Overall Study|Inadequate Therapeutic Effect|2
61713|NCT01398410|247776|P2|Overall Study|Participants Choice|11
61714|NCT01398410|247777|P1|Overall Study|Participants Choice|8
61715|NCT01398410|247776|P2|Overall Study|Adverse Event|16
61716|NCT01398410|247777|P1|Overall Study|Adverse Event|12
61717|NCT01398358|247788|P3|Overall Study|no longer eligible|1
61718|NCT01398358|247789|P2|Overall Study|no longer eligible|0
61719|NCT01398358|247790|P1|Overall Study|no longer eligible|1
61720|NCT01398358|247788|P3|Overall Study|Withdrawal by Subject|2
61721|NCT01398358|247789|P2|Overall Study|Withdrawal by Subject|2
61722|NCT01398358|247790|P1|Overall Study|Withdrawal by Subject|3
61723|NCT01398358|247788|P3|Overall Study|Lost to Follow-up|18
61724|NCT01398358|247789|P2|Overall Study|Lost to Follow-up|21
61725|NCT01398358|247790|P1|Overall Study|Lost to Follow-up|11
61726|NCT01398176|247803|P2|Overall Study|Physician Decision|3
61727|NCT01398176|247804|P1|Overall Study|Physician Decision|2
61728|NCT01398176|247803|P2|Overall Study|Lost to Follow-up|3
61729|NCT01398176|247804|P1|Overall Study|Lost to Follow-up|1
61730|NCT01397890|247812|P2|Overall Study|Others|1
61731|NCT01397890|247813|P1|Overall Study|Others|2
61732|NCT01397890|247812|P2|Overall Study|Severe Non-Compliance to Protocol|1
61733|NCT01397890|247813|P1|Overall Study|Severe Non-Compliance to Protocol|2
61734|NCT01397890|247812|P2|Overall Study|Adverse Event|2
61735|NCT01397890|247813|P1|Overall Study|Adverse Event|1
61736|NCT01397890|247812|P2|Overall Study|Condition under Investigation Worsened|3
61737|NCT01397890|247813|P1|Overall Study|Condition under Investigation Worsened|1
61738|NCT01397890|247812|P2|Overall Study|Lost to Follow-up|4
61739|NCT01397890|247813|P1|Overall Study|Lost to Follow-up|1
61740|NCT01397890|247812|P2|Overall Study|Death|3
61741|NCT01397890|247813|P1|Overall Study|Death|2
61742|NCT01397890|247812|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
61743|NCT01397890|247813|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
61744|NCT01397890|247812|P2|Overall Study|Withdrawal by Subject|11
61745|NCT01397890|247813|P1|Overall Study|Withdrawal by Subject|7
61746|NCT01397825|247884|P5|Overall Study|Withdrawal by Subject|0
61747|NCT01397825|247885|P4|Overall Study|Withdrawal by Subject|1
61748|NCT01397825|247886|P3|Overall Study|Withdrawal by Subject|5
61749|NCT01397825|247887|P2|Overall Study|Withdrawal by Subject|0
61750|NCT01397825|247888|P1|Overall Study|Withdrawal by Subject|1
61751|NCT01397825|247884|P5|Overall Study|Adverse Event|0
61752|NCT01397825|247885|P4|Overall Study|Adverse Event|1
61753|NCT01397825|247886|P3|Overall Study|Adverse Event|5
61754|NCT01397825|247887|P2|Overall Study|Adverse Event|1
61755|NCT01397825|247888|P1|Overall Study|Adverse Event|0
61756|NCT01397825|247884|P5|Overall Study|Symptomatic Deterioration|0
61757|NCT01397825|247885|P4|Overall Study|Symptomatic Deterioration|0
61758|NCT01397825|247886|P3|Overall Study|Symptomatic Deterioration|4
61759|NCT01397825|247887|P2|Overall Study|Symptomatic Deterioration|0
61760|NCT01397825|247888|P1|Overall Study|Symptomatic Deterioration|2
61761|NCT01397825|247884|P5|Overall Study|Progressive Disease|0
61762|NCT01397825|247885|P4|Overall Study|Progressive Disease|1
61763|NCT01397825|247886|P3|Overall Study|Progressive Disease|11
61764|NCT01397825|247887|P2|Overall Study|Progressive Disease|3
61765|NCT01397825|247888|P1|Overall Study|Progressive Disease|10
61766|NCT01397786|247958|P3|Phase B|Lack of Efficacy|14
61767|NCT01397786|247959|P2|Phase B|Lack of Efficacy|7
61768|NCT01397786|247960|P1|Phase B|Lack of Efficacy|22
61769|NCT01397786|247958|P3|Phase B|Protocol Deviation|4
61770|NCT01397786|247959|P2|Phase B|Protocol Deviation|2
61771|NCT01397786|247960|P1|Phase B|Protocol Deviation|1
61772|NCT01397786|247958|P3|Phase B|Withdrawal by Subject|30
61773|NCT01397786|247959|P2|Phase B|Withdrawal by Subject|45
61774|NCT01397786|247960|P1|Phase B|Withdrawal by Subject|102
61775|NCT01397786|247958|P3|Phase B|Physician Decision|3
61776|NCT01397786|247959|P2|Phase B|Physician Decision|1
61777|NCT01397786|247960|P1|Phase B|Physician Decision|9
61778|NCT01397786|247958|P3|Phase B|Subject Met Withdrawal Criteria|38
61779|NCT01397786|247959|P2|Phase B|Subject Met Withdrawal Criteria|5
61780|NCT01397786|247960|P1|Phase B|Subject Met Withdrawal Criteria|38
61781|NCT01397786|247958|P3|Phase B|Adverse Event|27
61782|NCT01397786|247959|P2|Phase B|Adverse Event|23
61783|NCT01397786|247960|P1|Phase B|Adverse Event|109
61784|NCT01397786|247958|P3|Phase B|Lost to Follow-up|22
61785|NCT01397786|247959|P2|Phase B|Lost to Follow-up|12
61786|NCT01397786|247960|P1|Phase B|Lost to Follow-up|22
61787|NCT01397786|247958|P3|Phase A|Lack of Efficacy|1
61788|NCT01397786|247959|P2|Phase A|Lack of Efficacy|0
61789|NCT01397786|247960|P1|Phase A|Lack of Efficacy|0
61790|NCT01397786|247958|P3|Phase A|Withdrawal by Subject|5
61791|NCT01397786|247959|P2|Phase A|Withdrawal by Subject|0
61792|NCT01397786|247960|P1|Phase A|Withdrawal by Subject|0
61793|NCT01397786|247958|P3|Phase A|Physician Decision|1
61794|NCT01397786|247959|P2|Phase A|Physician Decision|0
61795|NCT01397786|247960|P1|Phase A|Physician Decision|0
61796|NCT01397786|247958|P3|Phase A|Subject Met Withdrawal Criteria|7
61797|NCT01397786|247959|P2|Phase A|Subject Met Withdrawal Criteria|0
61798|NCT01397786|247960|P1|Phase A|Subject Met Withdrawal Criteria|0
61799|NCT01397786|247958|P3|Phase A|Adverse Event|8
61800|NCT01397786|247959|P2|Phase A|Adverse Event|0
61801|NCT01397786|247960|P1|Phase A|Adverse Event|0
61802|NCT01397786|247958|P3|Phase A|Lost to Follow-up|6
61803|NCT01397786|247959|P2|Phase A|Lost to Follow-up|0
61804|NCT01397786|247960|P1|Phase A|Lost to Follow-up|0
61805|NCT01397747|248026|P1|Overall Study|FIT excluded|34
61806|NCT01397747|248026|P1|Overall Study|Colonoscopy excluded|304
61807|NCT01397747|248026|P1|Overall Study|Multitarget DNA test excluded|689
61808|NCT01397461|248058|P3|Overall Study|Not treated|1
61809|NCT01397461|248059|P2|Overall Study|Not treated|0
61810|NCT01397461|248060|P1|Overall Study|Not treated|0
61811|NCT01397461|248058|P3|Overall Study|Lack of Efficacy|0
61812|NCT01397461|248059|P2|Overall Study|Lack of Efficacy|3
61813|NCT01397461|248060|P1|Overall Study|Lack of Efficacy|0
61814|NCT01397461|248058|P3|Overall Study|Lost to Follow-up|1
61815|NCT01397461|248059|P2|Overall Study|Lost to Follow-up|2
61816|NCT01397461|248060|P1|Overall Study|Lost to Follow-up|0
61817|NCT01397461|248058|P3|Overall Study|Withdrawal by Subject|0
61818|NCT01397461|248059|P2|Overall Study|Withdrawal by Subject|1
61819|NCT01397461|248060|P1|Overall Study|Withdrawal by Subject|2
61820|NCT01397448|248071|P3|Overall Study|Not specified|4
61821|NCT01397448|248072|P2|Overall Study|Not specified|7
61822|NCT01397448|248073|P1|Overall Study|Not specified|8
61823|NCT01397448|248071|P3|Overall Study|Lack of Efficacy|5
61824|NCT01397448|248072|P2|Overall Study|Lack of Efficacy|0
61825|NCT01397448|248073|P1|Overall Study|Lack of Efficacy|2
61826|NCT01397448|248071|P3|Overall Study|Withdrawal by Subject|3
61827|NCT01397448|248072|P2|Overall Study|Withdrawal by Subject|4
61828|NCT01397448|248073|P1|Overall Study|Withdrawal by Subject|4
61829|NCT01397448|248071|P3|Overall Study|Adverse Event|6
61830|NCT01397448|248072|P2|Overall Study|Adverse Event|4
61831|NCT01397448|248073|P1|Overall Study|Adverse Event|4
61832|NCT01397422|248088|P4|Overall Study|Increased bradykinesia related to PD|0
61833|NCT01397422|248089|P3|Overall Study|Increased bradykinesia related to PD|0
61834|NCT01397422|248090|P2|Overall Study|Increased bradykinesia related to PD|0
61835|NCT01397422|248091|P1|Overall Study|Increased bradykinesia related to PD|1
61836|NCT01397422|248088|P4|Overall Study|Withdrawal by Subject|0
61837|NCT01397422|248089|P3|Overall Study|Withdrawal by Subject|0
61838|NCT01397422|248090|P2|Overall Study|Withdrawal by Subject|0
61839|NCT01397422|248091|P1|Overall Study|Withdrawal by Subject|1
61840|NCT01397422|248088|P4|Overall Study|Adverse Event|8
61841|NCT01397422|248089|P3|Overall Study|Adverse Event|3
61842|NCT01397422|248090|P2|Overall Study|Adverse Event|3
61843|NCT01397422|248091|P1|Overall Study|Adverse Event|0
61844|NCT01397409|248131|P10|Stage 3|Other Miscellaneous Reasons|0
61845|NCT01397409|248132|P9|Stage 3|Other Miscellaneous Reasons|0
61846|NCT01397409|248133|P8|Stage 3|Other Miscellaneous Reasons|1
61847|NCT01397409|248134|P7|Stage 3|Other Miscellaneous Reasons|0
61848|NCT01397409|248135|P6|Stage 3|Other Miscellaneous Reasons|0
61849|NCT01397409|248136|P5|Stage 3|Other Miscellaneous Reasons|0
61850|NCT01397409|248137|P4|Stage 3|Other Miscellaneous Reasons|0
61851|NCT01397409|248138|P3|Stage 3|Other Miscellaneous Reasons|0
61852|NCT01397409|248139|P2|Stage 3|Other Miscellaneous Reasons|0
61853|NCT01397409|248140|P1|Stage 3|Other Miscellaneous Reasons|0
61854|NCT01397409|248131|P10|Stage 3|Adverse Event|0
61855|NCT01397409|248132|P9|Stage 3|Adverse Event|0
61856|NCT01397409|248133|P8|Stage 3|Adverse Event|1
61857|NCT01397409|248134|P7|Stage 3|Adverse Event|0
61858|NCT01397409|248135|P6|Stage 3|Adverse Event|0
61859|NCT01397409|248136|P5|Stage 3|Adverse Event|0
61860|NCT01397409|248137|P4|Stage 3|Adverse Event|0
61861|NCT01397409|248138|P3|Stage 3|Adverse Event|0
61862|NCT01397409|248139|P2|Stage 3|Adverse Event|0
61863|NCT01397409|248140|P1|Stage 3|Adverse Event|0
61864|NCT01397409|248131|P10|Stage 2|Other Miscellaneous Reasons|0
61865|NCT01397409|248132|P9|Stage 2|Other Miscellaneous Reasons|0
61866|NCT01397409|248133|P8|Stage 2|Other Miscellaneous Reasons|0
61867|NCT01397409|248134|P7|Stage 2|Other Miscellaneous Reasons|0
61868|NCT01397409|248135|P6|Stage 2|Other Miscellaneous Reasons|1
61869|NCT01397409|248136|P5|Stage 2|Other Miscellaneous Reasons|1
61870|NCT01397409|248137|P4|Stage 2|Other Miscellaneous Reasons|0
61871|NCT01397409|248138|P3|Stage 2|Other Miscellaneous Reasons|0
61872|NCT01397409|248139|P2|Stage 2|Other Miscellaneous Reasons|0
61873|NCT01397409|248140|P1|Stage 2|Other Miscellaneous Reasons|0
61874|NCT01397409|248131|P10|Stage 2|Personal Reasons|0
61875|NCT01397409|248132|P9|Stage 2|Personal Reasons|0
61876|NCT01397409|248133|P8|Stage 2|Personal Reasons|0
61877|NCT01397409|248134|P7|Stage 2|Personal Reasons|0
61878|NCT01397409|248135|P6|Stage 2|Personal Reasons|0
61879|NCT01397409|248136|P5|Stage 2|Personal Reasons|1
61880|NCT01397409|248137|P4|Stage 2|Personal Reasons|0
61881|NCT01397409|248138|P3|Stage 2|Personal Reasons|0
61882|NCT01397409|248139|P2|Stage 2|Personal Reasons|0
61883|NCT01397409|248140|P1|Stage 2|Personal Reasons|0
61884|NCT01397409|248131|P10|Stage 2|Adverse Event|0
61885|NCT01397409|248132|P9|Stage 2|Adverse Event|0
61886|NCT01397409|248133|P8|Stage 2|Adverse Event|0
61887|NCT01397409|248134|P7|Stage 2|Adverse Event|0
61888|NCT01397409|248135|P6|Stage 2|Adverse Event|3
61889|NCT01397409|248136|P5|Stage 2|Adverse Event|6
61890|NCT01397409|248137|P4|Stage 2|Adverse Event|0
61891|NCT01397409|248138|P3|Stage 2|Adverse Event|0
61892|NCT01397409|248139|P2|Stage 2|Adverse Event|0
61893|NCT01397409|248140|P1|Stage 2|Adverse Event|0
61894|NCT01397253|248180|P2|Overall Study|Reviewed by only 1 pharmacist|149
61895|NCT01397253|248181|P1|Overall Study|Reviewed by only 1 pharmacist|126
61896|NCT01397084|248187|P1|Overall Study|Used other proton pump inhibitor|1
61897|NCT01397084|248187|P1|Overall Study|Lost to Follow-up|1
61898|NCT01397084|248187|P1|Overall Study|Withdrawal by Subject|1
61899|NCT01397084|248187|P1|Overall Study|Adverse Event|2
61900|NCT01397084|248187|P1|Overall Study|Protocol Violation|2
61901|NCT01397084|248187|P1|Overall Study|Severe Non-Compliance to Protocol|1
61902|NCT01396525|248194|P1|Overall Study|Lost to Follow-up|4
61903|NCT01396525|248194|P1|Overall Study|Death|14
61904|NCT01396525|248194|P1|Overall Study|Withdrawal by Subject|8
61905|NCT01396512|248294|P2|Overall Study|Withdrawal by Subject|1
61906|NCT01396512|248295|P1|Overall Study|Withdrawal by Subject|0
61907|NCT01396447|248311|P4|Overall Study|Other Miscellaneous Reasons|0
61908|NCT01396447|248312|P3|Overall Study|Other Miscellaneous Reasons|1
61909|NCT01396447|248313|P2|Overall Study|Other Miscellaneous Reasons|2
61910|NCT01396447|248314|P1|Overall Study|Other Miscellaneous Reasons|0
61911|NCT01396447|248311|P4|Overall Study|Lost to Follow-up|9
61912|NCT01396447|248312|P3|Overall Study|Lost to Follow-up|7
61913|NCT01396447|248313|P2|Overall Study|Lost to Follow-up|8
61914|NCT01396447|248314|P1|Overall Study|Lost to Follow-up|4
61915|NCT01396447|248311|P4|Overall Study|Withdrawal of Consent|15
61916|NCT01396447|248312|P3|Overall Study|Withdrawal of Consent|4
61917|NCT01396447|248313|P2|Overall Study|Withdrawal of Consent|9
61918|NCT01396447|248314|P1|Overall Study|Withdrawal of Consent|11
61919|NCT01396447|248311|P4|Overall Study|Protocol Violation|7
61920|NCT01396447|248312|P3|Overall Study|Protocol Violation|3
61921|NCT01396447|248313|P2|Overall Study|Protocol Violation|2
61922|NCT01396447|248314|P1|Overall Study|Protocol Violation|5
61923|NCT01396447|248311|P4|Overall Study|Insufficient Therapeutic Response|4
61924|NCT01396447|248312|P3|Overall Study|Insufficient Therapeutic Response|2
61925|NCT01396447|248313|P2|Overall Study|Insufficient Therapeutic Response|5
61926|NCT01396447|248314|P1|Overall Study|Insufficient Therapeutic Response|5
61927|NCT01396447|248311|P4|Overall Study|Adverse Event|17
61928|NCT01396447|248312|P3|Overall Study|Adverse Event|12
61929|NCT01396447|248313|P2|Overall Study|Adverse Event|12
61930|NCT01396447|248314|P1|Overall Study|Adverse Event|15
61931|NCT01396447|248311|P4|Overall Study|Did Not Receive Treatment|0
61932|NCT01396447|248312|P3|Overall Study|Did Not Receive Treatment|1
61933|NCT01396447|248313|P2|Overall Study|Did Not Receive Treatment|2
61934|NCT01396447|248314|P1|Overall Study|Did Not Receive Treatment|3
61935|NCT01396434|248331|P3|Overall Study|Other|0
61936|NCT01396434|248332|P2|Overall Study|Other|0
61937|NCT01396434|248333|P1|Overall Study|Other|10
61938|NCT01396434|248331|P3|Overall Study|Lost to Follow-up|0
61939|NCT01396434|248332|P2|Overall Study|Lost to Follow-up|0
61940|NCT01396434|248333|P1|Overall Study|Lost to Follow-up|1
61941|NCT01396421|248345|P4|Overall Study|Lack of Efficacy|18
61942|NCT01396421|248346|P3|Overall Study|Lack of Efficacy|7
61943|NCT01396421|248347|P2|Overall Study|Lack of Efficacy|17
61944|NCT01396421|248348|P1|Overall Study|Lack of Efficacy|7
61945|NCT01396421|248345|P4|Overall Study|Protocol Deviation|0
61946|NCT01396421|248346|P3|Overall Study|Protocol Deviation|1
61947|NCT01396421|248347|P2|Overall Study|Protocol Deviation|1
61948|NCT01396421|248348|P1|Overall Study|Protocol Deviation|2
61949|NCT01396421|248345|P4|Overall Study|Withdrawal by Subject|21
61950|NCT01396421|248346|P3|Overall Study|Withdrawal by Subject|13
61951|NCT01396421|248347|P2|Overall Study|Withdrawal by Subject|24
61952|NCT01396421|248348|P1|Overall Study|Withdrawal by Subject|31
61953|NCT01396421|248345|P4|Overall Study|Physician Decision|3
61954|NCT01396421|248346|P3|Overall Study|Physician Decision|0
61955|NCT01396421|248347|P2|Overall Study|Physician Decision|1
61956|NCT01396421|248348|P1|Overall Study|Physician Decision|1
61957|NCT01396421|248345|P4|Overall Study|Participant Met Withdrawal Criteria|0
61958|NCT01396421|248346|P3|Overall Study|Participant Met Withdrawal Criteria|1
61959|NCT01396421|248347|P2|Overall Study|Participant Met Withdrawal Criteria|0
61960|NCT01396421|248348|P1|Overall Study|Participant Met Withdrawal Criteria|1
61961|NCT01396421|248345|P4|Overall Study|Adverse Event|32
61962|NCT01396421|248346|P3|Overall Study|Adverse Event|12
61963|NCT01396421|248347|P2|Overall Study|Adverse Event|15
61964|NCT01396421|248348|P1|Overall Study|Adverse Event|17
61965|NCT01396421|248345|P4|Overall Study|Lost to Follow-up|1
61966|NCT01396421|248346|P3|Overall Study|Lost to Follow-up|0
61967|NCT01396421|248347|P2|Overall Study|Lost to Follow-up|0
61968|NCT01396421|248348|P1|Overall Study|Lost to Follow-up|0
61969|NCT01396395|248420|P2|Overall Study|Other|1
61970|NCT01396395|248421|P1|Overall Study|Other|0
61971|NCT01396395|248420|P2|Overall Study|Lost to Follow-up|11
61972|NCT01396395|248421|P1|Overall Study|Lost to Follow-up|17
61973|NCT01396395|248420|P2|Overall Study|Adverse Event|2
61974|NCT01396395|248421|P1|Overall Study|Adverse Event|10
61975|NCT01396395|248420|P2|Overall Study|Protocol Violation|1
61976|NCT01396395|248421|P1|Overall Study|Protocol Violation|3
61977|NCT01396395|248420|P2|Overall Study|Withdrawal by Subject|12
61978|NCT01396395|248421|P1|Overall Study|Withdrawal by Subject|10
61979|NCT01396317|248463|P2|Overall Study|Adverse Event|0
61980|NCT01396317|248464|P1|Overall Study|Adverse Event|1
61981|NCT01396265|248478|P1|Rifa+Afatinib|Withdrawal by Subject|1
61982|NCT01396187|248567|P5|Overall Study|Other|1
61983|NCT01396187|248568|P4|Overall Study|Other|0
61984|NCT01396187|248569|P3|Overall Study|Other|0
61985|NCT01396187|248570|P2|Overall Study|Other|1
61986|NCT01396187|248571|P1|Overall Study|Other|1
61987|NCT01396187|248567|P5|Overall Study|Withdrawal by Subject|0
61988|NCT01396187|248568|P4|Overall Study|Withdrawal by Subject|0
61989|NCT01396187|248569|P3|Overall Study|Withdrawal by Subject|1
61990|NCT01396187|248570|P2|Overall Study|Withdrawal by Subject|1
61991|NCT01396187|248571|P1|Overall Study|Withdrawal by Subject|0
61992|NCT01396187|248567|P5|Overall Study|Adverse Event|0
61993|NCT01396187|248568|P4|Overall Study|Adverse Event|0
61994|NCT01396187|248569|P3|Overall Study|Adverse Event|0
61995|NCT01396187|248570|P2|Overall Study|Adverse Event|1
61996|NCT01396187|248571|P1|Overall Study|Adverse Event|0
61997|NCT01396161|248671|P7|Overall Study|Other|1
61998|NCT01396161|248672|P6|Overall Study|Other|0
61999|NCT01396161|248673|P5|Overall Study|Other|0
62000|NCT01396161|248674|P4|Overall Study|Other|0
62001|NCT01396161|248675|P3|Overall Study|Other|0
62002|NCT01396161|248676|P2|Overall Study|Other|0
62003|NCT01396161|248677|P1|Overall Study|Other|0
62004|NCT01396161|248671|P7|Overall Study|Withdrawal by Subject|0
62005|NCT01396161|248672|P6|Overall Study|Withdrawal by Subject|0
62006|NCT01396161|248673|P5|Overall Study|Withdrawal by Subject|1
62007|NCT01396161|248674|P4|Overall Study|Withdrawal by Subject|0
62008|NCT01396161|248675|P3|Overall Study|Withdrawal by Subject|0
62009|NCT01396161|248676|P2|Overall Study|Withdrawal by Subject|0
62010|NCT01396161|248677|P1|Overall Study|Withdrawal by Subject|0
62011|NCT01396148|248730|P1|Overall Study|Patient Decision|1
62012|NCT01396083|248757|P2|Overall Study|Lost to Follow-up|0
62013|NCT01396083|248758|P1|Overall Study|Lost to Follow-up|1
62014|NCT01396083|248757|P2|Overall Study|Administrative problems|0
62015|NCT01396083|248758|P1|Overall Study|Administrative problems|1
62016|NCT01396083|248757|P2|Overall Study|Abnormal laboratory value(s)|0
62017|NCT01396083|248758|P1|Overall Study|Abnormal laboratory value(s)|1
62018|NCT01396083|248757|P2|Overall Study|Protocol deviation(s)|1
62019|NCT01396083|248758|P1|Overall Study|Protocol deviation(s)|0
62020|NCT01396083|248757|P2|Overall Study|Consent withdrawn|5
62021|NCT01396083|248758|P1|Overall Study|Consent withdrawn|4
62022|NCT01396083|248757|P2|Overall Study|Unsatisfactory therapeutic effect|13
62023|NCT01396083|248758|P1|Overall Study|Unsatisfactory therapeutic effect|2
62024|NCT01396083|248757|P2|Overall Study|Adverse Event|28
62025|NCT01396083|248758|P1|Overall Study|Adverse Event|2
62026|NCT01396070|248782|P1|Overall Study|Lack of Efficacy|4
62027|NCT01396070|248782|P1|Overall Study|Physician Decision|3
62028|NCT01396070|248782|P1|Overall Study|Adverse Event|8
62029|NCT01396070|248782|P1|Overall Study|Death|2
62030|NCT01396070|248782|P1|Overall Study|Withdrawal by Subject|2
62031|NCT01396057|248791|P2|Overall Study|Consent withdrawn|2
62032|NCT01396057|248792|P1|Overall Study|Consent withdrawn|3
62033|NCT01396057|248791|P2|Overall Study|Protocol deviation|4
62034|NCT01396057|248792|P1|Overall Study|Protocol deviation|4
62035|NCT01396057|248791|P2|Overall Study|Unsatisfactory therapeutic effect|6
62036|NCT01396057|248792|P1|Overall Study|Unsatisfactory therapeutic effect|2
62037|NCT01396057|248791|P2|Overall Study|Adverse Event|6
62038|NCT01396057|248792|P1|Overall Study|Adverse Event|2
62039|NCT01396005|248841|P2|Overall Study|Non-compliance with protocol|1
62040|NCT01396005|248842|P1|Overall Study|Non-compliance with protocol|0
62041|NCT01396005|248841|P2|Overall Study|Withdrawal by Subject|1
62042|NCT01396005|248842|P1|Overall Study|Withdrawal by Subject|0
62043|NCT01395914|248873|P2|Overall Study|Lost to Follow-up|2
62044|NCT01395914|248874|P1|Overall Study|Lost to Follow-up|6
62045|NCT01395914|248873|P2|Overall Study|Study drug-related AE|0
62046|NCT01395914|248874|P1|Overall Study|Study drug-related AE|1
62047|NCT01395914|248873|P2|Overall Study|Withdrawal by patient|14
62048|NCT01395914|248874|P1|Overall Study|Withdrawal by patient|27
62049|NCT01395914|248873|P2|Overall Study|Other|3
62050|NCT01395914|248874|P1|Overall Study|Other|9
62051|NCT01395914|248873|P2|Overall Study|Death|17
62052|NCT01395914|248874|P1|Overall Study|Death|23
62053|NCT01395914|248873|P2|Overall Study|Unrelated to study drug AE|1
62054|NCT01395914|248874|P1|Overall Study|Unrelated to study drug AE|6
62055|NCT01395901|248888|P2|Overall Study|Withdrawal of consent|0
62056|NCT01395901|248889|P1|Overall Study|Withdrawal of consent|1
62057|NCT01395901|248888|P2|Overall Study|Adverse Event|1
62058|NCT01395901|248889|P1|Overall Study|Adverse Event|0
62059|NCT01395901|248888|P2|Overall Study|Randomized but not received study drug|4
62060|NCT01395901|248889|P1|Overall Study|Randomized but not received study drug|5
62061|NCT01395901|248888|P2|Overall Study|Lost to Follow-up|0
62062|NCT01395901|248889|P1|Overall Study|Lost to Follow-up|4
62063|NCT01395888|248905|P3|Treatment Period (TP)|Withdrawal by Subject|3
62064|NCT01395888|248906|P2|Treatment Period (TP)|Withdrawal by Subject|2
62065|NCT01395888|248907|P1|Treatment Period (TP)|Withdrawal by Subject|0
62066|NCT01395888|248905|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
62067|NCT01395888|248906|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
62068|NCT01395888|248907|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
62069|NCT01395888|248905|P3|Treatment Period (TP)|Protocol Violation|5
62070|NCT01395888|248906|P2|Treatment Period (TP)|Protocol Violation|1
62071|NCT01395888|248907|P1|Treatment Period (TP)|Protocol Violation|0
62072|NCT01395888|248905|P3|Treatment Period (TP)|Lack of Efficacy|3
62073|NCT01395888|248906|P2|Treatment Period (TP)|Lack of Efficacy|4
62074|NCT01395888|248907|P1|Treatment Period (TP)|Lack of Efficacy|0
62075|NCT01395888|248905|P3|Treatment Period (TP)|Adverse Event|6
62076|NCT01395888|248906|P2|Treatment Period (TP)|Adverse Event|7
62077|NCT01395888|248907|P1|Treatment Period (TP)|Adverse Event|0
62078|NCT01395888|248905|P3|2-week Run-in Period|Withdrawal by Subject|0
62079|NCT01395888|248906|P2|2-week Run-in Period|Withdrawal by Subject|0
62080|NCT01395888|248907|P1|2-week Run-in Period|Withdrawal by Subject|4
62081|NCT01395888|248905|P3|2-week Run-in Period|Protocol Violation|0
62082|NCT01395888|248906|P2|2-week Run-in Period|Protocol Violation|0
62083|NCT01395888|248907|P1|2-week Run-in Period|Protocol Violation|2
62084|NCT01395888|248905|P3|2-week Run-in Period|Lost to Follow-up|0
62085|NCT01395888|248906|P2|2-week Run-in Period|Lost to Follow-up|0
62086|NCT01395888|248907|P1|2-week Run-in Period|Lost to Follow-up|1
62087|NCT01395888|248905|P3|2-week Run-in Period|Continuation Criteria Not Met|0
62088|NCT01395888|248906|P2|2-week Run-in Period|Continuation Criteria Not Met|0
62089|NCT01395888|248907|P1|2-week Run-in Period|Continuation Criteria Not Met|13
62090|NCT01395888|248905|P3|2-week Run-in Period|Adverse Event|0
62091|NCT01395888|248906|P2|2-week Run-in Period|Adverse Event|0
62092|NCT01395888|248907|P1|2-week Run-in Period|Adverse Event|2
62093|NCT01395823|248915|P2|Overall Study|Withdrawal by Subject|4
62094|NCT01395823|248916|P1|Overall Study|Withdrawal by Subject|5
62095|NCT01395823|248915|P2|Overall Study|GI symptoms|0
62096|NCT01395823|248916|P1|Overall Study|GI symptoms|1
62097|NCT01395823|248915|P2|Overall Study|Transplant|0
62098|NCT01395823|248916|P1|Overall Study|Transplant|1
62099|NCT01395823|248915|P2|Overall Study|Lost to Follow-up|0
62100|NCT01395823|248916|P1|Overall Study|Lost to Follow-up|1
62101|NCT01395823|248915|P2|Overall Study|Physician Decision|1
62102|NCT01395823|248916|P1|Overall Study|Physician Decision|3
62103|NCT01395823|248915|P2|Overall Study|Death|4
62104|NCT01395823|248916|P1|Overall Study|Death|4
62105|NCT01395810|248926|P4|Overall Study|Unclassified|0
62106|NCT01395810|248927|P3|Overall Study|Unclassified|0
62107|NCT01395810|248928|P2|Overall Study|Unclassified|0
62108|NCT01395810|248929|P1|Overall Study|Unclassified|2
62109|NCT01395810|248926|P4|Overall Study|Withdrawal criteria|0
62110|NCT01395810|248927|P3|Overall Study|Withdrawal criteria|0
62111|NCT01395810|248928|P2|Overall Study|Withdrawal criteria|2
62112|NCT01395810|248929|P1|Overall Study|Withdrawal criteria|0
62113|NCT01395810|248926|P4|Overall Study|Lack of Efficacy|0
62114|NCT01395810|248927|P3|Overall Study|Lack of Efficacy|0
62115|NCT01395810|248928|P2|Overall Study|Lack of Efficacy|1
62116|NCT01395810|248929|P1|Overall Study|Lack of Efficacy|0
62117|NCT01395810|248926|P4|Overall Study|Adverse Event|0
62118|NCT01395810|248927|P3|Overall Study|Adverse Event|0
62119|NCT01395810|248928|P2|Overall Study|Adverse Event|1
62120|NCT01395810|248929|P1|Overall Study|Adverse Event|0
62121|NCT01395784|248988|P1|Overall Study|Physician Decision|5
62122|NCT01395784|248988|P1|Overall Study|Withdrawal by Subject|3
62123|NCT01395784|248988|P1|Overall Study|Lost to Follow-up|7
62124|NCT01395758|248995|P3|Open-label Treatment Period|Withdrawal by Subject|0
62125|NCT01395758|248996|P2|Open-label Treatment Period|Withdrawal by Subject|0
62126|NCT01395758|248997|P1|Open-label Treatment Period|Withdrawal by Subject|4
62127|NCT01395524|249011|P3|Overall Study|Subject had spinal surgery|1
62128|NCT01395524|249012|P2|Overall Study|Subject had spinal surgery|0
62129|NCT01395524|249013|P1|Overall Study|Subject had spinal surgery|0
62130|NCT01395524|249011|P3|Overall Study|Did not receive treatment|3
62131|NCT01395524|249012|P2|Overall Study|Did not receive treatment|1
62132|NCT01395524|249013|P1|Overall Study|Did not receive treatment|1
62133|NCT01395524|249011|P3|Overall Study|Withdrawal by Subject|8
62134|NCT01395524|249012|P2|Overall Study|Withdrawal by Subject|8
62135|NCT01395524|249013|P1|Overall Study|Withdrawal by Subject|4
62136|NCT01395524|249011|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
62137|NCT01395524|249012|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
62138|NCT01395524|249013|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
62139|NCT01395524|249011|P3|Overall Study|Death|0
62140|NCT01395524|249012|P2|Overall Study|Death|0
62141|NCT01395524|249013|P1|Overall Study|Death|1
62142|NCT01395524|249011|P3|Overall Study|Adverse Event|3
62143|NCT01395524|249012|P2|Overall Study|Adverse Event|4
62144|NCT01395524|249013|P1|Overall Study|Adverse Event|4
62145|NCT01395524|249011|P3|Overall Study|Severe noncompliance with protocol|0
62146|NCT01395524|249012|P2|Overall Study|Severe noncompliance with protocol|0
62147|NCT01395524|249013|P1|Overall Study|Severe noncompliance with protocol|1
62148|NCT01395524|249011|P3|Overall Study|Study-Specific Withdrawal Criteria|0
62149|NCT01395524|249012|P2|Overall Study|Study-Specific Withdrawal Criteria|2
62150|NCT01395524|249013|P1|Overall Study|Study-Specific Withdrawal Criteria|1
62151|NCT01395524|249011|P3|Overall Study|Lost to Follow-up|1
62152|NCT01395524|249012|P2|Overall Study|Lost to Follow-up|1
62153|NCT01395524|249013|P1|Overall Study|Lost to Follow-up|3
62154|NCT01395524|249011|P3|Overall Study|Non-compliance with study schedule|1
62155|NCT01395524|249012|P2|Overall Study|Non-compliance with study schedule|0
62156|NCT01395524|249013|P1|Overall Study|Non-compliance with study schedule|1
62157|NCT01395394|249036|P3|Baseline Study Visit|Protocol Violation|0
62158|NCT01395394|249037|P2|Baseline Study Visit|Protocol Violation|0
62159|NCT01395394|249038|P1|Baseline Study Visit|Protocol Violation|1
62160|NCT01395368|249049|P1|Overall Study|Withdrawal by Subject|2
62161|NCT01395368|249049|P1|Overall Study|Physician Decision|14
62162|NCT01395017|249071|P2|Overall Study|Sponsor discontinued study|4
62163|NCT01395017|249072|P1|Overall Study|Sponsor discontinued study|1
62164|NCT01395017|249071|P2|Overall Study|Disease progression|58
62165|NCT01395017|249072|P1|Overall Study|Disease progression|42
62166|NCT01395017|249071|P2|Overall Study|Death|3
62167|NCT01395017|249072|P1|Overall Study|Death|4
62168|NCT01395017|249071|P2|Overall Study|Protocol deviation|2
62169|NCT01395017|249072|P1|Overall Study|Protocol deviation|1
62170|NCT01395017|249071|P2|Overall Study|Withdrawal by Subject|8
62171|NCT01395017|249072|P1|Overall Study|Withdrawal by Subject|14
62172|NCT01395017|249071|P2|Overall Study|Physician Decision|15
62173|NCT01395017|249072|P1|Overall Study|Physician Decision|11
62174|NCT01395017|249071|P2|Overall Study|Adverse Event|12
62175|NCT01395017|249072|P1|Overall Study|Adverse Event|26
62176|NCT01395017|249071|P2|Overall Study|Lost to Follow-up|0
62177|NCT01395017|249072|P1|Overall Study|Lost to Follow-up|1
62178|NCT01394991|249082|P2|Overall Study|Prematurely Termination of Trial|10
62179|NCT01394991|249083|P1|Overall Study|Prematurely Termination of Trial|9
62180|NCT01394991|249082|P2|Overall Study|Disease Progression|7
62181|NCT01394991|249083|P1|Overall Study|Disease Progression|7
62182|NCT01394991|249082|P2|Overall Study|Chemotherapy Termination|15
62183|NCT01394991|249083|P1|Overall Study|Chemotherapy Termination|10
62184|NCT01394991|249082|P2|Overall Study|Withdrawal by Subject|17
62185|NCT01394991|249083|P1|Overall Study|Withdrawal by Subject|20
62186|NCT01394991|249082|P2|Overall Study|Protocol Violation|1
62187|NCT01394991|249083|P1|Overall Study|Protocol Violation|1
62188|NCT01394991|249082|P2|Overall Study|Physician Decision|3
62189|NCT01394991|249083|P1|Overall Study|Physician Decision|1
62190|NCT01394991|249082|P2|Overall Study|Lost to Follow-up|8
62191|NCT01394991|249083|P1|Overall Study|Lost to Follow-up|6
62192|NCT01394991|249082|P2|Overall Study|Lack of Efficacy|7
62193|NCT01394991|249083|P1|Overall Study|Lack of Efficacy|5
62194|NCT01394991|249082|P2|Overall Study|Adverse Event|4
62195|NCT01394991|249083|P1|Overall Study|Adverse Event|0
62196|NCT01394978|249105|P2|Overall Study|Death|7
62197|NCT01394978|249106|P1|Overall Study|Death|6
62198|NCT01394978|249105|P2|Overall Study|Lost to Follow-up|20
62199|NCT01394978|249106|P1|Overall Study|Lost to Follow-up|13
62200|NCT01394978|249105|P2|Overall Study|Withdrawal by Subject|4
62201|NCT01394978|249106|P1|Overall Study|Withdrawal by Subject|2
62202|NCT01394718|249123|P2|Overall Study|Met protocol-specific stopping criteria|1
62203|NCT01394718|249124|P1|Overall Study|Met protocol-specific stopping criteria|2
62204|NCT01394627|249145|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
62205|NCT01394627|249146|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
62206|NCT01394627|249145|P2|First Intervention (1 Day)|poor intravenous access|1
62207|NCT01394627|249146|P1|First Intervention (1 Day)|poor intravenous access|0
62208|NCT01394523|249166|P3|Overall Study|Unable to place block|0
62209|NCT01394523|249167|P2|Overall Study|Unable to place block|0
62210|NCT01394523|249168|P1|Overall Study|Unable to place block|1
62211|NCT01394276|249182|P1|Overall Study|Symptoms of concurrent diseases|1
62212|NCT01394276|249182|P1|Overall Study|unavailability of drug at the Hospital|2
62213|NCT01394276|249182|P1|Overall Study|Pregnancy|1
62214|NCT01394276|249182|P1|Overall Study|Participant moved to another site|1
62215|NCT01394276|249182|P1|Overall Study|Lost to Follow-up|5
62216|NCT01394276|249182|P1|Overall Study|Insufficient compliance|9
62217|NCT01394276|249182|P1|Overall Study|Insufficient therapeutic effect|17
62218|NCT01394276|249182|P1|Overall Study|Remission of disease|2
62219|NCT01394276|249182|P1|Overall Study|Not related AEs|9
62220|NCT01394276|249182|P1|Overall Study|Related Adverse event (AEs)|15
62221|NCT01394250|249206|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
62222|NCT01394250|249207|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
62223|NCT01394250|249206|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
62224|NCT01394250|249207|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
62225|NCT01394185|249215|P6|Overall Study|Protocol Violation|1
62226|NCT01394185|249216|P5|Overall Study|Protocol Violation|0
62227|NCT01394185|249217|P4|Overall Study|Protocol Violation|1
62228|NCT01394185|249218|P3|Overall Study|Protocol Violation|0
62229|NCT01394185|249219|P2|Overall Study|Protocol Violation|0
62230|NCT01394185|249220|P1|Overall Study|Protocol Violation|1
62231|NCT01394185|249215|P6|Overall Study|Change in protocol|0
62232|NCT01394185|249216|P5|Overall Study|Change in protocol|3
62233|NCT01394185|249217|P4|Overall Study|Change in protocol|0
62234|NCT01394185|249218|P3|Overall Study|Change in protocol|0
62235|NCT01394185|249219|P2|Overall Study|Change in protocol|0
62236|NCT01394185|249220|P1|Overall Study|Change in protocol|3
62237|NCT01394185|249215|P6|Overall Study|Withdrawal by Subject|0
62238|NCT01394185|249216|P5|Overall Study|Withdrawal by Subject|1
62239|NCT01394185|249217|P4|Overall Study|Withdrawal by Subject|0
62240|NCT01394185|249218|P3|Overall Study|Withdrawal by Subject|0
62241|NCT01394185|249219|P2|Overall Study|Withdrawal by Subject|0
62242|NCT01394185|249220|P1|Overall Study|Withdrawal by Subject|2
62243|NCT01393964|249258|P3|Overall Study|Subject to receive non-protocol therapy|1
62244|NCT01393964|249259|P2|Overall Study|Subject to receive non-protocol therapy|0
62245|NCT01393964|249260|P1|Overall Study|Subject to receive non-protocol therapy|0
62246|NCT01393964|249258|P3|Overall Study|Subject converted to roll-over study|0
62247|NCT01393964|249259|P2|Overall Study|Subject converted to roll-over study|1
62248|NCT01393964|249260|P1|Overall Study|Subject converted to roll-over study|0
62249|NCT01393964|249258|P3|Overall Study|Investigator removed subject from study|0
62250|NCT01393964|249259|P2|Overall Study|Investigator removed subject from study|1
62251|NCT01393964|249260|P1|Overall Study|Investigator removed subject from study|0
62252|NCT01393964|249258|P3|Overall Study|Subject plateaued in terms of effect|0
62253|NCT01393964|249259|P2|Overall Study|Subject plateaued in terms of effect|0
62254|NCT01393964|249260|P1|Overall Study|Subject plateaued in terms of effect|1
62255|NCT01393964|249258|P3|Overall Study|Subject switched to commercial supply|2
62256|NCT01393964|249259|P2|Overall Study|Subject switched to commercial supply|0
62257|NCT01393964|249260|P1|Overall Study|Subject switched to commercial supply|1
62258|NCT01393964|249258|P3|Overall Study|Subject decided to move to transplant|0
62259|NCT01393964|249259|P2|Overall Study|Subject decided to move to transplant|0
62260|NCT01393964|249260|P1|Overall Study|Subject decided to move to transplant|1
62261|NCT01393964|249258|P3|Overall Study|Subject request stop study treatment|0
62262|NCT01393964|249259|P2|Overall Study|Subject request stop study treatment|1
62263|NCT01393964|249260|P1|Overall Study|Subject request stop study treatment|0
62264|NCT01393964|249258|P3|Overall Study|Adverse event unrelated to study drug|0
62265|NCT01393964|249259|P2|Overall Study|Adverse event unrelated to study drug|3
62266|NCT01393964|249260|P1|Overall Study|Adverse event unrelated to study drug|0
62267|NCT01393964|249258|P3|Overall Study|Withdrawal by Subject|1
62268|NCT01393964|249259|P2|Overall Study|Withdrawal by Subject|0
62269|NCT01393964|249260|P1|Overall Study|Withdrawal by Subject|0
62270|NCT01393964|249258|P3|Overall Study|Study drug toxicity|0
62271|NCT01393964|249259|P2|Overall Study|Study drug toxicity|0
62272|NCT01393964|249260|P1|Overall Study|Study drug toxicity|1
62273|NCT01393964|249258|P3|Overall Study|Disease Progression|5
62274|NCT01393964|249259|P2|Overall Study|Disease Progression|3
62275|NCT01393964|249260|P1|Overall Study|Disease Progression|4
62276|NCT01393899|249301|P3|Overall Study|Adverse Event|3
62277|NCT01393899|249302|P2|Overall Study|Adverse Event|5
62278|NCT01393899|249303|P1|Overall Study|Adverse Event|1
62279|NCT01393899|249301|P3|Overall Study|Lack of Efficacy|16
62280|NCT01393899|249302|P2|Overall Study|Lack of Efficacy|21
62281|NCT01393899|249303|P1|Overall Study|Lack of Efficacy|26
62282|NCT01393899|249301|P3|Overall Study|Does not meet entrance criteria|1
62283|NCT01393899|249302|P2|Overall Study|Does not meet entrance criteria|0
62284|NCT01393899|249303|P1|Overall Study|Does not meet entrance criteria|1
62285|NCT01393899|249301|P3|Overall Study|Lost to Follow-up|1
62286|NCT01393899|249302|P2|Overall Study|Lost to Follow-up|0
62287|NCT01393899|249303|P1|Overall Study|Lost to Follow-up|0
62288|NCT01393899|249301|P3|Overall Study|Withdrawal by Subject|1
62289|NCT01393899|249302|P2|Overall Study|Withdrawal by Subject|2
62290|NCT01393899|249303|P1|Overall Study|Withdrawal by Subject|2
62291|NCT01393899|249301|P3|Overall Study|Other|0
62292|NCT01393899|249302|P2|Overall Study|Other|0
62293|NCT01393899|249303|P1|Overall Study|Other|1
62294|NCT01393899|249301|P3|Overall Study|Study terminated by sponsor|1
62295|NCT01393899|249302|P2|Overall Study|Study terminated by sponsor|0
62296|NCT01393899|249303|P1|Overall Study|Study terminated by sponsor|1
62297|NCT01393743|249357|P3|Extension Phase|Not specified|14
62298|NCT01393743|249358|P2|Extension Phase|Not specified|0
62299|NCT01393743|249359|P1|Extension Phase|Not specified|0
62300|NCT01393743|249357|P3|Extension Phase|Pregnancy|1
62301|NCT01393743|249358|P2|Extension Phase|Pregnancy|0
62302|NCT01393743|249359|P1|Extension Phase|Pregnancy|0
62303|NCT01393743|249357|P3|Extension Phase|Withdrawal by Subject|8
62304|NCT01393743|249358|P2|Extension Phase|Withdrawal by Subject|0
62305|NCT01393743|249359|P1|Extension Phase|Withdrawal by Subject|0
62306|NCT01393743|249357|P3|Extension Phase|Inadequate therapeutic effect|7
62307|NCT01393743|249358|P2|Extension Phase|Inadequate therapeutic effect|0
62308|NCT01393743|249359|P1|Extension Phase|Inadequate therapeutic effect|0
62309|NCT01393743|249357|P3|Extension Phase|Participant choice|16
62310|NCT01393743|249358|P2|Extension Phase|Participant choice|0
62311|NCT01393743|249359|P1|Extension Phase|Participant choice|0
62312|NCT01393743|249357|P3|Extension Phase|Lost to Follow-up|2
62313|NCT01393743|249358|P2|Extension Phase|Lost to Follow-up|0
62314|NCT01393743|249359|P1|Extension Phase|Lost to Follow-up|0
62315|NCT01393743|249357|P3|Extension Phase|Adverse Event|12
62316|NCT01393743|249358|P2|Extension Phase|Adverse Event|0
62317|NCT01393743|249359|P1|Extension Phase|Adverse Event|0
62318|NCT01393743|249357|P3|Core Study|Inadequate therapeutic effect|0
62319|NCT01393743|249358|P2|Core Study|Inadequate therapeutic effect|0
62320|NCT01393743|249359|P1|Core Study|Inadequate therapeutic effect|2
62321|NCT01393743|249357|P3|Core Study|Participant's Choice|0
62322|NCT01393743|249358|P2|Core Study|Participant's Choice|3
62323|NCT01393743|249359|P1|Core Study|Participant's Choice|2
62324|NCT01393743|249357|P3|Core Study|Lost to Follow-up|0
62325|NCT01393743|249358|P2|Core Study|Lost to Follow-up|1
62326|NCT01393743|249359|P1|Core Study|Lost to Follow-up|1
62327|NCT01393743|249357|P3|Core Study|Adverse Event|0
62328|NCT01393743|249358|P2|Core Study|Adverse Event|9
62329|NCT01393743|249359|P1|Core Study|Adverse Event|5
62330|NCT01393730|249382|P1|Overall Study|Adverse Event|1
62331|NCT01393730|249382|P1|Overall Study|Other|2
62332|NCT01393730|249382|P1|Overall Study|Withdrawal by Subject|3
62333|NCT01393626|249428|P4|Overall Study|Protocol Violation|0
62334|NCT01393626|249429|P3|Overall Study|Protocol Violation|2
62335|NCT01393626|249430|P2|Overall Study|Protocol Violation|0
62336|NCT01393626|249431|P1|Overall Study|Protocol Violation|1
62337|NCT01393626|249428|P4|Overall Study|Other|0
62338|NCT01393626|249429|P3|Overall Study|Other|0
62339|NCT01393626|249430|P2|Overall Study|Other|0
62340|NCT01393626|249431|P1|Overall Study|Other|1
62341|NCT01393626|249428|P4|Overall Study|Withdrawal by Subject|0
62342|NCT01393626|249429|P3|Overall Study|Withdrawal by Subject|0
62343|NCT01393626|249430|P2|Overall Study|Withdrawal by Subject|4
62344|NCT01393626|249431|P1|Overall Study|Withdrawal by Subject|6
62345|NCT01393626|249428|P4|Overall Study|Lost to Follow-up|0
62346|NCT01393626|249429|P3|Overall Study|Lost to Follow-up|1
62347|NCT01393626|249430|P2|Overall Study|Lost to Follow-up|1
62348|NCT01393626|249431|P1|Overall Study|Lost to Follow-up|1
62349|NCT01393626|249428|P4|Overall Study|Lack of Efficacy|1
62350|NCT01393626|249429|P3|Overall Study|Lack of Efficacy|4
62351|NCT01393626|249430|P2|Overall Study|Lack of Efficacy|6
62352|NCT01393626|249431|P1|Overall Study|Lack of Efficacy|6
62353|NCT01393626|249428|P4|Overall Study|Did not meet entrance criteria|0
62354|NCT01393626|249429|P3|Overall Study|Did not meet entrance criteria|0
62355|NCT01393626|249430|P2|Overall Study|Did not meet entrance criteria|0
62356|NCT01393626|249431|P1|Overall Study|Did not meet entrance criteria|1
62357|NCT01393626|249428|P4|Overall Study|Adverse Event|0
62358|NCT01393626|249429|P3|Overall Study|Adverse Event|5
62359|NCT01393626|249430|P2|Overall Study|Adverse Event|1
62360|NCT01393626|249431|P1|Overall Study|Adverse Event|2
62361|NCT01393613|249511|P4|Overall Study|Lack of Efficacy|21
62362|NCT01393613|249512|P3|Overall Study|Lack of Efficacy|16
62363|NCT01393613|249513|P2|Overall Study|Lack of Efficacy|20
62364|NCT01393613|249514|P1|Overall Study|Lack of Efficacy|9
62365|NCT01393613|249511|P4|Overall Study|Protocol Deviation|0
62366|NCT01393613|249512|P3|Overall Study|Protocol Deviation|0
62367|NCT01393613|249513|P2|Overall Study|Protocol Deviation|1
62368|NCT01393613|249514|P1|Overall Study|Protocol Deviation|2
62369|NCT01393613|249511|P4|Overall Study|Withdrawal by Subject|21
62370|NCT01393613|249512|P3|Overall Study|Withdrawal by Subject|23
62371|NCT01393613|249513|P2|Overall Study|Withdrawal by Subject|25
62372|NCT01393613|249514|P1|Overall Study|Withdrawal by Subject|15
62373|NCT01393613|249511|P4|Overall Study|Physician Decision|1
62374|NCT01393613|249512|P3|Overall Study|Physician Decision|0
62375|NCT01393613|249513|P2|Overall Study|Physician Decision|0
62376|NCT01393613|249514|P1|Overall Study|Physician Decision|2
62377|NCT01393613|249511|P4|Overall Study|Participant Met Withdrawal Criteria|1
62378|NCT01393613|249512|P3|Overall Study|Participant Met Withdrawal Criteria|2
62379|NCT01393613|249513|P2|Overall Study|Participant Met Withdrawal Criteria|0
62380|NCT01393613|249514|P1|Overall Study|Participant Met Withdrawal Criteria|0
62381|NCT01393613|249511|P4|Overall Study|Adverse Event|22
62382|NCT01393613|249512|P3|Overall Study|Adverse Event|13
62383|NCT01393613|249513|P2|Overall Study|Adverse Event|11
62384|NCT01393613|249514|P1|Overall Study|Adverse Event|11
62385|NCT01393600|249576|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
62386|NCT01393600|249577|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
62387|NCT01393600|249578|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
62388|NCT01393600|249579|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
62389|NCT01393600|249576|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
62390|NCT01393600|249577|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
62391|NCT01393600|249578|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
62392|NCT01393600|249579|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
62393|NCT01393600|249576|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
62394|NCT01393600|249577|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
62395|NCT01393600|249578|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
62396|NCT01393600|249579|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
62397|NCT01393600|249576|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
62398|NCT01393600|249577|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
62399|NCT01393600|249578|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
62400|NCT01393600|249579|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
62401|NCT01393600|249576|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
62402|NCT01393600|249577|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
62403|NCT01393600|249578|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
62404|NCT01393600|249579|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
62405|NCT01393600|249576|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
62406|NCT01393600|249577|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
62407|NCT01393600|249578|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
62408|NCT01393600|249579|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
62409|NCT01393600|249576|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
62410|NCT01393600|249577|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
62411|NCT01393600|249578|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
62412|NCT01393600|249579|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
62413|NCT01393444|249615|P1|Overall Study|Determined ineligible during screening.|2
62414|NCT01393444|249615|P1|Overall Study|Withdrawal by Subject|1
62415|NCT01393405|249620|P3|Maintenance Period Week|Lost to Follow-up|0
62416|NCT01393405|249621|P2|Maintenance Period Week|Lost to Follow-up|1
62417|NCT01393405|249622|P1|Maintenance Period Week|Lost to Follow-up|0
62418|NCT01393405|249620|P3|Maintenance Period Week|Withdrawal by Subject|0
62419|NCT01393405|249621|P2|Maintenance Period Week|Withdrawal by Subject|1
62420|NCT01393405|249622|P1|Maintenance Period Week|Withdrawal by Subject|0
62421|NCT01393405|249620|P3|Maintenance Period Week|Adverse Event|2
62422|NCT01393405|249621|P2|Maintenance Period Week|Adverse Event|5
62423|NCT01393405|249622|P1|Maintenance Period Week|Adverse Event|0
62424|NCT01393405|249620|P3|Maintenance Period Week|Lack of Efficacy|22
62425|NCT01393405|249621|P2|Maintenance Period Week|Lack of Efficacy|22
62426|NCT01393405|249622|P1|Maintenance Period Week|Lack of Efficacy|0
62427|NCT01393405|249620|P3|Induction Period (week1-16)|Withdrawal by Subject|0
62428|NCT01393405|249621|P2|Induction Period (week1-16)|Withdrawal by Subject|0
62429|NCT01393405|249622|P1|Induction Period (week1-16)|Withdrawal by Subject|9
62430|NCT01393405|249620|P3|Induction Period (week1-16)|Adverse Event|0
62431|NCT01393405|249621|P2|Induction Period (week1-16)|Adverse Event|0
62432|NCT01393405|249622|P1|Induction Period (week1-16)|Adverse Event|16
62433|NCT01393405|249620|P3|Induction Period (week1-16)|Lack of Efficacy|0
62434|NCT01393405|249621|P2|Induction Period (week1-16)|Lack of Efficacy|0
62435|NCT01393405|249622|P1|Induction Period (week1-16)|Lack of Efficacy|70
62436|NCT01393106|249654|P1|Overall Study|Lack of Efficacy|1
62437|NCT01393106|249654|P1|Overall Study|Withdrawal by Subject|1
62438|NCT01393106|249654|P1|Overall Study|Adverse Event|3
62439|NCT01392742|249671|P1|Overall Study|Missing information|13
62440|NCT01392742|249671|P1|Overall Study|Other|3
62441|NCT01392742|249671|P1|Overall Study|Protocol Violation|14
62442|NCT01392742|249671|P1|Overall Study|Adverse event/intercurrent illness|17
62443|NCT01392742|249671|P1|Overall Study|ITR and Protocol deviation|1
62444|NCT01392742|249671|P1|Overall Study|Insufficient therapeutic response (ITR)|30
62445|NCT01392742|249671|P1|Overall Study|Lost to Follow-up|34
62446|NCT01392742|249671|P1|Overall Study|No treatment/no cooperation/withdrew|12
62447|NCT01392742|249671|P1|Overall Study|Failure to return|35
62448|NCT01392742|249671|P1|Overall Study|Premature study termination|42
62449|NCT01392677|249717|P2|Overall Study|Other reason|2
62450|NCT01392677|249718|P1|Overall Study|Other reason|3
62451|NCT01392677|249717|P2|Overall Study|Incorrect enrollment|3
62452|NCT01392677|249718|P1|Overall Study|Incorrect enrollment|2
62453|NCT01392677|249717|P2|Overall Study|Withdrawal by Subject|2
62454|NCT01392677|249718|P1|Overall Study|Withdrawal by Subject|0
62455|NCT01392677|249717|P2|Overall Study|Adverse Event|1
62456|NCT01392677|249718|P1|Overall Study|Adverse Event|3
62457|NCT01392573|249753|P2|Overall Study|Unclassified|6
62458|NCT01392573|249754|P1|Overall Study|Unclassified|9
62459|NCT01392573|249753|P2|Overall Study|Site closure|7
62460|NCT01392573|249754|P1|Overall Study|Site closure|8
62461|NCT01392573|249753|P2|Overall Study|Withdrawal Criteria|15
62462|NCT01392573|249754|P1|Overall Study|Withdrawal Criteria|13
62463|NCT01392573|249753|P2|Overall Study|Protocol Violation|2
62464|NCT01392573|249754|P1|Overall Study|Protocol Violation|0
62465|NCT01392573|249753|P2|Overall Study|Lack of Efficacy|2
62466|NCT01392573|249754|P1|Overall Study|Lack of Efficacy|1
62467|NCT01392573|249753|P2|Overall Study|Adverse Event|3
62468|NCT01392573|249754|P1|Overall Study|Adverse Event|1
62469|NCT01392560|249762|P1|Overall Study|discontinued during placebo run-in|2
62470|NCT01392560|249762|P1|Overall Study|not entered|8
62471|NCT01392560|249762|P1|Overall Study|Adverse Event|2
62472|NCT01392547|249768|P1|Overall Study|Unclassified|1
62473|NCT01392547|249768|P1|Overall Study|Withdrawal criteria|3
62474|NCT01392547|249768|P1|Overall Study|Non-compliance|2
62475|NCT01392547|249768|P1|Overall Study|Adverse Event|2
62476|NCT01392495|249782|P1|Overall Study|Adverse Event|3
62477|NCT01392495|249782|P1|Overall Study|Withdrawal by Subject|2
62478|NCT01392495|249782|P1|Overall Study|Administrative problems|8
62479|NCT01392495|249782|P1|Overall Study|Death|3
62480|NCT01392378|249799|P5|Toddler Dose|Withdrawal by Parent|1
62481|NCT01392378|249800|P4|Toddler Dose|Withdrawal by Parent|1
62482|NCT01392378|249801|P3|Toddler Dose|Withdrawal by Parent|0
62483|NCT01392378|249802|P2|Toddler Dose|Withdrawal by Parent|1
62484|NCT01392378|249803|P1|Toddler Dose|Withdrawal by Parent|0
62485|NCT01392378|249799|P5|Toddler Dose|Lost to Follow-up|0
62486|NCT01392378|249800|P4|Toddler Dose|Lost to Follow-up|1
62487|NCT01392378|249801|P3|Toddler Dose|Lost to Follow-up|0
62488|NCT01392378|249802|P2|Toddler Dose|Lost to Follow-up|0
62489|NCT01392378|249803|P1|Toddler Dose|Lost to Follow-up|0
62490|NCT01392378|249799|P5|After Infant Series|Withdrawal by Parent|1
62491|NCT01392378|249800|P4|After Infant Series|Withdrawal by Parent|0
62492|NCT01392378|249801|P3|After Infant Series|Withdrawal by Parent|1
62493|NCT01392378|249802|P2|After Infant Series|Withdrawal by Parent|1
62494|NCT01392378|249803|P1|After Infant Series|Withdrawal by Parent|0
62495|NCT01392378|249799|P5|After Infant Series|Lost to Follow-up|0
62496|NCT01392378|249800|P4|After Infant Series|Lost to Follow-up|0
62497|NCT01392378|249801|P3|After Infant Series|Lost to Follow-up|1
62498|NCT01392378|249802|P2|After Infant Series|Lost to Follow-up|0
62499|NCT01392378|249803|P1|After Infant Series|Lost to Follow-up|0
62500|NCT01392378|249799|P5|Infant Series|Withdrawal by Parent|0
62501|NCT01392378|249800|P4|Infant Series|Withdrawal by Parent|0
62502|NCT01392378|249801|P3|Infant Series|Withdrawal by Parent|0
62503|NCT01392378|249802|P2|Infant Series|Withdrawal by Parent|1
62504|NCT01392378|249803|P1|Infant Series|Withdrawal by Parent|4
62505|NCT01392378|249799|P5|Infant Series|Protocol Violation|0
62506|NCT01392378|249800|P4|Infant Series|Protocol Violation|0
62507|NCT01392378|249801|P3|Infant Series|Protocol Violation|0
62508|NCT01392378|249802|P2|Infant Series|Protocol Violation|1
62509|NCT01392378|249803|P1|Infant Series|Protocol Violation|0
62510|NCT01392378|249799|P5|Infant Series|Lost to Follow-up|0
62511|NCT01392378|249800|P4|Infant Series|Lost to Follow-up|1
62512|NCT01392378|249801|P3|Infant Series|Lost to Follow-up|0
62513|NCT01392378|249802|P2|Infant Series|Lost to Follow-up|0
62514|NCT01392378|249803|P1|Infant Series|Lost to Follow-up|0
62515|NCT01392378|249799|P5|Infant Series|Adverse Event|0
62516|NCT01392378|249800|P4|Infant Series|Adverse Event|1
62517|NCT01392378|249801|P3|Infant Series|Adverse Event|0
62518|NCT01392378|249802|P2|Infant Series|Adverse Event|0
62519|NCT01392378|249803|P1|Infant Series|Adverse Event|0
62520|NCT01392326|249943|P3|Overall Study|Adverse Event|11
62521|NCT01392326|249944|P2|Overall Study|Adverse Event|6
62522|NCT01392326|249945|P1|Overall Study|Adverse Event|9
62523|NCT01392326|249943|P3|Overall Study|Lack of Efficacy|15
62524|NCT01392326|249944|P2|Overall Study|Lack of Efficacy|10
62525|NCT01392326|249945|P1|Overall Study|Lack of Efficacy|14
62526|NCT01392326|249943|P3|Overall Study|Lost to Follow-up|4
62527|NCT01392326|249944|P2|Overall Study|Lost to Follow-up|3
62528|NCT01392326|249945|P1|Overall Study|Lost to Follow-up|1
62529|NCT01392326|249943|P3|Overall Study|Physician Decision|2
62530|NCT01392326|249944|P2|Overall Study|Physician Decision|5
62531|NCT01392326|249945|P1|Overall Study|Physician Decision|7
62532|NCT01392326|249943|P3|Overall Study|Pregnancy|1
62533|NCT01392326|249944|P2|Overall Study|Pregnancy|0
62534|NCT01392326|249945|P1|Overall Study|Pregnancy|0
62535|NCT01392326|249943|P3|Overall Study|Protocol Violation|0
62536|NCT01392326|249944|P2|Overall Study|Protocol Violation|0
62537|NCT01392326|249945|P1|Overall Study|Protocol Violation|2
62538|NCT01392326|249943|P3|Overall Study|Withdrawal by Subject|15
62539|NCT01392326|249944|P2|Overall Study|Withdrawal by Subject|11
62540|NCT01392326|249945|P1|Overall Study|Withdrawal by Subject|12
62541|NCT01392326|249943|P3|Overall Study|Death|0
62542|NCT01392326|249944|P2|Overall Study|Death|0
62543|NCT01392326|249945|P1|Overall Study|Death|2
62544|NCT01392300|249982|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
62545|NCT01392300|249983|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
62546|NCT01392300|249984|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
62547|NCT01392300|249982|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
62548|NCT01392300|249983|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
62549|NCT01392300|249984|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
62550|NCT01392300|249982|P3|Open Label Extension (OLEX) Period|Adverse Event|7
62551|NCT01392300|249983|P2|Open Label Extension (OLEX) Period|Adverse Event|0
62552|NCT01392300|249984|P1|Open Label Extension (OLEX) Period|Adverse Event|0
62553|NCT01392300|249982|P3|Open Label Extension (OLEX) Period|Death|4
62554|NCT01392300|249983|P2|Open Label Extension (OLEX) Period|Death|0
62555|NCT01392300|249984|P1|Open Label Extension (OLEX) Period|Death|0
62556|NCT01392300|249982|P3|Open Label Extension (OLEX) Period|Non-compliance|1
62557|NCT01392300|249983|P2|Open Label Extension (OLEX) Period|Non-compliance|0
62558|NCT01392300|249984|P1|Open Label Extension (OLEX) Period|Non-compliance|0
62559|NCT01392300|249982|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
62560|NCT01392300|249983|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
62561|NCT01392300|249984|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
62562|NCT01392300|249982|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
62563|NCT01392300|249983|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
62564|NCT01392300|249984|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
62565|NCT01392300|249982|P3|Main Period (MP)|Non-compliance|0
62566|NCT01392300|249983|P2|Main Period (MP)|Non-compliance|0
62567|NCT01392300|249984|P1|Main Period (MP)|Non-compliance|1
62568|NCT01392300|249982|P3|Main Period (MP)|Lost to Follow-up|0
62569|NCT01392300|249983|P2|Main Period (MP)|Lost to Follow-up|3
62570|NCT01392300|249984|P1|Main Period (MP)|Lost to Follow-up|3
62571|NCT01392300|249982|P3|Main Period (MP)|Withdrawal by Subject|0
62572|NCT01392300|249983|P2|Main Period (MP)|Withdrawal by Subject|1
62573|NCT01392300|249984|P1|Main Period (MP)|Withdrawal by Subject|5
62574|NCT01392300|249982|P3|Main Period (MP)|Predefined discontinuation criteria|0
62575|NCT01392300|249983|P2|Main Period (MP)|Predefined discontinuation criteria|3
62576|NCT01392300|249984|P1|Main Period (MP)|Predefined discontinuation criteria|2
62577|NCT01392170|250089|P1|Overall Study|Ineligible|1
62578|NCT01392170|250089|P1|Overall Study|Withdrawal by Subject|1
62579|NCT01391819|250137|P1|Overall Study|Other|9
62580|NCT01391819|250137|P1|Overall Study|Death|3
62581|NCT01391819|250137|P1|Overall Study|Lost to Follow-up|252
62582|NCT01391819|250137|P1|Overall Study|Migrated/moved from study area|82
62583|NCT01391819|250137|P1|Overall Study|Withdrawal by Subject|56
62584|NCT01391663|250168|P4|Overall Study|Withdrawal by Subject|0
62585|NCT01391663|250169|P3|Overall Study|Withdrawal by Subject|1
62586|NCT01391663|250170|P2|Overall Study|Withdrawal by Subject|0
62587|NCT01391663|250171|P1|Overall Study|Withdrawal by Subject|0
62588|NCT01391546|250215|P2|Overall Study|History of Herpes Zoster (HZ)|0
62589|NCT01391546|250216|P1|Overall Study|History of Herpes Zoster (HZ)|1
62590|NCT01391507|250238|P4|Overall Study|Protocol Violation|2
62591|NCT01391507|250239|P3|Overall Study|Protocol Violation|1
62592|NCT01391507|250240|P2|Overall Study|Protocol Violation|1
62593|NCT01391507|250241|P1|Overall Study|Protocol Violation|2
62594|NCT01391507|250238|P4|Overall Study|Lack of Efficacy|1
62595|NCT01391507|250239|P3|Overall Study|Lack of Efficacy|0
62596|NCT01391507|250240|P2|Overall Study|Lack of Efficacy|0
62597|NCT01391507|250241|P1|Overall Study|Lack of Efficacy|0
62598|NCT01391507|250238|P4|Overall Study|Withdrawal by Subject|1
62599|NCT01391507|250239|P3|Overall Study|Withdrawal by Subject|1
62600|NCT01391507|250240|P2|Overall Study|Withdrawal by Subject|2
62601|NCT01391507|250241|P1|Overall Study|Withdrawal by Subject|1
62602|NCT01391507|250238|P4|Overall Study|Adverse Event|2
62603|NCT01391507|250239|P3|Overall Study|Adverse Event|2
62604|NCT01391507|250240|P2|Overall Study|Adverse Event|1
62605|NCT01391507|250241|P1|Overall Study|Adverse Event|1
62606|NCT01391507|250238|P4|Overall Study|Death|1
62607|NCT01391507|250239|P3|Overall Study|Death|0
62608|NCT01391507|250240|P2|Overall Study|Death|0
62609|NCT01391507|250241|P1|Overall Study|Death|0
62610|NCT01391000|250420|P2|Overall Study|Lost to Follow-up|0
62611|NCT01391000|250421|P1|Overall Study|Lost to Follow-up|2
62612|NCT01390948|250434|P3|Overall Study|Withdrew consent from survival follow-up|0
62613|NCT01390948|250435|P2|Overall Study|Withdrew consent from survival follow-up|5
62614|NCT01390948|250436|P1|Overall Study|Withdrew consent from survival follow-up|3
62615|NCT01390948|250434|P3|Overall Study|Ongoing|0
62616|NCT01390948|250435|P2|Overall Study|Ongoing|6
62617|NCT01390948|250436|P1|Overall Study|Ongoing|6
62618|NCT01390948|250434|P3|Overall Study|Death|2
62619|NCT01390948|250435|P2|Overall Study|Death|34
62620|NCT01390948|250436|P1|Overall Study|Death|30
62621|NCT01390948|250434|P3|Overall Study|Alive in follow-up|1
62622|NCT01390948|250435|P2|Overall Study|Alive in follow-up|17
62623|NCT01390948|250436|P1|Overall Study|Alive in follow-up|20
62624|NCT01390857|250502|P1|Overall Study|No Visit after the First Visit|7
62625|NCT01390857|250502|P1|Overall Study|Lost to Follow-up|1
62626|NCT01390857|250502|P1|Overall Study|Protocol Violation|2
62627|NCT01390844|250513|P4|Follow-Up Phase|Non-Medical Reasons|0
62628|NCT01390844|250514|P3|Follow-Up Phase|Non-Medical Reasons|1
62629|NCT01390844|250515|P2|Follow-Up Phase|Non-Medical Reasons|1
62630|NCT01390844|250516|P1|Follow-Up Phase|Non-Medical Reasons|1
62631|NCT01390844|250513|P4|Treatment Phase|Non-GCP Compliant|3
62632|NCT01390844|250514|P3|Treatment Phase|Non-GCP Compliant|10
62633|NCT01390844|250515|P2|Treatment Phase|Non-GCP Compliant|0
62634|NCT01390844|250516|P1|Treatment Phase|Non-GCP Compliant|0
62635|NCT01390844|250513|P4|Treatment Phase|Non-Medical Reasons|1
62636|NCT01390844|250514|P3|Treatment Phase|Non-Medical Reasons|8
62637|NCT01390844|250515|P2|Treatment Phase|Non-Medical Reasons|1
62638|NCT01390844|250516|P1|Treatment Phase|Non-Medical Reasons|5
62639|NCT01390844|250513|P4|Treatment Phase|Treatment Failure|13
62640|NCT01390844|250514|P3|Treatment Phase|Treatment Failure|10
62641|NCT01390844|250515|P2|Treatment Phase|Treatment Failure|25
62642|NCT01390844|250516|P1|Treatment Phase|Treatment Failure|23
62643|NCT01390844|250513|P4|Treatment Phase|Adverse Event|2
62644|NCT01390844|250514|P3|Treatment Phase|Adverse Event|3
62645|NCT01390844|250515|P2|Treatment Phase|Adverse Event|2
62646|NCT01390844|250516|P1|Treatment Phase|Adverse Event|12
62647|NCT01390779|250843|P1|Overall Study|Physician Decision|1
62648|NCT01390649|250848|P1|Overall Study|Physician Decision|1
62649|NCT01390441|250858|P5|Extension Period|Protocol Violation|0
62650|NCT01390441|250859|P4|Extension Period|Protocol Violation|1
62651|NCT01390441|250860|P3|Extension Period|Protocol Violation|0
62652|NCT01390441|250861|P2|Extension Period|Protocol Violation|1
62653|NCT01390441|250862|P1|Extension Period|Protocol Violation|3
62654|NCT01390441|250858|P5|Treatment Period|Lost to Follow-up|0
62655|NCT01390441|250859|P4|Treatment Period|Lost to Follow-up|0
62656|NCT01390441|250860|P3|Treatment Period|Lost to Follow-up|0
62657|NCT01390441|250861|P2|Treatment Period|Lost to Follow-up|0
62658|NCT01390441|250862|P1|Treatment Period|Lost to Follow-up|1
62659|NCT01390441|250858|P5|Treatment Period|Withdrawal by Subject|1
62660|NCT01390441|250859|P4|Treatment Period|Withdrawal by Subject|0
62661|NCT01390441|250860|P3|Treatment Period|Withdrawal by Subject|1
62662|NCT01390441|250861|P2|Treatment Period|Withdrawal by Subject|0
62663|NCT01390441|250862|P1|Treatment Period|Withdrawal by Subject|0
62664|NCT01390441|250858|P5|Treatment Period|Adverse Event|2
62665|NCT01390441|250859|P4|Treatment Period|Adverse Event|1
62666|NCT01390441|250860|P3|Treatment Period|Adverse Event|1
62667|NCT01390441|250861|P2|Treatment Period|Adverse Event|0
62668|NCT01390441|250862|P1|Treatment Period|Adverse Event|0
62669|NCT01390441|250858|P5|Treatment Period|Unknown due to early stopping of study|7
62670|NCT01390441|250859|P4|Treatment Period|Unknown due to early stopping of study|11
62671|NCT01390441|250860|P3|Treatment Period|Unknown due to early stopping of study|8
62672|NCT01390441|250861|P2|Treatment Period|Unknown due to early stopping of study|0
62673|NCT01390441|250862|P1|Treatment Period|Unknown due to early stopping of study|0
62674|NCT01390441|250858|P5|Treatment Period|Lack of Efficacy|1
62675|NCT01390441|250859|P4|Treatment Period|Lack of Efficacy|0
62676|NCT01390441|250860|P3|Treatment Period|Lack of Efficacy|0
62677|NCT01390441|250861|P2|Treatment Period|Lack of Efficacy|0
62678|NCT01390441|250862|P1|Treatment Period|Lack of Efficacy|0
62679|NCT01390441|250858|P5|Treatment Period|Physician Decision|0
62680|NCT01390441|250859|P4|Treatment Period|Physician Decision|1
62681|NCT01390441|250860|P3|Treatment Period|Physician Decision|0
62682|NCT01390441|250861|P2|Treatment Period|Physician Decision|0
62683|NCT01390441|250862|P1|Treatment Period|Physician Decision|0
62684|NCT01390441|250858|P5|Treatment Period|Protocol Violation|0
62685|NCT01390441|250859|P4|Treatment Period|Protocol Violation|0
62686|NCT01390441|250860|P3|Treatment Period|Protocol Violation|0
62687|NCT01390441|250861|P2|Treatment Period|Protocol Violation|1
62688|NCT01390441|250862|P1|Treatment Period|Protocol Violation|0
62689|NCT01390428|250927|P6|Overall Study|Withdrawal by Subject|0
62690|NCT01390428|250928|P5|Overall Study|Withdrawal by Subject|0
62691|NCT01390428|250929|P4|Overall Study|Withdrawal by Subject|0
62692|NCT01390428|250930|P3|Overall Study|Withdrawal by Subject|1
62693|NCT01390428|250931|P2|Overall Study|Withdrawal by Subject|0
62694|NCT01390428|250932|P1|Overall Study|Withdrawal by Subject|0
62695|NCT01390428|250927|P6|Overall Study|Elective Surgery|0
62696|NCT01390428|250928|P5|Overall Study|Elective Surgery|1
62697|NCT01390428|250929|P4|Overall Study|Elective Surgery|0
62698|NCT01390428|250930|P3|Overall Study|Elective Surgery|0
62699|NCT01390428|250931|P2|Overall Study|Elective Surgery|0
62700|NCT01390428|250932|P1|Overall Study|Elective Surgery|0
62701|NCT01390402|250995|P1|Overall Study|Disease Progression|4
62702|NCT01390402|250995|P1|Overall Study|Death|1
62703|NCT01390389|251001|P2|Overall Study|Screen Fail|1
62704|NCT01390389|251002|P1|Overall Study|Screen Fail|2
62705|NCT01390389|251001|P2|Overall Study|Withdrawal by Subject|0
62706|NCT01390389|251002|P1|Overall Study|Withdrawal by Subject|2
62707|NCT01390181|251050|P1|Overall Study|Study Terminated due to Low Accrual|3
62708|NCT01390181|251050|P1|Overall Study|Lost to Follow-up|1
62709|NCT01390038|251054|P1|Overall Study|Simpliciti System Removal|2
62710|NCT01390038|251054|P1|Overall Study|Withdrawal by Subject|4
62711|NCT01390038|251054|P1|Overall Study|Lost to Follow-up|1
62712|NCT01390038|251054|P1|Overall Study|Death|1
62713|NCT01389973|251064|P1|Overall Study|Other|10
62714|NCT01389973|251064|P1|Overall Study|Trial Stopped by Sponsor|9
62715|NCT01389973|251064|P1|Overall Study|Lost to Follow-up|1
62716|NCT01389882|251074|P2|Overall Study|Withdrawal by Subject|1
62717|NCT01389882|251075|P1|Overall Study|Withdrawal by Subject|0
62718|NCT01389882|251074|P2|Overall Study|Respiratory rate > 80/min during study|3
62719|NCT01389882|251075|P1|Overall Study|Respiratory rate > 80/min during study|1
62720|NCT01389817|251163|P2|Overall Study|Withdrawal by Subject|0
62721|NCT01389817|251164|P1|Overall Study|Withdrawal by Subject|2
62722|NCT01389817|251163|P2|Overall Study|Lost to Follow-up|0
62723|NCT01389817|251164|P1|Overall Study|Lost to Follow-up|1
62724|NCT01389817|251163|P2|Overall Study|Physician Decision|0
62725|NCT01389817|251164|P1|Overall Study|Physician Decision|1
62726|NCT01389596|251173|P3|Overall Study|Other Unspecified|0
62727|NCT01389596|251174|P2|Overall Study|Other Unspecified|1
62728|NCT01389596|251175|P1|Overall Study|Other Unspecified|2
62729|NCT01389596|251173|P3|Overall Study|Death|0
62730|NCT01389596|251174|P2|Overall Study|Death|1
62731|NCT01389596|251175|P1|Overall Study|Death|0
62732|NCT01389596|251173|P3|Overall Study|Adverse Event|0
62733|NCT01389596|251174|P2|Overall Study|Adverse Event|4
62734|NCT01389596|251175|P1|Overall Study|Adverse Event|1
62735|NCT01389596|251173|P3|Overall Study|Insufficient Clinical Response|5
62736|NCT01389596|251174|P2|Overall Study|Insufficient Clinical Response|4
62737|NCT01389596|251175|P1|Overall Study|Insufficient Clinical Response|3
62738|NCT01389596|251173|P3|Overall Study|Withdrawal by Subject|2
62739|NCT01389596|251174|P2|Overall Study|Withdrawal by Subject|2
62740|NCT01389596|251175|P1|Overall Study|Withdrawal by Subject|1
62741|NCT01389596|251173|P3|Overall Study|Protocol Violation|3
62742|NCT01389596|251174|P2|Overall Study|Protocol Violation|4
62743|NCT01389596|251175|P1|Overall Study|Protocol Violation|3
62744|NCT01389323|251234|P1|Follow-up Period (up to 48 Weeks)|Other|3
62745|NCT01389323|251234|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
62746|NCT01389323|251234|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
62747|NCT01389323|251234|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
62748|NCT01389323|251234|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
62749|NCT01389323|251234|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
62750|NCT01389323|251234|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
62751|NCT01389323|251234|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
62752|NCT01389323|251234|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
62753|NCT01389323|251234|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
62754|NCT01389323|251234|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
62755|NCT01389102|251297|P6|Overall Study|Investigator Judgement|0
62756|NCT01389102|251298|P5|Overall Study|Investigator Judgement|0
62757|NCT01389102|251299|P4|Overall Study|Investigator Judgement|0
62758|NCT01389102|251300|P3|Overall Study|Investigator Judgement|0
62759|NCT01389102|251301|P2|Overall Study|Investigator Judgement|1
62760|NCT01389102|251302|P1|Overall Study|Investigator Judgement|0
62761|NCT01389102|251297|P6|Overall Study|Unavailable due to husband's illness|0
62762|NCT01389102|251298|P5|Overall Study|Unavailable due to husband's illness|0
62763|NCT01389102|251299|P4|Overall Study|Unavailable due to husband's illness|0
62764|NCT01389102|251300|P3|Overall Study|Unavailable due to husband's illness|0
62765|NCT01389102|251301|P2|Overall Study|Unavailable due to husband's illness|1
62766|NCT01389102|251302|P1|Overall Study|Unavailable due to husband's illness|0
62767|NCT01389102|251297|P6|Overall Study|Subject Moved|0
62768|NCT01389102|251298|P5|Overall Study|Subject Moved|0
62769|NCT01389102|251299|P4|Overall Study|Subject Moved|0
62770|NCT01389102|251300|P3|Overall Study|Subject Moved|1
62771|NCT01389102|251301|P2|Overall Study|Subject Moved|0
62772|NCT01389102|251302|P1|Overall Study|Subject Moved|2
62773|NCT01389102|251297|P6|Overall Study|Subject Traveling Out of Country|0
62774|NCT01389102|251298|P5|Overall Study|Subject Traveling Out of Country|0
62775|NCT01389102|251299|P4|Overall Study|Subject Traveling Out of Country|1
62776|NCT01389102|251300|P3|Overall Study|Subject Traveling Out of Country|0
62777|NCT01389102|251301|P2|Overall Study|Subject Traveling Out of Country|0
62778|NCT01389102|251302|P1|Overall Study|Subject Traveling Out of Country|0
62779|NCT01389102|251297|P6|Overall Study|Withdrawal by Subject|3
62780|NCT01389102|251298|P5|Overall Study|Withdrawal by Subject|3
62781|NCT01389102|251299|P4|Overall Study|Withdrawal by Subject|2
62782|NCT01389102|251300|P3|Overall Study|Withdrawal by Subject|9
62783|NCT01389102|251301|P2|Overall Study|Withdrawal by Subject|4
62784|NCT01389102|251302|P1|Overall Study|Withdrawal by Subject|7
62785|NCT01389102|251297|P6|Overall Study|Protocol Violation|1
62786|NCT01389102|251298|P5|Overall Study|Protocol Violation|1
62787|NCT01389102|251299|P4|Overall Study|Protocol Violation|0
62788|NCT01389102|251300|P3|Overall Study|Protocol Violation|3
62789|NCT01389102|251301|P2|Overall Study|Protocol Violation|0
62790|NCT01389102|251302|P1|Overall Study|Protocol Violation|0
62791|NCT01389102|251297|P6|Overall Study|Lost to Follow-up|1
62792|NCT01389102|251298|P5|Overall Study|Lost to Follow-up|4
62793|NCT01389102|251299|P4|Overall Study|Lost to Follow-up|2
62794|NCT01389102|251300|P3|Overall Study|Lost to Follow-up|1
62795|NCT01389102|251301|P2|Overall Study|Lost to Follow-up|1
62796|NCT01389102|251302|P1|Overall Study|Lost to Follow-up|4
62797|NCT01389102|251297|P6|Overall Study|Hurricane Katrina|1
62798|NCT01389102|251298|P5|Overall Study|Hurricane Katrina|3
62799|NCT01389102|251299|P4|Overall Study|Hurricane Katrina|0
62800|NCT01389102|251300|P3|Overall Study|Hurricane Katrina|3
62801|NCT01389102|251301|P2|Overall Study|Hurricane Katrina|2
62802|NCT01389102|251302|P1|Overall Study|Hurricane Katrina|4
62803|NCT01389102|251297|P6|Overall Study|Adverse Event|2
62804|NCT01389102|251298|P5|Overall Study|Adverse Event|2
62805|NCT01389102|251299|P4|Overall Study|Adverse Event|2
62806|NCT01389102|251300|P3|Overall Study|Adverse Event|2
62807|NCT01389102|251301|P2|Overall Study|Adverse Event|3
62808|NCT01389102|251302|P1|Overall Study|Adverse Event|1
62809|NCT01388907|251380|P2|Overall Study|Adverse Event|0
62810|NCT01388907|251381|P1|Overall Study|Adverse Event|2
62811|NCT01388816|251397|P4|Overall Study|Protocol Violation|0
62812|NCT01388816|251398|P3|Overall Study|Protocol Violation|2
62813|NCT01388816|251399|P2|Overall Study|Protocol Violation|0
62814|NCT01388816|251400|P1|Overall Study|Protocol Violation|0
62815|NCT01388816|251397|P4|Overall Study|Withdrawal by Subject|0
62816|NCT01388816|251398|P3|Overall Study|Withdrawal by Subject|1
62817|NCT01388816|251399|P2|Overall Study|Withdrawal by Subject|1
62818|NCT01388816|251400|P1|Overall Study|Withdrawal by Subject|2
62819|NCT01388816|251397|P4|Overall Study|Lost to Follow-up|0
62820|NCT01388816|251398|P3|Overall Study|Lost to Follow-up|0
62821|NCT01388816|251399|P2|Overall Study|Lost to Follow-up|1
62822|NCT01388816|251400|P1|Overall Study|Lost to Follow-up|0
62823|NCT01388816|251397|P4|Overall Study|Adverse Event|0
62824|NCT01388816|251398|P3|Overall Study|Adverse Event|0
62825|NCT01388816|251399|P2|Overall Study|Adverse Event|2
62826|NCT01388816|251400|P1|Overall Study|Adverse Event|0
62827|NCT01388790|251429|P1|Overall Study|Ongoing at data cut−off date|8
62828|NCT01388647|251436|P2|Overall Study|Adverse Event|2
62829|NCT01388647|251437|P1|Overall Study|Adverse Event|1
62830|NCT01388530|251448|P1|Overall Study|Lost to Follow-up|5
62831|NCT01388491|251457|P2|Overall Study|Pregnancy|0
62832|NCT01388491|251458|P1|Overall Study|Pregnancy|1
62833|NCT01388491|251457|P2|Overall Study|Noncompliance|0
62834|NCT01388491|251458|P1|Overall Study|Noncompliance|2
62835|NCT01388491|251457|P2|Overall Study|Protocol Violation|0
62836|NCT01388491|251458|P1|Overall Study|Protocol Violation|2
62837|NCT01388491|251457|P2|Overall Study|Lost to Follow-up|3
62838|NCT01388491|251458|P1|Overall Study|Lost to Follow-up|4
62839|NCT01388491|251457|P2|Overall Study|Withdrawal by Subject|10
62840|NCT01388491|251458|P1|Overall Study|Withdrawal by Subject|6
62841|NCT01388491|251457|P2|Overall Study|Sponsor Request|7
62842|NCT01388491|251458|P1|Overall Study|Sponsor Request|9
62843|NCT01388491|251457|P2|Overall Study|Adverse Event|9
62844|NCT01388491|251458|P1|Overall Study|Adverse Event|10
62845|NCT01388361|251493|P3|Overall Study|Unclassified|1
62846|NCT01388361|251494|P2|Overall Study|Unclassified|0
62847|NCT01388361|251495|P1|Overall Study|Unclassified|0
62848|NCT01388361|251493|P3|Overall Study|Withdrawal criteria|10
62849|NCT01388361|251494|P2|Overall Study|Withdrawal criteria|7
62850|NCT01388361|251495|P1|Overall Study|Withdrawal criteria|12
62851|NCT01388361|251493|P3|Overall Study|Protocol Violation|2
62852|NCT01388361|251494|P2|Overall Study|Protocol Violation|0
62853|NCT01388361|251495|P1|Overall Study|Protocol Violation|0
62854|NCT01388361|251493|P3|Overall Study|Adverse Event|1
62855|NCT01388361|251494|P2|Overall Study|Adverse Event|5
62856|NCT01388361|251495|P1|Overall Study|Adverse Event|0
62857|NCT01388166|251512|P1|Overall Study|Others than specified above|13
62858|NCT01388166|251512|P1|Overall Study|Lost to Follow-up|30
62859|NCT01388166|251512|P1|Overall Study|Adverse Event|16
62860|NCT01387789|251518|P1|Overall Study|Lost to Follow-up|1
62861|NCT01387789|251518|P1|Overall Study|Lack of Efficacy|2
62862|NCT01387789|251518|P1|Overall Study|Adverse Event|5
62863|NCT01387737|251532|P2|Overall Study|Clearly not eligible for the study|3
62864|NCT01387737|251533|P1|Overall Study|Clearly not eligible for the study|1
62865|NCT01387737|251532|P2|Overall Study|Withdrawal by Subject|31
62866|NCT01387737|251533|P1|Overall Study|Withdrawal by Subject|27
62867|NCT01387737|251532|P2|Overall Study|Physician Decision|10
62868|NCT01387737|251533|P1|Overall Study|Physician Decision|3
62869|NCT01387737|251532|P2|Overall Study|Lack of Efficacy|0
62870|NCT01387737|251533|P1|Overall Study|Lack of Efficacy|1
62871|NCT01387737|251532|P2|Overall Study|Adverse Event|30
62872|NCT01387737|251533|P1|Overall Study|Adverse Event|20
62873|NCT01387594|251567|P2|Overall Study|Lost to Follow-up|1
62874|NCT01387594|251568|P1|Overall Study|Lost to Follow-up|0
62875|NCT01387594|251567|P2|Overall Study|Withdrawal by Subject|2
62876|NCT01387594|251568|P1|Overall Study|Withdrawal by Subject|0
62877|NCT01387542|251596|P1|Overall Study|Lost to Follow-up|1
62878|NCT01387542|251596|P1|Overall Study|Non-compliant|1
62879|NCT01387542|251596|P1|Overall Study|Insufficient response|1
62880|NCT01387542|251596|P1|Overall Study|Changed diagnosis|1
62881|NCT01387542|251596|P1|Overall Study|Withdrawal by Subject|1
62882|NCT01387542|251596|P1|Overall Study|Adverse Event|3
62883|NCT01387347|251614|P2|Overall Study|Lost to Follow-up|1
62884|NCT01387347|251615|P1|Overall Study|Lost to Follow-up|2
62885|NCT01387282|251627|P2|Overall Study|Lost to Follow-up|1
62886|NCT01387282|251628|P1|Overall Study|Lost to Follow-up|4
62887|NCT01387282|251627|P2|Overall Study|Study drug-related AE|2
62888|NCT01387282|251628|P1|Overall Study|Study drug-related AE|2
62889|NCT01387282|251627|P2|Overall Study|Withdrawal by patient|23
62890|NCT01387282|251628|P1|Overall Study|Withdrawal by patient|33
62891|NCT01387282|251627|P2|Overall Study|Unrelated AE|4
62892|NCT01387282|251628|P1|Overall Study|Unrelated AE|6
62893|NCT01387282|251627|P2|Overall Study|Other|1
62894|NCT01387282|251628|P1|Overall Study|Other|5
62895|NCT01387282|251627|P2|Overall Study|Death|16
62896|NCT01387282|251628|P1|Overall Study|Death|47
62897|NCT01387269|251644|P2|Overall Study|Lost to Follow-up|0
62898|NCT01387269|251645|P1|Overall Study|Lost to Follow-up|1
62899|NCT01387269|251644|P2|Overall Study|Study drug-related AE|0
62900|NCT01387269|251645|P1|Overall Study|Study drug-related AE|1
62901|NCT01387269|251644|P2|Overall Study|Withdrawal by patient|10
62902|NCT01387269|251645|P1|Overall Study|Withdrawal by patient|32
62903|NCT01387269|251644|P2|Overall Study|Unrelated AE|3
62904|NCT01387269|251645|P1|Overall Study|Unrelated AE|12
62905|NCT01387269|251644|P2|Overall Study|Other|7
62906|NCT01387269|251645|P1|Overall Study|Other|8
62907|NCT01387269|251644|P2|Overall Study|Death|20
62908|NCT01387269|251645|P1|Overall Study|Death|38
62909|NCT01387230|251662|P3|Overall Study|Withdrawal by Subject|0
62910|NCT01387230|251663|P2|Overall Study|Withdrawal by Subject|1
62911|NCT01387230|251664|P1|Overall Study|Withdrawal by Subject|4
62912|NCT01387230|251662|P3|Overall Study|Lost to Follow-up|1
62913|NCT01387230|251663|P2|Overall Study|Lost to Follow-up|0
62914|NCT01387230|251664|P1|Overall Study|Lost to Follow-up|0
62915|NCT01387230|251662|P3|Overall Study|Protocol-defined Stopping Criteria|5
62916|NCT01387230|251663|P2|Overall Study|Protocol-defined Stopping Criteria|0
62917|NCT01387230|251664|P1|Overall Study|Protocol-defined Stopping Criteria|6
62918|NCT01387230|251662|P3|Overall Study|Lack of Efficacy|4
62919|NCT01387230|251663|P2|Overall Study|Lack of Efficacy|5
62920|NCT01387230|251664|P1|Overall Study|Lack of Efficacy|8
62921|NCT01387230|251662|P3|Overall Study|Adverse Event|3
62922|NCT01387230|251663|P2|Overall Study|Adverse Event|1
62923|NCT01387230|251664|P1|Overall Study|Adverse Event|0
62924|NCT01387074|251710|P1|Overall Study|Lack of Efficacy|1
62925|NCT01387074|251710|P1|Overall Study|Lost to Follow-up|7
62926|NCT01387022|251723|P2|Overall Study|Lost to Follow-up|3
62927|NCT01387022|251724|P1|Overall Study|Lost to Follow-up|0
62928|NCT01387022|251723|P2|Overall Study|Death|1
62929|NCT01387022|251724|P1|Overall Study|Death|1
62930|NCT01386944|251751|P1|Overall Study|Unspecified reason|8
62931|NCT01386944|251751|P1|Overall Study|Lost to Follow-up|8
62932|NCT01386944|251751|P1|Overall Study|Lack of Efficacy|14
62933|NCT01386944|251751|P1|Overall Study|Adverse Event|26
62934|NCT01386788|251761|P1|Overall Study|Lost to Follow-up|2
62935|NCT01386684|251766|P1|Overall Study|Missing|3
62936|NCT01386684|251766|P1|Overall Study|Protocol Violation|4
62937|NCT01386684|251766|P1|Overall Study|Noncompliance|8
62938|NCT01386684|251766|P1|Overall Study|Adverse Event|20
62939|NCT01386684|251766|P1|Overall Study|Disease Progression|28
62940|NCT01386684|251766|P1|Overall Study|Alternative Therapy Required|37
62941|NCT01386684|251766|P1|Overall Study|Withdrawal of Consent|44
62942|NCT01386684|251766|P1|Overall Study|Death|47
62943|NCT01386684|251766|P1|Overall Study|Not Specified|51
62944|NCT01386684|251766|P1|Overall Study|Lost to Follow-up|51
62945|NCT01386606|251820|P4|Overall Study|T levels too high|0
62946|NCT01386606|251821|P3|Overall Study|T levels too high|1
62947|NCT01386606|251822|P2|Overall Study|T levels too high|1
62948|NCT01386606|251823|P1|Overall Study|T levels too high|0
62949|NCT01386606|251820|P4|Overall Study|Unable to draw PK|0
62950|NCT01386606|251821|P3|Overall Study|Unable to draw PK|0
62951|NCT01386606|251822|P2|Overall Study|Unable to draw PK|0
62952|NCT01386606|251823|P1|Overall Study|Unable to draw PK|1
62953|NCT01386606|251820|P4|Overall Study|Subject incarcerated|0
62954|NCT01386606|251821|P3|Overall Study|Subject incarcerated|0
62955|NCT01386606|251822|P2|Overall Study|Subject incarcerated|1
62956|NCT01386606|251823|P1|Overall Study|Subject incarcerated|0
62957|NCT01386606|251820|P4|Overall Study|Lost to Follow-up|0
62958|NCT01386606|251821|P3|Overall Study|Lost to Follow-up|0
62959|NCT01386606|251822|P2|Overall Study|Lost to Follow-up|0
62960|NCT01386606|251823|P1|Overall Study|Lost to Follow-up|2
62961|NCT01386606|251820|P4|Overall Study|Protocol Violation|1
62962|NCT01386606|251821|P3|Overall Study|Protocol Violation|1
62963|NCT01386606|251822|P2|Overall Study|Protocol Violation|0
62964|NCT01386606|251823|P1|Overall Study|Protocol Violation|1
62965|NCT01386606|251820|P4|Overall Study|Withdrawal by Subject|0
62966|NCT01386606|251821|P3|Overall Study|Withdrawal by Subject|1
62967|NCT01386606|251822|P2|Overall Study|Withdrawal by Subject|1
62968|NCT01386606|251823|P1|Overall Study|Withdrawal by Subject|0
62969|NCT01386606|251820|P4|Overall Study|Adverse Event|0
62970|NCT01386606|251821|P3|Overall Study|Adverse Event|0
62971|NCT01386606|251822|P2|Overall Study|Adverse Event|1
62972|NCT01386606|251823|P1|Overall Study|Adverse Event|0
62973|NCT01386125|251882|P2|Overall Study|Participant Leaving Country|0
62974|NCT01386125|251883|P1|Overall Study|Participant Leaving Country|1
62975|NCT01386125|251882|P2|Overall Study|Lack of Efficacy|1
62976|NCT01386125|251883|P1|Overall Study|Lack of Efficacy|0
62977|NCT01386125|251882|P2|Overall Study|Adverse Event|5
62978|NCT01386125|251883|P1|Overall Study|Adverse Event|2
62979|NCT01386125|251882|P2|Overall Study|Withdrawal by Subject|12
62980|NCT01386125|251883|P1|Overall Study|Withdrawal by Subject|13
62981|NCT01386125|251882|P2|Overall Study|Disease Progress|2
62982|NCT01386125|251883|P1|Overall Study|Disease Progress|1
62983|NCT01386125|251882|P2|Overall Study|Protocol Violation|7
62984|NCT01386125|251883|P1|Overall Study|Protocol Violation|5
62985|NCT01386125|251882|P2|Overall Study|Physician Decision|1
62986|NCT01386125|251883|P1|Overall Study|Physician Decision|0
62987|NCT01386125|251882|P2|Overall Study|Lost to Follow-up|9
62988|NCT01386125|251883|P1|Overall Study|Lost to Follow-up|3
62989|NCT01386008|251891|P1|Overall Study|Adverse Event|3
62990|NCT01386008|251891|P1|Overall Study|exited w/o incident /study discontinued|17
62991|NCT01385995|251900|P2|Period 1, 2 Months|Physician Decision|0
62992|NCT01385995|251901|P1|Period 1, 2 Months|Physician Decision|1
62993|NCT01385748|251918|P3|Overall Study|Adverse Event|1
62994|NCT01385748|251919|P2|Overall Study|Adverse Event|2
62995|NCT01385748|251920|P1|Overall Study|Adverse Event|4
62996|NCT01385748|251918|P3|Overall Study|Not specified|1
62997|NCT01385748|251919|P2|Overall Study|Not specified|7
62998|NCT01385748|251920|P1|Overall Study|Not specified|1
62999|NCT01385748|251918|P3|Overall Study|Noncompliance|6
63000|NCT01385748|251919|P2|Overall Study|Noncompliance|1
63001|NCT01385748|251920|P1|Overall Study|Noncompliance|3
63002|NCT01385748|251918|P3|Overall Study|Withdrawal by Subject|5
63003|NCT01385748|251919|P2|Overall Study|Withdrawal by Subject|4
63004|NCT01385748|251920|P1|Overall Study|Withdrawal by Subject|7
63005|NCT01385566|252005|P6|Overall Study|Withdrawal by Subject|0
63006|NCT01385566|252006|P5|Overall Study|Withdrawal by Subject|0
63007|NCT01385566|252007|P4|Overall Study|Withdrawal by Subject|1
63008|NCT01385566|252008|P3|Overall Study|Withdrawal by Subject|0
63009|NCT01385566|252009|P2|Overall Study|Withdrawal by Subject|0
63010|NCT01385566|252010|P1|Overall Study|Withdrawal by Subject|0
63011|NCT01385566|252005|P6|Overall Study|Lost to Follow-up|0
63012|NCT01385566|252006|P5|Overall Study|Lost to Follow-up|0
63013|NCT01385566|252007|P4|Overall Study|Lost to Follow-up|0
63014|NCT01385566|252008|P3|Overall Study|Lost to Follow-up|0
63015|NCT01385566|252009|P2|Overall Study|Lost to Follow-up|0
63016|NCT01385566|252010|P1|Overall Study|Lost to Follow-up|1
63017|NCT01385371|252064|P2|Overall Study|Administrative|2
63018|NCT01385371|252065|P1|Overall Study|Administrative|2
63019|NCT01385371|252064|P2|Overall Study|Protocol Violation|21
63020|NCT01385371|252065|P1|Overall Study|Protocol Violation|25
63021|NCT01385371|252064|P2|Overall Study|Withdrawal by Subject|39
63022|NCT01385371|252065|P1|Overall Study|Withdrawal by Subject|52
63023|NCT01385371|252064|P2|Overall Study|Lost to Follow-up|16
63024|NCT01385371|252065|P1|Overall Study|Lost to Follow-up|16
63025|NCT01385371|252064|P2|Overall Study|Adverse Event|19
63026|NCT01385371|252065|P1|Overall Study|Adverse Event|54
63027|NCT01385202|252095|P1|Overall Study|Withdrawn|1
63028|NCT01385202|252095|P1|Overall Study|Not Eligible|11
63029|NCT01385202|252095|P1|Overall Study|Lost to Follow-up|6
63030|NCT01385098|252147|P1|Overall Study|Lost to Follow-up|4
63031|NCT01385098|252147|P1|Overall Study|Adverse Event|10
63032|NCT01384760|252169|P2|Overall Study|Protocol Violation|0
63033|NCT01384760|252170|P1|Overall Study|Protocol Violation|16
63034|NCT01384760|252169|P2|Overall Study|Lost to Follow-up|6
63035|NCT01384760|252170|P1|Overall Study|Lost to Follow-up|0
63036|NCT01384292|252323|P3|Part B|Severe non-compliance to protocol|0
63037|NCT01384292|252324|P2|Part B|Severe non-compliance to protocol|0
63038|NCT01384292|252325|P1|Part B|Severe non-compliance to protocol|1
63039|NCT01384019|252337|P2|Overall Study|MRI refusal|6
63040|NCT01384019|252338|P1|Overall Study|MRI refusal|6
63041|NCT01384019|252337|P2|Overall Study|Death|0
63042|NCT01384019|252338|P1|Overall Study|Death|1
63043|NCT01384019|252337|P2|Overall Study|Withdrawal by Subject|0
63044|NCT01384019|252338|P1|Overall Study|Withdrawal by Subject|3
63045|NCT01383993|252347|P3|Overall Study|Marketed voriconazole in post-therapy|0
63046|NCT01383993|252348|P2|Overall Study|Marketed voriconazole in post-therapy|0
63047|NCT01383993|252349|P1|Overall Study|Marketed voriconazole in post-therapy|2
63048|NCT01383993|252347|P3|Overall Study|Withdrawal by Subject|1
63049|NCT01383993|252348|P2|Overall Study|Withdrawal by Subject|0
63050|NCT01383993|252349|P1|Overall Study|Withdrawal by Subject|0
63051|NCT01383993|252347|P3|Overall Study|Adverse Event|0
63052|NCT01383993|252348|P2|Overall Study|Adverse Event|1
63053|NCT01383993|252349|P1|Overall Study|Adverse Event|1
63054|NCT01383954|252396|P1|Overall Study|Reason Not Specified|9
63055|NCT01383954|252396|P1|Overall Study|Adverse Event|1
63056|NCT01383954|252396|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
63057|NCT01383954|252396|P1|Overall Study|Lack of Efficacy|2
63058|NCT01383928|252404|P3|Phase 2|Unsatisfactory therapeutic response|1
63059|NCT01383928|252405|P2|Phase 2|Unsatisfactory therapeutic response|0
63060|NCT01383928|252406|P1|Phase 2|Unsatisfactory therapeutic response|0
63061|NCT01383928|252404|P3|Phase 2|Withdrawal by Subject|4
63062|NCT01383928|252405|P2|Phase 2|Withdrawal by Subject|0
63063|NCT01383928|252406|P1|Phase 2|Withdrawal by Subject|0
63064|NCT01383928|252404|P3|Phase 2|Progressive Disease|5
63065|NCT01383928|252405|P2|Phase 2|Progressive Disease|0
63066|NCT01383928|252406|P1|Phase 2|Progressive Disease|0
63067|NCT01383928|252404|P3|Phase 2|Other|4
63068|NCT01383928|252405|P2|Phase 2|Other|0
63069|NCT01383928|252406|P1|Phase 2|Other|0
63070|NCT01383928|252404|P3|Phase 2|Adverse Event|8
63071|NCT01383928|252405|P2|Phase 2|Adverse Event|0
63072|NCT01383928|252406|P1|Phase 2|Adverse Event|0
63073|NCT01383928|252404|P3|Phase 2|Autologous Stem Cell Transplantation|18
63074|NCT01383928|252405|P2|Phase 2|Autologous Stem Cell Transplantation|0
63075|NCT01383928|252406|P1|Phase 2|Autologous Stem Cell Transplantation|0
63076|NCT01383928|252404|P3|Phase 1|Progressive Disease|0
63077|NCT01383928|252405|P2|Phase 1|Progressive Disease|1
63078|NCT01383928|252406|P1|Phase 1|Progressive Disease|1
63079|NCT01383928|252404|P3|Phase 1|Other|0
63080|NCT01383928|252405|P2|Phase 1|Other|3
63081|NCT01383928|252406|P1|Phase 1|Other|1
63082|NCT01383928|252404|P3|Phase 1|Adverse Event|0
63083|NCT01383928|252405|P2|Phase 1|Adverse Event|2
63084|NCT01383928|252406|P1|Phase 1|Adverse Event|1
63085|NCT01383928|252404|P3|Phase 1|Autologous Stem Cell Transplantation|0
63086|NCT01383928|252405|P2|Phase 1|Autologous Stem Cell Transplantation|1
63087|NCT01383928|252406|P1|Phase 1|Autologous Stem Cell Transplantation|2
63088|NCT01383707|252470|P1|Overall Study|Progressive disease|23
63089|NCT01383707|252470|P1|Overall Study|Adverse Event|14
63090|NCT01383707|252470|P1|Overall Study|Sponsor's decision|2
63091|NCT01383707|252470|P1|Overall Study|Not specified|8
63092|NCT01383707|252470|P1|Overall Study|Death|19
63093|NCT01383707|252470|P1|Overall Study|Consent withdrawal|6
63094|NCT01383499|252510|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
63095|NCT01383499|252511|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
63096|NCT01383499|252512|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
63097|NCT01383499|252513|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
63098|NCT01383486|252563|P1|Overall Study|Did not take any product|6
63099|NCT01383486|252563|P1|Overall Study|Incomplete information for analysis|2
63100|NCT01383486|252563|P1|Overall Study|Lost to Follow-up|10
63101|NCT01383356|252640|P2|Period 1|Personal|2
63102|NCT01383356|252641|P1|Period 1|Personal|0
63103|NCT01383356|252640|P2|Period 1|Out of Range Mid-study-Test|1
63104|NCT01383356|252641|P1|Period 1|Out of Range Mid-study-Test|0
63105|NCT01383356|252640|P2|Period 1|Non-compliance|0
63106|NCT01383356|252641|P1|Period 1|Non-compliance|3
63107|NCT01383356|252640|P2|Period 1|Adverse Event|3
63108|NCT01383356|252641|P1|Period 1|Adverse Event|5
63109|NCT01383317|252653|P2|Overall Study|Adverse Event|1
63110|NCT01383317|252654|P1|Overall Study|Adverse Event|0
63111|NCT01383317|252653|P2|Overall Study|Death|0
63112|NCT01383317|252654|P1|Overall Study|Death|1
63113|NCT01383317|252653|P2|Overall Study|Lost to Follow-up|1
63114|NCT01383317|252654|P1|Overall Study|Lost to Follow-up|2
63115|NCT01383174|252696|P2|6 Month Assessment|Refused to complete|0
63116|NCT01383174|252697|P1|6 Month Assessment|Refused to complete|4
63117|NCT01383174|252696|P2|6 Month Assessment|Lost to Follow-up|1
63118|NCT01383174|252697|P1|6 Month Assessment|Lost to Follow-up|1
63119|NCT01383174|252696|P2|3 Month Assessment|Refused to complete|0
63120|NCT01383174|252697|P1|3 Month Assessment|Refused to complete|4
63121|NCT01383174|252696|P2|3 Month Assessment|Lost to Follow-up|0
63122|NCT01383174|252697|P1|3 Month Assessment|Lost to Follow-up|2
63123|NCT01383174|252696|P2|3 Month Assessment|Death|1
63124|NCT01383174|252697|P1|3 Month Assessment|Death|0
63125|NCT01383161|252723|P2|Overall Study|Lack of Efficacy|1
63126|NCT01383161|252724|P1|Overall Study|Lack of Efficacy|0
63127|NCT01383161|252723|P2|Overall Study|Withdrawal by Subject|2
63128|NCT01383161|252724|P1|Overall Study|Withdrawal by Subject|0
63129|NCT01383161|252723|P2|Overall Study|Adverse Event|1
63130|NCT01383161|252724|P1|Overall Study|Adverse Event|5
63131|NCT01383096|252743|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
63132|NCT01383096|252744|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
63133|NCT01383096|252745|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
63134|NCT01383096|252743|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
63135|NCT01383096|252744|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
63136|NCT01383096|252745|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
63137|NCT01383096|252743|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
63138|NCT01383096|252744|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
63139|NCT01383096|252745|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
63140|NCT01383096|252743|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
63141|NCT01383096|252744|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
63142|NCT01383096|252745|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
63143|NCT01383096|252743|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
63144|NCT01383096|252744|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
63145|NCT01383096|252745|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
63146|NCT01383096|252743|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
63147|NCT01383096|252744|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
63148|NCT01383096|252745|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
63149|NCT01383096|252743|P3|Third Intervention (8 Days)|Adverse Event|0
63150|NCT01383096|252744|P2|Third Intervention (8 Days)|Adverse Event|0
63151|NCT01383096|252745|P1|Third Intervention (8 Days)|Adverse Event|1
63152|NCT01383096|252743|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
63153|NCT01383096|252744|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
63154|NCT01383096|252745|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
63155|NCT01383096|252743|P3|Third Intervention (8 Days)|Elevated AST|0
63156|NCT01383096|252744|P2|Third Intervention (8 Days)|Elevated AST|1
63157|NCT01383096|252745|P1|Third Intervention (8 Days)|Elevated AST|0
63158|NCT01383096|252743|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
63159|NCT01383096|252744|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
63160|NCT01383096|252745|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
63161|NCT01383096|252743|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
63162|NCT01383096|252744|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
63163|NCT01383096|252745|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
63164|NCT01382940|252813|P1|Overall Study|Protocol Violation|20
63165|NCT01382940|252813|P1|Overall Study|Withdrawal by Subject|23
63166|NCT01382940|252813|P1|Overall Study|Physician Decision|7
63167|NCT01382940|252813|P1|Overall Study|Lost to Follow-up|4
63168|NCT01382940|252813|P1|Overall Study|Adverse Event|19
63169|NCT01382602|252875|P2|Overall Study|Withdrawal by Subject|1
63170|NCT01382602|252876|P1|Overall Study|Withdrawal by Subject|0
63171|NCT01382602|252875|P2|Overall Study|Protocol Violation|3
63172|NCT01382602|252876|P1|Overall Study|Protocol Violation|0
63173|NCT01382446|252884|P2|Overall Study|Removal from Mechanical Ventilation|3
63174|NCT01382446|252885|P1|Overall Study|Removal from Mechanical Ventilation|3
63175|NCT01382446|252884|P2|Overall Study|Withdrawal by Subject|1
63176|NCT01382446|252885|P1|Overall Study|Withdrawal by Subject|0
63177|NCT01382251|252912|P2|Overall Study|Contacted after study closed|1
63178|NCT01382251|252913|P1|Overall Study|Contacted after study closed|1
63179|NCT01382251|252912|P2|Overall Study|Lost to Follow-up|4
63180|NCT01382251|252913|P1|Overall Study|Lost to Follow-up|4
63181|NCT01382251|252912|P2|Overall Study|Surgeries cancelled or delayed|16
63182|NCT01382251|252913|P1|Overall Study|Surgeries cancelled or delayed|16
63183|NCT01382225|252926|P2|Overall Study|Other|2
63184|NCT01382225|252927|P1|Overall Study|Other|4
63185|NCT01382225|252926|P2|Overall Study|Subject Withdrew Consent|2
63186|NCT01382225|252927|P1|Overall Study|Subject Withdrew Consent|5
63187|NCT01382225|252926|P2|Overall Study|Protocol Violation|1
63188|NCT01382225|252927|P1|Overall Study|Protocol Violation|2
63189|NCT01382225|252926|P2|Overall Study|Adverse Event|2
63190|NCT01382225|252927|P1|Overall Study|Adverse Event|3
63191|NCT01382212|252949|P1|Overall Study|Withdrew consent|1
63192|NCT01382212|252949|P1|Overall Study|Kidney transplant|1
63193|NCT01381926|253012|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
63194|NCT01381926|253013|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
63195|NCT01381926|253012|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
63196|NCT01381926|253013|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
63197|NCT01381900|253026|P3|Overall Study|Early withdraw|1
63198|NCT01381900|253027|P2|Overall Study|Early withdraw|1
63199|NCT01381900|253028|P1|Overall Study|Early withdraw|3
63200|NCT01381900|253026|P3|Overall Study|Withdrawal by Subject|1
63201|NCT01381900|253027|P2|Overall Study|Withdrawal by Subject|0
63202|NCT01381900|253028|P1|Overall Study|Withdrawal by Subject|0
63203|NCT01381900|253026|P3|Overall Study|Protocol Violation|1
63204|NCT01381900|253027|P2|Overall Study|Protocol Violation|1
63205|NCT01381900|253028|P1|Overall Study|Protocol Violation|0
63206|NCT01381900|253026|P3|Overall Study|Physician Decision|1
63207|NCT01381900|253027|P2|Overall Study|Physician Decision|1
63208|NCT01381900|253028|P1|Overall Study|Physician Decision|0
63209|NCT01381900|253026|P3|Overall Study|Noncompliance with study drug|1
63210|NCT01381900|253027|P2|Overall Study|Noncompliance with study drug|0
63211|NCT01381900|253028|P1|Overall Study|Noncompliance with study drug|0
63212|NCT01381900|253026|P3|Overall Study|Adverse Event|7
63213|NCT01381900|253027|P2|Overall Study|Adverse Event|6
63214|NCT01381900|253028|P1|Overall Study|Adverse Event|4
63215|NCT01381900|253026|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
63216|NCT01381900|253027|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
63217|NCT01381900|253028|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
63218|NCT01381679|253048|P1|Overall Study|Lost to Follow-up|885
63219|NCT01381679|253048|P1|Overall Study|Adverse Event|3
63220|NCT01381575|253063|P3|Overall Study|Withdrawal by Subject|4
63221|NCT01381575|253064|P2|Overall Study|Withdrawal by Subject|0
63222|NCT01381575|253065|P1|Overall Study|Withdrawal by Subject|0
63223|NCT01381575|253063|P3|Overall Study|Protocol Violation|1
63224|NCT01381575|253064|P2|Overall Study|Protocol Violation|0
63225|NCT01381575|253065|P1|Overall Study|Protocol Violation|0
63226|NCT01381575|253063|P3|Overall Study|Lost to Follow-up|1
63227|NCT01381575|253064|P2|Overall Study|Lost to Follow-up|0
63228|NCT01381575|253065|P1|Overall Study|Lost to Follow-up|0
63229|NCT01381575|253063|P3|Overall Study|Adverse Event|1
63230|NCT01381575|253064|P2|Overall Study|Adverse Event|0
63231|NCT01381575|253065|P1|Overall Study|Adverse Event|0
63232|NCT01381575|253063|P3|Overall Study|Other|0
63233|NCT01381575|253064|P2|Overall Study|Other|10
63234|NCT01381575|253065|P1|Overall Study|Other|2
63235|NCT01381562|253122|P3|Overall Study|Adverse Event|0
63236|NCT01381562|253123|P2|Overall Study|Adverse Event|1
63237|NCT01381562|253124|P1|Overall Study|Adverse Event|0
63238|NCT01381549|253192|P3|Overall Study|Ineligible: No organisms isolated|1
63239|NCT01381549|253193|P2|Overall Study|Ineligible: No organisms isolated|0
63240|NCT01381549|253194|P1|Overall Study|Ineligible: No organisms isolated|0
63241|NCT01381016|253320|P2|Overall Study|Physician Decision|2
63242|NCT01381016|253321|P1|Overall Study|Physician Decision|0
63243|NCT01381016|253320|P2|Overall Study|Withdrawal by Subject|1
63244|NCT01381016|253321|P1|Overall Study|Withdrawal by Subject|0
63245|NCT01381016|253320|P2|Overall Study|Screen Failure|2
63246|NCT01381016|253321|P1|Overall Study|Screen Failure|2
63247|NCT01381016|253320|P2|Overall Study|Lost to Follow-up|1
63248|NCT01381016|253321|P1|Overall Study|Lost to Follow-up|1
63249|NCT01380834|253331|P2|Overall Study|Physician Decision|0
63250|NCT01380834|253332|P1|Overall Study|Physician Decision|1
63251|NCT01380782|253344|P4|Overall Study|Withdrawal by Subject|1
63252|NCT01380782|253345|P3|Overall Study|Withdrawal by Subject|1
63253|NCT01380782|253346|P2|Overall Study|Withdrawal by Subject|0
63254|NCT01380782|253347|P1|Overall Study|Withdrawal by Subject|0
63255|NCT01380782|253344|P4|Overall Study|Physician Decision|0
63256|NCT01380782|253345|P3|Overall Study|Physician Decision|0
63257|NCT01380782|253346|P2|Overall Study|Physician Decision|0
63258|NCT01380782|253347|P1|Overall Study|Physician Decision|1
63259|NCT01380782|253344|P4|Overall Study|Lack of Efficacy|3
63260|NCT01380782|253345|P3|Overall Study|Lack of Efficacy|10
63261|NCT01380782|253346|P2|Overall Study|Lack of Efficacy|9
63262|NCT01380782|253347|P1|Overall Study|Lack of Efficacy|10
63263|NCT01380782|253344|P4|Overall Study|Death|0
63264|NCT01380782|253345|P3|Overall Study|Death|0
63265|NCT01380782|253346|P2|Overall Study|Death|0
63266|NCT01380782|253347|P1|Overall Study|Death|1
63267|NCT01380782|253344|P4|Overall Study|Adverse Event|0
63268|NCT01380782|253345|P3|Overall Study|Adverse Event|0
63269|NCT01380782|253346|P2|Overall Study|Adverse Event|1
63270|NCT01380782|253347|P1|Overall Study|Adverse Event|0
63271|NCT01380769|253370|P2|Overall Study|Protocol Violation|1
63272|NCT01380769|253371|P1|Overall Study|Protocol Violation|0
63273|NCT01380769|253370|P2|Overall Study|Adverse Event|1
63274|NCT01380769|253371|P1|Overall Study|Adverse Event|1
63275|NCT01380769|253370|P2|Overall Study|Physician Decision|1
63276|NCT01380769|253371|P1|Overall Study|Physician Decision|1
63277|NCT01380769|253370|P2|Overall Study|Withdrawal by Subject|11
63278|NCT01380769|253371|P1|Overall Study|Withdrawal by Subject|7
63279|NCT01380730|253387|P8|Overall Study|Death|0
63280|NCT01380730|253388|P7|Overall Study|Death|0
63281|NCT01380730|253389|P6|Overall Study|Death|0
63282|NCT01380730|253390|P5|Overall Study|Death|1
63283|NCT01380730|253391|P4|Overall Study|Death|0
63284|NCT01380730|253392|P3|Overall Study|Death|0
63285|NCT01380730|253393|P2|Overall Study|Death|0
63286|NCT01380730|253394|P1|Overall Study|Death|0
63287|NCT01380379|253461|P1|Overall Study|Pregnancy|1
63288|NCT01380327|253474|P3|Overall Study|Questionable onset of epilepsy|1
63289|NCT01380327|253475|P2|Overall Study|Questionable onset of epilepsy|0
63290|NCT01380327|253476|P1|Overall Study|Questionable onset of epilepsy|0
63291|NCT01380327|253474|P3|Overall Study|Housing situation precluded ability to k|1
63292|NCT01380327|253475|P2|Overall Study|Housing situation precluded ability to k|0
63293|NCT01380327|253476|P1|Overall Study|Housing situation precluded ability to k|0
63294|NCT01380327|253474|P3|Overall Study|Withdrawal by Subject|1
63295|NCT01380327|253475|P2|Overall Study|Withdrawal by Subject|0
63296|NCT01380327|253476|P1|Overall Study|Withdrawal by Subject|0
63297|NCT01380327|253474|P3|Overall Study|Protocol Violation|3
63298|NCT01380327|253475|P2|Overall Study|Protocol Violation|2
63299|NCT01380327|253476|P1|Overall Study|Protocol Violation|3
63300|NCT01380327|253474|P3|Overall Study|Lost to Follow-up|1
63301|NCT01380327|253475|P2|Overall Study|Lost to Follow-up|1
63302|NCT01380327|253476|P1|Overall Study|Lost to Follow-up|0
63303|NCT01380145|253507|P1|Overall Study|Progressive disease|4
63304|NCT01380093|253515|P9|Treatment Phase: Third Intervention|Other|1
63305|NCT01380093|253516|P8|Treatment Phase: Third Intervention|Other|0
63306|NCT01380093|253517|P7|Treatment Phase: Third Intervention|Other|0
63307|NCT01380093|253518|P6|Treatment Phase: Third Intervention|Other|0
63308|NCT01380093|253519|P5|Treatment Phase: Third Intervention|Other|0
63309|NCT01380093|253520|P4|Treatment Phase: Third Intervention|Other|0
63310|NCT01380093|253521|P3|Treatment Phase: Third Intervention|Other|0
63311|NCT01380093|253522|P2|Treatment Phase: Third Intervention|Other|0
63312|NCT01380093|253523|P1|Treatment Phase: Third Intervention|Other|0
63313|NCT01380093|253515|P9|Treatment Phase: Third Intervention|Non-compliance|1
63314|NCT01380093|253516|P8|Treatment Phase: Third Intervention|Non-compliance|0
63315|NCT01380093|253517|P7|Treatment Phase: Third Intervention|Non-compliance|0
63316|NCT01380093|253518|P6|Treatment Phase: Third Intervention|Non-compliance|0
63317|NCT01380093|253519|P5|Treatment Phase: Third Intervention|Non-compliance|0
63318|NCT01380093|253520|P4|Treatment Phase: Third Intervention|Non-compliance|0
63319|NCT01380093|253521|P3|Treatment Phase: Third Intervention|Non-compliance|0
63320|NCT01380093|253522|P2|Treatment Phase: Third Intervention|Non-compliance|0
63321|NCT01380093|253523|P1|Treatment Phase: Third Intervention|Non-compliance|0
63322|NCT01380093|253515|P9|Treatment Phase: Second Intervention|Other|0
63323|NCT01380093|253516|P8|Treatment Phase: Second Intervention|Other|0
63324|NCT01380093|253517|P7|Treatment Phase: Second Intervention|Other|0
63325|NCT01380093|253518|P6|Treatment Phase: Second Intervention|Other|0
63326|NCT01380093|253519|P5|Treatment Phase: Second Intervention|Other|0
63327|NCT01380093|253520|P4|Treatment Phase: Second Intervention|Other|1
63328|NCT01380093|253521|P3|Treatment Phase: Second Intervention|Other|0
63329|NCT01380093|253522|P2|Treatment Phase: Second Intervention|Other|0
63330|NCT01380093|253523|P1|Treatment Phase: Second Intervention|Other|0
63331|NCT01380093|253515|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
63332|NCT01380093|253516|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
63333|NCT01380093|253517|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
63334|NCT01380093|253518|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
63335|NCT01380093|253519|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
63336|NCT01380093|253520|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
63337|NCT01380093|253521|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
63338|NCT01380093|253522|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
63339|NCT01380093|253523|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
63340|NCT01380093|253515|P9|Drug Discrimination Phase: Day 2|Backup participant|0
63341|NCT01380093|253516|P8|Drug Discrimination Phase: Day 2|Backup participant|0
63342|NCT01380093|253517|P7|Drug Discrimination Phase: Day 2|Backup participant|0
63343|NCT01380093|253518|P6|Drug Discrimination Phase: Day 2|Backup participant|0
63344|NCT01380093|253519|P5|Drug Discrimination Phase: Day 2|Backup participant|0
63345|NCT01380093|253520|P4|Drug Discrimination Phase: Day 2|Backup participant|0
63346|NCT01380093|253521|P3|Drug Discrimination Phase: Day 2|Backup participant|1
63347|NCT01380093|253522|P2|Drug Discrimination Phase: Day 2|Backup participant|0
63348|NCT01380093|253523|P1|Drug Discrimination Phase: Day 2|Backup participant|0
63349|NCT01380093|253515|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
63350|NCT01380093|253516|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
63351|NCT01380093|253517|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
63352|NCT01380093|253518|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
63353|NCT01380093|253519|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
63354|NCT01380093|253520|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
63355|NCT01380093|253521|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
63356|NCT01380093|253522|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
63357|NCT01380093|253523|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
63358|NCT01380093|253515|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
63359|NCT01380093|253516|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
63360|NCT01380093|253517|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
63361|NCT01380093|253518|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
63362|NCT01380093|253519|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
63363|NCT01380093|253520|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
63364|NCT01380093|253521|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
63365|NCT01380093|253522|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
63366|NCT01380093|253523|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
63367|NCT01380093|253515|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
63368|NCT01380093|253516|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
63369|NCT01380093|253517|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
63370|NCT01380093|253518|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
63371|NCT01380093|253519|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
63372|NCT01380093|253520|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
63373|NCT01380093|253521|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
63374|NCT01380093|253522|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
63375|NCT01380093|253523|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
63376|NCT01380093|253515|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
63377|NCT01380093|253516|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
63378|NCT01380093|253517|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
63379|NCT01380093|253518|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
63380|NCT01380093|253519|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
63381|NCT01380093|253520|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
63382|NCT01380093|253521|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
63383|NCT01380093|253522|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
63384|NCT01380093|253523|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
63385|NCT01380093|253515|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
63386|NCT01380093|253516|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
63387|NCT01380093|253517|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
63388|NCT01380093|253518|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
63389|NCT01380093|253519|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
63390|NCT01380093|253520|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
63391|NCT01380093|253521|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
63392|NCT01380093|253522|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
63393|NCT01380093|253523|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
63394|NCT01380093|253515|P9|Naloxone Challenge Phase|Screen failures|0
63395|NCT01380093|253516|P8|Naloxone Challenge Phase|Screen failures|0
63396|NCT01380093|253517|P7|Naloxone Challenge Phase|Screen failures|0
63397|NCT01380093|253518|P6|Naloxone Challenge Phase|Screen failures|0
63398|NCT01380093|253519|P5|Naloxone Challenge Phase|Screen failures|0
63399|NCT01380093|253520|P4|Naloxone Challenge Phase|Screen failures|0
63400|NCT01380093|253521|P3|Naloxone Challenge Phase|Screen failures|0
63401|NCT01380093|253522|P2|Naloxone Challenge Phase|Screen failures|0
63402|NCT01380093|253523|P1|Naloxone Challenge Phase|Screen failures|21
63403|NCT01380080|253815|P2|Overall Study|Lost to Follow-up|0
63404|NCT01380080|253816|P1|Overall Study|Lost to Follow-up|2
63405|NCT01380080|253815|P2|Overall Study|Not willing to adhere to requirements|1
63406|NCT01380080|253816|P1|Overall Study|Not willing to adhere to requirements|3
63407|NCT01380080|253815|P2|Overall Study|Not able to get to clinic|0
63408|NCT01380080|253816|P1|Overall Study|Not able to get to clinic|4
63409|NCT01380080|253815|P2|Overall Study|Withdrawal by Subject|0
63410|NCT01380080|253816|P1|Overall Study|Withdrawal by Subject|4
63411|NCT01380080|253815|P2|Overall Study|Death|22
63412|NCT01380080|253816|P1|Overall Study|Death|20
63413|NCT01379937|253841|P4|Overall Study|Lost to Follow-up|0
63414|NCT01379937|253842|P3|Overall Study|Lost to Follow-up|2
63415|NCT01379937|253843|P2|Overall Study|Lost to Follow-up|2
63416|NCT01379937|253844|P1|Overall Study|Lost to Follow-up|1
63417|NCT01379937|253841|P4|Overall Study|Consent withdrawal|0
63418|NCT01379937|253842|P3|Overall Study|Consent withdrawal|0
63419|NCT01379937|253843|P2|Overall Study|Consent withdrawal|1
63420|NCT01379937|253844|P1|Overall Study|Consent withdrawal|0
63421|NCT01379937|253841|P4|Overall Study|Protocol Violation|1
63422|NCT01379937|253842|P3|Overall Study|Protocol Violation|0
63423|NCT01379937|253843|P2|Overall Study|Protocol Violation|0
63424|NCT01379937|253844|P1|Overall Study|Protocol Violation|0
63425|NCT01379781|253926|P2|Overall Study|Lost to Follow-up|8
63426|NCT01379781|253927|P1|Overall Study|Lost to Follow-up|11
63427|NCT01379768|253936|P3|Overall Study|Lost to Follow-up|0
63428|NCT01379768|253937|P2|Overall Study|Lost to Follow-up|0
63429|NCT01379768|253938|P1|Overall Study|Lost to Follow-up|2
63430|NCT01379768|253936|P3|Overall Study|Adverse Event|0
63431|NCT01379768|253937|P2|Overall Study|Adverse Event|1
63432|NCT01379768|253938|P1|Overall Study|Adverse Event|1
63433|NCT01379703|253961|P3|9 Months Through 18 Months|Reason Unknown|0
63434|NCT01379703|253962|P2|9 Months Through 18 Months|Reason Unknown|23
63435|NCT01379703|253963|P1|9 Months Through 18 Months|Reason Unknown|0
63436|NCT01379703|253961|P3|9 Months Through 18 Months|Fatigue|0
63437|NCT01379703|253962|P2|9 Months Through 18 Months|Fatigue|1
63438|NCT01379703|253963|P1|9 Months Through 18 Months|Fatigue|0
63439|NCT01379703|253961|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
63440|NCT01379703|253962|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
63441|NCT01379703|253963|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
63442|NCT01379703|253961|P3|9 Months Through 18 Months|Patient Noncompliance|0
63443|NCT01379703|253962|P2|9 Months Through 18 Months|Patient Noncompliance|4
63444|NCT01379703|253963|P1|9 Months Through 18 Months|Patient Noncompliance|0
63445|NCT01379703|253961|P3|9 Months Through 18 Months|Treatment failure|0
63446|NCT01379703|253962|P2|9 Months Through 18 Months|Treatment failure|5
63447|NCT01379703|253963|P1|9 Months Through 18 Months|Treatment failure|0
63448|NCT01379703|253961|P3|9 Months Through 18 Months|Adverse Event|0
63449|NCT01379703|253962|P2|9 Months Through 18 Months|Adverse Event|6
63450|NCT01379703|253963|P1|9 Months Through 18 Months|Adverse Event|0
63451|NCT01379703|253961|P3|9 Months Through 18 Months|Withdrawal by Subject|0
63452|NCT01379703|253962|P2|9 Months Through 18 Months|Withdrawal by Subject|11
63453|NCT01379703|253963|P1|9 Months Through 18 Months|Withdrawal by Subject|0
63454|NCT01379703|253961|P3|9 Months Through 18 Months|Lost to Follow-up|0
63455|NCT01379703|253962|P2|9 Months Through 18 Months|Lost to Follow-up|178
63456|NCT01379703|253963|P1|9 Months Through 18 Months|Lost to Follow-up|0
63457|NCT01379703|253961|P3|Study Start Through 9 Months|Reason unknown|24
63458|NCT01379703|253962|P2|Study Start Through 9 Months|Reason unknown|31
63459|NCT01379703|253963|P1|Study Start Through 9 Months|Reason unknown|2
63460|NCT01379703|253961|P3|Study Start Through 9 Months|Increased triglycerides|0
63461|NCT01379703|253962|P2|Study Start Through 9 Months|Increased triglycerides|1
63462|NCT01379703|253963|P1|Study Start Through 9 Months|Increased triglycerides|0
63463|NCT01379703|253961|P3|Study Start Through 9 Months|Poor general condition|0
63464|NCT01379703|253962|P2|Study Start Through 9 Months|Poor general condition|1
63465|NCT01379703|253963|P1|Study Start Through 9 Months|Poor general condition|0
63466|NCT01379703|253961|P3|Study Start Through 9 Months|Medication not available|1
63467|NCT01379703|253962|P2|Study Start Through 9 Months|Medication not available|2
63468|NCT01379703|253963|P1|Study Start Through 9 Months|Medication not available|0
63469|NCT01379703|253961|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
63470|NCT01379703|253962|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
63471|NCT01379703|253963|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
63472|NCT01379703|253961|P3|Study Start Through 9 Months|Patient Noncompliance|1
63473|NCT01379703|253962|P2|Study Start Through 9 Months|Patient Noncompliance|0
63474|NCT01379703|253963|P1|Study Start Through 9 Months|Patient Noncompliance|0
63475|NCT01379703|253961|P3|Study Start Through 9 Months|Treatment Failure|2
63476|NCT01379703|253962|P2|Study Start Through 9 Months|Treatment Failure|2
63477|NCT01379703|253963|P1|Study Start Through 9 Months|Treatment Failure|0
63478|NCT01379703|253961|P3|Study Start Through 9 Months|Withdrawal by Subject|1
63479|NCT01379703|253962|P2|Study Start Through 9 Months|Withdrawal by Subject|6
63480|NCT01379703|253963|P1|Study Start Through 9 Months|Withdrawal by Subject|0
63481|NCT01379703|253961|P3|Study Start Through 9 Months|Adverse Event|10
63482|NCT01379703|253962|P2|Study Start Through 9 Months|Adverse Event|14
63483|NCT01379703|253963|P1|Study Start Through 9 Months|Adverse Event|0
63484|NCT01379703|253961|P3|Study Start Through 9 Months|Lost to Follow-up|104
63485|NCT01379703|253962|P2|Study Start Through 9 Months|Lost to Follow-up|61
63486|NCT01379703|253963|P1|Study Start Through 9 Months|Lost to Follow-up|2
63487|NCT01379534|254063|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
63488|NCT01379534|254064|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
63489|NCT01379534|254063|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
63490|NCT01379534|254064|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
63491|NCT01379534|254063|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
63492|NCT01379534|254064|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
63493|NCT01379534|254063|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
63494|NCT01379534|254064|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
63495|NCT01379534|254063|P2|Treatment Phase|Adverse Event|7
63496|NCT01379534|254064|P1|Treatment Phase|Adverse Event|7
63497|NCT01379534|254063|P2|Treatment Phase|Progressive disease|22
63498|NCT01379534|254064|P1|Treatment Phase|Progressive disease|13
63499|NCT01379534|254063|P2|Treatment Phase|Withdrawal by Subject|2
63500|NCT01379534|254064|P1|Treatment Phase|Withdrawal by Subject|2
63501|NCT01379521|254084|P2|Post-Treatment Evaluations|Death|0
63502|NCT01379521|254085|P1|Post-Treatment Evaluations|Death|1
63503|NCT01379521|254084|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
63504|NCT01379521|254085|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
63505|NCT01379521|254084|P2|Post-Treatment Evaluations|Disease Progression|20
63506|NCT01379521|254085|P1|Post-Treatment Evaluations|Disease Progression|22
63507|NCT01379521|254084|P2|Overall Study -Treatment Period|Death|1
63508|NCT01379521|254085|P1|Overall Study -Treatment Period|Death|2
63509|NCT01379521|254084|P2|Overall Study -Treatment Period|Administrative Problems|0
63510|NCT01379521|254085|P1|Overall Study -Treatment Period|Administrative Problems|1
63511|NCT01379521|254084|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
63512|NCT01379521|254085|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
63513|NCT01379521|254084|P2|Overall Study -Treatment Period|Protocol Deviation|2
63514|NCT01379521|254085|P1|Overall Study -Treatment Period|Protocol Deviation|0
63515|NCT01379521|254084|P2|Overall Study -Treatment Period|New Cancer Therapy|0
63516|NCT01379521|254085|P1|Overall Study -Treatment Period|New Cancer Therapy|1
63517|NCT01379521|254084|P2|Overall Study -Treatment Period|Disease Progression|22
63518|NCT01379521|254085|P1|Overall Study -Treatment Period|Disease Progression|23
63519|NCT01379521|254084|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
63520|NCT01379521|254085|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
63521|NCT01379521|254084|P2|Overall Study -Treatment Period|Adverse Event|0
63522|NCT01379521|254085|P1|Overall Study -Treatment Period|Adverse Event|3
63523|NCT01378975|254155|P2|Overall Study|Withdrew Consent|3
63524|NCT01378975|254156|P1|Overall Study|Withdrew Consent|4
63525|NCT01378975|254155|P2|Overall Study|Lost to Follow-up|1
63526|NCT01378975|254156|P1|Overall Study|Lost to Follow-up|4
63527|NCT01378975|254155|P2|Overall Study|Investigator Request|0
63528|NCT01378975|254156|P1|Overall Study|Investigator Request|1
63529|NCT01378975|254155|P2|Overall Study|Death|46
63530|NCT01378975|254156|P1|Overall Study|Death|77
63531|NCT01378962|254182|P1|Overall Study|Other|2
63532|NCT01378962|254182|P1|Overall Study|Lost to Follow-up|1
63533|NCT01378962|254182|P1|Overall Study|Death|14
63534|NCT01378429|254208|P2|Overall Study|Noncompliance with study drug|0
63535|NCT01378429|254209|P1|Overall Study|Noncompliance with study drug|1
63536|NCT01378325|254251|P2|Overall Study|Protocol Violation|1
63537|NCT01378325|254252|P1|Overall Study|Protocol Violation|0
63538|NCT01378195|254269|P2|Overall Study|Lost to Follow-up|18
63539|NCT01378195|254270|P1|Overall Study|Lost to Follow-up|29
63540|NCT01378117|254283|P3|Overall Study|discharged before med given|1
63541|NCT01378117|254284|P2|Overall Study|discharged before med given|0
63542|NCT01378117|254285|P1|Overall Study|discharged before med given|2
63543|NCT01378117|254283|P3|Overall Study|withdrawal|2
63544|NCT01378117|254284|P2|Overall Study|withdrawal|1
63545|NCT01378117|254285|P1|Overall Study|withdrawal|2
63546|NCT01378104|254295|P2|Overall Study|Withdrawal by Subject|13
63547|NCT01378104|254296|P1|Overall Study|Withdrawal by Subject|12
63548|NCT01378104|254295|P2|Overall Study|Lack of Efficacy|5
63549|NCT01378104|254296|P1|Overall Study|Lack of Efficacy|7
63550|NCT01378104|254295|P2|Overall Study|Adverse Event|8
63551|NCT01378104|254296|P1|Overall Study|Adverse Event|8
63552|NCT01377922|254343|P2|Overall Study|rescue tx after part 2, entered part 4|0
63553|NCT01377922|254344|P1|Overall Study|rescue tx after part 2, entered part 4|1
63554|NCT01377480|254429|P4|Overall Study|Not specified|6
63555|NCT01377480|254430|P3|Overall Study|Not specified|7
63556|NCT01377480|254431|P2|Overall Study|Not specified|0
63557|NCT01377480|254432|P1|Overall Study|Not specified|0
63558|NCT01377480|254429|P4|Overall Study|Serious adverse event|1
63559|NCT01377480|254430|P3|Overall Study|Serious adverse event|1
63560|NCT01377480|254431|P2|Overall Study|Serious adverse event|0
63561|NCT01377480|254432|P1|Overall Study|Serious adverse event|0
63562|NCT01377480|254429|P4|Overall Study|Withdrawal by Subject|0
63563|NCT01377480|254430|P3|Overall Study|Withdrawal by Subject|1
63564|NCT01377480|254431|P2|Overall Study|Withdrawal by Subject|0
63565|NCT01377480|254432|P1|Overall Study|Withdrawal by Subject|0
63566|NCT01377480|254429|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
63567|NCT01377480|254430|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
63568|NCT01377480|254431|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
63569|NCT01377480|254432|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
63570|NCT01377480|254429|P4|Overall Study|Protocol Violation|4
63571|NCT01377480|254430|P3|Overall Study|Protocol Violation|0
63572|NCT01377480|254431|P2|Overall Study|Protocol Violation|0
63573|NCT01377480|254432|P1|Overall Study|Protocol Violation|0
63574|NCT01377233|254513|P5|Double-blind|Administrative or other|1
63575|NCT01377233|254514|P4|Double-blind|Administrative or other|1
63576|NCT01377233|254515|P3|Double-blind|Administrative or other|0
63577|NCT01377233|254516|P2|Double-blind|Administrative or other|0
63578|NCT01377233|254517|P1|Double-blind|Administrative or other|0
63579|NCT01377233|254513|P5|Double-blind|Withdrawal by Subject|0
63580|NCT01377233|254514|P4|Double-blind|Withdrawal by Subject|1
63581|NCT01377233|254515|P3|Double-blind|Withdrawal by Subject|0
63582|NCT01377233|254516|P2|Double-blind|Withdrawal by Subject|0
63583|NCT01377233|254517|P1|Double-blind|Withdrawal by Subject|0
63584|NCT01377233|254513|P5|Double-blind|Protocol Violation|1
63585|NCT01377233|254514|P4|Double-blind|Protocol Violation|0
63586|NCT01377233|254515|P3|Double-blind|Protocol Violation|0
63587|NCT01377233|254516|P2|Double-blind|Protocol Violation|0
63588|NCT01377233|254517|P1|Double-blind|Protocol Violation|0
63589|NCT01377233|254513|P5|Double-blind|Adverse Event|0
63590|NCT01377233|254514|P4|Double-blind|Adverse Event|2
63591|NCT01377233|254515|P3|Double-blind|Adverse Event|2
63592|NCT01377233|254516|P2|Double-blind|Adverse Event|1
63593|NCT01377233|254517|P1|Double-blind|Adverse Event|0
63594|NCT01377233|254513|P5|Open-label|Withdrawal by Subject|0
63595|NCT01377233|254514|P4|Open-label|Withdrawal by Subject|0
63596|NCT01377233|254515|P3|Open-label|Withdrawal by Subject|0
63597|NCT01377233|254516|P2|Open-label|Withdrawal by Subject|0
63598|NCT01377233|254517|P1|Open-label|Withdrawal by Subject|3
63599|NCT01377233|254513|P5|Open-label|Adverse Event|0
63600|NCT01377233|254514|P4|Open-label|Adverse Event|0
63601|NCT01377233|254515|P3|Open-label|Adverse Event|0
63602|NCT01377233|254516|P2|Open-label|Adverse Event|0
63603|NCT01377233|254517|P1|Open-label|Adverse Event|1
63604|NCT01377194|254544|P3|Overall Study|Lost to Follow-up|11
63605|NCT01377194|254545|P2|Overall Study|Lost to Follow-up|8
63606|NCT01377194|254546|P1|Overall Study|Lost to Follow-up|14
63607|NCT01377194|254544|P3|Overall Study|Withdrawal by Subject|7
63608|NCT01377194|254545|P2|Overall Study|Withdrawal by Subject|10
63609|NCT01377194|254546|P1|Overall Study|Withdrawal by Subject|8
63610|NCT01377194|254544|P3|Overall Study|Protocol Violation|6
63611|NCT01377194|254545|P2|Overall Study|Protocol Violation|10
63612|NCT01377194|254546|P1|Overall Study|Protocol Violation|4
63613|NCT01377194|254544|P3|Overall Study|Lack of Efficacy|3
63614|NCT01377194|254545|P2|Overall Study|Lack of Efficacy|3
63615|NCT01377194|254546|P1|Overall Study|Lack of Efficacy|3
63616|NCT01377194|254544|P3|Overall Study|Adverse Event|19
63617|NCT01377194|254545|P2|Overall Study|Adverse Event|12
63618|NCT01377194|254546|P1|Overall Study|Adverse Event|3
63619|NCT01377012|254560|P3|Extension Study, Weeks 104-260|Adverse Event|1
63620|NCT01377012|254561|P2|Extension Study, Weeks 104-260|Adverse Event|2
63621|NCT01377012|254562|P1|Extension Study, Weeks 104-260|Adverse Event|0
63622|NCT01377012|254560|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
63623|NCT01377012|254561|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
63624|NCT01377012|254562|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
63625|NCT01377012|254560|P3|Extension Study, Weeks 104-260|Physician Decision|0
63626|NCT01377012|254561|P2|Extension Study, Weeks 104-260|Physician Decision|0
63627|NCT01377012|254562|P1|Extension Study, Weeks 104-260|Physician Decision|1
63628|NCT01377012|254560|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
63629|NCT01377012|254561|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
63630|NCT01377012|254562|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
63631|NCT01377012|254560|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
63632|NCT01377012|254561|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
63633|NCT01377012|254562|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
63634|NCT01377012|254560|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
63635|NCT01377012|254561|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
63636|NCT01377012|254562|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
63637|NCT01377012|254560|P3|Core Study|Adverse Event|13
63638|NCT01377012|254561|P2|Core Study|Adverse Event|14
63639|NCT01377012|254562|P1|Core Study|Adverse Event|10
63640|NCT01377012|254560|P3|Core Study|Death|1
63641|NCT01377012|254561|P2|Core Study|Death|1
63642|NCT01377012|254562|P1|Core Study|Death|1
63643|NCT01377012|254560|P3|Core Study|Lack of Efficacy|37
63644|NCT01377012|254561|P2|Core Study|Lack of Efficacy|28
63645|NCT01377012|254562|P1|Core Study|Lack of Efficacy|41
63646|NCT01377012|254560|P3|Core Study|Lost to Follow-up|4
63647|NCT01377012|254561|P2|Core Study|Lost to Follow-up|5
63648|NCT01377012|254562|P1|Core Study|Lost to Follow-up|7
63649|NCT01377012|254560|P3|Core Study|No Longer require treatment|1
63650|NCT01377012|254561|P2|Core Study|No Longer require treatment|0
63651|NCT01377012|254562|P1|Core Study|No Longer require treatment|0
63652|NCT01377012|254560|P3|Core Study|Non-Compliant with study treatment|1
63653|NCT01377012|254561|P2|Core Study|Non-Compliant with study treatment|0
63654|NCT01377012|254562|P1|Core Study|Non-Compliant with study treatment|0
63655|NCT01377012|254560|P3|Core Study|Physician Decision|10
63656|NCT01377012|254561|P2|Core Study|Physician Decision|4
63657|NCT01377012|254562|P1|Core Study|Physician Decision|5
63658|NCT01377012|254560|P3|Core Study|Pregnancy|1
63659|NCT01377012|254561|P2|Core Study|Pregnancy|0
63660|NCT01377012|254562|P1|Core Study|Pregnancy|0
63661|NCT01377012|254560|P3|Core Study|Protocol Violation|2
63662|NCT01377012|254561|P2|Core Study|Protocol Violation|3
63663|NCT01377012|254562|P1|Core Study|Protocol Violation|7
63664|NCT01377012|254560|P3|Core Study|Withdrawal by Subject|18
63665|NCT01377012|254561|P2|Core Study|Withdrawal by Subject|23
63666|NCT01377012|254562|P1|Core Study|Withdrawal by Subject|15
63667|NCT01377012|254560|P3|Core Study|Technical problems|0
63668|NCT01377012|254561|P2|Core Study|Technical problems|0
63669|NCT01377012|254562|P1|Core Study|Technical problems|1
63670|NCT01377012|254560|P3|Core Study|Study terminated by Sponsor|46
63671|NCT01377012|254561|P2|Core Study|Study terminated by Sponsor|54
63672|NCT01377012|254562|P1|Core Study|Study terminated by Sponsor|47
63673|NCT01376908|254599|P2|Overall Study|Withdrawal by Subject|2
63674|NCT01376908|254600|P1|Overall Study|Withdrawal by Subject|1
63675|NCT01376908|254599|P2|Overall Study|Protocol Violation|1
63676|NCT01376908|254600|P1|Overall Study|Protocol Violation|1
63677|NCT01376804|254633|P1|Treatment Period|Patient did not receive study drug|1
63678|NCT01376804|254633|P1|Treatment Period|Adverse Event|6
63679|NCT01376804|254633|P1|Treatment Period|Withdrawal by Subject|1
63680|NCT01376700|254644|P1|Overall Study|Low or high titer inhibitor|8
63681|NCT01376700|254644|P1|Overall Study|Sponsor terminated study early|8
63682|NCT01376388|254706|P1|Overall Study|Withdrawal by Subject|3
63683|NCT01376388|254706|P1|Overall Study|Lack of Efficacy|2
63684|NCT01376388|254706|P1|Overall Study|Adverse Event|13
63685|NCT01376349|254744|P3|Raondomized Treatment|Alternative Treatment|1
63686|NCT01376349|254745|P2|Raondomized Treatment|Alternative Treatment|0
63687|NCT01376349|254746|P1|Raondomized Treatment|Alternative Treatment|0
63688|NCT01376349|254744|P3|Raondomized Treatment|Unkown|1
63689|NCT01376349|254745|P2|Raondomized Treatment|Unkown|2
63690|NCT01376349|254746|P1|Raondomized Treatment|Unkown|1
63691|NCT01376349|254744|P3|Raondomized Treatment|Adverse Event|14
63692|NCT01376349|254745|P2|Raondomized Treatment|Adverse Event|17
63693|NCT01376349|254746|P1|Raondomized Treatment|Adverse Event|13
63694|NCT01376349|254744|P3|Raondomized Treatment|Withdrawal by Subject|13
63695|NCT01376349|254745|P2|Raondomized Treatment|Withdrawal by Subject|16
63696|NCT01376349|254746|P1|Raondomized Treatment|Withdrawal by Subject|10
63697|NCT01376323|254760|P5|Overall Study|Withdrawal by Subject|0
63698|NCT01376323|254761|P4|Overall Study|Withdrawal by Subject|0
63699|NCT01376323|254762|P3|Overall Study|Withdrawal by Subject|1
63700|NCT01376323|254763|P2|Overall Study|Withdrawal by Subject|1
63701|NCT01376323|254764|P1|Overall Study|Withdrawal by Subject|0
63702|NCT01376323|254760|P5|Overall Study|Physician Decision|1
63703|NCT01376323|254761|P4|Overall Study|Physician Decision|1
63704|NCT01376323|254762|P3|Overall Study|Physician Decision|2
63705|NCT01376323|254763|P2|Overall Study|Physician Decision|0
63706|NCT01376323|254764|P1|Overall Study|Physician Decision|1
63707|NCT01376323|254760|P5|Overall Study|Lost to Follow-up|0
63708|NCT01376323|254761|P4|Overall Study|Lost to Follow-up|2
63709|NCT01376323|254762|P3|Overall Study|Lost to Follow-up|0
63710|NCT01376323|254763|P2|Overall Study|Lost to Follow-up|0
63711|NCT01376323|254764|P1|Overall Study|Lost to Follow-up|0
63712|NCT01376323|254760|P5|Overall Study|Adverse Event|0
63713|NCT01376323|254761|P4|Overall Study|Adverse Event|2
63714|NCT01376323|254762|P3|Overall Study|Adverse Event|0
63715|NCT01376323|254763|P2|Overall Study|Adverse Event|0
63716|NCT01376323|254764|P1|Overall Study|Adverse Event|1
63717|NCT01376245|254859|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
63718|NCT01376245|254860|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
63719|NCT01376245|254861|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
63720|NCT01376245|254862|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
63721|NCT01376245|254863|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
63722|NCT01376245|254859|P5|24-week, Double-blind Treatment Period|Physician Decision|0
63723|NCT01376245|254860|P4|24-week, Double-blind Treatment Period|Physician Decision|1
63724|NCT01376245|254861|P3|24-week, Double-blind Treatment Period|Physician Decision|1
63725|NCT01376245|254862|P2|24-week, Double-blind Treatment Period|Physician Decision|0
63726|NCT01376245|254863|P1|24-week, Double-blind Treatment Period|Physician Decision|0
63727|NCT01376245|254859|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
63728|NCT01376245|254860|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
63729|NCT01376245|254861|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
63730|NCT01376245|254862|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
63731|NCT01376245|254863|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
63732|NCT01376245|254859|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
63733|NCT01376245|254860|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
63734|NCT01376245|254861|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
63735|NCT01376245|254862|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
63736|NCT01376245|254863|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
63737|NCT01376245|254859|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
63738|NCT01376245|254860|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
63739|NCT01376245|254861|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
63740|NCT01376245|254862|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
63741|NCT01376245|254863|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
63742|NCT01376245|254859|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
63743|NCT01376245|254860|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
63744|NCT01376245|254861|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
63745|NCT01376245|254862|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
63746|NCT01376245|254863|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
63747|NCT01376245|254859|P5|24-week, Double-blind Treatment Period|Adverse Event|18
63748|NCT01376245|254860|P4|24-week, Double-blind Treatment Period|Adverse Event|8
63749|NCT01376245|254861|P3|24-week, Double-blind Treatment Period|Adverse Event|7
63750|NCT01376245|254862|P2|24-week, Double-blind Treatment Period|Adverse Event|16
63751|NCT01376245|254863|P1|24-week, Double-blind Treatment Period|Adverse Event|0
63752|NCT01376245|254859|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
63753|NCT01376245|254860|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
63754|NCT01376245|254861|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
63755|NCT01376245|254862|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
63756|NCT01376245|254863|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
63757|NCT01376245|254859|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
63758|NCT01376245|254860|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
63759|NCT01376245|254861|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
63760|NCT01376245|254862|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
63761|NCT01376245|254863|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
63762|NCT01376245|254859|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
63763|NCT01376245|254860|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
63764|NCT01376245|254861|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
63765|NCT01376245|254862|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
63766|NCT01376245|254863|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
63767|NCT01376245|254859|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
63768|NCT01376245|254860|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
63769|NCT01376245|254861|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
63770|NCT01376245|254862|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
63771|NCT01376245|254863|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
63772|NCT01376245|254859|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
63773|NCT01376245|254860|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
63774|NCT01376245|254861|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
63775|NCT01376245|254862|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
63776|NCT01376245|254863|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
63777|NCT01376167|254880|P3|Overall Study|Withdrawal by Subject|4
63778|NCT01376167|254881|P2|Overall Study|Withdrawal by Subject|5
63779|NCT01376167|254882|P1|Overall Study|Withdrawal by Subject|1
63780|NCT01376167|254880|P3|Overall Study|Physician Decision|0
63781|NCT01376167|254881|P2|Overall Study|Physician Decision|1
63782|NCT01376167|254882|P1|Overall Study|Physician Decision|1
63783|NCT01376167|254880|P3|Overall Study|Lost to Follow-up|2
63784|NCT01376167|254881|P2|Overall Study|Lost to Follow-up|4
63785|NCT01376167|254882|P1|Overall Study|Lost to Follow-up|2
63786|NCT01376089|254953|P2|Overall Study|Patient received no contrast media|4
63787|NCT01376089|254954|P1|Overall Study|Patient received no contrast media|3
63788|NCT01376037|254977|P2|Overall Study|Lost to Follow-up|2
63789|NCT01376037|254978|P1|Overall Study|Lost to Follow-up|0
63790|NCT01375777|255001|P9|Overall Study|Other|1
63791|NCT01375777|255002|P8|Overall Study|Other|0
63792|NCT01375777|255003|P7|Overall Study|Other|0
63793|NCT01375777|255004|P6|Overall Study|Other|0
63794|NCT01375777|255005|P5|Overall Study|Other|0
63795|NCT01375777|255006|P4|Overall Study|Other|0
63796|NCT01375777|255007|P3|Overall Study|Other|0
63797|NCT01375777|255008|P2|Overall Study|Other|1
63798|NCT01375777|255009|P1|Overall Study|Other|1
63799|NCT01375777|255001|P9|Overall Study|Lost to Follow-up|0
63800|NCT01375777|255002|P8|Overall Study|Lost to Follow-up|0
63801|NCT01375777|255003|P7|Overall Study|Lost to Follow-up|1
63802|NCT01375777|255004|P6|Overall Study|Lost to Follow-up|0
63803|NCT01375777|255005|P5|Overall Study|Lost to Follow-up|0
63804|NCT01375777|255006|P4|Overall Study|Lost to Follow-up|0
63805|NCT01375777|255007|P3|Overall Study|Lost to Follow-up|0
63806|NCT01375777|255008|P2|Overall Study|Lost to Follow-up|0
63807|NCT01375777|255009|P1|Overall Study|Lost to Follow-up|1
63808|NCT01375777|255001|P9|Overall Study|Withdrawal by Subject|1
63809|NCT01375777|255002|P8|Overall Study|Withdrawal by Subject|2
63810|NCT01375777|255003|P7|Overall Study|Withdrawal by Subject|1
63811|NCT01375777|255004|P6|Overall Study|Withdrawal by Subject|1
63812|NCT01375777|255005|P5|Overall Study|Withdrawal by Subject|1
63813|NCT01375777|255006|P4|Overall Study|Withdrawal by Subject|0
63814|NCT01375777|255007|P3|Overall Study|Withdrawal by Subject|1
63815|NCT01375777|255008|P2|Overall Study|Withdrawal by Subject|2
63816|NCT01375777|255009|P1|Overall Study|Withdrawal by Subject|0
63817|NCT01375764|255079|P5|Overall Study|Other|0
63818|NCT01375764|255080|P4|Overall Study|Other|1
63819|NCT01375764|255081|P3|Overall Study|Other|0
63820|NCT01375764|255082|P2|Overall Study|Other|0
63821|NCT01375764|255083|P1|Overall Study|Other|0
63822|NCT01375764|255079|P5|Overall Study|Withdrawal by Subject|1
63823|NCT01375764|255080|P4|Overall Study|Withdrawal by Subject|0
63824|NCT01375764|255081|P3|Overall Study|Withdrawal by Subject|0
63825|NCT01375764|255082|P2|Overall Study|Withdrawal by Subject|0
63826|NCT01375764|255083|P1|Overall Study|Withdrawal by Subject|2
63827|NCT01375764|255079|P5|Overall Study|Lost to Follow-up|0
63828|NCT01375764|255080|P4|Overall Study|Lost to Follow-up|0
63829|NCT01375764|255081|P3|Overall Study|Lost to Follow-up|0
63830|NCT01375764|255082|P2|Overall Study|Lost to Follow-up|1
63831|NCT01375764|255083|P1|Overall Study|Lost to Follow-up|0
63832|NCT01375751|255129|P3|Overall Study|Other|0
63833|NCT01375751|255130|P2|Overall Study|Other|1
63834|NCT01375751|255131|P1|Overall Study|Other|0
63835|NCT01375608|255175|P1|Overall Study|Withdrawal by Subject|2
63836|NCT01375374|255184|P1|Overall Study|Adverse Event|1
63837|NCT01375049|255234|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
63838|NCT01375049|255234|P1|Overall Study|Withdrawal by Subject|2
63839|NCT01375049|255234|P1|Overall Study|Lost to Follow-up|1
63840|NCT01375049|255234|P1|Overall Study|Adverse Event|2
63841|NCT01374971|255249|P1|Overall Study|Withdrawal by Subject|1
63842|NCT01374919|255254|P1|Overall Study|Withdrawal by Subject|2
63843|NCT01374906|255261|P2|Overall Study|Unsatisfactory therapeutic effect|19
63844|NCT01374906|255262|P1|Overall Study|Unsatisfactory therapeutic effect|11
63845|NCT01374906|255261|P2|Overall Study|Withdrawal by Subject|9
63846|NCT01374906|255262|P1|Overall Study|Withdrawal by Subject|15
63847|NCT01374906|255261|P2|Overall Study|Protocol Violation|2
63848|NCT01374906|255262|P1|Overall Study|Protocol Violation|2
63849|NCT01374906|255261|P2|Overall Study|Death|2
63850|NCT01374906|255262|P1|Overall Study|Death|0
63851|NCT01374906|255261|P2|Overall Study|Adverse Event|11
63852|NCT01374906|255262|P1|Overall Study|Adverse Event|10
63853|NCT01374906|255261|P2|Overall Study|Administrative problems|2
63854|NCT01374906|255262|P1|Overall Study|Administrative problems|2
63855|NCT01374906|255261|P2|Overall Study|Abnormal laboratory value(s)|3
63856|NCT01374906|255262|P1|Overall Study|Abnormal laboratory value(s)|0
63857|NCT01374568|255343|P2|Overall Study|Lab unable to analyze BTM|2
63858|NCT01374568|255344|P1|Overall Study|Lab unable to analyze BTM|0
63859|NCT01374451|255354|P2|Overall Study|Administrative problems|0
63860|NCT01374451|255355|P1|Overall Study|Administrative problems|1
63861|NCT01374425|255401|P2|Overall Study|Not Specified|43
63862|NCT01374425|255402|P1|Overall Study|Not Specified|41
63863|NCT01374425|255401|P2|Overall Study|Lost to Follow-up|1
63864|NCT01374425|255402|P1|Overall Study|Lost to Follow-up|2
63865|NCT01374425|255401|P2|Overall Study|Sponsor Decision|1
63866|NCT01374425|255402|P1|Overall Study|Sponsor Decision|0
63867|NCT01374425|255401|P2|Overall Study|Protocol Violation|3
63868|NCT01374425|255402|P1|Overall Study|Protocol Violation|2
63869|NCT01374425|255401|P2|Overall Study|Refused Treatment|24
63870|NCT01374425|255402|P1|Overall Study|Refused Treatment|10
63871|NCT01374425|255401|P2|Overall Study|Withdrawal by Subject|7
63872|NCT01374425|255402|P1|Overall Study|Withdrawal by Subject|6
63873|NCT01374425|255401|P2|Overall Study|Death (Adverse Event)|4
63874|NCT01374425|255402|P1|Overall Study|Death (Adverse Event)|2
63875|NCT01374425|255401|P2|Overall Study|Death (Progression of Disease)|0
63876|NCT01374425|255402|P1|Overall Study|Death (Progression of Disease)|1
63877|NCT01374425|255401|P2|Overall Study|Adverse Event|18
63878|NCT01374425|255402|P1|Overall Study|Adverse Event|29
63879|NCT01374425|255401|P2|Overall Study|Clinical Disease Progression|6
63880|NCT01374425|255402|P1|Overall Study|Clinical Disease Progression|9
63881|NCT01374425|255401|P2|Overall Study|Radiographic Disease Progression|81
63882|NCT01374425|255402|P1|Overall Study|Radiographic Disease Progression|86
63883|NCT01374269|255482|P2|Overall Study|closed research|2
63884|NCT01374269|255483|P1|Overall Study|closed research|1
63885|NCT01374269|255482|P2|Overall Study|Lost to Follow-up|3
63886|NCT01374269|255483|P1|Overall Study|Lost to Follow-up|1
63887|NCT01374269|255482|P2|Overall Study|Withdrawal by Subject|0
63888|NCT01374269|255483|P1|Overall Study|Withdrawal by Subject|4
63889|NCT01374178|255611|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
63890|NCT01374178|255612|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
63891|NCT01374178|255611|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
63892|NCT01374178|255612|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
63893|NCT01374087|255630|P2|Overall Study|Not provided|13
63894|NCT01374087|255631|P1|Overall Study|Not provided|13
63895|NCT01374087|255630|P2|Overall Study|Disease progression|2
63896|NCT01374087|255631|P1|Overall Study|Disease progression|2
63897|NCT01374087|255630|P2|Overall Study|Adverse Event|1
63898|NCT01374087|255631|P1|Overall Study|Adverse Event|0
63899|NCT01373918|255641|P2|Overall Study|Physician Decision|1
63900|NCT01373918|255642|P1|Overall Study|Physician Decision|0
63901|NCT01373346|255692|P1|Overall Study|Death|1
63902|NCT01373294|255715|P2|Overall Study|Adverse Event|0
63903|NCT01373294|255716|P1|Overall Study|Adverse Event|1
63904|NCT01373281|255725|P2|Overall Study|Serious adverse event|5
63905|NCT01373281|255726|P1|Overall Study|Serious adverse event|6
63906|NCT01373281|255725|P2|Overall Study|Adverse Event|4
63907|NCT01373281|255726|P1|Overall Study|Adverse Event|4
63908|NCT01373281|255725|P2|Overall Study|Lost to Follow-up|1
63909|NCT01373281|255726|P1|Overall Study|Lost to Follow-up|4
63910|NCT01373281|255725|P2|Overall Study|Protocol Violation|4
63911|NCT01373281|255726|P1|Overall Study|Protocol Violation|13
63912|NCT01373281|255725|P2|Overall Study|Withdrawal by Subject|31
63913|NCT01373281|255726|P1|Overall Study|Withdrawal by Subject|52
63914|NCT01373229|255742|P1|Overall Study|Physician Decision|3
63915|NCT01373229|255742|P1|Overall Study|Death|3
63916|NCT01373164|255756|P5|Overall Study|Withdrawal by Subject|2
63917|NCT01373164|255757|P4|Overall Study|Withdrawal by Subject|10
63918|NCT01373164|255758|P3|Overall Study|Withdrawal by Subject|0
63919|NCT01373164|255759|P2|Overall Study|Withdrawal by Subject|1
63920|NCT01373164|255760|P1|Overall Study|Withdrawal by Subject|0
63921|NCT01373164|255756|P5|Overall Study|Lost to Follow-up|0
63922|NCT01373164|255757|P4|Overall Study|Lost to Follow-up|2
63923|NCT01373164|255758|P3|Overall Study|Lost to Follow-up|1
63924|NCT01373164|255759|P2|Overall Study|Lost to Follow-up|0
63925|NCT01373164|255760|P1|Overall Study|Lost to Follow-up|0
63926|NCT01372995|255794|P3|Overall Study|Physician Decision|1
63927|NCT01372995|255795|P2|Overall Study|Physician Decision|0
63928|NCT01372995|255796|P1|Overall Study|Physician Decision|0
63929|NCT01372995|255794|P3|Overall Study|Spouse withdrew participant from study|0
63930|NCT01372995|255795|P2|Overall Study|Spouse withdrew participant from study|1
63931|NCT01372995|255796|P1|Overall Study|Spouse withdrew participant from study|0
63932|NCT01372878|255843|P1|Overall Study|incomplete study procedure|104
63933|NCT01372878|255843|P1|Overall Study|Protocol Violation|17
63934|NCT01372878|255843|P1|Overall Study|Withdrawal by Subject|63
63935|NCT01372748|255863|P2|Overall Study|Withdrawal by Subject|5
63936|NCT01372748|255864|P1|Overall Study|Withdrawal by Subject|7
63937|NCT01372748|255863|P2|Overall Study|Lost to Follow-up|34
63938|NCT01372748|255864|P1|Overall Study|Lost to Follow-up|16
63939|NCT01372618|255872|P1|Overall Study|PI Died. Study Terminated|9
63940|NCT01372605|255880|P2|Overall Study|Changed medical home|0
63941|NCT01372605|255881|P1|Overall Study|Changed medical home|2
63942|NCT01372605|255880|P2|Overall Study|Moved|0
63943|NCT01372605|255881|P1|Overall Study|Moved|3
63944|NCT01372605|255880|P2|Overall Study|Withdrawal by Subject|7
63945|NCT01372605|255881|P1|Overall Study|Withdrawal by Subject|4
63946|NCT01372605|255880|P2|Overall Study|Lost to Follow-up|1
63947|NCT01372605|255881|P1|Overall Study|Lost to Follow-up|2
63948|NCT01372605|255880|P2|Overall Study|Death|2
63949|NCT01372605|255881|P1|Overall Study|Death|1
63950|NCT01372501|255907|P1|Overall Study|Device migration|1
63951|NCT01372501|255907|P1|Overall Study|Adverse Event|4
63952|NCT01372410|255930|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
63953|NCT01372410|255931|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
63954|NCT01372410|255932|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
63955|NCT01372410|255933|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
63956|NCT01372410|255934|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
63957|NCT01372410|255935|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
63958|NCT01372410|255936|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
63959|NCT01372410|255937|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
63960|NCT01372410|255930|P8|Treatment Period 3 (7 Days)|Adverse Event|0
63961|NCT01372410|255931|P7|Treatment Period 3 (7 Days)|Adverse Event|0
63962|NCT01372410|255932|P6|Treatment Period 3 (7 Days)|Adverse Event|0
63963|NCT01372410|255933|P5|Treatment Period 3 (7 Days)|Adverse Event|0
63964|NCT01372410|255934|P4|Treatment Period 3 (7 Days)|Adverse Event|0
63965|NCT01372410|255935|P3|Treatment Period 3 (7 Days)|Adverse Event|1
63966|NCT01372410|255936|P2|Treatment Period 3 (7 Days)|Adverse Event|0
63967|NCT01372410|255937|P1|Treatment Period 3 (7 Days)|Adverse Event|0
63968|NCT01372410|255930|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
63969|NCT01372410|255931|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
63970|NCT01372410|255932|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
63971|NCT01372410|255933|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
63972|NCT01372410|255934|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
63973|NCT01372410|255935|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
63974|NCT01372410|255936|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
63975|NCT01372410|255937|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
63976|NCT01372410|255930|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
63977|NCT01372410|255931|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
63978|NCT01372410|255932|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
63979|NCT01372410|255933|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
63980|NCT01372410|255934|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
63981|NCT01372410|255935|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
63982|NCT01372410|255936|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
63983|NCT01372410|255937|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
63984|NCT01372410|255930|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
63985|NCT01372410|255931|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
63986|NCT01372410|255932|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
63987|NCT01372410|255933|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
63988|NCT01372410|255934|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
63989|NCT01372410|255935|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
63990|NCT01372410|255936|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
63991|NCT01372410|255937|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
63992|NCT01372410|255930|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
63993|NCT01372410|255931|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
63994|NCT01372410|255932|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
63995|NCT01372410|255933|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
63996|NCT01372410|255934|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
63997|NCT01372410|255935|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
63998|NCT01372410|255936|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
63999|NCT01372410|255937|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
64000|NCT01372410|255930|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
64001|NCT01372410|255931|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
64002|NCT01372410|255932|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
64003|NCT01372410|255933|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
64004|NCT01372410|255934|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
64005|NCT01372410|255935|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
64006|NCT01372410|255936|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
64007|NCT01372410|255937|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
64008|NCT01372410|255930|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
64009|NCT01372410|255931|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
64010|NCT01372410|255932|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
64011|NCT01372410|255933|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
64012|NCT01372410|255934|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
64013|NCT01372410|255935|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
64014|NCT01372410|255936|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
64015|NCT01372410|255937|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
64016|NCT01372410|255930|P8|Treatment Period 1 (7 Days)|Adverse Event|0
64017|NCT01372410|255931|P7|Treatment Period 1 (7 Days)|Adverse Event|1
64018|NCT01372410|255932|P6|Treatment Period 1 (7 Days)|Adverse Event|0
64019|NCT01372410|255933|P5|Treatment Period 1 (7 Days)|Adverse Event|0
64020|NCT01372410|255934|P4|Treatment Period 1 (7 Days)|Adverse Event|0
64021|NCT01372410|255935|P3|Treatment Period 1 (7 Days)|Adverse Event|0
64022|NCT01372410|255936|P2|Treatment Period 1 (7 Days)|Adverse Event|1
64023|NCT01372410|255937|P1|Treatment Period 1 (7 Days)|Adverse Event|0
64024|NCT01372410|255930|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
64025|NCT01372410|255931|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
64026|NCT01372410|255932|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
64027|NCT01372410|255933|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
64028|NCT01372410|255934|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
64029|NCT01372410|255935|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
64030|NCT01372410|255936|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
64031|NCT01372410|255937|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
64032|NCT01372384|255974|P1|Overall Study|Progression of disease|3
64033|NCT01372150|255997|P3|Overall Study|Randomized but not treated|0
64034|NCT01372150|255998|P2|Overall Study|Randomized but not treated|1
64035|NCT01372150|255999|P1|Overall Study|Randomized but not treated|0
64036|NCT01372150|255997|P3|Overall Study|Adverse Event|2
64037|NCT01372150|255998|P2|Overall Study|Adverse Event|1
64038|NCT01372150|255999|P1|Overall Study|Adverse Event|2
64039|NCT01372150|255997|P3|Overall Study|Other|2
64040|NCT01372150|255998|P2|Overall Study|Other|0
64041|NCT01372150|255999|P1|Overall Study|Other|1
64042|NCT01372150|255997|P3|Overall Study|Withdrawal by Subject|2
64043|NCT01372150|255998|P2|Overall Study|Withdrawal by Subject|7
64044|NCT01372150|255999|P1|Overall Study|Withdrawal by Subject|2
64045|NCT01372150|255997|P3|Overall Study|Protocol Violation|3
64046|NCT01372150|255998|P2|Overall Study|Protocol Violation|0
64047|NCT01372150|255999|P1|Overall Study|Protocol Violation|1
64048|NCT01372150|255997|P3|Overall Study|Lost to Follow-up|6
64049|NCT01372150|255998|P2|Overall Study|Lost to Follow-up|5
64050|NCT01372150|255999|P1|Overall Study|Lost to Follow-up|4
64051|NCT01372150|255997|P3|Overall Study|Lack of Efficacy|1
64052|NCT01372150|255998|P2|Overall Study|Lack of Efficacy|0
64053|NCT01372150|255999|P1|Overall Study|Lack of Efficacy|3
64054|NCT01371994|256018|P2|Overall Study|Miscellaneous Reasons|4
64055|NCT01371994|256019|P1|Overall Study|Miscellaneous Reasons|6
64056|NCT01371994|256018|P2|Overall Study|Physician Decision|1
64057|NCT01371994|256019|P1|Overall Study|Physician Decision|1
64058|NCT01371994|256018|P2|Overall Study|Randomized but Never Received Study Drug|6
64059|NCT01371994|256019|P1|Overall Study|Randomized but Never Received Study Drug|6
64060|NCT01371994|256018|P2|Overall Study|Protocol Violation|17
64061|NCT01371994|256019|P1|Overall Study|Protocol Violation|24
64062|NCT01371994|256018|P2|Overall Study|Lost to Follow-up|1
64063|NCT01371994|256019|P1|Overall Study|Lost to Follow-up|1
64064|NCT01371994|256018|P2|Overall Study|Withdrawal by Subject|7
64065|NCT01371994|256019|P1|Overall Study|Withdrawal by Subject|13
64066|NCT01371994|256018|P2|Overall Study|Lack of Efficacy|0
64067|NCT01371994|256019|P1|Overall Study|Lack of Efficacy|3
64068|NCT01371994|256018|P2|Overall Study|Adverse Event|6
64069|NCT01371994|256019|P1|Overall Study|Adverse Event|3
64070|NCT01371877|256063|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
64071|NCT01371877|256064|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
64072|NCT01371851|256076|P2|Overall Study|Blood Pressure outside study parameters|0
64073|NCT01371851|256077|P1|Overall Study|Blood Pressure outside study parameters|2
64074|NCT01371851|256076|P2|Overall Study|non study related adverse event|0
64075|NCT01371851|256077|P1|Overall Study|non study related adverse event|1
64076|NCT01371851|256076|P2|Overall Study|was arrested and put in jail|1
64077|NCT01371851|256077|P1|Overall Study|was arrested and put in jail|0
64078|NCT01371851|256076|P2|Overall Study|Lost to Follow-up|8
64079|NCT01371851|256077|P1|Overall Study|Lost to Follow-up|5
64080|NCT01371838|256085|P2|Overall Study|Surgery|0
64081|NCT01371838|256086|P1|Overall Study|Surgery|1
64082|NCT01371838|256085|P2|Overall Study|Lack of therapeutic response|1
64083|NCT01371838|256086|P1|Overall Study|Lack of therapeutic response|0
64084|NCT01371838|256085|P2|Overall Study|Last follow-up visit not conducted|0
64085|NCT01371838|256086|P1|Overall Study|Last follow-up visit not conducted|2
64086|NCT01371838|256085|P2|Overall Study|Investigator Decision|8
64087|NCT01371838|256086|P1|Overall Study|Investigator Decision|3
64088|NCT01371838|256085|P2|Overall Study|Protocol Violation|0
64089|NCT01371838|256086|P1|Overall Study|Protocol Violation|3
64090|NCT01371838|256085|P2|Overall Study|Death|4
64091|NCT01371838|256086|P1|Overall Study|Death|3
64092|NCT01371838|256085|P2|Overall Study|Lost to Follow-up|20
64093|NCT01371838|256086|P1|Overall Study|Lost to Follow-up|10
64094|NCT01371838|256085|P2|Overall Study|Withdrawal by Subject|33
64095|NCT01371838|256086|P1|Overall Study|Withdrawal by Subject|27
64096|NCT01371825|256122|P1|Primary Efficacy Analysis Period|Death|3
64097|NCT01371747|256157|P6|Overall Study|Other Reasons|1
64098|NCT01371747|256158|P5|Overall Study|Other Reasons|0
64099|NCT01371747|256159|P4|Overall Study|Other Reasons|0
64100|NCT01371747|256160|P3|Overall Study|Other Reasons|2
64101|NCT01371747|256161|P2|Overall Study|Other Reasons|1
64102|NCT01371747|256162|P1|Overall Study|Other Reasons|2
64103|NCT01371747|256157|P6|Overall Study|Withdrawal by Subject|4
64104|NCT01371747|256158|P5|Overall Study|Withdrawal by Subject|2
64105|NCT01371747|256159|P4|Overall Study|Withdrawal by Subject|2
64106|NCT01371747|256160|P3|Overall Study|Withdrawal by Subject|5
64107|NCT01371747|256161|P2|Overall Study|Withdrawal by Subject|12
64108|NCT01371747|256162|P1|Overall Study|Withdrawal by Subject|6
64109|NCT01371747|256157|P6|Overall Study|Physician Decision|0
64110|NCT01371747|256158|P5|Overall Study|Physician Decision|1
64111|NCT01371747|256159|P4|Overall Study|Physician Decision|0
64112|NCT01371747|256160|P3|Overall Study|Physician Decision|0
64113|NCT01371747|256161|P2|Overall Study|Physician Decision|0
64114|NCT01371747|256162|P1|Overall Study|Physician Decision|0
64115|NCT01371747|256157|P6|Overall Study|Non-Compliance|1
64116|NCT01371747|256158|P5|Overall Study|Non-Compliance|0
64117|NCT01371747|256159|P4|Overall Study|Non-Compliance|0
64118|NCT01371747|256160|P3|Overall Study|Non-Compliance|3
64119|NCT01371747|256161|P2|Overall Study|Non-Compliance|4
64120|NCT01371747|256162|P1|Overall Study|Non-Compliance|3
64121|NCT01371747|256157|P6|Overall Study|Protocol Violation|0
64122|NCT01371747|256158|P5|Overall Study|Protocol Violation|0
64123|NCT01371747|256159|P4|Overall Study|Protocol Violation|0
64124|NCT01371747|256160|P3|Overall Study|Protocol Violation|1
64125|NCT01371747|256161|P2|Overall Study|Protocol Violation|0
64126|NCT01371747|256162|P1|Overall Study|Protocol Violation|0
64127|NCT01371747|256157|P6|Overall Study|Low Serum Potassium Results|3
64128|NCT01371747|256158|P5|Overall Study|Low Serum Potassium Results|0
64129|NCT01371747|256159|P4|Overall Study|Low Serum Potassium Results|1
64130|NCT01371747|256160|P3|Overall Study|Low Serum Potassium Results|1
64131|NCT01371747|256161|P2|Overall Study|Low Serum Potassium Results|1
64132|NCT01371747|256162|P1|Overall Study|Low Serum Potassium Results|1
64133|NCT01371747|256157|P6|Overall Study|High Serum Potassium Results|2
64134|NCT01371747|256158|P5|Overall Study|High Serum Potassium Results|0
64135|NCT01371747|256159|P4|Overall Study|High Serum Potassium Results|2
64136|NCT01371747|256160|P3|Overall Study|High Serum Potassium Results|1
64137|NCT01371747|256161|P2|Overall Study|High Serum Potassium Results|1
64138|NCT01371747|256162|P1|Overall Study|High Serum Potassium Results|1
64139|NCT01371747|256157|P6|Overall Study|Abnormal Renal Function|1
64140|NCT01371747|256158|P5|Overall Study|Abnormal Renal Function|0
64141|NCT01371747|256159|P4|Overall Study|Abnormal Renal Function|1
64142|NCT01371747|256160|P3|Overall Study|Abnormal Renal Function|0
64143|NCT01371747|256161|P2|Overall Study|Abnormal Renal Function|2
64144|NCT01371747|256162|P1|Overall Study|Abnormal Renal Function|0
64145|NCT01371747|256157|P6|Overall Study|Death|0
64146|NCT01371747|256158|P5|Overall Study|Death|2
64147|NCT01371747|256159|P4|Overall Study|Death|1
64148|NCT01371747|256160|P3|Overall Study|Death|4
64149|NCT01371747|256161|P2|Overall Study|Death|0
64150|NCT01371747|256162|P1|Overall Study|Death|1
64151|NCT01371747|256157|P6|Overall Study|Adverse Event|2
64152|NCT01371747|256158|P5|Overall Study|Adverse Event|2
64153|NCT01371747|256159|P4|Overall Study|Adverse Event|2
64154|NCT01371747|256160|P3|Overall Study|Adverse Event|7
64155|NCT01371747|256161|P2|Overall Study|Adverse Event|2
64156|NCT01371747|256162|P1|Overall Study|Adverse Event|4
64157|NCT01371734|256227|P3|Overall Study|Lack of Efficacy|0
64158|NCT01371734|256228|P2|Overall Study|Lack of Efficacy|2
64159|NCT01371734|256229|P1|Overall Study|Lack of Efficacy|2
64160|NCT01371734|256227|P3|Overall Study|Adverse Event|3
64161|NCT01371734|256228|P2|Overall Study|Adverse Event|8
64162|NCT01371734|256229|P1|Overall Study|Adverse Event|8
64163|NCT01371734|256227|P3|Overall Study|Protocol Violation|2
64164|NCT01371734|256228|P2|Overall Study|Protocol Violation|1
64165|NCT01371734|256229|P1|Overall Study|Protocol Violation|3
64166|NCT01371734|256227|P3|Overall Study|Lost to Follow-up|1
64167|NCT01371734|256228|P2|Overall Study|Lost to Follow-up|3
64168|NCT01371734|256229|P1|Overall Study|Lost to Follow-up|5
64169|NCT01371734|256227|P3|Overall Study|Withdrawal by Subject|9
64170|NCT01371734|256228|P2|Overall Study|Withdrawal by Subject|4
64171|NCT01371734|256229|P1|Overall Study|Withdrawal by Subject|3
64172|NCT01371734|256227|P3|Overall Study|Not specified|2
64173|NCT01371734|256228|P2|Overall Study|Not specified|1
64174|NCT01371734|256229|P1|Overall Study|Not specified|2
64175|NCT01371721|256249|P3|Overall Study|Randomized but not treated|0
64176|NCT01371721|256250|P2|Overall Study|Randomized but not treated|0
64177|NCT01371721|256251|P1|Overall Study|Randomized but not treated|1
64178|NCT01371721|256249|P3|Overall Study|Lack of Efficacy|3
64179|NCT01371721|256250|P2|Overall Study|Lack of Efficacy|4
64180|NCT01371721|256251|P1|Overall Study|Lack of Efficacy|2
64181|NCT01371721|256249|P3|Overall Study|Not specified|0
64182|NCT01371721|256250|P2|Overall Study|Not specified|3
64183|NCT01371721|256251|P1|Overall Study|Not specified|2
64184|NCT01371721|256249|P3|Overall Study|Withdrawal by Subject|11
64185|NCT01371721|256250|P2|Overall Study|Withdrawal by Subject|7
64186|NCT01371721|256251|P1|Overall Study|Withdrawal by Subject|5
64187|NCT01371721|256249|P3|Overall Study|Lost to Follow-up|6
64188|NCT01371721|256250|P2|Overall Study|Lost to Follow-up|2
64189|NCT01371721|256251|P1|Overall Study|Lost to Follow-up|8
64190|NCT01371721|256249|P3|Overall Study|Protocol Violation|5
64191|NCT01371721|256250|P2|Overall Study|Protocol Violation|4
64192|NCT01371721|256251|P1|Overall Study|Protocol Violation|6
64193|NCT01371721|256249|P3|Overall Study|Adverse Event|5
64194|NCT01371721|256250|P2|Overall Study|Adverse Event|4
64195|NCT01371721|256251|P1|Overall Study|Adverse Event|5
64196|NCT01371708|256284|P3|Overall Study|Started but did not receive treatment|1
64197|NCT01371708|256285|P2|Overall Study|Started but did not receive treatment|0
64198|NCT01371708|256286|P1|Overall Study|Started but did not receive treatment|1
64199|NCT01371708|256284|P3|Overall Study|Adverse Event|12
64200|NCT01371708|256285|P2|Overall Study|Adverse Event|8
64201|NCT01371708|256286|P1|Overall Study|Adverse Event|5
64202|NCT01371708|256284|P3|Overall Study|Not specified|4
64203|NCT01371708|256285|P2|Overall Study|Not specified|2
64204|NCT01371708|256286|P1|Overall Study|Not specified|3
64205|NCT01371708|256284|P3|Overall Study|Medication error/not related to AE|0
64206|NCT01371708|256285|P2|Overall Study|Medication error/not related to AE|1
64207|NCT01371708|256286|P1|Overall Study|Medication error/not related to AE|0
64208|NCT01371708|256284|P3|Overall Study|No longer willing to participate|13
64209|NCT01371708|256285|P2|Overall Study|No longer willing to participate|7
64210|NCT01371708|256286|P1|Overall Study|No longer willing to participate|7
64211|NCT01371708|256284|P3|Overall Study|Protocol Violation|2
64212|NCT01371708|256285|P2|Overall Study|Protocol Violation|1
64213|NCT01371708|256286|P1|Overall Study|Protocol Violation|2
64214|NCT01371708|256284|P3|Overall Study|Lost to Follow-up|7
64215|NCT01371708|256285|P2|Overall Study|Lost to Follow-up|9
64216|NCT01371708|256286|P1|Overall Study|Lost to Follow-up|5
64217|NCT01371708|256284|P3|Overall Study|Insufficient clinical response|0
64218|NCT01371708|256285|P2|Overall Study|Insufficient clinical response|2
64219|NCT01371708|256286|P1|Overall Study|Insufficient clinical response|3
64220|NCT01371643|256318|P2|Overall Study|Withdrawal by Subject|0
64221|NCT01371643|256319|P1|Overall Study|Withdrawal by Subject|3
64222|NCT01371565|256329|P1|Overall Study|Resection of neuroendocrine tumor|1
64223|NCT01371565|256329|P1|Overall Study|Death|1
64224|NCT01371565|256329|P1|Overall Study|Withdrawal by Subject|1
64225|NCT01371552|256333|P6|Part 1, First 3 Days|Inconvenience|0
64226|NCT01371552|256334|P5|Part 1, First 3 Days|Inconvenience|0
64227|NCT01371552|256335|P4|Part 1, First 3 Days|Inconvenience|0
64228|NCT01371552|256336|P3|Part 1, First 3 Days|Inconvenience|1
64229|NCT01371552|256337|P2|Part 1, First 3 Days|Inconvenience|0
64230|NCT01371552|256338|P1|Part 1, First 3 Days|Inconvenience|0
64231|NCT01371539|256365|P2|Period Two: One Week|Time/job conflict|1
64232|NCT01371539|256366|P1|Period Two: One Week|Time/job conflict|0
64233|NCT01371539|256365|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
64234|NCT01371539|256366|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
64235|NCT01371539|256365|P2|Period Two: One Week|Lost to Follow-up|1
64236|NCT01371539|256366|P1|Period Two: One Week|Lost to Follow-up|0
64237|NCT01371539|256365|P2|Period One: One Week|Lost to Follow-up|1
64238|NCT01371539|256366|P1|Period One: One Week|Lost to Follow-up|0
64239|NCT01371006|256387|P2|Overall Study|Adverse Event|0
64240|NCT01371006|256388|P1|Overall Study|Adverse Event|1
64241|NCT01370863|256429|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
64242|NCT01370863|256430|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
64243|NCT01370863|256429|P2|Overall Study|Did not want second pH/MII monitoring|1
64244|NCT01370863|256430|P1|Overall Study|Did not want second pH/MII monitoring|1
64245|NCT01370863|256429|P2|Overall Study|Adverse Event|1
64246|NCT01370863|256430|P1|Overall Study|Adverse Event|1
64247|NCT01370733|256455|P2|Overall Study|Protocol Violation|3
64248|NCT01370733|256456|P1|Overall Study|Protocol Violation|1
64249|NCT01370733|256455|P2|Overall Study|Physician Decision|2
64250|NCT01370733|256456|P1|Overall Study|Physician Decision|0
64251|NCT01370733|256455|P2|Overall Study|Lack of Efficacy|5
64252|NCT01370733|256456|P1|Overall Study|Lack of Efficacy|3
64253|NCT01370733|256455|P2|Overall Study|Adverse Event|4
64254|NCT01370733|256456|P1|Overall Study|Adverse Event|2
64255|NCT01370733|256455|P2|Overall Study|Lost to Follow-up|0
64256|NCT01370733|256456|P1|Overall Study|Lost to Follow-up|3
64257|NCT01370733|256455|P2|Overall Study|Withdrawal by Subject|8
64258|NCT01370733|256456|P1|Overall Study|Withdrawal by Subject|8
64259|NCT01370694|256478|P1|Overall Study|Progressive disease|2
64260|NCT01370694|256478|P1|Overall Study|Switched to rituximab|4
64261|NCT01370655|256500|P12|Period 2|Withdrawal by Subject|0
64262|NCT01370655|256501|P11|Period 2|Withdrawal by Subject|0
64263|NCT01370655|256502|P10|Period 2|Withdrawal by Subject|0
64264|NCT01370655|256503|P9|Period 2|Withdrawal by Subject|1
64265|NCT01370655|256504|P8|Period 2|Withdrawal by Subject|0
64266|NCT01370655|256505|P7|Period 2|Withdrawal by Subject|0
64267|NCT01370655|256506|P6|Period 2|Withdrawal by Subject|0
64268|NCT01370655|256507|P5|Period 2|Withdrawal by Subject|0
64269|NCT01370655|256508|P4|Period 2|Withdrawal by Subject|0
64270|NCT01370655|256509|P3|Period 2|Withdrawal by Subject|0
64271|NCT01370655|256510|P2|Period 2|Withdrawal by Subject|0
64272|NCT01370655|256511|P1|Period 2|Withdrawal by Subject|0
64273|NCT01370655|256500|P12|Period 2|met protocol specified stopping criteria|0
64274|NCT01370655|256501|P11|Period 2|met protocol specified stopping criteria|1
64275|NCT01370655|256502|P10|Period 2|met protocol specified stopping criteria|0
64276|NCT01370655|256503|P9|Period 2|met protocol specified stopping criteria|1
64277|NCT01370655|256504|P8|Period 2|met protocol specified stopping criteria|0
64278|NCT01370655|256505|P7|Period 2|met protocol specified stopping criteria|1
64279|NCT01370655|256506|P6|Period 2|met protocol specified stopping criteria|0
64280|NCT01370655|256507|P5|Period 2|met protocol specified stopping criteria|0
64281|NCT01370655|256508|P4|Period 2|met protocol specified stopping criteria|0
64282|NCT01370655|256509|P3|Period 2|met protocol specified stopping criteria|1
64283|NCT01370655|256510|P2|Period 2|met protocol specified stopping criteria|0
64284|NCT01370655|256511|P1|Period 2|met protocol specified stopping criteria|0
64285|NCT01370655|256500|P12|Period 2|Adverse Event|0
64286|NCT01370655|256501|P11|Period 2|Adverse Event|0
64287|NCT01370655|256502|P10|Period 2|Adverse Event|0
64288|NCT01370655|256503|P9|Period 2|Adverse Event|0
64289|NCT01370655|256504|P8|Period 2|Adverse Event|1
64290|NCT01370655|256505|P7|Period 2|Adverse Event|0
64291|NCT01370655|256506|P6|Period 2|Adverse Event|0
64292|NCT01370655|256507|P5|Period 2|Adverse Event|1
64293|NCT01370655|256508|P4|Period 2|Adverse Event|0
64294|NCT01370655|256509|P3|Period 2|Adverse Event|1
64295|NCT01370655|256510|P2|Period 2|Adverse Event|0
64296|NCT01370655|256511|P1|Period 2|Adverse Event|0
64297|NCT01370655|256500|P12|Period 1|Adverse Event|0
64298|NCT01370655|256501|P11|Period 1|Adverse Event|0
64299|NCT01370655|256502|P10|Period 1|Adverse Event|0
64300|NCT01370655|256503|P9|Period 1|Adverse Event|0
64301|NCT01370655|256504|P8|Period 1|Adverse Event|0
64302|NCT01370655|256505|P7|Period 1|Adverse Event|1
64303|NCT01370655|256506|P6|Period 1|Adverse Event|0
64304|NCT01370655|256507|P5|Period 1|Adverse Event|0
64305|NCT01370655|256508|P4|Period 1|Adverse Event|0
64306|NCT01370655|256509|P3|Period 1|Adverse Event|0
64307|NCT01370655|256510|P2|Period 1|Adverse Event|0
64308|NCT01370655|256511|P1|Period 1|Adverse Event|2
64309|NCT01370642|256548|P3|Overall Study|Withdrawal by Subject|3
64310|NCT01370642|256549|P2|Overall Study|Withdrawal by Subject|4
64311|NCT01370642|256550|P1|Overall Study|Withdrawal by Subject|2
64312|NCT01370642|256548|P3|Overall Study|Physician Decision|2
64313|NCT01370642|256549|P2|Overall Study|Physician Decision|1
64314|NCT01370642|256550|P1|Overall Study|Physician Decision|4
64315|NCT01370642|256548|P3|Overall Study|Lost to Follow-up|1
64316|NCT01370642|256549|P2|Overall Study|Lost to Follow-up|0
64317|NCT01370642|256550|P1|Overall Study|Lost to Follow-up|0
64318|NCT01370642|256548|P3|Overall Study|Detectable HCV RNA|22
64319|NCT01370642|256549|P2|Overall Study|Detectable HCV RNA|0
64320|NCT01370642|256550|P1|Overall Study|Detectable HCV RNA|0
64321|NCT01370642|256548|P3|Overall Study|Adverse Event|1
64322|NCT01370642|256549|P2|Overall Study|Adverse Event|1
64323|NCT01370642|256550|P1|Overall Study|Adverse Event|2
64324|NCT01370616|256581|P2|Overall Study|Withdrawal by Subject|34
64325|NCT01370616|256582|P1|Overall Study|Withdrawal by Subject|34
64326|NCT01370616|256581|P2|Overall Study|Technical Problems|5
64327|NCT01370616|256582|P1|Overall Study|Technical Problems|3
64328|NCT01370616|256581|P2|Overall Study|Recovery|0
64329|NCT01370616|256582|P1|Overall Study|Recovery|1
64330|NCT01370616|256581|P2|Overall Study|Progressive Disease|1
64331|NCT01370616|256582|P1|Overall Study|Progressive Disease|0
64332|NCT01370616|256581|P2|Overall Study|Physician Decision|6
64333|NCT01370616|256582|P1|Overall Study|Physician Decision|6
64334|NCT01370616|256581|P2|Overall Study|Lost to Follow-up|3
64335|NCT01370616|256582|P1|Overall Study|Lost to Follow-up|0
64336|NCT01370616|256581|P2|Overall Study|Lack of Efficacy|2
64337|NCT01370616|256582|P1|Overall Study|Lack of Efficacy|6
64338|NCT01370616|256581|P2|Overall Study|Death|0
64339|NCT01370616|256582|P1|Overall Study|Death|1
64340|NCT01370616|256581|P2|Overall Study|Adverse Event|16
64341|NCT01370616|256582|P1|Overall Study|Adverse Event|11
64342|NCT01370603|256606|P2|Period 2|Withdrawal by Subject|0
64343|NCT01370603|256607|P1|Period 2|Withdrawal by Subject|1
64344|NCT01370603|256606|P2|Period 2|Lost to Follow-up|0
64345|NCT01370603|256607|P1|Period 2|Lost to Follow-up|1
64346|NCT01370603|256606|P2|Period 2|Adverse Event|4
64347|NCT01370603|256607|P1|Period 2|Adverse Event|1
64348|NCT01370603|256606|P2|Crossover Washout|Non-compliance with Study Drug|2
64349|NCT01370603|256607|P1|Crossover Washout|Non-compliance with Study Drug|0
64350|NCT01370603|256606|P2|Crossover Washout|Withdrawal by Subject|1
64351|NCT01370603|256607|P1|Crossover Washout|Withdrawal by Subject|4
64352|NCT01370603|256606|P2|Crossover Washout|Protocol Violation|0
64353|NCT01370603|256607|P1|Crossover Washout|Protocol Violation|1
64354|NCT01370603|256606|P2|Crossover Washout|Lost to Follow-up|0
64355|NCT01370603|256607|P1|Crossover Washout|Lost to Follow-up|2
64356|NCT01370603|256606|P2|Crossover Washout|Adverse Event|1
64357|NCT01370603|256607|P1|Crossover Washout|Adverse Event|2
64358|NCT01370603|256606|P2|Period 1|Withdrawal by Subject|5
64359|NCT01370603|256607|P1|Period 1|Withdrawal by Subject|5
64360|NCT01370603|256606|P2|Period 1|Protocol Violation|2
64361|NCT01370603|256607|P1|Period 1|Protocol Violation|2
64362|NCT01370603|256606|P2|Period 1|Lost to Follow-up|0
64363|NCT01370603|256607|P1|Period 1|Lost to Follow-up|2
64364|NCT01370603|256606|P2|Period 1|Adverse Event|3
64365|NCT01370603|256607|P1|Period 1|Adverse Event|5
64366|NCT01370590|256625|P2|Period 2|Withdrawal by Subject|1
64367|NCT01370590|256626|P1|Period 2|Withdrawal by Subject|1
64368|NCT01370590|256625|P2|Period 2|Adverse Event|1
64369|NCT01370590|256626|P1|Period 2|Adverse Event|0
64370|NCT01370590|256625|P2|Crossover Washout Period|Withdrawal by Subject|2
64371|NCT01370590|256626|P1|Crossover Washout Period|Withdrawal by Subject|2
64372|NCT01370590|256625|P2|Crossover Washout Period|Non-compliance with Study Drug|0
64373|NCT01370590|256626|P1|Crossover Washout Period|Non-compliance with Study Drug|1
64374|NCT01370590|256625|P2|Crossover Washout Period|Lost to Follow-up|0
64375|NCT01370590|256626|P1|Crossover Washout Period|Lost to Follow-up|2
64376|NCT01370590|256625|P2|Crossover Washout Period|Adverse Event|4
64377|NCT01370590|256626|P1|Crossover Washout Period|Adverse Event|1
64378|NCT01370590|256625|P2|Period 1|Could not access randomization system|1
64379|NCT01370590|256626|P1|Period 1|Could not access randomization system|0
64380|NCT01370590|256625|P2|Period 1|Withdrawal by Subject|2
64381|NCT01370590|256626|P1|Period 1|Withdrawal by Subject|4
64382|NCT01370590|256625|P2|Period 1|Protocol Violation|2
64383|NCT01370590|256626|P1|Period 1|Protocol Violation|2
64384|NCT01370590|256625|P2|Period 1|Lost to Follow-up|2
64385|NCT01370590|256626|P1|Period 1|Lost to Follow-up|2
64386|NCT01370590|256625|P2|Period 1|Adverse Event|4
64387|NCT01370590|256626|P1|Period 1|Adverse Event|8
64388|NCT01370538|256644|P2|Overall Study|Lost to follow up|10
64389|NCT01370538|256645|P1|Overall Study|Lost to follow up|6
64390|NCT01370538|256644|P2|Overall Study|Development of study specific withdrawal|1
64391|NCT01370538|256645|P1|Overall Study|Development of study specific withdrawal|1
64392|NCT01370538|256644|P2|Overall Study|Protocol Violation|5
64393|NCT01370538|256645|P1|Overall Study|Protocol Violation|8
64394|NCT01370538|256644|P2|Overall Study|Adverse Event|0
64395|NCT01370538|256645|P1|Overall Study|Adverse Event|1
64396|NCT01370538|256644|P2|Overall Study|Eligibility criteria not fulfilled|1
64397|NCT01370538|256645|P1|Overall Study|Eligibility criteria not fulfilled|0
64398|NCT01370538|256644|P2|Overall Study|Voluntary Discontinuation by Subject|2
64399|NCT01370538|256645|P1|Overall Study|Voluntary Discontinuation by Subject|3
64400|NCT01370525|256661|P2|Overall Study|Lost to follow up|6
64401|NCT01370525|256662|P1|Overall Study|Lost to follow up|2
64402|NCT01370525|256661|P2|Overall Study|Protocol Violation|1
64403|NCT01370525|256662|P1|Overall Study|Protocol Violation|2
64404|NCT01370525|256661|P2|Overall Study|Adverse Event|1
64405|NCT01370525|256662|P1|Overall Study|Adverse Event|0
64406|NCT01370525|256661|P2|Overall Study|Eligibility criteria not fulfilled|0
64407|NCT01370525|256662|P1|Overall Study|Eligibility criteria not fulfilled|2
64408|NCT01370525|256661|P2|Overall Study|Voluntary Discontinuation by Subject|3
64409|NCT01370525|256662|P1|Overall Study|Voluntary Discontinuation by Subject|2
64410|NCT01370408|256686|P1|Overall Study|treatment failure|9
64411|NCT01370356|256746|P2|Overall Study|AE Not Related to Study Drug|4
64412|NCT01370356|256747|P1|Overall Study|AE Not Related to Study Drug|1
64413|NCT01370356|256746|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
64414|NCT01370356|256747|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
64415|NCT01370356|256746|P2|Overall Study|Protocol Violation|3
64416|NCT01370356|256747|P1|Overall Study|Protocol Violation|3
64417|NCT01370356|256746|P2|Overall Study|Reason not specified|43
64418|NCT01370356|256747|P1|Overall Study|Reason not specified|39
64419|NCT01370356|256746|P2|Overall Study|Withdrawal by Subject|59
64420|NCT01370356|256747|P1|Overall Study|Withdrawal by Subject|54
64421|NCT01370356|256746|P2|Overall Study|Lost to Follow-up|81
64422|NCT01370356|256747|P1|Overall Study|Lost to Follow-up|76
64423|NCT01370356|256746|P2|Overall Study|Lack of Efficacy|28
64424|NCT01370356|256747|P1|Overall Study|Lack of Efficacy|6
64425|NCT01370356|256746|P2|Overall Study|Death|0
64426|NCT01370356|256747|P1|Overall Study|Death|1
64427|NCT01370265|256761|P2|First Intervention|Adverse Event|1
64428|NCT01370265|256762|P1|First Intervention|Adverse Event|1
64429|NCT01370083|256781|P2|Overall Study|Adverse Event|1
64430|NCT01370083|256782|P1|Overall Study|Adverse Event|0
64431|NCT01370083|256781|P2|Overall Study|Lost to Follow-up|0
64432|NCT01370083|256782|P1|Overall Study|Lost to Follow-up|2
64433|NCT01370005|256795|P3|Overall Study|Other reason not defined above|2
64434|NCT01370005|256796|P2|Overall Study|Other reason not defined above|0
64435|NCT01370005|256797|P1|Overall Study|Other reason not defined above|3
64436|NCT01370005|256795|P3|Overall Study|Patient refusal to continue,not due toAE|0
64437|NCT01370005|256796|P2|Overall Study|Patient refusal to continue,not due toAE|4
64438|NCT01370005|256797|P1|Overall Study|Patient refusal to continue,not due toAE|5
64439|NCT01370005|256795|P3|Overall Study|Lost to Follow-up|1
64440|NCT01370005|256796|P2|Overall Study|Lost to Follow-up|1
64441|NCT01370005|256797|P1|Overall Study|Lost to Follow-up|1
64442|NCT01370005|256795|P3|Overall Study|Non compliant with protocol|2
64443|NCT01370005|256796|P2|Overall Study|Non compliant with protocol|1
64444|NCT01370005|256797|P1|Overall Study|Non compliant with protocol|0
64445|NCT01370005|256795|P3|Overall Study|Lack of Efficacy|0
64446|NCT01370005|256796|P2|Overall Study|Lack of Efficacy|0
64447|NCT01370005|256797|P1|Overall Study|Lack of Efficacy|1
64448|NCT01370005|256795|P3|Overall Study|Adverse Event|6
64449|NCT01370005|256796|P2|Overall Study|Adverse Event|5
64450|NCT01370005|256797|P1|Overall Study|Adverse Event|5
64451|NCT01370005|256795|P3|Overall Study|Not treated|0
64452|NCT01370005|256796|P2|Overall Study|Not treated|0
64453|NCT01370005|256797|P1|Overall Study|Not treated|1
64454|NCT01369849|256879|P3|Overall Study|Ineligible after receiving treatment|0
64455|NCT01369849|256880|P2|Overall Study|Ineligible after receiving treatment|1
64456|NCT01369849|256881|P1|Overall Study|Ineligible after receiving treatment|0
64457|NCT01369849|256879|P3|Overall Study|Ineligible prior to treatment|1
64458|NCT01369849|256880|P2|Overall Study|Ineligible prior to treatment|0
64459|NCT01369849|256881|P1|Overall Study|Ineligible prior to treatment|0
64460|NCT01369784|256903|P1|Overall Study|Protocol Violation|12
64461|NCT01369680|256991|P4|Overall Study|Lost to Follow-up|2
64462|NCT01369680|256992|P3|Overall Study|Lost to Follow-up|1
64463|NCT01369680|256993|P2|Overall Study|Lost to Follow-up|0
64464|NCT01369680|256994|P1|Overall Study|Lost to Follow-up|0
64465|NCT01369641|257015|P1|Overall Study|Withdrawal by Subject|1
64466|NCT01369615|257021|P2|Overall Study|Lost to Follow-up|1
64467|NCT01369615|257022|P1|Overall Study|Lost to Follow-up|0
64468|NCT01369615|257021|P2|Overall Study|Withdrawal by Subject|1
64469|NCT01369615|257022|P1|Overall Study|Withdrawal by Subject|0
64470|NCT01369485|257030|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
64471|NCT01369485|257031|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
64472|NCT01369485|257030|P2|Open Label Phase (Week 12 to Month 12)|Death|1
64473|NCT01369485|257031|P1|Open Label Phase (Week 12 to Month 12)|Death|0
64474|NCT01369485|257030|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
64475|NCT01369485|257031|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
64476|NCT01369485|257030|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
64477|NCT01369485|257031|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
64478|NCT01369485|257030|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
64479|NCT01369485|257031|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
64480|NCT01369485|257030|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
64481|NCT01369485|257031|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
64482|NCT01369485|257030|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
64483|NCT01369485|257031|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
64484|NCT01369485|257030|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
64485|NCT01369485|257031|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
64486|NCT01369485|257030|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
64487|NCT01369485|257031|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
64488|NCT01369485|257030|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
64489|NCT01369485|257031|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
64490|NCT01369355|257077|P6|Overall Study|Not Treated|0
64491|NCT01369355|257078|P5|Overall Study|Not Treated|0
64492|NCT01369355|257079|P4|Overall Study|Not Treated|0
64493|NCT01369355|257080|P3|Overall Study|Not Treated|1
64494|NCT01369355|257081|P2|Overall Study|Not Treated|0
64495|NCT01369355|257082|P1|Overall Study|Not Treated|0
64496|NCT01369355|257077|P6|Overall Study|Other|0
64497|NCT01369355|257078|P5|Overall Study|Other|1
64498|NCT01369355|257079|P4|Overall Study|Other|0
64499|NCT01369355|257080|P3|Overall Study|Other|0
64500|NCT01369355|257081|P2|Overall Study|Other|0
64501|NCT01369355|257082|P1|Overall Study|Other|0
64502|NCT01369355|257077|P6|Overall Study|Withdrawal by Subject|22
64503|NCT01369355|257078|P5|Overall Study|Withdrawal by Subject|8
64504|NCT01369355|257079|P4|Overall Study|Withdrawal by Subject|6
64505|NCT01369355|257080|P3|Overall Study|Withdrawal by Subject|7
64506|NCT01369355|257081|P2|Overall Study|Withdrawal by Subject|2
64507|NCT01369355|257082|P1|Overall Study|Withdrawal by Subject|6
64508|NCT01369355|257077|P6|Overall Study|Lost to Follow-up|6
64509|NCT01369355|257078|P5|Overall Study|Lost to Follow-up|5
64510|NCT01369355|257079|P4|Overall Study|Lost to Follow-up|2
64511|NCT01369355|257080|P3|Overall Study|Lost to Follow-up|1
64512|NCT01369355|257081|P2|Overall Study|Lost to Follow-up|0
64513|NCT01369355|257082|P1|Overall Study|Lost to Follow-up|1
64514|NCT01369355|257077|P6|Overall Study|Protocol Violation|2
64515|NCT01369355|257078|P5|Overall Study|Protocol Violation|0
64516|NCT01369355|257079|P4|Overall Study|Protocol Violation|0
64517|NCT01369355|257080|P3|Overall Study|Protocol Violation|1
64518|NCT01369355|257081|P2|Overall Study|Protocol Violation|1
64519|NCT01369355|257082|P1|Overall Study|Protocol Violation|0
64520|NCT01369355|257077|P6|Overall Study|Lack of Efficacy|217
64521|NCT01369355|257078|P5|Overall Study|Lack of Efficacy|126
64522|NCT01369355|257079|P4|Overall Study|Lack of Efficacy|15
64523|NCT01369355|257080|P3|Overall Study|Lack of Efficacy|15
64524|NCT01369355|257081|P2|Overall Study|Lack of Efficacy|14
64525|NCT01369355|257082|P1|Overall Study|Lack of Efficacy|15
64526|NCT01369355|257077|P6|Overall Study|Adverse Event|25
64527|NCT01369355|257078|P5|Overall Study|Adverse Event|14
64528|NCT01369355|257079|P4|Overall Study|Adverse Event|7
64529|NCT01369355|257080|P3|Overall Study|Adverse Event|6
64530|NCT01369355|257081|P2|Overall Study|Adverse Event|12
64531|NCT01369355|257082|P1|Overall Study|Adverse Event|9
64532|NCT01369342|257111|P3|Overall Study|Not Treated|0
64533|NCT01369342|257112|P2|Overall Study|Not Treated|0
64534|NCT01369342|257113|P1|Overall Study|Not Treated|1
64535|NCT01369342|257111|P3|Overall Study|Lost to Follow-up|1
64536|NCT01369342|257112|P2|Overall Study|Lost to Follow-up|2
64537|NCT01369342|257113|P1|Overall Study|Lost to Follow-up|5
64538|NCT01369342|257111|P3|Overall Study|Withdrawal by Subject|2
64539|NCT01369342|257112|P2|Overall Study|Withdrawal by Subject|7
64540|NCT01369342|257113|P1|Overall Study|Withdrawal by Subject|7
64541|NCT01369329|257136|P3|Overall Study|Other|2
64542|NCT01369329|257137|P2|Overall Study|Other|3
64543|NCT01369329|257138|P1|Overall Study|Other|2
64544|NCT01369329|257136|P3|Overall Study|Lost to Follow-up|2
64545|NCT01369329|257137|P2|Overall Study|Lost to Follow-up|2
64546|NCT01369329|257138|P1|Overall Study|Lost to Follow-up|2
64547|NCT01369329|257136|P3|Overall Study|Withdrawal by Subject|10
64548|NCT01369329|257137|P2|Overall Study|Withdrawal by Subject|6
64549|NCT01369329|257138|P1|Overall Study|Withdrawal by Subject|8
64550|NCT01369225|257164|P6|Overall Study|Adverse Event|0
64551|NCT01369225|257165|P5|Overall Study|Adverse Event|1
64552|NCT01369225|257166|P4|Overall Study|Adverse Event|1
64553|NCT01369225|257167|P3|Overall Study|Adverse Event|0
64554|NCT01369225|257168|P2|Overall Study|Adverse Event|0
64555|NCT01369225|257169|P1|Overall Study|Adverse Event|0
64556|NCT01369225|257164|P6|Overall Study|Other|0
64557|NCT01369225|257165|P5|Overall Study|Other|1
64558|NCT01369225|257166|P4|Overall Study|Other|0
64559|NCT01369225|257167|P3|Overall Study|Other|0
64560|NCT01369225|257168|P2|Overall Study|Other|0
64561|NCT01369225|257169|P1|Overall Study|Other|1
64562|NCT01369225|257164|P6|Overall Study|Does Not Meet Entrance Criteria|0
64563|NCT01369225|257165|P5|Overall Study|Does Not Meet Entrance Criteria|0
64564|NCT01369225|257166|P4|Overall Study|Does Not Meet Entrance Criteria|0
64565|NCT01369225|257167|P3|Overall Study|Does Not Meet Entrance Criteria|1
64566|NCT01369225|257168|P2|Overall Study|Does Not Meet Entrance Criteria|0
64567|NCT01369225|257169|P1|Overall Study|Does Not Meet Entrance Criteria|0
64568|NCT01369225|257164|P6|Overall Study|Withdrawal by Subject|0
64569|NCT01369225|257165|P5|Overall Study|Withdrawal by Subject|0
64570|NCT01369225|257166|P4|Overall Study|Withdrawal by Subject|1
64571|NCT01369225|257167|P3|Overall Study|Withdrawal by Subject|2
64572|NCT01369225|257168|P2|Overall Study|Withdrawal by Subject|0
64573|NCT01369225|257169|P1|Overall Study|Withdrawal by Subject|1
64574|NCT01368965|257274|P1|Overall Study|Lost to Follow-up|12
64575|NCT01368900|257283|P1|Overall Study|Lost to Follow-up|7
64576|NCT01368835|257358|P1|Overall Study|Lost to Follow-up|11
64577|NCT01368835|257358|P1|Overall Study|Inclusion criteria/photography quality|22
64578|NCT01368536|257400|P3|Overall Study|Protocol deviation|1
64579|NCT01368536|257401|P2|Overall Study|Protocol deviation|3
64580|NCT01368536|257402|P1|Overall Study|Protocol deviation|0
64581|NCT01368536|257400|P3|Overall Study|Administrative problems|35
64582|NCT01368536|257401|P2|Overall Study|Administrative problems|39
64583|NCT01368536|257402|P1|Overall Study|Administrative problems|34
64584|NCT01368536|257400|P3|Overall Study|Lost to Follow-up|5
64585|NCT01368536|257401|P2|Overall Study|Lost to Follow-up|3
64586|NCT01368536|257402|P1|Overall Study|Lost to Follow-up|3
64587|NCT01368536|257400|P3|Overall Study|Withdrawal by Subject|4
64588|NCT01368536|257401|P2|Overall Study|Withdrawal by Subject|5
64589|NCT01368536|257402|P1|Overall Study|Withdrawal by Subject|2
64590|NCT01368536|257400|P3|Overall Study|No longer required study medication|1
64591|NCT01368536|257401|P2|Overall Study|No longer required study medication|0
64592|NCT01368536|257402|P1|Overall Study|No longer required study medication|0
64593|NCT01368536|257400|P3|Overall Study|Unsatisfactory therapeutic effect|2
64594|NCT01368536|257401|P2|Overall Study|Unsatisfactory therapeutic effect|2
64595|NCT01368536|257402|P1|Overall Study|Unsatisfactory therapeutic effect|7
64596|NCT01368536|257400|P3|Overall Study|Abnormal test procedure result(s)|1
64597|NCT01368536|257401|P2|Overall Study|Abnormal test procedure result(s)|0
64598|NCT01368536|257402|P1|Overall Study|Abnormal test procedure result(s)|0
64599|NCT01368536|257400|P3|Overall Study|Abnormal laboratory value(s)|2
64600|NCT01368536|257401|P2|Overall Study|Abnormal laboratory value(s)|1
64601|NCT01368536|257402|P1|Overall Study|Abnormal laboratory value(s)|0
64602|NCT01368536|257400|P3|Overall Study|Adverse Event|8
64603|NCT01368536|257401|P2|Overall Study|Adverse Event|6
64604|NCT01368536|257402|P1|Overall Study|Adverse Event|5
64605|NCT01368432|257425|P2|Overall Study|Lost to Follow-up|1
64606|NCT01368432|257426|P1|Overall Study|Lost to Follow-up|0
64607|NCT01368406|257460|P2|Overall Study|started working|3
64608|NCT01368406|257461|P1|Overall Study|started working|2
64609|NCT01368406|257460|P2|Overall Study|relapse of the disease|2
64610|NCT01368406|257461|P1|Overall Study|relapse of the disease|3
64611|NCT01368406|257460|P2|Overall Study|Withdrawal by Subject|4
64612|NCT01368406|257461|P1|Overall Study|Withdrawal by Subject|8
64613|NCT01368406|257460|P2|Overall Study|Lost to Follow-up|4
64614|NCT01368406|257461|P1|Overall Study|Lost to Follow-up|8
64615|NCT01368276|257469|P2|Overall Study|Death|10
64616|NCT01368276|257470|P1|Overall Study|Death|1
64617|NCT01368211|257507|P2|Second Platelets Transfusion|No need for additional transfusion|2
64618|NCT01368211|257508|P1|Second Platelets Transfusion|No need for additional transfusion|1
64619|NCT01368081|257536|P13|Overall Study|Other reason not defined above|3
64620|NCT01368081|257537|P12|Overall Study|Other reason not defined above|0
64621|NCT01368081|257538|P11|Overall Study|Other reason not defined above|0
64622|NCT01368081|257539|P10|Overall Study|Other reason not defined above|1
64623|NCT01368081|257540|P9|Overall Study|Other reason not defined above|0
64624|NCT01368081|257541|P8|Overall Study|Other reason not defined above|0
64625|NCT01368081|257542|P7|Overall Study|Other reason not defined above|2
64626|NCT01368081|257543|P6|Overall Study|Other reason not defined above|1
64627|NCT01368081|257544|P5|Overall Study|Other reason not defined above|0
64628|NCT01368081|257545|P4|Overall Study|Other reason not defined above|1
64629|NCT01368081|257546|P3|Overall Study|Other reason not defined above|0
64630|NCT01368081|257547|P2|Overall Study|Other reason not defined above|0
64631|NCT01368081|257548|P1|Overall Study|Other reason not defined above|2
64632|NCT01368081|257536|P13|Overall Study|Withdrawal by Subject|0
64633|NCT01368081|257537|P12|Overall Study|Withdrawal by Subject|2
64634|NCT01368081|257538|P11|Overall Study|Withdrawal by Subject|3
64635|NCT01368081|257539|P10|Overall Study|Withdrawal by Subject|4
64636|NCT01368081|257540|P9|Overall Study|Withdrawal by Subject|5
64637|NCT01368081|257541|P8|Overall Study|Withdrawal by Subject|2
64638|NCT01368081|257542|P7|Overall Study|Withdrawal by Subject|4
64639|NCT01368081|257543|P6|Overall Study|Withdrawal by Subject|3
64640|NCT01368081|257544|P5|Overall Study|Withdrawal by Subject|0
64641|NCT01368081|257545|P4|Overall Study|Withdrawal by Subject|1
64642|NCT01368081|257546|P3|Overall Study|Withdrawal by Subject|1
64643|NCT01368081|257547|P2|Overall Study|Withdrawal by Subject|4
64644|NCT01368081|257548|P1|Overall Study|Withdrawal by Subject|4
64645|NCT01368081|257536|P13|Overall Study|Lost to Follow-up|1
64646|NCT01368081|257537|P12|Overall Study|Lost to Follow-up|0
64647|NCT01368081|257538|P11|Overall Study|Lost to Follow-up|0
64648|NCT01368081|257539|P10|Overall Study|Lost to Follow-up|0
64649|NCT01368081|257540|P9|Overall Study|Lost to Follow-up|0
64650|NCT01368081|257541|P8|Overall Study|Lost to Follow-up|0
64651|NCT01368081|257542|P7|Overall Study|Lost to Follow-up|0
64652|NCT01368081|257543|P6|Overall Study|Lost to Follow-up|0
64653|NCT01368081|257544|P5|Overall Study|Lost to Follow-up|0
64654|NCT01368081|257545|P4|Overall Study|Lost to Follow-up|0
64655|NCT01368081|257546|P3|Overall Study|Lost to Follow-up|0
64656|NCT01368081|257547|P2|Overall Study|Lost to Follow-up|0
64657|NCT01368081|257548|P1|Overall Study|Lost to Follow-up|0
64658|NCT01368081|257536|P13|Overall Study|Protocol Violation|0
64659|NCT01368081|257537|P12|Overall Study|Protocol Violation|0
64660|NCT01368081|257538|P11|Overall Study|Protocol Violation|0
64661|NCT01368081|257539|P10|Overall Study|Protocol Violation|0
64662|NCT01368081|257540|P9|Overall Study|Protocol Violation|0
64663|NCT01368081|257541|P8|Overall Study|Protocol Violation|1
64664|NCT01368081|257542|P7|Overall Study|Protocol Violation|0
64665|NCT01368081|257543|P6|Overall Study|Protocol Violation|1
64666|NCT01368081|257544|P5|Overall Study|Protocol Violation|0
64667|NCT01368081|257545|P4|Overall Study|Protocol Violation|0
64668|NCT01368081|257546|P3|Overall Study|Protocol Violation|0
64669|NCT01368081|257547|P2|Overall Study|Protocol Violation|0
64670|NCT01368081|257548|P1|Overall Study|Protocol Violation|0
64671|NCT01368081|257536|P13|Overall Study|Lack of Efficacy|0
64672|NCT01368081|257537|P12|Overall Study|Lack of Efficacy|0
64673|NCT01368081|257538|P11|Overall Study|Lack of Efficacy|0
64674|NCT01368081|257539|P10|Overall Study|Lack of Efficacy|0
64675|NCT01368081|257540|P9|Overall Study|Lack of Efficacy|0
64676|NCT01368081|257541|P8|Overall Study|Lack of Efficacy|2
64677|NCT01368081|257542|P7|Overall Study|Lack of Efficacy|0
64678|NCT01368081|257543|P6|Overall Study|Lack of Efficacy|0
64679|NCT01368081|257544|P5|Overall Study|Lack of Efficacy|0
64680|NCT01368081|257545|P4|Overall Study|Lack of Efficacy|1
64681|NCT01368081|257546|P3|Overall Study|Lack of Efficacy|0
64682|NCT01368081|257547|P2|Overall Study|Lack of Efficacy|1
64683|NCT01368081|257548|P1|Overall Study|Lack of Efficacy|0
64684|NCT01368081|257536|P13|Overall Study|Adverse Event|3
64685|NCT01368081|257537|P12|Overall Study|Adverse Event|1
64686|NCT01368081|257538|P11|Overall Study|Adverse Event|6
64687|NCT01368081|257539|P10|Overall Study|Adverse Event|5
64688|NCT01368081|257540|P9|Overall Study|Adverse Event|3
64689|NCT01368081|257541|P8|Overall Study|Adverse Event|2
64690|NCT01368081|257542|P7|Overall Study|Adverse Event|6
64691|NCT01368081|257543|P6|Overall Study|Adverse Event|5
64692|NCT01368081|257544|P5|Overall Study|Adverse Event|2
64693|NCT01368081|257545|P4|Overall Study|Adverse Event|2
64694|NCT01368081|257546|P3|Overall Study|Adverse Event|3
64695|NCT01368081|257547|P2|Overall Study|Adverse Event|4
64696|NCT01368081|257548|P1|Overall Study|Adverse Event|4
64697|NCT01368042|257602|P1|Overall Study|Transplanted|1
64698|NCT01368042|257602|P1|Overall Study|Lost to Follow-up|4
64699|NCT01368042|257602|P1|Overall Study|Protocol Violation|11
64700|NCT01368042|257602|P1|Overall Study|Death|14
64701|NCT01367886|257622|P1|Overall Study|Death|1
64702|NCT01367886|257622|P1|Overall Study|Lack of Efficacy|2
64703|NCT01367886|257622|P1|Overall Study|Lost to Follow-up|4
64704|NCT01367834|257672|P2|Overall Study|Study was ended.|1
64705|NCT01367834|257673|P1|Overall Study|Study was ended.|0
64706|NCT01367834|257672|P2|Overall Study|Withdrawal by Subject|2
64707|NCT01367834|257673|P1|Overall Study|Withdrawal by Subject|2
64708|NCT01367704|257697|P2|Overall Study|Lost to Follow-up|161
64709|NCT01367704|257698|P1|Overall Study|Lost to Follow-up|47
64710|NCT01367457|257711|P3|Overall Study|Suspected DP/suspected active infection|0
64711|NCT01367457|257712|P2|Overall Study|Suspected DP/suspected active infection|0
64712|NCT01367457|257713|P1|Overall Study|Suspected DP/suspected active infection|1
64713|NCT01367457|257711|P3|Overall Study|Palliative. Overall decline|0
64714|NCT01367457|257712|P2|Overall Study|Palliative. Overall decline|0
64715|NCT01367457|257713|P1|Overall Study|Palliative. Overall decline|1
64716|NCT01367457|257711|P3|Overall Study|Patient's Wish|0
64717|NCT01367457|257712|P2|Overall Study|Patient's Wish|0
64718|NCT01367457|257713|P1|Overall Study|Patient's Wish|1
64719|NCT01367457|257711|P3|Overall Study|CD, Suspected disease progression (DP)|0
64720|NCT01367457|257712|P2|Overall Study|CD, Suspected disease progression (DP)|0
64721|NCT01367457|257713|P1|Overall Study|CD, Suspected disease progression (DP)|1
64722|NCT01367457|257711|P3|Overall Study|Death from septic shock|0
64723|NCT01367457|257712|P2|Overall Study|Death from septic shock|0
64724|NCT01367457|257713|P1|Overall Study|Death from septic shock|1
64725|NCT01367457|257711|P3|Overall Study|Lost to Follow-up|0
64726|NCT01367457|257712|P2|Overall Study|Lost to Follow-up|0
64727|NCT01367457|257713|P1|Overall Study|Lost to Follow-up|1
64728|NCT01367457|257711|P3|Overall Study|Rejection of treatment|0
64729|NCT01367457|257712|P2|Overall Study|Rejection of treatment|0
64730|NCT01367457|257713|P1|Overall Study|Rejection of treatment|1
64731|NCT01367457|257711|P3|Overall Study|Overall decline|0
64732|NCT01367457|257712|P2|Overall Study|Overall decline|0
64733|NCT01367457|257713|P1|Overall Study|Overall decline|1
64734|NCT01367457|257711|P3|Overall Study|Intestinal obstruction with necrosis|0
64735|NCT01367457|257712|P2|Overall Study|Intestinal obstruction with necrosis|0
64736|NCT01367457|257713|P1|Overall Study|Intestinal obstruction with necrosis|1
64737|NCT01367457|257711|P3|Overall Study|No clinical benefit|0
64738|NCT01367457|257712|P2|Overall Study|No clinical benefit|0
64739|NCT01367457|257713|P1|Overall Study|No clinical benefit|1
64740|NCT01367457|257711|P3|Overall Study|Stabilisation + frequent infections|0
64741|NCT01367457|257712|P2|Overall Study|Stabilisation + frequent infections|0
64742|NCT01367457|257713|P1|Overall Study|Stabilisation + frequent infections|1
64743|NCT01367457|257711|P3|Overall Study|Overall status worsens to grade 4|0
64744|NCT01367457|257712|P2|Overall Study|Overall status worsens to grade 4|0
64745|NCT01367457|257713|P1|Overall Study|Overall status worsens to grade 4|1
64746|NCT01367457|257711|P3|Overall Study|Uncontrolled pain|0
64747|NCT01367457|257712|P2|Overall Study|Uncontrolled pain|0
64748|NCT01367457|257713|P1|Overall Study|Uncontrolled pain|1
64749|NCT01367457|257711|P3|Overall Study|CD, associated leukaemia|0
64750|NCT01367457|257712|P2|Overall Study|CD, associated leukaemia|0
64751|NCT01367457|257713|P1|Overall Study|CD, associated leukaemia|1
64752|NCT01367457|257711|P3|Overall Study|Withdrawal by Subject|0
64753|NCT01367457|257712|P2|Overall Study|Withdrawal by Subject|0
64754|NCT01367457|257713|P1|Overall Study|Withdrawal by Subject|1
64755|NCT01367457|257711|P3|Overall Study|Choledocolithiasis and pancreatitis|0
64756|NCT01367457|257712|P2|Overall Study|Choledocolithiasis and pancreatitis|0
64757|NCT01367457|257713|P1|Overall Study|Choledocolithiasis and pancreatitis|1
64758|NCT01367457|257711|P3|Overall Study|low grade toxicities + stable disease|0
64759|NCT01367457|257712|P2|Overall Study|low grade toxicities + stable disease|0
64760|NCT01367457|257713|P1|Overall Study|low grade toxicities + stable disease|1
64761|NCT01367457|257711|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
64762|NCT01367457|257712|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
64763|NCT01367457|257713|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
64764|NCT01367457|257711|P3|Overall Study|Bleeding from cavernous haemangioma|0
64765|NCT01367457|257712|P2|Overall Study|Bleeding from cavernous haemangioma|0
64766|NCT01367457|257713|P1|Overall Study|Bleeding from cavernous haemangioma|1
64767|NCT01367457|257711|P3|Overall Study|Investigator's opinion, stable disease|0
64768|NCT01367457|257712|P2|Overall Study|Investigator's opinion, stable disease|0
64769|NCT01367457|257713|P1|Overall Study|Investigator's opinion, stable disease|1
64770|NCT01367457|257711|P3|Overall Study|Patient asks for rest + slow progression|0
64771|NCT01367457|257712|P2|Overall Study|Patient asks for rest + slow progression|0
64772|NCT01367457|257713|P1|Overall Study|Patient asks for rest + slow progression|1
64773|NCT01367457|257711|P3|Overall Study|Progression|0
64774|NCT01367457|257712|P2|Overall Study|Progression|0
64775|NCT01367457|257713|P1|Overall Study|Progression|137
64776|NCT01367457|257711|P3|Overall Study|Toxicity|0
64777|NCT01367457|257712|P2|Overall Study|Toxicity|0
64778|NCT01367457|257713|P1|Overall Study|Toxicity|16
64779|NCT01367457|257711|P3|Overall Study|Progression and death|0
64780|NCT01367457|257712|P2|Overall Study|Progression and death|0
64781|NCT01367457|257713|P1|Overall Study|Progression and death|8
64782|NCT01367457|257711|P3|Overall Study|Clinical decline (CD)|0
64783|NCT01367457|257712|P2|Overall Study|Clinical decline (CD)|0
64784|NCT01367457|257713|P1|Overall Study|Clinical decline (CD)|2
64785|NCT01367457|257711|P3|Overall Study|Investigator's decision|0
64786|NCT01367457|257712|P2|Overall Study|Investigator's decision|0
64787|NCT01367457|257713|P1|Overall Study|Investigator's decision|2
64788|NCT01367457|257711|P3|Overall Study|Death|0
64789|NCT01367457|257712|P2|Overall Study|Death|0
64790|NCT01367457|257713|P1|Overall Study|Death|2
64791|NCT01367249|257735|P2|Overall Study|Not Specified|10
64792|NCT01367249|257736|P1|Overall Study|Not Specified|3
64793|NCT01367249|257735|P2|Overall Study|Withdrawal by Subject|6
64794|NCT01367249|257736|P1|Overall Study|Withdrawal by Subject|6
64795|NCT01367158|257755|P11|Overall Study|Protocol Violation|0
64796|NCT01367158|257756|P10|Overall Study|Protocol Violation|0
64797|NCT01367158|257757|P9|Overall Study|Protocol Violation|0
64798|NCT01367158|257758|P8|Overall Study|Protocol Violation|0
64799|NCT01367158|257759|P7|Overall Study|Protocol Violation|0
64800|NCT01367158|257760|P6|Overall Study|Protocol Violation|0
64801|NCT01367158|257761|P5|Overall Study|Protocol Violation|0
64802|NCT01367158|257762|P4|Overall Study|Protocol Violation|0
64803|NCT01367158|257763|P3|Overall Study|Protocol Violation|0
64804|NCT01367158|257764|P2|Overall Study|Protocol Violation|1
64805|NCT01367158|257765|P1|Overall Study|Protocol Violation|0
64806|NCT01367158|257755|P11|Overall Study|Lost to Follow-up|1
64807|NCT01367158|257756|P10|Overall Study|Lost to Follow-up|0
64808|NCT01367158|257757|P9|Overall Study|Lost to Follow-up|0
64809|NCT01367158|257758|P8|Overall Study|Lost to Follow-up|1
64810|NCT01367158|257759|P7|Overall Study|Lost to Follow-up|0
64811|NCT01367158|257760|P6|Overall Study|Lost to Follow-up|2
64812|NCT01367158|257761|P5|Overall Study|Lost to Follow-up|0
64813|NCT01367158|257762|P4|Overall Study|Lost to Follow-up|1
64814|NCT01367158|257763|P3|Overall Study|Lost to Follow-up|0
64815|NCT01367158|257764|P2|Overall Study|Lost to Follow-up|0
64816|NCT01367158|257765|P1|Overall Study|Lost to Follow-up|0
64817|NCT01367158|257755|P11|Overall Study|Withdrew consent|0
64818|NCT01367158|257756|P10|Overall Study|Withdrew consent|0
64819|NCT01367158|257757|P9|Overall Study|Withdrew consent|0
64820|NCT01367158|257758|P8|Overall Study|Withdrew consent|1
64821|NCT01367158|257759|P7|Overall Study|Withdrew consent|0
64822|NCT01367158|257760|P6|Overall Study|Withdrew consent|0
64823|NCT01367158|257761|P5|Overall Study|Withdrew consent|2
64824|NCT01367158|257762|P4|Overall Study|Withdrew consent|0
64825|NCT01367158|257763|P3|Overall Study|Withdrew consent|1
64826|NCT01367158|257764|P2|Overall Study|Withdrew consent|2
64827|NCT01367158|257765|P1|Overall Study|Withdrew consent|0
64828|NCT01367119|257909|P2|Overall Study|Withdrawal by Subject|1
64829|NCT01367119|257910|P1|Overall Study|Withdrawal by Subject|1
64830|NCT01367119|257909|P2|Overall Study|Adverse Event|0
64831|NCT01367119|257910|P1|Overall Study|Adverse Event|1
64832|NCT01366846|257965|P4|Overall Study|Scheduling Conflicts|0
64833|NCT01366846|257966|P3|Overall Study|Scheduling Conflicts|1
64834|NCT01366846|257967|P2|Overall Study|Scheduling Conflicts|0
64835|NCT01366846|257968|P1|Overall Study|Scheduling Conflicts|0
64836|NCT01366846|257965|P4|Overall Study|Communication Difficulties|1
64837|NCT01366846|257966|P3|Overall Study|Communication Difficulties|0
64838|NCT01366846|257967|P2|Overall Study|Communication Difficulties|4
64839|NCT01366846|257968|P1|Overall Study|Communication Difficulties|1
64840|NCT01366846|257965|P4|Overall Study|Withdrawal by Subject|0
64841|NCT01366846|257966|P3|Overall Study|Withdrawal by Subject|0
64842|NCT01366846|257967|P2|Overall Study|Withdrawal by Subject|0
64843|NCT01366846|257968|P1|Overall Study|Withdrawal by Subject|2
64844|NCT01366638|257991|P3|Overall Study|Not specified|0
64845|NCT01366638|257992|P2|Overall Study|Not specified|0
64846|NCT01366638|257993|P1|Overall Study|Not specified|1
64847|NCT01366638|257991|P3|Overall Study|Withdrawal by Subject|6
64848|NCT01366638|257992|P2|Overall Study|Withdrawal by Subject|0
64849|NCT01366638|257993|P1|Overall Study|Withdrawal by Subject|0
64850|NCT01366534|258030|P3|Overall Study|Declined challenged|0
64851|NCT01366534|258031|P2|Overall Study|Declined challenged|1
64852|NCT01366534|258032|P1|Overall Study|Declined challenged|0
64853|NCT01366534|258030|P3|Overall Study|Migrated|0
64854|NCT01366534|258031|P2|Overall Study|Migrated|1
64855|NCT01366534|258032|P1|Overall Study|Migrated|1
64856|NCT01366534|258030|P3|Overall Study|Lost to Follow-up|0
64857|NCT01366534|258031|P2|Overall Study|Lost to Follow-up|0
64858|NCT01366534|258032|P1|Overall Study|Lost to Follow-up|1
64859|NCT01366521|258082|P4|Overall Study|Withdrawal by Subject|0
64860|NCT01366521|258083|P3|Overall Study|Withdrawal by Subject|0
64861|NCT01366521|258084|P2|Overall Study|Withdrawal by Subject|1
64862|NCT01366521|258085|P1|Overall Study|Withdrawal by Subject|0
64863|NCT01366521|258082|P4|Overall Study|Physician Decision|0
64864|NCT01366521|258083|P3|Overall Study|Physician Decision|1
64865|NCT01366521|258084|P2|Overall Study|Physician Decision|0
64866|NCT01366521|258085|P1|Overall Study|Physician Decision|0
64867|NCT01366521|258082|P4|Overall Study|Protocol Violation|0
64868|NCT01366521|258083|P3|Overall Study|Protocol Violation|1
64869|NCT01366521|258084|P2|Overall Study|Protocol Violation|0
64870|NCT01366521|258085|P1|Overall Study|Protocol Violation|0
64871|NCT01366521|258082|P4|Overall Study|Adverse Event|0
64872|NCT01366521|258083|P3|Overall Study|Adverse Event|0
64873|NCT01366521|258084|P2|Overall Study|Adverse Event|0
64874|NCT01366521|258085|P1|Overall Study|Adverse Event|1
64875|NCT01366443|258160|P1|Overall Study|Under 18 yo|1
64876|NCT01366443|258160|P1|Overall Study|Lost to Follow-up|2
64877|NCT01366209|258174|P2|Overall Study|Withdrew consent|3
64878|NCT01366209|258175|P1|Overall Study|Withdrew consent|4
64879|NCT01366209|258174|P2|Overall Study|Sponsors decision|1
64880|NCT01366209|258175|P1|Overall Study|Sponsors decision|0
64881|NCT01366209|258174|P2|Overall Study|Physician Decision|0
64882|NCT01366209|258175|P1|Overall Study|Physician Decision|1
64883|NCT01366209|258174|P2|Overall Study|Lost to Follow-up|1
64884|NCT01366209|258175|P1|Overall Study|Lost to Follow-up|2
64885|NCT01366209|258174|P2|Overall Study|Lung transplantation|1
64886|NCT01366209|258175|P1|Overall Study|Lung transplantation|6
64887|NCT01366209|258174|P2|Overall Study|Death|19
64888|NCT01366209|258175|P1|Overall Study|Death|12
64889|NCT01366209|258174|P2|Overall Study|Withdrawal by Subject|4
64890|NCT01366209|258175|P1|Overall Study|Withdrawal by Subject|4
64891|NCT01366209|258174|P2|Overall Study|Adverse Event|7
64892|NCT01366209|258175|P1|Overall Study|Adverse Event|6
64893|NCT01366092|258198|P1|Overall Study|Withdrawal by Subject|1
64894|NCT01366092|258198|P1|Overall Study|Physician Decision|1
64895|NCT01366092|258198|P1|Overall Study|Progressive cGVHD|2
64896|NCT01365910|258207|P1|Overall Study|pt did not get tx, nausea/vomiting|1
64897|NCT01365910|258207|P1|Overall Study|other complicating disease|1
64898|NCT01365910|258207|P1|Overall Study|Adverse Event|3
64899|NCT01365910|258207|P1|Overall Study|disease progression|18
64900|NCT01365910|258207|P1|Overall Study|Withdrawal by Subject|7
64901|NCT01365546|258310|P1|Overall Study|Study termination|1
64902|NCT01365546|258310|P1|Overall Study|Screen failure|9
64903|NCT01365546|258310|P1|Overall Study|Withdrawal by Subject|1
64904|NCT01365507|258320|P2|Overall Study|Unclassified|4
64905|NCT01365507|258321|P1|Overall Study|Unclassified|1
64906|NCT01365507|258320|P2|Overall Study|Withdrawal Criteria|5
64907|NCT01365507|258321|P1|Overall Study|Withdrawal Criteria|8
64908|NCT01365494|258337|P2|Overall Study|Lost to Follow-up|2
64909|NCT01365494|258338|P1|Overall Study|Lost to Follow-up|1
64910|NCT01365494|258337|P2|Overall Study|Withdrawal by Subject|1
64911|NCT01365494|258338|P1|Overall Study|Withdrawal by Subject|0
64912|NCT01365494|258337|P2|Overall Study|Adverse Event|0
64913|NCT01365494|258338|P1|Overall Study|Adverse Event|1
64914|NCT01365481|258354|P4|Overall Study|Unsatisfactory therapeutic effect|0
64915|NCT01365481|258355|P3|Overall Study|Unsatisfactory therapeutic effect|1
64916|NCT01365481|258356|P2|Overall Study|Unsatisfactory therapeutic effect|0
64917|NCT01365481|258357|P1|Overall Study|Unsatisfactory therapeutic effect|0
64918|NCT01365481|258354|P4|Overall Study|Protocol deviation|1
64919|NCT01365481|258355|P3|Overall Study|Protocol deviation|0
64920|NCT01365481|258356|P2|Overall Study|Protocol deviation|1
64921|NCT01365481|258357|P1|Overall Study|Protocol deviation|0
64922|NCT01365481|258354|P4|Overall Study|Administrative problems|0
64923|NCT01365481|258355|P3|Overall Study|Administrative problems|0
64924|NCT01365481|258356|P2|Overall Study|Administrative problems|1
64925|NCT01365481|258357|P1|Overall Study|Administrative problems|0
64926|NCT01365481|258354|P4|Overall Study|Abnormal laboratory value(s)|0
64927|NCT01365481|258355|P3|Overall Study|Abnormal laboratory value(s)|0
64928|NCT01365481|258356|P2|Overall Study|Abnormal laboratory value(s)|1
64929|NCT01365481|258357|P1|Overall Study|Abnormal laboratory value(s)|0
64930|NCT01365481|258354|P4|Overall Study|Lost to Follow-up|3
64931|NCT01365481|258355|P3|Overall Study|Lost to Follow-up|2
64932|NCT01365481|258356|P2|Overall Study|Lost to Follow-up|1
64933|NCT01365481|258357|P1|Overall Study|Lost to Follow-up|1
64934|NCT01365481|258354|P4|Overall Study|Withdrawal by Subject|1
64935|NCT01365481|258355|P3|Overall Study|Withdrawal by Subject|1
64936|NCT01365481|258356|P2|Overall Study|Withdrawal by Subject|2
64937|NCT01365481|258357|P1|Overall Study|Withdrawal by Subject|0
64938|NCT01365481|258354|P4|Overall Study|Adverse Event|2
64939|NCT01365481|258355|P3|Overall Study|Adverse Event|0
64940|NCT01365481|258356|P2|Overall Study|Adverse Event|9
64941|NCT01365481|258357|P1|Overall Study|Adverse Event|6
64942|NCT01365468|258377|P2|Overall Study|Lost to Follow-up|0
64943|NCT01365468|258378|P1|Overall Study|Lost to Follow-up|2
64944|NCT01365468|258377|P2|Overall Study|Disease progression|0
64945|NCT01365468|258378|P1|Overall Study|Disease progression|1
64946|NCT01365468|258377|P2|Overall Study|Physician Decision|0
64947|NCT01365468|258378|P1|Overall Study|Physician Decision|1
64948|NCT01365455|258393|P5|Maintenance Period|Subject/guardian decision|1
64949|NCT01365455|258394|P4|Maintenance Period|Subject/guardian decision|4
64950|NCT01365455|258395|P3|Maintenance Period|Subject/guardian decision|2
64951|NCT01365455|258396|P2|Maintenance Period|Subject/guardian decision|6
64952|NCT01365455|258397|P1|Maintenance Period|Subject/guardian decision|4
64953|NCT01365455|258393|P5|Maintenance Period|Protocol deviation|0
64954|NCT01365455|258394|P4|Maintenance Period|Protocol deviation|0
64955|NCT01365455|258395|P3|Maintenance Period|Protocol deviation|0
64956|NCT01365455|258396|P2|Maintenance Period|Protocol deviation|1
64957|NCT01365455|258397|P1|Maintenance Period|Protocol deviation|1
64958|NCT01365455|258393|P5|Maintenance Period|Pregnancy|2
64959|NCT01365455|258394|P4|Maintenance Period|Pregnancy|0
64960|NCT01365455|258395|P3|Maintenance Period|Pregnancy|0
64961|NCT01365455|258396|P2|Maintenance Period|Pregnancy|4
64962|NCT01365455|258397|P1|Maintenance Period|Pregnancy|0
64963|NCT01365455|258393|P5|Maintenance Period|Physician Decision|1
64964|NCT01365455|258394|P4|Maintenance Period|Physician Decision|0
64965|NCT01365455|258395|P3|Maintenance Period|Physician Decision|0
64966|NCT01365455|258396|P2|Maintenance Period|Physician Decision|1
64967|NCT01365455|258397|P1|Maintenance Period|Physician Decision|0
64968|NCT01365455|258393|P5|Maintenance Period|Non-compliance with study treatment|0
64969|NCT01365455|258394|P4|Maintenance Period|Non-compliance with study treatment|1
64970|NCT01365455|258395|P3|Maintenance Period|Non-compliance with study treatment|0
64971|NCT01365455|258396|P2|Maintenance Period|Non-compliance with study treatment|0
64972|NCT01365455|258397|P1|Maintenance Period|Non-compliance with study treatment|0
64973|NCT01365455|258393|P5|Maintenance Period|Lost to Follow-up|3
64974|NCT01365455|258394|P4|Maintenance Period|Lost to Follow-up|0
64975|NCT01365455|258395|P3|Maintenance Period|Lost to Follow-up|0
64976|NCT01365455|258396|P2|Maintenance Period|Lost to Follow-up|4
64977|NCT01365455|258397|P1|Maintenance Period|Lost to Follow-up|2
64978|NCT01365455|258393|P5|Maintenance Period|Lack of Efficacy|2
64979|NCT01365455|258394|P4|Maintenance Period|Lack of Efficacy|2
64980|NCT01365455|258395|P3|Maintenance Period|Lack of Efficacy|0
64981|NCT01365455|258396|P2|Maintenance Period|Lack of Efficacy|2
64982|NCT01365455|258397|P1|Maintenance Period|Lack of Efficacy|10
64983|NCT01365455|258393|P5|Maintenance Period|Adverse Event|4
64984|NCT01365455|258394|P4|Maintenance Period|Adverse Event|2
64985|NCT01365455|258395|P3|Maintenance Period|Adverse Event|1
64986|NCT01365455|258396|P2|Maintenance Period|Adverse Event|5
64987|NCT01365455|258397|P1|Maintenance Period|Adverse Event|12
64988|NCT01365455|258393|P5|Induction Period|Lost to Follow-up|0
64989|NCT01365455|258394|P4|Induction Period|Lost to Follow-up|0
64990|NCT01365455|258395|P3|Induction Period|Lost to Follow-up|3
64991|NCT01365455|258396|P2|Induction Period|Lost to Follow-up|0
64992|NCT01365455|258397|P1|Induction Period|Lost to Follow-up|0
64993|NCT01365455|258393|P5|Induction Period|Subject/guardian decision|0
64994|NCT01365455|258394|P4|Induction Period|Subject/guardian decision|0
64995|NCT01365455|258395|P3|Induction Period|Subject/guardian decision|8
64996|NCT01365455|258396|P2|Induction Period|Subject/guardian decision|1
64997|NCT01365455|258397|P1|Induction Period|Subject/guardian decision|9
64998|NCT01365455|258393|P5|Induction Period|Protocol deviation|0
64999|NCT01365455|258394|P4|Induction Period|Protocol deviation|0
65000|NCT01365455|258395|P3|Induction Period|Protocol deviation|1
65001|NCT01365455|258396|P2|Induction Period|Protocol deviation|1
65002|NCT01365455|258397|P1|Induction Period|Protocol deviation|0
65003|NCT01365455|258393|P5|Induction Period|Pregnancy|0
65004|NCT01365455|258394|P4|Induction Period|Pregnancy|0
65005|NCT01365455|258395|P3|Induction Period|Pregnancy|0
65006|NCT01365455|258396|P2|Induction Period|Pregnancy|1
65007|NCT01365455|258397|P1|Induction Period|Pregnancy|0
65008|NCT01365455|258393|P5|Induction Period|Lack of Efficacy|0
65009|NCT01365455|258394|P4|Induction Period|Lack of Efficacy|0
65010|NCT01365455|258395|P3|Induction Period|Lack of Efficacy|0
65011|NCT01365455|258396|P2|Induction Period|Lack of Efficacy|1
65012|NCT01365455|258397|P1|Induction Period|Lack of Efficacy|1
65013|NCT01365455|258393|P5|Induction Period|Adverse Event|0
65014|NCT01365455|258394|P4|Induction Period|Adverse Event|0
65015|NCT01365455|258395|P3|Induction Period|Adverse Event|4
65016|NCT01365455|258396|P2|Induction Period|Adverse Event|3
65017|NCT01365455|258397|P1|Induction Period|Adverse Event|5
65018|NCT01365273|258487|P2|Overall Study|Physician Decision|0
65019|NCT01365273|258488|P1|Overall Study|Physician Decision|1
65020|NCT01365273|258487|P2|Overall Study|Protocol Violation|1
65021|NCT01365273|258488|P1|Overall Study|Protocol Violation|0
65022|NCT01365273|258487|P2|Overall Study|Lost to Follow-up|0
65023|NCT01365273|258488|P1|Overall Study|Lost to Follow-up|1
65024|NCT01365130|258498|P1|Overall Study|Progression/worsening of Dx prior to txt|2
65025|NCT01365091|258507|P4|Period 2|Adverse Event|0
65026|NCT01365091|258508|P3|Period 2|Adverse Event|1
65027|NCT01365091|258509|P2|Period 2|Adverse Event|0
65028|NCT01365091|258510|P1|Period 2|Adverse Event|0
65029|NCT01365091|258507|P4|Period 2|Withdrawal by Subject|0
65030|NCT01365091|258508|P3|Period 2|Withdrawal by Subject|0
65031|NCT01365091|258509|P2|Period 2|Withdrawal by Subject|0
65032|NCT01365091|258510|P1|Period 2|Withdrawal by Subject|1
65033|NCT01365091|258507|P4|Period 1|Personal reasons|0
65034|NCT01365091|258508|P3|Period 1|Personal reasons|1
65035|NCT01365091|258509|P2|Period 1|Personal reasons|0
65036|NCT01365091|258510|P1|Period 1|Personal reasons|0
65037|NCT01365091|258507|P4|Period 1|Withdrawal by Subject|0
65038|NCT01365091|258508|P3|Period 1|Withdrawal by Subject|0
65039|NCT01365091|258509|P2|Period 1|Withdrawal by Subject|1
65040|NCT01365091|258510|P1|Period 1|Withdrawal by Subject|0
65041|NCT01365091|258507|P4|Period 1|No longer met study criteria|0
65042|NCT01365091|258508|P3|Period 1|No longer met study criteria|0
65043|NCT01365091|258509|P2|Period 1|No longer met study criteria|1
65044|NCT01365091|258510|P1|Period 1|No longer met study criteria|0
65045|NCT01365091|258507|P4|Period 1|Positive test result for drugs of abuse|0
65046|NCT01365091|258508|P3|Period 1|Positive test result for drugs of abuse|0
65047|NCT01365091|258509|P2|Period 1|Positive test result for drugs of abuse|0
65048|NCT01365091|258510|P1|Period 1|Positive test result for drugs of abuse|1
65049|NCT01365091|258507|P4|Period 1|Adverse Event|3
65050|NCT01365091|258508|P3|Period 1|Adverse Event|2
65051|NCT01365091|258509|P2|Period 1|Adverse Event|0
65052|NCT01365091|258510|P1|Period 1|Adverse Event|1
65053|NCT01365052|258538|P2|Overall Study|Adverse Event|4
65054|NCT01365052|258539|P1|Overall Study|Adverse Event|4
65055|NCT01365039|258555|P2|Overall Study|Study related symptoms and complaints|0
65056|NCT01365039|258556|P1|Overall Study|Study related symptoms and complaints|1
65057|NCT01364922|258567|P3|Double-Blind (DB) Period|Other, Unspecified|0
65058|NCT01364922|258568|P2|Double-Blind (DB) Period|Other, Unspecified|1
65059|NCT01364922|258569|P1|Double-Blind (DB) Period|Other, Unspecified|0
65060|NCT01364922|258567|P3|Double-Blind (DB) Period|Adverse Event|1
65061|NCT01364922|258568|P2|Double-Blind (DB) Period|Adverse Event|0
65062|NCT01364922|258569|P1|Double-Blind (DB) Period|Adverse Event|0
65063|NCT01364922|258567|P3|Double-Blind (DB) Period|Subject Noncompliant|0
65064|NCT01364922|258568|P2|Double-Blind (DB) Period|Subject Noncompliant|1
65065|NCT01364922|258569|P1|Double-Blind (DB) Period|Subject Noncompliant|0
65066|NCT01364922|258567|P3|Double-Blind (DB) Period|Lack of Efficacy|4
65067|NCT01364922|258568|P2|Double-Blind (DB) Period|Lack of Efficacy|3
65068|NCT01364922|258569|P1|Double-Blind (DB) Period|Lack of Efficacy|0
65069|NCT01364922|258567|P3|Open-label (OL) Period|Other, Unspecified|0
65070|NCT01364922|258568|P2|Open-label (OL) Period|Other, Unspecified|0
65071|NCT01364922|258569|P1|Open-label (OL) Period|Other, Unspecified|1
65072|NCT01364922|258567|P3|Open-label (OL) Period|Lost to Follow-up|0
65073|NCT01364922|258568|P2|Open-label (OL) Period|Lost to Follow-up|0
65074|NCT01364922|258569|P1|Open-label (OL) Period|Lost to Follow-up|1
65075|NCT01364922|258567|P3|Open-label (OL) Period|Lack of Efficacy|0
65076|NCT01364922|258568|P2|Open-label (OL) Period|Lack of Efficacy|0
65077|NCT01364922|258569|P1|Open-label (OL) Period|Lack of Efficacy|3
65078|NCT01364922|258567|P3|Open-label (OL) Period|Withdrawal by Subject|0
65079|NCT01364922|258568|P2|Open-label (OL) Period|Withdrawal by Subject|0
65080|NCT01364922|258569|P1|Open-label (OL) Period|Withdrawal by Subject|4
65081|NCT01364922|258567|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
65082|NCT01364922|258568|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
65083|NCT01364922|258569|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
65084|NCT01364922|258567|P3|Open-label (OL) Period|Adverse Event|0
65085|NCT01364922|258568|P2|Open-label (OL) Period|Adverse Event|0
65086|NCT01364922|258569|P1|Open-label (OL) Period|Adverse Event|7
65087|NCT01364870|258591|P3|Overall Study|Protocol Violation|0
65088|NCT01364870|258592|P2|Overall Study|Protocol Violation|0
65089|NCT01364870|258593|P1|Overall Study|Protocol Violation|1
65090|NCT01364870|258591|P3|Overall Study|Adverse Event|4
65091|NCT01364870|258592|P2|Overall Study|Adverse Event|6
65092|NCT01364870|258593|P1|Overall Study|Adverse Event|8
65093|NCT01364870|258591|P3|Overall Study|Withdrawal by Subject|10
65094|NCT01364870|258592|P2|Overall Study|Withdrawal by Subject|24
65095|NCT01364870|258593|P1|Overall Study|Withdrawal by Subject|13
65096|NCT01364727|258612|P1|Overall Study|Not Eligible|2
65097|NCT01364649|258620|P2|Overall Study|Other|1
65098|NCT01364649|258621|P1|Overall Study|Other|4
65099|NCT01364649|258620|P2|Overall Study|Lost to Follow-up|13
65100|NCT01364649|258621|P1|Overall Study|Lost to Follow-up|12
65101|NCT01364649|258620|P2|Overall Study|Withdrawal of Consent|7
65102|NCT01364649|258621|P1|Overall Study|Withdrawal of Consent|9
65103|NCT01364649|258620|P2|Overall Study|Protocol Deviations|8
65104|NCT01364649|258621|P1|Overall Study|Protocol Deviations|4
65105|NCT01364649|258620|P2|Overall Study|Non-compliance with Investigational Drug|0
65106|NCT01364649|258621|P1|Overall Study|Non-compliance with Investigational Drug|1
65107|NCT01364649|258620|P2|Overall Study|Lack of Efficacy|0
65108|NCT01364649|258621|P1|Overall Study|Lack of Efficacy|6
65109|NCT01364649|258620|P2|Overall Study|Pretreatment Event or Adverse Event|14
65110|NCT01364649|258621|P1|Overall Study|Pretreatment Event or Adverse Event|20
65111|NCT01364428|258643|P2|Overall Study|Other|3
65112|NCT01364428|258644|P1|Overall Study|Other|3
65113|NCT01364428|258643|P2|Overall Study|Withdrawal Criteria|10
65114|NCT01364428|258644|P1|Overall Study|Withdrawal Criteria|14
65115|NCT01364428|258643|P2|Overall Study|Protocol Violation|0
65116|NCT01364428|258644|P1|Overall Study|Protocol Violation|2
65117|NCT01364428|258643|P2|Overall Study|Adverse Event|2
65118|NCT01364428|258644|P1|Overall Study|Adverse Event|1
65119|NCT01364389|258661|P3|Overall Study|Adverse Event|0
65120|NCT01364389|258662|P2|Overall Study|Adverse Event|0
65121|NCT01364389|258663|P1|Overall Study|Adverse Event|1
65122|NCT01364389|258661|P3|Overall Study|Administrative problems|0
65123|NCT01364389|258662|P2|Overall Study|Administrative problems|0
65124|NCT01364389|258663|P1|Overall Study|Administrative problems|1
65125|NCT01364389|258661|P3|Overall Study|Protocol deviation|1
65126|NCT01364389|258662|P2|Overall Study|Protocol deviation|0
65127|NCT01364389|258663|P1|Overall Study|Protocol deviation|0
65128|NCT01364389|258661|P3|Overall Study|Withdrawal by Subject|0
65129|NCT01364389|258662|P2|Overall Study|Withdrawal by Subject|1
65130|NCT01364389|258663|P1|Overall Study|Withdrawal by Subject|0
65131|NCT01364298|258682|P2|Overall Study|Other|3
65132|NCT01364298|258683|P1|Overall Study|Other|1
65133|NCT01364298|258682|P2|Overall Study|Withdrawal by Subject|3
65134|NCT01364298|258683|P1|Overall Study|Withdrawal by Subject|3
65135|NCT01364298|258682|P2|Overall Study|Lost to Follow-up|10
65136|NCT01364298|258683|P1|Overall Study|Lost to Follow-up|5
65137|NCT01364298|258682|P2|Overall Study|Lack of Efficacy|0
65138|NCT01364298|258683|P1|Overall Study|Lack of Efficacy|1
65139|NCT01364298|258682|P2|Overall Study|Lack of adherence to treatment|3
65140|NCT01364298|258683|P1|Overall Study|Lack of adherence to treatment|1
65141|NCT01364298|258682|P2|Overall Study|Adverse Event|4
65142|NCT01364298|258683|P1|Overall Study|Adverse Event|3
65143|NCT01363986|258738|P1|Overall Study|Disease progression|1
65144|NCT01363908|258748|P2|Chronic Dosing (CD) Phase|Early study termination|3
65145|NCT01363908|258749|P1|Chronic Dosing (CD) Phase|Early study termination|9
65146|NCT01363908|258748|P2|Chronic Dosing (CD) Phase|Physician Decision|1
65147|NCT01363908|258749|P1|Chronic Dosing (CD) Phase|Physician Decision|0
65148|NCT01363908|258748|P2|Chronic Dosing (CD) Phase|Patient decision|1
65149|NCT01363908|258749|P1|Chronic Dosing (CD) Phase|Patient decision|0
65150|NCT01363908|258748|P2|Chronic Dosing (CD) Phase|Adverse Event|1
65151|NCT01363908|258749|P1|Chronic Dosing (CD) Phase|Adverse Event|1
65152|NCT01363765|258785|P2|Overall Study|smear during intervention|0
65153|NCT01363765|258786|P1|Overall Study|smear during intervention|2170
65154|NCT01363765|258785|P2|Overall Study|age not recorded (used for cross-linkage|354
65155|NCT01363765|258786|P1|Overall Study|age not recorded (used for cross-linkage|117
65156|NCT01363765|258785|P2|Overall Study|non-resident|76
65157|NCT01363765|258786|P1|Overall Study|non-resident|156
65158|NCT01363765|258785|P2|Overall Study|duplicate records|3177
65159|NCT01363765|258786|P1|Overall Study|duplicate records|736
65160|NCT01363765|258785|P2|Overall Study|non-diagnostic|1124
65161|NCT01363765|258786|P1|Overall Study|non-diagnostic|2621
65162|NCT01363713|258798|P1|Overall Study|Withdrawal by Subject|2
65163|NCT01363713|258798|P1|Overall Study|Protocol Violation|3
65164|NCT01363713|258798|P1|Overall Study|Adverse Event|1
65165|NCT01363700|258807|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
65166|NCT01363700|258808|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
65167|NCT01363700|258809|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
65168|NCT01363700|258810|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
65169|NCT01363700|258811|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
65170|NCT01363661|258830|P2|Overall Study|Lost to Follow-up|1
65171|NCT01363661|258831|P1|Overall Study|Lost to Follow-up|3
65172|NCT01363661|258830|P2|Overall Study|Protocol Violation|0
65173|NCT01363661|258831|P1|Overall Study|Protocol Violation|1
65174|NCT01363661|258830|P2|Overall Study|Withdrawal by Subject|1
65175|NCT01363661|258831|P1|Overall Study|Withdrawal by Subject|1
65176|NCT01363661|258830|P2|Overall Study|Adverse Event|2
65177|NCT01363661|258831|P1|Overall Study|Adverse Event|9
65178|NCT01363440|258872|P3|Overall Study|Other|2
65179|NCT01363440|258873|P2|Overall Study|Other|5
65180|NCT01363440|258874|P1|Overall Study|Other|4
65181|NCT01363440|258872|P3|Overall Study|Lost to Follow-up|5
65182|NCT01363440|258873|P2|Overall Study|Lost to Follow-up|4
65183|NCT01363440|258874|P1|Overall Study|Lost to Follow-up|2
65184|NCT01363440|258872|P3|Overall Study|Withdrawal by Subject|11
65185|NCT01363440|258873|P2|Overall Study|Withdrawal by Subject|11
65186|NCT01363440|258874|P1|Overall Study|Withdrawal by Subject|9
65187|NCT01363440|258872|P3|Overall Study|Death|5
65188|NCT01363440|258873|P2|Overall Study|Death|7
65189|NCT01363440|258874|P1|Overall Study|Death|3
65190|NCT01363440|258872|P3|Overall Study|Adverse Event|4
65191|NCT01363440|258873|P2|Overall Study|Adverse Event|4
65192|NCT01363440|258874|P1|Overall Study|Adverse Event|5
65193|NCT01363349|258920|P2|Overall Study|missing|2
65194|NCT01363349|258921|P1|Overall Study|missing|1
65195|NCT01363349|258920|P2|Overall Study|Not reported|37
65196|NCT01363349|258921|P1|Overall Study|Not reported|36
65197|NCT01363349|258920|P2|Overall Study|Lost to Follow-up|6
65198|NCT01363349|258921|P1|Overall Study|Lost to Follow-up|5
65199|NCT01363349|258920|P2|Overall Study|Withdrawal by Subject|6
65200|NCT01363349|258921|P1|Overall Study|Withdrawal by Subject|14
65201|NCT01363349|258920|P2|Overall Study|Non compliance/Protocol deviations|2
65202|NCT01363349|258921|P1|Overall Study|Non compliance/Protocol deviations|2
65203|NCT01363349|258920|P2|Overall Study|Lack of Efficacy|10
65204|NCT01363349|258921|P1|Overall Study|Lack of Efficacy|3
65205|NCT01363349|258920|P2|Overall Study|Adverse Event|7
65206|NCT01363349|258921|P1|Overall Study|Adverse Event|6
65207|NCT01363297|258932|P5|Overall Study|Death|30
65208|NCT01363297|258933|P4|Overall Study|Death|10
65209|NCT01363297|258934|P3|Overall Study|Death|6
65210|NCT01363297|258935|P2|Overall Study|Death|6
65211|NCT01363297|258936|P1|Overall Study|Death|3
65212|NCT01363297|258932|P5|Overall Study|Not specified|1
65213|NCT01363297|258933|P4|Overall Study|Not specified|0
65214|NCT01363297|258934|P3|Overall Study|Not specified|0
65215|NCT01363297|258935|P2|Overall Study|Not specified|0
65216|NCT01363297|258936|P1|Overall Study|Not specified|0
65217|NCT01363076|259028|P2|Overall Study|Withdrawal by Subject|1
65218|NCT01363076|259029|P1|Overall Study|Withdrawal by Subject|0
65219|NCT01363011|259061|P2|Extension Phase|Rolled Over to Another Gilead Study|1
65220|NCT01363011|259062|P1|Extension Phase|Rolled Over to Another Gilead Study|2
65221|NCT01363011|259061|P2|Extension Phase|Lost to Follow-up|2
65222|NCT01363011|259062|P1|Extension Phase|Lost to Follow-up|0
65223|NCT01363011|259061|P2|Extension Phase|Withdrew Consent|1
65224|NCT01363011|259062|P1|Extension Phase|Withdrew Consent|0
65225|NCT01363011|259061|P2|Extension Phase|Investigator's Discretion|2
65226|NCT01363011|259062|P1|Extension Phase|Investigator's Discretion|2
65227|NCT01363011|259061|P2|Extension Phase|Lack of Efficacy|1
65228|NCT01363011|259062|P1|Extension Phase|Lack of Efficacy|0
65229|NCT01363011|259061|P2|Extension Phase|Adverse Event|1
65230|NCT01363011|259062|P1|Extension Phase|Adverse Event|1
65231|NCT01363011|259061|P2|Main Study|Protocol Violation|1
65232|NCT01363011|259062|P1|Main Study|Protocol Violation|0
65233|NCT01363011|259061|P2|Main Study|Withdrew Consent|4
65234|NCT01363011|259062|P1|Main Study|Withdrew Consent|1
65235|NCT01363011|259061|P2|Main Study|Investigator's Discretion|1
65236|NCT01363011|259062|P1|Main Study|Investigator's Discretion|1
65237|NCT01363011|259061|P2|Main Study|Adverse Event|3
65238|NCT01363011|259062|P1|Main Study|Adverse Event|2
65239|NCT01362608|259187|P2|Overall Study|Adverse Event|2
65240|NCT01362608|259188|P1|Overall Study|Adverse Event|0
65241|NCT01362608|259187|P2|Overall Study|Lack of Efficacy|2
65242|NCT01362608|259188|P1|Overall Study|Lack of Efficacy|0
65243|NCT01362608|259187|P2|Overall Study|Withdrawal by Subject|2
65244|NCT01362608|259188|P1|Overall Study|Withdrawal by Subject|1
65245|NCT01362608|259187|P2|Overall Study|Lost to Follow-up|1
65246|NCT01362608|259188|P1|Overall Study|Lost to Follow-up|3
65247|NCT01362608|259187|P2|Overall Study|Protocol Violation|1
65248|NCT01362608|259188|P1|Overall Study|Protocol Violation|0
65249|NCT01362530|259226|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
65250|NCT01362530|259227|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
65251|NCT01362530|259226|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
65252|NCT01362530|259227|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
65253|NCT01362530|259226|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
65254|NCT01362530|259227|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
65255|NCT01362530|259226|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
65256|NCT01362530|259227|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
65257|NCT01362530|259226|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
65258|NCT01362530|259227|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
65259|NCT01362530|259226|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
65260|NCT01362530|259227|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
65261|NCT01362530|259226|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
65262|NCT01362530|259227|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
65263|NCT01362530|259226|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
65264|NCT01362530|259227|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
65265|NCT01362530|259226|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
65266|NCT01362530|259227|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
65267|NCT01362530|259226|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
65268|NCT01362530|259227|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
65269|NCT01362530|259226|P2|Base Study (Cycle 1)|Protocol Violation|0
65270|NCT01362530|259227|P1|Base Study (Cycle 1)|Protocol Violation|2
65271|NCT01362530|259226|P2|Base Study (Cycle 1)|Physician Decision|1
65272|NCT01362530|259227|P1|Base Study (Cycle 1)|Physician Decision|0
65273|NCT01362530|259226|P2|Base Study (Cycle 1)|Adverse Event|0
65274|NCT01362530|259227|P1|Base Study (Cycle 1)|Adverse Event|2
65275|NCT01362517|259240|P1|Overall Study|Lost to Follow-up|1
65276|NCT01362517|259240|P1|Overall Study|Protocol Violation|1
65277|NCT01362491|259251|P3|Overall Study|Ineligible|0
65278|NCT01362491|259252|P2|Overall Study|Ineligible|0
65279|NCT01362491|259253|P1|Overall Study|Ineligible|1
65280|NCT01362439|259301|P1|Overall Study|Participant who withdrew consent|8
65281|NCT01362439|259301|P1|Overall Study|Study medication non-compliant|1
65282|NCT01362439|259301|P1|Overall Study|Lost to Follow-up|2
65283|NCT01362439|259301|P1|Overall Study|Lack of Efficacy|3
65284|NCT01362439|259301|P1|Overall Study|Adverse Event|1
65285|NCT01362348|259316|P1|Overall Study|Study closed/terminated|5
65286|NCT01362348|259316|P1|Overall Study|Protocol-defined stopping criteria|9
65287|NCT01362296|259335|P4|Crossover Phase|Study Closed/Terminated|0
65288|NCT01362296|259336|P3|Crossover Phase|Study Closed/Terminated|1
65289|NCT01362296|259337|P2|Crossover Phase|Study Closed/Terminated|0
65290|NCT01362296|259338|P1|Crossover Phase|Study Closed/Terminated|0
65291|NCT01362296|259335|P4|Crossover Phase|Adverse Event|0
65292|NCT01362296|259336|P3|Crossover Phase|Adverse Event|4
65293|NCT01362296|259337|P2|Crossover Phase|Adverse Event|0
65294|NCT01362296|259338|P1|Crossover Phase|Adverse Event|0
65295|NCT01362296|259335|P4|Crossover Phase|Withdrawal by Subject|1
65296|NCT01362296|259336|P3|Crossover Phase|Withdrawal by Subject|2
65297|NCT01362296|259337|P2|Crossover Phase|Withdrawal by Subject|0
65298|NCT01362296|259338|P1|Crossover Phase|Withdrawal by Subject|0
65299|NCT01362296|259335|P4|Crossover Phase|PD including Death due to PD|1
65300|NCT01362296|259336|P3|Crossover Phase|PD including Death due to PD|16
65301|NCT01362296|259337|P2|Crossover Phase|PD including Death due to PD|0
65302|NCT01362296|259338|P1|Crossover Phase|PD including Death due to PD|0
65303|NCT01362296|259335|P4|Randomized Phase (RP)|Study Closed/Terminated|0
65304|NCT01362296|259336|P3|Randomized Phase (RP)|Study Closed/Terminated|0
65305|NCT01362296|259337|P2|Randomized Phase (RP)|Study Closed/Terminated|1
65306|NCT01362296|259338|P1|Randomized Phase (RP)|Study Closed/Terminated|8
65307|NCT01362296|259335|P4|Randomized Phase (RP)|Adverse Event|0
65308|NCT01362296|259336|P3|Randomized Phase (RP)|Adverse Event|0
65309|NCT01362296|259337|P2|Randomized Phase (RP)|Adverse Event|4
65310|NCT01362296|259338|P1|Randomized Phase (RP)|Adverse Event|20
65311|NCT01362296|259335|P4|Randomized Phase (RP)|Withdrawal by Subject|0
65312|NCT01362296|259336|P3|Randomized Phase (RP)|Withdrawal by Subject|0
65313|NCT01362296|259337|P2|Randomized Phase (RP)|Withdrawal by Subject|1
65314|NCT01362296|259338|P1|Randomized Phase (RP)|Withdrawal by Subject|2
65315|NCT01362296|259335|P4|Randomized Phase (RP)|Physician Decision|0
65316|NCT01362296|259336|P3|Randomized Phase (RP)|Physician Decision|0
65317|NCT01362296|259337|P2|Randomized Phase (RP)|Physician Decision|9
65318|NCT01362296|259338|P1|Randomized Phase (RP)|Physician Decision|1
65319|NCT01362296|259335|P4|Randomized Phase (RP)|PD including Death due to PD|0
65320|NCT01362296|259336|P3|Randomized Phase (RP)|PD including Death due to PD|0
65321|NCT01362296|259337|P2|Randomized Phase (RP)|PD including Death due to PD|28
65322|NCT01362296|259338|P1|Randomized Phase (RP)|PD including Death due to PD|56
65323|NCT01362244|259386|P2|Overall Study|Protocol Defined Stopping Criteria|1
65324|NCT01362244|259387|P1|Overall Study|Protocol Defined Stopping Criteria|0
65325|NCT01362244|259386|P2|Overall Study|Did not Meet Continuation Criteria|11
65326|NCT01362244|259387|P1|Overall Study|Did not Meet Continuation Criteria|17
65327|NCT01362244|259386|P2|Overall Study|Withdrawal by Subject|1
65328|NCT01362244|259387|P1|Overall Study|Withdrawal by Subject|2
65329|NCT01362244|259386|P2|Overall Study|Protocol Violation|1
65330|NCT01362244|259387|P1|Overall Study|Protocol Violation|5
65331|NCT01362244|259386|P2|Overall Study|Lost to Follow-up|2
65332|NCT01362244|259387|P1|Overall Study|Lost to Follow-up|0
65333|NCT01362244|259386|P2|Overall Study|Lack of Efficacy|11
65334|NCT01362244|259387|P1|Overall Study|Lack of Efficacy|5
65335|NCT01362244|259386|P2|Overall Study|Adverse Event|5
65336|NCT01362244|259387|P1|Overall Study|Adverse Event|3
65337|NCT01362140|259499|P2|Overall Study|Discontinued Without Receiving Treatment|1
65338|NCT01362140|259500|P1|Overall Study|Discontinued Without Receiving Treatment|0
65339|NCT01362140|259499|P2|Overall Study|Protocol-specified Criteria|2
65340|NCT01362140|259500|P1|Overall Study|Protocol-specified Criteria|1
65341|NCT01362140|259499|P2|Overall Study|Other|1
65342|NCT01362140|259500|P1|Overall Study|Other|1
65343|NCT01362140|259499|P2|Overall Study|Death|1
65344|NCT01362140|259500|P1|Overall Study|Death|2
65345|NCT01362140|259499|P2|Overall Study|Administrative Decision|1
65346|NCT01362140|259500|P1|Overall Study|Administrative Decision|0
65347|NCT01362140|259499|P2|Overall Study|Withdrawal by Subject|3
65348|NCT01362140|259500|P1|Overall Study|Withdrawal by Subject|3
65349|NCT01362140|259499|P2|Overall Study|Adverse Event|2
65350|NCT01362140|259500|P1|Overall Study|Adverse Event|2
65351|NCT01362140|259499|P2|Overall Study|Noncompliance|0
65352|NCT01362140|259500|P1|Overall Study|Noncompliance|1
65353|NCT01362062|259524|P2|Overall Study|Had significant improvement|0
65354|NCT01362062|259525|P1|Overall Study|Had significant improvement|9
65355|NCT01362062|259524|P2|Overall Study|Detected with Spondylo-arthritis|0
65356|NCT01362062|259525|P1|Overall Study|Detected with Spondylo-arthritis|1
65357|NCT01362062|259524|P2|Overall Study|Non-compliant participant|0
65358|NCT01362062|259525|P1|Overall Study|Non-compliant participant|2
65359|NCT01362062|259524|P2|Overall Study|Withdrawal by Subject|0
65360|NCT01362062|259525|P1|Overall Study|Withdrawal by Subject|2
65361|NCT01362062|259524|P2|Overall Study|Lost to Follow-up|0
65362|NCT01362062|259525|P1|Overall Study|Lost to Follow-up|11
65363|NCT01362062|259524|P2|Overall Study|Adverse Event|0
65364|NCT01362062|259525|P1|Overall Study|Adverse Event|1
65365|NCT01362049|259546|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
65366|NCT01362049|259547|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
65367|NCT01362049|259548|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
65368|NCT01362049|259549|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
65369|NCT01362049|259546|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
65370|NCT01362049|259547|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
65371|NCT01362049|259548|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
65372|NCT01362049|259549|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
65373|NCT01361607|259614|P2|Overall Study|Met Withdrawal Criteria|1
65374|NCT01361607|259615|P1|Overall Study|Met Withdrawal Criteria|1
65375|NCT01361607|259614|P2|Overall Study|Lost to Follow-up|0
65376|NCT01361607|259615|P1|Overall Study|Lost to Follow-up|1
65377|NCT01361607|259614|P2|Overall Study|Withdrawal by Investigator|3
65378|NCT01361607|259615|P1|Overall Study|Withdrawal by Investigator|5
65379|NCT01361607|259614|P2|Overall Study|Withdrawal by Subject|8
65380|NCT01361607|259615|P1|Overall Study|Withdrawal by Subject|19
65381|NCT01361607|259614|P2|Overall Study|Adverse Event|29
65382|NCT01361607|259615|P1|Overall Study|Adverse Event|38
65383|NCT01361594|259643|P2|Overall Study|Withdrawal by Subject|2
65384|NCT01361594|259644|P1|Overall Study|Withdrawal by Subject|1
65385|NCT01361568|259658|P6|Overall Study|Withdrawal by Subject|1
65386|NCT01361568|259659|P5|Overall Study|Withdrawal by Subject|0
65387|NCT01361568|259660|P4|Overall Study|Withdrawal by Subject|0
65388|NCT01361568|259661|P3|Overall Study|Withdrawal by Subject|0
65389|NCT01361568|259662|P2|Overall Study|Withdrawal by Subject|1
65390|NCT01361568|259663|P1|Overall Study|Withdrawal by Subject|2
65391|NCT01361568|259658|P6|Overall Study|Physician Decision|1
65392|NCT01361568|259659|P5|Overall Study|Physician Decision|0
65393|NCT01361568|259660|P4|Overall Study|Physician Decision|0
65394|NCT01361568|259661|P3|Overall Study|Physician Decision|0
65395|NCT01361568|259662|P2|Overall Study|Physician Decision|0
65396|NCT01361568|259663|P1|Overall Study|Physician Decision|0
65397|NCT01361568|259658|P6|Overall Study|Adverse Event|0
65398|NCT01361568|259659|P5|Overall Study|Adverse Event|1
65399|NCT01361568|259660|P4|Overall Study|Adverse Event|0
65400|NCT01361568|259661|P3|Overall Study|Adverse Event|0
65401|NCT01361568|259662|P2|Overall Study|Adverse Event|0
65402|NCT01361568|259663|P1|Overall Study|Adverse Event|0
65403|NCT01361464|259693|P1|Overall Study|Withdrawal by Subject|2
65404|NCT01361464|259693|P1|Overall Study|Death|1
65405|NCT01361308|259702|P2|Overall Study|Not Specified|1
65406|NCT01361308|259703|P1|Overall Study|Not Specified|0
65407|NCT01361308|259702|P2|Overall Study|Failed C-SSRS|2
65408|NCT01361308|259703|P1|Overall Study|Failed C-SSRS|5
65409|NCT01361308|259702|P2|Overall Study|Eligibility Criteria Not Met|3
65410|NCT01361308|259703|P1|Overall Study|Eligibility Criteria Not Met|2
65411|NCT01361308|259702|P2|Overall Study|Adverse Event|4
65412|NCT01361308|259703|P1|Overall Study|Adverse Event|8
65413|NCT01361308|259702|P2|Overall Study|Lost to Follow-up|4
65414|NCT01361308|259703|P1|Overall Study|Lost to Follow-up|5
65415|NCT01361308|259702|P2|Overall Study|Protocol Violation|0
65416|NCT01361308|259703|P1|Overall Study|Protocol Violation|1
65417|NCT01361308|259702|P2|Overall Study|Lack of Efficacy|0
65418|NCT01361308|259703|P1|Overall Study|Lack of Efficacy|2
65419|NCT01361308|259702|P2|Overall Study|Physician Decision|3
65420|NCT01361308|259703|P1|Overall Study|Physician Decision|3
65421|NCT01361308|259702|P2|Overall Study|Withdrawal by Subject|13
65422|NCT01361308|259703|P1|Overall Study|Withdrawal by Subject|9
65423|NCT01361178|259745|P2|Overall Study|Death|0
65424|NCT01361178|259746|P1|Overall Study|Death|13
65425|NCT01361126|259754|P2|Overall Study|Sponsor decision|2
65426|NCT01361126|259755|P1|Overall Study|Sponsor decision|0
65427|NCT01361009|259794|P1|Overall Study|Protocol Violation|116
65428|NCT01360996|259804|P3|Overall Study|Noncompliant|0
65429|NCT01360996|259805|P2|Overall Study|Noncompliant|0
65430|NCT01360996|259806|P1|Overall Study|Noncompliant|2
65431|NCT01360996|259804|P3|Overall Study|Withdrawal by Subject|2
65432|NCT01360996|259805|P2|Overall Study|Withdrawal by Subject|3
65433|NCT01360996|259806|P1|Overall Study|Withdrawal by Subject|4
65434|NCT01360840|259828|P3|Overall Study|Ongoing at data cut-off|9
65435|NCT01360840|259829|P2|Overall Study|Ongoing at data cut-off|10
65436|NCT01360840|259830|P1|Overall Study|Ongoing at data cut-off|10
65437|NCT01360645|259882|P4|Phase A+|Protocol Deviation|4
65438|NCT01360645|259883|P3|Phase A+|Protocol Deviation|0
65439|NCT01360645|259884|P2|Phase A+|Protocol Deviation|0
65440|NCT01360645|259885|P1|Phase A+|Protocol Deviation|0
65441|NCT01360645|259882|P4|Phase A+|Withdrawal by Subject|5
65442|NCT01360645|259883|P3|Phase A+|Withdrawal by Subject|0
65443|NCT01360645|259884|P2|Phase A+|Withdrawal by Subject|0
65444|NCT01360645|259885|P1|Phase A+|Withdrawal by Subject|0
65445|NCT01360645|259882|P4|Phase A+|Physician Decision|2
65446|NCT01360645|259883|P3|Phase A+|Physician Decision|0
65447|NCT01360645|259884|P2|Phase A+|Physician Decision|0
65448|NCT01360645|259885|P1|Phase A+|Physician Decision|0
65449|NCT01360645|259882|P4|Phase A+|Met Withdrawal Criteria|4
65450|NCT01360645|259883|P3|Phase A+|Met Withdrawal Criteria|0
65451|NCT01360645|259884|P2|Phase A+|Met Withdrawal Criteria|0
65452|NCT01360645|259885|P1|Phase A+|Met Withdrawal Criteria|0
65453|NCT01360645|259882|P4|Phase A+|Adverse Event|2
65454|NCT01360645|259883|P3|Phase A+|Adverse Event|0
65455|NCT01360645|259884|P2|Phase A+|Adverse Event|0
65456|NCT01360645|259885|P1|Phase A+|Adverse Event|0
65457|NCT01360645|259882|P4|Phase A+|Lost to Follow-up|7
65458|NCT01360645|259883|P3|Phase A+|Lost to Follow-up|0
65459|NCT01360645|259884|P2|Phase A+|Lost to Follow-up|0
65460|NCT01360645|259885|P1|Phase A+|Lost to Follow-up|0
65461|NCT01360645|259882|P4|Phase B (6 Weeks)|Protocol Deviation|0
65462|NCT01360645|259883|P3|Phase B (6 Weeks)|Protocol Deviation|3
65463|NCT01360645|259884|P2|Phase B (6 Weeks)|Protocol Deviation|1
65464|NCT01360645|259885|P1|Phase B (6 Weeks)|Protocol Deviation|0
65465|NCT01360645|259882|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
65466|NCT01360645|259883|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
65467|NCT01360645|259884|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
65468|NCT01360645|259885|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
65469|NCT01360645|259882|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
65470|NCT01360645|259883|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
65471|NCT01360645|259884|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
65472|NCT01360645|259885|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
65473|NCT01360645|259882|P4|Phase B (6 Weeks)|Adverse Event|0
65474|NCT01360645|259883|P3|Phase B (6 Weeks)|Adverse Event|0
65475|NCT01360645|259884|P2|Phase B (6 Weeks)|Adverse Event|6
65476|NCT01360645|259885|P1|Phase B (6 Weeks)|Adverse Event|0
65477|NCT01360645|259882|P4|Phase B (6 Weeks)|Lost to Follow-up|0
65478|NCT01360645|259883|P3|Phase B (6 Weeks)|Lost to Follow-up|0
65479|NCT01360645|259884|P2|Phase B (6 Weeks)|Lost to Follow-up|1
65480|NCT01360645|259885|P1|Phase B (6 Weeks)|Lost to Follow-up|0
65481|NCT01360645|259882|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
65482|NCT01360645|259883|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
65483|NCT01360645|259884|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
65484|NCT01360645|259885|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
65485|NCT01360645|259882|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
65486|NCT01360645|259883|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
65487|NCT01360645|259884|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
65488|NCT01360645|259885|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
65489|NCT01360645|259882|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
65490|NCT01360645|259883|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
65491|NCT01360645|259884|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
65492|NCT01360645|259885|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
65493|NCT01360645|259882|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
65494|NCT01360645|259883|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
65495|NCT01360645|259884|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
65496|NCT01360645|259885|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
65497|NCT01360645|259882|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
65498|NCT01360645|259883|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
65499|NCT01360645|259884|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
65500|NCT01360645|259885|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
65501|NCT01360645|259882|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
65502|NCT01360645|259883|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
65503|NCT01360645|259884|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
65504|NCT01360645|259885|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
65505|NCT01360632|259940|P5|Phase A+|Protocol Deviation|3
65506|NCT01360632|259941|P4|Phase A+|Protocol Deviation|0
65507|NCT01360632|259942|P3|Phase A+|Protocol Deviation|0
65508|NCT01360632|259943|P2|Phase A+|Protocol Deviation|0
65509|NCT01360632|259944|P1|Phase A+|Protocol Deviation|0
65510|NCT01360632|259940|P5|Phase A+|Withdrawal by Subject|8
65511|NCT01360632|259941|P4|Phase A+|Withdrawal by Subject|0
65512|NCT01360632|259942|P3|Phase A+|Withdrawal by Subject|0
65513|NCT01360632|259943|P2|Phase A+|Withdrawal by Subject|0
65514|NCT01360632|259944|P1|Phase A+|Withdrawal by Subject|0
65515|NCT01360632|259940|P5|Phase A+|Physician Decision|3
65516|NCT01360632|259941|P4|Phase A+|Physician Decision|0
65517|NCT01360632|259942|P3|Phase A+|Physician Decision|0
65518|NCT01360632|259943|P2|Phase A+|Physician Decision|0
65519|NCT01360632|259944|P1|Phase A+|Physician Decision|0
65520|NCT01360632|259940|P5|Phase A+|Met Withdrawal Criteria|7
65521|NCT01360632|259941|P4|Phase A+|Met Withdrawal Criteria|0
65522|NCT01360632|259942|P3|Phase A+|Met Withdrawal Criteria|0
65523|NCT01360632|259943|P2|Phase A+|Met Withdrawal Criteria|0
65524|NCT01360632|259944|P1|Phase A+|Met Withdrawal Criteria|0
65525|NCT01360632|259940|P5|Phase A+|Adverse Event|2
65526|NCT01360632|259941|P4|Phase A+|Adverse Event|0
65527|NCT01360632|259942|P3|Phase A+|Adverse Event|0
65528|NCT01360632|259943|P2|Phase A+|Adverse Event|0
65529|NCT01360632|259944|P1|Phase A+|Adverse Event|0
65530|NCT01360632|259940|P5|Phase A+|Lost to Follow-up|2
65531|NCT01360632|259941|P4|Phase A+|Lost to Follow-up|0
65532|NCT01360632|259942|P3|Phase A+|Lost to Follow-up|0
65533|NCT01360632|259943|P2|Phase A+|Lost to Follow-up|0
65534|NCT01360632|259944|P1|Phase A+|Lost to Follow-up|0
65535|NCT01360632|259940|P5|Phase B (6 Weeks)|Lack of Efficacy|0
65536|NCT01360632|259941|P4|Phase B (6 Weeks)|Lack of Efficacy|0
65537|NCT01360632|259942|P3|Phase B (6 Weeks)|Lack of Efficacy|0
65538|NCT01360632|259943|P2|Phase B (6 Weeks)|Lack of Efficacy|1
65539|NCT01360632|259944|P1|Phase B (6 Weeks)|Lack of Efficacy|0
65540|NCT01360632|259940|P5|Phase B (6 Weeks)|Protocol Deviation|0
65541|NCT01360632|259941|P4|Phase B (6 Weeks)|Protocol Deviation|1
65542|NCT01360632|259942|P3|Phase B (6 Weeks)|Protocol Deviation|4
65543|NCT01360632|259943|P2|Phase B (6 Weeks)|Protocol Deviation|1
65544|NCT01360632|259944|P1|Phase B (6 Weeks)|Protocol Deviation|0
65545|NCT01360632|259940|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
65546|NCT01360632|259941|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
65547|NCT01360632|259942|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
65548|NCT01360632|259943|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
65549|NCT01360632|259944|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
65550|NCT01360632|259940|P5|Phase B (6 Weeks)|Physician Decision|0
65551|NCT01360632|259941|P4|Phase B (6 Weeks)|Physician Decision|1
65552|NCT01360632|259942|P3|Phase B (6 Weeks)|Physician Decision|0
65553|NCT01360632|259943|P2|Phase B (6 Weeks)|Physician Decision|0
65554|NCT01360632|259944|P1|Phase B (6 Weeks)|Physician Decision|0
65555|NCT01360632|259940|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
65556|NCT01360632|259941|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
65557|NCT01360632|259942|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
65558|NCT01360632|259943|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
65559|NCT01360632|259944|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
65560|NCT01360632|259940|P5|Phase B (6 Weeks)|Adverse Event|0
65561|NCT01360632|259941|P4|Phase B (6 Weeks)|Adverse Event|3
65562|NCT01360632|259942|P3|Phase B (6 Weeks)|Adverse Event|9
65563|NCT01360632|259943|P2|Phase B (6 Weeks)|Adverse Event|3
65564|NCT01360632|259944|P1|Phase B (6 Weeks)|Adverse Event|0
65565|NCT01360632|259940|P5|Phase B (6 Weeks)|Lost to Follow-up|0
65566|NCT01360632|259941|P4|Phase B (6 Weeks)|Lost to Follow-up|0
65567|NCT01360632|259942|P3|Phase B (6 Weeks)|Lost to Follow-up|1
65568|NCT01360632|259943|P2|Phase B (6 Weeks)|Lost to Follow-up|1
65569|NCT01360632|259944|P1|Phase B (6 Weeks)|Lost to Follow-up|0
65570|NCT01360632|259940|P5|Phase A (8 Weeks)|Protocol Deviation|0
65571|NCT01360632|259941|P4|Phase A (8 Weeks)|Protocol Deviation|0
65572|NCT01360632|259942|P3|Phase A (8 Weeks)|Protocol Deviation|0
65573|NCT01360632|259943|P2|Phase A (8 Weeks)|Protocol Deviation|0
65574|NCT01360632|259944|P1|Phase A (8 Weeks)|Protocol Deviation|39
65575|NCT01360632|259940|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
65576|NCT01360632|259941|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
65577|NCT01360632|259942|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
65578|NCT01360632|259943|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
65579|NCT01360632|259944|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
65580|NCT01360632|259940|P5|Phase A (8 Weeks)|Physician Decision|0
65581|NCT01360632|259941|P4|Phase A (8 Weeks)|Physician Decision|0
65582|NCT01360632|259942|P3|Phase A (8 Weeks)|Physician Decision|0
65583|NCT01360632|259943|P2|Phase A (8 Weeks)|Physician Decision|0
65584|NCT01360632|259944|P1|Phase A (8 Weeks)|Physician Decision|10
65585|NCT01360632|259940|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
65586|NCT01360632|259941|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
65587|NCT01360632|259942|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
65588|NCT01360632|259943|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
65589|NCT01360632|259944|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
65590|NCT01360632|259940|P5|Phase A (8 Weeks)|Adverse Event|0
65591|NCT01360632|259941|P4|Phase A (8 Weeks)|Adverse Event|0
65592|NCT01360632|259942|P3|Phase A (8 Weeks)|Adverse Event|0
65593|NCT01360632|259943|P2|Phase A (8 Weeks)|Adverse Event|0
65594|NCT01360632|259944|P1|Phase A (8 Weeks)|Adverse Event|60
65595|NCT01360632|259940|P5|Phase A (8 Weeks)|Lost to Follow-up|0
65596|NCT01360632|259941|P4|Phase A (8 Weeks)|Lost to Follow-up|0
65597|NCT01360632|259942|P3|Phase A (8 Weeks)|Lost to Follow-up|0
65598|NCT01360632|259943|P2|Phase A (8 Weeks)|Lost to Follow-up|0
65599|NCT01360632|259944|P1|Phase A (8 Weeks)|Lost to Follow-up|27
65600|NCT01360554|260023|P2|Overall Study|Randomized but not treated.|3
65601|NCT01360554|260024|P1|Overall Study|Randomized but not treated.|3
65602|NCT01360554|260023|P2|Overall Study|Other, not specified|0
65603|NCT01360554|260024|P1|Overall Study|Other, not specified|1
65604|NCT01360554|260023|P2|Overall Study|Study terminated by sponsor|37
65605|NCT01360554|260024|P1|Overall Study|Study terminated by sponsor|49
65606|NCT01360554|260023|P2|Overall Study|Withdrawal by Subject|24
65607|NCT01360554|260024|P1|Overall Study|Withdrawal by Subject|23
65608|NCT01360554|260023|P2|Overall Study|Lost to Follow-up|4
65609|NCT01360554|260024|P1|Overall Study|Lost to Follow-up|4
65610|NCT01360554|260023|P2|Overall Study|Death|371
65611|NCT01360554|260024|P1|Overall Study|Death|359
65612|NCT01360021|260076|P3|Overall Study|Adverse Event|3
65613|NCT01360021|260077|P2|Overall Study|Adverse Event|3
65614|NCT01360021|260078|P1|Overall Study|Adverse Event|2
65615|NCT01360021|260076|P3|Overall Study|Withdrawal by Subject|2
65616|NCT01360021|260077|P2|Overall Study|Withdrawal by Subject|0
65617|NCT01360021|260078|P1|Overall Study|Withdrawal by Subject|4
65618|NCT01360021|260076|P3|Overall Study|Protocol Violation|1
65619|NCT01360021|260077|P2|Overall Study|Protocol Violation|0
65620|NCT01360021|260078|P1|Overall Study|Protocol Violation|0
65621|NCT01360021|260076|P3|Overall Study|Eligibility criteria + other|1
65622|NCT01360021|260077|P2|Overall Study|Eligibility criteria + other|1
65623|NCT01360021|260078|P1|Overall Study|Eligibility criteria + other|2
65624|NCT01359943|260104|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
65625|NCT01359943|260105|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
65626|NCT01359943|260106|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
65627|NCT01359943|260104|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
65628|NCT01359943|260105|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
65629|NCT01359943|260106|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
65630|NCT01359943|260104|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
65631|NCT01359943|260105|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
65632|NCT01359943|260106|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
65633|NCT01359943|260104|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
65634|NCT01359943|260105|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
65635|NCT01359943|260106|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
65636|NCT01359943|260104|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
65637|NCT01359943|260105|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
65638|NCT01359943|260106|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
65639|NCT01359943|260104|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
65640|NCT01359943|260105|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
65641|NCT01359943|260106|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
65642|NCT01359943|260104|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
65643|NCT01359943|260105|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
65644|NCT01359943|260106|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
65645|NCT01359943|260104|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
65646|NCT01359943|260105|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
65647|NCT01359943|260106|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
65648|NCT01359943|260104|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
65649|NCT01359943|260105|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
65650|NCT01359943|260106|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
65651|NCT01359943|260104|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
65652|NCT01359943|260105|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
65653|NCT01359943|260106|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
65654|NCT01359943|260104|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
65655|NCT01359943|260105|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
65656|NCT01359943|260106|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
65657|NCT01359943|260104|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
65658|NCT01359943|260105|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
65659|NCT01359943|260106|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
65660|NCT01359943|260104|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
65661|NCT01359943|260105|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
65662|NCT01359943|260106|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
65663|NCT01359943|260104|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
65664|NCT01359943|260105|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
65665|NCT01359943|260106|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
65666|NCT01359943|260104|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
65667|NCT01359943|260105|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
65668|NCT01359943|260106|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
65669|NCT01359904|260154|P2|Overall Study|Withdrawal by Subject|0
65670|NCT01359904|260155|P1|Overall Study|Withdrawal by Subject|1
65671|NCT01359644|260209|P10|Follow-up Period|Lost to Follow-up|0
65672|NCT01359644|260210|P9|Follow-up Period|Lost to Follow-up|0
65673|NCT01359644|260211|P8|Follow-up Period|Lost to Follow-up|2
65674|NCT01359644|260212|P7|Follow-up Period|Lost to Follow-up|1
65675|NCT01359644|260213|P6|Follow-up Period|Lost to Follow-up|0
65676|NCT01359644|260214|P5|Follow-up Period|Lost to Follow-up|0
65677|NCT01359644|260215|P4|Follow-up Period|Lost to Follow-up|0
65678|NCT01359644|260216|P3|Follow-up Period|Lost to Follow-up|0
65679|NCT01359644|260217|P2|Follow-up Period|Lost to Follow-up|0
65680|NCT01359644|260218|P1|Follow-up Period|Lost to Follow-up|0
65681|NCT01359644|260209|P10|Follow-up Period|Withdrawal by Subject|0
65682|NCT01359644|260210|P9|Follow-up Period|Withdrawal by Subject|0
65683|NCT01359644|260211|P8|Follow-up Period|Withdrawal by Subject|0
65684|NCT01359644|260212|P7|Follow-up Period|Withdrawal by Subject|0
65685|NCT01359644|260213|P6|Follow-up Period|Withdrawal by Subject|1
65686|NCT01359644|260214|P5|Follow-up Period|Withdrawal by Subject|0
65687|NCT01359644|260215|P4|Follow-up Period|Withdrawal by Subject|0
65688|NCT01359644|260216|P3|Follow-up Period|Withdrawal by Subject|0
65689|NCT01359644|260217|P2|Follow-up Period|Withdrawal by Subject|0
65690|NCT01359644|260218|P1|Follow-up Period|Withdrawal by Subject|0
65691|NCT01359644|260209|P10|Treatment Period|Lost to Follow-up|0
65692|NCT01359644|260210|P9|Treatment Period|Lost to Follow-up|0
65693|NCT01359644|260211|P8|Treatment Period|Lost to Follow-up|0
65694|NCT01359644|260212|P7|Treatment Period|Lost to Follow-up|0
65695|NCT01359644|260213|P6|Treatment Period|Lost to Follow-up|1
65696|NCT01359644|260214|P5|Treatment Period|Lost to Follow-up|0
65697|NCT01359644|260215|P4|Treatment Period|Lost to Follow-up|0
65698|NCT01359644|260216|P3|Treatment Period|Lost to Follow-up|0
65699|NCT01359644|260217|P2|Treatment Period|Lost to Follow-up|0
65700|NCT01359644|260218|P1|Treatment Period|Lost to Follow-up|0
65701|NCT01359644|260209|P10|Treatment Period|Adverse Event|0
65702|NCT01359644|260210|P9|Treatment Period|Adverse Event|0
65703|NCT01359644|260211|P8|Treatment Period|Adverse Event|0
65704|NCT01359644|260212|P7|Treatment Period|Adverse Event|0
65705|NCT01359644|260213|P6|Treatment Period|Adverse Event|1
65706|NCT01359644|260214|P5|Treatment Period|Adverse Event|0
65707|NCT01359644|260215|P4|Treatment Period|Adverse Event|0
65708|NCT01359644|260216|P3|Treatment Period|Adverse Event|1
65709|NCT01359644|260217|P2|Treatment Period|Adverse Event|0
65710|NCT01359644|260218|P1|Treatment Period|Adverse Event|0
65711|NCT01359644|260209|P10|Treatment Period|Lack of Efficacy|0
65712|NCT01359644|260210|P9|Treatment Period|Lack of Efficacy|0
65713|NCT01359644|260211|P8|Treatment Period|Lack of Efficacy|0
65714|NCT01359644|260212|P7|Treatment Period|Lack of Efficacy|0
65715|NCT01359644|260213|P6|Treatment Period|Lack of Efficacy|0
65716|NCT01359644|260214|P5|Treatment Period|Lack of Efficacy|0
65717|NCT01359644|260215|P4|Treatment Period|Lack of Efficacy|0
65718|NCT01359644|260216|P3|Treatment Period|Lack of Efficacy|0
65719|NCT01359644|260217|P2|Treatment Period|Lack of Efficacy|1
65720|NCT01359644|260218|P1|Treatment Period|Lack of Efficacy|0
65721|NCT01359449|260262|P2|Overall Study|Withdrawal by Subject|2
65722|NCT01359449|260263|P1|Overall Study|Withdrawal by Subject|3
65723|NCT01359449|260262|P2|Overall Study|Protocol Violation|2
65724|NCT01359449|260263|P1|Overall Study|Protocol Violation|0
65725|NCT01359449|260262|P2|Overall Study|Lost to Follow-up|0
65726|NCT01359449|260263|P1|Overall Study|Lost to Follow-up|1
65727|NCT01359254|260309|P2|Overall Study|Death|0
65728|NCT01359254|260310|P1|Overall Study|Death|1
65729|NCT01359150|260320|P2|Overall Study|Other|0
65730|NCT01359150|260321|P1|Overall Study|Other|1
65731|NCT01359150|260320|P2|Overall Study|Adverse Event|3
65732|NCT01359150|260321|P1|Overall Study|Adverse Event|4
65733|NCT01359150|260320|P2|Overall Study|Withdrawal by Subject|1
65734|NCT01359150|260321|P1|Overall Study|Withdrawal by Subject|1
65735|NCT01359150|260320|P2|Overall Study|Lack of Efficacy|1
65736|NCT01359150|260321|P1|Overall Study|Lack of Efficacy|1
65737|NCT01358877|260360|P2|Overall Study|Other|129
65738|NCT01358877|260361|P1|Overall Study|Other|142
65739|NCT01358877|260360|P2|Overall Study|Ongoing follow-up for overall survival|5
65740|NCT01358877|260361|P1|Overall Study|Ongoing follow-up for overall survival|7
65741|NCT01358877|260360|P2|Overall Study|Ongoing follow-up for IDFS event|2073
65742|NCT01358877|260361|P1|Overall Study|Ongoing follow-up for IDFS event|2084
65743|NCT01358877|260360|P2|Overall Study|Ongoing follow-up for post-recurrence|108
65744|NCT01358877|260361|P1|Overall Study|Ongoing follow-up for post-recurrence|87
65745|NCT01358877|260360|P2|Overall Study|Death|89
65746|NCT01358877|260361|P1|Overall Study|Death|80
65747|NCT01358864|260431|P8|Overall Study|Not treated|0
65748|NCT01358864|260432|P7|Overall Study|Not treated|1
65749|NCT01358864|260433|P6|Overall Study|Not treated|0
65750|NCT01358864|260434|P5|Overall Study|Not treated|0
65751|NCT01358864|260435|P4|Overall Study|Not treated|0
65752|NCT01358864|260436|P3|Overall Study|Not treated|0
65753|NCT01358864|260437|P2|Overall Study|Not treated|0
65754|NCT01358864|260438|P1|Overall Study|Not treated|0
65755|NCT01358864|260431|P8|Overall Study|Other reason not defined above|0
65756|NCT01358864|260432|P7|Overall Study|Other reason not defined above|2
65757|NCT01358864|260433|P6|Overall Study|Other reason not defined above|0
65758|NCT01358864|260434|P5|Overall Study|Other reason not defined above|0
65759|NCT01358864|260435|P4|Overall Study|Other reason not defined above|0
65760|NCT01358864|260436|P3|Overall Study|Other reason not defined above|0
65761|NCT01358864|260437|P2|Overall Study|Other reason not defined above|0
65762|NCT01358864|260438|P1|Overall Study|Other reason not defined above|2
65763|NCT01358864|260431|P8|Overall Study|Withdrawal by Subject|3
65764|NCT01358864|260432|P7|Overall Study|Withdrawal by Subject|1
65765|NCT01358864|260433|P6|Overall Study|Withdrawal by Subject|1
65766|NCT01358864|260434|P5|Overall Study|Withdrawal by Subject|0
65767|NCT01358864|260435|P4|Overall Study|Withdrawal by Subject|0
65768|NCT01358864|260436|P3|Overall Study|Withdrawal by Subject|2
65769|NCT01358864|260437|P2|Overall Study|Withdrawal by Subject|4
65770|NCT01358864|260438|P1|Overall Study|Withdrawal by Subject|3
65771|NCT01358864|260431|P8|Overall Study|Lost to Follow-up|1
65772|NCT01358864|260432|P7|Overall Study|Lost to Follow-up|0
65773|NCT01358864|260433|P6|Overall Study|Lost to Follow-up|0
65774|NCT01358864|260434|P5|Overall Study|Lost to Follow-up|0
65775|NCT01358864|260435|P4|Overall Study|Lost to Follow-up|0
65776|NCT01358864|260436|P3|Overall Study|Lost to Follow-up|1
65777|NCT01358864|260437|P2|Overall Study|Lost to Follow-up|0
65778|NCT01358864|260438|P1|Overall Study|Lost to Follow-up|0
65779|NCT01358864|260431|P8|Overall Study|Lack of Efficacy|44
65780|NCT01358864|260432|P7|Overall Study|Lack of Efficacy|49
65781|NCT01358864|260433|P6|Overall Study|Lack of Efficacy|4
65782|NCT01358864|260434|P5|Overall Study|Lack of Efficacy|7
65783|NCT01358864|260435|P4|Overall Study|Lack of Efficacy|19
65784|NCT01358864|260436|P3|Overall Study|Lack of Efficacy|4
65785|NCT01358864|260437|P2|Overall Study|Lack of Efficacy|3
65786|NCT01358864|260438|P1|Overall Study|Lack of Efficacy|26
65787|NCT01358864|260431|P8|Overall Study|Adverse Event|7
65788|NCT01358864|260432|P7|Overall Study|Adverse Event|12
65789|NCT01358864|260433|P6|Overall Study|Adverse Event|8
65790|NCT01358864|260434|P5|Overall Study|Adverse Event|4
65791|NCT01358864|260435|P4|Overall Study|Adverse Event|0
65792|NCT01358864|260436|P3|Overall Study|Adverse Event|9
65793|NCT01358864|260437|P2|Overall Study|Adverse Event|6
65794|NCT01358864|260438|P1|Overall Study|Adverse Event|0
65795|NCT01358825|260529|P2|Overall Study|Blood sample not drawn|1
65796|NCT01358825|260530|P1|Overall Study|Blood sample not drawn|0
65797|NCT01358760|260554|P3|Overall Study|Entry criteria not met/Non-compliance|16
65798|NCT01358760|260555|P2|Overall Study|Entry criteria not met/Non-compliance|12
65799|NCT01358760|260556|P1|Overall Study|Entry criteria not met/Non-compliance|12
65800|NCT01358760|260554|P3|Overall Study|Physician Decision|1
65801|NCT01358760|260555|P2|Overall Study|Physician Decision|0
65802|NCT01358760|260556|P1|Overall Study|Physician Decision|1
65803|NCT01358760|260554|P3|Overall Study|Withdrawal by Subject|2
65804|NCT01358760|260555|P2|Overall Study|Withdrawal by Subject|3
65805|NCT01358760|260556|P1|Overall Study|Withdrawal by Subject|5
65806|NCT01358760|260554|P3|Overall Study|Lost to Follow-up|3
65807|NCT01358760|260555|P2|Overall Study|Lost to Follow-up|1
65808|NCT01358760|260556|P1|Overall Study|Lost to Follow-up|1
65809|NCT01358760|260554|P3|Overall Study|Adverse Event|3
65810|NCT01358760|260555|P2|Overall Study|Adverse Event|4
65811|NCT01358760|260556|P1|Overall Study|Adverse Event|3
65812|NCT01358734|260591|P3|Overall Study|Not Specified|4
65813|NCT01358734|260592|P2|Overall Study|Not Specified|5
65814|NCT01358734|260593|P1|Overall Study|Not Specified|2
65815|NCT01358734|260591|P3|Overall Study|Non-compliance with study drug|1
65816|NCT01358734|260592|P2|Overall Study|Non-compliance with study drug|0
65817|NCT01358734|260593|P1|Overall Study|Non-compliance with study drug|0
65818|NCT01358734|260591|P3|Overall Study|Progressive Disease|13
65819|NCT01358734|260592|P2|Overall Study|Progressive Disease|11
65820|NCT01358734|260593|P1|Overall Study|Progressive Disease|5
65821|NCT01358734|260591|P3|Overall Study|Death|2
65822|NCT01358734|260592|P2|Overall Study|Death|7
65823|NCT01358734|260593|P1|Overall Study|Death|3
65824|NCT01358734|260591|P3|Overall Study|Withdrawal by Subject|3
65825|NCT01358734|260592|P2|Overall Study|Withdrawal by Subject|6
65826|NCT01358734|260593|P1|Overall Study|Withdrawal by Subject|1
65827|NCT01358734|260591|P3|Overall Study|Lack of Efficacy|3
65828|NCT01358734|260592|P2|Overall Study|Lack of Efficacy|1
65829|NCT01358734|260593|P1|Overall Study|Lack of Efficacy|0
65830|NCT01358734|260591|P3|Overall Study|Adverse Event|3
65831|NCT01358734|260592|P2|Overall Study|Adverse Event|7
65832|NCT01358734|260593|P1|Overall Study|Adverse Event|4
65833|NCT01358708|260612|P2|Double-Blind Treatment Phase|Protocol Violation|0
65834|NCT01358708|260613|P1|Double-Blind Treatment Phase|Protocol Violation|1
65835|NCT01358708|260612|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
65836|NCT01358708|260613|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
65837|NCT01358578|260636|P6|Follow-up Period|Physician Decision|0
65838|NCT01358578|260637|P5|Follow-up Period|Physician Decision|0
65839|NCT01358578|260638|P4|Follow-up Period|Physician Decision|2
65840|NCT01358578|260639|P3|Follow-up Period|Physician Decision|0
65841|NCT01358578|260640|P2|Follow-up Period|Physician Decision|1
65842|NCT01358578|260641|P1|Follow-up Period|Physician Decision|1
65843|NCT01358578|260636|P6|Follow-up Period|Withdrawal by Subject|0
65844|NCT01358578|260637|P5|Follow-up Period|Withdrawal by Subject|0
65845|NCT01358578|260638|P4|Follow-up Period|Withdrawal by Subject|12
65846|NCT01358578|260639|P3|Follow-up Period|Withdrawal by Subject|1
65847|NCT01358578|260640|P2|Follow-up Period|Withdrawal by Subject|3
65848|NCT01358578|260641|P1|Follow-up Period|Withdrawal by Subject|3
65849|NCT01358578|260636|P6|Follow-up Period|Pregnancy|0
65850|NCT01358578|260637|P5|Follow-up Period|Pregnancy|0
65851|NCT01358578|260638|P4|Follow-up Period|Pregnancy|0
65852|NCT01358578|260639|P3|Follow-up Period|Pregnancy|0
65853|NCT01358578|260640|P2|Follow-up Period|Pregnancy|0
65854|NCT01358578|260641|P1|Follow-up Period|Pregnancy|1
65855|NCT01358578|260636|P6|Follow-up Period|non- compliance with study treatment|0
65856|NCT01358578|260637|P5|Follow-up Period|non- compliance with study treatment|0
65857|NCT01358578|260638|P4|Follow-up Period|non- compliance with study treatment|0
65858|NCT01358578|260639|P3|Follow-up Period|non- compliance with study treatment|0
65859|NCT01358578|260640|P2|Follow-up Period|non- compliance with study treatment|0
65860|NCT01358578|260641|P1|Follow-up Period|non- compliance with study treatment|1
65861|NCT01358578|260636|P6|Follow-up Period|Lost to Follow-up|0
65862|NCT01358578|260637|P5|Follow-up Period|Lost to Follow-up|0
65863|NCT01358578|260638|P4|Follow-up Period|Lost to Follow-up|4
65864|NCT01358578|260639|P3|Follow-up Period|Lost to Follow-up|0
65865|NCT01358578|260640|P2|Follow-up Period|Lost to Follow-up|1
65866|NCT01358578|260641|P1|Follow-up Period|Lost to Follow-up|0
65867|NCT01358578|260636|P6|Follow-up Period|Lack of Efficacy|0
65868|NCT01358578|260637|P5|Follow-up Period|Lack of Efficacy|0
65869|NCT01358578|260638|P4|Follow-up Period|Lack of Efficacy|1
65870|NCT01358578|260639|P3|Follow-up Period|Lack of Efficacy|4
65871|NCT01358578|260640|P2|Follow-up Period|Lack of Efficacy|0
65872|NCT01358578|260641|P1|Follow-up Period|Lack of Efficacy|3
65873|NCT01358578|260636|P6|Follow-up Period|Adverse Event|0
65874|NCT01358578|260637|P5|Follow-up Period|Adverse Event|0
65875|NCT01358578|260638|P4|Follow-up Period|Adverse Event|0
65876|NCT01358578|260639|P3|Follow-up Period|Adverse Event|0
65877|NCT01358578|260640|P2|Follow-up Period|Adverse Event|1
65878|NCT01358578|260641|P1|Follow-up Period|Adverse Event|1
65879|NCT01358578|260636|P6|Maintenance Period|Withdrawal by Subject|3
65880|NCT01358578|260637|P5|Maintenance Period|Withdrawal by Subject|6
65881|NCT01358578|260638|P4|Maintenance Period|Withdrawal by Subject|15
65882|NCT01358578|260639|P3|Maintenance Period|Withdrawal by Subject|2
65883|NCT01358578|260640|P2|Maintenance Period|Withdrawal by Subject|7
65884|NCT01358578|260641|P1|Maintenance Period|Withdrawal by Subject|12
65885|NCT01358578|260636|P6|Maintenance Period|Protocol deviation|2
65886|NCT01358578|260637|P5|Maintenance Period|Protocol deviation|2
65887|NCT01358578|260638|P4|Maintenance Period|Protocol deviation|2
65888|NCT01358578|260639|P3|Maintenance Period|Protocol deviation|0
65889|NCT01358578|260640|P2|Maintenance Period|Protocol deviation|4
65890|NCT01358578|260641|P1|Maintenance Period|Protocol deviation|7
65891|NCT01358578|260636|P6|Maintenance Period|Pregnancy|0
65892|NCT01358578|260637|P5|Maintenance Period|Pregnancy|0
65893|NCT01358578|260638|P4|Maintenance Period|Pregnancy|0
65894|NCT01358578|260639|P3|Maintenance Period|Pregnancy|0
65895|NCT01358578|260640|P2|Maintenance Period|Pregnancy|0
65896|NCT01358578|260641|P1|Maintenance Period|Pregnancy|1
65897|NCT01358578|260636|P6|Maintenance Period|Physician Decision|0
65898|NCT01358578|260637|P5|Maintenance Period|Physician Decision|0
65899|NCT01358578|260638|P4|Maintenance Period|Physician Decision|1
65900|NCT01358578|260639|P3|Maintenance Period|Physician Decision|0
65901|NCT01358578|260640|P2|Maintenance Period|Physician Decision|1
65902|NCT01358578|260641|P1|Maintenance Period|Physician Decision|0
65903|NCT01358578|260636|P6|Maintenance Period|Non-compliance with study treatment|2
65904|NCT01358578|260637|P5|Maintenance Period|Non-compliance with study treatment|1
65905|NCT01358578|260638|P4|Maintenance Period|Non-compliance with study treatment|2
65906|NCT01358578|260639|P3|Maintenance Period|Non-compliance with study treatment|0
65907|NCT01358578|260640|P2|Maintenance Period|Non-compliance with study treatment|1
65908|NCT01358578|260641|P1|Maintenance Period|Non-compliance with study treatment|3
65909|NCT01358578|260636|P6|Maintenance Period|Lost to Follow-up|1
65910|NCT01358578|260637|P5|Maintenance Period|Lost to Follow-up|1
65911|NCT01358578|260638|P4|Maintenance Period|Lost to Follow-up|5
65912|NCT01358578|260639|P3|Maintenance Period|Lost to Follow-up|0
65913|NCT01358578|260640|P2|Maintenance Period|Lost to Follow-up|0
65914|NCT01358578|260641|P1|Maintenance Period|Lost to Follow-up|4
65915|NCT01358578|260636|P6|Maintenance Period|Lack of Efficacy|0
65916|NCT01358578|260637|P5|Maintenance Period|Lack of Efficacy|3
65917|NCT01358578|260638|P4|Maintenance Period|Lack of Efficacy|11
65918|NCT01358578|260639|P3|Maintenance Period|Lack of Efficacy|0
65919|NCT01358578|260640|P2|Maintenance Period|Lack of Efficacy|2
65920|NCT01358578|260641|P1|Maintenance Period|Lack of Efficacy|10
65921|NCT01358578|260636|P6|Maintenance Period|Adverse Event|3
65922|NCT01358578|260637|P5|Maintenance Period|Adverse Event|4
65923|NCT01358578|260638|P4|Maintenance Period|Adverse Event|6
65924|NCT01358578|260639|P3|Maintenance Period|Adverse Event|0
65925|NCT01358578|260640|P2|Maintenance Period|Adverse Event|7
65926|NCT01358578|260641|P1|Maintenance Period|Adverse Event|2
65927|NCT01358578|260636|P6|Induction Period|Withdrawal by Subject|0
65928|NCT01358578|260637|P5|Induction Period|Withdrawal by Subject|0
65929|NCT01358578|260638|P4|Induction Period|Withdrawal by Subject|6
65930|NCT01358578|260639|P3|Induction Period|Withdrawal by Subject|10
65931|NCT01358578|260640|P2|Induction Period|Withdrawal by Subject|5
65932|NCT01358578|260641|P1|Induction Period|Withdrawal by Subject|5
65933|NCT01358578|260636|P6|Induction Period|technical problems|0
65934|NCT01358578|260637|P5|Induction Period|technical problems|0
65935|NCT01358578|260638|P4|Induction Period|technical problems|1
65936|NCT01358578|260639|P3|Induction Period|technical problems|1
65937|NCT01358578|260640|P2|Induction Period|technical problems|0
65938|NCT01358578|260641|P1|Induction Period|technical problems|0
65939|NCT01358578|260636|P6|Induction Period|Protocol Deviation|0
65940|NCT01358578|260637|P5|Induction Period|Protocol Deviation|0
65941|NCT01358578|260638|P4|Induction Period|Protocol Deviation|3
65942|NCT01358578|260639|P3|Induction Period|Protocol Deviation|0
65943|NCT01358578|260640|P2|Induction Period|Protocol Deviation|5
65944|NCT01358578|260641|P1|Induction Period|Protocol Deviation|3
65945|NCT01358578|260636|P6|Induction Period|Physician Decision|0
65946|NCT01358578|260637|P5|Induction Period|Physician Decision|0
65947|NCT01358578|260638|P4|Induction Period|Physician Decision|0
65948|NCT01358578|260639|P3|Induction Period|Physician Decision|2
65949|NCT01358578|260640|P2|Induction Period|Physician Decision|1
65950|NCT01358578|260641|P1|Induction Period|Physician Decision|2
65951|NCT01358578|260636|P6|Induction Period|Lost to Follow-up|0
65952|NCT01358578|260637|P5|Induction Period|Lost to Follow-up|0
65953|NCT01358578|260638|P4|Induction Period|Lost to Follow-up|4
65954|NCT01358578|260639|P3|Induction Period|Lost to Follow-up|1
65955|NCT01358578|260640|P2|Induction Period|Lost to Follow-up|0
65956|NCT01358578|260641|P1|Induction Period|Lost to Follow-up|0
65957|NCT01358578|260636|P6|Induction Period|Lack of Efficacy|0
65958|NCT01358578|260637|P5|Induction Period|Lack of Efficacy|0
65959|NCT01358578|260638|P4|Induction Period|Lack of Efficacy|1
65960|NCT01358578|260639|P3|Induction Period|Lack of Efficacy|9
65961|NCT01358578|260640|P2|Induction Period|Lack of Efficacy|0
65962|NCT01358578|260641|P1|Induction Period|Lack of Efficacy|0
65963|NCT01358578|260636|P6|Induction Period|Adverse Event|0
65964|NCT01358578|260637|P5|Induction Period|Adverse Event|0
65965|NCT01358578|260638|P4|Induction Period|Adverse Event|6
65966|NCT01358578|260639|P3|Induction Period|Adverse Event|2
65967|NCT01358578|260640|P2|Induction Period|Adverse Event|4
65968|NCT01358578|260641|P1|Induction Period|Adverse Event|2
65969|NCT01358526|260693|P3|Double-blind Phase|Administrative|10
65970|NCT01358526|260694|P2|Double-blind Phase|Administrative|6
65971|NCT01358526|260695|P1|Double-blind Phase|Administrative|0
65972|NCT01358526|260693|P3|Double-blind Phase|Confirmed or suspected diversion|6
65973|NCT01358526|260694|P2|Double-blind Phase|Confirmed or suspected diversion|5
65974|NCT01358526|260695|P1|Double-blind Phase|Confirmed or suspected diversion|0
65975|NCT01358526|260693|P3|Double-blind Phase|Lack of Efficacy|73
65976|NCT01358526|260694|P2|Double-blind Phase|Lack of Efficacy|31
65977|NCT01358526|260695|P1|Double-blind Phase|Lack of Efficacy|0
65978|NCT01358526|260693|P3|Double-blind Phase|Lost to Follow-up|1
65979|NCT01358526|260694|P2|Double-blind Phase|Lost to Follow-up|4
65980|NCT01358526|260695|P1|Double-blind Phase|Lost to Follow-up|0
65981|NCT01358526|260693|P3|Double-blind Phase|Withdrawal by Subject|8
65982|NCT01358526|260694|P2|Double-blind Phase|Withdrawal by Subject|10
65983|NCT01358526|260695|P1|Double-blind Phase|Withdrawal by Subject|0
65984|NCT01358526|260693|P3|Double-blind Phase|Adverse Event|23
65985|NCT01358526|260694|P2|Double-blind Phase|Adverse Event|24
65986|NCT01358526|260695|P1|Double-blind Phase|Adverse Event|0
65987|NCT01358526|260693|P3|Open-label Titration Period|Did not qualify|0
65988|NCT01358526|260694|P2|Open-label Titration Period|Did not qualify|0
65989|NCT01358526|260695|P1|Open-label Titration Period|Did not qualify|178
65990|NCT01358526|260693|P3|Open-label Titration Period|Administrative|0
65991|NCT01358526|260694|P2|Open-label Titration Period|Administrative|0
65992|NCT01358526|260695|P1|Open-label Titration Period|Administrative|8
65993|NCT01358526|260693|P3|Open-label Titration Period|Confirmed or suspected diversion|0
65994|NCT01358526|260694|P2|Open-label Titration Period|Confirmed or suspected diversion|0
65995|NCT01358526|260695|P1|Open-label Titration Period|Confirmed or suspected diversion|16
65996|NCT01358526|260693|P3|Open-label Titration Period|Lack of Efficacy|0
65997|NCT01358526|260694|P2|Open-label Titration Period|Lack of Efficacy|0
65998|NCT01358526|260695|P1|Open-label Titration Period|Lack of Efficacy|107
65999|NCT01358526|260693|P3|Open-label Titration Period|Lost to Follow-up|0
66000|NCT01358526|260694|P2|Open-label Titration Period|Lost to Follow-up|0
66001|NCT01358526|260695|P1|Open-label Titration Period|Lost to Follow-up|25
66002|NCT01358526|260693|P3|Open-label Titration Period|Withdrawal by Subject|0
66003|NCT01358526|260694|P2|Open-label Titration Period|Withdrawal by Subject|0
66004|NCT01358526|260695|P1|Open-label Titration Period|Withdrawal by Subject|65
66005|NCT01358526|260693|P3|Open-label Titration Period|Adverse Event|0
66006|NCT01358526|260694|P2|Open-label Titration Period|Adverse Event|0
66007|NCT01358526|260695|P1|Open-label Titration Period|Adverse Event|95
66008|NCT01358357|260712|P3|Double-Blind Phase|Administrative|0
66009|NCT01358357|260713|P2|Double-Blind Phase|Administrative|1
66010|NCT01358357|260714|P1|Double-Blind Phase|Administrative|0
66011|NCT01358357|260712|P3|Double-Blind Phase|Recurrence of mood event|0
66012|NCT01358357|260713|P2|Double-Blind Phase|Recurrence of mood event|64
66013|NCT01358357|260714|P1|Double-Blind Phase|Recurrence of mood event|48
66014|NCT01358357|260712|P3|Double-Blind Phase|Terminated at study completion|0
66015|NCT01358357|260713|P2|Double-Blind Phase|Terminated at study completion|0
66016|NCT01358357|260714|P1|Double-Blind Phase|Terminated at study completion|2
66017|NCT01358357|260712|P3|Double-Blind Phase|Protocol Violation|0
66018|NCT01358357|260713|P2|Double-Blind Phase|Protocol Violation|12
66019|NCT01358357|260714|P1|Double-Blind Phase|Protocol Violation|16
66020|NCT01358357|260712|P3|Double-Blind Phase|Protocol Violation|0
66021|NCT01358357|260713|P2|Double-Blind Phase|Protocol Violation|11
66022|NCT01358357|260714|P1|Double-Blind Phase|Protocol Violation|1
66023|NCT01358357|260712|P3|Double-Blind Phase|Lost to Follow-up|0
66024|NCT01358357|260713|P2|Double-Blind Phase|Lost to Follow-up|7
66025|NCT01358357|260714|P1|Double-Blind Phase|Lost to Follow-up|5
66026|NCT01358357|260712|P3|Double-Blind Phase|Adverse Event|0
66027|NCT01358357|260713|P2|Double-Blind Phase|Adverse Event|5
66028|NCT01358357|260714|P1|Double-Blind Phase|Adverse Event|8
66029|NCT01358357|260712|P3|Open Label Phase|Mood episode|42
66030|NCT01358357|260713|P2|Open Label Phase|Mood episode|0
66031|NCT01358357|260714|P1|Open Label Phase|Mood episode|0
66032|NCT01358357|260712|P3|Open Label Phase|Terminated at study completion|5
66033|NCT01358357|260713|P2|Open Label Phase|Terminated at study completion|0
66034|NCT01358357|260714|P1|Open Label Phase|Terminated at study completion|0
66035|NCT01358357|260712|P3|Open Label Phase|Did not meet criteria for DB phase|16
66036|NCT01358357|260713|P2|Open Label Phase|Did not meet criteria for DB phase|0
66037|NCT01358357|260714|P1|Open Label Phase|Did not meet criteria for DB phase|0
66038|NCT01358357|260712|P3|Open Label Phase|Withdrawal by Subject|112
66039|NCT01358357|260713|P2|Open Label Phase|Withdrawal by Subject|0
66040|NCT01358357|260714|P1|Open Label Phase|Withdrawal by Subject|0
66041|NCT01358357|260712|P3|Open Label Phase|Protocol Violation|45
66042|NCT01358357|260713|P2|Open Label Phase|Protocol Violation|0
66043|NCT01358357|260714|P1|Open Label Phase|Protocol Violation|0
66044|NCT01358357|260712|P3|Open Label Phase|Lost to Follow-up|76
66045|NCT01358357|260713|P2|Open Label Phase|Lost to Follow-up|0
66046|NCT01358357|260714|P1|Open Label Phase|Lost to Follow-up|0
66047|NCT01358357|260712|P3|Open Label Phase|Lack of Efficacy|107
66048|NCT01358357|260713|P2|Open Label Phase|Lack of Efficacy|0
66049|NCT01358357|260714|P1|Open Label Phase|Lack of Efficacy|0
66050|NCT01358357|260712|P3|Open Label Phase|Adverse Event|59
66051|NCT01358357|260713|P2|Open Label Phase|Adverse Event|0
66052|NCT01358357|260714|P1|Open Label Phase|Adverse Event|0
66053|NCT01358175|260750|P3|Overall Study|Adverse Event|11
66054|NCT01358175|260751|P2|Overall Study|Adverse Event|11
66055|NCT01358175|260752|P1|Overall Study|Adverse Event|6
66056|NCT01358175|260750|P3|Overall Study|Lack of Efficacy|6
66057|NCT01358175|260751|P2|Overall Study|Lack of Efficacy|8
66058|NCT01358175|260752|P1|Overall Study|Lack of Efficacy|3
66059|NCT01358175|260750|P3|Overall Study|Lost to Follow-up|3
66060|NCT01358175|260751|P2|Overall Study|Lost to Follow-up|1
66061|NCT01358175|260752|P1|Overall Study|Lost to Follow-up|1
66062|NCT01358175|260750|P3|Overall Study|Non Compliance with Study Treatment|1
66063|NCT01358175|260751|P2|Overall Study|Non Compliance with Study Treatment|1
66064|NCT01358175|260752|P1|Overall Study|Non Compliance with Study Treatment|0
66065|NCT01358175|260750|P3|Overall Study|Physician Decision|0
66066|NCT01358175|260751|P2|Overall Study|Physician Decision|0
66067|NCT01358175|260752|P1|Overall Study|Physician Decision|1
66068|NCT01358175|260750|P3|Overall Study|Pregnancy|0
66069|NCT01358175|260751|P2|Overall Study|Pregnancy|1
66070|NCT01358175|260752|P1|Overall Study|Pregnancy|0
66071|NCT01358175|260750|P3|Overall Study|Technical issues|0
66072|NCT01358175|260751|P2|Overall Study|Technical issues|1
66073|NCT01358175|260752|P1|Overall Study|Technical issues|0
66074|NCT01358175|260750|P3|Overall Study|Withdrawal by Subject|10
66075|NCT01358175|260751|P2|Overall Study|Withdrawal by Subject|5
66076|NCT01358175|260752|P1|Overall Study|Withdrawal by Subject|9
66077|NCT01358175|260750|P3|Overall Study|Death|1
66078|NCT01358175|260751|P2|Overall Study|Death|0
66079|NCT01358175|260752|P1|Overall Study|Death|1
66080|NCT01357980|260789|P4|Overall Study|Consent withdrawn|0
66081|NCT01357980|260790|P3|Overall Study|Consent withdrawn|1
66082|NCT01357980|260791|P2|Overall Study|Consent withdrawn|0
66083|NCT01357980|260792|P1|Overall Study|Consent withdrawn|0
66084|NCT01357980|260789|P4|Overall Study|Lack of Efficacy|0
66085|NCT01357980|260790|P3|Overall Study|Lack of Efficacy|0
66086|NCT01357980|260791|P2|Overall Study|Lack of Efficacy|1
66087|NCT01357980|260792|P1|Overall Study|Lack of Efficacy|0
66088|NCT01357915|260836|P2|Overall Study|Lost to Follow-up|0
66089|NCT01357915|260837|P1|Overall Study|Lost to Follow-up|3
66090|NCT01357889|260852|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
66091|NCT01357889|260853|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
66092|NCT01357889|260852|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
66093|NCT01357889|260853|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
66094|NCT01357889|260852|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
66095|NCT01357889|260853|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
66096|NCT01357889|260852|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
66097|NCT01357889|260853|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
66098|NCT01357889|260852|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
66099|NCT01357889|260853|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
66100|NCT01357889|260852|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
66101|NCT01357889|260853|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
66102|NCT01357889|260852|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
66103|NCT01357889|260853|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
66104|NCT01357889|260852|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
66105|NCT01357889|260853|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
66106|NCT01357889|260852|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
66107|NCT01357889|260853|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
66108|NCT01357889|260852|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
66109|NCT01357889|260853|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
66110|NCT01357889|260852|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
66111|NCT01357889|260853|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
66112|NCT01357889|260852|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
66113|NCT01357889|260853|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
66114|NCT01357889|260852|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
66115|NCT01357889|260853|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
66116|NCT01357850|260897|P4|Overall Study|Lost to Follow-up|0
66117|NCT01357850|260898|P3|Overall Study|Lost to Follow-up|0
66118|NCT01357850|260899|P2|Overall Study|Lost to Follow-up|0
66119|NCT01357850|260900|P1|Overall Study|Lost to Follow-up|1
66120|NCT01357655|260991|P2|Overall Study|Subject Withdrew Consent|0
66121|NCT01357655|260992|P1|Overall Study|Subject Withdrew Consent|1
66122|NCT01357655|260991|P2|Overall Study|Study Drug Toxicity|0
66123|NCT01357655|260992|P1|Overall Study|Study Drug Toxicity|11
66124|NCT01357655|260991|P2|Overall Study|Reason Unspecified|0
66125|NCT01357655|260992|P1|Overall Study|Reason Unspecified|1
66126|NCT01357655|260991|P2|Overall Study|Maximum Clinical Benefit|0
66127|NCT01357655|260992|P1|Overall Study|Maximum Clinical Benefit|2
66128|NCT01357655|260991|P2|Overall Study|Lost to Follow-up|0
66129|NCT01357655|260992|P1|Overall Study|Lost to Follow-up|2
66130|NCT01357655|260991|P2|Overall Study|Disease Progression|0
66131|NCT01357655|260992|P1|Overall Study|Disease Progression|1
66132|NCT01357655|260991|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
66133|NCT01357655|260992|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
66134|NCT01357655|260991|P2|Overall Study|Administrative Reason by Sponsor|0
66135|NCT01357655|260992|P1|Overall Study|Administrative Reason by Sponsor|45
66136|NCT01357616|261009|P2|Overall Study|Withdrawal by Subject|0
66137|NCT01357616|261010|P1|Overall Study|Withdrawal by Subject|1
66138|NCT01357616|261009|P2|Overall Study|Decision Unrelated to Adverse Event|1
66139|NCT01357616|261010|P1|Overall Study|Decision Unrelated to Adverse Event|3
66140|NCT01357616|261009|P2|Overall Study|Inadequate Control of IOP|2
66141|NCT01357616|261010|P1|Overall Study|Inadequate Control of IOP|1
66142|NCT01357616|261009|P2|Overall Study|Protocol Violation|2
66143|NCT01357616|261010|P1|Overall Study|Protocol Violation|0
66144|NCT01357616|261009|P2|Overall Study|Lost to Follow-up|3
66145|NCT01357616|261010|P1|Overall Study|Lost to Follow-up|4
66146|NCT01357616|261009|P2|Overall Study|Adverse Event|1
66147|NCT01357616|261010|P1|Overall Study|Adverse Event|1
66148|NCT01357551|261024|P2|Overall Study|Lost to Follow-up|6
66149|NCT01357551|261025|P1|Overall Study|Lost to Follow-up|16
66150|NCT01357551|261024|P2|Overall Study|Death|1
66151|NCT01357551|261025|P1|Overall Study|Death|0
66152|NCT01357551|261024|P2|Overall Study|Withdrawal by Subject|4
66153|NCT01357551|261025|P1|Overall Study|Withdrawal by Subject|6
66154|NCT01357239|261052|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
66155|NCT01357239|261053|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
66156|NCT01357239|261054|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
66157|NCT01357239|261055|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
66158|NCT01357239|261052|P4|Stratum II: Partially-Methylated|Adverse Event|1
66159|NCT01357239|261053|P3|Stratum II: Partially-Methylated|Adverse Event|0
66160|NCT01357239|261054|P2|Stratum II: Partially-Methylated|Adverse Event|0
66161|NCT01357239|261055|P1|Stratum II: Partially-Methylated|Adverse Event|0
66162|NCT01357239|261052|P4|Stratum I: Fully-Methylated|Adverse Event|0
66163|NCT01357239|261053|P3|Stratum I: Fully-Methylated|Adverse Event|1
66164|NCT01357239|261054|P2|Stratum I: Fully-Methylated|Adverse Event|0
66165|NCT01357239|261055|P1|Stratum I: Fully-Methylated|Adverse Event|0
66166|NCT01357239|261052|P4|Stratum: All Patients|Subject withdrew consent|1
66167|NCT01357239|261053|P3|Stratum: All Patients|Subject withdrew consent|1
66168|NCT01357239|261054|P2|Stratum: All Patients|Subject withdrew consent|0
66169|NCT01357239|261055|P1|Stratum: All Patients|Subject withdrew consent|0
66170|NCT01357239|261052|P4|Stratum: All Patients|Adverse Event|1
66171|NCT01357239|261053|P3|Stratum: All Patients|Adverse Event|1
66172|NCT01357239|261054|P2|Stratum: All Patients|Adverse Event|0
66173|NCT01357239|261055|P1|Stratum: All Patients|Adverse Event|0
66174|NCT01357161|261113|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
66175|NCT01357161|261114|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
66176|NCT01357161|261115|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
66177|NCT01357161|261113|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
66178|NCT01357161|261114|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
66179|NCT01357161|261115|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
66180|NCT01357161|261113|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
66181|NCT01357161|261114|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
66182|NCT01357161|261115|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
66183|NCT01357161|261113|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
66184|NCT01357161|261114|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
66185|NCT01357161|261115|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
66186|NCT01357161|261113|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
66187|NCT01357161|261114|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
66188|NCT01357161|261115|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
66189|NCT01357161|261113|P3|Part 2 (Double-Blind Comparison)|Death|19
66190|NCT01357161|261114|P2|Part 2 (Double-Blind Comparison)|Death|22
66191|NCT01357161|261115|P1|Part 2 (Double-Blind Comparison)|Death|0
66192|NCT01357161|261113|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
66193|NCT01357161|261114|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
66194|NCT01357161|261115|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
66195|NCT01357161|261113|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
66196|NCT01357161|261114|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
66197|NCT01357161|261115|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
66198|NCT01357161|261113|P3|Part 1 (Open Label Run-in)|Physician Decision|0
66199|NCT01357161|261114|P2|Part 1 (Open Label Run-in)|Physician Decision|0
66200|NCT01357161|261115|P1|Part 1 (Open Label Run-in)|Physician Decision|1
66201|NCT01357161|261113|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
66202|NCT01357161|261114|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
66203|NCT01357161|261115|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
66204|NCT01357161|261113|P3|Part 1 (Open Label Run-in)|Death|0
66205|NCT01357161|261114|P2|Part 1 (Open Label Run-in)|Death|0
66206|NCT01357161|261115|P1|Part 1 (Open Label Run-in)|Death|5
66207|NCT01356966|261167|P2|Overall Study|Physician Decision|0
66208|NCT01356966|261168|P1|Overall Study|Physician Decision|1
66209|NCT01356966|261167|P2|Overall Study|Withdrawal by Subject|2
66210|NCT01356966|261168|P1|Overall Study|Withdrawal by Subject|1
66211|NCT01356940|261180|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
66212|NCT01356940|261181|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
66213|NCT01356940|261180|P2|First Intervention (28 Days)|Adverse Event|0
66214|NCT01356940|261181|P1|First Intervention (28 Days)|Adverse Event|1
66215|NCT01356602|261208|P3|Overall Study|Adverse Event|1
66216|NCT01356602|261209|P2|Overall Study|Adverse Event|1
66217|NCT01356602|261210|P1|Overall Study|Adverse Event|0
66218|NCT01356602|261208|P3|Overall Study|Lack of Efficacy|4
66219|NCT01356602|261209|P2|Overall Study|Lack of Efficacy|1
66220|NCT01356602|261210|P1|Overall Study|Lack of Efficacy|0
66221|NCT01356602|261208|P3|Overall Study|Withdrawal by Subject|7
66222|NCT01356602|261209|P2|Overall Study|Withdrawal by Subject|3
66223|NCT01356602|261210|P1|Overall Study|Withdrawal by Subject|4
66224|NCT01356602|261208|P3|Overall Study|Lost to Follow-up|6
66225|NCT01356602|261209|P2|Overall Study|Lost to Follow-up|5
66226|NCT01356602|261210|P1|Overall Study|Lost to Follow-up|4
66227|NCT01356602|261208|P3|Overall Study|Administrative Problems|5
66228|NCT01356602|261209|P2|Overall Study|Administrative Problems|4
66229|NCT01356602|261210|P1|Overall Study|Administrative Problems|1
66230|NCT01356602|261208|P3|Overall Study|Protocol Deviation|1
66231|NCT01356602|261209|P2|Overall Study|Protocol Deviation|1
66232|NCT01356602|261210|P1|Overall Study|Protocol Deviation|0
66233|NCT01356589|261269|P1|Overall Study|Dose data not recorded|2
66234|NCT01356589|261269|P1|Overall Study|Enrolled, but not treated|3
66235|NCT01356407|261326|P2|Overall Study|Not complete Endoscopy|2
66236|NCT01356407|261327|P1|Overall Study|Not complete Endoscopy|2
66237|NCT01356407|261326|P2|Overall Study|Could not afford IMP administration|1
66238|NCT01356407|261327|P1|Overall Study|Could not afford IMP administration|0
66239|NCT01356407|261326|P2|Overall Study|Patient Withdrew Consent|1
66240|NCT01356407|261327|P1|Overall Study|Patient Withdrew Consent|2
66241|NCT01356407|261326|P2|Overall Study|Lost to Follow-up|0
66242|NCT01356407|261327|P1|Overall Study|Lost to Follow-up|2
66243|NCT01355679|261365|P1|Overall Study|benign tumor types found at biopsy|2
66244|NCT01355627|261374|P2|Overall Study|Other|1
66245|NCT01355627|261375|P1|Overall Study|Other|1
66246|NCT01355627|261374|P2|Overall Study|Fatal Adverse Event|23
66247|NCT01355627|261375|P1|Overall Study|Fatal Adverse Event|19
66248|NCT01355627|261374|P2|Overall Study|Lost to Follow-up|7
66249|NCT01355627|261375|P1|Overall Study|Lost to Follow-up|8
66250|NCT01355627|261374|P2|Overall Study|Request By the Patient to Discontinue|7
66251|NCT01355627|261375|P1|Overall Study|Request By the Patient to Discontinue|5
66252|NCT01355523|261414|P2|Overall Study|Adverse Event|2
66253|NCT01355523|261415|P1|Overall Study|Adverse Event|0
66254|NCT01355523|261414|P2|Overall Study|Protocol Violation|2
66255|NCT01355523|261415|P1|Overall Study|Protocol Violation|0
66256|NCT01355523|261414|P2|Overall Study|Lost to Follow-up|2
66257|NCT01355523|261415|P1|Overall Study|Lost to Follow-up|0
66258|NCT01355523|261414|P2|Overall Study|Withdrawal by Subject|4
66259|NCT01355523|261415|P1|Overall Study|Withdrawal by Subject|1
66260|NCT01355302|261491|P3|Phase 1b|Study terminated by sponsor|0
66261|NCT01355302|261492|P2|Phase 1b|Study terminated by sponsor|0
66262|NCT01355302|261493|P1|Phase 1b|Study terminated by sponsor|2
66263|NCT01355302|261491|P3|Phase 1b|Death|0
66264|NCT01355302|261492|P2|Phase 1b|Death|0
66265|NCT01355302|261493|P1|Phase 1b|Death|4
66266|NCT01355289|261508|P5|Open Label Extension|Not specified|3
66267|NCT01355289|261509|P4|Open Label Extension|Not specified|0
66268|NCT01355289|261510|P3|Open Label Extension|Not specified|0
66269|NCT01355289|261511|P2|Open Label Extension|Not specified|0
66270|NCT01355289|261512|P1|Open Label Extension|Not specified|0
66271|NCT01355289|261508|P5|Open Label Extension|Inadequate Therapeutic Effect|29
66272|NCT01355289|261509|P4|Open Label Extension|Inadequate Therapeutic Effect|0
66273|NCT01355289|261510|P3|Open Label Extension|Inadequate Therapeutic Effect|0
66274|NCT01355289|261511|P2|Open Label Extension|Inadequate Therapeutic Effect|0
66275|NCT01355289|261512|P1|Open Label Extension|Inadequate Therapeutic Effect|0
66276|NCT01355289|261508|P5|Open Label Extension|Lost to Follow-up|1
66277|NCT01355289|261509|P4|Open Label Extension|Lost to Follow-up|0
66278|NCT01355289|261510|P3|Open Label Extension|Lost to Follow-up|0
66279|NCT01355289|261511|P2|Open Label Extension|Lost to Follow-up|0
66280|NCT01355289|261512|P1|Open Label Extension|Lost to Follow-up|0
66281|NCT01355289|261508|P5|Open Label Extension|Adverse Event, Non-Fatal|1
66282|NCT01355289|261509|P4|Open Label Extension|Adverse Event, Non-Fatal|0
66283|NCT01355289|261510|P3|Open Label Extension|Adverse Event, Non-Fatal|0
66284|NCT01355289|261511|P2|Open Label Extension|Adverse Event, Non-Fatal|0
66285|NCT01355289|261512|P1|Open Label Extension|Adverse Event, Non-Fatal|0
66286|NCT01355289|261508|P5|Core Study|Not specified|0
66287|NCT01355289|261509|P4|Core Study|Not specified|1
66288|NCT01355289|261510|P3|Core Study|Not specified|0
66289|NCT01355289|261511|P2|Core Study|Not specified|0
66290|NCT01355289|261512|P1|Core Study|Not specified|0
66291|NCT01355289|261508|P5|Core Study|Inadequate Therapeutic Effect|0
66292|NCT01355289|261509|P4|Core Study|Inadequate Therapeutic Effect|1
66293|NCT01355289|261510|P3|Core Study|Inadequate Therapeutic Effect|0
66294|NCT01355289|261511|P2|Core Study|Inadequate Therapeutic Effect|0
66295|NCT01355289|261512|P1|Core Study|Inadequate Therapeutic Effect|0
66296|NCT01355289|261508|P5|Core Study|Adverse Event, Non-Fatal|0
66297|NCT01355289|261509|P4|Core Study|Adverse Event, Non-Fatal|0
66298|NCT01355289|261510|P3|Core Study|Adverse Event, Non-Fatal|0
66299|NCT01355289|261511|P2|Core Study|Adverse Event, Non-Fatal|0
66300|NCT01355289|261512|P1|Core Study|Adverse Event, Non-Fatal|1
66301|NCT01355081|261565|P3|Overall Study|Non Compliance with Study Medication|0
66302|NCT01355081|261566|P2|Overall Study|Non Compliance with Study Medication|1
66303|NCT01355081|261567|P1|Overall Study|Non Compliance with Study Medication|0
66304|NCT01355081|261565|P3|Overall Study|Lack of Efficacy|1
66305|NCT01355081|261566|P2|Overall Study|Lack of Efficacy|1
66306|NCT01355081|261567|P1|Overall Study|Lack of Efficacy|2
66307|NCT01355081|261565|P3|Overall Study|Withdrawal of Consent|3
66308|NCT01355081|261566|P2|Overall Study|Withdrawal of Consent|3
66309|NCT01355081|261567|P1|Overall Study|Withdrawal of Consent|2
66310|NCT01355081|261565|P3|Overall Study|Lost to Follow-up|1
66311|NCT01355081|261566|P2|Overall Study|Lost to Follow-up|0
66312|NCT01355081|261567|P1|Overall Study|Lost to Follow-up|0
66313|NCT01355081|261565|P3|Overall Study|Major Protocol Deviation|0
66314|NCT01355081|261566|P2|Overall Study|Major Protocol Deviation|1
66315|NCT01355081|261567|P1|Overall Study|Major Protocol Deviation|0
66316|NCT01355081|261565|P3|Overall Study|Pretreatment Event or Adverse Event|6
66317|NCT01355081|261566|P2|Overall Study|Pretreatment Event or Adverse Event|4
66318|NCT01355081|261567|P1|Overall Study|Pretreatment Event or Adverse Event|3
66319|NCT01355068|261590|P2|First Intervention Period|Withdrawal by Subject|1
66320|NCT01355068|261591|P1|First Intervention Period|Withdrawal by Subject|0
66321|NCT01355068|261590|P2|First Intervention Period|Adverse Event|1
66322|NCT01355068|261591|P1|First Intervention Period|Adverse Event|0
66323|NCT01354938|261614|P1|Overall Study|Lost to Follow-up|1
66324|NCT01354899|261620|P1|Overall Study|Protocol Violation|1
66325|NCT01354899|261620|P1|Overall Study|discharge from the hospital|2
66326|NCT01354431|261669|P3|Participants Treated|Withdrawal by Subject|1
66327|NCT01354431|261670|P2|Participants Treated|Withdrawal by Subject|2
66328|NCT01354431|261671|P1|Participants Treated|Withdrawal by Subject|1
66329|NCT01354431|261669|P3|Participants Treated|Adverse Event|4
66330|NCT01354431|261670|P2|Participants Treated|Adverse Event|2
66331|NCT01354431|261671|P1|Participants Treated|Adverse Event|1
66332|NCT01354431|261669|P3|Participants Treated|Death|0
66333|NCT01354431|261670|P2|Participants Treated|Death|1
66334|NCT01354431|261671|P1|Participants Treated|Death|0
66335|NCT01354431|261669|P3|Participants Treated|Study Drug Toxicity|4
66336|NCT01354431|261670|P2|Participants Treated|Study Drug Toxicity|7
66337|NCT01354431|261671|P1|Participants Treated|Study Drug Toxicity|2
66338|NCT01354431|261669|P3|Participants Treated|Disease Progression|41
66339|NCT01354431|261670|P2|Participants Treated|Disease Progression|40
66340|NCT01354431|261671|P1|Participants Treated|Disease Progression|49
66341|NCT01354431|261669|P3|Participants Treated|Continuing Treatment|4
66342|NCT01354431|261670|P2|Participants Treated|Continuing Treatment|2
66343|NCT01354431|261671|P1|Participants Treated|Continuing Treatment|6
66344|NCT01354431|261669|P3|Randomized to Enter Treatment Period|No longer met criteria|0
66345|NCT01354431|261670|P2|Randomized to Enter Treatment Period|No longer met criteria|0
66346|NCT01354431|261671|P1|Randomized to Enter Treatment Period|No longer met criteria|1
66347|NCT01354314|261695|P4|Overall Study|Less than 90% Adherence|4
66348|NCT01354314|261696|P3|Overall Study|Less than 90% Adherence|6
66349|NCT01354314|261697|P2|Overall Study|Less than 90% Adherence|2
66350|NCT01354314|261698|P1|Overall Study|Less than 90% Adherence|4
66351|NCT01354314|261695|P4|Overall Study|Protocol Violation|0
66352|NCT01354314|261696|P3|Overall Study|Protocol Violation|0
66353|NCT01354314|261697|P2|Overall Study|Protocol Violation|1
66354|NCT01354314|261698|P1|Overall Study|Protocol Violation|1
66355|NCT01354314|261695|P4|Overall Study|Adverse Event|1
66356|NCT01354314|261696|P3|Overall Study|Adverse Event|0
66357|NCT01354314|261697|P2|Overall Study|Adverse Event|0
66358|NCT01354314|261698|P1|Overall Study|Adverse Event|0
66359|NCT01354314|261695|P4|Overall Study|Withdrawal by Subject|0
66360|NCT01354314|261696|P3|Overall Study|Withdrawal by Subject|1
66361|NCT01354314|261697|P2|Overall Study|Withdrawal by Subject|0
66362|NCT01354314|261698|P1|Overall Study|Withdrawal by Subject|0
66363|NCT01354314|261695|P4|Overall Study|Lost to Follow-up|1
66364|NCT01354314|261696|P3|Overall Study|Lost to Follow-up|1
66365|NCT01354314|261697|P2|Overall Study|Lost to Follow-up|0
66366|NCT01354314|261698|P1|Overall Study|Lost to Follow-up|1
66367|NCT01354223|261834|P2|Overall Study|Withdrawal by Subject|1
66368|NCT01354223|261835|P1|Overall Study|Withdrawal by Subject|3
66369|NCT01354132|261894|P2|1 Month Post Study Medication|Withdrawal by Subject|3
66370|NCT01354132|261895|P1|1 Month Post Study Medication|Withdrawal by Subject|1
66371|NCT01354132|261894|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
66372|NCT01354132|261895|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
66373|NCT01354132|261894|P2|Double Blind (Visits 1-7)|Adverse Event|0
66374|NCT01354132|261895|P1|Double Blind (Visits 1-7)|Adverse Event|1
66375|NCT01354132|261894|P2|Randomization|Withdrawal by Subject|1
66376|NCT01354132|261895|P1|Randomization|Withdrawal by Subject|0
66377|NCT01354132|261894|P2|Randomization|Physician Decision|0
66378|NCT01354132|261895|P1|Randomization|Physician Decision|1
66379|NCT01354106|261933|P1|Overall Study|Withdrawal by Subject|2
66380|NCT01354028|261939|P2|Overall Study|No quiet alert state|1
66381|NCT01354028|261940|P1|Overall Study|No quiet alert state|0
66382|NCT01354028|261939|P2|Overall Study|Discharged before study start|2
66383|NCT01354028|261940|P1|Overall Study|Discharged before study start|2
66384|NCT01354028|261939|P2|Overall Study|Physician Decision|2
66385|NCT01354028|261940|P1|Overall Study|Physician Decision|0
66386|NCT01353963|261976|P1|Overall Study|Adverse Event|2
66387|NCT01353911|261994|P8|Overall Study|Status Not Recorded|0
66388|NCT01353911|261995|P7|Overall Study|Status Not Recorded|0
66389|NCT01353911|261996|P6|Overall Study|Status Not Recorded|0
66390|NCT01353911|261997|P5|Overall Study|Status Not Recorded|0
66391|NCT01353911|261998|P4|Overall Study|Status Not Recorded|0
66392|NCT01353911|261999|P3|Overall Study|Status Not Recorded|1
66393|NCT01353911|262000|P2|Overall Study|Status Not Recorded|0
66394|NCT01353911|262001|P1|Overall Study|Status Not Recorded|4
66395|NCT01353911|261994|P8|Overall Study|Withdrawal by Subject|9
66396|NCT01353911|261995|P7|Overall Study|Withdrawal by Subject|3
66397|NCT01353911|261996|P6|Overall Study|Withdrawal by Subject|3
66398|NCT01353911|261997|P5|Overall Study|Withdrawal by Subject|2
66399|NCT01353911|261998|P4|Overall Study|Withdrawal by Subject|2
66400|NCT01353911|261999|P3|Overall Study|Withdrawal by Subject|4
66401|NCT01353911|262000|P2|Overall Study|Withdrawal by Subject|3
66402|NCT01353911|262001|P1|Overall Study|Withdrawal by Subject|2
66403|NCT01353911|261994|P8|Overall Study|Lost to Follow-up|6
66404|NCT01353911|261995|P7|Overall Study|Lost to Follow-up|3
66405|NCT01353911|261996|P6|Overall Study|Lost to Follow-up|4
66406|NCT01353911|261997|P5|Overall Study|Lost to Follow-up|4
66407|NCT01353911|261998|P4|Overall Study|Lost to Follow-up|0
66408|NCT01353911|261999|P3|Overall Study|Lost to Follow-up|4
66409|NCT01353911|262000|P2|Overall Study|Lost to Follow-up|6
66410|NCT01353911|262001|P1|Overall Study|Lost to Follow-up|2
66411|NCT01353898|262081|P6|Overall Study|Study site terminated|1
66412|NCT01353898|262082|P5|Overall Study|Study site terminated|0
66413|NCT01353898|262083|P4|Overall Study|Study site terminated|0
66414|NCT01353898|262084|P3|Overall Study|Study site terminated|0
66415|NCT01353898|262085|P2|Overall Study|Study site terminated|0
66416|NCT01353898|262086|P1|Overall Study|Study site terminated|0
66417|NCT01353859|262112|P1|Overall Study|Lack of Efficacy|1
66418|NCT01353859|262112|P1|Overall Study|Adverse Event|3
66419|NCT01353664|262125|P1|Overall Study|Disease Progression|16
66420|NCT01353664|262125|P1|Overall Study|Other|3
66421|NCT01353586|262131|P2|Overall Study|Neurological exam not done|1
66422|NCT01353586|262132|P1|Overall Study|Neurological exam not done|0
66423|NCT01353586|262131|P2|Overall Study|Never had insertion of study catheter|1
66424|NCT01353586|262132|P1|Overall Study|Never had insertion of study catheter|4
66425|NCT01353586|262131|P2|Overall Study|Procedure terminated prior to ablation|0
66426|NCT01353586|262132|P1|Overall Study|Procedure terminated prior to ablation|3
66427|NCT01353508|262150|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
66428|NCT01353508|262151|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
66429|NCT01353508|262152|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
66430|NCT01353508|262153|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
66431|NCT01353508|262150|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
66432|NCT01353508|262151|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
66433|NCT01353508|262152|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
66434|NCT01353508|262153|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
66435|NCT01353274|262231|P1|Overall Study|No case report form (CRF) collected|28
66436|NCT01353222|262241|P2|Overall Study|Site closed research department|0
66437|NCT01353222|262242|P1|Overall Study|Site closed research department|1
66438|NCT01353222|262241|P2|Overall Study|Study Terminated|37
66439|NCT01353222|262242|P1|Overall Study|Study Terminated|31
66440|NCT01353222|262241|P2|Overall Study|Withdrawal by Subject|5
66441|NCT01353222|262242|P1|Overall Study|Withdrawal by Subject|8
66442|NCT01353222|262241|P2|Overall Study|Death|30
66443|NCT01353222|262242|P1|Overall Study|Death|30
66444|NCT01352845|262276|P2|Overall Study|Death|0
66445|NCT01352845|262277|P1|Overall Study|Death|3
66446|NCT01352845|262276|P2|Overall Study|Protocol Violation|6
66447|NCT01352845|262277|P1|Overall Study|Protocol Violation|12
66448|NCT01352845|262276|P2|Overall Study|Other|7
66449|NCT01352845|262277|P1|Overall Study|Other|17
66450|NCT01352845|262276|P2|Overall Study|Adverse Event|6
66451|NCT01352845|262277|P1|Overall Study|Adverse Event|22
66452|NCT01352845|262276|P2|Overall Study|Pregnancy|7
66453|NCT01352845|262277|P1|Overall Study|Pregnancy|27
66454|NCT01352845|262276|P2|Overall Study|No Longer Meets Eligibility Criteria|11
66455|NCT01352845|262277|P1|Overall Study|No Longer Meets Eligibility Criteria|24
66456|NCT01352845|262276|P2|Overall Study|Withdrawal by Subject|16
66457|NCT01352845|262277|P1|Overall Study|Withdrawal by Subject|48
66458|NCT01352845|262276|P2|Overall Study|No Longer Willing to Participate|58
66459|NCT01352845|262277|P1|Overall Study|No Longer Willing to Participate|205
66460|NCT01352845|262276|P2|Overall Study|Lost to Follow-up|92
66461|NCT01352845|262277|P1|Overall Study|Lost to Follow-up|313
66462|NCT01352793|262366|P2|Overall Study|No longer meets eligibility criteria|15
66463|NCT01352793|262367|P1|Overall Study|No longer meets eligibility criteria|25
66464|NCT01352793|262366|P2|Overall Study|Randomized but not vaccinated|0
66465|NCT01352793|262367|P1|Overall Study|Randomized but not vaccinated|8
66466|NCT01352793|262366|P2|Overall Study|Death|0
66467|NCT01352793|262367|P1|Overall Study|Death|1
66468|NCT01352793|262366|P2|Overall Study|Medication error|2
66469|NCT01352793|262367|P1|Overall Study|Medication error|2
66470|NCT01352793|262366|P2|Overall Study|Other|7
66471|NCT01352793|262367|P1|Overall Study|Other|25
66472|NCT01352793|262366|P2|Overall Study|Pregnancy|8
66473|NCT01352793|262367|P1|Overall Study|Pregnancy|26
66474|NCT01352793|262366|P2|Overall Study|Physician Decision|0
66475|NCT01352793|262367|P1|Overall Study|Physician Decision|1
66476|NCT01352793|262366|P2|Overall Study|Adverse Event|10
66477|NCT01352793|262367|P1|Overall Study|Adverse Event|44
66478|NCT01352793|262366|P2|Overall Study|Protocol Violation|23
66479|NCT01352793|262367|P1|Overall Study|Protocol Violation|44
66480|NCT01352793|262366|P2|Overall Study|Withdrawal by Subject|55
66481|NCT01352793|262367|P1|Overall Study|Withdrawal by Subject|120
66482|NCT01352793|262366|P2|Overall Study|Lost to Follow-up|125
66483|NCT01352793|262367|P1|Overall Study|Lost to Follow-up|289
66484|NCT01352741|262391|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
66485|NCT01352741|262392|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
66486|NCT01352741|262391|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
66487|NCT01352741|262392|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
66488|NCT01352741|262391|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
66489|NCT01352741|262392|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
66490|NCT01352741|262391|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
66491|NCT01352741|262392|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
66492|NCT01352741|262391|P2|Double-blind Comparative Period|Not Specified|2
66493|NCT01352741|262392|P1|Double-blind Comparative Period|Not Specified|1
66494|NCT01352741|262391|P2|Double-blind Comparative Period|Withdrawal of consent|3
66495|NCT01352741|262392|P1|Double-blind Comparative Period|Withdrawal of consent|8
66496|NCT01352741|262391|P2|Double-blind Comparative Period|Death|1
66497|NCT01352741|262392|P1|Double-blind Comparative Period|Death|0
66498|NCT01352741|262391|P2|Double-blind Comparative Period|Lost to Follow-up|0
66499|NCT01352741|262392|P1|Double-blind Comparative Period|Lost to Follow-up|1
66500|NCT01352741|262391|P2|Double-blind Comparative Period|Adverse Event|17
66501|NCT01352741|262392|P1|Double-blind Comparative Period|Adverse Event|16
66502|NCT01352741|262391|P2|Double-blind Comparative Period|Lack of Efficacy|3
66503|NCT01352741|262392|P1|Double-blind Comparative Period|Lack of Efficacy|0
66504|NCT01352741|262391|P2|Double-blind Comparative Period|Protocol Violation|0
66505|NCT01352741|262392|P1|Double-blind Comparative Period|Protocol Violation|2
66506|NCT01352741|262391|P2|Open-label Tapentadol Titration Period|Not Specified|0
66507|NCT01352741|262392|P1|Open-label Tapentadol Titration Period|Not Specified|4
66508|NCT01352741|262391|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
66509|NCT01352741|262392|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
66510|NCT01352741|262391|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
66511|NCT01352741|262392|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
66512|NCT01352741|262391|P2|Open-label Tapentadol Titration Period|Adverse Event|0
66513|NCT01352741|262392|P1|Open-label Tapentadol Titration Period|Adverse Event|34
66514|NCT01352741|262391|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
66515|NCT01352741|262392|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
66516|NCT01352741|262391|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
66517|NCT01352741|262392|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
66518|NCT01352715|262486|P2|Overall Study|major ineligibility|1
66519|NCT01352715|262487|P1|Overall Study|major ineligibility|2
66520|NCT01352715|262486|P2|Overall Study|no final visit in closeout period|12
66521|NCT01352715|262487|P1|Overall Study|no final visit in closeout period|15
66522|NCT01352715|262486|P2|Overall Study|site closure|15
66523|NCT01352715|262487|P1|Overall Study|site closure|16
66524|NCT01352715|262486|P2|Overall Study|Withdrawal by Subject|8
66525|NCT01352715|262487|P1|Overall Study|Withdrawal by Subject|4
66526|NCT01352715|262486|P2|Overall Study|Lost to Follow-up|7
66527|NCT01352715|262487|P1|Overall Study|Lost to Follow-up|5
66528|NCT01352715|262486|P2|Overall Study|Death|3
66529|NCT01352715|262487|P1|Overall Study|Death|3
66530|NCT01352585|262509|P1|Overall Study|Not specified|7
66531|NCT01352585|262509|P1|Overall Study|Lost to Follow-up|1
66532|NCT01352585|262509|P1|Overall Study|Adverse Event|3
66533|NCT01352507|262526|P2|Treatment Period 2|Lack of Efficacy|0
66534|NCT01352507|262527|P1|Treatment Period 2|Lack of Efficacy|1
66535|NCT01352507|262526|P2|Treatment Period 2|Withdrawal by Subject|3
66536|NCT01352507|262527|P1|Treatment Period 2|Withdrawal by Subject|4
66537|NCT01352507|262526|P2|Treatment Period 2|Entry Criteria Not Met|0
66538|NCT01352507|262527|P1|Treatment Period 2|Entry Criteria Not Met|1
66539|NCT01352507|262526|P2|Washout Period|Withdrawal by Subject|1
66540|NCT01352507|262527|P1|Washout Period|Withdrawal by Subject|0
66541|NCT01352507|262526|P2|Treatment Period 1|Physician Decision|0
66542|NCT01352507|262527|P1|Treatment Period 1|Physician Decision|1
66543|NCT01352507|262526|P2|Treatment Period 1|Withdrawal by Subject|5
66544|NCT01352507|262527|P1|Treatment Period 1|Withdrawal by Subject|7
66545|NCT01352507|262526|P2|Treatment Period 1|Lost to Follow-up|4
66546|NCT01352507|262527|P1|Treatment Period 1|Lost to Follow-up|3
66547|NCT01352507|262526|P2|Treatment Period 1|Adverse Event|0
66548|NCT01352507|262527|P1|Treatment Period 1|Adverse Event|3
66549|NCT01352416|262580|P4|Overall Study|Physician Decision|1
66550|NCT01352416|262581|P3|Overall Study|Physician Decision|2
66551|NCT01352416|262582|P2|Overall Study|Physician Decision|2
66552|NCT01352416|262583|P1|Overall Study|Physician Decision|1
66553|NCT01352221|262595|P4|Open-label Phase|Worsening of IBD|0
66554|NCT01352221|262596|P3|Open-label Phase|Worsening of IBD|1
66555|NCT01352221|262597|P2|Open-label Phase|Worsening of IBD|0
66556|NCT01352221|262598|P1|Open-label Phase|Worsening of IBD|0
66557|NCT01352221|262595|P4|Open-label Phase|Withdrawal by Subject|6
66558|NCT01352221|262596|P3|Open-label Phase|Withdrawal by Subject|1
66559|NCT01352221|262597|P2|Open-label Phase|Withdrawal by Subject|0
66560|NCT01352221|262598|P1|Open-label Phase|Withdrawal by Subject|0
66561|NCT01352221|262595|P4|Open-label Phase|Adverse Event|4
66562|NCT01352221|262596|P3|Open-label Phase|Adverse Event|8
66563|NCT01352221|262597|P2|Open-label Phase|Adverse Event|0
66564|NCT01352221|262598|P1|Open-label Phase|Adverse Event|0
66565|NCT01352221|262595|P4|Open-label Phase|Pregnancy|0
66566|NCT01352221|262596|P3|Open-label Phase|Pregnancy|1
66567|NCT01352221|262597|P2|Open-label Phase|Pregnancy|0
66568|NCT01352221|262598|P1|Open-label Phase|Pregnancy|0
66569|NCT01352221|262595|P4|Open-label Phase|Physician Decision|1
66570|NCT01352221|262596|P3|Open-label Phase|Physician Decision|2
66571|NCT01352221|262597|P2|Open-label Phase|Physician Decision|0
66572|NCT01352221|262598|P1|Open-label Phase|Physician Decision|0
66573|NCT01352221|262595|P4|Double-blind Phase|Protocol Violation|0
66574|NCT01352221|262596|P3|Double-blind Phase|Protocol Violation|0
66575|NCT01352221|262597|P2|Double-blind Phase|Protocol Violation|1
66576|NCT01352221|262598|P1|Double-blind Phase|Protocol Violation|0
66577|NCT01352221|262595|P4|Double-blind Phase|Lost to Follow-up|0
66578|NCT01352221|262596|P3|Double-blind Phase|Lost to Follow-up|0
66579|NCT01352221|262597|P2|Double-blind Phase|Lost to Follow-up|1
66580|NCT01352221|262598|P1|Double-blind Phase|Lost to Follow-up|0
66581|NCT01352221|262595|P4|Double-blind Phase|Withdrawal by Subject|0
66582|NCT01352221|262596|P3|Double-blind Phase|Withdrawal by Subject|0
66583|NCT01352221|262597|P2|Double-blind Phase|Withdrawal by Subject|5
66584|NCT01352221|262598|P1|Double-blind Phase|Withdrawal by Subject|3
66585|NCT01352221|262595|P4|Double-blind Phase|Adverse Event|0
66586|NCT01352221|262596|P3|Double-blind Phase|Adverse Event|0
66587|NCT01352221|262597|P2|Double-blind Phase|Adverse Event|4
66588|NCT01352221|262598|P1|Double-blind Phase|Adverse Event|6
66589|NCT01352117|262658|P2|Overall Study|Ineligible (no KS diagnosis)|0
66590|NCT01352117|262659|P1|Overall Study|Ineligible (no KS diagnosis)|1
66591|NCT01352117|262658|P2|Overall Study|Did not initiate study treatment|0
66592|NCT01352117|262659|P1|Overall Study|Did not initiate study treatment|1
66593|NCT01352117|262658|P2|Overall Study|Non-adherent to study requirements|0
66594|NCT01352117|262659|P1|Overall Study|Non-adherent to study requirements|1
66595|NCT01352117|262658|P2|Overall Study|Lost to Follow-up|4
66596|NCT01352117|262659|P1|Overall Study|Lost to Follow-up|2
66597|NCT01352117|262658|P2|Overall Study|Withdrawal by Subject|0
66598|NCT01352117|262659|P1|Overall Study|Withdrawal by Subject|1
66599|NCT01352117|262658|P2|Overall Study|Death|12
66600|NCT01352117|262659|P1|Overall Study|Death|13
66601|NCT01352117|262658|P2|Overall Study|On study|80
66602|NCT01352117|262659|P1|Overall Study|On study|49
66603|NCT01351623|262711|P1|Overall Study|Death|2
66604|NCT01351623|262711|P1|Overall Study|Withdrawal by Subject|1
66605|NCT01351623|262711|P1|Overall Study|Adverse Event|4
66606|NCT01351623|262711|P1|Overall Study|Protocol Violation|2
66607|NCT01351415|262737|P2|Overall Study|Never Started|5
66608|NCT01351415|262738|P1|Overall Study|Never Started|5
66609|NCT01351415|262737|P2|Overall Study|Reason unknown|2
66610|NCT01351415|262738|P1|Overall Study|Reason unknown|0
66611|NCT01351415|262737|P2|Overall Study|Physician Decision|3
66612|NCT01351415|262738|P1|Overall Study|Physician Decision|2
66613|NCT01351415|262737|P2|Overall Study|Death|187
66614|NCT01351415|262738|P1|Overall Study|Death|190
66615|NCT01351415|262737|P2|Overall Study|Lost to Follow-up|7
66616|NCT01351415|262738|P1|Overall Study|Lost to Follow-up|5
66617|NCT01351415|262737|P2|Overall Study|Trial termination by the Sponsor|19
66618|NCT01351415|262738|P1|Overall Study|Trial termination by the Sponsor|28
66619|NCT01351415|262737|P2|Overall Study|Withdrawal by Subject|17
66620|NCT01351415|262738|P1|Overall Study|Withdrawal by Subject|15
66621|NCT01351025|262816|P2|Week 24 - 44|unable to get to clinic|1
66622|NCT01351025|262817|P1|Week 24 - 44|unable to get to clinic|1
66623|NCT01351025|262816|P2|Week 24 - 44|Site closed|1
66624|NCT01351025|262817|P1|Week 24 - 44|Site closed|0
66625|NCT01351025|262816|P2|Week 24 - 44|Lost to Follow-up|2
66626|NCT01351025|262817|P1|Week 24 - 44|Lost to Follow-up|0
66627|NCT01351025|262816|P2|Week 0 - 20|Withdrawal by Subject|0
66628|NCT01351025|262817|P1|Week 0 - 20|Withdrawal by Subject|1
66629|NCT01351025|262816|P2|Week 0 - 20|Lost to Follow-up|1
66630|NCT01351025|262817|P1|Week 0 - 20|Lost to Follow-up|2
66631|NCT01350999|262850|P3|Overall Study|Difficulty Making it to Study Visit|5
66632|NCT01350999|262851|P2|Overall Study|Difficulty Making it to Study Visit|1
66633|NCT01350999|262852|P1|Overall Study|Difficulty Making it to Study Visit|1
66634|NCT01350999|262850|P3|Overall Study|Voluntary withdrawal|6
66635|NCT01350999|262851|P2|Overall Study|Voluntary withdrawal|4
66636|NCT01350999|262852|P1|Overall Study|Voluntary withdrawal|3
66637|NCT01350999|262850|P3|Overall Study|Adverse Event|10
66638|NCT01350999|262851|P2|Overall Study|Adverse Event|9
66639|NCT01350999|262852|P1|Overall Study|Adverse Event|4
66640|NCT01350973|262890|P3|Overall Study|Voluntary Withdrawal|1
66641|NCT01350973|262891|P2|Overall Study|Voluntary Withdrawal|1
66642|NCT01350973|262892|P1|Overall Study|Voluntary Withdrawal|2
66643|NCT01350973|262890|P3|Overall Study|Adverse Event|7
66644|NCT01350973|262891|P2|Overall Study|Adverse Event|7
66645|NCT01350973|262892|P1|Overall Study|Adverse Event|4
66646|NCT01350934|262933|P2|Extension Study|Withdrawal by Subject|1
66647|NCT01350934|262934|P1|Extension Study|Withdrawal by Subject|0
66648|NCT01350934|262933|P2|Extension Study|Lack of Efficacy|1
66649|NCT01350934|262934|P1|Extension Study|Lack of Efficacy|0
66650|NCT01350934|262933|P2|Extension Study|Protocol Violation|1
66651|NCT01350934|262934|P1|Extension Study|Protocol Violation|1
66652|NCT01350934|262933|P2|Extension Study|Lost to Follow-up|0
66653|NCT01350934|262934|P1|Extension Study|Lost to Follow-up|2
66654|NCT01350934|262933|P2|Extension Study|Adverse Event|1
66655|NCT01350934|262934|P1|Extension Study|Adverse Event|2
66656|NCT01350934|262933|P2|Base Study|Non-Compliance With Study Drug|0
66657|NCT01350934|262934|P1|Base Study|Non-Compliance With Study Drug|2
66658|NCT01350934|262933|P2|Base Study|Withdrawal by Subject|2
66659|NCT01350934|262934|P1|Base Study|Withdrawal by Subject|1
66660|NCT01350934|262933|P2|Base Study|Protocol Violation|1
66661|NCT01350934|262934|P1|Base Study|Protocol Violation|1
66662|NCT01350934|262933|P2|Base Study|Lost to Follow-up|0
66663|NCT01350934|262934|P1|Base Study|Lost to Follow-up|1
66664|NCT01350934|262933|P2|Base Study|Adverse Event|0
66665|NCT01350934|262934|P1|Base Study|Adverse Event|6
66666|NCT01350804|262956|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
66667|NCT01350804|262957|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
66668|NCT01350804|262958|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
66669|NCT01350804|262959|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
66670|NCT01350804|262956|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
66671|NCT01350804|262957|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
66672|NCT01350804|262958|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
66673|NCT01350804|262959|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
66674|NCT01350804|262956|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
66675|NCT01350804|262957|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
66676|NCT01350804|262958|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
66677|NCT01350804|262959|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
66678|NCT01350804|262956|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
66679|NCT01350804|262957|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
66680|NCT01350804|262958|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
66681|NCT01350804|262959|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
66682|NCT01350804|262956|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
66683|NCT01350804|262957|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
66684|NCT01350804|262958|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
66685|NCT01350804|262959|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
66686|NCT01350804|262956|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
66687|NCT01350804|262957|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
66688|NCT01350804|262958|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
66689|NCT01350804|262959|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
66690|NCT01350804|262956|P4|Core Study|Adverse Event|8
66691|NCT01350804|262957|P3|Core Study|Adverse Event|8
66692|NCT01350804|262958|P2|Core Study|Adverse Event|10
66693|NCT01350804|262959|P1|Core Study|Adverse Event|8
66694|NCT01350804|262956|P4|Core Study|Death|0
66695|NCT01350804|262957|P3|Core Study|Death|1
66696|NCT01350804|262958|P2|Core Study|Death|1
66697|NCT01350804|262959|P1|Core Study|Death|1
66698|NCT01350804|262956|P4|Core Study|Lack of Efficacy|5
66699|NCT01350804|262957|P3|Core Study|Lack of Efficacy|18
66700|NCT01350804|262958|P2|Core Study|Lack of Efficacy|19
66701|NCT01350804|262959|P1|Core Study|Lack of Efficacy|16
66702|NCT01350804|262956|P4|Core Study|Lost to Follow-up|1
66703|NCT01350804|262957|P3|Core Study|Lost to Follow-up|2
66704|NCT01350804|262958|P2|Core Study|Lost to Follow-up|0
66705|NCT01350804|262959|P1|Core Study|Lost to Follow-up|3
66706|NCT01350804|262956|P4|Core Study|Physician Decision|3
66707|NCT01350804|262957|P3|Core Study|Physician Decision|1
66708|NCT01350804|262958|P2|Core Study|Physician Decision|0
66709|NCT01350804|262959|P1|Core Study|Physician Decision|1
66710|NCT01350804|262956|P4|Core Study|Protocol deviation|0
66711|NCT01350804|262957|P3|Core Study|Protocol deviation|1
66712|NCT01350804|262958|P2|Core Study|Protocol deviation|0
66713|NCT01350804|262959|P1|Core Study|Protocol deviation|1
66714|NCT01350804|262956|P4|Core Study|Study terminated by Sponsor|2
66715|NCT01350804|262957|P3|Core Study|Study terminated by Sponsor|0
66716|NCT01350804|262958|P2|Core Study|Study terminated by Sponsor|0
66717|NCT01350804|262959|P1|Core Study|Study terminated by Sponsor|0
66718|NCT01350804|262956|P4|Core Study|Withdrawal by Subject|7
66719|NCT01350804|262957|P3|Core Study|Withdrawal by Subject|16
66720|NCT01350804|262958|P2|Core Study|Withdrawal by Subject|17
66721|NCT01350804|262959|P1|Core Study|Withdrawal by Subject|11
66722|NCT01350544|263056|P2|Overall Study|Lost to Follow-up|15
66723|NCT01350544|263057|P1|Overall Study|Lost to Follow-up|18
66724|NCT01350544|263056|P2|Overall Study|Incarceration|0
66725|NCT01350544|263057|P1|Overall Study|Incarceration|1
66726|NCT01350544|263056|P2|Overall Study|Withdrawal by Subject|1
66727|NCT01350544|263057|P1|Overall Study|Withdrawal by Subject|0
66728|NCT01350544|263056|P2|Overall Study|Medical Issues|1
66729|NCT01350544|263057|P1|Overall Study|Medical Issues|1
66730|NCT01350544|263056|P2|Overall Study|Moved out of LA County|2
66731|NCT01350544|263057|P1|Overall Study|Moved out of LA County|2
66732|NCT01350544|263056|P2|Overall Study|Death|2
66733|NCT01350544|263057|P1|Overall Study|Death|1
66734|NCT01350544|263056|P2|Overall Study|Administrative Withdrawal|1
66735|NCT01350544|263057|P1|Overall Study|Administrative Withdrawal|0
66736|NCT01350414|263072|P1|Overall Study|Physician Decision|2
66737|NCT01350414|263072|P1|Overall Study|Withdrawal by Subject|4
66738|NCT01350414|263072|P1|Overall Study|Lost to Follow-up|13
66739|NCT01350271|263121|P3|Overall Study|Lost to Follow-up|26
66740|NCT01350271|263122|P2|Overall Study|Lost to Follow-up|17
66741|NCT01350271|263123|P1|Overall Study|Lost to Follow-up|21
66742|NCT01350141|263165|P3|Overall Study|Randomized but not treated|0
66743|NCT01350141|263166|P2|Overall Study|Randomized but not treated|0
66744|NCT01350141|263167|P1|Overall Study|Randomized but not treated|1
66745|NCT01350141|263165|P3|Overall Study|Withdrawal by Subject|0
66746|NCT01350141|263166|P2|Overall Study|Withdrawal by Subject|0
66747|NCT01350141|263167|P1|Overall Study|Withdrawal by Subject|1
66748|NCT01350141|263165|P3|Overall Study|Lost to Follow-up|1
66749|NCT01350141|263166|P2|Overall Study|Lost to Follow-up|0
66750|NCT01350141|263167|P1|Overall Study|Lost to Follow-up|1
66751|NCT01350128|263201|P1|Overall Study|Lost to Follow-up|2
66752|NCT01350128|263201|P1|Overall Study|Physician Decision|1
66753|NCT01350128|263201|P1|Overall Study|Protocol discontinuation criteria|8
66754|NCT01350128|263201|P1|Overall Study|Withdrawal by Subject|3
66755|NCT01350115|263265|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
66756|NCT01350115|263266|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
66757|NCT01350115|263265|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
66758|NCT01350115|263266|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
66759|NCT01350115|263265|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
66760|NCT01350115|263266|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
66761|NCT01350102|263282|P4|Overall Study|Adverse Event|0
66762|NCT01350102|263283|P3|Overall Study|Adverse Event|1
66763|NCT01350102|263284|P2|Overall Study|Adverse Event|0
66764|NCT01350102|263285|P1|Overall Study|Adverse Event|0
66765|NCT01349959|263322|P1|Overall Study|Patients are followed for survival|7
66766|NCT01349907|263358|P2|Overall Study|Administrative|1
66767|NCT01349907|263359|P1|Overall Study|Administrative|1
66768|NCT01349907|263358|P2|Overall Study|Protocol Violation|13
66769|NCT01349907|263359|P1|Overall Study|Protocol Violation|33
66770|NCT01349907|263358|P2|Overall Study|Withdrawal by Subject|8
66771|NCT01349907|263359|P1|Overall Study|Withdrawal by Subject|30
66772|NCT01349907|263358|P2|Overall Study|Lost to Follow-up|6
66773|NCT01349907|263359|P1|Overall Study|Lost to Follow-up|25
66774|NCT01349907|263358|P2|Overall Study|Treatment failure|4
66775|NCT01349907|263359|P1|Overall Study|Treatment failure|13
66776|NCT01349907|263358|P2|Overall Study|Adverse Event|11
66777|NCT01349907|263359|P1|Overall Study|Adverse Event|37
66778|NCT01349829|263397|P2|Overall Study|Migrated/moved|7
66779|NCT01349829|263398|P1|Overall Study|Migrated/moved|2
66780|NCT01349829|263397|P2|Overall Study|Consent withdrawal|8
66781|NCT01349829|263398|P1|Overall Study|Consent withdrawal|3
66782|NCT01349829|263397|P2|Overall Study|Lost to Follow-up|8
66783|NCT01349829|263398|P1|Overall Study|Lost to Follow-up|4
66784|NCT01349816|263416|P1|Overall Study|Protocol-specified criteria|8
66785|NCT01349816|263416|P1|Overall Study|Protocol Violation|1
66786|NCT01349816|263416|P1|Overall Study|Lost to Follow-up|2
66787|NCT01349816|263416|P1|Overall Study|Adverse Event|14
66788|NCT01349816|263416|P1|Overall Study|Physician Decision|1
66789|NCT01349816|263416|P1|Overall Study|Withdrawal by Subject|4
66790|NCT01349803|263482|P4|Overall Study|Protocol-specified criteria|0
66791|NCT01349803|263483|P3|Overall Study|Protocol-specified criteria|3
66792|NCT01349803|263484|P2|Overall Study|Protocol-specified criteria|1
66793|NCT01349803|263485|P1|Overall Study|Protocol-specified criteria|0
66794|NCT01349803|263482|P4|Overall Study|Withdrawal by Subject|0
66795|NCT01349803|263483|P3|Overall Study|Withdrawal by Subject|0
66796|NCT01349803|263484|P2|Overall Study|Withdrawal by Subject|0
66797|NCT01349803|263485|P1|Overall Study|Withdrawal by Subject|1
66798|NCT01349803|263482|P4|Overall Study|Adverse Event|2
66799|NCT01349803|263483|P3|Overall Study|Adverse Event|0
66800|NCT01349803|263484|P2|Overall Study|Adverse Event|0
66801|NCT01349803|263485|P1|Overall Study|Adverse Event|0
66802|NCT01349790|263555|P1|Overall Study|Lost to Follow-up|1
66803|NCT01349790|263555|P1|Overall Study|Adverse Event|1
66804|NCT01349790|263555|P1|Overall Study|Withdrawal by Patient|2
66805|NCT01349790|263555|P1|Overall Study|Death|2
66806|NCT01349790|263555|P1|Overall Study|Investigator Judgement|3
66807|NCT01349660|263577|P3|Overall Study|Declining Performance Status|1
66808|NCT01349660|263578|P2|Overall Study|Declining Performance Status|0
66809|NCT01349660|263579|P1|Overall Study|Declining Performance Status|0
66810|NCT01349660|263577|P3|Overall Study|Study Compliance|1
66811|NCT01349660|263578|P2|Overall Study|Study Compliance|0
66812|NCT01349660|263579|P1|Overall Study|Study Compliance|0
66813|NCT01349660|263577|P3|Overall Study|Non-Permitted Interventions|2
66814|NCT01349660|263578|P2|Overall Study|Non-Permitted Interventions|0
66815|NCT01349660|263579|P1|Overall Study|Non-Permitted Interventions|0
66816|NCT01349660|263577|P3|Overall Study|Death|0
66817|NCT01349660|263578|P2|Overall Study|Death|1
66818|NCT01349660|263579|P1|Overall Study|Death|1
66819|NCT01349660|263577|P3|Overall Study|Withdrawal by Subject|9
66820|NCT01349660|263578|P2|Overall Study|Withdrawal by Subject|0
66821|NCT01349660|263579|P1|Overall Study|Withdrawal by Subject|2
66822|NCT01349660|263577|P3|Overall Study|Adverse Event|12
66823|NCT01349660|263578|P2|Overall Study|Adverse Event|1
66824|NCT01349660|263579|P1|Overall Study|Adverse Event|1
66825|NCT01349660|263577|P3|Overall Study|Disease Progression|50
66826|NCT01349660|263578|P2|Overall Study|Disease Progression|4
66827|NCT01349660|263579|P1|Overall Study|Disease Progression|2
66828|NCT01349660|263577|P3|Overall Study|Still Receiving Study Treatment|1
66829|NCT01349660|263578|P2|Overall Study|Still Receiving Study Treatment|0
66830|NCT01349660|263579|P1|Overall Study|Still Receiving Study Treatment|0
66831|NCT01349595|263597|P2|Overall Study|Lack of funding|2
66832|NCT01349595|263598|P1|Overall Study|Lack of funding|2
66833|NCT01349465|263615|P2|Overall Study|Subject Ineligible To Continue The Trial|19
66834|NCT01349465|263616|P1|Overall Study|Subject Ineligible To Continue The Trial|0
66835|NCT01349465|263615|P2|Overall Study|Withdrawal by Subject|2
66836|NCT01349465|263616|P1|Overall Study|Withdrawal by Subject|4
66837|NCT01349465|263615|P2|Overall Study|Lost to Follow-up|1
66838|NCT01349465|263616|P1|Overall Study|Lost to Follow-up|10
66839|NCT01349465|263615|P2|Overall Study|Death|0
66840|NCT01349465|263616|P1|Overall Study|Death|3
66841|NCT01349465|263615|P2|Overall Study|Adverse Event|0
66842|NCT01349465|263616|P1|Overall Study|Adverse Event|1
66843|NCT01349192|263637|P2|Overall Study|Failure to adhere to Protocol|0
66844|NCT01349192|263638|P1|Overall Study|Failure to adhere to Protocol|2
66845|NCT01349192|263637|P2|Overall Study|Lost to Follow-up|3
66846|NCT01349192|263638|P1|Overall Study|Lost to Follow-up|1
66847|NCT01349192|263637|P2|Overall Study|Withdrawal by Subject|2
66848|NCT01349192|263638|P1|Overall Study|Withdrawal by Subject|0
66849|NCT01349192|263637|P2|Overall Study|Protocol Violation|1
66850|NCT01349192|263638|P1|Overall Study|Protocol Violation|0
66851|NCT01348854|263663|P2|Overall Study|Withdrawal by Subject|0
66852|NCT01348854|263664|P1|Overall Study|Withdrawal by Subject|1
66853|NCT01348854|263663|P2|Overall Study|Lost to Follow-up|1
66854|NCT01348854|263664|P1|Overall Study|Lost to Follow-up|2
66855|NCT01348789|263672|P1|Overall Study|Withdrawal by Subject|2
66856|NCT01348789|263672|P1|Overall Study|Protocol Violation|2
66857|NCT01348776|263683|P1|Overall Study|Lost to Follow-up|3
66858|NCT01348425|263714|P2|Overall Study|Imaging was not taken.|1
66859|NCT01348425|263715|P1|Overall Study|Imaging was not taken.|1
66860|NCT01348165|263727|P7|Overall Study|Adverse Event|1
66861|NCT01348165|263728|P6|Overall Study|Adverse Event|0
66862|NCT01348165|263729|P5|Overall Study|Adverse Event|0
66863|NCT01348165|263730|P4|Overall Study|Adverse Event|0
66864|NCT01348165|263731|P3|Overall Study|Adverse Event|0
66865|NCT01348165|263732|P2|Overall Study|Adverse Event|0
66866|NCT01348165|263733|P1|Overall Study|Adverse Event|0
66867|NCT01348139|263862|P6|Period 1|Adverse Event|0
66868|NCT01348139|263863|P5|Period 1|Adverse Event|0
66869|NCT01348139|263864|P4|Period 1|Adverse Event|0
66870|NCT01348139|263865|P3|Period 1|Adverse Event|0
66871|NCT01348139|263866|P2|Period 1|Adverse Event|0
66872|NCT01348139|263867|P1|Period 1|Adverse Event|1
66873|NCT01348100|263948|P7|Overall Study|Administrative Problems|1
66874|NCT01348100|263949|P6|Overall Study|Administrative Problems|1
66875|NCT01348100|263950|P5|Overall Study|Administrative Problems|0
66876|NCT01348100|263951|P4|Overall Study|Administrative Problems|0
66877|NCT01348100|263952|P3|Overall Study|Administrative Problems|0
66878|NCT01348100|263953|P2|Overall Study|Administrative Problems|0
66879|NCT01348100|263954|P1|Overall Study|Administrative Problems|0
66880|NCT01348100|263948|P7|Overall Study|Lost to Follow-up|1
66881|NCT01348100|263949|P6|Overall Study|Lost to Follow-up|0
66882|NCT01348100|263950|P5|Overall Study|Lost to Follow-up|0
66883|NCT01348100|263951|P4|Overall Study|Lost to Follow-up|0
66884|NCT01348100|263952|P3|Overall Study|Lost to Follow-up|0
66885|NCT01348100|263953|P2|Overall Study|Lost to Follow-up|0
66886|NCT01348100|263954|P1|Overall Study|Lost to Follow-up|0
66887|NCT01348100|263948|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
66888|NCT01348100|263949|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
66889|NCT01348100|263950|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
66890|NCT01348100|263951|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
66891|NCT01348100|263952|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
66892|NCT01348100|263953|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
66893|NCT01348100|263954|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
66894|NCT01348100|263948|P7|Overall Study|Protocol Deviation|0
66895|NCT01348100|263949|P6|Overall Study|Protocol Deviation|0
66896|NCT01348100|263950|P5|Overall Study|Protocol Deviation|0
66897|NCT01348100|263951|P4|Overall Study|Protocol Deviation|1
66898|NCT01348100|263952|P3|Overall Study|Protocol Deviation|0
66899|NCT01348100|263953|P2|Overall Study|Protocol Deviation|0
66900|NCT01348100|263954|P1|Overall Study|Protocol Deviation|0
66901|NCT01348100|263948|P7|Overall Study|Subject Withdrew Consent|1
66902|NCT01348100|263949|P6|Overall Study|Subject Withdrew Consent|0
66903|NCT01348100|263950|P5|Overall Study|Subject Withdrew Consent|1
66904|NCT01348100|263951|P4|Overall Study|Subject Withdrew Consent|0
66905|NCT01348100|263952|P3|Overall Study|Subject Withdrew Consent|2
66906|NCT01348100|263953|P2|Overall Study|Subject Withdrew Consent|0
66907|NCT01348100|263954|P1|Overall Study|Subject Withdrew Consent|0
66908|NCT01348087|263999|P1|Overall Study|Adverse Event|25
66909|NCT01348087|263999|P1|Overall Study|Subject withdrew consent|7
66910|NCT01348087|263999|P1|Overall Study|Lost to Follow-up|1
66911|NCT01348087|263999|P1|Overall Study|protocol deviation|1
66912|NCT01348087|263999|P1|Overall Study|Administrative problems|79
66913|NCT01348087|263999|P1|Overall Study|Unsatisfactory therapeutic effect|35
66914|NCT01347931|264013|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
66915|NCT01347879|264025|P2|Overall Study|Other|3
66916|NCT01347879|264026|P1|Overall Study|Other|2
66917|NCT01347879|264025|P2|Overall Study|Withdrawal by Subject|2
66918|NCT01347879|264026|P1|Overall Study|Withdrawal by Subject|3
66919|NCT01347879|264025|P2|Overall Study|Lost to Follow-up|0
66920|NCT01347879|264026|P1|Overall Study|Lost to Follow-up|2
66921|NCT01347879|264025|P2|Overall Study|Adverse Event|12
66922|NCT01347879|264026|P1|Overall Study|Adverse Event|0
66923|NCT01347840|264058|P1|Overall Study|Withdrawal by Subject|1
66924|NCT01347710|264081|P1|Overall Study|Other|3
66925|NCT01347710|264081|P1|Overall Study|Physician Decision|2
66926|NCT01347710|264081|P1|Overall Study|Lost to Follow-up|1
66927|NCT01347710|264081|P1|Overall Study|issue with vitals prior to dosing|1
66928|NCT01347710|264081|P1|Overall Study|Angio or SPECT not completed|18
66929|NCT01347710|264081|P1|Overall Study|Adverse Event|4
66930|NCT01347710|264081|P1|Overall Study|Withdrawal by Subject|2
66931|NCT01347580|264103|P2|Overall Study|Had other reason|6
66932|NCT01347580|264104|P1|Overall Study|Had other reason|9
66933|NCT01347580|264103|P2|Overall Study|Lost to Follow-up|1
66934|NCT01347580|264104|P1|Overall Study|Lost to Follow-up|3
66935|NCT01347580|264103|P2|Overall Study|Protocol Violation|7
66936|NCT01347580|264104|P1|Overall Study|Protocol Violation|10
66937|NCT01347580|264103|P2|Overall Study|Death|19
66938|NCT01347580|264104|P1|Overall Study|Death|30
66939|NCT01347580|264103|P2|Overall Study|Withdrawal by Subject|23
66940|NCT01347580|264104|P1|Overall Study|Withdrawal by Subject|13
66941|NCT01347554|264134|P2|Overall Study|Lack of Efficacy|11
66942|NCT01347554|264135|P1|Overall Study|Lack of Efficacy|7
66943|NCT01347112|264172|P2|Overall Study|Lost to Follow-up|5
66944|NCT01347112|264173|P1|Overall Study|Lost to Follow-up|3
66945|NCT01347112|264172|P2|Overall Study|Withdrawal by Subject|7
66946|NCT01347112|264173|P1|Overall Study|Withdrawal by Subject|1
66947|NCT01347086|264193|P10|Overall Study|failed screening visit|1
66948|NCT01347086|264194|P9|Overall Study|failed screening visit|0
66949|NCT01347086|264195|P8|Overall Study|failed screening visit|1
66950|NCT01347086|264196|P7|Overall Study|failed screening visit|1
66951|NCT01347086|264197|P6|Overall Study|failed screening visit|0
66952|NCT01347086|264198|P5|Overall Study|failed screening visit|0
66953|NCT01347086|264199|P4|Overall Study|failed screening visit|0
66954|NCT01347086|264200|P3|Overall Study|failed screening visit|1
66955|NCT01347086|264201|P2|Overall Study|failed screening visit|0
66956|NCT01347086|264202|P1|Overall Study|failed screening visit|0
66957|NCT01347073|264301|P1|Overall Study|Liver Transplant|1
66958|NCT01347073|264301|P1|Overall Study|Adverse Event|1
66959|NCT01346774|264380|P2|Overall Study|Adverse Event|2
66960|NCT01346774|264381|P1|Overall Study|Adverse Event|1
66961|NCT01346774|264380|P2|Overall Study|Protocol Violation|3
66962|NCT01346774|264381|P1|Overall Study|Protocol Violation|2
66963|NCT01346774|264380|P2|Overall Study|Withdrawal by Subject|4
66964|NCT01346774|264381|P1|Overall Study|Withdrawal by Subject|1
66965|NCT01346774|264380|P2|Overall Study|Lost to Follow-up|4
66966|NCT01346774|264381|P1|Overall Study|Lost to Follow-up|3
66967|NCT01346774|264380|P2|Overall Study|Did not take a single dose|4
66968|NCT01346774|264381|P1|Overall Study|Did not take a single dose|6
66969|NCT01346592|264390|P3|Overall Study|Unable to Classify|6
66970|NCT01346592|264391|P2|Overall Study|Unable to Classify|3
66971|NCT01346592|264392|P1|Overall Study|Unable to Classify|7
66972|NCT01346592|264390|P3|Overall Study|Administrative reason|0
66973|NCT01346592|264391|P2|Overall Study|Administrative reason|0
66974|NCT01346592|264392|P1|Overall Study|Administrative reason|1
66975|NCT01346592|264390|P3|Overall Study|Inappropriate enrollment|1
66976|NCT01346592|264391|P2|Overall Study|Inappropriate enrollment|1
66977|NCT01346592|264392|P1|Overall Study|Inappropriate enrollment|3
66978|NCT01346592|264390|P3|Overall Study|Withdrawal by Subject|38
66979|NCT01346592|264391|P2|Overall Study|Withdrawal by Subject|51
66980|NCT01346592|264392|P1|Overall Study|Withdrawal by Subject|77
66981|NCT01346592|264390|P3|Overall Study|Adverse Event|0
66982|NCT01346592|264391|P2|Overall Study|Adverse Event|1
66983|NCT01346592|264392|P1|Overall Study|Adverse Event|0
66984|NCT01346592|264390|P3|Overall Study|Death|4
66985|NCT01346592|264391|P2|Overall Study|Death|3
66986|NCT01346592|264392|P1|Overall Study|Death|1
66987|NCT01346592|264390|P3|Overall Study|Protocol Violation|0
66988|NCT01346592|264391|P2|Overall Study|Protocol Violation|1
66989|NCT01346592|264392|P1|Overall Study|Protocol Violation|2
66990|NCT01346592|264390|P3|Overall Study|Lost to Follow-up|29
66991|NCT01346592|264391|P2|Overall Study|Lost to Follow-up|29
66992|NCT01346592|264392|P1|Overall Study|Lost to Follow-up|62
66993|NCT01346514|264484|P2|Overall Study|Death|4
66994|NCT01346514|264485|P1|Overall Study|Death|3
66995|NCT01346514|264484|P2|Overall Study|Withdrawal by Subject|3
66996|NCT01346514|264485|P1|Overall Study|Withdrawal by Subject|7
66997|NCT01346514|264484|P2|Overall Study|Lost to Follow-up|30
66998|NCT01346514|264485|P1|Overall Study|Lost to Follow-up|19
66999|NCT01346501|264505|P2|Overall Study|Not Specified|12
67000|NCT01346501|264506|P1|Overall Study|Not Specified|8
67001|NCT01346501|264505|P2|Overall Study|Initiated Other Biological Agents|1
67002|NCT01346501|264506|P1|Overall Study|Initiated Other Biological Agents|3
67003|NCT01346475|264539|P2|First Intervention|Lost to Follow-up|3
67004|NCT01346475|264540|P1|First Intervention|Lost to Follow-up|4
67005|NCT01346410|264552|P1|Overall Study|Death|1
67006|NCT01346293|264569|P2|Overall Study|Other|0
67007|NCT01346293|264570|P1|Overall Study|Other|1
67008|NCT01346293|264569|P2|Overall Study|Withdrawal by Subject|4
67009|NCT01346293|264570|P1|Overall Study|Withdrawal by Subject|15
67010|NCT01346293|264569|P2|Overall Study|Lost to Follow-up|8
67011|NCT01346293|264570|P1|Overall Study|Lost to Follow-up|21
67012|NCT01346293|264569|P2|Overall Study|Protocol Violation|9
67013|NCT01346293|264570|P1|Overall Study|Protocol Violation|30
67014|NCT01346189|264600|P4|Overall Study|Travel|3
67015|NCT01346189|264601|P3|Overall Study|Travel|0
67016|NCT01346189|264602|P2|Overall Study|Travel|0
67017|NCT01346189|264603|P1|Overall Study|Travel|0
67018|NCT01346189|264600|P4|Overall Study|Non-health system primary care physician|0
67019|NCT01346189|264601|P3|Overall Study|Non-health system primary care physician|0
67020|NCT01346189|264602|P2|Overall Study|Non-health system primary care physician|5
67021|NCT01346189|264603|P1|Overall Study|Non-health system primary care physician|0
67022|NCT01346189|264600|P4|Overall Study|Death|0
67023|NCT01346189|264601|P3|Overall Study|Death|0
67024|NCT01346189|264602|P2|Overall Study|Death|3
67025|NCT01346189|264603|P1|Overall Study|Death|0
67026|NCT01346189|264600|P4|Overall Study|Other|3
67027|NCT01346189|264601|P3|Overall Study|Other|7
67028|NCT01346189|264602|P2|Overall Study|Other|4
67029|NCT01346189|264603|P1|Overall Study|Other|2
67030|NCT01346189|264600|P4|Overall Study|Moved|0
67031|NCT01346189|264601|P3|Overall Study|Moved|4
67032|NCT01346189|264602|P2|Overall Study|Moved|0
67033|NCT01346189|264603|P1|Overall Study|Moved|3
67034|NCT01346189|264600|P4|Overall Study|Physician Decision|0
67035|NCT01346189|264601|P3|Overall Study|Physician Decision|0
67036|NCT01346189|264602|P2|Overall Study|Physician Decision|0
67037|NCT01346189|264603|P1|Overall Study|Physician Decision|4
67038|NCT01346189|264600|P4|Overall Study|Withdrawal by Subject|5
67039|NCT01346189|264601|P3|Overall Study|Withdrawal by Subject|3
67040|NCT01346189|264602|P2|Overall Study|Withdrawal by Subject|5
67041|NCT01346189|264603|P1|Overall Study|Withdrawal by Subject|7
67042|NCT01346176|264620|P3|Completed Satisfaction Survey|Lost to Follow-up|4
67043|NCT01346176|264621|P2|Completed Satisfaction Survey|Lost to Follow-up|4
67044|NCT01346176|264622|P1|Completed Satisfaction Survey|Lost to Follow-up|3
67045|NCT01346176|264620|P3|Completed Satisfaction Survey|Death|2
67046|NCT01346176|264621|P2|Completed Satisfaction Survey|Death|0
67047|NCT01346176|264622|P1|Completed Satisfaction Survey|Death|3
67048|NCT01346176|264620|P3|Completed Advance Directive|Other reason did not complete AD|7
67049|NCT01346176|264621|P2|Completed Advance Directive|Other reason did not complete AD|12
67050|NCT01346176|264622|P1|Completed Advance Directive|Other reason did not complete AD|7
67051|NCT01346176|264620|P3|Completed Advance Directive|Became Ineligible|1
67052|NCT01346176|264621|P2|Completed Advance Directive|Became Ineligible|0
67053|NCT01346176|264622|P1|Completed Advance Directive|Became Ineligible|3
67054|NCT01346176|264620|P3|Completed Advance Directive|Death|2
67055|NCT01346176|264621|P2|Completed Advance Directive|Death|2
67056|NCT01346176|264622|P1|Completed Advance Directive|Death|3
67057|NCT01346176|264620|P3|Recruited|Protocol Violation|0
67058|NCT01346176|264621|P2|Recruited|Protocol Violation|0
67059|NCT01346176|264622|P1|Recruited|Protocol Violation|1
67060|NCT01346059|264651|P2|Overall Study|Withdrawal by Subject|0
67061|NCT01346059|264652|P1|Overall Study|Withdrawal by Subject|1
67062|NCT01345929|264664|P2|Overall Study|Patient withdrawal|1
67063|NCT01345929|264665|P1|Overall Study|Patient withdrawal|0
67064|NCT01345929|264664|P2|Overall Study|40,000 CFU/ML|0
67065|NCT01345929|264665|P1|Overall Study|40,000 CFU/ML|1
67066|NCT01345929|264664|P2|Overall Study|Didn't meet eligibility criteria|0
67067|NCT01345929|264665|P1|Overall Study|Didn't meet eligibility criteria|2
67068|NCT01345929|264664|P2|Overall Study|Adverse Event|1
67069|NCT01345929|264665|P1|Overall Study|Adverse Event|0
67070|NCT01345929|264664|P2|Overall Study|Lost to Follow-up|9
67071|NCT01345929|264665|P1|Overall Study|Lost to Follow-up|9
67072|NCT01345929|264664|P2|Overall Study|Withdrawal by Subject|8
67073|NCT01345929|264665|P1|Overall Study|Withdrawal by Subject|9
67074|NCT01345786|264677|P4|Overall Study|Lost to Follow-up|2
67075|NCT01345786|264678|P3|Overall Study|Lost to Follow-up|0
67076|NCT01345786|264679|P2|Overall Study|Lost to Follow-up|0
67077|NCT01345786|264680|P1|Overall Study|Lost to Follow-up|0
67078|NCT01345786|264677|P4|Overall Study|Administrative|0
67079|NCT01345786|264678|P3|Overall Study|Administrative|0
67080|NCT01345786|264679|P2|Overall Study|Administrative|5
67081|NCT01345786|264680|P1|Overall Study|Administrative|3
67082|NCT01345786|264677|P4|Overall Study|Noncompliance with protocol|0
67083|NCT01345786|264678|P3|Overall Study|Noncompliance with protocol|1
67084|NCT01345786|264679|P2|Overall Study|Noncompliance with protocol|0
67085|NCT01345786|264680|P1|Overall Study|Noncompliance with protocol|1
67086|NCT01345786|264677|P4|Overall Study|Subject withdrew consent|0
67087|NCT01345786|264678|P3|Overall Study|Subject withdrew consent|1
67088|NCT01345786|264679|P2|Overall Study|Subject withdrew consent|2
67089|NCT01345786|264680|P1|Overall Study|Subject withdrew consent|2
67090|NCT01345786|264677|P4|Overall Study|Adverse Event|1
67091|NCT01345786|264678|P3|Overall Study|Adverse Event|3
67092|NCT01345786|264679|P2|Overall Study|Adverse Event|1
67093|NCT01345786|264680|P1|Overall Study|Adverse Event|0
67094|NCT01345682|264760|P2|Overall Study|Reason other than those specified above|3
67095|NCT01345682|264761|P1|Overall Study|Reason other than those specified above|4
67096|NCT01345682|264760|P2|Overall Study|Not treated|1
67097|NCT01345682|264761|P1|Overall Study|Not treated|2
67098|NCT01345682|264760|P2|Overall Study|Refused to continue trial medication|9
67099|NCT01345682|264761|P1|Overall Study|Refused to continue trial medication|16
67100|NCT01345682|264760|P2|Overall Study|Lost to Follow-up|1
67101|NCT01345682|264761|P1|Overall Study|Lost to Follow-up|0
67102|NCT01345682|264760|P2|Overall Study|Non-compliance with protocol|1
67103|NCT01345682|264761|P1|Overall Study|Non-compliance with protocol|0
67104|NCT01345682|264760|P2|Overall Study|Adverse Event|41
67105|NCT01345682|264761|P1|Overall Study|Adverse Event|51
67106|NCT01345682|264760|P2|Overall Study|Worsening of underlying cancer disease|12
67107|NCT01345682|264761|P1|Overall Study|Worsening of underlying cancer disease|23
67108|NCT01345682|264760|P2|Overall Study|Progressive disease per RECIST|93
67109|NCT01345682|264761|P1|Overall Study|Progressive disease per RECIST|226
67110|NCT01345669|264795|P2|Overall Study|Other Reasons|60
67111|NCT01345669|264796|P1|Overall Study|Other Reasons|111
67112|NCT01345669|264795|P2|Overall Study|Withdrawal by Subject|13
67113|NCT01345669|264796|P1|Overall Study|Withdrawal by Subject|52
67114|NCT01345669|264795|P2|Overall Study|Lost to Follow-up|1
67115|NCT01345669|264796|P1|Overall Study|Lost to Follow-up|1
67116|NCT01345669|264795|P2|Overall Study|Protocol Violation|1
67117|NCT01345669|264796|P1|Overall Study|Protocol Violation|3
67118|NCT01345669|264795|P2|Overall Study|Adverse Event|9
67119|NCT01345669|264796|P1|Overall Study|Adverse Event|63
67120|NCT01345669|264795|P2|Overall Study|Second primary tumour|3
67121|NCT01345669|264796|P1|Overall Study|Second primary tumour|4
67122|NCT01345669|264795|P2|Overall Study|Primary tumour recurrence|32
67123|NCT01345669|264796|P1|Overall Study|Primary tumour recurrence|53
67124|NCT01345630|264814|P2|Overall Study|Insufficient clinical response|11
67125|NCT01345630|264815|P1|Overall Study|Insufficient clinical response|48
67126|NCT01345630|264814|P2|Overall Study|No longer willing to participate|12
67127|NCT01345630|264815|P1|Overall Study|No longer willing to participate|9
67128|NCT01345630|264814|P2|Overall Study|Withdrawn due to pregnancy|2
67129|NCT01345630|264815|P1|Overall Study|Withdrawn due to pregnancy|1
67130|NCT01345630|264814|P2|Overall Study|Other reasons|8
67131|NCT01345630|264815|P1|Overall Study|Other reasons|6
67132|NCT01345630|264814|P2|Overall Study|Study terminated by sponsor|285
67133|NCT01345630|264815|P1|Overall Study|Study terminated by sponsor|254
67134|NCT01345630|264814|P2|Overall Study|Medication error without associated AE|1
67135|NCT01345630|264815|P1|Overall Study|Medication error without associated AE|0
67136|NCT01345630|264814|P2|Overall Study|Protocol Violation|1
67137|NCT01345630|264815|P1|Overall Study|Protocol Violation|4
67138|NCT01345630|264814|P2|Overall Study|Lost to Follow-up|16
67139|NCT01345630|264815|P1|Overall Study|Lost to Follow-up|17
67140|NCT01345630|264814|P2|Overall Study|Adverse Event|23
67141|NCT01345630|264815|P1|Overall Study|Adverse Event|22
67142|NCT01345591|264871|P1|Overall Study|Lost to Follow-up|1
67143|NCT01345318|264880|P1|Overall Study|Other|3
67144|NCT01345318|264880|P1|Overall Study|Withdrawal by Subject|41
67145|NCT01345318|264880|P1|Overall Study|Protocol Violation|1
67146|NCT01345318|264880|P1|Overall Study|Lost to Follow-up|2
67147|NCT01345318|264880|P1|Overall Study|Lack of Efficacy|17
67148|NCT01345318|264880|P1|Overall Study|Adverse Event|16
67149|NCT01345292|264888|P3|Overall Study|Withdrawal by Subject|1
67150|NCT01345292|264889|P2|Overall Study|Withdrawal by Subject|0
67151|NCT01345292|264890|P1|Overall Study|Withdrawal by Subject|2
67152|NCT01345253|264921|P2|Overall Study|Withdrawal by Subject|19
67153|NCT01345253|264922|P1|Overall Study|Withdrawal by Subject|9
67154|NCT01345253|264921|P2|Overall Study|Physician Decision|12
67155|NCT01345253|264922|P1|Overall Study|Physician Decision|4
67156|NCT01345253|264921|P2|Overall Study|Lost to Follow-up|8
67157|NCT01345253|264922|P1|Overall Study|Lost to Follow-up|3
67158|NCT01345253|264921|P2|Overall Study|Met Protocol Defined Stopping Criteria|1
67159|NCT01345253|264922|P1|Overall Study|Met Protocol Defined Stopping Criteria|6
67160|NCT01345253|264921|P2|Overall Study|Protocol Violation|5
67161|NCT01345253|264922|P1|Overall Study|Protocol Violation|1
67162|NCT01345253|264921|P2|Overall Study|Lack of Efficacy|7
67163|NCT01345253|264922|P1|Overall Study|Lack of Efficacy|11
67164|NCT01345253|264921|P2|Overall Study|Adverse Event|27
67165|NCT01345253|264922|P1|Overall Study|Adverse Event|22
67166|NCT01345240|264941|P5|Overall Study|Serious Adverse Event|1
67167|NCT01345240|264942|P4|Overall Study|Serious Adverse Event|2
67168|NCT01345240|264943|P3|Overall Study|Serious Adverse Event|2
67169|NCT01345240|264944|P2|Overall Study|Serious Adverse Event|2
67170|NCT01345240|264945|P1|Overall Study|Serious Adverse Event|1
67171|NCT01345240|264941|P5|Overall Study|Lost to Follow-up|6
67172|NCT01345240|264942|P4|Overall Study|Lost to Follow-up|8
67173|NCT01345240|264943|P3|Overall Study|Lost to Follow-up|8
67174|NCT01345240|264944|P2|Overall Study|Lost to Follow-up|12
67175|NCT01345240|264945|P1|Overall Study|Lost to Follow-up|1
67176|NCT01345162|265040|P2|Overall Study|Protocol Violation|4
67177|NCT01345162|265041|P1|Overall Study|Protocol Violation|2
67178|NCT01345123|265050|P3|Overall Study|participants no longer with health plan|88
67179|NCT01345123|265051|P2|Overall Study|participants no longer with health plan|85
67180|NCT01345123|265052|P1|Overall Study|participants no longer with health plan|79
67181|NCT01345058|265074|P2|Overall Study|Participant No-Show at Multiple Visits|0
67182|NCT01345058|265075|P1|Overall Study|Participant No-Show at Multiple Visits|1
67183|NCT01345058|265074|P2|Overall Study|Participant Stopped Taking Study Drug|0
67184|NCT01345058|265075|P1|Overall Study|Participant Stopped Taking Study Drug|1
67185|NCT01345058|265074|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
67186|NCT01345058|265075|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
67187|NCT01345058|265074|P2|Overall Study|Participant Reported Increase in Events|0
67188|NCT01345058|265075|P1|Overall Study|Participant Reported Increase in Events|1
67189|NCT01345058|265074|P2|Overall Study|Withdrawal by Subject|0
67190|NCT01345058|265075|P1|Overall Study|Withdrawal by Subject|1
67191|NCT01345019|265091|P2|Overall Study|Other|3
67192|NCT01345019|265092|P1|Overall Study|Other|1
67193|NCT01345019|265091|P2|Overall Study|Protocol Deviation|0
67194|NCT01345019|265092|P1|Overall Study|Protocol Deviation|5
67195|NCT01345019|265091|P2|Overall Study|Lost to Follow-up|2
67196|NCT01345019|265092|P1|Overall Study|Lost to Follow-up|4
67197|NCT01345019|265091|P2|Overall Study|Ineligibility Determined|6
67198|NCT01345019|265092|P1|Overall Study|Ineligibility Determined|1
67199|NCT01345019|265091|P2|Overall Study|Noncompliance|4
67200|NCT01345019|265092|P1|Overall Study|Noncompliance|4
67201|NCT01345019|265091|P2|Overall Study|Administrative Decision|5
67202|NCT01345019|265092|P1|Overall Study|Administrative Decision|8
67203|NCT01345019|265091|P2|Overall Study|Adverse Event|13
67204|NCT01345019|265092|P1|Overall Study|Adverse Event|4
67205|NCT01345019|265091|P2|Overall Study|Disease Progression|8
67206|NCT01345019|265092|P1|Overall Study|Disease Progression|11
67207|NCT01345019|265091|P2|Overall Study|Completed Survival Follow-up|4
67208|NCT01345019|265092|P1|Overall Study|Completed Survival Follow-up|16
67209|NCT01345019|265091|P2|Overall Study|Withdrawal by Subject|107
67210|NCT01345019|265092|P1|Overall Study|Withdrawal by Subject|82
67211|NCT01345019|265091|P2|Overall Study|Death|120
67212|NCT01345019|265092|P1|Overall Study|Death|127
67213|NCT01344876|265112|P5|Overall Study|Definite progression of primary disease|0
67214|NCT01344876|265113|P4|Overall Study|Definite progression of primary disease|3
67215|NCT01344876|265114|P3|Overall Study|Definite progression of primary disease|0
67216|NCT01344876|265115|P2|Overall Study|Definite progression of primary disease|0
67217|NCT01344876|265116|P1|Overall Study|Definite progression of primary disease|1
67218|NCT01344876|265112|P5|Overall Study|Withdrawal by Subject|0
67219|NCT01344876|265113|P4|Overall Study|Withdrawal by Subject|0
67220|NCT01344876|265114|P3|Overall Study|Withdrawal by Subject|1
67221|NCT01344876|265115|P2|Overall Study|Withdrawal by Subject|0
67222|NCT01344876|265116|P1|Overall Study|Withdrawal by Subject|0
67223|NCT01344876|265112|P5|Overall Study|Adverse Event|1
67224|NCT01344876|265113|P4|Overall Study|Adverse Event|0
67225|NCT01344876|265114|P3|Overall Study|Adverse Event|0
67226|NCT01344876|265115|P2|Overall Study|Adverse Event|0
67227|NCT01344876|265116|P1|Overall Study|Adverse Event|0
67228|NCT01344824|265130|P1|Overall Study|Progression|15
67229|NCT01344824|265130|P1|Overall Study|Other complicating disease|1
67230|NCT01344824|265130|P1|Overall Study|Withdrawal by Subject|6
67231|NCT01344824|265130|P1|Overall Study|Adverse Event|15
67232|NCT01344759|265138|P2|Overall Study|Patients failed to reach sedation level|2
67233|NCT01344759|265139|P1|Overall Study|Patients failed to reach sedation level|0
67234|NCT01344629|265171|P2|Crossover Period 2|Withdrawal by Subject|1
67235|NCT01344629|265172|P1|Crossover Period 2|Withdrawal by Subject|0
67236|NCT01344538|265201|P2|Overall Study|Lost to Follow-up|0
67237|NCT01344538|265202|P1|Overall Study|Lost to Follow-up|1
67238|NCT01344538|265201|P2|Overall Study|Adverse Event|1
67239|NCT01344538|265202|P1|Overall Study|Adverse Event|1
67240|NCT01344460|265208|P1|Overall Study|Lost to Follow-up|2
67241|NCT01344460|265208|P1|Overall Study|Withdrawal by Subject|1
67242|NCT01344447|265253|P1|Overall Study|Error of power injector|1
67243|NCT01344447|265253|P1|Overall Study|Bolus tracking failed|1
67244|NCT01344447|265253|P1|Overall Study|MRA unsuccessful|1
67245|NCT01344447|265253|P1|Overall Study|Physician Decision|1
67246|NCT01344447|265253|P1|Overall Study|The contrast was not seen|1
67247|NCT01344447|265253|P1|Overall Study|Withdrawal by Subject|1
67248|NCT01344447|265253|P1|Overall Study|Protocol Violation|1
67249|NCT01344447|265253|P1|Overall Study|Adverse Event|1
67250|NCT01344369|265297|P2|Second Intervention|Emesis within 2 x Tmax|1
67251|NCT01344369|265298|P1|Second Intervention|Emesis within 2 x Tmax|0
67252|NCT01344369|265297|P2|Washout of 28 Days|Physician Decision|1
67253|NCT01344369|265298|P1|Washout of 28 Days|Physician Decision|0
67254|NCT01344369|265297|P2|Washout of 28 Days|Withdrawal by Subject|0
67255|NCT01344369|265298|P1|Washout of 28 Days|Withdrawal by Subject|1
67256|NCT01344161|265316|P2|Overall Study|Protocol Violation|1
67257|NCT01344161|265317|P1|Overall Study|Protocol Violation|1
67258|NCT01344161|265316|P2|Overall Study|Pregnancy|1
67259|NCT01344161|265317|P1|Overall Study|Pregnancy|0
67260|NCT01344161|265316|P2|Overall Study|Lost to Follow-up|1
67261|NCT01344161|265317|P1|Overall Study|Lost to Follow-up|4
67262|NCT01344057|265329|P1|Overall Study|Premature Withdrawal|1
67263|NCT01343901|265336|P1|Overall Study|Participant decision|1
67264|NCT01343901|265336|P1|Overall Study|Management by another medical team|11
67265|NCT01343901|265336|P1|Overall Study|Lost to Follow-up|12
67266|NCT01343901|265336|P1|Overall Study|Physician Decision|4
67267|NCT01343901|265336|P1|Overall Study|Death|85
67268|NCT01343888|265360|P3|Overall Study|other than stated above|1
67269|NCT01343888|265361|P2|Overall Study|other than stated above|0
67270|NCT01343888|265362|P1|Overall Study|other than stated above|0
67271|NCT01343888|265360|P3|Overall Study|Withdrawal by Subject|2
67272|NCT01343888|265361|P2|Overall Study|Withdrawal by Subject|4
67273|NCT01343888|265362|P1|Overall Study|Withdrawal by Subject|4
67274|NCT01343888|265360|P3|Overall Study|Protocol Violation|0
67275|NCT01343888|265361|P2|Overall Study|Protocol Violation|2
67276|NCT01343888|265362|P1|Overall Study|Protocol Violation|0
67277|NCT01343888|265360|P3|Overall Study|Lost to Follow-up|1
67278|NCT01343888|265361|P2|Overall Study|Lost to Follow-up|2
67279|NCT01343888|265362|P1|Overall Study|Lost to Follow-up|0
67280|NCT01343888|265360|P3|Overall Study|Lack of Efficacy|13
67281|NCT01343888|265361|P2|Overall Study|Lack of Efficacy|9
67282|NCT01343888|265362|P1|Overall Study|Lack of Efficacy|9
67283|NCT01343888|265360|P3|Overall Study|Adverse Event|5
67284|NCT01343888|265361|P2|Overall Study|Adverse Event|22
67285|NCT01343888|265362|P1|Overall Study|Adverse Event|12
67286|NCT01343823|265404|P4|Overall Study|Withdrawal by Subject|0
67287|NCT01343823|265405|P3|Overall Study|Withdrawal by Subject|0
67288|NCT01343823|265406|P2|Overall Study|Withdrawal by Subject|0
67289|NCT01343823|265407|P1|Overall Study|Withdrawal by Subject|1
67290|NCT01343823|265404|P4|Overall Study|Study Terminated|1
67291|NCT01343823|265405|P3|Overall Study|Study Terminated|0
67292|NCT01343823|265406|P2|Overall Study|Study Terminated|0
67293|NCT01343823|265407|P1|Overall Study|Study Terminated|1
67294|NCT01343368|265441|P2|Overall Study|Lost to Follow-up|0
67295|NCT01343368|265442|P1|Overall Study|Lost to Follow-up|1
67296|NCT01343368|265441|P2|Overall Study|Death|0
67297|NCT01343368|265442|P1|Overall Study|Death|1
67298|NCT01343277|265478|P2|Overall Study|Subsequent anticancer therapy|0
67299|NCT01343277|265479|P1|Overall Study|Subsequent anticancer therapy|1
67300|NCT01343277|265478|P2|Overall Study|Treatment ongoing|2
67301|NCT01343277|265479|P1|Overall Study|Treatment ongoing|8
67302|NCT01343277|265478|P2|Overall Study|Randomized not treated|21
67303|NCT01343277|265479|P1|Overall Study|Randomized not treated|6
67304|NCT01343277|265478|P2|Overall Study|Disease progression|138
67305|NCT01343277|265479|P1|Overall Study|Disease progression|270
67306|NCT01343277|265478|P2|Overall Study|Adverse Event|13
67307|NCT01343277|265479|P1|Overall Study|Adverse Event|67
67308|NCT01343277|265478|P2|Overall Study|Death|1
67309|NCT01343277|265479|P1|Overall Study|Death|10
67310|NCT01343277|265478|P2|Overall Study|Physician Decision|2
67311|NCT01343277|265479|P1|Overall Study|Physician Decision|1
67312|NCT01343277|265478|P2|Overall Study|Withdrawal by Subject|13
67313|NCT01343277|265479|P1|Overall Study|Withdrawal by Subject|18
67314|NCT01343277|265478|P2|Overall Study|Other|3
67315|NCT01343277|265479|P1|Overall Study|Other|3
67316|NCT01343082|265540|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
67317|NCT01343082|265541|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
67318|NCT01343082|265542|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
67319|NCT01343082|265540|P3|Treatment Period , Switched to DE-111|Physician Decision|2
67320|NCT01343082|265541|P2|Treatment Period , Switched to DE-111|Physician Decision|2
67321|NCT01343082|265542|P1|Treatment Period , Switched to DE-111|Physician Decision|0
67322|NCT01343082|265540|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
67323|NCT01343082|265541|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
67324|NCT01343082|265542|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
67325|NCT01343082|265540|P3|Treatment Period , Switched to DE-111|Adverse Event|3
67326|NCT01343082|265541|P2|Treatment Period , Switched to DE-111|Adverse Event|4
67327|NCT01343082|265542|P1|Treatment Period , Switched to DE-111|Adverse Event|1
67328|NCT01343082|265540|P3|The run-in Period|Not meeting criteria|5
67329|NCT01343082|265541|P2|The run-in Period|Not meeting criteria|4
67330|NCT01343082|265542|P1|The run-in Period|Not meeting criteria|3
67331|NCT01343056|265550|P4|Overall Study|Lost to Follow-up|9
67332|NCT01343056|265551|P3|Overall Study|Lost to Follow-up|3
67333|NCT01343056|265552|P2|Overall Study|Lost to Follow-up|5
67334|NCT01343056|265553|P1|Overall Study|Lost to Follow-up|7
67335|NCT01342965|265621|P2|Overall Study|Withdrawal by Subject|9
67336|NCT01342965|265622|P1|Overall Study|Withdrawal by Subject|2
67337|NCT01342965|265621|P2|Overall Study|Other Reasons- Unspecified|38
67338|NCT01342965|265622|P1|Overall Study|Other Reasons- Unspecified|44
67339|NCT01342965|265621|P2|Overall Study|Lost to Follow-up|3
67340|NCT01342965|265622|P1|Overall Study|Lost to Follow-up|5
67341|NCT01342965|265621|P2|Overall Study|Death|57
67342|NCT01342965|265622|P1|Overall Study|Death|58
67343|NCT01342926|265640|P4|Overall Study|Withdrawal by Subject|5
67344|NCT01342926|265641|P3|Overall Study|Withdrawal by Subject|3
67345|NCT01342926|265642|P2|Overall Study|Withdrawal by Subject|4
67346|NCT01342926|265643|P1|Overall Study|Withdrawal by Subject|2
67347|NCT01342926|265640|P4|Overall Study|Investigator Discretion|0
67348|NCT01342926|265641|P3|Overall Study|Investigator Discretion|0
67349|NCT01342926|265642|P2|Overall Study|Investigator Discretion|2
67350|NCT01342926|265643|P1|Overall Study|Investigator Discretion|2
67351|NCT01342926|265640|P4|Overall Study|Lost to Follow-up|0
67352|NCT01342926|265641|P3|Overall Study|Lost to Follow-up|1
67353|NCT01342926|265642|P2|Overall Study|Lost to Follow-up|1
67354|NCT01342926|265643|P1|Overall Study|Lost to Follow-up|0
67355|NCT01342926|265640|P4|Overall Study|Adverse Event|7
67356|NCT01342926|265641|P3|Overall Study|Adverse Event|10
67357|NCT01342926|265642|P2|Overall Study|Adverse Event|8
67358|NCT01342926|265643|P1|Overall Study|Adverse Event|5
67359|NCT01342913|265723|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
67360|NCT01342913|265724|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
67361|NCT01342913|265725|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
67362|NCT01342913|265723|P3|Double-Blind Treatment Period|Physician Decision|0
67363|NCT01342913|265724|P2|Double-Blind Treatment Period|Physician Decision|2
67364|NCT01342913|265725|P1|Double-Blind Treatment Period|Physician Decision|0
67365|NCT01342913|265723|P3|Double-Blind Treatment Period|Lost to Follow-up|3
67366|NCT01342913|265724|P2|Double-Blind Treatment Period|Lost to Follow-up|1
67367|NCT01342913|265725|P1|Double-Blind Treatment Period|Lost to Follow-up|0
67368|NCT01342913|265723|P3|Double-Blind Treatment Period|Protocol Violation|9
67369|NCT01342913|265724|P2|Double-Blind Treatment Period|Protocol Violation|6
67370|NCT01342913|265725|P1|Double-Blind Treatment Period|Protocol Violation|0
67371|NCT01342913|265723|P3|Double-Blind Treatment Period|Lack of Efficacy|3
67372|NCT01342913|265724|P2|Double-Blind Treatment Period|Lack of Efficacy|2
67373|NCT01342913|265725|P1|Double-Blind Treatment Period|Lack of Efficacy|0
67374|NCT01342913|265723|P3|Double-Blind Treatment Period|Adverse Event|6
67375|NCT01342913|265724|P2|Double-Blind Treatment Period|Adverse Event|3
67376|NCT01342913|265725|P1|Double-Blind Treatment Period|Adverse Event|0
67377|NCT01342913|265723|P3|2-week Run-in Period|Continuation Criteria Not Met|0
67378|NCT01342913|265724|P2|2-week Run-in Period|Continuation Criteria Not Met|0
67379|NCT01342913|265725|P1|2-week Run-in Period|Continuation Criteria Not Met|88
67380|NCT01342913|265723|P3|2-week Run-in Period|Protocol Violation|0
67381|NCT01342913|265724|P2|2-week Run-in Period|Protocol Violation|0
67382|NCT01342913|265725|P1|2-week Run-in Period|Protocol Violation|5
67383|NCT01342913|265723|P3|2-week Run-in Period|Adverse Event|0
67384|NCT01342913|265724|P2|2-week Run-in Period|Adverse Event|0
67385|NCT01342913|265725|P1|2-week Run-in Period|Adverse Event|2
67386|NCT01342913|265723|P3|2-week Run-in Period|Withdrawal by Subject|0
67387|NCT01342913|265724|P2|2-week Run-in Period|Withdrawal by Subject|0
67388|NCT01342913|265725|P1|2-week Run-in Period|Withdrawal by Subject|7
67389|NCT01342913|265723|P3|2-week Run-in Period|Physician Decision|0
67390|NCT01342913|265724|P2|2-week Run-in Period|Physician Decision|0
67391|NCT01342913|265725|P1|2-week Run-in Period|Physician Decision|6
67392|NCT01342913|265723|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
67393|NCT01342913|265724|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
67394|NCT01342913|265725|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
67395|NCT01342887|265735|P1|Overall Study|Death|2
67396|NCT01342640|265776|P1|Overall Study|Other|1
67397|NCT01342640|265776|P1|Overall Study|Lost to Follow-up|21
67398|NCT01342640|265776|P1|Overall Study|Protocol Violation|16
67399|NCT01342640|265776|P1|Overall Study|Adverse Event|3
67400|NCT01342510|265871|P4|Overall Study|Protocol Violation|11
67401|NCT01342510|265872|P3|Overall Study|Protocol Violation|13
67402|NCT01342510|265873|P2|Overall Study|Protocol Violation|6
67403|NCT01342510|265874|P1|Overall Study|Protocol Violation|12
67404|NCT01342484|265887|P3|Overall Study|Withdrawal by Subject|0
67405|NCT01342484|265888|P2|Overall Study|Withdrawal by Subject|0
67406|NCT01342484|265889|P1|Overall Study|Withdrawal by Subject|1
67407|NCT01342484|265887|P3|Overall Study|Protocol Violation|1
67408|NCT01342484|265888|P2|Overall Study|Protocol Violation|0
67409|NCT01342484|265889|P1|Overall Study|Protocol Violation|0
67410|NCT01342484|265887|P3|Overall Study|Other Reasons|0
67411|NCT01342484|265888|P2|Overall Study|Other Reasons|0
67412|NCT01342484|265889|P1|Overall Study|Other Reasons|1
67413|NCT01342445|265945|P2|Overall Study|Experienced side effects|2
67414|NCT01342445|265946|P1|Overall Study|Experienced side effects|0
67415|NCT01342341|265962|P2|Overall Study|Lost to Follow-up|4
67416|NCT01342341|265963|P1|Overall Study|Lost to Follow-up|4
67417|NCT01342211|265974|P5|Overall Study|Randomized, but not Treated|1
67418|NCT01342211|265975|P4|Overall Study|Randomized, but not Treated|0
67419|NCT01342211|265976|P3|Overall Study|Randomized, but not Treated|0
67420|NCT01342211|265977|P2|Overall Study|Randomized, but not Treated|2
67421|NCT01342211|265978|P1|Overall Study|Randomized, but not Treated|0
67422|NCT01342211|265974|P5|Overall Study|Withdrawal by Subject|0
67423|NCT01342211|265975|P4|Overall Study|Withdrawal by Subject|1
67424|NCT01342211|265976|P3|Overall Study|Withdrawal by Subject|0
67425|NCT01342211|265977|P2|Overall Study|Withdrawal by Subject|0
67426|NCT01342211|265978|P1|Overall Study|Withdrawal by Subject|0
67427|NCT01342211|265974|P5|Overall Study|Adverse Event|1
67428|NCT01342211|265975|P4|Overall Study|Adverse Event|0
67429|NCT01342211|265976|P3|Overall Study|Adverse Event|0
67430|NCT01342211|265977|P2|Overall Study|Adverse Event|0
67431|NCT01342211|265978|P1|Overall Study|Adverse Event|0
67432|NCT01342211|265974|P5|Overall Study|Lost to Follow-up|0
67433|NCT01342211|265975|P4|Overall Study|Lost to Follow-up|1
67434|NCT01342211|265976|P3|Overall Study|Lost to Follow-up|0
67435|NCT01342211|265977|P2|Overall Study|Lost to Follow-up|0
67436|NCT01342211|265978|P1|Overall Study|Lost to Follow-up|0
67437|NCT01342094|266059|P2|Overall Study|Withdrawal by Subject|2
67438|NCT01342094|266060|P1|Overall Study|Withdrawal by Subject|0
67439|NCT01342094|266059|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
67440|NCT01342094|266060|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
67441|NCT01342094|266059|P2|Overall Study|Adverse Event|0
67442|NCT01342094|266060|P1|Overall Study|Adverse Event|5
67443|NCT01342081|266069|P3|Overall Study|Withdrawal by Subject|0
67444|NCT01342081|266070|P2|Overall Study|Withdrawal by Subject|1
67445|NCT01342081|266071|P1|Overall Study|Withdrawal by Subject|1
67446|NCT01342081|266069|P3|Overall Study|Physician Decision|0
67447|NCT01342081|266070|P2|Overall Study|Physician Decision|1
67448|NCT01342081|266071|P1|Overall Study|Physician Decision|0
67449|NCT01342081|266069|P3|Overall Study|Adverse Event|0
67450|NCT01342081|266070|P2|Overall Study|Adverse Event|0
67451|NCT01342081|266071|P1|Overall Study|Adverse Event|1
67452|NCT01342081|266069|P3|Overall Study|Did not receive allocated intervention|1
67453|NCT01342081|266070|P2|Overall Study|Did not receive allocated intervention|0
67454|NCT01342081|266071|P1|Overall Study|Did not receive allocated intervention|0
67455|NCT01341990|266090|P2|Overall Study|Withdrawal by Subject|0
67456|NCT01341990|266091|P1|Overall Study|Withdrawal by Subject|2
67457|NCT01341990|266090|P2|Overall Study|Torn Study Lens|0
67458|NCT01341990|266091|P1|Overall Study|Torn Study Lens|1
67459|NCT01341990|266090|P2|Overall Study|Adverse Event|1
67460|NCT01341990|266091|P1|Overall Study|Adverse Event|0
67461|NCT01341782|266115|P2|Overall Study|Other|0
67462|NCT01341782|266116|P1|Overall Study|Other|5
67463|NCT01341782|266115|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
67464|NCT01341782|266116|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
67465|NCT01341782|266115|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
67466|NCT01341782|266116|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
67467|NCT01341782|266115|P2|Overall Study|Missed 3 consecutive doses|4
67468|NCT01341782|266116|P1|Overall Study|Missed 3 consecutive doses|0
67469|NCT01341782|266115|P2|Overall Study|Withdrawal by Subject|5
67470|NCT01341782|266116|P1|Overall Study|Withdrawal by Subject|6
67471|NCT01341782|266115|P2|Overall Study|Adverse Event|1
67472|NCT01341782|266116|P1|Overall Study|Adverse Event|1
67473|NCT01341587|266156|P2|Overall Study|stopped using the meters|10
67474|NCT01341587|266157|P1|Overall Study|stopped using the meters|2
67475|NCT01341587|266156|P2|Overall Study|Lost to Follow-up|0
67476|NCT01341587|266157|P1|Overall Study|Lost to Follow-up|2
67477|NCT01340937|266190|P4|Period 3: Toddler Vaccinations|Technical problem|0
67478|NCT01340937|266191|P3|Period 3: Toddler Vaccinations|Technical problem|1
67479|NCT01340937|266192|P2|Period 3: Toddler Vaccinations|Technical problem|1
67480|NCT01340937|266193|P1|Period 3: Toddler Vaccinations|Technical problem|1
67481|NCT01340937|266190|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
67482|NCT01340937|266191|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
67483|NCT01340937|266192|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
67484|NCT01340937|266193|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
67485|NCT01340937|266190|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
67486|NCT01340937|266191|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
67487|NCT01340937|266192|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
67488|NCT01340937|266193|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
67489|NCT01340937|266190|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
67490|NCT01340937|266191|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
67491|NCT01340937|266192|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
67492|NCT01340937|266193|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
67493|NCT01340937|266190|P4|Period 2: Interim Period|Technical problems|3
67494|NCT01340937|266191|P3|Period 2: Interim Period|Technical problems|6
67495|NCT01340937|266192|P2|Period 2: Interim Period|Technical problems|4
67496|NCT01340937|266193|P1|Period 2: Interim Period|Technical problems|4
67497|NCT01340937|266190|P4|Period 2: Interim Period|Protocol Violation|3
67498|NCT01340937|266191|P3|Period 2: Interim Period|Protocol Violation|6
67499|NCT01340937|266192|P2|Period 2: Interim Period|Protocol Violation|3
67500|NCT01340937|266193|P1|Period 2: Interim Period|Protocol Violation|5
67501|NCT01340937|266190|P4|Period 2: Interim Period|Physician Decision|0
67502|NCT01340937|266191|P3|Period 2: Interim Period|Physician Decision|1
67503|NCT01340937|266192|P2|Period 2: Interim Period|Physician Decision|1
67504|NCT01340937|266193|P1|Period 2: Interim Period|Physician Decision|0
67505|NCT01340937|266190|P4|Period 2: Interim Period|Lost to Follow-up|23
67506|NCT01340937|266191|P3|Period 2: Interim Period|Lost to Follow-up|53
67507|NCT01340937|266192|P2|Period 2: Interim Period|Lost to Follow-up|48
67508|NCT01340937|266193|P1|Period 2: Interim Period|Lost to Follow-up|29
67509|NCT01340937|266190|P4|Period 2: Interim Period|Adverse Event|0
67510|NCT01340937|266191|P3|Period 2: Interim Period|Adverse Event|1
67511|NCT01340937|266192|P2|Period 2: Interim Period|Adverse Event|0
67512|NCT01340937|266193|P1|Period 2: Interim Period|Adverse Event|1
67513|NCT01340937|266190|P4|Period 2: Interim Period|Withdrawal by Subject|12
67514|NCT01340937|266191|P3|Period 2: Interim Period|Withdrawal by Subject|17
67515|NCT01340937|266192|P2|Period 2: Interim Period|Withdrawal by Subject|23
67516|NCT01340937|266193|P1|Period 2: Interim Period|Withdrawal by Subject|28
67517|NCT01340937|266190|P4|Period 1: Infant Series|Randomized but not vaccinated|1
67518|NCT01340937|266191|P3|Period 1: Infant Series|Randomized but not vaccinated|2
67519|NCT01340937|266192|P2|Period 1: Infant Series|Randomized but not vaccinated|5
67520|NCT01340937|266193|P1|Period 1: Infant Series|Randomized but not vaccinated|0
67521|NCT01340937|266190|P4|Period 1: Infant Series|Withdrawal by Subject|15
67522|NCT01340937|266191|P3|Period 1: Infant Series|Withdrawal by Subject|30
67523|NCT01340937|266192|P2|Period 1: Infant Series|Withdrawal by Subject|32
67524|NCT01340937|266193|P1|Period 1: Infant Series|Withdrawal by Subject|33
67525|NCT01340937|266190|P4|Period 1: Infant Series|Protocol Violation|3
67526|NCT01340937|266191|P3|Period 1: Infant Series|Protocol Violation|4
67527|NCT01340937|266192|P2|Period 1: Infant Series|Protocol Violation|4
67528|NCT01340937|266193|P1|Period 1: Infant Series|Protocol Violation|1
67529|NCT01340937|266190|P4|Period 1: Infant Series|Physician Decision|0
67530|NCT01340937|266191|P3|Period 1: Infant Series|Physician Decision|1
67531|NCT01340937|266192|P2|Period 1: Infant Series|Physician Decision|3
67532|NCT01340937|266193|P1|Period 1: Infant Series|Physician Decision|2
67533|NCT01340937|266190|P4|Period 1: Infant Series|Lost to Follow-up|13
67534|NCT01340937|266191|P3|Period 1: Infant Series|Lost to Follow-up|12
67535|NCT01340937|266192|P2|Period 1: Infant Series|Lost to Follow-up|14
67536|NCT01340937|266193|P1|Period 1: Infant Series|Lost to Follow-up|20
67537|NCT01340937|266190|P4|Period 1: Infant Series|Death|0
67538|NCT01340937|266191|P3|Period 1: Infant Series|Death|2
67539|NCT01340937|266192|P2|Period 1: Infant Series|Death|0
67540|NCT01340937|266193|P1|Period 1: Infant Series|Death|2
67541|NCT01340937|266190|P4|Period 1: Infant Series|Adverse Event|0
67542|NCT01340937|266191|P3|Period 1: Infant Series|Adverse Event|4
67543|NCT01340937|266192|P2|Period 1: Infant Series|Adverse Event|1
67544|NCT01340937|266193|P1|Period 1: Infant Series|Adverse Event|0
67545|NCT01340937|266190|P4|Period 1: Infant Series|Other protocol criterion not met|0
67546|NCT01340937|266191|P3|Period 1: Infant Series|Other protocol criterion not met|1
67547|NCT01340937|266192|P2|Period 1: Infant Series|Other protocol criterion not met|1
67548|NCT01340937|266193|P1|Period 1: Infant Series|Other protocol criterion not met|0
67549|NCT01340794|266352|P2|Overall Study|Withdrawal by Subject|1
67550|NCT01340794|266353|P1|Overall Study|Withdrawal by Subject|0
67551|NCT01340768|266369|P2|Overall Study|Other|0
67552|NCT01340768|266370|P1|Overall Study|Other|2
67553|NCT01340768|266369|P2|Overall Study|Withdrawal by Subject|1
67554|NCT01340768|266370|P1|Overall Study|Withdrawal by Subject|5
67555|NCT01340768|266369|P2|Overall Study|Lost to Follow-up|4
67556|NCT01340768|266370|P1|Overall Study|Lost to Follow-up|10
67557|NCT01340664|266381|P3|Overall Study|Not specified|2
67558|NCT01340664|266382|P2|Overall Study|Not specified|2
67559|NCT01340664|266383|P1|Overall Study|Not specified|1
67560|NCT01340664|266381|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
67561|NCT01340664|266382|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
67562|NCT01340664|266383|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
67563|NCT01340664|266381|P3|Overall Study|Glycemic withdrawal criteria|0
67564|NCT01340664|266382|P2|Overall Study|Glycemic withdrawal criteria|0
67565|NCT01340664|266383|P1|Overall Study|Glycemic withdrawal criteria|2
67566|NCT01340664|266381|P3|Overall Study|Withdrawal by Subject|0
67567|NCT01340664|266382|P2|Overall Study|Withdrawal by Subject|4
67568|NCT01340664|266383|P1|Overall Study|Withdrawal by Subject|2
67569|NCT01340664|266381|P3|Overall Study|Lost to Follow-up|2
67570|NCT01340664|266382|P2|Overall Study|Lost to Follow-up|0
67571|NCT01340664|266383|P1|Overall Study|Lost to Follow-up|2
67572|NCT01340664|266381|P3|Overall Study|Adverse Event|7
67573|NCT01340664|266382|P2|Overall Study|Adverse Event|1
67574|NCT01340664|266383|P1|Overall Study|Adverse Event|0
67575|NCT01340651|266400|P1|Overall Study|Commercial Supply per Sponsor|12
67576|NCT01340651|266400|P1|Overall Study|Consent Withdrawn|2
67577|NCT01340651|266400|P1|Overall Study|Adverse Event|3
67578|NCT01340625|266416|P2|Washout Period of 28 Days|Withdrawal by Subject|0
67579|NCT01340625|266417|P1|Washout Period of 28 Days|Withdrawal by Subject|1
67580|NCT01340625|266416|P2|First Intervention|Adverse Event|0
67581|NCT01340625|266417|P1|First Intervention|Adverse Event|1
67582|NCT01340495|266522|P1|Overall Study|Withdrawal by Subject|1
67583|NCT01340300|266532|P4|Overall Study|Unrelated sickness, moving|1
67584|NCT01340300|266533|P3|Overall Study|Unrelated sickness, moving|0
67585|NCT01340300|266534|P2|Overall Study|Unrelated sickness, moving|2
67586|NCT01340300|266535|P1|Overall Study|Unrelated sickness, moving|1
67587|NCT01340300|266532|P4|Overall Study|Physician Decision|0
67588|NCT01340300|266533|P3|Overall Study|Physician Decision|1
67589|NCT01340300|266534|P2|Overall Study|Physician Decision|1
67590|NCT01340300|266535|P1|Overall Study|Physician Decision|2
67591|NCT01340300|266532|P4|Overall Study|Adverse Event|0
67592|NCT01340300|266533|P3|Overall Study|Adverse Event|2
67593|NCT01340300|266534|P2|Overall Study|Adverse Event|0
67594|NCT01340300|266535|P1|Overall Study|Adverse Event|0
67595|NCT01340300|266532|P4|Overall Study|Withdrawal by Subject|3
67596|NCT01340300|266533|P3|Overall Study|Withdrawal by Subject|6
67597|NCT01340300|266534|P2|Overall Study|Withdrawal by Subject|8
67598|NCT01340300|266535|P1|Overall Study|Withdrawal by Subject|5
67599|NCT01340300|266532|P4|Overall Study|Lost to Follow-up|17
67600|NCT01340300|266533|P3|Overall Study|Lost to Follow-up|12
67601|NCT01340300|266534|P2|Overall Study|Lost to Follow-up|3
67602|NCT01340300|266535|P1|Overall Study|Lost to Follow-up|7
67603|NCT01340209|266568|P3|Overall Study|Other reason not defined above|4
67604|NCT01340209|266569|P2|Overall Study|Other reason not defined above|5
67605|NCT01340209|266570|P1|Overall Study|Other reason not defined above|3
67606|NCT01340209|266568|P3|Overall Study|Withdrawal by Subject|1
67607|NCT01340209|266569|P2|Overall Study|Withdrawal by Subject|0
67608|NCT01340209|266570|P1|Overall Study|Withdrawal by Subject|0
67609|NCT01340209|266568|P3|Overall Study|Protocol Violation|1
67610|NCT01340209|266569|P2|Overall Study|Protocol Violation|2
67611|NCT01340209|266570|P1|Overall Study|Protocol Violation|1
67612|NCT01340209|266568|P3|Overall Study|Adverse Event|2
67613|NCT01340209|266569|P2|Overall Study|Adverse Event|1
67614|NCT01340209|266570|P1|Overall Study|Adverse Event|1
67615|NCT01340196|266605|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
67616|NCT01340066|266645|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
67617|NCT01340066|266646|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
67618|NCT01340066|266647|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
67619|NCT01340066|266645|P3|5 Week Double Blind Randomization Period|Physician Decision|0
67620|NCT01340066|266646|P2|5 Week Double Blind Randomization Period|Physician Decision|1
67621|NCT01340066|266647|P1|5 Week Double Blind Randomization Period|Physician Decision|0
67622|NCT01340066|266645|P3|5 Week Double Blind Randomization Period|Adverse Event|2
67623|NCT01340066|266646|P2|5 Week Double Blind Randomization Period|Adverse Event|2
67624|NCT01340066|266647|P1|5 Week Double Blind Randomization Period|Adverse Event|0
67625|NCT01340066|266645|P3|Placebo Run in Period|Screen Failures|0
67626|NCT01340066|266646|P2|Placebo Run in Period|Screen Failures|0
67627|NCT01340066|266647|P1|Placebo Run in Period|Screen Failures|27
67628|NCT01340027|266666|P12|Overall Study|Miscellaneous|0
67629|NCT01340027|266667|P11|Overall Study|Miscellaneous|1
67630|NCT01340027|266668|P10|Overall Study|Miscellaneous|0
67631|NCT01340027|266669|P9|Overall Study|Miscellaneous|0
67632|NCT01340027|266670|P8|Overall Study|Miscellaneous|0
67633|NCT01340027|266671|P7|Overall Study|Miscellaneous|0
67634|NCT01340027|266672|P6|Overall Study|Miscellaneous|0
67635|NCT01340027|266673|P5|Overall Study|Miscellaneous|0
67636|NCT01340027|266674|P4|Overall Study|Miscellaneous|1
67637|NCT01340027|266675|P3|Overall Study|Miscellaneous|0
67638|NCT01340027|266676|P2|Overall Study|Miscellaneous|0
67639|NCT01340027|266677|P1|Overall Study|Miscellaneous|0
67640|NCT01340027|266666|P12|Overall Study|Withdrawal by Subject|1
67641|NCT01340027|266667|P11|Overall Study|Withdrawal by Subject|0
67642|NCT01340027|266668|P10|Overall Study|Withdrawal by Subject|2
67643|NCT01340027|266669|P9|Overall Study|Withdrawal by Subject|1
67644|NCT01340027|266670|P8|Overall Study|Withdrawal by Subject|4
67645|NCT01340027|266671|P7|Overall Study|Withdrawal by Subject|3
67646|NCT01340027|266672|P6|Overall Study|Withdrawal by Subject|2
67647|NCT01340027|266673|P5|Overall Study|Withdrawal by Subject|3
67648|NCT01340027|266674|P4|Overall Study|Withdrawal by Subject|3
67649|NCT01340027|266675|P3|Overall Study|Withdrawal by Subject|1
67650|NCT01340027|266676|P2|Overall Study|Withdrawal by Subject|3
67651|NCT01340027|266677|P1|Overall Study|Withdrawal by Subject|4
67652|NCT01340027|266666|P12|Overall Study|Protocol Violation|0
67653|NCT01340027|266667|P11|Overall Study|Protocol Violation|0
67654|NCT01340027|266668|P10|Overall Study|Protocol Violation|2
67655|NCT01340027|266669|P9|Overall Study|Protocol Violation|2
67656|NCT01340027|266670|P8|Overall Study|Protocol Violation|1
67657|NCT01340027|266671|P7|Overall Study|Protocol Violation|0
67658|NCT01340027|266672|P6|Overall Study|Protocol Violation|0
67659|NCT01340027|266673|P5|Overall Study|Protocol Violation|6
67660|NCT01340027|266674|P4|Overall Study|Protocol Violation|0
67661|NCT01340027|266675|P3|Overall Study|Protocol Violation|0
67662|NCT01340027|266676|P2|Overall Study|Protocol Violation|2
67663|NCT01340027|266677|P1|Overall Study|Protocol Violation|1
67664|NCT01340027|266666|P12|Overall Study|Lost to Follow-up|0
67665|NCT01340027|266667|P11|Overall Study|Lost to Follow-up|0
67666|NCT01340027|266668|P10|Overall Study|Lost to Follow-up|1
67667|NCT01340027|266669|P9|Overall Study|Lost to Follow-up|0
67668|NCT01340027|266670|P8|Overall Study|Lost to Follow-up|0
67669|NCT01340027|266671|P7|Overall Study|Lost to Follow-up|1
67670|NCT01340027|266672|P6|Overall Study|Lost to Follow-up|0
67671|NCT01340027|266673|P5|Overall Study|Lost to Follow-up|0
67672|NCT01340027|266674|P4|Overall Study|Lost to Follow-up|0
67673|NCT01340027|266675|P3|Overall Study|Lost to Follow-up|0
67674|NCT01340027|266676|P2|Overall Study|Lost to Follow-up|1
67675|NCT01340027|266677|P1|Overall Study|Lost to Follow-up|0
67676|NCT01340027|266666|P12|Overall Study|Lack of Efficacy|0
67677|NCT01340027|266667|P11|Overall Study|Lack of Efficacy|0
67678|NCT01340027|266668|P10|Overall Study|Lack of Efficacy|0
67679|NCT01340027|266669|P9|Overall Study|Lack of Efficacy|1
67680|NCT01340027|266670|P8|Overall Study|Lack of Efficacy|1
67681|NCT01340027|266671|P7|Overall Study|Lack of Efficacy|1
67682|NCT01340027|266672|P6|Overall Study|Lack of Efficacy|0
67683|NCT01340027|266673|P5|Overall Study|Lack of Efficacy|0
67684|NCT01340027|266674|P4|Overall Study|Lack of Efficacy|0
67685|NCT01340027|266675|P3|Overall Study|Lack of Efficacy|0
67686|NCT01340027|266676|P2|Overall Study|Lack of Efficacy|0
67687|NCT01340027|266677|P1|Overall Study|Lack of Efficacy|0
67688|NCT01340027|266666|P12|Overall Study|Adverse Event|3
67689|NCT01340027|266667|P11|Overall Study|Adverse Event|1
67690|NCT01340027|266668|P10|Overall Study|Adverse Event|1
67691|NCT01340027|266669|P9|Overall Study|Adverse Event|4
67692|NCT01340027|266670|P8|Overall Study|Adverse Event|1
67693|NCT01340027|266671|P7|Overall Study|Adverse Event|2
67694|NCT01340027|266672|P6|Overall Study|Adverse Event|2
67695|NCT01340027|266673|P5|Overall Study|Adverse Event|1
67696|NCT01340027|266674|P4|Overall Study|Adverse Event|0
67697|NCT01340027|266675|P3|Overall Study|Adverse Event|2
67698|NCT01340027|266676|P2|Overall Study|Adverse Event|1
67699|NCT01340027|266677|P1|Overall Study|Adverse Event|0
67700|NCT01340027|266666|P12|Overall Study|Randomized but Never Received Study Drug|0
67701|NCT01340027|266667|P11|Overall Study|Randomized but Never Received Study Drug|0
67702|NCT01340027|266668|P10|Overall Study|Randomized but Never Received Study Drug|0
67703|NCT01340027|266669|P9|Overall Study|Randomized but Never Received Study Drug|0
67704|NCT01340027|266670|P8|Overall Study|Randomized but Never Received Study Drug|0
67705|NCT01340027|266671|P7|Overall Study|Randomized but Never Received Study Drug|0
67706|NCT01340027|266672|P6|Overall Study|Randomized but Never Received Study Drug|0
67707|NCT01340027|266673|P5|Overall Study|Randomized but Never Received Study Drug|0
67708|NCT01340027|266674|P4|Overall Study|Randomized but Never Received Study Drug|0
67709|NCT01340027|266675|P3|Overall Study|Randomized but Never Received Study Drug|1
67710|NCT01340027|266676|P2|Overall Study|Randomized but Never Received Study Drug|0
67711|NCT01340027|266677|P1|Overall Study|Randomized but Never Received Study Drug|0
67712|NCT01340014|267053|P2|Period 2, Second 7 Days|Adverse Event|1
67713|NCT01340014|267054|P1|Period 2, Second 7 Days|Adverse Event|0
67714|NCT01340014|267053|P2|Period 1, First 7 Days|Personal Reasons|0
67715|NCT01340014|267054|P1|Period 1, First 7 Days|Personal Reasons|1
67716|NCT01340014|267053|P2|Period 1, First 7 Days|Adverse Event|0
67717|NCT01340014|267054|P1|Period 1, First 7 Days|Adverse Event|1
67718|NCT01339923|267075|P7|Overall Study|Withdrawal by Subject|2
67719|NCT01339923|267076|P6|Overall Study|Withdrawal by Subject|3
67720|NCT01339923|267077|P5|Overall Study|Withdrawal by Subject|4
67721|NCT01339923|267078|P4|Overall Study|Withdrawal by Subject|1
67722|NCT01339923|267079|P3|Overall Study|Withdrawal by Subject|6
67723|NCT01339923|267080|P2|Overall Study|Withdrawal by Subject|11
67724|NCT01339923|267081|P1|Overall Study|Withdrawal by Subject|7
67725|NCT01339923|267075|P7|Overall Study|Unable to Classify|5
67726|NCT01339923|267076|P6|Overall Study|Unable to Classify|1
67727|NCT01339923|267077|P5|Overall Study|Unable to Classify|0
67728|NCT01339923|267078|P4|Overall Study|Unable to Classify|0
67729|NCT01339923|267079|P3|Overall Study|Unable to Classify|1
67730|NCT01339923|267080|P2|Overall Study|Unable to Classify|0
67731|NCT01339923|267081|P1|Overall Study|Unable to Classify|1
67732|NCT01339923|267075|P7|Overall Study|Protocol Violation|1
67733|NCT01339923|267076|P6|Overall Study|Protocol Violation|3
67734|NCT01339923|267077|P5|Overall Study|Protocol Violation|0
67735|NCT01339923|267078|P4|Overall Study|Protocol Violation|0
67736|NCT01339923|267079|P3|Overall Study|Protocol Violation|0
67737|NCT01339923|267080|P2|Overall Study|Protocol Violation|0
67738|NCT01339923|267081|P1|Overall Study|Protocol Violation|0
67739|NCT01339923|267075|P7|Overall Study|Lost to Follow-up|5
67740|NCT01339923|267076|P6|Overall Study|Lost to Follow-up|1
67741|NCT01339923|267077|P5|Overall Study|Lost to Follow-up|1
67742|NCT01339923|267078|P4|Overall Study|Lost to Follow-up|3
67743|NCT01339923|267079|P3|Overall Study|Lost to Follow-up|0
67744|NCT01339923|267080|P2|Overall Study|Lost to Follow-up|4
67745|NCT01339923|267081|P1|Overall Study|Lost to Follow-up|4
67746|NCT01339923|267075|P7|Overall Study|Inappropriate Enrollment|0
67747|NCT01339923|267076|P6|Overall Study|Inappropriate Enrollment|1
67748|NCT01339923|267077|P5|Overall Study|Inappropriate Enrollment|0
67749|NCT01339923|267078|P4|Overall Study|Inappropriate Enrollment|0
67750|NCT01339923|267079|P3|Overall Study|Inappropriate Enrollment|0
67751|NCT01339923|267080|P2|Overall Study|Inappropriate Enrollment|0
67752|NCT01339923|267081|P1|Overall Study|Inappropriate Enrollment|1
67753|NCT01339923|267075|P7|Overall Study|Adverse Event|1
67754|NCT01339923|267076|P6|Overall Study|Adverse Event|0
67755|NCT01339923|267077|P5|Overall Study|Adverse Event|0
67756|NCT01339923|267078|P4|Overall Study|Adverse Event|0
67757|NCT01339923|267079|P3|Overall Study|Adverse Event|1
67758|NCT01339923|267080|P2|Overall Study|Adverse Event|1
67759|NCT01339923|267081|P1|Overall Study|Adverse Event|1
67760|NCT01339910|267152|P2|Overall Study|Disease relapse|4
67761|NCT01339910|267153|P1|Overall Study|Disease relapse|1
67762|NCT01339910|267152|P2|Overall Study|Physician Decision|0
67763|NCT01339910|267153|P1|Overall Study|Physician Decision|1
67764|NCT01339910|267152|P2|Overall Study|Withdrawal by Subject|0
67765|NCT01339910|267153|P1|Overall Study|Withdrawal by Subject|1
67766|NCT01339897|267191|P4|Overall Study|Adverse Event|1
67767|NCT01339897|267192|P3|Overall Study|Adverse Event|0
67768|NCT01339897|267193|P2|Overall Study|Adverse Event|0
67769|NCT01339897|267194|P1|Overall Study|Adverse Event|1
67770|NCT01339832|267220|P1|Overall Study|Death|11
67771|NCT01339832|267220|P1|Overall Study|Lost to Follow-up|3
67772|NCT01339429|267231|P1|Overall Study|Physician Decision|3
67773|NCT01339429|267231|P1|Overall Study|Withdrawal by Subject|1
67774|NCT01339390|267271|P2|Overall Study|Lost to Follow-up|127
67775|NCT01339390|267272|P1|Overall Study|Lost to Follow-up|125
67776|NCT01339390|267271|P2|Overall Study|Death|29
67777|NCT01339390|267272|P1|Overall Study|Death|32
67778|NCT01339052|267330|P2|Overall Study|Physician Decision|0
67779|NCT01339052|267331|P1|Overall Study|Physician Decision|1
67780|NCT01339052|267330|P2|Overall Study|Withdrawal by Subject|3
67781|NCT01339052|267331|P1|Overall Study|Withdrawal by Subject|0
67782|NCT01339052|267330|P2|Overall Study|Adverse Event|1
67783|NCT01339052|267331|P1|Overall Study|Adverse Event|1
67784|NCT01339052|267330|P2|Overall Study|Disease progression|46
67785|NCT01339052|267331|P1|Overall Study|Disease progression|13
67786|NCT01339000|267357|P2|Overall Study|study closed due to lack of drug supply|0
67787|NCT01339000|267358|P1|Overall Study|study closed due to lack of drug supply|1
67788|NCT01338870|267378|P6|Overall Study|Adverse Event|1
67789|NCT01338870|267379|P5|Overall Study|Adverse Event|4
67790|NCT01338870|267380|P4|Overall Study|Adverse Event|5
67791|NCT01338870|267381|P3|Overall Study|Adverse Event|1
67792|NCT01338870|267382|P2|Overall Study|Adverse Event|4
67793|NCT01338870|267383|P1|Overall Study|Adverse Event|4
67794|NCT01338870|267378|P6|Overall Study|Protocol Violation|1
67795|NCT01338870|267379|P5|Overall Study|Protocol Violation|1
67796|NCT01338870|267380|P4|Overall Study|Protocol Violation|2
67797|NCT01338870|267381|P3|Overall Study|Protocol Violation|2
67798|NCT01338870|267382|P2|Overall Study|Protocol Violation|2
67799|NCT01338870|267383|P1|Overall Study|Protocol Violation|0
67800|NCT01338870|267378|P6|Overall Study|Other|2
67801|NCT01338870|267379|P5|Overall Study|Other|0
67802|NCT01338870|267380|P4|Overall Study|Other|2
67803|NCT01338870|267381|P3|Overall Study|Other|3
67804|NCT01338870|267382|P2|Overall Study|Other|3
67805|NCT01338870|267383|P1|Overall Study|Other|3
67806|NCT01338870|267378|P6|Overall Study|Withdrawal by Subject|2
67807|NCT01338870|267379|P5|Overall Study|Withdrawal by Subject|0
67808|NCT01338870|267380|P4|Overall Study|Withdrawal by Subject|0
67809|NCT01338870|267381|P3|Overall Study|Withdrawal by Subject|4
67810|NCT01338870|267382|P2|Overall Study|Withdrawal by Subject|3
67811|NCT01338870|267383|P1|Overall Study|Withdrawal by Subject|2
67812|NCT01338870|267378|P6|Overall Study|Lost to Follow-up|0
67813|NCT01338870|267379|P5|Overall Study|Lost to Follow-up|1
67814|NCT01338870|267380|P4|Overall Study|Lost to Follow-up|0
67815|NCT01338870|267381|P3|Overall Study|Lost to Follow-up|1
67816|NCT01338870|267382|P2|Overall Study|Lost to Follow-up|0
67817|NCT01338870|267383|P1|Overall Study|Lost to Follow-up|0
67818|NCT01338818|267438|P1|Overall Study|Protocol Deviation|4
67819|NCT01338818|267438|P1|Overall Study|Administrative problems|3
67820|NCT01338818|267438|P1|Overall Study|Lost to Follow-up|4
67821|NCT01338818|267438|P1|Overall Study|Withdrawal by Subject|11
67822|NCT01338818|267438|P1|Overall Study|no longer require study drug|1
67823|NCT01338818|267438|P1|Overall Study|Lack of Efficacy|5
67824|NCT01338818|267438|P1|Overall Study|Adverse Event|8
67825|NCT01338792|267444|P1|Overall Study|Withdrawal by Subject|1
67826|NCT01338792|267444|P1|Overall Study|Death|1
67827|NCT01338792|267444|P1|Overall Study|Adverse Event|2
67828|NCT01338636|267459|P1|Overall Study|Withdrawn due to lack of improvement|8
67829|NCT01338610|267473|P3|Overall Study|Adverse Event|0
67830|NCT01338610|267474|P2|Overall Study|Adverse Event|0
67831|NCT01338610|267475|P1|Overall Study|Adverse Event|3
67832|NCT01338610|267473|P3|Overall Study|Protocol Violation|1
67833|NCT01338610|267474|P2|Overall Study|Protocol Violation|0
67834|NCT01338610|267475|P1|Overall Study|Protocol Violation|1
67835|NCT01338610|267473|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
67836|NCT01338610|267474|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
67837|NCT01338610|267475|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
67838|NCT01338493|267482|P1|12 Months Follow up|Lost to Follow-up|9
67839|NCT01338493|267482|P1|6 Months Follow up|Missed visit|8
67840|NCT01338493|267482|P1|6 Months Follow up|Lost to Follow-up|11
67841|NCT01338493|267482|P1|Discharge|Missed visit|1
67842|NCT01338493|267482|P1|Discharge|Death|1
67843|NCT01338493|267482|P1|Enrolled|Patient not implanted|4
67844|NCT01338493|267482|P1|Enrolled|Withdrawal by Subject|1
67845|NCT01338415|267489|P2|Overall Study|Other (administrative reason)|0
67846|NCT01338415|267490|P1|Overall Study|Other (administrative reason)|1
67847|NCT01338415|267489|P2|Overall Study|Other (PAH not the main etiology of PH)|2
67848|NCT01338415|267490|P1|Overall Study|Other (PAH not the main etiology of PH)|0
67849|NCT01338415|267489|P2|Overall Study|Withdrawal by Subject|1
67850|NCT01338415|267490|P1|Overall Study|Withdrawal by Subject|1
67851|NCT01338415|267489|P2|Overall Study|Adverse Event|6
67852|NCT01338415|267490|P1|Overall Study|Adverse Event|8
67853|NCT01338298|267512|P2|Overall Study|Non-adherence|0
67854|NCT01338298|267513|P1|Overall Study|Non-adherence|1
67855|NCT01338298|267512|P2|Overall Study|Depressive symptoms and nausea|0
67856|NCT01338298|267513|P1|Overall Study|Depressive symptoms and nausea|1
67857|NCT01338298|267512|P2|Overall Study|Positive symptom worsening|0
67858|NCT01338298|267513|P1|Overall Study|Positive symptom worsening|1
67859|NCT01338298|267512|P2|Overall Study|Administrative error|1
67860|NCT01338298|267513|P1|Overall Study|Administrative error|0
67861|NCT01338298|267512|P2|Overall Study|Abdominal Pain and scheduled surgery|1
67948|NCT01336972|267818|P2|Overall Study|Adverse Event|1
67862|NCT01338298|267513|P1|Overall Study|Abdominal Pain and scheduled surgery|0
67863|NCT01338298|267512|P2|Overall Study|Withdrawal by Subject|1
67864|NCT01338298|267513|P1|Overall Study|Withdrawal by Subject|1
67865|NCT01338025|267523|P2|Overall Study|Found ineligible after starting|0
67866|NCT01338025|267524|P1|Overall Study|Found ineligible after starting|1
67867|NCT01338025|267523|P2|Overall Study|Withdrawal by Subject|2
67868|NCT01338025|267524|P1|Overall Study|Withdrawal by Subject|0
67869|NCT01338025|267523|P2|Overall Study|Unexpected closure of study|9
67870|NCT01338025|267524|P1|Overall Study|Unexpected closure of study|10
67871|NCT01338012|267536|P1|Overall Study|Study terminated|4
67872|NCT01338012|267536|P1|Overall Study|Death|4
67873|NCT01337960|267543|P3|Overall Study|Withdrawal by Subject|0
67874|NCT01337960|267544|P2|Overall Study|Withdrawal by Subject|0
67875|NCT01337960|267545|P1|Overall Study|Withdrawal by Subject|1
67876|NCT01337960|267543|P3|Overall Study|Lost to Follow-up|0
67877|NCT01337960|267544|P2|Overall Study|Lost to Follow-up|0
67878|NCT01337960|267545|P1|Overall Study|Lost to Follow-up|1
67879|NCT01337674|267578|P4|Treatment Period 2|Withdrawal by Subject|0
67880|NCT01337674|267579|P3|Treatment Period 2|Withdrawal by Subject|1
67881|NCT01337674|267580|P2|Treatment Period 2|Withdrawal by Subject|0
67882|NCT01337674|267581|P1|Treatment Period 2|Withdrawal by Subject|0
67883|NCT01337674|267578|P4|Treatment Period 1|Discontinued due to blood draws|1
67884|NCT01337674|267579|P3|Treatment Period 1|Discontinued due to blood draws|0
67885|NCT01337674|267580|P2|Treatment Period 1|Discontinued due to blood draws|0
67886|NCT01337674|267581|P1|Treatment Period 1|Discontinued due to blood draws|0
67887|NCT01337674|267578|P4|Treatment Period 1|Adverse Event|0
67888|NCT01337674|267579|P3|Treatment Period 1|Adverse Event|0
67889|NCT01337674|267580|P2|Treatment Period 1|Adverse Event|1
67890|NCT01337674|267581|P1|Treatment Period 1|Adverse Event|0
67891|NCT01337635|267599|P2|Overall Study|Lost to Follow-up|1
67892|NCT01337635|267600|P1|Overall Study|Lost to Follow-up|0
67893|NCT01337297|267648|P2|Overall Study|Lost to Follow-up|3
67894|NCT01337297|267649|P1|Overall Study|Lost to Follow-up|1
67895|NCT01337297|267648|P2|Overall Study|They entered to single anodal tDCS|3
67896|NCT01337297|267649|P1|Overall Study|They entered to single anodal tDCS|4
67897|NCT01337167|267657|P2|Toddler Vaccinations|Withdrawal by Subject|0
67898|NCT01337167|267658|P1|Toddler Vaccinations|Withdrawal by Subject|3
67899|NCT01337167|267657|P2|Toddler Vaccinations|Protocol Violation|1
67900|NCT01337167|267658|P1|Toddler Vaccinations|Protocol Violation|0
67901|NCT01337167|267657|P2|Toddler Vaccinations|Lost to Follow-up|12
67902|NCT01337167|267658|P1|Toddler Vaccinations|Lost to Follow-up|11
67903|NCT01337167|267657|P2|Interim Period|Other protocol criterion not met|1
67904|NCT01337167|267658|P1|Interim Period|Other protocol criterion not met|0
67905|NCT01337167|267657|P2|Interim Period|Withdrawal by Subject|10
67906|NCT01337167|267658|P1|Interim Period|Withdrawal by Subject|18
67907|NCT01337167|267657|P2|Interim Period|Protocol Violation|3
67908|NCT01337167|267658|P1|Interim Period|Protocol Violation|5
67909|NCT01337167|267657|P2|Interim Period|Physician Decision|3
67910|NCT01337167|267658|P1|Interim Period|Physician Decision|6
67911|NCT01337167|267657|P2|Interim Period|Non-compliance with study drug|0
67912|NCT01337167|267658|P1|Interim Period|Non-compliance with study drug|1
67913|NCT01337167|267657|P2|Interim Period|Lost to Follow-up|23
67914|NCT01337167|267658|P1|Interim Period|Lost to Follow-up|51
67915|NCT01337167|267657|P2|Infant Series|Randomized but not vaccinated|3
67916|NCT01337167|267658|P1|Infant Series|Randomized but not vaccinated|5
67917|NCT01337167|267657|P2|Infant Series|Withdrawal by Subject|4
67918|NCT01337167|267658|P1|Infant Series|Withdrawal by Subject|15
67919|NCT01337167|267657|P2|Infant Series|Protocol Violation|9
67920|NCT01337167|267658|P1|Infant Series|Protocol Violation|22
67921|NCT01337167|267657|P2|Infant Series|Physician Decision|1
67922|NCT01337167|267658|P1|Infant Series|Physician Decision|3
67923|NCT01337167|267657|P2|Infant Series|Non-compliance with study drug|1
67924|NCT01337167|267658|P1|Infant Series|Non-compliance with study drug|2
67925|NCT01337167|267657|P2|Infant Series|Lost to Follow-up|7
67926|NCT01337167|267658|P1|Infant Series|Lost to Follow-up|13
67927|NCT01337167|267657|P2|Infant Series|Death|1
67928|NCT01337167|267658|P1|Infant Series|Death|1
67929|NCT01337167|267657|P2|Infant Series|Adverse Event|1
67930|NCT01337167|267658|P1|Infant Series|Adverse Event|1
67931|NCT01337115|267726|P2|Overall Study|Protocol Violation|0
67932|NCT01337115|267727|P1|Overall Study|Protocol Violation|2
67933|NCT01337089|267739|P1|Overall Study|Lost to Follow-up|2
67934|NCT01337089|267739|P1|Overall Study|Met Withdrawal Criteria|3
67935|NCT01337089|267739|P1|Overall Study|Withdrawal by Investigator|33
67936|NCT01337089|267739|P1|Overall Study|Withdrawal by Subject|129
67937|NCT01337089|267739|P1|Overall Study|Adverse Event|237
67938|NCT01337050|267754|P3|Overall Study|Participants refused further follow-up|7
67939|NCT01337050|267755|P2|Overall Study|Participants refused further follow-up|7
67940|NCT01337050|267756|P1|Overall Study|Participants refused further follow-up|0
67941|NCT01337050|267754|P3|Overall Study|Other|8
67942|NCT01337050|267755|P2|Overall Study|Other|6
67943|NCT01337050|267756|P1|Overall Study|Other|4
67944|NCT01337050|267754|P3|Overall Study|Death|4
67945|NCT01337050|267755|P2|Overall Study|Death|0
67946|NCT01337050|267756|P1|Overall Study|Death|0
67947|NCT01336972|267817|P3|Overall Study|Adverse Event|0
67949|NCT01336972|267819|P1|Overall Study|Adverse Event|1
67950|NCT01336894|267856|P2|Follow-up|Study terminated prematurely|7
67951|NCT01336894|267857|P1|Follow-up|Study terminated prematurely|2
67952|NCT01336764|267877|P2|Overall Study|Withdrawal by Subject|5
67953|NCT01336764|267878|P1|Overall Study|Withdrawal by Subject|5
67954|NCT01336738|267889|P5|Overall Study|Other|4
67955|NCT01336738|267890|P4|Overall Study|Other|3
67956|NCT01336738|267891|P3|Overall Study|Other|2
67957|NCT01336738|267892|P2|Overall Study|Other|3
67958|NCT01336738|267893|P1|Overall Study|Other|3
67959|NCT01336738|267889|P5|Overall Study|Withdrawal by Subject|1
67960|NCT01336738|267890|P4|Overall Study|Withdrawal by Subject|1
67961|NCT01336738|267891|P3|Overall Study|Withdrawal by Subject|2
67962|NCT01336738|267892|P2|Overall Study|Withdrawal by Subject|0
67963|NCT01336738|267893|P1|Overall Study|Withdrawal by Subject|2
67964|NCT01336738|267889|P5|Overall Study|Protocol Violation|0
67965|NCT01336738|267890|P4|Overall Study|Protocol Violation|0
67966|NCT01336738|267891|P3|Overall Study|Protocol Violation|0
67967|NCT01336738|267892|P2|Overall Study|Protocol Violation|1
67968|NCT01336738|267893|P1|Overall Study|Protocol Violation|0
67969|NCT01336738|267889|P5|Overall Study|Did not meet entrance criteria|0
67970|NCT01336738|267890|P4|Overall Study|Did not meet entrance criteria|0
67971|NCT01336738|267891|P3|Overall Study|Did not meet entrance criteria|0
67972|NCT01336738|267892|P2|Overall Study|Did not meet entrance criteria|1
67973|NCT01336738|267893|P1|Overall Study|Did not meet entrance criteria|0
67974|NCT01336738|267889|P5|Overall Study|Lost to Follow-up|2
67975|NCT01336738|267890|P4|Overall Study|Lost to Follow-up|2
67976|NCT01336738|267891|P3|Overall Study|Lost to Follow-up|2
67977|NCT01336738|267892|P2|Overall Study|Lost to Follow-up|1
67978|NCT01336738|267893|P1|Overall Study|Lost to Follow-up|2
67979|NCT01336738|267889|P5|Overall Study|Adverse Event|3
67980|NCT01336738|267890|P4|Overall Study|Adverse Event|1
67981|NCT01336738|267891|P3|Overall Study|Adverse Event|2
67982|NCT01336738|267892|P2|Overall Study|Adverse Event|3
67983|NCT01336738|267893|P1|Overall Study|Adverse Event|0
67984|NCT01336712|267935|P1|Overall Study|Lack of Efficacy|1
67985|NCT01336712|267935|P1|Overall Study|Death|2
67986|NCT01336647|267948|P3|Overall Study|Lost to Follow-up|3
67987|NCT01336647|267949|P2|Overall Study|Lost to Follow-up|1
67988|NCT01336647|267950|P1|Overall Study|Lost to Follow-up|4
67989|NCT01336634|267964|P3|Overall Study|Ongoing|24
67990|NCT01336634|267965|P2|Overall Study|Ongoing|22
67991|NCT01336634|267966|P1|Overall Study|Ongoing|15
67992|NCT01336634|267964|P3|Overall Study|Physician Decision|0
67993|NCT01336634|267965|P2|Overall Study|Physician Decision|1
67994|NCT01336634|267966|P1|Overall Study|Physician Decision|1
67995|NCT01336634|267964|P3|Overall Study|Withdrawal by Subject|1
67996|NCT01336634|267965|P2|Overall Study|Withdrawal by Subject|0
67997|NCT01336634|267966|P1|Overall Study|Withdrawal by Subject|6
67998|NCT01336634|267964|P3|Overall Study|Lost to Follow-up|1
67999|NCT01336634|267965|P2|Overall Study|Lost to Follow-up|1
68000|NCT01336634|267966|P1|Overall Study|Lost to Follow-up|2
68001|NCT01336634|267964|P3|Overall Study|Death|10
68002|NCT01336634|267965|P2|Overall Study|Death|33
68003|NCT01336634|267966|P1|Overall Study|Death|60
68004|NCT01336621|268007|P1|Overall Study|Other: lost to follow up|2
68005|NCT01336621|268007|P1|Overall Study|Other: Reached stopping criteria|22
68006|NCT01336621|268007|P1|Overall Study|Physician Decision|3
68007|NCT01336621|268007|P1|Overall Study|Other: study terminated|11
68008|NCT01336621|268007|P1|Overall Study|Withdrawal by Subject|28
68009|NCT01336621|268007|P1|Overall Study|Protocol Violation|12
68010|NCT01336621|268007|P1|Overall Study|Lack of Efficacy|3
68011|NCT01336621|268007|P1|Overall Study|Adverse Event|17
68012|NCT01336608|268051|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
68013|NCT01336608|268052|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
68014|NCT01336608|268053|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
68015|NCT01336608|268054|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
68016|NCT01336608|268051|P4|24-week, Double-blind Treatment Period|Physician Decision|1
68017|NCT01336608|268052|P3|24-week, Double-blind Treatment Period|Physician Decision|1
68018|NCT01336608|268053|P2|24-week, Double-blind Treatment Period|Physician Decision|3
68019|NCT01336608|268054|P1|24-week, Double-blind Treatment Period|Physician Decision|0
68020|NCT01336608|268051|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
68021|NCT01336608|268052|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
68022|NCT01336608|268053|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
68023|NCT01336608|268054|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
68024|NCT01336608|268051|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
68025|NCT01336608|268052|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
68026|NCT01336608|268053|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
68027|NCT01336608|268054|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
68028|NCT01336608|268051|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
68029|NCT01336608|268052|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
68030|NCT01336608|268053|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
68031|NCT01336608|268054|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
68110|NCT01336023|268140|P2|Week 0 to Week 26|Adverse Event|10
68032|NCT01336608|268051|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
68033|NCT01336608|268052|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
68034|NCT01336608|268053|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
68035|NCT01336608|268054|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
68036|NCT01336608|268051|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
68037|NCT01336608|268052|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
68038|NCT01336608|268053|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
68039|NCT01336608|268054|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
68040|NCT01336608|268051|P4|24-week, Double-blind Treatment Period|Adverse Event|7
68041|NCT01336608|268052|P3|24-week, Double-blind Treatment Period|Adverse Event|6
68042|NCT01336608|268053|P2|24-week, Double-blind Treatment Period|Adverse Event|8
68043|NCT01336608|268054|P1|24-week, Double-blind Treatment Period|Adverse Event|0
68044|NCT01336608|268051|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
68045|NCT01336608|268052|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
68046|NCT01336608|268053|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
68047|NCT01336608|268054|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
68048|NCT01336608|268051|P4|2-week, Single-blind Run-In Period|Physician Decision|0
68049|NCT01336608|268052|P3|2-week, Single-blind Run-In Period|Physician Decision|0
68050|NCT01336608|268053|P2|2-week, Single-blind Run-In Period|Physician Decision|0
68051|NCT01336608|268054|P1|2-week, Single-blind Run-In Period|Physician Decision|1
68052|NCT01336608|268051|P4|2-week, Single-blind Run-In Period|Adverse Event|0
68053|NCT01336608|268052|P3|2-week, Single-blind Run-In Period|Adverse Event|0
68054|NCT01336608|268053|P2|2-week, Single-blind Run-In Period|Adverse Event|0
68055|NCT01336608|268054|P1|2-week, Single-blind Run-In Period|Adverse Event|1
68056|NCT01336608|268051|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
68057|NCT01336608|268052|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
68058|NCT01336608|268053|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
68059|NCT01336608|268054|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
68060|NCT01336608|268051|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
68061|NCT01336608|268052|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
68062|NCT01336608|268053|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
68063|NCT01336608|268054|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
68064|NCT01336569|268068|P1|Overall Study|Lost to Follow-up|4
68065|NCT01336205|268110|P2|Overall Study|Did not receive treatment|0
68066|NCT01336205|268111|P1|Overall Study|Did not receive treatment|4
68067|NCT01336205|268110|P2|Overall Study|Withdrawal by Subject|38
68068|NCT01336205|268111|P1|Overall Study|Withdrawal by Subject|72
68069|NCT01336205|268110|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
68070|NCT01336205|268111|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
68071|NCT01336205|268110|P2|Overall Study|Death|1
68072|NCT01336205|268111|P1|Overall Study|Death|1
68073|NCT01336205|268110|P2|Overall Study|Adverse Event|6
68074|NCT01336205|268111|P1|Overall Study|Adverse Event|56
68075|NCT01336205|268110|P2|Overall Study|Severe noncompliance with protocol|2
68076|NCT01336205|268111|P1|Overall Study|Severe noncompliance with protocol|9
68077|NCT01336205|268110|P2|Overall Study|Lack of Efficacy|0
68078|NCT01336205|268111|P1|Overall Study|Lack of Efficacy|4
68079|NCT01336205|268110|P2|Overall Study|Study-Specific Withdrawal Criteria|7
68080|NCT01336205|268111|P1|Overall Study|Study-Specific Withdrawal Criteria|16
68081|NCT01336205|268110|P2|Overall Study|Lost to Follow-up|20
68082|NCT01336205|268111|P1|Overall Study|Lost to Follow-up|40
68083|NCT01336205|268110|P2|Overall Study|Other|9
68084|NCT01336205|268111|P1|Overall Study|Other|22
68085|NCT01336023|268139|P3|Week 27 to 52|Unclassified|9
68086|NCT01336023|268140|P2|Week 27 to 52|Unclassified|18
68087|NCT01336023|268141|P1|Week 27 to 52|Unclassified|13
68088|NCT01336023|268139|P3|Week 27 to 52|Withdrawal Criteria|16
68089|NCT01336023|268140|P2|Week 27 to 52|Withdrawal Criteria|19
68090|NCT01336023|268141|P1|Week 27 to 52|Withdrawal Criteria|14
68091|NCT01336023|268139|P3|Week 27 to 52|Protocol Violation|1
68092|NCT01336023|268140|P2|Week 27 to 52|Protocol Violation|2
68093|NCT01336023|268141|P1|Week 27 to 52|Protocol Violation|0
68094|NCT01336023|268139|P3|Week 27 to 52|Adverse Event|2
68095|NCT01336023|268140|P2|Week 27 to 52|Adverse Event|5
68096|NCT01336023|268141|P1|Week 27 to 52|Adverse Event|1
68097|NCT01336023|268139|P3|Week 0 to Week 26|Unclassified|9
68098|NCT01336023|268140|P2|Week 0 to Week 26|Unclassified|16
68099|NCT01336023|268141|P1|Week 0 to Week 26|Unclassified|5
68100|NCT01336023|268139|P3|Week 0 to Week 26|Withdrawal Criteria|40
68101|NCT01336023|268140|P2|Week 0 to Week 26|Withdrawal Criteria|69
68102|NCT01336023|268141|P1|Week 0 to Week 26|Withdrawal Criteria|34
68103|NCT01336023|268139|P3|Week 0 to Week 26|Protocol Violation|0
68104|NCT01336023|268140|P2|Week 0 to Week 26|Protocol Violation|2
68105|NCT01336023|268141|P1|Week 0 to Week 26|Protocol Violation|1
68106|NCT01336023|268139|P3|Week 0 to Week 26|Lack of Efficacy|0
68107|NCT01336023|268140|P2|Week 0 to Week 26|Lack of Efficacy|1
68108|NCT01336023|268141|P1|Week 0 to Week 26|Lack of Efficacy|0
68109|NCT01336023|268139|P3|Week 0 to Week 26|Adverse Event|24
68111|NCT01336023|268141|P1|Week 0 to Week 26|Adverse Event|8
68112|NCT01335997|268162|P2|Period III|Lost to Follow-up|0
68113|NCT01335997|268163|P1|Period III|Lost to Follow-up|1
68114|NCT01335997|268162|P2|Period III|Protocol Violation|1
68115|NCT01335997|268163|P1|Period III|Protocol Violation|0
68116|NCT01335997|268162|P2|Period III|Study Terminated by Sponsor|76
68117|NCT01335997|268163|P1|Period III|Study Terminated by Sponsor|77
68118|NCT01335997|268162|P2|Period III|Adverse Event|2
68119|NCT01335997|268163|P1|Period III|Adverse Event|0
68120|NCT01335997|268162|P2|Period I and II|Physician Decision|1
68121|NCT01335997|268163|P1|Period I and II|Physician Decision|2
68122|NCT01335997|268162|P2|Period I and II|Protocol Violation|10
68123|NCT01335997|268163|P1|Period I and II|Protocol Violation|9
68124|NCT01335997|268162|P2|Period I and II|Study Terminated by Sponsor|415
68125|NCT01335997|268163|P1|Period I and II|Study Terminated by Sponsor|406
68126|NCT01335997|268162|P2|Period I and II|Withdrawal by Subject|4
68127|NCT01335997|268163|P1|Period I and II|Withdrawal by Subject|9
68128|NCT01335997|268162|P2|Period I and II|Lost to Follow-up|5
68129|NCT01335997|268163|P1|Period I and II|Lost to Follow-up|3
68130|NCT01335997|268162|P2|Period I and II|Noncompliance with Study Drug|1
68131|NCT01335997|268163|P1|Period I and II|Noncompliance with Study Drug|1
68132|NCT01335997|268162|P2|Period I and II|Adverse Event|43
68133|NCT01335997|268163|P1|Period I and II|Adverse Event|63
68134|NCT01335971|268176|P3|Overall Study|Did not complete bronchoscopy|1
68135|NCT01335971|268177|P2|Overall Study|Did not complete bronchoscopy|1
68136|NCT01335971|268178|P1|Overall Study|Did not complete bronchoscopy|1
68137|NCT01335971|268176|P3|Overall Study|Withdrawal by Subject|0
68138|NCT01335971|268177|P2|Overall Study|Withdrawal by Subject|0
68139|NCT01335971|268178|P1|Overall Study|Withdrawal by Subject|1
68140|NCT01335698|268283|P5|Treatment Stage 2|Continuing treatment|6
68141|NCT01335698|268284|P4|Treatment Stage 2|Continuing treatment|19
68142|NCT01335698|268285|P3|Treatment Stage 2|Continuing treatment|13
68143|NCT01335698|268286|P2|Treatment Stage 2|Continuing treatment|3
68144|NCT01335698|268287|P1|Treatment Stage 2|Continuing treatment|11
68145|NCT01335698|268283|P5|Treatment Stage 2|Poor compliance/noncompliance|0
68146|NCT01335698|268284|P4|Treatment Stage 2|Poor compliance/noncompliance|3
68147|NCT01335698|268285|P3|Treatment Stage 2|Poor compliance/noncompliance|0
68148|NCT01335698|268286|P2|Treatment Stage 2|Poor compliance/noncompliance|0
68149|NCT01335698|268287|P1|Treatment Stage 2|Poor compliance/noncompliance|1
68150|NCT01335698|268283|P5|Treatment Stage 2|Withdrawal by Subject|0
68151|NCT01335698|268284|P4|Treatment Stage 2|Withdrawal by Subject|0
68152|NCT01335698|268285|P3|Treatment Stage 2|Withdrawal by Subject|0
68153|NCT01335698|268286|P2|Treatment Stage 2|Withdrawal by Subject|0
68154|NCT01335698|268287|P1|Treatment Stage 2|Withdrawal by Subject|1
68155|NCT01335698|268283|P5|Treatment Stage 2|Adverse Event|0
68156|NCT01335698|268284|P4|Treatment Stage 2|Adverse Event|1
68157|NCT01335698|268285|P3|Treatment Stage 2|Adverse Event|0
68158|NCT01335698|268286|P2|Treatment Stage 2|Adverse Event|0
68159|NCT01335698|268287|P1|Treatment Stage 2|Adverse Event|0
68160|NCT01335698|268283|P5|Treatment Stage 2|Lack of Efficacy|0
68161|NCT01335698|268284|P4|Treatment Stage 2|Lack of Efficacy|1
68162|NCT01335698|268285|P3|Treatment Stage 2|Lack of Efficacy|3
68163|NCT01335698|268286|P2|Treatment Stage 2|Lack of Efficacy|1
68164|NCT01335698|268287|P1|Treatment Stage 2|Lack of Efficacy|2
68165|NCT01335698|268283|P5|Treatment Stage 1|Not specified|0
68166|NCT01335698|268284|P4|Treatment Stage 1|Not specified|1
68167|NCT01335698|268285|P3|Treatment Stage 1|Not specified|0
68168|NCT01335698|268286|P2|Treatment Stage 1|Not specified|0
68169|NCT01335698|268287|P1|Treatment Stage 1|Not specified|1
68170|NCT01335698|268283|P5|Treatment Stage 1|No longer meets study criteria|0
68171|NCT01335698|268284|P4|Treatment Stage 1|No longer meets study criteria|1
68172|NCT01335698|268285|P3|Treatment Stage 1|No longer meets study criteria|0
68173|NCT01335698|268286|P2|Treatment Stage 1|No longer meets study criteria|1
68174|NCT01335698|268287|P1|Treatment Stage 1|No longer meets study criteria|1
68175|NCT01335698|268283|P5|Treatment Stage 1|Poor compliance/noncompliance|0
68176|NCT01335698|268284|P4|Treatment Stage 1|Poor compliance/noncompliance|2
68177|NCT01335698|268285|P3|Treatment Stage 1|Poor compliance/noncompliance|0
68178|NCT01335698|268286|P2|Treatment Stage 1|Poor compliance/noncompliance|1
68179|NCT01335698|268287|P1|Treatment Stage 1|Poor compliance/noncompliance|0
68180|NCT01335698|268283|P5|Treatment Stage 1|Lost to Follow-up|0
68181|NCT01335698|268284|P4|Treatment Stage 1|Lost to Follow-up|0
68182|NCT01335698|268285|P3|Treatment Stage 1|Lost to Follow-up|0
68183|NCT01335698|268286|P2|Treatment Stage 1|Lost to Follow-up|1
68184|NCT01335698|268287|P1|Treatment Stage 1|Lost to Follow-up|1
68185|NCT01335698|268283|P5|Treatment Stage 1|Withdrawal by Subject|0
68186|NCT01335698|268284|P4|Treatment Stage 1|Withdrawal by Subject|1
68187|NCT01335698|268285|P3|Treatment Stage 1|Withdrawal by Subject|0
68188|NCT01335698|268286|P2|Treatment Stage 1|Withdrawal by Subject|2
68189|NCT01335698|268287|P1|Treatment Stage 1|Withdrawal by Subject|1
68190|NCT01335698|268283|P5|Treatment Stage 1|Adverse Event|1
68191|NCT01335698|268284|P4|Treatment Stage 1|Adverse Event|1
68192|NCT01335698|268285|P3|Treatment Stage 1|Adverse Event|2
68193|NCT01335698|268286|P2|Treatment Stage 1|Adverse Event|2
68194|NCT01335698|268287|P1|Treatment Stage 1|Adverse Event|1
68195|NCT01335698|268283|P5|Treatment Stage 1|Lack of Efficacy|1
68196|NCT01335698|268284|P4|Treatment Stage 1|Lack of Efficacy|3
68197|NCT01335698|268285|P3|Treatment Stage 1|Lack of Efficacy|3
68198|NCT01335698|268286|P2|Treatment Stage 1|Lack of Efficacy|1
68199|NCT01335698|268287|P1|Treatment Stage 1|Lack of Efficacy|3
68200|NCT01335685|268338|P8|Overall Study|Reason not Specified|0
68201|NCT01335685|268339|P7|Overall Study|Reason not Specified|0
68202|NCT01335685|268340|P6|Overall Study|Reason not Specified|1
68203|NCT01335685|268341|P5|Overall Study|Reason not Specified|0
68204|NCT01335685|268342|P4|Overall Study|Reason not Specified|0
68205|NCT01335685|268343|P3|Overall Study|Reason not Specified|1
68206|NCT01335685|268344|P2|Overall Study|Reason not Specified|0
68207|NCT01335685|268345|P1|Overall Study|Reason not Specified|0
68208|NCT01335685|268338|P8|Overall Study|Withdrawal by Subject|0
68209|NCT01335685|268339|P7|Overall Study|Withdrawal by Subject|0
68210|NCT01335685|268340|P6|Overall Study|Withdrawal by Subject|0
68211|NCT01335685|268341|P5|Overall Study|Withdrawal by Subject|0
68212|NCT01335685|268342|P4|Overall Study|Withdrawal by Subject|1
68213|NCT01335685|268343|P3|Overall Study|Withdrawal by Subject|0
68214|NCT01335685|268344|P2|Overall Study|Withdrawal by Subject|0
68215|NCT01335685|268345|P1|Overall Study|Withdrawal by Subject|1
68216|NCT01335685|268338|P8|Overall Study|Study Terminated by Sponsor|3
68217|NCT01335685|268339|P7|Overall Study|Study Terminated by Sponsor|2
68218|NCT01335685|268340|P6|Overall Study|Study Terminated by Sponsor|4
68219|NCT01335685|268341|P5|Overall Study|Study Terminated by Sponsor|0
68220|NCT01335685|268342|P4|Overall Study|Study Terminated by Sponsor|10
68221|NCT01335685|268343|P3|Overall Study|Study Terminated by Sponsor|1
68222|NCT01335685|268344|P2|Overall Study|Study Terminated by Sponsor|1
68223|NCT01335685|268345|P1|Overall Study|Study Terminated by Sponsor|2
68224|NCT01335477|268458|P2|Overall Study|Reason other than those stated above|2
68225|NCT01335477|268459|P1|Overall Study|Reason other than those stated above|2
68226|NCT01335477|268458|P2|Overall Study|Not treated|2
68227|NCT01335477|268459|P1|Overall Study|Not treated|1
68228|NCT01335477|268458|P2|Overall Study|Consent withdrawn, not due to AE|9
68229|NCT01335477|268459|P1|Overall Study|Consent withdrawn, not due to AE|7
68230|NCT01335477|268458|P2|Overall Study|Lost to Follow-up|2
68231|NCT01335477|268459|P1|Overall Study|Lost to Follow-up|1
68232|NCT01335477|268458|P2|Overall Study|Non compliant with protocol|2
68233|NCT01335477|268459|P1|Overall Study|Non compliant with protocol|0
68234|NCT01335477|268458|P2|Overall Study|Adverse Event|42
68235|NCT01335477|268459|P1|Overall Study|Adverse Event|30
68236|NCT01335464|268523|P2|Overall Study|Reason other than those stated above|1
68237|NCT01335464|268524|P1|Overall Study|Reason other than those stated above|1
68238|NCT01335464|268523|P2|Overall Study|Not treated|0
68239|NCT01335464|268524|P1|Overall Study|Not treated|2
68240|NCT01335464|268523|P2|Overall Study|Consent withdrawn, not due to AE|23
68241|NCT01335464|268524|P1|Overall Study|Consent withdrawn, not due to AE|12
68242|NCT01335464|268523|P2|Overall Study|Non compliant with protocol|0
68243|NCT01335464|268524|P1|Overall Study|Non compliant with protocol|2
68244|NCT01335464|268523|P2|Overall Study|Adverse Event|25
68245|NCT01335464|268524|P1|Overall Study|Adverse Event|15
68246|NCT01334918|268684|P2|Overall Study|Withdrawal by Subject|1
68247|NCT01334918|268685|P1|Overall Study|Withdrawal by Subject|0
68248|NCT01334918|268684|P2|Overall Study|Adverse Event|0
68249|NCT01334918|268685|P1|Overall Study|Adverse Event|2
68250|NCT01334918|268684|P2|Overall Study|Did not receive study drug|0
68251|NCT01334918|268685|P1|Overall Study|Did not receive study drug|6
68252|NCT01334866|268711|P1|Overall Study|medically necessary post-procedure|1
68253|NCT01334866|268711|P1|Overall Study|medically necessary prior to procedure|2
68254|NCT01334866|268711|P1|Overall Study|Physician Decision|3
68255|NCT01334866|268711|P1|Overall Study|Lost to Follow-up|3
68256|NCT01334866|268711|P1|Overall Study|Withdrawal by Subject|10
68257|NCT01334710|268748|P1|Overall Study|Trial was terminated|3
68258|NCT01334606|268753|P1|Overall Study|Study Terminated due to slow enrolment|18
68259|NCT01334554|268761|P2|Overall Study|Adverse Event|2
68260|NCT01334554|268762|P1|Overall Study|Adverse Event|4
68261|NCT01334515|268772|P2|Overall Study|Withdrawal by Subject|1
68262|NCT01334515|268773|P1|Overall Study|Withdrawal by Subject|1
68263|NCT01334515|268772|P2|Overall Study|Physician Decision|1
68264|NCT01334515|268773|P1|Overall Study|Physician Decision|1
68265|NCT01334515|268772|P2|Overall Study|Lack of Efficacy|21
68266|NCT01334515|268773|P1|Overall Study|Lack of Efficacy|8
68267|NCT01334515|268772|P2|Overall Study|Death|0
68268|NCT01334515|268773|P1|Overall Study|Death|1
68269|NCT01334515|268772|P2|Overall Study|Adverse Event|6
68270|NCT01334515|268773|P1|Overall Study|Adverse Event|1
68271|NCT01334125|268811|P2|Overall Study|Lost to Follow-up|3
68272|NCT01334125|268812|P1|Overall Study|Lost to Follow-up|3
68273|NCT01333956|268828|P4|Overall Study|Withdrawal by Subject|0
68274|NCT01333956|268829|P3|Overall Study|Withdrawal by Subject|1
68275|NCT01333956|268830|P2|Overall Study|Withdrawal by Subject|2
68276|NCT01333956|268831|P1|Overall Study|Withdrawal by Subject|0
68277|NCT01333956|268828|P4|Overall Study|Unable to complete study procedure|1
68278|NCT01333956|268829|P3|Overall Study|Unable to complete study procedure|0
68279|NCT01333956|268830|P2|Overall Study|Unable to complete study procedure|0
68280|NCT01333956|268831|P1|Overall Study|Unable to complete study procedure|1
68281|NCT01333956|268828|P4|Overall Study|Lost to Follow-up|1
68282|NCT01333956|268829|P3|Overall Study|Lost to Follow-up|0
68283|NCT01333956|268830|P2|Overall Study|Lost to Follow-up|2
68284|NCT01333956|268831|P1|Overall Study|Lost to Follow-up|1
68285|NCT01333943|268867|P2|Overall Study|Known neuropathy|0
68286|NCT01333943|268868|P1|Overall Study|Known neuropathy|1
68287|NCT01333865|268884|P1|Overall Study|Adverse Event|2
68288|NCT01333722|268904|P2|Overall Study|Withdrawal by Subject|1
68289|NCT01333722|268905|P1|Overall Study|Withdrawal by Subject|0
68290|NCT01333722|268904|P2|Overall Study|Lack of Efficacy|2
68291|NCT01333722|268905|P1|Overall Study|Lack of Efficacy|0
68292|NCT01333501|268930|P2|Overall Study|Withdrawn consent|12
68293|NCT01333501|268931|P1|Overall Study|Withdrawn consent|3
68294|NCT01333501|268930|P2|Overall Study|Unsatisfactory therapeutic effect|7
68295|NCT01333501|268931|P1|Overall Study|Unsatisfactory therapeutic effect|1
68296|NCT01333501|268930|P2|Overall Study|Abnormal laboratory value|1
68297|NCT01333501|268931|P1|Overall Study|Abnormal laboratory value|2
68298|NCT01333501|268930|P2|Overall Study|Adverse Event|1
68299|NCT01333501|268931|P1|Overall Study|Adverse Event|3
68300|NCT01333475|268998|P2|Overall Study|Toxicity|3
68301|NCT01333475|268999|P1|Overall Study|Toxicity|1
68302|NCT01333475|268998|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
68303|NCT01333475|268999|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
68304|NCT01333397|269025|P5|Overall Study|Lost to Follow-up|0
68305|NCT01333397|269026|P4|Overall Study|Lost to Follow-up|1
68306|NCT01333397|269027|P3|Overall Study|Lost to Follow-up|0
68307|NCT01333397|269028|P2|Overall Study|Lost to Follow-up|0
68308|NCT01333397|269029|P1|Overall Study|Lost to Follow-up|1
68309|NCT01333189|269103|P2|Overall Study|Moved from region|1
68310|NCT01333189|269104|P1|Overall Study|Moved from region|0
68311|NCT01333189|269103|P2|Overall Study|Transportation difficulties|1
68312|NCT01333189|269104|P1|Overall Study|Transportation difficulties|0
68313|NCT01333189|269103|P2|Overall Study|Adverse Event|0
68314|NCT01333189|269104|P1|Overall Study|Adverse Event|1
68315|NCT01333189|269103|P2|Overall Study|Time constraints|0
68316|NCT01333189|269104|P1|Overall Study|Time constraints|1
68317|NCT01333111|269135|P3|Overall Study|Ineffective therapy|1
68318|NCT01333111|269136|P2|Overall Study|Ineffective therapy|0
68319|NCT01333111|269137|P1|Overall Study|Ineffective therapy|0
68320|NCT01333111|269135|P3|Overall Study|Non-compliance|0
68321|NCT01333111|269136|P2|Overall Study|Non-compliance|0
68322|NCT01333111|269137|P1|Overall Study|Non-compliance|1
68323|NCT01333111|269135|P3|Overall Study|withdrawal criteria|0
68324|NCT01333111|269136|P2|Overall Study|withdrawal criteria|1
68325|NCT01333111|269137|P1|Overall Study|withdrawal criteria|0
68326|NCT01333111|269135|P3|Overall Study|unclassified|0
68327|NCT01333111|269136|P2|Overall Study|unclassified|0
68328|NCT01333111|269137|P1|Overall Study|unclassified|1
68329|NCT01333111|269135|P3|Overall Study|personal reasons|1
68330|NCT01333111|269136|P2|Overall Study|personal reasons|0
68331|NCT01333111|269137|P1|Overall Study|personal reasons|0
68332|NCT01333111|269135|P3|Overall Study|patient undergoing major surgery|0
68333|NCT01333111|269136|P2|Overall Study|patient undergoing major surgery|2
68334|NCT01333111|269137|P1|Overall Study|patient undergoing major surgery|0
68335|NCT01332994|269161|P1|Overall Study|Not Specified|8
68336|NCT01332994|269161|P1|Overall Study|Administrative Problem|2
68337|NCT01332994|269161|P1|Overall Study|Withdrawal by Subject|15
68338|NCT01332994|269161|P1|Overall Study|Protocol Violation|6
68339|NCT01332994|269161|P1|Overall Study|Lost to Follow-up|4
68340|NCT01332994|269161|P1|Overall Study|Lack of Efficacy|1
68341|NCT01332994|269161|P1|Overall Study|Death|1
68342|NCT01332994|269161|P1|Overall Study|Adverse Event|34
68343|NCT01332968|269230|P8|Follow-Up Period|Lost to Follow-up|2
68344|NCT01332968|269231|P7|Follow-Up Period|Lost to Follow-up|1
68345|NCT01332968|269232|P6|Follow-Up Period|Lost to Follow-up|0
68346|NCT01332968|269233|P5|Follow-Up Period|Lost to Follow-up|0
68347|NCT01332968|269234|P4|Follow-Up Period|Lost to Follow-up|0
68348|NCT01332968|269235|P3|Follow-Up Period|Lost to Follow-up|0
68349|NCT01332968|269236|P2|Follow-Up Period|Lost to Follow-up|0
68350|NCT01332968|269237|P1|Follow-Up Period|Lost to Follow-up|0
68351|NCT01332968|269230|P8|Follow-Up Period|Withdrawal by Subject|2
68352|NCT01332968|269231|P7|Follow-Up Period|Withdrawal by Subject|1
68353|NCT01332968|269232|P6|Follow-Up Period|Withdrawal by Subject|0
68354|NCT01332968|269233|P5|Follow-Up Period|Withdrawal by Subject|0
68355|NCT01332968|269234|P4|Follow-Up Period|Withdrawal by Subject|0
68356|NCT01332968|269235|P3|Follow-Up Period|Withdrawal by Subject|0
68357|NCT01332968|269236|P2|Follow-Up Period|Withdrawal by Subject|0
68358|NCT01332968|269237|P1|Follow-Up Period|Withdrawal by Subject|0
68359|NCT01332968|269230|P8|Follow-Up Period|Follow-up ongoing|505
68360|NCT01332968|269231|P7|Follow-Up Period|Follow-up ongoing|502
68361|NCT01332968|269232|P6|Follow-Up Period|Follow-up ongoing|0
68362|NCT01332968|269233|P5|Follow-Up Period|Follow-up ongoing|0
68363|NCT01332968|269234|P4|Follow-Up Period|Follow-up ongoing|0
68364|NCT01332968|269235|P3|Follow-Up Period|Follow-up ongoing|0
68365|NCT01332968|269236|P2|Follow-Up Period|Follow-up ongoing|0
68366|NCT01332968|269237|P1|Follow-Up Period|Follow-up ongoing|0
68367|NCT01332968|269230|P8|Follow-Up Period|Death|22
68368|NCT01332968|269231|P7|Follow-Up Period|Death|38
68369|NCT01332968|269232|P6|Follow-Up Period|Death|0
68370|NCT01332968|269233|P5|Follow-Up Period|Death|0
68371|NCT01332968|269234|P4|Follow-Up Period|Death|0
68372|NCT01332968|269235|P3|Follow-Up Period|Death|0
68373|NCT01332968|269236|P2|Follow-Up Period|Death|0
68374|NCT01332968|269237|P1|Follow-Up Period|Death|0
68375|NCT01332968|269230|P8|Maintenance/Observation Period|Treatment ongoing|0
68376|NCT01332968|269231|P7|Maintenance/Observation Period|Treatment ongoing|0
68377|NCT01332968|269232|P6|Maintenance/Observation Period|Treatment ongoing|8
68378|NCT01332968|269233|P5|Maintenance/Observation Period|Treatment ongoing|10
68379|NCT01332968|269234|P4|Maintenance/Observation Period|Treatment ongoing|62
68380|NCT01332968|269235|P3|Maintenance/Observation Period|Treatment ongoing|54
68381|NCT01332968|269236|P2|Maintenance/Observation Period|Treatment ongoing|0
68382|NCT01332968|269237|P1|Maintenance/Observation Period|Treatment ongoing|0
68383|NCT01332968|269230|P8|Maintenance/Observation Period|Adverse Event|0
68384|NCT01332968|269231|P7|Maintenance/Observation Period|Adverse Event|0
68385|NCT01332968|269232|P6|Maintenance/Observation Period|Adverse Event|0
68386|NCT01332968|269233|P5|Maintenance/Observation Period|Adverse Event|0
68387|NCT01332968|269234|P4|Maintenance/Observation Period|Adverse Event|65
68388|NCT01332968|269235|P3|Maintenance/Observation Period|Adverse Event|50
68389|NCT01332968|269236|P2|Maintenance/Observation Period|Adverse Event|0
68390|NCT01332968|269237|P1|Maintenance/Observation Period|Adverse Event|0
68391|NCT01332968|269230|P8|Maintenance/Observation Period|Death|0
68392|NCT01332968|269231|P7|Maintenance/Observation Period|Death|0
68393|NCT01332968|269232|P6|Maintenance/Observation Period|Death|0
68394|NCT01332968|269233|P5|Maintenance/Observation Period|Death|0
68395|NCT01332968|269234|P4|Maintenance/Observation Period|Death|6
68396|NCT01332968|269235|P3|Maintenance/Observation Period|Death|5
68397|NCT01332968|269236|P2|Maintenance/Observation Period|Death|0
68398|NCT01332968|269237|P1|Maintenance/Observation Period|Death|0
68399|NCT01332968|269230|P8|Maintenance/Observation Period|Lost to Follow-up|0
68400|NCT01332968|269231|P7|Maintenance/Observation Period|Lost to Follow-up|0
68401|NCT01332968|269232|P6|Maintenance/Observation Period|Lost to Follow-up|0
68402|NCT01332968|269233|P5|Maintenance/Observation Period|Lost to Follow-up|0
68403|NCT01332968|269234|P4|Maintenance/Observation Period|Lost to Follow-up|2
68404|NCT01332968|269235|P3|Maintenance/Observation Period|Lost to Follow-up|1
68405|NCT01332968|269236|P2|Maintenance/Observation Period|Lost to Follow-up|0
68406|NCT01332968|269237|P1|Maintenance/Observation Period|Lost to Follow-up|0
68407|NCT01332968|269230|P8|Maintenance/Observation Period|Non-compliance|0
68408|NCT01332968|269231|P7|Maintenance/Observation Period|Non-compliance|0
68409|NCT01332968|269232|P6|Maintenance/Observation Period|Non-compliance|1
68410|NCT01332968|269233|P5|Maintenance/Observation Period|Non-compliance|0
68411|NCT01332968|269234|P4|Maintenance/Observation Period|Non-compliance|3
68412|NCT01332968|269235|P3|Maintenance/Observation Period|Non-compliance|2
68413|NCT01332968|269236|P2|Maintenance/Observation Period|Non-compliance|0
68414|NCT01332968|269237|P1|Maintenance/Observation Period|Non-compliance|0
68415|NCT01332968|269230|P8|Maintenance/Observation Period|Other|0
68416|NCT01332968|269231|P7|Maintenance/Observation Period|Other|0
68417|NCT01332968|269232|P6|Maintenance/Observation Period|Other|0
68418|NCT01332968|269233|P5|Maintenance/Observation Period|Other|0
68419|NCT01332968|269234|P4|Maintenance/Observation Period|Other|5
68420|NCT01332968|269235|P3|Maintenance/Observation Period|Other|4
68421|NCT01332968|269236|P2|Maintenance/Observation Period|Other|0
68422|NCT01332968|269237|P1|Maintenance/Observation Period|Other|0
68423|NCT01332968|269230|P8|Maintenance/Observation Period|Physician Decision|0
68424|NCT01332968|269231|P7|Maintenance/Observation Period|Physician Decision|0
68425|NCT01332968|269232|P6|Maintenance/Observation Period|Physician Decision|0
68426|NCT01332968|269233|P5|Maintenance/Observation Period|Physician Decision|0
68427|NCT01332968|269234|P4|Maintenance/Observation Period|Physician Decision|19
68428|NCT01332968|269235|P3|Maintenance/Observation Period|Physician Decision|14
68429|NCT01332968|269236|P2|Maintenance/Observation Period|Physician Decision|0
68430|NCT01332968|269237|P1|Maintenance/Observation Period|Physician Decision|0
68431|NCT01332968|269230|P8|Maintenance/Observation Period|Progressive disease|0
68432|NCT01332968|269231|P7|Maintenance/Observation Period|Progressive disease|0
68433|NCT01332968|269232|P6|Maintenance/Observation Period|Progressive disease|0
68434|NCT01332968|269233|P5|Maintenance/Observation Period|Progressive disease|0
68435|NCT01332968|269234|P4|Maintenance/Observation Period|Progressive disease|39
68436|NCT01332968|269235|P3|Maintenance/Observation Period|Progressive disease|72
68437|NCT01332968|269236|P2|Maintenance/Observation Period|Progressive disease|0
68438|NCT01332968|269237|P1|Maintenance/Observation Period|Progressive disease|0
68439|NCT01332968|269230|P8|Maintenance/Observation Period|Protocol Violation|0
68440|NCT01332968|269231|P7|Maintenance/Observation Period|Protocol Violation|0
68441|NCT01332968|269232|P6|Maintenance/Observation Period|Protocol Violation|0
68442|NCT01332968|269233|P5|Maintenance/Observation Period|Protocol Violation|0
68443|NCT01332968|269234|P4|Maintenance/Observation Period|Protocol Violation|1
68444|NCT01332968|269235|P3|Maintenance/Observation Period|Protocol Violation|1
68445|NCT01332968|269236|P2|Maintenance/Observation Period|Protocol Violation|0
68446|NCT01332968|269237|P1|Maintenance/Observation Period|Protocol Violation|0
68447|NCT01332968|269230|P8|Maintenance/Observation Period|Withdrawal by Subject|0
68535|NCT01332318|269421|P4|Overall Study|Adverse Event|0
68448|NCT01332968|269231|P7|Maintenance/Observation Period|Withdrawal by Subject|0
68449|NCT01332968|269232|P6|Maintenance/Observation Period|Withdrawal by Subject|0
68450|NCT01332968|269233|P5|Maintenance/Observation Period|Withdrawal by Subject|0
68451|NCT01332968|269234|P4|Maintenance/Observation Period|Withdrawal by Subject|5
68452|NCT01332968|269235|P3|Maintenance/Observation Period|Withdrawal by Subject|10
68453|NCT01332968|269236|P2|Maintenance/Observation Period|Withdrawal by Subject|0
68454|NCT01332968|269237|P1|Maintenance/Observation Period|Withdrawal by Subject|0
68455|NCT01332968|269230|P8|Induction Period|Randomized, but not treated|0
68456|NCT01332968|269231|P7|Induction Period|Randomized, but not treated|0
68457|NCT01332968|269232|P6|Induction Period|Randomized, but not treated|0
68458|NCT01332968|269233|P5|Induction Period|Randomized, but not treated|0
68459|NCT01332968|269234|P4|Induction Period|Randomized, but not treated|0
68460|NCT01332968|269235|P3|Induction Period|Randomized, but not treated|0
68461|NCT01332968|269236|P2|Induction Period|Randomized, but not treated|7
68462|NCT01332968|269237|P1|Induction Period|Randomized, but not treated|4
68463|NCT01332968|269230|P8|Induction Period|Adverse Event|0
68464|NCT01332968|269231|P7|Induction Period|Adverse Event|0
68465|NCT01332968|269232|P6|Induction Period|Adverse Event|0
68466|NCT01332968|269233|P5|Induction Period|Adverse Event|0
68467|NCT01332968|269234|P4|Induction Period|Adverse Event|0
68468|NCT01332968|269235|P3|Induction Period|Adverse Event|0
68469|NCT01332968|269236|P2|Induction Period|Adverse Event|26
68470|NCT01332968|269237|P1|Induction Period|Adverse Event|23
68471|NCT01332968|269230|P8|Induction Period|Death|0
68472|NCT01332968|269231|P7|Induction Period|Death|0
68473|NCT01332968|269232|P6|Induction Period|Death|0
68474|NCT01332968|269233|P5|Induction Period|Death|0
68475|NCT01332968|269234|P4|Induction Period|Death|0
68476|NCT01332968|269235|P3|Induction Period|Death|0
68477|NCT01332968|269236|P2|Induction Period|Death|4
68478|NCT01332968|269237|P1|Induction Period|Death|1
68479|NCT01332968|269230|P8|Induction Period|Non-compliance|0
68480|NCT01332968|269231|P7|Induction Period|Non-compliance|0
68481|NCT01332968|269232|P6|Induction Period|Non-compliance|0
68482|NCT01332968|269233|P5|Induction Period|Non-compliance|0
68483|NCT01332968|269234|P4|Induction Period|Non-compliance|0
68484|NCT01332968|269235|P3|Induction Period|Non-compliance|0
68485|NCT01332968|269236|P2|Induction Period|Non-compliance|0
68486|NCT01332968|269237|P1|Induction Period|Non-compliance|1
68487|NCT01332968|269230|P8|Induction Period|Other|0
68488|NCT01332968|269231|P7|Induction Period|Other|0
68489|NCT01332968|269232|P6|Induction Period|Other|0
68490|NCT01332968|269233|P5|Induction Period|Other|0
68491|NCT01332968|269234|P4|Induction Period|Other|0
68492|NCT01332968|269235|P3|Induction Period|Other|0
68493|NCT01332968|269236|P2|Induction Period|Other|2
68494|NCT01332968|269237|P1|Induction Period|Other|2
68495|NCT01332968|269230|P8|Induction Period|Physician Decision|0
68496|NCT01332968|269231|P7|Induction Period|Physician Decision|0
68497|NCT01332968|269232|P6|Induction Period|Physician Decision|0
68498|NCT01332968|269233|P5|Induction Period|Physician Decision|0
68499|NCT01332968|269234|P4|Induction Period|Physician Decision|0
68500|NCT01332968|269235|P3|Induction Period|Physician Decision|0
68501|NCT01332968|269236|P2|Induction Period|Physician Decision|1
68502|NCT01332968|269237|P1|Induction Period|Physician Decision|6
68503|NCT01332968|269230|P8|Induction Period|Progressive disease|0
68504|NCT01332968|269231|P7|Induction Period|Progressive disease|0
68505|NCT01332968|269232|P6|Induction Period|Progressive disease|0
68506|NCT01332968|269233|P5|Induction Period|Progressive disease|0
68507|NCT01332968|269234|P4|Induction Period|Progressive disease|0
68508|NCT01332968|269235|P3|Induction Period|Progressive disease|0
68509|NCT01332968|269236|P2|Induction Period|Progressive disease|7
68510|NCT01332968|269237|P1|Induction Period|Progressive disease|15
68511|NCT01332968|269230|P8|Induction Period|Protocol Violation|0
68512|NCT01332968|269231|P7|Induction Period|Protocol Violation|0
68513|NCT01332968|269232|P6|Induction Period|Protocol Violation|0
68514|NCT01332968|269233|P5|Induction Period|Protocol Violation|0
68515|NCT01332968|269234|P4|Induction Period|Protocol Violation|0
68516|NCT01332968|269235|P3|Induction Period|Protocol Violation|0
68517|NCT01332968|269236|P2|Induction Period|Protocol Violation|4
68518|NCT01332968|269237|P1|Induction Period|Protocol Violation|3
68519|NCT01332968|269230|P8|Induction Period|Withdrawal by Subject|0
68520|NCT01332968|269231|P7|Induction Period|Withdrawal by Subject|0
68521|NCT01332968|269232|P6|Induction Period|Withdrawal by Subject|0
68522|NCT01332968|269233|P5|Induction Period|Withdrawal by Subject|0
68523|NCT01332968|269234|P4|Induction Period|Withdrawal by Subject|0
68524|NCT01332968|269235|P3|Induction Period|Withdrawal by Subject|0
68525|NCT01332968|269236|P2|Induction Period|Withdrawal by Subject|5
68526|NCT01332968|269237|P1|Induction Period|Withdrawal by Subject|3
68527|NCT01332318|269421|P4|Overall Study|Protocol Violation|1
68528|NCT01332318|269422|P3|Overall Study|Protocol Violation|1
68529|NCT01332318|269423|P2|Overall Study|Protocol Violation|0
68530|NCT01332318|269424|P1|Overall Study|Protocol Violation|1
68531|NCT01332318|269421|P4|Overall Study|Withdrawal by Subject|1
68532|NCT01332318|269422|P3|Overall Study|Withdrawal by Subject|0
68533|NCT01332318|269423|P2|Overall Study|Withdrawal by Subject|1
68534|NCT01332318|269424|P1|Overall Study|Withdrawal by Subject|1
68536|NCT01332318|269422|P3|Overall Study|Adverse Event|0
68537|NCT01332318|269423|P2|Overall Study|Adverse Event|3
68538|NCT01332318|269424|P1|Overall Study|Adverse Event|0
68539|NCT01332305|269535|P5|Overall Study|Physician Decision|0
68540|NCT01332305|269536|P4|Overall Study|Physician Decision|1
68541|NCT01332305|269537|P3|Overall Study|Physician Decision|0
68542|NCT01332305|269538|P2|Overall Study|Physician Decision|0
68543|NCT01332305|269539|P1|Overall Study|Physician Decision|0
68544|NCT01332305|269535|P5|Overall Study|Treatment Failure|0
68545|NCT01332305|269536|P4|Overall Study|Treatment Failure|0
68546|NCT01332305|269537|P3|Overall Study|Treatment Failure|0
68547|NCT01332305|269538|P2|Overall Study|Treatment Failure|1
68548|NCT01332305|269539|P1|Overall Study|Treatment Failure|1
68549|NCT01332305|269535|P5|Overall Study|Withdrawal by Sponsor|1
68550|NCT01332305|269536|P4|Overall Study|Withdrawal by Sponsor|1
68551|NCT01332305|269537|P3|Overall Study|Withdrawal by Sponsor|0
68552|NCT01332305|269538|P2|Overall Study|Withdrawal by Sponsor|0
68553|NCT01332305|269539|P1|Overall Study|Withdrawal by Sponsor|1
68554|NCT01332305|269535|P5|Overall Study|Protocol Violation|3
68555|NCT01332305|269536|P4|Overall Study|Protocol Violation|0
68556|NCT01332305|269537|P3|Overall Study|Protocol Violation|1
68557|NCT01332305|269538|P2|Overall Study|Protocol Violation|2
68558|NCT01332305|269539|P1|Overall Study|Protocol Violation|1
68559|NCT01332305|269535|P5|Overall Study|Lost to Follow-up|3
68560|NCT01332305|269536|P4|Overall Study|Lost to Follow-up|2
68561|NCT01332305|269537|P3|Overall Study|Lost to Follow-up|3
68562|NCT01332305|269538|P2|Overall Study|Lost to Follow-up|2
68563|NCT01332305|269539|P1|Overall Study|Lost to Follow-up|0
68564|NCT01332305|269535|P5|Overall Study|Withdrawal by Subject|0
68565|NCT01332305|269536|P4|Overall Study|Withdrawal by Subject|1
68566|NCT01332305|269537|P3|Overall Study|Withdrawal by Subject|4
68567|NCT01332305|269538|P2|Overall Study|Withdrawal by Subject|5
68568|NCT01332305|269539|P1|Overall Study|Withdrawal by Subject|6
68569|NCT01332305|269535|P5|Overall Study|Adverse Event|5
68570|NCT01332305|269536|P4|Overall Study|Adverse Event|3
68571|NCT01332305|269537|P3|Overall Study|Adverse Event|6
68572|NCT01332305|269538|P2|Overall Study|Adverse Event|4
68573|NCT01332305|269539|P1|Overall Study|Adverse Event|1
68574|NCT01332292|269561|P2|Treatment Period 2 (14 Days)|Physician Decision|1
68575|NCT01332292|269562|P1|Treatment Period 2 (14 Days)|Physician Decision|1
68576|NCT01332292|269561|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
68577|NCT01332292|269562|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
68578|NCT01332292|269561|P2|Treatment Period 1 (14 Days)|Adverse Event|0
68579|NCT01332292|269562|P1|Treatment Period 1 (14 Days)|Adverse Event|1
68580|NCT01332227|269653|P2|Overall Study|Patient began prohibited medication|1
68581|NCT01332227|269654|P1|Overall Study|Patient began prohibited medication|0
68582|NCT01332227|269653|P2|Overall Study|Patient moved from area|0
68583|NCT01332227|269654|P1|Overall Study|Patient moved from area|1
68584|NCT01332227|269653|P2|Overall Study|Poor compliance/noncompliance|1
68585|NCT01332227|269654|P1|Overall Study|Poor compliance/noncompliance|1
68586|NCT01332227|269653|P2|Overall Study|Lack of Efficacy|1
68587|NCT01332227|269654|P1|Overall Study|Lack of Efficacy|3
68588|NCT01332227|269653|P2|Overall Study|Lost to Follow-up|0
68589|NCT01332227|269654|P1|Overall Study|Lost to Follow-up|2
68590|NCT01332227|269653|P2|Overall Study|Withdrawal by Subject|1
68591|NCT01332227|269654|P1|Overall Study|Withdrawal by Subject|5
68592|NCT01332227|269653|P2|Overall Study|Adverse Event|1
68593|NCT01332227|269654|P1|Overall Study|Adverse Event|4
68594|NCT01332149|269835|P2|Overall Study|Randomized but not treated|2
68595|NCT01332149|269836|P1|Overall Study|Randomized but not treated|1
68596|NCT01332149|269835|P2|Overall Study|Did not meet entrance criteria|4
68597|NCT01332149|269836|P1|Overall Study|Did not meet entrance criteria|3
68598|NCT01332149|269835|P2|Overall Study|Insufficient clinical response|7
68599|NCT01332149|269836|P1|Overall Study|Insufficient clinical response|4
68600|NCT01332149|269835|P2|Overall Study|Lost to Follow-up|1
68601|NCT01332149|269836|P1|Overall Study|Lost to Follow-up|1
68602|NCT01332149|269835|P2|Overall Study|Withdrawal by Subject|5
68603|NCT01332149|269836|P1|Overall Study|Withdrawal by Subject|4
68604|NCT01332149|269835|P2|Overall Study|Protocol Violation|3
68605|NCT01332149|269836|P1|Overall Study|Protocol Violation|1
68606|NCT01332149|269835|P2|Overall Study|Other unspecified|7
68607|NCT01332149|269836|P1|Overall Study|Other unspecified|5
68608|NCT01332149|269835|P2|Overall Study|Adverse Event|9
68609|NCT01332149|269836|P1|Overall Study|Adverse Event|11
68610|NCT01332019|269914|P2|Overall Study|Adverse Event|22
68611|NCT01332019|269915|P1|Overall Study|Adverse Event|13
68612|NCT01332019|269914|P2|Overall Study|Lost to Follow-up|7
68613|NCT01332019|269915|P1|Overall Study|Lost to Follow-up|4
68614|NCT01332019|269914|P2|Overall Study|Withdrawal by Subject|71
68615|NCT01332019|269915|P1|Overall Study|Withdrawal by Subject|73
68616|NCT01332019|269914|P2|Overall Study|Physician Decision|3
68617|NCT01332019|269915|P1|Overall Study|Physician Decision|4
68618|NCT01332019|269914|P2|Overall Study|Death|1
68619|NCT01332019|269915|P1|Overall Study|Death|2
68620|NCT01332019|269914|P2|Overall Study|Not Specified|18
68621|NCT01332019|269915|P1|Overall Study|Not Specified|16
68622|NCT01332019|269914|P2|Overall Study|Was Not Dosed|0
68623|NCT01332019|269915|P1|Overall Study|Was Not Dosed|1
68624|NCT01331837|269999|P2|Overall Study|Withdrawal by Subject|16
68625|NCT01331837|270000|P1|Overall Study|Withdrawal by Subject|13
68626|NCT01331837|269999|P2|Overall Study|Info not recorded|16
68627|NCT01331837|270000|P1|Overall Study|Info not recorded|10
68628|NCT01331837|269999|P2|Overall Study|Lost to Follow-up|1
68629|NCT01331837|270000|P1|Overall Study|Lost to Follow-up|3
68630|NCT01331837|269999|P2|Overall Study|Death|34
68631|NCT01331837|270000|P1|Overall Study|Death|30
68632|NCT01331824|270040|P1|Overall Study|Withdrawal by Subject|1
68633|NCT01331824|270040|P1|Overall Study|Disease Progression|9
68634|NCT01331824|270040|P1|Overall Study|Death|1
68635|NCT01331824|270040|P1|Overall Study|Adverse Event|2
68636|NCT01331681|270075|P3|Overall Study|Not Received Study Treatment|2
68637|NCT01331681|270076|P2|Overall Study|Not Received Study Treatment|0
68638|NCT01331681|270077|P1|Overall Study|Not Received Study Treatment|0
68639|NCT01331681|270075|P3|Overall Study|Switching to other therapy|1
68640|NCT01331681|270076|P2|Overall Study|Switching to other therapy|0
68641|NCT01331681|270077|P1|Overall Study|Switching to other therapy|0
68642|NCT01331681|270075|P3|Overall Study|Sponsor decision|0
68643|NCT01331681|270076|P2|Overall Study|Sponsor decision|1
68644|NCT01331681|270077|P1|Overall Study|Sponsor decision|1
68645|NCT01331681|270075|P3|Overall Study|Therapeutic procedure required|0
68646|NCT01331681|270076|P2|Overall Study|Therapeutic procedure required|0
68647|NCT01331681|270077|P1|Overall Study|Therapeutic procedure required|1
68648|NCT01331681|270075|P3|Overall Study|Physician Decision|4
68649|NCT01331681|270076|P2|Overall Study|Physician Decision|0
68650|NCT01331681|270077|P1|Overall Study|Physician Decision|2
68651|NCT01331681|270075|P3|Overall Study|Lost to Follow-up|1
68652|NCT01331681|270076|P2|Overall Study|Lost to Follow-up|4
68653|NCT01331681|270077|P1|Overall Study|Lost to Follow-up|2
68654|NCT01331681|270075|P3|Overall Study|Protocol Violation|0
68655|NCT01331681|270076|P2|Overall Study|Protocol Violation|1
68656|NCT01331681|270077|P1|Overall Study|Protocol Violation|1
68657|NCT01331681|270075|P3|Overall Study|Withdrawal by Subject|15
68658|NCT01331681|270076|P2|Overall Study|Withdrawal by Subject|8
68659|NCT01331681|270077|P1|Overall Study|Withdrawal by Subject|12
68660|NCT01331681|270075|P3|Overall Study|Lack of Efficacy|0
68661|NCT01331681|270076|P2|Overall Study|Lack of Efficacy|1
68662|NCT01331681|270077|P1|Overall Study|Lack of Efficacy|0
68663|NCT01331681|270075|P3|Overall Study|Death|2
68664|NCT01331681|270076|P2|Overall Study|Death|6
68665|NCT01331681|270077|P1|Overall Study|Death|6
68666|NCT01331681|270075|P3|Overall Study|Adverse Event|10
68667|NCT01331681|270076|P2|Overall Study|Adverse Event|13
68668|NCT01331681|270077|P1|Overall Study|Adverse Event|10
68669|NCT01331291|270120|P2|Overall Study|Death|1
68670|NCT01331291|270121|P1|Overall Study|Death|0
68671|NCT01331291|270120|P2|Overall Study|Lack of Efficacy|8
68672|NCT01331291|270121|P1|Overall Study|Lack of Efficacy|2
68673|NCT01331161|270155|P2|Overall Study|Pregnancy|1
68674|NCT01331161|270156|P1|Overall Study|Pregnancy|0
68675|NCT01331161|270155|P2|Overall Study|Lost to Follow-up|1
68676|NCT01331161|270156|P1|Overall Study|Lost to Follow-up|0
68677|NCT01331161|270155|P2|Overall Study|Physician Decision|0
68678|NCT01331161|270156|P1|Overall Study|Physician Decision|1
68679|NCT01331109|270164|P1|Overall Study|Study Terminated by Sponsor|38
68680|NCT01331109|270164|P1|Overall Study|Lost to Follow-up|1
68681|NCT01331109|270164|P1|Overall Study|Withdrawal by Subject|7
68682|NCT01331109|270164|P1|Overall Study|Protocol Violation|3
68683|NCT01331109|270164|P1|Overall Study|Lack of Efficacy|2
68684|NCT01331109|270164|P1|Overall Study|Adverse Event|6
68685|NCT01331005|270176|P2|Overall Study|Withdrawal by Subject|3
68686|NCT01331005|270177|P1|Overall Study|Withdrawal by Subject|2
68687|NCT01331005|270176|P2|Overall Study|Lost to Follow-up|1
68688|NCT01331005|270177|P1|Overall Study|Lost to Follow-up|2
68689|NCT01330914|270183|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
68690|NCT01330914|270183|P1|Overall Study|Withdrawal by Subject|4
68691|NCT01330628|270189|P2|Overall Study|Didn't receive study treatment|0
68692|NCT01330628|270190|P1|Overall Study|Didn't receive study treatment|1
68693|NCT01330628|270189|P2|Overall Study|Withdrawn|6
68694|NCT01330628|270190|P1|Overall Study|Withdrawn|18
68695|NCT01330628|270189|P2|Overall Study|Adverse Event|25
68696|NCT01330628|270190|P1|Overall Study|Adverse Event|44
68697|NCT01330628|270189|P2|Overall Study|Lost to Follow-up|6
68698|NCT01330628|270190|P1|Overall Study|Lost to Follow-up|5
68699|NCT01330628|270189|P2|Overall Study|Death|3
68700|NCT01330628|270190|P1|Overall Study|Death|2
68701|NCT01330433|270200|P2|Overall Study|Lost to Follow-up|0
68702|NCT01330433|270201|P1|Overall Study|Lost to Follow-up|1
68703|NCT01330433|270200|P2|Overall Study|Death|3
68704|NCT01330433|270201|P1|Overall Study|Death|1
68705|NCT01330381|270240|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
68706|NCT01330381|270241|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
68707|NCT01330381|270242|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
68708|NCT01330381|270240|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
68709|NCT01330381|270241|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
68710|NCT01330381|270242|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
68711|NCT01330381|270240|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
68712|NCT01330381|270241|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
68713|NCT01330381|270242|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
68714|NCT01330381|270240|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
68715|NCT01330381|270241|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
68716|NCT01330381|270242|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
68717|NCT01330381|270240|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
68718|NCT01330381|270241|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
68719|NCT01330381|270242|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
68720|NCT01330381|270240|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
68721|NCT01330381|270241|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
68722|NCT01330381|270242|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
68723|NCT01330381|270240|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
68724|NCT01330381|270241|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
68725|NCT01330381|270242|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
68726|NCT01330381|270240|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
68727|NCT01330381|270241|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
68728|NCT01330381|270242|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
68729|NCT01330381|270240|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
68730|NCT01330381|270241|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
68731|NCT01330381|270242|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
68732|NCT01330381|270240|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
68733|NCT01330381|270241|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
68734|NCT01330381|270242|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
68735|NCT01330316|270303|P2|Overall Study|other than above|1
68736|NCT01330316|270304|P1|Overall Study|other than above|0
68737|NCT01330316|270303|P2|Overall Study|Withdrawal by Subject|1
68738|NCT01330316|270304|P1|Overall Study|Withdrawal by Subject|0
68739|NCT01330316|270303|P2|Overall Study|Lost to Follow-up|1
68740|NCT01330316|270304|P1|Overall Study|Lost to Follow-up|0
68741|NCT01330316|270303|P2|Overall Study|Lack of Efficacy|10
68742|NCT01330316|270304|P1|Overall Study|Lack of Efficacy|0
68743|NCT01330316|270303|P2|Overall Study|Adverse Event|2
68744|NCT01330316|270304|P1|Overall Study|Adverse Event|2
68745|NCT01330303|270340|P2|Period 1|Withdrawal by Subject|1
68746|NCT01330303|270341|P1|Period 1|Withdrawal by Subject|0
68747|NCT01330303|270340|P2|Period 1|Protocol Violation|1
68748|NCT01330303|270341|P1|Period 1|Protocol Violation|0
68749|NCT01330303|270340|P2|Period 1|Adverse Event|0
68750|NCT01330303|270341|P1|Period 1|Adverse Event|1
68751|NCT01330108|270375|P1|Overall Study|Withdrawal by Subject|4
68752|NCT01330030|270393|P2|Overall Study|Lost to Follow-up|17
68753|NCT01330030|270394|P1|Overall Study|Lost to Follow-up|16
68754|NCT01330017|270405|P5|Overall Study|Unknown Reason|2
68755|NCT01330017|270406|P4|Overall Study|Unknown Reason|7
68756|NCT01330017|270407|P3|Overall Study|Unknown Reason|5
68757|NCT01330017|270408|P2|Overall Study|Unknown Reason|3
68758|NCT01330017|270409|P1|Overall Study|Unknown Reason|5
68759|NCT01330017|270405|P5|Overall Study|Protocol Violation|0
68760|NCT01330017|270406|P4|Overall Study|Protocol Violation|1
68761|NCT01330017|270407|P3|Overall Study|Protocol Violation|0
68762|NCT01330017|270408|P2|Overall Study|Protocol Violation|0
68763|NCT01330017|270409|P1|Overall Study|Protocol Violation|0
68764|NCT01330017|270405|P5|Overall Study|Lost to Follow-up|0
68765|NCT01330017|270406|P4|Overall Study|Lost to Follow-up|0
68766|NCT01330017|270407|P3|Overall Study|Lost to Follow-up|1
68767|NCT01330017|270408|P2|Overall Study|Lost to Follow-up|0
68768|NCT01330017|270409|P1|Overall Study|Lost to Follow-up|0
68769|NCT01330017|270405|P5|Overall Study|Withdrawal by Subject|1
68770|NCT01330017|270406|P4|Overall Study|Withdrawal by Subject|0
68771|NCT01330017|270407|P3|Overall Study|Withdrawal by Subject|1
68772|NCT01330017|270408|P2|Overall Study|Withdrawal by Subject|0
68773|NCT01330017|270409|P1|Overall Study|Withdrawal by Subject|0
68774|NCT01330017|270405|P5|Overall Study|Adverse Event|0
68775|NCT01330017|270406|P4|Overall Study|Adverse Event|4
68776|NCT01330017|270407|P3|Overall Study|Adverse Event|1
68777|NCT01330017|270408|P2|Overall Study|Adverse Event|1
68778|NCT01330017|270409|P1|Overall Study|Adverse Event|0
68779|NCT01329978|270458|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
68780|NCT01329978|270459|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
68781|NCT01329978|270460|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
68782|NCT01329978|270461|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
68783|NCT01329978|270462|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
68784|NCT01329978|270458|P5|Rerandomization Treatment Period|Lost to Follow-up|3
68785|NCT01329978|270459|P4|Rerandomization Treatment Period|Lost to Follow-up|5
68786|NCT01329978|270460|P3|Rerandomization Treatment Period|Lost to Follow-up|0
68787|NCT01329978|270461|P2|Rerandomization Treatment Period|Lost to Follow-up|0
68788|NCT01329978|270462|P1|Rerandomization Treatment Period|Lost to Follow-up|0
68789|NCT01329978|270458|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
68790|NCT01329978|270459|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
68791|NCT01329978|270460|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
68792|NCT01329978|270461|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
68793|NCT01329978|270462|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
68794|NCT01329978|270458|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
68795|NCT01329978|270459|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
68796|NCT01329978|270460|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
68797|NCT01329978|270461|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
68798|NCT01329978|270462|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
68799|NCT01329978|270458|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
68800|NCT01329978|270459|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
68801|NCT01329978|270460|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
68802|NCT01329978|270461|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
68803|NCT01329978|270462|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
68804|NCT01329978|270458|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
68805|NCT01329978|270459|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
68806|NCT01329978|270460|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
68807|NCT01329978|270461|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
68808|NCT01329978|270462|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
68809|NCT01329978|270458|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
68810|NCT01329978|270459|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
68811|NCT01329978|270460|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
68812|NCT01329978|270461|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
68813|NCT01329978|270462|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
68814|NCT01329939|270536|P4|Overall Study|Adverse Event|3
68815|NCT01329939|270537|P3|Overall Study|Adverse Event|0
68816|NCT01329939|270538|P2|Overall Study|Adverse Event|0
68817|NCT01329939|270539|P1|Overall Study|Adverse Event|0
68818|NCT01329939|270536|P4|Overall Study|Withdrawal by Subject|0
68819|NCT01329939|270537|P3|Overall Study|Withdrawal by Subject|0
68820|NCT01329939|270538|P2|Overall Study|Withdrawal by Subject|1
68821|NCT01329939|270539|P1|Overall Study|Withdrawal by Subject|0
68822|NCT01329939|270536|P4|Overall Study|Lost to Follow-up|2
68823|NCT01329939|270537|P3|Overall Study|Lost to Follow-up|1
68824|NCT01329939|270538|P2|Overall Study|Lost to Follow-up|0
68825|NCT01329939|270539|P1|Overall Study|Lost to Follow-up|3
68826|NCT01329562|270603|P2|Overall Study|Physician Decision|1
68827|NCT01329562|270604|P1|Overall Study|Physician Decision|0
68828|NCT01329562|270603|P2|Overall Study|Subject withdrew due to personal issues.|2
68829|NCT01329562|270604|P1|Overall Study|Subject withdrew due to personal issues.|3
68830|NCT01329562|270603|P2|Overall Study|Lost to Follow-up|1
68831|NCT01329562|270604|P1|Overall Study|Lost to Follow-up|1
68832|NCT01329562|270603|P2|Overall Study|Protocol Violation|3
68833|NCT01329562|270604|P1|Overall Study|Protocol Violation|5
68834|NCT01329549|270653|P1|Overall Study|Adverse Event|1
68835|NCT01329549|270653|P1|Overall Study|Withdrawal by Subject|1
68836|NCT01329419|270664|P1|Overall Study|Protocol Violation|235
68837|NCT01329263|270672|P2|Overall Study|Withdrawal by Subject|2
68838|NCT01329263|270673|P1|Overall Study|Withdrawal by Subject|1
68839|NCT01329263|270672|P2|Overall Study|Lost to Follow-up|21
68840|NCT01329263|270673|P1|Overall Study|Lost to Follow-up|4
68841|NCT01329029|270710|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
68842|NCT01329029|270711|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
68843|NCT01329029|270710|P2|Overall Study|Lost to Follow-up|5
68844|NCT01329029|270711|P1|Overall Study|Lost to Follow-up|8
68845|NCT01329029|270710|P2|Overall Study|Physician Decision|13
68846|NCT01329029|270711|P1|Overall Study|Physician Decision|16
68847|NCT01329029|270710|P2|Overall Study|COPD Exacerbation|18
68848|NCT01329029|270711|P1|Overall Study|COPD Exacerbation|11
68849|NCT01329029|270710|P2|Overall Study|Other|20
68850|NCT01329029|270711|P1|Overall Study|Other|14
68851|NCT01329029|270710|P2|Overall Study|Death|19
68852|NCT01329029|270711|P1|Overall Study|Death|16
68853|NCT01329029|270710|P2|Overall Study|Adverse Event|29
68854|NCT01329029|270711|P1|Overall Study|Adverse Event|82
68855|NCT01329029|270710|P2|Overall Study|Withdrawal by Subject|87
68856|NCT01329029|270711|P1|Overall Study|Withdrawal by Subject|117
68857|NCT01328951|270801|P2|Overall Study|Not Specified|6
68858|NCT01328951|270802|P1|Overall Study|Not Specified|11
68859|NCT01328951|270801|P2|Overall Study|Study Closed by the Sponsor|31
68860|NCT01328951|270802|P1|Overall Study|Study Closed by the Sponsor|36
68861|NCT01328951|270801|P2|Overall Study|Withdrawal by Subject|6
68862|NCT01328951|270802|P1|Overall Study|Withdrawal by Subject|6
68863|NCT01328951|270801|P2|Overall Study|Lost to Follow-up|7
68864|NCT01328951|270802|P1|Overall Study|Lost to Follow-up|6
68865|NCT01328951|270801|P2|Overall Study|Death|258
68866|NCT01328951|270802|P1|Overall Study|Death|243
68867|NCT01328951|270801|P2|Overall Study|Adverse Event|0
68868|NCT01328951|270802|P1|Overall Study|Adverse Event|2
68869|NCT01328951|270801|P2|Overall Study|Disease Progression|14
68870|NCT01328951|270802|P1|Overall Study|Disease Progression|17
68871|NCT01328756|270871|P1|Overall Study|Other|29
68872|NCT01328756|270871|P1|Overall Study|Lost to Follow-up|5
68873|NCT01328756|270871|P1|Overall Study|Withdrawal by Subject|41
68874|NCT01328756|270871|P1|Overall Study|Lack of Efficacy|5
68875|NCT01328756|270871|P1|Overall Study|Adverse Event|39
68876|NCT01328756|270871|P1|Overall Study|Protocol Violation|4
68877|NCT01328717|270888|P1|Overall Study|Adverse Event|1
68878|NCT01328574|270893|P1|Overall Study|Refused further treatment|1
68879|NCT01328548|270907|P2|Overall Study|Protocol Violation|0
68880|NCT01328548|270908|P1|Overall Study|Protocol Violation|1
68881|NCT01328548|270907|P2|Overall Study|Death|0
68882|NCT01328548|270908|P1|Overall Study|Death|3
68883|NCT01328496|270928|P2|Overall Study|Significant Change in Health Status|0
68884|NCT01328496|270929|P1|Overall Study|Significant Change in Health Status|1
68885|NCT01328444|270947|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
68886|NCT01328444|270948|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
68887|NCT01328444|270949|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
68888|NCT01328444|270950|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
68889|NCT01328444|270951|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
68890|NCT01328444|270952|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
68891|NCT01328444|270947|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
68892|NCT01328444|270948|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
68893|NCT01328444|270949|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
68894|NCT01328444|270950|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
68895|NCT01328444|270951|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
68896|NCT01328444|270952|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
68897|NCT01328444|270947|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
68898|NCT01328444|270948|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
68899|NCT01328444|270949|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
68900|NCT01328444|270950|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
68901|NCT01328444|270951|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
68902|NCT01328444|270952|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
68903|NCT01328444|270947|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
68904|NCT01328444|270948|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
68905|NCT01328444|270949|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
68906|NCT01328444|270950|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
68907|NCT01328444|270951|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
68908|NCT01328444|270952|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
68909|NCT01328444|270947|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
68910|NCT01328444|270948|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
68911|NCT01328444|270949|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
68912|NCT01328444|270950|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
68913|NCT01328444|270951|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
68914|NCT01328444|270952|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
68915|NCT01328444|270947|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
68916|NCT01328444|270948|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
68917|NCT01328444|270949|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
68918|NCT01328444|270950|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
68919|NCT01328444|270951|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
68920|NCT01328444|270952|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
68921|NCT01328444|270947|P6|Washout Period (14 Days)|Withdrawal by Subject|1
68922|NCT01328444|270948|P5|Washout Period (14 Days)|Withdrawal by Subject|0
68923|NCT01328444|270949|P4|Washout Period (14 Days)|Withdrawal by Subject|0
68924|NCT01328444|270950|P3|Washout Period (14 Days)|Withdrawal by Subject|0
68925|NCT01328444|270951|P2|Washout Period (14 Days)|Withdrawal by Subject|0
68926|NCT01328444|270952|P1|Washout Period (14 Days)|Withdrawal by Subject|0
68927|NCT01328444|270947|P6|Washout Period (14 Days)|Lack of Efficacy|1
68928|NCT01328444|270948|P5|Washout Period (14 Days)|Lack of Efficacy|0
68929|NCT01328444|270949|P4|Washout Period (14 Days)|Lack of Efficacy|0
68930|NCT01328444|270950|P3|Washout Period (14 Days)|Lack of Efficacy|0
68931|NCT01328444|270951|P2|Washout Period (14 Days)|Lack of Efficacy|0
68932|NCT01328444|270952|P1|Washout Period (14 Days)|Lack of Efficacy|0
68933|NCT01328444|270947|P6|Washout Period (14 Days)|Adverse Event|2
68934|NCT01328444|270948|P5|Washout Period (14 Days)|Adverse Event|1
68935|NCT01328444|270949|P4|Washout Period (14 Days)|Adverse Event|1
68936|NCT01328444|270950|P3|Washout Period (14 Days)|Adverse Event|0
68937|NCT01328444|270951|P2|Washout Period (14 Days)|Adverse Event|1
68938|NCT01328444|270952|P1|Washout Period (14 Days)|Adverse Event|1
68939|NCT01328444|270947|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
68940|NCT01328444|270948|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
68941|NCT01328444|270949|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
68942|NCT01328444|270950|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
68943|NCT01328444|270951|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
68944|NCT01328444|270952|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
68945|NCT01328444|270947|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
68946|NCT01328444|270948|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
68947|NCT01328444|270949|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
68948|NCT01328444|270950|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
68949|NCT01328444|270951|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
68950|NCT01328444|270952|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
68951|NCT01328444|270947|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
69115|NCT01327053|271770|P1|Overall Study|Physician Decision|3
68952|NCT01328444|270948|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
68953|NCT01328444|270949|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
68954|NCT01328444|270950|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
68955|NCT01328444|270951|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
68956|NCT01328444|270952|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
68957|NCT01328444|270947|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
68958|NCT01328444|270948|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
68959|NCT01328444|270949|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
68960|NCT01328444|270950|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
68961|NCT01328444|270951|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
68962|NCT01328444|270952|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
68963|NCT01328444|270947|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
68964|NCT01328444|270948|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
68965|NCT01328444|270949|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
68966|NCT01328444|270950|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
68967|NCT01328444|270951|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
68968|NCT01328444|270952|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
68969|NCT01328444|270947|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
68970|NCT01328444|270948|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
68971|NCT01328444|270949|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
68972|NCT01328444|270950|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
68973|NCT01328444|270951|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
68974|NCT01328444|270952|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
68975|NCT01328431|270998|P2|12 Month (12M)|Lost to Follow-up|91
68976|NCT01328431|270999|P1|12 Month (12M)|Lost to Follow-up|82
68977|NCT01328431|270998|P2|12 Month (12M)|Death|6
68978|NCT01328431|270999|P1|12 Month (12M)|Death|2
68979|NCT01328431|270998|P2|3 Month (3M)|Lost to Follow-up|70
68980|NCT01328431|270999|P1|3 Month (3M)|Lost to Follow-up|75
68981|NCT01328431|270998|P2|3 Month (3M)|Death|2
68982|NCT01328431|270999|P1|3 Month (3M)|Death|2
68983|NCT01328431|270998|P2|1 Month (1M)|Lost to Follow-up|58
68984|NCT01328431|270999|P1|1 Month (1M)|Lost to Follow-up|55
68985|NCT01328431|270998|P2|Baseline|Protocol Violation|2
68986|NCT01328431|270999|P1|Baseline|Protocol Violation|0
68987|NCT01328366|271055|P1|Overall Study|Lost to Follow-up|7
68988|NCT01328366|271055|P1|Overall Study|Withdrawal by Subject|2
68989|NCT01328366|271055|P1|Overall Study|Death|1
68990|NCT01328080|271151|P1|Overall Study|Lost to Follow-up|5
68991|NCT01328054|271155|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
68992|NCT01328054|271156|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
68993|NCT01328054|271155|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
68994|NCT01328054|271156|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
68995|NCT01328054|271155|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
68996|NCT01328054|271156|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
68997|NCT01328041|271181|P1|Overall Study|Withdrawal by Subject|7
68998|NCT01328041|271181|P1|Overall Study|Physician Decision|2
68999|NCT01328041|271181|P1|Overall Study|Lost to Follow-up|7
69000|NCT01328041|271181|P1|Overall Study|Protocol Violation|7
69001|NCT01328041|271181|P1|Overall Study|Lack of Efficacy|27
69002|NCT01328041|271181|P1|Overall Study|Adverse Event|7
69003|NCT01327885|271230|P2|Overall Study|Ongoing|1
69004|NCT01327885|271231|P1|Overall Study|Ongoing|1
69005|NCT01327885|271230|P2|Overall Study|Not treated|1
69006|NCT01327885|271231|P1|Overall Study|Not treated|1
69007|NCT01327885|271230|P2|Overall Study|Withdrawal of consent from study|4
69008|NCT01327885|271231|P1|Overall Study|Withdrawal of consent from study|2
69009|NCT01327885|271230|P2|Overall Study|Not specified|6
69010|NCT01327885|271231|P1|Overall Study|Not specified|8
69011|NCT01327885|271230|P2|Overall Study|Subject choice|10
69012|NCT01327885|271231|P1|Overall Study|Subject choice|5
69013|NCT01327885|271230|P2|Overall Study|Adverse Event|10
69014|NCT01327885|271231|P1|Overall Study|Adverse Event|14
69015|NCT01327885|271230|P2|Overall Study|Clinical progression|27
69016|NCT01327885|271231|P1|Overall Study|Clinical progression|24
69017|NCT01327885|271230|P2|Overall Study|Disease progression-according to RECIST|165
69018|NCT01327885|271231|P1|Overall Study|Disease progression-according to RECIST|173
69019|NCT01327703|271243|P2|Second Treatment Period|Protocol Violation|1
69020|NCT01327703|271244|P1|Second Treatment Period|Protocol Violation|0
69021|NCT01327703|271243|P2|Second Treatment Period|Adverse Event|1
69022|NCT01327703|271244|P1|Second Treatment Period|Adverse Event|1
69023|NCT01327651|271300|P9|Post Study Follow-up|Lost to Follow-up|2
69024|NCT01327651|271301|P8|Post Study Follow-up|Lost to Follow-up|1
69025|NCT01327651|271302|P7|Post Study Follow-up|Lost to Follow-up|4
69026|NCT01327651|271303|P6|Post Study Follow-up|Lost to Follow-up|0
69027|NCT01327651|271304|P5|Post Study Follow-up|Lost to Follow-up|0
69028|NCT01327651|271305|P4|Post Study Follow-up|Lost to Follow-up|0
69029|NCT01327651|271306|P3|Post Study Follow-up|Lost to Follow-up|1
69030|NCT01327651|271307|P2|Post Study Follow-up|Lost to Follow-up|1
69031|NCT01327651|271308|P1|Post Study Follow-up|Lost to Follow-up|0
69032|NCT01327651|271300|P9|Self-administered Dosing Period|Withdrawal by Subject|1
69033|NCT01327651|271301|P8|Self-administered Dosing Period|Withdrawal by Subject|1
69034|NCT01327651|271302|P7|Self-administered Dosing Period|Withdrawal by Subject|2
69035|NCT01327651|271303|P6|Self-administered Dosing Period|Withdrawal by Subject|0
69036|NCT01327651|271304|P5|Self-administered Dosing Period|Withdrawal by Subject|0
69037|NCT01327651|271305|P4|Self-administered Dosing Period|Withdrawal by Subject|1
69038|NCT01327651|271306|P3|Self-administered Dosing Period|Withdrawal by Subject|0
69039|NCT01327651|271307|P2|Self-administered Dosing Period|Withdrawal by Subject|1
69040|NCT01327651|271308|P1|Self-administered Dosing Period|Withdrawal by Subject|0
69041|NCT01327651|271300|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
69042|NCT01327651|271301|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
69043|NCT01327651|271302|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
69044|NCT01327651|271303|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
69045|NCT01327651|271304|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
69046|NCT01327651|271305|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
69047|NCT01327651|271306|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
69048|NCT01327651|271307|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
69049|NCT01327651|271308|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
69050|NCT01327651|271300|P9|Self-administered Dosing Period|Lost to Follow-up|10
69051|NCT01327651|271301|P8|Self-administered Dosing Period|Lost to Follow-up|9
69052|NCT01327651|271302|P7|Self-administered Dosing Period|Lost to Follow-up|8
69053|NCT01327651|271303|P6|Self-administered Dosing Period|Lost to Follow-up|0
69054|NCT01327651|271304|P5|Self-administered Dosing Period|Lost to Follow-up|3
69055|NCT01327651|271305|P4|Self-administered Dosing Period|Lost to Follow-up|2
69056|NCT01327651|271306|P3|Self-administered Dosing Period|Lost to Follow-up|4
69057|NCT01327651|271307|P2|Self-administered Dosing Period|Lost to Follow-up|2
69058|NCT01327651|271308|P1|Self-administered Dosing Period|Lost to Follow-up|3
69059|NCT01327599|271427|P1|Overall Study|Withdrawal of Consent|1
69060|NCT01327599|271427|P1|Overall Study|Could Not Attend Visit|1
69061|NCT01327599|271427|P1|Overall Study|Adverse Event|1
69062|NCT01327547|271437|P2|Overall Study|By investigator in subject’s interest|1
69063|NCT01327547|271438|P1|Overall Study|By investigator in subject’s interest|0
69064|NCT01327547|271437|P2|Overall Study|Non-compliance with study procedures|0
69065|NCT01327547|271438|P1|Overall Study|Non-compliance with study procedures|1
69066|NCT01327547|271437|P2|Overall Study|Required prohibited medication|0
69067|NCT01327547|271438|P1|Overall Study|Required prohibited medication|2
69068|NCT01327547|271437|P2|Overall Study|Non-compliance due to alcohol intake|1
69069|NCT01327547|271438|P1|Overall Study|Non-compliance due to alcohol intake|0
69070|NCT01327547|271437|P2|Overall Study|Protocol Violation|0
69071|NCT01327547|271438|P1|Overall Study|Protocol Violation|1
69072|NCT01327547|271437|P2|Overall Study|Does Not Meet Entrance Criteria|2
69073|NCT01327547|271438|P1|Overall Study|Does Not Meet Entrance Criteria|2
69074|NCT01327547|271437|P2|Overall Study|Withdrawal by Subject|7
69075|NCT01327547|271438|P1|Overall Study|Withdrawal by Subject|3
69076|NCT01327547|271437|P2|Overall Study|Non-Compliance With Study Treatment|2
69077|NCT01327547|271438|P1|Overall Study|Non-Compliance With Study Treatment|0
69078|NCT01327547|271437|P2|Overall Study|Lost to Follow-up|6
69079|NCT01327547|271438|P1|Overall Study|Lost to Follow-up|6
69080|NCT01327547|271437|P2|Overall Study|Death|2
69081|NCT01327547|271438|P1|Overall Study|Death|1
69082|NCT01327547|271437|P2|Overall Study|Adverse Event|1
69083|NCT01327547|271438|P1|Overall Study|Adverse Event|4
69084|NCT01327495|271506|P6|Overall Study|Physician Decision|0
69085|NCT01327495|271507|P5|Overall Study|Physician Decision|2
69086|NCT01327495|271508|P4|Overall Study|Physician Decision|0
69087|NCT01327495|271509|P3|Overall Study|Physician Decision|0
69088|NCT01327495|271510|P2|Overall Study|Physician Decision|0
69089|NCT01327495|271511|P1|Overall Study|Physician Decision|0
69090|NCT01327495|271506|P6|Overall Study|Withdrawal by Subject|0
69091|NCT01327495|271507|P5|Overall Study|Withdrawal by Subject|1
69092|NCT01327495|271508|P4|Overall Study|Withdrawal by Subject|0
69093|NCT01327495|271509|P3|Overall Study|Withdrawal by Subject|1
69094|NCT01327495|271510|P2|Overall Study|Withdrawal by Subject|1
69095|NCT01327495|271511|P1|Overall Study|Withdrawal by Subject|0
69096|NCT01327495|271506|P6|Overall Study|Adverse Event|2
69097|NCT01327495|271507|P5|Overall Study|Adverse Event|0
69098|NCT01327495|271508|P4|Overall Study|Adverse Event|0
69099|NCT01327495|271509|P3|Overall Study|Adverse Event|1
69100|NCT01327495|271510|P2|Overall Study|Adverse Event|1
69101|NCT01327495|271511|P1|Overall Study|Adverse Event|2
69102|NCT01327482|271603|P1|Overall Study|Adverse Event|1
69103|NCT01327339|271608|P1|Overall Study|Protocol Violation|8
69104|NCT01327300|271743|P2|Washout (3 Weeks)|Withdrawal by Subject|0
69105|NCT01327300|271744|P1|Washout (3 Weeks)|Withdrawal by Subject|1
69106|NCT01327053|271769|P2|Overall Study|Untreated|1
69107|NCT01327053|271770|P1|Overall Study|Untreated|0
69108|NCT01327053|271769|P2|Overall Study|Withdrawal by Subject|28
69109|NCT01327053|271770|P1|Overall Study|Withdrawal by Subject|5
69110|NCT01327053|271769|P2|Overall Study|Protocol Violation|1
69111|NCT01327053|271770|P1|Overall Study|Protocol Violation|0
69112|NCT01327053|271769|P2|Overall Study|Progressive Disease|6
69113|NCT01327053|271770|P1|Overall Study|Progressive Disease|15
69114|NCT01327053|271769|P2|Overall Study|Physician Decision|10
69116|NCT01327053|271769|P2|Overall Study|Non-compliance with study treatment|3
69117|NCT01327053|271770|P1|Overall Study|Non-compliance with study treatment|0
69118|NCT01327053|271769|P2|Overall Study|Lost to Follow-up|4
69119|NCT01327053|271770|P1|Overall Study|Lost to Follow-up|1
69120|NCT01327053|271769|P2|Overall Study|Death|4
69121|NCT01327053|271770|P1|Overall Study|Death|0
69122|NCT01327053|271769|P2|Overall Study|Adverse Event|48
69123|NCT01327053|271770|P1|Overall Study|Adverse Event|16
69124|NCT01326962|271798|P1|Overall Study|Not Specified|2
69125|NCT01326962|271798|P1|Overall Study|Lost to Follow-up|3
69126|NCT01326962|271798|P1|Overall Study|Withdrawal by Subject|1
69127|NCT01326962|271798|P1|Overall Study|Adverse Event|1
69128|NCT01326910|271816|P2|Overall Study|Protocol Violation|1
69129|NCT01326910|271817|P1|Overall Study|Protocol Violation|1
69130|NCT01326910|271816|P2|Overall Study|Withdrawal by Subject|2
69131|NCT01326910|271817|P1|Overall Study|Withdrawal by Subject|3
69132|NCT01326845|271831|P2|Overall Study|Misisng|3
69133|NCT01326845|271832|P1|Overall Study|Misisng|1
69134|NCT01326845|271831|P2|Overall Study|Adverse Event|0
69135|NCT01326845|271832|P1|Overall Study|Adverse Event|1
69136|NCT01326845|271831|P2|Overall Study|Administrative Problems|2
69137|NCT01326845|271832|P1|Overall Study|Administrative Problems|5
69138|NCT01326533|271856|P2|Overall Study|Adverse Event|0
69139|NCT01326533|271857|P1|Overall Study|Adverse Event|1
69140|NCT01326533|271856|P2|Overall Study|Withdrawal by Subject|0
69141|NCT01326533|271857|P1|Overall Study|Withdrawal by Subject|1
69142|NCT01326533|271856|P2|Overall Study|Lost to Follow-up|0
69143|NCT01326533|271857|P1|Overall Study|Lost to Follow-up|2
69144|NCT01326026|271867|P2|Overall Study|Other|3
69145|NCT01326026|271868|P1|Overall Study|Other|3
69146|NCT01326026|271867|P2|Overall Study|Withdrawal Criteria|7
69147|NCT01326026|271868|P1|Overall Study|Withdrawal Criteria|5
69148|NCT01326026|271867|P2|Overall Study|Adverse Event|3
69149|NCT01326026|271868|P1|Overall Study|Adverse Event|4
69150|NCT01325701|271933|P2|Overall Study|Rollerover Extension Study|0
69151|NCT01325701|271934|P1|Overall Study|Rollerover Extension Study|4
69152|NCT01325701|271933|P2|Overall Study|Withdrawal by Subject|1
69153|NCT01325701|271934|P1|Overall Study|Withdrawal by Subject|2
69154|NCT01325701|271933|P2|Overall Study|Physician Decision|2
69155|NCT01325701|271934|P1|Overall Study|Physician Decision|2
69156|NCT01325701|271933|P2|Overall Study|Protocol Violation|0
69157|NCT01325701|271934|P1|Overall Study|Protocol Violation|1
69158|NCT01325701|271933|P2|Overall Study|Adverse Event|0
69159|NCT01325701|271934|P1|Overall Study|Adverse Event|12
69160|NCT01325623|271944|P1|Overall Study|Withdrawal by Subject|3
69161|NCT01325532|271988|P2|Overall Study|Withdrawal by Subject|0
69162|NCT01325532|271989|P1|Overall Study|Withdrawal by Subject|2
69163|NCT01325493|272001|P2|Overall Study|Allergy|0
69164|NCT01325493|272002|P1|Overall Study|Allergy|1
69165|NCT01325493|272001|P2|Overall Study|loss of neuromonitoring signals|2
69166|NCT01325493|272002|P1|Overall Study|loss of neuromonitoring signals|0
69167|NCT01325493|272001|P2|Overall Study|Protocol Violation|1
69168|NCT01325493|272002|P1|Overall Study|Protocol Violation|0
69169|NCT01325428|272014|P1|Part B|Other reason not defined above|1
69170|NCT01325428|272014|P1|Part B|Refused continue taking trial medication|2
69171|NCT01325428|272014|P1|Part A|Other reason not defined above|2
69172|NCT01325428|272014|P1|Part A|Refused continue taking trial medication|2
69173|NCT01325428|272014|P1|Part A|Other adverse event|1
69174|NCT01325428|272014|P1|Part A|Clinical signs, symptoms of progression|2
69175|NCT01325428|272014|P1|Part A|Progressive disease according to RECIST|9
69176|NCT01325350|272034|P5|Overall Study|Did Not Receive Treatment|1
69177|NCT01325350|272035|P4|Overall Study|Did Not Receive Treatment|0
69178|NCT01325350|272036|P3|Overall Study|Did Not Receive Treatment|1
69179|NCT01325350|272037|P2|Overall Study|Did Not Receive Treatment|1
69180|NCT01325350|272038|P1|Overall Study|Did Not Receive Treatment|0
69181|NCT01325350|272034|P5|Overall Study|Withdrawal by Subject|0
69182|NCT01325350|272035|P4|Overall Study|Withdrawal by Subject|1
69183|NCT01325350|272036|P3|Overall Study|Withdrawal by Subject|1
69184|NCT01325350|272037|P2|Overall Study|Withdrawal by Subject|0
69185|NCT01325350|272038|P1|Overall Study|Withdrawal by Subject|0
69186|NCT01325350|272034|P5|Overall Study|Protocol Violation|0
69187|NCT01325350|272035|P4|Overall Study|Protocol Violation|1
69188|NCT01325350|272036|P3|Overall Study|Protocol Violation|0
69189|NCT01325350|272037|P2|Overall Study|Protocol Violation|0
69190|NCT01325350|272038|P1|Overall Study|Protocol Violation|0
69191|NCT01325350|272034|P5|Overall Study|Personal Reasons|3
69192|NCT01325350|272035|P4|Overall Study|Personal Reasons|5
69193|NCT01325350|272036|P3|Overall Study|Personal Reasons|6
69194|NCT01325350|272037|P2|Overall Study|Personal Reasons|1
69195|NCT01325350|272038|P1|Overall Study|Personal Reasons|2
69196|NCT01325350|272034|P5|Overall Study|Lost to Follow-up|5
69197|NCT01325350|272035|P4|Overall Study|Lost to Follow-up|1
69198|NCT01325350|272036|P3|Overall Study|Lost to Follow-up|5
69199|NCT01325350|272037|P2|Overall Study|Lost to Follow-up|0
69200|NCT01325350|272038|P1|Overall Study|Lost to Follow-up|1
69201|NCT01325350|272034|P5|Overall Study|Pregnancy|1
69202|NCT01325350|272035|P4|Overall Study|Pregnancy|0
69203|NCT01325350|272036|P3|Overall Study|Pregnancy|1
69204|NCT01325350|272037|P2|Overall Study|Pregnancy|0
69205|NCT01325350|272038|P1|Overall Study|Pregnancy|0
69206|NCT01325350|272034|P5|Overall Study|Adverse Event|2
69207|NCT01325350|272035|P4|Overall Study|Adverse Event|1
69208|NCT01325350|272036|P3|Overall Study|Adverse Event|3
69209|NCT01325350|272037|P2|Overall Study|Adverse Event|3
69210|NCT01325350|272038|P1|Overall Study|Adverse Event|3
69211|NCT01325337|272080|P5|Overall Study|Withdrawal by Subject|1
69212|NCT01325337|272081|P4|Overall Study|Withdrawal by Subject|0
69213|NCT01325337|272082|P3|Overall Study|Withdrawal by Subject|1
69214|NCT01325337|272083|P2|Overall Study|Withdrawal by Subject|0
69215|NCT01325337|272084|P1|Overall Study|Withdrawal by Subject|1
69216|NCT01325337|272080|P5|Overall Study|Personal Reasons|3
69217|NCT01325337|272081|P4|Overall Study|Personal Reasons|8
69218|NCT01325337|272082|P3|Overall Study|Personal Reasons|4
69219|NCT01325337|272083|P2|Overall Study|Personal Reasons|5
69220|NCT01325337|272084|P1|Overall Study|Personal Reasons|2
69221|NCT01325337|272080|P5|Overall Study|Lost to Follow-up|2
69222|NCT01325337|272081|P4|Overall Study|Lost to Follow-up|1
69223|NCT01325337|272082|P3|Overall Study|Lost to Follow-up|2
69224|NCT01325337|272083|P2|Overall Study|Lost to Follow-up|2
69225|NCT01325337|272084|P1|Overall Study|Lost to Follow-up|2
69226|NCT01325337|272080|P5|Overall Study|Adverse Event|2
69227|NCT01325337|272081|P4|Overall Study|Adverse Event|1
69228|NCT01325337|272082|P3|Overall Study|Adverse Event|2
69229|NCT01325337|272083|P2|Overall Study|Adverse Event|2
69230|NCT01325337|272084|P1|Overall Study|Adverse Event|0
69231|NCT01324999|272167|P1|Overall Study|Withdrawal by Subject|2
69232|NCT01324999|272167|P1|Overall Study|Adverse Event|3
69233|NCT01324947|272178|P1|Overall Study|1 discontinued before starting drug|1
69234|NCT01324947|272178|P1|Overall Study|Withdrawal by Subject|3
69235|NCT01324947|272178|P1|Overall Study|Progressive Disease|50
69236|NCT01324947|272178|P1|Overall Study|Other|3
69237|NCT01324947|272178|P1|Overall Study|Death|10
69238|NCT01324947|272178|P1|Overall Study|Adverse Event|7
69239|NCT01324622|272234|P2|Overall Study|Lack of Efficacy|0
69240|NCT01324622|272235|P1|Overall Study|Lack of Efficacy|1
69241|NCT01324622|272234|P2|Overall Study|Death|0
69242|NCT01324622|272235|P1|Overall Study|Death|1
69243|NCT01324622|272234|P2|Overall Study|Lost to Follow-up|7
69244|NCT01324622|272235|P1|Overall Study|Lost to Follow-up|7
69245|NCT01324570|272265|P2|Overall Study|Administrative|2
69246|NCT01324570|272266|P1|Overall Study|Administrative|0
69247|NCT01324570|272265|P2|Overall Study|Confirmed or suspected diversion|1
69248|NCT01324570|272266|P1|Overall Study|Confirmed or suspected diversion|0
69249|NCT01324570|272265|P2|Overall Study|Lack of Efficacy|1
69250|NCT01324570|272266|P1|Overall Study|Lack of Efficacy|0
69251|NCT01324570|272265|P2|Overall Study|Withdrawal by Subject|3
69252|NCT01324570|272266|P1|Overall Study|Withdrawal by Subject|0
69253|NCT01324570|272265|P2|Overall Study|Adverse Event|7
69254|NCT01324570|272266|P1|Overall Study|Adverse Event|4
69255|NCT01324440|272303|P2|Overall Study|Subject moved|1
69256|NCT01324440|272304|P1|Overall Study|Subject moved|0
69257|NCT01324401|272318|P2|Overall Study|Adverse Event|3
69258|NCT01324401|272319|P1|Overall Study|Adverse Event|1
69259|NCT01324401|272318|P2|Overall Study|Withdrawn before any treatment|3
69260|NCT01324401|272319|P1|Overall Study|Withdrawn before any treatment|0
69261|NCT01324388|272330|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
69262|NCT01324388|272331|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
69263|NCT01324388|272332|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
69264|NCT01324388|272333|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
69265|NCT01324388|272330|P4|Part 2 of Study: First Intervention|Protocol Violation|1
69266|NCT01324388|272331|P3|Part 2 of Study: First Intervention|Protocol Violation|0
69267|NCT01324388|272332|P2|Part 2 of Study: First Intervention|Protocol Violation|0
69268|NCT01324388|272333|P1|Part 2 of Study: First Intervention|Protocol Violation|0
69269|NCT01324388|272330|P4|Part 1 of Study|Physician Decision|0
69270|NCT01324388|272331|P3|Part 1 of Study|Physician Decision|0
69271|NCT01324388|272332|P2|Part 1 of Study|Physician Decision|0
69272|NCT01324388|272333|P1|Part 1 of Study|Physician Decision|1
69273|NCT01324388|272330|P4|Part 1 of Study|Protocol Violation|0
69274|NCT01324388|272331|P3|Part 1 of Study|Protocol Violation|0
69275|NCT01324388|272332|P2|Part 1 of Study|Protocol Violation|2
69276|NCT01324388|272333|P1|Part 1 of Study|Protocol Violation|1
69277|NCT01324388|272330|P4|Part 1 of Study|Adverse Event|0
69278|NCT01324388|272331|P3|Part 1 of Study|Adverse Event|0
69279|NCT01324388|272332|P2|Part 1 of Study|Adverse Event|0
69280|NCT01324388|272333|P1|Part 1 of Study|Adverse Event|2
69281|NCT01324349|272354|P2|Overall Study|Withdrawal by Subject|1
69282|NCT01324349|272355|P1|Overall Study|Withdrawal by Subject|0
69283|NCT01324349|272354|P2|Overall Study|Death|1
69284|NCT01324349|272355|P1|Overall Study|Death|1
69285|NCT01324323|272365|P1|Overall Study|Withdrawal by Subject|1
69286|NCT01324310|272385|P1|Overall Study|Disease Progression|1
69287|NCT01324310|272385|P1|Overall Study|Adverse Event|1
69288|NCT01324271|272405|P2|Overall Study|Physician Decision|0
69289|NCT01324271|272406|P1|Overall Study|Physician Decision|1
69290|NCT01324271|272405|P2|Overall Study|Lost to Follow-up|0
69291|NCT01324271|272406|P1|Overall Study|Lost to Follow-up|3
69292|NCT01324102|272429|P2|Overall Study|illness|6
69293|NCT01324102|272430|P1|Overall Study|illness|1
69294|NCT01324024|272437|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
69295|NCT01324024|272438|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
69296|NCT01323972|272476|P4|Overall Study|Lost to Follow-up|1
69297|NCT01323972|272477|P3|Overall Study|Lost to Follow-up|1
69298|NCT01323972|272478|P2|Overall Study|Lost to Follow-up|1
69299|NCT01323972|272479|P1|Overall Study|Lost to Follow-up|0
69300|NCT01323972|272476|P4|Overall Study|Migrated/moved from study area|0
69301|NCT01323972|272477|P3|Overall Study|Migrated/moved from study area|0
69302|NCT01323972|272478|P2|Overall Study|Migrated/moved from study area|2
69303|NCT01323972|272479|P1|Overall Study|Migrated/moved from study area|1
69304|NCT01323972|272476|P4|Overall Study|Withdrawal by Subject|0
69305|NCT01323972|272477|P3|Overall Study|Withdrawal by Subject|1
69306|NCT01323972|272478|P2|Overall Study|Withdrawal by Subject|0
69307|NCT01323972|272479|P1|Overall Study|Withdrawal by Subject|1
69308|NCT01323920|272572|P1|Overall Study|Withdrawal by Subject|1
69309|NCT01323920|272572|P1|Overall Study|Death|5
69310|NCT01323790|272613|P3|Overall Study|Severe non-compliance with protocol|2
69311|NCT01323790|272614|P2|Overall Study|Severe non-compliance with protocol|2
69312|NCT01323790|272615|P1|Overall Study|Severe non-compliance with protocol|2
69313|NCT01323790|272613|P3|Overall Study|Did Not Receive Treatment|1
69314|NCT01323790|272614|P2|Overall Study|Did Not Receive Treatment|0
69315|NCT01323790|272615|P1|Overall Study|Did Not Receive Treatment|2
69316|NCT01323790|272613|P3|Overall Study|Withdrawal by Subject|13
69317|NCT01323790|272614|P2|Overall Study|Withdrawal by Subject|20
69318|NCT01323790|272615|P1|Overall Study|Withdrawal by Subject|23
69319|NCT01323790|272613|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
69320|NCT01323790|272614|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
69321|NCT01323790|272615|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
69322|NCT01323790|272613|P3|Overall Study|Adverse Event|12
69323|NCT01323790|272614|P2|Overall Study|Adverse Event|24
69324|NCT01323790|272615|P1|Overall Study|Adverse Event|11
69325|NCT01323790|272613|P3|Overall Study|Lack of Efficacy|3
69326|NCT01323790|272614|P2|Overall Study|Lack of Efficacy|0
69327|NCT01323790|272615|P1|Overall Study|Lack of Efficacy|3
69328|NCT01323790|272613|P3|Overall Study|Study-Specific Withdrawal Criteria|3
69329|NCT01323790|272614|P2|Overall Study|Study-Specific Withdrawal Criteria|3
69330|NCT01323790|272615|P1|Overall Study|Study-Specific Withdrawal Criteria|0
69331|NCT01323790|272613|P3|Overall Study|Lost to Follow-up|9
69332|NCT01323790|272614|P2|Overall Study|Lost to Follow-up|9
69333|NCT01323790|272615|P1|Overall Study|Lost to Follow-up|11
69334|NCT01323790|272613|P3|Overall Study|Other|1
69335|NCT01323790|272614|P2|Overall Study|Other|2
69336|NCT01323790|272615|P1|Overall Study|Other|3
69337|NCT01323673|272666|P2|Overall Study|Withdrawal by Subject|3
69338|NCT01323673|272667|P1|Overall Study|Withdrawal by Subject|2
69339|NCT01323673|272666|P2|Overall Study|Protocol Violation|0
69340|NCT01323673|272667|P1|Overall Study|Protocol Violation|1
69341|NCT01323673|272666|P2|Overall Study|Lost to Follow-up|1
69342|NCT01323673|272667|P1|Overall Study|Lost to Follow-up|0
69343|NCT01323673|272666|P2|Overall Study|Adverse Event|1
69344|NCT01323673|272667|P1|Overall Study|Adverse Event|0
69345|NCT01323660|272687|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
69346|NCT01323660|272688|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
69347|NCT01323660|272689|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
69348|NCT01323660|272690|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
69349|NCT01323660|272691|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
69350|NCT01323660|272692|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
69351|NCT01323660|272687|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
69352|NCT01323660|272688|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
69353|NCT01323660|272689|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
69354|NCT01323660|272690|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
69355|NCT01323660|272691|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
69356|NCT01323660|272692|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
69357|NCT01323660|272687|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
69358|NCT01323660|272688|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
69359|NCT01323660|272689|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
69360|NCT01323660|272690|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
69361|NCT01323660|272691|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
69362|NCT01323660|272692|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
69363|NCT01323660|272687|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
69364|NCT01323660|272688|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
69365|NCT01323660|272689|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
69366|NCT01323660|272690|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
69367|NCT01323660|272691|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
69368|NCT01323660|272692|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
69369|NCT01323660|272687|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
69370|NCT01323660|272688|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
69371|NCT01323660|272689|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
69372|NCT01323660|272690|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
69373|NCT01323660|272691|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
69374|NCT01323660|272692|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
69375|NCT01323660|272687|P6|Washout Period (14 Days)|Lack of Efficacy|2
69376|NCT01323660|272688|P5|Washout Period (14 Days)|Lack of Efficacy|2
69377|NCT01323660|272689|P4|Washout Period (14 Days)|Lack of Efficacy|3
69378|NCT01323660|272690|P3|Washout Period (14 Days)|Lack of Efficacy|1
69379|NCT01323660|272691|P2|Washout Period (14 Days)|Lack of Efficacy|0
69380|NCT01323660|272692|P1|Washout Period (14 Days)|Lack of Efficacy|0
69381|NCT01323660|272687|P6|Washout Period (14 Days)|Adverse Event|0
69382|NCT01323660|272688|P5|Washout Period (14 Days)|Adverse Event|1
69383|NCT01323660|272689|P4|Washout Period (14 Days)|Adverse Event|0
69384|NCT01323660|272690|P3|Washout Period (14 Days)|Adverse Event|0
69385|NCT01323660|272691|P2|Washout Period (14 Days)|Adverse Event|0
69386|NCT01323660|272692|P1|Washout Period (14 Days)|Adverse Event|0
69387|NCT01323660|272687|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
69388|NCT01323660|272688|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
69389|NCT01323660|272689|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
69390|NCT01323660|272690|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
69391|NCT01323660|272691|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
69392|NCT01323660|272692|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
69393|NCT01323660|272687|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
69394|NCT01323660|272688|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
69395|NCT01323660|272689|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
69396|NCT01323660|272690|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
69397|NCT01323660|272691|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
69398|NCT01323660|272692|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
69399|NCT01323660|272687|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
69400|NCT01323660|272688|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
69401|NCT01323660|272689|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
69402|NCT01323660|272690|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
69403|NCT01323660|272691|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
69404|NCT01323660|272692|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
69405|NCT01323660|272687|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
69406|NCT01323660|272688|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
69407|NCT01323660|272689|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
69408|NCT01323660|272690|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
69409|NCT01323660|272691|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
69410|NCT01323660|272692|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
69411|NCT01323660|272687|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
69412|NCT01323660|272688|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
69413|NCT01323660|272689|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
69414|NCT01323660|272690|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
69415|NCT01323660|272691|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
69416|NCT01323660|272692|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
69417|NCT01323660|272687|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
69418|NCT01323660|272688|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
69419|NCT01323660|272689|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
69420|NCT01323660|272690|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
69421|NCT01323660|272691|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
69422|NCT01323660|272692|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
69423|NCT01323647|272738|P2|Overall Study|Lost to Follow-up|0
69424|NCT01323647|272739|P1|Overall Study|Lost to Follow-up|2
69425|NCT01323647|272738|P2|Overall Study|Withdrawal by Subject|0
69426|NCT01323647|272739|P1|Overall Study|Withdrawal by Subject|5
69427|NCT01323647|272738|P2|Overall Study|Migrated/moved from study area|0
69428|NCT01323647|272739|P1|Overall Study|Migrated/moved from study area|2
69429|NCT01323634|272756|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
69430|NCT01323634|272757|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
69431|NCT01323634|272758|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
69432|NCT01323634|272756|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
69433|NCT01323634|272757|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
69434|NCT01323634|272758|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
69435|NCT01323634|272756|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
69436|NCT01323634|272757|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
69437|NCT01323634|272758|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
69438|NCT01323634|272756|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
69439|NCT01323634|272757|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
69440|NCT01323634|272758|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
69441|NCT01323634|272756|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
69442|NCT01323634|272757|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
69443|NCT01323634|272758|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
69444|NCT01323634|272756|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
69445|NCT01323634|272757|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
69446|NCT01323634|272758|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
69447|NCT01323634|272756|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
69448|NCT01323634|272757|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
69449|NCT01323634|272758|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
69450|NCT01323634|272756|P3|2-week Run-in Period|Adverse Event|0
69451|NCT01323634|272757|P2|2-week Run-in Period|Adverse Event|0
69452|NCT01323634|272758|P1|2-week Run-in Period|Adverse Event|1
69453|NCT01323634|272756|P3|2-week Run-in Period|Protocol Violation|0
69454|NCT01323634|272757|P2|2-week Run-in Period|Protocol Violation|0
69455|NCT01323634|272758|P1|2-week Run-in Period|Protocol Violation|1
69456|NCT01323634|272756|P3|2-week Run-in Period|Physician Decision|0
69457|NCT01323634|272757|P2|2-week Run-in Period|Physician Decision|0
69458|NCT01323634|272758|P1|2-week Run-in Period|Physician Decision|5
69459|NCT01323634|272756|P3|2-week Run-in Period|Withdrawal by Subject|0
69460|NCT01323634|272757|P2|2-week Run-in Period|Withdrawal by Subject|0
69461|NCT01323634|272758|P1|2-week Run-in Period|Withdrawal by Subject|7
69462|NCT01323634|272756|P3|2-week Run-in Period|Continuation Criteria not Met|0
69463|NCT01323634|272757|P2|2-week Run-in Period|Continuation Criteria not Met|0
69464|NCT01323634|272758|P1|2-week Run-in Period|Continuation Criteria not Met|73
69465|NCT01323634|272756|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
69466|NCT01323634|272757|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
69467|NCT01323634|272758|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
69468|NCT01323621|272768|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
69469|NCT01323621|272769|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
69470|NCT01323621|272770|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
69471|NCT01323621|272768|P3|12-week, Double-blind Treatment Period|Physician Decision|1
69472|NCT01323621|272769|P2|12-week, Double-blind Treatment Period|Physician Decision|2
69473|NCT01323621|272770|P1|12-week, Double-blind Treatment Period|Physician Decision|0
69474|NCT01323621|272768|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
69475|NCT01323621|272769|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
69476|NCT01323621|272770|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
69477|NCT01323621|272768|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
69478|NCT01323621|272769|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
69479|NCT01323621|272770|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
69480|NCT01323621|272768|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
69481|NCT01323621|272769|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
69482|NCT01323621|272770|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
69483|NCT01323621|272768|P3|12-week, Double-blind Treatment Period|Adverse Event|5
69484|NCT01323621|272769|P2|12-week, Double-blind Treatment Period|Adverse Event|1
69485|NCT01323621|272770|P1|12-week, Double-blind Treatment Period|Adverse Event|0
69486|NCT01323621|272768|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
69487|NCT01323621|272769|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
69488|NCT01323621|272770|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
69489|NCT01323621|272768|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
69490|NCT01323621|272769|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
69491|NCT01323621|272770|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
69492|NCT01323621|272768|P3|2-week, Single-blind Run In Period|Protocol Violation|0
69493|NCT01323621|272769|P2|2-week, Single-blind Run In Period|Protocol Violation|0
69494|NCT01323621|272770|P1|2-week, Single-blind Run In Period|Protocol Violation|1
69495|NCT01323621|272768|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
69496|NCT01323621|272769|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
69497|NCT01323621|272770|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
69498|NCT01323621|272768|P3|2-week, Single-blind Run In Period|Physician Decision|0
69499|NCT01323621|272769|P2|2-week, Single-blind Run In Period|Physician Decision|0
69500|NCT01323621|272770|P1|2-week, Single-blind Run In Period|Physician Decision|7
69501|NCT01323621|272768|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
69502|NCT01323621|272769|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
69503|NCT01323621|272770|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
69504|NCT01323582|272789|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
69505|NCT01323582|272790|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
69506|NCT01323582|272789|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
69507|NCT01323582|272790|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
69508|NCT01323582|272789|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
69509|NCT01323582|272790|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
69510|NCT01323478|272813|P1|Overall Study|Administrative or Other Reasons|8
69511|NCT01323478|272813|P1|Overall Study|Withdrawal of Consent|1
69512|NCT01323478|272813|P1|Overall Study|Protocol Violation|1
69513|NCT01323478|272813|P1|Overall Study|Non-compliance With Study Product|3
69514|NCT01323478|272813|P1|Overall Study|Lack of Efficacy|4
69515|NCT01323478|272813|P1|Overall Study|Adverse Event|7
69516|NCT01323387|272826|P1|Overall Study|Randomized but Never Treated|16
69517|NCT01323387|272826|P1|Overall Study|Protocol Violation|12
69518|NCT01323387|272826|P1|Overall Study|Revision|14
69519|NCT01323387|272826|P1|Overall Study|Radiographic Data Unavailable|1
69520|NCT01323387|272826|P1|Overall Study|Withdrawal by Subject|41
69521|NCT01323270|272839|P2|Overall Study|Randomized, but not vaccinated|0
69522|NCT01323270|272840|P1|Overall Study|Randomized, but not vaccinated|1
69523|NCT01323270|272839|P2|Overall Study|Death|0
69524|NCT01323270|272840|P1|Overall Study|Death|1
69525|NCT01323270|272839|P2|Overall Study|Not eligible|1
69526|NCT01323270|272840|P1|Overall Study|Not eligible|1
69527|NCT01323270|272839|P2|Overall Study|Physician Decision|2
69528|NCT01323270|272840|P1|Overall Study|Physician Decision|0
69529|NCT01323270|272839|P2|Overall Study|Other|3
69530|NCT01323270|272840|P1|Overall Study|Other|0
69531|NCT01323270|272839|P2|Overall Study|Adverse Event|0
69532|NCT01323270|272840|P1|Overall Study|Adverse Event|8
69533|NCT01323270|272839|P2|Overall Study|Lost to Follow-up|6
69534|NCT01323270|272840|P1|Overall Study|Lost to Follow-up|4
69535|NCT01323270|272839|P2|Overall Study|Protocol Violation|7
69536|NCT01323270|272840|P1|Overall Study|Protocol Violation|9
69537|NCT01323270|272839|P2|Overall Study|Withdrawal by Subject|10
69538|NCT01323270|272840|P1|Overall Study|Withdrawal by Subject|19
69539|NCT01323192|272862|P2|Overall Study|Nonmedical reasons|1
69540|NCT01323192|272863|P1|Overall Study|Nonmedical reasons|0
69541|NCT01323192|272862|P2|Overall Study|Noncompliance with study medication|3
69542|NCT01323192|272863|P1|Overall Study|Noncompliance with study medication|0
69543|NCT01323192|272862|P2|Overall Study|Withdrawal by Subject|1
69544|NCT01323192|272863|P1|Overall Study|Withdrawal by Subject|3
69545|NCT01323192|272862|P2|Overall Study|Adverse Event|1
69546|NCT01323192|272863|P1|Overall Study|Adverse Event|6
69547|NCT01322386|273102|P2|Overall Study|Physician Decision|1
69548|NCT01322386|273103|P1|Overall Study|Physician Decision|0
69549|NCT01322386|273102|P2|Overall Study|Protocol Violation|1
69550|NCT01322386|273103|P1|Overall Study|Protocol Violation|0
69551|NCT01322347|273118|P2|Overall Study|moved/changed dialysis|4
69552|NCT01322347|273119|P1|Overall Study|moved/changed dialysis|2
69553|NCT01322347|273118|P2|Overall Study|study drug withheld > 12 wks|1
69554|NCT01322347|273119|P1|Overall Study|study drug withheld > 12 wks|0
69555|NCT01322347|273118|P2|Overall Study|kidney transplant|1
69556|NCT01322347|273119|P1|Overall Study|kidney transplant|3
69557|NCT01322347|273118|P2|Overall Study|ineligible|3
69558|NCT01322347|273119|P1|Overall Study|ineligible|6
69559|NCT01322347|273118|P2|Overall Study|sponsor decision|3
69560|NCT01322347|273119|P1|Overall Study|sponsor decision|1
69561|NCT01322347|273118|P2|Overall Study|blood transfusion|5
69562|NCT01322347|273119|P1|Overall Study|blood transfusion|5
69563|NCT01322347|273118|P2|Overall Study|non-protocol change to ESA or IV iron|6
69564|NCT01322347|273119|P1|Overall Study|non-protocol change to ESA or IV iron|14
69565|NCT01322347|273118|P2|Overall Study|Withdrawal by Subject|4
69566|NCT01322347|273119|P1|Overall Study|Withdrawal by Subject|1
69567|NCT01322347|273118|P2|Overall Study|Protocol Violation|2
69568|NCT01322347|273119|P1|Overall Study|Protocol Violation|5
69569|NCT01322347|273118|P2|Overall Study|Physician Decision|1
69570|NCT01322347|273119|P1|Overall Study|Physician Decision|2
69571|NCT01322347|273118|P2|Overall Study|Death|3
69572|NCT01322347|273119|P1|Overall Study|Death|5
69573|NCT01322347|273118|P2|Overall Study|Adverse Event|2
69574|NCT01322347|273119|P1|Overall Study|Adverse Event|7
69575|NCT01322009|273182|P2|Overall Study|ng tube discontinued|1
69576|NCT01322009|273183|P1|Overall Study|ng tube discontinued|0
69577|NCT01322009|273182|P2|Overall Study|Adverse Event|1
69578|NCT01322009|273183|P1|Overall Study|Adverse Event|0
69579|NCT01322009|273182|P2|Overall Study|Death|1
69580|NCT01322009|273183|P1|Overall Study|Death|0
69581|NCT01321749|273193|P2|Overall Study|Withdrawal by Subject|4
69582|NCT01321749|273194|P1|Overall Study|Withdrawal by Subject|5
69583|NCT01321749|273193|P2|Overall Study|Protocol Violation|7
69584|NCT01321749|273194|P1|Overall Study|Protocol Violation|4
69585|NCT01321749|273193|P2|Overall Study|Lost to Follow-up|11
69586|NCT01321749|273194|P1|Overall Study|Lost to Follow-up|4
69587|NCT01321723|273203|P3|Overall Study|Withdrawal by Subject|2
69588|NCT01321723|273204|P2|Overall Study|Withdrawal by Subject|0
69589|NCT01321723|273205|P1|Overall Study|Withdrawal by Subject|2
69590|NCT01321723|273203|P3|Overall Study|Adverse Event|2
69591|NCT01321723|273204|P2|Overall Study|Adverse Event|5
69592|NCT01321723|273205|P1|Overall Study|Adverse Event|3
69593|NCT01321710|273227|P3|Overall Study|Lost to Follow-up|0
69594|NCT01321710|273228|P2|Overall Study|Lost to Follow-up|5
69595|NCT01321710|273229|P1|Overall Study|Lost to Follow-up|4
69596|NCT01321697|273244|P1|Overall Study|Study Terminated|7
69597|NCT01321554|273250|P4|OOL Lenvatinib Treatment Period|Death|1
69598|NCT01321554|273251|P3|OOL Lenvatinib Treatment Period|Death|1
69599|NCT01321554|273252|P2|OOL Lenvatinib Treatment Period|Death|0
69600|NCT01321554|273253|P1|OOL Lenvatinib Treatment Period|Death|0
69601|NCT01321554|273250|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
69602|NCT01321554|273251|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
69603|NCT01321554|273252|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
69604|NCT01321554|273253|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
69605|NCT01321554|273250|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
69606|NCT01321554|273251|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
69607|NCT01321554|273252|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
69608|NCT01321554|273253|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
69609|NCT01321554|273250|P4|OOL Lenvatinib Treatment Period|Not specified|0
69610|NCT01321554|273251|P3|OOL Lenvatinib Treatment Period|Not specified|5
69611|NCT01321554|273252|P2|OOL Lenvatinib Treatment Period|Not specified|0
69612|NCT01321554|273253|P1|OOL Lenvatinib Treatment Period|Not specified|0
69613|NCT01321554|273250|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
69614|NCT01321554|273251|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
69615|NCT01321554|273252|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
69616|NCT01321554|273253|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
69617|NCT01321554|273250|P4|OOL Lenvatinib Treatment Period|Participant choice|0
69618|NCT01321554|273251|P3|OOL Lenvatinib Treatment Period|Participant choice|3
69619|NCT01321554|273252|P2|OOL Lenvatinib Treatment Period|Participant choice|0
69620|NCT01321554|273253|P1|OOL Lenvatinib Treatment Period|Participant choice|0
69621|NCT01321554|273250|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
69622|NCT01321554|273251|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
69623|NCT01321554|273252|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
69624|NCT01321554|273253|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
69625|NCT01321554|273250|P4|Randomization Phase|Death|0
69626|NCT01321554|273251|P3|Randomization Phase|Death|0
69627|NCT01321554|273252|P2|Randomization Phase|Death|1
69628|NCT01321554|273253|P1|Randomization Phase|Death|0
69629|NCT01321554|273250|P4|Randomization Phase|Withdrawal by Subject|0
69630|NCT01321554|273251|P3|Randomization Phase|Withdrawal by Subject|0
69631|NCT01321554|273252|P2|Randomization Phase|Withdrawal by Subject|0
69632|NCT01321554|273253|P1|Randomization Phase|Withdrawal by Subject|4
69633|NCT01321554|273250|P4|Randomization Phase|Participant choice|0
69634|NCT01321554|273251|P3|Randomization Phase|Participant choice|0
69635|NCT01321554|273252|P2|Randomization Phase|Participant choice|0
69636|NCT01321554|273253|P1|Randomization Phase|Participant choice|4
69637|NCT01321554|273250|P4|Randomization Phase|Adverse Event|0
69638|NCT01321554|273251|P3|Randomization Phase|Adverse Event|0
69639|NCT01321554|273252|P2|Randomization Phase|Adverse Event|3
69640|NCT01321554|273253|P1|Randomization Phase|Adverse Event|37
69641|NCT01321073|273266|P1|Overall Study|Death|3
69642|NCT01321073|273266|P1|Overall Study|Did not attempt implant|4
69643|NCT01321008|273270|P1|Overall Study|Early Study Termination|1
69644|NCT01320943|273276|P2|Overall Study|Randomized but not Treated|1
69645|NCT01320943|273277|P1|Overall Study|Randomized but not Treated|0
69646|NCT01320943|273276|P2|Overall Study|Physician Decision|1
69647|NCT01320943|273277|P1|Overall Study|Physician Decision|0
69648|NCT01320943|273276|P2|Overall Study|Lost to Follow-up|0
69649|NCT01320943|273277|P1|Overall Study|Lost to Follow-up|1
69650|NCT01320735|273311|P1|Overall Study|Investigator Unable to be Contacted|17
69651|NCT01320735|273311|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
69652|NCT01320735|273311|P1|Overall Study|Not Specified|1
69653|NCT01320735|273311|P1|Overall Study|Protocol Violation|1
69654|NCT01320735|273311|P1|Overall Study|Progression/Hormone-Refractory Pca|55
69655|NCT01320735|273311|P1|Overall Study|Administrative Reason|6
69656|NCT01320735|273311|P1|Overall Study|Lost to Follow-up|13
69657|NCT01320735|273311|P1|Overall Study|Withdrawal by Subject|3
69658|NCT01320735|273311|P1|Overall Study|Adverse Event|3
69659|NCT01320722|273333|P5|Overall Study|Withdrew due to Health Condition|1
69660|NCT01320722|273334|P4|Overall Study|Withdrew due to Health Condition|0
69661|NCT01320722|273335|P3|Overall Study|Withdrew due to Health Condition|0
69662|NCT01320722|273336|P2|Overall Study|Withdrew due to Health Condition|0
69663|NCT01320722|273337|P1|Overall Study|Withdrew due to Health Condition|0
69664|NCT01320722|273333|P5|Overall Study|Started an Exclusionary Medication|1
69665|NCT01320722|273334|P4|Overall Study|Started an Exclusionary Medication|0
69666|NCT01320722|273335|P3|Overall Study|Started an Exclusionary Medication|0
69667|NCT01320722|273336|P2|Overall Study|Started an Exclusionary Medication|0
69668|NCT01320722|273337|P1|Overall Study|Started an Exclusionary Medication|0
69669|NCT01320722|273333|P5|Overall Study|Pregnancy|0
69670|NCT01320722|273334|P4|Overall Study|Pregnancy|1
69671|NCT01320722|273335|P3|Overall Study|Pregnancy|0
69672|NCT01320722|273336|P2|Overall Study|Pregnancy|0
69673|NCT01320722|273337|P1|Overall Study|Pregnancy|0
69674|NCT01320722|273333|P5|Overall Study|Not Compliant with Study Procedures|0
69675|NCT01320722|273334|P4|Overall Study|Not Compliant with Study Procedures|4
69676|NCT01320722|273335|P3|Overall Study|Not Compliant with Study Procedures|0
69677|NCT01320722|273336|P2|Overall Study|Not Compliant with Study Procedures|0
69678|NCT01320722|273337|P1|Overall Study|Not Compliant with Study Procedures|0
69679|NCT01320722|273333|P5|Overall Study|Adverse Event|0
69680|NCT01320722|273334|P4|Overall Study|Adverse Event|6
69681|NCT01320722|273335|P3|Overall Study|Adverse Event|3
69682|NCT01320722|273336|P2|Overall Study|Adverse Event|0
69683|NCT01320722|273337|P1|Overall Study|Adverse Event|0
69684|NCT01320722|273333|P5|Overall Study|Non-compliant with Medication|0
69685|NCT01320722|273334|P4|Overall Study|Non-compliant with Medication|0
69686|NCT01320722|273335|P3|Overall Study|Non-compliant with Medication|1
69687|NCT01320722|273336|P2|Overall Study|Non-compliant with Medication|0
69688|NCT01320722|273337|P1|Overall Study|Non-compliant with Medication|0
69689|NCT01320722|273333|P5|Overall Study|Participant Developed a Rash|1
69690|NCT01320722|273334|P4|Overall Study|Participant Developed a Rash|1
69691|NCT01320722|273335|P3|Overall Study|Participant Developed a Rash|2
69692|NCT01320722|273336|P2|Overall Study|Participant Developed a Rash|0
69693|NCT01320722|273337|P1|Overall Study|Participant Developed a Rash|0
69694|NCT01320722|273333|P5|Overall Study|Not Available for the 8 Week Visit|0
69695|NCT01320722|273334|P4|Overall Study|Not Available for the 8 Week Visit|0
69696|NCT01320722|273335|P3|Overall Study|Not Available for the 8 Week Visit|0
69697|NCT01320722|273336|P2|Overall Study|Not Available for the 8 Week Visit|3
69698|NCT01320722|273337|P1|Overall Study|Not Available for the 8 Week Visit|0
69699|NCT01320722|273333|P5|Overall Study|Lost to Follow-up|3
69700|NCT01320722|273334|P4|Overall Study|Lost to Follow-up|1
69701|NCT01320722|273335|P3|Overall Study|Lost to Follow-up|0
69702|NCT01320722|273336|P2|Overall Study|Lost to Follow-up|1
69703|NCT01320722|273337|P1|Overall Study|Lost to Follow-up|0
69704|NCT01320722|273333|P5|Overall Study|Did not Receive Intervention|2
69705|NCT01320722|273334|P4|Overall Study|Did not Receive Intervention|1
69706|NCT01320722|273335|P3|Overall Study|Did not Receive Intervention|1
69707|NCT01320722|273336|P2|Overall Study|Did not Receive Intervention|2
69708|NCT01320722|273337|P1|Overall Study|Did not Receive Intervention|3
69709|NCT01320683|273374|P1|Overall Study|Positive antibody response|1
69710|NCT01320293|273400|P1|Overall Study|Adverse Event|1
69711|NCT01320293|273400|P1|Overall Study|Lack of Efficacy|1
69712|NCT01320202|273408|P2|Overall Study|regained renal function|0
69713|NCT01320202|273409|P1|Overall Study|regained renal function|1
69714|NCT01320202|273408|P2|Overall Study|ineligible|0
69715|NCT01320202|273409|P1|Overall Study|ineligible|3
69716|NCT01320202|273408|P2|Overall Study|sponsor request|0
69717|NCT01320202|273409|P1|Overall Study|sponsor request|2
69718|NCT01320202|273408|P2|Overall Study|moved/changed dialysis|2
69719|NCT01320202|273409|P1|Overall Study|moved/changed dialysis|5
69720|NCT01320202|273408|P2|Overall Study|blood transfusion|7
69721|NCT01320202|273409|P1|Overall Study|blood transfusion|1
69722|NCT01320202|273408|P2|Overall Study|kidney transplant|2
69723|NCT01320202|273409|P1|Overall Study|kidney transplant|1
69724|NCT01320202|273408|P2|Overall Study|non-protocol change to ESA or IV iron|20
69725|NCT01320202|273409|P1|Overall Study|non-protocol change to ESA or IV iron|17
69726|NCT01320202|273408|P2|Overall Study|Withdrawal by Subject|3
69727|NCT01320202|273409|P1|Overall Study|Withdrawal by Subject|10
69728|NCT01320202|273408|P2|Overall Study|Protocol Violation|1
69729|NCT01320202|273409|P1|Overall Study|Protocol Violation|2
69730|NCT01320202|273408|P2|Overall Study|Physician Decision|1
69731|NCT01320202|273409|P1|Overall Study|Physician Decision|3
69732|NCT01320202|273408|P2|Overall Study|Lost to Follow-up|0
69733|NCT01320202|273409|P1|Overall Study|Lost to Follow-up|1
69734|NCT01320202|273408|P2|Overall Study|Death|3
69735|NCT01320202|273409|P1|Overall Study|Death|5
69736|NCT01320202|273408|P2|Overall Study|Adverse Event|5
69737|NCT01320202|273409|P1|Overall Study|Adverse Event|5
69738|NCT01319877|273473|P2|Overall Study|Reason Not Specified|5
69739|NCT01319877|273474|P1|Overall Study|Reason Not Specified|4
69740|NCT01319877|273473|P2|Overall Study|Withdrawal by Subject|1
69741|NCT01319877|273474|P1|Overall Study|Withdrawal by Subject|0
69742|NCT01319877|273473|P2|Overall Study|Disease Progression|2
69743|NCT01319877|273474|P1|Overall Study|Disease Progression|2
69744|NCT01319877|273473|P2|Overall Study|Physician Decision|0
69745|NCT01319877|273474|P1|Overall Study|Physician Decision|2
69746|NCT01319877|273473|P2|Overall Study|Lost to Follow-up|37
69747|NCT01319877|273474|P1|Overall Study|Lost to Follow-up|100
69748|NCT01319721|273624|P2|Overall Study|Lost to Follow-up|6
69749|NCT01319721|273625|P1|Overall Study|Lost to Follow-up|1
69750|NCT01319422|273678|P2|Overall Study|Withdrawal by Subject|0
69751|NCT01319422|273679|P1|Overall Study|Withdrawal by Subject|1
69752|NCT01319383|273697|P2|Overall Study|No in vivo response to interval doses|1
69753|NCT01319383|273698|P1|Overall Study|No in vivo response to interval doses|0
69754|NCT01319383|273697|P2|Overall Study|Lack of Efficacy|9
69755|NCT01319383|273698|P1|Overall Study|Lack of Efficacy|5
69756|NCT01319383|273697|P2|Overall Study|Physician Decision|0
69757|NCT01319383|273698|P1|Overall Study|Physician Decision|3
69758|NCT01319383|273697|P2|Overall Study|No ex vivo or in vivo response|0
69759|NCT01319383|273698|P1|Overall Study|No ex vivo or in vivo response|4
69760|NCT01318993|273737|P1|Overall Study|Withdrawal by Subject|24
69761|NCT01318993|273737|P1|Overall Study|Physician Decision|13
69762|NCT01318993|273737|P1|Overall Study|Lost to Follow-up|4
69763|NCT01318993|273737|P1|Overall Study|Study closed or terminated|174
69764|NCT01318993|273737|P1|Overall Study|Protocol based stopping criteria|6
69765|NCT01318993|273737|P1|Overall Study|Protocol Violation|3
69766|NCT01318993|273737|P1|Overall Study|Lack of Efficacy|121
69767|NCT01318993|273737|P1|Overall Study|Adverse Event|53
69768|NCT01318915|273758|P1|Overall Study|Ongoing in study|7
69769|NCT01318915|273758|P1|Overall Study|Lost to Follow-up|1
69770|NCT01318876|273762|P1|Day 29 Survey|survey not completed-don't know why|1825
69771|NCT01318876|273762|P1|Day 8 Survey|survey not completed-don't know why|1724
69772|NCT01318876|273762|P1|Day 8 Survey|email address invalid|96
69773|NCT01318512|273860|P1|Maintenance Period (6 Months)|Protocol Violation|9
69774|NCT01318512|273860|P1|Maintenance Period (6 Months)|Death|2
69775|NCT01318499|273879|P3|Overall Study|Not Specified|22
69776|NCT01318499|273880|P2|Overall Study|Not Specified|10
69777|NCT01318499|273881|P1|Overall Study|Not Specified|7
69778|NCT01318499|273879|P3|Overall Study|Patient Did Not Use Study Medication|14
69779|NCT01318499|273880|P2|Overall Study|Patient Did Not Use Study Medication|28
69780|NCT01318499|273881|P1|Overall Study|Patient Did Not Use Study Medication|18
69781|NCT01318499|273879|P3|Overall Study|Protocol Violation|2
69782|NCT01318499|273880|P2|Overall Study|Protocol Violation|4
69783|NCT01318499|273881|P1|Overall Study|Protocol Violation|2
69784|NCT01318499|273879|P3|Overall Study|Treatment Failure|101
69785|NCT01318499|273880|P2|Overall Study|Treatment Failure|19
69786|NCT01318499|273881|P1|Overall Study|Treatment Failure|19
69787|NCT01318499|273879|P3|Overall Study|Noncompliance|0
69788|NCT01318499|273880|P2|Overall Study|Noncompliance|3
69789|NCT01318499|273881|P1|Overall Study|Noncompliance|2
69790|NCT01318499|273879|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
69791|NCT01318499|273880|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
69792|NCT01318499|273881|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
69793|NCT01318499|273879|P3|Overall Study|Adverse Event|6
69794|NCT01318499|273880|P2|Overall Study|Adverse Event|11
69795|NCT01318499|273881|P1|Overall Study|Adverse Event|16
69796|NCT01318382|273904|P1|Overall Study|Protocol Violation|1
69797|NCT01318382|273904|P1|Overall Study|Device Malfunction|10
69798|NCT01318382|273904|P1|Overall Study|Physician Decision|2
69799|NCT01318135|273962|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
69800|NCT01318135|273963|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
69801|NCT01318135|273964|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
69802|NCT01318135|273965|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
69803|NCT01318135|273966|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
69804|NCT01318135|273967|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
69805|NCT01318135|273968|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
69806|NCT01318135|273969|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
69807|NCT01318135|273962|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
69808|NCT01318135|273963|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
69809|NCT01318135|273964|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
69810|NCT01318135|273965|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
69811|NCT01318135|273966|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
69812|NCT01318135|273967|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
69813|NCT01318135|273968|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
69814|NCT01318135|273969|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
69815|NCT01318135|273962|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
69816|NCT01318135|273963|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
69817|NCT01318135|273964|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
69818|NCT01318135|273965|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
69819|NCT01318135|273966|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
69820|NCT01318135|273967|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
69821|NCT01318135|273968|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
69822|NCT01318135|273969|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
69823|NCT01318135|273962|P8|Entered - Long-Term Extension Study|Protocol Violation|0
69824|NCT01318135|273963|P7|Entered - Long-Term Extension Study|Protocol Violation|0
69825|NCT01318135|273964|P6|Entered - Long-Term Extension Study|Protocol Violation|0
69826|NCT01318135|273965|P5|Entered - Long-Term Extension Study|Protocol Violation|1
69827|NCT01318135|273966|P4|Entered - Long-Term Extension Study|Protocol Violation|0
69828|NCT01318135|273967|P3|Entered - Long-Term Extension Study|Protocol Violation|0
69829|NCT01318135|273968|P2|Entered - Long-Term Extension Study|Protocol Violation|1
69830|NCT01318135|273969|P1|Entered - Long-Term Extension Study|Protocol Violation|1
69831|NCT01318135|273962|P8|Entered - Long-Term Extension Study|Adverse Event|0
69832|NCT01318135|273963|P7|Entered - Long-Term Extension Study|Adverse Event|0
69833|NCT01318135|273964|P6|Entered - Long-Term Extension Study|Adverse Event|2
69834|NCT01318135|273965|P5|Entered - Long-Term Extension Study|Adverse Event|4
69835|NCT01318135|273966|P4|Entered - Long-Term Extension Study|Adverse Event|3
69836|NCT01318135|273967|P3|Entered - Long-Term Extension Study|Adverse Event|4
69837|NCT01318135|273968|P2|Entered - Long-Term Extension Study|Adverse Event|3
69838|NCT01318135|273969|P1|Entered - Long-Term Extension Study|Adverse Event|9
69839|NCT01318135|273962|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
69840|NCT01318135|273963|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
69841|NCT01318135|273964|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
69842|NCT01318135|273965|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
69843|NCT01318135|273966|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
69844|NCT01318135|273967|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
69845|NCT01318135|273968|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
69846|NCT01318135|273969|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
69847|NCT01318135|273962|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
69848|NCT01318135|273963|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
69849|NCT01318135|273964|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
69850|NCT01318135|273965|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
69851|NCT01318135|273966|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
69852|NCT01318135|273967|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
69853|NCT01318135|273968|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
69854|NCT01318135|273969|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
69855|NCT01318122|274101|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
69856|NCT01318122|274102|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
69857|NCT01318122|274103|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
69858|NCT01318122|274104|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
69859|NCT01318122|274101|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
69860|NCT01318122|274102|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
69861|NCT01318122|274103|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
69862|NCT01318122|274104|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
69863|NCT01318122|274101|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
69864|NCT01318122|274102|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
69865|NCT01318122|274103|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
69866|NCT01318122|274104|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
69867|NCT01318122|274101|P4|Entered - Long-Term Extension Study|Adverse Event|4
69868|NCT01318122|274102|P3|Entered - Long-Term Extension Study|Adverse Event|2
69869|NCT01318122|274103|P2|Entered - Long-Term Extension Study|Adverse Event|6
69870|NCT01318122|274104|P1|Entered - Long-Term Extension Study|Adverse Event|6
69871|NCT01318122|274101|P4|Enrolled - Long-Term Extension Study|Other|0
69872|NCT01318122|274102|P3|Enrolled - Long-Term Extension Study|Other|0
69873|NCT01318122|274103|P2|Enrolled - Long-Term Extension Study|Other|0
69874|NCT01318122|274104|P1|Enrolled - Long-Term Extension Study|Other|1
69875|NCT01318122|274101|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
69876|NCT01318122|274102|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
69877|NCT01318122|274103|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
69878|NCT01318122|274104|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
69879|NCT01318109|274173|P3|Overall Study|Schedule Conflict|0
69880|NCT01318109|274174|P2|Overall Study|Schedule Conflict|1
69881|NCT01318109|274175|P1|Overall Study|Schedule Conflict|0
69882|NCT01318109|274173|P3|Overall Study|Withdrawal by Subject|0
69883|NCT01318109|274174|P2|Overall Study|Withdrawal by Subject|0
69884|NCT01318109|274175|P1|Overall Study|Withdrawal by Subject|1
69885|NCT01318109|274173|P3|Overall Study|Adverse Event|0
69886|NCT01318109|274174|P2|Overall Study|Adverse Event|2
69887|NCT01318109|274175|P1|Overall Study|Adverse Event|0
69888|NCT01318083|274210|P3|Overall Study|Lack of Study Medication Compliance|0
69889|NCT01318083|274211|P2|Overall Study|Lack of Study Medication Compliance|1
69890|NCT01318083|274212|P1|Overall Study|Lack of Study Medication Compliance|0
69891|NCT01318083|274210|P3|Overall Study|Treatment Complications|0
69892|NCT01318083|274211|P2|Overall Study|Treatment Complications|0
69893|NCT01318083|274212|P1|Overall Study|Treatment Complications|1
69894|NCT01318083|274210|P3|Overall Study|Lack of Efficacy|1
69895|NCT01318083|274211|P2|Overall Study|Lack of Efficacy|0
69896|NCT01318083|274212|P1|Overall Study|Lack of Efficacy|0
69897|NCT01318083|274210|P3|Overall Study|Withdrawal by Subject|2
69898|NCT01318083|274211|P2|Overall Study|Withdrawal by Subject|0
69899|NCT01318083|274212|P1|Overall Study|Withdrawal by Subject|1
69900|NCT01318083|274210|P3|Overall Study|Adverse Event|2
69901|NCT01318083|274211|P2|Overall Study|Adverse Event|1
69902|NCT01318083|274212|P1|Overall Study|Adverse Event|4
69903|NCT01318070|274247|P3|Overall Study|Principal Investigator Discretion|0
69904|NCT01318070|274248|P2|Overall Study|Principal Investigator Discretion|0
69905|NCT01318070|274249|P1|Overall Study|Principal Investigator Discretion|1
69906|NCT01318070|274247|P3|Overall Study|Lack of Efficacy|1
69907|NCT01318070|274248|P2|Overall Study|Lack of Efficacy|0
69908|NCT01318070|274249|P1|Overall Study|Lack of Efficacy|0
69909|NCT01318070|274247|P3|Overall Study|Withdrawal by Subject|1
69910|NCT01318070|274248|P2|Overall Study|Withdrawal by Subject|1
69911|NCT01318070|274249|P1|Overall Study|Withdrawal by Subject|0
69912|NCT01318070|274247|P3|Overall Study|Adverse Event|5
69913|NCT01318070|274248|P2|Overall Study|Adverse Event|1
69914|NCT01318070|274249|P1|Overall Study|Adverse Event|1
69915|NCT01317797|274293|P3|Overall Study|Withdrawal of Patient|1
69916|NCT01317797|274294|P2|Overall Study|Withdrawal of Patient|0
69917|NCT01317797|274295|P1|Overall Study|Withdrawal of Patient|0
69918|NCT01317797|274293|P3|Overall Study|Other|0
69919|NCT01317797|274294|P2|Overall Study|Other|1
69920|NCT01317797|274295|P1|Overall Study|Other|0
69921|NCT01317641|274372|P9|Overall Study|Withdrawal by Subject|0
69922|NCT01317641|274373|P8|Overall Study|Withdrawal by Subject|0
69923|NCT01317641|274374|P7|Overall Study|Withdrawal by Subject|1
69924|NCT01317641|274375|P6|Overall Study|Withdrawal by Subject|0
69925|NCT01317641|274376|P5|Overall Study|Withdrawal by Subject|0
69926|NCT01317641|274377|P4|Overall Study|Withdrawal by Subject|0
69927|NCT01317641|274378|P3|Overall Study|Withdrawal by Subject|0
69928|NCT01317641|274379|P2|Overall Study|Withdrawal by Subject|0
69929|NCT01317641|274380|P1|Overall Study|Withdrawal by Subject|0
69930|NCT01317641|274372|P9|Overall Study|Disease progression|4
69931|NCT01317641|274373|P8|Overall Study|Disease progression|3
69932|NCT01317641|274374|P7|Overall Study|Disease progression|0
69933|NCT01317641|274375|P6|Overall Study|Disease progression|0
69934|NCT01317641|274376|P5|Overall Study|Disease progression|0
69935|NCT01317641|274377|P4|Overall Study|Disease progression|0
69936|NCT01317641|274378|P3|Overall Study|Disease progression|0
69937|NCT01317641|274379|P2|Overall Study|Disease progression|0
69938|NCT01317641|274380|P1|Overall Study|Disease progression|0
69939|NCT01317641|274372|P9|Overall Study|Protocol Violation|0
69940|NCT01317641|274373|P8|Overall Study|Protocol Violation|0
69941|NCT01317641|274374|P7|Overall Study|Protocol Violation|0
69942|NCT01317641|274375|P6|Overall Study|Protocol Violation|0
69943|NCT01317641|274376|P5|Overall Study|Protocol Violation|0
69944|NCT01317641|274377|P4|Overall Study|Protocol Violation|0
69945|NCT01317641|274378|P3|Overall Study|Protocol Violation|0
69946|NCT01317641|274379|P2|Overall Study|Protocol Violation|0
69947|NCT01317641|274380|P1|Overall Study|Protocol Violation|1
69948|NCT01317641|274372|P9|Overall Study|Adverse Event|0
69949|NCT01317641|274373|P8|Overall Study|Adverse Event|1
69950|NCT01317641|274374|P7|Overall Study|Adverse Event|2
69951|NCT01317641|274375|P6|Overall Study|Adverse Event|0
69952|NCT01317641|274376|P5|Overall Study|Adverse Event|0
69953|NCT01317641|274377|P4|Overall Study|Adverse Event|1
69954|NCT01317641|274378|P3|Overall Study|Adverse Event|0
69955|NCT01317641|274379|P2|Overall Study|Adverse Event|1
69956|NCT01317641|274380|P1|Overall Study|Adverse Event|0
69957|NCT01317641|274372|P9|Overall Study|Not treated|1
69958|NCT01317641|274373|P8|Overall Study|Not treated|1
69959|NCT01317641|274374|P7|Overall Study|Not treated|0
69960|NCT01317641|274375|P6|Overall Study|Not treated|0
69961|NCT01317641|274376|P5|Overall Study|Not treated|0
69962|NCT01317641|274377|P4|Overall Study|Not treated|0
69963|NCT01317641|274378|P3|Overall Study|Not treated|0
69964|NCT01317641|274379|P2|Overall Study|Not treated|0
69965|NCT01317641|274380|P1|Overall Study|Not treated|0
69966|NCT01317615|274482|P1|Overall Study|Adverse Event|7
69967|NCT01317615|274482|P1|Overall Study|Abnormal laboratory value(s)|1
69968|NCT01317615|274482|P1|Overall Study|Withdrawal by Subject|5
69969|NCT01317615|274482|P1|Overall Study|Death|6
69970|NCT01317615|274482|P1|Overall Study|New cancer therapy|5
69971|NCT01317615|274482|P1|Overall Study|Disease progression|25
69972|NCT01317160|274493|P2|Overall Study|Withdrawal by Subject|2
69973|NCT01317160|274494|P1|Overall Study|Withdrawal by Subject|0
69974|NCT01317160|274493|P2|Overall Study|Lost to Follow-up|3
69975|NCT01317160|274494|P1|Overall Study|Lost to Follow-up|3
69976|NCT01317160|274493|P2|Overall Study|Incorrect inclusion|1
69977|NCT01317160|274494|P1|Overall Study|Incorrect inclusion|1
69978|NCT01317004|274519|P2|Overall Study|Adverse Event|3
69979|NCT01317004|274520|P1|Overall Study|Adverse Event|3
69980|NCT01317004|274519|P2|Overall Study|Protocol Violation|2
69981|NCT01317004|274520|P1|Overall Study|Protocol Violation|0
69982|NCT01317004|274519|P2|Overall Study|Withdrawal by Subject|4
69983|NCT01317004|274520|P1|Overall Study|Withdrawal by Subject|1
69984|NCT01316939|274541|P3|Overall Study|Protocol Violation|0
69985|NCT01316939|274542|P2|Overall Study|Protocol Violation|1
69986|NCT01316939|274543|P1|Overall Study|Protocol Violation|0
69987|NCT01316939|274541|P3|Overall Study|Met Liver chemistry stopping criteria|1
69988|NCT01316939|274542|P2|Overall Study|Met Liver chemistry stopping criteria|0
69989|NCT01316939|274543|P1|Overall Study|Met Liver chemistry stopping criteria|1
69990|NCT01316939|274541|P3|Overall Study|Lost to Follow-up|2
69991|NCT01316939|274542|P2|Overall Study|Lost to Follow-up|0
69992|NCT01316939|274543|P1|Overall Study|Lost to Follow-up|0
69993|NCT01316939|274541|P3|Overall Study|Physician Decision|1
69994|NCT01316939|274542|P2|Overall Study|Physician Decision|2
69995|NCT01316939|274543|P1|Overall Study|Physician Decision|2
69996|NCT01316939|274541|P3|Overall Study|Withdrawal by Subject|6
69997|NCT01316939|274542|P2|Overall Study|Withdrawal by Subject|3
69998|NCT01316939|274543|P1|Overall Study|Withdrawal by Subject|1
69999|NCT01316939|274541|P3|Overall Study|Adverse Event|11
70000|NCT01316939|274542|P2|Overall Study|Adverse Event|12
70001|NCT01316939|274543|P1|Overall Study|Adverse Event|9
70002|NCT01316939|274541|P3|Overall Study|Lack of Efficacy|25
70003|NCT01316939|274542|P2|Overall Study|Lack of Efficacy|25
70004|NCT01316939|274543|P1|Overall Study|Lack of Efficacy|24
70005|NCT01316939|274541|P3|Overall Study|Study closed/terminated|23
70006|NCT01316939|274542|P2|Overall Study|Study closed/terminated|25
70007|NCT01316939|274543|P1|Overall Study|Study closed/terminated|26
70008|NCT01316913|274638|P4|Overall Study|Withdrawal by Subject|6
70009|NCT01316913|274639|P3|Overall Study|Withdrawal by Subject|10
70010|NCT01316913|274640|P2|Overall Study|Withdrawal by Subject|9
70011|NCT01316913|274641|P1|Overall Study|Withdrawal by Subject|10
70012|NCT01316913|274638|P4|Overall Study|Lost to Follow-up|2
70013|NCT01316913|274639|P3|Overall Study|Lost to Follow-up|0
70014|NCT01316913|274640|P2|Overall Study|Lost to Follow-up|1
70015|NCT01316913|274641|P1|Overall Study|Lost to Follow-up|0
70016|NCT01316913|274638|P4|Overall Study|Protocol-defined Stopping Criteria|6
70017|NCT01316913|274639|P3|Overall Study|Protocol-defined Stopping Criteria|11
70018|NCT01316913|274640|P2|Overall Study|Protocol-defined Stopping Criteria|8
70019|NCT01316913|274641|P1|Overall Study|Protocol-defined Stopping Criteria|7
70020|NCT01316913|274638|P4|Overall Study|Protocol Violation|1
70021|NCT01316913|274639|P3|Overall Study|Protocol Violation|4
70022|NCT01316913|274640|P2|Overall Study|Protocol Violation|4
70023|NCT01316913|274641|P1|Overall Study|Protocol Violation|1
70024|NCT01316913|274638|P4|Overall Study|Lack of Efficacy|13
70025|NCT01316913|274639|P3|Overall Study|Lack of Efficacy|9
70026|NCT01316913|274640|P2|Overall Study|Lack of Efficacy|12
70027|NCT01316913|274641|P1|Overall Study|Lack of Efficacy|22
70028|NCT01316913|274638|P4|Overall Study|Adverse Event|11
70029|NCT01316913|274639|P3|Overall Study|Adverse Event|15
70030|NCT01316913|274640|P2|Overall Study|Adverse Event|20
70031|NCT01316913|274641|P1|Overall Study|Adverse Event|17
70032|NCT01316900|274663|P4|Overall Study|Withdrawal by Subject|9
70033|NCT01316900|274664|P3|Overall Study|Withdrawal by Subject|6
70034|NCT01316900|274665|P2|Overall Study|Withdrawal by Subject|8
70035|NCT01316900|274666|P1|Overall Study|Withdrawal by Subject|7
70036|NCT01316900|274663|P4|Overall Study|Lost to Follow-up|1
70037|NCT01316900|274664|P3|Overall Study|Lost to Follow-up|1
70038|NCT01316900|274665|P2|Overall Study|Lost to Follow-up|0
70039|NCT01316900|274666|P1|Overall Study|Lost to Follow-up|1
70040|NCT01316900|274663|P4|Overall Study|Protocol-defined Stopping Criteria|5
70041|NCT01316900|274664|P3|Overall Study|Protocol-defined Stopping Criteria|10
70042|NCT01316900|274665|P2|Overall Study|Protocol-defined Stopping Criteria|3
70043|NCT01316900|274666|P1|Overall Study|Protocol-defined Stopping Criteria|2
70044|NCT01316900|274663|P4|Overall Study|Protocol Violation|0
70045|NCT01316900|274664|P3|Overall Study|Protocol Violation|4
70046|NCT01316900|274665|P2|Overall Study|Protocol Violation|1
70047|NCT01316900|274666|P1|Overall Study|Protocol Violation|7
70048|NCT01316900|274663|P4|Overall Study|Lack of Efficacy|7
70049|NCT01316900|274664|P3|Overall Study|Lack of Efficacy|5
70050|NCT01316900|274665|P2|Overall Study|Lack of Efficacy|9
70051|NCT01316900|274666|P1|Overall Study|Lack of Efficacy|17
70052|NCT01316900|274663|P4|Overall Study|Adverse Event|9
70053|NCT01316900|274664|P3|Overall Study|Adverse Event|15
70054|NCT01316900|274665|P2|Overall Study|Adverse Event|10
70055|NCT01316900|274666|P1|Overall Study|Adverse Event|10
70056|NCT01316887|274687|P3|Overall Study|Withdrawal by Subject|15
70057|NCT01316887|274688|P2|Overall Study|Withdrawal by Subject|16
70058|NCT01316887|274689|P1|Overall Study|Withdrawal by Subject|8
70059|NCT01316887|274687|P3|Overall Study|Lost to Follow-up|5
70060|NCT01316887|274688|P2|Overall Study|Lost to Follow-up|7
70061|NCT01316887|274689|P1|Overall Study|Lost to Follow-up|1
70062|NCT01316887|274687|P3|Overall Study|Study Closed/Terminated|3
70063|NCT01316887|274688|P2|Overall Study|Study Closed/Terminated|4
70064|NCT01316887|274689|P1|Overall Study|Study Closed/Terminated|2
70065|NCT01316887|274687|P3|Overall Study|Protocol-defined Stopping Criteria|36
70066|NCT01316887|274688|P2|Overall Study|Protocol-defined Stopping Criteria|37
70067|NCT01316887|274689|P1|Overall Study|Protocol-defined Stopping Criteria|8
70068|NCT01316887|274687|P3|Overall Study|Protocol Violation|6
70069|NCT01316887|274688|P2|Overall Study|Protocol Violation|6
70070|NCT01316887|274689|P1|Overall Study|Protocol Violation|2
70071|NCT01316887|274687|P3|Overall Study|Lack of Efficacy|1
70072|NCT01316887|274688|P2|Overall Study|Lack of Efficacy|3
70073|NCT01316887|274689|P1|Overall Study|Lack of Efficacy|9
70074|NCT01316887|274687|P3|Overall Study|Adverse Event|17
70075|NCT01316887|274688|P2|Overall Study|Adverse Event|21
70076|NCT01316887|274689|P1|Overall Study|Adverse Event|13
70077|NCT01316692|274751|P1|Overall Study|Disease Progression|7
70078|NCT01316692|274751|P1|Overall Study|Adverse Event|5
70079|NCT01316614|274760|P1|Overall Study|Medically unstable|1
70080|NCT01316614|274760|P1|Overall Study|Inadequate number of passes|2
70081|NCT01316614|274760|P1|Overall Study|Cystic lesion|5
70082|NCT01316614|274760|P1|Overall Study|Cytology slides not available for review|4
70083|NCT01316614|274760|P1|Overall Study|No solid lesion and FNA not indicated|25
70084|NCT01316575|274777|P2|Overall Study|Required alternate treatment|1
70085|NCT01316575|274778|P1|Overall Study|Required alternate treatment|0
70086|NCT01316575|274777|P2|Overall Study|Withdrawal by Subject|0
70087|NCT01316575|274778|P1|Overall Study|Withdrawal by Subject|2
70088|NCT01316419|274790|P1|Overall Study|Lost to Follow-up|19
70089|NCT01316419|274790|P1|Overall Study|Violated inclusion/exclusion criterion|143
70090|NCT01316419|274790|P1|Overall Study|Not treated|103
70091|NCT01316380|274816|P3|Overall Study|Not treated|0
70092|NCT01316380|274817|P2|Overall Study|Not treated|0
70093|NCT01316380|274818|P1|Overall Study|Not treated|1
70094|NCT01316380|274816|P3|Overall Study|Other|1
70095|NCT01316380|274817|P2|Overall Study|Other|1
70096|NCT01316380|274818|P1|Overall Study|Other|0
70097|NCT01316380|274816|P3|Overall Study|Withdrawal by Subject|0
70098|NCT01316380|274817|P2|Overall Study|Withdrawal by Subject|2
70099|NCT01316380|274818|P1|Overall Study|Withdrawal by Subject|1
70100|NCT01316380|274816|P3|Overall Study|Protocol Violation|1
70101|NCT01316380|274817|P2|Overall Study|Protocol Violation|0
70102|NCT01316380|274818|P1|Overall Study|Protocol Violation|0
70103|NCT01316380|274816|P3|Overall Study|Adverse Event|1
70104|NCT01316380|274817|P2|Overall Study|Adverse Event|2
70105|NCT01316380|274818|P1|Overall Study|Adverse Event|0
70106|NCT01316224|274984|P1|Overall Study|Not Specified|1
70107|NCT01316224|274984|P1|Overall Study|Adverse Event With Treatment Failure|1
70108|NCT01316224|274984|P1|Overall Study|Withdrawal by Subject|1
70109|NCT01316224|274984|P1|Overall Study|Lack of Efficacy|1
70110|NCT01316224|274984|P1|Overall Study|Adverse Event|3
70111|NCT01316224|274984|P1|Overall Study|Protocol Violation|3
70112|NCT01316055|275001|P3|Overall Study|Lost to Follow-up|0
70113|NCT01316055|275002|P2|Overall Study|Lost to Follow-up|0
70114|NCT01316055|275003|P1|Overall Study|Lost to Follow-up|1
70115|NCT01315847|275034|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
70116|NCT01315847|275035|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
70117|NCT01315847|275034|P2|Part I, Period 1|Reached maximum number of arterial lines|0
70118|NCT01315847|275035|P1|Part I, Period 1|Reached maximum number of arterial lines|3
70119|NCT01315353|275080|P3|Overall Study|Inadvertent randomization/assignment|2
70120|NCT01315353|275081|P2|Overall Study|Inadvertent randomization/assignment|0
70121|NCT01315353|275082|P1|Overall Study|Inadvertent randomization/assignment|0
70122|NCT01315353|275080|P3|Overall Study|Taken off study by site in error|0
70123|NCT01315353|275081|P2|Overall Study|Taken off study by site in error|1
70124|NCT01315353|275082|P1|Overall Study|Taken off study by site in error|0
70125|NCT01315353|275080|P3|Overall Study|Site closing|0
70126|NCT01315353|275081|P2|Overall Study|Site closing|4
70127|NCT01315353|275082|P1|Overall Study|Site closing|7
70128|NCT01315353|275080|P3|Overall Study|Unwilling to adhere to requirements|4
70129|NCT01315353|275081|P2|Overall Study|Unwilling to adhere to requirements|5
70130|NCT01315353|275082|P1|Overall Study|Unwilling to adhere to requirements|5
70131|NCT01315353|275080|P3|Overall Study|Lost to Follow-up|6
70132|NCT01315353|275081|P2|Overall Study|Lost to Follow-up|6
70133|NCT01315353|275082|P1|Overall Study|Lost to Follow-up|13
70134|NCT01315353|275080|P3|Overall Study|Withdrawal by Subject|1
70135|NCT01315353|275081|P2|Overall Study|Withdrawal by Subject|6
70136|NCT01315353|275082|P1|Overall Study|Withdrawal by Subject|2
70137|NCT01315353|275080|P3|Overall Study|Death|0
70138|NCT01315353|275081|P2|Overall Study|Death|1
70139|NCT01315353|275082|P1|Overall Study|Death|2
70140|NCT01315249|275109|P2|Overall Study|Death|1
70141|NCT01315249|275110|P1|Overall Study|Death|0
70142|NCT01315249|275109|P2|Overall Study|Lost to Follow-up|2
70143|NCT01315249|275110|P1|Overall Study|Lost to Follow-up|0
70144|NCT01315249|275109|P2|Overall Study|Lack of Efficacy|1
70145|NCT01315249|275110|P1|Overall Study|Lack of Efficacy|0
70146|NCT01315249|275109|P2|Overall Study|inability to use device|0
70147|NCT01315249|275110|P1|Overall Study|inability to use device|1
70148|NCT01315249|275109|P2|Overall Study|Administrative problems|0
70149|NCT01315249|275110|P1|Overall Study|Administrative problems|1
70150|NCT01315249|275109|P2|Overall Study|Abnormal test results|2
70151|NCT01315249|275110|P1|Overall Study|Abnormal test results|1
70152|NCT01315249|275109|P2|Overall Study|Protocol Violation|5
70153|NCT01315249|275110|P1|Overall Study|Protocol Violation|8
70154|NCT01315249|275109|P2|Overall Study|Withdrawal by Subject|10
70155|NCT01315249|275110|P1|Overall Study|Withdrawal by Subject|11
70156|NCT01315249|275109|P2|Overall Study|Adverse Event|26
70157|NCT01315249|275110|P1|Overall Study|Adverse Event|22
70158|NCT01315028|275172|P2|Overall Study|Death|1
70159|NCT01315028|275173|P1|Overall Study|Death|0
70160|NCT01315028|275172|P2|Overall Study|Lost to Follow-up|0
70161|NCT01315028|275173|P1|Overall Study|Lost to Follow-up|1
70162|NCT01314872|275209|P15|Period 2|Lost to Follow-up|6
70163|NCT01314872|275210|P14|Period 2|Lost to Follow-up|2
70164|NCT01314872|275211|P13|Period 2|Lost to Follow-up|7
70165|NCT01314872|275212|P12|Period 2|Lost to Follow-up|6
70166|NCT01314872|275213|P11|Period 2|Lost to Follow-up|0
70167|NCT01314872|275214|P10|Period 2|Lost to Follow-up|0
70168|NCT01314872|275215|P9|Period 2|Lost to Follow-up|0
70169|NCT01314872|275216|P8|Period 2|Lost to Follow-up|0
70170|NCT01314872|275217|P7|Period 2|Lost to Follow-up|0
70171|NCT01314872|275218|P6|Period 2|Lost to Follow-up|0
70172|NCT01314872|275219|P5|Period 2|Lost to Follow-up|0
70173|NCT01314872|275220|P4|Period 2|Lost to Follow-up|0
70174|NCT01314872|275221|P3|Period 2|Lost to Follow-up|0
70175|NCT01314872|275222|P2|Period 2|Lost to Follow-up|0
70176|NCT01314872|275223|P1|Period 2|Lost to Follow-up|0
70177|NCT01314872|275209|P15|Period 2|Withdrawal by Subject|4
70178|NCT01314872|275210|P14|Period 2|Withdrawal by Subject|12
70179|NCT01314872|275211|P13|Period 2|Withdrawal by Subject|17
70180|NCT01314872|275212|P12|Period 2|Withdrawal by Subject|14
70181|NCT01314872|275213|P11|Period 2|Withdrawal by Subject|0
70182|NCT01314872|275214|P10|Period 2|Withdrawal by Subject|0
70183|NCT01314872|275215|P9|Period 2|Withdrawal by Subject|0
70184|NCT01314872|275216|P8|Period 2|Withdrawal by Subject|0
70185|NCT01314872|275217|P7|Period 2|Withdrawal by Subject|0
70186|NCT01314872|275218|P6|Period 2|Withdrawal by Subject|0
70187|NCT01314872|275219|P5|Period 2|Withdrawal by Subject|0
70188|NCT01314872|275220|P4|Period 2|Withdrawal by Subject|0
70189|NCT01314872|275221|P3|Period 2|Withdrawal by Subject|0
70190|NCT01314872|275222|P2|Period 2|Withdrawal by Subject|0
70191|NCT01314872|275223|P1|Period 2|Withdrawal by Subject|0
70192|NCT01314872|275209|P15|Period 2|Adverse event, non-fatal|9
70193|NCT01314872|275210|P14|Period 2|Adverse event, non-fatal|24
70194|NCT01314872|275211|P13|Period 2|Adverse event, non-fatal|16
70195|NCT01314872|275212|P12|Period 2|Adverse event, non-fatal|13
70196|NCT01314872|275213|P11|Period 2|Adverse event, non-fatal|0
70197|NCT01314872|275214|P10|Period 2|Adverse event, non-fatal|0
70198|NCT01314872|275215|P9|Period 2|Adverse event, non-fatal|0
70199|NCT01314872|275216|P8|Period 2|Adverse event, non-fatal|0
70200|NCT01314872|275217|P7|Period 2|Adverse event, non-fatal|0
70201|NCT01314872|275218|P6|Period 2|Adverse event, non-fatal|0
70202|NCT01314872|275219|P5|Period 2|Adverse event, non-fatal|0
70203|NCT01314872|275220|P4|Period 2|Adverse event, non-fatal|0
70204|NCT01314872|275221|P3|Period 2|Adverse event, non-fatal|0
70205|NCT01314872|275222|P2|Period 2|Adverse event, non-fatal|0
70206|NCT01314872|275223|P1|Period 2|Adverse event, non-fatal|0
70207|NCT01314872|275209|P15|Period 2|Study terminated by Sponsor|0
70208|NCT01314872|275210|P14|Period 2|Study terminated by Sponsor|3
70209|NCT01314872|275211|P13|Period 2|Study terminated by Sponsor|2
70210|NCT01314872|275212|P12|Period 2|Study terminated by Sponsor|2
70211|NCT01314872|275213|P11|Period 2|Study terminated by Sponsor|0
70212|NCT01314872|275214|P10|Period 2|Study terminated by Sponsor|0
70213|NCT01314872|275215|P9|Period 2|Study terminated by Sponsor|0
70214|NCT01314872|275216|P8|Period 2|Study terminated by Sponsor|0
70215|NCT01314872|275217|P7|Period 2|Study terminated by Sponsor|0
70216|NCT01314872|275218|P6|Period 2|Study terminated by Sponsor|0
70217|NCT01314872|275219|P5|Period 2|Study terminated by Sponsor|0
70218|NCT01314872|275220|P4|Period 2|Study terminated by Sponsor|0
70219|NCT01314872|275221|P3|Period 2|Study terminated by Sponsor|0
70220|NCT01314872|275222|P2|Period 2|Study terminated by Sponsor|0
70221|NCT01314872|275223|P1|Period 2|Study terminated by Sponsor|0
70222|NCT01314872|275209|P15|Period 2|Pregnancy|1
70223|NCT01314872|275210|P14|Period 2|Pregnancy|0
70224|NCT01314872|275211|P13|Period 2|Pregnancy|0
70225|NCT01314872|275212|P12|Period 2|Pregnancy|0
70226|NCT01314872|275213|P11|Period 2|Pregnancy|0
70227|NCT01314872|275214|P10|Period 2|Pregnancy|0
70228|NCT01314872|275215|P9|Period 2|Pregnancy|0
70229|NCT01314872|275216|P8|Period 2|Pregnancy|0
70230|NCT01314872|275217|P7|Period 2|Pregnancy|0
70231|NCT01314872|275218|P6|Period 2|Pregnancy|0
70232|NCT01314872|275219|P5|Period 2|Pregnancy|0
70233|NCT01314872|275220|P4|Period 2|Pregnancy|0
70234|NCT01314872|275221|P3|Period 2|Pregnancy|0
70235|NCT01314872|275222|P2|Period 2|Pregnancy|0
70236|NCT01314872|275223|P1|Period 2|Pregnancy|0
70237|NCT01314872|275209|P15|Period 2|Lack of Efficacy|2
70238|NCT01314872|275210|P14|Period 2|Lack of Efficacy|9
70239|NCT01314872|275211|P13|Period 2|Lack of Efficacy|12
70240|NCT01314872|275212|P12|Period 2|Lack of Efficacy|7
70241|NCT01314872|275213|P11|Period 2|Lack of Efficacy|0
70242|NCT01314872|275214|P10|Period 2|Lack of Efficacy|0
70243|NCT01314872|275215|P9|Period 2|Lack of Efficacy|0
70244|NCT01314872|275216|P8|Period 2|Lack of Efficacy|0
70245|NCT01314872|275217|P7|Period 2|Lack of Efficacy|0
70246|NCT01314872|275218|P6|Period 2|Lack of Efficacy|0
70247|NCT01314872|275219|P5|Period 2|Lack of Efficacy|0
70248|NCT01314872|275220|P4|Period 2|Lack of Efficacy|0
70249|NCT01314872|275221|P3|Period 2|Lack of Efficacy|0
70250|NCT01314872|275222|P2|Period 2|Lack of Efficacy|0
70251|NCT01314872|275223|P1|Period 2|Lack of Efficacy|0
70252|NCT01314872|275209|P15|Period 2|Non-compliance with study drug|2
70253|NCT01314872|275210|P14|Period 2|Non-compliance with study drug|1
70254|NCT01314872|275211|P13|Period 2|Non-compliance with study drug|3
70255|NCT01314872|275212|P12|Period 2|Non-compliance with study drug|3
70256|NCT01314872|275213|P11|Period 2|Non-compliance with study drug|0
70257|NCT01314872|275214|P10|Period 2|Non-compliance with study drug|0
70258|NCT01314872|275215|P9|Period 2|Non-compliance with study drug|0
70259|NCT01314872|275216|P8|Period 2|Non-compliance with study drug|0
70260|NCT01314872|275217|P7|Period 2|Non-compliance with study drug|0
70261|NCT01314872|275218|P6|Period 2|Non-compliance with study drug|0
70262|NCT01314872|275219|P5|Period 2|Non-compliance with study drug|0
70263|NCT01314872|275220|P4|Period 2|Non-compliance with study drug|0
70264|NCT01314872|275221|P3|Period 2|Non-compliance with study drug|0
70265|NCT01314872|275222|P2|Period 2|Non-compliance with study drug|0
70266|NCT01314872|275223|P1|Period 2|Non-compliance with study drug|0
70267|NCT01314872|275209|P15|Period 2|Protocol Violation|0
70268|NCT01314872|275210|P14|Period 2|Protocol Violation|2
70269|NCT01314872|275211|P13|Period 2|Protocol Violation|3
70270|NCT01314872|275212|P12|Period 2|Protocol Violation|3
70271|NCT01314872|275213|P11|Period 2|Protocol Violation|0
70272|NCT01314872|275214|P10|Period 2|Protocol Violation|0
70273|NCT01314872|275215|P9|Period 2|Protocol Violation|0
70274|NCT01314872|275216|P8|Period 2|Protocol Violation|0
70275|NCT01314872|275217|P7|Period 2|Protocol Violation|0
70276|NCT01314872|275218|P6|Period 2|Protocol Violation|0
70277|NCT01314872|275219|P5|Period 2|Protocol Violation|0
70278|NCT01314872|275220|P4|Period 2|Protocol Violation|0
70279|NCT01314872|275221|P3|Period 2|Protocol Violation|0
70280|NCT01314872|275222|P2|Period 2|Protocol Violation|0
70281|NCT01314872|275223|P1|Period 2|Protocol Violation|0
70282|NCT01314872|275209|P15|Treatment Period 1|Lost to Follow-up|0
70283|NCT01314872|275210|P14|Treatment Period 1|Lost to Follow-up|0
70284|NCT01314872|275211|P13|Treatment Period 1|Lost to Follow-up|0
70285|NCT01314872|275212|P12|Treatment Period 1|Lost to Follow-up|0
70286|NCT01314872|275213|P11|Treatment Period 1|Lost to Follow-up|0
70287|NCT01314872|275214|P10|Treatment Period 1|Lost to Follow-up|0
70288|NCT01314872|275215|P9|Treatment Period 1|Lost to Follow-up|1
70289|NCT01314872|275216|P8|Treatment Period 1|Lost to Follow-up|1
70290|NCT01314872|275217|P7|Treatment Period 1|Lost to Follow-up|1
70291|NCT01314872|275218|P6|Treatment Period 1|Lost to Follow-up|1
70292|NCT01314872|275219|P5|Treatment Period 1|Lost to Follow-up|1
70293|NCT01314872|275220|P4|Treatment Period 1|Lost to Follow-up|2
70294|NCT01314872|275221|P3|Treatment Period 1|Lost to Follow-up|2
70295|NCT01314872|275222|P2|Treatment Period 1|Lost to Follow-up|1
70296|NCT01314872|275223|P1|Treatment Period 1|Lost to Follow-up|0
70297|NCT01314872|275209|P15|Treatment Period 1|Withdrawal by Subject|0
70298|NCT01314872|275210|P14|Treatment Period 1|Withdrawal by Subject|0
70299|NCT01314872|275211|P13|Treatment Period 1|Withdrawal by Subject|0
70300|NCT01314872|275212|P12|Treatment Period 1|Withdrawal by Subject|0
70301|NCT01314872|275213|P11|Treatment Period 1|Withdrawal by Subject|1
70302|NCT01314872|275214|P10|Treatment Period 1|Withdrawal by Subject|2
70303|NCT01314872|275215|P9|Treatment Period 1|Withdrawal by Subject|2
70304|NCT01314872|275216|P8|Treatment Period 1|Withdrawal by Subject|2
70305|NCT01314872|275217|P7|Treatment Period 1|Withdrawal by Subject|3
70306|NCT01314872|275218|P6|Treatment Period 1|Withdrawal by Subject|1
70307|NCT01314872|275219|P5|Treatment Period 1|Withdrawal by Subject|3
70308|NCT01314872|275220|P4|Treatment Period 1|Withdrawal by Subject|2
70309|NCT01314872|275221|P3|Treatment Period 1|Withdrawal by Subject|0
70310|NCT01314872|275222|P2|Treatment Period 1|Withdrawal by Subject|1
70311|NCT01314872|275223|P1|Treatment Period 1|Withdrawal by Subject|3
70312|NCT01314872|275209|P15|Treatment Period 1|Adverse event, non-fatal|0
70313|NCT01314872|275210|P14|Treatment Period 1|Adverse event, non-fatal|0
70314|NCT01314872|275211|P13|Treatment Period 1|Adverse event, non-fatal|0
70315|NCT01314872|275212|P12|Treatment Period 1|Adverse event, non-fatal|0
70316|NCT01314872|275213|P11|Treatment Period 1|Adverse event, non-fatal|1
70317|NCT01314872|275214|P10|Treatment Period 1|Adverse event, non-fatal|0
70318|NCT01314872|275215|P9|Treatment Period 1|Adverse event, non-fatal|3
70319|NCT01314872|275216|P8|Treatment Period 1|Adverse event, non-fatal|2
70320|NCT01314872|275217|P7|Treatment Period 1|Adverse event, non-fatal|4
70321|NCT01314872|275218|P6|Treatment Period 1|Adverse event, non-fatal|4
70322|NCT01314872|275219|P5|Treatment Period 1|Adverse event, non-fatal|2
70323|NCT01314872|275220|P4|Treatment Period 1|Adverse event, non-fatal|2
70324|NCT01314872|275221|P3|Treatment Period 1|Adverse event, non-fatal|3
70325|NCT01314872|275222|P2|Treatment Period 1|Adverse event, non-fatal|2
70326|NCT01314872|275223|P1|Treatment Period 1|Adverse event, non-fatal|4
70327|NCT01314872|275209|P15|Treatment Period 1|Lack of Efficacy|0
70328|NCT01314872|275210|P14|Treatment Period 1|Lack of Efficacy|0
70329|NCT01314872|275211|P13|Treatment Period 1|Lack of Efficacy|0
70330|NCT01314872|275212|P12|Treatment Period 1|Lack of Efficacy|0
70331|NCT01314872|275213|P11|Treatment Period 1|Lack of Efficacy|0
70332|NCT01314872|275214|P10|Treatment Period 1|Lack of Efficacy|0
70333|NCT01314872|275215|P9|Treatment Period 1|Lack of Efficacy|0
70334|NCT01314872|275216|P8|Treatment Period 1|Lack of Efficacy|2
70335|NCT01314872|275217|P7|Treatment Period 1|Lack of Efficacy|0
70336|NCT01314872|275218|P6|Treatment Period 1|Lack of Efficacy|1
70337|NCT01314872|275219|P5|Treatment Period 1|Lack of Efficacy|0
70338|NCT01314872|275220|P4|Treatment Period 1|Lack of Efficacy|0
70339|NCT01314872|275221|P3|Treatment Period 1|Lack of Efficacy|0
70340|NCT01314872|275222|P2|Treatment Period 1|Lack of Efficacy|0
70341|NCT01314872|275223|P1|Treatment Period 1|Lack of Efficacy|1
70342|NCT01314872|275209|P15|Treatment Period 1|Physician Decision|0
70343|NCT01314872|275210|P14|Treatment Period 1|Physician Decision|0
70344|NCT01314872|275211|P13|Treatment Period 1|Physician Decision|0
70345|NCT01314872|275212|P12|Treatment Period 1|Physician Decision|0
70346|NCT01314872|275213|P11|Treatment Period 1|Physician Decision|0
70347|NCT01314872|275214|P10|Treatment Period 1|Physician Decision|1
70348|NCT01314872|275215|P9|Treatment Period 1|Physician Decision|0
70349|NCT01314872|275216|P8|Treatment Period 1|Physician Decision|0
70350|NCT01314872|275217|P7|Treatment Period 1|Physician Decision|0
70351|NCT01314872|275218|P6|Treatment Period 1|Physician Decision|0
70352|NCT01314872|275219|P5|Treatment Period 1|Physician Decision|0
70353|NCT01314872|275220|P4|Treatment Period 1|Physician Decision|1
70354|NCT01314872|275221|P3|Treatment Period 1|Physician Decision|0
70355|NCT01314872|275222|P2|Treatment Period 1|Physician Decision|1
70356|NCT01314872|275223|P1|Treatment Period 1|Physician Decision|0
70357|NCT01314872|275209|P15|Treatment Period 1|Protocol Violation|0
70358|NCT01314872|275210|P14|Treatment Period 1|Protocol Violation|0
70359|NCT01314872|275211|P13|Treatment Period 1|Protocol Violation|0
70360|NCT01314872|275212|P12|Treatment Period 1|Protocol Violation|0
70361|NCT01314872|275213|P11|Treatment Period 1|Protocol Violation|1
70362|NCT01314872|275214|P10|Treatment Period 1|Protocol Violation|1
70363|NCT01314872|275215|P9|Treatment Period 1|Protocol Violation|0
70364|NCT01314872|275216|P8|Treatment Period 1|Protocol Violation|0
70365|NCT01314872|275217|P7|Treatment Period 1|Protocol Violation|0
70366|NCT01314872|275218|P6|Treatment Period 1|Protocol Violation|0
70367|NCT01314872|275219|P5|Treatment Period 1|Protocol Violation|1
70368|NCT01314872|275220|P4|Treatment Period 1|Protocol Violation|0
70369|NCT01314872|275221|P3|Treatment Period 1|Protocol Violation|1
70370|NCT01314872|275222|P2|Treatment Period 1|Protocol Violation|1
70371|NCT01314872|275223|P1|Treatment Period 1|Protocol Violation|2
70372|NCT01314716|275327|P2|Open-Label Phase|Physician Decision|4
70373|NCT01314716|275328|P1|Open-Label Phase|Physician Decision|5
70374|NCT01314716|275327|P2|Open-Label Phase|Withdrawal by Subject|2
70375|NCT01314716|275328|P1|Open-Label Phase|Withdrawal by Subject|1
70376|NCT01314716|275327|P2|Open-Label Phase|Adverse Event|6
70377|NCT01314716|275328|P1|Open-Label Phase|Adverse Event|4
70378|NCT01314716|275327|P2|Double-Blind Phase|Physician Decision|1
70379|NCT01314716|275328|P1|Double-Blind Phase|Physician Decision|0
70380|NCT01314716|275327|P2|Double-Blind Phase|Sponsor request|2
70381|NCT01314716|275328|P1|Double-Blind Phase|Sponsor request|1
70382|NCT01314716|275327|P2|Double-Blind Phase|Lost to Follow-up|1
70383|NCT01314716|275328|P1|Double-Blind Phase|Lost to Follow-up|0
70384|NCT01314716|275327|P2|Double-Blind Phase|Withdrawal by Subject|6
70385|NCT01314716|275328|P1|Double-Blind Phase|Withdrawal by Subject|5
70386|NCT01314716|275327|P2|Double-Blind Phase|Adverse Event|4
70387|NCT01314716|275328|P1|Double-Blind Phase|Adverse Event|10
70388|NCT01314716|275327|P2|Double-Blind Phase|Randomized but not treated|1
70389|NCT01314716|275328|P1|Double-Blind Phase|Randomized but not treated|1
70390|NCT01314703|275340|P1|Overall Study|screen failure and closed enrollment|8
70391|NCT01314443|275349|P4|Overall Study|Protocol Violation|1
70392|NCT01314443|275350|P3|Overall Study|Protocol Violation|1
70393|NCT01314443|275351|P2|Overall Study|Protocol Violation|2
70394|NCT01314443|275352|P1|Overall Study|Protocol Violation|2
70395|NCT01314443|275349|P4|Overall Study|Withdrawal by Subject|1
70396|NCT01314443|275350|P3|Overall Study|Withdrawal by Subject|1
70397|NCT01314443|275351|P2|Overall Study|Withdrawal by Subject|1
70398|NCT01314443|275352|P1|Overall Study|Withdrawal by Subject|2
70399|NCT01314261|275401|P4|Overall Study|Virologic Failure|1
70400|NCT01314261|275402|P3|Overall Study|Virologic Failure|0
70401|NCT01314261|275403|P2|Overall Study|Virologic Failure|1
70402|NCT01314261|275404|P1|Overall Study|Virologic Failure|0
70403|NCT01314261|275401|P4|Overall Study|Lost to Follow-up|2
70404|NCT01314261|275402|P3|Overall Study|Lost to Follow-up|2
70405|NCT01314261|275403|P2|Overall Study|Lost to Follow-up|0
70406|NCT01314261|275404|P1|Overall Study|Lost to Follow-up|1
70407|NCT01314261|275401|P4|Overall Study|Withdrawal by Subject|0
70408|NCT01314261|275402|P3|Overall Study|Withdrawal by Subject|1
70409|NCT01314261|275403|P2|Overall Study|Withdrawal by Subject|3
70410|NCT01314261|275404|P1|Overall Study|Withdrawal by Subject|0
70411|NCT01314261|275401|P4|Overall Study|Adverse Event|0
70412|NCT01314261|275402|P3|Overall Study|Adverse Event|0
70413|NCT01314261|275403|P2|Overall Study|Adverse Event|0
70414|NCT01314261|275404|P1|Overall Study|Adverse Event|1
70415|NCT01314118|275455|P1|Overall Study|Ongoing|62
70416|NCT01314118|275455|P1|Overall Study|Other|2
70417|NCT01314118|275455|P1|Overall Study|Withdrawal by Subject|11
70418|NCT01314118|275455|P1|Overall Study|Protocol Violation|5
70419|NCT01314118|275455|P1|Overall Study|Death|4
70420|NCT01314118|275455|P1|Overall Study|Physician Decision|11
70421|NCT01314118|275455|P1|Overall Study|Progressive disease|27
70422|NCT01314118|275455|P1|Overall Study|Adverse Event|9
70423|NCT01314105|275464|P2|Overall Study|Other Adverse Event|1
70424|NCT01314105|275465|P1|Overall Study|Other Adverse Event|1
70425|NCT01314105|275464|P2|Overall Study|Refused to continue taking medication|1
70426|NCT01314105|275465|P1|Overall Study|Refused to continue taking medication|0
70427|NCT01314105|275464|P2|Overall Study|Progressive Disease|10
70428|NCT01314105|275465|P1|Overall Study|Progressive Disease|6
70429|NCT01313923|275578|P1|Overall Study|Physician Decision|3
70430|NCT01313884|275594|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
70431|NCT01313858|275602|P3|Overall Study|Lost to Follow-up|47
70432|NCT01313858|275603|P2|Overall Study|Lost to Follow-up|51
70433|NCT01313858|275604|P1|Overall Study|Lost to Follow-up|35
70434|NCT01313858|275602|P3|Overall Study|Premature Treatment Termination|191
70435|NCT01313858|275603|P2|Overall Study|Premature Treatment Termination|219
70436|NCT01313858|275604|P1|Overall Study|Premature Treatment Termination|251
70437|NCT01313780|275627|P2|Overall Study|missing data|3
70438|NCT01313780|275628|P1|Overall Study|missing data|3
70439|NCT01313780|275627|P2|Overall Study|Protocol Violation|4
70440|NCT01313780|275628|P1|Overall Study|Protocol Violation|10
70441|NCT01313780|275627|P2|Overall Study|Withdrawal by Subject|8
70442|NCT01313780|275628|P1|Overall Study|Withdrawal by Subject|2
70443|NCT01313780|275627|P2|Overall Study|Adverse Event|11
70444|NCT01313780|275628|P1|Overall Study|Adverse Event|6
70445|NCT01313780|275627|P2|Overall Study|Lack of Efficacy|2
70446|NCT01313780|275628|P1|Overall Study|Lack of Efficacy|4
70447|NCT01313728|275636|P1|Informed Consent to Baseline|Withdrawal by Subject|1
70448|NCT01313689|275653|P4|24-Week Randomization 2|Withdrawal by Subject|1
70449|NCT01313689|275654|P3|24-Week Randomization 2|Withdrawal by Subject|1
70450|NCT01313689|275655|P2|24-Week Randomization 2|Withdrawal by Subject|0
70451|NCT01313689|275656|P1|24-Week Randomization 2|Withdrawal by Subject|0
70452|NCT01313689|275653|P4|24-Week Randomization 2|Adverse Event|0
70453|NCT01313689|275654|P3|24-Week Randomization 2|Adverse Event|2
70454|NCT01313689|275655|P2|24-Week Randomization 2|Adverse Event|0
70455|NCT01313689|275656|P1|24-Week Randomization 2|Adverse Event|0
70456|NCT01313689|275653|P4|24-Week Randomization 1|Withdrawal by Subject|0
70457|NCT01313689|275654|P3|24-Week Randomization 1|Withdrawal by Subject|0
70458|NCT01313689|275655|P2|24-Week Randomization 1|Withdrawal by Subject|0
70459|NCT01313689|275656|P1|24-Week Randomization 1|Withdrawal by Subject|5
70460|NCT01313689|275653|P4|24-Week Randomization 1|Physician Decision|0
70461|NCT01313689|275654|P3|24-Week Randomization 1|Physician Decision|0
70462|NCT01313689|275655|P2|24-Week Randomization 1|Physician Decision|5
70463|NCT01313689|275656|P1|24-Week Randomization 1|Physician Decision|4
70464|NCT01313689|275653|P4|24-Week Randomization 1|Adverse Event|0
70465|NCT01313689|275654|P3|24-Week Randomization 1|Adverse Event|0
70466|NCT01313689|275655|P2|24-Week Randomization 1|Adverse Event|5
70467|NCT01313689|275656|P1|24-Week Randomization 1|Adverse Event|10
70468|NCT01313676|275723|P4|Overall Study|Missing|0
70469|NCT01313676|275724|P3|Overall Study|Missing|1
70470|NCT01313676|275725|P2|Overall Study|Missing|1
70471|NCT01313676|275726|P1|Overall Study|Missing|1
70472|NCT01313676|275723|P4|Overall Study|Investigator Site Closed|10
70473|NCT01313676|275724|P3|Overall Study|Investigator Site Closed|15
70474|NCT01313676|275725|P2|Overall Study|Investigator Site Closed|11
70475|NCT01313676|275726|P1|Overall Study|Investigator Site Closed|12
70476|NCT01313676|275723|P4|Overall Study|Sponsor Terminated Study Treatment|1
70477|NCT01313676|275724|P3|Overall Study|Sponsor Terminated Study Treatment|0
70478|NCT01313676|275725|P2|Overall Study|Sponsor Terminated Study Treatment|1
70479|NCT01313676|275726|P1|Overall Study|Sponsor Terminated Study Treatment|1
70480|NCT01313676|275723|P4|Overall Study|Decision by Participant or Proxy|492
70481|NCT01313676|275724|P3|Overall Study|Decision by Participant or Proxy|515
70482|NCT01313676|275725|P2|Overall Study|Decision by Participant or Proxy|527
70483|NCT01313676|275726|P1|Overall Study|Decision by Participant or Proxy|643
70484|NCT01313676|275723|P4|Overall Study|Physician Decision|48
70485|NCT01313676|275724|P3|Overall Study|Physician Decision|62
70486|NCT01313676|275725|P2|Overall Study|Physician Decision|64
70487|NCT01313676|275726|P1|Overall Study|Physician Decision|53
70488|NCT01313676|275723|P4|Overall Study|Lost to Follow-up|0
70489|NCT01313676|275724|P3|Overall Study|Lost to Follow-up|1
70490|NCT01313676|275725|P2|Overall Study|Lost to Follow-up|0
70491|NCT01313676|275726|P1|Overall Study|Lost to Follow-up|0
70492|NCT01313676|275723|P4|Overall Study|Study Closed/terminated|9
70493|NCT01313676|275724|P3|Overall Study|Study Closed/terminated|9
70494|NCT01313676|275725|P2|Overall Study|Study Closed/terminated|6
70495|NCT01313676|275726|P1|Overall Study|Study Closed/terminated|7
70496|NCT01313676|275723|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
70497|NCT01313676|275724|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
70498|NCT01313676|275725|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
70499|NCT01313676|275726|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
70500|NCT01313676|275723|P4|Overall Study|Protocol Violation|44
70501|NCT01313676|275724|P3|Overall Study|Protocol Violation|46
70502|NCT01313676|275725|P2|Overall Study|Protocol Violation|44
70503|NCT01313676|275726|P1|Overall Study|Protocol Violation|37
70504|NCT01313676|275723|P4|Overall Study|Lack of Efficacy|46
70505|NCT01313676|275724|P3|Overall Study|Lack of Efficacy|65
70506|NCT01313676|275725|P2|Overall Study|Lack of Efficacy|90
70507|NCT01313676|275726|P1|Overall Study|Lack of Efficacy|98
70508|NCT01313676|275723|P4|Overall Study|Adverse Event|333
70509|NCT01313676|275724|P3|Overall Study|Adverse Event|372
70510|NCT01313676|275725|P2|Overall Study|Adverse Event|365
70511|NCT01313676|275726|P1|Overall Study|Adverse Event|395
70512|NCT01313663|275746|P2|Overall Study|Withdrawal by Subject|1
70513|NCT01313663|275747|P1|Overall Study|Withdrawal by Subject|2
70514|NCT01313663|275746|P2|Overall Study|Physician Decision|2
70515|NCT01313663|275747|P1|Overall Study|Physician Decision|0
70516|NCT01313663|275746|P2|Overall Study|Lost to Follow-up|1
70517|NCT01313663|275747|P1|Overall Study|Lost to Follow-up|0
70518|NCT01313663|275746|P2|Overall Study|Study Closed/Terminated|4
70519|NCT01313663|275747|P1|Overall Study|Study Closed/Terminated|2
70520|NCT01313650|275785|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
70521|NCT01313650|275786|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
70522|NCT01313650|275787|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
70523|NCT01313650|275788|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
70524|NCT01313650|275785|P4|Overall Study|Protocol Violation|6
70525|NCT01313650|275786|P3|Overall Study|Protocol Violation|5
70526|NCT01313650|275787|P2|Overall Study|Protocol Violation|7
70527|NCT01313650|275788|P1|Overall Study|Protocol Violation|4
70528|NCT01313650|275785|P4|Overall Study|Withdrawal by Subject|15
70529|NCT01313650|275786|P3|Overall Study|Withdrawal by Subject|15
70530|NCT01313650|275787|P2|Overall Study|Withdrawal by Subject|20
70531|NCT01313650|275788|P1|Overall Study|Withdrawal by Subject|16
70532|NCT01313650|275785|P4|Overall Study|Lost to Follow-up|2
70533|NCT01313650|275786|P3|Overall Study|Lost to Follow-up|3
70534|NCT01313650|275787|P2|Overall Study|Lost to Follow-up|0
70535|NCT01313650|275788|P1|Overall Study|Lost to Follow-up|1
70536|NCT01313650|275785|P4|Overall Study|Lack of Efficacy|20
70537|NCT01313650|275786|P3|Overall Study|Lack of Efficacy|32
70538|NCT01313650|275787|P2|Overall Study|Lack of Efficacy|20
70539|NCT01313650|275788|P1|Overall Study|Lack of Efficacy|37
70540|NCT01313650|275785|P4|Overall Study|Adverse Event|23
70541|NCT01313650|275786|P3|Overall Study|Adverse Event|24
70542|NCT01313650|275787|P2|Overall Study|Adverse Event|34
70543|NCT01313650|275788|P1|Overall Study|Adverse Event|9
70544|NCT01313637|275814|P4|Overall Study|Withdrawal by Subject|15
70545|NCT01313637|275815|P3|Overall Study|Withdrawal by Subject|18
70546|NCT01313637|275816|P2|Overall Study|Withdrawal by Subject|13
70547|NCT01313637|275817|P1|Overall Study|Withdrawal by Subject|11
70548|NCT01313637|275814|P4|Overall Study|Lost to Follow-up|3
70549|NCT01313637|275815|P3|Overall Study|Lost to Follow-up|1
70550|NCT01313637|275816|P2|Overall Study|Lost to Follow-up|2
70551|NCT01313637|275817|P1|Overall Study|Lost to Follow-up|0
70552|NCT01313637|275814|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
70553|NCT01313637|275815|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
70554|NCT01313637|275816|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
70555|NCT01313637|275817|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
70556|NCT01313637|275814|P4|Overall Study|Protocol Violation|5
70557|NCT01313637|275815|P3|Overall Study|Protocol Violation|11
70558|NCT01313637|275816|P2|Overall Study|Protocol Violation|3
70559|NCT01313637|275817|P1|Overall Study|Protocol Violation|4
70560|NCT01313637|275814|P4|Overall Study|Lack of Efficacy|24
70561|NCT01313637|275815|P3|Overall Study|Lack of Efficacy|37
70562|NCT01313637|275816|P2|Overall Study|Lack of Efficacy|38
70563|NCT01313637|275817|P1|Overall Study|Lack of Efficacy|44
70564|NCT01313637|275814|P4|Overall Study|Adverse Event|18
70565|NCT01313637|275815|P3|Overall Study|Adverse Event|25
70566|NCT01313637|275816|P2|Overall Study|Adverse Event|24
70567|NCT01313637|275817|P1|Overall Study|Adverse Event|17
70568|NCT01313624|275841|P2|Open-Label Phase|Lost to Follow-up|1
70569|NCT01313624|275842|P1|Open-Label Phase|Lost to Follow-up|1
70570|NCT01313624|275841|P2|Open-Label Phase|Withdrawal by Subject|2
70571|NCT01313624|275842|P1|Open-Label Phase|Withdrawal by Subject|2
70572|NCT01313624|275841|P2|Open-Label Phase|Adverse Event|10
70573|NCT01313624|275842|P1|Open-Label Phase|Adverse Event|1
70574|NCT01313624|275841|P2|Double-Blind Phase|Lack of Efficacy|0
70575|NCT01313624|275842|P1|Double-Blind Phase|Lack of Efficacy|1
70576|NCT01313624|275841|P2|Double-Blind Phase|Physician Decision|0
70577|NCT01313624|275842|P1|Double-Blind Phase|Physician Decision|1
70578|NCT01313624|275841|P2|Double-Blind Phase|Lost to Follow-up|2
70579|NCT01313624|275842|P1|Double-Blind Phase|Lost to Follow-up|0
70580|NCT01313624|275841|P2|Double-Blind Phase|Withdrawal by Subject|4
70581|NCT01313624|275842|P1|Double-Blind Phase|Withdrawal by Subject|9
70582|NCT01313624|275841|P2|Double-Blind Phase|Adverse Event|4
70583|NCT01313624|275842|P1|Double-Blind Phase|Adverse Event|27
70584|NCT01313559|275856|P2|Overall Study|Rising PSA|0
70585|NCT01313559|275857|P1|Overall Study|Rising PSA|2
70586|NCT01313559|275856|P2|Overall Study|Disease progression|0
70587|NCT01313559|275857|P1|Overall Study|Disease progression|1
70588|NCT01313559|275856|P2|Overall Study|Withdrawal by Subject|2
70589|NCT01313559|275857|P1|Overall Study|Withdrawal by Subject|1
70590|NCT01313312|275953|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
70591|NCT01313312|275953|P1|Overall Study|Subject Withdrawn Early in Error|4
70592|NCT01313312|275953|P1|Overall Study|Observational Phase|1
70593|NCT01313312|275953|P1|Overall Study|Investigator Decision|1
70594|NCT01313312|275953|P1|Overall Study|Lack of Efficacy|3
70595|NCT01313312|275953|P1|Overall Study|Withdrawal by Subject|18
70596|NCT01313312|275953|P1|Overall Study|Adverse Event|5
70597|NCT01313299|276000|P3|Overall Study|Lack of subject compliance|1
70598|NCT01313299|276001|P2|Overall Study|Lack of subject compliance|0
70599|NCT01313299|276002|P1|Overall Study|Lack of subject compliance|0
70600|NCT01313299|276000|P3|Overall Study|Family reason and moved out of state|0
70601|NCT01313299|276001|P2|Overall Study|Family reason and moved out of state|2
70602|NCT01313299|276002|P1|Overall Study|Family reason and moved out of state|0
70603|NCT01313299|276000|P3|Overall Study|Withdrawal by Subject|2
70604|NCT01313299|276001|P2|Overall Study|Withdrawal by Subject|0
70605|NCT01313299|276002|P1|Overall Study|Withdrawal by Subject|1
70606|NCT01313299|276000|P3|Overall Study|Protocol Violation|0
70607|NCT01313299|276001|P2|Overall Study|Protocol Violation|0
70608|NCT01313299|276002|P1|Overall Study|Protocol Violation|2
70609|NCT01313299|276000|P3|Overall Study|Lost to Follow-up|0
70610|NCT01313299|276001|P2|Overall Study|Lost to Follow-up|0
70611|NCT01313299|276002|P1|Overall Study|Lost to Follow-up|1
70612|NCT01313299|276000|P3|Overall Study|Adverse Event|1
70613|NCT01313299|276001|P2|Overall Study|Adverse Event|1
70614|NCT01313299|276002|P1|Overall Study|Adverse Event|3
70615|NCT01313273|276018|P2|Overall Study|Screening Chromogranin A-in normal range|1
70616|NCT01313273|276019|P1|Overall Study|Screening Chromogranin A-in normal range|0
70617|NCT01313273|276018|P2|Overall Study|Withdrawal by Subject|0
70618|NCT01313273|276019|P1|Overall Study|Withdrawal by Subject|1
70619|NCT01313273|276018|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
70620|NCT01313273|276019|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
70621|NCT01313221|276034|P3|Overall Study|Pregnancy|2
70622|NCT01313221|276035|P2|Overall Study|Pregnancy|0
70623|NCT01313221|276036|P1|Overall Study|Pregnancy|0
70624|NCT01313221|276034|P3|Overall Study|Physician Decision|2
70625|NCT01313221|276035|P2|Overall Study|Physician Decision|0
70626|NCT01313221|276036|P1|Overall Study|Physician Decision|0
70627|NCT01313221|276034|P3|Overall Study|Disease progression|2
70628|NCT01313221|276035|P2|Overall Study|Disease progression|0
70629|NCT01313221|276036|P1|Overall Study|Disease progression|0
70630|NCT01313221|276034|P3|Overall Study|Adverse Event|7
70631|NCT01313221|276035|P2|Overall Study|Adverse Event|0
70632|NCT01313221|276036|P1|Overall Study|Adverse Event|0
70633|NCT01313221|276034|P3|Overall Study|Other|0
70634|NCT01313221|276035|P2|Overall Study|Other|0
70635|NCT01313221|276036|P1|Overall Study|Other|1
70636|NCT01313221|276034|P3|Overall Study|Lost to Follow-up|1
70637|NCT01313221|276035|P2|Overall Study|Lost to Follow-up|3
70638|NCT01313221|276036|P1|Overall Study|Lost to Follow-up|6
70639|NCT01313221|276034|P3|Overall Study|Requirement for alternative therapy|1
70640|NCT01313221|276035|P2|Overall Study|Requirement for alternative therapy|1
70641|NCT01313221|276036|P1|Overall Study|Requirement for alternative therapy|0
70642|NCT01313221|276034|P3|Overall Study|Withdrawal by Subject|5
70643|NCT01313221|276035|P2|Overall Study|Withdrawal by Subject|3
70644|NCT01313221|276036|P1|Overall Study|Withdrawal by Subject|2
70645|NCT01313221|276034|P3|Overall Study|Non-compliance|2
70646|NCT01313221|276035|P2|Overall Study|Non-compliance|0
70647|NCT01313221|276036|P1|Overall Study|Non-compliance|3
70648|NCT01313221|276034|P3|Overall Study|Protocol Violation|1
70649|NCT01313221|276035|P2|Overall Study|Protocol Violation|1
70650|NCT01313221|276036|P1|Overall Study|Protocol Violation|0
70651|NCT01313208|276088|P2|Open-label Phase (Weeks 13 - 24)|Other|0
70652|NCT01313208|276089|P1|Open-label Phase (Weeks 13 - 24)|Other|2
70653|NCT01313208|276088|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
70654|NCT01313208|276089|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
70655|NCT01313208|276088|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
70656|NCT01313208|276089|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
70657|NCT01313208|276088|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
70658|NCT01313208|276089|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
70659|NCT01313208|276088|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
70660|NCT01313208|276089|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
70661|NCT01313208|276088|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
70662|NCT01313208|276089|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
70663|NCT01313208|276088|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
70664|NCT01313208|276089|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
70665|NCT01313208|276088|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
70666|NCT01313208|276089|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
70667|NCT01313208|276088|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
70668|NCT01313208|276089|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
70669|NCT01313182|276179|P2|Overall Study|Protocol Violation|92
70670|NCT01313182|276180|P1|Overall Study|Protocol Violation|66
70671|NCT01313117|276186|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
70672|NCT01313117|276186|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
70673|NCT01313078|276193|P1|Overall Study|Withdrawal by Subject|1
70674|NCT01313078|276193|P1|Overall Study|Discontinued study drug|1
70675|NCT01313078|276193|P1|Overall Study|Death|1
70676|NCT01313039|276198|P1|Overall Study|Adverse Event|1
70677|NCT01313039|276198|P1|Overall Study|Physician Decision|1
70678|NCT01312961|276204|P2|Overall Study|Other than specified above|3
70679|NCT01312961|276205|P1|Overall Study|Other than specified above|2
70680|NCT01312961|276204|P2|Overall Study|Poor compliance to protocol|0
70681|NCT01312961|276205|P1|Overall Study|Poor compliance to protocol|1
70682|NCT01312961|276204|P2|Overall Study|Lack of Efficacy|1
70683|NCT01312961|276205|P1|Overall Study|Lack of Efficacy|11
70684|NCT01312961|276204|P2|Overall Study|Adverse Event|3
70685|NCT01312961|276205|P1|Overall Study|Adverse Event|3
70686|NCT01312467|276322|P1|Overall Study|Ineligible|4
70687|NCT01312467|276322|P1|Overall Study|Another medical condition|1
70688|NCT01312467|276322|P1|Overall Study|Deported to country of origin|1
70689|NCT01312467|276322|P1|Overall Study|Withdrawal by Subject|2
70690|NCT01312467|276322|P1|Overall Study|Lost to Follow-up|1
70691|NCT01312467|276322|P1|Overall Study|Adverse Event|4
70692|NCT01312428|276331|P2|Overall Study|Study Termination|4
70693|NCT01312428|276332|P1|Overall Study|Study Termination|3
70694|NCT01312129|276377|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
70695|NCT01312129|276378|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
70696|NCT01311687|276408|P2|PFS Follow-up Phase|On PFS follow-up at data cut-off|1
70697|NCT01311687|276409|P1|PFS Follow-up Phase|On PFS follow-up at data cut-off|3
70698|NCT01311687|276408|P2|Treatment Phase|On treatment at data cut-off|11
70699|NCT01311687|276409|P1|Treatment Phase|On treatment at data cut-off|60
70700|NCT01311661|276459|P1|Overall Study|Withdrawal by Subject|2
70701|NCT01311661|276459|P1|Overall Study|Protocol Violation|3
70702|NCT01311661|276459|P1|Overall Study|Adverse Event|2
70703|NCT01311557|276603|P2|Overall Study|Withdrawal by Subject|2
70704|NCT01311557|276604|P1|Overall Study|Withdrawal by Subject|1
70705|NCT01311557|276603|P2|Overall Study|Lost to Follow-up|1
70706|NCT01311557|276604|P1|Overall Study|Lost to Follow-up|0
70707|NCT01311557|276603|P2|Overall Study|Protocol Violation|2
70708|NCT01311557|276604|P1|Overall Study|Protocol Violation|4
70709|NCT01311557|276603|P2|Overall Study|Serious adverse event|1
70710|NCT01311557|276604|P1|Overall Study|Serious adverse event|0
70711|NCT01311505|276620|P2|First Intervention Period|Protocol Violation|1
70712|NCT01311505|276621|P1|First Intervention Period|Protocol Violation|0
70713|NCT01311024|276677|P2|Overall Study|Protocol Violation|22
70714|NCT01311024|276678|P1|Overall Study|Protocol Violation|35
70715|NCT01310868|276684|P1|Overall Study|Do not have histologically confirmed GBM|13
70716|NCT01310803|276701|P2|Overall Study|Subject terminated by Sponsor|0
70717|NCT01310803|276702|P1|Overall Study|Subject terminated by Sponsor|1
70718|NCT01310777|276713|P3|Overall Study|Other|2
70719|NCT01310777|276714|P2|Overall Study|Other|1
70720|NCT01310777|276715|P1|Overall Study|Other|4
70721|NCT01310777|276713|P3|Overall Study|Inadequate Control of IOP|10
70722|NCT01310777|276714|P2|Overall Study|Inadequate Control of IOP|7
70723|NCT01310777|276715|P1|Overall Study|Inadequate Control of IOP|5
70724|NCT01310777|276713|P3|Overall Study|Patient's Decision Unrelated to AE|2
70725|NCT01310777|276714|P2|Overall Study|Patient's Decision Unrelated to AE|1
70726|NCT01310777|276715|P1|Overall Study|Patient's Decision Unrelated to AE|1
70727|NCT01310777|276713|P3|Overall Study|Lost to Follow-up|1
70728|NCT01310777|276714|P2|Overall Study|Lost to Follow-up|4
70729|NCT01310777|276715|P1|Overall Study|Lost to Follow-up|0
70730|NCT01310777|276713|P3|Overall Study|Adverse Event|15
70731|NCT01310777|276714|P2|Overall Study|Adverse Event|1
70732|NCT01310777|276715|P1|Overall Study|Adverse Event|23
70733|NCT01310699|276725|P2|Overall Study|Patients did not complete tandem.|6
70734|NCT01310699|276726|P1|Overall Study|Patients did not complete tandem.|4
70735|NCT01310413|276753|P7|From Day U0 to Day U385|Lost to Follow-up|2
70736|NCT01310413|276754|P6|From Day U0 to Day U385|Lost to Follow-up|0
70737|NCT01310413|276755|P5|From Day U0 to Day U385|Lost to Follow-up|0
70738|NCT01310413|276756|P4|From Day U0 to Day U385|Lost to Follow-up|0
70739|NCT01310413|276757|P3|From Day U0 to Day U385|Lost to Follow-up|0
70740|NCT01310413|276758|P2|From Day U0 to Day U385|Lost to Follow-up|0
70741|NCT01310413|276759|P1|From Day U0 to Day U385|Lost to Follow-up|0
70742|NCT01310413|276753|P7|From Day U0 to Day U385|Withdrawal by Subject|1
70743|NCT01310413|276754|P6|From Day U0 to Day U385|Withdrawal by Subject|0
70744|NCT01310413|276755|P5|From Day U0 to Day U385|Withdrawal by Subject|0
70745|NCT01310413|276756|P4|From Day U0 to Day U385|Withdrawal by Subject|0
70746|NCT01310413|276757|P3|From Day U0 to Day U385|Withdrawal by Subject|0
70747|NCT01310413|276758|P2|From Day U0 to Day U385|Withdrawal by Subject|0
70748|NCT01310413|276759|P1|From Day U0 to Day U385|Withdrawal by Subject|0
70749|NCT01310413|276753|P7|Day 0 to Day 385|Other|0
70750|NCT01310413|276754|P6|Day 0 to Day 385|Other|0
70751|NCT01310413|276755|P5|Day 0 to Day 385|Other|0
70752|NCT01310413|276756|P4|Day 0 to Day 385|Other|0
70753|NCT01310413|276757|P3|Day 0 to Day 385|Other|3
70754|NCT01310413|276758|P2|Day 0 to Day 385|Other|0
70755|NCT01310413|276759|P1|Day 0 to Day 385|Other|1
70756|NCT01310413|276753|P7|Day 0 to Day 385|Migrated/moved from study area|0
70757|NCT01310413|276754|P6|Day 0 to Day 385|Migrated/moved from study area|0
70758|NCT01310413|276755|P5|Day 0 to Day 385|Migrated/moved from study area|1
70759|NCT01310413|276756|P4|Day 0 to Day 385|Migrated/moved from study area|1
70760|NCT01310413|276757|P3|Day 0 to Day 385|Migrated/moved from study area|1
70761|NCT01310413|276758|P2|Day 0 to Day 385|Migrated/moved from study area|3
70762|NCT01310413|276759|P1|Day 0 to Day 385|Migrated/moved from study area|3
70763|NCT01310413|276753|P7|Day 0 to Day 385|Lost to Follow-up|0
70764|NCT01310413|276754|P6|Day 0 to Day 385|Lost to Follow-up|2
70765|NCT01310413|276755|P5|Day 0 to Day 385|Lost to Follow-up|1
70766|NCT01310413|276756|P4|Day 0 to Day 385|Lost to Follow-up|5
70767|NCT01310413|276757|P3|Day 0 to Day 385|Lost to Follow-up|3
70768|NCT01310413|276758|P2|Day 0 to Day 385|Lost to Follow-up|3
70769|NCT01310413|276759|P1|Day 0 to Day 385|Lost to Follow-up|18
70770|NCT01310413|276753|P7|Day 0 to Day 385|Withdrawal by Subject|0
70771|NCT01310413|276754|P6|Day 0 to Day 385|Withdrawal by Subject|1
70772|NCT01310413|276755|P5|Day 0 to Day 385|Withdrawal by Subject|1
70773|NCT01310413|276756|P4|Day 0 to Day 385|Withdrawal by Subject|2
70774|NCT01310413|276757|P3|Day 0 to Day 385|Withdrawal by Subject|0
70775|NCT01310413|276758|P2|Day 0 to Day 385|Withdrawal by Subject|2
70776|NCT01310413|276759|P1|Day 0 to Day 385|Withdrawal by Subject|5
70777|NCT01310127|276941|P2|Overall Study|advanced psc cataract outlier|0
70778|NCT01310127|276942|P1|Overall Study|advanced psc cataract outlier|1
70779|NCT01310127|276941|P2|Overall Study|Protocol Violation|1
70780|NCT01310127|276942|P1|Overall Study|Protocol Violation|1
70781|NCT01309997|276956|P2|Overall Study|Withdrawal by Subject|1
70782|NCT01309997|276957|P1|Overall Study|Withdrawal by Subject|1
70783|NCT01309997|276956|P2|Overall Study|Lack of Efficacy|2
70784|NCT01309997|276957|P1|Overall Study|Lack of Efficacy|2
70785|NCT01309997|276956|P2|Overall Study|Death|3
70786|NCT01309997|276957|P1|Overall Study|Death|1
70787|NCT01309997|276956|P2|Overall Study|Adverse Event|0
70788|NCT01309997|276957|P1|Overall Study|Adverse Event|1
70789|NCT01309919|276981|P2|Overall Study|Did not receive a postpartum IUD|48
70790|NCT01309919|276982|P1|Overall Study|Did not receive a postpartum IUD|17
70791|NCT01309893|276994|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
70792|NCT01309893|276995|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
70793|NCT01309893|276994|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
70794|NCT01309893|276995|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
70795|NCT01309841|277019|P3|Overall Study|Severe non-compliance with protocol|2
70796|NCT01309841|277020|P2|Overall Study|Severe non-compliance with protocol|5
70797|NCT01309841|277021|P1|Overall Study|Severe non-compliance with protocol|0
70798|NCT01309841|277019|P3|Overall Study|Did Not Receive Treatment|1
70799|NCT01309841|277020|P2|Overall Study|Did Not Receive Treatment|0
70800|NCT01309841|277021|P1|Overall Study|Did Not Receive Treatment|2
70801|NCT01309841|277019|P3|Overall Study|Withdrawal by Subject|13
70802|NCT01309841|277020|P2|Overall Study|Withdrawal by Subject|6
70803|NCT01309841|277021|P1|Overall Study|Withdrawal by Subject|17
70804|NCT01309841|277019|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
70805|NCT01309841|277020|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
70806|NCT01309841|277021|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
70807|NCT01309841|277019|P3|Overall Study|Death|0
70808|NCT01309841|277020|P2|Overall Study|Death|0
70809|NCT01309841|277021|P1|Overall Study|Death|1
70810|NCT01309841|277019|P3|Overall Study|Adverse Event|11
70811|NCT01309841|277020|P2|Overall Study|Adverse Event|22
70812|NCT01309841|277021|P1|Overall Study|Adverse Event|9
70813|NCT01309841|277019|P3|Overall Study|Lack of Efficacy|2
70814|NCT01309841|277020|P2|Overall Study|Lack of Efficacy|0
70815|NCT01309841|277021|P1|Overall Study|Lack of Efficacy|0
70816|NCT01309841|277019|P3|Overall Study|Study-Specific Withdrawal Criteria|2
70817|NCT01309841|277020|P2|Overall Study|Study-Specific Withdrawal Criteria|1
70818|NCT01309841|277021|P1|Overall Study|Study-Specific Withdrawal Criteria|3
70819|NCT01309841|277019|P3|Overall Study|Lost to Follow-up|4
70820|NCT01309841|277020|P2|Overall Study|Lost to Follow-up|6
70821|NCT01309841|277021|P1|Overall Study|Lost to Follow-up|7
70822|NCT01309841|277019|P3|Overall Study|Other|1
70823|NCT01309841|277020|P2|Overall Study|Other|1
70824|NCT01309841|277021|P1|Overall Study|Other|0
70825|NCT01309828|277061|P2|Overall Study|Other|0
70826|NCT01309828|277062|P1|Overall Study|Other|1
70827|NCT01309828|277061|P2|Overall Study|Major Protocol Deviation|1
70828|NCT01309828|277062|P1|Overall Study|Major Protocol Deviation|0
70829|NCT01309828|277061|P2|Overall Study|Voluntary Withdrawal|4
70830|NCT01309828|277062|P1|Overall Study|Voluntary Withdrawal|5
70831|NCT01309828|277061|P2|Overall Study|Adverse Event|11
70832|NCT01309828|277062|P1|Overall Study|Adverse Event|10
70833|NCT01309737|277096|P5|Week 16 to 52|Other|0
70834|NCT01309737|277097|P4|Week 16 to 52|Other|2
70835|NCT01309737|277098|P3|Week 16 to 52|Other|0
70836|NCT01309737|277099|P2|Week 16 to 52|Other|12
70837|NCT01309737|277100|P1|Week 16 to 52|Other|10
70838|NCT01309737|277096|P5|Week 16 to 52|Withdrawal by Subject|2
70839|NCT01309737|277097|P4|Week 16 to 52|Withdrawal by Subject|0
70840|NCT01309737|277098|P3|Week 16 to 52|Withdrawal by Subject|0
70841|NCT01309737|277099|P2|Week 16 to 52|Withdrawal by Subject|6
70842|NCT01309737|277100|P1|Week 16 to 52|Withdrawal by Subject|5
70843|NCT01309737|277096|P5|Week 16 to 52|Lost to Follow-up|4
70844|NCT01309737|277097|P4|Week 16 to 52|Lost to Follow-up|1
70845|NCT01309737|277098|P3|Week 16 to 52|Lost to Follow-up|0
70846|NCT01309737|277099|P2|Week 16 to 52|Lost to Follow-up|2
70847|NCT01309737|277100|P1|Week 16 to 52|Lost to Follow-up|4
70848|NCT01309737|277096|P5|Week 16 to 52|Lack of Efficacy|21
70849|NCT01309737|277097|P4|Week 16 to 52|Lack of Efficacy|25
70850|NCT01309737|277098|P3|Week 16 to 52|Lack of Efficacy|0
70851|NCT01309737|277099|P2|Week 16 to 52|Lack of Efficacy|76
70852|NCT01309737|277100|P1|Week 16 to 52|Lack of Efficacy|107
70853|NCT01309737|277096|P5|Week 16 to 52|Adverse Event|5
70854|NCT01309737|277097|P4|Week 16 to 52|Adverse Event|6
70855|NCT01309737|277098|P3|Week 16 to 52|Adverse Event|0
70856|NCT01309737|277099|P2|Week 16 to 52|Adverse Event|7
70857|NCT01309737|277100|P1|Week 16 to 52|Adverse Event|7
70858|NCT01309737|277096|P5|Week 16 to 52|Death|1
70859|NCT01309737|277097|P4|Week 16 to 52|Death|0
70860|NCT01309737|277098|P3|Week 16 to 52|Death|0
70861|NCT01309737|277099|P2|Week 16 to 52|Death|0
70862|NCT01309737|277100|P1|Week 16 to 52|Death|0
70863|NCT01309737|277096|P5|Week 0 to 16|Randomized, but not treated|0
70864|NCT01309737|277097|P4|Week 0 to 16|Randomized, but not treated|0
70865|NCT01309737|277098|P3|Week 0 to 16|Randomized, but not treated|0
70866|NCT01309737|277099|P2|Week 0 to 16|Randomized, but not treated|0
70867|NCT01309737|277100|P1|Week 0 to 16|Randomized, but not treated|1
70868|NCT01309737|277096|P5|Week 0 to 16|Other|0
70869|NCT01309737|277097|P4|Week 0 to 16|Other|0
70870|NCT01309737|277098|P3|Week 0 to 16|Other|4
70871|NCT01309737|277099|P2|Week 0 to 16|Other|14
70872|NCT01309737|277100|P1|Week 0 to 16|Other|10
70873|NCT01309737|277096|P5|Week 0 to 16|Withdrawal by Subject|0
70874|NCT01309737|277097|P4|Week 0 to 16|Withdrawal by Subject|0
70875|NCT01309737|277098|P3|Week 0 to 16|Withdrawal by Subject|7
70876|NCT01309737|277099|P2|Week 0 to 16|Withdrawal by Subject|6
70877|NCT01309737|277100|P1|Week 0 to 16|Withdrawal by Subject|7
70878|NCT01309737|277096|P5|Week 0 to 16|Lost to Follow-up|0
70879|NCT01309737|277097|P4|Week 0 to 16|Lost to Follow-up|0
70880|NCT01309737|277098|P3|Week 0 to 16|Lost to Follow-up|3
70881|NCT01309737|277099|P2|Week 0 to 16|Lost to Follow-up|8
70882|NCT01309737|277100|P1|Week 0 to 16|Lost to Follow-up|7
70883|NCT01309737|277096|P5|Week 0 to 16|Lack of Efficacy|0
70884|NCT01309737|277097|P4|Week 0 to 16|Lack of Efficacy|0
70885|NCT01309737|277098|P3|Week 0 to 16|Lack of Efficacy|24
70886|NCT01309737|277099|P2|Week 0 to 16|Lack of Efficacy|2
70887|NCT01309737|277100|P1|Week 0 to 16|Lack of Efficacy|15
70888|NCT01309737|277096|P5|Week 0 to 16|Adverse Event|0
70889|NCT01309737|277097|P4|Week 0 to 16|Adverse Event|0
70890|NCT01309737|277098|P3|Week 0 to 16|Adverse Event|5
70891|NCT01309737|277099|P2|Week 0 to 16|Adverse Event|10
70892|NCT01309737|277100|P1|Week 0 to 16|Adverse Event|11
70893|NCT01309737|277096|P5|Week 0 to 16|Death|0
70894|NCT01309737|277097|P4|Week 0 to 16|Death|0
70895|NCT01309737|277098|P3|Week 0 to 16|Death|1
70896|NCT01309737|277099|P2|Week 0 to 16|Death|0
70897|NCT01309737|277100|P1|Week 0 to 16|Death|1
70898|NCT01309672|277295|P1|Overall Study|Withdrawal by Subject|3
70899|NCT01309672|277295|P1|Overall Study|Adverse Event|5
70900|NCT01309672|277295|P1|Overall Study|Other|9
70901|NCT01309672|277295|P1|Overall Study|Lack of Efficacy|20
70902|NCT01309659|277305|P2|Overall Study|Protocol Violation|1
70903|NCT01309659|277306|P1|Overall Study|Protocol Violation|0
70904|NCT01309386|277411|P2|Overall Study|Adverse Event|8
70905|NCT01309386|277412|P1|Overall Study|Adverse Event|5
70906|NCT01309386|277411|P2|Overall Study|Lack of Efficacy|1
70907|NCT01309386|277412|P1|Overall Study|Lack of Efficacy|3
70908|NCT01309386|277411|P2|Overall Study|Physician Decision|1
70909|NCT01309386|277412|P1|Overall Study|Physician Decision|1
70910|NCT01309386|277411|P2|Overall Study|Progressive disease|11
70911|NCT01309386|277412|P1|Overall Study|Progressive disease|9
70912|NCT01309386|277411|P2|Overall Study|Withdrawal by Subject|0
70913|NCT01309386|277412|P1|Overall Study|Withdrawal by Subject|2
70914|NCT01309386|277411|P2|Overall Study|Other|0
70915|NCT01309386|277412|P1|Overall Study|Other|2
70916|NCT01309308|277460|P2|Overall Study|Lost to Follow-up|4
70917|NCT01309308|277461|P1|Overall Study|Lost to Follow-up|6
70918|NCT01309282|277469|P1|Overall Study|Lost to Follow-up|1
70919|NCT01309269|277486|P1|Overall Study|Enrolled but not Treated|107
70920|NCT01309269|277486|P1|Overall Study|Study Completion Data Not Recorded|95
70921|NCT01309269|277486|P1|Overall Study|Other|1
70922|NCT01309269|277486|P1|Overall Study|Other|256
70923|NCT01309269|277486|P1|Overall Study|Administrative Problems|141
70924|NCT01309269|277486|P1|Overall Study|Kidney Transplant|25
70925|NCT01309269|277486|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
70926|NCT01309269|277486|P1|Overall Study|Lack of Acceptance|15
70927|NCT01309269|277486|P1|Overall Study|Withdrawal by Subject|25
70928|NCT01309269|277486|P1|Overall Study|Adverse Event|56
70929|NCT01309243|277494|P2|Extension Phase|Lost to Follow-up|0
70930|NCT01309243|277495|P1|Extension Phase|Lost to Follow-up|6
70931|NCT01309243|277494|P2|Randomized Phase Through Week 96|Protocol Violation|1
70932|NCT01309243|277495|P1|Randomized Phase Through Week 96|Protocol Violation|1
70933|NCT01309243|277494|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
70934|NCT01309243|277495|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
70935|NCT01309243|277494|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
70936|NCT01309243|277495|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
70937|NCT01309243|277494|P2|Randomized Phase Through Week 96|Withdrew Consent|18
70938|NCT01309243|277495|P1|Randomized Phase Through Week 96|Withdrew Consent|12
70939|NCT01309243|277494|P2|Randomized Phase Through Week 96|Investigators Discretion|6
70940|NCT01309243|277495|P1|Randomized Phase Through Week 96|Investigators Discretion|3
70941|NCT01309243|277494|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
70942|NCT01309243|277495|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
70943|NCT01309243|277494|P2|Randomized Phase Through Week 96|Pregnancy|0
70944|NCT01309243|277495|P1|Randomized Phase Through Week 96|Pregnancy|2
70945|NCT01309243|277494|P2|Randomized Phase Through Week 96|Death|1
70946|NCT01309243|277495|P1|Randomized Phase Through Week 96|Death|0
70947|NCT01309243|277494|P2|Randomized Phase Through Week 96|Adverse Event|43
70948|NCT01309243|277495|P1|Randomized Phase Through Week 96|Adverse Event|12
70949|NCT01309243|277494|P2|Randomized Phase Through Week 96|Randomized but not treated|7
70950|NCT01309243|277495|P1|Randomized Phase Through Week 96|Randomized but not treated|6
70951|NCT01309204|277521|P2|Overall Study|Other|1
70952|NCT01309204|277522|P1|Overall Study|Other|4
70953|NCT01309204|277521|P2|Overall Study|Inadequate control of IOP|4
70954|NCT01309204|277522|P1|Overall Study|Inadequate control of IOP|4
70955|NCT01309204|277521|P2|Overall Study|Subject's decision unrelated to an AE|10
70956|NCT01309204|277522|P1|Overall Study|Subject's decision unrelated to an AE|9
70957|NCT01309204|277521|P2|Overall Study|Lost to Follow-up|2
70958|NCT01309204|277522|P1|Overall Study|Lost to Follow-up|2
70959|NCT01309204|277521|P2|Overall Study|Adverse Event|58
70960|NCT01309204|277522|P1|Overall Study|Adverse Event|48
70961|NCT01309100|277528|P1|Overall Study|Positive Slit lamp finding|1
70962|NCT01309100|277528|P1|Overall Study|Protocol Violation|1
70963|NCT01308788|277576|P2|2-year Treatment|medication change by treating physician|11
70964|NCT01308788|277577|P1|2-year Treatment|medication change by treating physician|4
70965|NCT01308762|277612|P3|Overall Study|Protocol Violation|0
70966|NCT01308762|277613|P2|Overall Study|Protocol Violation|1
70967|NCT01308762|277614|P1|Overall Study|Protocol Violation|0
70968|NCT01308749|277627|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
70969|NCT01308749|277628|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
70970|NCT01308749|277627|P2|Period 2: Open Label Treatment|Adverse Event|1
70971|NCT01308749|277628|P1|Period 2: Open Label Treatment|Adverse Event|0
70972|NCT01308749|277627|P2|Period 1: Double Blind Treatment|Adverse Event|0
70973|NCT01308749|277628|P1|Period 1: Double Blind Treatment|Adverse Event|1
70974|NCT01308736|277658|P2|Overall Study|Did not attend a single session|5
70975|NCT01308736|277659|P1|Overall Study|Did not attend a single session|6
70976|NCT01308580|277682|P2|Overall Study|Lost to Follow-up|7
70977|NCT01308580|277683|P1|Overall Study|Lost to Follow-up|12
70978|NCT01308567|277726|P3|Overall Study|Lost to Follow-up|4
70979|NCT01308567|277727|P2|Overall Study|Lost to Follow-up|4
70980|NCT01308567|277728|P1|Overall Study|Lost to Follow-up|2
70981|NCT01308476|277768|P2|Overall Study|Other|0
70982|NCT01308476|277769|P1|Overall Study|Other|1
70983|NCT01308476|277768|P2|Overall Study|Lost to Follow-up|2
70984|NCT01308476|277769|P1|Overall Study|Lost to Follow-up|2
70985|NCT01308463|277789|P1|Overall Study|Revision|2
70986|NCT01308463|277789|P1|Overall Study|Death|4
70987|NCT01308463|277789|P1|Overall Study|Study Discontinued|23
70988|NCT01308424|277802|P3|Randomization|Physician Decision|1
70989|NCT01308424|277803|P2|Randomization|Physician Decision|1
70990|NCT01308424|277804|P1|Randomization|Physician Decision|0
70991|NCT01308424|277802|P3|Randomization|Lost to Follow-up|0
70992|NCT01308424|277803|P2|Randomization|Lost to Follow-up|1
70993|NCT01308424|277804|P1|Randomization|Lost to Follow-up|0
70994|NCT01308424|277802|P3|Randomization|Adverse Event|1
70995|NCT01308424|277803|P2|Randomization|Adverse Event|1
70996|NCT01308424|277804|P1|Randomization|Adverse Event|0
70997|NCT01308424|277802|P3|Baseline Eligibility|Screen Failures|0
70998|NCT01308424|277803|P2|Baseline Eligibility|Screen Failures|0
70999|NCT01308424|277804|P1|Baseline Eligibility|Screen Failures|71
71000|NCT01307891|277817|P2|Overall Study|Progressive Disease|1
71001|NCT01307891|277818|P1|Overall Study|Progressive Disease|3
71002|NCT01307787|277830|P2|Overall Study|Withdrawal by Subject|0
71003|NCT01307787|277831|P1|Overall Study|Withdrawal by Subject|2
71004|NCT01307423|277895|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
71005|NCT01307423|277896|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
71006|NCT01307423|277897|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
71007|NCT01307423|277898|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
71008|NCT01307423|277899|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
71009|NCT01307423|277900|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
71010|NCT01307423|277901|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
71011|NCT01307423|277895|P7|Active Treatment Phase (Week 25-52)|Other|0
71012|NCT01307423|277896|P6|Active Treatment Phase (Week 25-52)|Other|0
71013|NCT01307423|277897|P5|Active Treatment Phase (Week 25-52)|Other|0
71014|NCT01307423|277898|P4|Active Treatment Phase (Week 25-52)|Other|1
71015|NCT01307423|277899|P3|Active Treatment Phase (Week 25-52)|Other|0
71016|NCT01307423|277900|P2|Active Treatment Phase (Week 25-52)|Other|0
71017|NCT01307423|277901|P1|Active Treatment Phase (Week 25-52)|Other|0
71018|NCT01307423|277895|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
71019|NCT01307423|277896|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
71020|NCT01307423|277897|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
71021|NCT01307423|277898|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
71022|NCT01307423|277899|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
71023|NCT01307423|277900|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
71024|NCT01307423|277901|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
71025|NCT01307423|277895|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
71026|NCT01307423|277896|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
71027|NCT01307423|277897|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
71028|NCT01307423|277898|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
71029|NCT01307423|277899|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
71030|NCT01307423|277900|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
71031|NCT01307423|277901|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
71032|NCT01307423|277895|P7|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
71033|NCT01307423|277896|P6|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|1
71034|NCT01307423|277897|P5|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
71035|NCT01307423|277898|P4|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
71036|NCT01307423|277899|P3|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
71037|NCT01307423|277900|P2|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
71038|NCT01307423|277901|P1|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
71039|NCT01307423|277895|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
71040|NCT01307423|277896|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
71041|NCT01307423|277897|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
71042|NCT01307423|277898|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
71043|NCT01307423|277899|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
71044|NCT01307423|277900|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
71045|NCT01307423|277901|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
71046|NCT01307423|277895|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
71047|NCT01307423|277896|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
71048|NCT01307423|277897|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
71049|NCT01307423|277898|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
71050|NCT01307423|277899|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
71051|NCT01307423|277900|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
71052|NCT01307423|277901|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
71053|NCT01307423|277895|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
71054|NCT01307423|277896|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
71055|NCT01307423|277897|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
71056|NCT01307423|277898|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
71057|NCT01307423|277899|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
71058|NCT01307423|277900|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
71059|NCT01307423|277901|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
71060|NCT01307423|277895|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
71061|NCT01307423|277896|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
71062|NCT01307423|277897|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
71063|NCT01307423|277898|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
71064|NCT01307423|277899|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
71065|NCT01307423|277900|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
71066|NCT01307423|277901|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
71067|NCT01307423|277895|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
71068|NCT01307423|277896|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
71069|NCT01307423|277897|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
71070|NCT01307423|277898|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
71071|NCT01307423|277899|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
71072|NCT01307423|277900|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
71073|NCT01307423|277901|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
71074|NCT01307423|277895|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
71075|NCT01307423|277896|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
71076|NCT01307423|277897|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
71077|NCT01307423|277898|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
71078|NCT01307423|277899|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
71079|NCT01307423|277900|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
71080|NCT01307423|277901|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
71081|NCT01307423|277895|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
71082|NCT01307423|277896|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
71083|NCT01307423|277897|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
71084|NCT01307423|277898|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
71085|NCT01307423|277899|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
71086|NCT01307423|277900|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
71087|NCT01307423|277901|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
71088|NCT01307423|277895|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
71089|NCT01307423|277896|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
71090|NCT01307423|277897|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
71091|NCT01307423|277898|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
71092|NCT01307423|277899|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
71093|NCT01307423|277900|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
71094|NCT01307423|277901|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
71095|NCT01307423|277895|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
71096|NCT01307423|277896|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
71097|NCT01307423|277897|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
71098|NCT01307423|277898|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
71099|NCT01307423|277899|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
71100|NCT01307423|277900|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
71101|NCT01307423|277901|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
71102|NCT01307423|277895|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
71103|NCT01307423|277896|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
71104|NCT01307423|277897|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
71105|NCT01307423|277898|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
71106|NCT01307423|277899|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
71107|NCT01307423|277900|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
71108|NCT01307423|277901|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
71109|NCT01307319|278032|P3|Overall Study|Not specified|3
71110|NCT01307319|278033|P2|Overall Study|Not specified|4
71111|NCT01307319|278034|P1|Overall Study|Not specified|0
71112|NCT01307319|278032|P3|Overall Study|Withdrawal by Subject|2
71113|NCT01307319|278033|P2|Overall Study|Withdrawal by Subject|1
71114|NCT01307319|278034|P1|Overall Study|Withdrawal by Subject|0
71115|NCT01307319|278032|P3|Overall Study|Protocol Violation|0
71116|NCT01307319|278033|P2|Overall Study|Protocol Violation|1
71117|NCT01307319|278034|P1|Overall Study|Protocol Violation|1
71118|NCT01307319|278032|P3|Overall Study|Lost to Follow-up|1
71119|NCT01307319|278033|P2|Overall Study|Lost to Follow-up|0
71120|NCT01307319|278034|P1|Overall Study|Lost to Follow-up|1
71121|NCT01307319|278032|P3|Overall Study|Adverse Event|1
71122|NCT01307319|278033|P2|Overall Study|Adverse Event|2
71123|NCT01307319|278034|P1|Overall Study|Adverse Event|2
71124|NCT01307111|278048|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
71125|NCT01307111|278049|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
71126|NCT01307111|278048|P2|IUD Insertion|Lost to Follow-up|0
71127|NCT01307111|278049|P1|IUD Insertion|Lost to Follow-up|2
71128|NCT01307046|278059|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
71129|NCT01307046|278060|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
71130|NCT01307046|278059|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
71131|NCT01307046|278060|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
71132|NCT01307046|278059|P2|Overall Study|Withdrawal by Subject|1
71133|NCT01307046|278060|P1|Overall Study|Withdrawal by Subject|1
71134|NCT01307046|278059|P2|Overall Study|Physician Decision|0
71135|NCT01307046|278060|P1|Overall Study|Physician Decision|2
71136|NCT01307046|278059|P2|Overall Study|Lack of Efficacy|2
71137|NCT01307046|278060|P1|Overall Study|Lack of Efficacy|0
71138|NCT01307046|278059|P2|Overall Study|Adverse Event|3
71139|NCT01307046|278060|P1|Overall Study|Adverse Event|3
71140|NCT01307033|278072|P4|44-week Open-label Extension|Death|1
71141|NCT01307033|278073|P3|44-week Open-label Extension|Death|0
71142|NCT01307033|278074|P2|44-week Open-label Extension|Death|0
71143|NCT01307033|278075|P1|44-week Open-label Extension|Death|0
71144|NCT01307033|278072|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
71145|NCT01307033|278073|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
71146|NCT01307033|278074|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
71147|NCT01307033|278075|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
71148|NCT01307033|278072|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
71149|NCT01307033|278073|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
71150|NCT01307033|278074|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
71151|NCT01307033|278075|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
71152|NCT01307033|278072|P4|44-week Open-label Extension|Physician Decision|0
71153|NCT01307033|278073|P3|44-week Open-label Extension|Physician Decision|1
71154|NCT01307033|278074|P2|44-week Open-label Extension|Physician Decision|0
71155|NCT01307033|278075|P1|44-week Open-label Extension|Physician Decision|0
71156|NCT01307033|278072|P4|44-week Open-label Extension|Withdrawal by Subject|1
71157|NCT01307033|278073|P3|44-week Open-label Extension|Withdrawal by Subject|2
71158|NCT01307033|278074|P2|44-week Open-label Extension|Withdrawal by Subject|0
71159|NCT01307033|278075|P1|44-week Open-label Extension|Withdrawal by Subject|0
71160|NCT01307033|278072|P4|44-week Open-label Extension|Adverse Event|1
71161|NCT01307033|278073|P3|44-week Open-label Extension|Adverse Event|2
71162|NCT01307033|278074|P2|44-week Open-label Extension|Adverse Event|0
71163|NCT01307033|278075|P1|44-week Open-label Extension|Adverse Event|0
71164|NCT01307033|278072|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
71165|NCT01307033|278073|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
71166|NCT01307033|278074|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
71167|NCT01307033|278075|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
71168|NCT01307033|278072|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
71169|NCT01307033|278073|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
71170|NCT01307033|278074|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
71171|NCT01307033|278075|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
71172|NCT01307033|278072|P4|8-week Double-blind Period|Lack of Efficacy|0
71173|NCT01307033|278073|P3|8-week Double-blind Period|Lack of Efficacy|0
71174|NCT01307033|278074|P2|8-week Double-blind Period|Lack of Efficacy|0
71175|NCT01307033|278075|P1|8-week Double-blind Period|Lack of Efficacy|1
71176|NCT01307033|278072|P4|8-week Double-blind Period|Withdrawal by Subject|0
71177|NCT01307033|278073|P3|8-week Double-blind Period|Withdrawal by Subject|0
71178|NCT01307033|278074|P2|8-week Double-blind Period|Withdrawal by Subject|1
71179|NCT01307033|278075|P1|8-week Double-blind Period|Withdrawal by Subject|4
71180|NCT01307033|278072|P4|8-week Double-blind Period|Adverse Event|0
71181|NCT01307033|278073|P3|8-week Double-blind Period|Adverse Event|0
71182|NCT01307033|278074|P2|8-week Double-blind Period|Adverse Event|0
71183|NCT01307033|278075|P1|8-week Double-blind Period|Adverse Event|2
71184|NCT01307020|278097|P10|Overall Study|Electronic data capture failure|0
71185|NCT01307020|278098|P9|Overall Study|Electronic data capture failure|0
71186|NCT01307020|278099|P8|Overall Study|Electronic data capture failure|0
71187|NCT01307020|278100|P7|Overall Study|Electronic data capture failure|0
71188|NCT01307020|278101|P6|Overall Study|Electronic data capture failure|0
71189|NCT01307020|278102|P5|Overall Study|Electronic data capture failure|0
71190|NCT01307020|278103|P4|Overall Study|Electronic data capture failure|0
71191|NCT01307020|278104|P3|Overall Study|Electronic data capture failure|0
71192|NCT01307020|278105|P2|Overall Study|Electronic data capture failure|1
71193|NCT01307020|278106|P1|Overall Study|Electronic data capture failure|0
71194|NCT01307020|278097|P10|Overall Study|Lost to Follow-up|0
71195|NCT01307020|278098|P9|Overall Study|Lost to Follow-up|0
71196|NCT01307020|278099|P8|Overall Study|Lost to Follow-up|0
71197|NCT01307020|278100|P7|Overall Study|Lost to Follow-up|1
71198|NCT01307020|278101|P6|Overall Study|Lost to Follow-up|0
71199|NCT01307020|278102|P5|Overall Study|Lost to Follow-up|0
71200|NCT01307020|278103|P4|Overall Study|Lost to Follow-up|1
71201|NCT01307020|278104|P3|Overall Study|Lost to Follow-up|1
71202|NCT01307020|278105|P2|Overall Study|Lost to Follow-up|0
71203|NCT01307020|278106|P1|Overall Study|Lost to Follow-up|0
71204|NCT01306968|278161|P4|Overall Study|Withdrew over privacy concerns|1
71205|NCT01306968|278162|P3|Overall Study|Withdrew over privacy concerns|0
71206|NCT01306968|278163|P2|Overall Study|Withdrew over privacy concerns|0
71207|NCT01306968|278164|P1|Overall Study|Withdrew over privacy concerns|0
71208|NCT01306968|278161|P4|Overall Study|Withdrew - time commitment|2
71209|NCT01306968|278162|P3|Overall Study|Withdrew - time commitment|0
71210|NCT01306968|278163|P2|Overall Study|Withdrew - time commitment|0
71211|NCT01306968|278164|P1|Overall Study|Withdrew - time commitment|0
71212|NCT01306968|278161|P4|Overall Study|Relocated and left active duty|1
71213|NCT01306968|278162|P3|Overall Study|Relocated and left active duty|1
71214|NCT01306968|278163|P2|Overall Study|Relocated and left active duty|1
71215|NCT01306968|278164|P1|Overall Study|Relocated and left active duty|0
71216|NCT01306968|278161|P4|Overall Study|Physician Decision|0
71217|NCT01306968|278162|P3|Overall Study|Physician Decision|0
71218|NCT01306968|278163|P2|Overall Study|Physician Decision|1
71219|NCT01306968|278164|P1|Overall Study|Physician Decision|0
71220|NCT01306968|278161|P4|Overall Study|Lost to Follow-up|0
71221|NCT01306968|278162|P3|Overall Study|Lost to Follow-up|0
71222|NCT01306968|278163|P2|Overall Study|Lost to Follow-up|1
71223|NCT01306968|278164|P1|Overall Study|Lost to Follow-up|1
71224|NCT01306877|278188|P2|Overall Study|Physician Decision|1
71225|NCT01306877|278189|P1|Overall Study|Physician Decision|0
71226|NCT01306877|278188|P2|Overall Study|Lost to Follow-up|3
71227|NCT01306877|278189|P1|Overall Study|Lost to Follow-up|3
71228|NCT01306643|278207|P1|Overall Study|Other: Change in Eligibility Status|1
71229|NCT01306643|278207|P1|Overall Study|Disease Progression|7
71230|NCT01306643|278207|P1|Overall Study|Adverse Event|5
71231|NCT01306617|278219|P3|Overall Study|Non-compliance|0
71232|NCT01306617|278220|P2|Overall Study|Non-compliance|1
71233|NCT01306617|278221|P1|Overall Study|Non-compliance|0
71234|NCT01306617|278219|P3|Overall Study|Virologic Failure|5
71235|NCT01306617|278220|P2|Overall Study|Virologic Failure|0
71236|NCT01306617|278221|P1|Overall Study|Virologic Failure|0
71237|NCT01306617|278219|P3|Overall Study|Adverse Event|0
71238|NCT01306617|278220|P2|Overall Study|Adverse Event|0
71239|NCT01306617|278221|P1|Overall Study|Adverse Event|1
71240|NCT01306305|278264|P2|Overall Study|Withdrew consent|0
71241|NCT01306305|278265|P1|Overall Study|Withdrew consent|1
71242|NCT01306305|278264|P2|Overall Study|Lost to Follow-up|0
71243|NCT01306305|278265|P1|Overall Study|Lost to Follow-up|1
71244|NCT01306253|278302|P2|Overall Study|Lost to Follow-up|1
71245|NCT01306253|278303|P1|Overall Study|Lost to Follow-up|1
71246|NCT01306214|278320|P3|Overall Study|Not treated|1
71247|NCT01306214|278321|P2|Overall Study|Not treated|1
71248|NCT01306214|278322|P1|Overall Study|Not treated|1
71249|NCT01306214|278320|P3|Overall Study|Withdrawal by Subject|16
71250|NCT01306214|278321|P2|Overall Study|Withdrawal by Subject|22
71251|NCT01306214|278322|P1|Overall Study|Withdrawal by Subject|24
71252|NCT01306214|278320|P3|Overall Study|Lost to Follow-up|4
71253|NCT01306214|278321|P2|Overall Study|Lost to Follow-up|5
71254|NCT01306214|278322|P1|Overall Study|Lost to Follow-up|3
71255|NCT01306214|278320|P3|Overall Study|Death|1
71256|NCT01306214|278321|P2|Overall Study|Death|0
71257|NCT01306214|278322|P1|Overall Study|Death|0
71258|NCT01306201|278339|P1|Overall Study|Files unreadable|3
71259|NCT01306201|278339|P1|Overall Study|Files could not be processed|3
71260|NCT01306201|278339|P1|Overall Study|Arrhythmia|4
71261|NCT01306162|278361|P4|Washout 1|Non-compliance to protocol|0
71262|NCT01306162|278362|P3|Washout 1|Non-compliance to protocol|0
71263|NCT01306162|278363|P2|Washout 1|Non-compliance to protocol|1
71264|NCT01306162|278364|P1|Washout 1|Non-compliance to protocol|0
71265|NCT01306162|278361|P4|Period 1|Adverse Event|1
71266|NCT01306162|278362|P3|Period 1|Adverse Event|0
71267|NCT01306162|278363|P2|Period 1|Adverse Event|0
71268|NCT01306162|278364|P1|Period 1|Adverse Event|0
71269|NCT01306058|278392|P1|Overall Study|Enrolled but did not get treatment|1
71270|NCT01306058|278392|P1|Overall Study|Death|1
71271|NCT01306032|278418|P6|Disease Progression/Crossover|other/symptomatic progression|0
71272|NCT01306032|278419|P5|Disease Progression/Crossover|other/symptomatic progression|0
71273|NCT01306032|278420|P4|Disease Progression/Crossover|other/symptomatic progression|2
71274|NCT01306032|278421|P3|Disease Progression/Crossover|other/symptomatic progression|0
71275|NCT01306032|278422|P2|Disease Progression/Crossover|other/symptomatic progression|2
71276|NCT01306032|278423|P1|Disease Progression/Crossover|other/symptomatic progression|0
71277|NCT01306032|278418|P6|Disease Progression/Crossover|Withdrawal by Subject|0
71278|NCT01306032|278419|P5|Disease Progression/Crossover|Withdrawal by Subject|0
71279|NCT01306032|278420|P4|Disease Progression/Crossover|Withdrawal by Subject|1
71280|NCT01306032|278421|P3|Disease Progression/Crossover|Withdrawal by Subject|0
71281|NCT01306032|278422|P2|Disease Progression/Crossover|Withdrawal by Subject|0
71282|NCT01306032|278423|P1|Disease Progression/Crossover|Withdrawal by Subject|0
71283|NCT01306032|278418|P6|First Intervention|Progressive disease|0
71284|NCT01306032|278419|P5|First Intervention|Progressive disease|2
71285|NCT01306032|278420|P4|First Intervention|Progressive disease|0
71286|NCT01306032|278421|P3|First Intervention|Progressive disease|0
71287|NCT01306032|278422|P2|First Intervention|Progressive disease|0
71288|NCT01306032|278423|P1|First Intervention|Progressive disease|0
71289|NCT01306032|278418|P6|First Intervention|Ineligible|1
71290|NCT01306032|278419|P5|First Intervention|Ineligible|0
71291|NCT01306032|278420|P4|First Intervention|Ineligible|0
71292|NCT01306032|278421|P3|First Intervention|Ineligible|0
71293|NCT01306032|278422|P2|First Intervention|Ineligible|0
71294|NCT01306032|278423|P1|First Intervention|Ineligible|0
71295|NCT01306032|278418|P6|First Intervention|Death|0
71296|NCT01306032|278419|P5|First Intervention|Death|0
71297|NCT01306032|278420|P4|First Intervention|Death|0
71298|NCT01306032|278421|P3|First Intervention|Death|1
71299|NCT01306032|278422|P2|First Intervention|Death|0
71300|NCT01306032|278423|P1|First Intervention|Death|0
71301|NCT01306032|278418|P6|First Intervention|Withdrawal by Subject|0
71302|NCT01306032|278419|P5|First Intervention|Withdrawal by Subject|0
71303|NCT01306032|278420|P4|First Intervention|Withdrawal by Subject|1
71304|NCT01306032|278421|P3|First Intervention|Withdrawal by Subject|0
71305|NCT01306032|278422|P2|First Intervention|Withdrawal by Subject|2
71306|NCT01306032|278423|P1|First Intervention|Withdrawal by Subject|0
71307|NCT01306032|278418|P6|First Intervention|Adverse Event|1
71308|NCT01306032|278419|P5|First Intervention|Adverse Event|0
71309|NCT01306032|278420|P4|First Intervention|Adverse Event|0
71310|NCT01306032|278421|P3|First Intervention|Adverse Event|1
71311|NCT01306032|278422|P2|First Intervention|Adverse Event|0
71312|NCT01306032|278423|P1|First Intervention|Adverse Event|1
71313|NCT01305941|278475|P1|Overall Study|Death|1
71314|NCT01305941|278475|P1|Overall Study|Withdrawal by Subject|1
71315|NCT01305941|278475|P1|Overall Study|Clinical decline|2
71316|NCT01305941|278475|P1|Overall Study|Adverse Event|6
71317|NCT01305577|278515|P3|Overall Study|Protocol Deviation|1
71318|NCT01305577|278516|P2|Overall Study|Protocol Deviation|1
71319|NCT01305577|278517|P1|Overall Study|Protocol Deviation|0
71320|NCT01305577|278515|P3|Overall Study|Lost to Follow-up|2
71321|NCT01305577|278516|P2|Overall Study|Lost to Follow-up|3
71322|NCT01305577|278517|P1|Overall Study|Lost to Follow-up|4
71323|NCT01305577|278515|P3|Overall Study|Withdrawal by Subject|6
71324|NCT01305577|278516|P2|Overall Study|Withdrawal by Subject|5
71325|NCT01305577|278517|P1|Overall Study|Withdrawal by Subject|7
71326|NCT01305577|278515|P3|Overall Study|Adverse Event|1
71327|NCT01305577|278516|P2|Overall Study|Adverse Event|2
71328|NCT01305577|278517|P1|Overall Study|Adverse Event|2
71329|NCT01305564|278546|P1|Overall Study|Physician Decision|3
71330|NCT01305564|278546|P1|Overall Study|Withdrawal by Subject|1
71331|NCT01305564|278546|P1|Overall Study|Lost to Follow-up|12
71332|NCT01305564|278546|P1|Overall Study|Death|21
71333|NCT01305408|278573|P2|Overall Study|Not specified|0
71334|NCT01305408|278574|P1|Overall Study|Not specified|1
71335|NCT01305408|278573|P2|Overall Study|Noncompliance with study procedures|1
71336|NCT01305408|278574|P1|Overall Study|Noncompliance with study procedures|0
71337|NCT01305408|278573|P2|Overall Study|Noncompliance with study medication|1
71338|NCT01305408|278574|P1|Overall Study|Noncompliance with study medication|0
71339|NCT01305408|278573|P2|Overall Study|Lost to Follow-up|3
71340|NCT01305408|278574|P1|Overall Study|Lost to Follow-up|5
71341|NCT01305408|278573|P2|Overall Study|Protocol Violation|6
71342|NCT01305408|278574|P1|Overall Study|Protocol Violation|4
71343|NCT01305408|278573|P2|Overall Study|Withdrawal by Subject|9
71344|NCT01305408|278574|P1|Overall Study|Withdrawal by Subject|9
71345|NCT01305408|278573|P2|Overall Study|Lack of Efficacy|4
71346|NCT01305408|278574|P1|Overall Study|Lack of Efficacy|3
71347|NCT01305408|278573|P2|Overall Study|Adverse Event|7
71348|NCT01305408|278574|P1|Overall Study|Adverse Event|10
71349|NCT01305239|278650|P1|Overall Study|Exemestane taken prior to inclusion only|1
71350|NCT01305239|278650|P1|Overall Study|Adverse Event|22
71351|NCT01305200|278680|P3|Overall Study|Death|0
71352|NCT01305200|278681|P2|Overall Study|Death|2
71353|NCT01305200|278682|P1|Overall Study|Death|0
71354|NCT01305200|278680|P3|Overall Study|Ineligible|1
71355|NCT01305200|278681|P2|Overall Study|Ineligible|2
71356|NCT01305200|278682|P1|Overall Study|Ineligible|1
71357|NCT01305200|278680|P3|Overall Study|Withdrawal by Subject|1
71358|NCT01305200|278681|P2|Overall Study|Withdrawal by Subject|21
71359|NCT01305200|278682|P1|Overall Study|Withdrawal by Subject|24
71360|NCT01305200|278680|P3|Overall Study|Physician Decision|1
71361|NCT01305200|278681|P2|Overall Study|Physician Decision|6
71362|NCT01305200|278682|P1|Overall Study|Physician Decision|4
71363|NCT01305044|278712|P2|Overall Study|Withdrawal by Subject|6
71364|NCT01305044|278713|P1|Overall Study|Withdrawal by Subject|3
71365|NCT01304706|278743|P1|Overall Study|Discontinued due to failed drug admin.|1
71366|NCT01304706|278743|P1|Overall Study|Lost to Follow-up|7
71367|NCT01304706|278743|P1|Overall Study|Withdrawal by Subject|3
71368|NCT01304706|278743|P1|Overall Study|Death|3
71369|NCT01304706|278743|P1|Overall Study|Lack of Efficacy|1
71370|NCT01304706|278743|P1|Overall Study|Adverse Event|2
71371|NCT01304693|278752|P5|Overall Study|Decision Unrelated to an Adverse Event|0
71372|NCT01304693|278753|P4|Overall Study|Decision Unrelated to an Adverse Event|1
71373|NCT01304693|278754|P3|Overall Study|Decision Unrelated to an Adverse Event|1
71374|NCT01304693|278755|P2|Overall Study|Decision Unrelated to an Adverse Event|0
71375|NCT01304693|278756|P1|Overall Study|Decision Unrelated to an Adverse Event|0
71376|NCT01304693|278752|P5|Overall Study|Adverse Event|1
71377|NCT01304693|278753|P4|Overall Study|Adverse Event|0
71378|NCT01304693|278754|P3|Overall Study|Adverse Event|0
71379|NCT01304693|278755|P2|Overall Study|Adverse Event|0
71380|NCT01304693|278756|P1|Overall Study|Adverse Event|0
71381|NCT01304498|278803|P2|Overall Study|Lost to Follow-up|1
71382|NCT01304498|278804|P1|Overall Study|Lost to Follow-up|2
71383|NCT01304498|278803|P2|Overall Study|Protocol Violation|0
71384|NCT01304498|278804|P1|Overall Study|Protocol Violation|1
71385|NCT01304498|278803|P2|Overall Study|Withdrawal by Subject|3
71386|NCT01304498|278804|P1|Overall Study|Withdrawal by Subject|2
71387|NCT01304498|278803|P2|Overall Study|Adverse Event|1
71388|NCT01304498|278804|P1|Overall Study|Adverse Event|1
71389|NCT01304329|278824|P6|Third Intervention (3 Days)|Adverse Event|0
71390|NCT01304329|278825|P5|Third Intervention (3 Days)|Adverse Event|0
71391|NCT01304329|278826|P4|Third Intervention (3 Days)|Adverse Event|0
71392|NCT01304329|278827|P3|Third Intervention (3 Days)|Adverse Event|0
71393|NCT01304329|278828|P2|Third Intervention (3 Days)|Adverse Event|1
71394|NCT01304329|278829|P1|Third Intervention (3 Days)|Adverse Event|0
71395|NCT01304147|278963|P2|Second Intervention (7days)|Withdrawal by Subject|1
71396|NCT01304147|278964|P1|Second Intervention (7days)|Withdrawal by Subject|1
71397|NCT01303861|278998|P4|Overall Study|Pregnancy|0
71398|NCT01303861|278999|P3|Overall Study|Pregnancy|0
71399|NCT01303861|279000|P2|Overall Study|Pregnancy|0
71400|NCT01303861|279001|P1|Overall Study|Pregnancy|1
71401|NCT01303861|278998|P4|Overall Study|Adverse Event|5
71402|NCT01303861|278999|P3|Overall Study|Adverse Event|0
71403|NCT01303861|279000|P2|Overall Study|Adverse Event|1
71404|NCT01303861|279001|P1|Overall Study|Adverse Event|4
71405|NCT01303861|278998|P4|Overall Study|Withdrawal by Subject|23
71406|NCT01303861|278999|P3|Overall Study|Withdrawal by Subject|8
71407|NCT01303861|279000|P2|Overall Study|Withdrawal by Subject|8
71408|NCT01303861|279001|P1|Overall Study|Withdrawal by Subject|16
71409|NCT01303861|278998|P4|Overall Study|Lack of Efficacy|0
71410|NCT01303861|278999|P3|Overall Study|Lack of Efficacy|1
71411|NCT01303861|279000|P2|Overall Study|Lack of Efficacy|2
71412|NCT01303861|279001|P1|Overall Study|Lack of Efficacy|3
71413|NCT01303861|278998|P4|Overall Study|Lost to Follow-up|31
71414|NCT01303861|278999|P3|Overall Study|Lost to Follow-up|27
71415|NCT01303861|279000|P2|Overall Study|Lost to Follow-up|14
71416|NCT01303861|279001|P1|Overall Study|Lost to Follow-up|34
71417|NCT01303627|279060|P2|Overall Study|the failure while performing URS|1
71418|NCT01303627|279061|P1|Overall Study|the failure while performing URS|0
71419|NCT01303510|279069|P2|Overall Study|Lost to Follow-up|0
71420|NCT01303510|279070|P1|Overall Study|Lost to Follow-up|1
71421|NCT01303445|279084|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
71422|NCT01303445|279085|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
71423|NCT01303445|279084|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
71424|NCT01303445|279085|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
71425|NCT01303445|279084|P2|Washout (14 Days)|Lost to Follow-up|2
71426|NCT01303445|279085|P1|Washout (14 Days)|Lost to Follow-up|0
71427|NCT01303445|279084|P2|Washout (14 Days)|Protocol Violation|0
71428|NCT01303445|279085|P1|Washout (14 Days)|Protocol Violation|1
71429|NCT01303445|279084|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
71430|NCT01303445|279085|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
71431|NCT01303445|279084|P2|Second Intervention (7 Days)|Adverse Event|2
71432|NCT01303445|279085|P1|Second Intervention (7 Days)|Adverse Event|0
71433|NCT01303445|279084|P2|First Intervention (7 Days)|Withdrawal by Subject|0
71434|NCT01303445|279085|P1|First Intervention (7 Days)|Withdrawal by Subject|1
71435|NCT01303380|279126|P1|Overall Study|Lack of compliance to study procedures|1
71436|NCT01303159|279185|P1|Overall Study|Study Termination|7
71437|NCT01303159|279185|P1|Overall Study|Death|16
71438|NCT01302938|279192|P2|Overall Study|Adverse Event|0
71439|NCT01302938|279193|P1|Overall Study|Adverse Event|1
71440|NCT01302938|279192|P2|Overall Study|Withdrawal by Subject|0
71441|NCT01302938|279193|P1|Overall Study|Withdrawal by Subject|1
71442|NCT01302899|279238|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
71443|NCT01302899|279239|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
71444|NCT01302899|279238|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
71445|NCT01302899|279239|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
71446|NCT01302691|279319|P2|Overall Study|Protocol Violation|0
71447|NCT01302691|279320|P1|Overall Study|Protocol Violation|1
71448|NCT01302691|279319|P2|Overall Study|Physician Decision|1
71449|NCT01302691|279320|P1|Overall Study|Physician Decision|0
71450|NCT01302691|279319|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
71451|NCT01302691|279320|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
71452|NCT01302691|279319|P2|Overall Study|Lost to Follow-up|0
71453|NCT01302691|279320|P1|Overall Study|Lost to Follow-up|1
71454|NCT01302691|279319|P2|Overall Study|Death|1
71455|NCT01302691|279320|P1|Overall Study|Death|0
71456|NCT01302691|279319|P2|Overall Study|Adverse Event|0
71457|NCT01302691|279320|P1|Overall Study|Adverse Event|2
71458|NCT01302548|279340|P2|Overall Study|Lost to Follow-up|1
71459|NCT01302548|279341|P1|Overall Study|Lost to Follow-up|2
71460|NCT01302418|279391|P1|Overall Study|Non-evaluable|9
71461|NCT01302418|279391|P1|Overall Study|Protocol Violation|9
71462|NCT01302392|279397|P2|Overall Study|Withdrawal by Subject|1
71463|NCT01302392|279398|P1|Overall Study|Withdrawal by Subject|6
71464|NCT01302392|279397|P2|Overall Study|Lost to Follow-up|0
71465|NCT01302392|279398|P1|Overall Study|Lost to Follow-up|1
71466|NCT01302366|279418|P1|Overall Study|patient choice or noncompliance|5
71467|NCT01302119|279426|P2|Overall Study|Non-specific|1
71468|NCT01302119|279427|P1|Overall Study|Non-specific|4
71469|NCT01302119|279426|P2|Overall Study|Non-compliance|2
71470|NCT01302119|279427|P1|Overall Study|Non-compliance|4
71471|NCT01302119|279426|P2|Overall Study|Adverse Event|1
71472|NCT01302119|279427|P1|Overall Study|Adverse Event|2
71473|NCT01302119|279426|P2|Overall Study|Lost to Follow-up|4
71474|NCT01302119|279427|P1|Overall Study|Lost to Follow-up|10
71475|NCT01302119|279426|P2|Overall Study|Withdrawal by Subject|20
71476|NCT01302119|279427|P1|Overall Study|Withdrawal by Subject|30
71477|NCT01302067|279442|P3|Overall Study|Adverse Event|45
71478|NCT01302067|279443|P2|Overall Study|Adverse Event|14
71479|NCT01302067|279444|P1|Overall Study|Adverse Event|27
71480|NCT01302067|279442|P3|Overall Study|Protocol Violation|8
71481|NCT01302067|279443|P2|Overall Study|Protocol Violation|0
71482|NCT01302067|279444|P1|Overall Study|Protocol Violation|11
71483|NCT01302067|279442|P3|Overall Study|Not specified|3
71484|NCT01302067|279443|P2|Overall Study|Not specified|1
71485|NCT01302067|279444|P1|Overall Study|Not specified|1
71486|NCT01302067|279442|P3|Overall Study|Withdrawal by Subject|10
71487|NCT01302067|279443|P2|Overall Study|Withdrawal by Subject|6
71488|NCT01302067|279444|P1|Overall Study|Withdrawal by Subject|13
71489|NCT01302067|279442|P3|Overall Study|Lost to Follow-up|15
71490|NCT01302067|279443|P2|Overall Study|Lost to Follow-up|4
71491|NCT01302067|279444|P1|Overall Study|Lost to Follow-up|9
71492|NCT01302067|279442|P3|Overall Study|Lack of Efficacy|2
71493|NCT01302067|279443|P2|Overall Study|Lack of Efficacy|4
71494|NCT01302067|279444|P1|Overall Study|Lack of Efficacy|8
71495|NCT01302067|279442|P3|Overall Study|Physician Decision|14
71496|NCT01302067|279443|P2|Overall Study|Physician Decision|5
71497|NCT01302067|279444|P1|Overall Study|Physician Decision|9
71498|NCT01302067|279442|P3|Overall Study|Death|1
71499|NCT01302067|279443|P2|Overall Study|Death|0
71500|NCT01302067|279444|P1|Overall Study|Death|0
71501|NCT01302054|279515|P3|Double-Blind Treatment Phase|Other|9
71502|NCT01302054|279516|P2|Double-Blind Treatment Phase|Other|4
71503|NCT01302054|279517|P1|Double-Blind Treatment Phase|Other|0
71504|NCT01302054|279515|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
71505|NCT01302054|279516|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
71506|NCT01302054|279517|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
71507|NCT01302054|279515|P3|Double-Blind Treatment Phase|Adverse Event|10
71508|NCT01302054|279516|P2|Double-Blind Treatment Phase|Adverse Event|10
71509|NCT01302054|279517|P1|Double-Blind Treatment Phase|Adverse Event|0
71510|NCT01302054|279515|P3|Double-Blind Treatment Phase|Protocol Violation|6
71511|NCT01302054|279516|P2|Double-Blind Treatment Phase|Protocol Violation|3
71512|NCT01302054|279517|P1|Double-Blind Treatment Phase|Protocol Violation|0
71513|NCT01302054|279515|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
71514|NCT01302054|279516|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
71515|NCT01302054|279517|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
71516|NCT01302054|279515|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
71517|NCT01302054|279516|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
71518|NCT01302054|279517|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
71519|NCT01302054|279515|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
71520|NCT01302054|279516|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
71521|NCT01302054|279517|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
71522|NCT01302054|279515|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
71523|NCT01302054|279516|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
71524|NCT01302054|279517|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
71525|NCT01302054|279515|P3|Tolterodine Open-Label Run-In Phase|Other|0
71526|NCT01302054|279516|P2|Tolterodine Open-Label Run-In Phase|Other|0
71527|NCT01302054|279517|P1|Tolterodine Open-Label Run-In Phase|Other|7
71528|NCT01302054|279515|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
71529|NCT01302054|279516|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
71530|NCT01302054|279517|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
71531|NCT01302054|279515|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
71532|NCT01302054|279516|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
71533|NCT01302054|279517|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
71534|NCT01302054|279515|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
71535|NCT01302054|279516|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
71536|NCT01302054|279517|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
71537|NCT01302054|279515|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
71538|NCT01302054|279516|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
71539|NCT01302054|279517|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
71540|NCT01302054|279515|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
71541|NCT01302054|279516|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
71542|NCT01302054|279517|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
71543|NCT01302054|279515|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
71544|NCT01302054|279516|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
71545|NCT01302054|279517|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
71546|NCT01302041|279544|P1|Overall Study|Other - Miscellaneous Reason|1
71547|NCT01302041|279544|P1|Overall Study|Withdrawal by Subject|1
71548|NCT01302041|279544|P1|Overall Study|Death|3
71549|NCT01302041|279544|P1|Overall Study|Continuing on Study|45
71550|NCT01301950|279586|P2|Overall Study|Surgery was cancelled by patient|1
71551|NCT01301950|279587|P1|Overall Study|Surgery was cancelled by patient|0
71552|NCT01301833|279605|P4|Overall Study|Personal matter|0
71553|NCT01301833|279606|P3|Overall Study|Personal matter|0
71554|NCT01301833|279607|P2|Overall Study|Personal matter|0
71555|NCT01301833|279608|P1|Overall Study|Personal matter|1
71556|NCT01301833|279605|P4|Overall Study|Withdrawal by Subject|2
71557|NCT01301833|279606|P3|Overall Study|Withdrawal by Subject|1
71558|NCT01301833|279607|P2|Overall Study|Withdrawal by Subject|1
71559|NCT01301833|279608|P1|Overall Study|Withdrawal by Subject|3
71560|NCT01301833|279605|P4|Overall Study|Physician Decision|0
71561|NCT01301833|279606|P3|Overall Study|Physician Decision|1
71562|NCT01301833|279607|P2|Overall Study|Physician Decision|1
71563|NCT01301833|279608|P1|Overall Study|Physician Decision|3
71564|NCT01301833|279605|P4|Overall Study|Lack of Efficacy|0
71565|NCT01301833|279606|P3|Overall Study|Lack of Efficacy|0
71566|NCT01301833|279607|P2|Overall Study|Lack of Efficacy|1
71567|NCT01301833|279608|P1|Overall Study|Lack of Efficacy|1
71568|NCT01301833|279605|P4|Overall Study|Adverse Event|5
71569|NCT01301833|279606|P3|Overall Study|Adverse Event|5
71570|NCT01301833|279607|P2|Overall Study|Adverse Event|5
71571|NCT01301833|279608|P1|Overall Study|Adverse Event|7
71572|NCT01301729|279646|P1|Overall Study|Violated Selection Criteria|1
71573|NCT01301729|279646|P1|Overall Study|Participant did not Return for Treatment|1
71574|NCT01301729|279646|P1|Overall Study|Withdrawal by Subject|2
71575|NCT01301508|279659|P2|Overall Study|Lost to Follow-up|1
71576|NCT01301508|279660|P1|Overall Study|Lost to Follow-up|0
71577|NCT01301508|279659|P2|Overall Study|Withdrawal by Subject|2
71578|NCT01301508|279660|P1|Overall Study|Withdrawal by Subject|1
71579|NCT01301456|279690|P12|Stage 2|Adverse Event|0
71580|NCT01301456|279691|P11|Stage 2|Adverse Event|1
71581|NCT01301456|279692|P10|Stage 2|Adverse Event|0
71582|NCT01301456|279693|P9|Stage 2|Adverse Event|0
71583|NCT01301456|279694|P8|Stage 2|Adverse Event|0
71584|NCT01301456|279695|P7|Stage 2|Adverse Event|0
71585|NCT01301456|279696|P6|Stage 2|Adverse Event|0
71586|NCT01301456|279697|P5|Stage 2|Adverse Event|0
71587|NCT01301456|279698|P4|Stage 2|Adverse Event|0
71588|NCT01301456|279699|P3|Stage 2|Adverse Event|0
71589|NCT01301456|279700|P2|Stage 2|Adverse Event|0
71590|NCT01301456|279701|P1|Stage 2|Adverse Event|0
71591|NCT01301456|279690|P12|Stage 1|Randomized but not treated|0
71592|NCT01301456|279691|P11|Stage 1|Randomized but not treated|0
71593|NCT01301456|279692|P10|Stage 1|Randomized but not treated|0
71594|NCT01301456|279693|P9|Stage 1|Randomized but not treated|0
71595|NCT01301456|279694|P8|Stage 1|Randomized but not treated|0
71596|NCT01301456|279695|P7|Stage 1|Randomized but not treated|1
71597|NCT01301456|279696|P6|Stage 1|Randomized but not treated|0
71598|NCT01301456|279697|P5|Stage 1|Randomized but not treated|0
71599|NCT01301456|279698|P4|Stage 1|Randomized but not treated|0
71600|NCT01301456|279699|P3|Stage 1|Randomized but not treated|0
71601|NCT01301456|279700|P2|Stage 1|Randomized but not treated|0
71602|NCT01301456|279701|P1|Stage 1|Randomized but not treated|0
71603|NCT01301456|279690|P12|Stage 1|Withdrawal by Subject|0
71604|NCT01301456|279691|P11|Stage 1|Withdrawal by Subject|0
71605|NCT01301456|279692|P10|Stage 1|Withdrawal by Subject|0
71606|NCT01301456|279693|P9|Stage 1|Withdrawal by Subject|0
71607|NCT01301456|279694|P8|Stage 1|Withdrawal by Subject|0
71608|NCT01301456|279695|P7|Stage 1|Withdrawal by Subject|0
71609|NCT01301456|279696|P6|Stage 1|Withdrawal by Subject|0
71610|NCT01301456|279697|P5|Stage 1|Withdrawal by Subject|1
71611|NCT01301456|279698|P4|Stage 1|Withdrawal by Subject|0
71612|NCT01301456|279699|P3|Stage 1|Withdrawal by Subject|1
71613|NCT01301456|279700|P2|Stage 1|Withdrawal by Subject|0
71614|NCT01301456|279701|P1|Stage 1|Withdrawal by Subject|0
71615|NCT01301274|279929|P2|Overall Study|Physician Decision|1
71616|NCT01301274|279930|P1|Overall Study|Physician Decision|2
71617|NCT01301092|279945|P3|Overall Study|Lost to Follow-up|1
71618|NCT01301092|279946|P2|Overall Study|Lost to Follow-up|0
71619|NCT01301092|279947|P1|Overall Study|Lost to Follow-up|0
71620|NCT01301079|279964|P2|Overall Study|Lost to Follow-up|2
71621|NCT01301079|279965|P1|Overall Study|Lost to Follow-up|2
71622|NCT01301066|280043|P2|Overall Study|Other|0
71623|NCT01301066|280044|P1|Overall Study|Other|2
71624|NCT01301066|280043|P2|Overall Study|Physician Decision|1
71625|NCT01301066|280044|P1|Overall Study|Physician Decision|0
71626|NCT01301066|280043|P2|Overall Study|Sponsor Decision|1
71627|NCT01301066|280044|P1|Overall Study|Sponsor Decision|2
71628|NCT01301066|280043|P2|Overall Study|Adverse Event|6
71629|NCT01301066|280044|P1|Overall Study|Adverse Event|6
71630|NCT01301066|280043|P2|Overall Study|Withdrawal by Subject|9
71631|NCT01301066|280044|P1|Overall Study|Withdrawal by Subject|4
71632|NCT01301066|280043|P2|Overall Study|Protocol Violation|7
71633|NCT01301066|280044|P1|Overall Study|Protocol Violation|8
71634|NCT01301066|280043|P2|Overall Study|Lost to Follow-up|11
71635|NCT01301066|280044|P1|Overall Study|Lost to Follow-up|5
71636|NCT01301027|280052|P2|Overall Study|Volume Overload|0
71637|NCT01301027|280053|P1|Overall Study|Volume Overload|3
71638|NCT01301027|280052|P2|Overall Study|Transplant|2
71639|NCT01301027|280053|P1|Overall Study|Transplant|0
71640|NCT01301027|280052|P2|Overall Study|Fracture|3
71641|NCT01301027|280053|P1|Overall Study|Fracture|1
71642|NCT01301027|280052|P2|Overall Study|Adverse Event|2
71643|NCT01301027|280053|P1|Overall Study|Adverse Event|0
71644|NCT01301027|280052|P2|Overall Study|Withdrawal by Subject|3
71645|NCT01301027|280053|P1|Overall Study|Withdrawal by Subject|2
71646|NCT01301027|280052|P2|Overall Study|Physician Decision|0
71647|NCT01301027|280053|P1|Overall Study|Physician Decision|2
71648|NCT01301001|280065|P2|Second Intervention|Withdrawal by Subject|0
71649|NCT01301001|280066|P1|Second Intervention|Withdrawal by Subject|2
71650|NCT01301001|280065|P2|Second Intervention|Adverse Event|0
71651|NCT01301001|280066|P1|Second Intervention|Adverse Event|2
71652|NCT01301001|280065|P2|First Intervention|Protocol Violation|1
71653|NCT01301001|280066|P1|First Intervention|Protocol Violation|0
71654|NCT01301001|280065|P2|First Intervention|Adverse Event|0
71655|NCT01301001|280066|P1|First Intervention|Adverse Event|5
71656|NCT01301001|280065|P2|First Intervention|Withdrawal by Subject|4
71657|NCT01301001|280066|P1|First Intervention|Withdrawal by Subject|1
71658|NCT01301001|280065|P2|First Intervention|Lost to Follow-up|4
71659|NCT01301001|280066|P1|First Intervention|Lost to Follow-up|4
71660|NCT01300923|280076|P2|Overall Study|Physician Decision|2
71661|NCT01300923|280077|P1|Overall Study|Physician Decision|0
71662|NCT01300819|280090|P2|Overall Study|Follow up call was not done|0
71663|NCT01300819|280091|P1|Overall Study|Follow up call was not done|1
71664|NCT01300819|280090|P2|Overall Study|Safety follow up not done by mistake|1
71665|NCT01300819|280091|P1|Overall Study|Safety follow up not done by mistake|0
71666|NCT01300819|280090|P2|Overall Study|Administrative reason|1
71667|NCT01300819|280091|P1|Overall Study|Administrative reason|0
71668|NCT01300819|280090|P2|Overall Study|Refusal to down titrate study drug|1
71669|NCT01300819|280091|P1|Overall Study|Refusal to down titrate study drug|0
71670|NCT01300819|280090|P2|Overall Study|Patient was 1 month late for Visit 10|1
71671|NCT01300819|280091|P1|Overall Study|Patient was 1 month late for Visit 10|0
71672|NCT01300819|280090|P2|Overall Study|Withdrawal by Subject|12
71673|NCT01300819|280091|P1|Overall Study|Withdrawal by Subject|10
71674|NCT01300819|280090|P2|Overall Study|Lack of Efficacy|1
71675|NCT01300819|280091|P1|Overall Study|Lack of Efficacy|2
71676|NCT01300819|280090|P2|Overall Study|Adverse Event|27
71677|NCT01300819|280091|P1|Overall Study|Adverse Event|9
71678|NCT01300767|280119|P1|Overall Study|Unacceptable fit|1
71679|NCT01300767|280119|P1|Overall Study|Biomicroscopy|1
71680|NCT01300767|280119|P1|Overall Study|Discomfort|2
71681|NCT01300741|280147|P1|Overall Study|Discomfort|1
71682|NCT01300741|280147|P1|Overall Study|Lost to Follow-up|1
71683|NCT01300741|280147|P1|Overall Study|Lens deposits|1
71684|NCT01300728|280177|P2|Overall Study|Physician Decision|0
71685|NCT01300728|280178|P1|Overall Study|Physician Decision|1
71686|NCT01300728|280177|P2|Overall Study|Withdrawal by Subject|1
71687|NCT01300728|280178|P1|Overall Study|Withdrawal by Subject|1
71688|NCT01300650|280192|P1|Overall Study|Adverse Event|1
71689|NCT01300546|280219|P2|Overall Study|Adverse Event|1
71690|NCT01300546|280220|P1|Overall Study|Adverse Event|0
71691|NCT01300546|280219|P2|Overall Study|Lack of Efficacy|3
71692|NCT01300546|280220|P1|Overall Study|Lack of Efficacy|0
71693|NCT01300546|280219|P2|Overall Study|Lost to Follow-up|2
71694|NCT01300546|280220|P1|Overall Study|Lost to Follow-up|0
71695|NCT01300546|280219|P2|Overall Study|Withdrawal by Subject|0
71696|NCT01300546|280220|P1|Overall Study|Withdrawal by Subject|1
71697|NCT01300455|280250|P2|Washout|Withdrawal by Subject|0
71698|NCT01300455|280251|P1|Washout|Withdrawal by Subject|1
71699|NCT01300351|280271|P2|Overall Study|Withdrawal by Subject|10
71700|NCT01300351|280272|P1|Overall Study|Withdrawal by Subject|7
71701|NCT01300351|280271|P2|Overall Study|Adverse Event|4
71702|NCT01300351|280272|P1|Overall Study|Adverse Event|0
71703|NCT01300351|280271|P2|Overall Study|Lost to Follow-up|1
71704|NCT01300351|280272|P1|Overall Study|Lost to Follow-up|0
71705|NCT01300351|280271|P2|Overall Study|Ongoing treatment at data cut-off|23
71706|NCT01300351|280272|P1|Overall Study|Ongoing treatment at data cut-off|27
71707|NCT01300351|280271|P2|Overall Study|Did not receive treatment|0
71708|NCT01300351|280272|P1|Overall Study|Did not receive treatment|2
71709|NCT01300338|280288|P2|Overall Study|Lost to Follow-up|0
71710|NCT01300338|280289|P1|Overall Study|Lost to Follow-up|5
71711|NCT01300286|280297|P1|Overall Study|did not get dosed|1
71712|NCT01300260|280307|P2|Period 2 of Study: Second Intervention|Adverse Event|1
71713|NCT01300260|280308|P1|Period 2 of Study: Second Intervention|Adverse Event|0
71714|NCT01300260|280307|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
71715|NCT01300260|280308|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
71716|NCT01300260|280307|P2|Period 1 of Study: First Intervention|Adverse Event|1
71717|NCT01300260|280308|P1|Period 1 of Study: First Intervention|Adverse Event|0
71718|NCT01300247|280340|P2|Overall Study|Non-Compliance|1
71719|NCT01300247|280341|P1|Overall Study|Non-Compliance|0
71720|NCT01300247|280340|P2|Overall Study|Withdrawal by Subject|0
71721|NCT01300247|280341|P1|Overall Study|Withdrawal by Subject|1
71722|NCT01300247|280340|P2|Overall Study|Lost to Follow-up|0
71723|NCT01300247|280341|P1|Overall Study|Lost to Follow-up|2
71724|NCT01300247|280340|P2|Overall Study|Death|1
71725|NCT01300247|280341|P1|Overall Study|Death|1
71726|NCT01300234|280373|P2|Overall Study|Lost to Follow-up|2
71727|NCT01300234|280374|P1|Overall Study|Lost to Follow-up|0
71728|NCT01300234|280373|P2|Overall Study|Withdrawal by Subject|5
71729|NCT01300234|280374|P1|Overall Study|Withdrawal by Subject|1
71730|NCT01300234|280373|P2|Overall Study|Protocol Violation|3
71731|NCT01300234|280374|P1|Overall Study|Protocol Violation|2
71732|NCT01300234|280373|P2|Overall Study|Adverse Event|0
71733|NCT01300234|280374|P1|Overall Study|Adverse Event|1
71734|NCT01300052|280406|P2|Overall Study|Protocol Violation|1
71735|NCT01300052|280407|P1|Overall Study|Protocol Violation|1
71736|NCT01300052|280406|P2|Overall Study|Withdrawal by Subject|2
71737|NCT01300052|280407|P1|Overall Study|Withdrawal by Subject|2
71738|NCT01300052|280406|P2|Overall Study|Adverse Event|0
71739|NCT01300052|280407|P1|Overall Study|Adverse Event|3
71740|NCT01299961|280425|P1|Overall Study|Lost to Follow-up|1
71741|NCT01299961|280425|P1|Overall Study|Lack of Efficacy|2
71742|NCT01299961|280425|P1|Overall Study|Adverse Event|3
71743|NCT01299909|280434|P3|Overall Study|Lost to Follow-up|17
71744|NCT01299909|280435|P2|Overall Study|Lost to Follow-up|18
71745|NCT01299909|280436|P1|Overall Study|Lost to Follow-up|22
71746|NCT01299896|280451|P2|Overall Study|Lost to Follow-up|11
71747|NCT01299896|280452|P1|Overall Study|Lost to Follow-up|0
71748|NCT01299896|280451|P2|Overall Study|Withdrawal by Subject|7
71749|NCT01299896|280452|P1|Overall Study|Withdrawal by Subject|1
71750|NCT01299805|280460|P2|Overall Study|Adverse Event|0
71751|NCT01299805|280461|P1|Overall Study|Adverse Event|2
71752|NCT01299584|280539|P1|Overall Study|Protocol Violation|9
71753|NCT01299571|280546|P1|Overall Study|Protocol Violation|107
71754|NCT01299480|280557|P5|Overall Study|Started, but not vaccinated|0
71755|NCT01299480|280558|P4|Overall Study|Started, but not vaccinated|1
71756|NCT01299480|280559|P3|Overall Study|Started, but not vaccinated|1
71757|NCT01299480|280560|P2|Overall Study|Started, but not vaccinated|0
71758|NCT01299480|280561|P1|Overall Study|Started, but not vaccinated|0
71759|NCT01299480|280557|P5|Overall Study|Other|3
71760|NCT01299480|280558|P4|Overall Study|Other|0
71761|NCT01299480|280559|P3|Overall Study|Other|3
71762|NCT01299480|280560|P2|Overall Study|Other|2
71763|NCT01299480|280561|P1|Overall Study|Other|3
71764|NCT01299480|280557|P5|Overall Study|Lost to Follow-up|2
71765|NCT01299480|280558|P4|Overall Study|Lost to Follow-up|1
71766|NCT01299480|280559|P3|Overall Study|Lost to Follow-up|2
71767|NCT01299480|280560|P2|Overall Study|Lost to Follow-up|1
71768|NCT01299480|280561|P1|Overall Study|Lost to Follow-up|3
71769|NCT01299480|280557|P5|Overall Study|Physician Decision|0
71770|NCT01299480|280558|P4|Overall Study|Physician Decision|2
71771|NCT01299480|280559|P3|Overall Study|Physician Decision|0
71772|NCT01299480|280560|P2|Overall Study|Physician Decision|1
71773|NCT01299480|280561|P1|Overall Study|Physician Decision|1
71774|NCT01299480|280557|P5|Overall Study|Withdrawal due to pregnancy|0
71775|NCT01299480|280558|P4|Overall Study|Withdrawal due to pregnancy|0
71776|NCT01299480|280559|P3|Overall Study|Withdrawal due to pregnancy|1
71777|NCT01299480|280560|P2|Overall Study|Withdrawal due to pregnancy|1
71778|NCT01299480|280561|P1|Overall Study|Withdrawal due to pregnancy|0
71779|NCT01299480|280557|P5|Overall Study|Adverse Event|0
71780|NCT01299480|280558|P4|Overall Study|Adverse Event|4
71781|NCT01299480|280559|P3|Overall Study|Adverse Event|5
71782|NCT01299480|280560|P2|Overall Study|Adverse Event|4
71783|NCT01299480|280561|P1|Overall Study|Adverse Event|6
71784|NCT01299480|280557|P5|Overall Study|Withdrawal by Subject|4
71785|NCT01299480|280558|P4|Overall Study|Withdrawal by Subject|3
71786|NCT01299480|280559|P3|Overall Study|Withdrawal by Subject|7
71787|NCT01299480|280560|P2|Overall Study|Withdrawal by Subject|4
71788|NCT01299480|280561|P1|Overall Study|Withdrawal by Subject|3
71789|NCT01299480|280557|P5|Overall Study|Protocol Violation|1
71790|NCT01299480|280558|P4|Overall Study|Protocol Violation|1
71791|NCT01299480|280559|P3|Overall Study|Protocol Violation|8
71792|NCT01299480|280560|P2|Overall Study|Protocol Violation|5
71793|NCT01299480|280561|P1|Overall Study|Protocol Violation|7
71794|NCT01299480|280557|P5|Overall Study|No longer willing to participate|10
71795|NCT01299480|280558|P4|Overall Study|No longer willing to participate|13
71796|NCT01299480|280559|P3|Overall Study|No longer willing to participate|14
71797|NCT01299480|280560|P2|Overall Study|No longer willing to participate|17
71798|NCT01299480|280561|P1|Overall Study|No longer willing to participate|19
71799|NCT01299389|280763|P4|Post-observational|Other|6
71800|NCT01299389|280764|P3|Post-observational|Other|12
71801|NCT01299389|280765|P2|Post-observational|Other|0
71802|NCT01299389|280766|P1|Post-observational|Other|0
71803|NCT01299389|280763|P4|Double-blind|fail to meet “study population” criteria|0
71804|NCT01299389|280764|P3|Double-blind|fail to meet “study population” criteria|0
71805|NCT01299389|280765|P2|Double-blind|fail to meet “study population” criteria|1
71806|NCT01299389|280766|P1|Double-blind|fail to meet “study population” criteria|0
71807|NCT01299389|280763|P4|Double-blind|Other|0
71808|NCT01299389|280764|P3|Double-blind|Other|0
71809|NCT01299389|280765|P2|Double-blind|Other|1
71810|NCT01299389|280766|P1|Double-blind|Other|1
71811|NCT01299389|280763|P4|Double-blind|Withdrawal by Subject|0
71812|NCT01299389|280764|P3|Double-blind|Withdrawal by Subject|0
71813|NCT01299389|280765|P2|Double-blind|Withdrawal by Subject|13
71814|NCT01299389|280766|P1|Double-blind|Withdrawal by Subject|16
71815|NCT01299389|280763|P4|Double-blind|Lost to Follow-up|0
71816|NCT01299389|280764|P3|Double-blind|Lost to Follow-up|0
71817|NCT01299389|280765|P2|Double-blind|Lost to Follow-up|1
71818|NCT01299389|280766|P1|Double-blind|Lost to Follow-up|2
71819|NCT01299389|280763|P4|Double-blind|Lack of Efficacy|0
71820|NCT01299389|280764|P3|Double-blind|Lack of Efficacy|0
71821|NCT01299389|280765|P2|Double-blind|Lack of Efficacy|21
71822|NCT01299389|280766|P1|Double-blind|Lack of Efficacy|45
71823|NCT01299389|280763|P4|Double-blind|Adverse Event|0
71824|NCT01299389|280764|P3|Double-blind|Adverse Event|0
71825|NCT01299389|280765|P2|Double-blind|Adverse Event|27
71826|NCT01299389|280766|P1|Double-blind|Adverse Event|45
71827|NCT01299376|280788|P2|Extension (Weeks 9 to 52)|Physician Decision|0
71828|NCT01299376|280789|P1|Extension (Weeks 9 to 52)|Physician Decision|1
71829|NCT01299376|280788|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
71830|NCT01299376|280789|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
71831|NCT01299376|280788|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
71832|NCT01299376|280789|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
71833|NCT01299376|280788|P2|Extension (Weeks 9 to 52)|Adverse Event|3
71834|NCT01299376|280789|P1|Extension (Weeks 9 to 52)|Adverse Event|2
71835|NCT01299376|280788|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
71836|NCT01299376|280789|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
71837|NCT01299376|280788|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
71838|NCT01299376|280789|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
71839|NCT01299376|280788|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
71840|NCT01299376|280789|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
71841|NCT01299376|280788|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
71842|NCT01299376|280789|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
71843|NCT01299376|280788|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
71844|NCT01299376|280789|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
71845|NCT01299376|280788|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
71846|NCT01299376|280789|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
71847|NCT01299376|280788|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
71848|NCT01299376|280789|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
71849|NCT01299272|280832|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
71850|NCT01299272|280833|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
71851|NCT01299272|280834|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
71852|NCT01299272|280835|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
71853|NCT01299272|280832|P4|Double-blind (DB) Randomized Period|Physician Decision|1
71854|NCT01299272|280833|P3|Double-blind (DB) Randomized Period|Physician Decision|2
71855|NCT01299272|280834|P2|Double-blind (DB) Randomized Period|Physician Decision|0
71856|NCT01299272|280835|P1|Double-blind (DB) Randomized Period|Physician Decision|0
71857|NCT01299272|280832|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
71858|NCT01299272|280833|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
71859|NCT01299272|280834|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
71860|NCT01299272|280835|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
71861|NCT01299272|280832|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
71862|NCT01299272|280833|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
71863|NCT01299272|280834|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
71864|NCT01299272|280835|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
71865|NCT01299272|280832|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
71866|NCT01299272|280833|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
71867|NCT01299272|280834|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
71868|NCT01299272|280835|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
71869|NCT01299272|280832|P4|Double-blind (DB) Randomized Period|Adverse Event|9
71870|NCT01299272|280833|P3|Double-blind (DB) Randomized Period|Adverse Event|8
71871|NCT01299272|280834|P2|Double-blind (DB) Randomized Period|Adverse Event|0
71872|NCT01299272|280835|P1|Double-blind (DB) Randomized Period|Adverse Event|0
71873|NCT01299272|280832|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
71874|NCT01299272|280833|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
71875|NCT01299272|280834|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
71876|NCT01299272|280835|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
71877|NCT01299272|280832|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
71878|NCT01299272|280833|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
71879|NCT01299272|280834|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
71880|NCT01299272|280835|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
71881|NCT01299272|280832|P4|Stabilization Open-label (OL) Period|Physician Decision|0
71882|NCT01299272|280833|P3|Stabilization Open-label (OL) Period|Physician Decision|0
71883|NCT01299272|280834|P2|Stabilization Open-label (OL) Period|Physician Decision|3
71884|NCT01299272|280835|P1|Stabilization Open-label (OL) Period|Physician Decision|0
71885|NCT01299272|280832|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
71886|NCT01299272|280833|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
71887|NCT01299272|280834|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
71888|NCT01299272|280835|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
71889|NCT01299272|280832|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
71890|NCT01299272|280833|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
71891|NCT01299272|280834|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
71892|NCT01299272|280835|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
71893|NCT01299272|280832|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
71894|NCT01299272|280833|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
71895|NCT01299272|280834|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
71896|NCT01299272|280835|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
71897|NCT01299272|280832|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
71898|NCT01299272|280833|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
71899|NCT01299272|280834|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
71900|NCT01299272|280835|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
71901|NCT01299272|280832|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
71902|NCT01299272|280833|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
71903|NCT01299272|280834|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
71904|NCT01299272|280835|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
71905|NCT01299272|280832|P4|Stabilization Open-label (OL) Period|Adverse Event|0
71906|NCT01299272|280833|P3|Stabilization Open-label (OL) Period|Adverse Event|0
71907|NCT01299272|280834|P2|Stabilization Open-label (OL) Period|Adverse Event|42
71908|NCT01299272|280835|P1|Stabilization Open-label (OL) Period|Adverse Event|0
71909|NCT01299272|280832|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
71910|NCT01299272|280833|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
71911|NCT01299272|280834|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
71912|NCT01299272|280835|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
71913|NCT01299272|280832|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
71914|NCT01299272|280833|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
71915|NCT01299272|280834|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
71916|NCT01299272|280835|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
71917|NCT01299272|280832|P4|Acute Open-label (OL) Period|Physician Decision|0
71918|NCT01299272|280833|P3|Acute Open-label (OL) Period|Physician Decision|0
71919|NCT01299272|280834|P2|Acute Open-label (OL) Period|Physician Decision|0
71920|NCT01299272|280835|P1|Acute Open-label (OL) Period|Physician Decision|5
71921|NCT01299272|280832|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
71922|NCT01299272|280833|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
71923|NCT01299272|280834|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
71924|NCT01299272|280835|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
71925|NCT01299272|280832|P4|Acute Open-label (OL) Period|Sponsor Decision|0
71926|NCT01299272|280833|P3|Acute Open-label (OL) Period|Sponsor Decision|0
71927|NCT01299272|280834|P2|Acute Open-label (OL) Period|Sponsor Decision|0
71928|NCT01299272|280835|P1|Acute Open-label (OL) Period|Sponsor Decision|13
71929|NCT01299272|280832|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
71930|NCT01299272|280833|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
71931|NCT01299272|280834|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
71932|NCT01299272|280835|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
71933|NCT01299272|280832|P4|Acute Open-label (OL) Period|Protocol Violation|0
71934|NCT01299272|280833|P3|Acute Open-label (OL) Period|Protocol Violation|0
71935|NCT01299272|280834|P2|Acute Open-label (OL) Period|Protocol Violation|0
71936|NCT01299272|280835|P1|Acute Open-label (OL) Period|Protocol Violation|36
71937|NCT01299272|280832|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
71938|NCT01299272|280833|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
71939|NCT01299272|280834|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
71940|NCT01299272|280835|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
71941|NCT01299272|280832|P4|Acute Open-label (OL) Period|Adverse Event|0
71942|NCT01299272|280833|P3|Acute Open-label (OL) Period|Adverse Event|0
71943|NCT01299272|280834|P2|Acute Open-label (OL) Period|Adverse Event|0
71944|NCT01299272|280835|P1|Acute Open-label (OL) Period|Adverse Event|140
71945|NCT01299272|280832|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
71946|NCT01299272|280833|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
71947|NCT01299272|280834|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
71948|NCT01299272|280835|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
71949|NCT01299116|280890|P3|Overall Study|Lost to Follow-up|11
71950|NCT01299116|280891|P2|Overall Study|Lost to Follow-up|9
71951|NCT01299116|280892|P1|Overall Study|Lost to Follow-up|65
71952|NCT01299025|280937|P2|Overall Study|Lost to Follow-up|0
71953|NCT01299025|280938|P1|Overall Study|Lost to Follow-up|1
71954|NCT01299025|280937|P2|Overall Study|Withdrawal by Subject|1
71955|NCT01299025|280938|P1|Overall Study|Withdrawal by Subject|2
71956|NCT01298778|280952|P2|Overall Study|not meet inclusion/exclusion criteria|1
71957|NCT01298778|280953|P1|Overall Study|not meet inclusion/exclusion criteria|0
71958|NCT01298778|280952|P2|Overall Study|Protocol Violation|1
71959|NCT01298778|280953|P1|Overall Study|Protocol Violation|0
71960|NCT01298778|280952|P2|Overall Study|Withdrawal by Subject|1
71961|NCT01298778|280953|P1|Overall Study|Withdrawal by Subject|0
71962|NCT01298778|280952|P2|Overall Study|Incorrect use of VAS|0
71963|NCT01298778|280953|P1|Overall Study|Incorrect use of VAS|1
71964|NCT01298778|280952|P2|Overall Study|Lost to Follow-up|3
71965|NCT01298778|280953|P1|Overall Study|Lost to Follow-up|2
71966|NCT01298661|280976|P3|Overall Study|Withdrawal by Subject|2
71967|NCT01298661|280977|P2|Overall Study|Withdrawal by Subject|0
71968|NCT01298661|280978|P1|Overall Study|Withdrawal by Subject|2
71969|NCT01298648|281056|P1|Overall Study|Lost to Follow-up|21
71970|NCT01298648|281056|P1|Overall Study|Withdrawal by Subject|2
71971|NCT01298570|281067|P2|Overall Study|Ineligibility|1
71972|NCT01298570|281068|P1|Overall Study|Ineligibility|0
71973|NCT01298570|281067|P2|Overall Study|Death|1
71974|NCT01298570|281068|P1|Overall Study|Death|0
71975|NCT01298570|281067|P2|Overall Study|Symptomatic progression/deterioration|2
71976|NCT01298570|281068|P1|Overall Study|Symptomatic progression/deterioration|3
71977|NCT01298570|281067|P2|Overall Study|Surgery|1
71978|NCT01298570|281068|P1|Overall Study|Surgery|2
71979|NCT01298570|281067|P2|Overall Study|Other complicating disease|1
71980|NCT01298570|281068|P1|Overall Study|Other complicating disease|2
71981|NCT01298570|281067|P2|Overall Study|Physician Decision|2
71982|NCT01298570|281068|P1|Overall Study|Physician Decision|4
71983|NCT01298570|281067|P2|Overall Study|Treatment delay > 4 weeks|5
71984|NCT01298570|281068|P1|Overall Study|Treatment delay > 4 weeks|4
71985|NCT01298570|281067|P2|Overall Study|Withdrawal by Subject|6
71986|NCT01298570|281068|P1|Overall Study|Withdrawal by Subject|21
71987|NCT01298570|281067|P2|Overall Study|Adverse Event|2
71988|NCT01298570|281068|P1|Overall Study|Adverse Event|20
71989|NCT01298570|281067|P2|Overall Study|Disease progression, relapse during acti|40
71990|NCT01298570|281068|P1|Overall Study|Disease progression, relapse during acti|64
71991|NCT01298531|281095|P2|Overall Study|Not specified|1
71992|NCT01298531|281096|P1|Overall Study|Not specified|2
71993|NCT01298531|281095|P2|Overall Study|Does not meet entrance criteria|1
71994|NCT01298531|281096|P1|Overall Study|Does not meet entrance criteria|0
71995|NCT01298531|281095|P2|Overall Study|Adverse Event|3
71996|NCT01298531|281096|P1|Overall Study|Adverse Event|4
71997|NCT01298531|281095|P2|Overall Study|Protocol Violation|1
71998|NCT01298531|281096|P1|Overall Study|Protocol Violation|1
71999|NCT01298531|281095|P2|Overall Study|Lost to Follow-up|0
72000|NCT01298531|281096|P1|Overall Study|Lost to Follow-up|2
72001|NCT01298531|281095|P2|Overall Study|Lack of Efficacy|1
72002|NCT01298531|281096|P1|Overall Study|Lack of Efficacy|0
72003|NCT01298518|281225|P3|Overall Study|Withdrawal by Subject|1
72004|NCT01298518|281226|P2|Overall Study|Withdrawal by Subject|0
72005|NCT01298518|281227|P1|Overall Study|Withdrawal by Subject|0
72006|NCT01298492|281279|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
72007|NCT01298492|281279|P1|Overall Study|Adverse Event(Related to Study Drug)|8
72008|NCT01298492|281279|P1|Overall Study|Protocol Violation|2
72009|NCT01298492|281279|P1|Overall Study|Withdrawn Due to Pregnancy|1
72010|NCT01298492|281279|P1|Overall Study|Other (Unspecified)|7
72011|NCT01298492|281279|P1|Overall Study|Withdrawal by Subject|47
72012|NCT01298492|281279|P1|Overall Study|Lost to Follow-up|12
72013|NCT01298492|281279|P1|Overall Study|Insufficient Clinical Response|22
72014|NCT01298492|281279|P1|Overall Study|Death|2
72015|NCT01298362|281287|P2|Overall Study|Did not provide 12month BMD measurements|43
72016|NCT01298362|281288|P1|Overall Study|Did not provide 12month BMD measurements|38
72017|NCT01298323|281308|P2|Overall Study|Eligibility criteria not fulfilled|1
72018|NCT01298323|281309|P1|Overall Study|Eligibility criteria not fulfilled|0
72019|NCT01298323|281308|P2|Overall Study|Ongoing|55
72020|NCT01298323|281309|P1|Overall Study|Ongoing|55
72021|NCT01298323|281308|P2|Overall Study|Other|9
72022|NCT01298323|281309|P1|Overall Study|Other|10
72023|NCT01298323|281308|P2|Overall Study|Protocol Violation|0
72024|NCT01298323|281309|P1|Overall Study|Protocol Violation|1
72025|NCT01298323|281308|P2|Overall Study|Withdrawal by Subject|3
72026|NCT01298323|281309|P1|Overall Study|Withdrawal by Subject|6
72027|NCT01298323|281308|P2|Overall Study|Lost to Follow-up|0
72028|NCT01298323|281309|P1|Overall Study|Lost to Follow-up|1
72029|NCT01298323|281308|P2|Overall Study|Death|16
72030|NCT01298323|281309|P1|Overall Study|Death|11
72031|NCT01298323|281308|P2|Overall Study|Adverse Event|4
72032|NCT01298323|281309|P1|Overall Study|Adverse Event|2
72033|NCT01297920|281372|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
72034|NCT01297920|281373|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
72035|NCT01297920|281374|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
72036|NCT01297920|281372|P3|Overall Study|Inadequate Control of IOP|17
72037|NCT01297920|281373|P2|Overall Study|Inadequate Control of IOP|9
72038|NCT01297920|281374|P1|Overall Study|Inadequate Control of IOP|7
72039|NCT01297920|281372|P3|Overall Study|Protocol Violation|0
72040|NCT01297920|281373|P2|Overall Study|Protocol Violation|3
72041|NCT01297920|281374|P1|Overall Study|Protocol Violation|1
72042|NCT01297920|281372|P3|Overall Study|Noncompliance|0
72043|NCT01297920|281373|P2|Overall Study|Noncompliance|0
72044|NCT01297920|281374|P1|Overall Study|Noncompliance|1
72045|NCT01297920|281372|P3|Overall Study|Patient Decision Unrelated to AE|2
72046|NCT01297920|281373|P2|Overall Study|Patient Decision Unrelated to AE|5
72047|NCT01297920|281374|P1|Overall Study|Patient Decision Unrelated to AE|6
72048|NCT01297920|281372|P3|Overall Study|Adverse Event|38
72049|NCT01297920|281373|P2|Overall Study|Adverse Event|10
72050|NCT01297920|281374|P1|Overall Study|Adverse Event|42
72051|NCT01297517|281418|P3|Overall Study|Inadequate Control of IOP|2
72052|NCT01297517|281419|P2|Overall Study|Inadequate Control of IOP|1
72053|NCT01297517|281420|P1|Overall Study|Inadequate Control of IOP|1
72054|NCT01297517|281418|P3|Overall Study|Protocol Violation|1
72055|NCT01297517|281419|P2|Overall Study|Protocol Violation|1
72056|NCT01297517|281420|P1|Overall Study|Protocol Violation|1
72057|NCT01297517|281418|P3|Overall Study|Noncompliance|0
72058|NCT01297517|281419|P2|Overall Study|Noncompliance|0
72059|NCT01297517|281420|P1|Overall Study|Noncompliance|1
72060|NCT01297517|281418|P3|Overall Study|Patient Decision Unrelated to AE|7
72061|NCT01297517|281419|P2|Overall Study|Patient Decision Unrelated to AE|3
72062|NCT01297517|281420|P1|Overall Study|Patient Decision Unrelated to AE|2
72063|NCT01297517|281418|P3|Overall Study|Lost to Follow-up|1
72064|NCT01297517|281419|P2|Overall Study|Lost to Follow-up|0
72065|NCT01297517|281420|P1|Overall Study|Lost to Follow-up|1
72066|NCT01297517|281418|P3|Overall Study|Adverse Event|16
72067|NCT01297517|281419|P2|Overall Study|Adverse Event|7
72068|NCT01297517|281420|P1|Overall Study|Adverse Event|21
72069|NCT01297504|281428|P1|Overall Study|Protocol Violation|3
72070|NCT01297504|281428|P1|Overall Study|Site Closure|3
72071|NCT01297504|281428|P1|Overall Study|Withdrawal by Subject|9
72072|NCT01297504|281428|P1|Overall Study|Lost to Follow-up|43
72073|NCT01297504|281428|P1|Overall Study|Death|3
72074|NCT01297504|281428|P1|Overall Study|No Study Visits|4
72075|NCT01297504|281428|P1|Overall Study|Received Palivizumab in Previous Season|1
72076|NCT01297504|281428|P1|Overall Study|Invalid Consent|1
72077|NCT01297491|281442|P2|Overall Study|Death|1
72078|NCT01297491|281443|P1|Overall Study|Death|2
72079|NCT01297491|281442|P2|Overall Study|Patient/Guardian decision|4
72080|NCT01297491|281443|P1|Overall Study|Patient/Guardian decision|3
72081|NCT01297491|281442|P2|Overall Study|Progressive disease|20
72082|NCT01297491|281443|P1|Overall Study|Progressive disease|11
72083|NCT01297491|281442|P2|Overall Study|Physician Decision|2
72084|NCT01297491|281443|P1|Overall Study|Physician Decision|3
72085|NCT01297491|281442|P2|Overall Study|Adverse Event|6
72086|NCT01297491|281443|P1|Overall Study|Adverse Event|11
72087|NCT01297465|281461|P2|Overall Study|Intention to Freeze all Embryos|1
72088|NCT01297465|281462|P1|Overall Study|Intention to Freeze all Embryos|0
72089|NCT01297465|281461|P2|Overall Study|All Embryos Discarded|1
72090|NCT01297465|281462|P1|Overall Study|All Embryos Discarded|0
72091|NCT01297465|281461|P2|Overall Study|No Fertilization|4
72092|NCT01297465|281462|P1|Overall Study|No Fertilization|6
72093|NCT01297465|281461|P2|Overall Study|Poor oocyte quality|1
72094|NCT01297465|281462|P1|Overall Study|Poor oocyte quality|0
72095|NCT01297465|281461|P2|Overall Study|No Oocytes Retrieved|1
72096|NCT01297465|281462|P1|Overall Study|No Oocytes Retrieved|1
72097|NCT01297465|281461|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
72098|NCT01297465|281462|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
72099|NCT01297465|281461|P2|Overall Study|Lack of Ovarian Response|1
72100|NCT01297465|281462|P1|Overall Study|Lack of Ovarian Response|1
72101|NCT01297322|281515|P2|Overall Study|Withdrawal by Subject|1
72102|NCT01297322|281516|P1|Overall Study|Withdrawal by Subject|0
72103|NCT01297322|281515|P2|Overall Study|Lost to Follow-up|0
72104|NCT01297322|281516|P1|Overall Study|Lost to Follow-up|1
72105|NCT01297270|281544|P3|Overall Study|Not treated|0
72106|NCT01297270|281545|P2|Overall Study|Not treated|1
72107|NCT01297270|281546|P1|Overall Study|Not treated|0
72108|NCT01297270|281544|P3|Overall Study|Other reason not defined above|1
72109|NCT01297270|281545|P2|Overall Study|Other reason not defined above|3
72110|NCT01297270|281546|P1|Overall Study|Other reason not defined above|3
72111|NCT01297270|281544|P3|Overall Study|Withdrawal by Subject|7
72112|NCT01297270|281545|P2|Overall Study|Withdrawal by Subject|15
72113|NCT01297270|281546|P1|Overall Study|Withdrawal by Subject|7
72114|NCT01297270|281544|P3|Overall Study|Protocol Violation|0
72115|NCT01297270|281545|P2|Overall Study|Protocol Violation|2
72116|NCT01297270|281546|P1|Overall Study|Protocol Violation|0
72117|NCT01297270|281544|P3|Overall Study|Lost to Follow-up|1
72118|NCT01297270|281545|P2|Overall Study|Lost to Follow-up|2
72119|NCT01297270|281546|P1|Overall Study|Lost to Follow-up|1
72120|NCT01297270|281544|P3|Overall Study|Lack of Efficacy|15
72121|NCT01297270|281545|P2|Overall Study|Lack of Efficacy|17
72122|NCT01297270|281546|P1|Overall Study|Lack of Efficacy|15
72123|NCT01297270|281544|P3|Overall Study|Adverse Event|5
72124|NCT01297270|281545|P2|Overall Study|Adverse Event|32
72125|NCT01297270|281546|P1|Overall Study|Adverse Event|19
72126|NCT01297062|281595|P7|Overall Study|Subject Decision|2
72127|NCT01297062|281596|P6|Overall Study|Subject Decision|1
72128|NCT01297062|281597|P5|Overall Study|Subject Decision|1
72129|NCT01297062|281598|P4|Overall Study|Subject Decision|1
72130|NCT01297062|281599|P3|Overall Study|Subject Decision|0
72131|NCT01297062|281600|P2|Overall Study|Subject Decision|1
72132|NCT01297062|281601|P1|Overall Study|Subject Decision|1
72133|NCT01297062|281595|P7|Overall Study|Protocol Violation|0
72134|NCT01297062|281596|P6|Overall Study|Protocol Violation|0
72135|NCT01297062|281597|P5|Overall Study|Protocol Violation|1
72136|NCT01297062|281598|P4|Overall Study|Protocol Violation|0
72137|NCT01297062|281599|P3|Overall Study|Protocol Violation|0
72138|NCT01297062|281600|P2|Overall Study|Protocol Violation|0
72139|NCT01297062|281601|P1|Overall Study|Protocol Violation|0
72140|NCT01297062|281595|P7|Overall Study|Physician Decision|6
72141|NCT01297062|281596|P6|Overall Study|Physician Decision|0
72142|NCT01297062|281597|P5|Overall Study|Physician Decision|0
72143|NCT01297062|281598|P4|Overall Study|Physician Decision|0
72144|NCT01297062|281599|P3|Overall Study|Physician Decision|1
72145|NCT01297062|281600|P2|Overall Study|Physician Decision|0
72146|NCT01297062|281601|P1|Overall Study|Physician Decision|1
72147|NCT01297062|281595|P7|Overall Study|Adverse Event|0
72148|NCT01297062|281596|P6|Overall Study|Adverse Event|0
72149|NCT01297062|281597|P5|Overall Study|Adverse Event|0
72150|NCT01297062|281598|P4|Overall Study|Adverse Event|0
72151|NCT01297062|281599|P3|Overall Study|Adverse Event|1
72152|NCT01297062|281600|P2|Overall Study|Adverse Event|0
72153|NCT01297062|281601|P1|Overall Study|Adverse Event|2
72154|NCT01296698|281663|P2|Overall Study|Study Terminated by Sponsor|12
72155|NCT01296698|281664|P1|Overall Study|Study Terminated by Sponsor|209
72156|NCT01296698|281663|P2|Overall Study|Difficulty Contacting Subject|0
72157|NCT01296698|281664|P1|Overall Study|Difficulty Contacting Subject|2
72158|NCT01296698|281663|P2|Overall Study|Withdrawal by Subject|0
72159|NCT01296698|281664|P1|Overall Study|Withdrawal by Subject|12
72160|NCT01296698|281663|P2|Overall Study|Lost to Follow-up|1
72161|NCT01296698|281664|P1|Overall Study|Lost to Follow-up|19
72162|NCT01296698|281663|P2|Overall Study|Death|0
72163|NCT01296698|281664|P1|Overall Study|Death|1
72164|NCT01296698|281663|P2|Overall Study|Adverse Event|0
72165|NCT01296698|281664|P1|Overall Study|Adverse Event|1
72166|NCT01296672|281718|P2|Overall Study|Lost to Follow-up|18
72167|NCT01296672|281719|P1|Overall Study|Lost to Follow-up|73
72168|NCT01296412|281742|P2|Overall Study|Withdrawal by Subject|13
72169|NCT01296412|281743|P1|Overall Study|Withdrawal by Subject|10
72170|NCT01296412|281742|P2|Overall Study|Pregnancy|1
72171|NCT01296412|281743|P1|Overall Study|Pregnancy|0
72172|NCT01296412|281742|P2|Overall Study|Physician Decision|3
72173|NCT01296412|281743|P1|Overall Study|Physician Decision|1
72174|NCT01296412|281742|P2|Overall Study|Other reason not specified|15
72175|NCT01296412|281743|P1|Overall Study|Other reason not specified|20
72176|NCT01296412|281742|P2|Overall Study|Non-compliance with study drug|2
72177|NCT01296412|281743|P1|Overall Study|Non-compliance with study drug|1
72178|NCT01296412|281742|P2|Overall Study|Lost to Follow-up|7
72179|NCT01296412|281743|P1|Overall Study|Lost to Follow-up|10
72180|NCT01296412|281742|P2|Overall Study|Lack of Efficacy|0
72181|NCT01296412|281743|P1|Overall Study|Lack of Efficacy|1
72182|NCT01296412|281742|P2|Overall Study|Adverse Event|29
72183|NCT01296412|281743|P1|Overall Study|Adverse Event|8
72184|NCT01296152|281773|P1|Overall Study|Unwilling to adhere to study requirement|1
72185|NCT01296035|281800|P1|Overall Study|Withdrawal by Subject|1
72186|NCT01295905|281807|P2|Overall Study|Met exclusion criteria|0
72187|NCT01295905|281808|P1|Overall Study|Met exclusion criteria|1
72188|NCT01295905|281807|P2|Overall Study|Did not meet inclusion criteria|0
72189|NCT01295905|281808|P1|Overall Study|Did not meet inclusion criteria|1
72190|NCT01295814|281842|P2|Overall Study|Withdrawal by Subject|0
72191|NCT01295814|281843|P1|Overall Study|Withdrawal by Subject|2
72192|NCT01295814|281842|P2|Overall Study|Lack of Efficacy|2
72193|NCT01295814|281843|P1|Overall Study|Lack of Efficacy|0
72194|NCT01295671|281860|P3|Overall Study|Withdrawal by Subject|0
72195|NCT01295671|281861|P2|Overall Study|Withdrawal by Subject|1
72196|NCT01295671|281862|P1|Overall Study|Withdrawal by Subject|3
72197|NCT01295671|281860|P3|Overall Study|Lost to Follow-up|3
72198|NCT01295671|281861|P2|Overall Study|Lost to Follow-up|6
72199|NCT01295671|281862|P1|Overall Study|Lost to Follow-up|4
72200|NCT01295320|281900|P1|Overall Study|Unable to travel|1
72201|NCT01295320|281900|P1|Overall Study|Subject was bedridden|1
72202|NCT01295320|281900|P1|Overall Study|Withdrawal by Subject|2
72203|NCT01295320|281900|P1|Overall Study|Lost to Follow-up|4
72204|NCT01295320|281900|P1|Overall Study|Adverse Event|2
72205|NCT01295281|281917|P2|First Intervention (7 Days)|Death|1
72206|NCT01295281|281918|P1|First Intervention (7 Days)|Death|0
72207|NCT01295034|281956|P2|Overall Study|Lost to Follow-up|5
72208|NCT01295034|281957|P1|Overall Study|Lost to Follow-up|5
72209|NCT01294917|281965|P1|Overall Study|Inconvenience|1
72210|NCT01294917|281965|P1|Overall Study|Relocation|5
72211|NCT01294800|281975|P4|Overall Study|Did Not Meet Protocol Eligibility|0
72212|NCT01294800|281976|P3|Overall Study|Did Not Meet Protocol Eligibility|1
72213|NCT01294800|281977|P2|Overall Study|Did Not Meet Protocol Eligibility|1
72214|NCT01294800|281978|P1|Overall Study|Did Not Meet Protocol Eligibility|2
72215|NCT01294800|281975|P4|Overall Study|Non-compliance With Protocol|0
72216|NCT01294800|281976|P3|Overall Study|Non-compliance With Protocol|1
72217|NCT01294800|281977|P2|Overall Study|Non-compliance With Protocol|1
72218|NCT01294800|281978|P1|Overall Study|Non-compliance With Protocol|0
72219|NCT01294800|281975|P4|Overall Study|Lost to Follow-up|0
72220|NCT01294800|281976|P3|Overall Study|Lost to Follow-up|1
72221|NCT01294800|281977|P2|Overall Study|Lost to Follow-up|0
72222|NCT01294800|281978|P1|Overall Study|Lost to Follow-up|0
72223|NCT01294800|281975|P4|Overall Study|Subject Withdrew Consent|11
72224|NCT01294800|281976|P3|Overall Study|Subject Withdrew Consent|2
72225|NCT01294800|281977|P2|Overall Study|Subject Withdrew Consent|2
72226|NCT01294800|281978|P1|Overall Study|Subject Withdrew Consent|2
72227|NCT01294800|281975|P4|Overall Study|Adverse Event|5
72228|NCT01294800|281976|P3|Overall Study|Adverse Event|12
72229|NCT01294800|281977|P2|Overall Study|Adverse Event|6
72230|NCT01294800|281978|P1|Overall Study|Adverse Event|7
72231|NCT01294787|282004|P6|Period 3|Adverse Event|0
72232|NCT01294787|282005|P5|Period 3|Adverse Event|1
72233|NCT01294787|282006|P4|Period 3|Adverse Event|0
72234|NCT01294787|282007|P3|Period 3|Adverse Event|0
72235|NCT01294787|282008|P2|Period 3|Adverse Event|0
72236|NCT01294787|282009|P1|Period 3|Adverse Event|0
72237|NCT01294787|282004|P6|Period 2|No longer needs study drug|0
72238|NCT01294787|282005|P5|Period 2|No longer needs study drug|0
72239|NCT01294787|282006|P4|Period 2|No longer needs study drug|1
72240|NCT01294787|282007|P3|Period 2|No longer needs study drug|0
72241|NCT01294787|282008|P2|Period 2|No longer needs study drug|0
72242|NCT01294787|282009|P1|Period 2|No longer needs study drug|0
72243|NCT01294787|282004|P6|Period 2|Adverse Event|0
72244|NCT01294787|282005|P5|Period 2|Adverse Event|0
72245|NCT01294787|282006|P4|Period 2|Adverse Event|1
72246|NCT01294787|282007|P3|Period 2|Adverse Event|0
72247|NCT01294787|282008|P2|Period 2|Adverse Event|3
72248|NCT01294787|282009|P1|Period 2|Adverse Event|0
72249|NCT01294787|282004|P6|Period 1|Administrative problem|1
72250|NCT01294787|282005|P5|Period 1|Administrative problem|0
72251|NCT01294787|282006|P4|Period 1|Administrative problem|0
72252|NCT01294787|282007|P3|Period 1|Administrative problem|1
72253|NCT01294787|282008|P2|Period 1|Administrative problem|0
72254|NCT01294787|282009|P1|Period 1|Administrative problem|0
72255|NCT01294787|282004|P6|Period 1|Withdrawal by Subject|1
72256|NCT01294787|282005|P5|Period 1|Withdrawal by Subject|1
72257|NCT01294787|282006|P4|Period 1|Withdrawal by Subject|1
72258|NCT01294787|282007|P3|Period 1|Withdrawal by Subject|0
72259|NCT01294787|282008|P2|Period 1|Withdrawal by Subject|0
72260|NCT01294787|282009|P1|Period 1|Withdrawal by Subject|0
72261|NCT01294787|282004|P6|Period 1|Adverse Event|0
72262|NCT01294787|282005|P5|Period 1|Adverse Event|1
72263|NCT01294787|282006|P4|Period 1|Adverse Event|0
72264|NCT01294787|282007|P3|Period 1|Adverse Event|0
72265|NCT01294787|282008|P2|Period 1|Adverse Event|0
72266|NCT01294787|282009|P1|Period 1|Adverse Event|0
72267|NCT01294696|282100|P1|Overall Study|Site closure|52
72268|NCT01294696|282100|P1|Overall Study|Missing BPI Response|7
72269|NCT01294696|282100|P1|Overall Study|Protocol Violation|8
72270|NCT01294696|282100|P1|Overall Study|Screening failures|7
72271|NCT01294683|282114|P2|Post Crossover (Period III)|Withdrawal by Subject|2
72272|NCT01294683|282115|P1|Post Crossover (Period III)|Withdrawal by Subject|3
72273|NCT01294683|282114|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
72274|NCT01294683|282115|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
72275|NCT01294683|282114|P2|Post Crossover (Period III)|Lost to Follow-up|3
72276|NCT01294683|282115|P1|Post Crossover (Period III)|Lost to Follow-up|1
72277|NCT01294683|282114|P2|Post Crossover (Period III)|Adverse Event|6
72278|NCT01294683|282115|P1|Post Crossover (Period III)|Adverse Event|6
72279|NCT01294683|282114|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
72280|NCT01294683|282115|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
72281|NCT01294683|282114|P2|Precrossover (Periods I/II)|Technical Problems|1
72282|NCT01294683|282115|P1|Precrossover (Periods I/II)|Technical Problems|0
72283|NCT01294683|282114|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
72284|NCT01294683|282115|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
72285|NCT01294683|282114|P2|Precrossover (Periods I/II)|Protocol Violation|5
72286|NCT01294683|282115|P1|Precrossover (Periods I/II)|Protocol Violation|5
72287|NCT01294683|282114|P2|Precrossover (Periods I/II)|Physician Decision|0
72288|NCT01294683|282115|P1|Precrossover (Periods I/II)|Physician Decision|1
72289|NCT01294683|282114|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
72290|NCT01294683|282115|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
72291|NCT01294683|282114|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
72292|NCT01294683|282115|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
72293|NCT01294683|282114|P2|Precrossover (Periods I/II)|Adverse Event|52
72294|NCT01294683|282115|P1|Precrossover (Periods I/II)|Adverse Event|49
72295|NCT01294644|282168|P3|Overall Study|Miscellaneous Reason|4
72296|NCT01294644|282169|P2|Overall Study|Miscellaneous Reason|1
72297|NCT01294644|282170|P1|Overall Study|Miscellaneous Reason|2
72298|NCT01294644|282168|P3|Overall Study|Lost to Follow-up|5
72299|NCT01294644|282169|P2|Overall Study|Lost to Follow-up|2
72300|NCT01294644|282170|P1|Overall Study|Lost to Follow-up|3
72301|NCT01294644|282168|P3|Overall Study|Withdrawal by Subject|4
72302|NCT01294644|282169|P2|Overall Study|Withdrawal by Subject|7
72303|NCT01294644|282170|P1|Overall Study|Withdrawal by Subject|3
72304|NCT01294644|282168|P3|Overall Study|Adverse Event|1
72305|NCT01294644|282169|P2|Overall Study|Adverse Event|0
72306|NCT01294644|282170|P1|Overall Study|Adverse Event|2
72307|NCT01294592|282201|P2|Overall Study|Withdrawal by Subject|28
72308|NCT01294592|282202|P1|Overall Study|Withdrawal by Subject|28
72309|NCT01294592|282201|P2|Overall Study|Physician Decision|11
72310|NCT01294592|282202|P1|Overall Study|Physician Decision|6
72311|NCT01294592|282201|P2|Overall Study|Lost to Follow-up|9
72312|NCT01294592|282202|P1|Overall Study|Lost to Follow-up|7
72313|NCT01294592|282201|P2|Overall Study|Protocol Violation|7
72314|NCT01294592|282202|P1|Overall Study|Protocol Violation|1
72315|NCT01294592|282201|P2|Overall Study|Lack of Efficacy|5
72316|NCT01294592|282202|P1|Overall Study|Lack of Efficacy|7
72317|NCT01294592|282201|P2|Overall Study|Adverse Event|13
72318|NCT01294592|282202|P1|Overall Study|Adverse Event|28
72319|NCT01294553|282230|P1|Overall Study|Protocol Violation|268
72320|NCT01294553|282230|P1|Overall Study|Duplicated Participants|1
72321|NCT01294514|282236|P1|Overall Study|Excluded due to Arrhythmia|1
72322|NCT01294462|282246|P2|Overall Study|Withdrawal by Subject|63
72323|NCT01294462|282247|P1|Overall Study|Withdrawal by Subject|65
72324|NCT01294462|282246|P2|Overall Study|Lost to Follow-up|0
72325|NCT01294462|282247|P1|Overall Study|Lost to Follow-up|1
72326|NCT01294449|282261|P2|Overall Study|Withdrawal by Subject|3
72327|NCT01294449|282262|P1|Overall Study|Withdrawal by Subject|1
72328|NCT01294449|282261|P2|Overall Study|Death|12
72329|NCT01294449|282262|P1|Overall Study|Death|11
72330|NCT01294436|282270|P2|Overall Study|poor/non-compliance|5
72331|NCT01294436|282271|P1|Overall Study|poor/non-compliance|2
72332|NCT01294436|282270|P2|Overall Study|subject no longer meets study criteria|20
72333|NCT01294436|282271|P1|Overall Study|subject no longer meets study criteria|5
72334|NCT01294436|282270|P2|Overall Study|Withdrawal by Subject|28
72335|NCT01294436|282271|P1|Overall Study|Withdrawal by Subject|11
72336|NCT01294436|282270|P2|Overall Study|Adverse Event|17
72337|NCT01294436|282271|P1|Overall Study|Adverse Event|10
72338|NCT01294423|282306|P3|Overall Study|poor/non-compliance|1
72339|NCT01294423|282307|P2|Overall Study|poor/non-compliance|0
72340|NCT01294423|282308|P1|Overall Study|poor/non-compliance|1
72341|NCT01294423|282306|P3|Overall Study|subject no longer meets study criteria|2
72342|NCT01294423|282307|P2|Overall Study|subject no longer meets study criteria|5
72343|NCT01294423|282308|P1|Overall Study|subject no longer meets study criteria|2
72344|NCT01294423|282306|P3|Overall Study|Withdrawal by Subject|2
72345|NCT01294423|282307|P2|Overall Study|Withdrawal by Subject|2
72346|NCT01294423|282308|P1|Overall Study|Withdrawal by Subject|1
72347|NCT01294423|282306|P3|Overall Study|Adverse Event|3
72348|NCT01294423|282307|P2|Overall Study|Adverse Event|2
72349|NCT01294423|282308|P1|Overall Study|Adverse Event|1
72350|NCT01294397|282322|P1|Overall Study|Administrative Decision|1
72351|NCT01294397|282322|P1|Overall Study|Withdrawal by Subject|1
72352|NCT01294371|282366|P1|Overall Study|Other|14
72353|NCT01294371|282366|P1|Overall Study|Administrative Reason|1
72354|NCT01294371|282366|P1|Overall Study|Lost to Follow-up|6
72355|NCT01294371|282366|P1|Overall Study|Withdrawal by Subject|12
72356|NCT01294371|282366|P1|Overall Study|Adverse Event|1
72357|NCT01294150|282448|P2|Overall Study|Physician Decision|2
72358|NCT01294150|282449|P1|Overall Study|Physician Decision|2
72359|NCT01294046|282478|P1|Overall Study|Stimulation response inadqequate|1
72360|NCT01294046|282478|P1|Overall Study|Eligibility criteria expanded|1
72361|NCT01294046|282478|P1|Overall Study|Infection and surgical explant|1
72362|NCT01293968|282493|P2|Overall Study|non-cooperation|3
72363|NCT01293968|282494|P1|Overall Study|non-cooperation|3
72364|NCT01293695|282514|P2|Overall Study|Lost to Follow-up|6
72365|NCT01293695|282515|P1|Overall Study|Lost to Follow-up|8
72366|NCT01293695|282514|P2|Overall Study|Withdrawal by Subject|1
72367|NCT01293695|282515|P1|Overall Study|Withdrawal by Subject|7
72368|NCT01293539|282529|P1|Overall Study|Physician Decision|1
72369|NCT01293240|282533|P1|Overall Study|Noncompliance|2
72370|NCT01293084|282548|P1|Overall Study|Withdrawal by Subject|2
72371|NCT01293084|282548|P1|Overall Study|Physician Decision|3
72372|NCT01293032|282560|P4|Treatment|Disease Progression, relapse|0
72373|NCT01293032|282561|P3|Treatment|Disease Progression, relapse|0
72374|NCT01293032|282562|P2|Treatment|Disease Progression, relapse|1
72375|NCT01293032|282563|P1|Treatment|Disease Progression, relapse|0
72376|NCT01293032|282560|P4|Treatment|Withdrawal by Subject|0
72377|NCT01293032|282561|P3|Treatment|Withdrawal by Subject|0
72378|NCT01293032|282562|P2|Treatment|Withdrawal by Subject|4
72379|NCT01293032|282563|P1|Treatment|Withdrawal by Subject|2
72380|NCT01293032|282560|P4|Treatment|Adverse Event|1
72381|NCT01293032|282561|P3|Treatment|Adverse Event|1
72382|NCT01293032|282562|P2|Treatment|Adverse Event|0
72383|NCT01293032|282563|P1|Treatment|Adverse Event|0
72384|NCT01293032|282560|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
72385|NCT01293032|282561|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
72386|NCT01293032|282562|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
72387|NCT01293032|282563|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
72388|NCT01293006|282574|P4|Period 2|Lost to Follow-up|0
72389|NCT01293006|282575|P3|Period 2|Lost to Follow-up|0
72390|NCT01293006|282576|P2|Period 2|Lost to Follow-up|0
72391|NCT01293006|282577|P1|Period 2|Lost to Follow-up|1
72392|NCT01292928|282598|P1|Overall Study|Physician Decision|2
72393|NCT01292928|282598|P1|Overall Study|Lost to Follow-up|6
72394|NCT01292928|282598|P1|Overall Study|Withdrawal by Subject|8
72395|NCT01292928|282598|P1|Overall Study|Death|8
72396|NCT01292876|282615|P1|Overall Study|Physician Decision|4
72397|NCT01292837|282621|P1|Overall Study|Further treatment determined|1
72398|NCT01292837|282621|P1|Overall Study|Adverse Event|1
72554|NCT01292473|282733|P1|Overall Study|Adverse Event|1
72399|NCT01292603|282658|P6|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
72400|NCT01292603|282659|P5|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
72401|NCT01292603|282660|P4|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
72402|NCT01292603|282661|P3|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
72403|NCT01292603|282662|P2|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
72404|NCT01292603|282663|P1|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
72405|NCT01292603|282658|P6|Part 2: Survival Follow-UP|Death|3
72406|NCT01292603|282659|P5|Part 2: Survival Follow-UP|Death|1
72407|NCT01292603|282660|P4|Part 2: Survival Follow-UP|Death|0
72408|NCT01292603|282661|P3|Part 2: Survival Follow-UP|Death|0
72409|NCT01292603|282662|P2|Part 2: Survival Follow-UP|Death|0
72410|NCT01292603|282663|P1|Part 2: Survival Follow-UP|Death|0
72411|NCT01292603|282658|P6|Part 2: Regular Follow-Up|Noncompliance|0
72412|NCT01292603|282659|P5|Part 2: Regular Follow-Up|Noncompliance|1
72413|NCT01292603|282660|P4|Part 2: Regular Follow-Up|Noncompliance|0
72414|NCT01292603|282661|P3|Part 2: Regular Follow-Up|Noncompliance|0
72415|NCT01292603|282662|P2|Part 2: Regular Follow-Up|Noncompliance|0
72416|NCT01292603|282663|P1|Part 2: Regular Follow-Up|Noncompliance|0
72417|NCT01292603|282658|P6|Part 2: Regular Follow-Up|Disease Progression|4
72418|NCT01292603|282659|P5|Part 2: Regular Follow-Up|Disease Progression|2
72419|NCT01292603|282660|P4|Part 2: Regular Follow-Up|Disease Progression|0
72420|NCT01292603|282661|P3|Part 2: Regular Follow-Up|Disease Progression|0
72421|NCT01292603|282662|P2|Part 2: Regular Follow-Up|Disease Progression|0
72422|NCT01292603|282663|P1|Part 2: Regular Follow-Up|Disease Progression|0
72423|NCT01292603|282658|P6|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|72
72424|NCT01292603|282659|P5|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|73
72425|NCT01292603|282660|P4|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
72426|NCT01292603|282661|P3|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
72427|NCT01292603|282662|P2|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
72428|NCT01292603|282663|P1|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
72429|NCT01292603|282658|P6|Part 2: Regular Follow-Up|Death|2
72430|NCT01292603|282659|P5|Part 2: Regular Follow-Up|Death|2
72431|NCT01292603|282660|P4|Part 2: Regular Follow-Up|Death|0
72432|NCT01292603|282661|P3|Part 2: Regular Follow-Up|Death|0
72433|NCT01292603|282662|P2|Part 2: Regular Follow-Up|Death|0
72434|NCT01292603|282663|P1|Part 2: Regular Follow-Up|Death|0
72435|NCT01292603|282658|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
72436|NCT01292603|282659|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
72437|NCT01292603|282660|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
72438|NCT01292603|282661|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
72439|NCT01292603|282662|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
72440|NCT01292603|282663|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
72441|NCT01292603|282658|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
72442|NCT01292603|282659|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
72443|NCT01292603|282660|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
72444|NCT01292603|282661|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
72445|NCT01292603|282662|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
72446|NCT01292603|282663|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
72447|NCT01292603|282658|P6|Part 2: Dose Confirmation Period|Adverse Event|9
72448|NCT01292603|282659|P5|Part 2: Dose Confirmation Period|Adverse Event|7
72449|NCT01292603|282660|P4|Part 2: Dose Confirmation Period|Adverse Event|0
72450|NCT01292603|282661|P3|Part 2: Dose Confirmation Period|Adverse Event|0
72451|NCT01292603|282662|P2|Part 2: Dose Confirmation Period|Adverse Event|0
72452|NCT01292603|282663|P1|Part 2: Dose Confirmation Period|Adverse Event|0
72453|NCT01292603|282658|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
72454|NCT01292603|282659|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
72455|NCT01292603|282660|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
72456|NCT01292603|282661|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
72457|NCT01292603|282662|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
72458|NCT01292603|282663|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
72459|NCT01292603|282658|P6|Part 2: Dose Confirmation Period|Physician Decision|0
72460|NCT01292603|282659|P5|Part 2: Dose Confirmation Period|Physician Decision|2
72461|NCT01292603|282660|P4|Part 2: Dose Confirmation Period|Physician Decision|0
72462|NCT01292603|282661|P3|Part 2: Dose Confirmation Period|Physician Decision|0
72463|NCT01292603|282662|P2|Part 2: Dose Confirmation Period|Physician Decision|0
72464|NCT01292603|282663|P1|Part 2: Dose Confirmation Period|Physician Decision|0
72465|NCT01292603|282658|P6|Part 2: Dose Confirmation Period|Death|0
72466|NCT01292603|282659|P5|Part 2: Dose Confirmation Period|Death|1
72467|NCT01292603|282660|P4|Part 2: Dose Confirmation Period|Death|0
72468|NCT01292603|282661|P3|Part 2: Dose Confirmation Period|Death|0
72469|NCT01292603|282662|P2|Part 2: Dose Confirmation Period|Death|0
72470|NCT01292603|282663|P1|Part 2: Dose Confirmation Period|Death|0
72471|NCT01292603|282658|P6|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
72472|NCT01292603|282659|P5|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
72473|NCT01292603|282660|P4|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
72474|NCT01292603|282661|P3|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|1
72475|NCT01292603|282662|P2|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|2
72476|NCT01292603|282663|P1|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|3
72477|NCT01292603|282658|P6|Part 1: Survival Follow-Up|Death|0
72478|NCT01292603|282659|P5|Part 1: Survival Follow-Up|Death|0
72479|NCT01292603|282660|P4|Part 1: Survival Follow-Up|Death|0
72480|NCT01292603|282661|P3|Part 1: Survival Follow-Up|Death|1
72481|NCT01292603|282662|P2|Part 1: Survival Follow-Up|Death|0
72482|NCT01292603|282663|P1|Part 1: Survival Follow-Up|Death|1
72483|NCT01292603|282658|P6|Part 1: Regular Follow-Up Period|Adverse Event|0
72484|NCT01292603|282659|P5|Part 1: Regular Follow-Up Period|Adverse Event|0
72485|NCT01292603|282660|P4|Part 1: Regular Follow-Up Period|Adverse Event|0
72486|NCT01292603|282661|P3|Part 1: Regular Follow-Up Period|Adverse Event|0
72487|NCT01292603|282662|P2|Part 1: Regular Follow-Up Period|Adverse Event|0
72488|NCT01292603|282663|P1|Part 1: Regular Follow-Up Period|Adverse Event|1
72489|NCT01292603|282658|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
72490|NCT01292603|282659|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
72491|NCT01292603|282660|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
72492|NCT01292603|282661|P3|Part 1: Regular Follow-Up Period|Disease Progression|2
72493|NCT01292603|282662|P2|Part 1: Regular Follow-Up Period|Disease Progression|2
72494|NCT01292603|282663|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
72495|NCT01292603|282658|P6|Part 1: Regular Follow-Up Period|Death|0
72496|NCT01292603|282659|P5|Part 1: Regular Follow-Up Period|Death|0
72497|NCT01292603|282660|P4|Part 1: Regular Follow-Up Period|Death|0
72498|NCT01292603|282661|P3|Part 1: Regular Follow-Up Period|Death|2
72499|NCT01292603|282662|P2|Part 1: Regular Follow-Up Period|Death|0
72500|NCT01292603|282663|P1|Part 1: Regular Follow-Up Period|Death|1
72501|NCT01292603|282658|P6|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
72502|NCT01292603|282659|P5|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
72503|NCT01292603|282660|P4|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
72504|NCT01292603|282661|P3|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|19
72505|NCT01292603|282662|P2|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|15
72506|NCT01292603|282663|P1|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|11
72507|NCT01292603|282658|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
72508|NCT01292603|282659|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
72509|NCT01292603|282660|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
72510|NCT01292603|282661|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
72511|NCT01292603|282662|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
72512|NCT01292603|282663|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
72513|NCT01292603|282658|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
72514|NCT01292603|282659|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
72515|NCT01292603|282660|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
72516|NCT01292603|282661|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
72517|NCT01292603|282662|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
72518|NCT01292603|282663|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
72519|NCT01292603|282658|P6|Part 1: Pilot Dose Selection Period|Death|0
72520|NCT01292603|282659|P5|Part 1: Pilot Dose Selection Period|Death|0
72521|NCT01292603|282660|P4|Part 1: Pilot Dose Selection Period|Death|1
72522|NCT01292603|282661|P3|Part 1: Pilot Dose Selection Period|Death|0
72523|NCT01292603|282662|P2|Part 1: Pilot Dose Selection Period|Death|0
72524|NCT01292603|282663|P1|Part 1: Pilot Dose Selection Period|Death|0
72525|NCT01292603|282658|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
72526|NCT01292603|282659|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
72527|NCT01292603|282660|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
72528|NCT01292603|282661|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
72529|NCT01292603|282662|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
72530|NCT01292603|282663|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
72531|NCT01292486|282716|P1|Overall Study|Physician Decision|1
72532|NCT01292486|282716|P1|Overall Study|Adverse Event|1
72533|NCT01292486|282716|P1|Overall Study|Did not meet screening criteria|2
72534|NCT01292486|282716|P1|Overall Study|Protocol Violation|2
72535|NCT01292473|282730|P4|Overall Study|Disease Progression|6
72536|NCT01292473|282731|P3|Overall Study|Disease Progression|3
72537|NCT01292473|282732|P2|Overall Study|Disease Progression|1
72538|NCT01292473|282733|P1|Overall Study|Disease Progression|0
72539|NCT01292473|282730|P4|Overall Study|Physician Decision|0
72540|NCT01292473|282731|P3|Overall Study|Physician Decision|0
72541|NCT01292473|282732|P2|Overall Study|Physician Decision|1
72542|NCT01292473|282733|P1|Overall Study|Physician Decision|0
72543|NCT01292473|282730|P4|Overall Study|Withdrawal by Subject|3
72544|NCT01292473|282731|P3|Overall Study|Withdrawal by Subject|3
72545|NCT01292473|282732|P2|Overall Study|Withdrawal by Subject|4
72546|NCT01292473|282733|P1|Overall Study|Withdrawal by Subject|3
72547|NCT01292473|282730|P4|Overall Study|Lost to Follow-up|2
72548|NCT01292473|282731|P3|Overall Study|Lost to Follow-up|2
72549|NCT01292473|282732|P2|Overall Study|Lost to Follow-up|1
72550|NCT01292473|282733|P1|Overall Study|Lost to Follow-up|1
72551|NCT01292473|282730|P4|Overall Study|Adverse Event|1
72552|NCT01292473|282731|P3|Overall Study|Adverse Event|1
72553|NCT01292473|282732|P2|Overall Study|Adverse Event|0
72555|NCT01292239|282792|P2|Overall Study|Withdrawal by Subject|6
72556|NCT01292239|282793|P1|Overall Study|Withdrawal by Subject|3
72557|NCT01292239|282792|P2|Overall Study|Not specified|1
72558|NCT01292239|282793|P1|Overall Study|Not specified|1
72559|NCT01292226|282814|P1|Overall Study|Not specified|2
72560|NCT01292226|282814|P1|Overall Study|Withdrawal by Subject|1
72561|NCT01292226|282814|P1|Overall Study|Protocol Violation|3
72562|NCT01292226|282814|P1|Overall Study|Graft loss|1
72563|NCT01292226|282814|P1|Overall Study|Death|1
72564|NCT01292226|282814|P1|Overall Study|Adverse Event|5
72565|NCT01292187|282847|P2|Overall Study|All other reasons|3
72566|NCT01292187|282848|P1|Overall Study|All other reasons|1
72567|NCT01292187|282847|P2|Overall Study|Withdrawal by Subject|5
72568|NCT01292187|282848|P1|Overall Study|Withdrawal by Subject|6
72569|NCT01292187|282847|P2|Overall Study|Adverse Event|5
72570|NCT01292187|282848|P1|Overall Study|Adverse Event|10
72571|NCT01292057|282883|P2|Overall Study|Lost to Follow-up|1
72572|NCT01292057|282884|P1|Overall Study|Lost to Follow-up|1
72573|NCT01292057|282883|P2|Overall Study|Protocol Violation|1
72574|NCT01292057|282884|P1|Overall Study|Protocol Violation|1
72575|NCT01291277|282956|P2|Overall Study|Lost to Follow-up|1
72576|NCT01291277|282957|P1|Overall Study|Lost to Follow-up|3
72577|NCT01291277|282956|P2|Overall Study|Death|2
72578|NCT01291277|282957|P1|Overall Study|Death|2
72579|NCT01291225|282969|P2|Overall Study|Lost to Follow-up|39
72580|NCT01291225|282970|P1|Overall Study|Lost to Follow-up|85
72581|NCT01291173|282984|P4|Overall Study|Excluded therapy|0
72582|NCT01291173|282985|P3|Overall Study|Excluded therapy|1
72583|NCT01291173|282986|P2|Overall Study|Excluded therapy|0
72584|NCT01291173|282987|P1|Overall Study|Excluded therapy|0
72585|NCT01291173|282984|P4|Overall Study|Subject was unblinded|0
72586|NCT01291173|282985|P3|Overall Study|Subject was unblinded|1
72587|NCT01291173|282986|P2|Overall Study|Subject was unblinded|0
72588|NCT01291173|282987|P1|Overall Study|Subject was unblinded|0
72589|NCT01291173|282984|P4|Overall Study|Lack of compliance|1
72590|NCT01291173|282985|P3|Overall Study|Lack of compliance|0
72591|NCT01291173|282986|P2|Overall Study|Lack of compliance|0
72592|NCT01291173|282987|P1|Overall Study|Lack of compliance|0
72593|NCT01291173|282984|P4|Overall Study|Unable to meet visit schedule|0
72594|NCT01291173|282985|P3|Overall Study|Unable to meet visit schedule|1
72595|NCT01291173|282986|P2|Overall Study|Unable to meet visit schedule|0
72596|NCT01291173|282987|P1|Overall Study|Unable to meet visit schedule|0
72597|NCT01291173|282984|P4|Overall Study|Lost to Follow-up|2
72598|NCT01291173|282985|P3|Overall Study|Lost to Follow-up|3
72599|NCT01291173|282986|P2|Overall Study|Lost to Follow-up|6
72600|NCT01291173|282987|P1|Overall Study|Lost to Follow-up|4
72601|NCT01291173|282984|P4|Overall Study|Withdrawal by Subject|2
72602|NCT01291173|282985|P3|Overall Study|Withdrawal by Subject|4
72603|NCT01291173|282986|P2|Overall Study|Withdrawal by Subject|4
72604|NCT01291173|282987|P1|Overall Study|Withdrawal by Subject|6
72605|NCT01291173|282984|P4|Overall Study|Protocol Violation|5
72606|NCT01291173|282985|P3|Overall Study|Protocol Violation|2
72607|NCT01291173|282986|P2|Overall Study|Protocol Violation|2
72608|NCT01291173|282987|P1|Overall Study|Protocol Violation|7
72609|NCT01291173|282984|P4|Overall Study|Adverse Event|3
72610|NCT01291173|282985|P3|Overall Study|Adverse Event|1
72611|NCT01291173|282986|P2|Overall Study|Adverse Event|3
72612|NCT01291173|282987|P1|Overall Study|Adverse Event|0
72613|NCT01291017|283096|P1|Overall Study|Withdrawal by Subject|3
72614|NCT01291017|283096|P1|Overall Study|Lost to Follow-up|2
72615|NCT01290887|283129|P2|Overall Study|Not specified|6
72616|NCT01290887|283130|P1|Overall Study|Not specified|3
72617|NCT01290887|283129|P2|Overall Study|Sponsor closure of study|476
72618|NCT01290887|283130|P1|Overall Study|Sponsor closure of study|420
72619|NCT01290887|283129|P2|Overall Study|Non-compliance to study medications|0
72620|NCT01290887|283130|P1|Overall Study|Non-compliance to study medications|1
72621|NCT01290887|283129|P2|Overall Study|Non-compliance to study procedures|1
72622|NCT01290887|283130|P1|Overall Study|Non-compliance to study procedures|0
72623|NCT01290887|283129|P2|Overall Study|Lost to Follow-up|4
72624|NCT01290887|283130|P1|Overall Study|Lost to Follow-up|4
72625|NCT01290887|283129|P2|Overall Study|Protocol Violation|1
72626|NCT01290887|283130|P1|Overall Study|Protocol Violation|2
72627|NCT01290887|283129|P2|Overall Study|Withdrawal by Subject|32
72628|NCT01290887|283130|P1|Overall Study|Withdrawal by Subject|26
72629|NCT01290887|283129|P2|Overall Study|Lack of Efficacy|5
72630|NCT01290887|283130|P1|Overall Study|Lack of Efficacy|4
72631|NCT01290887|283129|P2|Overall Study|Adverse Event|11
72632|NCT01290887|283130|P1|Overall Study|Adverse Event|6
72633|NCT01290822|283191|P1|Overall Study|Physician Decision|10
72634|NCT01290822|283191|P1|Overall Study|Withdrawal by Subject|1
72635|NCT01290796|283200|P1|Overall Study|Withdrawal by Sponsor|1
72636|NCT01290796|283200|P1|Overall Study|Secondary Surgical Intervention|2
72637|NCT01290796|283200|P1|Overall Study|Physician Decision|2
72638|NCT01290796|283200|P1|Overall Study|Withdrawal by Subject|4
72639|NCT01290796|283200|P1|Overall Study|Lost to Follow-up|21
72640|NCT01290757|283216|P2|Overall Study|Other|1
72641|NCT01290757|283217|P1|Overall Study|Other|0
72642|NCT01290757|283216|P2|Overall Study|Protocol Violation|1
72643|NCT01290757|283217|P1|Overall Study|Protocol Violation|1
72644|NCT01290757|283216|P2|Overall Study|Adverse Event|0
72645|NCT01290757|283217|P1|Overall Study|Adverse Event|1
72646|NCT01290731|283233|P1|Overall Study|Withdrawal by Subject|1
72647|NCT01290718|283245|P1|Overall Study|Early termination of the study|4
72648|NCT01290679|283254|P2|Overall Study|Subject Entered Another Trial|5
72649|NCT01290679|283255|P1|Overall Study|Subject Entered Another Trial|0
72650|NCT01290679|283254|P2|Overall Study|Withdrawal by Subject|5
72651|NCT01290679|283255|P1|Overall Study|Withdrawal by Subject|6
72652|NCT01290679|283254|P2|Overall Study|Protocol Violation|1
72653|NCT01290679|283255|P1|Overall Study|Protocol Violation|0
72654|NCT01290679|283254|P2|Overall Study|Lost to Follow-up|10
72655|NCT01290679|283255|P1|Overall Study|Lost to Follow-up|8
72656|NCT01290679|283254|P2|Overall Study|Adverse Event|0
72657|NCT01290679|283255|P1|Overall Study|Adverse Event|2
72658|NCT01290666|283324|P1|Overall Study|Early Termination of Study|4
72659|NCT01290666|283324|P1|Overall Study|Withdrawal by Subject|23
72660|NCT01290666|283324|P1|Overall Study|Lost to Follow-up|11
72661|NCT01290601|283377|P4|Overall Study|Protocol Violation|0
72662|NCT01290601|283378|P3|Overall Study|Protocol Violation|0
72663|NCT01290601|283379|P2|Overall Study|Protocol Violation|0
72664|NCT01290601|283380|P1|Overall Study|Protocol Violation|1
72665|NCT01290601|283377|P4|Overall Study|Other|0
72666|NCT01290601|283378|P3|Overall Study|Other|0
72667|NCT01290601|283379|P2|Overall Study|Other|0
72668|NCT01290601|283380|P1|Overall Study|Other|1
72669|NCT01290601|283377|P4|Overall Study|Lost to Follow-up|0
72670|NCT01290601|283378|P3|Overall Study|Lost to Follow-up|0
72671|NCT01290601|283379|P2|Overall Study|Lost to Follow-up|2
72672|NCT01290601|283380|P1|Overall Study|Lost to Follow-up|7
72673|NCT01290601|283377|P4|Overall Study|Lack of Efficacy|0
72674|NCT01290601|283378|P3|Overall Study|Lack of Efficacy|0
72675|NCT01290601|283379|P2|Overall Study|Lack of Efficacy|1
72676|NCT01290601|283380|P1|Overall Study|Lack of Efficacy|2
72677|NCT01290601|283377|P4|Overall Study|Adverse Event|0
72678|NCT01290601|283378|P3|Overall Study|Adverse Event|0
72679|NCT01290601|283379|P2|Overall Study|Adverse Event|2
72680|NCT01290601|283380|P1|Overall Study|Adverse Event|0
72681|NCT01290341|283412|P2|Overall Study|Negative baseline culture and others|11
72682|NCT01290341|283413|P1|Overall Study|Negative baseline culture and others|44
72683|NCT01290341|283412|P2|Overall Study|Withdrawal by Subject|5
72684|NCT01290341|283413|P1|Overall Study|Withdrawal by Subject|19
72685|NCT01290341|283412|P2|Overall Study|Lost to Follow-up|10
72686|NCT01290341|283413|P1|Overall Study|Lost to Follow-up|21
72687|NCT01290341|283412|P2|Overall Study|Adverse Event|0
72688|NCT01290341|283413|P1|Overall Study|Adverse Event|1
72689|NCT01290341|283412|P2|Overall Study|Protocol Violation|3
72690|NCT01290341|283413|P1|Overall Study|Protocol Violation|7
72691|NCT01290315|283425|P4|Overall Study|Withdrawal by Subject|0
72692|NCT01290315|283426|P3|Overall Study|Withdrawal by Subject|0
72693|NCT01290315|283427|P2|Overall Study|Withdrawal by Subject|1
72694|NCT01290315|283428|P1|Overall Study|Withdrawal by Subject|1
72695|NCT01290315|283425|P4|Overall Study|Lost to Follow-up|0
72696|NCT01290315|283426|P3|Overall Study|Lost to Follow-up|0
72697|NCT01290315|283427|P2|Overall Study|Lost to Follow-up|1
72698|NCT01290315|283428|P1|Overall Study|Lost to Follow-up|0
72699|NCT01290315|283425|P4|Overall Study|Selection criteria/compliance|2
72700|NCT01290315|283426|P3|Overall Study|Selection criteria/compliance|0
72701|NCT01290315|283427|P2|Overall Study|Selection criteria/compliance|1
72702|NCT01290315|283428|P1|Overall Study|Selection criteria/compliance|2
72703|NCT01290315|283425|P4|Overall Study|Adverse Event|3
72704|NCT01290315|283426|P3|Overall Study|Adverse Event|0
72705|NCT01290315|283427|P2|Overall Study|Adverse Event|0
72706|NCT01290315|283428|P1|Overall Study|Adverse Event|0
72707|NCT01290263|283450|P5|Overall Study|Participant Non-Compliance|1
72708|NCT01290263|283451|P4|Overall Study|Participant Non-Compliance|1
72709|NCT01290263|283452|P3|Overall Study|Participant Non-Compliance|0
72710|NCT01290263|283453|P2|Overall Study|Participant Non-Compliance|0
72711|NCT01290263|283454|P1|Overall Study|Participant Non-Compliance|0
72712|NCT01290263|283450|P5|Overall Study|Withdrawal by Subject|2
72713|NCT01290263|283451|P4|Overall Study|Withdrawal by Subject|1
72714|NCT01290263|283452|P3|Overall Study|Withdrawal by Subject|0
72715|NCT01290263|283453|P2|Overall Study|Withdrawal by Subject|1
72716|NCT01290263|283454|P1|Overall Study|Withdrawal by Subject|3
72717|NCT01290263|283450|P5|Overall Study|Lack of Efficacy|33
72718|NCT01290263|283451|P4|Overall Study|Lack of Efficacy|24
72719|NCT01290263|283452|P3|Overall Study|Lack of Efficacy|7
72720|NCT01290263|283453|P2|Overall Study|Lack of Efficacy|2
72721|NCT01290263|283454|P1|Overall Study|Lack of Efficacy|8
72722|NCT01290263|283450|P5|Overall Study|Adverse Event|1
72723|NCT01290263|283451|P4|Overall Study|Adverse Event|1
72724|NCT01290263|283452|P3|Overall Study|Adverse Event|0
72725|NCT01290263|283453|P2|Overall Study|Adverse Event|0
72726|NCT01290263|283454|P1|Overall Study|Adverse Event|0
72727|NCT01290224|283481|P1|Overall Study|Refused Further Treatment|4
72728|NCT01290224|283481|P1|Overall Study|Adverse Event|1
72729|NCT01290094|283492|P1|Overall Study|Lost to Follow-up|5
72730|NCT01290094|283492|P1|Overall Study|Withdrawal by Subject|1
72731|NCT01290068|283505|P2|Overall Study|Other|1
72732|NCT01290068|283506|P1|Overall Study|Other|3
72733|NCT01290068|283505|P2|Overall Study|Withdrawal by subject prior to implant|2
72734|NCT01290068|283506|P1|Overall Study|Withdrawal by subject prior to implant|0
72735|NCT01290068|283505|P2|Overall Study|Lost to Follow-up|0
72736|NCT01290068|283506|P1|Overall Study|Lost to Follow-up|3
72737|NCT01290068|283505|P2|Overall Study|Adverse Event|3
72738|NCT01290068|283506|P1|Overall Study|Adverse Event|1
72739|NCT01290029|283518|P1|Overall Study|Other|2
72740|NCT01289990|283544|P13|Overall Study|Not treated|0
72741|NCT01289990|283545|P12|Overall Study|Not treated|2
72742|NCT01289990|283546|P11|Overall Study|Not treated|1
72743|NCT01289990|283547|P10|Overall Study|Not treated|0
72744|NCT01289990|283548|P9|Overall Study|Not treated|1
72745|NCT01289990|283549|P8|Overall Study|Not treated|0
72746|NCT01289990|283550|P7|Overall Study|Not treated|1
72747|NCT01289990|283551|P6|Overall Study|Not treated|0
72748|NCT01289990|283552|P5|Overall Study|Not treated|0
72749|NCT01289990|283553|P4|Overall Study|Not treated|0
72750|NCT01289990|283554|P3|Overall Study|Not treated|0
72751|NCT01289990|283555|P2|Overall Study|Not treated|0
72752|NCT01289990|283556|P1|Overall Study|Not treated|0
72753|NCT01289990|283544|P13|Overall Study|did not continue in extension|56
72754|NCT01289990|283545|P12|Overall Study|did not continue in extension|34
72755|NCT01289990|283546|P11|Overall Study|did not continue in extension|45
72756|NCT01289990|283547|P10|Overall Study|did not continue in extension|48
72757|NCT01289990|283548|P9|Overall Study|did not continue in extension|44
72758|NCT01289990|283549|P8|Overall Study|did not continue in extension|36
72759|NCT01289990|283550|P7|Overall Study|did not continue in extension|54
72760|NCT01289990|283551|P6|Overall Study|did not continue in extension|50
72761|NCT01289990|283552|P5|Overall Study|did not continue in extension|48
72762|NCT01289990|283553|P4|Overall Study|did not continue in extension|51
72763|NCT01289990|283554|P3|Overall Study|did not continue in extension|51
72764|NCT01289990|283555|P2|Overall Study|did not continue in extension|45
72765|NCT01289990|283556|P1|Overall Study|did not continue in extension|41
72766|NCT01289990|283544|P13|Overall Study|discontinued in preceding trial|24
72767|NCT01289990|283545|P12|Overall Study|discontinued in preceding trial|17
72768|NCT01289990|283546|P11|Overall Study|discontinued in preceding trial|17
72769|NCT01289990|283547|P10|Overall Study|discontinued in preceding trial|21
72770|NCT01289990|283548|P9|Overall Study|discontinued in preceding trial|17
72771|NCT01289990|283549|P8|Overall Study|discontinued in preceding trial|8
72772|NCT01289990|283550|P7|Overall Study|discontinued in preceding trial|18
72773|NCT01289990|283551|P6|Overall Study|discontinued in preceding trial|12
72774|NCT01289990|283552|P5|Overall Study|discontinued in preceding trial|11
72775|NCT01289990|283553|P4|Overall Study|discontinued in preceding trial|17
72776|NCT01289990|283554|P3|Overall Study|discontinued in preceding trial|41
72777|NCT01289990|283555|P2|Overall Study|discontinued in preceding trial|20
72778|NCT01289990|283556|P1|Overall Study|discontinued in preceding trial|18
72779|NCT01289990|283544|P13|Overall Study|Withdrawal by Subject|16
72780|NCT01289990|283545|P12|Overall Study|Withdrawal by Subject|13
72781|NCT01289990|283546|P11|Overall Study|Withdrawal by Subject|11
72782|NCT01289990|283547|P10|Overall Study|Withdrawal by Subject|13
72783|NCT01289990|283548|P9|Overall Study|Withdrawal by Subject|12
72784|NCT01289990|283549|P8|Overall Study|Withdrawal by Subject|9
72785|NCT01289990|283550|P7|Overall Study|Withdrawal by Subject|13
72786|NCT01289990|283551|P6|Overall Study|Withdrawal by Subject|7
72787|NCT01289990|283552|P5|Overall Study|Withdrawal by Subject|8
72788|NCT01289990|283553|P4|Overall Study|Withdrawal by Subject|13
72789|NCT01289990|283554|P3|Overall Study|Withdrawal by Subject|12
72790|NCT01289990|283555|P2|Overall Study|Withdrawal by Subject|14
72791|NCT01289990|283556|P1|Overall Study|Withdrawal by Subject|15
72792|NCT01289990|283544|P13|Overall Study|Lost to Follow-up|2
72793|NCT01289990|283545|P12|Overall Study|Lost to Follow-up|1
72794|NCT01289990|283546|P11|Overall Study|Lost to Follow-up|2
72795|NCT01289990|283547|P10|Overall Study|Lost to Follow-up|4
72796|NCT01289990|283548|P9|Overall Study|Lost to Follow-up|1
72797|NCT01289990|283549|P8|Overall Study|Lost to Follow-up|2
72798|NCT01289990|283550|P7|Overall Study|Lost to Follow-up|2
72799|NCT01289990|283551|P6|Overall Study|Lost to Follow-up|4
72800|NCT01289990|283552|P5|Overall Study|Lost to Follow-up|3
72801|NCT01289990|283553|P4|Overall Study|Lost to Follow-up|5
72802|NCT01289990|283554|P3|Overall Study|Lost to Follow-up|5
72803|NCT01289990|283555|P2|Overall Study|Lost to Follow-up|2
72804|NCT01289990|283556|P1|Overall Study|Lost to Follow-up|3
72805|NCT01289990|283544|P13|Overall Study|Death|0
72806|NCT01289990|283545|P12|Overall Study|Death|1
72807|NCT01289990|283546|P11|Overall Study|Death|0
72808|NCT01289990|283547|P10|Overall Study|Death|0
72809|NCT01289990|283548|P9|Overall Study|Death|0
72810|NCT01289990|283549|P8|Overall Study|Death|0
72811|NCT01289990|283550|P7|Overall Study|Death|0
72812|NCT01289990|283551|P6|Overall Study|Death|1
72813|NCT01289990|283552|P5|Overall Study|Death|2
72814|NCT01289990|283553|P4|Overall Study|Death|1
72815|NCT01289990|283554|P3|Overall Study|Death|0
72816|NCT01289990|283555|P2|Overall Study|Death|0
72817|NCT01289990|283556|P1|Overall Study|Death|0
72818|NCT01289847|283773|P1|Overall Study|Patient could not comply with visits|1
72819|NCT01289821|283782|P1|Survival Follow-up Period|Clinical endpoint reached|16
72820|NCT01289821|283782|P1|Survival Follow-up Period|Lost to Follow-up|1
72821|NCT01289821|283782|P1|Survival Follow-up Period|Protocol Violation|1
72822|NCT01289821|283782|P1|Safety Follow-up Period|Unspecified reason|1
72823|NCT01289821|283782|P1|Safety Follow-up Period|Protocol Violation|3
72824|NCT01289821|283782|P1|Safety Follow-up Period|Withdrawal by Subject|1
72825|NCT01289821|283782|P1|Treatment Period|Therapeutic procedure required|1
72826|NCT01289821|283782|P1|Treatment Period|Clinical Progression|2
72827|NCT01289821|283782|P1|Treatment Period|Radiological Progression|43
72828|NCT01289821|283782|P1|Treatment Period|Adverse Event|4
72829|NCT01289821|283782|P1|Treatment Period|Physician Decision|3
72830|NCT01289821|283782|P1|Treatment Period|Withdrawal by Subject|1
72831|NCT01289782|283793|P2|Overall Study|Reason not specified|2
72832|NCT01289782|283794|P1|Overall Study|Reason not specified|1
72833|NCT01289782|283793|P2|Overall Study|Sponsor's Decision|0
72834|NCT01289782|283794|P1|Overall Study|Sponsor's Decision|1
72835|NCT01289782|283793|P2|Overall Study|Withdrawal by Subject|2
72836|NCT01289782|283794|P1|Overall Study|Withdrawal by Subject|8
72837|NCT01289782|283793|P2|Overall Study|Protocol Violation|1
72838|NCT01289782|283794|P1|Overall Study|Protocol Violation|1
72839|NCT01289782|283793|P2|Overall Study|Lost to Follow-up|7
72840|NCT01289782|283794|P1|Overall Study|Lost to Follow-up|14
72841|NCT01289639|283866|P3|Overall Study|Lost to Follow-up|0
72842|NCT01289639|283867|P2|Overall Study|Lost to Follow-up|0
72843|NCT01289639|283868|P1|Overall Study|Lost to Follow-up|1
72844|NCT01289574|283894|P3|Overall Study|Subject wanted alternate treatment|0
72845|NCT01289574|283895|P2|Overall Study|Subject wanted alternate treatment|1
72846|NCT01289574|283896|P1|Overall Study|Subject wanted alternate treatment|0
72847|NCT01289574|283894|P3|Overall Study|Adverse Event|0
72848|NCT01289574|283895|P2|Overall Study|Adverse Event|1
72849|NCT01289574|283896|P1|Overall Study|Adverse Event|0
72850|NCT01289574|283894|P3|Overall Study|Withdrawal by Subject|1
72851|NCT01289574|283895|P2|Overall Study|Withdrawal by Subject|1
72852|NCT01289574|283896|P1|Overall Study|Withdrawal by Subject|1
72853|NCT01289574|283894|P3|Overall Study|Lost to Follow-up|1
72854|NCT01289574|283895|P2|Overall Study|Lost to Follow-up|0
72855|NCT01289574|283896|P1|Overall Study|Lost to Follow-up|2
72856|NCT01289574|283894|P3|Overall Study|Lack of Efficacy|1
72857|NCT01289574|283895|P2|Overall Study|Lack of Efficacy|0
72858|NCT01289574|283896|P1|Overall Study|Lack of Efficacy|4
72859|NCT01289418|283968|P1|Day 29 Survey|participants did not complete the survey|2185
72860|NCT01289418|283968|P1|Day 29 Survey|email address invalid|283
72861|NCT01289418|283968|P1|Day 8 Survey|participants did not complete the survey|1935
72862|NCT01289418|283968|P1|Day 8 Survey|email address invalid|283
72863|NCT01289210|284004|P1|Overall Study|Adverse Event|1
72864|NCT01289119|284014|P6|Overall Study|Other|0
72865|NCT01289119|284015|P5|Overall Study|Other|0
72866|NCT01289119|284016|P4|Overall Study|Other|0
72867|NCT01289119|284017|P3|Overall Study|Other|1
72868|NCT01289119|284018|P2|Overall Study|Other|0
72869|NCT01289119|284019|P1|Overall Study|Other|1
72870|NCT01289119|284014|P6|Overall Study|Lack of Efficacy|1
72871|NCT01289119|284015|P5|Overall Study|Lack of Efficacy|1
72872|NCT01289119|284016|P4|Overall Study|Lack of Efficacy|1
72873|NCT01289119|284017|P3|Overall Study|Lack of Efficacy|1
72874|NCT01289119|284018|P2|Overall Study|Lack of Efficacy|1
72875|NCT01289119|284019|P1|Overall Study|Lack of Efficacy|0
72876|NCT01289119|284014|P6|Overall Study|Pregnancy|0
72877|NCT01289119|284015|P5|Overall Study|Pregnancy|0
72878|NCT01289119|284016|P4|Overall Study|Pregnancy|0
72879|NCT01289119|284017|P3|Overall Study|Pregnancy|0
72880|NCT01289119|284018|P2|Overall Study|Pregnancy|1
72881|NCT01289119|284019|P1|Overall Study|Pregnancy|0
72882|NCT01289119|284014|P6|Overall Study|Withdrawal by Subject|1
72883|NCT01289119|284015|P5|Overall Study|Withdrawal by Subject|1
72884|NCT01289119|284016|P4|Overall Study|Withdrawal by Subject|3
72885|NCT01289119|284017|P3|Overall Study|Withdrawal by Subject|4
72886|NCT01289119|284018|P2|Overall Study|Withdrawal by Subject|2
72887|NCT01289119|284019|P1|Overall Study|Withdrawal by Subject|4
72888|NCT01289119|284014|P6|Overall Study|Lost to Follow-up|1
72889|NCT01289119|284015|P5|Overall Study|Lost to Follow-up|0
72890|NCT01289119|284016|P4|Overall Study|Lost to Follow-up|0
72891|NCT01289119|284017|P3|Overall Study|Lost to Follow-up|0
72892|NCT01289119|284018|P2|Overall Study|Lost to Follow-up|3
72893|NCT01289119|284019|P1|Overall Study|Lost to Follow-up|0
72894|NCT01289119|284014|P6|Overall Study|Major Protocol Deviation|1
72895|NCT01289119|284015|P5|Overall Study|Major Protocol Deviation|2
72896|NCT01289119|284016|P4|Overall Study|Major Protocol Deviation|0
72897|NCT01289119|284017|P3|Overall Study|Major Protocol Deviation|3
72898|NCT01289119|284018|P2|Overall Study|Major Protocol Deviation|1
72899|NCT01289119|284019|P1|Overall Study|Major Protocol Deviation|2
72900|NCT01289119|284014|P6|Overall Study|Adverse Event|0
72901|NCT01289119|284015|P5|Overall Study|Adverse Event|1
72902|NCT01289119|284016|P4|Overall Study|Adverse Event|2
72903|NCT01289119|284017|P3|Overall Study|Adverse Event|0
72904|NCT01289119|284018|P2|Overall Study|Adverse Event|1
72905|NCT01289119|284019|P1|Overall Study|Adverse Event|2
72906|NCT01289041|284140|P1|Overall Study|Death|1
72907|NCT01289041|284140|P1|Overall Study|Withdrawal by Subject|3
72908|NCT01289041|284140|P1|Overall Study|Progressive Disease|41
72909|NCT01289041|284140|P1|Overall Study|Physician Decision|1
72910|NCT01289041|284140|P1|Overall Study|Adverse Event|24
72911|NCT01289028|284152|P1|Overall Study|Missing reason for discon|1
72912|NCT01289028|284152|P1|Overall Study|Abnormal Lab Value|1
72913|NCT01289028|284152|P1|Overall Study|New Cancer Therapy|2
72914|NCT01289028|284152|P1|Overall Study|Lost to Follow-up|2
72915|NCT01289028|284152|P1|Overall Study|No longer required|2
72916|NCT01289028|284152|P1|Overall Study|Lack of Efficacy|2
72917|NCT01289028|284152|P1|Overall Study|Death|4
72918|NCT01289028|284152|P1|Overall Study|Withdrawal by Subject|6
72919|NCT01289028|284152|P1|Overall Study|Adverse Event|14
72920|NCT01289028|284152|P1|Overall Study|Progressive Disease|49
72921|NCT01289015|284166|P2|Overall Study|Negative baseline culture and others|20
72922|NCT01289015|284167|P1|Overall Study|Negative baseline culture and others|33
72923|NCT01289015|284166|P2|Overall Study|Disease progression|0
72924|NCT01289015|284167|P1|Overall Study|Disease progression|1
72925|NCT01289015|284166|P2|Overall Study|Withdrawal by Subject|8
72926|NCT01289015|284167|P1|Overall Study|Withdrawal by Subject|17
72927|NCT01289015|284166|P2|Overall Study|Lost to Follow-up|17
72928|NCT01289015|284167|P1|Overall Study|Lost to Follow-up|33
72929|NCT01289015|284166|P2|Overall Study|Adverse Event|0
72930|NCT01289015|284167|P1|Overall Study|Adverse Event|3
72931|NCT01289015|284166|P2|Overall Study|Protocol Violation|9
72932|NCT01289015|284167|P1|Overall Study|Protocol Violation|12
72933|NCT01288976|284178|P3|Overall Study|Data unavailable|7
72934|NCT01288976|284179|P2|Overall Study|Data unavailable|9
72935|NCT01288976|284180|P1|Overall Study|Data unavailable|22
72936|NCT01288976|284178|P3|Overall Study|Death|4
72937|NCT01288976|284179|P2|Overall Study|Death|6
72938|NCT01288976|284180|P1|Overall Study|Death|98
72939|NCT01288976|284178|P3|Overall Study|Withdrawal by Subject|9
72940|NCT01288976|284179|P2|Overall Study|Withdrawal by Subject|12
72941|NCT01288976|284180|P1|Overall Study|Withdrawal by Subject|58
72942|NCT01288911|284209|P2|Overall Study|Randomized but never received study drug|2
72943|NCT01288911|284210|P1|Overall Study|Randomized but never received study drug|1
72944|NCT01288911|284209|P2|Overall Study|Miscellaneous Reason|39
72945|NCT01288911|284210|P1|Overall Study|Miscellaneous Reason|23
72946|NCT01288911|284209|P2|Overall Study|Withdrawal by Subject|21
72947|NCT01288911|284210|P1|Overall Study|Withdrawal by Subject|21
72948|NCT01288911|284209|P2|Overall Study|Protocol Violation|0
72949|NCT01288911|284210|P1|Overall Study|Protocol Violation|1
72950|NCT01288911|284209|P2|Overall Study|Progressive Disease|99
72951|NCT01288911|284210|P1|Overall Study|Progressive Disease|69
72952|NCT01288911|284209|P2|Overall Study|Lost to Follow-up|2
72953|NCT01288911|284210|P1|Overall Study|Lost to Follow-up|0
72954|NCT01288911|284209|P2|Overall Study|Death|7
72955|NCT01288911|284210|P1|Overall Study|Death|10
72956|NCT01288729|284309|P2|Overall Study|Withdrawal by Subject|0
72957|NCT01288729|284310|P1|Overall Study|Withdrawal by Subject|1
72958|NCT01288612|284319|P3|Overall Study|Unable to intubate|0
72959|NCT01288612|284320|P2|Overall Study|Unable to intubate|3
72960|NCT01288612|284321|P1|Overall Study|Unable to intubate|0
72961|NCT01288612|284319|P3|Overall Study|Declined|62
72962|NCT01288612|284320|P2|Overall Study|Declined|63
72963|NCT01288612|284321|P1|Overall Study|Declined|78
72964|NCT01288612|284319|P3|Overall Study|Unable to contact|20
72965|NCT01288612|284320|P2|Overall Study|Unable to contact|16
72966|NCT01288612|284321|P1|Overall Study|Unable to contact|11
72967|NCT01288469|284370|P3|Overall Study|Exclusion criteria finally met|0
72968|NCT01288469|284371|P2|Overall Study|Exclusion criteria finally met|0
72969|NCT01288469|284372|P1|Overall Study|Exclusion criteria finally met|1
72970|NCT01288469|284370|P3|Overall Study|Consent withdrawn by subject|1
72971|NCT01288469|284371|P2|Overall Study|Consent withdrawn by subject|1
72972|NCT01288469|284372|P1|Overall Study|Consent withdrawn by subject|1
72973|NCT01288469|284370|P3|Overall Study|Participant Moved|0
72974|NCT01288469|284371|P2|Overall Study|Participant Moved|0
72975|NCT01288469|284372|P1|Overall Study|Participant Moved|1
72976|NCT01288469|284370|P3|Overall Study|Poor compliance to protocol|0
72977|NCT01288469|284371|P2|Overall Study|Poor compliance to protocol|1
72978|NCT01288469|284372|P1|Overall Study|Poor compliance to protocol|0
72979|NCT01288469|284370|P3|Overall Study|Adverse Event|1
72980|NCT01288469|284371|P2|Overall Study|Adverse Event|1
72981|NCT01288469|284372|P1|Overall Study|Adverse Event|4
72982|NCT01288443|284404|P6|Overall Study|Other than above|0
72983|NCT01288443|284405|P5|Overall Study|Other than above|1
72984|NCT01288443|284406|P4|Overall Study|Other than above|2
72985|NCT01288443|284407|P3|Overall Study|Other than above|0
72986|NCT01288443|284408|P2|Overall Study|Other than above|0
72987|NCT01288443|284409|P1|Overall Study|Other than above|0
72988|NCT01288443|284404|P6|Overall Study|Study drug auto-injector administration|1
72989|NCT01288443|284405|P5|Overall Study|Study drug auto-injector administration|1
72990|NCT01288443|284406|P4|Overall Study|Study drug auto-injector administration|0
72991|NCT01288443|284407|P3|Overall Study|Study drug auto-injector administration|0
72992|NCT01288443|284408|P2|Overall Study|Study drug auto-injector administration|0
72993|NCT01288443|284409|P1|Overall Study|Study drug auto-injector administration|0
72994|NCT01288443|284404|P6|Overall Study|Lost to Follow-up|0
72995|NCT01288443|284405|P5|Overall Study|Lost to Follow-up|0
72996|NCT01288443|284406|P4|Overall Study|Lost to Follow-up|0
72997|NCT01288443|284407|P3|Overall Study|Lost to Follow-up|0
72998|NCT01288443|284408|P2|Overall Study|Lost to Follow-up|1
72999|NCT01288443|284409|P1|Overall Study|Lost to Follow-up|0
73000|NCT01288443|284404|P6|Overall Study|Consent withdrawn by Participant|1
73001|NCT01288443|284405|P5|Overall Study|Consent withdrawn by Participant|0
73002|NCT01288443|284406|P4|Overall Study|Consent withdrawn by Participant|0
73003|NCT01288443|284407|P3|Overall Study|Consent withdrawn by Participant|0
73004|NCT01288443|284408|P2|Overall Study|Consent withdrawn by Participant|0
73005|NCT01288443|284409|P1|Overall Study|Consent withdrawn by Participant|0
73006|NCT01288443|284404|P6|Overall Study|Participant Moved|1
73007|NCT01288443|284405|P5|Overall Study|Participant Moved|2
73008|NCT01288443|284406|P4|Overall Study|Participant Moved|1
73009|NCT01288443|284407|P3|Overall Study|Participant Moved|0
73010|NCT01288443|284408|P2|Overall Study|Participant Moved|0
73011|NCT01288443|284409|P1|Overall Study|Participant Moved|0
73012|NCT01288443|284404|P6|Overall Study|Poor compliance to protocol|1
73013|NCT01288443|284405|P5|Overall Study|Poor compliance to protocol|0
73014|NCT01288443|284406|P4|Overall Study|Poor compliance to protocol|0
73015|NCT01288443|284407|P3|Overall Study|Poor compliance to protocol|0
73016|NCT01288443|284408|P2|Overall Study|Poor compliance to protocol|0
73017|NCT01288443|284409|P1|Overall Study|Poor compliance to protocol|0
73018|NCT01288443|284404|P6|Overall Study|Adverse Event|1
73019|NCT01288443|284405|P5|Overall Study|Adverse Event|3
73020|NCT01288443|284406|P4|Overall Study|Adverse Event|1
73021|NCT01288443|284407|P3|Overall Study|Adverse Event|1
73022|NCT01288443|284408|P2|Overall Study|Adverse Event|0
73023|NCT01288443|284409|P1|Overall Study|Adverse Event|0
73024|NCT01288287|284459|P1|Overall Study|Unknown Status|7
73025|NCT01288287|284459|P1|Overall Study|Unknown Reason|1
73026|NCT01288287|284459|P1|Overall Study|Other Reason|13
73027|NCT01288287|284459|P1|Overall Study|Lack of Efficacy|13
73028|NCT01288287|284459|P1|Overall Study|Withdrawal by Subject|4
73029|NCT01288287|284459|P1|Overall Study|Lost to Follow-up|8
73030|NCT01288209|284474|P2|Overall Study|Not specified|0
73031|NCT01288209|284475|P1|Overall Study|Not specified|1
73032|NCT01288209|284474|P2|Overall Study|Withdrawal by Subject|3
73033|NCT01288209|284475|P1|Overall Study|Withdrawal by Subject|1
73034|NCT01288079|284505|P4|Overall Study|Other or Study Termination|8
73035|NCT01288079|284506|P3|Overall Study|Other or Study Termination|14
73036|NCT01288079|284507|P2|Overall Study|Other or Study Termination|15
73037|NCT01288079|284508|P1|Overall Study|Other or Study Termination|11
73038|NCT01288079|284505|P4|Overall Study|Lost to Follow-up|0
73039|NCT01288079|284506|P3|Overall Study|Lost to Follow-up|1
73040|NCT01288079|284507|P2|Overall Study|Lost to Follow-up|1
73041|NCT01288079|284508|P1|Overall Study|Lost to Follow-up|1
73042|NCT01288079|284505|P4|Overall Study|Study-Specific Withdrawal Criteria|0
73043|NCT01288079|284506|P3|Overall Study|Study-Specific Withdrawal Criteria|0
73044|NCT01288079|284507|P2|Overall Study|Study-Specific Withdrawal Criteria|1
73045|NCT01288079|284508|P1|Overall Study|Study-Specific Withdrawal Criteria|1
73046|NCT01288079|284505|P4|Overall Study|Lack of Efficacy|2
73047|NCT01288079|284506|P3|Overall Study|Lack of Efficacy|0
73048|NCT01288079|284507|P2|Overall Study|Lack of Efficacy|2
73049|NCT01288079|284508|P1|Overall Study|Lack of Efficacy|2
73050|NCT01288079|284505|P4|Overall Study|Condition under Investigation Worsened|1
73051|NCT01288079|284506|P3|Overall Study|Condition under Investigation Worsened|0
73052|NCT01288079|284507|P2|Overall Study|Condition under Investigation Worsened|0
73053|NCT01288079|284508|P1|Overall Study|Condition under Investigation Worsened|0
73054|NCT01288079|284505|P4|Overall Study|Severe Non-Compliance to Protocol|3
73055|NCT01288079|284506|P3|Overall Study|Severe Non-Compliance to Protocol|1
73056|NCT01288079|284507|P2|Overall Study|Severe Non-Compliance to Protocol|3
73057|NCT01288079|284508|P1|Overall Study|Severe Non-Compliance to Protocol|1
73058|NCT01288079|284505|P4|Overall Study|Adverse Event|3
73059|NCT01288079|284506|P3|Overall Study|Adverse Event|2
73060|NCT01288079|284507|P2|Overall Study|Adverse Event|1
73061|NCT01288079|284508|P1|Overall Study|Adverse Event|2
73062|NCT01288079|284505|P4|Overall Study|Withdrawal by Subject|0
73063|NCT01288079|284506|P3|Overall Study|Withdrawal by Subject|1
73064|NCT01288079|284507|P2|Overall Study|Withdrawal by Subject|4
73065|NCT01288079|284508|P1|Overall Study|Withdrawal by Subject|2
73066|NCT01287897|284532|P4|Overall Study|Other|0
73067|NCT01287897|284533|P3|Overall Study|Other|1
73068|NCT01287897|284534|P2|Overall Study|Other|0
73069|NCT01287897|284535|P1|Overall Study|Other|1
73070|NCT01287897|284532|P4|Overall Study|Not meeting entrance criteria|0
73071|NCT01287897|284533|P3|Overall Study|Not meeting entrance criteria|0
73072|NCT01287897|284534|P2|Overall Study|Not meeting entrance criteria|1
73073|NCT01287897|284535|P1|Overall Study|Not meeting entrance criteria|1
73074|NCT01287897|284532|P4|Overall Study|Not consented properly|0
73075|NCT01287897|284533|P3|Overall Study|Not consented properly|0
73076|NCT01287897|284534|P2|Overall Study|Not consented properly|1
73077|NCT01287897|284535|P1|Overall Study|Not consented properly|0
73078|NCT01287897|284532|P4|Overall Study|Withdrawal by Subject|2
73079|NCT01287897|284533|P3|Overall Study|Withdrawal by Subject|3
73080|NCT01287897|284534|P2|Overall Study|Withdrawal by Subject|5
73081|NCT01287897|284535|P1|Overall Study|Withdrawal by Subject|1
73082|NCT01287897|284532|P4|Overall Study|Lost to Follow-up|0
73083|NCT01287897|284533|P3|Overall Study|Lost to Follow-up|2
73084|NCT01287897|284534|P2|Overall Study|Lost to Follow-up|0
73085|NCT01287897|284535|P1|Overall Study|Lost to Follow-up|0
73086|NCT01287897|284532|P4|Overall Study|Protocol Violation|1
73087|NCT01287897|284533|P3|Overall Study|Protocol Violation|0
73088|NCT01287897|284534|P2|Overall Study|Protocol Violation|1
73089|NCT01287897|284535|P1|Overall Study|Protocol Violation|1
73090|NCT01287897|284532|P4|Overall Study|Lack of Efficacy|0
73091|NCT01287897|284533|P3|Overall Study|Lack of Efficacy|0
73092|NCT01287897|284534|P2|Overall Study|Lack of Efficacy|0
73093|NCT01287897|284535|P1|Overall Study|Lack of Efficacy|2
73094|NCT01287897|284532|P4|Overall Study|Adverse Event|4
73095|NCT01287897|284533|P3|Overall Study|Adverse Event|6
73096|NCT01287897|284534|P2|Overall Study|Adverse Event|3
73097|NCT01287897|284535|P1|Overall Study|Adverse Event|5
73098|NCT01287832|284586|P2|Overall Study|Death|1
73099|NCT01287832|284587|P1|Overall Study|Death|0
73100|NCT01287832|284586|P2|Overall Study|Adverse Event|0
73101|NCT01287832|284587|P1|Overall Study|Adverse Event|1
73102|NCT01287754|284595|P2|Overall Study|Protocol Violation|3
73103|NCT01287754|284596|P1|Overall Study|Protocol Violation|0
73104|NCT01287754|284595|P2|Overall Study|Lost to Follow-up|6
73105|NCT01287754|284596|P1|Overall Study|Lost to Follow-up|1
73106|NCT01287754|284595|P2|Overall Study|Death|12
73107|NCT01287754|284596|P1|Overall Study|Death|2
73108|NCT01287741|284608|P2|Overall Study|Reason not specified|9
73109|NCT01287741|284609|P1|Overall Study|Reason not specified|14
73110|NCT01287741|284608|P2|Overall Study|Progressive disease|148
73111|NCT01287741|284609|P1|Overall Study|Progressive disease|173
73112|NCT01287741|284608|P2|Overall Study|Continued in the study|455
73113|NCT01287741|284609|P1|Overall Study|Continued in the study|446
73114|NCT01287741|284608|P2|Overall Study|Adverse Event|4
73115|NCT01287741|284609|P1|Overall Study|Adverse Event|3
73116|NCT01287741|284608|P2|Overall Study|Death|38
73117|NCT01287741|284609|P1|Overall Study|Death|31
73118|NCT01287741|284608|P2|Overall Study|Lost to Follow-up|8
73119|NCT01287741|284609|P1|Overall Study|Lost to Follow-up|5
73120|NCT01287741|284608|P2|Overall Study|Non-compliance|3
73121|NCT01287741|284609|P1|Overall Study|Non-compliance|2
73122|NCT01287741|284608|P2|Overall Study|Physician Decision|19
73123|NCT01287741|284609|P1|Overall Study|Physician Decision|12
73124|NCT01287741|284608|P2|Overall Study|Protocol Violation|0
73125|NCT01287741|284609|P1|Overall Study|Protocol Violation|1
73126|NCT01287741|284608|P2|Overall Study|Withdrawal by Subject|22
73127|NCT01287741|284609|P1|Overall Study|Withdrawal by Subject|25
73128|NCT01287611|284645|P2|Overall Study|Exclusion due to expanded Kerr incision|3
73129|NCT01287611|284646|P1|Overall Study|Exclusion due to expanded Kerr incision|4
73130|NCT01287611|284645|P2|Overall Study|Lost to Follow-up|16
73131|NCT01287611|284646|P1|Overall Study|Lost to Follow-up|29
73132|NCT01287416|284656|P2|6 Month Follow-up|Lost to Follow-up|2
73133|NCT01287416|284657|P1|6 Month Follow-up|Lost to Follow-up|3
73134|NCT01287416|284656|P2|Pre-post Training|Lost to Follow-up|1
73135|NCT01287416|284657|P1|Pre-post Training|Lost to Follow-up|5
73136|NCT01287416|284656|P2|Pre-post Training|Withdrawal by Subject|24
73137|NCT01287416|284657|P1|Pre-post Training|Withdrawal by Subject|17
73138|NCT01287403|284693|P1|1st Intervention (1 Day)|Adverse Event|1
73139|NCT01287364|284709|P2|Overall Study|Other Reason|2
73140|NCT01287364|284710|P1|Overall Study|Other Reason|4
73141|NCT01287364|284709|P2|Overall Study|Protocol Violation|5
73142|NCT01287364|284710|P1|Overall Study|Protocol Violation|5
73143|NCT01287364|284709|P2|Overall Study|Adverse Event|3
73144|NCT01287364|284710|P1|Overall Study|Adverse Event|0
73145|NCT01287221|284732|P2|Overall Study|Withdrawal by Subject|1
73146|NCT01287221|284733|P1|Overall Study|Withdrawal by Subject|0
73147|NCT01287221|284732|P2|Overall Study|Adverse Event|3
73148|NCT01287221|284733|P1|Overall Study|Adverse Event|3
73149|NCT01287221|284732|P2|Overall Study|Lack of Perceived Benefit|1
73150|NCT01287221|284733|P1|Overall Study|Lack of Perceived Benefit|1
73151|NCT01287195|284768|P1|Overall Study|Withdrawal by Subject|2
73152|NCT01287117|284783|P4|Overall Study|Disease Progression|5
73153|NCT01287117|284784|P3|Overall Study|Disease Progression|6
73154|NCT01287117|284785|P2|Overall Study|Disease Progression|5
73155|NCT01287117|284786|P1|Overall Study|Disease Progression|10
73156|NCT01287117|284783|P4|Overall Study|Patient/Legal Guardian's Decision|5
73157|NCT01287117|284784|P3|Overall Study|Patient/Legal Guardian's Decision|8
73158|NCT01287117|284785|P2|Overall Study|Patient/Legal Guardian's Decision|6
73159|NCT01287117|284786|P1|Overall Study|Patient/Legal Guardian's Decision|2
73160|NCT01287117|284783|P4|Overall Study|Physician Decision|1
73161|NCT01287117|284784|P3|Overall Study|Physician Decision|1
73162|NCT01287117|284785|P2|Overall Study|Physician Decision|1
73163|NCT01287117|284786|P1|Overall Study|Physician Decision|0
73164|NCT01287117|284783|P4|Overall Study|Lost to Follow-up|0
73165|NCT01287117|284784|P3|Overall Study|Lost to Follow-up|0
73166|NCT01287117|284785|P2|Overall Study|Lost to Follow-up|1
73167|NCT01287117|284786|P1|Overall Study|Lost to Follow-up|1
73168|NCT01287117|284783|P4|Overall Study|Adverse Event|1
73169|NCT01287117|284784|P3|Overall Study|Adverse Event|1
73170|NCT01287117|284785|P2|Overall Study|Adverse Event|1
73171|NCT01287117|284786|P1|Overall Study|Adverse Event|2
73172|NCT01287065|284832|P6|Treatment Period 1|Withdrawal by Subject|1
73173|NCT01287065|284833|P5|Treatment Period 1|Withdrawal by Subject|0
73174|NCT01287065|284834|P4|Treatment Period 1|Withdrawal by Subject|0
73175|NCT01287065|284835|P3|Treatment Period 1|Withdrawal by Subject|0
73176|NCT01287065|284836|P2|Treatment Period 1|Withdrawal by Subject|0
73177|NCT01287065|284837|P1|Treatment Period 1|Withdrawal by Subject|0
73178|NCT01287065|284832|P6|Treatment Period 1|Adverse Event|0
73179|NCT01287065|284833|P5|Treatment Period 1|Adverse Event|1
73180|NCT01287065|284834|P4|Treatment Period 1|Adverse Event|0
73181|NCT01287065|284835|P3|Treatment Period 1|Adverse Event|0
73182|NCT01287065|284836|P2|Treatment Period 1|Adverse Event|0
73183|NCT01287065|284837|P1|Treatment Period 1|Adverse Event|0
73184|NCT01287039|284856|P2|Overall Study|Lost to Follow-up|2
73185|NCT01287039|284857|P1|Overall Study|Lost to Follow-up|3
73186|NCT01287039|284856|P2|Overall Study|Withdrawal by Subject|11
73187|NCT01287039|284857|P1|Overall Study|Withdrawal by Subject|14
73188|NCT01287039|284856|P2|Overall Study|Adverse Event|4
73189|NCT01287039|284857|P1|Overall Study|Adverse Event|7
73190|NCT01287039|284856|P2|Overall Study|Change of residence|0
73191|NCT01287039|284857|P1|Overall Study|Change of residence|1
73192|NCT01287039|284856|P2|Overall Study|Death|0
73193|NCT01287039|284857|P1|Overall Study|Death|1
73194|NCT01287039|284856|P2|Overall Study|Problem with travel|1
73195|NCT01287039|284857|P1|Overall Study|Problem with travel|0
73196|NCT01287039|284856|P2|Overall Study|Noncompliance with study medication|1
73197|NCT01287039|284857|P1|Overall Study|Noncompliance with study medication|0
73198|NCT01287039|284856|P2|Overall Study|Excluded medication taken|0
73199|NCT01287039|284857|P1|Overall Study|Excluded medication taken|1
73200|NCT01287039|284856|P2|Overall Study|Protocol Violation|3
73201|NCT01287039|284857|P1|Overall Study|Protocol Violation|2
73202|NCT01287039|284856|P2|Overall Study|Elective surgery|1
73203|NCT01287039|284857|P1|Overall Study|Elective surgery|0
73204|NCT01287039|284856|P2|Overall Study|Change of location/residence|3
73205|NCT01287039|284857|P1|Overall Study|Change of location/residence|0
73206|NCT01287039|284856|P2|Overall Study|Noncompliance with study procedures|1
73207|NCT01287039|284857|P1|Overall Study|Noncompliance with study procedures|0
73208|NCT01287013|284890|P3|Overall Study|Non-evaluable|21
73209|NCT01287013|284891|P2|Overall Study|Non-evaluable|5
73210|NCT01287013|284892|P1|Overall Study|Non-evaluable|3
73211|NCT01286753|284944|P2|Overall Study|Participant to Receive Radiotherapy|0
73212|NCT01286753|284945|P1|Overall Study|Participant to Receive Radiotherapy|1
73213|NCT01286753|284944|P2|Overall Study|Discontinued to Join Extension Study|4
73214|NCT01286753|284945|P1|Overall Study|Discontinued to Join Extension Study|6
73215|NCT01286753|284944|P2|Overall Study|Withdrawal of Consent|2
73216|NCT01286753|284945|P1|Overall Study|Withdrawal of Consent|0
73217|NCT01286753|284944|P2|Overall Study|Refused Treatment|0
73218|NCT01286753|284945|P1|Overall Study|Refused Treatment|1
73219|NCT01286753|284944|P2|Overall Study|Progression|13
73220|NCT01286753|284945|P1|Overall Study|Progression|11
73221|NCT01286753|284944|P2|Overall Study|Adverse Event|6
73222|NCT01286753|284945|P1|Overall Study|Adverse Event|7
73223|NCT01286740|284963|P1|Overall Study|Protocol Violation|1
73224|NCT01286740|284963|P1|Overall Study|Enrolled but not treated|1
73225|NCT01286558|284981|P2|Overall Study|Withdrawal by Subject|1
73226|NCT01286558|284982|P1|Overall Study|Withdrawal by Subject|0
73227|NCT01286558|284981|P2|Overall Study|Adverse Event|1
73228|NCT01286558|284982|P1|Overall Study|Adverse Event|1
73229|NCT01286480|285018|P2|Overall Study|Withdrawal by Subject|3
73230|NCT01286480|285019|P1|Overall Study|Withdrawal by Subject|5
73231|NCT01286311|285105|P2|Overall Study|Physician did not want outreach sent|0
73232|NCT01286311|285106|P1|Overall Study|Physician did not want outreach sent|14
73233|NCT01286207|285123|P3|Overall Study|Other|13
73234|NCT01286207|285124|P2|Overall Study|Other|47
73235|NCT01286207|285125|P1|Overall Study|Other|37
73236|NCT01286207|285123|P3|Overall Study|Lack of Response|8
73237|NCT01286207|285124|P2|Overall Study|Lack of Response|38
73238|NCT01286207|285125|P1|Overall Study|Lack of Response|92
73239|NCT01286207|285123|P3|Overall Study|Withdrawal by Subject|41
73240|NCT01286207|285124|P2|Overall Study|Withdrawal by Subject|79
73241|NCT01286207|285125|P1|Overall Study|Withdrawal by Subject|93
73242|NCT01286207|285123|P3|Overall Study|Lost to Follow-up|20
73243|NCT01286207|285124|P2|Overall Study|Lost to Follow-up|43
73244|NCT01286207|285125|P1|Overall Study|Lost to Follow-up|49
73245|NCT01286207|285123|P3|Overall Study|Adverse Event|8
73246|NCT01286207|285124|P2|Overall Study|Adverse Event|41
73247|NCT01286207|285125|P1|Overall Study|Adverse Event|27
73248|NCT01286168|285145|P1|Overall Study|Surgical Drains Fell Out at Home|2
73249|NCT01286168|285145|P1|Overall Study|Withdrawal by Subject|1
73250|NCT01286129|285159|P2|Overall Study|Could not comply with study requirements|4
73251|NCT01286129|285160|P1|Overall Study|Could not comply with study requirements|4
73252|NCT01286129|285159|P2|Overall Study|Withdrawal by Subject|1
73253|NCT01286129|285160|P1|Overall Study|Withdrawal by Subject|4
73254|NCT01286077|285170|P2|Overall Study|refill medication not received in time|0
73255|NCT01286077|285171|P1|Overall Study|refill medication not received in time|1
73256|NCT01286077|285170|P2|Overall Study|Progression of disease|1
73257|NCT01286077|285171|P1|Overall Study|Progression of disease|0
73258|NCT01286077|285170|P2|Overall Study|Patient's decision to stop treatment|0
73259|NCT01286077|285171|P1|Overall Study|Patient's decision to stop treatment|3
73260|NCT01286077|285170|P2|Overall Study|The subject starts with alternative MMY|3
73261|NCT01286077|285171|P1|Overall Study|The subject starts with alternative MMY|0
73262|NCT01286077|285170|P2|Overall Study|Non-compliance|0
73263|NCT01286077|285171|P1|Overall Study|Non-compliance|1
73264|NCT01286077|285170|P2|Overall Study|Intercurrent illness|0
73265|NCT01286077|285171|P1|Overall Study|Intercurrent illness|1
73266|NCT01286077|285170|P2|Overall Study|Withdrawal by Subject|2
73267|NCT01286077|285171|P1|Overall Study|Withdrawal by Subject|0
73268|NCT01286077|285170|P2|Overall Study|Protocol Violation|1
73269|NCT01286077|285171|P1|Overall Study|Protocol Violation|1
73270|NCT01286077|285170|P2|Overall Study|Death|0
73271|NCT01286077|285171|P1|Overall Study|Death|1
73272|NCT01286077|285170|P2|Overall Study|Adverse Event|0
73273|NCT01286077|285171|P1|Overall Study|Adverse Event|2
73274|NCT01286012|285207|P2|Overall Study|peritoneal dialysis, randomized in error|3
73275|NCT01286012|285208|P1|Overall Study|peritoneal dialysis, randomized in error|1
73276|NCT01286012|285207|P2|Overall Study|Physician Decision|0
73277|NCT01286012|285208|P1|Overall Study|Physician Decision|2
73278|NCT01286012|285207|P2|Overall Study|Withdrawal by Subject|4
73279|NCT01286012|285208|P1|Overall Study|Withdrawal by Subject|4
73280|NCT01286012|285207|P2|Overall Study|Protocol Violation|1
73281|NCT01286012|285208|P1|Overall Study|Protocol Violation|1
73282|NCT01286012|285207|P2|Overall Study|Death|3
73283|NCT01286012|285208|P1|Overall Study|Death|2
73284|NCT01286012|285207|P2|Overall Study|Adverse Event|3
73285|NCT01286012|285208|P1|Overall Study|Adverse Event|3
73286|NCT01285908|285225|P3|Baseline Measurement|unable to tolerate procedure|0
73287|NCT01285908|285226|P2|Baseline Measurement|unable to tolerate procedure|0
73288|NCT01285908|285227|P1|Baseline Measurement|unable to tolerate procedure|1
73289|NCT01285908|285225|P3|Baseline Measurement|History of stroke, exclusion criteria|0
73290|NCT01285908|285226|P2|Baseline Measurement|History of stroke, exclusion criteria|0
73291|NCT01285908|285227|P1|Baseline Measurement|History of stroke, exclusion criteria|1
73292|NCT01285908|285225|P3|Baseline Measurement|unable to insert catheter|0
73293|NCT01285908|285226|P2|Baseline Measurement|unable to insert catheter|0
73294|NCT01285908|285227|P1|Baseline Measurement|unable to insert catheter|1
73295|NCT01285609|285321|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
73296|NCT01285609|285322|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
73297|NCT01285609|285321|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
73298|NCT01285609|285322|P1|Treated With Blinded Therapy|Poor/Non-Compliance|0
73299|NCT01285609|285321|P2|Treated With Blinded Therapy|Not Reported|4
73300|NCT01285609|285322|P1|Treated With Blinded Therapy|Not Reported|4
73301|NCT01285609|285321|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
73302|NCT01285609|285322|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
73303|NCT01285609|285321|P2|Treated With Blinded Therapy|Death|3
73304|NCT01285609|285322|P1|Treated With Blinded Therapy|Death|11
73305|NCT01285609|285321|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
73306|NCT01285609|285322|P1|Treated With Blinded Therapy|Withdrawal by Subject|18
73307|NCT01285609|285321|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
73308|NCT01285609|285322|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
73309|NCT01285609|285321|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
73310|NCT01285609|285322|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
73311|NCT01285609|285321|P2|Treated With Blinded Therapy|Progressive Disease|305
73312|NCT01285609|285322|P1|Treated With Blinded Therapy|Progressive Disease|220
73313|NCT01285609|285321|P2|Randomized|Randomized but not Treated|4
73314|NCT01285609|285322|P1|Randomized|Randomized but not Treated|4
73315|NCT01285609|285321|P2|Randomized|Undisclosed Reasons|0
73316|NCT01285609|285322|P1|Randomized|Undisclosed Reasons|1
73317|NCT01285609|285321|P2|Randomized|Subject No Longer Met Study Criteria|1
73318|NCT01285609|285322|P1|Randomized|Subject No Longer Met Study Criteria|1
73319|NCT01285609|285321|P2|Randomized|Withdrawal by Subject|11
73320|NCT01285609|285322|P1|Randomized|Withdrawal by Subject|8
73321|NCT01285609|285321|P2|Randomized|Death|7
73322|NCT01285609|285322|P1|Randomized|Death|5
73323|NCT01285609|285321|P2|Randomized|Study Drug Toxicity|14
73324|NCT01285609|285322|P1|Randomized|Study Drug Toxicity|13
73325|NCT01285609|285321|P2|Randomized|Adverse Event Unrelated to Study Drug|18
73326|NCT01285609|285322|P1|Randomized|Adverse Event Unrelated to Study Drug|18
73327|NCT01285609|285321|P2|Randomized|Progressive Disease|61
73328|NCT01285609|285322|P1|Randomized|Progressive Disease|41
73329|NCT01285518|285340|P8|Overall Study|Lost to Follow-up|0
73330|NCT01285518|285341|P7|Overall Study|Lost to Follow-up|0
73331|NCT01285518|285342|P6|Overall Study|Lost to Follow-up|1
73332|NCT01285518|285343|P5|Overall Study|Lost to Follow-up|0
73333|NCT01285518|285344|P4|Overall Study|Lost to Follow-up|0
73334|NCT01285518|285345|P3|Overall Study|Lost to Follow-up|0
73335|NCT01285518|285346|P2|Overall Study|Lost to Follow-up|0
73336|NCT01285518|285347|P1|Overall Study|Lost to Follow-up|0
73337|NCT01285492|285607|P2|Overall Study|Death|0
73338|NCT01285492|285608|P1|Overall Study|Death|1
73339|NCT01285492|285607|P2|Overall Study|Withdrawal by Subject|1
73340|NCT01285492|285608|P1|Overall Study|Withdrawal by Subject|2
73341|NCT01285492|285607|P2|Overall Study|Protocol Violation|0
73342|NCT01285492|285608|P1|Overall Study|Protocol Violation|3
73343|NCT01285492|285607|P2|Overall Study|Adverse Event|0
73344|NCT01285492|285608|P1|Overall Study|Adverse Event|11
73345|NCT01285401|285640|P2|Overall Study|Prematurely withdrawn from the study|29
73346|NCT01285401|285641|P1|Overall Study|Prematurely withdrawn from the study|17
73347|NCT01285323|285681|P2|Overall Study|Not specified|3
73348|NCT01285323|285682|P1|Overall Study|Not specified|1
73349|NCT01285323|285681|P2|Overall Study|Lost to Follow-up|1
73350|NCT01285323|285682|P1|Overall Study|Lost to Follow-up|1
73351|NCT01285323|285681|P2|Overall Study|Non-compliance with study procedures|3
73352|NCT01285323|285682|P1|Overall Study|Non-compliance with study procedures|2
73353|NCT01285323|285681|P2|Overall Study|Protocol Violation|2
73354|NCT01285323|285682|P1|Overall Study|Protocol Violation|1
73355|NCT01285323|285681|P2|Overall Study|Withdrawal by Subject|11
73356|NCT01285323|285682|P1|Overall Study|Withdrawal by Subject|15
73357|NCT01285323|285681|P2|Overall Study|Lack of Efficacy|2
73358|NCT01285323|285682|P1|Overall Study|Lack of Efficacy|4
73359|NCT01285323|285681|P2|Overall Study|Adverse Event|8
73360|NCT01285323|285682|P1|Overall Study|Adverse Event|9
73361|NCT01285310|285717|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
73362|NCT01285310|285718|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
73363|NCT01285310|285719|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
73364|NCT01285310|285720|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
73365|NCT01285310|285721|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
73366|NCT01285310|285717|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
73367|NCT01285310|285718|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
73368|NCT01285310|285719|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
73369|NCT01285310|285720|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
73370|NCT01285310|285721|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
73371|NCT01285310|285717|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
73372|NCT01285310|285718|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
73373|NCT01285310|285719|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
73374|NCT01285310|285720|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
73375|NCT01285310|285721|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
73376|NCT01285310|285717|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
73377|NCT01285310|285718|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
73378|NCT01285310|285719|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
73379|NCT01285310|285720|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
73380|NCT01285310|285721|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
73381|NCT01285310|285717|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
73382|NCT01285310|285718|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
73383|NCT01285310|285719|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
73384|NCT01285310|285720|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
73385|NCT01285310|285721|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
73386|NCT01285310|285717|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
73387|NCT01285310|285718|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
73388|NCT01285310|285719|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
73389|NCT01285310|285720|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
73390|NCT01285310|285721|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
73391|NCT01285310|285717|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
73392|NCT01285310|285718|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
73393|NCT01285310|285719|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
73394|NCT01285310|285720|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
73395|NCT01285310|285721|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
73396|NCT01285310|285717|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
73397|NCT01285310|285718|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
73398|NCT01285310|285719|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
73399|NCT01285310|285720|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
73400|NCT01285310|285721|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
73401|NCT01285310|285717|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
73402|NCT01285310|285718|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
73403|NCT01285310|285719|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
73404|NCT01285310|285720|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
73405|NCT01285310|285721|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
73406|NCT01285310|285717|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
73407|NCT01285310|285718|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
73408|NCT01285310|285719|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
73409|NCT01285310|285720|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
73410|NCT01285310|285721|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
73411|NCT01285310|285717|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
73412|NCT01285310|285718|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
73413|NCT01285310|285719|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
73414|NCT01285310|285720|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
73415|NCT01285310|285721|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
73416|NCT01285310|285717|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
73417|NCT01285310|285718|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
73418|NCT01285310|285719|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
73419|NCT01285310|285720|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
73420|NCT01285310|285721|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
73421|NCT01284959|285986|P3|Overall Study|Adverse Event|1
73422|NCT01284959|285987|P2|Overall Study|Adverse Event|0
73423|NCT01284959|285988|P1|Overall Study|Adverse Event|0
73424|NCT01284959|285986|P3|Overall Study|Withdrawal by Subject|0
73425|NCT01284959|285987|P2|Overall Study|Withdrawal by Subject|0
73426|NCT01284959|285988|P1|Overall Study|Withdrawal by Subject|1
73427|NCT01284634|286018|P4|Overall Study|Adverse Event|1
73428|NCT01284634|286019|P3|Overall Study|Adverse Event|2
73429|NCT01284634|286020|P2|Overall Study|Adverse Event|0
73430|NCT01284634|286021|P1|Overall Study|Adverse Event|1
73431|NCT01284621|286163|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
73432|NCT01284621|286164|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
73433|NCT01284621|286165|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
73434|NCT01284621|286166|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
73435|NCT01284621|286167|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
73436|NCT01284621|286168|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
73437|NCT01284491|286236|P1|Overall Study|Study termination|13
73438|NCT01284361|286246|P1|Overall Study|Lost to Follow-up|2
73439|NCT01284361|286246|P1|Overall Study|Adverse Event|1
73440|NCT01284361|286246|P1|Overall Study|Protocol Violation|5
73441|NCT01284361|286246|P1|Overall Study|Withdrawal by Subject|1
73442|NCT01284140|286269|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
73443|NCT01284140|286270|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
73444|NCT01284140|286269|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
73445|NCT01284140|286270|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
73446|NCT01284114|286284|P1|Overall Study|dizziness|1
73447|NCT01284114|286284|P1|Overall Study|Symptomatic hypotension|1
73448|NCT01284114|286284|P1|Overall Study|From the results of ALLTITUDE study|1
73449|NCT01284114|286284|P1|Overall Study|viral infection|1
73450|NCT01284062|286296|P4|Overall Study|Site Closed|0
73451|NCT01284062|286297|P3|Overall Study|Site Closed|1
73452|NCT01284062|286298|P2|Overall Study|Site Closed|0
73453|NCT01284062|286299|P1|Overall Study|Site Closed|0
73454|NCT01284062|286296|P4|Overall Study|Other|1
73455|NCT01284062|286297|P3|Overall Study|Other|0
73456|NCT01284062|286298|P2|Overall Study|Other|0
73457|NCT01284062|286299|P1|Overall Study|Other|0
73458|NCT01284062|286296|P4|Overall Study|Withdrawal by Subject|5
73459|NCT01284062|286297|P3|Overall Study|Withdrawal by Subject|2
73460|NCT01284062|286298|P2|Overall Study|Withdrawal by Subject|1
73461|NCT01284062|286299|P1|Overall Study|Withdrawal by Subject|3
73462|NCT01284062|286296|P4|Overall Study|Protocol Violation|2
73463|NCT01284062|286297|P3|Overall Study|Protocol Violation|0
73464|NCT01284062|286298|P2|Overall Study|Protocol Violation|0
73465|NCT01284062|286299|P1|Overall Study|Protocol Violation|1
73466|NCT01284062|286296|P4|Overall Study|Medication error without adverse event|0
73467|NCT01284062|286297|P3|Overall Study|Medication error without adverse event|1
73468|NCT01284062|286298|P2|Overall Study|Medication error without adverse event|0
73469|NCT01284062|286299|P1|Overall Study|Medication error without adverse event|0
73470|NCT01284062|286296|P4|Overall Study|Lack of Efficacy|1
73471|NCT01284062|286297|P3|Overall Study|Lack of Efficacy|2
73472|NCT01284062|286298|P2|Overall Study|Lack of Efficacy|2
73473|NCT01284062|286299|P1|Overall Study|Lack of Efficacy|3
73474|NCT01284062|286296|P4|Overall Study|Adverse Event|5
73475|NCT01284062|286297|P3|Overall Study|Adverse Event|0
73476|NCT01284062|286298|P2|Overall Study|Adverse Event|5
73477|NCT01284062|286299|P1|Overall Study|Adverse Event|4
73478|NCT01283971|286373|P2|Overall Study|Administrative reasons|1
73479|NCT01283971|286374|P1|Overall Study|Administrative reasons|1
73480|NCT01283971|286373|P2|Overall Study|Failure to return|1
73481|NCT01283971|286374|P1|Overall Study|Failure to return|0
73482|NCT01283971|286373|P2|Overall Study|Refused treatment|1
73483|NCT01283971|286374|P1|Overall Study|Refused treatment|3
73484|NCT01283971|286373|P2|Overall Study|Protocol Violation|1
73485|NCT01283971|286374|P1|Overall Study|Protocol Violation|5
73486|NCT01283971|286373|P2|Overall Study|Insufficient therapeutic responses|3
73487|NCT01283971|286374|P1|Overall Study|Insufficient therapeutic responses|3
73488|NCT01283971|286373|P2|Overall Study|Adverse Event|5
73489|NCT01283971|286374|P1|Overall Study|Adverse Event|3
73490|NCT01283581|286421|P3|Overall Study|"Early termination"|1
73491|NCT01283581|286422|P2|Overall Study|"Early termination"|0
73492|NCT01283581|286423|P1|Overall Study|"Early termination"|0
73493|NCT01283581|286421|P3|Overall Study|Investigator unblinded|1
73494|NCT01283581|286422|P2|Overall Study|Investigator unblinded|0
73495|NCT01283581|286423|P1|Overall Study|Investigator unblinded|0
73496|NCT01283581|286421|P3|Overall Study|Noncompliance|0
73497|NCT01283581|286422|P2|Overall Study|Noncompliance|0
73498|NCT01283581|286423|P1|Overall Study|Noncompliance|1
73499|NCT01283581|286421|P3|Overall Study|Protocol Violation|2
73500|NCT01283581|286422|P2|Overall Study|Protocol Violation|1
73501|NCT01283581|286423|P1|Overall Study|Protocol Violation|0
73502|NCT01283581|286421|P3|Overall Study|Physician Decision|2
73503|NCT01283581|286422|P2|Overall Study|Physician Decision|1
73504|NCT01283581|286423|P1|Overall Study|Physician Decision|0
73505|NCT01283581|286421|P3|Overall Study|Adverse Event|4
73506|NCT01283581|286422|P2|Overall Study|Adverse Event|1
73507|NCT01283581|286423|P1|Overall Study|Adverse Event|1
73508|NCT01283581|286421|P3|Overall Study|Withdrawal by Subject|2
73509|NCT01283581|286422|P2|Overall Study|Withdrawal by Subject|5
73510|NCT01283581|286423|P1|Overall Study|Withdrawal by Subject|2
73511|NCT01283581|286421|P3|Overall Study|Lost to Follow-up|8
73512|NCT01283581|286422|P2|Overall Study|Lost to Follow-up|6
73513|NCT01283581|286423|P1|Overall Study|Lost to Follow-up|8
73514|NCT01283516|286487|P9|Overall Study|Withdrawal by Subject|11
73515|NCT01283516|286488|P8|Overall Study|Withdrawal by Subject|0
73516|NCT01283516|286489|P7|Overall Study|Withdrawal by Subject|0
73517|NCT01283516|286490|P6|Overall Study|Withdrawal by Subject|0
73518|NCT01283516|286491|P5|Overall Study|Withdrawal by Subject|1
73519|NCT01283516|286492|P4|Overall Study|Withdrawal by Subject|0
73520|NCT01283516|286493|P3|Overall Study|Withdrawal by Subject|0
73521|NCT01283516|286494|P2|Overall Study|Withdrawal by Subject|0
73522|NCT01283516|286495|P1|Overall Study|Withdrawal by Subject|0
73523|NCT01283516|286487|P9|Overall Study|Disease Progression|81
73524|NCT01283516|286488|P8|Overall Study|Disease Progression|2
73525|NCT01283516|286489|P7|Overall Study|Disease Progression|6
73526|NCT01283516|286490|P6|Overall Study|Disease Progression|7
73527|NCT01283516|286491|P5|Overall Study|Disease Progression|12
73528|NCT01283516|286492|P4|Overall Study|Disease Progression|3
73529|NCT01283516|286493|P3|Overall Study|Disease Progression|2
73530|NCT01283516|286494|P2|Overall Study|Disease Progression|2
73531|NCT01283516|286495|P1|Overall Study|Disease Progression|2
73532|NCT01283516|286487|P9|Overall Study|Death|6
73533|NCT01283516|286488|P8|Overall Study|Death|1
73534|NCT01283516|286489|P7|Overall Study|Death|0
73535|NCT01283516|286490|P6|Overall Study|Death|1
73536|NCT01283516|286491|P5|Overall Study|Death|0
73537|NCT01283516|286492|P4|Overall Study|Death|0
73538|NCT01283516|286493|P3|Overall Study|Death|0
73539|NCT01283516|286494|P2|Overall Study|Death|0
73540|NCT01283516|286495|P1|Overall Study|Death|0
73541|NCT01283516|286487|P9|Overall Study|Adverse Event|24
73542|NCT01283516|286488|P8|Overall Study|Adverse Event|0
73543|NCT01283516|286489|P7|Overall Study|Adverse Event|2
73544|NCT01283516|286490|P6|Overall Study|Adverse Event|0
73545|NCT01283516|286491|P5|Overall Study|Adverse Event|0
73546|NCT01283516|286492|P4|Overall Study|Adverse Event|0
73547|NCT01283516|286493|P3|Overall Study|Adverse Event|0
73548|NCT01283516|286494|P2|Overall Study|Adverse Event|0
73549|NCT01283516|286495|P1|Overall Study|Adverse Event|0
73550|NCT01283464|286519|P2|Overall Study|Physician Decision|0
73551|NCT01283464|286520|P1|Overall Study|Physician Decision|1
73552|NCT01283464|286519|P2|Overall Study|Withdrawal by Subject|0
73553|NCT01283464|286520|P1|Overall Study|Withdrawal by Subject|1
73554|NCT01283464|286519|P2|Overall Study|Lost to Follow-up|1
73555|NCT01283464|286520|P1|Overall Study|Lost to Follow-up|0
73556|NCT01283334|286526|P1|Overall Study|Physician Decision|1
73557|NCT01283334|286526|P1|Overall Study|Adverse Event|4
73558|NCT01283334|286526|P1|Overall Study|Inability to Swallow Everolimus Pills|1
73559|NCT01283334|286526|P1|Overall Study|Withdrawal by Subject|1
73560|NCT01283282|286541|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
73561|NCT01283282|286542|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
73562|NCT01283282|286541|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
73563|NCT01283282|286542|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
73564|NCT01283282|286541|P2|First Intervention (6 Weeks)|Physician Decision|1
73565|NCT01283282|286542|P1|First Intervention (6 Weeks)|Physician Decision|0
73566|NCT01283152|286562|P2|Overall Study|Refused HESA|0
73567|NCT01283152|286563|P1|Overall Study|Refused HESA|1
73568|NCT01283152|286562|P2|Overall Study|Discharged prior to 24 hr assessment|0
73569|NCT01283152|286563|P1|Overall Study|Discharged prior to 24 hr assessment|1
73570|NCT01283139|286577|P4|Overall Study|Participant randomized in error|0
73571|NCT01283139|286578|P3|Overall Study|Participant randomized in error|1
73572|NCT01283139|286579|P2|Overall Study|Participant randomized in error|0
73573|NCT01283139|286580|P1|Overall Study|Participant randomized in error|0
73574|NCT01283139|286577|P4|Overall Study|Missed follow-up visit|2
73575|NCT01283139|286578|P3|Overall Study|Missed follow-up visit|2
73576|NCT01283139|286579|P2|Overall Study|Missed follow-up visit|1
73577|NCT01283139|286580|P1|Overall Study|Missed follow-up visit|0
73578|NCT01283139|286577|P4|Overall Study|Pregnancy|0
73579|NCT01283139|286578|P3|Overall Study|Pregnancy|1
73580|NCT01283139|286579|P2|Overall Study|Pregnancy|1
73581|NCT01283139|286580|P1|Overall Study|Pregnancy|0
73582|NCT01283139|286577|P4|Overall Study|Participant's refusal to continue|1
73583|NCT01283139|286578|P3|Overall Study|Participant's refusal to continue|1
73584|NCT01283139|286579|P2|Overall Study|Participant's refusal to continue|3
73585|NCT01283139|286580|P1|Overall Study|Participant's refusal to continue|0
73586|NCT01283139|286577|P4|Overall Study|Early termination due to AE/SAE|0
73587|NCT01283139|286578|P3|Overall Study|Early termination due to AE/SAE|0
73588|NCT01283139|286579|P2|Overall Study|Early termination due to AE/SAE|1
73589|NCT01283139|286580|P1|Overall Study|Early termination due to AE/SAE|1
73590|NCT01283139|286577|P4|Overall Study|Lack of Efficacy|1
73591|NCT01283139|286578|P3|Overall Study|Lack of Efficacy|2
73592|NCT01283139|286579|P2|Overall Study|Lack of Efficacy|2
73593|NCT01283139|286580|P1|Overall Study|Lack of Efficacy|1
73594|NCT01283139|286577|P4|Overall Study|Death|2
73595|NCT01283139|286578|P3|Overall Study|Death|2
73596|NCT01283139|286579|P2|Overall Study|Death|0
73597|NCT01283139|286580|P1|Overall Study|Death|2
73598|NCT01283139|286577|P4|Overall Study|Withdrawal by Subject|8
73599|NCT01283139|286578|P3|Overall Study|Withdrawal by Subject|6
73600|NCT01283139|286579|P2|Overall Study|Withdrawal by Subject|8
73601|NCT01283139|286580|P1|Overall Study|Withdrawal by Subject|8
73602|NCT01283139|286577|P4|Overall Study|Lost to Follow-up|1
73603|NCT01283139|286578|P3|Overall Study|Lost to Follow-up|3
73604|NCT01283139|286579|P2|Overall Study|Lost to Follow-up|2
73605|NCT01283139|286580|P1|Overall Study|Lost to Follow-up|5
73606|NCT01283035|286622|P1|Overall Study|Subject later found ineligible|1
73607|NCT01282866|286637|P1|Overall Study|Adverse Event|1
73608|NCT01282814|286645|P2|Washout of 7 Days|Withdrawal by Subject|0
73609|NCT01282814|286646|P1|Washout of 7 Days|Withdrawal by Subject|2
73610|NCT01282814|286645|P2|First Intervention|Emesis During Dosing Interval|3
73611|NCT01282814|286646|P1|First Intervention|Emesis During Dosing Interval|0
73612|NCT01282801|286658|P2|Second Intervention|Emesis During Critical Breakfast|1
73613|NCT01282801|286659|P1|Second Intervention|Emesis During Critical Breakfast|0
73614|NCT01282476|286683|P1|Overall Study|Death|11
73615|NCT01282424|286689|P1|Overall Study|Investigator Request|7
73616|NCT01282424|286689|P1|Overall Study|Withdrew Consent|4
73617|NCT01282424|286689|P1|Overall Study|Adverse Event|25
73618|NCT01282424|286689|P1|Overall Study|Treatment Ongoing|40
73619|NCT01282372|286706|P1|Overall Study|Adverse Event|12
73620|NCT01282372|286706|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
73621|NCT01282372|286706|P1|Overall Study|Presence of AE, Regression of Symptoms|1
73622|NCT01282372|286706|P1|Overall Study|Presence of AE, Lack of Efficacy|1
73623|NCT01282372|286706|P1|Overall Study|Death|1
73624|NCT01282372|286706|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
73625|NCT01282372|286706|P1|Overall Study|Withdrawal by Subject|11
73626|NCT01282372|286706|P1|Overall Study|Lost to Follow-up|23
73627|NCT01282372|286706|P1|Overall Study|Lack of Efficacy / Exacerbation|25
73628|NCT01282294|286734|P1|Overall Study|Physician Decision|1
73629|NCT01282294|286734|P1|Overall Study|Patient non-compliance|2
73630|NCT01282294|286734|P1|Overall Study|Adverse Event|1
73631|NCT01282294|286734|P1|Overall Study|Screening failure|1
73632|NCT01282294|286734|P1|Overall Study|Lost to Follow-up|14
73633|NCT01282229|286763|P1|Overall Study|Protocol Violation|2
73634|NCT01282203|286793|P1|Overall Study|Adverse Event|1
73635|NCT01282164|286815|P2|Overall Study|Lack of hypoglycemia during ITT|0
73636|NCT01282164|286816|P1|Overall Study|Lack of hypoglycemia during ITT|1
73637|NCT01281917|286867|P1|Overall Study|Withdrawal by Subject|1
73638|NCT01281865|286879|P2|Overall Study|Lack of Efficacy|0
73639|NCT01281865|286880|P1|Overall Study|Lack of Efficacy|1
73640|NCT01281865|286879|P2|Overall Study|Withdrawal by Subject|0
73641|NCT01281865|286880|P1|Overall Study|Withdrawal by Subject|1
73642|NCT01281865|286879|P2|Overall Study|Adverse Event|1
73643|NCT01281865|286880|P1|Overall Study|Adverse Event|1
73644|NCT01281839|286888|P2|Overall Study|Reason not specified|1
73645|NCT01281839|286889|P1|Overall Study|Reason not specified|0
73646|NCT01281839|286888|P2|Overall Study|Withdrawal by Subject|10
73647|NCT01281839|286889|P1|Overall Study|Withdrawal by Subject|4
73648|NCT01281839|286888|P2|Overall Study|Lost to Follow-up|3
73649|NCT01281839|286889|P1|Overall Study|Lost to Follow-up|6
73650|NCT01281644|286950|P1|Overall Study|Withdrawal by Subject|2
73651|NCT01281644|286950|P1|Overall Study|Lost to Follow-up|3
73652|NCT01281306|286991|P7|Overall Study|Randomized in error|0
73653|NCT01281306|286992|P6|Overall Study|Randomized in error|0
73654|NCT01281306|286993|P5|Overall Study|Randomized in error|0
73655|NCT01281306|286994|P4|Overall Study|Randomized in error|1
73656|NCT01281306|286995|P3|Overall Study|Randomized in error|0
73657|NCT01281306|286996|P2|Overall Study|Randomized in error|0
73658|NCT01281306|286997|P1|Overall Study|Randomized in error|1
73659|NCT01281306|286991|P7|Overall Study|Adverse Event|3
73660|NCT01281306|286992|P6|Overall Study|Adverse Event|3
73661|NCT01281306|286993|P5|Overall Study|Adverse Event|5
73662|NCT01281306|286994|P4|Overall Study|Adverse Event|3
73663|NCT01281306|286995|P3|Overall Study|Adverse Event|2
73664|NCT01281306|286996|P2|Overall Study|Adverse Event|2
73665|NCT01281306|286997|P1|Overall Study|Adverse Event|3
73666|NCT01281306|286991|P7|Overall Study|Death|0
73667|NCT01281306|286992|P6|Overall Study|Death|0
73668|NCT01281306|286993|P5|Overall Study|Death|0
73669|NCT01281306|286994|P4|Overall Study|Death|0
73670|NCT01281306|286995|P3|Overall Study|Death|0
73671|NCT01281306|286996|P2|Overall Study|Death|0
73672|NCT01281306|286997|P1|Overall Study|Death|1
73673|NCT01281306|286991|P7|Overall Study|Lost to Follow-up|1
73674|NCT01281306|286992|P6|Overall Study|Lost to Follow-up|0
73675|NCT01281306|286993|P5|Overall Study|Lost to Follow-up|0
73676|NCT01281306|286994|P4|Overall Study|Lost to Follow-up|2
73677|NCT01281306|286995|P3|Overall Study|Lost to Follow-up|0
73678|NCT01281306|286996|P2|Overall Study|Lost to Follow-up|0
73679|NCT01281306|286997|P1|Overall Study|Lost to Follow-up|1
73680|NCT01281306|286991|P7|Overall Study|Condition no longer requires study drug|1
73681|NCT01281306|286992|P6|Overall Study|Condition no longer requires study drug|1
73682|NCT01281306|286993|P5|Overall Study|Condition no longer requires study drug|0
73683|NCT01281306|286994|P4|Overall Study|Condition no longer requires study drug|0
73684|NCT01281306|286995|P3|Overall Study|Condition no longer requires study drug|0
73685|NCT01281306|286996|P2|Overall Study|Condition no longer requires study drug|0
73686|NCT01281306|286997|P1|Overall Study|Condition no longer requires study drug|1
73687|NCT01281306|286991|P7|Overall Study|Protocol deviation|0
73688|NCT01281306|286992|P6|Overall Study|Protocol deviation|0
73689|NCT01281306|286993|P5|Overall Study|Protocol deviation|1
73690|NCT01281306|286994|P4|Overall Study|Protocol deviation|1
73691|NCT01281306|286995|P3|Overall Study|Protocol deviation|1
73692|NCT01281306|286996|P2|Overall Study|Protocol deviation|1
73693|NCT01281306|286997|P1|Overall Study|Protocol deviation|0
73694|NCT01281306|286991|P7|Overall Study|Withdrawal by Subject|1
73695|NCT01281306|286992|P6|Overall Study|Withdrawal by Subject|3
73696|NCT01281306|286993|P5|Overall Study|Withdrawal by Subject|1
73697|NCT01281306|286994|P4|Overall Study|Withdrawal by Subject|4
73698|NCT01281306|286995|P3|Overall Study|Withdrawal by Subject|2
73699|NCT01281306|286996|P2|Overall Study|Withdrawal by Subject|0
73700|NCT01281306|286997|P1|Overall Study|Withdrawal by Subject|1
73701|NCT01281306|286991|P7|Overall Study|Lack of Efficacy|1
73702|NCT01281306|286992|P6|Overall Study|Lack of Efficacy|0
73703|NCT01281306|286993|P5|Overall Study|Lack of Efficacy|2
73704|NCT01281306|286994|P4|Overall Study|Lack of Efficacy|0
73705|NCT01281306|286995|P3|Overall Study|Lack of Efficacy|3
73706|NCT01281306|286996|P2|Overall Study|Lack of Efficacy|1
73707|NCT01281306|286997|P1|Overall Study|Lack of Efficacy|0
73708|NCT01281202|287113|P2|Overall Study|Incarceration|3
73709|NCT01281202|287114|P1|Overall Study|Incarceration|0
73710|NCT01281202|287113|P2|Overall Study|Lost to Follow-up|13
73711|NCT01281202|287114|P1|Overall Study|Lost to Follow-up|11
73712|NCT01281202|287113|P2|Overall Study|Administrative|8
73713|NCT01281202|287114|P1|Overall Study|Administrative|2
73714|NCT01281202|287113|P2|Overall Study|Protocol Violation|10
73715|NCT01281202|287114|P1|Overall Study|Protocol Violation|11
73716|NCT01281202|287113|P2|Overall Study|Withdrawal by Subject|2
73717|NCT01281202|287114|P1|Overall Study|Withdrawal by Subject|2
73718|NCT01281202|287113|P2|Overall Study|Adverse Event|0
73719|NCT01281202|287114|P1|Overall Study|Adverse Event|2
73720|NCT01281124|287122|P1|Overall Study|Death|1
73721|NCT01280981|287137|P1|Overall Study|Study site closure|1
73722|NCT01280981|287137|P1|Overall Study|Elective surgery|2
73723|NCT01280981|287137|P1|Overall Study|Withdrawal of consent|3
73724|NCT01280981|287137|P1|Overall Study|Non-compliance with protocol|3
73725|NCT01280981|287137|P1|Overall Study|Failed to return|45
73726|NCT01280981|287137|P1|Overall Study|Irregular or discontinued menses|3
73727|NCT01280981|287137|P1|Overall Study|Adverse Event|6
73728|NCT01280981|287137|P1|Overall Study|Lost to Follow-up|3
73729|NCT01280981|287137|P1|Overall Study|Lack of Efficacy|13
73730|NCT01280981|287137|P1|Overall Study|Protocol Violation|2
73731|NCT01280981|287137|P1|Overall Study|Withdrawal by Subject|11
73732|NCT01280968|287148|P2|Overall Study|Unable to Smoke in Supine Position|0
73733|NCT01280968|287149|P1|Overall Study|Unable to Smoke in Supine Position|1
73734|NCT01280968|287148|P2|Overall Study|Pre-existing Neurological Condition|0
73735|NCT01280968|287149|P1|Overall Study|Pre-existing Neurological Condition|1
73736|NCT01280968|287148|P2|Overall Study|Scheduling Conflicts|1
73737|NCT01280968|287149|P1|Overall Study|Scheduling Conflicts|1
73738|NCT01280968|287148|P2|Overall Study|Adverse Event|0
73739|NCT01280968|287149|P1|Overall Study|Adverse Event|1
73740|NCT01280968|287148|P2|Overall Study|Anxiety|0
73741|NCT01280968|287149|P1|Overall Study|Anxiety|2
73742|NCT01280968|287148|P2|Overall Study|Commuting Problems|0
73743|NCT01280968|287149|P1|Overall Study|Commuting Problems|2
73744|NCT01280968|287148|P2|Overall Study|Unable to Follow Experimental Protocol|0
73745|NCT01280968|287149|P1|Overall Study|Unable to Follow Experimental Protocol|2
73746|NCT01280968|287148|P2|Overall Study|Lost to Follow-up|2
73747|NCT01280968|287149|P1|Overall Study|Lost to Follow-up|8
73748|NCT01280955|287165|P1|Overall Study|Withdrawal by Subject|1
73749|NCT01280955|287165|P1|Overall Study|Death|2
73750|NCT01280903|287209|P2|Overall Study|Lost to Follow-up|16
73751|NCT01280903|287210|P1|Overall Study|Lost to Follow-up|23
73752|NCT01280656|287323|P3|Overall Study|Other|7
73753|NCT01280656|287324|P2|Overall Study|Other|7
73754|NCT01280656|287325|P1|Overall Study|Other|1
73755|NCT01280656|287323|P3|Overall Study|Treatment shortening (RGT)|5
73756|NCT01280656|287324|P2|Overall Study|Treatment shortening (RGT)|4
73757|NCT01280656|287325|P1|Overall Study|Treatment shortening (RGT)|0
73758|NCT01280656|287323|P3|Overall Study|Lack of Efficacy|38
73759|NCT01280656|287324|P2|Overall Study|Lack of Efficacy|22
73760|NCT01280656|287325|P1|Overall Study|Lack of Efficacy|1
73761|NCT01280656|287323|P3|Overall Study|Adverse Event|13
73762|NCT01280656|287324|P2|Overall Study|Adverse Event|14
73763|NCT01280656|287325|P1|Overall Study|Adverse Event|1
73764|NCT01280591|287392|P4|Overall Study|Does not meet exclusion #27 criteria|1
73765|NCT01280591|287393|P3|Overall Study|Does not meet exclusion #27 criteria|0
73766|NCT01280591|287394|P2|Overall Study|Does not meet exclusion #27 criteria|0
73767|NCT01280591|287395|P1|Overall Study|Does not meet exclusion #27 criteria|0
73768|NCT01280591|287392|P4|Overall Study|Withdrawal by Subject|2
73769|NCT01280591|287393|P3|Overall Study|Withdrawal by Subject|0
73770|NCT01280591|287394|P2|Overall Study|Withdrawal by Subject|0
73771|NCT01280591|287395|P1|Overall Study|Withdrawal by Subject|0
73772|NCT01280357|287500|P1|Overall Study|IInsufficient data/No data supplied|12
73773|NCT01280357|287500|P1|Overall Study|Excluded no internal monitoring|14
73774|NCT01280266|287509|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
73775|NCT01280266|287510|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
73776|NCT01280266|287509|P2|First Intervention (Week 1-4)|Adverse Event|0
73777|NCT01280266|287510|P1|First Intervention (Week 1-4)|Adverse Event|1
73778|NCT01279681|287592|P2|Overall Study|Other Reason|2
73779|NCT01279681|287593|P1|Overall Study|Other Reason|0
73780|NCT01279681|287592|P2|Overall Study|Physician Decision|0
73781|NCT01279681|287593|P1|Overall Study|Physician Decision|1
73782|NCT01279681|287592|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
73783|NCT01279681|287593|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
73784|NCT01279681|287592|P2|Overall Study|Death|1
73785|NCT01279681|287593|P1|Overall Study|Death|0
73786|NCT01279681|287592|P2|Overall Study|Adverse Event|3
73787|NCT01279681|287593|P1|Overall Study|Adverse Event|2
73788|NCT01279681|287592|P2|Overall Study|Withdrawal by Subject|4
73789|NCT01279681|287593|P1|Overall Study|Withdrawal by Subject|3
73790|NCT01279681|287592|P2|Overall Study|Disease Progression|6
73791|NCT01279681|287593|P1|Overall Study|Disease Progression|9
73792|NCT01279447|287616|P2|Overall Study|Lost to Follow-up|1
73793|NCT01279447|287617|P1|Overall Study|Lost to Follow-up|3
73794|NCT01279200|287644|P2|Overall Study|Adverse Event|0
73795|NCT01279200|287645|P1|Overall Study|Adverse Event|1
73796|NCT01279200|287644|P2|Overall Study|Lost to Follow-up|1
73797|NCT01279200|287645|P1|Overall Study|Lost to Follow-up|0
73798|NCT01279200|287644|P2|Overall Study|ultrasound screening failure|1
73799|NCT01279200|287645|P1|Overall Study|ultrasound screening failure|0
73800|NCT01279200|287644|P2|Overall Study|Inconvenience of ultrasound visit|1
73801|NCT01279200|287645|P1|Overall Study|Inconvenience of ultrasound visit|0
73802|NCT01279200|287644|P2|Overall Study|Patient withdrawal due to high cost|1
73803|NCT01279200|287645|P1|Overall Study|Patient withdrawal due to high cost|0
73804|NCT01279200|287644|P2|Overall Study|Withdrawal by Subject|3
73805|NCT01279200|287645|P1|Overall Study|Withdrawal by Subject|1
73806|NCT01279070|287683|P2|Overall Study|Acute exacerbation|1
73807|NCT01279070|287684|P1|Overall Study|Acute exacerbation|3
73808|NCT01279070|287683|P2|Overall Study|Withdrawal by Subject|3
73809|NCT01279070|287684|P1|Overall Study|Withdrawal by Subject|2
73810|NCT01279044|287703|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
73811|NCT01279044|287704|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
73812|NCT01279044|287705|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
73813|NCT01279044|287703|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
73814|NCT01279044|287704|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
73815|NCT01279044|287705|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
73816|NCT01279044|287703|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
73817|NCT01279044|287704|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
73818|NCT01279044|287705|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
73819|NCT01278797|287779|P2|Period 1|Protocol Violation|0
73820|NCT01278797|287780|P1|Period 1|Protocol Violation|1
73821|NCT01278797|287779|P2|Period 1|Adverse Event|1
73822|NCT01278797|287780|P1|Period 1|Adverse Event|0
73823|NCT01278745|287792|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
73824|NCT01278745|287793|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
73825|NCT01278745|287794|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
73826|NCT01278745|287795|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
73827|NCT01278745|287792|P4|Overall Study|Ineligible|61
73828|NCT01278745|287793|P3|Overall Study|Ineligible|42
73829|NCT01278745|287794|P2|Overall Study|Ineligible|0
73830|NCT01278745|287795|P1|Overall Study|Ineligible|0
73831|NCT01278745|287792|P4|Overall Study|Sponsor Decision|6
73832|NCT01278745|287793|P3|Overall Study|Sponsor Decision|62
73833|NCT01278745|287794|P2|Overall Study|Sponsor Decision|0
73834|NCT01278745|287795|P1|Overall Study|Sponsor Decision|1
73835|NCT01278745|287792|P4|Overall Study|Withdrawal by Subject|1
73836|NCT01278745|287793|P3|Overall Study|Withdrawal by Subject|5
73837|NCT01278745|287794|P2|Overall Study|Withdrawal by Subject|1
73838|NCT01278745|287795|P1|Overall Study|Withdrawal by Subject|1
73839|NCT01278745|287792|P4|Overall Study|Physician Decision|9
73840|NCT01278745|287793|P3|Overall Study|Physician Decision|0
73841|NCT01278745|287794|P2|Overall Study|Physician Decision|0
73842|NCT01278745|287795|P1|Overall Study|Physician Decision|1
73843|NCT01278745|287792|P4|Overall Study|Death|0
73844|NCT01278745|287793|P3|Overall Study|Death|7
73845|NCT01278745|287794|P2|Overall Study|Death|5
73846|NCT01278745|287795|P1|Overall Study|Death|2
73847|NCT01278615|287827|P1|Overall Study|Withdrawal by Subject|2
73848|NCT01278407|287853|P5|Extension Phase|Not Specified|3
73849|NCT01278407|287854|P4|Extension Phase|Not Specified|1
73850|NCT01278407|287855|P3|Extension Phase|Not Specified|0
73851|NCT01278407|287856|P2|Extension Phase|Not Specified|0
73852|NCT01278407|287857|P1|Extension Phase|Not Specified|0
73853|NCT01278407|287853|P5|Extension Phase|Participant's Choice|11
73854|NCT01278407|287854|P4|Extension Phase|Participant's Choice|4
73855|NCT01278407|287855|P3|Extension Phase|Participant's Choice|0
73856|NCT01278407|287856|P2|Extension Phase|Participant's Choice|0
73857|NCT01278407|287857|P1|Extension Phase|Participant's Choice|0
73858|NCT01278407|287853|P5|Extension Phase|Adverse Event|16
73859|NCT01278407|287854|P4|Extension Phase|Adverse Event|7
73860|NCT01278407|287855|P3|Extension Phase|Adverse Event|0
73861|NCT01278407|287856|P2|Extension Phase|Adverse Event|0
73862|NCT01278407|287857|P1|Extension Phase|Adverse Event|0
73863|NCT01278407|287853|P5|Confirmatory Phase|Not Specified|0
73864|NCT01278407|287854|P4|Confirmatory Phase|Not Specified|0
73865|NCT01278407|287855|P3|Confirmatory Phase|Not Specified|2
73866|NCT01278407|287856|P2|Confirmatory Phase|Not Specified|1
73867|NCT01278407|287857|P1|Confirmatory Phase|Not Specified|1
73868|NCT01278407|287853|P5|Confirmatory Phase|Participant's Choice|0
73869|NCT01278407|287854|P4|Confirmatory Phase|Participant's Choice|0
73870|NCT01278407|287855|P3|Confirmatory Phase|Participant's Choice|3
73871|NCT01278407|287856|P2|Confirmatory Phase|Participant's Choice|5
73872|NCT01278407|287857|P1|Confirmatory Phase|Participant's Choice|3
73873|NCT01278407|287853|P5|Confirmatory Phase|Adverse Event|0
73874|NCT01278407|287854|P4|Confirmatory Phase|Adverse Event|0
73875|NCT01278407|287855|P3|Confirmatory Phase|Adverse Event|1
73876|NCT01278407|287856|P2|Confirmatory Phase|Adverse Event|10
73877|NCT01278407|287857|P1|Confirmatory Phase|Adverse Event|5
73878|NCT01278394|287870|P1|Overall Study|Lost to Follow-up|1
73879|NCT01278342|287883|P3|Overall Study|Other|0
73880|NCT01278342|287884|P2|Overall Study|Other|0
73881|NCT01278342|287885|P1|Overall Study|Other|1
73882|NCT01278342|287883|P3|Overall Study|Administrative problems|0
73883|NCT01278342|287884|P2|Overall Study|Administrative problems|0
73884|NCT01278342|287885|P1|Overall Study|Administrative problems|2
73885|NCT01278342|287883|P3|Overall Study|Lost to Follow-up|0
73886|NCT01278342|287884|P2|Overall Study|Lost to Follow-up|0
73887|NCT01278342|287885|P1|Overall Study|Lost to Follow-up|1
73888|NCT01278342|287883|P3|Overall Study|Physician Decision|0
73889|NCT01278342|287884|P2|Overall Study|Physician Decision|1
73890|NCT01278342|287885|P1|Overall Study|Physician Decision|0
73891|NCT01278173|287905|P1|Overall Study|Withdrawal by Subject|1
73892|NCT01278173|287905|P1|Overall Study|Protocol Violation|1
73893|NCT01278173|287905|P1|Overall Study|Administrative or other reason|4
73894|NCT01278173|287905|P1|Overall Study|Adverse Event|8
73895|NCT01278173|287905|P1|Overall Study|Lack of Efficacy|13
73896|NCT01278160|287912|P2|Overall Study|Unclassified|2
73897|NCT01278160|287913|P1|Overall Study|Unclassified|1
73898|NCT01278160|287912|P2|Overall Study|Withdrawal by Subject|2
73899|NCT01278160|287913|P1|Overall Study|Withdrawal by Subject|3
73900|NCT01278160|287912|P2|Overall Study|Lost to Follow-up|1
73901|NCT01278160|287913|P1|Overall Study|Lost to Follow-up|0
73902|NCT01278160|287912|P2|Overall Study|Adverse Event|1
73903|NCT01278160|287913|P1|Overall Study|Adverse Event|1
73904|NCT01278030|287929|P2|Overall Study|Withdrawal by Subject|4
73905|NCT01278030|287930|P1|Overall Study|Withdrawal by Subject|8
73906|NCT01277887|287938|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
73907|NCT01277887|287939|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
73908|NCT01277887|287938|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
73909|NCT01277887|287939|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
73910|NCT01277887|287938|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
73911|NCT01277887|287939|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
73912|NCT01277861|287951|P2|Overall Study|Physician Decision|2
73913|NCT01277861|287952|P1|Overall Study|Physician Decision|2
73914|NCT01277822|287964|P2|Overall Study|Participant moved|0
73915|NCT01277822|287965|P1|Overall Study|Participant moved|1
73916|NCT01277822|287964|P2|Overall Study|Contraindicated medication used|1
73917|NCT01277822|287965|P1|Overall Study|Contraindicated medication used|2
73918|NCT01277822|287964|P2|Overall Study|Lost to Follow-up|1
73919|NCT01277822|287965|P1|Overall Study|Lost to Follow-up|2
73920|NCT01277822|287964|P2|Overall Study|Protocol Violation|0
73921|NCT01277822|287965|P1|Overall Study|Protocol Violation|1
73922|NCT01277822|287964|P2|Overall Study|Physician Decision|1
73923|NCT01277822|287965|P1|Overall Study|Physician Decision|1
73924|NCT01277822|287964|P2|Overall Study|Withdrawal by Subject|7
73925|NCT01277822|287965|P1|Overall Study|Withdrawal by Subject|6
73926|NCT01277822|287964|P2|Overall Study|Adverse Event|1
73927|NCT01277822|287965|P1|Overall Study|Adverse Event|2
73928|NCT01277757|287985|P1|Overall Study|Withdrawal by Subject|1
73929|NCT01277757|287985|P1|Overall Study|Disease Progression|1
73930|NCT01277718|287992|P2|Period 2 - Second Intervention|Physician Decision|2
73931|NCT01277718|287993|P1|Period 2 - Second Intervention|Physician Decision|0
73932|NCT01277718|287992|P2|Period 2 - Second Intervention|Protocol Violation|1
73933|NCT01277718|287993|P1|Period 2 - Second Intervention|Protocol Violation|0
73934|NCT01277666|288007|P3|Overall Study|Death|1
73935|NCT01277666|288008|P2|Overall Study|Death|0
73936|NCT01277666|288009|P1|Overall Study|Death|0
73937|NCT01277666|288007|P3|Overall Study|Withdrawal by Subject|6
73938|NCT01277666|288008|P2|Overall Study|Withdrawal by Subject|8
73939|NCT01277666|288009|P1|Overall Study|Withdrawal by Subject|7
73940|NCT01277666|288007|P3|Overall Study|Lost to Follow-up|2
73941|NCT01277666|288008|P2|Overall Study|Lost to Follow-up|1
73942|NCT01277666|288009|P1|Overall Study|Lost to Follow-up|1
73943|NCT01277666|288007|P3|Overall Study|Protocol Defined Stopping criteria|6
73944|NCT01277666|288008|P2|Overall Study|Protocol Defined Stopping criteria|2
73945|NCT01277666|288009|P1|Overall Study|Protocol Defined Stopping criteria|1
73946|NCT01277666|288007|P3|Overall Study|Protocol Violation|2
73947|NCT01277666|288008|P2|Overall Study|Protocol Violation|3
73948|NCT01277666|288009|P1|Overall Study|Protocol Violation|2
73949|NCT01277666|288007|P3|Overall Study|Lack of Efficacy|12
73950|NCT01277666|288008|P2|Overall Study|Lack of Efficacy|20
73951|NCT01277666|288009|P1|Overall Study|Lack of Efficacy|8
73952|NCT01277666|288007|P3|Overall Study|Adverse Event|20
73953|NCT01277666|288008|P2|Overall Study|Adverse Event|25
73954|NCT01277666|288009|P1|Overall Study|Adverse Event|26
73955|NCT01277601|288042|P4|Overall Study|Subject Terminated from Study by Sponsor|2
73956|NCT01277601|288043|P3|Overall Study|Subject Terminated from Study by Sponsor|0
73957|NCT01277601|288044|P2|Overall Study|Subject Terminated from Study by Sponsor|1
73958|NCT01277601|288045|P1|Overall Study|Subject Terminated from Study by Sponsor|0
73959|NCT01277601|288042|P4|Overall Study|Protocol Violation|0
73960|NCT01277601|288043|P3|Overall Study|Protocol Violation|5
73961|NCT01277601|288044|P2|Overall Study|Protocol Violation|2
73962|NCT01277601|288045|P1|Overall Study|Protocol Violation|0
73963|NCT01277601|288042|P4|Overall Study|Subject Never Dosed with Study Drug|1
73964|NCT01277601|288043|P3|Overall Study|Subject Never Dosed with Study Drug|3
73965|NCT01277601|288044|P2|Overall Study|Subject Never Dosed with Study Drug|2
73966|NCT01277601|288045|P1|Overall Study|Subject Never Dosed with Study Drug|1
73967|NCT01277601|288042|P4|Overall Study|Noncompliance with Study Drug|0
73968|NCT01277601|288043|P3|Overall Study|Noncompliance with Study Drug|2
73969|NCT01277601|288044|P2|Overall Study|Noncompliance with Study Drug|3
73970|NCT01277601|288045|P1|Overall Study|Noncompliance with Study Drug|1
73971|NCT01277601|288042|P4|Overall Study|Pregnancy|1
73972|NCT01277601|288043|P3|Overall Study|Pregnancy|4
73973|NCT01277601|288044|P2|Overall Study|Pregnancy|2
73974|NCT01277601|288045|P1|Overall Study|Pregnancy|2
73975|NCT01277601|288042|P4|Overall Study|Physician Decision|6
73976|NCT01277601|288043|P3|Overall Study|Physician Decision|1
73977|NCT01277601|288044|P2|Overall Study|Physician Decision|5
73978|NCT01277601|288045|P1|Overall Study|Physician Decision|3
73979|NCT01277601|288042|P4|Overall Study|Lost to Follow-up|2
73980|NCT01277601|288043|P3|Overall Study|Lost to Follow-up|4
73981|NCT01277601|288044|P2|Overall Study|Lost to Follow-up|9
73982|NCT01277601|288045|P1|Overall Study|Lost to Follow-up|7
73983|NCT01277601|288042|P4|Overall Study|Withdrawal by Subject|17
73984|NCT01277601|288043|P3|Overall Study|Withdrawal by Subject|8
73985|NCT01277601|288044|P2|Overall Study|Withdrawal by Subject|21
73986|NCT01277601|288045|P1|Overall Study|Withdrawal by Subject|18
73987|NCT01277601|288042|P4|Overall Study|Adverse Event|7
73988|NCT01277601|288043|P3|Overall Study|Adverse Event|0
73989|NCT01277601|288044|P2|Overall Study|Adverse Event|3
73990|NCT01277601|288045|P1|Overall Study|Adverse Event|5
73991|NCT01277549|288136|P2|Overall Study|Physician Decision|1
73992|NCT01277549|288137|P1|Overall Study|Physician Decision|2
73993|NCT01277549|288136|P2|Overall Study|Protocol Violation|1
73994|NCT01277549|288137|P1|Overall Study|Protocol Violation|10
73995|NCT01277549|288136|P2|Overall Study|Withdrawal by Subject|3
73996|NCT01277549|288137|P1|Overall Study|Withdrawal by Subject|1
73997|NCT01277549|288136|P2|Overall Study|Failed to meet eligibility criteria|9
73998|NCT01277549|288137|P1|Overall Study|Failed to meet eligibility criteria|13
73999|NCT01277523|288154|P3|Overall Study|Other Reason not Defined|0
74000|NCT01277523|288155|P2|Overall Study|Other Reason not Defined|1
74001|NCT01277523|288156|P1|Overall Study|Other Reason not Defined|0
74002|NCT01277523|288154|P3|Overall Study|Protocol Violation|0
74003|NCT01277523|288155|P2|Overall Study|Protocol Violation|0
74004|NCT01277523|288156|P1|Overall Study|Protocol Violation|2
74005|NCT01277523|288154|P3|Overall Study|Adverse Event|0
74006|NCT01277523|288155|P2|Overall Study|Adverse Event|0
74007|NCT01277523|288156|P1|Overall Study|Adverse Event|1
74008|NCT01277510|288208|P2|Open-label Phase|Never received investigational product|0
74009|NCT01277510|288209|P1|Open-label Phase|Never received investigational product|2
74010|NCT01277510|288208|P2|Open-label Phase|Protocol-specified criteria|0
74011|NCT01277510|288209|P1|Open-label Phase|Protocol-specified criteria|1
74012|NCT01277510|288208|P2|Open-label Phase|Administrative decision|3
74013|NCT01277510|288209|P1|Open-label Phase|Administrative decision|4
74014|NCT01277510|288208|P2|Double-blind Phase|Other|1
74015|NCT01277510|288209|P1|Double-blind Phase|Other|1
74016|NCT01277510|288208|P2|Double-blind Phase|Protocol-specified criteria|6
74017|NCT01277510|288209|P1|Double-blind Phase|Protocol-specified criteria|2
74018|NCT01277510|288208|P2|Double-blind Phase|Death|1
74019|NCT01277510|288209|P1|Double-blind Phase|Death|0
74020|NCT01277510|288208|P2|Double-blind Phase|Administrative decision|9
74021|NCT01277510|288209|P1|Double-blind Phase|Administrative decision|7
74022|NCT01277510|288208|P2|Double-blind Phase|Withdrawal by Subject|0
74023|NCT01277510|288209|P1|Double-blind Phase|Withdrawal by Subject|2
74024|NCT01277510|288208|P2|Double-blind Phase|Adverse Event|0
74025|NCT01277510|288209|P1|Double-blind Phase|Adverse Event|1
74026|NCT01277510|288208|P2|Double-blind Phase|Non-compliance|1
74027|NCT01277510|288209|P1|Double-blind Phase|Non-compliance|0
74028|NCT01277302|288243|P3|8-Month Alternate Dose Regimen Period|Relocation|1
74029|NCT01277302|288244|P2|8-Month Alternate Dose Regimen Period|Relocation|0
74030|NCT01277302|288245|P1|8-Month Alternate Dose Regimen Period|Relocation|1
74031|NCT01277302|288243|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
74032|NCT01277302|288244|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
74033|NCT01277302|288245|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
74034|NCT01277302|288243|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
74035|NCT01277302|288244|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
74036|NCT01277302|288245|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
74037|NCT01277302|288243|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
74038|NCT01277302|288244|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
74039|NCT01277302|288245|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
74040|NCT01277302|288243|P3|8-Month Alternate Dose Regimen Period|Death|0
74041|NCT01277302|288244|P2|8-Month Alternate Dose Regimen Period|Death|1
74042|NCT01277302|288245|P1|8-Month Alternate Dose Regimen Period|Death|0
74043|NCT01277302|288243|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
74044|NCT01277302|288244|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
74045|NCT01277302|288245|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
74046|NCT01277302|288243|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
74047|NCT01277302|288244|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
74048|NCT01277302|288245|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
74049|NCT01277302|288243|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
74050|NCT01277302|288244|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
74051|NCT01277302|288245|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
74052|NCT01277302|288243|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
74053|NCT01277302|288244|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
74054|NCT01277302|288245|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
74055|NCT01277211|288277|P2|Overall Study|Discontinued prior to treatment|13
74056|NCT01277211|288278|P1|Overall Study|Discontinued prior to treatment|24
74057|NCT01277211|288277|P2|Overall Study|Pregnancy wish|2
74058|NCT01277211|288278|P1|Overall Study|Pregnancy wish|0
74059|NCT01277211|288277|P2|Overall Study|Administrative|0
74060|NCT01277211|288278|P1|Overall Study|Administrative|3
74061|NCT01277211|288277|P2|Overall Study|Did not meet protocol eligibility|0
74062|NCT01277211|288278|P1|Overall Study|Did not meet protocol eligibility|1
74063|NCT01277211|288277|P2|Overall Study|Non-compliance with protocol|4
74064|NCT01277211|288278|P1|Overall Study|Non-compliance with protocol|13
74065|NCT01277211|288277|P2|Overall Study|Withdrew Consent|9
74066|NCT01277211|288278|P1|Overall Study|Withdrew Consent|9
74067|NCT01277211|288277|P2|Overall Study|Did not wish to continue|0
74068|NCT01277211|288278|P1|Overall Study|Did not wish to continue|17
74069|NCT01277211|288277|P2|Overall Study|Lost to Follow-up|9
74070|NCT01277211|288278|P1|Overall Study|Lost to Follow-up|14
74071|NCT01277211|288277|P2|Overall Study|Pregnancy|4
74072|NCT01277211|288278|P1|Overall Study|Pregnancy|9
74073|NCT01277211|288277|P2|Overall Study|Adverse Event|22
74074|NCT01277211|288278|P1|Overall Study|Adverse Event|60
74075|NCT01277042|288330|P2|Overall Study|Withdrawal by Subject|0
74076|NCT01277042|288331|P1|Overall Study|Withdrawal by Subject|2
74077|NCT01277042|288330|P2|Overall Study|Lost to Follow-up|2
74078|NCT01277042|288331|P1|Overall Study|Lost to Follow-up|2
74079|NCT01277042|288330|P2|Overall Study|Adverse Event|3
74080|NCT01277042|288331|P1|Overall Study|Adverse Event|4
74081|NCT01276847|288356|P3|Overall Study|Withdrawal by Subject|0
74082|NCT01276847|288357|P2|Overall Study|Withdrawal by Subject|0
74083|NCT01276847|288358|P1|Overall Study|Withdrawal by Subject|1
74084|NCT01276821|288368|P2|Overall Study|Protocol Violation|1
74085|NCT01276821|288369|P1|Overall Study|Protocol Violation|0
74086|NCT01276756|288389|P2|Overall Study|Adverse Event|2
74087|NCT01276756|288390|P1|Overall Study|Adverse Event|3
74088|NCT01276756|288389|P2|Overall Study|Lost to Follow-up|0
74089|NCT01276756|288390|P1|Overall Study|Lost to Follow-up|2
74090|NCT01276639|288435|P5|Week 16 to 52|Other|3
74091|NCT01276639|288436|P4|Week 16 to 52|Other|1
74092|NCT01276639|288437|P3|Week 16 to 52|Other|0
74093|NCT01276639|288438|P2|Week 16 to 52|Other|12
74094|NCT01276639|288439|P1|Week 16 to 52|Other|10
74095|NCT01276639|288435|P5|Week 16 to 52|Withdrawal by Subject|1
74096|NCT01276639|288436|P4|Week 16 to 52|Withdrawal by Subject|0
74097|NCT01276639|288437|P3|Week 16 to 52|Withdrawal by Subject|0
74098|NCT01276639|288438|P2|Week 16 to 52|Withdrawal by Subject|4
74099|NCT01276639|288439|P1|Week 16 to 52|Withdrawal by Subject|4
74100|NCT01276639|288435|P5|Week 16 to 52|Lost to Follow-up|1
74101|NCT01276639|288436|P4|Week 16 to 52|Lost to Follow-up|0
74102|NCT01276639|288437|P3|Week 16 to 52|Lost to Follow-up|0
74103|NCT01276639|288438|P2|Week 16 to 52|Lost to Follow-up|1
74104|NCT01276639|288439|P1|Week 16 to 52|Lost to Follow-up|3
74105|NCT01276639|288435|P5|Week 16 to 52|Lack of Efficacy|13
74106|NCT01276639|288436|P4|Week 16 to 52|Lack of Efficacy|14
74107|NCT01276639|288437|P3|Week 16 to 52|Lack of Efficacy|0
74108|NCT01276639|288438|P2|Week 16 to 52|Lack of Efficacy|71
74109|NCT01276639|288439|P1|Week 16 to 52|Lack of Efficacy|99
74110|NCT01276639|288435|P5|Week 16 to 52|Adverse Event|3
74111|NCT01276639|288436|P4|Week 16 to 52|Adverse Event|1
74112|NCT01276639|288437|P3|Week 16 to 52|Adverse Event|0
74113|NCT01276639|288438|P2|Week 16 to 52|Adverse Event|13
74114|NCT01276639|288439|P1|Week 16 to 52|Adverse Event|10
74115|NCT01276639|288435|P5|Week 16 to 52|Death|0
74116|NCT01276639|288436|P4|Week 16 to 52|Death|0
74117|NCT01276639|288437|P3|Week 16 to 52|Death|0
74118|NCT01276639|288438|P2|Week 16 to 52|Death|0
74119|NCT01276639|288439|P1|Week 16 to 52|Death|1
74120|NCT01276639|288435|P5|Week 0 to 16|Randomized, But Not Treated|0
74121|NCT01276639|288436|P4|Week 0 to 16|Randomized, But Not Treated|0
74122|NCT01276639|288437|P3|Week 0 to 16|Randomized, But Not Treated|0
74123|NCT01276639|288438|P2|Week 0 to 16|Randomized, But Not Treated|1
74124|NCT01276639|288439|P1|Week 0 to 16|Randomized, But Not Treated|0
74125|NCT01276639|288435|P5|Week 0 to 16|Other|0
74126|NCT01276639|288436|P4|Week 0 to 16|Other|0
74127|NCT01276639|288437|P3|Week 0 to 16|Other|2
74128|NCT01276639|288438|P2|Week 0 to 16|Other|7
74129|NCT01276639|288439|P1|Week 0 to 16|Other|7
74130|NCT01276639|288435|P5|Week 0 to 16|Withdrawal by Subject|0
74131|NCT01276639|288436|P4|Week 0 to 16|Withdrawal by Subject|0
74132|NCT01276639|288437|P3|Week 0 to 16|Withdrawal by Subject|4
74133|NCT01276639|288438|P2|Week 0 to 16|Withdrawal by Subject|5
74134|NCT01276639|288439|P1|Week 0 to 16|Withdrawal by Subject|8
74135|NCT01276639|288435|P5|Week 0 to 16|Lost to Follow-up|0
74136|NCT01276639|288436|P4|Week 0 to 16|Lost to Follow-up|0
74137|NCT01276639|288437|P3|Week 0 to 16|Lost to Follow-up|3
74138|NCT01276639|288438|P2|Week 0 to 16|Lost to Follow-up|5
74139|NCT01276639|288439|P1|Week 0 to 16|Lost to Follow-up|3
74140|NCT01276639|288435|P5|Week 0 to 16|Lack of Efficacy|0
74141|NCT01276639|288436|P4|Week 0 to 16|Lack of Efficacy|0
74142|NCT01276639|288437|P3|Week 0 to 16|Lack of Efficacy|25
74143|NCT01276639|288438|P2|Week 0 to 16|Lack of Efficacy|15
74144|NCT01276639|288439|P1|Week 0 to 16|Lack of Efficacy|20
74145|NCT01276639|288435|P5|Week 0 to 16|Adverse Event|0
74146|NCT01276639|288436|P4|Week 0 to 16|Adverse Event|0
74147|NCT01276639|288437|P3|Week 0 to 16|Adverse Event|11
74148|NCT01276639|288438|P2|Week 0 to 16|Adverse Event|8
74149|NCT01276639|288439|P1|Week 0 to 16|Adverse Event|11
74150|NCT01276639|288435|P5|Week 0 to 16|Death|0
74151|NCT01276639|288436|P4|Week 0 to 16|Death|0
74152|NCT01276639|288437|P3|Week 0 to 16|Death|0
74153|NCT01276639|288438|P2|Week 0 to 16|Death|0
74154|NCT01276639|288439|P1|Week 0 to 16|Death|1
74155|NCT01276509|288644|P4|Overall Study|Other|0
74156|NCT01276509|288645|P3|Overall Study|Other|0
74157|NCT01276509|288646|P2|Overall Study|Other|1
74158|NCT01276509|288647|P1|Overall Study|Other|0
74159|NCT01276509|288644|P4|Overall Study|Withdrawal by Subject|0
74160|NCT01276509|288645|P3|Overall Study|Withdrawal by Subject|0
74161|NCT01276509|288646|P2|Overall Study|Withdrawal by Subject|2
74162|NCT01276509|288647|P1|Overall Study|Withdrawal by Subject|1
74163|NCT01276509|288644|P4|Overall Study|Pregnancy|0
74164|NCT01276509|288645|P3|Overall Study|Pregnancy|0
74165|NCT01276509|288646|P2|Overall Study|Pregnancy|0
74166|NCT01276509|288647|P1|Overall Study|Pregnancy|1
74167|NCT01276509|288644|P4|Overall Study|Lack of Efficacy|2
74168|NCT01276509|288645|P3|Overall Study|Lack of Efficacy|1
74169|NCT01276509|288646|P2|Overall Study|Lack of Efficacy|1
74170|NCT01276509|288647|P1|Overall Study|Lack of Efficacy|2
74171|NCT01276509|288644|P4|Overall Study|Adverse Event|3
74172|NCT01276509|288645|P3|Overall Study|Adverse Event|4
74173|NCT01276509|288646|P2|Overall Study|Adverse Event|8
74174|NCT01276509|288647|P1|Overall Study|Adverse Event|9
74175|NCT01276457|288700|P2|Extension Study|Lack of Efficacy|1
74176|NCT01276457|288701|P1|Extension Study|Lack of Efficacy|3
74177|NCT01276457|288700|P2|Extension Study|Death|1
74178|NCT01276457|288701|P1|Extension Study|Death|0
74179|NCT01276457|288700|P2|Extension Study|Lost to Follow-up|0
74180|NCT01276457|288701|P1|Extension Study|Lost to Follow-up|3
74181|NCT01276457|288700|P2|Core Study|Lack of Efficacy|12
74182|NCT01276457|288701|P1|Core Study|Lack of Efficacy|3
74183|NCT01276457|288700|P2|Core Study|Death|2
74184|NCT01276457|288701|P1|Core Study|Death|2
74185|NCT01276457|288700|P2|Core Study|Administrative problems|1
74186|NCT01276457|288701|P1|Core Study|Administrative problems|1
74187|NCT01276457|288700|P2|Core Study|Lost to Follow-up|2
74188|NCT01276457|288701|P1|Core Study|Lost to Follow-up|1
74189|NCT01276457|288700|P2|Core Study|Adverse Event|3
74190|NCT01276457|288701|P1|Core Study|Adverse Event|6
74191|NCT01276353|288715|P2|Extension|Prohibited concomitant medications|1
74192|NCT01276353|288716|P1|Extension|Prohibited concomitant medications|0
74193|NCT01276353|288715|P2|Extension|Physician Decision|0
74194|NCT01276353|288716|P1|Extension|Physician Decision|1
74195|NCT01276353|288715|P2|Extension|Withdrawal of study drug 4 days in a row|1
74196|NCT01276353|288716|P1|Extension|Withdrawal of study drug 4 days in a row|3
74197|NCT01276353|288715|P2|Extension|Withdrawal by Subject|2
74198|NCT01276353|288716|P1|Extension|Withdrawal by Subject|1
74199|NCT01276353|288715|P2|Extension|Adverse Event|5
74200|NCT01276353|288716|P1|Extension|Adverse Event|2
74201|NCT01276353|288715|P2|Double-blind|Withdrawal by Subject|0
74202|NCT01276353|288716|P1|Double-blind|Withdrawal by Subject|1
74203|NCT01276353|288715|P2|Double-blind|Adverse Event|0
74204|NCT01276353|288716|P1|Double-blind|Adverse Event|2
74205|NCT01276327|288728|P2|Overall Study|Withdrawal by Subject|0
74206|NCT01276327|288729|P1|Overall Study|Withdrawal by Subject|1
74207|NCT01276327|288728|P2|Overall Study|Adverse Event|3
74208|NCT01276327|288729|P1|Overall Study|Adverse Event|1
74209|NCT01276288|288796|P4|Overall Study|not treated|0
74210|NCT01276288|288797|P3|Overall Study|not treated|0
74211|NCT01276288|288798|P2|Overall Study|not treated|0
74212|NCT01276288|288799|P1|Overall Study|not treated|1
74213|NCT01276288|288796|P4|Overall Study|Adverse Event|0
74214|NCT01276288|288797|P3|Overall Study|Adverse Event|0
74215|NCT01276288|288798|P2|Overall Study|Adverse Event|1
74216|NCT01276288|288799|P1|Overall Study|Adverse Event|1
74217|NCT01276223|288926|P3|Overall Study|Protocol Violation|0
74218|NCT01276223|288927|P2|Overall Study|Protocol Violation|0
74219|NCT01276223|288928|P1|Overall Study|Protocol Violation|1
74220|NCT01276223|288926|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
74221|NCT01276223|288927|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
74222|NCT01276223|288928|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
74223|NCT01276223|288926|P3|Overall Study|Not specified|1
74224|NCT01276223|288927|P2|Overall Study|Not specified|0
74225|NCT01276223|288928|P1|Overall Study|Not specified|0
74226|NCT01276223|288926|P3|Overall Study|Lost to Follow-up|1
74227|NCT01276223|288927|P2|Overall Study|Lost to Follow-up|0
74228|NCT01276223|288928|P1|Overall Study|Lost to Follow-up|0
74229|NCT01276223|288926|P3|Overall Study|Adverse Event|1
74230|NCT01276223|288927|P2|Overall Study|Adverse Event|4
74231|NCT01276223|288928|P1|Overall Study|Adverse Event|7
74232|NCT01276106|288969|P4|Overall Study|Insufficient therapeutic effects|0
74233|NCT01276106|288970|P3|Overall Study|Insufficient therapeutic effects|2
74234|NCT01276106|288971|P2|Overall Study|Insufficient therapeutic effects|0
74235|NCT01276106|288972|P1|Overall Study|Insufficient therapeutic effects|0
74236|NCT01276106|288969|P4|Overall Study|Protocol Violation|2
74237|NCT01276106|288970|P3|Overall Study|Protocol Violation|0
74238|NCT01276106|288971|P2|Overall Study|Protocol Violation|1
74239|NCT01276106|288972|P1|Overall Study|Protocol Violation|1
74240|NCT01276106|288969|P4|Overall Study|Physician Decision|1
74241|NCT01276106|288970|P3|Overall Study|Physician Decision|1
74242|NCT01276106|288971|P2|Overall Study|Physician Decision|0
74243|NCT01276106|288972|P1|Overall Study|Physician Decision|0
74244|NCT01276106|288969|P4|Overall Study|Lost to Follow-up|0
74245|NCT01276106|288970|P3|Overall Study|Lost to Follow-up|1
74246|NCT01276106|288971|P2|Overall Study|Lost to Follow-up|1
74247|NCT01276106|288972|P1|Overall Study|Lost to Follow-up|2
74248|NCT01276106|288969|P4|Overall Study|Lack of Efficacy|1
74249|NCT01276106|288970|P3|Overall Study|Lack of Efficacy|0
74250|NCT01276106|288971|P2|Overall Study|Lack of Efficacy|1
74251|NCT01276106|288972|P1|Overall Study|Lack of Efficacy|0
74252|NCT01276106|288969|P4|Overall Study|Withdrawal by Subject|6
74253|NCT01276106|288970|P3|Overall Study|Withdrawal by Subject|1
74254|NCT01276106|288971|P2|Overall Study|Withdrawal by Subject|3
74255|NCT01276106|288972|P1|Overall Study|Withdrawal by Subject|6
74256|NCT01276106|288969|P4|Overall Study|Adverse Event|3
74257|NCT01276106|288970|P3|Overall Study|Adverse Event|11
74258|NCT01276106|288971|P2|Overall Study|Adverse Event|3
74259|NCT01276106|288972|P1|Overall Study|Adverse Event|3
74260|NCT01276054|288984|P2|Overall Study|No one to oversee trial after P.I. left|2
74261|NCT01276054|288985|P1|Overall Study|No one to oversee trial after P.I. left|2
74262|NCT01275833|288993|P2|Overall Study|Study terminated|1
74263|NCT01275833|288994|P1|Overall Study|Study terminated|1
74264|NCT01275755|289002|P2|Run-out Placebo Period|Lost to Follow-up|0
74265|NCT01275755|289003|P1|Run-out Placebo Period|Lost to Follow-up|1
74266|NCT01275755|289002|P2|Double-blind Treatment Period|Withdrawal by Subject|0
74267|NCT01275755|289003|P1|Double-blind Treatment Period|Withdrawal by Subject|1
74268|NCT01275755|289002|P2|Double-blind Treatment Period|Lost to Follow-up|1
74269|NCT01275755|289003|P1|Double-blind Treatment Period|Lost to Follow-up|1
74270|NCT01275755|289002|P2|Double-blind Treatment Period|Adverse Event|2
74271|NCT01275755|289003|P1|Double-blind Treatment Period|Adverse Event|0
74272|NCT01275625|289017|P1|Overall Study|Not specified|1
74273|NCT01275625|289017|P1|Overall Study|Adverse Event|4
74274|NCT01275625|289017|P1|Overall Study|Protocol Violation|1
74275|NCT01275625|289017|P1|Overall Study|Withdrawal by Subject|3
74276|NCT01275625|289017|P1|Overall Study|Lost to Follow-up|1
74277|NCT01275625|289017|P1|Overall Study|Lack of Efficacy|2
74278|NCT01275625|289017|P1|Overall Study|Death|1
74279|NCT01275430|289035|P1|Overall Study|Inability to achieve maximum p-wave|1
74280|NCT01275430|289035|P1|Overall Study|Device Malfunction|1
74281|NCT01275430|289035|P1|Overall Study|No Contrast Injection|6
74282|NCT01275430|289035|P1|Overall Study|Adverse Event|1
74283|NCT01275196|289107|P2|Overall Study|Suboptimal response/treatment failure|6
74284|NCT01275196|289108|P1|Overall Study|Suboptimal response/treatment failure|5
74285|NCT01275196|289107|P2|Overall Study|Protocol Violation|0
74286|NCT01275196|289108|P1|Overall Study|Protocol Violation|1
74287|NCT01275196|289107|P2|Overall Study|Disease Progression|5
74288|NCT01275196|289108|P1|Overall Study|Disease Progression|6
74289|NCT01275196|289107|P2|Overall Study|Lost to Follow-up|0
74290|NCT01275196|289108|P1|Overall Study|Lost to Follow-up|1
74291|NCT01275196|289107|P2|Overall Study|Withdrawal by Subject|5
74292|NCT01275196|289108|P1|Overall Study|Withdrawal by Subject|4
74293|NCT01275196|289107|P2|Overall Study|Adverse Event|5
74294|NCT01275196|289108|P1|Overall Study|Adverse Event|3
74295|NCT01275131|289151|P4|Period 2 (Crossover)|Withdrawal by Subject|2
74296|NCT01275131|289152|P3|Period 2 (Crossover)|Withdrawal by Subject|1
74297|NCT01275131|289153|P2|Period 2 (Crossover)|Withdrawal by Subject|0
74298|NCT01275131|289154|P1|Period 2 (Crossover)|Withdrawal by Subject|1
74299|NCT01275131|289151|P4|Period 2 (Crossover)|Adverse Event|0
74300|NCT01275131|289152|P3|Period 2 (Crossover)|Adverse Event|0
74301|NCT01275131|289153|P2|Period 2 (Crossover)|Adverse Event|1
74302|NCT01275131|289154|P1|Period 2 (Crossover)|Adverse Event|0
74303|NCT01275131|289151|P4|Period 1|Physician Decision|0
74304|NCT01275131|289152|P3|Period 1|Physician Decision|0
74305|NCT01275131|289153|P2|Period 1|Physician Decision|0
74306|NCT01275131|289154|P1|Period 1|Physician Decision|1
74307|NCT01275131|289151|P4|Period 1|Withdrawal by Subject|2
74308|NCT01275131|289152|P3|Period 1|Withdrawal by Subject|3
74309|NCT01275131|289153|P2|Period 1|Withdrawal by Subject|0
74310|NCT01275131|289154|P1|Period 1|Withdrawal by Subject|1
74311|NCT01275066|289197|P3|Overall Study|Not Diagnosed w/ Disease|0
74312|NCT01275066|289198|P2|Overall Study|Not Diagnosed w/ Disease|0
74313|NCT01275066|289199|P1|Overall Study|Not Diagnosed w/ Disease|1
74314|NCT01275066|289197|P3|Overall Study|Withdrawal by Subject|1
74315|NCT01275066|289198|P2|Overall Study|Withdrawal by Subject|0
74316|NCT01275066|289199|P1|Overall Study|Withdrawal by Subject|0
74317|NCT01274715|289232|P1|Overall Study|After consent, met exclusion criteria.|1
74318|NCT01274715|289232|P1|Overall Study|After consent, met exclusion criteria.|1
74319|NCT01274715|289232|P1|Overall Study|After consent, met exclusion criteria.|1
74320|NCT01274715|289232|P1|Overall Study|Lost to Follow-up|1
74321|NCT01274637|289239|P2|Overall Study|Lost to Follow-up|1
74322|NCT01274637|289240|P1|Overall Study|Lost to Follow-up|0
74323|NCT01274637|289239|P2|Overall Study|Withdrawal by Subject|1
74324|NCT01274637|289240|P1|Overall Study|Withdrawal by Subject|0
74325|NCT01274559|289279|P2|Overall Study|Withdrawal by Subject|13
74326|NCT01274559|289280|P1|Overall Study|Withdrawal by Subject|25
74327|NCT01274559|289279|P2|Overall Study|Study Terminated by Sponsor|87
74328|NCT01274559|289280|P1|Overall Study|Study Terminated by Sponsor|79
74329|NCT01274559|289279|P2|Overall Study|Protocol Violation|23
74330|NCT01274559|289280|P1|Overall Study|Protocol Violation|28
74331|NCT01274559|289279|P2|Overall Study|Physician Decision|1
74332|NCT01274559|289280|P1|Overall Study|Physician Decision|2
74333|NCT01274559|289279|P2|Overall Study|Non-compliance with Study Drug|4
74334|NCT01274559|289280|P1|Overall Study|Non-compliance with Study Drug|2
74335|NCT01274559|289279|P2|Overall Study|Lost to Follow-up|3
74336|NCT01274559|289280|P1|Overall Study|Lost to Follow-up|3
74337|NCT01274559|289279|P2|Overall Study|Death|1
74338|NCT01274559|289280|P1|Overall Study|Death|1
74339|NCT01274559|289279|P2|Overall Study|Adverse Event|13
74340|NCT01274559|289280|P1|Overall Study|Adverse Event|57
74341|NCT01274533|289330|P1|Overall Study|Disease progression|2
74342|NCT01274533|289330|P1|Overall Study|Non-compliance|1
74343|NCT01274533|289330|P1|Overall Study|Withdrawal by Subject|1
74344|NCT01274429|289335|P1|Overall Study|Study closed do to lack of funding|5
74345|NCT01274182|289343|P3|Overall Study|Death|1
74346|NCT01274182|289344|P2|Overall Study|Death|0
74347|NCT01274182|289345|P1|Overall Study|Death|1
74348|NCT01274182|289343|P3|Overall Study|Protocol Violation|0
74349|NCT01274182|289344|P2|Overall Study|Protocol Violation|2
74350|NCT01274182|289345|P1|Overall Study|Protocol Violation|3
74351|NCT01274182|289343|P3|Overall Study|Lost to Follow-up|1
74352|NCT01274182|289344|P2|Overall Study|Lost to Follow-up|3
74353|NCT01274182|289345|P1|Overall Study|Lost to Follow-up|2
74354|NCT01274182|289343|P3|Overall Study|Withdrawal by Subject|3
74355|NCT01274182|289344|P2|Overall Study|Withdrawal by Subject|5
74356|NCT01274182|289345|P1|Overall Study|Withdrawal by Subject|5
74357|NCT01274182|289343|P3|Overall Study|Adverse Event|3
74358|NCT01274182|289344|P2|Overall Study|Adverse Event|5
74359|NCT01274182|289345|P1|Overall Study|Adverse Event|4
74360|NCT01274182|289343|P3|Overall Study|Unsatisfactory therapeutic effect|4
74361|NCT01274182|289344|P2|Overall Study|Unsatisfactory therapeutic effect|3
74362|NCT01274182|289345|P1|Overall Study|Unsatisfactory therapeutic effect|6
74363|NCT01273883|289386|P2|Second Intervention|Lack of Efficacy|0
74364|NCT01273883|289387|P1|Second Intervention|Lack of Efficacy|1
74365|NCT01273883|289386|P2|Second Intervention|Lost to Follow-up|1
74366|NCT01273883|289387|P1|Second Intervention|Lost to Follow-up|1
74367|NCT01273883|289386|P2|First Intervention|Adverse Event|1
74368|NCT01273883|289387|P1|First Intervention|Adverse Event|2
74369|NCT01273818|289413|P3|Overall Study|Physician Decision|9
74370|NCT01273818|289414|P2|Overall Study|Physician Decision|2
74371|NCT01273818|289415|P1|Overall Study|Physician Decision|13
74372|NCT01273805|289425|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
74373|NCT01273805|289426|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
74374|NCT01273623|289457|P1|Overall Study|did not meet IVUS criteria|29
74375|NCT01273597|289464|P1|Overall Study|Reason Not Reported|1
74376|NCT01273597|289464|P1|Overall Study|Underwent Kidney Transplantation|2
74377|NCT01273597|289464|P1|Overall Study|Adverse Event|5
74378|NCT01273519|289479|P3|Overall Study|Not Specified|1
74379|NCT01273519|289480|P2|Overall Study|Not Specified|1
74380|NCT01273519|289481|P1|Overall Study|Not Specified|6
74381|NCT01273519|289479|P3|Overall Study|Lack of Efficacy|4
74382|NCT01273519|289480|P2|Overall Study|Lack of Efficacy|3
74383|NCT01273519|289481|P1|Overall Study|Lack of Efficacy|8
74384|NCT01273519|289479|P3|Overall Study|Lost to Follow-up|3
74385|NCT01273519|289480|P2|Overall Study|Lost to Follow-up|1
74386|NCT01273519|289481|P1|Overall Study|Lost to Follow-up|2
74387|NCT01273519|289479|P3|Overall Study|Adverse Event|0
74388|NCT01273519|289480|P2|Overall Study|Adverse Event|0
74389|NCT01273519|289481|P1|Overall Study|Adverse Event|3
74390|NCT01273181|289518|P4|Phase 2, Dose 2|Death during treatment|1
74391|NCT01273181|289519|P3|Phase 2, Dose 2|Death during treatment|0
74392|NCT01273181|289520|P2|Phase 2, Dose 2|Death during treatment|0
74393|NCT01273181|289521|P1|Phase 2, Dose 2|Death during treatment|0
74394|NCT01273181|289518|P4|Phase 2, Dose 1|Study termination|0
74395|NCT01273181|289519|P3|Phase 2, Dose 1|Study termination|1
74396|NCT01273181|289520|P2|Phase 2, Dose 1|Study termination|0
74397|NCT01273181|289521|P1|Phase 2, Dose 1|Study termination|0
74398|NCT01273181|289518|P4|Phase I, Dose 2|Death during treatment|0
74399|NCT01273181|289519|P3|Phase I, Dose 2|Death during treatment|0
74400|NCT01273181|289520|P2|Phase I, Dose 2|Death during treatment|1
74401|NCT01273181|289521|P1|Phase I, Dose 2|Death during treatment|0
74402|NCT01273181|289518|P4|Phase I, Dose 1|Study termination|0
74403|NCT01273181|289519|P3|Phase I, Dose 1|Study termination|0
74404|NCT01273181|289520|P2|Phase I, Dose 1|Study termination|0
74405|NCT01273181|289521|P1|Phase I, Dose 1|Study termination|1
74406|NCT01273064|289540|P5|Overall Study|Physician Decision|1
74407|NCT01273064|289541|P4|Overall Study|Physician Decision|0
74408|NCT01273064|289542|P3|Overall Study|Physician Decision|0
74409|NCT01273064|289543|P2|Overall Study|Physician Decision|0
74410|NCT01273064|289544|P1|Overall Study|Physician Decision|0
74411|NCT01273064|289540|P5|Overall Study|Lost to Follow-up|0
74412|NCT01273064|289541|P4|Overall Study|Lost to Follow-up|0
74413|NCT01273064|289542|P3|Overall Study|Lost to Follow-up|0
74414|NCT01273064|289543|P2|Overall Study|Lost to Follow-up|0
74415|NCT01273064|289544|P1|Overall Study|Lost to Follow-up|1
74416|NCT01273064|289540|P5|Overall Study|Study Termination|8
74417|NCT01273064|289541|P4|Overall Study|Study Termination|16
74418|NCT01273064|289542|P3|Overall Study|Study Termination|26
74419|NCT01273064|289543|P2|Overall Study|Study Termination|27
74420|NCT01273064|289544|P1|Overall Study|Study Termination|13
74421|NCT01273064|289540|P5|Overall Study|Withdrawal by Subject|0
74422|NCT01273064|289541|P4|Overall Study|Withdrawal by Subject|2
74423|NCT01273064|289542|P3|Overall Study|Withdrawal by Subject|2
74424|NCT01273064|289543|P2|Overall Study|Withdrawal by Subject|2
74425|NCT01273064|289544|P1|Overall Study|Withdrawal by Subject|4
74426|NCT01273064|289540|P5|Overall Study|Adverse Event|1
74427|NCT01273064|289541|P4|Overall Study|Adverse Event|2
74428|NCT01273064|289542|P3|Overall Study|Adverse Event|3
74429|NCT01273064|289543|P2|Overall Study|Adverse Event|1
74430|NCT01273064|289544|P1|Overall Study|Adverse Event|5
74431|NCT01273038|289563|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
74432|NCT01273038|289564|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
74433|NCT01273038|289563|P2|Second Intervention (14 Days)|Adverse Event|1
74434|NCT01273038|289564|P1|Second Intervention (14 Days)|Adverse Event|0
74435|NCT01272947|289587|P2|Overall Study|Abnormal Laboratory Value|2
74436|NCT01272947|289588|P1|Overall Study|Abnormal Laboratory Value|2
74437|NCT01272934|289598|P2|Overall Study|Abnormal Laboratory Value|1
74438|NCT01272934|289599|P1|Overall Study|Abnormal Laboratory Value|0
74439|NCT01272934|289598|P2|Overall Study|Adverse Event|1
74440|NCT01272934|289599|P1|Overall Study|Adverse Event|0
74441|NCT01272921|289609|P2|Overall Study|Protocol Violation|1
74442|NCT01272921|289610|P1|Overall Study|Protocol Violation|2
74443|NCT01272908|289618|P1|Re-Treatment Period|Withdrawal by Subject|1
74444|NCT01272908|289618|P1|Re-Treatment Period|Lack of Efficacy|3
74445|NCT01272908|289618|P1|Re-Treatment Period|Adverse Event|2
74446|NCT01272908|289618|P1|Initial Treatment Period|Withdrawal by Subject|1
74447|NCT01272908|289618|P1|Initial Treatment Period|Protocol Violation|1
74448|NCT01272908|289618|P1|Initial Treatment Period|Lack of Efficacy|5
74449|NCT01272908|289618|P1|Initial Treatment Period|Adverse Event|1
74450|NCT01272869|289658|P2|Period 2 (14 Days)|Adverse Event|0
74451|NCT01272869|289659|P1|Period 2 (14 Days)|Adverse Event|1
74452|NCT01272804|289686|P6|Overall Study|Adverse Event|1
74453|NCT01272804|289687|P5|Overall Study|Adverse Event|2
74454|NCT01272804|289688|P4|Overall Study|Adverse Event|0
74455|NCT01272804|289689|P3|Overall Study|Adverse Event|0
74456|NCT01272804|289690|P2|Overall Study|Adverse Event|0
74457|NCT01272804|289691|P1|Overall Study|Adverse Event|1
74458|NCT01272661|289849|P3|Overall Study|lost to followup/case closed/ no birth|72
74459|NCT01272661|289850|P2|Overall Study|lost to followup/case closed/ no birth|209
74460|NCT01272661|289851|P1|Overall Study|lost to followup/case closed/ no birth|126
74461|NCT01272635|289876|P4|Overall Study|Lost to Follow-up|23
74462|NCT01272635|289877|P3|Overall Study|Lost to Follow-up|31
74463|NCT01272635|289878|P2|Overall Study|Lost to Follow-up|20
74464|NCT01272635|289879|P1|Overall Study|Lost to Follow-up|31
74465|NCT01272232|289952|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
74466|NCT01272232|289953|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
74467|NCT01272232|289954|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
74468|NCT01272232|289952|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
74469|NCT01272232|289953|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
74470|NCT01272232|289954|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
74471|NCT01272232|289952|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
74472|NCT01272232|289953|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
74473|NCT01272232|289954|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
74474|NCT01272232|289952|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
74475|NCT01272232|289953|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
74476|NCT01272232|289954|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
74477|NCT01272232|289952|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
74478|NCT01272232|289953|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
74479|NCT01272232|289954|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
74480|NCT01272232|289952|P3|Weeks 0-56|Unclassified|12
74481|NCT01272232|289953|P2|Weeks 0-56|Unclassified|7
74482|NCT01272232|289954|P1|Weeks 0-56|Unclassified|16
74483|NCT01272232|289952|P3|Weeks 0-56|Withdrawal criteria|37
74484|NCT01272232|289953|P2|Weeks 0-56|Withdrawal criteria|14
74485|NCT01272232|289954|P1|Weeks 0-56|Withdrawal criteria|32
74486|NCT01272232|289952|P3|Weeks 0-56|Protocol Violation|13
74487|NCT01272232|289953|P2|Weeks 0-56|Protocol Violation|8
74488|NCT01272232|289954|P1|Weeks 0-56|Protocol Violation|12
74489|NCT01272232|289952|P3|Weeks 0-56|Lack of Efficacy|3
74490|NCT01272232|289953|P2|Weeks 0-56|Lack of Efficacy|0
74491|NCT01272232|289954|P1|Weeks 0-56|Lack of Efficacy|0
74492|NCT01272232|289952|P3|Weeks 0-56|Adverse Event|7
74493|NCT01272232|289953|P2|Weeks 0-56|Adverse Event|18
74494|NCT01272232|289954|P1|Weeks 0-56|Adverse Event|39
74495|NCT01272219|289999|P6|Main + Extension Period: Week 0-172|Unclassified|51
74496|NCT01272219|290000|P5|Main + Extension Period: Week 0-172|Unclassified|61
74497|NCT01272219|290001|P4|Main + Extension Period: Week 0-172|Unclassified|0
74498|NCT01272219|290002|P3|Main + Extension Period: Week 0-172|Unclassified|0
74499|NCT01272219|290003|P2|Main + Extension Period: Week 0-172|Unclassified|0
74500|NCT01272219|290004|P1|Main + Extension Period: Week 0-172|Unclassified|0
74501|NCT01272219|289999|P6|Main + Extension Period: Week 0-172|Missing reason|0
74502|NCT01272219|290000|P5|Main + Extension Period: Week 0-172|Missing reason|1
74503|NCT01272219|290001|P4|Main + Extension Period: Week 0-172|Missing reason|0
74504|NCT01272219|290002|P3|Main + Extension Period: Week 0-172|Missing reason|0
74505|NCT01272219|290003|P2|Main + Extension Period: Week 0-172|Missing reason|0
74506|NCT01272219|290004|P1|Main + Extension Period: Week 0-172|Missing reason|0
74507|NCT01272219|289999|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
74508|NCT01272219|290000|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
74509|NCT01272219|290001|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
74510|NCT01272219|290002|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
74511|NCT01272219|290003|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
74512|NCT01272219|290004|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
74513|NCT01272219|289999|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
74514|NCT01272219|290000|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
74515|NCT01272219|290001|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
74516|NCT01272219|290002|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
74517|NCT01272219|290003|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
74518|NCT01272219|290004|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
74519|NCT01272219|289999|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
74520|NCT01272219|290000|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
74521|NCT01272219|290001|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
74522|NCT01272219|290002|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
74523|NCT01272219|290003|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
74524|NCT01272219|290004|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
74525|NCT01272219|289999|P6|Main + Extension Period: Week 0-172|Adverse Event|43
74526|NCT01272219|290000|P5|Main + Extension Period: Week 0-172|Adverse Event|191
74527|NCT01272219|290001|P4|Main + Extension Period: Week 0-172|Adverse Event|0
74528|NCT01272219|290002|P3|Main + Extension Period: Week 0-172|Adverse Event|0
74529|NCT01272219|290003|P2|Main + Extension Period: Week 0-172|Adverse Event|0
74530|NCT01272219|290004|P1|Main + Extension Period: Week 0-172|Adverse Event|0
74531|NCT01272219|289999|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
74532|NCT01272219|290000|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
74533|NCT01272219|290001|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
74534|NCT01272219|290002|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
74535|NCT01272219|290003|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
74536|NCT01272219|290004|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
74537|NCT01272219|289999|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
74538|NCT01272219|290000|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
74539|NCT01272219|290001|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
74540|NCT01272219|290002|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
74541|NCT01272219|290003|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
74542|NCT01272219|290004|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
74543|NCT01272219|289999|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
74544|NCT01272219|290000|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
74545|NCT01272219|290001|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
74546|NCT01272219|290002|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
74547|NCT01272219|290003|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
74548|NCT01272219|290004|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
74549|NCT01272219|289999|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
74550|NCT01272219|290000|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
74551|NCT01272219|290001|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
74552|NCT01272219|290002|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
74553|NCT01272219|290003|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
74554|NCT01272219|290004|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
74555|NCT01272219|289999|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
74556|NCT01272219|290000|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
74557|NCT01272219|290001|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
74558|NCT01272219|290002|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
74559|NCT01272219|290003|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
74560|NCT01272219|290004|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
74561|NCT01272219|289999|P6|Main Period: Week 0 to Week 56|Unclassified|34
74562|NCT01272219|290000|P5|Main Period: Week 0 to Week 56|Unclassified|42
74563|NCT01272219|290001|P4|Main Period: Week 0 to Week 56|Unclassified|29
74564|NCT01272219|290002|P3|Main Period: Week 0 to Week 56|Unclassified|0
74565|NCT01272219|290003|P2|Main Period: Week 0 to Week 56|Unclassified|0
74566|NCT01272219|290004|P1|Main Period: Week 0 to Week 56|Unclassified|36
74567|NCT01272219|289999|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
74568|NCT01272219|290000|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
74569|NCT01272219|290001|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
74570|NCT01272219|290002|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
74571|NCT01272219|290003|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
74572|NCT01272219|290004|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
74573|NCT01272219|289999|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
74574|NCT01272219|290000|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
74575|NCT01272219|290001|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
74576|NCT01272219|290002|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
74577|NCT01272219|290003|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
74578|NCT01272219|290004|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
74579|NCT01272219|289999|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
74580|NCT01272219|290000|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
74581|NCT01272219|290001|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
74582|NCT01272219|290002|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
74583|NCT01272219|290003|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
74584|NCT01272219|290004|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
74585|NCT01272219|289999|P6|Main Period: Week 0 to Week 56|Adverse Event|29
74586|NCT01272219|290000|P5|Main Period: Week 0 to Week 56|Adverse Event|152
74587|NCT01272219|290001|P4|Main Period: Week 0 to Week 56|Adverse Event|16
74588|NCT01272219|290002|P3|Main Period: Week 0 to Week 56|Adverse Event|0
74589|NCT01272219|290003|P2|Main Period: Week 0 to Week 56|Adverse Event|0
74590|NCT01272219|290004|P1|Main Period: Week 0 to Week 56|Adverse Event|86
74591|NCT01272193|290038|P2|Overall Study|Unclassified|7
74592|NCT01272193|290039|P1|Overall Study|Unclassified|8
74593|NCT01272193|290038|P2|Overall Study|Withdrawal Criteria|1
74594|NCT01272193|290039|P1|Overall Study|Withdrawal Criteria|1
74595|NCT01272193|290038|P2|Overall Study|Lack of Efficacy|3
74596|NCT01272193|290039|P1|Overall Study|Lack of Efficacy|0
74597|NCT01272193|290038|P2|Overall Study|Adverse Event|1
74598|NCT01272193|290039|P1|Overall Study|Adverse Event|1
74599|NCT01272180|290059|P4|Overall Study|Protocol Violation|1
74600|NCT01272180|290060|P3|Overall Study|Protocol Violation|0
74601|NCT01272180|290061|P2|Overall Study|Protocol Violation|1
74602|NCT01272180|290062|P1|Overall Study|Protocol Violation|0
74603|NCT01272180|290059|P4|Overall Study|Inappropriate enrollment|1
74604|NCT01272180|290060|P3|Overall Study|Inappropriate enrollment|1
74605|NCT01272180|290061|P2|Overall Study|Inappropriate enrollment|0
74606|NCT01272180|290062|P1|Overall Study|Inappropriate enrollment|0
74607|NCT01272180|290059|P4|Overall Study|Lost to Follow-up|10
74608|NCT01272180|290060|P3|Overall Study|Lost to Follow-up|8
74609|NCT01272180|290061|P2|Overall Study|Lost to Follow-up|14
74610|NCT01272180|290062|P1|Overall Study|Lost to Follow-up|15
74611|NCT01272180|290059|P4|Overall Study|Withdrawal by Subject|2
74612|NCT01272180|290060|P3|Overall Study|Withdrawal by Subject|3
74613|NCT01272180|290061|P2|Overall Study|Withdrawal by Subject|6
74614|NCT01272180|290062|P1|Overall Study|Withdrawal by Subject|2
74615|NCT01272180|290059|P4|Overall Study|Adverse Event|0
74616|NCT01272180|290060|P3|Overall Study|Adverse Event|1
74617|NCT01272180|290061|P2|Overall Study|Adverse Event|0
74618|NCT01272180|290062|P1|Overall Study|Adverse Event|0
74619|NCT01272011|290111|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
74620|NCT01272011|290112|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
74621|NCT01272011|290113|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
74622|NCT01271803|290193|P12|Stage 2|Ongoing in the Study|14
74623|NCT01271803|290194|P11|Stage 2|Ongoing in the Study|6
74624|NCT01271803|290195|P10|Stage 2|Ongoing in the Study|0
74625|NCT01271803|290196|P9|Stage 2|Ongoing in the Study|0
74626|NCT01271803|290197|P8|Stage 2|Ongoing in the Study|0
74627|NCT01271803|290198|P7|Stage 2|Ongoing in the Study|0
74628|NCT01271803|290199|P6|Stage 2|Ongoing in the Study|0
74629|NCT01271803|290200|P5|Stage 2|Ongoing in the Study|0
74630|NCT01271803|290201|P4|Stage 2|Ongoing in the Study|0
74631|NCT01271803|290202|P3|Stage 2|Ongoing in the Study|0
74632|NCT01271803|290203|P2|Stage 2|Ongoing in the Study|0
74633|NCT01271803|290204|P1|Stage 2|Ongoing in the Study|0
74634|NCT01271803|290193|P12|Stage 2|Other|0
74635|NCT01271803|290194|P11|Stage 2|Other|1
74636|NCT01271803|290195|P10|Stage 2|Other|0
74637|NCT01271803|290196|P9|Stage 2|Other|0
74638|NCT01271803|290197|P8|Stage 2|Other|0
74639|NCT01271803|290198|P7|Stage 2|Other|0
74640|NCT01271803|290199|P6|Stage 2|Other|0
74641|NCT01271803|290200|P5|Stage 2|Other|0
74642|NCT01271803|290201|P4|Stage 2|Other|0
74643|NCT01271803|290202|P3|Stage 2|Other|0
74644|NCT01271803|290203|P2|Stage 2|Other|0
74645|NCT01271803|290204|P1|Stage 2|Other|0
74646|NCT01271803|290193|P12|Stage 2|Physician Decision|1
74647|NCT01271803|290194|P11|Stage 2|Physician Decision|0
74648|NCT01271803|290195|P10|Stage 2|Physician Decision|0
74649|NCT01271803|290196|P9|Stage 2|Physician Decision|0
74650|NCT01271803|290197|P8|Stage 2|Physician Decision|0
74651|NCT01271803|290198|P7|Stage 2|Physician Decision|0
74652|NCT01271803|290199|P6|Stage 2|Physician Decision|0
74653|NCT01271803|290200|P5|Stage 2|Physician Decision|0
74654|NCT01271803|290201|P4|Stage 2|Physician Decision|0
74655|NCT01271803|290202|P3|Stage 2|Physician Decision|0
74656|NCT01271803|290203|P2|Stage 2|Physician Decision|0
74657|NCT01271803|290204|P1|Stage 2|Physician Decision|0
74658|NCT01271803|290193|P12|Stage 2|Withdrawal by Subject|2
74659|NCT01271803|290194|P11|Stage 2|Withdrawal by Subject|0
74660|NCT01271803|290195|P10|Stage 2|Withdrawal by Subject|0
74661|NCT01271803|290196|P9|Stage 2|Withdrawal by Subject|0
74662|NCT01271803|290197|P8|Stage 2|Withdrawal by Subject|0
74663|NCT01271803|290198|P7|Stage 2|Withdrawal by Subject|0
74664|NCT01271803|290199|P6|Stage 2|Withdrawal by Subject|0
74665|NCT01271803|290200|P5|Stage 2|Withdrawal by Subject|0
74666|NCT01271803|290201|P4|Stage 2|Withdrawal by Subject|0
74667|NCT01271803|290202|P3|Stage 2|Withdrawal by Subject|0
74668|NCT01271803|290203|P2|Stage 2|Withdrawal by Subject|0
74669|NCT01271803|290204|P1|Stage 2|Withdrawal by Subject|0
74670|NCT01271803|290193|P12|Stage 2|Death|2
74671|NCT01271803|290194|P11|Stage 2|Death|2
74672|NCT01271803|290195|P10|Stage 2|Death|0
74673|NCT01271803|290196|P9|Stage 2|Death|0
74674|NCT01271803|290197|P8|Stage 2|Death|0
74675|NCT01271803|290198|P7|Stage 2|Death|0
74676|NCT01271803|290199|P6|Stage 2|Death|0
74677|NCT01271803|290200|P5|Stage 2|Death|0
74678|NCT01271803|290201|P4|Stage 2|Death|0
74679|NCT01271803|290202|P3|Stage 2|Death|0
74680|NCT01271803|290203|P2|Stage 2|Death|0
74681|NCT01271803|290204|P1|Stage 2|Death|0
74682|NCT01271803|290193|P12|Stage 2|Adverse Event|3
74683|NCT01271803|290194|P11|Stage 2|Adverse Event|1
74684|NCT01271803|290195|P10|Stage 2|Adverse Event|0
74685|NCT01271803|290196|P9|Stage 2|Adverse Event|0
74686|NCT01271803|290197|P8|Stage 2|Adverse Event|0
74687|NCT01271803|290198|P7|Stage 2|Adverse Event|0
74688|NCT01271803|290199|P6|Stage 2|Adverse Event|0
74689|NCT01271803|290200|P5|Stage 2|Adverse Event|0
74690|NCT01271803|290201|P4|Stage 2|Adverse Event|0
74691|NCT01271803|290202|P3|Stage 2|Adverse Event|0
74692|NCT01271803|290203|P2|Stage 2|Adverse Event|0
74693|NCT01271803|290204|P1|Stage 2|Adverse Event|0
74694|NCT01271803|290193|P12|Stage 2|Progressive disease|17
74695|NCT01271803|290194|P11|Stage 2|Progressive disease|17
74696|NCT01271803|290195|P10|Stage 2|Progressive disease|0
74697|NCT01271803|290196|P9|Stage 2|Progressive disease|0
74698|NCT01271803|290197|P8|Stage 2|Progressive disease|0
74699|NCT01271803|290198|P7|Stage 2|Progressive disease|0
74700|NCT01271803|290199|P6|Stage 2|Progressive disease|0
74701|NCT01271803|290200|P5|Stage 2|Progressive disease|0
74702|NCT01271803|290201|P4|Stage 2|Progressive disease|0
74703|NCT01271803|290202|P3|Stage 2|Progressive disease|0
74704|NCT01271803|290203|P2|Stage 2|Progressive disease|0
74705|NCT01271803|290204|P1|Stage 2|Progressive disease|0
74706|NCT01271803|290193|P12|Stage 1|Ongoing in the Study|0
74707|NCT01271803|290194|P11|Stage 1|Ongoing in the Study|0
74708|NCT01271803|290195|P10|Stage 1|Ongoing in the Study|0
74709|NCT01271803|290196|P9|Stage 1|Ongoing in the Study|1
74710|NCT01271803|290197|P8|Stage 1|Ongoing in the Study|1
74711|NCT01271803|290198|P7|Stage 1|Ongoing in the Study|1
74712|NCT01271803|290199|P6|Stage 1|Ongoing in the Study|0
74713|NCT01271803|290200|P5|Stage 1|Ongoing in the Study|3
74714|NCT01271803|290201|P4|Stage 1|Ongoing in the Study|1
74715|NCT01271803|290202|P3|Stage 1|Ongoing in the Study|11
74716|NCT01271803|290203|P2|Stage 1|Ongoing in the Study|1
74717|NCT01271803|290204|P1|Stage 1|Ongoing in the Study|0
74718|NCT01271803|290193|P12|Stage 1|Other|0
74719|NCT01271803|290194|P11|Stage 1|Other|0
74720|NCT01271803|290195|P10|Stage 1|Other|0
74721|NCT01271803|290196|P9|Stage 1|Other|0
74722|NCT01271803|290197|P8|Stage 1|Other|0
74723|NCT01271803|290198|P7|Stage 1|Other|0
74724|NCT01271803|290199|P6|Stage 1|Other|0
74725|NCT01271803|290200|P5|Stage 1|Other|0
74726|NCT01271803|290201|P4|Stage 1|Other|0
74727|NCT01271803|290202|P3|Stage 1|Other|2
74728|NCT01271803|290203|P2|Stage 1|Other|0
74729|NCT01271803|290204|P1|Stage 1|Other|0
74730|NCT01271803|290193|P12|Stage 1|Withdrawal by Subject|0
74731|NCT01271803|290194|P11|Stage 1|Withdrawal by Subject|0
74732|NCT01271803|290195|P10|Stage 1|Withdrawal by Subject|0
74733|NCT01271803|290196|P9|Stage 1|Withdrawal by Subject|0
74734|NCT01271803|290197|P8|Stage 1|Withdrawal by Subject|0
74735|NCT01271803|290198|P7|Stage 1|Withdrawal by Subject|0
74736|NCT01271803|290199|P6|Stage 1|Withdrawal by Subject|0
74737|NCT01271803|290200|P5|Stage 1|Withdrawal by Subject|0
74738|NCT01271803|290201|P4|Stage 1|Withdrawal by Subject|0
74739|NCT01271803|290202|P3|Stage 1|Withdrawal by Subject|1
74740|NCT01271803|290203|P2|Stage 1|Withdrawal by Subject|0
74741|NCT01271803|290204|P1|Stage 1|Withdrawal by Subject|0
74742|NCT01271803|290193|P12|Stage 1|Physician Decision|0
74743|NCT01271803|290194|P11|Stage 1|Physician Decision|0
74744|NCT01271803|290195|P10|Stage 1|Physician Decision|0
74745|NCT01271803|290196|P9|Stage 1|Physician Decision|0
74746|NCT01271803|290197|P8|Stage 1|Physician Decision|0
74747|NCT01271803|290198|P7|Stage 1|Physician Decision|1
74748|NCT01271803|290199|P6|Stage 1|Physician Decision|0
74749|NCT01271803|290200|P5|Stage 1|Physician Decision|0
74750|NCT01271803|290201|P4|Stage 1|Physician Decision|0
74751|NCT01271803|290202|P3|Stage 1|Physician Decision|0
74752|NCT01271803|290203|P2|Stage 1|Physician Decision|0
74753|NCT01271803|290204|P1|Stage 1|Physician Decision|1
74754|NCT01271803|290193|P12|Stage 1|Death|0
74755|NCT01271803|290194|P11|Stage 1|Death|0
74756|NCT01271803|290195|P10|Stage 1|Death|0
74757|NCT01271803|290196|P9|Stage 1|Death|0
74758|NCT01271803|290197|P8|Stage 1|Death|0
74759|NCT01271803|290198|P7|Stage 1|Death|0
74760|NCT01271803|290199|P6|Stage 1|Death|1
74761|NCT01271803|290200|P5|Stage 1|Death|0
74762|NCT01271803|290201|P4|Stage 1|Death|0
74763|NCT01271803|290202|P3|Stage 1|Death|0
74764|NCT01271803|290203|P2|Stage 1|Death|0
74765|NCT01271803|290204|P1|Stage 1|Death|1
74766|NCT01271803|290193|P12|Stage 1|Adverse Event|0
74767|NCT01271803|290194|P11|Stage 1|Adverse Event|0
74768|NCT01271803|290195|P10|Stage 1|Adverse Event|0
74769|NCT01271803|290196|P9|Stage 1|Adverse Event|0
74770|NCT01271803|290197|P8|Stage 1|Adverse Event|0
74771|NCT01271803|290198|P7|Stage 1|Adverse Event|0
74772|NCT01271803|290199|P6|Stage 1|Adverse Event|0
74773|NCT01271803|290200|P5|Stage 1|Adverse Event|0
74774|NCT01271803|290201|P4|Stage 1|Adverse Event|0
74775|NCT01271803|290202|P3|Stage 1|Adverse Event|1
74776|NCT01271803|290203|P2|Stage 1|Adverse Event|0
74777|NCT01271803|290204|P1|Stage 1|Adverse Event|0
74778|NCT01271803|290193|P12|Stage 1|Progressive disease|0
74779|NCT01271803|290194|P11|Stage 1|Progressive disease|0
74780|NCT01271803|290195|P10|Stage 1|Progressive disease|2
74781|NCT01271803|290196|P9|Stage 1|Progressive disease|4
74782|NCT01271803|290197|P8|Stage 1|Progressive disease|2
74783|NCT01271803|290198|P7|Stage 1|Progressive disease|2
74784|NCT01271803|290199|P6|Stage 1|Progressive disease|3
74785|NCT01271803|290200|P5|Stage 1|Progressive disease|1
74786|NCT01271803|290201|P4|Stage 1|Progressive disease|2
74787|NCT01271803|290202|P3|Stage 1|Progressive disease|12
74788|NCT01271803|290203|P2|Stage 1|Progressive disease|7
74789|NCT01271803|290204|P1|Stage 1|Progressive disease|3
74790|NCT01271712|290377|P2|Survival Follow-up|Ongoing survival follow-up|6
74791|NCT01271712|290378|P1|Survival Follow-up|Ongoing survival follow-up|15
74792|NCT01271712|290377|P2|Safety Follow-up|Progressive disease|0
74793|NCT01271712|290378|P1|Safety Follow-up|Progressive disease|1
74794|NCT01271712|290377|P2|Safety Follow-up|No follow-up|1
74795|NCT01271712|290378|P1|Safety Follow-up|No follow-up|1
74796|NCT01271712|290377|P2|Safety Follow-up|Ongoing safety follow-up|4
74797|NCT01271712|290378|P1|Safety Follow-up|Ongoing safety follow-up|3
74798|NCT01271712|290377|P2|Safety Follow-up|Protocol Violation|1
74799|NCT01271712|290378|P1|Safety Follow-up|Protocol Violation|1
74800|NCT01271712|290377|P2|Safety Follow-up|Withdrawal by Subject|2
74801|NCT01271712|290378|P1|Safety Follow-up|Withdrawal by Subject|4
74802|NCT01271712|290377|P2|Safety Follow-up|Death|7
74803|NCT01271712|290378|P1|Safety Follow-up|Death|11
74804|NCT01271712|290377|P2|Open Label Treatment|Switching to other therapy|1
74805|NCT01271712|290378|P1|Open Label Treatment|Switching to other therapy|2
74806|NCT01271712|290377|P2|Open Label Treatment|Protocol Violation|1
74807|NCT01271712|290378|P1|Open Label Treatment|Protocol Violation|0
74808|NCT01271712|290377|P2|Open Label Treatment|Non-compliance with study drug|0
74809|NCT01271712|290378|P1|Open Label Treatment|Non-compliance with study drug|1
74810|NCT01271712|290377|P2|Open Label Treatment|Ongoing with open-label treatment|1
74811|NCT01271712|290378|P1|Open Label Treatment|Ongoing with open-label treatment|6
74812|NCT01271712|290377|P2|Open Label Treatment|Progressive disease|31
74813|NCT01271712|290378|P1|Open Label Treatment|Progressive disease|56
74814|NCT01271712|290377|P2|Open Label Treatment|Adverse Event|8
74815|NCT01271712|290378|P1|Open Label Treatment|Adverse Event|12
74816|NCT01271712|290377|P2|Open Label Treatment|Physician Decision|0
74817|NCT01271712|290378|P1|Open Label Treatment|Physician Decision|2
74818|NCT01271712|290377|P2|Open Label Treatment|Withdrawal by Subject|11
74819|NCT01271712|290378|P1|Open Label Treatment|Withdrawal by Subject|6
74820|NCT01271712|290377|P2|Open Label Treatment|Death|5
74821|NCT01271712|290378|P1|Open Label Treatment|Death|6
74822|NCT01271712|290377|P2|Double Blind Treatment|receive no study drug|0
74823|NCT01271712|290378|P1|Double Blind Treatment|receive no study drug|1
74824|NCT01271712|290377|P2|Double Blind Treatment|Non compliance with study drug|0
74825|NCT01271712|290378|P1|Double Blind Treatment|Non compliance with study drug|2
74826|NCT01271712|290377|P2|Double Blind Treatment|Withdrawal by Subject|1
74827|NCT01271712|290378|P1|Double Blind Treatment|Withdrawal by Subject|4
74828|NCT01271712|290377|P2|Double Blind Treatment|Progressive disease|3
74829|NCT01271712|290378|P1|Double Blind Treatment|Progressive disease|23
74830|NCT01271712|290377|P2|Double Blind Treatment|Adverse Event|4
74831|NCT01271712|290378|P1|Double Blind Treatment|Adverse Event|9
74832|NCT01271712|290377|P2|Double Blind Treatment|Lack of Efficacy|0
74833|NCT01271712|290378|P1|Double Blind Treatment|Lack of Efficacy|1
74834|NCT01271712|290377|P2|Double Blind Treatment|Death|0
74835|NCT01271712|290378|P1|Double Blind Treatment|Death|2
74836|NCT01271010|290472|P1|Overall Study|Disease progression|27
74837|NCT01271010|290472|P1|Overall Study|Withdrawal by Subject|18
74838|NCT01271010|290472|P1|Overall Study|Progression and relapse of disease|1
74839|NCT01271010|290472|P1|Overall Study|Death|2
74840|NCT01271010|290472|P1|Overall Study|Protocol Violation|1
74841|NCT01271010|290472|P1|Overall Study|Start of new CLL therapy|1
74842|NCT01271010|290472|P1|Overall Study|Reason not specified|11
74843|NCT01270971|290487|P2|Overall Study|Non-specific|3
74844|NCT01270971|290488|P1|Overall Study|Non-specific|7
74845|NCT01270971|290487|P2|Overall Study|Non compliance|2
74846|NCT01270971|290488|P1|Overall Study|Non compliance|2
74847|NCT01270971|290487|P2|Overall Study|Adverse Event|2
74848|NCT01270971|290488|P1|Overall Study|Adverse Event|1
74849|NCT01270971|290487|P2|Overall Study|Lost to Follow-up|5
74850|NCT01270971|290488|P1|Overall Study|Lost to Follow-up|18
74851|NCT01270971|290487|P2|Overall Study|Withdrawal by Subject|11
74852|NCT01270971|290488|P1|Overall Study|Withdrawal by Subject|24
74853|NCT01270958|290500|P1|Overall Study|Did not meet inclusion criteria for age|2
74854|NCT01270958|290500|P1|Overall Study|Lost to Follow-up|2
74855|NCT01270880|290529|P1|Overall Study|Never rec'd treatment, but registered.|1
74856|NCT01270841|290554|P4|Overall Study|Enrolled in error|0
74857|NCT01270841|290555|P3|Overall Study|Enrolled in error|0
74858|NCT01270841|290556|P2|Overall Study|Enrolled in error|1
74859|NCT01270841|290557|P1|Overall Study|Enrolled in error|0
74860|NCT01270841|290554|P4|Overall Study|Protocol Violation|0
74861|NCT01270841|290555|P3|Overall Study|Protocol Violation|0
74862|NCT01270841|290556|P2|Overall Study|Protocol Violation|5
74863|NCT01270841|290557|P1|Overall Study|Protocol Violation|1
74864|NCT01270841|290554|P4|Overall Study|Did not qualify|5
74865|NCT01270841|290555|P3|Overall Study|Did not qualify|4
74866|NCT01270841|290556|P2|Overall Study|Did not qualify|3
74867|NCT01270841|290557|P1|Overall Study|Did not qualify|6
74868|NCT01270841|290554|P4|Overall Study|Physician Decision|0
74869|NCT01270841|290555|P3|Overall Study|Physician Decision|0
74870|NCT01270841|290556|P2|Overall Study|Physician Decision|1
74871|NCT01270841|290557|P1|Overall Study|Physician Decision|0
74872|NCT01270841|290554|P4|Overall Study|Lost to Follow-up|2
74873|NCT01270841|290555|P3|Overall Study|Lost to Follow-up|4
74874|NCT01270841|290556|P2|Overall Study|Lost to Follow-up|1
74875|NCT01270841|290557|P1|Overall Study|Lost to Follow-up|3
74876|NCT01270841|290554|P4|Overall Study|Withdrawal by Subject|3
74877|NCT01270841|290555|P3|Overall Study|Withdrawal by Subject|3
74878|NCT01270841|290556|P2|Overall Study|Withdrawal by Subject|2
74879|NCT01270841|290557|P1|Overall Study|Withdrawal by Subject|3
74880|NCT01270841|290554|P4|Overall Study|Adverse Event|3
74881|NCT01270841|290555|P3|Overall Study|Adverse Event|0
74882|NCT01270841|290556|P2|Overall Study|Adverse Event|1
74883|NCT01270841|290557|P1|Overall Study|Adverse Event|0
74884|NCT01270828|290581|P3|Double Blind Phase|Adverse event related to study drug|0
74885|NCT01270828|290582|P2|Double Blind Phase|Adverse event related to study drug|7
74886|NCT01270828|290583|P1|Double Blind Phase|Adverse event related to study drug|5
74887|NCT01270828|290581|P3|Double Blind Phase|Adverse event not related to study drug|0
74888|NCT01270828|290582|P2|Double Blind Phase|Adverse event not related to study drug|1
74889|NCT01270828|290583|P1|Double Blind Phase|Adverse event not related to study drug|1
74890|NCT01270828|290581|P3|Double Blind Phase|Lack of Efficacy|0
74891|NCT01270828|290582|P2|Double Blind Phase|Lack of Efficacy|11
74892|NCT01270828|290583|P1|Double Blind Phase|Lack of Efficacy|2
74893|NCT01270828|290581|P3|Double Blind Phase|Lost to Follow-up|0
74894|NCT01270828|290582|P2|Double Blind Phase|Lost to Follow-up|2
74895|NCT01270828|290583|P1|Double Blind Phase|Lost to Follow-up|1
74896|NCT01270828|290581|P3|Double Blind Phase|Withdrawal by Subject|0
74897|NCT01270828|290582|P2|Double Blind Phase|Withdrawal by Subject|15
74898|NCT01270828|290583|P1|Double Blind Phase|Withdrawal by Subject|6
74899|NCT01270828|290581|P3|Double Blind Phase|Reason Unspecified|0
74900|NCT01270828|290582|P2|Double Blind Phase|Reason Unspecified|4
74901|NCT01270828|290583|P1|Double Blind Phase|Reason Unspecified|7
74902|NCT01270828|290581|P3|Double Blind Phase|Protocol and GCP non-compliance|0
74903|NCT01270828|290582|P2|Double Blind Phase|Protocol and GCP non-compliance|3
74904|NCT01270828|290583|P1|Double Blind Phase|Protocol and GCP non-compliance|4
74905|NCT01270828|290581|P3|Double Blind Phase|Protocol Violation|0
74906|NCT01270828|290582|P2|Double Blind Phase|Protocol Violation|1
74907|NCT01270828|290583|P1|Double Blind Phase|Protocol Violation|0
74908|NCT01270828|290581|P3|Double Blind Phase|Death|0
74909|NCT01270828|290582|P2|Double Blind Phase|Death|1
74910|NCT01270828|290583|P1|Double Blind Phase|Death|0
74911|NCT01270828|290581|P3|Pregabalin CR SB|Protocol Violation|8
74912|NCT01270828|290582|P2|Pregabalin CR SB|Protocol Violation|0
74913|NCT01270828|290583|P1|Pregabalin CR SB|Protocol Violation|0
74914|NCT01270828|290581|P3|Pregabalin CR SB|Unrelated AE|8
74915|NCT01270828|290582|P2|Pregabalin CR SB|Unrelated AE|0
74916|NCT01270828|290583|P1|Pregabalin CR SB|Unrelated AE|0
74917|NCT01270828|290581|P3|Pregabalin CR SB|Lost to Follow-up|10
74918|NCT01270828|290582|P2|Pregabalin CR SB|Lost to Follow-up|0
74919|NCT01270828|290583|P1|Pregabalin CR SB|Lost to Follow-up|0
74920|NCT01270828|290581|P3|Pregabalin CR SB|Withdrawal by Subject|29
74921|NCT01270828|290582|P2|Pregabalin CR SB|Withdrawal by Subject|0
74922|NCT01270828|290583|P1|Pregabalin CR SB|Withdrawal by Subject|0
74923|NCT01270828|290581|P3|Pregabalin CR SB|Lack of Efficacy|32
74924|NCT01270828|290582|P2|Pregabalin CR SB|Lack of Efficacy|0
74925|NCT01270828|290583|P1|Pregabalin CR SB|Lack of Efficacy|0
74926|NCT01270828|290581|P3|Pregabalin CR SB|Related adverse event|46
74927|NCT01270828|290582|P2|Pregabalin CR SB|Related adverse event|0
74928|NCT01270828|290583|P1|Pregabalin CR SB|Related adverse event|0
74929|NCT01270828|290581|P3|Pregabalin CR SB|Enrolled but not treated|5
74930|NCT01270828|290582|P2|Pregabalin CR SB|Enrolled but not treated|0
74931|NCT01270828|290583|P1|Pregabalin CR SB|Enrolled but not treated|0
74932|NCT01270828|290581|P3|Pregabalin CR SB|Reason Unspecified|8
74933|NCT01270828|290582|P2|Pregabalin CR SB|Reason Unspecified|0
74934|NCT01270828|290583|P1|Pregabalin CR SB|Reason Unspecified|0
74935|NCT01270802|290625|P2|Overall Study|Lost to Follow-up|1
74936|NCT01270802|290626|P1|Overall Study|Lost to Follow-up|0
74937|NCT01270802|290625|P2|Overall Study|Adverse Event|0
74938|NCT01270802|290626|P1|Overall Study|Adverse Event|1
74939|NCT01270802|290625|P2|Overall Study|Withdrawal by Subject|0
74940|NCT01270802|290626|P1|Overall Study|Withdrawal by Subject|1
74941|NCT01270620|290773|P2|Overall Study|Withdrawal by Subject|3
74942|NCT01270620|290774|P1|Overall Study|Withdrawal by Subject|1
74943|NCT01270503|290869|P1|Overall Study|Lost to Follow-up|1
74944|NCT01270464|290877|P3|Overall Study|Not Specified|3
74945|NCT01270464|290878|P2|Overall Study|Not Specified|1
74946|NCT01270464|290879|P1|Overall Study|Not Specified|1
74947|NCT01270464|290877|P3|Overall Study|Lost to Follow-up|1
74948|NCT01270464|290878|P2|Overall Study|Lost to Follow-up|3
74949|NCT01270464|290879|P1|Overall Study|Lost to Follow-up|2
74950|NCT01270464|290877|P3|Overall Study|Withdrawal by Subject|4
74951|NCT01270464|290878|P2|Overall Study|Withdrawal by Subject|1
74952|NCT01270464|290879|P1|Overall Study|Withdrawal by Subject|2
74953|NCT01270464|290877|P3|Overall Study|Adverse Event|7
74954|NCT01270464|290878|P2|Overall Study|Adverse Event|1
74955|NCT01270464|290879|P1|Overall Study|Adverse Event|9
74956|NCT01270464|290877|P3|Overall Study|Lack of Efficacy|1
74957|NCT01270464|290878|P2|Overall Study|Lack of Efficacy|3
74958|NCT01270464|290879|P1|Overall Study|Lack of Efficacy|2
74959|NCT01270464|290877|P3|Overall Study|Protocol Violation|2
74960|NCT01270464|290878|P2|Overall Study|Protocol Violation|3
74961|NCT01270464|290879|P1|Overall Study|Protocol Violation|4
74962|NCT01270256|290928|P2|Overall Study|Withdrawal by Subject|0
74963|NCT01270256|290929|P1|Overall Study|Withdrawal by Subject|1
74964|NCT01270139|290938|P3|Overall Study|Lost to Follow-up|2
74965|NCT01270139|290939|P2|Overall Study|Lost to Follow-up|9
74966|NCT01270139|290940|P1|Overall Study|Lost to Follow-up|10
74967|NCT01270139|290938|P3|Overall Study|Adverse Event|18
74968|NCT01270139|290939|P2|Overall Study|Adverse Event|17
74969|NCT01270139|290940|P1|Overall Study|Adverse Event|8
74970|NCT01269918|291009|P2|Overall Study|Did not receive study drug|3
74971|NCT01269918|291010|P1|Overall Study|Did not receive study drug|0
74972|NCT01269346|291085|P1|Extension Phase|Started a prohibited con med|1
74973|NCT01269346|291085|P1|Extension Phase|Clinical progression|1
74974|NCT01269346|291085|P1|Extension Phase|Physician decision or participant choice|9
74975|NCT01269346|291085|P1|Extension Phase|Disease progression|22
74976|NCT01269346|291085|P1|Extension Phase|Withdrawal by Subject|4
74977|NCT01269346|291085|P1|Extension Phase|Adverse Event|6
74978|NCT01269346|291085|P1|Treatment Phase|Not specified|2
74979|NCT01269346|291085|P1|Treatment Phase|Withdrawal by Subject|1
74980|NCT01269346|291085|P1|Treatment Phase|Adverse Event|3
74981|NCT01269346|291085|P1|Treatment Phase|Disease progression|3
74982|NCT01269125|291096|P3|Overall Study|Lost to Follow-up|0
74983|NCT01269125|291097|P2|Overall Study|Lost to Follow-up|0
74984|NCT01269125|291098|P1|Overall Study|Lost to Follow-up|4
74985|NCT01269125|291096|P3|Overall Study|Adverse Event|0
74986|NCT01269125|291097|P2|Overall Study|Adverse Event|5
74987|NCT01269125|291098|P1|Overall Study|Adverse Event|3
74988|NCT01268891|291157|P2|Overall Study|Administrative or other reason(s)|0
74989|NCT01268891|291158|P1|Overall Study|Administrative or other reason(s)|1
74990|NCT01268891|291157|P2|Overall Study|Withdrawal of Consent|1
74991|NCT01268891|291158|P1|Overall Study|Withdrawal of Consent|3
74992|NCT01268891|291157|P2|Overall Study|Lack of Efficacy|0
74993|NCT01268891|291158|P1|Overall Study|Lack of Efficacy|1
74994|NCT01268891|291157|P2|Overall Study|Adverse Event|7
74995|NCT01268891|291158|P1|Overall Study|Adverse Event|3
74996|NCT01268566|291177|P1|Overall Study|Death|30
74997|NCT01268566|291177|P1|Overall Study|Withdrawal by Subject|12
74998|NCT01268566|291177|P1|Overall Study|Lost to Follow-up|1
74999|NCT01268501|291204|P1|Overall Study|Handling Difficulties|2
75000|NCT01268501|291204|P1|Overall Study|Unacceptable Subjective Vision|3
75001|NCT01268501|291204|P1|Overall Study|Withdrawal by Subject|3
75002|NCT01268501|291204|P1|Overall Study|Lost to Follow-up|1
75003|NCT01268488|291208|P1|Overall Study|Physician Decision|2
75004|NCT01268488|291208|P1|Overall Study|Adverse Event|3
75005|NCT01268306|291215|P1|Overall Study|Lost to Follow-up|1
75006|NCT01268293|291219|P1|Overall Study|Subject choice|1
75007|NCT01268293|291219|P1|Overall Study|Adverse Event|1
75008|NCT01268293|291219|P1|Overall Study|Disease progression|7
75009|NCT01268267|291224|P1|Overall Study|Protocol Violation|1
75010|NCT01268150|291245|P1|Extension Phase|Not specified|6
75011|NCT01268150|291245|P1|Extension Phase|Disease progression|18
75012|NCT01268150|291245|P1|Extension Phase|Adverse Event|3
75013|NCT01268150|291245|P1|Treatment Phase|Not specified|4
75014|NCT01268150|291245|P1|Treatment Phase|Withdrawal by Subject|3
75015|NCT01268150|291245|P1|Treatment Phase|Adverse Event|3
75016|NCT01268150|291245|P1|Treatment Phase|Progression of disease|18
75017|NCT01268098|291264|P2|Overall Study|Adverse Event|0
75018|NCT01268098|291265|P1|Overall Study|Adverse Event|1
75019|NCT01267994|291273|P1|Overall Study|Adverse Event|2
75020|NCT01267266|291343|P2|Lead-in Phase|Withdrawal by Subject|0
75021|NCT01267266|291344|P1|Lead-in Phase|Withdrawal by Subject|1
75022|NCT01267266|291343|P2|Lead-in Phase|Adverse Event|0
75023|NCT01267266|291344|P1|Lead-in Phase|Adverse Event|2
75024|NCT01267266|291343|P2|Lead-in Phase|Lack of Efficacy|0
75025|NCT01267266|291344|P1|Lead-in Phase|Lack of Efficacy|20
75026|NCT01267266|291343|P2|Enrollment Phase|Withdrawal by Subject|0
75027|NCT01267266|291344|P1|Enrollment Phase|Withdrawal by Subject|2
75028|NCT01267253|291357|P1|Overall Study|Inevaluable-never received study treatme|2
75029|NCT01267253|291357|P1|Overall Study|Ineligible - required test not done|1
75030|NCT01267201|291396|P6|Second Intervention Period|Withdrawal by Subject|0
75031|NCT01267201|291397|P5|Second Intervention Period|Withdrawal by Subject|0
75032|NCT01267201|291398|P4|Second Intervention Period|Withdrawal by Subject|0
75033|NCT01267201|291399|P3|Second Intervention Period|Withdrawal by Subject|0
75034|NCT01267201|291400|P2|Second Intervention Period|Withdrawal by Subject|1
75035|NCT01267201|291401|P1|Second Intervention Period|Withdrawal by Subject|0
75036|NCT01267201|291396|P6|First Intervention Period|Withdrawal by Subject|0
75037|NCT01267201|291397|P5|First Intervention Period|Withdrawal by Subject|0
75038|NCT01267201|291398|P4|First Intervention Period|Withdrawal by Subject|0
75039|NCT01267201|291399|P3|First Intervention Period|Withdrawal by Subject|0
75040|NCT01267201|291400|P2|First Intervention Period|Withdrawal by Subject|0
75041|NCT01267201|291401|P1|First Intervention Period|Withdrawal by Subject|1
75042|NCT01267175|291418|P1|Overall Study|Lost to Follow-up|1
75043|NCT01267175|291418|P1|Overall Study|Withdrawal by Subject|1
75044|NCT01266967|291490|P2|Overall Study|Withdrawal by Subject|3
75045|NCT01266967|291491|P1|Overall Study|Withdrawal by Subject|3
75046|NCT01266967|291490|P2|Overall Study|Physician Decision|1
75047|NCT01266967|291491|P1|Overall Study|Physician Decision|0
75048|NCT01266967|291490|P2|Overall Study|Lost to Follow-up|1
75049|NCT01266967|291491|P1|Overall Study|Lost to Follow-up|2
75050|NCT01266967|291490|P2|Overall Study|Study Closed/Terminated|17
75051|NCT01266967|291491|P1|Overall Study|Study Closed/Terminated|15
75052|NCT01266967|291490|P2|Overall Study|Death|61
75053|NCT01266967|291491|P1|Overall Study|Death|69
75054|NCT01266876|291543|P5|Overall Study|Adverse Event|0
75055|NCT01266876|291544|P4|Overall Study|Adverse Event|1
75056|NCT01266876|291545|P3|Overall Study|Adverse Event|0
75057|NCT01266876|291546|P2|Overall Study|Adverse Event|0
75058|NCT01266876|291547|P1|Overall Study|Adverse Event|0
75059|NCT01266850|291654|P5|Overall Study|Site Closure|0
75060|NCT01266850|291655|P4|Overall Study|Site Closure|1
75061|NCT01266850|291656|P3|Overall Study|Site Closure|1
75062|NCT01266850|291657|P2|Overall Study|Site Closure|1
75063|NCT01266850|291658|P1|Overall Study|Site Closure|0
75064|NCT01266850|291654|P5|Overall Study|Adverse Event|1
75065|NCT01266850|291655|P4|Overall Study|Adverse Event|0
75066|NCT01266850|291656|P3|Overall Study|Adverse Event|0
75067|NCT01266850|291657|P2|Overall Study|Adverse Event|0
75068|NCT01266850|291658|P1|Overall Study|Adverse Event|0
75069|NCT01266850|291654|P5|Overall Study|Protocol Violation|2
75070|NCT01266850|291655|P4|Overall Study|Protocol Violation|1
75071|NCT01266850|291656|P3|Overall Study|Protocol Violation|0
75072|NCT01266850|291657|P2|Overall Study|Protocol Violation|1
75073|NCT01266850|291658|P1|Overall Study|Protocol Violation|0
75074|NCT01266850|291654|P5|Overall Study|Physician Decision|3
75075|NCT01266850|291655|P4|Overall Study|Physician Decision|4
75076|NCT01266850|291656|P3|Overall Study|Physician Decision|4
75077|NCT01266850|291657|P2|Overall Study|Physician Decision|6
75078|NCT01266850|291658|P1|Overall Study|Physician Decision|3
75079|NCT01266850|291654|P5|Overall Study|Withdrawal by Subject|12
75080|NCT01266850|291655|P4|Overall Study|Withdrawal by Subject|9
75081|NCT01266850|291656|P3|Overall Study|Withdrawal by Subject|6
75082|NCT01266850|291657|P2|Overall Study|Withdrawal by Subject|9
75083|NCT01266850|291658|P1|Overall Study|Withdrawal by Subject|8
75084|NCT01266850|291654|P5|Overall Study|Lost to Follow-up|12
75085|NCT01266850|291655|P4|Overall Study|Lost to Follow-up|13
75086|NCT01266850|291656|P3|Overall Study|Lost to Follow-up|13
75087|NCT01266850|291657|P2|Overall Study|Lost to Follow-up|19
75088|NCT01266850|291658|P1|Overall Study|Lost to Follow-up|19
75089|NCT01266824|291712|P2|Overall Study|Study terminated prior to completion|3
75090|NCT01266824|291713|P1|Overall Study|Study terminated prior to completion|2
75091|NCT01266317|291734|P1|Overall Study|Withdrawal by Subject|2
75092|NCT01266291|291739|P1|Overall Study|Adverse Event|1
75093|NCT01266265|291746|P2|Overall Study|Clinical worsening|1
75094|NCT01266265|291747|P1|Overall Study|Clinical worsening|1
75095|NCT01266265|291746|P2|Overall Study|Site closed early|3
75096|NCT01266265|291747|P1|Overall Study|Site closed early|4
75097|NCT01266265|291746|P2|Overall Study|Lung transplant|5
75098|NCT01266265|291747|P1|Overall Study|Lung transplant|6
75099|NCT01266265|291746|P2|Overall Study|Non-compliance|5
75100|NCT01266265|291747|P1|Overall Study|Non-compliance|8
75101|NCT01266265|291746|P2|Overall Study|Enrolled in another clinical study|26
75102|NCT01266265|291747|P1|Overall Study|Enrolled in another clinical study|15
75103|NCT01266265|291746|P2|Overall Study|Stopped/changed PAH medication(s)|9
75104|NCT01266265|291747|P1|Overall Study|Stopped/changed PAH medication(s)|16
75105|NCT01266265|291746|P2|Overall Study|Transferred care to another provider|28
75106|NCT01266265|291747|P1|Overall Study|Transferred care to another provider|22
75107|NCT01266265|291746|P2|Overall Study|Respiratory-related adverse event|1
75108|NCT01266265|291747|P1|Overall Study|Respiratory-related adverse event|2
75109|NCT01266265|291746|P2|Overall Study|Withdrawal by Subject|11
75110|NCT01266265|291747|P1|Overall Study|Withdrawal by Subject|13
75111|NCT01266265|291746|P2|Overall Study|Lost to Follow-up|28
75112|NCT01266265|291747|P1|Overall Study|Lost to Follow-up|23
75113|NCT01266265|291746|P2|Overall Study|Death|73
75114|NCT01266265|291747|P1|Overall Study|Death|95
75115|NCT01266148|291755|P2|Overall Study|missing mGFR value + AE|0
75116|NCT01266148|291756|P1|Overall Study|missing mGFR value + AE|1
75117|NCT01266148|291755|P2|Overall Study|Death|3
75118|NCT01266148|291756|P1|Overall Study|Death|2
75119|NCT01266148|291755|P2|Overall Study|2 2R rejections|0
75120|NCT01266148|291756|P1|Overall Study|2 2R rejections|1
75121|NCT01266148|291755|P2|Overall Study|Ongoing rejection|0
75122|NCT01266148|291756|P1|Overall Study|Ongoing rejection|1
75123|NCT01266148|291755|P2|Overall Study|Adverse Event|0
75124|NCT01266148|291756|P1|Overall Study|Adverse Event|2
75125|NCT01266122|291784|P2|Overall Study|Lost to Follow-up|6
75126|NCT01266122|291785|P1|Overall Study|Lost to Follow-up|6
75127|NCT01266070|291793|P1|Overall Study|Protocol Violation|1
75128|NCT01266070|291793|P1|Overall Study|Adverse Event|3
75129|NCT01266031|291801|P3|Overall Study|Adverse Event|3
75130|NCT01266031|291802|P2|Overall Study|Adverse Event|0
75131|NCT01266031|291803|P1|Overall Study|Adverse Event|0
75132|NCT01266031|291801|P3|Overall Study|Not treated|0
75133|NCT01266031|291802|P2|Overall Study|Not treated|3
75134|NCT01266031|291803|P1|Overall Study|Not treated|0
75135|NCT01266018|291811|P2|Overall Study|Progressive disease|1
75136|NCT01266018|291812|P1|Overall Study|Progressive disease|0
75137|NCT01266018|291811|P2|Overall Study|Physician Decision|0
75138|NCT01266018|291812|P1|Overall Study|Physician Decision|1
75139|NCT01265992|291823|P1|Overall Study|Did not receive treatment|1
75140|NCT01265992|291823|P1|Overall Study|Stopped treatment|3
75141|NCT01265992|291823|P1|Overall Study|Administrative reasons|2
75142|NCT01265992|291823|P1|Overall Study|Adverse Event|1
75143|NCT01265992|291823|P1|Overall Study|Withdrawal by Subject|1
75144|NCT01265992|291823|P1|Overall Study|Lost to Follow-up|1
75145|NCT01265953|291851|P2|Overall Study|Non compliance|3
75146|NCT01265953|291852|P1|Overall Study|Non compliance|5
75147|NCT01265875|291864|P1|Overall Study|Uncooperative/unreliable|1
75148|NCT01265823|291872|P1|Overall Study|Participant Request|1
75149|NCT01265823|291872|P1|Overall Study|Protocol Violation|1
75150|NCT01265823|291872|P1|Overall Study|Failure to Return|4
75151|NCT01265823|291872|P1|Overall Study|Unsatisfactory Response Efficacy|1
75152|NCT01265797|291901|P2|Open Label Month|Lost to Follow-up|1
75153|NCT01265797|291902|P1|Open Label Month|Lost to Follow-up|0
75154|NCT01265797|291901|P2|Blinded Month|Diary data incomplete|1
75155|NCT01265797|291902|P1|Blinded Month|Diary data incomplete|0
75156|NCT01265797|291901|P2|Blinded Month|Adverse Event|0
75157|NCT01265797|291902|P1|Blinded Month|Adverse Event|2
75158|NCT01265797|291901|P2|Blinded Month|Protocol Violation|1
75159|NCT01265797|291902|P1|Blinded Month|Protocol Violation|2
75160|NCT01265797|291901|P2|Blinded Month|Lost to Follow-up|0
75161|NCT01265797|291902|P1|Blinded Month|Lost to Follow-up|1
75162|NCT01265797|291901|P2|Blinded Month|Lack of Efficacy|0
75163|NCT01265797|291902|P1|Blinded Month|Lack of Efficacy|5
75164|NCT01265797|291901|P2|Run-in Month|1st seizure during run-in month|1
75165|NCT01265797|291902|P1|Run-in Month|1st seizure during run-in month|0
75166|NCT01265797|291901|P2|Run-in Month|Withdrawal by Subject|4
75167|NCT01265797|291902|P1|Run-in Month|Withdrawal by Subject|0
75168|NCT01265784|291933|P3|Overall Study|Incorrectly Randomized|1
75169|NCT01265784|291934|P2|Overall Study|Incorrectly Randomized|0
75170|NCT01265784|291935|P1|Overall Study|Incorrectly Randomized|0
75171|NCT01265784|291933|P3|Overall Study|Protocol Violation|0
75172|NCT01265784|291934|P2|Overall Study|Protocol Violation|0
75173|NCT01265784|291935|P1|Overall Study|Protocol Violation|2
75174|NCT01265784|291933|P3|Overall Study|Death|0
75175|NCT01265784|291934|P2|Overall Study|Death|0
75176|NCT01265784|291935|P1|Overall Study|Death|3
75177|NCT01265784|291933|P3|Overall Study|Adverse Event|0
75178|NCT01265784|291934|P2|Overall Study|Adverse Event|0
75179|NCT01265784|291935|P1|Overall Study|Adverse Event|1
75180|NCT01265784|291933|P3|Overall Study|Physician Decision|1
75181|NCT01265784|291934|P2|Overall Study|Physician Decision|0
75182|NCT01265784|291935|P1|Overall Study|Physician Decision|1
75183|NCT01265784|291933|P3|Overall Study|Withdrawal by Subject|0
75184|NCT01265784|291934|P2|Overall Study|Withdrawal by Subject|5
75185|NCT01265784|291935|P1|Overall Study|Withdrawal by Subject|0
75186|NCT01265784|291933|P3|Overall Study|Lost to Follow-up|2
75187|NCT01265784|291934|P2|Overall Study|Lost to Follow-up|3
75188|NCT01265784|291935|P1|Overall Study|Lost to Follow-up|5
75189|NCT01265615|292020|P4|Overall Study|Protocol Violation|3
75190|NCT01265615|292021|P3|Overall Study|Protocol Violation|4
75191|NCT01265615|292022|P2|Overall Study|Protocol Violation|2
75192|NCT01265615|292023|P1|Overall Study|Protocol Violation|2
75193|NCT01265563|292074|P5|Overall Study|Withdrawal by Subject|2
75194|NCT01265563|292075|P4|Overall Study|Withdrawal by Subject|0
75195|NCT01265563|292076|P3|Overall Study|Withdrawal by Subject|1
75196|NCT01265563|292077|P2|Overall Study|Withdrawal by Subject|1
75197|NCT01265563|292078|P1|Overall Study|Withdrawal by Subject|0
75198|NCT01265511|292173|P2|Overall Study|Met stopping rules|2
75199|NCT01265511|292174|P1|Overall Study|Met stopping rules|0
75200|NCT01265511|292173|P2|Overall Study|Lack of Efficacy|1
75201|NCT01265511|292174|P1|Overall Study|Lack of Efficacy|2
75202|NCT01265498|292188|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
75203|NCT01265498|292189|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
75204|NCT01265420|292325|P1|Overall Study|Lost to Follow-up|1
75205|NCT01265394|292329|P1|Overall Study|Subjects withdrawn|37
75206|NCT01265056|292336|P2|Follow up|Lost to Follow-up|3
75207|NCT01265056|292337|P1|Follow up|Lost to Follow-up|7
75208|NCT01265056|292336|P2|Initial Study Period|Withdrawal by Subject|1
75209|NCT01265056|292337|P1|Initial Study Period|Withdrawal by Subject|1
75210|NCT01265056|292336|P2|Initial Study Period|Withdrawal by Subject|1
75211|NCT01265056|292337|P1|Initial Study Period|Withdrawal by Subject|1
75212|NCT01264939|292368|P2|Overall Study|Disease Progression|11
75213|NCT01264939|292369|P1|Overall Study|Disease Progression|8
75214|NCT01264939|292368|P2|Overall Study|Patient/Guardian Decision|10
75215|NCT01264939|292369|P1|Overall Study|Patient/Guardian Decision|8
75216|NCT01264939|292368|P2|Overall Study|Physician Decision|1
75217|NCT01264939|292369|P1|Overall Study|Physician Decision|1
75218|NCT01264939|292368|P2|Overall Study|Lost to Follow-up|3
75219|NCT01264939|292369|P1|Overall Study|Lost to Follow-up|0
75220|NCT01264939|292368|P2|Overall Study|Adverse Event|3
75221|NCT01264939|292369|P1|Overall Study|Adverse Event|1
75222|NCT01264887|292395|P1|Overall Study|Not Specified|2
75223|NCT01264887|292395|P1|Overall Study|Sponsor Decision Administrative Reasons|2
75224|NCT01264887|292395|P1|Overall Study|Withdrawal by Subject|6
75225|NCT01264887|292395|P1|Overall Study|Physician Decision|4
75226|NCT01264887|292395|P1|Overall Study|Lack of Efficacy|5
75227|NCT01264887|292395|P1|Overall Study|Death|7
75228|NCT01264887|292395|P1|Overall Study|Adverse Event|5
75229|NCT01264835|292406|P1|Overall Study|Lost to Follow-up|1
75230|NCT01264770|292416|P6|Overall Study|Adverse Event|1
75231|NCT01264770|292417|P5|Overall Study|Adverse Event|2
75232|NCT01264770|292418|P4|Overall Study|Adverse Event|0
75233|NCT01264770|292419|P3|Overall Study|Adverse Event|8
75234|NCT01264770|292420|P2|Overall Study|Adverse Event|7
75235|NCT01264770|292421|P1|Overall Study|Adverse Event|7
75236|NCT01264770|292416|P6|Overall Study|Lost to Follow-up|0
75237|NCT01264770|292417|P5|Overall Study|Lost to Follow-up|0
75238|NCT01264770|292418|P4|Overall Study|Lost to Follow-up|1
75239|NCT01264770|292419|P3|Overall Study|Lost to Follow-up|1
75240|NCT01264770|292420|P2|Overall Study|Lost to Follow-up|0
75241|NCT01264770|292421|P1|Overall Study|Lost to Follow-up|0
75242|NCT01264770|292416|P6|Overall Study|Dev. of study specific discont. criteria|1
75243|NCT01264770|292417|P5|Overall Study|Dev. of study specific discont. criteria|1
75244|NCT01264770|292418|P4|Overall Study|Dev. of study specific discont. criteria|0
75245|NCT01264770|292419|P3|Overall Study|Dev. of study specific discont. criteria|0
75246|NCT01264770|292420|P2|Overall Study|Dev. of study specific discont. criteria|0
75247|NCT01264770|292421|P1|Overall Study|Dev. of study specific discont. criteria|2
75248|NCT01264770|292416|P6|Overall Study|Lack of therapeutic response|0
75249|NCT01264770|292417|P5|Overall Study|Lack of therapeutic response|1
75250|NCT01264770|292418|P4|Overall Study|Lack of therapeutic response|1
75251|NCT01264770|292419|P3|Overall Study|Lack of therapeutic response|2
75252|NCT01264770|292420|P2|Overall Study|Lack of therapeutic response|0
75253|NCT01264770|292421|P1|Overall Study|Lack of therapeutic response|1
75254|NCT01264770|292416|P6|Overall Study|Severe non-compliance to protocol|0
75255|NCT01264770|292417|P5|Overall Study|Severe non-compliance to protocol|0
75256|NCT01264770|292418|P4|Overall Study|Severe non-compliance to protocol|1
75257|NCT01264770|292419|P3|Overall Study|Severe non-compliance to protocol|1
75258|NCT01264770|292420|P2|Overall Study|Severe non-compliance to protocol|0
75259|NCT01264770|292421|P1|Overall Study|Severe non-compliance to protocol|0
75260|NCT01264770|292416|P6|Overall Study|e.g., change in circumstances|4
75261|NCT01264770|292417|P5|Overall Study|e.g., change in circumstances|4
75262|NCT01264770|292418|P4|Overall Study|e.g., change in circumstances|3
75263|NCT01264770|292419|P3|Overall Study|e.g., change in circumstances|3
75264|NCT01264770|292420|P2|Overall Study|e.g., change in circumstances|3
75265|NCT01264770|292421|P1|Overall Study|e.g., change in circumstances|8
75266|NCT01264770|292416|P6|Overall Study|Not reported|0
75267|NCT01264770|292417|P5|Overall Study|Not reported|0
75268|NCT01264770|292418|P4|Overall Study|Not reported|0
75269|NCT01264770|292419|P3|Overall Study|Not reported|1
75270|NCT01264770|292420|P2|Overall Study|Not reported|0
75271|NCT01264770|292421|P1|Overall Study|Not reported|0
75272|NCT01264679|292505|P1|Overall Study|Withdrawal by Subject|1
75273|NCT01264679|292505|P1|Overall Study|Sponsor's Suspension of Dosing|2
75274|NCT01264679|292505|P1|Overall Study|Physician Decision|1
75275|NCT01264679|292505|P1|Overall Study|Participation in Another Clinical Trial|1
75276|NCT01264380|292539|P3|Period C|Adverse Event|1
75277|NCT01264380|292540|P2|Period C|Adverse Event|0
75278|NCT01264380|292541|P1|Period C|Adverse Event|0
75279|NCT01264380|292539|P3|Period C|Withdrawal by Subject|1
75280|NCT01264380|292540|P2|Period C|Withdrawal by Subject|0
75281|NCT01264380|292541|P1|Period C|Withdrawal by Subject|0
75282|NCT01264380|292539|P3|Period C|Follow-up for survival status|6
75283|NCT01264380|292540|P2|Period C|Follow-up for survival status|0
75284|NCT01264380|292541|P1|Period C|Follow-up for survival status|0
75285|NCT01264380|292539|P3|Period C|Death|2
75286|NCT01264380|292540|P2|Period C|Death|0
75287|NCT01264380|292541|P1|Period C|Death|0
75288|NCT01264380|292539|P3|Period C|Disease Progression|4
75289|NCT01264380|292540|P2|Period C|Disease Progression|0
75290|NCT01264380|292541|P1|Period C|Disease Progression|0
75291|NCT01264081|292562|P1|Started Treatment|Not complete cycle 1 due to death|1
75292|NCT01264081|292562|P1|Started Treatment|Withdrawal by Subject|1
75293|NCT01264081|292562|P1|Participants Screened|Screening failures|30
75294|NCT01264016|292567|P1|Overall Study|Felt faint at sight of blood|1
75295|NCT01264016|292567|P1|Overall Study|Withdrawal by Subject|1
75296|NCT01263925|292575|P2|Overall Study|Withdrawal/ Not specified|1
75297|NCT01263925|292576|P1|Overall Study|Withdrawal/ Not specified|0
75298|NCT01263925|292575|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
75299|NCT01263925|292576|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
75300|NCT01263925|292575|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
75301|NCT01263925|292576|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
75302|NCT01263925|292575|P2|Overall Study|AE/ Withdrawal|4
75303|NCT01263925|292576|P1|Overall Study|AE/ Withdrawal|1
75304|NCT01263925|292575|P2|Overall Study|AE/ Unsatisfactory Compliance|2
75305|NCT01263925|292576|P1|Overall Study|AE/ Unsatisfactory Compliance|2
75306|NCT01263925|292575|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
75307|NCT01263925|292576|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
75308|NCT01263925|292575|P2|Overall Study|Lost to Follow-up|1
75309|NCT01263925|292576|P1|Overall Study|Lost to Follow-up|3
75310|NCT01263925|292575|P2|Overall Study|Not specified|4
75311|NCT01263925|292576|P1|Overall Study|Not specified|4
75312|NCT01263925|292575|P2|Overall Study|Withdrawal by Subject|8
75313|NCT01263925|292576|P1|Overall Study|Withdrawal by Subject|6
75314|NCT01263925|292575|P2|Overall Study|Unsatisfactory Compliance of Subject|5
75315|NCT01263925|292576|P1|Overall Study|Unsatisfactory Compliance of Subject|8
75316|NCT01263925|292575|P2|Overall Study|Adverse Event|22
75317|NCT01263925|292576|P1|Overall Study|Adverse Event|23
75318|NCT01263925|292575|P2|Overall Study|Lack of Efficacy|1
75319|NCT01263925|292576|P1|Overall Study|Lack of Efficacy|0
75320|NCT01263925|292575|P2|Overall Study|Protocol Violation|0
75321|NCT01263925|292576|P1|Overall Study|Protocol Violation|1
75322|NCT01263873|292610|P2|Overall Study|One provider unable to complete numbers|1
75323|NCT01263873|292611|P1|Overall Study|One provider unable to complete numbers|1
75324|NCT01263704|292652|P1|Overall Study|Principal Investigator (PI) decision|1
75325|NCT01263704|292652|P1|Overall Study|Colon metastases|1
75326|NCT01263704|292652|P1|Overall Study|Lost to Follow-up|1
75327|NCT01263704|292652|P1|Overall Study|Eligibility criteria not fulfilled|1
75328|NCT01263704|292652|P1|Overall Study|Patient withdrew consent|2
75329|NCT01263704|292652|P1|Overall Study|Death|2
75330|NCT01263704|292652|P1|Overall Study|Adverse Event|3
75331|NCT01263704|292652|P1|Overall Study|Progressive disease|18
75332|NCT01263691|292667|P6|Overall Study|Adverse Event|0
75333|NCT01263691|292668|P5|Overall Study|Adverse Event|0
75334|NCT01263691|292669|P4|Overall Study|Adverse Event|0
75335|NCT01263691|292670|P3|Overall Study|Adverse Event|0
75336|NCT01263691|292671|P2|Overall Study|Adverse Event|0
75337|NCT01263691|292672|P1|Overall Study|Adverse Event|1
75338|NCT01263691|292667|P6|Overall Study|Withdrawal by Subject|0
75339|NCT01263691|292668|P5|Overall Study|Withdrawal by Subject|0
75340|NCT01263691|292669|P4|Overall Study|Withdrawal by Subject|0
75341|NCT01263691|292670|P3|Overall Study|Withdrawal by Subject|0
75342|NCT01263691|292671|P2|Overall Study|Withdrawal by Subject|0
75343|NCT01263691|292672|P1|Overall Study|Withdrawal by Subject|1
75344|NCT01263691|292667|P6|Overall Study|Lost to Follow-up|0
75345|NCT01263691|292668|P5|Overall Study|Lost to Follow-up|0
75346|NCT01263691|292669|P4|Overall Study|Lost to Follow-up|1
75347|NCT01263691|292670|P3|Overall Study|Lost to Follow-up|1
75348|NCT01263691|292671|P2|Overall Study|Lost to Follow-up|0
75349|NCT01263691|292672|P1|Overall Study|Lost to Follow-up|1
75350|NCT01263665|292782|P1|Overall Study|Surgical Bypass|2
75351|NCT01263665|292782|P1|Overall Study|Amputation above the ankle|1
75352|NCT01263665|292782|P1|Overall Study|Death|2
75353|NCT01263665|292782|P1|Overall Study|Lost to Follow-up|3
75354|NCT01263665|292782|P1|Overall Study|Withdrew Consent|1
75355|NCT01263639|292789|P2|Overall Study|Exclusion =Admission greater than 7 days|9
75356|NCT01263639|292790|P1|Overall Study|Exclusion =Admission greater than 7 days|7
75357|NCT01263639|292789|P2|Overall Study|Lost to Follow-up|70
75358|NCT01263639|292790|P1|Overall Study|Lost to Follow-up|66
75359|NCT01263561|292798|P2|Overall Study|Death|2
75360|NCT01263561|292799|P1|Overall Study|Death|1
75361|NCT01263509|292811|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
75362|NCT01263509|292812|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
75363|NCT01263509|292813|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
75364|NCT01263509|292814|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
75365|NCT01263509|292811|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
75366|NCT01263509|292812|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
75367|NCT01263509|292813|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
75368|NCT01263509|292814|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
75369|NCT01263509|292811|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
75370|NCT01263509|292812|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
75371|NCT01263509|292813|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
75372|NCT01263509|292814|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
75373|NCT01263509|292811|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
75374|NCT01263509|292812|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
75375|NCT01263509|292813|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
75376|NCT01263509|292814|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
75377|NCT01263509|292811|P4|Entered - Long-Term Extension Study|Adverse Event|1
75378|NCT01263509|292812|P3|Entered - Long-Term Extension Study|Adverse Event|4
75379|NCT01263509|292813|P2|Entered - Long-Term Extension Study|Adverse Event|5
75380|NCT01263509|292814|P1|Entered - Long-Term Extension Study|Adverse Event|5
75381|NCT01263496|292943|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
75382|NCT01263496|292944|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
75383|NCT01263496|292945|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
75384|NCT01263496|292946|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
75385|NCT01263496|292947|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
75386|NCT01263496|292948|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
75387|NCT01263496|292949|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
75388|NCT01263496|292950|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
75389|NCT01263496|292951|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
75390|NCT01263496|292943|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
75391|NCT01263496|292944|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
75392|NCT01263496|292945|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
75393|NCT01263496|292946|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
75394|NCT01263496|292947|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
75395|NCT01263496|292948|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
75396|NCT01263496|292949|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
75397|NCT01263496|292950|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
75398|NCT01263496|292951|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
75399|NCT01263496|292943|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
75400|NCT01263496|292944|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
75401|NCT01263496|292945|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
75480|NCT01263470|293313|P3|Overall Study|Withdrawal by Subject|1
75402|NCT01263496|292946|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
75403|NCT01263496|292947|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
75404|NCT01263496|292948|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
75405|NCT01263496|292949|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
75406|NCT01263496|292950|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
75407|NCT01263496|292951|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
75408|NCT01263496|292943|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
75409|NCT01263496|292944|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
75410|NCT01263496|292945|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
75411|NCT01263496|292946|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
75412|NCT01263496|292947|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
75413|NCT01263496|292948|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
75414|NCT01263496|292949|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
75415|NCT01263496|292950|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
75416|NCT01263496|292951|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
75417|NCT01263496|292943|P9|Entered - Long-Term Extension Study|Adverse Event|1
75418|NCT01263496|292944|P8|Entered - Long-Term Extension Study|Adverse Event|0
75419|NCT01263496|292945|P7|Entered - Long-Term Extension Study|Adverse Event|0
75420|NCT01263496|292946|P6|Entered - Long-Term Extension Study|Adverse Event|0
75421|NCT01263496|292947|P5|Entered - Long-Term Extension Study|Adverse Event|1
75422|NCT01263496|292948|P4|Entered - Long-Term Extension Study|Adverse Event|3
75423|NCT01263496|292949|P3|Entered - Long-Term Extension Study|Adverse Event|6
75424|NCT01263496|292950|P2|Entered - Long-Term Extension Study|Adverse Event|5
75425|NCT01263496|292951|P1|Entered - Long-Term Extension Study|Adverse Event|0
75426|NCT01263496|292943|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
75427|NCT01263496|292944|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
75428|NCT01263496|292945|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
75429|NCT01263496|292946|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
75430|NCT01263496|292947|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
75431|NCT01263496|292948|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
75432|NCT01263496|292949|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
75433|NCT01263496|292950|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
75434|NCT01263496|292951|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
75435|NCT01263496|292943|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
75436|NCT01263496|292944|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
75437|NCT01263496|292945|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
75438|NCT01263496|292946|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
75439|NCT01263496|292947|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
75440|NCT01263496|292948|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
75441|NCT01263496|292949|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
75442|NCT01263496|292950|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
75443|NCT01263496|292951|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
75444|NCT01263483|293246|P3|Overall Study|Participant Unavailability|1
75445|NCT01263483|293247|P2|Overall Study|Participant Unavailability|1
75446|NCT01263483|293248|P1|Overall Study|Participant Unavailability|0
75447|NCT01263483|293246|P3|Overall Study|Protocol Violation|1
75448|NCT01263483|293247|P2|Overall Study|Protocol Violation|1
75449|NCT01263483|293248|P1|Overall Study|Protocol Violation|0
75450|NCT01263483|293246|P3|Overall Study|Lack of Efficacy|0
75451|NCT01263483|293247|P2|Overall Study|Lack of Efficacy|0
75452|NCT01263483|293248|P1|Overall Study|Lack of Efficacy|2
75453|NCT01263483|293246|P3|Overall Study|Withdrawal by Subject|0
75454|NCT01263483|293247|P2|Overall Study|Withdrawal by Subject|0
75455|NCT01263483|293248|P1|Overall Study|Withdrawal by Subject|1
75456|NCT01263483|293246|P3|Overall Study|Adverse Event|3
75457|NCT01263483|293247|P2|Overall Study|Adverse Event|0
75458|NCT01263483|293248|P1|Overall Study|Adverse Event|4
75459|NCT01263470|293310|P6|Overall Study|Study Drug Non-compliance|0
75460|NCT01263470|293311|P5|Overall Study|Study Drug Non-compliance|1
75461|NCT01263470|293312|P4|Overall Study|Study Drug Non-compliance|0
75462|NCT01263470|293313|P3|Overall Study|Study Drug Non-compliance|0
75463|NCT01263470|293314|P2|Overall Study|Study Drug Non-compliance|0
75464|NCT01263470|293315|P1|Overall Study|Study Drug Non-compliance|0
75465|NCT01263470|293310|P6|Overall Study|Participant Unavailability|0
75466|NCT01263470|293311|P5|Overall Study|Participant Unavailability|0
75467|NCT01263470|293312|P4|Overall Study|Participant Unavailability|0
75468|NCT01263470|293313|P3|Overall Study|Participant Unavailability|0
75469|NCT01263470|293314|P2|Overall Study|Participant Unavailability|1
75470|NCT01263470|293315|P1|Overall Study|Participant Unavailability|0
75471|NCT01263470|293310|P6|Overall Study|Lack of Efficacy|0
75472|NCT01263470|293311|P5|Overall Study|Lack of Efficacy|0
75473|NCT01263470|293312|P4|Overall Study|Lack of Efficacy|0
75474|NCT01263470|293313|P3|Overall Study|Lack of Efficacy|2
75475|NCT01263470|293314|P2|Overall Study|Lack of Efficacy|0
75476|NCT01263470|293315|P1|Overall Study|Lack of Efficacy|0
75477|NCT01263470|293310|P6|Overall Study|Withdrawal by Subject|2
75478|NCT01263470|293311|P5|Overall Study|Withdrawal by Subject|0
75479|NCT01263470|293312|P4|Overall Study|Withdrawal by Subject|2
75481|NCT01263470|293314|P2|Overall Study|Withdrawal by Subject|1
75482|NCT01263470|293315|P1|Overall Study|Withdrawal by Subject|0
75483|NCT01263470|293310|P6|Overall Study|Protocol Violation|1
75484|NCT01263470|293311|P5|Overall Study|Protocol Violation|0
75485|NCT01263470|293312|P4|Overall Study|Protocol Violation|0
75486|NCT01263470|293313|P3|Overall Study|Protocol Violation|0
75487|NCT01263470|293314|P2|Overall Study|Protocol Violation|1
75488|NCT01263470|293315|P1|Overall Study|Protocol Violation|0
75489|NCT01263470|293310|P6|Overall Study|Adverse Event|2
75490|NCT01263470|293311|P5|Overall Study|Adverse Event|2
75491|NCT01263470|293312|P4|Overall Study|Adverse Event|1
75492|NCT01263470|293313|P3|Overall Study|Adverse Event|1
75493|NCT01263470|293314|P2|Overall Study|Adverse Event|2
75494|NCT01263470|293315|P1|Overall Study|Adverse Event|2
75495|NCT01263444|293425|P1|Overall Study|Protocol Violation|1
75496|NCT01263444|293425|P1|Overall Study|Withdrawal by Subject|1
75497|NCT01263444|293425|P1|Overall Study|Adverse Event|8
75498|NCT01263054|293466|P2|Overall Study|Other|1
75499|NCT01263054|293467|P1|Overall Study|Other|0
75500|NCT01263054|293466|P2|Overall Study|Qualification Violation|0
75501|NCT01263054|293467|P1|Overall Study|Qualification Violation|1
75502|NCT01263054|293466|P2|Overall Study|Withdrawal by Subject|3
75503|NCT01263054|293467|P1|Overall Study|Withdrawal by Subject|1
75504|NCT01263054|293466|P2|Overall Study|Lost to Follow-up|2
75505|NCT01263054|293467|P1|Overall Study|Lost to Follow-up|2
75506|NCT01263054|293466|P2|Overall Study|Death|0
75507|NCT01263054|293467|P1|Overall Study|Death|1
75508|NCT01263028|293485|P1|Overall Study|Study terminated due to low enrollment.|4
75509|NCT01263028|293485|P1|Overall Study|Adverse Event|1
75510|NCT01263028|293485|P1|Overall Study|Withdrawal by Subject|1
75511|NCT01263015|293495|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
75512|NCT01263015|293496|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
75513|NCT01263015|293495|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
75514|NCT01263015|293496|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
75515|NCT01263015|293495|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
75516|NCT01263015|293496|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
75517|NCT01263015|293495|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
75518|NCT01263015|293496|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
75519|NCT01263015|293495|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
75520|NCT01263015|293496|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
75521|NCT01263015|293495|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
75522|NCT01263015|293496|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
75523|NCT01263015|293495|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
75524|NCT01263015|293496|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
75525|NCT01263015|293495|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
75526|NCT01263015|293496|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
75527|NCT01263015|293495|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
75528|NCT01263015|293496|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
75529|NCT01263015|293495|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
75530|NCT01263015|293496|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
75531|NCT01263015|293495|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
75532|NCT01263015|293496|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
75533|NCT01263015|293495|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
75534|NCT01263015|293496|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
75535|NCT01262989|293522|P2|Period 2|Intercurrent disease|1
75536|NCT01262989|293523|P1|Period 2|Intercurrent disease|0
75537|NCT01262989|293522|P2|Period 1|Positive answer for exclusion criteria|1
75538|NCT01262989|293523|P1|Period 1|Positive answer for exclusion criteria|0
75539|NCT01262989|293522|P2|Period 1|Intercurrent disease|1
75540|NCT01262989|293523|P1|Period 1|Intercurrent disease|0
75541|NCT01262989|293522|P2|Period 1|Lost to Follow-up|1
75542|NCT01262989|293523|P1|Period 1|Lost to Follow-up|1
75543|NCT01262898|293537|P4|Overall Study|Withdrawal by Subject|0
75544|NCT01262898|293538|P3|Overall Study|Withdrawal by Subject|0
75545|NCT01262898|293539|P2|Overall Study|Withdrawal by Subject|1
75546|NCT01262898|293540|P1|Overall Study|Withdrawal by Subject|1
75547|NCT01262898|293537|P4|Overall Study|Lost to Follow-up|0
75548|NCT01262898|293538|P3|Overall Study|Lost to Follow-up|0
75549|NCT01262898|293539|P2|Overall Study|Lost to Follow-up|0
75550|NCT01262898|293540|P1|Overall Study|Lost to Follow-up|1
75551|NCT01262898|293537|P4|Overall Study|Protocol Violation|0
75552|NCT01262898|293538|P3|Overall Study|Protocol Violation|0
75553|NCT01262898|293539|P2|Overall Study|Protocol Violation|1
75554|NCT01262898|293540|P1|Overall Study|Protocol Violation|1
75555|NCT01262872|293668|P8|Step 2|Migrated/moved from study area|3
75556|NCT01262872|293669|P7|Step 2|Migrated/moved from study area|2
75557|NCT01262872|293670|P6|Step 2|Migrated/moved from study area|6
75558|NCT01262872|293671|P5|Step 2|Migrated/moved from study area|2
75559|NCT01262872|293672|P4|Step 2|Migrated/moved from study area|3
75560|NCT01262872|293673|P3|Step 2|Migrated/moved from study area|4
75561|NCT01262872|293674|P2|Step 2|Migrated/moved from study area|0
75562|NCT01262872|293675|P1|Step 2|Migrated/moved from study area|0
75563|NCT01262872|293668|P8|Step 2|Withdrawal by Subject|1
75564|NCT01262872|293669|P7|Step 2|Withdrawal by Subject|2
75565|NCT01262872|293670|P6|Step 2|Withdrawal by Subject|1
75566|NCT01262872|293671|P5|Step 2|Withdrawal by Subject|3
75567|NCT01262872|293672|P4|Step 2|Withdrawal by Subject|6
75568|NCT01262872|293673|P3|Step 2|Withdrawal by Subject|4
75569|NCT01262872|293674|P2|Step 2|Withdrawal by Subject|0
75570|NCT01262872|293675|P1|Step 2|Withdrawal by Subject|0
75571|NCT01262872|293668|P8|Step 2|Protocol Violation|1
75572|NCT01262872|293669|P7|Step 2|Protocol Violation|3
75573|NCT01262872|293670|P6|Step 2|Protocol Violation|0
75574|NCT01262872|293671|P5|Step 2|Protocol Violation|0
75575|NCT01262872|293672|P4|Step 2|Protocol Violation|0
75576|NCT01262872|293673|P3|Step 2|Protocol Violation|1
75577|NCT01262872|293674|P2|Step 2|Protocol Violation|0
75578|NCT01262872|293675|P1|Step 2|Protocol Violation|0
75579|NCT01262872|293668|P8|Step 2|Death|1
75580|NCT01262872|293669|P7|Step 2|Death|2
75581|NCT01262872|293670|P6|Step 2|Death|2
75582|NCT01262872|293671|P5|Step 2|Death|0
75583|NCT01262872|293672|P4|Step 2|Death|1
75584|NCT01262872|293673|P3|Step 2|Death|0
75585|NCT01262872|293674|P2|Step 2|Death|0
75586|NCT01262872|293675|P1|Step 2|Death|0
75587|NCT01262820|293937|P1|Overall Study|Drug held for 21+ days|1
75588|NCT01262820|293937|P1|Overall Study|Lack of Efficacy|9
75589|NCT01262820|293937|P1|Overall Study|Adverse Event|5
75590|NCT01262651|293950|P2|Overall Study|Met Withdrawal Criteria|0
75591|NCT01262651|293951|P1|Overall Study|Met Withdrawal Criteria|1
75592|NCT01262651|293950|P2|Overall Study|Withdrawal by Investigator|2
75593|NCT01262651|293951|P1|Overall Study|Withdrawal by Investigator|2
75594|NCT01262651|293950|P2|Overall Study|Withdrawal by Subject|11
75595|NCT01262651|293951|P1|Overall Study|Withdrawal by Subject|15
75596|NCT01262651|293950|P2|Overall Study|Adverse Event|35
75597|NCT01262651|293951|P1|Overall Study|Adverse Event|40
75598|NCT01262573|293988|P2|Overall Study|Withdrawal by Subject|1
75599|NCT01262573|293989|P1|Overall Study|Withdrawal by Subject|0
75600|NCT01262560|294000|P3|Overall Study|Protocol Violation|2
75601|NCT01262560|294001|P2|Overall Study|Protocol Violation|1
75602|NCT01262560|294002|P1|Overall Study|Protocol Violation|0
75603|NCT01262456|294051|P3|1-Month Open-Label Extension Period|Other Reason|0
75604|NCT01262456|294052|P2|1-Month Open-Label Extension Period|Other Reason|1
75605|NCT01262456|294053|P1|1-Month Open-Label Extension Period|Other Reason|0
75606|NCT01262456|294051|P3|1-Month Open-Label Extension Period|Protocol Violation|2
75607|NCT01262456|294052|P2|1-Month Open-Label Extension Period|Protocol Violation|0
75608|NCT01262456|294053|P1|1-Month Open-Label Extension Period|Protocol Violation|1
75609|NCT01262456|294051|P3|1-Month Open-Label Extension Period|Adverse Event|2
75610|NCT01262456|294052|P2|1-Month Open-Label Extension Period|Adverse Event|0
75611|NCT01262456|294053|P1|1-Month Open-Label Extension Period|Adverse Event|2
75612|NCT01262456|294051|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
75613|NCT01262456|294052|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
75614|NCT01262456|294053|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
75615|NCT01262456|294051|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
75616|NCT01262456|294052|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
75617|NCT01262456|294053|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
75618|NCT01262456|294051|P3|3-Month Double-Blind Period|Protocol Violation|6
75619|NCT01262456|294052|P2|3-Month Double-Blind Period|Protocol Violation|6
75620|NCT01262456|294053|P1|3-Month Double-Blind Period|Protocol Violation|3
75621|NCT01262456|294051|P3|3-Month Double-Blind Period|Adverse Event|8
75622|NCT01262456|294052|P2|3-Month Double-Blind Period|Adverse Event|4
75623|NCT01262456|294053|P1|3-Month Double-Blind Period|Adverse Event|6
75624|NCT01262456|294051|P3|3-Month Double-Blind Period|Lost to Follow-up|3
75625|NCT01262456|294052|P2|3-Month Double-Blind Period|Lost to Follow-up|5
75626|NCT01262456|294053|P1|3-Month Double-Blind Period|Lost to Follow-up|4
75627|NCT01262456|294051|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
75628|NCT01262456|294052|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
75629|NCT01262456|294053|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
75630|NCT01262352|294096|P2|Washout|Extended Washout|1
75631|NCT01262352|294097|P1|Washout|Extended Washout|0
75632|NCT01262352|294096|P2|Washout|Adverse Event|1
75633|NCT01262352|294097|P1|Washout|Adverse Event|1
75634|NCT01262352|294096|P2|Period 1|Illness after randomization|0
75635|NCT01262352|294097|P1|Period 1|Illness after randomization|1
75636|NCT01262287|294115|P2|Overall Study|Lost to Follow-up|1
75637|NCT01262287|294116|P1|Overall Study|Lost to Follow-up|2
75638|NCT01262092|294177|P2|Gabapentin Taper|noncompliance - missed medications|0
75639|NCT01262092|294178|P1|Gabapentin Taper|noncompliance - missed medications|1
75640|NCT01262092|294177|P2|Buprenorphine Taper|noncompliance - missed medication|1
75641|NCT01262092|294178|P1|Buprenorphine Taper|noncompliance - missed medication|1
75642|NCT01262092|294177|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
75643|NCT01262092|294178|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
75644|NCT01262092|294177|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
75645|NCT01262092|294178|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
75646|NCT01262027|294184|P1|Overall Study|Protocol Violation|1
75647|NCT01262027|294184|P1|Overall Study|Withdrawal by Subject|3
75648|NCT01262027|294184|P1|Overall Study|Adverse Event|1
75649|NCT01261975|294189|P1|Overall Study|Surgical complication|1
75650|NCT01261780|294210|P2|Overall Study|Event not related to subject|2
75651|NCT01261780|294211|P1|Overall Study|Event not related to subject|1
75652|NCT01261780|294210|P2|Overall Study|Withdrawal by Subject|0
75653|NCT01261780|294211|P1|Overall Study|Withdrawal by Subject|1
75654|NCT01261624|294221|P2|Week 13 to Week 24|Insufficient Response|1
75655|NCT01261624|294222|P1|Week 13 to Week 24|Insufficient Response|0
75656|NCT01261624|294221|P2|Week 0 to Week 12|Insufficient Response|2
75657|NCT01261624|294222|P1|Week 0 to Week 12|Insufficient Response|0
75658|NCT01261624|294221|P2|Week 0 to Week 12|Disease Progression|1
75659|NCT01261624|294222|P1|Week 0 to Week 12|Disease Progression|1
75660|NCT01261390|294263|P4|Overall Study|Lost to Follow-up|6
75661|NCT01261390|294264|P3|Overall Study|Lost to Follow-up|5
75662|NCT01261390|294265|P2|Overall Study|Lost to Follow-up|6
75663|NCT01261390|294266|P1|Overall Study|Lost to Follow-up|1
75664|NCT01261390|294263|P4|Overall Study|Loss of Interest in the Study|0
75665|NCT01261390|294264|P3|Overall Study|Loss of Interest in the Study|0
75666|NCT01261390|294265|P2|Overall Study|Loss of Interest in the Study|1
75667|NCT01261390|294266|P1|Overall Study|Loss of Interest in the Study|3
75668|NCT01261390|294263|P4|Overall Study|Relocation|0
75669|NCT01261390|294264|P3|Overall Study|Relocation|0
75670|NCT01261390|294265|P2|Overall Study|Relocation|1
75671|NCT01261390|294266|P1|Overall Study|Relocation|0
75672|NCT01261390|294263|P4|Overall Study|Dissatisfaction with Treatment|2
75673|NCT01261390|294264|P3|Overall Study|Dissatisfaction with Treatment|1
75674|NCT01261390|294265|P2|Overall Study|Dissatisfaction with Treatment|1
75675|NCT01261390|294266|P1|Overall Study|Dissatisfaction with Treatment|2
75676|NCT01261390|294263|P4|Overall Study|Significant Concurrent Illness|0
75677|NCT01261390|294264|P3|Overall Study|Significant Concurrent Illness|1
75678|NCT01261390|294265|P2|Overall Study|Significant Concurrent Illness|0
75679|NCT01261390|294266|P1|Overall Study|Significant Concurrent Illness|1
75680|NCT01261325|294431|P3|Overall Study|AE, serious fatal|2
75681|NCT01261325|294432|P2|Overall Study|AE, serious fatal|0
75682|NCT01261325|294433|P1|Overall Study|AE, serious fatal|0
75683|NCT01261325|294431|P3|Overall Study|Lost to Follow-up|3
75684|NCT01261325|294432|P2|Overall Study|Lost to Follow-up|1
75685|NCT01261325|294433|P1|Overall Study|Lost to Follow-up|0
75686|NCT01261325|294431|P3|Overall Study|Protocol Violation|1
75687|NCT01261325|294432|P2|Overall Study|Protocol Violation|3
75688|NCT01261325|294433|P1|Overall Study|Protocol Violation|0
75689|NCT01261325|294431|P3|Overall Study|Randomized in Error|1
75690|NCT01261325|294432|P2|Overall Study|Randomized in Error|0
75691|NCT01261325|294433|P1|Overall Study|Randomized in Error|0
75692|NCT01261325|294431|P3|Overall Study|Screen Failure|0
75693|NCT01261325|294432|P2|Overall Study|Screen Failure|0
75694|NCT01261325|294433|P1|Overall Study|Screen Failure|1
75695|NCT01261325|294431|P3|Overall Study|Erroneously Randomized|0
75696|NCT01261325|294432|P2|Overall Study|Erroneously Randomized|0
75697|NCT01261325|294433|P1|Overall Study|Erroneously Randomized|1
75698|NCT01261325|294431|P3|Overall Study|Patient Randomized by Mistake|0
75699|NCT01261325|294432|P2|Overall Study|Patient Randomized by Mistake|1
75700|NCT01261325|294433|P1|Overall Study|Patient Randomized by Mistake|0
75701|NCT01261325|294431|P3|Overall Study|Non Compliance|0
75702|NCT01261325|294432|P2|Overall Study|Non Compliance|0
75703|NCT01261325|294433|P1|Overall Study|Non Compliance|2
75704|NCT01261325|294431|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
75705|NCT01261325|294432|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
75706|NCT01261325|294433|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
75707|NCT01261325|294431|P3|Overall Study|AE, non-serious non-fatal|13
75708|NCT01261325|294432|P2|Overall Study|AE, non-serious non-fatal|15
75709|NCT01261325|294433|P1|Overall Study|AE, non-serious non-fatal|9
75710|NCT01261325|294431|P3|Overall Study|SAE, non-fatal|1
75711|NCT01261325|294432|P2|Overall Study|SAE, non-fatal|5
75712|NCT01261325|294433|P1|Overall Study|SAE, non-fatal|1
75713|NCT01261325|294431|P3|Overall Study|Withdrawal by Subject|4
75714|NCT01261325|294432|P2|Overall Study|Withdrawal by Subject|2
75715|NCT01261325|294433|P1|Overall Study|Withdrawal by Subject|2
75716|NCT01261325|294431|P3|Overall Study|Lack of Efficacy|0
75717|NCT01261325|294432|P2|Overall Study|Lack of Efficacy|1
75718|NCT01261325|294433|P1|Overall Study|Lack of Efficacy|1
75719|NCT01261247|294465|P1|Overall Study|Ineligible|2
75720|NCT01261000|294478|P1|Overall Study|Screen failure|1
75721|NCT01260948|294484|P2|Second Intervention|Emesis|1
75722|NCT01260948|294485|P1|Second Intervention|Emesis|0
75723|NCT01260948|294484|P2|Washout of 28 Days|Withdrawal by Subject|3
75724|NCT01260948|294485|P1|Washout of 28 Days|Withdrawal by Subject|1
75725|NCT01260922|294495|P2|Second Intervention|Emesis|2
75726|NCT01260922|294496|P1|Second Intervention|Emesis|0
75727|NCT01260922|294495|P2|Washout of 28 Days|Withdrawal by Subject|2
75728|NCT01260922|294496|P1|Washout of 28 Days|Withdrawal by Subject|4
75729|NCT01260922|294495|P2|First Intervention|Withdrawal by Subject|1
75730|NCT01260922|294496|P1|First Intervention|Withdrawal by Subject|0
75731|NCT01260896|294506|P2|First Intervention|Withdrawn Due to Emesis|0
75732|NCT01260896|294507|P1|First Intervention|Withdrawn Due to Emesis|2
75733|NCT01260701|294565|P1|Overall Study|Did not begin protocol therapy|1
75734|NCT01260701|294565|P1|Overall Study|Ineligible|4
75735|NCT01260701|294565|P1|Overall Study|Under review|1
75736|NCT01260701|294565|P1|Overall Study|Not protocol specified|3
75737|NCT01260701|294565|P1|Overall Study|Death|2
75738|NCT01260701|294565|P1|Overall Study|Progression|53
75739|NCT01260701|294565|P1|Overall Study|Withdrawal by Subject|2
75740|NCT01260701|294565|P1|Overall Study|Adverse Event|9
75741|NCT01260584|294646|P4|Period 2|Withdrawal by Subject|0
75742|NCT01260584|294647|P3|Period 2|Withdrawal by Subject|0
75743|NCT01260584|294648|P2|Period 2|Withdrawal by Subject|1
75744|NCT01260584|294649|P1|Period 2|Withdrawal by Subject|0
75745|NCT01260584|294646|P4|Period 2|Adverse Event|0
75746|NCT01260584|294647|P3|Period 2|Adverse Event|2
75747|NCT01260584|294648|P2|Period 2|Adverse Event|0
75748|NCT01260584|294649|P1|Period 2|Adverse Event|1
75749|NCT01260584|294646|P4|Period 2|Protocol Violation|1
75750|NCT01260584|294647|P3|Period 2|Protocol Violation|3
75751|NCT01260584|294648|P2|Period 2|Protocol Violation|2
75752|NCT01260584|294649|P1|Period 2|Protocol Violation|0
75753|NCT01260584|294646|P4|Period 1|Adverse Event|0
75754|NCT01260584|294647|P3|Period 1|Adverse Event|1
75755|NCT01260584|294648|P2|Period 1|Adverse Event|0
75756|NCT01260584|294649|P1|Period 1|Adverse Event|0
75757|NCT01260584|294646|P4|Period 1|Protocol Violation|1
75758|NCT01260584|294647|P3|Period 1|Protocol Violation|1
75759|NCT01260584|294648|P2|Period 1|Protocol Violation|0
75760|NCT01260584|294649|P1|Period 1|Protocol Violation|0
75761|NCT01260467|294692|P1|Overall Study|Withdrawal by Subject|2
75762|NCT01260350|294724|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
75763|NCT01260350|294725|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
75764|NCT01260350|294726|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
75765|NCT01260350|294727|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
75766|NCT01260350|294728|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
75767|NCT01260350|294729|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
75768|NCT01260350|294730|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
75769|NCT01260350|294731|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
75770|NCT01260350|294732|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
75771|NCT01260350|294733|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
75772|NCT01260350|294734|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
75773|NCT01260350|294735|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
75774|NCT01260350|294736|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
75775|NCT01260350|294737|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
75776|NCT01260350|294738|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
75777|NCT01260350|294739|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
75778|NCT01260350|294740|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
75779|NCT01260350|294741|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
75780|NCT01260350|294742|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
75781|NCT01260350|294743|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
75782|NCT01260350|294744|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
75783|NCT01260350|294745|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
75784|NCT01260350|294724|P22|Overall Study|Lack of Efficacy|0
75785|NCT01260350|294725|P21|Overall Study|Lack of Efficacy|3
75786|NCT01260350|294726|P20|Overall Study|Lack of Efficacy|0
75787|NCT01260350|294727|P19|Overall Study|Lack of Efficacy|0
75788|NCT01260350|294728|P18|Overall Study|Lack of Efficacy|1
75789|NCT01260350|294729|P17|Overall Study|Lack of Efficacy|0
75790|NCT01260350|294730|P16|Overall Study|Lack of Efficacy|0
75791|NCT01260350|294731|P15|Overall Study|Lack of Efficacy|0
75792|NCT01260350|294732|P14|Overall Study|Lack of Efficacy|0
75793|NCT01260350|294733|P13|Overall Study|Lack of Efficacy|0
75794|NCT01260350|294734|P12|Overall Study|Lack of Efficacy|0
75795|NCT01260350|294735|P11|Overall Study|Lack of Efficacy|0
75796|NCT01260350|294736|P10|Overall Study|Lack of Efficacy|0
75797|NCT01260350|294737|P9|Overall Study|Lack of Efficacy|0
75798|NCT01260350|294738|P8|Overall Study|Lack of Efficacy|0
75799|NCT01260350|294739|P7|Overall Study|Lack of Efficacy|0
75800|NCT01260350|294740|P6|Overall Study|Lack of Efficacy|0
75801|NCT01260350|294741|P5|Overall Study|Lack of Efficacy|0
75802|NCT01260350|294742|P4|Overall Study|Lack of Efficacy|0
75803|NCT01260350|294743|P3|Overall Study|Lack of Efficacy|0
75804|NCT01260350|294744|P2|Overall Study|Lack of Efficacy|0
75805|NCT01260350|294745|P1|Overall Study|Lack of Efficacy|0
75806|NCT01260311|294952|P1|Overall Study|Fesoterodine Started Before Enrollment|1
75807|NCT01260311|294952|P1|Overall Study|Medication Stopped|1
75808|NCT01260311|294952|P1|Overall Study|Gone to Province|2
75809|NCT01260311|294952|P1|Overall Study|Financial Constraints|77
75810|NCT01260311|294952|P1|Overall Study|Withdrawal by Subject|6
75811|NCT01260311|294952|P1|Overall Study|Lost to Follow-up|25
75812|NCT01260311|294952|P1|Overall Study|Lack of Efficacy|4
75813|NCT01260311|294952|P1|Overall Study|Adverse Event|11
75814|NCT01260194|294983|P1|Overall Study|Withdrawal of Consent|1
75815|NCT01260142|295001|P6|Treatment Period 1|Withdrawal by Subject|1
75816|NCT01260142|295002|P5|Treatment Period 1|Withdrawal by Subject|0
75817|NCT01260142|295003|P4|Treatment Period 1|Withdrawal by Subject|0
75818|NCT01260142|295004|P3|Treatment Period 1|Withdrawal by Subject|0
75819|NCT01260142|295005|P2|Treatment Period 1|Withdrawal by Subject|0
75820|NCT01260142|295006|P1|Treatment Period 1|Withdrawal by Subject|0
75821|NCT01260142|295001|P6|Treatment Period 1|Unexplained elevated sys. BP|0
75822|NCT01260142|295002|P5|Treatment Period 1|Unexplained elevated sys. BP|1
75823|NCT01260142|295003|P4|Treatment Period 1|Unexplained elevated sys. BP|0
75824|NCT01260142|295004|P3|Treatment Period 1|Unexplained elevated sys. BP|0
75825|NCT01260142|295005|P2|Treatment Period 1|Unexplained elevated sys. BP|0
75826|NCT01260142|295006|P1|Treatment Period 1|Unexplained elevated sys. BP|0
75827|NCT01260142|295001|P6|Treatment Period 1|Study on hold|2
75828|NCT01260142|295002|P5|Treatment Period 1|Study on hold|1
75829|NCT01260142|295003|P4|Treatment Period 1|Study on hold|0
75830|NCT01260142|295004|P3|Treatment Period 1|Study on hold|0
75831|NCT01260142|295005|P2|Treatment Period 1|Study on hold|1
75832|NCT01260142|295006|P1|Treatment Period 1|Study on hold|1
75833|NCT01259726|295060|P4|Overall Study|Lost to Follow-up|3
75834|NCT01259726|295061|P3|Overall Study|Lost to Follow-up|1
75835|NCT01259726|295062|P2|Overall Study|Lost to Follow-up|1
75836|NCT01259726|295063|P1|Overall Study|Lost to Follow-up|1
75837|NCT01259726|295060|P4|Overall Study|Withdrawal by Subject|1
75838|NCT01259726|295061|P3|Overall Study|Withdrawal by Subject|2
75839|NCT01259726|295062|P2|Overall Study|Withdrawal by Subject|3
75840|NCT01259726|295063|P1|Overall Study|Withdrawal by Subject|1
75841|NCT01259726|295060|P4|Overall Study|Physician Decision|1
75842|NCT01259726|295061|P3|Overall Study|Physician Decision|1
75843|NCT01259726|295062|P2|Overall Study|Physician Decision|0
75844|NCT01259726|295063|P1|Overall Study|Physician Decision|2
75845|NCT01259726|295060|P4|Overall Study|Death|0
75846|NCT01259726|295061|P3|Overall Study|Death|0
75847|NCT01259726|295062|P2|Overall Study|Death|0
75848|NCT01259726|295063|P1|Overall Study|Death|1
75849|NCT01259713|295095|P2|Overall Study|Subject Withdrew Consent|7
75850|NCT01259713|295096|P1|Overall Study|Subject Withdrew Consent|12
75851|NCT01259713|295095|P2|Overall Study|Protocol Violation|4
75852|NCT01259713|295096|P1|Overall Study|Protocol Violation|5
75853|NCT01259713|295095|P2|Overall Study|Lack of Efficacy|0
75854|NCT01259713|295096|P1|Overall Study|Lack of Efficacy|2
75855|NCT01259713|295095|P2|Overall Study|Investigators Discretion|6
75856|NCT01259713|295096|P1|Overall Study|Investigators Discretion|14
75857|NCT01259713|295095|P2|Overall Study|Death Not Related to IFI|1
75858|NCT01259713|295096|P1|Overall Study|Death Not Related to IFI|8
75859|NCT01259713|295095|P2|Overall Study|Adverse Event|23
75860|NCT01259713|295096|P1|Overall Study|Adverse Event|54
75861|NCT01259492|295143|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
75862|NCT01259492|295144|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
75863|NCT01259492|295145|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
75864|NCT01259492|295146|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
75865|NCT01259492|295143|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
75866|NCT01259492|295144|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
75867|NCT01259492|295145|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
75868|NCT01259492|295146|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
75869|NCT01259492|295143|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
75870|NCT01259492|295144|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
75871|NCT01259492|295145|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
75872|NCT01259492|295146|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
75873|NCT01259492|295143|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
75874|NCT01259492|295144|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
75875|NCT01259492|295145|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
75876|NCT01259492|295146|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
75877|NCT01259492|295143|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
75878|NCT01259492|295144|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
75879|NCT01259492|295145|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
75880|NCT01259492|295146|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
75881|NCT01259492|295143|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
75882|NCT01259492|295144|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
75883|NCT01259492|295145|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
75884|NCT01259492|295146|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
75885|NCT01259492|295143|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
75886|NCT01259492|295144|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
75887|NCT01259492|295145|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
75888|NCT01259492|295146|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
75889|NCT01259492|295143|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
75890|NCT01259492|295144|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
75891|NCT01259492|295145|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
75892|NCT01259492|295146|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
75893|NCT01259492|295143|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
75894|NCT01259492|295144|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
75895|NCT01259492|295145|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
75896|NCT01259492|295146|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
75897|NCT01259492|295143|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
75898|NCT01259492|295144|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
75899|NCT01259492|295145|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
75900|NCT01259492|295146|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
75901|NCT01259492|295143|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
75902|NCT01259492|295144|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
75903|NCT01259492|295145|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
75904|NCT01259492|295146|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
75905|NCT01259492|295143|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
75906|NCT01259492|295144|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
75907|NCT01259492|295145|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
75908|NCT01259492|295146|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
75909|NCT01259492|295143|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
75910|NCT01259492|295144|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
75911|NCT01259492|295145|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
75912|NCT01259492|295146|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
75913|NCT01259492|295143|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
75914|NCT01259492|295144|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
75915|NCT01259492|295145|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
75916|NCT01259492|295146|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
75917|NCT01259492|295143|P4|Period 1 (9 Weeks)|Protocol Violation|1
75918|NCT01259492|295144|P3|Period 1 (9 Weeks)|Protocol Violation|3
75919|NCT01259492|295145|P2|Period 1 (9 Weeks)|Protocol Violation|6
75920|NCT01259492|295146|P1|Period 1 (9 Weeks)|Protocol Violation|5
75921|NCT01259492|295143|P4|Period 1 (9 Weeks)|Administrative Problems|2
75922|NCT01259492|295144|P3|Period 1 (9 Weeks)|Administrative Problems|1
75923|NCT01259492|295145|P2|Period 1 (9 Weeks)|Administrative Problems|1
75924|NCT01259492|295146|P1|Period 1 (9 Weeks)|Administrative Problems|0
75925|NCT01259492|295143|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
75926|NCT01259492|295144|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
75927|NCT01259492|295145|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
75928|NCT01259492|295146|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
75929|NCT01259492|295143|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
75930|NCT01259492|295144|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
75931|NCT01259492|295145|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
75932|NCT01259492|295146|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
75933|NCT01259492|295143|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
75934|NCT01259492|295144|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
75935|NCT01259492|295145|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
75936|NCT01259492|295146|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
75937|NCT01259492|295143|P4|Period 1 (9 Weeks)|Adverse Event|3
75938|NCT01259492|295144|P3|Period 1 (9 Weeks)|Adverse Event|26
75939|NCT01259492|295145|P2|Period 1 (9 Weeks)|Adverse Event|18
75940|NCT01259492|295146|P1|Period 1 (9 Weeks)|Adverse Event|13
75941|NCT01259466|295195|P2|Overall Study|Withdrawal by Subject|9
75942|NCT01259466|295196|P1|Overall Study|Withdrawal by Subject|1
75943|NCT01259401|295234|P2|4-month Follow-up|Lost to Follow-up|1
75944|NCT01259401|295235|P1|4-month Follow-up|Lost to Follow-up|0
75945|NCT01259401|295234|P2|4-month Follow-up|Death|1
75946|NCT01259401|295235|P1|4-month Follow-up|Death|0
75947|NCT01259375|295243|P1|Overall Study|Adverse Event|1
75948|NCT01259297|295260|P8|Double Blind Randomized Period|Other reasons|1
75949|NCT01259297|295261|P7|Double Blind Randomized Period|Other reasons|3
75950|NCT01259297|295262|P6|Double Blind Randomized Period|Other reasons|2
75951|NCT01259297|295263|P5|Double Blind Randomized Period|Other reasons|1
75952|NCT01259297|295264|P4|Double Blind Randomized Period|Other reasons|0
75953|NCT01259297|295265|P3|Double Blind Randomized Period|Other reasons|0
75954|NCT01259297|295266|P2|Double Blind Randomized Period|Other reasons|1
75955|NCT01259297|295267|P1|Double Blind Randomized Period|Other reasons|0
75956|NCT01259297|295260|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
75957|NCT01259297|295261|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
75958|NCT01259297|295262|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
75959|NCT01259297|295263|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
75960|NCT01259297|295264|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
75961|NCT01259297|295265|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
75962|NCT01259297|295266|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
75963|NCT01259297|295267|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
75964|NCT01259297|295260|P8|Double Blind Randomized Period|Death|1
75965|NCT01259297|295261|P7|Double Blind Randomized Period|Death|2
75966|NCT01259297|295262|P6|Double Blind Randomized Period|Death|5
75967|NCT01259297|295263|P5|Double Blind Randomized Period|Death|1
75968|NCT01259297|295264|P4|Double Blind Randomized Period|Death|2
75969|NCT01259297|295265|P3|Double Blind Randomized Period|Death|1
75970|NCT01259297|295266|P2|Double Blind Randomized Period|Death|1
75971|NCT01259297|295267|P1|Double Blind Randomized Period|Death|1
75972|NCT01259284|295298|P3|Overall Study|Study Termination|0
75973|NCT01259284|295299|P2|Overall Study|Study Termination|0
75974|NCT01259284|295300|P1|Overall Study|Study Termination|2
75975|NCT01259245|295310|P2|Overall Study|Death|2
75976|NCT01259245|295311|P1|Overall Study|Death|1
75977|NCT01259245|295310|P2|Overall Study|Withdrawal by Subject|24
75978|NCT01259245|295311|P1|Overall Study|Withdrawal by Subject|27
75979|NCT01259115|295335|P2|Period 2|Adverse Event|0
75980|NCT01259115|295336|P1|Period 2|Adverse Event|1
75981|NCT01259115|295335|P2|Period 1|Lost to Follow-up|1
75982|NCT01259115|295336|P1|Period 1|Lost to Follow-up|0
75983|NCT01259115|295335|P2|Period 1|Protocol Violation|0
75984|NCT01259115|295336|P1|Period 1|Protocol Violation|2
75985|NCT01259115|295335|P2|Period 1|Adverse Event|0
75986|NCT01259115|295336|P1|Period 1|Adverse Event|1
75987|NCT01259102|295372|P5|Overall Study|Other|1
75988|NCT01259102|295373|P4|Overall Study|Other|1
75989|NCT01259102|295374|P3|Overall Study|Other|1
75990|NCT01259102|295375|P2|Overall Study|Other|0
75991|NCT01259102|295376|P1|Overall Study|Other|0
75992|NCT01259102|295372|P5|Overall Study|Adverse Event|0
75993|NCT01259102|295373|P4|Overall Study|Adverse Event|1
75994|NCT01259102|295374|P3|Overall Study|Adverse Event|1
75995|NCT01259102|295375|P2|Overall Study|Adverse Event|0
75996|NCT01259102|295376|P1|Overall Study|Adverse Event|1
75997|NCT01259024|295442|P1|Overall Study|Physician Decision|1
75998|NCT01258998|295462|P1|Overall Study|Ineligible|1
75999|NCT01258803|295495|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
76000|NCT01258803|295496|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
76001|NCT01258803|295497|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
76002|NCT01258803|295498|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
76003|NCT01258803|295499|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
76004|NCT01258803|295500|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
76005|NCT01258803|295495|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
76006|NCT01258803|295496|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
76007|NCT01258803|295497|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
76008|NCT01258803|295498|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
76009|NCT01258803|295499|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
76010|NCT01258803|295500|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
76011|NCT01258803|295495|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
76012|NCT01258803|295496|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
76013|NCT01258803|295497|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
76014|NCT01258803|295498|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
76015|NCT01258803|295499|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
76016|NCT01258803|295500|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
76017|NCT01258738|295537|P2|Open-label Period|Withdrawn due to pregnancy|1
76018|NCT01258738|295538|P1|Open-label Period|Withdrawn due to pregnancy|1
76019|NCT01258738|295537|P2|Open-label Period|Other Reasons|1
76020|NCT01258738|295538|P1|Open-label Period|Other Reasons|0
76021|NCT01258738|295537|P2|Open-label Period|Adverse Event|5
76022|NCT01258738|295538|P1|Open-label Period|Adverse Event|4
76023|NCT01258738|295537|P2|Open-label Period|Protocol Violation|2
76024|NCT01258738|295538|P1|Open-label Period|Protocol Violation|2
76025|NCT01258738|295537|P2|Open-label Period|Withdrawal by Subject|6
76026|NCT01258738|295538|P1|Open-label Period|Withdrawal by Subject|5
76027|NCT01258738|295537|P2|Open-label Period|Lost to Follow-up|2
76028|NCT01258738|295538|P1|Open-label Period|Lost to Follow-up|0
76029|NCT01258738|295537|P2|Open-label Period|Insufficient clinical response|3
76030|NCT01258738|295538|P1|Open-label Period|Insufficient clinical response|5
76031|NCT01258738|295537|P2|Open-label Period|Did not meet inclusion criteria|1
76032|NCT01258738|295538|P1|Open-label Period|Did not meet inclusion criteria|0
76033|NCT01258738|295537|P2|Double-blind Period|Adverse Event|1
76034|NCT01258738|295538|P1|Double-blind Period|Adverse Event|3
76035|NCT01258738|295537|P2|Double-blind Period|Protocol Violation|1
76036|NCT01258738|295538|P1|Double-blind Period|Protocol Violation|1
76037|NCT01258738|295537|P2|Double-blind Period|Withdrawal by Subject|2
76038|NCT01258738|295538|P1|Double-blind Period|Withdrawal by Subject|2
76039|NCT01258738|295537|P2|Double-blind Period|Did not meet inclusion criteria|3
76040|NCT01258738|295538|P1|Double-blind Period|Did not meet inclusion criteria|3
76041|NCT01258660|295676|P2|Overall Study|Invalid for primary analysis data set|6
76042|NCT01258660|295677|P1|Overall Study|Invalid for primary analysis data set|4
76043|NCT01258660|295676|P2|Overall Study|Protocol Violation|1
76044|NCT01258660|295677|P1|Overall Study|Protocol Violation|0
76045|NCT01258660|295676|P2|Overall Study|due to relocation|0
76046|NCT01258660|295677|P1|Overall Study|due to relocation|2
76047|NCT01258660|295676|P2|Overall Study|Withdrawal by Subject|0
76048|NCT01258660|295677|P1|Overall Study|Withdrawal by Subject|3
76049|NCT01258660|295676|P2|Overall Study|Adverse Event|4
76050|NCT01258660|295677|P1|Overall Study|Adverse Event|2
76051|NCT01258595|295696|P2|Overall Study|Withdrawal by Subject|1
76052|NCT01258595|295697|P1|Overall Study|Withdrawal by Subject|0
76053|NCT01258595|295696|P2|Overall Study|Lost to Follow-up|0
76054|NCT01258595|295697|P1|Overall Study|Lost to Follow-up|1
76055|NCT01258101|295819|P4|Overall Study|Other reason|8
76056|NCT01258101|295820|P3|Overall Study|Other reason|1
76057|NCT01258101|295821|P2|Overall Study|Other reason|8
76058|NCT01258101|295822|P1|Overall Study|Other reason|7
76059|NCT01258101|295819|P4|Overall Study|PCR positive at week 24|1
76060|NCT01258101|295820|P3|Overall Study|PCR positive at week 24|0
76061|NCT01258101|295821|P2|Overall Study|PCR positive at week 24|0
76062|NCT01258101|295822|P1|Overall Study|PCR positive at week 24|0
76063|NCT01258101|295819|P4|Overall Study|Lost to Follow-up|6
76064|NCT01258101|295820|P3|Overall Study|Lost to Follow-up|0
76065|NCT01258101|295821|P2|Overall Study|Lost to Follow-up|5
76066|NCT01258101|295822|P1|Overall Study|Lost to Follow-up|5
76067|NCT01258101|295819|P4|Overall Study|Patient´s compliance|2
76068|NCT01258101|295820|P3|Overall Study|Patient´s compliance|1
76069|NCT01258101|295821|P2|Overall Study|Patient´s compliance|3
76070|NCT01258101|295822|P1|Overall Study|Patient´s compliance|4
76071|NCT01258101|295819|P4|Overall Study|Patient is not able to attend visits|6
76072|NCT01258101|295820|P3|Overall Study|Patient is not able to attend visits|7
76073|NCT01258101|295821|P2|Overall Study|Patient is not able to attend visits|9
76074|NCT01258101|295822|P1|Overall Study|Patient is not able to attend visits|8
76075|NCT01258101|295819|P4|Overall Study|Informed consent has been withdrawn|1
76076|NCT01258101|295820|P3|Overall Study|Informed consent has been withdrawn|1
76077|NCT01258101|295821|P2|Overall Study|Informed consent has been withdrawn|2
76078|NCT01258101|295822|P1|Overall Study|Informed consent has been withdrawn|2
76079|NCT01258101|295819|P4|Overall Study|Extra exclusion criterion amended|1
76080|NCT01258101|295820|P3|Overall Study|Extra exclusion criterion amended|1
76081|NCT01258101|295821|P2|Overall Study|Extra exclusion criterion amended|1
76082|NCT01258101|295822|P1|Overall Study|Extra exclusion criterion amended|2
76083|NCT01258101|295819|P4|Overall Study|Adverse Event|0
76084|NCT01258101|295820|P3|Overall Study|Adverse Event|0
76085|NCT01258101|295821|P2|Overall Study|Adverse Event|6
76086|NCT01258101|295822|P1|Overall Study|Adverse Event|5
76087|NCT01257737|295952|P2|Overall Study|Withdrew from study|1
76088|NCT01257737|295953|P1|Overall Study|Withdrew from study|0
76089|NCT01257737|295952|P2|Overall Study|Relocation out of the country|1
76090|NCT01257737|295953|P1|Overall Study|Relocation out of the country|0
76091|NCT01257737|295952|P2|Overall Study|Liver transplant|0
76092|NCT01257737|295953|P1|Overall Study|Liver transplant|1
76093|NCT01257737|295952|P2|Overall Study|Lost to Follow-up|2
76094|NCT01257737|295953|P1|Overall Study|Lost to Follow-up|1
76095|NCT01257581|295974|P3|Overall Study|Death|4
76096|NCT01257581|295975|P2|Overall Study|Death|2
76097|NCT01257581|295976|P1|Overall Study|Death|2
76098|NCT01257581|295974|P3|Overall Study|Early Termination|2
76099|NCT01257581|295975|P2|Overall Study|Early Termination|1
76100|NCT01257581|295976|P1|Overall Study|Early Termination|3
76101|NCT01257542|296016|P2|Overall Study|Withdrawal by Subject|2
76102|NCT01257542|296017|P1|Overall Study|Withdrawal by Subject|0
76103|NCT01257542|296016|P2|Overall Study|Protocol Violation|5
76104|NCT01257542|296017|P1|Overall Study|Protocol Violation|3
76105|NCT01257503|296037|P2|Overall Study|strep culture positive at enrollment|0
76106|NCT01257503|296038|P1|Overall Study|strep culture positive at enrollment|1
76107|NCT01257503|296037|P2|Overall Study|Over 5 years old at enrollment|1
76108|NCT01257503|296038|P1|Overall Study|Over 5 years old at enrollment|0
76109|NCT01257503|296037|P2|Overall Study|Lost to Follow-up|10
76110|NCT01257503|296038|P1|Overall Study|Lost to Follow-up|7
76111|NCT01257425|296067|P2|Overall Study|Death|0
76112|NCT01257425|296068|P1|Overall Study|Death|1
76113|NCT01257425|296067|P2|Overall Study|Withdrawal by Subject|1
76114|NCT01257425|296068|P1|Overall Study|Withdrawal by Subject|0
76115|NCT01257425|296067|P2|Overall Study|Protocol Violation|1
76116|NCT01257425|296068|P1|Overall Study|Protocol Violation|1
76117|NCT01257425|296067|P2|Overall Study|Adverse Event|1
76118|NCT01257425|296068|P1|Overall Study|Adverse Event|1
76119|NCT01257425|296067|P2|Overall Study|Lack of Efficacy|3
76120|NCT01257425|296068|P1|Overall Study|Lack of Efficacy|3
76121|NCT01257230|296110|P3|Overall Study|Other reason not defined above|3
76122|NCT01257230|296111|P2|Overall Study|Other reason not defined above|5
76123|NCT01257230|296112|P1|Overall Study|Other reason not defined above|1
76124|NCT01257230|296110|P3|Overall Study|Withdrawal by Subject|1
76125|NCT01257230|296111|P2|Overall Study|Withdrawal by Subject|4
76126|NCT01257230|296112|P1|Overall Study|Withdrawal by Subject|0
76127|NCT01257230|296110|P3|Overall Study|Protocol Violation|1
76128|NCT01257230|296111|P2|Overall Study|Protocol Violation|0
76129|NCT01257230|296112|P1|Overall Study|Protocol Violation|3
76130|NCT01257230|296110|P3|Overall Study|Lack of Efficacy|0
76131|NCT01257230|296111|P2|Overall Study|Lack of Efficacy|1
76132|NCT01257230|296112|P1|Overall Study|Lack of Efficacy|0
76133|NCT01257230|296110|P3|Overall Study|Adverse Event|0
76134|NCT01257230|296111|P2|Overall Study|Adverse Event|0
76135|NCT01257230|296112|P1|Overall Study|Adverse Event|2
76136|NCT01257230|296110|P3|Overall Study|Not Treated|1
76137|NCT01257230|296111|P2|Overall Study|Not Treated|0
76138|NCT01257230|296112|P1|Overall Study|Not Treated|0
76139|NCT01257204|296189|P3|Follow-up Period (up to Week 48)|Other|5
76140|NCT01257204|296190|P2|Follow-up Period (up to Week 48)|Other|0
76141|NCT01257204|296191|P1|Follow-up Period (up to Week 48)|Other|0
76142|NCT01257204|296189|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
76143|NCT01257204|296190|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
76144|NCT01257204|296191|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
76145|NCT01257204|296189|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
76146|NCT01257204|296190|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
76147|NCT01257204|296191|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
76148|NCT01257204|296189|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
76149|NCT01257204|296190|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
76150|NCT01257204|296191|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
76151|NCT01257204|296189|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
76152|NCT01257204|296190|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
76153|NCT01257204|296191|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
76154|NCT01257204|296189|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
76155|NCT01257204|296190|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
76156|NCT01257204|296191|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
76157|NCT01257204|296189|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
76158|NCT01257204|296190|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
76159|NCT01257204|296191|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
76160|NCT01257204|296189|P3|Treatment Period (up to Week 24)|Adverse Event|2
76161|NCT01257204|296190|P2|Treatment Period (up to Week 24)|Adverse Event|1
76162|NCT01257204|296191|P1|Treatment Period (up to Week 24)|Adverse Event|3
76163|NCT01257204|296189|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
76164|NCT01257204|296190|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
76165|NCT01257204|296191|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
76166|NCT01256684|296302|P3|Overall Study|Entry criteria not met/non-compliance|6
76167|NCT01256684|296303|P2|Overall Study|Entry criteria not met/non-compliance|7
76168|NCT01256684|296304|P1|Overall Study|Entry criteria not met/non-compliance|4
76169|NCT01256684|296302|P3|Overall Study|Lack of Efficacy|1
76170|NCT01256684|296303|P2|Overall Study|Lack of Efficacy|1
76171|NCT01256684|296304|P1|Overall Study|Lack of Efficacy|0
76172|NCT01256684|296302|P3|Overall Study|Physician Decision|0
76173|NCT01256684|296303|P2|Overall Study|Physician Decision|1
76174|NCT01256684|296304|P1|Overall Study|Physician Decision|0
76175|NCT01256684|296302|P3|Overall Study|Withdrawal by Subject|2
76176|NCT01256684|296303|P2|Overall Study|Withdrawal by Subject|0
76177|NCT01256684|296304|P1|Overall Study|Withdrawal by Subject|4
76178|NCT01256684|296302|P3|Overall Study|Adverse Event|2
76179|NCT01256684|296303|P2|Overall Study|Adverse Event|4
76180|NCT01256684|296304|P1|Overall Study|Adverse Event|1
76181|NCT01256671|296336|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
76182|NCT01256671|296336|P1|Overall Study|Lack of Efficacy|4
76183|NCT01256671|296336|P1|Overall Study|Physician Decision|3
76184|NCT01256671|296336|P1|Overall Study|Withdrawal by Subject|31
76185|NCT01256671|296336|P1|Overall Study|Lost to Follow-up|16
76186|NCT01256671|296336|P1|Overall Study|Adverse Event|29
76187|NCT01256658|296349|P2|Period 1|Death|44
76188|NCT01256658|296350|P1|Period 1|Death|48
76189|NCT01256658|296349|P2|Period 1|Withdrawal by Subject|43
76190|NCT01256658|296350|P1|Period 1|Withdrawal by Subject|35
76191|NCT01256658|296349|P2|Period 1|Lost to Follow-up|661
76192|NCT01256658|296350|P1|Period 1|Lost to Follow-up|837
76193|NCT01256567|296400|P1|Overall Study|Withdrawal by Subject|1
76194|NCT01256502|296410|P1|Overall Study|Protocol deviation|1
76195|NCT01256502|296410|P1|Overall Study|Personal reasons|5
76196|NCT01256502|296410|P1|Overall Study|Had scaffold removed|4
76197|NCT01256476|296422|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
76198|NCT01256476|296423|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
76199|NCT01256476|296422|P2|Overall Study|Subject non-compliance|1
76200|NCT01256476|296423|P1|Overall Study|Subject non-compliance|0
76201|NCT01256476|296422|P2|Overall Study|Physician Decision|1
76202|NCT01256476|296423|P1|Overall Study|Physician Decision|0
76203|NCT01256476|296422|P2|Overall Study|Persistent ALT or AST elevation|0
76204|NCT01256476|296423|P1|Overall Study|Persistent ALT or AST elevation|1
76205|NCT01256476|296422|P2|Overall Study|Lost to Follow-up|2
76206|NCT01256476|296423|P1|Overall Study|Lost to Follow-up|1
76207|NCT01256476|296422|P2|Overall Study|Withdrawal by Subject|1
76208|NCT01256476|296423|P1|Overall Study|Withdrawal by Subject|2
76209|NCT01256476|296422|P2|Overall Study|Adverse Event|1
76210|NCT01256476|296423|P1|Overall Study|Adverse Event|2
76211|NCT01256450|296431|P3|Double-blind Treatment|Not specified|12
76212|NCT01256450|296432|P2|Double-blind Treatment|Not specified|9
76213|NCT01256450|296433|P1|Double-blind Treatment|Not specified|0
76214|NCT01256450|296431|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
76215|NCT01256450|296432|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
76216|NCT01256450|296433|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
76217|NCT01256450|296431|P3|Double-blind Treatment|Non-compliance|4
76218|NCT01256450|296432|P2|Double-blind Treatment|Non-compliance|5
76219|NCT01256450|296433|P1|Double-blind Treatment|Non-compliance|0
76220|NCT01256450|296431|P3|Double-blind Treatment|Lack of analgesic effect|6
76221|NCT01256450|296432|P2|Double-blind Treatment|Lack of analgesic effect|5
76222|NCT01256450|296433|P1|Double-blind Treatment|Lack of analgesic effect|0
76223|NCT01256450|296431|P3|Double-blind Treatment|Withdrawal by Subject|1
76224|NCT01256450|296432|P2|Double-blind Treatment|Withdrawal by Subject|0
76225|NCT01256450|296433|P1|Double-blind Treatment|Withdrawal by Subject|0
76226|NCT01256450|296431|P3|Double-blind Treatment|Lost to Follow-up|7
76227|NCT01256450|296432|P2|Double-blind Treatment|Lost to Follow-up|1
76228|NCT01256450|296433|P1|Double-blind Treatment|Lost to Follow-up|0
76229|NCT01256450|296431|P3|Double-blind Treatment|Adverse Event|6
76230|NCT01256450|296432|P2|Double-blind Treatment|Adverse Event|8
76231|NCT01256450|296433|P1|Double-blind Treatment|Adverse Event|0
76232|NCT01256450|296431|P3|Open-label Titration|Not specified|0
76233|NCT01256450|296432|P2|Open-label Titration|Not specified|0
76234|NCT01256450|296433|P1|Open-label Titration|Not specified|13
76235|NCT01256450|296431|P3|Open-label Titration|Screen failure|0
76236|NCT01256450|296432|P2|Open-label Titration|Screen failure|0
76237|NCT01256450|296433|P1|Open-label Titration|Screen failure|1
76238|NCT01256450|296431|P3|Open-label Titration|Non-compliance|0
76239|NCT01256450|296432|P2|Open-label Titration|Non-compliance|0
76240|NCT01256450|296433|P1|Open-label Titration|Non-compliance|9
76241|NCT01256450|296431|P3|Open-label Titration|Lack of analgesic effect|0
76242|NCT01256450|296432|P2|Open-label Titration|Lack of analgesic effect|0
76243|NCT01256450|296433|P1|Open-label Titration|Lack of analgesic effect|30
76244|NCT01256450|296431|P3|Open-label Titration|Lost to Follow-up|0
76245|NCT01256450|296432|P2|Open-label Titration|Lost to Follow-up|0
76246|NCT01256450|296433|P1|Open-label Titration|Lost to Follow-up|7
76247|NCT01256450|296431|P3|Open-label Titration|Adverse Event|0
76248|NCT01256450|296432|P2|Open-label Titration|Adverse Event|0
76249|NCT01256450|296433|P1|Open-label Titration|Adverse Event|39
76250|NCT01256411|296491|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
76251|NCT01256411|296492|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
76252|NCT01256411|296493|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
76253|NCT01256411|296494|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
76254|NCT01256411|296495|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
76255|NCT01256411|296496|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
76256|NCT01256411|296491|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
76257|NCT01256411|296492|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
76258|NCT01256411|296493|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
76259|NCT01256411|296494|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
76260|NCT01256411|296495|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
76261|NCT01256411|296496|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
76262|NCT01256411|296491|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
76263|NCT01256411|296492|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
76264|NCT01256411|296493|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
76265|NCT01256411|296494|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
76266|NCT01256411|296495|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
76267|NCT01256411|296496|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
76268|NCT01256411|296491|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
76269|NCT01256411|296492|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
76270|NCT01256411|296493|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
76271|NCT01256411|296494|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
76272|NCT01256411|296495|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
76273|NCT01256411|296496|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
76274|NCT01256411|296491|P6|Extension by Mono or Combination Therapy|Adverse Event|1
76275|NCT01256411|296492|P5|Extension by Mono or Combination Therapy|Adverse Event|6
76276|NCT01256411|296493|P4|Extension by Mono or Combination Therapy|Adverse Event|0
76277|NCT01256411|296494|P3|Extension by Mono or Combination Therapy|Adverse Event|0
76278|NCT01256411|296495|P2|Extension by Mono or Combination Therapy|Adverse Event|0
76279|NCT01256411|296496|P1|Extension by Mono or Combination Therapy|Adverse Event|0
76280|NCT01256411|296491|P6|Extension by Maximum Treatment|Adverse Event|0
76281|NCT01256411|296492|P5|Extension by Maximum Treatment|Adverse Event|0
76282|NCT01256411|296493|P4|Extension by Maximum Treatment|Adverse Event|0
76283|NCT01256411|296494|P3|Extension by Maximum Treatment|Adverse Event|1
76284|NCT01256411|296495|P2|Extension by Maximum Treatment|Adverse Event|2
76285|NCT01256411|296496|P1|Extension by Maximum Treatment|Adverse Event|4
76286|NCT01256411|296491|P6|Extension by Maximum Treatment|Lack of Efficacy|0
76287|NCT01256411|296492|P5|Extension by Maximum Treatment|Lack of Efficacy|0
76288|NCT01256411|296493|P4|Extension by Maximum Treatment|Lack of Efficacy|0
76289|NCT01256411|296494|P3|Extension by Maximum Treatment|Lack of Efficacy|1
76290|NCT01256411|296495|P2|Extension by Maximum Treatment|Lack of Efficacy|0
76291|NCT01256411|296496|P1|Extension by Maximum Treatment|Lack of Efficacy|1
76292|NCT01256411|296491|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
76293|NCT01256411|296492|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
76294|NCT01256411|296493|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
76295|NCT01256411|296494|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
76296|NCT01256411|296495|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
76297|NCT01256411|296496|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
76298|NCT01256411|296491|P6|Extension by Maximum Treatment|Lost to Follow-up|0
76299|NCT01256411|296492|P5|Extension by Maximum Treatment|Lost to Follow-up|0
76300|NCT01256411|296493|P4|Extension by Maximum Treatment|Lost to Follow-up|0
76301|NCT01256411|296494|P3|Extension by Maximum Treatment|Lost to Follow-up|0
76302|NCT01256411|296495|P2|Extension by Maximum Treatment|Lost to Follow-up|2
76303|NCT01256411|296496|P1|Extension by Maximum Treatment|Lost to Follow-up|1
76304|NCT01256411|296491|P6|Extension by Maximum Treatment|Protocol deviation|0
76305|NCT01256411|296492|P5|Extension by Maximum Treatment|Protocol deviation|0
76306|NCT01256411|296493|P4|Extension by Maximum Treatment|Protocol deviation|0
76307|NCT01256411|296494|P3|Extension by Maximum Treatment|Protocol deviation|1
76308|NCT01256411|296495|P2|Extension by Maximum Treatment|Protocol deviation|0
76309|NCT01256411|296496|P1|Extension by Maximum Treatment|Protocol deviation|0
76310|NCT01256385|296522|P2|Overall Study|Withdrawal by Subject|2
76311|NCT01256385|296523|P1|Overall Study|Withdrawal by Subject|2
76312|NCT01256385|296522|P2|Overall Study|Physician Decision|1
76313|NCT01256385|296523|P1|Overall Study|Physician Decision|1
76314|NCT01256294|296543|P2|Overall Study|Protocol deviation|1
76315|NCT01256294|296544|P1|Overall Study|Protocol deviation|2
76316|NCT01256294|296543|P2|Overall Study|Withdrawal by Subject|1
76317|NCT01256294|296544|P1|Overall Study|Withdrawal by Subject|1
76318|NCT01256294|296543|P2|Overall Study|Adverse Event|0
76319|NCT01256294|296544|P1|Overall Study|Adverse Event|1
76320|NCT01256190|296566|P2|Overall Study|Lost to Follow-up|0
76321|NCT01256190|296567|P1|Overall Study|Lost to Follow-up|2
76322|NCT01256177|296583|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
76323|NCT01256177|296584|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
76324|NCT01256177|296583|P2|Overall Study|Lack of Efficacy|2
76325|NCT01256177|296584|P1|Overall Study|Lack of Efficacy|11
76326|NCT01256177|296583|P2|Overall Study|Condition under Investigation Worsened|0
76327|NCT01256177|296584|P1|Overall Study|Condition under Investigation Worsened|1
76328|NCT01256177|296583|P2|Overall Study|Severe Non-Compliance to Protocol|2
76329|NCT01256177|296584|P1|Overall Study|Severe Non-Compliance to Protocol|4
76330|NCT01256177|296583|P2|Overall Study|Adverse Event|9
76331|NCT01256177|296584|P1|Overall Study|Adverse Event|8
76332|NCT01256177|296583|P2|Overall Study|Lost to Follow-up|2
76333|NCT01256177|296584|P1|Overall Study|Lost to Follow-up|2
76334|NCT01256177|296583|P2|Overall Study|Withdrawal by Subject|22
76335|NCT01256177|296584|P1|Overall Study|Withdrawal by Subject|23
76336|NCT01256060|296640|P4|Overall Study|Lost to Follow-up|0
76337|NCT01256060|296641|P3|Overall Study|Lost to Follow-up|0
76338|NCT01256060|296642|P2|Overall Study|Lost to Follow-up|1
76339|NCT01256060|296643|P1|Overall Study|Lost to Follow-up|0
76340|NCT01256008|296662|P3|Overall Study|Withdrawal by Subject|10
76341|NCT01256008|296663|P2|Overall Study|Withdrawal by Subject|3
76342|NCT01256008|296664|P1|Overall Study|Withdrawal by Subject|2
76343|NCT01256008|296662|P3|Overall Study|Lost to Follow-up|11
76344|NCT01256008|296663|P2|Overall Study|Lost to Follow-up|4
76345|NCT01256008|296664|P1|Overall Study|Lost to Follow-up|6
76346|NCT01255904|296686|P2|Overall Study|Physician Decision|4
76347|NCT01255904|296687|P1|Overall Study|Physician Decision|1
76348|NCT01255787|296697|P4|Overall Study|Noncompliance with Study Drug|0
76349|NCT01255787|296698|P3|Overall Study|Noncompliance with Study Drug|0
76350|NCT01255787|296699|P2|Overall Study|Noncompliance with Study Drug|1
76351|NCT01255787|296700|P1|Overall Study|Noncompliance with Study Drug|3
76352|NCT01255787|296697|P4|Overall Study|Lack of Efficacy|2
76353|NCT01255787|296698|P3|Overall Study|Lack of Efficacy|2
76354|NCT01255787|296699|P2|Overall Study|Lack of Efficacy|2
76355|NCT01255787|296700|P1|Overall Study|Lack of Efficacy|2
76356|NCT01255787|296697|P4|Overall Study|Pregnancy|1
76357|NCT01255787|296698|P3|Overall Study|Pregnancy|0
76358|NCT01255787|296699|P2|Overall Study|Pregnancy|0
76359|NCT01255787|296700|P1|Overall Study|Pregnancy|0
76360|NCT01255787|296697|P4|Overall Study|Withdrawal of Consent|4
76361|NCT01255787|296698|P3|Overall Study|Withdrawal of Consent|3
76362|NCT01255787|296699|P2|Overall Study|Withdrawal of Consent|9
76363|NCT01255787|296700|P1|Overall Study|Withdrawal of Consent|3
76364|NCT01255787|296697|P4|Overall Study|Lost to Follow-up|2
76365|NCT01255787|296698|P3|Overall Study|Lost to Follow-up|4
76366|NCT01255787|296699|P2|Overall Study|Lost to Follow-up|2
76367|NCT01255787|296700|P1|Overall Study|Lost to Follow-up|1
76368|NCT01255787|296697|P4|Overall Study|Major Protocol Deviation|4
76369|NCT01255787|296698|P3|Overall Study|Major Protocol Deviation|0
76370|NCT01255787|296699|P2|Overall Study|Major Protocol Deviation|1
76371|NCT01255787|296700|P1|Overall Study|Major Protocol Deviation|1
76372|NCT01255787|296697|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
76373|NCT01255787|296698|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
76374|NCT01255787|296699|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
76375|NCT01255787|296700|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
76376|NCT01255761|296728|P2|Overall Study|Other Reasons|18
76377|NCT01255761|296729|P1|Overall Study|Other Reasons|37
76378|NCT01255761|296728|P2|Overall Study|Withdrawal by Subject|27
76379|NCT01255761|296729|P1|Overall Study|Withdrawal by Subject|11
76380|NCT01255761|296728|P2|Overall Study|Lost to Follow-up|8
76381|NCT01255761|296729|P1|Overall Study|Lost to Follow-up|10
76382|NCT01255761|296728|P2|Overall Study|Protocol Violation|5
76383|NCT01255761|296729|P1|Overall Study|Protocol Violation|9
76384|NCT01255761|296728|P2|Overall Study|Lack of Efficacy|74
76385|NCT01255761|296729|P1|Overall Study|Lack of Efficacy|86
76386|NCT01255761|296728|P2|Overall Study|Adverse Event|43
76387|NCT01255761|296729|P1|Overall Study|Adverse Event|29
76388|NCT01255722|296814|P3|Overall Study|beta-blocker contraindicated|0
76389|NCT01255722|296815|P2|Overall Study|beta-blocker contraindicated|0
76390|NCT01255722|296816|P1|Overall Study|beta-blocker contraindicated|2
76391|NCT01255722|296814|P3|Overall Study|asymptomatic patient|0
76392|NCT01255722|296815|P2|Overall Study|asymptomatic patient|0
76393|NCT01255722|296816|P1|Overall Study|asymptomatic patient|1
76394|NCT01255722|296814|P3|Overall Study|Adverse Event|1
76395|NCT01255722|296815|P2|Overall Study|Adverse Event|1
76396|NCT01255722|296816|P1|Overall Study|Adverse Event|0
76397|NCT01255631|296841|P2|Overall Study|poor enrollment, no data analyzed|6
76398|NCT01255631|296842|P1|Overall Study|poor enrollment, no data analyzed|9
76399|NCT01255592|296860|P2|Overall Study|Other|1
76400|NCT01255592|296861|P1|Overall Study|Other|0
76401|NCT01255592|296860|P2|Overall Study|Withdrawal by Subject|0
76402|NCT01255592|296861|P1|Overall Study|Withdrawal by Subject|1
76403|NCT01255592|296860|P2|Overall Study|Adverse Event|0
76404|NCT01255592|296861|P1|Overall Study|Adverse Event|5
76405|NCT01255436|296924|P2|Overall Study|Death, stroke, or MI|3
76406|NCT01255436|296925|P1|Overall Study|Death, stroke, or MI|4
76407|NCT01255436|296924|P2|Overall Study|Lost to Follow-up|191
76408|NCT01255436|296925|P1|Overall Study|Lost to Follow-up|178
76409|NCT01255423|296939|P2|Overall Study|Use of prohibited medications|1
76410|NCT01255423|296940|P1|Overall Study|Use of prohibited medications|0
76411|NCT01255423|296939|P2|Overall Study|Abnormal Laboratory value|2
76412|NCT01255423|296940|P1|Overall Study|Abnormal Laboratory value|3
76413|NCT01255306|296956|P2|Overall Study|Physician Decision|1
76414|NCT01255306|296957|P1|Overall Study|Physician Decision|1
76415|NCT01255163|296968|P2|Overall Study|AstraZeneca stopped support of the study|3
76416|NCT01255163|296969|P1|Overall Study|AstraZeneca stopped support of the study|1
76417|NCT01255163|296968|P2|Overall Study|Adverse Event|2
76418|NCT01255163|296969|P1|Overall Study|Adverse Event|0
76419|NCT01255163|296968|P2|Overall Study|Lost to Follow-up|0
76420|NCT01255163|296969|P1|Overall Study|Lost to Follow-up|2
76421|NCT01255163|296968|P2|Overall Study|Withdrawal by Subject|0
76422|NCT01255163|296969|P1|Overall Study|Withdrawal by Subject|1
76423|NCT01254890|296998|P2|Overall Study|Disease Progression|5
76424|NCT01254890|296999|P1|Overall Study|Disease Progression|0
76425|NCT01254890|296998|P2|Overall Study|Withdrawal by Subject|2
76426|NCT01254890|296999|P1|Overall Study|Withdrawal by Subject|1
76427|NCT01254890|296998|P2|Overall Study|Ineligible|3
76428|NCT01254890|296999|P1|Overall Study|Ineligible|0
76429|NCT01254747|297061|P4|Overall Study|Discomfort|0
76430|NCT01254747|297062|P3|Overall Study|Discomfort|0
76431|NCT01254747|297063|P2|Overall Study|Discomfort|4
76432|NCT01254747|297064|P1|Overall Study|Discomfort|0
76433|NCT01254747|297061|P4|Overall Study|Biomicroscopy|0
76434|NCT01254747|297062|P3|Overall Study|Biomicroscopy|1
76435|NCT01254747|297063|P2|Overall Study|Biomicroscopy|0
76436|NCT01254747|297064|P1|Overall Study|Biomicroscopy|0
76437|NCT01254747|297061|P4|Overall Study|Lost to Follow-up|0
76438|NCT01254747|297062|P3|Overall Study|Lost to Follow-up|1
76439|NCT01254747|297063|P2|Overall Study|Lost to Follow-up|0
76440|NCT01254747|297064|P1|Overall Study|Lost to Follow-up|0
76441|NCT01254747|297061|P4|Overall Study|Symptoms and problems|0
76442|NCT01254747|297062|P3|Overall Study|Symptoms and problems|1
76443|NCT01254747|297063|P2|Overall Study|Symptoms and problems|2
76444|NCT01254747|297064|P1|Overall Study|Symptoms and problems|0
76445|NCT01254747|297061|P4|Overall Study|Difficult removal handling|0
76446|NCT01254747|297062|P3|Overall Study|Difficult removal handling|1
76447|NCT01254747|297063|P2|Overall Study|Difficult removal handling|0
76448|NCT01254747|297064|P1|Overall Study|Difficult removal handling|0
76449|NCT01254747|297061|P4|Overall Study|Unacceptable subjective vision|2
76450|NCT01254747|297062|P3|Overall Study|Unacceptable subjective vision|0
76451|NCT01254747|297063|P2|Overall Study|Unacceptable subjective vision|0
76452|NCT01254747|297064|P1|Overall Study|Unacceptable subjective vision|0
76453|NCT01254721|297104|P2|Overall Study|Wrongly randomization|1
76454|NCT01254721|297105|P1|Overall Study|Wrongly randomization|0
76455|NCT01254721|297104|P2|Overall Study|Withdrawal by Subject|11
76456|NCT01254721|297105|P1|Overall Study|Withdrawal by Subject|8
76457|NCT01254721|297104|P2|Overall Study|Adverse Event|3
76458|NCT01254721|297105|P1|Overall Study|Adverse Event|2
76459|NCT01254721|297104|P2|Overall Study|technical problum|0
76460|NCT01254721|297105|P1|Overall Study|technical problum|1
76461|NCT01254721|297104|P2|Overall Study|Death|1
76462|NCT01254721|297105|P1|Overall Study|Death|0
76463|NCT01254721|297104|P2|Overall Study|Lack of Efficacy|2
76464|NCT01254721|297105|P1|Overall Study|Lack of Efficacy|4
76465|NCT01254721|297104|P2|Overall Study|Lost to Follow-up|4
76466|NCT01254721|297105|P1|Overall Study|Lost to Follow-up|0
76467|NCT01254669|297115|P2|Overall Study|called to clinic during intervention|1
76468|NCT01254669|297116|P1|Overall Study|called to clinic during intervention|1
76469|NCT01254669|297115|P2|Overall Study|time constraint|2
76470|NCT01254669|297116|P1|Overall Study|time constraint|2
76471|NCT01254669|297115|P2|Overall Study|Withdrawal by Subject|1
76472|NCT01254669|297116|P1|Overall Study|Withdrawal by Subject|0
76473|NCT01254656|297127|P3|Overall Study|Death|0
76474|NCT01254656|297128|P2|Overall Study|Death|1
76475|NCT01254656|297129|P1|Overall Study|Death|0
76476|NCT01254656|297127|P3|Overall Study|Adverse Event|0
76477|NCT01254656|297128|P2|Overall Study|Adverse Event|1
76478|NCT01254656|297129|P1|Overall Study|Adverse Event|1
76479|NCT01254656|297127|P3|Overall Study|Pregnancy|2
76480|NCT01254656|297128|P2|Overall Study|Pregnancy|0
76481|NCT01254656|297129|P1|Overall Study|Pregnancy|0
76482|NCT01254656|297127|P3|Overall Study|Withdrawal by Subject|1
76483|NCT01254656|297128|P2|Overall Study|Withdrawal by Subject|2
76484|NCT01254656|297129|P1|Overall Study|Withdrawal by Subject|2
76485|NCT01254656|297127|P3|Overall Study|Lost to Follow-up|2
76486|NCT01254656|297128|P2|Overall Study|Lost to Follow-up|0
76487|NCT01254656|297129|P1|Overall Study|Lost to Follow-up|1
76488|NCT01254656|297127|P3|Overall Study|Lack of Efficacy|0
76489|NCT01254656|297128|P2|Overall Study|Lack of Efficacy|0
76490|NCT01254656|297129|P1|Overall Study|Lack of Efficacy|3
76491|NCT01254656|297127|P3|Overall Study|Discontinued due to termination of study|13
76492|NCT01254656|297128|P2|Overall Study|Discontinued due to termination of study|39
76493|NCT01254656|297129|P1|Overall Study|Discontinued due to termination of study|40
76494|NCT01254643|297155|P1|Overall Study|Withdrawal by Subject|1
76495|NCT01254630|297167|P4|Overall Study|Status not recorded|0
76496|NCT01254630|297168|P3|Overall Study|Status not recorded|1
76497|NCT01254630|297169|P2|Overall Study|Status not recorded|0
76498|NCT01254630|297170|P1|Overall Study|Status not recorded|0
76499|NCT01254630|297167|P4|Overall Study|Study terminated by sponsor|1010
76500|NCT01254630|297168|P3|Overall Study|Study terminated by sponsor|0
76501|NCT01254630|297169|P2|Overall Study|Study terminated by sponsor|994
76502|NCT01254630|297170|P1|Overall Study|Study terminated by sponsor|0
76503|NCT01254630|297167|P4|Overall Study|Withdrawal by Subject|89
76504|NCT01254630|297168|P3|Overall Study|Withdrawal by Subject|188
76505|NCT01254630|297169|P2|Overall Study|Withdrawal by Subject|94
76506|NCT01254630|297170|P1|Overall Study|Withdrawal by Subject|201
76507|NCT01254630|297167|P4|Overall Study|Physician Decision|7
76508|NCT01254630|297168|P3|Overall Study|Physician Decision|16
76509|NCT01254630|297169|P2|Overall Study|Physician Decision|8
76510|NCT01254630|297170|P1|Overall Study|Physician Decision|24
76511|NCT01254630|297167|P4|Overall Study|Lost to Follow-up|32
76512|NCT01254630|297168|P3|Overall Study|Lost to Follow-up|89
76513|NCT01254630|297169|P2|Overall Study|Lost to Follow-up|26
76514|NCT01254630|297170|P1|Overall Study|Lost to Follow-up|80
76515|NCT01254630|297167|P4|Overall Study|Death|139
76516|NCT01254630|297168|P3|Overall Study|Death|478
76517|NCT01254630|297169|P2|Overall Study|Death|151
76518|NCT01254630|297170|P1|Overall Study|Death|461
76519|NCT01254630|297167|P4|Overall Study|Adverse Event|8
76520|NCT01254630|297168|P3|Overall Study|Adverse Event|40
76521|NCT01254630|297169|P2|Overall Study|Adverse Event|15
76522|NCT01254630|297170|P1|Overall Study|Adverse Event|36
76523|NCT01254604|297190|P2|Overall Study|Adverse Event|2
76524|NCT01254604|297191|P1|Overall Study|Adverse Event|3
76525|NCT01254604|297190|P2|Overall Study|Withdrawal by Subject|4
76526|NCT01254604|297191|P1|Overall Study|Withdrawal by Subject|2
76527|NCT01254604|297190|P2|Overall Study|Protocol Violation|2
76528|NCT01254604|297191|P1|Overall Study|Protocol Violation|2
76529|NCT01254604|297190|P2|Overall Study|Lost to Follow-up|1
76530|NCT01254604|297191|P1|Overall Study|Lost to Follow-up|1
76531|NCT01254565|297209|P6|Overall Study|Other|0
76532|NCT01254565|297210|P5|Overall Study|Other|0
76533|NCT01254565|297211|P4|Overall Study|Other|1
76534|NCT01254565|297212|P3|Overall Study|Other|0
76535|NCT01254565|297213|P2|Overall Study|Other|0
76536|NCT01254565|297214|P1|Overall Study|Other|0
76537|NCT01254565|297209|P6|Overall Study|Did not Receive Treatment|4
76538|NCT01254565|297210|P5|Overall Study|Did not Receive Treatment|3
76539|NCT01254565|297211|P4|Overall Study|Did not Receive Treatment|0
76540|NCT01254565|297212|P3|Overall Study|Did not Receive Treatment|0
76541|NCT01254565|297213|P2|Overall Study|Did not Receive Treatment|1
76542|NCT01254565|297214|P1|Overall Study|Did not Receive Treatment|1
76543|NCT01254565|297209|P6|Overall Study|Non-compliance to Study Procedures|0
76544|NCT01254565|297210|P5|Overall Study|Non-compliance to Study Procedures|1
76545|NCT01254565|297211|P4|Overall Study|Non-compliance to Study Procedures|0
76546|NCT01254565|297212|P3|Overall Study|Non-compliance to Study Procedures|0
76547|NCT01254565|297213|P2|Overall Study|Non-compliance to Study Procedures|0
76548|NCT01254565|297214|P1|Overall Study|Non-compliance to Study Procedures|0
76549|NCT01254409|297268|P4|Overall Study|Adverse Event|0
76550|NCT01254409|297269|P3|Overall Study|Adverse Event|0
76551|NCT01254409|297270|P2|Overall Study|Adverse Event|1
76552|NCT01254409|297271|P1|Overall Study|Adverse Event|0
76553|NCT01254344|297340|P2|Overall Study|Withdrawal by Subject|6
76554|NCT01254344|297341|P1|Overall Study|Withdrawal by Subject|3
76555|NCT01254344|297340|P2|Overall Study|Protocol Violation|4
76556|NCT01254344|297341|P1|Overall Study|Protocol Violation|1
76557|NCT01254344|297340|P2|Overall Study|Physician Decision|4
76558|NCT01254344|297341|P1|Overall Study|Physician Decision|7
76559|NCT01254344|297340|P2|Overall Study|Adverse Event|5
76560|NCT01254344|297341|P1|Overall Study|Adverse Event|2
76561|NCT01254331|297349|P1|Extension Phase|Lost to Follow-up|3
76562|NCT01254331|297349|P1|Extension Phase|Lack of Efficacy|1
76563|NCT01254331|297349|P1|Initial Phase|Pregnancy|1
76564|NCT01254331|297349|P1|Initial Phase|Withdrawal by Subject|1
76565|NCT01254331|297349|P1|Initial Phase|Adverse Event|3
76566|NCT01254318|297367|P1|Overall Study|Death|47
76567|NCT01254318|297367|P1|Overall Study|Lost to Follow-up|5
76568|NCT01254305|297376|P3|Overall Study|Other Reasons|2
76569|NCT01254305|297377|P2|Overall Study|Other Reasons|0
76570|NCT01254305|297378|P1|Overall Study|Other Reasons|0
76571|NCT01254305|297376|P3|Overall Study|Lost to Follow-up|5
76572|NCT01254305|297377|P2|Overall Study|Lost to Follow-up|6
76573|NCT01254305|297378|P1|Overall Study|Lost to Follow-up|10
76574|NCT01254305|297376|P3|Overall Study|Withdrawal by Subject|4
76575|NCT01254305|297377|P2|Overall Study|Withdrawal by Subject|2
76576|NCT01254305|297378|P1|Overall Study|Withdrawal by Subject|4
76577|NCT01254305|297376|P3|Overall Study|Protocol Violation|3
76578|NCT01254305|297377|P2|Overall Study|Protocol Violation|7
76579|NCT01254305|297378|P1|Overall Study|Protocol Violation|1
76580|NCT01254305|297376|P3|Overall Study|Lack of Efficacy|1
76581|NCT01254305|297377|P2|Overall Study|Lack of Efficacy|0
76582|NCT01254305|297378|P1|Overall Study|Lack of Efficacy|1
76583|NCT01254305|297376|P3|Overall Study|Adverse Event|2
76584|NCT01254305|297377|P2|Overall Study|Adverse Event|3
76585|NCT01254305|297378|P1|Overall Study|Adverse Event|6
76586|NCT01254292|297394|P2|LCS12 Extension Phase|Lost to Follow-up|0
76587|NCT01254292|297395|P1|LCS12 Extension Phase|Lost to Follow-up|1
76588|NCT01254292|297394|P2|LCS12 Extension Phase|Pregnancy|0
76589|NCT01254292|297395|P1|LCS12 Extension Phase|Pregnancy|2
76590|NCT01254292|297394|P2|LCS12 Extension Phase|Other unknown|0
76591|NCT01254292|297395|P1|LCS12 Extension Phase|Other unknown|4
76592|NCT01254292|297394|P2|LCS12 Extension Phase|Withdrawal by Subject|0
76593|NCT01254292|297395|P1|LCS12 Extension Phase|Withdrawal by Subject|7
76594|NCT01254292|297394|P2|LCS12 Extension Phase|Adverse Event|0
76595|NCT01254292|297395|P1|LCS12 Extension Phase|Adverse Event|9
76596|NCT01254292|297394|P2|LCS12 Extension Phase|Wish for pregnancy|0
76597|NCT01254292|297395|P1|LCS12 Extension Phase|Wish for pregnancy|14
76598|NCT01254292|297394|P2|Comparative Phase|Wish for pregnancy|6
76599|NCT01254292|297395|P1|Comparative Phase|Wish for pregnancy|4
76600|NCT01254292|297394|P2|Comparative Phase|Protocol Violation|2
76601|NCT01254292|297395|P1|Comparative Phase|Protocol Violation|1
76602|NCT01254292|297394|P2|Comparative Phase|Withdrawal by Subject|21
76603|NCT01254292|297395|P1|Comparative Phase|Withdrawal by Subject|20
76604|NCT01254292|297394|P2|Comparative Phase|Pregnancy|6
76605|NCT01254292|297395|P1|Comparative Phase|Pregnancy|2
76606|NCT01254292|297394|P2|Comparative Phase|Lost to Follow-up|21
76607|NCT01254292|297395|P1|Comparative Phase|Lost to Follow-up|3
76608|NCT01254292|297394|P2|Comparative Phase|Adverse Event|25
76609|NCT01254292|297395|P1|Comparative Phase|Adverse Event|25
76610|NCT01254188|297472|P1|Overall Study|per investigator discretion|20
76611|NCT01254188|297472|P1|Overall Study|Adverse Event|43
76612|NCT01254188|297472|P1|Overall Study|Withdrawal by Subject|7
76613|NCT01254188|297472|P1|Overall Study|Lost to Follow-up|5
76614|NCT01254188|297472|P1|Overall Study|Death|4
76615|NCT01254188|297472|P1|Overall Study|Pregnancy|2
76616|NCT01254188|297472|P1|Overall Study|Protocol Violation|6
76617|NCT01254188|297472|P1|Overall Study|Disease Progression|6
76618|NCT01254045|297483|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
76619|NCT01254045|297484|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
76620|NCT01254045|297485|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
76621|NCT01254045|297486|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
76622|NCT01254045|297487|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
76623|NCT01254045|297488|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
76624|NCT01253811|297542|P1|Overall Study|Withdrawal criteria|1
76625|NCT01253577|297573|P1|Overall Study|Lost to Follow-up|3
76626|NCT01253564|297581|P1|Overall Study|Serious Adverse Event|1
76627|NCT01253564|297581|P1|Overall Study|Withdrawal by Subject|1
76628|NCT01253564|297581|P1|Overall Study|Disease Progression|22
76629|NCT01253447|297625|P1|Overall Study|Adverse Event|2
76630|NCT01253421|297633|P5|Drug+Scanning Visit|Physician Decision|1
76631|NCT01253421|297634|P4|Drug+Scanning Visit|Physician Decision|0
76632|NCT01253421|297635|P3|Drug+Scanning Visit|Physician Decision|0
76633|NCT01253421|297636|P2|Drug+Scanning Visit|Physician Decision|0
76634|NCT01253421|297637|P1|Drug+Scanning Visit|Physician Decision|0
76635|NCT01253421|297633|P5|Assessment and Scheduling|Physician Decision|0
76636|NCT01253421|297634|P4|Assessment and Scheduling|Physician Decision|0
76637|NCT01253421|297635|P3|Assessment and Scheduling|Physician Decision|0
76638|NCT01253421|297636|P2|Assessment and Scheduling|Physician Decision|0
76639|NCT01253421|297637|P1|Assessment and Scheduling|Physician Decision|1
76640|NCT01253421|297633|P5|Assessment and Scheduling|Withdrawal by Subject|0
76641|NCT01253421|297634|P4|Assessment and Scheduling|Withdrawal by Subject|0
76642|NCT01253421|297635|P3|Assessment and Scheduling|Withdrawal by Subject|0
76643|NCT01253421|297636|P2|Assessment and Scheduling|Withdrawal by Subject|0
76644|NCT01253421|297637|P1|Assessment and Scheduling|Withdrawal by Subject|7
76645|NCT01253421|297633|P5|Assessment and Scheduling|Lost to Follow-up|0
76646|NCT01253421|297634|P4|Assessment and Scheduling|Lost to Follow-up|0
76647|NCT01253421|297635|P3|Assessment and Scheduling|Lost to Follow-up|0
76648|NCT01253421|297636|P2|Assessment and Scheduling|Lost to Follow-up|0
76649|NCT01253421|297637|P1|Assessment and Scheduling|Lost to Follow-up|17
76650|NCT01253421|297633|P5|Assessment and Scheduling|Found to be Ineligible|0
76651|NCT01253421|297634|P4|Assessment and Scheduling|Found to be Ineligible|0
76652|NCT01253421|297635|P3|Assessment and Scheduling|Found to be Ineligible|0
76653|NCT01253421|297636|P2|Assessment and Scheduling|Found to be Ineligible|0
76654|NCT01253421|297637|P1|Assessment and Scheduling|Found to be Ineligible|74
76655|NCT01253408|297686|P3|Overall Study|Adverse Event|0
76656|NCT01253408|297687|P2|Overall Study|Adverse Event|1
76657|NCT01253408|297688|P1|Overall Study|Adverse Event|0
76658|NCT01253369|297711|P1|Overall Study|Not Evaluable|3
76659|NCT01253369|297711|P1|Overall Study|Progressive disease|23
76660|NCT01253369|297711|P1|Overall Study|Death|1
76661|NCT01253369|297711|P1|Overall Study|Withdrawal by Subject|2
76662|NCT01253369|297711|P1|Overall Study|Adverse Event|4
76663|NCT01253317|297741|P1|Overall Study|Adverse Event|2
76664|NCT01253304|297753|P4|Overall Study|Adverse Event|1
76665|NCT01253304|297754|P3|Overall Study|Adverse Event|0
76666|NCT01253304|297755|P2|Overall Study|Adverse Event|0
76667|NCT01253304|297756|P1|Overall Study|Adverse Event|0
76668|NCT01253265|297795|P5|Overall Study|Withdrawal by Subject|1
76669|NCT01253265|297796|P4|Overall Study|Withdrawal by Subject|0
76670|NCT01253265|297797|P3|Overall Study|Withdrawal by Subject|0
76671|NCT01253265|297798|P2|Overall Study|Withdrawal by Subject|0
76672|NCT01253265|297799|P1|Overall Study|Withdrawal by Subject|0
76673|NCT01253265|297795|P5|Overall Study|Met Predefined Discontinuation Criteria|0
76674|NCT01253265|297796|P4|Overall Study|Met Predefined Discontinuation Criteria|0
76675|NCT01253265|297797|P3|Overall Study|Met Predefined Discontinuation Criteria|0
76676|NCT01253265|297798|P2|Overall Study|Met Predefined Discontinuation Criteria|0
76677|NCT01253265|297799|P1|Overall Study|Met Predefined Discontinuation Criteria|1
76678|NCT01253200|297848|P5|Overall Study|Attempts|0
76679|NCT01253200|297849|P4|Overall Study|Attempts|2
76680|NCT01253200|297850|P3|Overall Study|Attempts|1
76681|NCT01253200|297851|P2|Overall Study|Attempts|4
76682|NCT01253200|297852|P1|Overall Study|Attempts|6
76683|NCT01253200|297848|P5|Overall Study|intents|0
76684|NCT01253200|297849|P4|Overall Study|intents|3
76685|NCT01253200|297850|P3|Overall Study|intents|1
76686|NCT01253200|297851|P2|Overall Study|intents|10
76687|NCT01253200|297852|P1|Overall Study|intents|10
76688|NCT01253200|297848|P5|Overall Study|Protocol Violation|5
76689|NCT01253200|297849|P4|Overall Study|Protocol Violation|0
76690|NCT01253200|297850|P3|Overall Study|Protocol Violation|0
76691|NCT01253200|297851|P2|Overall Study|Protocol Violation|4
76692|NCT01253200|297852|P1|Overall Study|Protocol Violation|1
76693|NCT01253200|297848|P5|Overall Study|Withdrawal by Subject|0
76694|NCT01253200|297849|P4|Overall Study|Withdrawal by Subject|0
76695|NCT01253200|297850|P3|Overall Study|Withdrawal by Subject|0
76696|NCT01253200|297851|P2|Overall Study|Withdrawal by Subject|0
76697|NCT01253200|297852|P1|Overall Study|Withdrawal by Subject|2
76698|NCT01253200|297848|P5|Overall Study|Lost to Follow-up|0
76699|NCT01253200|297849|P4|Overall Study|Lost to Follow-up|0
76700|NCT01253200|297850|P3|Overall Study|Lost to Follow-up|0
76701|NCT01253200|297851|P2|Overall Study|Lost to Follow-up|1
76702|NCT01253200|297852|P1|Overall Study|Lost to Follow-up|1
76703|NCT01253200|297848|P5|Overall Study|Death|0
76704|NCT01253200|297849|P4|Overall Study|Death|0
76705|NCT01253200|297850|P3|Overall Study|Death|0
76706|NCT01253200|297851|P2|Overall Study|Death|0
76707|NCT01253200|297852|P1|Overall Study|Death|1
76708|NCT01253187|297867|P6|Period 3|non-compliance|0
76709|NCT01253187|297868|P5|Period 3|non-compliance|1
76710|NCT01253187|297869|P4|Period 3|non-compliance|0
76711|NCT01253187|297870|P3|Period 3|non-compliance|0
76712|NCT01253187|297871|P2|Period 3|non-compliance|0
76713|NCT01253187|297872|P1|Period 3|non-compliance|0
76714|NCT01253187|297867|P6|Period 3|difficulty with blood sampling|0
76715|NCT01253187|297868|P5|Period 3|difficulty with blood sampling|0
76716|NCT01253187|297869|P4|Period 3|difficulty with blood sampling|0
76717|NCT01253187|297870|P3|Period 3|difficulty with blood sampling|0
76718|NCT01253187|297871|P2|Period 3|difficulty with blood sampling|1
76719|NCT01253187|297872|P1|Period 3|difficulty with blood sampling|0
76720|NCT01253187|297867|P6|Period 3|Pregnancy|0
76721|NCT01253187|297868|P5|Period 3|Pregnancy|0
76722|NCT01253187|297869|P4|Period 3|Pregnancy|0
76723|NCT01253187|297870|P3|Period 3|Pregnancy|0
76724|NCT01253187|297871|P2|Period 3|Pregnancy|0
76725|NCT01253187|297872|P1|Period 3|Pregnancy|1
76726|NCT01253187|297867|P6|Period 2|Withdrawal by Subject|0
76727|NCT01253187|297868|P5|Period 2|Withdrawal by Subject|1
76728|NCT01253187|297869|P4|Period 2|Withdrawal by Subject|0
76729|NCT01253187|297870|P3|Period 2|Withdrawal by Subject|0
76730|NCT01253187|297871|P2|Period 2|Withdrawal by Subject|0
76731|NCT01253187|297872|P1|Period 2|Withdrawal by Subject|0
76732|NCT01253174|297901|P6|Period 3|Pregnancy|0
76733|NCT01253174|297902|P5|Period 3|Pregnancy|0
76734|NCT01253174|297903|P4|Period 3|Pregnancy|0
76735|NCT01253174|297904|P3|Period 3|Pregnancy|1
76736|NCT01253174|297905|P2|Period 3|Pregnancy|0
76737|NCT01253174|297906|P1|Period 3|Pregnancy|0
76738|NCT01253174|297901|P6|Period 3|Withdrawal by Subject|0
76739|NCT01253174|297902|P5|Period 3|Withdrawal by Subject|1
76740|NCT01253174|297903|P4|Period 3|Withdrawal by Subject|0
76741|NCT01253174|297904|P3|Period 3|Withdrawal by Subject|0
76742|NCT01253174|297905|P2|Period 3|Withdrawal by Subject|1
76743|NCT01253174|297906|P1|Period 3|Withdrawal by Subject|0
76744|NCT01253174|297901|P6|Period 2|Adverse Event|0
76745|NCT01253174|297902|P5|Period 2|Adverse Event|0
76746|NCT01253174|297903|P4|Period 2|Adverse Event|0
76747|NCT01253174|297904|P3|Period 2|Adverse Event|1
76748|NCT01253174|297905|P2|Period 2|Adverse Event|0
76749|NCT01253174|297906|P1|Period 2|Adverse Event|0
76750|NCT01253174|297901|P6|Period 1|Randomized but not treated|0
76751|NCT01253174|297902|P5|Period 1|Randomized but not treated|1
76752|NCT01253174|297903|P4|Period 1|Randomized but not treated|0
76753|NCT01253174|297904|P3|Period 1|Randomized but not treated|1
76754|NCT01253174|297905|P2|Period 1|Randomized but not treated|1
76755|NCT01253174|297906|P1|Period 1|Randomized but not treated|0
76756|NCT01253135|297941|P1|Amended Protocol|Non-compliance|1
76757|NCT01253135|297941|P1|Original Protocol|Protocol Amendment|15
76758|NCT01253044|297960|P2|Overall Study|Lost to Follow-up|29
76759|NCT01253044|297961|P1|Overall Study|Lost to Follow-up|38
76760|NCT01253018|297971|P2|Overall Study|Withdrawal by Subject|1
76761|NCT01253018|297972|P1|Overall Study|Withdrawal by Subject|1
76762|NCT01253018|297971|P2|Overall Study|Robot Repair Issues|0
76763|NCT01253018|297972|P1|Overall Study|Robot Repair Issues|2
76764|NCT01253018|297971|P2|Overall Study|Lost to Follow-up|1
76765|NCT01253018|297972|P1|Overall Study|Lost to Follow-up|1
76766|NCT01252966|297986|P2|Overall Study|Withdrawal by Subject|3
76767|NCT01252966|297987|P1|Overall Study|Withdrawal by Subject|7
76768|NCT01252966|297986|P2|Overall Study|Lost to Follow-up|10
76769|NCT01252966|297987|P1|Overall Study|Lost to Follow-up|16
76770|NCT01252953|298003|P2|Overall Study|Lost to Follow-up|21
76771|NCT01252953|298004|P1|Overall Study|Lost to Follow-up|22
76772|NCT01252953|298003|P2|Overall Study|Withdrawal by Subject|17
76773|NCT01252953|298004|P1|Overall Study|Withdrawal by Subject|16
76774|NCT01252940|298018|P2|Extension Phase|Withdrawal by Subject|1
76775|NCT01252940|298019|P1|Extension Phase|Withdrawal by Subject|1
76776|NCT01252940|298018|P2|Extension Phase|Subject Non-compliance|0
76777|NCT01252940|298019|P1|Extension Phase|Subject Non-compliance|1
76778|NCT01252940|298018|P2|Extension Phase|Physician Decision|1
76779|NCT01252940|298019|P1|Extension Phase|Physician Decision|0
76780|NCT01252940|298018|P2|Extension Phase|Lost to Follow-up|0
76781|NCT01252940|298019|P1|Extension Phase|Lost to Follow-up|5
76782|NCT01252940|298018|P2|Extension Phase|Lack of Efficacy|0
76783|NCT01252940|298019|P1|Extension Phase|Lack of Efficacy|1
76784|NCT01252940|298018|P2|Extension Phase|Adverse Event|1
76785|NCT01252940|298019|P1|Extension Phase|Adverse Event|2
76786|NCT01252940|298018|P2|Main Study Phase|Subject Non-compliance|1
76787|NCT01252940|298019|P1|Main Study Phase|Subject Non-compliance|1
76788|NCT01252940|298018|P2|Main Study Phase|Withdrawal by Subject|5
76789|NCT01252940|298019|P1|Main Study Phase|Withdrawal by Subject|6
76790|NCT01252940|298018|P2|Main Study Phase|Protocol Violation|2
76791|NCT01252940|298019|P1|Main Study Phase|Protocol Violation|4
76792|NCT01252940|298018|P2|Main Study Phase|Physician Decision|0
76793|NCT01252940|298019|P1|Main Study Phase|Physician Decision|1
76794|NCT01252940|298018|P2|Main Study Phase|Lost to Follow-up|1
76795|NCT01252940|298019|P1|Main Study Phase|Lost to Follow-up|6
76796|NCT01252940|298018|P2|Main Study Phase|Lack of Efficacy|0
76797|NCT01252940|298019|P1|Main Study Phase|Lack of Efficacy|1
76798|NCT01252940|298018|P2|Main Study Phase|Adverse Event|1
76799|NCT01252940|298019|P1|Main Study Phase|Adverse Event|3
76800|NCT01252940|298018|P2|Main Study Phase|Randomized but not treated|2
76801|NCT01252940|298019|P1|Main Study Phase|Randomized but not treated|4
76802|NCT01252810|298050|P2|Overall Study|Various reasons|0
76803|NCT01252810|298051|P1|Overall Study|Various reasons|8
76804|NCT01252810|298050|P2|Overall Study|Physician Decision|1
76805|NCT01252810|298051|P1|Overall Study|Physician Decision|2
76806|NCT01252810|298050|P2|Overall Study|Lost to Follow-up|1
76807|NCT01252810|298051|P1|Overall Study|Lost to Follow-up|0
76808|NCT01252810|298050|P2|Overall Study|Withdrawal by Subject|1
76809|NCT01252810|298051|P1|Overall Study|Withdrawal by Subject|4
76810|NCT01252355|298083|P3|Overall Study|Other Than Above|7
76811|NCT01252355|298084|P2|Overall Study|Other Than Above|7
76812|NCT01252355|298085|P1|Overall Study|Other Than Above|8
76813|NCT01252355|298083|P3|Overall Study|Randomized but not Treated|0
76814|NCT01252355|298084|P2|Overall Study|Randomized but not Treated|0
76815|NCT01252355|298085|P1|Overall Study|Randomized but not Treated|2
76816|NCT01252355|298083|P3|Overall Study|Sponsor Early Termination of Study|146
76817|NCT01252355|298084|P2|Overall Study|Sponsor Early Termination of Study|149
76818|NCT01252355|298085|P1|Overall Study|Sponsor Early Termination of Study|149
76819|NCT01252355|298083|P3|Overall Study|Progressive Disease|0
76820|NCT01252355|298084|P2|Overall Study|Progressive Disease|0
76821|NCT01252355|298085|P1|Overall Study|Progressive Disease|2
76822|NCT01252355|298083|P3|Overall Study|Poor Compliance to Protocol|1
76823|NCT01252355|298084|P2|Overall Study|Poor Compliance to Protocol|1
76824|NCT01252355|298085|P1|Overall Study|Poor Compliance to Protocol|1
76825|NCT01252355|298083|P3|Overall Study|Lost to Follow-up|1
76826|NCT01252355|298084|P2|Overall Study|Lost to Follow-up|0
76827|NCT01252355|298085|P1|Overall Study|Lost to Follow-up|0
76828|NCT01252355|298083|P3|Overall Study|Lack of Efficacy|2
76829|NCT01252355|298084|P2|Overall Study|Lack of Efficacy|4
76830|NCT01252355|298085|P1|Overall Study|Lack of Efficacy|6
76831|NCT01252355|298083|P3|Overall Study|Adverse Event|22
76832|NCT01252355|298084|P2|Overall Study|Adverse Event|17
76833|NCT01252355|298085|P1|Overall Study|Adverse Event|9
76834|NCT01252290|298123|P1|Overall Study|Withdrawal by Subject|1
76835|NCT01252251|298139|P1|Overall Study|Withdrawal by Subject|1
76836|NCT01252238|298151|P3|Overall Study|Sponsor terminated study|4
76837|NCT01252238|298152|P2|Overall Study|Sponsor terminated study|4
76838|NCT01252238|298153|P1|Overall Study|Sponsor terminated study|4
76839|NCT01252186|298170|P3|Overall Study|Other - Miscellaneous Reasons|7
76840|NCT01252186|298171|P2|Overall Study|Other - Miscellaneous Reasons|5
76841|NCT01252186|298172|P1|Overall Study|Other - Miscellaneous Reasons|5
76842|NCT01252186|298170|P3|Overall Study|Lost to Follow-up|11
76843|NCT01252186|298171|P2|Overall Study|Lost to Follow-up|10
76844|NCT01252186|298172|P1|Overall Study|Lost to Follow-up|10
76845|NCT01252186|298170|P3|Overall Study|Sponsor Request|0
76846|NCT01252186|298171|P2|Overall Study|Sponsor Request|1
76847|NCT01252186|298172|P1|Overall Study|Sponsor Request|2
76848|NCT01252186|298170|P3|Overall Study|Pregnancy|0
76849|NCT01252186|298171|P2|Overall Study|Pregnancy|2
76850|NCT01252186|298172|P1|Overall Study|Pregnancy|2
76851|NCT01252186|298170|P3|Overall Study|Protocol Violation|1
76852|NCT01252186|298171|P2|Overall Study|Protocol Violation|0
76853|NCT01252186|298172|P1|Overall Study|Protocol Violation|0
76854|NCT01252186|298170|P3|Overall Study|Non-compliance|4
76855|NCT01252186|298171|P2|Overall Study|Non-compliance|3
76856|NCT01252186|298172|P1|Overall Study|Non-compliance|0
76857|NCT01252186|298170|P3|Overall Study|Physician Decision|1
76858|NCT01252186|298171|P2|Overall Study|Physician Decision|0
76859|NCT01252186|298172|P1|Overall Study|Physician Decision|0
76860|NCT01252186|298170|P3|Overall Study|Withdrawal by Subject|2
76861|NCT01252186|298171|P2|Overall Study|Withdrawal by Subject|5
76862|NCT01252186|298172|P1|Overall Study|Withdrawal by Subject|2
76863|NCT01252186|298170|P3|Overall Study|Adverse Event|8
76864|NCT01252186|298171|P2|Overall Study|Adverse Event|6
76865|NCT01252186|298172|P1|Overall Study|Adverse Event|9
76866|NCT01252134|298245|P6|Period 1, 8 Hours|Personal Reasons|0
76867|NCT01252134|298246|P5|Period 1, 8 Hours|Personal Reasons|0
76868|NCT01252134|298247|P4|Period 1, 8 Hours|Personal Reasons|0
76869|NCT01252134|298248|P3|Period 1, 8 Hours|Personal Reasons|1
76870|NCT01252134|298249|P2|Period 1, 8 Hours|Personal Reasons|1
76871|NCT01252134|298250|P1|Period 1, 8 Hours|Personal Reasons|0
76872|NCT01252095|298269|P2|Overall Study|Disease progression|0
76873|NCT01252095|298270|P1|Overall Study|Disease progression|1
76874|NCT01251952|298288|P1|Overall Study|Adverse Event|1
76875|NCT01251770|298294|P2|Overall Study|Protocol Violation|7
76876|NCT01251770|298295|P1|Overall Study|Protocol Violation|13
76877|NCT01251653|298346|P9|Overall Study|Other reason not mentioned above|0
76878|NCT01251653|298347|P8|Overall Study|Other reason not mentioned above|2
76879|NCT01251653|298348|P7|Overall Study|Other reason not mentioned above|0
76880|NCT01251653|298349|P6|Overall Study|Other reason not mentioned above|0
76881|NCT01251653|298350|P5|Overall Study|Other reason not mentioned above|0
76882|NCT01251653|298351|P4|Overall Study|Other reason not mentioned above|0
76883|NCT01251653|298352|P3|Overall Study|Other reason not mentioned above|0
76884|NCT01251653|298353|P2|Overall Study|Other reason not mentioned above|0
76885|NCT01251653|298354|P1|Overall Study|Other reason not mentioned above|0
76886|NCT01251653|298346|P9|Overall Study|Withdrawal by Subject|0
76887|NCT01251653|298347|P8|Overall Study|Withdrawal by Subject|1
76888|NCT01251653|298348|P7|Overall Study|Withdrawal by Subject|0
76889|NCT01251653|298349|P6|Overall Study|Withdrawal by Subject|1
76890|NCT01251653|298350|P5|Overall Study|Withdrawal by Subject|1
76891|NCT01251653|298351|P4|Overall Study|Withdrawal by Subject|0
76892|NCT01251653|298352|P3|Overall Study|Withdrawal by Subject|1
76893|NCT01251653|298353|P2|Overall Study|Withdrawal by Subject|0
76894|NCT01251653|298354|P1|Overall Study|Withdrawal by Subject|1
76895|NCT01251653|298346|P9|Overall Study|Adverse Event|1
76896|NCT01251653|298347|P8|Overall Study|Adverse Event|2
76897|NCT01251653|298348|P7|Overall Study|Adverse Event|2
76898|NCT01251653|298349|P6|Overall Study|Adverse Event|0
76899|NCT01251653|298350|P5|Overall Study|Adverse Event|1
76900|NCT01251653|298351|P4|Overall Study|Adverse Event|1
76901|NCT01251653|298352|P3|Overall Study|Adverse Event|2
76902|NCT01251653|298353|P2|Overall Study|Adverse Event|0
76903|NCT01251653|298354|P1|Overall Study|Adverse Event|1
76904|NCT01251653|298346|P9|Overall Study|Dose-limiting toxicity|0
76905|NCT01251653|298347|P8|Overall Study|Dose-limiting toxicity|0
76906|NCT01251653|298348|P7|Overall Study|Dose-limiting toxicity|2
76907|NCT01251653|298349|P6|Overall Study|Dose-limiting toxicity|0
76908|NCT01251653|298350|P5|Overall Study|Dose-limiting toxicity|0
76909|NCT01251653|298351|P4|Overall Study|Dose-limiting toxicity|1
76910|NCT01251653|298352|P3|Overall Study|Dose-limiting toxicity|1
76911|NCT01251653|298353|P2|Overall Study|Dose-limiting toxicity|1
76912|NCT01251653|298354|P1|Overall Study|Dose-limiting toxicity|0
76913|NCT01251653|298346|P9|Overall Study|Progressive Disease|5
76914|NCT01251653|298347|P8|Overall Study|Progressive Disease|7
76915|NCT01251653|298348|P7|Overall Study|Progressive Disease|14
76916|NCT01251653|298349|P6|Overall Study|Progressive Disease|17
76917|NCT01251653|298350|P5|Overall Study|Progressive Disease|0
76918|NCT01251653|298351|P4|Overall Study|Progressive Disease|4
76919|NCT01251653|298352|P3|Overall Study|Progressive Disease|16
76920|NCT01251653|298353|P2|Overall Study|Progressive Disease|7
76921|NCT01251653|298354|P1|Overall Study|Progressive Disease|1
76922|NCT01251614|298482|P3|Overall Study|Lost to Follow-up|0
76923|NCT01251614|298483|P2|Overall Study|Lost to Follow-up|1
76924|NCT01251614|298484|P1|Overall Study|Lost to Follow-up|0
76925|NCT01251614|298482|P3|Overall Study|Withdrawal by Subject|1
76926|NCT01251614|298483|P2|Overall Study|Withdrawal by Subject|2
76927|NCT01251614|298484|P1|Overall Study|Withdrawal by Subject|0
76928|NCT01251614|298482|P3|Overall Study|Loss of Disease Control|0
76929|NCT01251614|298483|P2|Overall Study|Loss of Disease Control|1
76930|NCT01251614|298484|P1|Overall Study|Loss of Disease Control|0
76931|NCT01251614|298482|P3|Overall Study|Pregnancy|2
76932|NCT01251614|298483|P2|Overall Study|Pregnancy|0
76933|NCT01251614|298484|P1|Overall Study|Pregnancy|0
76934|NCT01251614|298482|P3|Overall Study|Clearing of Psoriatic Lesions|0
76935|NCT01251614|298483|P2|Overall Study|Clearing of Psoriatic Lesions|0
76936|NCT01251614|298484|P1|Overall Study|Clearing of Psoriatic Lesions|1
76937|NCT01251614|298482|P3|Overall Study|Lack of Efficacy|4
76938|NCT01251614|298483|P2|Overall Study|Lack of Efficacy|9
76939|NCT01251614|298484|P1|Overall Study|Lack of Efficacy|1
76940|NCT01251614|298482|P3|Overall Study|Adverse Event|1
76941|NCT01251614|298483|P2|Overall Study|Adverse Event|0
76942|NCT01251614|298484|P1|Overall Study|Adverse Event|1
76943|NCT01251380|298591|P1|Overall Study|Lost to Follow-up|2
76944|NCT01251380|298591|P1|Overall Study|Adverse Event|1
76945|NCT01251380|298591|P1|Overall Study|Lack of Efficacy|1
76946|NCT01251380|298591|P1|Overall Study|Withdrawal by Subject|6
76947|NCT01251380|298591|P1|Overall Study|Other (Not otherwise specified)|12
76948|NCT01251367|298615|P1|Overall Study|End of Study Visit Performed in Error|1
76949|NCT01251367|298615|P1|Overall Study|Subject had Personal or Medical Issues|4
76950|NCT01251367|298615|P1|Overall Study|No Study Drug Available|1
76951|NCT01251367|298615|P1|Overall Study|Subject Required Alternative Treatment|7
76952|NCT01251367|298615|P1|Overall Study|Lost to Follow-up|5
76953|NCT01251367|298615|P1|Overall Study|Withdrawal by Subject|36
76954|NCT01251367|298615|P1|Overall Study|Adverse Event|19
76955|NCT01251367|298615|P1|Overall Study|Lack of Efficacy|2
76956|NCT01251367|298615|P1|Overall Study|Protocol Violation|1
76957|NCT01251354|298650|P1|Overall Study|Disease Progression|4
76958|NCT01251354|298650|P1|Overall Study|Investigator's Decision|1
76959|NCT01251354|298650|P1|Overall Study|Adverse Event|1
76960|NCT01251276|298693|P2|Overall Study|Lost to Follow-up|1
76961|NCT01251276|298694|P1|Overall Study|Lost to Follow-up|0
76962|NCT01251276|298693|P2|Overall Study|Protocol Violation|0
76963|NCT01251276|298694|P1|Overall Study|Protocol Violation|1
76964|NCT01251146|298712|P2|Overall Study|Lost to Follow-up|10
76965|NCT01251146|298713|P1|Overall Study|Lost to Follow-up|3
76966|NCT01251120|298735|P2|Overall Study|Lack of Efficacy|1
76967|NCT01251120|298736|P1|Overall Study|Lack of Efficacy|0
76968|NCT01250925|298801|P3|Overall Study|Adverse Event|1
76969|NCT01250925|298802|P2|Overall Study|Adverse Event|0
76970|NCT01250925|298803|P1|Overall Study|Adverse Event|0
76971|NCT01250925|298801|P3|Overall Study|Physician Decision|1
76972|NCT01250925|298802|P2|Overall Study|Physician Decision|2
76973|NCT01250925|298803|P1|Overall Study|Physician Decision|0
76974|NCT01250925|298801|P3|Overall Study|Protocol Violation|0
76975|NCT01250925|298802|P2|Overall Study|Protocol Violation|0
76976|NCT01250925|298803|P1|Overall Study|Protocol Violation|2
76977|NCT01250925|298801|P3|Overall Study|Withdrawal by Subject|0
76978|NCT01250925|298802|P2|Overall Study|Withdrawal by Subject|0
76979|NCT01250925|298803|P1|Overall Study|Withdrawal by Subject|2
76980|NCT01250925|298801|P3|Overall Study|Lost to Follow-up|0
76981|NCT01250925|298802|P2|Overall Study|Lost to Follow-up|1
76982|NCT01250925|298803|P1|Overall Study|Lost to Follow-up|1
76983|NCT01250769|298869|P4|Overall Study|Adverse Event|0
76984|NCT01250769|298870|P3|Overall Study|Adverse Event|1
76985|NCT01250769|298871|P2|Overall Study|Adverse Event|0
76986|NCT01250769|298872|P1|Overall Study|Adverse Event|0
76987|NCT01250769|298869|P4|Overall Study|Withdrawal by Subject|0
76988|NCT01250769|298870|P3|Overall Study|Withdrawal by Subject|1
76989|NCT01250769|298871|P2|Overall Study|Withdrawal by Subject|1
76990|NCT01250769|298872|P1|Overall Study|Withdrawal by Subject|0
76991|NCT01250756|298904|P2|After Toddler Dose|Adverse Event|1
76992|NCT01250756|298905|P1|After Toddler Dose|Adverse Event|0
76993|NCT01250756|298904|P2|Toddler Dose|Adverse Event|1
76994|NCT01250756|298905|P1|Toddler Dose|Adverse Event|0
76995|NCT01250756|298904|P2|After Infant Series|Other|1
76996|NCT01250756|298905|P1|After Infant Series|Other|2
76997|NCT01250756|298904|P2|After Infant Series|Withdrawal by Subject|1
76998|NCT01250756|298905|P1|After Infant Series|Withdrawal by Subject|4
76999|NCT01250756|298904|P2|After Infant Series|Adverse Event|2
77000|NCT01250756|298905|P1|After Infant Series|Adverse Event|5
77001|NCT01250756|298904|P2|Infant Series|Other|0
77002|NCT01250756|298905|P1|Infant Series|Other|22
77003|NCT01250756|298904|P2|Infant Series|Randomized, Not Vaccinated|2
77004|NCT01250756|298905|P1|Infant Series|Randomized, Not Vaccinated|2
77005|NCT01250756|298904|P2|Infant Series|Withdrawal by Subject|5
77006|NCT01250756|298905|P1|Infant Series|Withdrawal by Subject|4
77007|NCT01250509|299022|P2|Overall Study|Lost to Follow-up|2
77008|NCT01250509|299023|P1|Overall Study|Lost to Follow-up|5
77009|NCT01250418|299037|P2|Overall Study|monitor data failure|1
77010|NCT01250418|299038|P1|Overall Study|monitor data failure|1
77011|NCT01250379|299046|P2|Overall Study|Participant noncompliance|0
77012|NCT01250379|299047|P1|Overall Study|Participant noncompliance|2
77013|NCT01250379|299046|P2|Overall Study|Not specified|4
77014|NCT01250379|299047|P1|Overall Study|Not specified|0
77015|NCT01250379|299046|P2|Overall Study|Adverse Event|4
77016|NCT01250379|299047|P1|Overall Study|Adverse Event|5
77017|NCT01250379|299046|P2|Overall Study|Lost to Follow-up|6
77018|NCT01250379|299047|P1|Overall Study|Lost to Follow-up|9
77019|NCT01250379|299046|P2|Overall Study|Protocol Violation|8
77020|NCT01250379|299047|P1|Overall Study|Protocol Violation|2
77021|NCT01250379|299046|P2|Overall Study|Physician Decision|3
77022|NCT01250379|299047|P1|Overall Study|Physician Decision|11
77023|NCT01250379|299046|P2|Overall Study|Withdrawal by Subject|20
77024|NCT01250379|299047|P1|Overall Study|Withdrawal by Subject|32
77025|NCT01250379|299046|P2|Overall Study|Death|148
77026|NCT01250379|299047|P1|Overall Study|Death|141
77027|NCT01250171|299136|P3|Overall Study|Administrative reasons|0
77028|NCT01250171|299137|P2|Overall Study|Administrative reasons|0
77029|NCT01250171|299138|P1|Overall Study|Administrative reasons|1
77030|NCT01250145|299169|P2|Overall Study|Withdrawal by Subject|4
77031|NCT01250145|299170|P1|Overall Study|Withdrawal by Subject|0
77032|NCT01250145|299169|P2|Overall Study|Adverse Event|1
77033|NCT01250145|299170|P1|Overall Study|Adverse Event|2
77034|NCT01250119|299190|P2|Treatment Phase|Unknown reason|4
77035|NCT01250119|299191|P1|Treatment Phase|Unknown reason|0
77036|NCT01250119|299190|P2|Treatment Phase|Adverse Event|2
77037|NCT01250119|299191|P1|Treatment Phase|Adverse Event|0
77038|NCT01250119|299190|P2|Treatment Phase|Withdrawal by Subject|1
77039|NCT01250119|299191|P1|Treatment Phase|Withdrawal by Subject|0
77040|NCT01250119|299190|P2|Treatment Phase|Death|2
77041|NCT01250119|299191|P1|Treatment Phase|Death|0
77042|NCT01250119|299190|P2|Treatment Phase|Progressive Disease|32
77043|NCT01250119|299191|P1|Treatment Phase|Progressive Disease|0
77044|NCT01250119|299190|P2|Diagnostic Phase|Participants Not Tested|0
77045|NCT01250119|299191|P1|Diagnostic Phase|Participants Not Tested|44
77046|NCT01250119|299190|P2|Diagnostic Phase|Failed to Produce a Test Results|0
77047|NCT01250119|299191|P1|Diagnostic Phase|Failed to Produce a Test Results|69
77048|NCT01250054|299206|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
77049|NCT01250054|299207|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
77050|NCT01250002|299215|P2|Overall Study|Change to open surgical procedure|3
77051|NCT01250002|299216|P1|Overall Study|Change to open surgical procedure|4
77052|NCT01249833|299281|P2|Overall Study|Lost to Follow-up|1
77053|NCT01249833|299282|P1|Overall Study|Lost to Follow-up|0
77054|NCT01249664|299296|P2|Overall Study|Adverse Event|0
77055|NCT01249664|299297|P1|Overall Study|Adverse Event|1
77056|NCT01249664|299296|P2|Overall Study|Withdrawal by Subject|0
77057|NCT01249664|299297|P1|Overall Study|Withdrawal by Subject|5
77058|NCT01249651|299347|P1|Overall Study|Sponsor Decision|1
77059|NCT01249651|299347|P1|Overall Study|Protocol Violation|1
77060|NCT01249651|299347|P1|Overall Study|Adverse Event|1
77061|NCT01249651|299347|P1|Overall Study|Withdrawal by Subject|4
77062|NCT01249417|299357|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
77063|NCT01249417|299358|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
77064|NCT01249417|299359|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
77065|NCT01249417|299357|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
77066|NCT01249417|299358|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
77067|NCT01249417|299359|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
77068|NCT01249417|299357|P3|Treatment Phase - ITT Population|Adverse Event|1
77069|NCT01249417|299358|P2|Treatment Phase - ITT Population|Adverse Event|0
77070|NCT01249417|299359|P1|Treatment Phase - ITT Population|Adverse Event|0
77071|NCT01249417|299357|P3|Treatment Phase - ITT Population|Not specified|1
77072|NCT01249417|299358|P2|Treatment Phase - ITT Population|Not specified|0
77073|NCT01249417|299359|P1|Treatment Phase - ITT Population|Not specified|0
77074|NCT01249417|299357|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
77075|NCT01249417|299358|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
77076|NCT01249417|299359|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
77077|NCT01249417|299357|P3|Randomised Population|Study treatment not received|2
77078|NCT01249417|299358|P2|Randomised Population|Study treatment not received|0
77079|NCT01249417|299359|P1|Randomised Population|Study treatment not received|0
77080|NCT01249404|299376|P3|Overall Study|Non compliance to visit schedule|0
77081|NCT01249404|299377|P2|Overall Study|Non compliance to visit schedule|1
77082|NCT01249404|299378|P1|Overall Study|Non compliance to visit schedule|0
77083|NCT01249404|299376|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
77084|NCT01249404|299377|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
77085|NCT01249404|299378|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
77086|NCT01249404|299376|P3|Overall Study|Withdrawal by Subject|0
77087|NCT01249404|299377|P2|Overall Study|Withdrawal by Subject|2
77088|NCT01249404|299378|P1|Overall Study|Withdrawal by Subject|2
77089|NCT01249404|299376|P3|Overall Study|Adverse Event|2
77090|NCT01249404|299377|P2|Overall Study|Adverse Event|2
77091|NCT01249404|299378|P1|Overall Study|Adverse Event|2
77092|NCT01249404|299376|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
77093|NCT01249404|299377|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
77094|NCT01249404|299378|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
77095|NCT01249404|299376|P3|Overall Study|Study treatment not received|2
77096|NCT01249404|299377|P2|Overall Study|Study treatment not received|1
77097|NCT01249404|299378|P1|Overall Study|Study treatment not received|0
77098|NCT01249274|299457|P2|Overall Study|Received inpatient substance treatment|2
77099|NCT01249274|299458|P1|Overall Study|Received inpatient substance treatment|1
77100|NCT01249274|299457|P2|Overall Study|Lost to Follow-up|4
77101|NCT01249274|299458|P1|Overall Study|Lost to Follow-up|3
77102|NCT01249261|299484|P2|Overall Study|Withdrawal by Subject|0
77103|NCT01249261|299485|P1|Overall Study|Withdrawal by Subject|1
77104|NCT01249157|299513|P1|Overall Study|Withdrawal by Subject|1
77105|NCT01249131|299517|P6|Washout Period of 10 Days|Adverse Event|0
77106|NCT01249131|299518|P5|Washout Period of 10 Days|Adverse Event|1
77107|NCT01249131|299519|P4|Washout Period of 10 Days|Adverse Event|0
77108|NCT01249131|299520|P3|Washout Period of 10 Days|Adverse Event|0
77109|NCT01249131|299521|P2|Washout Period of 10 Days|Adverse Event|0
77110|NCT01249131|299522|P1|Washout Period of 10 Days|Adverse Event|0
77111|NCT01249118|299542|P3|First Washout Period|Physician Decision|0
77112|NCT01249118|299543|P2|First Washout Period|Physician Decision|1
77113|NCT01249118|299544|P1|First Washout Period|Physician Decision|0
77114|NCT01249092|299578|P1|Overall Study|Unable to tolerate expected SE -nausea|1
77115|NCT01249092|299578|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
77116|NCT01248949|299589|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
77117|NCT01248949|299590|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
77118|NCT01248949|299591|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
77119|NCT01248949|299592|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
77120|NCT01248949|299593|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
77121|NCT01248949|299589|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
77122|NCT01248949|299590|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
77123|NCT01248949|299591|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
77124|NCT01248949|299592|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
77125|NCT01248949|299593|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
77126|NCT01248949|299589|P5|Overall Study|Pi Decision Due To Declining Status|0
77127|NCT01248949|299590|P4|Overall Study|Pi Decision Due To Declining Status|0
77128|NCT01248949|299591|P3|Overall Study|Pi Decision Due To Declining Status|1
77129|NCT01248949|299592|P2|Overall Study|Pi Decision Due To Declining Status|0
77130|NCT01248949|299593|P1|Overall Study|Pi Decision Due To Declining Status|0
77131|NCT01248949|299589|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
77132|NCT01248949|299590|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
77133|NCT01248949|299591|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
77134|NCT01248949|299592|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
77135|NCT01248949|299593|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
77136|NCT01248949|299589|P5|Overall Study|Participant Went To Hospice|0
77137|NCT01248949|299590|P4|Overall Study|Participant Went To Hospice|0
77138|NCT01248949|299591|P3|Overall Study|Participant Went To Hospice|1
77139|NCT01248949|299592|P2|Overall Study|Participant Went To Hospice|0
77140|NCT01248949|299593|P1|Overall Study|Participant Went To Hospice|0
77141|NCT01248949|299589|P5|Overall Study|Entered Hospice And Refused Follow Up|1
77142|NCT01248949|299590|P4|Overall Study|Entered Hospice And Refused Follow Up|0
77143|NCT01248949|299591|P3|Overall Study|Entered Hospice And Refused Follow Up|0
77144|NCT01248949|299592|P2|Overall Study|Entered Hospice And Refused Follow Up|0
77145|NCT01248949|299593|P1|Overall Study|Entered Hospice And Refused Follow Up|0
77146|NCT01248949|299589|P5|Overall Study|Palliative Radiation To Brain Metastases|0
77147|NCT01248949|299590|P4|Overall Study|Palliative Radiation To Brain Metastases|0
77148|NCT01248949|299591|P3|Overall Study|Palliative Radiation To Brain Metastases|0
77149|NCT01248949|299592|P2|Overall Study|Palliative Radiation To Brain Metastases|0
77150|NCT01248949|299593|P1|Overall Study|Palliative Radiation To Brain Metastases|1
77151|NCT01248949|299589|P5|Overall Study|Alternative Therapy.|0
77152|NCT01248949|299590|P4|Overall Study|Alternative Therapy.|0
77153|NCT01248949|299591|P3|Overall Study|Alternative Therapy.|0
77154|NCT01248949|299592|P2|Overall Study|Alternative Therapy.|0
77155|NCT01248949|299593|P1|Overall Study|Alternative Therapy.|1
77156|NCT01248949|299589|P5|Overall Study|Alternative Therapy|0
77157|NCT01248949|299590|P4|Overall Study|Alternative Therapy|0
77158|NCT01248949|299591|P3|Overall Study|Alternative Therapy|0
77159|NCT01248949|299592|P2|Overall Study|Alternative Therapy|0
77160|NCT01248949|299593|P1|Overall Study|Alternative Therapy|1
77161|NCT01248949|299589|P5|Overall Study|Death|2
77162|NCT01248949|299590|P4|Overall Study|Death|6
77163|NCT01248949|299591|P3|Overall Study|Death|21
77164|NCT01248949|299592|P2|Overall Study|Death|7
77165|NCT01248949|299593|P1|Overall Study|Death|22
77166|NCT01248949|299589|P5|Overall Study|Withdrawal by Subject|1
77167|NCT01248949|299590|P4|Overall Study|Withdrawal by Subject|3
77168|NCT01248949|299591|P3|Overall Study|Withdrawal by Subject|11
77169|NCT01248949|299592|P2|Overall Study|Withdrawal by Subject|3
77170|NCT01248949|299593|P1|Overall Study|Withdrawal by Subject|5
77171|NCT01248949|299589|P5|Overall Study|Lost to Follow-up|0
77172|NCT01248949|299590|P4|Overall Study|Lost to Follow-up|1
77173|NCT01248949|299591|P3|Overall Study|Lost to Follow-up|2
77174|NCT01248949|299592|P2|Overall Study|Lost to Follow-up|2
77175|NCT01248949|299593|P1|Overall Study|Lost to Follow-up|2
77176|NCT01248936|299705|P1|Overall Study|Other reason|3
77177|NCT01248936|299705|P1|Overall Study|Refused Treatment|1
77178|NCT01248936|299705|P1|Overall Study|Lost to Follow-up|7
77179|NCT01248936|299705|P1|Overall Study|Adverse Event|8
77180|NCT01248936|299705|P1|Overall Study|Withdrawal of Consent|20
77181|NCT01248936|299705|P1|Overall Study|Death|26
77182|NCT01248936|299705|P1|Overall Study|Progression of Disease|50
77183|NCT01248936|299705|P1|Overall Study|Sponsor Decision|259
77184|NCT01248884|299718|P3|Overall Study|Adverse Event|0
77185|NCT01248884|299719|P2|Overall Study|Adverse Event|0
77186|NCT01248884|299720|P1|Overall Study|Adverse Event|1
77187|NCT01248884|299718|P3|Overall Study|Withdrawal by Subject|1
77188|NCT01248884|299719|P2|Overall Study|Withdrawal by Subject|3
77189|NCT01248884|299720|P1|Overall Study|Withdrawal by Subject|1
77190|NCT01248793|299772|P2|Overall Study|Withdrawal by Subject|3
77191|NCT01248793|299773|P1|Overall Study|Withdrawal by Subject|3
77192|NCT01248793|299772|P2|Overall Study|Protocol Violation|1
77193|NCT01248793|299773|P1|Overall Study|Protocol Violation|0
77194|NCT01248793|299772|P2|Overall Study|Adverse Event|1
77195|NCT01248793|299773|P1|Overall Study|Adverse Event|1
77196|NCT01248793|299772|P2|Overall Study|Lost to Follow-up|1
77197|NCT01248793|299773|P1|Overall Study|Lost to Follow-up|0
77198|NCT01248780|299787|P2|Overall Study|Not treated|1
77199|NCT01248780|299788|P1|Overall Study|Not treated|0
77200|NCT01248780|299787|P2|Overall Study|Withdrawal by Subject|4
77201|NCT01248780|299788|P1|Overall Study|Withdrawal by Subject|4
77202|NCT01248780|299787|P2|Overall Study|Protocol Violation|1
77203|NCT01248780|299788|P1|Overall Study|Protocol Violation|1
77204|NCT01248780|299787|P2|Overall Study|Adverse Event|7
77205|NCT01248780|299788|P1|Overall Study|Adverse Event|2
77206|NCT01248780|299787|P2|Overall Study|Death|1
77207|NCT01248780|299788|P1|Overall Study|Death|0
77208|NCT01248780|299787|P2|Overall Study|Lost to Follow-up|1
77209|NCT01248780|299788|P1|Overall Study|Lost to Follow-up|0
77210|NCT01248780|299787|P2|Overall Study|Lack of Efficacy|0
77211|NCT01248780|299788|P1|Overall Study|Lack of Efficacy|2
77212|NCT01248728|299802|P2|Overall Study|Lack of Efficacy|0
77213|NCT01248728|299803|P1|Overall Study|Lack of Efficacy|1
77214|NCT01248728|299802|P2|Overall Study|Withdrawal by Subject|1
77215|NCT01248728|299803|P1|Overall Study|Withdrawal by Subject|2
77216|NCT01248728|299802|P2|Overall Study|Adverse Event|1
77217|NCT01248728|299803|P1|Overall Study|Adverse Event|1
77218|NCT01248715|299819|P2|Overall Study|Not influenza positive|510
77219|NCT01248715|299820|P1|Overall Study|Not influenza positive|501
77220|NCT01248468|299841|P3|Overall Study|Withdrawal by Subject|0
77221|NCT01248468|299842|P2|Overall Study|Withdrawal by Subject|2
77222|NCT01248468|299843|P1|Overall Study|Withdrawal by Subject|4
77223|NCT01248468|299841|P3|Overall Study|Pregnancy|0
77224|NCT01248468|299842|P2|Overall Study|Pregnancy|0
77225|NCT01248468|299843|P1|Overall Study|Pregnancy|1
77226|NCT01248468|299841|P3|Overall Study|Lost to Follow-up|4
77227|NCT01248468|299842|P2|Overall Study|Lost to Follow-up|12
77228|NCT01248468|299843|P1|Overall Study|Lost to Follow-up|9
77229|NCT01248468|299841|P3|Overall Study|Administrative problem|0
77230|NCT01248468|299842|P2|Overall Study|Administrative problem|0
77231|NCT01248468|299843|P1|Overall Study|Administrative problem|1
77232|NCT01248455|299860|P1|Overall Study|switched to alternate treatment|1
77233|NCT01248364|299869|P4|Overall Study|Adverse Event|0
77234|NCT01248364|299870|P3|Overall Study|Adverse Event|0
77235|NCT01248364|299871|P2|Overall Study|Adverse Event|1
77236|NCT01248364|299872|P1|Overall Study|Adverse Event|0
77237|NCT01248130|299935|P2|Overall Study|Ineligible|0
77238|NCT01248130|299936|P1|Overall Study|Ineligible|1
77239|NCT01248130|299935|P2|Overall Study|Protocol Violation|0
77240|NCT01248130|299936|P1|Overall Study|Protocol Violation|1
77241|NCT01248065|299946|P2|Overall Study|Other|5
77242|NCT01248065|299947|P1|Overall Study|Other|3
77243|NCT01248065|299946|P2|Overall Study|Third treatment failure event|1
77244|NCT01248065|299947|P1|Overall Study|Third treatment failure event|3
77245|NCT01248065|299946|P2|Overall Study|Adverse Event|0
77246|NCT01248065|299947|P1|Overall Study|Adverse Event|3
77247|NCT01248065|299946|P2|Overall Study|Withdrawal by Subject|11
77248|NCT01248065|299947|P1|Overall Study|Withdrawal by Subject|14
77249|NCT01248065|299946|P2|Overall Study|Lost to Follow-up|5
77250|NCT01248065|299947|P1|Overall Study|Lost to Follow-up|3
77251|NCT01248013|299957|P1|Overall Study|Withdrawal by Subject|14
77252|NCT01247922|299972|P1|Overall Study|Disease progression|4
77253|NCT01247350|300041|P5|Overall Study|Entry criteria not met|1
77254|NCT01247350|300042|P4|Overall Study|Entry criteria not met|0
77255|NCT01247350|300043|P3|Overall Study|Entry criteria not met|0
77256|NCT01247350|300044|P2|Overall Study|Entry criteria not met|0
77257|NCT01247350|300045|P1|Overall Study|Entry criteria not met|0
77258|NCT01247350|300041|P5|Overall Study|Withdrawal by Subject|0
77259|NCT01247350|300042|P4|Overall Study|Withdrawal by Subject|1
77260|NCT01247350|300043|P3|Overall Study|Withdrawal by Subject|0
77261|NCT01247350|300044|P2|Overall Study|Withdrawal by Subject|0
77262|NCT01247350|300045|P1|Overall Study|Withdrawal by Subject|0
77263|NCT01247350|300041|P5|Overall Study|Adverse Event|0
77264|NCT01247350|300042|P4|Overall Study|Adverse Event|0
77265|NCT01247350|300043|P3|Overall Study|Adverse Event|1
77266|NCT01247350|300044|P2|Overall Study|Adverse Event|0
77267|NCT01247350|300045|P1|Overall Study|Adverse Event|0
77268|NCT01247324|300103|P2|Overall Study|Lost to Follow-up|1
77269|NCT01247324|300104|P1|Overall Study|Lost to Follow-up|1
77270|NCT01247324|300103|P2|Overall Study|Adverse Event|13
77271|NCT01247324|300104|P1|Overall Study|Adverse Event|25
77272|NCT01247324|300103|P2|Overall Study|Consent withdrawn by participant|8
77273|NCT01247324|300104|P1|Overall Study|Consent withdrawn by participant|13
77274|NCT01247324|300103|P2|Overall Study|Reason not specified|8
77275|NCT01247324|300104|P1|Overall Study|Reason not specified|11
77276|NCT01247324|300103|P2|Overall Study|Protocol Violation|2
77277|NCT01247324|300104|P1|Overall Study|Protocol Violation|1
77278|NCT01247324|300103|P2|Overall Study|Pregnancy|3
77279|NCT01247324|300104|P1|Overall Study|Pregnancy|2
77280|NCT01247324|300103|P2|Overall Study|Non-compliance|0
77281|NCT01247324|300104|P1|Overall Study|Non-compliance|2
77282|NCT01247324|300103|P2|Overall Study|Lack of Efficacy|8
77283|NCT01247324|300104|P1|Overall Study|Lack of Efficacy|12
77284|NCT01247324|300103|P2|Overall Study|Non-compliance with study drug|0
77285|NCT01247324|300104|P1|Overall Study|Non-compliance with study drug|3
77286|NCT01247324|300103|P2|Overall Study|Physician Decision|1
77287|NCT01247324|300104|P1|Overall Study|Physician Decision|0
77288|NCT01247324|300103|P2|Overall Study|Death|0
77289|NCT01247324|300104|P1|Overall Study|Death|1
77290|NCT01247090|300197|P3|Overall Study|Withdrawal by Subject|0
77291|NCT01247090|300198|P2|Overall Study|Withdrawal by Subject|1
77292|NCT01247090|300199|P1|Overall Study|Withdrawal by Subject|0
77293|NCT01247090|300197|P3|Overall Study|Physician Decision|0
77294|NCT01247090|300198|P2|Overall Study|Physician Decision|0
77295|NCT01247090|300199|P1|Overall Study|Physician Decision|1
77296|NCT01246999|300228|P4|Overall Study|Withdrawal by Subject|2
77297|NCT01246999|300229|P3|Overall Study|Withdrawal by Subject|0
77298|NCT01246999|300230|P2|Overall Study|Withdrawal by Subject|0
77299|NCT01246999|300231|P1|Overall Study|Withdrawal by Subject|0
77300|NCT01246999|300228|P4|Overall Study|Lost to Follow-up|0
77301|NCT01246999|300229|P3|Overall Study|Lost to Follow-up|0
77302|NCT01246999|300230|P2|Overall Study|Lost to Follow-up|1
77303|NCT01246999|300231|P1|Overall Study|Lost to Follow-up|0
77304|NCT01246973|300266|P2|Overall Study|Withdrawal by Subject|13
77305|NCT01246973|300267|P1|Overall Study|Withdrawal by Subject|7
77306|NCT01246973|300266|P2|Overall Study|Adverse Event|9
77307|NCT01246973|300267|P1|Overall Study|Adverse Event|16
77308|NCT01246973|300266|P2|Overall Study|Other|25
77309|NCT01246973|300267|P1|Overall Study|Other|38
77310|NCT01246960|300277|P2|Overall Study|Withdrawal (by participant or physician)|3
77311|NCT01246960|300278|P1|Overall Study|Withdrawal (by participant or physician)|3
77312|NCT01246960|300277|P2|Overall Study|Lost to Follow-up|1
77313|NCT01246960|300278|P1|Overall Study|Lost to Follow-up|3
77314|NCT01246206|300386|P1|Overall Study|Patient did not receive study regiments.|1
77315|NCT01246011|300409|P3|Overall Study|Withdrawal by Subject|1
77316|NCT01246011|300410|P2|Overall Study|Withdrawal by Subject|0
77317|NCT01246011|300411|P1|Overall Study|Withdrawal by Subject|0
77318|NCT01246011|300409|P3|Overall Study|If needed warfarin clinically, withdrawn|3
77319|NCT01246011|300410|P2|Overall Study|If needed warfarin clinically, withdrawn|0
77320|NCT01246011|300411|P1|Overall Study|If needed warfarin clinically, withdrawn|0
77321|NCT01245764|300426|P4|Study Phase A|Lost to Follow-up|0
77322|NCT01245764|300427|P3|Study Phase A|Lost to Follow-up|5
77323|NCT01245764|300428|P2|Study Phase A|Lost to Follow-up|0
77324|NCT01245764|300429|P1|Study Phase A|Lost to Follow-up|0
77325|NCT01245764|300426|P4|Study Phase A|Protocol Violation|2
77326|NCT01245764|300427|P3|Study Phase A|Protocol Violation|2
77327|NCT01245764|300428|P2|Study Phase A|Protocol Violation|3
77328|NCT01245764|300429|P1|Study Phase A|Protocol Violation|6
77329|NCT01245764|300426|P4|Study Phase A|Other|1
77330|NCT01245764|300427|P3|Study Phase A|Other|3
77331|NCT01245764|300428|P2|Study Phase A|Other|2
77332|NCT01245764|300429|P1|Study Phase A|Other|3
77333|NCT01245751|300467|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
77334|NCT01245751|300468|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
77335|NCT01245751|300469|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
77336|NCT01245751|300470|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
77337|NCT01245751|300467|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
77338|NCT01245751|300468|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
77339|NCT01245751|300469|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
77340|NCT01245751|300470|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
77341|NCT01245751|300467|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
77342|NCT01245751|300468|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
77343|NCT01245751|300469|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
77344|NCT01245751|300470|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
77345|NCT01245387|300564|P1|Overall Study|Missing discontinuation status|369
77346|NCT01245387|300564|P1|Overall Study|Other|131
77347|NCT01245387|300564|P1|Overall Study|Death|3
77348|NCT01245387|300564|P1|Overall Study|Adverse Event|9
77349|NCT01245387|300564|P1|Overall Study|Lack of Efficacy|195
77350|NCT01245387|300564|P1|Overall Study|Lost to Follow-up|106
77351|NCT01245374|300613|P1|Overall Study|Withdrawal by Subject|3
77352|NCT01245374|300613|P1|Overall Study|Protocol Violation|1
77353|NCT01245283|300636|P3|Overall Study|Lost to Follow-up|11
77354|NCT01245283|300637|P2|Overall Study|Lost to Follow-up|11
77355|NCT01245283|300638|P1|Overall Study|Lost to Follow-up|14
77356|NCT01245140|300683|P2|Overall Study|Refused Treatment/Did Not Coopera|1
77357|NCT01245140|300684|P1|Overall Study|Refused Treatment/Did Not Coopera|0
77358|NCT01245140|300683|P2|Overall Study|Withdrawal by Subject|1
77359|NCT01245140|300684|P1|Overall Study|Withdrawal by Subject|0
77360|NCT01245140|300683|P2|Overall Study|Protocol Violation|1
77361|NCT01245140|300684|P1|Overall Study|Protocol Violation|0
77362|NCT01245140|300683|P2|Overall Study|Lack of Efficacy|4
77363|NCT01245140|300684|P1|Overall Study|Lack of Efficacy|2
77364|NCT01245140|300683|P2|Overall Study|Adverse Event|3
77365|NCT01245140|300684|P1|Overall Study|Adverse Event|1
77366|NCT01245101|300740|P2|Period 3 (Treatment)|Withdrawal by Subject|0
77367|NCT01245101|300741|P1|Period 3 (Treatment)|Withdrawal by Subject|1
77368|NCT01245101|300740|P2|Period 2 (Washout)|Withdrawal by Subject|0
77369|NCT01245101|300741|P1|Period 2 (Washout)|Withdrawal by Subject|1
77370|NCT01245101|300740|P2|Period 1 (Treatment)|Withdrawal by Subject|0
77371|NCT01245101|300741|P1|Period 1 (Treatment)|Withdrawal by Subject|2
77372|NCT01245062|300751|P3|Cross-over Phase|Study closed/ terminated|11
77373|NCT01245062|300752|P2|Cross-over Phase|Study closed/ terminated|0
77374|NCT01245062|300753|P1|Cross-over Phase|Study closed/ terminated|0
77375|NCT01245062|300751|P3|Cross-over Phase|Withdrew Consent|4
77376|NCT01245062|300752|P2|Cross-over Phase|Withdrew Consent|0
77377|NCT01245062|300753|P1|Cross-over Phase|Withdrew Consent|0
77378|NCT01245062|300751|P3|Cross-over Phase|Physician Decision|1
77379|NCT01245062|300752|P2|Cross-over Phase|Physician Decision|0
77380|NCT01245062|300753|P1|Cross-over Phase|Physician Decision|0
77381|NCT01245062|300751|P3|Cross-over Phase|Lost to Follow-up|1
77382|NCT01245062|300752|P2|Cross-over Phase|Lost to Follow-up|0
77383|NCT01245062|300753|P1|Cross-over Phase|Lost to Follow-up|0
77384|NCT01245062|300751|P3|Randomization and Crossover Phase|Study closed/ terminated|0
77385|NCT01245062|300752|P2|Randomization and Crossover Phase|Study closed/ terminated|14
77386|NCT01245062|300753|P1|Randomization and Crossover Phase|Study closed/ terminated|23
77387|NCT01245062|300751|P3|Randomization and Crossover Phase|Withdrew Consent|0
77388|NCT01245062|300752|P2|Randomization and Crossover Phase|Withdrew Consent|11
77389|NCT01245062|300753|P1|Randomization and Crossover Phase|Withdrew Consent|12
77390|NCT01245062|300751|P3|Randomization and Crossover Phase|Physician Decision|0
77391|NCT01245062|300752|P2|Randomization and Crossover Phase|Physician Decision|4
77392|NCT01245062|300753|P1|Randomization and Crossover Phase|Physician Decision|2
77393|NCT01245062|300751|P3|Randomization and Crossover Phase|Lost to Follow-up|0
77394|NCT01245062|300752|P2|Randomization and Crossover Phase|Lost to Follow-up|2
77395|NCT01245062|300753|P1|Randomization and Crossover Phase|Lost to Follow-up|4
77396|NCT01245049|300791|P2|Overall Study|Lost to Follow-up|2
77397|NCT01245049|300792|P1|Overall Study|Lost to Follow-up|1
77398|NCT01245049|300791|P2|Overall Study|Withdrawal by Subject|1
77399|NCT01245049|300792|P1|Overall Study|Withdrawal by Subject|0
77400|NCT01245049|300791|P2|Overall Study|Migrated/moved from study area|1
77401|NCT01245049|300792|P1|Overall Study|Migrated/moved from study area|0
77402|NCT01244984|300845|P3|Overall Study|Withdrawal by Subject|2
77403|NCT01244984|300846|P2|Overall Study|Withdrawal by Subject|2
77404|NCT01244984|300847|P1|Overall Study|Withdrawal by Subject|1
77405|NCT01244984|300845|P3|Overall Study|Protocol Defined Stopping Criteria|0
77406|NCT01244984|300846|P2|Overall Study|Protocol Defined Stopping Criteria|1
77407|NCT01244984|300847|P1|Overall Study|Protocol Defined Stopping Criteria|1
77408|NCT01244984|300845|P3|Overall Study|Protocol Violation|0
77409|NCT01244984|300846|P2|Overall Study|Protocol Violation|0
77410|NCT01244984|300847|P1|Overall Study|Protocol Violation|1
77411|NCT01244984|300845|P3|Overall Study|Adverse Event|2
77412|NCT01244984|300846|P2|Overall Study|Adverse Event|11
77413|NCT01244984|300847|P1|Overall Study|Adverse Event|2
77414|NCT01244906|300921|P1|Overall Study|Progression of disease post treatment|6
77415|NCT01244906|300921|P1|Overall Study|Death|2
77416|NCT01244893|300930|P2|1-Week Follow Up|Lost to Follow-up|0
77417|NCT01244893|300931|P1|1-Week Follow Up|Lost to Follow-up|1
77418|NCT01244893|300930|P2|Baseline|Protocol Violation|1
77419|NCT01244893|300931|P1|Baseline|Protocol Violation|0
77420|NCT01244828|300943|P1|Overall Study|Other reason (not specified)|1
77421|NCT01244828|300943|P1|Overall Study|Lost to Follow-up|2
77422|NCT01244828|300943|P1|Overall Study|Lack of Efficacy|7
77423|NCT01244828|300943|P1|Overall Study|Withdrawal by Subject|31
77424|NCT01244828|300943|P1|Overall Study|Adverse Event|37
77425|NCT01244815|300959|P4|Overall Study|Did Not Meet Protocol Eligibility|0
77426|NCT01244815|300960|P3|Overall Study|Did Not Meet Protocol Eligibility|0
77427|NCT01244815|300961|P2|Overall Study|Did Not Meet Protocol Eligibility|1
77428|NCT01244815|300962|P1|Overall Study|Did Not Meet Protocol Eligibility|0
77429|NCT01244815|300959|P4|Overall Study|Protocol Violation|1
77430|NCT01244815|300960|P3|Overall Study|Protocol Violation|3
77431|NCT01244815|300961|P2|Overall Study|Protocol Violation|4
77432|NCT01244815|300962|P1|Overall Study|Protocol Violation|7
77433|NCT01244815|300959|P4|Overall Study|Withdrawal by Subject|3
77434|NCT01244815|300960|P3|Overall Study|Withdrawal by Subject|0
77435|NCT01244815|300961|P2|Overall Study|Withdrawal by Subject|2
77436|NCT01244815|300962|P1|Overall Study|Withdrawal by Subject|0
77437|NCT01244815|300959|P4|Overall Study|Lost to Follow-up|2
77438|NCT01244815|300960|P3|Overall Study|Lost to Follow-up|3
77439|NCT01244815|300961|P2|Overall Study|Lost to Follow-up|2
77440|NCT01244815|300962|P1|Overall Study|Lost to Follow-up|3
77441|NCT01244815|300959|P4|Overall Study|Treatment Failure|1
77442|NCT01244815|300960|P3|Overall Study|Treatment Failure|0
77443|NCT01244815|300961|P2|Overall Study|Treatment Failure|0
77444|NCT01244815|300962|P1|Overall Study|Treatment Failure|0
77445|NCT01244815|300959|P4|Overall Study|Adverse Event|5
77446|NCT01244815|300960|P3|Overall Study|Adverse Event|5
77447|NCT01244815|300961|P2|Overall Study|Adverse Event|7
77448|NCT01244815|300962|P1|Overall Study|Adverse Event|4
77449|NCT01244815|300959|P4|Overall Study|Not Treated|0
77450|NCT01244815|300960|P3|Overall Study|Not Treated|0
77451|NCT01244815|300961|P2|Overall Study|Not Treated|1
77452|NCT01244815|300962|P1|Overall Study|Not Treated|0
77453|NCT01244620|301048|P4|Overall Study|Study terminated|4
77454|NCT01244620|301049|P3|Overall Study|Study terminated|4
77455|NCT01244620|301050|P2|Overall Study|Study terminated|4
77456|NCT01244620|301051|P1|Overall Study|Study terminated|4
77457|NCT01244516|301110|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
77458|NCT01244516|301111|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
77459|NCT01244516|301112|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
77460|NCT01244516|301110|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
77461|NCT01244516|301111|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
77462|NCT01244516|301112|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
77463|NCT01244516|301110|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
77464|NCT01244516|301111|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
77465|NCT01244516|301112|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
77466|NCT01244516|301110|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
77467|NCT01244516|301111|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
77468|NCT01244516|301112|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
77469|NCT01244516|301110|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
77470|NCT01244516|301111|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
77471|NCT01244516|301112|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
77472|NCT01244516|301110|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
77473|NCT01244516|301111|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
77474|NCT01244516|301112|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
77475|NCT01244516|301110|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
77476|NCT01244516|301111|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
77477|NCT01244516|301112|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
77478|NCT01244490|301133|P3|Overall Study|Not specified|1
77479|NCT01244490|301134|P2|Overall Study|Not specified|0
77480|NCT01244490|301135|P1|Overall Study|Not specified|0
77481|NCT01244490|301133|P3|Overall Study|Lost to Follow-up|3
77482|NCT01244490|301134|P2|Overall Study|Lost to Follow-up|6
77483|NCT01244490|301135|P1|Overall Study|Lost to Follow-up|0
77484|NCT01244490|301133|P3|Overall Study|Adverse Event|5
77485|NCT01244490|301134|P2|Overall Study|Adverse Event|9
77486|NCT01244490|301135|P1|Overall Study|Adverse Event|1
77487|NCT01244490|301133|P3|Overall Study|Withdrawal by Subject|9
77488|NCT01244490|301134|P2|Overall Study|Withdrawal by Subject|4
77489|NCT01244490|301135|P1|Overall Study|Withdrawal by Subject|4
77490|NCT01244490|301133|P3|Overall Study|Lack of Efficacy|5
77491|NCT01244490|301134|P2|Overall Study|Lack of Efficacy|5
77492|NCT01244490|301135|P1|Overall Study|Lack of Efficacy|14
77493|NCT01244425|301203|P2|Overall Study|Adverse Event|1
77494|NCT01244425|301204|P1|Overall Study|Adverse Event|1
77495|NCT01244425|301203|P2|Overall Study|Withdrawal by Subject|2
77496|NCT01244425|301204|P1|Overall Study|Withdrawal by Subject|2
77497|NCT01244126|301236|P3|Overall Study|Protocol Violation|9
77498|NCT01244126|301237|P2|Overall Study|Protocol Violation|3
77499|NCT01244126|301238|P1|Overall Study|Protocol Violation|3
77500|NCT01244061|301251|P2|Overall Study|Randomized but not treated|2
77501|NCT01244061|301252|P1|Overall Study|Randomized but not treated|2
77502|NCT01244061|301251|P2|Overall Study|Adverse Event|2
77503|NCT01244061|301252|P1|Overall Study|Adverse Event|5
77504|NCT01244061|301251|P2|Overall Study|Protocol Violation|1
77505|NCT01244061|301252|P1|Overall Study|Protocol Violation|1
77506|NCT01244061|301251|P2|Overall Study|Not specified|19
77507|NCT01244061|301252|P1|Overall Study|Not specified|8
77508|NCT01244061|301251|P2|Overall Study|Withdrawal by Subject|46
77509|NCT01244061|301252|P1|Overall Study|Withdrawal by Subject|29
77510|NCT01244061|301251|P2|Overall Study|Lost to Follow-up|30
77511|NCT01244061|301252|P1|Overall Study|Lost to Follow-up|34
77512|NCT01244061|301251|P2|Overall Study|Lack of Efficacy|3
77513|NCT01244061|301252|P1|Overall Study|Lack of Efficacy|1
77514|NCT01244061|301251|P2|Overall Study|Did not meet entrance criteria|0
77515|NCT01244061|301252|P1|Overall Study|Did not meet entrance criteria|1
77516|NCT01244061|301251|P2|Overall Study|Death|0
77517|NCT01244061|301252|P1|Overall Study|Death|1
77518|NCT01243944|301266|P2|Overall Study|Physician Decision|2
77519|NCT01243944|301267|P1|Overall Study|Physician Decision|2
77520|NCT01243944|301266|P2|Overall Study|Patient decision|5
77521|NCT01243944|301267|P1|Overall Study|Patient decision|6
77522|NCT01243944|301266|P2|Overall Study|Disease progression|1
77523|NCT01243944|301267|P1|Overall Study|Disease progression|5
77524|NCT01243944|301266|P2|Overall Study|Lack of Efficacy|98
77525|NCT01243944|301267|P1|Overall Study|Lack of Efficacy|0
77526|NCT01243944|301266|P2|Overall Study|Adverse Event|2
77527|NCT01243944|301267|P1|Overall Study|Adverse Event|4
77528|NCT01243892|301291|P2|Overall Study|Did not meet eligibility criteria|0
77529|NCT01243892|301292|P1|Overall Study|Did not meet eligibility criteria|2
77530|NCT01243775|301302|P1|Overall Study|Withdrawal by Subject|2
77531|NCT01243762|301316|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
77532|NCT01243762|301317|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
77533|NCT01243762|301318|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
77534|NCT01243762|301319|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
77535|NCT01243762|301320|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
77536|NCT01243762|301321|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
77537|NCT01243762|301322|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
77538|NCT01243762|301316|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
77539|NCT01243762|301317|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
77540|NCT01243762|301318|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
77541|NCT01243762|301319|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
77542|NCT01243762|301320|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
77543|NCT01243762|301321|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
77544|NCT01243762|301322|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
77545|NCT01243762|301316|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
77546|NCT01243762|301317|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
77547|NCT01243762|301318|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
77548|NCT01243762|301319|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
77549|NCT01243762|301320|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
77550|NCT01243762|301321|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
77551|NCT01243762|301322|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
77552|NCT01243762|301316|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
77553|NCT01243762|301317|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
77554|NCT01243762|301318|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
77555|NCT01243762|301319|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
77556|NCT01243762|301320|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
77557|NCT01243762|301321|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
77558|NCT01243762|301322|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
77559|NCT01243762|301316|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
77560|NCT01243762|301317|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
77561|NCT01243762|301318|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
77562|NCT01243762|301319|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
77563|NCT01243762|301320|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
77564|NCT01243762|301321|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
77565|NCT01243762|301322|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
77566|NCT01243762|301316|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
77567|NCT01243762|301317|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
77568|NCT01243762|301318|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
77569|NCT01243762|301319|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
77570|NCT01243762|301320|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
77571|NCT01243762|301321|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
77572|NCT01243762|301322|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
77573|NCT01243762|301316|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
77574|NCT01243762|301317|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
77575|NCT01243762|301318|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
77576|NCT01243762|301319|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
77577|NCT01243762|301320|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
77578|NCT01243762|301321|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
77579|NCT01243762|301322|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
77580|NCT01243762|301316|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
77581|NCT01243762|301317|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
77582|NCT01243762|301318|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
77583|NCT01243762|301319|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
77584|NCT01243762|301320|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
77585|NCT01243762|301321|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
77586|NCT01243762|301322|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
77587|NCT01243671|301341|P1|Overall Study|Not Specified|1
77588|NCT01243671|301341|P1|Overall Study|Anti-adalimumab antibody positive|1
77589|NCT01243671|301341|P1|Overall Study|Adverse Event|3
77590|NCT01243411|301418|P1|Overall Study|Other|8
77591|NCT01243411|301418|P1|Overall Study|Adverse Event|5
77592|NCT01243411|301418|P1|Overall Study|Lost to Follow-up|10
77593|NCT01243411|301418|P1|Overall Study|Withdrawal by Subject|18
77594|NCT01243242|301525|P2|Overall Study|non compliance|0
77595|NCT01243242|301526|P1|Overall Study|non compliance|1
77596|NCT01243242|301525|P2|Overall Study|sponsor decision|1
77597|NCT01243242|301526|P1|Overall Study|sponsor decision|0
77598|NCT01243242|301525|P2|Overall Study|Physician Decision|1
77599|NCT01243242|301526|P1|Overall Study|Physician Decision|0
77600|NCT01243242|301525|P2|Overall Study|Withdrawal by Subject|1
77601|NCT01243242|301526|P1|Overall Study|Withdrawal by Subject|1
77602|NCT01243242|301525|P2|Overall Study|Adverse Event|1
77603|NCT01243242|301526|P1|Overall Study|Adverse Event|1
77604|NCT01243177|301540|P2|Overall Study|Other Reason|12
77605|NCT01243177|301541|P1|Overall Study|Other Reason|11
77606|NCT01243177|301540|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
77607|NCT01243177|301541|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
77608|NCT01243177|301540|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
77609|NCT01243177|301541|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
77610|NCT01243177|301540|P2|Overall Study|AE, non-serious non-fatal|58
77611|NCT01243177|301541|P1|Overall Study|AE, non-serious non-fatal|40
77612|NCT01243177|301540|P2|Overall Study|SAE, non-fatal|9
77613|NCT01243177|301541|P1|Overall Study|SAE, non-fatal|7
77614|NCT01243177|301540|P2|Overall Study|AE, serious fatal|1
77615|NCT01243177|301541|P1|Overall Study|AE, serious fatal|0
77616|NCT01243177|301540|P2|Overall Study|Withdrawal by Subject|38
77617|NCT01243177|301541|P1|Overall Study|Withdrawal by Subject|46
77618|NCT01243177|301540|P2|Overall Study|Lost to Follow-up|18
77619|NCT01243177|301541|P1|Overall Study|Lost to Follow-up|15
77620|NCT01243177|301540|P2|Overall Study|Protocol Violation|10
77621|NCT01243177|301541|P1|Overall Study|Protocol Violation|11
77622|NCT01243177|301540|P2|Overall Study|Lack of Efficacy|31
77623|NCT01243177|301541|P1|Overall Study|Lack of Efficacy|47
77624|NCT01242813|301562|P1|Overall Study|Lost to Follow-up|2
77625|NCT01242748|301584|P2|Overall Study|Miscellaneous reasons|3
77626|NCT01242748|301585|P1|Overall Study|Miscellaneous reasons|8
77627|NCT01242748|301584|P2|Overall Study|Withdrawal by Subject|2
77628|NCT01242748|301585|P1|Overall Study|Withdrawal by Subject|10
77629|NCT01242748|301584|P2|Overall Study|Protocol Violation|0
77630|NCT01242748|301585|P1|Overall Study|Protocol Violation|1
77631|NCT01242748|301584|P2|Overall Study|Physician Decision|2
77632|NCT01242748|301585|P1|Overall Study|Physician Decision|3
77633|NCT01242748|301584|P2|Overall Study|Lost to Follow-up|2
77634|NCT01242748|301585|P1|Overall Study|Lost to Follow-up|6
77635|NCT01242748|301584|P2|Overall Study|Adverse Event|5
77636|NCT01242748|301585|P1|Overall Study|Adverse Event|10
77637|NCT01242514|301625|P3|Overall Study|Adverse Event|19
77638|NCT01242514|301626|P2|Overall Study|Adverse Event|18
77639|NCT01242514|301627|P1|Overall Study|Adverse Event|129
77640|NCT01242514|301625|P3|Overall Study|Lost to Follow-up|4
77641|NCT01242514|301626|P2|Overall Study|Lost to Follow-up|5
77642|NCT01242514|301627|P1|Overall Study|Lost to Follow-up|14
77643|NCT01242514|301625|P3|Overall Study|Dev. of study specific discont. criteria|5
77644|NCT01242514|301626|P2|Overall Study|Dev. of study specific discont. criteria|3
77645|NCT01242514|301627|P1|Overall Study|Dev. of study specific discont. criteria|21
77646|NCT01242514|301625|P3|Overall Study|Lack of therapeutic response|10
77647|NCT01242514|301626|P2|Overall Study|Lack of therapeutic response|16
77648|NCT01242514|301627|P1|Overall Study|Lack of therapeutic response|99
77649|NCT01242514|301625|P3|Overall Study|Severe non-compliance to protocol|1
77650|NCT01242514|301626|P2|Overall Study|Severe non-compliance to protocol|2
77651|NCT01242514|301627|P1|Overall Study|Severe non-compliance to protocol|5
77652|NCT01242514|301625|P3|Overall Study|Subject decision|2
77653|NCT01242514|301626|P2|Overall Study|Subject decision|8
77654|NCT01242514|301627|P1|Overall Study|Subject decision|33
77655|NCT01242514|301625|P3|Overall Study|e.g., project closure|171
77656|NCT01242514|301626|P2|Overall Study|e.g., project closure|305
77657|NCT01242514|301627|P1|Overall Study|e.g., project closure|1042
77658|NCT01242371|301646|P2|Overall Study|Protocol Violation|3
77659|NCT01242371|301647|P1|Overall Study|Protocol Violation|0
77660|NCT01242371|301646|P2|Overall Study|Withdrawal by Subject|2
77661|NCT01242371|301647|P1|Overall Study|Withdrawal by Subject|2
77662|NCT01242176|301653|P2|Washout Period of 7 Days|Non-compliant with protocol|0
77663|NCT01242176|301654|P1|Washout Period of 7 Days|Non-compliant with protocol|1
77664|NCT01242176|301653|P2|Washout Period of 7 Days|Adverse Event|2
77665|NCT01242176|301654|P1|Washout Period of 7 Days|Adverse Event|0
77666|NCT01242111|301664|P1|Overall Study|Did not consent to MOR-100 follow-up|1
77667|NCT01242111|301664|P1|Overall Study|Withdrawal by Subject|1
77668|NCT01242111|301664|P1|Overall Study|Adverse Event|1
77669|NCT01242085|301676|P3|Overall Study|medically unable to have surgery|0
77670|NCT01242085|301677|P2|Overall Study|medically unable to have surgery|5
77671|NCT01242085|301678|P1|Overall Study|medically unable to have surgery|4
77672|NCT01242085|301676|P3|Overall Study|Withdrawal by Subject|0
77673|NCT01242085|301677|P2|Overall Study|Withdrawal by Subject|2
77674|NCT01242085|301678|P1|Overall Study|Withdrawal by Subject|4
77675|NCT01242020|301688|P2|Overall Study|Failed screening|0
77676|NCT01242020|301689|P1|Overall Study|Failed screening|1
77677|NCT01242020|301688|P2|Overall Study|Withdrawal by Subject|0
77678|NCT01242020|301689|P1|Overall Study|Withdrawal by Subject|2
77679|NCT01241760|301719|P2|Overall Study|Not specified|1
77680|NCT01241760|301720|P1|Overall Study|Not specified|1
77681|NCT01241760|301719|P2|Overall Study|Switch To Commercially Available Medicat|4
77682|NCT01241760|301720|P1|Overall Study|Switch To Commercially Available Medicat|1
77683|NCT01241760|301719|P2|Overall Study|Withdrawal by Subject|13
77684|NCT01241760|301720|P1|Overall Study|Withdrawal by Subject|13
77685|NCT01241760|301719|P2|Overall Study|Lost to Follow-up|22
77686|NCT01241760|301720|P1|Overall Study|Lost to Follow-up|18
77687|NCT01241760|301719|P2|Overall Study|Adverse Event|0
77688|NCT01241760|301720|P1|Overall Study|Adverse Event|1
77689|NCT01241591|301743|P4|Overall Study|Adverse Event|4
77690|NCT01241591|301744|P3|Overall Study|Adverse Event|12
77691|NCT01241591|301745|P2|Overall Study|Adverse Event|11
77692|NCT01241591|301746|P1|Overall Study|Adverse Event|3
77693|NCT01241591|301743|P4|Overall Study|Not specified|1
77694|NCT01241591|301744|P3|Overall Study|Not specified|0
77695|NCT01241591|301745|P2|Overall Study|Not specified|1
77696|NCT01241591|301746|P1|Overall Study|Not specified|0
77697|NCT01241591|301743|P4|Overall Study|Withdrawal by Subject|2
77698|NCT01241591|301744|P3|Overall Study|Withdrawal by Subject|2
77699|NCT01241591|301745|P2|Overall Study|Withdrawal by Subject|4
77700|NCT01241591|301746|P1|Overall Study|Withdrawal by Subject|6
77701|NCT01241591|301743|P4|Overall Study|Screen Failure|0
77702|NCT01241591|301744|P3|Overall Study|Screen Failure|1
77703|NCT01241591|301745|P2|Overall Study|Screen Failure|2
77704|NCT01241591|301746|P1|Overall Study|Screen Failure|3
77705|NCT01241591|301743|P4|Overall Study|Lost to Follow-up|2
77706|NCT01241591|301744|P3|Overall Study|Lost to Follow-up|2
77707|NCT01241591|301745|P2|Overall Study|Lost to Follow-up|2
77708|NCT01241591|301746|P1|Overall Study|Lost to Follow-up|1
77709|NCT01241591|301743|P4|Overall Study|Protocol Violation|0
77710|NCT01241591|301744|P3|Overall Study|Protocol Violation|3
77711|NCT01241591|301745|P2|Overall Study|Protocol Violation|2
77712|NCT01241591|301746|P1|Overall Study|Protocol Violation|5
77713|NCT01241591|301743|P4|Overall Study|Lack of Efficacy|3
77714|NCT01241591|301744|P3|Overall Study|Lack of Efficacy|2
77715|NCT01241591|301745|P2|Overall Study|Lack of Efficacy|2
77716|NCT01241591|301746|P1|Overall Study|Lack of Efficacy|5
77717|NCT01241552|301949|P4|Overall Study|Lost to Follow-up|16
77718|NCT01241552|301950|P3|Overall Study|Lost to Follow-up|15
77719|NCT01241552|301951|P2|Overall Study|Lost to Follow-up|11
77720|NCT01241552|301952|P1|Overall Study|Lost to Follow-up|2
77721|NCT01241552|301949|P4|Overall Study|Physician Decision|3
77722|NCT01241552|301950|P3|Overall Study|Physician Decision|2
77723|NCT01241552|301951|P2|Overall Study|Physician Decision|4
77724|NCT01241552|301952|P1|Overall Study|Physician Decision|2
77725|NCT01241552|301949|P4|Overall Study|Withdrawal by Subject|15
77726|NCT01241552|301950|P3|Overall Study|Withdrawal by Subject|14
77727|NCT01241552|301951|P2|Overall Study|Withdrawal by Subject|15
77728|NCT01241552|301952|P1|Overall Study|Withdrawal by Subject|7
77729|NCT01241552|301949|P4|Overall Study|Protocol Violation|1
77730|NCT01241552|301950|P3|Overall Study|Protocol Violation|6
77731|NCT01241552|301951|P2|Overall Study|Protocol Violation|2
77732|NCT01241552|301952|P1|Overall Study|Protocol Violation|0
77733|NCT01241552|301949|P4|Overall Study|Progressive Disease|2
77734|NCT01241552|301950|P3|Overall Study|Progressive Disease|1
77735|NCT01241552|301951|P2|Overall Study|Progressive Disease|0
77736|NCT01241552|301952|P1|Overall Study|Progressive Disease|0
77737|NCT01241552|301949|P4|Overall Study|Technical Problems|2
77738|NCT01241552|301950|P3|Overall Study|Technical Problems|2
77739|NCT01241552|301951|P2|Overall Study|Technical Problems|0
77740|NCT01241552|301952|P1|Overall Study|Technical Problems|2
77741|NCT01241552|301949|P4|Overall Study|Adverse Event|0
77742|NCT01241552|301950|P3|Overall Study|Adverse Event|0
77743|NCT01241552|301951|P2|Overall Study|Adverse Event|1
77744|NCT01241552|301952|P1|Overall Study|Adverse Event|1
77745|NCT01241552|301949|P4|Overall Study|Death|25
77746|NCT01241552|301950|P3|Overall Study|Death|20
77747|NCT01241552|301951|P2|Overall Study|Death|30
77748|NCT01241552|301952|P1|Overall Study|Death|26
77749|NCT01241552|301949|P4|Overall Study|Lack of Efficacy|0
77750|NCT01241552|301950|P3|Overall Study|Lack of Efficacy|0
77751|NCT01241552|301951|P2|Overall Study|Lack of Efficacy|0
77752|NCT01241552|301952|P1|Overall Study|Lack of Efficacy|1
77753|NCT01241448|302049|P4|Overall Study|Excluded due to data integrity issues|2
77754|NCT01241448|302050|P3|Overall Study|Excluded due to data integrity issues|2
77755|NCT01241448|302051|P2|Overall Study|Excluded due to data integrity issues|2
77756|NCT01241448|302052|P1|Overall Study|Excluded due to data integrity issues|3
77757|NCT01241448|302049|P4|Overall Study|Withdrawal by Subject|6
77758|NCT01241448|302050|P3|Overall Study|Withdrawal by Subject|3
77759|NCT01241448|302051|P2|Overall Study|Withdrawal by Subject|5
77760|NCT01241448|302052|P1|Overall Study|Withdrawal by Subject|4
77761|NCT01241448|302049|P4|Overall Study|Sponsor Decision|6
77762|NCT01241448|302050|P3|Overall Study|Sponsor Decision|12
77763|NCT01241448|302051|P2|Overall Study|Sponsor Decision|14
77764|NCT01241448|302052|P1|Overall Study|Sponsor Decision|17
77765|NCT01241448|302049|P4|Overall Study|Protocol Violation|6
77766|NCT01241448|302050|P3|Overall Study|Protocol Violation|3
77767|NCT01241448|302051|P2|Overall Study|Protocol Violation|5
77768|NCT01241448|302052|P1|Overall Study|Protocol Violation|10
77769|NCT01241448|302049|P4|Overall Study|Physician Decision|0
77770|NCT01241448|302050|P3|Overall Study|Physician Decision|0
77771|NCT01241448|302051|P2|Overall Study|Physician Decision|2
77772|NCT01241448|302052|P1|Overall Study|Physician Decision|0
77773|NCT01241448|302049|P4|Overall Study|Lost to Follow-up|1
77774|NCT01241448|302050|P3|Overall Study|Lost to Follow-up|1
77775|NCT01241448|302051|P2|Overall Study|Lost to Follow-up|1
77776|NCT01241448|302052|P1|Overall Study|Lost to Follow-up|2
77777|NCT01241448|302049|P4|Overall Study|Adverse Event|2
77778|NCT01241448|302050|P3|Overall Study|Adverse Event|2
77779|NCT01241448|302051|P2|Overall Study|Adverse Event|0
77780|NCT01241448|302052|P1|Overall Study|Adverse Event|1
77781|NCT01241292|302118|P2|Overall Study|Participant Discontinued Treatment|2
77782|NCT01241292|302119|P1|Overall Study|Participant Discontinued Treatment|0
77783|NCT01241292|302118|P2|Overall Study|Study Drug Toxicity|1
77784|NCT01241292|302119|P1|Overall Study|Study Drug Toxicity|0
77785|NCT01241292|302118|P2|Overall Study|Disease Progression|0
77786|NCT01241292|302119|P1|Overall Study|Disease Progression|2
77787|NCT01241292|302118|P2|Overall Study|Administrative Reason by Sponsor|0
77788|NCT01241292|302119|P1|Overall Study|Administrative Reason by Sponsor|1
77789|NCT01241279|302143|P2|Overall Study|Lost to Follow-up|1
77790|NCT01241279|302144|P1|Overall Study|Lost to Follow-up|0
77791|NCT01241240|302154|P2|Overall Study|Personal Reasons|1
77792|NCT01241240|302155|P1|Overall Study|Personal Reasons|1
77793|NCT01241240|302154|P2|Overall Study|Lost to Follow-up|4
77794|NCT01241240|302155|P1|Overall Study|Lost to Follow-up|2
77795|NCT01241240|302154|P2|Overall Study|Adverse Event|4
77796|NCT01241240|302155|P1|Overall Study|Adverse Event|5
77797|NCT01240915|302173|P9|Overall Study|Insufficient Clinical Response|3
77798|NCT01240915|302174|P8|Overall Study|Insufficient Clinical Response|0
77799|NCT01240915|302175|P7|Overall Study|Insufficient Clinical Response|6
77800|NCT01240915|302176|P6|Overall Study|Insufficient Clinical Response|3
77801|NCT01240915|302177|P5|Overall Study|Insufficient Clinical Response|1
77802|NCT01240915|302178|P4|Overall Study|Insufficient Clinical Response|0
77803|NCT01240915|302179|P3|Overall Study|Insufficient Clinical Response|0
77804|NCT01240915|302180|P2|Overall Study|Insufficient Clinical Response|0
77805|NCT01240915|302181|P1|Overall Study|Insufficient Clinical Response|0
77806|NCT01240915|302173|P9|Overall Study|Other|0
77807|NCT01240915|302174|P8|Overall Study|Other|0
77808|NCT01240915|302175|P7|Overall Study|Other|0
77809|NCT01240915|302176|P6|Overall Study|Other|0
77810|NCT01240915|302177|P5|Overall Study|Other|2
77811|NCT01240915|302178|P4|Overall Study|Other|0
77812|NCT01240915|302179|P3|Overall Study|Other|0
77813|NCT01240915|302180|P2|Overall Study|Other|0
77814|NCT01240915|302181|P1|Overall Study|Other|0
77815|NCT01240915|302173|P9|Overall Study|Withdrawal by Subject|3
77816|NCT01240915|302174|P8|Overall Study|Withdrawal by Subject|3
77817|NCT01240915|302175|P7|Overall Study|Withdrawal by Subject|2
77818|NCT01240915|302176|P6|Overall Study|Withdrawal by Subject|4
77819|NCT01240915|302177|P5|Overall Study|Withdrawal by Subject|0
77820|NCT01240915|302178|P4|Overall Study|Withdrawal by Subject|2
77821|NCT01240915|302179|P3|Overall Study|Withdrawal by Subject|0
77822|NCT01240915|302180|P2|Overall Study|Withdrawal by Subject|1
77823|NCT01240915|302181|P1|Overall Study|Withdrawal by Subject|2
77824|NCT01240915|302173|P9|Overall Study|Lost to Follow-up|1
77825|NCT01240915|302174|P8|Overall Study|Lost to Follow-up|1
77826|NCT01240915|302175|P7|Overall Study|Lost to Follow-up|0
77827|NCT01240915|302176|P6|Overall Study|Lost to Follow-up|1
77828|NCT01240915|302177|P5|Overall Study|Lost to Follow-up|1
77829|NCT01240915|302178|P4|Overall Study|Lost to Follow-up|0
77830|NCT01240915|302179|P3|Overall Study|Lost to Follow-up|0
77831|NCT01240915|302180|P2|Overall Study|Lost to Follow-up|0
77832|NCT01240915|302181|P1|Overall Study|Lost to Follow-up|0
77833|NCT01240915|302173|P9|Overall Study|Adverse Event|1
77834|NCT01240915|302174|P8|Overall Study|Adverse Event|0
77835|NCT01240915|302175|P7|Overall Study|Adverse Event|0
77836|NCT01240915|302176|P6|Overall Study|Adverse Event|2
77837|NCT01240915|302177|P5|Overall Study|Adverse Event|0
77838|NCT01240915|302178|P4|Overall Study|Adverse Event|1
77839|NCT01240915|302179|P3|Overall Study|Adverse Event|0
77840|NCT01240915|302180|P2|Overall Study|Adverse Event|0
77841|NCT01240915|302181|P1|Overall Study|Adverse Event|0
77842|NCT01240863|302455|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
77843|NCT01240863|302456|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
77844|NCT01240863|302457|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
77845|NCT01240863|302455|P3|Double-blind Treatment Period (12 Weeks)|Not specified|5
77846|NCT01240863|302456|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
77847|NCT01240863|302457|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
77848|NCT01240863|302455|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
77849|NCT01240863|302456|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
77850|NCT01240863|302457|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
77851|NCT01240863|302455|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
77852|NCT01240863|302456|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
77853|NCT01240863|302457|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
77854|NCT01240863|302455|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
77855|NCT01240863|302456|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
77856|NCT01240863|302457|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
77857|NCT01240863|302455|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
77858|NCT01240863|302456|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
77859|NCT01240863|302457|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
77860|NCT01240863|302455|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
77861|NCT01240863|302456|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
77862|NCT01240863|302457|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
77863|NCT01240863|302455|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
77864|NCT01240863|302456|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
77865|NCT01240863|302457|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
77866|NCT01240863|302455|P3|Open-label Titration Period|Not specified|0
77867|NCT01240863|302456|P2|Open-label Titration Period|Not specified|0
77868|NCT01240863|302457|P1|Open-label Titration Period|Not specified|7
77869|NCT01240863|302455|P3|Open-label Titration Period|Dropped out prior to dosing|0
77870|NCT01240863|302456|P2|Open-label Titration Period|Dropped out prior to dosing|0
77871|NCT01240863|302457|P1|Open-label Titration Period|Dropped out prior to dosing|2
77872|NCT01240863|302455|P3|Open-label Titration Period|Noncompliance to study procedures|0
77873|NCT01240863|302456|P2|Open-label Titration Period|Noncompliance to study procedures|0
77874|NCT01240863|302457|P1|Open-label Titration Period|Noncompliance to study procedures|3
77875|NCT01240863|302455|P3|Open-label Titration Period|Noncompliance to study drug admin|0
77876|NCT01240863|302456|P2|Open-label Titration Period|Noncompliance to study drug admin|0
77877|NCT01240863|302457|P1|Open-label Titration Period|Noncompliance to study drug admin|3
77878|NCT01240863|302455|P3|Open-label Titration Period|Protocol Violation|0
77879|NCT01240863|302456|P2|Open-label Titration Period|Protocol Violation|0
77880|NCT01240863|302457|P1|Open-label Titration Period|Protocol Violation|7
77881|NCT01240863|302455|P3|Open-label Titration Period|Withdrawal by Subject|0
77882|NCT01240863|302456|P2|Open-label Titration Period|Withdrawal by Subject|0
77883|NCT01240863|302457|P1|Open-label Titration Period|Withdrawal by Subject|9
77884|NCT01240863|302455|P3|Open-label Titration Period|Lack of Efficacy|0
77885|NCT01240863|302456|P2|Open-label Titration Period|Lack of Efficacy|0
77886|NCT01240863|302457|P1|Open-label Titration Period|Lack of Efficacy|19
77887|NCT01240863|302455|P3|Open-label Titration Period|Adverse Event|0
77888|NCT01240863|302456|P2|Open-label Titration Period|Adverse Event|0
77889|NCT01240863|302457|P1|Open-label Titration Period|Adverse Event|47
77890|NCT01240811|302519|P3|Overall Study|Withdrawal by Subject|1
77891|NCT01240811|302520|P2|Overall Study|Withdrawal by Subject|0
77892|NCT01240811|302521|P1|Overall Study|Withdrawal by Subject|0
77893|NCT01240811|302519|P3|Overall Study|Physician Decision|0
77894|NCT01240811|302520|P2|Overall Study|Physician Decision|1
77895|NCT01240811|302521|P1|Overall Study|Physician Decision|0
77896|NCT01240785|302537|P2|Overall Study|Protocol Violation|3
77897|NCT01240785|302538|P1|Overall Study|Protocol Violation|0
77898|NCT01240785|302537|P2|Overall Study|Lost to Follow-up|0
77899|NCT01240785|302538|P1|Overall Study|Lost to Follow-up|1
77900|NCT01240746|302569|P3|Overall Study|Withdrawal by Subject|59
77901|NCT01240746|302570|P2|Overall Study|Withdrawal by Subject|13
77902|NCT01240746|302571|P1|Overall Study|Withdrawal by Subject|10
77903|NCT01240746|302569|P3|Overall Study|Protocol Violation|72
77904|NCT01240746|302570|P2|Overall Study|Protocol Violation|15
77905|NCT01240746|302571|P1|Overall Study|Protocol Violation|24
77906|NCT01240746|302569|P3|Overall Study|Lost to Follow-up|102
77907|NCT01240746|302570|P2|Overall Study|Lost to Follow-up|20
77908|NCT01240746|302571|P1|Overall Study|Lost to Follow-up|23
77909|NCT01240746|302569|P3|Overall Study|Adverse Event|10
77910|NCT01240746|302570|P2|Overall Study|Adverse Event|0
77911|NCT01240746|302571|P1|Overall Study|Adverse Event|2
77912|NCT01240590|302626|P5|Phase II|Refused further treatment|1
77913|NCT01240590|302627|P4|Phase II|Refused further treatment|2
77914|NCT01240590|302628|P3|Phase II|Refused further treatment|0
77915|NCT01240590|302629|P2|Phase II|Refused further treatment|0
77916|NCT01240590|302630|P1|Phase II|Refused further treatment|0
77917|NCT01240590|302626|P5|Phase I|Refused further treatment|0
77918|NCT01240590|302627|P4|Phase I|Refused further treatment|0
77919|NCT01240590|302628|P3|Phase I|Refused further treatment|3
77920|NCT01240590|302629|P2|Phase I|Refused further treatment|0
77921|NCT01240590|302630|P1|Phase I|Refused further treatment|0
77922|NCT01240551|302658|P2|Overall Study|Lost to Follow-up|1
77923|NCT01240551|302659|P1|Overall Study|Lost to Follow-up|1
77924|NCT01240551|302658|P2|Overall Study|Refused further treatment|2
77925|NCT01240551|302659|P1|Overall Study|Refused further treatment|3
77926|NCT01240382|302669|P2|Overall Study|Fear of adverse events|1
77927|NCT01240382|302670|P1|Overall Study|Fear of adverse events|0
77928|NCT01240382|302669|P2|Overall Study|Lack of Efficacy|2
77929|NCT01240382|302670|P1|Overall Study|Lack of Efficacy|0
77930|NCT01240382|302669|P2|Overall Study|Adverse Event|1
77931|NCT01240382|302670|P1|Overall Study|Adverse Event|2
77932|NCT01240356|302680|P2|Overall Study|MRI contraindication|0
77933|NCT01240356|302681|P1|Overall Study|MRI contraindication|1
77934|NCT01240356|302680|P2|Overall Study|Withdrawal by Subject|0
77935|NCT01240356|302681|P1|Overall Study|Withdrawal by Subject|2
77936|NCT01240200|302700|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
77937|NCT01240200|302701|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
77938|NCT01240135|302709|P2|Period Two, 14 Days of Wear|Adverse Event|1
77939|NCT01240135|302710|P1|Period Two, 14 Days of Wear|Adverse Event|0
77940|NCT01240135|302709|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
77941|NCT01240135|302710|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
77942|NCT01239992|302727|P1|Overall Study|Withdrawal by Subject|2
77943|NCT01239797|302736|P2|Treated Participants|Poor/Non-compliance|1
77944|NCT01239797|302737|P1|Treated Participants|Poor/Non-compliance|0
77945|NCT01239797|302736|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
77946|NCT01239797|302737|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
77947|NCT01239797|302736|P2|Treated Participants|Death|1
77948|NCT01239797|302737|P1|Treated Participants|Death|1
77949|NCT01239797|302736|P2|Treated Participants|Non-specified|11
77950|NCT01239797|302737|P1|Treated Participants|Non-specified|1
77951|NCT01239797|302736|P2|Treated Participants|Withdrawal by Subject|23
77952|NCT01239797|302737|P1|Treated Participants|Withdrawal by Subject|27
77953|NCT01239797|302736|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
77954|NCT01239797|302737|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
77955|NCT01239797|302736|P2|Treated Participants|Study Drug Toxicity|44
77956|NCT01239797|302737|P1|Treated Participants|Study Drug Toxicity|30
77957|NCT01239797|302736|P2|Treated Participants|Disease Progression|161
77958|NCT01239797|302737|P1|Treated Participants|Disease Progression|153
77959|NCT01239745|302745|P1|Overall Study|Adverse Event|1
77960|NCT01239745|302745|P1|Overall Study|Study terminated by sponsor|45
77961|NCT01239732|302756|P1|Overall Study|Other|19
77962|NCT01239732|302756|P1|Overall Study|Treatment failure|2
77963|NCT01239732|302756|P1|Overall Study|Investigator's decision|4
77964|NCT01239732|302756|P1|Overall Study|Study termination by sponsor|2
77965|NCT01239732|302756|P1|Overall Study|Participant non compliance|5
77966|NCT01239732|302756|P1|Overall Study|Protocol Violation|3
77967|NCT01239732|302756|P1|Overall Study|Adverse Event|6
77968|NCT01239732|302756|P1|Overall Study|Withdrawal by Subject|87
77969|NCT01239732|302756|P1|Overall Study|Death|226
77970|NCT01239732|302756|P1|Overall Study|Termination of study per protocol|667
77971|NCT01239680|302769|P2|Overall Study|Withdrawal by Subject|0
77972|NCT01239680|302770|P1|Overall Study|Withdrawal by Subject|2
77973|NCT01239394|302793|P1|Overall Study|Adverse Event|1
77974|NCT01239381|302800|P1|Overall Study|Withdrawal by Subject|1
77975|NCT01239381|302800|P1|Overall Study|Protocol Violation|1
77976|NCT01239342|302818|P2|Overall Study|Reason Unknown|1
77977|NCT01239342|302819|P1|Overall Study|Reason Unknown|1
77978|NCT01239342|302818|P2|Overall Study|Withdrawal by Subject|5
77979|NCT01239342|302819|P1|Overall Study|Withdrawal by Subject|1
77980|NCT01239342|302818|P2|Overall Study|Adverse Event|0
77981|NCT01239342|302819|P1|Overall Study|Adverse Event|1
77982|NCT01239316|302835|P1|Overall Study|Adverse Event|1
77983|NCT01239316|302835|P1|Overall Study|Progression/Relapse|11
77984|NCT01239121|302850|P3|Overall Study|Withdrawal by Subject|0
77985|NCT01239121|302851|P2|Overall Study|Withdrawal by Subject|4
77986|NCT01239121|302852|P1|Overall Study|Withdrawal by Subject|2
77987|NCT01239043|302874|P2|Overall Study|Protocol Violation|1
77988|NCT01239043|302875|P1|Overall Study|Protocol Violation|2
77989|NCT01238991|302903|P10|Overall Study|Admission to a nursing home|0
77990|NCT01238991|302904|P9|Overall Study|Admission to a nursing home|0
77991|NCT01238991|302905|P8|Overall Study|Admission to a nursing home|0
77992|NCT01238991|302906|P7|Overall Study|Admission to a nursing home|0
77993|NCT01238991|302907|P6|Overall Study|Admission to a nursing home|0
77994|NCT01238991|302908|P5|Overall Study|Admission to a nursing home|0
77995|NCT01238991|302909|P4|Overall Study|Admission to a nursing home|0
77996|NCT01238991|302910|P3|Overall Study|Admission to a nursing home|1
77997|NCT01238991|302911|P2|Overall Study|Admission to a nursing home|0
77998|NCT01238991|302912|P1|Overall Study|Admission to a nursing home|1
77999|NCT01238991|302903|P10|Overall Study|Caregiver's request|0
78000|NCT01238991|302904|P9|Overall Study|Caregiver's request|1
78001|NCT01238991|302905|P8|Overall Study|Caregiver's request|0
78002|NCT01238991|302906|P7|Overall Study|Caregiver's request|0
78003|NCT01238991|302907|P6|Overall Study|Caregiver's request|0
78004|NCT01238991|302908|P5|Overall Study|Caregiver's request|0
78005|NCT01238991|302909|P4|Overall Study|Caregiver's request|0
78006|NCT01238991|302910|P3|Overall Study|Caregiver's request|0
78007|NCT01238991|302911|P2|Overall Study|Caregiver's request|0
78008|NCT01238991|302912|P1|Overall Study|Caregiver's request|0
78009|NCT01238991|302903|P10|Overall Study|Study Terminated by Sponsor|2
78010|NCT01238991|302904|P9|Overall Study|Study Terminated by Sponsor|2
78011|NCT01238991|302905|P8|Overall Study|Study Terminated by Sponsor|4
78012|NCT01238991|302906|P7|Overall Study|Study Terminated by Sponsor|7
78013|NCT01238991|302907|P6|Overall Study|Study Terminated by Sponsor|0
78014|NCT01238991|302908|P5|Overall Study|Study Terminated by Sponsor|1
78015|NCT01238991|302909|P4|Overall Study|Study Terminated by Sponsor|0
78016|NCT01238991|302910|P3|Overall Study|Study Terminated by Sponsor|0
78017|NCT01238991|302911|P2|Overall Study|Study Terminated by Sponsor|0
78018|NCT01238991|302912|P1|Overall Study|Study Terminated by Sponsor|0
78019|NCT01238991|302903|P10|Overall Study|Withdrawal by Subject|0
78020|NCT01238991|302904|P9|Overall Study|Withdrawal by Subject|0
78021|NCT01238991|302905|P8|Overall Study|Withdrawal by Subject|0
78022|NCT01238991|302906|P7|Overall Study|Withdrawal by Subject|0
78023|NCT01238991|302907|P6|Overall Study|Withdrawal by Subject|0
78024|NCT01238991|302908|P5|Overall Study|Withdrawal by Subject|0
78025|NCT01238991|302909|P4|Overall Study|Withdrawal by Subject|0
78026|NCT01238991|302910|P3|Overall Study|Withdrawal by Subject|1
78027|NCT01238991|302911|P2|Overall Study|Withdrawal by Subject|0
78028|NCT01238991|302912|P1|Overall Study|Withdrawal by Subject|0
78029|NCT01238991|302903|P10|Overall Study|Lack of Efficacy|0
78030|NCT01238991|302904|P9|Overall Study|Lack of Efficacy|1
78031|NCT01238991|302905|P8|Overall Study|Lack of Efficacy|0
78032|NCT01238991|302906|P7|Overall Study|Lack of Efficacy|0
78033|NCT01238991|302907|P6|Overall Study|Lack of Efficacy|0
78034|NCT01238991|302908|P5|Overall Study|Lack of Efficacy|0
78035|NCT01238991|302909|P4|Overall Study|Lack of Efficacy|0
78036|NCT01238991|302910|P3|Overall Study|Lack of Efficacy|1
78037|NCT01238991|302911|P2|Overall Study|Lack of Efficacy|0
78038|NCT01238991|302912|P1|Overall Study|Lack of Efficacy|0
78039|NCT01238991|302903|P10|Overall Study|Death|0
78040|NCT01238991|302904|P9|Overall Study|Death|0
78041|NCT01238991|302905|P8|Overall Study|Death|0
78042|NCT01238991|302906|P7|Overall Study|Death|0
78043|NCT01238991|302907|P6|Overall Study|Death|0
78044|NCT01238991|302908|P5|Overall Study|Death|0
78045|NCT01238991|302909|P4|Overall Study|Death|1
78046|NCT01238991|302910|P3|Overall Study|Death|0
78047|NCT01238991|302911|P2|Overall Study|Death|0
78048|NCT01238991|302912|P1|Overall Study|Death|0
78049|NCT01238991|302903|P10|Overall Study|Adverse Event|0
78050|NCT01238991|302904|P9|Overall Study|Adverse Event|0
78051|NCT01238991|302905|P8|Overall Study|Adverse Event|1
78052|NCT01238991|302906|P7|Overall Study|Adverse Event|1
78053|NCT01238991|302907|P6|Overall Study|Adverse Event|0
78054|NCT01238991|302908|P5|Overall Study|Adverse Event|1
78055|NCT01238991|302909|P4|Overall Study|Adverse Event|1
78056|NCT01238991|302910|P3|Overall Study|Adverse Event|3
78057|NCT01238991|302911|P2|Overall Study|Adverse Event|0
78058|NCT01238991|302912|P1|Overall Study|Adverse Event|1
78059|NCT01238900|302999|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
78060|NCT01238900|302999|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
78061|NCT01238861|303013|P6|Overall Study|Withdrawal by Subject|9
78062|NCT01238861|303014|P5|Overall Study|Withdrawal by Subject|10
78063|NCT01238861|303015|P4|Overall Study|Withdrawal by Subject|8
78064|NCT01238861|303016|P3|Overall Study|Withdrawal by Subject|4
78065|NCT01238861|303017|P2|Overall Study|Withdrawal by Subject|5
78066|NCT01238861|303018|P1|Overall Study|Withdrawal by Subject|6
78067|NCT01238861|303013|P6|Overall Study|Adverse Event|0
78068|NCT01238861|303014|P5|Overall Study|Adverse Event|0
78069|NCT01238861|303015|P4|Overall Study|Adverse Event|0
78070|NCT01238861|303016|P3|Overall Study|Adverse Event|0
78071|NCT01238861|303017|P2|Overall Study|Adverse Event|1
78072|NCT01238861|303018|P1|Overall Study|Adverse Event|0
78073|NCT01238861|303013|P6|Overall Study|Lack of compliance|1
78074|NCT01238861|303014|P5|Overall Study|Lack of compliance|0
78075|NCT01238861|303015|P4|Overall Study|Lack of compliance|0
78076|NCT01238861|303016|P3|Overall Study|Lack of compliance|0
78077|NCT01238861|303017|P2|Overall Study|Lack of compliance|0
78078|NCT01238861|303018|P1|Overall Study|Lack of compliance|0
78079|NCT01238861|303013|P6|Overall Study|Serious adverse event|1
78080|NCT01238861|303014|P5|Overall Study|Serious adverse event|0
78081|NCT01238861|303015|P4|Overall Study|Serious adverse event|0
78082|NCT01238861|303016|P3|Overall Study|Serious adverse event|0
78083|NCT01238861|303017|P2|Overall Study|Serious adverse event|0
78084|NCT01238861|303018|P1|Overall Study|Serious adverse event|0
78085|NCT01238861|303013|P6|Overall Study|Unable to continue visits|1
78086|NCT01238861|303014|P5|Overall Study|Unable to continue visits|0
78087|NCT01238861|303015|P4|Overall Study|Unable to continue visits|1
78088|NCT01238861|303016|P3|Overall Study|Unable to continue visits|0
78089|NCT01238861|303017|P2|Overall Study|Unable to continue visits|0
78090|NCT01238861|303018|P1|Overall Study|Unable to continue visits|0
78091|NCT01238861|303013|P6|Overall Study|Personal problems|0
78092|NCT01238861|303014|P5|Overall Study|Personal problems|0
78093|NCT01238861|303015|P4|Overall Study|Personal problems|1
78094|NCT01238861|303016|P3|Overall Study|Personal problems|0
78095|NCT01238861|303017|P2|Overall Study|Personal problems|0
78096|NCT01238861|303018|P1|Overall Study|Personal problems|0
78097|NCT01238861|303013|P6|Overall Study|Strongyloides stercoralis antibodies +|0
78098|NCT01238861|303014|P5|Overall Study|Strongyloides stercoralis antibodies +|0
78099|NCT01238861|303015|P4|Overall Study|Strongyloides stercoralis antibodies +|1
78100|NCT01238861|303016|P3|Overall Study|Strongyloides stercoralis antibodies +|0
78101|NCT01238861|303017|P2|Overall Study|Strongyloides stercoralis antibodies +|0
78102|NCT01238861|303018|P1|Overall Study|Strongyloides stercoralis antibodies +|0
78103|NCT01238861|303013|P6|Overall Study|Subject moved out of state/area|0
78104|NCT01238861|303014|P5|Overall Study|Subject moved out of state/area|0
78105|NCT01238861|303015|P4|Overall Study|Subject moved out of state/area|1
78106|NCT01238861|303016|P3|Overall Study|Subject moved out of state/area|1
78107|NCT01238861|303017|P2|Overall Study|Subject moved out of state/area|0
78108|NCT01238861|303018|P1|Overall Study|Subject moved out of state/area|0
78109|NCT01238861|303013|P6|Overall Study|Subject traveled to Argentina by 1 year|0
78110|NCT01238861|303014|P5|Overall Study|Subject traveled to Argentina by 1 year|0
78111|NCT01238861|303015|P4|Overall Study|Subject traveled to Argentina by 1 year|0
78112|NCT01238861|303016|P3|Overall Study|Subject traveled to Argentina by 1 year|1
78113|NCT01238861|303017|P2|Overall Study|Subject traveled to Argentina by 1 year|0
78114|NCT01238861|303018|P1|Overall Study|Subject traveled to Argentina by 1 year|0
78115|NCT01238861|303013|P6|Overall Study|Incorrect enrollment/randomization|0
78116|NCT01238861|303014|P5|Overall Study|Incorrect enrollment/randomization|1
78117|NCT01238861|303015|P4|Overall Study|Incorrect enrollment/randomization|0
78118|NCT01238861|303016|P3|Overall Study|Incorrect enrollment/randomization|1
78119|NCT01238861|303017|P2|Overall Study|Incorrect enrollment/randomization|0
78120|NCT01238861|303018|P1|Overall Study|Incorrect enrollment/randomization|0
78121|NCT01238861|303013|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
78122|NCT01238861|303014|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
78123|NCT01238861|303015|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
78124|NCT01238861|303016|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
78125|NCT01238861|303017|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
78126|NCT01238861|303018|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
78127|NCT01238861|303013|P6|Overall Study|Unplanned surgery|0
78128|NCT01238861|303014|P5|Overall Study|Unplanned surgery|0
78129|NCT01238861|303015|P4|Overall Study|Unplanned surgery|0
78130|NCT01238861|303016|P3|Overall Study|Unplanned surgery|0
78131|NCT01238861|303017|P2|Overall Study|Unplanned surgery|0
78132|NCT01238861|303018|P1|Overall Study|Unplanned surgery|1
78133|NCT01238861|303013|P6|Overall Study|Lost to Follow-up|2
78134|NCT01238861|303014|P5|Overall Study|Lost to Follow-up|1
78135|NCT01238861|303015|P4|Overall Study|Lost to Follow-up|1
78136|NCT01238861|303016|P3|Overall Study|Lost to Follow-up|3
78137|NCT01238861|303017|P2|Overall Study|Lost to Follow-up|2
78138|NCT01238861|303018|P1|Overall Study|Lost to Follow-up|4
78139|NCT01238848|303098|P2|Overall Study|Physician Decision|5
78140|NCT01238848|303099|P1|Overall Study|Physician Decision|13
78141|NCT01238822|303107|P1|Overall Study|COULD NOT SWALLOW PILLS|3
78142|NCT01238588|303134|P1|Overall Study|Physician Decision|2
78143|NCT01238588|303134|P1|Overall Study|Withdrawal by Subject|1
78144|NCT01238575|303147|P2|Overall Study|Adverse Event|0
78145|NCT01238575|303148|P1|Overall Study|Adverse Event|2
78146|NCT01238575|303147|P2|Overall Study|Lack of Efficacy|4
78147|NCT01238575|303148|P1|Overall Study|Lack of Efficacy|2
78148|NCT01238211|303215|P1|Overall Study|Investigator/Patient Decision|3
78149|NCT01238211|303215|P1|Overall Study|Non-protocol treatment|4
78150|NCT01238211|303215|P1|Overall Study|Withdrawal by Subject|7
78151|NCT01238211|303215|P1|Overall Study|Relapse/Progression|2
78152|NCT01238211|303215|P1|Overall Study|Death|4
78153|NCT01238211|303215|P1|Overall Study|Adverse Event|7
78154|NCT01238211|303215|P1|Overall Study|Continues active treatment|31
78155|NCT01237678|303222|P3|Phase II|Randomized but were not treated|3
78156|NCT01237678|303223|P2|Phase II|Randomized but were not treated|4
78157|NCT01237678|303224|P1|Phase II|Randomized but were not treated|0
78158|NCT01237678|303222|P3|Phase II|Sponsor Decision/Study Closed|7
78159|NCT01237678|303223|P2|Phase II|Sponsor Decision/Study Closed|18
78160|NCT01237678|303224|P1|Phase II|Sponsor Decision/Study Closed|0
78161|NCT01237678|303222|P3|Phase II|Completed Cycles 4-6|21
78162|NCT01237678|303223|P2|Phase II|Completed Cycles 4-6|11
78163|NCT01237678|303224|P1|Phase II|Completed Cycles 4-6|0
78164|NCT01237678|303222|P3|Phase II|Withdrawal by Subject|5
78165|NCT01237678|303223|P2|Phase II|Withdrawal by Subject|1
78166|NCT01237678|303224|P1|Phase II|Withdrawal by Subject|0
78167|NCT01237678|303222|P3|Phase II|Lack of Efficacy|3
78168|NCT01237678|303223|P2|Phase II|Lack of Efficacy|25
78169|NCT01237678|303224|P1|Phase II|Lack of Efficacy|0
78170|NCT01237678|303222|P3|Phase II|Death|2
78171|NCT01237678|303223|P2|Phase II|Death|0
78172|NCT01237678|303224|P1|Phase II|Death|0
78173|NCT01237678|303222|P3|Phase II|Adverse Event|9
78174|NCT01237678|303223|P2|Phase II|Adverse Event|39
78175|NCT01237678|303224|P1|Phase II|Adverse Event|0
78176|NCT01237678|303222|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
78177|NCT01237678|303223|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
78178|NCT01237678|303224|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
78179|NCT01237678|303222|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
78180|NCT01237678|303223|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
78181|NCT01237678|303224|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
78182|NCT01237678|303222|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
78183|NCT01237678|303223|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
78184|NCT01237678|303224|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
78185|NCT01237678|303222|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
78186|NCT01237678|303223|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
78187|NCT01237678|303224|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
78188|NCT01237340|303272|P1|Overall Study|Early termination of the trial|36
78189|NCT01237340|303272|P1|Overall Study|Withdrawal by Subject|1
78190|NCT01237340|303272|P1|Overall Study|Adverse Event|3
78191|NCT01237327|303286|P2|Overall Study|Lost to Follow-up|0
78192|NCT01237327|303287|P1|Overall Study|Lost to Follow-up|3
78193|NCT01237327|303286|P2|Overall Study|Withdrawal by Subject|3
78194|NCT01237327|303287|P1|Overall Study|Withdrawal by Subject|1
78195|NCT01237327|303286|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
78196|NCT01237327|303287|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
78197|NCT01237327|303286|P2|Overall Study|Progression of Disease: Extension Study|13
78198|NCT01237327|303287|P1|Overall Study|Progression of Disease: Extension Study|15
78199|NCT01237327|303286|P2|Overall Study|Progression of Disease: Core Study|22
78200|NCT01237327|303287|P1|Overall Study|Progression of Disease: Core Study|18
78201|NCT01237327|303286|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
78202|NCT01237327|303287|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
78203|NCT01237327|303286|P2|Overall Study|Protocol Violation: Core Study|0
78204|NCT01237327|303287|P1|Overall Study|Protocol Violation: Core Study|1
78205|NCT01237223|303316|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
78206|NCT01237223|303317|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
78207|NCT01237223|303318|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
78208|NCT01237223|303319|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
78209|NCT01237223|303320|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
78210|NCT01237223|303321|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
78211|NCT01237223|303316|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
78212|NCT01237223|303317|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
78213|NCT01237223|303318|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
78214|NCT01237223|303319|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
78215|NCT01237223|303320|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
78216|NCT01237223|303321|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
78217|NCT01237223|303316|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
78218|NCT01237223|303317|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
78219|NCT01237223|303318|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
78220|NCT01237223|303319|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
78221|NCT01237223|303320|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
78222|NCT01237223|303321|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
78223|NCT01237223|303316|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
78224|NCT01237223|303317|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
78225|NCT01237223|303318|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
78226|NCT01237223|303319|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
78227|NCT01237223|303320|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
78228|NCT01237223|303321|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
78229|NCT01237223|303316|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
78230|NCT01237223|303317|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
78231|NCT01237223|303318|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
78232|NCT01237223|303319|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
78233|NCT01237223|303320|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
78234|NCT01237223|303321|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
78235|NCT01237223|303316|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
78236|NCT01237223|303317|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
78237|NCT01237223|303318|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
78238|NCT01237223|303319|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
78239|NCT01237223|303320|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
78240|NCT01237223|303321|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
78241|NCT01237223|303316|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
78242|NCT01237223|303317|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
78243|NCT01237223|303318|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
78244|NCT01237223|303319|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
78245|NCT01237223|303320|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
78246|NCT01237223|303321|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
78247|NCT01237223|303316|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
78248|NCT01237223|303317|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
78249|NCT01237223|303318|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
78250|NCT01237223|303319|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
78251|NCT01237223|303320|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
78252|NCT01237223|303321|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
78253|NCT01237223|303316|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
78254|NCT01237223|303317|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
78255|NCT01237223|303318|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
78256|NCT01237223|303319|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
78257|NCT01237223|303320|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
78258|NCT01237223|303321|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
78259|NCT01237223|303316|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
78260|NCT01237223|303317|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
78261|NCT01237223|303318|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
78262|NCT01237223|303319|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
78263|NCT01237223|303320|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
78264|NCT01237223|303321|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
78265|NCT01237054|303380|P1|Overall Study|imaging 10C0096|1
78266|NCT01236573|303445|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
78267|NCT01236573|303446|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78268|NCT01236573|303447|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78269|NCT01236573|303448|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78270|NCT01236573|303449|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78271|NCT01236573|303450|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78272|NCT01236573|303451|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78273|NCT01236573|303452|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78274|NCT01236573|303453|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78275|NCT01236573|303454|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78276|NCT01236573|303455|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
78277|NCT01236573|303445|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78278|NCT01236573|303446|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78279|NCT01236573|303447|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
78280|NCT01236573|303448|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78281|NCT01236573|303449|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78282|NCT01236573|303450|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78283|NCT01236573|303451|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78284|NCT01236573|303452|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78285|NCT01236573|303453|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78286|NCT01236573|303454|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78287|NCT01236573|303455|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
78288|NCT01236573|303445|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
78289|NCT01236573|303446|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
78290|NCT01236573|303447|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
78291|NCT01236573|303448|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
78292|NCT01236573|303449|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
78293|NCT01236573|303450|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
78294|NCT01236573|303451|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
78295|NCT01236573|303452|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
78296|NCT01236573|303453|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
78297|NCT01236573|303454|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
78298|NCT01236573|303455|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
78299|NCT01236534|303493|P2|Overall Study|Adverse Event|0
78300|NCT01236534|303494|P1|Overall Study|Adverse Event|3
78301|NCT01236365|303524|P2|Overall Study|Dropped at Randomization due to high LFT|0
78302|NCT01236365|303525|P1|Overall Study|Dropped at Randomization due to high LFT|1
78303|NCT01236365|303524|P2|Overall Study|Moved Out of State|0
78304|NCT01236365|303525|P1|Overall Study|Moved Out of State|1
78305|NCT01236365|303524|P2|Overall Study|Lost to Follow-up|2
78306|NCT01236365|303525|P1|Overall Study|Lost to Follow-up|0
78307|NCT01236339|303539|P2|Overall Study|Termination of study by sponsor|13
78308|NCT01236339|303540|P1|Overall Study|Termination of study by sponsor|11
78309|NCT01236118|303608|P3|Overall Study|Withdrawal by Subject|1
78310|NCT01236118|303609|P2|Overall Study|Withdrawal by Subject|0
78311|NCT01236118|303610|P1|Overall Study|Withdrawal by Subject|0
78312|NCT01236118|303608|P3|Overall Study|Physician Decision|0
78313|NCT01236118|303609|P2|Overall Study|Physician Decision|1
78314|NCT01236118|303610|P1|Overall Study|Physician Decision|0
78315|NCT01236118|303608|P3|Overall Study|Adverse Event|2
78316|NCT01236118|303609|P2|Overall Study|Adverse Event|0
78317|NCT01236118|303610|P1|Overall Study|Adverse Event|2
78318|NCT01236001|303811|P2|Overall Study|Planned Visit After End of Study|1
78319|NCT01236001|303812|P1|Overall Study|Planned Visit After End of Study|0
78320|NCT01236001|303811|P2|Overall Study|Incompliance|0
78321|NCT01236001|303812|P1|Overall Study|Incompliance|1
78322|NCT01236001|303811|P2|Overall Study|Lost to Follow-up|1
78323|NCT01236001|303812|P1|Overall Study|Lost to Follow-up|6
78324|NCT01236001|303811|P2|Overall Study|Lack of Efficacy|6
78325|NCT01236001|303812|P1|Overall Study|Lack of Efficacy|6
78326|NCT01236001|303811|P2|Overall Study|Adverse Event|14
78327|NCT01236001|303812|P1|Overall Study|Adverse Event|5
78328|NCT01235975|303844|P2|Overall Study|Lost to Follow-up|3
78329|NCT01235975|303845|P1|Overall Study|Lost to Follow-up|7
78330|NCT01235975|303844|P2|Overall Study|Migrated/moved from study area|1
78331|NCT01235975|303845|P1|Overall Study|Migrated/moved from study area|2
78332|NCT01235975|303844|P2|Overall Study|Withdrawal by Subject|2
78333|NCT01235975|303845|P1|Overall Study|Withdrawal by Subject|8
78334|NCT01235975|303844|P2|Overall Study|Serious Adverse Event|1
78335|NCT01235975|303845|P1|Overall Study|Serious Adverse Event|0
78336|NCT01235741|303900|P3|Follow-Up Post Treatment up to Month 6|not specified|0
78337|NCT01235741|303901|P2|Follow-Up Post Treatment up to Month 6|not specified|1
78338|NCT01235741|303902|P1|Follow-Up Post Treatment up to Month 6|not specified|0
78339|NCT01235741|303900|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
78340|NCT01235741|303901|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
78341|NCT01235741|303902|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
78342|NCT01235741|303900|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
78343|NCT01235741|303901|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
78344|NCT01235741|303902|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
78345|NCT01235741|303900|P3|Randomized to Treatment|Sponsor terminated study|34
78346|NCT01235741|303901|P2|Randomized to Treatment|Sponsor terminated study|35
78347|NCT01235741|303902|P1|Randomized to Treatment|Sponsor terminated study|0
78348|NCT01235741|303900|P3|Randomized to Treatment|Adverse Event|1
78349|NCT01235741|303901|P2|Randomized to Treatment|Adverse Event|1
78350|NCT01235741|303902|P1|Randomized to Treatment|Adverse Event|0
78351|NCT01235741|303900|P3|Randomized to Treatment|Withdrawal by Subject|1
78352|NCT01235741|303901|P2|Randomized to Treatment|Withdrawal by Subject|0
78353|NCT01235741|303902|P1|Randomized to Treatment|Withdrawal by Subject|0
78354|NCT01235741|303900|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
78355|NCT01235741|303901|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
78356|NCT01235741|303902|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
78357|NCT01235741|303900|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
78358|NCT01235741|303901|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
78359|NCT01235741|303902|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
78360|NCT01235741|303900|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
78361|NCT01235741|303901|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
78362|NCT01235741|303902|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
78363|NCT01235741|303900|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
78364|NCT01235741|303901|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
78365|NCT01235741|303902|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
78366|NCT01235741|303900|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
78367|NCT01235741|303901|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
78368|NCT01235741|303902|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
78369|NCT01235741|303900|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
78370|NCT01235741|303901|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
78371|NCT01235741|303902|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
78372|NCT01235728|303929|P8|Overall Study|Protocol Violation|0
78373|NCT01235728|303930|P7|Overall Study|Protocol Violation|0
78374|NCT01235728|303931|P6|Overall Study|Protocol Violation|0
78375|NCT01235728|303932|P5|Overall Study|Protocol Violation|0
78376|NCT01235728|303933|P4|Overall Study|Protocol Violation|1
78377|NCT01235728|303934|P3|Overall Study|Protocol Violation|0
78378|NCT01235728|303935|P2|Overall Study|Protocol Violation|0
78379|NCT01235728|303936|P1|Overall Study|Protocol Violation|0
78380|NCT01235715|303946|P2|Overall Study|Physician Decision|2
78381|NCT01235715|303947|P1|Overall Study|Physician Decision|0
78382|NCT01235689|303987|P2|Overall Study|Miscellaneous|5
78383|NCT01235689|303988|P1|Overall Study|Miscellaneous|1
78384|NCT01235689|303987|P2|Overall Study|Lost to Follow-up|2
78385|NCT01235689|303988|P1|Overall Study|Lost to Follow-up|1
78386|NCT01235689|303987|P2|Overall Study|Withdrawal by Subject|4
78387|NCT01235689|303988|P1|Overall Study|Withdrawal by Subject|3
78388|NCT01235689|303987|P2|Overall Study|Lack of Efficacy|5
78389|NCT01235689|303988|P1|Overall Study|Lack of Efficacy|12
78390|NCT01235689|303987|P2|Overall Study|Adverse Event|16
78391|NCT01235689|303988|P1|Overall Study|Adverse Event|12
78392|NCT01235598|304060|P2|Overall Study|Withdrawal by Subject|0
78393|NCT01235598|304061|P1|Overall Study|Withdrawal by Subject|1
78394|NCT01235598|304060|P2|Overall Study|Lack of Efficacy|1
78395|NCT01235598|304061|P1|Overall Study|Lack of Efficacy|0
78396|NCT01235598|304060|P2|Overall Study|Adverse Event|3
78397|NCT01235598|304061|P1|Overall Study|Adverse Event|0
78398|NCT01235546|304106|P2|Overall Study|Protocol Violation|1
78399|NCT01235546|304107|P1|Overall Study|Protocol Violation|1
78400|NCT01235546|304106|P2|Overall Study|Staff error, medication not administered|0
78401|NCT01235546|304107|P1|Overall Study|Staff error, medication not administered|1
78402|NCT01235507|304131|P1|Overall Study|Withdrawal by Subject|1
78403|NCT01235507|304131|P1|Overall Study|Adverse Event|1
78404|NCT01235442|304145|P2|Overall Study|Other unspecified|2
78405|NCT01235442|304146|P1|Overall Study|Other unspecified|1
78406|NCT01235442|304145|P2|Overall Study|Administrative decision|2
78407|NCT01235442|304146|P1|Overall Study|Administrative decision|1
78408|NCT01235442|304145|P2|Overall Study|Noncompliance|2
78409|NCT01235442|304146|P1|Overall Study|Noncompliance|1
78410|NCT01235442|304145|P2|Overall Study|Lack of Efficacy|3
78411|NCT01235442|304146|P1|Overall Study|Lack of Efficacy|1
78412|NCT01235442|304145|P2|Overall Study|Withdrawal by Subject|9
78413|NCT01235442|304146|P1|Overall Study|Withdrawal by Subject|15
78414|NCT01235442|304145|P2|Overall Study|Adverse Event|6
78415|NCT01235442|304146|P1|Overall Study|Adverse Event|4
78416|NCT01235442|304145|P2|Overall Study|Protocol Violation|3
78417|NCT01235442|304146|P1|Overall Study|Protocol Violation|3
78418|NCT01235442|304145|P2|Overall Study|Ineligibility determined|4
78419|NCT01235442|304146|P1|Overall Study|Ineligibility determined|5
78420|NCT01235442|304145|P2|Overall Study|Pregnancy|1
78421|NCT01235442|304146|P1|Overall Study|Pregnancy|1
78422|NCT01235442|304145|P2|Overall Study|Death|2
78423|NCT01235442|304146|P1|Overall Study|Death|0
78424|NCT01235442|304145|P2|Overall Study|Lost to Follow-up|10
78425|NCT01235442|304146|P1|Overall Study|Lost to Follow-up|12
78426|NCT01235403|304164|P1|Overall Study|Other reasons for premature termination|4
78427|NCT01235403|304164|P1|Overall Study|Lack of Efficacy|2
78428|NCT01235403|304164|P1|Overall Study|Withdrawal by Subject|4
78429|NCT01235403|304164|P1|Overall Study|Lost to Follow-up|2
78430|NCT01235403|304164|P1|Overall Study|Adverse Event|14
78431|NCT01235338|304181|P2|Overall Study|Prohibited meds|0
78432|NCT01235338|304182|P1|Overall Study|Prohibited meds|1
78433|NCT01235338|304181|P2|Overall Study|Positive drug screen|1
78434|NCT01235338|304182|P1|Overall Study|Positive drug screen|0
78435|NCT01235338|304181|P2|Overall Study|Exclusion criteria violations|1
78436|NCT01235338|304182|P1|Overall Study|Exclusion criteria violations|1
78437|NCT01235338|304181|P2|Overall Study|Withdrawal by Subject|0
78438|NCT01235338|304182|P1|Overall Study|Withdrawal by Subject|5
78439|NCT01235338|304181|P2|Overall Study|Protocol Violation|1
78440|NCT01235338|304182|P1|Overall Study|Protocol Violation|1
78441|NCT01235338|304181|P2|Overall Study|Adverse Event|2
78442|NCT01235338|304182|P1|Overall Study|Adverse Event|3
78443|NCT01235234|304227|P3|Overall Study|Adverse Event|1
78444|NCT01235234|304228|P2|Overall Study|Adverse Event|2
78445|NCT01235234|304229|P1|Overall Study|Adverse Event|2
78446|NCT01234883|304277|P2|Overall Study|Inclusion/exclusion failure|0
78447|NCT01234883|304278|P1|Overall Study|Inclusion/exclusion failure|1
78448|NCT01234883|304277|P2|Overall Study|Technical difficulties with IV infusion|1
78449|NCT01234883|304278|P1|Overall Study|Technical difficulties with IV infusion|0
78450|NCT01234883|304277|P2|Overall Study|Parent/guardian withdrew consent|2
78451|NCT01234883|304278|P1|Overall Study|Parent/guardian withdrew consent|1
78452|NCT01234883|304277|P2|Overall Study|Early treatment release|10
78453|NCT01234883|304278|P1|Overall Study|Early treatment release|8
78454|NCT01234675|304325|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
78455|NCT01234675|304326|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
78456|NCT01234675|304325|P2|First Intervention (6 Weeks)|Adverse Event|1
78457|NCT01234675|304326|P1|First Intervention (6 Weeks)|Adverse Event|0
78458|NCT01234467|304340|P1|Overall Study|Other complicating disease (stroke)|1
78459|NCT01234467|304340|P1|Overall Study|Physician Decision|1
78460|NCT01234467|304340|P1|Overall Study|Clinical deterioration|1
78461|NCT01234467|304340|P1|Overall Study|Disease Progression|2
78462|NCT01234467|304340|P1|Overall Study|Withdrawal by Subject|2
78463|NCT01234467|304340|P1|Overall Study|Death|2
78464|NCT01234467|304340|P1|Overall Study|Adverse Event|3
78465|NCT01234337|304351|P2|Overall Study|Withdrawal by Subject|7
78466|NCT01234337|304352|P1|Overall Study|Withdrawal by Subject|11
78467|NCT01234337|304351|P2|Overall Study|Protocol Violation|3
78468|NCT01234337|304352|P1|Overall Study|Protocol Violation|2
78469|NCT01234337|304351|P2|Overall Study|Lost to Follow-up|1
78470|NCT01234337|304352|P1|Overall Study|Lost to Follow-up|0
78471|NCT01234337|304351|P2|Overall Study|Randomized but not Treated|4
78472|NCT01234337|304352|P1|Overall Study|Randomized but not Treated|6
78473|NCT01234337|304351|P2|Overall Study|Non-compliant with study medication|2
78474|NCT01234337|304352|P1|Overall Study|Non-compliant with study medication|3
78475|NCT01234337|304351|P2|Overall Study|InvestigatorDecision notProtocolDriven|3
78476|NCT01234337|304352|P1|Overall Study|InvestigatorDecision notProtocolDriven|4
78477|NCT01234337|304351|P2|Overall Study|Ongoing|24
78478|NCT01234337|304352|P1|Overall Study|Ongoing|16
78479|NCT01234337|304351|P2|Overall Study|Adverse Event|20
78480|NCT01234337|304352|P1|Overall Study|Adverse Event|55
78481|NCT01233999|304412|P1|Overall Study|Lost to Follow-up|1
78482|NCT01233999|304412|P1|Overall Study|Withdrawal by Subject|1
78483|NCT01233869|304431|P4|Extended Treatment Period (46 Months)|Adverse Event|1
78484|NCT01233869|304432|P3|Extended Treatment Period (46 Months)|Adverse Event|0
78485|NCT01233869|304433|P2|Extended Treatment Period (46 Months)|Adverse Event|0
78486|NCT01233869|304434|P1|Extended Treatment Period (46 Months)|Adverse Event|1
78487|NCT01233869|304431|P4|Extended Treatment Period (46 Months)|Other|3
78488|NCT01233869|304432|P3|Extended Treatment Period (46 Months)|Other|0
78489|NCT01233869|304433|P2|Extended Treatment Period (46 Months)|Other|0
78490|NCT01233869|304434|P1|Extended Treatment Period (46 Months)|Other|3
78491|NCT01233869|304431|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
78492|NCT01233869|304432|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
78493|NCT01233869|304433|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
78494|NCT01233869|304434|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
78495|NCT01233869|304431|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
78496|NCT01233869|304432|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
78497|NCT01233869|304433|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
78498|NCT01233869|304434|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
78499|NCT01233869|304431|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
78500|NCT01233869|304432|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
78667|NCT01232296|305019|P1|Overall Study|Physician Decision|1
78501|NCT01233869|304433|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
78502|NCT01233869|304434|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
78503|NCT01233869|304431|P4|Initial Treatment Period (24 Months)|Adverse Event|3
78504|NCT01233869|304432|P3|Initial Treatment Period (24 Months)|Adverse Event|0
78505|NCT01233869|304433|P2|Initial Treatment Period (24 Months)|Adverse Event|17
78506|NCT01233869|304434|P1|Initial Treatment Period (24 Months)|Adverse Event|9
78507|NCT01233869|304431|P4|Initial Treatment Period (24 Months)|Death|0
78508|NCT01233869|304432|P3|Initial Treatment Period (24 Months)|Death|0
78509|NCT01233869|304433|P2|Initial Treatment Period (24 Months)|Death|0
78510|NCT01233869|304434|P1|Initial Treatment Period (24 Months)|Death|1
78511|NCT01233817|304520|P1|Overall Study|Withdrawal by Subject|2
78512|NCT01233817|304520|P1|Overall Study|Lost to Follow-up|1
78513|NCT01233687|304567|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
78514|NCT01233687|304567|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
78515|NCT01233687|304567|P1|Phase II AMG 102 + Erlotinib|Death|1
78516|NCT01233609|304577|P2|Overall Study|Withdrawal by Subject|0
78517|NCT01233609|304578|P1|Overall Study|Withdrawal by Subject|3
78518|NCT01233609|304577|P2|Overall Study|Adverse Event|1
78519|NCT01233609|304578|P1|Overall Study|Adverse Event|2
78520|NCT01233609|304577|P2|Overall Study|Lost to Follow-up|1
78521|NCT01233609|304578|P1|Overall Study|Lost to Follow-up|3
78522|NCT01233609|304577|P2|Overall Study|Death|0
78523|NCT01233609|304578|P1|Overall Study|Death|1
78524|NCT01233284|304602|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
78525|NCT01233284|304603|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
78526|NCT01233284|304604|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
78527|NCT01233284|304605|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
78528|NCT01233284|304606|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
78529|NCT01233284|304602|P5|Period 4 (4 Weeks)|Adverse Event|0
78530|NCT01233284|304603|P4|Period 4 (4 Weeks)|Adverse Event|0
78531|NCT01233284|304604|P3|Period 4 (4 Weeks)|Adverse Event|0
78532|NCT01233284|304605|P2|Period 4 (4 Weeks)|Adverse Event|1
78533|NCT01233284|304606|P1|Period 4 (4 Weeks)|Adverse Event|0
78534|NCT01233284|304602|P5|Period 3 (4 Weeks)|Other|0
78535|NCT01233284|304603|P4|Period 3 (4 Weeks)|Other|1
78536|NCT01233284|304604|P3|Period 3 (4 Weeks)|Other|0
78537|NCT01233284|304605|P2|Period 3 (4 Weeks)|Other|0
78538|NCT01233284|304606|P1|Period 3 (4 Weeks)|Other|0
78539|NCT01233284|304602|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
78540|NCT01233284|304603|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
78541|NCT01233284|304604|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
78542|NCT01233284|304605|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
78543|NCT01233284|304606|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
78544|NCT01233284|304602|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
78545|NCT01233284|304603|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
78546|NCT01233284|304604|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
78547|NCT01233284|304605|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
78548|NCT01233284|304606|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
78549|NCT01233284|304602|P5|Period 1 (4 Weeks)|Other|0
78550|NCT01233284|304603|P4|Period 1 (4 Weeks)|Other|0
78551|NCT01233284|304604|P3|Period 1 (4 Weeks)|Other|1
78552|NCT01233284|304605|P2|Period 1 (4 Weeks)|Other|0
78553|NCT01233284|304606|P1|Period 1 (4 Weeks)|Other|0
78554|NCT01233284|304602|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
78555|NCT01233284|304603|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
78556|NCT01233284|304604|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
78557|NCT01233284|304605|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
78558|NCT01233284|304606|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
78559|NCT01233284|304602|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
78560|NCT01233284|304603|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
78561|NCT01233284|304604|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
78562|NCT01233284|304605|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
78563|NCT01233284|304606|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
78564|NCT01233258|304687|P6|First Intervention (6 Months)|Non-compliance with study medication|0
78565|NCT01233258|304688|P5|First Intervention (6 Months)|Non-compliance with study medication|0
78566|NCT01233258|304689|P4|First Intervention (6 Months)|Non-compliance with study medication|0
78567|NCT01233258|304690|P3|First Intervention (6 Months)|Non-compliance with study medication|0
78568|NCT01233258|304691|P2|First Intervention (6 Months)|Non-compliance with study medication|0
78569|NCT01233258|304692|P1|First Intervention (6 Months)|Non-compliance with study medication|1
78570|NCT01233258|304687|P6|First Intervention (6 Months)|Protocol Violation|0
78571|NCT01233258|304688|P5|First Intervention (6 Months)|Protocol Violation|0
78572|NCT01233258|304689|P4|First Intervention (6 Months)|Protocol Violation|0
78573|NCT01233258|304690|P3|First Intervention (6 Months)|Protocol Violation|1
78574|NCT01233258|304691|P2|First Intervention (6 Months)|Protocol Violation|0
78575|NCT01233258|304692|P1|First Intervention (6 Months)|Protocol Violation|0
78576|NCT01233258|304687|P6|First Intervention (6 Months)|Withdrawal by Subject|1
78577|NCT01233258|304688|P5|First Intervention (6 Months)|Withdrawal by Subject|0
78578|NCT01233258|304689|P4|First Intervention (6 Months)|Withdrawal by Subject|1
78579|NCT01233258|304690|P3|First Intervention (6 Months)|Withdrawal by Subject|0
78580|NCT01233258|304691|P2|First Intervention (6 Months)|Withdrawal by Subject|0
78581|NCT01233258|304692|P1|First Intervention (6 Months)|Withdrawal by Subject|0
78582|NCT01233232|304712|P3|Overall Study|Voluntary Discontinuation by Subject|0
78583|NCT01233232|304713|P2|Overall Study|Voluntary Discontinuation by Subject|0
78584|NCT01233232|304714|P1|Overall Study|Voluntary Discontinuation by Subject|1
78585|NCT01233076|304767|P2|Period 2, One Week|Lost to Follow-up|0
78586|NCT01233076|304768|P1|Period 2, One Week|Lost to Follow-up|1
78587|NCT01233050|304776|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
78588|NCT01233050|304777|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
78589|NCT01232894|304810|P2|Overall Study|Physician Decision|1
78590|NCT01232894|304811|P1|Overall Study|Physician Decision|2
78591|NCT01232894|304810|P2|Overall Study|Withdrawal by Subject|5
78592|NCT01232894|304811|P1|Overall Study|Withdrawal by Subject|8
78593|NCT01232894|304810|P2|Overall Study|Protocol Violation|1
78594|NCT01232894|304811|P1|Overall Study|Protocol Violation|1
78595|NCT01232894|304810|P2|Overall Study|Death|0
78596|NCT01232894|304811|P1|Overall Study|Death|1
78597|NCT01232894|304810|P2|Overall Study|Lost to Follow-up|1
78598|NCT01232894|304811|P1|Overall Study|Lost to Follow-up|0
78599|NCT01232868|304819|P2|Overall Study|Lost to Follow-up|4
78600|NCT01232868|304820|P1|Overall Study|Lost to Follow-up|2
78601|NCT01232790|304834|P2|Second Crossover|Withdrawal by Subject|2
78602|NCT01232790|304835|P1|Second Crossover|Withdrawal by Subject|1
78603|NCT01232790|304834|P2|First Crossover|Withdrawal by Subject|0
78604|NCT01232790|304835|P1|First Crossover|Withdrawal by Subject|1
78605|NCT01232790|304834|P2|Initial Assessment|Withdrawal by Subject|1
78606|NCT01232790|304835|P1|Initial Assessment|Withdrawal by Subject|0
78607|NCT01232790|304834|P2|Randomization|Physician Decision|1
78608|NCT01232790|304835|P1|Randomization|Physician Decision|0
78609|NCT01232790|304834|P2|Randomization|Protocol Violation|1
78610|NCT01232790|304835|P1|Randomization|Protocol Violation|0
78611|NCT01232790|304834|P2|Randomization|Withdrawal by Subject|0
78612|NCT01232790|304835|P1|Randomization|Withdrawal by Subject|2
78613|NCT01232738|304889|P1|Overall Study|Adverse Event|5
78614|NCT01232738|304889|P1|Overall Study|Withdrawal by Subject|2
78615|NCT01232738|304889|P1|Overall Study|Lost to Follow-up|1
78616|NCT01232738|304889|P1|Overall Study|Physician Decision|2
78617|NCT01232738|304889|P1|Overall Study|Death|3
78618|NCT01232569|304905|P4|Double-blind Treatment Period|Death|0
78619|NCT01232569|304906|P3|Double-blind Treatment Period|Death|0
78620|NCT01232569|304907|P2|Double-blind Treatment Period|Death|0
78621|NCT01232569|304908|P1|Double-blind Treatment Period|Death|2
78622|NCT01232569|304905|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
78623|NCT01232569|304906|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
78624|NCT01232569|304907|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
78625|NCT01232569|304908|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
78626|NCT01232569|304905|P4|Double-blind Treatment Period|Physician Decision|0
78627|NCT01232569|304906|P3|Double-blind Treatment Period|Physician Decision|0
78628|NCT01232569|304907|P2|Double-blind Treatment Period|Physician Decision|0
78629|NCT01232569|304908|P1|Double-blind Treatment Period|Physician Decision|1
78630|NCT01232569|304905|P4|Double-blind Treatment Period|Lack of Efficacy|0
78631|NCT01232569|304906|P3|Double-blind Treatment Period|Lack of Efficacy|0
78632|NCT01232569|304907|P2|Double-blind Treatment Period|Lack of Efficacy|2
78633|NCT01232569|304908|P1|Double-blind Treatment Period|Lack of Efficacy|1
78634|NCT01232569|304905|P4|Double-blind Treatment Period|Lost to Follow-up|0
78635|NCT01232569|304906|P3|Double-blind Treatment Period|Lost to Follow-up|0
78636|NCT01232569|304907|P2|Double-blind Treatment Period|Lost to Follow-up|0
78637|NCT01232569|304908|P1|Double-blind Treatment Period|Lost to Follow-up|4
78638|NCT01232569|304905|P4|Double-blind Treatment Period|Escape|0
78639|NCT01232569|304906|P3|Double-blind Treatment Period|Escape|0
78640|NCT01232569|304907|P2|Double-blind Treatment Period|Escape|2
78641|NCT01232569|304908|P1|Double-blind Treatment Period|Escape|2
78642|NCT01232569|304905|P4|Double-blind Treatment Period|Withdrawal by Subject|0
78643|NCT01232569|304906|P3|Double-blind Treatment Period|Withdrawal by Subject|0
78644|NCT01232569|304907|P2|Double-blind Treatment Period|Withdrawal by Subject|2
78645|NCT01232569|304908|P1|Double-blind Treatment Period|Withdrawal by Subject|9
78646|NCT01232491|304988|P2|Overall Study|Other|18
78647|NCT01232491|304989|P1|Overall Study|Other|21
78648|NCT01232491|304988|P2|Overall Study|Withdrawal Criteria|21
78649|NCT01232491|304989|P1|Overall Study|Withdrawal Criteria|12
78650|NCT01232491|304988|P2|Overall Study|Protocol Violation|11
78651|NCT01232491|304989|P1|Overall Study|Protocol Violation|13
78652|NCT01232491|304988|P2|Overall Study|Lack of Efficacy|5
78653|NCT01232491|304989|P1|Overall Study|Lack of Efficacy|1
78654|NCT01232491|304988|P2|Overall Study|Adverse Event|8
78655|NCT01232491|304989|P1|Overall Study|Adverse Event|13
78656|NCT01232296|305018|P2|Overall Study|Death|6
78657|NCT01232296|305019|P1|Overall Study|Death|1
78658|NCT01232296|305018|P2|Overall Study|Subject/guardian decision|2
78659|NCT01232296|305019|P1|Overall Study|Subject/guardian decision|10
78660|NCT01232296|305018|P2|Overall Study|Technical problems|0
78661|NCT01232296|305019|P1|Overall Study|Technical problems|3
78662|NCT01232296|305018|P2|Overall Study|Study terminated by sponsor|1
78663|NCT01232296|305019|P1|Overall Study|Study terminated by sponsor|0
78664|NCT01232296|305018|P2|Overall Study|Progressive disease|61
78665|NCT01232296|305019|P1|Overall Study|Progressive disease|43
78666|NCT01232296|305018|P2|Overall Study|Physician Decision|1
78668|NCT01232296|305018|P2|Overall Study|Adverse Event|12
78669|NCT01232296|305019|P1|Overall Study|Adverse Event|24
78670|NCT01232283|305036|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
78671|NCT01232283|305037|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
78672|NCT01232283|305038|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
78673|NCT01232283|305039|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
78674|NCT01232283|305040|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
78675|NCT01232283|305041|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
78676|NCT01232283|305042|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
78677|NCT01232283|305043|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
78678|NCT01232283|305044|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
78679|NCT01232283|305045|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
78680|NCT01232283|305036|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
78681|NCT01232283|305037|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
78682|NCT01232283|305038|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
78683|NCT01232283|305039|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
78684|NCT01232283|305040|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
78685|NCT01232283|305041|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
78686|NCT01232283|305042|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
78687|NCT01232283|305043|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
78688|NCT01232283|305044|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
78689|NCT01232283|305045|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
78690|NCT01232283|305036|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
78691|NCT01232283|305037|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
78692|NCT01232283|305038|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
78693|NCT01232283|305039|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
78694|NCT01232283|305040|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
78695|NCT01232283|305041|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
78696|NCT01232283|305042|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
78697|NCT01232283|305043|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
78698|NCT01232283|305044|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
78699|NCT01232283|305045|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
78700|NCT01232283|305036|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
78701|NCT01232283|305037|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
78702|NCT01232283|305038|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
78703|NCT01232283|305039|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
78704|NCT01232283|305040|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
78705|NCT01232283|305041|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
78706|NCT01232283|305042|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
78707|NCT01232283|305043|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
78708|NCT01232283|305044|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
78709|NCT01232283|305045|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
78710|NCT01232283|305036|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
78711|NCT01232283|305037|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
78712|NCT01232283|305038|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
78713|NCT01232283|305039|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
78714|NCT01232283|305040|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
78715|NCT01232283|305041|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
78716|NCT01232283|305042|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
78717|NCT01232283|305043|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
78718|NCT01232283|305044|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
78719|NCT01232283|305045|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
78720|NCT01232283|305036|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
78721|NCT01232283|305037|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
78722|NCT01232283|305038|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
78723|NCT01232283|305039|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
78724|NCT01232283|305040|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
78725|NCT01232283|305041|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
78726|NCT01232283|305042|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
78727|NCT01232283|305043|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
78728|NCT01232283|305044|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
78729|NCT01232283|305045|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
78730|NCT01232283|305036|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
78731|NCT01232283|305037|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
78732|NCT01232283|305038|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
78733|NCT01232283|305039|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
78734|NCT01232283|305040|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
78735|NCT01232283|305041|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
78736|NCT01232283|305042|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
78737|NCT01232283|305043|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
79043|NCT01231581|305388|P2|Overall Study|Withdrawal by Subject|9
78738|NCT01232283|305044|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
78739|NCT01232283|305045|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
78740|NCT01232283|305036|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
78741|NCT01232283|305037|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
78742|NCT01232283|305038|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
78743|NCT01232283|305039|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
78744|NCT01232283|305040|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
78745|NCT01232283|305041|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
78746|NCT01232283|305042|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
78747|NCT01232283|305043|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
78748|NCT01232283|305044|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
78749|NCT01232283|305045|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
78750|NCT01232283|305036|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
78751|NCT01232283|305037|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
78752|NCT01232283|305038|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
78753|NCT01232283|305039|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
78754|NCT01232283|305040|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
78755|NCT01232283|305041|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
78756|NCT01232283|305042|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
78757|NCT01232283|305043|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
78758|NCT01232283|305044|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
78759|NCT01232283|305045|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
78760|NCT01232283|305036|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
78761|NCT01232283|305037|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
78762|NCT01232283|305038|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
78763|NCT01232283|305039|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
78764|NCT01232283|305040|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
78765|NCT01232283|305041|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
78766|NCT01232283|305042|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
78767|NCT01232283|305043|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
78768|NCT01232283|305044|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
78769|NCT01232283|305045|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
78770|NCT01232283|305036|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
78771|NCT01232283|305037|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
78772|NCT01232283|305038|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
78773|NCT01232283|305039|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
78774|NCT01232283|305040|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
78775|NCT01232283|305041|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
78776|NCT01232283|305042|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
78777|NCT01232283|305043|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
78778|NCT01232283|305044|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
78779|NCT01232283|305045|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
78780|NCT01232283|305036|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
78781|NCT01232283|305037|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
78782|NCT01232283|305038|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
78783|NCT01232283|305039|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
78784|NCT01232283|305040|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
78785|NCT01232283|305041|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
78786|NCT01232283|305042|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
78787|NCT01232283|305043|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
78788|NCT01232283|305044|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
78789|NCT01232283|305045|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
78790|NCT01232283|305036|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
78791|NCT01232283|305037|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
78792|NCT01232283|305038|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
78793|NCT01232283|305039|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
78794|NCT01232283|305040|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
78795|NCT01232283|305041|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
78796|NCT01232283|305042|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
78797|NCT01232283|305043|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
78798|NCT01232283|305044|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
78799|NCT01232283|305045|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
78800|NCT01232283|305036|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
78801|NCT01232283|305037|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
78802|NCT01232283|305038|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
78803|NCT01232283|305039|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
78804|NCT01232283|305040|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
78805|NCT01232283|305041|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
78806|NCT01232283|305042|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
78807|NCT01232283|305043|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
78808|NCT01232283|305044|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
78809|NCT01232283|305045|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
78810|NCT01232283|305036|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
78811|NCT01232283|305037|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
78812|NCT01232283|305038|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
78813|NCT01232283|305039|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
78814|NCT01232283|305040|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
78815|NCT01232283|305041|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
78816|NCT01232283|305042|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
78817|NCT01232283|305043|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
78818|NCT01232283|305044|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
78819|NCT01232283|305045|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
78820|NCT01232283|305036|P10|Maintenance Phase (Weeks16-32)|Other|0
78821|NCT01232283|305037|P9|Maintenance Phase (Weeks16-32)|Other|0
78822|NCT01232283|305038|P8|Maintenance Phase (Weeks16-32)|Other|0
78823|NCT01232283|305039|P7|Maintenance Phase (Weeks16-32)|Other|0
78824|NCT01232283|305040|P6|Maintenance Phase (Weeks16-32)|Other|0
78825|NCT01232283|305041|P5|Maintenance Phase (Weeks16-32)|Other|0
78826|NCT01232283|305042|P4|Maintenance Phase (Weeks16-32)|Other|0
78827|NCT01232283|305043|P3|Maintenance Phase (Weeks16-32)|Other|2
78828|NCT01232283|305044|P2|Maintenance Phase (Weeks16-32)|Other|0
78829|NCT01232283|305045|P1|Maintenance Phase (Weeks16-32)|Other|0
78830|NCT01232283|305036|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
78831|NCT01232283|305037|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
78832|NCT01232283|305038|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
78833|NCT01232283|305039|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
78834|NCT01232283|305040|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
78835|NCT01232283|305041|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
78836|NCT01232283|305042|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
78837|NCT01232283|305043|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
78838|NCT01232283|305044|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
78839|NCT01232283|305045|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
78840|NCT01232283|305036|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
78841|NCT01232283|305037|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
78842|NCT01232283|305038|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
78843|NCT01232283|305039|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
78844|NCT01232283|305040|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
78845|NCT01232283|305041|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
78846|NCT01232283|305042|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
78847|NCT01232283|305043|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
78848|NCT01232283|305044|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
78849|NCT01232283|305045|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
78850|NCT01232283|305036|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
78851|NCT01232283|305037|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
78852|NCT01232283|305038|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
78853|NCT01232283|305039|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
78854|NCT01232283|305040|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
78855|NCT01232283|305041|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
78856|NCT01232283|305042|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
78857|NCT01232283|305043|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
78858|NCT01232283|305044|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
78859|NCT01232283|305045|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
78860|NCT01232283|305036|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
78861|NCT01232283|305037|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
78862|NCT01232283|305038|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
78863|NCT01232283|305039|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
78864|NCT01232283|305040|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
78865|NCT01232283|305041|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
78866|NCT01232283|305042|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
78867|NCT01232283|305043|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
78868|NCT01232283|305044|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
78869|NCT01232283|305045|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
78870|NCT01232283|305036|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
78871|NCT01232283|305037|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
78872|NCT01232283|305038|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
78873|NCT01232283|305039|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
78874|NCT01232283|305040|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
78875|NCT01232283|305041|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
78876|NCT01232283|305042|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
78877|NCT01232283|305043|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
78878|NCT01232283|305044|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
78879|NCT01232283|305045|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
78880|NCT01232283|305036|P10|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
78881|NCT01232283|305037|P9|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
78882|NCT01232283|305038|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
78883|NCT01232283|305039|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
78884|NCT01232283|305040|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
78885|NCT01232283|305041|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
78886|NCT01232283|305042|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
78887|NCT01232283|305043|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
78888|NCT01232283|305044|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
78889|NCT01232283|305045|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
78890|NCT01232283|305036|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
78891|NCT01232283|305037|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
78892|NCT01232283|305038|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
78893|NCT01232283|305039|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
78894|NCT01232283|305040|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
78895|NCT01232283|305041|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
78896|NCT01232283|305042|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
78897|NCT01232283|305043|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
78898|NCT01232283|305044|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
78899|NCT01232283|305045|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
78900|NCT01232283|305036|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
78901|NCT01232283|305037|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
78902|NCT01232283|305038|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
78903|NCT01232283|305039|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
78904|NCT01232283|305040|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
78905|NCT01232283|305041|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
78906|NCT01232283|305042|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
78907|NCT01232283|305043|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
78908|NCT01232283|305044|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
78909|NCT01232283|305045|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
78910|NCT01232283|305036|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
78911|NCT01232283|305037|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
78912|NCT01232283|305038|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
78913|NCT01232283|305039|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
78914|NCT01232283|305040|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
78915|NCT01232283|305041|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
78916|NCT01232283|305042|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
78917|NCT01232283|305043|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
78918|NCT01232283|305044|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
78919|NCT01232283|305045|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
78920|NCT01232283|305036|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
78921|NCT01232283|305037|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
78922|NCT01232283|305038|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
78923|NCT01232283|305039|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
78924|NCT01232283|305040|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
78925|NCT01232283|305041|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
78926|NCT01232283|305042|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
78927|NCT01232283|305043|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
78928|NCT01232283|305044|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
78929|NCT01232283|305045|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
78930|NCT01232283|305036|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
78931|NCT01232283|305037|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
78932|NCT01232283|305038|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
78933|NCT01232283|305039|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
78934|NCT01232283|305040|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
78935|NCT01232283|305041|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
78936|NCT01232283|305042|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
78937|NCT01232283|305043|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
78938|NCT01232283|305044|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
78939|NCT01232283|305045|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
78940|NCT01232283|305036|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
78941|NCT01232283|305037|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
78942|NCT01232283|305038|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
78943|NCT01232283|305039|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
78944|NCT01232283|305040|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
78945|NCT01232283|305041|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
78946|NCT01232283|305042|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
78947|NCT01232283|305043|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
78948|NCT01232283|305044|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
78949|NCT01232283|305045|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
78950|NCT01232127|305086|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
78951|NCT01232127|305087|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
78952|NCT01232127|305088|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
78953|NCT01231984|305112|P4|Study Period 2|Did not continue to meet I/E Criteria|1
78954|NCT01231984|305113|P3|Study Period 2|Did not continue to meet I/E Criteria|0
78955|NCT01231984|305114|P2|Study Period 2|Did not continue to meet I/E Criteria|1
78956|NCT01231984|305115|P1|Study Period 2|Did not continue to meet I/E Criteria|1
78957|NCT01231984|305112|P4|Study Period 2|Lost to Follow-up|3
78958|NCT01231984|305113|P3|Study Period 2|Lost to Follow-up|0
78959|NCT01231984|305114|P2|Study Period 2|Lost to Follow-up|0
78960|NCT01231984|305115|P1|Study Period 2|Lost to Follow-up|1
78961|NCT01231984|305112|P4|Study Period 2|Withdrawal by Subject|0
78962|NCT01231984|305113|P3|Study Period 2|Withdrawal by Subject|0
78963|NCT01231984|305114|P2|Study Period 2|Withdrawal by Subject|1
78964|NCT01231984|305115|P1|Study Period 2|Withdrawal by Subject|1
78965|NCT01231984|305112|P4|Study Period 1|Not Specified|1
78966|NCT01231984|305113|P3|Study Period 1|Not Specified|0
78967|NCT01231984|305114|P2|Study Period 1|Not Specified|0
78968|NCT01231984|305115|P1|Study Period 1|Not Specified|0
78969|NCT01231984|305112|P4|Study Period 1|Adverse Event|0
78970|NCT01231984|305113|P3|Study Period 1|Adverse Event|0
78971|NCT01231984|305114|P2|Study Period 1|Adverse Event|0
78972|NCT01231984|305115|P1|Study Period 1|Adverse Event|1
78973|NCT01231984|305112|P4|Study Period 1|Protocol Violation|3
78974|NCT01231984|305113|P3|Study Period 1|Protocol Violation|2
78975|NCT01231984|305114|P2|Study Period 1|Protocol Violation|4
78976|NCT01231984|305115|P1|Study Period 1|Protocol Violation|3
78977|NCT01231984|305112|P4|Study Period 1|Non-compliance with study requirements|1
78978|NCT01231984|305113|P3|Study Period 1|Non-compliance with study requirements|2
78979|NCT01231984|305114|P2|Study Period 1|Non-compliance with study requirements|0
78980|NCT01231984|305115|P1|Study Period 1|Non-compliance with study requirements|5
78981|NCT01231984|305112|P4|Study Period 1|Screen Failure|1
78982|NCT01231984|305113|P3|Study Period 1|Screen Failure|0
78983|NCT01231984|305114|P2|Study Period 1|Screen Failure|0
78984|NCT01231984|305115|P1|Study Period 1|Screen Failure|0
78985|NCT01231984|305112|P4|Study Period 1|Did not continue to meet I/E Criteria|2
78986|NCT01231984|305113|P3|Study Period 1|Did not continue to meet I/E Criteria|2
78987|NCT01231984|305114|P2|Study Period 1|Did not continue to meet I/E Criteria|2
78988|NCT01231984|305115|P1|Study Period 1|Did not continue to meet I/E Criteria|2
78989|NCT01231984|305112|P4|Study Period 1|Lost to Follow-up|0
78990|NCT01231984|305113|P3|Study Period 1|Lost to Follow-up|1
78991|NCT01231984|305114|P2|Study Period 1|Lost to Follow-up|1
78992|NCT01231984|305115|P1|Study Period 1|Lost to Follow-up|1
78993|NCT01231984|305112|P4|Study Period 1|Withdrawal by Subject|1
78994|NCT01231984|305113|P3|Study Period 1|Withdrawal by Subject|0
78995|NCT01231984|305114|P2|Study Period 1|Withdrawal by Subject|0
78996|NCT01231984|305115|P1|Study Period 1|Withdrawal by Subject|0
78997|NCT01231620|305184|P3|Overall Study|Lost to Follow-up|9
78998|NCT01231620|305185|P2|Overall Study|Lost to Follow-up|4
78999|NCT01231620|305186|P1|Overall Study|Lost to Follow-up|3
79000|NCT01231620|305184|P3|Overall Study|Withdrawal by Subject|8
79001|NCT01231620|305185|P2|Overall Study|Withdrawal by Subject|6
79002|NCT01231620|305186|P1|Overall Study|Withdrawal by Subject|6
79003|NCT01231620|305184|P3|Overall Study|Adverse Event|1
79004|NCT01231620|305185|P2|Overall Study|Adverse Event|2
79005|NCT01231620|305186|P1|Overall Study|Adverse Event|2
79006|NCT01231620|305184|P3|Overall Study|Death|11
79007|NCT01231620|305185|P2|Overall Study|Death|14
79008|NCT01231620|305186|P1|Overall Study|Death|12
79009|NCT01231620|305184|P3|Overall Study|Physician Decision|10
79010|NCT01231620|305185|P2|Overall Study|Physician Decision|5
79011|NCT01231620|305186|P1|Overall Study|Physician Decision|3
79012|NCT01231607|305292|P5|Overall Study|Withdrawal by Subject|9
79013|NCT01231607|305293|P4|Overall Study|Withdrawal by Subject|17
79014|NCT01231607|305294|P3|Overall Study|Withdrawal by Subject|14
79015|NCT01231607|305295|P2|Overall Study|Withdrawal by Subject|9
79016|NCT01231607|305296|P1|Overall Study|Withdrawal by Subject|9
79017|NCT01231607|305292|P5|Overall Study|Protocol Violation|2
79018|NCT01231607|305293|P4|Overall Study|Protocol Violation|2
79019|NCT01231607|305294|P3|Overall Study|Protocol Violation|0
79020|NCT01231607|305295|P2|Overall Study|Protocol Violation|2
79021|NCT01231607|305296|P1|Overall Study|Protocol Violation|3
79022|NCT01231607|305292|P5|Overall Study|Physician Decision|4
79023|NCT01231607|305293|P4|Overall Study|Physician Decision|5
79024|NCT01231607|305294|P3|Overall Study|Physician Decision|3
79025|NCT01231607|305295|P2|Overall Study|Physician Decision|4
79026|NCT01231607|305296|P1|Overall Study|Physician Decision|4
79027|NCT01231607|305292|P5|Overall Study|Lost to Follow-up|4
79028|NCT01231607|305293|P4|Overall Study|Lost to Follow-up|10
79029|NCT01231607|305294|P3|Overall Study|Lost to Follow-up|10
79030|NCT01231607|305295|P2|Overall Study|Lost to Follow-up|11
79031|NCT01231607|305296|P1|Overall Study|Lost to Follow-up|13
79032|NCT01231607|305292|P5|Overall Study|Adverse Event|5
79033|NCT01231607|305293|P4|Overall Study|Adverse Event|4
79034|NCT01231607|305294|P3|Overall Study|Adverse Event|4
79035|NCT01231607|305295|P2|Overall Study|Adverse Event|8
79036|NCT01231607|305296|P1|Overall Study|Adverse Event|0
79037|NCT01231581|305388|P2|Overall Study|Ongoing|0
79038|NCT01231581|305389|P1|Overall Study|Ongoing|1
79039|NCT01231581|305388|P2|Overall Study|Death|64
79040|NCT01231581|305389|P1|Overall Study|Death|65
79041|NCT01231581|305388|P2|Overall Study|Study Closed/Terminated|5
79042|NCT01231581|305389|P1|Overall Study|Study Closed/Terminated|6
79044|NCT01231581|305389|P1|Overall Study|Withdrawal by Subject|6
79045|NCT01231581|305388|P2|Overall Study|Lost to Follow-up|2
79046|NCT01231581|305389|P1|Overall Study|Lost to Follow-up|2
79047|NCT01231555|305410|P3|Overall Study|Withdrawal by Subject|0
79048|NCT01231555|305411|P2|Overall Study|Withdrawal by Subject|2
79049|NCT01231555|305412|P1|Overall Study|Withdrawal by Subject|0
79050|NCT01231555|305410|P3|Overall Study|Study terminated|8
79051|NCT01231555|305411|P2|Overall Study|Study terminated|5
79052|NCT01231555|305412|P1|Overall Study|Study terminated|8
79053|NCT01231516|305443|P2|Open-label Phase|Ongoing at the time of analysis|23
79054|NCT01231516|305444|P1|Open-label Phase|Ongoing at the time of analysis|282
79055|NCT01231516|305443|P2|Open-label Phase|Withdrawal by Subject|0
79056|NCT01231516|305444|P1|Open-label Phase|Withdrawal by Subject|1
79057|NCT01231516|305443|P2|Open-label Phase|Lost to Follow-up|0
79058|NCT01231516|305444|P1|Open-label Phase|Lost to Follow-up|3
79059|NCT01231516|305443|P2|Open-label Phase|Protocol Violation|0
79060|NCT01231516|305444|P1|Open-label Phase|Protocol Violation|2
79061|NCT01231516|305443|P2|Open-label Phase|Lack of Efficacy|3
79062|NCT01231516|305444|P1|Open-label Phase|Lack of Efficacy|7
79063|NCT01231516|305443|P2|48 Week Double-blind Phase|Site Closed|1
79064|NCT01231516|305444|P1|48 Week Double-blind Phase|Site Closed|3
79065|NCT01231516|305443|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
79066|NCT01231516|305444|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
79067|NCT01231516|305443|P2|48 Week Double-blind Phase|Physician Decision|1
79068|NCT01231516|305444|P1|48 Week Double-blind Phase|Physician Decision|1
79069|NCT01231516|305443|P2|48 Week Double-blind Phase|Lost to Follow-up|10
79070|NCT01231516|305444|P1|48 Week Double-blind Phase|Lost to Follow-up|5
79071|NCT01231516|305443|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
79072|NCT01231516|305444|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
79073|NCT01231516|305443|P2|48 Week Double-blind Phase|Protocol Violation|6
79074|NCT01231516|305444|P1|48 Week Double-blind Phase|Protocol Violation|9
79075|NCT01231516|305443|P2|48 Week Double-blind Phase|Lack of Efficacy|42
79076|NCT01231516|305444|P1|48 Week Double-blind Phase|Lack of Efficacy|20
79077|NCT01231516|305443|P2|48 Week Double-blind Phase|Adverse Event|11
79078|NCT01231516|305444|P1|48 Week Double-blind Phase|Adverse Event|4
79079|NCT01231503|305474|P8|Overall Study|Protocol Violation|0
79080|NCT01231503|305475|P7|Overall Study|Protocol Violation|0
79081|NCT01231503|305476|P6|Overall Study|Protocol Violation|0
79082|NCT01231503|305477|P5|Overall Study|Protocol Violation|0
79083|NCT01231503|305478|P4|Overall Study|Protocol Violation|1
79084|NCT01231503|305479|P3|Overall Study|Protocol Violation|0
79085|NCT01231503|305480|P2|Overall Study|Protocol Violation|0
79086|NCT01231503|305481|P1|Overall Study|Protocol Violation|0
79087|NCT01231503|305474|P8|Overall Study|Lost to Follow-up|6
79088|NCT01231503|305475|P7|Overall Study|Lost to Follow-up|6
79089|NCT01231503|305476|P6|Overall Study|Lost to Follow-up|9
79090|NCT01231503|305477|P5|Overall Study|Lost to Follow-up|7
79091|NCT01231503|305478|P4|Overall Study|Lost to Follow-up|5
79092|NCT01231503|305479|P3|Overall Study|Lost to Follow-up|8
79093|NCT01231503|305480|P2|Overall Study|Lost to Follow-up|10
79094|NCT01231503|305481|P1|Overall Study|Lost to Follow-up|8
79095|NCT01231503|305474|P8|Overall Study|Withdrawal by Subject|2
79096|NCT01231503|305475|P7|Overall Study|Withdrawal by Subject|1
79097|NCT01231503|305476|P6|Overall Study|Withdrawal by Subject|5
79098|NCT01231503|305477|P5|Overall Study|Withdrawal by Subject|3
79099|NCT01231503|305478|P4|Overall Study|Withdrawal by Subject|1
79100|NCT01231503|305479|P3|Overall Study|Withdrawal by Subject|3
79101|NCT01231503|305480|P2|Overall Study|Withdrawal by Subject|3
79102|NCT01231503|305481|P1|Overall Study|Withdrawal by Subject|6
79103|NCT01231503|305474|P8|Overall Study|Adverse event, serious fatal|0
79104|NCT01231503|305475|P7|Overall Study|Adverse event, serious fatal|0
79105|NCT01231503|305476|P6|Overall Study|Adverse event, serious fatal|1
79106|NCT01231503|305477|P5|Overall Study|Adverse event, serious fatal|0
79107|NCT01231503|305478|P4|Overall Study|Adverse event, serious fatal|1
79108|NCT01231503|305479|P3|Overall Study|Adverse event, serious fatal|1
79109|NCT01231503|305480|P2|Overall Study|Adverse event, serious fatal|0
79110|NCT01231503|305481|P1|Overall Study|Adverse event, serious fatal|0
79111|NCT01231503|305474|P8|Overall Study|Adverse Event|0
79112|NCT01231503|305475|P7|Overall Study|Adverse Event|0
79113|NCT01231503|305476|P6|Overall Study|Adverse Event|1
79114|NCT01231503|305477|P5|Overall Study|Adverse Event|0
79115|NCT01231503|305478|P4|Overall Study|Adverse Event|0
79116|NCT01231503|305479|P3|Overall Study|Adverse Event|0
79117|NCT01231503|305480|P2|Overall Study|Adverse Event|0
79118|NCT01231503|305481|P1|Overall Study|Adverse Event|0
79119|NCT01231464|305705|P2|Overall Study|Withdrawal by Subject|2
79120|NCT01231464|305706|P1|Overall Study|Withdrawal by Subject|3
79121|NCT01231464|305705|P2|Overall Study|Lost to Follow-up|2
79122|NCT01231464|305706|P1|Overall Study|Lost to Follow-up|1
79123|NCT01231464|305705|P2|Overall Study|Protocol Violation|2
79124|NCT01231464|305706|P1|Overall Study|Protocol Violation|1
79125|NCT01231464|305705|P2|Overall Study|Adverse Event|1
79126|NCT01231464|305706|P1|Overall Study|Adverse Event|0
79127|NCT01231373|305755|P4|Overall Study|Withdrew Consent|0
79128|NCT01231373|305756|P3|Overall Study|Withdrew Consent|0
79129|NCT01231373|305757|P2|Overall Study|Withdrew Consent|0
79130|NCT01231373|305758|P1|Overall Study|Withdrew Consent|1
79131|NCT01231373|305755|P4|Overall Study|Lost to Follow-up|1
79132|NCT01231373|305756|P3|Overall Study|Lost to Follow-up|0
79133|NCT01231373|305757|P2|Overall Study|Lost to Follow-up|0
79134|NCT01231373|305758|P1|Overall Study|Lost to Follow-up|0
79135|NCT01231373|305755|P4|Overall Study|Withdrew consent prior to randomization|0
79136|NCT01231373|305756|P3|Overall Study|Withdrew consent prior to randomization|0
79137|NCT01231373|305757|P2|Overall Study|Withdrew consent prior to randomization|1
79138|NCT01231373|305758|P1|Overall Study|Withdrew consent prior to randomization|2
79139|NCT01231321|305797|P1|Overall Study|Lack of Efficacy|2
79140|NCT01231321|305797|P1|Overall Study|Adverse Event|3
79141|NCT01230892|305820|P2|Overall Study|Lost to Follow-up|0
79142|NCT01230892|305821|P1|Overall Study|Lost to Follow-up|2
79143|NCT01230892|305820|P2|Overall Study|Withdrawal by Subject|1
79144|NCT01230892|305821|P1|Overall Study|Withdrawal by Subject|1
79145|NCT01230827|305831|P4|Overall Study|Study terminated by Sponsor|63
79146|NCT01230827|305832|P3|Overall Study|Study terminated by Sponsor|56
79147|NCT01230827|305833|P2|Overall Study|Study terminated by Sponsor|2
79148|NCT01230827|305834|P1|Overall Study|Study terminated by Sponsor|0
79149|NCT01230827|305831|P4|Overall Study|Recovery|0
79150|NCT01230827|305832|P3|Overall Study|Recovery|0
79151|NCT01230827|305833|P2|Overall Study|Recovery|6
79152|NCT01230827|305834|P1|Overall Study|Recovery|0
79153|NCT01230827|305831|P4|Overall Study|Adverse Event|7
79154|NCT01230827|305832|P3|Overall Study|Adverse Event|3
79155|NCT01230827|305833|P2|Overall Study|Adverse Event|2
79156|NCT01230827|305834|P1|Overall Study|Adverse Event|4
79157|NCT01230827|305831|P4|Overall Study|Lack of Efficacy|3
79158|NCT01230827|305832|P3|Overall Study|Lack of Efficacy|2
79159|NCT01230827|305833|P2|Overall Study|Lack of Efficacy|1
79160|NCT01230827|305834|P1|Overall Study|Lack of Efficacy|14
79161|NCT01230827|305831|P4|Overall Study|Withdrawal by Subject|2
79162|NCT01230827|305832|P3|Overall Study|Withdrawal by Subject|3
79163|NCT01230827|305833|P2|Overall Study|Withdrawal by Subject|0
79164|NCT01230827|305834|P1|Overall Study|Withdrawal by Subject|1
79165|NCT01230827|305831|P4|Overall Study|Lost to Follow-up|3
79166|NCT01230827|305832|P3|Overall Study|Lost to Follow-up|1
79167|NCT01230827|305833|P2|Overall Study|Lost to Follow-up|0
79168|NCT01230827|305834|P1|Overall Study|Lost to Follow-up|0
79169|NCT01230814|305850|P2|Overall Study|Discontinued (not due to adverse event)|1
79170|NCT01230814|305851|P1|Overall Study|Discontinued (not due to adverse event)|2
79171|NCT01230814|305850|P2|Overall Study|Lost to Follow-up|3
79172|NCT01230814|305851|P1|Overall Study|Lost to Follow-up|11
79173|NCT01230788|305863|P1|Overall Study|Prescribed exclusion drug|1
79174|NCT01230749|305875|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
79175|NCT01230749|305876|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
79176|NCT01230749|305877|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
79177|NCT01230749|305878|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
79178|NCT01230749|305875|P4|Overall Study|Withdrawal by Subject|0
79179|NCT01230749|305876|P3|Overall Study|Withdrawal by Subject|0
79180|NCT01230749|305877|P2|Overall Study|Withdrawal by Subject|1
79181|NCT01230749|305878|P1|Overall Study|Withdrawal by Subject|0
79182|NCT01230749|305875|P4|Overall Study|Physician Decision|0
79183|NCT01230749|305876|P3|Overall Study|Physician Decision|1
79184|NCT01230749|305877|P2|Overall Study|Physician Decision|0
79185|NCT01230749|305878|P1|Overall Study|Physician Decision|0
79186|NCT01230749|305875|P4|Overall Study|Adverse Event|1
79187|NCT01230749|305876|P3|Overall Study|Adverse Event|0
79188|NCT01230749|305877|P2|Overall Study|Adverse Event|0
79189|NCT01230749|305878|P1|Overall Study|Adverse Event|0
79190|NCT01230710|305913|P1|Overall Study|Withdrawal of Consent|1
79191|NCT01230710|305913|P1|Overall Study|Death|4
79192|NCT01230710|305913|P1|Overall Study|Lost to Follow-up|3
79193|NCT01230710|305913|P1|Overall Study|Disease Progression|41
79194|NCT01230307|305968|P2|Overall Study|LVAD Placement|2
79195|NCT01230307|305969|P1|Overall Study|LVAD Placement|0
79196|NCT01230060|305989|P1|Overall Study|Withdrawal by Subject|1
79197|NCT01229735|306062|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
79198|NCT01229735|306063|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
79199|NCT01229735|306062|P2|Overall Study|AE, non-serious non-fatal|17
79200|NCT01229735|306063|P1|Overall Study|AE, non-serious non-fatal|13
79201|NCT01229735|306062|P2|Overall Study|SAE, non-fatal|4
79202|NCT01229735|306063|P1|Overall Study|SAE, non-fatal|0
79203|NCT01229735|306062|P2|Overall Study|Other Reason|10
79204|NCT01229735|306063|P1|Overall Study|Other Reason|13
79205|NCT01229735|306062|P2|Overall Study|Withdrawal by Subject|17
79206|NCT01229735|306063|P1|Overall Study|Withdrawal by Subject|18
79207|NCT01229735|306062|P2|Overall Study|Lost to Follow-up|2
79208|NCT01229735|306063|P1|Overall Study|Lost to Follow-up|0
79209|NCT01229735|306062|P2|Overall Study|Protocol Violation|8
79210|NCT01229735|306063|P1|Overall Study|Protocol Violation|13
79211|NCT01229735|306062|P2|Overall Study|Lack of Efficacy|8
79212|NCT01229735|306063|P1|Overall Study|Lack of Efficacy|8
79213|NCT01229436|306111|P1|Overall Study|Lost to Follow-up|3
79214|NCT01229436|306111|P1|Overall Study|Withdrawal by Subject|2
79215|NCT01229397|306173|P2|Overall Study|Migrated/moved from study area|0
79216|NCT01229397|306174|P1|Overall Study|Migrated/moved from study area|1
79217|NCT01229397|306173|P2|Overall Study|Lost to Follow-up|6
79218|NCT01229397|306174|P1|Overall Study|Lost to Follow-up|7
79219|NCT01229397|306173|P2|Overall Study|Withdrawal by Subject|3
79220|NCT01229397|306174|P1|Overall Study|Withdrawal by Subject|3
79221|NCT01229371|306192|P4|Overall Study|Withdrawal by Subject|0
79222|NCT01229371|306193|P3|Overall Study|Withdrawal by Subject|0
79223|NCT01229371|306194|P2|Overall Study|Withdrawal by Subject|1
79224|NCT01229371|306195|P1|Overall Study|Withdrawal by Subject|0
79225|NCT01229254|306220|P3|Overall Study|Non-compliance with Study Drug|1
79226|NCT01229254|306221|P2|Overall Study|Non-compliance with Study Drug|1
79227|NCT01229254|306222|P1|Overall Study|Non-compliance with Study Drug|0
79228|NCT01229254|306220|P3|Overall Study|Withdrawal by Subject|1
79229|NCT01229254|306221|P2|Overall Study|Withdrawal by Subject|0
79230|NCT01229254|306222|P1|Overall Study|Withdrawal by Subject|1
79231|NCT01229254|306220|P3|Overall Study|Protocol Violation|5
79232|NCT01229254|306221|P2|Overall Study|Protocol Violation|6
79233|NCT01229254|306222|P1|Overall Study|Protocol Violation|4
79234|NCT01229254|306220|P3|Overall Study|Physician Decision|0
79235|NCT01229254|306221|P2|Overall Study|Physician Decision|3
79236|NCT01229254|306222|P1|Overall Study|Physician Decision|0
79237|NCT01229254|306220|P3|Overall Study|Lost to Follow-up|1
79238|NCT01229254|306221|P2|Overall Study|Lost to Follow-up|0
79239|NCT01229254|306222|P1|Overall Study|Lost to Follow-up|3
79240|NCT01229254|306220|P3|Overall Study|Adverse Event|3
79241|NCT01229254|306221|P2|Overall Study|Adverse Event|5
79242|NCT01229254|306222|P1|Overall Study|Adverse Event|4
79243|NCT01229254|306220|P3|Overall Study|Not Continuing Into Safety Extension|1
79244|NCT01229254|306221|P2|Overall Study|Not Continuing Into Safety Extension|1
79245|NCT01229254|306222|P1|Overall Study|Not Continuing Into Safety Extension|3
79246|NCT01229176|306260|P8|Overall Study|Lost to Follow-up|2
79247|NCT01229176|306261|P7|Overall Study|Lost to Follow-up|0
79248|NCT01229176|306262|P6|Overall Study|Lost to Follow-up|1
79249|NCT01229176|306263|P5|Overall Study|Lost to Follow-up|1
79250|NCT01229176|306264|P4|Overall Study|Lost to Follow-up|0
79251|NCT01229176|306265|P3|Overall Study|Lost to Follow-up|0
79252|NCT01229176|306266|P2|Overall Study|Lost to Follow-up|3
79253|NCT01229176|306267|P1|Overall Study|Lost to Follow-up|0
79254|NCT01229176|306260|P8|Overall Study|Withdrawal by Subject|1
79255|NCT01229176|306261|P7|Overall Study|Withdrawal by Subject|0
79256|NCT01229176|306262|P6|Overall Study|Withdrawal by Subject|1
79257|NCT01229176|306263|P5|Overall Study|Withdrawal by Subject|1
79258|NCT01229176|306264|P4|Overall Study|Withdrawal by Subject|1
79259|NCT01229176|306265|P3|Overall Study|Withdrawal by Subject|0
79260|NCT01229176|306266|P2|Overall Study|Withdrawal by Subject|0
79261|NCT01229176|306267|P1|Overall Study|Withdrawal by Subject|0
79262|NCT01229150|306321|P4|Overall Study|Toxicity|0
79263|NCT01229150|306322|P3|Overall Study|Toxicity|0
79264|NCT01229150|306323|P2|Overall Study|Toxicity|2
79265|NCT01229150|306324|P1|Overall Study|Toxicity|2
79266|NCT01229111|306381|P1|Overall Study|Death|1
79267|NCT01228747|306430|P2|Overall Study|Other Reason|5
79268|NCT01228747|306431|P1|Overall Study|Other Reason|2
79269|NCT01228747|306430|P2|Overall Study|Withdrawal by Subject|1
79270|NCT01228747|306431|P1|Overall Study|Withdrawal by Subject|5
79271|NCT01228747|306430|P2|Overall Study|Lost to Follow-up|3
79272|NCT01228747|306431|P1|Overall Study|Lost to Follow-up|4
79273|NCT01228747|306430|P2|Overall Study|Protocol Violation|5
79274|NCT01228747|306431|P1|Overall Study|Protocol Violation|6
79275|NCT01228747|306430|P2|Overall Study|Lack of Efficacy|27
79276|NCT01228747|306431|P1|Overall Study|Lack of Efficacy|40
79277|NCT01228747|306430|P2|Overall Study|Adverse Event|4
79278|NCT01228747|306431|P1|Overall Study|Adverse Event|8
79279|NCT01228734|306447|P2|Overall Study|Randomized, but not treated|4
79280|NCT01228734|306448|P1|Overall Study|Randomized, but not treated|0
79281|NCT01228734|306447|P2|Overall Study|Ongoing at clinical cut-off date|4
79282|NCT01228734|306448|P1|Overall Study|Ongoing at clinical cut-off date|16
79283|NCT01228591|306462|P2|Baseline|Lack of Efficacy|2
79284|NCT01228591|306463|P1|Baseline|Lack of Efficacy|1
79285|NCT01228175|306492|P2|Overall Study|Physician Decision|1
79286|NCT01228175|306493|P1|Overall Study|Physician Decision|1
79287|NCT01228175|306492|P2|Overall Study|Withdrawal by Subject|2
79288|NCT01228175|306493|P1|Overall Study|Withdrawal by Subject|1
79289|NCT01228175|306492|P2|Overall Study|Lost to Follow-up|50
79290|NCT01228175|306493|P1|Overall Study|Lost to Follow-up|64
79291|NCT01228071|306535|P1|Overall Study|Withdrawal by Subject|1
79292|NCT01228071|306535|P1|Overall Study|Protocol Violation|1
79293|NCT01228019|306541|P1|Overall Study|Violation of Entry Criterion|9
79294|NCT01228019|306541|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
79295|NCT01228019|306541|P1|Overall Study|Missing pre-treatment data|72
79296|NCT01228019|306541|P1|Overall Study|Duplicate enrollment|1
79297|NCT01228019|306541|P1|Overall Study|Dose Violation|70
79298|NCT01227967|306607|P2|Overall Study|Taking Additional Antiviral Drug|0
79299|NCT01227967|306608|P1|Overall Study|Taking Additional Antiviral Drug|1
79300|NCT01227967|306607|P2|Overall Study|Never Started Treatment|4
79301|NCT01227967|306608|P1|Overall Study|Never Started Treatment|0
79302|NCT01227967|306607|P2|Overall Study|Physician Decision|1
79303|NCT01227967|306608|P1|Overall Study|Physician Decision|0
79304|NCT01227967|306607|P2|Overall Study|Withdrawal by Subject|3
79305|NCT01227967|306608|P1|Overall Study|Withdrawal by Subject|4
79306|NCT01227967|306607|P2|Overall Study|Lost to Follow-up|3
79307|NCT01227967|306608|P1|Overall Study|Lost to Follow-up|8
79308|NCT01227967|306607|P2|Overall Study|Death|1
79309|NCT01227967|306608|P1|Overall Study|Death|0
79310|NCT01227967|306607|P2|Overall Study|Protocol Violation|1
79311|NCT01227967|306608|P1|Overall Study|Protocol Violation|3
79312|NCT01227954|306642|P1|Overall Study|No protocol treatment|7
79313|NCT01227954|306642|P1|Overall Study|Protocol Violation|6
79314|NCT01227928|306656|P2|Overall Study|Death|12
79315|NCT01227928|306657|P1|Overall Study|Death|14
79316|NCT01227928|306656|P2|Overall Study|Withdrawal by Subject|3
79317|NCT01227928|306657|P1|Overall Study|Withdrawal by Subject|4
79318|NCT01227928|306656|P2|Overall Study|Lost to Follow-up|2
79319|NCT01227928|306657|P1|Overall Study|Lost to Follow-up|4
79320|NCT01227902|306695|P4|Overall Study|Withdrawal by Subject|3
79321|NCT01227902|306696|P3|Overall Study|Withdrawal by Subject|4
79322|NCT01227902|306697|P2|Overall Study|Withdrawal by Subject|2
79323|NCT01227902|306698|P1|Overall Study|Withdrawal by Subject|4
79324|NCT01227902|306695|P4|Overall Study|Physician Decision|0
79325|NCT01227902|306696|P3|Overall Study|Physician Decision|1
79326|NCT01227902|306697|P2|Overall Study|Physician Decision|1
79327|NCT01227902|306698|P1|Overall Study|Physician Decision|0
79328|NCT01227902|306695|P4|Overall Study|Lost to Follow-up|2
79329|NCT01227902|306696|P3|Overall Study|Lost to Follow-up|1
79330|NCT01227902|306697|P2|Overall Study|Lost to Follow-up|0
79331|NCT01227902|306698|P1|Overall Study|Lost to Follow-up|0
79332|NCT01227902|306695|P4|Overall Study|Protocol Violation|0
79333|NCT01227902|306696|P3|Overall Study|Protocol Violation|0
79334|NCT01227902|306697|P2|Overall Study|Protocol Violation|0
79335|NCT01227902|306698|P1|Overall Study|Protocol Violation|1
79336|NCT01227902|306695|P4|Overall Study|Lack of Efficacy|1
79337|NCT01227902|306696|P3|Overall Study|Lack of Efficacy|2
79338|NCT01227902|306697|P2|Overall Study|Lack of Efficacy|2
79339|NCT01227902|306698|P1|Overall Study|Lack of Efficacy|1
79340|NCT01227902|306695|P4|Overall Study|Adverse Event|4
79341|NCT01227902|306696|P3|Overall Study|Adverse Event|11
79342|NCT01227902|306697|P2|Overall Study|Adverse Event|8
79343|NCT01227902|306698|P1|Overall Study|Adverse Event|12
79344|NCT01227889|306791|P2|Crossover Phase|Withdrawal by Subject|1
79345|NCT01227889|306792|P1|Crossover Phase|Withdrawal by Subject|0
79346|NCT01227889|306791|P2|Crossover Phase|Study Terminated By Sponsor|1
79347|NCT01227889|306792|P1|Crossover Phase|Study Terminated By Sponsor|0
79348|NCT01227889|306791|P2|Crossover Phase|Progressive Disease|31
79349|NCT01227889|306792|P1|Crossover Phase|Progressive Disease|0
79350|NCT01227889|306791|P2|Crossover Phase|Physician Decision|3
79351|NCT01227889|306792|P1|Crossover Phase|Physician Decision|0
79352|NCT01227889|306791|P2|Crossover Phase|Adverse Event|1
79353|NCT01227889|306792|P1|Crossover Phase|Adverse Event|0
79354|NCT01227889|306791|P2|Randomized Phase (RP)|Withdrawal by Subject|3
79355|NCT01227889|306792|P1|Randomized Phase (RP)|Withdrawal by Subject|15
79356|NCT01227889|306791|P2|Randomized Phase (RP)|Missing|3
79357|NCT01227889|306792|P1|Randomized Phase (RP)|Missing|1
79358|NCT01227889|306791|P2|Randomized Phase (RP)|Study terminated by sponsor|0
79359|NCT01227889|306792|P1|Randomized Phase (RP)|Study terminated by sponsor|10
79360|NCT01227889|306791|P2|Randomized Phase (RP)|Progressive Disease|52
79361|NCT01227889|306792|P1|Randomized Phase (RP)|Progressive Disease|135
79362|NCT01227889|306791|P2|Randomized Phase (RP)|Physician Decision|5
79363|NCT01227889|306792|P1|Randomized Phase (RP)|Physician Decision|13
79364|NCT01227889|306791|P2|Randomized Phase (RP)|Adverse Event|0
79365|NCT01227889|306792|P1|Randomized Phase (RP)|Adverse Event|13
79366|NCT01227824|306819|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
79367|NCT01227824|306820|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
79368|NCT01227824|306821|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
79369|NCT01227824|306819|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
79370|NCT01227824|306820|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
79371|NCT01227824|306821|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
79372|NCT01227824|306819|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
79373|NCT01227824|306820|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
79374|NCT01227824|306821|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
79375|NCT01227824|306819|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
79376|NCT01227824|306820|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
79377|NCT01227824|306821|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
79378|NCT01227824|306819|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
79379|NCT01227824|306820|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
79380|NCT01227824|306821|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
79381|NCT01227824|306819|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
79382|NCT01227824|306820|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
79383|NCT01227824|306821|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
79384|NCT01227824|306819|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
79385|NCT01227824|306820|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
79386|NCT01227824|306821|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
79387|NCT01227824|306819|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
79388|NCT01227824|306820|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
79389|NCT01227824|306821|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
79390|NCT01227824|306819|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
79391|NCT01227824|306820|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
79392|NCT01227824|306821|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
79393|NCT01227824|306819|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
79394|NCT01227824|306820|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
79395|NCT01227824|306821|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
79396|NCT01227824|306819|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
79397|NCT01227824|306820|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
79398|NCT01227824|306821|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
79399|NCT01227824|306819|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
79400|NCT01227824|306820|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
79401|NCT01227824|306821|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
79402|NCT01227824|306819|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
79403|NCT01227824|306820|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
79404|NCT01227824|306821|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
79405|NCT01227824|306819|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
79406|NCT01227824|306820|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
79407|NCT01227824|306821|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
79408|NCT01227824|306819|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
79409|NCT01227824|306820|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
79410|NCT01227824|306821|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
79411|NCT01227707|306916|P1|Overall Study|Death|1
79412|NCT01227707|306916|P1|Overall Study|Medical decision|6
79413|NCT01227707|306916|P1|Overall Study|Patient non-compliance|3
79414|NCT01227707|306916|P1|Overall Study|Withdrawal by Subject|1
79415|NCT01227707|306916|P1|Overall Study|Progression of disease|3
79416|NCT01227707|306916|P1|Overall Study|Adverse Event|10
79417|NCT01227668|306943|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
79418|NCT01227668|306944|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
79419|NCT01227668|306943|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
79420|NCT01227668|306944|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
79421|NCT01227668|306943|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
79422|NCT01227668|306944|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
79423|NCT01227668|306943|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
79424|NCT01227668|306944|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
79425|NCT01227668|306943|P2|Phase 2 (Randomization Phase)|Adverse Event|1
79426|NCT01227668|306944|P1|Phase 2 (Randomization Phase)|Adverse Event|0
79427|NCT01227668|306943|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
79428|NCT01227668|306944|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
79429|NCT01227668|306943|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
79430|NCT01227668|306944|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
79431|NCT01227668|306943|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
79432|NCT01227668|306944|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
79433|NCT01227668|306943|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
79434|NCT01227668|306944|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
79435|NCT01227668|306943|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
79436|NCT01227668|306944|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
79437|NCT01227668|306943|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
79438|NCT01227668|306944|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
79439|NCT01227668|306943|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
79440|NCT01227668|306944|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
79441|NCT01227629|306990|P10|Overall Study|Not Specified|1
79442|NCT01227629|306991|P9|Overall Study|Not Specified|2
79443|NCT01227629|306992|P8|Overall Study|Not Specified|0
79444|NCT01227629|306993|P7|Overall Study|Not Specified|0
79445|NCT01227629|306994|P6|Overall Study|Not Specified|0
79446|NCT01227629|306995|P5|Overall Study|Not Specified|0
79447|NCT01227629|306996|P4|Overall Study|Not Specified|1
79448|NCT01227629|306997|P3|Overall Study|Not Specified|0
79449|NCT01227629|306998|P2|Overall Study|Not Specified|0
79450|NCT01227629|306999|P1|Overall Study|Not Specified|0
79451|NCT01227629|306990|P10|Overall Study|Withdrawal by Subject|1
79452|NCT01227629|306991|P9|Overall Study|Withdrawal by Subject|0
79453|NCT01227629|306992|P8|Overall Study|Withdrawal by Subject|0
79454|NCT01227629|306993|P7|Overall Study|Withdrawal by Subject|2
79455|NCT01227629|306994|P6|Overall Study|Withdrawal by Subject|0
79456|NCT01227629|306995|P5|Overall Study|Withdrawal by Subject|0
79457|NCT01227629|306996|P4|Overall Study|Withdrawal by Subject|0
79458|NCT01227629|306997|P3|Overall Study|Withdrawal by Subject|0
79459|NCT01227629|306998|P2|Overall Study|Withdrawal by Subject|0
79460|NCT01227629|306999|P1|Overall Study|Withdrawal by Subject|0
79461|NCT01227629|306990|P10|Overall Study|Lost to Follow-up|0
79462|NCT01227629|306991|P9|Overall Study|Lost to Follow-up|0
79463|NCT01227629|306992|P8|Overall Study|Lost to Follow-up|0
79464|NCT01227629|306993|P7|Overall Study|Lost to Follow-up|0
79465|NCT01227629|306994|P6|Overall Study|Lost to Follow-up|0
79466|NCT01227629|306995|P5|Overall Study|Lost to Follow-up|1
79467|NCT01227629|306996|P4|Overall Study|Lost to Follow-up|0
79468|NCT01227629|306997|P3|Overall Study|Lost to Follow-up|0
79469|NCT01227629|306998|P2|Overall Study|Lost to Follow-up|0
79470|NCT01227629|306999|P1|Overall Study|Lost to Follow-up|0
79471|NCT01227629|306990|P10|Overall Study|Protocol Violation|0
79472|NCT01227629|306991|P9|Overall Study|Protocol Violation|0
79473|NCT01227629|306992|P8|Overall Study|Protocol Violation|0
79474|NCT01227629|306993|P7|Overall Study|Protocol Violation|0
79475|NCT01227629|306994|P6|Overall Study|Protocol Violation|0
79476|NCT01227629|306995|P5|Overall Study|Protocol Violation|0
79477|NCT01227629|306996|P4|Overall Study|Protocol Violation|1
79478|NCT01227629|306997|P3|Overall Study|Protocol Violation|0
79479|NCT01227629|306998|P2|Overall Study|Protocol Violation|0
79480|NCT01227629|306999|P1|Overall Study|Protocol Violation|0
79481|NCT01227629|306990|P10|Overall Study|Adverse Event|0
79482|NCT01227629|306991|P9|Overall Study|Adverse Event|4
79483|NCT01227629|306992|P8|Overall Study|Adverse Event|6
79484|NCT01227629|306993|P7|Overall Study|Adverse Event|6
79485|NCT01227629|306994|P6|Overall Study|Adverse Event|1
79486|NCT01227629|306995|P5|Overall Study|Adverse Event|1
79487|NCT01227629|306996|P4|Overall Study|Adverse Event|6
79488|NCT01227629|306997|P3|Overall Study|Adverse Event|1
79489|NCT01227629|306998|P2|Overall Study|Adverse Event|2
79490|NCT01227629|306999|P1|Overall Study|Adverse Event|2
79491|NCT01227577|307235|P1|Overall Study|Adverse Event|17
79492|NCT01227577|307235|P1|Overall Study|Lack of Efficacy|5
79493|NCT01227577|307235|P1|Overall Study|Withdrawal by Subject|4
79494|NCT01227577|307235|P1|Overall Study|Lost to Follow-up|1
79495|NCT01227577|307235|P1|Overall Study|Administrative problems|2
79496|NCT01227577|307235|P1|Overall Study|Death|3
79497|NCT01227577|307235|P1|Overall Study|Protocol deviation|3
79498|NCT01227564|307250|P3|Overall Study|Participant moved to another town|1
79499|NCT01227564|307251|P2|Overall Study|Participant moved to another town|0
79500|NCT01227564|307252|P1|Overall Study|Participant moved to another town|0
79501|NCT01227564|307250|P3|Overall Study|No Longer Willing to Participate|5
79502|NCT01227564|307251|P2|Overall Study|No Longer Willing to Participate|2
79503|NCT01227564|307252|P1|Overall Study|No Longer Willing to Participate|4
79504|NCT01227512|307390|P2|Overall Study|Participant met withdrawal criteria|1
79505|NCT01227512|307391|P1|Overall Study|Participant met withdrawal criteria|0
79506|NCT01227512|307390|P2|Overall Study|Withdrawal by Subject|0
79507|NCT01227512|307391|P1|Overall Study|Withdrawal by Subject|3
79508|NCT01227512|307390|P2|Overall Study|Adverse Event|3
79509|NCT01227512|307391|P1|Overall Study|Adverse Event|4
79510|NCT01227512|307390|P2|Overall Study|Physician Decision|6
79511|NCT01227512|307391|P1|Overall Study|Physician Decision|6
79512|NCT01227421|307425|P3|Overall Study|Randomized in error|0
79513|NCT01227421|307426|P2|Overall Study|Randomized in error|1
79514|NCT01227421|307427|P1|Overall Study|Randomized in error|1
79515|NCT01227421|307425|P3|Overall Study|Protocol Violation|2
79516|NCT01227421|307426|P2|Overall Study|Protocol Violation|1
79517|NCT01227421|307427|P1|Overall Study|Protocol Violation|1
79518|NCT01227421|307425|P3|Overall Study|Withdrawal by Subject|1
79519|NCT01227421|307426|P2|Overall Study|Withdrawal by Subject|2
79520|NCT01227421|307427|P1|Overall Study|Withdrawal by Subject|1
79521|NCT01227421|307425|P3|Overall Study|Adverse Event|2
79522|NCT01227421|307426|P2|Overall Study|Adverse Event|7
79523|NCT01227421|307427|P1|Overall Study|Adverse Event|2
79524|NCT01227421|307425|P3|Overall Study|Lost to Follow-up|5
79525|NCT01227421|307426|P2|Overall Study|Lost to Follow-up|7
79526|NCT01227421|307427|P1|Overall Study|Lost to Follow-up|6
79527|NCT01227395|307479|P2|Overall Study|Protocol Violation|1
79528|NCT01227395|307480|P1|Overall Study|Protocol Violation|0
79529|NCT01227278|307520|P2|Overall Study|Other|2
79530|NCT01227278|307521|P1|Overall Study|Other|1
79531|NCT01227278|307520|P2|Overall Study|Death|2
79532|NCT01227278|307521|P1|Overall Study|Death|0
79533|NCT01227278|307520|P2|Overall Study|Withdrawal by Subject|4
79534|NCT01227278|307521|P1|Overall Study|Withdrawal by Subject|4
79535|NCT01227265|307548|P3|Overall Study|Adverse Event|5
79536|NCT01227265|307549|P2|Overall Study|Adverse Event|10
79537|NCT01227265|307550|P1|Overall Study|Adverse Event|6
79538|NCT01227265|307548|P3|Overall Study|Lost to Follow-up|3
79539|NCT01227265|307549|P2|Overall Study|Lost to Follow-up|0
79540|NCT01227265|307550|P1|Overall Study|Lost to Follow-up|2
79541|NCT01227265|307548|P3|Overall Study|Withdrawal by Subject|3
79542|NCT01227265|307549|P2|Overall Study|Withdrawal by Subject|7
79543|NCT01227265|307550|P1|Overall Study|Withdrawal by Subject|7
79544|NCT01227265|307548|P3|Overall Study|Protocol Violation|0
79545|NCT01227265|307549|P2|Overall Study|Protocol Violation|1
79546|NCT01227265|307550|P1|Overall Study|Protocol Violation|2
79547|NCT01227265|307548|P3|Overall Study|Did Not Meet Protocol Eligibility|1
79548|NCT01227265|307549|P2|Overall Study|Did Not Meet Protocol Eligibility|0
79549|NCT01227265|307550|P1|Overall Study|Did Not Meet Protocol Eligibility|0
79550|NCT01227265|307548|P3|Overall Study|Administrative|2
79551|NCT01227265|307549|P2|Overall Study|Administrative|0
79552|NCT01227265|307550|P1|Overall Study|Administrative|1
79553|NCT01227265|307548|P3|Overall Study|Did Not Receive Treatment|0
79554|NCT01227265|307549|P2|Overall Study|Did Not Receive Treatment|2
79555|NCT01227265|307550|P1|Overall Study|Did Not Receive Treatment|1
79556|NCT01227018|307587|P1|Overall Study|Withdrew after beginning treatment|4
79557|NCT01227018|307587|P1|Overall Study|Toxicity|2
79558|NCT01227018|307587|P1|Overall Study|Disease progression|9
79559|NCT01226745|307614|P6|Overall Study|Other|1
79560|NCT01226745|307615|P5|Overall Study|Other|3
79561|NCT01226745|307616|P4|Overall Study|Other|4
79562|NCT01226745|307617|P3|Overall Study|Other|8
79563|NCT01226745|307618|P2|Overall Study|Other|7
79564|NCT01226745|307619|P1|Overall Study|Other|6
79565|NCT01226745|307614|P6|Overall Study|Death|1
79566|NCT01226745|307615|P5|Overall Study|Death|0
79567|NCT01226745|307616|P4|Overall Study|Death|0
79568|NCT01226745|307617|P3|Overall Study|Death|0
79569|NCT01226745|307618|P2|Overall Study|Death|0
79570|NCT01226745|307619|P1|Overall Study|Death|1
79571|NCT01226745|307614|P6|Overall Study|Lost to Follow-up|2
79572|NCT01226745|307615|P5|Overall Study|Lost to Follow-up|1
79573|NCT01226745|307616|P4|Overall Study|Lost to Follow-up|1
79574|NCT01226745|307617|P3|Overall Study|Lost to Follow-up|6
79575|NCT01226745|307618|P2|Overall Study|Lost to Follow-up|6
79576|NCT01226745|307619|P1|Overall Study|Lost to Follow-up|2
79577|NCT01226745|307614|P6|Overall Study|Did not complete schedule of assessments|1
79578|NCT01226745|307615|P5|Overall Study|Did not complete schedule of assessments|0
79579|NCT01226745|307616|P4|Overall Study|Did not complete schedule of assessments|0
79580|NCT01226745|307617|P3|Overall Study|Did not complete schedule of assessments|6
79581|NCT01226745|307618|P2|Overall Study|Did not complete schedule of assessments|3
79582|NCT01226745|307619|P1|Overall Study|Did not complete schedule of assessments|8
79583|NCT01226511|307815|P2|Taper Period|Parent/Caregiver Decision|1
79584|NCT01226511|307816|P1|Taper Period|Parent/Caregiver Decision|1
79585|NCT01226511|307815|P2|Taper Period|Protocol Violation|0
79586|NCT01226511|307816|P1|Taper Period|Protocol Violation|1
79587|NCT01226511|307815|P2|Taper Period|Lost to Follow-up|2
79588|NCT01226511|307816|P1|Taper Period|Lost to Follow-up|2
79589|NCT01226511|307815|P2|Taper Period|Adverse Event|0
79590|NCT01226511|307816|P1|Taper Period|Adverse Event|1
79591|NCT01226511|307815|P2|Extension Treatment Period|Sponsor Decision|1
79592|NCT01226511|307816|P1|Extension Treatment Period|Sponsor Decision|1
79593|NCT01226511|307815|P2|Extension Treatment Period|Parent/Caregiver Decision|8
79594|NCT01226511|307816|P1|Extension Treatment Period|Parent/Caregiver Decision|8
79595|NCT01226511|307815|P2|Extension Treatment Period|Withdrawal by Subject|3
79596|NCT01226511|307816|P1|Extension Treatment Period|Withdrawal by Subject|1
79597|NCT01226511|307815|P2|Extension Treatment Period|Protocol Violation|2
79598|NCT01226511|307816|P1|Extension Treatment Period|Protocol Violation|2
79599|NCT01226511|307815|P2|Extension Treatment Period|Lost to Follow-up|3
79600|NCT01226511|307816|P1|Extension Treatment Period|Lost to Follow-up|4
79601|NCT01226511|307815|P2|Extension Treatment Period|Lack of Efficacy|2
79602|NCT01226511|307816|P1|Extension Treatment Period|Lack of Efficacy|3
79603|NCT01226511|307815|P2|Extension Treatment Period|Adverse Event|8
79604|NCT01226511|307816|P1|Extension Treatment Period|Adverse Event|8
79605|NCT01226511|307815|P2|Acute Treatment Period|Withdrawal by Subject|6
79606|NCT01226511|307816|P1|Acute Treatment Period|Withdrawal by Subject|10
79607|NCT01226511|307815|P2|Acute Treatment Period|Protocol Violation|5
79608|NCT01226511|307816|P1|Acute Treatment Period|Protocol Violation|5
79609|NCT01226511|307815|P2|Acute Treatment Period|Parent/caregiver decision|7
79610|NCT01226511|307816|P1|Acute Treatment Period|Parent/caregiver decision|5
79611|NCT01226511|307815|P2|Acute Treatment Period|Lost to Follow-up|6
79612|NCT01226511|307816|P1|Acute Treatment Period|Lost to Follow-up|3
79613|NCT01226511|307815|P2|Acute Treatment Period|Lack of Efficacy|1
79614|NCT01226511|307816|P1|Acute Treatment Period|Lack of Efficacy|2
79615|NCT01226511|307815|P2|Acute Treatment Period|Adverse Event|6
79616|NCT01226511|307816|P1|Acute Treatment Period|Adverse Event|7
79617|NCT01226459|307854|P2|Overall Study|Pregnancy|0
79618|NCT01226459|307855|P1|Overall Study|Pregnancy|1
79619|NCT01226459|307854|P2|Overall Study|Lost to Follow-up|8
79620|NCT01226459|307855|P1|Overall Study|Lost to Follow-up|4
79621|NCT01226459|307854|P2|Overall Study|Withdrawal by Subject|13
79622|NCT01226459|307855|P1|Overall Study|Withdrawal by Subject|10
79623|NCT01226459|307854|P2|Overall Study|Protocol Violation|3
79624|NCT01226459|307855|P1|Overall Study|Protocol Violation|4
79625|NCT01226459|307854|P2|Overall Study|Adverse Event|8
79626|NCT01226459|307855|P1|Overall Study|Adverse Event|2
79627|NCT01226121|307873|P3|Overall Study|Lost to Follow-up|1
79628|NCT01226121|307874|P2|Overall Study|Lost to Follow-up|0
79629|NCT01226121|307875|P1|Overall Study|Lost to Follow-up|2
79630|NCT01226095|307886|P1|Overall Study|Poor compliance|1
79631|NCT01226043|307911|P4|30-week Observational Phase|Physician Decision|2
79632|NCT01226043|307912|P3|30-week Observational Phase|Physician Decision|2
79633|NCT01226043|307913|P2|30-week Observational Phase|Physician Decision|0
79634|NCT01226043|307914|P1|30-week Observational Phase|Physician Decision|0
79635|NCT01226043|307911|P4|30-week Observational Phase|Withdrawal by Subject|7
79636|NCT01226043|307912|P3|30-week Observational Phase|Withdrawal by Subject|1
79637|NCT01226043|307913|P2|30-week Observational Phase|Withdrawal by Subject|0
79638|NCT01226043|307914|P1|30-week Observational Phase|Withdrawal by Subject|0
79639|NCT01226043|307911|P4|30-week Observational Phase|Lost to Follow-up|2
79640|NCT01226043|307912|P3|30-week Observational Phase|Lost to Follow-up|2
79641|NCT01226043|307913|P2|30-week Observational Phase|Lost to Follow-up|0
79642|NCT01226043|307914|P1|30-week Observational Phase|Lost to Follow-up|0
79643|NCT01226043|307911|P4|30-week Observational Phase|Protocol Violation|1
79644|NCT01226043|307912|P3|30-week Observational Phase|Protocol Violation|0
79645|NCT01226043|307913|P2|30-week Observational Phase|Protocol Violation|0
79646|NCT01226043|307914|P1|30-week Observational Phase|Protocol Violation|0
79647|NCT01226043|307911|P4|30-week Observational Phase|Adverse Event|1
79648|NCT01226043|307912|P3|30-week Observational Phase|Adverse Event|1
79649|NCT01226043|307913|P2|30-week Observational Phase|Adverse Event|0
79650|NCT01226043|307914|P1|30-week Observational Phase|Adverse Event|0
79651|NCT01226043|307911|P4|6-week Re-randomization Phase|completed in error|1
79652|NCT01226043|307912|P3|6-week Re-randomization Phase|completed in error|0
79653|NCT01226043|307913|P2|6-week Re-randomization Phase|completed in error|0
79654|NCT01226043|307914|P1|6-week Re-randomization Phase|completed in error|0
79655|NCT01226043|307911|P4|6-week Re-randomization Phase|Physician Decision|2
79656|NCT01226043|307912|P3|6-week Re-randomization Phase|Physician Decision|3
79657|NCT01226043|307913|P2|6-week Re-randomization Phase|Physician Decision|0
79658|NCT01226043|307914|P1|6-week Re-randomization Phase|Physician Decision|0
79659|NCT01226043|307911|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
79660|NCT01226043|307912|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
79661|NCT01226043|307913|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
79662|NCT01226043|307914|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
79663|NCT01226043|307911|P4|6-week Re-randomization Phase|Lost to Follow-up|3
79664|NCT01226043|307912|P3|6-week Re-randomization Phase|Lost to Follow-up|1
79665|NCT01226043|307913|P2|6-week Re-randomization Phase|Lost to Follow-up|0
79666|NCT01226043|307914|P1|6-week Re-randomization Phase|Lost to Follow-up|0
79667|NCT01226043|307911|P4|6-week Re-randomization Phase|Protocol Violation|1
79668|NCT01226043|307912|P3|6-week Re-randomization Phase|Protocol Violation|1
79669|NCT01226043|307913|P2|6-week Re-randomization Phase|Protocol Violation|0
79670|NCT01226043|307914|P1|6-week Re-randomization Phase|Protocol Violation|0
79671|NCT01226043|307911|P4|6-week Re-randomization Phase|Adverse Event|1
79672|NCT01226043|307912|P3|6-week Re-randomization Phase|Adverse Event|1
79673|NCT01226043|307913|P2|6-week Re-randomization Phase|Adverse Event|0
79674|NCT01226043|307914|P1|6-week Re-randomization Phase|Adverse Event|0
79675|NCT01226043|307911|P4|4-week Crossover Phase - Period 2|Physician Decision|0
79676|NCT01226043|307912|P3|4-week Crossover Phase - Period 2|Physician Decision|0
79677|NCT01226043|307913|P2|4-week Crossover Phase - Period 2|Physician Decision|5
79678|NCT01226043|307914|P1|4-week Crossover Phase - Period 2|Physician Decision|4
79679|NCT01226043|307911|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
79680|NCT01226043|307912|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
79681|NCT01226043|307913|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
79682|NCT01226043|307914|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
79683|NCT01226043|307911|P4|4-week Crossover Phase - Period 1|Physician Decision|0
79684|NCT01226043|307912|P3|4-week Crossover Phase - Period 1|Physician Decision|0
79685|NCT01226043|307913|P2|4-week Crossover Phase - Period 1|Physician Decision|6
79686|NCT01226043|307914|P1|4-week Crossover Phase - Period 1|Physician Decision|0
79687|NCT01226043|307911|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
79688|NCT01226043|307912|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
79689|NCT01226043|307913|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
79690|NCT01226043|307914|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
79691|NCT01226043|307911|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
79692|NCT01226043|307912|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
79693|NCT01226043|307913|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
79694|NCT01226043|307914|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
79695|NCT01226043|307911|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
79696|NCT01226043|307912|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
79697|NCT01226043|307913|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
79698|NCT01226043|307914|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
79699|NCT01225991|307952|P1|Overall Study|Withdrawal by Subject|6
79700|NCT01225952|307963|P3|Overall Study|Surgical complications|0
79701|NCT01225952|307964|P2|Overall Study|Surgical complications|0
79702|NCT01225952|307965|P1|Overall Study|Surgical complications|1
79703|NCT01225952|307963|P3|Overall Study|Withdrawal by Subject|5
79704|NCT01225952|307964|P2|Overall Study|Withdrawal by Subject|4
79705|NCT01225952|307965|P1|Overall Study|Withdrawal by Subject|4
79706|NCT01225952|307963|P3|Overall Study|Study Eye Explanted|1
79707|NCT01225952|307964|P2|Overall Study|Study Eye Explanted|0
79708|NCT01225952|307965|P1|Overall Study|Study Eye Explanted|0
79709|NCT01225952|307963|P3|Overall Study|Lost to Follow-up|0
79710|NCT01225952|307964|P2|Overall Study|Lost to Follow-up|0
79711|NCT01225952|307965|P1|Overall Study|Lost to Follow-up|1
79712|NCT01225887|308057|P1|Overall Study|Ineligible:inadequate pathology|2
79713|NCT01225887|308057|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
79714|NCT01225887|308057|P1|Overall Study|Ineligible:required test not done|2
79715|NCT01225835|308067|P2|Overall Study|not specified|1
79716|NCT01225835|308068|P1|Overall Study|not specified|1
79717|NCT01225835|308067|P2|Overall Study|Adverse Event|1
79718|NCT01225835|308068|P1|Overall Study|Adverse Event|2
79719|NCT01225835|308067|P2|Overall Study|Did not meet hCG criterion|0
79720|NCT01225835|308068|P1|Overall Study|Did not meet hCG criterion|2
79721|NCT01225835|308067|P2|Overall Study|Completed protocol|1
79722|NCT01225835|308068|P1|Overall Study|Completed protocol|2
79723|NCT01225822|308116|P5|Overall Study|Not Specified|7
79724|NCT01225822|308117|P4|Overall Study|Not Specified|10
79725|NCT01225822|308118|P3|Overall Study|Not Specified|7
79726|NCT01225822|308119|P2|Overall Study|Not Specified|10
79727|NCT01225822|308120|P1|Overall Study|Not Specified|13
79728|NCT01225822|308116|P5|Overall Study|Withdrawal by Subject|6
79729|NCT01225822|308117|P4|Overall Study|Withdrawal by Subject|11
79730|NCT01225822|308118|P3|Overall Study|Withdrawal by Subject|7
79731|NCT01225822|308119|P2|Overall Study|Withdrawal by Subject|7
79732|NCT01225822|308120|P1|Overall Study|Withdrawal by Subject|6
79733|NCT01225822|308116|P5|Overall Study|Lost to Follow-up|0
79734|NCT01225822|308117|P4|Overall Study|Lost to Follow-up|1
79735|NCT01225822|308118|P3|Overall Study|Lost to Follow-up|0
79736|NCT01225822|308119|P2|Overall Study|Lost to Follow-up|0
79737|NCT01225822|308120|P1|Overall Study|Lost to Follow-up|0
79738|NCT01225822|308116|P5|Overall Study|Protocol Violation|4
79739|NCT01225822|308117|P4|Overall Study|Protocol Violation|7
79740|NCT01225822|308118|P3|Overall Study|Protocol Violation|6
79741|NCT01225822|308119|P2|Overall Study|Protocol Violation|8
79742|NCT01225822|308120|P1|Overall Study|Protocol Violation|6
79743|NCT01225822|308116|P5|Overall Study|Adverse Event|14
79744|NCT01225822|308117|P4|Overall Study|Adverse Event|23
79745|NCT01225822|308118|P3|Overall Study|Adverse Event|18
79746|NCT01225822|308119|P2|Overall Study|Adverse Event|31
79747|NCT01225822|308120|P1|Overall Study|Adverse Event|13
79748|NCT01225731|308187|P13|Part 3|Withdrawal by Subject|4
79749|NCT01225731|308188|P12|Part 3|Withdrawal by Subject|6
79750|NCT01225731|308189|P11|Part 3|Withdrawal by Subject|4
79751|NCT01225731|308190|P10|Part 3|Withdrawal by Subject|0
79752|NCT01225731|308191|P9|Part 3|Withdrawal by Subject|0
79753|NCT01225731|308192|P8|Part 3|Withdrawal by Subject|0
79754|NCT01225731|308193|P7|Part 3|Withdrawal by Subject|0
79755|NCT01225731|308194|P6|Part 3|Withdrawal by Subject|0
79756|NCT01225731|308195|P5|Part 3|Withdrawal by Subject|0
79757|NCT01225731|308196|P4|Part 3|Withdrawal by Subject|0
79758|NCT01225731|308197|P3|Part 3|Withdrawal by Subject|0
79759|NCT01225731|308198|P2|Part 3|Withdrawal by Subject|0
79760|NCT01225731|308199|P1|Part 3|Withdrawal by Subject|0
79761|NCT01225731|308187|P13|Part 3|Physician Decision|2
79762|NCT01225731|308188|P12|Part 3|Physician Decision|1
79763|NCT01225731|308189|P11|Part 3|Physician Decision|0
79764|NCT01225731|308190|P10|Part 3|Physician Decision|0
79765|NCT01225731|308191|P9|Part 3|Physician Decision|0
79766|NCT01225731|308192|P8|Part 3|Physician Decision|0
79767|NCT01225731|308193|P7|Part 3|Physician Decision|0
79768|NCT01225731|308194|P6|Part 3|Physician Decision|0
79769|NCT01225731|308195|P5|Part 3|Physician Decision|0
79770|NCT01225731|308196|P4|Part 3|Physician Decision|0
79771|NCT01225731|308197|P3|Part 3|Physician Decision|0
79772|NCT01225731|308198|P2|Part 3|Physician Decision|0
79773|NCT01225731|308199|P1|Part 3|Physician Decision|0
79774|NCT01225731|308187|P13|Part 3|Lost to Follow-up|1
79775|NCT01225731|308188|P12|Part 3|Lost to Follow-up|2
79776|NCT01225731|308189|P11|Part 3|Lost to Follow-up|1
79777|NCT01225731|308190|P10|Part 3|Lost to Follow-up|0
79778|NCT01225731|308191|P9|Part 3|Lost to Follow-up|0
79779|NCT01225731|308192|P8|Part 3|Lost to Follow-up|0
79780|NCT01225731|308193|P7|Part 3|Lost to Follow-up|0
79781|NCT01225731|308194|P6|Part 3|Lost to Follow-up|0
79782|NCT01225731|308195|P5|Part 3|Lost to Follow-up|0
79783|NCT01225731|308196|P4|Part 3|Lost to Follow-up|0
79784|NCT01225731|308197|P3|Part 3|Lost to Follow-up|0
79785|NCT01225731|308198|P2|Part 3|Lost to Follow-up|0
79786|NCT01225731|308199|P1|Part 3|Lost to Follow-up|0
79787|NCT01225731|308187|P13|Part 3|Adverse Event|0
79788|NCT01225731|308188|P12|Part 3|Adverse Event|1
79789|NCT01225731|308189|P11|Part 3|Adverse Event|1
79790|NCT01225731|308190|P10|Part 3|Adverse Event|0
79791|NCT01225731|308191|P9|Part 3|Adverse Event|0
79792|NCT01225731|308192|P8|Part 3|Adverse Event|0
79793|NCT01225731|308193|P7|Part 3|Adverse Event|0
79794|NCT01225731|308194|P6|Part 3|Adverse Event|0
79795|NCT01225731|308195|P5|Part 3|Adverse Event|0
79796|NCT01225731|308196|P4|Part 3|Adverse Event|0
79797|NCT01225731|308197|P3|Part 3|Adverse Event|0
79798|NCT01225731|308198|P2|Part 3|Adverse Event|0
79799|NCT01225731|308199|P1|Part 3|Adverse Event|0
79800|NCT01225731|308187|P13|Part 2|Withdrawal by Subject|0
79801|NCT01225731|308188|P12|Part 2|Withdrawal by Subject|0
79802|NCT01225731|308189|P11|Part 2|Withdrawal by Subject|0
79803|NCT01225731|308190|P10|Part 2|Withdrawal by Subject|0
79804|NCT01225731|308191|P9|Part 2|Withdrawal by Subject|1
79805|NCT01225731|308192|P8|Part 2|Withdrawal by Subject|4
79806|NCT01225731|308193|P7|Part 2|Withdrawal by Subject|3
79807|NCT01225731|308194|P6|Part 2|Withdrawal by Subject|1
79808|NCT01225731|308195|P5|Part 2|Withdrawal by Subject|0
79809|NCT01225731|308196|P4|Part 2|Withdrawal by Subject|0
79810|NCT01225731|308197|P3|Part 2|Withdrawal by Subject|0
79811|NCT01225731|308198|P2|Part 2|Withdrawal by Subject|0
79812|NCT01225731|308199|P1|Part 2|Withdrawal by Subject|0
79813|NCT01225731|308187|P13|Part 2|Physician Decision|0
79814|NCT01225731|308188|P12|Part 2|Physician Decision|0
79815|NCT01225731|308189|P11|Part 2|Physician Decision|0
79816|NCT01225731|308190|P10|Part 2|Physician Decision|0
79817|NCT01225731|308191|P9|Part 2|Physician Decision|2
79818|NCT01225731|308192|P8|Part 2|Physician Decision|2
79819|NCT01225731|308193|P7|Part 2|Physician Decision|0
79820|NCT01225731|308194|P6|Part 2|Physician Decision|0
79821|NCT01225731|308195|P5|Part 2|Physician Decision|0
79822|NCT01225731|308196|P4|Part 2|Physician Decision|0
79823|NCT01225731|308197|P3|Part 2|Physician Decision|0
79824|NCT01225731|308198|P2|Part 2|Physician Decision|0
79825|NCT01225731|308199|P1|Part 2|Physician Decision|0
79826|NCT01225731|308187|P13|Part 2|Lost to Follow-up|0
79827|NCT01225731|308188|P12|Part 2|Lost to Follow-up|0
79828|NCT01225731|308189|P11|Part 2|Lost to Follow-up|0
79829|NCT01225731|308190|P10|Part 2|Lost to Follow-up|0
79830|NCT01225731|308191|P9|Part 2|Lost to Follow-up|1
79831|NCT01225731|308192|P8|Part 2|Lost to Follow-up|3
79832|NCT01225731|308193|P7|Part 2|Lost to Follow-up|0
79833|NCT01225731|308194|P6|Part 2|Lost to Follow-up|0
79834|NCT01225731|308195|P5|Part 2|Lost to Follow-up|0
79835|NCT01225731|308196|P4|Part 2|Lost to Follow-up|0
79836|NCT01225731|308197|P3|Part 2|Lost to Follow-up|0
79837|NCT01225731|308198|P2|Part 2|Lost to Follow-up|0
79838|NCT01225731|308199|P1|Part 2|Lost to Follow-up|0
79839|NCT01225731|308187|P13|Part 2|Pregnancy|0
79840|NCT01225731|308188|P12|Part 2|Pregnancy|0
79841|NCT01225731|308189|P11|Part 2|Pregnancy|0
79842|NCT01225731|308190|P10|Part 2|Pregnancy|0
79843|NCT01225731|308191|P9|Part 2|Pregnancy|1
79844|NCT01225731|308192|P8|Part 2|Pregnancy|0
79845|NCT01225731|308193|P7|Part 2|Pregnancy|1
79846|NCT01225731|308194|P6|Part 2|Pregnancy|0
79847|NCT01225731|308195|P5|Part 2|Pregnancy|0
79848|NCT01225731|308196|P4|Part 2|Pregnancy|0
79849|NCT01225731|308197|P3|Part 2|Pregnancy|0
79850|NCT01225731|308198|P2|Part 2|Pregnancy|0
79851|NCT01225731|308199|P1|Part 2|Pregnancy|0
79852|NCT01225731|308187|P13|Part 2|Lack of Efficacy|0
79853|NCT01225731|308188|P12|Part 2|Lack of Efficacy|0
79854|NCT01225731|308189|P11|Part 2|Lack of Efficacy|0
79855|NCT01225731|308190|P10|Part 2|Lack of Efficacy|0
79856|NCT01225731|308191|P9|Part 2|Lack of Efficacy|3
79857|NCT01225731|308192|P8|Part 2|Lack of Efficacy|12
79858|NCT01225731|308193|P7|Part 2|Lack of Efficacy|0
79859|NCT01225731|308194|P6|Part 2|Lack of Efficacy|1
79860|NCT01225731|308195|P5|Part 2|Lack of Efficacy|0
79861|NCT01225731|308196|P4|Part 2|Lack of Efficacy|0
79862|NCT01225731|308197|P3|Part 2|Lack of Efficacy|0
79863|NCT01225731|308198|P2|Part 2|Lack of Efficacy|0
79864|NCT01225731|308199|P1|Part 2|Lack of Efficacy|0
79865|NCT01225731|308187|P13|Part 2|Adverse Event|0
79866|NCT01225731|308188|P12|Part 2|Adverse Event|0
79867|NCT01225731|308189|P11|Part 2|Adverse Event|0
79868|NCT01225731|308190|P10|Part 2|Adverse Event|0
79869|NCT01225731|308191|P9|Part 2|Adverse Event|2
79870|NCT01225731|308192|P8|Part 2|Adverse Event|4
79871|NCT01225731|308193|P7|Part 2|Adverse Event|4
79872|NCT01225731|308194|P6|Part 2|Adverse Event|0
79873|NCT01225731|308195|P5|Part 2|Adverse Event|0
79874|NCT01225731|308196|P4|Part 2|Adverse Event|0
79875|NCT01225731|308197|P3|Part 2|Adverse Event|0
79876|NCT01225731|308198|P2|Part 2|Adverse Event|0
79877|NCT01225731|308199|P1|Part 2|Adverse Event|0
79878|NCT01225731|308187|P13|Part 2|Protocol Violation|0
79879|NCT01225731|308188|P12|Part 2|Protocol Violation|0
79880|NCT01225731|308189|P11|Part 2|Protocol Violation|0
79881|NCT01225731|308190|P10|Part 2|Protocol Violation|0
79882|NCT01225731|308191|P9|Part 2|Protocol Violation|1
79883|NCT01225731|308192|P8|Part 2|Protocol Violation|0
79884|NCT01225731|308193|P7|Part 2|Protocol Violation|0
79885|NCT01225731|308194|P6|Part 2|Protocol Violation|1
79886|NCT01225731|308195|P5|Part 2|Protocol Violation|0
79887|NCT01225731|308196|P4|Part 2|Protocol Violation|0
79888|NCT01225731|308197|P3|Part 2|Protocol Violation|0
79889|NCT01225731|308198|P2|Part 2|Protocol Violation|0
79890|NCT01225731|308199|P1|Part 2|Protocol Violation|0
79891|NCT01225731|308187|P13|Part 1|Protocol Violation|0
79892|NCT01225731|308188|P12|Part 1|Protocol Violation|0
79893|NCT01225731|308189|P11|Part 1|Protocol Violation|0
79894|NCT01225731|308190|P10|Part 1|Protocol Violation|0
79895|NCT01225731|308191|P9|Part 1|Protocol Violation|0
79896|NCT01225731|308192|P8|Part 1|Protocol Violation|0
79897|NCT01225731|308193|P7|Part 1|Protocol Violation|0
79898|NCT01225731|308194|P6|Part 1|Protocol Violation|0
79899|NCT01225731|308195|P5|Part 1|Protocol Violation|0
79900|NCT01225731|308196|P4|Part 1|Protocol Violation|1
79901|NCT01225731|308197|P3|Part 1|Protocol Violation|0
79902|NCT01225731|308198|P2|Part 1|Protocol Violation|0
79903|NCT01225731|308199|P1|Part 1|Protocol Violation|0
79904|NCT01225731|308187|P13|Part 1|Withdrawal by Subject|0
79905|NCT01225731|308188|P12|Part 1|Withdrawal by Subject|0
79906|NCT01225731|308189|P11|Part 1|Withdrawal by Subject|0
79907|NCT01225731|308190|P10|Part 1|Withdrawal by Subject|0
79908|NCT01225731|308191|P9|Part 1|Withdrawal by Subject|0
79909|NCT01225731|308192|P8|Part 1|Withdrawal by Subject|0
79910|NCT01225731|308193|P7|Part 1|Withdrawal by Subject|0
79911|NCT01225731|308194|P6|Part 1|Withdrawal by Subject|0
79912|NCT01225731|308195|P5|Part 1|Withdrawal by Subject|4
79913|NCT01225731|308196|P4|Part 1|Withdrawal by Subject|0
79914|NCT01225731|308197|P3|Part 1|Withdrawal by Subject|0
79915|NCT01225731|308198|P2|Part 1|Withdrawal by Subject|3
79916|NCT01225731|308199|P1|Part 1|Withdrawal by Subject|0
79917|NCT01225731|308187|P13|Part 1|Adverse Event|0
79918|NCT01225731|308188|P12|Part 1|Adverse Event|0
79919|NCT01225731|308189|P11|Part 1|Adverse Event|0
79920|NCT01225731|308190|P10|Part 1|Adverse Event|0
79921|NCT01225731|308191|P9|Part 1|Adverse Event|0
79922|NCT01225731|308192|P8|Part 1|Adverse Event|0
79923|NCT01225731|308193|P7|Part 1|Adverse Event|0
79924|NCT01225731|308194|P6|Part 1|Adverse Event|0
79925|NCT01225731|308195|P5|Part 1|Adverse Event|1
79926|NCT01225731|308196|P4|Part 1|Adverse Event|1
79927|NCT01225731|308197|P3|Part 1|Adverse Event|1
79928|NCT01225731|308198|P2|Part 1|Adverse Event|2
79929|NCT01225731|308199|P1|Part 1|Adverse Event|1
79930|NCT01225731|308187|P13|Part 1|Did not meet eligibility criteria|0
79931|NCT01225731|308188|P12|Part 1|Did not meet eligibility criteria|0
79932|NCT01225731|308189|P11|Part 1|Did not meet eligibility criteria|0
79933|NCT01225731|308190|P10|Part 1|Did not meet eligibility criteria|0
79934|NCT01225731|308191|P9|Part 1|Did not meet eligibility criteria|0
79935|NCT01225731|308192|P8|Part 1|Did not meet eligibility criteria|0
79936|NCT01225731|308193|P7|Part 1|Did not meet eligibility criteria|0
79937|NCT01225731|308194|P6|Part 1|Did not meet eligibility criteria|0
79938|NCT01225731|308195|P5|Part 1|Did not meet eligibility criteria|1
79939|NCT01225731|308196|P4|Part 1|Did not meet eligibility criteria|0
79940|NCT01225731|308197|P3|Part 1|Did not meet eligibility criteria|0
79941|NCT01225731|308198|P2|Part 1|Did not meet eligibility criteria|0
79942|NCT01225731|308199|P1|Part 1|Did not meet eligibility criteria|1
79943|NCT01225562|308294|P3|Overall Study|Lost to Follow-up|1
79944|NCT01225562|308295|P2|Overall Study|Lost to Follow-up|6
79945|NCT01225562|308296|P1|Overall Study|Lost to Follow-up|3
79946|NCT01225562|308294|P3|Overall Study|Withdrawal by Subject|52
79947|NCT01225562|308295|P2|Overall Study|Withdrawal by Subject|50
79948|NCT01225562|308296|P1|Overall Study|Withdrawal by Subject|52
79949|NCT01225549|308313|P10|Period 6 - Washout|Disallowed medication|0
79950|NCT01225549|308314|P9|Period 6 - Washout|Disallowed medication|0
79951|NCT01225549|308315|P8|Period 6 - Washout|Disallowed medication|0
79952|NCT01225549|308316|P7|Period 6 - Washout|Disallowed medication|0
79953|NCT01225549|308317|P6|Period 6 - Washout|Disallowed medication|0
79954|NCT01225549|308318|P5|Period 6 - Washout|Disallowed medication|0
79955|NCT01225549|308319|P4|Period 6 - Washout|Disallowed medication|1
79956|NCT01225549|308320|P3|Period 6 - Washout|Disallowed medication|0
79957|NCT01225549|308321|P2|Period 6 - Washout|Disallowed medication|0
79958|NCT01225549|308322|P1|Period 6 - Washout|Disallowed medication|0
79959|NCT01225549|308313|P10|Period 4 - Washout|Disallowed medication|0
79960|NCT01225549|308314|P9|Period 4 - Washout|Disallowed medication|0
79961|NCT01225549|308315|P8|Period 4 - Washout|Disallowed medication|0
79962|NCT01225549|308316|P7|Period 4 - Washout|Disallowed medication|0
79963|NCT01225549|308317|P6|Period 4 - Washout|Disallowed medication|0
79964|NCT01225549|308318|P5|Period 4 - Washout|Disallowed medication|0
79965|NCT01225549|308319|P4|Period 4 - Washout|Disallowed medication|0
79966|NCT01225549|308320|P3|Period 4 - Washout|Disallowed medication|0
79967|NCT01225549|308321|P2|Period 4 - Washout|Disallowed medication|1
79968|NCT01225549|308322|P1|Period 4 - Washout|Disallowed medication|0
79969|NCT01225211|308405|P10|Overall Study|Other|1
79970|NCT01225211|308406|P9|Overall Study|Other|0
79971|NCT01225211|308407|P8|Overall Study|Other|0
79972|NCT01225211|308408|P7|Overall Study|Other|0
79973|NCT01225211|308409|P6|Overall Study|Other|0
79974|NCT01225211|308410|P5|Overall Study|Other|0
79975|NCT01225211|308411|P4|Overall Study|Other|0
79976|NCT01225211|308412|P3|Overall Study|Other|0
79977|NCT01225211|308413|P2|Overall Study|Other|0
79978|NCT01225211|308414|P1|Overall Study|Other|0
79979|NCT01225211|308405|P10|Overall Study|Withdrawal by Subject|3
79980|NCT01225211|308406|P9|Overall Study|Withdrawal by Subject|1
79981|NCT01225211|308407|P8|Overall Study|Withdrawal by Subject|0
79982|NCT01225211|308408|P7|Overall Study|Withdrawal by Subject|1
79983|NCT01225211|308409|P6|Overall Study|Withdrawal by Subject|0
79984|NCT01225211|308410|P5|Overall Study|Withdrawal by Subject|0
79985|NCT01225211|308411|P4|Overall Study|Withdrawal by Subject|0
79986|NCT01225211|308412|P3|Overall Study|Withdrawal by Subject|0
79987|NCT01225211|308413|P2|Overall Study|Withdrawal by Subject|0
79988|NCT01225211|308414|P1|Overall Study|Withdrawal by Subject|0
79989|NCT01225211|308405|P10|Overall Study|Adverse Event|1
79990|NCT01225211|308406|P9|Overall Study|Adverse Event|0
79991|NCT01225211|308407|P8|Overall Study|Adverse Event|0
79992|NCT01225211|308408|P7|Overall Study|Adverse Event|0
79993|NCT01225211|308409|P6|Overall Study|Adverse Event|0
79994|NCT01225211|308410|P5|Overall Study|Adverse Event|0
79995|NCT01225211|308411|P4|Overall Study|Adverse Event|0
79996|NCT01225211|308412|P3|Overall Study|Adverse Event|1
79997|NCT01225211|308413|P2|Overall Study|Adverse Event|0
79998|NCT01225211|308414|P1|Overall Study|Adverse Event|0
79999|NCT01225159|308517|P2|Overall Study|Change operation|0
80000|NCT01225159|308518|P1|Overall Study|Change operation|1
80001|NCT01225146|308528|P2|Overall Study|Sponsor discontinued making 2mg drug|2
80002|NCT01225146|308529|P1|Overall Study|Sponsor discontinued making 2mg drug|0
80003|NCT01224821|308595|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
80004|NCT01224821|308595|P1|Long-Term Follow-Up|Death|2
80005|NCT01224821|308595|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
80006|NCT01224821|308595|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
80007|NCT01224821|308595|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
80008|NCT01224821|308595|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
80009|NCT01224821|308595|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
80010|NCT01224821|308595|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
80011|NCT01224782|308614|P1|Overall Study|Transplantation|1
80012|NCT01224782|308614|P1|Overall Study|Deterioration|1
80013|NCT01224782|308614|P1|Overall Study|Financial Reasons|1
80014|NCT01224782|308614|P1|Overall Study|Change of Treatment|1
80015|NCT01224782|308614|P1|Overall Study|Start of Dialysis|3
80016|NCT01224782|308614|P1|Overall Study|Not Specified|4
80017|NCT01224782|308614|P1|Overall Study|Noncompliance|10
80018|NCT01224782|308614|P1|Overall Study|Adverse Reaction|11
80019|NCT01224782|308614|P1|Overall Study|Adverse Event|12
80020|NCT01224782|308614|P1|Overall Study|Improvement|13
80021|NCT01224782|308614|P1|Overall Study|Death|14
80022|NCT01224782|308614|P1|Overall Study|Withdrawal by Subject|16
80023|NCT01224782|308614|P1|Overall Study|Lost to Follow-up|177
80024|NCT01224639|308631|P8|Overall Study|Adverse Event|1
80025|NCT01224639|308632|P7|Overall Study|Adverse Event|0
80026|NCT01224639|308633|P6|Overall Study|Adverse Event|0
80027|NCT01224639|308634|P5|Overall Study|Adverse Event|0
80028|NCT01224639|308635|P4|Overall Study|Adverse Event|0
80029|NCT01224639|308636|P3|Overall Study|Adverse Event|0
80030|NCT01224639|308637|P2|Overall Study|Adverse Event|0
80031|NCT01224639|308638|P1|Overall Study|Adverse Event|0
80032|NCT01224639|308631|P8|Overall Study|Withdrawal by Subject|1
80033|NCT01224639|308632|P7|Overall Study|Withdrawal by Subject|1
80034|NCT01224639|308633|P6|Overall Study|Withdrawal by Subject|0
80035|NCT01224639|308634|P5|Overall Study|Withdrawal by Subject|2
80036|NCT01224639|308635|P4|Overall Study|Withdrawal by Subject|0
80037|NCT01224639|308636|P3|Overall Study|Withdrawal by Subject|0
80038|NCT01224639|308637|P2|Overall Study|Withdrawal by Subject|0
80039|NCT01224639|308638|P1|Overall Study|Withdrawal by Subject|0
80040|NCT01224431|308756|P2|Overall Study|no video record|1
80041|NCT01224431|308757|P1|Overall Study|no video record|0
80042|NCT01224431|308756|P2|Overall Study|not randomized|4
80043|NCT01224431|308757|P1|Overall Study|not randomized|0
80044|NCT01224171|308776|P2|Overall Study|Lost to Follow-up|3
80045|NCT01224171|308777|P1|Overall Study|Lost to Follow-up|0
80046|NCT01224171|308776|P2|Overall Study|Withdrawal of Consent|4
80047|NCT01224171|308777|P1|Overall Study|Withdrawal of Consent|2
80048|NCT01224171|308776|P2|Overall Study|Lack of Efficacy|1
80049|NCT01224171|308777|P1|Overall Study|Lack of Efficacy|5
80050|NCT01224171|308776|P2|Overall Study|Protocol Violation|1
80051|NCT01224171|308777|P1|Overall Study|Protocol Violation|0
80052|NCT01224171|308776|P2|Overall Study|Adverse Event|4
80053|NCT01224171|308777|P1|Overall Study|Adverse Event|8
80054|NCT01223937|308817|P2|Overall Study|Not specified|1
80055|NCT01223937|308818|P1|Overall Study|Not specified|4
80056|NCT01223937|308817|P2|Overall Study|Protocol Violation|7
80057|NCT01223937|308818|P1|Overall Study|Protocol Violation|8
80058|NCT01223937|308817|P2|Overall Study|Adverse Event|4
80059|NCT01223937|308818|P1|Overall Study|Adverse Event|1
80060|NCT01223937|308817|P2|Overall Study|Lost to Follow-up|4
80061|NCT01223937|308818|P1|Overall Study|Lost to Follow-up|1
80062|NCT01223937|308817|P2|Overall Study|Withdrawal by Subject|2
80063|NCT01223937|308818|P1|Overall Study|Withdrawal by Subject|3
80064|NCT01223404|308864|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
80065|NCT01223404|308865|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
80066|NCT01223404|308866|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
80067|NCT01223404|308867|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
80068|NCT01223404|308868|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
80069|NCT01223404|308869|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
80070|NCT01223404|308864|P6|Second Intervention (1 Day)|Adverse Event|0
80071|NCT01223404|308865|P5|Second Intervention (1 Day)|Adverse Event|0
80072|NCT01223404|308866|P4|Second Intervention (1 Day)|Adverse Event|0
80073|NCT01223404|308867|P3|Second Intervention (1 Day)|Adverse Event|0
80074|NCT01223404|308868|P2|Second Intervention (1 Day)|Adverse Event|0
80075|NCT01223404|308869|P1|Second Intervention (1 Day)|Adverse Event|1
80076|NCT01223404|308864|P6|First Intervention (1 Day)|Adverse Event|0
80077|NCT01223404|308865|P5|First Intervention (1 Day)|Adverse Event|0
80078|NCT01223404|308866|P4|First Intervention (1 Day)|Adverse Event|1
80079|NCT01223404|308867|P3|First Intervention (1 Day)|Adverse Event|0
80080|NCT01223404|308868|P2|First Intervention (1 Day)|Adverse Event|0
80081|NCT01223404|308869|P1|First Intervention (1 Day)|Adverse Event|0
80082|NCT01223365|308892|P1|Open-label Treatment Period|Physician Decision|2
80083|NCT01223365|308892|P1|Open-label Treatment Period|Starting physical therapy|1
80084|NCT01223365|308892|P1|Open-label Treatment Period|"Out of window"|1
80167|NCT01222416|309245|P2|Overall Study|Death|0
80085|NCT01223365|308892|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
80086|NCT01223365|308892|P1|Open-label Treatment Period|Moved out of area|2
80087|NCT01223365|308892|P1|Open-label Treatment Period|Noncompliance with study procedures|6
80088|NCT01223365|308892|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
80089|NCT01223365|308892|P1|Open-label Treatment Period|Lost to Follow-up|7
80090|NCT01223365|308892|P1|Open-label Treatment Period|Protocol Violation|15
80091|NCT01223365|308892|P1|Open-label Treatment Period|Withdrawal by Subject|19
80092|NCT01223365|308892|P1|Open-label Treatment Period|Lack of Efficacy|2
80093|NCT01223365|308892|P1|Open-label Treatment Period|Adverse Event|39
80094|NCT01223365|308892|P1|Open-label Titration Period|Starting physical therapy|1
80095|NCT01223365|308892|P1|Open-label Titration Period|Noncompliance with study procedures|2
80096|NCT01223365|308892|P1|Open-label Titration Period|Noncompliance with study drug admin|1
80097|NCT01223365|308892|P1|Open-label Titration Period|Lost to Follow-up|2
80098|NCT01223365|308892|P1|Open-label Titration Period|Protocol Violation|1
80099|NCT01223365|308892|P1|Open-label Titration Period|Withdrawal by Subject|5
80100|NCT01223365|308892|P1|Open-label Titration Period|Lack of Efficacy|3
80101|NCT01223365|308892|P1|Open-label Titration Period|Adverse Event|23
80102|NCT01223365|308892|P1|Open-label Titration Period|Enrolled but not treated|1
80103|NCT01223235|308956|P1|Overall Study|Withdrawal by Subject|1
80104|NCT01223196|308964|P2|Overall Study|Withdrawal by Subject|0
80105|NCT01223196|308965|P1|Overall Study|Withdrawal by Subject|1
80106|NCT01223196|308964|P2|Overall Study|Physician Decision|0
80107|NCT01223196|308965|P1|Overall Study|Physician Decision|1
80108|NCT01223196|308964|P2|Overall Study|Lost to Follow-up|0
80109|NCT01223196|308965|P1|Overall Study|Lost to Follow-up|2
80110|NCT01223183|308977|P2|Washout Period (5-24 Days)|Physician Decision|0
80111|NCT01223183|308978|P1|Washout Period (5-24 Days)|Physician Decision|1
80112|NCT01223183|308977|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
80113|NCT01223183|308978|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
80114|NCT01223183|308977|P2|Imaging Day 1|Physician Decision|1
80115|NCT01223183|308978|P1|Imaging Day 1|Physician Decision|0
80116|NCT01223027|308988|P2|Overall Study|Study terminated by sponsor|8
80117|NCT01223027|308989|P1|Overall Study|Study terminated by sponsor|2
80118|NCT01223027|308988|P2|Overall Study|New therapy for study indication|8
80119|NCT01223027|308989|P1|Overall Study|New therapy for study indication|17
80120|NCT01223027|308988|P2|Overall Study|Subject/guardian decicion|16
80121|NCT01223027|308989|P1|Overall Study|Subject/guardian decicion|18
80122|NCT01223027|308988|P2|Overall Study|Protocol Violation|1
80123|NCT01223027|308989|P1|Overall Study|Protocol Violation|2
80124|NCT01223027|308988|P2|Overall Study|Progressive Disease|183
80125|NCT01223027|308989|P1|Overall Study|Progressive Disease|167
80126|NCT01223027|308988|P2|Overall Study|Physician Decision|8
80127|NCT01223027|308989|P1|Overall Study|Physician Decision|4
80128|NCT01223027|308988|P2|Overall Study|Lost to Follow-up|1
80129|NCT01223027|308989|P1|Overall Study|Lost to Follow-up|2
80130|NCT01223027|308988|P2|Overall Study|Death|42
80131|NCT01223027|308989|P1|Overall Study|Death|42
80132|NCT01223027|308988|P2|Overall Study|Adverse Event|10
80133|NCT01223027|308989|P1|Overall Study|Adverse Event|20
80134|NCT01222715|309041|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
80135|NCT01222715|309042|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
80136|NCT01222715|309041|P2|Overall Study|Ineligible|1
80137|NCT01222715|309042|P1|Overall Study|Ineligible|0
80138|NCT01222715|309041|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
80139|NCT01222715|309042|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
80140|NCT01222715|309041|P2|Overall Study|Refusal of further protocol therapy|4
80141|NCT01222715|309042|P1|Overall Study|Refusal of further protocol therapy|0
80142|NCT01222715|309041|P2|Overall Study|Physician Decision|2
80143|NCT01222715|309042|P1|Overall Study|Physician Decision|12
80144|NCT01222715|309041|P2|Overall Study|Lack of Efficacy|14
80145|NCT01222715|309042|P1|Overall Study|Lack of Efficacy|22
80146|NCT01222715|309041|P2|Overall Study|Death|1
80147|NCT01222715|309042|P1|Overall Study|Death|0
80148|NCT01222715|309041|P2|Overall Study|Adverse Event|4
80149|NCT01222715|309042|P1|Overall Study|Adverse Event|0
80150|NCT01222533|309081|P1|Overall Study|Other|4
80151|NCT01222533|309081|P1|Overall Study|Withdrawal by Subject|5
80152|NCT01222533|309081|P1|Overall Study|Adverse Event|5
80153|NCT01222520|309220|P2|Double-blind Period|Study medication stolen|0
80154|NCT01222520|309221|P1|Double-blind Period|Study medication stolen|1
80155|NCT01222520|309220|P2|Double-blind Period|Lack of Efficacy|1
80156|NCT01222520|309221|P1|Double-blind Period|Lack of Efficacy|0
80157|NCT01222520|309220|P2|Double-blind Period|Adverse Event|1
80158|NCT01222520|309221|P1|Double-blind Period|Adverse Event|0
80159|NCT01222520|309220|P2|Open-label run-in Period|Number of patients fulfilled|3
80160|NCT01222520|309221|P1|Open-label run-in Period|Number of patients fulfilled|0
80161|NCT01222520|309220|P2|Open-label run-in Period|Blood pressure criteria not met|18
80162|NCT01222520|309221|P1|Open-label run-in Period|Blood pressure criteria not met|0
80163|NCT01222520|309220|P2|Open-label run-in Period|Withdrawal by Subject|2
80164|NCT01222520|309221|P1|Open-label run-in Period|Withdrawal by Subject|0
80165|NCT01222507|309239|P1|Overall Study|Withdrawal by Subject|1
80166|NCT01222507|309239|P1|Overall Study|Physician Decision|1
80168|NCT01222416|309246|P1|Overall Study|Death|1
80169|NCT01222416|309245|P2|Overall Study|missed view/scan|0
80170|NCT01222416|309246|P1|Overall Study|missed view/scan|1
80171|NCT01222416|309245|P2|Overall Study|scheduling|0
80172|NCT01222416|309246|P1|Overall Study|scheduling|6
80173|NCT01222416|309245|P2|Overall Study|Withdrawal by Subject|0
80174|NCT01222416|309246|P1|Overall Study|Withdrawal by Subject|5
80175|NCT01222416|309245|P2|Overall Study|Adverse Event|0
80176|NCT01222416|309246|P1|Overall Study|Adverse Event|4
80177|NCT01222416|309245|P2|Overall Study|ineligible;metastasis|0
80178|NCT01222416|309246|P1|Overall Study|ineligible;metastasis|3
80179|NCT01222403|309256|P2|Overall Study|Inappropriate enrollment|2
80180|NCT01222403|309257|P1|Overall Study|Inappropriate enrollment|0
80181|NCT01222104|309366|P1|Overall Study|Death|10
80182|NCT01222104|309366|P1|Overall Study|Lost to Follow-up|37
80183|NCT01222078|309380|P1|Overall Study|Early termination of the study|1
80184|NCT01221948|309414|P1|Overall Study|Protocol Violation|4
80185|NCT01221948|309414|P1|Overall Study|Death|1
80186|NCT01221948|309414|P1|Overall Study|not disclosed|2
80187|NCT01221948|309414|P1|Overall Study|Withdrawal by Subject|2
80188|NCT01221948|309414|P1|Overall Study|Physician Decision|5
80189|NCT01221753|309425|P1|Overall Study|Adverse Event|1
80190|NCT01221727|309432|P2|Overall Study|Withdrawal by Subject|1
80191|NCT01221727|309433|P1|Overall Study|Withdrawal by Subject|1
80192|NCT01221727|309432|P2|Overall Study|Physician Decision|0
80193|NCT01221727|309433|P1|Overall Study|Physician Decision|2
80194|NCT01221623|309454|P2|Overall Study|Other|2
80195|NCT01221623|309455|P1|Overall Study|Other|5
80196|NCT01221623|309454|P2|Overall Study|Death|0
80197|NCT01221623|309455|P1|Overall Study|Death|1
80198|NCT01221623|309454|P2|Overall Study|Adverse Event|3
80199|NCT01221623|309455|P1|Overall Study|Adverse Event|6
80200|NCT01221623|309454|P2|Overall Study|Lost to Follow-up|1
80201|NCT01221623|309455|P1|Overall Study|Lost to Follow-up|7
80202|NCT01221623|309454|P2|Overall Study|Withdrawal by Subject|8
80203|NCT01221623|309455|P1|Overall Study|Withdrawal by Subject|19
80204|NCT01221597|309479|P2|Overall Study|Death|0
80205|NCT01221597|309480|P1|Overall Study|Death|2
80206|NCT01221597|309479|P2|Overall Study|Other|4
80207|NCT01221597|309480|P1|Overall Study|Other|3
80208|NCT01221597|309479|P2|Overall Study|Protocol Violation|0
80209|NCT01221597|309480|P1|Overall Study|Protocol Violation|1
80210|NCT01221597|309479|P2|Overall Study|Lost to Follow-up|5
80211|NCT01221597|309480|P1|Overall Study|Lost to Follow-up|6
80212|NCT01221597|309479|P2|Overall Study|Withdrawal by Subject|6
80213|NCT01221597|309480|P1|Overall Study|Withdrawal by Subject|20
80214|NCT01221597|309479|P2|Overall Study|Adverse Event|1
80215|NCT01221597|309480|P1|Overall Study|Adverse Event|4
80216|NCT01221363|309537|P2|Overall Study|Withdrawal by Subject|5
80217|NCT01221363|309538|P1|Overall Study|Withdrawal by Subject|11
80218|NCT01221363|309537|P2|Overall Study|Pregnancy|0
80219|NCT01221363|309538|P1|Overall Study|Pregnancy|1
80220|NCT01221350|309548|P2|Overall Study|Withdrawal by Subject|2
80221|NCT01221350|309549|P1|Overall Study|Withdrawal by Subject|4
80222|NCT01221350|309548|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
80223|NCT01221350|309549|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
80224|NCT01221350|309548|P2|Overall Study|Discontinued intervention (GERD)|0
80225|NCT01221350|309549|P1|Overall Study|Discontinued intervention (GERD)|1
80226|NCT01221285|309608|P1|Overall Study|Withdrawal by Subject|1
80227|NCT01221272|309617|P2|Period 2|Adverse Event|2
80228|NCT01221272|309618|P1|Period 2|Adverse Event|0
80229|NCT01221272|309617|P2|Period 1|Significant Dosing Noncompliance|1
80230|NCT01221272|309618|P1|Period 1|Significant Dosing Noncompliance|0
80231|NCT01221272|309617|P2|Period 1|Consent Withdrawal|1
80232|NCT01221272|309618|P1|Period 1|Consent Withdrawal|0
80233|NCT01221272|309617|P2|Period 1|Adverse Event|0
80234|NCT01221272|309618|P1|Period 1|Adverse Event|2
80235|NCT01221090|309637|P4|Overall Study|Withdrawal by Subject|2
80236|NCT01221090|309638|P3|Overall Study|Withdrawal by Subject|27
80237|NCT01221090|309639|P2|Overall Study|Withdrawal by Subject|22
80238|NCT01221090|309640|P1|Overall Study|Withdrawal by Subject|0
80239|NCT01221090|309637|P4|Overall Study|Non-Compliant or Unable to Contact|20
80240|NCT01221090|309638|P3|Overall Study|Non-Compliant or Unable to Contact|15
80241|NCT01221090|309639|P2|Overall Study|Non-Compliant or Unable to Contact|12
80242|NCT01221090|309640|P1|Overall Study|Non-Compliant or Unable to Contact|15
80243|NCT01220609|309689|P1|Overall Study|Ineligible-Never treated|1
80244|NCT01220609|309689|P1|Overall Study|Ineligible- Wrong cell type|1
80245|NCT01220609|309689|P1|Overall Study|Ineligible-Wrong primary cancer site|1
80246|NCT01220557|309703|P2|Overall Study|attended less than 6 lessons|2
80247|NCT01220557|309704|P1|Overall Study|attended less than 6 lessons|1
80248|NCT01220557|309703|P2|Overall Study|Lost to Follow-up|3
80249|NCT01220557|309704|P1|Overall Study|Lost to Follow-up|5
80250|NCT01220414|309737|P4|Overall Study|Withdrawal by Subject|1
80251|NCT01220414|309738|P3|Overall Study|Withdrawal by Subject|0
80252|NCT01220414|309739|P2|Overall Study|Withdrawal by Subject|0
80253|NCT01220414|309740|P1|Overall Study|Withdrawal by Subject|1
80254|NCT01220401|309747|P1|Overall Study|Protocol Violation|1
80255|NCT01220401|309747|P1|Overall Study|Withdrawal by Subject|2
80256|NCT01220297|309756|P1|Overall Study|Lost to Follow-up|1
80257|NCT01220297|309756|P1|Overall Study|Death|2
80258|NCT01220180|309773|P1|Overall Study|Randomized but not treated|1
80259|NCT01220180|309773|P1|Overall Study|Death|1
80260|NCT01220180|309773|P1|Overall Study|Lack of Efficacy|22
80261|NCT01220180|309773|P1|Overall Study|Adverse Event|35
80262|NCT01220180|309773|P1|Overall Study|Other|72
80263|NCT01220180|309773|P1|Overall Study|Lost to Follow-up|76
80264|NCT01220128|309803|P7|Overall Study|Consent withdrawn by subject|0
80265|NCT01220128|309804|P6|Overall Study|Consent withdrawn by subject|0
80266|NCT01220128|309805|P5|Overall Study|Consent withdrawn by subject|0
80267|NCT01220128|309806|P4|Overall Study|Consent withdrawn by subject|0
80268|NCT01220128|309807|P3|Overall Study|Consent withdrawn by subject|0
80269|NCT01220128|309808|P2|Overall Study|Consent withdrawn by subject|0
80270|NCT01220128|309809|P1|Overall Study|Consent withdrawn by subject|1
80271|NCT01220128|309803|P7|Overall Study|Other|0
80272|NCT01220128|309804|P6|Overall Study|Other|0
80273|NCT01220128|309805|P5|Overall Study|Other|0
80274|NCT01220128|309806|P4|Overall Study|Other|0
80275|NCT01220128|309807|P3|Overall Study|Other|1
80276|NCT01220128|309808|P2|Overall Study|Other|0
80277|NCT01220128|309809|P1|Overall Study|Other|0
80278|NCT01220128|309803|P7|Overall Study|Adverse event, non-fatal|3
80279|NCT01220128|309804|P6|Overall Study|Adverse event, non-fatal|0
80280|NCT01220128|309805|P5|Overall Study|Adverse event, non-fatal|0
80281|NCT01220128|309806|P4|Overall Study|Adverse event, non-fatal|0
80282|NCT01220128|309807|P3|Overall Study|Adverse event, non-fatal|0
80283|NCT01220128|309808|P2|Overall Study|Adverse event, non-fatal|0
80284|NCT01220128|309809|P1|Overall Study|Adverse event, non-fatal|1
80285|NCT01220128|309803|P7|Overall Study|Adverse event, serious fatal|1
80286|NCT01220128|309804|P6|Overall Study|Adverse event, serious fatal|0
80287|NCT01220128|309805|P5|Overall Study|Adverse event, serious fatal|0
80288|NCT01220128|309806|P4|Overall Study|Adverse event, serious fatal|0
80289|NCT01220128|309807|P3|Overall Study|Adverse event, serious fatal|0
80290|NCT01220128|309808|P2|Overall Study|Adverse event, serious fatal|0
80291|NCT01220128|309809|P1|Overall Study|Adverse event, serious fatal|2
80292|NCT01220128|309803|P7|Overall Study|Sponsor study termination|1
80293|NCT01220128|309804|P6|Overall Study|Sponsor study termination|0
80294|NCT01220128|309805|P5|Overall Study|Sponsor study termination|0
80295|NCT01220128|309806|P4|Overall Study|Sponsor study termination|0
80296|NCT01220128|309807|P3|Overall Study|Sponsor study termination|0
80297|NCT01220128|309808|P2|Overall Study|Sponsor study termination|1
80298|NCT01220128|309809|P1|Overall Study|Sponsor study termination|0
80299|NCT01220128|309803|P7|Overall Study|Progressive disease|0
80300|NCT01220128|309804|P6|Overall Study|Progressive disease|0
80301|NCT01220128|309805|P5|Overall Study|Progressive disease|0
80302|NCT01220128|309806|P4|Overall Study|Progressive disease|0
80303|NCT01220128|309807|P3|Overall Study|Progressive disease|2
80304|NCT01220128|309808|P2|Overall Study|Progressive disease|0
80305|NCT01220128|309809|P1|Overall Study|Progressive disease|0
80306|NCT01219985|310014|P1|Overall Study|Physician Decision|20
80307|NCT01219933|310020|P1|Overall Study|Lack of Efficacy|1
80308|NCT01219933|310020|P1|Overall Study|Protocol Violation|8
80309|NCT01219933|310020|P1|Overall Study|Withdrawal by Subject|5
80310|NCT01219933|310020|P1|Overall Study|GC free|1
80311|NCT01219933|310020|P1|Overall Study|Lost to Follow-up|3
80312|NCT01219933|310020|P1|Overall Study|No LDA maintained|7
80313|NCT01219933|310020|P1|Overall Study|No LDA reached|5
80314|NCT01219933|310020|P1|Overall Study|Adverse Event|8
80315|NCT01218867|310230|P11|Overall Study|Death during treatment|0
80316|NCT01218867|310231|P10|Overall Study|Death during treatment|0
80317|NCT01218867|310232|P9|Overall Study|Death during treatment|0
80318|NCT01218867|310233|P8|Overall Study|Death during treatment|0
80319|NCT01218867|310234|P7|Overall Study|Death during treatment|1
80320|NCT01218867|310235|P6|Overall Study|Death during treatment|0
80321|NCT01218867|310236|P5|Overall Study|Death during treatment|0
80322|NCT01218867|310237|P4|Overall Study|Death during treatment|0
80323|NCT01218867|310238|P3|Overall Study|Death during treatment|0
80324|NCT01218867|310239|P2|Overall Study|Death during treatment|0
80325|NCT01218867|310240|P1|Overall Study|Death during treatment|0
80326|NCT01218802|310288|P2|Overall Study|Incarcerated|0
80327|NCT01218802|310289|P1|Overall Study|Incarcerated|2
80328|NCT01218802|310288|P2|Overall Study|Adverse Event|2
80329|NCT01218802|310289|P1|Overall Study|Adverse Event|0
80330|NCT01218802|310288|P2|Overall Study|Withdrawal by Subject|10
80331|NCT01218802|310289|P1|Overall Study|Withdrawal by Subject|3
80332|NCT01218802|310288|P2|Overall Study|Lost to Follow-up|6
80333|NCT01218802|310289|P1|Overall Study|Lost to Follow-up|5
80334|NCT01218646|310301|P4|Overall Study|Protocol Violation|1
80335|NCT01218646|310302|P3|Overall Study|Protocol Violation|1
80336|NCT01218646|310303|P2|Overall Study|Protocol Violation|0
80337|NCT01218646|310304|P1|Overall Study|Protocol Violation|0
80338|NCT01218646|310301|P4|Overall Study|Lost to Follow-up|0
80339|NCT01218646|310302|P3|Overall Study|Lost to Follow-up|0
80340|NCT01218646|310303|P2|Overall Study|Lost to Follow-up|0
80341|NCT01218646|310304|P1|Overall Study|Lost to Follow-up|1
80342|NCT01218646|310301|P4|Overall Study|Adverse Event|0
80343|NCT01218646|310302|P3|Overall Study|Adverse Event|1
80344|NCT01218646|310303|P2|Overall Study|Adverse Event|0
80345|NCT01218646|310304|P1|Overall Study|Adverse Event|0
80346|NCT01218594|310342|P1|Overall Study|Physician Decision|6
80347|NCT01218594|310342|P1|Overall Study|Adverse Event|2
80348|NCT01218594|310342|P1|Overall Study|Withdrawal by Subject|3
80349|NCT01218594|310342|P1|Overall Study|Death|1
80350|NCT01218477|310350|P4|Overall Study|Maximum clinical benefit|0
80351|NCT01218477|310351|P3|Overall Study|Maximum clinical benefit|0
80352|NCT01218477|310352|P2|Overall Study|Maximum clinical benefit|2
80353|NCT01218477|310353|P1|Overall Study|Maximum clinical benefit|0
80354|NCT01218477|310350|P4|Overall Study|Administrative reason by sponsor|0
80355|NCT01218477|310351|P3|Overall Study|Administrative reason by sponsor|1
80356|NCT01218477|310352|P2|Overall Study|Administrative reason by sponsor|0
80357|NCT01218477|310353|P1|Overall Study|Administrative reason by sponsor|0
80358|NCT01218477|310350|P4|Overall Study|Prepared for cell transplantation|0
80359|NCT01218477|310351|P3|Overall Study|Prepared for cell transplantation|1
80360|NCT01218477|310352|P2|Overall Study|Prepared for cell transplantation|1
80361|NCT01218477|310353|P1|Overall Study|Prepared for cell transplantation|0
80362|NCT01218477|310350|P4|Overall Study|Withdrawal by Subject|0
80363|NCT01218477|310351|P3|Overall Study|Withdrawal by Subject|1
80364|NCT01218477|310352|P2|Overall Study|Withdrawal by Subject|0
80365|NCT01218477|310353|P1|Overall Study|Withdrawal by Subject|0
80366|NCT01218477|310350|P4|Overall Study|No longer meets study criteria|0
80367|NCT01218477|310351|P3|Overall Study|No longer meets study criteria|0
80368|NCT01218477|310352|P2|Overall Study|No longer meets study criteria|0
80369|NCT01218477|310353|P1|Overall Study|No longer meets study criteria|1
80370|NCT01218477|310350|P4|Overall Study|Study drug toxicity|0
80371|NCT01218477|310351|P3|Overall Study|Study drug toxicity|5
80372|NCT01218477|310352|P2|Overall Study|Study drug toxicity|2
80373|NCT01218477|310353|P1|Overall Study|Study drug toxicity|0
80374|NCT01218477|310350|P4|Overall Study|Disease progression|2
80375|NCT01218477|310351|P3|Overall Study|Disease progression|6
80376|NCT01218477|310352|P2|Overall Study|Disease progression|3
80377|NCT01218477|310353|P1|Overall Study|Disease progression|2
80378|NCT01218438|310370|P1|Epoch 4|Withdrawal by Subject|2
80379|NCT01218438|310370|P1|Epoch 4|Physician Decision|1
80380|NCT01218438|310370|P1|Epoch 3|Adverse Event|1
80381|NCT01218438|310370|P1|Epoch 3|Withdrawal by Subject|3
80382|NCT01218438|310370|P1|Epoch 1|Adverse Event|1
80383|NCT01218438|310370|P1|Epoch 1|Physician Decision|2
80384|NCT01218308|310536|P2|Overall Study|Other|21
80385|NCT01218308|310537|P1|Overall Study|Other|14
80386|NCT01218308|310536|P2|Overall Study|Lost to Follow-up|31
80387|NCT01218308|310537|P1|Overall Study|Lost to Follow-up|27
80388|NCT01218308|310536|P2|Overall Study|Withdrawal by Subject|64
80389|NCT01218308|310537|P1|Overall Study|Withdrawal by Subject|61
80390|NCT01218308|310536|P2|Overall Study|Protocol Violation|2
80391|NCT01218308|310537|P1|Overall Study|Protocol Violation|0
80392|NCT01218308|310536|P2|Overall Study|Adverse Event|2
80393|NCT01218308|310537|P1|Overall Study|Adverse Event|1
80394|NCT01218243|310581|P2|Overall Study|Protocol Violation|10
80395|NCT01218243|310582|P1|Overall Study|Protocol Violation|5
80396|NCT01218243|310581|P2|Overall Study|Lost to Follow-up|3
80397|NCT01218243|310582|P1|Overall Study|Lost to Follow-up|3
80398|NCT01218243|310581|P2|Overall Study|Lack of Efficacy|1
80399|NCT01218243|310582|P1|Overall Study|Lack of Efficacy|1
80400|NCT01218204|310598|P4|Part B Pooled Treatment Arm|Protocol Violation|1
80401|NCT01218204|310599|P3|Part B Pooled Treatment Arm|Protocol Violation|0
80402|NCT01218204|310600|P2|Part B Pooled Treatment Arm|Protocol Violation|0
80403|NCT01218204|310601|P1|Part B Pooled Treatment Arm|Protocol Violation|0
80404|NCT01218204|310598|P4|Part B Pooled Treatment Arm|Adverse Event|2
80405|NCT01218204|310599|P3|Part B Pooled Treatment Arm|Adverse Event|0
80406|NCT01218204|310600|P2|Part B Pooled Treatment Arm|Adverse Event|0
80407|NCT01218204|310601|P1|Part B Pooled Treatment Arm|Adverse Event|0
80408|NCT01218204|310598|P4|Part B Run-in|Withdrawal by Subject|0
80409|NCT01218204|310599|P3|Part B Run-in|Withdrawal by Subject|3
80410|NCT01218204|310600|P2|Part B Run-in|Withdrawal by Subject|0
80411|NCT01218204|310601|P1|Part B Run-in|Withdrawal by Subject|0
80412|NCT01218204|310598|P4|Part B Run-in|Protocol Violation|0
80413|NCT01218204|310599|P3|Part B Run-in|Protocol Violation|2
80414|NCT01218204|310600|P2|Part B Run-in|Protocol Violation|0
80415|NCT01218204|310601|P1|Part B Run-in|Protocol Violation|0
80416|NCT01218204|310598|P4|Part B Run-in|Adverse Event|0
80417|NCT01218204|310599|P3|Part B Run-in|Adverse Event|1
80418|NCT01218204|310600|P2|Part B Run-in|Adverse Event|0
80419|NCT01218204|310601|P1|Part B Run-in|Adverse Event|0
80420|NCT01218204|310598|P4|Part B Washout|Did not meet continuation criteria|0
80421|NCT01218204|310599|P3|Part B Washout|Did not meet continuation criteria|0
80422|NCT01218204|310600|P2|Part B Washout|Did not meet continuation criteria|112
80423|NCT01218204|310601|P1|Part B Washout|Did not meet continuation criteria|0
80424|NCT01218204|310598|P4|Part B Washout|Reached defined stopping criteria|0
80425|NCT01218204|310599|P3|Part B Washout|Reached defined stopping criteria|0
80426|NCT01218204|310600|P2|Part B Washout|Reached defined stopping criteria|2
80427|NCT01218204|310601|P1|Part B Washout|Reached defined stopping criteria|0
80428|NCT01218204|310598|P4|Part B Washout|Withdrawal by Subject|0
80429|NCT01218204|310599|P3|Part B Washout|Withdrawal by Subject|0
80430|NCT01218204|310600|P2|Part B Washout|Withdrawal by Subject|14
80431|NCT01218204|310601|P1|Part B Washout|Withdrawal by Subject|0
80432|NCT01218204|310598|P4|Part B Washout|Physician Decision|0
80433|NCT01218204|310599|P3|Part B Washout|Physician Decision|0
80434|NCT01218204|310600|P2|Part B Washout|Physician Decision|14
80435|NCT01218204|310601|P1|Part B Washout|Physician Decision|0
80436|NCT01218204|310598|P4|Part B Washout|Lost to Follow-up|0
80437|NCT01218204|310599|P3|Part B Washout|Lost to Follow-up|0
80438|NCT01218204|310600|P2|Part B Washout|Lost to Follow-up|2
80439|NCT01218204|310601|P1|Part B Washout|Lost to Follow-up|0
80440|NCT01218204|310598|P4|Part B Washout|Adverse Event|0
80441|NCT01218204|310599|P3|Part B Washout|Adverse Event|0
80442|NCT01218204|310600|P2|Part B Washout|Adverse Event|1
80443|NCT01218204|310601|P1|Part B Washout|Adverse Event|0
80444|NCT01218126|310865|P4|Overall Study|Withdrawal by Subject|6
80445|NCT01218126|310866|P3|Overall Study|Withdrawal by Subject|4
80446|NCT01218126|310867|P2|Overall Study|Withdrawal by Subject|5
80447|NCT01218126|310868|P1|Overall Study|Withdrawal by Subject|2
80448|NCT01218126|310865|P4|Overall Study|Physician Decision|2
80449|NCT01218126|310866|P3|Overall Study|Physician Decision|4
80450|NCT01218126|310867|P2|Overall Study|Physician Decision|2
80451|NCT01218126|310868|P1|Overall Study|Physician Decision|1
80452|NCT01218126|310865|P4|Overall Study|Lost to Follow-up|2
80453|NCT01218126|310866|P3|Overall Study|Lost to Follow-up|0
80454|NCT01218126|310867|P2|Overall Study|Lost to Follow-up|0
80455|NCT01218126|310868|P1|Overall Study|Lost to Follow-up|0
80456|NCT01218126|310865|P4|Overall Study|Protocol-defined stopping criteria|0
80457|NCT01218126|310866|P3|Overall Study|Protocol-defined stopping criteria|0
80458|NCT01218126|310867|P2|Overall Study|Protocol-defined stopping criteria|1
80459|NCT01218126|310868|P1|Overall Study|Protocol-defined stopping criteria|1
80460|NCT01218126|310865|P4|Overall Study|Protocol Violation|3
80461|NCT01218126|310866|P3|Overall Study|Protocol Violation|2
80462|NCT01218126|310867|P2|Overall Study|Protocol Violation|2
80463|NCT01218126|310868|P1|Overall Study|Protocol Violation|5
80464|NCT01218126|310865|P4|Overall Study|Lack of Efficacy|6
80465|NCT01218126|310866|P3|Overall Study|Lack of Efficacy|2
80466|NCT01218126|310867|P2|Overall Study|Lack of Efficacy|2
80467|NCT01218126|310868|P1|Overall Study|Lack of Efficacy|7
80468|NCT01218126|310865|P4|Overall Study|Adverse Event|16
80469|NCT01218126|310866|P3|Overall Study|Adverse Event|12
80470|NCT01218126|310867|P2|Overall Study|Adverse Event|10
80471|NCT01218126|310868|P1|Overall Study|Adverse Event|8
80472|NCT01218113|310909|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
80473|NCT01218113|310910|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
80474|NCT01218113|310911|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
80475|NCT01218113|310909|P3|Overall Study|Lost to Follow-up|4
80476|NCT01218113|310910|P2|Overall Study|Lost to Follow-up|1
80477|NCT01218113|310911|P1|Overall Study|Lost to Follow-up|4
80478|NCT01218113|310909|P3|Overall Study|Withdrawal by Subject|1
80479|NCT01218113|310910|P2|Overall Study|Withdrawal by Subject|0
80480|NCT01218113|310911|P1|Overall Study|Withdrawal by Subject|1
80481|NCT01218100|311092|P4|Overall Study|Other Reason|4
80482|NCT01218100|311093|P3|Overall Study|Other Reason|6
80483|NCT01218100|311094|P2|Overall Study|Other Reason|2
80484|NCT01218100|311095|P1|Overall Study|Other Reason|2
80485|NCT01218100|311092|P4|Overall Study|Lost to Follow-up|1
80486|NCT01218100|311093|P3|Overall Study|Lost to Follow-up|2
80487|NCT01218100|311094|P2|Overall Study|Lost to Follow-up|8
80488|NCT01218100|311095|P1|Overall Study|Lost to Follow-up|3
80489|NCT01218100|311092|P4|Overall Study|Withdrawal by Subject|7
80490|NCT01218100|311093|P3|Overall Study|Withdrawal by Subject|6
80491|NCT01218100|311094|P2|Overall Study|Withdrawal by Subject|2
80492|NCT01218100|311095|P1|Overall Study|Withdrawal by Subject|5
80493|NCT01218100|311092|P4|Overall Study|Protocol Violation|1
80494|NCT01218100|311093|P3|Overall Study|Protocol Violation|1
80495|NCT01218100|311094|P2|Overall Study|Protocol Violation|0
80496|NCT01218100|311095|P1|Overall Study|Protocol Violation|0
80497|NCT01218100|311092|P4|Overall Study|Lack of Efficacy|12
80498|NCT01218100|311093|P3|Overall Study|Lack of Efficacy|5
80499|NCT01218100|311094|P2|Overall Study|Lack of Efficacy|6
80500|NCT01218100|311095|P1|Overall Study|Lack of Efficacy|9
80501|NCT01218100|311092|P4|Overall Study|Adverse Event|7
80502|NCT01218100|311093|P3|Overall Study|Adverse Event|6
80503|NCT01218100|311094|P2|Overall Study|Adverse Event|6
80504|NCT01218100|311095|P1|Overall Study|Adverse Event|4
80505|NCT01218100|311092|P4|Overall Study|Did not meet InclusionExclusion criteria|2
80506|NCT01218100|311093|P3|Overall Study|Did not meet InclusionExclusion criteria|1
80507|NCT01218100|311094|P2|Overall Study|Did not meet InclusionExclusion criteria|1
80508|NCT01218100|311095|P1|Overall Study|Did not meet InclusionExclusion criteria|1
80509|NCT01218087|311111|P2|Overall Study|Transferred|5
80510|NCT01218087|311112|P1|Overall Study|Transferred|8
80511|NCT01218087|311111|P2|Overall Study|Withdrawal by Subject|0
80512|NCT01218087|311112|P1|Overall Study|Withdrawal by Subject|5
80513|NCT01218087|311111|P2|Overall Study|Death|1
80514|NCT01218087|311112|P1|Overall Study|Death|2
80515|NCT01218009|311122|P2|Overall Study|Sponsor terminated study|163
80516|NCT01218009|311123|P1|Overall Study|Sponsor terminated study|161
80517|NCT01218009|311122|P2|Overall Study|Withdrawal by Subject|1
80518|NCT01218009|311123|P1|Overall Study|Withdrawal by Subject|3
80519|NCT01218009|311122|P2|Overall Study|Protocol Violation|1
80520|NCT01218009|311123|P1|Overall Study|Protocol Violation|2
80521|NCT01217957|311146|P5|Phase 2|Withdrawal by Patient|1
80522|NCT01217957|311147|P4|Phase 2|Withdrawal by Patient|0
80523|NCT01217957|311148|P3|Phase 2|Withdrawal by Patient|0
80524|NCT01217957|311149|P2|Phase 2|Withdrawal by Patient|0
80525|NCT01217957|311150|P1|Phase 2|Withdrawal by Patient|0
80526|NCT01217957|311146|P5|Phase 1|Withdrawal by Patient|0
80527|NCT01217957|311147|P4|Phase 1|Withdrawal by Patient|1
80528|NCT01217957|311148|P3|Phase 1|Withdrawal by Patient|1
80529|NCT01217957|311149|P2|Phase 1|Withdrawal by Patient|0
80530|NCT01217957|311150|P1|Phase 1|Withdrawal by Patient|1
80531|NCT01217944|311209|P3|Overall Study|Lack of Efficacy|0
80532|NCT01217944|311210|P2|Overall Study|Lack of Efficacy|0
80533|NCT01217944|311211|P1|Overall Study|Lack of Efficacy|1
80534|NCT01217944|311209|P3|Overall Study|Withdrawal by Subject|0
80535|NCT01217944|311210|P2|Overall Study|Withdrawal by Subject|2
80536|NCT01217944|311211|P1|Overall Study|Withdrawal by Subject|1
80537|NCT01217944|311209|P3|Overall Study|Lost to Follow-up|0
80538|NCT01217944|311210|P2|Overall Study|Lost to Follow-up|1
80539|NCT01217944|311211|P1|Overall Study|Lost to Follow-up|3
80540|NCT01217944|311209|P3|Overall Study|Protocol Violation|0
80541|NCT01217944|311210|P2|Overall Study|Protocol Violation|1
80542|NCT01217944|311211|P1|Overall Study|Protocol Violation|1
80543|NCT01217892|311254|P4|Overall Study|Poor/Non-Compliance|0
80544|NCT01217892|311255|P3|Overall Study|Poor/Non-Compliance|1
80545|NCT01217892|311256|P2|Overall Study|Poor/Non-Compliance|0
80546|NCT01217892|311257|P1|Overall Study|Poor/Non-Compliance|0
80547|NCT01217892|311254|P4|Overall Study|Incorrect enrollment|0
80548|NCT01217892|311255|P3|Overall Study|Incorrect enrollment|1
80549|NCT01217892|311256|P2|Overall Study|Incorrect enrollment|1
80550|NCT01217892|311257|P1|Overall Study|Incorrect enrollment|0
80551|NCT01217892|311254|P4|Overall Study|Subject no longer meets study criteria|8
80552|NCT01217892|311255|P3|Overall Study|Subject no longer meets study criteria|4
80553|NCT01217892|311256|P2|Overall Study|Subject no longer meets study criteria|2
80554|NCT01217892|311257|P1|Overall Study|Subject no longer meets study criteria|5
80555|NCT01217892|311254|P4|Overall Study|Lab value|0
80556|NCT01217892|311255|P3|Overall Study|Lab value|1
80557|NCT01217892|311256|P2|Overall Study|Lab value|0
80558|NCT01217892|311257|P1|Overall Study|Lab value|1
80559|NCT01217892|311254|P4|Overall Study|Withdrawal by Subject|0
80560|NCT01217892|311255|P3|Overall Study|Withdrawal by Subject|1
80561|NCT01217892|311256|P2|Overall Study|Withdrawal by Subject|2
80562|NCT01217892|311257|P1|Overall Study|Withdrawal by Subject|0
80563|NCT01217892|311254|P4|Overall Study|Adverse Event|0
80564|NCT01217892|311255|P3|Overall Study|Adverse Event|1
80565|NCT01217892|311256|P2|Overall Study|Adverse Event|1
80566|NCT01217892|311257|P1|Overall Study|Adverse Event|1
80567|NCT01217814|311320|P3|Overall Study|Lack of Efficacy|1
80568|NCT01217814|311321|P2|Overall Study|Lack of Efficacy|0
80569|NCT01217814|311322|P1|Overall Study|Lack of Efficacy|0
80570|NCT01217814|311320|P3|Overall Study|Adverse Event|0
80571|NCT01217814|311321|P2|Overall Study|Adverse Event|1
80572|NCT01217814|311322|P1|Overall Study|Adverse Event|1
80573|NCT01217801|311348|P2|Period 1|Withdrawal by Subject|1
80574|NCT01217801|311349|P1|Period 1|Withdrawal by Subject|0
80575|NCT01217801|311348|P2|Period 1|Protocol Violation|1
80576|NCT01217801|311349|P1|Period 1|Protocol Violation|1
80577|NCT01217606|311378|P2|9-Month Masked Extension|Lack of Efficacy|0
80578|NCT01217606|311379|P1|9-Month Masked Extension|Lack of Efficacy|2
80579|NCT01217606|311378|P2|9-Month Masked Extension|Pregnancy|0
80580|NCT01217606|311379|P1|9-Month Masked Extension|Pregnancy|1
80581|NCT01217606|311378|P2|9-Month Masked Extension|Lost to Follow-up|0
80582|NCT01217606|311379|P1|9-Month Masked Extension|Lost to Follow-up|1
80583|NCT01217606|311378|P2|9-Month Masked Extension|Personal Reasons|1
80584|NCT01217606|311379|P1|9-Month Masked Extension|Personal Reasons|2
80585|NCT01217606|311378|P2|9-Month Masked Extension|Other Reasons|4
80586|NCT01217606|311379|P1|9-Month Masked Extension|Other Reasons|4
80587|NCT01217606|311378|P2|9-Month Masked Extension|Adverse Event|6
80588|NCT01217606|311379|P1|9-Month Masked Extension|Adverse Event|3
80589|NCT01217606|311378|P2|Initial Treatment Phase|Adverse Event|6
80590|NCT01217606|311379|P1|Initial Treatment Phase|Adverse Event|10
80591|NCT01217606|311378|P2|Initial Treatment Phase|Lack of Efficacy|0
80592|NCT01217606|311379|P1|Initial Treatment Phase|Lack of Efficacy|1
80593|NCT01217606|311378|P2|Initial Treatment Phase|Personal Reasons|2
80594|NCT01217606|311379|P1|Initial Treatment Phase|Personal Reasons|0
80595|NCT01217606|311378|P2|Initial Treatment Phase|Protocol Violation|2
80596|NCT01217606|311379|P1|Initial Treatment Phase|Protocol Violation|3
80597|NCT01217606|311378|P2|Initial Treatment Phase|Other Reasons|2
80598|NCT01217606|311379|P1|Initial Treatment Phase|Other Reasons|0
80599|NCT01217476|311410|P2|Overall Study|Other|0
80600|NCT01217476|311411|P1|Overall Study|Other|2
80601|NCT01217476|311410|P2|Overall Study|Protocol Deviation|0
80602|NCT01217476|311411|P1|Overall Study|Protocol Deviation|1
80603|NCT01217476|311410|P2|Overall Study|Surgery on the Target Limb|2
80604|NCT01217476|311411|P1|Overall Study|Surgery on the Target Limb|0
80605|NCT01217476|311410|P2|Overall Study|Withdrawal by Subject|3
80606|NCT01217476|311411|P1|Overall Study|Withdrawal by Subject|3
80607|NCT01217476|311410|P2|Overall Study|Physician Decision|1
80608|NCT01217476|311411|P1|Overall Study|Physician Decision|0
80609|NCT01217476|311410|P2|Overall Study|Adverse Event|1
80610|NCT01217476|311411|P1|Overall Study|Adverse Event|6
80611|NCT01217463|311421|P2|Overall Study|Other|1
80612|NCT01217463|311422|P1|Overall Study|Other|1
80613|NCT01217463|311421|P2|Overall Study|Patient Non-compliant|0
80614|NCT01217463|311422|P1|Overall Study|Patient Non-compliant|1
80615|NCT01217463|311421|P2|Overall Study|Surgery on the Target Limb|1
80616|NCT01217463|311422|P1|Overall Study|Surgery on the Target Limb|0
80617|NCT01217463|311421|P2|Overall Study|Withdrawal by Subject|0
80618|NCT01217463|311422|P1|Overall Study|Withdrawal by Subject|3
80619|NCT01217463|311421|P2|Overall Study|Physician Decision|1
80620|NCT01217463|311422|P1|Overall Study|Physician Decision|0
80621|NCT01217463|311421|P2|Overall Study|Adverse Event|5
80622|NCT01217463|311422|P1|Overall Study|Adverse Event|8
80623|NCT01217307|311442|P2|Overall Study|Withdrawal by Subject|1
80624|NCT01217307|311443|P1|Overall Study|Withdrawal by Subject|0
80625|NCT01217112|311458|P5|Overall Study|Physician Decision|1
80626|NCT01217112|311459|P4|Overall Study|Physician Decision|0
80627|NCT01217112|311460|P3|Overall Study|Physician Decision|0
80628|NCT01217112|311461|P2|Overall Study|Physician Decision|0
80629|NCT01217112|311462|P1|Overall Study|Physician Decision|0
80630|NCT01217112|311458|P5|Overall Study|Withdrawal by Subject|0
80631|NCT01217112|311459|P4|Overall Study|Withdrawal by Subject|0
80632|NCT01217112|311460|P3|Overall Study|Withdrawal by Subject|1
80633|NCT01217112|311461|P2|Overall Study|Withdrawal by Subject|0
80634|NCT01217112|311462|P1|Overall Study|Withdrawal by Subject|0
80635|NCT01217112|311458|P5|Overall Study|Adverse Event|0
80636|NCT01217112|311459|P4|Overall Study|Adverse Event|2
80637|NCT01217112|311460|P3|Overall Study|Adverse Event|0
80638|NCT01217112|311461|P2|Overall Study|Adverse Event|2
80639|NCT01217112|311462|P1|Overall Study|Adverse Event|0
80640|NCT01217073|311695|P8|Extension Period|Withdrawal by Subject|8
80641|NCT01217073|311696|P7|Extension Period|Withdrawal by Subject|30
80642|NCT01217073|311697|P6|Extension Period|Withdrawal by Subject|0
80643|NCT01217073|311698|P5|Extension Period|Withdrawal by Subject|0
80644|NCT01217073|311699|P4|Extension Period|Withdrawal by Subject|0
80645|NCT01217073|311700|P3|Extension Period|Withdrawal by Subject|0
80646|NCT01217073|311701|P2|Extension Period|Withdrawal by Subject|0
80647|NCT01217073|311702|P1|Extension Period|Withdrawal by Subject|0
80648|NCT01217073|311695|P8|Extension Period|Site discontinued study participation|2
80649|NCT01217073|311696|P7|Extension Period|Site discontinued study participation|7
80650|NCT01217073|311697|P6|Extension Period|Site discontinued study participation|0
80651|NCT01217073|311698|P5|Extension Period|Site discontinued study participation|0
80652|NCT01217073|311699|P4|Extension Period|Site discontinued study participation|0
80653|NCT01217073|311700|P3|Extension Period|Site discontinued study participation|0
80654|NCT01217073|311701|P2|Extension Period|Site discontinued study participation|0
80655|NCT01217073|311702|P1|Extension Period|Site discontinued study participation|0
80656|NCT01217073|311695|P8|Extension Period|Protocol Violation|1
80657|NCT01217073|311696|P7|Extension Period|Protocol Violation|2
80658|NCT01217073|311697|P6|Extension Period|Protocol Violation|0
80659|NCT01217073|311698|P5|Extension Period|Protocol Violation|0
80660|NCT01217073|311699|P4|Extension Period|Protocol Violation|0
80661|NCT01217073|311700|P3|Extension Period|Protocol Violation|0
80662|NCT01217073|311701|P2|Extension Period|Protocol Violation|0
80663|NCT01217073|311702|P1|Extension Period|Protocol Violation|0
80664|NCT01217073|311695|P8|Extension Period|Physician Decision|1
80665|NCT01217073|311696|P7|Extension Period|Physician Decision|4
80666|NCT01217073|311697|P6|Extension Period|Physician Decision|0
80667|NCT01217073|311698|P5|Extension Period|Physician Decision|0
80668|NCT01217073|311699|P4|Extension Period|Physician Decision|0
80669|NCT01217073|311700|P3|Extension Period|Physician Decision|0
80670|NCT01217073|311701|P2|Extension Period|Physician Decision|0
80671|NCT01217073|311702|P1|Extension Period|Physician Decision|0
80672|NCT01217073|311695|P8|Extension Period|Non-compliance with study drug|1
80673|NCT01217073|311696|P7|Extension Period|Non-compliance with study drug|0
80674|NCT01217073|311697|P6|Extension Period|Non-compliance with study drug|0
80675|NCT01217073|311698|P5|Extension Period|Non-compliance with study drug|0
80676|NCT01217073|311699|P4|Extension Period|Non-compliance with study drug|0
80677|NCT01217073|311700|P3|Extension Period|Non-compliance with study drug|0
80678|NCT01217073|311701|P2|Extension Period|Non-compliance with study drug|0
80679|NCT01217073|311702|P1|Extension Period|Non-compliance with study drug|0
80680|NCT01217073|311695|P8|Extension Period|Lost to Follow-up|1
80681|NCT01217073|311696|P7|Extension Period|Lost to Follow-up|9
80682|NCT01217073|311697|P6|Extension Period|Lost to Follow-up|0
80683|NCT01217073|311698|P5|Extension Period|Lost to Follow-up|0
80684|NCT01217073|311699|P4|Extension Period|Lost to Follow-up|0
80685|NCT01217073|311700|P3|Extension Period|Lost to Follow-up|0
80686|NCT01217073|311701|P2|Extension Period|Lost to Follow-up|0
80687|NCT01217073|311702|P1|Extension Period|Lost to Follow-up|0
80688|NCT01217073|311695|P8|Extension Period|Lack of Efficacy|0
80689|NCT01217073|311696|P7|Extension Period|Lack of Efficacy|3
80690|NCT01217073|311697|P6|Extension Period|Lack of Efficacy|0
80691|NCT01217073|311698|P5|Extension Period|Lack of Efficacy|0
80692|NCT01217073|311699|P4|Extension Period|Lack of Efficacy|0
80693|NCT01217073|311700|P3|Extension Period|Lack of Efficacy|0
80694|NCT01217073|311701|P2|Extension Period|Lack of Efficacy|0
80695|NCT01217073|311702|P1|Extension Period|Lack of Efficacy|0
80696|NCT01217073|311695|P8|Extension Period|Excluded medication|0
80697|NCT01217073|311696|P7|Extension Period|Excluded medication|2
80698|NCT01217073|311697|P6|Extension Period|Excluded medication|0
80699|NCT01217073|311698|P5|Extension Period|Excluded medication|0
80700|NCT01217073|311699|P4|Extension Period|Excluded medication|0
80701|NCT01217073|311700|P3|Extension Period|Excluded medication|0
80702|NCT01217073|311701|P2|Extension Period|Excluded medication|0
80703|NCT01217073|311702|P1|Extension Period|Excluded medication|0
80704|NCT01217073|311695|P8|Extension Period|Death|0
80705|NCT01217073|311696|P7|Extension Period|Death|1
80706|NCT01217073|311697|P6|Extension Period|Death|0
80707|NCT01217073|311698|P5|Extension Period|Death|0
80708|NCT01217073|311699|P4|Extension Period|Death|0
80709|NCT01217073|311700|P3|Extension Period|Death|0
80710|NCT01217073|311701|P2|Extension Period|Death|0
80711|NCT01217073|311702|P1|Extension Period|Death|0
80712|NCT01217073|311695|P8|Extension Period|Creatinine/eGFR|1
80713|NCT01217073|311696|P7|Extension Period|Creatinine/eGFR|11
80714|NCT01217073|311697|P6|Extension Period|Creatinine/eGFR|0
80715|NCT01217073|311698|P5|Extension Period|Creatinine/eGFR|0
80716|NCT01217073|311699|P4|Extension Period|Creatinine/eGFR|0
80717|NCT01217073|311700|P3|Extension Period|Creatinine/eGFR|0
80718|NCT01217073|311701|P2|Extension Period|Creatinine/eGFR|0
80719|NCT01217073|311702|P1|Extension Period|Creatinine/eGFR|0
80720|NCT01217073|311695|P8|Extension Period|Contraindication to study medication|0
80721|NCT01217073|311696|P7|Extension Period|Contraindication to study medication|1
80722|NCT01217073|311697|P6|Extension Period|Contraindication to study medication|0
80723|NCT01217073|311698|P5|Extension Period|Contraindication to study medication|0
80724|NCT01217073|311699|P4|Extension Period|Contraindication to study medication|0
80725|NCT01217073|311700|P3|Extension Period|Contraindication to study medication|0
80726|NCT01217073|311701|P2|Extension Period|Contraindication to study medication|0
80727|NCT01217073|311702|P1|Extension Period|Contraindication to study medication|0
80728|NCT01217073|311695|P8|Extension Period|ALT/AST|0
80729|NCT01217073|311696|P7|Extension Period|ALT/AST|2
80730|NCT01217073|311697|P6|Extension Period|ALT/AST|0
80731|NCT01217073|311698|P5|Extension Period|ALT/AST|0
80732|NCT01217073|311699|P4|Extension Period|ALT/AST|0
80733|NCT01217073|311700|P3|Extension Period|ALT/AST|0
80734|NCT01217073|311701|P2|Extension Period|ALT/AST|0
80735|NCT01217073|311702|P1|Extension Period|ALT/AST|0
80736|NCT01217073|311695|P8|Extension Period|Adverse Event|5
80737|NCT01217073|311696|P7|Extension Period|Adverse Event|19
80738|NCT01217073|311697|P6|Extension Period|Adverse Event|0
80739|NCT01217073|311698|P5|Extension Period|Adverse Event|0
80740|NCT01217073|311699|P4|Extension Period|Adverse Event|0
80741|NCT01217073|311700|P3|Extension Period|Adverse Event|0
80742|NCT01217073|311701|P2|Extension Period|Adverse Event|0
80743|NCT01217073|311702|P1|Extension Period|Adverse Event|0
80744|NCT01217073|311695|P8|Base Period|Withdrawal by Subject|0
80745|NCT01217073|311696|P7|Base Period|Withdrawal by Subject|0
80746|NCT01217073|311697|P6|Base Period|Withdrawal by Subject|5
80747|NCT01217073|311698|P5|Base Period|Withdrawal by Subject|5
80748|NCT01217073|311699|P4|Base Period|Withdrawal by Subject|1
80749|NCT01217073|311700|P3|Base Period|Withdrawal by Subject|5
80750|NCT01217073|311701|P2|Base Period|Withdrawal by Subject|5
80751|NCT01217073|311702|P1|Base Period|Withdrawal by Subject|4
80752|NCT01217073|311695|P8|Base Period|Protocol Violation|0
80753|NCT01217073|311696|P7|Base Period|Protocol Violation|0
80754|NCT01217073|311697|P6|Base Period|Protocol Violation|2
80755|NCT01217073|311698|P5|Base Period|Protocol Violation|1
80756|NCT01217073|311699|P4|Base Period|Protocol Violation|0
80757|NCT01217073|311700|P3|Base Period|Protocol Violation|0
80758|NCT01217073|311701|P2|Base Period|Protocol Violation|0
80759|NCT01217073|311702|P1|Base Period|Protocol Violation|1
80760|NCT01217073|311695|P8|Base Period|Physician Decision|0
80761|NCT01217073|311696|P7|Base Period|Physician Decision|0
80762|NCT01217073|311697|P6|Base Period|Physician Decision|0
80763|NCT01217073|311698|P5|Base Period|Physician Decision|1
80764|NCT01217073|311699|P4|Base Period|Physician Decision|0
80765|NCT01217073|311700|P3|Base Period|Physician Decision|0
80766|NCT01217073|311701|P2|Base Period|Physician Decision|0
80767|NCT01217073|311702|P1|Base Period|Physician Decision|0
80768|NCT01217073|311695|P8|Base Period|Lost to Follow-up|0
80769|NCT01217073|311696|P7|Base Period|Lost to Follow-up|0
80770|NCT01217073|311697|P6|Base Period|Lost to Follow-up|0
80771|NCT01217073|311698|P5|Base Period|Lost to Follow-up|3
80772|NCT01217073|311699|P4|Base Period|Lost to Follow-up|1
80773|NCT01217073|311700|P3|Base Period|Lost to Follow-up|1
80774|NCT01217073|311701|P2|Base Period|Lost to Follow-up|0
80775|NCT01217073|311702|P1|Base Period|Lost to Follow-up|0
80776|NCT01217073|311695|P8|Base Period|Lack of Efficacy|0
80777|NCT01217073|311696|P7|Base Period|Lack of Efficacy|0
80778|NCT01217073|311697|P6|Base Period|Lack of Efficacy|1
80779|NCT01217073|311698|P5|Base Period|Lack of Efficacy|0
80780|NCT01217073|311699|P4|Base Period|Lack of Efficacy|0
80781|NCT01217073|311700|P3|Base Period|Lack of Efficacy|0
80782|NCT01217073|311701|P2|Base Period|Lack of Efficacy|0
80783|NCT01217073|311702|P1|Base Period|Lack of Efficacy|0
80784|NCT01217073|311695|P8|Base Period|Excluded medication|0
80785|NCT01217073|311696|P7|Base Period|Excluded medication|0
80786|NCT01217073|311697|P6|Base Period|Excluded medication|0
80787|NCT01217073|311698|P5|Base Period|Excluded medication|1
80788|NCT01217073|311699|P4|Base Period|Excluded medication|0
80789|NCT01217073|311700|P3|Base Period|Excluded medication|0
80790|NCT01217073|311701|P2|Base Period|Excluded medication|0
80791|NCT01217073|311702|P1|Base Period|Excluded medication|0
80792|NCT01217073|311695|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
80793|NCT01217073|311696|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
80794|NCT01217073|311697|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
80795|NCT01217073|311698|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
80796|NCT01217073|311699|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
80797|NCT01217073|311700|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
80798|NCT01217073|311701|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
80799|NCT01217073|311702|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
80800|NCT01217073|311695|P8|Base Period|Adverse Event|0
80801|NCT01217073|311696|P7|Base Period|Adverse Event|0
80802|NCT01217073|311697|P6|Base Period|Adverse Event|1
80803|NCT01217073|311698|P5|Base Period|Adverse Event|4
80804|NCT01217073|311699|P4|Base Period|Adverse Event|0
80805|NCT01217073|311700|P3|Base Period|Adverse Event|1
80806|NCT01217073|311701|P2|Base Period|Adverse Event|0
80807|NCT01217073|311702|P1|Base Period|Adverse Event|1
80808|NCT01216319|311891|P1|Overall Study|Unanticipated chemo for breast cancer|2
80809|NCT01216319|311891|P1|Overall Study|Lost to Follow-up|2
80810|NCT01216163|311908|P3|Overall Study|Withdrawal by Subject|0
80811|NCT01216163|311909|P2|Overall Study|Withdrawal by Subject|1
80812|NCT01216163|311910|P1|Overall Study|Withdrawal by Subject|1
80813|NCT01216072|311962|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
80814|NCT01216072|311963|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
80815|NCT01216072|311962|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
80816|NCT01216072|311963|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
80817|NCT01216072|311962|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
80818|NCT01216072|311963|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
80819|NCT01216072|311962|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
80820|NCT01216072|311963|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
80821|NCT01216072|311962|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
80822|NCT01216072|311963|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
80823|NCT01216072|311962|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
80824|NCT01216072|311963|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
80825|NCT01216072|311962|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
80826|NCT01216072|311963|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
80827|NCT01216072|311962|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
80828|NCT01216072|311963|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
80829|NCT01216072|311962|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
80830|NCT01216072|311963|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
80831|NCT01216072|311962|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
80832|NCT01216072|311963|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
80833|NCT01215981|311991|P2|Overall Study|Withdrawal by Subject|0
80834|NCT01215981|311992|P1|Overall Study|Withdrawal by Subject|1
80835|NCT01215981|311991|P2|Overall Study|Protocol Violation|0
80836|NCT01215981|311992|P1|Overall Study|Protocol Violation|1
80837|NCT01215981|311991|P2|Overall Study|Physician Decision|1
80838|NCT01215981|311992|P1|Overall Study|Physician Decision|0
80839|NCT01215968|312002|P2|Overall Study|Not received study drug|1
80840|NCT01215968|312003|P1|Overall Study|Not received study drug|0
80841|NCT01215968|312002|P2|Overall Study|Protocol Violation|4
80842|NCT01215968|312003|P1|Overall Study|Protocol Violation|2
80843|NCT01215968|312002|P2|Overall Study|Adverse Event|2
80844|NCT01215968|312003|P1|Overall Study|Adverse Event|0
80845|NCT01215955|312023|P4|Overall Study|Quality Issues|2
80846|NCT01215955|312024|P3|Overall Study|Quality Issues|3
80847|NCT01215955|312025|P2|Overall Study|Quality Issues|0
80848|NCT01215955|312026|P1|Overall Study|Quality Issues|0
80849|NCT01215955|312023|P4|Overall Study|Withdrawal by Subject|9
80850|NCT01215955|312024|P3|Overall Study|Withdrawal by Subject|13
80851|NCT01215955|312025|P2|Overall Study|Withdrawal by Subject|15
80852|NCT01215955|312026|P1|Overall Study|Withdrawal by Subject|14
80853|NCT01215955|312023|P4|Overall Study|Sponsor Decision|1
80854|NCT01215955|312024|P3|Overall Study|Sponsor Decision|0
80855|NCT01215955|312025|P2|Overall Study|Sponsor Decision|2
80856|NCT01215955|312026|P1|Overall Study|Sponsor Decision|1
80857|NCT01215955|312023|P4|Overall Study|Protocol Violation|8
80858|NCT01215955|312024|P3|Overall Study|Protocol Violation|8
80859|NCT01215955|312025|P2|Overall Study|Protocol Violation|13
80860|NCT01215955|312026|P1|Overall Study|Protocol Violation|17
80861|NCT01215955|312023|P4|Overall Study|Physician Decision|11
80862|NCT01215955|312024|P3|Overall Study|Physician Decision|8
80863|NCT01215955|312025|P2|Overall Study|Physician Decision|10
80864|NCT01215955|312026|P1|Overall Study|Physician Decision|4
80865|NCT01215955|312023|P4|Overall Study|Lost to Follow-up|9
80866|NCT01215955|312024|P3|Overall Study|Lost to Follow-up|8
80867|NCT01215955|312025|P2|Overall Study|Lost to Follow-up|4
80868|NCT01215955|312026|P1|Overall Study|Lost to Follow-up|4
80869|NCT01215955|312023|P4|Overall Study|Lack of Efficacy|0
80870|NCT01215955|312024|P3|Overall Study|Lack of Efficacy|1
80871|NCT01215955|312025|P2|Overall Study|Lack of Efficacy|2
80872|NCT01215955|312026|P1|Overall Study|Lack of Efficacy|1
80873|NCT01215955|312023|P4|Overall Study|Entry Criteria Not Met|7
80874|NCT01215955|312024|P3|Overall Study|Entry Criteria Not Met|4
80875|NCT01215955|312025|P2|Overall Study|Entry Criteria Not Met|3
80876|NCT01215955|312026|P1|Overall Study|Entry Criteria Not Met|1
80877|NCT01215955|312023|P4|Overall Study|Death|3
80878|NCT01215955|312024|P3|Overall Study|Death|1
80879|NCT01215955|312025|P2|Overall Study|Death|0
80880|NCT01215955|312026|P1|Overall Study|Death|2
80881|NCT01215955|312023|P4|Overall Study|Adverse Event|3
80882|NCT01215955|312024|P3|Overall Study|Adverse Event|2
80883|NCT01215955|312025|P2|Overall Study|Adverse Event|4
80884|NCT01215955|312026|P1|Overall Study|Adverse Event|1
80885|NCT01215851|312107|P6|Follow up Period|Lost to Follow-up|1
80886|NCT01215851|312108|P5|Follow up Period|Lost to Follow-up|0
80887|NCT01215851|312109|P4|Follow up Period|Lost to Follow-up|0
80888|NCT01215851|312110|P3|Follow up Period|Lost to Follow-up|0
80889|NCT01215851|312111|P2|Follow up Period|Lost to Follow-up|0
80890|NCT01215851|312112|P1|Follow up Period|Lost to Follow-up|0
80891|NCT01215851|312107|P6|Treatment Period|Adverse Event|1
80892|NCT01215851|312108|P5|Treatment Period|Adverse Event|0
80893|NCT01215851|312109|P4|Treatment Period|Adverse Event|3
80894|NCT01215851|312110|P3|Treatment Period|Adverse Event|1
80895|NCT01215851|312111|P2|Treatment Period|Adverse Event|1
80896|NCT01215851|312112|P1|Treatment Period|Adverse Event|1
80897|NCT01215734|312171|P2|Overall Study|Death|1
80898|NCT01215734|312172|P1|Overall Study|Death|0
80899|NCT01215721|312180|P1|Overall Study|Adverse Event|2
80900|NCT01215513|312312|P1|Overall Study|Miscellaneous reasons (CS42A)|2
80901|NCT01215513|312312|P1|Overall Study|Withdrawal by subject (CS42A)|5
80902|NCT01215513|312312|P1|Overall Study|Physician decision (CS42A)|6
80903|NCT01215513|312312|P1|Overall Study|Adverse event (CS42A)|2
80904|NCT01215513|312312|P1|Overall Study|Not enrolled from CS42 to CS42A|21
80905|NCT01215513|312312|P1|Overall Study|Not completed CS42|9
80906|NCT01215435|312321|P2|Overall Study|Unclassified|5
80907|NCT01215435|312322|P1|Overall Study|Unclassified|5
80908|NCT01215435|312321|P2|Overall Study|Lost to Follow-up|0
80909|NCT01215435|312322|P1|Overall Study|Lost to Follow-up|3
80910|NCT01215435|312321|P2|Overall Study|Withdrawal Criteria|11
80911|NCT01215435|312322|P1|Overall Study|Withdrawal Criteria|8
80912|NCT01215435|312321|P2|Overall Study|Protocol Violation|0
80913|NCT01215435|312322|P1|Overall Study|Protocol Violation|2
80914|NCT01215435|312321|P2|Overall Study|Adverse Event|0
80915|NCT01215435|312322|P1|Overall Study|Adverse Event|1
80916|NCT01215422|312336|P4|Overall Study|Did not complete all intubations|0
80917|NCT01215422|312337|P3|Overall Study|Did not complete all intubations|0
80918|NCT01215422|312338|P2|Overall Study|Did not complete all intubations|0
80919|NCT01215422|312339|P1|Overall Study|Did not complete all intubations|7
80920|NCT01215422|312336|P4|Overall Study|Failed intubations|8
80921|NCT01215422|312337|P3|Overall Study|Failed intubations|3
80922|NCT01215422|312338|P2|Overall Study|Failed intubations|0
80923|NCT01215422|312339|P1|Overall Study|Failed intubations|0
80924|NCT01215422|312336|P4|Overall Study|Relocation|0
80925|NCT01215422|312337|P3|Overall Study|Relocation|0
80926|NCT01215422|312338|P2|Overall Study|Relocation|0
80927|NCT01215422|312339|P1|Overall Study|Relocation|1
80928|NCT01215357|312361|P1|Overall Study|Protocol Violation|9
80929|NCT01215357|312361|P1|Overall Study|Withdrawal by Subject|3
80930|NCT01215227|312480|P6|Overall Study|Randomized but not treated|1
80931|NCT01215227|312481|P5|Overall Study|Randomized but not treated|0
80932|NCT01215227|312482|P4|Overall Study|Randomized but not treated|1
80933|NCT01215227|312483|P3|Overall Study|Randomized but not treated|1
80934|NCT01215227|312484|P2|Overall Study|Randomized but not treated|0
80935|NCT01215227|312485|P1|Overall Study|Randomized but not treated|0
80936|NCT01215227|312480|P6|Overall Study|Missing Status|0
80937|NCT01215227|312481|P5|Overall Study|Missing Status|0
80938|NCT01215227|312482|P4|Overall Study|Missing Status|0
80939|NCT01215227|312483|P3|Overall Study|Missing Status|0
80940|NCT01215227|312484|P2|Overall Study|Missing Status|1
80941|NCT01215227|312485|P1|Overall Study|Missing Status|0
80942|NCT01215227|312480|P6|Overall Study|Administrative|40
80943|NCT01215227|312481|P5|Overall Study|Administrative|28
80944|NCT01215227|312482|P4|Overall Study|Administrative|24
80945|NCT01215227|312483|P3|Overall Study|Administrative|42
80946|NCT01215227|312484|P2|Overall Study|Administrative|73
80947|NCT01215227|312485|P1|Overall Study|Administrative|83
80948|NCT01215227|312480|P6|Overall Study|Non-Compliance With Protocol|0
80949|NCT01215227|312481|P5|Overall Study|Non-Compliance With Protocol|0
80950|NCT01215227|312482|P4|Overall Study|Non-Compliance With Protocol|0
80951|NCT01215227|312483|P3|Overall Study|Non-Compliance With Protocol|1
80952|NCT01215227|312484|P2|Overall Study|Non-Compliance With Protocol|6
80953|NCT01215227|312485|P1|Overall Study|Non-Compliance With Protocol|2
80954|NCT01215227|312480|P6|Overall Study|Subject Withdrew Consent|8
80955|NCT01215227|312481|P5|Overall Study|Subject Withdrew Consent|11
80956|NCT01215227|312482|P4|Overall Study|Subject Withdrew Consent|10
80957|NCT01215227|312483|P3|Overall Study|Subject Withdrew Consent|7
80958|NCT01215227|312484|P2|Overall Study|Subject Withdrew Consent|20
80959|NCT01215227|312485|P1|Overall Study|Subject Withdrew Consent|16
80960|NCT01215227|312480|P6|Overall Study|Lost to Follow-up|2
80961|NCT01215227|312481|P5|Overall Study|Lost to Follow-up|1
80962|NCT01215227|312482|P4|Overall Study|Lost to Follow-up|1
80963|NCT01215227|312483|P3|Overall Study|Lost to Follow-up|1
80964|NCT01215227|312484|P2|Overall Study|Lost to Follow-up|4
80965|NCT01215227|312485|P1|Overall Study|Lost to Follow-up|1
80966|NCT01215227|312480|P6|Overall Study|Treatment Failure|1
80967|NCT01215227|312481|P5|Overall Study|Treatment Failure|1
80968|NCT01215227|312482|P4|Overall Study|Treatment Failure|5
80969|NCT01215227|312483|P3|Overall Study|Treatment Failure|1
80970|NCT01215227|312484|P2|Overall Study|Treatment Failure|4
80971|NCT01215227|312485|P1|Overall Study|Treatment Failure|8
80972|NCT01215227|312480|P6|Overall Study|Adverse Event|6
80973|NCT01215227|312481|P5|Overall Study|Adverse Event|7
80974|NCT01215227|312482|P4|Overall Study|Adverse Event|8
80975|NCT01215227|312483|P3|Overall Study|Adverse Event|4
80976|NCT01215227|312484|P2|Overall Study|Adverse Event|11
80977|NCT01215227|312485|P1|Overall Study|Adverse Event|11
80978|NCT01215097|312604|P2|Overall Study|patient's private reason|1
80979|NCT01215097|312605|P1|Overall Study|patient's private reason|1
80980|NCT01215097|312604|P2|Overall Study|patient's refusal to come|2
80981|NCT01215097|312605|P1|Overall Study|patient's refusal to come|2
80982|NCT01215097|312604|P2|Overall Study|Lack of Efficacy|3
80983|NCT01215097|312605|P1|Overall Study|Lack of Efficacy|0
80984|NCT01215097|312604|P2|Overall Study|Withdrawal by Subject|3
80985|NCT01215097|312605|P1|Overall Study|Withdrawal by Subject|6
80986|NCT01215097|312604|P2|Overall Study|Lost to Follow-up|0
80987|NCT01215097|312605|P1|Overall Study|Lost to Follow-up|2
80988|NCT01215097|312604|P2|Overall Study|Protocol Violation|2
80989|NCT01215097|312605|P1|Overall Study|Protocol Violation|0
80990|NCT01215097|312604|P2|Overall Study|Adverse Event|3
80991|NCT01215097|312605|P1|Overall Study|Adverse Event|1
80992|NCT01215032|312637|P1|Overall Study|Lack of Efficacy|17
80993|NCT01215032|312637|P1|Overall Study|Adverse Event|3
80994|NCT01214915|312662|P1|Overall Study|Lack of Efficacy|3
80995|NCT01214915|312662|P1|Overall Study|Adverse Event|8
80996|NCT01214850|312673|P3|Overall Study|Unable to classify|1
80997|NCT01214850|312674|P2|Overall Study|Unable to classify|1
80998|NCT01214850|312675|P1|Overall Study|Unable to classify|2
80999|NCT01214850|312673|P3|Overall Study|Administrative reason|0
81000|NCT01214850|312674|P2|Overall Study|Administrative reason|0
81001|NCT01214850|312675|P1|Overall Study|Administrative reason|1
81002|NCT01214850|312673|P3|Overall Study|Inappropriate enrollment|0
81003|NCT01214850|312674|P2|Overall Study|Inappropriate enrollment|1
81004|NCT01214850|312675|P1|Overall Study|Inappropriate enrollment|2
81005|NCT01214850|312673|P3|Overall Study|Adverse event or death|3
81006|NCT01214850|312674|P2|Overall Study|Adverse event or death|8
81007|NCT01214850|312675|P1|Overall Study|Adverse event or death|11
81008|NCT01214850|312673|P3|Overall Study|Protocol Violation|6
81009|NCT01214850|312674|P2|Overall Study|Protocol Violation|5
81010|NCT01214850|312675|P1|Overall Study|Protocol Violation|5
81011|NCT01214850|312673|P3|Overall Study|Lost to Follow-up|123
81012|NCT01214850|312674|P2|Overall Study|Lost to Follow-up|98
81013|NCT01214850|312675|P1|Overall Study|Lost to Follow-up|124
81014|NCT01214850|312673|P3|Overall Study|Withdrawal by Subject|28
81015|NCT01214850|312674|P2|Overall Study|Withdrawal by Subject|31
81016|NCT01214850|312675|P1|Overall Study|Withdrawal by Subject|38
81017|NCT01214837|312759|P3|Overall Study|Unable to Classify|0
81018|NCT01214837|312760|P2|Overall Study|Unable to Classify|3
81019|NCT01214837|312761|P1|Overall Study|Unable to Classify|1
81020|NCT01214837|312759|P3|Overall Study|Protocol Violation|5
81021|NCT01214837|312760|P2|Overall Study|Protocol Violation|1
81022|NCT01214837|312761|P1|Overall Study|Protocol Violation|3
81023|NCT01214837|312759|P3|Overall Study|Administrative Reason|4
81024|NCT01214837|312760|P2|Overall Study|Administrative Reason|6
81025|NCT01214837|312761|P1|Overall Study|Administrative Reason|2
81026|NCT01214837|312759|P3|Overall Study|Inappropriate Enrolment|2
81027|NCT01214837|312760|P2|Overall Study|Inappropriate Enrolment|1
81028|NCT01214837|312761|P1|Overall Study|Inappropriate Enrolment|0
81029|NCT01214837|312759|P3|Overall Study|Lost to Follow-up|21
81030|NCT01214837|312760|P2|Overall Study|Lost to Follow-up|15
81031|NCT01214837|312761|P1|Overall Study|Lost to Follow-up|20
81032|NCT01214837|312759|P3|Overall Study|Withdrawal by Subject|28
81033|NCT01214837|312760|P2|Overall Study|Withdrawal by Subject|36
81034|NCT01214837|312761|P1|Overall Study|Withdrawal by Subject|27
81035|NCT01214837|312759|P3|Overall Study|Adverse Event|1
81036|NCT01214837|312760|P2|Overall Study|Adverse Event|2
81037|NCT01214837|312761|P1|Overall Study|Adverse Event|1
81038|NCT01214837|312759|P3|Overall Study|Death|1
81039|NCT01214837|312760|P2|Overall Study|Death|0
81040|NCT01214837|312761|P1|Overall Study|Death|0
81041|NCT01214720|312817|P2|Overall Study|Lost to Follow-up|2
81042|NCT01214720|312818|P1|Overall Study|Lost to Follow-up|6
81043|NCT01214720|312817|P2|Overall Study|Alive and in follow-up|48
81044|NCT01214720|312818|P1|Overall Study|Alive and in follow-up|45
81045|NCT01214720|312817|P2|Overall Study|Alive and still on treatment|18
81046|NCT01214720|312818|P1|Overall Study|Alive and still on treatment|34
81047|NCT01214616|312839|P4|Overall Study|Withdrawal by Subject|1
81048|NCT01214616|312840|P3|Overall Study|Withdrawal by Subject|0
81049|NCT01214616|312841|P2|Overall Study|Withdrawal by Subject|0
81050|NCT01214616|312842|P1|Overall Study|Withdrawal by Subject|1
81051|NCT01214616|312839|P4|Overall Study|Other adverse events|1
81052|NCT01214616|312840|P3|Overall Study|Other adverse events|1
81053|NCT01214616|312841|P2|Overall Study|Other adverse events|1
81054|NCT01214616|312842|P1|Overall Study|Other adverse events|0
81055|NCT01214616|312839|P4|Overall Study|Dose limiting toxicity|0
81056|NCT01214616|312840|P3|Overall Study|Dose limiting toxicity|0
81057|NCT01214616|312841|P2|Overall Study|Dose limiting toxicity|2
81058|NCT01214616|312842|P1|Overall Study|Dose limiting toxicity|0
81059|NCT01214616|312839|P4|Overall Study|Progressive disease|4
81060|NCT01214616|312840|P3|Overall Study|Progressive disease|2
81061|NCT01214616|312841|P2|Overall Study|Progressive disease|2
81062|NCT01214616|312842|P1|Overall Study|Progressive disease|2
81063|NCT01214434|312878|P2|Overall Study|Site error|0
81064|NCT01214434|312879|P1|Overall Study|Site error|1
81065|NCT01214434|312878|P2|Overall Study|Lost to Follow-up|2
81066|NCT01214434|312879|P1|Overall Study|Lost to Follow-up|2
81067|NCT01214434|312878|P2|Overall Study|Withdrawal by Subject|0
81068|NCT01214434|312879|P1|Overall Study|Withdrawal by Subject|1
81069|NCT01214395|312895|P1|Overall Study|All patients had infection|5
81070|NCT01214252|312904|P1|Overall Study|Not eligible per protocol|82
81071|NCT01214239|312912|P2|Overall Study|patient's private reason|1
81072|NCT01214239|312913|P1|Overall Study|patient's private reason|1
81073|NCT01214239|312912|P2|Overall Study|Lack of Efficacy|2
81074|NCT01214239|312913|P1|Overall Study|Lack of Efficacy|1
81075|NCT01214239|312912|P2|Overall Study|Withdrawal by Subject|9
81076|NCT01214239|312913|P1|Overall Study|Withdrawal by Subject|4
81077|NCT01214239|312912|P2|Overall Study|Lost to Follow-up|1
81078|NCT01214239|312913|P1|Overall Study|Lost to Follow-up|1
81079|NCT01214239|312912|P2|Overall Study|Protocol Violation|1
81080|NCT01214239|312913|P1|Overall Study|Protocol Violation|2
81081|NCT01214239|312912|P2|Overall Study|Adverse Event|4
81082|NCT01214239|312913|P1|Overall Study|Adverse Event|3
81083|NCT01214187|312947|P2|Overall Study|Withdrawal by Subject|3
81084|NCT01214187|312948|P1|Overall Study|Withdrawal by Subject|0
81085|NCT01214187|312947|P2|Overall Study|Death|1
81086|NCT01214187|312948|P1|Overall Study|Death|1
81087|NCT01214187|312947|P2|Overall Study|Adverse Event|2
81088|NCT01214187|312948|P1|Overall Study|Adverse Event|6
81089|NCT01214174|312965|P3|Overall Study|Withdrawal by Subject|1
81090|NCT01214174|312966|P2|Overall Study|Withdrawal by Subject|0
81091|NCT01214174|312967|P1|Overall Study|Withdrawal by Subject|0
81092|NCT01213966|313121|P4|Overall Study|Protocol Violation|1
81093|NCT01213966|313122|P3|Overall Study|Protocol Violation|3
81094|NCT01213966|313123|P2|Overall Study|Protocol Violation|0
81095|NCT01213966|313124|P1|Overall Study|Protocol Violation|1
81096|NCT01213836|313136|P2|Period 1, First Intervention|Withdrawal by Subject|1
81097|NCT01213836|313137|P1|Period 1, First Intervention|Withdrawal by Subject|1
81098|NCT01213836|313136|P2|Period 1, First Intervention|Protocol Violation|1
81099|NCT01213836|313137|P1|Period 1, First Intervention|Protocol Violation|0
81100|NCT01213836|313136|P2|Period 1, First Intervention|Adverse Event|1
81101|NCT01213836|313137|P1|Period 1, First Intervention|Adverse Event|2
81102|NCT01213264|313250|P3|Overall Study|Lost to Follow-up|6
81103|NCT01213264|313251|P2|Overall Study|Lost to Follow-up|2
81104|NCT01213264|313252|P1|Overall Study|Lost to Follow-up|1
81105|NCT01213264|313250|P3|Overall Study|Adverse Event|0
81106|NCT01213264|313251|P2|Overall Study|Adverse Event|0
81107|NCT01213264|313252|P1|Overall Study|Adverse Event|1
81108|NCT01213251|313272|P3|Overall Study|Missed 18-Month Follow-up|1
81109|NCT01213251|313273|P2|Overall Study|Missed 18-Month Follow-up|0
81110|NCT01213251|313274|P1|Overall Study|Missed 18-Month Follow-up|0
81111|NCT01213251|313272|P3|Overall Study|Protocol Violation|0
81112|NCT01213251|313273|P2|Overall Study|Protocol Violation|1
81113|NCT01213251|313274|P1|Overall Study|Protocol Violation|1
81114|NCT01213251|313272|P3|Overall Study|Exit|8
81115|NCT01213251|313273|P2|Overall Study|Exit|2
81116|NCT01213251|313274|P1|Overall Study|Exit|3
81117|NCT01213251|313272|P3|Overall Study|Death|2
81118|NCT01213251|313273|P2|Overall Study|Death|1
81119|NCT01213251|313274|P1|Overall Study|Death|2
81120|NCT01213173|313301|P2|Overall Study|Incorrect Enrollment|3
81121|NCT01213173|313302|P1|Overall Study|Incorrect Enrollment|1
81122|NCT01213173|313301|P2|Overall Study|Withdrawal by Subject|5
81123|NCT01213173|313302|P1|Overall Study|Withdrawal by Subject|5
81124|NCT01213173|313301|P2|Overall Study|Adverse Event|8
81125|NCT01213173|313302|P1|Overall Study|Adverse Event|4
81126|NCT01213173|313301|P2|Overall Study|Protocol Violation|0
81127|NCT01213173|313302|P1|Overall Study|Protocol Violation|2
81128|NCT01212991|313363|P2|Overall Study|Continuing Treatment|61
81129|NCT01212991|313364|P1|Overall Study|Continuing Treatment|367
81130|NCT01212991|313363|P2|Overall Study|Withdrawal by Subject|14
81131|NCT01212991|313364|P1|Overall Study|Withdrawal by Subject|4
81132|NCT01212991|313363|P2|Overall Study|Death|299
81133|NCT01212991|313364|P1|Overall Study|Death|241
81134|NCT01212991|313363|P2|Overall Study|Lost to Follow-up|0
81135|NCT01212991|313364|P1|Overall Study|Lost to Follow-up|1
81136|NCT01212770|313396|P9|Long-term Safety Phase (Year 5)|Death|0
81137|NCT01212770|313397|P8|Long-term Safety Phase (Year 5)|Death|1
81138|NCT01212770|313398|P7|Long-term Safety Phase (Year 5)|Death|0
81139|NCT01212770|313399|P6|Long-term Safety Phase (Year 5)|Death|0
81140|NCT01212770|313400|P5|Long-term Safety Phase (Year 5)|Death|0
81141|NCT01212770|313401|P4|Long-term Safety Phase (Year 5)|Death|0
81142|NCT01212770|313402|P3|Long-term Safety Phase (Year 5)|Death|0
81143|NCT01212770|313403|P2|Long-term Safety Phase (Year 5)|Death|0
81144|NCT01212770|313404|P1|Long-term Safety Phase (Year 5)|Death|0
81145|NCT01212770|313396|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
81146|NCT01212770|313397|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
81147|NCT01212770|313398|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
81148|NCT01212770|313399|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
81149|NCT01212770|313400|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
81150|NCT01212770|313401|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
81151|NCT01212770|313402|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
81152|NCT01212770|313403|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
81153|NCT01212770|313404|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
81154|NCT01212770|313396|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
81155|NCT01212770|313397|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
81156|NCT01212770|313398|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
81157|NCT01212770|313399|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
81158|NCT01212770|313400|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
81159|NCT01212770|313401|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
81160|NCT01212770|313402|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
81161|NCT01212770|313403|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
81162|NCT01212770|313404|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
81163|NCT01212770|313396|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
81164|NCT01212770|313397|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
81165|NCT01212770|313398|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
81166|NCT01212770|313399|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
81167|NCT01212770|313400|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
81168|NCT01212770|313401|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
81169|NCT01212770|313402|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
81170|NCT01212770|313403|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
81171|NCT01212770|313404|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
81172|NCT01212770|313396|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
81173|NCT01212770|313397|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
81174|NCT01212770|313398|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
81175|NCT01212770|313399|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
81176|NCT01212770|313400|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
81177|NCT01212770|313401|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
81178|NCT01212770|313402|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
81179|NCT01212770|313403|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
81180|NCT01212770|313404|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
81181|NCT01212770|313396|P9|Long-term Safety Phase (Year 5)|Missing|0
81182|NCT01212770|313397|P8|Long-term Safety Phase (Year 5)|Missing|0
81183|NCT01212770|313398|P7|Long-term Safety Phase (Year 5)|Missing|0
81184|NCT01212770|313399|P6|Long-term Safety Phase (Year 5)|Missing|0
81185|NCT01212770|313400|P5|Long-term Safety Phase (Year 5)|Missing|0
81186|NCT01212770|313401|P4|Long-term Safety Phase (Year 5)|Missing|0
81187|NCT01212770|313402|P3|Long-term Safety Phase (Year 5)|Missing|1
81188|NCT01212770|313403|P2|Long-term Safety Phase (Year 5)|Missing|0
81189|NCT01212770|313404|P1|Long-term Safety Phase (Year 5)|Missing|0
81190|NCT01212770|313396|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
81191|NCT01212770|313397|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
81192|NCT01212770|313398|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
81193|NCT01212770|313399|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
81194|NCT01212770|313400|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
81195|NCT01212770|313401|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
81196|NCT01212770|313402|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
81197|NCT01212770|313403|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
81198|NCT01212770|313404|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
81199|NCT01212770|313396|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
81200|NCT01212770|313397|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
81201|NCT01212770|313398|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
81202|NCT01212770|313399|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
81203|NCT01212770|313400|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
81204|NCT01212770|313401|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
81205|NCT01212770|313402|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
81206|NCT01212770|313403|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
81207|NCT01212770|313404|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
81208|NCT01212770|313396|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
81209|NCT01212770|313397|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
81210|NCT01212770|313398|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
81211|NCT01212770|313399|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
81212|NCT01212770|313400|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
81213|NCT01212770|313401|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
81214|NCT01212770|313402|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
81215|NCT01212770|313403|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
81216|NCT01212770|313404|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
81217|NCT01212770|313396|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
81218|NCT01212770|313397|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
81219|NCT01212770|313398|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
81220|NCT01212770|313399|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
81221|NCT01212770|313400|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
81222|NCT01212770|313401|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
81223|NCT01212770|313402|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
81224|NCT01212770|313403|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
81225|NCT01212770|313404|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
81226|NCT01212770|313396|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
81227|NCT01212770|313397|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
81228|NCT01212770|313398|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
81229|NCT01212770|313399|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
81230|NCT01212770|313400|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
81231|NCT01212770|313401|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
81232|NCT01212770|313402|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
81233|NCT01212770|313403|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
81234|NCT01212770|313404|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
81235|NCT01212770|313396|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
81236|NCT01212770|313397|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
81237|NCT01212770|313398|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
81238|NCT01212770|313399|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
81239|NCT01212770|313400|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
81240|NCT01212770|313401|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
81241|NCT01212770|313402|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
81242|NCT01212770|313403|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
81243|NCT01212770|313404|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
81244|NCT01212770|313396|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
81245|NCT01212770|313397|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
81246|NCT01212770|313398|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
81247|NCT01212770|313399|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
81248|NCT01212770|313400|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
81249|NCT01212770|313401|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
81250|NCT01212770|313402|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
81251|NCT01212770|313403|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
81252|NCT01212770|313404|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
81253|NCT01212770|313396|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
81254|NCT01212770|313397|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
81255|NCT01212770|313398|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
81256|NCT01212770|313399|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
81257|NCT01212770|313400|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
81258|NCT01212770|313401|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
81259|NCT01212770|313402|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
81260|NCT01212770|313403|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
81261|NCT01212770|313404|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
81262|NCT01212770|313396|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
81263|NCT01212770|313397|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
81264|NCT01212770|313398|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
81265|NCT01212770|313399|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
81266|NCT01212770|313400|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
81267|NCT01212770|313401|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
81268|NCT01212770|313402|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
81269|NCT01212770|313403|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
81270|NCT01212770|313404|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
81271|NCT01212770|313396|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
81272|NCT01212770|313397|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
81273|NCT01212770|313398|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
81274|NCT01212770|313399|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
81275|NCT01212770|313400|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
81276|NCT01212770|313401|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
81277|NCT01212770|313402|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
81278|NCT01212770|313403|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
81279|NCT01212770|313404|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
81280|NCT01212770|313396|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
81281|NCT01212770|313397|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
81282|NCT01212770|313398|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
81283|NCT01212770|313399|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
81284|NCT01212770|313400|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
81285|NCT01212770|313401|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
81286|NCT01212770|313402|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
81287|NCT01212770|313403|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
81288|NCT01212770|313404|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
81289|NCT01212770|313396|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
81290|NCT01212770|313397|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
81291|NCT01212770|313398|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
81292|NCT01212770|313399|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
81293|NCT01212770|313400|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
81294|NCT01212770|313401|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
81295|NCT01212770|313402|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
81296|NCT01212770|313403|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
81297|NCT01212770|313404|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
81298|NCT01212770|313396|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
81299|NCT01212770|313397|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
81300|NCT01212770|313398|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
81301|NCT01212770|313399|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
81302|NCT01212770|313400|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
81303|NCT01212770|313401|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
81304|NCT01212770|313402|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
81305|NCT01212770|313403|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
81306|NCT01212770|313404|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
81307|NCT01212770|313396|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
81308|NCT01212770|313397|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
81309|NCT01212770|313398|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
81310|NCT01212770|313399|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
81311|NCT01212770|313400|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
81312|NCT01212770|313401|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
81313|NCT01212770|313402|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
81314|NCT01212770|313403|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
81315|NCT01212770|313404|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
81316|NCT01212770|313396|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
81317|NCT01212770|313397|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
81318|NCT01212770|313398|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
81319|NCT01212770|313399|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
81320|NCT01212770|313400|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
81321|NCT01212770|313401|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
81322|NCT01212770|313402|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
81323|NCT01212770|313403|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
81324|NCT01212770|313404|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
81325|NCT01212770|313396|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
81326|NCT01212770|313397|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
81327|NCT01212770|313398|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
81328|NCT01212770|313399|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
81329|NCT01212770|313400|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
81330|NCT01212770|313401|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
81331|NCT01212770|313402|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
81332|NCT01212770|313403|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
81333|NCT01212770|313404|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
81334|NCT01212770|313396|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
81335|NCT01212770|313397|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
81336|NCT01212770|313398|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
81337|NCT01212770|313399|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
81338|NCT01212770|313400|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
81339|NCT01212770|313401|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
81340|NCT01212770|313402|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
81341|NCT01212770|313403|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
81342|NCT01212770|313404|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
81343|NCT01212770|313396|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
81344|NCT01212770|313397|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
81345|NCT01212770|313398|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
81346|NCT01212770|313399|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
81347|NCT01212770|313400|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
81348|NCT01212770|313401|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
81349|NCT01212770|313402|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
81350|NCT01212770|313403|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
81351|NCT01212770|313404|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
81352|NCT01212770|313396|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
81353|NCT01212770|313397|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
81354|NCT01212770|313398|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
81355|NCT01212770|313399|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
81356|NCT01212770|313400|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
81357|NCT01212770|313401|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
81358|NCT01212770|313402|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
81359|NCT01212770|313403|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
81360|NCT01212770|313404|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
81361|NCT01212770|313396|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
81362|NCT01212770|313397|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
81363|NCT01212770|313398|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
81364|NCT01212770|313399|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
81365|NCT01212770|313400|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
81366|NCT01212770|313401|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
81367|NCT01212770|313402|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
81368|NCT01212770|313403|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
81369|NCT01212770|313404|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
81370|NCT01212770|313396|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
81371|NCT01212770|313397|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
81372|NCT01212770|313398|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
81373|NCT01212770|313399|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
81374|NCT01212770|313400|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
81375|NCT01212770|313401|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
81376|NCT01212770|313402|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
81377|NCT01212770|313403|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
81378|NCT01212770|313404|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
81379|NCT01212770|313396|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
81380|NCT01212770|313397|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
81381|NCT01212770|313398|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
81382|NCT01212770|313399|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
81383|NCT01212770|313400|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
81384|NCT01212770|313401|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
81385|NCT01212770|313402|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
81386|NCT01212770|313403|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
81387|NCT01212770|313404|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
81388|NCT01212770|313396|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
81389|NCT01212770|313397|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
81390|NCT01212770|313398|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
81391|NCT01212770|313399|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
81392|NCT01212770|313400|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
81393|NCT01212770|313401|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
81394|NCT01212770|313402|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
81395|NCT01212770|313403|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
81396|NCT01212770|313404|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
81397|NCT01212770|313396|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
81398|NCT01212770|313397|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
81399|NCT01212770|313398|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
81400|NCT01212770|313399|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
81401|NCT01212770|313400|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
81402|NCT01212770|313401|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
81403|NCT01212770|313402|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
81404|NCT01212770|313403|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
81405|NCT01212770|313404|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
81406|NCT01212770|313396|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
81407|NCT01212770|313397|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
81408|NCT01212770|313398|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
81409|NCT01212770|313399|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
81410|NCT01212770|313400|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
81411|NCT01212770|313401|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
81412|NCT01212770|313402|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
81413|NCT01212770|313403|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
81414|NCT01212770|313404|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
81415|NCT01212770|313396|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81416|NCT01212770|313397|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81417|NCT01212770|313398|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81418|NCT01212770|313399|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81419|NCT01212770|313400|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81420|NCT01212770|313401|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81421|NCT01212770|313402|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
81422|NCT01212770|313403|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81423|NCT01212770|313404|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81424|NCT01212770|313396|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81425|NCT01212770|313397|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81426|NCT01212770|313398|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81427|NCT01212770|313399|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81428|NCT01212770|313400|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81429|NCT01212770|313401|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81430|NCT01212770|313402|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
81431|NCT01212770|313403|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81432|NCT01212770|313404|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
81433|NCT01212770|313396|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81434|NCT01212770|313397|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81435|NCT01212770|313398|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81436|NCT01212770|313399|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81437|NCT01212770|313400|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81438|NCT01212770|313401|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81439|NCT01212770|313402|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
81440|NCT01212770|313403|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
81441|NCT01212770|313404|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
81442|NCT01212770|313396|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81443|NCT01212770|313397|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81444|NCT01212770|313398|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81445|NCT01212770|313399|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81446|NCT01212770|313400|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81447|NCT01212770|313401|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81448|NCT01212770|313402|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
81449|NCT01212770|313403|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
81450|NCT01212770|313404|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
81451|NCT01212770|313396|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81452|NCT01212770|313397|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81453|NCT01212770|313398|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81454|NCT01212770|313399|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81455|NCT01212770|313400|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81456|NCT01212770|313401|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81457|NCT01212770|313402|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
81458|NCT01212770|313403|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
81459|NCT01212770|313404|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
81460|NCT01212757|313601|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
81461|NCT01212757|313602|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
81462|NCT01212757|313603|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
81463|NCT01212757|313604|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
81464|NCT01212757|313605|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
81465|NCT01212757|313606|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
81466|NCT01212757|313607|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
81467|NCT01212757|313608|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
81468|NCT01212757|313609|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
81469|NCT01212757|313601|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
81470|NCT01212757|313602|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
81471|NCT01212757|313603|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
81472|NCT01212757|313604|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
81473|NCT01212757|313605|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
81474|NCT01212757|313606|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
81475|NCT01212757|313607|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
81476|NCT01212757|313608|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
81477|NCT01212757|313609|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
81478|NCT01212757|313601|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
81479|NCT01212757|313602|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
81480|NCT01212757|313603|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
81481|NCT01212757|313604|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
81482|NCT01212757|313605|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
81483|NCT01212757|313606|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
81484|NCT01212757|313607|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
81485|NCT01212757|313608|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
81486|NCT01212757|313609|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
81487|NCT01212757|313601|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
81488|NCT01212757|313602|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
81489|NCT01212757|313603|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
81490|NCT01212757|313604|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
81491|NCT01212757|313605|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
81492|NCT01212757|313606|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
81493|NCT01212757|313607|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
81494|NCT01212757|313608|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
81495|NCT01212757|313609|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
81496|NCT01212757|313601|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
81497|NCT01212757|313602|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
81498|NCT01212757|313603|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
81499|NCT01212757|313604|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
81500|NCT01212757|313605|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
81501|NCT01212757|313606|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
81502|NCT01212757|313607|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
81503|NCT01212757|313608|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
81504|NCT01212757|313609|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
81505|NCT01212757|313601|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
81506|NCT01212757|313602|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
81507|NCT01212757|313603|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
81508|NCT01212757|313604|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
81509|NCT01212757|313605|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
81510|NCT01212757|313606|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
81511|NCT01212757|313607|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
81512|NCT01212757|313608|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
81513|NCT01212757|313609|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
81514|NCT01212757|313601|P9|Long-Term Safety Phase (Year 4)|Death|1
81515|NCT01212757|313602|P8|Long-Term Safety Phase (Year 4)|Death|0
81516|NCT01212757|313603|P7|Long-Term Safety Phase (Year 4)|Death|0
81517|NCT01212757|313604|P6|Long-Term Safety Phase (Year 4)|Death|0
81518|NCT01212757|313605|P5|Long-Term Safety Phase (Year 4)|Death|0
81519|NCT01212757|313606|P4|Long-Term Safety Phase (Year 4)|Death|0
81520|NCT01212757|313607|P3|Long-Term Safety Phase (Year 4)|Death|1
81521|NCT01212757|313608|P2|Long-Term Safety Phase (Year 4)|Death|0
81522|NCT01212757|313609|P1|Long-Term Safety Phase (Year 4)|Death|0
81523|NCT01212757|313601|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
81524|NCT01212757|313602|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
81525|NCT01212757|313603|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
81526|NCT01212757|313604|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
81527|NCT01212757|313605|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
81528|NCT01212757|313606|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
81529|NCT01212757|313607|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
81530|NCT01212757|313608|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
81531|NCT01212757|313609|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
81532|NCT01212757|313601|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
81533|NCT01212757|313602|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
81534|NCT01212757|313603|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
81535|NCT01212757|313604|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
81536|NCT01212757|313605|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
81537|NCT01212757|313606|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
81538|NCT01212757|313607|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
81539|NCT01212757|313608|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
81540|NCT01212757|313609|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
81541|NCT01212757|313601|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
81542|NCT01212757|313602|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
81543|NCT01212757|313603|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
81544|NCT01212757|313604|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
81545|NCT01212757|313605|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
81546|NCT01212757|313606|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
81547|NCT01212757|313607|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
81548|NCT01212757|313608|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
81549|NCT01212757|313609|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
81550|NCT01212757|313601|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
81551|NCT01212757|313602|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
81552|NCT01212757|313603|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
81553|NCT01212757|313604|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
81554|NCT01212757|313605|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
81555|NCT01212757|313606|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
81556|NCT01212757|313607|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
81557|NCT01212757|313608|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
81558|NCT01212757|313609|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
81559|NCT01212757|313601|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
81560|NCT01212757|313602|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
81561|NCT01212757|313603|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
81562|NCT01212757|313604|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
81563|NCT01212757|313605|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
81564|NCT01212757|313606|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
81565|NCT01212757|313607|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
81566|NCT01212757|313608|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
81567|NCT01212757|313609|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
81568|NCT01212757|313601|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
81569|NCT01212757|313602|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
81787|NCT01212159|313869|P1|Overall Study|Withdrawal by Subject|12
81570|NCT01212757|313603|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
81571|NCT01212757|313604|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
81572|NCT01212757|313605|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
81573|NCT01212757|313606|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
81574|NCT01212757|313607|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
81575|NCT01212757|313608|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
81576|NCT01212757|313609|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
81577|NCT01212757|313601|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
81578|NCT01212757|313602|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
81579|NCT01212757|313603|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
81580|NCT01212757|313604|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
81581|NCT01212757|313605|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
81582|NCT01212757|313606|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
81583|NCT01212757|313607|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
81584|NCT01212757|313608|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
81585|NCT01212757|313609|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
81586|NCT01212757|313601|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
81587|NCT01212757|313602|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
81588|NCT01212757|313603|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
81589|NCT01212757|313604|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
81590|NCT01212757|313605|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
81591|NCT01212757|313606|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
81592|NCT01212757|313607|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
81593|NCT01212757|313608|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
81594|NCT01212757|313609|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
81595|NCT01212757|313601|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
81596|NCT01212757|313602|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
81597|NCT01212757|313603|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
81598|NCT01212757|313604|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
81599|NCT01212757|313605|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
81600|NCT01212757|313606|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
81601|NCT01212757|313607|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
81602|NCT01212757|313608|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
81603|NCT01212757|313609|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
81604|NCT01212757|313601|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
81605|NCT01212757|313602|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
81606|NCT01212757|313603|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
81607|NCT01212757|313604|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
81608|NCT01212757|313605|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
81609|NCT01212757|313606|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
81610|NCT01212757|313607|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
81611|NCT01212757|313608|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
81612|NCT01212757|313609|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
81613|NCT01212757|313601|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
81614|NCT01212757|313602|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
81615|NCT01212757|313603|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
81616|NCT01212757|313604|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
81617|NCT01212757|313605|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
81618|NCT01212757|313606|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
81619|NCT01212757|313607|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
81620|NCT01212757|313608|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
81621|NCT01212757|313609|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
81622|NCT01212757|313601|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
81623|NCT01212757|313602|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
81624|NCT01212757|313603|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
81625|NCT01212757|313604|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
81626|NCT01212757|313605|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
81627|NCT01212757|313606|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
81628|NCT01212757|313607|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
81629|NCT01212757|313608|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
81630|NCT01212757|313609|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
81631|NCT01212757|313601|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
81632|NCT01212757|313602|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
81633|NCT01212757|313603|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
81634|NCT01212757|313604|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
81635|NCT01212757|313605|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
81636|NCT01212757|313606|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
81637|NCT01212757|313607|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
81638|NCT01212757|313608|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
81639|NCT01212757|313609|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
81640|NCT01212757|313601|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
81641|NCT01212757|313602|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
81870|NCT01210807|314163|P1|Overall Study|Not implanted bilaterally|2
81642|NCT01212757|313603|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
81643|NCT01212757|313604|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
81644|NCT01212757|313605|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
81645|NCT01212757|313606|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
81646|NCT01212757|313607|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
81647|NCT01212757|313608|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
81648|NCT01212757|313609|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
81649|NCT01212757|313601|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
81650|NCT01212757|313602|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
81651|NCT01212757|313603|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
81652|NCT01212757|313604|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
81653|NCT01212757|313605|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
81654|NCT01212757|313606|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
81655|NCT01212757|313607|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
81656|NCT01212757|313608|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
81657|NCT01212757|313609|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
81658|NCT01212757|313601|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
81659|NCT01212757|313602|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
81660|NCT01212757|313603|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
81661|NCT01212757|313604|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
81662|NCT01212757|313605|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
81663|NCT01212757|313606|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
81664|NCT01212757|313607|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
81665|NCT01212757|313608|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
81666|NCT01212757|313609|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
81667|NCT01212757|313601|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
81668|NCT01212757|313602|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
81669|NCT01212757|313603|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
81670|NCT01212757|313604|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
81671|NCT01212757|313605|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
81672|NCT01212757|313606|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
81673|NCT01212757|313607|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
81674|NCT01212757|313608|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
81675|NCT01212757|313609|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
81676|NCT01212757|313601|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
81677|NCT01212757|313602|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
81678|NCT01212757|313603|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
81679|NCT01212757|313604|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
81680|NCT01212757|313605|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
81681|NCT01212757|313606|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
81682|NCT01212757|313607|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
81683|NCT01212757|313608|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
81684|NCT01212757|313609|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
81685|NCT01212757|313601|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
81686|NCT01212757|313602|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
81687|NCT01212757|313603|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
81688|NCT01212757|313604|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
81689|NCT01212757|313605|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
81690|NCT01212757|313606|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
81691|NCT01212757|313607|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
81692|NCT01212757|313608|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
81693|NCT01212757|313609|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
81694|NCT01212757|313601|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
81695|NCT01212757|313602|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
81696|NCT01212757|313603|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
81697|NCT01212757|313604|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
81698|NCT01212757|313605|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
81699|NCT01212757|313606|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
81700|NCT01212757|313607|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
81701|NCT01212757|313608|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
81702|NCT01212757|313609|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
81703|NCT01212757|313601|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
81704|NCT01212757|313602|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
81705|NCT01212757|313603|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
81706|NCT01212757|313604|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
81707|NCT01212757|313605|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
81708|NCT01212757|313606|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
81709|NCT01212757|313607|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
81710|NCT01212757|313608|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
81711|NCT01212757|313609|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
81712|NCT01212757|313601|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
81713|NCT01212757|313602|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
81714|NCT01212757|313603|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
81715|NCT01212757|313604|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
81716|NCT01212757|313605|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
81717|NCT01212757|313606|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
81718|NCT01212757|313607|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
81719|NCT01212757|313608|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
81720|NCT01212757|313609|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
81721|NCT01212757|313601|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
81722|NCT01212757|313602|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
81723|NCT01212757|313603|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
81724|NCT01212757|313604|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
81725|NCT01212757|313605|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
81726|NCT01212757|313606|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
81727|NCT01212757|313607|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
81728|NCT01212757|313608|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
81729|NCT01212757|313609|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
81730|NCT01212757|313601|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81731|NCT01212757|313602|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81732|NCT01212757|313603|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81733|NCT01212757|313604|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81734|NCT01212757|313605|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81735|NCT01212757|313606|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81736|NCT01212757|313607|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
81737|NCT01212757|313608|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
81738|NCT01212757|313609|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
81739|NCT01212757|313601|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81740|NCT01212757|313602|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81741|NCT01212757|313603|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81742|NCT01212757|313604|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81743|NCT01212757|313605|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81744|NCT01212757|313606|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
81745|NCT01212757|313607|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
81746|NCT01212757|313608|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
81747|NCT01212757|313609|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
81748|NCT01212757|313601|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
81749|NCT01212757|313602|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
81750|NCT01212757|313603|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
81751|NCT01212757|313604|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
81752|NCT01212757|313605|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
81753|NCT01212757|313606|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
81754|NCT01212757|313607|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
81755|NCT01212757|313608|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
81756|NCT01212757|313609|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
81757|NCT01212757|313601|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81758|NCT01212757|313602|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81759|NCT01212757|313603|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81760|NCT01212757|313604|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81761|NCT01212757|313605|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81762|NCT01212757|313606|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
81763|NCT01212757|313607|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
81764|NCT01212757|313608|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
81765|NCT01212757|313609|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
81766|NCT01212757|313601|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81767|NCT01212757|313602|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81768|NCT01212757|313603|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81769|NCT01212757|313604|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81770|NCT01212757|313605|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81771|NCT01212757|313606|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
81772|NCT01212757|313607|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
81773|NCT01212757|313608|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
81774|NCT01212757|313609|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
81775|NCT01212757|313601|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81776|NCT01212757|313602|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81777|NCT01212757|313603|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81778|NCT01212757|313604|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81779|NCT01212757|313605|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81780|NCT01212757|313606|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
81781|NCT01212757|313607|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
81782|NCT01212757|313608|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
81783|NCT01212757|313609|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
81784|NCT01212185|313848|P2|Overall Study|Protocol Violation|1
81785|NCT01212185|313849|P1|Overall Study|Protocol Violation|2
81786|NCT01212159|313868|P2|Overall Study|Withdrawal by Subject|12
81788|NCT01212094|313882|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
81789|NCT01212094|313883|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
81790|NCT01212094|313884|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
81791|NCT01212094|313882|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
81792|NCT01212094|313883|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
81793|NCT01212094|313884|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
81794|NCT01212094|313882|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
81795|NCT01212094|313883|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
81796|NCT01212094|313884|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
81797|NCT01212094|313882|P3|Year 1: Baseline Monitoring|Started on DMT|0
81798|NCT01212094|313883|P2|Year 1: Baseline Monitoring|Started on DMT|0
81799|NCT01212094|313884|P1|Year 1: Baseline Monitoring|Started on DMT|2
81800|NCT01212094|313882|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
81801|NCT01212094|313883|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
81802|NCT01212094|313884|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
81803|NCT01212094|313882|P3|Year 1: Baseline Monitoring|Study terminated|0
81804|NCT01212094|313883|P2|Year 1: Baseline Monitoring|Study terminated|0
81805|NCT01212094|313884|P1|Year 1: Baseline Monitoring|Study terminated|7
81806|NCT01211769|313931|P4|Overall Study|Adverse Event|1
81807|NCT01211769|313932|P3|Overall Study|Adverse Event|1
81808|NCT01211769|313933|P2|Overall Study|Adverse Event|1
81809|NCT01211769|313934|P1|Overall Study|Adverse Event|0
81810|NCT01211769|313931|P4|Overall Study|Physician Decision|1
81811|NCT01211769|313932|P3|Overall Study|Physician Decision|2
81812|NCT01211769|313933|P2|Overall Study|Physician Decision|0
81813|NCT01211769|313934|P1|Overall Study|Physician Decision|2
81814|NCT01211769|313931|P4|Overall Study|Lost to Follow-up|9
81815|NCT01211769|313932|P3|Overall Study|Lost to Follow-up|5
81816|NCT01211769|313933|P2|Overall Study|Lost to Follow-up|9
81817|NCT01211769|313934|P1|Overall Study|Lost to Follow-up|7
81818|NCT01211665|313973|P2|Overall Study|Death|0
81819|NCT01211665|313974|P1|Overall Study|Death|1
81820|NCT01211665|313973|P2|Overall Study|Withdrawal by Subject|0
81821|NCT01211665|313974|P1|Overall Study|Withdrawal by Subject|1
81822|NCT01211613|314001|P3|Overall Study|Withdrawal by Subject|0
81823|NCT01211613|314002|P2|Overall Study|Withdrawal by Subject|0
81824|NCT01211613|314003|P1|Overall Study|Withdrawal by Subject|1
81825|NCT01211613|314001|P3|Overall Study|Lost to Follow-up|2
81826|NCT01211613|314002|P2|Overall Study|Lost to Follow-up|2
81827|NCT01211613|314003|P1|Overall Study|Lost to Follow-up|2
81828|NCT01211535|314016|P2|Overall Study|Adverse Event|1
81829|NCT01211535|314017|P1|Overall Study|Adverse Event|0
81830|NCT01211197|314036|P6|Washout Period 2 (7 Days)|Adverse Event|0
81831|NCT01211197|314037|P5|Washout Period 2 (7 Days)|Adverse Event|0
81832|NCT01211197|314038|P4|Washout Period 2 (7 Days)|Adverse Event|0
81833|NCT01211197|314039|P3|Washout Period 2 (7 Days)|Adverse Event|0
81834|NCT01211197|314040|P2|Washout Period 2 (7 Days)|Adverse Event|0
81835|NCT01211197|314041|P1|Washout Period 2 (7 Days)|Adverse Event|1
81836|NCT01211197|314036|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
81837|NCT01211197|314037|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
81838|NCT01211197|314038|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
81839|NCT01211197|314039|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
81840|NCT01211197|314040|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
81841|NCT01211197|314041|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
81842|NCT01211184|314088|P3|Overall Study|Withdrawal by Subject|1
81843|NCT01211184|314089|P2|Overall Study|Withdrawal by Subject|2
81844|NCT01211184|314090|P1|Overall Study|Withdrawal by Subject|0
81845|NCT01211145|314105|P4|Overall Study|Patient decision|2
81846|NCT01211145|314106|P3|Overall Study|Patient decision|0
81847|NCT01211145|314107|P2|Overall Study|Patient decision|1
81848|NCT01211145|314108|P1|Overall Study|Patient decision|2
81849|NCT01211145|314105|P4|Overall Study|Eligibility criteria not fulfilled|15
81850|NCT01211145|314106|P3|Overall Study|Eligibility criteria not fulfilled|10
81851|NCT01211145|314107|P2|Overall Study|Eligibility criteria not fulfilled|12
81852|NCT01211145|314108|P1|Overall Study|Eligibility criteria not fulfilled|16
81853|NCT01211145|314105|P4|Overall Study|Severe noncompliance to protocol|0
81854|NCT01211145|314106|P3|Overall Study|Severe noncompliance to protocol|0
81855|NCT01211145|314107|P2|Overall Study|Severe noncompliance to protocol|0
81856|NCT01211145|314108|P1|Overall Study|Severe noncompliance to protocol|1
81857|NCT01211145|314105|P4|Overall Study|Study-specific withdrawal criteria|0
81858|NCT01211145|314106|P3|Overall Study|Study-specific withdrawal criteria|0
81859|NCT01211145|314107|P2|Overall Study|Study-specific withdrawal criteria|0
81860|NCT01211145|314108|P1|Overall Study|Study-specific withdrawal criteria|1
81861|NCT01211145|314105|P4|Overall Study|Lost to Follow-up|2
81862|NCT01211145|314106|P3|Overall Study|Lost to Follow-up|1
81863|NCT01211145|314107|P2|Overall Study|Lost to Follow-up|2
81864|NCT01211145|314108|P1|Overall Study|Lost to Follow-up|3
81865|NCT01211145|314105|P4|Overall Study|Reason not specified|1
81866|NCT01211145|314106|P3|Overall Study|Reason not specified|2
81867|NCT01211145|314107|P2|Overall Study|Reason not specified|2
81868|NCT01211145|314108|P1|Overall Study|Reason not specified|3
81869|NCT01210807|314162|P2|Overall Study|Not implanted bilaterally|1
81871|NCT01210807|314162|P2|Overall Study|Lost to Follow-up|2
81872|NCT01210807|314163|P1|Overall Study|Lost to Follow-up|1
81873|NCT01210690|314178|P1|Overall Study|Patient could not take glucose|1
81874|NCT01210690|314178|P1|Overall Study|Patient refused to swallow|1
81875|NCT01210690|314178|P1|Overall Study|Withdrawal by Subject|1
81876|NCT01210690|314178|P1|Overall Study|Disease Remission|1
81877|NCT01210690|314178|P1|Overall Study|Lost to Follow-up|3
81878|NCT01210690|314178|P1|Overall Study|Lack of Efficacy|12
81879|NCT01210690|314178|P1|Overall Study|Adverse Event|7
81880|NCT01210651|314193|P2|Overall Study|Injury outside study|0
81881|NCT01210651|314194|P1|Overall Study|Injury outside study|2
81882|NCT01210651|314193|P2|Overall Study|Withdrawal by Subject|1
81883|NCT01210651|314194|P1|Overall Study|Withdrawal by Subject|1
81884|NCT01210651|314193|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
81885|NCT01210651|314194|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
81886|NCT01210651|314193|P2|Overall Study|schedule conflicts|5
81887|NCT01210651|314194|P1|Overall Study|schedule conflicts|1
81888|NCT01210651|314193|P2|Overall Study|Lost to Follow-up|1
81889|NCT01210651|314194|P1|Overall Study|Lost to Follow-up|1
81890|NCT01210495|314212|P4|Overall Study|Other unspecified|0
81891|NCT01210495|314213|P3|Overall Study|Other unspecified|6
81892|NCT01210495|314214|P2|Overall Study|Other unspecified|0
81893|NCT01210495|314215|P1|Overall Study|Other unspecified|0
81894|NCT01210495|314212|P4|Overall Study|Lost to Follow-up|1
81895|NCT01210495|314213|P3|Overall Study|Lost to Follow-up|1
81896|NCT01210495|314214|P2|Overall Study|Lost to Follow-up|0
81897|NCT01210495|314215|P1|Overall Study|Lost to Follow-up|0
81898|NCT01210495|314212|P4|Overall Study|Study Terminated by Sponsor|11
81899|NCT01210495|314213|P3|Overall Study|Study Terminated by Sponsor|4
81900|NCT01210495|314214|P2|Overall Study|Study Terminated by Sponsor|0
81901|NCT01210495|314215|P1|Overall Study|Study Terminated by Sponsor|0
81902|NCT01210495|314212|P4|Overall Study|Death|54
81903|NCT01210495|314213|P3|Overall Study|Death|112
81904|NCT01210495|314214|P2|Overall Study|Death|7
81905|NCT01210495|314215|P1|Overall Study|Death|14
81906|NCT01210495|314212|P4|Overall Study|Participant Refused Further Follow-Up|2
81907|NCT01210495|314213|P3|Overall Study|Participant Refused Further Follow-Up|11
81908|NCT01210495|314214|P2|Overall Study|Participant Refused Further Follow-Up|0
81909|NCT01210495|314215|P1|Overall Study|Participant Refused Further Follow-Up|1
81910|NCT01210443|314277|P1|Overall Study|Study terminated by sponsor|2
81911|NCT01210222|314285|P1|Overall Study|Never treated|1
81912|NCT01210222|314285|P1|Overall Study|Ineligible|2
81913|NCT01210144|314321|P2|Overall Study|No transfer|0
81914|NCT01210144|314322|P1|Overall Study|No transfer|1
81915|NCT01210144|314321|P2|Overall Study|No fertilization|0
81916|NCT01210144|314322|P1|Overall Study|No fertilization|1
81917|NCT01210144|314321|P2|Overall Study|Lack of ovarian response|0
81918|NCT01210144|314322|P1|Overall Study|Lack of ovarian response|1
81919|NCT01210118|314344|P2|Overall Study|Spontaneous abortion|3
81920|NCT01210118|314345|P1|Overall Study|Spontaneous abortion|1
81921|NCT01210118|314344|P2|Overall Study|Protocol Violation|1
81922|NCT01210118|314345|P1|Overall Study|Protocol Violation|1
81923|NCT01210118|314344|P2|Overall Study|Lost to Follow-up|1
81924|NCT01210118|314345|P1|Overall Study|Lost to Follow-up|1
81925|NCT01210001|314369|P3|Overall Study|Other reason not defined above|1
81926|NCT01210001|314370|P2|Overall Study|Other reason not defined above|2
81927|NCT01210001|314371|P1|Overall Study|Other reason not defined above|2
81928|NCT01210001|314369|P3|Overall Study|Patient refusal to continue,not due toAE|1
81929|NCT01210001|314370|P2|Overall Study|Patient refusal to continue,not due toAE|2
81930|NCT01210001|314371|P1|Overall Study|Patient refusal to continue,not due toAE|6
81931|NCT01210001|314369|P3|Overall Study|Lost to Follow-up|2
81932|NCT01210001|314370|P2|Overall Study|Lost to Follow-up|3
81933|NCT01210001|314371|P1|Overall Study|Lost to Follow-up|4
81934|NCT01210001|314369|P3|Overall Study|Non compliant with protocol|3
81935|NCT01210001|314370|P2|Overall Study|Non compliant with protocol|2
81936|NCT01210001|314371|P1|Overall Study|Non compliant with protocol|2
81937|NCT01210001|314369|P3|Overall Study|Adverse Event|5
81938|NCT01210001|314370|P2|Overall Study|Adverse Event|2
81939|NCT01210001|314371|P1|Overall Study|Adverse Event|4
81940|NCT01210001|314369|P3|Overall Study|Not treated|0
81941|NCT01210001|314370|P2|Overall Study|Not treated|0
81942|NCT01210001|314371|P1|Overall Study|Not treated|1
81943|NCT01209949|314391|P1|Overall Study|Lost to Follow-up|3
81944|NCT01209780|314401|P5|Overall Study|Inappropriate enrollment|1
81945|NCT01209780|314402|P4|Overall Study|Inappropriate enrollment|0
81946|NCT01209780|314403|P3|Overall Study|Inappropriate enrollment|0
81947|NCT01209780|314404|P2|Overall Study|Inappropriate enrollment|2
81948|NCT01209780|314405|P1|Overall Study|Inappropriate enrollment|0
81949|NCT01209780|314401|P5|Overall Study|Protocol Violation|0
81950|NCT01209780|314402|P4|Overall Study|Protocol Violation|0
81951|NCT01209780|314403|P3|Overall Study|Protocol Violation|0
81952|NCT01209780|314404|P2|Overall Study|Protocol Violation|1
81953|NCT01209780|314405|P1|Overall Study|Protocol Violation|0
81954|NCT01209780|314401|P5|Overall Study|Lost to Follow-up|4
81955|NCT01209780|314402|P4|Overall Study|Lost to Follow-up|9
81956|NCT01209780|314403|P3|Overall Study|Lost to Follow-up|3
81957|NCT01209780|314404|P2|Overall Study|Lost to Follow-up|12
81958|NCT01209780|314405|P1|Overall Study|Lost to Follow-up|17
81959|NCT01209780|314401|P5|Overall Study|Withdrawal by Subject|0
81960|NCT01209780|314402|P4|Overall Study|Withdrawal by Subject|1
81961|NCT01209780|314403|P3|Overall Study|Withdrawal by Subject|1
81962|NCT01209780|314404|P2|Overall Study|Withdrawal by Subject|2
81963|NCT01209780|314405|P1|Overall Study|Withdrawal by Subject|9
81964|NCT01209780|314401|P5|Overall Study|Adverse Event|0
81965|NCT01209780|314402|P4|Overall Study|Adverse Event|0
81966|NCT01209780|314403|P3|Overall Study|Adverse Event|0
81967|NCT01209780|314404|P2|Overall Study|Adverse Event|1
81968|NCT01209780|314405|P1|Overall Study|Adverse Event|0
81969|NCT01209767|314431|P1|Overall Study|Lost to Follow-up|3
81970|NCT01209767|314431|P1|Overall Study|Withdrawal by Subject|1
81971|NCT01209689|314500|P2|Overall Study|Sponsor's Decision to Stop the Study|17
81972|NCT01209689|314501|P1|Overall Study|Sponsor's Decision to Stop the Study|68
81973|NCT01209689|314500|P2|Overall Study|Failure to Return|0
81974|NCT01209689|314501|P1|Overall Study|Failure to Return|3
81975|NCT01209689|314500|P2|Overall Study|Violation of Selection Criteria at Entry|0
81976|NCT01209689|314501|P1|Overall Study|Violation of Selection Criteria at Entry|1
81977|NCT01209689|314500|P2|Overall Study|Adverse Event|0
81978|NCT01209689|314501|P1|Overall Study|Adverse Event|4
81979|NCT01209689|314500|P2|Overall Study|Refused Treatment|3
81980|NCT01209689|314501|P1|Overall Study|Refused Treatment|8
81981|NCT01209689|314500|P2|Overall Study|Insufficient Therapeutic Response|2
81982|NCT01209689|314501|P1|Overall Study|Insufficient Therapeutic Response|7
81983|NCT01209624|314507|P1|Overall Study|Other|4
81984|NCT01209624|314507|P1|Overall Study|Lost to Follow-up|290
81985|NCT01209624|314507|P1|Overall Study|Lack of Efficacy|17
81986|NCT01209624|314507|P1|Overall Study|Adverse Event|13
81987|NCT01209624|314507|P1|Overall Study|Death|2
81988|NCT01209598|314540|P2|Overall Study|Withdrawal by Subject|0
81989|NCT01209598|314541|P1|Overall Study|Withdrawal by Subject|1
81990|NCT01209520|314549|P1|Overall Study|Withdrawal by Subject|3
81991|NCT01209286|314557|P3|Overall Study|Other|0
81992|NCT01209286|314558|P2|Overall Study|Other|1
81993|NCT01209286|314559|P1|Overall Study|Other|0
81994|NCT01209286|314557|P3|Overall Study|Physician Decision|0
81995|NCT01209286|314558|P2|Overall Study|Physician Decision|2
81996|NCT01209286|314559|P1|Overall Study|Physician Decision|0
81997|NCT01209286|314557|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
81998|NCT01209286|314558|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
81999|NCT01209286|314559|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
82000|NCT01209286|314557|P3|Overall Study|Hematological Relapse After Remission|1
82001|NCT01209286|314558|P2|Overall Study|Hematological Relapse After Remission|1
82002|NCT01209286|314559|P1|Overall Study|Hematological Relapse After Remission|0
82003|NCT01209286|314557|P3|Overall Study|Adverse Event|1
82004|NCT01209286|314558|P2|Overall Study|Adverse Event|3
82005|NCT01209286|314559|P1|Overall Study|Adverse Event|4
82006|NCT01209143|314668|P2|Overall Study|Disease progression|16
82007|NCT01209143|314669|P1|Overall Study|Disease progression|11
82008|NCT01209143|314668|P2|Overall Study|Withdrawal by Subject|1
82009|NCT01209143|314669|P1|Overall Study|Withdrawal by Subject|2
82010|NCT01209143|314668|P2|Overall Study|Lost to Follow-up|0
82011|NCT01209143|314669|P1|Overall Study|Lost to Follow-up|1
82012|NCT01209143|314668|P2|Overall Study|Physician Decision|1
82013|NCT01209143|314669|P1|Overall Study|Physician Decision|3
82014|NCT01209143|314668|P2|Overall Study|Death|1
82015|NCT01209143|314669|P1|Overall Study|Death|0
82016|NCT01209143|314668|P2|Overall Study|Adverse Event|1
82017|NCT01209143|314669|P1|Overall Study|Adverse Event|2
82018|NCT01209078|314679|P2|Overall Study|Withdrawal by Subject|1
82019|NCT01209078|314680|P1|Overall Study|Withdrawal by Subject|2
82020|NCT01209078|314679|P2|Overall Study|Physician Decision|2
82021|NCT01209078|314680|P1|Overall Study|Physician Decision|5
82022|NCT01209078|314679|P2|Overall Study|Lost to Follow-up|0
82023|NCT01209078|314680|P1|Overall Study|Lost to Follow-up|4
82024|NCT01209078|314679|P2|Overall Study|Adverse Event|0
82025|NCT01209078|314680|P1|Overall Study|Adverse Event|5
82026|NCT01208961|314755|P2|High-Fat Period III|Protocol Violation|0
82027|NCT01208961|314756|P1|High-Fat Period III|Protocol Violation|1
82028|NCT01208870|314767|P2|Overall Study|Lost to Follow-up|8
82029|NCT01208870|314768|P1|Overall Study|Lost to Follow-up|2
82030|NCT01208415|314784|P1|Overall Study|Still be eligible for follow-up|33
82031|NCT01208415|314784|P1|Overall Study|Device not placed|1
82032|NCT01208415|314784|P1|Overall Study|Withdrawal by Subject|3
82033|NCT01208415|314784|P1|Overall Study|Lost to Follow-up|2
82034|NCT01208415|314784|P1|Overall Study|Death|1
82035|NCT01208402|314790|P2|Overall Study|Withdrawal by Subject|0
82036|NCT01208402|314791|P1|Overall Study|Withdrawal by Subject|1
82037|NCT01208337|314807|P1|Overall Study|Death|3
82038|NCT01208233|314821|P6|Overall Study|Withdrawal by Subject|2
82039|NCT01208233|314822|P5|Overall Study|Withdrawal by Subject|4
82040|NCT01208233|314823|P4|Overall Study|Withdrawal by Subject|1
82041|NCT01208233|314824|P3|Overall Study|Withdrawal by Subject|1
82042|NCT01208233|314825|P2|Overall Study|Withdrawal by Subject|0
82043|NCT01208233|314826|P1|Overall Study|Withdrawal by Subject|1
82044|NCT01208233|314821|P6|Overall Study|Other|1
82045|NCT01208233|314822|P5|Overall Study|Other|0
82046|NCT01208233|314823|P4|Overall Study|Other|0
82047|NCT01208233|314824|P3|Overall Study|Other|0
82048|NCT01208233|314825|P2|Overall Study|Other|1
82049|NCT01208233|314826|P1|Overall Study|Other|2
82050|NCT01208233|314821|P6|Overall Study|Protocol Violation|0
82051|NCT01208233|314822|P5|Overall Study|Protocol Violation|3
82052|NCT01208233|314823|P4|Overall Study|Protocol Violation|0
82053|NCT01208233|314824|P3|Overall Study|Protocol Violation|0
82054|NCT01208233|314825|P2|Overall Study|Protocol Violation|0
82055|NCT01208233|314826|P1|Overall Study|Protocol Violation|0
82056|NCT01208233|314821|P6|Overall Study|Study terminated by sponsor|7
82057|NCT01208233|314822|P5|Overall Study|Study terminated by sponsor|10
82058|NCT01208233|314823|P4|Overall Study|Study terminated by sponsor|0
82059|NCT01208233|314824|P3|Overall Study|Study terminated by sponsor|0
82060|NCT01208233|314825|P2|Overall Study|Study terminated by sponsor|0
82061|NCT01208233|314826|P1|Overall Study|Study terminated by sponsor|0
82062|NCT01208233|314821|P6|Overall Study|Medication error without adverse event|1
82063|NCT01208233|314822|P5|Overall Study|Medication error without adverse event|0
82064|NCT01208233|314823|P4|Overall Study|Medication error without adverse event|0
82065|NCT01208233|314824|P3|Overall Study|Medication error without adverse event|0
82066|NCT01208233|314825|P2|Overall Study|Medication error without adverse event|0
82067|NCT01208233|314826|P1|Overall Study|Medication error without adverse event|0
82068|NCT01208233|314821|P6|Overall Study|Did not meet entrance criteria|0
82069|NCT01208233|314822|P5|Overall Study|Did not meet entrance criteria|1
82070|NCT01208233|314823|P4|Overall Study|Did not meet entrance criteria|0
82071|NCT01208233|314824|P3|Overall Study|Did not meet entrance criteria|1
82072|NCT01208233|314825|P2|Overall Study|Did not meet entrance criteria|1
82073|NCT01208233|314826|P1|Overall Study|Did not meet entrance criteria|2
82074|NCT01208233|314821|P6|Overall Study|Death|5
82075|NCT01208233|314822|P5|Overall Study|Death|3
82076|NCT01208233|314823|P4|Overall Study|Death|0
82077|NCT01208233|314824|P3|Overall Study|Death|0
82078|NCT01208233|314825|P2|Overall Study|Death|0
82079|NCT01208233|314826|P1|Overall Study|Death|0
82080|NCT01208233|314821|P6|Overall Study|Adverse Event|5
82081|NCT01208233|314822|P5|Overall Study|Adverse Event|3
82082|NCT01208233|314823|P4|Overall Study|Adverse Event|0
82083|NCT01208233|314824|P3|Overall Study|Adverse Event|2
82084|NCT01208233|314825|P2|Overall Study|Adverse Event|1
82085|NCT01208233|314826|P1|Overall Study|Adverse Event|0
82086|NCT01208207|314951|P7|Part II|Technical Problems|0
82087|NCT01208207|314952|P6|Part II|Technical Problems|1
82088|NCT01208207|314953|P5|Part II|Technical Problems|0
82089|NCT01208207|314954|P4|Part II|Technical Problems|1
82090|NCT01208207|314955|P3|Part II|Technical Problems|0
82091|NCT01208207|314956|P2|Part II|Technical Problems|0
82092|NCT01208207|314957|P1|Part II|Technical Problems|0
82093|NCT01208207|314951|P7|Part II|Protocol Violation|0
82094|NCT01208207|314952|P6|Part II|Protocol Violation|0
82095|NCT01208207|314953|P5|Part II|Protocol Violation|0
82096|NCT01208207|314954|P4|Part II|Protocol Violation|1
82097|NCT01208207|314955|P3|Part II|Protocol Violation|0
82098|NCT01208207|314956|P2|Part II|Protocol Violation|0
82099|NCT01208207|314957|P1|Part II|Protocol Violation|0
82100|NCT01208207|314951|P7|Part II|Physician Decision|0
82101|NCT01208207|314952|P6|Part II|Physician Decision|2
82102|NCT01208207|314953|P5|Part II|Physician Decision|0
82103|NCT01208207|314954|P4|Part II|Physician Decision|1
82104|NCT01208207|314955|P3|Part II|Physician Decision|0
82105|NCT01208207|314956|P2|Part II|Physician Decision|0
82106|NCT01208207|314957|P1|Part II|Physician Decision|0
82107|NCT01208207|314951|P7|Part II|Non-Compliance With Study Drug|0
82108|NCT01208207|314952|P6|Part II|Non-Compliance With Study Drug|1
82109|NCT01208207|314953|P5|Part II|Non-Compliance With Study Drug|1
82110|NCT01208207|314954|P4|Part II|Non-Compliance With Study Drug|4
82111|NCT01208207|314955|P3|Part II|Non-Compliance With Study Drug|0
82112|NCT01208207|314956|P2|Part II|Non-Compliance With Study Drug|0
82113|NCT01208207|314957|P1|Part II|Non-Compliance With Study Drug|0
82114|NCT01208207|314951|P7|Part II|Lost to Follow-up|1
82115|NCT01208207|314952|P6|Part II|Lost to Follow-up|2
82116|NCT01208207|314953|P5|Part II|Lost to Follow-up|0
82117|NCT01208207|314954|P4|Part II|Lost to Follow-up|4
82118|NCT01208207|314955|P3|Part II|Lost to Follow-up|0
82119|NCT01208207|314956|P2|Part II|Lost to Follow-up|0
82120|NCT01208207|314957|P1|Part II|Lost to Follow-up|0
82121|NCT01208207|314951|P7|Part II|Lack of Efficacy|3
82122|NCT01208207|314952|P6|Part II|Lack of Efficacy|3
82123|NCT01208207|314953|P5|Part II|Lack of Efficacy|4
82124|NCT01208207|314954|P4|Part II|Lack of Efficacy|6
82125|NCT01208207|314955|P3|Part II|Lack of Efficacy|0
82126|NCT01208207|314956|P2|Part II|Lack of Efficacy|0
82127|NCT01208207|314957|P1|Part II|Lack of Efficacy|0
82128|NCT01208207|314951|P7|Part II|Adverse Event|2
82129|NCT01208207|314952|P6|Part II|Adverse Event|4
82130|NCT01208207|314953|P5|Part II|Adverse Event|9
82131|NCT01208207|314954|P4|Part II|Adverse Event|5
82132|NCT01208207|314955|P3|Part II|Adverse Event|0
82133|NCT01208207|314956|P2|Part II|Adverse Event|0
82134|NCT01208207|314957|P1|Part II|Adverse Event|0
82135|NCT01208207|314951|P7|Part II|Withdrawal by Subject|5
82136|NCT01208207|314952|P6|Part II|Withdrawal by Subject|3
82137|NCT01208207|314953|P5|Part II|Withdrawal by Subject|9
82138|NCT01208207|314954|P4|Part II|Withdrawal by Subject|10
82139|NCT01208207|314955|P3|Part II|Withdrawal by Subject|0
82140|NCT01208207|314956|P2|Part II|Withdrawal by Subject|0
82141|NCT01208207|314957|P1|Part II|Withdrawal by Subject|0
82142|NCT01208207|314951|P7|Part I|Withdrawal by Subject|0
82143|NCT01208207|314952|P6|Part I|Withdrawal by Subject|0
82144|NCT01208207|314953|P5|Part I|Withdrawal by Subject|0
82145|NCT01208207|314954|P4|Part I|Withdrawal by Subject|0
82146|NCT01208207|314955|P3|Part I|Withdrawal by Subject|4
82147|NCT01208207|314956|P2|Part I|Withdrawal by Subject|4
82148|NCT01208207|314957|P1|Part I|Withdrawal by Subject|14
82149|NCT01208207|314951|P7|Part I|Protocol Violation|0
82150|NCT01208207|314952|P6|Part I|Protocol Violation|0
82151|NCT01208207|314953|P5|Part I|Protocol Violation|0
82152|NCT01208207|314954|P4|Part I|Protocol Violation|0
82153|NCT01208207|314955|P3|Part I|Protocol Violation|2
82154|NCT01208207|314956|P2|Part I|Protocol Violation|0
82155|NCT01208207|314957|P1|Part I|Protocol Violation|8
82156|NCT01208207|314951|P7|Part I|Progressive Disease|0
82157|NCT01208207|314952|P6|Part I|Progressive Disease|0
82158|NCT01208207|314953|P5|Part I|Progressive Disease|0
82159|NCT01208207|314954|P4|Part I|Progressive Disease|0
82160|NCT01208207|314955|P3|Part I|Progressive Disease|0
82161|NCT01208207|314956|P2|Part I|Progressive Disease|0
82162|NCT01208207|314957|P1|Part I|Progressive Disease|1
82163|NCT01208207|314951|P7|Part I|Physician Decision|0
82164|NCT01208207|314952|P6|Part I|Physician Decision|0
82165|NCT01208207|314953|P5|Part I|Physician Decision|0
82166|NCT01208207|314954|P4|Part I|Physician Decision|0
82167|NCT01208207|314955|P3|Part I|Physician Decision|0
82168|NCT01208207|314956|P2|Part I|Physician Decision|1
82169|NCT01208207|314957|P1|Part I|Physician Decision|0
82170|NCT01208207|314951|P7|Part I|Non-Compliance With Study Drug|0
82171|NCT01208207|314952|P6|Part I|Non-Compliance With Study Drug|0
82172|NCT01208207|314953|P5|Part I|Non-Compliance With Study Drug|0
82173|NCT01208207|314954|P4|Part I|Non-Compliance With Study Drug|0
82174|NCT01208207|314955|P3|Part I|Non-Compliance With Study Drug|1
82175|NCT01208207|314956|P2|Part I|Non-Compliance With Study Drug|0
82176|NCT01208207|314957|P1|Part I|Non-Compliance With Study Drug|1
82177|NCT01208207|314951|P7|Part I|Lost to Follow-up|0
82178|NCT01208207|314952|P6|Part I|Lost to Follow-up|0
82179|NCT01208207|314953|P5|Part I|Lost to Follow-up|0
82180|NCT01208207|314954|P4|Part I|Lost to Follow-up|0
82181|NCT01208207|314955|P3|Part I|Lost to Follow-up|0
82182|NCT01208207|314956|P2|Part I|Lost to Follow-up|1
82183|NCT01208207|314957|P1|Part I|Lost to Follow-up|6
82184|NCT01208207|314951|P7|Part I|Lack of Efficacy|0
82185|NCT01208207|314952|P6|Part I|Lack of Efficacy|0
82186|NCT01208207|314953|P5|Part I|Lack of Efficacy|0
82187|NCT01208207|314954|P4|Part I|Lack of Efficacy|0
82188|NCT01208207|314955|P3|Part I|Lack of Efficacy|2
82189|NCT01208207|314956|P2|Part I|Lack of Efficacy|3
82190|NCT01208207|314957|P1|Part I|Lack of Efficacy|21
82191|NCT01208207|314951|P7|Part I|Adverse Event|0
82192|NCT01208207|314952|P6|Part I|Adverse Event|0
82193|NCT01208207|314953|P5|Part I|Adverse Event|0
82194|NCT01208207|314954|P4|Part I|Adverse Event|0
82195|NCT01208207|314955|P3|Part I|Adverse Event|6
82196|NCT01208207|314956|P2|Part I|Adverse Event|2
82197|NCT01208207|314957|P1|Part I|Adverse Event|19
82198|NCT01208181|314984|P5|Part 2|Lack of Efficacy|0
82199|NCT01208181|314985|P4|Part 2|Lack of Efficacy|7
82200|NCT01208181|314986|P3|Part 2|Lack of Efficacy|5
82201|NCT01208181|314987|P2|Part 2|Lack of Efficacy|0
82202|NCT01208181|314988|P1|Part 2|Lack of Efficacy|0
82203|NCT01208181|314984|P5|Part 2|Lost to Follow-up|0
82204|NCT01208181|314985|P4|Part 2|Lost to Follow-up|2
82205|NCT01208181|314986|P3|Part 2|Lost to Follow-up|1
82206|NCT01208181|314987|P2|Part 2|Lost to Follow-up|0
82207|NCT01208181|314988|P1|Part 2|Lost to Follow-up|0
82208|NCT01208181|314984|P5|Part 2|Non-compliance with study drug|0
82209|NCT01208181|314985|P4|Part 2|Non-compliance with study drug|1
82210|NCT01208181|314986|P3|Part 2|Non-compliance with study drug|1
82211|NCT01208181|314987|P2|Part 2|Non-compliance with study drug|0
82212|NCT01208181|314988|P1|Part 2|Non-compliance with study drug|0
82213|NCT01208181|314984|P5|Part 2|Physician Decision|0
82214|NCT01208181|314985|P4|Part 2|Physician Decision|2
82215|NCT01208181|314986|P3|Part 2|Physician Decision|1
82216|NCT01208181|314987|P2|Part 2|Physician Decision|0
82217|NCT01208181|314988|P1|Part 2|Physician Decision|0
82218|NCT01208181|314984|P5|Part 2|Protocol Violation|0
82219|NCT01208181|314985|P4|Part 2|Protocol Violation|0
82220|NCT01208181|314986|P3|Part 2|Protocol Violation|1
82221|NCT01208181|314987|P2|Part 2|Protocol Violation|0
82222|NCT01208181|314988|P1|Part 2|Protocol Violation|0
82223|NCT01208181|314984|P5|Part 2|Withdrawal by Subject|0
82224|NCT01208181|314985|P4|Part 2|Withdrawal by Subject|1
82225|NCT01208181|314986|P3|Part 2|Withdrawal by Subject|1
82226|NCT01208181|314987|P2|Part 2|Withdrawal by Subject|0
82227|NCT01208181|314988|P1|Part 2|Withdrawal by Subject|0
82228|NCT01208181|314984|P5|Part 2|Adverse Event|0
82229|NCT01208181|314985|P4|Part 2|Adverse Event|7
82230|NCT01208181|314986|P3|Part 2|Adverse Event|6
82231|NCT01208181|314987|P2|Part 2|Adverse Event|0
82232|NCT01208181|314988|P1|Part 2|Adverse Event|0
82233|NCT01208181|314984|P5|Part 1|Adverse Event|4
82234|NCT01208181|314985|P4|Part 1|Adverse Event|0
82235|NCT01208181|314986|P3|Part 1|Adverse Event|0
82236|NCT01208181|314987|P2|Part 1|Adverse Event|24
82237|NCT01208181|314988|P1|Part 1|Adverse Event|26
82238|NCT01208181|314984|P5|Part 1|Lack of Efficacy|17
82239|NCT01208181|314985|P4|Part 1|Lack of Efficacy|0
82240|NCT01208181|314986|P3|Part 1|Lack of Efficacy|0
82241|NCT01208181|314987|P2|Part 1|Lack of Efficacy|12
82242|NCT01208181|314988|P1|Part 1|Lack of Efficacy|37
82243|NCT01208181|314984|P5|Part 1|Lost to Follow-up|1
82244|NCT01208181|314985|P4|Part 1|Lost to Follow-up|0
82245|NCT01208181|314986|P3|Part 1|Lost to Follow-up|0
82246|NCT01208181|314987|P2|Part 1|Lost to Follow-up|3
82247|NCT01208181|314988|P1|Part 1|Lost to Follow-up|5
82248|NCT01208181|314984|P5|Part 1|Non-compliance with study drug|0
82249|NCT01208181|314985|P4|Part 1|Non-compliance with study drug|0
82250|NCT01208181|314986|P3|Part 1|Non-compliance with study drug|0
82251|NCT01208181|314987|P2|Part 1|Non-compliance with study drug|1
82252|NCT01208181|314988|P1|Part 1|Non-compliance with study drug|1
82253|NCT01208181|314984|P5|Part 1|Physician Decision|0
82254|NCT01208181|314985|P4|Part 1|Physician Decision|0
82255|NCT01208181|314986|P3|Part 1|Physician Decision|0
82256|NCT01208181|314987|P2|Part 1|Physician Decision|0
82257|NCT01208181|314988|P1|Part 1|Physician Decision|4
82258|NCT01208181|314984|P5|Part 1|Protocol Violation|0
82259|NCT01208181|314985|P4|Part 1|Protocol Violation|0
82260|NCT01208181|314986|P3|Part 1|Protocol Violation|0
82261|NCT01208181|314987|P2|Part 1|Protocol Violation|5
82262|NCT01208181|314988|P1|Part 1|Protocol Violation|10
82263|NCT01208181|314984|P5|Part 1|Technical problem|0
82264|NCT01208181|314985|P4|Part 1|Technical problem|0
82265|NCT01208181|314986|P3|Part 1|Technical problem|0
82266|NCT01208181|314987|P2|Part 1|Technical problem|0
82267|NCT01208181|314988|P1|Part 1|Technical problem|5
82268|NCT01208181|314984|P5|Part 1|Withdrawal by Subject|0
82269|NCT01208181|314985|P4|Part 1|Withdrawal by Subject|0
82270|NCT01208181|314986|P3|Part 1|Withdrawal by Subject|0
82271|NCT01208181|314987|P2|Part 1|Withdrawal by Subject|10
82272|NCT01208181|314988|P1|Part 1|Withdrawal by Subject|11
82273|NCT01207687|315045|P1|Overall Study|Withdrawal by Subject|1
82274|NCT01207687|315045|P1|Overall Study|Adverse Event|1
82275|NCT01207596|315079|P1|Overall Study|Withdrawal by Subject|1
82276|NCT01207596|315079|P1|Overall Study|Adverse Event|3
82277|NCT01207596|315079|P1|Overall Study|Lack of Efficacy|1
82278|NCT01207596|315079|P1|Overall Study|Physician Decision|4
82279|NCT01207583|315092|P3|Overall Study|Lost to Follow-up|0
82280|NCT01207583|315093|P2|Overall Study|Lost to Follow-up|2
82281|NCT01207583|315094|P1|Overall Study|Lost to Follow-up|0
82282|NCT01207583|315092|P3|Overall Study|Participant failed to return|0
82283|NCT01207583|315093|P2|Overall Study|Participant failed to return|0
82284|NCT01207583|315094|P1|Overall Study|Participant failed to return|1
82285|NCT01207583|315092|P3|Overall Study|Withdrawal by Subject|1
82286|NCT01207583|315093|P2|Overall Study|Withdrawal by Subject|3
82287|NCT01207583|315094|P1|Overall Study|Withdrawal by Subject|0
82288|NCT01207492|315147|P1|Overall Study|Toxicity|1
82289|NCT01207492|315147|P1|Overall Study|Progressive disease|3
82290|NCT01207492|315147|P1|Overall Study|Physician Decision|1
82291|NCT01207492|315147|P1|Overall Study|Withdrawal by Subject|9
82292|NCT01207492|315147|P1|Overall Study|Still on study|1
82293|NCT01207453|315162|P2|2nd Intervention|Lost to Follow-up|0
82294|NCT01207453|315163|P1|2nd Intervention|Lost to Follow-up|1
82295|NCT01207453|315162|P2|2nd Intervention|Adverse Event|2
82296|NCT01207453|315163|P1|2nd Intervention|Adverse Event|1
82297|NCT01207453|315162|P2|Washout|Lost to Follow-up|0
82298|NCT01207453|315163|P1|Washout|Lost to Follow-up|1
82299|NCT01207453|315162|P2|Washout|Adverse Event|0
82300|NCT01207453|315163|P1|Washout|Adverse Event|1
82301|NCT01207453|315162|P2|First Intervention|Adverse Event|1
82302|NCT01207453|315163|P1|First Intervention|Adverse Event|2
82303|NCT01207427|315185|P3|Double-blind Treatment Period|Withdrawal by Subject|0
82304|NCT01207427|315186|P2|Double-blind Treatment Period|Withdrawal by Subject|0
82305|NCT01207427|315187|P1|Double-blind Treatment Period|Withdrawal by Subject|1
82306|NCT01207427|315185|P3|Double-blind Treatment Period|Protocol Violation|1
82307|NCT01207427|315186|P2|Double-blind Treatment Period|Protocol Violation|1
82308|NCT01207427|315187|P1|Double-blind Treatment Period|Protocol Violation|2
82309|NCT01207427|315185|P3|Double-blind Treatment Period|Lost to Follow-up|1
82310|NCT01207427|315186|P2|Double-blind Treatment Period|Lost to Follow-up|0
82311|NCT01207427|315187|P1|Double-blind Treatment Period|Lost to Follow-up|0
82312|NCT01207427|315185|P3|Double-blind Treatment Period|Adverse Event|0
82313|NCT01207427|315186|P2|Double-blind Treatment Period|Adverse Event|1
82314|NCT01207427|315187|P1|Double-blind Treatment Period|Adverse Event|0
82315|NCT01207414|315197|P2|Overall Study|Randomized in error|0
82316|NCT01207414|315198|P1|Overall Study|Randomized in error|1
82317|NCT01207414|315197|P2|Overall Study|Protocol deviation|9
82318|NCT01207414|315198|P1|Overall Study|Protocol deviation|12
82319|NCT01207414|315197|P2|Overall Study|Administrative problems|1
82320|NCT01207414|315198|P1|Overall Study|Administrative problems|1
82321|NCT01207414|315197|P2|Overall Study|Lost to Follow-up|17
82322|NCT01207414|315198|P1|Overall Study|Lost to Follow-up|15
82323|NCT01207414|315197|P2|Overall Study|Patient withdrew consent|11
82324|NCT01207414|315198|P1|Overall Study|Patient withdrew consent|14
82325|NCT01207414|315197|P2|Overall Study|Unsatisfactory therapeutic effect|4
82326|NCT01207414|315198|P1|Overall Study|Unsatisfactory therapeutic effect|5
82327|NCT01207414|315197|P2|Overall Study|Abnormal test procedure results|1
82328|NCT01207414|315198|P1|Overall Study|Abnormal test procedure results|0
82329|NCT01207414|315197|P2|Overall Study|Adverse Event|39
82330|NCT01207414|315198|P1|Overall Study|Adverse Event|25
82331|NCT01207388|315223|P1|Overall Study|Other|1
82332|NCT01207388|315223|P1|Overall Study|Physician Decision|2
82333|NCT01207388|315223|P1|Overall Study|Disease Relapse|10
82334|NCT01207388|315223|P1|Overall Study|Adverse Event|20
82335|NCT01207219|315246|P3|Overall Study|Lost to Follow-up|6
82336|NCT01207219|315247|P2|Overall Study|Lost to Follow-up|8
82337|NCT01207219|315248|P1|Overall Study|Lost to Follow-up|6
82338|NCT01207219|315246|P3|Overall Study|changed diagnosis during study period|1
82339|NCT01207219|315247|P2|Overall Study|changed diagnosis during study period|3
82340|NCT01207219|315248|P1|Overall Study|changed diagnosis during study period|5
82341|NCT01207102|315268|P1|Overall Study|Withdrawal by Treating Physician|1
82342|NCT01207102|315268|P1|Overall Study|progression|2
82343|NCT01207102|315268|P1|Overall Study|Adverse Event|2
82344|NCT01207102|315268|P1|Overall Study|Withdrawal by Subject|5
82345|NCT01206777|315273|P1|Overall Study|Adverse Event|1
82346|NCT01206777|315273|P1|Overall Study|Death|1
82347|NCT01206582|315329|P2|Overall Study|Discontinued intervention before week 8|2
82348|NCT01206582|315330|P1|Overall Study|Discontinued intervention before week 8|1
82349|NCT01206582|315329|P2|Overall Study|Withdrew prior to study|0
82350|NCT01206582|315330|P1|Overall Study|Withdrew prior to study|1
82351|NCT01206517|315362|P6|Overall Study|Withdrawal by Subject|0
82352|NCT01206517|315363|P5|Overall Study|Withdrawal by Subject|1
82353|NCT01206517|315364|P4|Overall Study|Withdrawal by Subject|0
82354|NCT01206517|315365|P3|Overall Study|Withdrawal by Subject|2
82355|NCT01206517|315366|P2|Overall Study|Withdrawal by Subject|0
82356|NCT01206517|315367|P1|Overall Study|Withdrawal by Subject|0
82357|NCT01206439|315424|P1|Overall Study|subject did not meet inclusion criteria|1
82358|NCT01206322|315447|P4|Overall Study|Adverse Event|1
82359|NCT01206322|315448|P3|Overall Study|Adverse Event|0
82360|NCT01206322|315449|P2|Overall Study|Adverse Event|0
82361|NCT01206322|315450|P1|Overall Study|Adverse Event|0
82362|NCT01206140|315466|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
82363|NCT01206140|315467|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
82364|NCT01206101|315479|P2|Overall Study|Unclassified|0
82365|NCT01206101|315480|P1|Overall Study|Unclassified|1
82366|NCT01206101|315479|P2|Overall Study|Physician Decision|1
82367|NCT01206101|315480|P1|Overall Study|Physician Decision|0
82368|NCT01206101|315479|P2|Overall Study|Adverse Event|0
82369|NCT01206101|315480|P1|Overall Study|Adverse Event|1
82370|NCT01205776|315521|P2|3 Years Follow-up|Withdrawal by Subject|2
82371|NCT01205776|315522|P1|3 Years Follow-up|Withdrawal by Subject|1
82372|NCT01205776|315521|P2|3 Years Follow-up|Lost to Follow-up|22
82373|NCT01205776|315522|P1|3 Years Follow-up|Lost to Follow-up|15
82374|NCT01205776|315521|P2|2 Years Follow-up|Withdrawal by Subject|19
82375|NCT01205776|315522|P1|2 Years Follow-up|Withdrawal by Subject|4
82376|NCT01205776|315521|P2|2 Years Follow-up|Lost to Follow-up|13
82377|NCT01205776|315522|P1|2 Years Follow-up|Lost to Follow-up|12
82378|NCT01205776|315521|P2|1 Month Follow-up|Withdrawal by Subject|10
82379|NCT01205776|315522|P1|1 Month Follow-up|Withdrawal by Subject|5
82380|NCT01205776|315521|P2|1 Month Follow-up|Lost to Follow-up|2
82381|NCT01205776|315522|P1|1 Month Follow-up|Lost to Follow-up|0
82382|NCT01205685|315662|P1|Overall Study|Withdrawal by Subject|1
82383|NCT01205685|315662|P1|Overall Study|Disease Progression|10
82384|NCT01205581|315682|P6|Overall Study|Withdrawal by Subject|0
82385|NCT01205581|315683|P5|Overall Study|Withdrawal by Subject|0
82386|NCT01205581|315684|P4|Overall Study|Withdrawal by Subject|0
82387|NCT01205581|315685|P3|Overall Study|Withdrawal by Subject|0
82388|NCT01205581|315686|P2|Overall Study|Withdrawal by Subject|0
82389|NCT01205581|315687|P1|Overall Study|Withdrawal by Subject|1
82390|NCT01205529|315757|P1|Overall Study|No longer met criteria|30
82391|NCT01205529|315757|P1|Overall Study|Unstable post op|15
82392|NCT01205529|315757|P1|Overall Study|Physician Decision|4
82393|NCT01205529|315757|P1|Overall Study|Withdrawal by Subject|2
82394|NCT01205529|315757|P1|Overall Study|Procedure Cancelled|4
82395|NCT01205451|315780|P2|Overall Study|Withdrawal by Subject|9
82396|NCT01205451|315781|P1|Overall Study|Withdrawal by Subject|5
82397|NCT01205451|315780|P2|Overall Study|Lost to Follow-up|1
82398|NCT01205451|315781|P1|Overall Study|Lost to Follow-up|1
82399|NCT01205269|315829|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
82400|NCT01205269|315830|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
82401|NCT01205269|315831|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
82402|NCT01205269|315832|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
82403|NCT01205269|315833|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
82404|NCT01205269|315834|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
82405|NCT01205230|315874|P2|Overall Study|Physician Decision|0
82406|NCT01205230|315875|P1|Overall Study|Physician Decision|1
82407|NCT01205230|315874|P2|Overall Study|Adverse Event|0
82408|NCT01205230|315875|P1|Overall Study|Adverse Event|4
82409|NCT01205165|315918|P1|Overall Study|Lost to Follow-up|2
82410|NCT01205152|315931|P1|Overall Study|Death|1
82411|NCT01205126|315944|P2|Maintenance Phase|Withdrawal by Subject|11
82412|NCT01205126|315945|P1|Maintenance Phase|Withdrawal by Subject|8
82413|NCT01205126|315944|P2|Maintenance Phase|Lost to Follow-up|5
82414|NCT01205126|315945|P1|Maintenance Phase|Lost to Follow-up|5
82415|NCT01205126|315944|P2|Maintenance Phase|Other|8
82416|NCT01205126|315945|P1|Maintenance Phase|Other|11
82417|NCT01205126|315944|P2|Maintenance Phase|Prohibited drugs used|0
82418|NCT01205126|315945|P1|Maintenance Phase|Prohibited drugs used|1
82419|NCT01205126|315944|P2|Maintenance Phase|More than the maximum dosage required|5
82420|NCT01205126|315945|P1|Maintenance Phase|More than the maximum dosage required|5
82421|NCT01205126|315944|P2|Maintenance Phase|Death|4
82422|NCT01205126|315945|P1|Maintenance Phase|Death|4
82423|NCT01205126|315944|P2|Maintenance Phase|Adverse Event|7
82424|NCT01205126|315945|P1|Maintenance Phase|Adverse Event|3
82425|NCT01205126|315944|P2|Between Titration & Maintenance Phase|Other|4
82426|NCT01205126|315945|P1|Between Titration & Maintenance Phase|Other|0
82427|NCT01205126|315944|P2|Titration Phase|Other|6
82428|NCT01205126|315945|P1|Titration Phase|Other|8
82429|NCT01205126|315944|P2|Titration Phase|More than maximum dosage required|3
82430|NCT01205126|315945|P1|Titration Phase|More than maximum dosage required|2
82431|NCT01205126|315944|P2|Titration Phase|No stable titration dose|0
82432|NCT01205126|315945|P1|Titration Phase|No stable titration dose|1
82433|NCT01205126|315944|P2|Titration Phase|Lost to Follow-up|2
82434|NCT01205126|315945|P1|Titration Phase|Lost to Follow-up|2
82435|NCT01205126|315944|P2|Titration Phase|Withdrawal by Subject|5
82436|NCT01205126|315945|P1|Titration Phase|Withdrawal by Subject|5
82437|NCT01205126|315944|P2|Titration Phase|Adverse Event|3
82438|NCT01205126|315945|P1|Titration Phase|Adverse Event|5
82439|NCT01205035|315963|P2|Overall Study|Physician Decision|0
82440|NCT01205035|315964|P1|Overall Study|Physician Decision|1
82441|NCT01205035|315963|P2|Overall Study|Withdrawal by Subject|0
82442|NCT01205035|315964|P1|Overall Study|Withdrawal by Subject|1
82443|NCT01204918|315981|P3|Overall Study|Withdrawal by Subject|5
82444|NCT01204918|315982|P2|Overall Study|Withdrawal by Subject|10
82445|NCT01204918|315983|P1|Overall Study|Withdrawal by Subject|4
82446|NCT01204775|316021|P2|Overall Study|Withdrawal by Subject|0
82447|NCT01204775|316022|P1|Overall Study|Withdrawal by Subject|1
82448|NCT01204775|316021|P2|Overall Study|Poor/non-compliance|1
82449|NCT01204775|316022|P1|Overall Study|Poor/non-compliance|0
82450|NCT01204697|316047|P2|Overall Study|Randomized, but not treated|1
82451|NCT01204697|316048|P1|Overall Study|Randomized, but not treated|0
82452|NCT01204697|316047|P2|Overall Study|Withdrawal by Subject|4
82453|NCT01204697|316048|P1|Overall Study|Withdrawal by Subject|2
82454|NCT01204697|316047|P2|Overall Study|Lost to Follow-up|4
82455|NCT01204697|316048|P1|Overall Study|Lost to Follow-up|3
82456|NCT01204697|316047|P2|Overall Study|Death|27
82457|NCT01204697|316048|P1|Overall Study|Death|26
82458|NCT01204671|316069|P5|Overall Study|Physician Decision|0
82459|NCT01204671|316070|P4|Overall Study|Physician Decision|1
82460|NCT01204671|316071|P3|Overall Study|Physician Decision|0
82461|NCT01204671|316072|P2|Overall Study|Physician Decision|0
82462|NCT01204671|316073|P1|Overall Study|Physician Decision|0
82463|NCT01204671|316069|P5|Overall Study|Unknown Completion Status|0
82464|NCT01204671|316070|P4|Overall Study|Unknown Completion Status|0
82465|NCT01204671|316071|P3|Overall Study|Unknown Completion Status|0
82466|NCT01204671|316072|P2|Overall Study|Unknown Completion Status|1
82467|NCT01204671|316073|P1|Overall Study|Unknown Completion Status|1
82468|NCT01204671|316069|P5|Overall Study|Lost to Follow-up|0
82469|NCT01204671|316070|P4|Overall Study|Lost to Follow-up|4
82470|NCT01204671|316071|P3|Overall Study|Lost to Follow-up|6
82471|NCT01204671|316072|P2|Overall Study|Lost to Follow-up|8
82472|NCT01204671|316073|P1|Overall Study|Lost to Follow-up|7
82473|NCT01204671|316069|P5|Overall Study|Withdrawal by Subject|3
82474|NCT01204671|316070|P4|Overall Study|Withdrawal by Subject|5
82475|NCT01204671|316071|P3|Overall Study|Withdrawal by Subject|4
82476|NCT01204671|316072|P2|Overall Study|Withdrawal by Subject|3
82477|NCT01204671|316073|P1|Overall Study|Withdrawal by Subject|2
82478|NCT01204671|316069|P5|Overall Study|Adverse Event|1
82479|NCT01204671|316070|P4|Overall Study|Adverse Event|3
82480|NCT01204671|316071|P3|Overall Study|Adverse Event|3
82481|NCT01204671|316072|P2|Overall Study|Adverse Event|3
82482|NCT01204671|316073|P1|Overall Study|Adverse Event|4
82483|NCT01204658|316135|P4|Primary Phase|Adverse Event|0
82484|NCT01204658|316136|P3|Primary Phase|Adverse Event|1
82485|NCT01204658|316137|P2|Primary Phase|Adverse Event|0
82486|NCT01204658|316138|P1|Primary Phase|Adverse Event|0
82487|NCT01204398|316248|P1|Overall Study|Adverse Event|1
82488|NCT01204294|316265|P7|Overall Study|Other (house moving)|0
82489|NCT01204294|316266|P6|Overall Study|Other (house moving)|0
82490|NCT01204294|316267|P5|Overall Study|Other (house moving)|0
82491|NCT01204294|316268|P4|Overall Study|Other (house moving)|0
82492|NCT01204294|316269|P3|Overall Study|Other (house moving)|1
82493|NCT01204294|316270|P2|Overall Study|Other (house moving)|0
82494|NCT01204294|316271|P1|Overall Study|Other (house moving)|0
82495|NCT01204294|316265|P7|Overall Study|Lack of Efficacy|0
82496|NCT01204294|316266|P6|Overall Study|Lack of Efficacy|0
82497|NCT01204294|316267|P5|Overall Study|Lack of Efficacy|0
82498|NCT01204294|316268|P4|Overall Study|Lack of Efficacy|2
82499|NCT01204294|316269|P3|Overall Study|Lack of Efficacy|0
82500|NCT01204294|316270|P2|Overall Study|Lack of Efficacy|0
82501|NCT01204294|316271|P1|Overall Study|Lack of Efficacy|0
82502|NCT01204294|316265|P7|Overall Study|Withdrawal by Subject|2
82503|NCT01204294|316266|P6|Overall Study|Withdrawal by Subject|1
82504|NCT01204294|316267|P5|Overall Study|Withdrawal by Subject|1
82505|NCT01204294|316268|P4|Overall Study|Withdrawal by Subject|1
82506|NCT01204294|316269|P3|Overall Study|Withdrawal by Subject|2
82507|NCT01204294|316270|P2|Overall Study|Withdrawal by Subject|2
82508|NCT01204294|316271|P1|Overall Study|Withdrawal by Subject|0
82509|NCT01204294|316265|P7|Overall Study|Protocol Violation|0
82510|NCT01204294|316266|P6|Overall Study|Protocol Violation|0
82511|NCT01204294|316267|P5|Overall Study|Protocol Violation|0
82512|NCT01204294|316268|P4|Overall Study|Protocol Violation|1
82513|NCT01204294|316269|P3|Overall Study|Protocol Violation|2
82514|NCT01204294|316270|P2|Overall Study|Protocol Violation|0
82515|NCT01204294|316271|P1|Overall Study|Protocol Violation|1
82516|NCT01204294|316265|P7|Overall Study|Adverse Event|0
82517|NCT01204294|316266|P6|Overall Study|Adverse Event|4
82518|NCT01204294|316267|P5|Overall Study|Adverse Event|1
82519|NCT01204294|316268|P4|Overall Study|Adverse Event|7
82520|NCT01204294|316269|P3|Overall Study|Adverse Event|0
82521|NCT01204294|316270|P2|Overall Study|Adverse Event|6
82522|NCT01204294|316271|P1|Overall Study|Adverse Event|2
82523|NCT01203956|316305|P2|Second Two-week Period|Non-compliant: no evaluable results|6
82524|NCT01203956|316306|P1|Second Two-week Period|Non-compliant: no evaluable results|5
82525|NCT01203930|316315|P2|Overall Study|Adverse Event|5
82526|NCT01203930|316316|P1|Overall Study|Adverse Event|17
82527|NCT01203930|316315|P2|Overall Study|Poor tolerance of study drug|1
82528|NCT01203930|316316|P1|Overall Study|Poor tolerance of study drug|0
82529|NCT01203930|316315|P2|Overall Study|Study Terminated by Sponsor|12
82530|NCT01203930|316316|P1|Overall Study|Study Terminated by Sponsor|0
82531|NCT01203930|316315|P2|Overall Study|Investigator Request|8
82532|NCT01203930|316316|P1|Overall Study|Investigator Request|0
82533|NCT01203930|316315|P2|Overall Study|Withdrew Consent|10
82534|NCT01203930|316316|P1|Overall Study|Withdrew Consent|1
82535|NCT01203930|316315|P2|Overall Study|Death|1
82536|NCT01203930|316316|P1|Overall Study|Death|3
82537|NCT01203930|316315|P2|Overall Study|Disease Progression|4
82538|NCT01203930|316316|P1|Overall Study|Disease Progression|0
82539|NCT01203917|316338|P1|Overall Study|Due to EGFR M+I patient|1
82540|NCT01203917|316338|P1|Overall Study|Due to objective disease progression|1
82541|NCT01203917|316338|P1|Overall Study|Withdrawal by Subject|3
82542|NCT01203917|316338|P1|Overall Study|Lost to Follow-up|2
82543|NCT01203917|316338|P1|Overall Study|Death|29
82544|NCT01203878|316351|P3|Overall Study|Adverse Event|2
82545|NCT01203878|316352|P2|Overall Study|Adverse Event|0
82546|NCT01203878|316353|P1|Overall Study|Adverse Event|0
82547|NCT01203878|316351|P3|Overall Study|Withdrawal by Subject|1
82548|NCT01203878|316352|P2|Overall Study|Withdrawal by Subject|0
82549|NCT01203878|316353|P1|Overall Study|Withdrawal by Subject|0
82550|NCT01203852|316364|P1|Washout 2 Weeks|Physician Decision|46
82551|NCT01203852|316364|P1|Metoprolol 8 Weeks|Physician Decision|470
82552|NCT01203787|316382|P2|Overall Study|Adverse Event|15
82553|NCT01203787|316383|P1|Overall Study|Adverse Event|11
82554|NCT01203787|316382|P2|Overall Study|Lost to Follow-up|0
82555|NCT01203787|316383|P1|Overall Study|Lost to Follow-up|2
82556|NCT01203787|316382|P2|Overall Study|Withdrawal by Subject|2
82557|NCT01203787|316383|P1|Overall Study|Withdrawal by Subject|6
82558|NCT01203787|316382|P2|Overall Study|Death|10
82559|NCT01203787|316383|P1|Overall Study|Death|12
82560|NCT01203098|316454|P3|Overall Study|Withdrawal by Subject|3
82561|NCT01203098|316455|P2|Overall Study|Withdrawal by Subject|1
82562|NCT01203098|316456|P1|Overall Study|Withdrawal by Subject|1
82563|NCT01203098|316454|P3|Overall Study|Physician Decision|0
82564|NCT01203098|316455|P2|Overall Study|Physician Decision|2
82565|NCT01203098|316456|P1|Overall Study|Physician Decision|2
82566|NCT01203098|316454|P3|Overall Study|Lost to Follow-up|1
82567|NCT01203098|316455|P2|Overall Study|Lost to Follow-up|0
82568|NCT01203098|316456|P1|Overall Study|Lost to Follow-up|0
82569|NCT01203098|316454|P3|Overall Study|Adverse Event|7
82570|NCT01203098|316455|P2|Overall Study|Adverse Event|1
82571|NCT01203098|316456|P1|Overall Study|Adverse Event|3
82572|NCT01203072|316472|P5|Overall Study|Withdrawal by Subject|3
82573|NCT01203072|316473|P4|Overall Study|Withdrawal by Subject|2
82574|NCT01203072|316474|P3|Overall Study|Withdrawal by Subject|1
82575|NCT01203072|316475|P2|Overall Study|Withdrawal by Subject|2
82576|NCT01203072|316476|P1|Overall Study|Withdrawal by Subject|2
82577|NCT01203072|316472|P5|Overall Study|Protocol Violation|1
82578|NCT01203072|316473|P4|Overall Study|Protocol Violation|0
82579|NCT01203072|316474|P3|Overall Study|Protocol Violation|0
82580|NCT01203072|316475|P2|Overall Study|Protocol Violation|0
82581|NCT01203072|316476|P1|Overall Study|Protocol Violation|2
82582|NCT01203072|316472|P5|Overall Study|Lost to Follow-up|0
82583|NCT01203072|316473|P4|Overall Study|Lost to Follow-up|0
82584|NCT01203072|316474|P3|Overall Study|Lost to Follow-up|0
82585|NCT01203072|316475|P2|Overall Study|Lost to Follow-up|1
82586|NCT01203072|316476|P1|Overall Study|Lost to Follow-up|0
82587|NCT01203072|316472|P5|Overall Study|Lack of Efficacy|0
82588|NCT01203072|316473|P4|Overall Study|Lack of Efficacy|0
82589|NCT01203072|316474|P3|Overall Study|Lack of Efficacy|0
82590|NCT01203072|316475|P2|Overall Study|Lack of Efficacy|0
82591|NCT01203072|316476|P1|Overall Study|Lack of Efficacy|1
82592|NCT01203072|316472|P5|Overall Study|Adverse Event|2
82593|NCT01203072|316473|P4|Overall Study|Adverse Event|4
82594|NCT01203072|316474|P3|Overall Study|Adverse Event|2
82595|NCT01203072|316475|P2|Overall Study|Adverse Event|3
82596|NCT01203072|316476|P1|Overall Study|Adverse Event|5
82597|NCT01202955|316511|P2|Period 1: 10 Days|Withdrawal by Subject|2
82598|NCT01202955|316512|P1|Period 1: 10 Days|Withdrawal by Subject|0
82599|NCT01202903|316524|P2|Overall Study|Withdrawal by Subject|4
82600|NCT01202903|316525|P1|Overall Study|Withdrawal by Subject|4
82601|NCT01202903|316524|P2|Overall Study|Adverse Event|3
82602|NCT01202903|316525|P1|Overall Study|Adverse Event|3
82603|NCT01202903|316524|P2|Overall Study|Lack of Efficacy|3
82604|NCT01202903|316525|P1|Overall Study|Lack of Efficacy|1
82605|NCT01202903|316524|P2|Overall Study|Lost to Follow-up|1
82606|NCT01202903|316525|P1|Overall Study|Lost to Follow-up|1
82607|NCT01202903|316524|P2|Overall Study|Death|0
82608|NCT01202903|316525|P1|Overall Study|Death|1
82609|NCT01202903|316524|P2|Overall Study|Protocol Violation|1
82610|NCT01202903|316525|P1|Overall Study|Protocol Violation|0
82611|NCT01202903|316524|P2|Overall Study|Administrative Probelms|4
82612|NCT01202903|316525|P1|Overall Study|Administrative Probelms|1
82613|NCT01202877|316552|P3|Overall Study|Death|1
82614|NCT01202877|316553|P2|Overall Study|Death|0
82615|NCT01202877|316554|P1|Overall Study|Death|0
82616|NCT01202877|316552|P3|Overall Study|Withdrawal by Subject|1
82617|NCT01202877|316553|P2|Overall Study|Withdrawal by Subject|0
82618|NCT01202877|316554|P1|Overall Study|Withdrawal by Subject|0
82619|NCT01202877|316552|P3|Overall Study|Adverse Event|2
82620|NCT01202877|316553|P2|Overall Study|Adverse Event|0
82621|NCT01202877|316554|P1|Overall Study|Adverse Event|0
82622|NCT01202877|316552|P3|Overall Study|Disease Progression|2
82623|NCT01202877|316553|P2|Overall Study|Disease Progression|1
82624|NCT01202877|316554|P1|Overall Study|Disease Progression|0
82625|NCT01202773|316566|P3|Overall Study|Sponsor Decision|23
82626|NCT01202773|316567|P2|Overall Study|Sponsor Decision|20
82627|NCT01202773|316568|P1|Overall Study|Sponsor Decision|19
82628|NCT01202773|316566|P3|Overall Study|Protocol Violation|10
82629|NCT01202773|316567|P2|Overall Study|Protocol Violation|6
82630|NCT01202773|316568|P1|Overall Study|Protocol Violation|11
82631|NCT01202773|316566|P3|Overall Study|Physician Decision|0
82632|NCT01202773|316567|P2|Overall Study|Physician Decision|0
82633|NCT01202773|316568|P1|Overall Study|Physician Decision|2
82634|NCT01202773|316566|P3|Overall Study|Withdrawal by Subject|5
82635|NCT01202773|316567|P2|Overall Study|Withdrawal by Subject|6
82636|NCT01202773|316568|P1|Overall Study|Withdrawal by Subject|13
82637|NCT01202773|316566|P3|Overall Study|Lost to Follow-up|2
82638|NCT01202773|316567|P2|Overall Study|Lost to Follow-up|2
82639|NCT01202773|316568|P1|Overall Study|Lost to Follow-up|1
82640|NCT01202773|316566|P3|Overall Study|Entry Criteria Not Met|1
82641|NCT01202773|316567|P2|Overall Study|Entry Criteria Not Met|0
82642|NCT01202773|316568|P1|Overall Study|Entry Criteria Not Met|2
82643|NCT01202773|316566|P3|Overall Study|Lack of Efficacy|9
82644|NCT01202773|316567|P2|Overall Study|Lack of Efficacy|4
82645|NCT01202773|316568|P1|Overall Study|Lack of Efficacy|5
82646|NCT01202773|316566|P3|Overall Study|Adverse Event|5
82647|NCT01202773|316567|P2|Overall Study|Adverse Event|5
82648|NCT01202773|316568|P1|Overall Study|Adverse Event|4
82649|NCT01202760|316645|P3|Overall Study|Sponsor Decision|0
82650|NCT01202760|316646|P2|Overall Study|Sponsor Decision|4
82651|NCT01202760|316647|P1|Overall Study|Sponsor Decision|4
82652|NCT01202760|316645|P3|Overall Study|Protocol Violation|2
82653|NCT01202760|316646|P2|Overall Study|Protocol Violation|5
82654|NCT01202760|316647|P1|Overall Study|Protocol Violation|7
82655|NCT01202760|316645|P3|Overall Study|Physician Decision|0
82656|NCT01202760|316646|P2|Overall Study|Physician Decision|1
82657|NCT01202760|316647|P1|Overall Study|Physician Decision|0
82658|NCT01202760|316645|P3|Overall Study|Withdrawal by Subject|14
82659|NCT01202760|316646|P2|Overall Study|Withdrawal by Subject|18
82660|NCT01202760|316647|P1|Overall Study|Withdrawal by Subject|17
82661|NCT01202760|316645|P3|Overall Study|Parent / Caregiver Decision|0
82662|NCT01202760|316646|P2|Overall Study|Parent / Caregiver Decision|1
82663|NCT01202760|316647|P1|Overall Study|Parent / Caregiver Decision|0
82664|NCT01202760|316645|P3|Overall Study|Lost to Follow-up|1
82665|NCT01202760|316646|P2|Overall Study|Lost to Follow-up|2
82666|NCT01202760|316647|P1|Overall Study|Lost to Follow-up|0
82667|NCT01202760|316645|P3|Overall Study|Lack of Efficacy|7
82668|NCT01202760|316646|P2|Overall Study|Lack of Efficacy|8
82669|NCT01202760|316647|P1|Overall Study|Lack of Efficacy|6
82670|NCT01202760|316645|P3|Overall Study|Death|0
82671|NCT01202760|316646|P2|Overall Study|Death|1
82672|NCT01202760|316647|P1|Overall Study|Death|2
82673|NCT01202760|316645|P3|Overall Study|Adverse Event|10
82674|NCT01202760|316646|P2|Overall Study|Adverse Event|9
82675|NCT01202760|316647|P1|Overall Study|Adverse Event|11
82676|NCT01202760|316645|P3|Overall Study|Entry Criteria Not Met|1
82677|NCT01202760|316646|P2|Overall Study|Entry Criteria Not Met|3
82678|NCT01202760|316647|P1|Overall Study|Entry Criteria Not Met|0
82679|NCT01202747|316715|P1|Overall Study|Withdrawal by Subject|1
82680|NCT01202591|316747|P6|Overall Study|Objective Disease Progression|0
82681|NCT01202591|316748|P5|Overall Study|Objective Disease Progression|2
82682|NCT01202591|316749|P4|Overall Study|Objective Disease Progression|0
82683|NCT01202591|316750|P3|Overall Study|Objective Disease Progression|0
82684|NCT01202591|316751|P2|Overall Study|Objective Disease Progression|0
82685|NCT01202591|316752|P1|Overall Study|Objective Disease Progression|0
82686|NCT01202591|316747|P6|Overall Study|Withdrawal by Subject|1
82687|NCT01202591|316748|P5|Overall Study|Withdrawal by Subject|2
82688|NCT01202591|316749|P4|Overall Study|Withdrawal by Subject|0
82689|NCT01202591|316750|P3|Overall Study|Withdrawal by Subject|0
82690|NCT01202591|316751|P2|Overall Study|Withdrawal by Subject|0
82691|NCT01202591|316752|P1|Overall Study|Withdrawal by Subject|0
82692|NCT01202591|316747|P6|Overall Study|Other reason as per investigator|3
82693|NCT01202591|316748|P5|Overall Study|Other reason as per investigator|1
82694|NCT01202591|316749|P4|Overall Study|Other reason as per investigator|3
82695|NCT01202591|316750|P3|Overall Study|Other reason as per investigator|7
82696|NCT01202591|316751|P2|Overall Study|Other reason as per investigator|4
82697|NCT01202591|316752|P1|Overall Study|Other reason as per investigator|3
82698|NCT01202591|316747|P6|Overall Study|Adverse Event|0
82699|NCT01202591|316748|P5|Overall Study|Adverse Event|0
82700|NCT01202591|316749|P4|Overall Study|Adverse Event|4
82701|NCT01202591|316750|P3|Overall Study|Adverse Event|4
82702|NCT01202591|316751|P2|Overall Study|Adverse Event|1
82703|NCT01202591|316752|P1|Overall Study|Adverse Event|2
82704|NCT01202279|316798|P2|Overall Study|study compliance|2
82705|NCT01202279|316799|P1|Overall Study|study compliance|5
82706|NCT01202279|316798|P2|Overall Study|Protocol Violation|1
82707|NCT01202279|316799|P1|Overall Study|Protocol Violation|1
82708|NCT01202279|316798|P2|Overall Study|Lost to Follow-up|7
82709|NCT01202279|316799|P1|Overall Study|Lost to Follow-up|10
82710|NCT01202279|316798|P2|Overall Study|Physician Decision|1
82711|NCT01202279|316799|P1|Overall Study|Physician Decision|0
82712|NCT01202279|316798|P2|Overall Study|Withdrawal by Subject|10
82713|NCT01202279|316799|P1|Overall Study|Withdrawal by Subject|13
82714|NCT01202279|316798|P2|Overall Study|Adverse Event|6
82715|NCT01202279|316799|P1|Overall Study|Adverse Event|8
82716|NCT01202227|316851|P1|Overall Study|Lack of Efficacy|1
82717|NCT01202227|316851|P1|Overall Study|Withdrawal by Subject|2
82718|NCT01202227|316851|P1|Overall Study|Adverse Event|16
82719|NCT01202188|316875|P5|Overall Study|Abnormal test procedure result (s)|0
82720|NCT01202188|316876|P4|Overall Study|Abnormal test procedure result (s)|0
82721|NCT01202188|316877|P3|Overall Study|Abnormal test procedure result (s)|2
82722|NCT01202188|316878|P2|Overall Study|Abnormal test procedure result (s)|0
82723|NCT01202188|316879|P1|Overall Study|Abnormal test procedure result (s)|0
82724|NCT01202188|316875|P5|Overall Study|Death|0
82725|NCT01202188|316876|P4|Overall Study|Death|1
82726|NCT01202188|316877|P3|Overall Study|Death|1
82727|NCT01202188|316878|P2|Overall Study|Death|1
82728|NCT01202188|316879|P1|Overall Study|Death|1
82729|NCT01202188|316875|P5|Overall Study|Lost to Follow-up|1
82730|NCT01202188|316876|P4|Overall Study|Lost to Follow-up|4
82731|NCT01202188|316877|P3|Overall Study|Lost to Follow-up|0
82732|NCT01202188|316878|P2|Overall Study|Lost to Follow-up|1
82733|NCT01202188|316879|P1|Overall Study|Lost to Follow-up|1
82734|NCT01202188|316875|P5|Overall Study|Unsatisfactory therapeutic effect|8
82735|NCT01202188|316876|P4|Overall Study|Unsatisfactory therapeutic effect|5
82736|NCT01202188|316877|P3|Overall Study|Unsatisfactory therapeutic effect|2
82737|NCT01202188|316878|P2|Overall Study|Unsatisfactory therapeutic effect|8
82738|NCT01202188|316879|P1|Overall Study|Unsatisfactory therapeutic effect|2
82739|NCT01202188|316875|P5|Overall Study|Administrative problems|2
82740|NCT01202188|316876|P4|Overall Study|Administrative problems|1
82741|NCT01202188|316877|P3|Overall Study|Administrative problems|1
82742|NCT01202188|316878|P2|Overall Study|Administrative problems|2
82743|NCT01202188|316879|P1|Overall Study|Administrative problems|3
82744|NCT01202188|316875|P5|Overall Study|Adverse Event|10
82745|NCT01202188|316876|P4|Overall Study|Adverse Event|10
82746|NCT01202188|316877|P3|Overall Study|Adverse Event|13
82747|NCT01202188|316878|P2|Overall Study|Adverse Event|23
82748|NCT01202188|316879|P1|Overall Study|Adverse Event|5
82749|NCT01202188|316875|P5|Overall Study|Subject withdrew consent|13
82750|NCT01202188|316876|P4|Overall Study|Subject withdrew consent|11
82751|NCT01202188|316877|P3|Overall Study|Subject withdrew consent|22
82752|NCT01202188|316878|P2|Overall Study|Subject withdrew consent|13
82753|NCT01202188|316879|P1|Overall Study|Subject withdrew consent|12
82754|NCT01202188|316875|P5|Overall Study|Protocol deviation|11
82755|NCT01202188|316876|P4|Overall Study|Protocol deviation|10
82756|NCT01202188|316877|P3|Overall Study|Protocol deviation|12
82757|NCT01202188|316878|P2|Overall Study|Protocol deviation|8
82758|NCT01202188|316879|P1|Overall Study|Protocol deviation|14
82759|NCT01201967|317026|P2|Overall Study|Lost to Follow-up|5
82760|NCT01201967|317027|P1|Overall Study|Lost to Follow-up|6
82761|NCT01201915|317052|P3|Overall Study|Target Lesion Progression|0
82762|NCT01201915|317053|P2|Overall Study|Target Lesion Progression|3
82763|NCT01201915|317054|P1|Overall Study|Target Lesion Progression|0
82764|NCT01201915|317052|P3|Overall Study|Subject Decision|5
82765|NCT01201915|317053|P2|Overall Study|Subject Decision|3
82766|NCT01201915|317054|P1|Overall Study|Subject Decision|3
82767|NCT01201915|317052|P3|Overall Study|Physician Decision|0
82768|NCT01201915|317053|P2|Overall Study|Physician Decision|0
82769|NCT01201915|317054|P1|Overall Study|Physician Decision|3
82770|NCT01201915|317052|P3|Overall Study|Lost to Follow-up|0
82771|NCT01201915|317053|P2|Overall Study|Lost to Follow-up|4
82772|NCT01201915|317054|P1|Overall Study|Lost to Follow-up|0
82773|NCT01201915|317052|P3|Overall Study|Adverse Event|1
82774|NCT01201915|317053|P2|Overall Study|Adverse Event|1
82775|NCT01201915|317054|P1|Overall Study|Adverse Event|2
82776|NCT01201811|317065|P1|Overall Study|Physician Decision|1
82777|NCT01201811|317065|P1|Overall Study|Treatment Failure|2
82778|NCT01201811|317065|P1|Overall Study|Death|4
82779|NCT01201811|317065|P1|Overall Study|Withdrawal by Subject|3
82780|NCT01201811|317065|P1|Overall Study|Disease progression|3
82781|NCT01201811|317065|P1|Overall Study|Adverse Event|6
82782|NCT01201798|317087|P2|Overall Study|Treatment Failure|8
82783|NCT01201798|317088|P1|Overall Study|Treatment Failure|1
82784|NCT01201798|317087|P2|Overall Study|Protocol Violation|1
82785|NCT01201798|317088|P1|Overall Study|Protocol Violation|1
82786|NCT01201798|317087|P2|Overall Study|Noncompliance|0
82787|NCT01201798|317088|P1|Overall Study|Noncompliance|1
82788|NCT01201798|317087|P2|Overall Study|Decision Unrelated to an Adverse Event|1
82789|NCT01201798|317088|P1|Overall Study|Decision Unrelated to an Adverse Event|1
82790|NCT01201798|317087|P2|Overall Study|Lost to Follow-up|5
82791|NCT01201798|317088|P1|Overall Study|Lost to Follow-up|3
82792|NCT01201798|317087|P2|Overall Study|Adverse Event|0
82793|NCT01201798|317088|P1|Overall Study|Adverse Event|2
82794|NCT01201785|317112|P1|Overall Study|Lost to Follow-up|16
82795|NCT01201759|317129|P2|Visit 4 Crossover|Lost to Follow-up|1
82796|NCT01201759|317130|P1|Visit 4 Crossover|Lost to Follow-up|0
82797|NCT01201759|317129|P2|Visit 3 - Washout|Lost to Follow-up|0
82798|NCT01201759|317130|P1|Visit 3 - Washout|Lost to Follow-up|1
82799|NCT01201759|317129|P2|Visit 3 - Washout|Adverse Event|3
82800|NCT01201759|317130|P1|Visit 3 - Washout|Adverse Event|0
82801|NCT01201759|317129|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
82802|NCT01201759|317130|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
82803|NCT01201343|317159|P1|Overall Study|Randomized, not treated|3
82804|NCT01201343|317159|P1|Overall Study|Participant wrongly included in trial|1
82805|NCT01201343|317159|P1|Overall Study|Lack of Efficacy|2
82806|NCT01201343|317159|P1|Overall Study|Lost to Follow-up|2
82807|NCT01201343|317159|P1|Overall Study|Withdrawal by Subject|5
82808|NCT01201343|317159|P1|Overall Study|Adverse Event|6
82809|NCT01201317|317173|P3|Overall Study|Safety, possible history of tuberculosis|1
82810|NCT01201317|317174|P2|Overall Study|Safety, possible history of tuberculosis|0
82811|NCT01201317|317175|P1|Overall Study|Safety, possible history of tuberculosis|0
82812|NCT01201317|317173|P3|Overall Study|Lack of Efficacy|0
82813|NCT01201317|317174|P2|Overall Study|Lack of Efficacy|0
82814|NCT01201317|317175|P1|Overall Study|Lack of Efficacy|1
82815|NCT01201317|317173|P3|Overall Study|Decrease in renal function|0
82816|NCT01201317|317174|P2|Overall Study|Decrease in renal function|1
82817|NCT01201317|317175|P1|Overall Study|Decrease in renal function|0
82818|NCT01201317|317173|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
82819|NCT01201317|317174|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
82820|NCT01201317|317175|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
82821|NCT01201317|317173|P3|Overall Study|Study-specific withdrawal criteria|1
82822|NCT01201317|317174|P2|Overall Study|Study-specific withdrawal criteria|0
82823|NCT01201317|317175|P1|Overall Study|Study-specific withdrawal criteria|0
82824|NCT01201317|317173|P3|Overall Study|Death|0
82825|NCT01201317|317174|P2|Overall Study|Death|1
82826|NCT01201317|317175|P1|Overall Study|Death|0
82827|NCT01201317|317173|P3|Overall Study|Protocol Violation|1
82828|NCT01201317|317174|P2|Overall Study|Protocol Violation|1
82829|NCT01201317|317175|P1|Overall Study|Protocol Violation|0
82830|NCT01201317|317173|P3|Overall Study|Screen failure|0
82831|NCT01201317|317174|P2|Overall Study|Screen failure|1
82832|NCT01201317|317175|P1|Overall Study|Screen failure|1
82833|NCT01201317|317173|P3|Overall Study|Adverse Event|2
82834|NCT01201317|317174|P2|Overall Study|Adverse Event|2
82835|NCT01201317|317175|P1|Overall Study|Adverse Event|2
82836|NCT01201317|317173|P3|Overall Study|Withdrawal by Subject|3
82837|NCT01201317|317174|P2|Overall Study|Withdrawal by Subject|0
82838|NCT01201317|317175|P1|Overall Study|Withdrawal by Subject|5
82839|NCT01201265|317195|P1|Overall Study|Disease Progression|4
82840|NCT01201265|317195|P1|Overall Study|Withdrawal by Subject|7
82841|NCT01201265|317195|P1|Overall Study|Lost to Follow-up|10
82842|NCT01201265|317195|P1|Overall Study|Insufficient Therapeutic Response|3
82843|NCT01201265|317195|P1|Overall Study|Death|14
82844|NCT01200992|317209|P2|Overall Study|Randomized but not treated|0
82845|NCT01200992|317210|P1|Overall Study|Randomized but not treated|2
82846|NCT01200992|317209|P2|Overall Study|Study terminated early|41
82847|NCT01200992|317210|P1|Overall Study|Study terminated early|35
82848|NCT01200810|317224|P2|Overall Study|Sponsor stopped making study drug|3
82849|NCT01200810|317225|P1|Overall Study|Sponsor stopped making study drug|3
82850|NCT01200810|317224|P2|Overall Study|Withdrawal by Subject|2
82851|NCT01200810|317225|P1|Overall Study|Withdrawal by Subject|1
82852|NCT01200810|317224|P2|Overall Study|Physician Decision|0
82853|NCT01200810|317225|P1|Overall Study|Physician Decision|1
82854|NCT01200797|317245|P1|Overall Study|Disease Progression|13
82855|NCT01200797|317245|P1|Overall Study|Adverse Event|4
82856|NCT01200797|317245|P1|Overall Study|symptomatic deterioration|2
82857|NCT01200758|317255|P4|Stage 2|Death|5
82858|NCT01200758|317256|P3|Stage 2|Death|3
82859|NCT01200758|317257|P2|Stage 2|Death|0
82860|NCT01200758|317258|P1|Stage 2|Death|0
82861|NCT01200758|317255|P4|Stage 2|Protocol Violation|4
82862|NCT01200758|317256|P3|Stage 2|Protocol Violation|1
82863|NCT01200758|317257|P2|Stage 2|Protocol Violation|0
82864|NCT01200758|317258|P1|Stage 2|Protocol Violation|0
82865|NCT01200758|317255|P4|Stage 2|Lost to Follow-up|1
82866|NCT01200758|317256|P3|Stage 2|Lost to Follow-up|3
82867|NCT01200758|317257|P2|Stage 2|Lost to Follow-up|0
82868|NCT01200758|317258|P1|Stage 2|Lost to Follow-up|0
82869|NCT01200758|317255|P4|Stage 2|Withdrawal by Subject|1
82870|NCT01200758|317256|P3|Stage 2|Withdrawal by Subject|4
82871|NCT01200758|317257|P2|Stage 2|Withdrawal by Subject|0
82872|NCT01200758|317258|P1|Stage 2|Withdrawal by Subject|0
82873|NCT01200758|317255|P4|Stage 2|Adverse Event|9
82874|NCT01200758|317256|P3|Stage 2|Adverse Event|5
82875|NCT01200758|317257|P2|Stage 2|Adverse Event|0
82876|NCT01200758|317258|P1|Stage 2|Adverse Event|0
82877|NCT01200758|317255|P4|Stage 2|Physician Decision|7
82878|NCT01200758|317256|P3|Stage 2|Physician Decision|5
82879|NCT01200758|317257|P2|Stage 2|Physician Decision|0
82880|NCT01200758|317258|P1|Stage 2|Physician Decision|0
82881|NCT01200758|317255|P4|Stage 2|Lack of Efficacy|2
82882|NCT01200758|317256|P3|Stage 2|Lack of Efficacy|4
82883|NCT01200758|317257|P2|Stage 2|Lack of Efficacy|0
82884|NCT01200758|317258|P1|Stage 2|Lack of Efficacy|0
82885|NCT01200758|317255|P4|Stage 2|Disease Progression|21
82886|NCT01200758|317256|P3|Stage 2|Disease Progression|16
82887|NCT01200758|317257|P2|Stage 2|Disease Progression|0
82888|NCT01200758|317258|P1|Stage 2|Disease Progression|0
82889|NCT01200758|317255|P4|Stage I|Disease Progression|0
82890|NCT01200758|317256|P3|Stage I|Disease Progression|0
82891|NCT01200758|317257|P2|Stage I|Disease Progression|7
82892|NCT01200758|317258|P1|Stage I|Disease Progression|9
82893|NCT01200758|317255|P4|Stage I|Withdrawal by Subject|0
82894|NCT01200758|317256|P3|Stage I|Withdrawal by Subject|0
82895|NCT01200758|317257|P2|Stage I|Withdrawal by Subject|2
82896|NCT01200758|317258|P1|Stage I|Withdrawal by Subject|1
82897|NCT01200758|317255|P4|Stage I|Adverse Event|0
82898|NCT01200758|317256|P3|Stage I|Adverse Event|0
82899|NCT01200758|317257|P2|Stage I|Adverse Event|5
82900|NCT01200758|317258|P1|Stage I|Adverse Event|5
82901|NCT01200758|317255|P4|Stage I|Lack of Efficacy|0
82902|NCT01200758|317256|P3|Stage I|Lack of Efficacy|0
82903|NCT01200758|317257|P2|Stage I|Lack of Efficacy|1
82904|NCT01200758|317258|P1|Stage I|Lack of Efficacy|2
82905|NCT01200758|317255|P4|Stage I|Physician Decision|0
82906|NCT01200758|317256|P3|Stage I|Physician Decision|0
82907|NCT01200758|317257|P2|Stage I|Physician Decision|1
82908|NCT01200758|317258|P1|Stage I|Physician Decision|1
82909|NCT01200758|317255|P4|Stage I|Death|0
82910|NCT01200758|317256|P3|Stage I|Death|0
82911|NCT01200758|317257|P2|Stage I|Death|1
82912|NCT01200758|317258|P1|Stage I|Death|0
82913|NCT01200589|317331|P2|Overall Study|Study terminated|172
82914|NCT01200589|317332|P1|Overall Study|Study terminated|170
82915|NCT01200589|317331|P2|Overall Study|Lost to Follow-up|4
82916|NCT01200589|317332|P1|Overall Study|Lost to Follow-up|5
82917|NCT01200589|317331|P2|Overall Study|Physician Decision|2
82918|NCT01200589|317332|P1|Overall Study|Physician Decision|2
82919|NCT01200589|317331|P2|Overall Study|Withdrawal by Subject|11
82920|NCT01200589|317332|P1|Overall Study|Withdrawal by Subject|13
82921|NCT01200524|317359|P3|Overall Study|Non availability of study nurse|1
82922|NCT01200524|317360|P2|Overall Study|Non availability of study nurse|0
82923|NCT01200524|317361|P1|Overall Study|Non availability of study nurse|0
82924|NCT01200524|317359|P3|Overall Study|Adverse Event|0
82925|NCT01200524|317360|P2|Overall Study|Adverse Event|0
82926|NCT01200524|317361|P1|Overall Study|Adverse Event|1
82927|NCT01200524|317359|P3|Overall Study|Withdrawal by Subject|3
82928|NCT01200524|317360|P2|Overall Study|Withdrawal by Subject|1
82929|NCT01200524|317361|P1|Overall Study|Withdrawal by Subject|1
82930|NCT01200511|317381|P1|Overall Study|Adverse Event|1
82931|NCT01200511|317381|P1|Overall Study|Withdrawal by Subject|1
82932|NCT01200511|317381|P1|Overall Study|Lost to Follow-up|3
82933|NCT01200368|317419|P3|Toddler Dose|Adverse Event|1
82934|NCT01200368|317420|P2|Toddler Dose|Adverse Event|3
82935|NCT01200368|317421|P1|Toddler Dose|Adverse Event|0
82936|NCT01200368|317419|P3|After Infant Series|Other|2
82937|NCT01200368|317420|P2|After Infant Series|Other|2
82938|NCT01200368|317421|P1|After Infant Series|Other|1
82939|NCT01200368|317419|P3|After Infant Series|Lost to Follow-up|0
82940|NCT01200368|317420|P2|After Infant Series|Lost to Follow-up|0
82941|NCT01200368|317421|P1|After Infant Series|Lost to Follow-up|1
82942|NCT01200368|317419|P3|After Infant Series|Withdrawal by Subject|4
82943|NCT01200368|317420|P2|After Infant Series|Withdrawal by Subject|8
82944|NCT01200368|317421|P1|After Infant Series|Withdrawal by Subject|10
82945|NCT01200368|317419|P3|After Infant Series|Adverse Event|3
82946|NCT01200368|317420|P2|After Infant Series|Adverse Event|6
82947|NCT01200368|317421|P1|After Infant Series|Adverse Event|6
82948|NCT01200368|317419|P3|Infant Series|Other|0
82949|NCT01200368|317420|P2|Infant Series|Other|0
82950|NCT01200368|317421|P1|Infant Series|Other|1
82951|NCT01200368|317419|P3|Infant Series|Randomized, not vaccinated|1
82952|NCT01200368|317420|P2|Infant Series|Randomized, not vaccinated|1
82953|NCT01200368|317421|P1|Infant Series|Randomized, not vaccinated|0
82954|NCT01200368|317419|P3|Infant Series|Did not meet entrance criteria|0
82955|NCT01200368|317420|P2|Infant Series|Did not meet entrance criteria|1
82956|NCT01200368|317421|P1|Infant Series|Did not meet entrance criteria|0
82957|NCT01200368|317419|P3|Infant Series|Withdrawal by Subject|2
82958|NCT01200368|317420|P2|Infant Series|Withdrawal by Subject|2
82959|NCT01200368|317421|P1|Infant Series|Withdrawal by Subject|0
82960|NCT01200368|317419|P3|Infant Series|Adverse Event|3
82961|NCT01200368|317420|P2|Infant Series|Adverse Event|2
82962|NCT01200368|317421|P1|Infant Series|Adverse Event|2
82963|NCT01200355|317487|P2|Overall Study|Death|2
82964|NCT01200355|317488|P1|Overall Study|Death|7
82965|NCT01200342|317502|P1|Overall Study|Disease Progression|1
82966|NCT01200290|317507|P1|Post-Treatment Follow-Up Period|Death|2
82967|NCT01200290|317507|P1|Treatment Period|Adverse Event|1
82968|NCT01200069|317524|P2|Overall Study|Withdrawal by Subject|1
82969|NCT01200069|317525|P1|Overall Study|Withdrawal by Subject|0
82970|NCT01199939|317594|P1|Overall Study|Reached a virologic endpoint|4
82971|NCT01199939|317594|P1|Overall Study|Lost to Follow-up|2
82972|NCT01199939|317594|P1|Overall Study|Protocol Violation|3
82973|NCT01199939|317594|P1|Overall Study|Adverse Event|4
82974|NCT01199861|317626|P2|Overall Study|Adverse Event|0
82975|NCT01199861|317627|P1|Overall Study|Adverse Event|1
82976|NCT01199861|317626|P2|Overall Study|Administrative problems|0
82977|NCT01199861|317627|P1|Overall Study|Administrative problems|1
82978|NCT01199822|317648|P3|Overall Study|Investigator discontinued therapy|0
82979|NCT01199822|317649|P2|Overall Study|Investigator discontinued therapy|1
82980|NCT01199822|317650|P1|Overall Study|Investigator discontinued therapy|0
82981|NCT01199731|317699|P3|Overall Study|Withdrawal by Subject|0
82982|NCT01199731|317700|P2|Overall Study|Withdrawal by Subject|0
82983|NCT01199731|317701|P1|Overall Study|Withdrawal by Subject|2
82984|NCT01199731|317699|P3|Overall Study|Physician Decision|1
82985|NCT01199731|317700|P2|Overall Study|Physician Decision|1
82986|NCT01199731|317701|P1|Overall Study|Physician Decision|0
82987|NCT01199731|317699|P3|Overall Study|Lost to Follow-up|2
82988|NCT01199731|317700|P2|Overall Study|Lost to Follow-up|0
82989|NCT01199731|317701|P1|Overall Study|Lost to Follow-up|0
82990|NCT01199731|317699|P3|Overall Study|Study closed/terminated|7
82991|NCT01199731|317700|P2|Overall Study|Study closed/terminated|9
82992|NCT01199731|317701|P1|Overall Study|Study closed/terminated|7
82993|NCT01199731|317699|P3|Overall Study|Adverse Event|0
82994|NCT01199731|317700|P2|Overall Study|Adverse Event|1
82995|NCT01199731|317701|P1|Overall Study|Adverse Event|0
82996|NCT01199705|317739|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
82997|NCT01199601|317771|P2|Overall Study|Insecurity prevented staff interviewing.|9
82998|NCT01199601|317772|P1|Overall Study|Insecurity prevented staff interviewing.|7
82999|NCT01199601|317771|P2|Overall Study|Withdrawal by Subject|3
83000|NCT01199601|317772|P1|Overall Study|Withdrawal by Subject|15
83001|NCT01199601|317771|P2|Overall Study|Lost to Follow-up|66
83002|NCT01199601|317772|P1|Overall Study|Lost to Follow-up|47
83003|NCT01199471|317782|P1|Overall Study|Physician Decision|1
83004|NCT01199471|317782|P1|Overall Study|Withdrawal by Subject|1
83005|NCT01199471|317782|P1|Overall Study|Protocol Violation|4
83006|NCT01199042|317814|P1|At Home (3 Months)|Lost to Follow-up|1
83007|NCT01199042|317814|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
83008|NCT01199016|317823|P1|Overall Study|Lost to Follow-up|25
83009|NCT01199016|317823|P1|Overall Study|Withdrawal by Subject|21
83010|NCT01199016|317823|P1|Overall Study|Other|13
83011|NCT01199016|317823|P1|Overall Study|Protocol Violation|9
83012|NCT01199016|317823|P1|Overall Study|Entrance criteria|5
83013|NCT01199016|317823|P1|Overall Study|No longer meets eligibility criteria|4
83014|NCT01198977|317832|P2|Overall Study|Lost to Follow-up|0
83015|NCT01198977|317833|P1|Overall Study|Lost to Follow-up|1
83016|NCT01198873|317845|P2|Overall Study|Other than above|2
83017|NCT01198873|317846|P1|Overall Study|Other than above|4
83018|NCT01198873|317845|P2|Overall Study|Study closure|23
83019|NCT01198873|317846|P1|Overall Study|Study closure|29
83020|NCT01198873|317845|P2|Overall Study|Adverse Event|7
83021|NCT01198873|317846|P1|Overall Study|Adverse Event|4
83022|NCT01198795|317860|P1|Overall Study|Other Reason|4
83023|NCT01198795|317860|P1|Overall Study|Protocol Violation|2
83024|NCT01198795|317860|P1|Overall Study|Lack of Efficacy|5
83025|NCT01198795|317860|P1|Overall Study|Adverse Event|9
83026|NCT01198795|317860|P1|Overall Study|Lost to Follow-up|15
83027|NCT01198795|317860|P1|Overall Study|Withdrawal by Subject|17
83028|NCT01198795|317860|P1|Overall Study|Did not meet InclusionExclusion criteria|30
83029|NCT01198756|317877|P4|Overall Study|Lost to Follow-up|18
83030|NCT01198756|317878|P3|Overall Study|Lost to Follow-up|23
83031|NCT01198756|317879|P2|Overall Study|Lost to Follow-up|36
83032|NCT01198756|317880|P1|Overall Study|Lost to Follow-up|29
83033|NCT01198756|317877|P4|Overall Study|Withdrawal by Subject|5
83034|NCT01198756|317878|P3|Overall Study|Withdrawal by Subject|7
83035|NCT01198756|317879|P2|Overall Study|Withdrawal by Subject|4
83036|NCT01198756|317880|P1|Overall Study|Withdrawal by Subject|9
83037|NCT01198756|317877|P4|Overall Study|Protocol Violation|2
83038|NCT01198756|317878|P3|Overall Study|Protocol Violation|0
83039|NCT01198756|317879|P2|Overall Study|Protocol Violation|0
83040|NCT01198756|317880|P1|Overall Study|Protocol Violation|0
83041|NCT01198756|317877|P4|Overall Study|Adverse Event|1
83042|NCT01198756|317878|P3|Overall Study|Adverse Event|0
83043|NCT01198756|317879|P2|Overall Study|Adverse Event|0
83044|NCT01198756|317880|P1|Overall Study|Adverse Event|0
83045|NCT01198600|317991|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
83046|NCT01198600|317992|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
83047|NCT01198600|317993|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
83048|NCT01198600|317994|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
83049|NCT01198600|317991|P4|Phase 2: 56 Days of Wear|Relocation|0
83050|NCT01198600|317992|P3|Phase 2: 56 Days of Wear|Relocation|2
83051|NCT01198600|317993|P2|Phase 2: 56 Days of Wear|Relocation|0
83052|NCT01198600|317994|P1|Phase 2: 56 Days of Wear|Relocation|0
83053|NCT01198600|317991|P4|Phase 2: 56 Days of Wear|Inconvenience|0
83054|NCT01198600|317992|P3|Phase 2: 56 Days of Wear|Inconvenience|2
83055|NCT01198600|317993|P2|Phase 2: 56 Days of Wear|Inconvenience|0
83056|NCT01198600|317994|P1|Phase 2: 56 Days of Wear|Inconvenience|0
83057|NCT01198600|317991|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
83058|NCT01198600|317992|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
83059|NCT01198600|317993|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
83060|NCT01198600|317994|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
83061|NCT01198600|317991|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
83062|NCT01198600|317992|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
83063|NCT01198600|317993|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
83064|NCT01198600|317994|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
83065|NCT01198600|317991|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
83066|NCT01198600|317992|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
83067|NCT01198600|317993|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
83068|NCT01198600|317994|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
83069|NCT01198600|317991|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
83070|NCT01198600|317992|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
83071|NCT01198600|317993|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
83072|NCT01198600|317994|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
83073|NCT01198574|318020|P4|Overall Study|Resigned from schools|4
83074|NCT01198574|318021|P3|Overall Study|Resigned from schools|1
83075|NCT01198574|318022|P2|Overall Study|Resigned from schools|1
83076|NCT01198574|318023|P1|Overall Study|Resigned from schools|4
83077|NCT01198548|318041|P1|Overall Study|Administrative Decision|1
83078|NCT01198548|318041|P1|Overall Study|Disease Progression|9
83079|NCT01198509|318056|P6|Overall Study|Withdrawal by Subject|0
83080|NCT01198509|318057|P5|Overall Study|Withdrawal by Subject|0
83081|NCT01198509|318058|P4|Overall Study|Withdrawal by Subject|0
83082|NCT01198509|318059|P3|Overall Study|Withdrawal by Subject|0
83083|NCT01198509|318060|P2|Overall Study|Withdrawal by Subject|0
83084|NCT01198509|318061|P1|Overall Study|Withdrawal by Subject|1
83085|NCT01198275|318137|P2|Overall Study|spontaneous return to sinus rhythm|2
83086|NCT01198275|318138|P1|Overall Study|spontaneous return to sinus rhythm|4
83087|NCT01198275|318137|P2|Overall Study|Adverse Event|3
83088|NCT01198275|318138|P1|Overall Study|Adverse Event|2
83089|NCT01198145|318146|P2|Overall Study|Withdrawal by Subject|1
83090|NCT01198145|318147|P1|Overall Study|Withdrawal by Subject|1
83091|NCT01198132|318169|P2|Overall Study|Protocol Violation|0
83092|NCT01198132|318170|P1|Overall Study|Protocol Violation|1
83093|NCT01198132|318169|P2|Overall Study|Adverse Event|1
83094|NCT01198132|318170|P1|Overall Study|Adverse Event|0
83095|NCT01198132|318169|P2|Overall Study|Abnormal/clinically significant biologic|1
83096|NCT01198132|318170|P1|Overall Study|Abnormal/clinically significant biologic|1
83097|NCT01198132|318169|P2|Overall Study|Sign/symptoms of underlying disease|1
83098|NCT01198132|318170|P1|Overall Study|Sign/symptoms of underlying disease|2
83099|NCT01198132|318169|P2|Overall Study|Lack of Efficacy|3
83100|NCT01198132|318170|P1|Overall Study|Lack of Efficacy|2
83101|NCT01198132|318169|P2|Overall Study|Other Unspecified|6
83102|NCT01198132|318170|P1|Overall Study|Other Unspecified|3
83103|NCT01198132|318169|P2|Overall Study|Physician Decision|4
83104|NCT01198132|318170|P1|Overall Study|Physician Decision|5
83105|NCT01198132|318169|P2|Overall Study|Withdrawal by Subject|5
83106|NCT01198132|318170|P1|Overall Study|Withdrawal by Subject|4
83107|NCT01198002|318197|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
83108|NCT01198002|318198|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
83109|NCT01198002|318199|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
83110|NCT01198002|318197|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
83111|NCT01198002|318198|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
83112|NCT01198002|318199|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
83113|NCT01198002|318197|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
83114|NCT01198002|318198|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
83115|NCT01198002|318199|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
83116|NCT01198002|318197|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
83117|NCT01198002|318198|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
83118|NCT01198002|318199|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
83119|NCT01198002|318197|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
83120|NCT01198002|318198|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
83121|NCT01198002|318199|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
83122|NCT01198002|318197|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
83123|NCT01198002|318198|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
83124|NCT01198002|318199|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
83125|NCT01198002|318197|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
83126|NCT01198002|318198|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
83127|NCT01198002|318199|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
83128|NCT01198002|318197|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
83129|NCT01198002|318198|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
83130|NCT01198002|318199|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
83131|NCT01198002|318197|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
83132|NCT01198002|318198|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
83133|NCT01198002|318199|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
83134|NCT01198002|318197|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
83135|NCT01198002|318198|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
83136|NCT01198002|318199|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
83137|NCT01198002|318197|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
83138|NCT01198002|318198|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
83139|NCT01198002|318199|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
83140|NCT01198002|318197|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
83141|NCT01198002|318198|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
83142|NCT01198002|318199|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
83143|NCT01198002|318197|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
83144|NCT01198002|318198|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
83145|NCT01198002|318199|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
83146|NCT01198002|318197|P3|Treatment Period 1 (Weeks 0-52)|Death|1
83147|NCT01198002|318198|P2|Treatment Period 1 (Weeks 0-52)|Death|0
83148|NCT01198002|318199|P1|Treatment Period 1 (Weeks 0-52)|Death|2
83149|NCT01198002|318197|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
83150|NCT01198002|318198|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
83151|NCT01198002|318199|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
83152|NCT01197911|318314|P3|Overall Study|Adverse Event|1
83153|NCT01197911|318315|P2|Overall Study|Adverse Event|0
83154|NCT01197911|318316|P1|Overall Study|Adverse Event|0
83155|NCT01197794|318431|P7|Overall Study|Other|4
83156|NCT01197794|318432|P6|Overall Study|Other|2
83157|NCT01197794|318433|P5|Overall Study|Other|2
83158|NCT01197794|318434|P4|Overall Study|Other|0
83159|NCT01197794|318435|P3|Overall Study|Other|3
83160|NCT01197794|318436|P2|Overall Study|Other|1
83161|NCT01197794|318437|P1|Overall Study|Other|1
83162|NCT01197794|318431|P7|Overall Study|Lost to Follow-up|0
83163|NCT01197794|318432|P6|Overall Study|Lost to Follow-up|1
83164|NCT01197794|318433|P5|Overall Study|Lost to Follow-up|0
83165|NCT01197794|318434|P4|Overall Study|Lost to Follow-up|1
83166|NCT01197794|318435|P3|Overall Study|Lost to Follow-up|0
83167|NCT01197794|318436|P2|Overall Study|Lost to Follow-up|1
83168|NCT01197794|318437|P1|Overall Study|Lost to Follow-up|1
83169|NCT01197794|318431|P7|Overall Study|Withdrawal by Subject|6
83170|NCT01197794|318432|P6|Overall Study|Withdrawal by Subject|5
83171|NCT01197794|318433|P5|Overall Study|Withdrawal by Subject|1
83172|NCT01197794|318434|P4|Overall Study|Withdrawal by Subject|1
83173|NCT01197794|318435|P3|Overall Study|Withdrawal by Subject|4
83174|NCT01197794|318436|P2|Overall Study|Withdrawal by Subject|3
83175|NCT01197794|318437|P1|Overall Study|Withdrawal by Subject|3
83176|NCT01197794|318431|P7|Overall Study|Eligibility criteria not fulfilled|6
83177|NCT01197794|318432|P6|Overall Study|Eligibility criteria not fulfilled|9
83178|NCT01197794|318433|P5|Overall Study|Eligibility criteria not fulfilled|5
83179|NCT01197794|318434|P4|Overall Study|Eligibility criteria not fulfilled|5
83180|NCT01197794|318435|P3|Overall Study|Eligibility criteria not fulfilled|2
83181|NCT01197794|318436|P2|Overall Study|Eligibility criteria not fulfilled|8
83182|NCT01197794|318437|P1|Overall Study|Eligibility criteria not fulfilled|5
83183|NCT01197794|318431|P7|Overall Study|Development of study withdrawal criteria|1
83184|NCT01197794|318432|P6|Overall Study|Development of study withdrawal criteria|0
83185|NCT01197794|318433|P5|Overall Study|Development of study withdrawal criteria|0
83186|NCT01197794|318434|P4|Overall Study|Development of study withdrawal criteria|1
83187|NCT01197794|318435|P3|Overall Study|Development of study withdrawal criteria|0
83188|NCT01197794|318436|P2|Overall Study|Development of study withdrawal criteria|0
83189|NCT01197794|318437|P1|Overall Study|Development of study withdrawal criteria|3
83190|NCT01197794|318431|P7|Overall Study|Protocol Violation|1
83191|NCT01197794|318432|P6|Overall Study|Protocol Violation|0
83192|NCT01197794|318433|P5|Overall Study|Protocol Violation|2
83193|NCT01197794|318434|P4|Overall Study|Protocol Violation|0
83194|NCT01197794|318435|P3|Overall Study|Protocol Violation|0
83195|NCT01197794|318436|P2|Overall Study|Protocol Violation|0
83196|NCT01197794|318437|P1|Overall Study|Protocol Violation|0
83197|NCT01197794|318431|P7|Overall Study|Adverse Event|3
83198|NCT01197794|318432|P6|Overall Study|Adverse Event|2
83199|NCT01197794|318433|P5|Overall Study|Adverse Event|4
83200|NCT01197794|318434|P4|Overall Study|Adverse Event|4
83201|NCT01197794|318435|P3|Overall Study|Adverse Event|4
83202|NCT01197794|318436|P2|Overall Study|Adverse Event|2
83203|NCT01197794|318437|P1|Overall Study|Adverse Event|3
83204|NCT01197755|318519|P3|Overall Study|eg, change in circumstances|2
83205|NCT01197755|318520|P2|Overall Study|eg, change in circumstances|3
83206|NCT01197755|318521|P1|Overall Study|eg, change in circumstances|7
83207|NCT01197755|318519|P3|Overall Study|Lost to Follow-up|1
83208|NCT01197755|318520|P2|Overall Study|Lost to Follow-up|0
83209|NCT01197755|318521|P1|Overall Study|Lost to Follow-up|0
83210|NCT01197755|318519|P3|Overall Study|Withdrawal by Subject|0
83211|NCT01197755|318520|P2|Overall Study|Withdrawal by Subject|0
83212|NCT01197755|318521|P1|Overall Study|Withdrawal by Subject|1
83213|NCT01197755|318519|P3|Overall Study|Severe non-compliance to the protocol|2
83214|NCT01197755|318520|P2|Overall Study|Severe non-compliance to the protocol|1
83215|NCT01197755|318521|P1|Overall Study|Severe non-compliance to the protocol|2
83216|NCT01197755|318519|P3|Overall Study|Lack of therapeutic response|4
83217|NCT01197755|318520|P2|Overall Study|Lack of therapeutic response|7
83218|NCT01197755|318521|P1|Overall Study|Lack of therapeutic response|0
83219|NCT01197755|318519|P3|Overall Study|Entered the long-term extension study|35
83220|NCT01197755|318520|P2|Overall Study|Entered the long-term extension study|21
83221|NCT01197755|318521|P1|Overall Study|Entered the long-term extension study|18
83222|NCT01197755|318519|P3|Overall Study|Study-specific discontinuation criteria|0
83223|NCT01197755|318520|P2|Overall Study|Study-specific discontinuation criteria|1
83224|NCT01197755|318521|P1|Overall Study|Study-specific discontinuation criteria|2
83225|NCT01197755|318519|P3|Overall Study|Adverse Event|10
83226|NCT01197755|318520|P2|Overall Study|Adverse Event|10
83227|NCT01197755|318521|P1|Overall Study|Adverse Event|8
83228|NCT01197560|318574|P2|Overall Study|Missing|1
83229|NCT01197560|318575|P1|Overall Study|Missing|0
83230|NCT01197560|318574|P2|Overall Study|Elected to discontinue before cycle end|2
83231|NCT01197560|318575|P1|Overall Study|Elected to discontinue before cycle end|0
83232|NCT01197560|318574|P2|Overall Study|Proceeded to transplant|1
83233|NCT01197560|318575|P1|Overall Study|Proceeded to transplant|1
83234|NCT01197560|318574|P2|Overall Study|Disease progression|35
83235|NCT01197560|318575|P1|Overall Study|Disease progression|39
83236|NCT01197560|318574|P2|Overall Study|Withdrawal by Subject|1
83237|NCT01197560|318575|P1|Overall Study|Withdrawal by Subject|1
83238|NCT01197560|318574|P2|Overall Study|Death|5
83239|NCT01197560|318575|P1|Overall Study|Death|1
83240|NCT01197560|318574|P2|Overall Study|Adverse Event|8
83241|NCT01197560|318575|P1|Overall Study|Adverse Event|4
83242|NCT01197534|318608|P3|Overall Study|Adverse Event|24
83243|NCT01197534|318609|P2|Overall Study|Adverse Event|36
83244|NCT01197534|318610|P1|Overall Study|Adverse Event|35
83245|NCT01197534|318608|P3|Overall Study|Lost to Follow-up|2
83246|NCT01197534|318609|P2|Overall Study|Lost to Follow-up|4
83247|NCT01197534|318610|P1|Overall Study|Lost to Follow-up|1
83248|NCT01197534|318608|P3|Overall Study|Dev. of study specific discont. criteria|2
83249|NCT01197534|318609|P2|Overall Study|Dev. of study specific discont. criteria|6
83250|NCT01197534|318610|P1|Overall Study|Dev. of study specific discont. criteria|13
83251|NCT01197534|318608|P3|Overall Study|Lack of therapeutic response|9
83252|NCT01197534|318609|P2|Overall Study|Lack of therapeutic response|4
83253|NCT01197534|318610|P1|Overall Study|Lack of therapeutic response|9
83254|NCT01197534|318608|P3|Overall Study|Severe non-compliance to protocol|1
83255|NCT01197534|318609|P2|Overall Study|Severe non-compliance to protocol|4
83256|NCT01197534|318610|P1|Overall Study|Severe non-compliance to protocol|3
83257|NCT01197534|318608|P3|Overall Study|Enrolment in long term extension|119
83258|NCT01197534|318609|P2|Overall Study|Enrolment in long term extension|66
83259|NCT01197534|318610|P1|Overall Study|Enrolment in long term extension|57
83260|NCT01197534|318608|P3|Overall Study|Not reported|16
83261|NCT01197534|318609|P2|Overall Study|Not reported|10
83262|NCT01197534|318610|P1|Overall Study|Not reported|16
83263|NCT01197521|318654|P3|Overall Study|Adverse Event|24
83264|NCT01197521|318655|P2|Overall Study|Adverse Event|28
83265|NCT01197521|318656|P1|Overall Study|Adverse Event|25
83266|NCT01197521|318654|P3|Overall Study|Lost to Follow-up|2
83267|NCT01197521|318655|P2|Overall Study|Lost to Follow-up|2
83268|NCT01197521|318656|P1|Overall Study|Lost to Follow-up|3
83269|NCT01197521|318654|P3|Overall Study|Dev. of study specific discont. criteria|2
83270|NCT01197521|318655|P2|Overall Study|Dev. of study specific discont. criteria|16
83271|NCT01197521|318656|P1|Overall Study|Dev. of study specific discont. criteria|6
83272|NCT01197521|318654|P3|Overall Study|Lack of therapeutic response|4
83273|NCT01197521|318655|P2|Overall Study|Lack of therapeutic response|3
83274|NCT01197521|318656|P1|Overall Study|Lack of therapeutic response|2
83275|NCT01197521|318654|P3|Overall Study|Severe non-compliance to protocol|3
83276|NCT01197521|318655|P2|Overall Study|Severe non-compliance to protocol|3
83277|NCT01197521|318656|P1|Overall Study|Severe non-compliance to protocol|1
83278|NCT01197521|318654|P3|Overall Study|Enrolment in long term extension|87
83279|NCT01197521|318655|P2|Overall Study|Enrolment in long term extension|36
83280|NCT01197521|318656|P1|Overall Study|Enrolment in long term extension|42
83281|NCT01197521|318654|P3|Overall Study|Not reported|21
83282|NCT01197521|318655|P2|Overall Study|Not reported|25
83283|NCT01197521|318656|P1|Overall Study|Not reported|24
83284|NCT01197508|318701|P4|Overall Study|Not specified|2
83285|NCT01197508|318702|P3|Overall Study|Not specified|2
83286|NCT01197508|318703|P2|Overall Study|Not specified|3
83287|NCT01197508|318704|P1|Overall Study|Not specified|2
83288|NCT01197508|318701|P4|Overall Study|Lost to Follow-up|0
83289|NCT01197508|318702|P3|Overall Study|Lost to Follow-up|2
83290|NCT01197508|318703|P2|Overall Study|Lost to Follow-up|1
83291|NCT01197508|318704|P1|Overall Study|Lost to Follow-up|1
83292|NCT01197508|318701|P4|Overall Study|Study-specific withdrawal criteria|2
83293|NCT01197508|318702|P3|Overall Study|Study-specific withdrawal criteria|1
83294|NCT01197508|318703|P2|Overall Study|Study-specific withdrawal criteria|0
83295|NCT01197508|318704|P1|Overall Study|Study-specific withdrawal criteria|0
83296|NCT01197508|318701|P4|Overall Study|Lack of Efficacy|1
83297|NCT01197508|318702|P3|Overall Study|Lack of Efficacy|2
83298|NCT01197508|318703|P2|Overall Study|Lack of Efficacy|2
83299|NCT01197508|318704|P1|Overall Study|Lack of Efficacy|1
83300|NCT01197508|318701|P4|Overall Study|Condition under investigation worsened|1
83301|NCT01197508|318702|P3|Overall Study|Condition under investigation worsened|1
83302|NCT01197508|318703|P2|Overall Study|Condition under investigation worsened|1
83303|NCT01197508|318704|P1|Overall Study|Condition under investigation worsened|1
83304|NCT01197508|318701|P4|Overall Study|Severe non-compliance to protocol|3
83305|NCT01197508|318702|P3|Overall Study|Severe non-compliance to protocol|1
83306|NCT01197508|318703|P2|Overall Study|Severe non-compliance to protocol|3
83307|NCT01197508|318704|P1|Overall Study|Severe non-compliance to protocol|0
83308|NCT01197508|318701|P4|Overall Study|Adverse Event|3
83309|NCT01197508|318702|P3|Overall Study|Adverse Event|23
83310|NCT01197508|318703|P2|Overall Study|Adverse Event|13
83311|NCT01197508|318704|P1|Overall Study|Adverse Event|10
83312|NCT01197508|318701|P4|Overall Study|Eligiblity criteria not fulfilled|0
83313|NCT01197508|318702|P3|Overall Study|Eligiblity criteria not fulfilled|2
83314|NCT01197508|318703|P2|Overall Study|Eligiblity criteria not fulfilled|0
83315|NCT01197508|318704|P1|Overall Study|Eligiblity criteria not fulfilled|0
83316|NCT01197508|318701|P4|Overall Study|Withdrawal by Subject|4
83317|NCT01197508|318702|P3|Overall Study|Withdrawal by Subject|15
83318|NCT01197508|318703|P2|Overall Study|Withdrawal by Subject|7
83319|NCT01197508|318704|P1|Overall Study|Withdrawal by Subject|8
83320|NCT01197417|318814|P2|Overall Study|No 25-hour magnesium level|2
83321|NCT01197417|318815|P1|Overall Study|No 25-hour magnesium level|0
83322|NCT01197417|318814|P2|Overall Study|Found to be ineligible|5
83323|NCT01197417|318815|P1|Overall Study|Found to be ineligible|2
83324|NCT01197417|318814|P2|Overall Study|Hypotension|2
83325|NCT01197417|318815|P1|Overall Study|Hypotension|1
83326|NCT01197417|318814|P2|Overall Study|Not consented in time to receive drug|1
83327|NCT01197417|318815|P1|Overall Study|Not consented in time to receive drug|0
83328|NCT01197417|318814|P2|Overall Study|Subject transferred to intensive care|1
83329|NCT01197417|318815|P1|Overall Study|Subject transferred to intensive care|0
83330|NCT01197417|318814|P2|Overall Study|Site miscommunication|1
83331|NCT01197417|318815|P1|Overall Study|Site miscommunication|0
83332|NCT01197417|318814|P2|Overall Study|Withdrawal by Subject|4
83333|NCT01197417|318815|P1|Overall Study|Withdrawal by Subject|2
83334|NCT01197417|318814|P2|Overall Study|Physician Decision|2
83335|NCT01197417|318815|P1|Overall Study|Physician Decision|3
83336|NCT01196988|318848|P4|Overall Study|Other|0
83337|NCT01196988|318849|P3|Overall Study|Other|0
83338|NCT01196988|318850|P2|Overall Study|Other|0
83339|NCT01196988|318851|P1|Overall Study|Other|2
83340|NCT01196988|318848|P4|Overall Study|Lost to Follow-up|1
83341|NCT01196988|318849|P3|Overall Study|Lost to Follow-up|21
83342|NCT01196988|318850|P2|Overall Study|Lost to Follow-up|29
83343|NCT01196988|318851|P1|Overall Study|Lost to Follow-up|16
83344|NCT01196988|318848|P4|Overall Study|Withdrawal by Subject|0
83345|NCT01196988|318849|P3|Overall Study|Withdrawal by Subject|4
83346|NCT01196988|318850|P2|Overall Study|Withdrawal by Subject|1
83347|NCT01196988|318851|P1|Overall Study|Withdrawal by Subject|5
83348|NCT01196988|318848|P4|Overall Study|Adverse Event|0
83349|NCT01196988|318849|P3|Overall Study|Adverse Event|0
83350|NCT01196988|318850|P2|Overall Study|Adverse Event|2
83351|NCT01196988|318851|P1|Overall Study|Adverse Event|1
83352|NCT01196975|318945|P5|Overall Study|Lost to Follow-up|11
83353|NCT01196975|318946|P4|Overall Study|Lost to Follow-up|5
83354|NCT01196975|318947|P3|Overall Study|Lost to Follow-up|5
83355|NCT01196975|318948|P2|Overall Study|Lost to Follow-up|6
83356|NCT01196975|318949|P1|Overall Study|Lost to Follow-up|11
83357|NCT01196975|318945|P5|Overall Study|Withdrawal by Subject|0
83358|NCT01196975|318946|P4|Overall Study|Withdrawal by Subject|1
83359|NCT01196975|318947|P3|Overall Study|Withdrawal by Subject|0
83360|NCT01196975|318948|P2|Overall Study|Withdrawal by Subject|1
83361|NCT01196975|318949|P1|Overall Study|Withdrawal by Subject|2
83362|NCT01196975|318945|P5|Overall Study|Adverse Event|2
83363|NCT01196975|318946|P4|Overall Study|Adverse Event|0
83364|NCT01196975|318947|P3|Overall Study|Adverse Event|0
83365|NCT01196975|318948|P2|Overall Study|Adverse Event|2
83366|NCT01196975|318949|P1|Overall Study|Adverse Event|2
83367|NCT01196741|319110|P2|Overall Study|Protocol Violation|1
83368|NCT01196741|319111|P1|Overall Study|Protocol Violation|2
83369|NCT01196741|319110|P2|Overall Study|Other|2
83370|NCT01196741|319111|P1|Overall Study|Other|3
83371|NCT01196741|319110|P2|Overall Study|Other reason|3
83372|NCT01196741|319111|P1|Overall Study|Other reason|3
83373|NCT01196741|319110|P2|Overall Study|Withdrawal by Subject|0
83374|NCT01196741|319111|P1|Overall Study|Withdrawal by Subject|3
83375|NCT01196741|319110|P2|Overall Study|Dose limiting Adverse Event|1
83376|NCT01196741|319111|P1|Overall Study|Dose limiting Adverse Event|2
83377|NCT01196741|319110|P2|Overall Study|Serious Adverse Event|1
83378|NCT01196741|319111|P1|Overall Study|Serious Adverse Event|3
83379|NCT01196741|319110|P2|Overall Study|Adverse Event|6
83380|NCT01196741|319111|P1|Overall Study|Adverse Event|10
83381|NCT01196741|319110|P2|Overall Study|Disease progression|14
83382|NCT01196741|319111|P1|Overall Study|Disease progression|34
83383|NCT01196429|319137|P2|Overall Study|Refused – Never Treated|0
83384|NCT01196429|319138|P1|Overall Study|Refused – Never Treated|1
83385|NCT01196429|319137|P2|Overall Study|Ineligible - wrong cell type|0
83386|NCT01196429|319138|P1|Overall Study|Ineligible - wrong cell type|1
83387|NCT01196429|319137|P2|Overall Study|Ineligible - inadequate pathology|0
83388|NCT01196429|319138|P1|Overall Study|Ineligible - inadequate pathology|1
83389|NCT01196416|319154|P1|Overall Study|Withdrawal by Subject|2
83390|NCT01196104|319180|P2|Overall Study|Various|1
83391|NCT01196104|319181|P1|Overall Study|Various|0
83392|NCT01196104|319180|P2|Overall Study|Withdrawal by Subject|3
83393|NCT01196104|319181|P1|Overall Study|Withdrawal by Subject|3
83394|NCT01196104|319180|P2|Overall Study|Physician Decision|1
83395|NCT01196104|319181|P1|Overall Study|Physician Decision|0
83396|NCT01196104|319180|P2|Overall Study|Lost to Follow-up|0
83397|NCT01196104|319181|P1|Overall Study|Lost to Follow-up|1
83398|NCT01196078|319223|P2|Overall Study|Death|4
83399|NCT01196078|319224|P1|Overall Study|Death|6
83400|NCT01196078|319223|P2|Overall Study|Lost to Follow-up|0
83401|NCT01196078|319224|P1|Overall Study|Lost to Follow-up|1
83402|NCT01196078|319223|P2|Overall Study|Lack of Efficacy|23
83403|NCT01196078|319224|P1|Overall Study|Lack of Efficacy|17
83404|NCT01196078|319223|P2|Overall Study|Protocol Violation|1
83405|NCT01196078|319224|P1|Overall Study|Protocol Violation|2
83406|NCT01196078|319223|P2|Overall Study|Adverse Event|4
83407|NCT01196078|319224|P1|Overall Study|Adverse Event|4
83408|NCT01196078|319223|P2|Overall Study|Withdrawal by Subject|5
83409|NCT01196078|319224|P1|Overall Study|Withdrawal by Subject|3
83410|NCT01196052|319252|P1|Overall Study|Withdrawal by Subject|6
83411|NCT01196052|319252|P1|Overall Study|Reason not Specified|5
83412|NCT01196052|319252|P1|Overall Study|Noncompliance to Protocol Requirements|2
83413|NCT01196052|319252|P1|Overall Study|Lost to Follow-up|1
83414|NCT01196052|319252|P1|Overall Study|Adverse Event|9
83415|NCT01196026|319269|P6|Overall Study|Other|0
83416|NCT01196026|319270|P5|Overall Study|Other|0
83417|NCT01196026|319271|P4|Overall Study|Other|0
83418|NCT01196026|319272|P3|Overall Study|Other|0
83419|NCT01196026|319273|P2|Overall Study|Other|1
83420|NCT01196026|319274|P1|Overall Study|Other|0
83421|NCT01196026|319269|P6|Overall Study|Lost to Follow-up|0
83422|NCT01196026|319270|P5|Overall Study|Lost to Follow-up|1
83423|NCT01196026|319271|P4|Overall Study|Lost to Follow-up|0
83424|NCT01196026|319272|P3|Overall Study|Lost to Follow-up|0
83425|NCT01196026|319273|P2|Overall Study|Lost to Follow-up|3
83426|NCT01196026|319274|P1|Overall Study|Lost to Follow-up|0
83427|NCT01196026|319269|P6|Overall Study|Withdrawal by Subject|0
83428|NCT01196026|319270|P5|Overall Study|Withdrawal by Subject|0
83429|NCT01196026|319271|P4|Overall Study|Withdrawal by Subject|0
83430|NCT01196026|319272|P3|Overall Study|Withdrawal by Subject|0
83431|NCT01196026|319273|P2|Overall Study|Withdrawal by Subject|4
83432|NCT01196026|319274|P1|Overall Study|Withdrawal by Subject|1
83433|NCT01195948|319510|P3|Overall Study|Lost to Follow-up|2
83434|NCT01195948|319511|P2|Overall Study|Lost to Follow-up|1
83435|NCT01195948|319512|P1|Overall Study|Lost to Follow-up|0
83436|NCT01195844|319544|P1|Overall Study|Fecal sample not collected|40
83437|NCT01195831|319561|P2|Overall Study|Protocol Violation|2
83438|NCT01195831|319562|P1|Overall Study|Protocol Violation|0
83439|NCT01195831|319561|P2|Overall Study|Adverse Event|2
83440|NCT01195831|319562|P1|Overall Study|Adverse Event|4
83441|NCT01195831|319561|P2|Overall Study|Withdrawal by Subject|2
83442|NCT01195831|319562|P1|Overall Study|Withdrawal by Subject|2
83443|NCT01195831|319561|P2|Overall Study|Lost to Follow-up|4
83444|NCT01195831|319562|P1|Overall Study|Lost to Follow-up|2
83445|NCT01195675|319802|P1|Overall Study|Withdrawal by Subject|2
83446|NCT01195675|319802|P1|Overall Study|Adverse Event|1
83447|NCT01195662|319835|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
83448|NCT01195662|319836|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
83449|NCT01195662|319837|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
83450|NCT01195662|319835|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
83451|NCT01195662|319836|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
83452|NCT01195662|319837|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
83453|NCT01195662|319835|P3|Double Blind Treatment Period|Missing disposition information|1
83454|NCT01195662|319836|P2|Double Blind Treatment Period|Missing disposition information|1
83455|NCT01195662|319837|P1|Double Blind Treatment Period|Missing disposition information|0
83456|NCT01195662|319835|P3|Double Blind Treatment Period|Non-specified|0
83457|NCT01195662|319836|P2|Double Blind Treatment Period|Non-specified|0
83458|NCT01195662|319837|P1|Double Blind Treatment Period|Non-specified|3
83459|NCT01195662|319835|P3|Double Blind Treatment Period|Lack of Efficacy|0
83460|NCT01195662|319836|P2|Double Blind Treatment Period|Lack of Efficacy|0
83461|NCT01195662|319837|P1|Double Blind Treatment Period|Lack of Efficacy|2
83462|NCT01195662|319835|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
83463|NCT01195662|319836|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
83464|NCT01195662|319837|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
83465|NCT01195662|319835|P3|Double Blind Treatment Period|Requested discontinue treatment|1
83466|NCT01195662|319836|P2|Double Blind Treatment Period|Requested discontinue treatment|0
83467|NCT01195662|319837|P1|Double Blind Treatment Period|Requested discontinue treatment|1
83468|NCT01195662|319835|P3|Double Blind Treatment Period|Administrative reason|1
83469|NCT01195662|319836|P2|Double Blind Treatment Period|Administrative reason|1
83470|NCT01195662|319837|P1|Double Blind Treatment Period|Administrative reason|2
83471|NCT01195662|319835|P3|Double Blind Treatment Period|Lost to Follow-up|3
83472|NCT01195662|319836|P2|Double Blind Treatment Period|Lost to Follow-up|2
83473|NCT01195662|319837|P1|Double Blind Treatment Period|Lost to Follow-up|3
83474|NCT01195662|319835|P3|Double Blind Treatment Period|Withdrawal by Subject|4
83475|NCT01195662|319836|P2|Double Blind Treatment Period|Withdrawal by Subject|4
83476|NCT01195662|319837|P1|Double Blind Treatment Period|Withdrawal by Subject|6
83477|NCT01195662|319835|P3|Double Blind Treatment Period|Adverse Event|2
83478|NCT01195662|319836|P2|Double Blind Treatment Period|Adverse Event|1
83479|NCT01195662|319837|P1|Double Blind Treatment Period|Adverse Event|4
83480|NCT01195636|319867|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
83481|NCT01195636|319868|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
83482|NCT01195636|319867|P2|Second Intervention (3 Weeks)|Adverse Event|1
83483|NCT01195636|319868|P1|Second Intervention (3 Weeks)|Adverse Event|1
83484|NCT01195636|319867|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
83485|NCT01195636|319868|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
83486|NCT01195636|319867|P2|Washout Period (2 Weeks)|Adverse Event|1
83487|NCT01195636|319868|P1|Washout Period (2 Weeks)|Adverse Event|1
83488|NCT01195636|319867|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
83489|NCT01195636|319868|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
83490|NCT01195636|319867|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
83491|NCT01195636|319868|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
83492|NCT01195636|319867|P2|First Intervention (3 Weeks)|Protocol Violation|0
83493|NCT01195636|319868|P1|First Intervention (3 Weeks)|Protocol Violation|1
83494|NCT01195636|319867|P2|First Intervention (3 Weeks)|Adverse Event|3
83495|NCT01195636|319868|P1|First Intervention (3 Weeks)|Adverse Event|2
83496|NCT01195623|319894|P2|Overall Study|Lost to Follow-up|37
83497|NCT01195623|319895|P1|Overall Study|Lost to Follow-up|35
83498|NCT01195415|319929|P1|Overall Study|No repeat biopsy due to progression|2
83499|NCT01195363|319938|P2|Overall Study|incarceration|0
83500|NCT01195363|319939|P1|Overall Study|incarceration|1
83501|NCT01195363|319938|P2|Overall Study|Lack of Efficacy|4
83502|NCT01195363|319939|P1|Overall Study|Lack of Efficacy|0
83503|NCT01195363|319938|P2|Overall Study|Adverse Event|1
83504|NCT01195363|319939|P1|Overall Study|Adverse Event|3
83505|NCT01195363|319938|P2|Overall Study|Lost to Follow-up|4
83506|NCT01195363|319939|P1|Overall Study|Lost to Follow-up|7
83507|NCT01195272|319945|P1|Overall Study|Lack of Efficacy|3
83508|NCT01195272|319945|P1|Overall Study|Adverse Event|1
83509|NCT01195103|319974|P3|Overall Study|Withdrawal by Subject|0
83510|NCT01195103|319975|P2|Overall Study|Withdrawal by Subject|0
83511|NCT01195103|319976|P1|Overall Study|Withdrawal by Subject|1
83512|NCT01195090|319986|P2|Overall Study|Protocol Violation|4
83513|NCT01195090|319987|P1|Overall Study|Protocol Violation|3
83514|NCT01195090|319986|P2|Overall Study|Lost to Follow-up|2
83515|NCT01195090|319987|P1|Overall Study|Lost to Follow-up|2
83516|NCT01195090|319986|P2|Overall Study|Adverse Event|2
83517|NCT01195090|319987|P1|Overall Study|Adverse Event|1
83518|NCT01194999|320056|P1|Overall Study|Lost to Follow-up|17
83519|NCT01194973|320060|P1|26 Week Treatment Period|Pregnancy|1
83520|NCT01194973|320060|P1|26 Week Treatment Period|Lack of Efficacy|1
83521|NCT01194973|320060|P1|26 Week Treatment Period|Adverse Event|1
83522|NCT01194973|320060|P1|Screening Period|Screen Failure|3
83523|NCT01194869|320080|P1|Overall Study|Toxicity|2
83524|NCT01194869|320080|P1|Overall Study|Disease Progression|2
83525|NCT01194830|320111|P2|Overall Study|Other Reason|8
83526|NCT01194830|320112|P1|Overall Study|Other Reason|12
83527|NCT01194830|320111|P2|Overall Study|Non-compliance issues|4
83528|NCT01194830|320112|P1|Overall Study|Non-compliance issues|4
83529|NCT01194830|320111|P2|Overall Study|Lack of Efficacy|1
83530|NCT01194830|320112|P1|Overall Study|Lack of Efficacy|1
83531|NCT01194830|320111|P2|Overall Study|Withdrawal by Subject|1
83532|NCT01194830|320112|P1|Overall Study|Withdrawal by Subject|2
83533|NCT01194830|320111|P2|Overall Study|Lost to Follow-up|7
83534|NCT01194830|320112|P1|Overall Study|Lost to Follow-up|9
83535|NCT01194830|320111|P2|Overall Study|Protocol Violation|4
83536|NCT01194830|320112|P1|Overall Study|Protocol Violation|5
83537|NCT01194830|320111|P2|Overall Study|Adverse Event|2
83538|NCT01194830|320112|P1|Overall Study|Adverse Event|3
83539|NCT01194570|320143|P2|Overall Study|Lost to Follow-up|4
83540|NCT01194570|320144|P1|Overall Study|Lost to Follow-up|1
83541|NCT01194570|320143|P2|Overall Study|Pregnancy|1
83542|NCT01194570|320144|P1|Overall Study|Pregnancy|1
83543|NCT01194570|320143|P2|Overall Study|Withdrawal by Subject|22
83544|NCT01194570|320144|P1|Overall Study|Withdrawal by Subject|21
83545|NCT01194570|320143|P2|Overall Study|Lack of Efficacy|21
83546|NCT01194570|320144|P1|Overall Study|Lack of Efficacy|27
83547|NCT01194570|320143|P2|Overall Study|Non-compliance|2
83548|NCT01194570|320144|P1|Overall Study|Non-compliance|2
83549|NCT01194570|320143|P2|Overall Study|Adverse Event|18
83550|NCT01194570|320144|P1|Overall Study|Adverse Event|12
83551|NCT01194570|320143|P2|Overall Study|Non-compliance with study drug|2
83552|NCT01194570|320144|P1|Overall Study|Non-compliance with study drug|2
83553|NCT01194570|320143|P2|Overall Study|Protocol Violation|2
83554|NCT01194570|320144|P1|Overall Study|Protocol Violation|0
83555|NCT01194570|320143|P2|Overall Study|Reason not specified|20
83556|NCT01194570|320144|P1|Overall Study|Reason not specified|13
83557|NCT01194570|320143|P2|Overall Study|Physician Decision|6
83558|NCT01194570|320144|P1|Overall Study|Physician Decision|2
83559|NCT01194570|320143|P2|Overall Study|Ongoing at CCOD|387
83560|NCT01194570|320144|P1|Overall Study|Ongoing at CCOD|162
83561|NCT01194570|320143|P2|Overall Study|Death|3
83562|NCT01194570|320144|P1|Overall Study|Death|1
83563|NCT01194531|320164|P2|Overall Study|Physician Decision|2
83564|NCT01194531|320165|P1|Overall Study|Physician Decision|0
83565|NCT01194531|320164|P2|Overall Study|Protocol Violation|1
83566|NCT01194531|320165|P1|Overall Study|Protocol Violation|4
83567|NCT01194531|320164|P2|Overall Study|Withdrawal by Subject|0
83568|NCT01194531|320165|P1|Overall Study|Withdrawal by Subject|1
83569|NCT01194440|320209|P1|Overall Study|Lost to Follow-up|1
83570|NCT01194440|320209|P1|Overall Study|Withdrawal by Subject|2
83571|NCT01194440|320209|P1|Overall Study|Adverse Event|9
83572|NCT01194414|320219|P4|72 Weeks Open Label Extension|Death|2
83573|NCT01194414|320220|P3|72 Weeks Open Label Extension|Death|0
83574|NCT01194414|320221|P2|72 Weeks Open Label Extension|Death|2
83575|NCT01194414|320222|P1|72 Weeks Open Label Extension|Death|1
83576|NCT01194414|320219|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
83577|NCT01194414|320220|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
83578|NCT01194414|320221|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
83579|NCT01194414|320222|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
83580|NCT01194414|320219|P4|72 Weeks Open Label Extension|Adverse Event|12
83581|NCT01194414|320220|P3|72 Weeks Open Label Extension|Adverse Event|2
83582|NCT01194414|320221|P2|72 Weeks Open Label Extension|Adverse Event|21
83583|NCT01194414|320222|P1|72 Weeks Open Label Extension|Adverse Event|35
83584|NCT01194414|320219|P4|72 Weeks Open Label Extension|Protocol Violation|1
83585|NCT01194414|320220|P3|72 Weeks Open Label Extension|Protocol Violation|0
83586|NCT01194414|320221|P2|72 Weeks Open Label Extension|Protocol Violation|0
83587|NCT01194414|320222|P1|72 Weeks Open Label Extension|Protocol Violation|0
83588|NCT01194414|320219|P4|72 Weeks Open Label Extension|Other|0
83589|NCT01194414|320220|P3|72 Weeks Open Label Extension|Other|0
83590|NCT01194414|320221|P2|72 Weeks Open Label Extension|Other|1
83591|NCT01194414|320222|P1|72 Weeks Open Label Extension|Other|2
83592|NCT01194414|320219|P4|72 Weeks Open Label Extension|Pregnancy|1
83593|NCT01194414|320220|P3|72 Weeks Open Label Extension|Pregnancy|1
83594|NCT01194414|320221|P2|72 Weeks Open Label Extension|Pregnancy|3
83595|NCT01194414|320222|P1|72 Weeks Open Label Extension|Pregnancy|1
83596|NCT01194414|320219|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
83597|NCT01194414|320220|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
83598|NCT01194414|320221|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
83599|NCT01194414|320222|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
83600|NCT01194414|320219|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
83601|NCT01194414|320220|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
83602|NCT01194414|320221|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
83603|NCT01194414|320222|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
83604|NCT01194414|320219|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
83605|NCT01194414|320220|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
83606|NCT01194414|320221|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
83607|NCT01194414|320222|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
83608|NCT01194414|320219|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
83609|NCT01194414|320220|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
83610|NCT01194414|320221|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
83611|NCT01194414|320222|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
83612|NCT01194414|320219|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
83613|NCT01194414|320220|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
83614|NCT01194414|320221|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
83615|NCT01194414|320222|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
83616|NCT01194414|320219|P4|24 Weeks Double Blind Period|Death|0
83617|NCT01194414|320220|P3|24 Weeks Double Blind Period|Death|0
83618|NCT01194414|320221|P2|24 Weeks Double Blind Period|Death|1
83619|NCT01194414|320222|P1|24 Weeks Double Blind Period|Death|0
83620|NCT01194414|320219|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
83621|NCT01194414|320220|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
83622|NCT01194414|320221|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
83623|NCT01194414|320222|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
83624|NCT01194414|320219|P4|24 Weeks Double Blind Period|Adverse Event|0
83625|NCT01194414|320220|P3|24 Weeks Double Blind Period|Adverse Event|0
83626|NCT01194414|320221|P2|24 Weeks Double Blind Period|Adverse Event|40
83627|NCT01194414|320222|P1|24 Weeks Double Blind Period|Adverse Event|28
83628|NCT01194414|320219|P4|24 Weeks Double Blind Period|Other|0
83629|NCT01194414|320220|P3|24 Weeks Double Blind Period|Other|0
83630|NCT01194414|320221|P2|24 Weeks Double Blind Period|Other|1
83631|NCT01194414|320222|P1|24 Weeks Double Blind Period|Other|0
83632|NCT01194414|320219|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
83633|NCT01194414|320220|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
83634|NCT01194414|320221|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
83635|NCT01194414|320222|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
83636|NCT01194414|320219|P4|24 Weeks Double Blind Period|Pregnancy|0
83637|NCT01194414|320220|P3|24 Weeks Double Blind Period|Pregnancy|0
83638|NCT01194414|320221|P2|24 Weeks Double Blind Period|Pregnancy|2
83639|NCT01194414|320222|P1|24 Weeks Double Blind Period|Pregnancy|2
83640|NCT01194414|320219|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
83641|NCT01194414|320220|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
83642|NCT01194414|320221|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
83643|NCT01194414|320222|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
83644|NCT01194414|320219|P4|24 Weeks Double Blind Period|Protocol Violation|0
83645|NCT01194414|320220|P3|24 Weeks Double Blind Period|Protocol Violation|0
83646|NCT01194414|320221|P2|24 Weeks Double Blind Period|Protocol Violation|3
83647|NCT01194414|320222|P1|24 Weeks Double Blind Period|Protocol Violation|5
83648|NCT01194414|320219|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
83649|NCT01194414|320220|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
83650|NCT01194414|320221|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
83651|NCT01194414|320222|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
83652|NCT01194414|320219|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
83653|NCT01194414|320220|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
83654|NCT01194414|320221|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
83655|NCT01194414|320222|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
83656|NCT01194258|320293|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
83657|NCT01194258|320294|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
83658|NCT01194258|320295|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
83659|NCT01194258|320296|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
83660|NCT01194258|320297|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
83661|NCT01194258|320293|P5|Period 2 (12 Weeks)|Adverse Event|0
83662|NCT01194258|320294|P4|Period 2 (12 Weeks)|Adverse Event|0
83663|NCT01194258|320295|P3|Period 2 (12 Weeks)|Adverse Event|0
83664|NCT01194258|320296|P2|Period 2 (12 Weeks)|Adverse Event|1
83665|NCT01194258|320297|P1|Period 2 (12 Weeks)|Adverse Event|0
83666|NCT01194258|320293|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
83667|NCT01194258|320294|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
83668|NCT01194258|320295|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
83669|NCT01194258|320296|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
83670|NCT01194258|320297|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
83671|NCT01194258|320293|P5|Period 1 (12 Weeks)|Death|1
83672|NCT01194258|320294|P4|Period 1 (12 Weeks)|Death|0
83673|NCT01194258|320295|P3|Period 1 (12 Weeks)|Death|0
83674|NCT01194258|320296|P2|Period 1 (12 Weeks)|Death|0
83675|NCT01194258|320297|P1|Period 1 (12 Weeks)|Death|0
83676|NCT01194258|320293|P5|Titration Period|Titration failure|0
83677|NCT01194258|320294|P4|Titration Period|Titration failure|0
83678|NCT01194258|320295|P3|Titration Period|Titration failure|0
83679|NCT01194258|320296|P2|Titration Period|Titration failure|0
83680|NCT01194258|320297|P1|Titration Period|Titration failure|3
83681|NCT01194258|320293|P5|Titration Period|Lost to Follow-up|0
83682|NCT01194258|320294|P4|Titration Period|Lost to Follow-up|0
83683|NCT01194258|320295|P3|Titration Period|Lost to Follow-up|0
83684|NCT01194258|320296|P2|Titration Period|Lost to Follow-up|0
83685|NCT01194258|320297|P1|Titration Period|Lost to Follow-up|2
83686|NCT01194258|320293|P5|Titration Period|Withdrawal by Subject|0
83687|NCT01194258|320294|P4|Titration Period|Withdrawal by Subject|0
83688|NCT01194258|320295|P3|Titration Period|Withdrawal by Subject|0
83689|NCT01194258|320296|P2|Titration Period|Withdrawal by Subject|0
83690|NCT01194258|320297|P1|Titration Period|Withdrawal by Subject|6
83691|NCT01194245|320321|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
83692|NCT01194245|320322|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
83693|NCT01194245|320323|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
83694|NCT01194245|320324|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
83695|NCT01194245|320325|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
83696|NCT01194245|320321|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
83697|NCT01194245|320322|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
83698|NCT01194245|320323|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
83699|NCT01194245|320324|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
83700|NCT01194245|320325|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
83701|NCT01194245|320321|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
83702|NCT01194245|320322|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
83703|NCT01194245|320323|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
83704|NCT01194245|320324|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
83705|NCT01194245|320325|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
83706|NCT01194245|320321|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
83707|NCT01194245|320322|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
83708|NCT01194245|320323|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
83709|NCT01194245|320324|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
83710|NCT01194245|320325|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
83711|NCT01194245|320321|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
83712|NCT01194245|320322|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
83713|NCT01194245|320323|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
83714|NCT01194245|320324|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
83715|NCT01194245|320325|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
83716|NCT01194245|320321|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
83717|NCT01194245|320322|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
83718|NCT01194245|320323|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
83719|NCT01194245|320324|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
83720|NCT01194245|320325|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
83721|NCT01194219|320346|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
83722|NCT01194219|320347|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
83723|NCT01194219|320348|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
83724|NCT01194219|320349|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
83725|NCT01194219|320350|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
83726|NCT01194219|320351|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
83727|NCT01194219|320352|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
83728|NCT01194219|320353|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
83729|NCT01194219|320354|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
83730|NCT01194219|320355|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
83731|NCT01194219|320346|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
83732|NCT01194219|320347|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
83733|NCT01194219|320348|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
83734|NCT01194219|320349|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
83735|NCT01194219|320350|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
83736|NCT01194219|320351|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
83737|NCT01194219|320352|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
83738|NCT01194219|320353|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
83739|NCT01194219|320354|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
83740|NCT01194219|320355|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
83741|NCT01194219|320346|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
83742|NCT01194219|320347|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
83743|NCT01194219|320348|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
83744|NCT01194219|320349|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
83745|NCT01194219|320350|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
83746|NCT01194219|320351|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
83747|NCT01194219|320352|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
83748|NCT01194219|320353|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
83749|NCT01194219|320354|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
83750|NCT01194219|320355|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
83751|NCT01194219|320346|P10|Long-Term Extension Weeks 52 to 260|Death|1
83752|NCT01194219|320347|P9|Long-Term Extension Weeks 52 to 260|Death|1
83753|NCT01194219|320348|P8|Long-Term Extension Weeks 52 to 260|Death|0
83754|NCT01194219|320349|P7|Long-Term Extension Weeks 52 to 260|Death|0
83755|NCT01194219|320350|P6|Long-Term Extension Weeks 52 to 260|Death|0
83756|NCT01194219|320351|P5|Long-Term Extension Weeks 52 to 260|Death|0
83757|NCT01194219|320352|P4|Long-Term Extension Weeks 52 to 260|Death|0
83758|NCT01194219|320353|P3|Long-Term Extension Weeks 52 to 260|Death|0
83759|NCT01194219|320354|P2|Long-Term Extension Weeks 52 to 260|Death|0
83760|NCT01194219|320355|P1|Long-Term Extension Weeks 52 to 260|Death|0
83761|NCT01194219|320346|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
83762|NCT01194219|320347|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
83763|NCT01194219|320348|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
83764|NCT01194219|320349|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
83765|NCT01194219|320350|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
83766|NCT01194219|320351|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
83767|NCT01194219|320352|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
83768|NCT01194219|320353|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
83769|NCT01194219|320354|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
83770|NCT01194219|320355|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
83771|NCT01194219|320346|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
83772|NCT01194219|320347|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
83773|NCT01194219|320348|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
83774|NCT01194219|320349|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
83775|NCT01194219|320350|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
83776|NCT01194219|320351|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
83777|NCT01194219|320352|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
83778|NCT01194219|320353|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
83779|NCT01194219|320354|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
83780|NCT01194219|320355|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
83781|NCT01194219|320346|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
83782|NCT01194219|320347|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
83783|NCT01194219|320348|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
83784|NCT01194219|320349|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
83785|NCT01194219|320350|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
83786|NCT01194219|320351|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
83787|NCT01194219|320352|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
83788|NCT01194219|320353|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
83789|NCT01194219|320354|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
83790|NCT01194219|320355|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
83791|NCT01194219|320346|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
83792|NCT01194219|320347|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
83793|NCT01194219|320348|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
83794|NCT01194219|320349|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
83795|NCT01194219|320350|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
83796|NCT01194219|320351|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
83797|NCT01194219|320352|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
83798|NCT01194219|320353|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
83799|NCT01194219|320354|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
83800|NCT01194219|320355|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
83801|NCT01194219|320346|P10|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
83802|NCT01194219|320347|P9|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
83803|NCT01194219|320348|P8|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
83804|NCT01194219|320349|P7|Randomized Withdrawal Phase-Weeks 32-52|Not specified|1
83805|NCT01194219|320350|P6|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
83806|NCT01194219|320351|P5|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
83807|NCT01194219|320352|P4|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
83808|NCT01194219|320353|P3|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
83809|NCT01194219|320354|P2|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
83810|NCT01194219|320355|P1|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
83811|NCT01194219|320346|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
83812|NCT01194219|320347|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
83813|NCT01194219|320348|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
83814|NCT01194219|320349|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
83815|NCT01194219|320350|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
83816|NCT01194219|320351|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
83817|NCT01194219|320352|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
83818|NCT01194219|320353|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
83819|NCT01194219|320354|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
83820|NCT01194219|320355|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
83821|NCT01194219|320346|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
83822|NCT01194219|320347|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
83823|NCT01194219|320348|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
83824|NCT01194219|320349|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
83825|NCT01194219|320350|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
83826|NCT01194219|320351|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
83827|NCT01194219|320352|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
83828|NCT01194219|320353|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
83829|NCT01194219|320354|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
83830|NCT01194219|320355|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
83831|NCT01194219|320346|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
83832|NCT01194219|320347|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
83833|NCT01194219|320348|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
83834|NCT01194219|320349|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
83835|NCT01194219|320350|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
83836|NCT01194219|320351|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
83837|NCT01194219|320352|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
83838|NCT01194219|320353|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
83839|NCT01194219|320354|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
83840|NCT01194219|320355|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
83841|NCT01194219|320346|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
83842|NCT01194219|320347|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
83843|NCT01194219|320348|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
83844|NCT01194219|320349|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
83845|NCT01194219|320350|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
83846|NCT01194219|320351|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
83847|NCT01194219|320352|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
83848|NCT01194219|320353|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
83849|NCT01194219|320354|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
83850|NCT01194219|320355|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
83851|NCT01194219|320346|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
83852|NCT01194219|320347|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
83853|NCT01194219|320348|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
83854|NCT01194219|320349|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
83855|NCT01194219|320350|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
83856|NCT01194219|320351|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
83857|NCT01194219|320352|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
83858|NCT01194219|320353|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
83859|NCT01194219|320354|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
83860|NCT01194219|320355|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
83861|NCT01194219|320346|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
83862|NCT01194219|320347|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
83863|NCT01194219|320348|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
83864|NCT01194219|320349|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
83865|NCT01194219|320350|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
83866|NCT01194219|320351|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
83867|NCT01194219|320352|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
83868|NCT01194219|320353|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
83869|NCT01194219|320354|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
83870|NCT01194219|320355|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
83871|NCT01194219|320346|P10|Maintenance Phase Weeks16-32|Other|0
83872|NCT01194219|320347|P9|Maintenance Phase Weeks16-32|Other|0
83873|NCT01194219|320348|P8|Maintenance Phase Weeks16-32|Other|0
83874|NCT01194219|320349|P7|Maintenance Phase Weeks16-32|Other|0
83875|NCT01194219|320350|P6|Maintenance Phase Weeks16-32|Other|0
83876|NCT01194219|320351|P5|Maintenance Phase Weeks16-32|Other|0
83877|NCT01194219|320352|P4|Maintenance Phase Weeks16-32|Other|1
83878|NCT01194219|320353|P3|Maintenance Phase Weeks16-32|Other|2
83879|NCT01194219|320354|P2|Maintenance Phase Weeks16-32|Other|0
83880|NCT01194219|320355|P1|Maintenance Phase Weeks16-32|Other|0
83881|NCT01194219|320346|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
83882|NCT01194219|320347|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
83883|NCT01194219|320348|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
83884|NCT01194219|320349|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
83885|NCT01194219|320350|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
83886|NCT01194219|320351|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
83887|NCT01194219|320352|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
83888|NCT01194219|320353|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
83889|NCT01194219|320354|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
83890|NCT01194219|320355|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
83891|NCT01194219|320346|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
83892|NCT01194219|320347|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
83893|NCT01194219|320348|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
83894|NCT01194219|320349|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
83895|NCT01194219|320350|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
83896|NCT01194219|320351|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
83897|NCT01194219|320352|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
83898|NCT01194219|320353|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
83899|NCT01194219|320354|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
83900|NCT01194219|320355|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
83901|NCT01194219|320346|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
83902|NCT01194219|320347|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
83903|NCT01194219|320348|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
83904|NCT01194219|320349|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
83905|NCT01194219|320350|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
83906|NCT01194219|320351|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
83907|NCT01194219|320352|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
83908|NCT01194219|320353|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
83909|NCT01194219|320354|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
83910|NCT01194219|320355|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
83911|NCT01194219|320346|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
83912|NCT01194219|320347|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
83913|NCT01194219|320348|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
83914|NCT01194219|320349|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
83915|NCT01194219|320350|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
83916|NCT01194219|320351|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
83917|NCT01194219|320352|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
83918|NCT01194219|320353|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
83919|NCT01194219|320354|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
83920|NCT01194219|320355|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
83921|NCT01194219|320346|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
83922|NCT01194219|320347|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
83923|NCT01194219|320348|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
83924|NCT01194219|320349|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
83925|NCT01194219|320350|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
83926|NCT01194219|320351|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
83927|NCT01194219|320352|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
83928|NCT01194219|320353|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
83929|NCT01194219|320354|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
83930|NCT01194219|320355|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
83931|NCT01194219|320346|P10|Maintenance Phase Weeks16-32|Adverse Event|0
83932|NCT01194219|320347|P9|Maintenance Phase Weeks16-32|Adverse Event|0
83933|NCT01194219|320348|P8|Maintenance Phase Weeks16-32|Adverse Event|0
83934|NCT01194219|320349|P7|Maintenance Phase Weeks16-32|Adverse Event|0
83935|NCT01194219|320350|P6|Maintenance Phase Weeks16-32|Adverse Event|0
83936|NCT01194219|320351|P5|Maintenance Phase Weeks16-32|Adverse Event|0
83937|NCT01194219|320352|P4|Maintenance Phase Weeks16-32|Adverse Event|9
83938|NCT01194219|320353|P3|Maintenance Phase Weeks16-32|Adverse Event|8
83939|NCT01194219|320354|P2|Maintenance Phase Weeks16-32|Adverse Event|0
83940|NCT01194219|320355|P1|Maintenance Phase Weeks16-32|Adverse Event|0
83941|NCT01194219|320346|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
83942|NCT01194219|320347|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
83943|NCT01194219|320348|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
83944|NCT01194219|320349|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
83945|NCT01194219|320350|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
83946|NCT01194219|320351|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
83947|NCT01194219|320352|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
83948|NCT01194219|320353|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
83949|NCT01194219|320354|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
83950|NCT01194219|320355|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
83951|NCT01194219|320346|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
83952|NCT01194219|320347|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
83953|NCT01194219|320348|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
83954|NCT01194219|320349|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
83955|NCT01194219|320350|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
83956|NCT01194219|320351|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
83957|NCT01194219|320352|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
83958|NCT01194219|320353|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
83959|NCT01194219|320354|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
83960|NCT01194219|320355|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
83961|NCT01194219|320346|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
83962|NCT01194219|320347|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
83963|NCT01194219|320348|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
83964|NCT01194219|320349|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
83965|NCT01194219|320350|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
83966|NCT01194219|320351|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
83967|NCT01194219|320352|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
83968|NCT01194219|320353|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
83969|NCT01194219|320354|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
83970|NCT01194219|320355|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
83971|NCT01194219|320346|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
83972|NCT01194219|320347|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
83973|NCT01194219|320348|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
83974|NCT01194219|320349|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
83975|NCT01194219|320350|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
83976|NCT01194219|320351|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
83977|NCT01194219|320352|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
83978|NCT01194219|320353|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
83979|NCT01194219|320354|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
83980|NCT01194219|320355|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
83981|NCT01194219|320346|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
83982|NCT01194219|320347|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
83983|NCT01194219|320348|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
83984|NCT01194219|320349|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
83985|NCT01194219|320350|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
83986|NCT01194219|320351|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
83987|NCT01194219|320352|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
83988|NCT01194219|320353|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
83989|NCT01194219|320354|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
83990|NCT01194219|320355|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
83991|NCT01194219|320346|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
83992|NCT01194219|320347|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
83993|NCT01194219|320348|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
83994|NCT01194219|320349|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
83995|NCT01194219|320350|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
83996|NCT01194219|320351|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
83997|NCT01194219|320352|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
83998|NCT01194219|320353|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
83999|NCT01194219|320354|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
84000|NCT01194219|320355|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
84001|NCT01194219|320346|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
84002|NCT01194219|320347|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
84003|NCT01194219|320348|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
84004|NCT01194219|320349|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
84005|NCT01194219|320350|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
84006|NCT01194219|320351|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
84007|NCT01194219|320352|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
84008|NCT01194219|320353|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
84009|NCT01194219|320354|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
84010|NCT01194219|320355|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
84011|NCT01194219|320346|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
84012|NCT01194219|320347|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
84013|NCT01194219|320348|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
84014|NCT01194219|320349|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
84015|NCT01194219|320350|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
84016|NCT01194219|320351|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
84017|NCT01194219|320352|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
84018|NCT01194219|320353|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
84019|NCT01194219|320354|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
84020|NCT01194219|320355|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
84021|NCT01194154|320389|P2|Overall Study|Did not receive study medication|4
84022|NCT01194154|320390|P1|Overall Study|Did not receive study medication|2
84023|NCT01194154|320389|P2|Overall Study|Other|0
84024|NCT01194154|320390|P1|Overall Study|Other|4
84025|NCT01194154|320389|P2|Overall Study|Treatment with prohibited medication|5
84026|NCT01194154|320390|P1|Overall Study|Treatment with prohibited medication|4
84027|NCT01194154|320389|P2|Overall Study|Skipping of CERA treatment at two visits|0
84028|NCT01194154|320390|P1|Overall Study|Skipping of CERA treatment at two visits|3
84029|NCT01194154|320389|P2|Overall Study|Hemoglobin increase|3
84030|NCT01194154|320390|P1|Overall Study|Hemoglobin increase|12
84031|NCT01194154|320389|P2|Overall Study|Hemoglobin decrease|1
84032|NCT01194154|320390|P1|Overall Study|Hemoglobin decrease|0
84033|NCT01194154|320389|P2|Overall Study|Blood pressure increase|3
84034|NCT01194154|320390|P1|Overall Study|Blood pressure increase|5
84035|NCT01194154|320389|P2|Overall Study|Withdrawal by Subject|6
84036|NCT01194154|320390|P1|Overall Study|Withdrawal by Subject|5
84037|NCT01194154|320389|P2|Overall Study|Protocol Violation|1
84038|NCT01194154|320390|P1|Overall Study|Protocol Violation|0
84039|NCT01194154|320389|P2|Overall Study|Lost to Follow-up|3
84040|NCT01194154|320390|P1|Overall Study|Lost to Follow-up|2
84041|NCT01194154|320389|P2|Overall Study|Adverse Event|7
84042|NCT01194154|320390|P1|Overall Study|Adverse Event|12
84043|NCT01193920|320431|P10|Overall Study|Unable to classify|0
84044|NCT01193920|320432|P9|Overall Study|Unable to classify|0
84045|NCT01193920|320433|P8|Overall Study|Unable to classify|1
84046|NCT01193920|320434|P7|Overall Study|Unable to classify|0
84047|NCT01193920|320435|P6|Overall Study|Unable to classify|0
84048|NCT01193920|320436|P5|Overall Study|Unable to classify|0
84049|NCT01193920|320437|P4|Overall Study|Unable to classify|1
84050|NCT01193920|320438|P3|Overall Study|Unable to classify|0
84051|NCT01193920|320439|P2|Overall Study|Unable to classify|0
84052|NCT01193920|320440|P1|Overall Study|Unable to classify|0
84053|NCT01193920|320431|P10|Overall Study|Death|4
84054|NCT01193920|320432|P9|Overall Study|Death|2
84055|NCT01193920|320433|P8|Overall Study|Death|3
84056|NCT01193920|320434|P7|Overall Study|Death|2
84057|NCT01193920|320435|P6|Overall Study|Death|0
84058|NCT01193920|320436|P5|Overall Study|Death|0
84059|NCT01193920|320437|P4|Overall Study|Death|1
84060|NCT01193920|320438|P3|Overall Study|Death|0
84061|NCT01193920|320439|P2|Overall Study|Death|0
84062|NCT01193920|320440|P1|Overall Study|Death|0
84063|NCT01193920|320431|P10|Overall Study|Protocol Violation|0
84064|NCT01193920|320432|P9|Overall Study|Protocol Violation|0
84065|NCT01193920|320433|P8|Overall Study|Protocol Violation|0
84066|NCT01193920|320434|P7|Overall Study|Protocol Violation|0
84067|NCT01193920|320435|P6|Overall Study|Protocol Violation|0
84068|NCT01193920|320436|P5|Overall Study|Protocol Violation|0
84069|NCT01193920|320437|P4|Overall Study|Protocol Violation|0
84070|NCT01193920|320438|P3|Overall Study|Protocol Violation|0
84071|NCT01193920|320439|P2|Overall Study|Protocol Violation|0
84072|NCT01193920|320440|P1|Overall Study|Protocol Violation|1
84073|NCT01193920|320431|P10|Overall Study|Lost to Follow-up|3
84074|NCT01193920|320432|P9|Overall Study|Lost to Follow-up|2
84075|NCT01193920|320433|P8|Overall Study|Lost to Follow-up|0
84076|NCT01193920|320434|P7|Overall Study|Lost to Follow-up|1
84077|NCT01193920|320435|P6|Overall Study|Lost to Follow-up|3
84078|NCT01193920|320436|P5|Overall Study|Lost to Follow-up|3
84079|NCT01193920|320437|P4|Overall Study|Lost to Follow-up|1
84080|NCT01193920|320438|P3|Overall Study|Lost to Follow-up|1
84081|NCT01193920|320439|P2|Overall Study|Lost to Follow-up|0
84082|NCT01193920|320440|P1|Overall Study|Lost to Follow-up|1
84083|NCT01193920|320431|P10|Overall Study|Withdrawal by Subject|0
84084|NCT01193920|320432|P9|Overall Study|Withdrawal by Subject|1
84085|NCT01193920|320433|P8|Overall Study|Withdrawal by Subject|0
84086|NCT01193920|320434|P7|Overall Study|Withdrawal by Subject|3
84087|NCT01193920|320435|P6|Overall Study|Withdrawal by Subject|1
84088|NCT01193920|320436|P5|Overall Study|Withdrawal by Subject|3
84089|NCT01193920|320437|P4|Overall Study|Withdrawal by Subject|1
84090|NCT01193920|320438|P3|Overall Study|Withdrawal by Subject|5
84091|NCT01193920|320439|P2|Overall Study|Withdrawal by Subject|0
84092|NCT01193920|320440|P1|Overall Study|Withdrawal by Subject|1
84093|NCT01193686|320533|P2|Overall Study|Removed by Investigators; unable to matc|0
84094|NCT01193686|320534|P1|Overall Study|Removed by Investigators; unable to matc|3
84095|NCT01193686|320533|P2|Overall Study|Withdrawal by Subject|1
84096|NCT01193686|320534|P1|Overall Study|Withdrawal by Subject|4
84097|NCT01193660|320551|P3|Overall Study|Physician Decision|1
84098|NCT01193660|320552|P2|Overall Study|Physician Decision|0
84099|NCT01193660|320553|P1|Overall Study|Physician Decision|1
84100|NCT01193660|320551|P3|Overall Study|Death|0
84101|NCT01193660|320552|P2|Overall Study|Death|0
84102|NCT01193660|320553|P1|Overall Study|Death|1
84103|NCT01193660|320551|P3|Overall Study|Withdrawal by Subject|1
84104|NCT01193660|320552|P2|Overall Study|Withdrawal by Subject|3
84105|NCT01193660|320553|P1|Overall Study|Withdrawal by Subject|2
84106|NCT01193608|320597|P6|Overall Study|Adverse Event|0
84107|NCT01193608|320598|P5|Overall Study|Adverse Event|1
84108|NCT01193608|320599|P4|Overall Study|Adverse Event|0
84109|NCT01193608|320600|P3|Overall Study|Adverse Event|0
84110|NCT01193608|320601|P2|Overall Study|Adverse Event|0
84111|NCT01193608|320602|P1|Overall Study|Adverse Event|0
84112|NCT01193608|320597|P6|Overall Study|Lost to Follow-up|2
84113|NCT01193608|320598|P5|Overall Study|Lost to Follow-up|1
84114|NCT01193608|320599|P4|Overall Study|Lost to Follow-up|0
84115|NCT01193608|320600|P3|Overall Study|Lost to Follow-up|0
84116|NCT01193608|320601|P2|Overall Study|Lost to Follow-up|0
84117|NCT01193608|320602|P1|Overall Study|Lost to Follow-up|0
84118|NCT01193608|320597|P6|Overall Study|Withdrawal by Subject|0
84119|NCT01193608|320598|P5|Overall Study|Withdrawal by Subject|3
84120|NCT01193608|320599|P4|Overall Study|Withdrawal by Subject|3
84121|NCT01193608|320600|P3|Overall Study|Withdrawal by Subject|2
84122|NCT01193608|320601|P2|Overall Study|Withdrawal by Subject|1
84123|NCT01193608|320602|P1|Overall Study|Withdrawal by Subject|0
84124|NCT01193608|320597|P6|Overall Study|Other|0
84125|NCT01193608|320598|P5|Overall Study|Other|0
84126|NCT01193608|320599|P4|Overall Study|Other|0
84127|NCT01193608|320600|P3|Overall Study|Other|0
84128|NCT01193608|320601|P2|Overall Study|Other|1
84129|NCT01193608|320602|P1|Overall Study|Other|0
84130|NCT01193582|320839|P4|12 Month Follow-up|Withdrawal by Subject|11
84131|NCT01193582|320840|P3|12 Month Follow-up|Withdrawal by Subject|3
84132|NCT01193582|320841|P2|12 Month Follow-up|Withdrawal by Subject|0
84133|NCT01193582|320842|P1|12 Month Follow-up|Withdrawal by Subject|6
84134|NCT01193582|320839|P4|12 Month Follow-up|Death|0
84135|NCT01193582|320840|P3|12 Month Follow-up|Death|1
84136|NCT01193582|320841|P2|12 Month Follow-up|Death|0
84137|NCT01193582|320842|P1|12 Month Follow-up|Death|0
84138|NCT01193582|320839|P4|Vaccination Series|Withdrawal by Subject|3
84139|NCT01193582|320840|P3|Vaccination Series|Withdrawal by Subject|8
84140|NCT01193582|320841|P2|Vaccination Series|Withdrawal by Subject|13
84141|NCT01193582|320842|P1|Vaccination Series|Withdrawal by Subject|11
84142|NCT01193556|320872|P2|Overall Study|Study termination|25
84143|NCT01193556|320873|P1|Overall Study|Study termination|26
84144|NCT01193348|320881|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
84145|NCT01193348|320881|P1|Extension Treatment Period|Physician Decision|1
84146|NCT01193348|320881|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
84147|NCT01193348|320881|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
84148|NCT01193348|320881|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
84149|NCT01193348|320881|P1|Screening Period|Screen Failure|5
84150|NCT01193335|320901|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
84151|NCT01193335|320902|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
84152|NCT01193335|320901|P2|2-Year Follow-up|No Longer Willing to Participate|6
84153|NCT01193335|320902|P1|2-Year Follow-up|No Longer Willing to Participate|5
84154|NCT01193335|320901|P2|1-Year Follow-up|Lost to Follow-up|0
84155|NCT01193335|320902|P1|1-Year Follow-up|Lost to Follow-up|4
84156|NCT01193335|320901|P2|1-Year Follow-up|No Longer Willing to Participate|9
84157|NCT01193335|320902|P1|1-Year Follow-up|No Longer Willing to Participate|7
84158|NCT01193335|320901|P2|After Infant Series|No Longer Met Eligibility Criteria|1
84159|NCT01193335|320902|P1|After Infant Series|No Longer Met Eligibility Criteria|0
84160|NCT01193335|320901|P2|After Infant Series|Lost to Follow-up|2
84161|NCT01193335|320902|P1|After Infant Series|Lost to Follow-up|1
84162|NCT01193283|320997|P1|Overall Study|Death|1
84163|NCT01193244|321003|P2|Overall Study|Lost to Follow-up|15
84164|NCT01193244|321004|P1|Overall Study|Lost to Follow-up|6
84165|NCT01193244|321003|P2|Overall Study|Other|278
84166|NCT01193244|321004|P1|Overall Study|Other|303
84167|NCT01193244|321003|P2|Overall Study|Withdrawal by Subject|97
84168|NCT01193244|321004|P1|Overall Study|Withdrawal by Subject|79
84169|NCT01193218|321059|P8|12-52 Weeks|Other reason than above|0
84170|NCT01193218|321060|P7|12-52 Weeks|Other reason than above|0
84171|NCT01193218|321061|P6|12-52 Weeks|Other reason than above|0
84172|NCT01193218|321062|P5|12-52 Weeks|Other reason than above|1
84173|NCT01193218|321063|P4|12-52 Weeks|Other reason than above|1
84174|NCT01193218|321064|P3|12-52 Weeks|Other reason than above|0
84175|NCT01193218|321065|P2|12-52 Weeks|Other reason than above|0
84176|NCT01193218|321066|P1|12-52 Weeks|Other reason than above|1
84177|NCT01193218|321059|P8|12-52 Weeks|Withdrawal by Subject|2
84178|NCT01193218|321060|P7|12-52 Weeks|Withdrawal by Subject|1
84179|NCT01193218|321061|P6|12-52 Weeks|Withdrawal by Subject|2
84180|NCT01193218|321062|P5|12-52 Weeks|Withdrawal by Subject|0
84181|NCT01193218|321063|P4|12-52 Weeks|Withdrawal by Subject|0
84182|NCT01193218|321064|P3|12-52 Weeks|Withdrawal by Subject|3
84183|NCT01193218|321065|P2|12-52 Weeks|Withdrawal by Subject|0
84184|NCT01193218|321066|P1|12-52 Weeks|Withdrawal by Subject|3
84185|NCT01193218|321059|P8|12-52 Weeks|Lack of Efficacy|0
84186|NCT01193218|321060|P7|12-52 Weeks|Lack of Efficacy|1
84187|NCT01193218|321061|P6|12-52 Weeks|Lack of Efficacy|0
84188|NCT01193218|321062|P5|12-52 Weeks|Lack of Efficacy|0
84189|NCT01193218|321063|P4|12-52 Weeks|Lack of Efficacy|0
84190|NCT01193218|321064|P3|12-52 Weeks|Lack of Efficacy|0
84191|NCT01193218|321065|P2|12-52 Weeks|Lack of Efficacy|0
84192|NCT01193218|321066|P1|12-52 Weeks|Lack of Efficacy|0
84193|NCT01193218|321059|P8|12-52 Weeks|Adverse Event|2
84194|NCT01193218|321060|P7|12-52 Weeks|Adverse Event|1
84195|NCT01193218|321061|P6|12-52 Weeks|Adverse Event|3
84196|NCT01193218|321062|P5|12-52 Weeks|Adverse Event|3
84197|NCT01193218|321063|P4|12-52 Weeks|Adverse Event|2
84198|NCT01193218|321064|P3|12-52 Weeks|Adverse Event|1
84199|NCT01193218|321065|P2|12-52 Weeks|Adverse Event|0
84200|NCT01193218|321066|P1|12-52 Weeks|Adverse Event|1
84201|NCT01193218|321059|P8|0-12 Weeks|Withdrawal by Subject|0
84202|NCT01193218|321060|P7|0-12 Weeks|Withdrawal by Subject|1
84203|NCT01193218|321061|P6|0-12 Weeks|Withdrawal by Subject|0
84204|NCT01193218|321062|P5|0-12 Weeks|Withdrawal by Subject|0
84205|NCT01193218|321063|P4|0-12 Weeks|Withdrawal by Subject|0
84206|NCT01193218|321064|P3|0-12 Weeks|Withdrawal by Subject|2
84207|NCT01193218|321065|P2|0-12 Weeks|Withdrawal by Subject|0
84208|NCT01193218|321066|P1|0-12 Weeks|Withdrawal by Subject|3
84209|NCT01193218|321059|P8|0-12 Weeks|Protocol Violation|0
84210|NCT01193218|321060|P7|0-12 Weeks|Protocol Violation|0
84211|NCT01193218|321061|P6|0-12 Weeks|Protocol Violation|1
84212|NCT01193218|321062|P5|0-12 Weeks|Protocol Violation|1
84213|NCT01193218|321063|P4|0-12 Weeks|Protocol Violation|0
84214|NCT01193218|321064|P3|0-12 Weeks|Protocol Violation|0
84215|NCT01193218|321065|P2|0-12 Weeks|Protocol Violation|0
84216|NCT01193218|321066|P1|0-12 Weeks|Protocol Violation|0
84217|NCT01193218|321059|P8|0-12 Weeks|Adverse Event|0
84218|NCT01193218|321060|P7|0-12 Weeks|Adverse Event|2
84219|NCT01193218|321061|P6|0-12 Weeks|Adverse Event|2
84220|NCT01193218|321062|P5|0-12 Weeks|Adverse Event|0
84221|NCT01193218|321063|P4|0-12 Weeks|Adverse Event|0
84222|NCT01193218|321064|P3|0-12 Weeks|Adverse Event|1
84223|NCT01193218|321065|P2|0-12 Weeks|Adverse Event|0
84224|NCT01193218|321066|P1|0-12 Weeks|Adverse Event|6
84225|NCT01193153|321097|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
84226|NCT01193153|321098|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
84227|NCT01193153|321097|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
84228|NCT01193153|321098|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
84229|NCT01193153|321097|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
84230|NCT01193153|321098|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
84231|NCT01193153|321097|P2|Double Blind Relapse Prevention Period|Pregnancy|0
84232|NCT01193153|321098|P1|Double Blind Relapse Prevention Period|Pregnancy|1
84233|NCT01193153|321097|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
84234|NCT01193153|321098|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
84235|NCT01193153|321097|P2|Double Blind Relapse Prevention Period|Death|0
84236|NCT01193153|321098|P1|Double Blind Relapse Prevention Period|Death|2
84237|NCT01193153|321097|P2|Double Blind Relapse Prevention Period|Adverse Event|3
84238|NCT01193153|321098|P1|Double Blind Relapse Prevention Period|Adverse Event|12
84239|NCT01193153|321097|P2|Double Blind Relapse Prevention Period|Other|3
84240|NCT01193153|321098|P1|Double Blind Relapse Prevention Period|Other|2
84241|NCT01193153|321097|P2|Open-label Stabilization Period|Other|0
84242|NCT01193153|321098|P1|Open-label Stabilization Period|Other|8
84243|NCT01193153|321097|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
84244|NCT01193153|321098|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
84245|NCT01193153|321097|P2|Open-label Stabilization Period|Withdrawal by Subject|0
84246|NCT01193153|321098|P1|Open-label Stabilization Period|Withdrawal by Subject|29
84247|NCT01193153|321097|P2|Open-label Stabilization Period|Lack of Efficacy|0
84248|NCT01193153|321098|P1|Open-label Stabilization Period|Lack of Efficacy|5
84249|NCT01193153|321097|P2|Open-label Stabilization Period|Lost to Follow-up|0
84250|NCT01193153|321098|P1|Open-label Stabilization Period|Lost to Follow-up|10
84251|NCT01193153|321097|P2|Open-label Stabilization Period|Death|0
84252|NCT01193153|321098|P1|Open-label Stabilization Period|Death|2
84253|NCT01193153|321097|P2|Open-label Stabilization Period|Adverse Event|0
84254|NCT01193153|321098|P1|Open-label Stabilization Period|Adverse Event|9
84255|NCT01193153|321097|P2|Open-label Lead in Period|Lack of Efficacy|0
84256|NCT01193153|321098|P1|Open-label Lead in Period|Lack of Efficacy|26
84257|NCT01193153|321097|P2|Open-label Lead in Period|Death|0
84258|NCT01193153|321098|P1|Open-label Lead in Period|Death|1
84259|NCT01193153|321097|P2|Open-label Lead in Period|Adverse Event|0
84260|NCT01193153|321098|P1|Open-label Lead in Period|Adverse Event|41
84261|NCT01193153|321097|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
84262|NCT01193153|321098|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
84263|NCT01193153|321097|P2|Open-label Lead in Period|Other|0
84264|NCT01193153|321098|P1|Open-label Lead in Period|Other|14
84265|NCT01193153|321097|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
84266|NCT01193153|321098|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
84267|NCT01193153|321097|P2|Open-label Lead in Period|Withdrawal by Subject|0
84268|NCT01193153|321098|P1|Open-label Lead in Period|Withdrawal by Subject|69
84269|NCT01193153|321097|P2|Open-label Lead in Period|Pregnancy|0
84270|NCT01193153|321098|P1|Open-label Lead in Period|Pregnancy|1
84271|NCT01193153|321097|P2|Open-label Lead in Period|Lost to Follow-up|0
84272|NCT01193153|321098|P1|Open-label Lead in Period|Lost to Follow-up|32
84273|NCT01193127|321133|P4|Treated|Withdrawal by Subject|1
84274|NCT01193127|321134|P3|Treated|Withdrawal by Subject|0
84275|NCT01193127|321135|P2|Treated|Withdrawal by Subject|0
84276|NCT01193127|321136|P1|Treated|Withdrawal by Subject|0
84277|NCT01193127|321133|P4|Randomized|Surgery Cancelled|1
84278|NCT01193127|321134|P3|Randomized|Surgery Cancelled|0
84279|NCT01193127|321135|P2|Randomized|Surgery Cancelled|0
84280|NCT01193127|321136|P1|Randomized|Surgery Cancelled|0
84281|NCT01193101|321461|P4|Overall Study|Abnormal test procedure results|0
84282|NCT01193101|321462|P3|Overall Study|Abnormal test procedure results|0
84283|NCT01193101|321463|P2|Overall Study|Abnormal test procedure results|1
84284|NCT01193101|321464|P1|Overall Study|Abnormal test procedure results|0
84285|NCT01193101|321461|P4|Overall Study|Administrative problems|0
84286|NCT01193101|321462|P3|Overall Study|Administrative problems|1
84287|NCT01193101|321463|P2|Overall Study|Administrative problems|0
84288|NCT01193101|321464|P1|Overall Study|Administrative problems|0
84289|NCT01193101|321461|P4|Overall Study|Withdrawal by Subject|1
84290|NCT01193101|321462|P3|Overall Study|Withdrawal by Subject|1
84291|NCT01193101|321463|P2|Overall Study|Withdrawal by Subject|4
84292|NCT01193101|321464|P1|Overall Study|Withdrawal by Subject|2
84293|NCT01193101|321461|P4|Overall Study|Lack of Efficacy|8
84294|NCT01193101|321462|P3|Overall Study|Lack of Efficacy|0
84295|NCT01193101|321463|P2|Overall Study|Lack of Efficacy|1
84296|NCT01193101|321464|P1|Overall Study|Lack of Efficacy|3
84297|NCT01193101|321461|P4|Overall Study|Adverse Event|3
84298|NCT01193101|321462|P3|Overall Study|Adverse Event|1
84299|NCT01193101|321463|P2|Overall Study|Adverse Event|1
84300|NCT01193101|321464|P1|Overall Study|Adverse Event|0
84301|NCT01192776|321555|P4|Overall Study|Lost to Follow-up|5
84302|NCT01192776|321556|P3|Overall Study|Lost to Follow-up|3
84303|NCT01192776|321557|P2|Overall Study|Lost to Follow-up|6
84304|NCT01192776|321558|P1|Overall Study|Lost to Follow-up|3
84305|NCT01192776|321555|P4|Overall Study|Death|15
84306|NCT01192776|321556|P3|Overall Study|Death|18
84307|NCT01192776|321557|P2|Overall Study|Death|15
84308|NCT01192776|321558|P1|Overall Study|Death|8
84309|NCT01192516|321632|P3|Overall Study|Unable to follow Actiwatch instructions|0
84310|NCT01192516|321633|P2|Overall Study|Unable to follow Actiwatch instructions|2
84311|NCT01192516|321634|P1|Overall Study|Unable to follow Actiwatch instructions|4
84312|NCT01192516|321632|P3|Overall Study|started new treatment|0
84313|NCT01192516|321633|P2|Overall Study|started new treatment|1
84314|NCT01192516|321634|P1|Overall Study|started new treatment|5
84315|NCT01192516|321632|P3|Overall Study|Withdrawal by Subject|1
84316|NCT01192516|321633|P2|Overall Study|Withdrawal by Subject|4
84317|NCT01192516|321634|P1|Overall Study|Withdrawal by Subject|4
84318|NCT01192516|321632|P3|Overall Study|Lost to Follow-up|7
84319|NCT01192516|321633|P2|Overall Study|Lost to Follow-up|10
84320|NCT01192516|321634|P1|Overall Study|Lost to Follow-up|7
84321|NCT01192412|321668|P2|Overall Study|Withdrawal by Subject|1
84322|NCT01192412|321669|P1|Overall Study|Withdrawal by Subject|2
84323|NCT01192412|321668|P2|Overall Study|Lost to Follow-up|1
84324|NCT01192412|321669|P1|Overall Study|Lost to Follow-up|2
84325|NCT01192399|321677|P1|Overall Study|Lack of Efficacy|2
84326|NCT01192347|321687|P1|Overall Study|Patient did not show up for visits|1
84327|NCT01192347|321687|P1|Overall Study|Patient not visiting hospital regularly|1
84328|NCT01192347|321687|P1|Overall Study|Patient seen in different hospital|1
84329|NCT01192347|321687|P1|Overall Study|Suspected serious adverse drug reaction|1
84330|NCT01192347|321687|P1|Overall Study|Adverse Event|1
84331|NCT01192347|321687|P1|Overall Study|Withdrawal by Subject|1
84332|NCT01192347|321687|P1|Overall Study|Lost to Follow-up|3
84333|NCT01192347|321687|P1|Overall Study|Death|3
84334|NCT01192295|321710|P2|Overall Study|Administrative|6
84335|NCT01192295|321711|P1|Overall Study|Administrative|4
84336|NCT01192295|321710|P2|Overall Study|Lack of Efficacy|5
84337|NCT01192295|321711|P1|Overall Study|Lack of Efficacy|0
84338|NCT01192295|321710|P2|Overall Study|Lost to Follow-up|1
84339|NCT01192295|321711|P1|Overall Study|Lost to Follow-up|0
84340|NCT01192295|321710|P2|Overall Study|Withdrawal by Subject|4
84341|NCT01192295|321711|P1|Overall Study|Withdrawal by Subject|3
84342|NCT01192295|321710|P2|Overall Study|Adverse Event|7
84343|NCT01192295|321711|P1|Overall Study|Adverse Event|3
84344|NCT01192204|321745|P2|Overall Study|could not keep recall appointments|0
84345|NCT01192204|321746|P1|Overall Study|could not keep recall appointments|1
84346|NCT01192191|321758|P2|Overall Study|Withdrawal by Subject|6
84347|NCT01192191|321759|P1|Overall Study|Withdrawal by Subject|1
84348|NCT01192191|321758|P2|Overall Study|Lost to Follow-up|1
84349|NCT01192191|321759|P1|Overall Study|Lost to Follow-up|0
84350|NCT01192191|321758|P2|Overall Study|Participants Reached Stopping Criteria|2
84351|NCT01192191|321759|P1|Overall Study|Participants Reached Stopping Criteria|3
84352|NCT01192191|321758|P2|Overall Study|Adverse Event|12
84353|NCT01192191|321759|P1|Overall Study|Adverse Event|7
84354|NCT01192178|321785|P2|Overall Study|Lack of Efficacy|2
84355|NCT01192178|321786|P1|Overall Study|Lack of Efficacy|1
84356|NCT01192178|321785|P2|Overall Study|Adverse Event|1
84357|NCT01192178|321786|P1|Overall Study|Adverse Event|2
84358|NCT01192178|321785|P2|Overall Study|Lost to Follow-up|3
84359|NCT01192178|321786|P1|Overall Study|Lost to Follow-up|3
84360|NCT01192178|321785|P2|Overall Study|Physician Decision|4
84361|NCT01192178|321786|P1|Overall Study|Physician Decision|2
84362|NCT01192178|321785|P2|Overall Study|Protocol Violation|3
84363|NCT01192178|321786|P1|Overall Study|Protocol Violation|10
84364|NCT01192178|321785|P2|Overall Study|Withdrawal by Subject|10
84365|NCT01192178|321786|P1|Overall Study|Withdrawal by Subject|6
84366|NCT01192152|321806|P2|Period 3|family emergency|0
84367|NCT01192152|321807|P1|Period 3|family emergency|1
84368|NCT01192152|321806|P2|Period 1|left prematurely (while on treatment B)|1
84369|NCT01192152|321807|P1|Period 1|left prematurely (while on treatment B)|0
84370|NCT01192126|321978|P2|First Intervention (1 Week)|Lost to Follow-up|1
84371|NCT01192126|321979|P1|First Intervention (1 Week)|Lost to Follow-up|1
84372|NCT01192126|321978|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
84373|NCT01192126|321979|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
84374|NCT01192022|321991|P5|Overall Study|Parents did not allow all follow up|0
84375|NCT01192022|321992|P4|Overall Study|Parents did not allow all follow up|1
84376|NCT01192022|321993|P3|Overall Study|Parents did not allow all follow up|0
84377|NCT01192022|321994|P2|Overall Study|Parents did not allow all follow up|0
84378|NCT01192022|321995|P1|Overall Study|Parents did not allow all follow up|0
84379|NCT01192022|321991|P5|Overall Study|Patient needed surgery|0
84380|NCT01192022|321992|P4|Overall Study|Patient needed surgery|0
84381|NCT01192022|321993|P3|Overall Study|Patient needed surgery|0
84382|NCT01192022|321994|P2|Overall Study|Patient needed surgery|1
84383|NCT01192022|321995|P1|Overall Study|Patient needed surgery|0
84384|NCT01192022|321991|P5|Overall Study|Patient too sick from chemotherapy|0
84385|NCT01192022|321992|P4|Overall Study|Patient too sick from chemotherapy|0
84386|NCT01192022|321993|P3|Overall Study|Patient too sick from chemotherapy|0
84387|NCT01192022|321994|P2|Overall Study|Patient too sick from chemotherapy|1
84388|NCT01192022|321995|P1|Overall Study|Patient too sick from chemotherapy|0
84389|NCT01192022|321991|P5|Overall Study|Physician withdrew-patient hardship|0
84390|NCT01192022|321992|P4|Overall Study|Physician withdrew-patient hardship|0
84391|NCT01192022|321993|P3|Overall Study|Physician withdrew-patient hardship|0
84392|NCT01192022|321994|P2|Overall Study|Physician withdrew-patient hardship|0
84393|NCT01192022|321995|P1|Overall Study|Physician withdrew-patient hardship|1
84394|NCT01192022|321991|P5|Overall Study|Fatal Adverse Event|1
84395|NCT01192022|321992|P4|Overall Study|Fatal Adverse Event|0
84396|NCT01192022|321993|P3|Overall Study|Fatal Adverse Event|0
84397|NCT01192022|321994|P2|Overall Study|Fatal Adverse Event|6
84398|NCT01192022|321995|P1|Overall Study|Fatal Adverse Event|4
84399|NCT01192022|321991|P5|Overall Study|Adverse Event|0
84400|NCT01192022|321992|P4|Overall Study|Adverse Event|0
84401|NCT01192022|321993|P3|Overall Study|Adverse Event|0
84402|NCT01192022|321994|P2|Overall Study|Adverse Event|0
84403|NCT01192022|321995|P1|Overall Study|Adverse Event|1
84404|NCT01192022|321991|P5|Overall Study|Lost to Follow-up|0
84405|NCT01192022|321992|P4|Overall Study|Lost to Follow-up|1
84406|NCT01192022|321993|P3|Overall Study|Lost to Follow-up|1
84407|NCT01192022|321994|P2|Overall Study|Lost to Follow-up|2
84408|NCT01192022|321995|P1|Overall Study|Lost to Follow-up|4
84409|NCT01192022|321991|P5|Overall Study|Withdrawal of Consent|0
84410|NCT01192022|321992|P4|Overall Study|Withdrawal of Consent|0
84411|NCT01192022|321993|P3|Overall Study|Withdrawal of Consent|0
84412|NCT01192022|321994|P2|Overall Study|Withdrawal of Consent|1
84413|NCT01192022|321995|P1|Overall Study|Withdrawal of Consent|3
84414|NCT01191944|322018|P2|Overall Study|Other|3
84415|NCT01191944|322019|P1|Overall Study|Other|1
84416|NCT01191944|322018|P2|Overall Study|Withdrawal by Subject|2
84417|NCT01191944|322019|P1|Overall Study|Withdrawal by Subject|4
84418|NCT01191944|322018|P2|Overall Study|Protocol Violation|2
84419|NCT01191944|322019|P1|Overall Study|Protocol Violation|1
84420|NCT01191944|322018|P2|Overall Study|Adverse Event|12
84421|NCT01191944|322019|P1|Overall Study|Adverse Event|11
84422|NCT01191840|322065|P2|Overall Study|Withdrawal by Subject|0
84423|NCT01191840|322066|P1|Overall Study|Withdrawal by Subject|2
84424|NCT01191840|322065|P2|Overall Study|lab error speciation - non Staph infecti|1
84425|NCT01191840|322066|P1|Overall Study|lab error speciation - non Staph infecti|0
84426|NCT01191840|322065|P2|Overall Study|IRB approval lapse|2
84427|NCT01191840|322066|P1|Overall Study|IRB approval lapse|0
84428|NCT01191840|322065|P2|Overall Study|ineligible at enrollment|0
84429|NCT01191840|322066|P1|Overall Study|ineligible at enrollment|1
84430|NCT01191840|322065|P2|Overall Study|Non Staph Infection|3
84431|NCT01191840|322066|P1|Overall Study|Non Staph Infection|4
84432|NCT01191840|322065|P2|Overall Study|Lost to Follow-up|6
84433|NCT01191840|322066|P1|Overall Study|Lost to Follow-up|4
84434|NCT01191840|322065|P2|Overall Study|Subject discontinued treatment|2
84435|NCT01191840|322066|P1|Overall Study|Subject discontinued treatment|1
84436|NCT01191840|322065|P2|Overall Study|withdrew consent|1
84437|NCT01191840|322066|P1|Overall Study|withdrew consent|2
84438|NCT01191801|322091|P2|Overall Study|Not Provided|27
84439|NCT01191801|322092|P1|Overall Study|Not Provided|45
84440|NCT01191801|322091|P2|Overall Study|Withdrawal by Subject|4
84441|NCT01191801|322092|P1|Overall Study|Withdrawal by Subject|1
84442|NCT01191801|322091|P2|Overall Study|Physician Decision|24
84443|NCT01191801|322092|P1|Overall Study|Physician Decision|47
84444|NCT01191801|322091|P2|Overall Study|Protocol Violation|4
84445|NCT01191801|322092|P1|Overall Study|Protocol Violation|2
84446|NCT01191801|322091|P2|Overall Study|Adverse Event|8
84447|NCT01191801|322092|P1|Overall Study|Adverse Event|9
84448|NCT01191801|322091|P2|Overall Study|Lack of Efficacy|258
84449|NCT01191801|322092|P1|Overall Study|Lack of Efficacy|176
84450|NCT01191801|322091|P2|Overall Study|Death|12
84451|NCT01191801|322092|P1|Overall Study|Death|36
84452|NCT01191788|322112|P2|Overall Study|Lost to Follow-up|22
84453|NCT01191788|322113|P1|Overall Study|Lost to Follow-up|21
84454|NCT01191762|322123|P2|Overall Study|Adverse Event|0
84455|NCT01191762|322124|P1|Overall Study|Adverse Event|1
84456|NCT01191268|322282|P3|Overall Study|Sponsor Decision|0
84457|NCT01191268|322283|P2|Overall Study|Sponsor Decision|2
84458|NCT01191268|322284|P1|Overall Study|Sponsor Decision|0
84459|NCT01191268|322282|P3|Overall Study|Protocol Violation|1
84460|NCT01191268|322283|P2|Overall Study|Protocol Violation|0
84461|NCT01191268|322284|P1|Overall Study|Protocol Violation|1
84462|NCT01191268|322282|P3|Overall Study|Death|3
84463|NCT01191268|322283|P2|Overall Study|Death|1
84464|NCT01191268|322284|P1|Overall Study|Death|0
84465|NCT01191268|322282|P3|Overall Study|Entry Criteria Not Met|1
84466|NCT01191268|322283|P2|Overall Study|Entry Criteria Not Met|1
84467|NCT01191268|322284|P1|Overall Study|Entry Criteria Not Met|3
84468|NCT01191268|322282|P3|Overall Study|Lost to Follow-up|9
84469|NCT01191268|322283|P2|Overall Study|Lost to Follow-up|5
84470|NCT01191268|322284|P1|Overall Study|Lost to Follow-up|8
84471|NCT01191268|322282|P3|Overall Study|Physician Decision|9
84472|NCT01191268|322283|P2|Overall Study|Physician Decision|8
84473|NCT01191268|322284|P1|Overall Study|Physician Decision|6
84474|NCT01191268|322282|P3|Overall Study|Adverse Event|8
84475|NCT01191268|322283|P2|Overall Study|Adverse Event|13
84476|NCT01191268|322284|P1|Overall Study|Adverse Event|21
84477|NCT01191268|322282|P3|Overall Study|Withdrawal by Subject|21
84478|NCT01191268|322283|P2|Overall Study|Withdrawal by Subject|25
84479|NCT01191268|322284|P1|Overall Study|Withdrawal by Subject|19
84480|NCT01191190|322425|P1|Overall Study|Withdrawal by Subject|1
84481|NCT01191086|322438|P1|Overall Study|Other|1
84482|NCT01191086|322438|P1|Overall Study|Discontinuation criterion met|1
84483|NCT01191086|322438|P1|Overall Study|Withdrawal by Subject|24
84484|NCT01191086|322438|P1|Overall Study|Physician Decision|2
84485|NCT01191086|322438|P1|Overall Study|Lost to Follow-up|4
84486|NCT01191086|322438|P1|Overall Study|Lack of Efficacy|10
84487|NCT01191086|322438|P1|Overall Study|Adverse Event|20
84488|NCT01191008|322442|P1|Overall Study|Lost to Follow-up|8
84489|NCT01191008|322442|P1|Overall Study|Protocol Violation|7
84490|NCT01190891|322450|P2|Overall Study|Withdrawal by Subject|0
84491|NCT01190891|322451|P1|Overall Study|Withdrawal by Subject|5
84492|NCT01190891|322450|P2|Overall Study|Protocol Violation|0
84493|NCT01190891|322451|P1|Overall Study|Protocol Violation|1
84494|NCT01190865|322476|P1|Overall Study|Non-compliance|2
84495|NCT01190865|322476|P1|Overall Study|Withdrawal by Subject|1
84496|NCT01190839|322483|P2|Overall Study|Randomized but not treated|4
84497|NCT01190839|322484|P1|Overall Study|Randomized but not treated|2
84498|NCT01190839|322483|P2|Overall Study|Undefined|31
84499|NCT01190839|322484|P1|Overall Study|Undefined|35
84500|NCT01190839|322483|P2|Overall Study|Trial stopped by Sponsor|68
84501|NCT01190839|322484|P1|Overall Study|Trial stopped by Sponsor|71
84502|NCT01190839|322483|P2|Overall Study|Death|0
84503|NCT01190839|322484|P1|Overall Study|Death|1
84504|NCT01190839|322483|P2|Overall Study|Lost to Follow-up|1
84505|NCT01190839|322484|P1|Overall Study|Lost to Follow-up|7
84506|NCT01190839|322483|P2|Overall Study|Protocol Violation|2
84507|NCT01190839|322484|P1|Overall Study|Protocol Violation|2
84508|NCT01190839|322483|P2|Overall Study|Adverse Event|41
84509|NCT01190839|322484|P1|Overall Study|Adverse Event|32
84510|NCT01190813|322498|P2|Overall Study|Adverse Event|1
84511|NCT01190813|322499|P1|Overall Study|Adverse Event|0
84512|NCT01190813|322498|P2|Overall Study|Refused study treatment after randomized|0
84513|NCT01190813|322499|P1|Overall Study|Refused study treatment after randomized|1
84514|NCT01190813|322498|P2|Overall Study|Withdrawal by Subject|1
84515|NCT01190813|322499|P1|Overall Study|Withdrawal by Subject|2
84516|NCT01190813|322498|P2|Overall Study|Lost to Follow-up|2
84517|NCT01190813|322499|P1|Overall Study|Lost to Follow-up|1
84518|NCT01190514|322620|P4|Third Intervention (Period 3)|Adverse Event|0
84519|NCT01190514|322621|P3|Third Intervention (Period 3)|Adverse Event|0
84520|NCT01190514|322622|P2|Third Intervention (Period 3)|Adverse Event|0
84521|NCT01190514|322623|P1|Third Intervention (Period 3)|Adverse Event|1
84522|NCT01190514|322620|P4|First Intervention (Period 1)|Adverse Event|0
84523|NCT01190514|322621|P3|First Intervention (Period 1)|Adverse Event|0
84524|NCT01190514|322622|P2|First Intervention (Period 1)|Adverse Event|0
84525|NCT01190514|322623|P1|First Intervention (Period 1)|Adverse Event|1
84526|NCT01190436|322666|P1|Overall Study|Other|4
84527|NCT01190436|322666|P1|Overall Study|Lost to Follow-up|35
84528|NCT01190267|322691|P2|Overall Study|Protocol Violation|1
84529|NCT01190267|322692|P1|Overall Study|Protocol Violation|8
84530|NCT01190267|322691|P2|Overall Study|Withdrawal by Subject|1
84531|NCT01190267|322692|P1|Overall Study|Withdrawal by Subject|13
84532|NCT01190267|322691|P2|Overall Study|Lost to Follow-up|0
84533|NCT01190267|322692|P1|Overall Study|Lost to Follow-up|2
84534|NCT01190267|322691|P2|Overall Study|Treatment Failure|2
84535|NCT01190267|322692|P1|Overall Study|Treatment Failure|8
84536|NCT01190267|322691|P2|Overall Study|Adverse Event|0
84537|NCT01190267|322692|P1|Overall Study|Adverse Event|10
84538|NCT01190254|322703|P3|Overall Study|Did not meet protocol eligibility|0
84539|NCT01190254|322704|P2|Overall Study|Did not meet protocol eligibility|0
84540|NCT01190254|322705|P1|Overall Study|Did not meet protocol eligibility|1
84541|NCT01190254|322703|P3|Overall Study|Protocol Violation|2
84542|NCT01190254|322704|P2|Overall Study|Protocol Violation|0
84543|NCT01190254|322705|P1|Overall Study|Protocol Violation|2
84544|NCT01190254|322703|P3|Overall Study|Withdrawal by Subject|7
84545|NCT01190254|322704|P2|Overall Study|Withdrawal by Subject|5
84546|NCT01190254|322705|P1|Overall Study|Withdrawal by Subject|4
84547|NCT01190254|322703|P3|Overall Study|Lost to Follow-up|0
84548|NCT01190254|322704|P2|Overall Study|Lost to Follow-up|2
84549|NCT01190254|322705|P1|Overall Study|Lost to Follow-up|4
84550|NCT01190254|322703|P3|Overall Study|Lack of Efficacy|5
84551|NCT01190254|322704|P2|Overall Study|Lack of Efficacy|4
84552|NCT01190254|322705|P1|Overall Study|Lack of Efficacy|7
84553|NCT01190254|322703|P3|Overall Study|Adverse Event|8
84554|NCT01190254|322704|P2|Overall Study|Adverse Event|6
84555|NCT01190254|322705|P1|Overall Study|Adverse Event|3
84556|NCT01190228|322770|P3|Overall Study|Withdrawal by Subject|0
84557|NCT01190228|322771|P2|Overall Study|Withdrawal by Subject|0
84558|NCT01190228|322772|P1|Overall Study|Withdrawal by Subject|1
84559|NCT01190228|322770|P3|Overall Study|Protocol Violation|0
84560|NCT01190228|322771|P2|Overall Study|Protocol Violation|0
84561|NCT01190228|322772|P1|Overall Study|Protocol Violation|4
84562|NCT01190215|322795|P2|Up to Month 6|Lost to Follow-up|0
84563|NCT01190215|322796|P1|Up to Month 6|Lost to Follow-up|2
84564|NCT01190150|322866|P2|Washout|Difficulty in adherence|1
84565|NCT01190150|322867|P1|Washout|Difficulty in adherence|0
84566|NCT01190150|322866|P2|Washout|Withdrawal by Subject|1
84567|NCT01190150|322867|P1|Washout|Withdrawal by Subject|0
84568|NCT01190150|322866|P2|First Treatment|Withdrawal by Subject|0
84569|NCT01190150|322867|P1|First Treatment|Withdrawal by Subject|1
84570|NCT01190124|322894|P3|Overall Study|Lost to Follow-up|0
84571|NCT01190124|322895|P2|Overall Study|Lost to Follow-up|0
84572|NCT01190124|322896|P1|Overall Study|Lost to Follow-up|2
84573|NCT01190124|322894|P3|Overall Study|Therapeutic Failure|1
84574|NCT01190124|322895|P2|Overall Study|Therapeutic Failure|0
84575|NCT01190124|322896|P1|Overall Study|Therapeutic Failure|12
84576|NCT01190124|322894|P3|Overall Study|Death|0
84577|NCT01190124|322895|P2|Overall Study|Death|0
84578|NCT01190124|322896|P1|Overall Study|Death|3
84579|NCT01190098|322934|P2|Overall Study|Other|1
84580|NCT01190098|322935|P1|Overall Study|Other|0
84581|NCT01190098|322934|P2|Overall Study|Lack of transportation|0
84582|NCT01190098|322935|P1|Overall Study|Lack of transportation|1
84583|NCT01190098|322934|P2|Overall Study|Patient coomorbidity|1
84584|NCT01190098|322935|P1|Overall Study|Patient coomorbidity|0
84585|NCT01190098|322934|P2|Overall Study|Adverse Event|0
84586|NCT01190098|322935|P1|Overall Study|Adverse Event|2
84587|NCT01190007|322974|P1|Overall Study|Participant was arrested|1
84588|NCT01190007|322974|P1|Overall Study|Difficulty of visit for complications|1
84589|NCT01190007|322974|P1|Overall Study|Adverse Event|8
84590|NCT01190007|322974|P1|Overall Study|Withdrawal by Subject|4
84591|NCT01189890|322991|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
84592|NCT01189890|322992|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
84593|NCT01189890|322991|P2|Overall Study|Physician Decision|4
84594|NCT01189890|322992|P1|Overall Study|Physician Decision|5
84595|NCT01189890|322991|P2|Overall Study|Non Compliance|1
84596|NCT01189890|322992|P1|Overall Study|Non Compliance|0
84597|NCT01189890|322991|P2|Overall Study|Withdrawal by Subject|11
84598|NCT01189890|322992|P1|Overall Study|Withdrawal by Subject|15
84599|NCT01189890|322991|P2|Overall Study|Protocol Violation|5
84600|NCT01189890|322992|P1|Overall Study|Protocol Violation|1
84601|NCT01189890|322991|P2|Overall Study|Lost to Follow-up|7
84602|NCT01189890|322992|P1|Overall Study|Lost to Follow-up|1
84603|NCT01189890|322991|P2|Overall Study|Lack of Efficacy|2
84604|NCT01189890|322992|P1|Overall Study|Lack of Efficacy|7
84605|NCT01189890|322991|P2|Overall Study|Adverse Event|4
84606|NCT01189890|322992|P1|Overall Study|Adverse Event|3
84607|NCT01189812|323014|P2|Overall Study|Moved out of State|2
84608|NCT01189812|323015|P1|Overall Study|Moved out of State|1
84609|NCT01189812|323014|P2|Overall Study|Out of Window|3
84610|NCT01189812|323015|P1|Overall Study|Out of Window|4
84611|NCT01189812|323014|P2|Overall Study|Adverse Event|0
84612|NCT01189812|323015|P1|Overall Study|Adverse Event|1
84613|NCT01189812|323014|P2|Overall Study|Withdrawal by Subject|3
84614|NCT01189812|323015|P1|Overall Study|Withdrawal by Subject|2
84615|NCT01189604|323099|P7|Overall Study|Withdrawal by Subject|0
84616|NCT01189604|323100|P6|Overall Study|Withdrawal by Subject|0
84617|NCT01189604|323101|P5|Overall Study|Withdrawal by Subject|0
84618|NCT01189604|323102|P4|Overall Study|Withdrawal by Subject|0
84619|NCT01189604|323103|P3|Overall Study|Withdrawal by Subject|0
84620|NCT01189604|323104|P2|Overall Study|Withdrawal by Subject|0
84621|NCT01189604|323105|P1|Overall Study|Withdrawal by Subject|1
84622|NCT01189604|323099|P7|Overall Study|Adverse Event|1
84623|NCT01189604|323100|P6|Overall Study|Adverse Event|0
84624|NCT01189604|323101|P5|Overall Study|Adverse Event|2
84625|NCT01189604|323102|P4|Overall Study|Adverse Event|0
84626|NCT01189604|323103|P3|Overall Study|Adverse Event|0
84627|NCT01189604|323104|P2|Overall Study|Adverse Event|1
84628|NCT01189604|323105|P1|Overall Study|Adverse Event|0
84629|NCT01189604|323099|P7|Overall Study|Impossible to visit|0
84630|NCT01189604|323100|P6|Overall Study|Impossible to visit|1
84631|NCT01189604|323101|P5|Overall Study|Impossible to visit|0
84632|NCT01189604|323102|P4|Overall Study|Impossible to visit|0
84633|NCT01189604|323103|P3|Overall Study|Impossible to visit|0
84634|NCT01189604|323104|P2|Overall Study|Impossible to visit|0
84635|NCT01189604|323105|P1|Overall Study|Impossible to visit|0
84636|NCT01189500|323149|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
84637|NCT01189500|323149|P1|Period 1: TAMOX Alone|Adverse Event|1
84638|NCT01189487|323210|P1|Overall Study|Adverse Event|1
84639|NCT01189487|323210|P1|Overall Study|Lack of Efficacy|2
84640|NCT01189461|323218|P1|Overall Study|Other|8
84641|NCT01189461|323218|P1|Overall Study|Did not meet entrance criteria|3
84642|NCT01189461|323218|P1|Overall Study|Adverse Event|2
84643|NCT01189461|323218|P1|Overall Study|Protocol Violation|1
84644|NCT01189461|323218|P1|Overall Study|Withdrawal by Subject|6
84645|NCT01189461|323218|P1|Overall Study|Lost to Follow-up|1
84646|NCT01189461|323218|P1|Overall Study|Lack of Efficacy|13
84647|NCT01189435|323225|P1|Overall Study|Physician Decision|1
84648|NCT01189435|323225|P1|Overall Study|Withdrawal by Subject|1
84649|NCT01189227|323307|P2|Overall Study|Study terminated due to low accrual|3
84650|NCT01189227|323308|P1|Overall Study|Study terminated due to low accrual|6
84651|NCT01189201|323314|P1|Overall Study|Adverse Event|1
84652|NCT01189032|323417|P3|Overall Study|Protocol Violation|1
84653|NCT01189032|323418|P2|Overall Study|Protocol Violation|1
84654|NCT01189032|323419|P1|Overall Study|Protocol Violation|1
84655|NCT01189032|323417|P3|Overall Study|Withdrawal by Subject|1
84656|NCT01189032|323418|P2|Overall Study|Withdrawal by Subject|0
84657|NCT01189032|323419|P1|Overall Study|Withdrawal by Subject|1
84658|NCT01189032|323417|P3|Overall Study|Lack of Efficacy|0
84659|NCT01189032|323418|P2|Overall Study|Lack of Efficacy|3
84660|NCT01189032|323419|P1|Overall Study|Lack of Efficacy|2
84661|NCT01189032|323417|P3|Overall Study|Adverse Event|4
84662|NCT01189032|323418|P2|Overall Study|Adverse Event|3
84663|NCT01189032|323419|P1|Overall Study|Adverse Event|1
84664|NCT01188967|323429|P2|Overall Study|Lost to Follow-up|2
84665|NCT01188967|323430|P1|Overall Study|Lost to Follow-up|3
84666|NCT01188967|323429|P2|Overall Study|Physician Decision|1
84667|NCT01188967|323430|P1|Overall Study|Physician Decision|1
84668|NCT01188967|323429|P2|Overall Study|Withdrawal by Subject|1
84669|NCT01188967|323430|P1|Overall Study|Withdrawal by Subject|1
84670|NCT01188811|323483|P2|Overall Study|Adverse Event|0
84671|NCT01188811|323484|P1|Overall Study|Adverse Event|6
84672|NCT01188811|323483|P2|Overall Study|Withdrawal by Subject|2
84673|NCT01188811|323484|P1|Overall Study|Withdrawal by Subject|0
84674|NCT01188798|323496|P2|Overall Study|Protocol closure|1
84675|NCT01188798|323497|P1|Overall Study|Protocol closure|1
84676|NCT01188798|323496|P2|Overall Study|Required additional transplant|1
84677|NCT01188798|323497|P1|Overall Study|Required additional transplant|1
84678|NCT01188798|323496|P2|Overall Study|Death|1
84679|NCT01188798|323497|P1|Overall Study|Death|0
84680|NCT01188772|323509|P4|Overall Study|Withdrawal by Subject|0
84681|NCT01188772|323510|P3|Overall Study|Withdrawal by Subject|2
84682|NCT01188772|323511|P2|Overall Study|Withdrawal by Subject|0
84683|NCT01188772|323512|P1|Overall Study|Withdrawal by Subject|0
84684|NCT01188772|323509|P4|Overall Study|Virologic Failure|0
84685|NCT01188772|323510|P3|Overall Study|Virologic Failure|0
84686|NCT01188772|323511|P2|Overall Study|Virologic Failure|0
84687|NCT01188772|323512|P1|Overall Study|Virologic Failure|1
84688|NCT01188772|323509|P4|Overall Study|Treatment Failure|0
84689|NCT01188772|323510|P3|Overall Study|Treatment Failure|1
84690|NCT01188772|323511|P2|Overall Study|Treatment Failure|0
84691|NCT01188772|323512|P1|Overall Study|Treatment Failure|0
84692|NCT01188772|323509|P4|Overall Study|Terminated by Sponsor|0
84693|NCT01188772|323510|P3|Overall Study|Terminated by Sponsor|1
84694|NCT01188772|323511|P2|Overall Study|Terminated by Sponsor|0
84695|NCT01188772|323512|P1|Overall Study|Terminated by Sponsor|0
84696|NCT01188772|323509|P4|Overall Study|Physician Decision|0
84697|NCT01188772|323510|P3|Overall Study|Physician Decision|1
84698|NCT01188772|323511|P2|Overall Study|Physician Decision|0
84699|NCT01188772|323512|P1|Overall Study|Physician Decision|0
84700|NCT01188772|323509|P4|Overall Study|Non-responder|0
84701|NCT01188772|323510|P3|Overall Study|Non-responder|3
84702|NCT01188772|323511|P2|Overall Study|Non-responder|0
84703|NCT01188772|323512|P1|Overall Study|Non-responder|0
84704|NCT01188772|323509|P4|Overall Study|Lost to Follow-up|1
84705|NCT01188772|323510|P3|Overall Study|Lost to Follow-up|1
84706|NCT01188772|323511|P2|Overall Study|Lost to Follow-up|1
84707|NCT01188772|323512|P1|Overall Study|Lost to Follow-up|4
84708|NCT01188772|323509|P4|Overall Study|Adverse Event|0
84709|NCT01188772|323510|P3|Overall Study|Adverse Event|2
84710|NCT01188772|323511|P2|Overall Study|Adverse Event|1
84711|NCT01188772|323512|P1|Overall Study|Adverse Event|0
84712|NCT01188772|323509|P4|Overall Study|Randomized but Not Treated|0
84713|NCT01188772|323510|P3|Overall Study|Randomized but Not Treated|0
84714|NCT01188772|323511|P2|Overall Study|Randomized but Not Treated|1
84715|NCT01188772|323512|P1|Overall Study|Randomized but Not Treated|0
84716|NCT01188681|323584|P4|Overall Study|Withdrawal by Subject|1
84717|NCT01188681|323585|P3|Overall Study|Withdrawal by Subject|0
84718|NCT01188681|323586|P2|Overall Study|Withdrawal by Subject|0
84719|NCT01188681|323587|P1|Overall Study|Withdrawal by Subject|0
84720|NCT01188681|323584|P4|Overall Study|bladder cancer|0
84721|NCT01188681|323585|P3|Overall Study|bladder cancer|1
84722|NCT01188681|323586|P2|Overall Study|bladder cancer|0
84723|NCT01188681|323587|P1|Overall Study|bladder cancer|0
84724|NCT01188668|323601|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
84725|NCT01188668|323601|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
84726|NCT01188668|323601|P1|Period 1: ARIP Alone|Protocol Violation|2
84727|NCT01188655|323634|P1|Overall Study|Other|11
84728|NCT01188655|323634|P1|Overall Study|Lost to Follow-up|1
84729|NCT01188655|323634|P1|Overall Study|Lack of Efficacy|1
84730|NCT01188564|323678|P2|Double-blind Phase|randomized not treated|0
84731|NCT01188564|323679|P1|Double-blind Phase|randomized not treated|1
84732|NCT01188551|323691|P4|Overall Study|Pharmacy issues|0
84733|NCT01188551|323692|P3|Overall Study|Pharmacy issues|0
84734|NCT01188551|323693|P2|Overall Study|Pharmacy issues|0
84735|NCT01188551|323694|P1|Overall Study|Pharmacy issues|1
84736|NCT01188538|323710|P2|Overall Study|Lost to Follow-up|1
84737|NCT01188538|323711|P1|Overall Study|Lost to Follow-up|0
84738|NCT01188343|323798|P3|Overall Study|Withdrawal by Subject|0
84739|NCT01188343|323799|P2|Overall Study|Withdrawal by Subject|24
84740|NCT01188343|323800|P1|Overall Study|Withdrawal by Subject|1
84741|NCT01188343|323798|P3|Overall Study|Not vaccinated|1
84742|NCT01188343|323799|P2|Overall Study|Not vaccinated|2
84743|NCT01188343|323800|P1|Overall Study|Not vaccinated|0
84744|NCT01188226|323826|P1|Overall Study|Withdrawal by Subject|4
84745|NCT01187953|323872|P2|Overall Study|Withdrawal by Subject|3
84746|NCT01187953|323873|P1|Overall Study|Withdrawal by Subject|3
84747|NCT01187953|323872|P2|Overall Study|Lost to Follow-up|3
84748|NCT01187953|323873|P1|Overall Study|Lost to Follow-up|0
84749|NCT01187953|323872|P2|Overall Study|Adverse Event|2
84750|NCT01187953|323873|P1|Overall Study|Adverse Event|1
84751|NCT01187953|323872|P2|Overall Study|Death|13
84752|NCT01187953|323873|P1|Overall Study|Death|11
84753|NCT01187901|323887|P2|Overall Study|Pregnancy|2
84754|NCT01187901|323888|P1|Overall Study|Pregnancy|0
84917|NCT01186744|324302|P3|Overall Study|Lost to Follow-up|2
84755|NCT01187901|323887|P2|Overall Study|No Endpoint due to Early Study Halt|3
84756|NCT01187901|323888|P1|Overall Study|No Endpoint due to Early Study Halt|2
84757|NCT01187901|323887|P2|Overall Study|Adverse Event|0
84758|NCT01187901|323888|P1|Overall Study|Adverse Event|3
84759|NCT01187901|323887|P2|Overall Study|Suspected Allergic Reaction|1
84760|NCT01187901|323888|P1|Overall Study|Suspected Allergic Reaction|1
84761|NCT01187901|323887|P2|Overall Study|Unrelated Health Reasons|2
84762|NCT01187901|323888|P1|Overall Study|Unrelated Health Reasons|1
84763|NCT01187901|323887|P2|Overall Study|Lost to Follow-up|2
84764|NCT01187901|323888|P1|Overall Study|Lost to Follow-up|1
84765|NCT01187901|323887|P2|Overall Study|Protocol Violation|0
84766|NCT01187901|323888|P1|Overall Study|Protocol Violation|1
84767|NCT01187550|323929|P2|Overall Study|Randomized but not treated|0
84768|NCT01187550|323930|P1|Overall Study|Randomized but not treated|8
84769|NCT01187550|323929|P2|Overall Study|Other|0
84770|NCT01187550|323930|P1|Overall Study|Other|3
84771|NCT01187550|323929|P2|Overall Study|Protocol Violation|1
84772|NCT01187550|323930|P1|Overall Study|Protocol Violation|3
84773|NCT01187446|324086|P2|Overall Study|Patient started non-protocol therapy|1
84774|NCT01187446|324087|P1|Overall Study|Patient started non-protocol therapy|0
84775|NCT01187433|324103|P2|Overall Study|Withdrawal by Subject|2
84776|NCT01187433|324104|P1|Overall Study|Withdrawal by Subject|5
84777|NCT01187433|324103|P2|Overall Study|Protocol Violation|2
84778|NCT01187433|324104|P1|Overall Study|Protocol Violation|6
84779|NCT01187407|324134|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
84780|NCT01187407|324135|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
84781|NCT01187407|324136|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
84782|NCT01187407|324137|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
84783|NCT01187407|324138|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
84784|NCT01187407|324134|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
84785|NCT01187407|324135|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
84786|NCT01187407|324136|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
84787|NCT01187407|324137|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
84788|NCT01187407|324138|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
84789|NCT01187407|324134|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
84790|NCT01187407|324135|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
84791|NCT01187407|324136|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
84792|NCT01187407|324137|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
84793|NCT01187407|324138|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
84794|NCT01187407|324134|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
84795|NCT01187407|324135|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
84796|NCT01187407|324136|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
84797|NCT01187407|324137|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
84798|NCT01187407|324138|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
84799|NCT01187407|324134|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
84800|NCT01187407|324135|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
84801|NCT01187407|324136|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
84802|NCT01187407|324137|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
84803|NCT01187407|324138|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
84804|NCT01187407|324134|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
84805|NCT01187407|324135|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
84806|NCT01187407|324136|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
84807|NCT01187407|324137|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
84808|NCT01187407|324138|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
84809|NCT01187407|324134|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
84810|NCT01187407|324135|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
84811|NCT01187407|324136|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
84812|NCT01187407|324137|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
84813|NCT01187407|324138|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
84814|NCT01187407|324134|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
84815|NCT01187407|324135|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
84816|NCT01187407|324136|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
84817|NCT01187407|324137|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
84818|NCT01187407|324138|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
84819|NCT01187407|324134|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
84820|NCT01187407|324135|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
84821|NCT01187407|324136|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
84822|NCT01187407|324137|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
84823|NCT01187407|324138|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
84824|NCT01187407|324134|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
84825|NCT01187407|324135|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
84826|NCT01187407|324136|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
84827|NCT01187407|324137|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
84828|NCT01187407|324138|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
84829|NCT01187407|324134|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
84830|NCT01187407|324135|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
84831|NCT01187407|324136|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
84832|NCT01187407|324137|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
84833|NCT01187407|324138|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
84834|NCT01187407|324134|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
84835|NCT01187407|324135|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
84836|NCT01187407|324136|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
84837|NCT01187407|324137|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
84838|NCT01187407|324138|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
84839|NCT01187407|324134|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
84840|NCT01187407|324135|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
84841|NCT01187407|324136|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
84842|NCT01187407|324137|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
84843|NCT01187407|324138|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
84844|NCT01187407|324134|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
84845|NCT01187407|324135|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
84846|NCT01187407|324136|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
84847|NCT01187407|324137|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
84848|NCT01187407|324138|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
84849|NCT01187043|324236|P5|Overall Study|Unable to make scheduled visits|1
84850|NCT01187043|324237|P4|Overall Study|Unable to make scheduled visits|0
84851|NCT01187043|324238|P3|Overall Study|Unable to make scheduled visits|4
84852|NCT01187043|324239|P2|Overall Study|Unable to make scheduled visits|0
84853|NCT01187043|324240|P1|Overall Study|Unable to make scheduled visits|1
84854|NCT01187043|324236|P5|Overall Study|Adverse Event|1
84855|NCT01187043|324237|P4|Overall Study|Adverse Event|0
84856|NCT01187043|324238|P3|Overall Study|Adverse Event|0
84857|NCT01187043|324239|P2|Overall Study|Adverse Event|0
84858|NCT01187043|324240|P1|Overall Study|Adverse Event|0
84859|NCT01186939|324266|P1|Overall Study|Transformation to AML|1
84860|NCT01186939|324266|P1|Overall Study|Bone marrow transplant|1
84861|NCT01186939|324266|P1|Overall Study|Myocardial infarction|1
84862|NCT01186939|324266|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
84863|NCT01186939|324266|P1|Overall Study|Started additional treatment|1
84864|NCT01186939|324266|P1|Overall Study|Sponsor decision|4
84865|NCT01186939|324266|P1|Overall Study|Program closed|5
84866|NCT01186939|324266|P1|Overall Study|No longer receiving clinical benefit|17
84867|NCT01186939|324266|P1|Overall Study|Withdrawal by Subject|2
84868|NCT01186939|324266|P1|Overall Study|Death|7
84869|NCT01186848|324270|P1|Overall Study|Adverse Event|2
84870|NCT01186848|324270|P1|Overall Study|Withdrawal by Subject|2
84871|NCT01186848|324270|P1|Overall Study|Lost to Follow-up|4
84872|NCT01186796|324278|P2|Overall Study|Protocol Violation|1
84873|NCT01186796|324279|P1|Overall Study|Protocol Violation|0
84874|NCT01186796|324278|P2|Overall Study|Withdrawal by Subject|1
84875|NCT01186796|324279|P1|Overall Study|Withdrawal by Subject|1
84876|NCT01186796|324278|P2|Overall Study|Adverse Event|0
84877|NCT01186796|324279|P1|Overall Study|Adverse Event|3
84878|NCT01186744|324299|P6|Overall Study|Death|0
84879|NCT01186744|324300|P5|Overall Study|Death|0
84880|NCT01186744|324301|P4|Overall Study|Death|0
84881|NCT01186744|324302|P3|Overall Study|Death|0
84882|NCT01186744|324303|P2|Overall Study|Death|0
84883|NCT01186744|324304|P1|Overall Study|Death|1
84884|NCT01186744|324299|P6|Overall Study|Adverse Event|4
84885|NCT01186744|324300|P5|Overall Study|Adverse Event|1
84886|NCT01186744|324301|P4|Overall Study|Adverse Event|0
84887|NCT01186744|324302|P3|Overall Study|Adverse Event|1
84888|NCT01186744|324303|P2|Overall Study|Adverse Event|14
84889|NCT01186744|324304|P1|Overall Study|Adverse Event|10
84890|NCT01186744|324299|P6|Overall Study|Not specified|5
84891|NCT01186744|324300|P5|Overall Study|Not specified|1
84892|NCT01186744|324301|P4|Overall Study|Not specified|2
84893|NCT01186744|324302|P3|Overall Study|Not specified|1
84894|NCT01186744|324303|P2|Overall Study|Not specified|10
84895|NCT01186744|324304|P1|Overall Study|Not specified|9
84896|NCT01186744|324299|P6|Overall Study|Study terminated by Sponsor|0
84897|NCT01186744|324300|P5|Overall Study|Study terminated by Sponsor|0
84898|NCT01186744|324301|P4|Overall Study|Study terminated by Sponsor|0
84899|NCT01186744|324302|P3|Overall Study|Study terminated by Sponsor|0
84900|NCT01186744|324303|P2|Overall Study|Study terminated by Sponsor|0
84901|NCT01186744|324304|P1|Overall Study|Study terminated by Sponsor|1
84902|NCT01186744|324299|P6|Overall Study|Withdrawal by Subject|6
84903|NCT01186744|324300|P5|Overall Study|Withdrawal by Subject|0
84904|NCT01186744|324301|P4|Overall Study|Withdrawal by Subject|5
84905|NCT01186744|324302|P3|Overall Study|Withdrawal by Subject|2
84906|NCT01186744|324303|P2|Overall Study|Withdrawal by Subject|10
84907|NCT01186744|324304|P1|Overall Study|Withdrawal by Subject|14
84908|NCT01186744|324299|P6|Overall Study|Screen failure|0
84909|NCT01186744|324300|P5|Overall Study|Screen failure|0
84910|NCT01186744|324301|P4|Overall Study|Screen failure|1
84911|NCT01186744|324302|P3|Overall Study|Screen failure|0
84912|NCT01186744|324303|P2|Overall Study|Screen failure|1
84913|NCT01186744|324304|P1|Overall Study|Screen failure|1
84914|NCT01186744|324299|P6|Overall Study|Lost to Follow-up|4
84915|NCT01186744|324300|P5|Overall Study|Lost to Follow-up|1
84916|NCT01186744|324301|P4|Overall Study|Lost to Follow-up|1
84918|NCT01186744|324303|P2|Overall Study|Lost to Follow-up|16
84919|NCT01186744|324304|P1|Overall Study|Lost to Follow-up|15
84920|NCT01186744|324299|P6|Overall Study|Protocol Violation|2
84921|NCT01186744|324300|P5|Overall Study|Protocol Violation|1
84922|NCT01186744|324301|P4|Overall Study|Protocol Violation|1
84923|NCT01186744|324302|P3|Overall Study|Protocol Violation|0
84924|NCT01186744|324303|P2|Overall Study|Protocol Violation|2
84925|NCT01186744|324304|P1|Overall Study|Protocol Violation|1
84926|NCT01186744|324299|P6|Overall Study|Lack of Efficacy|5
84927|NCT01186744|324300|P5|Overall Study|Lack of Efficacy|2
84928|NCT01186744|324301|P4|Overall Study|Lack of Efficacy|2
84929|NCT01186744|324302|P3|Overall Study|Lack of Efficacy|0
84930|NCT01186744|324303|P2|Overall Study|Lack of Efficacy|99
84931|NCT01186744|324304|P1|Overall Study|Lack of Efficacy|156
84932|NCT01186692|324724|P1|Overall Study|Adverse Event|2
84933|NCT01186692|324724|P1|Overall Study|Futher testing contraindicated implant|19
84934|NCT01186692|324724|P1|Overall Study|Not Catheterized|11
84935|NCT01186458|324751|P1|Overall Study|Adverse Event|1
84936|NCT01186419|324760|P2|Overall Study|Not specified|1
84937|NCT01186419|324761|P1|Overall Study|Not specified|1
84938|NCT01186419|324760|P2|Overall Study|Physician Decision|3
84939|NCT01186419|324761|P1|Overall Study|Physician Decision|0
84940|NCT01186419|324760|P2|Overall Study|Adverse Event|2
84941|NCT01186419|324761|P1|Overall Study|Adverse Event|1
84942|NCT01186419|324760|P2|Overall Study|Withdrawal by Subject|3
84943|NCT01186419|324761|P1|Overall Study|Withdrawal by Subject|5
84944|NCT01185964|324799|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
84945|NCT01185964|324800|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
84946|NCT01185964|324801|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
84947|NCT01185964|324802|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
84948|NCT01185964|324799|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
84949|NCT01185964|324800|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
84950|NCT01185964|324801|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
84951|NCT01185964|324802|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
84952|NCT01185964|324799|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
84953|NCT01185964|324800|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
84954|NCT01185964|324801|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
84955|NCT01185964|324802|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
84956|NCT01185964|324799|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
84957|NCT01185964|324800|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
84958|NCT01185964|324801|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
84959|NCT01185964|324802|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
84960|NCT01185964|324799|P4|Phase 1b and Phase 2|Adverse Event|0
84961|NCT01185964|324800|P3|Phase 1b and Phase 2|Adverse Event|2
84962|NCT01185964|324801|P2|Phase 1b and Phase 2|Adverse Event|0
84963|NCT01185964|324802|P1|Phase 1b and Phase 2|Adverse Event|1
84964|NCT01185964|324799|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
84965|NCT01185964|324800|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
84966|NCT01185964|324801|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
84967|NCT01185964|324802|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
84968|NCT01185964|324799|P4|Phase 1b and Phase 2|Other Therapy Started|0
84969|NCT01185964|324800|P3|Phase 1b and Phase 2|Other Therapy Started|3
84970|NCT01185964|324801|P2|Phase 1b and Phase 2|Other Therapy Started|3
84971|NCT01185964|324802|P1|Phase 1b and Phase 2|Other Therapy Started|0
84972|NCT01185964|324799|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
84973|NCT01185964|324800|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
84974|NCT01185964|324801|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
84975|NCT01185964|324802|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
84976|NCT01185834|324828|P1|Overall Study|Early exit - Site error|2
84977|NCT01185834|324828|P1|Overall Study|Time/Job Conflict|2
84978|NCT01185834|324828|P1|Overall Study|Biomicroscopy|4
84979|NCT01185834|324828|P1|Overall Study|Discomfort|4
84980|NCT01185834|324828|P1|Overall Study|Lost to Follow-up|2
84981|NCT01185821|324838|P5|Overall Study|Administrative problems|2
84982|NCT01185821|324839|P4|Overall Study|Administrative problems|1
84983|NCT01185821|324840|P3|Overall Study|Administrative problems|1
84984|NCT01185821|324841|P2|Overall Study|Administrative problems|0
84985|NCT01185821|324842|P1|Overall Study|Administrative problems|0
84986|NCT01185821|324838|P5|Overall Study|Lost to Follow-up|2
84987|NCT01185821|324839|P4|Overall Study|Lost to Follow-up|1
84988|NCT01185821|324840|P3|Overall Study|Lost to Follow-up|2
84989|NCT01185821|324841|P2|Overall Study|Lost to Follow-up|1
84990|NCT01185821|324842|P1|Overall Study|Lost to Follow-up|1
84991|NCT01185821|324838|P5|Overall Study|Withdrawal by Subject|3
84992|NCT01185821|324839|P4|Overall Study|Withdrawal by Subject|1
84993|NCT01185821|324840|P3|Overall Study|Withdrawal by Subject|2
84994|NCT01185821|324841|P2|Overall Study|Withdrawal by Subject|2
84995|NCT01185821|324842|P1|Overall Study|Withdrawal by Subject|3
84996|NCT01185821|324838|P5|Overall Study|Lack of Efficacy|9
84997|NCT01185821|324839|P4|Overall Study|Lack of Efficacy|0
84998|NCT01185821|324840|P3|Overall Study|Lack of Efficacy|3
84999|NCT01185821|324841|P2|Overall Study|Lack of Efficacy|0
85000|NCT01185821|324842|P1|Overall Study|Lack of Efficacy|0
85001|NCT01185821|324838|P5|Overall Study|Adverse Event|5
85002|NCT01185821|324839|P4|Overall Study|Adverse Event|2
85003|NCT01185821|324840|P3|Overall Study|Adverse Event|1
85004|NCT01185821|324841|P2|Overall Study|Adverse Event|3
85005|NCT01185821|324842|P1|Overall Study|Adverse Event|2
85006|NCT01185821|324838|P5|Overall Study|Condition no longer required study drug|1
85007|NCT01185821|324839|P4|Overall Study|Condition no longer required study drug|0
85008|NCT01185821|324840|P3|Overall Study|Condition no longer required study drug|0
85009|NCT01185821|324841|P2|Overall Study|Condition no longer required study drug|0
85010|NCT01185821|324842|P1|Overall Study|Condition no longer required study drug|0
85011|NCT01185821|324838|P5|Overall Study|Death|0
85012|NCT01185821|324839|P4|Overall Study|Death|0
85013|NCT01185821|324840|P3|Overall Study|Death|0
85014|NCT01185821|324841|P2|Overall Study|Death|1
85015|NCT01185821|324842|P1|Overall Study|Death|0
85016|NCT01185821|324838|P5|Overall Study|Abnormal test procedure result|1
85017|NCT01185821|324839|P4|Overall Study|Abnormal test procedure result|0
85018|NCT01185821|324840|P3|Overall Study|Abnormal test procedure result|0
85019|NCT01185821|324841|P2|Overall Study|Abnormal test procedure result|0
85020|NCT01185821|324842|P1|Overall Study|Abnormal test procedure result|0
85021|NCT01185821|324838|P5|Overall Study|Protocol Violation|1
85022|NCT01185821|324839|P4|Overall Study|Protocol Violation|1
85023|NCT01185821|324840|P3|Overall Study|Protocol Violation|0
85024|NCT01185821|324841|P2|Overall Study|Protocol Violation|0
85025|NCT01185821|324842|P1|Overall Study|Protocol Violation|0
85026|NCT01185821|324838|P5|Overall Study|Abnormal laboratory value(s)|0
85027|NCT01185821|324839|P4|Overall Study|Abnormal laboratory value(s)|0
85028|NCT01185821|324840|P3|Overall Study|Abnormal laboratory value(s)|1
85029|NCT01185821|324841|P2|Overall Study|Abnormal laboratory value(s)|2
85030|NCT01185821|324842|P1|Overall Study|Abnormal laboratory value(s)|1
85031|NCT01185782|324893|P2|Overall Study|Randomized but not treated|4
85032|NCT01185782|324894|P1|Overall Study|Randomized but not treated|0
85033|NCT01185782|324893|P2|Overall Study|Other|5
85034|NCT01185782|324894|P1|Overall Study|Other|2
85035|NCT01185782|324893|P2|Overall Study|Poor Response to Treatment|1
85036|NCT01185782|324894|P1|Overall Study|Poor Response to Treatment|3
85037|NCT01185782|324893|P2|Overall Study|Protocol Violation|0
85038|NCT01185782|324894|P1|Overall Study|Protocol Violation|1
85039|NCT01185782|324893|P2|Overall Study|Adverse Event|1
85040|NCT01185782|324894|P1|Overall Study|Adverse Event|0
85041|NCT01185704|324922|P2|Overall Study|Ectopic pregnancy|1
85042|NCT01185704|324923|P1|Overall Study|Ectopic pregnancy|0
85043|NCT01185704|324922|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
85044|NCT01185704|324923|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
85045|NCT01185704|324922|P2|Overall Study|Lack of ovarian response|1
85046|NCT01185704|324923|P1|Overall Study|Lack of ovarian response|5
85047|NCT01185704|324922|P2|Overall Study|Randomized but not treated|3
85048|NCT01185704|324923|P1|Overall Study|Randomized but not treated|3
85049|NCT01185600|324959|P2|Overall Study|Hold by DSMB|2
85050|NCT01185600|324960|P1|Overall Study|Hold by DSMB|1
85051|NCT01185600|324959|P2|Overall Study|Withdrawal by Subject|1
85052|NCT01185600|324960|P1|Overall Study|Withdrawal by Subject|1
85053|NCT01185600|324959|P2|Overall Study|Physician Decision|35
85054|NCT01185600|324960|P1|Overall Study|Physician Decision|29
85055|NCT01185600|324959|P2|Overall Study|Lost to Follow-up|5
85056|NCT01185600|324960|P1|Overall Study|Lost to Follow-up|0
85057|NCT01185600|324959|P2|Overall Study|Death|1
85058|NCT01185600|324960|P1|Overall Study|Death|0
85059|NCT01185600|324959|P2|Overall Study|Adverse Event|1
85060|NCT01185600|324960|P1|Overall Study|Adverse Event|1
85061|NCT01185561|324982|P2|Overall Study|Withdrawal by Subject|8
85062|NCT01185561|324983|P1|Overall Study|Withdrawal by Subject|2
85063|NCT01185561|324982|P2|Overall Study|Lost to Follow-up|4
85064|NCT01185561|324983|P1|Overall Study|Lost to Follow-up|0
85065|NCT01185522|324995|P1|Overall Study|Other reasons|12
85066|NCT01185522|324995|P1|Overall Study|Poor tolerance|39
85067|NCT01185522|324995|P1|Overall Study|Withdrawal by Subject|10
85068|NCT01185522|324995|P1|Overall Study|Lost to Follow-up|19
85069|NCT01185522|324995|P1|Overall Study|Lack of Efficacy|28
85070|NCT01185509|325021|P2|Overall Study|Intercurrent Illness|1
85071|NCT01185509|325022|P1|Overall Study|Intercurrent Illness|0
85072|NCT01185509|325021|P2|Overall Study|Death|1
85073|NCT01185509|325022|P1|Overall Study|Death|0
85074|NCT01185509|325021|P2|Overall Study|Withdrawal by Subject|1
85075|NCT01185509|325022|P1|Overall Study|Withdrawal by Subject|0
85076|NCT01185509|325021|P2|Overall Study|Physician Decision|2
85077|NCT01185509|325022|P1|Overall Study|Physician Decision|2
85078|NCT01185509|325021|P2|Overall Study|Progression/Relapse|15
85079|NCT01185509|325022|P1|Overall Study|Progression/Relapse|9
85080|NCT01185353|325037|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
85081|NCT01185353|325038|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
85082|NCT01185353|325039|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
85083|NCT01185353|325040|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
85084|NCT01185353|325041|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
85085|NCT01185353|325042|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
85086|NCT01185353|325043|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
85087|NCT01185353|325044|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
85088|NCT01185353|325045|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
85089|NCT01185353|325046|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
85090|NCT01185353|325037|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
85091|NCT01185353|325038|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
85092|NCT01185353|325039|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
85093|NCT01185353|325040|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
85094|NCT01185353|325041|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
85095|NCT01185353|325042|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
85096|NCT01185353|325043|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
85097|NCT01185353|325044|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
85098|NCT01185353|325045|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
85099|NCT01185353|325046|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
85100|NCT01185353|325037|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
85101|NCT01185353|325038|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
85102|NCT01185353|325039|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
85103|NCT01185353|325040|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
85104|NCT01185353|325041|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
85105|NCT01185353|325042|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
85106|NCT01185353|325043|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
85107|NCT01185353|325044|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
85108|NCT01185353|325045|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
85109|NCT01185353|325046|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
85110|NCT01185353|325037|P10|Part C (Weeks 24 Through 76)|Reason missing|0
85111|NCT01185353|325038|P9|Part C (Weeks 24 Through 76)|Reason missing|1
85112|NCT01185353|325039|P8|Part C (Weeks 24 Through 76)|Reason missing|0
85113|NCT01185353|325040|P7|Part C (Weeks 24 Through 76)|Reason missing|0
85114|NCT01185353|325041|P6|Part C (Weeks 24 Through 76)|Reason missing|0
85115|NCT01185353|325042|P5|Part C (Weeks 24 Through 76)|Reason missing|0
85116|NCT01185353|325043|P4|Part C (Weeks 24 Through 76)|Reason missing|0
85117|NCT01185353|325044|P3|Part C (Weeks 24 Through 76)|Reason missing|0
85118|NCT01185353|325045|P2|Part C (Weeks 24 Through 76)|Reason missing|0
85119|NCT01185353|325046|P1|Part C (Weeks 24 Through 76)|Reason missing|0
85120|NCT01185353|325037|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
85121|NCT01185353|325038|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
85122|NCT01185353|325039|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
85123|NCT01185353|325040|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
85124|NCT01185353|325041|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
85125|NCT01185353|325042|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
85126|NCT01185353|325043|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
85127|NCT01185353|325044|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
85128|NCT01185353|325045|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
85129|NCT01185353|325046|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
85130|NCT01185353|325037|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
85131|NCT01185353|325038|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
85132|NCT01185353|325039|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
85133|NCT01185353|325040|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
85134|NCT01185353|325041|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
85135|NCT01185353|325042|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
85136|NCT01185353|325043|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
85137|NCT01185353|325044|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
85138|NCT01185353|325045|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
85139|NCT01185353|325046|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
85140|NCT01185353|325037|P10|Part C (Weeks 24 Through 76)|Death|1
85141|NCT01185353|325038|P9|Part C (Weeks 24 Through 76)|Death|0
85142|NCT01185353|325039|P8|Part C (Weeks 24 Through 76)|Death|0
85143|NCT01185353|325040|P7|Part C (Weeks 24 Through 76)|Death|0
85144|NCT01185353|325041|P6|Part C (Weeks 24 Through 76)|Death|0
85145|NCT01185353|325042|P5|Part C (Weeks 24 Through 76)|Death|0
85146|NCT01185353|325043|P4|Part C (Weeks 24 Through 76)|Death|0
85147|NCT01185353|325044|P3|Part C (Weeks 24 Through 76)|Death|0
85148|NCT01185353|325045|P2|Part C (Weeks 24 Through 76)|Death|0
85149|NCT01185353|325046|P1|Part C (Weeks 24 Through 76)|Death|0
85150|NCT01185353|325037|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
85151|NCT01185353|325038|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
85152|NCT01185353|325039|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
85153|NCT01185353|325040|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
85154|NCT01185353|325041|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
85155|NCT01185353|325042|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
85156|NCT01185353|325043|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
85157|NCT01185353|325044|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
85158|NCT01185353|325045|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
85159|NCT01185353|325046|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
85160|NCT01185353|325037|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
85161|NCT01185353|325038|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
85162|NCT01185353|325039|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
85163|NCT01185353|325040|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
85164|NCT01185353|325041|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
85165|NCT01185353|325042|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
85166|NCT01185353|325043|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
85167|NCT01185353|325044|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
85168|NCT01185353|325045|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
85169|NCT01185353|325046|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
85170|NCT01185353|325037|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
85171|NCT01185353|325038|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
85172|NCT01185353|325039|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
85173|NCT01185353|325040|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
85174|NCT01185353|325041|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
85175|NCT01185353|325042|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
85176|NCT01185353|325043|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
85177|NCT01185353|325044|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
85178|NCT01185353|325045|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
85179|NCT01185353|325046|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
85180|NCT01185353|325037|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
85181|NCT01185353|325038|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
85182|NCT01185353|325039|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
85183|NCT01185353|325040|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
85184|NCT01185353|325041|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
85185|NCT01185353|325042|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
85186|NCT01185353|325043|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
85187|NCT01185353|325044|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
85188|NCT01185353|325045|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
85189|NCT01185353|325046|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
85190|NCT01185353|325037|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
85191|NCT01185353|325038|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
85192|NCT01185353|325039|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
85193|NCT01185353|325040|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
85194|NCT01185353|325041|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
85195|NCT01185353|325042|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
85196|NCT01185353|325043|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
85197|NCT01185353|325044|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
85198|NCT01185353|325045|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
85199|NCT01185353|325046|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
85200|NCT01185353|325037|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
85201|NCT01185353|325038|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
85202|NCT01185353|325039|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
85203|NCT01185353|325040|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
85204|NCT01185353|325041|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
85205|NCT01185353|325042|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
85206|NCT01185353|325043|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
85207|NCT01185353|325044|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
85208|NCT01185353|325045|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
85209|NCT01185353|325046|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
85210|NCT01185353|325037|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
85211|NCT01185353|325038|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
85212|NCT01185353|325039|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
85213|NCT01185353|325040|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
85214|NCT01185353|325041|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
85215|NCT01185353|325042|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
85216|NCT01185353|325043|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
85217|NCT01185353|325044|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
85218|NCT01185353|325045|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
85219|NCT01185353|325046|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
85220|NCT01185353|325037|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
85221|NCT01185353|325038|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
85222|NCT01185353|325039|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
85223|NCT01185353|325040|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
85224|NCT01185353|325041|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
85225|NCT01185353|325042|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
85226|NCT01185353|325043|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
85227|NCT01185353|325044|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
85228|NCT01185353|325045|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
85229|NCT01185353|325046|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
85230|NCT01185353|325037|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
85231|NCT01185353|325038|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
85232|NCT01185353|325039|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
85233|NCT01185353|325040|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
85234|NCT01185353|325041|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
85235|NCT01185353|325042|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
85236|NCT01185353|325043|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
85237|NCT01185353|325044|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
85238|NCT01185353|325045|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
85239|NCT01185353|325046|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
85240|NCT01185353|325037|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
85241|NCT01185353|325038|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
85242|NCT01185353|325039|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
85243|NCT01185353|325040|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
85244|NCT01185353|325041|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
85245|NCT01185353|325042|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
85246|NCT01185353|325043|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
85247|NCT01185353|325044|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
85248|NCT01185353|325045|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
85249|NCT01185353|325046|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
85250|NCT01185353|325037|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
85251|NCT01185353|325038|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
85252|NCT01185353|325039|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
85253|NCT01185353|325040|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
85254|NCT01185353|325041|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
85255|NCT01185353|325042|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
85256|NCT01185353|325043|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
85257|NCT01185353|325044|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
85258|NCT01185353|325045|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
85259|NCT01185353|325046|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
85260|NCT01185353|325037|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
85261|NCT01185353|325038|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
85262|NCT01185353|325039|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
85263|NCT01185353|325040|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
85264|NCT01185353|325041|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
85265|NCT01185353|325042|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
85266|NCT01185353|325043|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
85267|NCT01185353|325044|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
85268|NCT01185353|325045|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
85269|NCT01185353|325046|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
85270|NCT01185353|325037|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
85271|NCT01185353|325038|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
85272|NCT01185353|325039|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
85273|NCT01185353|325040|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
85274|NCT01185353|325041|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
85275|NCT01185353|325042|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
85276|NCT01185353|325043|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
85277|NCT01185353|325044|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
85278|NCT01185353|325045|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
85279|NCT01185353|325046|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
85280|NCT01185353|325037|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
85281|NCT01185353|325038|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
85282|NCT01185353|325039|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
85283|NCT01185353|325040|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
85284|NCT01185353|325041|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
85285|NCT01185353|325042|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
85286|NCT01185353|325043|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
85287|NCT01185353|325044|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
85288|NCT01185353|325045|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
85289|NCT01185353|325046|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
85290|NCT01185353|325037|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
85291|NCT01185353|325038|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
85292|NCT01185353|325039|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
85293|NCT01185353|325040|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
85294|NCT01185353|325041|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
85295|NCT01185353|325042|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
85296|NCT01185353|325043|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
85297|NCT01185353|325044|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
85298|NCT01185353|325045|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
85299|NCT01185353|325046|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
85300|NCT01185340|325207|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
85301|NCT01185340|325208|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
85302|NCT01185340|325209|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
85303|NCT01185340|325210|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
85304|NCT01185340|325207|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
85305|NCT01185340|325208|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
85306|NCT01185340|325209|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
85307|NCT01185340|325210|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
85308|NCT01185340|325207|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
85309|NCT01185340|325208|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
85310|NCT01185340|325209|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
85311|NCT01185340|325210|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
85312|NCT01185340|325207|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
85313|NCT01185340|325208|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
85314|NCT01185340|325209|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
85315|NCT01185340|325210|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
85316|NCT01185340|325207|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
85317|NCT01185340|325208|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
85318|NCT01185340|325209|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
85319|NCT01185340|325210|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
85320|NCT01185340|325207|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
85321|NCT01185340|325208|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
85322|NCT01185340|325209|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
85323|NCT01185340|325210|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
85324|NCT01185340|325207|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
85325|NCT01185340|325208|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
85326|NCT01185340|325209|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
85327|NCT01185340|325210|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
85328|NCT01185340|325207|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
85329|NCT01185340|325208|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
85330|NCT01185340|325209|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
85331|NCT01185340|325210|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
85332|NCT01185340|325207|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
85333|NCT01185340|325208|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
85334|NCT01185340|325209|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
85335|NCT01185340|325210|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
85336|NCT01185340|325207|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
85337|NCT01185340|325208|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
85338|NCT01185340|325209|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
85339|NCT01185340|325210|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
85340|NCT01185340|325207|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
85341|NCT01185340|325208|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
85342|NCT01185340|325209|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
85343|NCT01185340|325210|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
85344|NCT01185340|325207|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
85345|NCT01185340|325208|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
85346|NCT01185340|325209|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
85347|NCT01185340|325210|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
85348|NCT01185340|325207|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
85349|NCT01185340|325208|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
85350|NCT01185340|325209|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
85351|NCT01185340|325210|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
85352|NCT01185340|325207|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
85353|NCT01185340|325208|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
85354|NCT01185340|325209|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
85355|NCT01185340|325210|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
85356|NCT01185301|325262|P4|Overall Study|Other Reason|2
85357|NCT01185301|325263|P3|Overall Study|Other Reason|2
85358|NCT01185301|325264|P2|Overall Study|Other Reason|2
85359|NCT01185301|325265|P1|Overall Study|Other Reason|3
85360|NCT01185301|325262|P4|Overall Study|Lost to Follow-up|1
85361|NCT01185301|325263|P3|Overall Study|Lost to Follow-up|0
85362|NCT01185301|325264|P2|Overall Study|Lost to Follow-up|0
85363|NCT01185301|325265|P1|Overall Study|Lost to Follow-up|2
85364|NCT01185301|325262|P4|Overall Study|Withdrawal by Subject|3
85365|NCT01185301|325263|P3|Overall Study|Withdrawal by Subject|2
85366|NCT01185301|325264|P2|Overall Study|Withdrawal by Subject|5
85367|NCT01185301|325265|P1|Overall Study|Withdrawal by Subject|7
85368|NCT01185301|325262|P4|Overall Study|Adverse Event|3
85369|NCT01185301|325263|P3|Overall Study|Adverse Event|2
85370|NCT01185301|325264|P2|Overall Study|Adverse Event|0
85371|NCT01185301|325265|P1|Overall Study|Adverse Event|3
85372|NCT01185288|325325|P2|Overall Study|Noncompliance|1
85373|NCT01185288|325326|P1|Overall Study|Noncompliance|0
85374|NCT01185288|325325|P2|Overall Study|Did not meet inclusion criteria|0
85375|NCT01185288|325326|P1|Overall Study|Did not meet inclusion criteria|1
85376|NCT01185288|325325|P2|Overall Study|Investigator discretion|0
85377|NCT01185288|325326|P1|Overall Study|Investigator discretion|1
85378|NCT01185288|325325|P2|Overall Study|Lack of Efficacy|0
85379|NCT01185288|325326|P1|Overall Study|Lack of Efficacy|2
85380|NCT01185288|325325|P2|Overall Study|Lost to Follow-up|5
85381|NCT01185288|325326|P1|Overall Study|Lost to Follow-up|2
85382|NCT01185288|325325|P2|Overall Study|Withdrawal by Subject|4
85383|NCT01185288|325326|P1|Overall Study|Withdrawal by Subject|6
85384|NCT01185288|325325|P2|Overall Study|Adverse Event|6
85385|NCT01185288|325326|P1|Overall Study|Adverse Event|7
85386|NCT01185249|325344|P1|Overall Study|Patients discharged or change in status|42
85387|NCT01185080|325352|P3|Overall Study|Personal reasons|1
85388|NCT01185080|325353|P2|Overall Study|Personal reasons|0
85389|NCT01185080|325354|P1|Overall Study|Personal reasons|0
85390|NCT01185080|325352|P3|Overall Study|Adverse Event|0
85391|NCT01185080|325353|P2|Overall Study|Adverse Event|1
85392|NCT01185080|325354|P1|Overall Study|Adverse Event|1
85393|NCT01184989|325406|P1|Overall Study|Withdrawal by Subject|1
85394|NCT01184989|325406|P1|Overall Study|Adverse Event|11
85395|NCT01184872|325426|P2|Overall Study|Protocol deviation|0
85396|NCT01184872|325427|P1|Overall Study|Protocol deviation|1
85397|NCT01184872|325426|P2|Overall Study|Administrative problems|1
85398|NCT01184872|325427|P1|Overall Study|Administrative problems|1
85399|NCT01184872|325426|P2|Overall Study|Lost to Follow-up|1
85400|NCT01184872|325427|P1|Overall Study|Lost to Follow-up|0
85401|NCT01184872|325426|P2|Overall Study|Withdrawal by Subject|0
85402|NCT01184872|325427|P1|Overall Study|Withdrawal by Subject|2
85403|NCT01184872|325426|P2|Overall Study|Unsatisfactory therapeutic effect|2
85404|NCT01184872|325427|P1|Overall Study|Unsatisfactory therapeutic effect|3
85405|NCT01184872|325426|P2|Overall Study|Adverse Event|4
85406|NCT01184872|325427|P1|Overall Study|Adverse Event|3
85407|NCT01184859|325446|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
85408|NCT01184859|325447|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
85409|NCT01184859|325448|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
85410|NCT01184859|325449|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
85411|NCT01184859|325450|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
85412|NCT01184859|325446|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
85413|NCT01184859|325447|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
85414|NCT01184859|325448|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
85415|NCT01184859|325449|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
85416|NCT01184859|325450|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
85417|NCT01184859|325446|P5|Period 1: Single Dose|Adverse Event|1
85418|NCT01184859|325447|P4|Period 1: Single Dose|Adverse Event|0
85419|NCT01184859|325448|P3|Period 1: Single Dose|Adverse Event|0
85420|NCT01184859|325449|P2|Period 1: Single Dose|Adverse Event|0
85421|NCT01184859|325450|P1|Period 1: Single Dose|Adverse Event|0
85422|NCT01184859|325446|P5|Period 1: Single Dose|Protocol Violation|0
85423|NCT01184859|325447|P4|Period 1: Single Dose|Protocol Violation|0
85424|NCT01184859|325448|P3|Period 1: Single Dose|Protocol Violation|0
85425|NCT01184859|325449|P2|Period 1: Single Dose|Protocol Violation|1
85426|NCT01184859|325450|P1|Period 1: Single Dose|Protocol Violation|0
85427|NCT01184859|325446|P5|Period 1: Single Dose|Insufficient urine production|0
85428|NCT01184859|325447|P4|Period 1: Single Dose|Insufficient urine production|0
85429|NCT01184859|325448|P3|Period 1: Single Dose|Insufficient urine production|0
85430|NCT01184859|325449|P2|Period 1: Single Dose|Insufficient urine production|1
85431|NCT01184859|325450|P1|Period 1: Single Dose|Insufficient urine production|0
85432|NCT01184846|325542|P1|Overall Study|Insufficient response|1
85433|NCT01184846|325542|P1|Overall Study|Adverse Event|2
85434|NCT01184118|325596|P1|Overall Study|Withdrawal by Subject|5
85435|NCT01184118|325596|P1|Overall Study|Exclusionary medical condition|2
85436|NCT01184118|325596|P1|Overall Study|FEV1 <60% predicted|2
85437|NCT01184118|325596|P1|Overall Study|No physiologic confirmation of asthma|8
85438|NCT01184118|325596|P1|Overall Study|Only asthma step 1 - screen fail|1
85439|NCT01184079|325604|P2|Overall Study|Lost to Follow-up|2
85440|NCT01184079|325605|P1|Overall Study|Lost to Follow-up|14
85441|NCT01184053|325615|P1|Overall Study|progression while on treatment|3
85442|NCT01183975|325631|P1|Overall Study|Lost to Follow-up|73
85443|NCT01183858|325638|P2|Overall Study|Lost to Follow-up|1
85444|NCT01183858|325639|P1|Overall Study|Lost to Follow-up|1
85445|NCT01183858|325638|P2|Overall Study|Death related to Progressive Disease|5
85446|NCT01183858|325639|P1|Overall Study|Death related to Progressive Disease|4
85447|NCT01183858|325638|P2|Overall Study|Progressive Disease|115
85448|NCT01183858|325639|P1|Overall Study|Progressive Disease|112
85449|NCT01183858|325638|P2|Overall Study|Administrative/Other|6
85450|NCT01183858|325639|P1|Overall Study|Administrative/Other|6
85451|NCT01183858|325638|P2|Overall Study|Protocol Violation|0
85452|NCT01183858|325639|P1|Overall Study|Protocol Violation|1
85453|NCT01183858|325638|P2|Overall Study|Discontinued Smoking|1
85454|NCT01183858|325639|P1|Overall Study|Discontinued Smoking|3
85455|NCT01183858|325638|P2|Overall Study|Withdrew Consent|4
85456|NCT01183858|325639|P1|Overall Study|Withdrew Consent|4
85457|NCT01183858|325638|P2|Overall Study|Refused Treatment|4
85458|NCT01183858|325639|P1|Overall Study|Refused Treatment|1
85459|NCT01183858|325638|P2|Overall Study|Insufficient Therapeutic Response|0
85460|NCT01183858|325639|P1|Overall Study|Insufficient Therapeutic Response|2
85461|NCT01183858|325638|P2|Overall Study|Investigator's Decision|3
85462|NCT01183858|325639|P1|Overall Study|Investigator's Decision|0
85463|NCT01183858|325638|P2|Overall Study|Adverse Event|11
85464|NCT01183858|325639|P1|Overall Study|Adverse Event|14
85465|NCT01183858|325638|P2|Overall Study|Death not related to Progressive Disease|6
85466|NCT01183858|325639|P1|Overall Study|Death not related to Progressive Disease|5
85467|NCT01183780|325661|P2|Overall Study|Lost to Follow-up|11
85468|NCT01183780|325662|P1|Overall Study|Lost to Follow-up|6
85469|NCT01183780|325661|P2|Overall Study|Withdrawal by Subject|14
85470|NCT01183780|325662|P1|Overall Study|Withdrawal by Subject|25
85471|NCT01183468|325795|P4|Overall Study|Withdrawal by Subject|0
85472|NCT01183468|325796|P3|Overall Study|Withdrawal by Subject|0
85473|NCT01183468|325797|P2|Overall Study|Withdrawal by Subject|1
85474|NCT01183468|325798|P1|Overall Study|Withdrawal by Subject|0
85475|NCT01183468|325795|P4|Overall Study|Physician Decision|0
85476|NCT01183468|325796|P3|Overall Study|Physician Decision|0
85477|NCT01183468|325797|P2|Overall Study|Physician Decision|0
85478|NCT01183468|325798|P1|Overall Study|Physician Decision|1
85479|NCT01183468|325795|P4|Overall Study|Lost to Follow-up|0
85480|NCT01183468|325796|P3|Overall Study|Lost to Follow-up|0
85481|NCT01183468|325797|P2|Overall Study|Lost to Follow-up|1
85482|NCT01183468|325798|P1|Overall Study|Lost to Follow-up|2
85483|NCT01183390|325808|P2|First Intervention|Adverse Event|1
85484|NCT01183390|325809|P1|First Intervention|Adverse Event|0
85485|NCT01183260|325842|P2|Overall Study|Death|0
85486|NCT01183260|325843|P1|Overall Study|Death|1
85487|NCT01183260|325842|P2|Overall Study|Revised within 30 days|1
85488|NCT01183260|325843|P1|Overall Study|Revised within 30 days|0
85489|NCT01183260|325842|P2|Overall Study|Withdrawal by Subject|1
85490|NCT01183260|325843|P1|Overall Study|Withdrawal by Subject|1
85491|NCT01183260|325842|P2|Overall Study|Intraop screen failure|0
85492|NCT01183260|325843|P1|Overall Study|Intraop screen failure|2
85493|NCT01183234|325853|P2|First Intervention|Adverse Event|0
85494|NCT01183234|325854|P1|First Intervention|Adverse Event|1
85495|NCT01183143|325946|P1|Overall Study|Subjects enrolled, but not treated|11
85496|NCT01183143|325946|P1|Overall Study|Subject Questionnaires not returned|5
85497|NCT01183143|325946|P1|Overall Study|Withdrawal by Subject|19
85498|NCT01183143|325946|P1|Overall Study|Protocol Violation|115
85499|NCT01183104|325962|P2|Overall Study|Did not receive study drug|9
85500|NCT01183104|325963|P1|Overall Study|Did not receive study drug|5
85501|NCT01183104|325962|P2|Overall Study|Nonparticipation in Extension Study|50
85502|NCT01183104|325963|P1|Overall Study|Nonparticipation in Extension Study|39
85503|NCT01183104|325962|P2|Overall Study|Withdrawal by Subject|11
85504|NCT01183104|325963|P1|Overall Study|Withdrawal by Subject|6
85505|NCT01183104|325962|P2|Overall Study|Physician Decision|8
85506|NCT01183104|325963|P1|Overall Study|Physician Decision|5
85507|NCT01183104|325962|P2|Overall Study|Lost to Follow-up|7
85508|NCT01183104|325963|P1|Overall Study|Lost to Follow-up|14
85509|NCT01183104|325962|P2|Overall Study|Death|1
85510|NCT01183104|325963|P1|Overall Study|Death|0
85511|NCT01183104|325962|P2|Overall Study|Adverse Event|6
85512|NCT01183104|325963|P1|Overall Study|Adverse Event|8
85513|NCT01183065|325979|P1|Overall Study|Patient no longer fits eligibility crite|1
85514|NCT01183013|325990|P7|Overall Study|Reasons other than stated above|13
85515|NCT01183013|325991|P6|Overall Study|Reasons other than stated above|15
85516|NCT01183013|325992|P5|Overall Study|Reasons other than stated above|12
85517|NCT01183013|325993|P4|Overall Study|Reasons other than stated above|12
85518|NCT01183013|325994|P3|Overall Study|Reasons other than stated above|17
85519|NCT01183013|325995|P2|Overall Study|Reasons other than stated above|11
85520|NCT01183013|325996|P1|Overall Study|Reasons other than stated above|15
85521|NCT01183013|325990|P7|Overall Study|Withdrawal by Subject|10
85522|NCT01183013|325991|P6|Overall Study|Withdrawal by Subject|9
85523|NCT01183013|325992|P5|Overall Study|Withdrawal by Subject|7
85524|NCT01183013|325993|P4|Overall Study|Withdrawal by Subject|8
85525|NCT01183013|325994|P3|Overall Study|Withdrawal by Subject|10
85526|NCT01183013|325995|P2|Overall Study|Withdrawal by Subject|13
85527|NCT01183013|325996|P1|Overall Study|Withdrawal by Subject|9
85528|NCT01183013|325990|P7|Overall Study|Lost to Follow-up|5
85529|NCT01183013|325991|P6|Overall Study|Lost to Follow-up|6
85530|NCT01183013|325992|P5|Overall Study|Lost to Follow-up|2
85531|NCT01183013|325993|P4|Overall Study|Lost to Follow-up|3
85532|NCT01183013|325994|P3|Overall Study|Lost to Follow-up|4
85533|NCT01183013|325995|P2|Overall Study|Lost to Follow-up|3
85534|NCT01183013|325996|P1|Overall Study|Lost to Follow-up|7
85535|NCT01183013|325990|P7|Overall Study|Protocol Violation|3
85536|NCT01183013|325991|P6|Overall Study|Protocol Violation|3
85537|NCT01183013|325992|P5|Overall Study|Protocol Violation|4
85538|NCT01183013|325993|P4|Overall Study|Protocol Violation|0
85539|NCT01183013|325994|P3|Overall Study|Protocol Violation|4
85540|NCT01183013|325995|P2|Overall Study|Protocol Violation|2
85541|NCT01183013|325996|P1|Overall Study|Protocol Violation|5
85542|NCT01183013|325990|P7|Overall Study|Lack of Efficacy|0
85543|NCT01183013|325991|P6|Overall Study|Lack of Efficacy|2
85544|NCT01183013|325992|P5|Overall Study|Lack of Efficacy|1
85545|NCT01183013|325993|P4|Overall Study|Lack of Efficacy|2
85546|NCT01183013|325994|P3|Overall Study|Lack of Efficacy|1
85547|NCT01183013|325995|P2|Overall Study|Lack of Efficacy|2
85548|NCT01183013|325996|P1|Overall Study|Lack of Efficacy|3
85549|NCT01183013|325990|P7|Overall Study|Adverse Event|6
85550|NCT01183013|325991|P6|Overall Study|Adverse Event|10
85551|NCT01183013|325992|P5|Overall Study|Adverse Event|10
85552|NCT01183013|325993|P4|Overall Study|Adverse Event|5
85553|NCT01183013|325994|P3|Overall Study|Adverse Event|5
85554|NCT01183013|325995|P2|Overall Study|Adverse Event|8
85555|NCT01183013|325996|P1|Overall Study|Adverse Event|6
85556|NCT01182428|326132|P2|Overall Study|Withdrawal by Subject|0
85557|NCT01182428|326133|P1|Overall Study|Withdrawal by Subject|1
85558|NCT01182428|326132|P2|Overall Study|Lost to Follow-up|1
85559|NCT01182428|326133|P1|Overall Study|Lost to Follow-up|9
85560|NCT01182428|326132|P2|Overall Study|Physician Decision|0
85561|NCT01182428|326133|P1|Overall Study|Physician Decision|1
85562|NCT01182415|326197|P1|Overall Study|Lost to Follow-up|1
85563|NCT01182337|326215|P2|Overall Study|Lost to Follow-up|1
85564|NCT01182337|326216|P1|Overall Study|Lost to Follow-up|0
85565|NCT01182337|326215|P2|Overall Study|Withdrawal by Subject|1
85566|NCT01182337|326216|P1|Overall Study|Withdrawal by Subject|3
85567|NCT01182298|326234|P1|Overall Study|Withdrawal by Subject|2
85568|NCT01182298|326234|P1|Overall Study|Lack of Efficacy|4
85569|NCT01182285|326238|P3|Third Intervention Week 11-52|Other|2
85570|NCT01182285|326239|P2|Third Intervention Week 11-52|Other|0
85571|NCT01182285|326240|P1|Third Intervention Week 11-52|Other|0
85572|NCT01182285|326238|P3|Third Intervention Week 11-52|Disease Progression|6
85573|NCT01182285|326239|P2|Third Intervention Week 11-52|Disease Progression|0
85574|NCT01182285|326240|P1|Third Intervention Week 11-52|Disease Progression|0
85575|NCT01182285|326238|P3|First Intervention Week 1-10|Non-compliance|0
85576|NCT01182285|326239|P2|First Intervention Week 1-10|Non-compliance|0
85577|NCT01182285|326240|P1|First Intervention Week 1-10|Non-compliance|1
85578|NCT01182285|326238|P3|First Intervention Week 1-10|Adverse Event|0
85579|NCT01182285|326239|P2|First Intervention Week 1-10|Adverse Event|0
85580|NCT01182285|326240|P1|First Intervention Week 1-10|Adverse Event|1
85581|NCT01182285|326238|P3|First Intervention Week 1-10|Disease progression|0
85582|NCT01182285|326239|P2|First Intervention Week 1-10|Disease progression|0
85583|NCT01182285|326240|P1|First Intervention Week 1-10|Disease progression|1
85584|NCT01182207|326250|P2|Second Intervention|Emeses within 1 hour of dosing|0
85585|NCT01182207|326251|P1|Second Intervention|Emeses within 1 hour of dosing|1
85586|NCT01182207|326250|P2|First Intervention|Positive Hepatitis Results|1
85587|NCT01182207|326251|P1|First Intervention|Positive Hepatitis Results|0
85588|NCT01182194|326269|P2|Washout of 28 Days|Withdrawal by Subject|0
85589|NCT01182194|326270|P1|Washout of 28 Days|Withdrawal by Subject|1
85590|NCT01182181|326288|P2|Washout of 21 Days|Withdrawal by Subject|1
85591|NCT01182181|326289|P1|Washout of 21 Days|Withdrawal by Subject|0
85592|NCT01182181|326288|P2|First Intervention|Adverse Event|0
85593|NCT01182181|326289|P1|First Intervention|Adverse Event|1
85594|NCT01181986|326314|P3|Phase 2|Medical condition|0
85595|NCT01181986|326315|P2|Phase 2|Medical condition|1
85596|NCT01181986|326316|P1|Phase 2|Medical condition|0
85597|NCT01181986|326314|P3|Phase 2|Adverse Event|0
85598|NCT01181986|326315|P2|Phase 2|Adverse Event|3
85599|NCT01181986|326316|P1|Phase 2|Adverse Event|0
85600|NCT01181986|326314|P3|Phase 1|Protocol Violation|0
85601|NCT01181986|326315|P2|Phase 1|Protocol Violation|0
85602|NCT01181986|326316|P1|Phase 1|Protocol Violation|1
85603|NCT01181986|326314|P3|Phase 1|Adverse Event|1
85604|NCT01181986|326315|P2|Phase 1|Adverse Event|0
85605|NCT01181986|326316|P1|Phase 1|Adverse Event|0
85606|NCT01181986|326314|P3|Phase 1|Lost to Follow-up|1
85607|NCT01181986|326315|P2|Phase 1|Lost to Follow-up|1
85608|NCT01181986|326316|P1|Phase 1|Lost to Follow-up|0
85609|NCT01181921|326337|P1|Overall Study|Lost to Follow-up|1
85610|NCT01181895|326344|P3|Overall Study|Withdrawal by Subject|5
85611|NCT01181895|326345|P2|Overall Study|Withdrawal by Subject|0
85612|NCT01181895|326346|P1|Overall Study|Withdrawal by Subject|3
85613|NCT01181895|326344|P3|Overall Study|Investigator Discretion|1
85614|NCT01181895|326345|P2|Overall Study|Investigator Discretion|2
85615|NCT01181895|326346|P1|Overall Study|Investigator Discretion|1
85616|NCT01181895|326344|P3|Overall Study|Lost to Follow-up|2
85617|NCT01181895|326345|P2|Overall Study|Lost to Follow-up|1
85618|NCT01181895|326346|P1|Overall Study|Lost to Follow-up|0
85619|NCT01181895|326344|P3|Overall Study|Protocol Violation|0
85620|NCT01181895|326345|P2|Overall Study|Protocol Violation|1
85621|NCT01181895|326346|P1|Overall Study|Protocol Violation|2
85622|NCT01181895|326344|P3|Overall Study|Lack of Efficacy|9
85623|NCT01181895|326345|P2|Overall Study|Lack of Efficacy|9
85624|NCT01181895|326346|P1|Overall Study|Lack of Efficacy|8
85625|NCT01181895|326344|P3|Overall Study|Adverse Event|1
85626|NCT01181895|326345|P2|Overall Study|Adverse Event|1
85627|NCT01181895|326346|P1|Overall Study|Adverse Event|3
85628|NCT01181778|326404|P1|Overall Study|Physician Decision|48
85629|NCT01181726|326412|P2|First Intervention|Adverse Event|0
85630|NCT01181726|326413|P1|First Intervention|Adverse Event|1
85631|NCT01181609|326459|P1|Overall Study|Death|50
85632|NCT01181609|326459|P1|Overall Study|Lost to Follow-up|1
85633|NCT01181609|326459|P1|Overall Study|Withdrawal by Subject|1
85634|NCT01181609|326459|P1|Overall Study|Adverse Event|1
85635|NCT01181531|326472|P2|Overall Study|Adverse Event|1
85636|NCT01181531|326473|P1|Overall Study|Adverse Event|0
85637|NCT01181531|326472|P2|Overall Study|Death|12
85638|NCT01181531|326473|P1|Overall Study|Death|9
85639|NCT01181531|326472|P2|Overall Study|Protocol Violation|6
85640|NCT01181531|326473|P1|Overall Study|Protocol Violation|6
85641|NCT01181531|326472|P2|Overall Study|Withdrawal by Subject|7
85642|NCT01181531|326473|P1|Overall Study|Withdrawal by Subject|8
85643|NCT01181531|326472|P2|Overall Study|Pregnancy|1
85644|NCT01181531|326473|P1|Overall Study|Pregnancy|0
85645|NCT01181531|326472|P2|Overall Study|Protocol Specified Criteria|8
85646|NCT01181531|326473|P1|Overall Study|Protocol Specified Criteria|15
85647|NCT01181531|326472|P2|Overall Study|Ineligibility determined|2
85648|NCT01181531|326473|P1|Overall Study|Ineligibility determined|1
85649|NCT01181531|326472|P2|Overall Study|Noncompliance|2
85650|NCT01181531|326473|P1|Overall Study|Noncompliance|2
85651|NCT01181531|326472|P2|Overall Study|Physician Decision|1
85652|NCT01181531|326473|P1|Overall Study|Physician Decision|3
85653|NCT01181531|326472|P2|Overall Study|Partial consent by subject withdrawn|1
85654|NCT01181531|326473|P1|Overall Study|Partial consent by subject withdrawn|0
85655|NCT01181531|326472|P2|Overall Study|Other|12
85656|NCT01181531|326473|P1|Overall Study|Other|17
85657|NCT01181271|326596|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
85658|NCT01181271|326596|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
85659|NCT01181271|326596|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
85660|NCT01181271|326596|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
85661|NCT01181167|326620|P2|Overall Study|Withdrawal by Subject|8
85662|NCT01181167|326621|P1|Overall Study|Withdrawal by Subject|6
85663|NCT01181167|326620|P2|Overall Study|Protocol Violation|0
85664|NCT01181167|326621|P1|Overall Study|Protocol Violation|3
85665|NCT01181167|326620|P2|Overall Study|Physician Decision|3
85666|NCT01181167|326621|P1|Overall Study|Physician Decision|2
85667|NCT01181167|326620|P2|Overall Study|Lost to Follow-up|0
85668|NCT01181167|326621|P1|Overall Study|Lost to Follow-up|1
85669|NCT01181167|326620|P2|Overall Study|Adverse Event|21
85670|NCT01181167|326621|P1|Overall Study|Adverse Event|11
85671|NCT01181141|326631|P2|Overall Study|Withdrawal by Subject|1
85672|NCT01181141|326632|P1|Overall Study|Withdrawal by Subject|3
85673|NCT01181141|326631|P2|Overall Study|Protocol Violation|1
85674|NCT01181141|326632|P1|Overall Study|Protocol Violation|3
85675|NCT01181141|326631|P2|Overall Study|Physician Decision|0
85676|NCT01181141|326632|P1|Overall Study|Physician Decision|2
85677|NCT01181141|326631|P2|Overall Study|Lost to Follow-up|1
85678|NCT01181141|326632|P1|Overall Study|Lost to Follow-up|1
85679|NCT01181141|326631|P2|Overall Study|Lack of Efficacy|0
85680|NCT01181141|326632|P1|Overall Study|Lack of Efficacy|1
85681|NCT01181141|326631|P2|Overall Study|Adverse Event|1
85682|NCT01181141|326632|P1|Overall Study|Adverse Event|2
85683|NCT01181128|326641|P3|Overall Study|Not Specified|1
85684|NCT01181128|326642|P2|Overall Study|Not Specified|1
85685|NCT01181128|326643|P1|Overall Study|Not Specified|1
85686|NCT01181128|326641|P3|Overall Study|Adverse Event|0
85687|NCT01181128|326642|P2|Overall Study|Adverse Event|2
85688|NCT01181128|326643|P1|Overall Study|Adverse Event|0
85689|NCT01181128|326641|P3|Overall Study|Physician Decision|0
85690|NCT01181128|326642|P2|Overall Study|Physician Decision|0
85691|NCT01181128|326643|P1|Overall Study|Physician Decision|2
85692|NCT01181128|326641|P3|Overall Study|Death|0
85693|NCT01181128|326642|P2|Overall Study|Death|0
85694|NCT01181128|326643|P1|Overall Study|Death|1
85695|NCT01181128|326641|P3|Overall Study|Withdrawal by Subject|0
85696|NCT01181128|326642|P2|Overall Study|Withdrawal by Subject|2
85697|NCT01181128|326643|P1|Overall Study|Withdrawal by Subject|2
85698|NCT01181102|326731|P2|Overall Study|Withdrawal by Subject|12
85699|NCT01181102|326732|P1|Overall Study|Withdrawal by Subject|10
85700|NCT01181102|326731|P2|Overall Study|Protocol Violation|6
85701|NCT01181102|326732|P1|Overall Study|Protocol Violation|5
85702|NCT01181102|326731|P2|Overall Study|Physician Decision|1
85703|NCT01181102|326732|P1|Overall Study|Physician Decision|3
85704|NCT01181102|326731|P2|Overall Study|Lost to Follow-up|0
85705|NCT01181102|326732|P1|Overall Study|Lost to Follow-up|2
85706|NCT01181102|326731|P2|Overall Study|Lack of Efficacy|1
85707|NCT01181102|326732|P1|Overall Study|Lack of Efficacy|3
85708|NCT01181102|326731|P2|Overall Study|Adverse Event|26
85709|NCT01181102|326732|P1|Overall Study|Adverse Event|28
85710|NCT01181011|326753|P1|Overall Study|Lost to Follow-up|1
85711|NCT01181011|326753|P1|Overall Study|Adverse Event|2
85712|NCT01180998|326803|P3|Overall Study|Poor lens handling|2
85713|NCT01180998|326804|P2|Overall Study|Poor lens handling|0
85714|NCT01180998|326805|P1|Overall Study|Poor lens handling|0
85715|NCT01180998|326803|P3|Overall Study|Poor comfort|4
85716|NCT01180998|326804|P2|Overall Study|Poor comfort|0
85717|NCT01180998|326805|P1|Overall Study|Poor comfort|3
85718|NCT01180998|326803|P3|Overall Study|Withdrawal by Subject|1
85719|NCT01180998|326804|P2|Overall Study|Withdrawal by Subject|0
85720|NCT01180998|326805|P1|Overall Study|Withdrawal by Subject|0
85721|NCT01180998|326803|P3|Overall Study|Protocol Violation|0
85722|NCT01180998|326804|P2|Overall Study|Protocol Violation|2
85723|NCT01180998|326805|P1|Overall Study|Protocol Violation|1
85724|NCT01180998|326803|P3|Overall Study|Lost to Follow-up|1
85725|NCT01180998|326804|P2|Overall Study|Lost to Follow-up|0
85726|NCT01180998|326805|P1|Overall Study|Lost to Follow-up|0
85727|NCT01180998|326803|P3|Overall Study|Poor Vision|2
85728|NCT01180998|326804|P2|Overall Study|Poor Vision|2
85729|NCT01180998|326805|P1|Overall Study|Poor Vision|0
85730|NCT01180985|326819|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
85731|NCT01180985|326820|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
85732|NCT01180790|326859|P7|Overall Study|Severe coronary atherosclerosis (death)|0
85733|NCT01180790|326860|P6|Overall Study|Severe coronary atherosclerosis (death)|0
85734|NCT01180790|326861|P5|Overall Study|Severe coronary atherosclerosis (death)|0
85735|NCT01180790|326862|P4|Overall Study|Severe coronary atherosclerosis (death)|0
85736|NCT01180790|326863|P3|Overall Study|Severe coronary atherosclerosis (death)|1
85737|NCT01180790|326864|P2|Overall Study|Severe coronary atherosclerosis (death)|0
85738|NCT01180790|326865|P1|Overall Study|Severe coronary atherosclerosis (death)|0
85739|NCT01180790|326859|P7|Overall Study|compliance|0
85740|NCT01180790|326860|P6|Overall Study|compliance|0
85741|NCT01180790|326861|P5|Overall Study|compliance|0
85742|NCT01180790|326862|P4|Overall Study|compliance|0
85743|NCT01180790|326863|P3|Overall Study|compliance|0
85744|NCT01180790|326864|P2|Overall Study|compliance|1
85745|NCT01180790|326865|P1|Overall Study|compliance|0
85746|NCT01180790|326859|P7|Overall Study|Lack of Efficacy|0
85747|NCT01180790|326860|P6|Overall Study|Lack of Efficacy|3
85748|NCT01180790|326861|P5|Overall Study|Lack of Efficacy|1
85749|NCT01180790|326862|P4|Overall Study|Lack of Efficacy|6
85750|NCT01180790|326863|P3|Overall Study|Lack of Efficacy|5
85751|NCT01180790|326864|P2|Overall Study|Lack of Efficacy|2
85752|NCT01180790|326865|P1|Overall Study|Lack of Efficacy|1
85753|NCT01180790|326859|P7|Overall Study|Physician Decision|0
85754|NCT01180790|326860|P6|Overall Study|Physician Decision|0
85755|NCT01180790|326861|P5|Overall Study|Physician Decision|0
85756|NCT01180790|326862|P4|Overall Study|Physician Decision|1
85757|NCT01180790|326863|P3|Overall Study|Physician Decision|0
85758|NCT01180790|326864|P2|Overall Study|Physician Decision|0
85759|NCT01180790|326865|P1|Overall Study|Physician Decision|1
85760|NCT01180790|326859|P7|Overall Study|Lost to Follow-up|1
85761|NCT01180790|326860|P6|Overall Study|Lost to Follow-up|0
85762|NCT01180790|326861|P5|Overall Study|Lost to Follow-up|1
85763|NCT01180790|326862|P4|Overall Study|Lost to Follow-up|2
85764|NCT01180790|326863|P3|Overall Study|Lost to Follow-up|0
85765|NCT01180790|326864|P2|Overall Study|Lost to Follow-up|1
85766|NCT01180790|326865|P1|Overall Study|Lost to Follow-up|3
85767|NCT01180790|326859|P7|Overall Study|Withdrawal by Subject|0
85768|NCT01180790|326860|P6|Overall Study|Withdrawal by Subject|1
85769|NCT01180790|326861|P5|Overall Study|Withdrawal by Subject|2
85770|NCT01180790|326862|P4|Overall Study|Withdrawal by Subject|0
85771|NCT01180790|326863|P3|Overall Study|Withdrawal by Subject|5
85772|NCT01180790|326864|P2|Overall Study|Withdrawal by Subject|0
85773|NCT01180790|326865|P1|Overall Study|Withdrawal by Subject|3
85774|NCT01180790|326859|P7|Overall Study|Adverse Event|0
85775|NCT01180790|326860|P6|Overall Study|Adverse Event|3
85776|NCT01180790|326861|P5|Overall Study|Adverse Event|1
85777|NCT01180790|326862|P4|Overall Study|Adverse Event|0
85778|NCT01180790|326863|P3|Overall Study|Adverse Event|2
85779|NCT01180790|326864|P2|Overall Study|Adverse Event|1
85780|NCT01180790|326865|P1|Overall Study|Adverse Event|1
85781|NCT01180777|326930|P1|Overall Study|Adverse Event|1
85782|NCT01180777|326930|P1|Overall Study|Lost to Follow-up|1
85783|NCT01180777|326930|P1|Overall Study|Poor lens fit|4
85784|NCT01180777|326930|P1|Overall Study|Protocol Violation|6
85785|NCT01180660|326944|P2|Overall Study|Changed to open surgery|0
85786|NCT01180660|326945|P1|Overall Study|Changed to open surgery|1
85787|NCT01180647|326955|P2|Overall Study|Lost to Follow-up|6
85788|NCT01180647|326956|P1|Overall Study|Lost to Follow-up|5
85789|NCT01180400|326991|P2|Overall Study|Not specified|1
85790|NCT01180400|326992|P1|Overall Study|Not specified|0
85791|NCT01180400|326991|P2|Overall Study|Lost to Follow-up|3
85792|NCT01180400|326992|P1|Overall Study|Lost to Follow-up|2
85793|NCT01180400|326991|P2|Overall Study|Study-specific withdrawal criteria|2
85794|NCT01180400|326992|P1|Overall Study|Study-specific withdrawal criteria|1
85795|NCT01180400|326991|P2|Overall Study|Lack of Efficacy|0
85796|NCT01180400|326992|P1|Overall Study|Lack of Efficacy|2
85797|NCT01180400|326991|P2|Overall Study|Condition under investigation worsened|1
85798|NCT01180400|326992|P1|Overall Study|Condition under investigation worsened|2
85799|NCT01180400|326991|P2|Overall Study|Severe non-compliance to protocol|2
85800|NCT01180400|326992|P1|Overall Study|Severe non-compliance to protocol|1
85801|NCT01180400|326991|P2|Overall Study|Adverse Event|10
85802|NCT01180400|326992|P1|Overall Study|Adverse Event|12
85803|NCT01180400|326991|P2|Overall Study|Eligibility criteria not fulfilled|2
85804|NCT01180400|326992|P1|Overall Study|Eligibility criteria not fulfilled|0
85805|NCT01180400|326991|P2|Overall Study|Withdrawal by Subject|6
85806|NCT01180400|326992|P1|Overall Study|Withdrawal by Subject|5
85807|NCT01180296|327040|P2|Overall Study|Protocol Violation|2
85808|NCT01180296|327041|P1|Overall Study|Protocol Violation|1
85809|NCT01180244|327049|P2|Overall Study|Lost to Follow-up|0
85810|NCT01180244|327050|P1|Overall Study|Lost to Follow-up|1
85811|NCT01180244|327049|P2|Overall Study|Protocol Violation|0
85812|NCT01180244|327050|P1|Overall Study|Protocol Violation|1
85813|NCT01180244|327049|P2|Overall Study|Withdrawal by Subject|1
85814|NCT01180244|327050|P1|Overall Study|Withdrawal by Subject|0
85815|NCT01180244|327049|P2|Overall Study|Adverse Event|0
85816|NCT01180244|327050|P1|Overall Study|Adverse Event|1
85817|NCT01180244|327049|P2|Overall Study|Physician Decision|0
85818|NCT01180244|327050|P1|Overall Study|Physician Decision|3
85819|NCT01180244|327049|P2|Overall Study|Lack of Efficacy|7
85820|NCT01180244|327050|P1|Overall Study|Lack of Efficacy|0
85821|NCT01180049|327095|P2|Overall Study|Ongoing on treatment|10
85822|NCT01180049|327096|P1|Overall Study|Ongoing on treatment|18
85823|NCT01180049|327095|P2|Overall Study|Death|28
85824|NCT01180049|327096|P1|Overall Study|Death|23
85825|NCT01180049|327095|P2|Overall Study|Lost to Follow-up|1
85826|NCT01180049|327096|P1|Overall Study|Lost to Follow-up|0
85827|NCT01180049|327095|P2|Overall Study|Participant Refused Follow Up|3
85828|NCT01180049|327096|P1|Overall Study|Participant Refused Follow Up|5
85829|NCT01180049|327095|P2|Overall Study|Enrolled to Another Clinical Trial|1
85830|NCT01180049|327096|P1|Overall Study|Enrolled to Another Clinical Trial|1
85831|NCT01179919|327122|P1|Overall Study|Adverse Event|1
85832|NCT01179919|327122|P1|Overall Study|Protocol Violation|1
85833|NCT01179737|327131|P4|Extension|The study was terminated|0
85834|NCT01179737|327132|P3|Extension|The study was terminated|0
85835|NCT01179737|327133|P2|Extension|The study was terminated|0
85836|NCT01179737|327134|P1|Extension|The study was terminated|3
85837|NCT01179737|327131|P4|Cohort 1 & Cohort 2 Expansion|Death|0
85838|NCT01179737|327132|P3|Cohort 1 & Cohort 2 Expansion|Death|0
85839|NCT01179737|327133|P2|Cohort 1 & Cohort 2 Expansion|Death|0
85840|NCT01179737|327134|P1|Cohort 1 & Cohort 2 Expansion|Death|1
85841|NCT01179737|327131|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
85842|NCT01179737|327132|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
85843|NCT01179737|327133|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
85844|NCT01179737|327134|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
85845|NCT01179737|327131|P4|Cohort 1 & Cohort 2|Death|0
85846|NCT01179737|327132|P3|Cohort 1 & Cohort 2|Death|1
85847|NCT01179737|327133|P2|Cohort 1 & Cohort 2|Death|0
85848|NCT01179737|327134|P1|Cohort 1 & Cohort 2|Death|0
85849|NCT01179737|327131|P4|Cohort 1 & Cohort 2|Administrative problems|4
85850|NCT01179737|327132|P3|Cohort 1 & Cohort 2|Administrative problems|2
85851|NCT01179737|327133|P2|Cohort 1 & Cohort 2|Administrative problems|0
85852|NCT01179737|327134|P1|Cohort 1 & Cohort 2|Administrative problems|0
85853|NCT01179737|327131|P4|Cohort 1 & Cohort 2|Withdrew consent|0
85854|NCT01179737|327132|P3|Cohort 1 & Cohort 2|Withdrew consent|0
85855|NCT01179737|327133|P2|Cohort 1 & Cohort 2|Withdrew consent|0
85856|NCT01179737|327134|P1|Cohort 1 & Cohort 2|Withdrew consent|2
85857|NCT01179737|327131|P4|Cohort 1 & Cohort 2|Adverse Event|0
85858|NCT01179737|327132|P3|Cohort 1 & Cohort 2|Adverse Event|1
85859|NCT01179737|327133|P2|Cohort 1 & Cohort 2|Adverse Event|1
85860|NCT01179737|327134|P1|Cohort 1 & Cohort 2|Adverse Event|3
85861|NCT01179672|327145|P2|Overall Study|Physician Decision|1
85862|NCT01179672|327146|P1|Overall Study|Physician Decision|1
85863|NCT01179672|327145|P2|Overall Study|Protocol Violation|2
85864|NCT01179672|327146|P1|Overall Study|Protocol Violation|2
85865|NCT01179672|327145|P2|Overall Study|Lost to Follow-up|1
85866|NCT01179672|327146|P1|Overall Study|Lost to Follow-up|0
85867|NCT01179672|327145|P2|Overall Study|Entry Criteria Not Met|2
85868|NCT01179672|327146|P1|Overall Study|Entry Criteria Not Met|0
85869|NCT01179672|327145|P2|Overall Study|Withdrawal by Subject|12
85870|NCT01179672|327146|P1|Overall Study|Withdrawal by Subject|10
85871|NCT01179672|327145|P2|Overall Study|Adverse Event|8
85872|NCT01179672|327146|P1|Overall Study|Adverse Event|17
85873|NCT01179516|327202|P3|Overall Study|Other|2
85874|NCT01179516|327203|P2|Overall Study|Other|0
85875|NCT01179516|327204|P1|Overall Study|Other|2
85876|NCT01179516|327202|P3|Overall Study|Lost to Follow-up|3
85877|NCT01179516|327203|P2|Overall Study|Lost to Follow-up|7
85878|NCT01179516|327204|P1|Overall Study|Lost to Follow-up|7
85879|NCT01179516|327202|P3|Overall Study|Withdrawal of Consent|10
85880|NCT01179516|327203|P2|Overall Study|Withdrawal of Consent|6
85881|NCT01179516|327204|P1|Overall Study|Withdrawal of Consent|2
85882|NCT01179516|327202|P3|Overall Study|Protocol Deviations|3
85883|NCT01179516|327203|P2|Overall Study|Protocol Deviations|3
85884|NCT01179516|327204|P1|Overall Study|Protocol Deviations|4
85885|NCT01179516|327202|P3|Overall Study|Noncompliance with Study Drug|1
85886|NCT01179516|327203|P2|Overall Study|Noncompliance with Study Drug|0
85887|NCT01179516|327204|P1|Overall Study|Noncompliance with Study Drug|2
85888|NCT01179516|327202|P3|Overall Study|Lack of Efficacy|0
85889|NCT01179516|327203|P2|Overall Study|Lack of Efficacy|2
85890|NCT01179516|327204|P1|Overall Study|Lack of Efficacy|4
85891|NCT01179516|327202|P3|Overall Study|Pretreatment Event or Adverse Event|12
85892|NCT01179516|327203|P2|Overall Study|Pretreatment Event or Adverse Event|8
85893|NCT01179516|327204|P1|Overall Study|Pretreatment Event or Adverse Event|6
85894|NCT01179399|327248|P1|Overall Study|Withdrawal by Subject|1
85895|NCT01179399|327248|P1|Overall Study|Lack of Efficacy|30
85896|NCT01179399|327248|P1|Overall Study|Adverse Event|1
85897|NCT01179347|327254|P2|Open-label Period (12 Weeks)|Other|4
85898|NCT01179347|327255|P1|Open-label Period (12 Weeks)|Other|7
85899|NCT01179347|327254|P2|Open-label Period (12 Weeks)|Protocol Violation|0
85900|NCT01179347|327255|P1|Open-label Period (12 Weeks)|Protocol Violation|1
85901|NCT01179347|327254|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
85902|NCT01179347|327255|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
85903|NCT01179347|327254|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
85904|NCT01179347|327255|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
85905|NCT01179347|327254|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
85906|NCT01179347|327255|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
85907|NCT01179347|327254|P2|Open-label Period (12 Weeks)|Adverse Event|9
85908|NCT01179347|327255|P1|Open-label Period (12 Weeks)|Adverse Event|5
85909|NCT01179347|327254|P2|Double-blind Period (12 Weeks)|Other|4
85910|NCT01179347|327255|P1|Double-blind Period (12 Weeks)|Other|2
85911|NCT01179347|327254|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
85912|NCT01179347|327255|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
85913|NCT01179347|327254|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
85914|NCT01179347|327255|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
85915|NCT01179347|327254|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
85916|NCT01179347|327255|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
85917|NCT01179347|327254|P2|Double-blind Period (12 Weeks)|Adverse Event|6
85918|NCT01179347|327255|P1|Double-blind Period (12 Weeks)|Adverse Event|2
85919|NCT01179334|327277|P2|Long-term Extension (LTE) Period|Adverse Event|4
85920|NCT01179334|327278|P1|Long-term Extension (LTE) Period|Adverse Event|2
85921|NCT01179334|327277|P2|Long-term Extension (LTE) Period|Death|0
85922|NCT01179334|327278|P1|Long-term Extension (LTE) Period|Death|3
85923|NCT01179334|327277|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
85924|NCT01179334|327278|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
85925|NCT01179334|327277|P2|Treatment Period|Adverse Event|0
85926|NCT01179334|327278|P1|Treatment Period|Adverse Event|1
85927|NCT01179191|327333|P1|Maintenance Phase (8 Weeks)|Other|66
85928|NCT01179191|327333|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
85929|NCT01179191|327333|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
85930|NCT01179191|327333|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
85931|NCT01179191|327333|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
85932|NCT01179191|327333|P1|Titration Phase (up to 6 Weeks)|Other|62
85933|NCT01179191|327333|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
85934|NCT01179191|327333|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
85935|NCT01179191|327333|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
85936|NCT01179191|327333|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
85937|NCT01179191|327333|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
85938|NCT01179048|327365|P2|Overall Study|Alive|142
85939|NCT01179048|327366|P1|Overall Study|Alive|127
85940|NCT01179048|327365|P2|Overall Study|Lost to Follow-up|9
85941|NCT01179048|327366|P1|Overall Study|Lost to Follow-up|8
85942|NCT01179048|327365|P2|Overall Study|Withdrawn - does not allow contact|8
85943|NCT01179048|327366|P1|Overall Study|Withdrawn - does not allow contact|4
85944|NCT01178853|327393|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
85945|NCT01178853|327394|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
85946|NCT01178853|327393|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
85947|NCT01178853|327394|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
85948|NCT01178853|327393|P2|Period 3 (Warfarin Titration)|Adverse Event|0
85949|NCT01178853|327394|P1|Period 3 (Warfarin Titration)|Adverse Event|1
85950|NCT01178853|327393|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
85951|NCT01178853|327394|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
85952|NCT01178853|327393|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
85953|NCT01178853|327394|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
85954|NCT01178762|327434|P1|Overall Study|Lost to Follow-up|15
85955|NCT01178671|327440|P2|Overall Study|Physician Decision|6
85956|NCT01178671|327441|P1|Overall Study|Physician Decision|4
85957|NCT01178671|327440|P2|Overall Study|Lost to Follow-up|1
85958|NCT01178671|327441|P1|Overall Study|Lost to Follow-up|3
85959|NCT01178671|327440|P2|Overall Study|Lack of Efficacy|1
85960|NCT01178671|327441|P1|Overall Study|Lack of Efficacy|0
85961|NCT01178671|327440|P2|Overall Study|Protocol Violation|1
85962|NCT01178671|327441|P1|Overall Study|Protocol Violation|1
85963|NCT01178671|327440|P2|Overall Study|Adverse Event|6
85964|NCT01178671|327441|P1|Overall Study|Adverse Event|4
85965|NCT01178385|327489|P2|Overall Study|Withdrawal by Subject|0
85966|NCT01178385|327490|P1|Overall Study|Withdrawal by Subject|2
85967|NCT01178294|327559|P1|Overall Study|Completion status could not be verified|1
85968|NCT01178294|327559|P1|Overall Study|Subject status is terminal|1
85969|NCT01178294|327559|P1|Overall Study|Development of inhibitors to OBI-1|1
85970|NCT01178294|327559|P1|Overall Study|Death|1
85971|NCT01178294|327559|P1|Overall Study|Lack of Efficacy|1
85972|NCT01178294|327559|P1|Overall Study|Lost to Follow-up|2
85973|NCT01178294|327559|P1|Overall Study|Adverse Event|4
85974|NCT01178281|327582|P2|Overall Study|Prohibited Medications|2
85975|NCT01178281|327583|P1|Overall Study|Prohibited Medications|0
85976|NCT01178281|327582|P2|Overall Study|Adverse Event|9
85977|NCT01178281|327583|P1|Overall Study|Adverse Event|39
85978|NCT01178281|327582|P2|Overall Study|Withdrawal by Subject|7
85979|NCT01178281|327583|P1|Overall Study|Withdrawal by Subject|18
85980|NCT01178281|327582|P2|Overall Study|Death|5
85981|NCT01178281|327583|P1|Overall Study|Death|4
85982|NCT01178281|327582|P2|Overall Study|Disease Progression|6
85983|NCT01178281|327583|P1|Overall Study|Disease Progression|18
85984|NCT01178281|327582|P2|Overall Study|Non-compliance to study drug|0
85985|NCT01178281|327583|P1|Overall Study|Non-compliance to study drug|1
85986|NCT01178281|327582|P2|Overall Study|Lack of Efficacy|38
85987|NCT01178281|327583|P1|Overall Study|Lack of Efficacy|60
85988|NCT01178281|327582|P2|Overall Study|Loss of Clinical Benefit|7
85989|NCT01178281|327583|P1|Overall Study|Loss of Clinical Benefit|5
85990|NCT01178281|327582|P2|Overall Study|Physician Decision|3
85991|NCT01178281|327583|P1|Overall Study|Physician Decision|4
85992|NCT01178138|327809|P1|Overall Study|Physician Decision|8
85993|NCT01178138|327809|P1|Overall Study|Withdrawal by Subject|7
85994|NCT01178138|327809|P1|Overall Study|Lost to Follow-up|8
85995|NCT01178125|327830|P1|Overall Study|Investigator Decision|5
85996|NCT01178125|327830|P1|Overall Study|Protocol Violation|17
85997|NCT01178125|327830|P1|Overall Study|Sponsor Decision|28
85998|NCT01178125|327830|P1|Overall Study|Other Reason|39
85999|NCT01178125|327830|P1|Overall Study|Pregnancy|55
86000|NCT01178125|327830|P1|Overall Study|Noncompliance|184
86001|NCT01178125|327830|P1|Overall Study|Withdrawal by Subject|209
86002|NCT01178125|327830|P1|Overall Study|Adverse Event|244
86003|NCT01178125|327830|P1|Overall Study|Lost to Follow-up|397
86004|NCT01178099|327861|P2|Overall Study|Physician Decision|1
86005|NCT01178099|327862|P1|Overall Study|Physician Decision|0
86006|NCT01178073|327903|P3|Overall Study|Missing Completion Status|0
86007|NCT01178073|327904|P2|Overall Study|Missing Completion Status|0
86008|NCT01178073|327905|P1|Overall Study|Missing Completion Status|1
86009|NCT01178073|327903|P3|Overall Study|Withdrawal by Subject|8
86010|NCT01178073|327904|P2|Overall Study|Withdrawal by Subject|6
86011|NCT01178073|327905|P1|Overall Study|Withdrawal by Subject|10
86012|NCT01178073|327903|P3|Overall Study|Physician Decision|10
86013|NCT01178073|327904|P2|Overall Study|Physician Decision|10
86014|NCT01178073|327905|P1|Overall Study|Physician Decision|14
86015|NCT01178073|327903|P3|Overall Study|Lost to Follow-up|3
86016|NCT01178073|327904|P2|Overall Study|Lost to Follow-up|0
86017|NCT01178073|327905|P1|Overall Study|Lost to Follow-up|2
86018|NCT01178073|327903|P3|Overall Study|Protocol Violation|1
86019|NCT01178073|327904|P2|Overall Study|Protocol Violation|1
86020|NCT01178073|327905|P1|Overall Study|Protocol Violation|1
86021|NCT01178073|327903|P3|Overall Study|Adverse Event|24
86022|NCT01178073|327904|P2|Overall Study|Adverse Event|27
86023|NCT01178073|327905|P1|Overall Study|Adverse Event|34
86024|NCT01177969|327936|P2|Overall Study|Withdrawal by Subject|2
86025|NCT01177969|327937|P1|Overall Study|Withdrawal by Subject|1
86026|NCT01177969|327936|P2|Overall Study|Protocol Violation|1
86027|NCT01177969|327937|P1|Overall Study|Protocol Violation|2
86028|NCT01177943|327960|P2|First Intervention|Withdrawal by Subject|0
86029|NCT01177943|327961|P1|First Intervention|Withdrawal by Subject|2
86030|NCT01177813|327974|P5|Overall Study|Other reason not defined above|2
86031|NCT01177813|327975|P4|Overall Study|Other reason not defined above|3
86032|NCT01177813|327976|P3|Overall Study|Other reason not defined above|2
86033|NCT01177813|327977|P2|Overall Study|Other reason not defined above|2
86034|NCT01177813|327978|P1|Overall Study|Other reason not defined above|5
86035|NCT01177813|327974|P5|Overall Study|Withdrawal by Subject|3
86036|NCT01177813|327975|P4|Overall Study|Withdrawal by Subject|5
86037|NCT01177813|327976|P3|Overall Study|Withdrawal by Subject|6
86038|NCT01177813|327977|P2|Overall Study|Withdrawal by Subject|7
86039|NCT01177813|327978|P1|Overall Study|Withdrawal by Subject|12
86040|NCT01177813|327974|P5|Overall Study|Lost to Follow-up|0
86041|NCT01177813|327975|P4|Overall Study|Lost to Follow-up|3
86042|NCT01177813|327976|P3|Overall Study|Lost to Follow-up|6
86043|NCT01177813|327977|P2|Overall Study|Lost to Follow-up|5
86044|NCT01177813|327978|P1|Overall Study|Lost to Follow-up|12
86045|NCT01177813|327974|P5|Overall Study|Protocol Violation|1
86046|NCT01177813|327975|P4|Overall Study|Protocol Violation|0
86047|NCT01177813|327976|P3|Overall Study|Protocol Violation|2
86048|NCT01177813|327977|P2|Overall Study|Protocol Violation|2
86049|NCT01177813|327978|P1|Overall Study|Protocol Violation|3
86050|NCT01177813|327974|P5|Overall Study|Lack of Efficacy|0
86051|NCT01177813|327975|P4|Overall Study|Lack of Efficacy|0
86052|NCT01177813|327976|P3|Overall Study|Lack of Efficacy|0
86053|NCT01177813|327977|P2|Overall Study|Lack of Efficacy|0
86054|NCT01177813|327978|P1|Overall Study|Lack of Efficacy|1
86055|NCT01177813|327974|P5|Overall Study|Adverse Event|3
86056|NCT01177813|327975|P4|Overall Study|Adverse Event|6
86057|NCT01177813|327976|P3|Overall Study|Adverse Event|4
86058|NCT01177813|327977|P2|Overall Study|Adverse Event|2
86059|NCT01177813|327978|P1|Overall Study|Adverse Event|8
86060|NCT01177800|328007|P2|Overall Study|Withdrawal of informed consent|1
86061|NCT01177800|328008|P1|Overall Study|Withdrawal of informed consent|0
86062|NCT01177800|328007|P2|Overall Study|Physician Decision|0
86063|NCT01177800|328008|P1|Overall Study|Physician Decision|1
86064|NCT01177800|328007|P2|Overall Study|Protocol Violation|1
86065|NCT01177800|328008|P1|Overall Study|Protocol Violation|0
86066|NCT01177800|328007|P2|Overall Study|Adverse Event|3
86067|NCT01177800|328008|P1|Overall Study|Adverse Event|9
86068|NCT01177722|328030|P4|Overall Study|Withdrawal by Subject|6
86069|NCT01177722|328031|P3|Overall Study|Withdrawal by Subject|4
86070|NCT01177722|328032|P2|Overall Study|Withdrawal by Subject|6
86071|NCT01177722|328033|P1|Overall Study|Withdrawal by Subject|10
86072|NCT01177722|328030|P4|Overall Study|Lost to Follow-up|1
86073|NCT01177722|328031|P3|Overall Study|Lost to Follow-up|3
86074|NCT01177722|328032|P2|Overall Study|Lost to Follow-up|4
86075|NCT01177722|328033|P1|Overall Study|Lost to Follow-up|3
86076|NCT01177722|328030|P4|Overall Study|Protocol Violation|0
86077|NCT01177722|328031|P3|Overall Study|Protocol Violation|1
86078|NCT01177722|328032|P2|Overall Study|Protocol Violation|0
86079|NCT01177722|328033|P1|Overall Study|Protocol Violation|0
86080|NCT01177722|328030|P4|Overall Study|Serious Adverse Event|0
86081|NCT01177722|328031|P3|Overall Study|Serious Adverse Event|1
86082|NCT01177722|328032|P2|Overall Study|Serious Adverse Event|0
86083|NCT01177722|328033|P1|Overall Study|Serious Adverse Event|0
86084|NCT01177670|328065|P1|Overall Study|Withdrawal by Subject|4
86085|NCT01177670|328065|P1|Overall Study|Physician Decision|50
86086|NCT01177670|328065|P1|Overall Study|Study Terminated|115
86087|NCT01177553|328072|P2|Overall Study|babies not yet 6 months of age|0
86088|NCT01177553|328073|P1|Overall Study|babies not yet 6 months of age|1
86089|NCT01177410|328082|P3|Overall Study|Lost to Follow-up|0
86090|NCT01177410|328083|P2|Overall Study|Lost to Follow-up|1
86091|NCT01177410|328084|P1|Overall Study|Lost to Follow-up|0
86092|NCT01177410|328082|P3|Overall Study|Withdrawal by Subject|3
86093|NCT01177410|328083|P2|Overall Study|Withdrawal by Subject|4
86094|NCT01177410|328084|P1|Overall Study|Withdrawal by Subject|1
86095|NCT01177410|328082|P3|Overall Study|Adverse Event|2
86096|NCT01177410|328083|P2|Overall Study|Adverse Event|2
86097|NCT01177410|328084|P1|Overall Study|Adverse Event|0
86098|NCT01177384|328097|P2|Overall Study|Withdrawal by Subject|12
86099|NCT01177384|328098|P1|Overall Study|Withdrawal by Subject|5
86100|NCT01177384|328097|P2|Overall Study|Protocol Violation|2
86101|NCT01177384|328098|P1|Overall Study|Protocol Violation|0
86102|NCT01177384|328097|P2|Overall Study|Physician Decision|3
86103|NCT01177384|328098|P1|Overall Study|Physician Decision|0
86104|NCT01177384|328097|P2|Overall Study|Lost to Follow-up|4
86105|NCT01177384|328098|P1|Overall Study|Lost to Follow-up|3
86106|NCT01177384|328097|P2|Overall Study|Lack of Efficacy|1
86107|NCT01177384|328098|P1|Overall Study|Lack of Efficacy|0
86108|NCT01177384|328097|P2|Overall Study|Adverse Event|4
86109|NCT01177384|328098|P1|Overall Study|Adverse Event|6
86110|NCT01177293|328110|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
86111|NCT01177293|328111|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
86112|NCT01177228|328129|P4|Overall Study|Withdrawal by Subject|0
86113|NCT01177228|328130|P3|Overall Study|Withdrawal by Subject|0
86114|NCT01177228|328131|P2|Overall Study|Withdrawal by Subject|1
86115|NCT01177228|328132|P1|Overall Study|Withdrawal by Subject|0
86116|NCT01177228|328129|P4|Overall Study|Worsening disease activity|0
86117|NCT01177228|328130|P3|Overall Study|Worsening disease activity|0
86118|NCT01177228|328131|P2|Overall Study|Worsening disease activity|0
86119|NCT01177228|328132|P1|Overall Study|Worsening disease activity|1
86120|NCT01177228|328129|P4|Overall Study|Positive tuberculosis test|0
86121|NCT01177228|328130|P3|Overall Study|Positive tuberculosis test|0
86122|NCT01177228|328131|P2|Overall Study|Positive tuberculosis test|1
86123|NCT01177228|328132|P1|Overall Study|Positive tuberculosis test|0
86124|NCT01177007|328189|P1|Overall Study|Change in treatment modality|21
86125|NCT01177007|328189|P1|Overall Study|Required additional Y90 treatment|6
86126|NCT01177007|328189|P1|Overall Study|Entered hospice care|5
86127|NCT01177007|328189|P1|Overall Study|Death|4
86128|NCT01177007|328189|P1|Overall Study|Lost to Follow-up|2
86129|NCT01176968|328203|P2|Overall Study|Reason not defined|3
86130|NCT01176968|328204|P1|Overall Study|Reason not defined|5
86131|NCT01176968|328203|P2|Overall Study|Study terminated by sponsor|1
86132|NCT01176968|328204|P1|Overall Study|Study terminated by sponsor|0
86133|NCT01176968|328203|P2|Overall Study|Did Not Meet Entrance Criteria|0
86134|NCT01176968|328204|P1|Overall Study|Did Not Meet Entrance Criteria|1
86135|NCT01176968|328203|P2|Overall Study|Protocol Violation|1
86136|NCT01176968|328204|P1|Overall Study|Protocol Violation|2
86137|NCT01176968|328203|P2|Overall Study|Withdrawal by Subject|48
86138|NCT01176968|328204|P1|Overall Study|Withdrawal by Subject|48
86139|NCT01176968|328203|P2|Overall Study|Lost to Follow-up|14
86140|NCT01176968|328204|P1|Overall Study|Lost to Follow-up|16
86141|NCT01176968|328203|P2|Overall Study|Lack of Efficacy|1
86142|NCT01176968|328204|P1|Overall Study|Lack of Efficacy|0
86143|NCT01176968|328203|P2|Overall Study|Death|3
86144|NCT01176968|328204|P1|Overall Study|Death|2
86145|NCT01176968|328203|P2|Overall Study|Adverse Event|11
86146|NCT01176968|328204|P1|Overall Study|Adverse Event|10
86147|NCT01176773|328255|P1|Overall Study|Withdrew consent|1
86148|NCT01176773|328255|P1|Overall Study|Screen Failure|2
86149|NCT01176565|328279|P2|Overall Study|Not Analyzed (any other reason)|2
86150|NCT01176565|328280|P1|Overall Study|Not Analyzed (any other reason)|1
86151|NCT01176565|328279|P2|Overall Study|Withdrawal by Subject|1
86152|NCT01176565|328280|P1|Overall Study|Withdrawal by Subject|7
86153|NCT01176565|328279|P2|Overall Study|Lost to Follow-up|16
86154|NCT01176565|328280|P1|Overall Study|Lost to Follow-up|12
86155|NCT01176513|328298|P1|Overall Study|Withdrew subjects prior to dosing|3
86156|NCT01176292|328326|P2|Overall Study|Has not scheduled one-year visit yet|2
86157|NCT01176292|328327|P1|Overall Study|Has not scheduled one-year visit yet|2
86158|NCT01176292|328326|P2|Overall Study|Physician Decision|2
86159|NCT01176292|328327|P1|Overall Study|Physician Decision|0
86160|NCT01176292|328326|P2|Overall Study|Adverse Event|1
86161|NCT01176292|328327|P1|Overall Study|Adverse Event|1
86162|NCT01176292|328326|P2|Overall Study|Lost to Follow-up|4
86163|NCT01176292|328327|P1|Overall Study|Lost to Follow-up|2
86164|NCT01176266|328345|P1|Overall Study|Withdrawal by Subject|3
86165|NCT01176266|328345|P1|Overall Study|Death|6
86166|NCT01176240|328369|P2|Study 306B|withdrew prior to dosing|1
86167|NCT01176240|328370|P1|Study 306B|withdrew prior to dosing|2
86168|NCT01176240|328369|P2|Study 306B|Lost to Follow-up|1
86169|NCT01176240|328370|P1|Study 306B|Lost to Follow-up|0
86170|NCT01176240|328369|P2|Study 306B|Supine Hypertension|2
86171|NCT01176240|328370|P1|Study 306B|Supine Hypertension|1
86172|NCT01176240|328369|P2|Study 306B|Physician Decision|1
86173|NCT01176240|328370|P1|Study 306B|Physician Decision|2
86174|NCT01176240|328369|P2|Study 306B|Withdrawal by Subject|1
86175|NCT01176240|328370|P1|Study 306B|Withdrawal by Subject|4
86176|NCT01176240|328369|P2|Study 306B|Protocol Violation|3
86177|NCT01176240|328370|P1|Study 306B|Protocol Violation|2
86178|NCT01176240|328369|P2|Study 306B|Adverse Event|5
86179|NCT01176240|328370|P1|Study 306B|Adverse Event|10
86180|NCT01176240|328369|P2|Study 306B|Lack of Efficacy|3
86181|NCT01176240|328370|P1|Study 306B|Lack of Efficacy|5
86182|NCT01176240|328369|P2|Study 306A|Stop due to diverse problems|0
86183|NCT01176240|328370|P1|Study 306A|Stop due to diverse problems|1
86184|NCT01176240|328369|P2|Study 306A|Withdrawal by Subject|1
86185|NCT01176240|328370|P1|Study 306A|Withdrawal by Subject|0
86186|NCT01176240|328369|P2|Study 306A|Protocol Violation|1
86187|NCT01176240|328370|P1|Study 306A|Protocol Violation|0
86188|NCT01176240|328369|P2|Study 306A|Lack of Efficacy|1
86189|NCT01176240|328370|P1|Study 306A|Lack of Efficacy|2
86190|NCT01176058|328396|P2|Overall Study|Withdrawal by Subject|0
86191|NCT01176058|328397|P1|Overall Study|Withdrawal by Subject|1
86192|NCT01176058|328396|P2|Overall Study|Insufficient mycological response|1
86193|NCT01176058|328397|P1|Overall Study|Insufficient mycological response|0
86194|NCT01176058|328396|P2|Overall Study|Insufficient clinical response|2
86195|NCT01176058|328397|P1|Overall Study|Insufficient clinical response|2
86196|NCT01176058|328396|P2|Overall Study|Adverse Event|0
86197|NCT01176058|328397|P1|Overall Study|Adverse Event|1
86198|NCT01176032|328421|P2|Overall Study|Not available|0
86199|NCT01176032|328422|P1|Overall Study|Not available|1
86200|NCT01176032|328421|P2|Overall Study|Informed consent withdrawn|0
86201|NCT01176032|328422|P1|Overall Study|Informed consent withdrawn|3
86202|NCT01176032|328421|P2|Overall Study|Protocol Violation|0
86203|NCT01176032|328422|P1|Overall Study|Protocol Violation|1
86204|NCT01176032|328421|P2|Overall Study|Unsatisfactory therapeutic effect|1
86205|NCT01176032|328422|P1|Overall Study|Unsatisfactory therapeutic effect|0
86206|NCT01176032|328421|P2|Overall Study|Adverse Event|0
86207|NCT01176032|328422|P1|Overall Study|Adverse Event|1
86208|NCT01175824|328546|P2|Overall Study|Entry Criteria Not Met|4
86209|NCT01175824|328547|P1|Overall Study|Entry Criteria Not Met|6
86210|NCT01175824|328546|P2|Overall Study|Sponsor Decision|0
86211|NCT01175824|328547|P1|Overall Study|Sponsor Decision|1
86212|NCT01175824|328546|P2|Overall Study|Withdrawal by Subject|7
86213|NCT01175824|328547|P1|Overall Study|Withdrawal by Subject|3
86214|NCT01175824|328546|P2|Overall Study|Protocol Violation|5
86215|NCT01175824|328547|P1|Overall Study|Protocol Violation|2
86216|NCT01175824|328546|P2|Overall Study|Physician Decision|4
86217|NCT01175824|328547|P1|Overall Study|Physician Decision|0
86218|NCT01175824|328546|P2|Overall Study|Lost to Follow-up|1
86219|NCT01175824|328547|P1|Overall Study|Lost to Follow-up|0
86220|NCT01175824|328546|P2|Overall Study|Lack of Efficacy|0
86221|NCT01175824|328547|P1|Overall Study|Lack of Efficacy|2
86222|NCT01175824|328546|P2|Overall Study|Adverse Event|1
86223|NCT01175824|328547|P1|Overall Study|Adverse Event|2
86224|NCT01175811|328581|P2|Overall Study|Withdrawal by Subject|7
86225|NCT01175811|328582|P1|Overall Study|Withdrawal by Subject|6
86226|NCT01175811|328581|P2|Overall Study|Protocol Violation|2
86227|NCT01175811|328582|P1|Overall Study|Protocol Violation|1
86228|NCT01175811|328581|P2|Overall Study|Physician Decision|1
86229|NCT01175811|328582|P1|Overall Study|Physician Decision|1
86230|NCT01175811|328581|P2|Overall Study|Lost to Follow-up|2
86231|NCT01175811|328582|P1|Overall Study|Lost to Follow-up|3
86232|NCT01175811|328581|P2|Overall Study|Lack of Efficacy|0
86233|NCT01175811|328582|P1|Overall Study|Lack of Efficacy|1
86234|NCT01175811|328581|P2|Overall Study|Entry criteria not met|1
86235|NCT01175811|328582|P1|Overall Study|Entry criteria not met|3
86236|NCT01175811|328581|P2|Overall Study|Adverse Event|1
86237|NCT01175811|328582|P1|Overall Study|Adverse Event|1
86238|NCT01175707|328617|P2|Overall Study|Adverse Event|6
86239|NCT01175707|328618|P1|Overall Study|Adverse Event|4
86240|NCT01175668|328654|P2|Overall Study|Withdrawal by Subject|0
86241|NCT01175668|328655|P1|Overall Study|Withdrawal by Subject|2
86242|NCT01175590|328665|P2|Overall Study|Protocol Violation|1
86243|NCT01175590|328666|P1|Overall Study|Protocol Violation|0
86244|NCT01175590|328665|P2|Overall Study|Herpes Simplex Dermatitis|0
86245|NCT01175590|328666|P1|Overall Study|Herpes Simplex Dermatitis|1
86246|NCT01175590|328665|P2|Overall Study|Treated not as randomized|2
86247|NCT01175590|328666|P1|Overall Study|Treated not as randomized|3
86248|NCT01175590|328665|P2|Overall Study|Residual Bacterial Conjunctivitis|0
86249|NCT01175590|328666|P1|Overall Study|Residual Bacterial Conjunctivitis|1
86250|NCT01175590|328665|P2|Overall Study|Lack of Efficacy|1
86251|NCT01175590|328666|P1|Overall Study|Lack of Efficacy|1
86252|NCT01175590|328665|P2|Overall Study|Physician Decision|4
86253|NCT01175590|328666|P1|Overall Study|Physician Decision|1
86254|NCT01175590|328665|P2|Overall Study|Adverse Event|0
86255|NCT01175590|328666|P1|Overall Study|Adverse Event|4
86256|NCT01175590|328665|P2|Overall Study|Withdrawal by Subject|2
86257|NCT01175590|328666|P1|Overall Study|Withdrawal by Subject|0
86258|NCT01175590|328665|P2|Overall Study|Lost to Follow-up|0
86259|NCT01175590|328666|P1|Overall Study|Lost to Follow-up|1
86260|NCT01175473|328700|P2|Overall Study|Adverse Event|2
86261|NCT01175473|328701|P1|Overall Study|Adverse Event|2
86262|NCT01175382|328742|P3|Overall Study|Unable to tolerate study meds|1
86263|NCT01175382|328743|P2|Overall Study|Unable to tolerate study meds|1
86264|NCT01175382|328744|P1|Overall Study|Unable to tolerate study meds|0
86265|NCT01175382|328742|P3|Overall Study|Unwilling to follow protocol|0
86266|NCT01175382|328743|P2|Overall Study|Unwilling to follow protocol|1
86267|NCT01175382|328744|P1|Overall Study|Unwilling to follow protocol|0
86268|NCT01175382|328742|P3|Overall Study|Unable/unwilling to attend visits|2
86269|NCT01175382|328743|P2|Overall Study|Unable/unwilling to attend visits|1
86270|NCT01175382|328744|P1|Overall Study|Unable/unwilling to attend visits|3
86271|NCT01175382|328742|P3|Overall Study|No longer having problem|1
86272|NCT01175382|328743|P2|Overall Study|No longer having problem|0
86273|NCT01175382|328744|P1|Overall Study|No longer having problem|1
86274|NCT01175382|328742|P3|Overall Study|Withdrawal by Subject|1
86275|NCT01175382|328743|P2|Overall Study|Withdrawal by Subject|0
86276|NCT01175382|328744|P1|Overall Study|Withdrawal by Subject|0
86277|NCT01175382|328742|P3|Overall Study|Physician Decision|0
86278|NCT01175382|328743|P2|Overall Study|Physician Decision|1
86279|NCT01175382|328744|P1|Overall Study|Physician Decision|0
86280|NCT01175382|328742|P3|Overall Study|Lost to Follow-up|1
86281|NCT01175382|328743|P2|Overall Study|Lost to Follow-up|3
86282|NCT01175382|328744|P1|Overall Study|Lost to Follow-up|4
86283|NCT01175356|328830|P1|Overall Study|Initiation other tx prior to completion|9
86284|NCT01175356|328830|P1|Overall Study|Inadequate stem cell for transplant|1
86285|NCT01175356|328830|P1|Overall Study|On other COG study w/tumor tx intent|7
86286|NCT01175356|328830|P1|Overall Study|Pts MIBG non-avid after enrollment|2
86287|NCT01175356|328830|P1|Overall Study|Refusal by patient/parent/guardian|6
86288|NCT01175356|328830|P1|Overall Study|Treatment Slot Not Available|18
86289|NCT01175356|328830|P1|Overall Study|Ineligible|1
86290|NCT01175356|328830|P1|Overall Study|Physician Decision|23
86291|NCT01175356|328830|P1|Overall Study|Lost to Follow-up|1
86292|NCT01175356|328830|P1|Overall Study|Lack of Efficacy|12
86293|NCT01175356|328830|P1|Overall Study|Death|1
86294|NCT01175213|328870|P2|Safety Follow-up|Adverse Event|0
86295|NCT01175213|328871|P1|Safety Follow-up|Adverse Event|1
86296|NCT01175213|328870|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
86297|NCT01175213|328871|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
86298|NCT01175213|328870|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
86299|NCT01175213|328871|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
86300|NCT01175213|328870|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
86301|NCT01175213|328871|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
86302|NCT01175213|328870|P2|IGSC, 10%/rHuPH20|Death|0
86303|NCT01175213|328871|P1|IGSC, 10%/rHuPH20|Death|1
86304|NCT01175213|328870|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
86305|NCT01175213|328871|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
86306|NCT01175135|328928|P4|Overall Study|Randomized But Not Treated|0
86307|NCT01175135|328929|P3|Overall Study|Randomized But Not Treated|1
86308|NCT01175135|328930|P2|Overall Study|Randomized But Not Treated|0
86309|NCT01175135|328931|P1|Overall Study|Randomized But Not Treated|0
86310|NCT01175135|328928|P4|Overall Study|Other|0
86311|NCT01175135|328929|P3|Overall Study|Other|3
86312|NCT01175135|328930|P2|Overall Study|Other|1
86313|NCT01175135|328931|P1|Overall Study|Other|3
86314|NCT01175135|328928|P4|Overall Study|Withdrawal by Subject|5
86315|NCT01175135|328929|P3|Overall Study|Withdrawal by Subject|5
86316|NCT01175135|328930|P2|Overall Study|Withdrawal by Subject|8
86317|NCT01175135|328931|P1|Overall Study|Withdrawal by Subject|4
86318|NCT01175135|328928|P4|Overall Study|Protocol Violation|0
86319|NCT01175135|328929|P3|Overall Study|Protocol Violation|0
86320|NCT01175135|328930|P2|Overall Study|Protocol Violation|1
86321|NCT01175135|328931|P1|Overall Study|Protocol Violation|1
86322|NCT01175135|328928|P4|Overall Study|Lost to Follow-up|0
86323|NCT01175135|328929|P3|Overall Study|Lost to Follow-up|0
86324|NCT01175135|328930|P2|Overall Study|Lost to Follow-up|2
86325|NCT01175135|328931|P1|Overall Study|Lost to Follow-up|1
86326|NCT01175135|328928|P4|Overall Study|Lack of Efficacy|5
86327|NCT01175135|328929|P3|Overall Study|Lack of Efficacy|0
86328|NCT01175135|328930|P2|Overall Study|Lack of Efficacy|5
86329|NCT01175135|328931|P1|Overall Study|Lack of Efficacy|4
86330|NCT01175135|328928|P4|Overall Study|Death|0
86331|NCT01175135|328929|P3|Overall Study|Death|0
86332|NCT01175135|328930|P2|Overall Study|Death|0
86333|NCT01175135|328931|P1|Overall Study|Death|1
86334|NCT01175135|328928|P4|Overall Study|Adverse Event|4
86335|NCT01175135|328929|P3|Overall Study|Adverse Event|3
86336|NCT01175135|328930|P2|Overall Study|Adverse Event|5
86337|NCT01175135|328931|P1|Overall Study|Adverse Event|2
86338|NCT01175018|329023|P2|Overall Study|Adverse Event|1
86339|NCT01175018|329024|P1|Overall Study|Adverse Event|3
86340|NCT01174550|329113|P2|Overall Study|Withdrawal by Subject|289
86341|NCT01174550|329114|P1|Overall Study|Withdrawal by Subject|543
86342|NCT01174550|329113|P2|Overall Study|Lost to Follow-up|510
86343|NCT01174550|329114|P1|Overall Study|Lost to Follow-up|652
86344|NCT01174550|329113|P2|Overall Study|Death|74
86345|NCT01174550|329114|P1|Overall Study|Death|75
86346|NCT01174459|329142|P1|Overall Study|case report form (CRF) not collected|5
86347|NCT01174446|329147|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
86348|NCT01174446|329148|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
86349|NCT01174446|329149|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
86350|NCT01174446|329150|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
86351|NCT01174446|329147|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
86352|NCT01174446|329148|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
86353|NCT01174446|329149|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
86354|NCT01174446|329150|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
86355|NCT01174446|329147|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
86356|NCT01174446|329148|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
86357|NCT01174446|329149|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
86358|NCT01174446|329150|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
86359|NCT01174446|329147|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
86360|NCT01174446|329148|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
86361|NCT01174446|329149|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
86362|NCT01174446|329150|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
86363|NCT01174342|329337|P1|Overall Study|Conversion to cesarean section|4
86364|NCT01174264|329344|P3|Steady-state Pharmacokinetics|Not evaluable|2
86365|NCT01174264|329345|P2|Steady-state Pharmacokinetics|Not evaluable|0
86366|NCT01174264|329346|P1|Steady-state Pharmacokinetics|Not evaluable|6
86367|NCT01174264|329344|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
86368|NCT01174264|329345|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
86369|NCT01174264|329346|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
86370|NCT01174264|329344|P3|Single Dose Pharmacokinetics|Early progressive disease|1
86371|NCT01174264|329345|P2|Single Dose Pharmacokinetics|Early progressive disease|0
86372|NCT01174264|329346|P1|Single Dose Pharmacokinetics|Early progressive disease|1
86373|NCT01174186|329380|P2|Overall Study|Withdrawal by Subject|2
86374|NCT01174186|329381|P1|Overall Study|Withdrawal by Subject|0
86375|NCT01174186|329380|P2|Overall Study|Lost to Follow-up|1
86376|NCT01174186|329381|P1|Overall Study|Lost to Follow-up|0
86377|NCT01174173|329388|P1|Overall Study|drug-drug interaction|1
86378|NCT01174160|329399|P2|Overall Study|Withdrawal by Subject|0
86379|NCT01174160|329400|P1|Overall Study|Withdrawal by Subject|1
86380|NCT01174160|329399|P2|Overall Study|Protocol Violation|6
86381|NCT01174160|329400|P1|Overall Study|Protocol Violation|4
86382|NCT01174160|329399|P2|Overall Study|Physician Decision|0
86383|NCT01174160|329400|P1|Overall Study|Physician Decision|1
86384|NCT01174160|329399|P2|Overall Study|Lost to Follow-up|0
86385|NCT01174160|329400|P1|Overall Study|Lost to Follow-up|1
86386|NCT01174160|329399|P2|Overall Study|Adverse Event|0
86387|NCT01174160|329400|P1|Overall Study|Adverse Event|1
86388|NCT01174043|329406|P1|Overall Study|Withdrawal by Subject|2
86389|NCT01174043|329406|P1|Overall Study|Death|1
86390|NCT01174043|329406|P1|Overall Study|Adverse Event|3
86391|NCT01174043|329406|P1|Overall Study|Disease progression|5
86392|NCT01174004|329445|P2|Overall Study|Physician Decision|0
86393|NCT01174004|329446|P1|Overall Study|Physician Decision|1
86394|NCT01174004|329445|P2|Overall Study|Protocol Violation|1
86395|NCT01174004|329446|P1|Overall Study|Protocol Violation|0
86396|NCT01174004|329445|P2|Overall Study|At Discretion of Sponsor|2
86397|NCT01174004|329446|P1|Overall Study|At Discretion of Sponsor|2
86398|NCT01174004|329445|P2|Overall Study|Withdrawal by Subject|3
86399|NCT01174004|329446|P1|Overall Study|Withdrawal by Subject|2
86400|NCT01174004|329445|P2|Overall Study|Adverse Event|10
86401|NCT01174004|329446|P1|Overall Study|Adverse Event|2
86402|NCT01173718|329477|P1|Overall Study|Abandonment of study graft|27
86403|NCT01173718|329477|P1|Overall Study|Death|17
86404|NCT01173679|329486|P1|Overall Study|Death|1
86405|NCT01173653|329494|P2|Overall Study|Pts unwilling to provide follow-up|41
86406|NCT01173653|329495|P1|Overall Study|Pts unwilling to provide follow-up|53
86407|NCT01173601|329505|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
86408|NCT01173601|329506|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
86409|NCT01173601|329507|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
86410|NCT01173601|329508|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
86411|NCT01173601|329509|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
86412|NCT01173601|329505|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
86413|NCT01173601|329506|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
86414|NCT01173601|329507|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
86415|NCT01173601|329508|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
86416|NCT01173601|329509|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
86417|NCT01173601|329505|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
86418|NCT01173601|329506|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
86419|NCT01173601|329507|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
86420|NCT01173601|329508|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
86421|NCT01173601|329509|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
86422|NCT01173601|329505|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
86423|NCT01173601|329506|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
86424|NCT01173601|329507|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
86425|NCT01173601|329508|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
86426|NCT01173601|329509|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
86427|NCT01173601|329505|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
86428|NCT01173601|329506|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
86429|NCT01173601|329507|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
86430|NCT01173601|329508|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
86431|NCT01173601|329509|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
86432|NCT01173601|329505|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
86433|NCT01173601|329506|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
86434|NCT01173601|329507|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
86435|NCT01173601|329508|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
86436|NCT01173601|329509|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
86437|NCT01173601|329505|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
86438|NCT01173601|329506|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
86439|NCT01173601|329507|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
86440|NCT01173601|329508|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
86441|NCT01173601|329509|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
86442|NCT01173601|329505|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
86443|NCT01173601|329506|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
86444|NCT01173601|329507|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
86445|NCT01173601|329508|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
86446|NCT01173601|329509|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
86447|NCT01173601|329505|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
86448|NCT01173601|329506|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
86449|NCT01173601|329507|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
86450|NCT01173601|329508|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
86451|NCT01173601|329509|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
86452|NCT01173601|329505|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
86453|NCT01173601|329506|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
86454|NCT01173601|329507|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
86455|NCT01173601|329508|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
86456|NCT01173601|329509|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
86457|NCT01173601|329505|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
86458|NCT01173601|329506|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
86459|NCT01173601|329507|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
86460|NCT01173601|329508|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
86461|NCT01173601|329509|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
86462|NCT01173601|329505|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
86463|NCT01173601|329506|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
86464|NCT01173601|329507|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
86465|NCT01173601|329508|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
86466|NCT01173601|329509|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
86467|NCT01173601|329505|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
86468|NCT01173601|329506|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
86469|NCT01173601|329507|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
86470|NCT01173601|329508|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
86471|NCT01173601|329509|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
86472|NCT01173601|329505|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
86473|NCT01173601|329506|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
86474|NCT01173601|329507|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
86475|NCT01173601|329508|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
86476|NCT01173601|329509|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
86477|NCT01173523|329586|P2|Overall Study|Other|3
86478|NCT01173523|329587|P1|Overall Study|Other|2
86479|NCT01173523|329586|P2|Overall Study|Progressive Disease|8
86480|NCT01173523|329587|P1|Overall Study|Progressive Disease|10
86481|NCT01173523|329586|P2|Overall Study|Clinical Progression|1
86482|NCT01173523|329587|P1|Overall Study|Clinical Progression|1
86483|NCT01173471|329603|P4|Overall Study|Reason given as Other|0
86484|NCT01173471|329604|P3|Overall Study|Reason given as Other|1
86485|NCT01173471|329605|P2|Overall Study|Reason given as Other|0
86486|NCT01173471|329606|P1|Overall Study|Reason given as Other|0
86487|NCT01173471|329603|P4|Overall Study|Lost to Follow-up|0
86488|NCT01173471|329604|P3|Overall Study|Lost to Follow-up|1
86489|NCT01173471|329605|P2|Overall Study|Lost to Follow-up|0
86490|NCT01173471|329606|P1|Overall Study|Lost to Follow-up|0
86491|NCT01173471|329603|P4|Overall Study|Condition under investigation worsened|0
86492|NCT01173471|329604|P3|Overall Study|Condition under investigation worsened|0
86493|NCT01173471|329605|P2|Overall Study|Condition under investigation worsened|0
86494|NCT01173471|329606|P1|Overall Study|Condition under investigation worsened|2
86495|NCT01173471|329603|P4|Overall Study|Eligibility criteria not fulfilled|1
86496|NCT01173471|329604|P3|Overall Study|Eligibility criteria not fulfilled|1
86497|NCT01173471|329605|P2|Overall Study|Eligibility criteria not fulfilled|0
86498|NCT01173471|329606|P1|Overall Study|Eligibility criteria not fulfilled|0
86499|NCT01173120|329736|P1|Overall Study|Switch-Difficulty With Device|12
86500|NCT01173120|329736|P1|Overall Study|Switch-Participant Decision|12
86501|NCT01173120|329736|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
86502|NCT01173120|329736|P1|Overall Study|Participant Decision|2
86503|NCT01173120|329736|P1|Overall Study|Lost to Follow-up|1
86504|NCT01173120|329736|P1|Overall Study|Lack of Efficacy|2
86505|NCT01173055|329754|P2|Period 2 - Day 64 to 112|Adverse Event|1
86506|NCT01173055|329755|P1|Period 2 - Day 64 to 112|Adverse Event|0
86507|NCT01173055|329754|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
86508|NCT01173055|329755|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
86509|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
86510|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
86511|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
86512|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
86513|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
86514|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
86515|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
86516|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
86517|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
86518|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
86519|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
86520|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
86521|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
86522|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
86523|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
86524|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
86525|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
86526|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
86527|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
86528|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
86529|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
86530|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
86531|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
86532|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
86533|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
86534|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
86535|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
86536|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
86537|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
86538|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
86539|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
86540|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
86541|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
86542|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
86543|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
86544|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
86545|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
86546|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
86547|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
86548|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
86549|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
86550|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
86551|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
86552|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
86553|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
86554|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
86555|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
86556|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
86557|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
86558|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
86559|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
86560|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
86561|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
86562|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
86563|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
86564|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
86565|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
86566|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
86567|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
86568|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
86569|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
86570|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
86571|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
86572|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
86573|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
86574|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
86575|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
86576|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
86577|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
86578|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
86579|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
86580|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
86581|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
86582|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
86583|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
86584|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
86585|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
86586|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
86587|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
86588|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
86589|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
86590|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
86591|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
86592|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
86593|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
86594|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
86595|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
86596|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
86597|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
86598|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
86599|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
86600|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
86601|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
86602|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
86603|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
86604|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
86605|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
86606|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
86607|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
86608|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
86609|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
86610|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
86611|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
86612|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
86613|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
86614|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
86615|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
86616|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
86617|NCT01172938|329794|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
86618|NCT01172938|329795|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
86619|NCT01172938|329796|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
86620|NCT01172938|329797|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
86621|NCT01172938|329798|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
86622|NCT01172938|329799|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
86623|NCT01172938|329800|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
86624|NCT01172938|329801|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
86625|NCT01172938|329802|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
86626|NCT01172938|329794|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
86627|NCT01172938|329795|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
86628|NCT01172938|329796|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
86629|NCT01172938|329797|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
86630|NCT01172938|329798|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
86631|NCT01172938|329799|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
86632|NCT01172938|329800|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
86633|NCT01172938|329801|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
86634|NCT01172938|329802|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
86635|NCT01172938|329794|P9|Active-Treatment Phase Weeks (104-156)|Death|0
86636|NCT01172938|329795|P8|Active-Treatment Phase Weeks (104-156)|Death|1
86637|NCT01172938|329796|P7|Active-Treatment Phase Weeks (104-156)|Death|0
86638|NCT01172938|329797|P6|Active-Treatment Phase Weeks (104-156)|Death|0
86639|NCT01172938|329798|P5|Active-Treatment Phase Weeks (104-156)|Death|0
86640|NCT01172938|329799|P4|Active-Treatment Phase Weeks (104-156)|Death|0
86641|NCT01172938|329800|P3|Active-Treatment Phase Weeks (104-156)|Death|0
86642|NCT01172938|329801|P2|Active-Treatment Phase Weeks (104-156)|Death|0
86643|NCT01172938|329802|P1|Active-Treatment Phase Weeks (104-156)|Death|0
86644|NCT01172938|329794|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
86645|NCT01172938|329795|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
86646|NCT01172938|329796|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
86647|NCT01172938|329797|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
86648|NCT01172938|329798|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
86649|NCT01172938|329799|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
86650|NCT01172938|329800|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
86651|NCT01172938|329801|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
86652|NCT01172938|329802|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
86653|NCT01172938|329794|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
86654|NCT01172938|329795|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
86655|NCT01172938|329796|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
86656|NCT01172938|329797|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
86657|NCT01172938|329798|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
86658|NCT01172938|329799|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
86659|NCT01172938|329800|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
86660|NCT01172938|329801|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
86661|NCT01172938|329802|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
86662|NCT01172938|329794|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
86663|NCT01172938|329795|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
86664|NCT01172938|329796|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
86665|NCT01172938|329797|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
86666|NCT01172938|329798|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
86667|NCT01172938|329799|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
86668|NCT01172938|329800|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
86669|NCT01172938|329801|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
86670|NCT01172938|329802|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
86671|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
86672|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
86673|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
86674|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
86675|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
86676|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
86677|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
86678|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
86679|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
86680|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
86681|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
86682|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
86683|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
86684|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
86685|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
86686|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
86687|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
86688|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
86689|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
86690|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
86691|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
86692|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
86693|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
86694|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
86695|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
86696|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
86697|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
86698|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
86699|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
86700|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
86701|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
86702|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
86703|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
86704|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
86705|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
86706|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
86707|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
86708|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
86709|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
86710|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
86711|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
86712|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
86713|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
86714|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
86715|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
86716|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
86717|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
86718|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
86719|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
86720|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
86721|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
86722|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
86723|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
86724|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
86725|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
86726|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
86727|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
86728|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
86729|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
86730|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
86731|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
86732|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
86733|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
86734|NCT01172938|329794|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
86735|NCT01172938|329795|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
86736|NCT01172938|329796|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
86737|NCT01172938|329797|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
86738|NCT01172938|329798|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
86739|NCT01172938|329799|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
86740|NCT01172938|329800|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
86741|NCT01172938|329801|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
86742|NCT01172938|329802|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
86743|NCT01172938|329794|P9|Active Treatment Phase (Weeks 25-52)|Not specified|0
86744|NCT01172938|329795|P8|Active Treatment Phase (Weeks 25-52)|Not specified|0
86745|NCT01172938|329796|P7|Active Treatment Phase (Weeks 25-52)|Not specified|1
86746|NCT01172938|329797|P6|Active Treatment Phase (Weeks 25-52)|Not specified|1
86747|NCT01172938|329798|P5|Active Treatment Phase (Weeks 25-52)|Not specified|0
86748|NCT01172938|329799|P4|Active Treatment Phase (Weeks 25-52)|Not specified|0
86749|NCT01172938|329800|P3|Active Treatment Phase (Weeks 25-52)|Not specified|0
86750|NCT01172938|329801|P2|Active Treatment Phase (Weeks 25-52)|Not specified|0
86751|NCT01172938|329802|P1|Active Treatment Phase (Weeks 25-52)|Not specified|0
86752|NCT01172938|329794|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
86753|NCT01172938|329795|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
86754|NCT01172938|329796|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
86755|NCT01172938|329797|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
86756|NCT01172938|329798|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
86757|NCT01172938|329799|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
86758|NCT01172938|329800|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
86759|NCT01172938|329801|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
86760|NCT01172938|329802|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
86761|NCT01172938|329794|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
86762|NCT01172938|329795|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
86763|NCT01172938|329796|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
86764|NCT01172938|329797|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
86765|NCT01172938|329798|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
86766|NCT01172938|329799|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
86767|NCT01172938|329800|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
86768|NCT01172938|329801|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
86769|NCT01172938|329802|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
86770|NCT01172938|329794|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
86771|NCT01172938|329795|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
86772|NCT01172938|329796|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
86773|NCT01172938|329797|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
86774|NCT01172938|329798|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
86775|NCT01172938|329799|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
86776|NCT01172938|329800|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
86777|NCT01172938|329801|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
86778|NCT01172938|329802|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
86779|NCT01172938|329794|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
86780|NCT01172938|329795|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
86781|NCT01172938|329796|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
86782|NCT01172938|329797|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
86783|NCT01172938|329798|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
86784|NCT01172938|329799|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
86785|NCT01172938|329800|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
86786|NCT01172938|329801|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
86787|NCT01172938|329802|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
86788|NCT01172938|329794|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
86789|NCT01172938|329795|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
86790|NCT01172938|329796|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
86791|NCT01172938|329797|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
86792|NCT01172938|329798|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
86793|NCT01172938|329799|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
86794|NCT01172938|329800|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
86795|NCT01172938|329801|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
86796|NCT01172938|329802|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
86797|NCT01172938|329794|P9|Placebo-controlled Phase (Week 0-24)|Not specified|0
86798|NCT01172938|329795|P8|Placebo-controlled Phase (Week 0-24)|Not specified|0
86799|NCT01172938|329796|P7|Placebo-controlled Phase (Week 0-24)|Not specified|0
86800|NCT01172938|329797|P6|Placebo-controlled Phase (Week 0-24)|Not specified|0
86801|NCT01172938|329798|P5|Placebo-controlled Phase (Week 0-24)|Not specified|0
86802|NCT01172938|329799|P4|Placebo-controlled Phase (Week 0-24)|Not specified|0
86803|NCT01172938|329800|P3|Placebo-controlled Phase (Week 0-24)|Not specified|1
86804|NCT01172938|329801|P2|Placebo-controlled Phase (Week 0-24)|Not specified|2
86805|NCT01172938|329802|P1|Placebo-controlled Phase (Week 0-24)|Not specified|0
86806|NCT01172938|329794|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
86807|NCT01172938|329795|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
86808|NCT01172938|329796|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
86809|NCT01172938|329797|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
86810|NCT01172938|329798|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
86811|NCT01172938|329799|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
86812|NCT01172938|329800|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
86813|NCT01172938|329801|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
86814|NCT01172938|329802|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
86815|NCT01172938|329794|P9|Placebo-controlled Phase (Week 0-24)|Death|0
86816|NCT01172938|329795|P8|Placebo-controlled Phase (Week 0-24)|Death|0
86817|NCT01172938|329796|P7|Placebo-controlled Phase (Week 0-24)|Death|0
86818|NCT01172938|329797|P6|Placebo-controlled Phase (Week 0-24)|Death|0
86819|NCT01172938|329798|P5|Placebo-controlled Phase (Week 0-24)|Death|0
86820|NCT01172938|329799|P4|Placebo-controlled Phase (Week 0-24)|Death|0
86821|NCT01172938|329800|P3|Placebo-controlled Phase (Week 0-24)|Death|0
86822|NCT01172938|329801|P2|Placebo-controlled Phase (Week 0-24)|Death|1
86823|NCT01172938|329802|P1|Placebo-controlled Phase (Week 0-24)|Death|0
86824|NCT01172938|329794|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
86825|NCT01172938|329795|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
86826|NCT01172938|329796|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
86827|NCT01172938|329797|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
86828|NCT01172938|329798|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
86829|NCT01172938|329799|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
86830|NCT01172938|329800|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
86831|NCT01172938|329801|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
86832|NCT01172938|329802|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
86833|NCT01172938|329794|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
86834|NCT01172938|329795|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
86835|NCT01172938|329796|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
86836|NCT01172938|329797|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
86837|NCT01172938|329798|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
86838|NCT01172938|329799|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
86839|NCT01172938|329800|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
86840|NCT01172938|329801|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
86841|NCT01172938|329802|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
86842|NCT01172938|329794|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
86843|NCT01172938|329795|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
86844|NCT01172938|329796|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
86845|NCT01172938|329797|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
86846|NCT01172938|329798|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
86847|NCT01172938|329799|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
86848|NCT01172938|329800|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
86849|NCT01172938|329801|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
86850|NCT01172938|329802|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
86851|NCT01172938|329794|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
86852|NCT01172938|329795|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
86853|NCT01172938|329796|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
86854|NCT01172938|329797|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
86855|NCT01172938|329798|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
86856|NCT01172938|329799|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
86857|NCT01172938|329800|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
86858|NCT01172938|329801|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
86859|NCT01172938|329802|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
86860|NCT01172873|329988|P2|Overall Study|Withdrawal by Subject|2
86861|NCT01172873|329989|P1|Overall Study|Withdrawal by Subject|3
86862|NCT01172847|329999|P1|Overall Study|Withdrawal by Subject|3
86863|NCT01172821|330028|P4|Overall Study|Other|3
86864|NCT01172821|330029|P3|Overall Study|Other|5
86865|NCT01172821|330030|P2|Overall Study|Other|4
86866|NCT01172821|330031|P1|Overall Study|Other|3
86867|NCT01172821|330028|P4|Overall Study|Withdrawal by Subject|3
86868|NCT01172821|330029|P3|Overall Study|Withdrawal by Subject|3
86869|NCT01172821|330030|P2|Overall Study|Withdrawal by Subject|3
86870|NCT01172821|330031|P1|Overall Study|Withdrawal by Subject|2
86871|NCT01172821|330028|P4|Overall Study|Lost to Follow-up|2
86872|NCT01172821|330029|P3|Overall Study|Lost to Follow-up|2
86873|NCT01172821|330030|P2|Overall Study|Lost to Follow-up|1
86874|NCT01172821|330031|P1|Overall Study|Lost to Follow-up|4
86875|NCT01172821|330028|P4|Overall Study|Protocol Violation|2
86876|NCT01172821|330029|P3|Overall Study|Protocol Violation|1
86877|NCT01172821|330030|P2|Overall Study|Protocol Violation|2
86878|NCT01172821|330031|P1|Overall Study|Protocol Violation|0
86879|NCT01172821|330028|P4|Overall Study|Adverse Event|7
86880|NCT01172821|330029|P3|Overall Study|Adverse Event|2
86881|NCT01172821|330030|P2|Overall Study|Adverse Event|2
86882|NCT01172821|330031|P1|Overall Study|Adverse Event|5
86883|NCT01172808|330121|P4|Overall Study|Other|7
86884|NCT01172808|330122|P3|Overall Study|Other|9
86885|NCT01172808|330123|P2|Overall Study|Other|5
86886|NCT01172808|330124|P1|Overall Study|Other|6
86887|NCT01172808|330121|P4|Overall Study|Withdrawal by Subject|2
86888|NCT01172808|330122|P3|Overall Study|Withdrawal by Subject|3
86889|NCT01172808|330123|P2|Overall Study|Withdrawal by Subject|1
86890|NCT01172808|330124|P1|Overall Study|Withdrawal by Subject|4
86891|NCT01172808|330121|P4|Overall Study|Lost to Follow-up|3
86892|NCT01172808|330122|P3|Overall Study|Lost to Follow-up|1
86893|NCT01172808|330123|P2|Overall Study|Lost to Follow-up|1
86894|NCT01172808|330124|P1|Overall Study|Lost to Follow-up|0
86895|NCT01172808|330121|P4|Overall Study|Protocol Violation|0
86896|NCT01172808|330122|P3|Overall Study|Protocol Violation|2
86897|NCT01172808|330123|P2|Overall Study|Protocol Violation|2
86898|NCT01172808|330124|P1|Overall Study|Protocol Violation|2
86899|NCT01172808|330121|P4|Overall Study|Lack of Efficacy|0
86900|NCT01172808|330122|P3|Overall Study|Lack of Efficacy|0
86901|NCT01172808|330123|P2|Overall Study|Lack of Efficacy|0
86902|NCT01172808|330124|P1|Overall Study|Lack of Efficacy|1
86903|NCT01172808|330121|P4|Overall Study|Adverse Event|3
86904|NCT01172808|330122|P3|Overall Study|Adverse Event|8
86905|NCT01172808|330123|P2|Overall Study|Adverse Event|4
86906|NCT01172808|330124|P1|Overall Study|Adverse Event|8
86907|NCT01172535|330243|P1|Overall Study|Unwilling to adhere to study requirement|1
86908|NCT01172535|330243|P1|Overall Study|Ineligible at study entry|1
86909|NCT01172535|330243|P1|Overall Study|Lost to Follow-up|1
86910|NCT01172535|330243|P1|Overall Study|Withdrawal by Subject|2
86911|NCT01172535|330243|P1|Overall Study|Death|3
86912|NCT01172288|330296|P2|Overall Study|Protocol Violation|1
86913|NCT01172288|330297|P1|Overall Study|Protocol Violation|0
86914|NCT01172288|330296|P2|Overall Study|Adverse Event|0
86915|NCT01172288|330297|P1|Overall Study|Adverse Event|1
86916|NCT01171989|330352|P3|Overall Study|Lost to Follow-up|1
86917|NCT01171989|330353|P2|Overall Study|Lost to Follow-up|0
86918|NCT01171989|330354|P1|Overall Study|Lost to Follow-up|0
86919|NCT01171976|330428|P3|Overall Study|Adverse Event|5
86920|NCT01171976|330429|P2|Overall Study|Adverse Event|2
86921|NCT01171976|330430|P1|Overall Study|Adverse Event|6
86922|NCT01171976|330428|P3|Overall Study|Abnormal test result|0
86923|NCT01171976|330429|P2|Overall Study|Abnormal test result|0
86924|NCT01171976|330430|P1|Overall Study|Abnormal test result|1
86925|NCT01171976|330428|P3|Overall Study|Withdrawal by Subject|6
86926|NCT01171976|330429|P2|Overall Study|Withdrawal by Subject|5
86927|NCT01171976|330430|P1|Overall Study|Withdrawal by Subject|1
86928|NCT01171976|330428|P3|Overall Study|Lost to Follow-up|2
86929|NCT01171976|330429|P2|Overall Study|Lost to Follow-up|0
86930|NCT01171976|330430|P1|Overall Study|Lost to Follow-up|4
86931|NCT01171976|330428|P3|Overall Study|Death|1
86932|NCT01171976|330429|P2|Overall Study|Death|4
86933|NCT01171976|330430|P1|Overall Study|Death|2
86934|NCT01171976|330428|P3|Overall Study|Protocol Violation|1
86935|NCT01171976|330429|P2|Overall Study|Protocol Violation|0
86936|NCT01171976|330430|P1|Overall Study|Protocol Violation|0
86937|NCT01171963|330467|P2|Overall Study|Withdrawal by Subject|129
86938|NCT01171963|330468|P1|Overall Study|Withdrawal by Subject|114
86939|NCT01171963|330467|P2|Overall Study|Other - diarrhoea|0
86940|NCT01171963|330468|P1|Overall Study|Other - diarrhoea|1
86941|NCT01171963|330467|P2|Overall Study|Lost to Follow-up|24
86942|NCT01171963|330468|P1|Overall Study|Lost to Follow-up|23
86943|NCT01171963|330467|P2|Overall Study|Adverse Event|15
86944|NCT01171963|330468|P1|Overall Study|Adverse Event|10
86945|NCT01171820|330535|P2|Overall Study|1-Year Missed Visit|1
86946|NCT01171820|330536|P1|Overall Study|1-Year Missed Visit|1
86947|NCT01171820|330535|P2|Overall Study|Physician Decision|1
86948|NCT01171820|330536|P1|Overall Study|Physician Decision|0
86949|NCT01171820|330535|P2|Overall Study|Withdrawal by Subject|0
86950|NCT01171820|330536|P1|Overall Study|Withdrawal by Subject|2
86951|NCT01171820|330535|P2|Overall Study|Lost to Follow-up|1
86952|NCT01171820|330536|P1|Overall Study|Lost to Follow-up|0
86953|NCT01171820|330535|P2|Overall Study|Death|3
86954|NCT01171820|330536|P1|Overall Study|Death|3
86955|NCT01171677|330614|P2|Overall Study|completed <70% IntenSati classes|0
86956|NCT01171677|330615|P1|Overall Study|completed <70% IntenSati classes|5
86957|NCT01171677|330614|P2|Overall Study|Adverse Event|0
86958|NCT01171677|330615|P1|Overall Study|Adverse Event|1
86959|NCT01171677|330614|P2|Overall Study|Withdrawal by Subject|3
86960|NCT01171677|330615|P1|Overall Study|Withdrawal by Subject|0
86961|NCT01171612|330647|P1|Overall Study|Lost to Follow-up|51
86962|NCT01171534|330657|P2|Overall Study|screen failure|1
86963|NCT01171534|330658|P1|Overall Study|screen failure|0
86964|NCT01171534|330657|P2|Overall Study|Lost to Follow-up|2
86965|NCT01171534|330658|P1|Overall Study|Lost to Follow-up|0
86966|NCT01171521|330670|P1|Overall Study|screen failure|1
86967|NCT01171521|330670|P1|Overall Study|Lost to Follow-up|5
86968|NCT01171183|330677|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
86969|NCT01171183|330678|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
86970|NCT01171183|330677|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
86971|NCT01171183|330678|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
86972|NCT01171183|330677|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
86973|NCT01171183|330678|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
86974|NCT01171183|330677|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
86975|NCT01171183|330678|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
86976|NCT01171183|330677|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
86977|NCT01171183|330678|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
86978|NCT01171183|330677|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
86979|NCT01171183|330678|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
86980|NCT01170962|330699|P3|Follow up Period|Others|3
86981|NCT01170962|330700|P2|Follow up Period|Others|7
86982|NCT01170962|330701|P1|Follow up Period|Others|10
86983|NCT01170962|330699|P3|Follow up Period|Death|0
86984|NCT01170962|330700|P2|Follow up Period|Death|2
86985|NCT01170962|330701|P1|Follow up Period|Death|2
86986|NCT01170962|330699|P3|Follow up Period|Lost to Follow-up|1
86987|NCT01170962|330700|P2|Follow up Period|Lost to Follow-up|8
86988|NCT01170962|330701|P1|Follow up Period|Lost to Follow-up|13
86989|NCT01170962|330699|P3|Follow up Period|Withdrawal by Subject|2
86990|NCT01170962|330700|P2|Follow up Period|Withdrawal by Subject|10
86991|NCT01170962|330701|P1|Follow up Period|Withdrawal by Subject|14
86992|NCT01170962|330699|P3|Treatment Period|Completed 24 Week treatment period only|0
86993|NCT01170962|330700|P2|Treatment Period|Completed 24 Week treatment period only|2
86994|NCT01170962|330701|P1|Treatment Period|Completed 24 Week treatment period only|10
86995|NCT01170962|330699|P3|Treatment Period|Request to discontinue treatment|1
86996|NCT01170962|330700|P2|Treatment Period|Request to discontinue treatment|3
86997|NCT01170962|330701|P1|Treatment Period|Request to discontinue treatment|7
86998|NCT01170962|330699|P3|Treatment Period|Participant no longer meets criteria|0
86999|NCT01170962|330700|P2|Treatment Period|Participant no longer meets criteria|1
87000|NCT01170962|330701|P1|Treatment Period|Participant no longer meets criteria|0
87001|NCT01170962|330699|P3|Treatment Period|Lost to Follow-up|1
87002|NCT01170962|330700|P2|Treatment Period|Lost to Follow-up|1
87003|NCT01170962|330701|P1|Treatment Period|Lost to Follow-up|1
87004|NCT01170962|330699|P3|Treatment Period|Withdrawal by Subject|0
87005|NCT01170962|330700|P2|Treatment Period|Withdrawal by Subject|1
87006|NCT01170962|330701|P1|Treatment Period|Withdrawal by Subject|2
87007|NCT01170962|330699|P3|Treatment Period|Adverse Event|3
87008|NCT01170962|330700|P2|Treatment Period|Adverse Event|12
87009|NCT01170962|330701|P1|Treatment Period|Adverse Event|11
87010|NCT01170962|330699|P3|Treatment Period|Lack of Efficacy|7
87011|NCT01170962|330700|P2|Treatment Period|Lack of Efficacy|91
87012|NCT01170962|330701|P1|Treatment Period|Lack of Efficacy|96
87013|NCT01170663|330796|P2|Overall Study|Withdrawal of consent without follow-up|11
87014|NCT01170663|330797|P1|Overall Study|Withdrawal of consent without follow-up|11
87015|NCT01170663|330796|P2|Overall Study|Lost to Follow-up|9
87016|NCT01170663|330797|P1|Overall Study|Lost to Follow-up|3
87017|NCT01170598|330825|P1|Overall Study|Refused|1
87018|NCT01170598|330825|P1|Overall Study|Lost to Follow-up|1
87019|NCT01170598|330825|P1|Overall Study|Death|3
87020|NCT01170598|330825|P1|Overall Study|Withdrawal by Subject|1
87021|NCT01170364|330888|P2|Overall Study|Protocol Violation|1
87022|NCT01170364|330889|P1|Overall Study|Protocol Violation|4
87023|NCT01170273|330897|P2|Overall Study|Adverse Event|1
87024|NCT01170273|330898|P1|Overall Study|Adverse Event|0
87025|NCT01170273|330897|P2|Overall Study|Death|0
87026|NCT01170273|330898|P1|Overall Study|Death|1
87027|NCT01170273|330897|P2|Overall Study|Protocol Violation|0
87028|NCT01170273|330898|P1|Overall Study|Protocol Violation|1
87029|NCT01170273|330897|P2|Overall Study|Lost to Follow-up|8
87030|NCT01170273|330898|P1|Overall Study|Lost to Follow-up|6
87031|NCT01170221|330915|P2|Overall Study|Randomized but not treated|0
87032|NCT01170221|330916|P1|Overall Study|Randomized but not treated|1
87033|NCT01170221|330915|P2|Overall Study|Subject completed only screening and LFU|0
87034|NCT01170221|330916|P1|Overall Study|Subject completed only screening and LFU|1
87035|NCT01170221|330915|P2|Overall Study|Withdrawal by Subject|7
87036|NCT01170221|330916|P1|Overall Study|Withdrawal by Subject|9
87037|NCT01170221|330915|P2|Overall Study|Lost to Follow-up|21
87038|NCT01170221|330916|P1|Overall Study|Lost to Follow-up|22
87039|NCT01170208|330939|P3|Overall Study|Protocol Violation|1
87040|NCT01170208|330940|P2|Overall Study|Protocol Violation|0
87041|NCT01170208|330941|P1|Overall Study|Protocol Violation|1
87042|NCT01170208|330939|P3|Overall Study|Withdrawal by Subject|1
87043|NCT01170208|330940|P2|Overall Study|Withdrawal by Subject|0
87044|NCT01170208|330941|P1|Overall Study|Withdrawal by Subject|5
87045|NCT01170091|330960|P1|Overall Study|Treatment duration is less than 4 weeks|21
87046|NCT01170091|330960|P1|Overall Study|Missing efficacy evaluation|3
87047|NCT01170039|330969|P2|Overall Study|Lack of funding, drug not available|3
87048|NCT01170039|330970|P1|Overall Study|Lack of funding, drug not available|3
87049|NCT01170039|330969|P2|Overall Study|Withdrawal by Subject|3
87050|NCT01170039|330970|P1|Overall Study|Withdrawal by Subject|5
87051|NCT01169987|330982|P1|Overall Study|Not Specified|4
87052|NCT01169987|330982|P1|Overall Study|Lost to Follow-up|24
87053|NCT01169987|330982|P1|Overall Study|Withdrawal by Subject|3
87054|NCT01169779|331048|P2|Overall Study|Familial and personal reasons|3
87055|NCT01169779|331049|P1|Overall Study|Familial and personal reasons|3
87056|NCT01169779|331048|P2|Overall Study|Withdrawal by Subject|2
87057|NCT01169779|331049|P1|Overall Study|Withdrawal by Subject|3
87058|NCT01169779|331048|P2|Overall Study|Protocol Violation|1
87059|NCT01169779|331049|P1|Overall Study|Protocol Violation|1
87060|NCT01169779|331048|P2|Overall Study|Lack of Efficacy|0
87061|NCT01169779|331049|P1|Overall Study|Lack of Efficacy|1
87062|NCT01169779|331048|P2|Overall Study|Adverse Event|11
87063|NCT01169779|331049|P1|Overall Study|Adverse Event|3
87064|NCT01169701|331084|P2|Overall Study|Sponsor decision|1
87065|NCT01169701|331085|P1|Overall Study|Sponsor decision|0
87066|NCT01169701|331084|P2|Overall Study|Serious adverse event|1
87067|NCT01169701|331085|P1|Overall Study|Serious adverse event|0
87068|NCT01169701|331084|P2|Overall Study|Administrative problems|1
87069|NCT01169701|331085|P1|Overall Study|Administrative problems|0
87070|NCT01169701|331084|P2|Overall Study|Death|1
87071|NCT01169701|331085|P1|Overall Study|Death|0
87072|NCT01169701|331084|P2|Overall Study|Exclusion criteria|0
87073|NCT01169701|331085|P1|Overall Study|Exclusion criteria|2
87074|NCT01169701|331084|P2|Overall Study|Adverse Event|2
87075|NCT01169701|331085|P1|Overall Study|Adverse Event|1
87076|NCT01169701|331084|P2|Overall Study|Withdrawal by Subject|3
87077|NCT01169701|331085|P1|Overall Study|Withdrawal by Subject|1
87078|NCT01169701|331084|P2|Overall Study|Lost to Follow-up|1
87079|NCT01169701|331085|P1|Overall Study|Lost to Follow-up|1
87080|NCT01169675|331122|P5|Overall Study|Other Reason Not Defined Above|1
87081|NCT01169675|331123|P4|Overall Study|Other Reason Not Defined Above|1
87082|NCT01169675|331124|P3|Overall Study|Other Reason Not Defined Above|0
87083|NCT01169675|331125|P2|Overall Study|Other Reason Not Defined Above|0
87084|NCT01169675|331126|P1|Overall Study|Other Reason Not Defined Above|0
87085|NCT01169675|331122|P5|Overall Study|Withdrawal by Subject|2
87086|NCT01169675|331123|P4|Overall Study|Withdrawal by Subject|1
87087|NCT01169675|331124|P3|Overall Study|Withdrawal by Subject|0
87088|NCT01169675|331125|P2|Overall Study|Withdrawal by Subject|0
87089|NCT01169675|331126|P1|Overall Study|Withdrawal by Subject|1
87090|NCT01169675|331122|P5|Overall Study|Adverse Event|0
87091|NCT01169675|331123|P4|Overall Study|Adverse Event|0
87092|NCT01169675|331124|P3|Overall Study|Adverse Event|2
87093|NCT01169675|331125|P2|Overall Study|Adverse Event|1
87094|NCT01169675|331126|P1|Overall Study|Adverse Event|5
87095|NCT01169675|331122|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
87096|NCT01169675|331123|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
87097|NCT01169675|331124|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
87098|NCT01169675|331125|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
87099|NCT01169675|331126|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
87100|NCT01169675|331122|P5|Overall Study|Progressive disease|1
87101|NCT01169675|331123|P4|Overall Study|Progressive disease|15
87102|NCT01169675|331124|P3|Overall Study|Progressive disease|5
87103|NCT01169675|331125|P2|Overall Study|Progressive disease|2
87104|NCT01169675|331126|P1|Overall Study|Progressive disease|13
87105|NCT01169649|331163|P1|Overall Study|Patient Not Treated|3
87106|NCT01169558|331175|P1|Overall Study|Partial response|2
87107|NCT01169558|331175|P1|Overall Study|Protocol Violation|2
87108|NCT01169558|331175|P1|Overall Study|Non-compliance|2
87109|NCT01169558|331175|P1|Overall Study|Need for Surgery|4
87110|NCT01169558|331175|P1|Overall Study|Lost to Follow-up|4
87111|NCT01169558|331175|P1|Overall Study|Stable Disease|4
87112|NCT01169558|331175|P1|Overall Study|Medical Decision|7
87113|NCT01169558|331175|P1|Overall Study|Withdrawal of Consent|8
87114|NCT01169558|331175|P1|Overall Study|Adverse Event|25
87115|NCT01169558|331175|P1|Overall Study|Disease progression|98
87116|NCT01169493|331200|P6|Period 3 (6 Months)|Physician Decision|0
87117|NCT01169493|331201|P5|Period 3 (6 Months)|Physician Decision|0
87118|NCT01169493|331202|P4|Period 3 (6 Months)|Physician Decision|0
87119|NCT01169493|331203|P3|Period 3 (6 Months)|Physician Decision|1
87120|NCT01169493|331204|P2|Period 3 (6 Months)|Physician Decision|1
87121|NCT01169493|331205|P1|Period 3 (6 Months)|Physician Decision|0
87122|NCT01169493|331200|P6|Period 3 (6 Months)|Adverse Event|0
87123|NCT01169493|331201|P5|Period 3 (6 Months)|Adverse Event|0
87124|NCT01169493|331202|P4|Period 3 (6 Months)|Adverse Event|0
87125|NCT01169493|331203|P3|Period 3 (6 Months)|Adverse Event|0
87126|NCT01169493|331204|P2|Period 3 (6 Months)|Adverse Event|1
87127|NCT01169493|331205|P1|Period 3 (6 Months)|Adverse Event|0
87128|NCT01169493|331200|P6|Period 1 (6 Months)|Withdrawal by Subject|3
87129|NCT01169493|331201|P5|Period 1 (6 Months)|Withdrawal by Subject|0
87130|NCT01169493|331202|P4|Period 1 (6 Months)|Withdrawal by Subject|0
87131|NCT01169493|331203|P3|Period 1 (6 Months)|Withdrawal by Subject|2
87132|NCT01169493|331204|P2|Period 1 (6 Months)|Withdrawal by Subject|1
87133|NCT01169493|331205|P1|Period 1 (6 Months)|Withdrawal by Subject|0
87134|NCT01169350|331251|P1|Overall Study|Lost to Follow-up|2
87135|NCT01169350|331251|P1|Overall Study|Physician Decision|3
87136|NCT01169103|331272|P2|Overall Study|Withdrawal by Subject|1
87137|NCT01169103|331273|P1|Overall Study|Withdrawal by Subject|3
87138|NCT01169103|331272|P2|Overall Study|Lost to Follow-up|3
87139|NCT01169103|331273|P1|Overall Study|Lost to Follow-up|3
87140|NCT01169038|331300|P1|Overall Study|Required antibiotic administration|1
87141|NCT01169038|331300|P1|Overall Study|Adverse Event|5
87142|NCT01169038|331300|P1|Overall Study|Death|1
87143|NCT01168999|331308|P4|Overall Study|Lost to Follow-up|0
87144|NCT01168999|331309|P3|Overall Study|Lost to Follow-up|0
87145|NCT01168999|331310|P2|Overall Study|Lost to Follow-up|1
87146|NCT01168999|331311|P1|Overall Study|Lost to Follow-up|2
87147|NCT01168973|331377|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
87148|NCT01168973|331378|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
87149|NCT01168973|331377|P2|Overall Study|Sponsor Decision|1
87150|NCT01168973|331378|P1|Overall Study|Sponsor Decision|2
87151|NCT01168973|331377|P2|Overall Study|Physician Decision|19
87152|NCT01168973|331378|P1|Overall Study|Physician Decision|37
87153|NCT01168973|331377|P2|Overall Study|Death|45
87154|NCT01168973|331378|P1|Overall Study|Death|42
87155|NCT01168973|331377|P2|Overall Study|Withdrawal by Subject|53
87156|NCT01168973|331378|P1|Overall Study|Withdrawal by Subject|90
87157|NCT01168973|331377|P2|Overall Study|Adverse Event|55
87158|NCT01168973|331378|P1|Overall Study|Adverse Event|94
87159|NCT01168973|331377|P2|Overall Study|Progressive Disease|429
87160|NCT01168973|331378|P1|Overall Study|Progressive Disease|341
87161|NCT01168856|331451|P2|Overall Study|Protocol Violation|6
87162|NCT01168856|331452|P1|Overall Study|Protocol Violation|4
87163|NCT01168856|331451|P2|Overall Study|Other|291
87164|NCT01168856|331452|P1|Overall Study|Other|1
87165|NCT01168856|331451|P2|Overall Study|Death|2
87166|NCT01168856|331452|P1|Overall Study|Death|0
87167|NCT01168856|331451|P2|Overall Study|Participant received anti-HCV treatment|0
87168|NCT01168856|331452|P1|Overall Study|Participant received anti-HCV treatment|1
87169|NCT01168856|331451|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
87170|NCT01168856|331452|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
87171|NCT01168856|331451|P2|Overall Study|Physician Decision|1
87172|NCT01168856|331452|P1|Overall Study|Physician Decision|2
87173|NCT01168856|331451|P2|Overall Study|Withdrawal by Subject|8
87174|NCT01168856|331452|P1|Overall Study|Withdrawal by Subject|6
87175|NCT01168856|331451|P2|Overall Study|Lost to Follow-up|34
87176|NCT01168856|331452|P1|Overall Study|Lost to Follow-up|4
87177|NCT01168596|331550|P2|Overall Study|Withdrawal by Subject|1
87178|NCT01168596|331551|P1|Overall Study|Withdrawal by Subject|3
87179|NCT01168427|331595|P1|Overall Study|Patient exited prior to implant|1
87180|NCT01168349|331600|P1|Overall Study|Protocol Violation|76
87181|NCT01168349|331600|P1|Overall Study|Other|22
87182|NCT01168349|331600|P1|Overall Study|Kidney transplantation|3
87183|NCT01168349|331600|P1|Overall Study|Withdrawal by Subject|9
87184|NCT01168349|331600|P1|Overall Study|Lost to Follow-up|34
87185|NCT01168349|331600|P1|Overall Study|Death|157
87186|NCT01168232|331706|P1|Overall Study|Ineligible-Inadequate pathology|1
87187|NCT01168232|331706|P1|Overall Study|Ineligible- Wrong cell type|6
87188|NCT01168232|331706|P1|Overall Study|Ineligible-Second primary cancer site|1
87189|NCT01167907|331734|P2|Overall Study|saphenous catheter dislodged before comp|1
87190|NCT01167907|331735|P1|Overall Study|saphenous catheter dislodged before comp|1
87191|NCT01167907|331734|P2|Overall Study|Protocol Violation|0
87192|NCT01167907|331735|P1|Overall Study|Protocol Violation|1
87193|NCT01167881|331753|P2|Overall Study|Other not defined above|55
87194|NCT01167881|331754|P1|Overall Study|Other not defined above|31
87195|NCT01167881|331753|P2|Overall Study|Not treated|0
87196|NCT01167881|331754|P1|Overall Study|Not treated|4
87197|NCT01167881|331753|P2|Overall Study|Patient refusal to cont., not due to AE|40
87198|NCT01167881|331754|P1|Overall Study|Patient refusal to cont., not due to AE|45
87199|NCT01167881|331753|P2|Overall Study|Lost to Follow-up|20
87200|NCT01167881|331754|P1|Overall Study|Lost to Follow-up|19
87201|NCT01167881|331753|P2|Overall Study|Non compliant with protocol|18
87202|NCT01167881|331754|P1|Overall Study|Non compliant with protocol|9
87203|NCT01167881|331753|P2|Overall Study|Lack of Efficacy|7
87204|NCT01167881|331754|P1|Overall Study|Lack of Efficacy|4
87205|NCT01167881|331753|P2|Overall Study|Adverse Event|51
87206|NCT01167881|331754|P1|Overall Study|Adverse Event|47
87207|NCT01167634|331808|P4|Overall Study|Withdrawal by Subject|0
87208|NCT01167634|331809|P3|Overall Study|Withdrawal by Subject|0
87209|NCT01167634|331810|P2|Overall Study|Withdrawal by Subject|1
87210|NCT01167634|331811|P1|Overall Study|Withdrawal by Subject|1
87211|NCT01167634|331808|P4|Overall Study|Lost to Follow-up|4
87212|NCT01167634|331809|P3|Overall Study|Lost to Follow-up|3
87213|NCT01167634|331810|P2|Overall Study|Lost to Follow-up|3
87214|NCT01167634|331811|P1|Overall Study|Lost to Follow-up|1
87215|NCT01167582|331832|P2|Overall Study|Lost to Follow-up|1
87216|NCT01167582|331833|P1|Overall Study|Lost to Follow-up|0
87217|NCT01167426|331855|P1|Overall Study|Sponsor Decision|1
87218|NCT01167426|331855|P1|Overall Study|Withdrawal by Subject|2
87219|NCT01167426|331855|P1|Overall Study|Protocol Violation|1
87220|NCT01167426|331855|P1|Overall Study|Lost to Follow-up|6
87221|NCT01167257|331863|P2|Overall Study|Withdrew consent|1
87222|NCT01167257|331864|P1|Overall Study|Withdrew consent|1
87223|NCT01167257|331863|P2|Overall Study|Lost to Follow-up|2
87224|NCT01167257|331864|P1|Overall Study|Lost to Follow-up|2
87225|NCT01167192|331886|P1|Overall Study|Insurance denial|1
87226|NCT01167192|331886|P1|Overall Study|Withdrawal by Subject|1
87227|NCT01167192|331886|P1|Overall Study|Death|1
87228|NCT01167192|331886|P1|Overall Study|Adverse Event|1
87229|NCT01167179|331903|P2|Overall Study|diverse|5
87230|NCT01167179|331904|P1|Overall Study|diverse|6
87231|NCT01167179|331903|P2|Overall Study|Withdrawal by Subject|2
87232|NCT01167179|331904|P1|Overall Study|Withdrawal by Subject|1
87233|NCT01167179|331903|P2|Overall Study|Death|10
87234|NCT01167179|331904|P1|Overall Study|Death|4
87235|NCT01167179|331903|P2|Overall Study|disease recurrence|4
87236|NCT01167179|331904|P1|Overall Study|disease recurrence|4
87237|NCT01167153|331914|P2|Overall Study|Subject initiation withdrawal, Other|8
87238|NCT01167153|331915|P1|Overall Study|Subject initiation withdrawal, Other|5
87239|NCT01167153|331914|P2|Overall Study|Withdrawal consent|1
87240|NCT01167153|331915|P1|Overall Study|Withdrawal consent|1
87241|NCT01167153|331914|P2|Overall Study|Investigator initiation withdrawal,Other|1
87242|NCT01167153|331915|P1|Overall Study|Investigator initiation withdrawal,Other|1
87243|NCT01167153|331914|P2|Overall Study|Non-compliance to concomitant medication|2
87244|NCT01167153|331915|P1|Overall Study|Non-compliance to concomitant medication|0
87245|NCT01167153|331914|P2|Overall Study|Lost to Follow-up|9
87246|NCT01167153|331915|P1|Overall Study|Lost to Follow-up|7
87247|NCT01167153|331914|P2|Overall Study|Hypotension|0
87248|NCT01167153|331915|P1|Overall Study|Hypotension|1
87249|NCT01167153|331914|P2|Overall Study|AE including clinical laboratory AE|8
87250|NCT01167153|331915|P1|Overall Study|AE including clinical laboratory AE|2
87251|NCT01167153|331914|P2|Overall Study|Non-effective therapy|4
87252|NCT01167153|331915|P1|Overall Study|Non-effective therapy|1
87253|NCT01167140|331933|P1|Overall Study|Withdrawal by Subject|1
87254|NCT01167023|331941|P3|Overall Study|Withdrawal by Subject|1
87255|NCT01167023|331942|P2|Overall Study|Withdrawal by Subject|0
87256|NCT01167023|331943|P1|Overall Study|Withdrawal by Subject|0
87257|NCT01167023|331941|P3|Overall Study|Sponsor Decision|0
87258|NCT01167023|331942|P2|Overall Study|Sponsor Decision|1
87259|NCT01167023|331943|P1|Overall Study|Sponsor Decision|0
87260|NCT01167023|331941|P3|Overall Study|Screen Failure|0
87261|NCT01167023|331942|P2|Overall Study|Screen Failure|1
87262|NCT01167023|331943|P1|Overall Study|Screen Failure|0
87263|NCT01167023|331941|P3|Overall Study|Lost to Follow-up|1
87264|NCT01167023|331942|P2|Overall Study|Lost to Follow-up|1
87265|NCT01167023|331943|P1|Overall Study|Lost to Follow-up|0
87266|NCT01166958|331983|P2|Overall Study|Withdrawal by Subject|0
87267|NCT01166958|331984|P1|Overall Study|Withdrawal by Subject|1
87268|NCT01166763|331998|P1|Overall Study|Withdrawal by Subject|3
87269|NCT01166750|332006|P2|Overall Study|Lost to Follow-up|0
87270|NCT01166750|332007|P1|Overall Study|Lost to Follow-up|1
87271|NCT01166659|332024|P1|Overall Study|Study Closed at Site|1
87272|NCT01166659|332024|P1|Overall Study|Lost to Follow-up|1
87273|NCT01166659|332024|P1|Overall Study|Death|1
87274|NCT01166659|332024|P1|Overall Study|Investigator Decision|2
87275|NCT01166659|332024|P1|Overall Study|Subject Decision|8
87276|NCT01166646|332033|P2|Overall Study|Adverse Event|0
87277|NCT01166646|332034|P1|Overall Study|Adverse Event|1
87278|NCT01166646|332033|P2|Overall Study|Protocol Violation|1
87279|NCT01166646|332034|P1|Overall Study|Protocol Violation|0
87280|NCT01166438|332052|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
87281|NCT01166438|332053|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
87282|NCT01166438|332052|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
87283|NCT01166438|332053|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
87284|NCT01166438|332052|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
87285|NCT01166438|332053|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
87286|NCT01166438|332052|P2|Double-blind Phase: 1st 6 Months|Not treated|1
87287|NCT01166438|332053|P1|Double-blind Phase: 1st 6 Months|Not treated|1
87288|NCT01166438|332052|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
87289|NCT01166438|332053|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
87290|NCT01166438|332052|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
87291|NCT01166438|332053|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
87292|NCT01166282|332102|P3|Open-label Period|Irregular Compliance|1
87293|NCT01166282|332103|P2|Open-label Period|Irregular Compliance|0
87294|NCT01166282|332104|P1|Open-label Period|Irregular Compliance|0
87295|NCT01166282|332102|P3|Open-label Period|Remission|4
87296|NCT01166282|332103|P2|Open-label Period|Remission|0
87297|NCT01166282|332104|P1|Open-label Period|Remission|0
87298|NCT01166282|332102|P3|Open-label Period|Lack of Efficacy|2
87299|NCT01166282|332103|P2|Open-label Period|Lack of Efficacy|0
87300|NCT01166282|332104|P1|Open-label Period|Lack of Efficacy|0
87301|NCT01166282|332102|P3|Open-label Period|Withdrawal by Subject|4
87302|NCT01166282|332103|P2|Open-label Period|Withdrawal by Subject|0
87303|NCT01166282|332104|P1|Open-label Period|Withdrawal by Subject|0
87304|NCT01166282|332102|P3|Open-label Period|Adverse Event|6
87305|NCT01166282|332103|P2|Open-label Period|Adverse Event|0
87306|NCT01166282|332104|P1|Open-label Period|Adverse Event|0
87307|NCT01166178|332143|P2|Overall Study|Study was terminated|8
87308|NCT01166178|332144|P1|Overall Study|Study was terminated|20
87309|NCT01166178|332143|P2|Overall Study|Withdrawal by Subject|0
87310|NCT01166178|332144|P1|Overall Study|Withdrawal by Subject|1
87311|NCT01165996|332183|P1|Overall Study|Physician Decision|1
87312|NCT01165996|332183|P1|Overall Study|Death|1
87313|NCT01165684|332250|P2|Overall Study|Unclassified|22
87314|NCT01165684|332251|P1|Overall Study|Unclassified|16
87315|NCT01165684|332250|P2|Overall Study|Withdrawal Criteria|13
87316|NCT01165684|332251|P1|Overall Study|Withdrawal Criteria|2
87317|NCT01165684|332250|P2|Overall Study|Protocol Violation|15
87318|NCT01165684|332251|P1|Overall Study|Protocol Violation|7
87319|NCT01165684|332250|P2|Overall Study|Lack of Efficacy|1
87320|NCT01165684|332251|P1|Overall Study|Lack of Efficacy|2
87321|NCT01165684|332250|P2|Overall Study|Adverse Event|1
87322|NCT01165684|332251|P1|Overall Study|Adverse Event|1
87323|NCT01165554|332285|P1|Overall Study|Withdrawal by Subject|23
87324|NCT01165424|332308|P1|Overall Study|Participant moved (relocated)|1
87325|NCT01165424|332308|P1|Overall Study|Did not meet entry criteria|1
87326|NCT01165424|332308|P1|Overall Study|Laboratory adverse experiences|1
87327|NCT01165424|332308|P1|Overall Study|Clinical adverse experiences|1
87328|NCT01165320|332315|P3|Overall Study|Reason unknown|0
87329|NCT01165320|332316|P2|Overall Study|Reason unknown|1
87330|NCT01165320|332317|P1|Overall Study|Reason unknown|0
87331|NCT01165320|332315|P3|Overall Study|Lack of Efficacy|0
87332|NCT01165320|332316|P2|Overall Study|Lack of Efficacy|2
87333|NCT01165320|332317|P1|Overall Study|Lack of Efficacy|0
87334|NCT01165320|332315|P3|Overall Study|Laboratory adverse experience|0
87335|NCT01165320|332316|P2|Overall Study|Laboratory adverse experience|0
87336|NCT01165320|332317|P1|Overall Study|Laboratory adverse experience|1
87337|NCT01165320|332315|P3|Overall Study|Clinical adverse experience|0
87338|NCT01165320|332316|P2|Overall Study|Clinical adverse experience|1
87339|NCT01165320|332317|P1|Overall Study|Clinical adverse experience|2
87340|NCT01165307|332327|P2|Overall Study|Subject not available for contact|0
87341|NCT01165307|332328|P1|Overall Study|Subject not available for contact|1
87342|NCT01165307|332327|P2|Overall Study|Withdrawal by Subject|0
87343|NCT01165307|332328|P1|Overall Study|Withdrawal by Subject|2
87344|NCT01165307|332327|P2|Overall Study|Lost to Follow-up|3
87345|NCT01165307|332328|P1|Overall Study|Lost to Follow-up|11
87346|NCT01165281|332358|P2|Overall Study|Other|0
87347|NCT01165281|332359|P1|Overall Study|Other|6
87348|NCT01165281|332358|P2|Overall Study|Progressive Disease|14
87349|NCT01165281|332359|P1|Overall Study|Progressive Disease|10
87350|NCT01165281|332358|P2|Overall Study|Noncompliance with Study Drug|4
87351|NCT01165281|332359|P1|Overall Study|Noncompliance with Study Drug|1
87352|NCT01165281|332358|P2|Overall Study|Withdrawal by Subject|7
87353|NCT01165281|332359|P1|Overall Study|Withdrawal by Subject|8
87354|NCT01165281|332358|P2|Overall Study|Protocol Violation|5
87355|NCT01165281|332359|P1|Overall Study|Protocol Violation|6
87356|NCT01165281|332358|P2|Overall Study|Physician Decision|1
87357|NCT01165281|332359|P1|Overall Study|Physician Decision|8
87358|NCT01165281|332358|P2|Overall Study|Lost to Follow-up|1
87359|NCT01165281|332359|P1|Overall Study|Lost to Follow-up|0
87360|NCT01165281|332358|P2|Overall Study|Lack of Efficacy|1
87361|NCT01165281|332359|P1|Overall Study|Lack of Efficacy|4
87362|NCT01165281|332358|P2|Overall Study|Death|4
87363|NCT01165281|332359|P1|Overall Study|Death|3
87364|NCT01165281|332358|P2|Overall Study|Adverse Event|14
87365|NCT01165281|332359|P1|Overall Study|Adverse Event|12
87366|NCT01165242|332380|P3|Overall Study|Lost to Follow-up|10
87367|NCT01165242|332381|P2|Overall Study|Lost to Follow-up|7
87368|NCT01165242|332382|P1|Overall Study|Lost to Follow-up|9
87369|NCT01165242|332380|P3|Overall Study|Extended Holiday|1
87370|NCT01165242|332381|P2|Overall Study|Extended Holiday|0
87371|NCT01165242|332382|P1|Overall Study|Extended Holiday|0
87372|NCT01165242|332380|P3|Overall Study|Withdrawal by Subject|2
87373|NCT01165242|332381|P2|Overall Study|Withdrawal by Subject|2
87374|NCT01165242|332382|P1|Overall Study|Withdrawal by Subject|0
87375|NCT01165242|332380|P3|Overall Study|Visit 2 Declined by Subject|1
87376|NCT01165242|332381|P2|Overall Study|Visit 2 Declined by Subject|0
87377|NCT01165242|332382|P1|Overall Study|Visit 2 Declined by Subject|0
87378|NCT01165242|332380|P3|Overall Study|Incarcerated Subjects|0
87379|NCT01165242|332381|P2|Overall Study|Incarcerated Subjects|1
87380|NCT01165242|332382|P1|Overall Study|Incarcerated Subjects|0
87381|NCT01165242|332380|P3|Overall Study|Unreachable Subjects|0
87382|NCT01165242|332381|P2|Overall Study|Unreachable Subjects|0
87383|NCT01165242|332382|P1|Overall Study|Unreachable Subjects|1
87384|NCT01165229|332416|P2|Overall Study|Screening criteria unmet|0
87385|NCT01165229|332417|P1|Overall Study|Screening criteria unmet|1
87386|NCT01165229|332416|P2|Overall Study|Lack of time|0
87387|NCT01165229|332417|P1|Overall Study|Lack of time|1
87388|NCT01165229|332416|P2|Overall Study|Missed visit|0
87389|NCT01165229|332417|P1|Overall Study|Missed visit|1
87390|NCT01165229|332416|P2|Overall Study|Sponsor study termination|0
87391|NCT01165229|332417|P1|Overall Study|Sponsor study termination|1
87392|NCT01165229|332416|P2|Overall Study|Investigator decision|2
87393|NCT01165229|332417|P1|Overall Study|Investigator decision|0
87394|NCT01165229|332416|P2|Overall Study|Personal reason|4
87395|NCT01165229|332417|P1|Overall Study|Personal reason|10
87396|NCT01165229|332416|P2|Overall Study|Site closure|20
87397|NCT01165229|332417|P1|Overall Study|Site closure|18
87398|NCT01165229|332416|P2|Overall Study|Health issues|56
87399|NCT01165229|332417|P1|Overall Study|Health issues|61
87400|NCT01165229|332416|P2|Overall Study|Patient not eligible|1
87401|NCT01165229|332417|P1|Overall Study|Patient not eligible|0
87402|NCT01165229|332416|P2|Overall Study|Page entered in error|1
87403|NCT01165229|332417|P1|Overall Study|Page entered in error|0
87404|NCT01165229|332416|P2|Overall Study|No reason from the subject|1
87405|NCT01165229|332417|P1|Overall Study|No reason from the subject|0
87406|NCT01165229|332416|P2|Overall Study|Suspected HZ Episode|2
87407|NCT01165229|332417|P1|Overall Study|Suspected HZ Episode|0
87408|NCT01165229|332416|P2|Overall Study|Lost to Follow-up|138
87409|NCT01165229|332417|P1|Overall Study|Lost to Follow-up|124
87410|NCT01165229|332416|P2|Overall Study|Migrated/moved from study area|46
87411|NCT01165229|332417|P1|Overall Study|Migrated/moved from study area|51
87412|NCT01165229|332416|P2|Overall Study|Withdrawal by Subject|403
87413|NCT01165229|332417|P1|Overall Study|Withdrawal by Subject|396
87414|NCT01165229|332416|P2|Overall Study|Protocol Violation|12
87415|NCT01165229|332417|P1|Overall Study|Protocol Violation|10
87416|NCT01165229|332416|P2|Overall Study|Non-Serious Adverse Event|15
87417|NCT01165229|332417|P1|Overall Study|Non-Serious Adverse Event|47
87418|NCT01165229|332416|P2|Overall Study|Serious Adverse Event|487
87419|NCT01165229|332417|P1|Overall Study|Serious Adverse Event|459
87420|NCT01165229|332416|P2|Overall Study|Unknown completion status|1
87421|NCT01165229|332417|P1|Overall Study|Unknown completion status|0
87422|NCT01165216|332545|P2|Overall Study|Disease progression|3
87423|NCT01165216|332546|P1|Overall Study|Disease progression|1
87424|NCT01165216|332545|P2|Overall Study|Withdrawal by Subject|1
87425|NCT01165216|332546|P1|Overall Study|Withdrawal by Subject|1
87426|NCT01165216|332545|P2|Overall Study|Adverse Event|3
87427|NCT01165216|332546|P1|Overall Study|Adverse Event|6
87428|NCT01165203|332568|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
87429|NCT01165203|332569|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
87430|NCT01165203|332568|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
87431|NCT01165203|332569|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
87432|NCT01165203|332568|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
87433|NCT01165203|332569|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
87434|NCT01165203|332568|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
87435|NCT01165203|332569|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
87436|NCT01165203|332568|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
87437|NCT01165203|332569|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
87438|NCT01165203|332568|P2|Active Phase|Lost to Follow-up|0
87439|NCT01165203|332569|P1|Active Phase|Lost to Follow-up|2
87440|NCT01165203|332568|P2|Active Phase|Migrated/moved from study area|1
87441|NCT01165203|332569|P1|Active Phase|Migrated/moved from study area|0
87442|NCT01165203|332568|P2|Active Phase|Withdrawal by Subject|1
87443|NCT01165203|332569|P1|Active Phase|Withdrawal by Subject|2
87444|NCT01165203|332568|P2|Active Phase|Serious Adverse Event|0
87445|NCT01165203|332569|P1|Active Phase|Serious Adverse Event|1
87446|NCT01165177|332659|P2|Overall Study|Death|1
87447|NCT01165177|332660|P1|Overall Study|Death|0
87448|NCT01165177|332659|P2|Overall Study|Personal Reasons|4
87449|NCT01165177|332660|P1|Overall Study|Personal Reasons|1
87450|NCT01165177|332659|P2|Overall Study|Physician Decision|1
87451|NCT01165177|332660|P1|Overall Study|Physician Decision|0
87452|NCT01165177|332659|P2|Overall Study|Non-serious Adverse Event|20
87453|NCT01165177|332660|P1|Overall Study|Non-serious Adverse Event|32
87454|NCT01165177|332659|P2|Overall Study|Migrated/moved from study area|43
87455|NCT01165177|332660|P1|Overall Study|Migrated/moved from study area|48
87456|NCT01165177|332659|P2|Overall Study|Subject missed visit|2
87457|NCT01165177|332660|P1|Overall Study|Subject missed visit|5
87458|NCT01165177|332659|P2|Overall Study|Previous health issues worsening|11
87459|NCT01165177|332660|P1|Overall Study|Previous health issues worsening|9
87460|NCT01165177|332659|P2|Overall Study|Subject non-compliant with procedures|2
87461|NCT01165177|332660|P1|Overall Study|Subject non-compliant with procedures|12
87462|NCT01165177|332659|P2|Overall Study|Site closure|5
87463|NCT01165177|332660|P1|Overall Study|Site closure|7
87464|NCT01165177|332659|P2|Overall Study|Protocol Violation|22
87465|NCT01165177|332660|P1|Overall Study|Protocol Violation|19
87466|NCT01165177|332659|P2|Overall Study|Lost to Follow-up|195
87467|NCT01165177|332660|P1|Overall Study|Lost to Follow-up|188
87468|NCT01165177|332659|P2|Overall Study|Serious Adverse Event|240
87469|NCT01165177|332660|P1|Overall Study|Serious Adverse Event|229
87470|NCT01165177|332659|P2|Overall Study|Withdrawal by Subject|356
87471|NCT01165177|332660|P1|Overall Study|Withdrawal by Subject|372
87472|NCT01165138|332785|P4|Overall Study|Withdrawal by Subject|3
87473|NCT01165138|332786|P3|Overall Study|Withdrawal by Subject|6
87474|NCT01165138|332787|P2|Overall Study|Withdrawal by Subject|6
87475|NCT01165138|332788|P1|Overall Study|Withdrawal by Subject|0
87476|NCT01165138|332785|P4|Overall Study|Physician Decision|6
87477|NCT01165138|332786|P3|Overall Study|Physician Decision|7
87478|NCT01165138|332787|P2|Overall Study|Physician Decision|6
87479|NCT01165138|332788|P1|Overall Study|Physician Decision|0
87480|NCT01165138|332785|P4|Overall Study|Lost to Follow-up|2
87481|NCT01165138|332786|P3|Overall Study|Lost to Follow-up|1
87482|NCT01165138|332787|P2|Overall Study|Lost to Follow-up|0
87483|NCT01165138|332788|P1|Overall Study|Lost to Follow-up|0
87484|NCT01165138|332785|P4|Overall Study|Protocol Violation|2
87485|NCT01165138|332786|P3|Overall Study|Protocol Violation|0
87486|NCT01165138|332787|P2|Overall Study|Protocol Violation|7
87487|NCT01165138|332788|P1|Overall Study|Protocol Violation|0
87488|NCT01165138|332785|P4|Overall Study|Lack of Efficacy|7
87489|NCT01165138|332786|P3|Overall Study|Lack of Efficacy|6
87490|NCT01165138|332787|P2|Overall Study|Lack of Efficacy|32
87491|NCT01165138|332788|P1|Overall Study|Lack of Efficacy|0
87492|NCT01165138|332785|P4|Overall Study|Adverse Event|2
87493|NCT01165138|332786|P3|Overall Study|Adverse Event|0
87494|NCT01165138|332787|P2|Overall Study|Adverse Event|1
87495|NCT01165138|332788|P1|Overall Study|Adverse Event|0
87496|NCT01165021|332858|P1|Overall Study|Death|1
87497|NCT01164891|332866|P1|Overall Study|Adverse Event|1
87498|NCT01164891|332866|P1|Overall Study|Disease Progression|5
87499|NCT01164865|332886|P2|Overall Study|Lost to Follow-up|1
87500|NCT01164865|332887|P1|Overall Study|Lost to Follow-up|2
87501|NCT01164722|332897|P2|Overall Study|enrolled on other study, concomitant med|3
87502|NCT01164722|332898|P1|Overall Study|enrolled on other study, concomitant med|1
87503|NCT01164722|332897|P2|Overall Study|met protocol criteria for non-treatment|1
87504|NCT01164722|332898|P1|Overall Study|met protocol criteria for non-treatment|11
87505|NCT01164722|332897|P2|Overall Study|Lost to Follow-up|6
87506|NCT01164722|332898|P1|Overall Study|Lost to Follow-up|3
87507|NCT01164722|332897|P2|Overall Study|Withdrawal by Subject|4
87508|NCT01164722|332898|P1|Overall Study|Withdrawal by Subject|3
87509|NCT01164722|332897|P2|Overall Study|Adverse Event|1
87510|NCT01164722|332898|P1|Overall Study|Adverse Event|0
87511|NCT01164579|332928|P3|Overall Study|Reason not specified|0
87512|NCT01164579|332929|P2|Overall Study|Reason not specified|0
87513|NCT01164579|332930|P1|Overall Study|Reason not specified|1
87514|NCT01164579|332928|P3|Overall Study|Adverse Event|5
87515|NCT01164579|332929|P2|Overall Study|Adverse Event|2
87516|NCT01164579|332930|P1|Overall Study|Adverse Event|4
87517|NCT01164579|332928|P3|Overall Study|Protocol Violation|2
87518|NCT01164579|332929|P2|Overall Study|Protocol Violation|1
87519|NCT01164579|332930|P1|Overall Study|Protocol Violation|0
87520|NCT01164579|332928|P3|Overall Study|Withdrawal by Subject|3
87521|NCT01164579|332929|P2|Overall Study|Withdrawal by Subject|5
87522|NCT01164579|332930|P1|Overall Study|Withdrawal by Subject|2
87523|NCT01164579|332928|P3|Overall Study|Lost to Follow-up|0
87524|NCT01164579|332929|P2|Overall Study|Lost to Follow-up|1
87525|NCT01164579|332930|P1|Overall Study|Lost to Follow-up|1
87526|NCT01164579|332928|P3|Overall Study|Lack of Efficacy|6
87527|NCT01164579|332929|P2|Overall Study|Lack of Efficacy|0
87528|NCT01164579|332930|P1|Overall Study|Lack of Efficacy|0
87529|NCT01164501|333010|P3|Overall Study|Other reason not defined above|4
87530|NCT01164501|333011|P2|Overall Study|Other reason not defined above|1
87531|NCT01164501|333012|P1|Overall Study|Other reason not defined above|9
87532|NCT01164501|333010|P3|Overall Study|Patient refusal to continue,not due toAE|8
87533|NCT01164501|333011|P2|Overall Study|Patient refusal to continue,not due toAE|4
87534|NCT01164501|333012|P1|Overall Study|Patient refusal to continue,not due toAE|10
87535|NCT01164501|333010|P3|Overall Study|Lost to Follow-up|3
87536|NCT01164501|333011|P2|Overall Study|Lost to Follow-up|0
87537|NCT01164501|333012|P1|Overall Study|Lost to Follow-up|3
87538|NCT01164501|333010|P3|Overall Study|Non compliant with protocol|4
87539|NCT01164501|333011|P2|Overall Study|Non compliant with protocol|1
87540|NCT01164501|333012|P1|Overall Study|Non compliant with protocol|1
87541|NCT01164501|333010|P3|Overall Study|Lack of Efficacy|1
87542|NCT01164501|333011|P2|Overall Study|Lack of Efficacy|0
87543|NCT01164501|333012|P1|Overall Study|Lack of Efficacy|0
87544|NCT01164501|333010|P3|Overall Study|Adverse Event|21
87545|NCT01164501|333011|P2|Overall Study|Adverse Event|4
87546|NCT01164501|333012|P1|Overall Study|Adverse Event|18
87547|NCT01164501|333010|P3|Overall Study|Not treated|1
87548|NCT01164501|333011|P2|Overall Study|Not treated|0
87549|NCT01164501|333012|P1|Overall Study|Not treated|2
87550|NCT01164475|333029|P2|Overall Study|Protocol Violation|0
87551|NCT01164475|333030|P1|Overall Study|Protocol Violation|1
87552|NCT01164475|333029|P2|Overall Study|Progressive disease|1
87553|NCT01164475|333030|P1|Overall Study|Progressive disease|0
87554|NCT01164475|333029|P2|Overall Study|Other|1
87555|NCT01164475|333030|P1|Overall Study|Other|0
87556|NCT01164475|333029|P2|Overall Study|Lack of Efficacy|0
87557|NCT01164475|333030|P1|Overall Study|Lack of Efficacy|1
87558|NCT01164007|333071|P1|Overall Study|Medical Decision|3
87559|NCT01164007|333071|P1|Overall Study|Withdrawal by Subject|1
87560|NCT01164007|333071|P1|Overall Study|Protocol Violation|1
87561|NCT01164007|333071|P1|Overall Study|Progression of Disease|30
87562|NCT01164007|333071|P1|Overall Study|Adverse Event|5
87563|NCT01163916|333097|P3|Overall Study|Other|16
87564|NCT01163916|333098|P2|Overall Study|Other|4
87565|NCT01163916|333099|P1|Overall Study|Other|24
87566|NCT01163916|333097|P3|Overall Study|Lack of Efficacy|1
87567|NCT01163916|333098|P2|Overall Study|Lack of Efficacy|0
87568|NCT01163916|333099|P1|Overall Study|Lack of Efficacy|2
87569|NCT01163916|333097|P3|Overall Study|Adverse Event|1
87570|NCT01163916|333098|P2|Overall Study|Adverse Event|0
87571|NCT01163916|333099|P1|Overall Study|Adverse Event|2
87572|NCT01163916|333097|P3|Overall Study|Withdrawal by Subject|2
87573|NCT01163916|333098|P2|Overall Study|Withdrawal by Subject|0
87574|NCT01163916|333099|P1|Overall Study|Withdrawal by Subject|2
87575|NCT01163851|333137|P2|Overall Study|Enrolled but not treated|0
87576|NCT01163851|333138|P1|Overall Study|Enrolled but not treated|1
87577|NCT01163851|333137|P2|Overall Study|Site Closure|1
87578|NCT01163851|333138|P1|Overall Study|Site Closure|0
87579|NCT01163747|333233|P2|Overall Study|Refused Treatment|4
87580|NCT01163747|333234|P1|Overall Study|Refused Treatment|6
87581|NCT01163747|333233|P2|Overall Study|Protocol Violation|1
87582|NCT01163747|333234|P1|Overall Study|Protocol Violation|0
87583|NCT01163747|333233|P2|Overall Study|Insufficient Therapeutic Response|1
87584|NCT01163747|333234|P1|Overall Study|Insufficient Therapeutic Response|0
87585|NCT01163747|333233|P2|Overall Study|Adverse Event|5
87586|NCT01163747|333234|P1|Overall Study|Adverse Event|0
87587|NCT01163721|333254|P2|Overall Study|Physician Decision|1
87588|NCT01163721|333255|P1|Overall Study|Physician Decision|0
87589|NCT01163721|333254|P2|Overall Study|Lost to Follow-up|1
87590|NCT01163721|333255|P1|Overall Study|Lost to Follow-up|0
87591|NCT01163721|333254|P2|Overall Study|Withdrawal by Subject|4
87592|NCT01163721|333255|P1|Overall Study|Withdrawal by Subject|3
87593|NCT01163721|333254|P2|Overall Study|Adverse Event|6
87594|NCT01163721|333255|P1|Overall Study|Adverse Event|5
87595|NCT01163617|333274|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
87596|NCT01163617|333275|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
87597|NCT01163617|333276|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
87598|NCT01163617|333277|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
87599|NCT01163617|333278|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
87600|NCT01163617|333279|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
87601|NCT01163617|333280|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
87602|NCT01163617|333281|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
87603|NCT01163617|333274|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
87604|NCT01163617|333275|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
87605|NCT01163617|333276|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
87606|NCT01163617|333277|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
87607|NCT01163617|333278|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
87608|NCT01163617|333279|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
87609|NCT01163617|333280|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
87610|NCT01163617|333281|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
87611|NCT01163617|333274|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
87612|NCT01163617|333275|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
87613|NCT01163617|333276|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
87614|NCT01163617|333277|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
87615|NCT01163617|333278|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
87616|NCT01163617|333279|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
87617|NCT01163617|333280|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
87618|NCT01163617|333281|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
87619|NCT01163474|333310|P1|Overall Study|Lost to Follow-up|3
87620|NCT01163474|333310|P1|Overall Study|Tech barriers to videoteleconference vis|12
87621|NCT01163474|333310|P1|Overall Study|Withdrawal by Subject|1
87622|NCT01163318|333321|P1|Overall Study|Multiple Reasons Per Participant|224
87623|NCT01163318|333321|P1|Overall Study|Participants Without Case Report Form|7
87624|NCT01163318|333321|P1|Overall Study|History/comorbidity of malignant tumor|3
87625|NCT01163318|333321|P1|Overall Study|Did Not Continue Use of Adalimumab|26
87626|NCT01163318|333321|P1|Overall Study|Off-Label Use of Adalimumab|8
87627|NCT01163292|333330|P2|Overall Study|No further visits|7
87628|NCT01163292|333331|P1|Overall Study|No further visits|5
87629|NCT01163292|333330|P2|Overall Study|Economic reasons|0
87630|NCT01163292|333331|P1|Overall Study|Economic reasons|6
87631|NCT01163292|333330|P2|Overall Study|Refusal to receive adalimumab|0
87632|NCT01163292|333331|P1|Overall Study|Refusal to receive adalimumab|7
87633|NCT01163292|333330|P2|Overall Study|Sufficient response to adalimumab|0
87634|NCT01163292|333331|P1|Overall Study|Sufficient response to adalimumab|8
87635|NCT01163292|333330|P2|Overall Study|Initiation of biological therapy|15
87636|NCT01163292|333331|P1|Overall Study|Initiation of biological therapy|0
87637|NCT01163292|333330|P2|Overall Study|Adverse Event|0
87638|NCT01163292|333331|P1|Overall Study|Adverse Event|6
87639|NCT01163292|333330|P2|Overall Study|Lack of Efficacy|0
87640|NCT01163292|333331|P1|Overall Study|Lack of Efficacy|9
87641|NCT01163279|333347|P2|Overall Study|Withdrawal by Subject|0
87642|NCT01163279|333348|P1|Overall Study|Withdrawal by Subject|2
87643|NCT01163266|333377|P3|Overall Study|Other|2
87644|NCT01163266|333378|P2|Overall Study|Other|1
87645|NCT01163266|333379|P1|Overall Study|Other|1
87646|NCT01163266|333377|P3|Overall Study|Lost to Follow-up|10
87647|NCT01163266|333378|P2|Overall Study|Lost to Follow-up|7
87648|NCT01163266|333379|P1|Overall Study|Lost to Follow-up|7
87649|NCT01163266|333377|P3|Overall Study|Withdrawal of Consent|3
87650|NCT01163266|333378|P2|Overall Study|Withdrawal of Consent|7
87651|NCT01163266|333379|P1|Overall Study|Withdrawal of Consent|5
87652|NCT01163266|333377|P3|Overall Study|Protocol Deviations|5
87653|NCT01163266|333378|P2|Overall Study|Protocol Deviations|2
87654|NCT01163266|333379|P1|Overall Study|Protocol Deviations|2
87655|NCT01163266|333377|P3|Overall Study|Noncompliance with Study Drug|0
87656|NCT01163266|333378|P2|Overall Study|Noncompliance with Study Drug|2
87657|NCT01163266|333379|P1|Overall Study|Noncompliance with Study Drug|0
87658|NCT01163266|333377|P3|Overall Study|Lack of Efficacy|1
87659|NCT01163266|333378|P2|Overall Study|Lack of Efficacy|3
87660|NCT01163266|333379|P1|Overall Study|Lack of Efficacy|1
87661|NCT01163266|333377|P3|Overall Study|Pretreatment Event or Adverse Event|7
87662|NCT01163266|333378|P2|Overall Study|Pretreatment Event or Adverse Event|9
87663|NCT01163266|333379|P1|Overall Study|Pretreatment Event or Adverse Event|2
87664|NCT01163253|333404|P2|Overall Study|Other Unspecified|34
87665|NCT01163253|333405|P1|Overall Study|Other Unspecified|170
87666|NCT01163253|333404|P2|Overall Study|Ongoing|4
87667|NCT01163253|333405|P1|Overall Study|Ongoing|13
87668|NCT01163253|333404|P2|Overall Study|Death|5
87669|NCT01163253|333405|P1|Overall Study|Death|17
87670|NCT01163253|333404|P2|Overall Study|Adverse Event|78
87671|NCT01163253|333405|P1|Overall Study|Adverse Event|300
87672|NCT01163253|333404|P2|Overall Study|Insufficient Clinical Response|29
87673|NCT01163253|333405|P1|Overall Study|Insufficient Clinical Response|423
87674|NCT01163253|333404|P2|Overall Study|Lost to Follow-up|23
87675|NCT01163253|333405|P1|Overall Study|Lost to Follow-up|125
87676|NCT01163253|333404|P2|Overall Study|Medication Error|0
87677|NCT01163253|333405|P1|Overall Study|Medication Error|1
87678|NCT01163253|333404|P2|Overall Study|Withdrawal by Subject|50
87679|NCT01163253|333405|P1|Overall Study|Withdrawal by Subject|199
87680|NCT01163253|333404|P2|Overall Study|Protocol Violation|12
87681|NCT01163253|333405|P1|Overall Study|Protocol Violation|43
87682|NCT01163253|333404|P2|Overall Study|Study Terminated by Sponsor|349
87683|NCT01163253|333405|P1|Overall Study|Study Terminated by Sponsor|978
87684|NCT01163253|333404|P2|Overall Study|Withdrawn Due to Pregnancy|2
87685|NCT01163253|333405|P1|Overall Study|Withdrawn Due to Pregnancy|12
87686|NCT01163149|333593|P3|Extension Treatment Period|Noncompliance|1
87687|NCT01163149|333594|P2|Extension Treatment Period|Noncompliance|0
87688|NCT01163149|333595|P1|Extension Treatment Period|Noncompliance|0
87689|NCT01163149|333593|P3|Extension Treatment Period|Adverse Event|0
87690|NCT01163149|333594|P2|Extension Treatment Period|Adverse Event|1
87691|NCT01163149|333595|P1|Extension Treatment Period|Adverse Event|0
87692|NCT01163149|333593|P3|Extension Treatment Period|Withdrawal by Subject|1
87693|NCT01163149|333594|P2|Extension Treatment Period|Withdrawal by Subject|0
87694|NCT01163149|333595|P1|Extension Treatment Period|Withdrawal by Subject|2
87695|NCT01163032|333695|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
87696|NCT01163032|333696|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
87697|NCT01163032|333697|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
87698|NCT01163032|333695|P3|Open Label Extension Phase|Study Termination|7
87699|NCT01163032|333696|P2|Open Label Extension Phase|Study Termination|0
87700|NCT01163032|333697|P1|Open Label Extension Phase|Study Termination|0
87701|NCT01163032|333695|P3|Open Label Extension Phase|Protocol Violation|1
87702|NCT01163032|333696|P2|Open Label Extension Phase|Protocol Violation|0
87703|NCT01163032|333697|P1|Open Label Extension Phase|Protocol Violation|0
87704|NCT01163032|333695|P3|Open Label Extension Phase|Withdrawal by Subject|3
87705|NCT01163032|333696|P2|Open Label Extension Phase|Withdrawal by Subject|0
87706|NCT01163032|333697|P1|Open Label Extension Phase|Withdrawal by Subject|0
87707|NCT01163032|333695|P3|Open Label Extension Phase|Adverse Event|3
87708|NCT01163032|333696|P2|Open Label Extension Phase|Adverse Event|0
87709|NCT01163032|333697|P1|Open Label Extension Phase|Adverse Event|0
87710|NCT01163032|333695|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
87711|NCT01163032|333696|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
87712|NCT01163032|333697|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
87713|NCT01163032|333695|P3|Randomization Phase|Various*|0
87714|NCT01163032|333696|P2|Randomization Phase|Various*|4
87715|NCT01163032|333697|P1|Randomization Phase|Various*|5
87716|NCT01163032|333695|P3|Randomization Phase|Protocol Violation|0
87717|NCT01163032|333696|P2|Randomization Phase|Protocol Violation|1
87718|NCT01163032|333697|P1|Randomization Phase|Protocol Violation|0
87719|NCT01163032|333695|P3|Randomization Phase|Adverse Event|0
87720|NCT01163032|333696|P2|Randomization Phase|Adverse Event|3
87721|NCT01163032|333697|P1|Randomization Phase|Adverse Event|3
87722|NCT01163032|333695|P3|Randomization Phase|Withdrawal by Subject|0
87723|NCT01163032|333696|P2|Randomization Phase|Withdrawal by Subject|3
87724|NCT01163032|333697|P1|Randomization Phase|Withdrawal by Subject|2
87725|NCT01162863|333730|P3|Overall Study|Adverse Event|0
87726|NCT01162863|333731|P2|Overall Study|Adverse Event|1
87727|NCT01162863|333732|P1|Overall Study|Adverse Event|0
87728|NCT01162863|333730|P3|Overall Study|Lack of Efficacy|0
87729|NCT01162863|333731|P2|Overall Study|Lack of Efficacy|0
87730|NCT01162863|333732|P1|Overall Study|Lack of Efficacy|1
87731|NCT01162499|333757|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
87732|NCT01162499|333758|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
87733|NCT01162473|333780|P2|Overall Study|Withdrawal by Subject|4
87734|NCT01162473|333781|P1|Overall Study|Withdrawal by Subject|0
87735|NCT01162473|333780|P2|Overall Study|Adverse Event|1
87736|NCT01162473|333781|P1|Overall Study|Adverse Event|2
87737|NCT01162421|333789|P2|Overall Study|Not specified|3
87738|NCT01162421|333790|P1|Overall Study|Not specified|2
87739|NCT01162421|333789|P2|Overall Study|Lack of Efficacy|2
87740|NCT01162421|333790|P1|Overall Study|Lack of Efficacy|2
87741|NCT01162421|333789|P2|Overall Study|Lost to Follow-up|2
87742|NCT01162421|333790|P1|Overall Study|Lost to Follow-up|0
87743|NCT01162421|333789|P2|Overall Study|Adverse Event|5
87744|NCT01162421|333790|P1|Overall Study|Adverse Event|2
87745|NCT01162421|333789|P2|Overall Study|Did not receive study drug|1
87746|NCT01162421|333790|P1|Overall Study|Did not receive study drug|2
87747|NCT01162343|333868|P1|Overall Study|Refused psychiatrist assessment|12
87748|NCT01162343|333868|P1|Overall Study|Left ED prior to psychiatrist assessment|80
87749|NCT01162304|333883|P1|Overall Study|Beck scale to high|11
87750|NCT01162135|333897|P1|Overall Study|Ineligible|1
87751|NCT01162135|333897|P1|Overall Study|Severe back pain|1
87752|NCT01162135|333897|P1|Overall Study|Withdrawal by Subject|1
87753|NCT01162122|333903|P2|Overall Study|Missing primary reason|0
87754|NCT01162122|333904|P1|Overall Study|Missing primary reason|1
87755|NCT01162122|333903|P2|Overall Study|Unable to classify|7
87756|NCT01162122|333904|P1|Overall Study|Unable to classify|3
87757|NCT01162122|333903|P2|Overall Study|Administrative reason|1
87758|NCT01162122|333904|P1|Overall Study|Administrative reason|1
87759|NCT01162122|333903|P2|Overall Study|Inappropriate enrollment|4
87760|NCT01162122|333904|P1|Overall Study|Inappropriate enrollment|5
87761|NCT01162122|333903|P2|Overall Study|Protocol Violation|2
87762|NCT01162122|333904|P1|Overall Study|Protocol Violation|2
87763|NCT01162122|333903|P2|Overall Study|Death|46
87764|NCT01162122|333904|P1|Overall Study|Death|51
87765|NCT01162122|333903|P2|Overall Study|Adverse Event|2
87766|NCT01162122|333904|P1|Overall Study|Adverse Event|3
87767|NCT01162122|333903|P2|Overall Study|Lost to Follow-up|91
87768|NCT01162122|333904|P1|Overall Study|Lost to Follow-up|73
87769|NCT01162122|333903|P2|Overall Study|Withdrawal by Subject|43
87770|NCT01162122|333904|P1|Overall Study|Withdrawal by Subject|52
87771|NCT01161628|333999|P1|Overall Study|Lack of Efficacy|2
87772|NCT01161628|333999|P1|Overall Study|Death|6
87773|NCT01161537|334022|P1|Part B|Withdrawal by Subject|2
87774|NCT01161498|334040|P2|Overall Study|Disease Progression|1
87775|NCT01161498|334041|P1|Overall Study|Disease Progression|0
87776|NCT01161472|334065|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
87777|NCT01161472|334066|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
87778|NCT01161472|334067|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
87779|NCT01161472|334068|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
87780|NCT01161446|334124|P2|Overall Study|Withdrawal by Subject|1
87781|NCT01161446|334125|P1|Overall Study|Withdrawal by Subject|0
87782|NCT01161446|334124|P2|Overall Study|Lost to Follow-up|14
87783|NCT01161446|334125|P1|Overall Study|Lost to Follow-up|18
87784|NCT01161407|334151|P2|Overall Study|Protocol Violation|1
87785|NCT01161407|334152|P1|Overall Study|Protocol Violation|3
87786|NCT01161173|334207|P1|Overall Study|Reasons Not Specified|23
87787|NCT01161173|334207|P1|Overall Study|End of Study|2
87788|NCT01161173|334207|P1|Overall Study|Death|194
87789|NCT01161173|334207|P1|Overall Study|Unacceptable Toxicity|21
87790|NCT01161173|334207|P1|Overall Study|Withdrawal of Consent|5
87791|NCT01161173|334207|P1|Overall Study|Progressive Disease|82
87792|NCT01161173|334207|P1|Overall Study|Lost to Follow-up|7
87793|NCT01161173|334207|P1|Overall Study|Protocol Violation|13
87794|NCT01160822|334334|P7|Overall Study|Protocol deviation|0
87795|NCT01160822|334335|P6|Overall Study|Protocol deviation|0
87796|NCT01160822|334336|P5|Overall Study|Protocol deviation|2
87797|NCT01160822|334337|P4|Overall Study|Protocol deviation|0
87798|NCT01160822|334338|P3|Overall Study|Protocol deviation|0
87799|NCT01160822|334339|P2|Overall Study|Protocol deviation|0
87800|NCT01160822|334340|P1|Overall Study|Protocol deviation|0
87801|NCT01160822|334334|P7|Overall Study|Administrative problems|0
87802|NCT01160822|334335|P6|Overall Study|Administrative problems|0
87803|NCT01160822|334336|P5|Overall Study|Administrative problems|1
87804|NCT01160822|334337|P4|Overall Study|Administrative problems|0
87805|NCT01160822|334338|P3|Overall Study|Administrative problems|0
87806|NCT01160822|334339|P2|Overall Study|Administrative problems|0
87807|NCT01160822|334340|P1|Overall Study|Administrative problems|0
87808|NCT01160822|334334|P7|Overall Study|Lost to Follow-up|0
87809|NCT01160822|334335|P6|Overall Study|Lost to Follow-up|0
87810|NCT01160822|334336|P5|Overall Study|Lost to Follow-up|1
87811|NCT01160822|334337|P4|Overall Study|Lost to Follow-up|0
87812|NCT01160822|334338|P3|Overall Study|Lost to Follow-up|0
87813|NCT01160822|334339|P2|Overall Study|Lost to Follow-up|0
87814|NCT01160822|334340|P1|Overall Study|Lost to Follow-up|0
87815|NCT01160822|334334|P7|Overall Study|Withdrawal by Subject|1
87816|NCT01160822|334335|P6|Overall Study|Withdrawal by Subject|0
87817|NCT01160822|334336|P5|Overall Study|Withdrawal by Subject|0
87818|NCT01160822|334337|P4|Overall Study|Withdrawal by Subject|0
87819|NCT01160822|334338|P3|Overall Study|Withdrawal by Subject|0
87820|NCT01160822|334339|P2|Overall Study|Withdrawal by Subject|0
87821|NCT01160822|334340|P1|Overall Study|Withdrawal by Subject|0
87822|NCT01160822|334334|P7|Overall Study|Unsatisfactory therapeutic effect|3
87823|NCT01160822|334335|P6|Overall Study|Unsatisfactory therapeutic effect|5
87824|NCT01160822|334336|P5|Overall Study|Unsatisfactory therapeutic effect|4
87825|NCT01160822|334337|P4|Overall Study|Unsatisfactory therapeutic effect|0
87826|NCT01160822|334338|P3|Overall Study|Unsatisfactory therapeutic effect|0
87827|NCT01160822|334339|P2|Overall Study|Unsatisfactory therapeutic effect|0
87828|NCT01160822|334340|P1|Overall Study|Unsatisfactory therapeutic effect|0
87829|NCT01160822|334334|P7|Overall Study|Adverse Event|5
87830|NCT01160822|334335|P6|Overall Study|Adverse Event|2
87831|NCT01160822|334336|P5|Overall Study|Adverse Event|1
87832|NCT01160822|334337|P4|Overall Study|Adverse Event|0
87833|NCT01160822|334338|P3|Overall Study|Adverse Event|0
87834|NCT01160822|334339|P2|Overall Study|Adverse Event|0
87835|NCT01160822|334340|P1|Overall Study|Adverse Event|0
87836|NCT01160770|334429|P1|Overall Study|Other Reasons|1
87837|NCT01160770|334429|P1|Overall Study|Lack of Efficacy|15
87838|NCT01160770|334429|P1|Overall Study|Death|9
87839|NCT01160770|334429|P1|Overall Study|Study termination or sponsor request|1
87840|NCT01160770|334429|P1|Overall Study|Lost to Follow-up|7
87841|NCT01160770|334429|P1|Overall Study|Physician Decision|1
87842|NCT01160770|334429|P1|Overall Study|Subject/parent/caregiver request|33
87843|NCT01160770|334429|P1|Overall Study|Protocol Violation|2
87844|NCT01160770|334429|P1|Overall Study|Adverse Event|10
87845|NCT01160744|334442|P4|Overall Study|Alive and Still on Treatment|14
87846|NCT01160744|334443|P3|Overall Study|Alive and Still on Treatment|8
87847|NCT01160744|334444|P2|Overall Study|Alive and Still on Treatment|11
87848|NCT01160744|334445|P1|Overall Study|Alive and Still on Treatment|9
87849|NCT01160744|334442|P4|Overall Study|Not Specified|4
87850|NCT01160744|334443|P3|Overall Study|Not Specified|5
87851|NCT01160744|334444|P2|Overall Study|Not Specified|9
87852|NCT01160744|334445|P1|Overall Study|Not Specified|5
87853|NCT01160744|334442|P4|Overall Study|Not meet inclusion/exclusion criteria|0
87854|NCT01160744|334443|P3|Overall Study|Not meet inclusion/exclusion criteria|1
87855|NCT01160744|334444|P2|Overall Study|Not meet inclusion/exclusion criteria|0
87856|NCT01160744|334445|P1|Overall Study|Not meet inclusion/exclusion criteria|0
87857|NCT01160744|334442|P4|Overall Study|Withdrawal by Subject|4
87858|NCT01160744|334443|P3|Overall Study|Withdrawal by Subject|6
87859|NCT01160744|334444|P2|Overall Study|Withdrawal by Subject|5
87860|NCT01160744|334445|P1|Overall Study|Withdrawal by Subject|6
87861|NCT01160640|334481|P2|Overall Study|Withdrawal by Subject|3
87862|NCT01160640|334482|P1|Overall Study|Withdrawal by Subject|0
87863|NCT01160640|334481|P2|Overall Study|Incarceration|0
87864|NCT01160640|334482|P1|Overall Study|Incarceration|1
87865|NCT01160640|334481|P2|Overall Study|Physician Decision|3
87866|NCT01160640|334482|P1|Overall Study|Physician Decision|3
87867|NCT01160614|334498|P2|Overall Study|Withdrawal by Subject|2
87868|NCT01160614|334499|P1|Overall Study|Withdrawal by Subject|0
87869|NCT01160484|334547|P1|Overall Study|inclusion/exclusion criteria failure|1
87870|NCT01160484|334547|P1|Overall Study|Withdrawal by Subject|2
87871|NCT01160484|334547|P1|Overall Study|Adverse Event|6
87872|NCT01160484|334547|P1|Overall Study|Lack of Efficacy|9
87873|NCT01160198|334628|P3|Overall Study|Participant lost drug; withdrew consent|1
87874|NCT01160198|334629|P2|Overall Study|Participant lost drug; withdrew consent|0
87875|NCT01160198|334630|P1|Overall Study|Participant lost drug; withdrew consent|0
87876|NCT01160198|334628|P3|Overall Study|Lost to Follow-up|0
87877|NCT01160198|334629|P2|Overall Study|Lost to Follow-up|1
87878|NCT01160198|334630|P1|Overall Study|Lost to Follow-up|0
87879|NCT01160198|334628|P3|Overall Study|Adverse Event|0
87880|NCT01160198|334629|P2|Overall Study|Adverse Event|1
87881|NCT01160198|334630|P1|Overall Study|Adverse Event|0
87882|NCT01160198|334628|P3|Overall Study|Withdrawal by Subject|0
87883|NCT01160198|334629|P2|Overall Study|Withdrawal by Subject|1
87884|NCT01160198|334630|P1|Overall Study|Withdrawal by Subject|2
87885|NCT01159938|334652|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
87886|NCT01159938|334653|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
87887|NCT01159938|334654|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
87888|NCT01159938|334655|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
87889|NCT01159938|334656|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
87890|NCT01159912|334719|P3|Overall Study|Withdrawal by Subject|3
87891|NCT01159912|334720|P2|Overall Study|Withdrawal by Subject|3
87892|NCT01159912|334721|P1|Overall Study|Withdrawal by Subject|10
87893|NCT01159912|334719|P3|Overall Study|Physician Decision|3
87894|NCT01159912|334720|P2|Overall Study|Physician Decision|0
87895|NCT01159912|334721|P1|Overall Study|Physician Decision|0
87896|NCT01159912|334719|P3|Overall Study|Lost to Follow-up|0
87897|NCT01159912|334720|P2|Overall Study|Lost to Follow-up|0
87898|NCT01159912|334721|P1|Overall Study|Lost to Follow-up|4
87899|NCT01159912|334719|P3|Overall Study|Protocol Violation|3
87900|NCT01159912|334720|P2|Overall Study|Protocol Violation|2
87901|NCT01159912|334721|P1|Overall Study|Protocol Violation|1
87902|NCT01159912|334719|P3|Overall Study|Lack of Efficacy|14
87903|NCT01159912|334720|P2|Overall Study|Lack of Efficacy|15
87904|NCT01159912|334721|P1|Overall Study|Lack of Efficacy|23
87905|NCT01159912|334719|P3|Overall Study|Adverse Event|3
87906|NCT01159912|334720|P2|Overall Study|Adverse Event|2
87907|NCT01159912|334721|P1|Overall Study|Adverse Event|2
87908|NCT01159769|334744|P1|Overall Study|Adverse Event|1
87909|NCT01159691|334764|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
87910|NCT01159691|334764|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
87911|NCT01159691|334764|P1|Overall Study|Disc. Neupro other & unknown reasons|7
87912|NCT01159691|334764|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
87913|NCT01159691|334764|P1|Overall Study|Discontinued Neupro due to other reasons|1
87914|NCT01159691|334764|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
87915|NCT01159691|334764|P1|Overall Study|Unknown reasons|1
87916|NCT01159691|334764|P1|Overall Study|Lost to Follow-up|2
87917|NCT01159665|334777|P6|Overall Study|Withdrawal by Subject|0
87918|NCT01159665|334778|P5|Overall Study|Withdrawal by Subject|0
87919|NCT01159665|334779|P4|Overall Study|Withdrawal by Subject|0
87920|NCT01159665|334780|P3|Overall Study|Withdrawal by Subject|0
87921|NCT01159665|334781|P2|Overall Study|Withdrawal by Subject|1
87922|NCT01159665|334782|P1|Overall Study|Withdrawal by Subject|0
87923|NCT01159600|334810|P8|Overall Study|Other reason not defined above|3
87924|NCT01159600|334811|P7|Overall Study|Other reason not defined above|3
87925|NCT01159600|334812|P6|Overall Study|Other reason not defined above|7
87926|NCT01159600|334813|P5|Overall Study|Other reason not defined above|5
87927|NCT01159600|334814|P4|Overall Study|Other reason not defined above|2
87928|NCT01159600|334815|P3|Overall Study|Other reason not defined above|4
87929|NCT01159600|334816|P2|Overall Study|Other reason not defined above|0
87930|NCT01159600|334817|P1|Overall Study|Other reason not defined above|3
87931|NCT01159600|334810|P8|Overall Study|Patient refusal to continue,not due toAE|5
87932|NCT01159600|334811|P7|Overall Study|Patient refusal to continue,not due toAE|2
87933|NCT01159600|334812|P6|Overall Study|Patient refusal to continue,not due toAE|4
87934|NCT01159600|334813|P5|Overall Study|Patient refusal to continue,not due toAE|4
87935|NCT01159600|334814|P4|Overall Study|Patient refusal to continue,not due toAE|5
87936|NCT01159600|334815|P3|Overall Study|Patient refusal to continue,not due toAE|4
87937|NCT01159600|334816|P2|Overall Study|Patient refusal to continue,not due toAE|2
87938|NCT01159600|334817|P1|Overall Study|Patient refusal to continue,not due toAE|7
87939|NCT01159600|334810|P8|Overall Study|Lost to Follow-up|2
87940|NCT01159600|334811|P7|Overall Study|Lost to Follow-up|3
87941|NCT01159600|334812|P6|Overall Study|Lost to Follow-up|0
87942|NCT01159600|334813|P5|Overall Study|Lost to Follow-up|3
87943|NCT01159600|334814|P4|Overall Study|Lost to Follow-up|3
87944|NCT01159600|334815|P3|Overall Study|Lost to Follow-up|4
87945|NCT01159600|334816|P2|Overall Study|Lost to Follow-up|3
87946|NCT01159600|334817|P1|Overall Study|Lost to Follow-up|2
87947|NCT01159600|334810|P8|Overall Study|Non compliant with protocol|0
87948|NCT01159600|334811|P7|Overall Study|Non compliant with protocol|2
87949|NCT01159600|334812|P6|Overall Study|Non compliant with protocol|0
87950|NCT01159600|334813|P5|Overall Study|Non compliant with protocol|2
87951|NCT01159600|334814|P4|Overall Study|Non compliant with protocol|0
87952|NCT01159600|334815|P3|Overall Study|Non compliant with protocol|0
87953|NCT01159600|334816|P2|Overall Study|Non compliant with protocol|1
87954|NCT01159600|334817|P1|Overall Study|Non compliant with protocol|2
87955|NCT01159600|334810|P8|Overall Study|Lack of Efficacy|1
87956|NCT01159600|334811|P7|Overall Study|Lack of Efficacy|0
87957|NCT01159600|334812|P6|Overall Study|Lack of Efficacy|0
87958|NCT01159600|334813|P5|Overall Study|Lack of Efficacy|2
87959|NCT01159600|334814|P4|Overall Study|Lack of Efficacy|0
87960|NCT01159600|334815|P3|Overall Study|Lack of Efficacy|0
87961|NCT01159600|334816|P2|Overall Study|Lack of Efficacy|0
87962|NCT01159600|334817|P1|Overall Study|Lack of Efficacy|0
87963|NCT01159600|334810|P8|Overall Study|Adverse Event|5
87964|NCT01159600|334811|P7|Overall Study|Adverse Event|7
87965|NCT01159600|334812|P6|Overall Study|Adverse Event|6
87966|NCT01159600|334813|P5|Overall Study|Adverse Event|8
87967|NCT01159600|334814|P4|Overall Study|Adverse Event|1
87968|NCT01159600|334815|P3|Overall Study|Adverse Event|5
87969|NCT01159600|334816|P2|Overall Study|Adverse Event|2
87970|NCT01159600|334817|P1|Overall Study|Adverse Event|7
87971|NCT01159600|334810|P8|Overall Study|Not treated|2
87972|NCT01159600|334811|P7|Overall Study|Not treated|2
87973|NCT01159600|334812|P6|Overall Study|Not treated|1
87974|NCT01159600|334813|P5|Overall Study|Not treated|0
87975|NCT01159600|334814|P4|Overall Study|Not treated|0
87976|NCT01159600|334815|P3|Overall Study|Not treated|1
87977|NCT01159600|334816|P2|Overall Study|Not treated|0
87978|NCT01159600|334817|P1|Overall Study|Not treated|0
87979|NCT01159574|334859|P1|Follow Up Phase|still being followed for overall surviva|18
87980|NCT01159574|334859|P1|Follow Up Phase|Lost to Follow-up|2
87981|NCT01159574|334859|P1|Treatment Phase|still on treatment|2
87982|NCT01159574|334859|P1|Treatment Phase|Withdrawal by Subject|7
87983|NCT01159574|334859|P1|Treatment Phase|Physician Decision|2
87984|NCT01159574|334859|P1|Treatment Phase|Death|6
87985|NCT01159574|334859|P1|Treatment Phase|Adverse Event|3
87986|NCT01159574|334859|P1|Treatment Phase|non-evaluable/not included in analysis|1
87987|NCT01159431|334880|P2|Overall Study|Lack of Efficacy|3
87988|NCT01159431|334881|P1|Overall Study|Lack of Efficacy|0
87989|NCT01159431|334880|P2|Overall Study|non-compliance|1
87990|NCT01159431|334881|P1|Overall Study|non-compliance|1
87991|NCT01159431|334880|P2|Overall Study|Adverse Event|2
87992|NCT01159431|334881|P1|Overall Study|Adverse Event|1
87993|NCT01159171|334934|P1|Overall Study|Death|1
87994|NCT01159171|334934|P1|Overall Study|Medical Decision|4
87995|NCT01159171|334934|P1|Overall Study|Need for Surgery|5
87996|NCT01159171|334934|P1|Overall Study|Protocol Violation|1
87997|NCT01159171|334934|P1|Overall Study|Progression of Disease|28
87998|NCT01159171|334934|P1|Overall Study|Adverse Event|11
87999|NCT01158924|335008|P2|Overall Study|Lost to Follow-up|1
88000|NCT01158924|335009|P1|Overall Study|Lost to Follow-up|0
88001|NCT01158924|335008|P2|Overall Study|Withdrawal by Subject|2
88002|NCT01158924|335009|P1|Overall Study|Withdrawal by Subject|1
88003|NCT01158534|335080|P1|Overall Study|Other|1
88004|NCT01158534|335080|P1|Overall Study|Death|1
88005|NCT01158534|335080|P1|Overall Study|Withdrawal by Subject|1
88006|NCT01158378|335090|P2|Overall Study|Withdrawal by Subject|0
88007|NCT01158378|335091|P1|Overall Study|Withdrawal by Subject|4
88008|NCT01158378|335090|P2|Overall Study|Lost to Follow-up|4
88009|NCT01158378|335091|P1|Overall Study|Lost to Follow-up|2
88010|NCT01158378|335090|P2|Overall Study|Death|5
88011|NCT01158378|335091|P1|Overall Study|Death|4
88012|NCT01158261|335103|P1|Overall Study|Withdrawal by Subject|1
88013|NCT01158261|335103|P1|Overall Study|Death|7
88014|NCT01158261|335103|P1|Overall Study|Lost to Follow-up|9
88015|NCT01158118|335109|P2|Overall Study|Death|1
88016|NCT01158118|335110|P1|Overall Study|Death|0
88017|NCT01158118|335109|P2|Overall Study|Suffered stroke prior to transplant|1
88018|NCT01158118|335110|P1|Overall Study|Suffered stroke prior to transplant|0
88019|NCT01158118|335109|P2|Overall Study|Donor match was a screen failure|1
88020|NCT01158118|335110|P1|Overall Study|Donor match was a screen failure|0
88021|NCT01158118|335109|P2|Overall Study|Screen failure|0
88022|NCT01158118|335110|P1|Overall Study|Screen failure|1
88023|NCT01157845|335126|P1|Overall Study|Device malfunction|1
88024|NCT01157845|335126|P1|Overall Study|Study was ended|1
88025|NCT01157845|335126|P1|Overall Study|Protocol Violation|13
88026|NCT01157845|335126|P1|Overall Study|Physician Decision|3
88027|NCT01157845|335126|P1|Overall Study|Withdrawal by Subject|12
88028|NCT01157845|335126|P1|Overall Study|Lost to Follow-up|5
88029|NCT01157377|335160|P7|Overall Study|Other Miscellaneous Reasons|1
88030|NCT01157377|335161|P6|Overall Study|Other Miscellaneous Reasons|1
88031|NCT01157377|335162|P5|Overall Study|Other Miscellaneous Reasons|1
88032|NCT01157377|335163|P4|Overall Study|Other Miscellaneous Reasons|0
88033|NCT01157377|335164|P3|Overall Study|Other Miscellaneous Reasons|0
88034|NCT01157377|335165|P2|Overall Study|Other Miscellaneous Reasons|2
88035|NCT01157377|335166|P1|Overall Study|Other Miscellaneous Reasons|0
88036|NCT01157377|335160|P7|Overall Study|Lack of Efficacy|1
88037|NCT01157377|335161|P6|Overall Study|Lack of Efficacy|0
88038|NCT01157377|335162|P5|Overall Study|Lack of Efficacy|0
88039|NCT01157377|335163|P4|Overall Study|Lack of Efficacy|0
88040|NCT01157377|335164|P3|Overall Study|Lack of Efficacy|0
88041|NCT01157377|335165|P2|Overall Study|Lack of Efficacy|0
88042|NCT01157377|335166|P1|Overall Study|Lack of Efficacy|0
88043|NCT01157377|335160|P7|Overall Study|Protocol Violation|0
88044|NCT01157377|335161|P6|Overall Study|Protocol Violation|1
88045|NCT01157377|335162|P5|Overall Study|Protocol Violation|0
88046|NCT01157377|335163|P4|Overall Study|Protocol Violation|0
88047|NCT01157377|335164|P3|Overall Study|Protocol Violation|0
88048|NCT01157377|335165|P2|Overall Study|Protocol Violation|0
88049|NCT01157377|335166|P1|Overall Study|Protocol Violation|0
88050|NCT01157377|335160|P7|Overall Study|Personal Reasons|0
88051|NCT01157377|335161|P6|Overall Study|Personal Reasons|0
88052|NCT01157377|335162|P5|Overall Study|Personal Reasons|0
88053|NCT01157377|335163|P4|Overall Study|Personal Reasons|1
88054|NCT01157377|335164|P3|Overall Study|Personal Reasons|0
88055|NCT01157377|335165|P2|Overall Study|Personal Reasons|1
88056|NCT01157377|335166|P1|Overall Study|Personal Reasons|2
88057|NCT01157377|335160|P7|Overall Study|Lost to Follow-up|0
88058|NCT01157377|335161|P6|Overall Study|Lost to Follow-up|1
88059|NCT01157377|335162|P5|Overall Study|Lost to Follow-up|1
88060|NCT01157377|335163|P4|Overall Study|Lost to Follow-up|0
88061|NCT01157377|335164|P3|Overall Study|Lost to Follow-up|1
88062|NCT01157377|335165|P2|Overall Study|Lost to Follow-up|0
88063|NCT01157377|335166|P1|Overall Study|Lost to Follow-up|0
88064|NCT01157351|335184|P2|Overall Study|Randomized but not Treated|2
88065|NCT01157351|335185|P1|Overall Study|Randomized but not Treated|4
88066|NCT01157351|335184|P2|Overall Study|Noncompliance with Study Drug|3
88067|NCT01157351|335185|P1|Overall Study|Noncompliance with Study Drug|0
88068|NCT01157351|335184|P2|Overall Study|Other|36
88069|NCT01157351|335185|P1|Overall Study|Other|32
88070|NCT01157351|335184|P2|Overall Study|Protocol Violation|1
88071|NCT01157351|335185|P1|Overall Study|Protocol Violation|0
88072|NCT01157351|335184|P2|Overall Study|Physician Decision|4
88073|NCT01157351|335185|P1|Overall Study|Physician Decision|5
88074|NCT01157351|335184|P2|Overall Study|Withdrawal by Subject|27
88075|NCT01157351|335185|P1|Overall Study|Withdrawal by Subject|37
88076|NCT01157351|335184|P2|Overall Study|Lost to Follow-up|55
88077|NCT01157351|335185|P1|Overall Study|Lost to Follow-up|53
88078|NCT01157351|335184|P2|Overall Study|Death|0
88079|NCT01157351|335185|P1|Overall Study|Death|1
88080|NCT01157351|335184|P2|Overall Study|Adverse Event|4
88081|NCT01157351|335185|P1|Overall Study|Adverse Event|5
88082|NCT01157234|335203|P2|Overall Study|Withdrawal by Subject|0
88083|NCT01157234|335204|P1|Overall Study|Withdrawal by Subject|1
88084|NCT01157182|335236|P2|Washout of 28 Days|Adverse Event|0
88085|NCT01157182|335237|P1|Washout of 28 Days|Adverse Event|2
88086|NCT01157169|335285|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
88087|NCT01157169|335286|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
88088|NCT01157169|335285|P2|First Intervention|Emesis Within 4 hrs of Administration|2
88089|NCT01157169|335286|P1|First Intervention|Emesis Within 4 hrs of Administration|4
88090|NCT01157169|335285|P2|First Intervention|Protocol Violation|0
88091|NCT01157169|335286|P1|First Intervention|Protocol Violation|0
88092|NCT01157117|335305|P3|Overall Study|Unknown (Pending Final Form Submission)|13
88093|NCT01157117|335306|P2|Overall Study|Unknown (Pending Final Form Submission)|5
88094|NCT01157117|335307|P1|Overall Study|Unknown (Pending Final Form Submission)|4
88095|NCT01157117|335305|P3|Overall Study|Lost to Follow-up|1
88096|NCT01157117|335306|P2|Overall Study|Lost to Follow-up|0
88097|NCT01157117|335307|P1|Overall Study|Lost to Follow-up|0
88098|NCT01157117|335305|P3|Overall Study|Lack of Efficacy|0
88099|NCT01157117|335306|P2|Overall Study|Lack of Efficacy|1
88100|NCT01157117|335307|P1|Overall Study|Lack of Efficacy|1
88101|NCT01157117|335305|P3|Overall Study|Withdrawal by Subject|1
88102|NCT01157117|335306|P2|Overall Study|Withdrawal by Subject|1
88103|NCT01157117|335307|P1|Overall Study|Withdrawal by Subject|4
88104|NCT01157117|335305|P3|Overall Study|Dosing Symptoms|0
88105|NCT01157117|335306|P2|Overall Study|Dosing Symptoms|4
88106|NCT01157117|335307|P1|Overall Study|Dosing Symptoms|0
88107|NCT01157078|335348|P2|Overall Study|Not specified|4
88108|NCT01157078|335349|P1|Overall Study|Not specified|2
88109|NCT01157078|335348|P2|Overall Study|Lost to Follow-up|5
88110|NCT01157078|335349|P1|Overall Study|Lost to Follow-up|7
88111|NCT01157078|335348|P2|Overall Study|Study-specific withdrawal criteria|2
88112|NCT01157078|335349|P1|Overall Study|Study-specific withdrawal criteria|2
88113|NCT01157078|335348|P2|Overall Study|Lack of Efficacy|0
88114|NCT01157078|335349|P1|Overall Study|Lack of Efficacy|2
88115|NCT01157078|335348|P2|Overall Study|Condition under investigation worsened|1
88116|NCT01157078|335349|P1|Overall Study|Condition under investigation worsened|0
88117|NCT01157078|335348|P2|Overall Study|Severe non-compliance to protocol|4
88118|NCT01157078|335349|P1|Overall Study|Severe non-compliance to protocol|2
88119|NCT01157078|335348|P2|Overall Study|Adverse Event|6
88120|NCT01157078|335349|P1|Overall Study|Adverse Event|6
88121|NCT01157078|335348|P2|Overall Study|Eligibility criteria not fulfilled|0
88122|NCT01157078|335349|P1|Overall Study|Eligibility criteria not fulfilled|2
88123|NCT01157078|335348|P2|Overall Study|Withdrawal by Subject|14
88124|NCT01157078|335349|P1|Overall Study|Withdrawal by Subject|12
88125|NCT01157065|335399|P2|Overall Study|Death|1
88126|NCT01157065|335400|P1|Overall Study|Death|0
88127|NCT01156844|335421|P4|Overall Study|Protocol deviation|0
88128|NCT01156844|335422|P3|Overall Study|Protocol deviation|0
88129|NCT01156844|335423|P2|Overall Study|Protocol deviation|0
88130|NCT01156844|335424|P1|Overall Study|Protocol deviation|2
88131|NCT01156844|335421|P4|Overall Study|Administrative problems|1
88132|NCT01156844|335422|P3|Overall Study|Administrative problems|0
88133|NCT01156844|335423|P2|Overall Study|Administrative problems|1
88134|NCT01156844|335424|P1|Overall Study|Administrative problems|0
88135|NCT01156844|335421|P4|Overall Study|Lost to Follow-up|0
88136|NCT01156844|335422|P3|Overall Study|Lost to Follow-up|1
88137|NCT01156844|335423|P2|Overall Study|Lost to Follow-up|0
88138|NCT01156844|335424|P1|Overall Study|Lost to Follow-up|0
88139|NCT01156844|335421|P4|Overall Study|Withdrawal by Subject|2
88140|NCT01156844|335422|P3|Overall Study|Withdrawal by Subject|2
88141|NCT01156844|335423|P2|Overall Study|Withdrawal by Subject|0
88142|NCT01156844|335424|P1|Overall Study|Withdrawal by Subject|0
88143|NCT01156844|335421|P4|Overall Study|Abnormal test procedure result(s)|2
88144|NCT01156844|335422|P3|Overall Study|Abnormal test procedure result(s)|2
88145|NCT01156844|335423|P2|Overall Study|Abnormal test procedure result(s)|1
88146|NCT01156844|335424|P1|Overall Study|Abnormal test procedure result(s)|0
88147|NCT01156844|335421|P4|Overall Study|Adverse Event|1
88148|NCT01156844|335422|P3|Overall Study|Adverse Event|1
88149|NCT01156844|335423|P2|Overall Study|Adverse Event|0
88150|NCT01156844|335424|P1|Overall Study|Adverse Event|0
88151|NCT01156792|335443|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
88152|NCT01156792|335443|P1|Overall Study|Withdrawal by Subject|9
88153|NCT01156792|335443|P1|Overall Study|Physician Decision|3
88154|NCT01156792|335443|P1|Overall Study|Lost to Follow-up|3
88155|NCT01156792|335443|P1|Overall Study|Protocol Violation|6
88156|NCT01156792|335443|P1|Overall Study|Lack of Efficacy|36
88157|NCT01156792|335443|P1|Overall Study|Adverse Event|1
88158|NCT01156675|335548|P3|Overall Study|No data|2
88159|NCT01156675|335549|P2|Overall Study|No data|22
88160|NCT01156675|335550|P1|Overall Study|No data|29
88161|NCT01156675|335548|P3|Overall Study|Death|0
88162|NCT01156675|335549|P2|Overall Study|Death|3
88163|NCT01156675|335550|P1|Overall Study|Death|5
88164|NCT01156532|335605|P1|Overall Study|Lost to Follow-up|1
88165|NCT01156532|335605|P1|Overall Study|Family Reasons|1
88166|NCT01156480|335617|P2|Overall Study|change in diagnosis|1
88167|NCT01156480|335618|P1|Overall Study|change in diagnosis|0
88168|NCT01156376|335629|P3|Overall Study|Withdrawal by Subject|3
88169|NCT01156376|335630|P2|Overall Study|Withdrawal by Subject|0
88170|NCT01156376|335631|P1|Overall Study|Withdrawal by Subject|0
88171|NCT01156376|335629|P3|Overall Study|Adverse Event|1
88172|NCT01156376|335630|P2|Overall Study|Adverse Event|0
88173|NCT01156376|335631|P1|Overall Study|Adverse Event|1
88174|NCT01156363|335852|P1|Overall Study|Other|6
88175|NCT01156363|335852|P1|Overall Study|Refused Treatment|4
88176|NCT01156363|335852|P1|Overall Study|Failure to Return|1
88177|NCT01156363|335852|P1|Overall Study|Insufficient Therapeutic Response|5
88178|NCT01156363|335852|P1|Overall Study|Adverse Event|6
88179|NCT01156311|335874|P4|6-month Add-on Therapy Period|Not Specified|2
88180|NCT01156311|335875|P3|6-month Add-on Therapy Period|Not Specified|1
88181|NCT01156311|335876|P2|6-month Add-on Therapy Period|Not Specified|0
88182|NCT01156311|335877|P1|6-month Add-on Therapy Period|Not Specified|0
88183|NCT01156311|335874|P4|6-month Add-on Therapy Period|Physician Decision|0
88184|NCT01156311|335875|P3|6-month Add-on Therapy Period|Physician Decision|1
88185|NCT01156311|335876|P2|6-month Add-on Therapy Period|Physician Decision|0
88186|NCT01156311|335877|P1|6-month Add-on Therapy Period|Physician Decision|0
88187|NCT01156311|335874|P4|6-month Add-on Therapy Period|Disease Activity|2
88188|NCT01156311|335875|P3|6-month Add-on Therapy Period|Disease Activity|1
88189|NCT01156311|335876|P2|6-month Add-on Therapy Period|Disease Activity|0
88190|NCT01156311|335877|P1|6-month Add-on Therapy Period|Disease Activity|0
88191|NCT01156311|335874|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
88192|NCT01156311|335875|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
88193|NCT01156311|335876|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
88194|NCT01156311|335877|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
88195|NCT01156311|335874|P4|6-month Add-on Therapy Period|Adverse Event|6
88196|NCT01156311|335875|P3|6-month Add-on Therapy Period|Adverse Event|7
88197|NCT01156311|335876|P2|6-month Add-on Therapy Period|Adverse Event|0
88198|NCT01156311|335877|P1|6-month Add-on Therapy Period|Adverse Event|0
88199|NCT01156311|335874|P4|2-Month Monotherapy Period|Not specified|0
88200|NCT01156311|335875|P3|2-Month Monotherapy Period|Not specified|0
88201|NCT01156311|335876|P2|2-Month Monotherapy Period|Not specified|0
88202|NCT01156311|335877|P1|2-Month Monotherapy Period|Not specified|1
88203|NCT01156311|335874|P4|2-Month Monotherapy Period|Physician Decision|0
88204|NCT01156311|335875|P3|2-Month Monotherapy Period|Physician Decision|0
88205|NCT01156311|335876|P2|2-Month Monotherapy Period|Physician Decision|1
88206|NCT01156311|335877|P1|2-Month Monotherapy Period|Physician Decision|0
88207|NCT01156311|335874|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
88208|NCT01156311|335875|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
88209|NCT01156311|335876|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
88210|NCT01156311|335877|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
88211|NCT01156142|335901|P2|Overall Study|Ineligible|1
88212|NCT01156142|335902|P1|Overall Study|Ineligible|0
88213|NCT01156142|335901|P2|Overall Study|Withdrawal by Subject|6
88214|NCT01156142|335902|P1|Overall Study|Withdrawal by Subject|8
88215|NCT01156116|335920|P2|Overall Study|CPAP intolerance|0
88216|NCT01156116|335921|P1|Overall Study|CPAP intolerance|2
88217|NCT01156116|335920|P2|Overall Study|Withdrawal by Subject|1
88218|NCT01156116|335921|P1|Overall Study|Withdrawal by Subject|3
88219|NCT01156051|335935|P2|Overall Study|patient not compliant with protocol|1
88220|NCT01156051|335936|P1|Overall Study|patient not compliant with protocol|0
88221|NCT01156051|335935|P2|Overall Study|Lost to Follow-up|0
88222|NCT01156051|335936|P1|Overall Study|Lost to Follow-up|1
88223|NCT01156012|335950|P2|Overall Study|Non respect of one of inclusion criteria|1
88224|NCT01156012|335951|P1|Overall Study|Non respect of one of inclusion criteria|2
88225|NCT01156012|335950|P2|Overall Study|use of commercial drug instead of study|1
88226|NCT01156012|335951|P1|Overall Study|use of commercial drug instead of study|0
88227|NCT01156012|335950|P2|Overall Study|Withdrawal by Subject|0
88228|NCT01156012|335951|P1|Overall Study|Withdrawal by Subject|1
88229|NCT01156012|335950|P2|Overall Study|Lost to Follow-up|0
88230|NCT01156012|335951|P1|Overall Study|Lost to Follow-up|1
88231|NCT01156012|335950|P2|Overall Study|Adverse Event|1
88232|NCT01156012|335951|P1|Overall Study|Adverse Event|3
88233|NCT01155869|335968|P2|Overall Study|Lost to Follow-up|1
88234|NCT01155869|335969|P1|Overall Study|Lost to Follow-up|3
88235|NCT01155726|335993|P4|Period 1, 3 Days (Masked)|Inconvenience|0
88236|NCT01155726|335994|P3|Period 1, 3 Days (Masked)|Inconvenience|2
88237|NCT01155726|335995|P2|Period 1, 3 Days (Masked)|Inconvenience|0
88238|NCT01155726|335996|P1|Period 1, 3 Days (Masked)|Inconvenience|1
88239|NCT01155661|336018|P1|Overall Study|Sponsor Decision|13
88240|NCT01155661|336018|P1|Overall Study|Withdrawal by Subject|73
88241|NCT01155661|336018|P1|Overall Study|Protocol Violation|35
88242|NCT01155661|336018|P1|Overall Study|Physician Decision|3
88243|NCT01155661|336018|P1|Overall Study|Lost to Follow-up|22
88244|NCT01155661|336018|P1|Overall Study|Lack of Efficacy|32
88245|NCT01155661|336018|P1|Overall Study|Death|1
88246|NCT01155661|336018|P1|Overall Study|Adverse Event|101
88247|NCT01155570|336044|P1|Overall Study|Other Reasons|23
88248|NCT01155570|336044|P1|Overall Study|Participant's Economic Reasons + Other|1
88249|NCT01155570|336044|P1|Overall Study|Adverse Event + Other Reasons|7
88250|NCT01155570|336044|P1|Overall Study|Adverse Event + Lack of Efficacy|2
88251|NCT01155570|336044|P1|Overall Study|No Hospital Visits|7
88252|NCT01155570|336044|P1|Overall Study|Participant's Economic Reasons|17
88253|NCT01155570|336044|P1|Overall Study|Lack of Efficacy|46
88254|NCT01155570|336044|P1|Overall Study|Adverse Event|39
88255|NCT01155531|336078|P4|Overall Study|Withdrawal by Subject|0
88256|NCT01155531|336079|P3|Overall Study|Withdrawal by Subject|1
88257|NCT01155531|336080|P2|Overall Study|Withdrawal by Subject|0
88258|NCT01155531|336081|P1|Overall Study|Withdrawal by Subject|1
88259|NCT01155531|336078|P4|Overall Study|Lost to Follow-up|1
88260|NCT01155531|336079|P3|Overall Study|Lost to Follow-up|0
88261|NCT01155531|336080|P2|Overall Study|Lost to Follow-up|0
88262|NCT01155531|336081|P1|Overall Study|Lost to Follow-up|0
88263|NCT01155531|336078|P4|Overall Study|Adverse Event|0
88264|NCT01155531|336079|P3|Overall Study|Adverse Event|1
88265|NCT01155531|336080|P2|Overall Study|Adverse Event|0
88266|NCT01155531|336081|P1|Overall Study|Adverse Event|0
88267|NCT01155479|336104|P5|Part II|Non-Compliance with Protocol|0
88268|NCT01155479|336105|P4|Part II|Non-Compliance with Protocol|2
88269|NCT01155479|336106|P3|Part II|Non-Compliance with Protocol|0
88270|NCT01155479|336107|P2|Part II|Non-Compliance with Protocol|1
88271|NCT01155479|336108|P1|Part II|Non-Compliance with Protocol|0
88272|NCT01155479|336104|P5|Part II|Treatment Failure|1
88273|NCT01155479|336105|P4|Part II|Treatment Failure|0
88274|NCT01155479|336106|P3|Part II|Treatment Failure|2
88275|NCT01155479|336107|P2|Part II|Treatment Failure|1
88276|NCT01155479|336108|P1|Part II|Treatment Failure|0
88277|NCT01155479|336104|P5|Part II|Lost to Follow-up|1
88278|NCT01155479|336105|P4|Part II|Lost to Follow-up|0
88279|NCT01155479|336106|P3|Part II|Lost to Follow-up|0
88280|NCT01155479|336107|P2|Part II|Lost to Follow-up|0
88281|NCT01155479|336108|P1|Part II|Lost to Follow-up|1
88282|NCT01155479|336104|P5|Part II|Withdrawal by Subject|3
88283|NCT01155479|336105|P4|Part II|Withdrawal by Subject|7
88284|NCT01155479|336106|P3|Part II|Withdrawal by Subject|12
88285|NCT01155479|336107|P2|Part II|Withdrawal by Subject|4
88286|NCT01155479|336108|P1|Part II|Withdrawal by Subject|8
88287|NCT01155479|336104|P5|Part II|Administrative|46
88288|NCT01155479|336105|P4|Part II|Administrative|38
88289|NCT01155479|336106|P3|Part II|Administrative|36
88290|NCT01155479|336107|P2|Part II|Administrative|49
88291|NCT01155479|336108|P1|Part II|Administrative|43
88292|NCT01155479|336104|P5|Part II|Adverse Event|4
88293|NCT01155479|336105|P4|Part II|Adverse Event|3
88294|NCT01155479|336106|P3|Part II|Adverse Event|8
88295|NCT01155479|336107|P2|Part II|Adverse Event|6
88296|NCT01155479|336108|P1|Part II|Adverse Event|7
88297|NCT01155479|336104|P5|Part I|Non-Compliance with Protocol|2
88298|NCT01155479|336105|P4|Part I|Non-Compliance with Protocol|3
88299|NCT01155479|336106|P3|Part I|Non-Compliance with Protocol|3
88300|NCT01155479|336107|P2|Part I|Non-Compliance with Protocol|1
88301|NCT01155479|336108|P1|Part I|Non-Compliance with Protocol|2
88302|NCT01155479|336104|P5|Part I|Did Not Receive Treatment|1
88303|NCT01155479|336105|P4|Part I|Did Not Receive Treatment|6
88304|NCT01155479|336106|P3|Part I|Did Not Receive Treatment|2
88305|NCT01155479|336107|P2|Part I|Did Not Receive Treatment|2
88306|NCT01155479|336108|P1|Part I|Did Not Receive Treatment|4
88307|NCT01155479|336104|P5|Part I|Treatment Failure|2
88308|NCT01155479|336105|P4|Part I|Treatment Failure|1
88309|NCT01155479|336106|P3|Part I|Treatment Failure|3
88310|NCT01155479|336107|P2|Part I|Treatment Failure|0
88311|NCT01155479|336108|P1|Part I|Treatment Failure|3
88312|NCT01155479|336104|P5|Part I|Lost to Follow-up|0
88313|NCT01155479|336105|P4|Part I|Lost to Follow-up|1
88314|NCT01155479|336106|P3|Part I|Lost to Follow-up|1
88315|NCT01155479|336107|P2|Part I|Lost to Follow-up|0
88316|NCT01155479|336108|P1|Part I|Lost to Follow-up|0
88317|NCT01155479|336104|P5|Part I|Withdrawal by Subject|9
88318|NCT01155479|336105|P4|Part I|Withdrawal by Subject|8
88319|NCT01155479|336106|P3|Part I|Withdrawal by Subject|8
88320|NCT01155479|336107|P2|Part I|Withdrawal by Subject|13
88321|NCT01155479|336108|P1|Part I|Withdrawal by Subject|11
88322|NCT01155479|336104|P5|Part I|Did Not Meet Protocol Eligibility|3
88323|NCT01155479|336105|P4|Part I|Did Not Meet Protocol Eligibility|1
88324|NCT01155479|336106|P3|Part I|Did Not Meet Protocol Eligibility|2
88325|NCT01155479|336107|P2|Part I|Did Not Meet Protocol Eligibility|1
88326|NCT01155479|336108|P1|Part I|Did Not Meet Protocol Eligibility|3
88327|NCT01155479|336104|P5|Part I|Administrative|0
88328|NCT01155479|336105|P4|Part I|Administrative|0
88329|NCT01155479|336106|P3|Part I|Administrative|2
88330|NCT01155479|336107|P2|Part I|Administrative|2
88331|NCT01155479|336108|P1|Part I|Administrative|2
88332|NCT01155479|336104|P5|Part I|Adverse Event|6
88333|NCT01155479|336105|P4|Part I|Adverse Event|7
88334|NCT01155479|336106|P3|Part I|Adverse Event|18
88335|NCT01155479|336107|P2|Part I|Adverse Event|8
88336|NCT01155479|336108|P1|Part I|Adverse Event|13
88337|NCT01155466|336160|P5|Overall Study|Randomized not treated|2
88338|NCT01155466|336161|P4|Overall Study|Randomized not treated|0
88339|NCT01155466|336162|P3|Overall Study|Randomized not treated|3
88340|NCT01155466|336163|P2|Overall Study|Randomized not treated|2
88341|NCT01155466|336164|P1|Overall Study|Randomized not treated|2
88342|NCT01155466|336160|P5|Overall Study|Administrative|0
88343|NCT01155466|336161|P4|Overall Study|Administrative|0
88344|NCT01155466|336162|P3|Overall Study|Administrative|0
88345|NCT01155466|336163|P2|Overall Study|Administrative|3
88346|NCT01155466|336164|P1|Overall Study|Administrative|0
88347|NCT01155466|336160|P5|Overall Study|Protocol Violation|1
88348|NCT01155466|336161|P4|Overall Study|Protocol Violation|0
88349|NCT01155466|336162|P3|Overall Study|Protocol Violation|2
88350|NCT01155466|336163|P2|Overall Study|Protocol Violation|0
88351|NCT01155466|336164|P1|Overall Study|Protocol Violation|0
88352|NCT01155466|336160|P5|Overall Study|Withdrawal by Subject|4
88353|NCT01155466|336161|P4|Overall Study|Withdrawal by Subject|4
88354|NCT01155466|336162|P3|Overall Study|Withdrawal by Subject|9
88355|NCT01155466|336163|P2|Overall Study|Withdrawal by Subject|5
88356|NCT01155466|336164|P1|Overall Study|Withdrawal by Subject|7
88357|NCT01155466|336160|P5|Overall Study|Lost to Follow-up|2
88358|NCT01155466|336161|P4|Overall Study|Lost to Follow-up|0
88359|NCT01155466|336162|P3|Overall Study|Lost to Follow-up|0
88360|NCT01155466|336163|P2|Overall Study|Lost to Follow-up|0
88361|NCT01155466|336164|P1|Overall Study|Lost to Follow-up|0
88362|NCT01155466|336160|P5|Overall Study|Adverse Event|18
88363|NCT01155466|336161|P4|Overall Study|Adverse Event|17
88364|NCT01155466|336162|P3|Overall Study|Adverse Event|6
88365|NCT01155466|336163|P2|Overall Study|Adverse Event|15
88366|NCT01155466|336164|P1|Overall Study|Adverse Event|13
88367|NCT01155388|336218|P2|Overall Study|Adverse Event|0
88368|NCT01155388|336219|P1|Overall Study|Adverse Event|1
88369|NCT01155375|336229|P2|Overall Study|Adverse Event|0
88370|NCT01155375|336230|P1|Overall Study|Adverse Event|1
88371|NCT01155323|336249|P2|Second Intervention|Lost to Follow-up|1
88372|NCT01155323|336250|P1|Second Intervention|Lost to Follow-up|1
88373|NCT01155323|336249|P2|First Intervention|exclusion criteria|1
88374|NCT01155323|336250|P1|First Intervention|exclusion criteria|1
88375|NCT01155284|336268|P2|Overall Study|Adverse Event|0
88376|NCT01155284|336269|P1|Overall Study|Adverse Event|1
88377|NCT01155284|336268|P2|Overall Study|Physician Decision|0
88378|NCT01155284|336269|P1|Overall Study|Physician Decision|1
88379|NCT01155284|336268|P2|Overall Study|Lost to Follow-up|2
88380|NCT01155284|336269|P1|Overall Study|Lost to Follow-up|1
88381|NCT01155284|336268|P2|Overall Study|Withdrawal by Subject|3
88382|NCT01155284|336269|P1|Overall Study|Withdrawal by Subject|4
88383|NCT01155219|336279|P2|Overall Study|non-medical reason|2
88384|NCT01155219|336280|P1|Overall Study|non-medical reason|1
88385|NCT01155219|336279|P2|Overall Study|Adverse Event|1
88386|NCT01155219|336280|P1|Overall Study|Adverse Event|3
88387|NCT01155167|336297|P2|Overall Study|Access site changed to femoral artery|0
88388|NCT01155167|336298|P1|Overall Study|Access site changed to femoral artery|1
88389|NCT01155167|336297|P2|Overall Study|Insufficient ultrasound data|0
88390|NCT01155167|336298|P1|Overall Study|Insufficient ultrasound data|2
88391|NCT01155141|336321|P1|Overall Study|Screen Failure|1
88392|NCT01155141|336321|P1|Overall Study|Withdrawal by Subject|1
88393|NCT01155063|336333|P1|Overall Study|Study terminated by sponsor|87
88394|NCT01155063|336333|P1|Overall Study|Withdrawal by Subject|1
88395|NCT01155063|336333|P1|Overall Study|Adverse Event|1
88396|NCT01155024|336343|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
88397|NCT01155024|336344|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
88398|NCT01155024|336343|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
88399|NCT01155024|336344|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
88400|NCT01155024|336343|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
88401|NCT01155024|336344|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
88402|NCT01155011|336354|P2|6 to 12 Months|Death|5
88403|NCT01155011|336355|P1|6 to 12 Months|Death|1
88404|NCT01155011|336354|P2|6 to 12 Months|Withdrawal by Subject|5
88405|NCT01155011|336355|P1|6 to 12 Months|Withdrawal by Subject|8
88406|NCT01155011|336354|P2|Baseline to 6 Months|Death|1
88407|NCT01155011|336355|P1|Baseline to 6 Months|Death|0
88408|NCT01155011|336354|P2|Baseline to 6 Months|investigator decision, moved|5
88409|NCT01155011|336355|P1|Baseline to 6 Months|investigator decision, moved|4
88410|NCT01155011|336354|P2|Baseline to 6 Months|Withdrawal by Subject|19
88411|NCT01155011|336355|P1|Baseline to 6 Months|Withdrawal by Subject|18
88412|NCT01154816|336396|P12|Overall Study|Adverse Event|0
88413|NCT01154816|336397|P11|Overall Study|Adverse Event|0
88414|NCT01154816|336398|P10|Overall Study|Adverse Event|0
88415|NCT01154816|336399|P9|Overall Study|Adverse Event|0
88416|NCT01154816|336400|P8|Overall Study|Adverse Event|1
88417|NCT01154816|336401|P7|Overall Study|Adverse Event|1
88418|NCT01154816|336402|P6|Overall Study|Adverse Event|0
88419|NCT01154816|336403|P5|Overall Study|Adverse Event|0
88420|NCT01154816|336404|P4|Overall Study|Adverse Event|0
88421|NCT01154816|336405|P3|Overall Study|Adverse Event|0
88422|NCT01154816|336406|P2|Overall Study|Adverse Event|2
88423|NCT01154816|336407|P1|Overall Study|Adverse Event|5
88424|NCT01154816|336396|P12|Overall Study|Physician Decision|1
88425|NCT01154816|336397|P11|Overall Study|Physician Decision|1
88426|NCT01154816|336398|P10|Overall Study|Physician Decision|1
88427|NCT01154816|336399|P9|Overall Study|Physician Decision|0
88428|NCT01154816|336400|P8|Overall Study|Physician Decision|0
88429|NCT01154816|336401|P7|Overall Study|Physician Decision|0
88430|NCT01154816|336402|P6|Overall Study|Physician Decision|0
88431|NCT01154816|336403|P5|Overall Study|Physician Decision|2
88432|NCT01154816|336404|P4|Overall Study|Physician Decision|0
88433|NCT01154816|336405|P3|Overall Study|Physician Decision|1
88434|NCT01154816|336406|P2|Overall Study|Physician Decision|0
88435|NCT01154816|336407|P1|Overall Study|Physician Decision|1
88436|NCT01154816|336396|P12|Overall Study|Progressive Disease|3
88437|NCT01154816|336397|P11|Overall Study|Progressive Disease|10
88438|NCT01154816|336398|P10|Overall Study|Progressive Disease|6
88439|NCT01154816|336399|P9|Overall Study|Progressive Disease|8
88440|NCT01154816|336400|P8|Overall Study|Progressive Disease|6
88441|NCT01154816|336401|P7|Overall Study|Progressive Disease|5
88442|NCT01154816|336402|P6|Overall Study|Progressive Disease|8
88443|NCT01154816|336403|P5|Overall Study|Progressive Disease|8
88444|NCT01154816|336404|P4|Overall Study|Progressive Disease|9
88445|NCT01154816|336405|P3|Overall Study|Progressive Disease|9
88446|NCT01154816|336406|P2|Overall Study|Progressive Disease|8
88447|NCT01154816|336407|P1|Overall Study|Progressive Disease|13
88448|NCT01154816|336396|P12|Overall Study|Withdrawal by Subject|0
88449|NCT01154816|336397|P11|Overall Study|Withdrawal by Subject|0
88450|NCT01154816|336398|P10|Overall Study|Withdrawal by Subject|3
88451|NCT01154816|336399|P9|Overall Study|Withdrawal by Subject|1
88452|NCT01154816|336400|P8|Overall Study|Withdrawal by Subject|0
88453|NCT01154816|336401|P7|Overall Study|Withdrawal by Subject|0
88454|NCT01154816|336402|P6|Overall Study|Withdrawal by Subject|0
88455|NCT01154816|336403|P5|Overall Study|Withdrawal by Subject|0
88456|NCT01154816|336404|P4|Overall Study|Withdrawal by Subject|1
88457|NCT01154816|336405|P3|Overall Study|Withdrawal by Subject|0
88458|NCT01154816|336406|P2|Overall Study|Withdrawal by Subject|0
88459|NCT01154816|336407|P1|Overall Study|Withdrawal by Subject|1
88460|NCT01154673|336484|P2|Overall Study|moved out of province|0
88461|NCT01154673|336485|P1|Overall Study|moved out of province|1
88462|NCT01154673|336484|P2|Overall Study|Lost to Follow-up|0
88463|NCT01154673|336485|P1|Overall Study|Lost to Follow-up|1
88464|NCT01154452|336540|P4|Phase II|Adverse Event|4
88465|NCT01154452|336541|P3|Phase II|Adverse Event|4
88466|NCT01154452|336542|P2|Phase II|Adverse Event|0
88467|NCT01154452|336543|P1|Phase II|Adverse Event|0
88468|NCT01154452|336540|P4|Phase II|Withdrawal by Subject|2
88469|NCT01154452|336541|P3|Phase II|Withdrawal by Subject|1
88470|NCT01154452|336542|P2|Phase II|Withdrawal by Subject|0
88471|NCT01154452|336543|P1|Phase II|Withdrawal by Subject|0
88472|NCT01154452|336540|P4|Phase Ib|Adverse Event|0
88473|NCT01154452|336541|P3|Phase Ib|Adverse Event|0
88474|NCT01154452|336542|P2|Phase Ib|Adverse Event|1
88475|NCT01154452|336543|P1|Phase Ib|Adverse Event|2
88476|NCT01154452|336540|P4|Phase Ib|Not Treated|0
88477|NCT01154452|336541|P3|Phase Ib|Not Treated|0
88478|NCT01154452|336542|P2|Phase Ib|Not Treated|0
88479|NCT01154452|336543|P1|Phase Ib|Not Treated|1
88480|NCT01154296|336573|P2|6-month Follow-up|Declined by Study Coordinator|4
88481|NCT01154296|336574|P1|6-month Follow-up|Declined by Study Coordinator|5
88482|NCT01154296|336573|P2|6-month Follow-up|Death|2
88483|NCT01154296|336574|P1|6-month Follow-up|Death|3
88484|NCT01154296|336573|P2|6-month Follow-up|Withdrew consent|15
88485|NCT01154296|336574|P1|6-month Follow-up|Withdrew consent|14
88486|NCT01154296|336573|P2|6-month Follow-up|Incarcerated|32
88487|NCT01154296|336574|P1|6-month Follow-up|Incarcerated|37
88488|NCT01154296|336573|P2|6-month Follow-up|Lost contact|275
88489|NCT01154296|336574|P1|6-month Follow-up|Lost contact|269
88490|NCT01154296|336573|P2|Randomization and Intervention|Left clinic early|0
88491|NCT01154296|336574|P1|Randomization and Intervention|Left clinic early|2
88492|NCT01154296|336573|P2|Randomization and Intervention|Left before test|1
88493|NCT01154296|336574|P1|Randomization and Intervention|Left before test|0
88494|NCT01154296|336573|P2|Randomization and Intervention|Did not return|0
88495|NCT01154296|336574|P1|Randomization and Intervention|Did not return|1
88496|NCT01154296|336573|P2|Randomization and Intervention|Declined by staff|0
88497|NCT01154296|336574|P1|Randomization and Intervention|Declined by staff|1
88498|NCT01154296|336573|P2|Randomization and Intervention|Decided to decline|1
88499|NCT01154296|336574|P1|Randomization and Intervention|Decided to decline|1
88500|NCT01154283|336592|P2|7-12 Weeks|Withdrawal by Subject|1
88501|NCT01154283|336593|P1|7-12 Weeks|Withdrawal by Subject|0
88502|NCT01154283|336592|P2|7-12 Weeks|Death|0
88503|NCT01154283|336593|P1|7-12 Weeks|Death|1
88504|NCT01154283|336592|P2|0-6 Weeks|Death|1
88505|NCT01154283|336593|P1|0-6 Weeks|Death|0
88506|NCT01154283|336592|P2|0-6 Weeks|Withdrawal by Subject|2
88507|NCT01154283|336593|P1|0-6 Weeks|Withdrawal by Subject|7
88508|NCT01154231|336605|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
88509|NCT01154231|336605|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
88510|NCT01154218|336611|P4|Fourth Intervention Period|Withdrawal by Subject|0
88511|NCT01154218|336612|P3|Fourth Intervention Period|Withdrawal by Subject|0
88512|NCT01154218|336613|P2|Fourth Intervention Period|Withdrawal by Subject|0
88513|NCT01154218|336614|P1|Fourth Intervention Period|Withdrawal by Subject|1
88514|NCT01154218|336611|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
88515|NCT01154218|336612|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
88516|NCT01154218|336613|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
88517|NCT01154218|336614|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
88518|NCT01154218|336611|P4|Third Intervention Period|Adverse Event|0
88519|NCT01154218|336612|P3|Third Intervention Period|Adverse Event|0
88520|NCT01154218|336613|P2|Third Intervention Period|Adverse Event|1
88521|NCT01154218|336614|P1|Third Intervention Period|Adverse Event|0
88522|NCT01154166|336666|P2|Overall Study|Poor Compliance|0
88523|NCT01154166|336667|P1|Overall Study|Poor Compliance|1
88524|NCT01154166|336666|P2|Overall Study|Disease Progression|0
88525|NCT01154166|336667|P1|Overall Study|Disease Progression|1
88526|NCT01154166|336666|P2|Overall Study|Lack of Efficacy|0
88527|NCT01154166|336667|P1|Overall Study|Lack of Efficacy|3
88528|NCT01154166|336666|P2|Overall Study|Withdrawal by Subject|1
88529|NCT01154166|336667|P1|Overall Study|Withdrawal by Subject|10
88530|NCT01154166|336666|P2|Overall Study|Protocol Violation|1
88531|NCT01154166|336667|P1|Overall Study|Protocol Violation|4
88532|NCT01154166|336666|P2|Overall Study|Lost to Follow-up|1
88533|NCT01154166|336667|P1|Overall Study|Lost to Follow-up|1
88534|NCT01154166|336666|P2|Overall Study|Adverse Event|9
88535|NCT01154166|336667|P1|Overall Study|Adverse Event|14
88536|NCT01154153|336699|P2|Overall Study|Withdrew consent|0
88537|NCT01154153|336700|P1|Overall Study|Withdrew consent|1
88538|NCT01154153|336699|P2|Overall Study|Unable to use labs|3
88539|NCT01154153|336700|P1|Overall Study|Unable to use labs|2
88540|NCT01154153|336699|P2|Overall Study|Poor compliance to protocol|0
88541|NCT01154153|336700|P1|Overall Study|Poor compliance to protocol|2
88542|NCT01154140|336718|P2|Overall Study|Randomized but not treated|2
88543|NCT01154140|336719|P1|Overall Study|Randomized but not treated|1
88544|NCT01154140|336718|P2|Overall Study|Other|1
88545|NCT01154140|336719|P1|Overall Study|Other|3
88546|NCT01154140|336718|P2|Overall Study|Withdrawal by Subject|13
88547|NCT01154140|336719|P1|Overall Study|Withdrawal by Subject|12
88548|NCT01154140|336718|P2|Overall Study|Lost to Follow-up|5
88549|NCT01154140|336719|P1|Overall Study|Lost to Follow-up|4
88550|NCT01154140|336718|P2|Overall Study|Death|81
88551|NCT01154140|336719|P1|Overall Study|Death|71
88552|NCT01154127|336772|P2|Period 2 (21 Days)|Protocol Deviation|1
88553|NCT01154127|336773|P1|Period 2 (21 Days)|Protocol Deviation|0
88554|NCT01154127|336772|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
88555|NCT01154127|336773|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
88556|NCT01154127|336772|P2|Washout (14 - 28 Days)|Adverse Event|0
88557|NCT01154127|336773|P1|Washout (14 - 28 Days)|Adverse Event|2
88558|NCT01154127|336772|P2|Period 1 (21 Days)|Withdrawal by Subject|2
88559|NCT01154127|336773|P1|Period 1 (21 Days)|Withdrawal by Subject|0
88560|NCT01154127|336772|P2|Period 1 (21 Days)|Adverse Event|4
88561|NCT01154127|336773|P1|Period 1 (21 Days)|Adverse Event|3
88562|NCT01154101|336800|P5|Overall Study|Withdrawal by Subject|1
88563|NCT01154101|336801|P4|Overall Study|Withdrawal by Subject|0
88564|NCT01154101|336802|P3|Overall Study|Withdrawal by Subject|2
88565|NCT01154101|336803|P2|Overall Study|Withdrawal by Subject|1
88566|NCT01154101|336804|P1|Overall Study|Withdrawal by Subject|0
88567|NCT01154101|336800|P5|Overall Study|Lost to Follow-up|0
88568|NCT01154101|336801|P4|Overall Study|Lost to Follow-up|1
88569|NCT01154101|336802|P3|Overall Study|Lost to Follow-up|0
88570|NCT01154101|336803|P2|Overall Study|Lost to Follow-up|1
88571|NCT01154101|336804|P1|Overall Study|Lost to Follow-up|0
88572|NCT01154101|336800|P5|Overall Study|Adverse Event|0
88573|NCT01154101|336801|P4|Overall Study|Adverse Event|1
88574|NCT01154101|336802|P3|Overall Study|Adverse Event|1
88575|NCT01154101|336803|P2|Overall Study|Adverse Event|2
88576|NCT01154101|336804|P1|Overall Study|Adverse Event|0
88577|NCT01154036|336859|P8|Phase II|Withdrawal by Subject|4
88578|NCT01154036|336860|P7|Phase II|Withdrawal by Subject|5
88579|NCT01154036|336861|P6|Phase II|Withdrawal by Subject|2
88580|NCT01154036|336862|P5|Phase II|Withdrawal by Subject|4
88581|NCT01154036|336863|P4|Phase II|Withdrawal by Subject|0
88582|NCT01154036|336864|P3|Phase II|Withdrawal by Subject|0
88583|NCT01154036|336865|P2|Phase II|Withdrawal by Subject|0
88584|NCT01154036|336866|P1|Phase II|Withdrawal by Subject|0
88585|NCT01154036|336859|P8|Phase II|Protocol Violation|0
88586|NCT01154036|336860|P7|Phase II|Protocol Violation|0
88587|NCT01154036|336861|P6|Phase II|Protocol Violation|2
88588|NCT01154036|336862|P5|Phase II|Protocol Violation|1
88589|NCT01154036|336863|P4|Phase II|Protocol Violation|0
88590|NCT01154036|336864|P3|Phase II|Protocol Violation|0
88591|NCT01154036|336865|P2|Phase II|Protocol Violation|0
88592|NCT01154036|336866|P1|Phase II|Protocol Violation|0
88593|NCT01154036|336859|P8|Phase II|Lost to Follow-up|1
88594|NCT01154036|336860|P7|Phase II|Lost to Follow-up|2
88595|NCT01154036|336861|P6|Phase II|Lost to Follow-up|0
88596|NCT01154036|336862|P5|Phase II|Lost to Follow-up|2
88597|NCT01154036|336863|P4|Phase II|Lost to Follow-up|1
88598|NCT01154036|336864|P3|Phase II|Lost to Follow-up|0
88599|NCT01154036|336865|P2|Phase II|Lost to Follow-up|0
88600|NCT01154036|336866|P1|Phase II|Lost to Follow-up|0
88601|NCT01154036|336859|P8|Phase II|Physician Decision|0
88602|NCT01154036|336860|P7|Phase II|Physician Decision|1
88603|NCT01154036|336861|P6|Phase II|Physician Decision|0
88604|NCT01154036|336862|P5|Phase II|Physician Decision|0
88605|NCT01154036|336863|P4|Phase II|Physician Decision|0
88606|NCT01154036|336864|P3|Phase II|Physician Decision|0
88607|NCT01154036|336865|P2|Phase II|Physician Decision|0
88608|NCT01154036|336866|P1|Phase II|Physician Decision|0
88609|NCT01154036|336859|P8|Phase II|Adverse Event|1
88610|NCT01154036|336860|P7|Phase II|Adverse Event|1
88611|NCT01154036|336861|P6|Phase II|Adverse Event|1
88612|NCT01154036|336862|P5|Phase II|Adverse Event|1
88613|NCT01154036|336863|P4|Phase II|Adverse Event|0
88614|NCT01154036|336864|P3|Phase II|Adverse Event|0
88615|NCT01154036|336865|P2|Phase II|Adverse Event|0
88616|NCT01154036|336866|P1|Phase II|Adverse Event|0
88617|NCT01154036|336859|P8|Phase I|Adverse Event|0
88618|NCT01154036|336860|P7|Phase I|Adverse Event|0
88619|NCT01154036|336861|P6|Phase I|Adverse Event|0
88620|NCT01154036|336862|P5|Phase I|Adverse Event|0
88621|NCT01154036|336863|P4|Phase I|Adverse Event|0
88622|NCT01154036|336864|P3|Phase I|Adverse Event|12
88623|NCT01154036|336865|P2|Phase I|Adverse Event|11
88624|NCT01154036|336866|P1|Phase I|Adverse Event|1
88625|NCT01154036|336859|P8|Phase I|Withdrawal by Subject|0
88626|NCT01154036|336860|P7|Phase I|Withdrawal by Subject|0
88627|NCT01154036|336861|P6|Phase I|Withdrawal by Subject|0
88628|NCT01154036|336862|P5|Phase I|Withdrawal by Subject|0
88629|NCT01154036|336863|P4|Phase I|Withdrawal by Subject|0
88630|NCT01154036|336864|P3|Phase I|Withdrawal by Subject|29
88631|NCT01154036|336865|P2|Phase I|Withdrawal by Subject|10
88632|NCT01154036|336866|P1|Phase I|Withdrawal by Subject|2
88633|NCT01154036|336859|P8|Phase I|Protocol Violation|0
88634|NCT01154036|336860|P7|Phase I|Protocol Violation|0
88635|NCT01154036|336861|P6|Phase I|Protocol Violation|0
88636|NCT01154036|336862|P5|Phase I|Protocol Violation|0
88637|NCT01154036|336863|P4|Phase I|Protocol Violation|0
88638|NCT01154036|336864|P3|Phase I|Protocol Violation|9
88639|NCT01154036|336865|P2|Phase I|Protocol Violation|3
88640|NCT01154036|336866|P1|Phase I|Protocol Violation|0
88641|NCT01154036|336859|P8|Phase I|Lost to Follow-up|0
88642|NCT01154036|336860|P7|Phase I|Lost to Follow-up|0
88643|NCT01154036|336861|P6|Phase I|Lost to Follow-up|0
88644|NCT01154036|336862|P5|Phase I|Lost to Follow-up|0
88645|NCT01154036|336863|P4|Phase I|Lost to Follow-up|0
88646|NCT01154036|336864|P3|Phase I|Lost to Follow-up|6
88647|NCT01154036|336865|P2|Phase I|Lost to Follow-up|3
88648|NCT01154036|336866|P1|Phase I|Lost to Follow-up|0
88649|NCT01154036|336859|P8|Phase I|Physician Decision|0
88650|NCT01154036|336860|P7|Phase I|Physician Decision|0
88651|NCT01154036|336861|P6|Phase I|Physician Decision|0
88652|NCT01154036|336862|P5|Phase I|Physician Decision|0
88653|NCT01154036|336863|P4|Phase I|Physician Decision|0
88654|NCT01154036|336864|P3|Phase I|Physician Decision|0
88655|NCT01154036|336865|P2|Phase I|Physician Decision|1
88656|NCT01154036|336866|P1|Phase I|Physician Decision|0
88657|NCT01154010|336990|P2|Overall Study|Lost to Follow-up|1
88658|NCT01154010|336991|P1|Overall Study|Lost to Follow-up|0
88659|NCT01153984|336997|P1|Overall Study|Adverse Event|1
88660|NCT01153984|336997|P1|Overall Study|Withdrawal by Subject|1
88661|NCT01153971|337008|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
88662|NCT01153971|337008|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
88663|NCT01153971|337008|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
88664|NCT01153971|337008|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
88665|NCT01153971|337008|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
88666|NCT01153971|337008|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
88667|NCT01153971|337008|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
88668|NCT01153958|337031|P2|Overall Study|Study Terminated|32
88669|NCT01153958|337032|P1|Overall Study|Study Terminated|36
88670|NCT01153893|337050|P2|Overall Study|Adverse Event|0
88671|NCT01153893|337051|P1|Overall Study|Adverse Event|1
88672|NCT01153841|337077|P2|Overall Study|Lost to Follow-up|0
88673|NCT01153841|337078|P1|Overall Study|Lost to Follow-up|2
88674|NCT01153841|337077|P2|Overall Study|Protocol Violation|0
88675|NCT01153841|337078|P1|Overall Study|Protocol Violation|2
88676|NCT01153841|337077|P2|Overall Study|Withdrawal by Subject|0
88677|NCT01153841|337078|P1|Overall Study|Withdrawal by Subject|1
88678|NCT01153841|337077|P2|Overall Study|Adverse Event|0
88679|NCT01153841|337078|P1|Overall Study|Adverse Event|1
88680|NCT01153815|337094|P2|Overall Study|Withdrawal by Subject|4
88681|NCT01153815|337095|P1|Overall Study|Withdrawal by Subject|6
88682|NCT01153815|337094|P2|Overall Study|Adverse Event|1
88683|NCT01153815|337095|P1|Overall Study|Adverse Event|3
88684|NCT01153763|337117|P1|Overall Study|Withdrawal by Subject|2
88685|NCT01153763|337117|P1|Overall Study|Physician Decision|2
88686|NCT01153763|337117|P1|Overall Study|Lost to Follow-up|1
88687|NCT01153763|337117|P1|Overall Study|Study Closed|16
88688|NCT01153724|337133|P1|Treatment Period 2|Other reason not defined above|1
88689|NCT01153724|337133|P1|Treatment Period 2|Adverse Event|1
88690|NCT01153724|337133|P1|Treatment Period 1|Withdrawal by Subject|1
88691|NCT01153698|337173|P1|Overall Study|Not treated with Pradaxa|5
88692|NCT01153698|337173|P1|Overall Study|Other|2
88693|NCT01153698|337173|P1|Overall Study|Switch to other anticoagulants|4
88694|NCT01153698|337173|P1|Overall Study|Withdrawal by Subject|2
88695|NCT01153698|337173|P1|Overall Study|Lost to Follow-up|4
88696|NCT01153698|337173|P1|Overall Study|Adverse Event|12
88697|NCT01153633|337224|P2|Overall Study|Therapeutic failure|3
88698|NCT01153633|337225|P1|Overall Study|Therapeutic failure|3
88699|NCT01153633|337224|P2|Overall Study|Protocol Violation|1
88700|NCT01153633|337225|P1|Overall Study|Protocol Violation|1
88701|NCT01153425|337275|P2|Overall Study|Withdrawal by Subject|3
88702|NCT01153425|337276|P1|Overall Study|Withdrawal by Subject|3
88703|NCT01153347|337288|P4|Overall Study|Death|0
88704|NCT01153347|337289|P3|Overall Study|Death|0
88705|NCT01153347|337290|P2|Overall Study|Death|0
88706|NCT01153347|337291|P1|Overall Study|Death|1
88707|NCT01153347|337288|P4|Overall Study|Not specified|0
88708|NCT01153347|337289|P3|Overall Study|Not specified|4
88709|NCT01153347|337290|P2|Overall Study|Not specified|5
88710|NCT01153347|337291|P1|Overall Study|Not specified|5
88711|NCT01153347|337288|P4|Overall Study|Lost to Follow-up|8
88712|NCT01153347|337289|P3|Overall Study|Lost to Follow-up|11
88713|NCT01153347|337290|P2|Overall Study|Lost to Follow-up|9
88714|NCT01153347|337291|P1|Overall Study|Lost to Follow-up|4
88715|NCT01153347|337288|P4|Overall Study|Study-specific withdrawal criteria|2
88716|NCT01153347|337289|P3|Overall Study|Study-specific withdrawal criteria|1
88717|NCT01153347|337290|P2|Overall Study|Study-specific withdrawal criteria|3
88718|NCT01153347|337291|P1|Overall Study|Study-specific withdrawal criteria|4
88719|NCT01153347|337288|P4|Overall Study|Lack of Efficacy|4
88720|NCT01153347|337289|P3|Overall Study|Lack of Efficacy|0
88721|NCT01153347|337290|P2|Overall Study|Lack of Efficacy|2
88722|NCT01153347|337291|P1|Overall Study|Lack of Efficacy|2
88723|NCT01153347|337288|P4|Overall Study|Condition under investigation worsened|0
88724|NCT01153347|337289|P3|Overall Study|Condition under investigation worsened|0
88725|NCT01153347|337290|P2|Overall Study|Condition under investigation worsened|1
88726|NCT01153347|337291|P1|Overall Study|Condition under investigation worsened|1
88727|NCT01153347|337288|P4|Overall Study|Severe non-compliance to protocol|3
88728|NCT01153347|337289|P3|Overall Study|Severe non-compliance to protocol|4
88729|NCT01153347|337290|P2|Overall Study|Severe non-compliance to protocol|7
88730|NCT01153347|337291|P1|Overall Study|Severe non-compliance to protocol|6
88731|NCT01153347|337288|P4|Overall Study|Adverse Event|7
88732|NCT01153347|337289|P3|Overall Study|Adverse Event|21
88733|NCT01153347|337290|P2|Overall Study|Adverse Event|9
88734|NCT01153347|337291|P1|Overall Study|Adverse Event|3
88735|NCT01153347|337288|P4|Overall Study|Eligibility criteria not fulfilled|1
88736|NCT01153347|337289|P3|Overall Study|Eligibility criteria not fulfilled|2
88737|NCT01153347|337290|P2|Overall Study|Eligibility criteria not fulfilled|1
88738|NCT01153347|337291|P1|Overall Study|Eligibility criteria not fulfilled|0
88739|NCT01153347|337288|P4|Overall Study|Withdrawal by Subject|7
88740|NCT01153347|337289|P3|Overall Study|Withdrawal by Subject|7
88741|NCT01153347|337290|P2|Overall Study|Withdrawal by Subject|7
88742|NCT01153347|337291|P1|Overall Study|Withdrawal by Subject|7
88743|NCT01153321|337391|P2|Overall Study|Adverse Event|1
88744|NCT01153321|337392|P1|Overall Study|Adverse Event|1
88745|NCT01153321|337391|P2|Overall Study|Withdrawal by Subject|1
88746|NCT01153321|337392|P1|Overall Study|Withdrawal by Subject|0
88747|NCT01153321|337391|P2|Overall Study|Development of study withdrawal criteria|1
88748|NCT01153321|337392|P1|Overall Study|Development of study withdrawal criteria|0
88749|NCT01153269|337504|P1|Overall Study|Antiretroviral therapy break|1
88750|NCT01153269|337504|P1|Overall Study|Withdrawal by Subject|1
88751|NCT01153009|337567|P4|Overall Study|Other|2
88752|NCT01153009|337568|P3|Overall Study|Other|3
88753|NCT01153009|337569|P2|Overall Study|Other|1
88754|NCT01153009|337570|P1|Overall Study|Other|1
88755|NCT01153009|337567|P4|Overall Study|Lost to Follow-up|15
88756|NCT01153009|337568|P3|Overall Study|Lost to Follow-up|11
88757|NCT01153009|337569|P2|Overall Study|Lost to Follow-up|8
88758|NCT01153009|337570|P1|Overall Study|Lost to Follow-up|8
88759|NCT01153009|337567|P4|Overall Study|Withdrawal of Consent|6
88760|NCT01153009|337568|P3|Overall Study|Withdrawal of Consent|4
88761|NCT01153009|337569|P2|Overall Study|Withdrawal of Consent|5
88762|NCT01153009|337570|P1|Overall Study|Withdrawal of Consent|5
88763|NCT01153009|337567|P4|Overall Study|Protocol Deviations|2
88764|NCT01153009|337568|P3|Overall Study|Protocol Deviations|3
88765|NCT01153009|337569|P2|Overall Study|Protocol Deviations|3
88766|NCT01153009|337570|P1|Overall Study|Protocol Deviations|4
88767|NCT01153009|337567|P4|Overall Study|Noncompliance with Study Medication|1
88768|NCT01153009|337568|P3|Overall Study|Noncompliance with Study Medication|4
88769|NCT01153009|337569|P2|Overall Study|Noncompliance with Study Medication|3
88770|NCT01153009|337570|P1|Overall Study|Noncompliance with Study Medication|1
88771|NCT01153009|337567|P4|Overall Study|Lack of Efficacy|1
88772|NCT01153009|337568|P3|Overall Study|Lack of Efficacy|2
88773|NCT01153009|337569|P2|Overall Study|Lack of Efficacy|0
88774|NCT01153009|337570|P1|Overall Study|Lack of Efficacy|9
88775|NCT01153009|337567|P4|Overall Study|Adverse Event|10
88776|NCT01153009|337568|P3|Overall Study|Adverse Event|14
88777|NCT01153009|337569|P2|Overall Study|Adverse Event|14
88778|NCT01153009|337570|P1|Overall Study|Adverse Event|4
88779|NCT01152996|337600|P1|Overall Study|Elevated liver enzymes|1
88780|NCT01152996|337600|P1|Overall Study|Protocol Violation|22
88781|NCT01152996|337600|P1|Overall Study|Other|36
88782|NCT01152996|337600|P1|Overall Study|Noncompliance|41
88783|NCT01152996|337600|P1|Overall Study|Lack of Efficacy|68
88784|NCT01152996|337600|P1|Overall Study|Lost to Follow-up|112
88785|NCT01152996|337600|P1|Overall Study|Adverse Event|115
88786|NCT01152996|337600|P1|Overall Study|Withdrawal by Subject|142
88787|NCT01152814|337613|P1|Overall Study|Lost to Follow-up|2
88788|NCT01152788|337622|P2|Overall Study|No treatment|1
88789|NCT01152788|337623|P1|Overall Study|No treatment|0
88790|NCT01152788|337622|P2|Overall Study|Withdrawal by Subject|3
88791|NCT01152788|337623|P1|Overall Study|Withdrawal by Subject|0
88792|NCT01152580|337660|P2|Overall Study|Withdrawal by Subject|1
88793|NCT01152580|337661|P1|Overall Study|Withdrawal by Subject|0
88794|NCT01152554|337683|P2|Overall Study|Death|1
88795|NCT01152554|337684|P1|Overall Study|Death|1
88796|NCT01152554|337683|P2|Overall Study|Not specified|8
88797|NCT01152554|337684|P1|Overall Study|Not specified|28
88798|NCT01152554|337683|P2|Overall Study|Lost to Follow-up|32
88799|NCT01152554|337684|P1|Overall Study|Lost to Follow-up|87
88800|NCT01152554|337683|P2|Overall Study|Study-specific withdrawal criteria|8
88801|NCT01152554|337684|P1|Overall Study|Study-specific withdrawal criteria|17
88802|NCT01152554|337683|P2|Overall Study|Lack of Efficacy|3
88803|NCT01152554|337684|P1|Overall Study|Lack of Efficacy|20
88804|NCT01152554|337683|P2|Overall Study|Condition under investigation worsened|2
88805|NCT01152554|337684|P1|Overall Study|Condition under investigation worsened|5
88806|NCT01152554|337683|P2|Overall Study|Severe non-compliance to protocol|14
88807|NCT01152554|337684|P1|Overall Study|Severe non-compliance to protocol|36
88808|NCT01152554|337683|P2|Overall Study|Adverse Event|14
88809|NCT01152554|337684|P1|Overall Study|Adverse Event|67
88810|NCT01152554|337683|P2|Overall Study|Eligiblity criteria not fulfilled|1
88811|NCT01152554|337684|P1|Overall Study|Eligiblity criteria not fulfilled|0
88812|NCT01152554|337683|P2|Overall Study|Withdrawal by Subject|28
88813|NCT01152554|337684|P1|Overall Study|Withdrawal by Subject|73
88814|NCT01152450|337706|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
88815|NCT01152450|337707|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
88816|NCT01152450|337708|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
88817|NCT01152450|337709|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
88818|NCT01152450|337710|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
88819|NCT01152450|337711|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
88820|NCT01152450|337706|P6|Period 1 (4 Weeks)|Protocol Violation|0
88821|NCT01152450|337707|P5|Period 1 (4 Weeks)|Protocol Violation|1
88822|NCT01152450|337708|P4|Period 1 (4 Weeks)|Protocol Violation|0
88823|NCT01152450|337709|P3|Period 1 (4 Weeks)|Protocol Violation|0
88824|NCT01152450|337710|P2|Period 1 (4 Weeks)|Protocol Violation|0
88825|NCT01152450|337711|P1|Period 1 (4 Weeks)|Protocol Violation|0
88826|NCT01152450|337706|P6|Period 1 (4 Weeks)|Adverse Event|1
88827|NCT01152450|337707|P5|Period 1 (4 Weeks)|Adverse Event|1
88828|NCT01152450|337708|P4|Period 1 (4 Weeks)|Adverse Event|0
88829|NCT01152450|337709|P3|Period 1 (4 Weeks)|Adverse Event|0
88830|NCT01152450|337710|P2|Period 1 (4 Weeks)|Adverse Event|0
88831|NCT01152450|337711|P1|Period 1 (4 Weeks)|Adverse Event|0
88832|NCT01152437|337782|P3|Overall Study|Refusal to continue taking trial medicat|2
88833|NCT01152437|337783|P2|Overall Study|Refusal to continue taking trial medicat|0
88834|NCT01152437|337784|P1|Overall Study|Refusal to continue taking trial medicat|1
88835|NCT01152437|337782|P3|Overall Study|Progressive disease|32
88836|NCT01152437|337783|P2|Overall Study|Progressive disease|13
88837|NCT01152437|337784|P1|Overall Study|Progressive disease|27
88838|NCT01152437|337782|P3|Overall Study|Not treated|2
88839|NCT01152437|337783|P2|Overall Study|Not treated|1
88840|NCT01152437|337784|P1|Overall Study|Not treated|0
88841|NCT01152437|337782|P3|Overall Study|Other Adverse Event|7
88842|NCT01152437|337783|P2|Overall Study|Other Adverse Event|1
88843|NCT01152437|337784|P1|Overall Study|Other Adverse Event|8
88844|NCT01152385|337804|P4|Overall Study|Other|3
88845|NCT01152385|337805|P3|Overall Study|Other|2
88846|NCT01152385|337806|P2|Overall Study|Other|3
88847|NCT01152385|337807|P1|Overall Study|Other|4
88848|NCT01152385|337804|P4|Overall Study|Study-specific withdrawal criteria|0
88849|NCT01152385|337805|P3|Overall Study|Study-specific withdrawal criteria|2
88850|NCT01152385|337806|P2|Overall Study|Study-specific withdrawal criteria|1
88851|NCT01152385|337807|P1|Overall Study|Study-specific withdrawal criteria|1
88852|NCT01152385|337804|P4|Overall Study|Adverse Event|0
88853|NCT01152385|337805|P3|Overall Study|Adverse Event|0
88854|NCT01152385|337806|P2|Overall Study|Adverse Event|1
88855|NCT01152385|337807|P1|Overall Study|Adverse Event|1
88856|NCT01152385|337804|P4|Overall Study|Protocol Violation|1
88857|NCT01152385|337805|P3|Overall Study|Protocol Violation|0
88858|NCT01152385|337806|P2|Overall Study|Protocol Violation|0
88859|NCT01152385|337807|P1|Overall Study|Protocol Violation|0
88860|NCT01152385|337804|P4|Overall Study|Withdrawal by Subject|1
88861|NCT01152385|337805|P3|Overall Study|Withdrawal by Subject|1
88862|NCT01152385|337806|P2|Overall Study|Withdrawal by Subject|1
88863|NCT01152385|337807|P1|Overall Study|Withdrawal by Subject|3
88864|NCT01152190|337874|P2|Overall Study|Withdrawal by Subject|3
88865|NCT01152190|337875|P1|Overall Study|Withdrawal by Subject|1
88866|NCT01152190|337874|P2|Overall Study|Protocol Violation|1
88867|NCT01152190|337875|P1|Overall Study|Protocol Violation|1
88868|NCT01152190|337874|P2|Overall Study|Death|0
88869|NCT01152190|337875|P1|Overall Study|Death|1
88870|NCT01152190|337874|P2|Overall Study|Adverse Event|4
88871|NCT01152190|337875|P1|Overall Study|Adverse Event|2
88872|NCT01151579|337934|P2|Overall Study|Not meet inclusion criteria|4
88873|NCT01151579|337935|P1|Overall Study|Not meet inclusion criteria|6
88874|NCT01151579|337934|P2|Overall Study|Withdrawal by Subject|2
88875|NCT01151579|337935|P1|Overall Study|Withdrawal by Subject|3
88876|NCT01151579|337934|P2|Overall Study|Physician Decision|1
88877|NCT01151579|337935|P1|Overall Study|Physician Decision|3
88878|NCT01151410|337989|P2|Overall Study|Abnormal laboratory value(s)|1
88879|NCT01151410|337990|P1|Overall Study|Abnormal laboratory value(s)|0
88880|NCT01151410|337989|P2|Overall Study|Unsatisfactory therapeutic effect|1
88881|NCT01151410|337990|P1|Overall Study|Unsatisfactory therapeutic effect|1
88882|NCT01151410|337989|P2|Overall Study|Administrative problems|1
88883|NCT01151410|337990|P1|Overall Study|Administrative problems|1
88884|NCT01151410|337989|P2|Overall Study|Protocol deviation|1
88885|NCT01151410|337990|P1|Overall Study|Protocol deviation|2
88886|NCT01151410|337989|P2|Overall Study|Adverse Event|2
88887|NCT01151410|337990|P1|Overall Study|Adverse Event|1
88888|NCT01151410|337989|P2|Overall Study|Lost to Follow-up|4
88889|NCT01151410|337990|P1|Overall Study|Lost to Follow-up|3
88890|NCT01151410|337989|P2|Overall Study|Withdrawal by Subject|5
88891|NCT01151410|337990|P1|Overall Study|Withdrawal by Subject|3
88892|NCT01151345|338034|P2|First Intervention Period|Protocol Violation|1
88893|NCT01151345|338035|P1|First Intervention Period|Protocol Violation|0
88894|NCT01151280|338049|P1|Overall Study|Lack of Efficacy|3
88895|NCT01151280|338049|P1|Overall Study|Adverse Event|1
88896|NCT01151215|338062|P3|Overall Study|Safety as judged by the investigator|1
88897|NCT01151215|338063|P2|Overall Study|Safety as judged by the investigator|0
88898|NCT01151215|338064|P1|Overall Study|Safety as judged by the investigator|0
88899|NCT01151215|338062|P3|Overall Study|Disease progression|1
88900|NCT01151215|338063|P2|Overall Study|Disease progression|1
88901|NCT01151215|338064|P1|Overall Study|Disease progression|0
88902|NCT01151215|338062|P3|Overall Study|Withdrawal by Subject|2
88903|NCT01151215|338063|P2|Overall Study|Withdrawal by Subject|1
88904|NCT01151215|338064|P1|Overall Study|Withdrawal by Subject|3
88905|NCT01151215|338062|P3|Overall Study|Lost to Follow-up|3
88906|NCT01151215|338063|P2|Overall Study|Lost to Follow-up|0
88907|NCT01151215|338064|P1|Overall Study|Lost to Follow-up|0
88908|NCT01151215|338062|P3|Overall Study|Death|11
88909|NCT01151215|338063|P2|Overall Study|Death|20
88910|NCT01151215|338064|P1|Overall Study|Death|16
88911|NCT01151215|338062|P3|Overall Study|Worsening of condition under study|1
88912|NCT01151215|338063|P2|Overall Study|Worsening of condition under study|1
88913|NCT01151215|338064|P1|Overall Study|Worsening of condition under study|1
88914|NCT01151137|338102|P2|Overall Study|Lost to Follow-up|1
88915|NCT01151137|338103|P1|Overall Study|Lost to Follow-up|1
88916|NCT01151137|338102|P2|Overall Study|Death|27
88917|NCT01151137|338103|P1|Overall Study|Death|15
88918|NCT01151098|338121|P1|Overall Study|Miscellaneous|13
88919|NCT01151098|338121|P1|Overall Study|Protocol Violation|1
88920|NCT01151098|338121|P1|Overall Study|Lack of Efficacy|15
88921|NCT01151098|338121|P1|Overall Study|Lost to Follow-up|6
88922|NCT01151098|338121|P1|Overall Study|Adverse Event|82
88923|NCT01151085|338125|P1|Overall Study|Protocol Violation|25
88924|NCT01151085|338125|P1|Overall Study|Lost to Follow-up|31
88925|NCT01151020|338156|P1|Overall Study|Still be eligible for follow-up|79
88926|NCT01151020|338156|P1|Overall Study|Patients did not receive the device|2
88927|NCT01151020|338156|P1|Overall Study|Withdrawal by Subject|12
88928|NCT01151020|338156|P1|Overall Study|Lost to Follow-up|1
88929|NCT01151020|338156|P1|Overall Study|Conversion to open repair|1
88930|NCT01151020|338156|P1|Overall Study|Death|15
88931|NCT01150474|338235|P2|Overall Study|Surgery Changed|0
88932|NCT01150474|338236|P1|Overall Study|Surgery Changed|1
88933|NCT01150474|338235|P2|Overall Study|Drug not administered|0
88934|NCT01150474|338236|P1|Overall Study|Drug not administered|1
88935|NCT01150474|338235|P2|Overall Study|Drug did not arrive in time|0
88936|NCT01150474|338236|P1|Overall Study|Drug did not arrive in time|1
88937|NCT01150474|338235|P2|Overall Study|Rectotomy|0
88938|NCT01150474|338236|P1|Overall Study|Rectotomy|1
88939|NCT01150474|338235|P2|Overall Study|Multiple Studies|1
88940|NCT01150474|338236|P1|Overall Study|Multiple Studies|0
88941|NCT01150474|338235|P2|Overall Study|Cancer found|0
88942|NCT01150474|338236|P1|Overall Study|Cancer found|1
88943|NCT01150474|338235|P2|Overall Study|Withdrawal by Subject|2
88944|NCT01150474|338236|P1|Overall Study|Withdrawal by Subject|5
88945|NCT01150357|338281|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
88946|NCT01150357|338282|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
88947|NCT01150357|338283|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
88948|NCT01150357|338281|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
88949|NCT01150357|338282|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
88950|NCT01150357|338283|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
88951|NCT01150357|338281|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
88952|NCT01150357|338282|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
88953|NCT01150357|338283|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
88954|NCT01150357|338281|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
88955|NCT01150357|338282|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
88956|NCT01150357|338283|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
88957|NCT01150357|338281|P3|Dose Response Phase (Phase 1)|Adverse Event|1
88958|NCT01150357|338282|P2|Dose Response Phase (Phase 1)|Adverse Event|0
88959|NCT01150357|338283|P1|Dose Response Phase (Phase 1)|Adverse Event|0
88960|NCT01150357|338281|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
88961|NCT01150357|338282|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
88962|NCT01150357|338283|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
88963|NCT01150357|338281|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
88964|NCT01150357|338282|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
88965|NCT01150357|338283|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
88966|NCT01150123|338363|P18|Overall Study|Lost to Follow-up|0
88967|NCT01150123|338364|P17|Overall Study|Lost to Follow-up|0
88968|NCT01150123|338365|P16|Overall Study|Lost to Follow-up|0
88969|NCT01150123|338366|P15|Overall Study|Lost to Follow-up|0
88970|NCT01150123|338367|P14|Overall Study|Lost to Follow-up|0
88971|NCT01150123|338368|P13|Overall Study|Lost to Follow-up|2
88972|NCT01150123|338369|P12|Overall Study|Lost to Follow-up|1
88973|NCT01150123|338370|P11|Overall Study|Lost to Follow-up|1
88974|NCT01150123|338371|P10|Overall Study|Lost to Follow-up|1
88975|NCT01150123|338372|P9|Overall Study|Lost to Follow-up|3
88976|NCT01150123|338373|P8|Overall Study|Lost to Follow-up|0
88977|NCT01150123|338374|P7|Overall Study|Lost to Follow-up|0
88978|NCT01150123|338375|P6|Overall Study|Lost to Follow-up|5
88979|NCT01150123|338376|P5|Overall Study|Lost to Follow-up|2
88980|NCT01150123|338377|P4|Overall Study|Lost to Follow-up|2
88981|NCT01150123|338378|P3|Overall Study|Lost to Follow-up|2
88982|NCT01150123|338379|P2|Overall Study|Lost to Follow-up|1
88983|NCT01150123|338380|P1|Overall Study|Lost to Follow-up|2
88984|NCT01150123|338363|P18|Overall Study|Withdrawal by Subject|1
88985|NCT01150123|338364|P17|Overall Study|Withdrawal by Subject|0
88986|NCT01150123|338365|P16|Overall Study|Withdrawal by Subject|1
88987|NCT01150123|338366|P15|Overall Study|Withdrawal by Subject|0
88988|NCT01150123|338367|P14|Overall Study|Withdrawal by Subject|0
88989|NCT01150123|338368|P13|Overall Study|Withdrawal by Subject|1
88990|NCT01150123|338369|P12|Overall Study|Withdrawal by Subject|0
88991|NCT01150123|338370|P11|Overall Study|Withdrawal by Subject|1
88992|NCT01150123|338371|P10|Overall Study|Withdrawal by Subject|0
88993|NCT01150123|338372|P9|Overall Study|Withdrawal by Subject|2
88994|NCT01150123|338373|P8|Overall Study|Withdrawal by Subject|3
88995|NCT01150123|338374|P7|Overall Study|Withdrawal by Subject|0
88996|NCT01150123|338375|P6|Overall Study|Withdrawal by Subject|1
88997|NCT01150123|338376|P5|Overall Study|Withdrawal by Subject|1
88998|NCT01150123|338377|P4|Overall Study|Withdrawal by Subject|1
88999|NCT01150123|338378|P3|Overall Study|Withdrawal by Subject|2
89000|NCT01150123|338379|P2|Overall Study|Withdrawal by Subject|1
89001|NCT01150123|338380|P1|Overall Study|Withdrawal by Subject|1
89002|NCT01150097|338556|P3|Months 24 to 48 Post-transplantation|Death|0
89003|NCT01150097|338557|P2|Months 24 to 48 Post-transplantation|Death|0
89004|NCT01150097|338558|P1|Months 24 to 48 Post-transplantation|Death|2
89005|NCT01150097|338556|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
89006|NCT01150097|338557|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
89007|NCT01150097|338558|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
89008|NCT01150097|338556|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
89009|NCT01150097|338557|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
89010|NCT01150097|338558|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
89011|NCT01150097|338556|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
89012|NCT01150097|338557|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
89013|NCT01150097|338558|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
89014|NCT01150097|338556|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
89015|NCT01150097|338557|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
89016|NCT01150097|338558|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
89017|NCT01150097|338556|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
89018|NCT01150097|338557|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
89019|NCT01150097|338558|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
89020|NCT01150097|338556|P3|Months 24 to 36 Post-transplantation|Death|0
89021|NCT01150097|338557|P2|Months 24 to 36 Post-transplantation|Death|0
89022|NCT01150097|338558|P1|Months 24 to 36 Post-transplantation|Death|2
89023|NCT01149863|338602|P1|Overall Study|Missing data or Not receiveing studydrug|3
89024|NCT01149655|338679|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
89025|NCT01149655|338680|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
89026|NCT01149655|338681|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
89027|NCT01149655|338682|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
89028|NCT01149655|338679|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
89029|NCT01149655|338680|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
89030|NCT01149655|338681|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
89031|NCT01149655|338682|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
89032|NCT01149655|338679|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
89033|NCT01149655|338680|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
89034|NCT01149655|338681|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
89035|NCT01149655|338682|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
89036|NCT01149655|338679|P4|Period 3-DB Maintenance Phase|Physician Decision|0
89037|NCT01149655|338680|P3|Period 3-DB Maintenance Phase|Physician Decision|1
89038|NCT01149655|338681|P2|Period 3-DB Maintenance Phase|Physician Decision|0
89039|NCT01149655|338682|P1|Period 3-DB Maintenance Phase|Physician Decision|0
89040|NCT01149655|338679|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
89041|NCT01149655|338680|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
89042|NCT01149655|338681|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
89043|NCT01149655|338682|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
89044|NCT01149655|338679|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
89045|NCT01149655|338680|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
89046|NCT01149655|338681|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
89047|NCT01149655|338682|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
89048|NCT01149655|338679|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
89049|NCT01149655|338680|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
89050|NCT01149655|338681|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
89051|NCT01149655|338682|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
89052|NCT01149655|338679|P4|Period 2-Stabilization Phase|Physician Decision|0
89053|NCT01149655|338680|P3|Period 2-Stabilization Phase|Physician Decision|0
89054|NCT01149655|338681|P2|Period 2-Stabilization Phase|Physician Decision|3
89055|NCT01149655|338682|P1|Period 2-Stabilization Phase|Physician Decision|0
89056|NCT01149655|338679|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
89057|NCT01149655|338680|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
89058|NCT01149655|338681|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
89059|NCT01149655|338682|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
89060|NCT01149655|338679|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
89061|NCT01149655|338680|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
89062|NCT01149655|338681|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
89063|NCT01149655|338682|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
89064|NCT01149655|338679|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
89065|NCT01149655|338680|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
89066|NCT01149655|338681|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
89067|NCT01149655|338682|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
89068|NCT01149655|338679|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
89069|NCT01149655|338680|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
89070|NCT01149655|338681|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
89071|NCT01149655|338682|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
89072|NCT01149655|338679|P4|Period 1 - Conversion Phase|Physician Decision|0
89073|NCT01149655|338680|P3|Period 1 - Conversion Phase|Physician Decision|0
89074|NCT01149655|338681|P2|Period 1 - Conversion Phase|Physician Decision|0
89075|NCT01149655|338682|P1|Period 1 - Conversion Phase|Physician Decision|2
89076|NCT01149655|338679|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
89077|NCT01149655|338680|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
89078|NCT01149655|338681|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
89079|NCT01149655|338682|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
89080|NCT01149655|338679|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
89081|NCT01149655|338680|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
89082|NCT01149655|338681|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
89083|NCT01149655|338682|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
89084|NCT01149655|338679|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
89085|NCT01149655|338680|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
89086|NCT01149655|338681|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
89087|NCT01149655|338682|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
89088|NCT01149538|338725|P2|Overall Study|Withdrawal by Subject|3
89089|NCT01149538|338726|P1|Overall Study|Withdrawal by Subject|5
89090|NCT01149538|338725|P2|Overall Study|Lost to Follow-up|1
89091|NCT01149538|338726|P1|Overall Study|Lost to Follow-up|0
89092|NCT01149486|338747|P2|First Intervention|Adverse Event|1
89093|NCT01149486|338748|P1|First Intervention|Adverse Event|0
89094|NCT01149473|338772|P2|Washout of 7 Days|Withdrawal by Subject|1
89095|NCT01149473|338773|P1|Washout of 7 Days|Withdrawal by Subject|1
89096|NCT01149473|338772|P2|First Intervention|Adverse Event|1
89097|NCT01149473|338773|P1|First Intervention|Adverse Event|1
89098|NCT01149460|338791|P2|Overall Study|Withdrawal by Subject|2
89099|NCT01149460|338792|P1|Overall Study|Withdrawal by Subject|0
89100|NCT01149421|338825|P3|Overall Study|Protocol Violation|6
89101|NCT01149421|338826|P2|Overall Study|Protocol Violation|2
89102|NCT01149421|338827|P1|Overall Study|Protocol Violation|2
89103|NCT01149421|338825|P3|Overall Study|Entry Criteria Not Met|2
89104|NCT01149421|338826|P2|Overall Study|Entry Criteria Not Met|1
89105|NCT01149421|338827|P1|Overall Study|Entry Criteria Not Met|1
89106|NCT01149421|338825|P3|Overall Study|Physician Decision|6
89107|NCT01149421|338826|P2|Overall Study|Physician Decision|3
89108|NCT01149421|338827|P1|Overall Study|Physician Decision|5
89109|NCT01149421|338825|P3|Overall Study|Lost to Follow-up|5
89110|NCT01149421|338826|P2|Overall Study|Lost to Follow-up|4
89111|NCT01149421|338827|P1|Overall Study|Lost to Follow-up|2
89112|NCT01149421|338825|P3|Overall Study|Sponsor Decision|1
89113|NCT01149421|338826|P2|Overall Study|Sponsor Decision|1
89114|NCT01149421|338827|P1|Overall Study|Sponsor Decision|0
89115|NCT01149421|338825|P3|Overall Study|Withdrawal by Subject|13
89116|NCT01149421|338826|P2|Overall Study|Withdrawal by Subject|12
89117|NCT01149421|338827|P1|Overall Study|Withdrawal by Subject|20
89118|NCT01149421|338825|P3|Overall Study|Adverse Event|11
89119|NCT01149421|338826|P2|Overall Study|Adverse Event|6
89120|NCT01149421|338827|P1|Overall Study|Adverse Event|22
89121|NCT01149148|338908|P2|Overall Study|Death|0
89122|NCT01149148|338909|P1|Overall Study|Death|1
89123|NCT01149148|338908|P2|Overall Study|Lost to Follow-up|2
89124|NCT01149148|338909|P1|Overall Study|Lost to Follow-up|1
89125|NCT01149057|338917|P1|Overall Study|Other|6
89126|NCT01149057|338917|P1|Overall Study|High Parathyroid Hormone Value|1
89127|NCT01149057|338917|P1|Overall Study|Lost to Follow-up|1
89128|NCT01149057|338917|P1|Overall Study|Participant Non-Compliance|2
89129|NCT01149057|338917|P1|Overall Study|B Cell Depletion|4
89130|NCT01149057|338917|P1|Overall Study|Positive Hepatitis B Core Antibody|5
89131|NCT01149057|338917|P1|Overall Study|Withdrawal by Subject|9
89132|NCT01149057|338917|P1|Overall Study|Adverse Event|13
89133|NCT01149057|338917|P1|Overall Study|Lack of Efficacy|16
89134|NCT01148979|338944|P2|Overall Study|Lost to Follow-up|1
89135|NCT01148979|338945|P1|Overall Study|Lost to Follow-up|0
89136|NCT01148862|338951|P2|Second Intervention|Withdrawal by Subject|2
89137|NCT01148862|338952|P1|Second Intervention|Withdrawal by Subject|0
89138|NCT01148771|338984|P2|Washout Period|Withdrawal by Subject|1
89139|NCT01148771|338985|P1|Washout Period|Withdrawal by Subject|0
89140|NCT01148693|339005|P2|Overall Study|Attempts for cannulation were failed|10
89141|NCT01148693|339006|P1|Overall Study|Attempts for cannulation were failed|13
89142|NCT01148537|339026|P3|Overall Study|Adverse Event|1
89143|NCT01148537|339027|P2|Overall Study|Adverse Event|0
89144|NCT01148537|339028|P1|Overall Study|Adverse Event|2
89145|NCT01148537|339026|P3|Overall Study|Withdrawal by Subject|2
89146|NCT01148537|339027|P2|Overall Study|Withdrawal by Subject|0
89147|NCT01148537|339028|P1|Overall Study|Withdrawal by Subject|1
89148|NCT01148511|339114|P3|Randomized|Not Specified|1
89149|NCT01148511|339115|P2|Randomized|Not Specified|1
89150|NCT01148511|339116|P1|Randomized|Not Specified|0
89151|NCT01148511|339114|P3|Randomized|Consent withdrawal|3
89152|NCT01148511|339115|P2|Randomized|Consent withdrawal|5
89153|NCT01148511|339116|P1|Randomized|Consent withdrawal|0
89154|NCT01148511|339114|P3|Randomized|Lost to Follow-up|1
89155|NCT01148511|339115|P2|Randomized|Lost to Follow-up|1
89156|NCT01148511|339116|P1|Randomized|Lost to Follow-up|0
89157|NCT01148511|339114|P3|Randomized|Protocol Violation|1
89158|NCT01148511|339115|P2|Randomized|Protocol Violation|2
89159|NCT01148511|339116|P1|Randomized|Protocol Violation|0
89160|NCT01148511|339114|P3|Randomized|Adverse Event|0
89161|NCT01148511|339115|P2|Randomized|Adverse Event|1
89162|NCT01148511|339116|P1|Randomized|Adverse Event|0
89163|NCT01148511|339114|P3|Exposed to Study Drug|Lost to Follow-up|0
89164|NCT01148511|339115|P2|Exposed to Study Drug|Lost to Follow-up|0
89165|NCT01148511|339116|P1|Exposed to Study Drug|Lost to Follow-up|4
89166|NCT01148511|339114|P3|Exposed to Study Drug|Protocol Violation|0
89167|NCT01148511|339115|P2|Exposed to Study Drug|Protocol Violation|0
89168|NCT01148511|339116|P1|Exposed to Study Drug|Protocol Violation|2
89169|NCT01148017|339154|P4|Overall Study|Unable to classify|0
89170|NCT01148017|339155|P3|Overall Study|Unable to classify|0
89171|NCT01148017|339156|P2|Overall Study|Unable to classify|1
89172|NCT01148017|339157|P1|Overall Study|Unable to classify|3
89173|NCT01148017|339154|P4|Overall Study|Administrative reason|0
89174|NCT01148017|339155|P3|Overall Study|Administrative reason|0
89175|NCT01148017|339156|P2|Overall Study|Administrative reason|9
89176|NCT01148017|339157|P1|Overall Study|Administrative reason|22
89177|NCT01148017|339154|P4|Overall Study|Inappropriate enrollment|0
89178|NCT01148017|339155|P3|Overall Study|Inappropriate enrollment|0
89179|NCT01148017|339156|P2|Overall Study|Inappropriate enrollment|0
89180|NCT01148017|339157|P1|Overall Study|Inappropriate enrollment|1
89181|NCT01148017|339154|P4|Overall Study|Lost to Follow-up|0
89182|NCT01148017|339155|P3|Overall Study|Lost to Follow-up|0
89183|NCT01148017|339156|P2|Overall Study|Lost to Follow-up|10
89184|NCT01148017|339157|P1|Overall Study|Lost to Follow-up|23
89185|NCT01148017|339154|P4|Overall Study|Withdrawal by Subject|0
89186|NCT01148017|339155|P3|Overall Study|Withdrawal by Subject|0
89187|NCT01148017|339156|P2|Overall Study|Withdrawal by Subject|14
89188|NCT01148017|339157|P1|Overall Study|Withdrawal by Subject|31
89189|NCT01147926|339196|P2|Overall Study|Colonoscopy result|1
89190|NCT01147926|339197|P1|Overall Study|Colonoscopy result|0
89191|NCT01147926|339196|P2|Overall Study|Went on holiday|1
89192|NCT01147926|339197|P1|Overall Study|Went on holiday|0
89193|NCT01147926|339196|P2|Overall Study|Too busy, no time for study|0
89194|NCT01147926|339197|P1|Overall Study|Too busy, no time for study|1
89195|NCT01147926|339196|P2|Overall Study|Lack of Efficacy|0
89196|NCT01147926|339197|P1|Overall Study|Lack of Efficacy|1
89197|NCT01147926|339196|P2|Overall Study|Sponsor's Decision|1
89198|NCT01147926|339197|P1|Overall Study|Sponsor's Decision|0
89199|NCT01147926|339196|P2|Overall Study|Lost to Follow-up|2
89200|NCT01147926|339197|P1|Overall Study|Lost to Follow-up|0
89201|NCT01147926|339196|P2|Overall Study|Selection criteria not met|1
89202|NCT01147926|339197|P1|Overall Study|Selection criteria not met|3
89203|NCT01147926|339196|P2|Overall Study|Principal investigator left hospital|3
89204|NCT01147926|339197|P1|Overall Study|Principal investigator left hospital|1
89205|NCT01147926|339196|P2|Overall Study|Subject Non-Compliant|4
89206|NCT01147926|339197|P1|Overall Study|Subject Non-Compliant|5
89207|NCT01147926|339196|P2|Overall Study|Adverse Event|6
89208|NCT01147926|339197|P1|Overall Study|Adverse Event|7
89209|NCT01147926|339196|P2|Overall Study|Subject Withdrew Consent|10
89210|NCT01147926|339197|P1|Overall Study|Subject Withdrew Consent|9
89211|NCT01147900|339232|P3|At Year 10|Lost to Follow-up|0
89212|NCT01147900|339233|P2|At Year 10|Lost to Follow-up|1
89213|NCT01147900|339234|P1|At Year 10|Lost to Follow-up|0
89214|NCT01147874|339293|P1|Overall Study|Withdrawal by Subject|24
89215|NCT01147874|339293|P1|Overall Study|Sponsor's Decision|2
89216|NCT01147874|339293|P1|Overall Study|Protocol Violation|5
89217|NCT01147874|339293|P1|Overall Study|Other|5
89218|NCT01147874|339293|P1|Overall Study|Lost to Follow-up|25
89219|NCT01147874|339293|P1|Overall Study|Investigator’s Request|1
89220|NCT01147874|339293|P1|Overall Study|Adverse Event|5
89221|NCT01147848|339301|P3|Randomized Phase|Withdrawal by Subject|9
89222|NCT01147848|339302|P2|Randomized Phase|Withdrawal by Subject|7
89223|NCT01147848|339303|P1|Randomized Phase|Withdrawal by Subject|0
89224|NCT01147848|339301|P3|Randomized Phase|Physician Decision|1
89225|NCT01147848|339302|P2|Randomized Phase|Physician Decision|0
89226|NCT01147848|339303|P1|Randomized Phase|Physician Decision|0
89227|NCT01147848|339301|P3|Randomized Phase|Lost to Follow-up|7
89228|NCT01147848|339302|P2|Randomized Phase|Lost to Follow-up|5
89229|NCT01147848|339303|P1|Randomized Phase|Lost to Follow-up|0
89230|NCT01147848|339301|P3|Randomized Phase|Protocol Violation|10
89231|NCT01147848|339302|P2|Randomized Phase|Protocol Violation|7
89232|NCT01147848|339303|P1|Randomized Phase|Protocol Violation|0
89233|NCT01147848|339301|P3|Randomized Phase|Lack of Efficacy|11
89234|NCT01147848|339302|P2|Randomized Phase|Lack of Efficacy|20
89235|NCT01147848|339303|P1|Randomized Phase|Lack of Efficacy|0
89236|NCT01147848|339301|P3|Randomized Phase|Adverse Event|8
89237|NCT01147848|339302|P2|Randomized Phase|Adverse Event|6
89238|NCT01147848|339303|P1|Randomized Phase|Adverse Event|0
89239|NCT01147848|339301|P3|Run-in Period|Run-in Failure|0
89240|NCT01147848|339302|P2|Run-in Period|Run-in Failure|0
89241|NCT01147848|339303|P1|Run-in Period|Run-in Failure|135
89242|NCT01147848|339301|P3|Run-in Period|Screen Failure|0
89243|NCT01147848|339302|P2|Run-in Period|Screen Failure|0
89244|NCT01147848|339303|P1|Run-in Period|Screen Failure|623
89245|NCT01147822|339335|P2|Overall Study|Not Completed/Ongoing|102
89246|NCT01147822|339336|P1|Overall Study|Not Completed/Ongoing|111
89247|NCT01147822|339335|P2|Overall Study|Withdrawal by Subject|13
89248|NCT01147822|339336|P1|Overall Study|Withdrawal by Subject|8
89249|NCT01147822|339335|P2|Overall Study|Physician Decision|2
89250|NCT01147822|339336|P1|Overall Study|Physician Decision|0
89251|NCT01147822|339335|P2|Overall Study|Lost to Follow-up|2
89252|NCT01147822|339336|P1|Overall Study|Lost to Follow-up|3
89253|NCT01147822|339335|P2|Overall Study|Protocol Violation|1
89254|NCT01147822|339336|P1|Overall Study|Protocol Violation|0
89255|NCT01147822|339335|P2|Overall Study|Death|59
89256|NCT01147822|339336|P1|Overall Study|Death|66
89257|NCT01147809|339356|P6|Phase II (168 Days)|Ongoing|0
89258|NCT01147809|339357|P5|Phase II (168 Days)|Ongoing|1
89259|NCT01147809|339358|P4|Phase II (168 Days)|Ongoing|0
89260|NCT01147809|339359|P3|Phase II (168 Days)|Ongoing|0
89261|NCT01147809|339360|P2|Phase II (168 Days)|Ongoing|0
89262|NCT01147809|339361|P1|Phase II (168 Days)|Ongoing|0
89263|NCT01147809|339356|P6|Phase II (168 Days)|Withdrawal by Subject|15
89264|NCT01147809|339357|P5|Phase II (168 Days)|Withdrawal by Subject|7
89265|NCT01147809|339358|P4|Phase II (168 Days)|Withdrawal by Subject|0
89266|NCT01147809|339359|P3|Phase II (168 Days)|Withdrawal by Subject|0
89267|NCT01147809|339360|P2|Phase II (168 Days)|Withdrawal by Subject|0
89268|NCT01147809|339361|P1|Phase II (168 Days)|Withdrawal by Subject|0
89269|NCT01147809|339356|P6|Phase II (168 Days)|Physician Decision|11
89270|NCT01147809|339357|P5|Phase II (168 Days)|Physician Decision|5
89271|NCT01147809|339358|P4|Phase II (168 Days)|Physician Decision|0
89272|NCT01147809|339359|P3|Phase II (168 Days)|Physician Decision|0
89273|NCT01147809|339360|P2|Phase II (168 Days)|Physician Decision|0
89274|NCT01147809|339361|P1|Phase II (168 Days)|Physician Decision|0
89275|NCT01147809|339356|P6|Phase II (168 Days)|Protocol Violation|1
89276|NCT01147809|339357|P5|Phase II (168 Days)|Protocol Violation|0
89277|NCT01147809|339358|P4|Phase II (168 Days)|Protocol Violation|0
89278|NCT01147809|339359|P3|Phase II (168 Days)|Protocol Violation|0
89279|NCT01147809|339360|P2|Phase II (168 Days)|Protocol Violation|0
89280|NCT01147809|339361|P1|Phase II (168 Days)|Protocol Violation|0
89281|NCT01147809|339356|P6|Phase II (168 Days)|Adverse Event|6
89282|NCT01147809|339357|P5|Phase II (168 Days)|Adverse Event|3
89283|NCT01147809|339358|P4|Phase II (168 Days)|Adverse Event|0
89284|NCT01147809|339359|P3|Phase II (168 Days)|Adverse Event|0
89285|NCT01147809|339360|P2|Phase II (168 Days)|Adverse Event|0
89286|NCT01147809|339361|P1|Phase II (168 Days)|Adverse Event|0
89287|NCT01147809|339356|P6|Phase I (168 Days)|Withdrawal by Subject|0
89288|NCT01147809|339357|P5|Phase I (168 Days)|Withdrawal by Subject|0
89289|NCT01147809|339358|P4|Phase I (168 Days)|Withdrawal by Subject|3
89290|NCT01147809|339359|P3|Phase I (168 Days)|Withdrawal by Subject|0
89291|NCT01147809|339360|P2|Phase I (168 Days)|Withdrawal by Subject|0
89292|NCT01147809|339361|P1|Phase I (168 Days)|Withdrawal by Subject|0
89293|NCT01147809|339356|P6|Phase I (168 Days)|Physician Decision|0
89294|NCT01147809|339357|P5|Phase I (168 Days)|Physician Decision|0
89295|NCT01147809|339358|P4|Phase I (168 Days)|Physician Decision|0
89296|NCT01147809|339359|P3|Phase I (168 Days)|Physician Decision|2
89297|NCT01147809|339360|P2|Phase I (168 Days)|Physician Decision|1
89298|NCT01147809|339361|P1|Phase I (168 Days)|Physician Decision|0
89299|NCT01147809|339356|P6|Phase I (168 Days)|Lost to Follow-up|0
89300|NCT01147809|339357|P5|Phase I (168 Days)|Lost to Follow-up|0
89301|NCT01147809|339358|P4|Phase I (168 Days)|Lost to Follow-up|1
89302|NCT01147809|339359|P3|Phase I (168 Days)|Lost to Follow-up|0
89303|NCT01147809|339360|P2|Phase I (168 Days)|Lost to Follow-up|0
89304|NCT01147809|339361|P1|Phase I (168 Days)|Lost to Follow-up|1
89305|NCT01147809|339356|P6|Phase I (168 Days)|Adverse Event|0
89306|NCT01147809|339357|P5|Phase I (168 Days)|Adverse Event|0
89307|NCT01147809|339358|P4|Phase I (168 Days)|Adverse Event|1
89308|NCT01147809|339359|P3|Phase I (168 Days)|Adverse Event|0
89309|NCT01147809|339360|P2|Phase I (168 Days)|Adverse Event|0
89310|NCT01147809|339361|P1|Phase I (168 Days)|Adverse Event|0
89311|NCT01147744|339482|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
89312|NCT01147744|339483|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
89313|NCT01147744|339484|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
89314|NCT01147744|339485|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
89315|NCT01147744|339486|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
89316|NCT01147744|339487|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
89317|NCT01147744|339488|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
89318|NCT01147744|339482|P7|Overall Study|Sponsor decision to amend protocol|6
89319|NCT01147744|339483|P6|Overall Study|Sponsor decision to amend protocol|2
89320|NCT01147744|339484|P5|Overall Study|Sponsor decision to amend protocol|7
89321|NCT01147744|339485|P4|Overall Study|Sponsor decision to amend protocol|5
89322|NCT01147744|339486|P3|Overall Study|Sponsor decision to amend protocol|2
89323|NCT01147744|339487|P2|Overall Study|Sponsor decision to amend protocol|4
89324|NCT01147744|339488|P1|Overall Study|Sponsor decision to amend protocol|7
89325|NCT01147744|339482|P7|Overall Study|Lost to Follow-up|0
89326|NCT01147744|339483|P6|Overall Study|Lost to Follow-up|0
89327|NCT01147744|339484|P5|Overall Study|Lost to Follow-up|0
89328|NCT01147744|339485|P4|Overall Study|Lost to Follow-up|0
89329|NCT01147744|339486|P3|Overall Study|Lost to Follow-up|0
89330|NCT01147744|339487|P2|Overall Study|Lost to Follow-up|1
89331|NCT01147744|339488|P1|Overall Study|Lost to Follow-up|0
89332|NCT01147744|339482|P7|Overall Study|Withdrawal by Subject|2
89333|NCT01147744|339483|P6|Overall Study|Withdrawal by Subject|5
89334|NCT01147744|339484|P5|Overall Study|Withdrawal by Subject|2
89335|NCT01147744|339485|P4|Overall Study|Withdrawal by Subject|2
89336|NCT01147744|339486|P3|Overall Study|Withdrawal by Subject|2
89337|NCT01147744|339487|P2|Overall Study|Withdrawal by Subject|4
89338|NCT01147744|339488|P1|Overall Study|Withdrawal by Subject|8
89339|NCT01147744|339482|P7|Overall Study|Adverse Event|2
89340|NCT01147744|339483|P6|Overall Study|Adverse Event|1
89341|NCT01147744|339484|P5|Overall Study|Adverse Event|2
89342|NCT01147744|339485|P4|Overall Study|Adverse Event|0
89343|NCT01147744|339486|P3|Overall Study|Adverse Event|3
89344|NCT01147744|339487|P2|Overall Study|Adverse Event|2
89345|NCT01147744|339488|P1|Overall Study|Adverse Event|1
89346|NCT01147744|339482|P7|Overall Study|Lack of Efficacy|7
89347|NCT01147744|339483|P6|Overall Study|Lack of Efficacy|8
89348|NCT01147744|339484|P5|Overall Study|Lack of Efficacy|13
89349|NCT01147744|339485|P4|Overall Study|Lack of Efficacy|11
89350|NCT01147744|339486|P3|Overall Study|Lack of Efficacy|9
89351|NCT01147744|339487|P2|Overall Study|Lack of Efficacy|11
89352|NCT01147744|339488|P1|Overall Study|Lack of Efficacy|11
89353|NCT01147744|339482|P7|Overall Study|Physician Decision|1
89354|NCT01147744|339483|P6|Overall Study|Physician Decision|0
89355|NCT01147744|339484|P5|Overall Study|Physician Decision|0
89356|NCT01147744|339485|P4|Overall Study|Physician Decision|0
89357|NCT01147744|339486|P3|Overall Study|Physician Decision|1
89358|NCT01147744|339487|P2|Overall Study|Physician Decision|1
89359|NCT01147744|339488|P1|Overall Study|Physician Decision|0
89360|NCT01147744|339482|P7|Overall Study|Protocol Violation|1
89361|NCT01147744|339483|P6|Overall Study|Protocol Violation|3
89362|NCT01147744|339484|P5|Overall Study|Protocol Violation|1
89363|NCT01147744|339485|P4|Overall Study|Protocol Violation|0
89364|NCT01147744|339486|P3|Overall Study|Protocol Violation|1
89365|NCT01147744|339487|P2|Overall Study|Protocol Violation|0
89366|NCT01147744|339488|P1|Overall Study|Protocol Violation|1
89367|NCT01147653|339583|P2|Year 2|Withdrawal by Subject|3
89368|NCT01147653|339584|P1|Year 2|Withdrawal by Subject|2
89369|NCT01147640|339645|P2|Overall Study|Didn't meet eligibility criteria|0
89370|NCT01147640|339646|P1|Overall Study|Didn't meet eligibility criteria|1
89371|NCT01147640|339645|P2|Overall Study|Lost to Follow-up|1
89372|NCT01147640|339646|P1|Overall Study|Lost to Follow-up|0
89373|NCT01147640|339645|P2|Overall Study|Withdrawal by Subject|0
89374|NCT01147640|339646|P1|Overall Study|Withdrawal by Subject|1
89375|NCT01147640|339645|P2|Overall Study|Physician Decision|0
89376|NCT01147640|339646|P1|Overall Study|Physician Decision|1
89377|NCT01147640|339645|P2|Overall Study|Adverse Event|0
89378|NCT01147640|339646|P1|Overall Study|Adverse Event|2
89379|NCT01147497|339678|P2|Overall Study|failed insertion|0
89380|NCT01147497|339679|P1|Overall Study|failed insertion|2
89381|NCT01147471|339699|P2|6 Month Follow Up|Lost to Follow-up|2
89382|NCT01147471|339700|P1|6 Month Follow Up|Lost to Follow-up|4
89383|NCT01147471|339699|P2|3 Month Follow Up|Physician Decision|1
89384|NCT01147471|339700|P1|3 Month Follow Up|Physician Decision|0
89385|NCT01147471|339699|P2|3 Month Follow Up|Lost to Follow-up|1
89386|NCT01147471|339700|P1|3 Month Follow Up|Lost to Follow-up|1
89387|NCT01147471|339699|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
89388|NCT01147471|339700|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
89389|NCT01147471|339699|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
89390|NCT01147471|339700|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
89391|NCT01147471|339699|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
89392|NCT01147471|339700|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
89393|NCT01147458|339714|P4|Second Intervention|Other|0
89394|NCT01147458|339715|P3|Second Intervention|Other|1
89395|NCT01147458|339716|P2|Second Intervention|Other|0
89396|NCT01147458|339717|P1|Second Intervention|Other|0
89397|NCT01147458|339714|P4|Second Intervention|Adverse Event|1
89398|NCT01147458|339715|P3|Second Intervention|Adverse Event|1
89399|NCT01147458|339716|P2|Second Intervention|Adverse Event|0
89400|NCT01147458|339717|P1|Second Intervention|Adverse Event|2
89401|NCT01147458|339714|P4|Second Intervention|Withdrawal by Subject|0
89402|NCT01147458|339715|P3|Second Intervention|Withdrawal by Subject|0
89403|NCT01147458|339716|P2|Second Intervention|Withdrawal by Subject|1
89404|NCT01147458|339717|P1|Second Intervention|Withdrawal by Subject|0
89405|NCT01147458|339714|P4|Second Intervention|Protocol Violation|0
89406|NCT01147458|339715|P3|Second Intervention|Protocol Violation|1
89407|NCT01147458|339716|P2|Second Intervention|Protocol Violation|1
89408|NCT01147458|339717|P1|Second Intervention|Protocol Violation|0
89409|NCT01147458|339714|P4|Second Intervention|Study terminated by sponsor|3
89410|NCT01147458|339715|P3|Second Intervention|Study terminated by sponsor|5
89411|NCT01147458|339716|P2|Second Intervention|Study terminated by sponsor|5
89412|NCT01147458|339717|P1|Second Intervention|Study terminated by sponsor|7
89413|NCT01147458|339714|P4|First Intervention|Other|0
89414|NCT01147458|339715|P3|First Intervention|Other|0
89415|NCT01147458|339716|P2|First Intervention|Other|2
89416|NCT01147458|339717|P1|First Intervention|Other|1
89417|NCT01147458|339714|P4|First Intervention|Adverse Event|3
89418|NCT01147458|339715|P3|First Intervention|Adverse Event|2
89419|NCT01147458|339716|P2|First Intervention|Adverse Event|3
89420|NCT01147458|339717|P1|First Intervention|Adverse Event|0
89421|NCT01147458|339714|P4|First Intervention|Withdrawal by Subject|0
89422|NCT01147458|339715|P3|First Intervention|Withdrawal by Subject|1
89423|NCT01147458|339716|P2|First Intervention|Withdrawal by Subject|0
89424|NCT01147458|339717|P1|First Intervention|Withdrawal by Subject|3
89425|NCT01147458|339714|P4|First Intervention|Protocol Violation|3
89426|NCT01147458|339715|P3|First Intervention|Protocol Violation|2
89427|NCT01147458|339716|P2|First Intervention|Protocol Violation|3
89428|NCT01147458|339717|P1|First Intervention|Protocol Violation|2
89429|NCT01147458|339714|P4|First Intervention|Study terminated by sponsor|8
89430|NCT01147458|339715|P3|First Intervention|Study terminated by sponsor|7
89431|NCT01147458|339716|P2|First Intervention|Study terminated by sponsor|8
89432|NCT01147458|339717|P1|First Intervention|Study terminated by sponsor|8
89433|NCT01147393|339796|P1|Dose Level -1|Dose Limited Toxicity|1
89434|NCT01147393|339796|P1|Dose Level 1|Dose limiting Toxicity|2
89435|NCT01147341|339817|P2|Open Label Period|Subject moved|0
89436|NCT01147341|339818|P1|Open Label Period|Subject moved|1
89437|NCT01147341|339817|P2|Open Label Period|Lack of Efficacy|0
89438|NCT01147341|339818|P1|Open Label Period|Lack of Efficacy|3
89439|NCT01147341|339817|P2|Double Blind Period|Withdrawal by Subject|1
89440|NCT01147341|339818|P1|Double Blind Period|Withdrawal by Subject|0
89441|NCT01147341|339817|P2|Double Blind Period|Lack of Efficacy|1
89442|NCT01147341|339818|P1|Double Blind Period|Lack of Efficacy|1
89443|NCT01147250|339881|P2|Overall Study|Other than specified|1
89444|NCT01147250|339882|P1|Overall Study|Other than specified|0
89445|NCT01147250|339881|P2|Overall Study|Site termination by sponsor|5
89446|NCT01147250|339882|P1|Overall Study|Site termination by sponsor|13
89447|NCT01147250|339881|P2|Overall Study|Withdrawal by Subject|88
89448|NCT01147250|339882|P1|Overall Study|Withdrawal by Subject|83
89449|NCT01147250|339881|P2|Overall Study|Lost to Follow-up|11
89450|NCT01147250|339882|P1|Overall Study|Lost to Follow-up|14
89451|NCT01147172|339894|P1|Overall Study|Lost to Follow-up|2
89452|NCT01147172|339894|P1|Overall Study|Withdrawal by Subject|2
89453|NCT01147068|339912|P7|Subjects That Completed Safety Follow-up|Ineligible|0
89454|NCT01147068|339913|P6|Subjects That Completed Safety Follow-up|Ineligible|0
89455|NCT01147068|339914|P5|Subjects That Completed Safety Follow-up|Ineligible|0
89456|NCT01147068|339915|P4|Subjects That Completed Safety Follow-up|Ineligible|0
89457|NCT01147068|339916|P3|Subjects That Completed Safety Follow-up|Ineligible|0
89458|NCT01147068|339917|P2|Subjects That Completed Safety Follow-up|Ineligible|1
89459|NCT01147068|339918|P1|Subjects That Completed Safety Follow-up|Ineligible|0
89460|NCT01147068|339912|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
89461|NCT01147068|339913|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
89462|NCT01147068|339914|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
89463|NCT01147068|339915|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
89464|NCT01147068|339916|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
89465|NCT01147068|339917|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
89466|NCT01147068|339918|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
89467|NCT01147068|339912|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
89468|NCT01147068|339913|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
89469|NCT01147068|339914|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
89470|NCT01147068|339915|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
89471|NCT01147068|339916|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
89472|NCT01147068|339917|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
89473|NCT01147068|339918|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
89474|NCT01147068|339912|P7|Subjects That Received 2nd Dose|Other|0
89475|NCT01147068|339913|P6|Subjects That Received 2nd Dose|Other|0
89476|NCT01147068|339914|P5|Subjects That Received 2nd Dose|Other|1
89477|NCT01147068|339915|P4|Subjects That Received 2nd Dose|Other|0
89478|NCT01147068|339916|P3|Subjects That Received 2nd Dose|Other|3
89479|NCT01147068|339917|P2|Subjects That Received 2nd Dose|Other|3
89480|NCT01147068|339918|P1|Subjects That Received 2nd Dose|Other|0
89481|NCT01147068|339912|P7|Subjects That Received 2nd Dose|Did not complete the study|0
89482|NCT01147068|339913|P6|Subjects That Received 2nd Dose|Did not complete the study|1
89483|NCT01147068|339914|P5|Subjects That Received 2nd Dose|Did not complete the study|0
89484|NCT01147068|339915|P4|Subjects That Received 2nd Dose|Did not complete the study|0
89485|NCT01147068|339916|P3|Subjects That Received 2nd Dose|Did not complete the study|0
89486|NCT01147068|339917|P2|Subjects That Received 2nd Dose|Did not complete the study|1
89487|NCT01147068|339918|P1|Subjects That Received 2nd Dose|Did not complete the study|0
89488|NCT01147068|339912|P7|Subjects That Received 2nd Dose|Ineligible|0
89489|NCT01147068|339913|P6|Subjects That Received 2nd Dose|Ineligible|0
89490|NCT01147068|339914|P5|Subjects That Received 2nd Dose|Ineligible|0
89491|NCT01147068|339915|P4|Subjects That Received 2nd Dose|Ineligible|0
89492|NCT01147068|339916|P3|Subjects That Received 2nd Dose|Ineligible|0
89493|NCT01147068|339917|P2|Subjects That Received 2nd Dose|Ineligible|1
89494|NCT01147068|339918|P1|Subjects That Received 2nd Dose|Ineligible|0
89495|NCT01147068|339912|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
89496|NCT01147068|339913|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
89497|NCT01147068|339914|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
89498|NCT01147068|339915|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
89499|NCT01147068|339916|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
89500|NCT01147068|339917|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
89501|NCT01147068|339918|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
89502|NCT01147055|339948|P2|First Intervention Period|Lost to Follow-up|0
89503|NCT01147055|339949|P1|First Intervention Period|Lost to Follow-up|1
89504|NCT01146951|339991|P2|Overall Study|Adverse Event|1
89505|NCT01146951|339992|P1|Overall Study|Adverse Event|4
89506|NCT01146912|340013|P8|Overall Study|Duplicate patient|0
89507|NCT01146912|340014|P7|Overall Study|Duplicate patient|0
89508|NCT01146912|340015|P6|Overall Study|Duplicate patient|0
89509|NCT01146912|340016|P5|Overall Study|Duplicate patient|0
89510|NCT01146912|340017|P4|Overall Study|Duplicate patient|0
89511|NCT01146912|340018|P3|Overall Study|Duplicate patient|1
89512|NCT01146912|340019|P2|Overall Study|Duplicate patient|0
89513|NCT01146912|340020|P1|Overall Study|Duplicate patient|0
89514|NCT01146912|340013|P8|Overall Study|< 14 weeks gestational age|0
89515|NCT01146912|340014|P7|Overall Study|< 14 weeks gestational age|0
89516|NCT01146912|340015|P6|Overall Study|< 14 weeks gestational age|0
89517|NCT01146912|340016|P5|Overall Study|< 14 weeks gestational age|0
89518|NCT01146912|340017|P4|Overall Study|< 14 weeks gestational age|2
89519|NCT01146912|340018|P3|Overall Study|< 14 weeks gestational age|3
89520|NCT01146912|340019|P2|Overall Study|< 14 weeks gestational age|0
89521|NCT01146912|340020|P1|Overall Study|< 14 weeks gestational age|0
89522|NCT01146912|340013|P8|Overall Study|Already received influenza vaccination|0
89523|NCT01146912|340014|P7|Overall Study|Already received influenza vaccination|56
89524|NCT01146912|340015|P6|Overall Study|Already received influenza vaccination|61
89525|NCT01146912|340016|P5|Overall Study|Already received influenza vaccination|41
89526|NCT01146912|340017|P4|Overall Study|Already received influenza vaccination|15
89527|NCT01146912|340018|P3|Overall Study|Already received influenza vaccination|13
89528|NCT01146912|340019|P2|Overall Study|Already received influenza vaccination|822
89529|NCT01146912|340020|P1|Overall Study|Already received influenza vaccination|817
89530|NCT01146873|340042|P2|Overall Study|Transfer out|6
89531|NCT01146873|340043|P1|Overall Study|Transfer out|0
89532|NCT01146860|340059|P2|Overall Study|Withdrawal by Subject|1
89533|NCT01146860|340060|P1|Overall Study|Withdrawal by Subject|0
89534|NCT01146782|340080|P1|Primary Endpoint Cohort|Physician Decision|1
89535|NCT01146782|340080|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
89536|NCT01146782|340080|P1|Safety Cohort|TST <4 hrs|14
89537|NCT01146782|340080|P1|Safety Cohort|Control AHI <5|4
89538|NCT01146782|340080|P1|Safety Cohort|Withdrawal by Subject|4
89539|NCT01146782|340080|P1|Safety Cohort|Screen Failure|61
89540|NCT01146782|340080|P1|Screening Cohort|Withdrawal by Subject|29
89541|NCT01146782|340080|P1|Screening Cohort|Physician Decision|1
89542|NCT01146782|340080|P1|Screening Cohort|Lost to Follow-up|4
89543|NCT01146782|340080|P1|Screening Cohort|Screen Failure|187
89544|NCT01146613|340089|P2|Overall Study|Outpatient detox|0
89545|NCT01146613|340090|P1|Overall Study|Outpatient detox|1
89546|NCT01146613|340089|P2|Overall Study|schedule conflict|0
89547|NCT01146613|340090|P1|Overall Study|schedule conflict|1
89548|NCT01146613|340089|P2|Overall Study|Withdrawal by Subject|3
89549|NCT01146613|340090|P1|Overall Study|Withdrawal by Subject|0
89550|NCT01146613|340089|P2|Overall Study|Physician Decision|0
89551|NCT01146613|340090|P1|Overall Study|Physician Decision|1
89552|NCT01146613|340089|P2|Overall Study|Death|0
89553|NCT01146613|340090|P1|Overall Study|Death|1
89554|NCT01146613|340089|P2|Overall Study|Lack of Efficacy|1
89555|NCT01146613|340090|P1|Overall Study|Lack of Efficacy|0
89556|NCT01146613|340089|P2|Overall Study|Lost to Follow-up|8
89557|NCT01146613|340090|P1|Overall Study|Lost to Follow-up|3
89558|NCT01146288|340181|P2|First Intervention(1 Day)|Adverse Event|1
89559|NCT01146288|340182|P1|First Intervention(1 Day)|Adverse Event|0
89560|NCT01146054|340196|P1|Overall Study|Lost to Follow-up|1
89561|NCT01146054|340196|P1|Overall Study|Other illness precluded treatment|2
89562|NCT01146054|340196|P1|Overall Study|Rapid tumor progression|2
89563|NCT01146054|340196|P1|Overall Study|Did not meet dose constraints for SBRT|5
89564|NCT01145898|340206|P2|3-year Treatment|medication change by treating physician|16
89565|NCT01145898|340207|P1|3-year Treatment|medication change by treating physician|3
89566|NCT01145755|340241|P3|Overall Study|Positive urine ethanol|0
89567|NCT01145755|340242|P2|Overall Study|Positive urine ethanol|1
89568|NCT01145755|340243|P1|Overall Study|Positive urine ethanol|0
89569|NCT01145755|340241|P3|Overall Study|Withdrawal by Subject|1
89570|NCT01145755|340242|P2|Overall Study|Withdrawal by Subject|0
89571|NCT01145755|340243|P1|Overall Study|Withdrawal by Subject|0
89572|NCT01145755|340241|P3|Overall Study|Patient could not swollow medication|1
89573|NCT01145755|340242|P2|Overall Study|Patient could not swollow medication|0
89574|NCT01145755|340243|P1|Overall Study|Patient could not swollow medication|0
89575|NCT01145755|340241|P3|Overall Study|Lack of Efficacy|0
89576|NCT01145755|340242|P2|Overall Study|Lack of Efficacy|1
89577|NCT01145755|340243|P1|Overall Study|Lack of Efficacy|0
89578|NCT01145755|340241|P3|Overall Study|Study Closure|17
89579|NCT01145755|340242|P2|Overall Study|Study Closure|14
89580|NCT01145755|340243|P1|Overall Study|Study Closure|14
89581|NCT01145755|340241|P3|Overall Study|Protocol Violation|1
89582|NCT01145755|340242|P2|Overall Study|Protocol Violation|3
89583|NCT01145755|340243|P1|Overall Study|Protocol Violation|0
89584|NCT01145755|340241|P3|Overall Study|Lost to Follow-up|1
89585|NCT01145755|340242|P2|Overall Study|Lost to Follow-up|3
89586|NCT01145755|340243|P1|Overall Study|Lost to Follow-up|2
89587|NCT01145755|340241|P3|Overall Study|Withdrawal by Subject|2
89588|NCT01145755|340242|P2|Overall Study|Withdrawal by Subject|2
89589|NCT01145755|340243|P1|Overall Study|Withdrawal by Subject|2
89590|NCT01145755|340241|P3|Overall Study|Adverse Event|2
89591|NCT01145755|340242|P2|Overall Study|Adverse Event|4
89592|NCT01145755|340243|P1|Overall Study|Adverse Event|2
89593|NCT01145625|340270|P2|Overall Study|Pregnancy|1
89594|NCT01145625|340271|P1|Overall Study|Pregnancy|0
89595|NCT01145625|340270|P2|Overall Study|Withdrawal by Subject|16
89596|NCT01145625|340271|P1|Overall Study|Withdrawal by Subject|7
89597|NCT01145625|340270|P2|Overall Study|Protocol Violation|1
89598|NCT01145625|340271|P1|Overall Study|Protocol Violation|3
89599|NCT01145625|340270|P2|Overall Study|Adverse Event|4
89600|NCT01145625|340271|P1|Overall Study|Adverse Event|6
89601|NCT01145625|340270|P2|Overall Study|Lost to Follow-up|9
89602|NCT01145625|340271|P1|Overall Study|Lost to Follow-up|8
89603|NCT01145560|340284|P3|Overall Study|Withdrawal of therapy|1
89604|NCT01145560|340285|P2|Overall Study|Withdrawal of therapy|0
89605|NCT01145560|340286|P1|Overall Study|Withdrawal of therapy|0
89606|NCT01145560|340284|P3|Overall Study|False insurance information|0
89607|NCT01145560|340285|P2|Overall Study|False insurance information|1
89608|NCT01145560|340286|P1|Overall Study|False insurance information|0
89609|NCT01145560|340284|P3|Overall Study|Accidental unblinding of study treatment|0
89610|NCT01145560|340285|P2|Overall Study|Accidental unblinding of study treatment|1
89611|NCT01145560|340286|P1|Overall Study|Accidental unblinding of study treatment|0
89612|NCT01145560|340284|P3|Overall Study|No study drug by 24h after organ failure|0
89613|NCT01145560|340285|P2|Overall Study|No study drug by 24h after organ failure|0
89614|NCT01145560|340286|P1|Overall Study|No study drug by 24h after organ failure|1
89615|NCT01145560|340284|P3|Overall Study|Lost to Follow-up|1
89616|NCT01145560|340285|P2|Overall Study|Lost to Follow-up|1
89617|NCT01145560|340286|P1|Overall Study|Lost to Follow-up|1
89618|NCT01145560|340284|P3|Overall Study|Withdrawal by Subject|0
89619|NCT01145560|340285|P2|Overall Study|Withdrawal by Subject|1
89620|NCT01145560|340286|P1|Overall Study|Withdrawal by Subject|2
89621|NCT01145508|340312|P2|Overall Study|Never started treatment|1
89622|NCT01145508|340313|P1|Overall Study|Never started treatment|1
89623|NCT01145508|340312|P2|Overall Study|Physician Decision|1
89624|NCT01145508|340313|P1|Overall Study|Physician Decision|2
89625|NCT01145508|340312|P2|Overall Study|Death|0
89626|NCT01145508|340313|P1|Overall Study|Death|1
89627|NCT01145508|340312|P2|Overall Study|Adverse Event|0
89628|NCT01145508|340313|P1|Overall Study|Adverse Event|1
89629|NCT01145495|340319|P1|Overall Study|Disease progression after respone|1
89630|NCT01145495|340319|P1|Overall Study|Withdrawal by Subject|5
89631|NCT01145495|340319|P1|Overall Study|Adverse Event|6
89632|NCT01145482|340325|P2|First Intervention (1 Day)|Withdrawal by Subject|1
89633|NCT01145482|340326|P1|First Intervention (1 Day)|Withdrawal by Subject|0
89634|NCT01145417|340336|P2|Overall Study|Other|0
89635|NCT01145417|340337|P1|Overall Study|Other|1
89636|NCT01145417|340336|P2|Overall Study|Study terminated by sponsor|43
89637|NCT01145417|340337|P1|Overall Study|Study terminated by sponsor|35
89638|NCT01145417|340336|P2|Overall Study|Adverse Event|1
89639|NCT01145417|340337|P1|Overall Study|Adverse Event|0
89640|NCT01145417|340336|P2|Overall Study|Pregnancy|0
89641|NCT01145417|340337|P1|Overall Study|Pregnancy|1
89642|NCT01145417|340336|P2|Overall Study|Withdrawal by Subject|2
89643|NCT01145417|340337|P1|Overall Study|Withdrawal by Subject|1
89644|NCT01145417|340336|P2|Overall Study|Lost to Follow-up|1
89645|NCT01145417|340337|P1|Overall Study|Lost to Follow-up|2
89646|NCT01145417|340336|P2|Overall Study|Death|0
89647|NCT01145417|340337|P1|Overall Study|Death|1
89648|NCT01145352|340370|P1|Overall Study|Syringe formulation was used|1
89649|NCT01145352|340370|P1|Overall Study|Treated before marketing approval|4
89650|NCT01145352|340370|P1|Overall Study|Found to have been registered twice|6
89651|NCT01145053|340378|P1|Overall Study|Other|18
89652|NCT01145053|340378|P1|Overall Study|Withdrawal by Subject|25
89653|NCT01145053|340378|P1|Overall Study|Lost to Follow-up|28
89654|NCT01145053|340378|P1|Overall Study|Adverse Event|22
89655|NCT01144715|340430|P2|Overall Study|Adverse Event|1
89656|NCT01144715|340431|P1|Overall Study|Adverse Event|0
89657|NCT01144715|340430|P2|Overall Study|Withdrawal by Subject|1
89658|NCT01144715|340431|P1|Overall Study|Withdrawal by Subject|2
89659|NCT01144715|340430|P2|Overall Study|Lost to Follow-up|1
89660|NCT01144715|340431|P1|Overall Study|Lost to Follow-up|2
89661|NCT01144416|340500|P2|Intervention Period|Other|5
89662|NCT01144416|340501|P1|Intervention Period|Other|7
89663|NCT01144416|340500|P2|Intervention Period|No/too few/bad quality embryos|3
89664|NCT01144416|340501|P1|Intervention Period|No/too few/bad quality embryos|3
89665|NCT01144416|340500|P2|Intervention Period|No or abnormal fertilization|10
89666|NCT01144416|340501|P1|Intervention Period|No or abnormal fertilization|25
89667|NCT01144416|340500|P2|Intervention Period|No/too few/bad oocytes|5
89668|NCT01144416|340501|P1|Intervention Period|No/too few/bad oocytes|7
89669|NCT01144416|340500|P2|Intervention Period|Too high ovarian response|2
89670|NCT01144416|340501|P1|Intervention Period|Too high ovarian response|4
89671|NCT01144416|340500|P2|Intervention Period|Risk of OHSS|1
89672|NCT01144416|340501|P1|Intervention Period|Risk of OHSS|0
89673|NCT01144416|340500|P2|Intervention Period|Insufficient ovarian response|17
89674|NCT01144416|340501|P1|Intervention Period|Insufficient ovarian response|11
89675|NCT01144416|340500|P2|Intervention Period|Adverse Event|6
89676|NCT01144416|340501|P1|Intervention Period|Adverse Event|5
89677|NCT01144403|340517|P1|Overall Study|Adverse Event|1
89678|NCT01144403|340517|P1|Overall Study|Death|1
89679|NCT01144403|340517|P1|Overall Study|Lost to Follow-up|3
89680|NCT01144377|340529|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
89681|NCT01144377|340530|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
89682|NCT01144377|340531|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
89683|NCT01144377|340532|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
89684|NCT01144377|340533|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
89685|NCT01144377|340529|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
89686|NCT01144377|340530|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
89687|NCT01144377|340531|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
89688|NCT01144377|340532|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
89689|NCT01144377|340533|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
89690|NCT01144377|340529|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
89691|NCT01144377|340530|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
89692|NCT01144377|340531|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
89693|NCT01144377|340532|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
89694|NCT01144377|340533|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
89695|NCT01144377|340529|P5|52 Week Treatment Period|Sponsor Decision|1
89696|NCT01144377|340530|P4|52 Week Treatment Period|Sponsor Decision|0
89697|NCT01144377|340531|P3|52 Week Treatment Period|Sponsor Decision|0
89698|NCT01144377|340532|P2|52 Week Treatment Period|Sponsor Decision|0
89699|NCT01144377|340533|P1|52 Week Treatment Period|Sponsor Decision|0
89700|NCT01144377|340529|P5|52 Week Treatment Period|Withdrawal by Subject|0
89701|NCT01144377|340530|P4|52 Week Treatment Period|Withdrawal by Subject|1
89702|NCT01144377|340531|P3|52 Week Treatment Period|Withdrawal by Subject|1
89703|NCT01144377|340532|P2|52 Week Treatment Period|Withdrawal by Subject|1
89704|NCT01144377|340533|P1|52 Week Treatment Period|Withdrawal by Subject|4
89705|NCT01144377|340529|P5|52 Week Treatment Period|Lost to Follow-up|0
89706|NCT01144377|340530|P4|52 Week Treatment Period|Lost to Follow-up|0
89707|NCT01144377|340531|P3|52 Week Treatment Period|Lost to Follow-up|0
89708|NCT01144377|340532|P2|52 Week Treatment Period|Lost to Follow-up|0
89709|NCT01144377|340533|P1|52 Week Treatment Period|Lost to Follow-up|1
89710|NCT01144377|340529|P5|52 Week Treatment Period|Protocol Violation|1
89711|NCT01144377|340530|P4|52 Week Treatment Period|Protocol Violation|0
89712|NCT01144377|340531|P3|52 Week Treatment Period|Protocol Violation|0
89713|NCT01144377|340532|P2|52 Week Treatment Period|Protocol Violation|0
89714|NCT01144377|340533|P1|52 Week Treatment Period|Protocol Violation|0
89715|NCT01144377|340529|P5|52 Week Treatment Period|Entry Criteria Not Met|0
89716|NCT01144377|340530|P4|52 Week Treatment Period|Entry Criteria Not Met|1
89717|NCT01144377|340531|P3|52 Week Treatment Period|Entry Criteria Not Met|1
89718|NCT01144377|340532|P2|52 Week Treatment Period|Entry Criteria Not Met|0
89719|NCT01144377|340533|P1|52 Week Treatment Period|Entry Criteria Not Met|0
89720|NCT01144377|340529|P5|52 Week Treatment Period|Adverse Event|1
89721|NCT01144377|340530|P4|52 Week Treatment Period|Adverse Event|2
89722|NCT01144377|340531|P3|52 Week Treatment Period|Adverse Event|3
89723|NCT01144377|340532|P2|52 Week Treatment Period|Adverse Event|0
89724|NCT01144377|340533|P1|52 Week Treatment Period|Adverse Event|0
89725|NCT01144364|340582|P3|Follow-Up/Maintenance Phase|Physician Decision|1
89726|NCT01144364|340583|P2|Follow-Up/Maintenance Phase|Physician Decision|0
89727|NCT01144364|340584|P1|Follow-Up/Maintenance Phase|Physician Decision|0
89728|NCT01144364|340582|P3|Follow-Up/Maintenance Phase|Relapse|5
89729|NCT01144364|340583|P2|Follow-Up/Maintenance Phase|Relapse|5
89730|NCT01144364|340584|P1|Follow-Up/Maintenance Phase|Relapse|0
89731|NCT01144364|340582|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
89732|NCT01144364|340583|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
89733|NCT01144364|340584|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
89734|NCT01144364|340582|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
89735|NCT01144364|340583|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
89736|NCT01144364|340584|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
89737|NCT01144364|340582|P3|Follow-Up/Maintenance Phase|Death|0
89738|NCT01144364|340583|P2|Follow-Up/Maintenance Phase|Death|2
89739|NCT01144364|340584|P1|Follow-Up/Maintenance Phase|Death|0
89740|NCT01144364|340582|P3|Follow-Up/Maintenance Phase|Adverse Event|1
89741|NCT01144364|340583|P2|Follow-Up/Maintenance Phase|Adverse Event|3
89742|NCT01144364|340584|P1|Follow-Up/Maintenance Phase|Adverse Event|0
89743|NCT01144364|340582|P3|Follow-Up/Maintenance Phase|Disease progression|29
89744|NCT01144364|340583|P2|Follow-Up/Maintenance Phase|Disease progression|23
89745|NCT01144364|340584|P1|Follow-Up/Maintenance Phase|Disease progression|0
89746|NCT01144364|340582|P3|Induction Phase|Protocol Violation|0
89747|NCT01144364|340583|P2|Induction Phase|Protocol Violation|0
89748|NCT01144364|340584|P1|Induction Phase|Protocol Violation|1
89749|NCT01144364|340582|P3|Induction Phase|Secondary neoplasia|0
89750|NCT01144364|340583|P2|Induction Phase|Secondary neoplasia|0
89751|NCT01144364|340584|P1|Induction Phase|Secondary neoplasia|1
89752|NCT01144364|340582|P3|Induction Phase|Stable disease|0
89753|NCT01144364|340583|P2|Induction Phase|Stable disease|0
89754|NCT01144364|340584|P1|Induction Phase|Stable disease|2
89755|NCT01144364|340582|P3|Induction Phase|Physician Decision|0
89756|NCT01144364|340583|P2|Induction Phase|Physician Decision|0
89757|NCT01144364|340584|P1|Induction Phase|Physician Decision|1
89758|NCT01144364|340582|P3|Induction Phase|Lost to Follow-up|0
89759|NCT01144364|340583|P2|Induction Phase|Lost to Follow-up|0
89760|NCT01144364|340584|P1|Induction Phase|Lost to Follow-up|2
89761|NCT01144364|340582|P3|Induction Phase|Withdrawal by Subject|0
89762|NCT01144364|340583|P2|Induction Phase|Withdrawal by Subject|0
89763|NCT01144364|340584|P1|Induction Phase|Withdrawal by Subject|1
89764|NCT01144364|340582|P3|Induction Phase|Death|0
89765|NCT01144364|340583|P2|Induction Phase|Death|0
89766|NCT01144364|340584|P1|Induction Phase|Death|1
89767|NCT01144364|340582|P3|Induction Phase|Adverse Event|0
89768|NCT01144364|340583|P2|Induction Phase|Adverse Event|0
89769|NCT01144364|340584|P1|Induction Phase|Adverse Event|9
89770|NCT01144364|340582|P3|Induction Phase|Disease progression|0
89771|NCT01144364|340583|P2|Induction Phase|Disease progression|0
89772|NCT01144364|340584|P1|Induction Phase|Disease progression|14
89773|NCT01144299|340610|P2|Overall Study|Withdrawal by Subject|0
89774|NCT01144299|340611|P1|Overall Study|Withdrawal by Subject|1
89775|NCT01144299|340610|P2|Overall Study|Lost to Follow-up|0
89776|NCT01144299|340611|P1|Overall Study|Lost to Follow-up|1
89777|NCT01144182|340656|P2|Overall Study|Lost to Follow-up|9
89778|NCT01144182|340657|P1|Overall Study|Lost to Follow-up|9
89779|NCT01144182|340656|P2|Overall Study|Withdrawal by Subject|6
89780|NCT01144182|340657|P1|Overall Study|Withdrawal by Subject|3
89781|NCT01144182|340656|P2|Overall Study|Death|6
89782|NCT01144182|340657|P1|Overall Study|Death|5
89783|NCT01144052|340717|P2|Overall Study|Withdrawal by Subject|1
89784|NCT01144052|340718|P1|Overall Study|Withdrawal by Subject|1
89785|NCT01143896|340749|P2|Overall Study|Death|3
89786|NCT01143896|340750|P1|Overall Study|Death|6
89787|NCT01143896|340749|P2|Overall Study|Withdrawal by Subject|5
89788|NCT01143896|340750|P1|Overall Study|Withdrawal by Subject|13
89789|NCT01143896|340749|P2|Overall Study|Lost to Follow-up|13
89790|NCT01143896|340750|P1|Overall Study|Lost to Follow-up|18
89791|NCT01143896|340749|P2|Overall Study|Did not complete Baseline Interview|4
89792|NCT01143896|340750|P1|Overall Study|Did not complete Baseline Interview|5
89793|NCT01143714|340862|P2|Overall Study|wound size increased|0
89794|NCT01143714|340863|P1|Overall Study|wound size increased|1
89795|NCT01143714|340862|P2|Overall Study|wound closed = deemed healed|0
89796|NCT01143714|340863|P1|Overall Study|wound closed = deemed healed|1
89797|NCT01143714|340862|P2|Overall Study|Subject non-compliance|1
89798|NCT01143714|340863|P1|Overall Study|Subject non-compliance|0
89799|NCT01143714|340862|P2|Overall Study|Withdrawal by Subject|0
89800|NCT01143714|340863|P1|Overall Study|Withdrawal by Subject|1
89801|NCT01143714|340862|P2|Overall Study|Adverse Event|2
89802|NCT01143714|340863|P1|Overall Study|Adverse Event|4
89803|NCT01143402|340968|P3|Overall Study|Not Treated|1
89804|NCT01143402|340969|P2|Overall Study|Not Treated|0
89805|NCT01143402|340970|P1|Overall Study|Not Treated|0
89806|NCT01143402|340968|P3|Overall Study|Rapid clinical decline|0
89807|NCT01143402|340969|P2|Overall Study|Rapid clinical decline|1
89808|NCT01143402|340970|P1|Overall Study|Rapid clinical decline|1
89809|NCT01143389|340981|P2|Overall Study|Lost to Follow-up|25
89810|NCT01143389|340982|P1|Overall Study|Lost to Follow-up|26
89811|NCT01143337|340996|P3|Overall Study|Other reason|5
89812|NCT01143337|340997|P2|Overall Study|Other reason|0
89813|NCT01143337|340998|P1|Overall Study|Other reason|0
89814|NCT01143337|340996|P3|Overall Study|Withdrawal by Subject|1
89815|NCT01143337|340997|P2|Overall Study|Withdrawal by Subject|0
89816|NCT01143337|340998|P1|Overall Study|Withdrawal by Subject|0
89817|NCT01143337|340996|P3|Overall Study|Protocol Violation|0
89818|NCT01143337|340997|P2|Overall Study|Protocol Violation|0
89819|NCT01143337|340998|P1|Overall Study|Protocol Violation|1
89820|NCT01143337|340996|P3|Overall Study|Lack of Efficacy|1
89821|NCT01143337|340997|P2|Overall Study|Lack of Efficacy|2
89822|NCT01143337|340998|P1|Overall Study|Lack of Efficacy|6
89823|NCT01143337|340996|P3|Overall Study|Adverse Event|5
89824|NCT01143337|340997|P2|Overall Study|Adverse Event|9
89825|NCT01143337|340998|P1|Overall Study|Adverse Event|3
89826|NCT01143324|341012|P1|Overall Study|Explant of the device|4
89827|NCT01143324|341012|P1|Overall Study|Withdrawal by Subject|4
89828|NCT01143324|341012|P1|Overall Study|Lost to Follow-up|11
89829|NCT01143259|341051|P2|Overall Study|Screen Failure|9
89830|NCT01143259|341052|P1|Overall Study|Screen Failure|7
89831|NCT01143259|341051|P2|Overall Study|Protocol Violation|9
89832|NCT01143259|341052|P1|Overall Study|Protocol Violation|13
89833|NCT01143259|341051|P2|Overall Study|Withdrawal by Subject|2
89834|NCT01143259|341052|P1|Overall Study|Withdrawal by Subject|3
89835|NCT01143207|341060|P1|Overall Study|Lost to Follow-up|2
89836|NCT01143090|341080|P1|Overall Study|Administrative|1
89837|NCT01143090|341080|P1|Overall Study|Failure to meet eligibility criteria|1
89838|NCT01143090|341080|P1|Overall Study|Non-compliance with study drug|1
89839|NCT01143090|341080|P1|Overall Study|Withdrawal by Subject|18
89840|NCT01143090|341080|P1|Overall Study|Protocol Violation|2
89841|NCT01143090|341080|P1|Overall Study|Lost to Follow-up|9
89842|NCT01143090|341080|P1|Overall Study|Adverse Event|17
89843|NCT01143090|341080|P1|Overall Study|Lack of Efficacy|2
89844|NCT01143077|341087|P3|Overall Study|Principal Investigator Decision|1
89845|NCT01143077|341088|P2|Overall Study|Principal Investigator Decision|0
89846|NCT01143077|341089|P1|Overall Study|Principal Investigator Decision|2
89847|NCT01143077|341087|P3|Overall Study|Administrative|0
89848|NCT01143077|341088|P2|Overall Study|Administrative|0
89849|NCT01143077|341089|P1|Overall Study|Administrative|1
89850|NCT01143077|341087|P3|Overall Study|Non-compliance with study drug|1
89851|NCT01143077|341088|P2|Overall Study|Non-compliance with study drug|1
89852|NCT01143077|341089|P1|Overall Study|Non-compliance with study drug|0
89853|NCT01143077|341087|P3|Overall Study|Withdrawal by Subject|3
89854|NCT01143077|341088|P2|Overall Study|Withdrawal by Subject|3
89855|NCT01143077|341089|P1|Overall Study|Withdrawal by Subject|4
89856|NCT01143077|341087|P3|Overall Study|Protocol Violation|0
89857|NCT01143077|341088|P2|Overall Study|Protocol Violation|0
89858|NCT01143077|341089|P1|Overall Study|Protocol Violation|2
89859|NCT01143077|341087|P3|Overall Study|Lost to Follow-up|4
89860|NCT01143077|341088|P2|Overall Study|Lost to Follow-up|3
89861|NCT01143077|341089|P1|Overall Study|Lost to Follow-up|2
89862|NCT01143077|341087|P3|Overall Study|Adverse Event|5
89863|NCT01143077|341088|P2|Overall Study|Adverse Event|6
89864|NCT01143077|341089|P1|Overall Study|Adverse Event|5
89865|NCT01143077|341087|P3|Overall Study|Lack of Efficacy|1
89866|NCT01143077|341088|P2|Overall Study|Lack of Efficacy|2
89867|NCT01143077|341089|P1|Overall Study|Lack of Efficacy|0
89868|NCT01143051|341106|P6|3-14 Day Washout|Withdrawal by Subject|1
89869|NCT01143051|341107|P5|3-14 Day Washout|Withdrawal by Subject|0
89870|NCT01143051|341108|P4|3-14 Day Washout|Withdrawal by Subject|0
89871|NCT01143051|341109|P3|3-14 Day Washout|Withdrawal by Subject|0
89872|NCT01143051|341110|P2|3-14 Day Washout|Withdrawal by Subject|0
89873|NCT01143051|341111|P1|3-14 Day Washout|Withdrawal by Subject|0
89874|NCT01143051|341106|P6|3-14 Day Washout|Withdrawal by Subject|0
89875|NCT01143051|341107|P5|3-14 Day Washout|Withdrawal by Subject|0
89876|NCT01143051|341108|P4|3-14 Day Washout|Withdrawal by Subject|0
89877|NCT01143051|341109|P3|3-14 Day Washout|Withdrawal by Subject|1
89878|NCT01143051|341110|P2|3-14 Day Washout|Withdrawal by Subject|0
89879|NCT01143051|341111|P1|3-14 Day Washout|Withdrawal by Subject|0
89880|NCT01143038|341134|P1|Overall Study|Death|1
89881|NCT01143038|341134|P1|Overall Study|Protocol Deviation|1
89882|NCT01143038|341134|P1|Overall Study|Lost to Follow-up|2
89883|NCT01143038|341134|P1|Overall Study|Adverse Event|3
89884|NCT01143038|341134|P1|Overall Study|Requirement for alternative therapy|5
89885|NCT01143038|341134|P1|Overall Study|Withdrawal by Subject|4
89886|NCT01142908|341144|P2|Overall Study|Withdrawal by Subject|0
89887|NCT01142908|341145|P1|Overall Study|Withdrawal by Subject|3
89888|NCT01142908|341144|P2|Overall Study|Excluded - did not meet criteria|5
89889|NCT01142908|341145|P1|Overall Study|Excluded - did not meet criteria|9
89890|NCT01142908|341144|P2|Overall Study|Death|4
89891|NCT01142908|341145|P1|Overall Study|Death|1
89892|NCT01142908|341144|P2|Overall Study|Lost to Follow-up|13
89893|NCT01142908|341145|P1|Overall Study|Lost to Follow-up|19
89894|NCT01142726|341194|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
89895|NCT01142726|341195|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
89896|NCT01142726|341196|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
89897|NCT01142726|341194|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
89898|NCT01142726|341195|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
89899|NCT01142726|341196|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
89900|NCT01142726|341194|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
89901|NCT01142726|341195|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
89902|NCT01142726|341196|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
89903|NCT01142726|341194|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
89904|NCT01142726|341195|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
89905|NCT01142726|341196|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
89906|NCT01142726|341194|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
89907|NCT01142726|341195|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
89908|NCT01142726|341196|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
89909|NCT01142726|341194|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
89910|NCT01142726|341195|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
89911|NCT01142726|341196|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
89912|NCT01142726|341194|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
89913|NCT01142726|341195|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
89914|NCT01142726|341196|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
89915|NCT01142726|341194|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
89916|NCT01142726|341195|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
89917|NCT01142726|341196|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
89918|NCT01142726|341194|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
89919|NCT01142726|341195|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
89920|NCT01142726|341196|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
89921|NCT01142726|341194|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
89922|NCT01142726|341195|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
89923|NCT01142726|341196|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
89924|NCT01142726|341194|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
89925|NCT01142726|341195|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
89926|NCT01142726|341196|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
89927|NCT01142726|341194|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
89928|NCT01142726|341195|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
89929|NCT01142726|341196|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
89930|NCT01142726|341194|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
89931|NCT01142726|341195|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
89932|NCT01142726|341196|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
89933|NCT01142726|341194|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
89934|NCT01142726|341195|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
89935|NCT01142726|341196|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
89936|NCT01142726|341194|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
89937|NCT01142726|341195|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
89938|NCT01142726|341196|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
89939|NCT01142726|341194|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
89940|NCT01142726|341195|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
89941|NCT01142726|341196|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
89942|NCT01142661|341259|P1|Overall Study|Physician Decision|1
89943|NCT01142661|341259|P1|Overall Study|Withdrawal by Subject|1
89944|NCT01142661|341259|P1|Overall Study|Adverse Event|2
89945|NCT01142596|341266|P2|Overall Study|Other reason (not specified)|4
89946|NCT01142596|341267|P1|Overall Study|Other reason (not specified)|5
89947|NCT01142596|341266|P2|Overall Study|Lost to Follow-up|3
89948|NCT01142596|341267|P1|Overall Study|Lost to Follow-up|2
89949|NCT01142596|341266|P2|Overall Study|Lack of Efficacy|9
89950|NCT01142596|341267|P1|Overall Study|Lack of Efficacy|5
89951|NCT01142596|341266|P2|Overall Study|Adverse Event|35
89952|NCT01142596|341267|P1|Overall Study|Adverse Event|8
89953|NCT01142596|341266|P2|Overall Study|Withdrawal by Subject|35
89954|NCT01142596|341267|P1|Overall Study|Withdrawal by Subject|9
89955|NCT01142466|341319|P2|Overall Study|Withdrawal by Subject|1
89956|NCT01142466|341320|P1|Overall Study|Withdrawal by Subject|1
89957|NCT01142466|341319|P2|Overall Study|Adverse Event|1
89958|NCT01142466|341320|P1|Overall Study|Adverse Event|2
89959|NCT01142388|341340|P2|Overall Study|Never started therapy|3
89960|NCT01142388|341341|P1|Overall Study|Never started therapy|7
89961|NCT01142388|341340|P2|Overall Study|Other|1
89962|NCT01142388|341341|P1|Overall Study|Other|1
89963|NCT01142388|341340|P2|Overall Study|Other complications|2
89964|NCT01142388|341341|P1|Overall Study|Other complications|0
89965|NCT01142388|341340|P2|Overall Study|Alternative therapy|0
89966|NCT01142388|341341|P1|Overall Study|Alternative therapy|1
89967|NCT01142388|341340|P2|Overall Study|Withdrawal by Subject|3
89968|NCT01142388|341341|P1|Overall Study|Withdrawal by Subject|5
89969|NCT01142388|341340|P2|Overall Study|Death|2
89970|NCT01142388|341341|P1|Overall Study|Death|3
89971|NCT01142388|341340|P2|Overall Study|Adverse Event|5
89972|NCT01142388|341341|P1|Overall Study|Adverse Event|9
89973|NCT01142388|341340|P2|Overall Study|Lack of Efficacy|31
89974|NCT01142388|341341|P1|Overall Study|Lack of Efficacy|21
89975|NCT01142336|341353|P2|Overall Study|Lost to Follow-up|1
89976|NCT01142336|341354|P1|Overall Study|Lost to Follow-up|0
89977|NCT01142336|341353|P2|Overall Study|Adverse Event|1
89978|NCT01142336|341354|P1|Overall Study|Adverse Event|1
89979|NCT01142193|341379|P2|Overall Study|Other|2
89980|NCT01142193|341380|P1|Overall Study|Other|1
89981|NCT01142193|341379|P2|Overall Study|Protocol Discontinuation Criterion Met|0
89982|NCT01142193|341380|P1|Overall Study|Protocol Discontinuation Criterion Met|1
89983|NCT01142193|341379|P2|Overall Study|Withdrawal by Subject|3
89984|NCT01142193|341380|P1|Overall Study|Withdrawal by Subject|4
89985|NCT01142193|341379|P2|Overall Study|Physician Decision|1
89986|NCT01142193|341380|P1|Overall Study|Physician Decision|1
89987|NCT01142193|341379|P2|Overall Study|Lack of Efficacy|1
89988|NCT01142193|341380|P1|Overall Study|Lack of Efficacy|2
89989|NCT01142193|341379|P2|Overall Study|Adverse Event|4
89990|NCT01142193|341380|P1|Overall Study|Adverse Event|12
89991|NCT01142128|341408|P1|Overall Study|Withdrawal by Subject|2
89992|NCT01142128|341408|P1|Overall Study|Lost to Follow-up|1
89993|NCT01142128|341408|P1|Overall Study|Physician Decision|1
89994|NCT01142115|341418|P2|First Intervention|Adverse Event|0
89995|NCT01142115|341419|P1|First Intervention|Adverse Event|1
89996|NCT01142115|341418|P2|First Intervention|Lack of Efficacy|1
89997|NCT01142115|341419|P1|First Intervention|Lack of Efficacy|1
89998|NCT01142089|341436|P2|Overall Study|Patient required rescue medication|17
89999|NCT01142089|341437|P1|Overall Study|Patient required rescue medication|8
90000|NCT01142089|341436|P2|Overall Study|Noncompliance with study procedures|1
90001|NCT01142089|341437|P1|Overall Study|Noncompliance with study procedures|2
90002|NCT01142089|341436|P2|Overall Study|Use of prohibited medications|1
90003|NCT01142089|341437|P1|Overall Study|Use of prohibited medications|0
90004|NCT01142089|341436|P2|Overall Study|Withdrawal by Subject|2
90005|NCT01142089|341437|P1|Overall Study|Withdrawal by Subject|1
90006|NCT01142089|341436|P2|Overall Study|Physician Decision|0
90007|NCT01142089|341437|P1|Overall Study|Physician Decision|1
90008|NCT01141712|341459|P1|Overall Study|Disease progression|3
90009|NCT01141660|341480|P2|Overall Study|Physician Decision|12
90010|NCT01141660|341481|P1|Overall Study|Physician Decision|0
90011|NCT01141283|341540|P1|Overall Study|Lack of Efficacy|10
90012|NCT01141283|341540|P1|Overall Study|Administrative|4
90013|NCT01141283|341540|P1|Overall Study|Withdrawal by Subject|14
90014|NCT01141283|341540|P1|Overall Study|Lost to Follow-up|4
90015|NCT01141283|341540|P1|Overall Study|Adverse Event|56
90016|NCT01141205|341546|P2|Overall Study|Withdrawal by Subject|1
90017|NCT01141205|341547|P1|Overall Study|Withdrawal by Subject|1
90018|NCT01141205|341546|P2|Overall Study|Lost to Follow-up|0
90019|NCT01141205|341547|P1|Overall Study|Lost to Follow-up|1
90020|NCT01141205|341546|P2|Overall Study|Physician Decision|1
90021|NCT01141205|341547|P1|Overall Study|Physician Decision|1
90022|NCT01140906|341563|P4|Overall Study|Administrative or other reason|2
90023|NCT01140906|341564|P3|Overall Study|Administrative or other reason|3
90024|NCT01140906|341565|P2|Overall Study|Administrative or other reason|5
90025|NCT01140906|341566|P1|Overall Study|Administrative or other reason|0
90026|NCT01140906|341563|P4|Overall Study|Lost to Follow-up|2
90027|NCT01140906|341564|P3|Overall Study|Lost to Follow-up|0
90028|NCT01140906|341565|P2|Overall Study|Lost to Follow-up|1
90029|NCT01140906|341566|P1|Overall Study|Lost to Follow-up|1
90030|NCT01140906|341563|P4|Overall Study|Withdrawal of consent|2
90031|NCT01140906|341564|P3|Overall Study|Withdrawal of consent|2
90032|NCT01140906|341565|P2|Overall Study|Withdrawal of consent|6
90033|NCT01140906|341566|P1|Overall Study|Withdrawal of consent|6
90034|NCT01140906|341563|P4|Overall Study|Protocol Violation|1
90035|NCT01140906|341564|P3|Overall Study|Protocol Violation|2
90036|NCT01140906|341565|P2|Overall Study|Protocol Violation|3
90037|NCT01140906|341566|P1|Overall Study|Protocol Violation|5
90038|NCT01140906|341563|P4|Overall Study|Non-compliance|1
90039|NCT01140906|341564|P3|Overall Study|Non-compliance|0
90040|NCT01140906|341565|P2|Overall Study|Non-compliance|1
90041|NCT01140906|341566|P1|Overall Study|Non-compliance|0
90042|NCT01140906|341563|P4|Overall Study|Lack of Efficacy|1
90043|NCT01140906|341564|P3|Overall Study|Lack of Efficacy|2
90044|NCT01140906|341565|P2|Overall Study|Lack of Efficacy|8
90045|NCT01140906|341566|P1|Overall Study|Lack of Efficacy|6
90046|NCT01140906|341563|P4|Overall Study|Adverse Event|7
90047|NCT01140906|341564|P3|Overall Study|Adverse Event|17
90048|NCT01140906|341565|P2|Overall Study|Adverse Event|10
90049|NCT01140906|341566|P1|Overall Study|Adverse Event|7
90050|NCT01140880|341606|P2|Overall Study|Protocol Violation|30
90051|NCT01140880|341607|P1|Overall Study|Protocol Violation|0
90052|NCT01140880|341606|P2|Overall Study|Lost to Follow-up|10
90053|NCT01140880|341607|P1|Overall Study|Lost to Follow-up|8
90054|NCT01140880|341606|P2|Overall Study|Withdrawal by Subject|3
90055|NCT01140880|341607|P1|Overall Study|Withdrawal by Subject|6
90056|NCT01140880|341606|P2|Overall Study|Death|1
90057|NCT01140880|341607|P1|Overall Study|Death|0
90058|NCT01140867|341619|P1|Overall Study|Medication Noncompliance|2
90059|NCT01140867|341619|P1|Overall Study|Uncooperative patient|2
90060|NCT01140867|341619|P1|Overall Study|Protocol Violation|1
90061|NCT01140867|341619|P1|Overall Study|Withdrawal by Subject|1
90062|NCT01140867|341619|P1|Overall Study|Lost to Follow-up|2
90063|NCT01140867|341619|P1|Overall Study|Lack of Efficacy|3
90064|NCT01140867|341619|P1|Overall Study|Adverse Event|22
90065|NCT01140646|341659|P1|Overall Study|Refused Further Treatment|5
90066|NCT01140646|341659|P1|Overall Study|Adverse Event|4
90067|NCT01140503|341663|P1|Overall Study|Withdrawal by Subject|1
90068|NCT01140477|341671|P2|Overall Study|Subject explanted|1
90069|NCT01140477|341672|P1|Overall Study|Subject explanted|0
90070|NCT01140477|341671|P2|Overall Study|Death|1
90071|NCT01140477|341672|P1|Overall Study|Death|1
90072|NCT01140477|341671|P2|Overall Study|Surgical complication preventing implant|0
90073|NCT01140477|341672|P1|Overall Study|Surgical complication preventing implant|2
90074|NCT01140477|341671|P2|Overall Study|Withdrawal by Subject|4
90075|NCT01140477|341672|P1|Overall Study|Withdrawal by Subject|1
90076|NCT01140477|341671|P2|Overall Study|Lost to Follow-up|0
90077|NCT01140477|341672|P1|Overall Study|Lost to Follow-up|4
90078|NCT01140347|341687|P2|Overall Study|Withdrawal by Subject|8
90079|NCT01140347|341688|P1|Overall Study|Withdrawal by Subject|13
90080|NCT01140347|341687|P2|Overall Study|Lost to Follow-up|6
90081|NCT01140347|341688|P1|Overall Study|Lost to Follow-up|5
90082|NCT01140061|341741|P10|Extension|Laboratory Adverse Event|1
90083|NCT01140061|341742|P9|Extension|Laboratory Adverse Event|0
90084|NCT01140061|341743|P8|Extension|Laboratory Adverse Event|0
90085|NCT01140061|341744|P7|Extension|Laboratory Adverse Event|0
90086|NCT01140061|341745|P6|Extension|Laboratory Adverse Event|0
90087|NCT01140061|341746|P5|Extension|Laboratory Adverse Event|0
90088|NCT01140061|341747|P4|Extension|Laboratory Adverse Event|0
90089|NCT01140061|341748|P3|Extension|Laboratory Adverse Event|0
90090|NCT01140061|341749|P2|Extension|Laboratory Adverse Event|0
90091|NCT01140061|341750|P1|Extension|Laboratory Adverse Event|0
90092|NCT01140061|341741|P10|Part I|Adverse Event|0
90093|NCT01140061|341742|P9|Part I|Adverse Event|0
90094|NCT01140061|341743|P8|Part I|Adverse Event|0
90095|NCT01140061|341744|P7|Part I|Adverse Event|0
90096|NCT01140061|341745|P6|Part I|Adverse Event|0
90097|NCT01140061|341746|P5|Part I|Adverse Event|0
90098|NCT01140061|341747|P4|Part I|Adverse Event|0
90099|NCT01140061|341748|P3|Part I|Adverse Event|0
90100|NCT01140061|341749|P2|Part I|Adverse Event|0
90101|NCT01140061|341750|P1|Part I|Adverse Event|1
90102|NCT01140048|341777|P1|Overall Study|Lost to Follow-up|31
90103|NCT01140048|341777|P1|Overall Study|Withdrawal by Subject|13
90104|NCT01140048|341777|P1|Overall Study|Physician Decision|1
90105|NCT01139775|341806|P3|Overall Study|Physician Decision|2
90106|NCT01139775|341807|P2|Overall Study|Physician Decision|2
90107|NCT01139775|341808|P1|Overall Study|Physician Decision|0
90108|NCT01139775|341806|P3|Overall Study|Withdrawal by Subject|2
90109|NCT01139775|341807|P2|Overall Study|Withdrawal by Subject|0
90110|NCT01139775|341808|P1|Overall Study|Withdrawal by Subject|1
90111|NCT01139775|341806|P3|Overall Study|Protocol Violation|0
90112|NCT01139775|341807|P2|Overall Study|Protocol Violation|5
90113|NCT01139775|341808|P1|Overall Study|Protocol Violation|0
90114|NCT01139775|341806|P3|Overall Study|Adverse Event|2
90115|NCT01139775|341807|P2|Overall Study|Adverse Event|6
90116|NCT01139775|341808|P1|Overall Study|Adverse Event|0
90117|NCT01139762|341840|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
90118|NCT01139762|341841|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
90119|NCT01139762|341842|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
90120|NCT01139762|341840|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
90121|NCT01139762|341841|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
90122|NCT01139762|341842|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
90123|NCT01139762|341840|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
90124|NCT01139762|341841|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
90125|NCT01139762|341842|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
90126|NCT01139762|341840|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
90127|NCT01139762|341841|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
90128|NCT01139762|341842|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
90129|NCT01139762|341840|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
90130|NCT01139762|341841|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
90131|NCT01139762|341842|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
90132|NCT01139762|341840|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
90133|NCT01139762|341841|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
90134|NCT01139762|341842|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
90135|NCT01139762|341840|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
90136|NCT01139762|341841|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
90137|NCT01139762|341842|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
90138|NCT01139762|341840|P3|Double-Blind Randomized Active Treatment|Death|1
90139|NCT01139762|341841|P2|Double-Blind Randomized Active Treatment|Death|1
90140|NCT01139762|341842|P1|Double-Blind Randomized Active Treatment|Death|0
90141|NCT01139762|341840|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
90142|NCT01139762|341841|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
90143|NCT01139762|341842|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
90144|NCT01139762|341840|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
90145|NCT01139762|341841|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
90146|NCT01139762|341842|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
90147|NCT01139762|341840|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
90148|NCT01139762|341841|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
90149|NCT01139762|341842|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
90150|NCT01139762|341840|P3|Washout and Placebo Lead-In Period|Physician Decision|0
90151|NCT01139762|341841|P2|Washout and Placebo Lead-In Period|Physician Decision|0
90152|NCT01139762|341842|P1|Washout and Placebo Lead-In Period|Physician Decision|12
90153|NCT01139762|341840|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
90154|NCT01139762|341841|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
90155|NCT01139762|341842|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
90156|NCT01139762|341840|P3|Washout and Placebo Lead-In Period|Adverse Event|0
90157|NCT01139762|341841|P2|Washout and Placebo Lead-In Period|Adverse Event|0
90158|NCT01139762|341842|P1|Washout and Placebo Lead-In Period|Adverse Event|1
90159|NCT01139762|341840|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
90160|NCT01139762|341841|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
90161|NCT01139762|341842|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
90162|NCT01139658|341877|P2|Overall Study|Not specified|75
90163|NCT01139658|341878|P1|Overall Study|Not specified|28
90164|NCT01139658|341877|P2|Overall Study|No documentation of treatment|0
90165|NCT01139658|341878|P1|Overall Study|No documentation of treatment|1
90166|NCT01139658|341877|P2|Overall Study|Withdrawal by Subject|4
90167|NCT01139658|341878|P1|Overall Study|Withdrawal by Subject|2
90168|NCT01139658|341877|P2|Overall Study|Lack of Efficacy|7
90169|NCT01139658|341878|P1|Overall Study|Lack of Efficacy|15
90170|NCT01139658|341877|P2|Overall Study|Adverse Event|27
90171|NCT01139658|341878|P1|Overall Study|Adverse Event|10
90172|NCT01139580|341916|P2|Overall Study|Participant Randomization in Error|1
90173|NCT01139580|341917|P1|Overall Study|Participant Randomization in Error|0
90174|NCT01139580|341916|P2|Overall Study|Beginning Study Exclusion Treatment|1
90175|NCT01139580|341917|P1|Overall Study|Beginning Study Exclusion Treatment|0
90176|NCT01139580|341916|P2|Overall Study|Misrandomized|0
90177|NCT01139580|341917|P1|Overall Study|Misrandomized|1
90178|NCT01139580|341916|P2|Overall Study|Did Not Meet Exclusion Criteria|0
90179|NCT01139580|341917|P1|Overall Study|Did Not Meet Exclusion Criteria|1
90180|NCT01139580|341916|P2|Overall Study|Used Excluded Medicine After Enrollment|0
90181|NCT01139580|341917|P1|Overall Study|Used Excluded Medicine After Enrollment|1
90182|NCT01139580|341916|P2|Overall Study|Withdrawal by Subject|9
90183|NCT01139580|341917|P1|Overall Study|Withdrawal by Subject|6
90184|NCT01139580|341916|P2|Overall Study|Lack of Efficacy|2
90185|NCT01139580|341917|P1|Overall Study|Lack of Efficacy|0
90186|NCT01139580|341916|P2|Overall Study|Lost to Follow-up|1
90187|NCT01139580|341917|P1|Overall Study|Lost to Follow-up|9
90188|NCT01139580|341916|P2|Overall Study|Adverse Event|4
90189|NCT01139580|341917|P1|Overall Study|Adverse Event|5
90190|NCT01139450|341965|P3|Overall Study|Adverse Event|3
90191|NCT01139450|341966|P2|Overall Study|Adverse Event|2
90192|NCT01139450|341967|P1|Overall Study|Adverse Event|2
90193|NCT01139450|341965|P3|Overall Study|Administrative|1
90194|NCT01139450|341966|P2|Overall Study|Administrative|0
90195|NCT01139450|341967|P1|Overall Study|Administrative|0
90196|NCT01139450|341965|P3|Overall Study|Lost to Follow-up|11
90197|NCT01139450|341966|P2|Overall Study|Lost to Follow-up|7
90198|NCT01139450|341967|P1|Overall Study|Lost to Follow-up|9
90199|NCT01139450|341965|P3|Overall Study|Protocol Violation|2
90200|NCT01139450|341966|P2|Overall Study|Protocol Violation|5
90201|NCT01139450|341967|P1|Overall Study|Protocol Violation|6
90202|NCT01139450|341965|P3|Overall Study|Lack of Efficacy|8
90203|NCT01139450|341966|P2|Overall Study|Lack of Efficacy|1
90204|NCT01139450|341967|P1|Overall Study|Lack of Efficacy|3
90205|NCT01139450|341965|P3|Overall Study|Withdrawal by Subject|13
90206|NCT01139450|341966|P2|Overall Study|Withdrawal by Subject|10
90207|NCT01139450|341967|P1|Overall Study|Withdrawal by Subject|7
90208|NCT01139164|342019|P3|Overall Study|Withdrawn prior to study start|0
90209|NCT01139164|342020|P2|Overall Study|Withdrawn prior to study start|2
90210|NCT01139164|342021|P1|Overall Study|Withdrawn prior to study start|0
90211|NCT01139125|342035|P1|Overall Study|Withdrawal by Subject|1
90212|NCT01139047|342039|P1|Overall Study|Withdrawal by Subject|1
90213|NCT01139021|342054|P6|Overall Study|Withdrawal by Subject|0
90214|NCT01139021|342055|P5|Overall Study|Withdrawal by Subject|4
90215|NCT01139021|342056|P4|Overall Study|Withdrawal by Subject|1
90216|NCT01139021|342057|P3|Overall Study|Withdrawal by Subject|0
90217|NCT01139021|342058|P2|Overall Study|Withdrawal by Subject|0
90218|NCT01139021|342059|P1|Overall Study|Withdrawal by Subject|0
90219|NCT01139021|342054|P6|Overall Study|Protocol Violation|0
90220|NCT01139021|342055|P5|Overall Study|Protocol Violation|2
90221|NCT01139021|342056|P4|Overall Study|Protocol Violation|0
90222|NCT01139021|342057|P3|Overall Study|Protocol Violation|0
90223|NCT01139021|342058|P2|Overall Study|Protocol Violation|0
90224|NCT01139021|342059|P1|Overall Study|Protocol Violation|1
90225|NCT01139021|342054|P6|Overall Study|Lost to Follow-up|0
90226|NCT01139021|342055|P5|Overall Study|Lost to Follow-up|2
90227|NCT01139021|342056|P4|Overall Study|Lost to Follow-up|0
90228|NCT01139021|342057|P3|Overall Study|Lost to Follow-up|0
90229|NCT01139021|342058|P2|Overall Study|Lost to Follow-up|0
90230|NCT01139021|342059|P1|Overall Study|Lost to Follow-up|0
90231|NCT01139021|342054|P6|Overall Study|Adverse Event|0
90232|NCT01139021|342055|P5|Overall Study|Adverse Event|1
90233|NCT01139021|342056|P4|Overall Study|Adverse Event|0
90234|NCT01139021|342057|P3|Overall Study|Adverse Event|0
90235|NCT01139021|342058|P2|Overall Study|Adverse Event|0
90236|NCT01139021|342059|P1|Overall Study|Adverse Event|0
90237|NCT01139008|342095|P1|Overall Study|Non-compliant, lost product|1
90238|NCT01139008|342095|P1|Overall Study|Withdrawal by Subject|5
90239|NCT01138826|342128|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
90240|NCT01138826|342129|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
90241|NCT01138826|342130|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
90242|NCT01138826|342131|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
90243|NCT01138826|342132|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
90244|NCT01138826|342133|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
90245|NCT01138657|342170|P2|Overall Study|Miscellaneous Reasons|4
90246|NCT01138657|342171|P1|Overall Study|Miscellaneous Reasons|3
90247|NCT01138657|342170|P2|Overall Study|Lost to Follow-up|3
90248|NCT01138657|342171|P1|Overall Study|Lost to Follow-up|0
90249|NCT01138657|342170|P2|Overall Study|Lack of Efficacy|1
90250|NCT01138657|342171|P1|Overall Study|Lack of Efficacy|2
90251|NCT01138657|342170|P2|Overall Study|Adverse Event|10
90252|NCT01138657|342171|P1|Overall Study|Adverse Event|3
90253|NCT01138501|342234|P1|Overall Study|Withdrawal by Subject|3
90254|NCT01138501|342234|P1|Overall Study|Protocol Violation|2
90255|NCT01138150|342278|P2|Overall Study|Physician Decision|0
90256|NCT01138150|342279|P1|Overall Study|Physician Decision|1
90257|NCT01138150|342278|P2|Overall Study|blood unable to be processed|1
90258|NCT01138150|342279|P1|Overall Study|blood unable to be processed|0
90259|NCT01138111|342360|P1|Overall Study|Lost to Follow-up|2
90260|NCT01138111|342360|P1|Overall Study|Death|1
90261|NCT01138111|342360|P1|Overall Study|Adverse Event|1
90262|NCT01138111|342360|P1|Overall Study|Withdrawal by Subject|5
90263|NCT01138046|342414|P1|Overall Study|Withdrawal due to death|6
90264|NCT01138007|342434|P3|Overall Study|Withdrawal by Subject|15
90265|NCT01138007|342435|P2|Overall Study|Withdrawal by Subject|6
90266|NCT01138007|342436|P1|Overall Study|Withdrawal by Subject|5
90267|NCT01138007|342434|P3|Overall Study|Physician Decision|3
90268|NCT01138007|342435|P2|Overall Study|Physician Decision|5
90269|NCT01138007|342436|P1|Overall Study|Physician Decision|0
90270|NCT01138007|342434|P3|Overall Study|Lost to Follow-up|5
90271|NCT01138007|342435|P2|Overall Study|Lost to Follow-up|3
90272|NCT01138007|342436|P1|Overall Study|Lost to Follow-up|3
90273|NCT01138007|342434|P3|Overall Study|Protocol-Defined Stopping Criteria|8
90274|NCT01138007|342435|P2|Overall Study|Protocol-Defined Stopping Criteria|1
90275|NCT01138007|342436|P1|Overall Study|Protocol-Defined Stopping Criteria|6
90276|NCT01138007|342434|P3|Overall Study|Protocol Violation|2
90277|NCT01138007|342435|P2|Overall Study|Protocol Violation|3
90278|NCT01138007|342436|P1|Overall Study|Protocol Violation|2
90279|NCT01138007|342434|P3|Overall Study|Lack of Efficacy|6
90280|NCT01138007|342435|P2|Overall Study|Lack of Efficacy|0
90281|NCT01138007|342436|P1|Overall Study|Lack of Efficacy|2
90282|NCT01138007|342434|P3|Overall Study|Adverse Event|9
90283|NCT01138007|342435|P2|Overall Study|Adverse Event|12
90284|NCT01138007|342436|P1|Overall Study|Adverse Event|4
90285|NCT01137812|342543|P2|Overall Study|Not specified|27
90286|NCT01137812|342544|P1|Overall Study|Not specified|19
90287|NCT01137812|342543|P2|Overall Study|Patient met glycemic withdrawal criteria|85
90288|NCT01137812|342544|P1|Overall Study|Patient met glycemic withdrawal criteria|40
90289|NCT01137812|342543|P2|Overall Study|Death|0
90290|NCT01137812|342544|P1|Overall Study|Death|2
90291|NCT01137812|342543|P2|Overall Study|Withdrawal by Subject|13
90292|NCT01137812|342544|P1|Overall Study|Withdrawal by Subject|5
90293|NCT01137812|342543|P2|Overall Study|Protocol Violation|4
90294|NCT01137812|342544|P1|Overall Study|Protocol Violation|5
90295|NCT01137812|342543|P2|Overall Study|Physician Decision|17
90296|NCT01137812|342544|P1|Overall Study|Physician Decision|25
90297|NCT01137812|342543|P2|Overall Study|Lost to Follow-up|8
90298|NCT01137812|342544|P1|Overall Study|Lost to Follow-up|6
90299|NCT01137812|342543|P2|Overall Study|Adverse Event|14
90300|NCT01137812|342544|P1|Overall Study|Adverse Event|21
90301|NCT01137786|342564|P2|Overall Study|Withdrawal by Subject|1
90302|NCT01137786|342565|P1|Overall Study|Withdrawal by Subject|1
90303|NCT01137786|342564|P2|Overall Study|Lost to Follow-up|2
90304|NCT01137786|342565|P1|Overall Study|Lost to Follow-up|0
90305|NCT01137773|342575|P2|Overall Study|Lost to Follow-up|0
90306|NCT01137773|342576|P1|Overall Study|Lost to Follow-up|6
90307|NCT01137773|342575|P2|Overall Study|Death|3
90308|NCT01137773|342576|P1|Overall Study|Death|3
90309|NCT01137682|342587|P3|Overall Study|Did not receive treatment in extension|1
90310|NCT01137682|342588|P2|Overall Study|Did not receive treatment in extension|0
90311|NCT01137682|342589|P1|Overall Study|Did not receive treatment in extension|0
90312|NCT01137682|342587|P3|Overall Study|Did not enter extension|2
90313|NCT01137682|342588|P2|Overall Study|Did not enter extension|3
90314|NCT01137682|342589|P1|Overall Study|Did not enter extension|2
90315|NCT01137682|342587|P3|Overall Study|Protocol Violation-Extension|0
90316|NCT01137682|342588|P2|Overall Study|Protocol Violation-Extension|1
90317|NCT01137682|342589|P1|Overall Study|Protocol Violation-Extension|2
90318|NCT01137682|342587|P3|Overall Study|Death-Extension|0
90319|NCT01137682|342588|P2|Overall Study|Death-Extension|0
90320|NCT01137682|342589|P1|Overall Study|Death-Extension|2
90321|NCT01137682|342587|P3|Overall Study|Administrative problems-Extension|0
90322|NCT01137682|342588|P2|Overall Study|Administrative problems-Extension|2
90323|NCT01137682|342589|P1|Overall Study|Administrative problems-Extension|0
90324|NCT01137682|342587|P3|Overall Study|Lost to Follow Up-Extension|0
90325|NCT01137682|342588|P2|Overall Study|Lost to Follow Up-Extension|1
90326|NCT01137682|342589|P1|Overall Study|Lost to Follow Up-Extension|0
90327|NCT01137682|342587|P3|Overall Study|Withdrawal by Subject-Extension|8
90328|NCT01137682|342588|P2|Overall Study|Withdrawal by Subject-Extension|8
90329|NCT01137682|342589|P1|Overall Study|Withdrawal by Subject-Extension|6
90330|NCT01137682|342587|P3|Overall Study|Lack of Efficacy-Extension|13
90331|NCT01137682|342588|P2|Overall Study|Lack of Efficacy-Extension|9
90332|NCT01137682|342589|P1|Overall Study|Lack of Efficacy-Extension|15
90333|NCT01137682|342587|P3|Overall Study|Adverse Event-Extension|7
90334|NCT01137682|342588|P2|Overall Study|Adverse Event-Extension|8
90335|NCT01137682|342589|P1|Overall Study|Adverse Event-Extension|4
90336|NCT01137682|342587|P3|Overall Study|Protocol Violation-CORE|1
90337|NCT01137682|342588|P2|Overall Study|Protocol Violation-CORE|1
90338|NCT01137682|342589|P1|Overall Study|Protocol Violation-CORE|0
90339|NCT01137682|342587|P3|Overall Study|Administrative problems-CORE|0
90340|NCT01137682|342588|P2|Overall Study|Administrative problems-CORE|1
90341|NCT01137682|342589|P1|Overall Study|Administrative problems-CORE|2
90342|NCT01137682|342587|P3|Overall Study|Withdrawal by Subject-CORE|2
90343|NCT01137682|342588|P2|Overall Study|Withdrawal by Subject-CORE|2
90344|NCT01137682|342589|P1|Overall Study|Withdrawal by Subject-CORE|2
90345|NCT01137682|342587|P3|Overall Study|Adverse Event-CORE|0
90346|NCT01137682|342588|P2|Overall Study|Adverse Event-CORE|4
90347|NCT01137682|342589|P1|Overall Study|Adverse Event-CORE|2
90348|NCT01137604|342639|P4|Overall Study|Clinical Decline|1
90349|NCT01137604|342640|P3|Overall Study|Clinical Decline|1
90350|NCT01137604|342641|P2|Overall Study|Clinical Decline|0
90351|NCT01137604|342642|P1|Overall Study|Clinical Decline|0
90352|NCT01137604|342639|P4|Overall Study|Participant's Decision|0
90353|NCT01137604|342640|P3|Overall Study|Participant's Decision|0
90354|NCT01137604|342641|P2|Overall Study|Participant's Decision|0
90355|NCT01137604|342642|P1|Overall Study|Participant's Decision|1
90356|NCT01137604|342639|P4|Overall Study|Clinical Progression|0
90357|NCT01137604|342640|P3|Overall Study|Clinical Progression|1
90358|NCT01137604|342641|P2|Overall Study|Clinical Progression|2
90359|NCT01137604|342642|P1|Overall Study|Clinical Progression|0
90360|NCT01137604|342639|P4|Overall Study|Withdrawal by Subject|1
90361|NCT01137604|342640|P3|Overall Study|Withdrawal by Subject|2
90362|NCT01137604|342641|P2|Overall Study|Withdrawal by Subject|2
90363|NCT01137604|342642|P1|Overall Study|Withdrawal by Subject|0
90364|NCT01137604|342639|P4|Overall Study|Adverse Event|9
90365|NCT01137604|342640|P3|Overall Study|Adverse Event|9
90366|NCT01137604|342641|P2|Overall Study|Adverse Event|6
90367|NCT01137604|342642|P1|Overall Study|Adverse Event|1
90368|NCT01137578|342676|P3|Overall Study|Not Specified|6
90369|NCT01137578|342677|P2|Overall Study|Not Specified|2
90370|NCT01137578|342678|P1|Overall Study|Not Specified|12
90371|NCT01137578|342676|P3|Overall Study|Withdrawal by Subject|0
90372|NCT01137578|342677|P2|Overall Study|Withdrawal by Subject|0
90373|NCT01137578|342678|P1|Overall Study|Withdrawal by Subject|1
90374|NCT01137578|342676|P3|Overall Study|Participant requested to Discontinue|0
90375|NCT01137578|342677|P2|Overall Study|Participant requested to Discontinue|0
90376|NCT01137578|342678|P1|Overall Study|Participant requested to Discontinue|3
90377|NCT01137474|342727|P4|Overall Study|Administrative reason by sponsor|0
90378|NCT01137474|342728|P3|Overall Study|Administrative reason by sponsor|0
90379|NCT01137474|342729|P2|Overall Study|Administrative reason by sponsor|1
90380|NCT01137474|342730|P1|Overall Study|Administrative reason by sponsor|0
90381|NCT01137474|342727|P4|Overall Study|Pregnancy|0
90382|NCT01137474|342728|P3|Overall Study|Pregnancy|0
90383|NCT01137474|342729|P2|Overall Study|Pregnancy|1
90384|NCT01137474|342730|P1|Overall Study|Pregnancy|0
90385|NCT01137474|342727|P4|Overall Study|Not specified|0
90386|NCT01137474|342728|P3|Overall Study|Not specified|0
90387|NCT01137474|342729|P2|Overall Study|Not specified|1
90388|NCT01137474|342730|P1|Overall Study|Not specified|3
90389|NCT01137474|342727|P4|Overall Study|Lack of Efficacy|2
90390|NCT01137474|342728|P3|Overall Study|Lack of Efficacy|0
90391|NCT01137474|342729|P2|Overall Study|Lack of Efficacy|0
90392|NCT01137474|342730|P1|Overall Study|Lack of Efficacy|0
90393|NCT01137474|342727|P4|Overall Study|Lost to Follow-up|2
90394|NCT01137474|342728|P3|Overall Study|Lost to Follow-up|0
90395|NCT01137474|342729|P2|Overall Study|Lost to Follow-up|1
90396|NCT01137474|342730|P1|Overall Study|Lost to Follow-up|5
90397|NCT01137474|342727|P4|Overall Study|No longer met study criteria|5
90398|NCT01137474|342728|P3|Overall Study|No longer met study criteria|0
90399|NCT01137474|342729|P2|Overall Study|No longer met study criteria|1
90400|NCT01137474|342730|P1|Overall Study|No longer met study criteria|6
90401|NCT01137474|342727|P4|Overall Study|Withdrawal by Subject|9
90402|NCT01137474|342728|P3|Overall Study|Withdrawal by Subject|6
90403|NCT01137474|342729|P2|Overall Study|Withdrawal by Subject|2
90404|NCT01137474|342730|P1|Overall Study|Withdrawal by Subject|7
90405|NCT01137474|342727|P4|Overall Study|Adverse Event|3
90406|NCT01137474|342728|P3|Overall Study|Adverse Event|1
90407|NCT01137474|342729|P2|Overall Study|Adverse Event|5
90408|NCT01137474|342730|P1|Overall Study|Adverse Event|3
90409|NCT01137435|342748|P1|Overall Study|Off label usage|4
90410|NCT01137435|342748|P1|Overall Study|Lost to Follow-up|24
90411|NCT01137292|342775|P1|Overall Study|Other|7
90412|NCT01137292|342775|P1|Overall Study|Lost to Follow-up|1
90413|NCT01137292|342775|P1|Overall Study|Lack of Efficacy|13
90414|NCT01137292|342775|P1|Overall Study|Adverse Event|3
90415|NCT01137292|342775|P1|Overall Study|Death|30
90416|NCT01137071|342782|P1|Overall Study|Wrongly Included|1
90417|NCT01137071|342782|P1|Overall Study|Withdrawal by Subject|2
90418|NCT01137071|342782|P1|Overall Study|Disease Progression|11
90419|NCT01136967|342851|P2|Overall Study|Diagnosis of Second Primary Cancer|1
90420|NCT01136967|342852|P1|Overall Study|Diagnosis of Second Primary Cancer|0
90421|NCT01136967|342851|P2|Overall Study|Increase in Lesion Size|2
90422|NCT01136967|342852|P1|Overall Study|Increase in Lesion Size|0
90423|NCT01136967|342851|P2|Overall Study|Investigator's Choice|1
90424|NCT01136967|342852|P1|Overall Study|Investigator's Choice|1
90425|NCT01136967|342851|P2|Overall Study|Non Compliance|0
90426|NCT01136967|342852|P1|Overall Study|Non Compliance|1
90427|NCT01136967|342851|P2|Overall Study|Radiation|0
90428|NCT01136967|342852|P1|Overall Study|Radiation|1
90429|NCT01136967|342851|P2|Overall Study|Clinical Progression|5
90430|NCT01136967|342852|P1|Overall Study|Clinical Progression|3
90431|NCT01136967|342851|P2|Overall Study|Withdrawal by Subject|2
90432|NCT01136967|342852|P1|Overall Study|Withdrawal by Subject|1
90433|NCT01136967|342851|P2|Overall Study|Lost to Follow-up|1
90434|NCT01136967|342852|P1|Overall Study|Lost to Follow-up|0
90435|NCT01136967|342851|P2|Overall Study|Participant Choice|3
90436|NCT01136967|342852|P1|Overall Study|Participant Choice|8
90437|NCT01136967|342851|P2|Overall Study|Adverse Event|12
90438|NCT01136967|342852|P1|Overall Study|Adverse Event|9
90439|NCT01136954|342870|P2|Overall Study|Not Specified|3
90440|NCT01136954|342871|P1|Overall Study|Not Specified|1
90441|NCT01136954|342870|P2|Overall Study|Physician Decision|1
90442|NCT01136954|342871|P1|Overall Study|Physician Decision|0
90443|NCT01136954|342870|P2|Overall Study|Lack of Efficacy|13
90444|NCT01136954|342871|P1|Overall Study|Lack of Efficacy|14
90445|NCT01136954|342870|P2|Overall Study|Withdrawal by Subject|2
90446|NCT01136954|342871|P1|Overall Study|Withdrawal by Subject|6
90447|NCT01136954|342870|P2|Overall Study|Adverse Event|2
90448|NCT01136954|342871|P1|Overall Study|Adverse Event|3
90449|NCT01136915|342885|P2|Overall Study|Exclusion criterion met|1
90450|NCT01136915|342886|P1|Overall Study|Exclusion criterion met|0
90451|NCT01136915|342885|P2|Overall Study|Lost to Follow-up|0
90452|NCT01136915|342886|P1|Overall Study|Lost to Follow-up|2
90453|NCT01136876|342896|P2|Overall Study|Physician Decision|5
90454|NCT01136876|342897|P1|Overall Study|Physician Decision|3
90455|NCT01136876|342896|P2|Overall Study|Lost to Follow-up|1
90456|NCT01136876|342897|P1|Overall Study|Lost to Follow-up|0
90457|NCT01136785|342907|P2|Overall Study|Protocol Violation|1
90458|NCT01136785|342908|P1|Overall Study|Protocol Violation|2
90459|NCT01136772|342923|P2|Overall Study|Did not follow up after first injection|2
90460|NCT01136772|342924|P1|Overall Study|Did not follow up after first injection|2
90461|NCT01136772|342923|P2|Overall Study|Did not receive injection|7
90462|NCT01136772|342924|P1|Overall Study|Did not receive injection|10
90463|NCT01136772|342923|P2|Overall Study|Withdrawal by Subject|36
90464|NCT01136772|342924|P1|Overall Study|Withdrawal by Subject|33
90465|NCT01136772|342923|P2|Overall Study|Administrative|12
90466|NCT01136772|342924|P1|Overall Study|Administrative|14
90467|NCT01136772|342923|P2|Overall Study|Lack of Efficacy|39
90468|NCT01136772|342924|P1|Overall Study|Lack of Efficacy|42
90469|NCT01136772|342923|P2|Overall Study|Adverse Event|14
90470|NCT01136772|342924|P1|Overall Study|Adverse Event|15
90471|NCT01136746|342934|P2|Overall Study|Death|0
90472|NCT01136746|342935|P1|Overall Study|Death|1
90473|NCT01136746|342934|P2|Overall Study|Protocol Violation|1
90474|NCT01136746|342935|P1|Overall Study|Protocol Violation|2
90475|NCT01136746|342934|P2|Overall Study|Lost to Follow-up|2
90476|NCT01136746|342935|P1|Overall Study|Lost to Follow-up|0
90477|NCT01136655|342995|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
90478|NCT01136655|342995|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
90479|NCT01136655|342995|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
90480|NCT01136655|342995|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
90481|NCT01136408|343028|P3|Overall Study|Protocol Violation|1
90482|NCT01136408|343029|P2|Overall Study|Protocol Violation|1
90483|NCT01136408|343030|P1|Overall Study|Protocol Violation|1
90484|NCT01136408|343028|P3|Overall Study|Adverse Event|4
90485|NCT01136408|343029|P2|Overall Study|Adverse Event|8
90486|NCT01136408|343030|P1|Overall Study|Adverse Event|4
90487|NCT01136382|343087|P2|Overall Study|Withdrawal by Subject|1
90488|NCT01136382|343088|P1|Overall Study|Withdrawal by Subject|4
90489|NCT01136382|343087|P2|Overall Study|Severe Non-Compliance to Protocol|2
90490|NCT01136382|343088|P1|Overall Study|Severe Non-Compliance to Protocol|0
90491|NCT01136382|343087|P2|Overall Study|Study-Specific Withdrawal Criteria|25
90492|NCT01136382|343088|P1|Overall Study|Study-Specific Withdrawal Criteria|48
90493|NCT01136382|343087|P2|Overall Study|Not Specified|3
90494|NCT01136382|343088|P1|Overall Study|Not Specified|8
90495|NCT01136356|343114|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
90496|NCT01136356|343115|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
90497|NCT01136356|343114|P2|First 18-day Withdrawal|Physician Decision|0
90498|NCT01136356|343115|P1|First 18-day Withdrawal|Physician Decision|1
90499|NCT01136356|343114|P2|First 18-day Withdrawal|Withdrawal by Subject|0
90500|NCT01136356|343115|P1|First 18-day Withdrawal|Withdrawal by Subject|3
90501|NCT01136291|343126|P2|Overall Study|Lost to Follow-up|1
90502|NCT01136291|343127|P1|Overall Study|Lost to Follow-up|1
90503|NCT01136174|343145|P4|Overall Study|Adverse Event|4
90504|NCT01136174|343146|P3|Overall Study|Adverse Event|0
90505|NCT01136174|343147|P2|Overall Study|Adverse Event|0
90506|NCT01136174|343148|P1|Overall Study|Adverse Event|0
90507|NCT01135992|343228|P1|Overall Study|Unclassified|7
90508|NCT01135992|343228|P1|Overall Study|Withdrawal criteria|10
90509|NCT01135992|343228|P1|Overall Study|Protocol Violation|2
90510|NCT01135992|343228|P1|Overall Study|Lack of Efficacy|1
90511|NCT01135992|343228|P1|Overall Study|Adverse Event|1
90512|NCT01135914|343240|P3|Overall Study|Adverse Event|2
90513|NCT01135914|343241|P2|Overall Study|Adverse Event|1
90514|NCT01135914|343242|P1|Overall Study|Adverse Event|0
90515|NCT01135914|343240|P3|Overall Study|Lack of Efficacy|10
90516|NCT01135914|343241|P2|Overall Study|Lack of Efficacy|1
90517|NCT01135914|343242|P1|Overall Study|Lack of Efficacy|2
90518|NCT01135914|343240|P3|Overall Study|Protocol Violation|3
90519|NCT01135914|343241|P2|Overall Study|Protocol Violation|0
90520|NCT01135914|343242|P1|Overall Study|Protocol Violation|0
90521|NCT01135914|343240|P3|Overall Study|Lost to Follow-up|1
90522|NCT01135914|343241|P2|Overall Study|Lost to Follow-up|0
90523|NCT01135914|343242|P1|Overall Study|Lost to Follow-up|1
90524|NCT01135914|343240|P3|Overall Study|Withdrawal by Subject|6
90525|NCT01135914|343241|P2|Overall Study|Withdrawal by Subject|3
90526|NCT01135914|343242|P1|Overall Study|Withdrawal by Subject|1
90527|NCT01135524|343271|P1|Overall Study|Lack of Efficacy|8
90528|NCT01135524|343271|P1|Overall Study|Administrative|151
90529|NCT01135524|343271|P1|Overall Study|Lost to Follow-up|3
90530|NCT01135524|343271|P1|Overall Study|Adverse Event|20
90531|NCT01135524|343271|P1|Overall Study|Withdrawal by Subject|14
90532|NCT01135511|343284|P9|Overall Study|Withdrawal by Subject|1
90533|NCT01135511|343285|P8|Overall Study|Withdrawal by Subject|0
90534|NCT01135511|343286|P7|Overall Study|Withdrawal by Subject|1
90535|NCT01135511|343287|P6|Overall Study|Withdrawal by Subject|0
90536|NCT01135511|343288|P5|Overall Study|Withdrawal by Subject|0
90537|NCT01135511|343289|P4|Overall Study|Withdrawal by Subject|0
90538|NCT01135511|343290|P3|Overall Study|Withdrawal by Subject|0
90539|NCT01135511|343291|P2|Overall Study|Withdrawal by Subject|0
90540|NCT01135511|343292|P1|Overall Study|Withdrawal by Subject|0
90541|NCT01135511|343284|P9|Overall Study|noncompliance with study drug taken|0
90542|NCT01135511|343285|P8|Overall Study|noncompliance with study drug taken|0
90543|NCT01135511|343286|P7|Overall Study|noncompliance with study drug taken|0
90544|NCT01135511|343287|P6|Overall Study|noncompliance with study drug taken|0
90545|NCT01135511|343288|P5|Overall Study|noncompliance with study drug taken|1
90546|NCT01135511|343289|P4|Overall Study|noncompliance with study drug taken|0
90547|NCT01135511|343290|P3|Overall Study|noncompliance with study drug taken|0
90548|NCT01135511|343291|P2|Overall Study|noncompliance with study drug taken|0
90549|NCT01135511|343292|P1|Overall Study|noncompliance with study drug taken|0
90550|NCT01135511|343284|P9|Overall Study|could not visit the clinic|0
90551|NCT01135511|343285|P8|Overall Study|could not visit the clinic|0
90552|NCT01135511|343286|P7|Overall Study|could not visit the clinic|0
90553|NCT01135511|343287|P6|Overall Study|could not visit the clinic|0
90554|NCT01135511|343288|P5|Overall Study|could not visit the clinic|0
90555|NCT01135511|343289|P4|Overall Study|could not visit the clinic|0
90556|NCT01135511|343290|P3|Overall Study|could not visit the clinic|2
90557|NCT01135511|343291|P2|Overall Study|could not visit the clinic|1
90558|NCT01135511|343292|P1|Overall Study|could not visit the clinic|0
90559|NCT01135511|343284|P9|Overall Study|Pregnancy|0
90560|NCT01135511|343285|P8|Overall Study|Pregnancy|0
90561|NCT01135511|343286|P7|Overall Study|Pregnancy|0
90562|NCT01135511|343287|P6|Overall Study|Pregnancy|0
90563|NCT01135511|343288|P5|Overall Study|Pregnancy|0
90564|NCT01135511|343289|P4|Overall Study|Pregnancy|1
90565|NCT01135511|343290|P3|Overall Study|Pregnancy|0
90566|NCT01135511|343291|P2|Overall Study|Pregnancy|0
90567|NCT01135511|343292|P1|Overall Study|Pregnancy|0
90568|NCT01135511|343284|P9|Overall Study|Protocol Violation|0
90569|NCT01135511|343285|P8|Overall Study|Protocol Violation|0
90570|NCT01135511|343286|P7|Overall Study|Protocol Violation|0
90571|NCT01135511|343287|P6|Overall Study|Protocol Violation|0
90572|NCT01135511|343288|P5|Overall Study|Protocol Violation|0
90573|NCT01135511|343289|P4|Overall Study|Protocol Violation|0
90574|NCT01135511|343290|P3|Overall Study|Protocol Violation|3
90575|NCT01135511|343291|P2|Overall Study|Protocol Violation|0
90576|NCT01135511|343292|P1|Overall Study|Protocol Violation|0
90577|NCT01135511|343284|P9|Overall Study|Lack of Efficacy|0
90578|NCT01135511|343285|P8|Overall Study|Lack of Efficacy|0
90579|NCT01135511|343286|P7|Overall Study|Lack of Efficacy|0
90580|NCT01135511|343287|P6|Overall Study|Lack of Efficacy|0
90581|NCT01135511|343288|P5|Overall Study|Lack of Efficacy|0
90582|NCT01135511|343289|P4|Overall Study|Lack of Efficacy|2
90583|NCT01135511|343290|P3|Overall Study|Lack of Efficacy|1
90584|NCT01135511|343291|P2|Overall Study|Lack of Efficacy|1
90585|NCT01135511|343292|P1|Overall Study|Lack of Efficacy|0
90586|NCT01135511|343284|P9|Overall Study|Adverse Event|0
90587|NCT01135511|343285|P8|Overall Study|Adverse Event|1
90588|NCT01135511|343286|P7|Overall Study|Adverse Event|0
90589|NCT01135511|343287|P6|Overall Study|Adverse Event|1
90590|NCT01135511|343288|P5|Overall Study|Adverse Event|0
90591|NCT01135511|343289|P4|Overall Study|Adverse Event|0
90592|NCT01135511|343290|P3|Overall Study|Adverse Event|2
90593|NCT01135511|343291|P2|Overall Study|Adverse Event|1
90594|NCT01135511|343292|P1|Overall Study|Adverse Event|0
90595|NCT01135498|343574|P1|Overall Study|Ongoing at time of analysis|2
90596|NCT01135498|343574|P1|Overall Study|Death|1
90597|NCT01135498|343574|P1|Overall Study|Withdrawal by Subject|4
90598|NCT01135498|343574|P1|Overall Study|Investigator judgement|25
90599|NCT01135498|343574|P1|Overall Study|Progressive disease|38
90600|NCT01135498|343574|P1|Overall Study|Adverse Event|20
90601|NCT01135134|343742|P2|Overall Study|Did not meet protocol eligibility|0
90602|NCT01135134|343743|P1|Overall Study|Did not meet protocol eligibility|1
90603|NCT01135134|343742|P2|Overall Study|Adverse Event|1
90604|NCT01135134|343743|P1|Overall Study|Adverse Event|1
90605|NCT01135017|343766|P2|Overall Study|Other than above|4
90606|NCT01135017|343767|P1|Overall Study|Other than above|3
90607|NCT01135017|343766|P2|Overall Study|Adverse Event|8
90608|NCT01135017|343767|P1|Overall Study|Adverse Event|3
90609|NCT01134939|343805|P8|Overall Study|Termination page not available|0
90610|NCT01134939|343806|P7|Overall Study|Termination page not available|7
90611|NCT01134939|343807|P6|Overall Study|Termination page not available|3
90612|NCT01134939|343808|P5|Overall Study|Termination page not available|0
90613|NCT01134939|343809|P4|Overall Study|Termination page not available|8
90614|NCT01134939|343810|P3|Overall Study|Termination page not available|5
90615|NCT01134939|343811|P2|Overall Study|Termination page not available|6
90616|NCT01134939|343812|P1|Overall Study|Termination page not available|4
90617|NCT01134939|343805|P8|Overall Study|Death|0
90618|NCT01134939|343806|P7|Overall Study|Death|0
90619|NCT01134939|343807|P6|Overall Study|Death|0
90620|NCT01134939|343808|P5|Overall Study|Death|0
90621|NCT01134939|343809|P4|Overall Study|Death|0
90622|NCT01134939|343810|P3|Overall Study|Death|0
90623|NCT01134939|343811|P2|Overall Study|Death|1
90624|NCT01134939|343812|P1|Overall Study|Death|0
90625|NCT01134939|343805|P8|Overall Study|Lost to Follow-up|0
90626|NCT01134939|343806|P7|Overall Study|Lost to Follow-up|0
90627|NCT01134939|343807|P6|Overall Study|Lost to Follow-up|1
90628|NCT01134939|343808|P5|Overall Study|Lost to Follow-up|2
90629|NCT01134939|343809|P4|Overall Study|Lost to Follow-up|1
90630|NCT01134939|343810|P3|Overall Study|Lost to Follow-up|0
90631|NCT01134939|343811|P2|Overall Study|Lost to Follow-up|3
90632|NCT01134939|343812|P1|Overall Study|Lost to Follow-up|2
90633|NCT01134939|343805|P8|Overall Study|Lack of Efficacy|0
90634|NCT01134939|343806|P7|Overall Study|Lack of Efficacy|1
90635|NCT01134939|343807|P6|Overall Study|Lack of Efficacy|0
90636|NCT01134939|343808|P5|Overall Study|Lack of Efficacy|3
90637|NCT01134939|343809|P4|Overall Study|Lack of Efficacy|0
90638|NCT01134939|343810|P3|Overall Study|Lack of Efficacy|1
90639|NCT01134939|343811|P2|Overall Study|Lack of Efficacy|5
90640|NCT01134939|343812|P1|Overall Study|Lack of Efficacy|2
90641|NCT01134939|343805|P8|Overall Study|Adverse Event|0
90642|NCT01134939|343806|P7|Overall Study|Adverse Event|1
90643|NCT01134939|343807|P6|Overall Study|Adverse Event|5
90644|NCT01134939|343808|P5|Overall Study|Adverse Event|5
90645|NCT01134939|343809|P4|Overall Study|Adverse Event|5
90646|NCT01134939|343810|P3|Overall Study|Adverse Event|4
90647|NCT01134939|343811|P2|Overall Study|Adverse Event|3
90648|NCT01134939|343812|P1|Overall Study|Adverse Event|9
90649|NCT01134783|343950|P2|Overall Study|Lost to Follow-up|20
90650|NCT01134783|343951|P1|Overall Study|Lost to Follow-up|5
90651|NCT01134783|343950|P2|Overall Study|Withdrawal by Subject|9
90652|NCT01134783|343951|P1|Overall Study|Withdrawal by Subject|15
90653|NCT01134783|343950|P2|Overall Study|Pregnancy|8
90654|NCT01134783|343951|P1|Overall Study|Pregnancy|16
90655|NCT01134731|343970|P3|Overall Study|Lost to Follow-up|3
90656|NCT01134731|343971|P2|Overall Study|Lost to Follow-up|4
90657|NCT01134731|343972|P1|Overall Study|Lost to Follow-up|5
90658|NCT01134731|343970|P3|Overall Study|Withdrawal by Subject|1
90659|NCT01134731|343971|P2|Overall Study|Withdrawal by Subject|3
90660|NCT01134731|343972|P1|Overall Study|Withdrawal by Subject|3
90661|NCT01134731|343970|P3|Overall Study|Lack of Efficacy|1
90662|NCT01134731|343971|P2|Overall Study|Lack of Efficacy|0
90663|NCT01134731|343972|P1|Overall Study|Lack of Efficacy|0
90664|NCT01134731|343970|P3|Overall Study|Physician Decision|2
90665|NCT01134731|343971|P2|Overall Study|Physician Decision|2
90666|NCT01134731|343972|P1|Overall Study|Physician Decision|2
90667|NCT01134731|343970|P3|Overall Study|Adverse Event|1
90668|NCT01134731|343971|P2|Overall Study|Adverse Event|2
90669|NCT01134731|343972|P1|Overall Study|Adverse Event|3
90670|NCT01134705|343985|P2|Overall Study|Other|6
90671|NCT01134705|343986|P1|Overall Study|Other|1
90672|NCT01134705|343985|P2|Overall Study|Protocol Violation|1
90673|NCT01134705|343986|P1|Overall Study|Protocol Violation|1
90674|NCT01134705|343985|P2|Overall Study|Lost to Follow-up|2
90675|NCT01134705|343986|P1|Overall Study|Lost to Follow-up|5
90676|NCT01134705|343985|P2|Overall Study|Pregnancy|0
90677|NCT01134705|343986|P1|Overall Study|Pregnancy|1
90678|NCT01134705|343985|P2|Overall Study|Withdrawal by Subject|6
90679|NCT01134705|343986|P1|Overall Study|Withdrawal by Subject|6
90680|NCT01134705|343985|P2|Overall Study|Adverse Event|7
90681|NCT01134705|343986|P1|Overall Study|Adverse Event|1
90682|NCT01134627|343998|P2|Overall Study|Other|14
90683|NCT01134627|343999|P1|Overall Study|Other|11
90684|NCT01134627|343998|P2|Overall Study|Planning to become pregnant/pregnancy|0
90685|NCT01134627|343999|P1|Overall Study|Planning to become pregnant/pregnancy|1
90686|NCT01134627|343998|P2|Overall Study|Withdrawal by Subject|3
90687|NCT01134627|343999|P1|Overall Study|Withdrawal by Subject|4
90688|NCT01134627|343998|P2|Overall Study|Lack of Efficacy|12
90689|NCT01134627|343999|P1|Overall Study|Lack of Efficacy|2
90690|NCT01134627|343998|P2|Overall Study|Protocol Violation|5
90691|NCT01134627|343999|P1|Overall Study|Protocol Violation|3
90692|NCT01134627|343998|P2|Overall Study|Lost to Follow-up|2
90693|NCT01134627|343999|P1|Overall Study|Lost to Follow-up|1
90694|NCT01134627|343998|P2|Overall Study|Adverse Event|31
90695|NCT01134627|343999|P1|Overall Study|Adverse Event|47
90696|NCT01134614|344029|P2|Overall Study|Patient in hospice care|1
90697|NCT01134614|344030|P1|Overall Study|Patient in hospice care|0
90698|NCT01134614|344029|P2|Overall Study|Symptomatic deterioration|1
90699|NCT01134614|344030|P1|Overall Study|Symptomatic deterioration|0
90700|NCT01134614|344029|P2|Overall Study|Pt received tx not allowed on study|1
90701|NCT01134614|344030|P1|Overall Study|Pt received tx not allowed on study|0
90702|NCT01134614|344029|P2|Overall Study|Never started treatment|1
90703|NCT01134614|344030|P1|Overall Study|Never started treatment|4
90704|NCT01134614|344029|P2|Overall Study|Physician's decision|1
90705|NCT01134614|344030|P1|Overall Study|Physician's decision|0
90706|NCT01134614|344029|P2|Overall Study|Complicating disease|1
90707|NCT01134614|344030|P1|Overall Study|Complicating disease|2
90708|NCT01134614|344029|P2|Overall Study|Alternative therapy|0
90709|NCT01134614|344030|P1|Overall Study|Alternative therapy|2
90710|NCT01134614|344029|P2|Overall Study|Withdrawal by Subject|2
90711|NCT01134614|344030|P1|Overall Study|Withdrawal by Subject|3
90712|NCT01134614|344029|P2|Overall Study|Death|8
90713|NCT01134614|344030|P1|Overall Study|Death|5
90714|NCT01134614|344029|P2|Overall Study|Adverse Event|39
90715|NCT01134614|344030|P1|Overall Study|Adverse Event|26
90716|NCT01134614|344029|P2|Overall Study|Progressive disease|54
90717|NCT01134614|344030|P1|Overall Study|Progressive disease|60
90718|NCT01134614|344029|P2|Overall Study|Still on treatment as of March 2013|13
90719|NCT01134614|344030|P1|Overall Study|Still on treatment as of March 2013|21
90720|NCT01134562|344045|P5|Overall Study|Adverse Event|0
90721|NCT01134562|344046|P4|Overall Study|Adverse Event|0
90722|NCT01134562|344047|P3|Overall Study|Adverse Event|0
90723|NCT01134562|344048|P2|Overall Study|Adverse Event|1
90724|NCT01134562|344049|P1|Overall Study|Adverse Event|0
90725|NCT01134393|344221|P1|Overall Study|Other|6
90726|NCT01134393|344221|P1|Overall Study|Withdrawal by Subject|11
90727|NCT01134393|344221|P1|Overall Study|Lost to Follow-up|3
90728|NCT01134393|344221|P1|Overall Study|Protocol Violation|12
90729|NCT01134393|344221|P1|Overall Study|Lack of Efficacy|2
90730|NCT01134393|344221|P1|Overall Study|Adverse Event|18
90731|NCT01134315|344342|P2|Overall Study|Other Reason|17
90732|NCT01134315|344343|P1|Overall Study|Other Reason|8
90733|NCT01134315|344342|P2|Overall Study|Adverse Event|2
90734|NCT01134315|344343|P1|Overall Study|Adverse Event|1
90735|NCT01134107|344378|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
90736|NCT01134107|344379|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
90737|NCT01134107|344378|P2|Period 2-Second Treatment Intervention|Physician Decision|0
90738|NCT01134107|344379|P1|Period 2-Second Treatment Intervention|Physician Decision|1
90739|NCT01134107|344378|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
90740|NCT01134107|344379|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
90741|NCT01134107|344378|P2|Period 1-First Treatment Intervention|Physician Decision|0
90742|NCT01134107|344379|P1|Period 1-First Treatment Intervention|Physician Decision|1
90743|NCT01134107|344378|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
90744|NCT01134107|344379|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
90745|NCT01134107|344378|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
90746|NCT01134107|344379|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
90747|NCT01134107|344378|P2|Period 1-First Treatment Intervention|Adverse Event|0
90748|NCT01134107|344379|P1|Period 1-First Treatment Intervention|Adverse Event|1
90749|NCT01134055|344426|P7|Overall Study|Physician Decision|1
90750|NCT01134055|344427|P6|Overall Study|Physician Decision|0
90751|NCT01134055|344428|P5|Overall Study|Physician Decision|0
90752|NCT01134055|344429|P4|Overall Study|Physician Decision|0
90753|NCT01134055|344430|P3|Overall Study|Physician Decision|0
90754|NCT01134055|344431|P2|Overall Study|Physician Decision|0
90755|NCT01134055|344432|P1|Overall Study|Physician Decision|0
90756|NCT01134055|344426|P7|Overall Study|Protocol Violation|0
90757|NCT01134055|344427|P6|Overall Study|Protocol Violation|0
90758|NCT01134055|344428|P5|Overall Study|Protocol Violation|1
90759|NCT01134055|344429|P4|Overall Study|Protocol Violation|1
90760|NCT01134055|344430|P3|Overall Study|Protocol Violation|0
90761|NCT01134055|344431|P2|Overall Study|Protocol Violation|0
90762|NCT01134055|344432|P1|Overall Study|Protocol Violation|0
90763|NCT01134055|344426|P7|Overall Study|Withdrawal by Subject|8
90764|NCT01134055|344427|P6|Overall Study|Withdrawal by Subject|0
90765|NCT01134055|344428|P5|Overall Study|Withdrawal by Subject|0
90766|NCT01134055|344429|P4|Overall Study|Withdrawal by Subject|2
90767|NCT01134055|344430|P3|Overall Study|Withdrawal by Subject|1
90768|NCT01134055|344431|P2|Overall Study|Withdrawal by Subject|3
90769|NCT01134055|344432|P1|Overall Study|Withdrawal by Subject|3
90770|NCT01134055|344426|P7|Overall Study|Lost to Follow-up|0
90771|NCT01134055|344427|P6|Overall Study|Lost to Follow-up|0
90772|NCT01134055|344428|P5|Overall Study|Lost to Follow-up|0
90773|NCT01134055|344429|P4|Overall Study|Lost to Follow-up|1
90774|NCT01134055|344430|P3|Overall Study|Lost to Follow-up|0
90775|NCT01134055|344431|P2|Overall Study|Lost to Follow-up|1
90776|NCT01134055|344432|P1|Overall Study|Lost to Follow-up|0
90777|NCT01134055|344426|P7|Overall Study|Adverse Event|2
90778|NCT01134055|344427|P6|Overall Study|Adverse Event|7
90779|NCT01134055|344428|P5|Overall Study|Adverse Event|5
90780|NCT01134055|344429|P4|Overall Study|Adverse Event|2
90781|NCT01134055|344430|P3|Overall Study|Adverse Event|2
90782|NCT01134055|344431|P2|Overall Study|Adverse Event|2
90783|NCT01134055|344432|P1|Overall Study|Adverse Event|5
90784|NCT01134042|344566|P3|Overall Study|Withdrawal by Subject|7
90785|NCT01134042|344567|P2|Overall Study|Withdrawal by Subject|4
90786|NCT01134042|344568|P1|Overall Study|Withdrawal by Subject|13
90787|NCT01134042|344566|P3|Overall Study|Physician Decision|1
90788|NCT01134042|344567|P2|Overall Study|Physician Decision|8
90789|NCT01134042|344568|P1|Overall Study|Physician Decision|4
90790|NCT01134042|344566|P3|Overall Study|Lost to Follow-up|1
90791|NCT01134042|344567|P2|Overall Study|Lost to Follow-up|0
90792|NCT01134042|344568|P1|Overall Study|Lost to Follow-up|2
90793|NCT01134042|344566|P3|Overall Study|Protocol Violation|5
90794|NCT01134042|344567|P2|Overall Study|Protocol Violation|3
90795|NCT01134042|344568|P1|Overall Study|Protocol Violation|5
90796|NCT01134042|344566|P3|Overall Study|Lack of Efficacy|18
90797|NCT01134042|344567|P2|Overall Study|Lack of Efficacy|6
90798|NCT01134042|344568|P1|Overall Study|Lack of Efficacy|21
90799|NCT01134042|344566|P3|Overall Study|Adverse Event|2
90800|NCT01134042|344567|P2|Overall Study|Adverse Event|7
90801|NCT01134042|344568|P1|Overall Study|Adverse Event|3
90802|NCT01133977|344644|P5|Overall Study|Withdrawal by Subject|1
90803|NCT01133977|344645|P4|Overall Study|Withdrawal by Subject|5
90804|NCT01133977|344646|P3|Overall Study|Withdrawal by Subject|0
90805|NCT01133977|344647|P2|Overall Study|Withdrawal by Subject|0
90806|NCT01133977|344648|P1|Overall Study|Withdrawal by Subject|0
90807|NCT01133977|344644|P5|Overall Study|Lost to Follow-up|1
90808|NCT01133977|344645|P4|Overall Study|Lost to Follow-up|2
90809|NCT01133977|344646|P3|Overall Study|Lost to Follow-up|0
90810|NCT01133977|344647|P2|Overall Study|Lost to Follow-up|0
90811|NCT01133977|344648|P1|Overall Study|Lost to Follow-up|0
90812|NCT01133977|344644|P5|Overall Study|Started a New Line of Therapy|33
90813|NCT01133977|344645|P4|Overall Study|Started a New Line of Therapy|25
90814|NCT01133977|344646|P3|Overall Study|Started a New Line of Therapy|4
90815|NCT01133977|344647|P2|Overall Study|Started a New Line of Therapy|6
90816|NCT01133977|344648|P1|Overall Study|Started a New Line of Therapy|2
90817|NCT01133977|344644|P5|Overall Study|Death|3
90818|NCT01133977|344645|P4|Overall Study|Death|7
90819|NCT01133977|344646|P3|Overall Study|Death|1
90820|NCT01133977|344647|P2|Overall Study|Death|1
90821|NCT01133977|344648|P1|Overall Study|Death|1
90822|NCT01133977|344644|P5|Overall Study|Adverse Event|0
90823|NCT01133977|344645|P4|Overall Study|Adverse Event|0
90824|NCT01133977|344646|P3|Overall Study|Adverse Event|1
90825|NCT01133977|344647|P2|Overall Study|Adverse Event|0
90826|NCT01133977|344648|P1|Overall Study|Adverse Event|0
90827|NCT01133847|344675|P3|Follow-Up Phase|Lost to Follow-up|7
90828|NCT01133847|344676|P2|Follow-Up Phase|Lost to Follow-up|3
90829|NCT01133847|344677|P1|Follow-Up Phase|Lost to Follow-up|1
90830|NCT01133847|344675|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
90831|NCT01133847|344676|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
90832|NCT01133847|344677|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
90833|NCT01133821|344717|P2|Overall Study|Refused participation|3
90834|NCT01133821|344718|P1|Overall Study|Refused participation|1
90835|NCT01133821|344717|P2|Overall Study|Protocol Violation|1
90836|NCT01133821|344718|P1|Overall Study|Protocol Violation|0
90837|NCT01133821|344717|P2|Overall Study|preferred other treatment|1
90838|NCT01133821|344718|P1|Overall Study|preferred other treatment|1
90839|NCT01133821|344717|P2|Overall Study|Withdrawal by Subject|3
90840|NCT01133821|344718|P1|Overall Study|Withdrawal by Subject|8
90841|NCT01133821|344717|P2|Overall Study|Lost to Follow-up|11
90842|NCT01133821|344718|P1|Overall Study|Lost to Follow-up|8
90843|NCT01133756|344729|P3|Overall Study|Progression of Disease|1
90844|NCT01133756|344730|P2|Overall Study|Progression of Disease|0
90845|NCT01133756|344731|P1|Overall Study|Progression of Disease|0
90846|NCT01133756|344729|P3|Overall Study|Withdrawal by Subject|0
90847|NCT01133756|344730|P2|Overall Study|Withdrawal by Subject|1
90848|NCT01133756|344731|P1|Overall Study|Withdrawal by Subject|0
90849|NCT01133756|344729|P3|Overall Study|Investigator Decision|0
90850|NCT01133756|344730|P2|Overall Study|Investigator Decision|0
90851|NCT01133756|344731|P1|Overall Study|Investigator Decision|1
90852|NCT01133756|344729|P3|Overall Study|Adverse Event|1
90853|NCT01133756|344730|P2|Overall Study|Adverse Event|2
90854|NCT01133756|344731|P1|Overall Study|Adverse Event|1
90855|NCT01133704|344747|P2|Overall Study|Study Closure|0
90856|NCT01133704|344748|P1|Overall Study|Study Closure|1
90857|NCT01133704|344747|P2|Overall Study|Patient refused to continue|0
90858|NCT01133704|344748|P1|Overall Study|Patient refused to continue|4
90859|NCT01133704|344747|P2|Overall Study|Death|26
90860|NCT01133704|344748|P1|Overall Study|Death|44
90861|NCT01133665|344756|P1|Overall Study|Physician Decision|2
90862|NCT01133626|344800|P3|Overall Study|Not specified|0
90863|NCT01133626|344801|P2|Overall Study|Not specified|2
90864|NCT01133626|344802|P1|Overall Study|Not specified|0
90865|NCT01133626|344800|P3|Overall Study|Withdrawal by Subject|2
90866|NCT01133626|344801|P2|Overall Study|Withdrawal by Subject|2
90867|NCT01133626|344802|P1|Overall Study|Withdrawal by Subject|1
90868|NCT01133626|344800|P3|Overall Study|Adverse Event|0
90869|NCT01133626|344801|P2|Overall Study|Adverse Event|1
90870|NCT01133626|344802|P1|Overall Study|Adverse Event|0
90871|NCT01133522|344820|P10|Overall Study|Physician Decision|0
90872|NCT01133522|344821|P9|Overall Study|Physician Decision|0
90873|NCT01133522|344822|P8|Overall Study|Physician Decision|0
90874|NCT01133522|344823|P7|Overall Study|Physician Decision|0
90875|NCT01133522|344824|P6|Overall Study|Physician Decision|0
90876|NCT01133522|344825|P5|Overall Study|Physician Decision|1
90877|NCT01133522|344826|P4|Overall Study|Physician Decision|0
90878|NCT01133522|344827|P3|Overall Study|Physician Decision|0
90879|NCT01133522|344828|P2|Overall Study|Physician Decision|0
90880|NCT01133522|344829|P1|Overall Study|Physician Decision|0
90881|NCT01133522|344820|P10|Overall Study|Withdrawal by Subject|0
90882|NCT01133522|344821|P9|Overall Study|Withdrawal by Subject|0
90883|NCT01133522|344822|P8|Overall Study|Withdrawal by Subject|0
90884|NCT01133522|344823|P7|Overall Study|Withdrawal by Subject|0
90885|NCT01133522|344824|P6|Overall Study|Withdrawal by Subject|0
90886|NCT01133522|344825|P5|Overall Study|Withdrawal by Subject|0
90887|NCT01133522|344826|P4|Overall Study|Withdrawal by Subject|1
90888|NCT01133522|344827|P3|Overall Study|Withdrawal by Subject|0
90889|NCT01133522|344828|P2|Overall Study|Withdrawal by Subject|1
90890|NCT01133522|344829|P1|Overall Study|Withdrawal by Subject|0
90891|NCT01133418|344897|P2|Overall Study|Lost to Follow-up|6
90892|NCT01133418|344898|P1|Overall Study|Lost to Follow-up|5
90893|NCT01133392|344912|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
90894|NCT01133392|344913|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
90895|NCT01133392|344912|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
90896|NCT01133392|344913|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
90897|NCT01133379|344930|P3|Overall Study|Lost to Follow-up|1
90898|NCT01133379|344931|P2|Overall Study|Lost to Follow-up|1
90899|NCT01133379|344932|P1|Overall Study|Lost to Follow-up|1
90900|NCT01133379|344930|P3|Overall Study|Withdrawal by Subject|1
90901|NCT01133379|344931|P2|Overall Study|Withdrawal by Subject|1
90902|NCT01133379|344932|P1|Overall Study|Withdrawal by Subject|0
90903|NCT01133288|344985|P1|Intervention Allocation|study terminated|2
90904|NCT01133288|344985|P1|Eligibility Assessment|met exclusion criteria|5
90905|NCT01133275|344990|P1|Overall Study|Cerebrovascular accident (CVA)|1
90906|NCT01133275|344990|P1|Overall Study|Withdrawal by Subject|1
90907|NCT01133171|344998|P3|Overall Study|Withdrawal by Subject|0
90908|NCT01133171|344999|P2|Overall Study|Withdrawal by Subject|2
90909|NCT01133171|345000|P1|Overall Study|Withdrawal by Subject|1
90910|NCT01132820|345065|P1|Overall Study|Inadequate data|1
90911|NCT01132820|345065|P1|Overall Study|Never treated|1
90912|NCT01132820|345065|P1|Overall Study|Ineligible:Inadequate pathology|1
90913|NCT01132820|345065|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
90914|NCT01132820|345065|P1|Overall Study|Ineligible: wrong cell type|1
90915|NCT01132664|345098|P5|BM Cohort|Withdrawal by Subject|1
90916|NCT01132664|345099|P4|BM Cohort|Withdrawal by Subject|0
90917|NCT01132664|345100|P3|BM Cohort|Withdrawal by Subject|0
90918|NCT01132664|345101|P2|BM Cohort|Withdrawal by Subject|0
90919|NCT01132664|345102|P1|BM Cohort|Withdrawal by Subject|0
90920|NCT01132664|345098|P5|BM Cohort|Adverse Event|1
90921|NCT01132664|345099|P4|BM Cohort|Adverse Event|0
90922|NCT01132664|345100|P3|BM Cohort|Adverse Event|0
90923|NCT01132664|345101|P2|BM Cohort|Adverse Event|0
90924|NCT01132664|345102|P1|BM Cohort|Adverse Event|0
90925|NCT01132664|345098|P5|BM Cohort|Disease progression|4
90926|NCT01132664|345099|P4|BM Cohort|Disease progression|3
90927|NCT01132664|345100|P3|BM Cohort|Disease progression|0
90928|NCT01132664|345101|P2|BM Cohort|Disease progression|0
90929|NCT01132664|345102|P1|BM Cohort|Disease progression|0
90930|NCT01132664|345098|P5|Phase ll|Disease progression|0
90931|NCT01132664|345099|P4|Phase ll|Disease progression|0
90932|NCT01132664|345100|P3|Phase ll|Disease progression|35
90933|NCT01132664|345101|P2|Phase ll|Disease progression|0
90934|NCT01132664|345102|P1|Phase ll|Disease progression|0
90935|NCT01132664|345098|P5|Phase ll|Withdrawal by Subject|0
90936|NCT01132664|345099|P4|Phase ll|Withdrawal by Subject|0
90937|NCT01132664|345100|P3|Phase ll|Withdrawal by Subject|3
90938|NCT01132664|345101|P2|Phase ll|Withdrawal by Subject|0
90939|NCT01132664|345102|P1|Phase ll|Withdrawal by Subject|0
90940|NCT01132664|345098|P5|Phase ll|Adverse Event|0
90941|NCT01132664|345099|P4|Phase ll|Adverse Event|0
90942|NCT01132664|345100|P3|Phase ll|Adverse Event|10
90943|NCT01132664|345101|P2|Phase ll|Adverse Event|0
90944|NCT01132664|345102|P1|Phase ll|Adverse Event|0
90945|NCT01132664|345098|P5|Phase ll|Death|0
90946|NCT01132664|345099|P4|Phase ll|Death|0
90947|NCT01132664|345100|P3|Phase ll|Death|2
90948|NCT01132664|345101|P2|Phase ll|Death|0
90949|NCT01132664|345102|P1|Phase ll|Death|0
90950|NCT01132664|345098|P5|Phase lb|Disease Progression|0
90951|NCT01132664|345099|P4|Phase lb|Disease Progression|0
90952|NCT01132664|345100|P3|Phase lb|Disease Progression|0
90953|NCT01132664|345101|P2|Phase lb|Disease Progression|9
90954|NCT01132664|345102|P1|Phase lb|Disease Progression|4
90955|NCT01132664|345098|P5|Phase lb|Withdrawal by Subject|0
90956|NCT01132664|345099|P4|Phase lb|Withdrawal by Subject|0
90957|NCT01132664|345100|P3|Phase lb|Withdrawal by Subject|0
90958|NCT01132664|345101|P2|Phase lb|Withdrawal by Subject|2
90959|NCT01132664|345102|P1|Phase lb|Withdrawal by Subject|1
90960|NCT01132664|345098|P5|Phase lb|Adverse Event|0
90961|NCT01132664|345099|P4|Phase lb|Adverse Event|0
90962|NCT01132664|345100|P3|Phase lb|Adverse Event|0
90963|NCT01132664|345101|P2|Phase lb|Adverse Event|1
90964|NCT01132664|345102|P1|Phase lb|Adverse Event|0
90965|NCT01132651|345136|P2|Overall Study|Lost to Follow-up|1
90966|NCT01132651|345137|P1|Overall Study|Lost to Follow-up|1
90967|NCT01132612|345148|P3|Overall Study|Lack of Efficacy|73
90968|NCT01132612|345149|P2|Overall Study|Lack of Efficacy|22
90969|NCT01132612|345150|P1|Overall Study|Lack of Efficacy|23
90970|NCT01132612|345148|P3|Overall Study|Administrative problems|52
90971|NCT01132612|345149|P2|Overall Study|Administrative problems|1
90972|NCT01132612|345150|P1|Overall Study|Administrative problems|5
90973|NCT01132612|345148|P3|Overall Study|Withdrawal by Subject|19
90974|NCT01132612|345149|P2|Overall Study|Withdrawal by Subject|8
90975|NCT01132612|345150|P1|Overall Study|Withdrawal by Subject|5
90976|NCT01132612|345148|P3|Overall Study|Adverse Event|15
90977|NCT01132612|345149|P2|Overall Study|Adverse Event|2
90978|NCT01132612|345150|P1|Overall Study|Adverse Event|5
90979|NCT01132612|345148|P3|Overall Study|Lost to Follow-up|7
90980|NCT01132612|345149|P2|Overall Study|Lost to Follow-up|2
90981|NCT01132612|345150|P1|Overall Study|Lost to Follow-up|2
90982|NCT01132612|345148|P3|Overall Study|Protocol deviation|3
90983|NCT01132612|345149|P2|Overall Study|Protocol deviation|0
90984|NCT01132612|345150|P1|Overall Study|Protocol deviation|0
90985|NCT01132612|345148|P3|Overall Study|Death|1
90986|NCT01132612|345149|P2|Overall Study|Death|0
90987|NCT01132612|345150|P1|Overall Study|Death|0
90988|NCT01132547|345166|P2|Overall Study|Death|0
90989|NCT01132547|345167|P1|Overall Study|Death|1
90990|NCT01132547|345166|P2|Overall Study|Withdrawal by Subject|1
90991|NCT01132547|345167|P1|Overall Study|Withdrawal by Subject|3
90992|NCT01132495|345237|P4|Overall Study|Various reasons|12
90993|NCT01132495|345238|P3|Overall Study|Various reasons|20
90994|NCT01132495|345239|P2|Overall Study|Various reasons|38
90995|NCT01132495|345240|P1|Overall Study|Various reasons|40
90996|NCT01132326|345253|P1|Overall Study|Subject Unable to Come To Visits|1
90997|NCT01132326|345253|P1|Overall Study|Death|5
90998|NCT01132326|345253|P1|Overall Study|Caregiver Withdrew Consent|1
90999|NCT01132326|345253|P1|Overall Study|Pregnancy|1
91000|NCT01132326|345253|P1|Overall Study|Declining Health|1
91001|NCT01132326|345253|P1|Overall Study|Study Termination|80
91002|NCT01132326|345253|P1|Overall Study|Physician Decision|10
91003|NCT01132326|345253|P1|Overall Study|Withdrawal by Subject|40
91004|NCT01132326|345253|P1|Overall Study|Lost to Follow-up|16
91005|NCT01132326|345253|P1|Overall Study|Protocol Violation|1
91006|NCT01132326|345253|P1|Overall Study|Adverse Event|37
91007|NCT01132326|345253|P1|Overall Study|Lack of Efficacy|25
91008|NCT01132313|345269|P12|Overall Study|Other reason not defined above|0
91009|NCT01132313|345270|P11|Overall Study|Other reason not defined above|0
91010|NCT01132313|345271|P10|Overall Study|Other reason not defined above|0
91011|NCT01132313|345272|P9|Overall Study|Other reason not defined above|0
91012|NCT01132313|345273|P8|Overall Study|Other reason not defined above|1
91013|NCT01132313|345274|P7|Overall Study|Other reason not defined above|0
91014|NCT01132313|345275|P6|Overall Study|Other reason not defined above|0
91015|NCT01132313|345276|P5|Overall Study|Other reason not defined above|0
91016|NCT01132313|345277|P4|Overall Study|Other reason not defined above|0
91017|NCT01132313|345278|P3|Overall Study|Other reason not defined above|0
91018|NCT01132313|345279|P2|Overall Study|Other reason not defined above|0
91019|NCT01132313|345280|P1|Overall Study|Other reason not defined above|0
91020|NCT01132313|345269|P12|Overall Study|Lack of antiviral response|0
91021|NCT01132313|345270|P11|Overall Study|Lack of antiviral response|1
91022|NCT01132313|345271|P10|Overall Study|Lack of antiviral response|0
91023|NCT01132313|345272|P9|Overall Study|Lack of antiviral response|0
91024|NCT01132313|345273|P8|Overall Study|Lack of antiviral response|0
91025|NCT01132313|345274|P7|Overall Study|Lack of antiviral response|21
91026|NCT01132313|345275|P6|Overall Study|Lack of antiviral response|18
91027|NCT01132313|345276|P5|Overall Study|Lack of antiviral response|18
91028|NCT01132313|345277|P4|Overall Study|Lack of antiviral response|18
91029|NCT01132313|345278|P3|Overall Study|Lack of antiviral response|12
91030|NCT01132313|345279|P2|Overall Study|Lack of antiviral response|0
91031|NCT01132313|345280|P1|Overall Study|Lack of antiviral response|0
91032|NCT01132313|345269|P12|Overall Study|Withdrawal by Subject|0
91033|NCT01132313|345270|P11|Overall Study|Withdrawal by Subject|0
91034|NCT01132313|345271|P10|Overall Study|Withdrawal by Subject|2
91035|NCT01132313|345272|P9|Overall Study|Withdrawal by Subject|0
91036|NCT01132313|345273|P8|Overall Study|Withdrawal by Subject|0
91037|NCT01132313|345274|P7|Overall Study|Withdrawal by Subject|1
91038|NCT01132313|345275|P6|Overall Study|Withdrawal by Subject|0
91039|NCT01132313|345276|P5|Overall Study|Withdrawal by Subject|6
91040|NCT01132313|345277|P4|Overall Study|Withdrawal by Subject|3
91041|NCT01132313|345278|P3|Overall Study|Withdrawal by Subject|3
91042|NCT01132313|345279|P2|Overall Study|Withdrawal by Subject|0
91043|NCT01132313|345280|P1|Overall Study|Withdrawal by Subject|0
91044|NCT01132313|345269|P12|Overall Study|Lost to Follow-up|0
91045|NCT01132313|345270|P11|Overall Study|Lost to Follow-up|0
91046|NCT01132313|345271|P10|Overall Study|Lost to Follow-up|0
91047|NCT01132313|345272|P9|Overall Study|Lost to Follow-up|0
91048|NCT01132313|345273|P8|Overall Study|Lost to Follow-up|1
91049|NCT01132313|345274|P7|Overall Study|Lost to Follow-up|0
91050|NCT01132313|345275|P6|Overall Study|Lost to Follow-up|0
91051|NCT01132313|345276|P5|Overall Study|Lost to Follow-up|0
91052|NCT01132313|345277|P4|Overall Study|Lost to Follow-up|0
91053|NCT01132313|345278|P3|Overall Study|Lost to Follow-up|1
91054|NCT01132313|345279|P2|Overall Study|Lost to Follow-up|0
91055|NCT01132313|345280|P1|Overall Study|Lost to Follow-up|0
91056|NCT01132313|345269|P12|Overall Study|Protocol Violation|0
91057|NCT01132313|345270|P11|Overall Study|Protocol Violation|0
91058|NCT01132313|345271|P10|Overall Study|Protocol Violation|0
91059|NCT01132313|345272|P9|Overall Study|Protocol Violation|0
91060|NCT01132313|345273|P8|Overall Study|Protocol Violation|0
91061|NCT01132313|345274|P7|Overall Study|Protocol Violation|0
91062|NCT01132313|345275|P6|Overall Study|Protocol Violation|0
91063|NCT01132313|345276|P5|Overall Study|Protocol Violation|0
91064|NCT01132313|345277|P4|Overall Study|Protocol Violation|1
91065|NCT01132313|345278|P3|Overall Study|Protocol Violation|0
91066|NCT01132313|345279|P2|Overall Study|Protocol Violation|0
91067|NCT01132313|345280|P1|Overall Study|Protocol Violation|0
91068|NCT01132313|345269|P12|Overall Study|Adverse Event|0
91069|NCT01132313|345270|P11|Overall Study|Adverse Event|0
91070|NCT01132313|345271|P10|Overall Study|Adverse Event|2
91071|NCT01132313|345272|P9|Overall Study|Adverse Event|7
91072|NCT01132313|345273|P8|Overall Study|Adverse Event|3
91073|NCT01132313|345274|P7|Overall Study|Adverse Event|5
91074|NCT01132313|345275|P6|Overall Study|Adverse Event|6
91075|NCT01132313|345276|P5|Overall Study|Adverse Event|19
91076|NCT01132313|345277|P4|Overall Study|Adverse Event|10
91077|NCT01132313|345278|P3|Overall Study|Adverse Event|4
91078|NCT01132313|345279|P2|Overall Study|Adverse Event|0
91079|NCT01132313|345280|P1|Overall Study|Adverse Event|0
91080|NCT01132313|345269|P12|Overall Study|Not treated|0
91081|NCT01132313|345270|P11|Overall Study|Not treated|0
91082|NCT01132313|345271|P10|Overall Study|Not treated|0
91083|NCT01132313|345272|P9|Overall Study|Not treated|0
91084|NCT01132313|345273|P8|Overall Study|Not treated|0
91085|NCT01132313|345274|P7|Overall Study|Not treated|3
91086|NCT01132313|345275|P6|Overall Study|Not treated|1
91087|NCT01132313|345276|P5|Overall Study|Not treated|2
91088|NCT01132313|345277|P4|Overall Study|Not treated|0
91089|NCT01132313|345278|P3|Overall Study|Not treated|0
91090|NCT01132313|345279|P2|Overall Study|Not treated|0
91091|NCT01132313|345280|P1|Overall Study|Not treated|2
91092|NCT01132313|345269|P12|Overall Study|Lack of Efficacy|0
91093|NCT01132313|345270|P11|Overall Study|Lack of Efficacy|0
91094|NCT01132313|345271|P10|Overall Study|Lack of Efficacy|16
91095|NCT01132313|345272|P9|Overall Study|Lack of Efficacy|14
91096|NCT01132313|345273|P8|Overall Study|Lack of Efficacy|3
91097|NCT01132313|345274|P7|Overall Study|Lack of Efficacy|0
91098|NCT01132313|345275|P6|Overall Study|Lack of Efficacy|0
91099|NCT01132313|345276|P5|Overall Study|Lack of Efficacy|0
91100|NCT01132313|345277|P4|Overall Study|Lack of Efficacy|0
91101|NCT01132313|345278|P3|Overall Study|Lack of Efficacy|0
91102|NCT01132313|345279|P2|Overall Study|Lack of Efficacy|0
91103|NCT01132313|345280|P1|Overall Study|Lack of Efficacy|1
91104|NCT01132118|345360|P2|Second Intervention (8 Weeks)|Adverse Event|1
91105|NCT01132118|345361|P1|Second Intervention (8 Weeks)|Adverse Event|0
91106|NCT01132118|345360|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
91107|NCT01132118|345361|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
91108|NCT01132118|345360|P2|First Intervention (8 Weeks)|Adverse Event|0
91109|NCT01132118|345361|P1|First Intervention (8 Weeks)|Adverse Event|1
91110|NCT01131676|345391|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
91111|NCT01131676|345392|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
91112|NCT01131676|345393|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
91113|NCT01131676|345391|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
91114|NCT01131676|345392|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
91115|NCT01131676|345393|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
91116|NCT01131676|345391|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
91117|NCT01131676|345392|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
91118|NCT01131676|345393|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
91119|NCT01131676|345391|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
91120|NCT01131676|345392|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
91121|NCT01131676|345393|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
91122|NCT01131676|345391|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
91123|NCT01131676|345392|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
91124|NCT01131676|345393|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
91125|NCT01131676|345391|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
91126|NCT01131676|345392|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
91127|NCT01131676|345393|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
91128|NCT01131676|345391|P3|Discontinuation From Treatment|Adverse Event|273
91129|NCT01131676|345392|P2|Discontinuation From Treatment|Adverse Event|267
91130|NCT01131676|345393|P1|Discontinuation From Treatment|Adverse Event|303
91131|NCT01131676|345391|P3|Discontinuation From Treatment|Other than those specified|125
91132|NCT01131676|345392|P2|Discontinuation From Treatment|Other than those specified|142
91133|NCT01131676|345393|P1|Discontinuation From Treatment|Other than those specified|162
91134|NCT01131676|345391|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
91135|NCT01131676|345392|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
91136|NCT01131676|345393|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
91137|NCT01131676|345391|P3|Discontinuation From Treatment|Lost to Follow-up|6
91138|NCT01131676|345392|P2|Discontinuation From Treatment|Lost to Follow-up|9
91139|NCT01131676|345393|P1|Discontinuation From Treatment|Lost to Follow-up|15
91140|NCT01131676|345391|P3|Discontinuation From Treatment|Non compliant with protocol|12
91141|NCT01131676|345392|P2|Discontinuation From Treatment|Non compliant with protocol|15
91142|NCT01131676|345393|P1|Discontinuation From Treatment|Non compliant with protocol|15
91143|NCT01131676|345391|P3|Discontinuation From Treatment|Lack of Efficacy|0
91144|NCT01131676|345392|P2|Discontinuation From Treatment|Lack of Efficacy|1
91145|NCT01131676|345393|P1|Discontinuation From Treatment|Lack of Efficacy|11
91146|NCT01131676|345391|P3|Discontinuation From Treatment|Not treated|2
91147|NCT01131676|345392|P2|Discontinuation From Treatment|Not treated|2
91148|NCT01131676|345393|P1|Discontinuation From Treatment|Not treated|4
91149|NCT01131676|345391|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
91150|NCT01131676|345392|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
91151|NCT01131676|345393|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
91152|NCT01131585|345428|P2|Overall Study|Study termination|32
91153|NCT01131585|345429|P1|Overall Study|Study termination|78
91154|NCT01131585|345428|P2|Overall Study|Administrative problems|1
91155|NCT01131585|345429|P1|Overall Study|Administrative problems|1
91156|NCT01131585|345428|P2|Overall Study|Lost to Follow-up|1
91157|NCT01131585|345429|P1|Overall Study|Lost to Follow-up|0
91158|NCT01131585|345428|P2|Overall Study|Withdrawal by Subject|3
91159|NCT01131585|345429|P1|Overall Study|Withdrawal by Subject|3
91160|NCT01131585|345428|P2|Overall Study|Protocol Violation|1
91161|NCT01131585|345429|P1|Overall Study|Protocol Violation|2
91162|NCT01131585|345428|P2|Overall Study|Unsatisfactory therapeutic effect|3
91163|NCT01131585|345429|P1|Overall Study|Unsatisfactory therapeutic effect|0
91164|NCT01131585|345428|P2|Overall Study|Abnormal laboratory value|0
91165|NCT01131585|345429|P1|Overall Study|Abnormal laboratory value|1
91166|NCT01131585|345428|P2|Overall Study|Adverse Event|2
91167|NCT01131585|345429|P1|Overall Study|Adverse Event|0
91168|NCT01131520|345437|P2|Overall Study|Subject changed history after enrollment|1
91169|NCT01131520|345438|P1|Overall Study|Subject changed history after enrollment|0
91170|NCT01131520|345437|P2|Overall Study|Counselor not available|3
91171|NCT01131520|345438|P1|Overall Study|Counselor not available|0
91172|NCT01131520|345437|P2|Overall Study|Computer problem|0
91173|NCT01131520|345438|P1|Overall Study|Computer problem|1
91174|NCT01131507|345460|P1|Overall Study|Withdrawal by Subject|1
91175|NCT01131507|345460|P1|Overall Study|Lost to Follow-up|1
91176|NCT01131507|345460|P1|Overall Study|Adverse Event|1
91177|NCT01131494|345465|P1|Overall Study|Withdrawal by Subject|2
91178|NCT01131455|345475|P3|Overall Study|Death of PI|0
91179|NCT01131455|345476|P2|Overall Study|Death of PI|4
91180|NCT01131455|345477|P1|Overall Study|Death of PI|6
91181|NCT01131299|345485|P2|Overall Study|Withdrawal by Subject|7
91182|NCT01131299|345486|P1|Overall Study|Withdrawal by Subject|4
91183|NCT01131182|345499|P2|Overall Study|Other Reason|0
91184|NCT01131182|345500|P1|Overall Study|Other Reason|1
91185|NCT01131182|345499|P2|Overall Study|Lost to Follow-up|15
91186|NCT01131182|345500|P1|Overall Study|Lost to Follow-up|14
91187|NCT01131182|345499|P2|Overall Study|Withdrawal by Subject|1
91188|NCT01131182|345500|P1|Overall Study|Withdrawal by Subject|1
91189|NCT01131130|345508|P1|Period 3- Crossover|+ Slit lamp finding|1
91190|NCT01131130|345508|P1|Period 1 - Baseline|Pregnancy|1
91191|NCT01131104|345521|P1|Overall Study|No Information on Index Date of Onset|1
91192|NCT01131104|345521|P1|Overall Study|Information Not Available|5
91193|NCT01131104|345521|P1|Overall Study|Physician Decision|4
91194|NCT01131104|345521|P1|Overall Study|Withdrawal by Subject|3
91195|NCT01131078|345528|P3|Overall Study|Other|0
91196|NCT01131078|345529|P2|Overall Study|Other|1
91197|NCT01131078|345530|P1|Overall Study|Other|0
91198|NCT01131078|345528|P3|Overall Study|Death|2
91199|NCT01131078|345529|P2|Overall Study|Death|0
91200|NCT01131078|345530|P1|Overall Study|Death|4
91201|NCT01131078|345528|P3|Overall Study|Physician Decision|8
91202|NCT01131078|345529|P2|Overall Study|Physician Decision|6
91203|NCT01131078|345530|P1|Overall Study|Physician Decision|10
91204|NCT01131078|345528|P3|Overall Study|Non-compliance|0
91205|NCT01131078|345529|P2|Overall Study|Non-compliance|0
91206|NCT01131078|345530|P1|Overall Study|Non-compliance|3
91207|NCT01131078|345528|P3|Overall Study|Withdrawal by Subject|3
91208|NCT01131078|345529|P2|Overall Study|Withdrawal by Subject|4
91209|NCT01131078|345530|P1|Overall Study|Withdrawal by Subject|2
91210|NCT01131078|345528|P3|Overall Study|Lost to Follow-up|1
91211|NCT01131078|345529|P2|Overall Study|Lost to Follow-up|1
91212|NCT01131078|345530|P1|Overall Study|Lost to Follow-up|1
91213|NCT01131078|345528|P3|Overall Study|Protocol Violation|0
91214|NCT01131078|345529|P2|Overall Study|Protocol Violation|0
91215|NCT01131078|345530|P1|Overall Study|Protocol Violation|1
91216|NCT01131078|345528|P3|Overall Study|Progressive Disease|71
91217|NCT01131078|345529|P2|Overall Study|Progressive Disease|77
91218|NCT01131078|345530|P1|Overall Study|Progressive Disease|58
91219|NCT01131078|345528|P3|Overall Study|Adverse Event|17
91220|NCT01131078|345529|P2|Overall Study|Adverse Event|12
91221|NCT01131078|345530|P1|Overall Study|Adverse Event|22
91222|NCT01130974|345617|P2|Overall Study|Ineligibility criteria|2
91223|NCT01130974|345618|P1|Overall Study|Ineligibility criteria|5
91224|NCT01130974|345617|P2|Overall Study|Withdrawal by Subject|1
91225|NCT01130974|345618|P1|Overall Study|Withdrawal by Subject|0
91226|NCT01130974|345617|P2|Overall Study|Protocol Violation|10
91227|NCT01130974|345618|P1|Overall Study|Protocol Violation|10
91228|NCT01130883|345638|P1|Overall Study|Adverse Event|3
91229|NCT01130883|345638|P1|Overall Study|Reason Unknown|1
91230|NCT01130883|345638|P1|Overall Study|Patient Noncompliance|6
91231|NCT01130831|345695|P1|Overall Study|Information was missing|3
91232|NCT01130831|345695|P1|Overall Study|Death|4
91233|NCT01130831|345695|P1|Overall Study|Withdrawal by Subject|7
91234|NCT01130597|345734|P1|Overall Study|Protocol Violation|1
91235|NCT01130597|345734|P1|Overall Study|Death|1
91236|NCT01130597|345734|P1|Overall Study|Adverse Event|4
91237|NCT01130597|345734|P1|Overall Study|Protocol-specified (High K+)|1
91238|NCT01130532|345759|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
91239|NCT01130532|345760|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
91240|NCT01130532|345761|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
91241|NCT01130532|345762|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
91242|NCT01130532|345759|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
91243|NCT01130532|345760|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
91244|NCT01130532|345761|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
91245|NCT01130532|345762|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
91246|NCT01130532|345759|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
91247|NCT01130532|345760|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
91248|NCT01130532|345761|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
91249|NCT01130532|345762|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
91250|NCT01130532|345759|P4|Period IV (Weeks 13-16)|Adverse Event|1
91251|NCT01130532|345760|P3|Period IV (Weeks 13-16)|Adverse Event|0
91252|NCT01130532|345761|P2|Period IV (Weeks 13-16)|Adverse Event|0
91253|NCT01130532|345762|P1|Period IV (Weeks 13-16)|Adverse Event|0
91254|NCT01130532|345759|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
91255|NCT01130532|345760|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
91256|NCT01130532|345761|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
91257|NCT01130532|345762|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
91258|NCT01130532|345759|P4|Period III (Weeks 0-12)|Sponsor Decision|0
91259|NCT01130532|345760|P3|Period III (Weeks 0-12)|Sponsor Decision|2
91260|NCT01130532|345761|P2|Period III (Weeks 0-12)|Sponsor Decision|4
91261|NCT01130532|345762|P1|Period III (Weeks 0-12)|Sponsor Decision|3
91262|NCT01130532|345759|P4|Period III (Weeks 0-12)|Protocol Violation|0
91263|NCT01130532|345760|P3|Period III (Weeks 0-12)|Protocol Violation|1
91264|NCT01130532|345761|P2|Period III (Weeks 0-12)|Protocol Violation|0
91265|NCT01130532|345762|P1|Period III (Weeks 0-12)|Protocol Violation|0
91266|NCT01130532|345759|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
91267|NCT01130532|345760|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
91268|NCT01130532|345761|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
91269|NCT01130532|345762|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
91270|NCT01130532|345759|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
91271|NCT01130532|345760|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
91272|NCT01130532|345761|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
91273|NCT01130532|345762|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
91274|NCT01130532|345759|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
91275|NCT01130532|345760|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
91276|NCT01130532|345761|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
91277|NCT01130532|345762|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
91278|NCT01130532|345759|P4|Period III (Weeks 0-12)|Adverse Event|0
91279|NCT01130532|345760|P3|Period III (Weeks 0-12)|Adverse Event|2
91280|NCT01130532|345761|P2|Period III (Weeks 0-12)|Adverse Event|3
91281|NCT01130532|345762|P1|Period III (Weeks 0-12)|Adverse Event|3
91282|NCT01130493|345807|P3|Part 2: OLE|Withdrawal by Subject|4
91283|NCT01130493|345808|P2|Part 2: OLE|Withdrawal by Subject|1
91284|NCT01130493|345809|P1|Part 2: OLE|Withdrawal by Subject|0
91285|NCT01130493|345807|P3|Part 2: OLE|Adverse Event|1
91286|NCT01130493|345808|P2|Part 2: OLE|Adverse Event|2
91287|NCT01130493|345809|P1|Part 2: OLE|Adverse Event|0
91288|NCT01130493|345807|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
91289|NCT01130493|345808|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
91290|NCT01130493|345809|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
91291|NCT01130493|345807|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
91292|NCT01130493|345808|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
91293|NCT01130493|345809|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
91294|NCT01130493|345807|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
91295|NCT01130493|345808|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
91296|NCT01130493|345809|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
91297|NCT01130493|345807|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
91298|NCT01130493|345808|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
91299|NCT01130493|345809|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
91300|NCT01130493|345807|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
91301|NCT01130493|345808|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
91302|NCT01130493|345809|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
91303|NCT01130493|345807|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
91304|NCT01130493|345808|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
91305|NCT01130493|345809|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
91306|NCT01130493|345807|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
91307|NCT01130493|345808|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
91308|NCT01130493|345809|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
91309|NCT01130493|345807|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
91310|NCT01130493|345808|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
91311|NCT01130493|345809|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
91312|NCT01130493|345807|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
91313|NCT01130493|345808|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
91314|NCT01130493|345809|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
91315|NCT01130493|345807|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
91488|NCT01128959|346256|P1|Treatment Period|Withdrawal by Subject|1
91316|NCT01130493|345808|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
91317|NCT01130493|345809|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
91318|NCT01130493|345807|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
91319|NCT01130493|345808|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
91320|NCT01130493|345809|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
91321|NCT01130493|345807|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
91322|NCT01130493|345808|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
91323|NCT01130493|345809|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
91324|NCT01130337|345826|P1|Overall Study|Surgical resection (R2)|1
91325|NCT01130337|345826|P1|Overall Study|Toxicity, AE/intercurrent disease|7
91326|NCT01130337|345826|P1|Overall Study|Disease progression|1
91327|NCT01130337|345826|P1|Overall Study|Death|1
91328|NCT01130337|345826|P1|Overall Study|Principal investigator decision|1
91329|NCT01130337|345826|P1|Overall Study|Withdrawal by Subject|3
91330|NCT01130168|345833|P6|Period 1|Adverse Event|0
91331|NCT01130168|345834|P5|Period 1|Adverse Event|0
91332|NCT01130168|345835|P4|Period 1|Adverse Event|1
91333|NCT01130168|345836|P3|Period 1|Adverse Event|0
91334|NCT01130168|345837|P2|Period 1|Adverse Event|0
91335|NCT01130168|345838|P1|Period 1|Adverse Event|0
91336|NCT01130168|345833|P6|Period 1|Discontinued For Other Reason|0
91337|NCT01130168|345834|P5|Period 1|Discontinued For Other Reason|0
91338|NCT01130168|345835|P4|Period 1|Discontinued For Other Reason|1
91339|NCT01130168|345836|P3|Period 1|Discontinued For Other Reason|1
91340|NCT01130168|345837|P2|Period 1|Discontinued For Other Reason|0
91341|NCT01130168|345838|P1|Period 1|Discontinued For Other Reason|0
91342|NCT01130168|345833|P6|Period 1|Withdrawal by Subject|0
91343|NCT01130168|345834|P5|Period 1|Withdrawal by Subject|0
91344|NCT01130168|345835|P4|Period 1|Withdrawal by Subject|1
91345|NCT01130168|345836|P3|Period 1|Withdrawal by Subject|0
91346|NCT01130168|345837|P2|Period 1|Withdrawal by Subject|1
91347|NCT01130168|345838|P1|Period 1|Withdrawal by Subject|0
91348|NCT01130103|345875|P2|Maintenance Treatment|Withdrawal by Subject|0
91349|NCT01130103|345876|P1|Maintenance Treatment|Withdrawal by Subject|1
91350|NCT01130103|345875|P2|Maintenance Treatment|Lost to Follow-up|1
91351|NCT01130103|345876|P1|Maintenance Treatment|Lost to Follow-up|1
91352|NCT01130103|345875|P2|Maintenance Treatment|Lack of Efficacy|1
91353|NCT01130103|345876|P1|Maintenance Treatment|Lack of Efficacy|0
91354|NCT01130103|345875|P2|Randomized Treatment|Withdrawal by Subject|2
91355|NCT01130103|345876|P1|Randomized Treatment|Withdrawal by Subject|1
91356|NCT01130103|345875|P2|Randomized Treatment|Protocol Violation|2
91357|NCT01130103|345876|P1|Randomized Treatment|Protocol Violation|3
91358|NCT01130103|345875|P2|Randomized Treatment|Lost to Follow-up|0
91359|NCT01130103|345876|P1|Randomized Treatment|Lost to Follow-up|1
91360|NCT01130103|345875|P2|Randomized Treatment|Adverse Event|1
91361|NCT01130103|345876|P1|Randomized Treatment|Adverse Event|1
91362|NCT01130051|345890|P2|Washout Period of 14 Days|Protocol Violation|1
91363|NCT01130051|345891|P1|Washout Period of 14 Days|Protocol Violation|1
91364|NCT01130051|345890|P2|Washout Period of 14 Days|Withdrawal by Subject|1
91365|NCT01130051|345891|P1|Washout Period of 14 Days|Withdrawal by Subject|0
91366|NCT01129960|345905|P4|Overall Study|Pregnancy|0
91367|NCT01129960|345906|P3|Overall Study|Pregnancy|0
91368|NCT01129960|345907|P2|Overall Study|Pregnancy|0
91369|NCT01129960|345908|P1|Overall Study|Pregnancy|1
91370|NCT01129960|345905|P4|Overall Study|Physician Decision|0
91371|NCT01129960|345906|P3|Overall Study|Physician Decision|0
91372|NCT01129960|345907|P2|Overall Study|Physician Decision|0
91373|NCT01129960|345908|P1|Overall Study|Physician Decision|1
91374|NCT01129960|345905|P4|Overall Study|Discontinuation of the study by Sponsor|0
91375|NCT01129960|345906|P3|Overall Study|Discontinuation of the study by Sponsor|0
91376|NCT01129960|345907|P2|Overall Study|Discontinuation of the study by Sponsor|1
91377|NCT01129960|345908|P1|Overall Study|Discontinuation of the study by Sponsor|0
91378|NCT01129960|345905|P4|Overall Study|Lost to Follow-up|3
91379|NCT01129960|345906|P3|Overall Study|Lost to Follow-up|3
91380|NCT01129960|345907|P2|Overall Study|Lost to Follow-up|2
91381|NCT01129960|345908|P1|Overall Study|Lost to Follow-up|0
91382|NCT01129960|345905|P4|Overall Study|Protocol Violation|0
91383|NCT01129960|345906|P3|Overall Study|Protocol Violation|3
91384|NCT01129960|345907|P2|Overall Study|Protocol Violation|2
91385|NCT01129960|345908|P1|Overall Study|Protocol Violation|1
91386|NCT01129960|345905|P4|Overall Study|Adverse Event|7
91387|NCT01129960|345906|P3|Overall Study|Adverse Event|16
91388|NCT01129960|345907|P2|Overall Study|Adverse Event|16
91389|NCT01129960|345908|P1|Overall Study|Adverse Event|23
91390|NCT01129960|345905|P4|Overall Study|Lack of Efficacy|1
91391|NCT01129960|345906|P3|Overall Study|Lack of Efficacy|1
91392|NCT01129960|345907|P2|Overall Study|Lack of Efficacy|1
91393|NCT01129960|345908|P1|Overall Study|Lack of Efficacy|1
91394|NCT01129960|345905|P4|Overall Study|Withdrawal by Subject|2
91395|NCT01129960|345906|P3|Overall Study|Withdrawal by Subject|3
91396|NCT01129960|345907|P2|Overall Study|Withdrawal by Subject|0
91397|NCT01129960|345908|P1|Overall Study|Withdrawal by Subject|3
91398|NCT01129921|345920|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
91399|NCT01129921|345921|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
91400|NCT01129921|345920|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
91401|NCT01129921|345921|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
91402|NCT01129921|345920|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
91403|NCT01129921|345921|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
91404|NCT01129921|345920|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
91405|NCT01129921|345921|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
91406|NCT01129622|345945|P1|Overall Study|Withdrawal by Subject|2
91407|NCT01129583|345952|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
91408|NCT01129583|345953|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
91409|NCT01129583|345952|P2|Overall Study|Lost to Follow-up|1
91410|NCT01129583|345953|P1|Overall Study|Lost to Follow-up|1
91411|NCT01129583|345952|P2|Overall Study|Death|0
91412|NCT01129583|345953|P1|Overall Study|Death|1
91413|NCT01129557|345966|P3|Overall Study|Novartis terminated study early|2
91414|NCT01129557|345967|P2|Overall Study|Novartis terminated study early|3
91415|NCT01129557|345968|P1|Overall Study|Novartis terminated study early|3
91416|NCT01129557|345966|P3|Overall Study|Adverse Event|2
91417|NCT01129557|345967|P2|Overall Study|Adverse Event|2
91418|NCT01129557|345968|P1|Overall Study|Adverse Event|1
91419|NCT01129336|346063|P2|Overall Study|Death|4
91420|NCT01129336|346064|P1|Overall Study|Death|0
91421|NCT01129336|346063|P2|Overall Study|Missing Study Completion Status|3
91422|NCT01129336|346064|P1|Overall Study|Missing Study Completion Status|2
91423|NCT01129336|346063|P2|Overall Study|Adverse Event|1
91424|NCT01129336|346064|P1|Overall Study|Adverse Event|0
91425|NCT01129336|346063|P2|Overall Study|Withdrawal by Subject|4
91426|NCT01129336|346064|P1|Overall Study|Withdrawal by Subject|7
91427|NCT01129336|346063|P2|Overall Study|Lost to Follow-up|0
91428|NCT01129336|346064|P1|Overall Study|Lost to Follow-up|1
91429|NCT01129336|346063|P2|Overall Study|Disease Progression|4
91430|NCT01129336|346064|P1|Overall Study|Disease Progression|1
91431|NCT01129336|346063|P2|Overall Study|Protocol Violation|0
91432|NCT01129336|346064|P1|Overall Study|Protocol Violation|1
91433|NCT01129284|346079|P3|Overall Study|Adverse Event|1
91434|NCT01129284|346080|P2|Overall Study|Adverse Event|0
91435|NCT01129284|346081|P1|Overall Study|Adverse Event|2
91436|NCT01129128|346121|P3|Overall Study|Physician Decision|0
91437|NCT01129128|346122|P2|Overall Study|Physician Decision|0
91438|NCT01129128|346123|P1|Overall Study|Physician Decision|1
91439|NCT01129128|346121|P3|Overall Study|Withdrawal by Subject|3
91440|NCT01129128|346122|P2|Overall Study|Withdrawal by Subject|1
91441|NCT01129128|346123|P1|Overall Study|Withdrawal by Subject|0
91442|NCT01129128|346121|P3|Overall Study|Protocol Violation|0
91443|NCT01129128|346122|P2|Overall Study|Protocol Violation|1
91444|NCT01129128|346123|P1|Overall Study|Protocol Violation|0
91445|NCT01129128|346121|P3|Overall Study|Lost to Follow-up|1
91446|NCT01129128|346122|P2|Overall Study|Lost to Follow-up|2
91447|NCT01129128|346123|P1|Overall Study|Lost to Follow-up|2
91448|NCT01129115|346147|P4|Overall Study|Protocol Violation|2
91449|NCT01129115|346148|P3|Overall Study|Protocol Violation|2
91450|NCT01129115|346149|P2|Overall Study|Protocol Violation|2
91451|NCT01129115|346150|P1|Overall Study|Protocol Violation|0
91452|NCT01129115|346147|P4|Overall Study|Withdrawal by Subject|4
91453|NCT01129115|346148|P3|Overall Study|Withdrawal by Subject|1
91454|NCT01129115|346149|P2|Overall Study|Withdrawal by Subject|3
91455|NCT01129115|346150|P1|Overall Study|Withdrawal by Subject|1
91456|NCT01129115|346147|P4|Overall Study|Adverse Event|3
91457|NCT01129115|346148|P3|Overall Study|Adverse Event|3
91458|NCT01129115|346149|P2|Overall Study|Adverse Event|2
91459|NCT01129115|346150|P1|Overall Study|Adverse Event|1
91460|NCT01129102|346187|P3|Overall Study|Lost to Follow-up|0
91461|NCT01129102|346188|P2|Overall Study|Lost to Follow-up|0
91462|NCT01129102|346189|P1|Overall Study|Lost to Follow-up|2
91463|NCT01129102|346187|P3|Overall Study|Adverse Event|1
91464|NCT01129102|346188|P2|Overall Study|Adverse Event|2
91465|NCT01129102|346189|P1|Overall Study|Adverse Event|2
91466|NCT01129102|346187|P3|Overall Study|Pregnancy|1
91467|NCT01129102|346188|P2|Overall Study|Pregnancy|0
91468|NCT01129102|346189|P1|Overall Study|Pregnancy|0
91469|NCT01129102|346187|P3|Overall Study|Protocol Violation|1
91470|NCT01129102|346188|P2|Overall Study|Protocol Violation|1
91471|NCT01129102|346189|P1|Overall Study|Protocol Violation|0
91472|NCT01129102|346187|P3|Overall Study|Withdrawal by Subject|3
91473|NCT01129102|346188|P2|Overall Study|Withdrawal by Subject|0
91474|NCT01129102|346189|P1|Overall Study|Withdrawal by Subject|2
91475|NCT01129102|346187|P3|Overall Study|No study drug treatment|1
91476|NCT01129102|346188|P2|Overall Study|No study drug treatment|3
91477|NCT01129102|346189|P1|Overall Study|No study drug treatment|2
91478|NCT01129011|346200|P2|Overall Study|misc|4
91479|NCT01129011|346201|P1|Overall Study|misc|7
91480|NCT01129011|346200|P2|Overall Study|Duodenal Ulcer|8
91481|NCT01129011|346201|P1|Overall Study|Duodenal Ulcer|2
91482|NCT01129011|346200|P2|Overall Study|Lost to Follow-up|7
91483|NCT01129011|346201|P1|Overall Study|Lost to Follow-up|6
91484|NCT01129011|346200|P2|Overall Study|Withdrawal by Subject|8
91485|NCT01129011|346201|P1|Overall Study|Withdrawal by Subject|24
91486|NCT01129011|346200|P2|Overall Study|Adverse Event|30
91487|NCT01129011|346201|P1|Overall Study|Adverse Event|20
91489|NCT01128959|346256|P1|Treatment Period|Adverse Event|3
91490|NCT01128959|346256|P1|Lead in Period|Adverse Event|3
91491|NCT01128946|346262|P4|Period III|Protocol Violation|0
91492|NCT01128946|346263|P3|Period III|Protocol Violation|0
91493|NCT01128946|346264|P2|Period III|Protocol Violation|0
91494|NCT01128946|346265|P1|Period III|Protocol Violation|1
91495|NCT01128946|346262|P4|Period II|Withdrawal by Subject|1
91496|NCT01128946|346263|P3|Period II|Withdrawal by Subject|0
91497|NCT01128946|346264|P2|Period II|Withdrawal by Subject|0
91498|NCT01128946|346265|P1|Period II|Withdrawal by Subject|0
91499|NCT01128946|346262|P4|Period II|Protocol Violation|0
91500|NCT01128946|346263|P3|Period II|Protocol Violation|0
91501|NCT01128946|346264|P2|Period II|Protocol Violation|1
91502|NCT01128946|346265|P1|Period II|Protocol Violation|0
91503|NCT01128946|346262|P4|Period I|Withdrawal by Subject|1
91504|NCT01128946|346263|P3|Period I|Withdrawal by Subject|1
91505|NCT01128946|346264|P2|Period I|Withdrawal by Subject|0
91506|NCT01128946|346265|P1|Period I|Withdrawal by Subject|0
91507|NCT01128946|346262|P4|Period I|Protocol Violation|0
91508|NCT01128946|346263|P3|Period I|Protocol Violation|0
91509|NCT01128946|346264|P2|Period I|Protocol Violation|1
91510|NCT01128946|346265|P1|Period I|Protocol Violation|0
91511|NCT01128894|346283|P2|Overall Study|Conflicting HbA1c Results at Screening|0
91512|NCT01128894|346284|P1|Overall Study|Conflicting HbA1c Results at Screening|1
91513|NCT01128894|346283|P2|Overall Study|Physician Decision|1
91514|NCT01128894|346284|P1|Overall Study|Physician Decision|2
91515|NCT01128894|346283|P2|Overall Study|Withdrawal by Subject|12
91516|NCT01128894|346284|P1|Overall Study|Withdrawal by Subject|10
91517|NCT01128894|346283|P2|Overall Study|Lost to Follow-up|8
91518|NCT01128894|346284|P1|Overall Study|Lost to Follow-up|8
91519|NCT01128894|346283|P2|Overall Study|Noncompliance|5
91520|NCT01128894|346284|P1|Overall Study|Noncompliance|4
91521|NCT01128894|346283|P2|Overall Study|Protocol Violation|1
91522|NCT01128894|346284|P1|Overall Study|Protocol Violation|2
91523|NCT01128894|346283|P2|Overall Study|Adverse Event|41
91524|NCT01128894|346284|P1|Overall Study|Adverse Event|31
91525|NCT01128738|346309|P2|Second TP|Withdrawal by Subject|2
91526|NCT01128738|346310|P1|Second TP|Withdrawal by Subject|0
91527|NCT01128738|346309|P2|Second TP|Lost to Follow-up|1
91528|NCT01128738|346310|P1|Second TP|Lost to Follow-up|0
91529|NCT01128738|346309|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
91530|NCT01128738|346310|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
91531|NCT01128738|346309|P2|First Treatment Phase (TP)|Lost to Follow-up|0
91532|NCT01128738|346310|P1|First Treatment Phase (TP)|Lost to Follow-up|1
91533|NCT01128621|346435|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
91534|NCT01128621|346436|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
91535|NCT01128595|346557|P4|Treatment Period 3|Withdrawal by Subject|0
91536|NCT01128595|346558|P3|Treatment Period 3|Withdrawal by Subject|0
91537|NCT01128595|346559|P2|Treatment Period 3|Withdrawal by Subject|1
91538|NCT01128595|346560|P1|Treatment Period 3|Withdrawal by Subject|0
91539|NCT01128569|346590|P6|Treatment Period 2|Withdrawal by Subject|0
91540|NCT01128569|346591|P5|Treatment Period 2|Withdrawal by Subject|0
91541|NCT01128569|346592|P4|Treatment Period 2|Withdrawal by Subject|0
91542|NCT01128569|346593|P3|Treatment Period 2|Withdrawal by Subject|0
91543|NCT01128569|346594|P2|Treatment Period 2|Withdrawal by Subject|1
91544|NCT01128569|346595|P1|Treatment Period 2|Withdrawal by Subject|0
91545|NCT01128569|346590|P6|Washout Period 1|Adverse Event|0
91546|NCT01128569|346591|P5|Washout Period 1|Adverse Event|0
91547|NCT01128569|346592|P4|Washout Period 1|Adverse Event|0
91548|NCT01128569|346593|P3|Washout Period 1|Adverse Event|1
91549|NCT01128569|346594|P2|Washout Period 1|Adverse Event|0
91550|NCT01128569|346595|P1|Washout Period 1|Adverse Event|0
91551|NCT01128543|346612|P1|Overall Study|Protocol Violation|1
91552|NCT01128543|346612|P1|Overall Study|Withdrawal by Subject|3
91553|NCT01128413|346638|P2|Overall Study|Pt made DNR|0
91554|NCT01128413|346639|P1|Overall Study|Pt made DNR|1
91555|NCT01128413|346638|P2|Overall Study|NICOM Monitor Problems|1
91556|NCT01128413|346639|P1|Overall Study|NICOM Monitor Problems|2
91557|NCT01128413|346638|P2|Overall Study|Withdrawal by Subject|0
91558|NCT01128413|346639|P1|Overall Study|Withdrawal by Subject|1
91559|NCT01128400|346648|P3|Overall Study|were not invited to participate on taste|15
91560|NCT01128400|346649|P2|Overall Study|were not invited to participate on taste|0
91561|NCT01128400|346650|P1|Overall Study|were not invited to participate on taste|0
91562|NCT01128400|346648|P3|Overall Study|Screening failure|0
91563|NCT01128400|346649|P2|Overall Study|Screening failure|0
91564|NCT01128400|346650|P1|Overall Study|Screening failure|1
91565|NCT01128400|346648|P3|Overall Study|Lost to Follow-up|1
91566|NCT01128400|346649|P2|Overall Study|Lost to Follow-up|0
91567|NCT01128400|346650|P1|Overall Study|Lost to Follow-up|1
91568|NCT01128387|346663|P2|Overall Study|Physician Decision|1
91569|NCT01128387|346664|P1|Overall Study|Physician Decision|0
91570|NCT01128361|346674|P2|Overall Study|Withdrawal by Subject|2
91571|NCT01128361|346675|P1|Overall Study|Withdrawal by Subject|5
91572|NCT01128361|346674|P2|Overall Study|Lost to Follow-up|1
91573|NCT01128361|346675|P1|Overall Study|Lost to Follow-up|0
91574|NCT01128296|346687|P6|Overall Study|Withdrawal by Subject|2
91575|NCT01128296|346688|P5|Overall Study|Withdrawal by Subject|0
91576|NCT01128296|346689|P4|Overall Study|Withdrawal by Subject|0
91577|NCT01128296|346690|P3|Overall Study|Withdrawal by Subject|0
91578|NCT01128296|346691|P2|Overall Study|Withdrawal by Subject|0
91579|NCT01128296|346692|P1|Overall Study|Withdrawal by Subject|0
91580|NCT01128296|346687|P6|Overall Study|Physician Decision|3
91581|NCT01128296|346688|P5|Overall Study|Physician Decision|0
91582|NCT01128296|346689|P4|Overall Study|Physician Decision|0
91583|NCT01128296|346690|P3|Overall Study|Physician Decision|0
91584|NCT01128296|346691|P2|Overall Study|Physician Decision|0
91585|NCT01128296|346692|P1|Overall Study|Physician Decision|0
91586|NCT01128244|346723|P1|Overall Study|Scheduling conflict|2
91587|NCT01128244|346723|P1|Overall Study|Adverse Event|1
91588|NCT01128179|346764|P2|Overall Study|Protocol Violation|0
91589|NCT01128179|346765|P1|Overall Study|Protocol Violation|1
91590|NCT01128179|346764|P2|Overall Study|Death|0
91591|NCT01128179|346765|P1|Overall Study|Death|1
91592|NCT01128153|346785|P2|Overall Study|Developed discontinuation criteria|1
91593|NCT01128153|346786|P1|Overall Study|Developed discontinuation criteria|1
91594|NCT01128153|346785|P2|Overall Study|Protocol Violation|0
91595|NCT01128153|346786|P1|Overall Study|Protocol Violation|2
91596|NCT01128153|346785|P2|Overall Study|Incorrect enrolment to study|1
91597|NCT01128153|346786|P1|Overall Study|Incorrect enrolment to study|2
91598|NCT01128153|346785|P2|Overall Study|Withdrawal by Subject|3
91599|NCT01128153|346786|P1|Overall Study|Withdrawal by Subject|2
91600|NCT01128153|346785|P2|Overall Study|Condition under investigation worsened|7
91601|NCT01128153|346786|P1|Overall Study|Condition under investigation worsened|8
91602|NCT01128153|346785|P2|Overall Study|Adverse Event|3
91603|NCT01128153|346786|P1|Overall Study|Adverse Event|1
91604|NCT01128114|346802|P1|Overall Study|Screening Failed|2
91605|NCT01128114|346802|P1|Overall Study|Treatment Withdrawn|6
91606|NCT01127763|346819|P1|Overall Study|Physician Decision|2
91607|NCT01127763|346819|P1|Overall Study|Withdrawal by Subject|1
91608|NCT01127763|346819|P1|Overall Study|Adverse Event|2
91609|NCT01127646|346864|P2|Overall Study|Protocol Violation|1
91610|NCT01127646|346865|P1|Overall Study|Protocol Violation|0
91611|NCT01127646|346864|P2|Overall Study|Entry Criteria Not Met|0
91612|NCT01127646|346865|P1|Overall Study|Entry Criteria Not Met|1
91613|NCT01127633|346899|P2|Overall Study|Not treated|0
91614|NCT01127633|346900|P1|Overall Study|Not treated|1
91615|NCT01127633|346899|P2|Overall Study|Abnormal Lab/ECG Result|1
91616|NCT01127633|346900|P1|Overall Study|Abnormal Lab/ECG Result|0
91617|NCT01127633|346899|P2|Overall Study|Protocol Violation|16
91618|NCT01127633|346900|P1|Overall Study|Protocol Violation|8
91619|NCT01127633|346899|P2|Overall Study|Sponsor Decision|195
91620|NCT01127633|346900|P1|Overall Study|Sponsor Decision|163
91621|NCT01127633|346899|P2|Overall Study|Withdrawal by Subject|72
91622|NCT01127633|346900|P1|Overall Study|Withdrawal by Subject|57
91623|NCT01127633|346899|P2|Overall Study|Physician Decision|45
91624|NCT01127633|346900|P1|Overall Study|Physician Decision|60
91625|NCT01127633|346899|P2|Overall Study|Parent/Caregiver Decision|228
91626|NCT01127633|346900|P1|Overall Study|Parent/Caregiver Decision|246
91627|NCT01127633|346899|P2|Overall Study|Lost to Follow-up|0
91628|NCT01127633|346900|P1|Overall Study|Lost to Follow-up|4
91629|NCT01127633|346899|P2|Overall Study|Death|43
91630|NCT01127633|346900|P1|Overall Study|Death|40
91631|NCT01127633|346899|P2|Overall Study|Adverse Event|73
91632|NCT01127633|346900|P1|Overall Study|Adverse Event|74
91633|NCT01127607|346932|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
91634|NCT01127607|346933|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
91635|NCT01127607|346932|P2|Phase II (Between Subjects)|Lost to Follow-up|2
91636|NCT01127607|346933|P1|Phase II (Between Subjects)|Lost to Follow-up|0
91637|NCT01127256|347108|P2|Overall Study|Protocol Violation|0
91638|NCT01127256|347109|P1|Overall Study|Protocol Violation|1
91639|NCT01127256|347108|P2|Overall Study|Withdrawal by Subject|9
91640|NCT01127256|347109|P1|Overall Study|Withdrawal by Subject|5
91641|NCT01127256|347108|P2|Overall Study|Lost to Follow-up|17
91642|NCT01127256|347109|P1|Overall Study|Lost to Follow-up|16
91643|NCT01127256|347108|P2|Overall Study|Lack of Efficacy|0
91644|NCT01127256|347109|P1|Overall Study|Lack of Efficacy|4
91645|NCT01127256|347108|P2|Overall Study|Adverse Event|13
91646|NCT01127256|347109|P1|Overall Study|Adverse Event|13
91647|NCT01127165|347121|P2|Overall Study|Protocol Violation|1
91648|NCT01127165|347122|P1|Overall Study|Protocol Violation|0
91649|NCT01127165|347121|P2|Overall Study|Withdrawal by Subject|3
91650|NCT01127165|347122|P1|Overall Study|Withdrawal by Subject|1
91651|NCT01127165|347121|P2|Overall Study|Lost to Follow-up|5
91652|NCT01127165|347122|P1|Overall Study|Lost to Follow-up|3
91653|NCT01127165|347121|P2|Overall Study|Lack of Efficacy|8
91654|NCT01127165|347122|P1|Overall Study|Lack of Efficacy|10
91655|NCT01127165|347121|P2|Overall Study|Adverse Event|2
91656|NCT01127165|347122|P1|Overall Study|Adverse Event|2
91657|NCT01127139|347134|P1|Overall Study|Reason not specified|1
91658|NCT01127139|347134|P1|Overall Study|Lack of Efficacy|4
91659|NCT01127139|347134|P1|Overall Study|Incompliance|12
91660|NCT01127139|347134|P1|Overall Study|Adverse Event|40
91661|NCT01126619|347196|P1|Overall Study|Non-compliance|1
91662|NCT01126619|347196|P1|Overall Study|Withdrawal by Subject|9
91663|NCT01126619|347196|P1|Overall Study|Serious adverse event|1
91664|NCT01126619|347196|P1|Overall Study|Investigator decision|4
91665|NCT01126619|347196|P1|Overall Study|Not eligible for the study|2
91666|NCT01126580|347224|P3|Overall Study|Treatment Non-compliance|3
91667|NCT01126580|347225|P2|Overall Study|Treatment Non-compliance|2
91668|NCT01126580|347226|P1|Overall Study|Treatment Non-compliance|0
91669|NCT01126580|347224|P3|Overall Study|Lost to Follow-up|9
91670|NCT01126580|347225|P2|Overall Study|Lost to Follow-up|13
91671|NCT01126580|347226|P1|Overall Study|Lost to Follow-up|15
91672|NCT01126580|347224|P3|Overall Study|Protocol Violation|2
91673|NCT01126580|347225|P2|Overall Study|Protocol Violation|1
91674|NCT01126580|347226|P1|Overall Study|Protocol Violation|0
91675|NCT01126580|347224|P3|Overall Study|Lack of Efficacy|4
91676|NCT01126580|347225|P2|Overall Study|Lack of Efficacy|3
91677|NCT01126580|347226|P1|Overall Study|Lack of Efficacy|2
91678|NCT01126580|347224|P3|Overall Study|Entry Criteria Not Met|2
91679|NCT01126580|347225|P2|Overall Study|Entry Criteria Not Met|1
91680|NCT01126580|347226|P1|Overall Study|Entry Criteria Not Met|1
91681|NCT01126580|347224|P3|Overall Study|Physician Decision|2
91682|NCT01126580|347225|P2|Overall Study|Physician Decision|1
91683|NCT01126580|347226|P1|Overall Study|Physician Decision|1
91684|NCT01126580|347224|P3|Overall Study|Sponsor Decision|7
91685|NCT01126580|347225|P2|Overall Study|Sponsor Decision|4
91686|NCT01126580|347226|P1|Overall Study|Sponsor Decision|5
91687|NCT01126580|347224|P3|Overall Study|Withdrawal by Subject|14
91688|NCT01126580|347225|P2|Overall Study|Withdrawal by Subject|19
91689|NCT01126580|347226|P1|Overall Study|Withdrawal by Subject|11
91690|NCT01126580|347224|P3|Overall Study|Adverse Event|12
91691|NCT01126580|347225|P2|Overall Study|Adverse Event|8
91692|NCT01126580|347226|P1|Overall Study|Adverse Event|14
91693|NCT01126541|347321|P3|Overall Study|Administrative reason or other|2
91694|NCT01126541|347322|P2|Overall Study|Administrative reason or other|1
91695|NCT01126541|347323|P1|Overall Study|Administrative reason or other|1
91696|NCT01126541|347321|P3|Overall Study|Protocol Violation|1
91697|NCT01126541|347322|P2|Overall Study|Protocol Violation|0
91698|NCT01126541|347323|P1|Overall Study|Protocol Violation|0
91699|NCT01126541|347321|P3|Overall Study|Withdrawal by Subject|6
91700|NCT01126541|347322|P2|Overall Study|Withdrawal by Subject|5
91701|NCT01126541|347323|P1|Overall Study|Withdrawal by Subject|2
91702|NCT01126541|347321|P3|Overall Study|Lost to Follow-up|2
91703|NCT01126541|347322|P2|Overall Study|Lost to Follow-up|2
91704|NCT01126541|347323|P1|Overall Study|Lost to Follow-up|1
91705|NCT01126541|347321|P3|Overall Study|Lack of Efficacy|11
91706|NCT01126541|347322|P2|Overall Study|Lack of Efficacy|1
91707|NCT01126541|347323|P1|Overall Study|Lack of Efficacy|6
91708|NCT01126541|347321|P3|Overall Study|Death|0
91709|NCT01126541|347322|P2|Overall Study|Death|1
91710|NCT01126541|347323|P1|Overall Study|Death|0
91711|NCT01126541|347321|P3|Overall Study|Adverse Event|4
91712|NCT01126541|347322|P2|Overall Study|Adverse Event|2
91713|NCT01126541|347323|P1|Overall Study|Adverse Event|0
91714|NCT01126437|347407|P3|Overall Study|Other reason not specified|178
91715|NCT01126437|347408|P2|Overall Study|Other reason not specified|176
91716|NCT01126437|347409|P1|Overall Study|Other reason not specified|210
91717|NCT01126437|347407|P3|Overall Study|Withdrawal by Subject|319
91718|NCT01126437|347408|P2|Overall Study|Withdrawal by Subject|335
91719|NCT01126437|347409|P1|Overall Study|Withdrawal by Subject|331
91720|NCT01126437|347407|P3|Overall Study|Lost to Follow-up|55
91721|NCT01126437|347408|P2|Overall Study|Lost to Follow-up|63
91722|NCT01126437|347409|P1|Overall Study|Lost to Follow-up|52
91723|NCT01126437|347407|P3|Overall Study|Protocol Violation|41
91724|NCT01126437|347408|P2|Overall Study|Protocol Violation|66
91725|NCT01126437|347409|P1|Overall Study|Protocol Violation|64
91726|NCT01126437|347407|P3|Overall Study|Lack of Efficacy|59
91727|NCT01126437|347408|P2|Overall Study|Lack of Efficacy|60
91728|NCT01126437|347409|P1|Overall Study|Lack of Efficacy|65
91729|NCT01126437|347407|P3|Overall Study|Adverse Event|635
91730|NCT01126437|347408|P2|Overall Study|Adverse Event|606
91731|NCT01126437|347409|P1|Overall Study|Adverse Event|602
91732|NCT01126437|347407|P3|Overall Study|Sites with data irregularities/fraud|7
91733|NCT01126437|347408|P2|Overall Study|Sites with data irregularities/fraud|6
91734|NCT01126437|347409|P1|Overall Study|Sites with data irregularities/fraud|6
91735|NCT01126437|347407|P3|Overall Study|Not treated|19
91736|NCT01126437|347408|P2|Overall Study|Not treated|18
91737|NCT01126437|347409|P1|Overall Study|Not treated|11
91738|NCT01126424|347447|P6|Overall Study|Withdrawal by Subject|0
91739|NCT01126424|347448|P5|Overall Study|Withdrawal by Subject|1
91740|NCT01126424|347449|P4|Overall Study|Withdrawal by Subject|3
91741|NCT01126424|347450|P3|Overall Study|Withdrawal by Subject|1
91742|NCT01126424|347451|P2|Overall Study|Withdrawal by Subject|0
91743|NCT01126424|347452|P1|Overall Study|Withdrawal by Subject|0
91744|NCT01126424|347447|P6|Overall Study|Adverse Event|0
91745|NCT01126424|347448|P5|Overall Study|Adverse Event|1
91746|NCT01126424|347449|P4|Overall Study|Adverse Event|0
91747|NCT01126424|347450|P3|Overall Study|Adverse Event|0
91748|NCT01126424|347451|P2|Overall Study|Adverse Event|0
91749|NCT01126424|347452|P1|Overall Study|Adverse Event|0
91750|NCT01126359|347475|P2|First Intervention (20-minutes)|Physician Decision|1
91751|NCT01126359|347476|P1|First Intervention (20-minutes)|Physician Decision|0
91752|NCT01126268|347488|P1|Overall Study|Adverse Event|1
91753|NCT01126060|347527|P2|Overall Study|Protocol Violation|2
91754|NCT01126060|347528|P1|Overall Study|Protocol Violation|0
91755|NCT01125930|347536|P2|Overall Study|Lost to Follow-up|2
91756|NCT01125930|347537|P1|Overall Study|Lost to Follow-up|0
91757|NCT01125930|347536|P2|Overall Study|Protocol Violation|1
91758|NCT01125930|347537|P1|Overall Study|Protocol Violation|0
91759|NCT01125930|347536|P2|Overall Study|Withdrawal by Subject|6
91760|NCT01125930|347537|P1|Overall Study|Withdrawal by Subject|1
91761|NCT01125930|347536|P2|Overall Study|Adverse Event|1
91762|NCT01125930|347537|P1|Overall Study|Adverse Event|0
91763|NCT01125917|347691|P1|Overall Study|Lack of Efficacy|19
91764|NCT01125917|347691|P1|Overall Study|Administrative|223
91765|NCT01125917|347691|P1|Overall Study|Withdrawal by Subject|31
91766|NCT01125917|347691|P1|Overall Study|Lost to Follow-up|23
91767|NCT01125917|347691|P1|Overall Study|Adverse Event|43
91768|NCT01125813|347695|P1|Overall Study|Screen Failures|4
91769|NCT01125813|347695|P1|Overall Study|Withdrawal by Subject|1
91770|NCT01125813|347695|P1|Overall Study|Death|1
91771|NCT01125800|347705|P5|Phase II|Disease progression|8
91772|NCT01125800|347706|P4|Phase II|Disease progression|1
91773|NCT01125800|347707|P3|Phase II|Disease progression|0
91774|NCT01125800|347708|P2|Phase II|Disease progression|0
91775|NCT01125800|347709|P1|Phase II|Disease progression|0
91776|NCT01125800|347705|P5|Phase II|Adverse Event|2
91777|NCT01125800|347706|P4|Phase II|Adverse Event|0
91778|NCT01125800|347707|P3|Phase II|Adverse Event|0
91779|NCT01125800|347708|P2|Phase II|Adverse Event|0
91780|NCT01125800|347709|P1|Phase II|Adverse Event|0
91781|NCT01125800|347705|P5|Phase II|Protocol Violation|1
91782|NCT01125800|347706|P4|Phase II|Protocol Violation|0
91783|NCT01125800|347707|P3|Phase II|Protocol Violation|0
91784|NCT01125800|347708|P2|Phase II|Protocol Violation|0
91785|NCT01125800|347709|P1|Phase II|Protocol Violation|0
91786|NCT01125800|347705|P5|Phase I|Disease progression|0
91787|NCT01125800|347706|P4|Phase I|Disease progression|3
91788|NCT01125800|347707|P3|Phase I|Disease progression|1
91789|NCT01125800|347708|P2|Phase I|Disease progression|4
91790|NCT01125800|347709|P1|Phase I|Disease progression|5
91791|NCT01125800|347705|P5|Phase I|Withdrawal by Subject|0
91792|NCT01125800|347706|P4|Phase I|Withdrawal by Subject|0
91793|NCT01125800|347707|P3|Phase I|Withdrawal by Subject|1
91794|NCT01125800|347708|P2|Phase I|Withdrawal by Subject|0
91795|NCT01125800|347709|P1|Phase I|Withdrawal by Subject|0
91796|NCT01125800|347705|P5|Phase I|Administrative problems|0
91797|NCT01125800|347706|P4|Phase I|Administrative problems|0
91798|NCT01125800|347707|P3|Phase I|Administrative problems|0
91799|NCT01125800|347708|P2|Phase I|Administrative problems|0
91800|NCT01125800|347709|P1|Phase I|Administrative problems|1
91801|NCT01125800|347705|P5|Phase I|Adverse Event|0
91802|NCT01125800|347706|P4|Phase I|Adverse Event|7
91803|NCT01125800|347707|P3|Phase I|Adverse Event|1
91804|NCT01125800|347708|P2|Phase I|Adverse Event|2
91805|NCT01125800|347709|P1|Phase I|Adverse Event|2
91806|NCT01125800|347705|P5|Phase I|Protocol Violation|0
91807|NCT01125800|347706|P4|Phase I|Protocol Violation|1
91808|NCT01125800|347707|P3|Phase I|Protocol Violation|1
91809|NCT01125800|347708|P2|Phase I|Protocol Violation|3
91810|NCT01125800|347709|P1|Phase I|Protocol Violation|0
91811|NCT01125748|347775|P2|Overall Study|Patient Decision to Withdraw|4
91812|NCT01125748|347776|P1|Overall Study|Patient Decision to Withdraw|2
91813|NCT01125748|347775|P2|Overall Study|Physician Decision|7
91814|NCT01125748|347776|P1|Overall Study|Physician Decision|8
91815|NCT01125748|347775|P2|Overall Study|Lost to Follow-up|1
91816|NCT01125748|347776|P1|Overall Study|Lost to Follow-up|0
91817|NCT01125748|347775|P2|Overall Study|Adverse Event|2
91818|NCT01125748|347776|P1|Overall Study|Adverse Event|0
91819|NCT01125722|347786|P2|Overall Study|Lost to Follow-up|0
91820|NCT01125722|347787|P1|Overall Study|Lost to Follow-up|1
91821|NCT01125722|347786|P2|Overall Study|Withdrawal by Subject|1
91822|NCT01125722|347787|P1|Overall Study|Withdrawal by Subject|2
91823|NCT01125566|347834|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|4
91824|NCT01125566|347835|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
91825|NCT01125566|347836|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
91826|NCT01125566|347834|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|20
91827|NCT01125566|347835|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
91828|NCT01125566|347836|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
91829|NCT01125566|347834|P3|Patients Before the Switch (26Apr2013)|Other than those stated above|0
91830|NCT01125566|347835|P2|Patients Before the Switch (26Apr2013)|Other than those stated above|5
91831|NCT01125566|347836|P1|Patients Before the Switch (26Apr2013)|Other than those stated above|23
91832|NCT01125566|347834|P3|Patients Before the Switch (26Apr2013)|Not treated|0
91833|NCT01125566|347835|P2|Patients Before the Switch (26Apr2013)|Not treated|0
91834|NCT01125566|347836|P1|Patients Before the Switch (26Apr2013)|Not treated|2
91835|NCT01125566|347834|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
91836|NCT01125566|347835|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|21
91837|NCT01125566|347836|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|25
91838|NCT01125566|347834|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
91839|NCT01125566|347835|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|1
91840|NCT01125566|347836|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
91841|NCT01125566|347834|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
91842|NCT01125566|347835|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
91843|NCT01125566|347836|P1|Patients Before the Switch (26Apr2013)|Adverse Event|24
91844|NCT01125566|347834|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
91845|NCT01125566|347835|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|4
91846|NCT01125566|347836|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|5
91847|NCT01125566|347834|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
91848|NCT01125566|347835|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|100
91849|NCT01125566|347836|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|181
91850|NCT01125514|347849|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
91851|NCT01125514|347849|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
91852|NCT01125514|347849|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
91853|NCT01125514|347849|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
91854|NCT01125514|347849|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
91855|NCT01125514|347849|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
91856|NCT01125189|347949|P3|Follow up Period|Other reasons|5
91857|NCT01125189|347950|P2|Follow up Period|Other reasons|4
91858|NCT01125189|347951|P1|Follow up Period|Other reasons|4
91859|NCT01125189|347949|P3|Follow up Period|Lost to Follow-up|6
91860|NCT01125189|347950|P2|Follow up Period|Lost to Follow-up|9
91861|NCT01125189|347951|P1|Follow up Period|Lost to Follow-up|12
91862|NCT01125189|347949|P3|Follow up Period|Death|0
91863|NCT01125189|347950|P2|Follow up Period|Death|0
91864|NCT01125189|347951|P1|Follow up Period|Death|1
91865|NCT01125189|347949|P3|Follow up Period|Withdrawal by Subject|5
91866|NCT01125189|347950|P2|Follow up Period|Withdrawal by Subject|2
91867|NCT01125189|347951|P1|Follow up Period|Withdrawal by Subject|3
91868|NCT01125189|347949|P3|Treatment Period|Completed 24 week treatment period only|2
91869|NCT01125189|347950|P2|Treatment Period|Completed 24 week treatment period only|1
91870|NCT01125189|347951|P1|Treatment Period|Completed 24 week treatment period only|2
91871|NCT01125189|347949|P3|Treatment Period|Other reasons|0
91872|NCT01125189|347950|P2|Treatment Period|Other reasons|1
91873|NCT01125189|347951|P1|Treatment Period|Other reasons|1
91874|NCT01125189|347949|P3|Treatment Period|Participants requested to discontinue|4
91875|NCT01125189|347950|P2|Treatment Period|Participants requested to discontinue|3
91876|NCT01125189|347951|P1|Treatment Period|Participants requested to discontinue|1
91877|NCT01125189|347949|P3|Treatment Period|Poor compliance/noncompliance|0
91878|NCT01125189|347950|P2|Treatment Period|Poor compliance/noncompliance|1
91879|NCT01125189|347951|P1|Treatment Period|Poor compliance/noncompliance|0
91880|NCT01125189|347949|P3|Treatment Period|Lost to Follow-up|1
91881|NCT01125189|347950|P2|Treatment Period|Lost to Follow-up|2
91882|NCT01125189|347951|P1|Treatment Period|Lost to Follow-up|1
91883|NCT01125189|347949|P3|Treatment Period|Death|0
91884|NCT01125189|347950|P2|Treatment Period|Death|0
91885|NCT01125189|347951|P1|Treatment Period|Death|1
91886|NCT01125189|347949|P3|Treatment Period|Withdrawal by Subject|1
91887|NCT01125189|347950|P2|Treatment Period|Withdrawal by Subject|1
91888|NCT01125189|347951|P1|Treatment Period|Withdrawal by Subject|3
91889|NCT01125189|347949|P3|Treatment Period|Adverse Event|8
91890|NCT01125189|347950|P2|Treatment Period|Adverse Event|8
91891|NCT01125189|347951|P1|Treatment Period|Adverse Event|7
91892|NCT01125189|347949|P3|Treatment Period|Lack of Efficacy|25
91893|NCT01125189|347950|P2|Treatment Period|Lack of Efficacy|18
91894|NCT01125189|347951|P1|Treatment Period|Lack of Efficacy|15
91895|NCT01124916|348005|P2|Overall Study|Lost to Follow-up|2
91896|NCT01124916|348006|P1|Overall Study|Lost to Follow-up|3
91897|NCT01124864|348020|P6|Overall Study|Protocol Violation|0
91898|NCT01124864|348021|P5|Overall Study|Protocol Violation|1
91899|NCT01124864|348022|P4|Overall Study|Protocol Violation|0
91900|NCT01124864|348023|P3|Overall Study|Protocol Violation|0
91901|NCT01124864|348024|P2|Overall Study|Protocol Violation|0
91902|NCT01124864|348025|P1|Overall Study|Protocol Violation|1
91903|NCT01124864|348020|P6|Overall Study|Lost to Follow-up|0
91904|NCT01124864|348021|P5|Overall Study|Lost to Follow-up|0
91905|NCT01124864|348022|P4|Overall Study|Lost to Follow-up|1
91906|NCT01124864|348023|P3|Overall Study|Lost to Follow-up|0
91907|NCT01124864|348024|P2|Overall Study|Lost to Follow-up|1
91908|NCT01124864|348025|P1|Overall Study|Lost to Follow-up|1
91909|NCT01124864|348020|P6|Overall Study|Withdrawal by Subject|1
91910|NCT01124864|348021|P5|Overall Study|Withdrawal by Subject|2
91911|NCT01124864|348022|P4|Overall Study|Withdrawal by Subject|0
91912|NCT01124864|348023|P3|Overall Study|Withdrawal by Subject|4
91913|NCT01124864|348024|P2|Overall Study|Withdrawal by Subject|3
91914|NCT01124864|348025|P1|Overall Study|Withdrawal by Subject|2
91915|NCT01124864|348020|P6|Overall Study|Death|0
91916|NCT01124864|348021|P5|Overall Study|Death|1
91917|NCT01124864|348022|P4|Overall Study|Death|2
91918|NCT01124864|348023|P3|Overall Study|Death|6
91919|NCT01124864|348024|P2|Overall Study|Death|9
91920|NCT01124864|348025|P1|Overall Study|Death|6
91921|NCT01124864|348020|P6|Overall Study|Follow up phase competed as per protocol|2
91922|NCT01124864|348021|P5|Overall Study|Follow up phase competed as per protocol|26
91923|NCT01124864|348022|P4|Overall Study|Follow up phase competed as per protocol|18
91924|NCT01124864|348023|P3|Overall Study|Follow up phase competed as per protocol|24
91925|NCT01124864|348024|P2|Overall Study|Follow up phase competed as per protocol|22
91926|NCT01124864|348025|P1|Overall Study|Follow up phase competed as per protocol|18
91927|NCT01124838|348059|P2|Overall Study|Lost to Follow-up|0
91928|NCT01124838|348060|P1|Overall Study|Lost to Follow-up|2
91929|NCT01124838|348059|P2|Overall Study|Withdrawal by Subject|2
91930|NCT01124838|348060|P1|Overall Study|Withdrawal by Subject|3
91931|NCT01124838|348059|P2|Overall Study|Lack of Efficacy|0
91932|NCT01124838|348060|P1|Overall Study|Lack of Efficacy|2
91933|NCT01124838|348059|P2|Overall Study|Adverse Event|11
91934|NCT01124838|348060|P1|Overall Study|Adverse Event|7
91935|NCT01124838|348059|P2|Overall Study|Miscellaneous|2
91936|NCT01124838|348060|P1|Overall Study|Miscellaneous|4
91937|NCT01124643|348127|P1|Overall Study|Death|1
91938|NCT01124617|348141|P2|Overall Study|Other|1
91939|NCT01124617|348142|P1|Overall Study|Other|2
91940|NCT01124617|348141|P2|Overall Study|Withdrawal by Subject|1
91941|NCT01124617|348142|P1|Overall Study|Withdrawal by Subject|9
91942|NCT01124617|348141|P2|Overall Study|Protocol Violation|1
91943|NCT01124617|348142|P1|Overall Study|Protocol Violation|1
91944|NCT01124617|348141|P2|Overall Study|Lack of Efficacy|1
91945|NCT01124617|348142|P1|Overall Study|Lack of Efficacy|2
91946|NCT01124617|348141|P2|Overall Study|Adverse Event|2
91947|NCT01124617|348142|P1|Overall Study|Adverse Event|5
91948|NCT01124604|348174|P2|Overall Study|Disease Progression|1
91949|NCT01124604|348175|P1|Overall Study|Disease Progression|0
91950|NCT01124604|348174|P2|Overall Study|Withdrawal by Subject|0
91951|NCT01124604|348175|P1|Overall Study|Withdrawal by Subject|4
91952|NCT01124604|348174|P2|Overall Study|Lack of Efficacy|0
91953|NCT01124604|348175|P1|Overall Study|Lack of Efficacy|1
91954|NCT01124604|348174|P2|Overall Study|Adverse Event|1
91955|NCT01124604|348175|P1|Overall Study|Adverse Event|10
91956|NCT01124448|348214|P2|Overall Study|Protocol Violation|0
91957|NCT01124448|348215|P1|Overall Study|Protocol Violation|2
91958|NCT01124448|348214|P2|Overall Study|Lost to Follow-up|3
91959|NCT01124448|348215|P1|Overall Study|Lost to Follow-up|0
91960|NCT01124422|348223|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
91961|NCT01124422|348224|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
91962|NCT01124422|348225|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
91963|NCT01124422|348223|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
91964|NCT01124422|348224|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
91965|NCT01124422|348225|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
91966|NCT01124422|348223|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
91967|NCT01124422|348224|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
91968|NCT01124422|348225|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
91969|NCT01124422|348223|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
91970|NCT01124422|348224|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
91971|NCT01124422|348225|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
91972|NCT01124422|348223|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
91973|NCT01124422|348224|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
91974|NCT01124422|348225|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
91975|NCT01124422|348223|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
91976|NCT01124422|348224|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
91977|NCT01124422|348225|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
91978|NCT01124422|348223|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
91979|NCT01124422|348224|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
91980|NCT01124422|348225|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
91981|NCT01124422|348223|P3|4-Week Open-label Run-in Phase|Physician Decision|0
91982|NCT01124422|348224|P2|4-Week Open-label Run-in Phase|Physician Decision|0
91983|NCT01124422|348225|P1|4-Week Open-label Run-in Phase|Physician Decision|4
91984|NCT01124422|348223|P3|4-Week Open-label Run-in Phase|Adverse Event|0
91985|NCT01124422|348224|P2|4-Week Open-label Run-in Phase|Adverse Event|0
91986|NCT01124422|348225|P1|4-Week Open-label Run-in Phase|Adverse Event|7
91987|NCT01124422|348223|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
91988|NCT01124422|348224|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
91989|NCT01124422|348225|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
91990|NCT01124292|348295|P3|Overall Study|piercing track closed|1
91991|NCT01124292|348296|P2|Overall Study|piercing track closed|2
91992|NCT01124292|348297|P1|Overall Study|piercing track closed|0
91993|NCT01124292|348295|P3|Overall Study|medical issue unrelated to the study|2
91994|NCT01124292|348296|P2|Overall Study|medical issue unrelated to the study|0
91995|NCT01124292|348297|P1|Overall Study|medical issue unrelated to the study|0
91996|NCT01124292|348295|P3|Overall Study|Withdrawal by Subject|2
91997|NCT01124292|348296|P2|Overall Study|Withdrawal by Subject|6
91998|NCT01124292|348297|P1|Overall Study|Withdrawal by Subject|0
91999|NCT01124292|348295|P3|Overall Study|Physician Decision|2
92000|NCT01124292|348296|P2|Overall Study|Physician Decision|3
92001|NCT01124292|348297|P1|Overall Study|Physician Decision|0
92002|NCT01124292|348295|P3|Overall Study|Lost to Follow-up|3
92003|NCT01124292|348296|P2|Overall Study|Lost to Follow-up|4
92004|NCT01124292|348297|P1|Overall Study|Lost to Follow-up|2
92005|NCT01124175|348368|P2|Washout of 7 Days|Withdrawal by Subject|2
92006|NCT01124175|348369|P1|Washout of 7 Days|Withdrawal by Subject|0
92007|NCT01124162|348387|P2|Washout of 7 Days|Withdrawal by Subject|0
92008|NCT01124162|348388|P1|Washout of 7 Days|Withdrawal by Subject|1
92009|NCT01124162|348387|P2|First Intervention|Adverse Event|0
92010|NCT01124162|348388|P1|First Intervention|Adverse Event|2
92011|NCT01124149|348404|P1|Maintenance Phase|Non-compliance|1
92012|NCT01124149|348404|P1|Maintenance Phase|Coordinator error|1
92013|NCT01124149|348404|P1|Maintenance Phase|Protocol Violation|5
92014|NCT01124149|348404|P1|Maintenance Phase|Withdrawal by Subject|10
92015|NCT01124149|348404|P1|Maintenance Phase|Lost to Follow-up|15
92016|NCT01124149|348404|P1|Maintenance Phase|Adverse Event|24
92017|NCT01124149|348404|P1|Maintenance Phase|Lack of Efficacy|40
92018|NCT01124149|348404|P1|Acute Phase|Sponsor decision|1
92019|NCT01124149|348404|P1|Acute Phase|Travelling to another country|1
92020|NCT01124149|348404|P1|Acute Phase|Low hemoglobin|1
92021|NCT01124149|348404|P1|Acute Phase|Non-compliance|1
92022|NCT01124149|348404|P1|Acute Phase|UC symptoms not ameliorated|1
92023|NCT01124149|348404|P1|Acute Phase|Sponsor request|1
92024|NCT01124149|348404|P1|Acute Phase|Prolonged antibiotic therapy|1
92025|NCT01124149|348404|P1|Acute Phase|Lost to Follow-up|2
92026|NCT01124149|348404|P1|Acute Phase|Protocol Violation|14
92027|NCT01124149|348404|P1|Acute Phase|Lack of Efficacy|17
92028|NCT01124149|348404|P1|Acute Phase|Adverse Event|21
92029|NCT01124149|348404|P1|Acute Phase|Withdrawal by Subject|22
92030|NCT01124097|348424|P4|Overall Study|Physician Decision|0
92031|NCT01124097|348425|P3|Overall Study|Physician Decision|0
92032|NCT01124097|348426|P2|Overall Study|Physician Decision|1
92033|NCT01124097|348427|P1|Overall Study|Physician Decision|2
92034|NCT01124097|348424|P4|Overall Study|Protocol Violation|1
92035|NCT01124097|348425|P3|Overall Study|Protocol Violation|2
92036|NCT01124097|348426|P2|Overall Study|Protocol Violation|0
92037|NCT01124097|348427|P1|Overall Study|Protocol Violation|2
92038|NCT01124097|348424|P4|Overall Study|Adverse Event|7
92039|NCT01124097|348425|P3|Overall Study|Adverse Event|15
92040|NCT01124097|348426|P2|Overall Study|Adverse Event|15
92041|NCT01124097|348427|P1|Overall Study|Adverse Event|24
92042|NCT01124097|348424|P4|Overall Study|Lack of Efficacy|3
92043|NCT01124097|348425|P3|Overall Study|Lack of Efficacy|1
92044|NCT01124097|348426|P2|Overall Study|Lack of Efficacy|3
92045|NCT01124097|348427|P1|Overall Study|Lack of Efficacy|2
92046|NCT01124097|348424|P4|Overall Study|Withdrawal by Subject|3
92047|NCT01124097|348425|P3|Overall Study|Withdrawal by Subject|2
92048|NCT01124097|348426|P2|Overall Study|Withdrawal by Subject|3
92049|NCT01124097|348427|P1|Overall Study|Withdrawal by Subject|4
92050|NCT01124045|348439|P2|Overall Study|Physician Decision|2
92051|NCT01124045|348440|P1|Overall Study|Physician Decision|0
92052|NCT01124045|348439|P2|Overall Study|Lost to Follow-up|1
92053|NCT01124045|348440|P1|Overall Study|Lost to Follow-up|0
92054|NCT01124006|348473|P3|Overall Study|Other|1
92055|NCT01124006|348474|P2|Overall Study|Other|0
92056|NCT01124006|348475|P1|Overall Study|Other|0
92057|NCT01124006|348473|P3|Overall Study|Lost to Follow-up|1
92058|NCT01124006|348474|P2|Overall Study|Lost to Follow-up|0
92059|NCT01124006|348475|P1|Overall Study|Lost to Follow-up|1
92060|NCT01124006|348473|P3|Overall Study|Withdrawal by Subject|0
92061|NCT01124006|348474|P2|Overall Study|Withdrawal by Subject|2
92062|NCT01124006|348475|P1|Overall Study|Withdrawal by Subject|2
92063|NCT01123980|348503|P2|Overall Study|Unclassified|7
92064|NCT01123980|348504|P1|Overall Study|Unclassified|6
92065|NCT01123980|348503|P2|Overall Study|Withdrawal by Subject|3
92066|NCT01123980|348504|P1|Overall Study|Withdrawal by Subject|5
92067|NCT01123980|348503|P2|Overall Study|Protocol Violation|6
92068|NCT01123980|348504|P1|Overall Study|Protocol Violation|6
92069|NCT01123980|348503|P2|Overall Study|Lost to Follow-up|6
92070|NCT01123980|348504|P1|Overall Study|Lost to Follow-up|0
92071|NCT01123980|348503|P2|Overall Study|Physician Decision|1
92072|NCT01123980|348504|P1|Overall Study|Physician Decision|0
92073|NCT01123980|348503|P2|Overall Study|Lack of Efficacy|0
92074|NCT01123980|348504|P1|Overall Study|Lack of Efficacy|1
92075|NCT01123980|348503|P2|Overall Study|Adverse Event|1
92076|NCT01123980|348504|P1|Overall Study|Adverse Event|1
92077|NCT01123941|348524|P2|Overall Study|Lost to Follow-up|1
92078|NCT01123941|348525|P1|Overall Study|Lost to Follow-up|2
92079|NCT01123889|348560|P2|Overall Study|Lost to Follow-up|1
92080|NCT01123889|348561|P1|Overall Study|Lost to Follow-up|3
92081|NCT01123850|348571|P1|Overall Study|Slow enrollment|45
92082|NCT01123642|348576|P1|Overall Study|ineligible at baseline assessment|36
92083|NCT01123642|348576|P1|Overall Study|Withdrawal by Subject|9
92084|NCT01123642|348576|P1|Overall Study|Lost to Follow-up|23
92085|NCT01123395|348589|P2|Washout Period of 14 Days|Withdrawal by Subject|1
92086|NCT01123395|348590|P1|Washout Period of 14 Days|Withdrawal by Subject|0
92087|NCT01123382|348602|P2|Overall Study|Lost to Follow-up|2
92088|NCT01123382|348603|P1|Overall Study|Lost to Follow-up|1
92089|NCT01123382|348602|P2|Overall Study|Withdrawal by Subject|4
92090|NCT01123382|348603|P1|Overall Study|Withdrawal by Subject|1
92091|NCT01123356|348625|P1|Overall Study|Withdrawal by Subject|1
92092|NCT01123356|348625|P1|Overall Study|Lack of Efficacy|4
92093|NCT01123356|348625|P1|Overall Study|Adverse Event|2
92094|NCT01123200|348633|P1|Overall Study|Withdrawal by Subject|1
92095|NCT01123161|348640|P2|Overall Study|Withdrawal by Subject|0
92096|NCT01123161|348641|P1|Overall Study|Withdrawal by Subject|1
92097|NCT01123161|348640|P2|Overall Study|Lost to Follow-up|0
92098|NCT01123161|348641|P1|Overall Study|Lost to Follow-up|1
92099|NCT01123148|348659|P1|Overall Study|Didn't meet milestone criteria|1
92100|NCT01123148|348659|P1|Overall Study|Coughing caused unacceptable EEG quality|1
92101|NCT01123083|348665|P2|Overall Study|Participant/legal representative request|3
92102|NCT01123083|348666|P1|Overall Study|Participant/legal representative request|7
92103|NCT01123083|348665|P2|Overall Study|Withdrew for another reason not covered|1
92104|NCT01123083|348666|P1|Overall Study|Withdrew for another reason not covered|0
92105|NCT01123083|348665|P2|Overall Study|Adverse Event|0
92106|NCT01123083|348666|P1|Overall Study|Adverse Event|1
92107|NCT01123083|348665|P2|Overall Study|Lost to Follow-up|6
92108|NCT01123083|348666|P1|Overall Study|Lost to Follow-up|2
92109|NCT01123083|348665|P2|Overall Study|Administrative reasons|4
92110|NCT01123083|348666|P1|Overall Study|Administrative reasons|0
92111|NCT01123083|348665|P2|Overall Study|Investigator recommendation|1
92112|NCT01123083|348666|P1|Overall Study|Investigator recommendation|1
92113|NCT01122927|348690|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
92114|NCT01122927|348691|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
92115|NCT01122927|348690|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
92116|NCT01122927|348691|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
92117|NCT01122927|348690|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
92118|NCT01122927|348691|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
92119|NCT01122927|348690|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
92120|NCT01122927|348691|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
92121|NCT01122927|348690|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
92122|NCT01122927|348691|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
92123|NCT01122927|348690|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
92124|NCT01122927|348691|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
92125|NCT01122927|348690|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
92126|NCT01122927|348691|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
92127|NCT01122927|348690|P2|Period 1 - Conversion Phase|Protocol Deviation|0
92128|NCT01122927|348691|P1|Period 1 - Conversion Phase|Protocol Deviation|1
92129|NCT01122927|348690|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
92130|NCT01122927|348691|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
92131|NCT01122927|348690|P2|Period 1 - Conversion Phase|Physician Decision|0
92132|NCT01122927|348691|P1|Period 1 - Conversion Phase|Physician Decision|2
92133|NCT01122927|348690|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
92134|NCT01122927|348691|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
92135|NCT01122927|348690|P2|Period 1 - Conversion Phase|Adverse Event|0
92136|NCT01122927|348691|P1|Period 1 - Conversion Phase|Adverse Event|3
92137|NCT01122862|348743|P3|Period 2|Adverse Event|1
92138|NCT01122862|348744|P2|Period 2|Adverse Event|0
92139|NCT01122862|348745|P1|Period 2|Adverse Event|0
92140|NCT01122862|348743|P3|Period 1|Protocol Violation|0
92141|NCT01122862|348744|P2|Period 1|Protocol Violation|1
92142|NCT01122862|348745|P1|Period 1|Protocol Violation|0
92143|NCT01122680|348851|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
92144|NCT01122680|348852|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
92145|NCT01122680|348853|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
92146|NCT01122680|348854|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
92147|NCT01122680|348851|P4|Period 3 (4 Weeks)|Adverse Event|0
92148|NCT01122680|348852|P3|Period 3 (4 Weeks)|Adverse Event|0
92149|NCT01122680|348853|P2|Period 3 (4 Weeks)|Adverse Event|0
92150|NCT01122680|348854|P1|Period 3 (4 Weeks)|Adverse Event|1
92151|NCT01122680|348851|P4|Period 2 (4 Weeks)|Other|0
92152|NCT01122680|348852|P3|Period 2 (4 Weeks)|Other|0
92153|NCT01122680|348853|P2|Period 2 (4 Weeks)|Other|0
92154|NCT01122680|348854|P1|Period 2 (4 Weeks)|Other|1
92155|NCT01122680|348851|P4|Period 2 (4 Weeks)|Protocol Violation|1
92156|NCT01122680|348852|P3|Period 2 (4 Weeks)|Protocol Violation|0
92157|NCT01122680|348853|P2|Period 2 (4 Weeks)|Protocol Violation|0
92158|NCT01122680|348854|P1|Period 2 (4 Weeks)|Protocol Violation|0
92159|NCT01122680|348851|P4|Period 1 (4 Weeks)|Other|0
92160|NCT01122680|348852|P3|Period 1 (4 Weeks)|Other|0
92161|NCT01122680|348853|P2|Period 1 (4 Weeks)|Other|1
92162|NCT01122680|348854|P1|Period 1 (4 Weeks)|Other|1
92163|NCT01122680|348851|P4|Period 1 (4 Weeks)|Protocol Violation|0
92164|NCT01122680|348852|P3|Period 1 (4 Weeks)|Protocol Violation|0
92165|NCT01122680|348853|P2|Period 1 (4 Weeks)|Protocol Violation|0
92166|NCT01122680|348854|P1|Period 1 (4 Weeks)|Protocol Violation|1
92167|NCT01122680|348851|P4|Period 1 (4 Weeks)|Adverse Event|0
92168|NCT01122680|348852|P3|Period 1 (4 Weeks)|Adverse Event|0
92169|NCT01122680|348853|P2|Period 1 (4 Weeks)|Adverse Event|0
92170|NCT01122680|348854|P1|Period 1 (4 Weeks)|Adverse Event|1
92171|NCT01122576|348919|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
92172|NCT01122576|348920|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
92173|NCT01122576|348921|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
92174|NCT01122576|348919|P3|Post-Cataract Surgery|Central Macular Edema|1
92175|NCT01122576|348920|P2|Post-Cataract Surgery|Central Macular Edema|0
92176|NCT01122576|348921|P1|Post-Cataract Surgery|Central Macular Edema|0
92177|NCT01122576|348919|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
92178|NCT01122576|348920|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
92179|NCT01122576|348921|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
92180|NCT01122394|349075|P2|Overall Study|Adverse Event|1
92181|NCT01122394|349076|P1|Overall Study|Adverse Event|0
92182|NCT01122394|349075|P2|Overall Study|Lost to Follow-up|2
92183|NCT01122394|349076|P1|Overall Study|Lost to Follow-up|2
92184|NCT01122394|349075|P2|Overall Study|Withdrawal by Subject|1
92185|NCT01122394|349076|P1|Overall Study|Withdrawal by Subject|1
92186|NCT01122381|349092|P2|Overall Study|study terminated early|1
92187|NCT01122381|349093|P1|Overall Study|study terminated early|0
92188|NCT01122264|349102|P3|Overall Study|Lack of Efficacy|1
92189|NCT01122264|349103|P2|Overall Study|Lack of Efficacy|1
92190|NCT01122264|349104|P1|Overall Study|Lack of Efficacy|3
92191|NCT01122264|349102|P3|Overall Study|Physician Decision|1
92192|NCT01122264|349103|P2|Overall Study|Physician Decision|1
92193|NCT01122264|349104|P1|Overall Study|Physician Decision|3
92194|NCT01122264|349102|P3|Overall Study|Withdrawal by Subject|16
92195|NCT01122264|349103|P2|Overall Study|Withdrawal by Subject|6
92196|NCT01122264|349104|P1|Overall Study|Withdrawal by Subject|6
92197|NCT01122264|349102|P3|Overall Study|Protocol Violation|9
92198|NCT01122264|349103|P2|Overall Study|Protocol Violation|7
92199|NCT01122264|349104|P1|Overall Study|Protocol Violation|7
92200|NCT01122264|349102|P3|Overall Study|Entry Criteria Not Met|0
92201|NCT01122264|349103|P2|Overall Study|Entry Criteria Not Met|0
92202|NCT01122264|349104|P1|Overall Study|Entry Criteria Not Met|1
92203|NCT01122264|349102|P3|Overall Study|Lost to Follow-up|13
92204|NCT01122264|349103|P2|Overall Study|Lost to Follow-up|9
92205|NCT01122264|349104|P1|Overall Study|Lost to Follow-up|5
92206|NCT01122264|349102|P3|Overall Study|Death|0
92207|NCT01122264|349103|P2|Overall Study|Death|0
92208|NCT01122264|349104|P1|Overall Study|Death|1
92209|NCT01122264|349102|P3|Overall Study|Adverse Event|7
92210|NCT01122264|349103|P2|Overall Study|Adverse Event|5
92211|NCT01122264|349104|P1|Overall Study|Adverse Event|6
92212|NCT01121991|349430|P1|Overall Study|No Fertilization|1
92213|NCT01121991|349430|P1|Overall Study|No Oocytes Retrieved|3
92214|NCT01121991|349430|P1|Overall Study|Lack of Ovarian Response|2
92215|NCT01121926|349455|P2|Washout Period|Positive pregnancy test|1
92216|NCT01121926|349456|P1|Washout Period|Positive pregnancy test|0
92217|NCT01121926|349455|P2|Washout Period|Adverse Event|1
92218|NCT01121926|349456|P1|Washout Period|Adverse Event|0
92219|NCT01121926|349455|P2|First Intervention Period|Adverse Event|0
92220|NCT01121926|349456|P1|First Intervention Period|Adverse Event|1
92221|NCT01121913|349474|P4|Third Washout Period|Adverse Event|0
92222|NCT01121913|349475|P3|Third Washout Period|Adverse Event|0
92223|NCT01121913|349476|P2|Third Washout Period|Adverse Event|0
92224|NCT01121913|349477|P1|Third Washout Period|Adverse Event|1
92225|NCT01121913|349474|P4|Second Washout Period|Withdrawal by Subject|0
92226|NCT01121913|349475|P3|Second Washout Period|Withdrawal by Subject|1
92227|NCT01121913|349476|P2|Second Washout Period|Withdrawal by Subject|0
92228|NCT01121913|349477|P1|Second Washout Period|Withdrawal by Subject|0
92229|NCT01121913|349474|P4|Second Intervention Period|Adverse Event|0
92230|NCT01121913|349475|P3|Second Intervention Period|Adverse Event|1
92231|NCT01121913|349476|P2|Second Intervention Period|Adverse Event|0
92232|NCT01121913|349477|P1|Second Intervention Period|Adverse Event|0
92233|NCT01121913|349474|P4|First Washout Period|Withdrawal by Subject|0
92234|NCT01121913|349475|P3|First Washout Period|Withdrawal by Subject|0
92235|NCT01121913|349476|P2|First Washout Period|Withdrawal by Subject|0
92236|NCT01121913|349477|P1|First Washout Period|Withdrawal by Subject|1
92237|NCT01121913|349474|P4|First Intervention Period|Adverse Event|0
92238|NCT01121913|349475|P3|First Intervention Period|Adverse Event|1
92239|NCT01121913|349476|P2|First Intervention Period|Adverse Event|0
92240|NCT01121913|349477|P1|First Intervention Period|Adverse Event|0
92241|NCT01121900|349507|P2|Washout Period of 7 Days|Withdrawal by Subject|1
92242|NCT01121900|349508|P1|Washout Period of 7 Days|Withdrawal by Subject|0
92243|NCT01121900|349507|P2|First Intervention Period|Adverse Event|1
92244|NCT01121900|349508|P1|First Intervention Period|Adverse Event|1
92245|NCT01121757|349528|P2|Combination|Disease Progression|0
92246|NCT01121757|349529|P1|Combination|Disease Progression|2
92247|NCT01121757|349528|P2|Combination|Physician Decision|1
92248|NCT01121757|349529|P1|Combination|Physician Decision|0
92249|NCT01121757|349528|P2|First Drug|Disease Progression|2
92250|NCT01121757|349529|P1|First Drug|Disease Progression|0
92251|NCT01121757|349528|P2|First Drug|Death|0
92252|NCT01121757|349529|P1|First Drug|Death|1
92253|NCT01121666|349545|P2|Overall Study|Protocol Violation|10
92254|NCT01121666|349546|P1|Overall Study|Protocol Violation|29
92255|NCT01121575|349602|P6|Overall Study|Death|1
92256|NCT01121575|349603|P5|Overall Study|Death|7
92257|NCT01121575|349604|P4|Overall Study|Death|1
92258|NCT01121575|349605|P3|Overall Study|Death|0
92259|NCT01121575|349606|P2|Overall Study|Death|0
92260|NCT01121575|349607|P1|Overall Study|Death|6
92261|NCT01121575|349602|P6|Overall Study|Unspecified Reasons|10
92262|NCT01121575|349603|P5|Overall Study|Unspecified Reasons|13
92263|NCT01121575|349604|P4|Overall Study|Unspecified Reasons|5
92264|NCT01121575|349605|P3|Overall Study|Unspecified Reasons|7
92265|NCT01121575|349606|P2|Overall Study|Unspecified Reasons|6
92266|NCT01121575|349607|P1|Overall Study|Unspecified Reasons|8
92267|NCT01121575|349602|P6|Overall Study|Participant Refused Further Follow-Up|1
92268|NCT01121575|349603|P5|Overall Study|Participant Refused Further Follow-Up|5
92269|NCT01121575|349604|P4|Overall Study|Participant Refused Further Follow-Up|0
92270|NCT01121575|349605|P3|Overall Study|Participant Refused Further Follow-Up|0
92271|NCT01121575|349606|P2|Overall Study|Participant Refused Further Follow-Up|0
92272|NCT01121575|349607|P1|Overall Study|Participant Refused Further Follow-Up|0
92273|NCT01121562|349731|P1|Overall Study|Met study discontinuation criteria|1
92274|NCT01121562|349731|P1|Overall Study|Sponsor Decision|1
92275|NCT01121562|349731|P1|Overall Study|Adverse Event|1
92276|NCT01121562|349731|P1|Overall Study|Withdrawal by Subject|1
92277|NCT01121562|349731|P1|Overall Study|Objective progression or relapse|8
92278|NCT01121549|349740|P1|Overall Study|Other|58
92279|NCT01121549|349740|P1|Overall Study|Withdrawal by Subject|16
92280|NCT01121549|349740|P1|Overall Study|Protocol Violation|33
92281|NCT01121549|349740|P1|Overall Study|Pregnancy|1
92282|NCT01121549|349740|P1|Overall Study|Study terminated by sponsor|197
92283|NCT01121549|349740|P1|Overall Study|Did not meet entrance criteria|9
92284|NCT01121549|349740|P1|Overall Study|Lost to Follow-up|12
92285|NCT01121549|349740|P1|Overall Study|Lack of Efficacy|11
92286|NCT01121549|349740|P1|Overall Study|Adverse Event|10
92287|NCT01121536|349751|P1|Overall Study|Not specified|118
92288|NCT01121536|349751|P1|Overall Study|Lost to Follow-up|39
92289|NCT01121536|349751|P1|Overall Study|Noncompliance with study procedures|9
92290|NCT01121536|349751|P1|Overall Study|Noncompliance with study medication|12
92291|NCT01121536|349751|P1|Overall Study|Protocol Violation|20
92292|NCT01121536|349751|P1|Overall Study|Withdrawal by Subject|65
92293|NCT01121536|349751|P1|Overall Study|Lack of Efficacy|35
92294|NCT01121536|349751|P1|Overall Study|Adverse Event|63
92295|NCT01121484|349772|P2|Overall Study|Randomized, not treated|4
92296|NCT01121484|349773|P1|Overall Study|Randomized, not treated|1
92297|NCT01121484|349772|P2|Overall Study|Other|3
92298|NCT01121484|349773|P1|Overall Study|Other|3
92299|NCT01121484|349772|P2|Overall Study|Discontinuation of study by sponsor|1
92300|NCT01121484|349773|P1|Overall Study|Discontinuation of study by sponsor|0
92301|NCT01121484|349772|P2|Overall Study|Withdrawal by Subject|7
92302|NCT01121484|349773|P1|Overall Study|Withdrawal by Subject|8
92303|NCT01121484|349772|P2|Overall Study|Protocol Violation|0
92304|NCT01121484|349773|P1|Overall Study|Protocol Violation|1
92305|NCT01121484|349772|P2|Overall Study|Physician Decision|3
92306|NCT01121484|349773|P1|Overall Study|Physician Decision|0
92307|NCT01121484|349772|P2|Overall Study|Lost to Follow-up|9
92308|NCT01121484|349773|P1|Overall Study|Lost to Follow-up|5
92309|NCT01121484|349772|P2|Overall Study|Lack of Efficacy|11
92310|NCT01121484|349773|P1|Overall Study|Lack of Efficacy|3
92311|NCT01121484|349772|P2|Overall Study|Adverse Event|5
92312|NCT01121484|349773|P1|Overall Study|Adverse Event|12
92313|NCT01121406|349791|P2|Overall Study|Not treated|0
92314|NCT01121406|349792|P1|Overall Study|Not treated|1
92315|NCT01121406|349791|P2|Overall Study|Reason other than specified above|6
92316|NCT01121406|349792|P1|Overall Study|Reason other than specified above|2
92317|NCT01121406|349791|P2|Overall Study|Refused continuation of study med.|2
92318|NCT01121406|349792|P1|Overall Study|Refused continuation of study med.|1
92319|NCT01121406|349791|P2|Overall Study|Lost to Follow-up|1
92320|NCT01121406|349792|P1|Overall Study|Lost to Follow-up|0
92321|NCT01121406|349791|P2|Overall Study|Non−compliant with protocol|2
92322|NCT01121406|349792|P1|Overall Study|Non−compliant with protocol|0
92323|NCT01121406|349791|P2|Overall Study|Other AE|10
92324|NCT01121406|349792|P1|Overall Study|Other AE|3
92325|NCT01121406|349791|P2|Overall Study|Wors. or AE of underlying cancer disease|6
92326|NCT01121406|349792|P1|Overall Study|Wors. or AE of underlying cancer disease|4
92327|NCT01121406|349791|P2|Overall Study|Progressive disease RECIST|28
92328|NCT01121406|349792|P1|Overall Study|Progressive disease RECIST|44
92329|NCT01121393|349842|P2|Overall Study|Not treated|9
92330|NCT01121393|349843|P1|Overall Study|Not treated|3
92331|NCT01121393|349842|P2|Overall Study|Refused cont. medication|7
92332|NCT01121393|349843|P1|Overall Study|Refused cont. medication|7
92333|NCT01121393|349842|P2|Overall Study|Lost to Follow-up|0
92334|NCT01121393|349843|P1|Overall Study|Lost to Follow-up|1
92335|NCT01121393|349842|P2|Overall Study|Non-compliant with protocol|3
92336|NCT01121393|349843|P1|Overall Study|Non-compliant with protocol|0
92337|NCT01121393|349842|P2|Overall Study|Other Adverse events|45
92338|NCT01121393|349843|P1|Overall Study|Other Adverse events|22
92339|NCT01121393|349842|P2|Overall Study|Progressive disease|20
92340|NCT01121393|349843|P1|Overall Study|Progressive disease|186
92341|NCT01121263|349888|P2|Overall Study|Withdrawal by Subject|1
92342|NCT01121263|349889|P1|Overall Study|Withdrawal by Subject|0
92343|NCT01121263|349888|P2|Overall Study|Lost to Follow-up|12
92344|NCT01121263|349889|P1|Overall Study|Lost to Follow-up|22
92345|NCT01121263|349888|P2|Overall Study|Death|2
92346|NCT01121263|349889|P1|Overall Study|Death|3
92347|NCT01121185|349935|P2|Overall Study|Not transplanted|0
92348|NCT01121185|349936|P1|Overall Study|Not transplanted|1
92349|NCT01121185|349935|P2|Overall Study|Not infused|1
92350|NCT01121185|349936|P1|Overall Study|Not infused|0
92351|NCT01121146|349970|P2|Overall Study|Lost to Follow-up|16
92352|NCT01121146|349971|P1|Overall Study|Lost to Follow-up|7
92353|NCT01121146|349970|P2|Overall Study|Adverse Event|11
92354|NCT01121146|349971|P1|Overall Study|Adverse Event|2
92355|NCT01121146|349970|P2|Overall Study|Death|15
92356|NCT01121146|349971|P1|Overall Study|Death|17
92357|NCT01120899|349992|P1|Overall Study|Withdrawal by Subject|3
92358|NCT01120782|350020|P1|Overall Study|Test article shipping error|11
92359|NCT01120717|350026|P2|Overall Study|Abnormal Test Procedure Result(s)|0
92360|NCT01120717|350027|P1|Overall Study|Abnormal Test Procedure Result(s)|1
92361|NCT01120717|350026|P2|Overall Study|Death|1
92362|NCT01120717|350027|P1|Overall Study|Death|3
92363|NCT01120717|350026|P2|Overall Study|Lost to Follow-up|3
92364|NCT01120717|350027|P1|Overall Study|Lost to Follow-up|2
92365|NCT01120717|350026|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
92366|NCT01120717|350027|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
92367|NCT01120717|350026|P2|Overall Study|Protocol Deviation|5
92368|NCT01120717|350027|P1|Overall Study|Protocol Deviation|2
92369|NCT01120717|350026|P2|Overall Study|Adverse Event|6
92370|NCT01120717|350027|P1|Overall Study|Adverse Event|10
92371|NCT01120717|350026|P2|Overall Study|Withdrawal by Subject|6
92372|NCT01120717|350027|P1|Overall Study|Withdrawal by Subject|11
92373|NCT01120691|350133|P3|Overall Study|Abnormal laboratory value(s)|4
92374|NCT01120691|350134|P2|Overall Study|Abnormal laboratory value(s)|3
92375|NCT01120691|350135|P1|Overall Study|Abnormal laboratory value(s)|1
92376|NCT01120691|350133|P3|Overall Study|Patient's inability to use the device|0
92377|NCT01120691|350134|P2|Overall Study|Patient's inability to use the device|1
92378|NCT01120691|350135|P1|Overall Study|Patient's inability to use the device|3
92379|NCT01120691|350133|P3|Overall Study|Abnormal test procedure result(s)|1
92380|NCT01120691|350134|P2|Overall Study|Abnormal test procedure result(s)|2
92381|NCT01120691|350135|P1|Overall Study|Abnormal test procedure result(s)|3
92382|NCT01120691|350133|P3|Overall Study|Lost to Follow-up|4
92383|NCT01120691|350134|P2|Overall Study|Lost to Follow-up|6
92384|NCT01120691|350135|P1|Overall Study|Lost to Follow-up|5
92385|NCT01120691|350133|P3|Overall Study|Protocol deviation|12
92386|NCT01120691|350134|P2|Overall Study|Protocol deviation|12
92387|NCT01120691|350135|P1|Overall Study|Protocol deviation|13
92388|NCT01120691|350133|P3|Overall Study|Administrative problems|9
92389|NCT01120691|350134|P2|Overall Study|Administrative problems|8
92390|NCT01120691|350135|P1|Overall Study|Administrative problems|15
92391|NCT01120691|350133|P3|Overall Study|Unsatisfactory therapeutic effect|38
92392|NCT01120691|350134|P2|Overall Study|Unsatisfactory therapeutic effect|32
92393|NCT01120691|350135|P1|Overall Study|Unsatisfactory therapeutic effect|18
92394|NCT01120691|350133|P3|Overall Study|Death|24
92395|NCT01120691|350134|P2|Overall Study|Death|22
92396|NCT01120691|350135|P1|Overall Study|Death|21
92397|NCT01120691|350133|P3|Overall Study|Subject withdrew consent|44
92398|NCT01120691|350134|P2|Overall Study|Subject withdrew consent|50
92399|NCT01120691|350135|P1|Overall Study|Subject withdrew consent|33
92400|NCT01120691|350133|P3|Overall Study|Adverse Event|47
92401|NCT01120691|350134|P2|Overall Study|Adverse Event|67
92402|NCT01120691|350135|P1|Overall Study|Adverse Event|59
92403|NCT01120626|350179|P2|Overall Study|Withdrawal by Subject|0
92404|NCT01120626|350180|P1|Overall Study|Withdrawal by Subject|1
92405|NCT01120600|350190|P2|Overall Study|Withdrawal by Subject|11
92406|NCT01120600|350191|P1|Overall Study|Withdrawal by Subject|10
92407|NCT01120600|350190|P2|Overall Study|Protocol Violation|4
92408|NCT01120600|350191|P1|Overall Study|Protocol Violation|0
92409|NCT01120600|350190|P2|Overall Study|Physician Decision|3
92410|NCT01120600|350191|P1|Overall Study|Physician Decision|1
92411|NCT01120600|350190|P2|Overall Study|Lost to Follow-up|3
92412|NCT01120600|350191|P1|Overall Study|Lost to Follow-up|1
92413|NCT01120600|350190|P2|Overall Study|Excessive Bone Loss|4
92414|NCT01120600|350191|P1|Overall Study|Excessive Bone Loss|0
92415|NCT01120600|350190|P2|Overall Study|Adverse Event|7
92416|NCT01120600|350191|P1|Overall Study|Adverse Event|7
92417|NCT01120379|350246|P1|Four Year Timepoint|Any other reason for early termination|217
92418|NCT01120379|350246|P1|Four Year Timepoint|Physician Decision|5
92419|NCT01120379|350246|P1|Four Year Timepoint|Death|131
92420|NCT01120379|350246|P1|Four Year Timepoint|Lost to Follow-up|10
92421|NCT01120379|350246|P1|Four Year Timepoint|Withdrawal by Subject|5
92422|NCT01120379|350246|P1|Three Year Timepoint|Any other reason for early termination|17
92423|NCT01120379|350246|P1|Three Year Timepoint|Physician Decision|9
92424|NCT01120379|350246|P1|Three Year Timepoint|Death|120
92425|NCT01120379|350246|P1|Three Year Timepoint|Lost to Follow-up|43
92426|NCT01120379|350246|P1|Three Year Timepoint|Withdrawal by Subject|25
92427|NCT01120379|350246|P1|Two Year Timepoint|Any other reason for early termination|4
92428|NCT01120379|350246|P1|Two Year Timepoint|Physician Decision|12
92429|NCT01120379|350246|P1|Two Year Timepoint|Death|123
92430|NCT01120379|350246|P1|Two Year Timepoint|Lost to Follow-up|87
92431|NCT01120379|350246|P1|Two Year Timepoint|Withdrawal by Subject|11
92432|NCT01120379|350246|P1|One Year Timepoint|Any other reason for early termination|5
92433|NCT01120379|350246|P1|One Year Timepoint|Physician Decision|9
92434|NCT01120379|350246|P1|One Year Timepoint|Death|108
92435|NCT01120379|350246|P1|One Year Timepoint|Lost to Follow-up|115
92436|NCT01120379|350246|P1|One Year Timepoint|Withdrawal by Subject|41
92437|NCT01120275|350282|P1|Overall Study|Not specific|1
92438|NCT01120275|350282|P1|Overall Study|Refusal|1
92439|NCT01120275|350282|P1|Overall Study|Withdrawal by Subject|1
92440|NCT01120275|350282|P1|Overall Study|Ineligible|3
92441|NCT01120275|350282|P1|Overall Study|Progression|27
92442|NCT01120275|350282|P1|Overall Study|Adverse Event|3
92443|NCT01120210|350349|P2|MAIN INFUSION|Withdrawal by Subject|1
92444|NCT01120210|350350|P1|MAIN INFUSION|Withdrawal by Subject|0
92445|NCT01120210|350349|P2|MAIN INFUSION|Adverse Event|0
92446|NCT01120210|350350|P1|MAIN INFUSION|Adverse Event|1
92447|NCT01120184|350400|P3|Overall Study|Death|169
92448|NCT01120184|350401|P2|Overall Study|Death|176
92449|NCT01120184|350402|P1|Overall Study|Death|170
92450|NCT01120184|350400|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
92451|NCT01120184|350401|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
92452|NCT01120184|350402|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
92453|NCT01120184|350400|P3|Overall Study|Sponsor Decision to Terminate Study|143
92454|NCT01120184|350401|P2|Overall Study|Sponsor Decision to Terminate Study|144
92455|NCT01120184|350402|P1|Overall Study|Sponsor Decision to Terminate Study|133
92456|NCT01120184|350400|P3|Overall Study|Reason not Specified|12
92457|NCT01120184|350401|P2|Overall Study|Reason not Specified|3
92458|NCT01120184|350402|P1|Overall Study|Reason not Specified|8
92459|NCT01120184|350400|P3|Overall Study|Physician Decision|3
92460|NCT01120184|350401|P2|Overall Study|Physician Decision|1
92461|NCT01120184|350402|P1|Overall Study|Physician Decision|9
92462|NCT01120184|350400|P3|Overall Study|Lost to Follow-up|11
92463|NCT01120184|350401|P2|Overall Study|Lost to Follow-up|13
92464|NCT01120184|350402|P1|Overall Study|Lost to Follow-up|13
92465|NCT01120184|350400|P3|Overall Study|Adverse Event|0
92466|NCT01120184|350401|P2|Overall Study|Adverse Event|1
92467|NCT01120184|350402|P1|Overall Study|Adverse Event|0
92468|NCT01120093|350524|P5|Treatment Period 5|Adverse Event|0
92469|NCT01120093|350525|P4|Treatment Period 5|Adverse Event|1
92470|NCT01120093|350526|P3|Treatment Period 5|Adverse Event|0
92471|NCT01120093|350527|P2|Treatment Period 5|Adverse Event|1
92472|NCT01120093|350528|P1|Treatment Period 5|Adverse Event|0
92473|NCT01120093|350524|P5|Treatment Period 4|Adverse Event|0
92474|NCT01120093|350525|P4|Treatment Period 4|Adverse Event|0
92475|NCT01120093|350526|P3|Treatment Period 4|Adverse Event|0
92476|NCT01120093|350527|P2|Treatment Period 4|Adverse Event|0
92477|NCT01120093|350528|P1|Treatment Period 4|Adverse Event|1
92478|NCT01120093|350524|P5|Treatment Period 3|Withdrawal by Subject|0
92479|NCT01120093|350525|P4|Treatment Period 3|Withdrawal by Subject|0
92480|NCT01120093|350526|P3|Treatment Period 3|Withdrawal by Subject|1
92481|NCT01120093|350527|P2|Treatment Period 3|Withdrawal by Subject|0
92482|NCT01120093|350528|P1|Treatment Period 3|Withdrawal by Subject|0
92483|NCT01120093|350524|P5|Treatment Period 3|Adverse Event|1
92484|NCT01120093|350525|P4|Treatment Period 3|Adverse Event|0
92485|NCT01120093|350526|P3|Treatment Period 3|Adverse Event|0
92486|NCT01120093|350527|P2|Treatment Period 3|Adverse Event|0
92487|NCT01120093|350528|P1|Treatment Period 3|Adverse Event|0
92488|NCT01120093|350524|P5|Treatment Period 3|Lack of Efficacy|0
92489|NCT01120093|350525|P4|Treatment Period 3|Lack of Efficacy|1
92490|NCT01120093|350526|P3|Treatment Period 3|Lack of Efficacy|0
92491|NCT01120093|350527|P2|Treatment Period 3|Lack of Efficacy|0
92492|NCT01120093|350528|P1|Treatment Period 3|Lack of Efficacy|0
92493|NCT01120093|350524|P5|Treatment Period 2|Withdrawal by Subject|1
92494|NCT01120093|350525|P4|Treatment Period 2|Withdrawal by Subject|0
92495|NCT01120093|350526|P3|Treatment Period 2|Withdrawal by Subject|0
92496|NCT01120093|350527|P2|Treatment Period 2|Withdrawal by Subject|0
92497|NCT01120093|350528|P1|Treatment Period 2|Withdrawal by Subject|0
92498|NCT01120093|350524|P5|Treatment Period 2|Adverse Event|0
92499|NCT01120093|350525|P4|Treatment Period 2|Adverse Event|1
92500|NCT01120093|350526|P3|Treatment Period 2|Adverse Event|0
92501|NCT01120093|350527|P2|Treatment Period 2|Adverse Event|0
92502|NCT01120093|350528|P1|Treatment Period 2|Adverse Event|0
92503|NCT01120093|350524|P5|Treatment Period 1|Withdrawal by Subject|0
92504|NCT01120093|350525|P4|Treatment Period 1|Withdrawal by Subject|0
92505|NCT01120093|350526|P3|Treatment Period 1|Withdrawal by Subject|0
92506|NCT01120093|350527|P2|Treatment Period 1|Withdrawal by Subject|1
92507|NCT01120093|350528|P1|Treatment Period 1|Withdrawal by Subject|0
92508|NCT01120093|350524|P5|Treatment Period 1|Adverse Event|1
92509|NCT01120093|350525|P4|Treatment Period 1|Adverse Event|0
92510|NCT01120093|350526|P3|Treatment Period 1|Adverse Event|1
92511|NCT01120093|350527|P2|Treatment Period 1|Adverse Event|0
92512|NCT01120093|350528|P1|Treatment Period 1|Adverse Event|0
92513|NCT01120067|350557|P2|Overall Study|fail to engage >3 sessions|0
92514|NCT01120067|350558|P1|Overall Study|fail to engage >3 sessions|2
92515|NCT01120067|350557|P2|Overall Study|Lost to Follow-up|1
92516|NCT01120067|350558|P1|Overall Study|Lost to Follow-up|3
92517|NCT01119963|350566|P2|Overall Study|Lost to Follow-up|1
92518|NCT01119963|350567|P1|Overall Study|Lost to Follow-up|1
92519|NCT01119950|350575|P1|Overall Study|Death|1
92520|NCT01119950|350575|P1|Overall Study|Abnormal lab value|1
92521|NCT01119950|350575|P1|Overall Study|Administrative|2
92522|NCT01119950|350575|P1|Overall Study|Lost to Follow-up|4
92523|NCT01119950|350575|P1|Overall Study|Protocol Violation|5
92524|NCT01119950|350575|P1|Overall Study|Withdrawal by Subject|9
92525|NCT01119950|350575|P1|Overall Study|Adverse Event|25
92526|NCT01119937|350822|P2|Overall Study|Withdrawal by Subject|1
92527|NCT01119937|350823|P1|Overall Study|Withdrawal by Subject|2
92528|NCT01119937|350822|P2|Overall Study|Unsatisfactory therapeutic effect|0
92529|NCT01119937|350823|P1|Overall Study|Unsatisfactory therapeutic effect|3
92530|NCT01119937|350822|P2|Overall Study|Protocol deviation|1
92531|NCT01119937|350823|P1|Overall Study|Protocol deviation|3
92532|NCT01119937|350822|P2|Overall Study|Adverse Event|5
92533|NCT01119937|350823|P1|Overall Study|Adverse Event|11
92534|NCT01119859|350851|P2|Overall Study|Failure to return|0
92535|NCT01119859|350852|P1|Overall Study|Failure to return|3
92536|NCT01119859|350851|P2|Overall Study|Refused treatment|6
92537|NCT01119859|350852|P1|Overall Study|Refused treatment|3
92538|NCT01119859|350851|P2|Overall Study|Insufficient therapeutic response|14
92539|NCT01119859|350852|P1|Overall Study|Insufficient therapeutic response|7
92540|NCT01119859|350851|P2|Overall Study|Death|0
92541|NCT01119859|350852|P1|Overall Study|Death|2
92542|NCT01119859|350851|P2|Overall Study|Adverse Event|10
92543|NCT01119859|350852|P1|Overall Study|Adverse Event|9
92544|NCT01119846|350871|P3|Overall Study|Withdrawal by Subject|4
92545|NCT01119846|350872|P2|Overall Study|Withdrawal by Subject|0
92546|NCT01119846|350873|P1|Overall Study|Withdrawal by Subject|0
92547|NCT01119846|350871|P3|Overall Study|Protocol Violation|1
92548|NCT01119846|350872|P2|Overall Study|Protocol Violation|0
92549|NCT01119846|350873|P1|Overall Study|Protocol Violation|0
92550|NCT01119846|350871|P3|Overall Study|Physician Decision|0
92551|NCT01119846|350872|P2|Overall Study|Physician Decision|0
92552|NCT01119846|350873|P1|Overall Study|Physician Decision|1
92553|NCT01119846|350871|P3|Overall Study|Adverse Event|6
92554|NCT01119846|350872|P2|Overall Study|Adverse Event|0
92555|NCT01119846|350873|P1|Overall Study|Adverse Event|1
92556|NCT01119768|351087|P2|Treatment Period|Lack of Efficacy|25
92557|NCT01119768|351088|P1|Treatment Period|Lack of Efficacy|18
92558|NCT01119703|351144|P2|Overall Study|Adverse Event|1
92559|NCT01119703|351145|P1|Overall Study|Adverse Event|0
92560|NCT01119625|351159|P2|Overall Study|Other|1
92561|NCT01119625|351160|P1|Overall Study|Other|0
92562|NCT01119625|351159|P2|Overall Study|Withdrawal by Subject|1
92563|NCT01119625|351160|P1|Overall Study|Withdrawal by Subject|2
92564|NCT01119625|351159|P2|Overall Study|Lost to Follow-up|2
92565|NCT01119625|351160|P1|Overall Study|Lost to Follow-up|1
92566|NCT01119443|351202|P2|Crossover Period 1 (5 Days)|Adverse Event|1
92567|NCT01119443|351203|P1|Crossover Period 1 (5 Days)|Adverse Event|0
92568|NCT01119287|351246|P6|Overall Study|Patient Decision, not related to AE|0
92569|NCT01119287|351247|P5|Overall Study|Patient Decision, not related to AE|1
92570|NCT01119287|351248|P4|Overall Study|Patient Decision, not related to AE|2
92571|NCT01119287|351249|P3|Overall Study|Patient Decision, not related to AE|2
92572|NCT01119287|351250|P2|Overall Study|Patient Decision, not related to AE|0
92573|NCT01119287|351251|P1|Overall Study|Patient Decision, not related to AE|0
92574|NCT01119131|351308|P3|Overall Study|Physician Decision|1
92575|NCT01119131|351309|P2|Overall Study|Physician Decision|0
92576|NCT01119131|351310|P1|Overall Study|Physician Decision|0
92577|NCT01119131|351308|P3|Overall Study|Non-Compliance|4
92578|NCT01119131|351309|P2|Overall Study|Non-Compliance|0
92579|NCT01119131|351310|P1|Overall Study|Non-Compliance|1
92580|NCT01119131|351308|P3|Overall Study|Adverse Event|1
92581|NCT01119131|351309|P2|Overall Study|Adverse Event|1
92582|NCT01119131|351310|P1|Overall Study|Adverse Event|1
92583|NCT01119118|351339|P1|Overall Study|Adverse Event|1
92584|NCT01119001|351351|P1|Overall Study|Withdrawal by Subject|2
92585|NCT01118975|351395|P2|Overall Study|Adverse Event|1
92586|NCT01118975|351396|P1|Overall Study|Adverse Event|0
92587|NCT01118962|351402|P1|Overall Study|Non-compliance with Medicinal Product|1
92588|NCT01118962|351402|P1|Overall Study|Pregnancy|1
92589|NCT01118962|351402|P1|Overall Study|Withdrawal by Subject|4
92590|NCT01118962|351402|P1|Overall Study|Protocol Violation|1
92591|NCT01118962|351402|P1|Overall Study|Lack of Efficacy|1
92592|NCT01118962|351402|P1|Overall Study|Adverse Event|2
92593|NCT01118949|351407|P1|Overall Study|Withdrawal by Subject|4
92594|NCT01118949|351407|P1|Overall Study|Adverse Event|5
92595|NCT01118780|351437|P2|Overall Study|Withdrawal by Subject|8
92596|NCT01118780|351438|P1|Overall Study|Withdrawal by Subject|13
92597|NCT01118780|351437|P2|Overall Study|Protocol Violation|6
92598|NCT01118780|351438|P1|Overall Study|Protocol Violation|3
92599|NCT01118780|351437|P2|Overall Study|Physician Decision|0
92600|NCT01118780|351438|P1|Overall Study|Physician Decision|2
92601|NCT01118780|351437|P2|Overall Study|Lack of Efficacy|6
92602|NCT01118780|351438|P1|Overall Study|Lack of Efficacy|2
92603|NCT01118780|351437|P2|Overall Study|Death|0
92604|NCT01118780|351438|P1|Overall Study|Death|1
92605|NCT01118780|351437|P2|Overall Study|Adverse Event|15
92606|NCT01118780|351438|P1|Overall Study|Adverse Event|15
92607|NCT01118728|351496|P1|Overall Study|Lost to Follow-up|4
92608|NCT01118728|351496|P1|Overall Study|Withdrawal by Subject|3
92609|NCT01118728|351496|P1|Overall Study|Sponsor's decision to discontinue study|172
92610|NCT01118728|351496|P1|Overall Study|Lack of Efficacy|27
92611|NCT01118728|351496|P1|Overall Study|Adverse Event|17
92612|NCT01118663|351503|P2|Overall Study|Withdrawal by Subject|1
92613|NCT01118663|351504|P1|Overall Study|Withdrawal by Subject|0
92614|NCT01118663|351503|P2|Overall Study|Adverse Event|1
92615|NCT01118663|351504|P1|Overall Study|Adverse Event|2
92616|NCT01118455|351527|P2|Baseline [Visits 1 & 2]|Adverse Event|0
92617|NCT01118455|351528|P1|Baseline [Visits 1 & 2]|Adverse Event|1
92618|NCT01118377|351556|P1|Overall Study|Failure to Return|3
92619|NCT01118377|351556|P1|Overall Study|Death|38
92620|NCT01118377|351556|P1|Overall Study|Did Not Receive Study Medication|1
92621|NCT01118325|351565|P3|Overall Study|Adverse Event|1
92622|NCT01118325|351566|P2|Overall Study|Adverse Event|0
92623|NCT01118325|351567|P1|Overall Study|Adverse Event|1
92624|NCT01118312|351613|P2|Overall Study|Withdrawal by Subject|3
92625|NCT01118312|351614|P1|Overall Study|Withdrawal by Subject|1
92626|NCT01118312|351613|P2|Overall Study|Lost to Follow-up|32
92627|NCT01118312|351614|P1|Overall Study|Lost to Follow-up|33
92628|NCT01118143|351812|P2|Overall Study|Withdrawal by Subject|5
92629|NCT01118143|351813|P1|Overall Study|Withdrawal by Subject|2
92630|NCT01118117|351823|P2|Overall Study|Missed 12 Month Visit|0
92631|NCT01118117|351824|P1|Overall Study|Missed 12 Month Visit|7
92632|NCT01118117|351823|P2|Overall Study|Lost to Follow-up|0
92633|NCT01118117|351824|P1|Overall Study|Lost to Follow-up|6
92634|NCT01118117|351823|P2|Overall Study|Death|0
92635|NCT01118117|351824|P1|Overall Study|Death|8
92636|NCT01118052|351856|P1|Overall Study|Never treated|2
92637|NCT01117987|351879|P2|Overall Study|Administrative problems|22
92638|NCT01117987|351880|P1|Overall Study|Administrative problems|25
92639|NCT01117987|351879|P2|Overall Study|Adverse Event|26
92640|NCT01117987|351880|P1|Overall Study|Adverse Event|19
92641|NCT01117987|351879|P2|Overall Study|Withdrawal by Subject|10
92642|NCT01117987|351880|P1|Overall Study|Withdrawal by Subject|5
92643|NCT01117987|351879|P2|Overall Study|Death|10
92644|NCT01117987|351880|P1|Overall Study|Death|5
92645|NCT01117987|351879|P2|Overall Study|Lack of Efficacy|4
92646|NCT01117987|351880|P1|Overall Study|Lack of Efficacy|3
92647|NCT01117987|351879|P2|Overall Study|Abnormal test procedure result|0
92648|NCT01117987|351880|P1|Overall Study|Abnormal test procedure result|2
92649|NCT01117987|351879|P2|Overall Study|Lost to Follow-up|1
92650|NCT01117987|351880|P1|Overall Study|Lost to Follow-up|1
92651|NCT01117987|351879|P2|Overall Study|Subject no longer requires study drug|0
92652|NCT01117987|351880|P1|Overall Study|Subject no longer requires study drug|1
92653|NCT01117987|351879|P2|Overall Study|Protocol deviation|1
92654|NCT01117987|351880|P1|Overall Study|Protocol deviation|0
92655|NCT01117870|351901|P2|Overall Study|Inability to place needle|0
92656|NCT01117870|351902|P1|Overall Study|Inability to place needle|1
92657|NCT01117857|351916|P1|Overall Study|Physician Decision|1
92658|NCT01117857|351916|P1|Overall Study|Withdrawal by Subject|4
92659|NCT01117857|351916|P1|Overall Study|Lost to Follow-up|4
92660|NCT01117766|351924|P2|Second Intervention|Withdrawal by Subject|1
92661|NCT01117766|351925|P1|Second Intervention|Withdrawal by Subject|0
92662|NCT01117766|351924|P2|Second Intervention|Adverse Event|2
92663|NCT01117766|351925|P1|Second Intervention|Adverse Event|0
92664|NCT01117766|351924|P2|Second Intervention|Other|2
92665|NCT01117766|351925|P1|Second Intervention|Other|1
92666|NCT01117766|351924|P2|Second Intervention|Lost to Follow-up|0
92667|NCT01117766|351925|P1|Second Intervention|Lost to Follow-up|1
92668|NCT01117766|351924|P2|Washout Period|Protocol Violation|2
92669|NCT01117766|351925|P1|Washout Period|Protocol Violation|0
92670|NCT01117766|351924|P2|First Intervention|Protocol Violation|0
92671|NCT01117766|351925|P1|First Intervention|Protocol Violation|1
92672|NCT01117766|351924|P2|First Intervention|Other|0
92673|NCT01117766|351925|P1|First Intervention|Other|0
92674|NCT01117766|351924|P2|First Intervention|Adverse Event|1
92675|NCT01117766|351925|P1|First Intervention|Adverse Event|0
92676|NCT01117623|351962|P8|Overall Study|Invest. text: completed all planned txs|0
92677|NCT01117623|351963|P7|Overall Study|Invest. text: completed all planned txs|0
92678|NCT01117623|351964|P6|Overall Study|Invest. text: completed all planned txs|1
92679|NCT01117623|351965|P5|Overall Study|Invest. text: completed all planned txs|0
92680|NCT01117623|351966|P4|Overall Study|Invest. text: completed all planned txs|0
92681|NCT01117623|351967|P3|Overall Study|Invest. text: completed all planned txs|0
92682|NCT01117623|351968|P2|Overall Study|Invest. text: completed all planned txs|0
92683|NCT01117623|351969|P1|Overall Study|Invest. text: completed all planned txs|0
92684|NCT01117623|351962|P8|Overall Study|Non-compliance with study medication|1
92685|NCT01117623|351963|P7|Overall Study|Non-compliance with study medication|0
92686|NCT01117623|351964|P6|Overall Study|Non-compliance with study medication|0
92687|NCT01117623|351965|P5|Overall Study|Non-compliance with study medication|0
92688|NCT01117623|351966|P4|Overall Study|Non-compliance with study medication|0
92689|NCT01117623|351967|P3|Overall Study|Non-compliance with study medication|0
92690|NCT01117623|351968|P2|Overall Study|Non-compliance with study medication|0
92691|NCT01117623|351969|P1|Overall Study|Non-compliance with study medication|0
92692|NCT01117623|351962|P8|Overall Study|Withdrawal by Subject|1
92693|NCT01117623|351963|P7|Overall Study|Withdrawal by Subject|1
92694|NCT01117623|351964|P6|Overall Study|Withdrawal by Subject|1
92695|NCT01117623|351965|P5|Overall Study|Withdrawal by Subject|0
92696|NCT01117623|351966|P4|Overall Study|Withdrawal by Subject|0
92697|NCT01117623|351967|P3|Overall Study|Withdrawal by Subject|2
92698|NCT01117623|351968|P2|Overall Study|Withdrawal by Subject|0
92699|NCT01117623|351969|P1|Overall Study|Withdrawal by Subject|0
92700|NCT01117623|351962|P8|Overall Study|Disease progression, recurrence, relapse|22
92701|NCT01117623|351963|P7|Overall Study|Disease progression, recurrence, relapse|5
92702|NCT01117623|351964|P6|Overall Study|Disease progression, recurrence, relapse|14
92703|NCT01117623|351965|P5|Overall Study|Disease progression, recurrence, relapse|8
92704|NCT01117623|351966|P4|Overall Study|Disease progression, recurrence, relapse|6
92705|NCT01117623|351967|P3|Overall Study|Disease progression, recurrence, relapse|5
92706|NCT01117623|351968|P2|Overall Study|Disease progression, recurrence, relapse|6
92707|NCT01117623|351969|P1|Overall Study|Disease progression, recurrence, relapse|3
92708|NCT01117623|351962|P8|Overall Study|Adverse Event|2
92709|NCT01117623|351963|P7|Overall Study|Adverse Event|0
92710|NCT01117623|351964|P6|Overall Study|Adverse Event|0
92711|NCT01117623|351965|P5|Overall Study|Adverse Event|2
92712|NCT01117623|351966|P4|Overall Study|Adverse Event|0
92713|NCT01117623|351967|P3|Overall Study|Adverse Event|4
92714|NCT01117623|351968|P2|Overall Study|Adverse Event|2
92715|NCT01117623|351969|P1|Overall Study|Adverse Event|0
92716|NCT01117480|352121|P1|Overall Study|Did Not Start Adalimumab Therapy|20
92717|NCT01117480|352121|P1|Overall Study|Protocol Violation|8
92718|NCT01117454|352129|P2|Overall Study|Pregnancy|1
92719|NCT01117454|352130|P1|Overall Study|Pregnancy|0
92720|NCT01117428|352142|P6|Overall Study|Progressive disease|17
92721|NCT01117428|352143|P5|Overall Study|Progressive disease|16
92722|NCT01117428|352144|P4|Overall Study|Progressive disease|12
92723|NCT01117428|352145|P3|Overall Study|Progressive disease|10
92724|NCT01117428|352146|P2|Overall Study|Progressive disease|27
92725|NCT01117428|352147|P1|Overall Study|Progressive disease|15
92726|NCT01117428|352142|P6|Overall Study|Withdrawal by Subject|0
92727|NCT01117428|352143|P5|Overall Study|Withdrawal by Subject|0
92728|NCT01117428|352144|P4|Overall Study|Withdrawal by Subject|0
92729|NCT01117428|352145|P3|Overall Study|Withdrawal by Subject|1
92730|NCT01117428|352146|P2|Overall Study|Withdrawal by Subject|0
92731|NCT01117428|352147|P1|Overall Study|Withdrawal by Subject|0
92732|NCT01117428|352142|P6|Overall Study|Physician Decision|0
92733|NCT01117428|352143|P5|Overall Study|Physician Decision|0
92734|NCT01117428|352144|P4|Overall Study|Physician Decision|0
92735|NCT01117428|352145|P3|Overall Study|Physician Decision|0
92736|NCT01117428|352146|P2|Overall Study|Physician Decision|1
92737|NCT01117428|352147|P1|Overall Study|Physician Decision|0
92738|NCT01117428|352142|P6|Overall Study|Death|1
92739|NCT01117428|352143|P5|Overall Study|Death|0
92740|NCT01117428|352144|P4|Overall Study|Death|0
92741|NCT01117428|352145|P3|Overall Study|Death|2
92742|NCT01117428|352146|P2|Overall Study|Death|1
92743|NCT01117428|352147|P1|Overall Study|Death|0
92744|NCT01117428|352142|P6|Overall Study|Adverse Event|2
92745|NCT01117428|352143|P5|Overall Study|Adverse Event|1
92746|NCT01117428|352144|P4|Overall Study|Adverse Event|0
92747|NCT01117428|352145|P3|Overall Study|Adverse Event|0
92748|NCT01117428|352146|P2|Overall Study|Adverse Event|0
92749|NCT01117428|352147|P1|Overall Study|Adverse Event|4
92750|NCT01117428|352142|P6|Overall Study|Lack of Efficacy|0
92751|NCT01117428|352143|P5|Overall Study|Lack of Efficacy|0
92752|NCT01117428|352144|P4|Overall Study|Lack of Efficacy|0
92753|NCT01117428|352145|P3|Overall Study|Lack of Efficacy|0
92754|NCT01117428|352146|P2|Overall Study|Lack of Efficacy|0
92755|NCT01117428|352147|P1|Overall Study|Lack of Efficacy|1
92756|NCT01117350|352181|P2|Extension Period|Prohibited medication|1
92757|NCT01117350|352182|P1|Extension Period|Prohibited medication|0
92758|NCT01117350|352181|P2|Extension Period|Inclusion criteria not respected|1
92759|NCT01117350|352182|P1|Extension Period|Inclusion criteria not respected|0
92760|NCT01117350|352181|P2|Extension Period|Lack of Efficacy|2
92761|NCT01117350|352182|P1|Extension Period|Lack of Efficacy|0
92762|NCT01117350|352181|P2|Extension Period|Withdrawal by Subject|3
92763|NCT01117350|352182|P1|Extension Period|Withdrawal by Subject|0
92764|NCT01117350|352181|P2|Extension Period|Lost to Follow-up|2
92765|NCT01117350|352182|P1|Extension Period|Lost to Follow-up|0
92766|NCT01117350|352181|P2|Extension Period|Protocol Violation|2
92767|NCT01117350|352182|P1|Extension Period|Protocol Violation|0
92768|NCT01117350|352181|P2|Extension Period|Adverse Event|2
92769|NCT01117350|352182|P1|Extension Period|Adverse Event|0
92770|NCT01117350|352181|P2|Extension Period|Not included in extension, not treated|50
92771|NCT01117350|352182|P1|Extension Period|Not included in extension, not treated|0
92772|NCT01117350|352181|P2|Comparative Period|Move to another city/country|1
92773|NCT01117350|352182|P1|Comparative Period|Move to another city/country|2
92774|NCT01117350|352181|P2|Comparative Period|Physician Decision|1
92775|NCT01117350|352182|P1|Comparative Period|Physician Decision|0
92776|NCT01117350|352181|P2|Comparative Period|Lack of Efficacy|0
92777|NCT01117350|352182|P1|Comparative Period|Lack of Efficacy|1
92778|NCT01117350|352181|P2|Comparative Period|Protocol Violation|12
92779|NCT01117350|352182|P1|Comparative Period|Protocol Violation|8
92780|NCT01117350|352181|P2|Comparative Period|Withdrawal by Subject|13
92781|NCT01117350|352182|P1|Comparative Period|Withdrawal by Subject|9
92782|NCT01117350|352181|P2|Comparative Period|Lost to Follow-up|7
92783|NCT01117350|352182|P1|Comparative Period|Lost to Follow-up|11
92784|NCT01117350|352181|P2|Comparative Period|Adverse Event|33
92785|NCT01117350|352182|P1|Comparative Period|Adverse Event|6
92786|NCT01117350|352181|P2|Comparative Period|Not Treated|8
92787|NCT01117350|352182|P1|Comparative Period|Not Treated|5
92788|NCT01117337|352214|P2|Overall Study|Lost to Follow-up|0
92789|NCT01117337|352215|P1|Overall Study|Lost to Follow-up|4
92790|NCT01117181|352236|P2|Overall Study|Withdrawal by Subject|2
92791|NCT01117181|352237|P1|Overall Study|Withdrawal by Subject|0
92792|NCT01117181|352236|P2|Overall Study|Lost to Follow-up|0
92793|NCT01117181|352237|P1|Overall Study|Lost to Follow-up|1
92794|NCT01117051|352268|P2|Overall Study|Convenience issue|0
92795|NCT01117051|352269|P1|Overall Study|Convenience issue|1
92796|NCT01117051|352268|P2|Overall Study|Randomized by mistake|1
92797|NCT01117051|352269|P1|Overall Study|Randomized by mistake|0
92798|NCT01117051|352268|P2|Overall Study|Surgical procedure|1
92799|NCT01117051|352269|P1|Overall Study|Surgical procedure|0
92800|NCT01117051|352268|P2|Overall Study|Sponsor's decision|1
92801|NCT01117051|352269|P1|Overall Study|Sponsor's decision|3
92802|NCT01117051|352268|P2|Overall Study|Did not meet in-/exclusion criteria|1
92803|NCT01117051|352269|P1|Overall Study|Did not meet in-/exclusion criteria|0
92804|NCT01117051|352268|P2|Overall Study|Lost to Follow-up|1
92805|NCT01117051|352269|P1|Overall Study|Lost to Follow-up|0
92806|NCT01117051|352268|P2|Overall Study|Adverse Event|3
92807|NCT01117051|352269|P1|Overall Study|Adverse Event|4
92808|NCT01117051|352268|P2|Overall Study|Withdrawal by Subject|3
92809|NCT01117051|352269|P1|Overall Study|Withdrawal by Subject|5
92810|NCT01117012|352279|P2|Overall Study|Undefined|3
92811|NCT01117012|352280|P1|Overall Study|Undefined|4
92812|NCT01117012|352279|P2|Overall Study|Withdrawal by Subject|0
92813|NCT01117012|352280|P1|Overall Study|Withdrawal by Subject|3
92814|NCT01117012|352279|P2|Overall Study|Death|1
92815|NCT01117012|352280|P1|Overall Study|Death|1
92816|NCT01117012|352279|P2|Overall Study|Adverse Event|1
92817|NCT01117012|352280|P1|Overall Study|Adverse Event|0
92818|NCT01116882|352421|P2|12-month|Withdrawal by Subject|8
92819|NCT01116882|352422|P1|12-month|Withdrawal by Subject|5
92820|NCT01116882|352421|P2|12-month|Other Reasons|49
92821|NCT01116882|352422|P1|12-month|Other Reasons|151
92822|NCT01116882|352421|P2|12-month|Lost to Follow-up|42
92823|NCT01116882|352422|P1|12-month|Lost to Follow-up|111
92824|NCT01116882|352421|P2|30-day|Other Reasons|6
92825|NCT01116882|352422|P1|30-day|Other Reasons|16
92826|NCT01116882|352421|P2|30-day|Withdrawal by Subject|4
92827|NCT01116882|352422|P1|30-day|Withdrawal by Subject|2
92828|NCT01116882|352421|P2|30-day|Lost to Follow-up|21
92829|NCT01116882|352422|P1|30-day|Lost to Follow-up|50
92830|NCT01116687|352460|P1|Overall Study|Withdrawal by Subject|4
92831|NCT01116427|352477|P2|Extension Phase|Not using appropriate birth control|0
92832|NCT01116427|352478|P1|Extension Phase|Not using appropriate birth control|1
92833|NCT01116427|352477|P2|Extension Phase|Withdrawal by Subject|1
92834|NCT01116427|352478|P1|Extension Phase|Withdrawal by Subject|5
92835|NCT01116427|352477|P2|Extension Phase|Lost to Follow-up|0
92836|NCT01116427|352478|P1|Extension Phase|Lost to Follow-up|2
92837|NCT01116427|352477|P2|Extension Phase|Adverse Event|1
92838|NCT01116427|352478|P1|Extension Phase|Adverse Event|1
92839|NCT01116427|352477|P2|Core Phase|Worsening Multiple Sclerosis|0
92840|NCT01116427|352478|P1|Core Phase|Worsening Multiple Sclerosis|1
92841|NCT01116427|352477|P2|Core Phase|Withdrawal by Subject|0
92842|NCT01116427|352478|P1|Core Phase|Withdrawal by Subject|3
92843|NCT01116427|352477|P2|Core Phase|Lost to Follow-up|0
92844|NCT01116427|352478|P1|Core Phase|Lost to Follow-up|1
92845|NCT01116427|352477|P2|Core Phase|Adverse Event|1
92846|NCT01116427|352478|P1|Core Phase|Adverse Event|0
92847|NCT01116232|352519|P1|Overall Study|Progressive diease|4
92848|NCT01115998|352627|P2|Overall Study|Lost to Follow-up|6
92849|NCT01115998|352628|P1|Overall Study|Lost to Follow-up|6
92850|NCT01115933|352638|P1|Overall Study|Did not receive XIENCE PRIME SV|1
92851|NCT01115855|352735|P2|Overall Study|Other|6
92852|NCT01115855|352736|P1|Overall Study|Other|8
92853|NCT01115855|352735|P2|Overall Study|Withdrawal by Subject|5
92854|NCT01115855|352736|P1|Overall Study|Withdrawal by Subject|5
92855|NCT01115855|352735|P2|Overall Study|Protocol Violation|1
92856|NCT01115855|352736|P1|Overall Study|Protocol Violation|0
92857|NCT01115855|352735|P2|Overall Study|Lab Abnormality|1
92858|NCT01115855|352736|P1|Overall Study|Lab Abnormality|1
92859|NCT01115855|352735|P2|Overall Study|Death|5
92860|NCT01115855|352736|P1|Overall Study|Death|6
92861|NCT01115855|352735|P2|Overall Study|Adverse Event|18
92862|NCT01115855|352736|P1|Overall Study|Adverse Event|16
92863|NCT01115738|352787|P3|Overall Study|Withdrawal by Subject|9
92864|NCT01115738|352788|P2|Overall Study|Withdrawal by Subject|6
92865|NCT01115738|352789|P1|Overall Study|Withdrawal by Subject|6
92866|NCT01115738|352787|P3|Overall Study|Physician Decision|17
92867|NCT01115738|352788|P2|Overall Study|Physician Decision|15
92868|NCT01115738|352789|P1|Overall Study|Physician Decision|18
92869|NCT01115738|352787|P3|Overall Study|Lost to Follow-up|1
92870|NCT01115738|352788|P2|Overall Study|Lost to Follow-up|0
92871|NCT01115738|352789|P1|Overall Study|Lost to Follow-up|0
92872|NCT01115738|352787|P3|Overall Study|Death|0
92873|NCT01115738|352788|P2|Overall Study|Death|0
92874|NCT01115738|352789|P1|Overall Study|Death|1
92875|NCT01115569|352987|P2|Maintenance Phase|Administrative|1
92876|NCT01115569|352988|P1|Maintenance Phase|Administrative|0
92877|NCT01115569|352987|P2|Maintenance Phase|Non-Compliance with Study Drug|48
92878|NCT01115569|352988|P1|Maintenance Phase|Non-Compliance with Study Drug|0
92879|NCT01115569|352987|P2|Maintenance Phase|Withdrawal by Subject|27
92880|NCT01115569|352988|P1|Maintenance Phase|Withdrawal by Subject|0
92881|NCT01115569|352987|P2|Maintenance Phase|Protocol Violation|9
92882|NCT01115569|352988|P1|Maintenance Phase|Protocol Violation|0
92883|NCT01115569|352987|P2|Maintenance Phase|Physician Decision|3
92884|NCT01115569|352988|P1|Maintenance Phase|Physician Decision|0
92885|NCT01115569|352987|P2|Maintenance Phase|Lost to Follow-up|8
92886|NCT01115569|352988|P1|Maintenance Phase|Lost to Follow-up|0
92887|NCT01115569|352987|P2|Maintenance Phase|Adverse Event|43
92888|NCT01115569|352988|P1|Maintenance Phase|Adverse Event|0
92889|NCT01115569|352987|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
92890|NCT01115569|352988|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
92891|NCT01115569|352987|P2|Conversion/Titration Phase|Withdrawal by Subject|0
92892|NCT01115569|352988|P1|Conversion/Titration Phase|Withdrawal by Subject|26
92893|NCT01115569|352987|P2|Conversion/Titration Phase|Protocol Violation|0
92894|NCT01115569|352988|P1|Conversion/Titration Phase|Protocol Violation|68
92895|NCT01115569|352987|P2|Conversion/Titration Phase|Physician Decision|0
92896|NCT01115569|352988|P1|Conversion/Titration Phase|Physician Decision|5
92897|NCT01115569|352987|P2|Conversion/Titration Phase|Lost to Follow-up|0
92898|NCT01115569|352988|P1|Conversion/Titration Phase|Lost to Follow-up|3
92899|NCT01115569|352987|P2|Conversion/Titration Phase|Adverse Event|0
92900|NCT01115569|352988|P1|Conversion/Titration Phase|Adverse Event|59
92901|NCT01115491|353017|P1|Overall Study|Physician Decision|1
92902|NCT01115491|353017|P1|Overall Study|Withdrawal by Subject|1
92903|NCT01115491|353017|P1|Overall Study|Lost to Follow-up|3
92904|NCT01115491|353017|P1|Overall Study|Adverse Event|3
92905|NCT01115491|353017|P1|Overall Study|Death|22
92906|NCT01114880|353192|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
92907|NCT01114880|353193|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
92908|NCT01114880|353192|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
92909|NCT01114880|353193|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
92910|NCT01114880|353192|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
92911|NCT01114880|353193|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
92912|NCT01114880|353192|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
92913|NCT01114880|353193|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
92914|NCT01114880|353192|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
92915|NCT01114880|353193|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
92916|NCT01114880|353192|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
92917|NCT01114880|353193|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
92918|NCT01114828|353245|P2|Overall Study|Withdrawal by Subject|1
92919|NCT01114828|353246|P1|Overall Study|Withdrawal by Subject|0
92920|NCT01114828|353245|P2|Overall Study|Protocol Violation|0
92921|NCT01114828|353246|P1|Overall Study|Protocol Violation|2
92922|NCT01114828|353245|P2|Overall Study|Lack of Efficacy|2
92923|NCT01114828|353246|P1|Overall Study|Lack of Efficacy|0
92924|NCT01114828|353245|P2|Overall Study|Adverse Event|1
92925|NCT01114828|353246|P1|Overall Study|Adverse Event|1
92926|NCT01114737|353256|P2|Open-Label Treatment Period|Difficult Personal Events|0
92927|NCT01114737|353257|P1|Open-Label Treatment Period|Difficult Personal Events|1
92928|NCT01114737|353256|P2|Open-Label Treatment Period|Lost to Follow-up|1
92929|NCT01114737|353257|P1|Open-Label Treatment Period|Lost to Follow-up|3
92930|NCT01114737|353256|P2|Open-Label Treatment Period|Withdrawal by Subject|1
92931|NCT01114737|353257|P1|Open-Label Treatment Period|Withdrawal by Subject|1
92932|NCT01114737|353256|P2|Randomized Treatment Period|Pregnancy|0
92933|NCT01114737|353257|P1|Randomized Treatment Period|Pregnancy|1
92934|NCT01114737|353256|P2|Randomized Treatment Period|Lost to Follow-up|1
92935|NCT01114737|353257|P1|Randomized Treatment Period|Lost to Follow-up|1
92936|NCT01114737|353256|P2|Randomized Treatment Period|Withdrawal by Subject|0
92937|NCT01114737|353257|P1|Randomized Treatment Period|Withdrawal by Subject|1
92938|NCT01114724|353305|P1|Overall Study|Withdrawal by Subject|1
92939|NCT01114724|353305|P1|Overall Study|Lost to Follow-up|1
92940|NCT01114724|353305|P1|Overall Study|Death|8
92941|NCT01114672|353325|P2|Overall Study|transplanted|0
92942|NCT01114672|353326|P1|Overall Study|transplanted|1
92943|NCT01114672|353325|P2|Overall Study|Lost to Follow-up|0
92944|NCT01114672|353326|P1|Overall Study|Lost to Follow-up|1
92945|NCT01114672|353325|P2|Overall Study|Withdrawal by Subject|1
92946|NCT01114672|353326|P1|Overall Study|Withdrawal by Subject|2
92947|NCT01114672|353325|P2|Overall Study|Death|1
92948|NCT01114672|353326|P1|Overall Study|Death|0
92949|NCT01114529|353377|P3|Completed Study Phase at Month 24|Missing|0
92950|NCT01114529|353378|P2|Completed Study Phase at Month 24|Missing|0
92951|NCT01114529|353379|P1|Completed Study Phase at Month 24|Missing|2
92952|NCT01114529|353377|P3|Completed Study Phase at Month 24|Other|0
92953|NCT01114529|353378|P2|Completed Study Phase at Month 24|Other|0
92954|NCT01114529|353379|P1|Completed Study Phase at Month 24|Other|2
92955|NCT01114529|353377|P3|Completed Study Phase at Month 24|Death|4
92956|NCT01114529|353378|P2|Completed Study Phase at Month 24|Death|5
92957|NCT01114529|353379|P1|Completed Study Phase at Month 24|Death|8
92958|NCT01114529|353377|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
92959|NCT01114529|353378|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
92960|NCT01114529|353379|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
92961|NCT01114529|353377|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
92962|NCT01114529|353378|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
92963|NCT01114529|353379|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
92964|NCT01114529|353377|P3|Completed Study Medication at Month 24|Missing|0
92965|NCT01114529|353378|P2|Completed Study Medication at Month 24|Missing|0
92966|NCT01114529|353379|P1|Completed Study Medication at Month 24|Missing|2
92967|NCT01114529|353377|P3|Completed Study Medication at Month 24|Protocol Violation|2
92968|NCT01114529|353378|P2|Completed Study Medication at Month 24|Protocol Violation|5
92969|NCT01114529|353379|P1|Completed Study Medication at Month 24|Protocol Violation|0
92970|NCT01114529|353377|P3|Completed Study Medication at Month 24|Graft loss|0
92971|NCT01114529|353378|P2|Completed Study Medication at Month 24|Graft loss|2
92972|NCT01114529|353379|P1|Completed Study Medication at Month 24|Graft loss|0
92973|NCT01114529|353377|P3|Completed Study Medication at Month 24|Death|2
92974|NCT01114529|353378|P2|Completed Study Medication at Month 24|Death|1
92975|NCT01114529|353379|P1|Completed Study Medication at Month 24|Death|2
92976|NCT01114529|353377|P3|Completed Study Medication at Month 24|Administrative problems|2
92977|NCT01114529|353378|P2|Completed Study Medication at Month 24|Administrative problems|1
92978|NCT01114529|353379|P1|Completed Study Medication at Month 24|Administrative problems|2
92979|NCT01114529|353377|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
92980|NCT01114529|353378|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
92981|NCT01114529|353379|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
92982|NCT01114529|353377|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
92983|NCT01114529|353378|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
92984|NCT01114529|353379|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
92985|NCT01114529|353377|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
92986|NCT01114529|353378|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
92987|NCT01114529|353379|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
92988|NCT01114529|353377|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
92989|NCT01114529|353378|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
92990|NCT01114529|353379|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
92991|NCT01114529|353377|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
92992|NCT01114529|353378|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
92993|NCT01114529|353379|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
92994|NCT01114529|353377|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
92995|NCT01114529|353378|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
92996|NCT01114529|353379|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
92997|NCT01114529|353377|P3|Completed Study Medication at Month 24|Adverse Event|17
92998|NCT01114529|353378|P2|Completed Study Medication at Month 24|Adverse Event|18
92999|NCT01114529|353379|P1|Completed Study Medication at Month 24|Adverse Event|87
93000|NCT01114516|353398|P2|Overall Study|Lost to Follow-up|1
93001|NCT01114516|353399|P1|Overall Study|Lost to Follow-up|2
93002|NCT01114438|353434|P1|Overall Study|Withdrawal by Subject|2
93003|NCT01114438|353434|P1|Overall Study|Physician Decision|1
93004|NCT01114438|353434|P1|Overall Study|concomitant medication|1
93005|NCT01114438|353434|P1|Overall Study|Adverse Event|10
93006|NCT01114373|353444|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
93007|NCT01114373|353445|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
93008|NCT01114373|353444|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
93009|NCT01114373|353445|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
93010|NCT01114373|353444|P2|Intervention 1 (4 Weeks)|Incarceration|0
93011|NCT01114373|353445|P1|Intervention 1 (4 Weeks)|Incarceration|1
93012|NCT01114373|353444|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
93013|NCT01114373|353445|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
93014|NCT01114360|353477|P2|Intervention 1 (4 Weeks)|Physician Decision|1
93015|NCT01114360|353478|P1|Intervention 1 (4 Weeks)|Physician Decision|0
93016|NCT01113931|353529|P2|Overall Study|Withdrawal by Subject|0
93017|NCT01113931|353530|P1|Overall Study|Withdrawal by Subject|3
93018|NCT01113931|353529|P2|Overall Study|Various|4
93019|NCT01113931|353530|P1|Overall Study|Various|2
93020|NCT01113931|353529|P2|Overall Study|Lost to Follow-up|9
93021|NCT01113931|353530|P1|Overall Study|Lost to Follow-up|12
93022|NCT01113931|353529|P2|Overall Study|Physician Decision|2
93023|NCT01113931|353530|P1|Overall Study|Physician Decision|0
93024|NCT01113931|353529|P2|Overall Study|Adverse Event|2
93025|NCT01113931|353530|P1|Overall Study|Adverse Event|2
93026|NCT01113801|353546|P4|Overall Study|Clinical Endpoint (ESRD)|5
93027|NCT01113801|353547|P3|Overall Study|Clinical Endpoint (ESRD)|2
93028|NCT01113801|353548|P2|Overall Study|Clinical Endpoint (ESRD)|4
93029|NCT01113801|353549|P1|Overall Study|Clinical Endpoint (ESRD)|7
93030|NCT01113801|353546|P4|Overall Study|Sponsor Decision|15
93031|NCT01113801|353547|P3|Overall Study|Sponsor Decision|20
93032|NCT01113801|353548|P2|Overall Study|Sponsor Decision|21
93033|NCT01113801|353549|P1|Overall Study|Sponsor Decision|15
93034|NCT01113801|353546|P4|Overall Study|Physician Decision|3
93035|NCT01113801|353547|P3|Overall Study|Physician Decision|3
93036|NCT01113801|353548|P2|Overall Study|Physician Decision|2
93037|NCT01113801|353549|P1|Overall Study|Physician Decision|2
93038|NCT01113801|353546|P4|Overall Study|Withdrawal by Subject|8
93039|NCT01113801|353547|P3|Overall Study|Withdrawal by Subject|7
93040|NCT01113801|353548|P2|Overall Study|Withdrawal by Subject|7
93041|NCT01113801|353549|P1|Overall Study|Withdrawal by Subject|9
93042|NCT01113801|353546|P4|Overall Study|Protocol Violation|0
93043|NCT01113801|353547|P3|Overall Study|Protocol Violation|0
93044|NCT01113801|353548|P2|Overall Study|Protocol Violation|1
93045|NCT01113801|353549|P1|Overall Study|Protocol Violation|0
93046|NCT01113801|353546|P4|Overall Study|Death|4
93047|NCT01113801|353547|P3|Overall Study|Death|3
93048|NCT01113801|353548|P2|Overall Study|Death|5
93049|NCT01113801|353549|P1|Overall Study|Death|4
93050|NCT01113801|353546|P4|Overall Study|Adverse Event|6
93051|NCT01113801|353547|P3|Overall Study|Adverse Event|2
93052|NCT01113801|353548|P2|Overall Study|Adverse Event|0
93053|NCT01113801|353549|P1|Overall Study|Adverse Event|4
93054|NCT01113749|353577|P2|Overall Study|Lost to Follow-up|2
93055|NCT01113749|353578|P1|Overall Study|Lost to Follow-up|1
93056|NCT01113710|353601|P1|Overall Study|Subject Did Not Receive Neupro|3
93057|NCT01113710|353601|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
93058|NCT01113710|353601|P1|Overall Study|Lack of Patient's Compliance/Other|1
93059|NCT01113710|353601|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
93060|NCT01113710|353601|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
93061|NCT01113710|353601|P1|Overall Study|Compliance/Efficacy/AE/Other|1
93062|NCT01113710|353601|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
93063|NCT01113710|353601|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
93064|NCT01113710|353601|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
93065|NCT01113710|353601|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
93066|NCT01113710|353601|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
93067|NCT01113710|353601|P1|Overall Study|Lack of Efficacy/Adverse Event|3
93068|NCT01113710|353601|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
93069|NCT01113710|353601|P1|Overall Study|Lack of Efficacy/Other|4
93070|NCT01113710|353601|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
93071|NCT01113710|353601|P1|Overall Study|Adverse Event/Other|5
93072|NCT01113710|353601|P1|Overall Study|Other|7
93073|NCT01113710|353601|P1|Overall Study|Lack of Patient's Compliance|8
93074|NCT01113710|353601|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
93075|NCT01113710|353601|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
93076|NCT01113710|353601|P1|Overall Study|Lost to Follow-up|20
93077|NCT01113710|353601|P1|Overall Study|Withdrawal by Subject|28
93078|NCT01113710|353601|P1|Overall Study|No Information Available|40
93079|NCT01113710|353601|P1|Overall Study|Lack of Efficacy|41
93080|NCT01113710|353601|P1|Overall Study|Adverse Event|64
93081|NCT01113580|353629|P2|Overall Study|Protocol Violation|0
93082|NCT01113580|353630|P1|Overall Study|Protocol Violation|1
93083|NCT01113541|353644|P1|Overall Study|Adverse Event|4
93084|NCT01113541|353644|P1|Overall Study|Study Terminated by Sponsor|7
93085|NCT01113541|353644|P1|Overall Study|Protocol Violation|1
93086|NCT01113541|353644|P1|Overall Study|Withdrawal by Subject|1
93087|NCT01113463|353677|P1|Overall Study|Physician Decision|5
93088|NCT01112917|353707|P2|Overall Study|Unable to Convert Filter|0
93089|NCT01112917|353708|P1|Overall Study|Unable to Convert Filter|3
93090|NCT01112917|353707|P2|Overall Study|Withdrawal by Subject|3
93091|NCT01112917|353708|P1|Overall Study|Withdrawal by Subject|1
93092|NCT01112917|353707|P2|Overall Study|Lost to Follow-up|1
93093|NCT01112917|353708|P1|Overall Study|Lost to Follow-up|1
93094|NCT01112917|353707|P2|Overall Study|Death|11
93095|NCT01112917|353708|P1|Overall Study|Death|2
93096|NCT01112579|353785|P2|Overall Study|Death|2
93097|NCT01112579|353786|P1|Overall Study|Death|0
93098|NCT01112579|353785|P2|Overall Study|Missed Visit|1
93099|NCT01112579|353786|P1|Overall Study|Missed Visit|1
93100|NCT01112514|353796|P1|Overall Study|Lost to Follow-up|1
93101|NCT01112267|353802|P2|Overall Study|Participants not receive any study drug|2
93102|NCT01112267|353803|P1|Overall Study|Participants not receive any study drug|1
93103|NCT01112267|353802|P2|Overall Study|Participants not compliant|2
93104|NCT01112267|353803|P1|Overall Study|Participants not compliant|1
93105|NCT01112267|353802|P2|Overall Study|Protocol Violation|3
93106|NCT01112267|353803|P1|Overall Study|Protocol Violation|5
93107|NCT01112267|353802|P2|Overall Study|Withdrawal by Subject|5
93108|NCT01112267|353803|P1|Overall Study|Withdrawal by Subject|3
93109|NCT01112267|353802|P2|Overall Study|Adverse Event|6
93110|NCT01112267|353803|P1|Overall Study|Adverse Event|24
93111|NCT01112059|353836|P2|Overall Study|Withdrawal by Subject|0
93112|NCT01112059|353837|P1|Overall Study|Withdrawal by Subject|1
93113|NCT01111851|353851|P2|Overall Study|All planned PET scans were not obtained.|0
93114|NCT01111851|353852|P1|Overall Study|All planned PET scans were not obtained.|2
93115|NCT01111838|353864|P1|Overall Study|Other Complicating Disease|1
93116|NCT01111838|353864|P1|Overall Study|Clinical deterioration|1
93117|NCT01111838|353864|P1|Overall Study|Not Treated|3
93118|NCT01111838|353864|P1|Overall Study|Patient Ineligible|2
93119|NCT01111825|353872|P4|Overall Study|Discontinuation by Sponsor|20
93120|NCT01111825|353873|P3|Overall Study|Discontinuation by Sponsor|0
93121|NCT01111825|353874|P2|Overall Study|Discontinuation by Sponsor|0
93122|NCT01111825|353875|P1|Overall Study|Discontinuation by Sponsor|0
93123|NCT01111825|353872|P4|Overall Study|Disease Progression|0
93124|NCT01111825|353873|P3|Overall Study|Disease Progression|0
93125|NCT01111825|353874|P2|Overall Study|Disease Progression|0
93126|NCT01111825|353875|P1|Overall Study|Disease Progression|1
93127|NCT01111825|353872|P4|Overall Study|Adverse Event|0
93128|NCT01111825|353873|P3|Overall Study|Adverse Event|4
93129|NCT01111825|353874|P2|Overall Study|Adverse Event|1
93130|NCT01111825|353875|P1|Overall Study|Adverse Event|2
93131|NCT01111825|353872|P4|Overall Study|Lost to Follow-up|1
93132|NCT01111825|353873|P3|Overall Study|Lost to Follow-up|3
93133|NCT01111825|353874|P2|Overall Study|Lost to Follow-up|0
93134|NCT01111825|353875|P1|Overall Study|Lost to Follow-up|0
93135|NCT01111825|353872|P4|Overall Study|Withdrawal by Subject|0
93136|NCT01111825|353873|P3|Overall Study|Withdrawal by Subject|1
93137|NCT01111825|353874|P2|Overall Study|Withdrawal by Subject|0
93138|NCT01111825|353875|P1|Overall Study|Withdrawal by Subject|0
93139|NCT01111526|353894|P3|Overall Study|GVHD Disease Progression|2
93140|NCT01111526|353895|P2|Overall Study|GVHD Disease Progression|1
93141|NCT01111526|353896|P1|Overall Study|GVHD Disease Progression|0
93142|NCT01111461|353908|P1|Overall Study|Not specified|6
93143|NCT01111461|353908|P1|Overall Study|Withdrawal by Subject|1
93144|NCT01111461|353908|P1|Overall Study|Lost to Follow-up|1
93145|NCT01111461|353908|P1|Overall Study|Participant choice|11
93146|NCT01111461|353908|P1|Overall Study|Adverse Event|32
93147|NCT01111292|354088|P2|Treatment|Physician Decision|1
93148|NCT01111292|354089|P1|Treatment|Physician Decision|1
93149|NCT01111240|354095|P1|Overall Study|Not Specified|312
93150|NCT01111240|354095|P1|Overall Study|Lack of Efficacy and Adverse Event|19
93151|NCT01111240|354095|P1|Overall Study|Lack of Efficacy|545
93152|NCT01111240|354095|P1|Overall Study|Adverse Event|190
93153|NCT01111149|354125|P3|Overall Study|Withdrawal by Subject|2
93154|NCT01111149|354126|P2|Overall Study|Withdrawal by Subject|0
93155|NCT01111149|354127|P1|Overall Study|Withdrawal by Subject|1
93156|NCT01111149|354125|P3|Overall Study|Protocol Violation|2
93157|NCT01111149|354126|P2|Overall Study|Protocol Violation|1
93158|NCT01111149|354127|P1|Overall Study|Protocol Violation|1
93159|NCT01111123|354203|P2|Maintenance Phase|Lost to Follow-up|2
93160|NCT01111123|354204|P1|Maintenance Phase|Lost to Follow-up|0
93161|NCT01111123|354203|P2|Open- Label Phase|Failed to be clear or almost cleared|0
93162|NCT01111123|354204|P1|Open- Label Phase|Failed to be clear or almost cleared|14
93163|NCT01110915|354238|P2|Overall Study|Withdrawal by Subject|1
93164|NCT01110915|354239|P1|Overall Study|Withdrawal by Subject|7
93165|NCT01110915|354238|P2|Overall Study|Lost to Follow-up|0
93166|NCT01110915|354239|P1|Overall Study|Lost to Follow-up|1
93167|NCT01110915|354238|P2|Overall Study|Death|1
93168|NCT01110915|354239|P1|Overall Study|Death|2
93169|NCT01110707|354256|P2|Overall Study|Protocol Violation|3
93170|NCT01110707|354257|P1|Overall Study|Protocol Violation|0
93171|NCT01110408|354337|P2|Overall Study|Protocol Violation|0
93172|NCT01110408|354338|P1|Overall Study|Protocol Violation|1
93173|NCT01110382|354358|P2|Overall Study|Protocol Violation|1
93174|NCT01110382|354359|P1|Overall Study|Protocol Violation|0
93175|NCT01110382|354358|P2|Overall Study|Withdrawal by Subject|1
93176|NCT01110382|354359|P1|Overall Study|Withdrawal by Subject|0
93177|NCT01110330|354380|P3|Overall Study|Not specified|1
93178|NCT01110330|354381|P2|Overall Study|Not specified|1
93179|NCT01110330|354382|P1|Overall Study|Not specified|1
93180|NCT01110330|354380|P3|Overall Study|Withdrawal by Subject|2
93181|NCT01110330|354381|P2|Overall Study|Withdrawal by Subject|6
93182|NCT01110330|354382|P1|Overall Study|Withdrawal by Subject|0
93183|NCT01110330|354380|P3|Overall Study|Protocol Violation|4
93184|NCT01110330|354381|P2|Overall Study|Protocol Violation|0
93185|NCT01110330|354382|P1|Overall Study|Protocol Violation|2
93186|NCT01110330|354380|P3|Overall Study|Physician Decision|0
93187|NCT01110330|354381|P2|Overall Study|Physician Decision|1
93188|NCT01110330|354382|P1|Overall Study|Physician Decision|0
93189|NCT01110330|354380|P3|Overall Study|Lost to Follow-up|15
93190|NCT01110330|354381|P2|Overall Study|Lost to Follow-up|10
93191|NCT01110330|354382|P1|Overall Study|Lost to Follow-up|9
93192|NCT01110330|354380|P3|Overall Study|Lack of Efficacy|1
93193|NCT01110330|354381|P2|Overall Study|Lack of Efficacy|1
93194|NCT01110330|354382|P1|Overall Study|Lack of Efficacy|3
93195|NCT01110330|354380|P3|Overall Study|Adverse Event|3
93196|NCT01110330|354381|P2|Overall Study|Adverse Event|4
93197|NCT01110330|354382|P1|Overall Study|Adverse Event|0
93198|NCT01110239|354410|P4|7.5 Min Ischemia|Withdrawal by Subject|0
93199|NCT01110239|354411|P3|7.5 Min Ischemia|Withdrawal by Subject|1
93200|NCT01110239|354412|P2|7.5 Min Ischemia|Withdrawal by Subject|0
93201|NCT01110239|354413|P1|7.5 Min Ischemia|Withdrawal by Subject|0
93202|NCT01110239|354410|P4|Sham Preconditioning|Withdrawal by Subject|0
93203|NCT01110239|354411|P3|Sham Preconditioning|Withdrawal by Subject|1
93204|NCT01110239|354412|P2|Sham Preconditioning|Withdrawal by Subject|0
93205|NCT01110239|354413|P1|Sham Preconditioning|Withdrawal by Subject|0
93206|NCT01110200|354429|P2|Overall Study|Lost to Follow-up|7
93207|NCT01110200|354430|P1|Overall Study|Lost to Follow-up|10
93208|NCT01110200|354429|P2|Overall Study|Physician Decision|17
93209|NCT01110200|354430|P1|Overall Study|Physician Decision|13
93210|NCT01110200|354429|P2|Overall Study|Protocol Violation|12
93211|NCT01110200|354430|P1|Overall Study|Protocol Violation|14
93212|NCT01110200|354429|P2|Overall Study|Lack of Efficacy|25
93213|NCT01110200|354430|P1|Overall Study|Lack of Efficacy|16
93214|NCT01110200|354429|P2|Overall Study|Withdrawal by Subject|32
93215|NCT01110200|354430|P1|Overall Study|Withdrawal by Subject|25
93216|NCT01110200|354429|P2|Overall Study|Adverse Event|28
93217|NCT01110200|354430|P1|Overall Study|Adverse Event|28
93218|NCT01110005|354461|P2|Overall Study|Withdrawal by Subject|1
93219|NCT01110005|354462|P1|Overall Study|Withdrawal by Subject|0
93220|NCT01110005|354461|P2|Overall Study|missing consent|2
93221|NCT01110005|354462|P1|Overall Study|missing consent|3
93222|NCT01110005|354461|P2|Overall Study|ineligible|2
93223|NCT01110005|354462|P1|Overall Study|ineligible|1
93224|NCT01109979|354474|P2|Overall Study|Withdrawal by Subject|1
93225|NCT01109979|354475|P1|Overall Study|Withdrawal by Subject|0
93226|NCT01109979|354474|P2|Overall Study|Physician Decision|0
93227|NCT01109979|354475|P1|Overall Study|Physician Decision|2
93228|NCT01109849|354483|P5|Adaptive Randomization: Weight Recovery|moved away|0
93229|NCT01109849|354484|P4|Adaptive Randomization: Weight Recovery|moved away|2
93230|NCT01109849|354485|P3|Adaptive Randomization: Weight Recovery|moved away|0
93231|NCT01109849|354486|P2|Adaptive Randomization: Weight Recovery|moved away|0
93232|NCT01109849|354487|P1|Adaptive Randomization: Weight Recovery|moved away|0
93233|NCT01109849|354483|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
93234|NCT01109849|354484|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
93235|NCT01109849|354485|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
93236|NCT01109849|354486|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
93237|NCT01109849|354487|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
93238|NCT01109849|354483|P5|Initial Randomization: ADHD Treatment|move away|0
93239|NCT01109849|354484|P4|Initial Randomization: ADHD Treatment|move away|0
93240|NCT01109849|354485|P3|Initial Randomization: ADHD Treatment|move away|0
93241|NCT01109849|354486|P2|Initial Randomization: ADHD Treatment|move away|7
93242|NCT01109849|354487|P1|Initial Randomization: ADHD Treatment|move away|2
93243|NCT01109849|354483|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
93244|NCT01109849|354484|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
93245|NCT01109849|354485|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
93246|NCT01109849|354486|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
93247|NCT01109849|354487|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
93248|NCT01109849|354483|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
93249|NCT01109849|354484|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
93250|NCT01109849|354485|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
93251|NCT01109849|354486|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
93252|NCT01109849|354487|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
93253|NCT01109849|354483|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
93254|NCT01109849|354484|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
93255|NCT01109849|354485|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
93256|NCT01109849|354486|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
93257|NCT01109849|354487|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
93258|NCT01109524|354556|P1|Overall Study|Not specified|5
93259|NCT01109524|354556|P1|Overall Study|Participant requested to end treatment|4
93260|NCT01109524|354556|P1|Overall Study|No longer meets criteria|2
93261|NCT01109524|354556|P1|Overall Study|Death|2
93262|NCT01109524|354556|P1|Overall Study|Maximum clinical benefit|3
93263|NCT01109524|354556|P1|Overall Study|Withdrawal by Subject|2
93264|NCT01109524|354556|P1|Overall Study|Adverse Event|4
93265|NCT01109524|354556|P1|Overall Study|Study Drug toxicity|6
93266|NCT01109524|354556|P1|Overall Study|Disease Progression|29
93267|NCT01109316|354578|P3|Study Period 3|Withdrawal by Subject|1
93268|NCT01109316|354579|P2|Study Period 3|Withdrawal by Subject|1
93269|NCT01109316|354580|P1|Study Period 3|Withdrawal by Subject|0
93270|NCT01109316|354578|P3|Study Period 3|Lost to Follow-up|0
93271|NCT01109316|354579|P2|Study Period 3|Lost to Follow-up|1
93272|NCT01109316|354580|P1|Study Period 3|Lost to Follow-up|0
93273|NCT01109316|354578|P3|Study Period 2|Withdrawal by Subject|0
93274|NCT01109316|354579|P2|Study Period 2|Withdrawal by Subject|1
93275|NCT01109316|354580|P1|Study Period 2|Withdrawal by Subject|1
93276|NCT01109316|354578|P3|Study Period 2|Protocol Violation|0
93277|NCT01109316|354579|P2|Study Period 2|Protocol Violation|1
93278|NCT01109316|354580|P1|Study Period 2|Protocol Violation|0
93279|NCT01109316|354578|P3|Study Period 2|Physician Decision|1
93280|NCT01109316|354579|P2|Study Period 2|Physician Decision|0
93281|NCT01109316|354580|P1|Study Period 2|Physician Decision|0
93282|NCT01109316|354578|P3|Study Period 2|Entry Criteria Not Met|1
93283|NCT01109316|354579|P2|Study Period 2|Entry Criteria Not Met|0
93284|NCT01109316|354580|P1|Study Period 2|Entry Criteria Not Met|0
93285|NCT01109316|354578|P3|Study Period 1|Sponsor Decision|2
93286|NCT01109316|354579|P2|Study Period 1|Sponsor Decision|0
93287|NCT01109316|354580|P1|Study Period 1|Sponsor Decision|0
93288|NCT01109316|354578|P3|Study Period 1|Withdrawal by Subject|2
93289|NCT01109316|354579|P2|Study Period 1|Withdrawal by Subject|1
93290|NCT01109316|354580|P1|Study Period 1|Withdrawal by Subject|0
93291|NCT01109316|354578|P3|Study Period 1|Lost to Follow-up|0
93292|NCT01109316|354579|P2|Study Period 1|Lost to Follow-up|2
93293|NCT01109316|354580|P1|Study Period 1|Lost to Follow-up|0
93294|NCT01109316|354578|P3|Study Period 1|Adverse Event|0
93295|NCT01109316|354579|P2|Study Period 1|Adverse Event|1
93296|NCT01109316|354580|P1|Study Period 1|Adverse Event|0
93297|NCT01109173|354628|P4|Overall Study|Not Specifiied|14
93298|NCT01109173|354629|P3|Overall Study|Not Specifiied|9
93299|NCT01109173|354630|P2|Overall Study|Not Specifiied|4
93300|NCT01109173|354631|P1|Overall Study|Not Specifiied|5
93301|NCT01109173|354628|P4|Overall Study|Patient Did Not Use Study Medication|7
93302|NCT01109173|354629|P3|Overall Study|Patient Did Not Use Study Medication|11
93303|NCT01109173|354630|P2|Overall Study|Patient Did Not Use Study Medication|26
93304|NCT01109173|354631|P1|Overall Study|Patient Did Not Use Study Medication|34
93305|NCT01109173|354628|P4|Overall Study|Protocol Violation|2
93306|NCT01109173|354629|P3|Overall Study|Protocol Violation|1
93307|NCT01109173|354630|P2|Overall Study|Protocol Violation|5
93308|NCT01109173|354631|P1|Overall Study|Protocol Violation|4
93309|NCT01109173|354628|P4|Overall Study|Treatment Failure|64
93310|NCT01109173|354629|P3|Overall Study|Treatment Failure|69
93311|NCT01109173|354630|P2|Overall Study|Treatment Failure|32
93312|NCT01109173|354631|P1|Overall Study|Treatment Failure|25
93313|NCT01109173|354628|P4|Overall Study|Noncompliance|0
93314|NCT01109173|354629|P3|Overall Study|Noncompliance|0
93315|NCT01109173|354630|P2|Overall Study|Noncompliance|1
93316|NCT01109173|354631|P1|Overall Study|Noncompliance|0
93317|NCT01109173|354628|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
93318|NCT01109173|354629|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
93319|NCT01109173|354630|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
93320|NCT01109173|354631|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
93321|NCT01109173|354628|P4|Overall Study|Lost to Follow-up|0
93322|NCT01109173|354629|P3|Overall Study|Lost to Follow-up|0
93323|NCT01109173|354630|P2|Overall Study|Lost to Follow-up|1
93324|NCT01109173|354631|P1|Overall Study|Lost to Follow-up|0
93325|NCT01109173|354628|P4|Overall Study|Adverse Event|6
93326|NCT01109173|354629|P3|Overall Study|Adverse Event|9
93327|NCT01109173|354630|P2|Overall Study|Adverse Event|17
93328|NCT01109173|354631|P1|Overall Study|Adverse Event|15
93329|NCT01108809|354697|P1|Overall Study|Lost to Follow-up|1
93330|NCT01108809|354697|P1|Overall Study|Adverse Event|3
93331|NCT01108796|354714|P2|Overall Study|Lost to Follow-up|6
93332|NCT01108796|354715|P1|Overall Study|Lost to Follow-up|7
93333|NCT01108796|354714|P2|Overall Study|Adverse Event|1
93334|NCT01108796|354715|P1|Overall Study|Adverse Event|0
93335|NCT01108731|354758|P2|Overall Study|Adverse Event|3
93336|NCT01108731|354759|P1|Overall Study|Adverse Event|3
93337|NCT01108731|354758|P2|Overall Study|Withdrawal by Subject|1
93338|NCT01108731|354759|P1|Overall Study|Withdrawal by Subject|1
93339|NCT01108718|354771|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
93340|NCT01108718|354772|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
93341|NCT01108523|354777|P1|Overall Study|Protocol Violation|4
93342|NCT01108510|354784|P2|Overall Study|Death|1
93343|NCT01108510|354785|P1|Overall Study|Death|1
93344|NCT01108510|354784|P2|Overall Study|Pregnancy|3
93345|NCT01108510|354785|P1|Overall Study|Pregnancy|0
93346|NCT01108510|354784|P2|Overall Study|Lack of Efficacy|0
93347|NCT01108510|354785|P1|Overall Study|Lack of Efficacy|3
93348|NCT01108510|354784|P2|Overall Study|Participant Noncompliance|7
93349|NCT01108510|354785|P1|Overall Study|Participant Noncompliance|5
93350|NCT01108510|354784|P2|Overall Study|Investigator’s Discretion|10
93351|NCT01108510|354785|P1|Overall Study|Investigator’s Discretion|12
93352|NCT01108510|354784|P2|Overall Study|Withdrew Consent|15
93353|NCT01108510|354785|P1|Overall Study|Withdrew Consent|21
93354|NCT01108510|354784|P2|Overall Study|Lost to Follow-up|17
93355|NCT01108510|354785|P1|Overall Study|Lost to Follow-up|20
93356|NCT01108510|354784|P2|Overall Study|Adverse Event|19
93357|NCT01108510|354785|P1|Overall Study|Adverse Event|26
93358|NCT01108510|354784|P2|Overall Study|Joined Another Gilead-sponsored Study|195
93359|NCT01108510|354785|P1|Overall Study|Joined Another Gilead-sponsored Study|186
93360|NCT01108510|354784|P2|Overall Study|Randomized but Not Treated|1
93361|NCT01108510|354785|P1|Overall Study|Randomized but Not Treated|5
93362|NCT01108458|354805|P1|Overall Study|Withdrawal by Subject|1
93363|NCT01108341|354857|P1|Overall Study|not specified|1
93364|NCT01108341|354857|P1|Overall Study|Lost to Follow-up|1
93365|NCT01108341|354857|P1|Overall Study|Withdrawal by Subject|1
93366|NCT01108341|354857|P1|Overall Study|Death|2
93367|NCT01108263|354864|P2|Overall Study|Adverse Event|1
93368|NCT01108263|354865|P1|Overall Study|Adverse Event|0
93369|NCT01108237|354875|P2|Overall Study|Did not meet criteria for analysis|0
93370|NCT01108237|354876|P1|Overall Study|Did not meet criteria for analysis|7
93371|NCT01108237|354875|P2|Overall Study|No alignment data|17
93372|NCT01108237|354876|P1|Overall Study|No alignment data|2
93373|NCT01108185|354882|P1|Overall Study|Lost to Follow-up|12
93374|NCT01108185|354882|P1|Overall Study|Non-compliance|15
93375|NCT01108068|354918|P2|Overall Study|5 not started, 1 stop due to side effect|0
93376|NCT01108068|354919|P1|Overall Study|5 not started, 1 stop due to side effect|6
93377|NCT01108055|354926|P1|Overall Study|Not evaluable- didn't complete treatment|4
93378|NCT01108055|354926|P1|Overall Study|Ineligible|11
93379|NCT01107925|354964|P6|Period 2|Withdrawal by Subject|1
93380|NCT01107925|354965|P5|Period 2|Withdrawal by Subject|0
93381|NCT01107925|354966|P4|Period 2|Withdrawal by Subject|0
93382|NCT01107925|354967|P3|Period 2|Withdrawal by Subject|0
93383|NCT01107925|354968|P2|Period 2|Withdrawal by Subject|1
93384|NCT01107925|354969|P1|Period 2|Withdrawal by Subject|0
93385|NCT01107925|354964|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
93386|NCT01107925|354965|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
93387|NCT01107925|354966|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
93388|NCT01107925|354967|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
93389|NCT01107925|354968|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
93390|NCT01107925|354969|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
93391|NCT01107912|355007|P6|Period 3|Withdrawal by Subject|0
93392|NCT01107912|355008|P5|Period 3|Withdrawal by Subject|0
93393|NCT01107912|355009|P4|Period 3|Withdrawal by Subject|1
93394|NCT01107912|355010|P3|Period 3|Withdrawal by Subject|0
93395|NCT01107912|355011|P2|Period 3|Withdrawal by Subject|0
93396|NCT01107912|355012|P1|Period 3|Withdrawal by Subject|0
93397|NCT01107912|355007|P6|Period 3|Adverse Event|0
93398|NCT01107912|355008|P5|Period 3|Adverse Event|0
93399|NCT01107912|355009|P4|Period 3|Adverse Event|0
93400|NCT01107912|355010|P3|Period 3|Adverse Event|1
93401|NCT01107912|355011|P2|Period 3|Adverse Event|1
93402|NCT01107912|355012|P1|Period 3|Adverse Event|0
93403|NCT01107912|355007|P6|Period 2|Physician Decision|0
93404|NCT01107912|355008|P5|Period 2|Physician Decision|0
93405|NCT01107912|355009|P4|Period 2|Physician Decision|0
93406|NCT01107912|355010|P3|Period 2|Physician Decision|1
93407|NCT01107912|355011|P2|Period 2|Physician Decision|0
93408|NCT01107912|355012|P1|Period 2|Physician Decision|0
93409|NCT01107912|355007|P6|Period 1|Withdrawal by Subject|0
93410|NCT01107912|355008|P5|Period 1|Withdrawal by Subject|0
93411|NCT01107912|355009|P4|Period 1|Withdrawal by Subject|0
93412|NCT01107912|355010|P3|Period 1|Withdrawal by Subject|0
93413|NCT01107912|355011|P2|Period 1|Withdrawal by Subject|0
93414|NCT01107912|355012|P1|Period 1|Withdrawal by Subject|1
93415|NCT01107912|355007|P6|Period 1|Physician Decision|0
93416|NCT01107912|355008|P5|Period 1|Physician Decision|1
93417|NCT01107912|355009|P4|Period 1|Physician Decision|0
93418|NCT01107912|355010|P3|Period 1|Physician Decision|0
93419|NCT01107912|355011|P2|Period 1|Physician Decision|0
93420|NCT01107912|355012|P1|Period 1|Physician Decision|0
93421|NCT01107912|355007|P6|Period 1|Adverse Event|0
93422|NCT01107912|355008|P5|Period 1|Adverse Event|2
93423|NCT01107912|355009|P4|Period 1|Adverse Event|0
93424|NCT01107912|355010|P3|Period 1|Adverse Event|0
93425|NCT01107912|355011|P2|Period 1|Adverse Event|0
93426|NCT01107912|355012|P1|Period 1|Adverse Event|0
93427|NCT01107899|355049|P3|Overall Study|Withdrawal by Subject|1
93428|NCT01107899|355050|P2|Overall Study|Withdrawal by Subject|0
93429|NCT01107899|355051|P1|Overall Study|Withdrawal by Subject|0
93430|NCT01107899|355049|P3|Overall Study|Physician Decision|3
93431|NCT01107899|355050|P2|Overall Study|Physician Decision|0
93432|NCT01107899|355051|P1|Overall Study|Physician Decision|5
93433|NCT01107886|355097|P2|Overall Study|Administrative withdrawal of consent|5
93434|NCT01107886|355098|P1|Overall Study|Administrative withdrawal of consent|7
93435|NCT01107886|355097|P2|Overall Study|Withdrawal by Subject|196
93436|NCT01107886|355098|P1|Overall Study|Withdrawal by Subject|180
93437|NCT01107886|355097|P2|Overall Study|Lost to Follow-up|13
93438|NCT01107886|355098|P1|Overall Study|Lost to Follow-up|15
93439|NCT01107743|355127|P1|Overall Study|Protocol Violation|46
93440|NCT01107535|355226|P1|Overall Study|Death|5
93441|NCT01107457|355239|P6|Part B and C|Clinical Relapse|4
93442|NCT01107457|355240|P5|Part B and C|Clinical Relapse|0
93443|NCT01107457|355241|P4|Part B and C|Clinical Relapse|0
93444|NCT01107457|355242|P3|Part B and C|Clinical Relapse|0
93445|NCT01107457|355243|P2|Part B and C|Clinical Relapse|0
93446|NCT01107457|355244|P1|Part B and C|Clinical Relapse|0
93447|NCT01107457|355239|P6|Part B and C|Withdrawal by Subject|16
93448|NCT01107457|355240|P5|Part B and C|Withdrawal by Subject|0
93449|NCT01107457|355241|P4|Part B and C|Withdrawal by Subject|0
93450|NCT01107457|355242|P3|Part B and C|Withdrawal by Subject|0
93451|NCT01107457|355243|P2|Part B and C|Withdrawal by Subject|0
93452|NCT01107457|355244|P1|Part B and C|Withdrawal by Subject|0
93453|NCT01107457|355239|P6|Part B and C|Sponsor Decision|66
93454|NCT01107457|355240|P5|Part B and C|Sponsor Decision|0
93455|NCT01107457|355241|P4|Part B and C|Sponsor Decision|0
93456|NCT01107457|355242|P3|Part B and C|Sponsor Decision|0
93457|NCT01107457|355243|P2|Part B and C|Sponsor Decision|0
93458|NCT01107457|355244|P1|Part B and C|Sponsor Decision|0
93459|NCT01107457|355239|P6|Part B and C|Protocol Violation|1
93460|NCT01107457|355240|P5|Part B and C|Protocol Violation|0
93461|NCT01107457|355241|P4|Part B and C|Protocol Violation|0
93462|NCT01107457|355242|P3|Part B and C|Protocol Violation|0
93463|NCT01107457|355243|P2|Part B and C|Protocol Violation|0
93464|NCT01107457|355244|P1|Part B and C|Protocol Violation|0
93465|NCT01107457|355239|P6|Part B and C|Lost to Follow-up|10
93466|NCT01107457|355240|P5|Part B and C|Lost to Follow-up|0
93467|NCT01107457|355241|P4|Part B and C|Lost to Follow-up|0
93468|NCT01107457|355242|P3|Part B and C|Lost to Follow-up|0
93469|NCT01107457|355243|P2|Part B and C|Lost to Follow-up|0
93470|NCT01107457|355244|P1|Part B and C|Lost to Follow-up|0
93471|NCT01107457|355239|P6|Part B and C|Lack of Efficacy|7
93472|NCT01107457|355240|P5|Part B and C|Lack of Efficacy|0
93473|NCT01107457|355241|P4|Part B and C|Lack of Efficacy|0
93474|NCT01107457|355242|P3|Part B and C|Lack of Efficacy|0
93475|NCT01107457|355243|P2|Part B and C|Lack of Efficacy|0
93476|NCT01107457|355244|P1|Part B and C|Lack of Efficacy|0
93477|NCT01107457|355239|P6|Part B and C|Physician Decision|3
93478|NCT01107457|355240|P5|Part B and C|Physician Decision|0
93479|NCT01107457|355241|P4|Part B and C|Physician Decision|0
93480|NCT01107457|355242|P3|Part B and C|Physician Decision|0
93481|NCT01107457|355243|P2|Part B and C|Physician Decision|0
93482|NCT01107457|355244|P1|Part B and C|Physician Decision|0
93483|NCT01107457|355239|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
93484|NCT01107457|355240|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
93485|NCT01107457|355241|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
93486|NCT01107457|355242|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
93487|NCT01107457|355243|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
93488|NCT01107457|355244|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
93489|NCT01107457|355239|P6|Part B and C|Adverse Event|12
93490|NCT01107457|355240|P5|Part B and C|Adverse Event|0
93491|NCT01107457|355241|P4|Part B and C|Adverse Event|0
93492|NCT01107457|355242|P3|Part B and C|Adverse Event|0
93493|NCT01107457|355243|P2|Part B and C|Adverse Event|0
93494|NCT01107457|355244|P1|Part B and C|Adverse Event|0
93495|NCT01107457|355239|P6|Part A|Protocol Violation|0
93496|NCT01107457|355240|P5|Part A|Protocol Violation|0
93497|NCT01107457|355241|P4|Part A|Protocol Violation|0
93498|NCT01107457|355242|P3|Part A|Protocol Violation|0
93499|NCT01107457|355243|P2|Part A|Protocol Violation|1
93500|NCT01107457|355244|P1|Part A|Protocol Violation|0
93501|NCT01107457|355239|P6|Part A|Lack of Efficacy|0
93502|NCT01107457|355240|P5|Part A|Lack of Efficacy|0
93503|NCT01107457|355241|P4|Part A|Lack of Efficacy|0
93504|NCT01107457|355242|P3|Part A|Lack of Efficacy|0
93505|NCT01107457|355243|P2|Part A|Lack of Efficacy|0
93506|NCT01107457|355244|P1|Part A|Lack of Efficacy|1
93507|NCT01107457|355239|P6|Part A|Lost to Follow-up|0
93508|NCT01107457|355240|P5|Part A|Lost to Follow-up|0
93509|NCT01107457|355241|P4|Part A|Lost to Follow-up|0
93510|NCT01107457|355242|P3|Part A|Lost to Follow-up|0
93511|NCT01107457|355243|P2|Part A|Lost to Follow-up|1
93512|NCT01107457|355244|P1|Part A|Lost to Follow-up|0
93513|NCT01107457|355239|P6|Part A|Withdrawal by Subject|0
93514|NCT01107457|355240|P5|Part A|Withdrawal by Subject|1
93515|NCT01107457|355241|P4|Part A|Withdrawal by Subject|3
93516|NCT01107457|355242|P3|Part A|Withdrawal by Subject|0
93517|NCT01107457|355243|P2|Part A|Withdrawal by Subject|3
93518|NCT01107457|355244|P1|Part A|Withdrawal by Subject|3
93519|NCT01107457|355239|P6|Part A|Adverse Event|0
93520|NCT01107457|355240|P5|Part A|Adverse Event|0
93521|NCT01107457|355241|P4|Part A|Adverse Event|0
93522|NCT01107457|355242|P3|Part A|Adverse Event|1
93523|NCT01107457|355243|P2|Part A|Adverse Event|2
93524|NCT01107457|355244|P1|Part A|Adverse Event|1
93525|NCT01107418|355374|P1|Overall Study|Entered Extension Study|1
93526|NCT01107418|355374|P1|Overall Study|Started Other Therapy|1
93527|NCT01107418|355374|P1|Overall Study|Study Closing|1
93528|NCT01107418|355374|P1|Overall Study|Withdrawal by Subject|1
93529|NCT01107418|355374|P1|Overall Study|Adverse Event|3
93530|NCT01107418|355374|P1|Overall Study|Disease Progression|45
93531|NCT01107405|355447|P5|Overall Study|Protocol Violation|0
93532|NCT01107405|355448|P4|Overall Study|Protocol Violation|1
93533|NCT01107405|355449|P3|Overall Study|Protocol Violation|1
93534|NCT01107405|355450|P2|Overall Study|Protocol Violation|0
93535|NCT01107405|355451|P1|Overall Study|Protocol Violation|0
93536|NCT01107405|355447|P5|Overall Study|Withdrawal by Subject|1
93537|NCT01107405|355448|P4|Overall Study|Withdrawal by Subject|2
93538|NCT01107405|355449|P3|Overall Study|Withdrawal by Subject|1
93539|NCT01107405|355450|P2|Overall Study|Withdrawal by Subject|0
93540|NCT01107405|355451|P1|Overall Study|Withdrawal by Subject|1
93541|NCT01107405|355447|P5|Overall Study|Adverse Event|2
93542|NCT01107405|355448|P4|Overall Study|Adverse Event|0
93543|NCT01107405|355449|P3|Overall Study|Adverse Event|0
93544|NCT01107405|355450|P2|Overall Study|Adverse Event|1
93545|NCT01107405|355451|P1|Overall Study|Adverse Event|1
93546|NCT01107392|355490|P2|Overall Study|Administrative decision|0
93547|NCT01107392|355491|P1|Overall Study|Administrative decision|1
93548|NCT01107392|355490|P2|Overall Study|Personal Reasons|3
93549|NCT01107392|355491|P1|Overall Study|Personal Reasons|2
93550|NCT01107392|355490|P2|Overall Study|Adverse Event|0
93551|NCT01107392|355491|P1|Overall Study|Adverse Event|2
93552|NCT01107379|355503|P1|Overall Study|Lost to Follow-up|3
93553|NCT01107379|355503|P1|Overall Study|Withdrawal by Subject|18
93554|NCT01107353|355514|P2|Overall Study|Positive Drug Screen|0
93555|NCT01107353|355515|P1|Overall Study|Positive Drug Screen|1
93556|NCT01107197|355523|P2|Overall Study|Withdrawal by Subject|5
93557|NCT01107197|355524|P1|Overall Study|Withdrawal by Subject|3
93558|NCT01107197|355523|P2|Overall Study|Lost to Follow-up|8
93559|NCT01107197|355524|P1|Overall Study|Lost to Follow-up|5
93560|NCT01107197|355523|P2|Overall Study|Death|10
93561|NCT01107197|355524|P1|Overall Study|Death|12
93562|NCT01106976|355559|P1|Overall Study|Lost to Follow-up|8
93563|NCT01106911|355573|P1|Overall Study|deemed ineligible after screening|3
93564|NCT01106911|355573|P1|Overall Study|Physician Decision|2
93565|NCT01106898|355577|P1|Overall Study|Adverse Event|6
93566|NCT01106846|355622|P2|Overall Study|Change in surgical procedure|1
93567|NCT01106846|355623|P1|Overall Study|Change in surgical procedure|0
93568|NCT01106690|355632|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
93569|NCT01106690|355633|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
93570|NCT01106690|355634|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
93571|NCT01106690|355632|P3|Extension Period: Week 26 to Week 52|Not specified|4
93572|NCT01106690|355633|P2|Extension Period: Week 26 to Week 52|Not specified|3
93573|NCT01106690|355634|P1|Extension Period: Week 26 to Week 52|Not specified|8
93574|NCT01106690|355632|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
93575|NCT01106690|355633|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
93576|NCT01106690|355634|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
93577|NCT01106690|355632|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
93578|NCT01106690|355633|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
93579|NCT01106690|355634|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
93580|NCT01106690|355632|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
93581|NCT01106690|355633|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
93582|NCT01106690|355634|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
93583|NCT01106690|355632|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
93584|NCT01106690|355633|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
93585|NCT01106690|355634|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
93586|NCT01106690|355632|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
93587|NCT01106690|355633|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
93588|NCT01106690|355634|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
93589|NCT01106690|355632|P3|Core Period: Baseline to Week 26|Not specified|6
93590|NCT01106690|355633|P2|Core Period: Baseline to Week 26|Not specified|2
93591|NCT01106690|355634|P1|Core Period: Baseline to Week 26|Not specified|10
93592|NCT01106690|355632|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
93593|NCT01106690|355633|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
93594|NCT01106690|355634|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
93595|NCT01106690|355632|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
93596|NCT01106690|355633|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
93597|NCT01106690|355634|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
93598|NCT01106690|355632|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
93599|NCT01106690|355633|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
93600|NCT01106690|355634|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
93601|NCT01106690|355632|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
93602|NCT01106690|355633|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
93603|NCT01106690|355634|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
93604|NCT01106690|355632|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
93605|NCT01106690|355633|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
93606|NCT01106690|355634|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
93607|NCT01106690|355632|P3|Core Period: Baseline to Week 26|Protocol Violation|0
93608|NCT01106690|355633|P2|Core Period: Baseline to Week 26|Protocol Violation|0
93609|NCT01106690|355634|P1|Core Period: Baseline to Week 26|Protocol Violation|1
93610|NCT01106690|355632|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
93611|NCT01106690|355633|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
93612|NCT01106690|355634|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
93613|NCT01106690|355632|P3|Core Period: Baseline to Week 26|Adverse Event|4
93614|NCT01106690|355633|P2|Core Period: Baseline to Week 26|Adverse Event|1
93615|NCT01106690|355634|P1|Core Period: Baseline to Week 26|Adverse Event|6
93616|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Not specified|5
93617|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Not specified|8
93618|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Not specified|5
93619|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Not specified|6
93620|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
93621|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
93622|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
93623|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
93624|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
93625|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
93626|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
93627|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
93628|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
93629|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
93630|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
93631|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
93632|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
93633|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
93634|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
93635|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
93636|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
93637|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
93638|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
93639|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
93640|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
93641|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
93642|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
93643|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
93644|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
93645|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
93646|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
93647|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
93648|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Death|1
93649|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Death|0
93650|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Death|0
93651|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Death|0
93652|NCT01106677|355670|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
93653|NCT01106677|355671|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
93654|NCT01106677|355672|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
93655|NCT01106677|355673|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
93656|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Pregnancy|0
93657|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Pregnancy|0
93658|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Pregnancy|1
93659|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Pregnancy|0
93660|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Not specified|23
93661|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Not specified|8
93662|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Not specified|14
93663|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Not specified|8
93664|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Product quality complaint|0
93665|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Product quality complaint|1
93666|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Product quality complaint|1
93667|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Product quality complaint|0
93668|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
93669|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
93670|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
93671|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
93672|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
93673|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
93674|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
93675|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
93676|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
93677|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
93678|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
93679|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
93680|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
93681|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
93682|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
93683|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
93684|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Protocol Violation|3
93685|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Protocol Violation|0
93686|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Protocol Violation|1
93687|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Protocol Violation|0
93688|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Physician Decision|1
93689|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Physician Decision|3
93690|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Physician Decision|1
93691|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Physician Decision|2
93692|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
93693|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
93694|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
93695|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
93696|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
93697|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
93698|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
93699|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
93700|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Death|0
93701|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Death|1
93702|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Death|0
93703|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Death|0
93704|NCT01106677|355670|P4|Core Period: Baseline to Week 26|Adverse Event|8
93705|NCT01106677|355671|P3|Core Period: Baseline to Week 26|Adverse Event|6
93706|NCT01106677|355672|P2|Core Period: Baseline to Week 26|Adverse Event|18
93707|NCT01106677|355673|P1|Core Period: Baseline to Week 26|Adverse Event|7
93708|NCT01106651|355736|P3|Overall Study|Death|0
93709|NCT01106651|355737|P2|Overall Study|Death|3
93710|NCT01106651|355738|P1|Overall Study|Death|0
93711|NCT01106651|355736|P3|Overall Study|Not specified|21
93712|NCT01106651|355737|P2|Overall Study|Not specified|31
93713|NCT01106651|355738|P1|Overall Study|Not specified|34
93714|NCT01106651|355736|P3|Overall Study|Noncompliance with study drug|2
93715|NCT01106651|355737|P2|Overall Study|Noncompliance with study drug|0
93716|NCT01106651|355738|P1|Overall Study|Noncompliance with study drug|1
93717|NCT01106651|355736|P3|Overall Study|Withdrawal by Subject|4
93718|NCT01106651|355737|P2|Overall Study|Withdrawal by Subject|7
93719|NCT01106651|355738|P1|Overall Study|Withdrawal by Subject|14
93720|NCT01106651|355736|P3|Overall Study|Protocol Violation|1
93721|NCT01106651|355737|P2|Overall Study|Protocol Violation|2
93722|NCT01106651|355738|P1|Overall Study|Protocol Violation|1
93723|NCT01106651|355736|P3|Overall Study|Physician Decision|1
93724|NCT01106651|355737|P2|Overall Study|Physician Decision|3
93725|NCT01106651|355738|P1|Overall Study|Physician Decision|4
93726|NCT01106651|355736|P3|Overall Study|Lost to Follow-up|6
93727|NCT01106651|355737|P2|Overall Study|Lost to Follow-up|2
93728|NCT01106651|355738|P1|Overall Study|Lost to Follow-up|8
93729|NCT01106651|355736|P3|Overall Study|Adverse Event|23
93730|NCT01106651|355737|P2|Overall Study|Adverse Event|9
93731|NCT01106651|355738|P1|Overall Study|Adverse Event|17
93732|NCT01106625|355791|P3|Extension Period: Week 26 to Week 52|Not specified|4
93733|NCT01106625|355792|P2|Extension Period: Week 26 to Week 52|Not specified|5
93734|NCT01106625|355793|P1|Extension Period: Week 26 to Week 52|Not specified|5
93735|NCT01106625|355791|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
93736|NCT01106625|355792|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
93737|NCT01106625|355793|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
93738|NCT01106625|355791|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
93739|NCT01106625|355792|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
93740|NCT01106625|355793|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
93741|NCT01106625|355791|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
93742|NCT01106625|355792|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
93743|NCT01106625|355793|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
93744|NCT01106625|355791|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
93745|NCT01106625|355792|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
93746|NCT01106625|355793|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
93747|NCT01106625|355791|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
93748|NCT01106625|355792|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
93749|NCT01106625|355793|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
93750|NCT01106625|355791|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
93751|NCT01106625|355792|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
93752|NCT01106625|355793|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
93753|NCT01106625|355791|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
93754|NCT01106625|355792|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
93755|NCT01106625|355793|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
93756|NCT01106625|355791|P3|Core Period: Baseline to Week 26|Not specified|4
93757|NCT01106625|355792|P2|Core Period: Baseline to Week 26|Not specified|7
93758|NCT01106625|355793|P1|Core Period: Baseline to Week 26|Not specified|8
93759|NCT01106625|355791|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
93760|NCT01106625|355792|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
93761|NCT01106625|355793|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
93762|NCT01106625|355791|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
93763|NCT01106625|355792|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
93764|NCT01106625|355793|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
93765|NCT01106625|355791|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
93766|NCT01106625|355792|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
93767|NCT01106625|355793|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
93768|NCT01106625|355791|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
93769|NCT01106625|355792|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
93770|NCT01106625|355793|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
93771|NCT01106625|355791|P3|Core Period: Baseline to Week 26|Protocol Violation|3
93772|NCT01106625|355792|P2|Core Period: Baseline to Week 26|Protocol Violation|1
93773|NCT01106625|355793|P1|Core Period: Baseline to Week 26|Protocol Violation|2
93774|NCT01106625|355791|P3|Core Period: Baseline to Week 26|Physician Decision|0
93775|NCT01106625|355792|P2|Core Period: Baseline to Week 26|Physician Decision|0
93776|NCT01106625|355793|P1|Core Period: Baseline to Week 26|Physician Decision|1
93777|NCT01106625|355791|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
93778|NCT01106625|355792|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
93779|NCT01106625|355793|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
93780|NCT01106625|355791|P3|Core Period: Baseline to Week 26|Adverse Event|8
93781|NCT01106625|355792|P2|Core Period: Baseline to Week 26|Adverse Event|8
93782|NCT01106625|355793|P1|Core Period: Baseline to Week 26|Adverse Event|6
93783|NCT01106586|355824|P2|Overall Study|Participant Transferred to Another Study|197
93784|NCT01106586|355825|P1|Overall Study|Participant Transferred to Another Study|212
93785|NCT01106586|355824|P2|Overall Study|Protocol Violation|0
93786|NCT01106586|355825|P1|Overall Study|Protocol Violation|1
93787|NCT01106586|355824|P2|Overall Study|Participant Noncompliance|10
93788|NCT01106586|355825|P1|Overall Study|Participant Noncompliance|12
93789|NCT01106586|355824|P2|Overall Study|Lost to Follow-up|20
93790|NCT01106586|355825|P1|Overall Study|Lost to Follow-up|24
93791|NCT01106586|355824|P2|Overall Study|Withdrew Consent|30
93792|NCT01106586|355825|P1|Overall Study|Withdrew Consent|18
93793|NCT01106586|355824|P2|Overall Study|Investigator's Discretion|8
93794|NCT01106586|355825|P1|Overall Study|Investigator's Discretion|5
93795|NCT01106586|355824|P2|Overall Study|Lack of Efficacy|0
93796|NCT01106586|355825|P1|Overall Study|Lack of Efficacy|1
93797|NCT01106586|355824|P2|Overall Study|Pregnancy|2
93798|NCT01106586|355825|P1|Overall Study|Pregnancy|2
93799|NCT01106586|355824|P2|Overall Study|Death|3
93800|NCT01106586|355825|P1|Overall Study|Death|1
93801|NCT01106586|355824|P2|Overall Study|Adverse Event|15
93802|NCT01106586|355825|P1|Overall Study|Adverse Event|9
93803|NCT01106534|355843|P1|Overall Study|Physician Decision|1
93804|NCT01106534|355843|P1|Overall Study|Death|16
93805|NCT01106534|355843|P1|Overall Study|Lost to Follow-up|2
93806|NCT01106534|355843|P1|Overall Study|Withdrawal by Subject|18
93807|NCT01106430|355875|P2|Overall Study|Withdrawal by Subject|4
93808|NCT01106430|355876|P1|Overall Study|Withdrawal by Subject|8
93809|NCT01106430|355875|P2|Overall Study|Protocol Violation|2
93810|NCT01106430|355876|P1|Overall Study|Protocol Violation|7
93811|NCT01106430|355875|P2|Overall Study|Previous Use Of Marijuana|0
93812|NCT01106430|355876|P1|Overall Study|Previous Use Of Marijuana|1
93813|NCT01106430|355875|P2|Overall Study|Hard Time Swallowing The Pills|0
93814|NCT01106430|355876|P1|Overall Study|Hard Time Swallowing The Pills|1
93815|NCT01106430|355875|P2|Overall Study|Noncompliance|1
93816|NCT01106430|355876|P1|Overall Study|Noncompliance|0
93817|NCT01106430|355875|P2|Overall Study|Refused To Take Medication|1
93818|NCT01106430|355876|P1|Overall Study|Refused To Take Medication|0
93819|NCT01106430|355875|P2|Overall Study|Moved Out Of State|1
93820|NCT01106430|355876|P1|Overall Study|Moved Out Of State|0
93821|NCT01106430|355875|P2|Overall Study|Early Termination Requested By Sponsor|0
93822|NCT01106430|355876|P1|Overall Study|Early Termination Requested By Sponsor|1
93823|NCT01106430|355875|P2|Overall Study|Lost to Follow-up|1
93824|NCT01106430|355876|P1|Overall Study|Lost to Follow-up|5
93825|NCT01106430|355875|P2|Overall Study|Lack of Efficacy|13
93826|NCT01106430|355876|P1|Overall Study|Lack of Efficacy|2
93827|NCT01106430|355875|P2|Overall Study|Adverse Event|10
93828|NCT01106430|355876|P1|Overall Study|Adverse Event|8
93829|NCT01106404|355898|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
93830|NCT01106404|355899|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
93831|NCT01106404|355898|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
93832|NCT01106404|355899|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
93833|NCT01106404|355898|P2|Period I (First 6 Weeks)|Physician Decision|0
93834|NCT01106404|355899|P1|Period I (First 6 Weeks)|Physician Decision|1
93835|NCT01106404|355898|P2|Period I (First 6 Weeks)|Adverse Event|0
93836|NCT01106404|355899|P1|Period I (First 6 Weeks)|Adverse Event|2
93837|NCT01106352|355922|P5|Overall Study|Home hospice since July 2013|0
93838|NCT01106352|355923|P4|Overall Study|Home hospice since July 2013|1
93839|NCT01106352|355924|P3|Overall Study|Home hospice since July 2013|0
93840|NCT01106352|355925|P2|Overall Study|Home hospice since July 2013|0
93841|NCT01106352|355926|P1|Overall Study|Home hospice since July 2013|0
93842|NCT01106352|355922|P5|Overall Study|Subject entered hospice|0
93843|NCT01106352|355923|P4|Overall Study|Subject entered hospice|1
93844|NCT01106352|355924|P3|Overall Study|Subject entered hospice|0
93845|NCT01106352|355925|P2|Overall Study|Subject entered hospice|0
93846|NCT01106352|355926|P1|Overall Study|Subject entered hospice|0
93847|NCT01106352|355922|P5|Overall Study|Went on hospice|0
93848|NCT01106352|355923|P4|Overall Study|Went on hospice|1
93849|NCT01106352|355924|P3|Overall Study|Went on hospice|0
93850|NCT01106352|355925|P2|Overall Study|Went on hospice|0
93851|NCT01106352|355926|P1|Overall Study|Went on hospice|0
93852|NCT01106352|355922|P5|Overall Study|Withdrawal by Subject|2
93853|NCT01106352|355923|P4|Overall Study|Withdrawal by Subject|3
93854|NCT01106352|355924|P3|Overall Study|Withdrawal by Subject|0
93855|NCT01106352|355925|P2|Overall Study|Withdrawal by Subject|0
93856|NCT01106352|355926|P1|Overall Study|Withdrawal by Subject|0
93857|NCT01106352|355922|P5|Overall Study|Disease progression|0
93858|NCT01106352|355923|P4|Overall Study|Disease progression|1
93859|NCT01106352|355924|P3|Overall Study|Disease progression|0
93860|NCT01106352|355925|P2|Overall Study|Disease progression|0
93861|NCT01106352|355926|P1|Overall Study|Disease progression|0
93862|NCT01106352|355922|P5|Overall Study|Death|1
93863|NCT01106352|355923|P4|Overall Study|Death|3
93864|NCT01106352|355924|P3|Overall Study|Death|1
93865|NCT01106352|355925|P2|Overall Study|Death|0
93866|NCT01106352|355926|P1|Overall Study|Death|0
93867|NCT01106352|355922|P5|Overall Study|Lost to Follow-up|1
93868|NCT01106352|355923|P4|Overall Study|Lost to Follow-up|0
93869|NCT01106352|355924|P3|Overall Study|Lost to Follow-up|0
93870|NCT01106352|355925|P2|Overall Study|Lost to Follow-up|0
93871|NCT01106352|355926|P1|Overall Study|Lost to Follow-up|0
93872|NCT01106352|355922|P5|Overall Study|Too ill to come in for the visit|0
93873|NCT01106352|355923|P4|Overall Study|Too ill to come in for the visit|0
93874|NCT01106352|355924|P3|Overall Study|Too ill to come in for the visit|1
93875|NCT01106352|355925|P2|Overall Study|Too ill to come in for the visit|0
93876|NCT01106352|355926|P1|Overall Study|Too ill to come in for the visit|0
93877|NCT01106352|355922|P5|Overall Study|Sponsor Decision|0
93878|NCT01106352|355923|P4|Overall Study|Sponsor Decision|0
93879|NCT01106352|355924|P3|Overall Study|Sponsor Decision|0
93880|NCT01106352|355925|P2|Overall Study|Sponsor Decision|0
93881|NCT01106352|355926|P1|Overall Study|Sponsor Decision|1
93882|NCT01106352|355922|P5|Overall Study|Subjects untreated|4
93883|NCT01106352|355923|P4|Overall Study|Subjects untreated|3
93884|NCT01106352|355924|P3|Overall Study|Subjects untreated|0
93885|NCT01106352|355925|P2|Overall Study|Subjects untreated|0
93886|NCT01106352|355926|P1|Overall Study|Subjects untreated|0
93887|NCT01106287|356022|P4|Overall Study|Adverse Event|0
93888|NCT01106287|356023|P3|Overall Study|Adverse Event|0
93889|NCT01106287|356024|P2|Overall Study|Adverse Event|0
93890|NCT01106287|356025|P1|Overall Study|Adverse Event|1
93891|NCT01106248|356045|P1|Overall Study|Administrative|2
93892|NCT01106248|356045|P1|Overall Study|Adverse Event|1
93893|NCT01106157|356053|P2|Overall Study|Withdrawal by Subject|0
93894|NCT01106157|356054|P1|Overall Study|Withdrawal by Subject|1
93895|NCT01106092|356082|P4|Overall Study|Withdrawal by Subject|1
93896|NCT01106092|356083|P3|Overall Study|Withdrawal by Subject|0
93897|NCT01106092|356084|P2|Overall Study|Withdrawal by Subject|0
93898|NCT01106092|356085|P1|Overall Study|Withdrawal by Subject|0
93899|NCT01106027|356168|P1|Overall Study|Lost graft early, discontinued|1
93900|NCT01106014|356174|P2|Overall Study|Lost to Follow-up|3
93901|NCT01106014|356175|P1|Overall Study|Lost to Follow-up|2
93902|NCT01106014|356174|P2|Overall Study|Administrative reason|6
93903|NCT01106014|356175|P1|Overall Study|Administrative reason|7
93904|NCT01106014|356174|P2|Overall Study|Withdrawal by Subject|37
93905|NCT01106014|356175|P1|Overall Study|Withdrawal by Subject|43
93906|NCT01106014|356174|P2|Overall Study|Adverse Event|42
93907|NCT01106014|356175|P1|Overall Study|Adverse Event|78
93908|NCT01106014|356174|P2|Overall Study|Morbidity or Mortality primary endpoint|242
93909|NCT01106014|356175|P1|Overall Study|Morbidity or Mortality primary endpoint|155
93910|NCT01105975|356195|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
93911|NCT01105975|356196|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
93912|NCT01105975|356197|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
93913|NCT01105975|356198|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
93914|NCT01105975|356199|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
93915|NCT01105975|356200|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
93916|NCT01105975|356201|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
93917|NCT01105975|356202|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
93918|NCT01105975|356203|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
93919|NCT01105975|356204|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
93920|NCT01105975|356195|P10|Overall Study|Protocol Violation|2
93921|NCT01105975|356196|P9|Overall Study|Protocol Violation|2
93922|NCT01105975|356197|P8|Overall Study|Protocol Violation|1
93923|NCT01105975|356198|P7|Overall Study|Protocol Violation|1
93924|NCT01105975|356199|P6|Overall Study|Protocol Violation|1
93925|NCT01105975|356200|P5|Overall Study|Protocol Violation|1
93926|NCT01105975|356201|P4|Overall Study|Protocol Violation|0
93927|NCT01105975|356202|P3|Overall Study|Protocol Violation|2
93928|NCT01105975|356203|P2|Overall Study|Protocol Violation|2
93929|NCT01105975|356204|P1|Overall Study|Protocol Violation|0
93930|NCT01105975|356195|P10|Overall Study|Physician Decision|0
93931|NCT01105975|356196|P9|Overall Study|Physician Decision|0
93932|NCT01105975|356197|P8|Overall Study|Physician Decision|0
93933|NCT01105975|356198|P7|Overall Study|Physician Decision|2
93934|NCT01105975|356199|P6|Overall Study|Physician Decision|0
93935|NCT01105975|356200|P5|Overall Study|Physician Decision|0
93936|NCT01105975|356201|P4|Overall Study|Physician Decision|0
93937|NCT01105975|356202|P3|Overall Study|Physician Decision|0
93938|NCT01105975|356203|P2|Overall Study|Physician Decision|0
93939|NCT01105975|356204|P1|Overall Study|Physician Decision|0
93940|NCT01105975|356195|P10|Overall Study|Lost to Follow-up|0
93941|NCT01105975|356196|P9|Overall Study|Lost to Follow-up|1
93942|NCT01105975|356197|P8|Overall Study|Lost to Follow-up|0
93943|NCT01105975|356198|P7|Overall Study|Lost to Follow-up|0
93944|NCT01105975|356199|P6|Overall Study|Lost to Follow-up|0
93945|NCT01105975|356200|P5|Overall Study|Lost to Follow-up|1
93946|NCT01105975|356201|P4|Overall Study|Lost to Follow-up|1
93947|NCT01105975|356202|P3|Overall Study|Lost to Follow-up|0
93948|NCT01105975|356203|P2|Overall Study|Lost to Follow-up|0
93949|NCT01105975|356204|P1|Overall Study|Lost to Follow-up|1
93950|NCT01105975|356195|P10|Overall Study|Withdrawal by Subject|3
93951|NCT01105975|356196|P9|Overall Study|Withdrawal by Subject|0
93952|NCT01105975|356197|P8|Overall Study|Withdrawal by Subject|1
93953|NCT01105975|356198|P7|Overall Study|Withdrawal by Subject|2
93954|NCT01105975|356199|P6|Overall Study|Withdrawal by Subject|1
93955|NCT01105975|356200|P5|Overall Study|Withdrawal by Subject|4
93956|NCT01105975|356201|P4|Overall Study|Withdrawal by Subject|0
93957|NCT01105975|356202|P3|Overall Study|Withdrawal by Subject|2
93958|NCT01105975|356203|P2|Overall Study|Withdrawal by Subject|2
93959|NCT01105975|356204|P1|Overall Study|Withdrawal by Subject|2
93960|NCT01105975|356195|P10|Overall Study|Adverse Event|4
93961|NCT01105975|356196|P9|Overall Study|Adverse Event|1
93962|NCT01105975|356197|P8|Overall Study|Adverse Event|4
93963|NCT01105975|356198|P7|Overall Study|Adverse Event|2
93964|NCT01105975|356199|P6|Overall Study|Adverse Event|1
93965|NCT01105975|356200|P5|Overall Study|Adverse Event|0
93966|NCT01105975|356201|P4|Overall Study|Adverse Event|1
93967|NCT01105975|356202|P3|Overall Study|Adverse Event|5
93968|NCT01105975|356203|P2|Overall Study|Adverse Event|1
93969|NCT01105975|356204|P1|Overall Study|Adverse Event|2
93970|NCT01105936|356352|P4|Period 3|Protocol Violation|0
93971|NCT01105936|356353|P3|Period 3|Protocol Violation|0
93972|NCT01105936|356354|P2|Period 3|Protocol Violation|2
93973|NCT01105936|356355|P1|Period 3|Protocol Violation|0
93974|NCT01105936|356352|P4|Period 2|Adverse Event|0
93975|NCT01105936|356353|P3|Period 2|Adverse Event|0
93976|NCT01105936|356354|P2|Period 2|Adverse Event|0
93977|NCT01105936|356355|P1|Period 2|Adverse Event|1
93978|NCT01105936|356352|P4|Period 1|Adverse Event|1
93979|NCT01105936|356353|P3|Period 1|Adverse Event|0
93980|NCT01105936|356354|P2|Period 1|Adverse Event|0
93981|NCT01105936|356355|P1|Period 1|Adverse Event|0
93982|NCT01105767|356384|P3|Overall Study|Lost to Follow-up|1184
93983|NCT01105767|356385|P2|Overall Study|Lost to Follow-up|1614
93984|NCT01105767|356386|P1|Overall Study|Lost to Follow-up|1160
93985|NCT01105533|356438|P9|Overall Study|Physician Decision|0
93986|NCT01105533|356439|P8|Overall Study|Physician Decision|1
93987|NCT01105533|356440|P7|Overall Study|Physician Decision|0
93988|NCT01105533|356441|P6|Overall Study|Physician Decision|0
93989|NCT01105533|356442|P5|Overall Study|Physician Decision|0
93990|NCT01105533|356443|P4|Overall Study|Physician Decision|0
93991|NCT01105533|356444|P3|Overall Study|Physician Decision|0
93992|NCT01105533|356445|P2|Overall Study|Physician Decision|0
93993|NCT01105533|356446|P1|Overall Study|Physician Decision|0
93994|NCT01105533|356438|P9|Overall Study|Other|2
93995|NCT01105533|356439|P8|Overall Study|Other|1
93996|NCT01105533|356440|P7|Overall Study|Other|3
93997|NCT01105533|356441|P6|Overall Study|Other|0
93998|NCT01105533|356442|P5|Overall Study|Other|1
93999|NCT01105533|356443|P4|Overall Study|Other|0
94000|NCT01105533|356444|P3|Overall Study|Other|0
94001|NCT01105533|356445|P2|Overall Study|Other|0
94002|NCT01105533|356446|P1|Overall Study|Other|0
94003|NCT01105533|356438|P9|Overall Study|Adverse Event|1
94004|NCT01105533|356439|P8|Overall Study|Adverse Event|0
94005|NCT01105533|356440|P7|Overall Study|Adverse Event|2
94006|NCT01105533|356441|P6|Overall Study|Adverse Event|2
94007|NCT01105533|356442|P5|Overall Study|Adverse Event|1
94008|NCT01105533|356443|P4|Overall Study|Adverse Event|0
94009|NCT01105533|356444|P3|Overall Study|Adverse Event|0
94010|NCT01105533|356445|P2|Overall Study|Adverse Event|0
94011|NCT01105533|356446|P1|Overall Study|Adverse Event|0
94012|NCT01105533|356438|P9|Overall Study|Lack of Efficacy|9
94013|NCT01105533|356439|P8|Overall Study|Lack of Efficacy|2
94014|NCT01105533|356440|P7|Overall Study|Lack of Efficacy|3
94015|NCT01105533|356441|P6|Overall Study|Lack of Efficacy|5
94016|NCT01105533|356442|P5|Overall Study|Lack of Efficacy|4
94017|NCT01105533|356443|P4|Overall Study|Lack of Efficacy|3
94018|NCT01105533|356444|P3|Overall Study|Lack of Efficacy|3
94019|NCT01105533|356445|P2|Overall Study|Lack of Efficacy|1
94020|NCT01105533|356446|P1|Overall Study|Lack of Efficacy|1
94021|NCT01105533|356438|P9|Overall Study|Death|0
94022|NCT01105533|356439|P8|Overall Study|Death|0
94023|NCT01105533|356440|P7|Overall Study|Death|0
94024|NCT01105533|356441|P6|Overall Study|Death|0
94025|NCT01105533|356442|P5|Overall Study|Death|1
94026|NCT01105533|356443|P4|Overall Study|Death|0
94027|NCT01105533|356444|P3|Overall Study|Death|0
94028|NCT01105533|356445|P2|Overall Study|Death|0
94029|NCT01105533|356446|P1|Overall Study|Death|0
94030|NCT01105377|356536|P2|Overall Study|Withdrawal by Subject|1
94031|NCT01105377|356537|P1|Overall Study|Withdrawal by Subject|0
94032|NCT01105130|356585|P3|Overall Study|Multiple Reasons|2
94033|NCT01105130|356586|P2|Overall Study|Multiple Reasons|0
94034|NCT01105130|356587|P1|Overall Study|Multiple Reasons|3
94035|NCT01105130|356585|P3|Overall Study|Toxicity|2
94036|NCT01105130|356586|P2|Overall Study|Toxicity|3
94037|NCT01105130|356587|P1|Overall Study|Toxicity|1
94038|NCT01105130|356585|P3|Overall Study|Never Started|4
94039|NCT01105130|356586|P2|Overall Study|Never Started|2
94040|NCT01105130|356587|P1|Overall Study|Never Started|2
94041|NCT01105130|356585|P3|Overall Study|Withdrawal by Subject|2
94042|NCT01105130|356586|P2|Overall Study|Withdrawal by Subject|6
94043|NCT01105130|356587|P1|Overall Study|Withdrawal by Subject|4
94044|NCT01105091|356617|P2|Overall Study|Death|0
94045|NCT01105091|356618|P1|Overall Study|Death|2
94046|NCT01105065|356642|P1|Overall Study|Technical Problems|1
94047|NCT01105065|356642|P1|Overall Study|Adverse Event|5
94048|NCT01104870|356651|P3|Overall Study|Withdrawal by Subject|1
94049|NCT01104870|356652|P2|Overall Study|Withdrawal by Subject|0
94050|NCT01104870|356653|P1|Overall Study|Withdrawal by Subject|0
94051|NCT01104870|356651|P3|Overall Study|Death|1
94052|NCT01104870|356652|P2|Overall Study|Death|0
94053|NCT01104870|356653|P1|Overall Study|Death|0
94054|NCT01104870|356651|P3|Overall Study|Adverse Event|0
94055|NCT01104870|356652|P2|Overall Study|Adverse Event|1
94056|NCT01104870|356653|P1|Overall Study|Adverse Event|1
94057|NCT01104701|356686|P4|Overall Study|Physician Decision|0
94058|NCT01104701|356687|P3|Overall Study|Physician Decision|0
94059|NCT01104701|356688|P2|Overall Study|Physician Decision|2
94060|NCT01104701|356689|P1|Overall Study|Physician Decision|0
94061|NCT01104701|356686|P4|Overall Study|Adverse Event|1
94062|NCT01104701|356687|P3|Overall Study|Adverse Event|0
94063|NCT01104701|356688|P2|Overall Study|Adverse Event|0
94064|NCT01104701|356689|P1|Overall Study|Adverse Event|0
94065|NCT01104701|356686|P4|Overall Study|Withdrawal by Subject|1
94066|NCT01104701|356687|P3|Overall Study|Withdrawal by Subject|2
94067|NCT01104701|356688|P2|Overall Study|Withdrawal by Subject|1
94068|NCT01104701|356689|P1|Overall Study|Withdrawal by Subject|0
94069|NCT01104662|356751|P8|Overall Study|Randomized but not treated|0
94070|NCT01104662|356752|P7|Overall Study|Randomized but not treated|0
94071|NCT01104662|356753|P6|Overall Study|Randomized but not treated|1
94072|NCT01104662|356754|P5|Overall Study|Randomized but not treated|0
94073|NCT01104662|356755|P4|Overall Study|Randomized but not treated|0
94074|NCT01104662|356756|P3|Overall Study|Randomized but not treated|1
94075|NCT01104662|356757|P2|Overall Study|Randomized but not treated|4
94076|NCT01104662|356758|P1|Overall Study|Randomized but not treated|3
94077|NCT01104662|356751|P8|Overall Study|Reason not specified|0
94078|NCT01104662|356752|P7|Overall Study|Reason not specified|0
94079|NCT01104662|356753|P6|Overall Study|Reason not specified|1
94080|NCT01104662|356754|P5|Overall Study|Reason not specified|0
94081|NCT01104662|356755|P4|Overall Study|Reason not specified|0
94082|NCT01104662|356756|P3|Overall Study|Reason not specified|0
94083|NCT01104662|356757|P2|Overall Study|Reason not specified|3
94084|NCT01104662|356758|P1|Overall Study|Reason not specified|3
94085|NCT01104662|356751|P8|Overall Study|Participant left investigator’s care|0
94086|NCT01104662|356752|P7|Overall Study|Participant left investigator’s care|0
94087|NCT01104662|356753|P6|Overall Study|Participant left investigator’s care|0
94088|NCT01104662|356754|P5|Overall Study|Participant left investigator’s care|0
94089|NCT01104662|356755|P4|Overall Study|Participant left investigator’s care|0
94090|NCT01104662|356756|P3|Overall Study|Participant left investigator’s care|0
94091|NCT01104662|356757|P2|Overall Study|Participant left investigator’s care|1
94092|NCT01104662|356758|P1|Overall Study|Participant left investigator’s care|1
94093|NCT01104662|356751|P8|Overall Study|Clinical Failure|0
94094|NCT01104662|356752|P7|Overall Study|Clinical Failure|0
94095|NCT01104662|356753|P6|Overall Study|Clinical Failure|1
94096|NCT01104662|356754|P5|Overall Study|Clinical Failure|0
94097|NCT01104662|356755|P4|Overall Study|Clinical Failure|0
94098|NCT01104662|356756|P3|Overall Study|Clinical Failure|0
94099|NCT01104662|356757|P2|Overall Study|Clinical Failure|0
94100|NCT01104662|356758|P1|Overall Study|Clinical Failure|1
94101|NCT01104662|356751|P8|Overall Study|Adverse Event|0
94102|NCT01104662|356752|P7|Overall Study|Adverse Event|0
94103|NCT01104662|356753|P6|Overall Study|Adverse Event|1
94104|NCT01104662|356754|P5|Overall Study|Adverse Event|1
94105|NCT01104662|356755|P4|Overall Study|Adverse Event|1
94106|NCT01104662|356756|P3|Overall Study|Adverse Event|0
94107|NCT01104662|356757|P2|Overall Study|Adverse Event|2
94108|NCT01104662|356758|P1|Overall Study|Adverse Event|2
94109|NCT01104636|356784|P1|Overall Study|Ongoing|21
94110|NCT01104636|356784|P1|Overall Study|Adverse Event|40
94111|NCT01104636|356784|P1|Overall Study|Pregnancy|2
94112|NCT01104636|356784|P1|Overall Study|Study terminated by sponsor|1
94113|NCT01104636|356784|P1|Overall Study|Other|43
94114|NCT01104636|356784|P1|Overall Study|Withdrawal by Subject|4
94115|NCT01104636|356784|P1|Overall Study|Lost to Follow-up|24
94116|NCT01104636|356784|P1|Overall Study|Lack of Efficacy|43
94117|NCT01104584|356789|P1|Overall Study|Study prematurely discontinued|2
94118|NCT01104584|356789|P1|Overall Study|Study drug never administered|21
94119|NCT01104558|356859|P1|Overall Study|Missing of genetic analysis results|1
94120|NCT01104558|356859|P1|Overall Study|Missing of primary efficacy assessment|10
94121|NCT01104558|356859|P1|Overall Study|Protocol Violation|6
94122|NCT01104493|356902|P2|Overall Study|Lost to Follow-up|2
94123|NCT01104493|356903|P1|Overall Study|Lost to Follow-up|0
94124|NCT01104415|356921|P1|Overall Study|Withdrawal by Subject|1
94125|NCT01104376|356964|P1|Overall Study|Consented but excluded after labs|13
94126|NCT01104376|356964|P1|Overall Study|Withdrawal by Subject|15
94127|NCT01104311|356970|P2|Overall Study|Adverse Event|2
94128|NCT01104311|356971|P1|Overall Study|Adverse Event|1
94129|NCT01104311|356970|P2|Overall Study|low compliance|1
94130|NCT01104311|356971|P1|Overall Study|low compliance|1
94131|NCT01104311|356970|P2|Overall Study|Physician Decision|2
94132|NCT01104311|356971|P1|Overall Study|Physician Decision|2
94133|NCT01104311|356970|P2|Overall Study|Protocol Violation|1
94134|NCT01104311|356971|P1|Overall Study|Protocol Violation|0
94135|NCT01104311|356970|P2|Overall Study|Withdrawal by Subject|6
94136|NCT01104311|356971|P1|Overall Study|Withdrawal by Subject|6
94137|NCT01104246|356998|P1|Overall Study|did not meet inclusion criteria|4
94138|NCT01104246|356998|P1|Overall Study|Withdrawal by Subject|1
94139|NCT01104155|357013|P2|Overall Study|Not specified|4
94140|NCT01104155|357014|P1|Overall Study|Not specified|3
94141|NCT01104155|357013|P2|Overall Study|Withdrawal of consent|1
94142|NCT01104155|357014|P1|Overall Study|Withdrawal of consent|1
94143|NCT01104155|357013|P2|Overall Study|Participant choice|5
94144|NCT01104155|357014|P1|Overall Study|Participant choice|6
94145|NCT01104155|357013|P2|Overall Study|Adverse Event|8
94146|NCT01104155|357014|P1|Overall Study|Adverse Event|15
94147|NCT01103960|357057|P2|Overall Study|Other|0
94148|NCT01103960|357058|P1|Overall Study|Other|1
94149|NCT01103960|357057|P2|Overall Study|Withdrawal by Subject|1
94150|NCT01103960|357058|P1|Overall Study|Withdrawal by Subject|2
94151|NCT01103960|357057|P2|Overall Study|Adverse Event|1
94152|NCT01103960|357058|P1|Overall Study|Adverse Event|2
94153|NCT01103713|357093|P1|Overall Study|Not specified|1
94154|NCT01103713|357093|P1|Overall Study|Study terminated by sponsor|2
94155|NCT01103713|357093|P1|Overall Study|Withdrawal by Subject|8
94156|NCT01103713|357093|P1|Overall Study|Lost to Follow-up|2
94157|NCT01103479|357126|P3|Overall Study|Saw non-study physician|0
94158|NCT01103479|357127|P2|Overall Study|Saw non-study physician|0
94159|NCT01103479|357128|P1|Overall Study|Saw non-study physician|2
94160|NCT01103479|357126|P3|Overall Study|Active cancer|0
94161|NCT01103479|357127|P2|Overall Study|Active cancer|0
94162|NCT01103479|357128|P1|Overall Study|Active cancer|1
94163|NCT01103479|357126|P3|Overall Study|Family history of CRC|2
94164|NCT01103479|357127|P2|Overall Study|Family history of CRC|0
94165|NCT01103479|357128|P1|Overall Study|Family history of CRC|1
94166|NCT01103479|357126|P3|Overall Study|Up to date with CRC screening|12
94167|NCT01103479|357127|P2|Overall Study|Up to date with CRC screening|9
94168|NCT01103479|357128|P1|Overall Study|Up to date with CRC screening|1
94169|NCT01103466|357141|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
94170|NCT01103466|357142|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
94171|NCT01103466|357143|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
94172|NCT01103466|357141|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
94173|NCT01103466|357142|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
94174|NCT01103466|357143|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
94175|NCT01103466|357141|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
94176|NCT01103466|357142|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
94177|NCT01103466|357143|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
94178|NCT01103466|357141|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
94179|NCT01103466|357142|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
94180|NCT01103466|357143|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
94181|NCT01103466|357141|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
94182|NCT01103466|357142|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
94183|NCT01103466|357143|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
94184|NCT01103466|357141|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
94185|NCT01103466|357142|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
94186|NCT01103466|357143|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
94187|NCT01103362|357233|P1|Overall Study|study terminated|596
94188|NCT01103323|357239|P2|Switched From Placebo to Regorafenib|Adverse Event|1
94189|NCT01103323|357240|P1|Switched From Placebo to Regorafenib|Adverse Event|0
94190|NCT01103323|357239|P2|Without/Before Drug Switch|Switch to Regorafenib|4
94191|NCT01103323|357240|P1|Without/Before Drug Switch|Switch to Regorafenib|0
94192|NCT01103323|357239|P2|Without/Before Drug Switch|did not receive study treatment|2
94193|NCT01103323|357240|P1|Without/Before Drug Switch|did not receive study treatment|5
94194|NCT01103323|357239|P2|Without/Before Drug Switch|Physician Decision|0
94195|NCT01103323|357240|P1|Without/Before Drug Switch|Physician Decision|2
94196|NCT01103323|357239|P2|Without/Before Drug Switch|Protocol Violation|0
94197|NCT01103323|357240|P1|Without/Before Drug Switch|Protocol Violation|2
94198|NCT01103323|357239|P2|Without/Before Drug Switch|Withdrawal by Subject|5
94199|NCT01103323|357240|P1|Without/Before Drug Switch|Withdrawal by Subject|17
94200|NCT01103323|357239|P2|Without/Before Drug Switch|Adverse Event|7
94201|NCT01103323|357240|P1|Without/Before Drug Switch|Adverse Event|50
94202|NCT01103284|357257|P2|Overall Study|Missing CRF entries for study completion|2
94203|NCT01103284|357258|P1|Overall Study|Missing CRF entries for study completion|0
94204|NCT01103284|357257|P2|Overall Study|Not described|1
94205|NCT01103284|357258|P1|Overall Study|Not described|2
94206|NCT01103284|357257|P2|Overall Study|Termination by the Sponsor|1
94207|NCT01103284|357258|P1|Overall Study|Termination by the Sponsor|0
94208|NCT01103284|357257|P2|Overall Study|Dermal Hypersensitivity|1
94209|NCT01103284|357258|P1|Overall Study|Dermal Hypersensitivity|0
94210|NCT01103284|357257|P2|Overall Study|Withdrawal by Subject|18
94211|NCT01103284|357258|P1|Overall Study|Withdrawal by Subject|14
94212|NCT01103284|357257|P2|Overall Study|Adverse Event|5
94213|NCT01103284|357258|P1|Overall Study|Adverse Event|0
94214|NCT01103284|357257|P2|Overall Study|Protocol Violation|5
94215|NCT01103284|357258|P1|Overall Study|Protocol Violation|12
94216|NCT01103284|357257|P2|Overall Study|Pregnancy|1
94217|NCT01103284|357258|P1|Overall Study|Pregnancy|3
94218|NCT01103284|357257|P2|Overall Study|Lost to Follow-up|10
94219|NCT01103284|357258|P1|Overall Study|Lost to Follow-up|9
94220|NCT01103284|357257|P2|Overall Study|Death|0
94221|NCT01103284|357258|P1|Overall Study|Death|2
94222|NCT01103232|357284|P2|Overall Study|Protocol Violation|1
94223|NCT01103232|357285|P1|Overall Study|Protocol Violation|0
94224|NCT01103232|357284|P2|Overall Study|Withdrawal by Subject|1
94225|NCT01103232|357285|P1|Overall Study|Withdrawal by Subject|1
94226|NCT01103141|357293|P2|Overall Study|Lost to Follow-up|1
94227|NCT01103141|357294|P1|Overall Study|Lost to Follow-up|2
94228|NCT01103141|357293|P2|Overall Study|Death|1
94229|NCT01103141|357294|P1|Overall Study|Death|0
94230|NCT01103063|357302|P2|Overall Study|Death|1
94231|NCT01103063|357303|P1|Overall Study|Death|3
94232|NCT01103063|357302|P2|Overall Study|Study terminated by Sponsor|342
94233|NCT01103063|357303|P1|Overall Study|Study terminated by Sponsor|326
94234|NCT01103063|357302|P2|Overall Study|Protocol Violation|0
94235|NCT01103063|357303|P1|Overall Study|Protocol Violation|1
94236|NCT01103063|357302|P2|Overall Study|Not specified|11
94237|NCT01103063|357303|P1|Overall Study|Not specified|16
94238|NCT01103063|357302|P2|Overall Study|Withdrawal by Subject|15
94239|NCT01103063|357303|P1|Overall Study|Withdrawal by Subject|60
94240|NCT01103063|357302|P2|Overall Study|Lost to Follow-up|51
94241|NCT01103063|357303|P1|Overall Study|Lost to Follow-up|68
94242|NCT01103063|357302|P2|Overall Study|Adverse Event|1
94243|NCT01103063|357303|P1|Overall Study|Adverse Event|3
94244|NCT01102972|357371|P2|Overall Study|Withdrawal by Subject|6
94245|NCT01102972|357372|P1|Overall Study|Withdrawal by Subject|6
94246|NCT01102972|357371|P2|Overall Study|Investigator Discretion|0
94247|NCT01102972|357372|P1|Overall Study|Investigator Discretion|2
94248|NCT01102972|357371|P2|Overall Study|Lost to Follow-up|5
94249|NCT01102972|357372|P1|Overall Study|Lost to Follow-up|10
94250|NCT01102972|357371|P2|Overall Study|Protocol Violation|0
94251|NCT01102972|357372|P1|Overall Study|Protocol Violation|1
94252|NCT01102972|357371|P2|Overall Study|Lack of Efficacy|1
94253|NCT01102972|357372|P1|Overall Study|Lack of Efficacy|2
94254|NCT01102972|357371|P2|Overall Study|Adverse Event|2
94255|NCT01102972|357372|P1|Overall Study|Adverse Event|8
94256|NCT01102803|357436|P2|Post to Follow-Up|Lost to Follow-up|3
94257|NCT01102803|357437|P1|Post to Follow-Up|Lost to Follow-up|1
94258|NCT01102803|357436|P2|Baseline to Post-Treatment|Lost to Follow-up|0
94259|NCT01102803|357437|P1|Baseline to Post-Treatment|Lost to Follow-up|3
94260|NCT01102777|357451|P2|Overall Study|Lost to Follow-up|10
94261|NCT01102777|357452|P1|Overall Study|Lost to Follow-up|7
94262|NCT01102777|357451|P2|Overall Study|Death|6
94263|NCT01102777|357452|P1|Overall Study|Death|2
94264|NCT01102491|357491|P2|Overall Study|Protocol Violation|12
94265|NCT01102491|357492|P1|Overall Study|Protocol Violation|11
94266|NCT01102374|357511|P2|Overall Study|Lost to Follow-up|6
94267|NCT01102374|357512|P1|Overall Study|Lost to Follow-up|7
94268|NCT01102374|357511|P2|Overall Study|Death|13
94269|NCT01102374|357512|P1|Overall Study|Death|9
94270|NCT01102257|357561|P2|Overall Study|Adverse Event|0
94271|NCT01102257|357562|P1|Overall Study|Adverse Event|1
94272|NCT01102257|357561|P2|Overall Study|Adverse Event|0
94273|NCT01102257|357562|P1|Overall Study|Adverse Event|1
94274|NCT01102140|357579|P2|Overall Study|Investigator terminated study|2
94275|NCT01102140|357580|P1|Overall Study|Investigator terminated study|2
94276|NCT01102140|357579|P2|Overall Study|Lost to Follow-up|0
94277|NCT01102140|357580|P1|Overall Study|Lost to Follow-up|1
94278|NCT01101841|357635|P2|Overall Study|Eligibility Criteria|2
94279|NCT01101841|357636|P1|Overall Study|Eligibility Criteria|1
94280|NCT01101841|357635|P2|Overall Study|Suicidality Tracking Scale|1
94281|NCT01101841|357636|P1|Overall Study|Suicidality Tracking Scale|3
94282|NCT01101841|357635|P2|Overall Study|Not Specified|1
94283|NCT01101841|357636|P1|Overall Study|Not Specified|0
94284|NCT01101841|357635|P2|Overall Study|Lack of Efficacy|2
94285|NCT01101841|357636|P1|Overall Study|Lack of Efficacy|0
94286|NCT01101841|357635|P2|Overall Study|Physician Decision|2
94287|NCT01101841|357636|P1|Overall Study|Physician Decision|0
94288|NCT01101841|357635|P2|Overall Study|Protocol Violation|1
94289|NCT01101841|357636|P1|Overall Study|Protocol Violation|1
94290|NCT01101841|357635|P2|Overall Study|Withdrawal by Subject|40
94291|NCT01101841|357636|P1|Overall Study|Withdrawal by Subject|21
94292|NCT01101841|357635|P2|Overall Study|Lost to Follow-up|3
94293|NCT01101841|357636|P1|Overall Study|Lost to Follow-up|9
94294|NCT01101841|357635|P2|Overall Study|Adverse Event|15
94295|NCT01101841|357636|P1|Overall Study|Adverse Event|15
94296|NCT01101542|357674|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
94297|NCT01101542|357674|P1|Year 6 Surveillance Period|Pregnancy|1
94298|NCT01101542|357674|P1|Year 6 Surveillance Period|Lost to Follow-up|986
94299|NCT01101542|357674|P1|Year 5 Surveillance Period|Pregnancy|1
94300|NCT01101542|357674|P1|Year 5 Surveillance Period|Lost to Follow-up|140
94301|NCT01101542|357674|P1|Year 4 Surveillance Period|Other|287
94302|NCT01101542|357674|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
94303|NCT01101542|357674|P1|Year 3 Surveillance Period|Lost to Follow-up|7
94304|NCT01101477|357693|P3|Overall Study|Protocol Violation|1
94305|NCT01101477|357694|P2|Overall Study|Protocol Violation|3
94306|NCT01101477|357695|P1|Overall Study|Protocol Violation|5
94307|NCT01101321|357716|P2|Period 1|Adverse Event|3
94308|NCT01101321|357717|P1|Period 1|Adverse Event|3
94309|NCT01101321|357716|P2|Period 1|Withdrawal by Subject|1
94310|NCT01101321|357717|P1|Period 1|Withdrawal by Subject|1
94311|NCT01101308|357727|P2|Period 1|Positive for cotinine|0
94312|NCT01101308|357728|P1|Period 1|Positive for cotinine|1
94313|NCT01101308|357727|P2|Period 1|Adverse Event|1
94314|NCT01101308|357728|P1|Period 1|Adverse Event|2
94315|NCT01101191|357739|P2|Period 1|Adverse Event|2
94316|NCT01101191|357740|P1|Period 1|Adverse Event|1
94317|NCT01101191|357739|P2|Period 1|Withdrawal by Subject|0
94318|NCT01101191|357740|P1|Period 1|Withdrawal by Subject|1
94319|NCT01101178|357751|P2|Period 2|Withdrawal by Subject|1
94320|NCT01101178|357752|P1|Period 2|Withdrawal by Subject|0
94321|NCT01101178|357751|P2|Period 1|Adverse Event|1
94322|NCT01101178|357752|P1|Period 1|Adverse Event|2
94323|NCT01101178|357751|P2|Period 1|Positive drug screen|1
94324|NCT01101178|357752|P1|Period 1|Positive drug screen|1
94325|NCT01101178|357751|P2|Period 1|Withdrawal by Subject|2
94326|NCT01101178|357752|P1|Period 1|Withdrawal by Subject|1
94327|NCT01101165|357763|P2|Period 2|Adverse Event|0
94328|NCT01101165|357764|P1|Period 2|Adverse Event|1
94329|NCT01101165|357763|P2|Period 2|Withdrawal by Subject|1
94330|NCT01101165|357764|P1|Period 2|Withdrawal by Subject|3
94331|NCT01101165|357763|P2|Period 1|Lost to Follow-up|0
94332|NCT01101165|357764|P1|Period 1|Lost to Follow-up|1
94333|NCT01101165|357763|P2|Period 1|Positive Drug Screen|1
94334|NCT01101165|357764|P1|Period 1|Positive Drug Screen|0
94335|NCT01101165|357763|P2|Period 1|Withdrawal by Subject|2
94336|NCT01101165|357764|P1|Period 1|Withdrawal by Subject|0
94337|NCT01101165|357763|P2|Period 1|Adverse Event|2
94338|NCT01101165|357764|P1|Period 1|Adverse Event|1
94339|NCT01101022|357776|P2|Overall Study|Vacation|1
94340|NCT01101022|357777|P1|Overall Study|Vacation|0
94341|NCT01101022|357776|P2|Overall Study|Work schedule|1
94342|NCT01101022|357777|P1|Overall Study|Work schedule|1
94343|NCT01101022|357776|P2|Overall Study|Non-compliance|0
94344|NCT01101022|357777|P1|Overall Study|Non-compliance|1
94345|NCT01101022|357776|P2|Overall Study|Sponsor decision|1
94346|NCT01101022|357777|P1|Overall Study|Sponsor decision|1
94347|NCT01101022|357776|P2|Overall Study|Lack of Efficacy|7
94348|NCT01101022|357777|P1|Overall Study|Lack of Efficacy|0
94349|NCT01101022|357776|P2|Overall Study|Lost to Follow-up|4
94350|NCT01101022|357777|P1|Overall Study|Lost to Follow-up|1
94351|NCT01101022|357776|P2|Overall Study|Withdrawal by Subject|8
94352|NCT01101022|357777|P1|Overall Study|Withdrawal by Subject|3
94353|NCT01101022|357776|P2|Overall Study|Protocol Violation|3
94354|NCT01101022|357777|P1|Overall Study|Protocol Violation|4
94355|NCT01101022|357776|P2|Overall Study|Adverse Event|2
94356|NCT01101022|357777|P1|Overall Study|Adverse Event|6
94357|NCT01100944|357811|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
94358|NCT01100944|357812|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
94359|NCT01100944|357813|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
94360|NCT01100944|357811|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
94361|NCT01100944|357812|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
94362|NCT01100944|357813|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
94363|NCT01100944|357811|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
94364|NCT01100944|357812|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
94365|NCT01100944|357813|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
94366|NCT01100944|357811|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
94367|NCT01100944|357812|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
94368|NCT01100944|357813|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
94369|NCT01100853|357871|P2|Overall Study|Withdrawal by Subject|4
94370|NCT01100853|357872|P1|Overall Study|Withdrawal by Subject|6
94371|NCT01100853|357871|P2|Overall Study|Received <4 study injections|13
94372|NCT01100853|357872|P1|Overall Study|Received <4 study injections|10
94373|NCT01100853|357871|P2|Overall Study|Lost to Follow-up|6
94374|NCT01100853|357872|P1|Overall Study|Lost to Follow-up|11
94375|NCT01100658|357918|P1|Overall Study|Withdrawal by Subject|1
94376|NCT01100567|357950|P2|Overall Study|Deemed ineligible after consent|1
94377|NCT01100567|357951|P1|Overall Study|Deemed ineligible after consent|0
94378|NCT01100567|357950|P2|Overall Study|Physician Decision|1
94379|NCT01100567|357951|P1|Overall Study|Physician Decision|0
94380|NCT01100567|357950|P2|Overall Study|Lost to Follow-up|2
94381|NCT01100567|357951|P1|Overall Study|Lost to Follow-up|1
94382|NCT01100567|357950|P2|Overall Study|Early Hospital Discharge|4
94383|NCT01100567|357951|P1|Overall Study|Early Hospital Discharge|6
94384|NCT01100567|357950|P2|Overall Study|Withdrawal by Subject|8
94385|NCT01100567|357951|P1|Overall Study|Withdrawal by Subject|5
94386|NCT01100502|357961|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
94387|NCT01100502|357962|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
94388|NCT01100502|357961|P2|Long-Term Follow-up|Lost to Follow-up|2
94389|NCT01100502|357962|P1|Long-Term Follow-up|Lost to Follow-up|5
94390|NCT01100502|357961|P2|Long-Term Follow-up|Withdrawal by Subject|8
94391|NCT01100502|357962|P1|Long-Term Follow-up|Withdrawal by Subject|10
94392|NCT01100502|357961|P2|Treatment Period|Progressive Disease|69
94393|NCT01100502|357962|P1|Treatment Period|Progressive Disease|24
94394|NCT01100502|357961|P2|Treatment Period|Withdrawal by Subject|4
94395|NCT01100502|357962|P1|Treatment Period|Withdrawal by Subject|9
94396|NCT01100502|357961|P2|Treatment Period|Adverse Event|10
94397|NCT01100502|357962|P1|Treatment Period|Adverse Event|54
94398|NCT01100437|357972|P3|Maintenance|Sponsor termination of study|1
94399|NCT01100437|357973|P2|Maintenance|Sponsor termination of study|0
94400|NCT01100437|357974|P1|Maintenance|Sponsor termination of study|0
94401|NCT01100437|357972|P3|Maintenance|Withdrawal by Subject|1
94402|NCT01100437|357973|P2|Maintenance|Withdrawal by Subject|0
94403|NCT01100437|357974|P1|Maintenance|Withdrawal by Subject|0
94404|NCT01100437|357972|P3|Titration/Stabilization|Sponsor canceled study|1
94405|NCT01100437|357973|P2|Titration/Stabilization|Sponsor canceled study|0
94406|NCT01100437|357974|P1|Titration/Stabilization|Sponsor canceled study|0
94407|NCT01100437|357972|P3|Titration/Stabilization|Non-compliance|1
94408|NCT01100437|357973|P2|Titration/Stabilization|Non-compliance|0
94409|NCT01100437|357974|P1|Titration/Stabilization|Non-compliance|0
94410|NCT01100437|357972|P3|Titration/Stabilization|Adverse Event|4
94411|NCT01100437|357973|P2|Titration/Stabilization|Adverse Event|0
94412|NCT01100437|357974|P1|Titration/Stabilization|Adverse Event|0
94413|NCT01100320|358011|P2|Period 2|Withdrawal by Subject|1
94414|NCT01100320|358012|P1|Period 2|Withdrawal by Subject|1
94415|NCT01100320|358011|P2|Period 1|Adverse Event|2
94416|NCT01100320|358012|P1|Period 1|Adverse Event|2
94417|NCT01100320|358011|P2|Period 1|Positive Drug Screen|1
94418|NCT01100320|358012|P1|Period 1|Positive Drug Screen|1
94419|NCT01100320|358011|P2|Period 1|Withdrawal by Subject|4
94420|NCT01100320|358012|P1|Period 1|Withdrawal by Subject|2
94421|NCT01100307|358024|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
94422|NCT01100307|358025|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
94423|NCT01100307|358024|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
94424|NCT01100307|358025|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
94425|NCT01100307|358024|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
94426|NCT01100307|358025|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
94427|NCT01100307|358024|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
94428|NCT01100307|358025|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
94429|NCT01100307|358024|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
94430|NCT01100307|358025|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
94431|NCT01100307|358024|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
94432|NCT01100307|358025|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
94433|NCT01100086|358094|P2|Period 1|Withdrawal by Subject|0
94434|NCT01100086|358095|P1|Period 1|Withdrawal by Subject|1
94435|NCT01100073|358105|P1|Overall Study|Missing|5
94436|NCT01100073|358105|P1|Overall Study|Other|8
94437|NCT01100073|358105|P1|Overall Study|Insufficient tolerability +patients wish|8
94438|NCT01100073|358105|P1|Overall Study|Lack of effect + patient's wish|2
94439|NCT01100073|358105|P1|Overall Study|Lost to Follow-up|39
94440|NCT01100073|358105|P1|Overall Study|Withdrawal by Subject|13
94441|NCT01100073|358105|P1|Overall Study|Insufficient Tolerability|21
94442|NCT01100073|358105|P1|Overall Study|Lack of Efficacy|4
94443|NCT01099917|358120|P1|Overall Study|Not Treated|24
94444|NCT01099917|358120|P1|Overall Study|Adverse Event|3
94445|NCT01099709|358182|P2|Period 1|Adverse Event|0
94446|NCT01099709|358183|P1|Period 1|Adverse Event|1
94447|NCT01099709|358182|P2|Period 1|Positive cotinine test|1
94448|NCT01099709|358183|P1|Period 1|Positive cotinine test|0
94449|NCT01099709|358182|P2|Period 1|Withdrawal by Subject|1
94450|NCT01099709|358183|P1|Period 1|Withdrawal by Subject|0
94451|NCT01099579|358209|P3|Stage 2 (ATV Capsule)|Adverse Event|0
94452|NCT01099579|358210|P2|Stage 2 (ATV Capsule)|Adverse Event|1
94453|NCT01099579|358211|P1|Stage 2 (ATV Capsule)|Adverse Event|0
94454|NCT01099579|358209|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
94455|NCT01099579|358210|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
94456|NCT01099579|358211|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
94457|NCT01099579|358209|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
94458|NCT01099579|358210|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
94459|NCT01099579|358211|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
94460|NCT01099579|358209|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
94461|NCT01099579|358210|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
94462|NCT01099579|358211|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
94463|NCT01099579|358209|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
94464|NCT01099579|358210|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
94465|NCT01099579|358211|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
94466|NCT01099579|358209|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
94467|NCT01099579|358210|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
94468|NCT01099579|358211|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
94469|NCT01099579|358209|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
94470|NCT01099579|358210|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
94471|NCT01099579|358211|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
94472|NCT01099579|358209|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
94473|NCT01099579|358210|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
94474|NCT01099579|358211|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
94475|NCT01099579|358209|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
94476|NCT01099579|358210|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
94477|NCT01099579|358211|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
94478|NCT01099579|358209|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
94479|NCT01099579|358210|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
94480|NCT01099579|358211|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
94481|NCT01099397|358280|P1|Overall Study|Withdrawal by Subject|5
94482|NCT01099397|358280|P1|Overall Study|Protocol Violation|4
94483|NCT01099397|358280|P1|Overall Study|Lost to Follow-up|4
94484|NCT01099267|358307|P1|MDS-003 Study|Secondary Malign Disease|1
94485|NCT01099267|358307|P1|MDS-003 Study|Loss of Response|1
94486|NCT01099267|358307|P1|MDS-003 Study|Non-Compliance|2
94487|NCT01099267|358307|P1|MDS-003 Study|Investigator Decision|2
94488|NCT01099267|358307|P1|MDS-003 Study|Disease Progression|7
94489|NCT01099267|358307|P1|MDS-003 Study|Study Closed by Sponsor|2
94490|NCT01099267|358307|P1|MDS-003 Study|Death|11
94491|NCT01099267|358307|P1|MDS-003 Study|Lost to Follow-up|1
94492|NCT01099267|358307|P1|MDS-003 Study|Withdrawal by Subject|8
94493|NCT01099267|358307|P1|MDS-003 Study|Lack of Efficacy|52
94494|NCT01099267|358307|P1|MDS-003 Study|Adverse Event|37
94495|NCT01099215|358317|P2|Overall Study|Adverse Event|1
94496|NCT01099215|358318|P1|Overall Study|Adverse Event|0
94497|NCT01099215|358317|P2|Overall Study|Withdrawal by Subject|0
94498|NCT01099215|358318|P1|Overall Study|Withdrawal by Subject|1
94499|NCT01098851|358388|P2|Overall Study|Equipment failure|0
94500|NCT01098851|358389|P1|Overall Study|Equipment failure|1
94501|NCT01098812|358400|P3|Overall Study|Lost to Follow-up|0
94502|NCT01098812|358401|P2|Overall Study|Lost to Follow-up|1
94503|NCT01098812|358402|P1|Overall Study|Lost to Follow-up|0
94504|NCT01098812|358400|P3|Overall Study|Death|1
94505|NCT01098812|358401|P2|Overall Study|Death|0
94506|NCT01098812|358402|P1|Overall Study|Death|2
94507|NCT01098539|358478|P2|Overall Study|Physician Decision|3
94508|NCT01098539|358479|P1|Overall Study|Physician Decision|5
94509|NCT01098539|358478|P2|Overall Study|Withdrawal by Subject|26
94510|NCT01098539|358479|P1|Overall Study|Withdrawal by Subject|12
94511|NCT01098539|358478|P2|Overall Study|Lost to Follow-up|4
94512|NCT01098539|358479|P1|Overall Study|Lost to Follow-up|4
94513|NCT01098539|358478|P2|Overall Study|Noncompliance|5
94514|NCT01098539|358479|P1|Overall Study|Noncompliance|3
94515|NCT01098539|358478|P2|Overall Study|Protocol Violation|4
94516|NCT01098539|358479|P1|Overall Study|Protocol Violation|1
94517|NCT01098539|358478|P2|Overall Study|Adverse Event|26
94518|NCT01098539|358479|P1|Overall Study|Adverse Event|26
94519|NCT01098487|358530|P1|Overall Study|Physician Decision|1
94520|NCT01098487|358530|P1|Overall Study|Lost to Follow-up|3
94521|NCT01098487|358530|P1|Overall Study|Withdrawal by Subject|7
94522|NCT01098487|358530|P1|Overall Study|Lack of Efficacy|11
94523|NCT01098487|358530|P1|Overall Study|Adverse Event|22
94524|NCT01098461|358546|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
94525|NCT01098461|358547|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
94526|NCT01098461|358548|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
94527|NCT01098461|358549|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
94528|NCT01098461|358546|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
94529|NCT01098461|358547|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
94530|NCT01098461|358548|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
94531|NCT01098461|358549|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
94532|NCT01098461|358546|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
94533|NCT01098461|358547|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
94534|NCT01098461|358548|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
94535|NCT01098461|358549|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
94536|NCT01098461|358546|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
94537|NCT01098461|358547|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
94538|NCT01098461|358548|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
94539|NCT01098461|358549|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
94540|NCT01098461|358546|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
94541|NCT01098461|358547|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
94542|NCT01098461|358548|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
94543|NCT01098461|358549|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
94544|NCT01098461|358546|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
94545|NCT01098461|358547|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
94546|NCT01098461|358548|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
94547|NCT01098461|358549|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
94548|NCT01098461|358546|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
94549|NCT01098461|358547|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
94550|NCT01098461|358548|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
94551|NCT01098461|358549|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
94552|NCT01098305|358609|P2|Overall Study|Lost to Follow-up|33
94553|NCT01098305|358610|P1|Overall Study|Lost to Follow-up|31
94554|NCT01098240|358629|P3|Double-Blind Phase|Adverse Event|3
94555|NCT01098240|358630|P2|Double-Blind Phase|Adverse Event|3
94556|NCT01098240|358631|P1|Double-Blind Phase|Adverse Event|0
94557|NCT01098240|358629|P3|Double-Blind Phase|Withdrawal by Subject|3
94558|NCT01098240|358630|P2|Double-Blind Phase|Withdrawal by Subject|1
94559|NCT01098240|358631|P1|Double-Blind Phase|Withdrawal by Subject|0
94560|NCT01098240|358629|P3|Double-Blind Phase|Insufficient Clinical Response|2
94561|NCT01098240|358630|P2|Double-Blind Phase|Insufficient Clinical Response|1
94562|NCT01098240|358631|P1|Double-Blind Phase|Insufficient Clinical Response|0
94563|NCT01098240|358629|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
94564|NCT01098240|358630|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
94565|NCT01098240|358631|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
94566|NCT01098240|358629|P3|Double-Blind Phase|Other|2
94567|NCT01098240|358630|P2|Double-Blind Phase|Other|2
94568|NCT01098240|358631|P1|Double-Blind Phase|Other|0
94569|NCT01098240|358629|P3|Double-Blind Phase|Lost to Follow-up|0
94570|NCT01098240|358630|P2|Double-Blind Phase|Lost to Follow-up|2
94571|NCT01098240|358631|P1|Double-Blind Phase|Lost to Follow-up|0
94572|NCT01098240|358629|P3|Double-Blind Phase|Protocol Violation|4
94573|NCT01098240|358630|P2|Double-Blind Phase|Protocol Violation|2
94574|NCT01098240|358631|P1|Double-Blind Phase|Protocol Violation|0
94575|NCT01098240|358629|P3|Double-Blind Phase|Study Terminated by Sponsor|8
94576|NCT01098240|358630|P2|Double-Blind Phase|Study Terminated by Sponsor|5
94577|NCT01098240|358631|P1|Double-Blind Phase|Study Terminated by Sponsor|0
94578|NCT01098240|358629|P3|Open-Label Phase|Adverse Event|0
94579|NCT01098240|358630|P2|Open-Label Phase|Adverse Event|0
94580|NCT01098240|358631|P1|Open-Label Phase|Adverse Event|12
94581|NCT01098240|358629|P3|Open-Label Phase|Withdrawal by Subject|0
94582|NCT01098240|358630|P2|Open-Label Phase|Withdrawal by Subject|0
94583|NCT01098240|358631|P1|Open-Label Phase|Withdrawal by Subject|9
94584|NCT01098240|358629|P3|Open-Label Phase|Pregnancy|0
94585|NCT01098240|358630|P2|Open-Label Phase|Pregnancy|0
94586|NCT01098240|358631|P1|Open-Label Phase|Pregnancy|1
94587|NCT01098240|358629|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
94588|NCT01098240|358630|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
94589|NCT01098240|358631|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
94590|NCT01098240|358629|P3|Open-Label Phase|Other|0
94591|NCT01098240|358630|P2|Open-Label Phase|Other|0
94592|NCT01098240|358631|P1|Open-Label Phase|Other|19
94593|NCT01098240|358629|P3|Open-Label Phase|Lost to Follow-up|0
94594|NCT01098240|358630|P2|Open-Label Phase|Lost to Follow-up|0
94595|NCT01098240|358631|P1|Open-Label Phase|Lost to Follow-up|13
94596|NCT01098240|358629|P3|Open-Label Phase|Protocol Violation|0
94597|NCT01098240|358630|P2|Open-Label Phase|Protocol Violation|0
94598|NCT01098240|358631|P1|Open-Label Phase|Protocol Violation|4
94599|NCT01098240|358629|P3|Open-Label Phase|Study Terminated by Sponsor|0
94600|NCT01098240|358630|P2|Open-Label Phase|Study Terminated by Sponsor|0
94601|NCT01098240|358631|P1|Open-Label Phase|Study Terminated by Sponsor|27
94602|NCT01098162|358661|P1|Overall Study|Reason Unknown|26
94603|NCT01098162|358661|P1|Overall Study|Other Reason|1
94604|NCT01098162|358661|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
94605|NCT01098162|358661|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
94606|NCT01098162|358661|P1|Overall Study|Adverse Event & Lost to Follow-up|2
94607|NCT01098162|358661|P1|Overall Study|Adverse Event & Wish of Patient|13
94608|NCT01098162|358661|P1|Overall Study|Adverse Event & Lack of Efficacy|6
94609|NCT01098162|358661|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
94610|NCT01098162|358661|P1|Overall Study|Lost to Follow-up|9
94611|NCT01098162|358661|P1|Overall Study|Wish of Patient|7
94612|NCT01098162|358661|P1|Overall Study|Lack of Efficacy|4
94613|NCT01098162|358661|P1|Overall Study|Adverse Event|37
94614|NCT01098110|358673|P3|Overall Study|Untreated|0
94615|NCT01098110|358674|P2|Overall Study|Untreated|1
94616|NCT01098110|358675|P1|Overall Study|Untreated|1
94617|NCT01098110|358673|P3|Overall Study|Not Specified|5
94618|NCT01098110|358674|P2|Overall Study|Not Specified|7
94619|NCT01098110|358675|P1|Overall Study|Not Specified|4
94620|NCT01098110|358673|P3|Overall Study|Lack of Efficacy|27
94621|NCT01098110|358674|P2|Overall Study|Lack of Efficacy|9
94622|NCT01098110|358675|P1|Overall Study|Lack of Efficacy|13
94623|NCT01098110|358673|P3|Overall Study|Adverse Event|43
94624|NCT01098110|358674|P2|Overall Study|Adverse Event|32
94625|NCT01098110|358675|P1|Overall Study|Adverse Event|30
94626|NCT01098110|358673|P3|Overall Study|Withdrawal by Subject|19
94627|NCT01098110|358674|P2|Overall Study|Withdrawal by Subject|24
94628|NCT01098110|358675|P1|Overall Study|Withdrawal by Subject|14
94629|NCT01098097|358716|P1|Overall Study|No reason reported|31
94630|NCT01098097|358716|P1|Overall Study|Status unknown|16
94631|NCT01098097|358716|P1|Overall Study|Lost to Follow-up|18
94632|NCT01098097|358716|P1|Overall Study|Adverse Event|17
94633|NCT01098071|358725|P1|Overall Study|Lost to Follow-up|13
94634|NCT01098071|358725|P1|Overall Study|Surgery (adenoidectomy)|2
94635|NCT01098032|358738|P2|Overall Study|Withdrawal by Subject|1
94636|NCT01098032|358739|P1|Overall Study|Withdrawal by Subject|1
94637|NCT01097863|358848|P3|Overall Study|Did not return for final visit|1
94638|NCT01097863|358849|P2|Overall Study|Did not return for final visit|0
94639|NCT01097863|358850|P1|Overall Study|Did not return for final visit|0
94640|NCT01097863|358848|P3|Overall Study|Discomfort|1
94641|NCT01097863|358849|P2|Overall Study|Discomfort|0
94642|NCT01097863|358850|P1|Overall Study|Discomfort|1
94643|NCT01097694|358871|P2|Overall Study|Withdrawal by Subject|1
94644|NCT01097694|358872|P1|Overall Study|Withdrawal by Subject|3
94645|NCT01097694|358871|P2|Overall Study|Lost to Follow-up|3
94646|NCT01097694|358872|P1|Overall Study|Lost to Follow-up|0
94647|NCT01097694|358871|P2|Overall Study|Adverse Event|0
94648|NCT01097694|358872|P1|Overall Study|Adverse Event|5
94649|NCT01097668|358934|P2|Overall Study|Lost to Follow-up|0
94650|NCT01097668|358935|P1|Overall Study|Lost to Follow-up|1
94651|NCT01097668|358934|P2|Overall Study|Withdrawal by Subject|2
94652|NCT01097668|358935|P1|Overall Study|Withdrawal by Subject|1
94653|NCT01097655|358945|P1|Overall Study|Did Not Meet Inclusion Criteria|8
94654|NCT01097655|358945|P1|Overall Study|Subject Documented Twice|1
94655|NCT01097655|358945|P1|Overall Study|Withdrawal by Subject|1
94656|NCT01097629|358955|P8|DB RO Phase|Lost to Follow-up|0
94657|NCT01097629|358956|P7|DB RO Phase|Lost to Follow-up|2
94658|NCT01097629|358957|P6|DB RO Phase|Lost to Follow-up|0
94659|NCT01097629|358958|P5|DB RO Phase|Lost to Follow-up|0
94660|NCT01097629|358959|P4|DB RO Phase|Lost to Follow-up|0
94661|NCT01097629|358960|P3|DB RO Phase|Lost to Follow-up|0
94662|NCT01097629|358961|P2|DB RO Phase|Lost to Follow-up|0
94663|NCT01097629|358962|P1|DB RO Phase|Lost to Follow-up|0
94664|NCT01097629|358955|P8|DB RO Phase|Protocol Violation|0
94665|NCT01097629|358956|P7|DB RO Phase|Protocol Violation|1
94666|NCT01097629|358957|P6|DB RO Phase|Protocol Violation|1
94667|NCT01097629|358958|P5|DB RO Phase|Protocol Violation|0
94668|NCT01097629|358959|P4|DB RO Phase|Protocol Violation|1
94669|NCT01097629|358960|P3|DB RO Phase|Protocol Violation|0
94670|NCT01097629|358961|P2|DB RO Phase|Protocol Violation|0
94671|NCT01097629|358962|P1|DB RO Phase|Protocol Violation|0
94672|NCT01097629|358955|P8|DB RO Phase|Withdrawal by Subject|1
94673|NCT01097629|358956|P7|DB RO Phase|Withdrawal by Subject|0
94674|NCT01097629|358957|P6|DB RO Phase|Withdrawal by Subject|0
94675|NCT01097629|358958|P5|DB RO Phase|Withdrawal by Subject|0
94676|NCT01097629|358959|P4|DB RO Phase|Withdrawal by Subject|0
94677|NCT01097629|358960|P3|DB RO Phase|Withdrawal by Subject|0
94678|NCT01097629|358961|P2|DB RO Phase|Withdrawal by Subject|0
94679|NCT01097629|358962|P1|DB RO Phase|Withdrawal by Subject|0
94680|NCT01097629|358955|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94681|NCT01097629|358956|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94682|NCT01097629|358957|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94683|NCT01097629|358958|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94684|NCT01097629|358959|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94685|NCT01097629|358960|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
94686|NCT01097629|358961|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
94687|NCT01097629|358962|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
94688|NCT01097629|358955|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94689|NCT01097629|358956|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94690|NCT01097629|358957|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94691|NCT01097629|358958|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94692|NCT01097629|358959|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94693|NCT01097629|358960|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94694|NCT01097629|358961|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
94695|NCT01097629|358962|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
94696|NCT01097629|358955|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94697|NCT01097629|358956|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94698|NCT01097629|358957|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94699|NCT01097629|358958|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94700|NCT01097629|358959|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94701|NCT01097629|358960|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
94702|NCT01097629|358961|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
94703|NCT01097629|358962|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
94704|NCT01097629|358955|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94705|NCT01097629|358956|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94706|NCT01097629|358957|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94707|NCT01097629|358958|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94708|NCT01097629|358959|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94709|NCT01097629|358960|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
94710|NCT01097629|358961|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
94711|NCT01097629|358962|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
94712|NCT01097629|358955|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94713|NCT01097629|358956|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94714|NCT01097629|358957|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94715|NCT01097629|358958|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94716|NCT01097629|358959|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94717|NCT01097629|358960|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
94718|NCT01097629|358961|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
94719|NCT01097629|358962|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
94720|NCT01097629|358955|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94721|NCT01097629|358956|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94722|NCT01097629|358957|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94723|NCT01097629|358958|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94724|NCT01097629|358959|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94725|NCT01097629|358960|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
94726|NCT01097629|358961|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
94727|NCT01097629|358962|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
94728|NCT01097629|358955|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94729|NCT01097629|358956|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94730|NCT01097629|358957|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94731|NCT01097629|358958|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94732|NCT01097629|358959|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94733|NCT01097629|358960|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
94734|NCT01097629|358961|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
94735|NCT01097629|358962|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
94736|NCT01097616|359013|P8|DB RO Phase|Not Treated in RO|0
94737|NCT01097616|359014|P7|DB RO Phase|Not Treated in RO|0
94738|NCT01097616|359015|P6|DB RO Phase|Not Treated in RO|1
94739|NCT01097616|359016|P5|DB RO Phase|Not Treated in RO|0
94740|NCT01097616|359017|P4|DB RO Phase|Not Treated in RO|0
94741|NCT01097616|359018|P3|DB RO Phase|Not Treated in RO|0
94742|NCT01097616|359019|P2|DB RO Phase|Not Treated in RO|0
94743|NCT01097616|359020|P1|DB RO Phase|Not Treated in RO|0
94744|NCT01097616|359013|P8|DB RO Phase|Lost to Follow-up|1
94745|NCT01097616|359014|P7|DB RO Phase|Lost to Follow-up|0
94746|NCT01097616|359015|P6|DB RO Phase|Lost to Follow-up|0
94747|NCT01097616|359016|P5|DB RO Phase|Lost to Follow-up|1
94748|NCT01097616|359017|P4|DB RO Phase|Lost to Follow-up|1
94749|NCT01097616|359018|P3|DB RO Phase|Lost to Follow-up|0
94750|NCT01097616|359019|P2|DB RO Phase|Lost to Follow-up|0
94751|NCT01097616|359020|P1|DB RO Phase|Lost to Follow-up|0
94752|NCT01097616|359013|P8|DB RO Phase|Withdrawal by Subject|0
94753|NCT01097616|359014|P7|DB RO Phase|Withdrawal by Subject|0
94754|NCT01097616|359015|P6|DB RO Phase|Withdrawal by Subject|1
94755|NCT01097616|359016|P5|DB RO Phase|Withdrawal by Subject|0
94756|NCT01097616|359017|P4|DB RO Phase|Withdrawal by Subject|0
94757|NCT01097616|359018|P3|DB RO Phase|Withdrawal by Subject|0
94758|NCT01097616|359019|P2|DB RO Phase|Withdrawal by Subject|0
94759|NCT01097616|359020|P1|DB RO Phase|Withdrawal by Subject|0
94760|NCT01097616|359013|P8|DB RO Phase|Adverse Event|0
94761|NCT01097616|359014|P7|DB RO Phase|Adverse Event|1
94762|NCT01097616|359015|P6|DB RO Phase|Adverse Event|0
94763|NCT01097616|359016|P5|DB RO Phase|Adverse Event|0
94764|NCT01097616|359017|P4|DB RO Phase|Adverse Event|0
94765|NCT01097616|359018|P3|DB RO Phase|Adverse Event|0
94766|NCT01097616|359019|P2|DB RO Phase|Adverse Event|0
94767|NCT01097616|359020|P1|DB RO Phase|Adverse Event|0
94768|NCT01097616|359013|P8|Optional DB EXT Phase|Physician Decision|0
94769|NCT01097616|359014|P7|Optional DB EXT Phase|Physician Decision|0
94770|NCT01097616|359015|P6|Optional DB EXT Phase|Physician Decision|0
94771|NCT01097616|359016|P5|Optional DB EXT Phase|Physician Decision|0
94772|NCT01097616|359017|P4|Optional DB EXT Phase|Physician Decision|0
94773|NCT01097616|359018|P3|Optional DB EXT Phase|Physician Decision|0
94774|NCT01097616|359019|P2|Optional DB EXT Phase|Physician Decision|0
94775|NCT01097616|359020|P1|Optional DB EXT Phase|Physician Decision|1
94776|NCT01097616|359013|P8|Optional DB EXT Phase|Lack of Efficacy|0
94777|NCT01097616|359014|P7|Optional DB EXT Phase|Lack of Efficacy|0
94778|NCT01097616|359015|P6|Optional DB EXT Phase|Lack of Efficacy|0
94779|NCT01097616|359016|P5|Optional DB EXT Phase|Lack of Efficacy|0
94780|NCT01097616|359017|P4|Optional DB EXT Phase|Lack of Efficacy|0
94781|NCT01097616|359018|P3|Optional DB EXT Phase|Lack of Efficacy|1
94782|NCT01097616|359019|P2|Optional DB EXT Phase|Lack of Efficacy|1
94783|NCT01097616|359020|P1|Optional DB EXT Phase|Lack of Efficacy|1
94784|NCT01097616|359013|P8|Optional DB EXT Phase|Lost to Follow-up|0
94785|NCT01097616|359014|P7|Optional DB EXT Phase|Lost to Follow-up|0
94786|NCT01097616|359015|P6|Optional DB EXT Phase|Lost to Follow-up|0
94787|NCT01097616|359016|P5|Optional DB EXT Phase|Lost to Follow-up|0
94788|NCT01097616|359017|P4|Optional DB EXT Phase|Lost to Follow-up|0
94789|NCT01097616|359018|P3|Optional DB EXT Phase|Lost to Follow-up|1
94790|NCT01097616|359019|P2|Optional DB EXT Phase|Lost to Follow-up|5
94791|NCT01097616|359020|P1|Optional DB EXT Phase|Lost to Follow-up|1
94792|NCT01097616|359013|P8|Optional DB EXT Phase|Protocol Violation|0
94793|NCT01097616|359014|P7|Optional DB EXT Phase|Protocol Violation|0
94794|NCT01097616|359015|P6|Optional DB EXT Phase|Protocol Violation|0
94795|NCT01097616|359016|P5|Optional DB EXT Phase|Protocol Violation|0
94796|NCT01097616|359017|P4|Optional DB EXT Phase|Protocol Violation|0
94797|NCT01097616|359018|P3|Optional DB EXT Phase|Protocol Violation|3
94798|NCT01097616|359019|P2|Optional DB EXT Phase|Protocol Violation|2
94799|NCT01097616|359020|P1|Optional DB EXT Phase|Protocol Violation|0
94800|NCT01097616|359013|P8|Optional DB EXT Phase|Withdrawal by Subject|0
94801|NCT01097616|359014|P7|Optional DB EXT Phase|Withdrawal by Subject|0
94802|NCT01097616|359015|P6|Optional DB EXT Phase|Withdrawal by Subject|0
94803|NCT01097616|359016|P5|Optional DB EXT Phase|Withdrawal by Subject|0
94804|NCT01097616|359017|P4|Optional DB EXT Phase|Withdrawal by Subject|0
94805|NCT01097616|359018|P3|Optional DB EXT Phase|Withdrawal by Subject|3
94806|NCT01097616|359019|P2|Optional DB EXT Phase|Withdrawal by Subject|6
94807|NCT01097616|359020|P1|Optional DB EXT Phase|Withdrawal by Subject|12
94808|NCT01097616|359013|P8|Optional DB EXT Phase|Adverse Event|0
94809|NCT01097616|359014|P7|Optional DB EXT Phase|Adverse Event|0
94810|NCT01097616|359015|P6|Optional DB EXT Phase|Adverse Event|0
94811|NCT01097616|359016|P5|Optional DB EXT Phase|Adverse Event|0
94812|NCT01097616|359017|P4|Optional DB EXT Phase|Adverse Event|0
94813|NCT01097616|359018|P3|Optional DB EXT Phase|Adverse Event|2
94814|NCT01097616|359019|P2|Optional DB EXT Phase|Adverse Event|7
94815|NCT01097616|359020|P1|Optional DB EXT Phase|Adverse Event|0
94816|NCT01097616|359013|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94817|NCT01097616|359014|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94818|NCT01097616|359015|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94819|NCT01097616|359016|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94820|NCT01097616|359017|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94821|NCT01097616|359018|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
94822|NCT01097616|359019|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94823|NCT01097616|359020|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
94824|NCT01097616|359013|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94825|NCT01097616|359014|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94826|NCT01097616|359015|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94827|NCT01097616|359016|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94828|NCT01097616|359017|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94829|NCT01097616|359018|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
94830|NCT01097616|359019|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
94831|NCT01097616|359020|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
94832|NCT01097616|359013|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
94833|NCT01097616|359014|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
94834|NCT01097616|359015|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
94835|NCT01097616|359016|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
94836|NCT01097616|359017|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
94837|NCT01097616|359018|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
94838|NCT01097616|359019|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
94839|NCT01097616|359020|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
94840|NCT01097616|359013|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94841|NCT01097616|359014|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94842|NCT01097616|359015|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94843|NCT01097616|359016|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94844|NCT01097616|359017|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
94845|NCT01097616|359018|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
94846|NCT01097616|359019|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
94847|NCT01097616|359020|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
94848|NCT01097616|359013|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94849|NCT01097616|359014|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94850|NCT01097616|359015|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94851|NCT01097616|359016|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94852|NCT01097616|359017|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94853|NCT01097616|359018|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
94854|NCT01097616|359019|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
94855|NCT01097616|359020|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
94856|NCT01097616|359013|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94857|NCT01097616|359014|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94858|NCT01097616|359015|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94859|NCT01097616|359016|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94860|NCT01097616|359017|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
94861|NCT01097616|359018|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
94862|NCT01097616|359019|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
94863|NCT01097616|359020|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
94864|NCT01097616|359013|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94865|NCT01097616|359014|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94866|NCT01097616|359015|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94867|NCT01097616|359016|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94868|NCT01097616|359017|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
94869|NCT01097616|359018|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
94870|NCT01097616|359019|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
94871|NCT01097616|359020|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
94872|NCT01097616|359013|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94873|NCT01097616|359014|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94874|NCT01097616|359015|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94875|NCT01097616|359016|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94876|NCT01097616|359017|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
94877|NCT01097616|359018|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
94878|NCT01097616|359019|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
94879|NCT01097616|359020|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
94880|NCT01097421|359095|P1|Overall Study|Withdrawal by Subject|3
94881|NCT01097421|359095|P1|Overall Study|Lost to Follow-up|1
94882|NCT01097421|359095|P1|Overall Study|Protocol Violation|2
94883|NCT01097421|359095|P1|Overall Study|Adverse Event|8
94884|NCT01097057|359119|P1|Overall Study|Physician Decision|3
94885|NCT01097005|359126|P1|Overall Study|Discontinuance by complication|50
94886|NCT01097005|359126|P1|Overall Study|Adverse Event|14
94887|NCT01097005|359126|P1|Overall Study|Deviation from exclusion criteria|37
94888|NCT01097005|359126|P1|Overall Study|No examination data available|244
94889|NCT01097005|359126|P1|Overall Study|Poor medication compliance|1
94890|NCT01097005|359126|P1|Overall Study|Subjects cannot visit the hospital|1
94891|NCT01097005|359126|P1|Overall Study|Case Report Form not collected|18
94892|NCT01096784|359170|P2|Overall Study|Other Unspecified|1
94893|NCT01096784|359171|P1|Overall Study|Other Unspecified|0
94894|NCT01096784|359170|P2|Overall Study|Administrative Decision|1
94895|NCT01096784|359171|P1|Overall Study|Administrative Decision|0
94896|NCT01096784|359170|P2|Overall Study|Protocol Deviation|2
94897|NCT01096784|359171|P1|Overall Study|Protocol Deviation|2
94898|NCT01096784|359170|P2|Overall Study|Adverse Event|9
94899|NCT01096784|359171|P1|Overall Study|Adverse Event|11
94900|NCT01096784|359170|P2|Overall Study|Withdrawal by Subject|1
94901|NCT01096784|359171|P1|Overall Study|Withdrawal by Subject|2
94902|NCT01096667|359276|P5|Overall Study|Not treated|0
94903|NCT01096667|359277|P4|Overall Study|Not treated|0
94904|NCT01096667|359278|P3|Overall Study|Not treated|0
94905|NCT01096667|359279|P2|Overall Study|Not treated|0
94906|NCT01096667|359280|P1|Overall Study|Not treated|1
94907|NCT01096667|359276|P5|Overall Study|Protocol Violation|0
94908|NCT01096667|359277|P4|Overall Study|Protocol Violation|1
94909|NCT01096667|359278|P3|Overall Study|Protocol Violation|0
94910|NCT01096667|359279|P2|Overall Study|Protocol Violation|0
94911|NCT01096667|359280|P1|Overall Study|Protocol Violation|0
94912|NCT01096667|359276|P5|Overall Study|Reason not available|0
94913|NCT01096667|359277|P4|Overall Study|Reason not available|1
94914|NCT01096667|359278|P3|Overall Study|Reason not available|1
94915|NCT01096667|359279|P2|Overall Study|Reason not available|1
94916|NCT01096667|359280|P1|Overall Study|Reason not available|0
94917|NCT01096667|359276|P5|Overall Study|Withdrawal by Subject|0
94918|NCT01096667|359277|P4|Overall Study|Withdrawal by Subject|1
94919|NCT01096667|359278|P3|Overall Study|Withdrawal by Subject|0
94920|NCT01096667|359279|P2|Overall Study|Withdrawal by Subject|0
94921|NCT01096667|359280|P1|Overall Study|Withdrawal by Subject|1
94922|NCT01096667|359276|P5|Overall Study|Lost to Follow-up|0
94923|NCT01096667|359277|P4|Overall Study|Lost to Follow-up|0
94924|NCT01096667|359278|P3|Overall Study|Lost to Follow-up|1
94925|NCT01096667|359279|P2|Overall Study|Lost to Follow-up|1
94926|NCT01096667|359280|P1|Overall Study|Lost to Follow-up|1
94927|NCT01096589|359422|P4|Overall Study|found treatment exhausting|1
94928|NCT01096589|359423|P3|Overall Study|found treatment exhausting|0
94929|NCT01096589|359424|P2|Overall Study|found treatment exhausting|0
94930|NCT01096589|359425|P1|Overall Study|found treatment exhausting|0
94931|NCT01096589|359422|P4|Overall Study|Compliance with protocol|0
94932|NCT01096589|359423|P3|Overall Study|Compliance with protocol|1
94933|NCT01096589|359424|P2|Overall Study|Compliance with protocol|0
94934|NCT01096589|359425|P1|Overall Study|Compliance with protocol|0
94935|NCT01096589|359422|P4|Overall Study|Withdrawal by Subject|1
94936|NCT01096589|359423|P3|Overall Study|Withdrawal by Subject|1
94937|NCT01096589|359424|P2|Overall Study|Withdrawal by Subject|1
94938|NCT01096589|359425|P1|Overall Study|Withdrawal by Subject|2
94939|NCT01096589|359422|P4|Overall Study|Adverse Event|1
94940|NCT01096589|359423|P3|Overall Study|Adverse Event|2
94941|NCT01096589|359424|P2|Overall Study|Adverse Event|1
94942|NCT01096589|359425|P1|Overall Study|Adverse Event|2
94943|NCT01096550|359437|P2|Overall Study|Lost to Follow-up|9
94944|NCT01096550|359438|P1|Overall Study|Lost to Follow-up|12
94945|NCT01096550|359437|P2|Overall Study|non-African American participant|6
94946|NCT01096550|359438|P1|Overall Study|non-African American participant|13
94947|NCT01096550|359437|P2|Overall Study|Withdrawal by Subject|1
94948|NCT01096550|359438|P1|Overall Study|Withdrawal by Subject|0
94949|NCT01096550|359437|P2|Overall Study|clinic readmission|1
94950|NCT01096550|359438|P1|Overall Study|clinic readmission|1
94951|NCT01096550|359437|P2|Overall Study|non-regular treatment track at clinic|1
94952|NCT01096550|359438|P1|Overall Study|non-regular treatment track at clinic|1
94953|NCT01096550|359437|P2|Overall Study|discontinued site|11
94954|NCT01096550|359438|P1|Overall Study|discontinued site|10
94955|NCT01096446|359446|P2|Overall Study|Protocol Violation|0
94956|NCT01096446|359447|P1|Overall Study|Protocol Violation|2
94957|NCT01096446|359446|P2|Overall Study|Death|0
94958|NCT01096446|359447|P1|Overall Study|Death|1
94959|NCT01096342|359452|P1|Overall Study|Protocol Violation|1
94960|NCT01096316|359460|P2|Overall Study|Lost to Follow-up|9
94961|NCT01096316|359461|P1|Overall Study|Lost to Follow-up|15
94962|NCT01096186|359471|P1|Overall Study|Noncompliance with study drug|1
94963|NCT01096186|359471|P1|Overall Study|Physician Decision|1
94964|NCT01096186|359471|P1|Overall Study|Withdrawal by Subject|22
94965|NCT01096186|359471|P1|Overall Study|Lost to Follow-up|2
94966|NCT01096186|359471|P1|Overall Study|Lack of Efficacy|4
94967|NCT01096186|359471|P1|Overall Study|Death|4
94968|NCT01096186|359471|P1|Overall Study|Adverse Event|16
94969|NCT01096056|359479|P2|Overall Study|Lost to Follow-up|1
94970|NCT01096056|359480|P1|Overall Study|Lost to Follow-up|0
94971|NCT01096017|359512|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
94972|NCT01096017|359513|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
94973|NCT01095978|359541|P1|Overall Study|Adverse Event|1
94974|NCT01095978|359541|P1|Overall Study|Did not take Klacid SR|2
94975|NCT01095835|359575|P3|Overall Study|Protocol Violation|0
94976|NCT01095835|359576|P2|Overall Study|Protocol Violation|2
94977|NCT01095835|359577|P1|Overall Study|Protocol Violation|1
94978|NCT01095835|359575|P3|Overall Study|Non study compliance|1
94979|NCT01095835|359576|P2|Overall Study|Non study compliance|0
94980|NCT01095835|359577|P1|Overall Study|Non study compliance|0
94981|NCT01095835|359575|P3|Overall Study|Withdrawal by Subject|0
94982|NCT01095835|359576|P2|Overall Study|Withdrawal by Subject|3
94983|NCT01095835|359577|P1|Overall Study|Withdrawal by Subject|1
94984|NCT01095835|359575|P3|Overall Study|Physician Decision|1
94985|NCT01095835|359576|P2|Overall Study|Physician Decision|0
94986|NCT01095835|359577|P1|Overall Study|Physician Decision|0
94987|NCT01095835|359575|P3|Overall Study|Lack of Efficacy|0
94988|NCT01095835|359576|P2|Overall Study|Lack of Efficacy|1
94989|NCT01095835|359577|P1|Overall Study|Lack of Efficacy|0
94990|NCT01095835|359575|P3|Overall Study|Adverse Event|6
94991|NCT01095835|359576|P2|Overall Study|Adverse Event|6
94992|NCT01095835|359577|P1|Overall Study|Adverse Event|8
94993|NCT01095796|359615|P2|Overall Study|Participant Transferred to Another Study|200
94994|NCT01095796|359616|P1|Overall Study|Participant Transferred to Another Study|215
94995|NCT01095796|359615|P2|Overall Study|Protocol Violation|0
94996|NCT01095796|359616|P1|Overall Study|Protocol Violation|1
94997|NCT01095796|359615|P2|Overall Study|Participant Noncompliance|10
94998|NCT01095796|359616|P1|Overall Study|Participant Noncompliance|5
94999|NCT01095796|359615|P2|Overall Study|Lost to Follow-up|29
95000|NCT01095796|359616|P1|Overall Study|Lost to Follow-up|27
95001|NCT01095796|359615|P2|Overall Study|Withdrew Consent|22
95002|NCT01095796|359616|P1|Overall Study|Withdrew Consent|16
95003|NCT01095796|359615|P2|Overall Study|Investigator's Discretion|2
95004|NCT01095796|359616|P1|Overall Study|Investigator's Discretion|7
95005|NCT01095796|359615|P2|Overall Study|Lack of Efficacy|3
95006|NCT01095796|359616|P1|Overall Study|Lack of Efficacy|5
95007|NCT01095796|359615|P2|Overall Study|Pregnancy|0
95008|NCT01095796|359616|P1|Overall Study|Pregnancy|2
95009|NCT01095796|359615|P2|Overall Study|Death|2
95010|NCT01095796|359616|P1|Overall Study|Death|3
95011|NCT01095796|359615|P2|Overall Study|Adverse Event|19
95012|NCT01095796|359616|P1|Overall Study|Adverse Event|9
95013|NCT01095796|359615|P2|Overall Study|Randomized but Not Treated|2
95014|NCT01095796|359616|P1|Overall Study|Randomized but Not Treated|5
95015|NCT01095666|359646|P3|Overall Study|Non-compliance, not met criteria etc.|2
95016|NCT01095666|359647|P2|Overall Study|Non-compliance, not met criteria etc.|2
95017|NCT01095666|359648|P1|Overall Study|Non-compliance, not met criteria etc.|7
95018|NCT01095666|359646|P3|Overall Study|Withdrawal by Subject|1
95019|NCT01095666|359647|P2|Overall Study|Withdrawal by Subject|6
95020|NCT01095666|359648|P1|Overall Study|Withdrawal by Subject|6
95021|NCT01095666|359646|P3|Overall Study|Lost to Follow-up|0
95022|NCT01095666|359647|P2|Overall Study|Lost to Follow-up|2
95023|NCT01095666|359648|P1|Overall Study|Lost to Follow-up|2
95024|NCT01095666|359646|P3|Overall Study|Adverse Event|3
95025|NCT01095666|359647|P2|Overall Study|Adverse Event|1
95026|NCT01095666|359648|P1|Overall Study|Adverse Event|2
95027|NCT01095666|359646|P3|Overall Study|Lack of Efficacy|1
95028|NCT01095666|359647|P2|Overall Study|Lack of Efficacy|0
95029|NCT01095666|359648|P1|Overall Study|Lack of Efficacy|0
95030|NCT01095653|359671|P3|Overall Study|non-compliance, not met criteria, etc.|5
95031|NCT01095653|359672|P2|Overall Study|non-compliance, not met criteria, etc.|6
95032|NCT01095653|359673|P1|Overall Study|non-compliance, not met criteria, etc.|10
95033|NCT01095653|359671|P3|Overall Study|Withdrawal by Subject|3
95034|NCT01095653|359672|P2|Overall Study|Withdrawal by Subject|5
95035|NCT01095653|359673|P1|Overall Study|Withdrawal by Subject|4
95036|NCT01095653|359671|P3|Overall Study|Lost to Follow-up|4
95037|NCT01095653|359672|P2|Overall Study|Lost to Follow-up|0
95038|NCT01095653|359673|P1|Overall Study|Lost to Follow-up|1
95039|NCT01095653|359671|P3|Overall Study|Adverse Event|4
95040|NCT01095653|359672|P2|Overall Study|Adverse Event|4
95041|NCT01095653|359673|P1|Overall Study|Adverse Event|1
95042|NCT01095653|359671|P3|Overall Study|Lack of Efficacy|0
95043|NCT01095653|359672|P2|Overall Study|Lack of Efficacy|0
95044|NCT01095653|359673|P1|Overall Study|Lack of Efficacy|3
95045|NCT01095250|359731|P4|Overall Study|Withdrawal by Subject|0
95046|NCT01095250|359732|P3|Overall Study|Withdrawal by Subject|1
95047|NCT01095250|359733|P2|Overall Study|Withdrawal by Subject|0
95048|NCT01095250|359734|P1|Overall Study|Withdrawal by Subject|0
95049|NCT01095250|359731|P4|Overall Study|administrative reasons|5
95050|NCT01095250|359732|P3|Overall Study|administrative reasons|7
95051|NCT01095250|359733|P2|Overall Study|administrative reasons|10
95052|NCT01095250|359734|P1|Overall Study|administrative reasons|8
95053|NCT01095094|359764|P1|Overall Study|Physician Decision|1
95054|NCT01095094|359764|P1|Overall Study|Death|1
95055|NCT01095094|359764|P1|Overall Study|Withdrawal by Subject|1
95056|NCT01094886|359769|P1|Overall Study|Withdrawal by Subject|5
95057|NCT01094886|359769|P1|Overall Study|Adverse Event|2
95058|NCT01094808|359779|P3|Overall Study|Withdrawal by Subject|0
95059|NCT01094808|359780|P2|Overall Study|Withdrawal by Subject|1
95060|NCT01094808|359781|P1|Overall Study|Withdrawal by Subject|1
95061|NCT01094743|359816|P1|Period 1|Unsatisfactory comfort at lens fitting|2
95062|NCT01094730|359833|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
95063|NCT01094730|359834|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
95064|NCT01094730|359833|P2|Period 2 (14 Days)|Adverse Event|1
95065|NCT01094730|359834|P1|Period 2 (14 Days)|Adverse Event|0
95066|NCT01094730|359833|P2|Period 2 (14 Days)|No time for the follow-up visit|0
95067|NCT01094730|359834|P1|Period 2 (14 Days)|No time for the follow-up visit|1
95068|NCT01094730|359833|P2|Period 2 (14 Days)|Protocol Violation|0
95069|NCT01094730|359834|P1|Period 2 (14 Days)|Protocol Violation|2
95070|NCT01094730|359833|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
95071|NCT01094730|359834|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
95072|NCT01094730|359833|P2|Period 1 (14 Days)|No time for the follow-up visit|0
95073|NCT01094730|359834|P1|Period 1 (14 Days)|No time for the follow-up visit|1
95074|NCT01094730|359833|P2|Period 1 (14 Days)|Withdrawal by Subject|1
95075|NCT01094730|359834|P1|Period 1 (14 Days)|Withdrawal by Subject|0
95076|NCT01094730|359833|P2|Period 1 (14 Days)|Lost to Follow-up|1
95077|NCT01094730|359834|P1|Period 1 (14 Days)|Lost to Follow-up|0
95078|NCT01094184|359953|P2|Overall Study|Death|11
95079|NCT01094184|359954|P1|Overall Study|Death|35
95080|NCT01094171|360188|P1|Overall Study|Other|1
95081|NCT01094171|360188|P1|Overall Study|Migration from the study area|3
95082|NCT01094171|360188|P1|Overall Study|Informed consent withdrawal|4
95083|NCT01094171|360188|P1|Overall Study|Lost to Follow-up|2
95084|NCT01094119|360197|P2|Overall Study|Lack of Efficacy|4
95085|NCT01094119|360198|P1|Overall Study|Lack of Efficacy|2
95086|NCT01093846|360213|P3|Overall Study|Administrative Problems|15
95087|NCT01093846|360214|P2|Overall Study|Administrative Problems|17
95088|NCT01093846|360215|P1|Overall Study|Administrative Problems|18
95089|NCT01093846|360213|P3|Overall Study|Condition no longer required study drug|1
95090|NCT01093846|360214|P2|Overall Study|Condition no longer required study drug|1
95091|NCT01093846|360215|P1|Overall Study|Condition no longer required study drug|1
95092|NCT01093846|360213|P3|Overall Study|Lack of Efficacy|4
95093|NCT01093846|360214|P2|Overall Study|Lack of Efficacy|0
95094|NCT01093846|360215|P1|Overall Study|Lack of Efficacy|0
95095|NCT01093846|360213|P3|Overall Study|Adverse Event|1
95096|NCT01093846|360214|P2|Overall Study|Adverse Event|0
95097|NCT01093846|360215|P1|Overall Study|Adverse Event|0
95098|NCT01093755|360240|P2|Overall Study|Withdrawal by Subject|4
95099|NCT01093755|360241|P1|Overall Study|Withdrawal by Subject|3
95100|NCT01093625|360281|P2|1-Year Visit|Lost to Follow-up|3
95101|NCT01093625|360282|P1|1-Year Visit|Lost to Follow-up|5
95102|NCT01093625|360281|P2|6-Month Visit|Lost to Follow-up|2
95103|NCT01093625|360282|P1|6-Month Visit|Lost to Follow-up|2
95104|NCT01093625|360281|P2|6-Month Visit|Withdrawal by Subject|7
95105|NCT01093625|360282|P1|6-Month Visit|Withdrawal by Subject|6
95106|NCT01093625|360281|P2|3-Month Visit|Lost to Follow-up|0
95107|NCT01093625|360282|P1|3-Month Visit|Lost to Follow-up|2
95108|NCT01093625|360281|P2|1-Month Visit|Lost to Follow-up|0
95109|NCT01093625|360282|P1|1-Month Visit|Lost to Follow-up|2
95110|NCT01093625|360281|P2|2-Week Visit|Withdrawal by Subject|0
95111|NCT01093625|360282|P1|2-Week Visit|Withdrawal by Subject|1
95112|NCT01093625|360281|P2|Baseline and Dispensed|Withdrawal by Subject|0
95113|NCT01093625|360282|P1|Baseline and Dispensed|Withdrawal by Subject|2
95114|NCT01093599|360302|P2|Overall Study|Lost to Follow-up|46
95115|NCT01093599|360303|P1|Overall Study|Lost to Follow-up|32
95116|NCT01093534|360312|P3|Overall Study|Other|4
95117|NCT01093534|360313|P2|Overall Study|Other|3
95118|NCT01093534|360314|P1|Overall Study|Other|1
95119|NCT01093534|360312|P3|Overall Study|Withdrawal by Subject|2
95120|NCT01093534|360313|P2|Overall Study|Withdrawal by Subject|7
95121|NCT01093534|360314|P1|Overall Study|Withdrawal by Subject|5
95122|NCT01093534|360312|P3|Overall Study|Lack of Efficacy|1
95123|NCT01093534|360313|P2|Overall Study|Lack of Efficacy|1
95124|NCT01093534|360314|P1|Overall Study|Lack of Efficacy|2
95125|NCT01093534|360312|P3|Overall Study|Adverse Event|2
95126|NCT01093534|360313|P2|Overall Study|Adverse Event|5
95127|NCT01093534|360314|P1|Overall Study|Adverse Event|2
95128|NCT01093222|360462|P1|Overall Study|Not protocol specified|1
95129|NCT01093222|360462|P1|Overall Study|Death|2
95130|NCT01093222|360462|P1|Overall Study|Progression/relapse|24
95131|NCT01093222|360462|P1|Overall Study|Adverse Event|7
95132|NCT01093222|360462|P1|Overall Study|Ineligible|6
95133|NCT01092832|360526|P2|Overall Study|Not specified|0
95134|NCT01092832|360527|P1|Overall Study|Not specified|1
95135|NCT01092780|360539|P4|Washout Period 2|Adverse Event|0
95136|NCT01092780|360540|P3|Washout Period 2|Adverse Event|1
95137|NCT01092780|360541|P2|Washout Period 2|Adverse Event|1
95138|NCT01092780|360542|P1|Washout Period 2|Adverse Event|0
95139|NCT01092780|360539|P4|Washout Period 1|Noncompliance with nCPAP|0
95140|NCT01092780|360540|P3|Washout Period 1|Noncompliance with nCPAP|0
95141|NCT01092780|360541|P2|Washout Period 1|Noncompliance with nCPAP|0
95142|NCT01092780|360542|P1|Washout Period 1|Noncompliance with nCPAP|1
95143|NCT01092780|360539|P4|Washout Period 1|Adverse Event|0
95144|NCT01092780|360540|P3|Washout Period 1|Adverse Event|0
95145|NCT01092780|360541|P2|Washout Period 1|Adverse Event|1
95146|NCT01092780|360542|P1|Washout Period 1|Adverse Event|0
95147|NCT01092728|360578|P2|Overall Study|Prohibited Concomitant Medications|0
95148|NCT01092728|360579|P1|Overall Study|Prohibited Concomitant Medications|1
95149|NCT01092728|360578|P2|Overall Study|Disease Progression|13
95150|NCT01092728|360579|P1|Overall Study|Disease Progression|1
95151|NCT01092728|360578|P2|Overall Study|Adverse Event|1
95152|NCT01092728|360579|P1|Overall Study|Adverse Event|0
95153|NCT01092728|360578|P2|Overall Study|Withdrawal by Subject|0
95154|NCT01092728|360579|P1|Overall Study|Withdrawal by Subject|2
95155|NCT01092702|360587|P1|Overall Study|Lost to Follow-up|2
95156|NCT01092702|360587|P1|Overall Study|Withdrawal by Subject|7
95157|NCT01092663|360593|P2|Overall Study|Protocol Violation|1
95158|NCT01092663|360594|P1|Overall Study|Protocol Violation|0
95159|NCT01092663|360593|P2|Overall Study|Adverse Event|1
95160|NCT01092663|360594|P1|Overall Study|Adverse Event|1
95161|NCT01092663|360593|P2|Overall Study|High fasting triglyceride|0
95162|NCT01092663|360594|P1|Overall Study|High fasting triglyceride|2
95163|NCT01092663|360593|P2|Overall Study|Glucose >300mg/dL|0
95164|NCT01092663|360594|P1|Overall Study|Glucose >300mg/dL|1
95165|NCT01092663|360593|P2|Overall Study|Withdrawal by Subject|2
95166|NCT01092663|360594|P1|Overall Study|Withdrawal by Subject|3
95167|NCT01092637|360642|P2|Overall Study|Death|49
95168|NCT01092637|360643|P1|Overall Study|Death|47
95169|NCT01092546|360658|P1|Overall Study|Subjects withdrawn prior to dosing|4
95170|NCT01092507|360665|P2|Overall Study|Withdrawal by Subject|0
95171|NCT01092507|360666|P1|Overall Study|Withdrawal by Subject|2
95172|NCT01092416|360701|P1|12-Month Follow-up|Data collected after close of 1Y window|2
95173|NCT01092416|360701|P1|12-Month Follow-up|Missed 1-year follow-up|1
95174|NCT01092416|360701|P1|12-Month Follow-up|Withdrawal by Subject|2
95175|NCT01092416|360701|P1|12-Month Follow-up|Lost to Follow-up|4
95176|NCT01092416|360701|P1|12-Month Follow-up|Death|16
95177|NCT01092416|360701|P1|30-Day Follow-up|Data collected after close of 30D window|5
95178|NCT01092416|360701|P1|30-Day Follow-up|Missed 30-day follow-up|3
95179|NCT01092416|360701|P1|30-Day Follow-up|Death|2
95180|NCT01092416|360701|P1|Enrollment|Atherectomy device not inserted|3
95181|NCT01091974|360738|P4|Overall Study|side-effects|2
95182|NCT01091974|360739|P3|Overall Study|side-effects|0
95183|NCT01091974|360740|P2|Overall Study|side-effects|1
95184|NCT01091974|360741|P1|Overall Study|side-effects|1
95185|NCT01091974|360738|P4|Overall Study|Withdrawal by Subject|2
95186|NCT01091974|360739|P3|Overall Study|Withdrawal by Subject|2
95187|NCT01091974|360740|P2|Overall Study|Withdrawal by Subject|3
95188|NCT01091974|360741|P1|Overall Study|Withdrawal by Subject|1
95189|NCT01091974|360738|P4|Overall Study|resumed sleep medication|2
95190|NCT01091974|360739|P3|Overall Study|resumed sleep medication|1
95191|NCT01091974|360740|P2|Overall Study|resumed sleep medication|0
95192|NCT01091974|360741|P1|Overall Study|resumed sleep medication|0
95193|NCT01091974|360738|P4|Overall Study|Did not start intervention|1
95194|NCT01091974|360739|P3|Overall Study|Did not start intervention|3
95195|NCT01091974|360740|P2|Overall Study|Did not start intervention|1
95196|NCT01091974|360741|P1|Overall Study|Did not start intervention|3
95197|NCT01091675|360776|P1|Overall Study|Lack of Efficacy|27
95198|NCT01091675|360776|P1|Overall Study|Adverse Event|7
95199|NCT01091662|360782|P2|Overall Study|unable to swallow capsule|1
95200|NCT01091662|360783|P1|Overall Study|unable to swallow capsule|0
95201|NCT01091662|360782|P2|Overall Study|Protocol Violation|2
95202|NCT01091662|360783|P1|Overall Study|Protocol Violation|0
95203|NCT01091662|360782|P2|Overall Study|Pregnancy|1
95204|NCT01091662|360783|P1|Overall Study|Pregnancy|0
95205|NCT01091662|360782|P2|Overall Study|Lost to Follow-up|1
95206|NCT01091662|360783|P1|Overall Study|Lost to Follow-up|0
95207|NCT01091662|360782|P2|Overall Study|met exclusion criteria|0
95208|NCT01091662|360783|P1|Overall Study|met exclusion criteria|1
95209|NCT01091662|360782|P2|Overall Study|met exit criteria|13
95210|NCT01091662|360783|P1|Overall Study|met exit criteria|7
95211|NCT01091662|360782|P2|Overall Study|Withdrawal by Subject|6
95212|NCT01091662|360783|P1|Overall Study|Withdrawal by Subject|7
95213|NCT01091662|360782|P2|Overall Study|Physician Decision|1
95214|NCT01091662|360783|P1|Overall Study|Physician Decision|1
95215|NCT01091662|360782|P2|Overall Study|Adverse Event|9
95216|NCT01091662|360783|P1|Overall Study|Adverse Event|1
95217|NCT01091519|360821|P2|Overall Study|Randomized not treated|4
95218|NCT01091519|360822|P1|Overall Study|Randomized not treated|4
95219|NCT01091519|360821|P2|Overall Study|Other|8
95220|NCT01091519|360822|P1|Overall Study|Other|6
95221|NCT01091519|360821|P2|Overall Study|Withdrawal by Subject|2
95222|NCT01091519|360822|P1|Overall Study|Withdrawal by Subject|2
95223|NCT01091519|360821|P2|Overall Study|Lost to Follow-up|24
95224|NCT01091519|360822|P1|Overall Study|Lost to Follow-up|14
95225|NCT01091519|360821|P2|Overall Study|Lack of Efficacy|19
95226|NCT01091519|360822|P1|Overall Study|Lack of Efficacy|16
95227|NCT01091519|360821|P2|Overall Study|Death|0
95228|NCT01091519|360822|P1|Overall Study|Death|1
95229|NCT01091519|360821|P2|Overall Study|Adverse Event|16
95230|NCT01091519|360822|P1|Overall Study|Adverse Event|12
95231|NCT01091454|360834|P1|Overall Study|Ineligible|1
95232|NCT01091259|360843|P1|Overall Study|Lack of Efficacy|2
95233|NCT01091259|360843|P1|Overall Study|Adverse Event|3
95234|NCT01091246|360854|P3|Overall Study|Subject not dosed|1
95235|NCT01091246|360855|P2|Overall Study|Subject not dosed|0
95236|NCT01091246|360856|P1|Overall Study|Subject not dosed|2
95237|NCT01091246|360854|P3|Overall Study|Withdrawal by Subject|4
95238|NCT01091246|360855|P2|Overall Study|Withdrawal by Subject|5
95239|NCT01091246|360856|P1|Overall Study|Withdrawal by Subject|9
95240|NCT01091246|360854|P3|Overall Study|Adverse Event|1
95241|NCT01091246|360855|P2|Overall Study|Adverse Event|0
95242|NCT01091246|360856|P1|Overall Study|Adverse Event|1
95243|NCT01091246|360854|P3|Overall Study|Lost to Follow-up|7
95244|NCT01091246|360855|P2|Overall Study|Lost to Follow-up|11
95245|NCT01091246|360856|P1|Overall Study|Lost to Follow-up|23
95246|NCT01091103|360995|P1|Overall Study|Progressive Disease|3
95247|NCT01091103|360995|P1|Overall Study|Adverse Event|1
95248|NCT01090973|361015|P1|Overall Study|Disease progression|1
95249|NCT01090765|361031|P6|Overall Study|Vasovagal reaction with first infusion|0
95250|NCT01090765|361032|P5|Overall Study|Vasovagal reaction with first infusion|1
95251|NCT01090765|361033|P4|Overall Study|Vasovagal reaction with first infusion|0
95252|NCT01090765|361034|P3|Overall Study|Vasovagal reaction with first infusion|0
95253|NCT01090765|361035|P2|Overall Study|Vasovagal reaction with first infusion|0
95254|NCT01090765|361036|P1|Overall Study|Vasovagal reaction with first infusion|0
95255|NCT01090765|361031|P6|Overall Study|Developed a DVT, needed anticoagulation|0
95256|NCT01090765|361032|P5|Overall Study|Developed a DVT, needed anticoagulation|0
95257|NCT01090765|361033|P4|Overall Study|Developed a DVT, needed anticoagulation|1
95258|NCT01090765|361034|P3|Overall Study|Developed a DVT, needed anticoagulation|0
95259|NCT01090765|361035|P2|Overall Study|Developed a DVT, needed anticoagulation|0
95260|NCT01090765|361036|P1|Overall Study|Developed a DVT, needed anticoagulation|0
95261|NCT01090765|361031|P6|Overall Study|Patient withdrew consent|1
95262|NCT01090765|361032|P5|Overall Study|Patient withdrew consent|1
95263|NCT01090765|361033|P4|Overall Study|Patient withdrew consent|0
95264|NCT01090765|361034|P3|Overall Study|Patient withdrew consent|0
95265|NCT01090765|361035|P2|Overall Study|Patient withdrew consent|0
95266|NCT01090765|361036|P1|Overall Study|Patient withdrew consent|0
95267|NCT01090739|361082|P1|36 Month Follow-up|Visit still pending|17
95268|NCT01090739|361082|P1|36 Month Follow-up|Withdrawal by Subject|6
95269|NCT01090739|361082|P1|24 Month Follow-up|Death|1
95270|NCT01090739|361082|P1|24 Month Follow-up|Lost to Follow-up|1
95271|NCT01090739|361082|P1|24 Month Follow-up|Withdrawal by Subject|7
95272|NCT01090739|361082|P1|12 Month Follow-up|Death|1
95273|NCT01090739|361082|P1|12 Month Follow-up|Physician Decision|1
95274|NCT01090739|361082|P1|12 Month Follow-up|Lost to Follow-up|1
95275|NCT01090739|361082|P1|12 Month Follow-up|Withdrawal by Subject|2
95276|NCT01090739|361082|P1|Enrollment|Adverse Event|1
95277|NCT01090739|361082|P1|Enrollment|Study implant limit reached|2
95278|NCT01090739|361082|P1|Enrollment|Sponsor termination of site|4
95279|NCT01090739|361082|P1|Enrollment|Physician Decision|5
95280|NCT01090739|361082|P1|Enrollment|Lost to Follow-up|5
95281|NCT01090739|361082|P1|Enrollment|Protocol Violation|14
95282|NCT01090739|361082|P1|Enrollment|Withdrawal by Subject|24
95283|NCT01090492|361107|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
95284|NCT01090492|361108|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
95285|NCT01090492|361109|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
95286|NCT01090492|361110|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
95287|NCT01090492|361111|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
95288|NCT01090492|361112|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
95289|NCT01090492|361113|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
95290|NCT01090492|361114|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
95291|NCT01090492|361107|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
95292|NCT01090492|361108|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
95293|NCT01090492|361109|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
95294|NCT01090492|361110|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
95295|NCT01090492|361111|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
95296|NCT01090492|361112|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
95297|NCT01090492|361113|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
95298|NCT01090492|361114|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
95299|NCT01090492|361107|P8|Second Intervention Period (4 Weeks)|Other|0
95300|NCT01090492|361108|P7|Second Intervention Period (4 Weeks)|Other|0
95301|NCT01090492|361109|P6|Second Intervention Period (4 Weeks)|Other|0
95302|NCT01090492|361110|P5|Second Intervention Period (4 Weeks)|Other|0
95303|NCT01090492|361111|P4|Second Intervention Period (4 Weeks)|Other|0
95304|NCT01090492|361112|P3|Second Intervention Period (4 Weeks)|Other|1
95305|NCT01090492|361113|P2|Second Intervention Period (4 Weeks)|Other|1
95306|NCT01090492|361114|P1|Second Intervention Period (4 Weeks)|Other|0
95307|NCT01090492|361107|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
95308|NCT01090492|361108|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
95309|NCT01090492|361109|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
95310|NCT01090492|361110|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
95311|NCT01090492|361111|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
95312|NCT01090492|361112|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
95313|NCT01090492|361113|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
95314|NCT01090492|361114|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
95315|NCT01090492|361107|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
95316|NCT01090492|361108|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
95317|NCT01090492|361109|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
95318|NCT01090492|361110|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
95319|NCT01090492|361111|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
95320|NCT01090492|361112|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
95321|NCT01090492|361113|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
95322|NCT01090492|361114|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
95323|NCT01090492|361107|P8|First Intervention Period (4 Weeks)|Adverse Event|5
95324|NCT01090492|361108|P7|First Intervention Period (4 Weeks)|Adverse Event|0
95325|NCT01090492|361109|P6|First Intervention Period (4 Weeks)|Adverse Event|2
95326|NCT01090492|361110|P5|First Intervention Period (4 Weeks)|Adverse Event|1
95327|NCT01090492|361111|P4|First Intervention Period (4 Weeks)|Adverse Event|3
95328|NCT01090492|361112|P3|First Intervention Period (4 Weeks)|Adverse Event|0
95329|NCT01090492|361113|P2|First Intervention Period (4 Weeks)|Adverse Event|2
95330|NCT01090492|361114|P1|First Intervention Period (4 Weeks)|Adverse Event|0
95331|NCT01090492|361107|P8|First Intervention Period (4 Weeks)|Pregnancy|0
95332|NCT01090492|361108|P7|First Intervention Period (4 Weeks)|Pregnancy|0
95333|NCT01090492|361109|P6|First Intervention Period (4 Weeks)|Pregnancy|0
95334|NCT01090492|361110|P5|First Intervention Period (4 Weeks)|Pregnancy|1
95335|NCT01090492|361111|P4|First Intervention Period (4 Weeks)|Pregnancy|0
95336|NCT01090492|361112|P3|First Intervention Period (4 Weeks)|Pregnancy|0
95337|NCT01090492|361113|P2|First Intervention Period (4 Weeks)|Pregnancy|0
95338|NCT01090492|361114|P1|First Intervention Period (4 Weeks)|Pregnancy|0
95339|NCT01090492|361107|P8|First Intervention Period (4 Weeks)|Other|0
95340|NCT01090492|361108|P7|First Intervention Period (4 Weeks)|Other|0
95341|NCT01090492|361109|P6|First Intervention Period (4 Weeks)|Other|0
95342|NCT01090492|361110|P5|First Intervention Period (4 Weeks)|Other|2
95343|NCT01090492|361111|P4|First Intervention Period (4 Weeks)|Other|1
95344|NCT01090492|361112|P3|First Intervention Period (4 Weeks)|Other|1
95345|NCT01090492|361113|P2|First Intervention Period (4 Weeks)|Other|0
95346|NCT01090492|361114|P1|First Intervention Period (4 Weeks)|Other|0
95347|NCT01090492|361107|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
95348|NCT01090492|361108|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
95349|NCT01090492|361109|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
95350|NCT01090492|361110|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
95351|NCT01090492|361111|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
95352|NCT01090492|361112|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
95353|NCT01090492|361113|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
95354|NCT01090492|361114|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
95355|NCT01090492|361107|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
95356|NCT01090492|361108|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
95357|NCT01090492|361109|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
95358|NCT01090492|361110|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
95359|NCT01090492|361111|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
95360|NCT01090492|361112|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
95361|NCT01090492|361113|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
95362|NCT01090492|361114|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
95363|NCT01090492|361107|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
95364|NCT01090492|361108|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
95365|NCT01090492|361109|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
95366|NCT01090492|361110|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
95367|NCT01090492|361111|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
95368|NCT01090492|361112|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
95453|NCT01090310|361285|P3|Core Study|Abnormal test procedure result|1
95369|NCT01090492|361113|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
95370|NCT01090492|361114|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
95371|NCT01090453|361182|P2|Overall Study|Eligibility Criteria|1
95372|NCT01090453|361183|P1|Overall Study|Eligibility Criteria|0
95373|NCT01090453|361182|P2|Overall Study|Other|4
95374|NCT01090453|361183|P1|Overall Study|Other|2
95375|NCT01090453|361182|P2|Overall Study|Protocol Violation|0
95376|NCT01090453|361183|P1|Overall Study|Protocol Violation|2
95377|NCT01090453|361182|P2|Overall Study|Non serious AEs|0
95378|NCT01090453|361183|P1|Overall Study|Non serious AEs|1
95379|NCT01090453|361182|P2|Overall Study|Lost to Follow-up|7
95380|NCT01090453|361183|P1|Overall Study|Lost to Follow-up|7
95381|NCT01090453|361182|P2|Overall Study|Withdrawal by Subject|2
95382|NCT01090453|361183|P1|Overall Study|Withdrawal by Subject|1
95383|NCT01090427|361230|P7|After Controlled Period|Adverse Event|0
95384|NCT01090427|361231|P6|After Controlled Period|Adverse Event|1
95385|NCT01090427|361232|P5|After Controlled Period|Adverse Event|0
95386|NCT01090427|361233|P4|After Controlled Period|Adverse Event|2
95387|NCT01090427|361234|P3|After Controlled Period|Adverse Event|0
95388|NCT01090427|361235|P2|After Controlled Period|Adverse Event|0
95389|NCT01090427|361236|P1|After Controlled Period|Adverse Event|0
95390|NCT01090427|361230|P7|After Controlled Period|Lack of Efficacy|2
95391|NCT01090427|361231|P6|After Controlled Period|Lack of Efficacy|3
95392|NCT01090427|361232|P5|After Controlled Period|Lack of Efficacy|0
95393|NCT01090427|361233|P4|After Controlled Period|Lack of Efficacy|0
95394|NCT01090427|361234|P3|After Controlled Period|Lack of Efficacy|0
95395|NCT01090427|361235|P2|After Controlled Period|Lack of Efficacy|0
95396|NCT01090427|361236|P1|After Controlled Period|Lack of Efficacy|0
95397|NCT01090427|361230|P7|After Controlled Period|Death|0
95398|NCT01090427|361231|P6|After Controlled Period|Death|1
95399|NCT01090427|361232|P5|After Controlled Period|Death|0
95400|NCT01090427|361233|P4|After Controlled Period|Death|0
95401|NCT01090427|361234|P3|After Controlled Period|Death|0
95402|NCT01090427|361235|P2|After Controlled Period|Death|0
95403|NCT01090427|361236|P1|After Controlled Period|Death|0
95404|NCT01090323|361271|P2|Overall Study|Stopped end of extension 1#|1
95405|NCT01090323|361272|P1|Overall Study|Stopped end of extension 1#|3
95406|NCT01090323|361271|P2|Overall Study|Stopped end of core|0
95407|NCT01090323|361272|P1|Overall Study|Stopped end of core|7
95408|NCT01090323|361271|P2|Overall Study|Death|2
95409|NCT01090323|361272|P1|Overall Study|Death|1
95410|NCT01090323|361271|P2|Overall Study|Administrative problems|4
95411|NCT01090323|361272|P1|Overall Study|Administrative problems|6
95412|NCT01090323|361271|P2|Overall Study|Lost to Follow-up|6
95413|NCT01090323|361272|P1|Overall Study|Lost to Follow-up|11
95414|NCT01090323|361271|P2|Overall Study|Withdrew consent|11
95415|NCT01090323|361272|P1|Overall Study|Withdrew consent|33
95416|NCT01090323|361271|P2|Overall Study|Protocol Violation|1
95417|NCT01090323|361272|P1|Overall Study|Protocol Violation|2
95418|NCT01090323|361271|P2|Overall Study|Condition no longer requires drug|4
95419|NCT01090323|361272|P1|Overall Study|Condition no longer requires drug|5
95420|NCT01090323|361271|P2|Overall Study|Unsatisfactory therapeutic effect|2
95421|NCT01090323|361272|P1|Overall Study|Unsatisfactory therapeutic effect|4
95422|NCT01090323|361271|P2|Overall Study|Abnormal Test Procedure Results|0
95423|NCT01090323|361272|P1|Overall Study|Abnormal Test Procedure Results|2
95424|NCT01090323|361271|P2|Overall Study|Abnormal Lab Values|1
95425|NCT01090323|361272|P1|Overall Study|Abnormal Lab Values|3
95426|NCT01090323|361271|P2|Overall Study|Adverse Event|2
95427|NCT01090323|361272|P1|Overall Study|Adverse Event|12
95428|NCT01090310|361284|P4|Extension Study|Subject withdrew consent|0
95429|NCT01090310|361285|P3|Extension Study|Subject withdrew consent|0
95430|NCT01090310|361286|P2|Extension Study|Subject withdrew consent|1
95431|NCT01090310|361287|P1|Extension Study|Subject withdrew consent|0
95432|NCT01090310|361284|P4|Extension Study|Unsatisfactory therapeutic effect|1
95433|NCT01090310|361285|P3|Extension Study|Unsatisfactory therapeutic effect|1
95434|NCT01090310|361286|P2|Extension Study|Unsatisfactory therapeutic effect|0
95435|NCT01090310|361287|P1|Extension Study|Unsatisfactory therapeutic effect|1
95436|NCT01090310|361284|P4|Extension Study|Adverse Event|1
95437|NCT01090310|361285|P3|Extension Study|Adverse Event|0
95438|NCT01090310|361286|P2|Extension Study|Adverse Event|0
95439|NCT01090310|361287|P1|Extension Study|Adverse Event|0
95440|NCT01090310|361284|P4|Extension Study|Aministrative problems|18
95441|NCT01090310|361285|P3|Extension Study|Aministrative problems|14
95442|NCT01090310|361286|P2|Extension Study|Aministrative problems|15
95443|NCT01090310|361287|P1|Extension Study|Aministrative problems|13
95444|NCT01090310|361284|P4|Core Study|Protocol deviation|1
95445|NCT01090310|361285|P3|Core Study|Protocol deviation|0
95446|NCT01090310|361286|P2|Core Study|Protocol deviation|0
95447|NCT01090310|361287|P1|Core Study|Protocol deviation|1
95448|NCT01090310|361284|P4|Core Study|Administrative reasons|4
95449|NCT01090310|361285|P3|Core Study|Administrative reasons|4
95450|NCT01090310|361286|P2|Core Study|Administrative reasons|6
95451|NCT01090310|361287|P1|Core Study|Administrative reasons|5
95452|NCT01090310|361284|P4|Core Study|Abnormal test procedure result|0
95454|NCT01090310|361286|P2|Core Study|Abnormal test procedure result|0
95455|NCT01090310|361287|P1|Core Study|Abnormal test procedure result|0
95456|NCT01090310|361284|P4|Core Study|Subject withdrew consent|1
95457|NCT01090310|361285|P3|Core Study|Subject withdrew consent|1
95458|NCT01090310|361286|P2|Core Study|Subject withdrew consent|3
95459|NCT01090310|361287|P1|Core Study|Subject withdrew consent|0
95460|NCT01090310|361284|P4|Core Study|Adverse Event|1
95461|NCT01090310|361285|P3|Core Study|Adverse Event|1
95462|NCT01090310|361286|P2|Core Study|Adverse Event|2
95463|NCT01090310|361287|P1|Core Study|Adverse Event|2
95464|NCT01090102|361326|P2|Second 12 Weeks|Withdrawal by Subject|1
95465|NCT01090102|361327|P1|Second 12 Weeks|Withdrawal by Subject|0
95466|NCT01090102|361326|P2|First 12 Weeks|Death|1
95467|NCT01090102|361327|P1|First 12 Weeks|Death|1
95468|NCT01090102|361326|P2|First 12 Weeks|Adverse Event|0
95469|NCT01090102|361327|P1|First 12 Weeks|Adverse Event|2
95470|NCT01090102|361326|P2|First 12 Weeks|Withdrawal by Subject|1
95471|NCT01090102|361327|P1|First 12 Weeks|Withdrawal by Subject|1
95472|NCT01090076|361337|P2|Overall Study|Withdrawal by Subject|1
95473|NCT01090076|361338|P1|Overall Study|Withdrawal by Subject|0
95474|NCT01090076|361337|P2|Overall Study|Death|1
95475|NCT01090076|361338|P1|Overall Study|Death|1
95476|NCT01090063|361348|P1|Treatment|Withdrawal by Subject|4
95477|NCT01090063|361348|P1|Screen|Screen Failed|4
95478|NCT01090050|361364|P2|Overall Study|Physician Decision|1
95479|NCT01090050|361365|P1|Overall Study|Physician Decision|0
95480|NCT01090050|361364|P2|Overall Study|Lack of Efficacy|5
95481|NCT01090050|361365|P1|Overall Study|Lack of Efficacy|1
95482|NCT01090050|361364|P2|Overall Study|Lost to Follow-up|1
95483|NCT01090050|361365|P1|Overall Study|Lost to Follow-up|0
95484|NCT01090011|361385|P1|Overall Study|Other reason not defined above|5
95485|NCT01090011|361385|P1|Overall Study|Refusal to start/continue medication|5
95486|NCT01090011|361385|P1|Overall Study|Protocol Violation|1
95487|NCT01090011|361385|P1|Overall Study|Adverse Event|32
95488|NCT01090011|361385|P1|Overall Study|Progressive disease|128
95489|NCT01089608|361478|P2|Overall Study|Lost to Follow-up|2
95490|NCT01089608|361479|P1|Overall Study|Lost to Follow-up|0
95491|NCT01089608|361478|P2|Overall Study|Adverse Event|4
95492|NCT01089608|361479|P1|Overall Study|Adverse Event|0
95493|NCT01089582|361496|P1|Overall Study|Withdrawal by Subject|1
95494|NCT01089582|361496|P1|Overall Study|Other|4
95495|NCT01089582|361496|P1|Overall Study|Lost to Follow-up|8
95496|NCT01089582|361496|P1|Overall Study|Adverse Event|15
95497|NCT01089582|361496|P1|Overall Study|Death|2
95498|NCT01089556|361539|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
95499|NCT01089556|361540|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
95500|NCT01089556|361541|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
95501|NCT01089556|361542|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
95502|NCT01089556|361543|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
95503|NCT01089556|361544|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
95504|NCT01089556|361539|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
95505|NCT01089556|361540|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
95506|NCT01089556|361541|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
95507|NCT01089556|361542|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
95508|NCT01089556|361543|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
95509|NCT01089556|361544|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
95510|NCT01089556|361539|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
95511|NCT01089556|361540|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
95512|NCT01089556|361541|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
95513|NCT01089556|361542|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
95514|NCT01089556|361543|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
95515|NCT01089556|361544|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
95516|NCT01089556|361539|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
95517|NCT01089556|361540|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
95518|NCT01089556|361541|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
95519|NCT01089556|361542|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
95520|NCT01089556|361543|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
95521|NCT01089556|361544|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
95522|NCT01089556|361539|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
95523|NCT01089556|361540|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
95524|NCT01089556|361541|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
95525|NCT01089556|361542|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
95526|NCT01089556|361543|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
95527|NCT01089556|361544|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
95528|NCT01089556|361539|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
95529|NCT01089556|361540|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
95530|NCT01089556|361541|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
95531|NCT01089556|361542|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
95532|NCT01089556|361543|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
95533|NCT01089556|361544|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
95534|NCT01089556|361539|P6|Study Period III (Weeks 9-16)|Adverse Event|3
95535|NCT01089556|361540|P5|Study Period III (Weeks 9-16)|Adverse Event|4
95536|NCT01089556|361541|P4|Study Period III (Weeks 9-16)|Adverse Event|2
95537|NCT01089556|361542|P3|Study Period III (Weeks 9-16)|Adverse Event|4
95538|NCT01089556|361543|P2|Study Period III (Weeks 9-16)|Adverse Event|0
95539|NCT01089556|361544|P1|Study Period III (Weeks 9-16)|Adverse Event|0
95540|NCT01089556|361539|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
95541|NCT01089556|361540|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
95542|NCT01089556|361541|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
95543|NCT01089556|361542|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
95544|NCT01089556|361543|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
95545|NCT01089556|361544|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
95546|NCT01089556|361539|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
95547|NCT01089556|361540|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
95548|NCT01089556|361541|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
95549|NCT01089556|361542|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
95550|NCT01089556|361543|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
95551|NCT01089556|361544|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
95552|NCT01089556|361539|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
95553|NCT01089556|361540|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
95554|NCT01089556|361541|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
95555|NCT01089556|361542|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
95556|NCT01089556|361543|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
95557|NCT01089556|361544|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
95558|NCT01089556|361539|P6|Study Period II (Weeks 1-8)|Physician Decision|0
95559|NCT01089556|361540|P5|Study Period II (Weeks 1-8)|Physician Decision|0
95560|NCT01089556|361541|P4|Study Period II (Weeks 1-8)|Physician Decision|0
95561|NCT01089556|361542|P3|Study Period II (Weeks 1-8)|Physician Decision|0
95562|NCT01089556|361543|P2|Study Period II (Weeks 1-8)|Physician Decision|0
95563|NCT01089556|361544|P1|Study Period II (Weeks 1-8)|Physician Decision|4
95564|NCT01089556|361539|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
95565|NCT01089556|361540|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
95566|NCT01089556|361541|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
95567|NCT01089556|361542|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
95568|NCT01089556|361543|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
95569|NCT01089556|361544|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
95570|NCT01089556|361539|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
95571|NCT01089556|361540|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
95572|NCT01089556|361541|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
95573|NCT01089556|361542|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
95574|NCT01089556|361543|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
95575|NCT01089556|361544|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
95576|NCT01089556|361539|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
95577|NCT01089556|361540|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
95578|NCT01089556|361541|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
95579|NCT01089556|361542|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
95580|NCT01089556|361543|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
95581|NCT01089556|361544|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
95582|NCT01089556|361539|P6|Study Period II (Weeks 1-8)|Adverse Event|0
95583|NCT01089556|361540|P5|Study Period II (Weeks 1-8)|Adverse Event|0
95584|NCT01089556|361541|P4|Study Period II (Weeks 1-8)|Adverse Event|0
95585|NCT01089556|361542|P3|Study Period II (Weeks 1-8)|Adverse Event|0
95586|NCT01089556|361543|P2|Study Period II (Weeks 1-8)|Adverse Event|39
95587|NCT01089556|361544|P1|Study Period II (Weeks 1-8)|Adverse Event|35
95588|NCT01089543|361618|P4|Overall Study|Adverse Event|0
95589|NCT01089543|361619|P3|Overall Study|Adverse Event|0
95590|NCT01089543|361620|P2|Overall Study|Adverse Event|1
95591|NCT01089543|361621|P1|Overall Study|Adverse Event|0
95592|NCT01089543|361618|P4|Overall Study|Physician Decision|1
95593|NCT01089543|361619|P3|Overall Study|Physician Decision|0
95594|NCT01089543|361620|P2|Overall Study|Physician Decision|0
95595|NCT01089543|361621|P1|Overall Study|Physician Decision|1
95596|NCT01089543|361618|P4|Overall Study|Withdrawal by Subject|1
95597|NCT01089543|361619|P3|Overall Study|Withdrawal by Subject|3
95598|NCT01089543|361620|P2|Overall Study|Withdrawal by Subject|3
95599|NCT01089543|361621|P1|Overall Study|Withdrawal by Subject|2
95600|NCT01089504|361656|P2|Overall Study|Withdrawal by Subject|0
95601|NCT01089504|361657|P1|Overall Study|Withdrawal by Subject|2
95602|NCT01089504|361656|P2|Overall Study|Lost to Follow-up|1
95603|NCT01089504|361657|P1|Overall Study|Lost to Follow-up|1
95604|NCT01089413|361670|P1|Overall Study|Other|71
95605|NCT01089413|361670|P1|Overall Study|Metastasectomy|13
95606|NCT01089413|361670|P1|Overall Study|Death|10
95607|NCT01089413|361670|P1|Overall Study|Unacceptable Toxicity|12
95608|NCT01089413|361670|P1|Overall Study|Participant Withdrew Consent|1
95609|NCT01089413|361670|P1|Overall Study|Progressive Disease|93
95610|NCT01089413|361670|P1|Overall Study|Lost to Follow-up|1
95611|NCT01089361|361689|P2|Overall Study|Death|0
95612|NCT01089361|361690|P1|Overall Study|Death|1
95613|NCT01089127|361739|P6|Overall Study|Protocol deviation|0
95614|NCT01089127|361740|P5|Overall Study|Protocol deviation|1
95615|NCT01089127|361741|P4|Overall Study|Protocol deviation|0
95616|NCT01089127|361742|P3|Overall Study|Protocol deviation|0
95617|NCT01089127|361743|P2|Overall Study|Protocol deviation|1
95618|NCT01089127|361744|P1|Overall Study|Protocol deviation|0
95619|NCT01089127|361739|P6|Overall Study|Lost to Follow-up|0
95620|NCT01089127|361740|P5|Overall Study|Lost to Follow-up|1
95621|NCT01089127|361741|P4|Overall Study|Lost to Follow-up|0
95622|NCT01089127|361742|P3|Overall Study|Lost to Follow-up|0
95623|NCT01089127|361743|P2|Overall Study|Lost to Follow-up|1
95624|NCT01089127|361744|P1|Overall Study|Lost to Follow-up|1
95625|NCT01089127|361739|P6|Overall Study|Abnormal test procedure result(s)|0
95626|NCT01089127|361740|P5|Overall Study|Abnormal test procedure result(s)|0
95627|NCT01089127|361741|P4|Overall Study|Abnormal test procedure result(s)|0
95628|NCT01089127|361742|P3|Overall Study|Abnormal test procedure result(s)|0
95629|NCT01089127|361743|P2|Overall Study|Abnormal test procedure result(s)|1
95630|NCT01089127|361744|P1|Overall Study|Abnormal test procedure result(s)|2
95631|NCT01089127|361739|P6|Overall Study|Subject withdrew consent|2
95632|NCT01089127|361740|P5|Overall Study|Subject withdrew consent|0
95633|NCT01089127|361741|P4|Overall Study|Subject withdrew consent|1
95634|NCT01089127|361742|P3|Overall Study|Subject withdrew consent|1
95635|NCT01089127|361743|P2|Overall Study|Subject withdrew consent|1
95636|NCT01089127|361744|P1|Overall Study|Subject withdrew consent|0
95637|NCT01089127|361739|P6|Overall Study|Adverse Event|1
95638|NCT01089127|361740|P5|Overall Study|Adverse Event|0
95639|NCT01089127|361741|P4|Overall Study|Adverse Event|0
95640|NCT01089127|361742|P3|Overall Study|Adverse Event|1
95641|NCT01089127|361743|P2|Overall Study|Adverse Event|1
95642|NCT01089127|361744|P1|Overall Study|Adverse Event|5
95643|NCT01089023|361798|P1|Overall Study|Lack of Efficacy|1
95644|NCT01089023|361798|P1|Overall Study|Protocol Violation|1
95645|NCT01089023|361798|P1|Overall Study|Withdrawal by Subject|1
95646|NCT01089023|361798|P1|Overall Study|Adverse Event|1
95647|NCT01089023|361798|P1|Overall Study|Lost to Follow-up|3
95648|NCT01088997|361812|P2|Overall Study|Excluded prior to receiving drug|1
95649|NCT01088997|361813|P1|Overall Study|Excluded prior to receiving drug|1
95650|NCT01088997|361812|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
95651|NCT01088997|361813|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
95652|NCT01088997|361812|P2|Overall Study|Physician Decision|1
95653|NCT01088997|361813|P1|Overall Study|Physician Decision|1
95654|NCT01088984|361824|P2|Phase 2|Not Specified|1
95655|NCT01088984|361825|P1|Phase 2|Not Specified|0
95656|NCT01088984|361824|P2|Phase 2|DIsease Progression|25
95657|NCT01088984|361825|P1|Phase 2|DIsease Progression|0
95658|NCT01088984|361824|P2|Phase 2|Withdrawal by Subject|1
95659|NCT01088984|361825|P1|Phase 2|Withdrawal by Subject|0
95660|NCT01088984|361824|P2|Phase 2|Death|5
95661|NCT01088984|361825|P1|Phase 2|Death|0
95662|NCT01088984|361824|P2|Phase 1|Not Specified|1
95663|NCT01088984|361825|P1|Phase 1|Not Specified|1
95664|NCT01088984|361824|P2|Phase 1|Disease Progression|4
95665|NCT01088984|361825|P1|Phase 1|Disease Progression|2
95666|NCT01088984|361824|P2|Phase 1|Death|1
95667|NCT01088984|361825|P1|Phase 1|Death|2
95668|NCT01088529|361886|P2|Overall Study|Did not receive study treatment|1
95669|NCT01088529|361887|P1|Overall Study|Did not receive study treatment|0
95670|NCT01088503|361900|P3|Overall Study|Death|7
95671|NCT01088503|361901|P2|Overall Study|Death|358
95672|NCT01088503|361902|P1|Overall Study|Death|64
95673|NCT01088503|361900|P3|Overall Study|Withdrawal by Subject|10
95674|NCT01088503|361901|P2|Overall Study|Withdrawal by Subject|327
95675|NCT01088503|361902|P1|Overall Study|Withdrawal by Subject|118
95676|NCT01088438|361980|P2|Overall Study|Lost to Follow-up|30
95677|NCT01088438|361981|P1|Overall Study|Lost to Follow-up|18
95678|NCT01088438|361980|P2|Overall Study|Withdrawal by Subject|6
95679|NCT01088438|361981|P1|Overall Study|Withdrawal by Subject|11
95680|NCT01088399|361994|P3|Overall Study|Study summary visit not completed|80
95681|NCT01088399|361995|P2|Overall Study|Study summary visit not completed|283
95682|NCT01088399|361996|P1|Overall Study|Study summary visit not completed|2398
95683|NCT01088399|361994|P3|Overall Study|Enrollment criteria not met|70
95684|NCT01088399|361995|P2|Overall Study|Enrollment criteria not met|119
95685|NCT01088399|361996|P1|Overall Study|Enrollment criteria not met|48
95686|NCT01088399|361994|P3|Overall Study|Protocol Violation|0
95687|NCT01088399|361995|P2|Overall Study|Protocol Violation|1
95688|NCT01088399|361996|P1|Overall Study|Protocol Violation|10
95689|NCT01088399|361994|P3|Overall Study|Sponsor decision|7
95690|NCT01088399|361995|P2|Overall Study|Sponsor decision|298
95691|NCT01088399|361996|P1|Overall Study|Sponsor decision|1573
95692|NCT01088399|361994|P3|Overall Study|Change to or start of somatropin therapy|12
95693|NCT01088399|361995|P2|Overall Study|Change to or start of somatropin therapy|17
95694|NCT01088399|361996|P1|Overall Study|Change to or start of somatropin therapy|234
95695|NCT01088399|361994|P3|Overall Study|Withdrawal by Subject|33
95696|NCT01088399|361995|P2|Overall Study|Withdrawal by Subject|195
95697|NCT01088399|361996|P1|Overall Study|Withdrawal by Subject|544
95698|NCT01088399|361994|P3|Overall Study|Physician Decision|16
95699|NCT01088399|361995|P2|Overall Study|Physician Decision|88
95700|NCT01088399|361996|P1|Overall Study|Physician Decision|531
95701|NCT01088399|361994|P3|Overall Study|Lost to Follow-up|58
95702|NCT01088399|361995|P2|Overall Study|Lost to Follow-up|278
95703|NCT01088399|361996|P1|Overall Study|Lost to Follow-up|1070
95704|NCT01088399|361994|P3|Overall Study|Lack of Efficacy|5
95705|NCT01088399|361995|P2|Overall Study|Lack of Efficacy|7
95706|NCT01088399|361996|P1|Overall Study|Lack of Efficacy|298
95707|NCT01088399|361994|P3|Overall Study|Death|0
95708|NCT01088399|361995|P2|Overall Study|Death|45
95709|NCT01088399|361996|P1|Overall Study|Death|204
95710|NCT01088399|361994|P3|Overall Study|Adverse Event|0
95711|NCT01088399|361995|P2|Overall Study|Adverse Event|16
95712|NCT01088399|361996|P1|Overall Study|Adverse Event|211
95713|NCT01088243|362025|P2|Overall Study|Adverse Event|0
95714|NCT01088243|362026|P1|Overall Study|Adverse Event|1
95715|NCT01087970|362067|P1|Overall Study|Protocol Violation|2
95716|NCT01087957|362079|P2|Overall Study|Physician Decision|9
95717|NCT01087957|362080|P1|Overall Study|Physician Decision|5
95718|NCT01087957|362079|P2|Overall Study|Withdrawal by Subject|15
95719|NCT01087957|362080|P1|Overall Study|Withdrawal by Subject|18
95720|NCT01087957|362079|P2|Overall Study|Protocol Violation|25
95721|NCT01087957|362080|P1|Overall Study|Protocol Violation|13
95722|NCT01087957|362079|P2|Overall Study|Lost to Follow-up|4
95723|NCT01087957|362080|P1|Overall Study|Lost to Follow-up|3
95724|NCT01087957|362079|P2|Overall Study|Death|2
95725|NCT01087957|362080|P1|Overall Study|Death|2
95726|NCT01087944|362106|P2|Period 2 (Week 4-6)|Adverse Event|2
95727|NCT01087944|362107|P1|Period 2 (Week 4-6)|Adverse Event|0
95728|NCT01087944|362106|P2|Period 1 (Week 1-3)|Adverse Event|0
95729|NCT01087944|362107|P1|Period 1 (Week 1-3)|Adverse Event|1
95730|NCT01087905|362172|P8|Overall Study|Withdrawal by Subject|5
95731|NCT01087905|362173|P7|Overall Study|Withdrawal by Subject|3
95732|NCT01087905|362174|P6|Overall Study|Withdrawal by Subject|3
95733|NCT01087905|362175|P5|Overall Study|Withdrawal by Subject|4
95734|NCT01087905|362176|P4|Overall Study|Withdrawal by Subject|5
95735|NCT01087905|362177|P3|Overall Study|Withdrawal by Subject|4
95736|NCT01087905|362178|P2|Overall Study|Withdrawal by Subject|4
95737|NCT01087905|362179|P1|Overall Study|Withdrawal by Subject|5
95738|NCT01087905|362172|P8|Overall Study|Lost to Follow-up|24
95739|NCT01087905|362173|P7|Overall Study|Lost to Follow-up|20
95740|NCT01087905|362174|P6|Overall Study|Lost to Follow-up|25
95741|NCT01087905|362175|P5|Overall Study|Lost to Follow-up|27
95742|NCT01087905|362176|P4|Overall Study|Lost to Follow-up|31
95743|NCT01087905|362177|P3|Overall Study|Lost to Follow-up|18
95744|NCT01087905|362178|P2|Overall Study|Lost to Follow-up|28
95745|NCT01087905|362179|P1|Overall Study|Lost to Follow-up|24
95746|NCT01087814|362201|P2|Second Intervention (5 Days)|Physician Decision|0
95747|NCT01087814|362202|P1|Second Intervention (5 Days)|Physician Decision|1
95748|NCT01087814|362201|P2|First Intervention (5 Days)|Withdrawal by Subject|1
95749|NCT01087814|362202|P1|First Intervention (5 Days)|Withdrawal by Subject|3
95750|NCT01087788|362220|P3|Open-Label Period (OL-P)|Personal reasons|1
95751|NCT01087788|362221|P2|Open-Label Period (OL-P)|Personal reasons|0
95752|NCT01087788|362222|P1|Open-Label Period (OL-P)|Personal reasons|0
95753|NCT01087788|362220|P3|Open-Label Period (OL-P)|No participation in study extension|1
95754|NCT01087788|362221|P2|Open-Label Period (OL-P)|No participation in study extension|0
95755|NCT01087788|362222|P1|Open-Label Period (OL-P)|No participation in study extension|0
95756|NCT01087788|362220|P3|Open-Label Period (OL-P)|Principal investigator decision|2
95757|NCT01087788|362221|P2|Open-Label Period (OL-P)|Principal investigator decision|1
95758|NCT01087788|362222|P1|Open-Label Period (OL-P)|Principal investigator decision|0
95759|NCT01087788|362220|P3|Open-Label Period (OL-P)|Sponsor request|0
95760|NCT01087788|362221|P2|Open-Label Period (OL-P)|Sponsor request|0
95761|NCT01087788|362222|P1|Open-Label Period (OL-P)|Sponsor request|1
95762|NCT01087788|362220|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
95763|NCT01087788|362221|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
95764|NCT01087788|362222|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
95765|NCT01087788|362220|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
95766|NCT01087788|362221|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
95767|NCT01087788|362222|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
95768|NCT01087788|362220|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
95769|NCT01087788|362221|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
95770|NCT01087788|362222|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
95771|NCT01087788|362220|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
95772|NCT01087788|362221|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
95773|NCT01087788|362222|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
95774|NCT01087788|362220|P3|Open-Label Period (OL-P)|AE, serious fatal|1
95775|NCT01087788|362221|P2|Open-Label Period (OL-P)|AE, serious fatal|0
95776|NCT01087788|362222|P1|Open-Label Period (OL-P)|AE, serious fatal|2
95777|NCT01087788|362220|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
95778|NCT01087788|362221|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
95779|NCT01087788|362222|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
95780|NCT01087788|362220|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
95781|NCT01087788|362221|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
95782|NCT01087788|362222|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
95783|NCT01087788|362220|P3|Open-Label Period (OL-P)|Protocol Violation|0
95784|NCT01087788|362221|P2|Open-Label Period (OL-P)|Protocol Violation|1
95785|NCT01087788|362222|P1|Open-Label Period (OL-P)|Protocol Violation|2
95786|NCT01087788|362220|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
95787|NCT01087788|362221|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
95788|NCT01087788|362222|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
95789|NCT01087788|362220|P3|24-weeks Dose-blind Period|Patient moved|1
95790|NCT01087788|362221|P2|24-weeks Dose-blind Period|Patient moved|0
95791|NCT01087788|362222|P1|24-weeks Dose-blind Period|Patient moved|0
95792|NCT01087788|362220|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
95793|NCT01087788|362221|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
95794|NCT01087788|362222|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
95795|NCT01087788|362220|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
95796|NCT01087788|362221|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
95797|NCT01087788|362222|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
95798|NCT01087788|362220|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
95799|NCT01087788|362221|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
95800|NCT01087788|362222|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
95801|NCT01087788|362220|P3|24-weeks Dose-blind Period|AE, serious fatal|0
95802|NCT01087788|362221|P2|24-weeks Dose-blind Period|AE, serious fatal|1
95803|NCT01087788|362222|P1|24-weeks Dose-blind Period|AE, serious fatal|0
95804|NCT01087788|362220|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
95805|NCT01087788|362221|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
95806|NCT01087788|362222|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
95807|NCT01087788|362220|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
95808|NCT01087788|362221|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
95809|NCT01087788|362222|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
95810|NCT01087788|362220|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
95811|NCT01087788|362221|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
95812|NCT01087788|362222|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
95813|NCT01087788|362220|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
95814|NCT01087788|362221|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
95815|NCT01087788|362222|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
95816|NCT01087788|362220|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
95817|NCT01087788|362221|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
95818|NCT01087788|362222|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
95819|NCT01087788|362220|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
95820|NCT01087788|362221|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
95821|NCT01087788|362222|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
95822|NCT01087788|362220|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
95823|NCT01087788|362221|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
95824|NCT01087788|362222|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
95825|NCT01087788|362220|P3|24-weeks Double-blind Period|AE, unknown type|1
95826|NCT01087788|362221|P2|24-weeks Double-blind Period|AE, unknown type|0
95827|NCT01087788|362222|P1|24-weeks Double-blind Period|AE, unknown type|0
95828|NCT01087788|362220|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
95829|NCT01087788|362221|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
95830|NCT01087788|362222|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
95831|NCT01087788|362220|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
95832|NCT01087788|362221|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
95833|NCT01087788|362222|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
95834|NCT01087788|362220|P3|24-weeks Double-blind Period|AE, serious fatal|1
95835|NCT01087788|362221|P2|24-weeks Double-blind Period|AE, serious fatal|1
95836|NCT01087788|362222|P1|24-weeks Double-blind Period|AE, serious fatal|0
95837|NCT01087788|362220|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
95838|NCT01087788|362221|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
95839|NCT01087788|362222|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
95840|NCT01087788|362220|P3|24-weeks Double-blind Period|Lost to Follow-up|1
95841|NCT01087788|362221|P2|24-weeks Double-blind Period|Lost to Follow-up|1
95842|NCT01087788|362222|P1|24-weeks Double-blind Period|Lost to Follow-up|4
95843|NCT01087788|362220|P3|24-weeks Double-blind Period|Protocol Violation|0
95844|NCT01087788|362221|P2|24-weeks Double-blind Period|Protocol Violation|1
95845|NCT01087788|362222|P1|24-weeks Double-blind Period|Protocol Violation|0
95846|NCT01087788|362220|P3|24-weeks Double-blind Period|Lack of Efficacy|1
95847|NCT01087788|362221|P2|24-weeks Double-blind Period|Lack of Efficacy|0
95848|NCT01087788|362222|P1|24-weeks Double-blind Period|Lack of Efficacy|2
95849|NCT01087762|362252|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
95850|NCT01087762|362253|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
95851|NCT01087762|362254|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
95852|NCT01087762|362255|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
95853|NCT01087762|362256|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
95854|NCT01087762|362252|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
95855|NCT01087762|362253|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
95856|NCT01087762|362254|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
95857|NCT01087762|362255|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
95858|NCT01087762|362256|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
95859|NCT01087762|362252|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
95860|NCT01087762|362253|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
95861|NCT01087762|362254|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
95862|NCT01087762|362255|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
95863|NCT01087762|362256|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
95864|NCT01087762|362252|P5|Open-Label Period (Weeks 48-204)|Other|4
95865|NCT01087762|362253|P4|Open-Label Period (Weeks 48-204)|Other|2
95866|NCT01087762|362254|P3|Open-Label Period (Weeks 48-204)|Other|0
95867|NCT01087762|362255|P2|Open-Label Period (Weeks 48-204)|Other|0
95868|NCT01087762|362256|P1|Open-Label Period (Weeks 48-204)|Other|0
95869|NCT01087762|362252|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
95870|NCT01087762|362253|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
95871|NCT01087762|362254|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
95872|NCT01087762|362255|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
95873|NCT01087762|362256|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
95874|NCT01087762|362252|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
95875|NCT01087762|362253|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
95876|NCT01087762|362254|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
95877|NCT01087762|362255|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
95878|NCT01087762|362256|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
95879|NCT01087762|362252|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
95880|NCT01087762|362253|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
95881|NCT01087762|362254|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
95882|NCT01087762|362255|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
95883|NCT01087762|362256|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
95884|NCT01087762|362252|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
95885|NCT01087762|362253|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
95886|NCT01087762|362254|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
95887|NCT01087762|362255|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
95888|NCT01087762|362256|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
95889|NCT01087762|362252|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
95890|NCT01087762|362253|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
95891|NCT01087762|362254|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
95892|NCT01087762|362255|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
95893|NCT01087762|362256|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
95894|NCT01087762|362252|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
95895|NCT01087762|362253|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
95896|NCT01087762|362254|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
95897|NCT01087762|362255|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
95898|NCT01087762|362256|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
95899|NCT01087762|362252|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
95900|NCT01087762|362253|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
95901|NCT01087762|362254|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
95902|NCT01087762|362255|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
95903|NCT01087762|362256|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
95904|NCT01087762|362252|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
95905|NCT01087762|362253|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
95906|NCT01087762|362254|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
95907|NCT01087762|362255|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
95908|NCT01087762|362256|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
95909|NCT01087762|362252|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
95910|NCT01087762|362253|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
95911|NCT01087762|362254|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
95912|NCT01087762|362255|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
95913|NCT01087762|362256|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
95914|NCT01087736|362304|P2|Overall Study|Withdrawal by Subject|1
95915|NCT01087736|362305|P1|Overall Study|Withdrawal by Subject|0
95916|NCT01087736|362304|P2|Overall Study|Death|1
95917|NCT01087736|362305|P1|Overall Study|Death|0
95918|NCT01087736|362304|P2|Overall Study|Lost to Follow-up|0
95919|NCT01087736|362305|P1|Overall Study|Lost to Follow-up|1
95920|NCT01087723|362315|P2|Overall Study|Reason Not Specified|2
95921|NCT01087723|362316|P1|Overall Study|Reason Not Specified|1
95922|NCT01087723|362315|P2|Overall Study|Lost to Follow-up|4
95923|NCT01087723|362316|P1|Overall Study|Lost to Follow-up|1
95924|NCT01087723|362315|P2|Overall Study|Physician Decision|0
95925|NCT01087723|362316|P1|Overall Study|Physician Decision|2
95926|NCT01087723|362315|P2|Overall Study|Withdrawal by Subject|13
95927|NCT01087723|362316|P1|Overall Study|Withdrawal by Subject|10
95928|NCT01087723|362315|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
95929|NCT01087723|362316|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
95930|NCT01087528|362357|P1|Overall Study|Incomplete CE procedure|6
95931|NCT01087528|362357|P1|Overall Study|Withdrawal by Subject|1
95932|NCT01087502|362363|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
95933|NCT01087502|362364|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
95934|NCT01087502|362363|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
95935|NCT01087502|362364|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
95936|NCT01087502|362363|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
95937|NCT01087502|362364|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
95938|NCT01087502|362363|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
95939|NCT01087502|362364|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
95940|NCT01087502|362363|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
95941|NCT01087502|362364|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
95942|NCT01087502|362363|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
95943|NCT01087502|362364|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
95944|NCT01087502|362363|P2|Up to Final Analysis (Week 52)|Adverse Event|10
95945|NCT01087502|362364|P1|Up to Final Analysis (Week 52)|Adverse Event|17
95946|NCT01087502|362363|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
95947|NCT01087502|362364|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
95948|NCT01087502|362363|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
95949|NCT01087502|362364|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
95950|NCT01087502|362363|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
95951|NCT01087502|362364|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
95952|NCT01087502|362363|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
95953|NCT01087502|362364|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
95954|NCT01087502|362363|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
95955|NCT01087502|362364|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
95956|NCT01087489|362383|P2|Overall Study|unable to survey by telephone|1
95957|NCT01087489|362384|P1|Overall Study|unable to survey by telephone|0
95958|NCT01087489|362383|P2|Overall Study|Death|1
95959|NCT01087489|362384|P1|Overall Study|Death|0
95960|NCT01087489|362383|P2|Overall Study|enrolled in another VA study|1
95961|NCT01087489|362384|P1|Overall Study|enrolled in another VA study|0
95962|NCT01086969|362397|P3|Overall Study|Withdrawal by Subject|0
95963|NCT01086969|362398|P2|Overall Study|Withdrawal by Subject|2
95964|NCT01086969|362399|P1|Overall Study|Withdrawal by Subject|1
95965|NCT01086423|362509|P3|Overall Study|Lost to Follow-up|1
95966|NCT01086423|362510|P2|Overall Study|Lost to Follow-up|0
95967|NCT01086423|362511|P1|Overall Study|Lost to Follow-up|0
95968|NCT01086423|362509|P3|Overall Study|Withdrawal by Subject|3
95969|NCT01086423|362510|P2|Overall Study|Withdrawal by Subject|1
95970|NCT01086423|362511|P1|Overall Study|Withdrawal by Subject|5
95971|NCT01086423|362509|P3|Overall Study|Adverse event, non-fatal|0
95972|NCT01086423|362510|P2|Overall Study|Adverse event, non-fatal|1
95973|NCT01086423|362511|P1|Overall Study|Adverse event, non-fatal|2
95974|NCT01086423|362509|P3|Overall Study|Adverse event, fatal|0
95975|NCT01086423|362510|P2|Overall Study|Adverse event, fatal|1
95976|NCT01086423|362511|P1|Overall Study|Adverse event, fatal|1
95977|NCT01086423|362509|P3|Overall Study|Migrated/moved from study area|4
95978|NCT01086423|362510|P2|Overall Study|Migrated/moved from study area|0
95979|NCT01086423|362511|P1|Overall Study|Migrated/moved from study area|2
95980|NCT01086423|362509|P3|Overall Study|Protocol Violation|1
95981|NCT01086423|362510|P2|Overall Study|Protocol Violation|0
95982|NCT01086423|362511|P1|Overall Study|Protocol Violation|0
95983|NCT01086410|362556|P4|Overall Study|Lost to Follow-up|0
95984|NCT01086410|362557|P3|Overall Study|Lost to Follow-up|1
95985|NCT01086410|362558|P2|Overall Study|Lost to Follow-up|0
95986|NCT01086410|362559|P1|Overall Study|Lost to Follow-up|0
95987|NCT01086410|362556|P4|Overall Study|Protocol Violation|0
95988|NCT01086410|362557|P3|Overall Study|Protocol Violation|0
95989|NCT01086410|362558|P2|Overall Study|Protocol Violation|1
95990|NCT01086410|362559|P1|Overall Study|Protocol Violation|1
95991|NCT01086410|362556|P4|Overall Study|Lack of Efficacy|0
95992|NCT01086410|362557|P3|Overall Study|Lack of Efficacy|0
95993|NCT01086410|362558|P2|Overall Study|Lack of Efficacy|1
95994|NCT01086410|362559|P1|Overall Study|Lack of Efficacy|1
95995|NCT01086410|362556|P4|Overall Study|Adverse Event|2
95996|NCT01086410|362557|P3|Overall Study|Adverse Event|0
95997|NCT01086410|362558|P2|Overall Study|Adverse Event|0
95998|NCT01086410|362559|P1|Overall Study|Adverse Event|1
95999|NCT01086384|362655|P3|Treatment Period|Received Treatment in Error|0
96000|NCT01086384|362656|P2|Treatment Period|Received Treatment in Error|1
96001|NCT01086384|362657|P1|Treatment Period|Received Treatment in Error|0
96002|NCT01086384|362655|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
96003|NCT01086384|362656|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
96004|NCT01086384|362657|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
96005|NCT01086384|362655|P3|Treatment Period|Study Closed/Terminated|8
96006|NCT01086384|362656|P2|Treatment Period|Study Closed/Terminated|7
96007|NCT01086384|362657|P1|Treatment Period|Study Closed/Terminated|0
96008|NCT01086384|362655|P3|Treatment Period|Physician Decision|6
96009|NCT01086384|362656|P2|Treatment Period|Physician Decision|9
96010|NCT01086384|362657|P1|Treatment Period|Physician Decision|0
96011|NCT01086384|362655|P3|Treatment Period|Lost to Follow-up|9
96012|NCT01086384|362656|P2|Treatment Period|Lost to Follow-up|11
96013|NCT01086384|362657|P1|Treatment Period|Lost to Follow-up|0
96014|NCT01086384|362655|P3|Treatment Period|Adverse Event|15
96015|NCT01086384|362656|P2|Treatment Period|Adverse Event|19
96016|NCT01086384|362657|P1|Treatment Period|Adverse Event|0
96017|NCT01086384|362655|P3|Treatment Period|Lack of Efficacy|13
96018|NCT01086384|362656|P2|Treatment Period|Lack of Efficacy|22
96019|NCT01086384|362657|P1|Treatment Period|Lack of Efficacy|0
96020|NCT01086384|362655|P3|Treatment Period|Protocol Violation|17
96021|NCT01086384|362656|P2|Treatment Period|Protocol Violation|26
96022|NCT01086384|362657|P1|Treatment Period|Protocol Violation|0
96023|NCT01086384|362655|P3|Treatment Period|Withdrawal by Subject|55
96024|NCT01086384|362656|P2|Treatment Period|Withdrawal by Subject|53
96025|NCT01086384|362657|P1|Treatment Period|Withdrawal by Subject|0
96026|NCT01086384|362655|P3|2-week Run-in Period|Randomized in Error|0
96027|NCT01086384|362656|P2|2-week Run-in Period|Randomized in Error|0
96028|NCT01086384|362657|P1|2-week Run-in Period|Randomized in Error|1
96029|NCT01086384|362655|P3|2-week Run-in Period|Continuation Criteria Not Met|0
96030|NCT01086384|362656|P2|2-week Run-in Period|Continuation Criteria Not Met|0
96031|NCT01086384|362657|P1|2-week Run-in Period|Continuation Criteria Not Met|92
96032|NCT01086384|362655|P3|2-week Run-in Period|Study Closed/Terminated|0
96033|NCT01086384|362656|P2|2-week Run-in Period|Study Closed/Terminated|0
96034|NCT01086384|362657|P1|2-week Run-in Period|Study Closed/Terminated|42
96035|NCT01086384|362655|P3|2-week Run-in Period|Withdrawal by Subject|0
96036|NCT01086384|362656|P2|2-week Run-in Period|Withdrawal by Subject|0
96037|NCT01086384|362657|P1|2-week Run-in Period|Withdrawal by Subject|19
96038|NCT01086384|362655|P3|2-week Run-in Period|Physician Decision|0
96039|NCT01086384|362656|P2|2-week Run-in Period|Physician Decision|0
96040|NCT01086384|362657|P1|2-week Run-in Period|Physician Decision|6
96041|NCT01086384|362655|P3|2-week Run-in Period|Lost to Follow-up|0
96042|NCT01086384|362656|P2|2-week Run-in Period|Lost to Follow-up|0
96043|NCT01086384|362657|P1|2-week Run-in Period|Lost to Follow-up|1
96044|NCT01086384|362655|P3|2-week Run-in Period|Protocol Violation|0
96045|NCT01086384|362656|P2|2-week Run-in Period|Protocol Violation|0
96046|NCT01086384|362657|P1|2-week Run-in Period|Protocol Violation|1
96047|NCT01086384|362655|P3|2-week Run-in Period|Adverse Event|0
96048|NCT01086384|362656|P2|2-week Run-in Period|Adverse Event|0
96049|NCT01086384|362657|P1|2-week Run-in Period|Adverse Event|1
96050|NCT01086358|362667|P2|Second Intervention|Lost to Follow-up|4
96051|NCT01086358|362668|P1|Second Intervention|Lost to Follow-up|4
96052|NCT01086358|362667|P2|First Intervention|Withdrawal by Subject|1
96053|NCT01086358|362668|P1|First Intervention|Withdrawal by Subject|0
96054|NCT01086358|362667|P2|First Intervention|Lost to Follow-up|4
96055|NCT01086358|362668|P1|First Intervention|Lost to Follow-up|9
96056|NCT01086215|362738|P4|Overall Study|Lost to Follow-up|2
96057|NCT01086215|362739|P3|Overall Study|Lost to Follow-up|18
96058|NCT01086215|362740|P2|Overall Study|Lost to Follow-up|39
96059|NCT01086215|362741|P1|Overall Study|Lost to Follow-up|22
96060|NCT01086215|362738|P4|Overall Study|Death|1
96061|NCT01086215|362739|P3|Overall Study|Death|8
96062|NCT01086215|362740|P2|Overall Study|Death|8
96063|NCT01086215|362741|P1|Overall Study|Death|14
96064|NCT01086033|362759|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
96065|NCT01086033|362759|P1|Overall Study|AE and Other Reason|1
96066|NCT01086033|362759|P1|Overall Study|AE and Lost to Follow-up|1
96067|NCT01086033|362759|P1|Overall Study|Death|1
96068|NCT01086033|362759|P1|Overall Study|AE and Lack of Efficacy|4
96069|NCT01086033|362759|P1|Overall Study|Withdrew consent and Other Reason|4
96070|NCT01086033|362759|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
96071|NCT01086033|362759|P1|Overall Study|AE and Withdrew Consent|5
96072|NCT01086033|362759|P1|Overall Study|Other|13
96073|NCT01086033|362759|P1|Overall Study|Other|14
96074|NCT01086033|362759|P1|Overall Study|Withdrawal by Subject|41
96075|NCT01086033|362759|P1|Overall Study|Adverse Event|42
96076|NCT01086033|362759|P1|Overall Study|Lost to Follow-up|86
96077|NCT01086033|362759|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
96078|NCT01085734|362865|P2|Overall Study|Withdrawal by Subject|1
96079|NCT01085734|362866|P1|Overall Study|Withdrawal by Subject|0
96080|NCT01085734|362865|P2|Overall Study|Lost to Follow-up|1
96081|NCT01085734|362866|P1|Overall Study|Lost to Follow-up|0
96082|NCT01085734|362865|P2|Overall Study|Death|0
96083|NCT01085734|362866|P1|Overall Study|Death|1
96084|NCT01085734|362865|P2|Overall Study|Adverse Event|2
96085|NCT01085734|362866|P1|Overall Study|Adverse Event|0
96086|NCT01085682|362878|P2|Overall Study|Withdrawal by Subject|25
96087|NCT01085682|362879|P1|Overall Study|Withdrawal by Subject|25
96088|NCT01085591|362897|P3|Overall Study|Not Properly Consented|0
96089|NCT01085591|362898|P2|Overall Study|Not Properly Consented|0
96090|NCT01085591|362899|P1|Overall Study|Not Properly Consented|1
96091|NCT01085591|362897|P3|Overall Study|Other|0
96092|NCT01085591|362898|P2|Overall Study|Other|1
96093|NCT01085591|362899|P1|Overall Study|Other|0
96094|NCT01085591|362897|P3|Overall Study|Protocol Violation|1
96095|NCT01085591|362898|P2|Overall Study|Protocol Violation|1
96096|NCT01085591|362899|P1|Overall Study|Protocol Violation|1
96097|NCT01085591|362897|P3|Overall Study|Lost to Follow-up|1
96098|NCT01085591|362898|P2|Overall Study|Lost to Follow-up|1
96099|NCT01085591|362899|P1|Overall Study|Lost to Follow-up|0
96100|NCT01085591|362897|P3|Overall Study|Withdrawal by Subject|1
96101|NCT01085591|362898|P2|Overall Study|Withdrawal by Subject|2
96102|NCT01085591|362899|P1|Overall Study|Withdrawal by Subject|0
96103|NCT01085591|362897|P3|Overall Study|Physician Decision|1
96104|NCT01085591|362898|P2|Overall Study|Physician Decision|0
96105|NCT01085591|362899|P1|Overall Study|Physician Decision|1
96106|NCT01085591|362897|P3|Overall Study|Adverse Event|3
96107|NCT01085591|362898|P2|Overall Study|Adverse Event|1
96108|NCT01085591|362899|P1|Overall Study|Adverse Event|0
96109|NCT01085357|362950|P2|Overall Study|Lost to Follow-up|0
96110|NCT01085357|362951|P1|Overall Study|Lost to Follow-up|2
96111|NCT01085357|362950|P2|Overall Study|Death|1
96112|NCT01085357|362951|P1|Overall Study|Death|11
96113|NCT01085357|362950|P2|Overall Study|Investigator Decision|1
96114|NCT01085357|362951|P1|Overall Study|Investigator Decision|1
96115|NCT01085357|362950|P2|Overall Study|Subject Decision|3
96116|NCT01085357|362951|P1|Overall Study|Subject Decision|4
96117|NCT01085357|362950|P2|Overall Study|Adverse Event|1
96118|NCT01085357|362951|P1|Overall Study|Adverse Event|1
96119|NCT01085214|363014|P1|Overall Study|Alternate treatment required|1
96120|NCT01085201|363026|P5|Overall Study|Fond ineligible after consent|0
96121|NCT01085201|363027|P4|Overall Study|Fond ineligible after consent|0
96122|NCT01085201|363028|P3|Overall Study|Fond ineligible after consent|1
96123|NCT01085201|363029|P2|Overall Study|Fond ineligible after consent|1
96124|NCT01085201|363030|P1|Overall Study|Fond ineligible after consent|0
96125|NCT01085201|363026|P5|Overall Study|Unknown- no study drug|0
96126|NCT01085201|363027|P4|Overall Study|Unknown- no study drug|0
96127|NCT01085201|363028|P3|Overall Study|Unknown- no study drug|0
96128|NCT01085201|363029|P2|Overall Study|Unknown- no study drug|0
96129|NCT01085201|363030|P1|Overall Study|Unknown- no study drug|2
96130|NCT01085201|363026|P5|Overall Study|Scheduling conflict|0
96131|NCT01085201|363027|P4|Overall Study|Scheduling conflict|0
96132|NCT01085201|363028|P3|Overall Study|Scheduling conflict|1
96133|NCT01085201|363029|P2|Overall Study|Scheduling conflict|0
96134|NCT01085201|363030|P1|Overall Study|Scheduling conflict|1
96135|NCT01085136|363052|P3|Part B|Other reason not defined above|3
96136|NCT01085136|363053|P2|Part B|Other reason not defined above|6
96137|NCT01085136|363054|P1|Part B|Other reason not defined above|0
96138|NCT01085136|363052|P3|Part B|Not treated|8
96139|NCT01085136|363053|P2|Part B|Not treated|4
96140|NCT01085136|363054|P1|Part B|Not treated|0
96141|NCT01085136|363052|P3|Part B|Refusal to continue trial medication|7
96142|NCT01085136|363053|P2|Part B|Refusal to continue trial medication|12
96143|NCT01085136|363054|P1|Part B|Refusal to continue trial medication|0
96144|NCT01085136|363052|P3|Part B|Other AE|8
96145|NCT01085136|363053|P2|Part B|Other AE|29
96146|NCT01085136|363054|P1|Part B|Other AE|0
96147|NCT01085136|363052|P3|Part A|Other reason not defined above|0
96148|NCT01085136|363053|P2|Part A|Other reason not defined above|0
96149|NCT01085136|363054|P1|Part A|Other reason not defined above|30
96150|NCT01085136|363052|P3|Part A|Refusal to continue trial medication|0
96151|NCT01085136|363053|P2|Part A|Refusal to continue trial medication|0
96152|NCT01085136|363054|P1|Part A|Refusal to continue trial medication|64
96153|NCT01085136|363052|P3|Part A|Lost to Follow-up|0
96154|NCT01085136|363053|P2|Part A|Lost to Follow-up|0
96155|NCT01085136|363054|P1|Part A|Lost to Follow-up|3
96156|NCT01085136|363052|P3|Part A|Protocol Violation|0
96157|NCT01085136|363053|P2|Part A|Protocol Violation|0
96158|NCT01085136|363054|P1|Part A|Protocol Violation|3
96159|NCT01085136|363052|P3|Part A|Other Adverse event|0
96160|NCT01085136|363053|P2|Part A|Other Adverse event|0
96161|NCT01085136|363054|P1|Part A|Other Adverse event|223
96162|NCT01085045|363070|P1|Part B|Adverse Event|6
96163|NCT01085045|363070|P1|Part B|Lost to Follow-up|1
96164|NCT01085045|363070|P1|Part B|Protocol Specified Criteria|6
96165|NCT01085045|363070|P1|Part B|Withdrawal by Subject|2
96166|NCT01085045|363070|P1|Part A|Protocol Specified Criteria|7
96167|NCT01085045|363070|P1|Part A|Protocol Violation|1
96168|NCT01085045|363070|P1|Part A|Adverse Event|6
96169|NCT01085045|363070|P1|Part A|Withdrawal by Subject|4
96170|NCT01084707|363185|P1|Overall Study|Withdrawal by Subject|6
96171|NCT01084668|363219|P1|Overall Study|Non-compliance|1
96172|NCT01084668|363219|P1|Overall Study|Pregnancy|1
96173|NCT01084668|363219|P1|Overall Study|Withdrawal by Subject|2
96174|NCT01084668|363219|P1|Overall Study|Lack of Efficacy|5
96175|NCT01084603|363228|P1|Washout Period 4|Adverse Event|1
96176|NCT01084603|363228|P1|Oral Nicotine 1|Withdrawal by Subject|1
96177|NCT01084603|363228|P1|Nicorette® Gum|Withdrawal by Subject|1
96178|NCT01084603|363228|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
96179|NCT01084603|363228|P1|Baseline|Withdrawal by Subject|2
96180|NCT01084551|363264|P3|Overall Study|Physician Decision|0
96181|NCT01084551|363265|P2|Overall Study|Physician Decision|0
96182|NCT01084551|363266|P1|Overall Study|Physician Decision|1
96183|NCT01084551|363264|P3|Overall Study|Lost to Follow-up|3
96184|NCT01084551|363265|P2|Overall Study|Lost to Follow-up|0
96185|NCT01084551|363266|P1|Overall Study|Lost to Follow-up|0
96186|NCT01084551|363264|P3|Overall Study|Protocol Violation|0
96187|NCT01084551|363265|P2|Overall Study|Protocol Violation|4
96188|NCT01084551|363266|P1|Overall Study|Protocol Violation|2
96189|NCT01084551|363264|P3|Overall Study|Withdrawal by Subject|0
96190|NCT01084551|363265|P2|Overall Study|Withdrawal by Subject|1
96191|NCT01084551|363266|P1|Overall Study|Withdrawal by Subject|2
96192|NCT01084551|363264|P3|Overall Study|Lack of Efficacy|1
96193|NCT01084551|363265|P2|Overall Study|Lack of Efficacy|0
96194|NCT01084551|363266|P1|Overall Study|Lack of Efficacy|2
96195|NCT01084551|363264|P3|Overall Study|Adverse Event|4
96196|NCT01084551|363265|P2|Overall Study|Adverse Event|9
96197|NCT01084551|363266|P1|Overall Study|Adverse Event|2
96198|NCT01084538|363304|P1|Overall Study|Reason unknown|8
96199|NCT01084538|363304|P1|Overall Study|Over-suppression of parathyroid gland|2
96200|NCT01084538|363304|P1|Overall Study|Change of residence|2
96201|NCT01084538|363304|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
96202|NCT01084538|363304|P1|Overall Study|Hyperphosphatemia|2
96203|NCT01084538|363304|P1|Overall Study|Patient noncompliance|2
96204|NCT01084538|363304|P1|Overall Study|Lack of effectiveness|2
96205|NCT01084538|363304|P1|Overall Study|Serious Adverse Event|3
96206|NCT01084538|363304|P1|Overall Study|Kidney transplant|6
96207|NCT01084538|363304|P1|Overall Study|Adverse Event|9
96208|NCT01084538|363304|P1|Overall Study|Drug not available|30
96209|NCT01084239|363415|P2|28-Day Follow-up|Lost to Follow-up|9
96210|NCT01084239|363416|P1|28-Day Follow-up|Lost to Follow-up|4
96211|NCT01084174|363434|P2|Overall Study|Participant noncompliance|1
96212|NCT01084174|363435|P1|Overall Study|Participant noncompliance|0
96213|NCT01084174|363434|P2|Overall Study|Anaphylaxis|1
96214|NCT01084174|363435|P1|Overall Study|Anaphylaxis|0
96215|NCT01084174|363434|P2|Overall Study|Eosinophilic esophagitis|1
96216|NCT01084174|363435|P1|Overall Study|Eosinophilic esophagitis|0
96217|NCT01084174|363434|P2|Overall Study|gastrointestinal symptoms|1
96218|NCT01084174|363435|P1|Overall Study|gastrointestinal symptoms|1
96219|NCT01084135|363468|P2|20 Week|Physician Decision|1
96220|NCT01084135|363469|P1|20 Week|Physician Decision|0
96221|NCT01084083|363479|P1|Overall Study|Never started assigned therapy|1
96222|NCT01084083|363479|P1|Overall Study|Other|2
96223|NCT01084083|363479|P1|Overall Study|Complicating disease|1
96224|NCT01084083|363479|P1|Overall Study|Withdrawal by Subject|2
96225|NCT01084083|363479|P1|Overall Study|Death|1
96226|NCT01084083|363479|P1|Overall Study|Adverse Event|5
96227|NCT01084005|363487|P2|Overall Study|Withdrawal by Subject|1
96228|NCT01084005|363488|P1|Overall Study|Withdrawal by Subject|1
96229|NCT01084005|363487|P2|Overall Study|Protocol Violation|7
96230|NCT01084005|363488|P1|Overall Study|Protocol Violation|3
96231|NCT01084005|363487|P2|Overall Study|Adverse Event|8
96232|NCT01084005|363488|P1|Overall Study|Adverse Event|1
96233|NCT01083810|363569|P3|Overall Study|Virologic failure|0
96234|NCT01083810|363570|P2|Overall Study|Virologic failure|8
96235|NCT01083810|363571|P1|Overall Study|Virologic failure|1
96236|NCT01083810|363569|P3|Overall Study|Therapy break|2
96237|NCT01083810|363570|P2|Overall Study|Therapy break|2
96238|NCT01083810|363571|P1|Overall Study|Therapy break|1
96239|NCT01083810|363569|P3|Overall Study|Participation in study|0
96240|NCT01083810|363570|P2|Overall Study|Participation in study|0
96241|NCT01083810|363571|P1|Overall Study|Participation in study|1
96242|NCT01083810|363569|P3|Overall Study|Co-morbidities|0
96243|NCT01083810|363570|P2|Overall Study|Co-morbidities|0
96244|NCT01083810|363571|P1|Overall Study|Co-morbidities|1
96245|NCT01083810|363569|P3|Overall Study|Death|3
96246|NCT01083810|363570|P2|Overall Study|Death|2
96247|NCT01083810|363571|P1|Overall Study|Death|2
96248|NCT01083810|363569|P3|Overall Study|Simplification|0
96249|NCT01083810|363570|P2|Overall Study|Simplification|1
96250|NCT01083810|363571|P1|Overall Study|Simplification|4
96251|NCT01083810|363569|P3|Overall Study|Non-compliance|2
96252|NCT01083810|363570|P2|Overall Study|Non-compliance|7
96253|NCT01083810|363571|P1|Overall Study|Non-compliance|4
96254|NCT01083810|363569|P3|Overall Study|Reason not reported|1
96255|NCT01083810|363570|P2|Overall Study|Reason not reported|1
96256|NCT01083810|363571|P1|Overall Study|Reason not reported|6
96257|NCT01083810|363569|P3|Overall Study|Withdrawal by Subject|4
96258|NCT01083810|363570|P2|Overall Study|Withdrawal by Subject|2
96259|NCT01083810|363571|P1|Overall Study|Withdrawal by Subject|7
96260|NCT01083810|363569|P3|Overall Study|Adverse Event|4
96261|NCT01083810|363570|P2|Overall Study|Adverse Event|11
96262|NCT01083810|363571|P1|Overall Study|Adverse Event|15
96263|NCT01083810|363569|P3|Overall Study|Lost to Follow-up|4
96264|NCT01083810|363570|P2|Overall Study|Lost to Follow-up|11
96265|NCT01083810|363571|P1|Overall Study|Lost to Follow-up|23
96266|NCT01083771|363592|P1|Overall Study|Withdrawal by Subject|3
96267|NCT01083771|363592|P1|Overall Study|non-compliant|2
96268|NCT01083693|363693|P3|Overall Study|Reason unknown|1
96269|NCT01083693|363694|P2|Overall Study|Reason unknown|0
96270|NCT01083693|363695|P1|Overall Study|Reason unknown|0
96271|NCT01083693|363693|P3|Overall Study|Withdrawal by Subject|2
96272|NCT01083693|363694|P2|Overall Study|Withdrawal by Subject|0
96273|NCT01083693|363695|P1|Overall Study|Withdrawal by Subject|3
96274|NCT01083693|363693|P3|Overall Study|Other medical condition/surgery|0
96275|NCT01083693|363694|P2|Overall Study|Other medical condition/surgery|1
96276|NCT01083693|363695|P1|Overall Study|Other medical condition/surgery|1
96277|NCT01083693|363693|P3|Overall Study|Complete remission|0
96278|NCT01083693|363694|P2|Overall Study|Complete remission|1
96279|NCT01083693|363695|P1|Overall Study|Complete remission|0
96280|NCT01083693|363693|P3|Overall Study|Patient Moved|0
96281|NCT01083693|363694|P2|Overall Study|Patient Moved|1
96282|NCT01083693|363695|P1|Overall Study|Patient Moved|0
96283|NCT01083693|363693|P3|Overall Study|Lack of effectiveness|2
96284|NCT01083693|363694|P2|Overall Study|Lack of effectiveness|2
96285|NCT01083693|363695|P1|Overall Study|Lack of effectiveness|13
96286|NCT01083693|363693|P3|Overall Study|Lost to Follow-up|2
96287|NCT01083693|363694|P2|Overall Study|Lost to Follow-up|0
96288|NCT01083693|363695|P1|Overall Study|Lost to Follow-up|2
96289|NCT01083693|363693|P3|Overall Study|Adverse Event|0
96290|NCT01083693|363694|P2|Overall Study|Adverse Event|1
96291|NCT01083693|363695|P1|Overall Study|Adverse Event|1
96292|NCT01083680|363730|P1|Overall Study|Withdrawal by Subject|1086
96293|NCT01083680|363730|P1|Overall Study|Lost to Follow-up|2758
96294|NCT01083641|363753|P1|Overall Study|Withdrawal by Subject|2
96295|NCT01083602|363760|P1|Overall Study|Lack of Efficacy|36
96296|NCT01083602|363760|P1|Overall Study|Withdrawal by Subject|5
96297|NCT01083602|363760|P1|Overall Study|Death|1
96298|NCT01083602|363760|P1|Overall Study|New Cancer Therapy|2
96299|NCT01083602|363760|P1|Overall Study|Adverse Event|11
96300|NCT01083576|363771|P2|Overall Study|Treatment Failure|1
96301|NCT01083576|363772|P1|Overall Study|Treatment Failure|6
96302|NCT01083485|363802|P2|Overall Study|Other|0
96303|NCT01083485|363803|P1|Overall Study|Other|1
96304|NCT01083485|363802|P2|Overall Study|Withdrawal by Subject|2
96305|NCT01083485|363803|P1|Overall Study|Withdrawal by Subject|5
96306|NCT01083485|363802|P2|Overall Study|Protocol Violation|0
96307|NCT01083485|363803|P1|Overall Study|Protocol Violation|1
96308|NCT01083485|363802|P2|Overall Study|Adverse Event|1
96309|NCT01083485|363803|P1|Overall Study|Adverse Event|0
96310|NCT01083316|363820|P1|Overall Study|Withdrawal by Subject|1
96311|NCT01083316|363820|P1|Overall Study|Adverse Event|2
96312|NCT01083186|363831|P1|Overall Study|Non-compliance to Study Treatment|1
96313|NCT01083186|363831|P1|Overall Study|Administrative Reasons|2
96314|NCT01083186|363831|P1|Overall Study|Hemodialysis Initiation|28
96315|NCT01083186|363831|P1|Overall Study|Lack of Efficacy|2
96316|NCT01083186|363831|P1|Overall Study|Adverse Event|3
96317|NCT01083186|363831|P1|Overall Study|Death|3
96318|NCT01083186|363831|P1|Overall Study|Consent Withdrawal|7
96319|NCT01083186|363831|P1|Overall Study|Lost to Follow-up|48
96320|NCT01083173|363872|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
96321|NCT01083173|363873|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
96322|NCT01083173|363872|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
96323|NCT01083173|363873|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
96324|NCT01083173|363872|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
96325|NCT01083173|363873|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
96326|NCT01083173|363872|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
96327|NCT01083173|363873|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
96328|NCT01083173|363872|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
96329|NCT01083173|363873|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
96330|NCT01083173|363872|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
96331|NCT01083173|363873|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
96332|NCT01083173|363872|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
96333|NCT01083173|363873|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
96334|NCT01083173|363872|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
96335|NCT01083173|363873|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
96336|NCT01083173|363872|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
96337|NCT01083173|363873|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
96338|NCT01083173|363872|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
96339|NCT01083173|363873|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
96340|NCT01083173|363872|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
96341|NCT01083173|363873|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
96342|NCT01083160|363891|P1|Overall Study|Adverse Event|1
96343|NCT01083121|363898|P1|Overall Study|Use of Humira outside the approved label|81
96344|NCT01082965|363908|P2|Overall Study|Other|1
96345|NCT01082965|363909|P1|Overall Study|Other|1
96346|NCT01082965|363908|P2|Overall Study|Protocol Violation|1
96347|NCT01082965|363909|P1|Overall Study|Protocol Violation|0
96348|NCT01082874|363946|P4|Overall Study|Withdrawal by Subject|3
96349|NCT01082874|363947|P3|Overall Study|Withdrawal by Subject|5
96350|NCT01082874|363948|P2|Overall Study|Withdrawal by Subject|2
96351|NCT01082874|363949|P1|Overall Study|Withdrawal by Subject|1
96352|NCT01082874|363946|P4|Overall Study|Lost to Follow-up|10
96353|NCT01082874|363947|P3|Overall Study|Lost to Follow-up|6
96354|NCT01082874|363948|P2|Overall Study|Lost to Follow-up|10
96355|NCT01082874|363949|P1|Overall Study|Lost to Follow-up|10
96356|NCT01082640|363962|P3|Overall Study|Other|3
96357|NCT01082640|363963|P2|Overall Study|Other|1
96358|NCT01082640|363964|P1|Overall Study|Other|2
96359|NCT01082640|363962|P3|Overall Study|Lost to Follow-up|0
96360|NCT01082640|363963|P2|Overall Study|Lost to Follow-up|3
96361|NCT01082640|363964|P1|Overall Study|Lost to Follow-up|0
96362|NCT01082640|363962|P3|Overall Study|Major protocol deviation|0
96363|NCT01082640|363963|P2|Overall Study|Major protocol deviation|3
96364|NCT01082640|363964|P1|Overall Study|Major protocol deviation|3
96365|NCT01082640|363962|P3|Overall Study|Withdrawal by Subject|2
96366|NCT01082640|363963|P2|Overall Study|Withdrawal by Subject|3
96367|NCT01082640|363964|P1|Overall Study|Withdrawal by Subject|3
96368|NCT01082640|363962|P3|Overall Study|Adverse Event|3
96369|NCT01082640|363963|P2|Overall Study|Adverse Event|5
96370|NCT01082640|363964|P1|Overall Study|Adverse Event|9
96371|NCT01082614|363986|P2|Overall Study|Physician Decision|0
96372|NCT01082614|363987|P1|Overall Study|Physician Decision|2
96373|NCT01082614|363986|P2|Overall Study|Equipment Malfunction|1
96374|NCT01082614|363987|P1|Overall Study|Equipment Malfunction|0
96375|NCT01082614|363986|P2|Overall Study|Adverse Event|4
96376|NCT01082614|363987|P1|Overall Study|Adverse Event|1
96377|NCT01082367|364058|P2|Follow-up (F-U) Period|Adverse Event|1
96378|NCT01082367|364059|P1|Follow-up (F-U) Period|Adverse Event|0
96379|NCT01082367|364058|P2|Follow-up (F-U) Period|Abnormal lab values|0
96380|NCT01082367|364059|P1|Follow-up (F-U) Period|Abnormal lab values|1
96381|NCT01082367|364058|P2|Follow-up (F-U) Period|Administrative problems|0
96382|NCT01082367|364059|P1|Follow-up (F-U) Period|Administrative problems|1
96383|NCT01082367|364058|P2|Double-blind Period|Adverse Event|1
96384|NCT01082367|364059|P1|Double-blind Period|Adverse Event|0
96385|NCT01082367|364058|P2|Double-blind Period|Lack of Efficacy|11
96386|NCT01082367|364059|P1|Double-blind Period|Lack of Efficacy|5
96387|NCT01082367|364058|P2|Double-blind Period|Administrative problems|1
96388|NCT01082367|364059|P1|Double-blind Period|Administrative problems|0
96389|NCT01082328|364073|P1|Overall Study|Adverse Event|1
96390|NCT01082211|364082|P1|Overall Study|No protocol treatment received|3
96391|NCT01082211|364082|P1|Overall Study|Protocol Violation|4
96392|NCT01082081|364102|P3|Overall Study|Other Reason|0
96393|NCT01082081|364103|P2|Overall Study|Other Reason|1
96394|NCT01082081|364104|P1|Overall Study|Other Reason|0
96395|NCT01082081|364102|P3|Overall Study|Withdrawal by Subject|1
96396|NCT01082081|364103|P2|Overall Study|Withdrawal by Subject|0
96397|NCT01082081|364104|P1|Overall Study|Withdrawal by Subject|0
96398|NCT01082081|364102|P3|Overall Study|Lost to Follow-up|1
96399|NCT01082081|364103|P2|Overall Study|Lost to Follow-up|0
96400|NCT01082081|364104|P1|Overall Study|Lost to Follow-up|0
96401|NCT01081951|364156|P2|Overall Study|Lost to Follow-up|1
96402|NCT01081951|364157|P1|Overall Study|Lost to Follow-up|0
96403|NCT01081951|364156|P2|Overall Study|Allocated treatment but did not take it|1
96404|NCT01081951|364157|P1|Overall Study|Allocated treatment but did not take it|0
96405|NCT01081951|364156|P2|Overall Study|Withdrawal by Subject|6
96406|NCT01081951|364157|P1|Overall Study|Withdrawal by Subject|2
96407|NCT01081951|364156|P2|Overall Study|Death|47
96408|NCT01081951|364157|P1|Overall Study|Death|54
96409|NCT01081912|364167|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
96410|NCT01081912|364168|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
96411|NCT01081912|364169|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
96412|NCT01081912|364167|P3|Maintenance Treatment|Non-Compliance|7
96413|NCT01081912|364168|P2|Maintenance Treatment|Non-Compliance|4
96414|NCT01081912|364169|P1|Maintenance Treatment|Non-Compliance|0
96415|NCT01081912|364167|P3|Maintenance Treatment|Withdrawal by Subject|5
96416|NCT01081912|364168|P2|Maintenance Treatment|Withdrawal by Subject|5
96417|NCT01081912|364169|P1|Maintenance Treatment|Withdrawal by Subject|0
96418|NCT01081912|364167|P3|Maintenance Treatment|Protocol Violation|2
96419|NCT01081912|364168|P2|Maintenance Treatment|Protocol Violation|1
96420|NCT01081912|364169|P1|Maintenance Treatment|Protocol Violation|0
96421|NCT01081912|364167|P3|Maintenance Treatment|Physician Decision|1
96422|NCT01081912|364168|P2|Maintenance Treatment|Physician Decision|0
96423|NCT01081912|364169|P1|Maintenance Treatment|Physician Decision|0
96424|NCT01081912|364167|P3|Maintenance Treatment|Lost to Follow-up|0
96425|NCT01081912|364168|P2|Maintenance Treatment|Lost to Follow-up|1
96426|NCT01081912|364169|P1|Maintenance Treatment|Lost to Follow-up|0
96427|NCT01081912|364167|P3|Maintenance Treatment|Lack of Efficacy|64
96428|NCT01081912|364168|P2|Maintenance Treatment|Lack of Efficacy|14
96429|NCT01081912|364169|P1|Maintenance Treatment|Lack of Efficacy|0
96430|NCT01081912|364167|P3|Maintenance Treatment|Adverse Event|12
96431|NCT01081912|364168|P2|Maintenance Treatment|Adverse Event|2
96432|NCT01081912|364169|P1|Maintenance Treatment|Adverse Event|0
96433|NCT01081912|364167|P3|Conversion/Titration|Non-Compliance|0
96434|NCT01081912|364168|P2|Conversion/Titration|Non-Compliance|0
96435|NCT01081912|364169|P1|Conversion/Titration|Non-Compliance|47
96436|NCT01081912|364167|P3|Conversion/Titration|Withdrawal by Subject|0
96437|NCT01081912|364168|P2|Conversion/Titration|Withdrawal by Subject|0
96438|NCT01081912|364169|P1|Conversion/Titration|Withdrawal by Subject|23
96439|NCT01081912|364167|P3|Conversion/Titration|Protocol Violation|0
96440|NCT01081912|364168|P2|Conversion/Titration|Protocol Violation|0
96441|NCT01081912|364169|P1|Conversion/Titration|Protocol Violation|67
96442|NCT01081912|364167|P3|Conversion/Titration|Physician Decision|0
96443|NCT01081912|364168|P2|Conversion/Titration|Physician Decision|0
96444|NCT01081912|364169|P1|Conversion/Titration|Physician Decision|2
96445|NCT01081912|364167|P3|Conversion/Titration|Lost to Follow-up|0
96446|NCT01081912|364168|P2|Conversion/Titration|Lost to Follow-up|0
96447|NCT01081912|364169|P1|Conversion/Titration|Lost to Follow-up|5
96448|NCT01081912|364167|P3|Conversion/Titration|Lack of Efficacy|0
96449|NCT01081912|364168|P2|Conversion/Titration|Lack of Efficacy|0
96450|NCT01081912|364169|P1|Conversion/Titration|Lack of Efficacy|17
96451|NCT01081912|364167|P3|Conversion/Titration|Adverse Event|0
96452|NCT01081912|364168|P2|Conversion/Titration|Adverse Event|0
96453|NCT01081912|364169|P1|Conversion/Titration|Adverse Event|47
96454|NCT01081886|364178|P2|Overall Study|Study termination|13
96455|NCT01081886|364179|P1|Overall Study|Study termination|11
96456|NCT01081873|364187|P1|Overall Study|Other|47
96457|NCT01081873|364187|P1|Overall Study|Progression of prostate cancer|13
96458|NCT01081873|364187|P1|Overall Study|Lost to Follow-up|142
96459|NCT01081873|364187|P1|Overall Study|Withdrawal by Subject|10
96460|NCT01081873|364187|P1|Overall Study|Death|86
96461|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
96462|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
96463|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
96464|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
96465|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
96466|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
96467|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
96468|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
96469|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
96470|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
96471|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Not specified|0
96472|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Not specified|0
96473|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Not specified|4
96474|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Not specified|5
96475|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Not specified|4
96476|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
96477|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
96478|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
96479|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
96480|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
96481|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
96482|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
96483|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
96484|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
96485|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
96486|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
96487|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
96488|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
96489|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
96490|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
96491|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
96492|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
96493|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
96494|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
96495|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
96496|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
96497|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
96498|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
96499|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
96500|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
96501|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Death|0
96502|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Death|0
96503|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Death|0
96504|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Death|0
96505|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Death|1
96506|NCT01081834|364259|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
96507|NCT01081834|364260|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
96508|NCT01081834|364261|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
96509|NCT01081834|364262|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
96510|NCT01081834|364263|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
96511|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
96512|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
96513|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
96514|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
96515|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
96516|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Not specified|0
96517|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Not specified|1
96518|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Not specified|3
96519|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Not specified|4
96520|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Not specified|4
96521|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
96522|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
96602|NCT01081769|364364|P1|CORE Intent-To-Treat|Lack of Efficacy|2
96523|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
96524|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
96525|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
96526|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
96527|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
96528|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
96529|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
96530|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
96531|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
96532|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
96533|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
96534|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
96535|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
96536|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Protocol Violation|2
96537|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Protocol Violation|0
96538|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Protocol Violation|0
96539|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Protocol Violation|4
96540|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Protocol Violation|0
96541|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
96542|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
96543|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
96544|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
96545|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
96546|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Death|0
96547|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Death|0
96548|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Death|0
96549|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Death|0
96550|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Death|1
96551|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Adverse Event|1
96552|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Adverse Event|1
96553|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Adverse Event|3
96554|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Adverse Event|5
96555|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Adverse Event|2
96556|NCT01081834|364259|P5|Core Period: Baseline to Week 26|Pregnancy|0
96557|NCT01081834|364260|P4|Core Period: Baseline to Week 26|Pregnancy|0
96558|NCT01081834|364261|P3|Core Period: Baseline to Week 26|Pregnancy|0
96559|NCT01081834|364262|P2|Core Period: Baseline to Week 26|Pregnancy|0
96560|NCT01081834|364263|P1|Core Period: Baseline to Week 26|Pregnancy|1
96561|NCT01081795|364324|P3|Overall Study|Other|0
96562|NCT01081795|364325|P2|Overall Study|Other|2
96563|NCT01081795|364326|P1|Overall Study|Other|1
96564|NCT01081795|364324|P3|Overall Study|Using drug with restricted days of use|2
96565|NCT01081795|364325|P2|Overall Study|Using drug with restricted days of use|3
96566|NCT01081795|364326|P1|Overall Study|Using drug with restricted days of use|2
96567|NCT01081795|364324|P3|Overall Study|Use of a prohibited concomitant drug|1
96568|NCT01081795|364325|P2|Overall Study|Use of a prohibited concomitant drug|1
96569|NCT01081795|364326|P1|Overall Study|Use of a prohibited concomitant drug|1
96570|NCT01081795|364324|P3|Overall Study|Ineligible for participation|0
96571|NCT01081795|364325|P2|Overall Study|Ineligible for participation|0
96572|NCT01081795|364326|P1|Overall Study|Ineligible for participation|1
96573|NCT01081795|364324|P3|Overall Study|Revocation of informed consent|0
96574|NCT01081795|364325|P2|Overall Study|Revocation of informed consent|0
96575|NCT01081795|364326|P1|Overall Study|Revocation of informed consent|2
96576|NCT01081795|364324|P3|Overall Study|Subject’s schedule|2
96577|NCT01081795|364325|P2|Overall Study|Subject’s schedule|1
96578|NCT01081795|364326|P1|Overall Study|Subject’s schedule|1
96579|NCT01081795|364324|P3|Overall Study|Lack of Efficacy|19
96580|NCT01081795|364325|P2|Overall Study|Lack of Efficacy|5
96581|NCT01081795|364326|P1|Overall Study|Lack of Efficacy|7
96582|NCT01081795|364324|P3|Overall Study|Adverse Event|6
96583|NCT01081795|364325|P2|Overall Study|Adverse Event|23
96584|NCT01081795|364326|P1|Overall Study|Adverse Event|18
96585|NCT01081769|364363|P2|CORE Intent-To-Treat|Patient Moved|2
96586|NCT01081769|364364|P1|CORE Intent-To-Treat|Patient Moved|2
96587|NCT01081769|364363|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
96588|NCT01081769|364364|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
96589|NCT01081769|364363|P2|CORE Intent-To-Treat|Ineligibility|4
96590|NCT01081769|364364|P1|CORE Intent-To-Treat|Ineligibility|3
96591|NCT01081769|364363|P2|CORE Intent-To-Treat|Other|1
96592|NCT01081769|364364|P1|CORE Intent-To-Treat|Other|0
96593|NCT01081769|364363|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
96594|NCT01081769|364364|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
96595|NCT01081769|364363|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
96596|NCT01081769|364364|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
96597|NCT01081769|364363|P2|CORE Intent-To-Treat|Pregnancy|0
96598|NCT01081769|364364|P1|CORE Intent-To-Treat|Pregnancy|1
96599|NCT01081769|364363|P2|CORE Intent-To-Treat|Lost to Follow-up|5
96600|NCT01081769|364364|P1|CORE Intent-To-Treat|Lost to Follow-up|4
96601|NCT01081769|364363|P2|CORE Intent-To-Treat|Lack of Efficacy|6
96603|NCT01081769|364363|P2|CORE Intent-To-Treat|Death|1
96604|NCT01081769|364364|P1|CORE Intent-To-Treat|Death|1
96605|NCT01081769|364363|P2|CORE Intent-To-Treat|Adverse Event|11
96606|NCT01081769|364364|P1|CORE Intent-To-Treat|Adverse Event|14
96607|NCT01081769|364363|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
96608|NCT01081769|364364|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
96609|NCT01081769|364363|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
96610|NCT01081769|364364|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
96611|NCT01081769|364363|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
96612|NCT01081769|364364|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
96613|NCT01081769|364363|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
96614|NCT01081769|364364|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
96615|NCT01081665|364398|P1|Overall Study|Lack of Efficacy|1
96616|NCT01081665|364398|P1|Overall Study|Adverse Event|1
96617|NCT01081665|364398|P1|Overall Study|Change in renal replacement therapy|2
96618|NCT01081665|364398|P1|Overall Study|Regulation of iPTH|5
96619|NCT01081665|364398|P1|Overall Study|Change of dialysis unit|10
96620|NCT01081665|364398|P1|Overall Study|Withdrawal by Subject|17
96621|NCT01081665|364398|P1|Overall Study|Lost to Follow-up|18
96622|NCT01081665|364398|P1|Overall Study|Death|41
96623|NCT01081626|364410|P2|Overall Study|Other|30
96624|NCT01081626|364411|P1|Overall Study|Other|33
96625|NCT01081626|364410|P2|Overall Study|Lost to Follow-up|1
96626|NCT01081626|364411|P1|Overall Study|Lost to Follow-up|0
96627|NCT01081626|364410|P2|Overall Study|Overstimulation|1
96628|NCT01081626|364411|P1|Overall Study|Overstimulation|0
96629|NCT01081626|364410|P2|Overall Study|Low antral follicle count|0
96630|NCT01081626|364411|P1|Overall Study|Low antral follicle count|1
96631|NCT01081626|364410|P2|Overall Study|Missing Estradiol|28
96632|NCT01081626|364411|P1|Overall Study|Missing Estradiol|25
96633|NCT01081626|364410|P2|Overall Study|Dosing error|1
96634|NCT01081626|364411|P1|Overall Study|Dosing error|1
96635|NCT01081301|364437|P1|Overall Study|Lost to Follow-up|4
96636|NCT01081301|364437|P1|Overall Study|Patient too ill|2
96637|NCT01081301|364437|P1|Overall Study|Too busy|5
96638|NCT01081301|364437|P1|Overall Study|Bereaved|3
96639|NCT01081249|364475|P2|Overall Study|Diagnosed with Bipolar Disorder|1
96640|NCT01081249|364476|P1|Overall Study|Diagnosed with Bipolar Disorder|0
96641|NCT01081145|364482|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
96642|NCT01081145|364483|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
96643|NCT01081145|364482|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
96644|NCT01081145|364483|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
96645|NCT01081145|364482|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
96646|NCT01081145|364483|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
96647|NCT01081145|364482|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
96648|NCT01081145|364483|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
96649|NCT01081145|364482|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
96650|NCT01081145|364483|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
96651|NCT01081145|364482|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
96652|NCT01081145|364483|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
96653|NCT01081145|364482|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
96654|NCT01081145|364483|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
96655|NCT01081145|364482|P2|Open-Label Phase|Protocol Violation|0
96656|NCT01081145|364483|P1|Open-Label Phase|Protocol Violation|4
96657|NCT01081145|364482|P2|Open-Label Phase|Lost to Follow-up|0
96658|NCT01081145|364483|P1|Open-Label Phase|Lost to Follow-up|11
96659|NCT01081145|364482|P2|Open-Label Phase|Not specified|0
96660|NCT01081145|364483|P1|Open-Label Phase|Not specified|12
96661|NCT01081145|364482|P2|Open-Label Phase|Withdrawal by Subject|0
96662|NCT01081145|364483|P1|Open-Label Phase|Withdrawal by Subject|41
96663|NCT01081145|364482|P2|Open-Label Phase|Adverse Event|0
96664|NCT01081145|364483|P1|Open-Label Phase|Adverse Event|42
96665|NCT01081145|364482|P2|Open-Label Phase|Response criteria not met|0
96666|NCT01081145|364483|P1|Open-Label Phase|Response criteria not met|46
96667|NCT01081145|364482|P2|Open-Label Phase|Lack of Efficacy|0
96668|NCT01081145|364483|P1|Open-Label Phase|Lack of Efficacy|56
96669|NCT01081132|364511|P2|Overall Study|Protocol Violation|1
96670|NCT01081132|364512|P1|Overall Study|Protocol Violation|3
96671|NCT01081132|364511|P2|Overall Study|Declined Taper Phase|1
96672|NCT01081132|364512|P1|Overall Study|Declined Taper Phase|0
96673|NCT01081132|364511|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
96674|NCT01081132|364512|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
96675|NCT01081132|364511|P2|Overall Study|Stopped Taking Meds|0
96676|NCT01081132|364512|P1|Overall Study|Stopped Taking Meds|2
96677|NCT01081132|364511|P2|Overall Study|Missed Visits|1
96678|NCT01081132|364512|P1|Overall Study|Missed Visits|1
96679|NCT01081132|364511|P2|Overall Study|Lack Of Compliance|1
96680|NCT01081132|364512|P1|Overall Study|Lack Of Compliance|0
96681|NCT01081132|364511|P2|Overall Study|Non Compliance|2
96682|NCT01081132|364512|P1|Overall Study|Non Compliance|4
96683|NCT01081132|364511|P2|Overall Study|Adverse Event|9
96684|NCT01081132|364512|P1|Overall Study|Adverse Event|3
96685|NCT01081132|364511|P2|Overall Study|Lost to Follow-up|11
96686|NCT01081132|364512|P1|Overall Study|Lost to Follow-up|4
96687|NCT01081132|364511|P2|Overall Study|Withdrawal by Subject|16
96688|NCT01081132|364512|P1|Overall Study|Withdrawal by Subject|13
96689|NCT01081132|364511|P2|Overall Study|Lack of Efficacy|9
96690|NCT01081132|364512|P1|Overall Study|Lack of Efficacy|25
96691|NCT01080807|364596|P2|Overall Study|Moved away without notifying center|0
96692|NCT01080807|364597|P1|Overall Study|Moved away without notifying center|1
96693|NCT01080807|364596|P2|Overall Study|Switched to first shift|0
96694|NCT01080807|364597|P1|Overall Study|Switched to first shift|1
96695|NCT01080807|364596|P2|Overall Study|Work schedule and travel|1
96696|NCT01080807|364597|P1|Overall Study|Work schedule and travel|0
96697|NCT01080807|364596|P2|Overall Study|Work schedule changing|1
96698|NCT01080807|364597|P1|Overall Study|Work schedule changing|1
96699|NCT01080807|364596|P2|Overall Study|Stopped working consistent night shifts|1
96700|NCT01080807|364597|P1|Overall Study|Stopped working consistent night shifts|0
96701|NCT01080807|364596|P2|Overall Study|Laid off or terminated from job|2
96702|NCT01080807|364597|P1|Overall Study|Laid off or terminated from job|1
96703|NCT01080807|364596|P2|Overall Study|Began working day shift|2
96704|NCT01080807|364597|P1|Overall Study|Began working day shift|0
96705|NCT01080807|364596|P2|Overall Study|Noncompliance to study procedures|1
96706|NCT01080807|364597|P1|Overall Study|Noncompliance to study procedures|1
96707|NCT01080807|364596|P2|Overall Study|Noncompliance with drug administration|1
96708|NCT01080807|364597|P1|Overall Study|Noncompliance with drug administration|1
96709|NCT01080807|364596|P2|Overall Study|Lost to Follow-up|4
96710|NCT01080807|364597|P1|Overall Study|Lost to Follow-up|6
96711|NCT01080807|364596|P2|Overall Study|Protocol Violation|6
96712|NCT01080807|364597|P1|Overall Study|Protocol Violation|7
96713|NCT01080807|364596|P2|Overall Study|Withdrawal by Subject|2
96714|NCT01080807|364597|P1|Overall Study|Withdrawal by Subject|7
96715|NCT01080807|364596|P2|Overall Study|Lack of Efficacy|1
96716|NCT01080807|364597|P1|Overall Study|Lack of Efficacy|0
96717|NCT01080807|364596|P2|Overall Study|Adverse Event|1
96718|NCT01080807|364597|P1|Overall Study|Adverse Event|9
96719|NCT01080768|364706|P2|Overall Study|Protocol Deviation|1
96720|NCT01080768|364707|P1|Overall Study|Protocol Deviation|2
96721|NCT01080625|364738|P3|Overall Study|Physician Decision|1
96722|NCT01080625|364739|P2|Overall Study|Physician Decision|2
96723|NCT01080625|364740|P1|Overall Study|Physician Decision|0
96724|NCT01080391|364750|P2|Overall Study|Withdrawal by Subject|10
96725|NCT01080391|364751|P1|Overall Study|Withdrawal by Subject|19
96726|NCT01080391|364750|P2|Overall Study|Lost to Follow-up|3
96727|NCT01080391|364751|P1|Overall Study|Lost to Follow-up|4
96728|NCT01080326|364769|P1|Overall Study|Surgeon decision|1
96729|NCT01080326|364769|P1|Overall Study|Patient deterioration prior to procedure|3
96730|NCT01080300|364775|P2|Overall Study|Reasons not specified|6
96731|NCT01080300|364776|P1|Overall Study|Reasons not specified|4
96732|NCT01080300|364775|P2|Overall Study|Withdrawal by Subject|28
96733|NCT01080300|364776|P1|Overall Study|Withdrawal by Subject|12
96734|NCT01080300|364775|P2|Overall Study|Death|1
96735|NCT01080300|364776|P1|Overall Study|Death|0
96736|NCT01080300|364775|P2|Overall Study|Lost to Follow-up|6
96737|NCT01080300|364776|P1|Overall Study|Lost to Follow-up|10
96738|NCT01080300|364775|P2|Overall Study|Protocol Violation|13
96739|NCT01080300|364776|P1|Overall Study|Protocol Violation|7
96740|NCT01080300|364775|P2|Overall Study|Lack of Efficacy|15
96741|NCT01080300|364776|P1|Overall Study|Lack of Efficacy|12
96742|NCT01080300|364775|P2|Overall Study|Adverse Event|35
96743|NCT01080300|364776|P1|Overall Study|Adverse Event|49
96744|NCT01080131|364861|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
96745|NCT01080131|364862|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
96746|NCT01080131|364861|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
96747|NCT01080131|364862|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
96748|NCT01080131|364861|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
96749|NCT01080131|364862|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
96750|NCT01080131|364861|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
96751|NCT01080131|364862|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
96752|NCT01080131|364861|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
96753|NCT01080131|364862|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
96754|NCT01080131|364861|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
96755|NCT01080131|364862|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
96756|NCT01080131|364861|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
96757|NCT01080131|364862|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
96758|NCT01080131|364861|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
96759|NCT01080131|364862|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
96760|NCT01080131|364861|P2|Core Study (0- 12 Weeks)|Death|0
96761|NCT01080131|364862|P1|Core Study (0- 12 Weeks)|Death|1
96762|NCT01080131|364861|P2|Core Study (0- 12 Weeks)|Administrative problems|1
96763|NCT01080131|364862|P1|Core Study (0- 12 Weeks)|Administrative problems|0
96764|NCT01080131|364861|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
96765|NCT01080131|364862|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
96766|NCT01080131|364861|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
96767|NCT01080131|364862|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
96768|NCT01080131|364861|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
96769|NCT01080131|364862|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
96770|NCT01079988|364957|P5|Overall Study|Other|1
96771|NCT01079988|364958|P4|Overall Study|Other|2
96772|NCT01079988|364959|P3|Overall Study|Other|0
96773|NCT01079988|364960|P2|Overall Study|Other|0
96774|NCT01079988|364961|P1|Overall Study|Other|0
96775|NCT01079988|364957|P5|Overall Study|Lack of Efficacy|0
96776|NCT01079988|364958|P4|Overall Study|Lack of Efficacy|0
96777|NCT01079988|364959|P3|Overall Study|Lack of Efficacy|0
96778|NCT01079988|364960|P2|Overall Study|Lack of Efficacy|0
96779|NCT01079988|364961|P1|Overall Study|Lack of Efficacy|1
96780|NCT01079988|364957|P5|Overall Study|Lost to Follow-up|0
96781|NCT01079988|364958|P4|Overall Study|Lost to Follow-up|1
96782|NCT01079988|364959|P3|Overall Study|Lost to Follow-up|0
96783|NCT01079988|364960|P2|Overall Study|Lost to Follow-up|0
96784|NCT01079988|364961|P1|Overall Study|Lost to Follow-up|0
96785|NCT01079962|364980|P2|Overall Study|Due to arrhythmia/bradycardia|1
96786|NCT01079962|364981|P1|Overall Study|Due to arrhythmia/bradycardia|1
96787|NCT01079962|364980|P2|Overall Study|Participant not returning for next visit|0
96788|NCT01079962|364981|P1|Overall Study|Participant not returning for next visit|1
96789|NCT01079962|364980|P2|Overall Study|Inclusion/exclusion criteria|3
96790|NCT01079962|364981|P1|Overall Study|Inclusion/exclusion criteria|1
96791|NCT01079962|364980|P2|Overall Study|No blood pressure (BP) control|0
96792|NCT01079962|364981|P1|Overall Study|No blood pressure (BP) control|3
96793|NCT01079962|364980|P2|Overall Study|Protocol Violation|2
96794|NCT01079962|364981|P1|Overall Study|Protocol Violation|2
96795|NCT01079962|364980|P2|Overall Study|Withdrawal by Subject|7
96796|NCT01079962|364981|P1|Overall Study|Withdrawal by Subject|5
96797|NCT01079962|364980|P2|Overall Study|Adverse Event|2
96798|NCT01079962|364981|P1|Overall Study|Adverse Event|2
96799|NCT01079949|365009|P2|Overall Study|Randomized but not treated|0
96800|NCT01079949|365010|P1|Overall Study|Randomized but not treated|1
96801|NCT01079949|365009|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
96802|NCT01079949|365010|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
96803|NCT01079949|365009|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
96804|NCT01079949|365010|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
96805|NCT01079949|365009|P2|Overall Study|Withdrawal before r-hCG administration|3
96806|NCT01079949|365010|P1|Overall Study|Withdrawal before r-hCG administration|2
96807|NCT01079936|365056|P5|Phase II|Insurance Issue|1
96808|NCT01079936|365057|P4|Phase II|Insurance Issue|0
96809|NCT01079936|365058|P3|Phase II|Insurance Issue|0
96810|NCT01079936|365059|P2|Phase II|Insurance Issue|0
96811|NCT01079936|365060|P1|Phase II|Insurance Issue|0
96812|NCT01079936|365056|P5|Phase II|Adverse Event|0
96813|NCT01079936|365057|P4|Phase II|Adverse Event|0
96814|NCT01079936|365058|P3|Phase II|Adverse Event|1
96815|NCT01079936|365059|P2|Phase II|Adverse Event|0
96816|NCT01079936|365060|P1|Phase II|Adverse Event|0
96817|NCT01079936|365056|P5|Phase I: MTD|No Stem Cell Transplantation|0
96818|NCT01079936|365057|P4|Phase I: MTD|No Stem Cell Transplantation|0
96819|NCT01079936|365058|P3|Phase I: MTD|No Stem Cell Transplantation|0
96820|NCT01079936|365059|P2|Phase I: MTD|No Stem Cell Transplantation|0
96821|NCT01079936|365060|P1|Phase I: MTD|No Stem Cell Transplantation|2
96822|NCT01079936|365056|P5|Phase I: MTD|First Remission Status|0
96823|NCT01079936|365057|P4|Phase I: MTD|First Remission Status|0
96824|NCT01079936|365058|P3|Phase I: MTD|First Remission Status|0
96825|NCT01079936|365059|P2|Phase I: MTD|First Remission Status|0
96826|NCT01079936|365060|P1|Phase I: MTD|First Remission Status|2
96827|NCT01079832|365079|P1|Overall Study|Withdrawal by Subject|1
96828|NCT01079806|365089|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|2
96829|NCT01079806|365090|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|0
96830|NCT01079806|365089|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
96831|NCT01079806|365090|P1|Day 1 to Week 96|Poor compliance or noncompliance|1
96832|NCT01079806|365089|P2|Day 1 to Week 96|Pregnancy|1
96833|NCT01079806|365090|P1|Day 1 to Week 96|Pregnancy|0
96834|NCT01079806|365089|P2|Day 1 to Week 96|Withdrawal by Subject|1
96835|NCT01079806|365090|P1|Day 1 to Week 96|Withdrawal by Subject|3
96836|NCT01079806|365089|P2|Day 1 to Week 96|Adverse Event|2
96837|NCT01079806|365090|P1|Day 1 to Week 96|Adverse Event|0
96838|NCT01079741|365115|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
96839|NCT01079741|365116|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
96840|NCT01079741|365117|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
96841|NCT01079741|365118|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
96842|NCT01079741|365119|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
96843|NCT01079741|365115|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
96844|NCT01079741|365116|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
96845|NCT01079741|365117|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
96846|NCT01079741|365118|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
96847|NCT01079741|365119|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
96848|NCT01079234|365167|P4|Extension: Week 27 to 52|Unclassified|7
96849|NCT01079234|365168|P3|Extension: Week 27 to 52|Unclassified|4
96850|NCT01079234|365169|P2|Extension: Week 27 to 52|Unclassified|0
96851|NCT01079234|365170|P1|Extension: Week 27 to 52|Unclassified|0
96852|NCT01079234|365167|P4|Extension: Week 27 to 52|Withdrawal criteria|2
96853|NCT01079234|365168|P3|Extension: Week 27 to 52|Withdrawal criteria|4
96854|NCT01079234|365169|P2|Extension: Week 27 to 52|Withdrawal criteria|0
96855|NCT01079234|365170|P1|Extension: Week 27 to 52|Withdrawal criteria|0
96856|NCT01079234|365167|P4|Extension: Week 27 to 52|Protocol Violation|5
96857|NCT01079234|365168|P3|Extension: Week 27 to 52|Protocol Violation|2
96858|NCT01079234|365169|P2|Extension: Week 27 to 52|Protocol Violation|0
96859|NCT01079234|365170|P1|Extension: Week 27 to 52|Protocol Violation|0
96860|NCT01079234|365167|P4|Extension: Week 27 to 52|Lack of Efficacy|2
96861|NCT01079234|365168|P3|Extension: Week 27 to 52|Lack of Efficacy|0
96862|NCT01079234|365169|P2|Extension: Week 27 to 52|Lack of Efficacy|0
96863|NCT01079234|365170|P1|Extension: Week 27 to 52|Lack of Efficacy|0
96864|NCT01079234|365167|P4|Extension: Week 27 to 52|Adverse Event|0
96865|NCT01079234|365168|P3|Extension: Week 27 to 52|Adverse Event|1
96866|NCT01079234|365169|P2|Extension: Week 27 to 52|Adverse Event|0
96867|NCT01079234|365170|P1|Extension: Week 27 to 52|Adverse Event|0
96868|NCT01079234|365167|P4|Main: Week 0 to 26|Unclassified|0
96869|NCT01079234|365168|P3|Main: Week 0 to 26|Unclassified|4
96870|NCT01079234|365169|P2|Main: Week 0 to 26|Unclassified|13
96871|NCT01079234|365170|P1|Main: Week 0 to 26|Unclassified|7
96872|NCT01079234|365167|P4|Main: Week 0 to 26|Withdrawal criteria|0
96873|NCT01079234|365168|P3|Main: Week 0 to 26|Withdrawal criteria|2
96874|NCT01079234|365169|P2|Main: Week 0 to 26|Withdrawal criteria|6
96875|NCT01079234|365170|P1|Main: Week 0 to 26|Withdrawal criteria|6
96876|NCT01079234|365167|P4|Main: Week 0 to 26|Protocol Violation|0
96877|NCT01079234|365168|P3|Main: Week 0 to 26|Protocol Violation|4
96878|NCT01079234|365169|P2|Main: Week 0 to 26|Protocol Violation|2
96879|NCT01079234|365170|P1|Main: Week 0 to 26|Protocol Violation|6
96880|NCT01079234|365167|P4|Main: Week 0 to 26|Lack of Efficacy|0
96881|NCT01079234|365168|P3|Main: Week 0 to 26|Lack of Efficacy|1
96882|NCT01079234|365169|P2|Main: Week 0 to 26|Lack of Efficacy|1
96883|NCT01079234|365170|P1|Main: Week 0 to 26|Lack of Efficacy|2
96884|NCT01079234|365167|P4|Main: Week 0 to 26|Adverse Event|0
96885|NCT01079234|365168|P3|Main: Week 0 to 26|Adverse Event|1
96886|NCT01079234|365169|P2|Main: Week 0 to 26|Adverse Event|4
96887|NCT01079234|365170|P1|Main: Week 0 to 26|Adverse Event|5
96888|NCT01079195|365188|P1|Overall Study|Non-compliance|2
96889|NCT01079195|365188|P1|Overall Study|No Follow-up Documentation Available|4
96890|NCT01079195|365188|P1|Overall Study|Improved Status of Participant|4
96891|NCT01079195|365188|P1|Overall Study|Physician Decision|4
96892|NCT01079195|365188|P1|Overall Study|Lack of Effectiveness|12
96893|NCT01079195|365188|P1|Overall Study|Financial Reasons|15
96894|NCT01079195|365188|P1|Overall Study|Withdrawal by Subject|18
96895|NCT01079195|365188|P1|Overall Study|Reason Unknown|39
96896|NCT01079195|365188|P1|Overall Study|Adverse Event|157
96897|NCT01079195|365188|P1|Overall Study|No Documentation Available|437
96898|NCT01079195|365188|P1|Overall Study|No Documentation of Tarka Therapy|739
96899|NCT01079182|365194|P1|Overall Study|Reasons not Evaluated|271
96900|NCT01079182|365194|P1|Overall Study|ADR and Lack of Effectiveness|39
96901|NCT01079182|365194|P1|Overall Study|Lack of Efficacy|514
96902|NCT01079182|365194|P1|Overall Study|Adverse Drug Reaction (ADR)|261
96903|NCT01079182|365194|P1|Overall Study|Lost to Follow-up|1634
96904|NCT01079130|365302|P6|Overall Study|Lost to Follow-up|0
96905|NCT01079130|365303|P5|Overall Study|Lost to Follow-up|1
96906|NCT01079130|365304|P4|Overall Study|Lost to Follow-up|0
96907|NCT01079130|365305|P3|Overall Study|Lost to Follow-up|0
96908|NCT01079130|365306|P2|Overall Study|Lost to Follow-up|0
96909|NCT01079130|365307|P1|Overall Study|Lost to Follow-up|0
96910|NCT01079130|365302|P6|Overall Study|Unsatisfactory therapeutic effect|0
96911|NCT01079130|365303|P5|Overall Study|Unsatisfactory therapeutic effect|0
96912|NCT01079130|365304|P4|Overall Study|Unsatisfactory therapeutic effect|2
96913|NCT01079130|365305|P3|Overall Study|Unsatisfactory therapeutic effect|0
96914|NCT01079130|365306|P2|Overall Study|Unsatisfactory therapeutic effect|0
96915|NCT01079130|365307|P1|Overall Study|Unsatisfactory therapeutic effect|0
96916|NCT01079130|365302|P6|Overall Study|Abnormal test procedure result(s)|0
96917|NCT01079130|365303|P5|Overall Study|Abnormal test procedure result(s)|1
96918|NCT01079130|365304|P4|Overall Study|Abnormal test procedure result(s)|0
96919|NCT01079130|365305|P3|Overall Study|Abnormal test procedure result(s)|0
96920|NCT01079130|365306|P2|Overall Study|Abnormal test procedure result(s)|0
96921|NCT01079130|365307|P1|Overall Study|Abnormal test procedure result(s)|0
96922|NCT01079130|365302|P6|Overall Study|Protocol deviation|0
96923|NCT01079130|365303|P5|Overall Study|Protocol deviation|0
96924|NCT01079130|365304|P4|Overall Study|Protocol deviation|2
96925|NCT01079130|365305|P3|Overall Study|Protocol deviation|1
96926|NCT01079130|365306|P2|Overall Study|Protocol deviation|2
96927|NCT01079130|365307|P1|Overall Study|Protocol deviation|0
96928|NCT01079130|365302|P6|Overall Study|Withdrawal by Subject|3
96929|NCT01079130|365303|P5|Overall Study|Withdrawal by Subject|1
96930|NCT01079130|365304|P4|Overall Study|Withdrawal by Subject|0
96931|NCT01079130|365305|P3|Overall Study|Withdrawal by Subject|0
96932|NCT01079130|365306|P2|Overall Study|Withdrawal by Subject|1
96933|NCT01079130|365307|P1|Overall Study|Withdrawal by Subject|0
96934|NCT01079130|365302|P6|Overall Study|Administrative problems|1
96935|NCT01079130|365303|P5|Overall Study|Administrative problems|0
96936|NCT01079130|365304|P4|Overall Study|Administrative problems|0
96937|NCT01079130|365305|P3|Overall Study|Administrative problems|0
96938|NCT01079130|365306|P2|Overall Study|Administrative problems|3
96939|NCT01079130|365307|P1|Overall Study|Administrative problems|1
96940|NCT01079130|365302|P6|Overall Study|Adverse Event|1
96941|NCT01079130|365303|P5|Overall Study|Adverse Event|5
96942|NCT01079130|365304|P4|Overall Study|Adverse Event|1
96943|NCT01079130|365305|P3|Overall Study|Adverse Event|0
96944|NCT01079130|365306|P2|Overall Study|Adverse Event|1
96945|NCT01079130|365307|P1|Overall Study|Adverse Event|1
96946|NCT01078974|365327|P1|Overall Study|Adverse Event|3
96947|NCT01078922|365332|P1|Overall Study|Adverse Event|1
96948|NCT01078805|365373|P1|Overall Study|Didn't take study drug|82
96949|NCT01078805|365373|P1|Overall Study|Other|173
96950|NCT01078805|365373|P1|Overall Study|Withdrawal by Subject|739
96951|NCT01078805|365373|P1|Overall Study|Sponsor decision|46
96952|NCT01078805|365373|P1|Overall Study|Serious adverse event|26
96953|NCT01078805|365373|P1|Overall Study|Physician Decision|169
96954|NCT01078805|365373|P1|Overall Study|Lost to Follow-up|676
96955|NCT01078805|365373|P1|Overall Study|Death|134
96956|NCT01078805|365373|P1|Overall Study|Clinically significant abnormal lab|5
96957|NCT01078675|365400|P2|Overall Study|Adverse Event|0
96958|NCT01078675|365401|P1|Overall Study|Adverse Event|3
96959|NCT01078675|365400|P2|Overall Study|Provided in CRF for specific reasons|3
96960|NCT01078675|365401|P1|Overall Study|Provided in CRF for specific reasons|2
96961|NCT01078675|365400|P2|Overall Study|Protocol Violation|0
96962|NCT01078675|365401|P1|Overall Study|Protocol Violation|56
96963|NCT01078675|365400|P2|Overall Study|Withdrawal by Subject|3
96964|NCT01078675|365401|P1|Overall Study|Withdrawal by Subject|7
96965|NCT01078662|365423|P5|Overall Study|Lost to Follow-up|0
96966|NCT01078662|365424|P4|Overall Study|Lost to Follow-up|0
96967|NCT01078662|365425|P3|Overall Study|Lost to Follow-up|0
96968|NCT01078662|365426|P2|Overall Study|Lost to Follow-up|0
96969|NCT01078662|365427|P1|Overall Study|Lost to Follow-up|1
96970|NCT01078662|365423|P5|Overall Study|Protocol Violation|0
96971|NCT01078662|365424|P4|Overall Study|Protocol Violation|0
96972|NCT01078662|365425|P3|Overall Study|Protocol Violation|0
96973|NCT01078662|365426|P2|Overall Study|Protocol Violation|1
96974|NCT01078662|365427|P1|Overall Study|Protocol Violation|0
96975|NCT01078662|365423|P5|Overall Study|Withdrawal by Subject|0
96976|NCT01078662|365424|P4|Overall Study|Withdrawal by Subject|0
96977|NCT01078662|365425|P3|Overall Study|Withdrawal by Subject|1
96978|NCT01078662|365426|P2|Overall Study|Withdrawal by Subject|11
96979|NCT01078662|365427|P1|Overall Study|Withdrawal by Subject|4
96980|NCT01078662|365423|P5|Overall Study|Patients reached data cut-off|3
96981|NCT01078662|365424|P4|Overall Study|Patients reached data cut-off|2
96982|NCT01078662|365425|P3|Overall Study|Patients reached data cut-off|2
96983|NCT01078662|365426|P2|Overall Study|Patients reached data cut-off|53
96984|NCT01078662|365427|P1|Overall Study|Patients reached data cut-off|12
96985|NCT01078662|365423|P5|Overall Study|Death|8
96986|NCT01078662|365424|P4|Overall Study|Death|5
96987|NCT01078662|365425|P3|Overall Study|Death|18
96988|NCT01078662|365426|P2|Overall Study|Death|103
96989|NCT01078662|365427|P1|Overall Study|Death|41
96990|NCT01078623|365466|P20|Treatment Period 4|Withdrawal by Subject|0
96991|NCT01078623|365467|P19|Treatment Period 4|Withdrawal by Subject|0
96992|NCT01078623|365468|P18|Treatment Period 4|Withdrawal by Subject|0
96993|NCT01078623|365469|P17|Treatment Period 4|Withdrawal by Subject|0
96994|NCT01078623|365470|P16|Treatment Period 4|Withdrawal by Subject|1
96995|NCT01078623|365471|P15|Treatment Period 4|Withdrawal by Subject|0
96996|NCT01078623|365472|P14|Treatment Period 4|Withdrawal by Subject|0
96997|NCT01078623|365473|P13|Treatment Period 4|Withdrawal by Subject|0
96998|NCT01078623|365474|P12|Treatment Period 4|Withdrawal by Subject|0
96999|NCT01078623|365475|P11|Treatment Period 4|Withdrawal by Subject|0
97000|NCT01078623|365476|P10|Treatment Period 4|Withdrawal by Subject|0
97001|NCT01078623|365477|P9|Treatment Period 4|Withdrawal by Subject|0
97002|NCT01078623|365478|P8|Treatment Period 4|Withdrawal by Subject|0
97003|NCT01078623|365479|P7|Treatment Period 4|Withdrawal by Subject|0
97004|NCT01078623|365480|P6|Treatment Period 4|Withdrawal by Subject|0
97005|NCT01078623|365481|P5|Treatment Period 4|Withdrawal by Subject|0
97006|NCT01078623|365482|P4|Treatment Period 4|Withdrawal by Subject|0
97007|NCT01078623|365483|P3|Treatment Period 4|Withdrawal by Subject|0
97008|NCT01078623|365484|P2|Treatment Period 4|Withdrawal by Subject|0
97009|NCT01078623|365485|P1|Treatment Period 4|Withdrawal by Subject|0
97010|NCT01078623|365466|P20|Treatment Period 4|Adverse Event|0
97011|NCT01078623|365467|P19|Treatment Period 4|Adverse Event|0
97012|NCT01078623|365468|P18|Treatment Period 4|Adverse Event|0
97013|NCT01078623|365469|P17|Treatment Period 4|Adverse Event|0
97014|NCT01078623|365470|P16|Treatment Period 4|Adverse Event|0
97015|NCT01078623|365471|P15|Treatment Period 4|Adverse Event|0
97016|NCT01078623|365472|P14|Treatment Period 4|Adverse Event|0
97017|NCT01078623|365473|P13|Treatment Period 4|Adverse Event|0
97018|NCT01078623|365474|P12|Treatment Period 4|Adverse Event|0
97019|NCT01078623|365475|P11|Treatment Period 4|Adverse Event|0
97020|NCT01078623|365476|P10|Treatment Period 4|Adverse Event|0
97021|NCT01078623|365477|P9|Treatment Period 4|Adverse Event|0
97022|NCT01078623|365478|P8|Treatment Period 4|Adverse Event|0
97023|NCT01078623|365479|P7|Treatment Period 4|Adverse Event|0
97024|NCT01078623|365480|P6|Treatment Period 4|Adverse Event|0
97025|NCT01078623|365481|P5|Treatment Period 4|Adverse Event|0
97026|NCT01078623|365482|P4|Treatment Period 4|Adverse Event|0
97027|NCT01078623|365483|P3|Treatment Period 4|Adverse Event|1
97028|NCT01078623|365484|P2|Treatment Period 4|Adverse Event|0
97029|NCT01078623|365485|P1|Treatment Period 4|Adverse Event|0
97030|NCT01078623|365466|P20|Treatment Period 3|Adverse Event|0
97031|NCT01078623|365467|P19|Treatment Period 3|Adverse Event|0
97032|NCT01078623|365468|P18|Treatment Period 3|Adverse Event|0
97033|NCT01078623|365469|P17|Treatment Period 3|Adverse Event|0
97034|NCT01078623|365470|P16|Treatment Period 3|Adverse Event|0
97035|NCT01078623|365471|P15|Treatment Period 3|Adverse Event|0
97036|NCT01078623|365472|P14|Treatment Period 3|Adverse Event|1
97037|NCT01078623|365473|P13|Treatment Period 3|Adverse Event|0
97038|NCT01078623|365474|P12|Treatment Period 3|Adverse Event|0
97039|NCT01078623|365475|P11|Treatment Period 3|Adverse Event|0
97040|NCT01078623|365476|P10|Treatment Period 3|Adverse Event|0
97041|NCT01078623|365477|P9|Treatment Period 3|Adverse Event|0
97042|NCT01078623|365478|P8|Treatment Period 3|Adverse Event|0
97043|NCT01078623|365479|P7|Treatment Period 3|Adverse Event|0
97044|NCT01078623|365480|P6|Treatment Period 3|Adverse Event|0
97045|NCT01078623|365481|P5|Treatment Period 3|Adverse Event|1
97046|NCT01078623|365482|P4|Treatment Period 3|Adverse Event|0
97047|NCT01078623|365483|P3|Treatment Period 3|Adverse Event|0
97048|NCT01078623|365484|P2|Treatment Period 3|Adverse Event|0
97049|NCT01078623|365485|P1|Treatment Period 3|Adverse Event|0
97050|NCT01078623|365466|P20|Treatment Period 2|Withdrawal by Subject|0
97051|NCT01078623|365467|P19|Treatment Period 2|Withdrawal by Subject|0
97052|NCT01078623|365468|P18|Treatment Period 2|Withdrawal by Subject|0
97053|NCT01078623|365469|P17|Treatment Period 2|Withdrawal by Subject|0
97054|NCT01078623|365470|P16|Treatment Period 2|Withdrawal by Subject|0
97055|NCT01078623|365471|P15|Treatment Period 2|Withdrawal by Subject|0
97056|NCT01078623|365472|P14|Treatment Period 2|Withdrawal by Subject|0
97057|NCT01078623|365473|P13|Treatment Period 2|Withdrawal by Subject|0
97058|NCT01078623|365474|P12|Treatment Period 2|Withdrawal by Subject|0
97059|NCT01078623|365475|P11|Treatment Period 2|Withdrawal by Subject|0
97060|NCT01078623|365476|P10|Treatment Period 2|Withdrawal by Subject|0
97061|NCT01078623|365477|P9|Treatment Period 2|Withdrawal by Subject|0
97062|NCT01078623|365478|P8|Treatment Period 2|Withdrawal by Subject|0
97063|NCT01078623|365479|P7|Treatment Period 2|Withdrawal by Subject|0
97064|NCT01078623|365480|P6|Treatment Period 2|Withdrawal by Subject|1
97065|NCT01078623|365481|P5|Treatment Period 2|Withdrawal by Subject|0
97066|NCT01078623|365482|P4|Treatment Period 2|Withdrawal by Subject|0
97067|NCT01078623|365483|P3|Treatment Period 2|Withdrawal by Subject|0
97068|NCT01078623|365484|P2|Treatment Period 2|Withdrawal by Subject|0
97069|NCT01078623|365485|P1|Treatment Period 2|Withdrawal by Subject|0
97070|NCT01078623|365466|P20|Treatment Period 2|Adverse Event|0
97071|NCT01078623|365467|P19|Treatment Period 2|Adverse Event|1
97072|NCT01078623|365468|P18|Treatment Period 2|Adverse Event|0
97073|NCT01078623|365469|P17|Treatment Period 2|Adverse Event|0
97074|NCT01078623|365470|P16|Treatment Period 2|Adverse Event|0
97075|NCT01078623|365471|P15|Treatment Period 2|Adverse Event|0
97076|NCT01078623|365472|P14|Treatment Period 2|Adverse Event|0
97077|NCT01078623|365473|P13|Treatment Period 2|Adverse Event|0
97078|NCT01078623|365474|P12|Treatment Period 2|Adverse Event|0
97079|NCT01078623|365475|P11|Treatment Period 2|Adverse Event|0
97080|NCT01078623|365476|P10|Treatment Period 2|Adverse Event|0
97081|NCT01078623|365477|P9|Treatment Period 2|Adverse Event|0
97082|NCT01078623|365478|P8|Treatment Period 2|Adverse Event|0
97083|NCT01078623|365479|P7|Treatment Period 2|Adverse Event|1
97084|NCT01078623|365480|P6|Treatment Period 2|Adverse Event|0
97085|NCT01078623|365481|P5|Treatment Period 2|Adverse Event|0
97086|NCT01078623|365482|P4|Treatment Period 2|Adverse Event|0
97087|NCT01078623|365483|P3|Treatment Period 2|Adverse Event|0
97088|NCT01078623|365484|P2|Treatment Period 2|Adverse Event|0
97089|NCT01078623|365485|P1|Treatment Period 2|Adverse Event|0
97090|NCT01078623|365466|P20|Treatment Period 1|Protocol Violation|0
97091|NCT01078623|365467|P19|Treatment Period 1|Protocol Violation|0
97092|NCT01078623|365468|P18|Treatment Period 1|Protocol Violation|0
97093|NCT01078623|365469|P17|Treatment Period 1|Protocol Violation|0
97094|NCT01078623|365470|P16|Treatment Period 1|Protocol Violation|0
97095|NCT01078623|365471|P15|Treatment Period 1|Protocol Violation|0
97096|NCT01078623|365472|P14|Treatment Period 1|Protocol Violation|0
97097|NCT01078623|365473|P13|Treatment Period 1|Protocol Violation|0
97098|NCT01078623|365474|P12|Treatment Period 1|Protocol Violation|0
97099|NCT01078623|365475|P11|Treatment Period 1|Protocol Violation|0
97100|NCT01078623|365476|P10|Treatment Period 1|Protocol Violation|0
97101|NCT01078623|365477|P9|Treatment Period 1|Protocol Violation|0
97102|NCT01078623|365478|P8|Treatment Period 1|Protocol Violation|0
97103|NCT01078623|365479|P7|Treatment Period 1|Protocol Violation|0
97104|NCT01078623|365480|P6|Treatment Period 1|Protocol Violation|1
97105|NCT01078623|365481|P5|Treatment Period 1|Protocol Violation|0
97106|NCT01078623|365482|P4|Treatment Period 1|Protocol Violation|0
97107|NCT01078623|365483|P3|Treatment Period 1|Protocol Violation|0
97108|NCT01078623|365484|P2|Treatment Period 1|Protocol Violation|0
97109|NCT01078623|365485|P1|Treatment Period 1|Protocol Violation|0
97110|NCT01078623|365466|P20|Treatment Period 1|Withdrawal by Subject|0
97111|NCT01078623|365467|P19|Treatment Period 1|Withdrawal by Subject|0
97112|NCT01078623|365468|P18|Treatment Period 1|Withdrawal by Subject|0
97113|NCT01078623|365469|P17|Treatment Period 1|Withdrawal by Subject|0
97114|NCT01078623|365470|P16|Treatment Period 1|Withdrawal by Subject|0
97115|NCT01078623|365471|P15|Treatment Period 1|Withdrawal by Subject|0
97116|NCT01078623|365472|P14|Treatment Period 1|Withdrawal by Subject|0
97117|NCT01078623|365473|P13|Treatment Period 1|Withdrawal by Subject|0
97118|NCT01078623|365474|P12|Treatment Period 1|Withdrawal by Subject|0
97119|NCT01078623|365475|P11|Treatment Period 1|Withdrawal by Subject|1
97120|NCT01078623|365476|P10|Treatment Period 1|Withdrawal by Subject|0
97121|NCT01078623|365477|P9|Treatment Period 1|Withdrawal by Subject|0
97122|NCT01078623|365478|P8|Treatment Period 1|Withdrawal by Subject|1
97123|NCT01078623|365479|P7|Treatment Period 1|Withdrawal by Subject|0
97124|NCT01078623|365480|P6|Treatment Period 1|Withdrawal by Subject|0
97125|NCT01078623|365481|P5|Treatment Period 1|Withdrawal by Subject|0
97126|NCT01078623|365482|P4|Treatment Period 1|Withdrawal by Subject|0
97127|NCT01078623|365483|P3|Treatment Period 1|Withdrawal by Subject|0
97128|NCT01078623|365484|P2|Treatment Period 1|Withdrawal by Subject|0
97129|NCT01078623|365485|P1|Treatment Period 1|Withdrawal by Subject|0
97130|NCT01078623|365466|P20|Treatment Period 1|Adverse Event|0
97131|NCT01078623|365467|P19|Treatment Period 1|Adverse Event|0
97132|NCT01078623|365468|P18|Treatment Period 1|Adverse Event|0
97133|NCT01078623|365469|P17|Treatment Period 1|Adverse Event|0
97134|NCT01078623|365470|P16|Treatment Period 1|Adverse Event|0
97135|NCT01078623|365471|P15|Treatment Period 1|Adverse Event|0
97136|NCT01078623|365472|P14|Treatment Period 1|Adverse Event|0
97137|NCT01078623|365473|P13|Treatment Period 1|Adverse Event|0
97138|NCT01078623|365474|P12|Treatment Period 1|Adverse Event|0
97139|NCT01078623|365475|P11|Treatment Period 1|Adverse Event|0
97140|NCT01078623|365476|P10|Treatment Period 1|Adverse Event|1
97141|NCT01078623|365477|P9|Treatment Period 1|Adverse Event|1
97142|NCT01078623|365478|P8|Treatment Period 1|Adverse Event|0
97143|NCT01078623|365479|P7|Treatment Period 1|Adverse Event|1
97144|NCT01078623|365480|P6|Treatment Period 1|Adverse Event|0
97145|NCT01078623|365481|P5|Treatment Period 1|Adverse Event|0
97146|NCT01078623|365482|P4|Treatment Period 1|Adverse Event|0
97147|NCT01078623|365483|P3|Treatment Period 1|Adverse Event|1
97148|NCT01078623|365484|P2|Treatment Period 1|Adverse Event|1
97149|NCT01078623|365485|P1|Treatment Period 1|Adverse Event|1
97150|NCT01078584|365507|P1|Overall Study|Multiple Reasons|2
97151|NCT01078584|365507|P1|Overall Study|Serious Adverse Event|27
97152|NCT01078584|365507|P1|Overall Study|Protocol Violation|75
97153|NCT01078584|365507|P1|Overall Study|Lack of Efficacy|98
97154|NCT01078584|365507|P1|Overall Study|Physician Discontinued Patient|12
97155|NCT01078584|365507|P1|Overall Study|Physician Switched Medication|26
97156|NCT01078584|365507|P1|Overall Study|Blood Pressure Controlled|49
97157|NCT01078584|365507|P1|Overall Study|Non-compliance|67
97158|NCT01078584|365507|P1|Overall Study|Physician Withdrew from Study|90
97159|NCT01078584|365507|P1|Overall Study|Withdrawal of Consent|244
97160|NCT01078584|365507|P1|Overall Study|Non-serious Adverse Event|577
97161|NCT01078584|365507|P1|Overall Study|Lost to Follow-up|670
97162|NCT01078584|365507|P1|Overall Study|Final Status Unknown|1073
97163|NCT01078571|365588|P1|Overall Study|Protocol Violation|2
97164|NCT01078571|365588|P1|Overall Study|Lost to Follow-up|8
97165|NCT01078571|365588|P1|Overall Study|Withdrawal by Subject|12
97166|NCT01078571|365588|P1|Overall Study|Reason not reported|21
97167|NCT01078571|365588|P1|Overall Study|Lack of effectiveness|36
97168|NCT01078571|365588|P1|Overall Study|Adverse Event|36
97169|NCT01078545|365604|P1|Overall Study|Participant moved to another physician|1
97170|NCT01078545|365604|P1|Overall Study|Death|3
97171|NCT01078545|365604|P1|Overall Study|Withdrawal by Subject|3
97172|NCT01078545|365604|P1|Overall Study|Physician Decision|6
97173|NCT01078545|365604|P1|Overall Study|Lost to Follow-up|13
97174|NCT01078454|365614|P2|Overall Study|Death|1
97175|NCT01078454|365615|P1|Overall Study|Death|0
97176|NCT01078454|365614|P2|Overall Study|Adverse Event|1
97177|NCT01078454|365615|P1|Overall Study|Adverse Event|1
97178|NCT01078441|365621|P1|Overall Study|Withdrawal by Subject|1
97179|NCT01078389|365661|P2|Overall Study|Other|2
97180|NCT01078389|365662|P1|Overall Study|Other|9
97181|NCT01078389|365661|P2|Overall Study|Voluntary Withdrawal|36
97182|NCT01078389|365662|P1|Overall Study|Voluntary Withdrawal|20
97183|NCT01078389|365661|P2|Overall Study|Lost to Follow-up|23
97184|NCT01078389|365662|P1|Overall Study|Lost to Follow-up|23
97185|NCT01078389|365661|P2|Overall Study|Major Protocol Deviation|0
97186|NCT01078389|365662|P1|Overall Study|Major Protocol Deviation|2
97187|NCT01078389|365661|P2|Overall Study|Adverse Event|6
97188|NCT01078389|365662|P1|Overall Study|Adverse Event|10
97189|NCT01078298|365823|P2|Overall Study|Other|32
97190|NCT01078298|365824|P1|Overall Study|Other|24
97191|NCT01078298|365823|P2|Overall Study|Did not meet entrance criteria|1
97192|NCT01078298|365824|P1|Overall Study|Did not meet entrance criteria|0
97193|NCT01078298|365823|P2|Overall Study|Death|0
97194|NCT01078298|365824|P1|Overall Study|Death|2
97195|NCT01078298|365823|P2|Overall Study|Adverse Event|5
97196|NCT01078298|365824|P1|Overall Study|Adverse Event|6
97197|NCT01078298|365823|P2|Overall Study|Protocol Violation|6
97198|NCT01078298|365824|P1|Overall Study|Protocol Violation|6
97199|NCT01078298|365823|P2|Overall Study|Withdrawal by Subject|33
97200|NCT01078298|365824|P1|Overall Study|Withdrawal by Subject|31
97201|NCT01078298|365823|P2|Overall Study|Lost to Follow-up|13
97202|NCT01078298|365824|P1|Overall Study|Lost to Follow-up|12
97203|NCT01078168|365934|P2|Overall Study|Physician Decision|1
97204|NCT01078168|365935|P1|Overall Study|Physician Decision|0
97205|NCT01078155|365941|P1|Overall Study|Lost to Follow-up|15
97206|NCT01078155|365941|P1|Overall Study|Participant's Decision|6
97207|NCT01078155|365941|P1|Overall Study|Lack of Efficacy|16
97208|NCT01078155|365941|P1|Overall Study|Adverse Event|7
97209|NCT01078116|365957|P1|Overall Study|Case report form not completed|3
97210|NCT01078116|365957|P1|Overall Study|Lack of effectiveness|15
97211|NCT01078116|365957|P1|Overall Study|Withdrawal by Subject|8
97212|NCT01078116|365957|P1|Overall Study|Adverse Event|5
97213|NCT01078116|365957|P1|Overall Study|Lost to Follow-up|17
97214|NCT01078090|365965|P1|Overall Study|Other|523
97215|NCT01078090|365965|P1|Overall Study|ADR and lack of efficacy|61
97216|NCT01078090|365965|P1|Overall Study|Lack of Efficacy|1193
97217|NCT01078090|365965|P1|Overall Study|Adverse drug reaction (ADR)|453
97218|NCT01078090|365965|P1|Overall Study|Lost to Follow-up|2363
97219|NCT01077960|366059|P1|Overall Study|Reason unspecified|1
97220|NCT01077960|366059|P1|Overall Study|Subject decision|1
97221|NCT01077960|366059|P1|Overall Study|Lost to Follow-up|5
97222|NCT01077960|366059|P1|Overall Study|Protocol Violation|3
97223|NCT01077960|366059|P1|Overall Study|Adverse Event|6
97224|NCT01077804|366309|P1|Overall Study|Other|18
97225|NCT01077804|366309|P1|Overall Study|Refused to continue|79
97226|NCT01077804|366309|P1|Overall Study|Unreachable|102
97227|NCT01077739|366318|P2|Overall Study|Not specified|2
97228|NCT01077739|366319|P1|Overall Study|Not specified|2
97229|NCT01077739|366318|P2|Overall Study|Unacceptable toxicity|2
97230|NCT01077739|366319|P1|Overall Study|Unacceptable toxicity|1
97231|NCT01077739|366318|P2|Overall Study|Death|3
97232|NCT01077739|366319|P1|Overall Study|Death|0
97233|NCT01077739|366318|P2|Overall Study|Withdrawal by Subject|0
97234|NCT01077739|366319|P1|Overall Study|Withdrawal by Subject|1
97235|NCT01077739|366318|P2|Overall Study|Premature withdrawal|3
97236|NCT01077739|366319|P1|Overall Study|Premature withdrawal|1
97237|NCT01077713|366333|P2|Overall Study|Other|2
97238|NCT01077713|366334|P1|Overall Study|Other|4
97239|NCT01077713|366333|P2|Overall Study|Adverse Event|1
97240|NCT01077713|366334|P1|Overall Study|Adverse Event|2
97241|NCT01077713|366333|P2|Overall Study|Lost to Follow-up|1
97242|NCT01077713|366334|P1|Overall Study|Lost to Follow-up|1
97243|NCT01077713|366333|P2|Overall Study|Death|29
97244|NCT01077713|366334|P1|Overall Study|Death|28
97245|NCT01077713|366333|P2|Overall Study|Progressive Disease (PD)|1
97246|NCT01077713|366334|P1|Overall Study|Progressive Disease (PD)|0
97247|NCT01077713|366333|P2|Overall Study|Withdrawal by Subject|2
97248|NCT01077713|366334|P1|Overall Study|Withdrawal by Subject|1
97249|NCT01077622|366358|P1|Overall Study|Withdrawal by Subject|1
97250|NCT01077622|366358|P1|Overall Study|Physician Decision|2
97251|NCT01077544|366478|P2|Overall Study|Disease Progression|1
97252|NCT01077544|366479|P1|Overall Study|Disease Progression|0
97253|NCT01077544|366478|P2|Overall Study|Adverse Event|1
97254|NCT01077544|366479|P1|Overall Study|Adverse Event|0
97255|NCT01077544|366478|P2|Overall Study|New Cancer Therapy|3
97256|NCT01077544|366479|P1|Overall Study|New Cancer Therapy|3
97257|NCT01077375|366520|P2|Overall Study|Other Reason|1
97258|NCT01077375|366521|P1|Overall Study|Other Reason|0
97259|NCT01077375|366520|P2|Overall Study|Lost to Follow-up|5
97260|NCT01077375|366521|P1|Overall Study|Lost to Follow-up|2
97261|NCT01077375|366520|P2|Overall Study|Withdrawal by Subject|6
97262|NCT01077375|366521|P1|Overall Study|Withdrawal by Subject|0
97263|NCT01077375|366520|P2|Overall Study|Lack of Efficacy|8
97264|NCT01077375|366521|P1|Overall Study|Lack of Efficacy|6
97265|NCT01077375|366520|P2|Overall Study|Adverse Event|15
97266|NCT01077375|366521|P1|Overall Study|Adverse Event|2
97267|NCT01077362|366532|P3|Overall Study|Not Specified|2
97268|NCT01077362|366533|P2|Overall Study|Not Specified|1
97269|NCT01077362|366534|P1|Overall Study|Not Specified|0
97270|NCT01077362|366532|P3|Overall Study|Withdrawal by Subject|5
97271|NCT01077362|366533|P2|Overall Study|Withdrawal by Subject|3
97272|NCT01077362|366534|P1|Overall Study|Withdrawal by Subject|5
97273|NCT01077362|366532|P3|Overall Study|Adverse Event|4
97274|NCT01077362|366533|P2|Overall Study|Adverse Event|7
97275|NCT01077362|366534|P1|Overall Study|Adverse Event|12
97276|NCT01077362|366532|P3|Overall Study|Lost to Follow-up|3
97277|NCT01077362|366533|P2|Overall Study|Lost to Follow-up|0
97278|NCT01077362|366534|P1|Overall Study|Lost to Follow-up|1
97279|NCT01077362|366532|P3|Overall Study|Lack of Efficacy|10
97280|NCT01077362|366533|P2|Overall Study|Lack of Efficacy|8
97281|NCT01077362|366534|P1|Overall Study|Lack of Efficacy|13
97282|NCT01077323|366570|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
97283|NCT01077323|366571|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
97284|NCT01077323|366572|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
97285|NCT01077323|366570|P3|Overall Study|Dispensing of drug in baseline period|256446
97286|NCT01077323|366571|P2|Overall Study|Dispensing of drug in baseline period|120229
97287|NCT01077323|366572|P1|Overall Study|Dispensing of drug in baseline period|0
97288|NCT01077323|366570|P3|Overall Study|<9 months enroll before drug dispensed|11655523
97289|NCT01077323|366571|P2|Overall Study|<9 months enroll before drug dispensed|263954
97290|NCT01077323|366572|P1|Overall Study|<9 months enroll before drug dispensed|11226
97291|NCT01077284|366615|P3|Overall Study|Other|1
97292|NCT01077284|366616|P2|Overall Study|Other|0
97293|NCT01077284|366617|P1|Overall Study|Other|0
97294|NCT01077284|366615|P3|Overall Study|Withdrawal by Subject|1
97295|NCT01077284|366616|P2|Overall Study|Withdrawal by Subject|3
97296|NCT01077284|366617|P1|Overall Study|Withdrawal by Subject|2
97297|NCT01077284|366615|P3|Overall Study|Lost to Follow-up|0
97298|NCT01077284|366616|P2|Overall Study|Lost to Follow-up|2
97299|NCT01077284|366617|P1|Overall Study|Lost to Follow-up|1
97300|NCT01077284|366615|P3|Overall Study|Adverse Event|1
97301|NCT01077284|366616|P2|Overall Study|Adverse Event|0
97302|NCT01077284|366617|P1|Overall Study|Adverse Event|2
97303|NCT01077271|366638|P1|Overall Study|Mother unconvinced of the necessity|1
97304|NCT01077271|366638|P1|Overall Study|End of RSV season nearly reached|1
97305|NCT01077271|366638|P1|Overall Study|Parents thought too many injections|2
97306|NCT01077271|366638|P1|Overall Study|Changed doctors|2
97307|NCT01077271|366638|P1|Overall Study|Quota used up (insurance reimb issue)|2
97308|NCT01077271|366638|P1|Overall Study|Noncompliance|2
97309|NCT01077271|366638|P1|Overall Study|Screen failure, did not take palivizumab|4
97310|NCT01077271|366638|P1|Overall Study|Parental desire|8
97311|NCT01077258|366676|P1|Overall Study|Other reasons|260
97312|NCT01077258|366676|P1|Overall Study|Clinical remission|37
97313|NCT01077258|366676|P1|Overall Study|Lack of Efficacy|663
97314|NCT01077258|366676|P1|Overall Study|Adverse drug reaction|218
97315|NCT01077258|366676|P1|Overall Study|Lost to Follow-up|1390
97316|NCT01077193|366712|P1|Overall Study|Study Terminated by Sponsor|40
97317|NCT01077193|366712|P1|Overall Study|Lack of Efficacy|1
97318|NCT01077193|366712|P1|Overall Study|Withdrawal by Subject|2
97319|NCT01077193|366712|P1|Overall Study|Lost to Follow-up|1
97320|NCT01077128|366716|P1|Overall Study|Not available|54
97321|NCT01077128|366716|P1|Overall Study|Lack of efficacy/disease exacerbation|1
97322|NCT01077128|366716|P1|Overall Study|Adverse event and disease exacerbation|1
97323|NCT01077128|366716|P1|Overall Study|Adverse event and consent withdrawal|1
97324|NCT01077128|366716|P1|Overall Study|Disease exacerbation|1
97325|NCT01077128|366716|P1|Overall Study|Lack of Efficacy|1
97326|NCT01077128|366716|P1|Overall Study|Adverse Event|8
97327|NCT01077076|366774|P6|Third Intervention|Death in the participant's family|1
97328|NCT01077076|366775|P5|Third Intervention|Death in the participant's family|0
97329|NCT01077076|366776|P4|Third Intervention|Death in the participant's family|0
97330|NCT01077076|366777|P3|Third Intervention|Death in the participant's family|0
97331|NCT01077076|366778|P2|Third Intervention|Death in the participant's family|0
97332|NCT01077076|366779|P1|Third Intervention|Death in the participant's family|0
97333|NCT01077076|366774|P6|First Intervention|Withdrawal by Subject|0
97334|NCT01077076|366775|P5|First Intervention|Withdrawal by Subject|0
97335|NCT01077076|366776|P4|First Intervention|Withdrawal by Subject|0
97336|NCT01077076|366777|P3|First Intervention|Withdrawal by Subject|0
97337|NCT01077076|366778|P2|First Intervention|Withdrawal by Subject|0
97338|NCT01077076|366779|P1|First Intervention|Withdrawal by Subject|1
97339|NCT01077063|366789|P2|Overall Study|Withdrawal by Subject|2
97340|NCT01077063|366790|P1|Overall Study|Withdrawal by Subject|0
97341|NCT01077063|366789|P2|Overall Study|Death|1
97342|NCT01077063|366790|P1|Overall Study|Death|1
97343|NCT01077063|366789|P2|Overall Study|Adverse Event|0
97344|NCT01077063|366790|P1|Overall Study|Adverse Event|3
97345|NCT01077050|366796|P1|Overall Study|Screen failure|8
97346|NCT01077050|366796|P1|Overall Study|Subjects signed ICF could not be located|1
97347|NCT01077024|366802|P2|Overall Study|Other|4
97348|NCT01077024|366803|P1|Overall Study|Other|4
97349|NCT01077024|366802|P2|Overall Study|Incarcerated|8
97350|NCT01077024|366803|P1|Overall Study|Incarcerated|7
97351|NCT01077024|366802|P2|Overall Study|Withdrawal by Subject|2
97352|NCT01077024|366803|P1|Overall Study|Withdrawal by Subject|0
97353|NCT01077024|366802|P2|Overall Study|Lost to Follow-up|14
97354|NCT01077024|366803|P1|Overall Study|Lost to Follow-up|20
97355|NCT01076959|366842|P1|Overall Study|Other|119
97356|NCT01076959|366842|P1|Overall Study|Lost to Follow-up|241
97357|NCT01076959|366842|P1|Overall Study|Non-compliance|274
97358|NCT01076959|366842|P1|Overall Study|Lack of Efficacy|849
97359|NCT01076959|366842|P1|Overall Study|Adverse Event|767
97360|NCT01076647|366878|P2|Overall Study|Unclassified|12
97361|NCT01076647|366879|P1|Overall Study|Unclassified|12
97362|NCT01076647|366878|P2|Overall Study|Withdrawal criteria|2
97363|NCT01076647|366879|P1|Overall Study|Withdrawal criteria|2
97364|NCT01076647|366878|P2|Overall Study|Protocol Violation|9
97365|NCT01076647|366879|P1|Overall Study|Protocol Violation|7
97366|NCT01076647|366878|P2|Overall Study|Lack of Efficacy|1
97367|NCT01076647|366879|P1|Overall Study|Lack of Efficacy|0
97368|NCT01076647|366878|P2|Overall Study|Adverse Event|1
97369|NCT01076647|366879|P1|Overall Study|Adverse Event|4
97370|NCT01076400|366910|P3|Overall Study|Progressive Disease|0
97371|NCT01076400|366911|P2|Overall Study|Progressive Disease|0
97372|NCT01076400|366912|P1|Overall Study|Progressive Disease|5
97373|NCT01076400|366910|P3|Overall Study|Adverse Event|0
97374|NCT01076400|366911|P2|Overall Study|Adverse Event|0
97375|NCT01076400|366912|P1|Overall Study|Adverse Event|2
97376|NCT01076361|366918|P1|Overall Study|22 leads were excluded from analysis|21
97377|NCT01076335|366926|P1|Overall Study|Withdrawal without treatment|1
97378|NCT01076335|366926|P1|Overall Study|Withdrawal by Subject|3
97379|NCT01076192|366978|P1|Overall Study|Not specified|197
97380|NCT01076179|366993|P1|Overall Study|Withdrawal by Subject|1
97381|NCT01076166|367016|P1|Overall Study|Symptoms improved/resolved|6
97382|NCT01076166|367016|P1|Overall Study|Adverse Event|3
97383|NCT01076153|367023|P1|Overall Study|Adverse Event|1
97384|NCT01076153|367023|P1|Overall Study|Symptoms improved/resolved|10
97385|NCT01076088|367037|P6|Overall Study|Other protocol specified criteria|1
97386|NCT01076088|367038|P5|Overall Study|Other protocol specified criteria|0
97387|NCT01076088|367039|P4|Overall Study|Other protocol specified criteria|0
97388|NCT01076088|367040|P3|Overall Study|Other protocol specified criteria|0
97389|NCT01076088|367041|P2|Overall Study|Other protocol specified criteria|0
97390|NCT01076088|367042|P1|Overall Study|Other protocol specified criteria|0
97391|NCT01076088|367037|P6|Overall Study|Withdrawal by Subject|17
97392|NCT01076088|367038|P5|Overall Study|Withdrawal by Subject|11
97393|NCT01076088|367039|P4|Overall Study|Withdrawal by Subject|10
97394|NCT01076088|367040|P3|Overall Study|Withdrawal by Subject|14
97395|NCT01076088|367041|P2|Overall Study|Withdrawal by Subject|8
97396|NCT01076088|367042|P1|Overall Study|Withdrawal by Subject|8
97397|NCT01076088|367037|P6|Overall Study|Physician Decision|0
97398|NCT01076088|367038|P5|Overall Study|Physician Decision|1
97399|NCT01076088|367039|P4|Overall Study|Physician Decision|1
97400|NCT01076088|367040|P3|Overall Study|Physician Decision|0
97401|NCT01076088|367041|P2|Overall Study|Physician Decision|3
97402|NCT01076088|367042|P1|Overall Study|Physician Decision|1
97403|NCT01076088|367037|P6|Overall Study|Non-compliance with study drug|0
97404|NCT01076088|367038|P5|Overall Study|Non-compliance with study drug|0
97405|NCT01076088|367039|P4|Overall Study|Non-compliance with study drug|1
97406|NCT01076088|367040|P3|Overall Study|Non-compliance with study drug|0
97407|NCT01076088|367041|P2|Overall Study|Non-compliance with study drug|0
97408|NCT01076088|367042|P1|Overall Study|Non-compliance with study drug|0
97409|NCT01076088|367037|P6|Overall Study|Lost to Follow-up|2
97410|NCT01076088|367038|P5|Overall Study|Lost to Follow-up|1
97411|NCT01076088|367039|P4|Overall Study|Lost to Follow-up|1
97412|NCT01076088|367040|P3|Overall Study|Lost to Follow-up|0
97413|NCT01076088|367041|P2|Overall Study|Lost to Follow-up|1
97414|NCT01076088|367042|P1|Overall Study|Lost to Follow-up|1
97415|NCT01076088|367037|P6|Overall Study|Adverse Event|3
97416|NCT01076088|367038|P5|Overall Study|Adverse Event|3
97417|NCT01076088|367039|P4|Overall Study|Adverse Event|2
97418|NCT01076088|367040|P3|Overall Study|Adverse Event|3
97419|NCT01076088|367041|P2|Overall Study|Adverse Event|6
97420|NCT01076088|367042|P1|Overall Study|Adverse Event|1
97421|NCT01076075|367070|P2|Overall Study|Withdrawal by Subject|19
97422|NCT01076075|367071|P1|Overall Study|Withdrawal by Subject|8
97423|NCT01076075|367070|P2|Overall Study|Protocol Violation|1
97424|NCT01076075|367071|P1|Overall Study|Protocol Violation|0
97425|NCT01076075|367070|P2|Overall Study|other|9
97426|NCT01076075|367071|P1|Overall Study|other|19
97427|NCT01076075|367070|P2|Overall Study|Lost to Follow-up|5
97428|NCT01076075|367071|P1|Overall Study|Lost to Follow-up|6
97429|NCT01076075|367070|P2|Overall Study|Lack of Efficacy|4
97430|NCT01076075|367071|P1|Overall Study|Lack of Efficacy|5
97431|NCT01076075|367070|P2|Overall Study|Adverse Event|9
97432|NCT01076075|367071|P1|Overall Study|Adverse Event|3
97433|NCT01076036|367085|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
97434|NCT01075984|367095|P5|Follow-up Phase|Treatment failure|4
97435|NCT01075984|367096|P4|Follow-up Phase|Treatment failure|0
97436|NCT01075984|367097|P3|Follow-up Phase|Treatment failure|0
97437|NCT01075984|367098|P2|Follow-up Phase|Treatment failure|0
97438|NCT01075984|367099|P1|Follow-up Phase|Treatment failure|0
97439|NCT01075984|367095|P5|Follow-up Phase|Progression of disease|2
97440|NCT01075984|367096|P4|Follow-up Phase|Progression of disease|0
97441|NCT01075984|367097|P3|Follow-up Phase|Progression of disease|0
97442|NCT01075984|367098|P2|Follow-up Phase|Progression of disease|0
97443|NCT01075984|367099|P1|Follow-up Phase|Progression of disease|0
97444|NCT01075984|367095|P5|Follow-up Phase|Withdrawal by Subject|10
97445|NCT01075984|367096|P4|Follow-up Phase|Withdrawal by Subject|0
97446|NCT01075984|367097|P3|Follow-up Phase|Withdrawal by Subject|0
97447|NCT01075984|367098|P2|Follow-up Phase|Withdrawal by Subject|0
97448|NCT01075984|367099|P1|Follow-up Phase|Withdrawal by Subject|0
97449|NCT01075984|367095|P5|Follow-up Phase|Administrative|1
97450|NCT01075984|367096|P4|Follow-up Phase|Administrative|0
97451|NCT01075984|367097|P3|Follow-up Phase|Administrative|0
97452|NCT01075984|367098|P2|Follow-up Phase|Administrative|0
97453|NCT01075984|367099|P1|Follow-up Phase|Administrative|0
97454|NCT01075984|367095|P5|Follow-up Phase|Adverse Event|27
97455|NCT01075984|367096|P4|Follow-up Phase|Adverse Event|2
97456|NCT01075984|367097|P3|Follow-up Phase|Adverse Event|0
97457|NCT01075984|367098|P2|Follow-up Phase|Adverse Event|0
97458|NCT01075984|367099|P1|Follow-up Phase|Adverse Event|0
97459|NCT01075984|367095|P5|Follow-up Phase|Protocol Violation|3
97460|NCT01075984|367096|P4|Follow-up Phase|Protocol Violation|0
97461|NCT01075984|367097|P3|Follow-up Phase|Protocol Violation|1
97462|NCT01075984|367098|P2|Follow-up Phase|Protocol Violation|0
97463|NCT01075984|367099|P1|Follow-up Phase|Protocol Violation|0
97464|NCT01075984|367095|P5|Treatment Phase|Progression of disease|2
97465|NCT01075984|367096|P4|Treatment Phase|Progression of disease|0
97466|NCT01075984|367097|P3|Treatment Phase|Progression of disease|0
97467|NCT01075984|367098|P2|Treatment Phase|Progression of disease|0
97468|NCT01075984|367099|P1|Treatment Phase|Progression of disease|0
97469|NCT01075984|367095|P5|Treatment Phase|Treatment Failure|5
97470|NCT01075984|367096|P4|Treatment Phase|Treatment Failure|0
97471|NCT01075984|367097|P3|Treatment Phase|Treatment Failure|1
97472|NCT01075984|367098|P2|Treatment Phase|Treatment Failure|0
97473|NCT01075984|367099|P1|Treatment Phase|Treatment Failure|0
97474|NCT01075984|367095|P5|Treatment Phase|Withdrawal by Subject|15
97475|NCT01075984|367096|P4|Treatment Phase|Withdrawal by Subject|0
97476|NCT01075984|367097|P3|Treatment Phase|Withdrawal by Subject|2
97477|NCT01075984|367098|P2|Treatment Phase|Withdrawal by Subject|0
97478|NCT01075984|367099|P1|Treatment Phase|Withdrawal by Subject|0
97479|NCT01075984|367095|P5|Treatment Phase|Protocol Violation|3
97480|NCT01075984|367096|P4|Treatment Phase|Protocol Violation|0
97481|NCT01075984|367097|P3|Treatment Phase|Protocol Violation|1
97482|NCT01075984|367098|P2|Treatment Phase|Protocol Violation|0
97483|NCT01075984|367099|P1|Treatment Phase|Protocol Violation|0
97484|NCT01075984|367095|P5|Treatment Phase|Adverse Event|35
97485|NCT01075984|367096|P4|Treatment Phase|Adverse Event|7
97486|NCT01075984|367097|P3|Treatment Phase|Adverse Event|3
97487|NCT01075984|367098|P2|Treatment Phase|Adverse Event|1
97488|NCT01075984|367099|P1|Treatment Phase|Adverse Event|0
97489|NCT01075958|367157|P1|Overall Study|Blood sample could not be obtained|44
97490|NCT01075815|367173|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
97491|NCT01075815|367174|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
97492|NCT01075815|367173|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
97493|NCT01075815|367174|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
97494|NCT01075815|367173|P2|Overall Study|Withdrawal before r-hCG administration|1
97495|NCT01075815|367174|P1|Overall Study|Withdrawal before r-hCG administration|6
97496|NCT01075763|367212|P2|Overall Study|Withdrawal by Subject|2
97497|NCT01075763|367213|P1|Overall Study|Withdrawal by Subject|2
97498|NCT01075763|367212|P2|Overall Study|Lack of Efficacy|1
97499|NCT01075763|367213|P1|Overall Study|Lack of Efficacy|0
97500|NCT01075763|367212|P2|Overall Study|Lost to Follow-up|1
97501|NCT01075763|367213|P1|Overall Study|Lost to Follow-up|2
97502|NCT01075685|367237|P2|Overall Study|Lost to Follow-up|220
97503|NCT01075685|367238|P1|Overall Study|Lost to Follow-up|563
97504|NCT01075685|367237|P2|Overall Study|Withdrawal by Subject|5
97505|NCT01075685|367238|P1|Overall Study|Withdrawal by Subject|20
97506|NCT01075685|367237|P2|Overall Study|Protocol Violation|1
97507|NCT01075685|367238|P1|Overall Study|Protocol Violation|9
97508|NCT01075646|367254|P4|Overall Study|Lost to Follow-up|2
97509|NCT01075646|367255|P3|Overall Study|Lost to Follow-up|1
97510|NCT01075646|367256|P2|Overall Study|Lost to Follow-up|3
97511|NCT01075646|367257|P1|Overall Study|Lost to Follow-up|4
97512|NCT01075412|367289|P2|Overall Study|Withdrawal by Subject|1
97513|NCT01075412|367290|P1|Overall Study|Withdrawal by Subject|0
97514|NCT01075282|367318|P3|Overall Study|Death|2
97515|NCT01075282|367319|P2|Overall Study|Death|1
97516|NCT01075282|367320|P1|Overall Study|Death|0
97517|NCT01075282|367318|P3|Overall Study|Protocol Violation|1
97518|NCT01075282|367319|P2|Overall Study|Protocol Violation|2
97519|NCT01075282|367320|P1|Overall Study|Protocol Violation|0
97520|NCT01075282|367318|P3|Overall Study|Treatment Non-compliance|2
97521|NCT01075282|367319|P2|Overall Study|Treatment Non-compliance|2
97522|NCT01075282|367320|P1|Overall Study|Treatment Non-compliance|1
97523|NCT01075282|367318|P3|Overall Study|Lack of Efficacy|0
97524|NCT01075282|367319|P2|Overall Study|Lack of Efficacy|1
97525|NCT01075282|367320|P1|Overall Study|Lack of Efficacy|1
97526|NCT01075282|367318|P3|Overall Study|Physician Decision|3
97527|NCT01075282|367319|P2|Overall Study|Physician Decision|3
97528|NCT01075282|367320|P1|Overall Study|Physician Decision|3
97529|NCT01075282|367318|P3|Overall Study|Lost to Follow-up|3
97530|NCT01075282|367319|P2|Overall Study|Lost to Follow-up|3
97531|NCT01075282|367320|P1|Overall Study|Lost to Follow-up|3
97532|NCT01075282|367318|P3|Overall Study|Entry Criteria Not Met|0
97533|NCT01075282|367319|P2|Overall Study|Entry Criteria Not Met|2
97534|NCT01075282|367320|P1|Overall Study|Entry Criteria Not Met|3
97535|NCT01075282|367318|P3|Overall Study|Adverse Event|5
97536|NCT01075282|367319|P2|Overall Study|Adverse Event|8
97537|NCT01075282|367320|P1|Overall Study|Adverse Event|9
97538|NCT01075282|367318|P3|Overall Study|Withdrawal by Subject|11
97539|NCT01075282|367319|P2|Overall Study|Withdrawal by Subject|7
97540|NCT01075282|367320|P1|Overall Study|Withdrawal by Subject|11
97541|NCT01075256|367403|P3|Overall Study|Withdrawal by Subject|0
97542|NCT01075256|367404|P2|Overall Study|Withdrawal by Subject|0
97543|NCT01075256|367405|P1|Overall Study|Withdrawal by Subject|1
97544|NCT01075243|367437|P3|Overall Study|Withdrawal by Subject|0
97545|NCT01075243|367438|P2|Overall Study|Withdrawal by Subject|1
97546|NCT01075243|367439|P1|Overall Study|Withdrawal by Subject|1
97547|NCT01075243|367437|P3|Overall Study|Lost to Follow-up|0
97548|NCT01075243|367438|P2|Overall Study|Lost to Follow-up|2
97549|NCT01075243|367439|P1|Overall Study|Lost to Follow-up|5
97550|NCT01075217|367491|P2|Overall Study|Physician Decision|0
97551|NCT01075217|367492|P1|Overall Study|Physician Decision|1
97552|NCT01075217|367491|P2|Overall Study|Adverse Event|1
97553|NCT01075217|367492|P1|Overall Study|Adverse Event|1
97554|NCT01075191|367525|P1|Overall Study|Unknown Reasons|1
97555|NCT01075191|367525|P1|Overall Study|Patient's Wish|2
97556|NCT01075191|367525|P1|Overall Study|Therapy Break|3
97557|NCT01075191|367525|P1|Overall Study|Noncompliance|3
97558|NCT01075191|367525|P1|Overall Study|Adverse Event|4
97559|NCT01075191|367525|P1|Overall Study|Co-morbidities|1
97560|NCT01075191|367525|P1|Overall Study|Intensification|3
97561|NCT01075191|367525|P1|Overall Study|Death|1
97562|NCT01075178|367536|P2|Subject Chart Review|matched partner excluded (reasons above)|3
97563|NCT01075178|367537|P1|Subject Chart Review|matched partner excluded (reasons above)|6
97564|NCT01075178|367536|P2|Subject Chart Review|no data collected due to site closure|4
97565|NCT01075178|367537|P1|Subject Chart Review|no data collected due to site closure|3
97566|NCT01075178|367536|P2|Subject Chart Review|died before chart review period|2
97567|NCT01075178|367537|P1|Subject Chart Review|died before chart review period|0
97568|NCT01075178|367536|P2|Subject Matching|eligible but not matched|403
97569|NCT01075178|367537|P1|Subject Matching|eligible but not matched|130
97570|NCT01075152|367551|P2|Overall Study|Withdrawal by Subject|0
97571|NCT01075152|367552|P1|Overall Study|Withdrawal by Subject|1
97572|NCT01075100|367578|P2|Overall Study|Other|1
97573|NCT01075100|367579|P1|Overall Study|Other|3
97574|NCT01075100|367578|P2|Overall Study|Disease Progression|29
97575|NCT01075100|367579|P1|Overall Study|Disease Progression|25
97576|NCT01075100|367578|P2|Overall Study|Investigator Request|1
97577|NCT01075100|367579|P1|Overall Study|Investigator Request|2
97578|NCT01075100|367578|P2|Overall Study|Patient Request|4
97579|NCT01075100|367579|P1|Overall Study|Patient Request|4
97580|NCT01075100|367578|P2|Overall Study|Adverse Event|18
97581|NCT01075100|367579|P1|Overall Study|Adverse Event|15
97582|NCT01075074|367609|P3|Overall Study|Surgeon changed to open incisional case|2
97583|NCT01075074|367610|P2|Overall Study|Surgeon changed to open incisional case|2
97584|NCT01075074|367611|P1|Overall Study|Surgeon changed to open incisional case|1
97585|NCT01074944|367628|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
97586|NCT01074944|367629|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
97587|NCT01074944|367630|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
97588|NCT01074944|367631|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
97589|NCT01074944|367632|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
97590|NCT01074944|367628|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
97591|NCT01074944|367629|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
97592|NCT01074944|367630|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
97593|NCT01074944|367631|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
97594|NCT01074944|367632|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
97595|NCT01074944|367628|P5|Long Term Treatment|Withdrawal by Subject|0
97596|NCT01074944|367629|P4|Long Term Treatment|Withdrawal by Subject|2
97597|NCT01074944|367630|P3|Long Term Treatment|Withdrawal by Subject|0
97598|NCT01074944|367631|P2|Long Term Treatment|Withdrawal by Subject|0
97599|NCT01074944|367632|P1|Long Term Treatment|Withdrawal by Subject|0
97600|NCT01074944|367628|P5|Long Term Treatment|Entered in Period, But Not Treated|0
97601|NCT01074944|367629|P4|Long Term Treatment|Entered in Period, But Not Treated|1
97602|NCT01074944|367630|P3|Long Term Treatment|Entered in Period, But Not Treated|0
97603|NCT01074944|367631|P2|Long Term Treatment|Entered in Period, But Not Treated|0
97604|NCT01074944|367632|P1|Long Term Treatment|Entered in Period, But Not Treated|0
97605|NCT01074944|367628|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
97606|NCT01074944|367629|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
97607|NCT01074944|367630|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
97608|NCT01074944|367631|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
97609|NCT01074944|367632|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
97610|NCT01074944|367628|P5|Long Term Treatment|Lost to Follow-up|0
97611|NCT01074944|367629|P4|Long Term Treatment|Lost to Follow-up|2
97612|NCT01074944|367630|P3|Long Term Treatment|Lost to Follow-up|0
97613|NCT01074944|367631|P2|Long Term Treatment|Lost to Follow-up|0
97614|NCT01074944|367632|P1|Long Term Treatment|Lost to Follow-up|0
97615|NCT01074944|367628|P5|Long Term Treatment|Adverse Event|0
97616|NCT01074944|367629|P4|Long Term Treatment|Adverse Event|3
97617|NCT01074944|367630|P3|Long Term Treatment|Adverse Event|0
97618|NCT01074944|367631|P2|Long Term Treatment|Adverse Event|0
97619|NCT01074944|367632|P1|Long Term Treatment|Adverse Event|0
97620|NCT01074944|367628|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
97621|NCT01074944|367629|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
97622|NCT01074944|367630|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
97623|NCT01074944|367631|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
97624|NCT01074944|367632|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
97625|NCT01074944|367628|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
97626|NCT01074944|367629|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
97627|NCT01074944|367630|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
97628|NCT01074944|367631|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
97629|NCT01074944|367632|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
97630|NCT01074944|367628|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
97631|NCT01074944|367629|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
97632|NCT01074944|367630|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
97633|NCT01074944|367631|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
97634|NCT01074944|367632|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
97635|NCT01074944|367628|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
97636|NCT01074944|367629|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
97637|NCT01074944|367630|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
97638|NCT01074944|367631|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
97639|NCT01074944|367632|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
97640|NCT01074944|367628|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
97641|NCT01074944|367629|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
97642|NCT01074944|367630|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
97643|NCT01074944|367631|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
97644|NCT01074944|367632|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
97645|NCT01074944|367628|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
97646|NCT01074944|367629|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
97647|NCT01074944|367630|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
97648|NCT01074944|367631|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
97649|NCT01074944|367632|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
97650|NCT01074944|367628|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
97651|NCT01074944|367629|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
97652|NCT01074944|367630|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
97653|NCT01074944|367631|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
97654|NCT01074944|367632|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
97655|NCT01074944|367628|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
97656|NCT01074944|367629|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
97657|NCT01074944|367630|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
97658|NCT01074944|367631|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
97659|NCT01074944|367632|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
97660|NCT01074944|367628|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
97661|NCT01074944|367629|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
97662|NCT01074944|367630|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
97663|NCT01074944|367631|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
97664|NCT01074944|367632|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
97665|NCT01074931|367686|P1|Overall Study|Death|5
97666|NCT01074931|367686|P1|Overall Study|Economic reasons|1
97667|NCT01074658|367698|P1|Overall Study|No implant attempted|19
97668|NCT01074554|367706|P2|Overall Study|Lost to Follow-up|1
97669|NCT01074554|367707|P1|Overall Study|Lost to Follow-up|0
97670|NCT01074554|367706|P2|Overall Study|Adverse Event|3
97671|NCT01074554|367707|P1|Overall Study|Adverse Event|3
97672|NCT01074502|367717|P1|Overall Study|Withdrawal by Subject|1
97673|NCT01074450|367741|P2|Second Intervention|Physician Decision|1
97674|NCT01074450|367742|P1|Second Intervention|Physician Decision|0
97675|NCT01074450|367741|P2|Second Intervention|Protocol Violation|0
97676|NCT01074450|367742|P1|Second Intervention|Protocol Violation|1
97677|NCT01074450|367741|P2|First Intervention|Emesis in Dosing Interval|2
97678|NCT01074450|367742|P1|First Intervention|Emesis in Dosing Interval|0
97679|NCT01074307|367763|P2|Overall Study|Protocol Violation|5
97680|NCT01074307|367764|P1|Overall Study|Protocol Violation|8
97681|NCT01074307|367763|P2|Overall Study|Exclusion criterion|1
97682|NCT01074307|367764|P1|Overall Study|Exclusion criterion|0
97683|NCT01074307|367763|P2|Overall Study|No primary endpoint evaluation|6
97684|NCT01074307|367764|P1|Overall Study|No primary endpoint evaluation|14
97685|NCT01074268|367786|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
97686|NCT01074268|367787|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
97687|NCT01074268|367786|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
97688|NCT01074268|367787|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
97689|NCT01074268|367786|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
97690|NCT01074268|367787|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
97691|NCT01074268|367786|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
97692|NCT01074268|367787|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
97693|NCT01074268|367786|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
97694|NCT01074268|367787|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
97695|NCT01074268|367786|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
97696|NCT01074268|367787|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
97697|NCT01074268|367786|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
97698|NCT01074268|367787|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
97699|NCT01074268|367786|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
97700|NCT01074268|367787|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
97701|NCT01074268|367786|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
97702|NCT01074268|367787|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
97703|NCT01074255|367813|P1|Overall Study|Did not receive EMEND|2
97704|NCT01074242|367817|P1|Overall Study|Duplicate Case Report Form|5
97705|NCT01074242|367817|P1|Overall Study|Violation of vaccine dose or dosage|351
97706|NCT01074242|367817|P1|Overall Study|Case report unclear|6
97707|NCT01074242|367817|P1|Overall Study|Lost to Follow-up|1
97708|NCT01074242|367817|P1|Overall Study|Case report before date of contract|40
97709|NCT01074229|367825|P3|Overall Study|Change to open surgical procedure|4
97710|NCT01074229|367826|P2|Overall Study|Change to open surgical procedure|3
97711|NCT01074229|367827|P1|Overall Study|Change to open surgical procedure|1
97712|NCT01074229|367825|P3|Overall Study|Lost to Follow-up|0
97713|NCT01074229|367826|P2|Overall Study|Lost to Follow-up|0
97714|NCT01074229|367827|P1|Overall Study|Lost to Follow-up|1
97715|NCT01074216|367838|P1|Overall Study|Not Treated|12
97716|NCT01074216|367838|P1|Overall Study|Physician Decision|1
97717|NCT01074047|367902|P2|Extension Phase|Death|0
97718|NCT01074047|367903|P1|Extension Phase|Death|5
97719|NCT01074047|367902|P2|Extension Phase|Withdrawal by Subject|0
97720|NCT01074047|367903|P1|Extension Phase|Withdrawal by Subject|2
97721|NCT01074047|367902|P2|Extension Phase|Disease Progression|0
97722|NCT01074047|367903|P1|Extension Phase|Disease Progression|9
97723|NCT01074047|367902|P2|Extension Phase|Adverse Event|0
97724|NCT01074047|367903|P1|Extension Phase|Adverse Event|5
97725|NCT01074047|367902|P2|Extension Phase|Physician Decision|0
97726|NCT01074047|367903|P1|Extension Phase|Physician Decision|1
97727|NCT01074047|367902|P2|Survival Follow-Up Phase|Alive at study closure|3
97728|NCT01074047|367903|P1|Survival Follow-Up Phase|Alive at study closure|1
97729|NCT01074047|367902|P2|Survival Follow-Up Phase|Death|124
97730|NCT01074047|367903|P1|Survival Follow-Up Phase|Death|116
97731|NCT01074047|367902|P2|Survival Follow-Up Phase|Lost to Follow-up|1
97732|NCT01074047|367903|P1|Survival Follow-Up Phase|Lost to Follow-up|2
97733|NCT01074047|367902|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
97734|NCT01074047|367903|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
97735|NCT01074047|367902|P2|Treatment Phase|Miscellaneous|39
97736|NCT01074047|367903|P1|Treatment Phase|Miscellaneous|32
97737|NCT01074047|367902|P2|Treatment Phase|Protocol Violation|1
97738|NCT01074047|367903|P1|Treatment Phase|Protocol Violation|0
97739|NCT01074047|367902|P2|Treatment Phase|Lost to Follow-up|1
97740|NCT01074047|367903|P1|Treatment Phase|Lost to Follow-up|0
97741|NCT01074047|367902|P2|Treatment Phase|Death|58
97742|NCT01074047|367903|P1|Treatment Phase|Death|53
97743|NCT01074047|367902|P2|Treatment Phase|Withdrawal by Subject|48
97744|NCT01074047|367903|P1|Treatment Phase|Withdrawal by Subject|27
97745|NCT01074047|367902|P2|Treatment Phase|Disease Progression|21
97746|NCT01074047|367903|P1|Treatment Phase|Disease Progression|16
97747|NCT01074047|367902|P2|Treatment Phase|Adverse Event|66
97748|NCT01074047|367903|P1|Treatment Phase|Adverse Event|89
97749|NCT01074008|367991|P9|Overall Study|Lost to Follow-up|4
97750|NCT01074008|367992|P8|Overall Study|Lost to Follow-up|0
97751|NCT01074008|367993|P7|Overall Study|Lost to Follow-up|1
97752|NCT01074008|367994|P6|Overall Study|Lost to Follow-up|0
97753|NCT01074008|367995|P5|Overall Study|Lost to Follow-up|1
97754|NCT01074008|367996|P4|Overall Study|Lost to Follow-up|1
97755|NCT01074008|367997|P3|Overall Study|Lost to Follow-up|1
97756|NCT01074008|367998|P2|Overall Study|Lost to Follow-up|1
97757|NCT01074008|367999|P1|Overall Study|Lost to Follow-up|0
97758|NCT01074008|367991|P9|Overall Study|Withdrawal by Subject|0
97759|NCT01074008|367992|P8|Overall Study|Withdrawal by Subject|0
97760|NCT01074008|367993|P7|Overall Study|Withdrawal by Subject|0
97761|NCT01074008|367994|P6|Overall Study|Withdrawal by Subject|0
97762|NCT01074008|367995|P5|Overall Study|Withdrawal by Subject|1
97763|NCT01074008|367996|P4|Overall Study|Withdrawal by Subject|0
97764|NCT01074008|367997|P3|Overall Study|Withdrawal by Subject|1
97765|NCT01074008|367998|P2|Overall Study|Withdrawal by Subject|1
97766|NCT01074008|367999|P1|Overall Study|Withdrawal by Subject|1
97767|NCT01074008|367991|P9|Overall Study|Adverse Event|0
97768|NCT01074008|367992|P8|Overall Study|Adverse Event|0
97769|NCT01074008|367993|P7|Overall Study|Adverse Event|0
97770|NCT01074008|367994|P6|Overall Study|Adverse Event|0
97771|NCT01074008|367995|P5|Overall Study|Adverse Event|0
97772|NCT01074008|367996|P4|Overall Study|Adverse Event|0
97773|NCT01074008|367997|P3|Overall Study|Adverse Event|0
97774|NCT01074008|367998|P2|Overall Study|Adverse Event|1
97775|NCT01074008|367999|P1|Overall Study|Adverse Event|0
97776|NCT01073943|368109|P2|Overall Study|Could not tolerate prep|0
97777|NCT01073943|368110|P1|Overall Study|Could not tolerate prep|1
97778|NCT01073943|368109|P2|Overall Study|Unable to return for follow-up|1
97779|NCT01073943|368110|P1|Overall Study|Unable to return for follow-up|0
97780|NCT01073943|368109|P2|Overall Study|Subject forgot|1
97781|NCT01073943|368110|P1|Overall Study|Subject forgot|0
97782|NCT01073943|368109|P2|Overall Study|Power outage; colonoscopy not done|0
97783|NCT01073943|368110|P1|Overall Study|Power outage; colonoscopy not done|1
97784|NCT01073943|368109|P2|Overall Study|Lost to Follow-up|2
97785|NCT01073943|368110|P1|Overall Study|Lost to Follow-up|0
97786|NCT01073943|368109|P2|Overall Study|Adverse Event|1
97787|NCT01073943|368110|P1|Overall Study|Adverse Event|1
97788|NCT01073943|368109|P2|Overall Study|Protocol Violation|1
97789|NCT01073943|368110|P1|Overall Study|Protocol Violation|2
97790|NCT01073943|368109|P2|Overall Study|Withdrawal by Subject|2
97791|NCT01073943|368110|P1|Overall Study|Withdrawal by Subject|8
97792|NCT01073930|368136|P2|Overall Study|Inadequate prep; unable to do procedure|1
97793|NCT01073930|368137|P1|Overall Study|Inadequate prep; unable to do procedure|0
97794|NCT01073930|368136|P2|Overall Study|Noncompliance with study drug|1
97795|NCT01073930|368137|P1|Overall Study|Noncompliance with study drug|0
97796|NCT01073930|368136|P2|Overall Study|Adverse Event|1
97797|NCT01073930|368137|P1|Overall Study|Adverse Event|0
97798|NCT01073930|368136|P2|Overall Study|Lost to Follow-up|1
97799|NCT01073930|368137|P1|Overall Study|Lost to Follow-up|0
97800|NCT01073930|368136|P2|Overall Study|Withdrawal by Subject|2
97801|NCT01073930|368137|P1|Overall Study|Withdrawal by Subject|3
97802|NCT01073865|368161|P2|Overall Study|Withdrawal by Subject|5
97803|NCT01073865|368162|P1|Overall Study|Withdrawal by Subject|5
97804|NCT01073865|368161|P2|Overall Study|Death|2
97805|NCT01073865|368162|P1|Overall Study|Death|3
97806|NCT01073865|368161|P2|Overall Study|Lost to Follow-up|1
97807|NCT01073865|368162|P1|Overall Study|Lost to Follow-up|1
97808|NCT01073865|368161|P2|Overall Study|Reasons other than below|31
97809|NCT01073865|368162|P1|Overall Study|Reasons other than below|19
97810|NCT01073631|368181|P1|Overall Study|Other|63
97811|NCT01073631|368181|P1|Overall Study|Adverse Event|24
97812|NCT01073631|368181|P1|Overall Study|Death|82
97813|NCT01073618|368186|P1|Overall Study|Other|80
97814|NCT01073618|368186|P1|Overall Study|Adverse Event|19
97815|NCT01073618|368186|P1|Overall Study|Death|208
97816|NCT01073605|368194|P3|Overall Study|Randomized But Not Treated|1
97817|NCT01073605|368195|P2|Overall Study|Randomized But Not Treated|1
97818|NCT01073605|368196|P1|Overall Study|Randomized But Not Treated|0
97819|NCT01073605|368194|P3|Overall Study|Withdrawal by Subject|22
97820|NCT01073605|368195|P2|Overall Study|Withdrawal by Subject|39
97821|NCT01073605|368196|P1|Overall Study|Withdrawal by Subject|31
97822|NCT01073605|368194|P3|Overall Study|Other|29
97823|NCT01073605|368195|P2|Overall Study|Other|21
97824|NCT01073605|368196|P1|Overall Study|Other|25
97825|NCT01073605|368194|P3|Overall Study|Lost to Follow-up|9
97826|NCT01073605|368195|P2|Overall Study|Lost to Follow-up|4
97827|NCT01073605|368196|P1|Overall Study|Lost to Follow-up|3
97828|NCT01073605|368194|P3|Overall Study|Adverse Event|0
97829|NCT01073605|368195|P2|Overall Study|Adverse Event|1
97830|NCT01073605|368196|P1|Overall Study|Adverse Event|2
97831|NCT01073605|368194|P3|Overall Study|Ongoing at Cutoff Date|0
97832|NCT01073605|368195|P2|Overall Study|Ongoing at Cutoff Date|1
97833|NCT01073605|368196|P1|Overall Study|Ongoing at Cutoff Date|1
97834|NCT01073566|368242|P2|Period 2 (6 Weeks)|Adverse Event|0
97835|NCT01073566|368243|P1|Period 2 (6 Weeks)|Adverse Event|1
97836|NCT01073462|368255|P1|Overall Study|Lost to Follow-up|7
97837|NCT01073462|368255|P1|Overall Study|Serious adverse event|2
97838|NCT01073462|368255|P1|Overall Study|Low parathyroid hormone levels|8
97839|NCT01073462|368255|P1|Overall Study|Kidney transplant|10
97840|NCT01073462|368255|P1|Overall Study|Death|14
97841|NCT01073293|368274|P2|Overall Study|Withdrawal by Subject|10
97842|NCT01073293|368275|P1|Overall Study|Withdrawal by Subject|5
97843|NCT01073293|368274|P2|Overall Study|Lost to Follow-up|1
97844|NCT01073293|368275|P1|Overall Study|Lost to Follow-up|0
97845|NCT01073267|368297|P1|Overall Study|Disease Progression|3
97846|NCT01073163|368301|P1|Overall Study|Early termination|1
97847|NCT01073163|368301|P1|Overall Study|Disease Progression|1
97848|NCT01073163|368301|P1|Overall Study|Adverse Event|1
97849|NCT01072929|368324|P3|Overall Study|Not specified|0
97850|NCT01072929|368325|P2|Overall Study|Not specified|3
97851|NCT01072929|368326|P1|Overall Study|Not specified|0
97852|NCT01072929|368324|P3|Overall Study|Noncompliance with study procedures|1
97853|NCT01072929|368325|P2|Overall Study|Noncompliance with study procedures|0
97854|NCT01072929|368326|P1|Overall Study|Noncompliance with study procedures|1
97855|NCT01072929|368324|P3|Overall Study|Noncompliance with study medication|0
97856|NCT01072929|368325|P2|Overall Study|Noncompliance with study medication|3
97857|NCT01072929|368326|P1|Overall Study|Noncompliance with study medication|0
97858|NCT01072929|368324|P3|Overall Study|Lost to Follow-up|1
97859|NCT01072929|368325|P2|Overall Study|Lost to Follow-up|4
97860|NCT01072929|368326|P1|Overall Study|Lost to Follow-up|8
97861|NCT01072929|368324|P3|Overall Study|Protocol Violation|2
97862|NCT01072929|368325|P2|Overall Study|Protocol Violation|11
97863|NCT01072929|368326|P1|Overall Study|Protocol Violation|13
97864|NCT01072929|368324|P3|Overall Study|Withdrawal by Subject|3
97865|NCT01072929|368325|P2|Overall Study|Withdrawal by Subject|15
97866|NCT01072929|368326|P1|Overall Study|Withdrawal by Subject|7
97867|NCT01072929|368324|P3|Overall Study|Lack of Efficacy|0
97868|NCT01072929|368325|P2|Overall Study|Lack of Efficacy|4
97869|NCT01072929|368326|P1|Overall Study|Lack of Efficacy|7
97870|NCT01072929|368324|P3|Overall Study|Adverse Event|2
97871|NCT01072929|368325|P2|Overall Study|Adverse Event|11
97872|NCT01072929|368326|P1|Overall Study|Adverse Event|8
97873|NCT01072877|368405|P5|Overall Study|Lost to Follow-up|0
97874|NCT01072877|368406|P4|Overall Study|Lost to Follow-up|2
97875|NCT01072877|368407|P3|Overall Study|Lost to Follow-up|0
97876|NCT01072877|368408|P2|Overall Study|Lost to Follow-up|1
97877|NCT01072877|368409|P1|Overall Study|Lost to Follow-up|1
97878|NCT01072630|368472|P3|Overall Study|Not specified|1
97879|NCT01072630|368473|P2|Overall Study|Not specified|2
97880|NCT01072630|368474|P1|Overall Study|Not specified|3
97881|NCT01072630|368472|P3|Overall Study|Noncompliance with study procedures|1
97882|NCT01072630|368473|P2|Overall Study|Noncompliance with study procedures|2
97883|NCT01072630|368474|P1|Overall Study|Noncompliance with study procedures|1
97884|NCT01072630|368472|P3|Overall Study|Noncompliance with study medication|1
97885|NCT01072630|368473|P2|Overall Study|Noncompliance with study medication|1
97886|NCT01072630|368474|P1|Overall Study|Noncompliance with study medication|1
97887|NCT01072630|368472|P3|Overall Study|Lost to Follow-up|1
97888|NCT01072630|368473|P2|Overall Study|Lost to Follow-up|11
97889|NCT01072630|368474|P1|Overall Study|Lost to Follow-up|11
97890|NCT01072630|368472|P3|Overall Study|Protocol Violation|4
97891|NCT01072630|368473|P2|Overall Study|Protocol Violation|8
97892|NCT01072630|368474|P1|Overall Study|Protocol Violation|10
97893|NCT01072630|368472|P3|Overall Study|Withdrawal by Subject|2
97894|NCT01072630|368473|P2|Overall Study|Withdrawal by Subject|7
97895|NCT01072630|368474|P1|Overall Study|Withdrawal by Subject|8
97896|NCT01072630|368472|P3|Overall Study|Lack of Efficacy|1
97897|NCT01072630|368473|P2|Overall Study|Lack of Efficacy|10
97898|NCT01072630|368474|P1|Overall Study|Lack of Efficacy|10
97899|NCT01072630|368472|P3|Overall Study|Adverse Event|2
97900|NCT01072630|368473|P2|Overall Study|Adverse Event|19
97901|NCT01072630|368474|P1|Overall Study|Adverse Event|11
97902|NCT01072539|368555|P1|Overall Study|Protocol Violation|2
97903|NCT01072539|368555|P1|Overall Study|Treated prior to the Site Initiation|1
97904|NCT01072500|368579|P2|Overall Study|Withdrawal by Subject|10
97905|NCT01072500|368580|P1|Overall Study|Withdrawal by Subject|17
97906|NCT01072500|368579|P2|Overall Study|Lost to Follow-up|2
97907|NCT01072500|368580|P1|Overall Study|Lost to Follow-up|5
97908|NCT01072500|368579|P2|Overall Study|Death|2
97909|NCT01072500|368580|P1|Overall Study|Death|2
97910|NCT01072448|368590|P2|Overall Study|Death|2
97911|NCT01072448|368591|P1|Overall Study|Death|0
97912|NCT01072448|368590|P2|Overall Study|Abnormal laboratory value(s)|1
97913|NCT01072448|368591|P1|Overall Study|Abnormal laboratory value(s)|0
97914|NCT01072448|368590|P2|Overall Study|Lost to Follow-up|1
97915|NCT01072448|368591|P1|Overall Study|Lost to Follow-up|1
97916|NCT01072448|368590|P2|Overall Study|Unsatisfactory therapeutic effect|3
97917|NCT01072448|368591|P1|Overall Study|Unsatisfactory therapeutic effect|1
97918|NCT01072448|368590|P2|Overall Study|Abnormal test procedure result(s)|0
97919|NCT01072448|368591|P1|Overall Study|Abnormal test procedure result(s)|1
97920|NCT01072448|368590|P2|Overall Study|Protocol deviation|4
97921|NCT01072448|368591|P1|Overall Study|Protocol deviation|3
97922|NCT01072448|368590|P2|Overall Study|Subject withdrew consent|9
97923|NCT01072448|368591|P1|Overall Study|Subject withdrew consent|4
97924|NCT01072448|368590|P2|Overall Study|Adverse Event|10
97925|NCT01072448|368591|P1|Overall Study|Adverse Event|9
97926|NCT01072396|368605|P2|Period Two|Lost to Follow-up|0
97927|NCT01072396|368606|P1|Period Two|Lost to Follow-up|1
97928|NCT01072396|368605|P2|Period Two|Adverse Event|3
97929|NCT01072396|368606|P1|Period Two|Adverse Event|0
97930|NCT01072396|368605|P2|Washout Period|Missing termination information|1
97931|NCT01072396|368606|P1|Washout Period|Missing termination information|0
97932|NCT01072396|368605|P2|Period One|Withdrawal by Subject|0
97933|NCT01072396|368606|P1|Period One|Withdrawal by Subject|2
97934|NCT01072396|368605|P2|Period One|Protocol Violation|1
97935|NCT01072396|368606|P1|Period One|Protocol Violation|2
97936|NCT01072396|368605|P2|Period One|Adverse Event|1
97937|NCT01072396|368606|P1|Period One|Adverse Event|1
97938|NCT01072357|368618|P2|Overall Study|Lost to Follow-up|1
97939|NCT01072357|368619|P1|Overall Study|Lost to Follow-up|0
97940|NCT01072344|368629|P2|Overall Study|Lost to Follow-up|4
97941|NCT01072344|368630|P1|Overall Study|Lost to Follow-up|3
97942|NCT01072344|368629|P2|Overall Study|Protocol Violation|2
97943|NCT01072344|368630|P1|Overall Study|Protocol Violation|1
97944|NCT01072344|368629|P2|Overall Study|Relasped-reached end point|12
97945|NCT01072344|368630|P1|Overall Study|Relasped-reached end point|7
97946|NCT01072201|368668|P2|Overall Study|Lost to Follow-up|1
97947|NCT01072201|368669|P1|Overall Study|Lost to Follow-up|0
97948|NCT01072175|368702|P13|Part D (HPMC Capsules)|Ongoing|34
97949|NCT01072175|368703|P12|Part D (HPMC Capsules)|Ongoing|34
97950|NCT01072175|368704|P11|Part D (HPMC Capsules)|Ongoing|12
97951|NCT01072175|368705|P10|Part D (HPMC Capsules)|Ongoing|10
97952|NCT01072175|368706|P9|Part D (HPMC Capsules)|Ongoing|0
97953|NCT01072175|368707|P8|Part D (HPMC Capsules)|Ongoing|0
97954|NCT01072175|368708|P7|Part D (HPMC Capsules)|Ongoing|0
97955|NCT01072175|368709|P6|Part D (HPMC Capsules)|Ongoing|0
97956|NCT01072175|368710|P5|Part D (HPMC Capsules)|Ongoing|0
97957|NCT01072175|368711|P4|Part D (HPMC Capsules)|Ongoing|0
97958|NCT01072175|368712|P3|Part D (HPMC Capsules)|Ongoing|0
97959|NCT01072175|368713|P2|Part D (HPMC Capsules)|Ongoing|0
97960|NCT01072175|368714|P1|Part D (HPMC Capsules)|Ongoing|0
97961|NCT01072175|368702|P13|Part D (HPMC Capsules)|Death|5
97962|NCT01072175|368703|P12|Part D (HPMC Capsules)|Death|6
97963|NCT01072175|368704|P11|Part D (HPMC Capsules)|Death|4
97964|NCT01072175|368705|P10|Part D (HPMC Capsules)|Death|2
97965|NCT01072175|368706|P9|Part D (HPMC Capsules)|Death|0
97966|NCT01072175|368707|P8|Part D (HPMC Capsules)|Death|0
97967|NCT01072175|368708|P7|Part D (HPMC Capsules)|Death|0
97968|NCT01072175|368709|P6|Part D (HPMC Capsules)|Death|0
97969|NCT01072175|368710|P5|Part D (HPMC Capsules)|Death|0
97970|NCT01072175|368711|P4|Part D (HPMC Capsules)|Death|0
97971|NCT01072175|368712|P3|Part D (HPMC Capsules)|Death|0
97972|NCT01072175|368713|P2|Part D (HPMC Capsules)|Death|0
97973|NCT01072175|368714|P1|Part D (HPMC Capsules)|Death|0
97974|NCT01072175|368702|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
97975|NCT01072175|368703|P12|Part D (HPMC Capsules)|Withdrawal by Subject|1
97976|NCT01072175|368704|P11|Part D (HPMC Capsules)|Withdrawal by Subject|0
97977|NCT01072175|368705|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
97978|NCT01072175|368706|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
97979|NCT01072175|368707|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
97980|NCT01072175|368708|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
97981|NCT01072175|368709|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
97982|NCT01072175|368710|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
97983|NCT01072175|368711|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
97984|NCT01072175|368712|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
97985|NCT01072175|368713|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
97986|NCT01072175|368714|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
97987|NCT01072175|368702|P13|Part D (HPMC Capsules)|Lost to Follow-up|0
97988|NCT01072175|368703|P12|Part D (HPMC Capsules)|Lost to Follow-up|2
97989|NCT01072175|368704|P11|Part D (HPMC Capsules)|Lost to Follow-up|0
97990|NCT01072175|368705|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
97991|NCT01072175|368706|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
97992|NCT01072175|368707|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
97993|NCT01072175|368708|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
97994|NCT01072175|368709|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
97995|NCT01072175|368710|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
97996|NCT01072175|368711|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
97997|NCT01072175|368712|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
97998|NCT01072175|368713|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
97999|NCT01072175|368714|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
98000|NCT01072175|368702|P13|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98001|NCT01072175|368703|P12|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98002|NCT01072175|368704|P11|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98003|NCT01072175|368705|P10|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98004|NCT01072175|368706|P9|Part C (Phase II: Crossover Phase [CP])|Ongoing|28
98005|NCT01072175|368707|P8|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98006|NCT01072175|368708|P7|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98007|NCT01072175|368709|P6|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98008|NCT01072175|368710|P5|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98009|NCT01072175|368711|P4|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98010|NCT01072175|368712|P3|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98011|NCT01072175|368713|P2|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98012|NCT01072175|368714|P1|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
98013|NCT01072175|368702|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
98014|NCT01072175|368703|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
98015|NCT01072175|368704|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
98016|NCT01072175|368705|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
98017|NCT01072175|368706|P9|Part C (Phase II: Crossover Phase [CP])|Death|15
98018|NCT01072175|368707|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
98019|NCT01072175|368708|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
98020|NCT01072175|368709|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
98021|NCT01072175|368710|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
98022|NCT01072175|368711|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
98023|NCT01072175|368712|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
98024|NCT01072175|368713|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
98025|NCT01072175|368714|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
98026|NCT01072175|368702|P13|Part C (Phase II: Randomized Phase)|Ongoing|0
98027|NCT01072175|368703|P12|Part C (Phase II: Randomized Phase)|Ongoing|0
98028|NCT01072175|368704|P11|Part C (Phase II: Randomized Phase)|Ongoing|0
98029|NCT01072175|368705|P10|Part C (Phase II: Randomized Phase)|Ongoing|0
98030|NCT01072175|368706|P9|Part C (Phase II: Randomized Phase)|Ongoing|0
98031|NCT01072175|368707|P8|Part C (Phase II: Randomized Phase)|Ongoing|40
98032|NCT01072175|368708|P7|Part C (Phase II: Randomized Phase)|Ongoing|32
98033|NCT01072175|368709|P6|Part C (Phase II: Randomized Phase)|Ongoing|35
98034|NCT01072175|368710|P5|Part C (Phase II: Randomized Phase)|Ongoing|0
98035|NCT01072175|368711|P4|Part C (Phase II: Randomized Phase)|Ongoing|0
98036|NCT01072175|368712|P3|Part C (Phase II: Randomized Phase)|Ongoing|0
98037|NCT01072175|368713|P2|Part C (Phase II: Randomized Phase)|Ongoing|0
98038|NCT01072175|368714|P1|Part C (Phase II: Randomized Phase)|Ongoing|0
98039|NCT01072175|368702|P13|Part C (Phase II: Randomized Phase)|Death|0
98040|NCT01072175|368703|P12|Part C (Phase II: Randomized Phase)|Death|0
98041|NCT01072175|368704|P11|Part C (Phase II: Randomized Phase)|Death|0
98042|NCT01072175|368705|P10|Part C (Phase II: Randomized Phase)|Death|0
98043|NCT01072175|368706|P9|Part C (Phase II: Randomized Phase)|Death|0
98044|NCT01072175|368707|P8|Part C (Phase II: Randomized Phase)|Death|14
98045|NCT01072175|368708|P7|Part C (Phase II: Randomized Phase)|Death|18
98046|NCT01072175|368709|P6|Part C (Phase II: Randomized Phase)|Death|19
98047|NCT01072175|368710|P5|Part C (Phase II: Randomized Phase)|Death|0
98048|NCT01072175|368711|P4|Part C (Phase II: Randomized Phase)|Death|0
98049|NCT01072175|368712|P3|Part C (Phase II: Randomized Phase)|Death|0
98050|NCT01072175|368713|P2|Part C (Phase II: Randomized Phase)|Death|0
98051|NCT01072175|368714|P1|Part C (Phase II: Randomized Phase)|Death|0
98052|NCT01072175|368702|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98053|NCT01072175|368703|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98054|NCT01072175|368704|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98055|NCT01072175|368705|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98056|NCT01072175|368706|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98057|NCT01072175|368707|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98058|NCT01072175|368708|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|4
98059|NCT01072175|368709|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98060|NCT01072175|368710|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98061|NCT01072175|368711|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98062|NCT01072175|368712|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98063|NCT01072175|368713|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98064|NCT01072175|368714|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
98065|NCT01072175|368702|P13|Part B (Dose Escalation and Expansion)|Ongoing|0
98066|NCT01072175|368703|P12|Part B (Dose Escalation and Expansion)|Ongoing|0
98067|NCT01072175|368704|P11|Part B (Dose Escalation and Expansion)|Ongoing|0
98068|NCT01072175|368705|P10|Part B (Dose Escalation and Expansion)|Ongoing|0
98069|NCT01072175|368706|P9|Part B (Dose Escalation and Expansion)|Ongoing|0
98070|NCT01072175|368707|P8|Part B (Dose Escalation and Expansion)|Ongoing|0
98071|NCT01072175|368708|P7|Part B (Dose Escalation and Expansion)|Ongoing|0
98072|NCT01072175|368709|P6|Part B (Dose Escalation and Expansion)|Ongoing|0
98073|NCT01072175|368710|P5|Part B (Dose Escalation and Expansion)|Ongoing|28
98074|NCT01072175|368711|P4|Part B (Dose Escalation and Expansion)|Ongoing|9
98075|NCT01072175|368712|P3|Part B (Dose Escalation and Expansion)|Ongoing|10
98076|NCT01072175|368713|P2|Part B (Dose Escalation and Expansion)|Ongoing|2
98077|NCT01072175|368714|P1|Part B (Dose Escalation and Expansion)|Ongoing|0
98078|NCT01072175|368702|P13|Part B (Dose Escalation and Expansion)|Death|0
98079|NCT01072175|368703|P12|Part B (Dose Escalation and Expansion)|Death|0
98080|NCT01072175|368704|P11|Part B (Dose Escalation and Expansion)|Death|0
98081|NCT01072175|368705|P10|Part B (Dose Escalation and Expansion)|Death|0
98082|NCT01072175|368706|P9|Part B (Dose Escalation and Expansion)|Death|0
98083|NCT01072175|368707|P8|Part B (Dose Escalation and Expansion)|Death|0
98084|NCT01072175|368708|P7|Part B (Dose Escalation and Expansion)|Death|0
98085|NCT01072175|368709|P6|Part B (Dose Escalation and Expansion)|Death|0
98086|NCT01072175|368710|P5|Part B (Dose Escalation and Expansion)|Death|36
98087|NCT01072175|368711|P4|Part B (Dose Escalation and Expansion)|Death|12
98088|NCT01072175|368712|P3|Part B (Dose Escalation and Expansion)|Death|10
98089|NCT01072175|368713|P2|Part B (Dose Escalation and Expansion)|Death|3
98090|NCT01072175|368714|P1|Part B (Dose Escalation and Expansion)|Death|0
98091|NCT01072175|368702|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98092|NCT01072175|368703|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98093|NCT01072175|368704|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98094|NCT01072175|368705|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98095|NCT01072175|368706|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98096|NCT01072175|368707|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98097|NCT01072175|368708|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98098|NCT01072175|368709|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98099|NCT01072175|368710|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
98100|NCT01072175|368711|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
98101|NCT01072175|368712|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98102|NCT01072175|368713|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98103|NCT01072175|368714|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
98104|NCT01072175|368702|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
98105|NCT01072175|368703|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
98106|NCT01072175|368704|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
98107|NCT01072175|368705|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
98108|NCT01072175|368706|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
98109|NCT01072175|368707|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
98110|NCT01072175|368708|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
98111|NCT01072175|368709|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
98112|NCT01072175|368710|P5|Part B (Dose Escalation and Expansion)|Physician Decision|13
98113|NCT01072175|368711|P4|Part B (Dose Escalation and Expansion)|Physician Decision|4
98114|NCT01072175|368712|P3|Part B (Dose Escalation and Expansion)|Physician Decision|3
98115|NCT01072175|368713|P2|Part B (Dose Escalation and Expansion)|Physician Decision|1
98116|NCT01072175|368714|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
98117|NCT01072175|368702|P13|Part A (Drug-Drug Interaction)|Death|0
98118|NCT01072175|368703|P12|Part A (Drug-Drug Interaction)|Death|0
98119|NCT01072175|368704|P11|Part A (Drug-Drug Interaction)|Death|0
98120|NCT01072175|368705|P10|Part A (Drug-Drug Interaction)|Death|0
98121|NCT01072175|368706|P9|Part A (Drug-Drug Interaction)|Death|0
98122|NCT01072175|368707|P8|Part A (Drug-Drug Interaction)|Death|0
98123|NCT01072175|368708|P7|Part A (Drug-Drug Interaction)|Death|0
98124|NCT01072175|368709|P6|Part A (Drug-Drug Interaction)|Death|0
98125|NCT01072175|368710|P5|Part A (Drug-Drug Interaction)|Death|0
98126|NCT01072175|368711|P4|Part A (Drug-Drug Interaction)|Death|0
98127|NCT01072175|368712|P3|Part A (Drug-Drug Interaction)|Death|0
98128|NCT01072175|368713|P2|Part A (Drug-Drug Interaction)|Death|0
98129|NCT01072175|368714|P1|Part A (Drug-Drug Interaction)|Death|1
98130|NCT01072175|368702|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98131|NCT01072175|368703|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98132|NCT01072175|368704|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98133|NCT01072175|368705|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98134|NCT01072175|368706|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98135|NCT01072175|368707|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98136|NCT01072175|368708|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98137|NCT01072175|368709|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98138|NCT01072175|368710|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98139|NCT01072175|368711|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98140|NCT01072175|368712|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98141|NCT01072175|368713|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
98142|NCT01072175|368714|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
98143|NCT01072175|368702|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
98144|NCT01072175|368703|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
98145|NCT01072175|368704|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
98146|NCT01072175|368705|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
98147|NCT01072175|368706|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
98148|NCT01072175|368707|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
98149|NCT01072175|368708|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
98150|NCT01072175|368709|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
98151|NCT01072175|368710|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
98152|NCT01072175|368711|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
98153|NCT01072175|368712|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
98154|NCT01072175|368713|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
98155|NCT01072175|368714|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
98156|NCT01072149|368897|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98157|NCT01072149|368898|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98158|NCT01072149|368899|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98159|NCT01072149|368900|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98160|NCT01072149|368901|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
98161|NCT01072149|368902|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98162|NCT01072149|368903|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98163|NCT01072149|368904|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98164|NCT01072149|368905|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98165|NCT01072149|368906|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98166|NCT01072149|368907|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98167|NCT01072149|368908|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98168|NCT01072149|368909|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98169|NCT01072149|368910|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98170|NCT01072149|368911|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98171|NCT01072149|368912|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
98172|NCT01072149|368913|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98173|NCT01072149|368914|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
98174|NCT01072149|368897|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
98175|NCT01072149|368898|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
98176|NCT01072149|368899|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
98177|NCT01072149|368900|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
98178|NCT01072149|368901|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
98179|NCT01072149|368902|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
98180|NCT01072149|368903|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
98181|NCT01072149|368904|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
98182|NCT01072149|368905|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
98183|NCT01072149|368906|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
98184|NCT01072149|368907|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
98185|NCT01072149|368908|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
98186|NCT01072149|368909|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
98187|NCT01072149|368910|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
98188|NCT01072149|368911|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
98189|NCT01072149|368912|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
98190|NCT01072149|368913|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
98191|NCT01072149|368914|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
98192|NCT01072149|368897|P18|Washout Period 2 (14 Days)|Adverse Event|0
98193|NCT01072149|368898|P17|Washout Period 2 (14 Days)|Adverse Event|0
98194|NCT01072149|368899|P16|Washout Period 2 (14 Days)|Adverse Event|1
98195|NCT01072149|368900|P15|Washout Period 2 (14 Days)|Adverse Event|0
98196|NCT01072149|368901|P14|Washout Period 2 (14 Days)|Adverse Event|0
98197|NCT01072149|368902|P13|Washout Period 2 (14 Days)|Adverse Event|0
98198|NCT01072149|368903|P12|Washout Period 2 (14 Days)|Adverse Event|0
98199|NCT01072149|368904|P11|Washout Period 2 (14 Days)|Adverse Event|0
98200|NCT01072149|368905|P10|Washout Period 2 (14 Days)|Adverse Event|0
98201|NCT01072149|368906|P9|Washout Period 2 (14 Days)|Adverse Event|0
98202|NCT01072149|368907|P8|Washout Period 2 (14 Days)|Adverse Event|0
98203|NCT01072149|368908|P7|Washout Period 2 (14 Days)|Adverse Event|0
98204|NCT01072149|368909|P6|Washout Period 2 (14 Days)|Adverse Event|0
98205|NCT01072149|368910|P5|Washout Period 2 (14 Days)|Adverse Event|0
98206|NCT01072149|368911|P4|Washout Period 2 (14 Days)|Adverse Event|0
98207|NCT01072149|368912|P3|Washout Period 2 (14 Days)|Adverse Event|0
98208|NCT01072149|368913|P2|Washout Period 2 (14 Days)|Adverse Event|0
98209|NCT01072149|368914|P1|Washout Period 2 (14 Days)|Adverse Event|0
98210|NCT01072149|368897|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98211|NCT01072149|368898|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98212|NCT01072149|368899|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
98213|NCT01072149|368900|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98214|NCT01072149|368901|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98215|NCT01072149|368902|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98216|NCT01072149|368903|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98217|NCT01072149|368904|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98218|NCT01072149|368905|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98219|NCT01072149|368906|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98220|NCT01072149|368907|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98221|NCT01072149|368908|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98222|NCT01072149|368909|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98223|NCT01072149|368910|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98224|NCT01072149|368911|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98225|NCT01072149|368912|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98226|NCT01072149|368913|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98227|NCT01072149|368914|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
98228|NCT01072149|368897|P18|Washout Period 2 (14 Days)|Physician Decision|0
98229|NCT01072149|368898|P17|Washout Period 2 (14 Days)|Physician Decision|0
98230|NCT01072149|368899|P16|Washout Period 2 (14 Days)|Physician Decision|0
98231|NCT01072149|368900|P15|Washout Period 2 (14 Days)|Physician Decision|0
98232|NCT01072149|368901|P14|Washout Period 2 (14 Days)|Physician Decision|0
98233|NCT01072149|368902|P13|Washout Period 2 (14 Days)|Physician Decision|0
98234|NCT01072149|368903|P12|Washout Period 2 (14 Days)|Physician Decision|0
98235|NCT01072149|368904|P11|Washout Period 2 (14 Days)|Physician Decision|0
98236|NCT01072149|368905|P10|Washout Period 2 (14 Days)|Physician Decision|0
98237|NCT01072149|368906|P9|Washout Period 2 (14 Days)|Physician Decision|0
98238|NCT01072149|368907|P8|Washout Period 2 (14 Days)|Physician Decision|0
98239|NCT01072149|368908|P7|Washout Period 2 (14 Days)|Physician Decision|0
98240|NCT01072149|368909|P6|Washout Period 2 (14 Days)|Physician Decision|0
98241|NCT01072149|368910|P5|Washout Period 2 (14 Days)|Physician Decision|0
98242|NCT01072149|368911|P4|Washout Period 2 (14 Days)|Physician Decision|0
98243|NCT01072149|368912|P3|Washout Period 2 (14 Days)|Physician Decision|0
98244|NCT01072149|368913|P2|Washout Period 2 (14 Days)|Physician Decision|0
98245|NCT01072149|368914|P1|Washout Period 2 (14 Days)|Physician Decision|1
98246|NCT01072149|368897|P18|Treatment Period 2 (28 Days)|Physician Decision|0
98247|NCT01072149|368898|P17|Treatment Period 2 (28 Days)|Physician Decision|0
98248|NCT01072149|368899|P16|Treatment Period 2 (28 Days)|Physician Decision|0
98249|NCT01072149|368900|P15|Treatment Period 2 (28 Days)|Physician Decision|0
98250|NCT01072149|368901|P14|Treatment Period 2 (28 Days)|Physician Decision|0
98251|NCT01072149|368902|P13|Treatment Period 2 (28 Days)|Physician Decision|0
98252|NCT01072149|368903|P12|Treatment Period 2 (28 Days)|Physician Decision|0
98253|NCT01072149|368904|P11|Treatment Period 2 (28 Days)|Physician Decision|0
98254|NCT01072149|368905|P10|Treatment Period 2 (28 Days)|Physician Decision|0
98255|NCT01072149|368906|P9|Treatment Period 2 (28 Days)|Physician Decision|0
98256|NCT01072149|368907|P8|Treatment Period 2 (28 Days)|Physician Decision|1
98257|NCT01072149|368908|P7|Treatment Period 2 (28 Days)|Physician Decision|0
98258|NCT01072149|368909|P6|Treatment Period 2 (28 Days)|Physician Decision|0
98259|NCT01072149|368910|P5|Treatment Period 2 (28 Days)|Physician Decision|0
98260|NCT01072149|368911|P4|Treatment Period 2 (28 Days)|Physician Decision|0
98261|NCT01072149|368912|P3|Treatment Period 2 (28 Days)|Physician Decision|0
98262|NCT01072149|368913|P2|Treatment Period 2 (28 Days)|Physician Decision|0
98263|NCT01072149|368914|P1|Treatment Period 2 (28 Days)|Physician Decision|0
98264|NCT01072149|368897|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98265|NCT01072149|368898|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98266|NCT01072149|368899|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98267|NCT01072149|368900|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98268|NCT01072149|368901|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98269|NCT01072149|368902|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98270|NCT01072149|368903|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98271|NCT01072149|368904|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98272|NCT01072149|368905|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98273|NCT01072149|368906|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98274|NCT01072149|368907|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98275|NCT01072149|368908|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98276|NCT01072149|368909|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98277|NCT01072149|368910|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98278|NCT01072149|368911|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98279|NCT01072149|368912|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
98280|NCT01072149|368913|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98281|NCT01072149|368914|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
98282|NCT01072149|368897|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98283|NCT01072149|368898|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98284|NCT01072149|368899|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98285|NCT01072149|368900|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98286|NCT01072149|368901|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98287|NCT01072149|368902|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98288|NCT01072149|368903|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98289|NCT01072149|368904|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98290|NCT01072149|368905|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98291|NCT01072149|368906|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98292|NCT01072149|368907|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98293|NCT01072149|368908|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98294|NCT01072149|368909|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98295|NCT01072149|368910|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98296|NCT01072149|368911|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98297|NCT01072149|368912|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98298|NCT01072149|368913|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
98299|NCT01072149|368914|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
98300|NCT01072149|368897|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98301|NCT01072149|368898|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98302|NCT01072149|368899|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98303|NCT01072149|368900|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98304|NCT01072149|368901|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98305|NCT01072149|368902|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98306|NCT01072149|368903|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98307|NCT01072149|368904|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
98308|NCT01072149|368905|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98309|NCT01072149|368906|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98310|NCT01072149|368907|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98311|NCT01072149|368908|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98312|NCT01072149|368909|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98313|NCT01072149|368910|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98314|NCT01072149|368911|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98315|NCT01072149|368912|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98316|NCT01072149|368913|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98317|NCT01072149|368914|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
98318|NCT01072149|368897|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
98319|NCT01072149|368898|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
98320|NCT01072149|368899|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
98321|NCT01072149|368900|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
98322|NCT01072149|368901|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
98323|NCT01072149|368902|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
98324|NCT01072149|368903|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
98325|NCT01072149|368904|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
98326|NCT01072149|368905|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
98327|NCT01072149|368906|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
98328|NCT01072149|368907|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
98329|NCT01072149|368908|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
98330|NCT01072149|368909|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
98331|NCT01072149|368910|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
98332|NCT01072149|368911|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
98333|NCT01072149|368912|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
98334|NCT01072149|368913|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
98335|NCT01072149|368914|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
98336|NCT01072149|368897|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98337|NCT01072149|368898|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98338|NCT01072149|368899|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98339|NCT01072149|368900|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98340|NCT01072149|368901|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98341|NCT01072149|368902|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98342|NCT01072149|368903|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98343|NCT01072149|368904|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98344|NCT01072149|368905|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98345|NCT01072149|368906|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98346|NCT01072149|368907|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98347|NCT01072149|368908|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98348|NCT01072149|368909|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98349|NCT01072149|368910|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98350|NCT01072149|368911|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98351|NCT01072149|368912|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
98352|NCT01072149|368913|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98353|NCT01072149|368914|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
98354|NCT01071915|369003|P1|Overall Study|Miscellaneous Reasons|2
98355|NCT01071915|369003|P1|Overall Study|Withdrawal by Subject|2
98356|NCT01071915|369003|P1|Overall Study|Physician Decision|2
98357|NCT01071915|369003|P1|Overall Study|Adverse Event|3
98358|NCT01071798|369013|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
98359|NCT01071798|369013|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
98360|NCT01071798|369013|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
98361|NCT01071798|369013|P1|Subpopulation Who Received Two Cycles|Remission|1
98362|NCT01071798|369013|P1|Participants Who Received One Cycle|Severe concomitant disease|2
98363|NCT01071798|369013|P1|Participants Who Received One Cycle|Change of therapy|6
98364|NCT01071798|369013|P1|Participants Who Received One Cycle|Death|5
98365|NCT01071798|369013|P1|Participants Who Received One Cycle|Patient requirement|20
98366|NCT01071798|369013|P1|Participants Who Received One Cycle|Lack of tolerability|14
98367|NCT01071798|369013|P1|Participants Who Received One Cycle|Lack of Efficacy|18
98368|NCT01071512|369043|P1|Overall Study|positive anti-JC virus antibody test|2
98369|NCT01071512|369043|P1|Overall Study|Development of antibodies to drug|2
98370|NCT01071512|369043|P1|Overall Study|Adverse Event|1
98371|NCT01071395|369053|P2|Overall Study|Adverse Event|1
98372|NCT01071395|369054|P1|Overall Study|Adverse Event|3
98373|NCT01071395|369053|P2|Overall Study|Withdrawal by Subject|1
98374|NCT01071395|369054|P1|Overall Study|Withdrawal by Subject|2
98375|NCT01071278|369071|P1|Overall Study|Completion Status Unknown|459
98376|NCT01071278|369071|P1|Overall Study|Premature Discontinuation|254
98377|NCT01071252|369082|P5|Overall Study|Death|1
98378|NCT01071252|369083|P4|Overall Study|Death|0
98379|NCT01071252|369084|P3|Overall Study|Death|0
98380|NCT01071252|369085|P2|Overall Study|Death|0
98381|NCT01071252|369086|P1|Overall Study|Death|0
98382|NCT01071252|369082|P5|Overall Study|Adverse Event|0
98383|NCT01071252|369083|P4|Overall Study|Adverse Event|1
98384|NCT01071252|369084|P3|Overall Study|Adverse Event|0
98385|NCT01071252|369085|P2|Overall Study|Adverse Event|1
98386|NCT01071252|369086|P1|Overall Study|Adverse Event|1
98387|NCT01071252|369082|P5|Overall Study|Lost to Follow-up|0
98388|NCT01071252|369083|P4|Overall Study|Lost to Follow-up|2
98389|NCT01071252|369084|P3|Overall Study|Lost to Follow-up|1
98390|NCT01071252|369085|P2|Overall Study|Lost to Follow-up|0
98391|NCT01071252|369086|P1|Overall Study|Lost to Follow-up|1
98392|NCT01071252|369082|P5|Overall Study|administrative problems|1
98393|NCT01071252|369083|P4|Overall Study|administrative problems|2
98394|NCT01071252|369084|P3|Overall Study|administrative problems|0
98395|NCT01071252|369085|P2|Overall Study|administrative problems|1
98396|NCT01071252|369086|P1|Overall Study|administrative problems|1
98397|NCT01071252|369082|P5|Overall Study|Withdrawal by Subject|3
98398|NCT01071252|369083|P4|Overall Study|Withdrawal by Subject|2
98399|NCT01071252|369084|P3|Overall Study|Withdrawal by Subject|1
98400|NCT01071252|369085|P2|Overall Study|Withdrawal by Subject|2
98401|NCT01071252|369086|P1|Overall Study|Withdrawal by Subject|8
98402|NCT01071252|369082|P5|Overall Study|unsatisfactory therapeutic effect|6
98403|NCT01071252|369083|P4|Overall Study|unsatisfactory therapeutic effect|0
98404|NCT01071252|369084|P3|Overall Study|unsatisfactory therapeutic effect|2
98405|NCT01071252|369085|P2|Overall Study|unsatisfactory therapeutic effect|6
98406|NCT01071252|369086|P1|Overall Study|unsatisfactory therapeutic effect|4
98407|NCT01071200|369114|P2|Overall Study|No viable embryos|1
98408|NCT01071200|369115|P1|Overall Study|No viable embryos|0
98409|NCT01071200|369114|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
98410|NCT01071200|369115|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
98411|NCT01071200|369114|P2|Overall Study|No oocytes retrieved|1
98412|NCT01071200|369115|P1|Overall Study|No oocytes retrieved|1
98413|NCT01071200|369114|P2|Overall Study|No fertilization|0
98414|NCT01071200|369115|P1|Overall Study|No fertilization|4
98415|NCT01071200|369114|P2|Overall Study|Lack of ovarian response|1
98416|NCT01071200|369115|P1|Overall Study|Lack of ovarian response|1
98417|NCT01071096|369147|P2|First Intervention (90 Days)|Lost to Follow-up|0
98418|NCT01071096|369148|P1|First Intervention (90 Days)|Lost to Follow-up|1
98419|NCT01071083|369172|P5|Overall Study|Subject Refused to Continue|0
98420|NCT01071083|369173|P4|Overall Study|Subject Refused to Continue|0
98421|NCT01071083|369174|P3|Overall Study|Subject Refused to Continue|0
98422|NCT01071083|369175|P2|Overall Study|Subject Refused to Continue|0
98423|NCT01071083|369176|P1|Overall Study|Subject Refused to Continue|1
98424|NCT01071083|369172|P5|Overall Study|Did Not Want Per Protocol Treatment|1
98425|NCT01071083|369173|P4|Overall Study|Did Not Want Per Protocol Treatment|0
98426|NCT01071083|369174|P3|Overall Study|Did Not Want Per Protocol Treatment|1
98427|NCT01071083|369175|P2|Overall Study|Did Not Want Per Protocol Treatment|0
98428|NCT01071083|369176|P1|Overall Study|Did Not Want Per Protocol Treatment|0
98429|NCT01071083|369172|P5|Overall Study|Did Not Meet Eligibility Criteria|1
98430|NCT01071083|369173|P4|Overall Study|Did Not Meet Eligibility Criteria|1
98431|NCT01071083|369174|P3|Overall Study|Did Not Meet Eligibility Criteria|1
98432|NCT01071083|369175|P2|Overall Study|Did Not Meet Eligibility Criteria|0
98433|NCT01071083|369176|P1|Overall Study|Did Not Meet Eligibility Criteria|0
98434|NCT01071083|369172|P5|Overall Study|Images Not Usable (Motion)|0
98435|NCT01071083|369173|P4|Overall Study|Images Not Usable (Motion)|0
98436|NCT01071083|369174|P3|Overall Study|Images Not Usable (Motion)|0
98437|NCT01071083|369175|P2|Overall Study|Images Not Usable (Motion)|1
98438|NCT01071083|369176|P1|Overall Study|Images Not Usable (Motion)|0
98439|NCT01071083|369172|P5|Overall Study|Subject Moved|0
98440|NCT01071083|369173|P4|Overall Study|Subject Moved|0
98441|NCT01071083|369174|P3|Overall Study|Subject Moved|0
98442|NCT01071083|369175|P2|Overall Study|Subject Moved|1
98443|NCT01071083|369176|P1|Overall Study|Subject Moved|0
98444|NCT01071083|369172|P5|Overall Study|Early Rescue|1
98445|NCT01071083|369173|P4|Overall Study|Early Rescue|0
98446|NCT01071083|369174|P3|Overall Study|Early Rescue|0
98447|NCT01071083|369175|P2|Overall Study|Early Rescue|0
98448|NCT01071083|369176|P1|Overall Study|Early Rescue|1
98449|NCT01071083|369172|P5|Overall Study|Physician Decision|1
98450|NCT01071083|369173|P4|Overall Study|Physician Decision|1
98451|NCT01071083|369174|P3|Overall Study|Physician Decision|0
98452|NCT01071083|369175|P2|Overall Study|Physician Decision|0
98453|NCT01071083|369176|P1|Overall Study|Physician Decision|1
98454|NCT01071083|369172|P5|Overall Study|Withdrawal by Subject|3
98455|NCT01071083|369173|P4|Overall Study|Withdrawal by Subject|0
98456|NCT01071083|369174|P3|Overall Study|Withdrawal by Subject|2
98457|NCT01071083|369175|P2|Overall Study|Withdrawal by Subject|0
98458|NCT01071083|369176|P1|Overall Study|Withdrawal by Subject|3
98459|NCT01071083|369172|P5|Overall Study|Adverse Event|1
98460|NCT01071083|369173|P4|Overall Study|Adverse Event|0
98461|NCT01071083|369174|P3|Overall Study|Adverse Event|1
98462|NCT01071083|369175|P2|Overall Study|Adverse Event|0
98463|NCT01071083|369176|P1|Overall Study|Adverse Event|1
98464|NCT01071070|369195|P2|Overall Study|Hypercalcemia|0
98465|NCT01071070|369196|P1|Overall Study|Hypercalcemia|1
98466|NCT01071070|369195|P2|Overall Study|Missed 3 consecutive doses of study drug|0
98467|NCT01071070|369196|P1|Overall Study|Missed 3 consecutive doses of study drug|2
98468|NCT01071070|369195|P2|Overall Study|Withdrawal by Subject|0
98469|NCT01071070|369196|P1|Overall Study|Withdrawal by Subject|1
98470|NCT01071070|369195|P2|Overall Study|Adverse Event|3
98471|NCT01071070|369196|P1|Overall Study|Adverse Event|0
98472|NCT01070979|369242|P3|Overall Study|No study drug taken|0
98473|NCT01070979|369243|P2|Overall Study|No study drug taken|1
98474|NCT01070979|369244|P1|Overall Study|No study drug taken|0
98475|NCT01070979|369242|P3|Overall Study|Withdrawal by Subject|1
98476|NCT01070979|369243|P2|Overall Study|Withdrawal by Subject|1
98477|NCT01070979|369244|P1|Overall Study|Withdrawal by Subject|3
98478|NCT01070979|369242|P3|Overall Study|Surgery, moving, personal, abn. labs|2
98479|NCT01070979|369243|P2|Overall Study|Surgery, moving, personal, abn. labs|4
98480|NCT01070979|369244|P1|Overall Study|Surgery, moving, personal, abn. labs|4
98481|NCT01070979|369242|P3|Overall Study|Protocol Violation|6
98482|NCT01070979|369243|P2|Overall Study|Protocol Violation|2
98483|NCT01070979|369244|P1|Overall Study|Protocol Violation|0
98484|NCT01070979|369242|P3|Overall Study|Lost to Follow-up|1
98485|NCT01070979|369243|P2|Overall Study|Lost to Follow-up|1
98486|NCT01070979|369244|P1|Overall Study|Lost to Follow-up|2
98487|NCT01070979|369242|P3|Overall Study|Adverse Event|3
98488|NCT01070979|369243|P2|Overall Study|Adverse Event|3
98489|NCT01070979|369244|P1|Overall Study|Adverse Event|2
98490|NCT01070966|369270|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
98491|NCT01070966|369270|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
98492|NCT01070966|369270|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
98493|NCT01070966|369270|P1|Participants for Safety Evaluation|TMT given before date of contract|3
98494|NCT01070966|369270|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
98495|NCT01070966|369270|P1|Participants for Safety Evaluation|Duplicate Participants|4
98496|NCT01070966|369270|P1|Participants for Safety Evaluation|Off-label use|9
98497|NCT01070966|369270|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
98498|NCT01070953|369281|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
98499|NCT01070953|369281|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
98500|NCT01070953|369281|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
98501|NCT01070953|369281|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
98502|NCT01070953|369281|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
98503|NCT01070953|369281|P1|Participants for Safety Evaluation|Uncontracted participants|4
98504|NCT01070953|369281|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
98505|NCT01070953|369281|P1|Participants for Safety Evaluation|Duplicated participants|22
98506|NCT01070953|369281|P1|Participants for Safety Evaluation|Off-label use|283
98596|NCT01070550|369433|P2|Overall Study|Relapse|5
98507|NCT01070953|369281|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
98508|NCT01070888|369294|P2|Washout (14 Days)|Physician Decision|0
98509|NCT01070888|369295|P1|Washout (14 Days)|Physician Decision|1
98510|NCT01070888|369294|P2|First Intervention (14 Days)|Lost to Follow-up|1
98511|NCT01070888|369295|P1|First Intervention (14 Days)|Lost to Follow-up|0
98512|NCT01070888|369294|P2|First Intervention (14 Days)|Adverse Event|1
98513|NCT01070888|369295|P1|First Intervention (14 Days)|Adverse Event|0
98514|NCT01070784|369320|P2|Overall Study|Adverse Event|9
98515|NCT01070784|369321|P1|Overall Study|Adverse Event|14
98516|NCT01070784|369320|P2|Overall Study|Withdrawal by Subject|9
98517|NCT01070784|369321|P1|Overall Study|Withdrawal by Subject|6
98518|NCT01070771|369409|P1|Overall Study|Protocol Violation|1
98519|NCT01070771|369409|P1|Overall Study|Adverse Event|2
98520|NCT01070550|369429|P6|Overall Study|Withdrawal by Subject|0
98521|NCT01070550|369430|P5|Overall Study|Withdrawal by Subject|0
98522|NCT01070550|369431|P4|Overall Study|Withdrawal by Subject|0
98523|NCT01070550|369432|P3|Overall Study|Withdrawal by Subject|3
98524|NCT01070550|369433|P2|Overall Study|Withdrawal by Subject|0
98525|NCT01070550|369434|P1|Overall Study|Withdrawal by Subject|35
98526|NCT01070550|369429|P6|Overall Study|Other|0
98527|NCT01070550|369430|P5|Overall Study|Other|0
98528|NCT01070550|369431|P4|Overall Study|Other|1
98529|NCT01070550|369432|P3|Overall Study|Other|0
98530|NCT01070550|369433|P2|Overall Study|Other|0
98531|NCT01070550|369434|P1|Overall Study|Other|5
98532|NCT01070550|369429|P6|Overall Study|Treatment was stopped early|0
98533|NCT01070550|369430|P5|Overall Study|Treatment was stopped early|0
98534|NCT01070550|369431|P4|Overall Study|Treatment was stopped early|0
98535|NCT01070550|369432|P3|Overall Study|Treatment was stopped early|0
98536|NCT01070550|369433|P2|Overall Study|Treatment was stopped early|0
98537|NCT01070550|369434|P1|Overall Study|Treatment was stopped early|7
98538|NCT01070550|369429|P6|Overall Study|Treatment unavailable|0
98539|NCT01070550|369430|P5|Overall Study|Treatment unavailable|0
98540|NCT01070550|369431|P4|Overall Study|Treatment unavailable|0
98541|NCT01070550|369432|P3|Overall Study|Treatment unavailable|0
98542|NCT01070550|369433|P2|Overall Study|Treatment unavailable|0
98543|NCT01070550|369434|P1|Overall Study|Treatment unavailable|1
98544|NCT01070550|369429|P6|Overall Study|Treatment stopped|0
98545|NCT01070550|369430|P5|Overall Study|Treatment stopped|0
98546|NCT01070550|369431|P4|Overall Study|Treatment stopped|0
98547|NCT01070550|369432|P3|Overall Study|Treatment stopped|0
98548|NCT01070550|369433|P2|Overall Study|Treatment stopped|0
98549|NCT01070550|369434|P1|Overall Study|Treatment stopped|3
98550|NCT01070550|369429|P6|Overall Study|Treatment restarted|0
98551|NCT01070550|369430|P5|Overall Study|Treatment restarted|0
98552|NCT01070550|369431|P4|Overall Study|Treatment restarted|0
98553|NCT01070550|369432|P3|Overall Study|Treatment restarted|0
98554|NCT01070550|369433|P2|Overall Study|Treatment restarted|1
98555|NCT01070550|369434|P1|Overall Study|Treatment restarted|0
98556|NCT01070550|369429|P6|Overall Study|Treatment not started|0
98557|NCT01070550|369430|P5|Overall Study|Treatment not started|0
98558|NCT01070550|369431|P4|Overall Study|Treatment not started|0
98559|NCT01070550|369432|P3|Overall Study|Treatment not started|4
98560|NCT01070550|369433|P2|Overall Study|Treatment not started|2
98561|NCT01070550|369434|P1|Overall Study|Treatment not started|14
98562|NCT01070550|369429|P6|Overall Study|Treatment interrupted|0
98563|NCT01070550|369430|P5|Overall Study|Treatment interrupted|0
98564|NCT01070550|369431|P4|Overall Study|Treatment interrupted|1
98565|NCT01070550|369432|P3|Overall Study|Treatment interrupted|1
98566|NCT01070550|369433|P2|Overall Study|Treatment interrupted|0
98567|NCT01070550|369434|P1|Overall Study|Treatment interrupted|7
98568|NCT01070550|369429|P6|Overall Study|Treatment duration shortened|0
98569|NCT01070550|369430|P5|Overall Study|Treatment duration shortened|0
98570|NCT01070550|369431|P4|Overall Study|Treatment duration shortened|0
98571|NCT01070550|369432|P3|Overall Study|Treatment duration shortened|0
98572|NCT01070550|369433|P2|Overall Study|Treatment duration shortened|0
98573|NCT01070550|369434|P1|Overall Study|Treatment duration shortened|1
98574|NCT01070550|369429|P6|Overall Study|Sponsor decision|0
98575|NCT01070550|369430|P5|Overall Study|Sponsor decision|0
98576|NCT01070550|369431|P4|Overall Study|Sponsor decision|0
98577|NCT01070550|369432|P3|Overall Study|Sponsor decision|0
98578|NCT01070550|369433|P2|Overall Study|Sponsor decision|0
98579|NCT01070550|369434|P1|Overall Study|Sponsor decision|1
98580|NCT01070550|369429|P6|Overall Study|Screen failure|0
98581|NCT01070550|369430|P5|Overall Study|Screen failure|0
98582|NCT01070550|369431|P4|Overall Study|Screen failure|0
98583|NCT01070550|369432|P3|Overall Study|Screen failure|0
98584|NCT01070550|369433|P2|Overall Study|Screen failure|0
98585|NCT01070550|369434|P1|Overall Study|Screen failure|1
98586|NCT01070550|369429|P6|Overall Study|Result not available|0
98587|NCT01070550|369430|P5|Overall Study|Result not available|0
98588|NCT01070550|369431|P4|Overall Study|Result not available|0
98589|NCT01070550|369432|P3|Overall Study|Result not available|3
98590|NCT01070550|369433|P2|Overall Study|Result not available|1
98591|NCT01070550|369434|P1|Overall Study|Result not available|3
98592|NCT01070550|369429|P6|Overall Study|Relapse|0
98593|NCT01070550|369430|P5|Overall Study|Relapse|0
98594|NCT01070550|369431|P4|Overall Study|Relapse|4
98595|NCT01070550|369432|P3|Overall Study|Relapse|14
98597|NCT01070550|369434|P1|Overall Study|Relapse|44
98598|NCT01070550|369429|P6|Overall Study|Protocol Violation|0
98599|NCT01070550|369430|P5|Overall Study|Protocol Violation|0
98600|NCT01070550|369431|P4|Overall Study|Protocol Violation|1
98601|NCT01070550|369432|P3|Overall Study|Protocol Violation|1
98602|NCT01070550|369433|P2|Overall Study|Protocol Violation|1
98603|NCT01070550|369434|P1|Overall Study|Protocol Violation|15
98604|NCT01070550|369429|P6|Overall Study|Not categorized|1
98605|NCT01070550|369430|P5|Overall Study|Not categorized|0
98606|NCT01070550|369431|P4|Overall Study|Not categorized|1
98607|NCT01070550|369432|P3|Overall Study|Not categorized|6
98608|NCT01070550|369433|P2|Overall Study|Not categorized|2
98609|NCT01070550|369434|P1|Overall Study|Not categorized|33
98610|NCT01070550|369429|P6|Overall Study|Non-responders|2
98611|NCT01070550|369430|P5|Overall Study|Non-responders|0
98612|NCT01070550|369431|P4|Overall Study|Non-responders|20
98613|NCT01070550|369432|P3|Overall Study|Non-responders|21
98614|NCT01070550|369433|P2|Overall Study|Non-responders|4
98615|NCT01070550|369434|P1|Overall Study|Non-responders|493
98616|NCT01070550|369429|P6|Overall Study|New treatment started|0
98617|NCT01070550|369430|P5|Overall Study|New treatment started|0
98618|NCT01070550|369431|P4|Overall Study|New treatment started|2
98619|NCT01070550|369432|P3|Overall Study|New treatment started|0
98620|NCT01070550|369433|P2|Overall Study|New treatment started|1
98621|NCT01070550|369434|P1|Overall Study|New treatment started|3
98622|NCT01070550|369429|P6|Overall Study|Miscellaneous|0
98623|NCT01070550|369430|P5|Overall Study|Miscellaneous|0
98624|NCT01070550|369431|P4|Overall Study|Miscellaneous|1
98625|NCT01070550|369432|P3|Overall Study|Miscellaneous|3
98626|NCT01070550|369433|P2|Overall Study|Miscellaneous|2
98627|NCT01070550|369434|P1|Overall Study|Miscellaneous|12
98628|NCT01070550|369429|P6|Overall Study|Lack of Efficacy|1
98629|NCT01070550|369430|P5|Overall Study|Lack of Efficacy|0
98630|NCT01070550|369431|P4|Overall Study|Lack of Efficacy|5
98631|NCT01070550|369432|P3|Overall Study|Lack of Efficacy|5
98632|NCT01070550|369433|P2|Overall Study|Lack of Efficacy|1
98633|NCT01070550|369434|P1|Overall Study|Lack of Efficacy|65
98634|NCT01070550|369429|P6|Overall Study|Lab test not done|1
98635|NCT01070550|369430|P5|Overall Study|Lab test not done|0
98636|NCT01070550|369431|P4|Overall Study|Lab test not done|1
98637|NCT01070550|369432|P3|Overall Study|Lab test not done|4
98638|NCT01070550|369433|P2|Overall Study|Lab test not done|3
98639|NCT01070550|369434|P1|Overall Study|Lab test not done|22
98640|NCT01070550|369429|P6|Overall Study|Incomplete treatment|0
98641|NCT01070550|369430|P5|Overall Study|Incomplete treatment|0
98642|NCT01070550|369431|P4|Overall Study|Incomplete treatment|0
98643|NCT01070550|369432|P3|Overall Study|Incomplete treatment|0
98644|NCT01070550|369433|P2|Overall Study|Incomplete treatment|0
98645|NCT01070550|369434|P1|Overall Study|Incomplete treatment|2
98646|NCT01070550|369429|P6|Overall Study|Failed to return|2
98647|NCT01070550|369430|P5|Overall Study|Failed to return|1
98648|NCT01070550|369431|P4|Overall Study|Failed to return|40
98649|NCT01070550|369432|P3|Overall Study|Failed to return|144
98650|NCT01070550|369433|P2|Overall Study|Failed to return|33
98651|NCT01070550|369434|P1|Overall Study|Failed to return|450
98652|NCT01070550|369429|P6|Overall Study|Early termination|0
98653|NCT01070550|369430|P5|Overall Study|Early termination|0
98654|NCT01070550|369431|P4|Overall Study|Early termination|0
98655|NCT01070550|369432|P3|Overall Study|Early termination|0
98656|NCT01070550|369433|P2|Overall Study|Early termination|0
98657|NCT01070550|369434|P1|Overall Study|Early termination|3
98658|NCT01070550|369429|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
98659|NCT01070550|369430|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
98660|NCT01070550|369431|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
98661|NCT01070550|369432|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
98662|NCT01070550|369433|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
98663|NCT01070550|369434|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
98664|NCT01070550|369429|P6|Overall Study|Death|0
98665|NCT01070550|369430|P5|Overall Study|Death|0
98666|NCT01070550|369431|P4|Overall Study|Death|0
98667|NCT01070550|369432|P3|Overall Study|Death|3
98668|NCT01070550|369433|P2|Overall Study|Death|4
98669|NCT01070550|369434|P1|Overall Study|Death|20
98670|NCT01070550|369429|P6|Overall Study|Adverse Event|0
98671|NCT01070550|369430|P5|Overall Study|Adverse Event|0
98672|NCT01070550|369431|P4|Overall Study|Adverse Event|0
98673|NCT01070550|369432|P3|Overall Study|Adverse Event|3
98674|NCT01070550|369433|P2|Overall Study|Adverse Event|1
98675|NCT01070550|369434|P1|Overall Study|Adverse Event|43
98676|NCT01070394|369574|P1|Overall Study|Withdrawal by Subject|1
98677|NCT01070394|369574|P1|Overall Study|Adverse Event|6
98678|NCT01070381|369585|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
98679|NCT01070381|369586|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
98680|NCT01070381|369585|P2|Period 2, 1 Week of Wear|Handling|1
98681|NCT01070381|369586|P1|Period 2, 1 Week of Wear|Handling|0
98682|NCT01070329|369594|P2|Overall Study|Sponsor Decision|1
98683|NCT01070329|369595|P1|Overall Study|Sponsor Decision|0
98684|NCT01070329|369594|P2|Overall Study|Entry Criteria Not Met|0
98685|NCT01070329|369595|P1|Overall Study|Entry Criteria Not Met|1
98686|NCT01070329|369594|P2|Overall Study|Physician Decision|1
98687|NCT01070329|369595|P1|Overall Study|Physician Decision|2
98688|NCT01070329|369594|P2|Overall Study|Lack of Efficacy|6
98689|NCT01070329|369595|P1|Overall Study|Lack of Efficacy|2
98690|NCT01070329|369594|P2|Overall Study|Protocol Violation|8
98691|NCT01070329|369595|P1|Overall Study|Protocol Violation|3
98692|NCT01070329|369594|P2|Overall Study|Withdrawal by Subject|11
98693|NCT01070329|369595|P1|Overall Study|Withdrawal by Subject|9
98694|NCT01070329|369594|P2|Overall Study|Lost to Follow-up|12
98695|NCT01070329|369595|P1|Overall Study|Lost to Follow-up|22
98696|NCT01070329|369594|P2|Overall Study|Adverse Event|10
98697|NCT01070329|369595|P1|Overall Study|Adverse Event|13
98698|NCT01070316|369627|P1|Extension Phase|Withdrawal by Subject|1
98699|NCT01070316|369627|P1|Extension Phase|Lack of Efficacy|3
98700|NCT01070303|369634|P1|Overall Study|Other|18
98701|NCT01070303|369634|P1|Overall Study|Administrative Reason|1
98702|NCT01070303|369634|P1|Overall Study|Lack of Efficacy|2
98703|NCT01070303|369634|P1|Overall Study|Protocol Violation|0
98704|NCT01070303|369634|P1|Overall Study|Lost to Follow-up|9
98705|NCT01070303|369634|P1|Overall Study|Withdrawal by Subject|20
98706|NCT01070303|369634|P1|Overall Study|Adverse Event|39
98707|NCT01070043|369708|P3|Double-Blind Treatment|Adverse Event|2
98708|NCT01070043|369709|P2|Double-Blind Treatment|Adverse Event|0
98709|NCT01070043|369710|P1|Double-Blind Treatment|Adverse Event|0
98710|NCT01070043|369708|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
98711|NCT01070043|369709|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
98712|NCT01070043|369710|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
98713|NCT01069939|369726|P2|Randomised and Included in the Analyses|Removal|0
98714|NCT01069939|369727|P1|Randomised and Included in the Analyses|Removal|1
98715|NCT01069939|369726|P2|Randomised and Included in the Analyses|Physician Decision|2
98716|NCT01069939|369727|P1|Randomised and Included in the Analyses|Physician Decision|0
98717|NCT01069939|369726|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
98718|NCT01069939|369727|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
98719|NCT01069939|369726|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
98720|NCT01069939|369727|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
98721|NCT01069939|369726|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
98722|NCT01069939|369727|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
98723|NCT01069939|369726|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
98724|NCT01069939|369727|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
98725|NCT01069939|369726|P2|Randomised and Included in the Analyses|Protocol Violation|1
98726|NCT01069939|369727|P1|Randomised and Included in the Analyses|Protocol Violation|0
98727|NCT01069939|369726|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
98728|NCT01069939|369727|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
98729|NCT01069939|369726|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
98730|NCT01069939|369727|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
98731|NCT01069939|369726|P2|Randomised and Included in the Analyses|Adverse Event|22
98732|NCT01069939|369727|P1|Randomised and Included in the Analyses|Adverse Event|17
98733|NCT01069900|369753|P2|Overall Study|Insufficient Therapeutic effect|0
98734|NCT01069900|369754|P1|Overall Study|Insufficient Therapeutic effect|1
98735|NCT01069900|369753|P2|Overall Study|Protocol Violation|1
98736|NCT01069900|369754|P1|Overall Study|Protocol Violation|4
98737|NCT01069900|369753|P2|Overall Study|Withdrawal by Subject|1
98738|NCT01069900|369754|P1|Overall Study|Withdrawal by Subject|6
98739|NCT01069900|369753|P2|Overall Study|Lost to Follow-up|1
98740|NCT01069900|369754|P1|Overall Study|Lost to Follow-up|7
98741|NCT01069900|369753|P2|Overall Study|Technical problems|1
98742|NCT01069900|369754|P1|Overall Study|Technical problems|0
98743|NCT01069861|369798|P1|Overall Study|Did not meet entrance criteria|1
98744|NCT01069861|369798|P1|Overall Study|Adverse Event|1
98745|NCT01069861|369798|P1|Overall Study|Death|1
98746|NCT01069627|369811|P1|Overall Study|Protocol Violation|1
98747|NCT01069627|369811|P1|Overall Study|Adverse Event|12
98748|NCT01069627|369811|P1|Overall Study|Disease progression|7
98749|NCT01069523|369861|P2|Overall Study|Withdrawal by Subject|7
98750|NCT01069523|369862|P1|Overall Study|Withdrawal by Subject|4
98751|NCT01069484|369872|P2|Overall Study|Illness mother or child|1
98752|NCT01069484|369873|P1|Overall Study|Illness mother or child|3
98753|NCT01069484|369872|P2|Overall Study|No specific reason|2
98754|NCT01069484|369873|P1|Overall Study|No specific reason|8
98755|NCT01069484|369872|P2|Overall Study|Death-in-near-family|0
98756|NCT01069484|369873|P1|Overall Study|Death-in-near-family|1
98757|NCT01069419|369881|P1|Overall Study|Missing termination information|13
98758|NCT01069419|369881|P1|Overall Study|Other Reason|43
98759|NCT01069419|369881|P1|Overall Study|Withdrawal by Subject|34
98760|NCT01069419|369881|P1|Overall Study|Remission of disease|11
98761|NCT01069419|369881|P1|Overall Study|Lost to Follow-up|49
98762|NCT01069419|369881|P1|Overall Study|Lack of Efficacy|332
98763|NCT01069419|369881|P1|Overall Study|Adverse Event|233
98764|NCT01069341|369910|P1|Overall Study|Lost to Follow-up|1
98765|NCT01069289|369923|P2|Overall Study|Due to deteriorating health condition|0
98766|NCT01069289|369924|P1|Overall Study|Due to deteriorating health condition|1
98767|NCT01069289|369923|P2|Overall Study|Severe non-compliance to protocol|2
98768|NCT01069289|369924|P1|Overall Study|Severe non-compliance to protocol|3
98769|NCT01069289|369923|P2|Overall Study|Eligibility criteria not fulfilled|0
98770|NCT01069289|369924|P1|Overall Study|Eligibility criteria not fulfilled|2
98771|NCT01069289|369923|P2|Overall Study|Adverse Event|28
98772|NCT01069289|369924|P1|Overall Study|Adverse Event|21
98773|NCT01069289|369923|P2|Overall Study|Withdrawal by Subject|26
98774|NCT01069289|369924|P1|Overall Study|Withdrawal by Subject|15
98775|NCT01069172|369973|P2|Overall Study|Withdrawal by Subject|0
98776|NCT01069172|369974|P1|Overall Study|Withdrawal by Subject|1
98777|NCT01069120|369984|P1|Overall Study|Study prematurely terminated|27
98778|NCT01068912|370021|P3|Overall Study|other underlying illness|3
98779|NCT01068912|370022|P2|Overall Study|other underlying illness|3
98780|NCT01068912|370023|P1|Overall Study|other underlying illness|0
98781|NCT01068912|370021|P3|Overall Study|aggravation influenza|1
98782|NCT01068912|370022|P2|Overall Study|aggravation influenza|1
98783|NCT01068912|370023|P1|Overall Study|aggravation influenza|1
98784|NCT01068912|370021|P3|Overall Study|Protocol Violation|0
98785|NCT01068912|370022|P2|Overall Study|Protocol Violation|2
98786|NCT01068912|370023|P1|Overall Study|Protocol Violation|0
98787|NCT01068912|370021|P3|Overall Study|Lost to Follow-up|3
98788|NCT01068912|370022|P2|Overall Study|Lost to Follow-up|7
98789|NCT01068912|370023|P1|Overall Study|Lost to Follow-up|3
98790|NCT01068912|370021|P3|Overall Study|Withdrawal by Subject|6
98791|NCT01068912|370022|P2|Overall Study|Withdrawal by Subject|6
98792|NCT01068912|370023|P1|Overall Study|Withdrawal by Subject|5
98793|NCT01068912|370021|P3|Overall Study|Adverse Event|2
98794|NCT01068912|370022|P2|Overall Study|Adverse Event|3
98795|NCT01068912|370023|P1|Overall Study|Adverse Event|2
98796|NCT01068860|370041|P10|Overall Study|Lost to Follow-up|0
98797|NCT01068860|370042|P9|Overall Study|Lost to Follow-up|0
98798|NCT01068860|370043|P8|Overall Study|Lost to Follow-up|0
98799|NCT01068860|370044|P7|Overall Study|Lost to Follow-up|0
98800|NCT01068860|370045|P6|Overall Study|Lost to Follow-up|0
98801|NCT01068860|370046|P5|Overall Study|Lost to Follow-up|0
98802|NCT01068860|370047|P4|Overall Study|Lost to Follow-up|0
98803|NCT01068860|370048|P3|Overall Study|Lost to Follow-up|0
98804|NCT01068860|370049|P2|Overall Study|Lost to Follow-up|1
98805|NCT01068860|370050|P1|Overall Study|Lost to Follow-up|0
98806|NCT01068860|370041|P10|Overall Study|Administrative problems; misrandomized|1
98807|NCT01068860|370042|P9|Overall Study|Administrative problems; misrandomized|0
98808|NCT01068860|370043|P8|Overall Study|Administrative problems; misrandomized|0
98809|NCT01068860|370044|P7|Overall Study|Administrative problems; misrandomized|0
98810|NCT01068860|370045|P6|Overall Study|Administrative problems; misrandomized|0
98811|NCT01068860|370046|P5|Overall Study|Administrative problems; misrandomized|0
98812|NCT01068860|370047|P4|Overall Study|Administrative problems; misrandomized|1
98813|NCT01068860|370048|P3|Overall Study|Administrative problems; misrandomized|0
98814|NCT01068860|370049|P2|Overall Study|Administrative problems; misrandomized|0
98815|NCT01068860|370050|P1|Overall Study|Administrative problems; misrandomized|0
98816|NCT01068860|370041|P10|Overall Study|Withdrawal by Subject|3
98817|NCT01068860|370042|P9|Overall Study|Withdrawal by Subject|0
98818|NCT01068860|370043|P8|Overall Study|Withdrawal by Subject|0
98819|NCT01068860|370044|P7|Overall Study|Withdrawal by Subject|0
98820|NCT01068860|370045|P6|Overall Study|Withdrawal by Subject|2
98821|NCT01068860|370046|P5|Overall Study|Withdrawal by Subject|0
98822|NCT01068860|370047|P4|Overall Study|Withdrawal by Subject|0
98823|NCT01068860|370048|P3|Overall Study|Withdrawal by Subject|0
98824|NCT01068860|370049|P2|Overall Study|Withdrawal by Subject|0
98825|NCT01068860|370050|P1|Overall Study|Withdrawal by Subject|0
98826|NCT01068769|370233|P1|Overall Study|Ineligible|1
98827|NCT01068743|370238|P4|Period 3|Adverse Event|0
98828|NCT01068743|370239|P3|Period 3|Adverse Event|0
98829|NCT01068743|370240|P2|Period 3|Adverse Event|1
98830|NCT01068743|370241|P1|Period 3|Adverse Event|0
98831|NCT01068730|370315|P4|Period 4|Family emergency|0
98832|NCT01068730|370316|P3|Period 4|Family emergency|0
98833|NCT01068730|370317|P2|Period 4|Family emergency|1
98834|NCT01068730|370318|P1|Period 4|Family emergency|0
98835|NCT01068730|370315|P4|Period 3|Personal reason|0
98836|NCT01068730|370316|P3|Period 3|Personal reason|0
98837|NCT01068730|370317|P2|Period 3|Personal reason|0
98838|NCT01068730|370318|P1|Period 3|Personal reason|1
98839|NCT01068717|370372|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
98840|NCT01068717|370373|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
98841|NCT01068717|370374|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
98842|NCT01068717|370375|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
98843|NCT01068678|370431|P2|Overall Study|Unclassified|15
98844|NCT01068678|370432|P1|Overall Study|Unclassified|18
98845|NCT01068678|370431|P2|Overall Study|Withdrawal criteria|6
98846|NCT01068678|370432|P1|Overall Study|Withdrawal criteria|12
98847|NCT01068678|370431|P2|Overall Study|Protocol Violation|1
98848|NCT01068678|370432|P1|Overall Study|Protocol Violation|5
98849|NCT01068678|370431|P2|Overall Study|Lack of Efficacy|2
98850|NCT01068678|370432|P1|Overall Study|Lack of Efficacy|3
98851|NCT01068665|370442|P2|Overall Study|Other|12
98852|NCT01068665|370443|P1|Overall Study|Other|17
98853|NCT01068665|370442|P2|Overall Study|Withdrawal Criteria|9
98854|NCT01068665|370443|P1|Overall Study|Withdrawal Criteria|3
98855|NCT01068665|370442|P2|Overall Study|Protocol Violation|2
98856|NCT01068665|370443|P1|Overall Study|Protocol Violation|5
98857|NCT01068665|370442|P2|Overall Study|Lack of Efficacy|2
98858|NCT01068665|370443|P1|Overall Study|Lack of Efficacy|0
98859|NCT01068665|370442|P2|Overall Study|Adverse Event|4
98860|NCT01068665|370443|P1|Overall Study|Adverse Event|5
98861|NCT01068652|370453|P2|Overall Study|Unclassified|4
98862|NCT01068652|370454|P1|Overall Study|Unclassified|7
98863|NCT01068652|370453|P2|Overall Study|Patient was not eligible|0
98864|NCT01068652|370454|P1|Overall Study|Patient was not eligible|1
98865|NCT01068652|370453|P2|Overall Study|Withdrawal criteria|2
98866|NCT01068652|370454|P1|Overall Study|Withdrawal criteria|1
98867|NCT01068652|370453|P2|Overall Study|Protocol Violation|6
98868|NCT01068652|370454|P1|Overall Study|Protocol Violation|3
98869|NCT01068652|370453|P2|Overall Study|Lost to Follow-up|1
98870|NCT01068652|370454|P1|Overall Study|Lost to Follow-up|2
98871|NCT01068652|370453|P2|Overall Study|Lack of Efficacy|2
98872|NCT01068652|370454|P1|Overall Study|Lack of Efficacy|0
98873|NCT01068652|370453|P2|Overall Study|Adverse Event|0
98874|NCT01068652|370454|P1|Overall Study|Adverse Event|4
98875|NCT01068626|370494|P2|Overall Study|Withdrawal by Subject|2
98876|NCT01068626|370495|P1|Overall Study|Withdrawal by Subject|0
98877|NCT01068626|370494|P2|Overall Study|Adverse Event|0
98878|NCT01068626|370495|P1|Overall Study|Adverse Event|3
98879|NCT01068600|370513|P2|Overall Study|Administrative problems|1
98880|NCT01068600|370514|P1|Overall Study|Administrative problems|0
98881|NCT01068600|370513|P2|Overall Study|Unsatisfactory therapeutic effect|4
98882|NCT01068600|370514|P1|Overall Study|Unsatisfactory therapeutic effect|0
98883|NCT01068600|370513|P2|Overall Study|Protocol deviation|1
98884|NCT01068600|370514|P1|Overall Study|Protocol deviation|1
98885|NCT01068600|370513|P2|Overall Study|Lost to Follow-up|2
98886|NCT01068600|370514|P1|Overall Study|Lost to Follow-up|1
98887|NCT01068600|370513|P2|Overall Study|Abnormal laboratory value(s)|0
98888|NCT01068600|370514|P1|Overall Study|Abnormal laboratory value(s)|1
98889|NCT01068600|370513|P2|Overall Study|Adverse Event|3
98890|NCT01068600|370514|P1|Overall Study|Adverse Event|3
98891|NCT01068600|370513|P2|Overall Study|Withdrawal by Subject|6
98892|NCT01068600|370514|P1|Overall Study|Withdrawal by Subject|5
98893|NCT01068509|370534|P3|Overall Study|Reason Not Specified|0
98894|NCT01068509|370535|P2|Overall Study|Reason Not Specified|1
98895|NCT01068509|370536|P1|Overall Study|Reason Not Specified|0
98896|NCT01068509|370534|P3|Overall Study|Withdrew Consent|2
98897|NCT01068509|370535|P2|Overall Study|Withdrew Consent|1
98898|NCT01068509|370536|P1|Overall Study|Withdrew Consent|0
98899|NCT01068509|370534|P3|Overall Study|Lost to Follow-up|0
98900|NCT01068509|370535|P2|Overall Study|Lost to Follow-up|0
98901|NCT01068509|370536|P1|Overall Study|Lost to Follow-up|1
98902|NCT01068509|370534|P3|Overall Study|Disease Progression|18
98903|NCT01068509|370535|P2|Overall Study|Disease Progression|20
98904|NCT01068509|370536|P1|Overall Study|Disease Progression|5
98905|NCT01068509|370534|P3|Overall Study|Death|1
98906|NCT01068509|370535|P2|Overall Study|Death|0
98907|NCT01068509|370536|P1|Overall Study|Death|0
98908|NCT01068418|370549|P1|Overall Study|Physician Decision|12
98909|NCT01068262|370558|P4|Overall Study|Withdrawal by Subject|0
98910|NCT01068262|370559|P3|Overall Study|Withdrawal by Subject|0
98911|NCT01068262|370560|P2|Overall Study|Withdrawal by Subject|1
98912|NCT01068262|370561|P1|Overall Study|Withdrawal by Subject|0
98913|NCT01068262|370558|P4|Overall Study|Protocol Violation|0
98914|NCT01068262|370559|P3|Overall Study|Protocol Violation|0
98915|NCT01068262|370560|P2|Overall Study|Protocol Violation|0
98916|NCT01068262|370561|P1|Overall Study|Protocol Violation|1
98917|NCT01068262|370558|P4|Overall Study|Adverse Event|0
98918|NCT01068262|370559|P3|Overall Study|Adverse Event|1
98919|NCT01068262|370560|P2|Overall Study|Adverse Event|0
98920|NCT01068262|370561|P1|Overall Study|Adverse Event|2
98921|NCT01068158|370591|P2|Overall Study|Protocol Violation|2
98922|NCT01068158|370592|P1|Overall Study|Protocol Violation|0
98923|NCT01068158|370591|P2|Overall Study|Lost to Follow-up|0
98924|NCT01068158|370592|P1|Overall Study|Lost to Follow-up|7
98925|NCT01068158|370591|P2|Overall Study|Withdrawal by Subject|2
98926|NCT01068158|370592|P1|Overall Study|Withdrawal by Subject|1
98927|NCT01067976|370604|P1|Overall Study|Study prematurely discontinued|2
98928|NCT01067976|370604|P1|Overall Study|Study drug never administered|20
98929|NCT01067846|370665|P2|Overall Study|participation in other tx study|0
98930|NCT01067846|370666|P1|Overall Study|participation in other tx study|1
98931|NCT01067846|370665|P2|Overall Study|Withdrawal by Subject|0
98932|NCT01067846|370666|P1|Overall Study|Withdrawal by Subject|1
98933|NCT01067846|370665|P2|Overall Study|Lost to Follow-up|19
98934|NCT01067846|370666|P1|Overall Study|Lost to Follow-up|17
98935|NCT01067352|370738|P3|Overall Study|Physician Decision|0
98936|NCT01067352|370739|P2|Overall Study|Physician Decision|1
98937|NCT01067352|370740|P1|Overall Study|Physician Decision|0
98938|NCT01067352|370738|P3|Overall Study|Withdrawal by Subject|1
98939|NCT01067352|370739|P2|Overall Study|Withdrawal by Subject|2
98940|NCT01067352|370740|P1|Overall Study|Withdrawal by Subject|1
98941|NCT01067339|370756|P2|Overall Study|Withdrawal by Subject|5
98942|NCT01067339|370757|P1|Overall Study|Withdrawal by Subject|6
98943|NCT01067326|370767|P2|Overall Study|Early Study Termination|1
98944|NCT01067326|370768|P1|Overall Study|Early Study Termination|1
98945|NCT01067326|370767|P2|Overall Study|Withdrawal by Subject|0
98946|NCT01067326|370768|P1|Overall Study|Withdrawal by Subject|1
98947|NCT01067326|370767|P2|Overall Study|Adverse Event|2
98948|NCT01067326|370768|P1|Overall Study|Adverse Event|0
98949|NCT01067105|370780|P1|Overall Study|Other|31
98950|NCT01067105|370780|P1|Overall Study|Physician Decision|6
98951|NCT01067105|370780|P1|Overall Study|Lost to Follow-up|6
98952|NCT01067105|370780|P1|Overall Study|Withdrawal by Subject|36
98953|NCT01067105|370780|P1|Overall Study|Protocol Violation|48
98954|NCT01067105|370780|P1|Overall Study|Adverse Event|14
98955|NCT01066923|370801|P4|Overall Study|Withdrawal by Subject|8
98956|NCT01066923|370802|P3|Overall Study|Withdrawal by Subject|8
98957|NCT01066923|370803|P2|Overall Study|Withdrawal by Subject|3
98958|NCT01066923|370804|P1|Overall Study|Withdrawal by Subject|3
98959|NCT01066897|370828|P2|Overall Study|stopped study after developing the flu.|0
98960|NCT01066897|370829|P1|Overall Study|stopped study after developing the flu.|1
98961|NCT01066897|370828|P2|Overall Study|Withdrawal by Subject|0
98962|NCT01066897|370829|P1|Overall Study|Withdrawal by Subject|1
98963|NCT01066871|370843|P4|Overall Study|Other|2
98964|NCT01066871|370844|P3|Overall Study|Other|1
98965|NCT01066871|370845|P2|Overall Study|Other|2
98966|NCT01066871|370846|P1|Overall Study|Other|0
98967|NCT01066871|370843|P4|Overall Study|Withdrawal by Subject|0
98968|NCT01066871|370844|P3|Overall Study|Withdrawal by Subject|0
98969|NCT01066871|370845|P2|Overall Study|Withdrawal by Subject|1
98970|NCT01066871|370846|P1|Overall Study|Withdrawal by Subject|3
98971|NCT01066871|370843|P4|Overall Study|Lack of Efficacy|1
98972|NCT01066871|370844|P3|Overall Study|Lack of Efficacy|0
98973|NCT01066871|370845|P2|Overall Study|Lack of Efficacy|0
98974|NCT01066871|370846|P1|Overall Study|Lack of Efficacy|0
98975|NCT01066871|370843|P4|Overall Study|Protocol Violation|2
98976|NCT01066871|370844|P3|Overall Study|Protocol Violation|3
98977|NCT01066871|370845|P2|Overall Study|Protocol Violation|0
98978|NCT01066871|370846|P1|Overall Study|Protocol Violation|1
98979|NCT01066871|370843|P4|Overall Study|Lost to Follow-up|0
98980|NCT01066871|370844|P3|Overall Study|Lost to Follow-up|2
98981|NCT01066871|370845|P2|Overall Study|Lost to Follow-up|2
98982|NCT01066871|370846|P1|Overall Study|Lost to Follow-up|0
98983|NCT01066819|370910|P6|Overall Study|Other|0
98984|NCT01066819|370911|P5|Overall Study|Other|0
98985|NCT01066819|370912|P4|Overall Study|Other|0
98986|NCT01066819|370913|P3|Overall Study|Other|1
98987|NCT01066819|370914|P2|Overall Study|Other|1
98988|NCT01066819|370915|P1|Overall Study|Other|5
98989|NCT01066819|370910|P6|Overall Study|Treatment stopped|0
98990|NCT01066819|370911|P5|Overall Study|Treatment stopped|0
98991|NCT01066819|370912|P4|Overall Study|Treatment stopped|1
98992|NCT01066819|370913|P3|Overall Study|Treatment stopped|2
98993|NCT01066819|370914|P2|Overall Study|Treatment stopped|1
98994|NCT01066819|370915|P1|Overall Study|Treatment stopped|12
98995|NCT01066819|370910|P6|Overall Study|Treatment never started|2
98996|NCT01066819|370911|P5|Overall Study|Treatment never started|2
98997|NCT01066819|370912|P4|Overall Study|Treatment never started|3
98998|NCT01066819|370913|P3|Overall Study|Treatment never started|19
98999|NCT01066819|370914|P2|Overall Study|Treatment never started|19
99000|NCT01066819|370915|P1|Overall Study|Treatment never started|85
99001|NCT01066819|370910|P6|Overall Study|Spontaneous cure|0
99002|NCT01066819|370911|P5|Overall Study|Spontaneous cure|0
99003|NCT01066819|370912|P4|Overall Study|Spontaneous cure|0
99004|NCT01066819|370913|P3|Overall Study|Spontaneous cure|0
99005|NCT01066819|370914|P2|Overall Study|Spontaneous cure|0
99006|NCT01066819|370915|P1|Overall Study|Spontaneous cure|1
99007|NCT01066819|370910|P6|Overall Study|Screen failure|0
99008|NCT01066819|370911|P5|Overall Study|Screen failure|0
99009|NCT01066819|370912|P4|Overall Study|Screen failure|0
99010|NCT01066819|370913|P3|Overall Study|Screen failure|0
99011|NCT01066819|370914|P2|Overall Study|Screen failure|0
99012|NCT01066819|370915|P1|Overall Study|Screen failure|1
99013|NCT01066819|370910|P6|Overall Study|Results not available|0
99014|NCT01066819|370911|P5|Overall Study|Results not available|0
99015|NCT01066819|370912|P4|Overall Study|Results not available|0
99016|NCT01066819|370913|P3|Overall Study|Results not available|0
99017|NCT01066819|370914|P2|Overall Study|Results not available|0
99018|NCT01066819|370915|P1|Overall Study|Results not available|1
99019|NCT01066819|370910|P6|Overall Study|Relapse|0
99020|NCT01066819|370911|P5|Overall Study|Relapse|0
99021|NCT01066819|370912|P4|Overall Study|Relapse|0
99022|NCT01066819|370913|P3|Overall Study|Relapse|3
99023|NCT01066819|370914|P2|Overall Study|Relapse|4
99024|NCT01066819|370915|P1|Overall Study|Relapse|16
99025|NCT01066819|370910|P6|Overall Study|Not categorised|0
99026|NCT01066819|370911|P5|Overall Study|Not categorised|0
99027|NCT01066819|370912|P4|Overall Study|Not categorised|1
99028|NCT01066819|370913|P3|Overall Study|Not categorised|6
99029|NCT01066819|370914|P2|Overall Study|Not categorised|2
99030|NCT01066819|370915|P1|Overall Study|Not categorised|9
99031|NCT01066819|370910|P6|Overall Study|Non responders|1
99032|NCT01066819|370911|P5|Overall Study|Non responders|0
99033|NCT01066819|370912|P4|Overall Study|Non responders|2
99034|NCT01066819|370913|P3|Overall Study|Non responders|7
99035|NCT01066819|370914|P2|Overall Study|Non responders|2
99036|NCT01066819|370915|P1|Overall Study|Non responders|123
99037|NCT01066819|370910|P6|Overall Study|Miscellaneous|0
99038|NCT01066819|370911|P5|Overall Study|Miscellaneous|0
99039|NCT01066819|370912|P4|Overall Study|Miscellaneous|1
99040|NCT01066819|370913|P3|Overall Study|Miscellaneous|18
99041|NCT01066819|370914|P2|Overall Study|Miscellaneous|10
99042|NCT01066819|370915|P1|Overall Study|Miscellaneous|28
99043|NCT01066819|370910|P6|Overall Study|Lab test not done|0
99044|NCT01066819|370911|P5|Overall Study|Lab test not done|0
99045|NCT01066819|370912|P4|Overall Study|Lab test not done|1
99046|NCT01066819|370913|P3|Overall Study|Lab test not done|2
99047|NCT01066819|370914|P2|Overall Study|Lab test not done|0
99048|NCT01066819|370915|P1|Overall Study|Lab test not done|9
99049|NCT01066819|370910|P6|Overall Study|Failed to return|3
99050|NCT01066819|370911|P5|Overall Study|Failed to return|2
99051|NCT01066819|370912|P4|Overall Study|Failed to return|7
99052|NCT01066819|370913|P3|Overall Study|Failed to return|68
99053|NCT01066819|370914|P2|Overall Study|Failed to return|107
99054|NCT01066819|370915|P1|Overall Study|Failed to return|298
99055|NCT01066819|370910|P6|Overall Study|Early termination|0
99056|NCT01066819|370911|P5|Overall Study|Early termination|0
99057|NCT01066819|370912|P4|Overall Study|Early termination|0
99058|NCT01066819|370913|P3|Overall Study|Early termination|0
99059|NCT01066819|370914|P2|Overall Study|Early termination|0
99060|NCT01066819|370915|P1|Overall Study|Early termination|2
99061|NCT01066819|370910|P6|Overall Study|Not met inclusion/exclusion criteria|0
99062|NCT01066819|370911|P5|Overall Study|Not met inclusion/exclusion criteria|0
99063|NCT01066819|370912|P4|Overall Study|Not met inclusion/exclusion criteria|0
99064|NCT01066819|370913|P3|Overall Study|Not met inclusion/exclusion criteria|0
99065|NCT01066819|370914|P2|Overall Study|Not met inclusion/exclusion criteria|0
99066|NCT01066819|370915|P1|Overall Study|Not met inclusion/exclusion criteria|1
99067|NCT01066819|370910|P6|Overall Study|Administrative|0
99068|NCT01066819|370911|P5|Overall Study|Administrative|0
99069|NCT01066819|370912|P4|Overall Study|Administrative|0
99070|NCT01066819|370913|P3|Overall Study|Administrative|2
99071|NCT01066819|370914|P2|Overall Study|Administrative|4
99072|NCT01066819|370915|P1|Overall Study|Administrative|6
99073|NCT01066819|370910|P6|Overall Study|Withdrawal by Subject|0
99074|NCT01066819|370911|P5|Overall Study|Withdrawal by Subject|0
99075|NCT01066819|370912|P4|Overall Study|Withdrawal by Subject|0
99076|NCT01066819|370913|P3|Overall Study|Withdrawal by Subject|6
99077|NCT01066819|370914|P2|Overall Study|Withdrawal by Subject|11
99078|NCT01066819|370915|P1|Overall Study|Withdrawal by Subject|29
99079|NCT01066819|370910|P6|Overall Study|Protocol Violation|0
99080|NCT01066819|370911|P5|Overall Study|Protocol Violation|0
99081|NCT01066819|370912|P4|Overall Study|Protocol Violation|0
99082|NCT01066819|370913|P3|Overall Study|Protocol Violation|0
99083|NCT01066819|370914|P2|Overall Study|Protocol Violation|6
99084|NCT01066819|370915|P1|Overall Study|Protocol Violation|12
99085|NCT01066819|370910|P6|Overall Study|Physician Decision|0
99086|NCT01066819|370911|P5|Overall Study|Physician Decision|0
99087|NCT01066819|370912|P4|Overall Study|Physician Decision|0
99088|NCT01066819|370913|P3|Overall Study|Physician Decision|3
99089|NCT01066819|370914|P2|Overall Study|Physician Decision|2
99090|NCT01066819|370915|P1|Overall Study|Physician Decision|6
99091|NCT01066819|370910|P6|Overall Study|Lack of Efficacy|0
99092|NCT01066819|370911|P5|Overall Study|Lack of Efficacy|0
99093|NCT01066819|370912|P4|Overall Study|Lack of Efficacy|1
99094|NCT01066819|370913|P3|Overall Study|Lack of Efficacy|2
99095|NCT01066819|370914|P2|Overall Study|Lack of Efficacy|1
99096|NCT01066819|370915|P1|Overall Study|Lack of Efficacy|22
99097|NCT01066819|370910|P6|Overall Study|Death|0
99098|NCT01066819|370911|P5|Overall Study|Death|0
99099|NCT01066819|370912|P4|Overall Study|Death|0
99100|NCT01066819|370913|P3|Overall Study|Death|1
99101|NCT01066819|370914|P2|Overall Study|Death|0
99102|NCT01066819|370915|P1|Overall Study|Death|5
99103|NCT01066819|370910|P6|Overall Study|Adverse Event|0
99104|NCT01066819|370911|P5|Overall Study|Adverse Event|0
99105|NCT01066819|370912|P4|Overall Study|Adverse Event|0
99106|NCT01066819|370913|P3|Overall Study|Adverse Event|6
99107|NCT01066819|370914|P2|Overall Study|Adverse Event|1
99108|NCT01066819|370915|P1|Overall Study|Adverse Event|18
99109|NCT01066793|371056|P6|Overall Study|Treatment Stopped|0
99110|NCT01066793|371057|P5|Overall Study|Treatment Stopped|0
99111|NCT01066793|371058|P4|Overall Study|Treatment Stopped|1
99112|NCT01066793|371059|P3|Overall Study|Treatment Stopped|0
99113|NCT01066793|371060|P2|Overall Study|Treatment Stopped|1
99114|NCT01066793|371061|P1|Overall Study|Treatment Stopped|2
99115|NCT01066793|371056|P6|Overall Study|Treatment Never Started|0
99116|NCT01066793|371057|P5|Overall Study|Treatment Never Started|0
99117|NCT01066793|371058|P4|Overall Study|Treatment Never Started|1
99118|NCT01066793|371059|P3|Overall Study|Treatment Never Started|4
99119|NCT01066793|371060|P2|Overall Study|Treatment Never Started|5
99120|NCT01066793|371061|P1|Overall Study|Treatment Never Started|18
99121|NCT01066793|371056|P6|Overall Study|Treatment Interrupted|0
99122|NCT01066793|371057|P5|Overall Study|Treatment Interrupted|0
99123|NCT01066793|371058|P4|Overall Study|Treatment Interrupted|0
99124|NCT01066793|371059|P3|Overall Study|Treatment Interrupted|0
99125|NCT01066793|371060|P2|Overall Study|Treatment Interrupted|1
99126|NCT01066793|371061|P1|Overall Study|Treatment Interrupted|1
99127|NCT01066793|371056|P6|Overall Study|Result Not Available|0
99128|NCT01066793|371057|P5|Overall Study|Result Not Available|0
99129|NCT01066793|371058|P4|Overall Study|Result Not Available|0
99130|NCT01066793|371059|P3|Overall Study|Result Not Available|0
99131|NCT01066793|371060|P2|Overall Study|Result Not Available|0
99132|NCT01066793|371061|P1|Overall Study|Result Not Available|1
99133|NCT01066793|371056|P6|Overall Study|Relapse|0
99134|NCT01066793|371057|P5|Overall Study|Relapse|0
99135|NCT01066793|371058|P4|Overall Study|Relapse|3
99136|NCT01066793|371059|P3|Overall Study|Relapse|2
99137|NCT01066793|371060|P2|Overall Study|Relapse|8
99138|NCT01066793|371061|P1|Overall Study|Relapse|20
99139|NCT01066793|371056|P6|Overall Study|Other|0
99140|NCT01066793|371057|P5|Overall Study|Other|0
99141|NCT01066793|371058|P4|Overall Study|Other|2
99142|NCT01066793|371059|P3|Overall Study|Other|6
99143|NCT01066793|371060|P2|Overall Study|Other|5
99144|NCT01066793|371061|P1|Overall Study|Other|15
99145|NCT01066793|371056|P6|Overall Study|Non-responders|0
99146|NCT01066793|371057|P5|Overall Study|Non-responders|0
99147|NCT01066793|371058|P4|Overall Study|Non-responders|25
99148|NCT01066793|371059|P3|Overall Study|Non-responders|11
99149|NCT01066793|371060|P2|Overall Study|Non-responders|5
99150|NCT01066793|371061|P1|Overall Study|Non-responders|104
99151|NCT01066793|371056|P6|Overall Study|Miscellaneous|0
99152|NCT01066793|371057|P5|Overall Study|Miscellaneous|0
99153|NCT01066793|371058|P4|Overall Study|Miscellaneous|0
99154|NCT01066793|371059|P3|Overall Study|Miscellaneous|6
99155|NCT01066793|371060|P2|Overall Study|Miscellaneous|5
99156|NCT01066793|371061|P1|Overall Study|Miscellaneous|4
99157|NCT01066793|371056|P6|Overall Study|Lab test not done|0
99158|NCT01066793|371057|P5|Overall Study|Lab test not done|0
99159|NCT01066793|371058|P4|Overall Study|Lab test not done|1
99160|NCT01066793|371059|P3|Overall Study|Lab test not done|0
99161|NCT01066793|371060|P2|Overall Study|Lab test not done|0
99162|NCT01066793|371061|P1|Overall Study|Lab test not done|7
99163|NCT01066793|371056|P6|Overall Study|Early Termination|0
99164|NCT01066793|371057|P5|Overall Study|Early Termination|0
99165|NCT01066793|371058|P4|Overall Study|Early Termination|0
99166|NCT01066793|371059|P3|Overall Study|Early Termination|0
99167|NCT01066793|371060|P2|Overall Study|Early Termination|0
99168|NCT01066793|371061|P1|Overall Study|Early Termination|3
99169|NCT01066793|371056|P6|Overall Study|Withdrawal by Subject|0
99170|NCT01066793|371057|P5|Overall Study|Withdrawal by Subject|0
99171|NCT01066793|371058|P4|Overall Study|Withdrawal by Subject|0
99172|NCT01066793|371059|P3|Overall Study|Withdrawal by Subject|1
99173|NCT01066793|371060|P2|Overall Study|Withdrawal by Subject|4
99174|NCT01066793|371061|P1|Overall Study|Withdrawal by Subject|7
99175|NCT01066793|371056|P6|Overall Study|Protocol Violation|0
99176|NCT01066793|371057|P5|Overall Study|Protocol Violation|0
99177|NCT01066793|371058|P4|Overall Study|Protocol Violation|0
99178|NCT01066793|371059|P3|Overall Study|Protocol Violation|2
99179|NCT01066793|371060|P2|Overall Study|Protocol Violation|2
99180|NCT01066793|371061|P1|Overall Study|Protocol Violation|3
99181|NCT01066793|371056|P6|Overall Study|Physician Decision|0
99182|NCT01066793|371057|P5|Overall Study|Physician Decision|0
99183|NCT01066793|371058|P4|Overall Study|Physician Decision|0
99184|NCT01066793|371059|P3|Overall Study|Physician Decision|0
99185|NCT01066793|371060|P2|Overall Study|Physician Decision|0
99186|NCT01066793|371061|P1|Overall Study|Physician Decision|3
99187|NCT01066793|371056|P6|Overall Study|Lost to Follow-up|1
99188|NCT01066793|371057|P5|Overall Study|Lost to Follow-up|0
99189|NCT01066793|371058|P4|Overall Study|Lost to Follow-up|16
99190|NCT01066793|371059|P3|Overall Study|Lost to Follow-up|82
99191|NCT01066793|371060|P2|Overall Study|Lost to Follow-up|39
99192|NCT01066793|371061|P1|Overall Study|Lost to Follow-up|180
99193|NCT01066793|371056|P6|Overall Study|Lack of Efficacy|0
99194|NCT01066793|371057|P5|Overall Study|Lack of Efficacy|0
99195|NCT01066793|371058|P4|Overall Study|Lack of Efficacy|0
99196|NCT01066793|371059|P3|Overall Study|Lack of Efficacy|0
99197|NCT01066793|371060|P2|Overall Study|Lack of Efficacy|1
99198|NCT01066793|371061|P1|Overall Study|Lack of Efficacy|2
99199|NCT01066793|371056|P6|Overall Study|Death|0
99200|NCT01066793|371057|P5|Overall Study|Death|0
99201|NCT01066793|371058|P4|Overall Study|Death|0
99202|NCT01066793|371059|P3|Overall Study|Death|1
99203|NCT01066793|371060|P2|Overall Study|Death|1
99204|NCT01066793|371061|P1|Overall Study|Death|4
99205|NCT01066780|371201|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
99206|NCT01066780|371202|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
99207|NCT01066585|371221|P2|Overall Study|Withdrawal by Subject|3
99208|NCT01066585|371222|P1|Overall Study|Withdrawal by Subject|0
99209|NCT01066585|371221|P2|Overall Study|Protocol Violation|0
99210|NCT01066585|371222|P1|Overall Study|Protocol Violation|1
99211|NCT01066546|371234|P1|Overall Study|Study terminated by sponsor|5
99212|NCT01066156|371264|P1|Overall Study|Withdrawal by Subject|1
99213|NCT01066156|371264|P1|Overall Study|Lost to Follow-up|7
99214|NCT01066156|371264|P1|Overall Study|ineligible|2
99215|NCT01066143|371268|P1|Overall Study|ineligible for the study|8
99216|NCT01066104|371274|P2|Overall Study|Protocol Violation|0
99217|NCT01066104|371275|P1|Overall Study|Protocol Violation|1
99218|NCT01066104|371274|P2|Overall Study|Adverse Event|1
99219|NCT01066104|371275|P1|Overall Study|Adverse Event|1
99220|NCT01066039|371283|P1|Overall Study|Drug/Dose Adjustment Required|1
99221|NCT01066039|371283|P1|Overall Study|Failure to Control Blood Pressure|1
99222|NCT01066039|371283|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
99223|NCT01066039|371283|P1|Overall Study|Additional Antihypertensive Required|4
99224|NCT01066039|371283|P1|Overall Study|Dropout due to Insulin Administration|1
99225|NCT01066039|371283|P1|Overall Study|Investigator’s Request|1
99226|NCT01066039|371283|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
99227|NCT01066039|371283|P1|Overall Study|Protocol Violation|2
99228|NCT01066039|371283|P1|Overall Study|Withdrawal by Subject|17
99229|NCT01066039|371283|P1|Overall Study|Adverse Event|6
99230|NCT01066000|371296|P1|Overall Study|Adverse Event|1
99231|NCT01066000|371296|P1|Overall Study|Withdrawal by Subject|1
99232|NCT01066000|371296|P1|Overall Study|Death|3
99233|NCT01066000|371296|P1|Overall Study|Protocol Violation|4
99234|NCT01065844|371307|P1|Overall Study|Adverse Event|5
99235|NCT01065818|371311|P1|Overall Study|Not a candidate for surgery|1
99236|NCT01065818|371311|P1|Overall Study|Withdrawal by Subject|1
99237|NCT01065779|371315|P1|Overall Study|Inclusion Criteria Violation|7
99238|NCT01065779|371315|P1|Overall Study|Failed to Follow-up|10
99239|NCT01065779|371315|P1|Overall Study|Not Administered With Study Drug|17
99240|NCT01065779|371315|P1|Overall Study|Non-enrollment Period Administration|10
99241|NCT01065779|371315|P1|Overall Study|Investigation Before Contract Date|37
99242|NCT01065779|371315|P1|Overall Study|Duplicate Investigation|1
99243|NCT01065766|371326|P1|Overall Study|Violated dosage/administration|25
99244|NCT01065766|371326|P1|Overall Study|Contraindication to administration|6
99245|NCT01065766|371326|P1|Overall Study|Assessed before the contracted date|1
99246|NCT01065597|371345|P1|Overall Study|Adverse Event|1
99247|NCT01065454|371379|P4|Follow up|study ongoing|41
99248|NCT01065454|371380|P3|Follow up|study ongoing|15
99249|NCT01065454|371381|P2|Follow up|study ongoing|22
99250|NCT01065454|371382|P1|Follow up|study ongoing|37
99251|NCT01065454|371379|P4|Follow up|Withdrawal by Subject|0
99252|NCT01065454|371380|P3|Follow up|Withdrawal by Subject|1
99253|NCT01065454|371381|P2|Follow up|Withdrawal by Subject|1
99254|NCT01065454|371382|P1|Follow up|Withdrawal by Subject|1
99255|NCT01065454|371379|P4|Follow up|Progressive disease|1
99256|NCT01065454|371380|P3|Follow up|Progressive disease|0
99257|NCT01065454|371381|P2|Follow up|Progressive disease|0
99258|NCT01065454|371382|P1|Follow up|Progressive disease|0
99259|NCT01065454|371379|P4|Follow up|Lost to Follow-up|1
99260|NCT01065454|371380|P3|Follow up|Lost to Follow-up|0
99261|NCT01065454|371381|P2|Follow up|Lost to Follow-up|0
99262|NCT01065454|371382|P1|Follow up|Lost to Follow-up|0
99263|NCT01065454|371379|P4|Follow up|Death|0
99264|NCT01065454|371380|P3|Follow up|Death|1
99265|NCT01065454|371381|P2|Follow up|Death|1
99266|NCT01065454|371382|P1|Follow up|Death|0
99267|NCT01065454|371379|P4|Follow up|Adverse Event|1
99268|NCT01065454|371380|P3|Follow up|Adverse Event|0
99269|NCT01065454|371381|P2|Follow up|Adverse Event|0
99270|NCT01065454|371382|P1|Follow up|Adverse Event|1
99271|NCT01065454|371379|P4|Treatment|Withdrawal by Subject|3
99272|NCT01065454|371380|P3|Treatment|Withdrawal by Subject|2
99273|NCT01065454|371381|P2|Treatment|Withdrawal by Subject|1
99274|NCT01065454|371382|P1|Treatment|Withdrawal by Subject|3
99275|NCT01065454|371379|P4|Treatment|Protocol Violation|0
99276|NCT01065454|371380|P3|Treatment|Protocol Violation|1
99277|NCT01065454|371381|P2|Treatment|Protocol Violation|0
99278|NCT01065454|371382|P1|Treatment|Protocol Violation|1
99279|NCT01065454|371379|P4|Treatment|Protocol Decision|2
99280|NCT01065454|371380|P3|Treatment|Protocol Decision|3
99281|NCT01065454|371381|P2|Treatment|Protocol Decision|0
99282|NCT01065454|371382|P1|Treatment|Protocol Decision|0
99283|NCT01065454|371379|P4|Treatment|Non-compliance|1
99284|NCT01065454|371380|P3|Treatment|Non-compliance|0
99285|NCT01065454|371381|P2|Treatment|Non-compliance|0
99286|NCT01065454|371382|P1|Treatment|Non-compliance|1
99287|NCT01065454|371379|P4|Treatment|Death|0
99288|NCT01065454|371380|P3|Treatment|Death|0
99289|NCT01065454|371381|P2|Treatment|Death|0
99290|NCT01065454|371382|P1|Treatment|Death|1
99291|NCT01065454|371379|P4|Treatment|Adverse Event|6
99292|NCT01065454|371380|P3|Treatment|Adverse Event|3
99293|NCT01065454|371381|P2|Treatment|Adverse Event|4
99294|NCT01065454|371382|P1|Treatment|Adverse Event|7
99295|NCT01065350|371505|P2|Overall Study|Received incorrect drug allocation|1
99296|NCT01065350|371506|P1|Overall Study|Received incorrect drug allocation|0
99297|NCT01064947|371567|P1|Overall Study|negative culture|41
99298|NCT01064856|371608|P4|Open-label (OL) Period|Not specified|7
99299|NCT01064856|371609|P3|Open-label (OL) Period|Not specified|7
99300|NCT01064856|371610|P2|Open-label (OL) Period|Not specified|0
99301|NCT01064856|371611|P1|Open-label (OL) Period|Not specified|0
99302|NCT01064856|371608|P4|Open-label (OL) Period|Lost to Follow-up|1
99303|NCT01064856|371609|P3|Open-label (OL) Period|Lost to Follow-up|2
99304|NCT01064856|371610|P2|Open-label (OL) Period|Lost to Follow-up|0
99305|NCT01064856|371611|P1|Open-label (OL) Period|Lost to Follow-up|0
99306|NCT01064856|371608|P4|Open-label (OL) Period|Consent withdrawn by participant|6
99307|NCT01064856|371609|P3|Open-label (OL) Period|Consent withdrawn by participant|5
99308|NCT01064856|371610|P2|Open-label (OL) Period|Consent withdrawn by participant|0
99309|NCT01064856|371611|P1|Open-label (OL) Period|Consent withdrawn by participant|0
99310|NCT01064856|371608|P4|Open-label (OL) Period|Adverse Event|6
99311|NCT01064856|371609|P3|Open-label (OL) Period|Adverse Event|12
99312|NCT01064856|371610|P2|Open-label (OL) Period|Adverse Event|0
99313|NCT01064856|371611|P1|Open-label (OL) Period|Adverse Event|0
99314|NCT01064856|371608|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
99315|NCT01064856|371609|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
99316|NCT01064856|371610|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
99317|NCT01064856|371611|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
99318|NCT01064856|371608|P4|Double-blind (DB) Period|Adverse Event|0
99319|NCT01064856|371609|P3|Double-blind (DB) Period|Adverse Event|0
99320|NCT01064856|371610|P2|Double-blind (DB) Period|Adverse Event|0
99321|NCT01064856|371611|P1|Double-blind (DB) Period|Adverse Event|1
99322|NCT01064817|371655|P2|Study Completion|Withdrawal by Subject|0
99323|NCT01064817|371656|P1|Study Completion|Withdrawal by Subject|1
99324|NCT01064817|371655|P2|Study Completion|Physician Decision|0
99325|NCT01064817|371656|P1|Study Completion|Physician Decision|1
99326|NCT01064739|371668|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
99327|NCT01064687|371728|P4|Overall Study|Treatment Noncompliance|0
99328|NCT01064687|371729|P3|Overall Study|Treatment Noncompliance|1
99329|NCT01064687|371730|P2|Overall Study|Treatment Noncompliance|1
99330|NCT01064687|371731|P1|Overall Study|Treatment Noncompliance|1
99331|NCT01064687|371728|P4|Overall Study|Withdrawal by Subject|5
99332|NCT01064687|371729|P3|Overall Study|Withdrawal by Subject|12
99333|NCT01064687|371730|P2|Overall Study|Withdrawal by Subject|7
99334|NCT01064687|371731|P1|Overall Study|Withdrawal by Subject|9
99335|NCT01064687|371728|P4|Overall Study|Sponsor Decision|0
99336|NCT01064687|371729|P3|Overall Study|Sponsor Decision|3
99337|NCT01064687|371730|P2|Overall Study|Sponsor Decision|0
99338|NCT01064687|371731|P1|Overall Study|Sponsor Decision|0
99339|NCT01064687|371728|P4|Overall Study|Protocol Violation|1
99340|NCT01064687|371729|P3|Overall Study|Protocol Violation|0
99341|NCT01064687|371730|P2|Overall Study|Protocol Violation|1
99342|NCT01064687|371731|P1|Overall Study|Protocol Violation|1
99343|NCT01064687|371728|P4|Overall Study|Physician Decision|0
99344|NCT01064687|371729|P3|Overall Study|Physician Decision|0
99345|NCT01064687|371730|P2|Overall Study|Physician Decision|2
99346|NCT01064687|371731|P1|Overall Study|Physician Decision|2
99347|NCT01064687|371728|P4|Overall Study|Lost to Follow-up|5
99348|NCT01064687|371729|P3|Overall Study|Lost to Follow-up|13
99349|NCT01064687|371730|P2|Overall Study|Lost to Follow-up|10
99350|NCT01064687|371731|P1|Overall Study|Lost to Follow-up|7
99351|NCT01064687|371728|P4|Overall Study|Lack of Efficacy|3
99352|NCT01064687|371729|P3|Overall Study|Lack of Efficacy|2
99353|NCT01064687|371730|P2|Overall Study|Lack of Efficacy|0
99354|NCT01064687|371731|P1|Overall Study|Lack of Efficacy|1
99355|NCT01064687|371728|P4|Overall Study|Entry Criteria Not Met|0
99356|NCT01064687|371729|P3|Overall Study|Entry Criteria Not Met|0
99357|NCT01064687|371730|P2|Overall Study|Entry Criteria Not Met|0
99358|NCT01064687|371731|P1|Overall Study|Entry Criteria Not Met|3
99359|NCT01064687|371728|P4|Overall Study|Death|0
99360|NCT01064687|371729|P3|Overall Study|Death|0
99361|NCT01064687|371730|P2|Overall Study|Death|1
99362|NCT01064687|371731|P1|Overall Study|Death|1
99363|NCT01064687|371728|P4|Overall Study|Adverse Event|3
99364|NCT01064687|371729|P3|Overall Study|Adverse Event|10
99365|NCT01064687|371730|P2|Overall Study|Adverse Event|4
99366|NCT01064687|371731|P1|Overall Study|Adverse Event|9
99367|NCT01064622|371911|P2|Randomized Phase II|Protocol Violation|1
99368|NCT01064622|371912|P1|Randomized Phase II|Protocol Violation|0
99369|NCT01064622|371911|P2|Randomized Phase II|Withdrawal by Subject|2
99370|NCT01064622|371912|P1|Randomized Phase II|Withdrawal by Subject|2
99371|NCT01064414|371936|P3|Extension Period: Week 26 to Week 52|Not specified|1
99372|NCT01064414|371937|P2|Extension Period: Week 26 to Week 52|Not specified|2
99373|NCT01064414|371938|P1|Extension Period: Week 26 to Week 52|Not specified|5
99374|NCT01064414|371936|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
99375|NCT01064414|371937|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
99376|NCT01064414|371938|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
99377|NCT01064414|371936|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
99378|NCT01064414|371937|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
99379|NCT01064414|371938|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
99380|NCT01064414|371936|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
99381|NCT01064414|371937|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
99382|NCT01064414|371938|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
99383|NCT01064414|371936|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
99384|NCT01064414|371937|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
99385|NCT01064414|371938|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
99386|NCT01064414|371936|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
99387|NCT01064414|371937|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
99388|NCT01064414|371938|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
99389|NCT01064414|371936|P3|Extension Period: Week 26 to Week 52|Death|0
99390|NCT01064414|371937|P2|Extension Period: Week 26 to Week 52|Death|1
99391|NCT01064414|371938|P1|Extension Period: Week 26 to Week 52|Death|0
99392|NCT01064414|371936|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
99393|NCT01064414|371937|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
99394|NCT01064414|371938|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
99395|NCT01064414|371936|P3|Core Period: Baseline to Week 26|Not specified|2
99396|NCT01064414|371937|P2|Core Period: Baseline to Week 26|Not specified|7
99397|NCT01064414|371938|P1|Core Period: Baseline to Week 26|Not specified|4
99398|NCT01064414|371936|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
99399|NCT01064414|371937|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
99400|NCT01064414|371938|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
99401|NCT01064414|371936|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
99402|NCT01064414|371937|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
99403|NCT01064414|371938|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
99404|NCT01064414|371936|P3|Core Period: Baseline to Week 26|Protocol Violation|1
99405|NCT01064414|371937|P2|Core Period: Baseline to Week 26|Protocol Violation|0
99406|NCT01064414|371938|P1|Core Period: Baseline to Week 26|Protocol Violation|1
99407|NCT01064414|371936|P3|Core Period: Baseline to Week 26|Death|0
99408|NCT01064414|371937|P2|Core Period: Baseline to Week 26|Death|1
99409|NCT01064414|371938|P1|Core Period: Baseline to Week 26|Death|0
99410|NCT01064414|371936|P3|Core Period: Baseline to Week 26|Adverse Event|2
99411|NCT01064414|371937|P2|Core Period: Baseline to Week 26|Adverse Event|4
99412|NCT01064414|371938|P1|Core Period: Baseline to Week 26|Adverse Event|4
99413|NCT01064401|371957|P2|Overall Study|Not Specified|1
99414|NCT01064401|371958|P1|Overall Study|Not Specified|2
99415|NCT01064401|371957|P2|Overall Study|Site Closure|5
99416|NCT01064401|371958|P1|Overall Study|Site Closure|4
99417|NCT01064401|371957|P2|Overall Study|Noncompliance|8
99418|NCT01064401|371958|P1|Overall Study|Noncompliance|7
99419|NCT01064401|371957|P2|Overall Study|Pregnancy|7
99420|NCT01064401|371958|P1|Overall Study|Pregnancy|4
99421|NCT01064401|371957|P2|Overall Study|Death|0
99422|NCT01064401|371958|P1|Overall Study|Death|4
99423|NCT01064401|371957|P2|Overall Study|Investigator Decision|6
99424|NCT01064401|371958|P1|Overall Study|Investigator Decision|4
99425|NCT01064401|371957|P2|Overall Study|Consent Withdrawn|80
99426|NCT01064401|371958|P1|Overall Study|Consent Withdrawn|98
99427|NCT01064401|371957|P2|Overall Study|Lost to Follow-up|9
99428|NCT01064401|371958|P1|Overall Study|Lost to Follow-up|12
99429|NCT01064401|371957|P2|Overall Study|Lack of Efficacy|23
99430|NCT01064401|371958|P1|Overall Study|Lack of Efficacy|46
99431|NCT01064401|371957|P2|Overall Study|Adverse Event|56
99432|NCT01064401|371958|P1|Overall Study|Adverse Event|47
99433|NCT01064310|372007|P3|Open Label Pazopinib|Physician Decision|20
99434|NCT01064310|372008|P2|Open Label Pazopinib|Physician Decision|0
99435|NCT01064310|372009|P1|Open Label Pazopinib|Physician Decision|0
99436|NCT01064310|372007|P3|Open Label Pazopinib|Lack of Efficacy|51
99437|NCT01064310|372008|P2|Open Label Pazopinib|Lack of Efficacy|0
99438|NCT01064310|372009|P1|Open Label Pazopinib|Lack of Efficacy|0
99439|NCT01064310|372007|P3|Open Label Pazopinib|Adverse Event|12
99440|NCT01064310|372008|P2|Open Label Pazopinib|Adverse Event|0
99441|NCT01064310|372009|P1|Open Label Pazopinib|Adverse Event|0
99442|NCT01064310|372007|P3|Open Label Pazopinib|Withdrawal by Subject|1
99443|NCT01064310|372008|P2|Open Label Pazopinib|Withdrawal by Subject|0
99444|NCT01064310|372009|P1|Open Label Pazopinib|Withdrawal by Subject|0
99445|NCT01064310|372007|P3|Period 2|Lack of Efficacy|0
99446|NCT01064310|372008|P2|Period 2|Lack of Efficacy|4
99447|NCT01064310|372009|P1|Period 2|Lack of Efficacy|1
99448|NCT01064310|372007|P3|Period 2|Entered Open-label Period|0
99449|NCT01064310|372008|P2|Period 2|Entered Open-label Period|0
99450|NCT01064310|372009|P1|Period 2|Entered Open-label Period|1
99451|NCT01064310|372007|P3|Period 2|Physician Decision|0
99452|NCT01064310|372008|P2|Period 2|Physician Decision|1
99453|NCT01064310|372009|P1|Period 2|Physician Decision|0
99454|NCT01064310|372007|P3|Period 2|Adverse Event|0
99455|NCT01064310|372008|P2|Period 2|Adverse Event|1
99456|NCT01064310|372009|P1|Period 2|Adverse Event|2
99457|NCT01064310|372007|P3|Period 1|Entered Open-label Period|0
99458|NCT01064310|372008|P2|Period 1|Entered Open-label Period|1
99459|NCT01064310|372009|P1|Period 1|Entered Open-label Period|1
99460|NCT01064310|372007|P3|Period 1|Lack of Efficacy|0
99461|NCT01064310|372008|P2|Period 1|Lack of Efficacy|5
99462|NCT01064310|372009|P1|Period 1|Lack of Efficacy|3
99463|NCT01064310|372007|P3|Period 1|Withdrawal by Subject|0
99464|NCT01064310|372008|P2|Period 1|Withdrawal by Subject|2
99465|NCT01064310|372009|P1|Period 1|Withdrawal by Subject|2
99466|NCT01064310|372007|P3|Period 1|Physician Decision|0
99467|NCT01064310|372008|P2|Period 1|Physician Decision|0
99468|NCT01064310|372009|P1|Period 1|Physician Decision|1
99469|NCT01064310|372007|P3|Period 1|Adverse Event|0
99470|NCT01064310|372008|P2|Period 1|Adverse Event|10
99471|NCT01064310|372009|P1|Period 1|Adverse Event|7
99472|NCT01064297|372039|P3|Overall Study|Lost to Follow-up|133
99473|NCT01064297|372040|P2|Overall Study|Lost to Follow-up|48
99474|NCT01064297|372041|P1|Overall Study|Lost to Follow-up|791
99475|NCT01064167|372110|P2|Overall Study|Protocol Violation|15
99476|NCT01064167|372111|P1|Overall Study|Protocol Violation|14
99477|NCT01063881|372158|P3|Overall Study|Reason for not completed not specified|0
99478|NCT01063881|372159|P2|Overall Study|Reason for not completed not specified|1
99479|NCT01063881|372160|P1|Overall Study|Reason for not completed not specified|5
99480|NCT01063881|372158|P3|Overall Study|Withdrawal by Subject|0
99481|NCT01063881|372159|P2|Overall Study|Withdrawal by Subject|1
99482|NCT01063881|372160|P1|Overall Study|Withdrawal by Subject|25
99483|NCT01063881|372158|P3|Overall Study|Lost to Follow-up|1
99484|NCT01063881|372159|P2|Overall Study|Lost to Follow-up|7
99485|NCT01063881|372160|P1|Overall Study|Lost to Follow-up|13
99486|NCT01063881|372158|P3|Overall Study|Adverse Event|0
99487|NCT01063881|372159|P2|Overall Study|Adverse Event|2
99488|NCT01063881|372160|P1|Overall Study|Adverse Event|12
99489|NCT01063868|372184|P2|Overall Study|Study Terminated By Sponsor|4
99490|NCT01063868|372185|P1|Overall Study|Study Terminated By Sponsor|23
99491|NCT01063868|372184|P2|Overall Study|Withdrawal by Subject|1
99492|NCT01063868|372185|P1|Overall Study|Withdrawal by Subject|3
99493|NCT01063868|372184|P2|Overall Study|Adverse Event|7
99494|NCT01063868|372185|P1|Overall Study|Adverse Event|9
99495|NCT01063855|372193|P2|Overall Study|Reason not specified|11
99496|NCT01063855|372194|P1|Overall Study|Reason not specified|13
99497|NCT01063855|372193|P2|Overall Study|Withdrawal by Subject|8
99498|NCT01063855|372194|P1|Overall Study|Withdrawal by Subject|11
99499|NCT01063855|372193|P2|Overall Study|Lack of Efficacy|1
99500|NCT01063855|372194|P1|Overall Study|Lack of Efficacy|0
99501|NCT01063855|372193|P2|Overall Study|Pregnancy|0
99502|NCT01063855|372194|P1|Overall Study|Pregnancy|1
99503|NCT01063855|372193|P2|Overall Study|Lost to Follow-up|4
99504|NCT01063855|372194|P1|Overall Study|Lost to Follow-up|8
99505|NCT01063855|372193|P2|Overall Study|Death|1
99506|NCT01063855|372194|P1|Overall Study|Death|0
99507|NCT01063855|372193|P2|Overall Study|Adverse Event|4
99508|NCT01063855|372194|P1|Overall Study|Adverse Event|4
99509|NCT01063764|372241|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
99510|NCT01063764|372241|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
99511|NCT01063764|372241|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
99512|NCT01063764|372241|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
99513|NCT01063764|372241|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
99514|NCT01063764|372241|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
99515|NCT01063764|372241|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
99516|NCT01063595|372260|P2|First Intervention|Reason not Specified|1
99517|NCT01063595|372261|P1|First Intervention|Reason not Specified|0
99518|NCT01063595|372260|P2|First Intervention|Withdrawal by Subject|0
99519|NCT01063595|372261|P1|First Intervention|Withdrawal by Subject|1
99520|NCT01063595|372260|P2|First Intervention|Adverse Event|4
99521|NCT01063595|372261|P1|First Intervention|Adverse Event|1
99522|NCT01063595|372260|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
99523|NCT01063595|372261|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
99524|NCT01063595|372260|P2|Enrolled in Study and Randomized|Adverse Event|1
99525|NCT01063595|372261|P1|Enrolled in Study and Randomized|Adverse Event|0
99526|NCT01063595|372260|P2|Enrolled in Study and Randomized|Reason not Specified|0
99527|NCT01063595|372261|P1|Enrolled in Study and Randomized|Reason not Specified|1
99528|NCT01063517|372273|P2|Overall Study|Death|48
99529|NCT01063517|372274|P1|Overall Study|Death|33
99530|NCT01063517|372273|P2|Overall Study|Withdrawal by Subject|2
99531|NCT01063517|372274|P1|Overall Study|Withdrawal by Subject|1
99532|NCT01063517|372273|P2|Overall Study|Lost to Follow-up|3
99533|NCT01063517|372274|P1|Overall Study|Lost to Follow-up|4
99534|NCT01063517|372273|P2|Overall Study|Study reached data cut-off|7
99535|NCT01063517|372274|P1|Overall Study|Study reached data cut-off|19
99536|NCT01063517|372273|P2|Overall Study|Consent withdrawal|0
99537|NCT01063517|372274|P1|Overall Study|Consent withdrawal|1
99538|NCT01063348|372314|P2|Overall Study|Lost to Follow-up|10
99539|NCT01063348|372315|P1|Overall Study|Lost to Follow-up|3
99540|NCT01063153|372325|P2|Overall Study|Physician Decision|4
99541|NCT01063153|372326|P1|Overall Study|Physician Decision|0
99542|NCT01063153|372325|P2|Overall Study|Withdrawal by Subject|1
99543|NCT01063153|372326|P1|Overall Study|Withdrawal by Subject|0
99544|NCT01063153|372325|P2|Overall Study|Lost to Follow-up|7
99545|NCT01063153|372326|P1|Overall Study|Lost to Follow-up|0
99546|NCT01063153|372325|P2|Overall Study|Found Ineligible During Screening|0
99547|NCT01063153|372326|P1|Overall Study|Found Ineligible During Screening|2
99548|NCT01063062|372357|P2|Overall Study|Miscellaneous reason|1
99549|NCT01063062|372358|P1|Overall Study|Miscellaneous reason|0
99550|NCT01063062|372357|P2|Overall Study|Lost to Follow-up|2
99551|NCT01063062|372358|P1|Overall Study|Lost to Follow-up|0
99552|NCT01063062|372357|P2|Overall Study|Investigator's request|0
99553|NCT01063062|372358|P1|Overall Study|Investigator's request|1
99554|NCT01063062|372357|P2|Overall Study|Protocol Violation|4
99555|NCT01063062|372358|P1|Overall Study|Protocol Violation|5
99556|NCT01063062|372357|P2|Overall Study|Adverse Event|4
99557|NCT01063062|372358|P1|Overall Study|Adverse Event|2
99558|NCT01063062|372357|P2|Overall Study|Patient withdrew consent|1
99559|NCT01063062|372358|P1|Overall Study|Patient withdrew consent|0
99560|NCT01063036|372412|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
99561|NCT01063036|372412|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
99562|NCT01063036|372412|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
99563|NCT01063036|372412|P1|Participants Treated With Study Drug|Pregnancy|1
99564|NCT01063036|372412|P1|Participants Treated With Study Drug|Lost to Follow-up|1
99565|NCT01063036|372412|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
99566|NCT01063036|372412|P1|Participants Treated With Study Drug|Protocol Violation|1
99567|NCT01063036|372412|P1|Participants Treated With Study Drug|Adverse Event|1
99568|NCT01062841|372428|P2|Overall Study|Withdrawal by Study|0
99569|NCT01062841|372429|P1|Overall Study|Withdrawal by Study|3
99570|NCT01062841|372428|P2|Overall Study|Withdrawal by Subject|0
99571|NCT01062841|372429|P1|Overall Study|Withdrawal by Subject|2
99572|NCT01062841|372428|P2|Overall Study|Death|5
99573|NCT01062841|372429|P1|Overall Study|Death|3
99574|NCT01062841|372428|P2|Overall Study|Indwelling Device Removed|48
99575|NCT01062841|372429|P1|Overall Study|Indwelling Device Removed|41
99576|NCT01062763|372459|P2|Overall Study|Adverse Event|4
99577|NCT01062763|372460|P1|Overall Study|Adverse Event|3
99578|NCT01062425|372472|P2|Overall Study|Protocol Violation|6
99579|NCT01062425|372473|P1|Overall Study|Protocol Violation|3
99580|NCT01062399|372490|P5|Overall Study|Protocol Violation|4
99581|NCT01062399|372491|P4|Overall Study|Protocol Violation|6
99582|NCT01062399|372492|P3|Overall Study|Protocol Violation|0
99583|NCT01062399|372493|P2|Overall Study|Protocol Violation|1
99584|NCT01062399|372494|P1|Overall Study|Protocol Violation|0
99585|NCT01062256|372538|P3|Overall Study|Administrative|0
99586|NCT01062256|372539|P2|Overall Study|Administrative|2
99587|NCT01062256|372540|P1|Overall Study|Administrative|0
99588|NCT01062256|372538|P3|Overall Study|Ineligible|3
99589|NCT01062256|372539|P2|Overall Study|Ineligible|4
99590|NCT01062256|372540|P1|Overall Study|Ineligible|1
99591|NCT01062256|372538|P3|Overall Study|Withdrawal by Subject|1
99592|NCT01062256|372539|P2|Overall Study|Withdrawal by Subject|1
99593|NCT01062256|372540|P1|Overall Study|Withdrawal by Subject|1
99594|NCT01062256|372538|P3|Overall Study|Adverse Event|0
99595|NCT01062256|372539|P2|Overall Study|Adverse Event|0
99596|NCT01062256|372540|P1|Overall Study|Adverse Event|1
99597|NCT01062113|372574|P3|Overall Study|Withdrawal by Subject|0
99598|NCT01062113|372575|P2|Overall Study|Withdrawal by Subject|0
99599|NCT01062113|372576|P1|Overall Study|Withdrawal by Subject|1
99600|NCT01062113|372574|P3|Overall Study|Lack of Efficacy|31
99601|NCT01062113|372575|P2|Overall Study|Lack of Efficacy|22
99602|NCT01062113|372576|P1|Overall Study|Lack of Efficacy|38
99603|NCT01062113|372574|P3|Overall Study|Adverse Event|0
99604|NCT01062113|372575|P2|Overall Study|Adverse Event|0
99605|NCT01062113|372576|P1|Overall Study|Adverse Event|1
99606|NCT01062061|372594|P1|Overall Study|Failed to meet inclusion criteria|2
99607|NCT01062061|372594|P1|Overall Study|Outside chief indications|10
99608|NCT01062061|372594|P1|Overall Study|Investigated before study start|13
99609|NCT01062061|372594|P1|Overall Study|Enrolled more than once|2
99610|NCT01061866|372608|P1|Overall Study|Adverse Event|2
99611|NCT01061775|372612|P1|Overall Study|Lost to Follow-up|1
99612|NCT01061775|372612|P1|Overall Study|Physician Decision|2
99613|NCT01061736|372629|P10|Overall Study|Other than specified above|21
99614|NCT01061736|372630|P9|Overall Study|Other than specified above|15
99615|NCT01061736|372631|P8|Overall Study|Other than specified above|18
99616|NCT01061736|372632|P7|Overall Study|Other than specified above|0
99617|NCT01061736|372633|P6|Overall Study|Other than specified above|0
99618|NCT01061736|372634|P5|Overall Study|Other than specified above|1
99619|NCT01061736|372635|P4|Overall Study|Other than specified above|0
99620|NCT01061736|372636|P3|Overall Study|Other than specified above|2
99621|NCT01061736|372637|P2|Overall Study|Other than specified above|1
99622|NCT01061736|372638|P1|Overall Study|Other than specified above|0
99623|NCT01061736|372629|P10|Overall Study|Not treated|0
99624|NCT01061736|372630|P9|Overall Study|Not treated|1
99625|NCT01061736|372631|P8|Overall Study|Not treated|2
99626|NCT01061736|372632|P7|Overall Study|Not treated|0
99627|NCT01061736|372633|P6|Overall Study|Not treated|0
99628|NCT01061736|372634|P5|Overall Study|Not treated|1
99629|NCT01061736|372635|P4|Overall Study|Not treated|0
99630|NCT01061736|372636|P3|Overall Study|Not treated|0
99631|NCT01061736|372637|P2|Overall Study|Not treated|0
99632|NCT01061736|372638|P1|Overall Study|Not treated|0
99633|NCT01061736|372629|P10|Overall Study|Poor compliance to protocol|9
99634|NCT01061736|372630|P9|Overall Study|Poor compliance to protocol|5
99635|NCT01061736|372631|P8|Overall Study|Poor compliance to protocol|2
99636|NCT01061736|372632|P7|Overall Study|Poor compliance to protocol|0
99637|NCT01061736|372633|P6|Overall Study|Poor compliance to protocol|0
99638|NCT01061736|372634|P5|Overall Study|Poor compliance to protocol|0
99639|NCT01061736|372635|P4|Overall Study|Poor compliance to protocol|0
99640|NCT01061736|372636|P3|Overall Study|Poor compliance to protocol|0
99641|NCT01061736|372637|P2|Overall Study|Poor compliance to protocol|0
99642|NCT01061736|372638|P1|Overall Study|Poor compliance to protocol|0
99643|NCT01061736|372629|P10|Overall Study|Lack of Efficacy|10
99644|NCT01061736|372630|P9|Overall Study|Lack of Efficacy|9
99645|NCT01061736|372631|P8|Overall Study|Lack of Efficacy|9
99646|NCT01061736|372632|P7|Overall Study|Lack of Efficacy|1
99647|NCT01061736|372633|P6|Overall Study|Lack of Efficacy|2
99648|NCT01061736|372634|P5|Overall Study|Lack of Efficacy|1
99649|NCT01061736|372635|P4|Overall Study|Lack of Efficacy|1
99650|NCT01061736|372636|P3|Overall Study|Lack of Efficacy|1
99651|NCT01061736|372637|P2|Overall Study|Lack of Efficacy|2
99652|NCT01061736|372638|P1|Overall Study|Lack of Efficacy|0
99653|NCT01061736|372629|P10|Overall Study|Adverse Event|34
99654|NCT01061736|372630|P9|Overall Study|Adverse Event|67
99655|NCT01061736|372631|P8|Overall Study|Adverse Event|63
99656|NCT01061736|372632|P7|Overall Study|Adverse Event|4
99657|NCT01061736|372633|P6|Overall Study|Adverse Event|1
99658|NCT01061736|372634|P5|Overall Study|Adverse Event|4
99659|NCT01061736|372635|P4|Overall Study|Adverse Event|2
99660|NCT01061736|372636|P3|Overall Study|Adverse Event|3
99661|NCT01061736|372637|P2|Overall Study|Adverse Event|1
99662|NCT01061736|372638|P1|Overall Study|Adverse Event|13
99663|NCT01061736|372629|P10|Overall Study|Dose regimen not selected|0
99664|NCT01061736|372630|P9|Overall Study|Dose regimen not selected|0
99665|NCT01061736|372631|P8|Overall Study|Dose regimen not selected|0
99666|NCT01061736|372632|P7|Overall Study|Dose regimen not selected|79
99667|NCT01061736|372633|P6|Overall Study|Dose regimen not selected|0
99668|NCT01061736|372634|P5|Overall Study|Dose regimen not selected|0
99669|NCT01061736|372635|P4|Overall Study|Dose regimen not selected|0
99670|NCT01061736|372636|P3|Overall Study|Dose regimen not selected|0
99671|NCT01061736|372637|P2|Overall Study|Dose regimen not selected|0
99672|NCT01061736|372638|P1|Overall Study|Dose regimen not selected|0
99673|NCT01061723|372677|P6|Overall Study|Other than specified above|1
99674|NCT01061723|372678|P5|Overall Study|Other than specified above|0
99675|NCT01061723|372679|P4|Overall Study|Other than specified above|1
99676|NCT01061723|372680|P3|Overall Study|Other than specified above|1
99677|NCT01061723|372681|P2|Overall Study|Other than specified above|1
99678|NCT01061723|372682|P1|Overall Study|Other than specified above|2
99679|NCT01061723|372677|P6|Overall Study|Randomized but not treated|1
99680|NCT01061723|372678|P5|Overall Study|Randomized but not treated|0
99681|NCT01061723|372679|P4|Overall Study|Randomized but not treated|0
99682|NCT01061723|372680|P3|Overall Study|Randomized but not treated|0
99683|NCT01061723|372681|P2|Overall Study|Randomized but not treated|0
99684|NCT01061723|372682|P1|Overall Study|Randomized but not treated|0
99685|NCT01061723|372677|P6|Overall Study|Lack of Efficacy|1
99686|NCT01061723|372678|P5|Overall Study|Lack of Efficacy|1
99687|NCT01061723|372679|P4|Overall Study|Lack of Efficacy|2
99688|NCT01061723|372680|P3|Overall Study|Lack of Efficacy|4
99689|NCT01061723|372681|P2|Overall Study|Lack of Efficacy|3
99690|NCT01061723|372682|P1|Overall Study|Lack of Efficacy|2
99691|NCT01061723|372677|P6|Overall Study|Adverse Event|6
99692|NCT01061723|372678|P5|Overall Study|Adverse Event|2
99693|NCT01061723|372679|P4|Overall Study|Adverse Event|5
99694|NCT01061723|372680|P3|Overall Study|Adverse Event|5
99695|NCT01061723|372681|P2|Overall Study|Adverse Event|2
99696|NCT01061723|372682|P1|Overall Study|Adverse Event|0
99697|NCT01061710|372762|P1|Overall Study|Protocol Violation|14
99698|NCT01061671|372772|P2|Overall Study|Death|30
99699|NCT01061671|372773|P1|Overall Study|Death|28
99700|NCT01061671|372772|P2|Overall Study|Lost to Follow-up|5
99701|NCT01061671|372773|P1|Overall Study|Lost to Follow-up|3
99702|NCT01061671|372772|P2|Overall Study|Withdrawal by Subject|20
99703|NCT01061671|372773|P1|Overall Study|Withdrawal by Subject|16
99704|NCT01061606|372785|P1|Overall Study|alternative therapy|2
99705|NCT01061606|372785|P1|Overall Study|Disease Progression|4
99706|NCT01061606|372785|P1|Overall Study|Death|1
99707|NCT01061606|372785|P1|Overall Study|Adverse Event|1
99708|NCT01061567|372794|P1|Overall Study|Other reason than stated above|3
99709|NCT01061567|372794|P1|Overall Study|Withdrawal by Subject|11
99710|NCT01061567|372794|P1|Overall Study|Protocol Violation|1
99711|NCT01061567|372794|P1|Overall Study|Lost to Follow-up|24
99712|NCT01061567|372794|P1|Overall Study|Lack of Efficacy|3
99713|NCT01061567|372794|P1|Overall Study|Death|2
99714|NCT01061567|372794|P1|Overall Study|Adverse Event|32
99715|NCT01061385|372809|P2|Overall Study|subject decision not related to AE|1
99716|NCT01061385|372810|P1|Overall Study|subject decision not related to AE|0
99717|NCT01061385|372809|P2|Overall Study|Lost to Follow-up|0
99718|NCT01061385|372810|P1|Overall Study|Lost to Follow-up|1
99719|NCT01061359|372818|P1|Overall Study|Secondary neoplasm|11
99720|NCT01061359|372818|P1|Overall Study|Relapse|187
99721|NCT01061359|372818|P1|Overall Study|Lost to Follow-up|1072
99722|NCT01061359|372818|P1|Overall Study|Death|32
99723|NCT01061333|372824|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
99724|NCT01061333|372825|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
99725|NCT01061177|372863|P1|Overall Study|Death|4
99726|NCT01061177|372863|P1|Overall Study|Administratie problems|4
99727|NCT01061177|372863|P1|Overall Study|Abnormal test procedure results|4
99728|NCT01061177|372863|P1|Overall Study|Abnormal laboratory values|6
99729|NCT01061177|372863|P1|Overall Study|New cancer therapy|9
99730|NCT01061177|372863|P1|Overall Study|Lost to Follow-up|9
99731|NCT01061177|372863|P1|Overall Study|Protocol Violation|11
99732|NCT01061177|372863|P1|Overall Study|Disease progression|17
99733|NCT01061177|372863|P1|Overall Study|Withdrawal by Subject|27
99734|NCT01061177|372863|P1|Overall Study|Adverse Event|117
99735|NCT01061151|372886|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
99736|NCT01061151|372887|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
99737|NCT01061151|372888|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
99738|NCT01061151|372889|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
99739|NCT01061151|372886|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
99740|NCT01061151|372887|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
99741|NCT01061151|372888|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
99742|NCT01061151|372889|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
99743|NCT01061151|372886|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
99744|NCT01061151|372887|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
99745|NCT01061151|372888|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
99746|NCT01061151|372889|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
99747|NCT01061151|372886|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
99748|NCT01061151|372887|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
99749|NCT01061151|372888|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
99750|NCT01061151|372889|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
99751|NCT01061151|372886|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
99752|NCT01061151|372887|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
99753|NCT01061151|372888|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
99754|NCT01061151|372889|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
99755|NCT01061151|372886|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
99756|NCT01061151|372887|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
99757|NCT01061151|372888|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
99758|NCT01061151|372889|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
99759|NCT01061151|372886|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
99760|NCT01061151|372887|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
99761|NCT01061151|372888|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
99762|NCT01061151|372889|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
99763|NCT01061151|372886|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
99764|NCT01061151|372887|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
99765|NCT01061151|372888|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
99766|NCT01061151|372889|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
99767|NCT01061151|372886|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
99768|NCT01061151|372887|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
99769|NCT01061151|372888|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
99770|NCT01061151|372889|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
99771|NCT01061151|372886|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
99772|NCT01061151|372887|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
99773|NCT01061151|372888|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
99774|NCT01061151|372889|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
99775|NCT01061151|372886|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
99776|NCT01061151|372887|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
99777|NCT01061151|372888|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
99778|NCT01061151|372889|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
99779|NCT01061151|372886|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
99780|NCT01061151|372887|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
99781|NCT01061151|372888|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
99782|NCT01061151|372889|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
99783|NCT01061151|372886|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
99784|NCT01061151|372887|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
99785|NCT01061151|372888|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
99786|NCT01061151|372889|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
99787|NCT01061151|372886|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
99788|NCT01061151|372887|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
99789|NCT01061151|372888|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
99790|NCT01061151|372889|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
99791|NCT01061151|372886|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
99792|NCT01061151|372887|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
99793|NCT01061151|372888|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
99794|NCT01061151|372889|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
99795|NCT01061008|372948|P2|Overall Study|Adverse Event|1
99796|NCT01061008|372949|P1|Overall Study|Adverse Event|0
99797|NCT01061008|372948|P2|Overall Study|Unable to exercise following surgery|0
99798|NCT01061008|372949|P1|Overall Study|Unable to exercise following surgery|1
99799|NCT01061008|372948|P2|Overall Study|Withdrawal by Subject|3
99800|NCT01061008|372949|P1|Overall Study|Withdrawal by Subject|1
99801|NCT01061008|372948|P2|Overall Study|Death|0
99802|NCT01061008|372949|P1|Overall Study|Death|1
99803|NCT01061008|372948|P2|Overall Study|Badiocephalic fistula failed|2
99804|NCT01061008|372949|P1|Overall Study|Badiocephalic fistula failed|3
99805|NCT01060670|372957|P2|Run In|screen failure|238
99806|NCT01060670|372958|P1|Run In|screen failure|0
99807|NCT01060553|372993|P2|Overall Study|Lack of Efficacy|0
99808|NCT01060553|372994|P1|Overall Study|Lack of Efficacy|1
99809|NCT01060553|372993|P2|Overall Study|Withdrawal by Subject|5
99810|NCT01060553|372994|P1|Overall Study|Withdrawal by Subject|5
99811|NCT01060553|372993|P2|Overall Study|Lost to Follow-up|5
99812|NCT01060553|372994|P1|Overall Study|Lost to Follow-up|3
99813|NCT01060540|373001|P2|Overall Study|Physician Decision|1
99814|NCT01060540|373002|P1|Overall Study|Physician Decision|0
99815|NCT01060540|373001|P2|Overall Study|Death|1
99816|NCT01060540|373002|P1|Overall Study|Death|2
99817|NCT01060540|373001|P2|Overall Study|Lost to Follow-up|43
99818|NCT01060540|373002|P1|Overall Study|Lost to Follow-up|52
99819|NCT01060540|373001|P2|Overall Study|Withdrawal by Subject|20
99820|NCT01060540|373002|P1|Overall Study|Withdrawal by Subject|10
99821|NCT01060150|373016|P1|Overall Study|Enrolled, but not treated|2
99822|NCT01060150|373016|P1|Overall Study|Withdrawal by Subject|8
99823|NCT01060150|373016|P1|Overall Study|Protocol Violation|6
99824|NCT01060150|373016|P1|Overall Study|Lost to Follow-up|1
99825|NCT01060150|373016|P1|Overall Study|Adverse Event|6
99826|NCT01060124|373031|P1|Overall Study|Withdrawal by Subject|7
99827|NCT01060124|373031|P1|Overall Study|Adverse Event|14
99828|NCT01060124|373031|P1|Overall Study|Other|16
99829|NCT01060111|373042|P3|Overall Study|Other|4
99830|NCT01060111|373043|P2|Overall Study|Other|3
99831|NCT01060111|373044|P1|Overall Study|Other|2
99832|NCT01060111|373042|P3|Overall Study|Participants' non-cooperation|0
99833|NCT01060111|373043|P2|Overall Study|Participants' non-cooperation|0
99834|NCT01060111|373044|P1|Overall Study|Participants' non-cooperation|1
99835|NCT01060111|373042|P3|Overall Study|Adverse event and insufficient effect|0
99836|NCT01060111|373043|P2|Overall Study|Adverse event and insufficient effect|1
99837|NCT01060111|373044|P1|Overall Study|Adverse event and insufficient effect|0
99838|NCT01060111|373042|P3|Overall Study|Participants' non-cooperation|6
99839|NCT01060111|373043|P2|Overall Study|Participants' non-cooperation|6
99840|NCT01060111|373044|P1|Overall Study|Participants' non-cooperation|8
99841|NCT01060111|373042|P3|Overall Study|Participants' evasion for hospital visit|2
99842|NCT01060111|373043|P2|Overall Study|Participants' evasion for hospital visit|3
99843|NCT01060111|373044|P1|Overall Study|Participants' evasion for hospital visit|0
99844|NCT01060111|373042|P3|Overall Study|Inappropriate participant|5
99845|NCT01060111|373043|P2|Overall Study|Inappropriate participant|4
99846|NCT01060111|373044|P1|Overall Study|Inappropriate participant|5
99847|NCT01060111|373042|P3|Overall Study|Lack of Efficacy|0
99848|NCT01060111|373043|P2|Overall Study|Lack of Efficacy|1
99849|NCT01060111|373044|P1|Overall Study|Lack of Efficacy|2
99850|NCT01060111|373042|P3|Overall Study|Adverse Event|18
99851|NCT01060111|373043|P2|Overall Study|Adverse Event|5
99852|NCT01060111|373044|P1|Overall Study|Adverse Event|9
99853|NCT01060072|373063|P2|Overall Study|Excluded Medications|1
99854|NCT01060072|373064|P1|Overall Study|Excluded Medications|0
99855|NCT01060072|373063|P2|Overall Study|Acute cholecystitis|0
99856|NCT01060072|373064|P1|Overall Study|Acute cholecystitis|1
99857|NCT01060072|373063|P2|Overall Study|Protocol Violation|1
99858|NCT01060072|373064|P1|Overall Study|Protocol Violation|0
99859|NCT01060072|373063|P2|Overall Study|Physician Decision|2
99860|NCT01060072|373064|P1|Overall Study|Physician Decision|0
99861|NCT01060072|373063|P2|Overall Study|Adverse Event|1
99862|NCT01060072|373064|P1|Overall Study|Adverse Event|1
99863|NCT01060059|373080|P2|Overall Study|lack of compliance|2
99864|NCT01060059|373081|P1|Overall Study|lack of compliance|5
99865|NCT01060059|373080|P2|Overall Study|lack of glycemic control|1
99866|NCT01060059|373081|P1|Overall Study|lack of glycemic control|2
99867|NCT01060059|373080|P2|Overall Study|Withdrawal by Subject|23
99868|NCT01060059|373081|P1|Overall Study|Withdrawal by Subject|35
99869|NCT01060059|373080|P2|Overall Study|entry criteria not met|3
99870|NCT01060059|373081|P1|Overall Study|entry criteria not met|4
99871|NCT01060059|373080|P2|Overall Study|Lost to Follow-up|34
99872|NCT01060059|373081|P1|Overall Study|Lost to Follow-up|18
99873|NCT01060059|373080|P2|Overall Study|Death|3
99874|NCT01060059|373081|P1|Overall Study|Death|2
99875|NCT01060059|373080|P2|Overall Study|Adverse Event|1
99876|NCT01060059|373081|P1|Overall Study|Adverse Event|1
99877|NCT01060007|373139|P1|Overall Study|Inevaluable for response at surgery|3
99878|NCT01060007|373139|P1|Overall Study|Withdrawal by Subject|1
99879|NCT01059903|373176|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
99880|NCT01059903|373177|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
99881|NCT01059864|373211|P3|Double-Blind Treatment Phase|Adverse Event|3
99882|NCT01059864|373212|P2|Double-Blind Treatment Phase|Adverse Event|3
99883|NCT01059864|373213|P1|Double-Blind Treatment Phase|Adverse Event|0
99884|NCT01059864|373211|P3|Open-Label Run-In Phase|Protocol Violation|0
99885|NCT01059864|373212|P2|Open-Label Run-In Phase|Protocol Violation|0
99886|NCT01059864|373213|P1|Open-Label Run-In Phase|Protocol Violation|2
99887|NCT01059864|373211|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
99888|NCT01059864|373212|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
99889|NCT01059864|373213|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
99890|NCT01059864|373211|P3|Open-Label Run-In Phase|Lost to Follow-up|0
99891|NCT01059864|373212|P2|Open-Label Run-In Phase|Lost to Follow-up|0
99892|NCT01059864|373213|P1|Open-Label Run-In Phase|Lost to Follow-up|2
99893|NCT01059864|373211|P3|Open-Label Run-In Phase|Lack of Efficacy|0
99894|NCT01059864|373212|P2|Open-Label Run-In Phase|Lack of Efficacy|0
99895|NCT01059864|373213|P1|Open-Label Run-In Phase|Lack of Efficacy|1
99896|NCT01059864|373211|P3|Open-Label Run-In Phase|Adverse Event|0
99897|NCT01059864|373212|P2|Open-Label Run-In Phase|Adverse Event|0
99898|NCT01059864|373213|P1|Open-Label Run-In Phase|Adverse Event|7
99899|NCT01059825|373287|P7|Treatment Period|Adverse event not related to study drug|0
99900|NCT01059825|373288|P6|Treatment Period|Adverse event not related to study drug|1
99901|NCT01059825|373289|P5|Treatment Period|Adverse event not related to study drug|1
99902|NCT01059825|373290|P4|Treatment Period|Adverse event not related to study drug|1
99903|NCT01059825|373291|P3|Treatment Period|Adverse event not related to study drug|2
99904|NCT01059825|373292|P2|Treatment Period|Adverse event not related to study drug|1
99905|NCT01059825|373293|P1|Treatment Period|Adverse event not related to study drug|0
99906|NCT01059825|373287|P7|Treatment Period|Insufficient clinical response|0
99907|NCT01059825|373288|P6|Treatment Period|Insufficient clinical response|0
99908|NCT01059825|373289|P5|Treatment Period|Insufficient clinical response|0
99909|NCT01059825|373290|P4|Treatment Period|Insufficient clinical response|0
99910|NCT01059825|373291|P3|Treatment Period|Insufficient clinical response|0
99911|NCT01059825|373292|P2|Treatment Period|Insufficient clinical response|0
99912|NCT01059825|373293|P1|Treatment Period|Insufficient clinical response|3
99913|NCT01059825|373287|P7|Treatment Period|Adverse event related to study drug|0
99914|NCT01059825|373288|P6|Treatment Period|Adverse event related to study drug|0
99915|NCT01059825|373289|P5|Treatment Period|Adverse event related to study drug|0
99916|NCT01059825|373290|P4|Treatment Period|Adverse event related to study drug|1
99917|NCT01059825|373291|P3|Treatment Period|Adverse event related to study drug|1
99918|NCT01059825|373292|P2|Treatment Period|Adverse event related to study drug|0
99919|NCT01059825|373293|P1|Treatment Period|Adverse event related to study drug|1
99920|NCT01059825|373287|P7|Treatment Period|Protocol Violation|0
99921|NCT01059825|373288|P6|Treatment Period|Protocol Violation|1
99922|NCT01059825|373289|P5|Treatment Period|Protocol Violation|1
99923|NCT01059825|373290|P4|Treatment Period|Protocol Violation|1
99924|NCT01059825|373291|P3|Treatment Period|Protocol Violation|1
99925|NCT01059825|373292|P2|Treatment Period|Protocol Violation|0
99926|NCT01059825|373293|P1|Treatment Period|Protocol Violation|0
99927|NCT01059825|373287|P7|Treatment Period|Other reason not specified|0
99928|NCT01059825|373288|P6|Treatment Period|Other reason not specified|0
99929|NCT01059825|373289|P5|Treatment Period|Other reason not specified|0
99930|NCT01059825|373290|P4|Treatment Period|Other reason not specified|2
99931|NCT01059825|373291|P3|Treatment Period|Other reason not specified|1
99932|NCT01059825|373292|P2|Treatment Period|Other reason not specified|2
99933|NCT01059825|373293|P1|Treatment Period|Other reason not specified|1
99934|NCT01059825|373287|P7|Treatment Period|Withdrawal by Subject|0
99935|NCT01059825|373288|P6|Treatment Period|Withdrawal by Subject|1
99936|NCT01059825|373289|P5|Treatment Period|Withdrawal by Subject|4
99937|NCT01059825|373290|P4|Treatment Period|Withdrawal by Subject|5
99938|NCT01059825|373291|P3|Treatment Period|Withdrawal by Subject|1
99939|NCT01059825|373292|P2|Treatment Period|Withdrawal by Subject|0
99940|NCT01059825|373293|P1|Treatment Period|Withdrawal by Subject|3
99941|NCT01059825|373287|P7|Treatment Period|Lost to Follow-up|0
99942|NCT01059825|373288|P6|Treatment Period|Lost to Follow-up|0
99943|NCT01059825|373289|P5|Treatment Period|Lost to Follow-up|2
99944|NCT01059825|373290|P4|Treatment Period|Lost to Follow-up|1
99945|NCT01059825|373291|P3|Treatment Period|Lost to Follow-up|0
99946|NCT01059825|373292|P2|Treatment Period|Lost to Follow-up|1
99947|NCT01059825|373293|P1|Treatment Period|Lost to Follow-up|2
99948|NCT01059825|373287|P7|Enrolled, Run-in Period|Protocol Violation|5
99949|NCT01059825|373288|P6|Enrolled, Run-in Period|Protocol Violation|0
99950|NCT01059825|373289|P5|Enrolled, Run-in Period|Protocol Violation|0
99951|NCT01059825|373290|P4|Enrolled, Run-in Period|Protocol Violation|0
99952|NCT01059825|373291|P3|Enrolled, Run-in Period|Protocol Violation|0
99953|NCT01059825|373292|P2|Enrolled, Run-in Period|Protocol Violation|0
99954|NCT01059825|373293|P1|Enrolled, Run-in Period|Protocol Violation|0
99955|NCT01059825|373287|P7|Enrolled, Run-in Period|Other reason not specified|7
99956|NCT01059825|373288|P6|Enrolled, Run-in Period|Other reason not specified|0
99957|NCT01059825|373289|P5|Enrolled, Run-in Period|Other reason not specified|0
99958|NCT01059825|373290|P4|Enrolled, Run-in Period|Other reason not specified|0
99959|NCT01059825|373291|P3|Enrolled, Run-in Period|Other reason not specified|0
99960|NCT01059825|373292|P2|Enrolled, Run-in Period|Other reason not specified|0
99961|NCT01059825|373293|P1|Enrolled, Run-in Period|Other reason not specified|0
99962|NCT01059825|373287|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
99963|NCT01059825|373288|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
99964|NCT01059825|373289|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
99965|NCT01059825|373290|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
99966|NCT01059825|373291|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
99967|NCT01059825|373292|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
99968|NCT01059825|373293|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
99969|NCT01059825|373287|P7|Enrolled, Run-in Period|Lost to Follow-up|5
99970|NCT01059825|373288|P6|Enrolled, Run-in Period|Lost to Follow-up|0
99971|NCT01059825|373289|P5|Enrolled, Run-in Period|Lost to Follow-up|0
99972|NCT01059825|373290|P4|Enrolled, Run-in Period|Lost to Follow-up|0
99973|NCT01059825|373291|P3|Enrolled, Run-in Period|Lost to Follow-up|0
99974|NCT01059825|373292|P2|Enrolled, Run-in Period|Lost to Follow-up|0
99975|NCT01059825|373293|P1|Enrolled, Run-in Period|Lost to Follow-up|0
99976|NCT01059825|373287|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
99977|NCT01059825|373288|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
99978|NCT01059825|373289|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
99979|NCT01059825|373290|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
99980|NCT01059825|373291|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
99981|NCT01059825|373292|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
99982|NCT01059825|373293|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
99983|NCT01059825|373287|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
99984|NCT01059825|373288|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
99985|NCT01059825|373289|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
99986|NCT01059825|373290|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
99987|NCT01059825|373291|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
99988|NCT01059825|373292|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
99989|NCT01059825|373293|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
99990|NCT01059812|373480|P2|Overall Study|Unclassified|4
99991|NCT01059812|373481|P1|Overall Study|Unclassified|14
99992|NCT01059812|373480|P2|Overall Study|Withdrawal Criteria|4
99993|NCT01059812|373481|P1|Overall Study|Withdrawal Criteria|9
99994|NCT01059812|373480|P2|Overall Study|Protocol Violation|1
99995|NCT01059812|373481|P1|Overall Study|Protocol Violation|3
99996|NCT01059812|373480|P2|Overall Study|Lack of Efficacy|2
99997|NCT01059812|373481|P1|Overall Study|Lack of Efficacy|2
99998|NCT01059812|373480|P2|Overall Study|Adverse Event|5
99999|NCT01059812|373481|P1|Overall Study|Adverse Event|9
100000|NCT01059799|373497|P2|Overall Study|Other|3
100001|NCT01059799|373498|P1|Overall Study|Other|12
100002|NCT01059799|373497|P2|Overall Study|Withdrawal criteria|2
100003|NCT01059799|373498|P1|Overall Study|Withdrawal criteria|13
100004|NCT01059799|373497|P2|Overall Study|Protocol Violation|2
100005|NCT01059799|373498|P1|Overall Study|Protocol Violation|3
100006|NCT01059799|373497|P2|Overall Study|Lack of Efficacy|0
100007|NCT01059799|373498|P1|Overall Study|Lack of Efficacy|1
100008|NCT01059799|373497|P2|Overall Study|Adverse Event|3
100009|NCT01059799|373498|P1|Overall Study|Adverse Event|2
100010|NCT01059773|373512|P2|Overall Study|Other|3
100011|NCT01059773|373513|P1|Overall Study|Other|1
100012|NCT01059773|373512|P2|Overall Study|Ineligible follow TB screening criteria|1
100013|NCT01059773|373513|P1|Overall Study|Ineligible follow TB screening criteria|0
100014|NCT01059773|373512|P2|Overall Study|Malignancy including squamous cell skin|1
100015|NCT01059773|373513|P1|Overall Study|Malignancy including squamous cell skin|0
100016|NCT01059773|373512|P2|Overall Study|Death|1
100017|NCT01059773|373513|P1|Overall Study|Death|0
100018|NCT01059773|373512|P2|Overall Study|Lack of Efficacy|3
100019|NCT01059773|373513|P1|Overall Study|Lack of Efficacy|3
100020|NCT01059773|373512|P2|Overall Study|Physician Decision|4
100021|NCT01059773|373513|P1|Overall Study|Physician Decision|5
100022|NCT01059773|373512|P2|Overall Study|Protocol Violation|2
100023|NCT01059773|373513|P1|Overall Study|Protocol Violation|6
100024|NCT01059773|373512|P2|Overall Study|Pregnancy|1
100025|NCT01059773|373513|P1|Overall Study|Pregnancy|1
100026|NCT01059773|373512|P2|Overall Study|Lost to Follow-up|1
100027|NCT01059773|373513|P1|Overall Study|Lost to Follow-up|1
100028|NCT01059773|373512|P2|Overall Study|Withdrawal by Subject|5
100029|NCT01059773|373513|P1|Overall Study|Withdrawal by Subject|1
100030|NCT01059773|373512|P2|Overall Study|Adverse Event|2
100031|NCT01059773|373513|P1|Overall Study|Adverse Event|2
100032|NCT01059643|373652|P1|Overall Study|Physician Decision|1
100033|NCT01059643|373652|P1|Overall Study|Withdrawal by Subject|2
100034|NCT01059643|373652|P1|Overall Study|Adverse Event|3
100035|NCT01059630|373667|P2|Maintenance Period (up to 2 Years)|Other|3
100036|NCT01059630|373668|P1|Maintenance Period (up to 2 Years)|Other|0
100037|NCT01059630|373667|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
100038|NCT01059630|373668|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
100039|NCT01059630|373667|P2|Maintenance Period (up to 2 Years)|Death|2
100040|NCT01059630|373668|P1|Maintenance Period (up to 2 Years)|Death|0
100041|NCT01059630|373667|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
100042|NCT01059630|373668|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
100043|NCT01059630|373667|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
100044|NCT01059630|373668|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
100045|NCT01059630|373667|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
100046|NCT01059630|373668|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
100047|NCT01059630|373667|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
100048|NCT01059630|373668|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
100049|NCT01059630|373667|P2|Induction Period (6 Months)|Randomized but not Treated|0
100050|NCT01059630|373668|P1|Induction Period (6 Months)|Randomized but not Treated|4
100051|NCT01059630|373667|P2|Induction Period (6 Months)|Other|0
100052|NCT01059630|373668|P1|Induction Period (6 Months)|Other|1
100053|NCT01059630|373667|P2|Induction Period (6 Months)|Physician Decision|4
100054|NCT01059630|373668|P1|Induction Period (6 Months)|Physician Decision|2
100055|NCT01059630|373667|P2|Induction Period (6 Months)|Death|2
100056|NCT01059630|373668|P1|Induction Period (6 Months)|Death|2
100057|NCT01059630|373667|P2|Induction Period (6 Months)|Withdrawal by Subject|2
100058|NCT01059630|373668|P1|Induction Period (6 Months)|Withdrawal by Subject|7
100059|NCT01059630|373667|P2|Induction Period (6 Months)|Progressive Disease|9
100060|NCT01059630|373668|P1|Induction Period (6 Months)|Progressive Disease|14
100061|NCT01059630|373667|P2|Induction Period (6 Months)|Adverse Event|15
100062|NCT01059630|373668|P1|Induction Period (6 Months)|Adverse Event|30
100063|NCT01059630|373667|P2|Induction Period (6 Months)|Induction ongoing|6
100064|NCT01059630|373668|P1|Induction Period (6 Months)|Induction ongoing|13
100065|NCT01059617|373728|P4|Overall Study|Other|6
100066|NCT01059617|373729|P3|Overall Study|Other|8
100067|NCT01059617|373730|P2|Overall Study|Other|1
100068|NCT01059617|373731|P1|Overall Study|Other|7
100069|NCT01059565|373901|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
100070|NCT01059565|373902|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
100071|NCT01059565|373901|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
100072|NCT01059565|373902|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
100073|NCT01059565|373901|P2|24-Week Open-Label Phase|Subject noncompliance|0
100074|NCT01059565|373902|P1|24-Week Open-Label Phase|Subject noncompliance|1
100075|NCT01059565|373901|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
100076|NCT01059565|373902|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
100077|NCT01059565|373901|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
100078|NCT01059565|373902|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
100079|NCT01059565|373901|P2|24-Week Open-Label Phase|Adverse Event|0
100080|NCT01059565|373902|P1|24-Week Open-Label Phase|Adverse Event|2
100081|NCT01059565|373901|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
100082|NCT01059565|373902|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
100083|NCT01059565|373901|P2|24-Week Randomized Phase|Lost to Follow-up|1
100084|NCT01059565|373902|P1|24-Week Randomized Phase|Lost to Follow-up|0
100085|NCT01059565|373901|P2|24-Week Randomized Phase|Withdrawal by Subject|1
100086|NCT01059565|373902|P1|24-Week Randomized Phase|Withdrawal by Subject|3
100087|NCT01059565|373901|P2|24-Week Randomized Phase|Adverse Event|0
100088|NCT01059565|373902|P1|24-Week Randomized Phase|Adverse Event|5
100089|NCT01059565|373901|P2|24-Week Randomized Phase|Randomized but not treated|0
100090|NCT01059565|373902|P1|24-Week Randomized Phase|Randomized but not treated|1
100091|NCT01059526|373938|P2|Overall Study|Patient found to be dermatographic|0
100092|NCT01059526|373939|P1|Overall Study|Patient found to be dermatographic|1
100093|NCT01059526|373938|P2|Overall Study|Lost to Follow-up|1
100094|NCT01059526|373939|P1|Overall Study|Lost to Follow-up|4
100095|NCT01059526|373938|P2|Overall Study|Withdrawal by Subject|1
100096|NCT01059526|373939|P1|Overall Study|Withdrawal by Subject|3
100097|NCT01059526|373938|P2|Overall Study|Protocol Violation|1
100098|NCT01059526|373939|P1|Overall Study|Protocol Violation|0
100099|NCT01059526|373938|P2|Overall Study|Adverse Event|2
100100|NCT01059526|373939|P1|Overall Study|Adverse Event|2
100101|NCT01059526|373938|P2|Overall Study|Patient enrolled but not treated|17
100102|NCT01059526|373939|P1|Overall Study|Patient enrolled but not treated|20
100103|NCT01059344|373949|P2|Overall Study|Other|6
100104|NCT01059344|373950|P1|Overall Study|Other|3
100105|NCT01059344|373949|P2|Overall Study|Lost to Follow-up|1
100106|NCT01059344|373950|P1|Overall Study|Lost to Follow-up|1
100107|NCT01059344|373949|P2|Overall Study|Withdrawal by Subject|9
100108|NCT01059344|373950|P1|Overall Study|Withdrawal by Subject|6
100109|NCT01059344|373949|P2|Overall Study|Adverse Event|30
100110|NCT01059344|373950|P1|Overall Study|Adverse Event|12
100111|NCT01059175|373974|P2|Overall Study|Lost to Follow-up|1
100112|NCT01059175|373975|P1|Overall Study|Lost to Follow-up|0
100113|NCT01059175|373974|P2|Overall Study|Adverse Event|2
100114|NCT01059175|373975|P1|Overall Study|Adverse Event|4
100115|NCT01059175|373974|P2|Overall Study|Death|17
100116|NCT01059175|373975|P1|Overall Study|Death|17
100117|NCT01059071|373997|P4|Overall Study|Physician Decision|1
100118|NCT01059071|373998|P3|Overall Study|Physician Decision|0
100119|NCT01059071|373999|P2|Overall Study|Physician Decision|0
100120|NCT01059071|374000|P1|Overall Study|Physician Decision|0
100121|NCT01059071|373997|P4|Overall Study|Withdrawal by Subject|2
100122|NCT01059071|373998|P3|Overall Study|Withdrawal by Subject|0
100123|NCT01059071|373999|P2|Overall Study|Withdrawal by Subject|0
100124|NCT01059071|374000|P1|Overall Study|Withdrawal by Subject|1
100125|NCT01059071|373997|P4|Overall Study|Lack of Efficacy|3
100126|NCT01059071|373998|P3|Overall Study|Lack of Efficacy|2
100127|NCT01059071|373999|P2|Overall Study|Lack of Efficacy|4
100128|NCT01059071|374000|P1|Overall Study|Lack of Efficacy|1
100129|NCT01058863|374027|P1|Overall Study|Randomized in error|1
100130|NCT01058863|374027|P1|Overall Study|Sponsor requested withdrawal|1
100131|NCT01058863|374027|P1|Overall Study|Withdrawal by Subject|1
100132|NCT01058863|374027|P1|Overall Study|Lost to Follow-up|1
100133|NCT01058668|374048|P3|Double-blind Treatment Phase|Other Unspecified|0
100134|NCT01058668|374049|P2|Double-blind Treatment Phase|Other Unspecified|1
100135|NCT01058668|374050|P1|Double-blind Treatment Phase|Other Unspecified|1
100136|NCT01058668|374048|P3|Double-blind Treatment Phase|Lost to Follow-up|1
100137|NCT01058668|374049|P2|Double-blind Treatment Phase|Lost to Follow-up|1
100138|NCT01058668|374050|P1|Double-blind Treatment Phase|Lost to Follow-up|0
100139|NCT01058668|374048|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
100140|NCT01058668|374049|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
100141|NCT01058668|374050|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
100142|NCT01058668|374048|P3|Double-blind Treatment Phase|Protocol Violation|2
100143|NCT01058668|374049|P2|Double-blind Treatment Phase|Protocol Violation|1
100144|NCT01058668|374050|P1|Double-blind Treatment Phase|Protocol Violation|1
100145|NCT01058668|374048|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
100146|NCT01058668|374049|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
100147|NCT01058668|374050|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
100148|NCT01058668|374048|P3|Double-blind Treatment Phase|Adverse Event|25
100149|NCT01058668|374049|P2|Double-blind Treatment Phase|Adverse Event|15
100150|NCT01058668|374050|P1|Double-blind Treatment Phase|Adverse Event|8
100151|NCT01058655|374065|P4|Overall Study|Other|4
100152|NCT01058655|374066|P3|Overall Study|Other|0
100153|NCT01058655|374067|P2|Overall Study|Other|0
100154|NCT01058655|374068|P1|Overall Study|Other|0
100155|NCT01058655|374065|P4|Overall Study|Disease Progression|24
100156|NCT01058655|374066|P3|Overall Study|Disease Progression|4
100157|NCT01058655|374067|P2|Overall Study|Disease Progression|2
100158|NCT01058655|374068|P1|Overall Study|Disease Progression|1
100159|NCT01058655|374065|P4|Overall Study|Death|0
100160|NCT01058655|374066|P3|Overall Study|Death|1
100161|NCT01058655|374067|P2|Overall Study|Death|1
100162|NCT01058655|374068|P1|Overall Study|Death|0
100163|NCT01058655|374065|P4|Overall Study|Clinical Progression (non-RECIST)|7
100164|NCT01058655|374066|P3|Overall Study|Clinical Progression (non-RECIST)|0
100165|NCT01058655|374067|P2|Overall Study|Clinical Progression (non-RECIST)|0
100166|NCT01058655|374068|P1|Overall Study|Clinical Progression (non-RECIST)|1
100167|NCT01058655|374065|P4|Overall Study|Symptomatic Deterioration|1
100168|NCT01058655|374066|P3|Overall Study|Symptomatic Deterioration|0
100169|NCT01058655|374067|P2|Overall Study|Symptomatic Deterioration|0
100170|NCT01058655|374068|P1|Overall Study|Symptomatic Deterioration|0
100171|NCT01058655|374065|P4|Overall Study|Prolonged Treatment Delay|2
100172|NCT01058655|374066|P3|Overall Study|Prolonged Treatment Delay|0
100173|NCT01058655|374067|P2|Overall Study|Prolonged Treatment Delay|0
100174|NCT01058655|374068|P1|Overall Study|Prolonged Treatment Delay|0
100175|NCT01058655|374065|P4|Overall Study|Withdrawal by Subject|4
100176|NCT01058655|374066|P3|Overall Study|Withdrawal by Subject|3
100177|NCT01058655|374067|P2|Overall Study|Withdrawal by Subject|0
100178|NCT01058655|374068|P1|Overall Study|Withdrawal by Subject|1
100179|NCT01058642|374086|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
100180|NCT01058642|374087|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
100181|NCT01058642|374088|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
100182|NCT01058642|374089|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
100183|NCT01058642|374086|P4|Treatment Period 1|Protocol Violation|1
100184|NCT01058642|374087|P3|Treatment Period 1|Protocol Violation|0
100185|NCT01058642|374088|P2|Treatment Period 1|Protocol Violation|0
100186|NCT01058642|374089|P1|Treatment Period 1|Protocol Violation|0
100187|NCT01058642|374086|P4|Treatment Period 1|Lack of Efficacy|1
100188|NCT01058642|374087|P3|Treatment Period 1|Lack of Efficacy|0
100189|NCT01058642|374088|P2|Treatment Period 1|Lack of Efficacy|0
100190|NCT01058642|374089|P1|Treatment Period 1|Lack of Efficacy|0
100191|NCT01058642|374086|P4|Treatment Period 1|Withdrawal by Subject|0
100192|NCT01058642|374087|P3|Treatment Period 1|Withdrawal by Subject|0
100193|NCT01058642|374088|P2|Treatment Period 1|Withdrawal by Subject|0
100194|NCT01058642|374089|P1|Treatment Period 1|Withdrawal by Subject|1
100195|NCT01058642|374086|P4|Treatment Period 1|Physician Decision|0
100196|NCT01058642|374087|P3|Treatment Period 1|Physician Decision|1
100197|NCT01058642|374088|P2|Treatment Period 1|Physician Decision|0
100198|NCT01058642|374089|P1|Treatment Period 1|Physician Decision|0
100199|NCT01058642|374086|P4|Treatment Period 1|Adverse Event|0
100200|NCT01058642|374087|P3|Treatment Period 1|Adverse Event|1
100201|NCT01058642|374088|P2|Treatment Period 1|Adverse Event|1
100202|NCT01058642|374089|P1|Treatment Period 1|Adverse Event|0
100203|NCT01058421|374099|P2|6 Month Outcomes|Remained in Other Facility|3
100204|NCT01058421|374100|P1|6 Month Outcomes|Remained in Other Facility|1
100205|NCT01058421|374099|P2|6 Month Outcomes|Lost to Follow-up|21
100206|NCT01058421|374100|P1|6 Month Outcomes|Lost to Follow-up|16
100207|NCT01058421|374099|P2|6 Month Outcomes|Death|2
100208|NCT01058421|374100|P1|6 Month Outcomes|Death|2
100209|NCT01058421|374099|P2|3 Month Outcomes|Remained in Other Facility|8
100210|NCT01058421|374100|P1|3 Month Outcomes|Remained in Other Facility|5
100211|NCT01058421|374099|P2|3 Month Outcomes|Remained in Hospital|2
100212|NCT01058421|374100|P1|3 Month Outcomes|Remained in Hospital|0
100213|NCT01058421|374099|P2|3 Month Outcomes|Lost to Follow-up|11
100214|NCT01058421|374100|P1|3 Month Outcomes|Lost to Follow-up|12
100215|NCT01058421|374099|P2|3 Month Outcomes|Death|5
100216|NCT01058421|374100|P1|3 Month Outcomes|Death|3
100217|NCT01058421|374099|P2|1 Month Outcomes|Remained in Other Facility|17
100218|NCT01058421|374100|P1|1 Month Outcomes|Remained in Other Facility|16
100219|NCT01058421|374099|P2|1 Month Outcomes|Remained in Hospital|12
100220|NCT01058421|374100|P1|1 Month Outcomes|Remained in Hospital|5
100221|NCT01058421|374099|P2|1 Month Outcomes|Lost to Follow-up|7
100222|NCT01058421|374100|P1|1 Month Outcomes|Lost to Follow-up|8
100223|NCT01058421|374099|P2|1 Month Outcomes|Death|6
100224|NCT01058421|374100|P1|1 Month Outcomes|Death|10
100225|NCT01058356|374122|P1|Overall Study|Lost to Follow-up|4
100226|NCT01058356|374122|P1|Overall Study|Withdrawal by Subject|21
100227|NCT01058356|374122|P1|Overall Study|Administration of contraindicated drugs|12
100228|NCT01058356|374122|P1|Overall Study|Adverse Event|5
100229|NCT01058304|374129|P2|Overall Study|Developed exclusion criterion|12
100230|NCT01058304|374130|P1|Overall Study|Developed exclusion criterion|6
100231|NCT01058304|374129|P2|Overall Study|Lost to Follow-up|16
100232|NCT01058304|374130|P1|Overall Study|Lost to Follow-up|13
100233|NCT01058304|374129|P2|Overall Study|Withdrawal by Subject|5
100234|NCT01058304|374130|P1|Overall Study|Withdrawal by Subject|8
100235|NCT01058265|374140|P2|Overall Study|Lost to Follow-up|12
100236|NCT01058265|374141|P1|Overall Study|Lost to Follow-up|11
100237|NCT01058096|374160|P2|Double-blind Treatment Phase|Other Unspecified|0
100238|NCT01058096|374161|P1|Double-blind Treatment Phase|Other Unspecified|2
100239|NCT01058096|374160|P2|Double-blind Treatment Phase|Lost to Follow-up|1
100240|NCT01058096|374161|P1|Double-blind Treatment Phase|Lost to Follow-up|0
100241|NCT01058096|374160|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
100242|NCT01058096|374161|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
100243|NCT01058096|374160|P2|Double-blind Treatment Phase|Protocol Violation|1
100244|NCT01058096|374161|P1|Double-blind Treatment Phase|Protocol Violation|2
100245|NCT01058096|374160|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
100246|NCT01058096|374161|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
100247|NCT01058096|374160|P2|Double-blind Treatment Phase|Adverse Event|15
100248|NCT01058096|374161|P1|Double-blind Treatment Phase|Adverse Event|11
100249|NCT01058005|374177|P3|Overall Study|Reason Missing|1
100250|NCT01058005|374178|P2|Overall Study|Reason Missing|3
100251|NCT01058005|374179|P1|Overall Study|Reason Missing|5
100252|NCT01058005|374177|P3|Overall Study|Withdrawn Due to Study Termination|7
100253|NCT01058005|374178|P2|Overall Study|Withdrawn Due to Study Termination|13
100254|NCT01058005|374179|P1|Overall Study|Withdrawn Due to Study Termination|27
100255|NCT01058005|374177|P3|Overall Study|Withdrawal by Subject|11
100256|NCT01058005|374178|P2|Overall Study|Withdrawal by Subject|5
100257|NCT01058005|374179|P1|Overall Study|Withdrawal by Subject|4
100258|NCT01058005|374177|P3|Overall Study|Physician Decision|0
100259|NCT01058005|374178|P2|Overall Study|Physician Decision|2
100260|NCT01058005|374179|P1|Overall Study|Physician Decision|2
100261|NCT01058005|374177|P3|Overall Study|Adverse Event|1
100262|NCT01058005|374178|P2|Overall Study|Adverse Event|2
100263|NCT01058005|374179|P1|Overall Study|Adverse Event|0
100264|NCT01057862|374214|P2|Overall Study|Withdrawal by Subject|2
100265|NCT01057862|374215|P1|Overall Study|Withdrawal by Subject|1
100266|NCT01057810|374225|P2|Overall Study|Other|14
100267|NCT01057810|374226|P1|Overall Study|Other|7
100268|NCT01057810|374225|P2|Overall Study|No longer met study criteria|1
100269|NCT01057810|374226|P1|Overall Study|No longer met study criteria|0
100270|NCT01057810|374225|P2|Overall Study|Poor/non-compliance|1
100271|NCT01057810|374226|P1|Overall Study|Poor/non-compliance|0
100272|NCT01057810|374225|P2|Overall Study|Maximum clinical benefit|5
100273|NCT01057810|374226|P1|Overall Study|Maximum clinical benefit|5
100274|NCT01057810|374225|P2|Overall Study|Death|12
100275|NCT01057810|374226|P1|Overall Study|Death|2
100276|NCT01057810|374225|P2|Overall Study|Withdrawal by Subject|25
100277|NCT01057810|374226|P1|Overall Study|Withdrawal by Subject|10
100278|NCT01057810|374225|P2|Overall Study|Adverse event unrelated to study drug|29
100279|NCT01057810|374226|P1|Overall Study|Adverse event unrelated to study drug|13
100280|NCT01057810|374225|P2|Overall Study|Study drug toxicity|114
100281|NCT01057810|374226|P1|Overall Study|Study drug toxicity|5
100282|NCT01057810|374225|P2|Overall Study|Disease progression|197
100283|NCT01057810|374226|P1|Overall Study|Disease progression|156
100284|NCT01057693|374242|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
100285|NCT01057693|374243|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
100286|NCT01057693|374244|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
100287|NCT01057693|374242|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
100288|NCT01057693|374243|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
100289|NCT01057693|374244|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
100290|NCT01057693|374242|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
100291|NCT01057693|374243|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
100292|NCT01057693|374244|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
100293|NCT01057693|374242|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
100294|NCT01057693|374243|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
100295|NCT01057693|374244|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
100296|NCT01057693|374242|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
100297|NCT01057693|374243|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
100298|NCT01057693|374244|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
100299|NCT01057693|374242|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
100300|NCT01057693|374243|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
100301|NCT01057693|374244|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
100302|NCT01057693|374242|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
100303|NCT01057693|374243|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
100304|NCT01057693|374244|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
100305|NCT01057693|374242|P3|Between Single-Blind and Double-Blind|Other|0
100306|NCT01057693|374243|P2|Between Single-Blind and Double-Blind|Other|0
100307|NCT01057693|374244|P1|Between Single-Blind and Double-Blind|Other|6
100308|NCT01057693|374242|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
100309|NCT01057693|374243|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
100310|NCT01057693|374244|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
100311|NCT01057693|374242|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
100312|NCT01057693|374243|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
100313|NCT01057693|374244|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
100314|NCT01057693|374242|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
100315|NCT01057693|374243|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
100316|NCT01057693|374244|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
100317|NCT01057693|374242|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
100318|NCT01057693|374243|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
100319|NCT01057693|374244|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
100320|NCT01057693|374242|P3|Between Single-Blind and Double-Blind|Adverse Event|0
100321|NCT01057693|374243|P2|Between Single-Blind and Double-Blind|Adverse Event|0
100322|NCT01057693|374244|P1|Between Single-Blind and Double-Blind|Adverse Event|5
100323|NCT01057693|374242|P3|Single-Blind Phase (Up to Week 6)|Other|0
100324|NCT01057693|374243|P2|Single-Blind Phase (Up to Week 6)|Other|0
100325|NCT01057693|374244|P1|Single-Blind Phase (Up to Week 6)|Other|2
100326|NCT01057693|374242|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
100327|NCT01057693|374243|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
100328|NCT01057693|374244|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
100329|NCT01057693|374242|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
100330|NCT01057693|374243|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
100331|NCT01057693|374244|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
100332|NCT01057693|374242|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
100333|NCT01057693|374243|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
100334|NCT01057693|374244|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
100335|NCT01057693|374242|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
100336|NCT01057693|374243|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
100337|NCT01057693|374244|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
100338|NCT01057693|374242|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
100339|NCT01057693|374243|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
100340|NCT01057693|374244|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
100341|NCT01057589|374290|P1|Overall Study|Lost to Follow-up|1
100342|NCT01057589|374290|P1|Overall Study|Death|8
100343|NCT01057589|374290|P1|Overall Study|Sponsor Decision|1
100344|NCT01057589|374290|P1|Overall Study|Withdrawal by Subject|3
100345|NCT01057589|374290|P1|Overall Study|Physician Decision|8
100346|NCT01057589|374290|P1|Overall Study|Adverse Event|10
100347|NCT01057589|374290|P1|Overall Study|Disease Progression|35
100348|NCT01057433|374299|P1|Overall Study|Adverse Event|1
100349|NCT01057394|374303|P2|Overall Study|Not eligible|2
100350|NCT01057394|374304|P1|Overall Study|Not eligible|0
100351|NCT01057251|374314|P2|Overall Study|Other Reason|1
100352|NCT01057251|374315|P1|Overall Study|Other Reason|1
100353|NCT01057251|374314|P2|Overall Study|Lost to Follow-up|6
100354|NCT01057251|374315|P1|Overall Study|Lost to Follow-up|7
100355|NCT01057251|374314|P2|Overall Study|Withdrawal by Subject|5
100356|NCT01057251|374315|P1|Overall Study|Withdrawal by Subject|4
100357|NCT01057251|374314|P2|Overall Study|Protocol Violation|2
100358|NCT01057251|374315|P1|Overall Study|Protocol Violation|6
100359|NCT01057251|374314|P2|Overall Study|Lack of Efficacy|11
100360|NCT01057251|374315|P1|Overall Study|Lack of Efficacy|2
100361|NCT01057251|374314|P2|Overall Study|Adverse Event|2
100362|NCT01057251|374315|P1|Overall Study|Adverse Event|4
100363|NCT01057251|374314|P2|Overall Study|Did not meet InclusionExclusion criteria|2
100364|NCT01057251|374315|P1|Overall Study|Did not meet InclusionExclusion criteria|4
100365|NCT01056822|374393|P2|Overall Study|Lost to Follow-up|0
100366|NCT01056822|374394|P1|Overall Study|Lost to Follow-up|1
100367|NCT01056822|374393|P2|Overall Study|Withdrawal by Subject|1
100368|NCT01056822|374394|P1|Overall Study|Withdrawal by Subject|1
100369|NCT01056822|374393|P2|Overall Study|Protocol Violation|5
100370|NCT01056822|374394|P1|Overall Study|Protocol Violation|6
100371|NCT01056822|374393|P2|Overall Study|Adverse Event|1
100372|NCT01056822|374394|P1|Overall Study|Adverse Event|0
100373|NCT01056718|374443|P1|Overall Study|Ischemia on baseline stress test|1
100374|NCT01056718|374443|P1|Overall Study|Withdrawal by Subject|2
100375|NCT01056653|374476|P3|Overall Study|Lost to Follow-up|2
100376|NCT01056653|374477|P2|Overall Study|Lost to Follow-up|0
100377|NCT01056653|374478|P1|Overall Study|Lost to Follow-up|0
100378|NCT01056640|374494|P2|Overall Study|Death|4
100379|NCT01056640|374495|P1|Overall Study|Death|15
100380|NCT01056640|374494|P2|Overall Study|Withdrawal by Subject|8
100381|NCT01056640|374495|P1|Overall Study|Withdrawal by Subject|11
100382|NCT01056523|374507|P7|Overall Study|Death|1
100383|NCT01056523|374508|P6|Overall Study|Death|0
100384|NCT01056523|374509|P5|Overall Study|Death|0
100385|NCT01056523|374510|P4|Overall Study|Death|3
100386|NCT01056523|374511|P3|Overall Study|Death|2
100387|NCT01056523|374512|P2|Overall Study|Death|0
100388|NCT01056523|374513|P1|Overall Study|Death|1
100389|NCT01056510|374523|P2|Overall Study|Missing|1
100390|NCT01056510|374524|P1|Overall Study|Missing|0
100391|NCT01056510|374523|P2|Overall Study|Not Specified|12
100392|NCT01056510|374524|P1|Overall Study|Not Specified|10
100393|NCT01056510|374523|P2|Overall Study|Lost to Follow-up|6
100394|NCT01056510|374524|P1|Overall Study|Lost to Follow-up|5
100395|NCT01056510|374523|P2|Overall Study|Physician Decision|5
100396|NCT01056510|374524|P1|Overall Study|Physician Decision|4
100397|NCT01056510|374523|P2|Overall Study|Noncompliance|3
100398|NCT01056510|374524|P1|Overall Study|Noncompliance|1
100399|NCT01056510|374523|P2|Overall Study|Death|34
100400|NCT01056510|374524|P1|Overall Study|Death|29
100401|NCT01056510|374523|P2|Overall Study|Withdrawal by Subject|2
100402|NCT01056510|374524|P1|Overall Study|Withdrawal by Subject|4
100403|NCT01056510|374523|P2|Overall Study|Dropout Before Start of Treatment|1
100404|NCT01056510|374524|P1|Overall Study|Dropout Before Start of Treatment|1
100405|NCT01056484|374570|P2|Follow up - Non-randomized|Withdrawal by Subject|2
100406|NCT01056484|374571|P1|Follow up - Non-randomized|Withdrawal by Subject|0
100407|NCT01056484|374570|P2|Randomized Controlled Trial|Physician Decision|0
100408|NCT01056484|374571|P1|Randomized Controlled Trial|Physician Decision|1
100409|NCT01056484|374570|P2|Randomized Controlled Trial|Withdrawal by Subject|1
100410|NCT01056484|374571|P1|Randomized Controlled Trial|Withdrawal by Subject|6
100411|NCT01056380|374587|P2|Overall Study|Lost to Follow-up|3
100412|NCT01056380|374588|P1|Overall Study|Lost to Follow-up|2
100413|NCT01056341|374615|P5|Overall Study|Other reasons|5
100414|NCT01056341|374616|P4|Overall Study|Other reasons|9
100415|NCT01056341|374617|P3|Overall Study|Other reasons|8
100416|NCT01056341|374618|P2|Overall Study|Other reasons|4
100417|NCT01056341|374619|P1|Overall Study|Other reasons|4
100418|NCT01056341|374615|P5|Overall Study|Lack of Efficacy|9
100419|NCT01056341|374616|P4|Overall Study|Lack of Efficacy|25
100420|NCT01056341|374617|P3|Overall Study|Lack of Efficacy|7
100421|NCT01056341|374618|P2|Overall Study|Lack of Efficacy|30
100422|NCT01056341|374619|P1|Overall Study|Lack of Efficacy|32
100423|NCT01056341|374615|P5|Overall Study|Treatment Intolerance|0
100424|NCT01056341|374616|P4|Overall Study|Treatment Intolerance|2
100425|NCT01056341|374617|P3|Overall Study|Treatment Intolerance|0
100426|NCT01056341|374618|P2|Overall Study|Treatment Intolerance|2
100427|NCT01056341|374619|P1|Overall Study|Treatment Intolerance|0
100428|NCT01056289|374692|P4|Double-blind Phase|Physician Decision|0
100429|NCT01056289|374693|P3|Double-blind Phase|Physician Decision|1
100430|NCT01056289|374694|P2|Double-blind Phase|Physician Decision|0
100431|NCT01056289|374695|P1|Double-blind Phase|Physician Decision|0
100432|NCT01056289|374692|P4|Double-blind Phase|Discontinuation symptom|2
100433|NCT01056289|374693|P3|Double-blind Phase|Discontinuation symptom|2
100434|NCT01056289|374694|P2|Double-blind Phase|Discontinuation symptom|1
100435|NCT01056289|374695|P1|Double-blind Phase|Discontinuation symptom|0
100436|NCT01056289|374692|P4|Double-blind Phase|Withdrawal by Subject|2
100437|NCT01056289|374693|P3|Double-blind Phase|Withdrawal by Subject|4
100438|NCT01056289|374694|P2|Double-blind Phase|Withdrawal by Subject|0
100439|NCT01056289|374695|P1|Double-blind Phase|Withdrawal by Subject|0
100440|NCT01056289|374692|P4|Double-blind Phase|Protocol Violation|1
100441|NCT01056289|374693|P3|Double-blind Phase|Protocol Violation|1
100442|NCT01056289|374694|P2|Double-blind Phase|Protocol Violation|0
100443|NCT01056289|374695|P1|Double-blind Phase|Protocol Violation|0
100444|NCT01056289|374692|P4|Double-blind Phase|Other|2
100445|NCT01056289|374693|P3|Double-blind Phase|Other|1
100446|NCT01056289|374694|P2|Double-blind Phase|Other|0
100447|NCT01056289|374695|P1|Double-blind Phase|Other|0
100448|NCT01056289|374692|P4|Double-blind Phase|Lost to Follow-up|2
100449|NCT01056289|374693|P3|Double-blind Phase|Lost to Follow-up|2
100450|NCT01056289|374694|P2|Double-blind Phase|Lost to Follow-up|2
100451|NCT01056289|374695|P1|Double-blind Phase|Lost to Follow-up|0
100452|NCT01056289|374692|P4|Double-blind Phase|Adverse Event|1
100453|NCT01056289|374693|P3|Double-blind Phase|Adverse Event|2
100454|NCT01056289|374694|P2|Double-blind Phase|Adverse Event|1
100455|NCT01056289|374695|P1|Double-blind Phase|Adverse Event|0
100456|NCT01056289|374692|P4|Open-label Phase|Not randomized to Double-blind phase|0
100457|NCT01056289|374693|P3|Open-label Phase|Not randomized to Double-blind phase|0
100458|NCT01056289|374694|P2|Open-label Phase|Not randomized to Double-blind phase|0
100459|NCT01056289|374695|P1|Open-label Phase|Not randomized to Double-blind phase|1
100460|NCT01056289|374692|P4|Open-label Phase|Lack of Efficacy|0
100461|NCT01056289|374693|P3|Open-label Phase|Lack of Efficacy|0
100462|NCT01056289|374694|P2|Open-label Phase|Lack of Efficacy|0
100463|NCT01056289|374695|P1|Open-label Phase|Lack of Efficacy|18
100464|NCT01056289|374692|P4|Open-label Phase|Withdrawal by Subject|0
100465|NCT01056289|374693|P3|Open-label Phase|Withdrawal by Subject|0
100466|NCT01056289|374694|P2|Open-label Phase|Withdrawal by Subject|0
100467|NCT01056289|374695|P1|Open-label Phase|Withdrawal by Subject|26
100468|NCT01056289|374692|P4|Open-label Phase|Protocol Violation|0
100469|NCT01056289|374693|P3|Open-label Phase|Protocol Violation|0
100470|NCT01056289|374694|P2|Open-label Phase|Protocol Violation|0
100471|NCT01056289|374695|P1|Open-label Phase|Protocol Violation|6
100472|NCT01056289|374692|P4|Open-label Phase|Other|0
100473|NCT01056289|374693|P3|Open-label Phase|Other|0
100474|NCT01056289|374694|P2|Open-label Phase|Other|0
100475|NCT01056289|374695|P1|Open-label Phase|Other|9
100476|NCT01056289|374692|P4|Open-label Phase|Lost to Follow-up|0
100477|NCT01056289|374693|P3|Open-label Phase|Lost to Follow-up|0
100478|NCT01056289|374694|P2|Open-label Phase|Lost to Follow-up|0
100479|NCT01056289|374695|P1|Open-label Phase|Lost to Follow-up|30
100480|NCT01056289|374692|P4|Open-label Phase|Adverse Event|0
100481|NCT01056289|374693|P3|Open-label Phase|Adverse Event|0
100482|NCT01056289|374694|P2|Open-label Phase|Adverse Event|0
100483|NCT01056289|374695|P1|Open-label Phase|Adverse Event|29
100484|NCT01056276|374712|P2|Maintenance Therapy|Continuing maintenance therapy|14
100485|NCT01056276|374713|P1|Maintenance Therapy|Continuing maintenance therapy|0
100486|NCT01056276|374712|P2|Maintenance Therapy|Intercurrent Illness|1
100487|NCT01056276|374713|P1|Maintenance Therapy|Intercurrent Illness|0
100488|NCT01056276|374712|P2|Maintenance Therapy|Withdrawal by Subject|1
100489|NCT01056276|374713|P1|Maintenance Therapy|Withdrawal by Subject|0
100490|NCT01056276|374712|P2|Maintenance Therapy|Physician Decision|1
100491|NCT01056276|374713|P1|Maintenance Therapy|Physician Decision|0
100492|NCT01056276|374712|P2|Maintenance Therapy|Progressive Disease|9
100493|NCT01056276|374713|P1|Maintenance Therapy|Progressive Disease|0
100494|NCT01056276|374712|P2|Maintenance Therapy|Toxicity|2
100495|NCT01056276|374713|P1|Maintenance Therapy|Toxicity|0
100496|NCT01056276|374712|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
100497|NCT01056276|374713|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
100498|NCT01056276|374712|P2|Treatment Period-Cycles 1-8|Death|1
100499|NCT01056276|374713|P1|Treatment Period-Cycles 1-8|Death|3
100500|NCT01056276|374712|P2|Treatment Period-Cycles 1-8|Physician Decision|0
100501|NCT01056276|374713|P1|Treatment Period-Cycles 1-8|Physician Decision|3
100502|NCT01056276|374712|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
100503|NCT01056276|374713|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
100504|NCT01056276|374712|P2|Treatment Period-Cycles 1-8|Disease Progression|2
100505|NCT01056276|374713|P1|Treatment Period-Cycles 1-8|Disease Progression|2
100506|NCT01056276|374712|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
100507|NCT01056276|374713|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
100508|NCT01056276|374712|P2|Treatment Period-Cycles 1-8|Toxicity|1
100509|NCT01056276|374713|P1|Treatment Period-Cycles 1-8|Toxicity|2
100510|NCT01056263|374727|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
100511|NCT01056263|374727|P1|Overall Study|Objective progression or relapse|1
100512|NCT01056263|374727|P1|Overall Study|Neoplasm progression|1
100513|NCT01056263|374727|P1|Overall Study|Progressive disease|2
100514|NCT01056263|374727|P1|Overall Study|Lack of Efficacy|29
100515|NCT01056263|374727|P1|Overall Study|Withdrawal by Subject|1
100516|NCT01056263|374727|P1|Overall Study|Death|1
100517|NCT01056263|374727|P1|Overall Study|Adverse Event|12
100518|NCT01056107|374750|P4|Overall Study|Withdrawal by Subject|0
100519|NCT01056107|374751|P3|Overall Study|Withdrawal by Subject|3
100520|NCT01056107|374752|P2|Overall Study|Withdrawal by Subject|1
100521|NCT01056107|374753|P1|Overall Study|Withdrawal by Subject|0
100522|NCT01055886|374810|P2|Overall Study|Withdrawal by PI|1
100523|NCT01055886|374811|P1|Overall Study|Withdrawal by PI|0
100524|NCT01055886|374810|P2|Overall Study|Lost to Follow-up|1
100525|NCT01055886|374811|P1|Overall Study|Lost to Follow-up|1
100526|NCT01055886|374810|P2|Overall Study|Withdrawal by Subject|9
100527|NCT01055886|374811|P1|Overall Study|Withdrawal by Subject|4
100528|NCT01055834|374823|P2|Treatment Period I|Adverse Event|0
100529|NCT01055834|374824|P1|Treatment Period I|Adverse Event|1
100530|NCT01055639|374909|P2|Overall Study|Withdrawal by Subject|11
100531|NCT01055639|374910|P1|Overall Study|Withdrawal by Subject|8
100532|NCT01055639|374909|P2|Overall Study|Protocol Violation|5
100533|NCT01055639|374910|P1|Overall Study|Protocol Violation|5
100534|NCT01055639|374909|P2|Overall Study|Lost to Follow-up|11
100535|NCT01055639|374910|P1|Overall Study|Lost to Follow-up|8
100536|NCT01055639|374909|P2|Overall Study|Lack of Efficacy|1
100537|NCT01055639|374910|P1|Overall Study|Lack of Efficacy|0
100538|NCT01055639|374909|P2|Overall Study|Adverse Event|1
100539|NCT01055639|374910|P1|Overall Study|Adverse Event|0
100540|NCT01055613|374934|P2|Overall Study|Subject Disinterest|1
100541|NCT01055613|374935|P1|Overall Study|Subject Disinterest|1
100542|NCT01055613|374934|P2|Overall Study|Protocol Violation|1
100543|NCT01055613|374935|P1|Overall Study|Protocol Violation|1
100544|NCT01055613|374934|P2|Overall Study|Lost to Follow-up|1
100545|NCT01055613|374935|P1|Overall Study|Lost to Follow-up|1
100546|NCT01055613|374934|P2|Overall Study|Discomfort|1
100547|NCT01055613|374935|P1|Overall Study|Discomfort|2
100548|NCT01055613|374934|P2|Overall Study|Unacceptable lens fit|0
100549|NCT01055613|374935|P1|Overall Study|Unacceptable lens fit|1
100550|NCT01055613|374934|P2|Overall Study|No Longer Meets Eligibility Criteria|0
100551|NCT01055613|374935|P1|Overall Study|No Longer Meets Eligibility Criteria|3
100552|NCT01055457|374953|P10|Overall Study|Adverse Event|0
100553|NCT01055457|374954|P9|Overall Study|Adverse Event|0
100554|NCT01055457|374955|P8|Overall Study|Adverse Event|0
100555|NCT01055457|374956|P7|Overall Study|Adverse Event|0
100556|NCT01055457|374957|P6|Overall Study|Adverse Event|0
100557|NCT01055457|374958|P5|Overall Study|Adverse Event|0
100558|NCT01055457|374959|P4|Overall Study|Adverse Event|1
100559|NCT01055457|374960|P3|Overall Study|Adverse Event|0
100560|NCT01055457|374961|P2|Overall Study|Adverse Event|0
100561|NCT01055457|374962|P1|Overall Study|Adverse Event|0
100562|NCT01055457|374953|P10|Overall Study|Pregnancy|0
100563|NCT01055457|374954|P9|Overall Study|Pregnancy|0
100564|NCT01055457|374955|P8|Overall Study|Pregnancy|0
100565|NCT01055457|374956|P7|Overall Study|Pregnancy|0
100566|NCT01055457|374957|P6|Overall Study|Pregnancy|0
100567|NCT01055457|374958|P5|Overall Study|Pregnancy|0
100568|NCT01055457|374959|P4|Overall Study|Pregnancy|1
100569|NCT01055457|374960|P3|Overall Study|Pregnancy|0
100570|NCT01055457|374961|P2|Overall Study|Pregnancy|0
100571|NCT01055457|374962|P1|Overall Study|Pregnancy|0
100572|NCT01055457|374953|P10|Overall Study|Discomfort|0
100573|NCT01055457|374954|P9|Overall Study|Discomfort|0
100574|NCT01055457|374955|P8|Overall Study|Discomfort|0
100575|NCT01055457|374956|P7|Overall Study|Discomfort|0
100576|NCT01055457|374957|P6|Overall Study|Discomfort|0
100577|NCT01055457|374958|P5|Overall Study|Discomfort|1
100578|NCT01055457|374959|P4|Overall Study|Discomfort|0
100579|NCT01055457|374960|P3|Overall Study|Discomfort|0
100580|NCT01055457|374961|P2|Overall Study|Discomfort|0
100581|NCT01055457|374962|P1|Overall Study|Discomfort|0
100582|NCT01055457|374953|P10|Overall Study|Subject Ineligible|0
100583|NCT01055457|374954|P9|Overall Study|Subject Ineligible|0
100584|NCT01055457|374955|P8|Overall Study|Subject Ineligible|0
100585|NCT01055457|374956|P7|Overall Study|Subject Ineligible|0
100586|NCT01055457|374957|P6|Overall Study|Subject Ineligible|0
100587|NCT01055457|374958|P5|Overall Study|Subject Ineligible|1
100588|NCT01055457|374959|P4|Overall Study|Subject Ineligible|0
100589|NCT01055457|374960|P3|Overall Study|Subject Ineligible|1
100590|NCT01055457|374961|P2|Overall Study|Subject Ineligible|0
100591|NCT01055457|374962|P1|Overall Study|Subject Ineligible|1
100592|NCT01055457|374953|P10|Overall Study|Subject Disinterest|0
100593|NCT01055457|374954|P9|Overall Study|Subject Disinterest|0
100594|NCT01055457|374955|P8|Overall Study|Subject Disinterest|1
100595|NCT01055457|374956|P7|Overall Study|Subject Disinterest|0
100596|NCT01055457|374957|P6|Overall Study|Subject Disinterest|0
100597|NCT01055457|374958|P5|Overall Study|Subject Disinterest|0
100598|NCT01055457|374959|P4|Overall Study|Subject Disinterest|0
100599|NCT01055457|374960|P3|Overall Study|Subject Disinterest|0
100600|NCT01055457|374961|P2|Overall Study|Subject Disinterest|0
100601|NCT01055457|374962|P1|Overall Study|Subject Disinterest|0
100602|NCT01055457|374953|P10|Overall Study|Protocol Violation|1
100603|NCT01055457|374954|P9|Overall Study|Protocol Violation|0
100604|NCT01055457|374955|P8|Overall Study|Protocol Violation|0
100605|NCT01055457|374956|P7|Overall Study|Protocol Violation|1
100606|NCT01055457|374957|P6|Overall Study|Protocol Violation|2
100607|NCT01055457|374958|P5|Overall Study|Protocol Violation|1
100608|NCT01055457|374959|P4|Overall Study|Protocol Violation|1
100609|NCT01055457|374960|P3|Overall Study|Protocol Violation|1
100610|NCT01055457|374961|P2|Overall Study|Protocol Violation|0
100611|NCT01055457|374962|P1|Overall Study|Protocol Violation|0
100612|NCT01055457|374953|P10|Overall Study|Lost to Follow-up|0
100613|NCT01055457|374954|P9|Overall Study|Lost to Follow-up|0
100614|NCT01055457|374955|P8|Overall Study|Lost to Follow-up|0
100615|NCT01055457|374956|P7|Overall Study|Lost to Follow-up|0
100616|NCT01055457|374957|P6|Overall Study|Lost to Follow-up|1
100617|NCT01055457|374958|P5|Overall Study|Lost to Follow-up|0
100618|NCT01055457|374959|P4|Overall Study|Lost to Follow-up|0
100619|NCT01055457|374960|P3|Overall Study|Lost to Follow-up|0
100620|NCT01055457|374961|P2|Overall Study|Lost to Follow-up|1
100621|NCT01055457|374962|P1|Overall Study|Lost to Follow-up|0
100622|NCT01055314|374996|P2|Overall Study|No treatment|0
100623|NCT01055314|374997|P1|Overall Study|No treatment|1
100624|NCT01055314|374996|P2|Overall Study|Refusal of further protocol therapy|4
100625|NCT01055314|374997|P1|Overall Study|Refusal of further protocol therapy|10
100626|NCT01055314|374996|P2|Overall Study|Ineligible|5
100627|NCT01055314|374997|P1|Overall Study|Ineligible|3
100628|NCT01055314|374996|P2|Overall Study|Withdrawal by Subject|0
100629|NCT01055314|374997|P1|Overall Study|Withdrawal by Subject|1
100630|NCT01055314|374996|P2|Overall Study|Physician Decision|5
100631|NCT01055314|374997|P1|Overall Study|Physician Decision|10
100632|NCT01055314|374996|P2|Overall Study|Lack of Efficacy|19
100633|NCT01055314|374997|P1|Overall Study|Lack of Efficacy|11
100634|NCT01055314|374996|P2|Overall Study|Death|1
100635|NCT01055314|374997|P1|Overall Study|Death|2
100636|NCT01055314|374996|P2|Overall Study|Adverse Event|4
100637|NCT01055314|374997|P1|Overall Study|Adverse Event|7
100638|NCT01055262|375009|P1|Overall Study|Uncooperativeness|1
100639|NCT01055262|375009|P1|Overall Study|Protocol Violation|3
100640|NCT01055262|375009|P1|Overall Study|Adverse Event|5
100641|NCT01055197|375050|P2|Overall Study|Withdrawal by Subject|0
100642|NCT01055197|375051|P1|Overall Study|Withdrawal by Subject|2
100643|NCT01055197|375050|P2|Overall Study|Protocol Violation|2
100644|NCT01055197|375051|P1|Overall Study|Protocol Violation|7
100645|NCT01055132|375078|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
100646|NCT01055132|375079|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
100647|NCT01055132|375078|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
100648|NCT01055132|375079|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
100649|NCT01055028|375092|P2|Inter-treatment Period|Did not start Cycle 4|3
100650|NCT01055028|375093|P1|Inter-treatment Period|Did not start Cycle 4|0
100651|NCT01055028|375092|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
100652|NCT01055028|375093|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
100653|NCT01055028|375092|P2|Treatment Cycles 1 to 3|Adverse Event|1
100654|NCT01055028|375093|P1|Treatment Cycles 1 to 3|Adverse Event|0
100655|NCT01055028|375092|P2|Screening|Screen Failure|1
100656|NCT01055028|375093|P1|Screening|Screen Failure|1
100657|NCT01054976|375107|P1|Overall Study|Not specified|8
100658|NCT01054976|375107|P1|Overall Study|Withdrawal by Subject|4
100659|NCT01054976|375107|P1|Overall Study|Uncooperative participations to study|7
100660|NCT01054976|375107|P1|Overall Study|Adverse Event|16
100661|NCT01054885|375128|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
100662|NCT01054885|375129|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
100663|NCT01054885|375130|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
100664|NCT01054885|375131|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
100665|NCT01054885|375132|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
100666|NCT01054885|375133|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
100667|NCT01054885|375134|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
100668|NCT01054885|375128|P7|24-week, Double-blind Treatment Period|Physician Decision|1
100669|NCT01054885|375129|P6|24-week, Double-blind Treatment Period|Physician Decision|1
100670|NCT01054885|375130|P5|24-week, Double-blind Treatment Period|Physician Decision|3
100671|NCT01054885|375131|P4|24-week, Double-blind Treatment Period|Physician Decision|6
100672|NCT01054885|375132|P3|24-week, Double-blind Treatment Period|Physician Decision|1
100673|NCT01054885|375133|P2|24-week, Double-blind Treatment Period|Physician Decision|4
100674|NCT01054885|375134|P1|24-week, Double-blind Treatment Period|Physician Decision|0
100675|NCT01054885|375128|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
100676|NCT01054885|375129|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
100677|NCT01054885|375130|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
100678|NCT01054885|375131|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
100679|NCT01054885|375132|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
100680|NCT01054885|375133|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
100681|NCT01054885|375134|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
100682|NCT01054885|375128|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
100683|NCT01054885|375129|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
100684|NCT01054885|375130|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
100685|NCT01054885|375131|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
100686|NCT01054885|375132|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
100687|NCT01054885|375133|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
100688|NCT01054885|375134|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
100689|NCT01054885|375128|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
100690|NCT01054885|375129|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
100691|NCT01054885|375130|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
100692|NCT01054885|375131|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
100693|NCT01054885|375132|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
100694|NCT01054885|375133|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
100695|NCT01054885|375134|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
100696|NCT01054885|375128|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
100697|NCT01054885|375129|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
100698|NCT01054885|375130|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
100699|NCT01054885|375131|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
100700|NCT01054885|375132|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
100701|NCT01054885|375133|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
100702|NCT01054885|375134|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
100703|NCT01054885|375128|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
100704|NCT01054885|375129|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
100705|NCT01054885|375130|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
100706|NCT01054885|375131|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
100707|NCT01054885|375132|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
100708|NCT01054885|375133|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
100709|NCT01054885|375134|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
100710|NCT01054885|375128|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
100711|NCT01054885|375129|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
100712|NCT01054885|375130|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
100713|NCT01054885|375131|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
100714|NCT01054885|375132|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
100715|NCT01054885|375133|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
100716|NCT01054885|375134|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
100717|NCT01054885|375128|P7|24-week, Double-blind Treatment Period|Adverse Event|19
100718|NCT01054885|375129|P6|24-week, Double-blind Treatment Period|Adverse Event|17
100719|NCT01054885|375130|P5|24-week, Double-blind Treatment Period|Adverse Event|15
100720|NCT01054885|375131|P4|24-week, Double-blind Treatment Period|Adverse Event|15
100721|NCT01054885|375132|P3|24-week, Double-blind Treatment Period|Adverse Event|12
100722|NCT01054885|375133|P2|24-week, Double-blind Treatment Period|Adverse Event|18
100723|NCT01054885|375134|P1|24-week, Double-blind Treatment Period|Adverse Event|0
100724|NCT01054885|375128|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100725|NCT01054885|375129|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100726|NCT01054885|375130|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100727|NCT01054885|375131|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100728|NCT01054885|375132|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100729|NCT01054885|375133|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100730|NCT01054885|375134|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
100731|NCT01054885|375128|P7|2-week, Single-blind Run-In Period|Adverse Event|0
100732|NCT01054885|375129|P6|2-week, Single-blind Run-In Period|Adverse Event|0
100733|NCT01054885|375130|P5|2-week, Single-blind Run-In Period|Adverse Event|0
100734|NCT01054885|375131|P4|2-week, Single-blind Run-In Period|Adverse Event|0
100735|NCT01054885|375132|P3|2-week, Single-blind Run-In Period|Adverse Event|0
100736|NCT01054885|375133|P2|2-week, Single-blind Run-In Period|Adverse Event|0
100737|NCT01054885|375134|P1|2-week, Single-blind Run-In Period|Adverse Event|7
100738|NCT01054885|375128|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100739|NCT01054885|375129|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100740|NCT01054885|375130|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100741|NCT01054885|375131|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100742|NCT01054885|375132|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100743|NCT01054885|375133|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100744|NCT01054885|375134|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
100745|NCT01054885|375128|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100746|NCT01054885|375129|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100747|NCT01054885|375130|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100748|NCT01054885|375131|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100749|NCT01054885|375132|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100750|NCT01054885|375133|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100751|NCT01054885|375134|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
100752|NCT01054885|375128|P7|2-week, Single-blind Run-In Period|Physician Decision|0
100753|NCT01054885|375129|P6|2-week, Single-blind Run-In Period|Physician Decision|0
100754|NCT01054885|375130|P5|2-week, Single-blind Run-In Period|Physician Decision|0
100755|NCT01054885|375131|P4|2-week, Single-blind Run-In Period|Physician Decision|0
100756|NCT01054885|375132|P3|2-week, Single-blind Run-In Period|Physician Decision|0
100757|NCT01054885|375133|P2|2-week, Single-blind Run-In Period|Physician Decision|0
100758|NCT01054885|375134|P1|2-week, Single-blind Run-In Period|Physician Decision|6
100759|NCT01054885|375128|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100760|NCT01054885|375129|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100761|NCT01054885|375130|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100762|NCT01054885|375131|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100763|NCT01054885|375132|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100764|NCT01054885|375133|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100765|NCT01054885|375134|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
100766|NCT01054846|375174|P2|Overall Study|Lost to Follow-up|17
100767|NCT01054846|375175|P1|Overall Study|Lost to Follow-up|76
100768|NCT01054820|375182|P1|Overall Study|Withdrawal by Subject|2
100769|NCT01054729|375204|P4|Overall Study|Lack of Efficacy|1
100770|NCT01054729|375205|P3|Overall Study|Lack of Efficacy|0
100771|NCT01054729|375206|P2|Overall Study|Lack of Efficacy|0
100772|NCT01054729|375207|P1|Overall Study|Lack of Efficacy|0
100773|NCT01054729|375204|P4|Overall Study|Subject moved|0
100774|NCT01054729|375205|P3|Overall Study|Subject moved|1
100775|NCT01054729|375206|P2|Overall Study|Subject moved|0
100776|NCT01054729|375207|P1|Overall Study|Subject moved|0
100777|NCT01054729|375204|P4|Overall Study|Personal/Obligations|0
100778|NCT01054729|375205|P3|Overall Study|Personal/Obligations|0
100779|NCT01054729|375206|P2|Overall Study|Personal/Obligations|1
100780|NCT01054729|375207|P1|Overall Study|Personal/Obligations|0
100781|NCT01054729|375204|P4|Overall Study|PEG/RBV Non-responder|0
100782|NCT01054729|375205|P3|Overall Study|PEG/RBV Non-responder|1
100783|NCT01054729|375206|P2|Overall Study|PEG/RBV Non-responder|0
100784|NCT01054729|375207|P1|Overall Study|PEG/RBV Non-responder|1
100785|NCT01054729|375204|P4|Overall Study|Non-responder|1
100786|NCT01054729|375205|P3|Overall Study|Non-responder|1
100787|NCT01054729|375206|P2|Overall Study|Non-responder|0
100788|NCT01054729|375207|P1|Overall Study|Non-responder|1
100789|NCT01054729|375204|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
100790|NCT01054729|375205|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
100791|NCT01054729|375206|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
100792|NCT01054729|375207|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
100793|NCT01054729|375204|P4|Overall Study|Lost to Follow-up|0
100794|NCT01054729|375205|P3|Overall Study|Lost to Follow-up|0
100795|NCT01054729|375206|P2|Overall Study|Lost to Follow-up|1
100796|NCT01054729|375207|P1|Overall Study|Lost to Follow-up|0
100797|NCT01054729|375204|P4|Overall Study|Withdrawal by Subject|0
100798|NCT01054729|375205|P3|Overall Study|Withdrawal by Subject|1
100799|NCT01054729|375206|P2|Overall Study|Withdrawal by Subject|0
100800|NCT01054729|375207|P1|Overall Study|Withdrawal by Subject|1
100801|NCT01054729|375204|P4|Overall Study|Adverse Event|1
100802|NCT01054729|375205|P3|Overall Study|Adverse Event|2
100803|NCT01054729|375206|P2|Overall Study|Adverse Event|1
100804|NCT01054729|375207|P1|Overall Study|Adverse Event|1
100805|NCT01054729|375204|P4|Overall Study|Randomized but Not Treated|0
100806|NCT01054729|375205|P3|Overall Study|Randomized but Not Treated|0
100807|NCT01054729|375206|P2|Overall Study|Randomized but Not Treated|1
100808|NCT01054729|375207|P1|Overall Study|Randomized but Not Treated|0
100809|NCT01054599|375305|P2|Overall Study|Withdrawal by Subject|1
100810|NCT01054599|375306|P1|Overall Study|Withdrawal by Subject|0
100811|NCT01054599|375305|P2|Overall Study|Adverse Event|1
100812|NCT01054599|375306|P1|Overall Study|Adverse Event|0
100813|NCT01054599|375305|P2|Overall Study|Lost to Follow-up|2
100814|NCT01054599|375306|P1|Overall Study|Lost to Follow-up|0
100815|NCT01054599|375305|P2|Overall Study|Visual impairment, WTAR <80|1
100816|NCT01054599|375306|P1|Overall Study|Visual impairment, WTAR <80|0
100817|NCT01054599|375305|P2|Overall Study|Timing/scheduling difficulties|1
100818|NCT01054599|375306|P1|Overall Study|Timing/scheduling difficulties|1
100819|NCT01054599|375305|P2|Overall Study|Spells/seizure-like episodes|1
100820|NCT01054599|375306|P1|Overall Study|Spells/seizure-like episodes|1
100821|NCT01054599|375305|P2|Overall Study|Protocol Violation|0
100822|NCT01054599|375306|P1|Overall Study|Protocol Violation|1
100823|NCT01054599|375305|P2|Overall Study|Dizziness due to phenytoin toxicity|0
100824|NCT01054599|375306|P1|Overall Study|Dizziness due to phenytoin toxicity|1
100825|NCT01054573|375413|P4|Overall Study|Withdrawal by Subject|1
100826|NCT01054573|375414|P3|Overall Study|Withdrawal by Subject|2
100827|NCT01054573|375415|P2|Overall Study|Withdrawal by Subject|2
100828|NCT01054573|375416|P1|Overall Study|Withdrawal by Subject|0
100829|NCT01054573|375413|P4|Overall Study|Lost to Follow-up|0
100830|NCT01054573|375414|P3|Overall Study|Lost to Follow-up|0
100831|NCT01054573|375415|P2|Overall Study|Lost to Follow-up|2
100832|NCT01054573|375416|P1|Overall Study|Lost to Follow-up|0
100833|NCT01054573|375413|P4|Overall Study|Adverse Event|1
100834|NCT01054573|375414|P3|Overall Study|Adverse Event|1
100835|NCT01054573|375415|P2|Overall Study|Adverse Event|0
100836|NCT01054573|375416|P1|Overall Study|Adverse Event|1
100837|NCT01054560|375462|P2|Overall Study|Physician Decision|0
100838|NCT01054560|375463|P1|Overall Study|Physician Decision|1
100839|NCT01054560|375462|P2|Overall Study|Withdrawal by Subject|2
100840|NCT01054560|375463|P1|Overall Study|Withdrawal by Subject|0
100841|NCT01054560|375462|P2|Overall Study|Lost to Follow-up|5
100842|NCT01054560|375463|P1|Overall Study|Lost to Follow-up|2
100843|NCT01054560|375462|P2|Overall Study|Death|21
100844|NCT01054560|375463|P1|Overall Study|Death|10
100845|NCT01054222|375513|P1|Overall Study|Withdrawal by Subject|6
100846|NCT01054222|375513|P1|Overall Study|Lost to Follow-up|4
100847|NCT01054222|375513|P1|Overall Study|Lack of Efficacy|1
100848|NCT01054170|375545|P2|Overall Study|Adverse Event|4
100849|NCT01054170|375546|P1|Overall Study|Adverse Event|0
100850|NCT01054170|375545|P2|Overall Study|Withdrawal by Subject|2
100851|NCT01054170|375546|P1|Overall Study|Withdrawal by Subject|3
100852|NCT01054170|375545|P2|Overall Study|Protocol Violation|0
100853|NCT01054170|375546|P1|Overall Study|Protocol Violation|1
100854|NCT01053988|375611|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
100855|NCT01053988|375612|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
100856|NCT01053988|375613|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
100857|NCT01053988|375614|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
100858|NCT01053988|375615|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
100859|NCT01053988|375616|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
100860|NCT01053988|375611|P6|24-week, Double-blind Treatment Period|Physician Decision|4
100861|NCT01053988|375612|P5|24-week, Double-blind Treatment Period|Physician Decision|5
100862|NCT01053988|375613|P4|24-week, Double-blind Treatment Period|Physician Decision|5
100863|NCT01053988|375614|P3|24-week, Double-blind Treatment Period|Physician Decision|2
100864|NCT01053988|375615|P2|24-week, Double-blind Treatment Period|Physician Decision|5
100865|NCT01053988|375616|P1|24-week, Double-blind Treatment Period|Physician Decision|0
100866|NCT01053988|375611|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
100867|NCT01053988|375612|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
100868|NCT01053988|375613|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
100869|NCT01053988|375614|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
100870|NCT01053988|375615|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
100871|NCT01053988|375616|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
100872|NCT01053988|375611|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
100873|NCT01053988|375612|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
100874|NCT01053988|375613|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
100875|NCT01053988|375614|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
100876|NCT01053988|375615|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
100877|NCT01053988|375616|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
100878|NCT01053988|375611|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
100879|NCT01053988|375612|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
100880|NCT01053988|375613|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
100881|NCT01053988|375614|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
100882|NCT01053988|375615|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
100883|NCT01053988|375616|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
100884|NCT01053988|375611|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
100885|NCT01053988|375612|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
100886|NCT01053988|375613|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
100887|NCT01053988|375614|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
100888|NCT01053988|375615|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
100889|NCT01053988|375616|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
100890|NCT01053988|375611|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
100891|NCT01053988|375612|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
100892|NCT01053988|375613|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
100893|NCT01053988|375614|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
100894|NCT01053988|375615|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
100895|NCT01053988|375616|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
100896|NCT01053988|375611|P6|24-week, Double-blind Treatment Period|Adverse Event|14
100897|NCT01053988|375612|P5|24-week, Double-blind Treatment Period|Adverse Event|17
100898|NCT01053988|375613|P4|24-week, Double-blind Treatment Period|Adverse Event|24
100899|NCT01053988|375614|P3|24-week, Double-blind Treatment Period|Adverse Event|23
100900|NCT01053988|375615|P2|24-week, Double-blind Treatment Period|Adverse Event|15
100901|NCT01053988|375616|P1|24-week, Double-blind Treatment Period|Adverse Event|0
100902|NCT01053988|375611|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100903|NCT01053988|375612|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100904|NCT01053988|375613|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100905|NCT01053988|375614|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100906|NCT01053988|375615|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
100907|NCT01053988|375616|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
100908|NCT01053988|375611|P6|2-week, Single-blind Run-In Period|Physician Decision|0
100909|NCT01053988|375612|P5|2-week, Single-blind Run-In Period|Physician Decision|0
100910|NCT01053988|375613|P4|2-week, Single-blind Run-In Period|Physician Decision|0
100911|NCT01053988|375614|P3|2-week, Single-blind Run-In Period|Physician Decision|0
100912|NCT01053988|375615|P2|2-week, Single-blind Run-In Period|Physician Decision|0
100913|NCT01053988|375616|P1|2-week, Single-blind Run-In Period|Physician Decision|5
100914|NCT01053988|375611|P6|2-week, Single-blind Run-In Period|Adverse Event|0
100915|NCT01053988|375612|P5|2-week, Single-blind Run-In Period|Adverse Event|0
100916|NCT01053988|375613|P4|2-week, Single-blind Run-In Period|Adverse Event|0
100917|NCT01053988|375614|P3|2-week, Single-blind Run-In Period|Adverse Event|0
100918|NCT01053988|375615|P2|2-week, Single-blind Run-In Period|Adverse Event|0
100919|NCT01053988|375616|P1|2-week, Single-blind Run-In Period|Adverse Event|6
100920|NCT01053988|375611|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100921|NCT01053988|375612|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100922|NCT01053988|375613|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100923|NCT01053988|375614|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100924|NCT01053988|375615|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
100925|NCT01053988|375616|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
100926|NCT01053988|375611|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100927|NCT01053988|375612|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100928|NCT01053988|375613|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100929|NCT01053988|375614|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100930|NCT01053988|375615|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
100931|NCT01053988|375616|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
100932|NCT01053988|375611|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100933|NCT01053988|375612|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100934|NCT01053988|375613|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100935|NCT01053988|375614|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100936|NCT01053988|375615|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
100937|NCT01053988|375616|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
100938|NCT01053741|375667|P2|2nd Study Intervention|Physician Decision|1
100939|NCT01053741|375668|P1|2nd Study Intervention|Physician Decision|0
100940|NCT01053663|375677|P1|Overall Study|Negative Influenza Diagnosis|1
100941|NCT01053663|375677|P1|Overall Study|Transferred to Another Hospital|1
100942|NCT01053663|375677|P1|Overall Study|Poor IV Access|1
100943|NCT01053663|375677|P1|Overall Study|Lost to Follow-up|1
100944|NCT01053663|375677|P1|Overall Study|Death|2
100945|NCT01053429|375735|P1|Overall Study|Other|309
100946|NCT01053429|375735|P1|Overall Study|Adverse Event|64
100947|NCT01053247|375765|P3|Overall Study|Adverse Event|3
100948|NCT01053247|375766|P2|Overall Study|Adverse Event|9
100949|NCT01053247|375767|P1|Overall Study|Adverse Event|0
100950|NCT01053247|375765|P3|Overall Study|Lost to Follow-up|7
100951|NCT01053247|375766|P2|Overall Study|Lost to Follow-up|5
100952|NCT01053247|375767|P1|Overall Study|Lost to Follow-up|8
100953|NCT01053247|375765|P3|Overall Study|Protocol Violation|2
100954|NCT01053247|375766|P2|Overall Study|Protocol Violation|1
100955|NCT01053247|375767|P1|Overall Study|Protocol Violation|2
100956|NCT01053247|375765|P3|Overall Study|Lack of Efficacy|1
100957|NCT01053247|375766|P2|Overall Study|Lack of Efficacy|0
100958|NCT01053247|375767|P1|Overall Study|Lack of Efficacy|1
100959|NCT01053247|375765|P3|Overall Study|Withdrawal by Subject|15
100960|NCT01053247|375766|P2|Overall Study|Withdrawal by Subject|4
100961|NCT01053247|375767|P1|Overall Study|Withdrawal by Subject|9
100962|NCT01052844|375861|P2|Overall Study|Adverse Event|1
100963|NCT01052844|375862|P1|Overall Study|Adverse Event|0
100964|NCT01052779|375883|P2|Overall Study|Other-Missed Week 5 Visit|0
100965|NCT01052779|375884|P1|Overall Study|Other-Missed Week 5 Visit|2
100966|NCT01052779|375883|P2|Overall Study|Other-Surgery|2
100967|NCT01052779|375884|P1|Overall Study|Other-Surgery|0
100968|NCT01052779|375883|P2|Overall Study|Other-Protocol Violation|1
100969|NCT01052779|375884|P1|Overall Study|Other-Protocol Violation|1
100970|NCT01052779|375883|P2|Overall Study|Withdrawal by Subject|2
100971|NCT01052779|375884|P1|Overall Study|Withdrawal by Subject|1
100972|NCT01052779|375883|P2|Overall Study|Adverse Event|4
100973|NCT01052779|375884|P1|Overall Study|Adverse Event|1
100974|NCT01052714|375894|P3|Overall Study|Withdrawal by Subject|1
100975|NCT01052714|375895|P2|Overall Study|Withdrawal by Subject|12
100976|NCT01052714|375896|P1|Overall Study|Withdrawal by Subject|7
100977|NCT01052714|375894|P3|Overall Study|Physician Decision|1
100978|NCT01052714|375895|P2|Overall Study|Physician Decision|9
100979|NCT01052714|375896|P1|Overall Study|Physician Decision|9
100980|NCT01052714|375894|P3|Overall Study|Lost to Follow-up|0
100981|NCT01052714|375895|P2|Overall Study|Lost to Follow-up|3
100982|NCT01052714|375896|P1|Overall Study|Lost to Follow-up|2
100983|NCT01052714|375894|P3|Overall Study|Death|0
100984|NCT01052714|375895|P2|Overall Study|Death|2
100985|NCT01052714|375896|P1|Overall Study|Death|1
100986|NCT01052714|375894|P3|Overall Study|Adverse Event|0
100987|NCT01052714|375895|P2|Overall Study|Adverse Event|3
100988|NCT01052714|375896|P1|Overall Study|Adverse Event|6
100989|NCT01052662|375950|P3|Overall Study|Administrative|0
100990|NCT01052662|375951|P2|Overall Study|Administrative|3
100991|NCT01052662|375952|P1|Overall Study|Administrative|0
100992|NCT01052662|375950|P3|Overall Study|Legal Problem|0
100993|NCT01052662|375951|P2|Overall Study|Legal Problem|0
100994|NCT01052662|375952|P1|Overall Study|Legal Problem|2
100995|NCT01052662|375950|P3|Overall Study|Adverse Event|0
100996|NCT01052662|375951|P2|Overall Study|Adverse Event|1
100997|NCT01052662|375952|P1|Overall Study|Adverse Event|1
100998|NCT01052662|375950|P3|Overall Study|Pharmacy issue|3
100999|NCT01052662|375951|P2|Overall Study|Pharmacy issue|3
101000|NCT01052662|375952|P1|Overall Study|Pharmacy issue|1
101001|NCT01052662|375950|P3|Overall Study|Withdrawal by Subject|1
101002|NCT01052662|375951|P2|Overall Study|Withdrawal by Subject|2
101003|NCT01052662|375952|P1|Overall Study|Withdrawal by Subject|3
101004|NCT01052662|375950|P3|Overall Study|Lost to Follow-up|18
101005|NCT01052662|375951|P2|Overall Study|Lost to Follow-up|13
101006|NCT01052662|375952|P1|Overall Study|Lost to Follow-up|15
101007|NCT01052480|375983|P2|Overall Study|Death|5
101008|NCT01052480|375984|P1|Overall Study|Death|1
101009|NCT01052480|375983|P2|Overall Study|Physician Decision|2
101010|NCT01052480|375984|P1|Overall Study|Physician Decision|0
101011|NCT01052480|375983|P2|Overall Study|Withdrawal by Subject|7
101012|NCT01052480|375984|P1|Overall Study|Withdrawal by Subject|3
101013|NCT01052480|375983|P2|Overall Study|Protocol Violation|0
101014|NCT01052480|375984|P1|Overall Study|Protocol Violation|1
101015|NCT01052480|375983|P2|Overall Study|Lost to Follow-up|3
101016|NCT01052480|375984|P1|Overall Study|Lost to Follow-up|3
101017|NCT01052428|376034|P2|Overall Study|Withdrawal by Subject|1
101018|NCT01052428|376035|P1|Overall Study|Withdrawal by Subject|0
101019|NCT01052428|376034|P2|Overall Study|Death|0
101020|NCT01052428|376035|P1|Overall Study|Death|1
101021|NCT01052272|376057|P4|Overall Study|decline in health|0
101022|NCT01052272|376058|P3|Overall Study|decline in health|1
101023|NCT01052272|376059|P2|Overall Study|decline in health|0
101024|NCT01052272|376060|P1|Overall Study|decline in health|0
101025|NCT01052272|376057|P4|Overall Study|placed in long-term care|0
101026|NCT01052272|376058|P3|Overall Study|placed in long-term care|1
101027|NCT01052272|376059|P2|Overall Study|placed in long-term care|0
101028|NCT01052272|376060|P1|Overall Study|placed in long-term care|0
101029|NCT01052272|376057|P4|Overall Study|Withdrawal by Subject|2
101030|NCT01052272|376058|P3|Overall Study|Withdrawal by Subject|3
101031|NCT01052272|376059|P2|Overall Study|Withdrawal by Subject|2
101032|NCT01052272|376060|P1|Overall Study|Withdrawal by Subject|0
101033|NCT01052272|376057|P4|Overall Study|patient refuses follow-up|4
101034|NCT01052272|376058|P3|Overall Study|patient refuses follow-up|2
101035|NCT01052272|376059|P2|Overall Study|patient refuses follow-up|4
101036|NCT01052272|376060|P1|Overall Study|patient refuses follow-up|5
101037|NCT01052272|376057|P4|Overall Study|Physician Decision|0
101038|NCT01052272|376058|P3|Overall Study|Physician Decision|0
101039|NCT01052272|376059|P2|Overall Study|Physician Decision|1
101040|NCT01052272|376060|P1|Overall Study|Physician Decision|0
101041|NCT01052272|376057|P4|Overall Study|Death|1
101042|NCT01052272|376058|P3|Overall Study|Death|1
101043|NCT01052272|376059|P2|Overall Study|Death|0
101044|NCT01052272|376060|P1|Overall Study|Death|0
101045|NCT01052116|376105|P2|Overall Study|Spirometry not performed|4
101046|NCT01052116|376106|P1|Overall Study|Spirometry not performed|0
101047|NCT01052116|376105|P2|Overall Study|Withdrawal by Subject|6
101048|NCT01052116|376106|P1|Overall Study|Withdrawal by Subject|3
101049|NCT01052116|376105|P2|Overall Study|Lost to Follow-up|17
101050|NCT01052116|376106|P1|Overall Study|Lost to Follow-up|11
101051|NCT01052077|376114|P4|Phase A+|Withdrawal by Subject|7
101052|NCT01052077|376115|P3|Phase A+|Withdrawal by Subject|0
101053|NCT01052077|376116|P2|Phase A+|Withdrawal by Subject|0
101054|NCT01052077|376117|P1|Phase A+|Withdrawal by Subject|0
101055|NCT01052077|376114|P4|Phase A+|Met Withdrawal Criteria|2
101056|NCT01052077|376115|P3|Phase A+|Met Withdrawal Criteria|0
101057|NCT01052077|376116|P2|Phase A+|Met Withdrawal Criteria|0
101058|NCT01052077|376117|P1|Phase A+|Met Withdrawal Criteria|0
101059|NCT01052077|376114|P4|Phase A+|Adverse Event|4
101060|NCT01052077|376115|P3|Phase A+|Adverse Event|0
101061|NCT01052077|376116|P2|Phase A+|Adverse Event|0
101062|NCT01052077|376117|P1|Phase A+|Adverse Event|0
101063|NCT01052077|376114|P4|Phase A+|Lost to Follow-up|8
101064|NCT01052077|376115|P3|Phase A+|Lost to Follow-up|0
101065|NCT01052077|376116|P2|Phase A+|Lost to Follow-up|0
101066|NCT01052077|376117|P1|Phase A+|Lost to Follow-up|0
101067|NCT01052077|376114|P4|Phase B|Lack of Efficacy|0
101068|NCT01052077|376115|P3|Phase B|Lack of Efficacy|0
101069|NCT01052077|376116|P2|Phase B|Lack of Efficacy|1
101070|NCT01052077|376117|P1|Phase B|Lack of Efficacy|0
101071|NCT01052077|376114|P4|Phase B|Protocol Deviation|0
101072|NCT01052077|376115|P3|Phase B|Protocol Deviation|4
101073|NCT01052077|376116|P2|Phase B|Protocol Deviation|3
101074|NCT01052077|376117|P1|Phase B|Protocol Deviation|0
101075|NCT01052077|376114|P4|Phase B|Withdrawal by Subject|0
101076|NCT01052077|376115|P3|Phase B|Withdrawal by Subject|5
101077|NCT01052077|376116|P2|Phase B|Withdrawal by Subject|0
101078|NCT01052077|376117|P1|Phase B|Withdrawal by Subject|0
101079|NCT01052077|376114|P4|Phase B|Physician Decision|0
101080|NCT01052077|376115|P3|Phase B|Physician Decision|1
101081|NCT01052077|376116|P2|Phase B|Physician Decision|1
101082|NCT01052077|376117|P1|Phase B|Physician Decision|0
101083|NCT01052077|376114|P4|Phase B|Met Withdrawal Criteria|0
101084|NCT01052077|376115|P3|Phase B|Met Withdrawal Criteria|1
101085|NCT01052077|376116|P2|Phase B|Met Withdrawal Criteria|2
101086|NCT01052077|376117|P1|Phase B|Met Withdrawal Criteria|0
101087|NCT01052077|376114|P4|Phase B|Adverse Event|0
101088|NCT01052077|376115|P3|Phase B|Adverse Event|2
101089|NCT01052077|376116|P2|Phase B|Adverse Event|9
101090|NCT01052077|376117|P1|Phase B|Adverse Event|0
101091|NCT01052077|376114|P4|Phase B|Lost to Follow-up|0
101092|NCT01052077|376115|P3|Phase B|Lost to Follow-up|3
101093|NCT01052077|376116|P2|Phase B|Lost to Follow-up|2
101094|NCT01052077|376117|P1|Phase B|Lost to Follow-up|0
101095|NCT01052077|376114|P4|Phase A|Protocol Deviation|0
101096|NCT01052077|376115|P3|Phase A|Protocol Deviation|0
101097|NCT01052077|376116|P2|Phase A|Protocol Deviation|0
101098|NCT01052077|376117|P1|Phase A|Protocol Deviation|27
101099|NCT01052077|376114|P4|Phase A|Withdrawal by Subject|0
101100|NCT01052077|376115|P3|Phase A|Withdrawal by Subject|0
101101|NCT01052077|376116|P2|Phase A|Withdrawal by Subject|0
101102|NCT01052077|376117|P1|Phase A|Withdrawal by Subject|29
101103|NCT01052077|376114|P4|Phase A|Physician Decision|0
101104|NCT01052077|376115|P3|Phase A|Physician Decision|0
101105|NCT01052077|376116|P2|Phase A|Physician Decision|0
101106|NCT01052077|376117|P1|Phase A|Physician Decision|10
101107|NCT01052077|376114|P4|Phase A|Met Withdrawal Criteria|0
101108|NCT01052077|376115|P3|Phase A|Met Withdrawal Criteria|0
101109|NCT01052077|376116|P2|Phase A|Met Withdrawal Criteria|0
101110|NCT01052077|376117|P1|Phase A|Met Withdrawal Criteria|26
101111|NCT01052077|376114|P4|Phase A|Adverse Event|0
101112|NCT01052077|376115|P3|Phase A|Adverse Event|0
101113|NCT01052077|376116|P2|Phase A|Adverse Event|0
101114|NCT01052077|376117|P1|Phase A|Adverse Event|32
101115|NCT01052077|376114|P4|Phase A|Lost to Follow-up|0
101116|NCT01052077|376115|P3|Phase A|Lost to Follow-up|0
101117|NCT01052077|376116|P2|Phase A|Lost to Follow-up|0
101118|NCT01052077|376117|P1|Phase A|Lost to Follow-up|22
101119|NCT01052038|376144|P3|Overall Study|Protocol Violation|3
101120|NCT01052038|376145|P2|Overall Study|Protocol Violation|3
101121|NCT01052038|376146|P1|Overall Study|Protocol Violation|2
101122|NCT01052038|376144|P3|Overall Study|Lost to Follow-up|1
101123|NCT01052038|376145|P2|Overall Study|Lost to Follow-up|3
101124|NCT01052038|376146|P1|Overall Study|Lost to Follow-up|2
101125|NCT01051986|376168|P2|Overall Study|Protocol Violation|3
101126|NCT01051986|376169|P1|Overall Study|Protocol Violation|2
101127|NCT01051986|376168|P2|Overall Study|Withdrawal by Subject|1
101128|NCT01051986|376169|P1|Overall Study|Withdrawal by Subject|2
101129|NCT01051986|376168|P2|Overall Study|Death|0
101130|NCT01051986|376169|P1|Overall Study|Death|1
101131|NCT01051921|376183|P1|Overall Study|patient moved|1
101132|NCT01051921|376183|P1|Overall Study|virological failure|1
101133|NCT01051921|376183|P1|Overall Study|Lost to Follow-up|4
101134|NCT01051921|376183|P1|Overall Study|Withdrawal by Subject|7
101135|NCT01051921|376183|P1|Overall Study|Adverse Event|8
101136|NCT01051921|376183|P1|Overall Study|Physician Decision|9
101137|NCT01051856|376190|P2|Overall Study|Withdrawal by Subject|0
101138|NCT01051856|376191|P1|Overall Study|Withdrawal by Subject|1
101139|NCT01051817|376201|P2|Overall Study|Protocol Violation|1
101140|NCT01051817|376202|P1|Overall Study|Protocol Violation|0
101141|NCT01051817|376201|P2|Overall Study|Withdrawal by Subject|5
101142|NCT01051817|376202|P1|Overall Study|Withdrawal by Subject|3
101143|NCT01051817|376201|P2|Overall Study|Abnormal Test Proceedure reults|1
101144|NCT01051817|376202|P1|Overall Study|Abnormal Test Proceedure reults|0
101145|NCT01051817|376201|P2|Overall Study|Adverse Event|2
101146|NCT01051817|376202|P1|Overall Study|Adverse Event|0
101147|NCT01051791|376212|P1|Overall Study|Withdrawal by Subject|1
101148|NCT01051791|376212|P1|Overall Study|Failed screening|3
101149|NCT01051739|376230|P2|Overall Study|Withdrawal by Subject|10
101150|NCT01051739|376231|P1|Overall Study|Withdrawal by Subject|25
101151|NCT01051739|376230|P2|Overall Study|Death|3
101152|NCT01051739|376231|P1|Overall Study|Death|3
101153|NCT01051557|376248|P7|Overall Study|Adverse Event|4
101154|NCT01051557|376249|P6|Overall Study|Adverse Event|3
101155|NCT01051557|376250|P5|Overall Study|Adverse Event|1
101156|NCT01051557|376251|P4|Overall Study|Adverse Event|1
101157|NCT01051557|376252|P3|Overall Study|Adverse Event|0
101158|NCT01051557|376253|P2|Overall Study|Adverse Event|0
101159|NCT01051557|376254|P1|Overall Study|Adverse Event|0
101160|NCT01051557|376248|P7|Overall Study|Withdrawal by Subject|1
101161|NCT01051557|376249|P6|Overall Study|Withdrawal by Subject|0
101162|NCT01051557|376250|P5|Overall Study|Withdrawal by Subject|2
101163|NCT01051557|376251|P4|Overall Study|Withdrawal by Subject|0
101164|NCT01051557|376252|P3|Overall Study|Withdrawal by Subject|1
101165|NCT01051557|376253|P2|Overall Study|Withdrawal by Subject|0
101166|NCT01051557|376254|P1|Overall Study|Withdrawal by Subject|0
101167|NCT01051557|376248|P7|Overall Study|disease progression|1
101168|NCT01051557|376249|P6|Overall Study|disease progression|3
101169|NCT01051557|376250|P5|Overall Study|disease progression|4
101170|NCT01051557|376251|P4|Overall Study|disease progression|2
101171|NCT01051557|376252|P3|Overall Study|disease progression|5
101172|NCT01051557|376253|P2|Overall Study|disease progression|3
101173|NCT01051557|376254|P1|Overall Study|disease progression|3
101174|NCT01051557|376248|P7|Overall Study|Physician Decision|0
101175|NCT01051557|376249|P6|Overall Study|Physician Decision|0
101176|NCT01051557|376250|P5|Overall Study|Physician Decision|0
101177|NCT01051557|376251|P4|Overall Study|Physician Decision|0
101178|NCT01051557|376252|P3|Overall Study|Physician Decision|0
101179|NCT01051557|376253|P2|Overall Study|Physician Decision|0
101180|NCT01051557|376254|P1|Overall Study|Physician Decision|1
101181|NCT01051466|376273|P2|Overall Study|Physician Decision|0
101182|NCT01051466|376274|P1|Overall Study|Physician Decision|1
101183|NCT01051466|376273|P2|Overall Study|Entry Criteria Not Met|3
101184|NCT01051466|376274|P1|Overall Study|Entry Criteria Not Met|0
101185|NCT01051466|376273|P2|Overall Study|Withdrawal by Subject|1
101186|NCT01051466|376274|P1|Overall Study|Withdrawal by Subject|5
101187|NCT01051466|376273|P2|Overall Study|Lost to Follow-up|1
101188|NCT01051466|376274|P1|Overall Study|Lost to Follow-up|1
101189|NCT01051466|376273|P2|Overall Study|Adverse Event|0
101190|NCT01051466|376274|P1|Overall Study|Adverse Event|1
101191|NCT01051323|376321|P1|Overall Study|Missing|37
101192|NCT01051323|376321|P1|Overall Study|Other|148
101193|NCT01051323|376321|P1|Overall Study|Hospitalization|28
101194|NCT01051323|376321|P1|Overall Study|Death|129
101195|NCT01051323|376321|P1|Overall Study|Lost to Follow-up|31
101196|NCT01051323|376321|P1|Overall Study|Withdrawal by Subject|13
101197|NCT01051323|376321|P1|Overall Study|Dialysis dependency|22
101198|NCT01051323|376321|P1|Overall Study|Transplantation|28
101199|NCT01051323|376321|P1|Overall Study|Discontinuation of treatment|103
101200|NCT01050998|376348|P5|Overall Study|Data integrity issues|4
101201|NCT01050998|376349|P4|Overall Study|Data integrity issues|1
101202|NCT01050998|376350|P3|Overall Study|Data integrity issues|1
101203|NCT01050998|376351|P2|Overall Study|Data integrity issues|0
101204|NCT01050998|376352|P1|Overall Study|Data integrity issues|0
101205|NCT01050998|376348|P5|Overall Study|Other|5
101206|NCT01050998|376349|P4|Overall Study|Other|1
101207|NCT01050998|376350|P3|Overall Study|Other|1
101208|NCT01050998|376351|P2|Overall Study|Other|2
101209|NCT01050998|376352|P1|Overall Study|Other|3
101210|NCT01050998|376348|P5|Overall Study|Withdrawal by Subject|3
101211|NCT01050998|376349|P4|Overall Study|Withdrawal by Subject|1
101212|NCT01050998|376350|P3|Overall Study|Withdrawal by Subject|0
101213|NCT01050998|376351|P2|Overall Study|Withdrawal by Subject|0
101214|NCT01050998|376352|P1|Overall Study|Withdrawal by Subject|0
101215|NCT01050998|376348|P5|Overall Study|Adverse Event|2
101216|NCT01050998|376349|P4|Overall Study|Adverse Event|0
101217|NCT01050998|376350|P3|Overall Study|Adverse Event|1
101218|NCT01050998|376351|P2|Overall Study|Adverse Event|0
101219|NCT01050998|376352|P1|Overall Study|Adverse Event|1
101220|NCT01050816|376686|P1|Overall Study|patient's refusal|2
101221|NCT01050816|376686|P1|Overall Study|Lost to Follow-up|2
101222|NCT01050790|376692|P1|Overall Study|Adverse Event|1
101223|NCT01050764|376702|P1|Overall Study|Death, after HSCT|1
101224|NCT01050764|376702|P1|Overall Study|Donor mobilization failure, death|1
101225|NCT01050764|376702|P1|Overall Study|Death, before HSCT|1
101226|NCT01050673|376713|P2|Overall Study|Physician Decision|5
101227|NCT01050673|376714|P1|Overall Study|Physician Decision|4
101228|NCT01050634|376782|P1|Overall Study|Ongoing at Date of Cut-Off|5
101229|NCT01050634|376782|P1|Overall Study|Other|21
101230|NCT01050634|376782|P1|Overall Study|Lost to Follow-up|2
101231|NCT01050634|376782|P1|Overall Study|Adverse Event|42
101232|NCT01050634|376782|P1|Overall Study|Death|2
101233|NCT01050634|376782|P1|Overall Study|Enrolled, but Not Treated|56
101234|NCT01050569|376806|P3|Overall Study|Physician Decision|3
101235|NCT01050569|376807|P2|Overall Study|Physician Decision|3
101236|NCT01050569|376808|P1|Overall Study|Physician Decision|3
101237|NCT01050569|376806|P3|Overall Study|Adverse Event|0
101238|NCT01050569|376807|P2|Overall Study|Adverse Event|0
101239|NCT01050569|376808|P1|Overall Study|Adverse Event|1
101240|NCT01050569|376806|P3|Overall Study|Lack of Efficacy|3
101241|NCT01050569|376807|P2|Overall Study|Lack of Efficacy|4
101242|NCT01050569|376808|P1|Overall Study|Lack of Efficacy|5
101243|NCT01050569|376806|P3|Overall Study|Withdrawal by Subject|11
101244|NCT01050569|376807|P2|Overall Study|Withdrawal by Subject|3
101245|NCT01050569|376808|P1|Overall Study|Withdrawal by Subject|9
101246|NCT01050569|376806|P3|Overall Study|Lost to Follow-up|16
101247|NCT01050569|376807|P2|Overall Study|Lost to Follow-up|14
101248|NCT01050569|376808|P1|Overall Study|Lost to Follow-up|20
101249|NCT01050543|376827|P2|Overall Study|Administrative|1
101250|NCT01050543|376828|P1|Overall Study|Administrative|4
101251|NCT01050543|376827|P2|Overall Study|Protocol Violation|1
101252|NCT01050543|376828|P1|Overall Study|Protocol Violation|0
101253|NCT01050543|376827|P2|Overall Study|Withdrawal by Subject|2
101254|NCT01050543|376828|P1|Overall Study|Withdrawal by Subject|0
101255|NCT01050530|376836|P2|Overall Study|Protocol Violation|0
101256|NCT01050530|376837|P1|Overall Study|Protocol Violation|1
101257|NCT01050530|376836|P2|Overall Study|Withdrawal by Subject|3
101258|NCT01050530|376837|P1|Overall Study|Withdrawal by Subject|0
101259|NCT01050530|376836|P2|Overall Study|Lack of Efficacy|4
101260|NCT01050530|376837|P1|Overall Study|Lack of Efficacy|1
101261|NCT01050530|376836|P2|Overall Study|Adverse Event|3
101262|NCT01050530|376837|P1|Overall Study|Adverse Event|6
101263|NCT01050257|376848|P3|Overall Study|Death|1
101264|NCT01050257|376849|P2|Overall Study|Death|0
101265|NCT01050257|376850|P1|Overall Study|Death|0
101266|NCT01050257|376848|P3|Overall Study|Failure to return|0
101267|NCT01050257|376849|P2|Overall Study|Failure to return|2
101268|NCT01050257|376850|P1|Overall Study|Failure to return|0
101269|NCT01050257|376848|P3|Overall Study|Violation criteria|0
101270|NCT01050257|376849|P2|Overall Study|Violation criteria|1
101271|NCT01050257|376850|P1|Overall Study|Violation criteria|0
101272|NCT01050257|376848|P3|Overall Study|Refused treatment/ Did not Cooperate|0
101273|NCT01050257|376849|P2|Overall Study|Refused treatment/ Did not Cooperate|1
101274|NCT01050257|376850|P1|Overall Study|Refused treatment/ Did not Cooperate|1
101275|NCT01050257|376848|P3|Overall Study|No reason specified|2
101276|NCT01050257|376849|P2|Overall Study|No reason specified|0
101277|NCT01050257|376850|P1|Overall Study|No reason specified|0
101278|NCT01050257|376848|P3|Overall Study|Withdrawal by Subject|0
101279|NCT01050257|376849|P2|Overall Study|Withdrawal by Subject|3
101280|NCT01050257|376850|P1|Overall Study|Withdrawal by Subject|0
101281|NCT01050257|376848|P3|Overall Study|Admin/Other (did not switch to oral)|2
101282|NCT01050257|376849|P2|Overall Study|Admin/Other (did not switch to oral)|2
101283|NCT01050257|376850|P1|Overall Study|Admin/Other (did not switch to oral)|6
101284|NCT01050257|376848|P3|Overall Study|Adverse Event|2
101285|NCT01050257|376849|P2|Overall Study|Adverse Event|4
101286|NCT01050257|376850|P1|Overall Study|Adverse Event|4
101287|NCT01050218|376885|P1|Overall Study|Family emergency|1
101288|NCT01050218|376885|P1|Overall Study|Serious Adverse Event|1
101289|NCT01050218|376885|P1|Overall Study|Failed to return|7
101290|NCT01050218|376885|P1|Overall Study|Compliance|2
101291|NCT01050218|376885|P1|Overall Study|Discontinued by sponsor|18
101292|NCT01050218|376885|P1|Overall Study|Withdrawal by Subject|18
101293|NCT01050218|376885|P1|Overall Study|Protocol Violation|3
101294|NCT01050218|376885|P1|Overall Study|Lack of Efficacy|8
101295|NCT01050218|376885|P1|Overall Study|Adverse Event|37
101296|NCT01050205|376891|P2|Overall Study|Discontinued Intervention|0
101297|NCT01050205|376892|P1|Overall Study|Discontinued Intervention|2
101298|NCT01050205|376891|P2|Overall Study|Relocated from area|2
101299|NCT01050205|376892|P1|Overall Study|Relocated from area|1
101300|NCT01050205|376891|P2|Overall Study|Withdrawal by Subject|1
101301|NCT01050205|376892|P1|Overall Study|Withdrawal by Subject|1
101302|NCT01050205|376891|P2|Overall Study|Lost to Follow-up|1
101303|NCT01050205|376892|P1|Overall Study|Lost to Follow-up|7
101304|NCT01050062|376949|P2|Overall Study|Others|11
101305|NCT01050062|376950|P1|Overall Study|Others|17
101306|NCT01050062|376949|P2|Overall Study|Physician Decision|9
101307|NCT01050062|376950|P1|Overall Study|Physician Decision|74
101308|NCT01050062|376949|P2|Overall Study|Lack of Efficacy|35
101309|NCT01050062|376950|P1|Overall Study|Lack of Efficacy|22
101310|NCT01050062|376949|P2|Overall Study|Lost to Follow-up|35
101311|NCT01050062|376950|P1|Overall Study|Lost to Follow-up|83
101312|NCT01050062|376949|P2|Overall Study|Adverse Event|22
101313|NCT01050062|376950|P1|Overall Study|Adverse Event|75
101314|NCT01049984|376972|P2|Overall Study|Treatment failure|2
101315|NCT01049984|376973|P1|Overall Study|Treatment failure|0
101316|NCT01049984|376972|P2|Overall Study|Adverse Event|7
101317|NCT01049984|376973|P1|Overall Study|Adverse Event|13
101318|NCT01049984|376972|P2|Overall Study|Lost to Follow-up|1
101319|NCT01049984|376973|P1|Overall Study|Lost to Follow-up|2
101320|NCT01049984|376972|P2|Overall Study|Protocol Violation|4
101321|NCT01049984|376973|P1|Overall Study|Protocol Violation|3
101322|NCT01049984|376972|P2|Overall Study|Withdrawal by Subject|5
101323|NCT01049984|376973|P1|Overall Study|Withdrawal by Subject|1
101324|NCT01049581|377033|P2|Overall Study|Lost to Follow-up|1
101325|NCT01049581|377034|P1|Overall Study|Lost to Follow-up|2
101326|NCT01049503|377049|P6|Overall Study|Lost to Follow-up|8
101327|NCT01049503|377050|P5|Overall Study|Lost to Follow-up|27
101328|NCT01049503|377051|P4|Overall Study|Lost to Follow-up|26
101329|NCT01049503|377052|P3|Overall Study|Lost to Follow-up|24
101330|NCT01049503|377053|P2|Overall Study|Lost to Follow-up|12
101331|NCT01049503|377054|P1|Overall Study|Lost to Follow-up|11
101332|NCT01049412|377085|P2|Period II|Lost to Follow-up|0
101333|NCT01049412|377086|P1|Period II|Lost to Follow-up|1
101334|NCT01049412|377085|P2|Period II|Adverse Event|0
101335|NCT01049412|377086|P1|Period II|Adverse Event|1
101336|NCT01049412|377085|P2|Period II|Withdrawal by Subject|3
101337|NCT01049412|377086|P1|Period II|Withdrawal by Subject|2
101338|NCT01049412|377085|P2|Period I|Adverse Event|0
101339|NCT01049412|377086|P1|Period I|Adverse Event|1
101340|NCT01049412|377085|P2|Period I|Protocol Violation|2
101341|NCT01049412|377086|P1|Period I|Protocol Violation|1
101342|NCT01049412|377085|P2|Period I|Physician Decision|3
101343|NCT01049412|377086|P1|Period I|Physician Decision|0
101344|NCT01049412|377085|P2|Period I|Lost to Follow-up|2
101345|NCT01049412|377086|P1|Period I|Lost to Follow-up|2
101346|NCT01049412|377085|P2|Period I|Withdrawal by Subject|6
101347|NCT01049412|377086|P1|Period I|Withdrawal by Subject|4
101348|NCT01049373|377115|P2|Overall Study|Non-cooperation|1
101349|NCT01049373|377116|P1|Overall Study|Non-cooperation|0
101350|NCT01049373|377115|P2|Overall Study|Not specified|1
101351|NCT01049373|377116|P1|Overall Study|Not specified|1
101352|NCT01049373|377115|P2|Overall Study|no evaluable study values|21
101353|NCT01049373|377116|P1|Overall Study|no evaluable study values|9
101354|NCT01049373|377115|P2|Overall Study|Lost to Follow-up|4
101355|NCT01049373|377116|P1|Overall Study|Lost to Follow-up|9
101356|NCT01049373|377115|P2|Overall Study|Adverse Event|3
101357|NCT01049373|377116|P1|Overall Study|Adverse Event|3
101358|NCT01049373|377115|P2|Overall Study|Withdrawal by Subject|5
101359|NCT01049373|377116|P1|Overall Study|Withdrawal by Subject|8
101360|NCT01049373|377115|P2|Overall Study|Protocol Violation|9
101361|NCT01049373|377116|P1|Overall Study|Protocol Violation|9
101362|NCT01049360|377130|P20|Period 4|Withdrawal by Subject|0
101363|NCT01049360|377131|P19|Period 4|Withdrawal by Subject|0
101364|NCT01049360|377132|P18|Period 4|Withdrawal by Subject|0
101365|NCT01049360|377133|P17|Period 4|Withdrawal by Subject|0
101366|NCT01049360|377134|P16|Period 4|Withdrawal by Subject|0
101367|NCT01049360|377135|P15|Period 4|Withdrawal by Subject|0
101368|NCT01049360|377136|P14|Period 4|Withdrawal by Subject|0
101369|NCT01049360|377137|P13|Period 4|Withdrawal by Subject|0
101370|NCT01049360|377138|P12|Period 4|Withdrawal by Subject|0
101371|NCT01049360|377139|P11|Period 4|Withdrawal by Subject|0
101372|NCT01049360|377140|P10|Period 4|Withdrawal by Subject|0
101373|NCT01049360|377141|P9|Period 4|Withdrawal by Subject|0
101374|NCT01049360|377142|P8|Period 4|Withdrawal by Subject|0
101375|NCT01049360|377143|P7|Period 4|Withdrawal by Subject|0
101376|NCT01049360|377144|P6|Period 4|Withdrawal by Subject|0
101377|NCT01049360|377145|P5|Period 4|Withdrawal by Subject|0
101378|NCT01049360|377146|P4|Period 4|Withdrawal by Subject|1
101379|NCT01049360|377147|P3|Period 4|Withdrawal by Subject|0
101380|NCT01049360|377148|P2|Period 4|Withdrawal by Subject|0
101381|NCT01049360|377149|P1|Period 4|Withdrawal by Subject|0
101382|NCT01049360|377130|P20|Period 4|Protocol Violation|0
101383|NCT01049360|377131|P19|Period 4|Protocol Violation|0
101384|NCT01049360|377132|P18|Period 4|Protocol Violation|1
101385|NCT01049360|377133|P17|Period 4|Protocol Violation|0
101386|NCT01049360|377134|P16|Period 4|Protocol Violation|0
101387|NCT01049360|377135|P15|Period 4|Protocol Violation|0
101388|NCT01049360|377136|P14|Period 4|Protocol Violation|0
101389|NCT01049360|377137|P13|Period 4|Protocol Violation|0
101390|NCT01049360|377138|P12|Period 4|Protocol Violation|0
101391|NCT01049360|377139|P11|Period 4|Protocol Violation|0
101392|NCT01049360|377140|P10|Period 4|Protocol Violation|0
101393|NCT01049360|377141|P9|Period 4|Protocol Violation|0
101394|NCT01049360|377142|P8|Period 4|Protocol Violation|0
101395|NCT01049360|377143|P7|Period 4|Protocol Violation|0
101396|NCT01049360|377144|P6|Period 4|Protocol Violation|0
101397|NCT01049360|377145|P5|Period 4|Protocol Violation|0
101398|NCT01049360|377146|P4|Period 4|Protocol Violation|0
101399|NCT01049360|377147|P3|Period 4|Protocol Violation|0
101400|NCT01049360|377148|P2|Period 4|Protocol Violation|0
101401|NCT01049360|377149|P1|Period 4|Protocol Violation|0
101402|NCT01049360|377130|P20|Period 2|Lack of Efficacy|0
101403|NCT01049360|377131|P19|Period 2|Lack of Efficacy|0
101404|NCT01049360|377132|P18|Period 2|Lack of Efficacy|0
101405|NCT01049360|377133|P17|Period 2|Lack of Efficacy|0
101406|NCT01049360|377134|P16|Period 2|Lack of Efficacy|0
101407|NCT01049360|377135|P15|Period 2|Lack of Efficacy|0
101408|NCT01049360|377136|P14|Period 2|Lack of Efficacy|0
101409|NCT01049360|377137|P13|Period 2|Lack of Efficacy|0
101410|NCT01049360|377138|P12|Period 2|Lack of Efficacy|0
101411|NCT01049360|377139|P11|Period 2|Lack of Efficacy|0
101412|NCT01049360|377140|P10|Period 2|Lack of Efficacy|0
101413|NCT01049360|377141|P9|Period 2|Lack of Efficacy|0
101414|NCT01049360|377142|P8|Period 2|Lack of Efficacy|0
101415|NCT01049360|377143|P7|Period 2|Lack of Efficacy|0
101416|NCT01049360|377144|P6|Period 2|Lack of Efficacy|1
101417|NCT01049360|377145|P5|Period 2|Lack of Efficacy|0
101418|NCT01049360|377146|P4|Period 2|Lack of Efficacy|0
101419|NCT01049360|377147|P3|Period 2|Lack of Efficacy|0
101420|NCT01049360|377148|P2|Period 2|Lack of Efficacy|0
101421|NCT01049360|377149|P1|Period 2|Lack of Efficacy|0
101422|NCT01049360|377130|P20|Period 2|Withdrawal by Subject|1
101423|NCT01049360|377131|P19|Period 2|Withdrawal by Subject|0
101424|NCT01049360|377132|P18|Period 2|Withdrawal by Subject|0
101425|NCT01049360|377133|P17|Period 2|Withdrawal by Subject|0
101426|NCT01049360|377134|P16|Period 2|Withdrawal by Subject|0
101427|NCT01049360|377135|P15|Period 2|Withdrawal by Subject|1
101428|NCT01049360|377136|P14|Period 2|Withdrawal by Subject|0
101429|NCT01049360|377137|P13|Period 2|Withdrawal by Subject|0
101430|NCT01049360|377138|P12|Period 2|Withdrawal by Subject|0
101431|NCT01049360|377139|P11|Period 2|Withdrawal by Subject|0
101432|NCT01049360|377140|P10|Period 2|Withdrawal by Subject|0
101433|NCT01049360|377141|P9|Period 2|Withdrawal by Subject|0
101434|NCT01049360|377142|P8|Period 2|Withdrawal by Subject|0
101435|NCT01049360|377143|P7|Period 2|Withdrawal by Subject|0
101436|NCT01049360|377144|P6|Period 2|Withdrawal by Subject|0
101437|NCT01049360|377145|P5|Period 2|Withdrawal by Subject|0
101438|NCT01049360|377146|P4|Period 2|Withdrawal by Subject|1
101439|NCT01049360|377147|P3|Period 2|Withdrawal by Subject|0
101440|NCT01049360|377148|P2|Period 2|Withdrawal by Subject|0
101441|NCT01049360|377149|P1|Period 2|Withdrawal by Subject|0
101442|NCT01049360|377130|P20|Period 2|Adverse Event|1
101443|NCT01049360|377131|P19|Period 2|Adverse Event|0
101444|NCT01049360|377132|P18|Period 2|Adverse Event|0
101445|NCT01049360|377133|P17|Period 2|Adverse Event|0
101446|NCT01049360|377134|P16|Period 2|Adverse Event|0
101447|NCT01049360|377135|P15|Period 2|Adverse Event|0
101448|NCT01049360|377136|P14|Period 2|Adverse Event|0
101449|NCT01049360|377137|P13|Period 2|Adverse Event|0
101450|NCT01049360|377138|P12|Period 2|Adverse Event|0
101451|NCT01049360|377139|P11|Period 2|Adverse Event|0
101452|NCT01049360|377140|P10|Period 2|Adverse Event|0
101453|NCT01049360|377141|P9|Period 2|Adverse Event|1
101454|NCT01049360|377142|P8|Period 2|Adverse Event|0
101455|NCT01049360|377143|P7|Period 2|Adverse Event|0
101456|NCT01049360|377144|P6|Period 2|Adverse Event|0
101457|NCT01049360|377145|P5|Period 2|Adverse Event|0
101458|NCT01049360|377146|P4|Period 2|Adverse Event|0
101459|NCT01049360|377147|P3|Period 2|Adverse Event|0
101460|NCT01049360|377148|P2|Period 2|Adverse Event|1
101461|NCT01049360|377149|P1|Period 2|Adverse Event|0
101462|NCT01049360|377130|P20|Period 2|Protocol Violation|0
101463|NCT01049360|377131|P19|Period 2|Protocol Violation|0
101464|NCT01049360|377132|P18|Period 2|Protocol Violation|0
101465|NCT01049360|377133|P17|Period 2|Protocol Violation|0
101466|NCT01049360|377134|P16|Period 2|Protocol Violation|1
101467|NCT01049360|377135|P15|Period 2|Protocol Violation|1
101468|NCT01049360|377136|P14|Period 2|Protocol Violation|0
101469|NCT01049360|377137|P13|Period 2|Protocol Violation|0
101470|NCT01049360|377138|P12|Period 2|Protocol Violation|0
101471|NCT01049360|377139|P11|Period 2|Protocol Violation|0
101472|NCT01049360|377140|P10|Period 2|Protocol Violation|0
101473|NCT01049360|377141|P9|Period 2|Protocol Violation|0
101474|NCT01049360|377142|P8|Period 2|Protocol Violation|0
101475|NCT01049360|377143|P7|Period 2|Protocol Violation|0
101476|NCT01049360|377144|P6|Period 2|Protocol Violation|0
101477|NCT01049360|377145|P5|Period 2|Protocol Violation|0
101478|NCT01049360|377146|P4|Period 2|Protocol Violation|1
101479|NCT01049360|377147|P3|Period 2|Protocol Violation|0
101480|NCT01049360|377148|P2|Period 2|Protocol Violation|0
101481|NCT01049360|377149|P1|Period 2|Protocol Violation|0
101482|NCT01049360|377130|P20|Period 1|Withdrawal by Subject|0
101483|NCT01049360|377131|P19|Period 1|Withdrawal by Subject|0
101484|NCT01049360|377132|P18|Period 1|Withdrawal by Subject|0
101485|NCT01049360|377133|P17|Period 1|Withdrawal by Subject|0
101486|NCT01049360|377134|P16|Period 1|Withdrawal by Subject|0
101487|NCT01049360|377135|P15|Period 1|Withdrawal by Subject|0
101488|NCT01049360|377136|P14|Period 1|Withdrawal by Subject|0
101489|NCT01049360|377137|P13|Period 1|Withdrawal by Subject|1
101490|NCT01049360|377138|P12|Period 1|Withdrawal by Subject|0
101491|NCT01049360|377139|P11|Period 1|Withdrawal by Subject|1
101492|NCT01049360|377140|P10|Period 1|Withdrawal by Subject|0
101493|NCT01049360|377141|P9|Period 1|Withdrawal by Subject|1
101494|NCT01049360|377142|P8|Period 1|Withdrawal by Subject|0
101495|NCT01049360|377143|P7|Period 1|Withdrawal by Subject|0
101496|NCT01049360|377144|P6|Period 1|Withdrawal by Subject|0
101497|NCT01049360|377145|P5|Period 1|Withdrawal by Subject|0
101498|NCT01049360|377146|P4|Period 1|Withdrawal by Subject|0
101499|NCT01049360|377147|P3|Period 1|Withdrawal by Subject|0
101500|NCT01049360|377148|P2|Period 1|Withdrawal by Subject|0
101501|NCT01049360|377149|P1|Period 1|Withdrawal by Subject|0
101502|NCT01049360|377130|P20|Period 1|Did not meet inc/exc criteria|0
101503|NCT01049360|377131|P19|Period 1|Did not meet inc/exc criteria|0
101504|NCT01049360|377132|P18|Period 1|Did not meet inc/exc criteria|0
101505|NCT01049360|377133|P17|Period 1|Did not meet inc/exc criteria|0
101506|NCT01049360|377134|P16|Period 1|Did not meet inc/exc criteria|0
101507|NCT01049360|377135|P15|Period 1|Did not meet inc/exc criteria|0
101508|NCT01049360|377136|P14|Period 1|Did not meet inc/exc criteria|0
101509|NCT01049360|377137|P13|Period 1|Did not meet inc/exc criteria|0
101510|NCT01049360|377138|P12|Period 1|Did not meet inc/exc criteria|0
101511|NCT01049360|377139|P11|Period 1|Did not meet inc/exc criteria|0
101512|NCT01049360|377140|P10|Period 1|Did not meet inc/exc criteria|0
101513|NCT01049360|377141|P9|Period 1|Did not meet inc/exc criteria|1
101514|NCT01049360|377142|P8|Period 1|Did not meet inc/exc criteria|1
101515|NCT01049360|377143|P7|Period 1|Did not meet inc/exc criteria|0
101516|NCT01049360|377144|P6|Period 1|Did not meet inc/exc criteria|0
101517|NCT01049360|377145|P5|Period 1|Did not meet inc/exc criteria|0
101518|NCT01049360|377146|P4|Period 1|Did not meet inc/exc criteria|0
101519|NCT01049360|377147|P3|Period 1|Did not meet inc/exc criteria|0
101520|NCT01049360|377148|P2|Period 1|Did not meet inc/exc criteria|0
101521|NCT01049360|377149|P1|Period 1|Did not meet inc/exc criteria|0
101522|NCT01049360|377130|P20|Period 1|Adverse Event|0
101523|NCT01049360|377131|P19|Period 1|Adverse Event|1
101524|NCT01049360|377132|P18|Period 1|Adverse Event|0
101525|NCT01049360|377133|P17|Period 1|Adverse Event|1
101526|NCT01049360|377134|P16|Period 1|Adverse Event|0
101527|NCT01049360|377135|P15|Period 1|Adverse Event|0
101528|NCT01049360|377136|P14|Period 1|Adverse Event|1
101529|NCT01049360|377137|P13|Period 1|Adverse Event|1
101530|NCT01049360|377138|P12|Period 1|Adverse Event|0
101531|NCT01049360|377139|P11|Period 1|Adverse Event|0
101532|NCT01049360|377140|P10|Period 1|Adverse Event|0
101533|NCT01049360|377141|P9|Period 1|Adverse Event|0
101534|NCT01049360|377142|P8|Period 1|Adverse Event|1
101535|NCT01049360|377143|P7|Period 1|Adverse Event|0
101536|NCT01049360|377144|P6|Period 1|Adverse Event|0
101537|NCT01049360|377145|P5|Period 1|Adverse Event|0
101538|NCT01049360|377146|P4|Period 1|Adverse Event|1
101539|NCT01049360|377147|P3|Period 1|Adverse Event|0
101540|NCT01049360|377148|P2|Period 1|Adverse Event|1
101541|NCT01049360|377149|P1|Period 1|Adverse Event|0
101542|NCT01049334|377173|P2|Overall Study|Protocol Violation|1
101543|NCT01049334|377174|P1|Overall Study|Protocol Violation|0
101544|NCT01049334|377173|P2|Overall Study|Physician Decision|0
101545|NCT01049334|377174|P1|Overall Study|Physician Decision|2
101546|NCT01049334|377173|P2|Overall Study|Adverse Event|3
101547|NCT01049334|377174|P1|Overall Study|Adverse Event|2
101548|NCT01049334|377173|P2|Overall Study|Withdrawal by Subject|3
101549|NCT01049334|377174|P1|Overall Study|Withdrawal by Subject|5
101550|NCT01049308|377210|P1|Pill Counts|Withdrawal by Subject|83
101551|NCT01049217|377224|P2|Overall Study|Randomized but not Treated|2
101552|NCT01049217|377225|P1|Overall Study|Randomized but not Treated|0
101553|NCT01049217|377224|P2|Overall Study|Other|2
101554|NCT01049217|377225|P1|Overall Study|Other|1
101555|NCT01049217|377224|P2|Overall Study|Study Terminated by Sponsor|43
101556|NCT01049217|377225|P1|Overall Study|Study Terminated by Sponsor|43
101557|NCT01049217|377224|P2|Overall Study|Pregnancy|0
101558|NCT01049217|377225|P1|Overall Study|Pregnancy|1
101559|NCT01049217|377224|P2|Overall Study|Protocol Violation|3
101560|NCT01049217|377225|P1|Overall Study|Protocol Violation|1
101561|NCT01049217|377224|P2|Overall Study|Withdrawal by Subject|3
101562|NCT01049217|377225|P1|Overall Study|Withdrawal by Subject|4
101563|NCT01049217|377224|P2|Overall Study|Lost to Follow-up|8
101564|NCT01049217|377225|P1|Overall Study|Lost to Follow-up|3
101565|NCT01049217|377224|P2|Overall Study|Lack of Efficacy|1
101566|NCT01049217|377225|P1|Overall Study|Lack of Efficacy|1
101567|NCT01049217|377224|P2|Overall Study|Adverse Event|1
101568|NCT01049217|377225|P1|Overall Study|Adverse Event|2
101569|NCT01049009|377297|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
101570|NCT01049009|377298|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
101571|NCT01049009|377297|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
101572|NCT01049009|377298|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
101573|NCT01049009|377297|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
101574|NCT01049009|377298|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
101575|NCT01049009|377297|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
101576|NCT01049009|377298|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
101577|NCT01048944|377310|P4|Overall Study|Protocol Violation|2
101578|NCT01048944|377311|P3|Overall Study|Protocol Violation|10
101579|NCT01048944|377312|P2|Overall Study|Protocol Violation|10
101580|NCT01048944|377313|P1|Overall Study|Protocol Violation|8
101581|NCT01048866|377345|P2|Overall Study|not specified|1
101582|NCT01048866|377346|P1|Overall Study|not specified|1
101583|NCT01048866|377345|P2|Overall Study|Lost to Follow-up|2
101584|NCT01048866|377346|P1|Overall Study|Lost to Follow-up|0
101585|NCT01048866|377345|P2|Overall Study|Withdrawal by Subject|2
101586|NCT01048866|377346|P1|Overall Study|Withdrawal by Subject|0
101587|NCT01048866|377345|P2|Overall Study|Physician Decision|0
101588|NCT01048866|377346|P1|Overall Study|Physician Decision|1
101589|NCT01048866|377345|P2|Overall Study|Protocol Violation|0
101590|NCT01048866|377346|P1|Overall Study|Protocol Violation|1
101591|NCT01048866|377345|P2|Overall Study|Adverse Event|0
101592|NCT01048866|377346|P1|Overall Study|Adverse Event|1
101593|NCT01048788|377391|P3|Overall Study|Withdrawal by Subject|0
101594|NCT01048788|377392|P2|Overall Study|Withdrawal by Subject|1
101595|NCT01048788|377393|P1|Overall Study|Withdrawal by Subject|0
101596|NCT01048788|377391|P3|Overall Study|Lack of Efficacy|1
101597|NCT01048788|377392|P2|Overall Study|Lack of Efficacy|0
101598|NCT01048788|377393|P1|Overall Study|Lack of Efficacy|0
101599|NCT01048788|377391|P3|Overall Study|Adverse Event|1
101600|NCT01048788|377392|P2|Overall Study|Adverse Event|1
101601|NCT01048788|377393|P1|Overall Study|Adverse Event|5
101602|NCT01048671|377415|P3|Overall Study|Protocol Violation|1
101603|NCT01048671|377416|P2|Overall Study|Protocol Violation|1
101604|NCT01048671|377417|P1|Overall Study|Protocol Violation|0
101605|NCT01048541|377485|P2|Overall Study|Withdrawal by Subject|0
101606|NCT01048541|377486|P1|Overall Study|Withdrawal by Subject|1
101607|NCT01048502|377496|P4|Overall Study|Physician Decision|1
101608|NCT01048502|377497|P3|Overall Study|Physician Decision|0
101609|NCT01048502|377498|P2|Overall Study|Physician Decision|3
101610|NCT01048502|377499|P1|Overall Study|Physician Decision|0
101611|NCT01048502|377496|P4|Overall Study|Withdrawal by Subject|3
101612|NCT01048502|377497|P3|Overall Study|Withdrawal by Subject|5
101613|NCT01048502|377498|P2|Overall Study|Withdrawal by Subject|4
101614|NCT01048502|377499|P1|Overall Study|Withdrawal by Subject|1
101615|NCT01048502|377496|P4|Overall Study|Adverse Event|0
101616|NCT01048502|377497|P3|Overall Study|Adverse Event|0
101617|NCT01048502|377498|P2|Overall Study|Adverse Event|0
101618|NCT01048502|377499|P1|Overall Study|Adverse Event|1
101619|NCT01048502|377496|P4|Overall Study|Lost to Follow-up|0
101620|NCT01048502|377497|P3|Overall Study|Lost to Follow-up|0
101621|NCT01048502|377498|P2|Overall Study|Lost to Follow-up|0
101622|NCT01048502|377499|P1|Overall Study|Lost to Follow-up|2
101623|NCT01048333|377535|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
101624|NCT01048333|377536|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
101625|NCT01048333|377537|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
101626|NCT01048333|377538|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
101627|NCT01048333|377539|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
101628|NCT01048333|377540|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
101629|NCT01048242|377562|P2|Overall Study|See study flow chart|2
101630|NCT01048242|377563|P1|Overall Study|See study flow chart|4
101631|NCT01048099|377578|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
101632|NCT01048099|377578|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
101633|NCT01047553|377608|P2|Overall Study|PI's decision|1
101634|NCT01047553|377609|P1|Overall Study|PI's decision|0
101635|NCT01047553|377608|P2|Overall Study|Sever Non-Compliance to Protocol|0
101636|NCT01047553|377609|P1|Overall Study|Sever Non-Compliance to Protocol|1
101637|NCT01047553|377608|P2|Overall Study|Lost to Follow-up|0
101638|NCT01047553|377609|P1|Overall Study|Lost to Follow-up|1
101639|NCT01047553|377608|P2|Overall Study|Development of Study-Specific Withdrawal|1
101640|NCT01047553|377609|P1|Overall Study|Development of Study-Specific Withdrawal|1
101641|NCT01047553|377608|P2|Overall Study|Withdrawal by Subject|2
101642|NCT01047553|377609|P1|Overall Study|Withdrawal by Subject|4
101643|NCT01047553|377608|P2|Overall Study|Adverse Event|5
101644|NCT01047553|377609|P1|Overall Study|Adverse Event|10
101645|NCT01047436|377716|P2|Overall Study|Protocol Violation|0
101646|NCT01047436|377717|P1|Overall Study|Protocol Violation|1
101647|NCT01047345|377742|P3|Extension|Lost to Follow-up|5
101648|NCT01047345|377743|P2|Extension|Lost to Follow-up|0
101649|NCT01047345|377744|P1|Extension|Lost to Follow-up|0
101650|NCT01047345|377742|P3|Extension|Withdrawal by Subject|1
101651|NCT01047345|377743|P2|Extension|Withdrawal by Subject|0
101652|NCT01047345|377744|P1|Extension|Withdrawal by Subject|0
101653|NCT01047345|377742|P3|Base Study|Withdrawal by Subject|0
101654|NCT01047345|377743|P2|Base Study|Withdrawal by Subject|4
101655|NCT01047345|377744|P1|Base Study|Withdrawal by Subject|12
101656|NCT01047345|377742|P3|Base Study|Protocol Violation|0
101657|NCT01047345|377743|P2|Base Study|Protocol Violation|1
101658|NCT01047345|377744|P1|Base Study|Protocol Violation|3
101659|NCT01047345|377742|P3|Base Study|Lost to Follow-up|0
101660|NCT01047345|377743|P2|Base Study|Lost to Follow-up|1
101661|NCT01047345|377744|P1|Base Study|Lost to Follow-up|4
101662|NCT01047345|377742|P3|Base Study|Adverse Event|0
101663|NCT01047345|377743|P2|Base Study|Adverse Event|0
101664|NCT01047345|377744|P1|Base Study|Adverse Event|3
101665|NCT01047332|377766|P2|Overall Study|Lost to Follow-up|3
101666|NCT01047332|377767|P1|Overall Study|Lost to Follow-up|8
101667|NCT01047332|377766|P2|Overall Study|Died Unobstructed|41
101668|NCT01047332|377767|P1|Overall Study|Died Unobstructed|38
101669|NCT01047332|377766|P2|Overall Study|SEMS Obstruction|20
101670|NCT01047332|377767|P1|Overall Study|SEMS Obstruction|11
101671|NCT01047306|377781|P2|Overall Study|Lost to Follow-up|0
101672|NCT01047306|377782|P1|Overall Study|Lost to Follow-up|1
101673|NCT01047306|377781|P2|Overall Study|Withdrawal by Subject|0
101674|NCT01047306|377782|P1|Overall Study|Withdrawal by Subject|2
101675|NCT01047293|377856|P4|Overall Study|DLT criteria not fulfilled|0
101676|NCT01047293|377857|P3|Overall Study|DLT criteria not fulfilled|0
101677|NCT01047293|377858|P2|Overall Study|DLT criteria not fulfilled|1
101678|NCT01047293|377859|P1|Overall Study|DLT criteria not fulfilled|1
101679|NCT01046903|377886|P1|Overall Study|Other|5
101680|NCT01046903|377886|P1|Overall Study|Withdrawal by Subject|3
101681|NCT01046903|377886|P1|Overall Study|Adverse Event|4
101682|NCT01046903|377886|P1|Overall Study|Lost to Follow-up|16
101683|NCT01046877|377899|P1|Overall Study|Exited voluntarily after tube extrusion|11
101684|NCT01046877|377899|P1|Overall Study|Exited voluntarily before tube extrusion|7
101685|NCT01046695|377915|P2|Overall Study|TENS interfered with the cardiac monitor|1
101686|NCT01046695|377916|P1|Overall Study|TENS interfered with the cardiac monitor|0
101687|NCT01046695|377915|P2|Overall Study|Subject had a pacemaker|1
101688|NCT01046695|377916|P1|Overall Study|Subject had a pacemaker|0
101689|NCT01046682|377928|P2|Overall Study|Adverse Event|0
101690|NCT01046682|377929|P1|Overall Study|Adverse Event|2
101691|NCT01046643|377937|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
101692|NCT01046643|377938|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
101693|NCT01046643|377939|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
101694|NCT01046643|377940|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
101695|NCT01046565|377962|P1|Overall Study|Withdrawal by Subject|7
101696|NCT01046565|377962|P1|Overall Study|Adverse Event|2
101697|NCT01046396|377971|P1|Overall Study|Withdrawal by Subject|5
101698|NCT01046253|377982|P2|Second Intervention|Protocol Violation|1
101699|NCT01046253|377983|P1|Second Intervention|Protocol Violation|0
101700|NCT01046253|377982|P2|Second Intervention|Adverse Event|1
101701|NCT01046253|377983|P1|Second Intervention|Adverse Event|0
101702|NCT01046136|377995|P2|Overall Study|Lost to Follow-up|3
101703|NCT01046136|377996|P1|Overall Study|Lost to Follow-up|3
101704|NCT01046136|377995|P2|Overall Study|Physician Decision|1
101705|NCT01046136|377996|P1|Overall Study|Physician Decision|1
101706|NCT01046136|377995|P2|Overall Study|Withdrawal by Subject|4
101707|NCT01046136|377996|P1|Overall Study|Withdrawal by Subject|0
101708|NCT01046110|378008|P2|Overall Study|Unclassified|35
101709|NCT01046110|378009|P1|Overall Study|Unclassified|36
101710|NCT01046110|378008|P2|Overall Study|Withdrawal Criteria|5
101711|NCT01046110|378009|P1|Overall Study|Withdrawal Criteria|3
101712|NCT01046110|378008|P2|Overall Study|Protocol Violation|12
101713|NCT01046110|378009|P1|Overall Study|Protocol Violation|7
101714|NCT01046110|378008|P2|Overall Study|Lack of Efficacy|1
101715|NCT01046110|378009|P1|Overall Study|Lack of Efficacy|0
101716|NCT01046110|378008|P2|Overall Study|Adverse Event|2
101717|NCT01046110|378009|P1|Overall Study|Adverse Event|9
101718|NCT01046084|378019|P2|Third Washout of 7 Days|Withdrawal by Subject|0
101719|NCT01046084|378020|P1|Third Washout of 7 Days|Withdrawal by Subject|2
101720|NCT01045993|378034|P4|Overall Study|Treated-later found eligibility not met|0
101721|NCT01045993|378035|P3|Overall Study|Treated-later found eligibility not met|0
101722|NCT01045993|378036|P2|Overall Study|Treated-later found eligibility not met|1
101723|NCT01045993|378037|P1|Overall Study|Treated-later found eligibility not met|0
101724|NCT01045967|378113|P2|Second Intervention|Protocol Violation|1
101725|NCT01045967|378114|P1|Second Intervention|Protocol Violation|0
101726|NCT01045798|378126|P2|Overall Study|Received Systemic Antifungal Prestudy|1
101727|NCT01045798|378127|P1|Overall Study|Received Systemic Antifungal Prestudy|0
101728|NCT01045798|378126|P2|Overall Study|Changed to Other Antifungal Therapy|2
101729|NCT01045798|378127|P1|Overall Study|Changed to Other Antifungal Therapy|1
101730|NCT01045798|378126|P2|Overall Study|Invasive Fungal Infection at Baseline|1
101731|NCT01045798|378127|P1|Overall Study|Invasive Fungal Infection at Baseline|0
101732|NCT01045798|378126|P2|Overall Study|Changed to Open-Label Caspofungin|0
101733|NCT01045798|378127|P1|Overall Study|Changed to Open-Label Caspofungin|1
101734|NCT01045707|378135|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
101735|NCT01045707|378136|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
101736|NCT01045707|378135|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
101737|NCT01045707|378136|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
101738|NCT01045707|378135|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
101739|NCT01045707|378136|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
101740|NCT01045707|378135|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
101741|NCT01045707|378136|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
101742|NCT01045707|378135|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
101743|NCT01045707|378136|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
101744|NCT01045707|378135|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
101745|NCT01045707|378136|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
101746|NCT01045707|378135|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
101747|NCT01045707|378136|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
101748|NCT01045707|378135|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
101749|NCT01045707|378136|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
101750|NCT01045707|378135|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
101751|NCT01045707|378136|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
101752|NCT01045694|378152|P1|Overall Study|Withdrawal by Subject|2
101753|NCT01045447|378168|P2|Overall Study|Unclassified|13
101754|NCT01045447|378169|P1|Overall Study|Unclassified|17
101755|NCT01045447|378168|P2|Overall Study|Withdrawal Criteria|10
101756|NCT01045447|378169|P1|Overall Study|Withdrawal Criteria|10
101757|NCT01045447|378168|P2|Overall Study|Protocol Violation|3
101758|NCT01045447|378169|P1|Overall Study|Protocol Violation|6
101759|NCT01045447|378168|P2|Overall Study|Lack of Efficacy|1
101760|NCT01045447|378169|P1|Overall Study|Lack of Efficacy|3
101761|NCT01045447|378168|P2|Overall Study|Adverse Event|1
101762|NCT01045447|378169|P1|Overall Study|Adverse Event|0
101763|NCT01045421|378183|P11|Phase 2|Other|1
101764|NCT01045421|378184|P10|Phase 2|Other|0
101765|NCT01045421|378185|P9|Phase 2|Other|0
101766|NCT01045421|378186|P8|Phase 2|Other|3
101767|NCT01045421|378187|P7|Phase 2|Other|0
101768|NCT01045421|378188|P6|Phase 2|Other|0
101769|NCT01045421|378189|P5|Phase 2|Other|0
101770|NCT01045421|378190|P4|Phase 2|Other|0
101771|NCT01045421|378191|P3|Phase 2|Other|0
101772|NCT01045421|378192|P2|Phase 2|Other|0
101773|NCT01045421|378193|P1|Phase 2|Other|0
101774|NCT01045421|378183|P11|Phase 2|Death|0
101775|NCT01045421|378184|P10|Phase 2|Death|2
101776|NCT01045421|378185|P9|Phase 2|Death|1
101777|NCT01045421|378186|P8|Phase 2|Death|1
101778|NCT01045421|378187|P7|Phase 2|Death|0
101779|NCT01045421|378188|P6|Phase 2|Death|0
101780|NCT01045421|378189|P5|Phase 2|Death|0
101781|NCT01045421|378190|P4|Phase 2|Death|0
101782|NCT01045421|378191|P3|Phase 2|Death|0
101783|NCT01045421|378192|P2|Phase 2|Death|0
101784|NCT01045421|378193|P1|Phase 2|Death|0
101785|NCT01045421|378183|P11|Phase 2|Progressive Disease|1
101786|NCT01045421|378184|P10|Phase 2|Progressive Disease|1
101787|NCT01045421|378185|P9|Phase 2|Progressive Disease|1
101788|NCT01045421|378186|P8|Phase 2|Progressive Disease|1
101789|NCT01045421|378187|P7|Phase 2|Progressive Disease|0
101790|NCT01045421|378188|P6|Phase 2|Progressive Disease|0
101791|NCT01045421|378189|P5|Phase 2|Progressive Disease|0
101792|NCT01045421|378190|P4|Phase 2|Progressive Disease|0
101793|NCT01045421|378191|P3|Phase 2|Progressive Disease|0
101794|NCT01045421|378192|P2|Phase 2|Progressive Disease|0
101795|NCT01045421|378193|P1|Phase 2|Progressive Disease|0
101796|NCT01045421|378183|P11|Phase 1|Withdrawal by Subject|0
101797|NCT01045421|378184|P10|Phase 1|Withdrawal by Subject|0
101798|NCT01045421|378185|P9|Phase 1|Withdrawal by Subject|0
101799|NCT01045421|378186|P8|Phase 1|Withdrawal by Subject|0
101800|NCT01045421|378187|P7|Phase 1|Withdrawal by Subject|0
101801|NCT01045421|378188|P6|Phase 1|Withdrawal by Subject|0
101802|NCT01045421|378189|P5|Phase 1|Withdrawal by Subject|0
101803|NCT01045421|378190|P4|Phase 1|Withdrawal by Subject|1
101804|NCT01045421|378191|P3|Phase 1|Withdrawal by Subject|0
101805|NCT01045421|378192|P2|Phase 1|Withdrawal by Subject|0
101806|NCT01045421|378193|P1|Phase 1|Withdrawal by Subject|0
101807|NCT01045421|378183|P11|Phase 1|Progressive Disease|0
101808|NCT01045421|378184|P10|Phase 1|Progressive Disease|0
101809|NCT01045421|378185|P9|Phase 1|Progressive Disease|0
101810|NCT01045421|378186|P8|Phase 1|Progressive Disease|0
101811|NCT01045421|378187|P7|Phase 1|Progressive Disease|0
101812|NCT01045421|378188|P6|Phase 1|Progressive Disease|0
101813|NCT01045421|378189|P5|Phase 1|Progressive Disease|1
101814|NCT01045421|378190|P4|Phase 1|Progressive Disease|0
101815|NCT01045421|378191|P3|Phase 1|Progressive Disease|0
101816|NCT01045421|378192|P2|Phase 1|Progressive Disease|0
101817|NCT01045421|378193|P1|Phase 1|Progressive Disease|0
101818|NCT01045161|378287|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
101819|NCT01045161|378288|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
101820|NCT01045161|378289|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
101821|NCT01045161|378287|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
101822|NCT01045161|378288|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
101823|NCT01045161|378289|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
101824|NCT01045161|378287|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
101825|NCT01045161|378288|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
101826|NCT01045161|378289|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
101827|NCT01045161|378287|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
101828|NCT01045161|378288|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
101829|NCT01045161|378289|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
101830|NCT01045161|378287|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
101831|NCT01045161|378288|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
101832|NCT01045161|378289|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
101833|NCT01045161|378287|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
101834|NCT01045161|378288|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
101835|NCT01045161|378289|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
101836|NCT01045161|378287|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
101837|NCT01045161|378288|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
101838|NCT01045161|378289|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
101839|NCT01045161|378287|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
101840|NCT01045161|378288|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
101841|NCT01045161|378289|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
101842|NCT01045161|378287|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
101843|NCT01045161|378288|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
101844|NCT01045161|378289|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
101845|NCT01045161|378287|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
101846|NCT01045161|378288|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
101847|NCT01045161|378289|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
101848|NCT01045161|378287|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
101849|NCT01045161|378288|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
101850|NCT01045161|378289|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
101851|NCT01045161|378287|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
101852|NCT01045161|378288|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
101853|NCT01045161|378289|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
101854|NCT01045161|378287|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
101855|NCT01045161|378288|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
101856|NCT01045161|378289|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
101857|NCT01045161|378287|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
101858|NCT01045161|378288|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
101859|NCT01045161|378289|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
101860|NCT01045096|378319|P3|Overall Study|Other|0
101861|NCT01045096|378320|P2|Overall Study|Other|0
101862|NCT01045096|378321|P1|Overall Study|Other|1
101863|NCT01045096|378319|P3|Overall Study|Withdrawal by Subject|0
101864|NCT01045096|378320|P2|Overall Study|Withdrawal by Subject|0
101865|NCT01045096|378321|P1|Overall Study|Withdrawal by Subject|2
101866|NCT01044732|378432|P2|Overall Study|Technical error or malfunction|14
101867|NCT01044732|378433|P1|Overall Study|Technical error or malfunction|15
101868|NCT01044732|378432|P2|Overall Study|Inability to reach cecum|2
101869|NCT01044732|378433|P1|Overall Study|Inability to reach cecum|5
101870|NCT01044732|378432|P2|Overall Study|Inadequate bowel preparation|17
101871|NCT01044732|378433|P1|Overall Study|Inadequate bowel preparation|11
101872|NCT01044732|378432|P2|Overall Study|Withdrawal by Subject|1
101873|NCT01044732|378433|P1|Overall Study|Withdrawal by Subject|0
101874|NCT01044732|378432|P2|Overall Study|Protocol Violation|12
101875|NCT01044732|378433|P1|Overall Study|Protocol Violation|11
101876|NCT01044732|378432|P2|Overall Study|Physician Decision|3
101877|NCT01044732|378433|P1|Overall Study|Physician Decision|5
101878|NCT01044732|378432|P2|Overall Study|Lost to Follow-up|1
101879|NCT01044732|378433|P1|Overall Study|Lost to Follow-up|2
101880|NCT01044498|378622|P2|Overall Study|Not specified|0
101881|NCT01044498|378623|P1|Overall Study|Not specified|1
101882|NCT01044498|378622|P2|Overall Study|Adverse Event|1
101883|NCT01044498|378623|P1|Overall Study|Adverse Event|1
101884|NCT01044498|378622|P2|Overall Study|Withdrew consent|1
101885|NCT01044498|378623|P1|Overall Study|Withdrew consent|1
101886|NCT01044459|378649|P2|Overall Study|Lost to Follow-up|12
101887|NCT01044459|378650|P1|Overall Study|Lost to Follow-up|18
101888|NCT01044459|378649|P2|Overall Study|COPD exacerbation|8
101889|NCT01044459|378650|P1|Overall Study|COPD exacerbation|9
101890|NCT01044459|378649|P2|Overall Study|Other Reason|14
101891|NCT01044459|378650|P1|Overall Study|Other Reason|7
101892|NCT01044459|378649|P2|Overall Study|Protocol Violation|16
101893|NCT01044459|378650|P1|Overall Study|Protocol Violation|11
101894|NCT01044459|378649|P2|Overall Study|Lack of Efficacy|12
101895|NCT01044459|378650|P1|Overall Study|Lack of Efficacy|23
101896|NCT01044459|378649|P2|Overall Study|Adverse Event|20
101897|NCT01044459|378650|P1|Overall Study|Adverse Event|22
101898|NCT01044459|378649|P2|Overall Study|Terminated by Sponsor|21
101899|NCT01044459|378650|P1|Overall Study|Terminated by Sponsor|22
101900|NCT01044459|378649|P2|Overall Study|Withdrawal by Subject|28
101901|NCT01044459|378650|P1|Overall Study|Withdrawal by Subject|21
101902|NCT01044303|378658|P1|Overall Study|Lost to Follow-up|2
101903|NCT01044290|378668|P3|Follow-Up 2|Withdrawal by Subject|1
101904|NCT01044290|378669|P2|Follow-Up 2|Withdrawal by Subject|1
101905|NCT01044290|378670|P1|Follow-Up 2|Withdrawal by Subject|0
101906|NCT01044290|378668|P3|Follow-Up 2|Death|1
101907|NCT01044290|378669|P2|Follow-Up 2|Death|1
101908|NCT01044290|378670|P1|Follow-Up 2|Death|0
101909|NCT01044290|378668|P3|Follow-up 1|Withdrawal by Subject|0
101910|NCT01044290|378669|P2|Follow-up 1|Withdrawal by Subject|2
101911|NCT01044290|378670|P1|Follow-up 1|Withdrawal by Subject|2
101912|NCT01044290|378668|P3|Follow-up 1|Death|1
101913|NCT01044290|378669|P2|Follow-up 1|Death|3
101914|NCT01044290|378670|P1|Follow-up 1|Death|3
101915|NCT01043874|378786|P1|Overall Study|Administrative Problems|1
101916|NCT01043874|378786|P1|Overall Study|Lack of Efficacy|1
101917|NCT01043874|378786|P1|Overall Study|Withdrawal by Subject|1
101918|NCT01043874|378786|P1|Overall Study|Adverse Event|3
101919|NCT01043705|378796|P3|Overall Study|Other|25
101920|NCT01043705|378797|P2|Overall Study|Other|19
101921|NCT01043705|378798|P1|Overall Study|Other|0
101922|NCT01043705|378796|P3|Overall Study|Screen Fail|0
101923|NCT01043705|378797|P2|Overall Study|Screen Fail|0
101924|NCT01043705|378798|P1|Overall Study|Screen Fail|21
101925|NCT01043705|378796|P3|Overall Study|Adverse Event|0
101926|NCT01043705|378797|P2|Overall Study|Adverse Event|2
101927|NCT01043705|378798|P1|Overall Study|Adverse Event|0
101928|NCT01043705|378796|P3|Overall Study|Subsequent Procedure|29
101929|NCT01043705|378797|P2|Overall Study|Subsequent Procedure|24
101930|NCT01043705|378798|P1|Overall Study|Subsequent Procedure|9
101931|NCT01043705|378796|P3|Overall Study|Site Closure|0
101932|NCT01043705|378797|P2|Overall Study|Site Closure|0
101933|NCT01043705|378798|P1|Overall Study|Site Closure|8
101934|NCT01043705|378796|P3|Overall Study|Withdrawal by Subject|0
101935|NCT01043705|378797|P2|Overall Study|Withdrawal by Subject|6
101936|NCT01043705|378798|P1|Overall Study|Withdrawal by Subject|8
101937|NCT01043705|378796|P3|Overall Study|Protocol Violation|0
101938|NCT01043705|378797|P2|Overall Study|Protocol Violation|1
101939|NCT01043705|378798|P1|Overall Study|Protocol Violation|2
101940|NCT01043705|378796|P3|Overall Study|Multiple Reasons|0
101941|NCT01043705|378797|P2|Overall Study|Multiple Reasons|7
101942|NCT01043705|378798|P1|Overall Study|Multiple Reasons|4
101943|NCT01043705|378796|P3|Overall Study|Lost to Follow-up|0
101944|NCT01043705|378797|P2|Overall Study|Lost to Follow-up|12
101945|NCT01043705|378798|P1|Overall Study|Lost to Follow-up|27
101946|NCT01043705|378796|P3|Overall Study|Death|26
101947|NCT01043705|378797|P2|Overall Study|Death|60
101948|NCT01043705|378798|P1|Overall Study|Death|28
101949|NCT01043185|378887|P10|Period 6 - Third Washout Period|Protocol Violation|0
101950|NCT01043185|378888|P9|Period 6 - Third Washout Period|Protocol Violation|1
101951|NCT01043185|378889|P8|Period 6 - Third Washout Period|Protocol Violation|0
101952|NCT01043185|378890|P7|Period 6 - Third Washout Period|Protocol Violation|0
101953|NCT01043185|378891|P6|Period 6 - Third Washout Period|Protocol Violation|0
101954|NCT01043185|378892|P5|Period 6 - Third Washout Period|Protocol Violation|0
101955|NCT01043185|378893|P4|Period 6 - Third Washout Period|Protocol Violation|0
101956|NCT01043185|378894|P3|Period 6 - Third Washout Period|Protocol Violation|0
101957|NCT01043185|378895|P2|Period 6 - Third Washout Period|Protocol Violation|0
101958|NCT01043185|378896|P1|Period 6 - Third Washout Period|Protocol Violation|0
101959|NCT01042977|378972|P2|Overall Study|Various|0
101960|NCT01042977|378973|P1|Overall Study|Various|3
101961|NCT01042977|378972|P2|Overall Study|Administrative reason by sponsor|1
101962|NCT01042977|378973|P1|Overall Study|Administrative reason by sponsor|0
101963|NCT01042977|378972|P2|Overall Study|Safety|2
101964|NCT01042977|378973|P1|Overall Study|Safety|0
101965|NCT01042977|378972|P2|Overall Study|Incorrect enrollment|4
101966|NCT01042977|378973|P1|Overall Study|Incorrect enrollment|6
101967|NCT01042977|378972|P2|Overall Study|Subject no longer meets study criteria|13
101968|NCT01042977|378973|P1|Overall Study|Subject no longer meets study criteria|15
101969|NCT01042977|378972|P2|Overall Study|Poor/non-compliance|4
101970|NCT01042977|378973|P1|Overall Study|Poor/non-compliance|3
101971|NCT01042977|378972|P2|Overall Study|Lost to Follow-up|2
101972|NCT01042977|378973|P1|Overall Study|Lost to Follow-up|0
101973|NCT01042977|378972|P2|Overall Study|Withdrawal by Subject|16
101974|NCT01042977|378973|P1|Overall Study|Withdrawal by Subject|8
101975|NCT01042977|378972|P2|Overall Study|Death|1
101976|NCT01042977|378973|P1|Overall Study|Death|2
101977|NCT01042977|378972|P2|Overall Study|Adverse Event|12
101978|NCT01042977|378973|P1|Overall Study|Adverse Event|4
101979|NCT01042938|378993|P2|Overall Study|Ineligible: RTOG study conflict|0
101980|NCT01042938|378994|P1|Overall Study|Ineligible: RTOG study conflict|1
101981|NCT01042938|378993|P2|Overall Study|Protocol Violation|1
101982|NCT01042938|378994|P1|Overall Study|Protocol Violation|1
101983|NCT01042938|378993|P2|Overall Study|Withdrawal by Subject|1
101984|NCT01042938|378994|P1|Overall Study|Withdrawal by Subject|1
101985|NCT01042678|379013|P6|Overall Study|Physician Decision|0
101986|NCT01042678|379014|P5|Overall Study|Physician Decision|0
101987|NCT01042678|379015|P4|Overall Study|Physician Decision|0
101988|NCT01042678|379016|P3|Overall Study|Physician Decision|0
101989|NCT01042678|379017|P2|Overall Study|Physician Decision|0
101990|NCT01042678|379018|P1|Overall Study|Physician Decision|1
101991|NCT01042600|379056|P2|Overall Study|Ineligible|0
101992|NCT01042600|379057|P1|Overall Study|Ineligible|1
101993|NCT01042535|379065|P1|Overall Study|complications from other disease|2
101994|NCT01042535|379065|P1|Overall Study|disease progression during treatment|3
101995|NCT01042535|379065|P1|Overall Study|disease progression prior to treatment|3
101996|NCT01042392|379099|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
101997|NCT01042392|379100|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
101998|NCT01042392|379101|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
101999|NCT01042392|379102|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
102077|NCT01041859|379256|P3|Double-Blind Maintenance|Physician Decision|1
102000|NCT01042392|379099|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
102001|NCT01042392|379100|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
102002|NCT01042392|379101|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
102003|NCT01042392|379102|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
102004|NCT01042392|379099|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
102005|NCT01042392|379100|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
102006|NCT01042392|379101|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
102007|NCT01042392|379102|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
102008|NCT01042392|379099|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
102009|NCT01042392|379100|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
102010|NCT01042392|379101|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
102011|NCT01042392|379102|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
102012|NCT01042392|379099|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
102013|NCT01042392|379100|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
102014|NCT01042392|379101|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
102015|NCT01042392|379102|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
102016|NCT01042392|379099|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
102017|NCT01042392|379100|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
102018|NCT01042392|379101|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
102019|NCT01042392|379102|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
102020|NCT01042392|379099|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
102021|NCT01042392|379100|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
102022|NCT01042392|379101|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
102023|NCT01042392|379102|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
102024|NCT01042392|379099|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
102025|NCT01042392|379100|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
102026|NCT01042392|379101|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
102027|NCT01042392|379102|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
102028|NCT01042392|379099|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
102029|NCT01042392|379100|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
102030|NCT01042392|379101|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
102031|NCT01042392|379102|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
102032|NCT01042236|379150|P6|Treatment Period 3|Protocol Violation|0
102033|NCT01042236|379151|P5|Treatment Period 3|Protocol Violation|0
102034|NCT01042236|379152|P4|Treatment Period 3|Protocol Violation|1
102035|NCT01042236|379153|P3|Treatment Period 3|Protocol Violation|0
102036|NCT01042236|379154|P2|Treatment Period 3|Protocol Violation|0
102037|NCT01042236|379155|P1|Treatment Period 3|Protocol Violation|0
102038|NCT01042236|379150|P6|Treatment Period 3|Adverse Event|0
102039|NCT01042236|379151|P5|Treatment Period 3|Adverse Event|0
102040|NCT01042236|379152|P4|Treatment Period 3|Adverse Event|1
102041|NCT01042236|379153|P3|Treatment Period 3|Adverse Event|0
102042|NCT01042236|379154|P2|Treatment Period 3|Adverse Event|0
102043|NCT01042236|379155|P1|Treatment Period 3|Adverse Event|0
102044|NCT01042236|379150|P6|Treatment Period 1|Adverse Event|0
102045|NCT01042236|379151|P5|Treatment Period 1|Adverse Event|1
102046|NCT01042236|379152|P4|Treatment Period 1|Adverse Event|0
102047|NCT01042236|379153|P3|Treatment Period 1|Adverse Event|0
102048|NCT01042236|379154|P2|Treatment Period 1|Adverse Event|1
102049|NCT01042236|379155|P1|Treatment Period 1|Adverse Event|0
102050|NCT01042158|379192|P1|Overall Study|Physician Decision|1
102051|NCT01042093|379222|P4|Overall Study|Withdrawal by Subject|1
102052|NCT01042093|379223|P3|Overall Study|Withdrawal by Subject|0
102053|NCT01042093|379224|P2|Overall Study|Withdrawal by Subject|0
102054|NCT01042093|379225|P1|Overall Study|Withdrawal by Subject|0
102055|NCT01042093|379222|P4|Overall Study|Protocol Violation|3
102056|NCT01042093|379223|P3|Overall Study|Protocol Violation|2
102057|NCT01042093|379224|P2|Overall Study|Protocol Violation|2
102058|NCT01042093|379225|P1|Overall Study|Protocol Violation|2
102059|NCT01041976|379245|P2|Overall Study|Death|4
102060|NCT01041976|379246|P1|Overall Study|Death|0
102061|NCT01041976|379245|P2|Overall Study|Incarceration|0
102062|NCT01041976|379246|P1|Overall Study|Incarceration|2
102063|NCT01041976|379245|P2|Overall Study|Withdrawal by Subject|0
102064|NCT01041976|379246|P1|Overall Study|Withdrawal by Subject|3
102065|NCT01041859|379256|P3|Double-Blind Maintenance|Withdrawal by Subject|9
102066|NCT01041859|379257|P2|Double-Blind Maintenance|Withdrawal by Subject|8
102067|NCT01041859|379258|P1|Double-Blind Maintenance|Withdrawal by Subject|0
102068|NCT01041859|379256|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
102069|NCT01041859|379257|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
102070|NCT01041859|379258|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
102071|NCT01041859|379256|P3|Double-Blind Maintenance|Other|2
102072|NCT01041859|379257|P2|Double-Blind Maintenance|Other|6
102073|NCT01041859|379258|P1|Double-Blind Maintenance|Other|0
102074|NCT01041859|379256|P3|Double-Blind Maintenance|Protocol Violation|3
102075|NCT01041859|379257|P2|Double-Blind Maintenance|Protocol Violation|1
102076|NCT01041859|379258|P1|Double-Blind Maintenance|Protocol Violation|0
102078|NCT01041859|379257|P2|Double-Blind Maintenance|Physician Decision|2
102079|NCT01041859|379258|P1|Double-Blind Maintenance|Physician Decision|0
102080|NCT01041859|379256|P3|Double-Blind Maintenance|Lost to Follow-up|0
102081|NCT01041859|379257|P2|Double-Blind Maintenance|Lost to Follow-up|1
102082|NCT01041859|379258|P1|Double-Blind Maintenance|Lost to Follow-up|0
102083|NCT01041859|379256|P3|Double-Blind Maintenance|Lack of Efficacy|11
102084|NCT01041859|379257|P2|Double-Blind Maintenance|Lack of Efficacy|3
102085|NCT01041859|379258|P1|Double-Blind Maintenance|Lack of Efficacy|0
102086|NCT01041859|379256|P3|Double-Blind Maintenance|Adverse Event|13
102087|NCT01041859|379257|P2|Double-Blind Maintenance|Adverse Event|23
102088|NCT01041859|379258|P1|Double-Blind Maintenance|Adverse Event|0
102089|NCT01041859|379256|P3|Open-Label Titration|Withdrawal by Subject|0
102090|NCT01041859|379257|P2|Open-Label Titration|Withdrawal by Subject|0
102091|NCT01041859|379258|P1|Open-Label Titration|Withdrawal by Subject|11
102092|NCT01041859|379256|P3|Open-Label Titration|Noncompliance With Study Drug|0
102093|NCT01041859|379257|P2|Open-Label Titration|Noncompliance With Study Drug|0
102094|NCT01041859|379258|P1|Open-Label Titration|Noncompliance With Study Drug|8
102095|NCT01041859|379256|P3|Open-Label Titration|Other|0
102096|NCT01041859|379257|P2|Open-Label Titration|Other|0
102097|NCT01041859|379258|P1|Open-Label Titration|Other|7
102098|NCT01041859|379256|P3|Open-Label Titration|Protocol Violation|0
102099|NCT01041859|379257|P2|Open-Label Titration|Protocol Violation|0
102100|NCT01041859|379258|P1|Open-Label Titration|Protocol Violation|1
102101|NCT01041859|379256|P3|Open-Label Titration|Physician Decision|0
102102|NCT01041859|379257|P2|Open-Label Titration|Physician Decision|0
102103|NCT01041859|379258|P1|Open-Label Titration|Physician Decision|1
102104|NCT01041859|379256|P3|Open-Label Titration|Lost to Follow-up|0
102105|NCT01041859|379257|P2|Open-Label Titration|Lost to Follow-up|0
102106|NCT01041859|379258|P1|Open-Label Titration|Lost to Follow-up|1
102107|NCT01041859|379256|P3|Open-Label Titration|Lack of Efficacy|0
102108|NCT01041859|379257|P2|Open-Label Titration|Lack of Efficacy|0
102109|NCT01041859|379258|P1|Open-Label Titration|Lack of Efficacy|3
102110|NCT01041859|379256|P3|Open-Label Titration|Adverse Event|0
102111|NCT01041859|379257|P2|Open-Label Titration|Adverse Event|0
102112|NCT01041859|379258|P1|Open-Label Titration|Adverse Event|69
102113|NCT01041638|379273|P1|Overall Study|Withdrawal by Subject|11
102114|NCT01041638|379273|P1|Overall Study|Physician Decision|4
102115|NCT01041638|379273|P1|Overall Study|Lack of Efficacy|7
102116|NCT01041638|379273|P1|Overall Study|Death|1
102117|NCT01041638|379273|P1|Overall Study|Adverse Event|4
102118|NCT01041573|379281|P4|Overall Study|positive to anti-HCV|0
102119|NCT01041573|379282|P3|Overall Study|positive to anti-HCV|0
102120|NCT01041573|379283|P2|Overall Study|positive to anti-HCV|0
102121|NCT01041573|379284|P1|Overall Study|positive to anti-HCV|1
102122|NCT01041573|379281|P4|Overall Study|further blood extraction|0
102123|NCT01041573|379282|P3|Overall Study|further blood extraction|0
102124|NCT01041573|379283|P2|Overall Study|further blood extraction|1
102125|NCT01041573|379284|P1|Overall Study|further blood extraction|0
102126|NCT01041573|379281|P4|Overall Study|relocation|1
102127|NCT01041573|379282|P3|Overall Study|relocation|3
102128|NCT01041573|379283|P2|Overall Study|relocation|4
102129|NCT01041573|379284|P1|Overall Study|relocation|1
102130|NCT01041573|379281|P4|Overall Study|Adverse Event|0
102131|NCT01041573|379282|P3|Overall Study|Adverse Event|0
102132|NCT01041573|379283|P2|Overall Study|Adverse Event|2
102133|NCT01041573|379284|P1|Overall Study|Adverse Event|0
102134|NCT01041573|379281|P4|Overall Study|Lost to Follow-up|1
102135|NCT01041573|379282|P3|Overall Study|Lost to Follow-up|2
102136|NCT01041573|379283|P2|Overall Study|Lost to Follow-up|1
102137|NCT01041573|379284|P1|Overall Study|Lost to Follow-up|0
102138|NCT01041573|379281|P4|Overall Study|Death|0
102139|NCT01041573|379282|P3|Overall Study|Death|0
102140|NCT01041573|379283|P2|Overall Study|Death|0
102141|NCT01041573|379284|P1|Overall Study|Death|1
102142|NCT01041573|379281|P4|Overall Study|Withdrawal by Subject|0
102143|NCT01041573|379282|P3|Overall Study|Withdrawal by Subject|2
102144|NCT01041573|379283|P2|Overall Study|Withdrawal by Subject|5
102145|NCT01041573|379284|P1|Overall Study|Withdrawal by Subject|2
102146|NCT01041417|379296|P2|Overall Study|Death|0
102147|NCT01041417|379297|P1|Overall Study|Death|1
102148|NCT01041417|379296|P2|Overall Study|Lost to Follow-up|1
102149|NCT01041417|379297|P1|Overall Study|Lost to Follow-up|1
102150|NCT01041417|379296|P2|Overall Study|Adverse Event|2
102151|NCT01041417|379297|P1|Overall Study|Adverse Event|5
102152|NCT01041404|379335|P2|Overall Study|Not Specified|23
102153|NCT01041404|379336|P1|Overall Study|Not Specified|11
102154|NCT01041404|379335|P2|Overall Study|Failure to Return|2
102155|NCT01041404|379336|P1|Overall Study|Failure to Return|1
102156|NCT01041404|379335|P2|Overall Study|Withdrawal by Subject|23
102157|NCT01041404|379336|P1|Overall Study|Withdrawal by Subject|29
102158|NCT01041404|379335|P2|Overall Study|Protocol Violation|0
102159|NCT01041404|379336|P1|Overall Study|Protocol Violation|4
102160|NCT01041404|379335|P2|Overall Study|Violation of Selection Criteria|1
102161|NCT01041404|379336|P1|Overall Study|Violation of Selection Criteria|0
102162|NCT01041404|379335|P2|Overall Study|Lack of Efficacy|210
102163|NCT01041404|379336|P1|Overall Study|Lack of Efficacy|200
102164|NCT01041404|379335|P2|Overall Study|Adverse Event|35
102165|NCT01041404|379336|P1|Overall Study|Adverse Event|45
102166|NCT01041287|379377|P2|Treatment Period 2 (3 Months)|Adverse Event|2
102167|NCT01041287|379378|P1|Treatment Period 2 (3 Months)|Adverse Event|0
102168|NCT01041287|379377|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
102169|NCT01041287|379378|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
102170|NCT01040871|379401|P2|Overall Study|Randomized and Not Treated|1
102171|NCT01040871|379402|P1|Overall Study|Randomized and Not Treated|2
102172|NCT01040871|379401|P2|Overall Study|drug supply issue|0
102173|NCT01040871|379402|P1|Overall Study|drug supply issue|1
102174|NCT01040871|379401|P2|Overall Study|Lack of Efficacy|1
102175|NCT01040871|379402|P1|Overall Study|Lack of Efficacy|1
102176|NCT01040871|379401|P2|Overall Study|Death|3
102177|NCT01040871|379402|P1|Overall Study|Death|1
102178|NCT01040871|379401|P2|Overall Study|Withdrawal by Subject|0
102179|NCT01040871|379402|P1|Overall Study|Withdrawal by Subject|2
102180|NCT01040871|379401|P2|Overall Study|Adverse Event|2
102181|NCT01040871|379402|P1|Overall Study|Adverse Event|6
102182|NCT01040845|379453|P2|Overall Study|Physician Decision|0
102183|NCT01040845|379454|P1|Overall Study|Physician Decision|1
102184|NCT01040845|379453|P2|Overall Study|Withdrawal by Subject|1
102185|NCT01040845|379454|P1|Overall Study|Withdrawal by Subject|1
102186|NCT01040832|379469|P2|Overall Study|Other|1
102187|NCT01040832|379470|P1|Overall Study|Other|2
102188|NCT01040832|379469|P2|Overall Study|Symptomatic deterioration|5
102189|NCT01040832|379470|P1|Overall Study|Symptomatic deterioration|2
102190|NCT01040832|379469|P2|Overall Study|Progressive disease|17
102191|NCT01040832|379470|P1|Overall Study|Progressive disease|32
102192|NCT01040832|379469|P2|Overall Study|Withdrawal by Subject|3
102193|NCT01040832|379470|P1|Overall Study|Withdrawal by Subject|2
102194|NCT01040832|379469|P2|Overall Study|Death|6
102195|NCT01040832|379470|P1|Overall Study|Death|4
102196|NCT01040832|379469|P2|Overall Study|Adverse Event|5
102197|NCT01040832|379470|P1|Overall Study|Adverse Event|4
102198|NCT01040793|379493|P6|Overall Study|Other reasons not listed above|0
102199|NCT01040793|379494|P5|Overall Study|Other reasons not listed above|1
102200|NCT01040793|379495|P4|Overall Study|Other reasons not listed above|0
102201|NCT01040793|379496|P3|Overall Study|Other reasons not listed above|1
102202|NCT01040793|379497|P2|Overall Study|Other reasons not listed above|0
102203|NCT01040793|379498|P1|Overall Study|Other reasons not listed above|0
102204|NCT01040793|379493|P6|Overall Study|Withdrawal by Subject|0
102205|NCT01040793|379494|P5|Overall Study|Withdrawal by Subject|0
102206|NCT01040793|379495|P4|Overall Study|Withdrawal by Subject|2
102207|NCT01040793|379496|P3|Overall Study|Withdrawal by Subject|0
102208|NCT01040793|379497|P2|Overall Study|Withdrawal by Subject|0
102209|NCT01040793|379498|P1|Overall Study|Withdrawal by Subject|0
102210|NCT01040793|379493|P6|Overall Study|Lost to Follow-up|0
102211|NCT01040793|379494|P5|Overall Study|Lost to Follow-up|0
102212|NCT01040793|379495|P4|Overall Study|Lost to Follow-up|0
102213|NCT01040793|379496|P3|Overall Study|Lost to Follow-up|1
102214|NCT01040793|379497|P2|Overall Study|Lost to Follow-up|1
102215|NCT01040793|379498|P1|Overall Study|Lost to Follow-up|0
102216|NCT01040793|379493|P6|Overall Study|Protocol Violation|0
102217|NCT01040793|379494|P5|Overall Study|Protocol Violation|1
102218|NCT01040793|379495|P4|Overall Study|Protocol Violation|0
102219|NCT01040793|379496|P3|Overall Study|Protocol Violation|1
102220|NCT01040793|379497|P2|Overall Study|Protocol Violation|1
102221|NCT01040793|379498|P1|Overall Study|Protocol Violation|1
102222|NCT01040793|379493|P6|Overall Study|Adverse Event|1
102223|NCT01040793|379494|P5|Overall Study|Adverse Event|2
102224|NCT01040793|379495|P4|Overall Study|Adverse Event|2
102225|NCT01040793|379496|P3|Overall Study|Adverse Event|0
102226|NCT01040793|379497|P2|Overall Study|Adverse Event|3
102227|NCT01040793|379498|P1|Overall Study|Adverse Event|5
102228|NCT01040780|379577|P2|Overall Study|Protocol Violation|3
102229|NCT01040780|379578|P1|Overall Study|Protocol Violation|1
102230|NCT01040728|379592|P4|Overall Study|Other reasons not listed above|0
102231|NCT01040728|379593|P3|Overall Study|Other reasons not listed above|0
102232|NCT01040728|379594|P2|Overall Study|Other reasons not listed above|1
102233|NCT01040728|379595|P1|Overall Study|Other reasons not listed above|0
102234|NCT01040728|379592|P4|Overall Study|Lack of Efficacy|1
102235|NCT01040728|379593|P3|Overall Study|Lack of Efficacy|0
102236|NCT01040728|379594|P2|Overall Study|Lack of Efficacy|1
102237|NCT01040728|379595|P1|Overall Study|Lack of Efficacy|0
102238|NCT01040728|379592|P4|Overall Study|Protocol Violation|1
102239|NCT01040728|379593|P3|Overall Study|Protocol Violation|0
102240|NCT01040728|379594|P2|Overall Study|Protocol Violation|0
102241|NCT01040728|379595|P1|Overall Study|Protocol Violation|0
102242|NCT01040728|379592|P4|Overall Study|Withdrawal by Subject|0
102243|NCT01040728|379593|P3|Overall Study|Withdrawal by Subject|1
102244|NCT01040728|379594|P2|Overall Study|Withdrawal by Subject|1
102245|NCT01040728|379595|P1|Overall Study|Withdrawal by Subject|0
102246|NCT01040728|379592|P4|Overall Study|Adverse Event|4
102247|NCT01040728|379593|P3|Overall Study|Adverse Event|0
102248|NCT01040728|379594|P2|Overall Study|Adverse Event|8
102249|NCT01040728|379595|P1|Overall Study|Adverse Event|4
102250|NCT01040689|379665|P4|Overall Study|Other reasons not listed above|0
102251|NCT01040689|379666|P3|Overall Study|Other reasons not listed above|0
102252|NCT01040689|379667|P2|Overall Study|Other reasons not listed above|1
102253|NCT01040689|379668|P1|Overall Study|Other reasons not listed above|0
102254|NCT01040689|379665|P4|Overall Study|Withdrawal by Subject|0
102255|NCT01040689|379666|P3|Overall Study|Withdrawal by Subject|1
102256|NCT01040689|379667|P2|Overall Study|Withdrawal by Subject|1
102257|NCT01040689|379668|P1|Overall Study|Withdrawal by Subject|2
102258|NCT01040689|379665|P4|Overall Study|Lost to Follow-up|0
102259|NCT01040689|379666|P3|Overall Study|Lost to Follow-up|0
102260|NCT01040689|379667|P2|Overall Study|Lost to Follow-up|0
102261|NCT01040689|379668|P1|Overall Study|Lost to Follow-up|1
102262|NCT01040689|379665|P4|Overall Study|Lack of Efficacy|0
102263|NCT01040689|379666|P3|Overall Study|Lack of Efficacy|1
102264|NCT01040689|379667|P2|Overall Study|Lack of Efficacy|0
102265|NCT01040689|379668|P1|Overall Study|Lack of Efficacy|0
102266|NCT01040689|379665|P4|Overall Study|Adverse Event|4
102267|NCT01040689|379666|P3|Overall Study|Adverse Event|2
102268|NCT01040689|379667|P2|Overall Study|Adverse Event|0
102269|NCT01040689|379668|P1|Overall Study|Adverse Event|0
102270|NCT01040403|379747|P1|Overall Study|Other reason not defined above|6
102271|NCT01040403|379747|P1|Overall Study|Not treated|1
102272|NCT01040403|379747|P1|Overall Study|Lost to Follow-up|1
102273|NCT01040403|379747|P1|Overall Study|Protocol Violation|2
102274|NCT01040403|379747|P1|Overall Study|Adverse Event|10
102275|NCT01040351|379935|P2|Overall Study|poor ovarian response|2
102276|NCT01040351|379936|P1|Overall Study|poor ovarian response|1
102277|NCT01040169|379974|P2|Overall Study|Lost to Follow-up|8
102278|NCT01040169|379975|P1|Overall Study|Lost to Follow-up|3
102279|NCT01040130|379983|P6|Overall Study|Other reasons not listed above|0
102280|NCT01040130|379984|P5|Overall Study|Other reasons not listed above|0
102281|NCT01040130|379985|P4|Overall Study|Other reasons not listed above|0
102282|NCT01040130|379986|P3|Overall Study|Other reasons not listed above|0
102283|NCT01040130|379987|P2|Overall Study|Other reasons not listed above|0
102284|NCT01040130|379988|P1|Overall Study|Other reasons not listed above|2
102285|NCT01040130|379983|P6|Overall Study|Withdrawal by Subject|1
102286|NCT01040130|379984|P5|Overall Study|Withdrawal by Subject|0
102287|NCT01040130|379985|P4|Overall Study|Withdrawal by Subject|0
102288|NCT01040130|379986|P3|Overall Study|Withdrawal by Subject|0
102289|NCT01040130|379987|P2|Overall Study|Withdrawal by Subject|2
102290|NCT01040130|379988|P1|Overall Study|Withdrawal by Subject|0
102291|NCT01040130|379983|P6|Overall Study|Protocol Violation|0
102292|NCT01040130|379984|P5|Overall Study|Protocol Violation|0
102293|NCT01040130|379985|P4|Overall Study|Protocol Violation|0
102294|NCT01040130|379986|P3|Overall Study|Protocol Violation|2
102295|NCT01040130|379987|P2|Overall Study|Protocol Violation|0
102296|NCT01040130|379988|P1|Overall Study|Protocol Violation|0
102297|NCT01040130|379983|P6|Overall Study|Adverse Event|3
102298|NCT01040130|379984|P5|Overall Study|Adverse Event|0
102299|NCT01040130|379985|P4|Overall Study|Adverse Event|5
102300|NCT01040130|379986|P3|Overall Study|Adverse Event|0
102301|NCT01040130|379987|P2|Overall Study|Adverse Event|1
102302|NCT01040130|379988|P1|Overall Study|Adverse Event|1
102303|NCT01039688|380081|P3|Overall Study|Death|0
102304|NCT01039688|380082|P2|Overall Study|Death|0
102305|NCT01039688|380083|P1|Overall Study|Death|2
102306|NCT01039688|380081|P3|Overall Study|Withdrawal by Subject|13
102307|NCT01039688|380082|P2|Overall Study|Withdrawal by Subject|27
102308|NCT01039688|380083|P1|Overall Study|Withdrawal by Subject|23
102309|NCT01039688|380081|P3|Overall Study|Not specified|12
102310|NCT01039688|380082|P2|Overall Study|Not specified|25
102311|NCT01039688|380083|P1|Overall Study|Not specified|13
102312|NCT01039688|380081|P3|Overall Study|Lost to Follow-up|5
102313|NCT01039688|380082|P2|Overall Study|Lost to Follow-up|9
102314|NCT01039688|380083|P1|Overall Study|Lost to Follow-up|11
102315|NCT01039688|380081|P3|Overall Study|Lack of Efficacy|26
102316|NCT01039688|380082|P2|Overall Study|Lack of Efficacy|11
102317|NCT01039688|380083|P1|Overall Study|Lack of Efficacy|20
102318|NCT01039688|380081|P3|Overall Study|Adverse Event|24
102319|NCT01039688|380082|P2|Overall Study|Adverse Event|39
102320|NCT01039688|380083|P1|Overall Study|Adverse Event|38
102321|NCT01039675|380354|P2|Overall Study|Physician Decision|1
102322|NCT01039675|380355|P1|Overall Study|Physician Decision|0
102323|NCT01039675|380354|P2|Overall Study|Lost to Follow-up|1
102324|NCT01039675|380355|P1|Overall Study|Lost to Follow-up|0
102325|NCT01039675|380354|P2|Overall Study|Withdrawal by Subject|1
102326|NCT01039675|380355|P1|Overall Study|Withdrawal by Subject|0
102327|NCT01039675|380354|P2|Overall Study|Lack of Efficacy|2
102328|NCT01039675|380355|P1|Overall Study|Lack of Efficacy|0
102329|NCT01039675|380354|P2|Overall Study|Adverse Event|2
102330|NCT01039675|380355|P1|Overall Study|Adverse Event|0
102331|NCT01039584|380368|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
102332|NCT01039584|380369|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
102333|NCT01039584|380370|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
102334|NCT01039584|380368|P3|Overall Study|Pap smear with significant pathology|3
102335|NCT01039584|380369|P2|Overall Study|Pap smear with significant pathology|10
102336|NCT01039584|380370|P1|Overall Study|Pap smear with significant pathology|10
102337|NCT01039584|380368|P3|Overall Study|other|1
102338|NCT01039584|380369|P2|Overall Study|other|3
102339|NCT01039584|380370|P1|Overall Study|other|1
102340|NCT01039584|380368|P3|Overall Study|Lack of Efficacy|10
102341|NCT01039584|380369|P2|Overall Study|Lack of Efficacy|6
102342|NCT01039584|380370|P1|Overall Study|Lack of Efficacy|7
102343|NCT01039584|380368|P3|Overall Study|Negative Baseline culture for Candida|24
102344|NCT01039584|380369|P2|Overall Study|Negative Baseline culture for Candida|59
102345|NCT01039584|380370|P1|Overall Study|Negative Baseline culture for Candida|59
102346|NCT01039584|380368|P3|Overall Study|Lost to Follow-up|4
102347|NCT01039584|380369|P2|Overall Study|Lost to Follow-up|3
102348|NCT01039584|380370|P1|Overall Study|Lost to Follow-up|5
102349|NCT01039584|380368|P3|Overall Study|Protocol Violation|6
102350|NCT01039584|380369|P2|Overall Study|Protocol Violation|4
102351|NCT01039584|380370|P1|Overall Study|Protocol Violation|10
102352|NCT01039584|380368|P3|Overall Study|Withdrawal by Subject|1
102353|NCT01039584|380369|P2|Overall Study|Withdrawal by Subject|2
102354|NCT01039584|380370|P1|Overall Study|Withdrawal by Subject|4
102355|NCT01039519|380384|P1|Survival Follow-up|Sponsor decision|4
102356|NCT01039519|380384|P1|Survival Follow-up|Death|23
102357|NCT01039519|380384|P1|Treatment|Physician Decision|2
102358|NCT01039519|380384|P1|Treatment|Adverse Event|3
102359|NCT01039519|380384|P1|Treatment|Treatment failure|2
102360|NCT01039519|380384|P1|Treatment|Progressive disease|20
102361|NCT01039428|380395|P2|Overall Study|Withdrawal by Subject|0
102362|NCT01039428|380396|P1|Overall Study|Withdrawal by Subject|1
102363|NCT01039428|380395|P2|Overall Study|Protocol Violation|0
102364|NCT01039428|380396|P1|Overall Study|Protocol Violation|1
102365|NCT01039376|380420|P2|Overall Study|Ongoing|182
102366|NCT01039376|380421|P1|Overall Study|Ongoing|189
102367|NCT01039376|380420|P2|Overall Study|Withdrawal by Subject|17
102368|NCT01039376|380421|P1|Overall Study|Withdrawal by Subject|11
102369|NCT01039376|380420|P2|Overall Study|Physician Decision|2
102370|NCT01039376|380421|P1|Overall Study|Physician Decision|4
102371|NCT01039376|380420|P2|Overall Study|Lost to Follow-up|1
102372|NCT01039376|380421|P1|Overall Study|Lost to Follow-up|2
102373|NCT01038921|380489|P2|Overall Study|Physician Decision|0
102374|NCT01038921|380490|P1|Overall Study|Physician Decision|1
102375|NCT01038921|380489|P2|Overall Study|Withdrawal by Subject|0
102376|NCT01038921|380490|P1|Overall Study|Withdrawal by Subject|1
102377|NCT01038869|380496|P1|Overall Study|Lost to Follow-up|6
102378|NCT01038869|380496|P1|Overall Study|Withdrawal by Subject|1
102379|NCT01038856|380504|P1|Overall Study|Adverse Event|2
102380|NCT01038752|380513|P2|Overall Study|Lost to Follow-up|3
102381|NCT01038752|380514|P1|Overall Study|Lost to Follow-up|3
102382|NCT01038752|380513|P2|Overall Study|Tumor Progression|2
102383|NCT01038752|380514|P1|Overall Study|Tumor Progression|2
102384|NCT01038713|380537|P3|Overall Study|Autoimmune Pancreatitis|0
102385|NCT01038713|380538|P2|Overall Study|Autoimmune Pancreatitis|0
102386|NCT01038713|380539|P1|Overall Study|Autoimmune Pancreatitis|1
102387|NCT01038713|380537|P3|Overall Study|died from PEP|0
102388|NCT01038713|380538|P2|Overall Study|died from PEP|1
102389|NCT01038713|380539|P1|Overall Study|died from PEP|0
102390|NCT01038713|380537|P3|Overall Study|Neuroendocrine Tumor|0
102391|NCT01038713|380538|P2|Overall Study|Neuroendocrine Tumor|1
102392|NCT01038713|380539|P1|Overall Study|Neuroendocrine Tumor|0
102393|NCT01038713|380537|P3|Overall Study|Lost to Follow-up|0
102394|NCT01038713|380538|P2|Overall Study|Lost to Follow-up|0
102395|NCT01038713|380539|P1|Overall Study|Lost to Follow-up|3
102396|NCT01038713|380537|P3|Overall Study|Patient to hospice|1
102397|NCT01038713|380538|P2|Overall Study|Patient to hospice|1
102398|NCT01038713|380539|P1|Overall Study|Patient to hospice|1
102399|NCT01038635|380568|P9|Overall Study|Death|2
102400|NCT01038635|380569|P8|Overall Study|Death|1
102401|NCT01038635|380570|P7|Overall Study|Death|1
102402|NCT01038635|380571|P6|Overall Study|Death|0
102403|NCT01038635|380572|P5|Overall Study|Death|1
102404|NCT01038635|380573|P4|Overall Study|Death|0
102405|NCT01038635|380574|P3|Overall Study|Death|0
102406|NCT01038635|380575|P2|Overall Study|Death|0
102407|NCT01038635|380576|P1|Overall Study|Death|0
102408|NCT01038635|380568|P9|Overall Study|Disease Progression|0
102409|NCT01038635|380569|P8|Overall Study|Disease Progression|4
102410|NCT01038635|380570|P7|Overall Study|Disease Progression|1
102411|NCT01038635|380571|P6|Overall Study|Disease Progression|0
102412|NCT01038635|380572|P5|Overall Study|Disease Progression|0
102413|NCT01038635|380573|P4|Overall Study|Disease Progression|0
102414|NCT01038635|380574|P3|Overall Study|Disease Progression|0
102415|NCT01038635|380575|P2|Overall Study|Disease Progression|0
102416|NCT01038635|380576|P1|Overall Study|Disease Progression|2
102417|NCT01038609|380602|P5|Overall Study|Refusal of Blood Draws|0
102418|NCT01038609|380603|P4|Overall Study|Refusal of Blood Draws|0
102419|NCT01038609|380604|P3|Overall Study|Refusal of Blood Draws|0
102420|NCT01038609|380605|P2|Overall Study|Refusal of Blood Draws|1
102421|NCT01038609|380606|P1|Overall Study|Refusal of Blood Draws|0
102422|NCT01038609|380602|P5|Overall Study|Death in the Family|0
102423|NCT01038609|380603|P4|Overall Study|Death in the Family|0
102424|NCT01038609|380604|P3|Overall Study|Death in the Family|0
102425|NCT01038609|380605|P2|Overall Study|Death in the Family|0
102426|NCT01038609|380606|P1|Overall Study|Death in the Family|1
102427|NCT01038609|380602|P5|Overall Study|Dosing Error|1
102428|NCT01038609|380603|P4|Overall Study|Dosing Error|1
102429|NCT01038609|380604|P3|Overall Study|Dosing Error|0
102430|NCT01038609|380605|P2|Overall Study|Dosing Error|0
102431|NCT01038609|380606|P1|Overall Study|Dosing Error|0
102432|NCT01038609|380602|P5|Overall Study|Adverse Event|0
102433|NCT01038609|380603|P4|Overall Study|Adverse Event|0
102434|NCT01038609|380604|P3|Overall Study|Adverse Event|1
102435|NCT01038609|380605|P2|Overall Study|Adverse Event|0
102436|NCT01038609|380606|P1|Overall Study|Adverse Event|0
102437|NCT01038323|380685|P3|Overall Study|Withdrawal by Subject|4
102438|NCT01038323|380686|P2|Overall Study|Withdrawal by Subject|2
102439|NCT01038323|380687|P1|Overall Study|Withdrawal by Subject|3
102440|NCT01038128|380701|P1|Overall Study|Withdrawal by Subject|2
102441|NCT01038128|380701|P1|Overall Study|Lost to Follow-up|1
102442|NCT01038128|380701|P1|Overall Study|Lack of Efficacy|1
102443|NCT01037244|380785|P4|Overall Study|Various|1
102444|NCT01037244|380786|P3|Overall Study|Various|1
102445|NCT01037244|380787|P2|Overall Study|Various|2
102446|NCT01037244|380788|P1|Overall Study|Various|3
102447|NCT01037244|380785|P4|Overall Study|Partner Withdrew Consent|0
102448|NCT01037244|380786|P3|Overall Study|Partner Withdrew Consent|0
102449|NCT01037244|380787|P2|Overall Study|Partner Withdrew Consent|1
102450|NCT01037244|380788|P1|Overall Study|Partner Withdrew Consent|2
102451|NCT01037244|380785|P4|Overall Study|Withdrawal by Subject|5
102452|NCT01037244|380786|P3|Overall Study|Withdrawal by Subject|3
102453|NCT01037244|380787|P2|Overall Study|Withdrawal by Subject|5
102454|NCT01037244|380788|P1|Overall Study|Withdrawal by Subject|1
102455|NCT01037244|380785|P4|Overall Study|Lost to Follow-up|4
102456|NCT01037244|380786|P3|Overall Study|Lost to Follow-up|4
102457|NCT01037244|380787|P2|Overall Study|Lost to Follow-up|3
102458|NCT01037244|380788|P1|Overall Study|Lost to Follow-up|3
102459|NCT01037244|380785|P4|Overall Study|Lack of Efficacy|1
102460|NCT01037244|380786|P3|Overall Study|Lack of Efficacy|0
102461|NCT01037244|380787|P2|Overall Study|Lack of Efficacy|1
102462|NCT01037244|380788|P1|Overall Study|Lack of Efficacy|1
102463|NCT01037244|380785|P4|Overall Study|Adverse Event|3
102464|NCT01037244|380786|P3|Overall Study|Adverse Event|6
102465|NCT01037244|380787|P2|Overall Study|Adverse Event|2
102466|NCT01037244|380788|P1|Overall Study|Adverse Event|3
102467|NCT01037218|380850|P4|Overall Study|Various|1
102468|NCT01037218|380851|P3|Overall Study|Various|3
102469|NCT01037218|380852|P2|Overall Study|Various|2
102470|NCT01037218|380853|P1|Overall Study|Various|3
102471|NCT01037218|380850|P4|Overall Study|Protocol Violation|2
102472|NCT01037218|380851|P3|Overall Study|Protocol Violation|2
102473|NCT01037218|380852|P2|Overall Study|Protocol Violation|0
102474|NCT01037218|380853|P1|Overall Study|Protocol Violation|0
102475|NCT01037218|380850|P4|Overall Study|Partner Withdrew Consent|1
102476|NCT01037218|380851|P3|Overall Study|Partner Withdrew Consent|2
102477|NCT01037218|380852|P2|Overall Study|Partner Withdrew Consent|3
102478|NCT01037218|380853|P1|Overall Study|Partner Withdrew Consent|0
102479|NCT01037218|380850|P4|Overall Study|Withdrawal by Subject|4
102480|NCT01037218|380851|P3|Overall Study|Withdrawal by Subject|7
102481|NCT01037218|380852|P2|Overall Study|Withdrawal by Subject|7
102482|NCT01037218|380853|P1|Overall Study|Withdrawal by Subject|6
102483|NCT01037218|380850|P4|Overall Study|Lost to Follow-up|2
102484|NCT01037218|380851|P3|Overall Study|Lost to Follow-up|4
102485|NCT01037218|380852|P2|Overall Study|Lost to Follow-up|5
102486|NCT01037218|380853|P1|Overall Study|Lost to Follow-up|3
102487|NCT01037218|380850|P4|Overall Study|Lack of Efficacy|5
102488|NCT01037218|380851|P3|Overall Study|Lack of Efficacy|1
102489|NCT01037218|380852|P2|Overall Study|Lack of Efficacy|2
102490|NCT01037218|380853|P1|Overall Study|Lack of Efficacy|0
102491|NCT01037218|380850|P4|Overall Study|Adverse Event|1
102492|NCT01037218|380851|P3|Overall Study|Adverse Event|2
102493|NCT01037218|380852|P2|Overall Study|Adverse Event|2
102494|NCT01037218|380853|P1|Overall Study|Adverse Event|4
102495|NCT01037127|380924|P2|Overall Study|Study Closed Terminated|17
102496|NCT01037127|380925|P1|Overall Study|Study Closed Terminated|2
102497|NCT01037127|380924|P2|Overall Study|Physician Decision|0
102498|NCT01037127|380925|P1|Overall Study|Physician Decision|1
102499|NCT01037127|380924|P2|Overall Study|Lost to Follow-up|4
102500|NCT01037127|380925|P1|Overall Study|Lost to Follow-up|2
102501|NCT01037114|380957|P1|Year 20|Others|1
102502|NCT01037088|380970|P1|Overall Study|Withdrawal by Subject|3
102503|NCT01036763|381002|P1|Overall Study|Other reason (not specified)|40
102504|NCT01036763|381002|P1|Overall Study|Lost to Follow-up|28
102505|NCT01036763|381002|P1|Overall Study|Adverse Event|25
102506|NCT01036724|381014|P2|Overall Study|Protocol Violation|5
102507|NCT01036724|381015|P1|Overall Study|Protocol Violation|4
102508|NCT01036724|381014|P2|Overall Study|Lack of Efficacy|1
102509|NCT01036724|381015|P1|Overall Study|Lack of Efficacy|1
102510|NCT01036724|381014|P2|Overall Study|Adverse Event|2
102511|NCT01036724|381015|P1|Overall Study|Adverse Event|1
102512|NCT01036529|381025|P2|Overall Study|Sponsor study termination|12
102513|NCT01036529|381026|P1|Overall Study|Sponsor study termination|11
102514|NCT01036529|381025|P2|Overall Study|Withdrawal by Subject|1
102515|NCT01036529|381026|P1|Overall Study|Withdrawal by Subject|1
102516|NCT01036529|381025|P2|Overall Study|Physician Decision|0
102517|NCT01036529|381026|P1|Overall Study|Physician Decision|1
102518|NCT01036529|381025|P2|Overall Study|Lost to Follow-up|1
102519|NCT01036529|381026|P1|Overall Study|Lost to Follow-up|0
102520|NCT01036529|381025|P2|Overall Study|Adverse Event|1
102521|NCT01036529|381026|P1|Overall Study|Adverse Event|0
102522|NCT01036438|381053|P2|Overall Study|No effect of study treatment|1
102523|NCT01036438|381054|P1|Overall Study|No effect of study treatment|3
102524|NCT01036438|381053|P2|Overall Study|Death|1
102525|NCT01036438|381054|P1|Overall Study|Death|0
102526|NCT01036438|381053|P2|Overall Study|Adverse Event|8
102527|NCT01036438|381054|P1|Overall Study|Adverse Event|7
102528|NCT01036321|381062|P2|Overall Study|Adverse Event|1
102529|NCT01036321|381063|P1|Overall Study|Adverse Event|2
102530|NCT01036321|381062|P2|Overall Study|Withdrawal by Subject|2
102531|NCT01036321|381063|P1|Overall Study|Withdrawal by Subject|3
102532|NCT01036321|381062|P2|Overall Study|Ineligible after randomization|1
102533|NCT01036321|381063|P1|Overall Study|Ineligible after randomization|0
102534|NCT01036165|381087|P1|Overall Study|Problems finding proper area to inject|1
102535|NCT01036165|381087|P1|Overall Study|Device Related Issues|3
102536|NCT01036165|381087|P1|Overall Study|Withdrawal by Subject|3
102537|NCT01036165|381087|P1|Overall Study|Lost to Follow-up|2
102538|NCT01036165|381087|P1|Overall Study|Adverse Event|6
102539|NCT01036022|381098|P6|Overall Study|Withdrawal by Subject|0
102540|NCT01036022|381099|P5|Overall Study|Withdrawal by Subject|2
102541|NCT01036022|381100|P4|Overall Study|Withdrawal by Subject|1
102542|NCT01036022|381101|P3|Overall Study|Withdrawal by Subject|0
102543|NCT01036022|381102|P2|Overall Study|Withdrawal by Subject|0
102544|NCT01036022|381103|P1|Overall Study|Withdrawal by Subject|0
102545|NCT01036022|381098|P6|Overall Study|Physician Decision|0
102546|NCT01036022|381099|P5|Overall Study|Physician Decision|0
102547|NCT01036022|381100|P4|Overall Study|Physician Decision|0
102548|NCT01036022|381101|P3|Overall Study|Physician Decision|1
102549|NCT01036022|381102|P2|Overall Study|Physician Decision|0
102550|NCT01036022|381103|P1|Overall Study|Physician Decision|0
102551|NCT01036022|381098|P6|Overall Study|Lack of Efficacy|1
102552|NCT01036022|381099|P5|Overall Study|Lack of Efficacy|1
102553|NCT01036022|381100|P4|Overall Study|Lack of Efficacy|0
102554|NCT01036022|381101|P3|Overall Study|Lack of Efficacy|1
102555|NCT01036022|381102|P2|Overall Study|Lack of Efficacy|1
102556|NCT01036022|381103|P1|Overall Study|Lack of Efficacy|1
102557|NCT01036022|381098|P6|Overall Study|Adverse Event|2
102558|NCT01036022|381099|P5|Overall Study|Adverse Event|0
102559|NCT01036022|381100|P4|Overall Study|Adverse Event|1
102560|NCT01036022|381101|P3|Overall Study|Adverse Event|2
102561|NCT01036022|381102|P2|Overall Study|Adverse Event|3
102562|NCT01036022|381103|P1|Overall Study|Adverse Event|1
102563|NCT01035905|381239|P2|Overall Study|Lack of Efficacy|1
102564|NCT01035905|381240|P1|Overall Study|Lack of Efficacy|1
102565|NCT01035606|381413|P3|Overall Study|change in health, job demands,family|4
102566|NCT01035606|381414|P2|Overall Study|change in health, job demands,family|3
102567|NCT01035606|381415|P1|Overall Study|change in health, job demands,family|3
102568|NCT01035255|381457|P2|Overall Study|patient's request|13
102569|NCT01035255|381458|P1|Overall Study|patient's request|15
102570|NCT01035255|381457|P2|Overall Study|Lost to Follow-up|5
102571|NCT01035255|381458|P1|Overall Study|Lost to Follow-up|2
102572|NCT01035255|381457|P2|Overall Study|Death|844
102573|NCT01035255|381458|P1|Overall Study|Death|724
102574|NCT01035229|381476|P2|Overall Study|Disease Progression|152
102575|NCT01035229|381477|P1|Overall Study|Disease Progression|261
102576|NCT01035229|381476|P2|Overall Study|Sponsor's decision to end study|3
102577|NCT01035229|381477|P1|Overall Study|Sponsor's decision to end study|3
102578|NCT01035229|381476|P2|Overall Study|Protocol Violation|2
102579|NCT01035229|381477|P1|Overall Study|Protocol Violation|0
102580|NCT01035229|381476|P2|Overall Study|New cancer therapy|0
102581|NCT01035229|381477|P1|Overall Study|New cancer therapy|2
102582|NCT01035229|381476|P2|Overall Study|Death|5
102583|NCT01035229|381477|P1|Overall Study|Death|13
102584|NCT01035229|381476|P2|Overall Study|Administrative problems|1
102585|NCT01035229|381477|P1|Overall Study|Administrative problems|1
102586|NCT01035229|381476|P2|Overall Study|Lost to Follow-up|0
102587|NCT01035229|381477|P1|Overall Study|Lost to Follow-up|1
102588|NCT01035229|381476|P2|Overall Study|Withdrawal by Subject|7
102589|NCT01035229|381477|P1|Overall Study|Withdrawal by Subject|20
102590|NCT01035229|381476|P2|Overall Study|Adverse Event|14
102591|NCT01035229|381477|P1|Overall Study|Adverse Event|61
102592|NCT01035138|381498|P3|Overall Study|Lost to Follow-up|1
102593|NCT01035138|381499|P2|Overall Study|Lost to Follow-up|0
102594|NCT01035138|381500|P1|Overall Study|Lost to Follow-up|0
102595|NCT01035138|381498|P3|Overall Study|Sponsor Decision|42
102596|NCT01035138|381499|P2|Overall Study|Sponsor Decision|60
102597|NCT01035138|381500|P1|Overall Study|Sponsor Decision|66
102598|NCT01035138|381498|P3|Overall Study|Physician Decision|1
102599|NCT01035138|381499|P2|Overall Study|Physician Decision|0
102600|NCT01035138|381500|P1|Overall Study|Physician Decision|0
102601|NCT01035138|381498|P3|Overall Study|Withdrawal by Subject|0
102602|NCT01035138|381499|P2|Overall Study|Withdrawal by Subject|0
102603|NCT01035138|381500|P1|Overall Study|Withdrawal by Subject|1
102604|NCT01035138|381498|P3|Overall Study|Caregiver Decision|1
102605|NCT01035138|381499|P2|Overall Study|Caregiver Decision|0
102606|NCT01035138|381500|P1|Overall Study|Caregiver Decision|2
102607|NCT01035138|381498|P3|Overall Study|Adverse Event|2
102608|NCT01035138|381499|P2|Overall Study|Adverse Event|0
102609|NCT01035138|381500|P1|Overall Study|Adverse Event|4
102610|NCT01035060|381556|P2|Overall Study|Physician Decision|0
102611|NCT01035060|381557|P1|Overall Study|Physician Decision|2
102612|NCT01035060|381556|P2|Overall Study|Withdrawal by Subject|6
102613|NCT01035060|381557|P1|Overall Study|Withdrawal by Subject|8
102614|NCT01035060|381556|P2|Overall Study|Did not quality after 2nd screening|1
102615|NCT01035060|381557|P1|Overall Study|Did not quality after 2nd screening|14
102616|NCT01035060|381556|P2|Overall Study|Lost to Follow-up|7
102617|NCT01035060|381557|P1|Overall Study|Lost to Follow-up|0
102618|NCT01034709|381582|P2|Overall Study|Protocol Violation|16
102619|NCT01034709|381583|P1|Overall Study|Protocol Violation|9
102620|NCT01034657|381589|P3|Randomized Phase|Adverse Event|1
102621|NCT01034657|381590|P2|Randomized Phase|Adverse Event|2
102622|NCT01034657|381591|P1|Randomized Phase|Adverse Event|0
102623|NCT01034657|381589|P3|Randomized Phase|Abnormal laboratory value|0
102624|NCT01034657|381590|P2|Randomized Phase|Abnormal laboratory value|1
102625|NCT01034657|381591|P1|Randomized Phase|Abnormal laboratory value|0
102626|NCT01034657|381589|P3|Randomized Phase|Lack of Efficacy|0
102627|NCT01034657|381590|P2|Randomized Phase|Lack of Efficacy|1
102628|NCT01034657|381591|P1|Randomized Phase|Lack of Efficacy|5
102629|NCT01034657|381589|P3|Randomized Phase|Withdrawal by Subject|0
102630|NCT01034657|381590|P2|Randomized Phase|Withdrawal by Subject|2
102631|NCT01034657|381591|P1|Randomized Phase|Withdrawal by Subject|0
102632|NCT01034657|381589|P3|Core Phase|Protocol Violation|0
102633|NCT01034657|381590|P2|Core Phase|Protocol Violation|0
102634|NCT01034657|381591|P1|Core Phase|Protocol Violation|2
102635|NCT01034657|381589|P3|Core Phase|Adverse Event|0
102636|NCT01034657|381590|P2|Core Phase|Adverse Event|0
102637|NCT01034657|381591|P1|Core Phase|Adverse Event|8
102638|NCT01034657|381589|P3|Core Phase|Abnormal laboratory value|0
102639|NCT01034657|381590|P2|Core Phase|Abnormal laboratory value|0
102640|NCT01034657|381591|P1|Core Phase|Abnormal laboratory value|1
102641|NCT01034657|381589|P3|Core Phase|Lack of Efficacy|0
102642|NCT01034657|381590|P2|Core Phase|Lack of Efficacy|0
102643|NCT01034657|381591|P1|Core Phase|Lack of Efficacy|2
102644|NCT01034657|381589|P3|Core Phase|Withdrawal by Subject|0
102645|NCT01034657|381590|P2|Core Phase|Withdrawal by Subject|0
102646|NCT01034657|381591|P1|Core Phase|Withdrawal by Subject|1
102647|NCT01034631|381632|P3|Phase II|Determined Ineligible per protocol|0
102648|NCT01034631|381633|P2|Phase II|Determined Ineligible per protocol|1
102649|NCT01034631|381634|P1|Phase II|Determined Ineligible per protocol|0
102650|NCT01034631|381632|P3|Phase II|Not Evaluable per protocol|2
102651|NCT01034631|381633|P2|Phase II|Not Evaluable per protocol|0
102652|NCT01034631|381634|P1|Phase II|Not Evaluable per protocol|0
102653|NCT01034631|381632|P3|Phase I|Symptomatic Deterioration before Treatme|0
102654|NCT01034631|381633|P2|Phase I|Symptomatic Deterioration before Treatme|0
102655|NCT01034631|381634|P1|Phase I|Symptomatic Deterioration before Treatme|3
102656|NCT01034540|381701|P2|Overall Study|Adverse Event|1
102657|NCT01034540|381702|P1|Overall Study|Adverse Event|0
102658|NCT01034462|381712|P2|Overall Study|Other reasons|2
102659|NCT01034462|381713|P1|Overall Study|Other reasons|1
102660|NCT01034462|381712|P2|Overall Study|Lost to Follow-up|16
102661|NCT01034462|381713|P1|Overall Study|Lost to Follow-up|14
102662|NCT01034462|381712|P2|Overall Study|Withdrawal by Subject|8
102663|NCT01034462|381713|P1|Overall Study|Withdrawal by Subject|9
102664|NCT01034462|381712|P2|Overall Study|Protocol Violation|7
102665|NCT01034462|381713|P1|Overall Study|Protocol Violation|10
102666|NCT01034462|381712|P2|Overall Study|Lack of Efficacy|4
102667|NCT01034462|381713|P1|Overall Study|Lack of Efficacy|4
102668|NCT01034462|381712|P2|Overall Study|Adverse Event|17
102669|NCT01034462|381713|P1|Overall Study|Adverse Event|7
102670|NCT01034397|381723|P2|Overall Study|Not specified|1
102671|NCT01034397|381724|P1|Overall Study|Not specified|0
102672|NCT01034397|381723|P2|Overall Study|Adverse Event|0
102673|NCT01034397|381724|P1|Overall Study|Adverse Event|4
102674|NCT01034397|381723|P2|Overall Study|Lack of Efficacy|0
102675|NCT01034397|381724|P1|Overall Study|Lack of Efficacy|3
102676|NCT01034397|381723|P2|Overall Study|Lack of compliance|1
102677|NCT01034397|381724|P1|Overall Study|Lack of compliance|0
102678|NCT01034358|381873|P1|Overall Study|Protocol Violation|1
102679|NCT01034358|381873|P1|Overall Study|Withdrawal by Subject|1
102680|NCT01034306|381879|P2|Overall Study|Noncomplience|0
102681|NCT01034306|381880|P1|Overall Study|Noncomplience|1
102682|NCT01034306|381879|P2|Overall Study|hospitalized and decided to stop|0
102683|NCT01034306|381880|P1|Overall Study|hospitalized and decided to stop|1
102684|NCT01034306|381879|P2|Overall Study|Withdrawal by Subject|2
102685|NCT01034306|381880|P1|Overall Study|Withdrawal by Subject|2
102686|NCT01034306|381879|P2|Overall Study|Lost to Follow-up|1
102687|NCT01034306|381880|P1|Overall Study|Lost to Follow-up|0
102688|NCT01034306|381879|P2|Overall Study|Adverse Event|0
102689|NCT01034306|381880|P1|Overall Study|Adverse Event|1
102690|NCT01034176|381888|P2|Overall Study|Lost to Follow-up|1
102691|NCT01034176|381889|P1|Overall Study|Lost to Follow-up|0
102692|NCT01034176|381888|P2|Overall Study|Withdrawal by Subject|1
102693|NCT01034176|381889|P1|Overall Study|Withdrawal by Subject|0
102694|NCT01034176|381888|P2|Overall Study|Physician Decision|0
102695|NCT01034176|381889|P1|Overall Study|Physician Decision|2
102696|NCT01034163|381899|P2|Overall Study|Abnormal laboratory value|0
102697|NCT01034163|381900|P1|Overall Study|Abnormal laboratory value|1
102698|NCT01034163|381899|P2|Overall Study|Administrative problems|1
102699|NCT01034163|381900|P1|Overall Study|Administrative problems|0
102700|NCT01034163|381899|P2|Overall Study|Adverse Event|0
102701|NCT01034163|381900|P1|Overall Study|Adverse Event|6
102702|NCT01034163|381899|P2|Overall Study|Disease progression|4
102703|NCT01034163|381900|P1|Overall Study|Disease progression|3
102704|NCT01034163|381899|P2|Overall Study|Protocol deviation|0
102705|NCT01034163|381900|P1|Overall Study|Protocol deviation|1
102706|NCT01034163|381899|P2|Overall Study|Withdrawal by Subject|2
102707|NCT01034163|381900|P1|Overall Study|Withdrawal by Subject|8
102708|NCT01034163|381899|P2|Overall Study|Treatment completed as per protocol|7
102709|NCT01034163|381900|P1|Overall Study|Treatment completed as per protocol|8
102710|NCT01034137|381909|P3|Overall Study|Administrative or other|4
102711|NCT01034137|381910|P2|Overall Study|Administrative or other|3
102712|NCT01034137|381911|P1|Overall Study|Administrative or other|2
102713|NCT01034137|381909|P3|Overall Study|Refused treatment or did not cooperate|1
102714|NCT01034137|381910|P2|Overall Study|Refused treatment or did not cooperate|0
102715|NCT01034137|381911|P1|Overall Study|Refused treatment or did not cooperate|2
102716|NCT01034137|381909|P3|Overall Study|Protocol Violation|1
102717|NCT01034137|381910|P2|Overall Study|Protocol Violation|2
102718|NCT01034137|381911|P1|Overall Study|Protocol Violation|2
102719|NCT01034137|381909|P3|Overall Study|Lack of Efficacy|13
102720|NCT01034137|381910|P2|Overall Study|Lack of Efficacy|4
102721|NCT01034137|381911|P1|Overall Study|Lack of Efficacy|9
102722|NCT01034137|381909|P3|Overall Study|Withdrawal by Subject|3
102723|NCT01034137|381910|P2|Overall Study|Withdrawal by Subject|3
102724|NCT01034137|381911|P1|Overall Study|Withdrawal by Subject|4
102725|NCT01034137|381909|P3|Overall Study|Adverse Event|8
102726|NCT01034137|381910|P2|Overall Study|Adverse Event|10
102727|NCT01034137|381911|P1|Overall Study|Adverse Event|9
102728|NCT01033942|382050|P3|Overall Study|Enrolled in Extension Study|0
102729|NCT01033942|382051|P2|Overall Study|Enrolled in Extension Study|3
102730|NCT01033942|382052|P1|Overall Study|Enrolled in Extension Study|0
102731|NCT01033942|382050|P3|Overall Study|Lost to Follow-up|0
102732|NCT01033942|382051|P2|Overall Study|Lost to Follow-up|0
102733|NCT01033942|382052|P1|Overall Study|Lost to Follow-up|1
102734|NCT01033942|382050|P3|Overall Study|Withdrawal by Subject|1
102735|NCT01033942|382051|P2|Overall Study|Withdrawal by Subject|1
102736|NCT01033942|382052|P1|Overall Study|Withdrawal by Subject|1
102737|NCT01033851|382350|P2|Overall Study|Withdrawal by Subject|7
102738|NCT01033851|382351|P1|Overall Study|Withdrawal by Subject|3
102739|NCT01033825|382366|P7|Overall Study|Other|0
102740|NCT01033825|382367|P6|Overall Study|Other|0
102741|NCT01033825|382368|P5|Overall Study|Other|1
102742|NCT01033825|382369|P4|Overall Study|Other|0
102743|NCT01033825|382370|P3|Overall Study|Other|0
102744|NCT01033825|382371|P2|Overall Study|Other|0
102745|NCT01033825|382372|P1|Overall Study|Other|0
102746|NCT01033825|382366|P7|Overall Study|Protocol Violation|0
102747|NCT01033825|382367|P6|Overall Study|Protocol Violation|0
102748|NCT01033825|382368|P5|Overall Study|Protocol Violation|0
102749|NCT01033825|382369|P4|Overall Study|Protocol Violation|0
102750|NCT01033825|382370|P3|Overall Study|Protocol Violation|0
102751|NCT01033825|382371|P2|Overall Study|Protocol Violation|0
102752|NCT01033825|382372|P1|Overall Study|Protocol Violation|1
102753|NCT01033825|382366|P7|Overall Study|Adverse Event|0
102754|NCT01033825|382367|P6|Overall Study|Adverse Event|0
102755|NCT01033825|382368|P5|Overall Study|Adverse Event|0
102756|NCT01033825|382369|P4|Overall Study|Adverse Event|1
102757|NCT01033825|382370|P3|Overall Study|Adverse Event|0
102758|NCT01033825|382371|P2|Overall Study|Adverse Event|0
102759|NCT01033825|382372|P1|Overall Study|Adverse Event|0
102760|NCT01033825|382366|P7|Overall Study|Withdrawal by Subject|0
102761|NCT01033825|382367|P6|Overall Study|Withdrawal by Subject|0
102762|NCT01033825|382368|P5|Overall Study|Withdrawal by Subject|1
102763|NCT01033825|382369|P4|Overall Study|Withdrawal by Subject|1
102764|NCT01033825|382370|P3|Overall Study|Withdrawal by Subject|2
102765|NCT01033825|382371|P2|Overall Study|Withdrawal by Subject|3
102766|NCT01033825|382372|P1|Overall Study|Withdrawal by Subject|2
102767|NCT01033747|382593|P2|Overall Study|Stopped at end of Extension 1|0
102768|NCT01033747|382594|P1|Overall Study|Stopped at end of Extension 1|2
102769|NCT01033747|382593|P2|Overall Study|Stopped at end of prolongation visit 1|0
102770|NCT01033747|382594|P1|Overall Study|Stopped at end of prolongation visit 1|1
102771|NCT01033747|382593|P2|Overall Study|Withdrawal by Subject|6
102772|NCT01033747|382594|P1|Overall Study|Withdrawal by Subject|9
102773|NCT01033747|382593|P2|Overall Study|Protocol Violation|0
102774|NCT01033747|382594|P1|Overall Study|Protocol Violation|1
102775|NCT01033747|382593|P2|Overall Study|Unsatisfactory therapeutic effect|4
102776|NCT01033747|382594|P1|Overall Study|Unsatisfactory therapeutic effect|14
102777|NCT01033747|382593|P2|Overall Study|Abnormal test procedure|1
102778|NCT01033747|382594|P1|Overall Study|Abnormal test procedure|0
102779|NCT01033747|382593|P2|Overall Study|Abnormal Laboratory Value|0
102780|NCT01033747|382594|P1|Overall Study|Abnormal Laboratory Value|1
102781|NCT01033747|382593|P2|Overall Study|Adverse Event|4
102782|NCT01033747|382594|P1|Overall Study|Adverse Event|9
102783|NCT01033734|382602|P1|Overall Study|Withdrawal by Subject|1
102784|NCT01033487|382658|P10|Fourth Intervention Period|Adverse Event|0
102785|NCT01033487|382659|P9|Fourth Intervention Period|Adverse Event|1
102786|NCT01033487|382660|P8|Fourth Intervention Period|Adverse Event|0
102787|NCT01033487|382661|P7|Fourth Intervention Period|Adverse Event|0
102788|NCT01033487|382662|P6|Fourth Intervention Period|Adverse Event|0
102789|NCT01033487|382663|P5|Fourth Intervention Period|Adverse Event|0
102790|NCT01033487|382664|P4|Fourth Intervention Period|Adverse Event|0
102791|NCT01033487|382665|P3|Fourth Intervention Period|Adverse Event|0
102792|NCT01033487|382666|P2|Fourth Intervention Period|Adverse Event|0
102793|NCT01033487|382667|P1|Fourth Intervention Period|Adverse Event|0
102794|NCT01033448|382721|P1|Overall Study|Unknown disposition|1
102795|NCT01033448|382721|P1|Overall Study|Withdrew due to other reasons|3
102796|NCT01033448|382721|P1|Overall Study|Lost to Follow-up|3
102797|NCT01033448|382721|P1|Overall Study|Positive HCV-RNA at week 48|1
102798|NCT01033448|382721|P1|Overall Study|Withdrawal by Subject|4
102799|NCT01033071|382768|P3|Overall Study|Other|3
102800|NCT01033071|382769|P2|Overall Study|Other|4
102801|NCT01033071|382770|P1|Overall Study|Other|6
102802|NCT01033071|382768|P3|Overall Study|Lack of Efficacy|1
102803|NCT01033071|382769|P2|Overall Study|Lack of Efficacy|1
102804|NCT01033071|382770|P1|Overall Study|Lack of Efficacy|0
102805|NCT01033071|382768|P3|Overall Study|Withdrawal by Subject|11
102806|NCT01033071|382769|P2|Overall Study|Withdrawal by Subject|14
102807|NCT01033071|382770|P1|Overall Study|Withdrawal by Subject|17
102808|NCT01033071|382768|P3|Overall Study|Lost to Follow-up|5
102809|NCT01033071|382769|P2|Overall Study|Lost to Follow-up|5
102810|NCT01033071|382770|P1|Overall Study|Lost to Follow-up|4
102811|NCT01033071|382768|P3|Overall Study|Protocol Violation|1
102812|NCT01033071|382769|P2|Overall Study|Protocol Violation|2
102813|NCT01033071|382770|P1|Overall Study|Protocol Violation|0
102814|NCT01033071|382768|P3|Overall Study|Adverse Event|26
102815|NCT01033071|382769|P2|Overall Study|Adverse Event|51
102816|NCT01033071|382770|P1|Overall Study|Adverse Event|28
102817|NCT01033019|382841|P2|Overall Study|Withdrawal by Subject|0
102818|NCT01033019|382842|P1|Overall Study|Withdrawal by Subject|1
102819|NCT01032915|382880|P4|Overall Study|Protocol Violation|1
102820|NCT01032915|382881|P3|Overall Study|Protocol Violation|0
102821|NCT01032915|382882|P2|Overall Study|Protocol Violation|0
102822|NCT01032915|382883|P1|Overall Study|Protocol Violation|1
102823|NCT01032915|382880|P4|Overall Study|Administrative reasons|4
102824|NCT01032915|382881|P3|Overall Study|Administrative reasons|4
102825|NCT01032915|382882|P2|Overall Study|Administrative reasons|6
102826|NCT01032915|382883|P1|Overall Study|Administrative reasons|5
102827|NCT01032915|382880|P4|Overall Study|Withdrawal by Subject|1
102828|NCT01032915|382881|P3|Overall Study|Withdrawal by Subject|1
102829|NCT01032915|382882|P2|Overall Study|Withdrawal by Subject|3
102830|NCT01032915|382883|P1|Overall Study|Withdrawal by Subject|0
102831|NCT01032915|382880|P4|Overall Study|Abnormal test procedure result|0
102832|NCT01032915|382881|P3|Overall Study|Abnormal test procedure result|1
102833|NCT01032915|382882|P2|Overall Study|Abnormal test procedure result|0
102834|NCT01032915|382883|P1|Overall Study|Abnormal test procedure result|0
102835|NCT01032915|382880|P4|Overall Study|Adverse Event|1
102836|NCT01032915|382881|P3|Overall Study|Adverse Event|1
102837|NCT01032915|382882|P2|Overall Study|Adverse Event|2
102838|NCT01032915|382883|P1|Overall Study|Adverse Event|2
102839|NCT01032889|382908|P3|Overall Study|Miscellaneous Reasons|1
102840|NCT01032889|382909|P2|Overall Study|Miscellaneous Reasons|1
102841|NCT01032889|382910|P1|Overall Study|Miscellaneous Reasons|2
102842|NCT01032889|382908|P3|Overall Study|Lack of Submental Fat|1
102843|NCT01032889|382909|P2|Overall Study|Lack of Submental Fat|8
102844|NCT01032889|382910|P1|Overall Study|Lack of Submental Fat|2
102845|NCT01032889|382908|P3|Overall Study|Lost to Follow-up|0
102846|NCT01032889|382909|P2|Overall Study|Lost to Follow-up|1
102847|NCT01032889|382910|P1|Overall Study|Lost to Follow-up|1
102848|NCT01032889|382908|P3|Overall Study|Patient Request|0
102849|NCT01032889|382909|P2|Overall Study|Patient Request|1
102850|NCT01032889|382910|P1|Overall Study|Patient Request|0
102851|NCT01032889|382908|P3|Overall Study|Withdrawal of Consent|1
102852|NCT01032889|382909|P2|Overall Study|Withdrawal of Consent|2
102853|NCT01032889|382910|P1|Overall Study|Withdrawal of Consent|1
102854|NCT01032889|382908|P3|Overall Study|Adverse Event|0
102855|NCT01032889|382909|P2|Overall Study|Adverse Event|2
102856|NCT01032889|382910|P1|Overall Study|Adverse Event|2
102857|NCT01032837|382941|P4|Overall Study|Refused treatment|1
102858|NCT01032837|382942|P3|Overall Study|Refused treatment|0
102859|NCT01032837|382943|P2|Overall Study|Refused treatment|0
102860|NCT01032837|382944|P1|Overall Study|Refused treatment|0
102861|NCT01032837|382941|P4|Overall Study|Failed to return|0
102862|NCT01032837|382942|P3|Overall Study|Failed to return|1
102863|NCT01032837|382943|P2|Overall Study|Failed to return|0
102864|NCT01032837|382944|P1|Overall Study|Failed to return|0
102865|NCT01032837|382941|P4|Overall Study|Withdrew consent|1
102866|NCT01032837|382942|P3|Overall Study|Withdrew consent|0
102867|NCT01032837|382943|P2|Overall Study|Withdrew consent|2
102868|NCT01032837|382944|P1|Overall Study|Withdrew consent|0
102869|NCT01032837|382941|P4|Overall Study|Adverse event/internal illness|1
102870|NCT01032837|382942|P3|Overall Study|Adverse event/internal illness|0
102871|NCT01032837|382943|P2|Overall Study|Adverse event/internal illness|1
102872|NCT01032837|382944|P1|Overall Study|Adverse event/internal illness|0
102873|NCT01032382|383049|P2|Overall Study|Index lesion relapse|3
102874|NCT01032382|383050|P1|Overall Study|Index lesion relapse|1
102875|NCT01032382|383049|P2|Overall Study|Treatment failure|1
102876|NCT01032382|383050|P1|Overall Study|Treatment failure|3
102877|NCT01032382|383049|P2|Overall Study|Disease dissemination|1
102878|NCT01032382|383050|P1|Overall Study|Disease dissemination|1
102879|NCT01032291|383079|P3|Proof of Concept|Never Received Study Drug|0
102880|NCT01032291|383080|P2|Proof of Concept|Never Received Study Drug|1
102881|NCT01032291|383081|P1|Proof of Concept|Never Received Study Drug|0
102882|NCT01032291|383079|P3|Proof of Concept|Lack of Efficacy|0
102883|NCT01032291|383080|P2|Proof of Concept|Lack of Efficacy|1
102884|NCT01032291|383081|P1|Proof of Concept|Lack of Efficacy|0
102885|NCT01032291|383079|P3|Proof of Concept|Death|2
102886|NCT01032291|383080|P2|Proof of Concept|Death|1
102887|NCT01032291|383081|P1|Proof of Concept|Death|0
102888|NCT01032291|383079|P3|Proof of Concept|Adverse Event|1
102889|NCT01032291|383080|P2|Proof of Concept|Adverse Event|5
102890|NCT01032291|383081|P1|Proof of Concept|Adverse Event|0
102891|NCT01032291|383079|P3|Safety Lead-in|Death|0
102892|NCT01032291|383080|P2|Safety Lead-in|Death|0
102893|NCT01032291|383081|P1|Safety Lead-in|Death|1
102894|NCT01032291|383079|P3|Safety Lead-in|Adverse Event|0
102895|NCT01032291|383080|P2|Safety Lead-in|Adverse Event|0
102896|NCT01032291|383081|P1|Safety Lead-in|Adverse Event|1
102897|NCT01032239|383128|P2|Overall Study|Protocol Violation|0
102898|NCT01032239|383129|P1|Overall Study|Protocol Violation|1
102899|NCT01032239|383128|P2|Overall Study|Death|0
102900|NCT01032239|383129|P1|Overall Study|Death|1
102901|NCT01032239|383128|P2|Overall Study|Withdrawal by Subject|3
102902|NCT01032239|383129|P1|Overall Study|Withdrawal by Subject|2
102903|NCT01032239|383128|P2|Overall Study|Lost to Follow-up|2
102904|NCT01032239|383129|P1|Overall Study|Lost to Follow-up|3
102905|NCT01032200|383159|P2|Overall Study|Multiple|1
102906|NCT01032200|383160|P1|Overall Study|Multiple|1
102907|NCT01032200|383159|P2|Overall Study|Progression|0
102908|NCT01032200|383160|P1|Overall Study|Progression|1
102909|NCT01032200|383159|P2|Overall Study|Toxicity|2
102910|NCT01032200|383160|P1|Overall Study|Toxicity|0
102911|NCT01032200|383159|P2|Overall Study|Withdrawal by Subject|3
102912|NCT01032200|383160|P1|Overall Study|Withdrawal by Subject|1
102913|NCT01032200|383159|P2|Overall Study|Death|1
102914|NCT01032200|383160|P1|Overall Study|Death|1
102915|NCT01032174|383176|P2|Overall Study|Adverse Event|1
102916|NCT01032174|383177|P1|Overall Study|Adverse Event|0
102917|NCT01032070|383417|P2|Overall Study|Withdrawal by Subject|2
102918|NCT01032070|383418|P1|Overall Study|Withdrawal by Subject|0
102919|NCT01032070|383417|P2|Overall Study|Medical or ethical reasons|2
102920|NCT01032070|383418|P1|Overall Study|Medical or ethical reasons|0
102921|NCT01032070|383417|P2|Overall Study|Disease progression|8
102922|NCT01032070|383418|P1|Overall Study|Disease progression|13
102923|NCT01032044|383447|P2|Overall Study|Lost to Follow-up|11
102924|NCT01032044|383448|P1|Overall Study|Lost to Follow-up|11
102925|NCT01032044|383447|P2|Overall Study|Adverse Event|1
102926|NCT01032044|383448|P1|Overall Study|Adverse Event|0
102927|NCT01032044|383447|P2|Overall Study|Protocol Violation|8
102928|NCT01032044|383448|P1|Overall Study|Protocol Violation|14
102929|NCT01032018|383456|P2|Overall Study|Death|1
102930|NCT01032018|383457|P1|Overall Study|Death|0
102931|NCT01032018|383456|P2|Overall Study|Lost to Follow-up|5
102932|NCT01032018|383457|P1|Overall Study|Lost to Follow-up|6
102933|NCT01031979|383467|P2|Overall Study|Lost to Follow-up|4
102934|NCT01031979|383468|P1|Overall Study|Lost to Follow-up|5
102935|NCT01031706|383506|P2|Overall Study|Withdrawal by Subject|1
102936|NCT01031706|383507|P1|Overall Study|Withdrawal by Subject|1
102937|NCT01031706|383506|P2|Overall Study|Adverse Event|0
102938|NCT01031706|383507|P1|Overall Study|Adverse Event|1
102939|NCT01031680|383517|P2|Overall Study|Various|2
102940|NCT01031680|383518|P1|Overall Study|Various|0
102941|NCT01031680|383517|P2|Overall Study|Administrative Reason by Sponsor|1
102942|NCT01031680|383518|P1|Overall Study|Administrative Reason by Sponsor|0
102943|NCT01031680|383517|P2|Overall Study|Incorrect Enrolment|2
102944|NCT01031680|383518|P1|Overall Study|Incorrect Enrolment|1
102945|NCT01031680|383517|P2|Overall Study|Safety|0
102946|NCT01031680|383518|P1|Overall Study|Safety|1
102947|NCT01031680|383517|P2|Overall Study|Poor/Non-compliance|6
102948|NCT01031680|383518|P1|Overall Study|Poor/Non-compliance|5
102949|NCT01031680|383517|P2|Overall Study|Subject No Longer Meets Study Criteria|17
102950|NCT01031680|383518|P1|Overall Study|Subject No Longer Meets Study Criteria|26
102951|NCT01031680|383517|P2|Overall Study|Death|1
102952|NCT01031680|383518|P1|Overall Study|Death|2
102953|NCT01031680|383517|P2|Overall Study|Withdrawal by Subject|16
102954|NCT01031680|383518|P1|Overall Study|Withdrawal by Subject|12
102955|NCT01031680|383517|P2|Overall Study|Lost to Follow-up|10
102956|NCT01031680|383518|P1|Overall Study|Lost to Follow-up|2
102957|NCT01031680|383517|P2|Overall Study|Adverse Event|3
102958|NCT01031680|383518|P1|Overall Study|Adverse Event|8
102959|NCT01031628|383538|P4|Overall Study|Study terminated early|0
102960|NCT01031628|383539|P3|Overall Study|Study terminated early|3
102961|NCT01031628|383540|P2|Overall Study|Study terminated early|1
102962|NCT01031628|383541|P1|Overall Study|Study terminated early|0
102963|NCT01031446|383579|P1|Overall Study|Still on treatment|1
102964|NCT01031446|383579|P1|Overall Study|Withdrawal by Subject|3
102965|NCT01031446|383579|P1|Overall Study|Physician Decision|4
102966|NCT01031446|383579|P1|Overall Study|Adverse Event|9
102967|NCT01031446|383579|P1|Overall Study|Disease Progression|38
102968|NCT01031381|383588|P1|Overall Study|Withdrawal by Subject|6
102969|NCT01031381|383588|P1|Overall Study|Physician Decision|3
102970|NCT01031004|383619|P2|Overall Study|Lost to Follow-up|0
102971|NCT01031004|383620|P1|Overall Study|Lost to Follow-up|1
102972|NCT01031004|383619|P2|Overall Study|Protocol Violation|1
102973|NCT01031004|383620|P1|Overall Study|Protocol Violation|0
102974|NCT01030965|383664|P4|Overall Study|Withdrawal by Subject|2
102975|NCT01030965|383665|P3|Overall Study|Withdrawal by Subject|0
102976|NCT01030965|383666|P2|Overall Study|Withdrawal by Subject|1
102977|NCT01030965|383667|P1|Overall Study|Withdrawal by Subject|0
102978|NCT01030965|383664|P4|Overall Study|Protocol-defined Stopping Criteria|0
102979|NCT01030965|383665|P3|Overall Study|Protocol-defined Stopping Criteria|1
102980|NCT01030965|383666|P2|Overall Study|Protocol-defined Stopping Criteria|1
102981|NCT01030965|383667|P1|Overall Study|Protocol-defined Stopping Criteria|0
102982|NCT01030965|383664|P4|Overall Study|Adverse Event|1
102983|NCT01030965|383665|P3|Overall Study|Adverse Event|2
102984|NCT01030965|383666|P2|Overall Study|Adverse Event|1
102985|NCT01030965|383667|P1|Overall Study|Adverse Event|0
102986|NCT01030965|383664|P4|Overall Study|Protocol Violation|1
102987|NCT01030965|383665|P3|Overall Study|Protocol Violation|1
102988|NCT01030965|383666|P2|Overall Study|Protocol Violation|1
102989|NCT01030965|383667|P1|Overall Study|Protocol Violation|1
102990|NCT01030965|383664|P4|Overall Study|Lack of Efficacy|3
102991|NCT01030965|383665|P3|Overall Study|Lack of Efficacy|0
102992|NCT01030965|383666|P2|Overall Study|Lack of Efficacy|2
102993|NCT01030965|383667|P1|Overall Study|Lack of Efficacy|3
102994|NCT01030952|383687|P2|Overall Study|Unexplained|1
102995|NCT01030952|383688|P1|Overall Study|Unexplained|1
102996|NCT01030952|383687|P2|Overall Study|Lost to Follow-up|1
102997|NCT01030952|383688|P1|Overall Study|Lost to Follow-up|0
102998|NCT01030952|383687|P2|Overall Study|Informed consent withdrawal|0
102999|NCT01030952|383688|P1|Overall Study|Informed consent withdrawal|1
103000|NCT01030952|383687|P2|Overall Study|Protocol Violation|1
103001|NCT01030952|383688|P1|Overall Study|Protocol Violation|0
103002|NCT01030822|383725|P3|Overall Study|Lost to Follow-up|7
103003|NCT01030822|383726|P2|Overall Study|Lost to Follow-up|4
103004|NCT01030822|383727|P1|Overall Study|Lost to Follow-up|9
103005|NCT01030822|383725|P3|Overall Study|Withdrawal by Subject|16
103006|NCT01030822|383726|P2|Overall Study|Withdrawal by Subject|13
103007|NCT01030822|383727|P1|Overall Study|Withdrawal by Subject|16
103008|NCT01030822|383725|P3|Overall Study|Moved/migrated from study area|3
103009|NCT01030822|383726|P2|Overall Study|Moved/migrated from study area|7
103010|NCT01030822|383727|P1|Overall Study|Moved/migrated from study area|6
103011|NCT01030718|383782|P3|Study CA180-036 Only|Other Reasons|0
103012|NCT01030718|383783|P2|Study CA180-036 Only|Other Reasons|2
103013|NCT01030718|383784|P1|Study CA180-036 Only|Other Reasons|0
103014|NCT01030718|383782|P3|Study CA180-036 Only|Death|0
103015|NCT01030718|383783|P2|Study CA180-036 Only|Death|1
103016|NCT01030718|383784|P1|Study CA180-036 Only|Death|0
103017|NCT01030718|383782|P3|Study CA180-036 Only|Adverse Event|0
103018|NCT01030718|383783|P2|Study CA180-036 Only|Adverse Event|3
103019|NCT01030718|383784|P1|Study CA180-036 Only|Adverse Event|2
103020|NCT01030718|383782|P3|Study CA180-036 Only|insufficient effect|5
103021|NCT01030718|383783|P2|Study CA180-036 Only|insufficient effect|1
103022|NCT01030718|383784|P1|Study CA180-036 Only|insufficient effect|1
103023|NCT01030718|383782|P3|Studies CA180-031 and -036 Combined|other reasons|0
103024|NCT01030718|383783|P2|Studies CA180-031 and -036 Combined|other reasons|2
103025|NCT01030718|383784|P1|Studies CA180-031 and -036 Combined|other reasons|0
103026|NCT01030718|383782|P3|Studies CA180-031 and -036 Combined|Death|0
103027|NCT01030718|383783|P2|Studies CA180-031 and -036 Combined|Death|1
103028|NCT01030718|383784|P1|Studies CA180-031 and -036 Combined|Death|0
103029|NCT01030718|383782|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
103030|NCT01030718|383783|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
103031|NCT01030718|383784|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
103032|NCT01030718|383782|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
103033|NCT01030718|383783|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
103034|NCT01030718|383784|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
103035|NCT01030666|383845|P2|Overall Study|Lost to Follow-up|2
103036|NCT01030666|383846|P1|Overall Study|Lost to Follow-up|3
103037|NCT01030536|383871|P5|Overall Study|Death|0
103038|NCT01030536|383872|P4|Overall Study|Death|0
103039|NCT01030536|383873|P3|Overall Study|Death|0
103040|NCT01030536|383874|P2|Overall Study|Death|1
103041|NCT01030536|383875|P1|Overall Study|Death|0
103042|NCT01030536|383871|P5|Overall Study|Progressive disease|0
103043|NCT01030536|383872|P4|Overall Study|Progressive disease|2
103044|NCT01030536|383873|P3|Overall Study|Progressive disease|3
103045|NCT01030536|383874|P2|Overall Study|Progressive disease|2
103046|NCT01030536|383875|P1|Overall Study|Progressive disease|6
103047|NCT01030536|383871|P5|Overall Study|Adverse Event|1
103048|NCT01030536|383872|P4|Overall Study|Adverse Event|0
103049|NCT01030536|383873|P3|Overall Study|Adverse Event|1
103050|NCT01030536|383874|P2|Overall Study|Adverse Event|3
103051|NCT01030536|383875|P1|Overall Study|Adverse Event|0
103052|NCT01030536|383871|P5|Overall Study|undefined|0
103053|NCT01030536|383872|P4|Overall Study|undefined|1
103054|NCT01030536|383873|P3|Overall Study|undefined|1
103055|NCT01030536|383874|P2|Overall Study|undefined|0
103056|NCT01030536|383875|P1|Overall Study|undefined|1
103057|NCT01030536|383871|P5|Overall Study|Withdrawal by Subject|0
103058|NCT01030536|383872|P4|Overall Study|Withdrawal by Subject|0
103059|NCT01030536|383873|P3|Overall Study|Withdrawal by Subject|1
103060|NCT01030536|383874|P2|Overall Study|Withdrawal by Subject|0
103061|NCT01030536|383875|P1|Overall Study|Withdrawal by Subject|0
103062|NCT01030458|383980|P2|Overall Study|Side effect of medication|1
103063|NCT01030458|383981|P1|Overall Study|Side effect of medication|1
103064|NCT01030458|383980|P2|Overall Study|Moved or changed job|13
103065|NCT01030458|383981|P1|Overall Study|Moved or changed job|6
103066|NCT01030458|383980|P2|Overall Study|Logistical reasons|5
103067|NCT01030458|383981|P1|Overall Study|Logistical reasons|9
103068|NCT01030458|383980|P2|Overall Study|Withdrawal by Subject|3
103069|NCT01030458|383981|P1|Overall Study|Withdrawal by Subject|2
103070|NCT01030458|383980|P2|Overall Study|Lost to Follow-up|10
103071|NCT01030458|383981|P1|Overall Study|Lost to Follow-up|9
103072|NCT01029925|383993|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
103073|NCT01029925|383993|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
103074|NCT01029925|383993|P1|Completion of Cycle 1 (28 Days)|Death|2
103075|NCT01029886|384012|P2|Overall Study|Loss Glucose Control|1
103076|NCT01029886|384013|P1|Overall Study|Loss Glucose Control|7
103077|NCT01029886|384012|P2|Overall Study|Sponsor Decision|0
103078|NCT01029886|384013|P1|Overall Study|Sponsor Decision|1
103079|NCT01029886|384012|P2|Overall Study|Entry Criteria Not Met|5
103080|NCT01029886|384013|P1|Overall Study|Entry Criteria Not Met|13
103081|NCT01029886|384012|P2|Overall Study|Withdrawal by Subject|18
103082|NCT01029886|384013|P1|Overall Study|Withdrawal by Subject|8
103083|NCT01029886|384012|P2|Overall Study|Protocol Violation|5
103084|NCT01029886|384013|P1|Overall Study|Protocol Violation|17
103085|NCT01029886|384012|P2|Overall Study|Physician Decision|6
103086|NCT01029886|384013|P1|Overall Study|Physician Decision|2
103087|NCT01029886|384012|P2|Overall Study|Lost to Follow-up|0
103088|NCT01029886|384013|P1|Overall Study|Lost to Follow-up|1
103089|NCT01029886|384012|P2|Overall Study|Adverse Event|25
103090|NCT01029886|384013|P1|Overall Study|Adverse Event|12
103091|NCT01029795|384041|P2|Overall Study|Withdrawal by Subject|3
103092|NCT01029795|384042|P1|Overall Study|Withdrawal by Subject|1
103093|NCT01029795|384041|P2|Overall Study|Sponsor Decision|17
103094|NCT01029795|384042|P1|Overall Study|Sponsor Decision|11
103095|NCT01029795|384041|P2|Overall Study|Physician Decision|1
103096|NCT01029795|384042|P1|Overall Study|Physician Decision|2
103097|NCT01029795|384041|P2|Overall Study|Entry Criteria Not Met|1
103098|NCT01029795|384042|P1|Overall Study|Entry Criteria Not Met|2
103099|NCT01029691|384140|P3|Continued APAP to Delivery|Death|1
103100|NCT01029691|384141|P2|Continued APAP to Delivery|Death|0
103101|NCT01029691|384142|P1|Continued APAP to Delivery|Death|0
103102|NCT01029652|384167|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
103103|NCT01029652|384168|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
103104|NCT01029652|384167|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
103105|NCT01029652|384168|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
103106|NCT01029652|384167|P2|Extension Study 2 (25-72 Weeks)|Death|1
103107|NCT01029652|384168|P1|Extension Study 2 (25-72 Weeks)|Death|1
103108|NCT01029652|384167|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
103109|NCT01029652|384168|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
103110|NCT01029652|384167|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
103111|NCT01029652|384168|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
103112|NCT01029652|384167|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
103113|NCT01029652|384168|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
103114|NCT01029652|384167|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
103115|NCT01029652|384168|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
103116|NCT01029652|384167|P2|Core Study (0-12 Weeks)|Death|1
103117|NCT01029652|384168|P1|Core Study (0-12 Weeks)|Death|0
103118|NCT01029652|384167|P2|Core Study (0-12 Weeks)|Administrative problems|1
103119|NCT01029652|384168|P1|Core Study (0-12 Weeks)|Administrative problems|2
103120|NCT01029652|384167|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
103121|NCT01029652|384168|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
103122|NCT01029652|384167|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
103123|NCT01029652|384168|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
103124|NCT01029652|384167|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
103125|NCT01029652|384168|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
103126|NCT01029535|384246|P1|Overall Study|Death|1
103127|NCT01029535|384246|P1|Overall Study|Use of Another Treatment|1
103128|NCT01029535|384246|P1|Overall Study|Adverse Event|1
103129|NCT01029535|384246|P1|Overall Study|Participant Withdrew Consent|2
103130|NCT01029535|384246|P1|Overall Study|Protocol Violation|2
103131|NCT01029535|384246|P1|Overall Study|Lost to Follow-up|24
103132|NCT01029405|384275|P4|Overall Study|Other|1
103133|NCT01029405|384276|P3|Overall Study|Other|0
103134|NCT01029405|384277|P2|Overall Study|Other|1
103135|NCT01029405|384278|P1|Overall Study|Other|0
103136|NCT01029405|384275|P4|Overall Study|Lost to Follow-up|2
103137|NCT01029405|384276|P3|Overall Study|Lost to Follow-up|1
103138|NCT01029405|384277|P2|Overall Study|Lost to Follow-up|1
103139|NCT01029405|384278|P1|Overall Study|Lost to Follow-up|2
103140|NCT01029405|384275|P4|Overall Study|Adverse Event|1
103141|NCT01029405|384276|P3|Overall Study|Adverse Event|1
103142|NCT01029405|384277|P2|Overall Study|Adverse Event|0
103143|NCT01029405|384278|P1|Overall Study|Adverse Event|0
103144|NCT01029405|384275|P4|Overall Study|Protocol Violation|1
103145|NCT01029405|384276|P3|Overall Study|Protocol Violation|0
103146|NCT01029405|384277|P2|Overall Study|Protocol Violation|0
103147|NCT01029405|384278|P1|Overall Study|Protocol Violation|0
103148|NCT01029405|384275|P4|Overall Study|Withdrawal by Subject|0
103149|NCT01029405|384276|P3|Overall Study|Withdrawal by Subject|2
103150|NCT01029405|384277|P2|Overall Study|Withdrawal by Subject|1
103151|NCT01029405|384278|P1|Overall Study|Withdrawal by Subject|0
103152|NCT01029392|384290|P2|Overall Study|Physician Decision|0
103153|NCT01029392|384291|P1|Overall Study|Physician Decision|2
103154|NCT01029392|384290|P2|Overall Study|Withdrawal by Subject|11
103155|NCT01029392|384291|P1|Overall Study|Withdrawal by Subject|18
103156|NCT01029366|384301|P2|Overall Study|manufacturing failure|1
103157|NCT01029366|384302|P1|Overall Study|manufacturing failure|0
103158|NCT01029366|384301|P2|Overall Study|disease progression|0
103159|NCT01029366|384302|P1|Overall Study|disease progression|2
103160|NCT01029366|384301|P2|Overall Study|Death|1
103161|NCT01029366|384302|P1|Overall Study|Death|1
103162|NCT01029366|384301|P2|Overall Study|Withdrawal by Subject|0
103163|NCT01029366|384302|P1|Overall Study|Withdrawal by Subject|1
103164|NCT01029340|384314|P6|Extension Period|Physician Decision|1
103165|NCT01029340|384315|P5|Extension Period|Physician Decision|0
103166|NCT01029340|384316|P4|Extension Period|Physician Decision|0
103167|NCT01029340|384317|P3|Extension Period|Physician Decision|0
103168|NCT01029340|384318|P2|Extension Period|Physician Decision|0
103169|NCT01029340|384319|P1|Extension Period|Physician Decision|0
103170|NCT01029340|384314|P6|Extension Period|Withdrawal by Subject|1
103171|NCT01029340|384315|P5|Extension Period|Withdrawal by Subject|0
103172|NCT01029340|384316|P4|Extension Period|Withdrawal by Subject|0
103173|NCT01029340|384317|P3|Extension Period|Withdrawal by Subject|0
103174|NCT01029340|384318|P2|Extension Period|Withdrawal by Subject|0
103175|NCT01029340|384319|P1|Extension Period|Withdrawal by Subject|0
103176|NCT01029340|384314|P6|Extension Period|non-compliance|1
103177|NCT01029340|384315|P5|Extension Period|non-compliance|0
103178|NCT01029340|384316|P4|Extension Period|non-compliance|0
103179|NCT01029340|384317|P3|Extension Period|non-compliance|0
103180|NCT01029340|384318|P2|Extension Period|non-compliance|0
103181|NCT01029340|384319|P1|Extension Period|non-compliance|0
103182|NCT01029340|384314|P6|Extension Period|starting another study|8
103183|NCT01029340|384315|P5|Extension Period|starting another study|0
103184|NCT01029340|384316|P4|Extension Period|starting another study|0
103185|NCT01029340|384317|P3|Extension Period|starting another study|0
103186|NCT01029340|384318|P2|Extension Period|starting another study|0
103187|NCT01029340|384319|P1|Extension Period|starting another study|0
103188|NCT01029340|384314|P6|Extension Period|Adverse Event|1
103189|NCT01029340|384315|P5|Extension Period|Adverse Event|0
103190|NCT01029340|384316|P4|Extension Period|Adverse Event|0
103191|NCT01029340|384317|P3|Extension Period|Adverse Event|0
103192|NCT01029340|384318|P2|Extension Period|Adverse Event|0
103193|NCT01029340|384319|P1|Extension Period|Adverse Event|0
103194|NCT01029340|384314|P6|Part B Treatment Period|Protocol Violation|0
103195|NCT01029340|384315|P5|Part B Treatment Period|Protocol Violation|0
103196|NCT01029340|384316|P4|Part B Treatment Period|Protocol Violation|0
103197|NCT01029340|384317|P3|Part B Treatment Period|Protocol Violation|1
103198|NCT01029340|384318|P2|Part B Treatment Period|Protocol Violation|0
103199|NCT01029340|384319|P1|Part B Treatment Period|Protocol Violation|0
103200|NCT01029340|384314|P6|Part B Treatment Period|Withdrawal by Subject|0
103201|NCT01029340|384315|P5|Part B Treatment Period|Withdrawal by Subject|0
103202|NCT01029340|384316|P4|Part B Treatment Period|Withdrawal by Subject|0
103203|NCT01029340|384317|P3|Part B Treatment Period|Withdrawal by Subject|1
103204|NCT01029340|384318|P2|Part B Treatment Period|Withdrawal by Subject|0
103205|NCT01029340|384319|P1|Part B Treatment Period|Withdrawal by Subject|0
103206|NCT01029262|384350|P2|Overall Study|Other|5
103207|NCT01029262|384351|P1|Overall Study|Other|1
103208|NCT01029262|384350|P2|Overall Study|Protocol Violation|3
103209|NCT01029262|384351|P1|Overall Study|Protocol Violation|2
103210|NCT01029262|384350|P2|Overall Study|Withdrawal by Subject|16
103211|NCT01029262|384351|P1|Overall Study|Withdrawal by Subject|10
103212|NCT01029262|384350|P2|Overall Study|Lack of therapeutic effect|69
103213|NCT01029262|384351|P1|Overall Study|Lack of therapeutic effect|56
103214|NCT01029262|384350|P2|Overall Study|Adverse Event|52
103215|NCT01029262|384351|P1|Overall Study|Adverse Event|9
103216|NCT01028651|384509|P1|Overall Study|Adverse Event|1
103217|NCT01028651|384509|P1|Overall Study|Death|2
103218|NCT01028391|384532|P2|Overall Study|Needed excluded medication|1
103219|NCT01028391|384533|P1|Overall Study|Needed excluded medication|1
103220|NCT01028391|384532|P2|Overall Study|Withdrawal by Subject|3
103221|NCT01028391|384533|P1|Overall Study|Withdrawal by Subject|6
103222|NCT01028391|384532|P2|Overall Study|Physician Decision|1
103223|NCT01028391|384533|P1|Overall Study|Physician Decision|0
103224|NCT01028391|384532|P2|Overall Study|Lost to Follow-up|4
103225|NCT01028391|384533|P1|Overall Study|Lost to Follow-up|3
103226|NCT01028391|384532|P2|Overall Study|Lack of Efficacy|2
103227|NCT01028391|384533|P1|Overall Study|Lack of Efficacy|0
103228|NCT01028391|384532|P2|Overall Study|Adverse Event|0
103229|NCT01028391|384533|P1|Overall Study|Adverse Event|4
103230|NCT01028378|384541|P1|Overall Study|Adminstrative Reasons|4
103231|NCT01028378|384541|P1|Overall Study|Withdrawal by Subject|1
103232|NCT01028378|384541|P1|Overall Study|Lost to Follow-up|12
103233|NCT01028352|384553|P1|Overall Study|Withdrawal by Subject|1
103234|NCT01028352|384553|P1|Overall Study|Ineligible due to baseline average pain|5
103235|NCT01028300|384558|P1|Overall Study|Study Terminated|4
103236|NCT01028222|384567|P2|Overall Study|Adverse Event|0
103237|NCT01028222|384568|P1|Overall Study|Adverse Event|2
103238|NCT01028222|384567|P2|Overall Study|Crossover to nilotinib w/out progression|2
103239|NCT01028222|384568|P1|Overall Study|Crossover to nilotinib w/out progression|0
103240|NCT01028222|384567|P2|Overall Study|Withdrawal by Subject|0
103241|NCT01028222|384568|P1|Overall Study|Withdrawal by Subject|1
103242|NCT01028222|384567|P2|Overall Study|Lost to Follow-up|1
103243|NCT01028222|384568|P1|Overall Study|Lost to Follow-up|0
103244|NCT01028222|384567|P2|Overall Study|Administrative problems|1
103245|NCT01028222|384568|P1|Overall Study|Administrative problems|1
103246|NCT01028222|384567|P2|Overall Study|Disease progression|9
103247|NCT01028222|384568|P1|Overall Study|Disease progression|33
103248|NCT01028222|384567|P2|Overall Study|Protocol deviation|0
103249|NCT01028222|384568|P1|Overall Study|Protocol deviation|1
103250|NCT01028053|384610|P1|Overall Study|Various reasons|4
103251|NCT01028053|384610|P1|Overall Study|Terminated by Sponsor|1
103252|NCT01028053|384610|P1|Overall Study|Technical Problem|1
103253|NCT01028053|384610|P1|Overall Study|Physician Decision|2
103254|NCT01028053|384610|P1|Overall Study|Protocol Violation|1
103255|NCT01028053|384610|P1|Overall Study|Patient Request|11
103256|NCT01028053|384610|P1|Overall Study|Screen Failure|113
103257|NCT01028027|384618|P2|Overall Study|Lack of Efficacy|1
103258|NCT01028027|384619|P1|Overall Study|Lack of Efficacy|0
103259|NCT01028027|384618|P2|Overall Study|Protocol Violation|1
103260|NCT01028027|384619|P1|Overall Study|Protocol Violation|3
103261|NCT01028027|384618|P2|Overall Study|Adverse Event|7
103262|NCT01028027|384619|P1|Overall Study|Adverse Event|4
103263|NCT01028027|384618|P2|Overall Study|Withdrawal by Subject|3
103264|NCT01028027|384619|P1|Overall Study|Withdrawal by Subject|5
103265|NCT01028027|384618|P2|Overall Study|Lost to Follow-up|1
103266|NCT01028027|384619|P1|Overall Study|Lost to Follow-up|4
103267|NCT01028014|384641|P6|Overall Study|Lost to Follow-up|2
103268|NCT01028014|384642|P5|Overall Study|Lost to Follow-up|1
103269|NCT01028014|384643|P4|Overall Study|Lost to Follow-up|1
103270|NCT01028014|384644|P3|Overall Study|Lost to Follow-up|0
103271|NCT01028014|384645|P2|Overall Study|Lost to Follow-up|2
103272|NCT01028014|384646|P1|Overall Study|Lost to Follow-up|1
103273|NCT01027897|384687|P1|Overall Study|Withdrawal by Subject|1
103274|NCT01027897|384687|P1|Overall Study|Protocol Violation|1
103275|NCT01027884|384695|P2|Overall Study|Spinal fixation surgery|3
103276|NCT01027884|384696|P1|Overall Study|Spinal fixation surgery|0
103277|NCT01027884|384695|P2|Overall Study|Lost to Follow-up|1
103278|NCT01027884|384696|P1|Overall Study|Lost to Follow-up|0
103279|NCT01027884|384695|P2|Overall Study|Withdrawal by Subject|1
103280|NCT01027884|384696|P1|Overall Study|Withdrawal by Subject|0
103281|NCT01027884|384695|P2|Overall Study|Non-compliance|1
103282|NCT01027884|384696|P1|Overall Study|Non-compliance|1
103283|NCT01027884|384695|P2|Overall Study|Protocol Violation|0
103284|NCT01027884|384696|P1|Overall Study|Protocol Violation|1
103285|NCT01027884|384695|P2|Overall Study|Adverse Event|1
103286|NCT01027884|384696|P1|Overall Study|Adverse Event|2
103287|NCT01027702|384732|P7|Overall Study|Death|0
103288|NCT01027702|384733|P6|Overall Study|Death|0
103289|NCT01027702|384734|P5|Overall Study|Death|0
103290|NCT01027702|384735|P4|Overall Study|Death|0
103291|NCT01027702|384736|P3|Overall Study|Death|1
103292|NCT01027702|384737|P2|Overall Study|Death|0
103293|NCT01027702|384738|P1|Overall Study|Death|0
103294|NCT01027702|384732|P7|Overall Study|Received subsequent therapy|1
103295|NCT01027702|384733|P6|Overall Study|Received subsequent therapy|0
103296|NCT01027702|384734|P5|Overall Study|Received subsequent therapy|1
103297|NCT01027702|384735|P4|Overall Study|Received subsequent therapy|4
103298|NCT01027702|384736|P3|Overall Study|Received subsequent therapy|0
103299|NCT01027702|384737|P2|Overall Study|Received subsequent therapy|2
103300|NCT01027702|384738|P1|Overall Study|Received subsequent therapy|1
103301|NCT01027650|384764|P8|Overall Study|Lack of Efficacy|0
103302|NCT01027650|384765|P7|Overall Study|Lack of Efficacy|0
103303|NCT01027650|384766|P6|Overall Study|Lack of Efficacy|1
103304|NCT01027650|384767|P5|Overall Study|Lack of Efficacy|0
103305|NCT01027650|384768|P4|Overall Study|Lack of Efficacy|0
103306|NCT01027650|384769|P3|Overall Study|Lack of Efficacy|0
103307|NCT01027650|384770|P2|Overall Study|Lack of Efficacy|0
103308|NCT01027650|384771|P1|Overall Study|Lack of Efficacy|0
103309|NCT01027650|384764|P8|Overall Study|Lost to Follow-up|0
103310|NCT01027650|384765|P7|Overall Study|Lost to Follow-up|1
103311|NCT01027650|384766|P6|Overall Study|Lost to Follow-up|0
103312|NCT01027650|384767|P5|Overall Study|Lost to Follow-up|0
103313|NCT01027650|384768|P4|Overall Study|Lost to Follow-up|0
103314|NCT01027650|384769|P3|Overall Study|Lost to Follow-up|0
103315|NCT01027650|384770|P2|Overall Study|Lost to Follow-up|0
103316|NCT01027650|384771|P1|Overall Study|Lost to Follow-up|0
103317|NCT01027650|384764|P8|Overall Study|Personal Reasons|0
103318|NCT01027650|384765|P7|Overall Study|Personal Reasons|0
103319|NCT01027650|384766|P6|Overall Study|Personal Reasons|1
103320|NCT01027650|384767|P5|Overall Study|Personal Reasons|2
103321|NCT01027650|384768|P4|Overall Study|Personal Reasons|0
103322|NCT01027650|384769|P3|Overall Study|Personal Reasons|0
103323|NCT01027650|384770|P2|Overall Study|Personal Reasons|0
103324|NCT01027650|384771|P1|Overall Study|Personal Reasons|0
103325|NCT01027416|384832|P2|Overall Study|Physician Decision|4
103326|NCT01027416|384833|P1|Overall Study|Physician Decision|1
103327|NCT01027416|384832|P2|Overall Study|Withdrawal by Subject|1
103328|NCT01027416|384833|P1|Overall Study|Withdrawal by Subject|0
103329|NCT01027364|384845|P4|Overall Study|Withdrawal by Subject|0
103330|NCT01027364|384846|P3|Overall Study|Withdrawal by Subject|0
103331|NCT01027364|384847|P2|Overall Study|Withdrawal by Subject|2
103332|NCT01027364|384848|P1|Overall Study|Withdrawal by Subject|1
103333|NCT01027364|384845|P4|Overall Study|Protocol Violation|1
103334|NCT01027364|384846|P3|Overall Study|Protocol Violation|0
103335|NCT01027364|384847|P2|Overall Study|Protocol Violation|0
103336|NCT01027364|384848|P1|Overall Study|Protocol Violation|1
103337|NCT01027364|384845|P4|Overall Study|Lost to Follow-up|0
103338|NCT01027364|384846|P3|Overall Study|Lost to Follow-up|0
103339|NCT01027364|384847|P2|Overall Study|Lost to Follow-up|0
103340|NCT01027364|384848|P1|Overall Study|Lost to Follow-up|1
103341|NCT01027364|384845|P4|Overall Study|Adverse Event|0
103342|NCT01027364|384846|P3|Overall Study|Adverse Event|1
103343|NCT01027364|384847|P2|Overall Study|Adverse Event|0
103344|NCT01027364|384848|P1|Overall Study|Adverse Event|1
103345|NCT01027351|384943|P6|Overall Study|Protocol Violation|0
103346|NCT01027351|384944|P5|Overall Study|Protocol Violation|1
103347|NCT01027351|384945|P4|Overall Study|Protocol Violation|1
103348|NCT01027351|384946|P3|Overall Study|Protocol Violation|0
103349|NCT01027351|384947|P2|Overall Study|Protocol Violation|0
103350|NCT01027351|384948|P1|Overall Study|Protocol Violation|1
103351|NCT01027351|384943|P6|Overall Study|Inappropriate enrollment|0
103352|NCT01027351|384944|P5|Overall Study|Inappropriate enrollment|1
103353|NCT01027351|384945|P4|Overall Study|Inappropriate enrollment|0
103354|NCT01027351|384946|P3|Overall Study|Inappropriate enrollment|0
103355|NCT01027351|384947|P2|Overall Study|Inappropriate enrollment|0
103356|NCT01027351|384948|P1|Overall Study|Inappropriate enrollment|0
103357|NCT01027351|384943|P6|Overall Study|Lost to Follow-up|0
103358|NCT01027351|384944|P5|Overall Study|Lost to Follow-up|6
103359|NCT01027351|384945|P4|Overall Study|Lost to Follow-up|1
103360|NCT01027351|384946|P3|Overall Study|Lost to Follow-up|0
103361|NCT01027351|384947|P2|Overall Study|Lost to Follow-up|1
103362|NCT01027351|384948|P1|Overall Study|Lost to Follow-up|1
103363|NCT01027351|384943|P6|Overall Study|Withdrawal by Subject|5
103364|NCT01027351|384944|P5|Overall Study|Withdrawal by Subject|3
103365|NCT01027351|384945|P4|Overall Study|Withdrawal by Subject|0
103366|NCT01027351|384946|P3|Overall Study|Withdrawal by Subject|1
103367|NCT01027351|384947|P2|Overall Study|Withdrawal by Subject|0
103368|NCT01027351|384948|P1|Overall Study|Withdrawal by Subject|1
103369|NCT01027286|385032|P2|Overall Study|Lost to Follow-up|1
103370|NCT01027286|385033|P1|Overall Study|Lost to Follow-up|0
103371|NCT01027286|385032|P2|Overall Study|Unable to Obtain Required Blood Volume|0
103372|NCT01027286|385033|P1|Overall Study|Unable to Obtain Required Blood Volume|1
103373|NCT01027273|385053|P2|Overall Study|Death|2
103374|NCT01027273|385054|P1|Overall Study|Death|2
103375|NCT01027273|385053|P2|Overall Study|Lost to Follow-up|31
103376|NCT01027273|385054|P1|Overall Study|Lost to Follow-up|57
103377|NCT01026974|385101|P4|Overall Study|Inappropriate enrollment|0
103378|NCT01026974|385102|P3|Overall Study|Inappropriate enrollment|1
103379|NCT01026974|385103|P2|Overall Study|Inappropriate enrollment|0
103380|NCT01026974|385104|P1|Overall Study|Inappropriate enrollment|0
103381|NCT01026974|385101|P4|Overall Study|Adverse Event|1
103382|NCT01026974|385102|P3|Overall Study|Adverse Event|0
103383|NCT01026974|385103|P2|Overall Study|Adverse Event|0
103384|NCT01026974|385104|P1|Overall Study|Adverse Event|0
103385|NCT01026974|385101|P4|Overall Study|Lost to Follow-up|0
103386|NCT01026974|385102|P3|Overall Study|Lost to Follow-up|4
103387|NCT01026974|385103|P2|Overall Study|Lost to Follow-up|1
103388|NCT01026974|385104|P1|Overall Study|Lost to Follow-up|1
103389|NCT01026974|385101|P4|Overall Study|Withdrawal by Subject|2
103390|NCT01026974|385102|P3|Overall Study|Withdrawal by Subject|7
103391|NCT01026974|385103|P2|Overall Study|Withdrawal by Subject|1
103392|NCT01026974|385104|P1|Overall Study|Withdrawal by Subject|0
103393|NCT01026948|385161|P1|Overall Study|Physician Decision|8
103394|NCT01026831|385194|P2|Overall Study|Withdrawal by Subject|5
103395|NCT01026831|385195|P1|Overall Study|Withdrawal by Subject|7
103396|NCT01026831|385194|P2|Overall Study|Protocol Violation|2
103397|NCT01026831|385195|P1|Overall Study|Protocol Violation|0
103398|NCT01026831|385194|P2|Overall Study|Physician Decision|1
103399|NCT01026831|385195|P1|Overall Study|Physician Decision|1
103400|NCT01026831|385194|P2|Overall Study|Lost to Follow-up|0
103401|NCT01026831|385195|P1|Overall Study|Lost to Follow-up|2
103402|NCT01026831|385194|P2|Overall Study|Adverse Event|3
103403|NCT01026831|385195|P1|Overall Study|Adverse Event|4
103404|NCT01026818|385206|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
103405|NCT01026818|385207|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
103406|NCT01026818|385208|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
103407|NCT01026818|385209|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
103408|NCT01026818|385206|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
103409|NCT01026818|385207|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
103410|NCT01026818|385208|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
103411|NCT01026818|385209|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
103412|NCT01026818|385206|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
103413|NCT01026818|385207|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
103414|NCT01026818|385208|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
103415|NCT01026818|385209|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
103416|NCT01026818|385206|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
103417|NCT01026818|385207|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
103418|NCT01026818|385208|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
103419|NCT01026818|385209|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
103420|NCT01026818|385206|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
103421|NCT01026818|385207|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
103422|NCT01026818|385208|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
103423|NCT01026818|385209|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
103424|NCT01026818|385206|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
103425|NCT01026818|385207|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
103426|NCT01026818|385208|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
103427|NCT01026818|385209|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
103428|NCT01026818|385206|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
103429|NCT01026818|385207|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
103430|NCT01026818|385208|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
103431|NCT01026818|385209|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
103432|NCT01026818|385206|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
103433|NCT01026818|385207|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
103434|NCT01026818|385208|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
103435|NCT01026818|385209|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
103436|NCT01026818|385206|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
103437|NCT01026818|385207|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
103438|NCT01026818|385208|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
103439|NCT01026818|385209|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
103440|NCT01026818|385206|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
103441|NCT01026818|385207|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
103442|NCT01026818|385208|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
103443|NCT01026818|385209|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
103444|NCT01026818|385206|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
103445|NCT01026818|385207|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
103446|NCT01026818|385208|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
103447|NCT01026818|385209|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
103448|NCT01026818|385206|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
103449|NCT01026818|385207|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
103450|NCT01026818|385208|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
103451|NCT01026818|385209|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
103452|NCT01026818|385206|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
103453|NCT01026818|385207|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
103454|NCT01026818|385208|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
103455|NCT01026818|385209|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
103456|NCT01026818|385206|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
103457|NCT01026818|385207|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
103458|NCT01026818|385208|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
103459|NCT01026818|385209|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
103460|NCT01026818|385206|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
103461|NCT01026818|385207|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
103462|NCT01026818|385208|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
103463|NCT01026818|385209|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
103464|NCT01026818|385206|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
103465|NCT01026818|385207|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
103466|NCT01026818|385208|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
103467|NCT01026818|385209|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
103468|NCT01026818|385206|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
103469|NCT01026818|385207|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
103470|NCT01026818|385208|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
103471|NCT01026818|385209|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
103472|NCT01026818|385206|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
103473|NCT01026818|385207|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
103559|NCT01026142|385781|P2|Overall Study|Death|98
103474|NCT01026818|385208|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
103475|NCT01026818|385209|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
103476|NCT01026818|385206|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
103477|NCT01026818|385207|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
103478|NCT01026818|385208|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
103479|NCT01026818|385209|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
103480|NCT01026818|385206|P4|Screening Period|Physician Decision|0
103481|NCT01026818|385207|P3|Screening Period|Physician Decision|0
103482|NCT01026818|385208|P2|Screening Period|Physician Decision|0
103483|NCT01026818|385209|P1|Screening Period|Physician Decision|1
103484|NCT01026818|385206|P4|Screening Period|Adverse Event|0
103485|NCT01026818|385207|P3|Screening Period|Adverse Event|0
103486|NCT01026818|385208|P2|Screening Period|Adverse Event|0
103487|NCT01026818|385209|P1|Screening Period|Adverse Event|2
103488|NCT01026818|385206|P4|Screening Period|Protocol Deviation|0
103489|NCT01026818|385207|P3|Screening Period|Protocol Deviation|0
103490|NCT01026818|385208|P2|Screening Period|Protocol Deviation|0
103491|NCT01026818|385209|P1|Screening Period|Protocol Deviation|3
103492|NCT01026818|385206|P4|Screening Period|Withdrawal by Subject|0
103493|NCT01026818|385207|P3|Screening Period|Withdrawal by Subject|0
103494|NCT01026818|385208|P2|Screening Period|Withdrawal by Subject|0
103495|NCT01026818|385209|P1|Screening Period|Withdrawal by Subject|49
103496|NCT01026818|385206|P4|Screening Period|Entry Criteria Not Met|0
103497|NCT01026818|385207|P3|Screening Period|Entry Criteria Not Met|0
103498|NCT01026818|385208|P2|Screening Period|Entry Criteria Not Met|0
103499|NCT01026818|385209|P1|Screening Period|Entry Criteria Not Met|105
103500|NCT01026792|385297|P1|Overall Study|Protocol Violation|1
103501|NCT01026493|385309|P8|Overall Study|Protocol Violation|1
103502|NCT01026493|385310|P7|Overall Study|Protocol Violation|4
103503|NCT01026493|385311|P6|Overall Study|Protocol Violation|3
103504|NCT01026493|385312|P5|Overall Study|Protocol Violation|2
103505|NCT01026493|385313|P4|Overall Study|Protocol Violation|0
103506|NCT01026493|385314|P3|Overall Study|Protocol Violation|0
103507|NCT01026493|385315|P2|Overall Study|Protocol Violation|1
103508|NCT01026493|385316|P1|Overall Study|Protocol Violation|0
103509|NCT01026454|385344|P2|Second Intervention|Pregnancy|1
103510|NCT01026454|385345|P1|Second Intervention|Pregnancy|1
103511|NCT01026389|385694|P2|Overall Study|change of treatment, patient moved|2
103512|NCT01026389|385695|P1|Overall Study|change of treatment, patient moved|4
103513|NCT01026389|385694|P2|Overall Study|Withdrawal by Subject|3
103514|NCT01026389|385695|P1|Overall Study|Withdrawal by Subject|1
103515|NCT01026324|385710|P3|Follow up/Survival|Withdrawal by Subject|0
103516|NCT01026324|385711|P2|Follow up/Survival|Withdrawal by Subject|0
103517|NCT01026324|385712|P1|Follow up/Survival|Withdrawal by Subject|1
103518|NCT01026220|385722|P3|Consolidation Maintenance|Withdrawal by Subject|6
103519|NCT01026220|385723|P2|Consolidation Maintenance|Withdrawal by Subject|2
103520|NCT01026220|385724|P1|Consolidation Maintenance|Withdrawal by Subject|0
103521|NCT01026220|385722|P3|Consolidation Maintenance|Physician Decision|7
103522|NCT01026220|385723|P2|Consolidation Maintenance|Physician Decision|2
103523|NCT01026220|385724|P1|Consolidation Maintenance|Physician Decision|0
103524|NCT01026220|385722|P3|Consolidation Maintenance|Lack of Efficacy|1
103525|NCT01026220|385723|P2|Consolidation Maintenance|Lack of Efficacy|1
103526|NCT01026220|385724|P1|Consolidation Maintenance|Lack of Efficacy|0
103527|NCT01026220|385722|P3|Consolidation Maintenance|Death|0
103528|NCT01026220|385723|P2|Consolidation Maintenance|Death|1
103529|NCT01026220|385724|P1|Consolidation Maintenance|Death|0
103530|NCT01026220|385722|P3|Induction|Ineligible|0
103531|NCT01026220|385723|P2|Induction|Ineligible|0
103532|NCT01026220|385724|P1|Induction|Ineligible|1
103533|NCT01026220|385722|P3|Induction|Withdrawal by Subject|0
103534|NCT01026220|385723|P2|Induction|Withdrawal by Subject|0
103535|NCT01026220|385724|P1|Induction|Withdrawal by Subject|9
103536|NCT01026220|385722|P3|Induction|Physician Decision|0
103537|NCT01026220|385723|P2|Induction|Physician Decision|0
103538|NCT01026220|385724|P1|Induction|Physician Decision|12
103539|NCT01026220|385722|P3|Induction|Lack of Efficacy|0
103540|NCT01026220|385723|P2|Induction|Lack of Efficacy|0
103541|NCT01026220|385724|P1|Induction|Lack of Efficacy|2
103542|NCT01026220|385722|P3|Induction|Death|0
103543|NCT01026220|385723|P2|Induction|Death|0
103544|NCT01026220|385724|P1|Induction|Death|1
103545|NCT01026194|385748|P2|Period 2：Open-label Period|Withdrawal by Subject|4
103546|NCT01026194|385749|P1|Period 2：Open-label Period|Withdrawal by Subject|0
103547|NCT01026194|385748|P2|Period 2：Open-label Period|Physician Decision|1
103548|NCT01026194|385749|P1|Period 2：Open-label Period|Physician Decision|3
103549|NCT01026194|385748|P2|Period 2：Open-label Period|Adverse Event|5
103550|NCT01026194|385749|P1|Period 2：Open-label Period|Adverse Event|4
103551|NCT01026194|385748|P2|Period 1：Double Blind Period|Physician Decision|4
103552|NCT01026194|385749|P1|Period 1：Double Blind Period|Physician Decision|0
103553|NCT01026194|385748|P2|Period 1：Double Blind Period|Lack of Efficacy|0
103554|NCT01026194|385749|P1|Period 1：Double Blind Period|Lack of Efficacy|1
103555|NCT01026194|385748|P2|Period 1：Double Blind Period|Adverse Event|1
103556|NCT01026194|385749|P1|Period 1：Double Blind Period|Adverse Event|2
103557|NCT01026142|385781|P2|Overall Study|Reasons not specified|23
103558|NCT01026142|385782|P1|Overall Study|Reasons not specified|25
103560|NCT01026142|385782|P1|Overall Study|Death|114
103561|NCT01026103|385804|P1|Overall Study|did not receive study device bc of error|1
103562|NCT01026103|385804|P1|Overall Study|Physician Decision|1
103563|NCT01026038|385814|P3|Overall Study|Lost to Follow-up|0
103564|NCT01026038|385815|P2|Overall Study|Lost to Follow-up|1
103565|NCT01026038|385816|P1|Overall Study|Lost to Follow-up|1
103566|NCT01025843|385865|P10|Washout 4|Withdrawal by Subject|0
103567|NCT01025843|385866|P9|Washout 4|Withdrawal by Subject|0
103568|NCT01025843|385867|P8|Washout 4|Withdrawal by Subject|0
103569|NCT01025843|385868|P7|Washout 4|Withdrawal by Subject|0
103570|NCT01025843|385869|P6|Washout 4|Withdrawal by Subject|0
103571|NCT01025843|385870|P5|Washout 4|Withdrawal by Subject|0
103572|NCT01025843|385871|P4|Washout 4|Withdrawal by Subject|1
103573|NCT01025843|385872|P3|Washout 4|Withdrawal by Subject|1
103574|NCT01025843|385873|P2|Washout 4|Withdrawal by Subject|0
103575|NCT01025843|385874|P1|Washout 4|Withdrawal by Subject|0
103576|NCT01025817|385968|P2|Completed Study|Lost to Follow-up|1
103577|NCT01025817|385969|P1|Completed Study|Lost to Follow-up|0
103578|NCT01025817|385968|P2|Completed Study|Missing|0
103579|NCT01025817|385969|P1|Completed Study|Missing|2
103580|NCT01025817|385968|P2|Completed Study|Death|5
103581|NCT01025817|385969|P1|Completed Study|Death|6
103582|NCT01025817|385968|P2|Completed Study|Withdrawal by Subject|16
103583|NCT01025817|385969|P1|Completed Study|Withdrawal by Subject|8
103584|NCT01025817|385968|P2|Completed Study Medication|Lost to Follow-up|1
103585|NCT01025817|385969|P1|Completed Study Medication|Lost to Follow-up|0
103586|NCT01025817|385968|P2|Completed Study Medication|Subject no longer required study drug|1
103587|NCT01025817|385969|P1|Completed Study Medication|Subject no longer required study drug|0
103588|NCT01025817|385968|P2|Completed Study Medication|Abnormal lab values|2
103589|NCT01025817|385969|P1|Completed Study Medication|Abnormal lab values|0
103590|NCT01025817|385968|P2|Completed Study Medication|Death|2
103591|NCT01025817|385969|P1|Completed Study Medication|Death|2
103592|NCT01025817|385968|P2|Completed Study Medication|Graft loss|5
103593|NCT01025817|385969|P1|Completed Study Medication|Graft loss|2
103594|NCT01025817|385968|P2|Completed Study Medication|Abnormal test procedure|0
103595|NCT01025817|385969|P1|Completed Study Medication|Abnormal test procedure|4
103596|NCT01025817|385968|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
103597|NCT01025817|385969|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
103598|NCT01025817|385968|P2|Completed Study Medication|Administrative problems|5
103599|NCT01025817|385969|P1|Completed Study Medication|Administrative problems|7
103600|NCT01025817|385968|P2|Completed Study Medication|Withdrawal by Subject|9
103601|NCT01025817|385969|P1|Completed Study Medication|Withdrawal by Subject|8
103602|NCT01025817|385968|P2|Completed Study Medication|Protocol Deviation|8
103603|NCT01025817|385969|P1|Completed Study Medication|Protocol Deviation|9
103604|NCT01025817|385968|P2|Completed Study Medication|Adverse Event|39
103605|NCT01025817|385969|P1|Completed Study Medication|Adverse Event|66
103606|NCT01025635|385989|P2|Overall Study|Reason not known|2
103607|NCT01025635|385990|P1|Overall Study|Reason not known|4
103608|NCT01025635|385989|P2|Overall Study|Lost to Follow-up|13
103609|NCT01025635|385990|P1|Overall Study|Lost to Follow-up|9
103610|NCT01025635|385989|P2|Overall Study|Lack of Efficacy|1
103611|NCT01025635|385990|P1|Overall Study|Lack of Efficacy|0
103612|NCT01025635|385989|P2|Overall Study|Protocol Violation|2
103613|NCT01025635|385990|P1|Overall Study|Protocol Violation|4
103614|NCT01025635|385989|P2|Overall Study|Withdrawal by Subject|7
103615|NCT01025635|385990|P1|Overall Study|Withdrawal by Subject|6
103616|NCT01025336|386011|P5|Overall Study|Protocol Violation|0
103617|NCT01025336|386012|P4|Overall Study|Protocol Violation|2
103618|NCT01025336|386013|P3|Overall Study|Protocol Violation|0
103619|NCT01025336|386014|P2|Overall Study|Protocol Violation|0
103620|NCT01025336|386015|P1|Overall Study|Protocol Violation|0
103621|NCT01025284|386070|P3|Overall Study|Withdrawal by Subject|0
103622|NCT01025284|386071|P2|Overall Study|Withdrawal by Subject|1
103623|NCT01025284|386072|P1|Overall Study|Withdrawal by Subject|0
103624|NCT01025284|386070|P3|Overall Study|Investigator Decision|0
103625|NCT01025284|386071|P2|Overall Study|Investigator Decision|1
103626|NCT01025284|386072|P1|Overall Study|Investigator Decision|0
103627|NCT01025232|386097|P2|Overall Study|Study drug no longer available|6
103628|NCT01025232|386098|P1|Overall Study|Study drug no longer available|3
103629|NCT01025193|386116|P1|Overall Study|Adverse Event|3
103630|NCT01025193|386116|P1|Overall Study|Protocol Violation|1
103631|NCT01025154|386126|P1|Overall Study|Withdrawal by Subject|1
103632|NCT01025154|386126|P1|Overall Study|Lost to Follow-up|1
103633|NCT01025037|386135|P1|Overall Study|Withdrawal by Subject|1
103634|NCT01025037|386135|P1|Overall Study|Lost to Follow-up|7
103635|NCT01025037|386135|P1|Overall Study|Adverse Event|3
103636|NCT01024959|386157|P1|Overall Study|missing results required for analysis|17
103637|NCT01024959|386157|P1|Overall Study|results not evaluable|12
103638|NCT01024959|386157|P1|Overall Study|ineligible|12
103639|NCT01024946|386166|P1|Overall Study|Adverse Event|1
103640|NCT01024946|386166|P1|Overall Study|Withdrawal by Subject|1
103641|NCT01024946|386166|P1|Overall Study|Screen Failure|3
103642|NCT01024855|386170|P1|Overall Study|Inclusion/exclusion criteria|1
103643|NCT01024751|386177|P2|Eligible Participants|Ineligible|1
103644|NCT01024751|386178|P1|Eligible Participants|Ineligible|0
103645|NCT01024751|386177|P2|Eligible Participants|Lost to Follow-up|1
103646|NCT01024751|386178|P1|Eligible Participants|Lost to Follow-up|0
103647|NCT01024751|386177|P2|Eligible Participants|Withdrawal by Subject|1
103648|NCT01024751|386178|P1|Eligible Participants|Withdrawal by Subject|0
103649|NCT01024751|386177|P2|Enrolled Participants|Ineligible at baseline|4
103650|NCT01024751|386178|P1|Enrolled Participants|Ineligible at baseline|3
103651|NCT01024608|386201|P2|Overall Study|Never received study treatment|0
103652|NCT01024608|386202|P1|Overall Study|Never received study treatment|2
103653|NCT01024608|386201|P2|Overall Study|Protocol Violation|3
103654|NCT01024608|386202|P1|Overall Study|Protocol Violation|0
103655|NCT01024608|386201|P2|Overall Study|Lost to Follow-up|1
103656|NCT01024608|386202|P1|Overall Study|Lost to Follow-up|0
103657|NCT01024608|386201|P2|Overall Study|Withdrawal by Subject|0
103658|NCT01024608|386202|P1|Overall Study|Withdrawal by Subject|1
103659|NCT01024608|386201|P2|Overall Study|Adverse Event|0
103660|NCT01024608|386202|P1|Overall Study|Adverse Event|1
103661|NCT01024465|386214|P1|Overall Study|Physician Decision|1
103662|NCT01024465|386214|P1|Overall Study|Adverse Event|2
103663|NCT01024387|386218|P1|Overall Study|Other|5
103664|NCT01024387|386218|P1|Overall Study|Adverse Event|3
103665|NCT01024387|386218|P1|Overall Study|Prolonged Treatment Delay|1
103666|NCT01024387|386218|P1|Overall Study|Death|2
103667|NCT01024387|386218|P1|Overall Study|Withdrawal by Subject|5
103668|NCT01024387|386218|P1|Overall Study|Physician Decision|5
103669|NCT01024387|386218|P1|Overall Study|Symptomatic Progression|10
103670|NCT01024387|386218|P1|Overall Study|Radiographic Progression|29
103671|NCT01024309|386239|P2|Overall Study|Withdrawal by Subject|4
103672|NCT01024309|386240|P1|Overall Study|Withdrawal by Subject|4
103673|NCT01024309|386239|P2|Overall Study|Physician Decision|0
103674|NCT01024309|386240|P1|Overall Study|Physician Decision|4
103675|NCT01024244|386272|P5|Overall Study|Withdrawal by Subject|0
103676|NCT01024244|386273|P4|Overall Study|Withdrawal by Subject|0
103677|NCT01024244|386274|P3|Overall Study|Withdrawal by Subject|0
103678|NCT01024244|386275|P2|Overall Study|Withdrawal by Subject|1
103679|NCT01024244|386276|P1|Overall Study|Withdrawal by Subject|0
103680|NCT01024244|386272|P5|Overall Study|Sponsor Decision|10
103681|NCT01024244|386273|P4|Overall Study|Sponsor Decision|12
103682|NCT01024244|386274|P3|Overall Study|Sponsor Decision|14
103683|NCT01024244|386275|P2|Overall Study|Sponsor Decision|7
103684|NCT01024244|386276|P1|Overall Study|Sponsor Decision|14
103685|NCT01024244|386272|P5|Overall Study|Protocol Violation|2
103686|NCT01024244|386273|P4|Overall Study|Protocol Violation|0
103687|NCT01024244|386274|P3|Overall Study|Protocol Violation|0
103688|NCT01024244|386275|P2|Overall Study|Protocol Violation|0
103689|NCT01024244|386276|P1|Overall Study|Protocol Violation|1
103690|NCT01024244|386272|P5|Overall Study|Lack of Efficacy|0
103691|NCT01024244|386273|P4|Overall Study|Lack of Efficacy|0
103692|NCT01024244|386274|P3|Overall Study|Lack of Efficacy|0
103693|NCT01024244|386275|P2|Overall Study|Lack of Efficacy|0
103694|NCT01024244|386276|P1|Overall Study|Lack of Efficacy|1
103695|NCT01024244|386272|P5|Overall Study|Entry Criteria Not Met|0
103696|NCT01024244|386273|P4|Overall Study|Entry Criteria Not Met|0
103697|NCT01024244|386274|P3|Overall Study|Entry Criteria Not Met|0
103698|NCT01024244|386275|P2|Overall Study|Entry Criteria Not Met|1
103699|NCT01024244|386276|P1|Overall Study|Entry Criteria Not Met|0
103700|NCT01024244|386272|P5|Overall Study|Adverse Event|2
103701|NCT01024244|386273|P4|Overall Study|Adverse Event|1
103702|NCT01024244|386274|P3|Overall Study|Adverse Event|0
103703|NCT01024244|386275|P2|Overall Study|Adverse Event|2
103704|NCT01024244|386276|P1|Overall Study|Adverse Event|1
103705|NCT01024036|386390|P2|Follow-Up Period|Adverse Event|1
103706|NCT01024036|386391|P1|Follow-Up Period|Adverse Event|4
103707|NCT01024036|386390|P2|Follow-Up Period|Withdrawal by Subject|1
103708|NCT01024036|386391|P1|Follow-Up Period|Withdrawal by Subject|0
103709|NCT01024036|386390|P2|Follow-Up Period|Lost to Follow-up|1
103710|NCT01024036|386391|P1|Follow-Up Period|Lost to Follow-up|1
103711|NCT01024036|386390|P2|Unblinded Treatment|Lack of Efficacy|2
103712|NCT01024036|386391|P1|Unblinded Treatment|Lack of Efficacy|0
103713|NCT01024036|386390|P2|Unblinded Treatment|Adverse Event|1
103714|NCT01024036|386391|P1|Unblinded Treatment|Adverse Event|0
103715|NCT01024036|386390|P2|Blinded Treatment|Withdrawal by Subject|3
103716|NCT01024036|386391|P1|Blinded Treatment|Withdrawal by Subject|4
103717|NCT01024036|386390|P2|Blinded Treatment|Death|2
103718|NCT01024036|386391|P1|Blinded Treatment|Death|0
103719|NCT01024036|386390|P2|Blinded Treatment|Physician Decision|0
103720|NCT01024036|386391|P1|Blinded Treatment|Physician Decision|1
103721|NCT01024036|386390|P2|Blinded Treatment|Lack of Efficacy|14
103722|NCT01024036|386391|P1|Blinded Treatment|Lack of Efficacy|16
103723|NCT01024036|386390|P2|Blinded Treatment|Adverse Event|1
103724|NCT01024036|386391|P1|Blinded Treatment|Adverse Event|1
103725|NCT01023958|386422|P1|Overall Study|Refused to continue medication|1
103726|NCT01023958|386422|P1|Overall Study|Other adverse event|1
103727|NCT01023958|386422|P1|Overall Study|Progressive disease|48
103728|NCT01023815|386470|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
103729|NCT01023815|386471|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
103730|NCT01023815|386472|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
103731|NCT01023815|386473|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
103732|NCT01023815|386470|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
103733|NCT01023815|386471|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
103734|NCT01023815|386472|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
103735|NCT01023815|386473|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
103736|NCT01023815|386470|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
103737|NCT01023815|386471|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
103738|NCT01023815|386472|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
103739|NCT01023815|386473|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
103740|NCT01023815|386470|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
103741|NCT01023815|386471|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
103742|NCT01023815|386472|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
103743|NCT01023815|386473|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
103744|NCT01023815|386470|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
103745|NCT01023815|386471|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
103746|NCT01023815|386472|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
103747|NCT01023815|386473|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
103748|NCT01023789|386492|P1|3 - Year Visit|Lost to Follow-up|13
103749|NCT01023789|386492|P1|3 - Year Visit|Withdrawal of consent|1
103750|NCT01023789|386492|P1|3 - Year Visit|Death|29
103751|NCT01023672|386578|P1|Overall Study|Death|1
103752|NCT01023672|386578|P1|Overall Study|Worsening disease|2
103753|NCT01023659|386585|P3|Overall Study|Lost to Follow-up|99
103754|NCT01023659|386586|P2|Overall Study|Lost to Follow-up|228
103755|NCT01023659|386587|P1|Overall Study|Lost to Follow-up|73
103756|NCT01023581|386603|P7|Overall Study|Other|0
103757|NCT01023581|386604|P6|Overall Study|Other|0
103758|NCT01023581|386605|P5|Overall Study|Other|1
103759|NCT01023581|386606|P4|Overall Study|Other|0
103760|NCT01023581|386607|P3|Overall Study|Other|1
103761|NCT01023581|386608|P2|Overall Study|Other|0
103762|NCT01023581|386609|P1|Overall Study|Other|1
103763|NCT01023581|386603|P7|Overall Study|Physician Decision|1
103764|NCT01023581|386604|P6|Overall Study|Physician Decision|1
103765|NCT01023581|386605|P5|Overall Study|Physician Decision|1
103766|NCT01023581|386606|P4|Overall Study|Physician Decision|1
103767|NCT01023581|386607|P3|Overall Study|Physician Decision|2
103768|NCT01023581|386608|P2|Overall Study|Physician Decision|0
103769|NCT01023581|386609|P1|Overall Study|Physician Decision|2
103770|NCT01023581|386603|P7|Overall Study|Lack of Efficacy|1
103771|NCT01023581|386604|P6|Overall Study|Lack of Efficacy|2
103772|NCT01023581|386605|P5|Overall Study|Lack of Efficacy|1
103773|NCT01023581|386606|P4|Overall Study|Lack of Efficacy|2
103774|NCT01023581|386607|P3|Overall Study|Lack of Efficacy|6
103775|NCT01023581|386608|P2|Overall Study|Lack of Efficacy|3
103776|NCT01023581|386609|P1|Overall Study|Lack of Efficacy|9
103777|NCT01023581|386603|P7|Overall Study|Pregnancy|0
103778|NCT01023581|386604|P6|Overall Study|Pregnancy|1
103779|NCT01023581|386605|P5|Overall Study|Pregnancy|0
103780|NCT01023581|386606|P4|Overall Study|Pregnancy|2
103781|NCT01023581|386607|P3|Overall Study|Pregnancy|0
103782|NCT01023581|386608|P2|Overall Study|Pregnancy|0
103783|NCT01023581|386609|P1|Overall Study|Pregnancy|0
103784|NCT01023581|386603|P7|Overall Study|Withdrawal by Subject|5
103785|NCT01023581|386604|P6|Overall Study|Withdrawal by Subject|8
103786|NCT01023581|386605|P5|Overall Study|Withdrawal by Subject|6
103787|NCT01023581|386606|P4|Overall Study|Withdrawal by Subject|10
103788|NCT01023581|386607|P3|Overall Study|Withdrawal by Subject|16
103789|NCT01023581|386608|P2|Overall Study|Withdrawal by Subject|8
103790|NCT01023581|386609|P1|Overall Study|Withdrawal by Subject|13
103791|NCT01023581|386603|P7|Overall Study|Lost to Follow-up|2
103792|NCT01023581|386604|P6|Overall Study|Lost to Follow-up|2
103793|NCT01023581|386605|P5|Overall Study|Lost to Follow-up|5
103794|NCT01023581|386606|P4|Overall Study|Lost to Follow-up|2
103795|NCT01023581|386607|P3|Overall Study|Lost to Follow-up|7
103796|NCT01023581|386608|P2|Overall Study|Lost to Follow-up|8
103797|NCT01023581|386609|P1|Overall Study|Lost to Follow-up|4
103798|NCT01023581|386603|P7|Overall Study|Major protocol deviation|0
103799|NCT01023581|386604|P6|Overall Study|Major protocol deviation|0
103800|NCT01023581|386605|P5|Overall Study|Major protocol deviation|0
103801|NCT01023581|386606|P4|Overall Study|Major protocol deviation|0
103802|NCT01023581|386607|P3|Overall Study|Major protocol deviation|3
103803|NCT01023581|386608|P2|Overall Study|Major protocol deviation|0
103804|NCT01023581|386609|P1|Overall Study|Major protocol deviation|2
103805|NCT01023581|386603|P7|Overall Study|Adverse Event|11
103806|NCT01023581|386604|P6|Overall Study|Adverse Event|5
103807|NCT01023581|386605|P5|Overall Study|Adverse Event|2
103808|NCT01023581|386606|P4|Overall Study|Adverse Event|3
103809|NCT01023581|386607|P3|Overall Study|Adverse Event|7
103810|NCT01023581|386608|P2|Overall Study|Adverse Event|4
103811|NCT01023581|386609|P1|Overall Study|Adverse Event|4
103812|NCT01023516|386666|P2|Overall Study|Incorrect enrolment|2
103813|NCT01023516|386667|P1|Overall Study|Incorrect enrolment|4
103814|NCT01023516|386666|P2|Overall Study|Study-specific criteria|2
103815|NCT01023516|386667|P1|Overall Study|Study-specific criteria|4
103816|NCT01023516|386666|P2|Overall Study|Safety reason|3
103817|NCT01023516|386667|P1|Overall Study|Safety reason|0
103818|NCT01023516|386666|P2|Overall Study|Adverse Event|6
103819|NCT01023516|386667|P1|Overall Study|Adverse Event|9
103820|NCT01023516|386666|P2|Overall Study|Voluntary discontinuation|5
103821|NCT01023516|386667|P1|Overall Study|Voluntary discontinuation|7
103822|NCT01023308|386749|P2|Overall Study|Withdrawal by Subject|18
103823|NCT01023308|386750|P1|Overall Study|Withdrawal by Subject|34
103824|NCT01023308|386749|P2|Overall Study|Lost to Follow-up|0
103825|NCT01023308|386750|P1|Overall Study|Lost to Follow-up|1
103826|NCT01023308|386749|P2|Overall Study|Untreated|5
103827|NCT01023308|386750|P1|Overall Study|Untreated|5
103828|NCT01023308|386749|P2|Overall Study|Protocol Violation|4
103829|NCT01023308|386750|P1|Overall Study|Protocol Violation|3
103830|NCT01023308|386749|P2|Overall Study|New Cancer therapy|7
103831|NCT01023308|386750|P1|Overall Study|New Cancer therapy|4
103832|NCT01023308|386749|P2|Overall Study|Disease progression|153
103833|NCT01023308|386750|P1|Overall Study|Disease progression|82
103834|NCT01023308|386749|P2|Overall Study|Death|17
103835|NCT01023308|386750|P1|Overall Study|Death|21
103836|NCT01023308|386749|P2|Overall Study|Adverse Event|66
103837|NCT01023308|386750|P1|Overall Study|Adverse Event|130
103838|NCT01023308|386749|P2|Overall Study|Administrative problems|1
103839|NCT01023308|386750|P1|Overall Study|Administrative problems|2
103840|NCT01023308|386749|P2|Overall Study|Abnormal test proceedure results|8
103841|NCT01023308|386750|P1|Overall Study|Abnormal test proceedure results|3
103842|NCT01023256|386780|P4|Overall Study|Withdrawal by Subject|2
103843|NCT01023256|386781|P3|Overall Study|Withdrawal by Subject|0
103844|NCT01023256|386782|P2|Overall Study|Withdrawal by Subject|0
103845|NCT01023256|386783|P1|Overall Study|Withdrawal by Subject|0
103846|NCT01023256|386780|P4|Overall Study|Adverse Event|1
103847|NCT01023256|386781|P3|Overall Study|Adverse Event|0
103848|NCT01023256|386782|P2|Overall Study|Adverse Event|0
103849|NCT01023256|386783|P1|Overall Study|Adverse Event|0
103850|NCT01023256|386780|P4|Overall Study|Not specified|2
103851|NCT01023256|386781|P3|Overall Study|Not specified|0
103852|NCT01023256|386782|P2|Overall Study|Not specified|0
103853|NCT01023256|386783|P1|Overall Study|Not specified|1
103854|NCT01023256|386780|P4|Overall Study|Randomized but not treated|0
103855|NCT01023256|386781|P3|Overall Study|Randomized but not treated|1
103856|NCT01023256|386782|P2|Overall Study|Randomized but not treated|0
103857|NCT01023256|386783|P1|Overall Study|Randomized but not treated|1
103858|NCT01023256|386780|P4|Overall Study|Protocol Violation|0
103859|NCT01023256|386781|P3|Overall Study|Protocol Violation|0
103860|NCT01023256|386782|P2|Overall Study|Protocol Violation|3
103861|NCT01023256|386783|P1|Overall Study|Protocol Violation|2
103862|NCT01023217|386825|P2|Overall Study|Withdrawal by Subject|0
103863|NCT01023217|386826|P1|Overall Study|Withdrawal by Subject|1
103864|NCT01023061|386864|P1|Overall Study|Withdrawal prior to treatment|2
103865|NCT01023035|386873|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
103866|NCT01023035|386874|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
103867|NCT01023035|386875|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
103868|NCT01023035|386873|P3|Follow-up Period (up to Week 72)|Adverse Event|1
103869|NCT01023035|386874|P2|Follow-up Period (up to Week 72)|Adverse Event|0
103870|NCT01023035|386875|P1|Follow-up Period (up to Week 72)|Adverse Event|2
103871|NCT01023035|386873|P3|Treatment Period|Treatment Failure|24
103872|NCT01023035|386874|P2|Treatment Period|Treatment Failure|31
103873|NCT01023035|386875|P1|Treatment Period|Treatment Failure|26
103874|NCT01023035|386873|P3|Treatment Period|Non-Medical Reasons|44
103875|NCT01023035|386874|P2|Treatment Period|Non-Medical Reasons|22
103876|NCT01023035|386875|P1|Treatment Period|Non-Medical Reasons|19
103877|NCT01023035|386873|P3|Treatment Period|Adverse Event|50
103878|NCT01023035|386874|P2|Treatment Period|Adverse Event|32
103879|NCT01023035|386875|P1|Treatment Period|Adverse Event|27
103880|NCT01023022|386885|P1|Overall Study|due to technical issues|2
103881|NCT01023022|386885|P1|Overall Study|Lost to Follow-up|7
103882|NCT01023022|386885|P1|Overall Study|Death|5
103883|NCT01022996|386891|P1|Overall Study|Protocol Violation|1
103884|NCT01022996|386891|P1|Overall Study|Disease Progression|32
103885|NCT01022996|386891|P1|Overall Study|Administrative problems|6
103886|NCT01022996|386891|P1|Overall Study|Lost to Follow-up|1
103887|NCT01022996|386891|P1|Overall Study|Withdrawal by Subject|3
103888|NCT01022996|386891|P1|Overall Study|Adverse Event|14
103889|NCT01022762|386902|P2|Overall Study|Unclassified|20
103890|NCT01022762|386903|P1|Overall Study|Unclassified|12
103891|NCT01022762|386902|P2|Overall Study|Protocol Violation|6
103892|NCT01022762|386903|P1|Overall Study|Protocol Violation|7
103893|NCT01022762|386902|P2|Overall Study|Lack of Efficacy|1
103894|NCT01022762|386903|P1|Overall Study|Lack of Efficacy|0
103895|NCT01022762|386902|P2|Overall Study|Adverse Event|1
103896|NCT01022762|386903|P1|Overall Study|Adverse Event|3
103897|NCT01022502|386938|P1|Overall Study|Withdrawal by Subject|1
103898|NCT01022502|386938|P1|Overall Study|employment related reasons|1
103899|NCT01022502|386938|P1|Overall Study|Adverse Event|1
103900|NCT01022398|386954|P2|Overall Study|Study terminated|2
103901|NCT01022398|386955|P1|Overall Study|Study terminated|2
103902|NCT01022203|386980|P2|Follow-Up Assessment|Lost to Follow-up|2
103903|NCT01022203|386981|P1|Follow-Up Assessment|Lost to Follow-up|2
103904|NCT01022203|386980|P2|Post Treatment Assessment|Adverse Event|2
103905|NCT01022203|386981|P1|Post Treatment Assessment|Adverse Event|0
103906|NCT01022203|386980|P2|Post Treatment Assessment|Physician Decision|0
103907|NCT01022203|386981|P1|Post Treatment Assessment|Physician Decision|2
103908|NCT01022203|386980|P2|Post Treatment Assessment|Withdrawal by Subject|12
103909|NCT01022203|386981|P1|Post Treatment Assessment|Withdrawal by Subject|12
103910|NCT01022112|387000|P5|Overall Study|Fasting plasma glucose level increased|7
103911|NCT01022112|387001|P4|Overall Study|Fasting plasma glucose level increased|0
103912|NCT01022112|387002|P3|Overall Study|Fasting plasma glucose level increased|0
103913|NCT01022112|387003|P2|Overall Study|Fasting plasma glucose level increased|0
103914|NCT01022112|387004|P1|Overall Study|Fasting plasma glucose level increased|1
103915|NCT01022112|387000|P5|Overall Study|Withdrawal by Subject|1
103916|NCT01022112|387001|P4|Overall Study|Withdrawal by Subject|2
103917|NCT01022112|387002|P3|Overall Study|Withdrawal by Subject|2
103918|NCT01022112|387003|P2|Overall Study|Withdrawal by Subject|1
103919|NCT01022112|387004|P1|Overall Study|Withdrawal by Subject|0
103920|NCT01022112|387000|P5|Overall Study|Physician Decision|1
103921|NCT01022112|387001|P4|Overall Study|Physician Decision|0
103922|NCT01022112|387002|P3|Overall Study|Physician Decision|1
103923|NCT01022112|387003|P2|Overall Study|Physician Decision|0
103924|NCT01022112|387004|P1|Overall Study|Physician Decision|0
103925|NCT01022112|387000|P5|Overall Study|Lack of Efficacy|1
103926|NCT01022112|387001|P4|Overall Study|Lack of Efficacy|0
103927|NCT01022112|387002|P3|Overall Study|Lack of Efficacy|0
103928|NCT01022112|387003|P2|Overall Study|Lack of Efficacy|0
103929|NCT01022112|387004|P1|Overall Study|Lack of Efficacy|1
103930|NCT01022112|387000|P5|Overall Study|Adverse Event|0
103931|NCT01022112|387001|P4|Overall Study|Adverse Event|1
103932|NCT01022112|387002|P3|Overall Study|Adverse Event|0
103933|NCT01022112|387003|P2|Overall Study|Adverse Event|2
103934|NCT01022112|387004|P1|Overall Study|Adverse Event|1
103935|NCT01021878|387027|P2|Overall Study|Transplantation|1
103936|NCT01021878|387028|P1|Overall Study|Transplantation|6
103937|NCT01021878|387027|P2|Overall Study|Adverse Event|5
103938|NCT01021878|387028|P1|Overall Study|Adverse Event|6
103939|NCT01021878|387027|P2|Overall Study|Death|1
103940|NCT01021878|387028|P1|Overall Study|Death|0
103941|NCT01021878|387027|P2|Overall Study|Lost to Follow-up|3
103942|NCT01021878|387028|P1|Overall Study|Lost to Follow-up|4
103943|NCT01021852|387050|P8|Treatment Period 2|Withdrawal by Subject|2
103944|NCT01021852|387051|P7|Treatment Period 2|Withdrawal by Subject|1
103945|NCT01021852|387052|P6|Treatment Period 2|Withdrawal by Subject|0
103946|NCT01021852|387053|P5|Treatment Period 2|Withdrawal by Subject|0
103947|NCT01021852|387054|P4|Treatment Period 2|Withdrawal by Subject|0
103948|NCT01021852|387055|P3|Treatment Period 2|Withdrawal by Subject|0
103949|NCT01021852|387056|P2|Treatment Period 2|Withdrawal by Subject|0
103950|NCT01021852|387057|P1|Treatment Period 2|Withdrawal by Subject|0
103951|NCT01021852|387050|P8|Treatment Period 2|Protocol Violation|0
103952|NCT01021852|387051|P7|Treatment Period 2|Protocol Violation|1
103953|NCT01021852|387052|P6|Treatment Period 2|Protocol Violation|0
103954|NCT01021852|387053|P5|Treatment Period 2|Protocol Violation|1
103955|NCT01021852|387054|P4|Treatment Period 2|Protocol Violation|0
103956|NCT01021852|387055|P3|Treatment Period 2|Protocol Violation|0
103957|NCT01021852|387056|P2|Treatment Period 2|Protocol Violation|0
103958|NCT01021852|387057|P1|Treatment Period 2|Protocol Violation|0
103959|NCT01021852|387050|P8|Treatment Period 2|Physician Decision|0
103960|NCT01021852|387051|P7|Treatment Period 2|Physician Decision|0
103961|NCT01021852|387052|P6|Treatment Period 2|Physician Decision|0
103962|NCT01021852|387053|P5|Treatment Period 2|Physician Decision|0
103963|NCT01021852|387054|P4|Treatment Period 2|Physician Decision|0
103964|NCT01021852|387055|P3|Treatment Period 2|Physician Decision|1
103965|NCT01021852|387056|P2|Treatment Period 2|Physician Decision|0
103966|NCT01021852|387057|P1|Treatment Period 2|Physician Decision|0
103967|NCT01021852|387050|P8|Treatment Period 2|Lack of Efficacy|0
103968|NCT01021852|387051|P7|Treatment Period 2|Lack of Efficacy|0
103969|NCT01021852|387052|P6|Treatment Period 2|Lack of Efficacy|1
103970|NCT01021852|387053|P5|Treatment Period 2|Lack of Efficacy|0
103971|NCT01021852|387054|P4|Treatment Period 2|Lack of Efficacy|0
103972|NCT01021852|387055|P3|Treatment Period 2|Lack of Efficacy|0
103973|NCT01021852|387056|P2|Treatment Period 2|Lack of Efficacy|0
103974|NCT01021852|387057|P1|Treatment Period 2|Lack of Efficacy|0
103975|NCT01021852|387050|P8|Treatment Period 2|Adverse Event|0
103976|NCT01021852|387051|P7|Treatment Period 2|Adverse Event|1
103977|NCT01021852|387052|P6|Treatment Period 2|Adverse Event|0
103978|NCT01021852|387053|P5|Treatment Period 2|Adverse Event|1
103979|NCT01021852|387054|P4|Treatment Period 2|Adverse Event|0
103980|NCT01021852|387055|P3|Treatment Period 2|Adverse Event|0
103981|NCT01021852|387056|P2|Treatment Period 2|Adverse Event|1
103982|NCT01021852|387057|P1|Treatment Period 2|Adverse Event|0
103983|NCT01021852|387050|P8|Washout Period-No Drug|Adverse Event|0
103984|NCT01021852|387051|P7|Washout Period-No Drug|Adverse Event|0
103985|NCT01021852|387052|P6|Washout Period-No Drug|Adverse Event|1
103986|NCT01021852|387053|P5|Washout Period-No Drug|Adverse Event|0
103987|NCT01021852|387054|P4|Washout Period-No Drug|Adverse Event|0
103988|NCT01021852|387055|P3|Washout Period-No Drug|Adverse Event|0
103989|NCT01021852|387056|P2|Washout Period-No Drug|Adverse Event|0
103990|NCT01021852|387057|P1|Washout Period-No Drug|Adverse Event|1
103991|NCT01021852|387050|P8|Washout Period-Placebo|Protocol Violation|0
103992|NCT01021852|387051|P7|Washout Period-Placebo|Protocol Violation|1
103993|NCT01021852|387052|P6|Washout Period-Placebo|Protocol Violation|0
103994|NCT01021852|387053|P5|Washout Period-Placebo|Protocol Violation|0
103995|NCT01021852|387054|P4|Washout Period-Placebo|Protocol Violation|0
103996|NCT01021852|387055|P3|Washout Period-Placebo|Protocol Violation|0
103997|NCT01021852|387056|P2|Washout Period-Placebo|Protocol Violation|0
103998|NCT01021852|387057|P1|Washout Period-Placebo|Protocol Violation|0
103999|NCT01021852|387050|P8|Washout Period-Placebo|Lost to Follow-up|0
104000|NCT01021852|387051|P7|Washout Period-Placebo|Lost to Follow-up|0
104001|NCT01021852|387052|P6|Washout Period-Placebo|Lost to Follow-up|0
104002|NCT01021852|387053|P5|Washout Period-Placebo|Lost to Follow-up|1
104003|NCT01021852|387054|P4|Washout Period-Placebo|Lost to Follow-up|0
104004|NCT01021852|387055|P3|Washout Period-Placebo|Lost to Follow-up|0
104005|NCT01021852|387056|P2|Washout Period-Placebo|Lost to Follow-up|0
104006|NCT01021852|387057|P1|Washout Period-Placebo|Lost to Follow-up|0
104007|NCT01021852|387050|P8|Washout Period-Placebo|Adverse Event|0
104008|NCT01021852|387051|P7|Washout Period-Placebo|Adverse Event|0
104009|NCT01021852|387052|P6|Washout Period-Placebo|Adverse Event|1
104010|NCT01021852|387053|P5|Washout Period-Placebo|Adverse Event|0
104011|NCT01021852|387054|P4|Washout Period-Placebo|Adverse Event|1
104012|NCT01021852|387055|P3|Washout Period-Placebo|Adverse Event|0
104013|NCT01021852|387056|P2|Washout Period-Placebo|Adverse Event|0
104014|NCT01021852|387057|P1|Washout Period-Placebo|Adverse Event|0
104015|NCT01021852|387050|P8|Treatment Period 1|Not Treated|0
104016|NCT01021852|387051|P7|Treatment Period 1|Not Treated|0
104017|NCT01021852|387052|P6|Treatment Period 1|Not Treated|0
104018|NCT01021852|387053|P5|Treatment Period 1|Not Treated|0
104019|NCT01021852|387054|P4|Treatment Period 1|Not Treated|2
104020|NCT01021852|387055|P3|Treatment Period 1|Not Treated|0
104021|NCT01021852|387056|P2|Treatment Period 1|Not Treated|0
104022|NCT01021852|387057|P1|Treatment Period 1|Not Treated|0
104023|NCT01021852|387050|P8|Treatment Period 1|Withdrawal by Subject|1
104024|NCT01021852|387051|P7|Treatment Period 1|Withdrawal by Subject|0
104025|NCT01021852|387052|P6|Treatment Period 1|Withdrawal by Subject|0
104026|NCT01021852|387053|P5|Treatment Period 1|Withdrawal by Subject|1
104027|NCT01021852|387054|P4|Treatment Period 1|Withdrawal by Subject|0
104028|NCT01021852|387055|P3|Treatment Period 1|Withdrawal by Subject|0
104029|NCT01021852|387056|P2|Treatment Period 1|Withdrawal by Subject|0
104030|NCT01021852|387057|P1|Treatment Period 1|Withdrawal by Subject|0
104031|NCT01021852|387050|P8|Treatment Period 1|Pregnancy|0
104032|NCT01021852|387051|P7|Treatment Period 1|Pregnancy|0
104033|NCT01021852|387052|P6|Treatment Period 1|Pregnancy|0
104034|NCT01021852|387053|P5|Treatment Period 1|Pregnancy|0
104035|NCT01021852|387054|P4|Treatment Period 1|Pregnancy|0
104036|NCT01021852|387055|P3|Treatment Period 1|Pregnancy|1
104037|NCT01021852|387056|P2|Treatment Period 1|Pregnancy|0
104038|NCT01021852|387057|P1|Treatment Period 1|Pregnancy|0
104039|NCT01021852|387050|P8|Treatment Period 1|Adverse Event|0
104040|NCT01021852|387051|P7|Treatment Period 1|Adverse Event|0
104041|NCT01021852|387052|P6|Treatment Period 1|Adverse Event|2
104042|NCT01021852|387053|P5|Treatment Period 1|Adverse Event|2
104043|NCT01021852|387054|P4|Treatment Period 1|Adverse Event|0
104044|NCT01021852|387055|P3|Treatment Period 1|Adverse Event|1
104045|NCT01021852|387056|P2|Treatment Period 1|Adverse Event|1
104046|NCT01021852|387057|P1|Treatment Period 1|Adverse Event|3
104047|NCT01021813|387093|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
104048|NCT01021813|387094|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
104049|NCT01021813|387095|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
104050|NCT01021813|387096|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
104051|NCT01021813|387097|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
104052|NCT01021813|387093|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
104053|NCT01021813|387094|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
104054|NCT01021813|387095|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
104055|NCT01021813|387096|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
104056|NCT01021813|387097|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
104057|NCT01021813|387093|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
104058|NCT01021813|387094|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
104059|NCT01021813|387095|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
104060|NCT01021813|387096|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
104061|NCT01021813|387097|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
104062|NCT01021813|387093|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
104063|NCT01021813|387094|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
104064|NCT01021813|387095|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
104065|NCT01021813|387096|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
104066|NCT01021813|387097|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
104067|NCT01021813|387093|P5|DB Randomized Discontinuation Phase|Adverse Event|1
104068|NCT01021813|387094|P4|DB Randomized Discontinuation Phase|Adverse Event|3
104069|NCT01021813|387095|P3|DB Randomized Discontinuation Phase|Adverse Event|0
104070|NCT01021813|387096|P2|DB Randomized Discontinuation Phase|Adverse Event|0
104071|NCT01021813|387097|P1|DB Randomized Discontinuation Phase|Adverse Event|0
104072|NCT01021813|387093|P5|DB Treatment Phase|Withdrawal by Subject|0
104073|NCT01021813|387094|P4|DB Treatment Phase|Withdrawal by Subject|0
104074|NCT01021813|387095|P3|DB Treatment Phase|Withdrawal by Subject|0
104075|NCT01021813|387096|P2|DB Treatment Phase|Withdrawal by Subject|24
104076|NCT01021813|387097|P1|DB Treatment Phase|Withdrawal by Subject|60
104077|NCT01021813|387093|P5|DB Treatment Phase|Protocol Violation|0
104078|NCT01021813|387094|P4|DB Treatment Phase|Protocol Violation|0
104079|NCT01021813|387095|P3|DB Treatment Phase|Protocol Violation|0
104080|NCT01021813|387096|P2|DB Treatment Phase|Protocol Violation|3
104081|NCT01021813|387097|P1|DB Treatment Phase|Protocol Violation|4
104082|NCT01021813|387093|P5|DB Treatment Phase|Pregnancy|0
104083|NCT01021813|387094|P4|DB Treatment Phase|Pregnancy|0
104084|NCT01021813|387095|P3|DB Treatment Phase|Pregnancy|0
104085|NCT01021813|387096|P2|DB Treatment Phase|Pregnancy|0
104086|NCT01021813|387097|P1|DB Treatment Phase|Pregnancy|1
104087|NCT01021813|387093|P5|DB Treatment Phase|Physician Decision|0
104088|NCT01021813|387094|P4|DB Treatment Phase|Physician Decision|0
104089|NCT01021813|387095|P3|DB Treatment Phase|Physician Decision|0
104090|NCT01021813|387096|P2|DB Treatment Phase|Physician Decision|8
104091|NCT01021813|387097|P1|DB Treatment Phase|Physician Decision|17
104092|NCT01021813|387093|P5|DB Treatment Phase|Lost to Follow-up|0
104093|NCT01021813|387094|P4|DB Treatment Phase|Lost to Follow-up|0
104094|NCT01021813|387095|P3|DB Treatment Phase|Lost to Follow-up|0
104095|NCT01021813|387096|P2|DB Treatment Phase|Lost to Follow-up|12
104096|NCT01021813|387097|P1|DB Treatment Phase|Lost to Follow-up|14
104097|NCT01021813|387093|P5|DB Treatment Phase|Lack of Efficacy|0
104098|NCT01021813|387094|P4|DB Treatment Phase|Lack of Efficacy|0
104099|NCT01021813|387095|P3|DB Treatment Phase|Lack of Efficacy|0
104100|NCT01021813|387096|P2|DB Treatment Phase|Lack of Efficacy|28
104101|NCT01021813|387097|P1|DB Treatment Phase|Lack of Efficacy|44
104102|NCT01021813|387093|P5|DB Treatment Phase|Adverse Event|0
104103|NCT01021813|387094|P4|DB Treatment Phase|Adverse Event|0
104104|NCT01021813|387095|P3|DB Treatment Phase|Adverse Event|0
104105|NCT01021813|387096|P2|DB Treatment Phase|Adverse Event|22
104106|NCT01021813|387097|P1|DB Treatment Phase|Adverse Event|60
104107|NCT01021683|387149|P1|Overall Study|Other|8
104108|NCT01021683|387149|P1|Overall Study|Recovery of neutrophil count|51
104109|NCT01021683|387149|P1|Overall Study|Lack of Efficacy|12
104110|NCT01021553|387175|P3|Overall Study|Withdrawal by Subject|0
104111|NCT01021553|387176|P2|Overall Study|Withdrawal by Subject|1
104112|NCT01021553|387177|P1|Overall Study|Withdrawal by Subject|1
104113|NCT01021553|387175|P3|Overall Study|Lost to Follow-up|1
104114|NCT01021553|387176|P2|Overall Study|Lost to Follow-up|0
104115|NCT01021553|387177|P1|Overall Study|Lost to Follow-up|0
104116|NCT01021553|387175|P3|Overall Study|Protocol Violation|2
104117|NCT01021553|387176|P2|Overall Study|Protocol Violation|2
104118|NCT01021553|387177|P1|Overall Study|Protocol Violation|0
104119|NCT01021553|387175|P3|Overall Study|Lack of Efficacy|0
104120|NCT01021553|387176|P2|Overall Study|Lack of Efficacy|2
104121|NCT01021553|387177|P1|Overall Study|Lack of Efficacy|2
104122|NCT01021553|387175|P3|Overall Study|Adverse Event|0
104123|NCT01021553|387176|P2|Overall Study|Adverse Event|0
104124|NCT01021553|387177|P1|Overall Study|Adverse Event|1
104125|NCT01021423|387231|P2|Overall Study|Study terminated|5
104126|NCT01021423|387232|P1|Overall Study|Study terminated|4
104127|NCT01021332|387248|P1|Overall Study|Miscellaneous|3
104128|NCT01021332|387248|P1|Overall Study|Protocol Violation|9
104129|NCT01021332|387248|P1|Overall Study|Lost to Follow-up|4
104130|NCT01021332|387248|P1|Overall Study|Withdrawal of Consent|23
104131|NCT01021332|387248|P1|Overall Study|Lack of Efficacy|19
104132|NCT01021332|387248|P1|Overall Study|Adverse Event|43
104133|NCT01021332|387248|P1|Overall Study|Not fulfilling incl./excl.criteria|5
104134|NCT01021293|387309|P2|Overall Study|Lost to Follow-up|1
104135|NCT01021293|387310|P1|Overall Study|Lost to Follow-up|1
104136|NCT01021293|387309|P2|Overall Study|Migrated/moved from study area|18
104137|NCT01021293|387310|P1|Overall Study|Migrated/moved from study area|6
104138|NCT01021293|387309|P2|Overall Study|Withdrawal by Subject|3
104139|NCT01021293|387310|P1|Overall Study|Withdrawal by Subject|1
104140|NCT01021293|387309|P2|Overall Study|Adverse Event|1
104141|NCT01021293|387310|P1|Overall Study|Adverse Event|2
104142|NCT01021293|387309|P2|Overall Study|Serious Adverse Event|1
104143|NCT01021293|387310|P1|Overall Study|Serious Adverse Event|2
104144|NCT01021215|387329|P2|Overall Study|Lost to Follow-up|0
104145|NCT01021215|387330|P1|Overall Study|Lost to Follow-up|3
104146|NCT01021020|387345|P1|14 Day Washout Period A|Physician Decision|1
104147|NCT01021020|387345|P1|Period I|Withdrawal by Subject|1
104148|NCT01021020|387345|P1|Period I|Protocol Violation|1
104149|NCT01021007|387361|P2|Overall Study|Adverse Event|3
104150|NCT01021007|387362|P1|Overall Study|Adverse Event|1
104151|NCT01021007|387361|P2|Overall Study|Lost to Follow-up|1
104152|NCT01021007|387362|P1|Overall Study|Lost to Follow-up|1
104153|NCT01020981|387374|P2|Overall Study|Participant declined to complete survey|0
104154|NCT01020981|387375|P1|Overall Study|Participant declined to complete survey|2
104155|NCT01020981|387374|P2|Overall Study|Survey returned undeliverable|32
104156|NCT01020981|387375|P1|Overall Study|Survey returned undeliverable|8
104157|NCT01020981|387374|P2|Overall Study|Did not return mailed survey|58
104158|NCT01020981|387375|P1|Overall Study|Did not return mailed survey|74
104159|NCT01020877|387396|P2|Second Intervention|Withdrawal by Subject|0
104160|NCT01020877|387397|P1|Second Intervention|Withdrawal by Subject|1
104161|NCT01020838|387407|P1|Overall Study|Most common: Study ended by sponsor|77
104162|NCT01020838|387407|P1|Overall Study|Lost to Follow-up|6
104163|NCT01020838|387407|P1|Overall Study|Withdrawal by Subject|9
104164|NCT01020838|387407|P1|Overall Study|Adverse Event|1
104165|NCT01020838|387407|P1|Overall Study|Death|90
104166|NCT01020812|387422|P1|Overall Study|Protocol Violation|1
104167|NCT01020812|387422|P1|Overall Study|Withdrawal by Subject|1
104168|NCT01020812|387422|P1|Overall Study|Physician Decision|1
104169|NCT01020799|387432|P3|Overall Study|Lost to Follow-up|2
104170|NCT01020799|387433|P2|Overall Study|Lost to Follow-up|4
104171|NCT01020799|387434|P1|Overall Study|Lost to Follow-up|6
104172|NCT01020799|387432|P3|Overall Study|Withdrawal by Subject|3
104173|NCT01020799|387433|P2|Overall Study|Withdrawal by Subject|2
104174|NCT01020799|387434|P1|Overall Study|Withdrawal by Subject|2
104175|NCT01020799|387432|P3|Overall Study|Protocol Violation|0
104176|NCT01020799|387433|P2|Overall Study|Protocol Violation|2
104177|NCT01020799|387434|P1|Overall Study|Protocol Violation|3
104178|NCT01020799|387432|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
104179|NCT01020799|387433|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
104180|NCT01020799|387434|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
104181|NCT01020799|387432|P3|Overall Study|Adverse Event|2
104182|NCT01020799|387433|P2|Overall Study|Adverse Event|3
104183|NCT01020799|387434|P1|Overall Study|Adverse Event|4
104184|NCT01020786|387457|P1|Maintenance Period|Sponsor Decision|1
104185|NCT01020786|387457|P1|Maintenance Period|Withdrawal by Subject|8
104186|NCT01020786|387457|P1|Maintenance Period|Progressive Disease|43
104187|NCT01020786|387457|P1|Maintenance Period|Adverse Event|8
104188|NCT01020786|387457|P1|Induction Period|Withdrawal by Subject|3
104189|NCT01020786|387457|P1|Induction Period|Investigator Decision|3
104190|NCT01020786|387457|P1|Induction Period|Progressive Disease|31
104191|NCT01020786|387457|P1|Induction Period|Adverse Event|10
104192|NCT01020786|387457|P1|Induction Period|Entry Criteria Not Met|2
104193|NCT01020773|387471|P2|Overall Study|Withdrawal by Subject|3
104194|NCT01020773|387472|P1|Overall Study|Withdrawal by Subject|4
104195|NCT01020747|387478|P1|Overall Study|Withdrawal by Subject|1
104196|NCT01020526|387494|P1|Overall Study|Adverse Event|2
104197|NCT01020526|387494|P1|Overall Study|Lost to Follow-up|1
104198|NCT01020526|387494|P1|Overall Study|Insufficient clinical response|3
104199|NCT01020526|387494|P1|Overall Study|Other reasons|3
104200|NCT01020526|387494|P1|Overall Study|Withdrawal by Subject|5
104201|NCT01020474|387500|P2|Overall Study|Insufficient Clinical Response|3
104202|NCT01020474|387501|P1|Overall Study|Insufficient Clinical Response|0
104203|NCT01020474|387500|P2|Overall Study|Other Reasons|1
104204|NCT01020474|387501|P1|Overall Study|Other Reasons|1
104205|NCT01020474|387500|P2|Overall Study|Withdrawal by Subject|7
104206|NCT01020474|387501|P1|Overall Study|Withdrawal by Subject|5
104207|NCT01020474|387500|P2|Overall Study|Protocol Violation|2
104208|NCT01020474|387501|P1|Overall Study|Protocol Violation|0
104209|NCT01020474|387500|P2|Overall Study|Adverse Event|4
104210|NCT01020474|387501|P1|Overall Study|Adverse Event|4
104211|NCT01020448|387521|P1|Treatment|Lost to Follow-up|2
104212|NCT01020448|387521|P1|Treatment|Lack of Efficacy|8
104213|NCT01020448|387521|P1|Treatment|Disease Progression|2
104214|NCT01020448|387521|P1|Treatment|Consent Withdrawn|3
104215|NCT01020448|387521|P1|Treatment|Adverse Event|11
104216|NCT01020448|387521|P1|Pre-assignment|Does Not Meet Entry Criteria|2
104217|NCT01020448|387521|P1|Pre-assignment|Withdrawal by Subject|5
104218|NCT01020448|387521|P1|Pre-assignment|Adverse Event|6
104219|NCT01020435|387532|P2|Overall Study|Lost to Follow-up|1
104220|NCT01020435|387533|P1|Overall Study|Lost to Follow-up|0
104221|NCT01020305|387541|P1|Overall Study|Adverse Event|2
104222|NCT01020123|387552|P7|Extention Period|Lost to Follow-up|0
104223|NCT01020123|387553|P6|Extention Period|Lost to Follow-up|2
104224|NCT01020123|387554|P5|Extention Period|Lost to Follow-up|0
104225|NCT01020123|387555|P4|Extention Period|Lost to Follow-up|0
104226|NCT01020123|387556|P3|Extention Period|Lost to Follow-up|0
104227|NCT01020123|387557|P2|Extention Period|Lost to Follow-up|0
104228|NCT01020123|387558|P1|Extention Period|Lost to Follow-up|0
104229|NCT01020123|387552|P7|Extention Period|Protocol Violation|1
104230|NCT01020123|387553|P6|Extention Period|Protocol Violation|0
104231|NCT01020123|387554|P5|Extention Period|Protocol Violation|0
104232|NCT01020123|387555|P4|Extention Period|Protocol Violation|0
104233|NCT01020123|387556|P3|Extention Period|Protocol Violation|1
104234|NCT01020123|387557|P2|Extention Period|Protocol Violation|1
104235|NCT01020123|387558|P1|Extention Period|Protocol Violation|1
104236|NCT01020123|387552|P7|Extention Period|Adverse Event|0
104237|NCT01020123|387553|P6|Extention Period|Adverse Event|0
104238|NCT01020123|387554|P5|Extention Period|Adverse Event|0
104239|NCT01020123|387555|P4|Extention Period|Adverse Event|1
104240|NCT01020123|387556|P3|Extention Period|Adverse Event|0
104241|NCT01020123|387557|P2|Extention Period|Adverse Event|0
104242|NCT01020123|387558|P1|Extention Period|Adverse Event|0
104243|NCT01020123|387552|P7|Extention Period|Withdrawal by Subject|0
104244|NCT01020123|387553|P6|Extention Period|Withdrawal by Subject|0
104245|NCT01020123|387554|P5|Extention Period|Withdrawal by Subject|0
104246|NCT01020123|387555|P4|Extention Period|Withdrawal by Subject|0
104247|NCT01020123|387556|P3|Extention Period|Withdrawal by Subject|1
104248|NCT01020123|387557|P2|Extention Period|Withdrawal by Subject|1
104249|NCT01020123|387558|P1|Extention Period|Withdrawal by Subject|2
104250|NCT01020123|387552|P7|Main Period|Unclasified|6
104251|NCT01020123|387553|P6|Main Period|Unclasified|3
104252|NCT01020123|387554|P5|Main Period|Unclasified|1
104253|NCT01020123|387555|P4|Main Period|Unclasified|0
104254|NCT01020123|387556|P3|Main Period|Unclasified|1
104255|NCT01020123|387557|P2|Main Period|Unclasified|0
104256|NCT01020123|387558|P1|Main Period|Unclasified|2
104257|NCT01020123|387552|P7|Main Period|Lost to Follow-up|0
104258|NCT01020123|387553|P6|Main Period|Lost to Follow-up|0
104259|NCT01020123|387554|P5|Main Period|Lost to Follow-up|0
104260|NCT01020123|387555|P4|Main Period|Lost to Follow-up|0
104261|NCT01020123|387556|P3|Main Period|Lost to Follow-up|0
104262|NCT01020123|387557|P2|Main Period|Lost to Follow-up|2
104263|NCT01020123|387558|P1|Main Period|Lost to Follow-up|0
104264|NCT01020123|387552|P7|Main Period|Protocol Violation|2
104265|NCT01020123|387553|P6|Main Period|Protocol Violation|3
104266|NCT01020123|387554|P5|Main Period|Protocol Violation|2
104267|NCT01020123|387555|P4|Main Period|Protocol Violation|5
104268|NCT01020123|387556|P3|Main Period|Protocol Violation|2
104269|NCT01020123|387557|P2|Main Period|Protocol Violation|4
104270|NCT01020123|387558|P1|Main Period|Protocol Violation|4
104271|NCT01020123|387552|P7|Main Period|Adverse Event|1
104272|NCT01020123|387553|P6|Main Period|Adverse Event|2
104273|NCT01020123|387554|P5|Main Period|Adverse Event|1
104274|NCT01020123|387555|P4|Main Period|Adverse Event|1
104275|NCT01020123|387556|P3|Main Period|Adverse Event|2
104276|NCT01020123|387557|P2|Main Period|Adverse Event|2
104277|NCT01020123|387558|P1|Main Period|Adverse Event|5
104278|NCT01020123|387552|P7|Main Period|Eligibility Criteria not fullfilled|0
104279|NCT01020123|387553|P6|Main Period|Eligibility Criteria not fullfilled|0
104280|NCT01020123|387554|P5|Main Period|Eligibility Criteria not fullfilled|1
104281|NCT01020123|387555|P4|Main Period|Eligibility Criteria not fullfilled|0
104282|NCT01020123|387556|P3|Main Period|Eligibility Criteria not fullfilled|0
104283|NCT01020123|387557|P2|Main Period|Eligibility Criteria not fullfilled|1
104284|NCT01020123|387558|P1|Main Period|Eligibility Criteria not fullfilled|0
104285|NCT01020123|387552|P7|Main Period|Withdrawal by Subject|2
104286|NCT01020123|387553|P6|Main Period|Withdrawal by Subject|3
104287|NCT01020123|387554|P5|Main Period|Withdrawal by Subject|6
104288|NCT01020123|387555|P4|Main Period|Withdrawal by Subject|1
104289|NCT01020123|387556|P3|Main Period|Withdrawal by Subject|3
104290|NCT01020123|387557|P2|Main Period|Withdrawal by Subject|5
104291|NCT01020123|387558|P1|Main Period|Withdrawal by Subject|6
104292|NCT01020019|387753|P2|Overall Study|moving|2
104293|NCT01020019|387754|P1|Overall Study|moving|0
104294|NCT01020019|387753|P2|Overall Study|not interested in treatment|4
104295|NCT01020019|387754|P1|Overall Study|not interested in treatment|4
104296|NCT01020019|387753|P2|Overall Study|Adverse Event|5
104297|NCT01020019|387754|P1|Overall Study|Adverse Event|1
104298|NCT01020019|387753|P2|Overall Study|Lost to Follow-up|18
104299|NCT01020019|387754|P1|Overall Study|Lost to Follow-up|21
104300|NCT01019980|387775|P2|Overall Study|Drug not available.|0
104301|NCT01019980|387776|P1|Overall Study|Drug not available.|2
104302|NCT01019694|387839|P3|Overall Study|Other reason (not specified)|6
104303|NCT01019694|387840|P2|Overall Study|Other reason (not specified)|5
104304|NCT01019694|387841|P1|Overall Study|Other reason (not specified)|1
104305|NCT01019694|387839|P3|Overall Study|Not treated|3
104306|NCT01019694|387840|P2|Overall Study|Not treated|2
104307|NCT01019694|387841|P1|Overall Study|Not treated|0
104308|NCT01019694|387839|P3|Overall Study|Withdrawal by Subject|12
104309|NCT01019694|387840|P2|Overall Study|Withdrawal by Subject|6
104310|NCT01019694|387841|P1|Overall Study|Withdrawal by Subject|4
104311|NCT01019694|387839|P3|Overall Study|Lost to Follow-up|3
104312|NCT01019694|387840|P2|Overall Study|Lost to Follow-up|3
104313|NCT01019694|387841|P1|Overall Study|Lost to Follow-up|5
104314|NCT01019694|387839|P3|Overall Study|Protocol Violation|4
104315|NCT01019694|387840|P2|Overall Study|Protocol Violation|6
104316|NCT01019694|387841|P1|Overall Study|Protocol Violation|2
104317|NCT01019694|387839|P3|Overall Study|Adverse Event|19
104318|NCT01019694|387840|P2|Overall Study|Adverse Event|16
104319|NCT01019694|387841|P1|Overall Study|Adverse Event|12
104320|NCT01019486|387966|P3|Overall Study|Withdrawal by Subject|1
104321|NCT01019486|387967|P2|Overall Study|Withdrawal by Subject|1
104322|NCT01019486|387968|P1|Overall Study|Withdrawal by Subject|1
104323|NCT01019369|387982|P2|Overall Study|Withdrawal by Subject|1
104324|NCT01019369|387983|P1|Overall Study|Withdrawal by Subject|0
104325|NCT01019369|387982|P2|Overall Study|Lost to Follow-up|6
104326|NCT01019369|387983|P1|Overall Study|Lost to Follow-up|10
104327|NCT01019317|387989|P1|Overall Study|Not Eligible|4
104328|NCT01019135|387996|P3|Overall Study|Did not attend CR|6
104329|NCT01019135|387997|P2|Overall Study|Did not attend CR|13
104330|NCT01019135|387998|P1|Overall Study|Did not attend CR|8
104331|NCT01019135|387996|P3|Overall Study|Did not receive allocated intervention|25
104332|NCT01019135|387997|P2|Overall Study|Did not receive allocated intervention|6
104333|NCT01019135|387998|P1|Overall Study|Did not receive allocated intervention|12
104334|NCT01018992|388026|P2|Overall Study|Lost to Follow-up|1
104335|NCT01018992|388027|P1|Overall Study|Lost to Follow-up|5
104336|NCT01018992|388026|P2|Overall Study|Protocol Violation|4
104337|NCT01018992|388027|P1|Overall Study|Protocol Violation|0
104338|NCT01018992|388026|P2|Overall Study|Withdrawal by Subject|8
104339|NCT01018992|388027|P1|Overall Study|Withdrawal by Subject|3
104340|NCT01018992|388026|P2|Overall Study|Adverse Event|3
104341|NCT01018992|388027|P1|Overall Study|Adverse Event|8
104342|NCT01018979|388041|P2|Overall Study|Not received at least one dose|1
104343|NCT01018979|388042|P1|Overall Study|Not received at least one dose|0
104344|NCT01018979|388041|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
104345|NCT01018979|388042|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
104346|NCT01018953|388072|P1|Overall Study|Study termination by sponsor|5
104347|NCT01018953|388072|P1|Overall Study|Withdrawal by Subject|1
104348|NCT01018953|388072|P1|Overall Study|Adverse Event|2
104349|NCT01018862|388085|P3|Overall Study|administrative problems|4
104350|NCT01018862|388086|P2|Overall Study|administrative problems|4
104351|NCT01018862|388087|P1|Overall Study|administrative problems|5
104352|NCT01018862|388085|P3|Overall Study|Withdrawal by Subject|1
104353|NCT01018862|388086|P2|Overall Study|Withdrawal by Subject|2
104354|NCT01018862|388087|P1|Overall Study|Withdrawal by Subject|1
104355|NCT01018862|388085|P3|Overall Study|Protocol Violation|3
104356|NCT01018862|388086|P2|Overall Study|Protocol Violation|3
104357|NCT01018862|388087|P1|Overall Study|Protocol Violation|1
104358|NCT01018862|388085|P3|Overall Study|Lost to Follow-up|0
104359|NCT01018862|388086|P2|Overall Study|Lost to Follow-up|1
104360|NCT01018862|388087|P1|Overall Study|Lost to Follow-up|3
104361|NCT01018862|388085|P3|Overall Study|Lack of Efficacy|2
104362|NCT01018862|388086|P2|Overall Study|Lack of Efficacy|0
104363|NCT01018862|388087|P1|Overall Study|Lack of Efficacy|1
104364|NCT01018862|388085|P3|Overall Study|Adverse Event|6
104365|NCT01018862|388086|P2|Overall Study|Adverse Event|0
104366|NCT01018862|388087|P1|Overall Study|Adverse Event|2
104367|NCT01018810|388109|P5|Overall Study|Sponsor Decision|1
104368|NCT01018810|388110|P4|Overall Study|Sponsor Decision|1
104369|NCT01018810|388111|P3|Overall Study|Sponsor Decision|1
104370|NCT01018810|388112|P2|Overall Study|Sponsor Decision|0
104371|NCT01018810|388113|P1|Overall Study|Sponsor Decision|2
104372|NCT01018810|388109|P5|Overall Study|Withdrawal by Subject|0
104373|NCT01018810|388110|P4|Overall Study|Withdrawal by Subject|0
104374|NCT01018810|388111|P3|Overall Study|Withdrawal by Subject|0
104375|NCT01018810|388112|P2|Overall Study|Withdrawal by Subject|1
104376|NCT01018810|388113|P1|Overall Study|Withdrawal by Subject|0
104377|NCT01018732|388173|P3|Overall Study|Unable to Classify|1
104378|NCT01018732|388174|P2|Overall Study|Unable to Classify|0
104379|NCT01018732|388175|P1|Overall Study|Unable to Classify|0
104380|NCT01018732|388173|P3|Overall Study|Inappropriate Enrollment|0
104381|NCT01018732|388174|P2|Overall Study|Inappropriate Enrollment|1
104382|NCT01018732|388175|P1|Overall Study|Inappropriate Enrollment|0
104383|NCT01018732|388173|P3|Overall Study|Protocol Violation|0
104384|NCT01018732|388174|P2|Overall Study|Protocol Violation|1
104385|NCT01018732|388175|P1|Overall Study|Protocol Violation|1
104386|NCT01018732|388173|P3|Overall Study|Lost to Follow-up|3
104387|NCT01018732|388174|P2|Overall Study|Lost to Follow-up|0
104388|NCT01018732|388175|P1|Overall Study|Lost to Follow-up|0
104389|NCT01018680|388209|P2|Overall Study|Physician Decision|1
104390|NCT01018680|388210|P1|Overall Study|Physician Decision|3
104391|NCT01018680|388209|P2|Overall Study|Entry Criteria Not Met|4
104392|NCT01018680|388210|P1|Overall Study|Entry Criteria Not Met|1
104393|NCT01018680|388209|P2|Overall Study|Lost to Follow-up|3
104394|NCT01018680|388210|P1|Overall Study|Lost to Follow-up|5
104395|NCT01018680|388209|P2|Overall Study|Lack of Efficacy|2
104396|NCT01018680|388210|P1|Overall Study|Lack of Efficacy|8
104397|NCT01018680|388209|P2|Overall Study|Sponsor Decision|7
104398|NCT01018680|388210|P1|Overall Study|Sponsor Decision|6
104399|NCT01018680|388209|P2|Overall Study|Protocol Violation|8
104400|NCT01018680|388210|P1|Overall Study|Protocol Violation|5
104401|NCT01018680|388209|P2|Overall Study|Withdrawal by Subject|10
104402|NCT01018680|388210|P1|Overall Study|Withdrawal by Subject|10
104403|NCT01018680|388209|P2|Overall Study|Adverse Event|40
104404|NCT01018680|388210|P1|Overall Study|Adverse Event|23
104405|NCT01020487|388253|P3|Part 2 Open-label Period|Adverse Event|1
104406|NCT01020487|388254|P2|Part 2 Open-label Period|Adverse Event|4
104407|NCT01020487|388255|P1|Part 2 Open-label Period|Adverse Event|0
104408|NCT01020487|388253|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
104409|NCT01020487|388254|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
104410|NCT01020487|388255|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
104411|NCT01020487|388253|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
104412|NCT01020487|388254|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
104413|NCT01020487|388255|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
104414|NCT01020487|388253|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
104415|NCT01020487|388254|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
104416|NCT01020487|388255|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
104417|NCT01020487|388253|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
104418|NCT01020487|388254|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
104419|NCT01020487|388255|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
104420|NCT01018511|388280|P4|Overall Study|Miscellaneous|0
104421|NCT01018511|388281|P3|Overall Study|Miscellaneous|0
104422|NCT01018511|388282|P2|Overall Study|Miscellaneous|2
104423|NCT01018511|388283|P1|Overall Study|Miscellaneous|0
104424|NCT01018511|388280|P4|Overall Study|Protocol Violation|9
104425|NCT01018511|388281|P3|Overall Study|Protocol Violation|7
104426|NCT01018511|388282|P2|Overall Study|Protocol Violation|8
104427|NCT01018511|388283|P1|Overall Study|Protocol Violation|5
104428|NCT01018511|388280|P4|Overall Study|Lost to Follow-up|0
104429|NCT01018511|388281|P3|Overall Study|Lost to Follow-up|1
104430|NCT01018511|388282|P2|Overall Study|Lost to Follow-up|0
104431|NCT01018511|388283|P1|Overall Study|Lost to Follow-up|0
104432|NCT01018511|388280|P4|Overall Study|Withdrawal by Subject|9
104433|NCT01018511|388281|P3|Overall Study|Withdrawal by Subject|11
104434|NCT01018511|388282|P2|Overall Study|Withdrawal by Subject|5
104435|NCT01018511|388283|P1|Overall Study|Withdrawal by Subject|6
104436|NCT01018511|388280|P4|Overall Study|Lack of Efficacy|2
104437|NCT01018511|388281|P3|Overall Study|Lack of Efficacy|1
104438|NCT01018511|388282|P2|Overall Study|Lack of Efficacy|1
104439|NCT01018511|388283|P1|Overall Study|Lack of Efficacy|4
104440|NCT01018511|388280|P4|Overall Study|Adverse Event|10
104441|NCT01018511|388281|P3|Overall Study|Adverse Event|13
104442|NCT01018511|388282|P2|Overall Study|Adverse Event|9
104443|NCT01018511|388283|P1|Overall Study|Adverse Event|5
104444|NCT01018511|388280|P4|Overall Study|Not fulfilling eligibility criteria|3
104445|NCT01018511|388281|P3|Overall Study|Not fulfilling eligibility criteria|7
104446|NCT01018511|388282|P2|Overall Study|Not fulfilling eligibility criteria|7
104447|NCT01018511|388283|P1|Overall Study|Not fulfilling eligibility criteria|6
104448|NCT01018394|388480|P2|Overall Study|Lost to Follow-up|3
104449|NCT01018394|388481|P1|Overall Study|Lost to Follow-up|4
104450|NCT01018394|388480|P2|Overall Study|Withdrawal by Subject|5
104451|NCT01018394|388481|P1|Overall Study|Withdrawal by Subject|5
104452|NCT01018264|388491|P2|Overall Study|Lost to Follow-up|1
104453|NCT01018264|388492|P1|Overall Study|Lost to Follow-up|0
104454|NCT01018264|388491|P2|Overall Study|Withdrawal by Subject|0
104455|NCT01018264|388492|P1|Overall Study|Withdrawal by Subject|1
104456|NCT01018186|388509|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
104457|NCT01018186|388510|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
104458|NCT01018186|388511|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
104459|NCT01018186|388512|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
104460|NCT01018186|388509|P4|52-week Double-blind Treatment Period|Physician Decision|3
104461|NCT01018186|388510|P3|52-week Double-blind Treatment Period|Physician Decision|0
104462|NCT01018186|388511|P2|52-week Double-blind Treatment Period|Physician Decision|1
104463|NCT01018186|388512|P1|52-week Double-blind Treatment Period|Physician Decision|0
104464|NCT01018186|388509|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
104465|NCT01018186|388510|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
104466|NCT01018186|388511|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
104467|NCT01018186|388512|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
104468|NCT01018186|388509|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
104469|NCT01018186|388510|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
104470|NCT01018186|388511|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
104471|NCT01018186|388512|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
104472|NCT01018186|388509|P4|52-week Double-blind Treatment Period|Protocol Violation|2
104473|NCT01018186|388510|P3|52-week Double-blind Treatment Period|Protocol Violation|8
104474|NCT01018186|388511|P2|52-week Double-blind Treatment Period|Protocol Violation|8
104475|NCT01018186|388512|P1|52-week Double-blind Treatment Period|Protocol Violation|0
104476|NCT01018186|388509|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
104477|NCT01018186|388510|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
104478|NCT01018186|388511|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
104479|NCT01018186|388512|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
104480|NCT01018186|388509|P4|52-week Double-blind Treatment Period|Adverse Event|6
104481|NCT01018186|388510|P3|52-week Double-blind Treatment Period|Adverse Event|3
104482|NCT01018186|388511|P2|52-week Double-blind Treatment Period|Adverse Event|5
104483|NCT01018186|388512|P1|52-week Double-blind Treatment Period|Adverse Event|0
104484|NCT01018186|388509|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
104485|NCT01018186|388510|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
104486|NCT01018186|388511|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
104487|NCT01018186|388512|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
104488|NCT01018186|388509|P4|2-week Run-in Period|Withdrawal by Subject|0
104489|NCT01018186|388510|P3|2-week Run-in Period|Withdrawal by Subject|0
104490|NCT01018186|388511|P2|2-week Run-in Period|Withdrawal by Subject|0
104491|NCT01018186|388512|P1|2-week Run-in Period|Withdrawal by Subject|11
104492|NCT01018186|388509|P4|2-week Run-in Period|Physician Decision|0
104493|NCT01018186|388510|P3|2-week Run-in Period|Physician Decision|0
104494|NCT01018186|388511|P2|2-week Run-in Period|Physician Decision|0
104495|NCT01018186|388512|P1|2-week Run-in Period|Physician Decision|3
104496|NCT01018186|388509|P4|2-week Run-in Period|Lost to Follow-up|0
104497|NCT01018186|388510|P3|2-week Run-in Period|Lost to Follow-up|0
104498|NCT01018186|388511|P2|2-week Run-in Period|Lost to Follow-up|0
104499|NCT01018186|388512|P1|2-week Run-in Period|Lost to Follow-up|2
104500|NCT01018186|388509|P4|2-week Run-in Period|Protocol Violation|0
104501|NCT01018186|388510|P3|2-week Run-in Period|Protocol Violation|0
104502|NCT01018186|388511|P2|2-week Run-in Period|Protocol Violation|0
104503|NCT01018186|388512|P1|2-week Run-in Period|Protocol Violation|1
104504|NCT01018030|388713|P3|Overall Study|Did Not Receive Study Drug|0
104505|NCT01018030|388714|P2|Overall Study|Did Not Receive Study Drug|3
104506|NCT01018030|388715|P1|Overall Study|Did Not Receive Study Drug|1
104507|NCT01018030|388713|P3|Overall Study|Lack of Efficacy|0
104508|NCT01018030|388714|P2|Overall Study|Lack of Efficacy|0
104509|NCT01018030|388715|P1|Overall Study|Lack of Efficacy|1
104510|NCT01018030|388713|P3|Overall Study|Physician Decision|1
104511|NCT01018030|388714|P2|Overall Study|Physician Decision|0
104512|NCT01018030|388715|P1|Overall Study|Physician Decision|1
104513|NCT01018030|388713|P3|Overall Study|Protocol Violation|0
104514|NCT01018030|388714|P2|Overall Study|Protocol Violation|1
104515|NCT01018030|388715|P1|Overall Study|Protocol Violation|2
104516|NCT01018030|388713|P3|Overall Study|Lost to Follow-up|3
104517|NCT01018030|388714|P2|Overall Study|Lost to Follow-up|0
104518|NCT01018030|388715|P1|Overall Study|Lost to Follow-up|2
104519|NCT01018030|388713|P3|Overall Study|Withdrawal by Subject|4
104520|NCT01018030|388714|P2|Overall Study|Withdrawal by Subject|2
104521|NCT01018030|388715|P1|Overall Study|Withdrawal by Subject|2
104522|NCT01018030|388713|P3|Overall Study|Adverse Event|5
104523|NCT01018030|388714|P2|Overall Study|Adverse Event|5
104524|NCT01018030|388715|P1|Overall Study|Adverse Event|10
104525|NCT01017952|388766|P5|52-week, Double-blind Treatment Period|Physician Decision|7
104526|NCT01017952|388767|P4|52-week, Double-blind Treatment Period|Physician Decision|9
104527|NCT01017952|388768|P3|52-week, Double-blind Treatment Period|Physician Decision|8
104528|NCT01017952|388769|P2|52-week, Double-blind Treatment Period|Physician Decision|10
104529|NCT01017952|388770|P1|52-week, Double-blind Treatment Period|Physician Decision|0
104530|NCT01017952|388766|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
104531|NCT01017952|388767|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
104532|NCT01017952|388768|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
104533|NCT01017952|388769|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
104534|NCT01017952|388770|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
104535|NCT01017952|388766|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
104536|NCT01017952|388767|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
104537|NCT01017952|388768|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
104538|NCT01017952|388769|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
104539|NCT01017952|388770|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
104540|NCT01017952|388766|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
104541|NCT01017952|388767|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
104542|NCT01017952|388768|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
104543|NCT01017952|388769|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
104544|NCT01017952|388770|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
104545|NCT01017952|388766|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
104546|NCT01017952|388767|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
104547|NCT01017952|388768|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
104548|NCT01017952|388769|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
104549|NCT01017952|388770|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
104550|NCT01017952|388766|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
104551|NCT01017952|388767|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
104552|NCT01017952|388768|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
104553|NCT01017952|388769|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
104554|NCT01017952|388770|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
104555|NCT01017952|388766|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
104556|NCT01017952|388767|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
104557|NCT01017952|388768|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
104558|NCT01017952|388769|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
104559|NCT01017952|388770|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
104560|NCT01017952|388766|P5|52-week, Double-blind Treatment Period|Adverse Event|30
104561|NCT01017952|388767|P4|52-week, Double-blind Treatment Period|Adverse Event|35
104562|NCT01017952|388768|P3|52-week, Double-blind Treatment Period|Adverse Event|32
104563|NCT01017952|388769|P2|52-week, Double-blind Treatment Period|Adverse Event|25
104564|NCT01017952|388770|P1|52-week, Double-blind Treatment Period|Adverse Event|0
104565|NCT01017952|388766|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
104566|NCT01017952|388767|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
104567|NCT01017952|388768|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
104568|NCT01017952|388769|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
104569|NCT01017952|388770|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
104570|NCT01017952|388766|P5|4-week, Open-label Run-In Period|Physician Decision|0
104571|NCT01017952|388767|P4|4-week, Open-label Run-In Period|Physician Decision|0
104572|NCT01017952|388768|P3|4-week, Open-label Run-In Period|Physician Decision|0
104573|NCT01017952|388769|P2|4-week, Open-label Run-In Period|Physician Decision|0
104574|NCT01017952|388770|P1|4-week, Open-label Run-In Period|Physician Decision|10
104575|NCT01017952|388766|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
104576|NCT01017952|388767|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
104577|NCT01017952|388768|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
104578|NCT01017952|388769|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
104579|NCT01017952|388770|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
104580|NCT01017952|388766|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
104581|NCT01017952|388767|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
104582|NCT01017952|388768|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
104583|NCT01017952|388769|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
104584|NCT01017952|388770|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
104585|NCT01017952|388766|P5|4-week, Open-label Run-In Period|Adverse Event|0
104586|NCT01017952|388767|P4|4-week, Open-label Run-In Period|Adverse Event|0
104587|NCT01017952|388768|P3|4-week, Open-label Run-In Period|Adverse Event|0
104588|NCT01017952|388769|P2|4-week, Open-label Run-In Period|Adverse Event|0
104589|NCT01017952|388770|P1|4-week, Open-label Run-In Period|Adverse Event|23
104590|NCT01017952|388766|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
104591|NCT01017952|388767|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
104592|NCT01017952|388768|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
104593|NCT01017952|388769|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
104594|NCT01017952|388770|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
104595|NCT01017874|388794|P2|Overall Study|Physician Decision|3
104596|NCT01017874|388795|P1|Overall Study|Physician Decision|1
104597|NCT01017874|388794|P2|Overall Study|Lost to Follow-up|2
104598|NCT01017874|388795|P1|Overall Study|Lost to Follow-up|3
104599|NCT01017874|388794|P2|Overall Study|Sponsor decision|1
104600|NCT01017874|388795|P1|Overall Study|Sponsor decision|3
104601|NCT01017874|388794|P2|Overall Study|Withdrawal by Subject|20
104602|NCT01017874|388795|P1|Overall Study|Withdrawal by Subject|23
104603|NCT01017731|388813|P1|Overall Study|Adverse Event|1
104604|NCT01017731|388813|P1|Overall Study|Physician Decision|2
104605|NCT01017731|388813|P1|Overall Study|Withdrawal by Subject|3
104606|NCT01017731|388813|P1|Overall Study|Lost to Follow-up|2
104607|NCT01017601|388842|P2|Overall Study|Withdrawal by Subject|1
104608|NCT01017601|388843|P1|Overall Study|Withdrawal by Subject|0
104609|NCT01017601|388842|P2|Overall Study|Disease Progression|12
104610|NCT01017601|388843|P1|Overall Study|Disease Progression|12
104611|NCT01017575|388870|P5|Overall Study|Withdrawal by Subject|0
104612|NCT01017575|388871|P4|Overall Study|Withdrawal by Subject|0
104613|NCT01017575|388872|P3|Overall Study|Withdrawal by Subject|0
104614|NCT01017575|388873|P2|Overall Study|Withdrawal by Subject|0
104615|NCT01017575|388874|P1|Overall Study|Withdrawal by Subject|1
104616|NCT01017575|388870|P5|Overall Study|Adverse Event|2
104617|NCT01017575|388871|P4|Overall Study|Adverse Event|0
104618|NCT01017575|388872|P3|Overall Study|Adverse Event|0
104619|NCT01017575|388873|P2|Overall Study|Adverse Event|1
104620|NCT01017575|388874|P1|Overall Study|Adverse Event|0
104621|NCT01017575|388870|P5|Overall Study|Lack of Efficacy|1
104622|NCT01017575|388871|P4|Overall Study|Lack of Efficacy|1
104623|NCT01017575|388872|P3|Overall Study|Lack of Efficacy|0
104624|NCT01017575|388873|P2|Overall Study|Lack of Efficacy|1
104625|NCT01017575|388874|P1|Overall Study|Lack of Efficacy|0
104626|NCT01017549|388911|P1|One-year Follow-up|Withdrawal by Subject|5
104627|NCT01017549|388911|P1|One-year Follow-up|Lost to Follow-up|2
104628|NCT01017549|388911|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
104629|NCT01017263|388942|P1|Overall Study|not eligible|12
104630|NCT01017146|389023|P2|Overall Study|Change in Work Situation|0
104631|NCT01017146|389024|P1|Overall Study|Change in Work Situation|1
104632|NCT01017146|389023|P2|Overall Study|Did Not Meet Eligibility Criteria|2
104633|NCT01017146|389024|P1|Overall Study|Did Not Meet Eligibility Criteria|1
104634|NCT01017146|389023|P2|Overall Study|Took Excluded Medication|0
104635|NCT01017146|389024|P1|Overall Study|Took Excluded Medication|2
104636|NCT01017146|389023|P2|Overall Study|Protocol Violation|0
104637|NCT01017146|389024|P1|Overall Study|Protocol Violation|2
104638|NCT01017146|389023|P2|Overall Study|Pregnancy|1
104639|NCT01017146|389024|P1|Overall Study|Pregnancy|2
104640|NCT01017146|389023|P2|Overall Study|Relocation|4
104641|NCT01017146|389024|P1|Overall Study|Relocation|0
104642|NCT01017146|389023|P2|Overall Study|Withdrawal by Subject|16
104643|NCT01017146|389024|P1|Overall Study|Withdrawal by Subject|32
104644|NCT01017146|389023|P2|Overall Study|Noncompliance with Study Product|1
104645|NCT01017146|389024|P1|Overall Study|Noncompliance with Study Product|1
104646|NCT01017146|389023|P2|Overall Study|Lost to Follow-up|14
104647|NCT01017146|389024|P1|Overall Study|Lost to Follow-up|14
104648|NCT01017146|389023|P2|Overall Study|Adverse Event|1
104649|NCT01017146|389024|P1|Overall Study|Adverse Event|11
104650|NCT01017120|389062|P2|Overall Study|Parent Unable to Provide Transportation|0
104651|NCT01017120|389063|P1|Overall Study|Parent Unable to Provide Transportation|1
104652|NCT01017120|389062|P2|Overall Study|Protocol Violation|0
104653|NCT01017120|389063|P1|Overall Study|Protocol Violation|1
104654|NCT01017120|389062|P2|Overall Study|Relocated Out of Town|2
104655|NCT01017120|389063|P1|Overall Study|Relocated Out of Town|0
104656|NCT01017120|389062|P2|Overall Study|Did Not Meet Eligibility Criteria|0
104657|NCT01017120|389063|P1|Overall Study|Did Not Meet Eligibility Criteria|1
104658|NCT01017120|389062|P2|Overall Study|Pregnancy|1
104659|NCT01017120|389063|P1|Overall Study|Pregnancy|1
104660|NCT01017120|389062|P2|Overall Study|Withdrawal by Subject|21
104661|NCT01017120|389063|P1|Overall Study|Withdrawal by Subject|39
104662|NCT01017120|389062|P2|Overall Study|Lack of Efficacy|0
104663|NCT01017120|389063|P1|Overall Study|Lack of Efficacy|1
104664|NCT01017120|389062|P2|Overall Study|Lost to Follow-up|11
104665|NCT01017120|389063|P1|Overall Study|Lost to Follow-up|13
104666|NCT01017120|389062|P2|Overall Study|Adverse Event|0
104667|NCT01017120|389063|P1|Overall Study|Adverse Event|9
104668|NCT01017029|389124|P2|Overall Study|Death|1
104669|NCT01017029|389125|P1|Overall Study|Death|3
104670|NCT01017029|389124|P2|Overall Study|Administrative problem|1
104671|NCT01017029|389125|P1|Overall Study|Administrative problem|0
104672|NCT01017029|389124|P2|Overall Study|Lost to Follow-up|0
104673|NCT01017029|389125|P1|Overall Study|Lost to Follow-up|1
104674|NCT01016977|389153|P2|Overall Study|Withdrawal by Subject|2
104675|NCT01016977|389154|P1|Overall Study|Withdrawal by Subject|2
104676|NCT01016977|389153|P2|Overall Study|Lost to Follow-up|0
104677|NCT01016977|389154|P1|Overall Study|Lost to Follow-up|1
104678|NCT01016964|389190|P2|Overall Study|Lost to Follow-up|3
104679|NCT01016964|389191|P1|Overall Study|Lost to Follow-up|3
104680|NCT01016912|389207|P5|Follow-up Period|Other reason|0
104681|NCT01016912|389208|P4|Follow-up Period|Other reason|1
104682|NCT01016912|389209|P3|Follow-up Period|Other reason|1
104683|NCT01016912|389210|P2|Follow-up Period|Other reason|0
104684|NCT01016912|389211|P1|Follow-up Period|Other reason|0
104685|NCT01016912|389207|P5|End of Treatment Period|Completed double-blind period only|0
104686|NCT01016912|389208|P4|End of Treatment Period|Completed double-blind period only|0
104687|NCT01016912|389209|P3|End of Treatment Period|Completed double-blind period only|0
104688|NCT01016912|389210|P2|End of Treatment Period|Completed double-blind period only|1
104689|NCT01016912|389211|P1|End of Treatment Period|Completed double-blind period only|0
104690|NCT01016912|389207|P5|End of Treatment Period|Adverse Event|0
104691|NCT01016912|389208|P4|End of Treatment Period|Adverse Event|0
104692|NCT01016912|389209|P3|End of Treatment Period|Adverse Event|1
104693|NCT01016912|389210|P2|End of Treatment Period|Adverse Event|1
104694|NCT01016912|389211|P1|End of Treatment Period|Adverse Event|0
104695|NCT01016912|389207|P5|End of Treatment Period|Lack of Efficacy|4
104696|NCT01016912|389208|P4|End of Treatment Period|Lack of Efficacy|4
104697|NCT01016912|389209|P3|End of Treatment Period|Lack of Efficacy|0
104698|NCT01016912|389210|P2|End of Treatment Period|Lack of Efficacy|1
104699|NCT01016912|389211|P1|End of Treatment Period|Lack of Efficacy|0
104700|NCT01016600|389372|P4|Overall Study|Did not start treatment|0
104701|NCT01016600|389373|P3|Overall Study|Did not start treatment|0
104702|NCT01016600|389374|P2|Overall Study|Did not start treatment|0
104703|NCT01016600|389375|P1|Overall Study|Did not start treatment|1
104704|NCT01016132|389560|P1|Overall Study|Discomfort|1
104705|NCT01016067|389575|P2|Overall Study|Withdrew due to Relocation|1
104706|NCT01016067|389576|P1|Overall Study|Withdrew due to Relocation|0
104707|NCT01016067|389575|P2|Overall Study|Physician Decision|1
104708|NCT01016067|389576|P1|Overall Study|Physician Decision|1
104709|NCT01016067|389575|P2|Overall Study|Lost to Follow-up|2
104710|NCT01016067|389576|P1|Overall Study|Lost to Follow-up|1
104711|NCT01016015|389594|P1|Overall Study|Adverse Event|15
104712|NCT01016015|389594|P1|Overall Study|Withdrawal by Subject|1
104713|NCT01016015|389594|P1|Overall Study|Not Treated|3
104714|NCT01015833|389605|P2|Overall Study|Did not start treatment|0
104715|NCT01015833|389606|P1|Overall Study|Did not start treatment|1
104716|NCT01015833|389605|P2|Overall Study|Motor Vehicle Accidents|0
104717|NCT01015833|389606|P1|Overall Study|Motor Vehicle Accidents|1
104718|NCT01015833|389605|P2|Overall Study|Other|1
104719|NCT01015833|389606|P1|Overall Study|Other|5
104720|NCT01015833|389605|P2|Overall Study|Symptomatic deterioration|1
104721|NCT01015833|389606|P1|Overall Study|Symptomatic deterioration|0
104722|NCT01015833|389605|P2|Overall Study|Physician Decision|0
104723|NCT01015833|389606|P1|Overall Study|Physician Decision|2
104724|NCT01015833|389605|P2|Overall Study|Adverse Event|1
104725|NCT01015833|389606|P1|Overall Study|Adverse Event|0
104726|NCT01015833|389605|P2|Overall Study|Withdrawal by Subject|2
104727|NCT01015833|389606|P1|Overall Study|Withdrawal by Subject|3
104728|NCT01015833|389605|P2|Overall Study|Death|0
104729|NCT01015833|389606|P1|Overall Study|Death|1
104730|NCT01015820|389622|P2|Overall Study|Suboptimal measurements|0
104731|NCT01015820|389623|P1|Overall Study|Suboptimal measurements|1
104732|NCT01015703|389658|P5|Overall Study|Protocol Violation|0
104733|NCT01015703|389659|P4|Overall Study|Protocol Violation|0
104734|NCT01015703|389660|P3|Overall Study|Protocol Violation|0
104735|NCT01015703|389661|P2|Overall Study|Protocol Violation|0
104736|NCT01015703|389662|P1|Overall Study|Protocol Violation|1
104737|NCT01015703|389658|P5|Overall Study|Adverse Event|0
104738|NCT01015703|389659|P4|Overall Study|Adverse Event|0
104739|NCT01015703|389660|P3|Overall Study|Adverse Event|0
104740|NCT01015703|389661|P2|Overall Study|Adverse Event|0
104741|NCT01015703|389662|P1|Overall Study|Adverse Event|1
104742|NCT01015703|389658|P5|Overall Study|Withdrawal by Subject|0
104743|NCT01015703|389659|P4|Overall Study|Withdrawal by Subject|0
104744|NCT01015703|389660|P3|Overall Study|Withdrawal by Subject|0
104745|NCT01015703|389661|P2|Overall Study|Withdrawal by Subject|1
104746|NCT01015703|389662|P1|Overall Study|Withdrawal by Subject|0
104747|NCT01015677|389677|P3|Overall Study|Withdrawal by Subject|0
104748|NCT01015677|389678|P2|Overall Study|Withdrawal by Subject|1
104749|NCT01015677|389679|P1|Overall Study|Withdrawal by Subject|1
104750|NCT01015677|389677|P3|Overall Study|Protocol Violation|0
104751|NCT01015677|389678|P2|Overall Study|Protocol Violation|1
104752|NCT01015677|389679|P1|Overall Study|Protocol Violation|0
104753|NCT01015677|389677|P3|Overall Study|Lack of Efficacy|0
104754|NCT01015677|389678|P2|Overall Study|Lack of Efficacy|1
104755|NCT01015677|389679|P1|Overall Study|Lack of Efficacy|0
104756|NCT01015677|389677|P3|Overall Study|Adverse Event|0
104757|NCT01015677|389678|P2|Overall Study|Adverse Event|1
104758|NCT01015677|389679|P1|Overall Study|Adverse Event|0
104759|NCT01015638|389701|P2|Overall Study|Withdrawal by Subject|0
104760|NCT01015638|389702|P1|Overall Study|Withdrawal by Subject|1
104761|NCT01015560|389730|P1|Overall Study|Withdrawal by Subject|1
104762|NCT01015560|389730|P1|Overall Study|Not protocol specified|1
104763|NCT01015560|389730|P1|Overall Study|Adverse Event|1
104764|NCT01015287|389779|P2|Overall Study|Protocol Violation|1
104765|NCT01015287|389780|P1|Overall Study|Protocol Violation|1
104766|NCT01015287|389779|P2|Overall Study|Lost to Follow-up|1
104767|NCT01015287|389780|P1|Overall Study|Lost to Follow-up|2
104768|NCT01015287|389779|P2|Overall Study|Entry Criteria not Met|14
104769|NCT01015287|389780|P1|Overall Study|Entry Criteria not Met|11
104770|NCT01015287|389779|P2|Overall Study|Withdrawal by Subject|19
104771|NCT01015287|389780|P1|Overall Study|Withdrawal by Subject|14
104772|NCT01015287|389779|P2|Overall Study|Physician Decision|21
104773|NCT01015287|389780|P1|Overall Study|Physician Decision|19
104774|NCT01015287|389779|P2|Overall Study|Sponsor Decision|7
104775|NCT01015287|389780|P1|Overall Study|Sponsor Decision|3
104776|NCT01015287|389779|P2|Overall Study|Adverse Event|0
104777|NCT01015287|389780|P1|Overall Study|Adverse Event|1
104778|NCT01015287|389779|P2|Overall Study|Death|16
104779|NCT01015287|389780|P1|Overall Study|Death|21
104780|NCT01015131|389812|P1|Overall Study|Other Protocol Specified Criteria|4
104781|NCT01015131|389812|P1|Overall Study|Withdrawal by Subject|2
104782|NCT01015131|389812|P1|Overall Study|Protocol Violation|1
104783|NCT01015131|389812|P1|Overall Study|Physician Decision|1
104784|NCT01015118|389828|P2|Overall Study|Other than stated above|23
104785|NCT01015118|389829|P1|Overall Study|Other than stated above|42
104786|NCT01015118|389828|P2|Overall Study|Not treated|5
104787|NCT01015118|389829|P1|Overall Study|Not treated|9
104788|NCT01015118|389828|P2|Overall Study|Progressive disease|229
104789|NCT01015118|389829|P1|Overall Study|Progressive disease|364
104790|NCT01015118|389828|P2|Overall Study|Worsening or AE of underlying disease|4
104791|NCT01015118|389829|P1|Overall Study|Worsening or AE of underlying disease|5
104792|NCT01015118|389828|P2|Overall Study|Other Adverse Event (AE)|33
104793|NCT01015118|389829|P1|Overall Study|Other Adverse Event (AE)|141
104794|NCT01015118|389828|P2|Overall Study|Withdrawal by Subject|27
104795|NCT01015118|389829|P1|Overall Study|Withdrawal by Subject|103
104796|NCT01015118|389828|P2|Overall Study|Protocol Violation|6
104797|NCT01015118|389829|P1|Overall Study|Protocol Violation|5
104798|NCT01014988|389857|P6|Overall Study|Withdrawal by Subject|0
104799|NCT01014988|389858|P5|Overall Study|Withdrawal by Subject|0
104800|NCT01014988|389859|P4|Overall Study|Withdrawal by Subject|0
104801|NCT01014988|389860|P3|Overall Study|Withdrawal by Subject|0
104802|NCT01014988|389861|P2|Overall Study|Withdrawal by Subject|0
104803|NCT01014988|389862|P1|Overall Study|Withdrawal by Subject|1
104804|NCT01014988|389857|P6|Overall Study|Physician Decision|0
104805|NCT01014988|389858|P5|Overall Study|Physician Decision|0
104806|NCT01014988|389859|P4|Overall Study|Physician Decision|0
104807|NCT01014988|389860|P3|Overall Study|Physician Decision|0
104808|NCT01014988|389861|P2|Overall Study|Physician Decision|0
104809|NCT01014988|389862|P1|Overall Study|Physician Decision|1
104810|NCT01014988|389857|P6|Overall Study|Lost to Follow-up|0
104811|NCT01014988|389858|P5|Overall Study|Lost to Follow-up|0
104812|NCT01014988|389859|P4|Overall Study|Lost to Follow-up|0
104813|NCT01014988|389860|P3|Overall Study|Lost to Follow-up|1
104814|NCT01014988|389861|P2|Overall Study|Lost to Follow-up|0
104815|NCT01014988|389862|P1|Overall Study|Lost to Follow-up|1
104816|NCT01014988|389857|P6|Overall Study|Adverse Event|3
104817|NCT01014988|389858|P5|Overall Study|Adverse Event|1
104818|NCT01014988|389859|P4|Overall Study|Adverse Event|0
104819|NCT01014988|389860|P3|Overall Study|Adverse Event|1
104820|NCT01014988|389861|P2|Overall Study|Adverse Event|0
104821|NCT01014988|389862|P1|Overall Study|Adverse Event|20
104822|NCT01014975|390034|P3|Overall Study|Lost to Follow-up|1
104823|NCT01014975|390035|P2|Overall Study|Lost to Follow-up|0
104824|NCT01014975|390036|P1|Overall Study|Lost to Follow-up|0
104825|NCT01014975|390034|P3|Overall Study|Death|4
104826|NCT01014975|390035|P2|Overall Study|Death|3
104827|NCT01014975|390036|P1|Overall Study|Death|3
104828|NCT01014975|390034|P3|Overall Study|Withdrawal by Subject|1
104829|NCT01014975|390035|P2|Overall Study|Withdrawal by Subject|0
104830|NCT01014975|390036|P1|Overall Study|Withdrawal by Subject|1
104831|NCT01014910|390541|P2|Overall Study|Withdrawal by Subject|2
104832|NCT01014910|390542|P1|Overall Study|Withdrawal by Subject|0
104833|NCT01014689|390586|P2|Overall Study|Pregnancy|0
104834|NCT01014689|390587|P1|Overall Study|Pregnancy|1
104835|NCT01014689|390586|P2|Overall Study|Lost to Follow-up|7
104836|NCT01014689|390587|P1|Overall Study|Lost to Follow-up|3
104837|NCT01014689|390586|P2|Overall Study|Protocol Violation|1
104838|NCT01014689|390587|P1|Overall Study|Protocol Violation|1
104839|NCT01014689|390586|P2|Overall Study|Withdrawal by Subject|4
104840|NCT01014689|390587|P1|Overall Study|Withdrawal by Subject|5
104841|NCT01014689|390586|P2|Overall Study|Adverse Event|0
104842|NCT01014689|390587|P1|Overall Study|Adverse Event|3
104843|NCT01014689|390586|P2|Overall Study|Lack of Efficacy|1
104844|NCT01014689|390587|P1|Overall Study|Lack of Efficacy|0
104845|NCT01014585|390622|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
104846|NCT01014585|390623|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
104847|NCT01014585|390624|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
104848|NCT01014585|390625|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
104849|NCT01014585|390622|P4|Overall Study|Lost to Follow-up|2
104850|NCT01014585|390623|P3|Overall Study|Lost to Follow-up|0
104851|NCT01014585|390624|P2|Overall Study|Lost to Follow-up|0
104852|NCT01014585|390625|P1|Overall Study|Lost to Follow-up|0
104853|NCT01014585|390622|P4|Overall Study|Withdrawal by Subject|3
104854|NCT01014585|390623|P3|Overall Study|Withdrawal by Subject|1
104855|NCT01014585|390624|P2|Overall Study|Withdrawal by Subject|0
104856|NCT01014585|390625|P1|Overall Study|Withdrawal by Subject|2
104857|NCT01014585|390622|P4|Overall Study|Adverse Event|3
104858|NCT01014585|390623|P3|Overall Study|Adverse Event|0
104859|NCT01014585|390624|P2|Overall Study|Adverse Event|2
104860|NCT01014585|390625|P1|Overall Study|Adverse Event|0
104861|NCT01014533|390645|P2|Overall Study|unable to come to appointment|3
104862|NCT01014533|390646|P1|Overall Study|unable to come to appointment|0
104863|NCT01014533|390645|P2|Overall Study|Withdrawal by Subject|0
104864|NCT01014533|390646|P1|Overall Study|Withdrawal by Subject|2
104865|NCT01014533|390645|P2|Overall Study|Protocol Violation|2
104866|NCT01014533|390646|P1|Overall Study|Protocol Violation|3
104867|NCT01014442|390667|P2|Overall Study|Unspecified Reason|1
104868|NCT01014442|390668|P1|Overall Study|Unspecified Reason|1
104869|NCT01014442|390667|P2|Overall Study|Lack of Compliance|1
104870|NCT01014442|390668|P1|Overall Study|Lack of Compliance|0
104871|NCT01014442|390667|P2|Overall Study|Protocol Violation|5
104872|NCT01014442|390668|P1|Overall Study|Protocol Violation|2
104873|NCT01014442|390667|P2|Overall Study|Withdrawal by Subject|4
104874|NCT01014442|390668|P1|Overall Study|Withdrawal by Subject|4
104875|NCT01014442|390667|P2|Overall Study|Adverse Event|8
104876|NCT01014442|390668|P1|Overall Study|Adverse Event|0
104877|NCT01014208|390788|P2|Overall Study|Study Closed/terminated|83
104878|NCT01014208|390789|P1|Overall Study|Study Closed/terminated|78
104879|NCT01014208|390788|P2|Overall Study|Did Not Receive Study Drug|0
104880|NCT01014208|390789|P1|Overall Study|Did Not Receive Study Drug|2
104881|NCT01014208|390788|P2|Overall Study|Participant Withdrew Consent|12
104882|NCT01014208|390789|P1|Overall Study|Participant Withdrew Consent|12
104883|NCT01014208|390788|P2|Overall Study|Lost to Follow-up|5
104884|NCT01014208|390789|P1|Overall Study|Lost to Follow-up|2
104885|NCT01014143|390831|P3|Second Intervention|Lost to Follow-up|0
104886|NCT01014143|390832|P2|Second Intervention|Lost to Follow-up|0
104887|NCT01014143|390833|P1|Second Intervention|Lost to Follow-up|2
104888|NCT01014013|390928|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
104889|NCT01014013|390929|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
104890|NCT01014013|390928|P2|Overall Study|Appendectomy|0
104891|NCT01014013|390929|P1|Overall Study|Appendectomy|1
104892|NCT01014013|390928|P2|Overall Study|Another antibiotic therapy required|1
104893|NCT01014013|390929|P1|Overall Study|Another antibiotic therapy required|0
104894|NCT01014013|390928|P2|Overall Study|Physician Decision|1
104895|NCT01014013|390929|P1|Overall Study|Physician Decision|0
104896|NCT01014013|390928|P2|Overall Study|Pathogen resistant|4
104897|NCT01014013|390929|P1|Overall Study|Pathogen resistant|7
104898|NCT01014013|390928|P2|Overall Study|Negative urine culture|0
104899|NCT01014013|390929|P1|Overall Study|Negative urine culture|2
104900|NCT01014013|390928|P2|Overall Study|Pathogen culture = no growth|34
104901|NCT01014013|390929|P1|Overall Study|Pathogen culture = no growth|26
104902|NCT01014013|390928|P2|Overall Study|Clinical/microbiologic failure|2
104903|NCT01014013|390929|P1|Overall Study|Clinical/microbiologic failure|1
104904|NCT01014013|390928|P2|Overall Study|Withdrawal by Subject|4
104905|NCT01014013|390929|P1|Overall Study|Withdrawal by Subject|7
104906|NCT01014013|390928|P2|Overall Study|Protocol Violation|3
104907|NCT01014013|390929|P1|Overall Study|Protocol Violation|1
104908|NCT01014013|390928|P2|Overall Study|Laboratory adverse experience|1
104909|NCT01014013|390929|P1|Overall Study|Laboratory adverse experience|1
104910|NCT01014013|390928|P2|Overall Study|Clinical adverse experience|2
104911|NCT01014013|390929|P1|Overall Study|Clinical adverse experience|4
104912|NCT01014013|390928|P2|Overall Study|Inclusion/Exclusion criteria not met|3
104913|NCT01014013|390929|P1|Overall Study|Inclusion/Exclusion criteria not met|1
104914|NCT01013961|390941|P2|Overall Study|Physician Decision|1
104915|NCT01013961|390942|P1|Overall Study|Physician Decision|0
104916|NCT01013961|390941|P2|Overall Study|Withdrawal by Subject|0
104917|NCT01013961|390942|P1|Overall Study|Withdrawal by Subject|1
104918|NCT01013961|390941|P2|Overall Study|Adverse Event|2
104919|NCT01013961|390942|P1|Overall Study|Adverse Event|2
104920|NCT01013883|390960|P2|Overall Study|Lost to Follow-up|2
104921|NCT01013883|390961|P1|Overall Study|Lost to Follow-up|2
104922|NCT01013870|390973|P2|Overall Study|Lost to Follow-up|3
104923|NCT01013870|390974|P1|Overall Study|Lost to Follow-up|1
104924|NCT01013792|391023|P2|Overall Study|Lost to Follow-up|1
104925|NCT01013792|391024|P1|Overall Study|Lost to Follow-up|0
104926|NCT01013792|391023|P2|Overall Study|Adverse Event|3
104927|NCT01013792|391024|P1|Overall Study|Adverse Event|0
104928|NCT01013792|391023|P2|Overall Study|Study suspended|1
104929|NCT01013792|391024|P1|Overall Study|Study suspended|2
104930|NCT01013753|391030|P1|Overall Study|Other|2
104931|NCT01013753|391030|P1|Overall Study|Withdrawal by Subject|2
104932|NCT01013753|391030|P1|Overall Study|Lost to Follow-up|1
104933|NCT01013753|391030|P1|Overall Study|Protocol Violation|3
104934|NCT01013753|391030|P1|Overall Study|Adverse Event|8
104935|NCT01013740|391226|P2|Overall Study|Ongoing: Study records not completed|2
104936|NCT01013740|391227|P1|Overall Study|Ongoing: Study records not completed|0
104937|NCT01013740|391226|P2|Overall Study|Missing|1
104938|NCT01013740|391227|P1|Overall Study|Missing|2
104939|NCT01013740|391226|P2|Overall Study|study close / terminated : done in error|1
104940|NCT01013740|391227|P1|Overall Study|study close / terminated : done in error|2
104941|NCT01013740|391226|P2|Overall Study|Withdrawal by Subject|10
104942|NCT01013740|391227|P1|Overall Study|Withdrawal by Subject|2
104943|NCT01013740|391226|P2|Overall Study|Physician Decision|0
104944|NCT01013740|391227|P1|Overall Study|Physician Decision|2
104945|NCT01013740|391226|P2|Overall Study|Lost to Follow-up|5
104946|NCT01013740|391227|P1|Overall Study|Lost to Follow-up|3
104947|NCT01013701|391251|P1|Overall Study|study prematurely terminated|7
104948|NCT01013597|391258|P1|Overall Study|Withdrawal by Subject|1
104949|NCT01013207|391268|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
104950|NCT01012999|391286|P1|Overall Study|Protocol Violation|1
104951|NCT01012973|391292|P2|Overall Study|Withdrawal by Subject|6
104952|NCT01012973|391293|P1|Overall Study|Withdrawal by Subject|4
104953|NCT01012973|391292|P2|Overall Study|Protocol Violation|2
104954|NCT01012973|391293|P1|Overall Study|Protocol Violation|5
104955|NCT01012973|391292|P2|Overall Study|Increase in vis. acuity, never injected|1
104956|NCT01012973|391293|P1|Overall Study|Increase in vis. acuity, never injected|0
104957|NCT01012973|391292|P2|Overall Study|(Overseas travel - indefinite period)|0
104958|NCT01012973|391293|P1|Overall Study|(Overseas travel - indefinite period)|1
104959|NCT01012973|391292|P2|Overall Study|Lost to Follow-up|0
104960|NCT01012973|391293|P1|Overall Study|Lost to Follow-up|1
104961|NCT01012973|391292|P2|Overall Study|Lack of Efficacy|5
104962|NCT01012973|391293|P1|Overall Study|Lack of Efficacy|0
104963|NCT01012973|391292|P2|Overall Study|Adverse Event|5
104964|NCT01012973|391293|P1|Overall Study|Adverse Event|5
104965|NCT01012947|391318|P5|Overall Study|Lost to Follow-up|142
104966|NCT01012947|391319|P4|Overall Study|Lost to Follow-up|118
104967|NCT01012947|391320|P3|Overall Study|Lost to Follow-up|130
104968|NCT01012947|391321|P2|Overall Study|Lost to Follow-up|135
104969|NCT01012947|391322|P1|Overall Study|Lost to Follow-up|131
104970|NCT01012765|391343|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
104971|NCT01012765|391344|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
104972|NCT01012765|391345|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
104973|NCT01012765|391346|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
104974|NCT01012765|391347|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
104975|NCT01012765|391348|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
104976|NCT01012765|391343|P6|Treatment Period 2|Adverse Event|0
104977|NCT01012765|391344|P5|Treatment Period 2|Adverse Event|0
104978|NCT01012765|391345|P4|Treatment Period 2|Adverse Event|0
104979|NCT01012765|391346|P3|Treatment Period 2|Adverse Event|1
104980|NCT01012765|391347|P2|Treatment Period 2|Adverse Event|1
104981|NCT01012765|391348|P1|Treatment Period 2|Adverse Event|0
104982|NCT01012765|391343|P6|Treatment Period 2|Abnormal laboratory value(s)|1
104983|NCT01012765|391344|P5|Treatment Period 2|Abnormal laboratory value(s)|0
104984|NCT01012765|391345|P4|Treatment Period 2|Abnormal laboratory value(s)|0
104985|NCT01012765|391346|P3|Treatment Period 2|Abnormal laboratory value(s)|0
104986|NCT01012765|391347|P2|Treatment Period 2|Abnormal laboratory value(s)|0
104987|NCT01012765|391348|P1|Treatment Period 2|Abnormal laboratory value(s)|0
104988|NCT01012765|391343|P6|Treatment Period 2|Withdrawal by Subject|0
104989|NCT01012765|391344|P5|Treatment Period 2|Withdrawal by Subject|1
104990|NCT01012765|391345|P4|Treatment Period 2|Withdrawal by Subject|0
104991|NCT01012765|391346|P3|Treatment Period 2|Withdrawal by Subject|1
104992|NCT01012765|391347|P2|Treatment Period 2|Withdrawal by Subject|0
104993|NCT01012765|391348|P1|Treatment Period 2|Withdrawal by Subject|1
104994|NCT01012765|391343|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
104995|NCT01012765|391344|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
104996|NCT01012765|391345|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
104997|NCT01012765|391346|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
104998|NCT01012765|391347|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
104999|NCT01012765|391348|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
105000|NCT01012765|391343|P6|Treatment Period 1|Protocol Violation|0
105001|NCT01012765|391344|P5|Treatment Period 1|Protocol Violation|1
105002|NCT01012765|391345|P4|Treatment Period 1|Protocol Violation|2
105003|NCT01012765|391346|P3|Treatment Period 1|Protocol Violation|0
105004|NCT01012765|391347|P2|Treatment Period 1|Protocol Violation|0
105005|NCT01012765|391348|P1|Treatment Period 1|Protocol Violation|0
105006|NCT01012765|391343|P6|Treatment Period 1|Administrative problems|0
105007|NCT01012765|391344|P5|Treatment Period 1|Administrative problems|1
105008|NCT01012765|391345|P4|Treatment Period 1|Administrative problems|1
105009|NCT01012765|391346|P3|Treatment Period 1|Administrative problems|1
105010|NCT01012765|391347|P2|Treatment Period 1|Administrative problems|0
105011|NCT01012765|391348|P1|Treatment Period 1|Administrative problems|0
105012|NCT01012765|391343|P6|Treatment Period 1|Withdrawal by Subject|0
105013|NCT01012765|391344|P5|Treatment Period 1|Withdrawal by Subject|0
105014|NCT01012765|391345|P4|Treatment Period 1|Withdrawal by Subject|0
105015|NCT01012765|391346|P3|Treatment Period 1|Withdrawal by Subject|0
105016|NCT01012765|391347|P2|Treatment Period 1|Withdrawal by Subject|0
105017|NCT01012765|391348|P1|Treatment Period 1|Withdrawal by Subject|2
105018|NCT01012765|391343|P6|Treatment Period 1|Adverse Event|0
105019|NCT01012765|391344|P5|Treatment Period 1|Adverse Event|0
105020|NCT01012765|391345|P4|Treatment Period 1|Adverse Event|0
105021|NCT01012765|391346|P3|Treatment Period 1|Adverse Event|1
105022|NCT01012765|391347|P2|Treatment Period 1|Adverse Event|0
105023|NCT01012765|391348|P1|Treatment Period 1|Adverse Event|1
105024|NCT01012739|391377|P4|Treatment Period 2|Abnormal test procedure results|1
105025|NCT01012739|391378|P3|Treatment Period 2|Abnormal test procedure results|0
105026|NCT01012739|391379|P2|Treatment Period 2|Abnormal test procedure results|0
105027|NCT01012739|391380|P1|Treatment Period 2|Abnormal test procedure results|0
105028|NCT01012739|391377|P4|Treatment Period 1|Adverse Event|1
105029|NCT01012739|391378|P3|Treatment Period 1|Adverse Event|0
105030|NCT01012739|391379|P2|Treatment Period 1|Adverse Event|0
105031|NCT01012739|391380|P1|Treatment Period 1|Adverse Event|0
105032|NCT01012713|391408|P1|Overall Study|Lack of Efficacy|3
105033|NCT01012622|391434|P1|Overall Study|withdrawal of consent by a parent|2
105034|NCT01012622|391434|P1|Overall Study|screening failure|1
105035|NCT01012622|391434|P1|Overall Study|Other|1
105036|NCT01012622|391434|P1|Overall Study|non-compliance with the drug|9
105037|NCT01012622|391434|P1|Overall Study|Adverse Event|7
105038|NCT01012622|391434|P1|Overall Study|Lost to Follow-up|5
105039|NCT01012622|391434|P1|Overall Study|Withdrawal by Subject|6
105040|NCT01012440|391458|P1|Overall Study|Withdrawal by Subject|2
105041|NCT01012414|391462|P1|Overall Study|Trial was stopped before completed|7
105042|NCT01012414|391462|P1|Overall Study|Lost to Follow-up|1
105043|NCT01012414|391462|P1|Overall Study|Withdrawal by Subject|2
105044|NCT01012323|391503|P1|Overall Study|Investigator Judgment|1
105045|NCT01012258|391540|P1|Overall Study|Ongoing|29
105046|NCT01012258|391540|P1|Overall Study|Another Tumor Discovered|1
105047|NCT01012258|391540|P1|Overall Study|Another Anti-cancer Drug Received|1
105048|NCT01012258|391540|P1|Overall Study|Symptomatic Deterioration|1
105049|NCT01012258|391540|P1|Overall Study|Progressive Disease (PD)|18
105050|NCT01012258|391540|P1|Overall Study|Adverse Event|1
105051|NCT01012258|391540|P1|Overall Study|Lost to Follow-up|1
105052|NCT01012258|391540|P1|Overall Study|Death|14
105053|NCT01012219|391587|P1|Period 2|Withdrawal by Subject|1
105054|NCT01012219|391587|P1|Period 1|Withdrawal by Subject|1
105055|NCT01012037|391856|P3|Overall Study|Other reason (not specified)|1
105056|NCT01012037|391857|P2|Overall Study|Other reason (not specified)|1
105057|NCT01012037|391858|P1|Overall Study|Other reason (not specified)|1
105058|NCT01012037|391856|P3|Overall Study|Withdrawal by Subject|1
105059|NCT01012037|391857|P2|Overall Study|Withdrawal by Subject|4
105060|NCT01012037|391858|P1|Overall Study|Withdrawal by Subject|0
105061|NCT01012037|391856|P3|Overall Study|Protocol Violation|5
105062|NCT01012037|391857|P2|Overall Study|Protocol Violation|3
105063|NCT01012037|391858|P1|Overall Study|Protocol Violation|0
105064|NCT01012037|391856|P3|Overall Study|Adverse Event|3
105065|NCT01012037|391857|P2|Overall Study|Adverse Event|8
105066|NCT01012037|391858|P1|Overall Study|Adverse Event|0
105067|NCT01011946|391893|P1|Overall Study|No pathological lab value|1
105068|NCT01011946|391893|P1|Overall Study|Transferred to another hospital|2
105069|NCT01011933|391897|P1|Overall Study|Never treated|1
105070|NCT01011933|391897|P1|Overall Study|Inadequate pathology|1
105071|NCT01011933|391897|P1|Overall Study|Improper pre-protocol Rx|1
105072|NCT01011933|391897|P1|Overall Study|Wrong cell type|1
105073|NCT01011907|391914|P2|Overall Study|Adverse Event|4
105074|NCT01011907|391915|P1|Overall Study|Adverse Event|1
105075|NCT01011907|391914|P2|Overall Study|Withdrawal by Subject|11
105076|NCT01011907|391915|P1|Overall Study|Withdrawal by Subject|13
105077|NCT01011868|391932|P3|After Week 78 Follow-up|Other reason not defined above|16
105078|NCT01011868|391933|P2|After Week 78 Follow-up|Other reason not defined above|5
105079|NCT01011868|391934|P1|After Week 78 Follow-up|Other reason not defined above|5
105080|NCT01011868|391932|P3|After Week 78 Follow-up|Withdrawal by Subject|1
105081|NCT01011868|391933|P2|After Week 78 Follow-up|Withdrawal by Subject|8
105082|NCT01011868|391934|P1|After Week 78 Follow-up|Withdrawal by Subject|9
105083|NCT01011868|391932|P3|After Week 78 Follow-up|Lost to Follow-up|4
105084|NCT01011868|391933|P2|After Week 78 Follow-up|Lost to Follow-up|6
105085|NCT01011868|391934|P1|After Week 78 Follow-up|Lost to Follow-up|11
105086|NCT01011868|391932|P3|After Week 78 Follow-up|Protocol Violation|2
105087|NCT01011868|391933|P2|After Week 78 Follow-up|Protocol Violation|1
105088|NCT01011868|391934|P1|After Week 78 Follow-up|Protocol Violation|9
105089|NCT01011868|391932|P3|After Week 78 Follow-up|Lack of Efficacy|0
105090|NCT01011868|391933|P2|After Week 78 Follow-up|Lack of Efficacy|0
105091|NCT01011868|391934|P1|After Week 78 Follow-up|Lack of Efficacy|4
105092|NCT01011868|391932|P3|After Week 78 Follow-up|Adverse Event|21
105093|NCT01011868|391933|P2|After Week 78 Follow-up|Adverse Event|18
105094|NCT01011868|391934|P1|After Week 78 Follow-up|Adverse Event|14
105095|NCT01011868|391932|P3|After Week 18 Follow-up|Other reason not defined above|12
105096|NCT01011868|391933|P2|After Week 18 Follow-up|Other reason not defined above|3
105097|NCT01011868|391934|P1|After Week 18 Follow-up|Other reason not defined above|2
105098|NCT01011868|391932|P3|After Week 18 Follow-up|Withdrawal by Subject|0
105099|NCT01011868|391933|P2|After Week 18 Follow-up|Withdrawal by Subject|3
105100|NCT01011868|391934|P1|After Week 18 Follow-up|Withdrawal by Subject|6
105101|NCT01011868|391932|P3|After Week 18 Follow-up|Lost to Follow-up|0
105102|NCT01011868|391933|P2|After Week 18 Follow-up|Lost to Follow-up|3
105103|NCT01011868|391934|P1|After Week 18 Follow-up|Lost to Follow-up|5
105104|NCT01011868|391932|P3|After Week 18 Follow-up|Protocol Violation|1
105105|NCT01011868|391933|P2|After Week 18 Follow-up|Protocol Violation|1
105106|NCT01011868|391934|P1|After Week 18 Follow-up|Protocol Violation|1
105107|NCT01011868|391932|P3|After Week 18 Follow-up|Lack of Efficacy|0
105108|NCT01011868|391933|P2|After Week 18 Follow-up|Lack of Efficacy|0
105109|NCT01011868|391934|P1|After Week 18 Follow-up|Lack of Efficacy|1
105110|NCT01011868|391932|P3|After Week 18 Follow-up|Adverse Event|13
105111|NCT01011868|391933|P2|After Week 18 Follow-up|Adverse Event|6
105112|NCT01011868|391934|P1|After Week 18 Follow-up|Adverse Event|8
105113|NCT01011738|391996|P3|Overall Study|Unknown reasons|17
105114|NCT01011738|391997|P2|Overall Study|Unknown reasons|291
105115|NCT01011738|391998|P1|Overall Study|Unknown reasons|312
105116|NCT01011738|391996|P3|Overall Study|Death|0
105117|NCT01011738|391997|P2|Overall Study|Death|3
105118|NCT01011738|391998|P1|Overall Study|Death|12
105119|NCT01011673|392038|P2|24 Hour Follow-up|Lost to Follow-up|3
105120|NCT01011673|392039|P1|24 Hour Follow-up|Lost to Follow-up|3
105121|NCT01011673|392038|P2|Randomized|Secondary headache|1
105122|NCT01011673|392039|P1|Randomized|Secondary headache|2
105123|NCT01011556|392062|P4|Overall Study|Inclusion/exclusion criteria not met|5
105124|NCT01011556|392063|P3|Overall Study|Inclusion/exclusion criteria not met|3
105125|NCT01011556|392064|P2|Overall Study|Inclusion/exclusion criteria not met|1
105126|NCT01011556|392065|P1|Overall Study|Inclusion/exclusion criteria not met|2
105127|NCT01011556|392062|P4|Overall Study|Sponsor decision|2
105128|NCT01011556|392063|P3|Overall Study|Sponsor decision|1
105129|NCT01011556|392064|P2|Overall Study|Sponsor decision|1
105130|NCT01011556|392065|P1|Overall Study|Sponsor decision|0
105131|NCT01011556|392062|P4|Overall Study|Withdrawal by Subject|4
105132|NCT01011556|392063|P3|Overall Study|Withdrawal by Subject|4
105133|NCT01011556|392064|P2|Overall Study|Withdrawal by Subject|2
105134|NCT01011556|392065|P1|Overall Study|Withdrawal by Subject|1
105135|NCT01011556|392062|P4|Overall Study|Protocol Violation|0
105136|NCT01011556|392063|P3|Overall Study|Protocol Violation|0
105137|NCT01011556|392064|P2|Overall Study|Protocol Violation|1
105138|NCT01011556|392065|P1|Overall Study|Protocol Violation|0
105139|NCT01011556|392062|P4|Overall Study|Physician Decision|1
105140|NCT01011556|392063|P3|Overall Study|Physician Decision|0
105141|NCT01011556|392064|P2|Overall Study|Physician Decision|0
105142|NCT01011556|392065|P1|Overall Study|Physician Decision|1
105143|NCT01011556|392062|P4|Overall Study|Lost to Follow-up|0
105144|NCT01011556|392063|P3|Overall Study|Lost to Follow-up|0
105145|NCT01011556|392064|P2|Overall Study|Lost to Follow-up|0
105146|NCT01011556|392065|P1|Overall Study|Lost to Follow-up|1
105147|NCT01011556|392062|P4|Overall Study|Adverse Event|1
105148|NCT01011556|392063|P3|Overall Study|Adverse Event|2
105149|NCT01011556|392064|P2|Overall Study|Adverse Event|3
105150|NCT01011556|392065|P1|Overall Study|Adverse Event|1
105151|NCT01011465|392143|P8|Overall Study|Withdrawal by Subject|0
105152|NCT01011465|392144|P7|Overall Study|Withdrawal by Subject|1
105153|NCT01011465|392145|P6|Overall Study|Withdrawal by Subject|0
105154|NCT01011465|392146|P5|Overall Study|Withdrawal by Subject|1
105155|NCT01011465|392147|P4|Overall Study|Withdrawal by Subject|0
105156|NCT01011465|392148|P3|Overall Study|Withdrawal by Subject|0
105157|NCT01011465|392149|P2|Overall Study|Withdrawal by Subject|1
105158|NCT01011465|392150|P1|Overall Study|Withdrawal by Subject|2
105159|NCT01011387|392178|P1|Overall Study|Protocol Violation|1
105160|NCT01011387|392178|P1|Overall Study|Adverse Event|2
105161|NCT01011387|392178|P1|Overall Study|Withdrawal by Subject|3
105162|NCT01011335|392186|P13|Overall Study|Adverse Event|1
105163|NCT01011335|392187|P12|Overall Study|Adverse Event|0
105164|NCT01011335|392188|P11|Overall Study|Adverse Event|4
105165|NCT01011335|392189|P10|Overall Study|Adverse Event|0
105166|NCT01011335|392190|P9|Overall Study|Adverse Event|0
105167|NCT01011335|392191|P8|Overall Study|Adverse Event|0
105168|NCT01011335|392192|P7|Overall Study|Adverse Event|0
105169|NCT01011335|392193|P6|Overall Study|Adverse Event|0
105170|NCT01011335|392194|P5|Overall Study|Adverse Event|0
105171|NCT01011335|392195|P4|Overall Study|Adverse Event|0
105172|NCT01011335|392196|P3|Overall Study|Adverse Event|0
105173|NCT01011335|392197|P2|Overall Study|Adverse Event|0
105174|NCT01011335|392198|P1|Overall Study|Adverse Event|0
105175|NCT01011335|392186|P13|Overall Study|Moved/deployed or no booster|0
105176|NCT01011335|392187|P12|Overall Study|Moved/deployed or no booster|0
105177|NCT01011335|392188|P11|Overall Study|Moved/deployed or no booster|2
105178|NCT01011335|392189|P10|Overall Study|Moved/deployed or no booster|0
105179|NCT01011335|392190|P9|Overall Study|Moved/deployed or no booster|1
105180|NCT01011335|392191|P8|Overall Study|Moved/deployed or no booster|0
105181|NCT01011335|392192|P7|Overall Study|Moved/deployed or no booster|1
105182|NCT01011335|392193|P6|Overall Study|Moved/deployed or no booster|0
105183|NCT01011335|392194|P5|Overall Study|Moved/deployed or no booster|0
105184|NCT01011335|392195|P4|Overall Study|Moved/deployed or no booster|1
105185|NCT01011335|392196|P3|Overall Study|Moved/deployed or no booster|0
105186|NCT01011335|392197|P2|Overall Study|Moved/deployed or no booster|0
105187|NCT01011335|392198|P1|Overall Study|Moved/deployed or no booster|1
105188|NCT01011335|392186|P13|Overall Study|Protocol Violation|0
105189|NCT01011335|392187|P12|Overall Study|Protocol Violation|0
105190|NCT01011335|392188|P11|Overall Study|Protocol Violation|0
105191|NCT01011335|392189|P10|Overall Study|Protocol Violation|0
105192|NCT01011335|392190|P9|Overall Study|Protocol Violation|0
105193|NCT01011335|392191|P8|Overall Study|Protocol Violation|0
105194|NCT01011335|392192|P7|Overall Study|Protocol Violation|0
105195|NCT01011335|392193|P6|Overall Study|Protocol Violation|0
105196|NCT01011335|392194|P5|Overall Study|Protocol Violation|0
105197|NCT01011335|392195|P4|Overall Study|Protocol Violation|0
105198|NCT01011335|392196|P3|Overall Study|Protocol Violation|0
105199|NCT01011335|392197|P2|Overall Study|Protocol Violation|1
105200|NCT01011335|392198|P1|Overall Study|Protocol Violation|0
105201|NCT01011335|392186|P13|Overall Study|Lost to Follow-up|2
105202|NCT01011335|392187|P12|Overall Study|Lost to Follow-up|1
105203|NCT01011335|392188|P11|Overall Study|Lost to Follow-up|0
105204|NCT01011335|392189|P10|Overall Study|Lost to Follow-up|0
105205|NCT01011335|392190|P9|Overall Study|Lost to Follow-up|1
105206|NCT01011335|392191|P8|Overall Study|Lost to Follow-up|2
105207|NCT01011335|392192|P7|Overall Study|Lost to Follow-up|2
105208|NCT01011335|392193|P6|Overall Study|Lost to Follow-up|1
105209|NCT01011335|392194|P5|Overall Study|Lost to Follow-up|1
105210|NCT01011335|392195|P4|Overall Study|Lost to Follow-up|1
105211|NCT01011335|392196|P3|Overall Study|Lost to Follow-up|1
105212|NCT01011335|392197|P2|Overall Study|Lost to Follow-up|0
105213|NCT01011335|392198|P1|Overall Study|Lost to Follow-up|0
105214|NCT01011309|392238|P3|Overall Study|Protocol Violation|3
105215|NCT01011309|392239|P2|Overall Study|Protocol Violation|1
105216|NCT01011309|392240|P1|Overall Study|Protocol Violation|0
105217|NCT01011309|392238|P3|Overall Study|Lack of Efficacy|0
105218|NCT01011309|392239|P2|Overall Study|Lack of Efficacy|1
105219|NCT01011309|392240|P1|Overall Study|Lack of Efficacy|0
105220|NCT01011309|392238|P3|Overall Study|Adverse Event|2
105221|NCT01011309|392239|P2|Overall Study|Adverse Event|1
105222|NCT01011309|392240|P1|Overall Study|Adverse Event|2
105223|NCT01011283|392256|P2|Overall Study|Not Specified|2
105224|NCT01011283|392257|P1|Overall Study|Not Specified|2
105225|NCT01011283|392256|P2|Overall Study|Terminated by Sponsor|5
105226|NCT01011283|392257|P1|Overall Study|Terminated by Sponsor|5
105227|NCT01011283|392256|P2|Overall Study|Progressive Disease|2
105228|NCT01011283|392257|P1|Overall Study|Progressive Disease|0
105229|NCT01011283|392256|P2|Overall Study|Adverse Event|2
105230|NCT01011283|392257|P1|Overall Study|Adverse Event|4
105231|NCT01011153|392277|P3|Overall Study|Less than 78 cases completed|9
105232|NCT01011153|392278|P2|Overall Study|Less than 78 cases completed|11
105233|NCT01011153|392279|P1|Overall Study|Less than 78 cases completed|8
105234|NCT01011049|392308|P4|Overall Study|Withdrawal by Subject|0
105235|NCT01011049|392309|P3|Overall Study|Withdrawal by Subject|1
105236|NCT01011049|392310|P2|Overall Study|Withdrawal by Subject|0
105237|NCT01011049|392311|P1|Overall Study|Withdrawal by Subject|0
105238|NCT01011049|392308|P4|Overall Study|Lost to Follow-up|0
105239|NCT01011049|392309|P3|Overall Study|Lost to Follow-up|1
105240|NCT01011049|392310|P2|Overall Study|Lost to Follow-up|2
105241|NCT01011049|392311|P1|Overall Study|Lost to Follow-up|1
105242|NCT01011049|392308|P4|Overall Study|Protocol Violation|0
105243|NCT01011049|392309|P3|Overall Study|Protocol Violation|2
105244|NCT01011049|392310|P2|Overall Study|Protocol Violation|0
105245|NCT01011049|392311|P1|Overall Study|Protocol Violation|0
105246|NCT01010971|392336|P3|Overall Study|Other|2
105247|NCT01010971|392337|P2|Overall Study|Other|0
105248|NCT01010971|392338|P1|Overall Study|Other|1
105249|NCT01010971|392336|P3|Overall Study|Lost to Follow-up|3
105250|NCT01010971|392337|P2|Overall Study|Lost to Follow-up|2
105251|NCT01010971|392338|P1|Overall Study|Lost to Follow-up|0
105252|NCT01010971|392336|P3|Overall Study|Withdrawal by Subject|5
105253|NCT01010971|392337|P2|Overall Study|Withdrawal by Subject|2
105254|NCT01010971|392338|P1|Overall Study|Withdrawal by Subject|0
105255|NCT01010971|392336|P3|Overall Study|Adverse Event|3
105256|NCT01010971|392337|P2|Overall Study|Adverse Event|4
105257|NCT01010971|392338|P1|Overall Study|Adverse Event|2
105258|NCT01010867|392466|P1|Overall Study|< 50% adherence to probiotic|1
105259|NCT01010776|392478|P1|Extension Phase|Not specified|3
105260|NCT01010776|392478|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
105261|NCT01010776|392478|P1|Main Phase|Did not received study medication|5
105262|NCT01010776|392478|P1|Main Phase|Not specified|1
105263|NCT01010776|392478|P1|Main Phase|Inform consent withdrawal|1
105264|NCT01010776|392478|P1|Main Phase|Selection failure|2
105265|NCT01010776|392478|P1|Main Phase|Non-compliance to study medication|5
105266|NCT01010776|392478|P1|Main Phase|Lost to Follow-up|6
105267|NCT01010776|392478|P1|Main Phase|Adverse Event|7
105268|NCT01010776|392478|P1|Main Phase|Lack of Efficacy|8
105269|NCT01010776|392478|P1|Main Phase|Withdrawal by Subject|14
105270|NCT01010750|392506|P6|Second Intervention|Adverse Event|0
105271|NCT01010750|392507|P5|Second Intervention|Adverse Event|0
105272|NCT01010750|392508|P4|Second Intervention|Adverse Event|0
105273|NCT01010750|392509|P3|Second Intervention|Adverse Event|0
105274|NCT01010750|392510|P2|Second Intervention|Adverse Event|1
105275|NCT01010750|392511|P1|Second Intervention|Adverse Event|0
105276|NCT01010633|392536|P2|Overall Study|Investigator decision|1
105277|NCT01010633|392537|P1|Overall Study|Investigator decision|0
105278|NCT01010633|392536|P2|Overall Study|Withdrawal by Subject|1
105279|NCT01010633|392537|P1|Overall Study|Withdrawal by Subject|2
105280|NCT01010633|392536|P2|Overall Study|Protocol Violation|2
105281|NCT01010633|392537|P1|Overall Study|Protocol Violation|1
105282|NCT01010633|392536|P2|Overall Study|Adverse Event|1
105283|NCT01010633|392537|P1|Overall Study|Adverse Event|1
105284|NCT01010503|392564|P1|Overall Study|Death|1
105285|NCT01010503|392564|P1|Overall Study|Adverse Event|1
105286|NCT01010230|392623|P2|Overall Study|Lost to Follow-up|2
105287|NCT01010230|392624|P1|Overall Study|Lost to Follow-up|4
105288|NCT01010230|392623|P2|Overall Study|Withdrawal by Subject|5
105289|NCT01010230|392624|P1|Overall Study|Withdrawal by Subject|6
105290|NCT01010204|392656|P2|Overall Study|psychiatric hospitalization|1
105291|NCT01010204|392657|P1|Overall Study|psychiatric hospitalization|2
105292|NCT01010204|392656|P2|Overall Study|Withdrawal by Subject|3
105293|NCT01010204|392657|P1|Overall Study|Withdrawal by Subject|2
105294|NCT01010204|392656|P2|Overall Study|Adverse Event|3
105295|NCT01010204|392657|P1|Overall Study|Adverse Event|1
105296|NCT01010204|392656|P2|Overall Study|Lost to Follow-up|2
105297|NCT01010204|392657|P1|Overall Study|Lost to Follow-up|2
105298|NCT01010061|392669|P2|Overall Study|Failure to Return|2
105299|NCT01010061|392670|P1|Overall Study|Failure to Return|3
105300|NCT01010061|392669|P2|Overall Study|Refused Treatment/Did Not Cooperate|1
105301|NCT01010061|392670|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
105302|NCT01010061|392669|P2|Overall Study|Administrative/Other|14
105303|NCT01010061|392670|P1|Overall Study|Administrative/Other|19
105304|NCT01010061|392669|P2|Overall Study|Death|7
105305|NCT01010061|392670|P1|Overall Study|Death|23
105306|NCT01010061|392669|P2|Overall Study|Withdrew Consent|4
105307|NCT01010061|392670|P1|Overall Study|Withdrew Consent|9
105308|NCT01010061|392669|P2|Overall Study|Progression of Disease|63
105309|NCT01010061|392670|P1|Overall Study|Progression of Disease|71
105310|NCT01010061|392669|P2|Overall Study|Adverse Events or Intercurrent Illness|4
105311|NCT01010061|392670|P1|Overall Study|Adverse Events or Intercurrent Illness|7
105312|NCT01009983|392720|P1|Overall Study|necessary scans not completed|1
105313|NCT01009840|392733|P1|Overall Study|Subject Withdrew Consent to Participate|1
105314|NCT01009840|392733|P1|Overall Study|Subject was Withdrawn by Investigator|1
105315|NCT01009840|392733|P1|Overall Study|Subject Met Withdrawal Criteria|7
105316|NCT01009840|392733|P1|Overall Study|Adverse Event|4
105317|NCT01009840|392733|P1|Overall Study|Lost to Follow-up|1
105318|NCT01009645|392763|P4|Overall Study|Lost to Follow-up|5
105319|NCT01009645|392764|P3|Overall Study|Lost to Follow-up|4
105320|NCT01009645|392765|P2|Overall Study|Lost to Follow-up|8
105321|NCT01009645|392766|P1|Overall Study|Lost to Follow-up|2
105322|NCT01009580|392803|P2|Overall Study|Unclassified|21
105323|NCT01009580|392804|P1|Overall Study|Unclassified|17
105324|NCT01009580|392803|P2|Overall Study|Withdrawal Criteria|6
105325|NCT01009580|392804|P1|Overall Study|Withdrawal Criteria|4
105326|NCT01009580|392803|P2|Overall Study|Protocol Violation|3
105327|NCT01009580|392804|P1|Overall Study|Protocol Violation|2
105328|NCT01009580|392803|P2|Overall Study|Lack of Efficacy|1
105329|NCT01009580|392804|P1|Overall Study|Lack of Efficacy|0
105330|NCT01009580|392803|P2|Overall Study|Adverse Event|4
105331|NCT01009580|392804|P1|Overall Study|Adverse Event|4
105332|NCT01009554|392818|P2|Overall Study|Noncompliant with Study Product|3
105333|NCT01009554|392819|P1|Overall Study|Noncompliant with Study Product|0
105334|NCT01009554|392818|P2|Overall Study|Withdrawal by Subject|3
105335|NCT01009554|392819|P1|Overall Study|Withdrawal by Subject|1
105336|NCT01009554|392818|P2|Overall Study|Adverse Event|1
105337|NCT01009554|392819|P1|Overall Study|Adverse Event|1
105338|NCT01009515|392951|P1|Overall Study|Withdrawal by Subject|3
105339|NCT01009463|392962|P5|52-week, Double-blind Treatment Period|Physician Decision|8
105340|NCT01009463|392963|P4|52-week, Double-blind Treatment Period|Physician Decision|6
105341|NCT01009463|392964|P3|52-week, Double-blind Treatment Period|Physician Decision|6
105342|NCT01009463|392965|P2|52-week, Double-blind Treatment Period|Physician Decision|4
105343|NCT01009463|392966|P1|52-week, Double-blind Treatment Period|Physician Decision|0
105344|NCT01009463|392962|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
105345|NCT01009463|392963|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
105346|NCT01009463|392964|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
105347|NCT01009463|392965|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
105348|NCT01009463|392966|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
105349|NCT01009463|392962|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
105350|NCT01009463|392963|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
105351|NCT01009463|392964|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
105352|NCT01009463|392965|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
105353|NCT01009463|392966|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
105354|NCT01009463|392962|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
105355|NCT01009463|392963|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
105356|NCT01009463|392964|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
105357|NCT01009463|392965|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
105358|NCT01009463|392966|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
105359|NCT01009463|392962|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
105360|NCT01009463|392963|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
105361|NCT01009463|392964|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
105362|NCT01009463|392965|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
105363|NCT01009463|392966|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
105364|NCT01009463|392962|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
105365|NCT01009463|392963|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
105366|NCT01009463|392964|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
105367|NCT01009463|392965|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
105368|NCT01009463|392966|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
105369|NCT01009463|392962|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
105370|NCT01009463|392963|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
105371|NCT01009463|392964|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
105372|NCT01009463|392965|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
105373|NCT01009463|392966|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
105374|NCT01009463|392962|P5|52-week, Double-blind Treatment Period|Adverse Event|31
105375|NCT01009463|392963|P4|52-week, Double-blind Treatment Period|Adverse Event|29
105376|NCT01009463|392964|P3|52-week, Double-blind Treatment Period|Adverse Event|25
105377|NCT01009463|392965|P2|52-week, Double-blind Treatment Period|Adverse Event|22
105378|NCT01009463|392966|P1|52-week, Double-blind Treatment Period|Adverse Event|0
105379|NCT01009463|392962|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
105380|NCT01009463|392963|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
105381|NCT01009463|392964|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
105382|NCT01009463|392965|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
105383|NCT01009463|392966|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
105384|NCT01009463|392962|P5|4-week, Open-label Run-In Period|Physician Decision|0
105385|NCT01009463|392963|P4|4-week, Open-label Run-In Period|Physician Decision|0
105386|NCT01009463|392964|P3|4-week, Open-label Run-In Period|Physician Decision|0
105387|NCT01009463|392965|P2|4-week, Open-label Run-In Period|Physician Decision|0
105388|NCT01009463|392966|P1|4-week, Open-label Run-In Period|Physician Decision|10
105389|NCT01009463|392962|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
105390|NCT01009463|392963|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
105391|NCT01009463|392964|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
105392|NCT01009463|392965|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
105393|NCT01009463|392966|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
105394|NCT01009463|392962|P5|4-week, Open-label Run-In Period|Adverse Event|0
105395|NCT01009463|392963|P4|4-week, Open-label Run-In Period|Adverse Event|0
105396|NCT01009463|392964|P3|4-week, Open-label Run-In Period|Adverse Event|0
105397|NCT01009463|392965|P2|4-week, Open-label Run-In Period|Adverse Event|0
105398|NCT01009463|392966|P1|4-week, Open-label Run-In Period|Adverse Event|10
105399|NCT01009463|392962|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
105400|NCT01009463|392963|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
105401|NCT01009463|392964|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
105402|NCT01009463|392965|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
105403|NCT01009463|392966|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
105404|NCT01009203|393011|P1|Overall Study|Treatment-unrelated death|1
105405|NCT01009203|393011|P1|Overall Study|Adverse Event|5
105406|NCT01009203|393011|P1|Overall Study|Withdrawal by Subject|1
105407|NCT01009099|393051|P2|Overall Study|Death|1
105408|NCT01009099|393052|P1|Overall Study|Death|0
105409|NCT01009099|393051|P2|Overall Study|Withdrawal by Subject|1
105410|NCT01009099|393052|P1|Overall Study|Withdrawal by Subject|1
105411|NCT01009099|393051|P2|Overall Study|Physician Decision|2
105412|NCT01009099|393052|P1|Overall Study|Physician Decision|3
105413|NCT01009099|393051|P2|Overall Study|Lost to Follow-up|0
105414|NCT01009099|393052|P1|Overall Study|Lost to Follow-up|1
105415|NCT01009086|393061|P3|Overall Study|Other|1
105416|NCT01009086|393062|P2|Overall Study|Other|5
105417|NCT01009086|393063|P1|Overall Study|Other|3
105418|NCT01009086|393061|P3|Overall Study|Withdrawal by Subject|13
105419|NCT01009086|393062|P2|Overall Study|Withdrawal by Subject|11
105420|NCT01009086|393063|P1|Overall Study|Withdrawal by Subject|9
105421|NCT01009086|393061|P3|Overall Study|Adverse Event|8
105422|NCT01009086|393062|P2|Overall Study|Adverse Event|11
105423|NCT01009086|393063|P1|Overall Study|Adverse Event|12
105424|NCT01009086|393061|P3|Overall Study|Lost to Follow-up|3
105425|NCT01009086|393062|P2|Overall Study|Lost to Follow-up|5
105426|NCT01009086|393063|P1|Overall Study|Lost to Follow-up|4
105427|NCT01009086|393061|P3|Overall Study|Lack of Efficacy|9
105428|NCT01009086|393062|P2|Overall Study|Lack of Efficacy|15
105429|NCT01009086|393063|P1|Overall Study|Lack of Efficacy|16
105430|NCT01009060|393098|P2|Overall Study|Withdrawal by Subject|1
105431|NCT01009060|393099|P1|Overall Study|Withdrawal by Subject|1
105432|NCT01009060|393098|P2|Overall Study|Physician Decision|1
105433|NCT01009060|393099|P1|Overall Study|Physician Decision|1
105434|NCT01009060|393098|P2|Overall Study|Lost to Follow-up|0
105435|NCT01009060|393099|P1|Overall Study|Lost to Follow-up|1
105436|NCT01009060|393098|P2|Overall Study|Protocol Violation|1
105437|NCT01009060|393099|P1|Overall Study|Protocol Violation|0
105438|NCT01009060|393098|P2|Overall Study|Adverse Event|2
105439|NCT01009060|393099|P1|Overall Study|Adverse Event|1
105440|NCT01009047|393137|P2|Overall Study|Other|2
105441|NCT01009047|393138|P1|Overall Study|Other|3
105442|NCT01009047|393137|P2|Overall Study|Withdrawal by consent|11
105443|NCT01009047|393138|P1|Overall Study|Withdrawal by consent|16
105444|NCT01009047|393137|P2|Overall Study|Lack of Efficacy|11
105445|NCT01009047|393138|P1|Overall Study|Lack of Efficacy|4
105446|NCT01009047|393137|P2|Overall Study|Lost to Follow-up|2
105447|NCT01009047|393138|P1|Overall Study|Lost to Follow-up|0
105448|NCT01009047|393137|P2|Overall Study|Adverse Event|0
105449|NCT01009047|393138|P1|Overall Study|Adverse Event|5
105450|NCT01009034|393160|P1|Overall Study|Withdrawal by Subject|2
105451|NCT01009034|393160|P1|Overall Study|Lost to Follow-up|2
105452|NCT01008995|393168|P4|After Controlled Period|Not specified|0
105453|NCT01008995|393169|P3|After Controlled Period|Not specified|1
105454|NCT01008995|393170|P2|After Controlled Period|Not specified|0
105455|NCT01008995|393171|P1|After Controlled Period|Not specified|0
105456|NCT01008995|393168|P4|After Controlled Period|Adverse Event|1
105457|NCT01008995|393169|P3|After Controlled Period|Adverse Event|1
105458|NCT01008995|393170|P2|After Controlled Period|Adverse Event|0
105459|NCT01008995|393171|P1|After Controlled Period|Adverse Event|0
105460|NCT01008995|393168|P4|Controlled Period|Not specified|0
105461|NCT01008995|393169|P3|Controlled Period|Not specified|0
105462|NCT01008995|393170|P2|Controlled Period|Not specified|1
105463|NCT01008995|393171|P1|Controlled Period|Not specified|2
105464|NCT01008995|393168|P4|Controlled Period|Adverse Event|0
105465|NCT01008995|393169|P3|Controlled Period|Adverse Event|0
105466|NCT01008995|393170|P2|Controlled Period|Adverse Event|2
105467|NCT01008995|393171|P1|Controlled Period|Adverse Event|1
105468|NCT01008943|393188|P1|Overall Study|Withdrawal by Subject|1
105469|NCT01008904|393195|P1|Overall Study|unexpected unrelated surgery|1
105470|NCT01008904|393195|P1|Overall Study|Adverse Event|2
105471|NCT01008904|393195|P1|Overall Study|Lost to Follow-up|1
105472|NCT01008696|393213|P2|Overall Study|Other|2
105473|NCT01008696|393214|P1|Overall Study|Other|0
105474|NCT01008696|393213|P2|Overall Study|Other|3
105475|NCT01008696|393214|P1|Overall Study|Other|2
105476|NCT01008696|393213|P2|Overall Study|Participants' non-cooperation|3
105477|NCT01008696|393214|P1|Overall Study|Participants' non-cooperation|2
105478|NCT01008696|393213|P2|Overall Study|Adverse Event|0
105479|NCT01008696|393214|P1|Overall Study|Adverse Event|1
105480|NCT01008696|393213|P2|Overall Study|Physician Decision|1
105481|NCT01008696|393214|P1|Overall Study|Physician Decision|5
105482|NCT01008696|393213|P2|Overall Study|Withdrawal by Subject|4
105483|NCT01008696|393214|P1|Overall Study|Withdrawal by Subject|2
105484|NCT01008696|393213|P2|Overall Study|Participant's evasion of hospital visit|4
105485|NCT01008696|393214|P1|Overall Study|Participant's evasion of hospital visit|5
105486|NCT01008618|393224|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
105487|NCT01008618|393225|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
105488|NCT01008618|393226|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
105489|NCT01008618|393224|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
105490|NCT01008618|393225|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
105491|NCT01008618|393226|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
105492|NCT01008618|393224|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
105493|NCT01008618|393225|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
105494|NCT01008618|393226|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
105495|NCT01008618|393224|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
105496|NCT01008618|393225|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
105497|NCT01008618|393226|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
105498|NCT01008618|393224|P3|Period 2 (Double-Blind Period)|Physician Decision|0
105499|NCT01008618|393225|P2|Period 2 (Double-Blind Period)|Physician Decision|1
105500|NCT01008618|393226|P1|Period 2 (Double-Blind Period)|Physician Decision|0
105501|NCT01008618|393224|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
105502|NCT01008618|393225|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
105503|NCT01008618|393226|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
105504|NCT01008618|393224|P3|Period 2 (Double-Blind Period)|Adverse Event|2
105505|NCT01008618|393225|P2|Period 2 (Double-Blind Period)|Adverse Event|11
105506|NCT01008618|393226|P1|Period 2 (Double-Blind Period)|Adverse Event|0
105507|NCT01008618|393224|P3|Period 1 (Titration Period)|Aggravated symptom|0
105508|NCT01008618|393225|P2|Period 1 (Titration Period)|Aggravated symptom|0
105509|NCT01008618|393226|P1|Period 1 (Titration Period)|Aggravated symptom|2
105510|NCT01008618|393224|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
105511|NCT01008618|393225|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
105512|NCT01008618|393226|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
105513|NCT01008618|393224|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
105514|NCT01008618|393225|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
105515|NCT01008618|393226|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
105516|NCT01008618|393224|P3|Period 1 (Titration Period)|Adverse Event|0
105517|NCT01008618|393225|P2|Period 1 (Titration Period)|Adverse Event|0
105518|NCT01008618|393226|P1|Period 1 (Titration Period)|Adverse Event|33
105519|NCT01008618|393224|P3|Period 1 (Titration Period)|Physician Decision|0
105520|NCT01008618|393225|P2|Period 1 (Titration Period)|Physician Decision|0
105521|NCT01008618|393226|P1|Period 1 (Titration Period)|Physician Decision|2
105522|NCT01008553|393275|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
105523|NCT01008553|393276|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
105524|NCT01008553|393277|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
105525|NCT01008553|393275|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
105526|NCT01008553|393276|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
105527|NCT01008553|393277|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
105528|NCT01008553|393275|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
105529|NCT01008553|393276|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
105530|NCT01008553|393277|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
105531|NCT01008553|393275|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
105532|NCT01008553|393276|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
105533|NCT01008553|393277|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
105534|NCT01008553|393275|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
105535|NCT01008553|393276|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
105536|NCT01008553|393277|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
105537|NCT01008553|393275|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
105538|NCT01008553|393276|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
105539|NCT01008553|393277|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
105540|NCT01008553|393275|P3|Period 2 (Double-Blind Period)|Adverse Event|4
105541|NCT01008553|393276|P2|Period 2 (Double-Blind Period)|Adverse Event|14
105542|NCT01008553|393277|P1|Period 2 (Double-Blind Period)|Adverse Event|0
105543|NCT01008553|393275|P3|Period 2 (Double-Blind Period)|Physician Decision|2
105544|NCT01008553|393276|P2|Period 2 (Double-Blind Period)|Physician Decision|1
105545|NCT01008553|393277|P1|Period 2 (Double-Blind Period)|Physician Decision|0
105546|NCT01008553|393275|P3|Period 1 (Titration Period)|Not appropriate for this study|0
105547|NCT01008553|393276|P2|Period 1 (Titration Period)|Not appropriate for this study|0
105548|NCT01008553|393277|P1|Period 1 (Titration Period)|Not appropriate for this study|1
105549|NCT01008553|393275|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
105550|NCT01008553|393276|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
105551|NCT01008553|393277|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
105552|NCT01008553|393275|P3|Period 1 (Titration Period)|Determined to increase dosage|0
105553|NCT01008553|393276|P2|Period 1 (Titration Period)|Determined to increase dosage|0
105554|NCT01008553|393277|P1|Period 1 (Titration Period)|Determined to increase dosage|3
105555|NCT01008553|393275|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
105556|NCT01008553|393276|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
105557|NCT01008553|393277|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
105558|NCT01008553|393275|P3|Period 1 (Titration Period)|Adverse Event|0
105559|NCT01008553|393276|P2|Period 1 (Titration Period)|Adverse Event|0
105560|NCT01008553|393277|P1|Period 1 (Titration Period)|Adverse Event|33
105561|NCT01008553|393275|P3|Period 1 (Titration Period)|Physician Decision|0
105562|NCT01008553|393276|P2|Period 1 (Titration Period)|Physician Decision|0
105563|NCT01008553|393277|P1|Period 1 (Titration Period)|Physician Decision|2
105564|NCT01008475|393309|P7|Overall Study|Ongoing treatment at data cut-off date|4
105565|NCT01008475|393310|P6|Overall Study|Ongoing treatment at data cut-off date|6
105566|NCT01008475|393311|P5|Overall Study|Ongoing treatment at data cut-off date|5
105567|NCT01008475|393312|P4|Overall Study|Ongoing treatment at data cut-off date|0
105568|NCT01008475|393313|P3|Overall Study|Ongoing treatment at data cut-off date|0
105569|NCT01008475|393314|P2|Overall Study|Ongoing treatment at data cut-off date|0
105570|NCT01008475|393315|P1|Overall Study|Ongoing treatment at data cut-off date|0
105571|NCT01008449|393345|P2|Overall Study|Lost to Follow-up|19
105572|NCT01008449|393346|P1|Overall Study|Lost to Follow-up|29
105573|NCT01007916|393392|P2|Period 2, 4 Weeks of Wear|Relocation|0
105574|NCT01007916|393393|P1|Period 2, 4 Weeks of Wear|Relocation|1
105575|NCT01007916|393392|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
105576|NCT01007916|393393|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
105577|NCT01007942|393401|P2|Overall Study|Patients untreated|3
105578|NCT01007942|393402|P1|Overall Study|Patients untreated|4
105579|NCT01007942|393401|P2|Overall Study|Death|2
105580|NCT01007942|393402|P1|Overall Study|Death|3
105581|NCT01007942|393401|P2|Overall Study|Administrative problems|0
105582|NCT01007942|393402|P1|Overall Study|Administrative problems|2
105583|NCT01007942|393401|P2|Overall Study|Lost to Follow-up|0
105584|NCT01007942|393402|P1|Overall Study|Lost to Follow-up|1
105585|NCT01007942|393401|P2|Overall Study|Withdrawal by Subject|14
105586|NCT01007942|393402|P1|Overall Study|Withdrawal by Subject|19
105587|NCT01007942|393401|P2|Overall Study|Protocol Violation|1
105588|NCT01007942|393402|P1|Overall Study|Protocol Violation|1
105589|NCT01007942|393401|P2|Overall Study|New cancer therapy|1
105590|NCT01007942|393402|P1|Overall Study|New cancer therapy|5
105591|NCT01007942|393401|P2|Overall Study|Disease progression|242
105592|NCT01007942|393402|P1|Overall Study|Disease progression|217
105593|NCT01007942|393401|P2|Overall Study|Abnormal test procedure|1
105594|NCT01007942|393402|P1|Overall Study|Abnormal test procedure|0
105595|NCT01007942|393401|P2|Overall Study|Adverse Event|14
105596|NCT01007942|393402|P1|Overall Study|Adverse Event|29
105597|NCT01007838|393428|P4|Overall Study|Started home haemodialysis|0
105598|NCT01007838|393429|P3|Overall Study|Started home haemodialysis|0
105599|NCT01007838|393430|P2|Overall Study|Started home haemodialysis|0
105600|NCT01007838|393431|P1|Overall Study|Started home haemodialysis|1
105601|NCT01007838|393428|P4|Overall Study|Physician Decision|0
105602|NCT01007838|393429|P3|Overall Study|Physician Decision|0
105603|NCT01007838|393430|P2|Overall Study|Physician Decision|0
105604|NCT01007838|393431|P1|Overall Study|Physician Decision|1
105605|NCT01007838|393428|P4|Overall Study|Withdrawal by Subject|0
105606|NCT01007838|393429|P3|Overall Study|Withdrawal by Subject|0
105607|NCT01007838|393430|P2|Overall Study|Withdrawal by Subject|0
105608|NCT01007838|393431|P1|Overall Study|Withdrawal by Subject|1
105609|NCT01007812|393441|P2|Period 1, One Week|Discomfort|0
105610|NCT01007812|393442|P1|Period 1, One Week|Discomfort|1
105611|NCT01007812|393441|P2|Period 1, One Week|Lost to Follow-up|1
105612|NCT01007812|393442|P1|Period 1, One Week|Lost to Follow-up|0
105613|NCT01007552|393475|P1|Overall Study|Withdrawal by Subject|1
105614|NCT01007435|393489|P4|Overall Study|Reason not Specified|1
105615|NCT01007435|393490|P3|Overall Study|Reason not Specified|2
105616|NCT01007435|393491|P2|Overall Study|Reason not Specified|1
105617|NCT01007435|393492|P1|Overall Study|Reason not Specified|1
105618|NCT01007435|393489|P4|Overall Study|Failure to Return|6
105619|NCT01007435|393490|P3|Overall Study|Failure to Return|3
105620|NCT01007435|393491|P2|Overall Study|Failure to Return|4
105621|NCT01007435|393492|P1|Overall Study|Failure to Return|5
105622|NCT01007435|393489|P4|Overall Study|Refused Treatment|8
105623|NCT01007435|393490|P3|Overall Study|Refused Treatment|5
105624|NCT01007435|393491|P2|Overall Study|Refused Treatment|13
105625|NCT01007435|393492|P1|Overall Study|Refused Treatment|13
105626|NCT01007435|393489|P4|Overall Study|Other Protocol Violation|0
105627|NCT01007435|393490|P3|Overall Study|Other Protocol Violation|1
105628|NCT01007435|393491|P2|Overall Study|Other Protocol Violation|0
105629|NCT01007435|393492|P1|Overall Study|Other Protocol Violation|2
105630|NCT01007435|393489|P4|Overall Study|Violation of Selection Criteria at Entry|0
105631|NCT01007435|393490|P3|Overall Study|Violation of Selection Criteria at Entry|2
105632|NCT01007435|393491|P2|Overall Study|Violation of Selection Criteria at Entry|5
105633|NCT01007435|393492|P1|Overall Study|Violation of Selection Criteria at Entry|3
105634|NCT01007435|393489|P4|Overall Study|Insufficient Therapeutic Response|9
105635|NCT01007435|393490|P3|Overall Study|Insufficient Therapeutic Response|2
105636|NCT01007435|393491|P2|Overall Study|Insufficient Therapeutic Response|7
105637|NCT01007435|393492|P1|Overall Study|Insufficient Therapeutic Response|21
105638|NCT01007435|393489|P4|Overall Study|Death|1
105639|NCT01007435|393490|P3|Overall Study|Death|2
105640|NCT01007435|393491|P2|Overall Study|Death|4
105641|NCT01007435|393492|P1|Overall Study|Death|2
105642|NCT01007435|393489|P4|Overall Study|Adverse Event|31
105643|NCT01007435|393490|P3|Overall Study|Adverse Event|47
105644|NCT01007435|393491|P2|Overall Study|Adverse Event|25
105645|NCT01007435|393492|P1|Overall Study|Adverse Event|16
105646|NCT01007396|393534|P1|Overall Study|Lost to Follow-up|47
105647|NCT01007253|393539|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
105648|NCT01007253|393540|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
105649|NCT01007253|393541|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
105650|NCT01007253|393542|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
105651|NCT01007149|393574|P2|Overall Study|Administrative problems|1
105652|NCT01007149|393575|P1|Overall Study|Administrative problems|0
105653|NCT01007123|393601|P4|Overall Study|Lost to Follow-up|0
105654|NCT01007123|393602|P3|Overall Study|Lost to Follow-up|0
105655|NCT01007123|393603|P2|Overall Study|Lost to Follow-up|1
105656|NCT01007123|393604|P1|Overall Study|Lost to Follow-up|0
105657|NCT01007123|393601|P4|Overall Study|Withdrawal by Subject|0
105658|NCT01007123|393602|P3|Overall Study|Withdrawal by Subject|1
105659|NCT01007123|393603|P2|Overall Study|Withdrawal by Subject|0
105660|NCT01007123|393604|P1|Overall Study|Withdrawal by Subject|1
105661|NCT01007123|393601|P4|Overall Study|Protocol Violation|1
105662|NCT01007123|393602|P3|Overall Study|Protocol Violation|2
105663|NCT01007123|393603|P2|Overall Study|Protocol Violation|1
105664|NCT01007123|393604|P1|Overall Study|Protocol Violation|1
105665|NCT01007123|393601|P4|Overall Study|Lack of Efficacy|4
105666|NCT01007123|393602|P3|Overall Study|Lack of Efficacy|1
105667|NCT01007123|393603|P2|Overall Study|Lack of Efficacy|0
105668|NCT01007123|393604|P1|Overall Study|Lack of Efficacy|1
105669|NCT01007123|393601|P4|Overall Study|Adverse Event|1
105670|NCT01007123|393602|P3|Overall Study|Adverse Event|7
105671|NCT01007123|393603|P2|Overall Study|Adverse Event|4
105672|NCT01007123|393604|P1|Overall Study|Adverse Event|3
105673|NCT01006980|393663|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
105674|NCT01006980|393664|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
105675|NCT01006980|393663|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
105676|NCT01006980|393664|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
105677|NCT01006980|393663|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
105678|NCT01006980|393664|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
105679|NCT01006980|393663|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
105680|NCT01006980|393664|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
105681|NCT01006980|393663|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
105682|NCT01006980|393664|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
105683|NCT01006980|393663|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
105684|NCT01006980|393664|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
105685|NCT01006980|393663|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
105686|NCT01006980|393664|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
105687|NCT01006980|393663|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
105688|NCT01006980|393664|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
105689|NCT01006980|393663|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
105690|NCT01006980|393664|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
105691|NCT01006980|393663|P2|Vemurafenib and Dacarbazine|Progression|218
105692|NCT01006980|393664|P1|Vemurafenib and Dacarbazine|Progression|257
105693|NCT01006980|393663|P2|Vemurafenib and Dacarbazine|Death|12
105694|NCT01006980|393664|P1|Vemurafenib and Dacarbazine|Death|13
105695|NCT01006980|393663|P2|Vemurafenib and Dacarbazine|Adverse Event|5
105696|NCT01006980|393664|P1|Vemurafenib and Dacarbazine|Adverse Event|25
105697|NCT01006980|393663|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
105698|NCT01006980|393664|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
105699|NCT01006889|393684|P1|Overall Study|Withdrawal by Subject|3
105700|NCT01006707|393695|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
105701|NCT01006707|393696|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
105702|NCT01006707|393697|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
105703|NCT01006707|393695|P3|Study Session 1|Lost to Follow-up|0
105704|NCT01006707|393696|P2|Study Session 1|Lost to Follow-up|0
105705|NCT01006707|393697|P1|Study Session 1|Lost to Follow-up|2
105706|NCT01006629|393717|P1|Overall Study|Parent unable to perform site visit|4
105707|NCT01006629|393717|P1|Overall Study|Parent refused to continue participation|1
105708|NCT01006629|393717|P1|Overall Study|Adverse Event|1
105709|NCT01006616|393732|P4|Period 2 (18 Months)|Study Terminated|70
105710|NCT01006616|393733|P3|Period 2 (18 Months)|Study Terminated|44
105711|NCT01006616|393734|P2|Period 2 (18 Months)|Study Terminated|46
105712|NCT01006616|393735|P1|Period 2 (18 Months)|Study Terminated|63
105713|NCT01006616|393732|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
105714|NCT01006616|393733|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
105715|NCT01006616|393734|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
105716|NCT01006616|393735|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
105717|NCT01006616|393732|P4|Period 2 (18 Months)|Withdrawal by Subject|1
105718|NCT01006616|393733|P3|Period 2 (18 Months)|Withdrawal by Subject|0
105719|NCT01006616|393734|P2|Period 2 (18 Months)|Withdrawal by Subject|4
105720|NCT01006616|393735|P1|Period 2 (18 Months)|Withdrawal by Subject|1
105721|NCT01006616|393732|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
105722|NCT01006616|393733|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
105723|NCT01006616|393734|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
105724|NCT01006616|393735|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
105725|NCT01006616|393732|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
105726|NCT01006616|393733|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
105727|NCT01006616|393734|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
105728|NCT01006616|393735|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
105729|NCT01006616|393732|P4|Period 2 (18 Months)|Lost to Follow-up|0
105730|NCT01006616|393733|P3|Period 2 (18 Months)|Lost to Follow-up|0
105731|NCT01006616|393734|P2|Period 2 (18 Months)|Lost to Follow-up|0
105732|NCT01006616|393735|P1|Period 2 (18 Months)|Lost to Follow-up|2
105733|NCT01006616|393732|P4|Period 2 (18 Months)|Lack of Efficacy|2
105734|NCT01006616|393733|P3|Period 2 (18 Months)|Lack of Efficacy|1
105735|NCT01006616|393734|P2|Period 2 (18 Months)|Lack of Efficacy|0
105736|NCT01006616|393735|P1|Period 2 (18 Months)|Lack of Efficacy|0
105737|NCT01006616|393732|P4|Period 2 (18 Months)|Adverse Event|4
105738|NCT01006616|393733|P3|Period 2 (18 Months)|Adverse Event|6
105739|NCT01006616|393734|P2|Period 2 (18 Months)|Adverse Event|6
105740|NCT01006616|393735|P1|Period 2 (18 Months)|Adverse Event|6
105741|NCT01006616|393732|P4|Period 1 (6 Months)|Not Treated|1
105742|NCT01006616|393733|P3|Period 1 (6 Months)|Not Treated|1
105743|NCT01006616|393734|P2|Period 1 (6 Months)|Not Treated|0
105744|NCT01006616|393735|P1|Period 1 (6 Months)|Not Treated|0
105745|NCT01006616|393732|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
105746|NCT01006616|393733|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
105747|NCT01006616|393734|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
105748|NCT01006616|393735|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
105749|NCT01006616|393732|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
105750|NCT01006616|393733|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
105751|NCT01006616|393734|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
105752|NCT01006616|393735|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
105753|NCT01006616|393732|P4|Period 1 (6 Months)|Withdrawal by Subject|0
105754|NCT01006616|393733|P3|Period 1 (6 Months)|Withdrawal by Subject|2
105755|NCT01006616|393734|P2|Period 1 (6 Months)|Withdrawal by Subject|2
105756|NCT01006616|393735|P1|Period 1 (6 Months)|Withdrawal by Subject|2
105757|NCT01006616|393732|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
105758|NCT01006616|393733|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
105759|NCT01006616|393734|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
105760|NCT01006616|393735|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
105761|NCT01006616|393732|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
105762|NCT01006616|393733|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
105763|NCT01006616|393734|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
105764|NCT01006616|393735|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
105765|NCT01006616|393732|P4|Period 1 (6 Months)|Lost to Follow-up|0
105766|NCT01006616|393733|P3|Period 1 (6 Months)|Lost to Follow-up|1
105767|NCT01006616|393734|P2|Period 1 (6 Months)|Lost to Follow-up|0
105768|NCT01006616|393735|P1|Period 1 (6 Months)|Lost to Follow-up|0
105769|NCT01006616|393732|P4|Period 1 (6 Months)|Lack of Efficacy|4
105770|NCT01006616|393733|P3|Period 1 (6 Months)|Lack of Efficacy|0
105771|NCT01006616|393734|P2|Period 1 (6 Months)|Lack of Efficacy|4
105772|NCT01006616|393735|P1|Period 1 (6 Months)|Lack of Efficacy|3
105773|NCT01006616|393732|P4|Period 1 (6 Months)|Adverse Event|9
105774|NCT01006616|393733|P3|Period 1 (6 Months)|Adverse Event|37
105775|NCT01006616|393734|P2|Period 1 (6 Months)|Adverse Event|31
105776|NCT01006616|393735|P1|Period 1 (6 Months)|Adverse Event|10
105777|NCT01006603|393871|P2|Overall Study|Other|7
105778|NCT01006603|393872|P1|Overall Study|Other|3
105779|NCT01006603|393871|P2|Overall Study|Study specific discontinuation criteria|34
105780|NCT01006603|393872|P1|Overall Study|Study specific discontinuation criteria|33
105781|NCT01006603|393871|P2|Overall Study|Death|1
105782|NCT01006603|393872|P1|Overall Study|Death|1
105783|NCT01006603|393871|P2|Overall Study|Adverse Event|7
105784|NCT01006603|393872|P1|Overall Study|Adverse Event|15
105785|NCT01006603|393871|P2|Overall Study|Incorrect enrolment|2
105786|NCT01006603|393872|P1|Overall Study|Incorrect enrolment|0
105787|NCT01006603|393871|P2|Overall Study|Protocol Violation|3
105788|NCT01006603|393872|P1|Overall Study|Protocol Violation|1
105789|NCT01006603|393871|P2|Overall Study|Safety reason|1
105790|NCT01006603|393872|P1|Overall Study|Safety reason|1
105791|NCT01006603|393871|P2|Overall Study|Lost to Follow-up|1
105792|NCT01006603|393872|P1|Overall Study|Lost to Follow-up|0
105793|NCT01006603|393871|P2|Overall Study|Withdrawal by Subject|19
105794|NCT01006603|393872|P1|Overall Study|Withdrawal by Subject|17
105795|NCT01006590|393892|P2|Overall Study|Not specified|2
105796|NCT01006590|393893|P1|Overall Study|Not specified|3
105797|NCT01006590|393892|P2|Overall Study|Study specific discontinuation criteria|23
105798|NCT01006590|393893|P1|Overall Study|Study specific discontinuation criteria|16
105799|NCT01006590|393892|P2|Overall Study|Withdrawal by Subject|2
105800|NCT01006590|393893|P1|Overall Study|Withdrawal by Subject|4
105801|NCT01006590|393892|P2|Overall Study|Protocol Violation|0
105802|NCT01006590|393893|P1|Overall Study|Protocol Violation|1
105803|NCT01006590|393892|P2|Overall Study|Lost to Follow-up|1
105804|NCT01006590|393893|P1|Overall Study|Lost to Follow-up|1
105805|NCT01006590|393892|P2|Overall Study|Death|1
105806|NCT01006590|393893|P1|Overall Study|Death|1
105807|NCT01006590|393892|P2|Overall Study|Adverse Event|3
105808|NCT01006590|393893|P1|Overall Study|Adverse Event|2
105809|NCT01006356|393909|P1|Overall Study|Other|23
105810|NCT01006356|393909|P1|Overall Study|Protocol Violation|3
105811|NCT01006356|393909|P1|Overall Study|Choice by participants|2
105812|NCT01006356|393909|P1|Overall Study|Withdrawal by Subject|1
105813|NCT01006356|393909|P1|Overall Study|Paticipants did not cooperate|6
105814|NCT01006356|393909|P1|Overall Study|Physician Decision|1
105815|NCT01006356|393909|P1|Overall Study|Adverse Event|6
105816|NCT01006291|393924|P3|Overall Study|Other|17
105817|NCT01006291|393925|P2|Overall Study|Other|14
105818|NCT01006291|393926|P1|Overall Study|Other|14
105819|NCT01006291|393924|P3|Overall Study|Withdrawal criteria|4
105820|NCT01006291|393925|P2|Overall Study|Withdrawal criteria|4
105821|NCT01006291|393926|P1|Overall Study|Withdrawal criteria|5
105822|NCT01006291|393924|P3|Overall Study|Protocol Violation|3
105823|NCT01006291|393925|P2|Overall Study|Protocol Violation|3
105824|NCT01006291|393926|P1|Overall Study|Protocol Violation|3
105825|NCT01006291|393924|P3|Overall Study|Lack of Efficacy|1
105826|NCT01006291|393925|P2|Overall Study|Lack of Efficacy|2
105827|NCT01006291|393926|P1|Overall Study|Lack of Efficacy|2
105828|NCT01006291|393924|P3|Overall Study|Adverse Event|2
105829|NCT01006291|393925|P2|Overall Study|Adverse Event|1
105830|NCT01006291|393926|P1|Overall Study|Adverse Event|2
105831|NCT01006135|393943|P1|Overall Study|Other|72
105832|NCT01006135|393943|P1|Overall Study|Lost to Follow-up|32
105833|NCT01006135|393943|P1|Overall Study|Protocol Violation|14
105834|NCT01006135|393943|P1|Overall Study|Adverse Event|22
105835|NCT01006122|393950|P2|Second Double-blind Intervention Period|Death|1
105836|NCT01006122|393951|P1|Second Double-blind Intervention Period|Death|0
105837|NCT01006122|393950|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
105838|NCT01006122|393951|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
105839|NCT01006122|393950|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
105840|NCT01006122|393951|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
105841|NCT01006122|393950|P2|Second Double-blind Intervention Period|Protocol Violation|0
105842|NCT01006122|393951|P1|Second Double-blind Intervention Period|Protocol Violation|1
105843|NCT01006122|393950|P2|Second Double-blind Intervention Period|Adverse Event|1
105844|NCT01006122|393951|P1|Second Double-blind Intervention Period|Adverse Event|1
105845|NCT01006122|393950|P2|First Double-blind Intervention Period|Adverse Event|4
105846|NCT01006122|393951|P1|First Double-blind Intervention Period|Adverse Event|0
105847|NCT01006122|393950|P2|First Double-blind Intervention Period|Other|0
105848|NCT01006122|393951|P1|First Double-blind Intervention Period|Other|3
105849|NCT01006122|393950|P2|First Double-blind Intervention Period|Lack of Efficacy|1
105850|NCT01006122|393951|P1|First Double-blind Intervention Period|Lack of Efficacy|2
105851|NCT01006122|393950|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
105852|NCT01006122|393951|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
105853|NCT01006122|393950|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
105854|NCT01006122|393951|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
105855|NCT01006122|393950|P2|First Double-blind Intervention Period|Pregnancy|1
105856|NCT01006122|393951|P1|First Double-blind Intervention Period|Pregnancy|0
105857|NCT01006122|393950|P2|First Double-blind Intervention Period|Protocol Violation|1
105858|NCT01006122|393951|P1|First Double-blind Intervention Period|Protocol Violation|1
105859|NCT01006122|393950|P2|First Double-blind Intervention Period|Lost to Follow-up|2
105860|NCT01006122|393951|P1|First Double-blind Intervention Period|Lost to Follow-up|0
105861|NCT01005966|394002|P5|Treatment Period 4 (14 Days)|Other Reason|1
105862|NCT01005966|394003|P4|Treatment Period 4 (14 Days)|Other Reason|0
105863|NCT01005966|394004|P3|Treatment Period 4 (14 Days)|Other Reason|0
105864|NCT01005966|394005|P2|Treatment Period 4 (14 Days)|Other Reason|0
105865|NCT01005966|394006|P1|Treatment Period 4 (14 Days)|Other Reason|0
105866|NCT01005966|394002|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
105867|NCT01005966|394003|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
105868|NCT01005966|394004|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
105869|NCT01005966|394005|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
105870|NCT01005966|394006|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
105871|NCT01005966|394002|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
105872|NCT01005966|394003|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
105873|NCT01005966|394004|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
105874|NCT01005966|394005|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
105875|NCT01005966|394006|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
105876|NCT01005966|394002|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
105877|NCT01005966|394003|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
105878|NCT01005966|394004|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
105879|NCT01005966|394005|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
105880|NCT01005966|394006|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
105881|NCT01005966|394002|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
105882|NCT01005966|394003|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
105883|NCT01005966|394004|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
105884|NCT01005966|394005|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
105885|NCT01005966|394006|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
105886|NCT01005966|394002|P5|Treatment Period 2 (14 Days)|Adverse Event|0
105887|NCT01005966|394003|P4|Treatment Period 2 (14 Days)|Adverse Event|0
105888|NCT01005966|394004|P3|Treatment Period 2 (14 Days)|Adverse Event|1
105889|NCT01005966|394005|P2|Treatment Period 2 (14 Days)|Adverse Event|1
105890|NCT01005966|394006|P1|Treatment Period 2 (14 Days)|Adverse Event|0
105891|NCT01005966|394002|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
105892|NCT01005966|394003|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
105893|NCT01005966|394004|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
105894|NCT01005966|394005|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
105895|NCT01005966|394006|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
105896|NCT01005966|394002|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
105897|NCT01005966|394003|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
105898|NCT01005966|394004|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
105899|NCT01005966|394005|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
105900|NCT01005966|394006|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
105901|NCT01005966|394002|P5|Treatment Period 1 (14 Days)|Adverse Event|0
105902|NCT01005966|394003|P4|Treatment Period 1 (14 Days)|Adverse Event|0
105903|NCT01005966|394004|P3|Treatment Period 1 (14 Days)|Adverse Event|0
105904|NCT01005966|394005|P2|Treatment Period 1 (14 Days)|Adverse Event|0
105905|NCT01005966|394006|P1|Treatment Period 1 (14 Days)|Adverse Event|1
105906|NCT01005914|394026|P1|Overall Study|Withdrawal by Subject|1
105907|NCT01005914|394026|P1|Overall Study|Lack of Efficacy|1
105908|NCT01005914|394026|P1|Overall Study|Death|4
105909|NCT01005914|394026|P1|Overall Study|Adverse Event|4
105910|NCT01005901|394032|P2|Overall Study|No longer requires study drug|1
105911|NCT01005901|394033|P1|Overall Study|No longer requires study drug|0
105912|NCT01005901|394032|P2|Overall Study|Patient's inability to use the device|1
105913|NCT01005901|394033|P1|Overall Study|Patient's inability to use the device|1
105914|NCT01005901|394032|P2|Overall Study|Lost to Follow-up|2
105915|NCT01005901|394033|P1|Overall Study|Lost to Follow-up|1
105916|NCT01005901|394032|P2|Overall Study|Death|3
105917|NCT01005901|394033|P1|Overall Study|Death|2
105918|NCT01005901|394032|P2|Overall Study|Protocol Violation|3
105919|NCT01005901|394033|P1|Overall Study|Protocol Violation|4
105920|NCT01005901|394032|P2|Overall Study|Unsatisfactory therapeutic effect|5
105921|NCT01005901|394033|P1|Overall Study|Unsatisfactory therapeutic effect|5
105922|NCT01005901|394032|P2|Overall Study|Administrative problems|13
105923|NCT01005901|394033|P1|Overall Study|Administrative problems|21
105924|NCT01005901|394032|P2|Overall Study|Adverse Event|16
105925|NCT01005901|394033|P1|Overall Study|Adverse Event|30
105926|NCT01005901|394032|P2|Overall Study|Withdrawal by Subject|14
105927|NCT01005901|394033|P1|Overall Study|Withdrawal by Subject|38
105928|NCT01005875|394096|P1|Overall Study|Death|3
105929|NCT01005745|394104|P1|Overall Study|Inappropriate antidiuretic hormone|1
105930|NCT01005745|394104|P1|Overall Study|Death prior to treatment|1
105931|NCT01005745|394104|P1|Overall Study|Disease progressed during TIL growth|3
105932|NCT01005745|394104|P1|Overall Study|No TIL growth|1
105933|NCT01005732|394109|P1|Overall Study|Death|1
105934|NCT01005732|394109|P1|Overall Study|Lost to Follow-up|10
105935|NCT01005719|394125|P6|Period 2|Adverse Event|1
105936|NCT01005719|394126|P5|Period 2|Adverse Event|1
105937|NCT01005719|394127|P4|Period 2|Adverse Event|0
105938|NCT01005719|394128|P3|Period 2|Adverse Event|0
105939|NCT01005719|394129|P2|Period 2|Adverse Event|0
105940|NCT01005719|394130|P1|Period 2|Adverse Event|0
105941|NCT01005719|394125|P6|Period 1|Delay in completing study procedures|1
105942|NCT01005719|394126|P5|Period 1|Delay in completing study procedures|0
105943|NCT01005719|394127|P4|Period 1|Delay in completing study procedures|0
105944|NCT01005719|394128|P3|Period 1|Delay in completing study procedures|0
105945|NCT01005719|394129|P2|Period 1|Delay in completing study procedures|0
105946|NCT01005719|394130|P1|Period 1|Delay in completing study procedures|0
105947|NCT01005719|394125|P6|Period 1|Adverse Event|0
105948|NCT01005719|394126|P5|Period 1|Adverse Event|0
105949|NCT01005719|394127|P4|Period 1|Adverse Event|1
105950|NCT01005719|394128|P3|Period 1|Adverse Event|0
105951|NCT01005719|394129|P2|Period 1|Adverse Event|0
105952|NCT01005719|394130|P1|Period 1|Adverse Event|0
105953|NCT01005680|394197|P2|Overall Study|Physician Decision|1
105954|NCT01005680|394198|P1|Overall Study|Physician Decision|1
105955|NCT01005680|394197|P2|Overall Study|Withdrawal by Subject|4
105956|NCT01005680|394198|P1|Overall Study|Withdrawal by Subject|1
105957|NCT01005680|394197|P2|Overall Study|Lost to Follow-up|6
105958|NCT01005680|394198|P1|Overall Study|Lost to Follow-up|4
105959|NCT01005602|394222|P2|Overall Study|Excluded due to unreliable clinical data|0
105960|NCT01005602|394223|P1|Overall Study|Excluded due to unreliable clinical data|1
105961|NCT01005329|394311|P1|Overall Study|Ineligible or received no protocol trt.|4
105962|NCT01005316|394324|P4|Overall Study|Retransplanted|0
105963|NCT01005316|394325|P3|Overall Study|Retransplanted|0
105964|NCT01005316|394326|P2|Overall Study|Retransplanted|1
105965|NCT01005316|394327|P1|Overall Study|Retransplanted|0
105966|NCT01005316|394324|P4|Overall Study|Transferred Care|3
105967|NCT01005316|394325|P3|Overall Study|Transferred Care|1
105968|NCT01005316|394326|P2|Overall Study|Transferred Care|0
105969|NCT01005316|394327|P1|Overall Study|Transferred Care|1
105970|NCT01005316|394324|P4|Overall Study|Delisted|0
105971|NCT01005316|394325|P3|Overall Study|Delisted|0
105972|NCT01005316|394326|P2|Overall Study|Delisted|0
105973|NCT01005316|394327|P1|Overall Study|Delisted|8
105974|NCT01005316|394324|P4|Overall Study|Consented to Another Study|0
105975|NCT01005316|394325|P3|Overall Study|Consented to Another Study|0
105976|NCT01005316|394326|P2|Overall Study|Consented to Another Study|0
105977|NCT01005316|394327|P1|Overall Study|Consented to Another Study|2
105978|NCT01005316|394324|P4|Overall Study|Withdrawal by Subject|2
105979|NCT01005316|394325|P3|Overall Study|Withdrawal by Subject|0
105980|NCT01005316|394326|P2|Overall Study|Withdrawal by Subject|1
105981|NCT01005316|394327|P1|Overall Study|Withdrawal by Subject|1
105982|NCT01005316|394324|P4|Overall Study|Sponsor Decision|0
105983|NCT01005316|394325|P3|Overall Study|Sponsor Decision|0
105984|NCT01005316|394326|P2|Overall Study|Sponsor Decision|3
105985|NCT01005316|394327|P1|Overall Study|Sponsor Decision|6
105986|NCT01005316|394324|P4|Overall Study|Physician Decision|0
105987|NCT01005316|394325|P3|Overall Study|Physician Decision|0
105988|NCT01005316|394326|P2|Overall Study|Physician Decision|0
105989|NCT01005316|394327|P1|Overall Study|Physician Decision|6
105990|NCT01005316|394324|P4|Overall Study|Lost to Follow-up|2
105991|NCT01005316|394325|P3|Overall Study|Lost to Follow-up|0
105992|NCT01005316|394326|P2|Overall Study|Lost to Follow-up|3
105993|NCT01005316|394327|P1|Overall Study|Lost to Follow-up|1
105994|NCT01005316|394324|P4|Overall Study|Study Termination|85
105995|NCT01005316|394325|P3|Overall Study|Study Termination|9
105996|NCT01005316|394326|P2|Overall Study|Study Termination|63
105997|NCT01005316|394327|P1|Overall Study|Study Termination|5
105998|NCT01005316|394324|P4|Overall Study|Death|15
105999|NCT01005316|394325|P3|Overall Study|Death|1
106000|NCT01005316|394326|P2|Overall Study|Death|5
106001|NCT01005316|394327|P1|Overall Study|Death|20
106002|NCT01005316|394324|P4|Overall Study|Adverse Event|1
106003|NCT01005316|394325|P3|Overall Study|Adverse Event|0
106004|NCT01005316|394326|P2|Overall Study|Adverse Event|0
106005|NCT01005316|394327|P1|Overall Study|Adverse Event|0
106006|NCT01005251|394394|P5|Overall Study|Lack of Efficacy|0
106007|NCT01005251|394395|P4|Overall Study|Lack of Efficacy|1
106008|NCT01005251|394396|P3|Overall Study|Lack of Efficacy|1
106009|NCT01005251|394397|P2|Overall Study|Lack of Efficacy|0
106010|NCT01005251|394398|P1|Overall Study|Lack of Efficacy|0
106011|NCT01005251|394394|P5|Overall Study|Randomized in error|0
106012|NCT01005251|394395|P4|Overall Study|Randomized in error|1
106013|NCT01005251|394396|P3|Overall Study|Randomized in error|1
106014|NCT01005251|394397|P2|Overall Study|Randomized in error|0
106015|NCT01005251|394398|P1|Overall Study|Randomized in error|0
106016|NCT01005251|394394|P5|Overall Study|Wrong drug dispensed|0
106017|NCT01005251|394395|P4|Overall Study|Wrong drug dispensed|0
106018|NCT01005251|394396|P3|Overall Study|Wrong drug dispensed|0
106019|NCT01005251|394397|P2|Overall Study|Wrong drug dispensed|1
106020|NCT01005251|394398|P1|Overall Study|Wrong drug dispensed|0
106021|NCT01005251|394394|P5|Overall Study|Patient moved|0
106022|NCT01005251|394395|P4|Overall Study|Patient moved|0
106023|NCT01005251|394396|P3|Overall Study|Patient moved|0
106024|NCT01005251|394397|P2|Overall Study|Patient moved|0
106025|NCT01005251|394398|P1|Overall Study|Patient moved|1
106026|NCT01005251|394394|P5|Overall Study|Physician Decision|2
106027|NCT01005251|394395|P4|Overall Study|Physician Decision|0
106028|NCT01005251|394396|P3|Overall Study|Physician Decision|0
106029|NCT01005251|394397|P2|Overall Study|Physician Decision|0
106030|NCT01005251|394398|P1|Overall Study|Physician Decision|0
106031|NCT01005251|394394|P5|Overall Study|Lost to Follow-up|0
106032|NCT01005251|394395|P4|Overall Study|Lost to Follow-up|0
106033|NCT01005251|394396|P3|Overall Study|Lost to Follow-up|2
106034|NCT01005251|394397|P2|Overall Study|Lost to Follow-up|4
106035|NCT01005251|394398|P1|Overall Study|Lost to Follow-up|1
106036|NCT01005251|394394|P5|Overall Study|Developed study-specific withdrawal crit|1
106037|NCT01005251|394395|P4|Overall Study|Developed study-specific withdrawal crit|0
106038|NCT01005251|394396|P3|Overall Study|Developed study-specific withdrawal crit|3
106039|NCT01005251|394397|P2|Overall Study|Developed study-specific withdrawal crit|0
106040|NCT01005251|394398|P1|Overall Study|Developed study-specific withdrawal crit|2
106041|NCT01005251|394394|P5|Overall Study|Protocol Violation|2
106042|NCT01005251|394395|P4|Overall Study|Protocol Violation|0
106043|NCT01005251|394396|P3|Overall Study|Protocol Violation|0
106044|NCT01005251|394397|P2|Overall Study|Protocol Violation|0
106045|NCT01005251|394398|P1|Overall Study|Protocol Violation|1
106046|NCT01005251|394394|P5|Overall Study|Adverse Event|4
106047|NCT01005251|394395|P4|Overall Study|Adverse Event|5
106048|NCT01005251|394396|P3|Overall Study|Adverse Event|8
106049|NCT01005251|394397|P2|Overall Study|Adverse Event|6
106050|NCT01005251|394398|P1|Overall Study|Adverse Event|2
106051|NCT01005251|394394|P5|Overall Study|Eligibility criteria not fulfilled|0
106052|NCT01005251|394395|P4|Overall Study|Eligibility criteria not fulfilled|1
106053|NCT01005251|394396|P3|Overall Study|Eligibility criteria not fulfilled|4
106054|NCT01005251|394397|P2|Overall Study|Eligibility criteria not fulfilled|0
106055|NCT01005251|394398|P1|Overall Study|Eligibility criteria not fulfilled|4
106056|NCT01005251|394394|P5|Overall Study|Withdrawal by Subject|9
106057|NCT01005251|394395|P4|Overall Study|Withdrawal by Subject|4
106058|NCT01005251|394396|P3|Overall Study|Withdrawal by Subject|3
106059|NCT01005251|394397|P2|Overall Study|Withdrawal by Subject|5
106060|NCT01005251|394398|P1|Overall Study|Withdrawal by Subject|2
106061|NCT01004848|394471|P2|Overall Study|Lost to Follow-up|45
106062|NCT01004848|394472|P1|Overall Study|Lost to Follow-up|55
106063|NCT01004822|394510|P8|Overall Study|Other|0
106064|NCT01004822|394511|P7|Overall Study|Other|0
106065|NCT01004822|394512|P6|Overall Study|Other|1
106066|NCT01004822|394513|P5|Overall Study|Other|0
106067|NCT01004822|394514|P4|Overall Study|Other|1
106068|NCT01004822|394515|P3|Overall Study|Other|4
106069|NCT01004822|394516|P2|Overall Study|Other|0
106070|NCT01004822|394517|P1|Overall Study|Other|0
106071|NCT01004822|394510|P8|Overall Study|Adverse Event|1
106072|NCT01004822|394511|P7|Overall Study|Adverse Event|1
106073|NCT01004822|394512|P6|Overall Study|Adverse Event|0
106074|NCT01004822|394513|P5|Overall Study|Adverse Event|0
106075|NCT01004822|394514|P4|Overall Study|Adverse Event|0
106076|NCT01004822|394515|P3|Overall Study|Adverse Event|0
106077|NCT01004822|394516|P2|Overall Study|Adverse Event|0
106078|NCT01004822|394517|P1|Overall Study|Adverse Event|0
106079|NCT01004822|394510|P8|Overall Study|No longer willing to continue|0
106080|NCT01004822|394511|P7|Overall Study|No longer willing to continue|1
106081|NCT01004822|394512|P6|Overall Study|No longer willing to continue|1
106082|NCT01004822|394513|P5|Overall Study|No longer willing to continue|2
106083|NCT01004822|394514|P4|Overall Study|No longer willing to continue|1
106084|NCT01004822|394515|P3|Overall Study|No longer willing to continue|0
106085|NCT01004822|394516|P2|Overall Study|No longer willing to continue|0
106086|NCT01004822|394517|P1|Overall Study|No longer willing to continue|0
106087|NCT01004822|394510|P8|Overall Study|Global deterioration of health status|0
106088|NCT01004822|394511|P7|Overall Study|Global deterioration of health status|1
106089|NCT01004822|394512|P6|Overall Study|Global deterioration of health status|0
106090|NCT01004822|394513|P5|Overall Study|Global deterioration of health status|0
106091|NCT01004822|394514|P4|Overall Study|Global deterioration of health status|1
106092|NCT01004822|394515|P3|Overall Study|Global deterioration of health status|0
106093|NCT01004822|394516|P2|Overall Study|Global deterioration of health status|0
106094|NCT01004822|394517|P1|Overall Study|Global deterioration of health status|0
106095|NCT01004822|394510|P8|Overall Study|Objective progression or relapse|4
106096|NCT01004822|394511|P7|Overall Study|Objective progression or relapse|1
106097|NCT01004822|394512|P6|Overall Study|Objective progression or relapse|2
106098|NCT01004822|394513|P5|Overall Study|Objective progression or relapse|2
106099|NCT01004822|394514|P4|Overall Study|Objective progression or relapse|1
106100|NCT01004822|394515|P3|Overall Study|Objective progression or relapse|0
106101|NCT01004822|394516|P2|Overall Study|Objective progression or relapse|3
106102|NCT01004822|394517|P1|Overall Study|Objective progression or relapse|3
106103|NCT01004614|394682|P4|Washout|Withdrawal by Subject|0
106104|NCT01004614|394683|P3|Washout|Withdrawal by Subject|0
106105|NCT01004614|394684|P2|Washout|Withdrawal by Subject|1
106106|NCT01004614|394685|P1|Washout|Withdrawal by Subject|0
106107|NCT01004510|394719|P1|Overall Study|Adverse Event|1
106108|NCT01004432|394723|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
106109|NCT01004432|394724|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
106110|NCT01004432|394725|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
106111|NCT01004432|394726|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
106112|NCT01004432|394727|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
106113|NCT01004432|394723|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
106114|NCT01004432|394724|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
106115|NCT01004432|394725|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
106116|NCT01004432|394726|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
106117|NCT01004432|394727|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
106118|NCT01004432|394723|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
106119|NCT01004432|394724|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
106120|NCT01004432|394725|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
106121|NCT01004432|394726|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
106122|NCT01004432|394727|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
106123|NCT01004432|394723|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
106124|NCT01004432|394724|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
106125|NCT01004432|394725|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
106126|NCT01004432|394726|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
106127|NCT01004432|394727|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
106128|NCT01004432|394723|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
106129|NCT01004432|394724|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
106130|NCT01004432|394725|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
106131|NCT01004432|394726|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
106132|NCT01004432|394727|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
106133|NCT01004432|394723|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
106134|NCT01004432|394724|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
106135|NCT01004432|394725|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
106136|NCT01004432|394726|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
106137|NCT01004432|394727|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
106138|NCT01004432|394723|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
106139|NCT01004432|394724|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
106140|NCT01004432|394725|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
106141|NCT01004432|394726|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
106142|NCT01004432|394727|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
106143|NCT01004432|394723|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
106144|NCT01004432|394724|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
106145|NCT01004432|394725|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
106146|NCT01004432|394726|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
106147|NCT01004432|394727|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
106148|NCT01004432|394723|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
106149|NCT01004432|394724|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
106150|NCT01004432|394725|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
106151|NCT01004432|394726|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
106152|NCT01004432|394727|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
106153|NCT01004432|394723|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
106154|NCT01004432|394724|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
106155|NCT01004432|394725|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
106156|NCT01004432|394726|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
106157|NCT01004432|394727|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
106158|NCT01004432|394723|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
106159|NCT01004432|394724|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
106160|NCT01004432|394725|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
106161|NCT01004432|394726|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
106162|NCT01004432|394727|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
106163|NCT01004432|394723|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
106164|NCT01004432|394724|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
106165|NCT01004432|394725|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
106166|NCT01004432|394726|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
106167|NCT01004432|394727|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
106168|NCT01004432|394723|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
106169|NCT01004432|394724|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
106170|NCT01004432|394725|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
106171|NCT01004432|394726|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
106172|NCT01004432|394727|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
106173|NCT01004432|394723|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
106174|NCT01004432|394724|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
106175|NCT01004432|394725|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
106176|NCT01004432|394726|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
106177|NCT01004432|394727|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
106178|NCT01004432|394723|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
106179|NCT01004432|394724|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
106180|NCT01004432|394725|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
106181|NCT01004432|394726|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
106182|NCT01004432|394727|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
106183|NCT01004263|394770|P1|Overall Study|Lack of Qualifying Event|2
106184|NCT01004263|394770|P1|Overall Study|Physician Decision|15
106185|NCT01004263|394770|P1|Overall Study|Pregnancy|2
106186|NCT01004263|394770|P1|Overall Study|Lack of Efficacy|13
106187|NCT01004263|394770|P1|Overall Study|Lost to Follow-up|64
106188|NCT01004263|394770|P1|Overall Study|Protocol Violation|10
106189|NCT01004263|394770|P1|Overall Study|Withdrawal by Subject|58
106190|NCT01004263|394770|P1|Overall Study|Adverse Event|15
106191|NCT01004250|394778|P1|Follow-Up (FU) Period|Lost to Follow-up|1
106192|NCT01004250|394778|P1|Maintenance Therapy Period|Physician Decision|4
106193|NCT01004250|394778|P1|Maintenance Therapy Period|Withdrawal by Subject|5
106194|NCT01004250|394778|P1|Maintenance Therapy Period|Protocol Violation|1
106195|NCT01004250|394778|P1|Maintenance Therapy Period|Lost to Follow-up|1
106196|NCT01004250|394778|P1|Maintenance Therapy Period|Adverse Event|15
106197|NCT01004250|394778|P1|Induction Therapy Period|Physician Decision|2
106198|NCT01004250|394778|P1|Induction Therapy Period|Withdrawal by Subject|2
106199|NCT01004250|394778|P1|Induction Therapy Period|Entry Criteria Not Met|1
106200|NCT01004250|394778|P1|Induction Therapy Period|Adverse Event|10
106201|NCT01004185|394790|P2|Overall Study|Withdrawal by Subject|1
106202|NCT01004185|394791|P1|Overall Study|Withdrawal by Subject|2
106203|NCT01004185|394790|P2|Overall Study|Sponsor Terminated Study|5
106204|NCT01004185|394791|P1|Overall Study|Sponsor Terminated Study|4
106205|NCT01004185|394790|P2|Overall Study|Lack of Efficacy|1
106206|NCT01004185|394791|P1|Overall Study|Lack of Efficacy|2
106207|NCT01004185|394790|P2|Overall Study|Lost to Follow-up|1
106208|NCT01004185|394791|P1|Overall Study|Lost to Follow-up|0
106209|NCT01004185|394790|P2|Overall Study|Adverse Event|1
106210|NCT01004185|394791|P1|Overall Study|Adverse Event|1
106211|NCT01004172|394799|P1|Overall Study|Symptomatic Deterioration|2
106212|NCT01004172|394799|P1|Overall Study|Physician Decision|1
106213|NCT01004172|394799|P1|Overall Study|Adverse Event|1
106214|NCT01004172|394799|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
106215|NCT01004172|394799|P1|Overall Study|Progressive Disease in Non-CNS Only|16
106216|NCT01004172|394799|P1|Overall Study|Progressive Disease in CNS Only|16
106217|NCT01004159|394805|P1|Overall Study|Disease Progression|18
106218|NCT01004159|394805|P1|Overall Study|Adverse Event|2
106219|NCT01004146|394812|P2|Overall Study|Withdrawal by Subject|5
106220|NCT01004146|394813|P1|Overall Study|Withdrawal by Subject|4
106221|NCT01004003|394828|P9|Overall Study|Other|0
106222|NCT01004003|394829|P8|Overall Study|Other|0
106223|NCT01004003|394830|P7|Overall Study|Other|0
106224|NCT01004003|394831|P6|Overall Study|Other|1
106225|NCT01004003|394832|P5|Overall Study|Other|0
106226|NCT01004003|394833|P4|Overall Study|Other|0
106227|NCT01004003|394834|P3|Overall Study|Other|0
106228|NCT01004003|394835|P2|Overall Study|Other|0
106229|NCT01004003|394836|P1|Overall Study|Other|0
106230|NCT01004003|394828|P9|Overall Study|Refused to continue taking trial med.|2
106231|NCT01004003|394829|P8|Overall Study|Refused to continue taking trial med.|0
106232|NCT01004003|394830|P7|Overall Study|Refused to continue taking trial med.|0
106233|NCT01004003|394831|P6|Overall Study|Refused to continue taking trial med.|0
106234|NCT01004003|394832|P5|Overall Study|Refused to continue taking trial med.|0
106235|NCT01004003|394833|P4|Overall Study|Refused to continue taking trial med.|0
106236|NCT01004003|394834|P3|Overall Study|Refused to continue taking trial med.|0
106237|NCT01004003|394835|P2|Overall Study|Refused to continue taking trial med.|0
106238|NCT01004003|394836|P1|Overall Study|Refused to continue taking trial med.|0
106239|NCT01004003|394828|P9|Overall Study|Adverse Event|6
106240|NCT01004003|394829|P8|Overall Study|Adverse Event|21
106241|NCT01004003|394830|P7|Overall Study|Adverse Event|7
106242|NCT01004003|394831|P6|Overall Study|Adverse Event|2
106243|NCT01004003|394832|P5|Overall Study|Adverse Event|2
106244|NCT01004003|394833|P4|Overall Study|Adverse Event|3
106245|NCT01004003|394834|P3|Overall Study|Adverse Event|3
106246|NCT01004003|394835|P2|Overall Study|Adverse Event|2
106247|NCT01004003|394836|P1|Overall Study|Adverse Event|4
106248|NCT01004003|394828|P9|Overall Study|Progressive disease|22
106249|NCT01004003|394829|P8|Overall Study|Progressive disease|39
106250|NCT01004003|394830|P7|Overall Study|Progressive disease|1
106251|NCT01004003|394831|P6|Overall Study|Progressive disease|1
106252|NCT01004003|394832|P5|Overall Study|Progressive disease|2
106253|NCT01004003|394833|P4|Overall Study|Progressive disease|0
106254|NCT01004003|394834|P3|Overall Study|Progressive disease|1
106255|NCT01004003|394835|P2|Overall Study|Progressive disease|1
106256|NCT01004003|394836|P1|Overall Study|Progressive disease|2
106257|NCT01003990|394867|P3|Overall Study|Subject Withdrew Consent|7
106258|NCT01003990|394868|P2|Overall Study|Subject Withdrew Consent|5
106259|NCT01003990|394869|P1|Overall Study|Subject Withdrew Consent|12
106260|NCT01003990|394867|P3|Overall Study|No Longer Met Study Criteria|0
106261|NCT01003990|394868|P2|Overall Study|No Longer Met Study Criteria|1
106262|NCT01003990|394869|P1|Overall Study|No Longer Met Study Criteria|4
106263|NCT01003990|394867|P3|Overall Study|Pregnancy|4
106264|NCT01003990|394868|P2|Overall Study|Pregnancy|2
106265|NCT01003990|394869|P1|Overall Study|Pregnancy|10
106266|NCT01003990|394867|P3|Overall Study|Poor/Non-compliance|2
106267|NCT01003990|394868|P2|Overall Study|Poor/Non-compliance|3
106268|NCT01003990|394869|P1|Overall Study|Poor/Non-compliance|4
106269|NCT01003990|394867|P3|Overall Study|Reasons Not Identified|8
106270|NCT01003990|394868|P2|Overall Study|Reasons Not Identified|13
106271|NCT01003990|394869|P1|Overall Study|Reasons Not Identified|14
106272|NCT01003990|394867|P3|Overall Study|Lost to Follow-up|7
106273|NCT01003990|394868|P2|Overall Study|Lost to Follow-up|12
106274|NCT01003990|394869|P1|Overall Study|Lost to Follow-up|30
106275|NCT01003990|394867|P3|Overall Study|Lack of Efficacy|3
106276|NCT01003990|394868|P2|Overall Study|Lack of Efficacy|2
106277|NCT01003990|394869|P1|Overall Study|Lack of Efficacy|10
106278|NCT01003990|394867|P3|Overall Study|Death|1
106279|NCT01003990|394868|P2|Overall Study|Death|8
106280|NCT01003990|394869|P1|Overall Study|Death|0
106281|NCT01003990|394867|P3|Overall Study|Adverse Event|11
106282|NCT01003990|394868|P2|Overall Study|Adverse Event|5
106283|NCT01003990|394869|P1|Overall Study|Adverse Event|8
106284|NCT01003899|394886|P1|Overall Study|Progressive disease|34
106285|NCT01003899|394886|P1|Overall Study|Not treated|1
106286|NCT01003899|394886|P1|Overall Study|Not entered|4
106287|NCT01003899|394886|P1|Overall Study|Other Adverse Event|8
106288|NCT01003886|394895|P1|Overall Study|Adverse Event|3
106289|NCT01003886|394895|P1|Overall Study|Other|14
106290|NCT01003886|394895|P1|Overall Study|Withdrawal by Subject|39
106291|NCT01003886|394895|P1|Overall Study|Lost to Follow-up|169
106292|NCT01003886|394895|P1|Overall Study|Lack of Efficacy|5
106293|NCT01003249|394929|P2|Second Intervention (4 Weeks)|Adverse Event|0
106294|NCT01003249|394930|P1|Second Intervention (4 Weeks)|Adverse Event|1
106295|NCT01003249|394929|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
106296|NCT01003249|394930|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
106297|NCT01003249|394929|P2|First Intervention (4 Weeks)|Non-Serious Event|1
106298|NCT01003249|394930|P1|First Intervention (4 Weeks)|Non-Serious Event|1
106299|NCT01003249|394929|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
106300|NCT01003249|394930|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
106301|NCT01003210|394948|P2|Overall Study|Lost to Follow-up|3
106302|NCT01003210|394949|P1|Overall Study|Lost to Follow-up|1
106303|NCT01003184|394959|P2|Overall Study|Physician Decision|0
106304|NCT01003184|394960|P1|Overall Study|Physician Decision|1
106305|NCT01003184|394959|P2|Overall Study|Withdrawal by Subject|6
106306|NCT01003184|394960|P1|Overall Study|Withdrawal by Subject|1
106307|NCT01003184|394959|P2|Overall Study|Protocol Violation|0
106308|NCT01003184|394960|P1|Overall Study|Protocol Violation|3
106309|NCT01003184|394959|P2|Overall Study|Loss of glucose control|1
106310|NCT01003184|394960|P1|Overall Study|Loss of glucose control|1
106311|NCT01003184|394959|P2|Overall Study|Lost to Follow-up|0
106312|NCT01003184|394960|P1|Overall Study|Lost to Follow-up|1
106313|NCT01003184|394959|P2|Overall Study|Adverse Event|5
106314|NCT01003184|394960|P1|Overall Study|Adverse Event|12
106315|NCT01002989|395043|P1|Overall Study|exclusion criteria, no consent|5
106316|NCT01002742|395052|P2|Overall Study|Determined to be ineligible|1
106317|NCT01002742|395053|P1|Overall Study|Determined to be ineligible|0
106318|NCT01002573|395089|P2|Overall Study|Subject did not receive at least 1 dose|7
106319|NCT01002573|395090|P1|Overall Study|Subject did not receive at least 1 dose|11
106320|NCT01002482|395110|P2|Overall Study|Included twice|0
106321|NCT01002482|395111|P1|Overall Study|Included twice|1
106322|NCT01002482|395110|P2|Overall Study|Withdrawal by Subject|21
106323|NCT01002482|395111|P1|Overall Study|Withdrawal by Subject|14
106324|NCT01002339|395145|P3|Overall Study|Randomized. Not transplanted|1
106325|NCT01002339|395146|P2|Overall Study|Randomized. Not transplanted|0
106326|NCT01002339|395147|P1|Overall Study|Randomized. Not transplanted|0
106327|NCT01002339|395145|P3|Overall Study|Lung cancer detected before transplant|1
106328|NCT01002339|395146|P2|Overall Study|Lung cancer detected before transplant|0
106329|NCT01002339|395147|P1|Overall Study|Lung cancer detected before transplant|0
106330|NCT01002339|395145|P3|Overall Study|Protocol Violation|2
106331|NCT01002339|395146|P2|Overall Study|Protocol Violation|0
106332|NCT01002339|395147|P1|Overall Study|Protocol Violation|0
106333|NCT01002339|395145|P3|Overall Study|Incorrect treatment assignment|1
106334|NCT01002339|395146|P2|Overall Study|Incorrect treatment assignment|0
106335|NCT01002339|395147|P1|Overall Study|Incorrect treatment assignment|0
106336|NCT01002339|395145|P3|Overall Study|Withdrawal by Subject|0
106337|NCT01002339|395146|P2|Overall Study|Withdrawal by Subject|1
106338|NCT01002339|395147|P1|Overall Study|Withdrawal by Subject|0
106339|NCT01002105|395223|P2|Overall Study|condition worsened|2
106340|NCT01002105|395224|P1|Overall Study|condition worsened|4
106341|NCT01002105|395223|P2|Overall Study|non compliance|3
106342|NCT01002105|395224|P1|Overall Study|non compliance|5
106343|NCT01002105|395223|P2|Overall Study|Lost to Follow-up|16
106344|NCT01002105|395224|P1|Overall Study|Lost to Follow-up|10
106345|NCT01001988|395240|P1|Overall Study|Lost to Follow-up|15
106346|NCT01001988|395240|P1|Overall Study|Withdrawal by Subject|18
106347|NCT01001988|395240|P1|Overall Study|Protocol Violation|84
106348|NCT01001832|395258|P2|Follow-up Period|Not specified|1
106349|NCT01001832|395259|P1|Follow-up Period|Not specified|2
106350|NCT01001832|395258|P2|Follow-up Period|Follow-up no longer required /protocol|20
106351|NCT01001832|395259|P1|Follow-up Period|Follow-up no longer required /protocol|15
106352|NCT01001832|395258|P2|Follow-up Period|Withdrawal by Subject|0
106353|NCT01001832|395259|P1|Follow-up Period|Withdrawal by Subject|1
106354|NCT01001832|395258|P2|Long-term Period|Not specified|2
106355|NCT01001832|395259|P1|Long-term Period|Not specified|1
106356|NCT01001832|395258|P2|Long-term Period|Lack of Efficacy|2
106357|NCT01001832|395259|P1|Long-term Period|Lack of Efficacy|0
106358|NCT01001832|395258|P2|Long-term Period|Withdrawal by Subject|0
106359|NCT01001832|395259|P1|Long-term Period|Withdrawal by Subject|1
106360|NCT01001832|395258|P2|Long-term Period|Adverse Event|1
106361|NCT01001832|395259|P1|Long-term Period|Adverse Event|2
106362|NCT01001832|395258|P2|Short-term Period|Adverse Event|3
106363|NCT01001832|395259|P1|Short-term Period|Adverse Event|2
106364|NCT01001767|395317|P2|Overall Study|Physician Decision|0
106365|NCT01001767|395318|P1|Overall Study|Physician Decision|1
106366|NCT01001767|395317|P2|Overall Study|Lost to Follow-up|0
106367|NCT01001767|395318|P1|Overall Study|Lost to Follow-up|1
106368|NCT01001767|395317|P2|Overall Study|Protocol Violation|0
106369|NCT01001767|395318|P1|Overall Study|Protocol Violation|1
106370|NCT01001767|395317|P2|Overall Study|no baseline study performed|0
106371|NCT01001767|395318|P1|Overall Study|no baseline study performed|1
106372|NCT01001702|395324|P1|Overall Study|Lack of Efficacy per Investigator|3
106373|NCT01001702|395324|P1|Overall Study|Withdrawal by Subject|19
106374|NCT01001702|395324|P1|Overall Study|Investigator withdrew Subject|10
106375|NCT01001702|395324|P1|Overall Study|Subject met Withdrawal Criteria|22
106376|NCT01001702|395324|P1|Overall Study|Sponsor Discontinued Study|4
106377|NCT01001702|395324|P1|Overall Study|Adverse Event|7
106378|NCT01001702|395324|P1|Overall Study|Lost to Follow-up|7
106379|NCT01001572|395337|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
106380|NCT01001572|395338|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
106381|NCT01001572|395339|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
106382|NCT01001572|395337|P3|Double-Blind Treatment Phase|Protocol deviation|1
106383|NCT01001572|395338|P2|Double-Blind Treatment Phase|Protocol deviation|0
106384|NCT01001572|395339|P1|Double-Blind Treatment Phase|Protocol deviation|0
106385|NCT01001572|395337|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
106386|NCT01001572|395338|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
106387|NCT01001572|395339|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
106388|NCT01001572|395337|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
106389|NCT01001572|395338|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
106390|NCT01001572|395339|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
106391|NCT01001572|395337|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
106392|NCT01001572|395338|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
106393|NCT01001572|395339|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
106394|NCT01001572|395337|P3|Double-Blind Treatment Phase|Adverse Event|2
106395|NCT01001572|395338|P2|Double-Blind Treatment Phase|Adverse Event|2
106396|NCT01001572|395339|P1|Double-Blind Treatment Phase|Adverse Event|0
106397|NCT01001572|395337|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
106398|NCT01001572|395338|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
106399|NCT01001572|395339|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
106400|NCT01001572|395337|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
106401|NCT01001572|395338|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
106402|NCT01001572|395339|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
106403|NCT01001572|395337|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
106404|NCT01001572|395338|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
106405|NCT01001572|395339|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
106406|NCT01001572|395337|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
106407|NCT01001572|395338|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
106408|NCT01001572|395339|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
106409|NCT01001572|395337|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
106410|NCT01001572|395338|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
106411|NCT01001572|395339|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
106412|NCT01001572|395337|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
106413|NCT01001572|395338|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
106414|NCT01001572|395339|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
106415|NCT01001572|395337|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
106416|NCT01001572|395338|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
106417|NCT01001572|395339|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
106418|NCT01001572|395337|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
106419|NCT01001572|395338|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
106420|NCT01001572|395339|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
106421|NCT01001520|395377|P2|Medication Period 2|Withdrawal by Subject|3
106422|NCT01001520|395378|P1|Medication Period 2|Withdrawal by Subject|0
106423|NCT01001520|395377|P2|Washout Period|Withdrawal by Subject|1
106424|NCT01001520|395378|P1|Washout Period|Withdrawal by Subject|2
106425|NCT01001520|395377|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
106426|NCT01001520|395378|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
106427|NCT01001520|395377|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
106428|NCT01001520|395378|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
106429|NCT01001520|395377|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
106430|NCT01001520|395378|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
106431|NCT01001520|395377|P2|Medication Period 1|Withdrawal by Subject|2
106432|NCT01001520|395378|P1|Medication Period 1|Withdrawal by Subject|2
106433|NCT01001494|395405|P3|Overall Study|Other|3
106434|NCT01001494|395406|P2|Overall Study|Other|1
106435|NCT01001494|395407|P1|Overall Study|Other|0
106436|NCT01001494|395405|P3|Overall Study|Lack of Efficacy|8
106437|NCT01001494|395406|P2|Overall Study|Lack of Efficacy|0
106438|NCT01001494|395407|P1|Overall Study|Lack of Efficacy|2
106439|NCT01001494|395405|P3|Overall Study|COPD exacerbation|5
106440|NCT01001494|395406|P2|Overall Study|COPD exacerbation|4
106441|NCT01001494|395407|P1|Overall Study|COPD exacerbation|3
106442|NCT01001494|395405|P3|Overall Study|Withdrawal by Subject|17
106443|NCT01001494|395406|P2|Overall Study|Withdrawal by Subject|7
106444|NCT01001494|395407|P1|Overall Study|Withdrawal by Subject|9
106445|NCT01001494|395405|P3|Overall Study|Lost to Follow-up|1
106446|NCT01001494|395406|P2|Overall Study|Lost to Follow-up|0
106447|NCT01001494|395407|P1|Overall Study|Lost to Follow-up|2
106448|NCT01001494|395405|P3|Overall Study|Protocol Violation|1
106449|NCT01001494|395406|P2|Overall Study|Protocol Violation|1
106450|NCT01001494|395407|P1|Overall Study|Protocol Violation|0
106451|NCT01001494|395405|P3|Overall Study|Adverse Event|6
106452|NCT01001494|395406|P2|Overall Study|Adverse Event|4
106453|NCT01001494|395407|P1|Overall Study|Adverse Event|8
106454|NCT01001429|395492|P2|Overall Study|surgery cancelled|1
106455|NCT01001429|395493|P1|Overall Study|surgery cancelled|0
106456|NCT01001390|395532|P2|Overall Study|Failure to wear AFO device|0
106457|NCT01001390|395533|P1|Overall Study|Failure to wear AFO device|2
106458|NCT01001377|395541|P2|Overall Study|Death|384
106459|NCT01001377|395542|P1|Overall Study|Death|391
106460|NCT01001377|395541|P2|Overall Study|Lost to Follow-up|17
106461|NCT01001377|395542|P1|Overall Study|Lost to Follow-up|14
106462|NCT01001377|395541|P2|Overall Study|Withdrawal by Subject|20
106463|NCT01001377|395542|P1|Overall Study|Withdrawal by Subject|19
106464|NCT01001377|395541|P2|Overall Study|Ineligibility determined|0
106465|NCT01001377|395542|P1|Overall Study|Ineligibility determined|2
106466|NCT01001325|395572|P2|Overall Study|Protocol Violation|0
106467|NCT01001325|395573|P1|Overall Study|Protocol Violation|2
106468|NCT01001325|395572|P2|Overall Study|Lost to Follow-up|10
106469|NCT01001325|395573|P1|Overall Study|Lost to Follow-up|16
106470|NCT01001299|395579|P1|Overall Study|Withdrew Consent|1
106471|NCT01001299|395579|P1|Overall Study|Began Taking Commercially Available Drug|2
106472|NCT01001299|395579|P1|Overall Study|Death|1
106473|NCT01001299|395579|P1|Overall Study|Adverse event or Intercurrent Illness|1
106474|NCT01001299|395579|P1|Overall Study|Insufficient Therapeutic Response|20
106475|NCT01001234|395608|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
106476|NCT01001234|395609|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
106477|NCT01001234|395610|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
106478|NCT01001234|395611|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
106479|NCT01001234|395612|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
106480|NCT01001234|395608|P5|Overall Study|Not Treated: Physician Decision|0
106481|NCT01001234|395609|P4|Overall Study|Not Treated: Physician Decision|0
106482|NCT01001234|395610|P3|Overall Study|Not Treated: Physician Decision|0
106483|NCT01001234|395611|P2|Overall Study|Not Treated: Physician Decision|4
106484|NCT01001234|395612|P1|Overall Study|Not Treated: Physician Decision|37
106485|NCT01001234|395608|P5|Overall Study|Not Treated: Pregnancy|0
106486|NCT01001234|395609|P4|Overall Study|Not Treated: Pregnancy|0
106487|NCT01001234|395610|P3|Overall Study|Not Treated: Pregnancy|0
106488|NCT01001234|395611|P2|Overall Study|Not Treated: Pregnancy|0
106489|NCT01001234|395612|P1|Overall Study|Not Treated: Pregnancy|3
106490|NCT01001234|395608|P5|Overall Study|Not Treated: Lost to Follow-up|0
106491|NCT01001234|395609|P4|Overall Study|Not Treated: Lost to Follow-up|5
106492|NCT01001234|395610|P3|Overall Study|Not Treated: Lost to Follow-up|7
106493|NCT01001234|395611|P2|Overall Study|Not Treated: Lost to Follow-up|4
106494|NCT01001234|395612|P1|Overall Study|Not Treated: Lost to Follow-up|53
106495|NCT01001234|395608|P5|Overall Study|Not Treated: Protocol Violation|0
106496|NCT01001234|395609|P4|Overall Study|Not Treated: Protocol Violation|0
106497|NCT01001234|395610|P3|Overall Study|Not Treated: Protocol Violation|0
106498|NCT01001234|395611|P2|Overall Study|Not Treated: Protocol Violation|0
106499|NCT01001234|395612|P1|Overall Study|Not Treated: Protocol Violation|3
106500|NCT01001234|395608|P5|Overall Study|Not Treated: Withdrawal by Subject|0
106501|NCT01001234|395609|P4|Overall Study|Not Treated: Withdrawal by Subject|0
106502|NCT01001234|395610|P3|Overall Study|Not Treated: Withdrawal by Subject|2
106503|NCT01001234|395611|P2|Overall Study|Not Treated: Withdrawal by Subject|2
106504|NCT01001234|395612|P1|Overall Study|Not Treated: Withdrawal by Subject|23
106505|NCT01001234|395608|P5|Overall Study|Not Treated: Adverse Event|0
106506|NCT01001234|395609|P4|Overall Study|Not Treated: Adverse Event|0
106507|NCT01001234|395610|P3|Overall Study|Not Treated: Adverse Event|0
106508|NCT01001234|395611|P2|Overall Study|Not Treated: Adverse Event|0
106509|NCT01001234|395612|P1|Overall Study|Not Treated: Adverse Event|1
106510|NCT01001234|395608|P5|Overall Study|Physician Decision|0
106511|NCT01001234|395609|P4|Overall Study|Physician Decision|0
106512|NCT01001234|395610|P3|Overall Study|Physician Decision|0
106513|NCT01001234|395611|P2|Overall Study|Physician Decision|0
106514|NCT01001234|395612|P1|Overall Study|Physician Decision|1
106515|NCT01001234|395608|P5|Overall Study|Lost to Follow-up|0
106516|NCT01001234|395609|P4|Overall Study|Lost to Follow-up|2
106517|NCT01001234|395610|P3|Overall Study|Lost to Follow-up|1
106518|NCT01001234|395611|P2|Overall Study|Lost to Follow-up|0
106519|NCT01001234|395612|P1|Overall Study|Lost to Follow-up|0
106520|NCT01001234|395608|P5|Overall Study|Protocol Violation|0
106521|NCT01001234|395609|P4|Overall Study|Protocol Violation|18
106522|NCT01001234|395610|P3|Overall Study|Protocol Violation|19
106523|NCT01001234|395611|P2|Overall Study|Protocol Violation|3
106524|NCT01001234|395612|P1|Overall Study|Protocol Violation|34
106525|NCT01001234|395608|P5|Overall Study|Withdrawal by Subject|0
106526|NCT01001234|395609|P4|Overall Study|Withdrawal by Subject|0
106527|NCT01001234|395610|P3|Overall Study|Withdrawal by Subject|3
106528|NCT01001234|395611|P2|Overall Study|Withdrawal by Subject|0
106529|NCT01001234|395612|P1|Overall Study|Withdrawal by Subject|2
106530|NCT01001221|395628|P5|Overall Study|Not treated; protocol exclusion|0
106531|NCT01001221|395629|P4|Overall Study|Not treated; protocol exclusion|0
106532|NCT01001221|395630|P3|Overall Study|Not treated; protocol exclusion|1
106533|NCT01001221|395631|P2|Overall Study|Not treated; protocol exclusion|0
106534|NCT01001221|395632|P1|Overall Study|Not treated; protocol exclusion|0
106535|NCT01001221|395628|P5|Overall Study|Not specified|0
106536|NCT01001221|395629|P4|Overall Study|Not specified|0
106537|NCT01001221|395630|P3|Overall Study|Not specified|0
106538|NCT01001221|395631|P2|Overall Study|Not specified|1
106539|NCT01001221|395632|P1|Overall Study|Not specified|1
106540|NCT01001221|395628|P5|Overall Study|Disease progression|0
106541|NCT01001221|395629|P4|Overall Study|Disease progression|4
106542|NCT01001221|395630|P3|Overall Study|Disease progression|2
106543|NCT01001221|395631|P2|Overall Study|Disease progression|2
106544|NCT01001221|395632|P1|Overall Study|Disease progression|3
106545|NCT01001221|395628|P5|Overall Study|Adverse Event|0
106546|NCT01001221|395629|P4|Overall Study|Adverse Event|2
106547|NCT01001221|395630|P3|Overall Study|Adverse Event|0
106548|NCT01001221|395631|P2|Overall Study|Adverse Event|2
106549|NCT01001221|395632|P1|Overall Study|Adverse Event|1
106550|NCT01001208|395807|P2|Overall Study|Other|2
106551|NCT01001208|395808|P1|Overall Study|Other|0
106552|NCT01001208|395807|P2|Overall Study|Disease Progression|3
106553|NCT01001208|395808|P1|Overall Study|Disease Progression|0
106554|NCT01001208|395807|P2|Overall Study|Noncompliance|7
106555|NCT01001208|395808|P1|Overall Study|Noncompliance|4
106556|NCT01001208|395807|P2|Overall Study|Ineligibility Determined|2
106557|NCT01001208|395808|P1|Overall Study|Ineligibility Determined|4
106558|NCT01001208|395807|P2|Overall Study|Withdrawal by Subject|5
106559|NCT01001208|395808|P1|Overall Study|Withdrawal by Subject|4
106560|NCT01001208|395807|P2|Overall Study|Physician Decision|0
106561|NCT01001208|395808|P1|Overall Study|Physician Decision|1
106562|NCT01001208|395807|P2|Overall Study|Lost to Follow-up|9
106563|NCT01001208|395808|P1|Overall Study|Lost to Follow-up|5
106564|NCT01001208|395807|P2|Overall Study|Adverse Event|5
106565|NCT01001208|395808|P1|Overall Study|Adverse Event|10
106566|NCT01001169|395851|P2|Overall Study|Withdrawal by Subject|1
106567|NCT01001169|395852|P1|Overall Study|Withdrawal by Subject|2
106568|NCT01001104|395960|P4|Overall Study|Withdrawal by Subject|2
106569|NCT01001104|395961|P3|Overall Study|Withdrawal by Subject|0
106570|NCT01001104|395962|P2|Overall Study|Withdrawal by Subject|0
106571|NCT01001104|395963|P1|Overall Study|Withdrawal by Subject|0
106572|NCT01001104|395960|P4|Overall Study|Entry Criteria Not Met|1
106573|NCT01001104|395961|P3|Overall Study|Entry Criteria Not Met|0
106574|NCT01001104|395962|P2|Overall Study|Entry Criteria Not Met|0
106575|NCT01001104|395963|P1|Overall Study|Entry Criteria Not Met|0
106576|NCT01001104|395960|P4|Overall Study|Lost to Follow-up|0
106577|NCT01001104|395961|P3|Overall Study|Lost to Follow-up|1
106578|NCT01001104|395962|P2|Overall Study|Lost to Follow-up|0
106579|NCT01001104|395963|P1|Overall Study|Lost to Follow-up|0
106580|NCT01001104|395960|P4|Overall Study|Adverse Event|0
106581|NCT01001104|395961|P3|Overall Study|Adverse Event|0
106582|NCT01001104|395962|P2|Overall Study|Adverse Event|1
106583|NCT01001104|395963|P1|Overall Study|Adverse Event|2
106584|NCT01000974|396054|P3|Booster Vaccination Phase|Other|4
106585|NCT01000974|396055|P2|Booster Vaccination Phase|Other|6
106586|NCT01000974|396056|P1|Booster Vaccination Phase|Other|24
106587|NCT01000974|396054|P3|Booster Vaccination Phase|Lost to Follow-up|7
106588|NCT01000974|396055|P2|Booster Vaccination Phase|Lost to Follow-up|5
106589|NCT01000974|396056|P1|Booster Vaccination Phase|Lost to Follow-up|40
106590|NCT01000974|396054|P3|Booster Vaccination Phase|Withdrawal by Subject|1
106591|NCT01000974|396055|P2|Booster Vaccination Phase|Withdrawal by Subject|1
106592|NCT01000974|396056|P1|Booster Vaccination Phase|Withdrawal by Subject|3
106593|NCT01000974|396054|P3|Booster Vaccination Phase|Protocol Violation|2
106594|NCT01000974|396055|P2|Booster Vaccination Phase|Protocol Violation|0
106595|NCT01000974|396056|P1|Booster Vaccination Phase|Protocol Violation|0
106596|NCT01000974|396054|P3|Primary Vaccination Phase|Other|12
106597|NCT01000974|396055|P2|Primary Vaccination Phase|Other|9
106598|NCT01000974|396056|P1|Primary Vaccination Phase|Other|4
106599|NCT01000974|396054|P3|Primary Vaccination Phase|Adverse Event|2
106600|NCT01000974|396055|P2|Primary Vaccination Phase|Adverse Event|2
106601|NCT01000974|396056|P1|Primary Vaccination Phase|Adverse Event|14
106602|NCT01000974|396054|P3|Primary Vaccination Phase|Protocol Violation|2
106603|NCT01000974|396055|P2|Primary Vaccination Phase|Protocol Violation|3
106604|NCT01000974|396056|P1|Primary Vaccination Phase|Protocol Violation|40
106605|NCT01000974|396054|P3|Primary Vaccination Phase|Lost to Follow-up|26
106606|NCT01000974|396055|P2|Primary Vaccination Phase|Lost to Follow-up|19
106607|NCT01000974|396056|P1|Primary Vaccination Phase|Lost to Follow-up|171
106608|NCT01000974|396054|P3|Primary Vaccination Phase|Withdrawal by Subject|21
106609|NCT01000974|396055|P2|Primary Vaccination Phase|Withdrawal by Subject|17
106610|NCT01000974|396056|P1|Primary Vaccination Phase|Withdrawal by Subject|109
106611|NCT01000961|396163|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
106612|NCT01000961|396164|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
106613|NCT01000961|396163|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
106614|NCT01000961|396164|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
106615|NCT01000805|396187|P2|Overall Study|Sponsor Decision|1
106616|NCT01000805|396188|P1|Overall Study|Sponsor Decision|0
106617|NCT01000805|396187|P2|Overall Study|Withdrawal by Subject|6
106618|NCT01000805|396188|P1|Overall Study|Withdrawal by Subject|16
106619|NCT01000805|396187|P2|Overall Study|Protocol Violation|8
106620|NCT01000805|396188|P1|Overall Study|Protocol Violation|12
106621|NCT01000805|396187|P2|Overall Study|Physician Decision|1
106622|NCT01000805|396188|P1|Overall Study|Physician Decision|0
106623|NCT01000805|396187|P2|Overall Study|Lost to Follow-up|21
106624|NCT01000805|396188|P1|Overall Study|Lost to Follow-up|16
106625|NCT01000805|396187|P2|Overall Study|Lack of Efficacy|16
106626|NCT01000805|396188|P1|Overall Study|Lack of Efficacy|5
106627|NCT01000805|396187|P2|Overall Study|Adverse Event|9
106628|NCT01000805|396188|P1|Overall Study|Adverse Event|21
106629|NCT01000727|396222|P2|Overall Study|Study closed/terminated|24
106630|NCT01000727|396223|P1|Overall Study|Study closed/terminated|23
106631|NCT01000727|396222|P2|Overall Study|Withdrawal by Subject|109
106632|NCT01000727|396223|P1|Overall Study|Withdrawal by Subject|111
106633|NCT01000727|396222|P2|Overall Study|Lost to Follow-up|43
106634|NCT01000727|396223|P1|Overall Study|Lost to Follow-up|41
106635|NCT01000649|396264|P4|Overall Study|Lost to Follow-up|2
106636|NCT01000649|396265|P3|Overall Study|Lost to Follow-up|0
106637|NCT01000649|396266|P2|Overall Study|Lost to Follow-up|2
106638|NCT01000649|396267|P1|Overall Study|Lost to Follow-up|0
106639|NCT01000649|396264|P4|Overall Study|Adverse Event|4
106640|NCT01000649|396265|P3|Overall Study|Adverse Event|2
106641|NCT01000649|396266|P2|Overall Study|Adverse Event|1
106642|NCT01000649|396267|P1|Overall Study|Adverse Event|5
106643|NCT01000610|396348|P1|Overall Study|Treatment failure|1
106644|NCT01000610|396348|P1|Overall Study|Lost to Follow-up|4
106645|NCT01000610|396348|P1|Overall Study|Adverse Event|1
106646|NCT01000506|396359|P4|Overall Study|Withdrawal by Subject|7
106647|NCT01000506|396360|P3|Overall Study|Withdrawal by Subject|2
106648|NCT01000506|396361|P2|Overall Study|Withdrawal by Subject|8
106649|NCT01000506|396362|P1|Overall Study|Withdrawal by Subject|11
106650|NCT01000506|396359|P4|Overall Study|Physician Decision|3
106651|NCT01000506|396360|P3|Overall Study|Physician Decision|3
106652|NCT01000506|396361|P2|Overall Study|Physician Decision|3
106653|NCT01000506|396362|P1|Overall Study|Physician Decision|1
106654|NCT01000506|396359|P4|Overall Study|Lost to Follow-up|0
106655|NCT01000506|396360|P3|Overall Study|Lost to Follow-up|4
106656|NCT01000506|396361|P2|Overall Study|Lost to Follow-up|1
106657|NCT01000506|396362|P1|Overall Study|Lost to Follow-up|1
106658|NCT01000506|396359|P4|Overall Study|Protocol Violation|0
106659|NCT01000506|396360|P3|Overall Study|Protocol Violation|0
106660|NCT01000506|396361|P2|Overall Study|Protocol Violation|1
106661|NCT01000506|396362|P1|Overall Study|Protocol Violation|1
106662|NCT01000506|396359|P4|Overall Study|Lack of Efficacy|4
106663|NCT01000506|396360|P3|Overall Study|Lack of Efficacy|4
106664|NCT01000506|396361|P2|Overall Study|Lack of Efficacy|6
106665|NCT01000506|396362|P1|Overall Study|Lack of Efficacy|8
106666|NCT01000506|396359|P4|Overall Study|Adverse Event|9
106667|NCT01000506|396360|P3|Overall Study|Adverse Event|8
106668|NCT01000506|396361|P2|Overall Study|Adverse Event|5
106669|NCT01000506|396362|P1|Overall Study|Adverse Event|6
106670|NCT01000493|396406|P2|Overall Study|Withdrawal by Subject|7
106671|NCT01000493|396407|P1|Overall Study|Withdrawal by Subject|3
106672|NCT01000493|396406|P2|Overall Study|Physician Decision|1
106673|NCT01000493|396407|P1|Overall Study|Physician Decision|1
106674|NCT01000493|396406|P2|Overall Study|Lost to Follow-up|9
106675|NCT01000493|396407|P1|Overall Study|Lost to Follow-up|5
106676|NCT01000493|396406|P2|Overall Study|Study closed/terminated|23
106677|NCT01000493|396407|P1|Overall Study|Study closed/terminated|25
106678|NCT01000493|396406|P2|Overall Study|Protocol Violation|8
106679|NCT01000493|396407|P1|Overall Study|Protocol Violation|1
106680|NCT01000493|396406|P2|Overall Study|Lack of Efficacy|1
106681|NCT01000493|396407|P1|Overall Study|Lack of Efficacy|1
106682|NCT01000493|396406|P2|Overall Study|Adverse Event|6
106683|NCT01000493|396407|P1|Overall Study|Adverse Event|3
106684|NCT01000480|396457|P1|Concurrent Therapy Phase|Physician Decision|1
106685|NCT01000480|396457|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
106686|NCT01000480|396457|P1|Concurrent Therapy Phase|Protocol Violation|2
106687|NCT01000480|396457|P1|Concurrent Therapy Phase|Adverse Event|4
106688|NCT01000480|396457|P1|Induction Phase|Entry Criteria Not Met|3
106689|NCT01000480|396457|P1|Induction Phase|Physician Decision|1
106690|NCT01000480|396457|P1|Induction Phase|Lost to Follow-up|1
106691|NCT01000480|396457|P1|Induction Phase|Adverse Event|2
106692|NCT01000376|396465|P2|Cycle 1 Day 1|Progressive Disease|0
106693|NCT01000376|396466|P1|Cycle 1 Day 1|Progressive Disease|1
106694|NCT01000376|396465|P2|Cycle 1 Day 1|Adverse Event|0
106695|NCT01000376|396466|P1|Cycle 1 Day 1|Adverse Event|1
106696|NCT01000337|396476|P2|Overall Study|Lost to Follow-up|3
106697|NCT01000337|396477|P1|Overall Study|Lost to Follow-up|4
106698|NCT01000311|396495|P2|Overall Study|Administrative reason|15
106699|NCT01000311|396496|P1|Overall Study|Administrative reason|9
106700|NCT01000311|396495|P2|Overall Study|Inappropriate enrollment|0
106701|NCT01000311|396496|P1|Overall Study|Inappropriate enrollment|2
106702|NCT01000311|396495|P2|Overall Study|Protocol Violation|2
106703|NCT01000311|396496|P1|Overall Study|Protocol Violation|1
106704|NCT01000311|396495|P2|Overall Study|Lost to Follow-up|24
106705|NCT01000311|396496|P1|Overall Study|Lost to Follow-up|15
106706|NCT01000311|396495|P2|Overall Study|Withdrawal by Subject|24
106707|NCT01000311|396496|P1|Overall Study|Withdrawal by Subject|16
106708|NCT01000311|396495|P2|Overall Study|Adverse Event|5
106709|NCT01000311|396496|P1|Overall Study|Adverse Event|2
106710|NCT01000155|396546|P1|Overall Study|Adverse Event|1
106711|NCT01000155|396546|P1|Overall Study|Withdrawal by Subject|1
106712|NCT01000064|396552|P2|Overall Study|Withdrawal by Subject|1
106713|NCT01000064|396553|P1|Overall Study|Withdrawal by Subject|1
106714|NCT01000025|396576|P2|Overall Study|Intercurrent Illness|7
106715|NCT01000025|396577|P1|Overall Study|Intercurrent Illness|26
106716|NCT01000025|396576|P2|Overall Study|Lack of Efficacy|208
106717|NCT01000025|396577|P1|Overall Study|Lack of Efficacy|363
106718|NCT01000025|396576|P2|Overall Study|Death|13
106719|NCT01000025|396577|P1|Overall Study|Death|23
106720|NCT01000025|396576|P2|Overall Study|Withdrawal by Subject|8
106721|NCT01000025|396577|P1|Overall Study|Withdrawal by Subject|13
106722|NCT01000025|396576|P2|Overall Study|Adverse Event|2
106723|NCT01000025|396577|P1|Overall Study|Adverse Event|43
106724|NCT00999921|396595|P2|Overall Study|Lost to Follow-up|19
106725|NCT00999921|396596|P1|Overall Study|Lost to Follow-up|10
106726|NCT00999908|396606|P3|Treatment Period 2|Protocol Violation|0
106727|NCT00999908|396607|P2|Treatment Period 2|Protocol Violation|0
106728|NCT00999908|396608|P1|Treatment Period 2|Protocol Violation|1
106729|NCT00999908|396606|P3|Treatment Period 1|Subject withdrew consent|0
106730|NCT00999908|396607|P2|Treatment Period 1|Subject withdrew consent|0
106731|NCT00999908|396608|P1|Treatment Period 1|Subject withdrew consent|2
106732|NCT00999804|396637|P2|Overall Study|Ineligible|0
106733|NCT00999804|396638|P1|Overall Study|Ineligible|3
106734|NCT00999804|396637|P2|Overall Study|Death|0
106735|NCT00999804|396638|P1|Overall Study|Death|1
106736|NCT00999804|396637|P2|Overall Study|Withdrawal by Subject|0
106737|NCT00999804|396638|P1|Overall Study|Withdrawal by Subject|4
106738|NCT00999804|396637|P2|Overall Study|Adverse Event|3
106739|NCT00999804|396638|P1|Overall Study|Adverse Event|4
106740|NCT00999804|396637|P2|Overall Study|Lack of Efficacy|2
106741|NCT00999804|396638|P1|Overall Study|Lack of Efficacy|9
106742|NCT00999713|396652|P2|Overall Study|Physician Decision|0
106743|NCT00999713|396653|P1|Overall Study|Physician Decision|2
106744|NCT00999687|396667|P1|Second Intervention|Lack of Efficacy|1
106745|NCT00999687|396667|P1|Second Intervention|Withdrawal by Subject|2
106746|NCT00999687|396667|P1|First Intervention|Withdrawal by Subject|1
106747|NCT00999661|396674|P1|Overall Study|Not meeting eligibility criteria|9
106748|NCT00999661|396674|P1|Overall Study|Withdrawal by Subject|1
106749|NCT00999661|396674|P1|Overall Study|Adverse Event|1
106750|NCT00999661|396674|P1|Overall Study|Lost to Follow-up|59
106751|NCT00999596|396695|P1|Overall Study|Statistical population not required|101
106752|NCT00999544|396700|P1|Overall Study|Withdrawal by Subject|1
106753|NCT00999466|396736|P3|Main Part|Adverse Event|2
106754|NCT00999466|396737|P2|Main Part|Adverse Event|4
106755|NCT00999466|396738|P1|Main Part|Adverse Event|0
106756|NCT00999466|396736|P3|Main Part|Withdrawal by Subject|2
106757|NCT00999466|396737|P2|Main Part|Withdrawal by Subject|0
106758|NCT00999466|396738|P1|Main Part|Withdrawal by Subject|0
106759|NCT00999167|397015|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
106760|NCT00999167|397016|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
106761|NCT00999167|397017|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
106762|NCT00999167|397015|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
106763|NCT00999167|397016|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
106764|NCT00999167|397017|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
106765|NCT00999167|397015|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
106766|NCT00999167|397016|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
106767|NCT00999167|397017|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
106768|NCT00999167|397015|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
106769|NCT00999167|397016|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
106770|NCT00999167|397017|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
106771|NCT00999167|397015|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
106772|NCT00999167|397016|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
106773|NCT00999167|397017|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
106774|NCT00999167|397015|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
106775|NCT00999167|397016|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
106776|NCT00999167|397017|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
106777|NCT00999167|397015|P3|Part A: Open Label Safety run-in|Adverse Event|0
106778|NCT00999167|397016|P2|Part A: Open Label Safety run-in|Adverse Event|0
106779|NCT00999167|397017|P1|Part A: Open Label Safety run-in|Adverse Event|3
106780|NCT00999167|397015|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
106781|NCT00999167|397016|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
106782|NCT00999167|397017|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
106783|NCT00998985|397140|P14|Overall Study|Protocol Violation|0
106784|NCT00998985|397141|P13|Overall Study|Protocol Violation|0
106785|NCT00998985|397142|P12|Overall Study|Protocol Violation|0
106786|NCT00998985|397143|P11|Overall Study|Protocol Violation|0
106787|NCT00998985|397144|P10|Overall Study|Protocol Violation|0
106788|NCT00998985|397145|P9|Overall Study|Protocol Violation|0
106789|NCT00998985|397146|P8|Overall Study|Protocol Violation|0
106790|NCT00998985|397147|P7|Overall Study|Protocol Violation|0
106791|NCT00998985|397148|P6|Overall Study|Protocol Violation|1
106792|NCT00998985|397149|P5|Overall Study|Protocol Violation|0
106793|NCT00998985|397150|P4|Overall Study|Protocol Violation|0
106794|NCT00998985|397151|P3|Overall Study|Protocol Violation|0
106795|NCT00998985|397152|P2|Overall Study|Protocol Violation|0
106796|NCT00998985|397153|P1|Overall Study|Protocol Violation|0
106797|NCT00998985|397140|P14|Overall Study|Withdrawal by Subject|0
106798|NCT00998985|397141|P13|Overall Study|Withdrawal by Subject|0
106799|NCT00998985|397142|P12|Overall Study|Withdrawal by Subject|0
106800|NCT00998985|397143|P11|Overall Study|Withdrawal by Subject|0
106801|NCT00998985|397144|P10|Overall Study|Withdrawal by Subject|0
106802|NCT00998985|397145|P9|Overall Study|Withdrawal by Subject|1
106803|NCT00998985|397146|P8|Overall Study|Withdrawal by Subject|0
106804|NCT00998985|397147|P7|Overall Study|Withdrawal by Subject|0
106805|NCT00998985|397148|P6|Overall Study|Withdrawal by Subject|0
106806|NCT00998985|397149|P5|Overall Study|Withdrawal by Subject|0
106807|NCT00998985|397150|P4|Overall Study|Withdrawal by Subject|0
106808|NCT00998985|397151|P3|Overall Study|Withdrawal by Subject|0
106809|NCT00998985|397152|P2|Overall Study|Withdrawal by Subject|0
106810|NCT00998985|397153|P1|Overall Study|Withdrawal by Subject|0
106811|NCT00998881|397221|P2|Overall Study|Personal matter|0
106812|NCT00998881|397222|P1|Overall Study|Personal matter|1
106813|NCT00998881|397221|P2|Overall Study|Withdrawal by Subject|0
106814|NCT00998881|397222|P1|Overall Study|Withdrawal by Subject|1
106815|NCT00998881|397221|P2|Overall Study|Physician Decision|0
106816|NCT00998881|397222|P1|Overall Study|Physician Decision|3
106817|NCT00998881|397221|P2|Overall Study|Lack of Efficacy|0
106818|NCT00998881|397222|P1|Overall Study|Lack of Efficacy|1
106819|NCT00998881|397221|P2|Overall Study|Adverse Event|2
106820|NCT00998881|397222|P1|Overall Study|Adverse Event|2
106821|NCT00998764|397243|P2|Overall Study|Recurrent Episode of vasogenic edema|0
106822|NCT00998764|397244|P1|Overall Study|Recurrent Episode of vasogenic edema|1
106823|NCT00998764|397243|P2|Overall Study|Not specified|4
106824|NCT00998764|397244|P1|Overall Study|Not specified|4
106825|NCT00998764|397243|P2|Overall Study|Loss of Caregiver|3
106826|NCT00998764|397244|P1|Overall Study|Loss of Caregiver|0
106827|NCT00998764|397243|P2|Overall Study|Lost to Follow-up|1
106828|NCT00998764|397244|P1|Overall Study|Lost to Follow-up|1
106829|NCT00998764|397243|P2|Overall Study|Failed to Return|1
106830|NCT00998764|397244|P1|Overall Study|Failed to Return|1
106831|NCT00998764|397243|P2|Overall Study|Protocol Violation|1
106832|NCT00998764|397244|P1|Overall Study|Protocol Violation|0
106833|NCT00998764|397243|P2|Overall Study|Discontinuation of Study by Sponsor|217
106834|NCT00998764|397244|P1|Overall Study|Discontinuation of Study by Sponsor|164
106835|NCT00998764|397243|P2|Overall Study|Death|1
106836|NCT00998764|397244|P1|Overall Study|Death|3
106837|NCT00998764|397243|P2|Overall Study|Physician Decision|3
106838|NCT00998764|397244|P1|Overall Study|Physician Decision|3
106839|NCT00998764|397243|P2|Overall Study|Withdrawal by Subject|25
106840|NCT00998764|397244|P1|Overall Study|Withdrawal by Subject|19
106841|NCT00998764|397243|P2|Overall Study|Adverse Event|12
106842|NCT00998764|397244|P1|Overall Study|Adverse Event|17
106843|NCT00998764|397243|P2|Overall Study|Lack of Efficacy|6
106844|NCT00998764|397244|P1|Overall Study|Lack of Efficacy|3
106845|NCT00998738|397266|P1|Overall Study|Uknown|1
106846|NCT00998335|397349|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
106847|NCT00998335|397350|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
106848|NCT00998309|397378|P1|Overall Study|Protocol Violation|4
106849|NCT00998296|397445|P11|Overall Study|Reason other than those specified above|0
106850|NCT00998296|397446|P10|Overall Study|Reason other than those specified above|1
106851|NCT00998296|397447|P9|Overall Study|Reason other than those specified above|0
106852|NCT00998296|397448|P8|Overall Study|Reason other than those specified above|0
106853|NCT00998296|397449|P7|Overall Study|Reason other than those specified above|0
106854|NCT00998296|397450|P6|Overall Study|Reason other than those specified above|0
106855|NCT00998296|397451|P5|Overall Study|Reason other than those specified above|0
106856|NCT00998296|397452|P4|Overall Study|Reason other than those specified above|0
106857|NCT00998296|397453|P3|Overall Study|Reason other than those specified above|0
106858|NCT00998296|397454|P2|Overall Study|Reason other than those specified above|0
106859|NCT00998296|397455|P1|Overall Study|Reason other than those specified above|0
106860|NCT00998296|397445|P11|Overall Study|Refused to continue taking trial med.|0
106861|NCT00998296|397446|P10|Overall Study|Refused to continue taking trial med.|2
106862|NCT00998296|397447|P9|Overall Study|Refused to continue taking trial med.|0
106863|NCT00998296|397448|P8|Overall Study|Refused to continue taking trial med.|0
106864|NCT00998296|397449|P7|Overall Study|Refused to continue taking trial med.|0
106865|NCT00998296|397450|P6|Overall Study|Refused to continue taking trial med.|0
106866|NCT00998296|397451|P5|Overall Study|Refused to continue taking trial med.|0
106867|NCT00998296|397452|P4|Overall Study|Refused to continue taking trial med.|0
106868|NCT00998296|397453|P3|Overall Study|Refused to continue taking trial med.|0
106869|NCT00998296|397454|P2|Overall Study|Refused to continue taking trial med.|0
106870|NCT00998296|397455|P1|Overall Study|Refused to continue taking trial med.|0
106871|NCT00998296|397445|P11|Overall Study|Other adverse event|2
106872|NCT00998296|397446|P10|Overall Study|Other adverse event|1
106873|NCT00998296|397447|P9|Overall Study|Other adverse event|0
106874|NCT00998296|397448|P8|Overall Study|Other adverse event|0
106875|NCT00998296|397449|P7|Overall Study|Other adverse event|0
106876|NCT00998296|397450|P6|Overall Study|Other adverse event|0
106877|NCT00998296|397451|P5|Overall Study|Other adverse event|1
106878|NCT00998296|397452|P4|Overall Study|Other adverse event|0
106879|NCT00998296|397453|P3|Overall Study|Other adverse event|0
106880|NCT00998296|397454|P2|Overall Study|Other adverse event|0
106881|NCT00998296|397455|P1|Overall Study|Other adverse event|0
106882|NCT00998296|397445|P11|Overall Study|Dose limiting or dose reducing toxicity|0
106883|NCT00998296|397446|P10|Overall Study|Dose limiting or dose reducing toxicity|0
106884|NCT00998296|397447|P9|Overall Study|Dose limiting or dose reducing toxicity|2
106885|NCT00998296|397448|P8|Overall Study|Dose limiting or dose reducing toxicity|2
106886|NCT00998296|397449|P7|Overall Study|Dose limiting or dose reducing toxicity|0
106887|NCT00998296|397450|P6|Overall Study|Dose limiting or dose reducing toxicity|0
106888|NCT00998296|397451|P5|Overall Study|Dose limiting or dose reducing toxicity|1
106889|NCT00998296|397452|P4|Overall Study|Dose limiting or dose reducing toxicity|0
106890|NCT00998296|397453|P3|Overall Study|Dose limiting or dose reducing toxicity|0
106891|NCT00998296|397454|P2|Overall Study|Dose limiting or dose reducing toxicity|0
106892|NCT00998296|397455|P1|Overall Study|Dose limiting or dose reducing toxicity|0
106893|NCT00998296|397445|P11|Overall Study|Progressive disease|5
106894|NCT00998296|397446|P10|Overall Study|Progressive disease|14
106895|NCT00998296|397447|P9|Overall Study|Progressive disease|0
106896|NCT00998296|397448|P8|Overall Study|Progressive disease|0
106897|NCT00998296|397449|P7|Overall Study|Progressive disease|1
106898|NCT00998296|397450|P6|Overall Study|Progressive disease|0
106899|NCT00998296|397451|P5|Overall Study|Progressive disease|0
106900|NCT00998296|397452|P4|Overall Study|Progressive disease|0
106901|NCT00998296|397453|P3|Overall Study|Progressive disease|0
106902|NCT00998296|397454|P2|Overall Study|Progressive disease|1
106903|NCT00998296|397455|P1|Overall Study|Progressive disease|0
106904|NCT00997984|397550|P3|Overall Study|Work schedule|2
106905|NCT00997984|397551|P2|Overall Study|Work schedule|0
106906|NCT00997984|397552|P1|Overall Study|Work schedule|0
106907|NCT00997984|397550|P3|Overall Study|Suicidal ideation|1
106908|NCT00997984|397551|P2|Overall Study|Suicidal ideation|0
106909|NCT00997984|397552|P1|Overall Study|Suicidal ideation|0
106910|NCT00997984|397550|P3|Overall Study|Wrong medication dispensed|0
106911|NCT00997984|397551|P2|Overall Study|Wrong medication dispensed|1
106912|NCT00997984|397552|P1|Overall Study|Wrong medication dispensed|0
106913|NCT00997984|397550|P3|Overall Study|non-compliance|3
106914|NCT00997984|397551|P2|Overall Study|non-compliance|2
106915|NCT00997984|397552|P1|Overall Study|non-compliance|0
106916|NCT00997984|397550|P3|Overall Study|Met exclusion criteria|0
106917|NCT00997984|397551|P2|Overall Study|Met exclusion criteria|0
106918|NCT00997984|397552|P1|Overall Study|Met exclusion criteria|1
106919|NCT00997984|397550|P3|Overall Study|Lack of Efficacy|3
106920|NCT00997984|397551|P2|Overall Study|Lack of Efficacy|6
106921|NCT00997984|397552|P1|Overall Study|Lack of Efficacy|20
106922|NCT00997984|397550|P3|Overall Study|Lost to Follow-up|4
106923|NCT00997984|397551|P2|Overall Study|Lost to Follow-up|5
106924|NCT00997984|397552|P1|Overall Study|Lost to Follow-up|8
106925|NCT00997984|397550|P3|Overall Study|Withdrawal by Subject|5
106926|NCT00997984|397551|P2|Overall Study|Withdrawal by Subject|9
106927|NCT00997984|397552|P1|Overall Study|Withdrawal by Subject|6
106928|NCT00997984|397550|P3|Overall Study|Protocol Violation|0
106929|NCT00997984|397551|P2|Overall Study|Protocol Violation|3
106930|NCT00997984|397552|P1|Overall Study|Protocol Violation|1
106931|NCT00997984|397550|P3|Overall Study|Adverse Event|8
106932|NCT00997984|397551|P2|Overall Study|Adverse Event|8
106933|NCT00997984|397552|P1|Overall Study|Adverse Event|1
106934|NCT00997503|397710|P1|Overall Study|Other reason|13
106935|NCT00997503|397710|P1|Overall Study|Missed 12-month follow-up|85
106936|NCT00997503|397710|P1|Overall Study|Physician Decision|10
106937|NCT00997503|397710|P1|Overall Study|Adverse Event|3
106938|NCT00997503|397710|P1|Overall Study|Lost to Follow-up|33
106939|NCT00997503|397710|P1|Overall Study|Withdrawal by Subject|76
106940|NCT00997503|397710|P1|Overall Study|Death|53
106941|NCT00997438|397753|P3|Overall Study|Exclusion criteria at visit 1|3
106942|NCT00997438|397754|P2|Overall Study|Exclusion criteria at visit 1|2
106943|NCT00997438|397755|P1|Overall Study|Exclusion criteria at visit 1|2
106944|NCT00997438|397753|P3|Overall Study|Withdrawal by Subject|0
106945|NCT00997438|397754|P2|Overall Study|Withdrawal by Subject|1
106946|NCT00997438|397755|P1|Overall Study|Withdrawal by Subject|1
106947|NCT00997438|397753|P3|Overall Study|Blood draw difficulty|1
106948|NCT00997438|397754|P2|Overall Study|Blood draw difficulty|0
106949|NCT00997438|397755|P1|Overall Study|Blood draw difficulty|2
106950|NCT00997373|397797|P2|Overall Study|could not have hysterectomy|0
106951|NCT00997373|397798|P1|Overall Study|could not have hysterectomy|6
106952|NCT00997373|397797|P2|Overall Study|wrong tumor type|0
106953|NCT00997373|397798|P1|Overall Study|wrong tumor type|4
106954|NCT00997373|397797|P2|Overall Study|Withdrawal by Subject|0
106955|NCT00997373|397798|P1|Overall Study|Withdrawal by Subject|5
106956|NCT00997334|397804|P1|Overall Study|Ineligible|1
106957|NCT00997334|397804|P1|Overall Study|No lesion amenable|1
106958|NCT00997334|397804|P1|Overall Study|Urgent Palliative Care|2
106959|NCT00997334|397804|P1|Overall Study|Death|2
106960|NCT00997334|397804|P1|Overall Study|Withdrawal by Subject|3
106961|NCT00997334|397804|P1|Overall Study|Patient non-compliance|1
106962|NCT00997334|397804|P1|Overall Study|Adverse Event|3
106963|NCT00997334|397804|P1|Overall Study|still on therapy|12
106964|NCT00997321|397813|P2|Overall Study|did not undergo sedation after enrollmen|3
106965|NCT00997321|397814|P1|Overall Study|did not undergo sedation after enrollmen|0
106966|NCT00997243|397826|P1|Overall Study|Early termination of study by sponsor|7
106967|NCT00997126|397858|P2|Overall Study|Physician Decision|11
106968|NCT00997126|397859|P1|Overall Study|Physician Decision|7
106969|NCT00997035|397888|P2|3-month Follow-up Visit|Lost to Follow-up|6
106970|NCT00997035|397889|P1|3-month Follow-up Visit|Lost to Follow-up|12
106971|NCT00997035|397888|P2|3-week Followup Visit|Lost to Follow-up|6
106972|NCT00997035|397889|P1|3-week Followup Visit|Lost to Follow-up|9
106973|NCT00996996|397909|P1|Overall Study|Did Not Receive Study Medications|1
106974|NCT00996996|397909|P1|Overall Study|Death|5
106975|NCT00996996|397909|P1|Overall Study|Lost to Follow-up|9
106976|NCT00996996|397909|P1|Overall Study|Non-compliance|8
106977|NCT00996996|397909|P1|Overall Study|Progressive Disease|10
106978|NCT00996944|397943|P2|Long-term Treatment Period|Study Closed/Terminated|5
106979|NCT00996944|397944|P1|Long-term Treatment Period|Study Closed/Terminated|12
106980|NCT00996944|397943|P2|Double-blind Treatment Period|Withdrawal by Subject|1
106981|NCT00996944|397944|P1|Double-blind Treatment Period|Withdrawal by Subject|1
106982|NCT00996944|397943|P2|Double-blind Treatment Period|Study Closed/Terminated|5
106983|NCT00996944|397944|P1|Double-blind Treatment Period|Study Closed/Terminated|6
106984|NCT00996944|397943|P2|Double-blind Treatment Period|Protocol Violation|0
106985|NCT00996944|397944|P1|Double-blind Treatment Period|Protocol Violation|1
106986|NCT00996944|397943|P2|Double-blind Treatment Period|Adverse Event|1
106987|NCT00996944|397944|P1|Double-blind Treatment Period|Adverse Event|2
106988|NCT00996918|397996|P5|Overall Study|Not Specified|0
106989|NCT00996918|397997|P4|Overall Study|Not Specified|0
106990|NCT00996918|397998|P3|Overall Study|Not Specified|0
106991|NCT00996918|397999|P2|Overall Study|Not Specified|1
106992|NCT00996918|398000|P1|Overall Study|Not Specified|3
106993|NCT00996918|397996|P5|Overall Study|Loss of Caregiver|0
106994|NCT00996918|397997|P4|Overall Study|Loss of Caregiver|0
106995|NCT00996918|397998|P3|Overall Study|Loss of Caregiver|0
106996|NCT00996918|397999|P2|Overall Study|Loss of Caregiver|1
106997|NCT00996918|398000|P1|Overall Study|Loss of Caregiver|0
106998|NCT00996918|397996|P5|Overall Study|Discontinuation of Study by Sponsor|2
106999|NCT00996918|397997|P4|Overall Study|Discontinuation of Study by Sponsor|45
107000|NCT00996918|397998|P3|Overall Study|Discontinuation of Study by Sponsor|30
107001|NCT00996918|397999|P2|Overall Study|Discontinuation of Study by Sponsor|54
107002|NCT00996918|398000|P1|Overall Study|Discontinuation of Study by Sponsor|31
107003|NCT00996918|397996|P5|Overall Study|Physician Decision|0
107004|NCT00996918|397997|P4|Overall Study|Physician Decision|0
107005|NCT00996918|397998|P3|Overall Study|Physician Decision|0
107006|NCT00996918|397999|P2|Overall Study|Physician Decision|0
107007|NCT00996918|398000|P1|Overall Study|Physician Decision|1
107008|NCT00996918|397996|P5|Overall Study|Withdrawal by Subject|2
107009|NCT00996918|397997|P4|Overall Study|Withdrawal by Subject|3
107010|NCT00996918|397998|P3|Overall Study|Withdrawal by Subject|3
107011|NCT00996918|397999|P2|Overall Study|Withdrawal by Subject|4
107012|NCT00996918|398000|P1|Overall Study|Withdrawal by Subject|1
107013|NCT00996918|397996|P5|Overall Study|Adverse Event|0
107014|NCT00996918|397997|P4|Overall Study|Adverse Event|6
107015|NCT00996918|397998|P3|Overall Study|Adverse Event|2
107016|NCT00996918|397999|P2|Overall Study|Adverse Event|5
107017|NCT00996918|398000|P1|Overall Study|Adverse Event|2
107018|NCT00996918|397996|P5|Overall Study|Lack of Efficacy|0
107019|NCT00996918|397997|P4|Overall Study|Lack of Efficacy|2
107020|NCT00996918|397998|P3|Overall Study|Lack of Efficacy|2
107021|NCT00996918|397999|P2|Overall Study|Lack of Efficacy|1
107022|NCT00996918|398000|P1|Overall Study|Lack of Efficacy|1
107023|NCT00996892|398044|P20|Expansion Stage 2A|Disease Progression|31
107024|NCT00996892|398045|P19|Expansion Stage 2A|Disease Progression|0
107025|NCT00996892|398046|P18|Expansion Stage 2A|Disease Progression|0
107026|NCT00996892|398047|P17|Expansion Stage 2A|Disease Progression|0
107027|NCT00996892|398048|P16|Expansion Stage 2A|Disease Progression|0
107028|NCT00996892|398049|P15|Expansion Stage 2A|Disease Progression|0
107029|NCT00996892|398050|P14|Expansion Stage 2A|Disease Progression|0
107030|NCT00996892|398051|P13|Expansion Stage 2A|Disease Progression|0
107031|NCT00996892|398052|P12|Expansion Stage 2A|Disease Progression|0
107032|NCT00996892|398053|P11|Expansion Stage 2A|Disease Progression|0
107033|NCT00996892|398054|P10|Expansion Stage 2A|Disease Progression|0
107034|NCT00996892|398055|P9|Expansion Stage 2A|Disease Progression|0
107035|NCT00996892|398056|P8|Expansion Stage 2A|Disease Progression|0
107036|NCT00996892|398057|P7|Expansion Stage 2A|Disease Progression|0
107037|NCT00996892|398058|P6|Expansion Stage 2A|Disease Progression|0
107038|NCT00996892|398059|P5|Expansion Stage 2A|Disease Progression|0
107039|NCT00996892|398060|P4|Expansion Stage 2A|Disease Progression|0
107040|NCT00996892|398061|P3|Expansion Stage 2A|Disease Progression|0
107041|NCT00996892|398062|P2|Expansion Stage 2A|Disease Progression|0
107042|NCT00996892|398063|P1|Expansion Stage 2A|Disease Progression|0
107043|NCT00996892|398044|P20|Expansion Stage 2A|Withdrawal by Subject|4
107044|NCT00996892|398045|P19|Expansion Stage 2A|Withdrawal by Subject|0
107045|NCT00996892|398046|P18|Expansion Stage 2A|Withdrawal by Subject|0
107046|NCT00996892|398047|P17|Expansion Stage 2A|Withdrawal by Subject|0
107047|NCT00996892|398048|P16|Expansion Stage 2A|Withdrawal by Subject|0
107048|NCT00996892|398049|P15|Expansion Stage 2A|Withdrawal by Subject|0
107049|NCT00996892|398050|P14|Expansion Stage 2A|Withdrawal by Subject|0
107050|NCT00996892|398051|P13|Expansion Stage 2A|Withdrawal by Subject|0
107051|NCT00996892|398052|P12|Expansion Stage 2A|Withdrawal by Subject|0
107052|NCT00996892|398053|P11|Expansion Stage 2A|Withdrawal by Subject|0
107053|NCT00996892|398054|P10|Expansion Stage 2A|Withdrawal by Subject|0
107054|NCT00996892|398055|P9|Expansion Stage 2A|Withdrawal by Subject|0
107055|NCT00996892|398056|P8|Expansion Stage 2A|Withdrawal by Subject|0
107056|NCT00996892|398057|P7|Expansion Stage 2A|Withdrawal by Subject|0
107057|NCT00996892|398058|P6|Expansion Stage 2A|Withdrawal by Subject|0
107058|NCT00996892|398059|P5|Expansion Stage 2A|Withdrawal by Subject|0
107059|NCT00996892|398060|P4|Expansion Stage 2A|Withdrawal by Subject|0
107060|NCT00996892|398061|P3|Expansion Stage 2A|Withdrawal by Subject|0
107061|NCT00996892|398062|P2|Expansion Stage 2A|Withdrawal by Subject|0
107062|NCT00996892|398063|P1|Expansion Stage 2A|Withdrawal by Subject|0
107063|NCT00996892|398044|P20|Expansion Stage 2A|Physician Decision|2
107064|NCT00996892|398045|P19|Expansion Stage 2A|Physician Decision|0
107065|NCT00996892|398046|P18|Expansion Stage 2A|Physician Decision|0
107066|NCT00996892|398047|P17|Expansion Stage 2A|Physician Decision|0
107067|NCT00996892|398048|P16|Expansion Stage 2A|Physician Decision|0
107068|NCT00996892|398049|P15|Expansion Stage 2A|Physician Decision|0
107069|NCT00996892|398050|P14|Expansion Stage 2A|Physician Decision|0
107070|NCT00996892|398051|P13|Expansion Stage 2A|Physician Decision|0
107071|NCT00996892|398052|P12|Expansion Stage 2A|Physician Decision|0
107072|NCT00996892|398053|P11|Expansion Stage 2A|Physician Decision|0
107073|NCT00996892|398054|P10|Expansion Stage 2A|Physician Decision|0
107074|NCT00996892|398055|P9|Expansion Stage 2A|Physician Decision|0
107075|NCT00996892|398056|P8|Expansion Stage 2A|Physician Decision|0
107076|NCT00996892|398057|P7|Expansion Stage 2A|Physician Decision|0
107077|NCT00996892|398058|P6|Expansion Stage 2A|Physician Decision|0
107078|NCT00996892|398059|P5|Expansion Stage 2A|Physician Decision|0
107079|NCT00996892|398060|P4|Expansion Stage 2A|Physician Decision|0
107080|NCT00996892|398061|P3|Expansion Stage 2A|Physician Decision|0
107081|NCT00996892|398062|P2|Expansion Stage 2A|Physician Decision|0
107082|NCT00996892|398063|P1|Expansion Stage 2A|Physician Decision|0
107083|NCT00996892|398044|P20|Expansion Stage 2A|Adverse Event|8
107084|NCT00996892|398045|P19|Expansion Stage 2A|Adverse Event|0
107085|NCT00996892|398046|P18|Expansion Stage 2A|Adverse Event|0
107086|NCT00996892|398047|P17|Expansion Stage 2A|Adverse Event|0
107087|NCT00996892|398048|P16|Expansion Stage 2A|Adverse Event|0
107088|NCT00996892|398049|P15|Expansion Stage 2A|Adverse Event|0
107089|NCT00996892|398050|P14|Expansion Stage 2A|Adverse Event|0
107090|NCT00996892|398051|P13|Expansion Stage 2A|Adverse Event|0
107091|NCT00996892|398052|P12|Expansion Stage 2A|Adverse Event|0
107092|NCT00996892|398053|P11|Expansion Stage 2A|Adverse Event|0
107093|NCT00996892|398054|P10|Expansion Stage 2A|Adverse Event|0
107094|NCT00996892|398055|P9|Expansion Stage 2A|Adverse Event|0
107095|NCT00996892|398056|P8|Expansion Stage 2A|Adverse Event|0
107096|NCT00996892|398057|P7|Expansion Stage 2A|Adverse Event|0
107097|NCT00996892|398058|P6|Expansion Stage 2A|Adverse Event|0
107098|NCT00996892|398059|P5|Expansion Stage 2A|Adverse Event|0
107099|NCT00996892|398060|P4|Expansion Stage 2A|Adverse Event|0
107100|NCT00996892|398061|P3|Expansion Stage 2A|Adverse Event|0
107101|NCT00996892|398062|P2|Expansion Stage 2A|Adverse Event|0
107102|NCT00996892|398063|P1|Expansion Stage 2A|Adverse Event|0
107103|NCT00996892|398044|P20|Expansion Stage 2|Disease Progression|0
107104|NCT00996892|398045|P19|Expansion Stage 2|Disease Progression|28
107105|NCT00996892|398046|P18|Expansion Stage 2|Disease Progression|0
107106|NCT00996892|398047|P17|Expansion Stage 2|Disease Progression|0
107107|NCT00996892|398048|P16|Expansion Stage 2|Disease Progression|0
107108|NCT00996892|398049|P15|Expansion Stage 2|Disease Progression|0
107109|NCT00996892|398050|P14|Expansion Stage 2|Disease Progression|0
107110|NCT00996892|398051|P13|Expansion Stage 2|Disease Progression|0
107111|NCT00996892|398052|P12|Expansion Stage 2|Disease Progression|0
107112|NCT00996892|398053|P11|Expansion Stage 2|Disease Progression|0
107113|NCT00996892|398054|P10|Expansion Stage 2|Disease Progression|0
107114|NCT00996892|398055|P9|Expansion Stage 2|Disease Progression|0
107115|NCT00996892|398056|P8|Expansion Stage 2|Disease Progression|0
107116|NCT00996892|398057|P7|Expansion Stage 2|Disease Progression|0
107117|NCT00996892|398058|P6|Expansion Stage 2|Disease Progression|0
107118|NCT00996892|398059|P5|Expansion Stage 2|Disease Progression|0
107119|NCT00996892|398060|P4|Expansion Stage 2|Disease Progression|0
107120|NCT00996892|398061|P3|Expansion Stage 2|Disease Progression|0
107121|NCT00996892|398062|P2|Expansion Stage 2|Disease Progression|0
107122|NCT00996892|398063|P1|Expansion Stage 2|Disease Progression|0
107123|NCT00996892|398044|P20|Expansion Stage 2|Withdrawal by Subject|0
107124|NCT00996892|398045|P19|Expansion Stage 2|Withdrawal by Subject|1
107125|NCT00996892|398046|P18|Expansion Stage 2|Withdrawal by Subject|0
107126|NCT00996892|398047|P17|Expansion Stage 2|Withdrawal by Subject|0
107127|NCT00996892|398048|P16|Expansion Stage 2|Withdrawal by Subject|0
107128|NCT00996892|398049|P15|Expansion Stage 2|Withdrawal by Subject|0
107129|NCT00996892|398050|P14|Expansion Stage 2|Withdrawal by Subject|0
107130|NCT00996892|398051|P13|Expansion Stage 2|Withdrawal by Subject|0
107131|NCT00996892|398052|P12|Expansion Stage 2|Withdrawal by Subject|0
107132|NCT00996892|398053|P11|Expansion Stage 2|Withdrawal by Subject|0
107133|NCT00996892|398054|P10|Expansion Stage 2|Withdrawal by Subject|0
107134|NCT00996892|398055|P9|Expansion Stage 2|Withdrawal by Subject|0
107135|NCT00996892|398056|P8|Expansion Stage 2|Withdrawal by Subject|0
107136|NCT00996892|398057|P7|Expansion Stage 2|Withdrawal by Subject|0
107137|NCT00996892|398058|P6|Expansion Stage 2|Withdrawal by Subject|0
107138|NCT00996892|398059|P5|Expansion Stage 2|Withdrawal by Subject|0
107139|NCT00996892|398060|P4|Expansion Stage 2|Withdrawal by Subject|0
107140|NCT00996892|398061|P3|Expansion Stage 2|Withdrawal by Subject|0
107141|NCT00996892|398062|P2|Expansion Stage 2|Withdrawal by Subject|0
107142|NCT00996892|398063|P1|Expansion Stage 2|Withdrawal by Subject|0
107143|NCT00996892|398044|P20|Expansion Stage 2|Physician Decision|0
107144|NCT00996892|398045|P19|Expansion Stage 2|Physician Decision|1
107145|NCT00996892|398046|P18|Expansion Stage 2|Physician Decision|0
107146|NCT00996892|398047|P17|Expansion Stage 2|Physician Decision|0
107147|NCT00996892|398048|P16|Expansion Stage 2|Physician Decision|0
107148|NCT00996892|398049|P15|Expansion Stage 2|Physician Decision|0
107149|NCT00996892|398050|P14|Expansion Stage 2|Physician Decision|0
107150|NCT00996892|398051|P13|Expansion Stage 2|Physician Decision|0
107151|NCT00996892|398052|P12|Expansion Stage 2|Physician Decision|0
107152|NCT00996892|398053|P11|Expansion Stage 2|Physician Decision|0
107153|NCT00996892|398054|P10|Expansion Stage 2|Physician Decision|0
107154|NCT00996892|398055|P9|Expansion Stage 2|Physician Decision|0
107155|NCT00996892|398056|P8|Expansion Stage 2|Physician Decision|0
107156|NCT00996892|398057|P7|Expansion Stage 2|Physician Decision|0
107157|NCT00996892|398058|P6|Expansion Stage 2|Physician Decision|0
107158|NCT00996892|398059|P5|Expansion Stage 2|Physician Decision|0
107159|NCT00996892|398060|P4|Expansion Stage 2|Physician Decision|0
107160|NCT00996892|398061|P3|Expansion Stage 2|Physician Decision|0
107161|NCT00996892|398062|P2|Expansion Stage 2|Physician Decision|0
107162|NCT00996892|398063|P1|Expansion Stage 2|Physician Decision|0
107163|NCT00996892|398044|P20|Expansion Stage 2|Death|0
107164|NCT00996892|398045|P19|Expansion Stage 2|Death|2
107165|NCT00996892|398046|P18|Expansion Stage 2|Death|0
107166|NCT00996892|398047|P17|Expansion Stage 2|Death|0
107167|NCT00996892|398048|P16|Expansion Stage 2|Death|0
107168|NCT00996892|398049|P15|Expansion Stage 2|Death|0
107169|NCT00996892|398050|P14|Expansion Stage 2|Death|0
107170|NCT00996892|398051|P13|Expansion Stage 2|Death|0
107171|NCT00996892|398052|P12|Expansion Stage 2|Death|0
107172|NCT00996892|398053|P11|Expansion Stage 2|Death|0
107173|NCT00996892|398054|P10|Expansion Stage 2|Death|0
107174|NCT00996892|398055|P9|Expansion Stage 2|Death|0
107175|NCT00996892|398056|P8|Expansion Stage 2|Death|0
107176|NCT00996892|398057|P7|Expansion Stage 2|Death|0
107177|NCT00996892|398058|P6|Expansion Stage 2|Death|0
107178|NCT00996892|398059|P5|Expansion Stage 2|Death|0
107179|NCT00996892|398060|P4|Expansion Stage 2|Death|0
107180|NCT00996892|398061|P3|Expansion Stage 2|Death|0
107181|NCT00996892|398062|P2|Expansion Stage 2|Death|0
107182|NCT00996892|398063|P1|Expansion Stage 2|Death|0
107183|NCT00996892|398044|P20|Expansion Stage 2|Adverse Event|0
107184|NCT00996892|398045|P19|Expansion Stage 2|Adverse Event|3
107185|NCT00996892|398046|P18|Expansion Stage 2|Adverse Event|0
107186|NCT00996892|398047|P17|Expansion Stage 2|Adverse Event|0
107187|NCT00996892|398048|P16|Expansion Stage 2|Adverse Event|0
107188|NCT00996892|398049|P15|Expansion Stage 2|Adverse Event|0
107189|NCT00996892|398050|P14|Expansion Stage 2|Adverse Event|0
107190|NCT00996892|398051|P13|Expansion Stage 2|Adverse Event|0
107191|NCT00996892|398052|P12|Expansion Stage 2|Adverse Event|0
107192|NCT00996892|398053|P11|Expansion Stage 2|Adverse Event|0
107193|NCT00996892|398054|P10|Expansion Stage 2|Adverse Event|0
107194|NCT00996892|398055|P9|Expansion Stage 2|Adverse Event|0
107195|NCT00996892|398056|P8|Expansion Stage 2|Adverse Event|0
107196|NCT00996892|398057|P7|Expansion Stage 2|Adverse Event|0
107197|NCT00996892|398058|P6|Expansion Stage 2|Adverse Event|0
107198|NCT00996892|398059|P5|Expansion Stage 2|Adverse Event|0
107199|NCT00996892|398060|P4|Expansion Stage 2|Adverse Event|0
107200|NCT00996892|398061|P3|Expansion Stage 2|Adverse Event|0
107201|NCT00996892|398062|P2|Expansion Stage 2|Adverse Event|0
107202|NCT00996892|398063|P1|Expansion Stage 2|Adverse Event|0
107203|NCT00996892|398044|P20|Dose-Escalation Stage 1B|Disease Progression|0
107204|NCT00996892|398045|P19|Dose-Escalation Stage 1B|Disease Progression|0
107205|NCT00996892|398046|P18|Dose-Escalation Stage 1B|Disease Progression|3
107206|NCT00996892|398047|P17|Dose-Escalation Stage 1B|Disease Progression|3
107207|NCT00996892|398048|P16|Dose-Escalation Stage 1B|Disease Progression|3
107208|NCT00996892|398049|P15|Dose-Escalation Stage 1B|Disease Progression|4
107209|NCT00996892|398050|P14|Dose-Escalation Stage 1B|Disease Progression|0
107210|NCT00996892|398051|P13|Dose-Escalation Stage 1B|Disease Progression|0
107211|NCT00996892|398052|P12|Dose-Escalation Stage 1B|Disease Progression|0
107212|NCT00996892|398053|P11|Dose-Escalation Stage 1B|Disease Progression|0
107213|NCT00996892|398054|P10|Dose-Escalation Stage 1B|Disease Progression|0
107214|NCT00996892|398055|P9|Dose-Escalation Stage 1B|Disease Progression|0
107215|NCT00996892|398056|P8|Dose-Escalation Stage 1B|Disease Progression|0
107216|NCT00996892|398057|P7|Dose-Escalation Stage 1B|Disease Progression|0
107217|NCT00996892|398058|P6|Dose-Escalation Stage 1B|Disease Progression|0
107218|NCT00996892|398059|P5|Dose-Escalation Stage 1B|Disease Progression|0
107219|NCT00996892|398060|P4|Dose-Escalation Stage 1B|Disease Progression|0
107220|NCT00996892|398061|P3|Dose-Escalation Stage 1B|Disease Progression|0
107221|NCT00996892|398062|P2|Dose-Escalation Stage 1B|Disease Progression|0
107222|NCT00996892|398063|P1|Dose-Escalation Stage 1B|Disease Progression|0
107223|NCT00996892|398044|P20|Dose-Escalation Stage 1B|Physician Decision|0
107224|NCT00996892|398045|P19|Dose-Escalation Stage 1B|Physician Decision|0
107225|NCT00996892|398046|P18|Dose-Escalation Stage 1B|Physician Decision|2
107226|NCT00996892|398047|P17|Dose-Escalation Stage 1B|Physician Decision|0
107227|NCT00996892|398048|P16|Dose-Escalation Stage 1B|Physician Decision|0
107228|NCT00996892|398049|P15|Dose-Escalation Stage 1B|Physician Decision|0
107229|NCT00996892|398050|P14|Dose-Escalation Stage 1B|Physician Decision|0
107230|NCT00996892|398051|P13|Dose-Escalation Stage 1B|Physician Decision|0
107231|NCT00996892|398052|P12|Dose-Escalation Stage 1B|Physician Decision|0
107232|NCT00996892|398053|P11|Dose-Escalation Stage 1B|Physician Decision|0
107233|NCT00996892|398054|P10|Dose-Escalation Stage 1B|Physician Decision|0
107234|NCT00996892|398055|P9|Dose-Escalation Stage 1B|Physician Decision|0
107235|NCT00996892|398056|P8|Dose-Escalation Stage 1B|Physician Decision|0
107236|NCT00996892|398057|P7|Dose-Escalation Stage 1B|Physician Decision|0
107237|NCT00996892|398058|P6|Dose-Escalation Stage 1B|Physician Decision|0
107238|NCT00996892|398059|P5|Dose-Escalation Stage 1B|Physician Decision|0
107239|NCT00996892|398060|P4|Dose-Escalation Stage 1B|Physician Decision|0
107240|NCT00996892|398061|P3|Dose-Escalation Stage 1B|Physician Decision|0
107241|NCT00996892|398062|P2|Dose-Escalation Stage 1B|Physician Decision|0
107242|NCT00996892|398063|P1|Dose-Escalation Stage 1B|Physician Decision|0
107243|NCT00996892|398044|P20|Dose-Escalation Stage 1A|Disease Progression|0
107244|NCT00996892|398045|P19|Dose-Escalation Stage 1A|Disease Progression|0
107245|NCT00996892|398046|P18|Dose-Escalation Stage 1A|Disease Progression|0
107246|NCT00996892|398047|P17|Dose-Escalation Stage 1A|Disease Progression|0
107247|NCT00996892|398048|P16|Dose-Escalation Stage 1A|Disease Progression|0
107248|NCT00996892|398049|P15|Dose-Escalation Stage 1A|Disease Progression|0
107249|NCT00996892|398050|P14|Dose-Escalation Stage 1A|Disease Progression|4
107250|NCT00996892|398051|P13|Dose-Escalation Stage 1A|Disease Progression|6
107251|NCT00996892|398052|P12|Dose-Escalation Stage 1A|Disease Progression|7
107252|NCT00996892|398053|P11|Dose-Escalation Stage 1A|Disease Progression|5
107253|NCT00996892|398054|P10|Dose-Escalation Stage 1A|Disease Progression|1
107254|NCT00996892|398055|P9|Dose-Escalation Stage 1A|Disease Progression|3
107255|NCT00996892|398056|P8|Dose-Escalation Stage 1A|Disease Progression|2
107256|NCT00996892|398057|P7|Dose-Escalation Stage 1A|Disease Progression|0
107257|NCT00996892|398058|P6|Dose-Escalation Stage 1A|Disease Progression|0
107258|NCT00996892|398059|P5|Dose-Escalation Stage 1A|Disease Progression|0
107259|NCT00996892|398060|P4|Dose-Escalation Stage 1A|Disease Progression|0
107260|NCT00996892|398061|P3|Dose-Escalation Stage 1A|Disease Progression|0
107261|NCT00996892|398062|P2|Dose-Escalation Stage 1A|Disease Progression|0
107262|NCT00996892|398063|P1|Dose-Escalation Stage 1A|Disease Progression|0
107263|NCT00996892|398044|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107264|NCT00996892|398045|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107265|NCT00996892|398046|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107266|NCT00996892|398047|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107267|NCT00996892|398048|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107268|NCT00996892|398049|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107269|NCT00996892|398050|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107270|NCT00996892|398051|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
107271|NCT00996892|398052|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
107272|NCT00996892|398053|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
107273|NCT00996892|398054|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
107274|NCT00996892|398055|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107275|NCT00996892|398056|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107276|NCT00996892|398057|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107277|NCT00996892|398058|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107278|NCT00996892|398059|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107279|NCT00996892|398060|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107280|NCT00996892|398061|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107281|NCT00996892|398062|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107282|NCT00996892|398063|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
107283|NCT00996892|398044|P20|Dose-Escalation Stage 1A|Physician Decision|0
107284|NCT00996892|398045|P19|Dose-Escalation Stage 1A|Physician Decision|0
107285|NCT00996892|398046|P18|Dose-Escalation Stage 1A|Physician Decision|0
107286|NCT00996892|398047|P17|Dose-Escalation Stage 1A|Physician Decision|0
107287|NCT00996892|398048|P16|Dose-Escalation Stage 1A|Physician Decision|0
107288|NCT00996892|398049|P15|Dose-Escalation Stage 1A|Physician Decision|0
107289|NCT00996892|398050|P14|Dose-Escalation Stage 1A|Physician Decision|0
107290|NCT00996892|398051|P13|Dose-Escalation Stage 1A|Physician Decision|0
107291|NCT00996892|398052|P12|Dose-Escalation Stage 1A|Physician Decision|0
107292|NCT00996892|398053|P11|Dose-Escalation Stage 1A|Physician Decision|0
107293|NCT00996892|398054|P10|Dose-Escalation Stage 1A|Physician Decision|0
107294|NCT00996892|398055|P9|Dose-Escalation Stage 1A|Physician Decision|0
107295|NCT00996892|398056|P8|Dose-Escalation Stage 1A|Physician Decision|1
107296|NCT00996892|398057|P7|Dose-Escalation Stage 1A|Physician Decision|0
107297|NCT00996892|398058|P6|Dose-Escalation Stage 1A|Physician Decision|0
107298|NCT00996892|398059|P5|Dose-Escalation Stage 1A|Physician Decision|0
107299|NCT00996892|398060|P4|Dose-Escalation Stage 1A|Physician Decision|0
107300|NCT00996892|398061|P3|Dose-Escalation Stage 1A|Physician Decision|0
107301|NCT00996892|398062|P2|Dose-Escalation Stage 1A|Physician Decision|0
107302|NCT00996892|398063|P1|Dose-Escalation Stage 1A|Physician Decision|0
107303|NCT00996892|398044|P20|Dose-Escalation Stage 1A|Death|0
107304|NCT00996892|398045|P19|Dose-Escalation Stage 1A|Death|0
107305|NCT00996892|398046|P18|Dose-Escalation Stage 1A|Death|0
107306|NCT00996892|398047|P17|Dose-Escalation Stage 1A|Death|0
107307|NCT00996892|398048|P16|Dose-Escalation Stage 1A|Death|0
107308|NCT00996892|398049|P15|Dose-Escalation Stage 1A|Death|0
107309|NCT00996892|398050|P14|Dose-Escalation Stage 1A|Death|0
107310|NCT00996892|398051|P13|Dose-Escalation Stage 1A|Death|1
107311|NCT00996892|398052|P12|Dose-Escalation Stage 1A|Death|1
107312|NCT00996892|398053|P11|Dose-Escalation Stage 1A|Death|0
107313|NCT00996892|398054|P10|Dose-Escalation Stage 1A|Death|2
107314|NCT00996892|398055|P9|Dose-Escalation Stage 1A|Death|0
107315|NCT00996892|398056|P8|Dose-Escalation Stage 1A|Death|0
107316|NCT00996892|398057|P7|Dose-Escalation Stage 1A|Death|0
107317|NCT00996892|398058|P6|Dose-Escalation Stage 1A|Death|0
107318|NCT00996892|398059|P5|Dose-Escalation Stage 1A|Death|0
107319|NCT00996892|398060|P4|Dose-Escalation Stage 1A|Death|0
107320|NCT00996892|398061|P3|Dose-Escalation Stage 1A|Death|0
107321|NCT00996892|398062|P2|Dose-Escalation Stage 1A|Death|0
107322|NCT00996892|398063|P1|Dose-Escalation Stage 1A|Death|0
107323|NCT00996892|398044|P20|Dose-Escalation Stage 1A|Adverse Event|0
107324|NCT00996892|398045|P19|Dose-Escalation Stage 1A|Adverse Event|0
107325|NCT00996892|398046|P18|Dose-Escalation Stage 1A|Adverse Event|0
107326|NCT00996892|398047|P17|Dose-Escalation Stage 1A|Adverse Event|0
107327|NCT00996892|398048|P16|Dose-Escalation Stage 1A|Adverse Event|0
107328|NCT00996892|398049|P15|Dose-Escalation Stage 1A|Adverse Event|0
107329|NCT00996892|398050|P14|Dose-Escalation Stage 1A|Adverse Event|1
107330|NCT00996892|398051|P13|Dose-Escalation Stage 1A|Adverse Event|0
107331|NCT00996892|398052|P12|Dose-Escalation Stage 1A|Adverse Event|0
107332|NCT00996892|398053|P11|Dose-Escalation Stage 1A|Adverse Event|1
107333|NCT00996892|398054|P10|Dose-Escalation Stage 1A|Adverse Event|0
107334|NCT00996892|398055|P9|Dose-Escalation Stage 1A|Adverse Event|0
107335|NCT00996892|398056|P8|Dose-Escalation Stage 1A|Adverse Event|0
107336|NCT00996892|398057|P7|Dose-Escalation Stage 1A|Adverse Event|0
107337|NCT00996892|398058|P6|Dose-Escalation Stage 1A|Adverse Event|0
107338|NCT00996892|398059|P5|Dose-Escalation Stage 1A|Adverse Event|0
107339|NCT00996892|398060|P4|Dose-Escalation Stage 1A|Adverse Event|0
107340|NCT00996892|398061|P3|Dose-Escalation Stage 1A|Adverse Event|0
107341|NCT00996892|398062|P2|Dose-Escalation Stage 1A|Adverse Event|0
107342|NCT00996892|398063|P1|Dose-Escalation Stage 1A|Adverse Event|0
107343|NCT00996892|398044|P20|Dose-Escalation Stage 1|Disease Progression|0
107344|NCT00996892|398045|P19|Dose-Escalation Stage 1|Disease Progression|0
107345|NCT00996892|398046|P18|Dose-Escalation Stage 1|Disease Progression|0
107346|NCT00996892|398047|P17|Dose-Escalation Stage 1|Disease Progression|0
107347|NCT00996892|398048|P16|Dose-Escalation Stage 1|Disease Progression|0
107348|NCT00996892|398049|P15|Dose-Escalation Stage 1|Disease Progression|0
107349|NCT00996892|398050|P14|Dose-Escalation Stage 1|Disease Progression|0
107350|NCT00996892|398051|P13|Dose-Escalation Stage 1|Disease Progression|0
107351|NCT00996892|398052|P12|Dose-Escalation Stage 1|Disease Progression|0
107352|NCT00996892|398053|P11|Dose-Escalation Stage 1|Disease Progression|0
107353|NCT00996892|398054|P10|Dose-Escalation Stage 1|Disease Progression|0
107354|NCT00996892|398055|P9|Dose-Escalation Stage 1|Disease Progression|0
107355|NCT00996892|398056|P8|Dose-Escalation Stage 1|Disease Progression|0
107356|NCT00996892|398057|P7|Dose-Escalation Stage 1|Disease Progression|0
107357|NCT00996892|398058|P6|Dose-Escalation Stage 1|Disease Progression|7
107358|NCT00996892|398059|P5|Dose-Escalation Stage 1|Disease Progression|10
107359|NCT00996892|398060|P4|Dose-Escalation Stage 1|Disease Progression|4
107360|NCT00996892|398061|P3|Dose-Escalation Stage 1|Disease Progression|3
107361|NCT00996892|398062|P2|Dose-Escalation Stage 1|Disease Progression|2
107362|NCT00996892|398063|P1|Dose-Escalation Stage 1|Disease Progression|2
107363|NCT00996892|398044|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
107364|NCT00996892|398045|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
107365|NCT00996892|398046|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
107366|NCT00996892|398047|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
107367|NCT00996892|398048|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
107368|NCT00996892|398049|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
107369|NCT00996892|398050|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
107370|NCT00996892|398051|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
107371|NCT00996892|398052|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
107372|NCT00996892|398053|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
107373|NCT00996892|398054|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
107374|NCT00996892|398055|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
107375|NCT00996892|398056|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
107376|NCT00996892|398057|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
107377|NCT00996892|398058|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
107378|NCT00996892|398059|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
107379|NCT00996892|398060|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
107380|NCT00996892|398061|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
107381|NCT00996892|398062|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
107382|NCT00996892|398063|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
107383|NCT00996892|398044|P20|Dose-Escalation Stage 1|Physician Decision|0
107384|NCT00996892|398045|P19|Dose-Escalation Stage 1|Physician Decision|0
107385|NCT00996892|398046|P18|Dose-Escalation Stage 1|Physician Decision|0
107386|NCT00996892|398047|P17|Dose-Escalation Stage 1|Physician Decision|0
107387|NCT00996892|398048|P16|Dose-Escalation Stage 1|Physician Decision|0
107388|NCT00996892|398049|P15|Dose-Escalation Stage 1|Physician Decision|0
107389|NCT00996892|398050|P14|Dose-Escalation Stage 1|Physician Decision|0
107390|NCT00996892|398051|P13|Dose-Escalation Stage 1|Physician Decision|0
107391|NCT00996892|398052|P12|Dose-Escalation Stage 1|Physician Decision|0
107392|NCT00996892|398053|P11|Dose-Escalation Stage 1|Physician Decision|0
107393|NCT00996892|398054|P10|Dose-Escalation Stage 1|Physician Decision|0
107394|NCT00996892|398055|P9|Dose-Escalation Stage 1|Physician Decision|0
107395|NCT00996892|398056|P8|Dose-Escalation Stage 1|Physician Decision|0
107396|NCT00996892|398057|P7|Dose-Escalation Stage 1|Physician Decision|2
107397|NCT00996892|398058|P6|Dose-Escalation Stage 1|Physician Decision|1
107398|NCT00996892|398059|P5|Dose-Escalation Stage 1|Physician Decision|0
107399|NCT00996892|398060|P4|Dose-Escalation Stage 1|Physician Decision|1
107400|NCT00996892|398061|P3|Dose-Escalation Stage 1|Physician Decision|0
107401|NCT00996892|398062|P2|Dose-Escalation Stage 1|Physician Decision|0
107402|NCT00996892|398063|P1|Dose-Escalation Stage 1|Physician Decision|1
107403|NCT00996892|398044|P20|Dose-Escalation Stage 1|Death|0
107404|NCT00996892|398045|P19|Dose-Escalation Stage 1|Death|0
107405|NCT00996892|398046|P18|Dose-Escalation Stage 1|Death|0
107406|NCT00996892|398047|P17|Dose-Escalation Stage 1|Death|0
107407|NCT00996892|398048|P16|Dose-Escalation Stage 1|Death|0
107408|NCT00996892|398049|P15|Dose-Escalation Stage 1|Death|0
107409|NCT00996892|398050|P14|Dose-Escalation Stage 1|Death|0
107410|NCT00996892|398051|P13|Dose-Escalation Stage 1|Death|0
107411|NCT00996892|398052|P12|Dose-Escalation Stage 1|Death|0
107412|NCT00996892|398053|P11|Dose-Escalation Stage 1|Death|0
107413|NCT00996892|398054|P10|Dose-Escalation Stage 1|Death|0
107414|NCT00996892|398055|P9|Dose-Escalation Stage 1|Death|0
107415|NCT00996892|398056|P8|Dose-Escalation Stage 1|Death|0
107416|NCT00996892|398057|P7|Dose-Escalation Stage 1|Death|0
107417|NCT00996892|398058|P6|Dose-Escalation Stage 1|Death|1
107418|NCT00996892|398059|P5|Dose-Escalation Stage 1|Death|0
107419|NCT00996892|398060|P4|Dose-Escalation Stage 1|Death|0
107420|NCT00996892|398061|P3|Dose-Escalation Stage 1|Death|0
107421|NCT00996892|398062|P2|Dose-Escalation Stage 1|Death|0
107422|NCT00996892|398063|P1|Dose-Escalation Stage 1|Death|1
107423|NCT00996892|398044|P20|Dose-Escalation Stage 1|Adverse Event|0
107424|NCT00996892|398045|P19|Dose-Escalation Stage 1|Adverse Event|0
107425|NCT00996892|398046|P18|Dose-Escalation Stage 1|Adverse Event|0
107426|NCT00996892|398047|P17|Dose-Escalation Stage 1|Adverse Event|0
107427|NCT00996892|398048|P16|Dose-Escalation Stage 1|Adverse Event|0
107428|NCT00996892|398049|P15|Dose-Escalation Stage 1|Adverse Event|0
107429|NCT00996892|398050|P14|Dose-Escalation Stage 1|Adverse Event|0
107430|NCT00996892|398051|P13|Dose-Escalation Stage 1|Adverse Event|0
107431|NCT00996892|398052|P12|Dose-Escalation Stage 1|Adverse Event|0
107432|NCT00996892|398053|P11|Dose-Escalation Stage 1|Adverse Event|0
107433|NCT00996892|398054|P10|Dose-Escalation Stage 1|Adverse Event|0
107434|NCT00996892|398055|P9|Dose-Escalation Stage 1|Adverse Event|0
107435|NCT00996892|398056|P8|Dose-Escalation Stage 1|Adverse Event|0
107436|NCT00996892|398057|P7|Dose-Escalation Stage 1|Adverse Event|1
107437|NCT00996892|398058|P6|Dose-Escalation Stage 1|Adverse Event|0
107438|NCT00996892|398059|P5|Dose-Escalation Stage 1|Adverse Event|0
107439|NCT00996892|398060|P4|Dose-Escalation Stage 1|Adverse Event|2
107440|NCT00996892|398061|P3|Dose-Escalation Stage 1|Adverse Event|0
107441|NCT00996892|398062|P2|Dose-Escalation Stage 1|Adverse Event|0
107442|NCT00996892|398063|P1|Dose-Escalation Stage 1|Adverse Event|0
107443|NCT00996840|398657|P5|Overall Study|Withdrawal by Subject|0
107444|NCT00996840|398658|P4|Overall Study|Withdrawal by Subject|0
107445|NCT00996840|398659|P3|Overall Study|Withdrawal by Subject|0
107446|NCT00996840|398660|P2|Overall Study|Withdrawal by Subject|1
107447|NCT00996840|398661|P1|Overall Study|Withdrawal by Subject|1
107448|NCT00996840|398657|P5|Overall Study|Physician Decision|2
107449|NCT00996840|398658|P4|Overall Study|Physician Decision|1
107450|NCT00996840|398659|P3|Overall Study|Physician Decision|1
107451|NCT00996840|398660|P2|Overall Study|Physician Decision|0
107452|NCT00996840|398661|P1|Overall Study|Physician Decision|0
107453|NCT00996840|398657|P5|Overall Study|Adverse Event|0
107454|NCT00996840|398658|P4|Overall Study|Adverse Event|0
107455|NCT00996840|398659|P3|Overall Study|Adverse Event|0
107456|NCT00996840|398660|P2|Overall Study|Adverse Event|1
107457|NCT00996840|398661|P1|Overall Study|Adverse Event|0
107458|NCT00996801|398811|P6|Overall Study|Withdrawal by Subject|9
107459|NCT00996801|398812|P5|Overall Study|Withdrawal by Subject|5
107460|NCT00996801|398813|P4|Overall Study|Withdrawal by Subject|5
107461|NCT00996801|398814|P3|Overall Study|Withdrawal by Subject|9
107462|NCT00996801|398815|P2|Overall Study|Withdrawal by Subject|6
107463|NCT00996801|398816|P1|Overall Study|Withdrawal by Subject|8
107464|NCT00996801|398811|P6|Overall Study|Study Terminated by Sponsor|0
107465|NCT00996801|398812|P5|Overall Study|Study Terminated by Sponsor|46
107466|NCT00996801|398813|P4|Overall Study|Study Terminated by Sponsor|0
107467|NCT00996801|398814|P3|Overall Study|Study Terminated by Sponsor|0
107468|NCT00996801|398815|P2|Overall Study|Study Terminated by Sponsor|1
107469|NCT00996801|398816|P1|Overall Study|Study Terminated by Sponsor|0
107470|NCT00996801|398811|P6|Overall Study|Protocol Violation|4
107471|NCT00996801|398812|P5|Overall Study|Protocol Violation|3
107472|NCT00996801|398813|P4|Overall Study|Protocol Violation|2
107473|NCT00996801|398814|P3|Overall Study|Protocol Violation|1
107474|NCT00996801|398815|P2|Overall Study|Protocol Violation|4
107475|NCT00996801|398816|P1|Overall Study|Protocol Violation|3
107476|NCT00996801|398811|P6|Overall Study|Progressive Disease|0
107477|NCT00996801|398812|P5|Overall Study|Progressive Disease|0
107478|NCT00996801|398813|P4|Overall Study|Progressive Disease|0
107479|NCT00996801|398814|P3|Overall Study|Progressive Disease|0
107480|NCT00996801|398815|P2|Overall Study|Progressive Disease|1
107481|NCT00996801|398816|P1|Overall Study|Progressive Disease|0
107482|NCT00996801|398811|P6|Overall Study|Physician Decision|0
107483|NCT00996801|398812|P5|Overall Study|Physician Decision|0
107484|NCT00996801|398813|P4|Overall Study|Physician Decision|1
107485|NCT00996801|398814|P3|Overall Study|Physician Decision|0
107486|NCT00996801|398815|P2|Overall Study|Physician Decision|0
107487|NCT00996801|398816|P1|Overall Study|Physician Decision|0
107488|NCT00996801|398811|P6|Overall Study|Lost to Follow-up|2
107489|NCT00996801|398812|P5|Overall Study|Lost to Follow-up|3
107490|NCT00996801|398813|P4|Overall Study|Lost to Follow-up|3
107491|NCT00996801|398814|P3|Overall Study|Lost to Follow-up|0
107492|NCT00996801|398815|P2|Overall Study|Lost to Follow-up|0
107493|NCT00996801|398816|P1|Overall Study|Lost to Follow-up|0
107494|NCT00996801|398811|P6|Overall Study|Lack of Efficacy|1
107495|NCT00996801|398812|P5|Overall Study|Lack of Efficacy|0
107496|NCT00996801|398813|P4|Overall Study|Lack of Efficacy|3
107497|NCT00996801|398814|P3|Overall Study|Lack of Efficacy|1
107498|NCT00996801|398815|P2|Overall Study|Lack of Efficacy|0
107499|NCT00996801|398816|P1|Overall Study|Lack of Efficacy|3
107500|NCT00996801|398811|P6|Overall Study|Adverse Event|3
107501|NCT00996801|398812|P5|Overall Study|Adverse Event|31
107502|NCT00996801|398813|P4|Overall Study|Adverse Event|17
107503|NCT00996801|398814|P3|Overall Study|Adverse Event|12
107504|NCT00996801|398815|P2|Overall Study|Adverse Event|4
107505|NCT00996801|398816|P1|Overall Study|Adverse Event|6
107506|NCT00996736|398928|P2|Overall Study|Visit not within 3-month window|3
107507|NCT00996736|398929|P1|Overall Study|Visit not within 3-month window|5
107508|NCT00996736|398928|P2|Overall Study|Lost to Follow-up|14
107509|NCT00996736|398929|P1|Overall Study|Lost to Follow-up|15
107510|NCT00996736|398928|P2|Overall Study|Death|1
107511|NCT00996736|398929|P1|Overall Study|Death|1
107512|NCT00996658|398949|P2|Overall Study|Other|7
107513|NCT00996658|398950|P1|Overall Study|Other|9
107514|NCT00996658|398949|P2|Overall Study|Non-compliance issues|3
107515|NCT00996658|398950|P1|Overall Study|Non-compliance issues|3
107516|NCT00996658|398949|P2|Overall Study|Lost to Follow-up|5
107517|NCT00996658|398950|P1|Overall Study|Lost to Follow-up|2
107518|NCT00996658|398949|P2|Overall Study|Protocol Violation|1
107519|NCT00996658|398950|P1|Overall Study|Protocol Violation|0
107520|NCT00996658|398949|P2|Overall Study|Adverse Event|5
107521|NCT00996658|398950|P1|Overall Study|Adverse Event|2
107522|NCT00996632|398978|P2|Overall Study|Physician Decision|0
107523|NCT00996632|398979|P1|Overall Study|Physician Decision|0
107524|NCT00996606|398987|P1|Overall Study|Withdrawal by Subject|3
107525|NCT00996606|398987|P1|Overall Study|Protocol Violation|1
107526|NCT00996606|398987|P1|Overall Study|Insufficient Therapeutic Response|2
107527|NCT00996606|398987|P1|Overall Study|Adverse Event or Intercurrent Illness|2
107528|NCT00996593|399081|P1|Long-Term Follow-Up|Site Closed|1
107529|NCT00996593|399081|P1|Long-Term Follow-Up|Withdrawal by Subject|2
107530|NCT00996593|399081|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
107531|NCT00996593|399081|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
107532|NCT00996593|399081|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
107533|NCT00996593|399081|P1|Dosimetric and Therapeutic Treatment|Death|1
107534|NCT00996593|399081|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
107535|NCT00996593|399081|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
107536|NCT00996593|399081|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
107537|NCT00996580|399109|P1|Overall Study|Not specified|29
107538|NCT00996580|399109|P1|Overall Study|Withdrawal by Subject|217
107539|NCT00996580|399109|P1|Overall Study|Sponsor requested participant withdrawal|35
107540|NCT00996580|399109|P1|Overall Study|Protocol Violation|16
107541|NCT00996580|399109|P1|Overall Study|Pregnancy|68
107542|NCT00996580|399109|P1|Overall Study|Physician Decision|5
107543|NCT00996580|399109|P1|Overall Study|Noncompliance with the protocol|137
107544|NCT00996580|399109|P1|Overall Study|Lost to Follow-up|480
107545|NCT00996580|399109|P1|Overall Study|Adverse Event|466
107546|NCT00996476|399146|P5|Overall Study|Adverse Event|1
107547|NCT00996476|399147|P4|Overall Study|Adverse Event|0
107548|NCT00996476|399148|P3|Overall Study|Adverse Event|0
107549|NCT00996476|399149|P2|Overall Study|Adverse Event|1
107550|NCT00996476|399150|P1|Overall Study|Adverse Event|0
107551|NCT00996476|399146|P5|Overall Study|Withdrawal by Subject|1
107552|NCT00996476|399147|P4|Overall Study|Withdrawal by Subject|0
107553|NCT00996476|399148|P3|Overall Study|Withdrawal by Subject|1
107554|NCT00996476|399149|P2|Overall Study|Withdrawal by Subject|2
107555|NCT00996476|399150|P1|Overall Study|Withdrawal by Subject|1
107556|NCT00996437|399218|P2|Overall Study|Missed|5
107557|NCT00996437|399219|P1|Overall Study|Missed|2
107558|NCT00996437|399218|P2|Overall Study|Dropped|2
107559|NCT00996437|399219|P1|Overall Study|Dropped|2
107560|NCT00996437|399218|P2|Overall Study|Death|0
107561|NCT00996437|399219|P1|Overall Study|Death|1
107562|NCT00996333|399264|P1|Overall Study|Other|5
107563|NCT00996333|399264|P1|Overall Study|Physician Decision|1
107564|NCT00996333|399264|P1|Overall Study|Adverse Event|1
107565|NCT00996333|399264|P1|Overall Study|Death|4
107566|NCT00996333|399264|P1|Overall Study|Withdrawal by Subject|1
107567|NCT00996333|399264|P1|Overall Study|Screen failure|1
107568|NCT00996307|399274|P4|Overall Study|Unable to classify|1
107569|NCT00996307|399275|P3|Overall Study|Unable to classify|2
107570|NCT00996307|399276|P2|Overall Study|Unable to classify|0
107571|NCT00996307|399277|P1|Overall Study|Unable to classify|4
107572|NCT00996307|399274|P4|Overall Study|Administrative reason|0
107573|NCT00996307|399275|P3|Overall Study|Administrative reason|0
107574|NCT00996307|399276|P2|Overall Study|Administrative reason|1
107575|NCT00996307|399277|P1|Overall Study|Administrative reason|0
107576|NCT00996307|399274|P4|Overall Study|Lost to Follow-up|15
107577|NCT00996307|399275|P3|Overall Study|Lost to Follow-up|7
107578|NCT00996307|399276|P2|Overall Study|Lost to Follow-up|13
107579|NCT00996307|399277|P1|Overall Study|Lost to Follow-up|13
107580|NCT00996307|399274|P4|Overall Study|Withdrawal by Subject|5
107581|NCT00996307|399275|P3|Overall Study|Withdrawal by Subject|5
107582|NCT00996307|399276|P2|Overall Study|Withdrawal by Subject|2
107583|NCT00996307|399277|P1|Overall Study|Withdrawal by Subject|3
107584|NCT00996307|399274|P4|Overall Study|Adverse Event|0
107585|NCT00996307|399275|P3|Overall Study|Adverse Event|0
107586|NCT00996307|399276|P2|Overall Study|Adverse Event|1
107587|NCT00996307|399277|P1|Overall Study|Adverse Event|0
107588|NCT00996281|399337|P2|Overall Study|Other|7
107589|NCT00996281|399338|P1|Overall Study|Other|5
107590|NCT00996281|399337|P2|Overall Study|Lack of Efficacy|2
107591|NCT00996281|399338|P1|Overall Study|Lack of Efficacy|0
107592|NCT00996281|399337|P2|Overall Study|Withdrawal by Subject|20
107593|NCT00996281|399338|P1|Overall Study|Withdrawal by Subject|31
107594|NCT00996281|399337|P2|Overall Study|Lost to Follow-up|16
107595|NCT00996281|399338|P1|Overall Study|Lost to Follow-up|14
107596|NCT00996281|399337|P2|Overall Study|Major Protocol Deviation|7
107597|NCT00996281|399338|P1|Overall Study|Major Protocol Deviation|6
107598|NCT00996281|399337|P2|Overall Study|Adverse Event|37
107599|NCT00996281|399338|P1|Overall Study|Adverse Event|75
107600|NCT00996216|399346|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
107601|NCT00996216|399346|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
107602|NCT00996216|399346|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
107603|NCT00996203|399362|P1|Overall Study|Protocol Violation|2
107604|NCT00996203|399362|P1|Overall Study|Lack of Efficacy|1
107605|NCT00996203|399362|P1|Overall Study|Lost to Follow-up|1
107606|NCT00996203|399362|P1|Overall Study|Adverse Event|3
107607|NCT00996125|399394|P2|Overall Study|Withdrawal by Subject|3
107608|NCT00996125|399395|P1|Overall Study|Withdrawal by Subject|4
107609|NCT00996125|399394|P2|Overall Study|Lost to Follow-up|6
107610|NCT00996125|399395|P1|Overall Study|Lost to Follow-up|1
107611|NCT00996125|399394|P2|Overall Study|Adverse Event|2
107612|NCT00996125|399395|P1|Overall Study|Adverse Event|0
107613|NCT00996034|399415|P1|Overall Study|withdrawn by PI|1
107614|NCT00996034|399415|P1|Overall Study|Lost to Follow-up|2
107615|NCT00995930|399421|P2|Overall Study|Adverse Event|14
107616|NCT00995930|399422|P1|Overall Study|Adverse Event|11
107617|NCT00995930|399421|P2|Overall Study|Withdrawal by Subject|4
107618|NCT00995930|399422|P1|Overall Study|Withdrawal by Subject|3
107619|NCT00995930|399421|P2|Overall Study|Lost to Follow-up|2
107620|NCT00995930|399422|P1|Overall Study|Lost to Follow-up|1
107621|NCT00995930|399421|P2|Overall Study|Administrative problems|2
107622|NCT00995930|399422|P1|Overall Study|Administrative problems|4
107623|NCT00995930|399421|P2|Overall Study|Death|1
107624|NCT00995930|399422|P1|Overall Study|Death|0
107625|NCT00995930|399421|P2|Overall Study|Protocol deviation|5
107626|NCT00995930|399422|P1|Overall Study|Protocol deviation|2
107627|NCT00995865|399473|P3|Overall Study|Lost to Follow-up|1
107628|NCT00995865|399474|P2|Overall Study|Lost to Follow-up|0
107629|NCT00995865|399475|P1|Overall Study|Lost to Follow-up|0
107630|NCT00995865|399473|P3|Overall Study|Protocol Violation|0
107631|NCT00995865|399474|P2|Overall Study|Protocol Violation|0
107632|NCT00995865|399475|P1|Overall Study|Protocol Violation|2
107633|NCT00995774|399497|P2|Training Period 2|Withdrawal by Subject|0
107634|NCT00995774|399498|P1|Training Period 2|Withdrawal by Subject|2
107635|NCT00995709|399530|P3|Overall Study|Protocol Violation|0
107636|NCT00995709|399531|P2|Overall Study|Protocol Violation|1
107637|NCT00995709|399532|P1|Overall Study|Protocol Violation|2
107638|NCT00995709|399530|P3|Overall Study|Death|0
107639|NCT00995709|399531|P2|Overall Study|Death|1
107640|NCT00995709|399532|P1|Overall Study|Death|0
107641|NCT00995709|399530|P3|Overall Study|Lost to Follow-up|0
107642|NCT00995709|399531|P2|Overall Study|Lost to Follow-up|0
107643|NCT00995709|399532|P1|Overall Study|Lost to Follow-up|1
107644|NCT00995709|399530|P3|Overall Study|Withdrawal by Subject|1
107645|NCT00995709|399531|P2|Overall Study|Withdrawal by Subject|4
107646|NCT00995709|399532|P1|Overall Study|Withdrawal by Subject|0
107647|NCT00995709|399530|P3|Overall Study|Lack of Efficacy|4
107648|NCT00995709|399531|P2|Overall Study|Lack of Efficacy|1
107649|NCT00995709|399532|P1|Overall Study|Lack of Efficacy|0
107650|NCT00995709|399530|P3|Overall Study|Adverse Event|0
107651|NCT00995709|399531|P2|Overall Study|Adverse Event|2
107652|NCT00995709|399532|P1|Overall Study|Adverse Event|4
107653|NCT00995670|399558|P3|Overall Study|Failed arterial cannulation|3
107654|NCT00995670|399559|P2|Overall Study|Failed arterial cannulation|0
107655|NCT00995670|399560|P1|Overall Study|Failed arterial cannulation|1
107656|NCT00995566|399568|P1|Overall Study|Early study termination|52
107657|NCT00995566|399568|P1|Overall Study|Adverse Event|2
107658|NCT00995553|399582|P2|Overall Study|Withdrawal by Subject|6
107659|NCT00995553|399583|P1|Overall Study|Withdrawal by Subject|2
107660|NCT00995488|399632|P1|Overall Study|Withdrawal by Subject|1
107661|NCT00995436|399655|P3|Overall Study|Withdrawal by Subject|0
107662|NCT00995436|399656|P2|Overall Study|Withdrawal by Subject|5
107663|NCT00995436|399657|P1|Overall Study|Withdrawal by Subject|2
107664|NCT00995410|399665|P1|Overall Study|Misc|28
107665|NCT00995410|399665|P1|Overall Study|Lost to Follow-up|2
107666|NCT00995410|399665|P1|Overall Study|Withdrawal by Subject|7
107667|NCT00995410|399665|P1|Overall Study|Adverse Event|51
107668|NCT00995371|399672|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
107669|NCT00995371|399673|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
107670|NCT00995345|399691|P5|Overall Study|all other reasons combined|3
107671|NCT00995345|399692|P4|Overall Study|all other reasons combined|1
107672|NCT00995345|399693|P3|Overall Study|all other reasons combined|2
107673|NCT00995345|399694|P2|Overall Study|all other reasons combined|2
107674|NCT00995345|399695|P1|Overall Study|all other reasons combined|2
107675|NCT00995345|399691|P5|Overall Study|Lost to Follow-up|0
107676|NCT00995345|399692|P4|Overall Study|Lost to Follow-up|1
107677|NCT00995345|399693|P3|Overall Study|Lost to Follow-up|2
107678|NCT00995345|399694|P2|Overall Study|Lost to Follow-up|2
107679|NCT00995345|399695|P1|Overall Study|Lost to Follow-up|2
107680|NCT00995345|399691|P5|Overall Study|Adverse Event|1
107681|NCT00995345|399692|P4|Overall Study|Adverse Event|0
107682|NCT00995345|399693|P3|Overall Study|Adverse Event|2
107683|NCT00995345|399694|P2|Overall Study|Adverse Event|1
107684|NCT00995345|399695|P1|Overall Study|Adverse Event|3
107685|NCT00995345|399691|P5|Overall Study|Withdrawal by Subject|1
107686|NCT00995345|399692|P4|Overall Study|Withdrawal by Subject|3
107687|NCT00995345|399693|P3|Overall Study|Withdrawal by Subject|1
107688|NCT00995345|399694|P2|Overall Study|Withdrawal by Subject|2
107689|NCT00995345|399695|P1|Overall Study|Withdrawal by Subject|4
107690|NCT00995085|399722|P1|Overall Study|Withdrawal by Subject|5
107691|NCT00995020|399728|P2|Overall Study|specimen fragmentation, thermal damage|2
107692|NCT00995020|399729|P1|Overall Study|specimen fragmentation, thermal damage|1
107693|NCT00995020|399728|P2|Overall Study|margin analysis not performed|5
107694|NCT00995020|399729|P1|Overall Study|margin analysis not performed|2
107695|NCT00995007|399739|P2|Overall Study|Toxicity|0
107696|NCT00995007|399740|P1|Overall Study|Toxicity|8
107697|NCT00995007|399739|P2|Overall Study|Refused further treatment|2
107698|NCT00995007|399740|P1|Overall Study|Refused further treatment|8
107699|NCT00995007|399739|P2|Overall Study|Withdrew consent|0
107700|NCT00995007|399740|P1|Overall Study|Withdrew consent|1
107701|NCT00994682|399803|P2|Pioglitazone Open Label|Physician Decision|1
107702|NCT00994682|399804|P1|Pioglitazone Open Label|Physician Decision|6
107703|NCT00994682|399803|P2|Pioglitazone Open Label|Lost to Follow-up|2
107704|NCT00994682|399804|P1|Pioglitazone Open Label|Lost to Follow-up|3
107705|NCT00994682|399803|P2|Pioglitazone Open Label|Withdrawal by Subject|4
107706|NCT00994682|399804|P1|Pioglitazone Open Label|Withdrawal by Subject|4
107707|NCT00994682|399803|P2|Double Bilnd|Adverse Event|0
107708|NCT00994682|399804|P1|Double Bilnd|Adverse Event|1
107709|NCT00994682|399803|P2|Double Bilnd|Lost to Follow-up|3
107710|NCT00994682|399804|P1|Double Bilnd|Lost to Follow-up|3
107711|NCT00994682|399803|P2|Double Bilnd|Withdrawal by Subject|6
107712|NCT00994682|399804|P1|Double Bilnd|Withdrawal by Subject|5
107713|NCT00994643|399848|P1|Overall Study|Withdrawal by Subject|1
107714|NCT00994461|399862|P3|Overall Study|Adverse Event|0
107715|NCT00994461|399863|P2|Overall Study|Adverse Event|1
107716|NCT00994461|399864|P1|Overall Study|Adverse Event|2
107717|NCT00994448|399892|P2|Overall Study|Physician Decision|0
107718|NCT00994448|399893|P1|Overall Study|Physician Decision|1
107719|NCT00994448|399892|P2|Overall Study|Withdrawal by Subject|1
107720|NCT00994448|399893|P1|Overall Study|Withdrawal by Subject|1
107721|NCT00994448|399892|P2|Overall Study|Lost to Follow-up|1
107722|NCT00994448|399893|P1|Overall Study|Lost to Follow-up|5
107723|NCT00994448|399892|P2|Overall Study|Adverse Event|0
107724|NCT00994448|399893|P1|Overall Study|Adverse Event|1
107725|NCT00994422|399901|P2|Overall Study|Lost to Follow-up|1
107726|NCT00994422|399902|P1|Overall Study|Lost to Follow-up|7
107727|NCT00994279|399927|P2|Overall Study|Multiple reasons|3
107728|NCT00994279|399928|P1|Overall Study|Multiple reasons|1
107729|NCT00994279|399927|P2|Overall Study|Toxicity|0
107730|NCT00994279|399928|P1|Overall Study|Toxicity|1
107731|NCT00994279|399927|P2|Overall Study|Withdrawal by Subject|2
107732|NCT00994279|399928|P1|Overall Study|Withdrawal by Subject|2
107733|NCT00994240|399938|P2|Overall Study|study termination|3
107734|NCT00994240|399939|P1|Overall Study|study termination|2
107735|NCT00994240|399938|P2|Overall Study|Withdrawal by Subject|0
107736|NCT00994240|399939|P1|Overall Study|Withdrawal by Subject|1
107737|NCT00994240|399938|P2|Overall Study|Lost to Follow-up|2
107738|NCT00994240|399939|P1|Overall Study|Lost to Follow-up|3
107739|NCT00994214|399949|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
107740|NCT00994214|399950|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
107741|NCT00994214|399951|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
107742|NCT00994214|399952|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
107743|NCT00994214|399949|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
107744|NCT00994214|399950|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
107745|NCT00994214|399951|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
107746|NCT00994214|399952|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
107747|NCT00994214|399949|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
107748|NCT00994214|399950|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
107749|NCT00994214|399951|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
107750|NCT00994214|399952|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
107751|NCT00994214|399949|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
107752|NCT00994214|399950|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
107753|NCT00994214|399951|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
107754|NCT00994214|399952|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
107755|NCT00994214|399949|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
107756|NCT00994214|399950|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
107757|NCT00994214|399951|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
107758|NCT00994214|399952|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
107759|NCT00994214|399949|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
107760|NCT00994214|399950|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
107761|NCT00994214|399951|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
107762|NCT00994214|399952|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
107763|NCT00994110|400031|P2|Overall Study|Pt not eligible|5
107764|NCT00994110|400032|P1|Overall Study|Pt not eligible|10
107765|NCT00994110|400031|P2|Overall Study|Patient not resected|52
107766|NCT00994110|400032|P1|Overall Study|Patient not resected|41
107767|NCT00994110|400031|P2|Overall Study|Adverse Event|0
107768|NCT00994110|400032|P1|Overall Study|Adverse Event|1
107769|NCT00994110|400031|P2|Overall Study|Not Treated|8
107770|NCT00994110|400032|P1|Overall Study|Not Treated|4
107771|NCT00994110|400031|P2|Overall Study|Withdrawal by Subject|9
107772|NCT00994110|400032|P1|Overall Study|Withdrawal by Subject|9
107773|NCT00993967|400038|P1|Overall Study|Protocol Violation|2
107774|NCT00993967|400038|P1|Overall Study|Withdrawal by Subject|36
107775|NCT00993967|400038|P1|Overall Study|Lost to Follow-up|14
107776|NCT00993967|400038|P1|Overall Study|Death|1
107777|NCT00993967|400038|P1|Overall Study|Adverse Event|8
107778|NCT00993954|400045|P2|Overall Study|Protocol Violation|2
107779|NCT00993954|400046|P1|Overall Study|Protocol Violation|21
107780|NCT00993928|400059|P2|Overall Study|ineligible|0
107781|NCT00993928|400060|P1|Overall Study|ineligible|1
107782|NCT00993928|400059|P2|Overall Study|Withdrawal by Subject|7
107783|NCT00993928|400060|P1|Overall Study|Withdrawal by Subject|4
107784|NCT00993915|400074|P1|Overall Study|Ongoing|3
107785|NCT00993915|400074|P1|Overall Study|Not specified|1
107786|NCT00993915|400074|P1|Overall Study|Withdrawal by Subject|2
107787|NCT00993915|400074|P1|Overall Study|Insufficient clinical response|3
107788|NCT00993668|400100|P2|Open-Label Period|Lost to Follow-up|1
107789|NCT00993668|400101|P1|Open-Label Period|Lost to Follow-up|6
107790|NCT00993668|400100|P2|Open-Label Period|Withdrawal by Subject|3
107791|NCT00993668|400101|P1|Open-Label Period|Withdrawal by Subject|4
107792|NCT00993668|400100|P2|Open-Label Period|Lack of Efficacy|3
107793|NCT00993668|400101|P1|Open-Label Period|Lack of Efficacy|4
107794|NCT00993668|400100|P2|Open-Label Period|Adverse Event|8
107795|NCT00993668|400101|P1|Open-Label Period|Adverse Event|9
107796|NCT00993668|400100|P2|Single-Blind Period|Lost to Follow-up|1
107797|NCT00993668|400101|P1|Single-Blind Period|Lost to Follow-up|3
107798|NCT00993668|400100|P2|Single-Blind Period|Lack of Efficacy|1
107799|NCT00993668|400101|P1|Single-Blind Period|Lack of Efficacy|0
107800|NCT00993668|400100|P2|Single-Blind Period|Adverse Event|1
107801|NCT00993668|400101|P1|Single-Blind Period|Adverse Event|1
107802|NCT00993616|400145|P1|Overall Study|Never treated|1
107803|NCT00993616|400145|P1|Overall Study|No tumor at entry|1
107804|NCT00993499|400163|P6|Discontinued After Starting Course 3|Other adverse event|0
107805|NCT00993499|400164|P5|Discontinued After Starting Course 3|Other adverse event|0
107806|NCT00993499|400165|P4|Discontinued After Starting Course 3|Other adverse event|0
107807|NCT00993499|400166|P3|Discontinued After Starting Course 3|Other adverse event|1
107808|NCT00993499|400167|P2|Discontinued After Starting Course 3|Other adverse event|0
107809|NCT00993499|400168|P1|Discontinued After Starting Course 3|Other adverse event|1
107810|NCT00993499|400163|P6|Discontinued After Starting Course 3|DLT|0
107811|NCT00993499|400164|P5|Discontinued After Starting Course 3|DLT|0
107812|NCT00993499|400165|P4|Discontinued After Starting Course 3|DLT|1
107813|NCT00993499|400166|P3|Discontinued After Starting Course 3|DLT|2
107814|NCT00993499|400167|P2|Discontinued After Starting Course 3|DLT|0
107815|NCT00993499|400168|P1|Discontinued After Starting Course 3|DLT|1
107816|NCT00993499|400163|P6|Discontinued After Starting Course 3|Progressive Disease|3
107817|NCT00993499|400164|P5|Discontinued After Starting Course 3|Progressive Disease|3
107818|NCT00993499|400165|P4|Discontinued After Starting Course 3|Progressive Disease|1
107819|NCT00993499|400166|P3|Discontinued After Starting Course 3|Progressive Disease|3
107820|NCT00993499|400167|P2|Discontinued After Starting Course 3|Progressive Disease|4
107821|NCT00993499|400168|P1|Discontinued After Starting Course 3|Progressive Disease|6
107822|NCT00993499|400163|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
107823|NCT00993499|400164|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
107824|NCT00993499|400165|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
107825|NCT00993499|400166|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
107826|NCT00993499|400167|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
107827|NCT00993499|400168|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
107828|NCT00993499|400163|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
107829|NCT00993499|400164|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
107830|NCT00993499|400165|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
107831|NCT00993499|400166|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
107832|NCT00993499|400167|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
107833|NCT00993499|400168|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
107834|NCT00993499|400163|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
107835|NCT00993499|400164|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
107836|NCT00993499|400165|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
107837|NCT00993499|400166|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
107838|NCT00993499|400167|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
107839|NCT00993499|400168|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
107840|NCT00993499|400163|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
107841|NCT00993499|400164|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
107842|NCT00993499|400165|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
107843|NCT00993499|400166|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
107844|NCT00993499|400167|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
107845|NCT00993499|400168|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
107846|NCT00993499|400163|P6|Discontinued Before Starting Course 3|Progressive Disease|0
107847|NCT00993499|400164|P5|Discontinued Before Starting Course 3|Progressive Disease|0
107848|NCT00993499|400165|P4|Discontinued Before Starting Course 3|Progressive Disease|0
107849|NCT00993499|400166|P3|Discontinued Before Starting Course 3|Progressive Disease|0
107850|NCT00993499|400167|P2|Discontinued Before Starting Course 3|Progressive Disease|2
107851|NCT00993499|400168|P1|Discontinued Before Starting Course 3|Progressive Disease|2
107852|NCT00993499|400163|P6|Run-in Period (8 Days)|Progressive disease|0
107853|NCT00993499|400164|P5|Run-in Period (8 Days)|Progressive disease|0
107854|NCT00993499|400165|P4|Run-in Period (8 Days)|Progressive disease|0
107855|NCT00993499|400166|P3|Run-in Period (8 Days)|Progressive disease|1
107856|NCT00993499|400167|P2|Run-in Period (8 Days)|Progressive disease|1
107857|NCT00993499|400168|P1|Run-in Period (8 Days)|Progressive disease|0
107858|NCT00993499|400163|P6|Run-in Period (8 Days)|Consent withdrawn|0
107859|NCT00993499|400164|P5|Run-in Period (8 Days)|Consent withdrawn|0
107860|NCT00993499|400165|P4|Run-in Period (8 Days)|Consent withdrawn|0
107861|NCT00993499|400166|P3|Run-in Period (8 Days)|Consent withdrawn|0
107862|NCT00993499|400167|P2|Run-in Period (8 Days)|Consent withdrawn|1
107863|NCT00993499|400168|P1|Run-in Period (8 Days)|Consent withdrawn|0
107864|NCT00993499|400163|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
107865|NCT00993499|400164|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
107866|NCT00993499|400165|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
107867|NCT00993499|400166|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
107868|NCT00993499|400167|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
107869|NCT00993499|400168|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
107870|NCT00993499|400163|P6|Run-in Period (8 Days)|Adverse Event|0
107871|NCT00993499|400164|P5|Run-in Period (8 Days)|Adverse Event|0
107872|NCT00993499|400165|P4|Run-in Period (8 Days)|Adverse Event|0
107873|NCT00993499|400166|P3|Run-in Period (8 Days)|Adverse Event|0
107874|NCT00993499|400167|P2|Run-in Period (8 Days)|Adverse Event|1
107875|NCT00993499|400168|P1|Run-in Period (8 Days)|Adverse Event|0
107876|NCT00993473|400250|P2|Overall Study|Family event|0
107877|NCT00993473|400251|P1|Overall Study|Family event|1
107878|NCT00993473|400250|P2|Overall Study|Technical problem with CGM device|1
107879|NCT00993473|400251|P1|Overall Study|Technical problem with CGM device|0
107880|NCT00993473|400250|P2|Overall Study|Withdrawal by Subject|5
107881|NCT00993473|400251|P1|Overall Study|Withdrawal by Subject|1
107882|NCT00993473|400250|P2|Overall Study|Lost to Follow-up|0
107883|NCT00993473|400251|P1|Overall Study|Lost to Follow-up|1
107884|NCT00993473|400250|P2|Overall Study|Protocol Violation|2
107885|NCT00993473|400251|P1|Overall Study|Protocol Violation|1
107886|NCT00993473|400250|P2|Overall Study|Adverse Event|2
107887|NCT00993473|400251|P1|Overall Study|Adverse Event|0
107888|NCT00993447|400289|P2|Overall Study|Adverse Event|0
107889|NCT00993447|400290|P1|Overall Study|Adverse Event|1
107890|NCT00993447|400289|P2|Overall Study|Lost to Follow-up|3
107891|NCT00993447|400290|P1|Overall Study|Lost to Follow-up|1
107892|NCT00993447|400289|P2|Overall Study|Protocol Violation|8
107893|NCT00993447|400290|P1|Overall Study|Protocol Violation|12
107894|NCT00993447|400289|P2|Overall Study|Withdrawal by Subject|8
107895|NCT00993447|400290|P1|Overall Study|Withdrawal by Subject|23
107896|NCT00993421|400327|P7|Overall Study|Protocol Violation|1
107897|NCT00993421|400328|P6|Overall Study|Protocol Violation|2
107898|NCT00993421|400329|P5|Overall Study|Protocol Violation|0
107899|NCT00993421|400330|P4|Overall Study|Protocol Violation|0
107900|NCT00993421|400331|P3|Overall Study|Protocol Violation|0
107901|NCT00993421|400332|P2|Overall Study|Protocol Violation|0
107902|NCT00993421|400333|P1|Overall Study|Protocol Violation|0
107903|NCT00993421|400327|P7|Overall Study|Physician Decision|1
107904|NCT00993421|400328|P6|Overall Study|Physician Decision|1
107905|NCT00993421|400329|P5|Overall Study|Physician Decision|0
107906|NCT00993421|400330|P4|Overall Study|Physician Decision|0
107907|NCT00993421|400331|P3|Overall Study|Physician Decision|0
107908|NCT00993421|400332|P2|Overall Study|Physician Decision|0
107909|NCT00993421|400333|P1|Overall Study|Physician Decision|0
107910|NCT00993421|400327|P7|Overall Study|Entry Criteria Exclusion|0
107911|NCT00993421|400328|P6|Overall Study|Entry Criteria Exclusion|1
107912|NCT00993421|400329|P5|Overall Study|Entry Criteria Exclusion|0
107913|NCT00993421|400330|P4|Overall Study|Entry Criteria Exclusion|3
107914|NCT00993421|400331|P3|Overall Study|Entry Criteria Exclusion|1
107915|NCT00993421|400332|P2|Overall Study|Entry Criteria Exclusion|0
107916|NCT00993421|400333|P1|Overall Study|Entry Criteria Exclusion|0
107917|NCT00993421|400327|P7|Overall Study|Death|1
107918|NCT00993421|400328|P6|Overall Study|Death|0
107919|NCT00993421|400329|P5|Overall Study|Death|0
107920|NCT00993421|400330|P4|Overall Study|Death|0
107921|NCT00993421|400331|P3|Overall Study|Death|0
107922|NCT00993421|400332|P2|Overall Study|Death|0
107923|NCT00993421|400333|P1|Overall Study|Death|0
107924|NCT00993421|400327|P7|Overall Study|Withdrawal by Subject|3
107925|NCT00993421|400328|P6|Overall Study|Withdrawal by Subject|5
107926|NCT00993421|400329|P5|Overall Study|Withdrawal by Subject|3
107927|NCT00993421|400330|P4|Overall Study|Withdrawal by Subject|3
107928|NCT00993421|400331|P3|Overall Study|Withdrawal by Subject|3
107929|NCT00993421|400332|P2|Overall Study|Withdrawal by Subject|2
107930|NCT00993421|400333|P1|Overall Study|Withdrawal by Subject|3
107931|NCT00993421|400327|P7|Overall Study|Lost to Follow-up|6
107932|NCT00993421|400328|P6|Overall Study|Lost to Follow-up|0
107933|NCT00993421|400329|P5|Overall Study|Lost to Follow-up|0
107934|NCT00993421|400330|P4|Overall Study|Lost to Follow-up|0
107935|NCT00993421|400331|P3|Overall Study|Lost to Follow-up|5
107936|NCT00993421|400332|P2|Overall Study|Lost to Follow-up|5
107937|NCT00993421|400333|P1|Overall Study|Lost to Follow-up|3
107938|NCT00993421|400327|P7|Overall Study|Sponsor Decision|29
107939|NCT00993421|400328|P6|Overall Study|Sponsor Decision|30
107940|NCT00993421|400329|P5|Overall Study|Sponsor Decision|38
107941|NCT00993421|400330|P4|Overall Study|Sponsor Decision|30
107942|NCT00993421|400331|P3|Overall Study|Sponsor Decision|28
107943|NCT00993421|400332|P2|Overall Study|Sponsor Decision|31
107944|NCT00993421|400333|P1|Overall Study|Sponsor Decision|36
107945|NCT00993421|400327|P7|Overall Study|Adverse Event|1
107946|NCT00993421|400328|P6|Overall Study|Adverse Event|7
107947|NCT00993421|400329|P5|Overall Study|Adverse Event|5
107948|NCT00993421|400330|P4|Overall Study|Adverse Event|9
107949|NCT00993421|400331|P3|Overall Study|Adverse Event|6
107950|NCT00993421|400332|P2|Overall Study|Adverse Event|7
107951|NCT00993421|400333|P1|Overall Study|Adverse Event|2
107952|NCT00993317|400484|P2|Overall Study|Early study termination at the site|0
107953|NCT00993317|400485|P1|Overall Study|Early study termination at the site|1
107954|NCT00993317|400484|P2|Overall Study|Investigator's opinion|1
107955|NCT00993317|400485|P1|Overall Study|Investigator's opinion|0
107956|NCT00993317|400484|P2|Overall Study|Withdrawal by Subject|2
107957|NCT00993317|400485|P1|Overall Study|Withdrawal by Subject|0
107958|NCT00993317|400484|P2|Overall Study|Lack of Efficacy|18
107959|NCT00993317|400485|P1|Overall Study|Lack of Efficacy|18
107960|NCT00993317|400484|P2|Overall Study|Adverse Event|4
107961|NCT00993317|400485|P1|Overall Study|Adverse Event|2
107962|NCT00993291|400503|P1|Overall Study|Withdrawal by Subject|1
107963|NCT00993265|400509|P2|Overall Study|Non-compliant with study medication|0
107964|NCT00993265|400510|P1|Overall Study|Non-compliant with study medication|1
107965|NCT00993265|400509|P2|Overall Study|Changed dose of concomitant drug|0
107966|NCT00993265|400510|P1|Overall Study|Changed dose of concomitant drug|2
107967|NCT00993265|400509|P2|Overall Study|Adverse Event|0
107968|NCT00993265|400510|P1|Overall Study|Adverse Event|1
107969|NCT00993148|400562|P1|Overall Study|never initiated treatment|1
107970|NCT00993148|400562|P1|Overall Study|Lost to Follow-up|2
107971|NCT00993044|400574|P1|Irinotecan 50 mg|Physician Decision|1
107972|NCT00993031|400581|P2|Overall Study|Lost to Follow-up|13
107973|NCT00993031|400582|P1|Overall Study|Lost to Follow-up|19
107974|NCT00993031|400581|P2|Overall Study|Withdrawal by Subject|3
107975|NCT00993031|400582|P1|Overall Study|Withdrawal by Subject|3
107976|NCT00993031|400581|P2|Overall Study|Physician Decision|2
107977|NCT00993031|400582|P1|Overall Study|Physician Decision|0
107978|NCT00993031|400581|P2|Overall Study|Death|1
107979|NCT00993031|400582|P1|Overall Study|Death|0
107980|NCT00992992|400600|P1|Overall Study|Sponsor Closed the Study|4
107981|NCT00992992|400600|P1|Overall Study|GlaxoSmithKline Closed the Study|2
107982|NCT00992992|400600|P1|Overall Study|Death|16
107983|NCT00992992|400600|P1|Overall Study|Lost to Follow-up|3
107984|NCT00992836|400631|P1|Overall Study|Protocol Violation|2
107985|NCT00992836|400631|P1|Overall Study|Withdrawal by Subject|2
107986|NCT00992836|400631|P1|Overall Study|Lost to Follow-up|1
107987|NCT00992784|400646|P3|Overall Study|Withdrawal by Subject|1
107988|NCT00992784|400647|P2|Overall Study|Withdrawal by Subject|1
107989|NCT00992784|400648|P1|Overall Study|Withdrawal by Subject|1
107990|NCT00992784|400646|P3|Overall Study|Adverse Event|0
107991|NCT00992784|400647|P2|Overall Study|Adverse Event|1
107992|NCT00992784|400648|P1|Overall Study|Adverse Event|2
107993|NCT00992589|400760|P4|Double-Blind Phase|Not specified|3
107994|NCT00992589|400761|P3|Double-Blind Phase|Not specified|6
107995|NCT00992589|400762|P2|Double-Blind Phase|Not specified|1
107996|NCT00992589|400763|P1|Double-Blind Phase|Not specified|0
107997|NCT00992589|400760|P4|Double-Blind Phase|Lost to Follow-up|2
107998|NCT00992589|400761|P3|Double-Blind Phase|Lost to Follow-up|0
107999|NCT00992589|400762|P2|Double-Blind Phase|Lost to Follow-up|0
108000|NCT00992589|400763|P1|Double-Blind Phase|Lost to Follow-up|0
108001|NCT00992589|400760|P4|Double-Blind Phase|Withdrawal by Subject|2
108002|NCT00992589|400761|P3|Double-Blind Phase|Withdrawal by Subject|5
108003|NCT00992589|400762|P2|Double-Blind Phase|Withdrawal by Subject|6
108004|NCT00992589|400763|P1|Double-Blind Phase|Withdrawal by Subject|0
108005|NCT00992589|400760|P4|Double-Blind Phase|Adverse Event|3
108006|NCT00992589|400761|P3|Double-Blind Phase|Adverse Event|2
108007|NCT00992589|400762|P2|Double-Blind Phase|Adverse Event|6
108008|NCT00992589|400763|P1|Double-Blind Phase|Adverse Event|0
108009|NCT00992589|400760|P4|Open-Label Phase|Not specified|0
108010|NCT00992589|400761|P3|Open-Label Phase|Not specified|0
108011|NCT00992589|400762|P2|Open-Label Phase|Not specified|0
108012|NCT00992589|400763|P1|Open-Label Phase|Not specified|45
108013|NCT00992589|400760|P4|Open-Label Phase|Physician Decision|0
108014|NCT00992589|400761|P3|Open-Label Phase|Physician Decision|0
108015|NCT00992589|400762|P2|Open-Label Phase|Physician Decision|0
108016|NCT00992589|400763|P1|Open-Label Phase|Physician Decision|4
108017|NCT00992589|400760|P4|Open-Label Phase|Protocol Violation|0
108018|NCT00992589|400761|P3|Open-Label Phase|Protocol Violation|0
108019|NCT00992589|400762|P2|Open-Label Phase|Protocol Violation|0
108020|NCT00992589|400763|P1|Open-Label Phase|Protocol Violation|3
108021|NCT00992589|400760|P4|Open-Label Phase|Lost to Follow-up|0
108022|NCT00992589|400761|P3|Open-Label Phase|Lost to Follow-up|0
108023|NCT00992589|400762|P2|Open-Label Phase|Lost to Follow-up|0
108024|NCT00992589|400763|P1|Open-Label Phase|Lost to Follow-up|1
108025|NCT00992589|400760|P4|Open-Label Phase|Withdrawal by Subject|0
108026|NCT00992589|400761|P3|Open-Label Phase|Withdrawal by Subject|0
108027|NCT00992589|400762|P2|Open-Label Phase|Withdrawal by Subject|0
108028|NCT00992589|400763|P1|Open-Label Phase|Withdrawal by Subject|20
108029|NCT00992589|400760|P4|Open-Label Phase|Adverse Event|0
108030|NCT00992589|400761|P3|Open-Label Phase|Adverse Event|0
108031|NCT00992589|400762|P2|Open-Label Phase|Adverse Event|0
108032|NCT00992589|400763|P1|Open-Label Phase|Adverse Event|4
108033|NCT00992459|400807|P2|Overall Study|Adverse Event|0
108034|NCT00992459|400808|P1|Overall Study|Adverse Event|1
108035|NCT00992459|400807|P2|Overall Study|Withdrawal by Subject|1
108036|NCT00992459|400808|P1|Overall Study|Withdrawal by Subject|0
108037|NCT00992446|400832|P1|Overall Study|Maintenance Therapy Screen Fail|5
108038|NCT00992446|400832|P1|Overall Study|Withdrawal by Subject|2
108039|NCT00992446|400832|P1|Overall Study|Disease Progression|1
108040|NCT00992407|400904|P2|Overall Study|Study medication not administered|13
108041|NCT00992407|400905|P1|Overall Study|Study medication not administered|17
108042|NCT00992407|400904|P2|Overall Study|Loss of follow-up & Adverse events|1
108043|NCT00992407|400905|P1|Overall Study|Loss of follow-up & Adverse events|2
108044|NCT00992407|400904|P2|Overall Study|Other|0
108045|NCT00992407|400905|P1|Overall Study|Other|2
108046|NCT00992407|400904|P2|Overall Study|protocol Violation & Adverse events|4
108047|NCT00992407|400905|P1|Overall Study|protocol Violation & Adverse events|2
108048|NCT00992407|400904|P2|Overall Study|Adverse Event|2
108049|NCT00992407|400905|P1|Overall Study|Adverse Event|3
108050|NCT00992407|400904|P2|Overall Study|Lost to Follow-up|3
108051|NCT00992407|400905|P1|Overall Study|Lost to Follow-up|3
108052|NCT00992407|400904|P2|Overall Study|Protocol Violation|1
108053|NCT00992407|400905|P1|Overall Study|Protocol Violation|2
108054|NCT00992394|400955|P2|Overall Study|Other event|0
108055|NCT00992394|400956|P1|Overall Study|Other event|1
108056|NCT00992394|400955|P2|Overall Study|Lost to Follow-up|0
108057|NCT00992394|400956|P1|Overall Study|Lost to Follow-up|2
108058|NCT00992394|400955|P2|Overall Study|Protocol Violation|4
108059|NCT00992394|400956|P1|Overall Study|Protocol Violation|2
108060|NCT00992394|400955|P2|Overall Study|Physician Decision|0
108061|NCT00992394|400956|P1|Overall Study|Physician Decision|1
108062|NCT00992394|400955|P2|Overall Study|Withdrawal by Subject|2
108063|NCT00992394|400956|P1|Overall Study|Withdrawal by Subject|8
108064|NCT00992394|400955|P2|Overall Study|Adverse Event|5
108065|NCT00992394|400956|P1|Overall Study|Adverse Event|4
108066|NCT00992394|400955|P2|Overall Study|Lack of Efficacy|3
108067|NCT00992394|400956|P1|Overall Study|Lack of Efficacy|6
108068|NCT00992186|401043|P1|Overall Study|Refusal To Receive Study Agent|3
108069|NCT00992186|401043|P1|Overall Study|Progressive Disease|30
108070|NCT00992186|401043|P1|Overall Study|Adverse Event|9
108071|NCT00992186|401043|P1|Overall Study|Physician Decision|1
108072|NCT00992186|401043|P1|Overall Study|Protocol Violation|1
108073|NCT00992186|401043|P1|Overall Study|Withdrawal by Subject|2
108074|NCT00992108|401062|P2|Overall Study|Lost to Follow-up|1
108075|NCT00992108|401063|P1|Overall Study|Lost to Follow-up|0
108076|NCT00992056|401077|P2|Washout Period (2 Weeks)|Physician Decision|0
108077|NCT00992056|401078|P1|Washout Period (2 Weeks)|Physician Decision|1
108078|NCT00992056|401077|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
108079|NCT00992056|401078|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
108080|NCT00992017|401084|P1|Overall Study|Not adhere to study requirements|1
108081|NCT00992017|401084|P1|Overall Study|Unable to get to clinic|5
108082|NCT00992017|401084|P1|Overall Study|Withdrawal by Subject|2
108083|NCT00992017|401084|P1|Overall Study|Lost to Follow-up|2
108084|NCT00991952|401099|P2|Overall Study|Adverse Event|1
108085|NCT00991952|401100|P1|Overall Study|Adverse Event|0
108086|NCT00991939|401108|P2|Overall Study|Entire study terminated|1
108087|NCT00991939|401109|P1|Overall Study|Entire study terminated|4
108088|NCT00991939|401108|P2|Overall Study|Withdrawal by Subject|0
108089|NCT00991939|401109|P1|Overall Study|Withdrawal by Subject|1
108090|NCT00991939|401108|P2|Overall Study|Lost to Follow-up|1
108091|NCT00991939|401109|P1|Overall Study|Lost to Follow-up|0
108092|NCT00991887|401143|P2|Overall Study|Lost to Follow-up|1
108093|NCT00991887|401144|P1|Overall Study|Lost to Follow-up|2
108094|NCT00991510|401163|P2|Period III (Days 29-112)|Adverse Event|1
108095|NCT00991510|401164|P1|Period III (Days 29-112)|Adverse Event|1
108096|NCT00991510|401163|P2|Period I (Days 1-14)|Adverse Event|0
108097|NCT00991510|401164|P1|Period I (Days 1-14)|Adverse Event|1
108098|NCT00991341|401210|P2|Overall Study|Withdrawal by Subject|4
108099|NCT00991341|401211|P1|Overall Study|Withdrawal by Subject|3
108100|NCT00991341|401210|P2|Overall Study|Physician Decision|2
108101|NCT00991341|401211|P1|Overall Study|Physician Decision|1
108102|NCT00991341|401210|P2|Overall Study|no RBCs received 96hrs after randomized|155
108103|NCT00991341|401211|P1|Overall Study|no RBCs received 96hrs after randomized|186
108104|NCT00991341|401210|P2|Overall Study|Death|0
108105|NCT00991341|401211|P1|Overall Study|Death|3
108106|NCT00991341|401210|P2|Overall Study|no surgery w/in 30 days of randomization|18
108107|NCT00991341|401211|P1|Overall Study|no surgery w/in 30 days of randomization|11
108108|NCT00991302|401249|P2|Overall Study|Lost to Follow-up|12
108109|NCT00991302|401250|P1|Overall Study|Lost to Follow-up|14
108110|NCT00991302|401249|P2|Overall Study|Death|1
108111|NCT00991302|401250|P1|Overall Study|Death|0
108112|NCT00991289|401266|P1|Overall Study|Protocol Violation|2
108113|NCT00991289|401266|P1|Overall Study|Lost to Follow-up|4
108114|NCT00991289|401266|P1|Overall Study|Withdrawal by Subject|3
108115|NCT00991289|401266|P1|Overall Study|Physician Decision|2
108116|NCT00991289|401266|P1|Overall Study|Adverse Event|1
108117|NCT00991276|401286|P6|Third Intervention Period|Withdrawal by Subject|0
108118|NCT00991276|401287|P5|Third Intervention Period|Withdrawal by Subject|0
108119|NCT00991276|401288|P4|Third Intervention Period|Withdrawal by Subject|1
108120|NCT00991276|401289|P3|Third Intervention Period|Withdrawal by Subject|0
108121|NCT00991276|401290|P2|Third Intervention Period|Withdrawal by Subject|0
108122|NCT00991276|401291|P1|Third Intervention Period|Withdrawal by Subject|0
108123|NCT00991276|401286|P6|Third Intervention Period|Adverse Event|0
108124|NCT00991276|401287|P5|Third Intervention Period|Adverse Event|0
108125|NCT00991276|401288|P4|Third Intervention Period|Adverse Event|0
108126|NCT00991276|401289|P3|Third Intervention Period|Adverse Event|1
108127|NCT00991276|401290|P2|Third Intervention Period|Adverse Event|0
108128|NCT00991276|401291|P1|Third Intervention Period|Adverse Event|0
108129|NCT00991276|401286|P6|Third Intervention Period|Other|1
108130|NCT00991276|401287|P5|Third Intervention Period|Other|0
108131|NCT00991276|401288|P4|Third Intervention Period|Other|0
108132|NCT00991276|401289|P3|Third Intervention Period|Other|0
108133|NCT00991276|401290|P2|Third Intervention Period|Other|0
108134|NCT00991276|401291|P1|Third Intervention Period|Other|0
108135|NCT00991276|401286|P6|Third Intervention Period|Protocol Violation|0
108136|NCT00991276|401287|P5|Third Intervention Period|Protocol Violation|0
108137|NCT00991276|401288|P4|Third Intervention Period|Protocol Violation|0
108138|NCT00991276|401289|P3|Third Intervention Period|Protocol Violation|0
108139|NCT00991276|401290|P2|Third Intervention Period|Protocol Violation|0
108140|NCT00991276|401291|P1|Third Intervention Period|Protocol Violation|1
108141|NCT00991276|401286|P6|Second Intervention Period|Other|1
108142|NCT00991276|401287|P5|Second Intervention Period|Other|0
108143|NCT00991276|401288|P4|Second Intervention Period|Other|1
108144|NCT00991276|401289|P3|Second Intervention Period|Other|0
108145|NCT00991276|401290|P2|Second Intervention Period|Other|0
108146|NCT00991276|401291|P1|Second Intervention Period|Other|0
108147|NCT00991276|401286|P6|Second Intervention Period|Protocol Violation|0
108148|NCT00991276|401287|P5|Second Intervention Period|Protocol Violation|0
108149|NCT00991276|401288|P4|Second Intervention Period|Protocol Violation|0
108150|NCT00991276|401289|P3|Second Intervention Period|Protocol Violation|0
108151|NCT00991276|401290|P2|Second Intervention Period|Protocol Violation|0
108152|NCT00991276|401291|P1|Second Intervention Period|Protocol Violation|1
108153|NCT00991276|401286|P6|Second Intervention Period|Adverse Event|0
108154|NCT00991276|401287|P5|Second Intervention Period|Adverse Event|1
108155|NCT00991276|401288|P4|Second Intervention Period|Adverse Event|1
108156|NCT00991276|401289|P3|Second Intervention Period|Adverse Event|0
108157|NCT00991276|401290|P2|Second Intervention Period|Adverse Event|2
108158|NCT00991276|401291|P1|Second Intervention Period|Adverse Event|0
108159|NCT00991276|401286|P6|First Intervention Period|Lost to Follow-up|0
108160|NCT00991276|401287|P5|First Intervention Period|Lost to Follow-up|0
108161|NCT00991276|401288|P4|First Intervention Period|Lost to Follow-up|1
108162|NCT00991276|401289|P3|First Intervention Period|Lost to Follow-up|0
108163|NCT00991276|401290|P2|First Intervention Period|Lost to Follow-up|1
108164|NCT00991276|401291|P1|First Intervention Period|Lost to Follow-up|0
108165|NCT00991276|401286|P6|First Intervention Period|Withdrawal by Subject|1
108166|NCT00991276|401287|P5|First Intervention Period|Withdrawal by Subject|0
108167|NCT00991276|401288|P4|First Intervention Period|Withdrawal by Subject|1
108168|NCT00991276|401289|P3|First Intervention Period|Withdrawal by Subject|0
108169|NCT00991276|401290|P2|First Intervention Period|Withdrawal by Subject|1
108170|NCT00991276|401291|P1|First Intervention Period|Withdrawal by Subject|0
108171|NCT00991276|401286|P6|First Intervention Period|Other|0
108172|NCT00991276|401287|P5|First Intervention Period|Other|1
108173|NCT00991276|401288|P4|First Intervention Period|Other|1
108174|NCT00991276|401289|P3|First Intervention Period|Other|0
108175|NCT00991276|401290|P2|First Intervention Period|Other|0
108176|NCT00991276|401291|P1|First Intervention Period|Other|0
108177|NCT00991276|401286|P6|First Intervention Period|Insufficient clinical response|0
108178|NCT00991276|401287|P5|First Intervention Period|Insufficient clinical response|1
108179|NCT00991276|401288|P4|First Intervention Period|Insufficient clinical response|0
108180|NCT00991276|401289|P3|First Intervention Period|Insufficient clinical response|0
108181|NCT00991276|401290|P2|First Intervention Period|Insufficient clinical response|0
108182|NCT00991276|401291|P1|First Intervention Period|Insufficient clinical response|0
108183|NCT00991276|401286|P6|First Intervention Period|Protocol Violation|0
108184|NCT00991276|401287|P5|First Intervention Period|Protocol Violation|2
108185|NCT00991276|401288|P4|First Intervention Period|Protocol Violation|0
108186|NCT00991276|401289|P3|First Intervention Period|Protocol Violation|0
108187|NCT00991276|401290|P2|First Intervention Period|Protocol Violation|0
108188|NCT00991276|401291|P1|First Intervention Period|Protocol Violation|0
108189|NCT00991276|401286|P6|First Intervention Period|Adverse Event|0
108190|NCT00991276|401287|P5|First Intervention Period|Adverse Event|0
108191|NCT00991276|401288|P4|First Intervention Period|Adverse Event|1
108192|NCT00991276|401289|P3|First Intervention Period|Adverse Event|0
108193|NCT00991276|401290|P2|First Intervention Period|Adverse Event|1
108194|NCT00991276|401291|P1|First Intervention Period|Adverse Event|0
108195|NCT00990821|401448|P14|Overall Study|Withdrawal by Subject|1
108196|NCT00990821|401449|P13|Overall Study|Withdrawal by Subject|2
108197|NCT00990821|401450|P12|Overall Study|Withdrawal by Subject|5
108198|NCT00990821|401451|P11|Overall Study|Withdrawal by Subject|3
108199|NCT00990821|401452|P10|Overall Study|Withdrawal by Subject|1
108200|NCT00990821|401453|P9|Overall Study|Withdrawal by Subject|0
108201|NCT00990821|401454|P8|Overall Study|Withdrawal by Subject|0
108202|NCT00990821|401455|P7|Overall Study|Withdrawal by Subject|1
108203|NCT00990821|401456|P6|Overall Study|Withdrawal by Subject|3
108204|NCT00990821|401457|P5|Overall Study|Withdrawal by Subject|3
108205|NCT00990821|401458|P4|Overall Study|Withdrawal by Subject|0
108206|NCT00990821|401459|P3|Overall Study|Withdrawal by Subject|0
108207|NCT00990821|401460|P2|Overall Study|Withdrawal by Subject|2
108208|NCT00990821|401461|P1|Overall Study|Withdrawal by Subject|0
108209|NCT00990704|401498|P2|Overall Study|Physician Decision|1
108210|NCT00990704|401499|P1|Overall Study|Physician Decision|0
108211|NCT00990704|401498|P2|Overall Study|Adverse Event|1
108212|NCT00990704|401499|P1|Overall Study|Adverse Event|1
108213|NCT00990652|401519|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
108214|NCT00990652|401519|P1|Pre-surgical Bortezomib|Adverse Event|1
108215|NCT00990340|401553|P2|First 14-day Treatment|Protocol Violation|2
108216|NCT00990340|401554|P1|First 14-day Treatment|Protocol Violation|2
108217|NCT00990340|401553|P2|First 14-day Treatment|Lost to Follow-up|1
108218|NCT00990340|401554|P1|First 14-day Treatment|Lost to Follow-up|2
108219|NCT00990340|401553|P2|First 14-day Treatment|Not Compliant|1
108220|NCT00990340|401554|P1|First 14-day Treatment|Not Compliant|2
108221|NCT00990184|401601|P1|Overall Study|Physician Decision|1
108222|NCT00990106|401609|P2|Overall Study|scheduling conflicts|2
108223|NCT00990106|401610|P1|Overall Study|scheduling conflicts|0
108224|NCT00990106|401609|P2|Overall Study|planned major surgery|1
108225|NCT00990106|401610|P1|Overall Study|planned major surgery|0
108226|NCT00990106|401609|P2|Overall Study|started exclusionary medication|1
108227|NCT00990106|401610|P1|Overall Study|started exclusionary medication|0
108228|NCT00990106|401609|P2|Overall Study|relocation/deployment|1
108229|NCT00990106|401610|P1|Overall Study|relocation/deployment|4
108230|NCT00990106|401609|P2|Overall Study|opted for open label prazosin|1
108231|NCT00990106|401610|P1|Overall Study|opted for open label prazosin|1
108232|NCT00990106|401609|P2|Overall Study|Withdrawal by Subject|1
108233|NCT00990106|401610|P1|Overall Study|Withdrawal by Subject|2
108234|NCT00990106|401609|P2|Overall Study|Lost to Follow-up|3
108235|NCT00990106|401610|P1|Overall Study|Lost to Follow-up|1
108236|NCT00990106|401609|P2|Overall Study|"too busy to continue"|2
108237|NCT00990106|401610|P1|Overall Study|"too busy to continue"|1
108238|NCT00990093|401620|P2|Test Period 2 (15-28 Days)|Not specified|1
108239|NCT00990093|401621|P1|Test Period 2 (15-28 Days)|Not specified|0
108240|NCT00990093|401620|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
108241|NCT00990093|401621|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
108242|NCT00990093|401620|P2|Test Period 2 (15-28 Days)|Adverse Event|0
108243|NCT00990093|401621|P1|Test Period 2 (15-28 Days)|Adverse Event|1
108244|NCT00990093|401620|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
108245|NCT00990093|401621|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
108246|NCT00990093|401620|P2|Test Period 1 (1-14 Days)|Not Specified|0
108247|NCT00990093|401621|P1|Test Period 1 (1-14 Days)|Not Specified|1
108248|NCT00990093|401620|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
108249|NCT00990093|401621|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
108250|NCT00990093|401620|P2|Test Period 1 (1-14 Days)|Adverse Event|0
108251|NCT00990093|401621|P1|Test Period 1 (1-14 Days)|Adverse Event|1
108252|NCT00989950|401674|P4|Randomized Phase|Adverse Event|0
108253|NCT00989950|401675|P3|Randomized Phase|Adverse Event|0
108254|NCT00989950|401676|P2|Randomized Phase|Adverse Event|1
108255|NCT00989950|401677|P1|Randomized Phase|Adverse Event|0
108256|NCT00989950|401674|P4|Randomized Phase|Protocol Violation|0
108257|NCT00989950|401675|P3|Randomized Phase|Protocol Violation|0
108258|NCT00989950|401676|P2|Randomized Phase|Protocol Violation|0
108259|NCT00989950|401677|P1|Randomized Phase|Protocol Violation|1
108260|NCT00989833|401694|P3|Overall Study|Incorrectly randomized|0
108261|NCT00989833|401695|P2|Overall Study|Incorrectly randomized|0
108262|NCT00989833|401696|P1|Overall Study|Incorrectly randomized|1
108263|NCT00989833|401694|P3|Overall Study|Withdrawal by Subject|1
108264|NCT00989833|401695|P2|Overall Study|Withdrawal by Subject|0
108265|NCT00989833|401696|P1|Overall Study|Withdrawal by Subject|0
108266|NCT00989833|401694|P3|Overall Study|Protocol Violation|1
108267|NCT00989833|401695|P2|Overall Study|Protocol Violation|2
108268|NCT00989833|401696|P1|Overall Study|Protocol Violation|1
108269|NCT00989833|401694|P3|Overall Study|Lost to Follow-up|0
108270|NCT00989833|401695|P2|Overall Study|Lost to Follow-up|1
108271|NCT00989833|401696|P1|Overall Study|Lost to Follow-up|0
108272|NCT00989781|401727|P2|Ovarian Response to hCG|Lost to Follow-up|2
108273|NCT00989781|401728|P1|Ovarian Response to hCG|Lost to Follow-up|3
108274|NCT00989664|401755|P1|Long-Term Follow-Up|Death|3
108275|NCT00989664|401755|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
108276|NCT00989664|401755|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
108277|NCT00989664|401755|P1|Dosimetric and Therapeutic Treatment|Death|1
108278|NCT00989664|401755|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
108279|NCT00989664|401755|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
108280|NCT00989664|401755|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
108281|NCT00989287|401801|P2|Overall Study|Lost to Follow-up|1
108282|NCT00989287|401802|P1|Overall Study|Lost to Follow-up|0
108283|NCT00989287|401801|P2|Overall Study|Adverse Event|0
108284|NCT00989287|401802|P1|Overall Study|Adverse Event|1
108285|NCT00989235|401904|P2|Overall Study|Lost to Follow-up|1
108286|NCT00989235|401905|P1|Overall Study|Lost to Follow-up|0
108287|NCT00989235|401904|P2|Overall Study|Randomized by Mistake|2
108288|NCT00989235|401905|P1|Overall Study|Randomized by Mistake|0
108289|NCT00989235|401904|P2|Overall Study|Desire to Become Pregnant|0
108290|NCT00989235|401905|P1|Overall Study|Desire to Become Pregnant|1
108291|NCT00989235|401904|P2|Overall Study|Withdrawal of Consent|1
108292|NCT00989235|401905|P1|Overall Study|Withdrawal of Consent|1
108293|NCT00989235|401904|P2|Overall Study|Lack of Efficacy|0
108294|NCT00989235|401905|P1|Overall Study|Lack of Efficacy|1
108295|NCT00989235|401904|P2|Overall Study|Adverse Event|1
108296|NCT00989235|401905|P1|Overall Study|Adverse Event|0
108297|NCT00989235|401904|P2|Overall Study|Death|1
108298|NCT00989235|401905|P1|Overall Study|Death|0
108299|NCT00989196|401950|P2|Treatment Period|Lost to Follow-up|0
108300|NCT00989196|401951|P1|Treatment Period|Lost to Follow-up|1
108301|NCT00989092|401989|P2|Overall Study|Did not receive study drug|0
108302|NCT00989092|401990|P1|Overall Study|Did not receive study drug|2
108303|NCT00989092|401989|P2|Overall Study|Erythropoietin therapy initiated|0
108304|NCT00989092|401990|P1|Overall Study|Erythropoietin therapy initiated|2
108305|NCT00989092|401989|P2|Overall Study|Protocol deviation|0
108306|NCT00989092|401990|P1|Overall Study|Protocol deviation|2
108307|NCT00989092|401989|P2|Overall Study|Other|1
108308|NCT00989092|401990|P1|Overall Study|Other|3
108309|NCT00989092|401989|P2|Overall Study|Lost to Follow-up|2
108310|NCT00989092|401990|P1|Overall Study|Lost to Follow-up|6
108311|NCT00989092|401989|P2|Overall Study|Ineligibility determined|3
108312|NCT00989092|401990|P1|Overall Study|Ineligibility determined|3
108313|NCT00989092|401989|P2|Overall Study|Death|2
108314|NCT00989092|401990|P1|Overall Study|Death|14
108315|NCT00989092|401989|P2|Overall Study|Withdrawal by Subject|9
108316|NCT00989092|401990|P1|Overall Study|Withdrawal by Subject|17
108317|NCT00989092|401989|P2|Overall Study|Chemotherapy initiated|4
108318|NCT00989092|401990|P1|Overall Study|Chemotherapy initiated|12
108319|NCT00989092|401989|P2|Overall Study|Adverse Event|1
108320|NCT00989092|401990|P1|Overall Study|Adverse Event|20
108321|NCT00989092|401989|P2|Overall Study|Physician Decision|6
108322|NCT00989092|401990|P1|Overall Study|Physician Decision|9
108323|NCT00988884|402042|P2|Overall Study|Withdrawal by Subject|18
108324|NCT00988884|402043|P1|Overall Study|Withdrawal by Subject|15
108325|NCT00988884|402042|P2|Overall Study|Protocol Violation|1
108326|NCT00988884|402043|P1|Overall Study|Protocol Violation|0
108327|NCT00988884|402042|P2|Overall Study|Lost to Follow-up|16
108328|NCT00988884|402043|P1|Overall Study|Lost to Follow-up|20
108329|NCT00988884|402042|P2|Overall Study|Adverse Event|1
108330|NCT00988884|402043|P1|Overall Study|Adverse Event|0
108331|NCT00988858|402065|P1|Overall Study|Sponsor Decision|1
108332|NCT00988858|402065|P1|Overall Study|Physician Decision|1
108333|NCT00988858|402065|P1|Overall Study|Death|1
108334|NCT00988858|402065|P1|Overall Study|Adverse Event|7
108335|NCT00988637|402114|P2|Overall Study|non-compliance with study drug|1
108336|NCT00988637|402115|P1|Overall Study|non-compliance with study drug|0
108337|NCT00988637|402114|P2|Overall Study|Withdrawal by Subject|1
108338|NCT00988637|402115|P1|Overall Study|Withdrawal by Subject|1
108339|NCT00988637|402114|P2|Overall Study|Lost to Follow-up|1
108340|NCT00988637|402115|P1|Overall Study|Lost to Follow-up|2
108341|NCT00988533|402145|P1|Overall Study|Lost to Follow-up|3
108342|NCT00988442|402159|P2|Overall Study|Early Study Closure|25
108343|NCT00988442|402160|P1|Overall Study|Early Study Closure|29
108344|NCT00988442|402159|P2|Overall Study|Lost to Follow-up|1
108345|NCT00988442|402160|P1|Overall Study|Lost to Follow-up|0
108346|NCT00988442|402159|P2|Overall Study|Death|2
108347|NCT00988442|402160|P1|Overall Study|Death|1
108348|NCT00988429|402223|P3|Overall Study|other reasons|1
108349|NCT00988429|402224|P2|Overall Study|other reasons|8
108350|NCT00988429|402225|P1|Overall Study|other reasons|8
108351|NCT00988429|402223|P3|Overall Study|Administrative Reasons|1
108352|NCT00988429|402224|P2|Overall Study|Administrative Reasons|2
108353|NCT00988429|402225|P1|Overall Study|Administrative Reasons|1
108354|NCT00988429|402223|P3|Overall Study|Withdrawal by Subject|12
108355|NCT00988429|402224|P2|Overall Study|Withdrawal by Subject|7
108356|NCT00988429|402225|P1|Overall Study|Withdrawal by Subject|7
108357|NCT00988429|402223|P3|Overall Study|Protocol Violation|3
108358|NCT00988429|402224|P2|Overall Study|Protocol Violation|3
108359|NCT00988429|402225|P1|Overall Study|Protocol Violation|4
108360|NCT00988429|402223|P3|Overall Study|Pregnancy|0
108361|NCT00988429|402224|P2|Overall Study|Pregnancy|1
108362|NCT00988429|402225|P1|Overall Study|Pregnancy|2
108363|NCT00988429|402223|P3|Overall Study|Physician Decision|3
108364|NCT00988429|402224|P2|Overall Study|Physician Decision|0
108365|NCT00988429|402225|P1|Overall Study|Physician Decision|1
108366|NCT00988429|402223|P3|Overall Study|Non-Compliance with Study Drug|3
108367|NCT00988429|402224|P2|Overall Study|Non-Compliance with Study Drug|1
108368|NCT00988429|402225|P1|Overall Study|Non-Compliance with Study Drug|5
108369|NCT00988429|402223|P3|Overall Study|Lack of Efficacy|1
108370|NCT00988429|402224|P2|Overall Study|Lack of Efficacy|0
108371|NCT00988429|402225|P1|Overall Study|Lack of Efficacy|0
108372|NCT00988429|402223|P3|Overall Study|Adverse Event|45
108373|NCT00988429|402224|P2|Overall Study|Adverse Event|21
108374|NCT00988429|402225|P1|Overall Study|Adverse Event|9
108375|NCT00988351|402238|P2|Overall Study|not using CPAP|3
108376|NCT00988351|402239|P1|Overall Study|not using CPAP|5
108377|NCT00988351|402238|P2|Overall Study|Lost to Follow-up|9
108378|NCT00988351|402239|P1|Overall Study|Lost to Follow-up|6
108379|NCT00988351|402238|P2|Overall Study|Withdrawal by Subject|0
108380|NCT00988351|402239|P1|Overall Study|Withdrawal by Subject|8
108381|NCT00988247|402316|P2|Overall Study|Not specified|0
108382|NCT00988247|402317|P1|Overall Study|Not specified|3
108383|NCT00988247|402316|P2|Overall Study|Sponsor requested withdrawal|1
108384|NCT00988247|402317|P1|Overall Study|Sponsor requested withdrawal|3
108385|NCT00988247|402316|P2|Overall Study|Protocol Violation|5
108386|NCT00988247|402317|P1|Overall Study|Protocol Violation|4
108387|NCT00988247|402316|P2|Overall Study|Lost to Follow-up|2
108388|NCT00988247|402317|P1|Overall Study|Lost to Follow-up|11
108389|NCT00988247|402316|P2|Overall Study|Pregnancy|2
108390|NCT00988247|402317|P1|Overall Study|Pregnancy|1
108391|NCT00988247|402316|P2|Overall Study|Withdrawal by Subject|13
108392|NCT00988247|402317|P1|Overall Study|Withdrawal by Subject|44
108393|NCT00988247|402316|P2|Overall Study|Adverse Event|3
108394|NCT00988247|402317|P1|Overall Study|Adverse Event|17
108395|NCT00988221|402336|P4|Part III|Refused Treatment|0
108396|NCT00988221|402337|P3|Part III|Refused Treatment|1
108397|NCT00988221|402338|P2|Part III|Refused Treatment|0
108398|NCT00988221|402339|P1|Part III|Refused Treatment|0
108399|NCT00988221|402336|P4|Part III|Insufficient Therapeutic Response|0
108400|NCT00988221|402337|P3|Part III|Insufficient Therapeutic Response|1
108401|NCT00988221|402338|P2|Part III|Insufficient Therapeutic Response|1
108402|NCT00988221|402339|P1|Part III|Insufficient Therapeutic Response|0
108403|NCT00988221|402336|P4|Part III|Adverse Event|0
108404|NCT00988221|402337|P3|Part III|Adverse Event|1
108405|NCT00988221|402338|P2|Part III|Adverse Event|0
108406|NCT00988221|402339|P1|Part III|Adverse Event|1
108407|NCT00988221|402336|P4|Part II|Reason not Specified|0
108408|NCT00988221|402337|P3|Part II|Reason not Specified|1
108409|NCT00988221|402338|P2|Part II|Reason not Specified|0
108410|NCT00988221|402339|P1|Part II|Reason not Specified|0
108411|NCT00988221|402336|P4|Part II|Withdrawal by Subject|2
108412|NCT00988221|402337|P3|Part II|Withdrawal by Subject|2
108413|NCT00988221|402338|P2|Part II|Withdrawal by Subject|0
108414|NCT00988221|402339|P1|Part II|Withdrawal by Subject|0
108415|NCT00988221|402336|P4|Part II|Adverse Event|1
108416|NCT00988221|402337|P3|Part II|Adverse Event|0
108417|NCT00988221|402338|P2|Part II|Adverse Event|0
108418|NCT00988221|402339|P1|Part II|Adverse Event|1
108419|NCT00988221|402336|P4|Part I|Lost to Follow-up|0
108420|NCT00988221|402337|P3|Part I|Lost to Follow-up|0
108421|NCT00988221|402338|P2|Part I|Lost to Follow-up|1
108422|NCT00988221|402339|P1|Part I|Lost to Follow-up|0
108423|NCT00988221|402336|P4|Part I|Refused Treatment|0
108424|NCT00988221|402337|P3|Part I|Refused Treatment|1
108425|NCT00988221|402338|P2|Part I|Refused Treatment|2
108426|NCT00988221|402339|P1|Part I|Refused Treatment|0
108427|NCT00988221|402336|P4|Part I|Insufficient Therapeutic Response|0
108428|NCT00988221|402337|P3|Part I|Insufficient Therapeutic Response|5
108429|NCT00988221|402338|P2|Part I|Insufficient Therapeutic Response|6
108430|NCT00988221|402339|P1|Part I|Insufficient Therapeutic Response|4
108431|NCT00988221|402336|P4|Part I|Adverse Event|0
108432|NCT00988221|402337|P3|Part I|Adverse Event|2
108433|NCT00988221|402338|P2|Part I|Adverse Event|1
108434|NCT00988221|402339|P1|Part I|Adverse Event|0
108435|NCT00988208|402512|P2|Overall Study|Other|3
108436|NCT00988208|402513|P1|Overall Study|Other|8
108437|NCT00988208|402512|P2|Overall Study|Subject Decision/Investigator Discretion|32
108438|NCT00988208|402513|P1|Overall Study|Subject Decision/Investigator Discretion|32
108439|NCT00988208|402512|P2|Overall Study|Clinical Deterioration|14
108440|NCT00988208|402513|P1|Overall Study|Clinical Deterioration|7
108441|NCT00988208|402512|P2|Overall Study|Biochemical Progression|7
108442|NCT00988208|402513|P1|Overall Study|Biochemical Progression|21
108443|NCT00988208|402512|P2|Overall Study|Clinical Progression|16
108444|NCT00988208|402513|P1|Overall Study|Clinical Progression|17
108445|NCT00988208|402512|P2|Overall Study|Sponsor Decision|78
108446|NCT00988208|402513|P1|Overall Study|Sponsor Decision|102
108447|NCT00988208|402512|P2|Overall Study|Protocol Violation|2
108448|NCT00988208|402513|P1|Overall Study|Protocol Violation|9
108449|NCT00988208|402512|P2|Overall Study|Lost to Follow-up|3
108450|NCT00988208|402513|P1|Overall Study|Lost to Follow-up|2
108451|NCT00988208|402512|P2|Overall Study|Death|15
108452|NCT00988208|402513|P1|Overall Study|Death|9
108453|NCT00988208|402512|P2|Overall Study|Withdrawal by Subject|57
108454|NCT00988208|402513|P1|Overall Study|Withdrawal by Subject|50
108455|NCT00988208|402512|P2|Overall Study|Disease Progression|89
108456|NCT00988208|402513|P1|Overall Study|Disease Progression|103
108457|NCT00988208|402512|P2|Overall Study|Adverse Event|122
108458|NCT00988208|402513|P1|Overall Study|Adverse Event|71
108459|NCT00988169|402531|P1|Overall Study|Withdrawal by Subject|1
108460|NCT00988117|402583|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
108461|NCT00988117|402583|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
108462|NCT00988091|402592|P2|Open-label Period|Not specified|3
108463|NCT00988091|402593|P1|Open-label Period|Not specified|2
108464|NCT00988091|402592|P2|Open-label Period|Lost to Follow-up|5
108465|NCT00988091|402593|P1|Open-label Period|Lost to Follow-up|3
108466|NCT00988091|402592|P2|Open-label Period|Withdrawal by Subject|16
108467|NCT00988091|402593|P1|Open-label Period|Withdrawal by Subject|10
108468|NCT00988091|402592|P2|Open-label Period|Protocol Violation|1
108469|NCT00988091|402593|P1|Open-label Period|Protocol Violation|1
108470|NCT00988091|402592|P2|Open-label Period|Use of exclusionary medication|1
108471|NCT00988091|402593|P1|Open-label Period|Use of exclusionary medication|1
108472|NCT00988091|402592|P2|Open-label Period|Adverse Event|7
108473|NCT00988091|402593|P1|Open-label Period|Adverse Event|4
108474|NCT00988091|402592|P2|Double-blind Period|Use of exclusionary medication|3
108475|NCT00988091|402593|P1|Double-blind Period|Use of exclusionary medication|2
108476|NCT00988091|402592|P2|Double-blind Period|Adverse Event|9
108477|NCT00988091|402593|P1|Double-blind Period|Adverse Event|6
108478|NCT00988091|402592|P2|Double-blind Period|Not specified|8
108479|NCT00988091|402593|P1|Double-blind Period|Not specified|8
108480|NCT00988091|402592|P2|Double-blind Period|Lost to Follow-up|14
108481|NCT00988091|402593|P1|Double-blind Period|Lost to Follow-up|12
108482|NCT00988091|402592|P2|Double-blind Period|Withdrawal by Subject|13
108483|NCT00988091|402593|P1|Double-blind Period|Withdrawal by Subject|15
108484|NCT00988065|402615|P3|Overall Study|Noncompliance with protocol|9
108485|NCT00988065|402616|P2|Overall Study|Noncompliance with protocol|6
108486|NCT00988065|402617|P1|Overall Study|Noncompliance with protocol|5
108487|NCT00988065|402615|P3|Overall Study|Subject withdrew consent|2
108488|NCT00988065|402616|P2|Overall Study|Subject withdrew consent|5
108489|NCT00988065|402617|P1|Overall Study|Subject withdrew consent|3
108490|NCT00988065|402615|P3|Overall Study|Lost to Follow-up|2
108491|NCT00988065|402616|P2|Overall Study|Lost to Follow-up|2
108492|NCT00988065|402617|P1|Overall Study|Lost to Follow-up|1
108493|NCT00988065|402615|P3|Overall Study|Adverse Event|2
108494|NCT00988065|402616|P2|Overall Study|Adverse Event|10
108495|NCT00988065|402617|P1|Overall Study|Adverse Event|4
108496|NCT00987935|402651|P9|Overall Study|Reason other than those specified above|1
108497|NCT00987935|402652|P8|Overall Study|Reason other than those specified above|0
108498|NCT00987935|402653|P7|Overall Study|Reason other than those specified above|0
108499|NCT00987935|402654|P6|Overall Study|Reason other than those specified above|0
108500|NCT00987935|402655|P5|Overall Study|Reason other than those specified above|0
108501|NCT00987935|402656|P4|Overall Study|Reason other than those specified above|0
108502|NCT00987935|402657|P3|Overall Study|Reason other than those specified above|0
108503|NCT00987935|402658|P2|Overall Study|Reason other than those specified above|0
108504|NCT00987935|402659|P1|Overall Study|Reason other than those specified above|0
108505|NCT00987935|402651|P9|Overall Study|Refused to continue taking trial med.|2
108506|NCT00987935|402652|P8|Overall Study|Refused to continue taking trial med.|4
108507|NCT00987935|402653|P7|Overall Study|Refused to continue taking trial med.|4
108508|NCT00987935|402654|P6|Overall Study|Refused to continue taking trial med.|0
108509|NCT00987935|402655|P5|Overall Study|Refused to continue taking trial med.|1
108510|NCT00987935|402656|P4|Overall Study|Refused to continue taking trial med.|0
108511|NCT00987935|402657|P3|Overall Study|Refused to continue taking trial med.|0
108512|NCT00987935|402658|P2|Overall Study|Refused to continue taking trial med.|0
108513|NCT00987935|402659|P1|Overall Study|Refused to continue taking trial med.|1
108514|NCT00987935|402651|P9|Overall Study|Adverse Event|6
108515|NCT00987935|402652|P8|Overall Study|Adverse Event|10
108516|NCT00987935|402653|P7|Overall Study|Adverse Event|2
108517|NCT00987935|402654|P6|Overall Study|Adverse Event|0
108518|NCT00987935|402655|P5|Overall Study|Adverse Event|1
108519|NCT00987935|402656|P4|Overall Study|Adverse Event|1
108520|NCT00987935|402657|P3|Overall Study|Adverse Event|0
108521|NCT00987935|402658|P2|Overall Study|Adverse Event|1
108522|NCT00987935|402659|P1|Overall Study|Adverse Event|0
108523|NCT00987935|402651|P9|Overall Study|Progressive disease|23
108524|NCT00987935|402652|P8|Overall Study|Progressive disease|48
108525|NCT00987935|402653|P7|Overall Study|Progressive disease|9
108526|NCT00987935|402654|P6|Overall Study|Progressive disease|3
108527|NCT00987935|402655|P5|Overall Study|Progressive disease|5
108528|NCT00987935|402656|P4|Overall Study|Progressive disease|2
108529|NCT00987935|402657|P3|Overall Study|Progressive disease|3
108530|NCT00987935|402658|P2|Overall Study|Progressive disease|2
108531|NCT00987935|402659|P1|Overall Study|Progressive disease|3
108532|NCT00987831|402715|P3|Overall Study|Lost to Follow-up|0
108533|NCT00987831|402716|P2|Overall Study|Lost to Follow-up|3
108534|NCT00987831|402717|P1|Overall Study|Lost to Follow-up|0
108535|NCT00987831|402715|P3|Overall Study|Never flared in 12 months|0
108536|NCT00987831|402716|P2|Overall Study|Never flared in 12 months|0
108537|NCT00987831|402717|P1|Overall Study|Never flared in 12 months|1
108538|NCT00987623|402739|P2|Overall Study|Influenza|1
108539|NCT00987623|402740|P1|Overall Study|Influenza|0
108540|NCT00987623|402739|P2|Overall Study|Biomicroscopy|1
108541|NCT00987623|402740|P1|Overall Study|Biomicroscopy|0
108542|NCT00987623|402739|P2|Overall Study|Discomfort|0
108543|NCT00987623|402740|P1|Overall Study|Discomfort|1
108544|NCT00987623|402739|P2|Overall Study|Time/job conflict|0
108545|NCT00987623|402740|P1|Overall Study|Time/job conflict|2
108546|NCT00987623|402739|P2|Overall Study|Lost to Follow-up|1
108547|NCT00987623|402740|P1|Overall Study|Lost to Follow-up|2
108548|NCT00987467|402760|P1|Overall Study|Lost to Follow-up|2
108549|NCT00987402|402784|P2|Overall Study|Insufficient data entry|98
108550|NCT00987402|402785|P1|Overall Study|Insufficient data entry|86
108551|NCT00987337|402794|P3|Overall Study|Participant Relapsed|5
108552|NCT00987337|402795|P2|Overall Study|Participant Relapsed|20
108553|NCT00987337|402796|P1|Overall Study|Participant Relapsed|18
108554|NCT00987337|402794|P3|Overall Study|Protocol Violation|2
108555|NCT00987337|402795|P2|Overall Study|Protocol Violation|0
108556|NCT00987337|402796|P1|Overall Study|Protocol Violation|1
108557|NCT00987337|402794|P3|Overall Study|Other|5
108558|NCT00987337|402795|P2|Overall Study|Other|2
108559|NCT00987337|402796|P1|Overall Study|Other|0
108560|NCT00987337|402794|P3|Overall Study|Withdrawal by Subject|9
108561|NCT00987337|402795|P2|Overall Study|Withdrawal by Subject|9
108562|NCT00987337|402796|P1|Overall Study|Withdrawal by Subject|6
108563|NCT00987337|402794|P3|Overall Study|Lost to Follow-up|2
108564|NCT00987337|402795|P2|Overall Study|Lost to Follow-up|6
108565|NCT00987337|402796|P1|Overall Study|Lost to Follow-up|10
108566|NCT00987337|402794|P3|Overall Study|Virologic Breakthrough|8
108567|NCT00987337|402795|P2|Overall Study|Virologic Breakthrough|2
108568|NCT00987337|402796|P1|Overall Study|Virologic Breakthrough|2
108569|NCT00987337|402794|P3|Overall Study|Insufficient Virologic Response|12
108570|NCT00987337|402795|P2|Overall Study|Insufficient Virologic Response|7
108571|NCT00987337|402796|P1|Overall Study|Insufficient Virologic Response|10
108572|NCT00987337|402794|P3|Overall Study|Adverse Event|8
108573|NCT00987337|402795|P2|Overall Study|Adverse Event|9
108574|NCT00987337|402796|P1|Overall Study|Adverse Event|10
108575|NCT00986986|402851|P2|Overall Study|Lost to Follow-up|1
108576|NCT00986986|402852|P1|Overall Study|Lost to Follow-up|0
108577|NCT00986973|402862|P1|Overall Study|Withdrawn by study team|1
108578|NCT00986921|402888|P2|Overall Study|Physician Decision|0
108579|NCT00986921|402889|P1|Overall Study|Physician Decision|1
108580|NCT00986674|402925|P3|Overall Study|unknown/not specify|9
108581|NCT00986674|402926|P2|Overall Study|unknown/not specify|7
108582|NCT00986674|402927|P1|Overall Study|unknown/not specify|0
108583|NCT00986674|402925|P3|Overall Study|not start protocol therapy|1
108584|NCT00986674|402926|P2|Overall Study|not start protocol therapy|3
108585|NCT00986674|402927|P1|Overall Study|not start protocol therapy|4
108586|NCT00986674|402925|P3|Overall Study|alternative therapy|1
108587|NCT00986674|402926|P2|Overall Study|alternative therapy|0
108588|NCT00986674|402927|P1|Overall Study|alternative therapy|0
108589|NCT00986674|402925|P3|Overall Study|Withdrawal by Subject|1
108590|NCT00986674|402926|P2|Overall Study|Withdrawal by Subject|2
108591|NCT00986674|402927|P1|Overall Study|Withdrawal by Subject|6
108592|NCT00986674|402925|P3|Overall Study|Death|4
108593|NCT00986674|402926|P2|Overall Study|Death|0
108594|NCT00986674|402927|P1|Overall Study|Death|5
108595|NCT00986674|402925|P3|Overall Study|Adverse Event|9
108596|NCT00986674|402926|P2|Overall Study|Adverse Event|8
108597|NCT00986674|402927|P1|Overall Study|Adverse Event|4
108598|NCT00986674|402925|P3|Overall Study|Lack of Efficacy|23
108599|NCT00986674|402926|P2|Overall Study|Lack of Efficacy|25
108600|NCT00986674|402927|P1|Overall Study|Lack of Efficacy|28
108601|NCT00986570|402960|P1|Overall Study|Potential bias for objective assessment|1
108602|NCT00986570|402960|P1|Overall Study|Lost to Follow-up|6
108603|NCT00986479|402977|P2|Period 1|Administrative reasons|0
108604|NCT00986479|402978|P1|Period 1|Administrative reasons|1
108605|NCT00986479|402977|P2|Period 1|Improved mood|0
108606|NCT00986479|402978|P1|Period 1|Improved mood|1
108607|NCT00986427|403024|P2|Overall Study|Withdrawal by Subject|0
108608|NCT00986427|403025|P1|Overall Study|Withdrawal by Subject|1
108609|NCT00986427|403024|P2|Overall Study|Lack of Efficacy|0
108610|NCT00986427|403025|P1|Overall Study|Lack of Efficacy|1
108611|NCT00986427|403024|P2|Overall Study|Lost to Follow-up|0
108612|NCT00986427|403025|P1|Overall Study|Lost to Follow-up|2
108613|NCT00986362|403053|P2|Overall Study|Lost to Follow-up|1
108614|NCT00986362|403054|P1|Overall Study|Lost to Follow-up|0
108615|NCT00986362|403053|P2|Overall Study|Death|0
108616|NCT00986362|403054|P1|Overall Study|Death|2
108617|NCT00986349|403060|P1|Overall Study|device migration|1
108618|NCT00986349|403060|P1|Overall Study|Physician Decision|1
108619|NCT00986349|403060|P1|Overall Study|Adverse Event|2
108620|NCT00986349|403060|P1|Overall Study|Unsuccessful implant procedure|3
108621|NCT00986258|403073|P1|Maintenance Period|Withdrawal by Subject|2
108622|NCT00986258|403073|P1|Maintenance Period|Lack of Efficacy|2
108623|NCT00986258|403073|P1|Maintenance Period|Adverse Event|5
108624|NCT00986258|403073|P1|Titration and Optimal Dose Period|Other|1
108625|NCT00986258|403073|P1|Titration and Optimal Dose Period|Non-Compliance|1
108626|NCT00986258|403073|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
108627|NCT00986258|403073|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
108628|NCT00986258|403073|P1|Titration and Optimal Dose Period|Adverse Event|15
108629|NCT00986258|403073|P1|Observation Period|Not eligible to be dosed|11
108630|NCT00986245|403101|P2|Second Intervention|Protocol Violation|1
108631|NCT00986245|403102|P1|Second Intervention|Protocol Violation|0
108632|NCT00986245|403101|P2|Second Intervention|Lost to Follow-up|0
108633|NCT00986245|403102|P1|Second Intervention|Lost to Follow-up|1
108634|NCT00986245|403101|P2|Second Intervention|Poor compliance|0
108635|NCT00986245|403102|P1|Second Intervention|Poor compliance|1
108636|NCT00986245|403101|P2|First Intervention|Out of indication|0
108637|NCT00986245|403102|P1|First Intervention|Out of indication|1
108638|NCT00986245|403101|P2|First Intervention|Protocol Violation|1
108639|NCT00986245|403102|P1|First Intervention|Protocol Violation|0
108640|NCT00986245|403101|P2|First Intervention|Withdrawal by Subject|1
108641|NCT00986245|403102|P1|First Intervention|Withdrawal by Subject|0
108642|NCT00986245|403101|P2|First Intervention|Lack of Efficacy|2
108643|NCT00986245|403102|P1|First Intervention|Lack of Efficacy|1
108644|NCT00986245|403101|P2|First Intervention|Poor compliance|4
108645|NCT00986245|403102|P1|First Intervention|Poor compliance|8
108646|NCT00986232|403139|P4|Overall Study|Incomplete safety follow-up|2
108647|NCT00986232|403140|P3|Overall Study|Incomplete safety follow-up|2
108648|NCT00986232|403141|P2|Overall Study|Incomplete safety follow-up|7
108649|NCT00986232|403142|P1|Overall Study|Incomplete safety follow-up|3
108650|NCT00986232|403139|P4|Overall Study|Missed one or more bleeds|7
108651|NCT00986232|403140|P3|Overall Study|Missed one or more bleeds|6
108652|NCT00986232|403141|P2|Overall Study|Missed one or more bleeds|10
108653|NCT00986232|403142|P1|Overall Study|Missed one or more bleeds|13
108654|NCT00986232|403139|P4|Overall Study|Withdrawal by Subject|3
108655|NCT00986232|403140|P3|Overall Study|Withdrawal by Subject|12
108656|NCT00986232|403141|P2|Overall Study|Withdrawal by Subject|16
108657|NCT00986232|403142|P1|Overall Study|Withdrawal by Subject|13
108658|NCT00986232|403139|P4|Overall Study|Protocol Violation|1
108659|NCT00986232|403140|P3|Overall Study|Protocol Violation|0
108660|NCT00986232|403141|P2|Overall Study|Protocol Violation|3
108661|NCT00986232|403142|P1|Overall Study|Protocol Violation|2
108662|NCT00986232|403139|P4|Overall Study|Lost to Follow-up|7
108663|NCT00986232|403140|P3|Overall Study|Lost to Follow-up|12
108664|NCT00986232|403141|P2|Overall Study|Lost to Follow-up|12
108665|NCT00986232|403142|P1|Overall Study|Lost to Follow-up|19
108666|NCT00986232|403139|P4|Overall Study|Adverse Event|0
108667|NCT00986232|403140|P3|Overall Study|Adverse Event|3
108668|NCT00986232|403141|P2|Overall Study|Adverse Event|2
108669|NCT00986232|403142|P1|Overall Study|Adverse Event|1
108670|NCT00986180|403216|P2|Overall Study|Miscellanies|11
108671|NCT00986180|403217|P1|Overall Study|Miscellanies|10
108672|NCT00986180|403216|P2|Overall Study|Withdrawal by Subject|9
108673|NCT00986180|403217|P1|Overall Study|Withdrawal by Subject|1
108674|NCT00986180|403216|P2|Overall Study|Protocol Violation|0
108675|NCT00986180|403217|P1|Overall Study|Protocol Violation|2
108676|NCT00986180|403216|P2|Overall Study|Physician Decision|3
108677|NCT00986180|403217|P1|Overall Study|Physician Decision|1
108678|NCT00986180|403216|P2|Overall Study|Lost to Follow-up|7
108679|NCT00986180|403217|P1|Overall Study|Lost to Follow-up|5
108680|NCT00986180|403216|P2|Overall Study|Lack of Efficacy|3
108681|NCT00986180|403217|P1|Overall Study|Lack of Efficacy|4
108682|NCT00986180|403216|P2|Overall Study|Adverse Event|23
108683|NCT00986180|403217|P1|Overall Study|Adverse Event|21
108684|NCT00986154|403295|P2|Overall Study|never received study drug|27
108685|NCT00986154|403296|P1|Overall Study|never received study drug|25
108686|NCT00986154|403295|P2|Overall Study|investigator/subject decide not continue|3
108687|NCT00986154|403296|P1|Overall Study|investigator/subject decide not continue|6
108688|NCT00986154|403295|P2|Overall Study|Withdrawal by Subject|33
108689|NCT00986154|403296|P1|Overall Study|Withdrawal by Subject|32
108690|NCT00986154|403295|P2|Overall Study|Lost to Follow-up|4
108691|NCT00986154|403296|P1|Overall Study|Lost to Follow-up|7
108692|NCT00986154|403295|P2|Overall Study|Death|127
108693|NCT00986154|403296|P1|Overall Study|Death|136
108694|NCT00986102|403310|P4|Overall Study|Withdrawal by Subject|0
108695|NCT00986102|403311|P3|Overall Study|Withdrawal by Subject|0
108696|NCT00986102|403312|P2|Overall Study|Withdrawal by Subject|1
108697|NCT00986102|403313|P1|Overall Study|Withdrawal by Subject|1
108698|NCT00986102|403310|P4|Overall Study|Lost to Follow-up|1
108699|NCT00986102|403311|P3|Overall Study|Lost to Follow-up|0
108700|NCT00986102|403312|P2|Overall Study|Lost to Follow-up|1
108701|NCT00986102|403313|P1|Overall Study|Lost to Follow-up|0
108702|NCT00985985|403363|P4|Overall Study|Other Reason|2
108703|NCT00985985|403364|P3|Overall Study|Other Reason|4
108704|NCT00985985|403365|P2|Overall Study|Other Reason|1
108705|NCT00985985|403366|P1|Overall Study|Other Reason|6
108706|NCT00985985|403363|P4|Overall Study|Withdrawal by Subject|2
108707|NCT00985985|403364|P3|Overall Study|Withdrawal by Subject|2
108708|NCT00985985|403365|P2|Overall Study|Withdrawal by Subject|2
108709|NCT00985985|403366|P1|Overall Study|Withdrawal by Subject|4
108710|NCT00985985|403363|P4|Overall Study|Lack of Efficacy|3
108711|NCT00985985|403364|P3|Overall Study|Lack of Efficacy|1
108712|NCT00985985|403365|P2|Overall Study|Lack of Efficacy|6
108713|NCT00985985|403366|P1|Overall Study|Lack of Efficacy|5
108714|NCT00985985|403363|P4|Overall Study|Protocol Violation|1
108715|NCT00985985|403364|P3|Overall Study|Protocol Violation|0
108716|NCT00985985|403365|P2|Overall Study|Protocol Violation|2
108717|NCT00985985|403366|P1|Overall Study|Protocol Violation|1
108718|NCT00985985|403363|P4|Overall Study|Lost to Follow-up|3
108719|NCT00985985|403364|P3|Overall Study|Lost to Follow-up|2
108720|NCT00985985|403365|P2|Overall Study|Lost to Follow-up|11
108721|NCT00985985|403366|P1|Overall Study|Lost to Follow-up|4
108722|NCT00985985|403363|P4|Overall Study|Adverse Event|2
108723|NCT00985985|403364|P3|Overall Study|Adverse Event|2
108724|NCT00985985|403365|P2|Overall Study|Adverse Event|2
108725|NCT00985985|403366|P1|Overall Study|Adverse Event|4
108726|NCT00985959|403407|P3|Overall Study|Other|11
108727|NCT00985959|403408|P2|Overall Study|Other|0
108728|NCT00985959|403409|P1|Overall Study|Other|0
108729|NCT00985959|403407|P3|Overall Study|Complete response observed over 2 cycles|4
108730|NCT00985959|403408|P2|Overall Study|Complete response observed over 2 cycles|1
108731|NCT00985959|403409|P1|Overall Study|Complete response observed over 2 cycles|0
108732|NCT00985959|403407|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
108733|NCT00985959|403408|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
108734|NCT00985959|403409|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
108735|NCT00985959|403407|P3|Overall Study|Unrecovered toxicity|7
108736|NCT00985959|403408|P2|Overall Study|Unrecovered toxicity|0
108737|NCT00985959|403409|P1|Overall Study|Unrecovered toxicity|0
108738|NCT00985959|403407|P3|Overall Study|Progressive disease|8
108739|NCT00985959|403408|P2|Overall Study|Progressive disease|2
108740|NCT00985959|403409|P1|Overall Study|Progressive disease|1
108741|NCT00985959|403407|P3|Overall Study|Withdrawal by Subject|8
108742|NCT00985959|403408|P2|Overall Study|Withdrawal by Subject|0
108743|NCT00985959|403409|P1|Overall Study|Withdrawal by Subject|0
108744|NCT00985959|403407|P3|Overall Study|Adverse Event|19
108745|NCT00985959|403408|P2|Overall Study|Adverse Event|0
108746|NCT00985959|403409|P1|Overall Study|Adverse Event|0
108747|NCT00985946|403432|P1|Overall Study|Withdrawal by Subject|1
108748|NCT00985946|403432|P1|Overall Study|Lost to Follow-up|6
108749|NCT00985790|403451|P2|Overall Study|Lost to Follow-up|7
108750|NCT00985790|403452|P1|Overall Study|Lost to Follow-up|6
108751|NCT00985790|403451|P2|Overall Study|Withdrawal by Subject|1
108752|NCT00985790|403452|P1|Overall Study|Withdrawal by Subject|1
108753|NCT00985751|403493|P5|Overall Study|Adverse Event|1
108754|NCT00985751|403494|P4|Overall Study|Adverse Event|0
108755|NCT00985751|403495|P3|Overall Study|Adverse Event|0
108756|NCT00985751|403496|P2|Overall Study|Adverse Event|0
108757|NCT00985751|403497|P1|Overall Study|Adverse Event|0
108758|NCT00985738|403560|P2|Overall Study|Study closed prematurely|8
108759|NCT00985738|403561|P1|Overall Study|Study closed prematurely|8
108760|NCT00985725|403569|P2|Overall Study|Out-of-window visits|1
108761|NCT00985725|403570|P1|Overall Study|Out-of-window visits|0
108762|NCT00985725|403569|P2|Overall Study|Non-compliance|2
108763|NCT00985725|403570|P1|Overall Study|Non-compliance|1
108764|NCT00985725|403569|P2|Overall Study|Lack of Efficacy|1
108765|NCT00985725|403570|P1|Overall Study|Lack of Efficacy|0
108766|NCT00985725|403569|P2|Overall Study|Lost to Follow-up|1
108767|NCT00985725|403570|P1|Overall Study|Lost to Follow-up|1
108768|NCT00985725|403569|P2|Overall Study|Withdrawal by Subject|4
108769|NCT00985725|403570|P1|Overall Study|Withdrawal by Subject|4
108770|NCT00985725|403569|P2|Overall Study|Protocol Violation|3
108771|NCT00985725|403570|P1|Overall Study|Protocol Violation|1
108772|NCT00985725|403569|P2|Overall Study|Adverse Event|1
108773|NCT00985725|403570|P1|Overall Study|Adverse Event|4
108774|NCT00985712|403606|P2|Overall Study|Sponsor decision|2
108775|NCT00985712|403607|P1|Overall Study|Sponsor decision|0
108776|NCT00985712|403606|P2|Overall Study|Withdrawal by Subject|1
108777|NCT00985712|403607|P1|Overall Study|Withdrawal by Subject|4
108778|NCT00985712|403606|P2|Overall Study|Protocol Violation|1
108779|NCT00985712|403607|P1|Overall Study|Protocol Violation|0
108780|NCT00985712|403606|P2|Overall Study|Lost to Follow-up|2
108781|NCT00985712|403607|P1|Overall Study|Lost to Follow-up|2
108782|NCT00985712|403606|P2|Overall Study|Adverse Event|1
108783|NCT00985712|403607|P1|Overall Study|Adverse Event|0
108784|NCT00985686|403625|P4|Overall Study|Lost to Follow-up|2
108785|NCT00985686|403626|P3|Overall Study|Lost to Follow-up|0
108786|NCT00985686|403627|P2|Overall Study|Lost to Follow-up|1
108787|NCT00985686|403628|P1|Overall Study|Lost to Follow-up|1
108788|NCT00985673|403642|P6|Overall Study|Other|0
108789|NCT00985673|403643|P5|Overall Study|Other|1
108790|NCT00985673|403644|P4|Overall Study|Other|0
108791|NCT00985673|403645|P3|Overall Study|Other|1
108792|NCT00985673|403646|P2|Overall Study|Other|0
108793|NCT00985673|403647|P1|Overall Study|Other|1
108794|NCT00985673|403642|P6|Overall Study|Withdrawal by Subject|3
108795|NCT00985673|403643|P5|Overall Study|Withdrawal by Subject|2
108796|NCT00985673|403644|P4|Overall Study|Withdrawal by Subject|2
108797|NCT00985673|403645|P3|Overall Study|Withdrawal by Subject|5
108798|NCT00985673|403646|P2|Overall Study|Withdrawal by Subject|4
108799|NCT00985673|403647|P1|Overall Study|Withdrawal by Subject|0
108800|NCT00985673|403642|P6|Overall Study|Lost to Follow-up|3
108801|NCT00985673|403643|P5|Overall Study|Lost to Follow-up|5
108802|NCT00985673|403644|P4|Overall Study|Lost to Follow-up|10
108803|NCT00985673|403645|P3|Overall Study|Lost to Follow-up|6
108804|NCT00985673|403646|P2|Overall Study|Lost to Follow-up|7
108805|NCT00985673|403647|P1|Overall Study|Lost to Follow-up|6
108806|NCT00985504|403909|P2|Optimization Period|Withdrawal by Subject|8
108807|NCT00985504|403910|P1|Optimization Period|Withdrawal by Subject|10
108808|NCT00985504|403909|P2|Optimization Period|Protocol Violation|1
108809|NCT00985504|403910|P1|Optimization Period|Protocol Violation|3
108810|NCT00985504|403909|P2|Optimization Period|Physician Decision|0
108811|NCT00985504|403910|P1|Optimization Period|Physician Decision|1
108812|NCT00985504|403909|P2|Optimization Period|Lost to Follow-up|1
108813|NCT00985504|403910|P1|Optimization Period|Lost to Follow-up|0
108814|NCT00985504|403909|P2|Optimization Period|Lack of Efficacy|3
108815|NCT00985504|403910|P1|Optimization Period|Lack of Efficacy|5
108816|NCT00985504|403909|P2|Optimization Period|Death|1
108817|NCT00985504|403910|P1|Optimization Period|Death|0
108818|NCT00985504|403909|P2|Optimization Period|Adverse Event|9
108819|NCT00985504|403910|P1|Optimization Period|Adverse Event|7
108820|NCT00985504|403909|P2|Acute Treatment Period|Withdrawal by Subject|5
108821|NCT00985504|403910|P1|Acute Treatment Period|Withdrawal by Subject|9
108822|NCT00985504|403909|P2|Acute Treatment Period|Sponsor Decision|1
108823|NCT00985504|403910|P1|Acute Treatment Period|Sponsor Decision|0
108824|NCT00985504|403909|P2|Acute Treatment Period|Protocol Violation|0
108825|NCT00985504|403910|P1|Acute Treatment Period|Protocol Violation|2
108826|NCT00985504|403909|P2|Acute Treatment Period|Entry Criteria Not Met|2
108827|NCT00985504|403910|P1|Acute Treatment Period|Entry Criteria Not Met|1
108828|NCT00985504|403909|P2|Acute Treatment Period|Adverse Event|4
108829|NCT00985504|403910|P1|Acute Treatment Period|Adverse Event|3
108830|NCT00985491|403936|P1|Overall Study|implant failure|3
108831|NCT00985491|403936|P1|Overall Study|Withdrawal by Subject|1
108832|NCT00985491|403936|P1|Overall Study|device migration|7
108833|NCT00985491|403936|P1|Overall Study|Adverse Event|8
108834|NCT00985439|403945|P4|Overall Study|Adverse Event|0
108835|NCT00985439|403946|P3|Overall Study|Adverse Event|1
108836|NCT00985439|403947|P2|Overall Study|Adverse Event|0
108837|NCT00985439|403948|P1|Overall Study|Adverse Event|0
108838|NCT00985231|403964|P2|Overall Study|Study related symptoms & complaints|2
108839|NCT00985231|403965|P1|Overall Study|Study related symptoms & complaints|0
108840|NCT00985231|403964|P2|Overall Study|Lost to Follow-up|1
108841|NCT00985231|403965|P1|Overall Study|Lost to Follow-up|0
108842|NCT00985231|403964|P2|Overall Study|Withdrawal by Subject|0
108843|NCT00985231|403965|P1|Overall Study|Withdrawal by Subject|1
108844|NCT00985231|403964|P2|Overall Study|Protocol Violation|0
108845|NCT00985231|403965|P1|Overall Study|Protocol Violation|1
108846|NCT00985231|403964|P2|Overall Study|ineligible|0
108847|NCT00985231|403965|P1|Overall Study|ineligible|1
108848|NCT00985192|403973|P1|Overall Study|Determined to be Ineligible During Trial|2
108849|NCT00985192|403973|P1|Overall Study|Disease Progression|1
108850|NCT00985192|403973|P1|Overall Study|Withdrawal by Subject|1
108851|NCT00985166|403985|P3|Overall Study|Other|1
108852|NCT00985166|403986|P2|Overall Study|Other|0
108853|NCT00985166|403987|P1|Overall Study|Other|1
108854|NCT00985166|403985|P3|Overall Study|Test not done|4
108855|NCT00985166|403986|P2|Overall Study|Test not done|0
108856|NCT00985166|403987|P1|Overall Study|Test not done|2
108857|NCT00985166|403985|P3|Overall Study|Withdrawal by Subject|0
108858|NCT00985166|403986|P2|Overall Study|Withdrawal by Subject|2
108859|NCT00985166|403987|P1|Overall Study|Withdrawal by Subject|3
108860|NCT00985166|403985|P3|Overall Study|Lost to Follow-up|2
108861|NCT00985166|403986|P2|Overall Study|Lost to Follow-up|2
108862|NCT00985166|403987|P1|Overall Study|Lost to Follow-up|3
108863|NCT00985153|404007|P4|Overall Study|Incomplete Safety Follow-up|4
108864|NCT00985153|404008|P3|Overall Study|Incomplete Safety Follow-up|4
108865|NCT00985153|404009|P2|Overall Study|Incomplete Safety Follow-up|5
108866|NCT00985153|404010|P1|Overall Study|Incomplete Safety Follow-up|3
108867|NCT00985153|404007|P4|Overall Study|Missed One or More Bleeds|10
108868|NCT00985153|404008|P3|Overall Study|Missed One or More Bleeds|8
108869|NCT00985153|404009|P2|Overall Study|Missed One or More Bleeds|7
108870|NCT00985153|404010|P1|Overall Study|Missed One or More Bleeds|7
108871|NCT00985153|404007|P4|Overall Study|Withdrawal by Subject|10
108872|NCT00985153|404008|P3|Overall Study|Withdrawal by Subject|11
108873|NCT00985153|404009|P2|Overall Study|Withdrawal by Subject|11
108874|NCT00985153|404010|P1|Overall Study|Withdrawal by Subject|6
108875|NCT00985153|404007|P4|Overall Study|Protocol Violation|3
108876|NCT00985153|404008|P3|Overall Study|Protocol Violation|4
108877|NCT00985153|404009|P2|Overall Study|Protocol Violation|2
108878|NCT00985153|404010|P1|Overall Study|Protocol Violation|3
108879|NCT00985153|404007|P4|Overall Study|Lost to Follow-up|20
108880|NCT00985153|404008|P3|Overall Study|Lost to Follow-up|17
108881|NCT00985153|404009|P2|Overall Study|Lost to Follow-up|19
108882|NCT00985153|404010|P1|Overall Study|Lost to Follow-up|16
108883|NCT00985114|404058|P2|Overall Study|Withdrawal by Subject|2
108884|NCT00985114|404059|P1|Overall Study|Withdrawal by Subject|0
108885|NCT00985114|404058|P2|Overall Study|Adverse Event|0
108886|NCT00985114|404059|P1|Overall Study|Adverse Event|1
108887|NCT00985088|404073|P8|Overall Study|Lost to Follow-up|2
108888|NCT00985088|404074|P7|Overall Study|Lost to Follow-up|3
108889|NCT00985088|404075|P6|Overall Study|Lost to Follow-up|5
108890|NCT00985088|404076|P5|Overall Study|Lost to Follow-up|6
108891|NCT00985088|404077|P4|Overall Study|Lost to Follow-up|6
108892|NCT00985088|404078|P3|Overall Study|Lost to Follow-up|2
108893|NCT00985088|404079|P2|Overall Study|Lost to Follow-up|1
108894|NCT00985088|404080|P1|Overall Study|Lost to Follow-up|6
108895|NCT00985088|404073|P8|Overall Study|Migrated/moved from study area|1
108896|NCT00985088|404074|P7|Overall Study|Migrated/moved from study area|0
108897|NCT00985088|404075|P6|Overall Study|Migrated/moved from study area|0
108898|NCT00985088|404076|P5|Overall Study|Migrated/moved from study area|0
108899|NCT00985088|404077|P4|Overall Study|Migrated/moved from study area|0
108900|NCT00985088|404078|P3|Overall Study|Migrated/moved from study area|1
108901|NCT00985088|404079|P2|Overall Study|Migrated/moved from study area|0
108902|NCT00985088|404080|P1|Overall Study|Migrated/moved from study area|0
108903|NCT00985088|404073|P8|Overall Study|Withdrawal by Subject|2
108904|NCT00985088|404074|P7|Overall Study|Withdrawal by Subject|1
108905|NCT00985088|404075|P6|Overall Study|Withdrawal by Subject|2
108906|NCT00985088|404076|P5|Overall Study|Withdrawal by Subject|3
108907|NCT00985088|404077|P4|Overall Study|Withdrawal by Subject|1
108908|NCT00985088|404078|P3|Overall Study|Withdrawal by Subject|0
108909|NCT00985088|404079|P2|Overall Study|Withdrawal by Subject|0
108910|NCT00985088|404080|P1|Overall Study|Withdrawal by Subject|4
108911|NCT00985088|404073|P8|Overall Study|Adverse Event|0
108912|NCT00985088|404074|P7|Overall Study|Adverse Event|0
108913|NCT00985088|404075|P6|Overall Study|Adverse Event|0
108914|NCT00985088|404076|P5|Overall Study|Adverse Event|0
108915|NCT00985088|404077|P4|Overall Study|Adverse Event|0
108916|NCT00985088|404078|P3|Overall Study|Adverse Event|1
108917|NCT00985088|404079|P2|Overall Study|Adverse Event|0
108918|NCT00985088|404080|P1|Overall Study|Adverse Event|0
108919|NCT00985088|404073|P8|Overall Study|Serious Adverse Event|1
108920|NCT00985088|404074|P7|Overall Study|Serious Adverse Event|0
108921|NCT00985088|404075|P6|Overall Study|Serious Adverse Event|0
108922|NCT00985088|404076|P5|Overall Study|Serious Adverse Event|0
108923|NCT00985088|404077|P4|Overall Study|Serious Adverse Event|0
108924|NCT00985088|404078|P3|Overall Study|Serious Adverse Event|0
108925|NCT00985088|404079|P2|Overall Study|Serious Adverse Event|1
108926|NCT00985088|404080|P1|Overall Study|Serious Adverse Event|1
108927|NCT00984867|404349|P2|Overall Study|lack of efficacy and subject compliance|0
108928|NCT00984867|404350|P1|Overall Study|lack of efficacy and subject compliance|1
108929|NCT00984867|404349|P2|Overall Study|site closing|0
108930|NCT00984867|404350|P1|Overall Study|site closing|1
108931|NCT00984867|404349|P2|Overall Study|Subject no longer meets study criteria|1
108932|NCT00984867|404350|P1|Overall Study|Subject no longer meets study criteria|1
108933|NCT00984867|404349|P2|Overall Study|Poor/non-compliance|1
108934|NCT00984867|404350|P1|Overall Study|Poor/non-compliance|0
108935|NCT00984867|404349|P2|Overall Study|Lost to Follow-up|4
108936|NCT00984867|404350|P1|Overall Study|Lost to Follow-up|3
108937|NCT00984867|404349|P2|Overall Study|Withdrawal by Subject|4
108938|NCT00984867|404350|P1|Overall Study|Withdrawal by Subject|13
108939|NCT00984867|404349|P2|Overall Study|Death|0
108940|NCT00984867|404350|P1|Overall Study|Death|1
108941|NCT00984867|404349|P2|Overall Study|Adverse Event|7
108942|NCT00984867|404350|P1|Overall Study|Adverse Event|3
108943|NCT00984659|404390|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
108944|NCT00984659|404391|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
108945|NCT00984659|404392|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
108946|NCT00984659|404393|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
108947|NCT00984659|404390|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
108948|NCT00984659|404391|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
108949|NCT00984659|404392|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
108950|NCT00984659|404393|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
108951|NCT00984659|404390|P4|6-week Double-blind Treatment Period|Protocol Violation|4
108952|NCT00984659|404391|P3|6-week Double-blind Treatment Period|Protocol Violation|0
108953|NCT00984659|404392|P2|6-week Double-blind Treatment Period|Protocol Violation|0
108954|NCT00984659|404393|P1|6-week Double-blind Treatment Period|Protocol Violation|0
108955|NCT00984659|404390|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
108956|NCT00984659|404391|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
108957|NCT00984659|404392|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
108958|NCT00984659|404393|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
108959|NCT00984659|404390|P4|6-week Double-blind Treatment Period|Adverse Event|7
108960|NCT00984659|404391|P3|6-week Double-blind Treatment Period|Adverse Event|3
108961|NCT00984659|404392|P2|6-week Double-blind Treatment Period|Adverse Event|3
108962|NCT00984659|404393|P1|6-week Double-blind Treatment Period|Adverse Event|0
108963|NCT00984659|404390|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
108964|NCT00984659|404391|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
108965|NCT00984659|404392|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
108966|NCT00984659|404393|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
108967|NCT00984659|404390|P4|2-week Run-in Period|Withdrawal by Subject|0
108968|NCT00984659|404391|P3|2-week Run-in Period|Withdrawal by Subject|0
108969|NCT00984659|404392|P2|2-week Run-in Period|Withdrawal by Subject|0
108970|NCT00984659|404393|P1|2-week Run-in Period|Withdrawal by Subject|10
108971|NCT00984659|404390|P4|2-week Run-in Period|Physician Decision|0
108972|NCT00984659|404391|P3|2-week Run-in Period|Physician Decision|0
108973|NCT00984659|404392|P2|2-week Run-in Period|Physician Decision|0
108974|NCT00984659|404393|P1|2-week Run-in Period|Physician Decision|10
108975|NCT00984659|404390|P4|2-week Run-in Period|Lost to Follow-up|0
108976|NCT00984659|404391|P3|2-week Run-in Period|Lost to Follow-up|0
108977|NCT00984659|404392|P2|2-week Run-in Period|Lost to Follow-up|0
108978|NCT00984659|404393|P1|2-week Run-in Period|Lost to Follow-up|3
108979|NCT00984659|404390|P4|2-week Run-in Period|Study Closed/Terminated|0
108980|NCT00984659|404391|P3|2-week Run-in Period|Study Closed/Terminated|0
108981|NCT00984659|404392|P2|2-week Run-in Period|Study Closed/Terminated|0
108982|NCT00984659|404393|P1|2-week Run-in Period|Study Closed/Terminated|2
108983|NCT00984659|404390|P4|2-week Run-in Period|Protocol Violation|0
108984|NCT00984659|404391|P3|2-week Run-in Period|Protocol Violation|0
108985|NCT00984659|404392|P2|2-week Run-in Period|Protocol Violation|0
108986|NCT00984659|404393|P1|2-week Run-in Period|Protocol Violation|5
108987|NCT00984659|404390|P4|2-week Run-in Period|Adverse Event|0
108988|NCT00984659|404391|P3|2-week Run-in Period|Adverse Event|0
108989|NCT00984659|404392|P2|2-week Run-in Period|Adverse Event|0
108990|NCT00984659|404393|P1|2-week Run-in Period|Adverse Event|8
108991|NCT00984620|404420|P2|Overall Study|reason other than listed above|4
108992|NCT00984620|404421|P1|Overall Study|reason other than listed above|0
108993|NCT00984620|404420|P2|Overall Study|Withdrawal by Subject|2
108994|NCT00984620|404421|P1|Overall Study|Withdrawal by Subject|0
108995|NCT00984620|404420|P2|Overall Study|Lost to Follow-up|1
108996|NCT00984620|404421|P1|Overall Study|Lost to Follow-up|1
108997|NCT00984620|404420|P2|Overall Study|Adverse Event|5
108998|NCT00984620|404421|P1|Overall Study|Adverse Event|5
108999|NCT00984594|404459|P2|Overall Study|Withdrawal by Subject|1
109000|NCT00984594|404460|P1|Overall Study|Withdrawal by Subject|0
109001|NCT00984594|404459|P2|Overall Study|Lost to Follow-up|0
109002|NCT00984594|404460|P1|Overall Study|Lost to Follow-up|1
109003|NCT00984568|404476|P2|Overall Study|Unknown Reason|3
109004|NCT00984568|404477|P1|Overall Study|Unknown Reason|1
109005|NCT00984568|404476|P2|Overall Study|Opportunistic Infection|0
109006|NCT00984568|404477|P1|Overall Study|Opportunistic Infection|1
109007|NCT00984568|404476|P2|Overall Study|Lost to Follow-up|1
109008|NCT00984568|404477|P1|Overall Study|Lost to Follow-up|0
109009|NCT00984568|404476|P2|Overall Study|Did Not Meet Randomization Criteria|0
109010|NCT00984568|404477|P1|Overall Study|Did Not Meet Randomization Criteria|1
109011|NCT00984568|404476|P2|Overall Study|Adverse Event|0
109012|NCT00984568|404477|P1|Overall Study|Adverse Event|2
109013|NCT00984568|404476|P2|Overall Study|Lack of Efficacy|0
109014|NCT00984568|404477|P1|Overall Study|Lack of Efficacy|2
109015|NCT00984568|404476|P2|Overall Study|Withdrawal by Subject|2
109016|NCT00984568|404477|P1|Overall Study|Withdrawal by Subject|1
109017|NCT00984542|404485|P1|Overall Study|clinical deterioration|2
109018|NCT00984542|404485|P1|Overall Study|Withdrawal by Subject|3
109019|NCT00984542|404485|P1|Overall Study|complicating disease|3
109020|NCT00984542|404485|P1|Overall Study|Death|7
109021|NCT00984542|404485|P1|Overall Study|toxicity|7
109022|NCT00984542|404485|P1|Overall Study|disease progression|19
109023|NCT00984295|404535|P3|Overall Study|Incomplete safety follow-up|3
109024|NCT00984295|404536|P2|Overall Study|Incomplete safety follow-up|2
109025|NCT00984295|404537|P1|Overall Study|Incomplete safety follow-up|11
109026|NCT00984295|404535|P3|Overall Study|Missed one or more blood samplings|2
109027|NCT00984295|404536|P2|Overall Study|Missed one or more blood samplings|7
109028|NCT00984295|404537|P1|Overall Study|Missed one or more blood samplings|3
109029|NCT00984295|404535|P3|Overall Study|CAE – discontinued test vaccine|3
109030|NCT00984295|404536|P2|Overall Study|CAE – discontinued test vaccine|1
109031|NCT00984295|404537|P1|Overall Study|CAE – discontinued test vaccine|0
109032|NCT00984295|404535|P3|Overall Study|Withdrawal by Subject|12
109033|NCT00984295|404536|P2|Overall Study|Withdrawal by Subject|9
109034|NCT00984295|404537|P1|Overall Study|Withdrawal by Subject|18
109035|NCT00984295|404535|P3|Overall Study|Protocol Violation|4
109036|NCT00984295|404536|P2|Overall Study|Protocol Violation|1
109037|NCT00984295|404537|P1|Overall Study|Protocol Violation|2
109038|NCT00984295|404535|P3|Overall Study|Lost to Follow-up|13
109039|NCT00984295|404536|P2|Overall Study|Lost to Follow-up|12
109040|NCT00984295|404537|P1|Overall Study|Lost to Follow-up|31
109041|NCT00984282|404604|P2|Long Term Follow-up|Ongoing with treatment|26
109042|NCT00984282|404605|P1|Long Term Follow-up|Ongoing with treatment|33
109043|NCT00984282|404604|P2|Long Term Follow-up|Lost to Follow-up|4
109044|NCT00984282|404605|P1|Long Term Follow-up|Lost to Follow-up|8
109045|NCT00984282|404604|P2|Long Term Follow-up|Death|72
109046|NCT00984282|404605|P1|Long Term Follow-up|Death|55
109047|NCT00984282|404604|P2|Long Term Follow-up|Withdrawal by Subject|15
109048|NCT00984282|404605|P1|Long Term Follow-up|Withdrawal by Subject|18
109049|NCT00984282|404604|P2|Open-label Treatment|Target lesion removed|1
109050|NCT00984282|404605|P1|Open-label Treatment|Target lesion removed|0
109051|NCT00984282|404604|P2|Open-label Treatment|Non-compliant with study medication|0
109052|NCT00984282|404605|P1|Open-label Treatment|Non-compliant with study medication|1
109053|NCT00984282|404604|P2|Open-label Treatment|Ongoing with treatment|18
109054|NCT00984282|404605|P1|Open-label Treatment|Ongoing with treatment|19
109055|NCT00984282|404604|P2|Open-label Treatment|Lost to Follow-up|0
109056|NCT00984282|404605|P1|Open-label Treatment|Lost to Follow-up|1
109057|NCT00984282|404604|P2|Open-label Treatment|Progression, recurrence or relapse|77
109058|NCT00984282|404605|P1|Open-label Treatment|Progression, recurrence or relapse|37
109059|NCT00984282|404604|P2|Open-label Treatment|Death|15
109060|NCT00984282|404605|P1|Open-label Treatment|Death|5
109061|NCT00984282|404604|P2|Open-label Treatment|Withdrawal by Subject|21
109062|NCT00984282|404605|P1|Open-label Treatment|Withdrawal by Subject|6
109063|NCT00984282|404604|P2|Open-label Treatment|Adverse Event|29
109064|NCT00984282|404605|P1|Open-label Treatment|Adverse Event|17
109065|NCT00984282|404604|P2|Double Blind Treatment|Switched to follow-up|4
109066|NCT00984282|404605|P1|Double Blind Treatment|Switched to follow-up|12
109067|NCT00984282|404604|P2|Double Blind Treatment|Not treated|1
109068|NCT00984282|404605|P1|Double Blind Treatment|Not treated|0
109069|NCT00984282|404604|P2|Double Blind Treatment|Death|4
109070|NCT00984282|404605|P1|Double Blind Treatment|Death|8
109071|NCT00984282|404604|P2|Double Blind Treatment|Lost to Follow-up|0
109072|NCT00984282|404605|P1|Double Blind Treatment|Lost to Follow-up|3
109073|NCT00984282|404604|P2|Double Blind Treatment|Withdrawal by Subject|18
109074|NCT00984282|404605|P1|Double Blind Treatment|Withdrawal by Subject|14
109075|NCT00984282|404604|P2|Double Blind Treatment|Progression by clinical judgment|0
109076|NCT00984282|404605|P1|Double Blind Treatment|Progression by clinical judgment|1
109077|NCT00984282|404604|P2|Double Blind Treatment|Noncompliance with study medication|0
109078|NCT00984282|404605|P1|Double Blind Treatment|Noncompliance with study medication|3
109079|NCT00984282|404604|P2|Double Blind Treatment|Physician Decision|2
109080|NCT00984282|404605|P1|Double Blind Treatment|Physician Decision|1
109081|NCT00984282|404604|P2|Double Blind Treatment|Progression, recurrence or relapse|3
109082|NCT00984282|404605|P1|Double Blind Treatment|Progression, recurrence or relapse|24
109083|NCT00984282|404604|P2|Double Blind Treatment|Adverse Event|6
109084|NCT00984282|404605|P1|Double Blind Treatment|Adverse Event|38
109085|NCT00984256|404628|P2|Overall Study|Withdrawal by Subject|1
109086|NCT00984256|404629|P1|Overall Study|Withdrawal by Subject|0
109087|NCT00984204|404649|P1|Overall Study|Lack of Efficacy|10
109088|NCT00984204|404649|P1|Overall Study|Lost to Follow-up|4
109089|NCT00984204|404649|P1|Overall Study|Death|1
109090|NCT00984165|404659|P4|Overall Study|removed with a pair recipient|1
109091|NCT00984165|404660|P3|Overall Study|removed with a pair recipient|0
109092|NCT00984165|404661|P2|Overall Study|removed with a pair recipient|0
109093|NCT00984165|404662|P1|Overall Study|removed with a pair recipient|0
109094|NCT00984165|404659|P4|Overall Study|P+/donor pair removed from protocol|1
109095|NCT00984165|404660|P3|Overall Study|P+/donor pair removed from protocol|0
109096|NCT00984165|404661|P2|Overall Study|P+/donor pair removed from protocol|0
109097|NCT00984165|404662|P1|Overall Study|P+/donor pair removed from protocol|0
109098|NCT00984165|404659|P4|Overall Study|New protocol|1
109099|NCT00984165|404660|P3|Overall Study|New protocol|0
109100|NCT00984165|404661|P2|Overall Study|New protocol|0
109101|NCT00984165|404662|P1|Overall Study|New protocol|0
109102|NCT00984165|404659|P4|Overall Study|Death of recipient|1
109103|NCT00984165|404660|P3|Overall Study|Death of recipient|0
109104|NCT00984165|404661|P2|Overall Study|Death of recipient|0
109105|NCT00984165|404662|P1|Overall Study|Death of recipient|0
109106|NCT00984165|404659|P4|Overall Study|Disease progression on study|0
109107|NCT00984165|404660|P3|Overall Study|Disease progression on study|0
109108|NCT00984165|404661|P2|Overall Study|Disease progression on study|1
109109|NCT00984165|404662|P1|Overall Study|Disease progression on study|5
109110|NCT00984165|404659|P4|Overall Study|Death on study|0
109111|NCT00984165|404660|P3|Overall Study|Death on study|0
109112|NCT00984165|404661|P2|Overall Study|Death on study|0
109113|NCT00984165|404662|P1|Overall Study|Death on study|2
109114|NCT00984126|404691|P4|Overall Study|Withdrawal criteria|9
109115|NCT00984126|404692|P3|Overall Study|Withdrawal criteria|3
109116|NCT00984126|404693|P2|Overall Study|Withdrawal criteria|1
109117|NCT00984126|404694|P1|Overall Study|Withdrawal criteria|0
109118|NCT00984126|404691|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
109119|NCT00984126|404692|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
109120|NCT00984126|404693|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
109121|NCT00984126|404694|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
109122|NCT00984126|404691|P4|Overall Study|Adverse Event|2
109123|NCT00984126|404692|P3|Overall Study|Adverse Event|0
109124|NCT00984126|404693|P2|Overall Study|Adverse Event|0
109125|NCT00984126|404694|P1|Overall Study|Adverse Event|0
109126|NCT00984126|404691|P4|Overall Study|Protocol Violation|2
109127|NCT00984126|404692|P3|Overall Study|Protocol Violation|1
109128|NCT00984126|404693|P2|Overall Study|Protocol Violation|0
109129|NCT00984126|404694|P1|Overall Study|Protocol Violation|0
109130|NCT00984061|404719|P1|Clarithromycin Alone|Protocol Violation|1
109131|NCT00984022|404732|P2|Overall Study|Lost to Follow-up|14
109132|NCT00984022|404733|P1|Overall Study|Lost to Follow-up|10
109133|NCT00984009|404743|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
109134|NCT00983957|404776|P1|Overall Study|Personal Reasons|1
109135|NCT00983957|404776|P1|Overall Study|Adverse Event|1
109136|NCT00983931|404810|P1|14 Day Washout Period|Physician Decision|1
109137|NCT00983918|404824|P4|Overall Study|conversion to open cholecystectomy|2
109138|NCT00983918|404825|P3|Overall Study|conversion to open cholecystectomy|2
109139|NCT00983918|404826|P2|Overall Study|conversion to open cholecystectomy|2
109140|NCT00983918|404827|P1|Overall Study|conversion to open cholecystectomy|0
109141|NCT00983905|404837|P1|Colchicine Alone|Adverse Event|2
109142|NCT00983905|404837|P1|Theophylline Alone|Adverse Event|1
109143|NCT00983892|404850|P2|Overall Study|Withdrawal by Subject|12
109144|NCT00983892|404851|P1|Overall Study|Withdrawal by Subject|10
109145|NCT00983853|404863|P6|Overall Study|Unable to come to study follow-up visits|0
109146|NCT00983853|404864|P5|Overall Study|Unable to come to study follow-up visits|0
109147|NCT00983853|404865|P4|Overall Study|Unable to come to study follow-up visits|0
109148|NCT00983853|404866|P3|Overall Study|Unable to come to study follow-up visits|0
109149|NCT00983853|404867|P2|Overall Study|Unable to come to study follow-up visits|1
109150|NCT00983853|404868|P1|Overall Study|Unable to come to study follow-up visits|0
109151|NCT00983853|404863|P6|Overall Study|Withdrawal by Subject|0
109152|NCT00983853|404864|P5|Overall Study|Withdrawal by Subject|1
109153|NCT00983853|404865|P4|Overall Study|Withdrawal by Subject|0
109154|NCT00983853|404866|P3|Overall Study|Withdrawal by Subject|1
109155|NCT00983853|404867|P2|Overall Study|Withdrawal by Subject|0
109156|NCT00983853|404868|P1|Overall Study|Withdrawal by Subject|0
109157|NCT00983853|404863|P6|Overall Study|Lost to Follow-up|1
109158|NCT00983853|404864|P5|Overall Study|Lost to Follow-up|2
109159|NCT00983853|404865|P4|Overall Study|Lost to Follow-up|2
109160|NCT00983853|404866|P3|Overall Study|Lost to Follow-up|2
109161|NCT00983853|404867|P2|Overall Study|Lost to Follow-up|1
109162|NCT00983853|404868|P1|Overall Study|Lost to Follow-up|1
109163|NCT00983827|404896|P1|Overall Study|Withdrawal by Subject|1
109164|NCT00983749|404914|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
109165|NCT00983749|404915|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
109166|NCT00983580|404940|P2|Overall Study|Ineligible|0
109167|NCT00983580|404941|P1|Overall Study|Ineligible|3
109168|NCT00983580|404940|P2|Overall Study|Protocol Violation|1
109169|NCT00983580|404941|P1|Overall Study|Protocol Violation|1
109170|NCT00983580|404940|P2|Overall Study|Cancel Prior to treatment|3
109171|NCT00983580|404941|P1|Overall Study|Cancel Prior to treatment|1
109172|NCT00983515|404967|P1|Colchicine With Ritonavir|Lost to Follow-up|1
109173|NCT00983515|404967|P1|Ritonavir Alone|liver panel out of range|6
109174|NCT00983476|404994|P3|Overall Study|Did not receive intervention|0
109175|NCT00983476|404995|P2|Overall Study|Did not receive intervention|22
109176|NCT00983476|404996|P1|Overall Study|Did not receive intervention|17
109177|NCT00983437|405028|P1|Overall Study|Other Reason|26
109178|NCT00983437|405028|P1|Overall Study|Lost to Follow-up|2
109179|NCT00983437|405028|P1|Overall Study|Noncompliance to Study Procedures|1
109180|NCT00983437|405028|P1|Overall Study|Withdrawal by Subject|8
109181|NCT00983437|405028|P1|Overall Study|Lack of Efficacy|1
109182|NCT00983437|405028|P1|Overall Study|Adverse Event|9
109183|NCT00983385|405047|P1|Observation Period|Not Evaluable due to Non Compliance|12
109184|NCT00983385|405047|P1|Observation Period|Not eligible to be dosed|20
109185|NCT00983372|405092|P1|Diltiazem ER Alone|Adverse Event|1
109186|NCT00983372|405092|P1|Diltiazem ER Alone|missed diltiazem dose|2
109187|NCT00983372|405092|P1|14 Day Washout Period|Withdrawal by Subject|1
109188|NCT00983294|405119|P1|Colchicine With Azithromycin|Adverse Event|1
109189|NCT00983294|405119|P1|14 Day Washout Period|Withdrawal by Subject|2
109190|NCT00983073|405161|P1|Maintenance Period|Other Reason|7
109191|NCT00983073|405161|P1|Maintenance Period|Lack of Efficacy|2
109192|NCT00983073|405161|P1|Maintenance Period|Withdrawal by Subject|2
109193|NCT00983073|405161|P1|Maintenance Period|Adverse Event|5
109194|NCT00983073|405161|P1|Titration and Optimal Dose Period|Other reason|4
109195|NCT00983073|405161|P1|Titration and Optimal Dose Period|Non-Compliance|1
109196|NCT00983073|405161|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
109197|NCT00983073|405161|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
109198|NCT00983073|405161|P1|Titration and Optimal Dose Period|Adverse Event|19
109199|NCT00982735|405187|P1|Overall Study|Patient ineligible for trial|224
109200|NCT00982735|405187|P1|Overall Study|Lost to Follow-up|6
109201|NCT00982657|405197|P4|Overall Study|On going at date of cut-off|1
109202|NCT00982657|405198|P3|Overall Study|On going at date of cut-off|0
109203|NCT00982657|405199|P2|Overall Study|On going at date of cut-off|0
109204|NCT00982657|405200|P1|Overall Study|On going at date of cut-off|0
109205|NCT00982657|405197|P4|Overall Study|Other|4
109206|NCT00982657|405198|P3|Overall Study|Other|0
109207|NCT00982657|405199|P2|Overall Study|Other|0
109208|NCT00982657|405200|P1|Overall Study|Other|0
109209|NCT00982657|405197|P4|Overall Study|Withdrawal by Subject|3
109210|NCT00982657|405198|P3|Overall Study|Withdrawal by Subject|1
109211|NCT00982657|405199|P2|Overall Study|Withdrawal by Subject|0
109212|NCT00982657|405200|P1|Overall Study|Withdrawal by Subject|0
109213|NCT00982657|405197|P4|Overall Study|Death|1
109214|NCT00982657|405198|P3|Overall Study|Death|1
109215|NCT00982657|405199|P2|Overall Study|Death|0
109216|NCT00982657|405200|P1|Overall Study|Death|1
109217|NCT00982644|405241|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
109218|NCT00982644|405242|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
109219|NCT00982644|405241|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
109220|NCT00982644|405242|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
109221|NCT00982644|405241|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
109222|NCT00982644|405242|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
109223|NCT00982644|405241|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
109224|NCT00982644|405242|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
109225|NCT00982644|405241|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
109226|NCT00982644|405242|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
109227|NCT00982644|405241|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
109228|NCT00982644|405242|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
109229|NCT00982644|405241|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
109230|NCT00982644|405242|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
109231|NCT00982644|405241|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
109232|NCT00982644|405242|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
109233|NCT00982644|405241|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
109234|NCT00982644|405242|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
109235|NCT00982644|405241|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
109236|NCT00982644|405242|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
109237|NCT00982488|405293|P5|Overall Study|Withdrawal by Subject|0
109238|NCT00982488|405294|P4|Overall Study|Withdrawal by Subject|0
109239|NCT00982488|405295|P3|Overall Study|Withdrawal by Subject|1
109240|NCT00982488|405296|P2|Overall Study|Withdrawal by Subject|1
109241|NCT00982488|405297|P1|Overall Study|Withdrawal by Subject|5
109242|NCT00982488|405293|P5|Overall Study|Study drug toxicity|0
109243|NCT00982488|405294|P4|Overall Study|Study drug toxicity|0
109244|NCT00982488|405295|P3|Overall Study|Study drug toxicity|6
109245|NCT00982488|405296|P2|Overall Study|Study drug toxicity|1
109246|NCT00982488|405297|P1|Overall Study|Study drug toxicity|34
109247|NCT00982488|405293|P5|Overall Study|Stem cell transplant|0
109248|NCT00982488|405294|P4|Overall Study|Stem cell transplant|1
109249|NCT00982488|405295|P3|Overall Study|Stem cell transplant|0
109250|NCT00982488|405296|P2|Overall Study|Stem cell transplant|0
109251|NCT00982488|405297|P1|Overall Study|Stem cell transplant|2
109252|NCT00982488|405293|P5|Overall Study|Poor compliance/noncompliance|0
109253|NCT00982488|405294|P4|Overall Study|Poor compliance/noncompliance|0
109254|NCT00982488|405295|P3|Overall Study|Poor compliance/noncompliance|0
109255|NCT00982488|405296|P2|Overall Study|Poor compliance/noncompliance|1
109256|NCT00982488|405297|P1|Overall Study|Poor compliance/noncompliance|0
109257|NCT00982488|405293|P5|Overall Study|Not specified|0
109258|NCT00982488|405294|P4|Overall Study|Not specified|1
109259|NCT00982488|405295|P3|Overall Study|Not specified|3
109260|NCT00982488|405296|P2|Overall Study|Not specified|1
109261|NCT00982488|405297|P1|Overall Study|Not specified|15
109262|NCT00982488|405293|P5|Overall Study|Maximum clinical benefit|0
109263|NCT00982488|405294|P4|Overall Study|Maximum clinical benefit|0
109264|NCT00982488|405295|P3|Overall Study|Maximum clinical benefit|1
109265|NCT00982488|405296|P2|Overall Study|Maximum clinical benefit|1
109266|NCT00982488|405297|P1|Overall Study|Maximum clinical benefit|1
109267|NCT00982488|405293|P5|Overall Study|Lost to Follow-up|0
109268|NCT00982488|405294|P4|Overall Study|Lost to Follow-up|0
109269|NCT00982488|405295|P3|Overall Study|Lost to Follow-up|0
109270|NCT00982488|405296|P2|Overall Study|Lost to Follow-up|0
109271|NCT00982488|405297|P1|Overall Study|Lost to Follow-up|1
109272|NCT00982488|405293|P5|Overall Study|Disease progression|1
109273|NCT00982488|405294|P4|Overall Study|Disease progression|1
109274|NCT00982488|405295|P3|Overall Study|Disease progression|10
109275|NCT00982488|405296|P2|Overall Study|Disease progression|5
109276|NCT00982488|405297|P1|Overall Study|Disease progression|30
109277|NCT00982488|405293|P5|Overall Study|Death|0
109278|NCT00982488|405294|P4|Overall Study|Death|0
109279|NCT00982488|405295|P3|Overall Study|Death|2
109280|NCT00982488|405296|P2|Overall Study|Death|0
109281|NCT00982488|405297|P1|Overall Study|Death|11
109282|NCT00982488|405293|P5|Overall Study|Adverse event unrelated to study drug|0
109283|NCT00982488|405294|P4|Overall Study|Adverse event unrelated to study drug|0
109284|NCT00982488|405295|P3|Overall Study|Adverse event unrelated to study drug|0
109285|NCT00982488|405296|P2|Overall Study|Adverse event unrelated to study drug|1
109286|NCT00982488|405297|P1|Overall Study|Adverse event unrelated to study drug|5
109287|NCT00982488|405293|P5|Overall Study|Administrative reason by sponsor|0
109288|NCT00982488|405294|P4|Overall Study|Administrative reason by sponsor|0
109289|NCT00982488|405295|P3|Overall Study|Administrative reason by sponsor|11
109290|NCT00982488|405296|P2|Overall Study|Administrative reason by sponsor|3
109291|NCT00982488|405297|P1|Overall Study|Administrative reason by sponsor|81
109292|NCT00982410|405330|P2|12-month Follow-up Assessment|scheduled, no-show|0
109293|NCT00982410|405331|P1|12-month Follow-up Assessment|scheduled, no-show|1
109294|NCT00982410|405330|P2|12-month Follow-up Assessment|incarceration|1
109295|NCT00982410|405331|P1|12-month Follow-up Assessment|incarceration|2
109296|NCT00982410|405330|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
109297|NCT00982410|405331|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
109298|NCT00982410|405330|P2|12-month Follow-up Assessment|could not reach to schedule|5
109299|NCT00982410|405331|P1|12-month Follow-up Assessment|could not reach to schedule|6
109300|NCT00982410|405330|P2|12-month Follow-up Assessment|Death|2
109301|NCT00982410|405331|P1|12-month Follow-up Assessment|Death|0
109302|NCT00982410|405330|P2|6-month Follow-up Assessment|scheduled, no-show|1
109303|NCT00982410|405331|P1|6-month Follow-up Assessment|scheduled, no-show|0
109304|NCT00982410|405330|P2|6-month Follow-up Assessment|patent surgery|1
109305|NCT00982410|405331|P1|6-month Follow-up Assessment|patent surgery|0
109306|NCT00982410|405330|P2|6-month Follow-up Assessment|incarceration|2
109307|NCT00982410|405331|P1|6-month Follow-up Assessment|incarceration|0
109308|NCT00982410|405330|P2|6-month Follow-up Assessment|participant no transportation|0
109309|NCT00982410|405331|P1|6-month Follow-up Assessment|participant no transportation|1
109310|NCT00982410|405330|P2|6-month Follow-up Assessment|Could not reach to schedule|7
109311|NCT00982410|405331|P1|6-month Follow-up Assessment|Could not reach to schedule|5
109312|NCT00982410|405330|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
109313|NCT00982410|405331|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
109314|NCT00982410|405330|P2|3-month Follow-up Assessment|Scheduled, no-show|2
109315|NCT00982410|405331|P1|3-month Follow-up Assessment|Scheduled, no-show|1
109316|NCT00982410|405330|P2|3-month Follow-up Assessment|Could not reach to schedule|9
109317|NCT00982410|405331|P1|3-month Follow-up Assessment|Could not reach to schedule|8
109318|NCT00982280|405370|P1|Maintenance Period|Adverse Event|1
109319|NCT00982280|405370|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
109320|NCT00982280|405370|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
109321|NCT00982280|405370|P1|Titration and Optimal Dose Period|Adverse Event|5
109322|NCT00982280|405370|P1|Observation Period|Not eligible to be dosed|19
109323|NCT00982228|405395|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
109324|NCT00982228|405396|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
109325|NCT00982228|405395|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
109326|NCT00982228|405396|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
109327|NCT00982228|405395|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
109328|NCT00982228|405396|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
109329|NCT00982228|405395|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
109330|NCT00982228|405396|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
109331|NCT00982228|405395|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
109332|NCT00982228|405396|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
109333|NCT00982228|405395|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
109334|NCT00982228|405396|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
109335|NCT00982228|405395|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
109336|NCT00982228|405396|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
109337|NCT00982228|405395|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
109338|NCT00982228|405396|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
109339|NCT00982228|405395|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
109340|NCT00982228|405396|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
109341|NCT00982228|405395|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
109342|NCT00982228|405396|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
109343|NCT00982137|405455|P4|Overall Study|Withdrawal by Subject|0
109344|NCT00982137|405456|P3|Overall Study|Withdrawal by Subject|0
109345|NCT00982137|405457|P2|Overall Study|Withdrawal by Subject|1
109346|NCT00982137|405458|P1|Overall Study|Withdrawal by Subject|0
109347|NCT00982137|405455|P4|Overall Study|Lost to Follow-up|1
109348|NCT00982137|405456|P3|Overall Study|Lost to Follow-up|0
109349|NCT00982137|405457|P2|Overall Study|Lost to Follow-up|0
109350|NCT00982137|405458|P1|Overall Study|Lost to Follow-up|0
109351|NCT00982111|405490|P2|Overall Study|Withdrawal by Subject|17
109352|NCT00982111|405491|P1|Overall Study|Withdrawal by Subject|16
109353|NCT00982111|405490|P2|Overall Study|On Study Treatment at Conclusion|0
109354|NCT00982111|405491|P1|Overall Study|On Study Treatment at Conclusion|7
109355|NCT00982111|405490|P2|Overall Study|New Anti-Cancer Therapy|5
109356|NCT00982111|405491|P1|Overall Study|New Anti-Cancer Therapy|5
109357|NCT00982111|405490|P2|Overall Study|Lost to Follow-up|6
109358|NCT00982111|405491|P1|Overall Study|Lost to Follow-up|9
109359|NCT00982111|405490|P2|Overall Study|Progressive Disease|37
109360|NCT00982111|405491|P1|Overall Study|Progressive Disease|37
109361|NCT00982111|405490|P2|Overall Study|Adverse Event|1
109362|NCT00982111|405491|P1|Overall Study|Adverse Event|1
109363|NCT00982020|405524|P2|Overall Study|Clinical Relapse|1
109364|NCT00982020|405525|P1|Overall Study|Clinical Relapse|0
109365|NCT00982020|405524|P2|Overall Study|Protocol Violation|2
109366|NCT00982020|405525|P1|Overall Study|Protocol Violation|0
109367|NCT00982020|405524|P2|Overall Study|Entry Criteria Not Met|1
109368|NCT00982020|405525|P1|Overall Study|Entry Criteria Not Met|2
109369|NCT00982020|405524|P2|Overall Study|Physician Decision|5
109370|NCT00982020|405525|P1|Overall Study|Physician Decision|2
109371|NCT00982020|405524|P2|Overall Study|Treatment Non-compliance|6
109372|NCT00982020|405525|P1|Overall Study|Treatment Non-compliance|3
109373|NCT00982020|405524|P2|Overall Study|Parent/Caregiver Decision|5
109374|NCT00982020|405525|P1|Overall Study|Parent/Caregiver Decision|5
109375|NCT00982020|405524|P2|Overall Study|Lack of Efficacy|4
109376|NCT00982020|405525|P1|Overall Study|Lack of Efficacy|10
109377|NCT00982020|405524|P2|Overall Study|Lost to Follow-up|11
109378|NCT00982020|405525|P1|Overall Study|Lost to Follow-up|5
109379|NCT00982020|405524|P2|Overall Study|Withdrawal by Subject|14
109380|NCT00982020|405525|P1|Overall Study|Withdrawal by Subject|11
109381|NCT00982020|405524|P2|Overall Study|Adverse Event|15
109382|NCT00982020|405525|P1|Overall Study|Adverse Event|19
109383|NCT00981461|405625|P2|Overall Study|Lost to Follow-up|2
109384|NCT00981461|405626|P1|Overall Study|Lost to Follow-up|5
109385|NCT00981409|405650|P2|Overall Study|Prostate Cancer Treatment before Trial|0
109386|NCT00981409|405651|P1|Overall Study|Prostate Cancer Treatment before Trial|2
109387|NCT00981409|405650|P2|Overall Study|Protocol Violation|1
109388|NCT00981409|405651|P1|Overall Study|Protocol Violation|0
109389|NCT00981409|405650|P2|Overall Study|Adverse Event|0
109390|NCT00981409|405651|P1|Overall Study|Adverse Event|4
109391|NCT00981292|405690|P6|Day 3|Protocol Violation|1
109392|NCT00981292|405691|P5|Day 3|Protocol Violation|0
109393|NCT00981292|405692|P4|Day 3|Protocol Violation|0
109394|NCT00981292|405693|P3|Day 3|Protocol Violation|0
109395|NCT00981292|405694|P2|Day 3|Protocol Violation|0
109396|NCT00981292|405695|P1|Day 3|Protocol Violation|0
109397|NCT00981292|405690|P6|Day 2|Protocol Violation|0
109398|NCT00981292|405691|P5|Day 2|Protocol Violation|0
109399|NCT00981292|405692|P4|Day 2|Protocol Violation|0
109400|NCT00981292|405693|P3|Day 2|Protocol Violation|0
109401|NCT00981292|405694|P2|Day 2|Protocol Violation|0
109402|NCT00981292|405695|P1|Day 2|Protocol Violation|2
109403|NCT00981292|405690|P6|Day 1|Protocol Violation|2
109404|NCT00981292|405691|P5|Day 1|Protocol Violation|0
109405|NCT00981292|405692|P4|Day 1|Protocol Violation|0
109406|NCT00981292|405693|P3|Day 1|Protocol Violation|0
109407|NCT00981292|405694|P2|Day 1|Protocol Violation|0
109408|NCT00981292|405695|P1|Day 1|Protocol Violation|1
109409|NCT00981175|405779|P2|Booster Dose Vaccination|Lost to Follow-up|3
109410|NCT00981175|405780|P1|Booster Dose Vaccination|Lost to Follow-up|2
109411|NCT00981175|405779|P2|Primary Dose Vaccination|Lost to Follow-up|1
109412|NCT00981175|405780|P1|Primary Dose Vaccination|Lost to Follow-up|2
109413|NCT00981175|405779|P2|Primary Dose Vaccination|Protocol Violation|1
109414|NCT00981175|405780|P1|Primary Dose Vaccination|Protocol Violation|0
109415|NCT00981175|405779|P2|Primary Dose Vaccination|Adverse Event|0
109416|NCT00981175|405780|P1|Primary Dose Vaccination|Adverse Event|1
109417|NCT00981149|405805|P2|Overall Study|Withdrawal by Subject|1
109418|NCT00981149|405806|P1|Overall Study|Withdrawal by Subject|1
109419|NCT00981149|405805|P2|Overall Study|Lost to Follow-up|2
109420|NCT00981149|405806|P1|Overall Study|Lost to Follow-up|1
109421|NCT00981084|405816|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
109422|NCT00981084|405817|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
109423|NCT00981084|405816|P2|Post Intervention (Data Analysis)|poor effort|1
109424|NCT00981084|405817|P1|Post Intervention (Data Analysis)|poor effort|1
109425|NCT00981058|405833|P2|Overall Study|On study treatment at conclusion|0
109426|NCT00981058|405834|P1|Overall Study|On study treatment at conclusion|9
109427|NCT00981058|405833|P2|Overall Study|Withdrawal by Subject|23
109428|NCT00981058|405834|P1|Overall Study|Withdrawal by Subject|25
109429|NCT00981058|405833|P2|Overall Study|Randomization Error|2
109430|NCT00981058|405834|P1|Overall Study|Randomization Error|1
109431|NCT00981058|405833|P2|Overall Study|Radiologist Error|1
109432|NCT00981058|405834|P1|Overall Study|Radiologist Error|0
109433|NCT00981058|405833|P2|Overall Study|Noncompliance|0
109434|NCT00981058|405834|P1|Overall Study|Noncompliance|1
109435|NCT00981058|405833|P2|Overall Study|New Anticancer Therapy|6
109436|NCT00981058|405834|P1|Overall Study|New Anticancer Therapy|6
109437|NCT00981058|405833|P2|Overall Study|Lost to Follow-up|15
109438|NCT00981058|405834|P1|Overall Study|Lost to Follow-up|16
109439|NCT00981058|405833|P2|Overall Study|Progressive Disease|49
109440|NCT00981058|405834|P1|Overall Study|Progressive Disease|61
109441|NCT00981058|405833|P2|Overall Study|Adverse Event|1
109442|NCT00981058|405834|P1|Overall Study|Adverse Event|1
109443|NCT00981019|405865|P1|Overall Study|Hit the survey after closure|79
109444|NCT00981019|405865|P1|Overall Study|Inadvertent exclusion|239
109445|NCT00981019|405865|P1|Overall Study|Did not match target population|94
109446|NCT00981019|405865|P1|Overall Study|Did not respond|65
109447|NCT00980980|405872|P3|Overall Study|Withdrawal by Hospital|0
109448|NCT00980980|405873|P2|Overall Study|Withdrawal by Hospital|1
109449|NCT00980980|405874|P1|Overall Study|Withdrawal by Hospital|0
109450|NCT00980798|405905|P2|Overall Study|Other|1
109451|NCT00980798|405906|P1|Overall Study|Other|0
109452|NCT00980798|405905|P2|Overall Study|Withdrawal by Subject|11
109453|NCT00980798|405906|P1|Overall Study|Withdrawal by Subject|8
109454|NCT00980798|405905|P2|Overall Study|Physician Decision|1
109455|NCT00980798|405906|P1|Overall Study|Physician Decision|2
109456|NCT00980798|405905|P2|Overall Study|Lost to Follow-up|1
109457|NCT00980798|405906|P1|Overall Study|Lost to Follow-up|0
109458|NCT00980798|405905|P2|Overall Study|Lack of Efficacy|5
109459|NCT00980798|405906|P1|Overall Study|Lack of Efficacy|16
109460|NCT00980798|405905|P2|Overall Study|Adverse Event|36
109461|NCT00980798|405906|P1|Overall Study|Adverse Event|7
109462|NCT00980655|405947|P2|Overall Study|Other|1
109463|NCT00980655|405948|P1|Overall Study|Other|0
109464|NCT00980655|405947|P2|Overall Study|Parent/legal guardian request|0
109465|NCT00980655|405948|P1|Overall Study|Parent/legal guardian request|1
109466|NCT00980655|405947|P2|Overall Study|Lost to Follow-up|1
109467|NCT00980655|405948|P1|Overall Study|Lost to Follow-up|0
109468|NCT00980655|405947|P2|Overall Study|Withdrawal by Subject|4
109469|NCT00980655|405948|P1|Overall Study|Withdrawal by Subject|0
109470|NCT00980655|405947|P2|Overall Study|Protocol Violation|7
109471|NCT00980655|405948|P1|Overall Study|Protocol Violation|2
109472|NCT00980655|405947|P2|Overall Study|Death|7
109473|NCT00980655|405948|P1|Overall Study|Death|0
109474|NCT00980655|405947|P2|Overall Study|Adverse Event|31
109475|NCT00980655|405948|P1|Overall Study|Adverse Event|13
109476|NCT00980343|406024|P2|Overall Study|no tumor at surgery - treatment effect|3
109477|NCT00980343|406025|P1|Overall Study|no tumor at surgery - treatment effect|1
109478|NCT00980330|406049|P7|Overall Study|(not specified)|0
109479|NCT00980330|406050|P6|Overall Study|(not specified)|1
109480|NCT00980330|406051|P5|Overall Study|(not specified)|1
109481|NCT00980330|406052|P4|Overall Study|(not specified)|1
109482|NCT00980330|406053|P3|Overall Study|(not specified)|0
109483|NCT00980330|406054|P2|Overall Study|(not specified)|0
109484|NCT00980330|406055|P1|Overall Study|(not specified)|2
109485|NCT00980330|406049|P7|Overall Study|Withdrawal by Subject|5
109486|NCT00980330|406050|P6|Overall Study|Withdrawal by Subject|2
109487|NCT00980330|406051|P5|Overall Study|Withdrawal by Subject|3
109488|NCT00980330|406052|P4|Overall Study|Withdrawal by Subject|1
109489|NCT00980330|406053|P3|Overall Study|Withdrawal by Subject|4
109490|NCT00980330|406054|P2|Overall Study|Withdrawal by Subject|4
109491|NCT00980330|406055|P1|Overall Study|Withdrawal by Subject|2
109492|NCT00980330|406049|P7|Overall Study|Lost to Follow-up|2
109493|NCT00980330|406050|P6|Overall Study|Lost to Follow-up|1
109494|NCT00980330|406051|P5|Overall Study|Lost to Follow-up|1
109495|NCT00980330|406052|P4|Overall Study|Lost to Follow-up|2
109496|NCT00980330|406053|P3|Overall Study|Lost to Follow-up|4
109497|NCT00980330|406054|P2|Overall Study|Lost to Follow-up|1
109498|NCT00980330|406055|P1|Overall Study|Lost to Follow-up|1
109499|NCT00980330|406049|P7|Overall Study|Adverse Event|0
109500|NCT00980330|406050|P6|Overall Study|Adverse Event|0
109501|NCT00980330|406051|P5|Overall Study|Adverse Event|0
109502|NCT00980330|406052|P4|Overall Study|Adverse Event|1
109503|NCT00980330|406053|P3|Overall Study|Adverse Event|0
109504|NCT00980330|406054|P2|Overall Study|Adverse Event|0
109505|NCT00980330|406055|P1|Overall Study|Adverse Event|0
109506|NCT00980200|406170|P5|7-day Treatment Period 3|Lack of Efficacy|1
109507|NCT00980200|406171|P4|7-day Treatment Period 3|Lack of Efficacy|0
109508|NCT00980200|406172|P3|7-day Treatment Period 3|Lack of Efficacy|0
109509|NCT00980200|406173|P2|7-day Treatment Period 3|Lack of Efficacy|1
109510|NCT00980200|406174|P1|7-day Treatment Period 3|Lack of Efficacy|0
109511|NCT00980200|406170|P5|7-day Treatment Period 1|Withdrawal by Subject|0
109512|NCT00980200|406171|P4|7-day Treatment Period 1|Withdrawal by Subject|0
109513|NCT00980200|406172|P3|7-day Treatment Period 1|Withdrawal by Subject|0
109514|NCT00980200|406173|P2|7-day Treatment Period 1|Withdrawal by Subject|1
109515|NCT00980200|406174|P1|7-day Treatment Period 1|Withdrawal by Subject|0
109516|NCT00980174|406193|P2|Overall Study|Other|1
109517|NCT00980174|406194|P1|Overall Study|Other|0
109518|NCT00980174|406193|P2|Overall Study|Death|1
109519|NCT00980174|406194|P1|Overall Study|Death|1
109520|NCT00980174|406193|P2|Overall Study|Ineligibility determined|1
109521|NCT00980174|406194|P1|Overall Study|Ineligibility determined|2
109522|NCT00980174|406193|P2|Overall Study|Adverse Event|3
109523|NCT00980174|406194|P1|Overall Study|Adverse Event|0
109524|NCT00980174|406193|P2|Overall Study|Withdrawal by Subject|4
109525|NCT00980174|406194|P1|Overall Study|Withdrawal by Subject|1
109526|NCT00980148|406212|P2|Overall Study|Various other reasons|9
109527|NCT00980148|406213|P1|Overall Study|Various other reasons|8
109528|NCT00980148|406212|P2|Overall Study|Negative for chlamydia at enrollment|9
109529|NCT00980148|406213|P1|Overall Study|Negative for chlamydia at enrollment|12
109530|NCT00980148|406212|P2|Overall Study|Received other antichlamydia treatment|14
109531|NCT00980148|406213|P1|Overall Study|Received other antichlamydia treatment|20
109532|NCT00980148|406212|P2|Overall Study|Discharged from facility|96
109533|NCT00980148|406213|P1|Overall Study|Discharged from facility|89
109534|NCT00980044|406222|P3|Overall Study|Protocol Violation|2
109535|NCT00980044|406223|P2|Overall Study|Protocol Violation|0
109536|NCT00980044|406224|P1|Overall Study|Protocol Violation|0
109537|NCT00980044|406222|P3|Overall Study|Withdrawal by Subject|3
109538|NCT00980044|406223|P2|Overall Study|Withdrawal by Subject|7
109539|NCT00980044|406224|P1|Overall Study|Withdrawal by Subject|5
109540|NCT00980005|406243|P2|Overall Study|Other|3
109541|NCT00980005|406244|P1|Overall Study|Other|4
109542|NCT00980005|406243|P2|Overall Study|Lost to Follow-up|43
109543|NCT00980005|406244|P1|Overall Study|Lost to Follow-up|37
109544|NCT00980005|406243|P2|Overall Study|Withdrawal by Subject|17
109545|NCT00980005|406244|P1|Overall Study|Withdrawal by Subject|6
109546|NCT00979992|406284|P1|Overall Study|Refused – Never Treated|2
109547|NCT00979992|406284|P1|Overall Study|Ineligible - wrong cell type|2
109548|NCT00979992|406284|P1|Overall Study|Ineligible - inadequate pathology|1
109549|NCT00979953|406296|P4|Overall Study|Protocol Violation|2
109550|NCT00979953|406297|P3|Overall Study|Protocol Violation|2
109551|NCT00979953|406298|P2|Overall Study|Protocol Violation|0
109552|NCT00979953|406299|P1|Overall Study|Protocol Violation|1
109553|NCT00979953|406296|P4|Overall Study|Withdrawal by Subject|1
109554|NCT00979953|406297|P3|Overall Study|Withdrawal by Subject|2
109555|NCT00979953|406298|P2|Overall Study|Withdrawal by Subject|0
109556|NCT00979953|406299|P1|Overall Study|Withdrawal by Subject|0
109557|NCT00979953|406296|P4|Overall Study|Lost to Follow-up|0
109558|NCT00979953|406297|P3|Overall Study|Lost to Follow-up|1
109559|NCT00979953|406298|P2|Overall Study|Lost to Follow-up|1
109560|NCT00979953|406299|P1|Overall Study|Lost to Follow-up|1
109561|NCT00979953|406296|P4|Overall Study|Lack of Efficacy|0
109562|NCT00979953|406297|P3|Overall Study|Lack of Efficacy|0
109563|NCT00979953|406298|P2|Overall Study|Lack of Efficacy|2
109564|NCT00979953|406299|P1|Overall Study|Lack of Efficacy|1
109565|NCT00979953|406296|P4|Overall Study|Adverse Event|4
109566|NCT00979953|406297|P3|Overall Study|Adverse Event|17
109567|NCT00979953|406298|P2|Overall Study|Adverse Event|2
109568|NCT00979953|406299|P1|Overall Study|Adverse Event|5
109569|NCT00979901|406322|P4|Overall Study|Treatment Group Terminated by Sponsor|112
109570|NCT00979901|406323|P3|Overall Study|Treatment Group Terminated by Sponsor|0
109571|NCT00979901|406324|P2|Overall Study|Treatment Group Terminated by Sponsor|0
109572|NCT00979901|406325|P1|Overall Study|Treatment Group Terminated by Sponsor|0
109573|NCT00979901|406322|P4|Overall Study|Left Country|0
109574|NCT00979901|406323|P3|Overall Study|Left Country|1
109575|NCT00979901|406324|P2|Overall Study|Left Country|0
109576|NCT00979901|406325|P1|Overall Study|Left Country|0
109577|NCT00979901|406322|P4|Overall Study|Discontinued in Error|0
109578|NCT00979901|406323|P3|Overall Study|Discontinued in Error|0
109579|NCT00979901|406324|P2|Overall Study|Discontinued in Error|1
109580|NCT00979901|406325|P1|Overall Study|Discontinued in Error|0
109581|NCT00979901|406322|P4|Overall Study|elevated lab values pre-randomization|0
109582|NCT00979901|406323|P3|Overall Study|elevated lab values pre-randomization|0
109583|NCT00979901|406324|P2|Overall Study|elevated lab values pre-randomization|0
109584|NCT00979901|406325|P1|Overall Study|elevated lab values pre-randomization|1
109585|NCT00979901|406322|P4|Overall Study|vacation|0
109586|NCT00979901|406323|P3|Overall Study|vacation|0
109587|NCT00979901|406324|P2|Overall Study|vacation|0
109588|NCT00979901|406325|P1|Overall Study|vacation|1
109589|NCT00979901|406322|P4|Overall Study|out-of-state|0
109590|NCT00979901|406323|P3|Overall Study|out-of-state|0
109591|NCT00979901|406324|P2|Overall Study|out-of-state|0
109592|NCT00979901|406325|P1|Overall Study|out-of-state|1
109593|NCT00979901|406322|P4|Overall Study|Noncompliance|0
109594|NCT00979901|406323|P3|Overall Study|Noncompliance|0
109595|NCT00979901|406324|P2|Overall Study|Noncompliance|0
109596|NCT00979901|406325|P1|Overall Study|Noncompliance|1
109597|NCT00979901|406322|P4|Overall Study|Withdrawal by Subject|1
109598|NCT00979901|406323|P3|Overall Study|Withdrawal by Subject|1
109599|NCT00979901|406324|P2|Overall Study|Withdrawal by Subject|1
109600|NCT00979901|406325|P1|Overall Study|Withdrawal by Subject|2
109601|NCT00979901|406322|P4|Overall Study|Protocol Violation|1
109602|NCT00979901|406323|P3|Overall Study|Protocol Violation|7
109603|NCT00979901|406324|P2|Overall Study|Protocol Violation|2
109604|NCT00979901|406325|P1|Overall Study|Protocol Violation|2
109605|NCT00979901|406322|P4|Overall Study|Lost to Follow-up|0
109606|NCT00979901|406323|P3|Overall Study|Lost to Follow-up|2
109607|NCT00979901|406324|P2|Overall Study|Lost to Follow-up|1
109608|NCT00979901|406325|P1|Overall Study|Lost to Follow-up|1
109609|NCT00979901|406322|P4|Overall Study|Lack of Efficacy|0
109610|NCT00979901|406323|P3|Overall Study|Lack of Efficacy|9
109611|NCT00979901|406324|P2|Overall Study|Lack of Efficacy|4
109612|NCT00979901|406325|P1|Overall Study|Lack of Efficacy|8
109613|NCT00979901|406322|P4|Overall Study|Adverse Event|2
109614|NCT00979901|406323|P3|Overall Study|Adverse Event|9
109615|NCT00979901|406324|P2|Overall Study|Adverse Event|3
109616|NCT00979901|406325|P1|Overall Study|Adverse Event|1
109617|NCT00979654|406398|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
109618|NCT00979654|406398|P1|Overall Study|Serious Adverse Event|1
109619|NCT00979654|406398|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
109620|NCT00979654|406398|P1|Overall Study|Per Principal Investigator’s Discretion|1
109621|NCT00979654|406398|P1|Overall Study|Adverse Event of Diverticulitis|1
109622|NCT00979654|406398|P1|Overall Study|Adverse Event|1
109623|NCT00979654|406398|P1|Overall Study|Lack of Efficacy|6
109624|NCT00979654|406398|P1|Overall Study|Death|1
109625|NCT00979654|406398|P1|Overall Study|Withdrawal by Subject|22
109626|NCT00979654|406398|P1|Overall Study|Lost to Follow-up|1
109627|NCT00979628|406413|P3|Overall Study|transferred to ICU|1
109628|NCT00979628|406414|P2|Overall Study|transferred to ICU|2
109629|NCT00979628|406415|P1|Overall Study|transferred to ICU|1
109630|NCT00979628|406413|P3|Overall Study|received steroids|0
109631|NCT00979628|406414|P2|Overall Study|received steroids|1
109632|NCT00979628|406415|P1|Overall Study|received steroids|1
109633|NCT00979628|406413|P3|Overall Study|received regimen < 24 hours|5
109634|NCT00979628|406414|P2|Overall Study|received regimen < 24 hours|6
109635|NCT00979628|406415|P1|Overall Study|received regimen < 24 hours|7
109636|NCT00979602|406442|P2|Overall Study|Others|3
109637|NCT00979602|406443|P1|Overall Study|Others|3
109638|NCT00979602|406442|P2|Overall Study|Migrated/moved from study area|6
109639|NCT00979602|406443|P1|Overall Study|Migrated/moved from study area|3
109640|NCT00979602|406442|P2|Overall Study|Lost to Follow-up|96
109641|NCT00979602|406443|P1|Overall Study|Lost to Follow-up|100
109642|NCT00979602|406442|P2|Overall Study|Withdrawal by Subject|25
109643|NCT00979602|406443|P1|Overall Study|Withdrawal by Subject|31
109644|NCT00979602|406442|P2|Overall Study|Protocol Violation|0
109645|NCT00979602|406443|P1|Overall Study|Protocol Violation|3
109646|NCT00979602|406442|P2|Overall Study|Serious Adverse Event|3
109647|NCT00979602|406443|P1|Overall Study|Serious Adverse Event|5
109648|NCT00979576|406614|P3|Combination Followed by Monotherapy|Progressive Disease|1
109649|NCT00979576|406615|P2|Combination Followed by Monotherapy|Progressive Disease|2
109650|NCT00979576|406616|P1|Combination Followed by Monotherapy|Progressive Disease|0
109651|NCT00979576|406614|P3|Combination Treatment Phase|Adverse Event|2
109652|NCT00979576|406615|P2|Combination Treatment Phase|Adverse Event|2
109653|NCT00979576|406616|P1|Combination Treatment Phase|Adverse Event|0
109654|NCT00979576|406614|P3|Combination Treatment Phase|Dose limiting toxicity|2
109655|NCT00979576|406615|P2|Combination Treatment Phase|Dose limiting toxicity|3
109656|NCT00979576|406616|P1|Combination Treatment Phase|Dose limiting toxicity|0
109657|NCT00979576|406614|P3|Combination Treatment Phase|Progressive disease|5
109658|NCT00979576|406615|P2|Combination Treatment Phase|Progressive disease|1
109659|NCT00979576|406616|P1|Combination Treatment Phase|Progressive disease|3
109660|NCT00979420|406673|P4|Overall Study|Other reasons not related to Viramune|1
109661|NCT00979420|406674|P3|Overall Study|Other reasons not related to Viramune|0
109662|NCT00979420|406675|P2|Overall Study|Other reasons not related to Viramune|0
109663|NCT00979420|406676|P1|Overall Study|Other reasons not related to Viramune|3
109664|NCT00979420|406673|P4|Overall Study|Lack of Efficacy|1
109665|NCT00979420|406674|P3|Overall Study|Lack of Efficacy|1
109666|NCT00979420|406675|P2|Overall Study|Lack of Efficacy|0
109667|NCT00979420|406676|P1|Overall Study|Lack of Efficacy|3
109668|NCT00979420|406673|P4|Overall Study|Adverse Event|0
109669|NCT00979420|406674|P3|Overall Study|Adverse Event|0
109670|NCT00979420|406675|P2|Overall Study|Adverse Event|0
109671|NCT00979420|406676|P1|Overall Study|Adverse Event|1
109672|NCT00979212|406757|P2|Overall Study|No protocol therapy received|0
109673|NCT00979212|406758|P1|Overall Study|No protocol therapy received|1
109674|NCT00979212|406757|P2|Overall Study|Protocol Violation|8
109675|NCT00979212|406758|P1|Overall Study|Protocol Violation|1
109676|NCT00978757|406818|P2|Overall Study|Physician Decision|3
109677|NCT00978757|406819|P1|Overall Study|Physician Decision|1
109678|NCT00978731|406829|P4|Overall Study|No response|0
109679|NCT00978731|406830|P3|Overall Study|No response|0
109680|NCT00978731|406831|P2|Overall Study|No response|0
109681|NCT00978731|406832|P1|Overall Study|No response|1
109682|NCT00978731|406829|P4|Overall Study|Study closure|1
109683|NCT00978731|406830|P3|Overall Study|Study closure|1
109684|NCT00978731|406831|P2|Overall Study|Study closure|4
109685|NCT00978731|406832|P1|Overall Study|Study closure|3
109686|NCT00978731|406829|P4|Overall Study|Disease progression/relapse|2
109687|NCT00978731|406830|P3|Overall Study|Disease progression/relapse|2
109688|NCT00978731|406831|P2|Overall Study|Disease progression/relapse|4
109689|NCT00978731|406832|P1|Overall Study|Disease progression/relapse|5
109690|NCT00978731|406829|P4|Overall Study|Deterioration without progression|0
109691|NCT00978731|406830|P3|Overall Study|Deterioration without progression|0
109692|NCT00978731|406831|P2|Overall Study|Deterioration without progression|1
109693|NCT00978731|406832|P1|Overall Study|Deterioration without progression|0
109694|NCT00978731|406829|P4|Overall Study|Administrative reason|0
109695|NCT00978731|406830|P3|Overall Study|Administrative reason|1
109696|NCT00978731|406831|P2|Overall Study|Administrative reason|3
109697|NCT00978731|406832|P1|Overall Study|Administrative reason|3
109698|NCT00978731|406829|P4|Overall Study|Participant's request|0
109699|NCT00978731|406830|P3|Overall Study|Participant's request|0
109700|NCT00978731|406831|P2|Overall Study|Participant's request|0
109701|NCT00978731|406832|P1|Overall Study|Participant's request|1
109702|NCT00978731|406829|P4|Overall Study|Adverse Event|0
109703|NCT00978731|406830|P3|Overall Study|Adverse Event|0
109704|NCT00978731|406831|P2|Overall Study|Adverse Event|2
109705|NCT00978731|406832|P1|Overall Study|Adverse Event|5
109706|NCT00978731|406829|P4|Overall Study|Lost to Follow-up|1
109707|NCT00978731|406830|P3|Overall Study|Lost to Follow-up|0
109708|NCT00978731|406831|P2|Overall Study|Lost to Follow-up|0
109709|NCT00978731|406832|P1|Overall Study|Lost to Follow-up|0
109710|NCT00978731|406829|P4|Overall Study|Death|0
109711|NCT00978731|406830|P3|Overall Study|Death|1
109712|NCT00978731|406831|P2|Overall Study|Death|1
109713|NCT00978731|406832|P1|Overall Study|Death|4
109714|NCT00978627|406872|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
109715|NCT00978627|406873|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
109716|NCT00978627|406872|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
109717|NCT00978627|406873|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
109718|NCT00978627|406872|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
109719|NCT00978627|406873|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
109720|NCT00978627|406872|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
109721|NCT00978627|406873|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
109722|NCT00978627|406872|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
109723|NCT00978627|406873|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
109724|NCT00978627|406872|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
109725|NCT00978627|406873|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
109726|NCT00978627|406872|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
109727|NCT00978627|406873|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
109728|NCT00978627|406872|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
109729|NCT00978627|406873|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
109730|NCT00978627|406872|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
109731|NCT00978627|406873|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
109732|NCT00978432|406911|P3|Overall Study|Adverse Event|1
109733|NCT00978432|406912|P2|Overall Study|Adverse Event|0
109734|NCT00978432|406913|P1|Overall Study|Adverse Event|2
109735|NCT00978432|406911|P3|Overall Study|Lack of Efficacy|3
109736|NCT00978432|406912|P2|Overall Study|Lack of Efficacy|1
109737|NCT00978432|406913|P1|Overall Study|Lack of Efficacy|1
109738|NCT00978432|406911|P3|Overall Study|Withdrawal by Subject|1
109739|NCT00978432|406912|P2|Overall Study|Withdrawal by Subject|0
109740|NCT00978432|406913|P1|Overall Study|Withdrawal by Subject|0
109741|NCT00978380|406933|P1|Overall Study|Unclassified|8
109742|NCT00978380|406933|P1|Overall Study|Withdrawal criteria|9
109743|NCT00978380|406933|P1|Overall Study|Protocol Violation|2
109744|NCT00978341|406939|P2|Washout Period of 2 Weeks|Adverse Event|0
109745|NCT00978341|406940|P1|Washout Period of 2 Weeks|Adverse Event|1
109746|NCT00978120|406962|P4|Overall Study|Moved out of state|1
109747|NCT00978120|406963|P3|Overall Study|Moved out of state|0
109748|NCT00978120|406964|P2|Overall Study|Moved out of state|0
109749|NCT00978120|406965|P1|Overall Study|Moved out of state|0
109750|NCT00978120|406962|P4|Overall Study|Withdrawal by Subject|0
109751|NCT00978120|406963|P3|Overall Study|Withdrawal by Subject|0
109752|NCT00978120|406964|P2|Overall Study|Withdrawal by Subject|0
109753|NCT00978120|406965|P1|Overall Study|Withdrawal by Subject|2
109754|NCT00978120|406962|P4|Overall Study|Lost to Follow-up|0
109755|NCT00978120|406963|P3|Overall Study|Lost to Follow-up|3
109756|NCT00978120|406964|P2|Overall Study|Lost to Follow-up|0
109757|NCT00978120|406965|P1|Overall Study|Lost to Follow-up|0
109758|NCT00978120|406962|P4|Overall Study|Death|1
109759|NCT00978120|406963|P3|Overall Study|Death|0
109760|NCT00978120|406964|P2|Overall Study|Death|0
109761|NCT00978120|406965|P1|Overall Study|Death|0
109762|NCT00978042|407017|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
109763|NCT00978042|407018|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
109764|NCT00978042|407017|P2|Initial Treatment Period|Consent withdrawn|9
109765|NCT00978042|407018|P1|Initial Treatment Period|Consent withdrawn|22
109766|NCT00978042|407017|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
109767|NCT00978042|407018|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
109768|NCT00978042|407017|P2|Initial Treatment Period|Adverse Event|0
109769|NCT00978042|407018|P1|Initial Treatment Period|Adverse Event|2
109770|NCT00978042|407017|P2|Initial Treatment Period|Lost to Follow-up|3
109771|NCT00978042|407018|P1|Initial Treatment Period|Lost to Follow-up|21
109772|NCT00978042|407017|P2|Initial Treatment Period|Ineligibility|0
109773|NCT00978042|407018|P1|Initial Treatment Period|Ineligibility|1
109774|NCT00978042|407017|P2|Initial Treatment Period|Treated in Error|3
109775|NCT00978042|407018|P1|Initial Treatment Period|Treated in Error|0
109776|NCT00978029|407031|P3|Overall Study|Protocol Violation|0
109777|NCT00978029|407032|P2|Overall Study|Protocol Violation|1
109778|NCT00978029|407033|P1|Overall Study|Protocol Violation|0
109779|NCT00978029|407031|P3|Overall Study|Withdrawal by Subject|1
109780|NCT00978029|407032|P2|Overall Study|Withdrawal by Subject|0
109781|NCT00978029|407033|P1|Overall Study|Withdrawal by Subject|0
109782|NCT00978029|407031|P3|Overall Study|Adverse Event|5
109783|NCT00978029|407032|P2|Overall Study|Adverse Event|2
109784|NCT00978029|407033|P1|Overall Study|Adverse Event|1
109785|NCT00977938|407060|P4|Observation (30-33 mo. Post Procedure)|Other|0
109786|NCT00977938|407061|P3|Observation (30-33 mo. Post Procedure)|Other|0
109787|NCT00977938|407062|P2|Observation (30-33 mo. Post Procedure)|Other|4
109788|NCT00977938|407063|P1|Observation (30-33 mo. Post Procedure)|Other|8
109789|NCT00977938|407060|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
109790|NCT00977938|407061|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
109791|NCT00977938|407062|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
109792|NCT00977938|407063|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
109793|NCT00977938|407060|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
109794|NCT00977938|407061|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
109795|NCT00977938|407062|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
109796|NCT00977938|407063|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
109797|NCT00977938|407060|P4|Treatment (12-30 mo. Post Procedure)|Other|4
109798|NCT00977938|407061|P3|Treatment (12-30 mo. Post Procedure)|Other|3
109799|NCT00977938|407062|P2|Treatment (12-30 mo. Post Procedure)|Other|18
109800|NCT00977938|407063|P1|Treatment (12-30 mo. Post Procedure)|Other|17
109801|NCT00977938|407060|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
109802|NCT00977938|407061|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
109803|NCT00977938|407062|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
109804|NCT00977938|407063|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
109805|NCT00977938|407060|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
109806|NCT00977938|407061|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
109807|NCT00977938|407062|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
109808|NCT00977938|407063|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
109809|NCT00977665|407127|P2|Overall Study|Treatment failure|1
109810|NCT00977665|407128|P1|Overall Study|Treatment failure|0
109811|NCT00977665|407127|P2|Overall Study|Adverse Event|7
109812|NCT00977665|407128|P1|Overall Study|Adverse Event|14
109813|NCT00977665|407127|P2|Overall Study|Death|2
109814|NCT00977665|407128|P1|Overall Study|Death|3
109815|NCT00977665|407127|P2|Overall Study|Lost to Follow-up|0
109816|NCT00977665|407128|P1|Overall Study|Lost to Follow-up|1
109817|NCT00977665|407127|P2|Overall Study|Sponsor requested withdrawal|1
109818|NCT00977665|407128|P1|Overall Study|Sponsor requested withdrawal|0
109819|NCT00977665|407127|P2|Overall Study|Physician Decision|1
109820|NCT00977665|407128|P1|Overall Study|Physician Decision|2
109821|NCT00977665|407127|P2|Overall Study|Withdrawal by Subject|3
109822|NCT00977665|407128|P1|Overall Study|Withdrawal by Subject|1
109823|NCT00977613|407160|P1|Overall Study|Lost to Follow-up|16
109824|NCT00977574|407167|P3|Overall Study|Never Treated|4
109825|NCT00977574|407168|P2|Overall Study|Never Treated|2
109826|NCT00977574|407169|P1|Overall Study|Never Treated|4
109827|NCT00977561|407188|P2|Overall Study|Other|0
109828|NCT00977561|407189|P1|Overall Study|Other|2
109829|NCT00977561|407188|P2|Overall Study|Study terminated|2
109830|NCT00977561|407189|P1|Overall Study|Study terminated|0
109831|NCT00977561|407188|P2|Overall Study|Death|2
109832|NCT00977561|407189|P1|Overall Study|Death|3
109833|NCT00977548|407216|P1|Overall Study|Withdrawal by Subject|1
109834|NCT00977548|407216|P1|Overall Study|Adverse Event|8
109835|NCT00977548|407216|P1|Overall Study|Ineligible|4
109836|NCT00977470|407225|P2|Overall Study|Still on-study|0
109837|NCT00977470|407226|P1|Overall Study|Still on-study|2
109838|NCT00977470|407225|P2|Overall Study|prolonged recovery post-surgery|1
109839|NCT00977470|407226|P1|Overall Study|prolonged recovery post-surgery|0
109840|NCT00977470|407225|P2|Overall Study|clinical decline|1
109841|NCT00977470|407226|P1|Overall Study|clinical decline|0
109842|NCT00977470|407225|P2|Overall Study|Death|2
109843|NCT00977470|407226|P1|Overall Study|Death|0
109844|NCT00977470|407225|P2|Overall Study|Withdrawal by Subject|2
109845|NCT00977470|407226|P1|Overall Study|Withdrawal by Subject|0
109846|NCT00977470|407225|P2|Overall Study|Protocol Violation|0
109847|NCT00977470|407226|P1|Overall Study|Protocol Violation|1
109848|NCT00977470|407225|P2|Overall Study|Adverse Event|2
109849|NCT00977470|407226|P1|Overall Study|Adverse Event|1
109850|NCT00977470|407225|P2|Overall Study|Physician Decision|0
109851|NCT00977470|407226|P1|Overall Study|Physician Decision|2
109852|NCT00977470|407225|P2|Overall Study|Lack of Efficacy|30
109853|NCT00977470|407226|P1|Overall Study|Lack of Efficacy|32
109854|NCT00977379|407246|P2|Overall Study|Randomization Error|1
109855|NCT00977379|407247|P1|Overall Study|Randomization Error|0
109856|NCT00977379|407246|P2|Overall Study|Participant Moving House|1
109857|NCT00977379|407247|P1|Overall Study|Participant Moving House|0
109858|NCT00977379|407246|P2|Overall Study|Premature Study Termination|0
109859|NCT00977379|407247|P1|Overall Study|Premature Study Termination|4
109860|NCT00977379|407246|P2|Overall Study|Death|9
109861|NCT00977379|407247|P1|Overall Study|Death|7
109862|NCT00977379|407246|P2|Overall Study|Withdrawal by Subject|1
109863|NCT00977379|407247|P1|Overall Study|Withdrawal by Subject|1
109864|NCT00977314|407283|P2|Overall Study|Physician Decision|0
109865|NCT00977314|407284|P1|Overall Study|Physician Decision|1
109866|NCT00977314|407283|P2|Overall Study|Withdrawal by Subject|0
109867|NCT00977314|407284|P1|Overall Study|Withdrawal by Subject|1
109868|NCT00977197|407292|P2|Overall Study|Nonadherence|1
109869|NCT00977197|407293|P1|Overall Study|Nonadherence|1
109870|NCT00977197|407292|P2|Overall Study|Lost to Follow-up|3
109871|NCT00977197|407293|P1|Overall Study|Lost to Follow-up|1
109872|NCT00977197|407292|P2|Overall Study|Lack of Efficacy|0
109873|NCT00977197|407293|P1|Overall Study|Lack of Efficacy|1
109874|NCT00977197|407292|P2|Overall Study|Adverse Event|1
109875|NCT00977197|407293|P1|Overall Study|Adverse Event|3
109876|NCT00977197|407292|P2|Overall Study|Withdrawal by Subject|4
109877|NCT00977197|407293|P1|Overall Study|Withdrawal by Subject|3
109878|NCT00977106|407356|P2|Overall Study|Not specified|0
109879|NCT00977106|407357|P1|Overall Study|Not specified|1
109880|NCT00977106|407356|P2|Overall Study|Protocol Violation|1
109881|NCT00977106|407357|P1|Overall Study|Protocol Violation|0
109882|NCT00977106|407356|P2|Overall Study|Lack of Efficacy|2
109883|NCT00977106|407357|P1|Overall Study|Lack of Efficacy|2
109884|NCT00977106|407356|P2|Overall Study|Withdrawal by Subject|2
109885|NCT00977106|407357|P1|Overall Study|Withdrawal by Subject|2
109886|NCT00977106|407356|P2|Overall Study|Adverse Event|6
109887|NCT00977106|407357|P1|Overall Study|Adverse Event|5
109888|NCT00977080|407449|P4|Overall Study|Travel for family reasons|0
109889|NCT00977080|407450|P3|Overall Study|Travel for family reasons|0
109890|NCT00977080|407451|P2|Overall Study|Travel for family reasons|0
109891|NCT00977080|407452|P1|Overall Study|Travel for family reasons|1
109892|NCT00977080|407449|P4|Overall Study|Required kidney transplantation|1
109893|NCT00977080|407450|P3|Overall Study|Required kidney transplantation|3
109894|NCT00977080|407451|P2|Overall Study|Required kidney transplantation|3
109895|NCT00977080|407452|P1|Overall Study|Required kidney transplantation|1
109896|NCT00977080|407449|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
109897|NCT00977080|407450|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
109898|NCT00977080|407451|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
109899|NCT00977080|407452|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
109900|NCT00977080|407449|P4|Overall Study|Noncompliance|0
109901|NCT00977080|407450|P3|Overall Study|Noncompliance|1
109902|NCT00977080|407451|P2|Overall Study|Noncompliance|2
109903|NCT00977080|407452|P1|Overall Study|Noncompliance|0
109904|NCT00977080|407449|P4|Overall Study|Protocol Violation|3
109905|NCT00977080|407450|P3|Overall Study|Protocol Violation|4
109906|NCT00977080|407451|P2|Overall Study|Protocol Violation|3
109907|NCT00977080|407452|P1|Overall Study|Protocol Violation|7
109908|NCT00977080|407449|P4|Overall Study|Withdrawal by Subject|5
109909|NCT00977080|407450|P3|Overall Study|Withdrawal by Subject|1
109910|NCT00977080|407451|P2|Overall Study|Withdrawal by Subject|5
109911|NCT00977080|407452|P1|Overall Study|Withdrawal by Subject|1
109912|NCT00977080|407449|P4|Overall Study|Adverse Event|7
109913|NCT00977080|407450|P3|Overall Study|Adverse Event|7
109914|NCT00977080|407451|P2|Overall Study|Adverse Event|7
109915|NCT00977080|407452|P1|Overall Study|Adverse Event|2
109916|NCT00976989|407485|P3|Overall Study|Other|1
109917|NCT00976989|407486|P2|Overall Study|Other|0
109918|NCT00976989|407487|P1|Overall Study|Other|1
109919|NCT00976989|407485|P3|Overall Study|Recurrence of Disease|0
109920|NCT00976989|407486|P2|Overall Study|Recurrence of Disease|1
109921|NCT00976989|407487|P1|Overall Study|Recurrence of Disease|0
109922|NCT00976989|407485|P3|Overall Study|Failure to Return|0
109923|NCT00976989|407486|P2|Overall Study|Failure to Return|1
109924|NCT00976989|407487|P1|Overall Study|Failure to Return|2
109925|NCT00976989|407485|P3|Overall Study|Refused Treatment|5
109926|NCT00976989|407486|P2|Overall Study|Refused Treatment|3
109927|NCT00976989|407487|P1|Overall Study|Refused Treatment|4
109928|NCT00976989|407485|P3|Overall Study|Death|10
109929|NCT00976989|407486|P2|Overall Study|Death|7
109930|NCT00976989|407487|P1|Overall Study|Death|5
109931|NCT00976989|407485|P3|Overall Study|Violation of Selection Criteria at Entry|1
109932|NCT00976989|407486|P2|Overall Study|Violation of Selection Criteria at Entry|0
109933|NCT00976989|407487|P1|Overall Study|Violation of Selection Criteria at Entry|1
109934|NCT00976950|407528|P1|Overall Study|Events with no relationship to Aptivus|3
109935|NCT00976950|407528|P1|Overall Study|Adverse Event|3
109936|NCT00976937|407536|P2|Overall Study|Personal and Familial Reason|2
109937|NCT00976937|407537|P1|Overall Study|Personal and Familial Reason|2
109938|NCT00976937|407536|P2|Overall Study|Poor compliance to protocol|0
109939|NCT00976937|407537|P1|Overall Study|Poor compliance to protocol|3
109940|NCT00976937|407536|P2|Overall Study|Withdrawal by Subject|3
109941|NCT00976937|407537|P1|Overall Study|Withdrawal by Subject|5
109942|NCT00976937|407536|P2|Overall Study|Lost to Follow-up|1
109943|NCT00976937|407537|P1|Overall Study|Lost to Follow-up|2
109944|NCT00976937|407536|P2|Overall Study|Adverse Event|5
109945|NCT00976937|407537|P1|Overall Study|Adverse Event|4
109946|NCT00976911|407579|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
109947|NCT00976911|407580|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
109948|NCT00976911|407579|P2|Overall Study|Not Specified|9
109949|NCT00976911|407580|P1|Overall Study|Not Specified|8
109950|NCT00976911|407579|P2|Overall Study|Protocol Violation|0
109951|NCT00976911|407580|P1|Overall Study|Protocol Violation|2
109952|NCT00976911|407579|P2|Overall Study|Adverse Event|1
109953|NCT00976911|407580|P1|Overall Study|Adverse Event|0
109954|NCT00976911|407579|P2|Overall Study|Death|126
109955|NCT00976911|407580|P1|Overall Study|Death|138
109956|NCT00976911|407579|P2|Overall Study|Withdrawal by Subject|6
109957|NCT00976911|407580|P1|Overall Study|Withdrawal by Subject|4
109958|NCT00976898|407598|P1|Overall Study|Progressive Disease|1
109959|NCT00976898|407598|P1|Overall Study|Liver Transplant|1
109960|NCT00976898|407598|P1|Overall Study|Physician Decision|1
109961|NCT00976898|407598|P1|Overall Study|Adverse Event|1
109962|NCT00976898|407598|P1|Overall Study|Protocol Violation|1
109963|NCT00976820|407609|P4|Overall Study|Withdrawal by Subject|4
109964|NCT00976820|407610|P3|Overall Study|Withdrawal by Subject|1
109965|NCT00976820|407611|P2|Overall Study|Withdrawal by Subject|4
109966|NCT00976820|407612|P1|Overall Study|Withdrawal by Subject|2
109967|NCT00976820|407609|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
109968|NCT00976820|407610|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
109969|NCT00976820|407611|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
110145|NCT00975507|408589|P2|Overall Study|Protocol Violation|0
109970|NCT00976820|407612|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
109971|NCT00976820|407609|P4|Overall Study|Lost to Follow-up|3
109972|NCT00976820|407610|P3|Overall Study|Lost to Follow-up|2
109973|NCT00976820|407611|P2|Overall Study|Lost to Follow-up|16
109974|NCT00976820|407612|P1|Overall Study|Lost to Follow-up|5
109975|NCT00976716|407948|P1|Overall Study|Adverse Event|1
109976|NCT00976703|407966|P2|Overall Study|ineligible for study|2
109977|NCT00976703|407967|P1|Overall Study|ineligible for study|2
109978|NCT00976703|407966|P2|Overall Study|Physician Decision|1
109979|NCT00976703|407967|P1|Overall Study|Physician Decision|1
109980|NCT00976677|407981|P2|Overall Study|Unknown/Missing|0
109981|NCT00976677|407982|P1|Overall Study|Unknown/Missing|1
109982|NCT00976677|407981|P2|Overall Study|Trial unblinded|2
109983|NCT00976677|407982|P1|Overall Study|Trial unblinded|2
109984|NCT00976677|407981|P2|Overall Study|Disease progression|1
109985|NCT00976677|407982|P1|Overall Study|Disease progression|1
109986|NCT00976677|407981|P2|Overall Study|Withdrawal by Subject|2
109987|NCT00976677|407982|P1|Overall Study|Withdrawal by Subject|0
109988|NCT00976677|407981|P2|Overall Study|Adverse Event|0
109989|NCT00976677|407982|P1|Overall Study|Adverse Event|1
109990|NCT00976573|408190|P2|Overall Study|Cancel prior to receiving treatment|2
109991|NCT00976573|408191|P1|Overall Study|Cancel prior to receiving treatment|4
109992|NCT00976573|408190|P2|Overall Study|Ineligible|1
109993|NCT00976573|408191|P1|Overall Study|Ineligible|0
109994|NCT00976560|408205|P2|Overall Study|Withdrawal by Subject|3
109995|NCT00976560|408206|P1|Overall Study|Withdrawal by Subject|2
109996|NCT00976560|408205|P2|Overall Study|Physician Decision|0
109997|NCT00976560|408206|P1|Overall Study|Physician Decision|2
109998|NCT00976560|408205|P2|Overall Study|Lost to Follow-up|0
109999|NCT00976560|408206|P1|Overall Study|Lost to Follow-up|1
110000|NCT00976560|408205|P2|Overall Study|Protocol Violation|0
110001|NCT00976560|408206|P1|Overall Study|Protocol Violation|1
110002|NCT00976560|408205|P2|Overall Study|Lack of Efficacy|5
110003|NCT00976560|408206|P1|Overall Study|Lack of Efficacy|3
110004|NCT00976560|408205|P2|Overall Study|Adverse Event|5
110005|NCT00976560|408206|P1|Overall Study|Adverse Event|5
110006|NCT00976508|408275|P2|Overall Study|Terminated by the Sponsor|1
110007|NCT00976508|408276|P1|Overall Study|Terminated by the Sponsor|0
110008|NCT00976508|408275|P2|Overall Study|Subject Enrolled in Hospice|0
110009|NCT00976508|408276|P1|Overall Study|Subject Enrolled in Hospice|1
110010|NCT00976508|408275|P2|Overall Study|Disease Progression|4
110011|NCT00976508|408276|P1|Overall Study|Disease Progression|4
110012|NCT00976508|408275|P2|Overall Study|Withdrawal by Subject|0
110013|NCT00976508|408276|P1|Overall Study|Withdrawal by Subject|1
110014|NCT00976508|408275|P2|Overall Study|Lost to Follow-up|0
110015|NCT00976508|408276|P1|Overall Study|Lost to Follow-up|1
110016|NCT00976508|408275|P2|Overall Study|Death|1
110017|NCT00976508|408276|P1|Overall Study|Death|7
110018|NCT00976495|408309|P3|Overall Study|Withdrawal by Subject|0
110019|NCT00976495|408310|P2|Overall Study|Withdrawal by Subject|1
110020|NCT00976495|408311|P1|Overall Study|Withdrawal by Subject|0
110021|NCT00976482|408328|P1|Overall Study|Protocol Violation|5
110022|NCT00976482|408328|P1|Overall Study|Center terminated|1
110023|NCT00976482|408328|P1|Overall Study|Withdrawal by Subject|45
110024|NCT00976482|408328|P1|Overall Study|Death|208
110025|NCT00976456|408334|P2|Overall Study|screening failure, unknown|4
110026|NCT00976456|408335|P1|Overall Study|screening failure, unknown|11
110027|NCT00976456|408334|P2|Overall Study|Withdrawal by Subject|1
110028|NCT00976456|408335|P1|Overall Study|Withdrawal by Subject|3
110029|NCT00976456|408334|P2|Overall Study|Lack of Efficacy|2
110030|NCT00976456|408335|P1|Overall Study|Lack of Efficacy|5
110031|NCT00976456|408334|P2|Overall Study|Death|9
110032|NCT00976456|408335|P1|Overall Study|Death|7
110033|NCT00976456|408334|P2|Overall Study|Adverse Event|22
110034|NCT00976456|408335|P1|Overall Study|Adverse Event|17
110035|NCT00976391|408362|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
110036|NCT00976391|408363|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
110037|NCT00976391|408362|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
110038|NCT00976391|408363|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
110039|NCT00976391|408362|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
110040|NCT00976391|408363|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
110041|NCT00976391|408362|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
110042|NCT00976391|408363|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
110043|NCT00976391|408362|P2|Follow-up Period (8 Weeks)|Noncompliance|2
110044|NCT00976391|408363|P1|Follow-up Period (8 Weeks)|Noncompliance|2
110045|NCT00976391|408362|P2|Follow-up Period (8 Weeks)|Adverse Event|1
110046|NCT00976391|408363|P1|Follow-up Period (8 Weeks)|Adverse Event|3
110047|NCT00976391|408362|P2|Treatment Period (52 Weeks)|Pregnancy|0
110048|NCT00976391|408363|P1|Treatment Period (52 Weeks)|Pregnancy|1
110049|NCT00976391|408362|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
110050|NCT00976391|408363|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
110051|NCT00976391|408362|P2|Treatment Period (52 Weeks)|Physician Decision|1
110052|NCT00976391|408363|P1|Treatment Period (52 Weeks)|Physician Decision|1
110053|NCT00976391|408362|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
110054|NCT00976391|408363|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
110055|NCT00976391|408362|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
110056|NCT00976391|408363|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
110057|NCT00976391|408362|P2|Treatment Period (52 Weeks)|Noncompliance|4
110058|NCT00976391|408363|P1|Treatment Period (52 Weeks)|Noncompliance|4
110059|NCT00976391|408362|P2|Treatment Period (52 Weeks)|Protocol Violation|1
110060|NCT00976391|408363|P1|Treatment Period (52 Weeks)|Protocol Violation|1
110061|NCT00976391|408362|P2|Treatment Period (52 Weeks)|Adverse Event|2
110062|NCT00976391|408363|P1|Treatment Period (52 Weeks)|Adverse Event|16
110063|NCT00976274|408411|P2|Overall Study|Physician Decision|2
110064|NCT00976274|408412|P1|Overall Study|Physician Decision|1
110065|NCT00976274|408411|P2|Overall Study|Withdrawal by Subject|1
110066|NCT00976274|408412|P1|Overall Study|Withdrawal by Subject|1
110067|NCT00976274|408411|P2|Overall Study|Lost to Follow-up|5
110068|NCT00976274|408412|P1|Overall Study|Lost to Follow-up|5
110069|NCT00976209|408428|P2|Treatment Period 2|Lost to Follow-up|1
110070|NCT00976209|408429|P1|Treatment Period 2|Lost to Follow-up|0
110071|NCT00976209|408428|P2|Treatment Period 2|Withdrawal by Subject|1
110072|NCT00976209|408429|P1|Treatment Period 2|Withdrawal by Subject|0
110073|NCT00976209|408428|P2|Wash-out Period|Other|0
110074|NCT00976209|408429|P1|Wash-out Period|Other|1
110075|NCT00976209|408428|P2|Wash-out Period|Protocol Violation|0
110076|NCT00976209|408429|P1|Wash-out Period|Protocol Violation|1
110077|NCT00976209|408428|P2|Wash-out Period|Lost to Follow-up|0
110078|NCT00976209|408429|P1|Wash-out Period|Lost to Follow-up|1
110079|NCT00976209|408428|P2|Wash-out Period|Adverse Event|2
110080|NCT00976209|408429|P1|Wash-out Period|Adverse Event|1
110081|NCT00976209|408428|P2|Treatment Period 1|Other|1
110082|NCT00976209|408429|P1|Treatment Period 1|Other|0
110083|NCT00976209|408428|P2|Treatment Period 1|Lost to Follow-up|0
110084|NCT00976209|408429|P1|Treatment Period 1|Lost to Follow-up|2
110085|NCT00976209|408428|P2|Treatment Period 1|Protocol Violation|0
110086|NCT00976209|408429|P1|Treatment Period 1|Protocol Violation|1
110087|NCT00976027|408442|P2|Overall Study|Withdrawal by Subject|66
110088|NCT00976027|408443|P1|Overall Study|Withdrawal by Subject|107
110089|NCT00976027|408442|P2|Overall Study|Lost to Follow-up|103
110090|NCT00976027|408443|P1|Overall Study|Lost to Follow-up|208
110091|NCT00976027|408442|P2|Overall Study|Protocol Violation|27
110092|NCT00976027|408443|P1|Overall Study|Protocol Violation|60
110093|NCT00976027|408442|P2|Overall Study|Adverse Event|2
110094|NCT00976027|408443|P1|Overall Study|Adverse Event|0
110095|NCT00976027|408442|P2|Overall Study|Serious Adverse Event|17
110096|NCT00976027|408443|P1|Overall Study|Serious Adverse Event|36
110097|NCT00975975|408455|P1|Overall Study|Death|6
110098|NCT00975923|408463|P2|Overall Study|Withdrawal by Subject|1
110099|NCT00975923|408464|P1|Overall Study|Withdrawal by Subject|0
110100|NCT00975806|408475|P3|Overall Study|Physician decision and disease related|1
110101|NCT00975806|408476|P2|Overall Study|Physician decision and disease related|0
110102|NCT00975806|408477|P1|Overall Study|Physician decision and disease related|1
110103|NCT00975806|408475|P3|Overall Study|Death|0
110104|NCT00975806|408476|P2|Overall Study|Death|1
110105|NCT00975806|408477|P1|Overall Study|Death|0
110106|NCT00975806|408475|P3|Overall Study|Withdrawal by Subject|0
110107|NCT00975806|408476|P2|Overall Study|Withdrawal by Subject|0
110108|NCT00975806|408477|P1|Overall Study|Withdrawal by Subject|1
110109|NCT00975806|408475|P3|Overall Study|Disease Progression|1
110110|NCT00975806|408476|P2|Overall Study|Disease Progression|5
110111|NCT00975806|408477|P1|Overall Study|Disease Progression|1
110112|NCT00975806|408475|P3|Overall Study|Adverse Event|2
110113|NCT00975806|408476|P2|Overall Study|Adverse Event|1
110114|NCT00975806|408477|P1|Overall Study|Adverse Event|2
110115|NCT00975780|408501|P2|Follow Up|Discharged from Facility|12
110116|NCT00975780|408502|P1|Follow Up|Discharged from Facility|7
110117|NCT00975780|408501|P2|Follow Up|Facility Withdrawal|23
110118|NCT00975780|408502|P1|Follow Up|Facility Withdrawal|7
110119|NCT00975780|408501|P2|Follow Up|Death|122
110120|NCT00975780|408502|P1|Follow Up|Death|88
110121|NCT00975715|408512|P2|Maintenance Period|Adverse Event|1
110122|NCT00975715|408513|P1|Maintenance Period|Adverse Event|2
110123|NCT00975715|408512|P2|Titration Period|Protocol Violation|0
110124|NCT00975715|408513|P1|Titration Period|Protocol Violation|1
110125|NCT00975715|408512|P2|Titration Period|Adverse Event|0
110126|NCT00975715|408513|P1|Titration Period|Adverse Event|6
110127|NCT00975689|408529|P2|Overall Study|Physician Decision|0
110128|NCT00975689|408530|P1|Overall Study|Physician Decision|1
110129|NCT00975689|408529|P2|Overall Study|Withdrawal by Subject|0
110130|NCT00975689|408530|P1|Overall Study|Withdrawal by Subject|1
110131|NCT00975689|408529|P2|Overall Study|Adverse Event|3
110132|NCT00975689|408530|P1|Overall Study|Adverse Event|0
110133|NCT00975611|408562|P1|Overall Study|Physician Decision|1
110134|NCT00975611|408562|P1|Overall Study|Screen Fail|16
110135|NCT00975585|408568|P2|Overall Study|Lens issue|2
110136|NCT00975585|408569|P1|Overall Study|Lens issue|2
110137|NCT00975585|408568|P2|Overall Study|Withdrawal by Subject|1
110138|NCT00975585|408569|P1|Overall Study|Withdrawal by Subject|2
110139|NCT00975585|408568|P2|Overall Study|Lost to Follow-up|5
110140|NCT00975585|408569|P1|Overall Study|Lost to Follow-up|3
110141|NCT00975585|408568|P2|Overall Study|Adverse Event|4
110142|NCT00975585|408569|P1|Overall Study|Adverse Event|0
110143|NCT00975507|408589|P2|Overall Study|Withdrawal by Subject|3
110144|NCT00975507|408590|P1|Overall Study|Withdrawal by Subject|10
110146|NCT00975507|408590|P1|Overall Study|Protocol Violation|2
110147|NCT00975507|408589|P2|Overall Study|Lost to Follow-up|1
110148|NCT00975507|408590|P1|Overall Study|Lost to Follow-up|7
110149|NCT00975507|408589|P2|Overall Study|Adverse Event|0
110150|NCT00975507|408590|P1|Overall Study|Adverse Event|1
110151|NCT00975481|408610|P6|Fifth Intervention Period|Withdrawal by Subject|0
110152|NCT00975481|408611|P5|Fifth Intervention Period|Withdrawal by Subject|1
110153|NCT00975481|408612|P4|Fifth Intervention Period|Withdrawal by Subject|0
110154|NCT00975481|408613|P3|Fifth Intervention Period|Withdrawal by Subject|0
110155|NCT00975481|408614|P2|Fifth Intervention Period|Withdrawal by Subject|0
110156|NCT00975481|408615|P1|Fifth Intervention Period|Withdrawal by Subject|0
110157|NCT00975481|408610|P6|Fourth Intervention Period|Withdrawal by Subject|0
110158|NCT00975481|408611|P5|Fourth Intervention Period|Withdrawal by Subject|0
110159|NCT00975481|408612|P4|Fourth Intervention Period|Withdrawal by Subject|1
110160|NCT00975481|408613|P3|Fourth Intervention Period|Withdrawal by Subject|1
110161|NCT00975481|408614|P2|Fourth Intervention Period|Withdrawal by Subject|0
110162|NCT00975481|408615|P1|Fourth Intervention Period|Withdrawal by Subject|0
110163|NCT00975481|408610|P6|Second Intervention Period|Withdrawal by Subject|0
110164|NCT00975481|408611|P5|Second Intervention Period|Withdrawal by Subject|0
110165|NCT00975481|408612|P4|Second Intervention Period|Withdrawal by Subject|0
110166|NCT00975481|408613|P3|Second Intervention Period|Withdrawal by Subject|1
110167|NCT00975481|408614|P2|Second Intervention Period|Withdrawal by Subject|0
110168|NCT00975481|408615|P1|Second Intervention Period|Withdrawal by Subject|0
110169|NCT00975481|408610|P6|Second Intervention Period|Adverse Event|0
110170|NCT00975481|408611|P5|Second Intervention Period|Adverse Event|0
110171|NCT00975481|408612|P4|Second Intervention Period|Adverse Event|0
110172|NCT00975481|408613|P3|Second Intervention Period|Adverse Event|0
110173|NCT00975481|408614|P2|Second Intervention Period|Adverse Event|1
110174|NCT00975481|408615|P1|Second Intervention Period|Adverse Event|2
110175|NCT00975416|408715|P2|Overall Study|early discharge from tx|5
110176|NCT00975416|408716|P1|Overall Study|early discharge from tx|3
110177|NCT00975286|408725|P2|Overall Study|Sponsor Decision|2
110178|NCT00975286|408726|P1|Overall Study|Sponsor Decision|0
110179|NCT00975286|408725|P2|Overall Study|Poor Compliance to Protocol|2
110180|NCT00975286|408726|P1|Overall Study|Poor Compliance to Protocol|0
110181|NCT00975286|408725|P2|Overall Study|Familial and Personal Reasons|2
110182|NCT00975286|408726|P1|Overall Study|Familial and Personal Reasons|2
110183|NCT00975286|408725|P2|Overall Study|Withdrawal by Subject|2
110184|NCT00975286|408726|P1|Overall Study|Withdrawal by Subject|0
110185|NCT00975286|408725|P2|Overall Study|Protocol Violation|2
110186|NCT00975286|408726|P1|Overall Study|Protocol Violation|1
110187|NCT00975286|408725|P2|Overall Study|Adverse Event|19
110188|NCT00975286|408726|P1|Overall Study|Adverse Event|9
110189|NCT00975221|408758|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
110190|NCT00975221|408759|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
110191|NCT00975221|408758|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
110192|NCT00975221|408759|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
110193|NCT00975221|408758|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
110194|NCT00975221|408759|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
110195|NCT00975221|408758|P2|Titration Phase (Weeks 1-12)|Other|1
110196|NCT00975221|408759|P1|Titration Phase (Weeks 1-12)|Other|0
110197|NCT00975221|408758|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
110198|NCT00975221|408759|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
110199|NCT00975221|408758|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
110200|NCT00975221|408759|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
110201|NCT00975195|408775|P2|Overall Study|Not treated|2
110202|NCT00975195|408776|P1|Overall Study|Not treated|1
110203|NCT00975195|408775|P2|Overall Study|Other reason not defined above|33
110204|NCT00975195|408776|P1|Overall Study|Other reason not defined above|29
110205|NCT00975195|408775|P2|Overall Study|Withdrawal by Subject|61
110206|NCT00975195|408776|P1|Overall Study|Withdrawal by Subject|48
110207|NCT00975195|408775|P2|Overall Study|Lost to Follow-up|7
110208|NCT00975195|408776|P1|Overall Study|Lost to Follow-up|9
110209|NCT00975195|408775|P2|Overall Study|Protocol Violation|23
110210|NCT00975195|408776|P1|Overall Study|Protocol Violation|27
110211|NCT00975195|408775|P2|Overall Study|Lack of Efficacy|6
110212|NCT00975195|408776|P1|Overall Study|Lack of Efficacy|6
110213|NCT00975195|408775|P2|Overall Study|Adverse Event|101
110214|NCT00975195|408776|P1|Overall Study|Adverse Event|108
110215|NCT00975156|408836|P2|Overall Study|Protocol Violation|1
110216|NCT00975156|408837|P1|Overall Study|Protocol Violation|0
110217|NCT00975143|408849|P2|Overall Study|Details not available|4
110218|NCT00975143|408850|P1|Overall Study|Details not available|10
110219|NCT00975143|408849|P2|Overall Study|Physician Decision|2
110220|NCT00975143|408850|P1|Overall Study|Physician Decision|1
110221|NCT00975143|408849|P2|Overall Study|Non-compliance|8
110222|NCT00975143|408850|P1|Overall Study|Non-compliance|5
110223|NCT00975143|408849|P2|Overall Study|Lost to Follow-up|16
110224|NCT00975143|408850|P1|Overall Study|Lost to Follow-up|20
110225|NCT00975143|408849|P2|Overall Study|Withdrawal by Subject|15
110226|NCT00975143|408850|P1|Overall Study|Withdrawal by Subject|15
110227|NCT00975143|408849|P2|Overall Study|Adverse Event|15
110228|NCT00975143|408850|P1|Overall Study|Adverse Event|19
110229|NCT00975130|408860|P3|Study Part 2|Protocol Violation|1
110230|NCT00975130|408861|P2|Study Part 2|Protocol Violation|0
110231|NCT00975130|408862|P1|Study Part 2|Protocol Violation|0
110232|NCT00975130|408860|P3|Study Part 2|Administrative|0
110233|NCT00975130|408861|P2|Study Part 2|Administrative|1
110234|NCT00975130|408862|P1|Study Part 2|Administrative|0
110235|NCT00975130|408860|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
110236|NCT00975130|408861|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
110237|NCT00975130|408862|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
110238|NCT00975130|408860|P3|Study Part 2|Withdrew Consent|2
110239|NCT00975130|408861|P2|Study Part 2|Withdrew Consent|6
110240|NCT00975130|408862|P1|Study Part 2|Withdrew Consent|0
110241|NCT00975130|408860|P3|Study Part 2|Withdrawal by Subject|5
110242|NCT00975130|408861|P2|Study Part 2|Withdrawal by Subject|13
110243|NCT00975130|408862|P1|Study Part 2|Withdrawal by Subject|0
110244|NCT00975130|408860|P3|Study Part 2|Lost to Follow-up|1
110245|NCT00975130|408861|P2|Study Part 2|Lost to Follow-up|0
110246|NCT00975130|408862|P1|Study Part 2|Lost to Follow-up|0
110247|NCT00975130|408860|P3|Study Part 2|Adverse Event|7
110248|NCT00975130|408861|P2|Study Part 2|Adverse Event|14
110249|NCT00975130|408862|P1|Study Part 2|Adverse Event|0
110250|NCT00975130|408860|P3|Study Part 1|Withdrew Consent|0
110251|NCT00975130|408861|P2|Study Part 1|Withdrew Consent|0
110252|NCT00975130|408862|P1|Study Part 1|Withdrew Consent|24
110253|NCT00975130|408860|P3|Study Part 1|Administrative|0
110254|NCT00975130|408861|P2|Study Part 1|Administrative|0
110255|NCT00975130|408862|P1|Study Part 1|Administrative|4
110256|NCT00975130|408860|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
110257|NCT00975130|408861|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
110258|NCT00975130|408862|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
110259|NCT00975130|408860|P3|Study Part 1|Protocol Violation|0
110260|NCT00975130|408861|P2|Study Part 1|Protocol Violation|0
110261|NCT00975130|408862|P1|Study Part 1|Protocol Violation|13
110262|NCT00975130|408860|P3|Study Part 1|Withdrawal by Subject|0
110263|NCT00975130|408861|P2|Study Part 1|Withdrawal by Subject|0
110264|NCT00975130|408862|P1|Study Part 1|Withdrawal by Subject|61
110265|NCT00975130|408860|P3|Study Part 1|Lost to Follow-up|0
110266|NCT00975130|408861|P2|Study Part 1|Lost to Follow-up|0
110267|NCT00975130|408862|P1|Study Part 1|Lost to Follow-up|19
110268|NCT00975130|408860|P3|Study Part 1|Adverse Event|0
110269|NCT00975130|408861|P2|Study Part 1|Adverse Event|0
110270|NCT00975130|408862|P1|Study Part 1|Adverse Event|150
110271|NCT00975000|409046|P2|Overall Study|Non-compliance|1
110272|NCT00975000|409047|P1|Overall Study|Non-compliance|0
110273|NCT00975000|409046|P2|Overall Study|Protocol-specified Criteria|0
110274|NCT00975000|409047|P1|Overall Study|Protocol-specified Criteria|1
110275|NCT00975000|409046|P2|Overall Study|Lost to Follow-up|1
110276|NCT00975000|409047|P1|Overall Study|Lost to Follow-up|0
110277|NCT00975000|409046|P2|Overall Study|Withdrawal by Subject|2
110278|NCT00975000|409047|P1|Overall Study|Withdrawal by Subject|2
110279|NCT00975000|409046|P2|Overall Study|Adverse Event|1
110280|NCT00975000|409047|P1|Overall Study|Adverse Event|1
110281|NCT00975000|409046|P2|Overall Study|Other|0
110282|NCT00975000|409047|P1|Overall Study|Other|1
110283|NCT00974974|409071|P2|Maintenance - Double Blind Treatment|Various|0
110284|NCT00974974|409072|P1|Maintenance - Double Blind Treatment|Various|4
110285|NCT00974974|409071|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
110286|NCT00974974|409072|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
110287|NCT00974974|409071|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
110288|NCT00974974|409072|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
110289|NCT00974974|409071|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
110290|NCT00974974|409072|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
110291|NCT00974974|409071|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
110292|NCT00974974|409072|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
110293|NCT00974974|409071|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
110294|NCT00974974|409072|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
110295|NCT00974974|409071|P2|Maintenance - Double Blind Treatment|Adverse Event|3
110296|NCT00974974|409072|P1|Maintenance - Double Blind Treatment|Adverse Event|3
110297|NCT00974974|409071|P2|IPX066 Dose Conversion|Protocol Violation|0
110298|NCT00974974|409072|P1|IPX066 Dose Conversion|Protocol Violation|4
110299|NCT00974974|409071|P2|IPX066 Dose Conversion|Various|0
110300|NCT00974974|409072|P1|IPX066 Dose Conversion|Various|3
110301|NCT00974974|409071|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
110302|NCT00974974|409072|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
110303|NCT00974974|409071|P2|IPX066 Dose Conversion|Lack of Efficacy|0
110304|NCT00974974|409072|P1|IPX066 Dose Conversion|Lack of Efficacy|13
110305|NCT00974974|409071|P2|IPX066 Dose Conversion|Death|0
110306|NCT00974974|409072|P1|IPX066 Dose Conversion|Death|2
110307|NCT00974974|409071|P2|IPX066 Dose Conversion|Adverse Event|0
110308|NCT00974974|409072|P1|IPX066 Dose Conversion|Adverse Event|23
110309|NCT00974974|409071|P2|IR CD-LD Dose Adjustment|Various|9
110310|NCT00974974|409072|P1|IR CD-LD Dose Adjustment|Various|0
110311|NCT00974974|409071|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
110312|NCT00974974|409072|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
110313|NCT00974974|409071|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
110314|NCT00974974|409072|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
110315|NCT00974974|409071|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
110316|NCT00974974|409072|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
110317|NCT00974974|409071|P2|IR CD-LD Dose Adjustment|Adverse Event|3
110318|NCT00974974|409072|P1|IR CD-LD Dose Adjustment|Adverse Event|0
110319|NCT00974922|409082|P1|Overall Study|study terminated|24
110320|NCT00974675|409100|P4|Overall Study|Participant on holiday; unable to attend|1
110321|NCT00974675|409101|P3|Overall Study|Participant on holiday; unable to attend|0
110322|NCT00974675|409102|P2|Overall Study|Participant on holiday; unable to attend|0
110323|NCT00974675|409103|P1|Overall Study|Participant on holiday; unable to attend|0
110324|NCT00974675|409100|P4|Overall Study|Physician Decision|0
110325|NCT00974675|409101|P3|Overall Study|Physician Decision|1
110326|NCT00974675|409102|P2|Overall Study|Physician Decision|0
110327|NCT00974675|409103|P1|Overall Study|Physician Decision|0
110328|NCT00974675|409100|P4|Overall Study|Adverse Event|1
110329|NCT00974675|409101|P3|Overall Study|Adverse Event|1
110330|NCT00974675|409102|P2|Overall Study|Adverse Event|1
110331|NCT00974675|409103|P1|Overall Study|Adverse Event|2
110332|NCT00974571|409152|P3|Overall Study|Other|10
110333|NCT00974571|409153|P2|Overall Study|Other|0
110334|NCT00974571|409154|P1|Overall Study|Other|4
110335|NCT00974571|409152|P3|Overall Study|Patient Moved|1
110336|NCT00974571|409153|P2|Overall Study|Patient Moved|0
110337|NCT00974571|409154|P1|Overall Study|Patient Moved|1
110338|NCT00974571|409152|P3|Overall Study|Withdrawal by Subject|16
110339|NCT00974571|409153|P2|Overall Study|Withdrawal by Subject|5
110340|NCT00974571|409154|P1|Overall Study|Withdrawal by Subject|14
110341|NCT00974571|409152|P3|Overall Study|Protocol Violation|18
110342|NCT00974571|409153|P2|Overall Study|Protocol Violation|4
110343|NCT00974571|409154|P1|Overall Study|Protocol Violation|13
110344|NCT00974571|409152|P3|Overall Study|Lost to Follow-up|2
110345|NCT00974571|409153|P2|Overall Study|Lost to Follow-up|1
110346|NCT00974571|409154|P1|Overall Study|Lost to Follow-up|2
110347|NCT00974571|409152|P3|Overall Study|Lack of Efficacy|9
110348|NCT00974571|409153|P2|Overall Study|Lack of Efficacy|2
110349|NCT00974571|409154|P1|Overall Study|Lack of Efficacy|3
110350|NCT00974571|409152|P3|Overall Study|Adverse Event|27
110351|NCT00974571|409153|P2|Overall Study|Adverse Event|4
110352|NCT00974571|409154|P1|Overall Study|Adverse Event|31
110353|NCT00974311|409251|P2|Overall Study|Continuing Treatment|19
110354|NCT00974311|409252|P1|Overall Study|Continuing Treatment|231
110355|NCT00974311|409251|P2|Overall Study|Withdrawal of consent|5
110356|NCT00974311|409252|P1|Overall Study|Withdrawal of consent|9
110357|NCT00974311|409251|P2|Overall Study|Death|211
110358|NCT00974311|409252|P1|Overall Study|Death|305
110359|NCT00974311|409251|P2|Overall Study|Lost to Follow-up|1
110360|NCT00974311|409252|P1|Overall Study|Lost to Follow-up|1
110361|NCT00974233|409282|P1|Maintenance Lenalidomide|Adverse Event|8
110362|NCT00974233|409282|P1|Maintenance Lenalidomide|Lack of Efficacy|5
110363|NCT00974233|409282|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
110364|NCT00974233|409282|P1|Induction Chemoimmunotherapy|Adverse Event|7
110365|NCT00974233|409282|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
110366|NCT00974233|409282|P1|Induction Chemoimmunotherapy|Death|2
110367|NCT00974220|409297|P2|Treatment Period 1|noncompliant subjects|1
110368|NCT00974220|409298|P1|Treatment Period 1|noncompliant subjects|0
110369|NCT00974220|409297|P2|Treatment Period 1|Adverse Event|1
110370|NCT00974220|409298|P1|Treatment Period 1|Adverse Event|2
110371|NCT00974090|409343|P2|Period 2: Open-label Period|Withdrawal by Subject|0
110372|NCT00974090|409344|P1|Period 2: Open-label Period|Withdrawal by Subject|1
110373|NCT00974090|409343|P2|Period 2: Open-label Period|Physician Decision|3
110374|NCT00974090|409344|P1|Period 2: Open-label Period|Physician Decision|0
110375|NCT00974090|409343|P2|Period 2: Open-label Period|Lack of Efficacy|1
110376|NCT00974090|409344|P1|Period 2: Open-label Period|Lack of Efficacy|3
110377|NCT00974090|409343|P2|Period 2: Open-label Period|Adverse Event|6
110378|NCT00974090|409344|P1|Period 2: Open-label Period|Adverse Event|4
110379|NCT00974090|409343|P2|Period 1: Double Blind Period|Physician Decision|0
110380|NCT00974090|409344|P1|Period 1: Double Blind Period|Physician Decision|1
110381|NCT00974090|409343|P2|Period 1: Double Blind Period|Adverse Event|1
110382|NCT00974090|409344|P1|Period 1: Double Blind Period|Adverse Event|2
110383|NCT00973921|409378|P1|Overall Study|IVUS results were not available|9
110384|NCT00973765|409387|P2|Overall Study|Lost to Follow-up|14
110385|NCT00973765|409388|P1|Overall Study|Lost to Follow-up|8
110386|NCT00973700|409410|P5|Overall Study|Unable to Classify|1
110387|NCT00973700|409411|P4|Overall Study|Unable to Classify|2
110388|NCT00973700|409412|P3|Overall Study|Unable to Classify|1
110389|NCT00973700|409413|P2|Overall Study|Unable to Classify|0
110390|NCT00973700|409414|P1|Overall Study|Unable to Classify|0
110391|NCT00973700|409410|P5|Overall Study|Inappropriate enrolment|0
110392|NCT00973700|409411|P4|Overall Study|Inappropriate enrolment|4
110393|NCT00973700|409412|P3|Overall Study|Inappropriate enrolment|0
110394|NCT00973700|409413|P2|Overall Study|Inappropriate enrolment|0
110395|NCT00973700|409414|P1|Overall Study|Inappropriate enrolment|0
110396|NCT00973700|409410|P5|Overall Study|Lost to Follow-up|5
110397|NCT00973700|409411|P4|Overall Study|Lost to Follow-up|8
110398|NCT00973700|409412|P3|Overall Study|Lost to Follow-up|1
110399|NCT00973700|409413|P2|Overall Study|Lost to Follow-up|0
110400|NCT00973700|409414|P1|Overall Study|Lost to Follow-up|5
110401|NCT00973700|409410|P5|Overall Study|Withdrawal by Subject|4
110402|NCT00973700|409411|P4|Overall Study|Withdrawal by Subject|4
110403|NCT00973700|409412|P3|Overall Study|Withdrawal by Subject|8
110404|NCT00973700|409413|P2|Overall Study|Withdrawal by Subject|2
110405|NCT00973700|409414|P1|Overall Study|Withdrawal by Subject|2
110406|NCT00973622|409463|P2|Overall Study|did not complete rTMS sessions|2
110407|NCT00973622|409464|P1|Overall Study|did not complete rTMS sessions|11
110408|NCT00973622|409463|P2|Overall Study|did not pass MRI screen|0
110409|NCT00973622|409464|P1|Overall Study|did not pass MRI screen|6
110410|NCT00973622|409463|P2|Overall Study|did not attend MRI|3
110411|NCT00973622|409464|P1|Overall Study|did not attend MRI|14
110412|NCT00973479|409472|P2|Overall Study|Not Specified|7
110413|NCT00973479|409473|P1|Overall Study|Not Specified|1
110414|NCT00973479|409472|P2|Overall Study|Protocol Violation|2
110415|NCT00973479|409473|P1|Overall Study|Protocol Violation|2
110416|NCT00973479|409472|P2|Overall Study|Adverse Event|32
110417|NCT00973479|409473|P1|Overall Study|Adverse Event|12
110418|NCT00973479|409472|P2|Overall Study|Lack of Efficacy|7
110419|NCT00973479|409473|P1|Overall Study|Lack of Efficacy|5
110420|NCT00973479|409472|P2|Overall Study|Withdrawal by Subject|16
110421|NCT00973479|409473|P1|Overall Study|Withdrawal by Subject|15
110422|NCT00973479|409472|P2|Overall Study|Death|2
110423|NCT00973479|409473|P1|Overall Study|Death|2
110424|NCT00973479|409472|P2|Overall Study|Lost to Follow-up|3
110425|NCT00973479|409473|P1|Overall Study|Lost to Follow-up|0
110426|NCT00973362|409491|P2|3-Year Follow-up|Lost to Follow-up|0
110427|NCT00973362|409492|P1|3-Year Follow-up|Lost to Follow-up|17
110428|NCT00973362|409491|P2|Baseline Evaluation|Inevaluable|223
110429|NCT00973362|409492|P1|Baseline Evaluation|Inevaluable|686
110430|NCT00973362|409491|P2|Baseline Evaluation|No colposcopy visit|0
110431|NCT00973362|409492|P1|Baseline Evaluation|No colposcopy visit|62
110432|NCT00973362|409491|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
110433|NCT00973362|409492|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
110434|NCT00973349|409517|P16|Overall Study|Unable to classify|0
110435|NCT00973349|409518|P15|Overall Study|Unable to classify|0
110436|NCT00973349|409519|P14|Overall Study|Unable to classify|0
110437|NCT00973349|409520|P13|Overall Study|Unable to classify|0
110438|NCT00973349|409521|P12|Overall Study|Unable to classify|0
110439|NCT00973349|409522|P11|Overall Study|Unable to classify|0
110440|NCT00973349|409523|P10|Overall Study|Unable to classify|1
110441|NCT00973349|409524|P9|Overall Study|Unable to classify|0
110442|NCT00973349|409525|P8|Overall Study|Unable to classify|0
110443|NCT00973349|409526|P7|Overall Study|Unable to classify|0
110444|NCT00973349|409527|P6|Overall Study|Unable to classify|1
110445|NCT00973349|409528|P5|Overall Study|Unable to classify|1
110446|NCT00973349|409529|P4|Overall Study|Unable to classify|0
110447|NCT00973349|409530|P3|Overall Study|Unable to classify|0
110448|NCT00973349|409531|P2|Overall Study|Unable to classify|0
110449|NCT00973349|409532|P1|Overall Study|Unable to classify|0
110450|NCT00973349|409517|P16|Overall Study|Protocol Violation|0
110451|NCT00973349|409518|P15|Overall Study|Protocol Violation|0
110452|NCT00973349|409519|P14|Overall Study|Protocol Violation|0
110453|NCT00973349|409520|P13|Overall Study|Protocol Violation|0
110454|NCT00973349|409521|P12|Overall Study|Protocol Violation|0
110455|NCT00973349|409522|P11|Overall Study|Protocol Violation|0
110456|NCT00973349|409523|P10|Overall Study|Protocol Violation|0
110457|NCT00973349|409524|P9|Overall Study|Protocol Violation|1
110458|NCT00973349|409525|P8|Overall Study|Protocol Violation|0
110459|NCT00973349|409526|P7|Overall Study|Protocol Violation|0
110460|NCT00973349|409527|P6|Overall Study|Protocol Violation|0
110461|NCT00973349|409528|P5|Overall Study|Protocol Violation|0
110462|NCT00973349|409529|P4|Overall Study|Protocol Violation|0
110463|NCT00973349|409530|P3|Overall Study|Protocol Violation|0
110464|NCT00973349|409531|P2|Overall Study|Protocol Violation|0
110465|NCT00973349|409532|P1|Overall Study|Protocol Violation|0
110466|NCT00973349|409517|P16|Overall Study|Inappropriate enrolment|1
110467|NCT00973349|409518|P15|Overall Study|Inappropriate enrolment|1
110468|NCT00973349|409519|P14|Overall Study|Inappropriate enrolment|0
110469|NCT00973349|409520|P13|Overall Study|Inappropriate enrolment|1
110470|NCT00973349|409521|P12|Overall Study|Inappropriate enrolment|0
110471|NCT00973349|409522|P11|Overall Study|Inappropriate enrolment|0
110472|NCT00973349|409523|P10|Overall Study|Inappropriate enrolment|2
110473|NCT00973349|409524|P9|Overall Study|Inappropriate enrolment|0
110474|NCT00973349|409525|P8|Overall Study|Inappropriate enrolment|0
110475|NCT00973349|409526|P7|Overall Study|Inappropriate enrolment|0
110476|NCT00973349|409527|P6|Overall Study|Inappropriate enrolment|0
110477|NCT00973349|409528|P5|Overall Study|Inappropriate enrolment|0
110478|NCT00973349|409529|P4|Overall Study|Inappropriate enrolment|0
110479|NCT00973349|409530|P3|Overall Study|Inappropriate enrolment|1
110480|NCT00973349|409531|P2|Overall Study|Inappropriate enrolment|0
110481|NCT00973349|409532|P1|Overall Study|Inappropriate enrolment|0
110482|NCT00973349|409517|P16|Overall Study|Lost to Follow-up|1
110483|NCT00973349|409518|P15|Overall Study|Lost to Follow-up|0
110484|NCT00973349|409519|P14|Overall Study|Lost to Follow-up|0
110485|NCT00973349|409520|P13|Overall Study|Lost to Follow-up|0
110486|NCT00973349|409521|P12|Overall Study|Lost to Follow-up|1
110487|NCT00973349|409522|P11|Overall Study|Lost to Follow-up|0
110488|NCT00973349|409523|P10|Overall Study|Lost to Follow-up|1
110489|NCT00973349|409524|P9|Overall Study|Lost to Follow-up|2
110490|NCT00973349|409525|P8|Overall Study|Lost to Follow-up|1
110491|NCT00973349|409526|P7|Overall Study|Lost to Follow-up|0
110492|NCT00973349|409527|P6|Overall Study|Lost to Follow-up|3
110493|NCT00973349|409528|P5|Overall Study|Lost to Follow-up|1
110494|NCT00973349|409529|P4|Overall Study|Lost to Follow-up|2
110495|NCT00973349|409530|P3|Overall Study|Lost to Follow-up|2
110496|NCT00973349|409531|P2|Overall Study|Lost to Follow-up|1
110497|NCT00973349|409532|P1|Overall Study|Lost to Follow-up|3
110498|NCT00973349|409517|P16|Overall Study|Withdrawal by Subject|0
110499|NCT00973349|409518|P15|Overall Study|Withdrawal by Subject|0
110500|NCT00973349|409519|P14|Overall Study|Withdrawal by Subject|0
110501|NCT00973349|409520|P13|Overall Study|Withdrawal by Subject|0
110502|NCT00973349|409521|P12|Overall Study|Withdrawal by Subject|1
110503|NCT00973349|409522|P11|Overall Study|Withdrawal by Subject|0
110504|NCT00973349|409523|P10|Overall Study|Withdrawal by Subject|2
110505|NCT00973349|409524|P9|Overall Study|Withdrawal by Subject|0
110506|NCT00973349|409525|P8|Overall Study|Withdrawal by Subject|2
110507|NCT00973349|409526|P7|Overall Study|Withdrawal by Subject|2
110508|NCT00973349|409527|P6|Overall Study|Withdrawal by Subject|0
110509|NCT00973349|409528|P5|Overall Study|Withdrawal by Subject|2
110510|NCT00973349|409529|P4|Overall Study|Withdrawal by Subject|3
110511|NCT00973349|409530|P3|Overall Study|Withdrawal by Subject|2
110512|NCT00973349|409531|P2|Overall Study|Withdrawal by Subject|2
110513|NCT00973349|409532|P1|Overall Study|Withdrawal by Subject|1
110514|NCT00973349|409517|P16|Overall Study|Adverse Event|0
110515|NCT00973349|409518|P15|Overall Study|Adverse Event|1
110516|NCT00973349|409519|P14|Overall Study|Adverse Event|0
110517|NCT00973349|409520|P13|Overall Study|Adverse Event|0
110518|NCT00973349|409521|P12|Overall Study|Adverse Event|0
110519|NCT00973349|409522|P11|Overall Study|Adverse Event|0
110520|NCT00973349|409523|P10|Overall Study|Adverse Event|0
110521|NCT00973349|409524|P9|Overall Study|Adverse Event|1
110522|NCT00973349|409525|P8|Overall Study|Adverse Event|0
110523|NCT00973349|409526|P7|Overall Study|Adverse Event|0
110524|NCT00973349|409527|P6|Overall Study|Adverse Event|0
110525|NCT00973349|409528|P5|Overall Study|Adverse Event|1
110526|NCT00973349|409529|P4|Overall Study|Adverse Event|0
110527|NCT00973349|409530|P3|Overall Study|Adverse Event|0
110528|NCT00973349|409531|P2|Overall Study|Adverse Event|0
110529|NCT00973349|409532|P1|Overall Study|Adverse Event|0
110530|NCT00972816|409653|P8|Overall Study|Unable to classify|0
110531|NCT00972816|409654|P7|Overall Study|Unable to classify|0
110532|NCT00972816|409655|P6|Overall Study|Unable to classify|0
110533|NCT00972816|409656|P5|Overall Study|Unable to classify|1
110534|NCT00972816|409657|P4|Overall Study|Unable to classify|0
110535|NCT00972816|409658|P3|Overall Study|Unable to classify|0
110536|NCT00972816|409659|P2|Overall Study|Unable to classify|0
110537|NCT00972816|409660|P1|Overall Study|Unable to classify|2
110538|NCT00972816|409653|P8|Overall Study|Inappropriate enrolment|0
110539|NCT00972816|409654|P7|Overall Study|Inappropriate enrolment|2
110540|NCT00972816|409655|P6|Overall Study|Inappropriate enrolment|0
110541|NCT00972816|409656|P5|Overall Study|Inappropriate enrolment|0
110542|NCT00972816|409657|P4|Overall Study|Inappropriate enrolment|0
110543|NCT00972816|409658|P3|Overall Study|Inappropriate enrolment|0
110544|NCT00972816|409659|P2|Overall Study|Inappropriate enrolment|0
110545|NCT00972816|409660|P1|Overall Study|Inappropriate enrolment|0
110546|NCT00972816|409653|P8|Overall Study|Lost to Follow-up|7
110547|NCT00972816|409654|P7|Overall Study|Lost to Follow-up|7
110548|NCT00972816|409655|P6|Overall Study|Lost to Follow-up|10
110549|NCT00972816|409656|P5|Overall Study|Lost to Follow-up|11
110550|NCT00972816|409657|P4|Overall Study|Lost to Follow-up|5
110551|NCT00972816|409658|P3|Overall Study|Lost to Follow-up|7
110552|NCT00972816|409659|P2|Overall Study|Lost to Follow-up|9
110553|NCT00972816|409660|P1|Overall Study|Lost to Follow-up|11
110554|NCT00972816|409653|P8|Overall Study|Withdrawal by Subject|2
110555|NCT00972816|409654|P7|Overall Study|Withdrawal by Subject|1
110556|NCT00972816|409655|P6|Overall Study|Withdrawal by Subject|1
110557|NCT00972816|409656|P5|Overall Study|Withdrawal by Subject|0
110558|NCT00972816|409657|P4|Overall Study|Withdrawal by Subject|3
110559|NCT00972816|409658|P3|Overall Study|Withdrawal by Subject|1
110560|NCT00972816|409659|P2|Overall Study|Withdrawal by Subject|2
110561|NCT00972816|409660|P1|Overall Study|Withdrawal by Subject|4
110562|NCT00972816|409653|P8|Overall Study|Adverse Event|0
110563|NCT00972816|409654|P7|Overall Study|Adverse Event|0
110564|NCT00972816|409655|P6|Overall Study|Adverse Event|0
110565|NCT00972816|409656|P5|Overall Study|Adverse Event|0
110566|NCT00972816|409657|P4|Overall Study|Adverse Event|0
110567|NCT00972816|409658|P3|Overall Study|Adverse Event|1
110568|NCT00972816|409659|P2|Overall Study|Adverse Event|0
110569|NCT00972816|409660|P1|Overall Study|Adverse Event|0
110570|NCT00972777|409744|P2|Overall Study|Missed visit|0
110571|NCT00972777|409745|P1|Overall Study|Missed visit|1
110572|NCT00972777|409744|P2|Overall Study|Screening Failure|1
110573|NCT00972777|409745|P1|Overall Study|Screening Failure|2
110574|NCT00972777|409744|P2|Overall Study|Protocol Violation|2
110575|NCT00972777|409745|P1|Overall Study|Protocol Violation|0
110576|NCT00972777|409744|P2|Overall Study|Physician Decision|0
110577|NCT00972777|409745|P1|Overall Study|Physician Decision|4
110578|NCT00972777|409744|P2|Overall Study|Withdrawal by Subject|5
110579|NCT00972777|409745|P1|Overall Study|Withdrawal by Subject|4
110580|NCT00972777|409744|P2|Overall Study|Lost to Follow-up|4
110581|NCT00972777|409745|P1|Overall Study|Lost to Follow-up|0
110582|NCT00972777|409744|P2|Overall Study|Adverse Event|2
110583|NCT00972777|409745|P1|Overall Study|Adverse Event|3
110584|NCT00972738|409760|P3|Overall Study|Other|1
110585|NCT00972738|409761|P2|Overall Study|Other|2
110586|NCT00972738|409762|P1|Overall Study|Other|1
110587|NCT00972738|409760|P3|Overall Study|Moved|1
110588|NCT00972738|409761|P2|Overall Study|Moved|0
110589|NCT00972738|409762|P1|Overall Study|Moved|0
110590|NCT00972738|409760|P3|Overall Study|Withdrawal by Subject|4
110591|NCT00972738|409761|P2|Overall Study|Withdrawal by Subject|1
110592|NCT00972738|409762|P1|Overall Study|Withdrawal by Subject|5
110593|NCT00972738|409760|P3|Overall Study|Lack of Efficacy|11
110594|NCT00972738|409761|P2|Overall Study|Lack of Efficacy|1
110595|NCT00972738|409762|P1|Overall Study|Lack of Efficacy|5
110596|NCT00972738|409760|P3|Overall Study|Lost to Follow-up|1
110597|NCT00972738|409761|P2|Overall Study|Lost to Follow-up|0
110598|NCT00972738|409762|P1|Overall Study|Lost to Follow-up|1
110599|NCT00972738|409760|P3|Overall Study|Protocol Violation|3
110600|NCT00972738|409761|P2|Overall Study|Protocol Violation|1
110601|NCT00972738|409762|P1|Overall Study|Protocol Violation|2
110602|NCT00972738|409760|P3|Overall Study|Adverse Event|8
110603|NCT00972738|409761|P2|Overall Study|Adverse Event|1
110604|NCT00972738|409762|P1|Overall Study|Adverse Event|7
110605|NCT00972595|409879|P2|Period 1|Adverse Event|0
110606|NCT00972595|409880|P1|Period 1|Adverse Event|1
110607|NCT00972543|409890|P2|Overall Study|Early study termination by sponsor|1
110608|NCT00972543|409891|P1|Overall Study|Early study termination by sponsor|4
110609|NCT00972543|409890|P2|Overall Study|Adverse Event|0
110610|NCT00972543|409891|P1|Overall Study|Adverse Event|1
110611|NCT00972504|409974|P1|Overall Study|Investigator discretion|1
110612|NCT00972504|409974|P1|Overall Study|Adverse Event|2
110613|NCT00972478|410006|P2|Overall Study|Not start protocol treatment|2
110614|NCT00972478|410007|P1|Overall Study|Not start protocol treatment|1
110615|NCT00972478|410006|P2|Overall Study|Ineligible|7
110616|NCT00972478|410007|P1|Overall Study|Ineligible|1
110617|NCT00972478|410006|P2|Overall Study|Not protocol specified|1
110618|NCT00972478|410007|P1|Overall Study|Not protocol specified|1
110619|NCT00972478|410006|P2|Overall Study|Death|2
110620|NCT00972478|410007|P1|Overall Study|Death|0
110621|NCT00972478|410006|P2|Overall Study|Progression/Relapse|2
110622|NCT00972478|410007|P1|Overall Study|Progression/Relapse|0
110623|NCT00972478|410006|P2|Overall Study|Withdrawal by Subject|8
110624|NCT00972478|410007|P1|Overall Study|Withdrawal by Subject|1
110625|NCT00972478|410006|P2|Overall Study|Adverse Event|16
110626|NCT00972478|410007|P1|Overall Study|Adverse Event|3
110627|NCT00972322|410052|P2|Overall Study|Consistently high glucose values|0
110628|NCT00972322|410053|P1|Overall Study|Consistently high glucose values|1
110629|NCT00972322|410052|P2|Overall Study|Lost to Follow-up|1
110630|NCT00972322|410053|P1|Overall Study|Lost to Follow-up|0
110631|NCT00972322|410052|P2|Overall Study|Positive drug screen|1
110632|NCT00972322|410053|P1|Overall Study|Positive drug screen|0
110633|NCT00972322|410052|P2|Overall Study|Adverse Event|1
110634|NCT00972322|410053|P1|Overall Study|Adverse Event|2
110635|NCT00972283|410065|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
110636|NCT00972283|410066|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
110637|NCT00972283|410065|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
110638|NCT00972283|410066|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
110639|NCT00972283|410065|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
110640|NCT00972283|410066|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
110641|NCT00972283|410065|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
110642|NCT00972283|410066|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
110643|NCT00972283|410065|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
110644|NCT00972283|410066|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
110645|NCT00972283|410065|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
110646|NCT00972283|410066|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
110647|NCT00972283|410065|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
110648|NCT00972283|410066|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
110649|NCT00972283|410065|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
110650|NCT00972283|410066|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
110651|NCT00972283|410065|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
110652|NCT00972283|410066|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
110653|NCT00972283|410065|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
110654|NCT00972283|410066|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
110655|NCT00972244|410093|P5|Overall Study|Various|2
110656|NCT00972244|410094|P4|Overall Study|Various|0
110657|NCT00972244|410095|P3|Overall Study|Various|0
110658|NCT00972244|410096|P2|Overall Study|Various|0
110659|NCT00972244|410097|P1|Overall Study|Various|0
110660|NCT00972244|410093|P5|Overall Study|Death|0
110661|NCT00972244|410094|P4|Overall Study|Death|0
110662|NCT00972244|410095|P3|Overall Study|Death|0
110663|NCT00972244|410096|P2|Overall Study|Death|0
110664|NCT00972244|410097|P1|Overall Study|Death|1
110665|NCT00972244|410093|P5|Overall Study|Safety|1
110666|NCT00972244|410094|P4|Overall Study|Safety|0
110667|NCT00972244|410095|P3|Overall Study|Safety|0
110668|NCT00972244|410096|P2|Overall Study|Safety|0
110669|NCT00972244|410097|P1|Overall Study|Safety|0
110670|NCT00972244|410093|P5|Overall Study|Withdrawal by Subject|1
110671|NCT00972244|410094|P4|Overall Study|Withdrawal by Subject|0
110672|NCT00972244|410095|P3|Overall Study|Withdrawal by Subject|1
110673|NCT00972244|410096|P2|Overall Study|Withdrawal by Subject|2
110674|NCT00972244|410097|P1|Overall Study|Withdrawal by Subject|1
110675|NCT00972244|410093|P5|Overall Study|Subject No Longer Meets Study Criteria|5
110676|NCT00972244|410094|P4|Overall Study|Subject No Longer Meets Study Criteria|0
110677|NCT00972244|410095|P3|Overall Study|Subject No Longer Meets Study Criteria|0
110678|NCT00972244|410096|P2|Overall Study|Subject No Longer Meets Study Criteria|2
110679|NCT00972244|410097|P1|Overall Study|Subject No Longer Meets Study Criteria|2
110680|NCT00972244|410093|P5|Overall Study|Adverse Event|0
110681|NCT00972244|410094|P4|Overall Study|Adverse Event|0
110682|NCT00972244|410095|P3|Overall Study|Adverse Event|1
110683|NCT00972244|410096|P2|Overall Study|Adverse Event|1
110684|NCT00972244|410097|P1|Overall Study|Adverse Event|0
110685|NCT00972244|410093|P5|Overall Study|Incorrect Enrolment|0
110686|NCT00972244|410094|P4|Overall Study|Incorrect Enrolment|0
110687|NCT00972244|410095|P3|Overall Study|Incorrect Enrolment|0
110688|NCT00972244|410096|P2|Overall Study|Incorrect Enrolment|0
110689|NCT00972244|410097|P1|Overall Study|Incorrect Enrolment|1
110690|NCT00972153|410129|P3|Overall Study|Equipment malfunction during case|0
110691|NCT00972153|410130|P2|Overall Study|Equipment malfunction during case|1
110692|NCT00972153|410131|P1|Overall Study|Equipment malfunction during case|0
110693|NCT00972023|410146|P1|Overall Study|Withdrawal by Subject|1
110694|NCT00971997|410153|P1|Overall Study|Physician Decision|7
110695|NCT00971997|410153|P1|Overall Study|Withdrawal by Subject|5
110696|NCT00971997|410153|P1|Overall Study|Protocol Violation|4
110697|NCT00971997|410153|P1|Overall Study|Death|1
110698|NCT00971997|410153|P1|Overall Study|Adverse Event|2
110699|NCT00971932|410171|P1|Overall Study|Ongoing|4
110700|NCT00971932|410171|P1|Overall Study|Investigator's decision|2
110701|NCT00971932|410171|P1|Overall Study|Withdrawal by Subject|1
110702|NCT00971425|410251|P2|Overall Study|Withdrawal by Subject|1
110703|NCT00971425|410252|P1|Overall Study|Withdrawal by Subject|0
110704|NCT00971425|410251|P2|Overall Study|Adverse Event|1
110705|NCT00971425|410252|P1|Overall Study|Adverse Event|1
110706|NCT00971243|410316|P5|Open-label Period|Other reason|2
110707|NCT00971243|410317|P4|Open-label Period|Other reason|0
110708|NCT00971243|410318|P3|Open-label Period|Other reason|0
110709|NCT00971243|410319|P2|Open-label Period|Other reason|0
110710|NCT00971243|410320|P1|Open-label Period|Other reason|0
110711|NCT00971243|410316|P5|Open-label Period|Withdrawal by Subject|1
110712|NCT00971243|410317|P4|Open-label Period|Withdrawal by Subject|2
110713|NCT00971243|410318|P3|Open-label Period|Withdrawal by Subject|0
110714|NCT00971243|410319|P2|Open-label Period|Withdrawal by Subject|0
110715|NCT00971243|410320|P1|Open-label Period|Withdrawal by Subject|1
110716|NCT00971243|410316|P5|Open-label Period|Protocol Violation|1
110717|NCT00971243|410317|P4|Open-label Period|Protocol Violation|0
110718|NCT00971243|410318|P3|Open-label Period|Protocol Violation|1
110719|NCT00971243|410319|P2|Open-label Period|Protocol Violation|1
110720|NCT00971243|410320|P1|Open-label Period|Protocol Violation|1
110721|NCT00971243|410316|P5|Open-label Period|Physician Decision|2
110722|NCT00971243|410317|P4|Open-label Period|Physician Decision|7
110723|NCT00971243|410318|P3|Open-label Period|Physician Decision|3
110724|NCT00971243|410319|P2|Open-label Period|Physician Decision|9
110725|NCT00971243|410320|P1|Open-label Period|Physician Decision|5
110726|NCT00971243|410316|P5|Open-label Period|Adverse Event|0
110727|NCT00971243|410317|P4|Open-label Period|Adverse Event|1
110728|NCT00971243|410318|P3|Open-label Period|Adverse Event|1
110729|NCT00971243|410319|P2|Open-label Period|Adverse Event|0
110730|NCT00971243|410320|P1|Open-label Period|Adverse Event|1
110731|NCT00971243|410316|P5|Double Blind Period|Other reasons|1
110732|NCT00971243|410317|P4|Double Blind Period|Other reasons|0
110733|NCT00971243|410318|P3|Double Blind Period|Other reasons|2
110734|NCT00971243|410319|P2|Double Blind Period|Other reasons|0
110735|NCT00971243|410320|P1|Double Blind Period|Other reasons|1
110736|NCT00971243|410316|P5|Double Blind Period|Withdrawal by Subject|4
110737|NCT00971243|410317|P4|Double Blind Period|Withdrawal by Subject|4
110738|NCT00971243|410318|P3|Double Blind Period|Withdrawal by Subject|4
110739|NCT00971243|410319|P2|Double Blind Period|Withdrawal by Subject|1
110740|NCT00971243|410320|P1|Double Blind Period|Withdrawal by Subject|4
110741|NCT00971243|410316|P5|Double Blind Period|Protocol Violation|2
110742|NCT00971243|410317|P4|Double Blind Period|Protocol Violation|2
110743|NCT00971243|410318|P3|Double Blind Period|Protocol Violation|3
110744|NCT00971243|410319|P2|Double Blind Period|Protocol Violation|0
110745|NCT00971243|410320|P1|Double Blind Period|Protocol Violation|2
110746|NCT00971243|410316|P5|Double Blind Period|Physician Decision|7
110747|NCT00971243|410317|P4|Double Blind Period|Physician Decision|6
110748|NCT00971243|410318|P3|Double Blind Period|Physician Decision|7
110749|NCT00971243|410319|P2|Double Blind Period|Physician Decision|6
110750|NCT00971243|410320|P1|Double Blind Period|Physician Decision|10
110751|NCT00971243|410316|P5|Double Blind Period|Lost to Follow-up|1
110752|NCT00971243|410317|P4|Double Blind Period|Lost to Follow-up|0
110753|NCT00971243|410318|P3|Double Blind Period|Lost to Follow-up|1
110754|NCT00971243|410319|P2|Double Blind Period|Lost to Follow-up|1
110755|NCT00971243|410320|P1|Double Blind Period|Lost to Follow-up|0
110756|NCT00971243|410316|P5|Double Blind Period|Adverse Event|3
110757|NCT00971243|410317|P4|Double Blind Period|Adverse Event|2
110758|NCT00971243|410318|P3|Double Blind Period|Adverse Event|2
110759|NCT00971243|410319|P2|Double Blind Period|Adverse Event|3
110760|NCT00971243|410320|P1|Double Blind Period|Adverse Event|2
110761|NCT00971204|410337|P1|Overall Study|Lost to Follow-up|10
110762|NCT00971204|410337|P1|Overall Study|Did not meet all criteria-not treated|14
110763|NCT00971048|410345|P4|Overall Study|Physician Decision|1
110764|NCT00971048|410346|P3|Overall Study|Physician Decision|0
110765|NCT00971048|410347|P2|Overall Study|Physician Decision|0
110766|NCT00971048|410348|P1|Overall Study|Physician Decision|0
110767|NCT00971048|410345|P4|Overall Study|Adverse Event|0
110768|NCT00971048|410346|P3|Overall Study|Adverse Event|1
110769|NCT00971048|410347|P2|Overall Study|Adverse Event|0
110770|NCT00971048|410348|P1|Overall Study|Adverse Event|0
110771|NCT00971048|410345|P4|Overall Study|Protocol Violation|1
110772|NCT00971048|410346|P3|Overall Study|Protocol Violation|0
110773|NCT00971048|410347|P2|Overall Study|Protocol Violation|2
110774|NCT00971048|410348|P1|Overall Study|Protocol Violation|1
110775|NCT00970944|410372|P2|Overall Study|Physician Decision|2
110776|NCT00970944|410373|P1|Overall Study|Physician Decision|0
110777|NCT00970944|410372|P2|Overall Study|Death|0
110778|NCT00970944|410373|P1|Overall Study|Death|1
110779|NCT00970684|410425|P1|Overall Study|Withdrawal by Subject|1
110780|NCT00970684|410425|P1|Overall Study|Adverse Event|4
110781|NCT00970684|410425|P1|Overall Study|Lack of Efficacy|5
110782|NCT00970632|410434|P3|Overall Study|Sponsor decision|1
110783|NCT00970632|410435|P2|Overall Study|Sponsor decision|0
110784|NCT00970632|410436|P1|Overall Study|Sponsor decision|1
110785|NCT00970632|410434|P3|Overall Study|Entry criteria not met|2
110786|NCT00970632|410435|P2|Overall Study|Entry criteria not met|2
110787|NCT00970632|410436|P1|Overall Study|Entry criteria not met|0
110788|NCT00970632|410434|P3|Overall Study|Withdrawal by Subject|4
110789|NCT00970632|410435|P2|Overall Study|Withdrawal by Subject|6
110790|NCT00970632|410436|P1|Overall Study|Withdrawal by Subject|7
110791|NCT00970632|410434|P3|Overall Study|Protocol Violation|8
110792|NCT00970632|410435|P2|Overall Study|Protocol Violation|5
110793|NCT00970632|410436|P1|Overall Study|Protocol Violation|8
110794|NCT00970632|410434|P3|Overall Study|Lost to Follow-up|2
110795|NCT00970632|410435|P2|Overall Study|Lost to Follow-up|0
110796|NCT00970632|410436|P1|Overall Study|Lost to Follow-up|3
110797|NCT00970632|410434|P3|Overall Study|Lack of Efficacy|0
110798|NCT00970632|410435|P2|Overall Study|Lack of Efficacy|0
110799|NCT00970632|410436|P1|Overall Study|Lack of Efficacy|3
110800|NCT00970632|410434|P3|Overall Study|Adverse Event|1
110801|NCT00970632|410435|P2|Overall Study|Adverse Event|2
110802|NCT00970632|410436|P1|Overall Study|Adverse Event|2
110803|NCT00970502|410501|P1|Overall Study|Withdrawal by Subject|1
110804|NCT00970489|410512|P2|Overall Study|Death/Withdrew/Criteria Violation|41
110805|NCT00970489|410513|P1|Overall Study|Death/Withdrew/Criteria Violation|54
110806|NCT00970359|410525|P1|Overall Study|Not Treated|4
110807|NCT00970307|410555|P3|Overall Study|Withdrawal by Subject|2
110808|NCT00970307|410556|P2|Overall Study|Withdrawal by Subject|3
110809|NCT00970307|410557|P1|Overall Study|Withdrawal by Subject|2
110810|NCT00970307|410555|P3|Overall Study|Serious Adverse Event|0
110811|NCT00970307|410556|P2|Overall Study|Serious Adverse Event|0
110812|NCT00970307|410557|P1|Overall Study|Serious Adverse Event|1
110813|NCT00970294|410631|P1|Overall Study|Withdrawal by Subject|1
110814|NCT00970294|410631|P1|Overall Study|Physician Decision|4
110815|NCT00970281|410639|P2|Overall Study|Physician Decision|1
110816|NCT00970281|410640|P1|Overall Study|Physician Decision|1
110817|NCT00970281|410639|P2|Overall Study|Withdrawal by Subject|1
110818|NCT00970281|410640|P1|Overall Study|Withdrawal by Subject|0
110819|NCT00970281|410639|P2|Overall Study|Lack of Efficacy|14
110820|NCT00970281|410640|P1|Overall Study|Lack of Efficacy|1
110821|NCT00970268|410658|P2|Overall Study|Inclusion/Exclusion Criteria|0
110822|NCT00970268|410659|P1|Overall Study|Inclusion/Exclusion Criteria|1
110823|NCT00970268|410658|P2|Overall Study|Lost to Follow-up|2
110824|NCT00970268|410659|P1|Overall Study|Lost to Follow-up|1
110825|NCT00970268|410658|P2|Overall Study|COPD Exacerbation|2
110826|NCT00970268|410659|P1|Overall Study|COPD Exacerbation|4
110827|NCT00970268|410658|P2|Overall Study|Other Reason|1
110828|NCT00970268|410659|P1|Overall Study|Other Reason|3
110829|NCT00970268|410658|P2|Overall Study|Protocol Violation|7
110830|NCT00970268|410659|P1|Overall Study|Protocol Violation|4
110831|NCT00970268|410658|P2|Overall Study|Lack of Efficacy|6
110832|NCT00970268|410659|P1|Overall Study|Lack of Efficacy|3
110833|NCT00970268|410658|P2|Overall Study|Adverse Event|12
110834|NCT00970268|410659|P1|Overall Study|Adverse Event|15
110835|NCT00970268|410658|P2|Overall Study|Withdrawal by Subject|19
110836|NCT00970268|410659|P1|Overall Study|Withdrawal by Subject|12
110837|NCT00969709|410692|P4|Overall Study|Other reasons|0
110838|NCT00969709|410693|P3|Overall Study|Other reasons|3
110839|NCT00969709|410694|P2|Overall Study|Other reasons|0
110840|NCT00969709|410695|P1|Overall Study|Other reasons|0
110841|NCT00969709|410692|P4|Overall Study|Lost to Follow-up|15
110842|NCT00969709|410693|P3|Overall Study|Lost to Follow-up|8
110843|NCT00969709|410694|P2|Overall Study|Lost to Follow-up|14
110844|NCT00969709|410695|P1|Overall Study|Lost to Follow-up|10
110845|NCT00969709|410692|P4|Overall Study|Withdrawal by Subject|23
110846|NCT00969709|410693|P3|Overall Study|Withdrawal by Subject|11
110847|NCT00969709|410694|P2|Overall Study|Withdrawal by Subject|12
110848|NCT00969709|410695|P1|Overall Study|Withdrawal by Subject|9
110849|NCT00969709|410692|P4|Overall Study|Protocol Violation|10
110850|NCT00969709|410693|P3|Overall Study|Protocol Violation|9
110851|NCT00969709|410694|P2|Overall Study|Protocol Violation|5
110852|NCT00969709|410695|P1|Overall Study|Protocol Violation|9
110853|NCT00969709|410692|P4|Overall Study|Lack of Efficacy|3
110854|NCT00969709|410693|P3|Overall Study|Lack of Efficacy|1
110855|NCT00969709|410694|P2|Overall Study|Lack of Efficacy|4
110856|NCT00969709|410695|P1|Overall Study|Lack of Efficacy|7
110857|NCT00969709|410692|P4|Overall Study|Adverse Event|12
110858|NCT00969709|410693|P3|Overall Study|Adverse Event|26
110859|NCT00969709|410694|P2|Overall Study|Adverse Event|13
110860|NCT00969709|410695|P1|Overall Study|Adverse Event|3
110861|NCT00969618|410709|P1|Overall Study|Withdrawal by Subject|27
110862|NCT00969618|410709|P1|Overall Study|Protocol Violation|9
110863|NCT00969618|410709|P1|Overall Study|Physician Decision|1
110864|NCT00969618|410709|P1|Overall Study|Lost to Follow-up|7
110865|NCT00969618|410709|P1|Overall Study|Lack of Efficacy|2
110866|NCT00969618|410709|P1|Overall Study|Entry Criteria Not Met|3
110867|NCT00969618|410709|P1|Overall Study|Adverse Event|29
110868|NCT00969540|410722|P2|Overall Study|Lost to Follow-up|1
110869|NCT00969540|410723|P1|Overall Study|Lost to Follow-up|1
110870|NCT00969436|410748|P3|Overall Study|Lost to Follow-up|5
110871|NCT00969436|410749|P2|Overall Study|Lost to Follow-up|8
110872|NCT00969436|410750|P1|Overall Study|Lost to Follow-up|8
110873|NCT00969436|410748|P3|Overall Study|Withdrawal by Subject|2
110874|NCT00969436|410749|P2|Overall Study|Withdrawal by Subject|0
110875|NCT00969436|410750|P1|Overall Study|Withdrawal by Subject|3
110876|NCT00969436|410748|P3|Overall Study|Subject eliminated (other vaccine)|0
110877|NCT00969436|410749|P2|Overall Study|Subject eliminated (other vaccine)|0
110878|NCT00969436|410750|P1|Overall Study|Subject eliminated (other vaccine)|1
110879|NCT00969436|410748|P3|Overall Study|Parents personal problem|1
110880|NCT00969436|410749|P2|Overall Study|Parents personal problem|0
110881|NCT00969436|410750|P1|Overall Study|Parents personal problem|0
110882|NCT00969436|410748|P3|Overall Study|Father - serious health problem|1
110883|NCT00969436|410749|P2|Overall Study|Father - serious health problem|0
110884|NCT00969436|410750|P1|Overall Study|Father - serious health problem|0
110885|NCT00969436|410748|P3|Overall Study|Migrated/moved from study area|2
110886|NCT00969436|410749|P2|Overall Study|Migrated/moved from study area|10
110887|NCT00969436|410750|P1|Overall Study|Migrated/moved from study area|12
110888|NCT00969436|410748|P3|Overall Study|Protocol Violation|0
110889|NCT00969436|410749|P2|Overall Study|Protocol Violation|3
110890|NCT00969436|410750|P1|Overall Study|Protocol Violation|1
110891|NCT00969280|410784|P2|Overall Study|infection of influenza A(H1N1)|1
110892|NCT00969280|410785|P1|Overall Study|infection of influenza A(H1N1)|0
110893|NCT00969280|410784|P2|Overall Study|Withdrawal by Subject|1
110894|NCT00969280|410785|P1|Overall Study|Withdrawal by Subject|0
110895|NCT00969280|410784|P2|Overall Study|Protocol Violation|1
110896|NCT00969280|410785|P1|Overall Study|Protocol Violation|2
110897|NCT00969228|410793|P2|Overall Study|Porcine circovirus detection in vaccine|14
110898|NCT00969228|410794|P1|Overall Study|Porcine circovirus detection in vaccine|38
110899|NCT00969228|410793|P2|Overall Study|Withdrawal by Subject|0
110900|NCT00969228|410794|P1|Overall Study|Withdrawal by Subject|4
110901|NCT00969228|410793|P2|Overall Study|Adverse Event|0
110902|NCT00969228|410794|P1|Overall Study|Adverse Event|1
110903|NCT00969150|410812|P2|Overall Study|Other reasons|0
110904|NCT00969150|410813|P1|Overall Study|Other reasons|1
110905|NCT00969150|410812|P2|Overall Study|Lost to Follow-up|4
110906|NCT00969150|410813|P1|Overall Study|Lost to Follow-up|5
110907|NCT00969150|410812|P2|Overall Study|Withdrawal by Subject|9
110908|NCT00969150|410813|P1|Overall Study|Withdrawal by Subject|13
110909|NCT00969150|410812|P2|Overall Study|Protocol Violation|12
110910|NCT00969150|410813|P1|Overall Study|Protocol Violation|9
110911|NCT00969150|410812|P2|Overall Study|Lack of Efficacy|1
110912|NCT00969150|410813|P1|Overall Study|Lack of Efficacy|1
110913|NCT00969150|410812|P2|Overall Study|Adverse Event|14
110914|NCT00969150|410813|P1|Overall Study|Adverse Event|4
110915|NCT00969124|410821|P1|Overall Study|Technical error|1
110916|NCT00969124|410821|P1|Overall Study|Previously unrecognized disease|3
110917|NCT00969124|410821|P1|Overall Study|Inability to reach cecum|9
110918|NCT00969124|410821|P1|Overall Study|Inadequate bowel preparation|15
110919|NCT00969124|410821|P1|Overall Study|Protocol Violation|2
110920|NCT00968981|410830|P3|Overall Study|Withdrawal by Subject|3
110921|NCT00968981|410831|P2|Overall Study|Withdrawal by Subject|3
110922|NCT00968981|410832|P1|Overall Study|Withdrawal by Subject|1
110923|NCT00968981|410830|P3|Overall Study|Physician Decision|5
110924|NCT00968981|410831|P2|Overall Study|Physician Decision|3
110925|NCT00968981|410832|P1|Overall Study|Physician Decision|5
110926|NCT00968981|410830|P3|Overall Study|Lost to Follow-up|1
110927|NCT00968981|410831|P2|Overall Study|Lost to Follow-up|0
110928|NCT00968981|410832|P1|Overall Study|Lost to Follow-up|0
110929|NCT00968981|410830|P3|Overall Study|Disease Progression|13
110930|NCT00968981|410831|P2|Overall Study|Disease Progression|16
110931|NCT00968981|410832|P1|Overall Study|Disease Progression|14
110932|NCT00968981|410830|P3|Overall Study|Adverse Event|0
110933|NCT00968981|410831|P2|Overall Study|Adverse Event|0
110934|NCT00968981|410832|P1|Overall Study|Adverse Event|2
110935|NCT00968864|410899|P1|Overall Study|Protocol exception/ not evaluable|1
110936|NCT00968812|410927|P3|Overall Study|Not specified|40
110937|NCT00968812|410928|P2|Overall Study|Not specified|37
110938|NCT00968812|410929|P1|Overall Study|Not specified|25
110939|NCT00968812|410927|P3|Overall Study|Unable to take rescue therapy|17
110940|NCT00968812|410928|P2|Overall Study|Unable to take rescue therapy|12
110941|NCT00968812|410929|P1|Overall Study|Unable to take rescue therapy|12
110942|NCT00968812|410927|P3|Overall Study|Noncompliance with study drug|6
110943|NCT00968812|410928|P2|Overall Study|Noncompliance with study drug|1
110944|NCT00968812|410929|P1|Overall Study|Noncompliance with study drug|4
110945|NCT00968812|410927|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
110946|NCT00968812|410928|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
110947|NCT00968812|410929|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
110948|NCT00968812|410927|P3|Overall Study|Withdrawal by Subject|25
110949|NCT00968812|410928|P2|Overall Study|Withdrawal by Subject|23
110950|NCT00968812|410929|P1|Overall Study|Withdrawal by Subject|17
110951|NCT00968812|410927|P3|Overall Study|Protocol Violation|3
110952|NCT00968812|410928|P2|Overall Study|Protocol Violation|4
110953|NCT00968812|410929|P1|Overall Study|Protocol Violation|7
110954|NCT00968812|410927|P3|Overall Study|Physician Decision|9
110955|NCT00968812|410928|P2|Overall Study|Physician Decision|5
110956|NCT00968812|410929|P1|Overall Study|Physician Decision|8
110957|NCT00968812|410927|P3|Overall Study|Lost to Follow-up|11
110958|NCT00968812|410928|P2|Overall Study|Lost to Follow-up|12
110959|NCT00968812|410929|P1|Overall Study|Lost to Follow-up|17
110960|NCT00968812|410927|P3|Overall Study|Lack of Efficacy|16
110961|NCT00968812|410928|P2|Overall Study|Lack of Efficacy|7
110962|NCT00968812|410929|P1|Overall Study|Lack of Efficacy|9
110963|NCT00968812|410927|P3|Overall Study|Death|1
110964|NCT00968812|410928|P2|Overall Study|Death|2
110965|NCT00968812|410929|P1|Overall Study|Death|2
110966|NCT00968812|410927|P3|Overall Study|Adverse Event|33
110967|NCT00968812|410928|P2|Overall Study|Adverse Event|46
110968|NCT00968812|410929|P1|Overall Study|Adverse Event|30
110969|NCT00968799|410949|P1|Overall Study|Advanced disease, HIPEC not applicable|2
110970|NCT00968708|410959|P2|Overall Study|Other|34
110971|NCT00968708|410960|P1|Overall Study|Other|26
110972|NCT00968708|410959|P2|Overall Study|Investigator Discretion|1
110973|NCT00968708|410960|P1|Overall Study|Investigator Discretion|0
110974|NCT00968708|410959|P2|Overall Study|Voluntary Withdrawal|101
110975|NCT00968708|410960|P1|Overall Study|Voluntary Withdrawal|104
110976|NCT00968708|410959|P2|Overall Study|Lost to Follow-up|11
110977|NCT00968708|410960|P1|Overall Study|Lost to Follow-up|19
110978|NCT00968708|410959|P2|Overall Study|Major Protocol Deviation|1
110979|NCT00968708|410960|P1|Overall Study|Major Protocol Deviation|0
110980|NCT00968708|410959|P2|Overall Study|Adverse Event|150
110981|NCT00968708|410960|P1|Overall Study|Adverse Event|169
110982|NCT00968669|410972|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
110983|NCT00968669|410973|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
110984|NCT00968669|410974|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
110985|NCT00968669|410975|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
110986|NCT00968669|410972|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
110987|NCT00968669|410973|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
110988|NCT00968669|410974|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
110989|NCT00968669|410975|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
110990|NCT00968669|410972|P4|Overall Study|SUBJECT INCARCERATED|0
110991|NCT00968669|410973|P3|Overall Study|SUBJECT INCARCERATED|0
110992|NCT00968669|410974|P2|Overall Study|SUBJECT INCARCERATED|1
110993|NCT00968669|410975|P1|Overall Study|SUBJECT INCARCERATED|0
110994|NCT00968669|410972|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
110995|NCT00968669|410973|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
110996|NCT00968669|410974|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
110997|NCT00968669|410975|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
110998|NCT00968669|410972|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
110999|NCT00968669|410973|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
111000|NCT00968669|410974|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
111001|NCT00968669|410975|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
111002|NCT00968669|410972|P4|Overall Study|SPONSOR DECISION|0
111003|NCT00968669|410973|P3|Overall Study|SPONSOR DECISION|0
111004|NCT00968669|410974|P2|Overall Study|SPONSOR DECISION|1
111005|NCT00968669|410975|P1|Overall Study|SPONSOR DECISION|0
111006|NCT00968669|410972|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
111007|NCT00968669|410973|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
111008|NCT00968669|410974|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
111009|NCT00968669|410975|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
111010|NCT00968669|410972|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
111011|NCT00968669|410973|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
111012|NCT00968669|410974|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
111013|NCT00968669|410975|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
111014|NCT00968669|410972|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
111015|NCT00968669|410973|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
111016|NCT00968669|410974|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
111017|NCT00968669|410975|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
111018|NCT00968669|410972|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
111019|NCT00968669|410973|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
111020|NCT00968669|410974|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
111021|NCT00968669|410975|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
111022|NCT00968669|410972|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
111023|NCT00968669|410973|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
111024|NCT00968669|410974|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
111025|NCT00968669|410975|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
111026|NCT00968669|410972|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
111027|NCT00968669|410973|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
111028|NCT00968669|410974|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
111029|NCT00968669|410975|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
111030|NCT00968669|410972|P4|Overall Study|EARLY WITHDRAWAL|0
111031|NCT00968669|410973|P3|Overall Study|EARLY WITHDRAWAL|0
111032|NCT00968669|410974|P2|Overall Study|EARLY WITHDRAWAL|1
111033|NCT00968669|410975|P1|Overall Study|EARLY WITHDRAWAL|0
111034|NCT00968669|410972|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
111035|NCT00968669|410973|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
111036|NCT00968669|410974|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
111037|NCT00968669|410975|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
111038|NCT00968669|410972|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
111039|NCT00968669|410973|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
111040|NCT00968669|410974|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
111041|NCT00968669|410975|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
111042|NCT00968669|410972|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
111043|NCT00968669|410973|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
111044|NCT00968669|410974|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
111045|NCT00968669|410975|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
111046|NCT00968669|410972|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
111047|NCT00968669|410973|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
111048|NCT00968669|410974|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
111049|NCT00968669|410975|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
111050|NCT00968669|410972|P4|Overall Study|AE|0
111051|NCT00968669|410973|P3|Overall Study|AE|0
111052|NCT00968669|410974|P2|Overall Study|AE|0
111053|NCT00968669|410975|P1|Overall Study|AE|1
111054|NCT00968669|410972|P4|Overall Study|Pregnancy|0
111055|NCT00968669|410973|P3|Overall Study|Pregnancy|2
111056|NCT00968669|410974|P2|Overall Study|Pregnancy|0
111057|NCT00968669|410975|P1|Overall Study|Pregnancy|0
111058|NCT00968669|410972|P4|Overall Study|Withdrawal by Subject|3
111059|NCT00968669|410973|P3|Overall Study|Withdrawal by Subject|5
111060|NCT00968669|410974|P2|Overall Study|Withdrawal by Subject|7
111061|NCT00968669|410975|P1|Overall Study|Withdrawal by Subject|9
111062|NCT00968669|410972|P4|Overall Study|Lost to Follow-up|4
111063|NCT00968669|410973|P3|Overall Study|Lost to Follow-up|1
111064|NCT00968669|410974|P2|Overall Study|Lost to Follow-up|2
111065|NCT00968669|410975|P1|Overall Study|Lost to Follow-up|5
111066|NCT00968617|411065|P1|Overall Study|Study terminated by sponsor|6
111067|NCT00968539|411079|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
111068|NCT00968539|411080|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
111069|NCT00968253|411141|P3|Overall Study|Adverse Event|1
111070|NCT00968253|411142|P2|Overall Study|Adverse Event|0
111071|NCT00968253|411143|P1|Overall Study|Adverse Event|0
111072|NCT00968253|411141|P3|Overall Study|Disease Progression|3
111073|NCT00968253|411142|P2|Overall Study|Disease Progression|3
111074|NCT00968253|411143|P1|Overall Study|Disease Progression|0
111075|NCT00968253|411141|P3|Overall Study|Withdrawal by Subject|1
111076|NCT00968253|411142|P2|Overall Study|Withdrawal by Subject|0
111077|NCT00968253|411143|P1|Overall Study|Withdrawal by Subject|0
111078|NCT00968253|411141|P3|Overall Study|Death|2
111079|NCT00968253|411142|P2|Overall Study|Death|0
111080|NCT00968253|411143|P1|Overall Study|Death|0
111081|NCT00968201|411164|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
111082|NCT00968201|411165|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
111083|NCT00968201|411166|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
111084|NCT00968201|411164|P3|Extension Study - (Period III)|Not Specified|2
111085|NCT00968201|411165|P2|Extension Study - (Period III)|Not Specified|0
111086|NCT00968201|411166|P1|Extension Study - (Period III)|Not Specified|0
111087|NCT00968201|411164|P3|Extension Study - (Period III)|Noncompliance|3
111088|NCT00968201|411165|P2|Extension Study - (Period III)|Noncompliance|0
111089|NCT00968201|411166|P1|Extension Study - (Period III)|Noncompliance|0
111090|NCT00968201|411164|P3|Extension Study - (Period III)|Patient Relocated|1
111091|NCT00968201|411165|P2|Extension Study - (Period III)|Patient Relocated|1
111092|NCT00968201|411166|P1|Extension Study - (Period III)|Patient Relocated|0
111093|NCT00968201|411164|P3|Extension Study - (Period III)|Withdrawal by Subject|40
111094|NCT00968201|411165|P2|Extension Study - (Period III)|Withdrawal by Subject|20
111095|NCT00968201|411166|P1|Extension Study - (Period III)|Withdrawal by Subject|0
111096|NCT00968201|411164|P3|Extension Study - (Period III)|Protocol Violation|14
111097|NCT00968201|411165|P2|Extension Study - (Period III)|Protocol Violation|17
111098|NCT00968201|411166|P1|Extension Study - (Period III)|Protocol Violation|0
111099|NCT00968201|411164|P3|Extension Study - (Period III)|Lost to Follow-up|13
111100|NCT00968201|411165|P2|Extension Study - (Period III)|Lost to Follow-up|7
111101|NCT00968201|411166|P1|Extension Study - (Period III)|Lost to Follow-up|0
111102|NCT00968201|411164|P3|Extension Study - (Period III)|Adverse Event|22
111103|NCT00968201|411165|P2|Extension Study - (Period III)|Adverse Event|5
111104|NCT00968201|411166|P1|Extension Study - (Period III)|Adverse Event|0
111105|NCT00968201|411164|P3|Base Study - (Period II)|Site Error|1
111106|NCT00968201|411165|P2|Base Study - (Period II)|Site Error|0
111107|NCT00968201|411166|P1|Base Study - (Period II)|Site Error|0
111108|NCT00968201|411164|P3|Base Study - (Period II)|Withdrawal by Subject|8
111109|NCT00968201|411165|P2|Base Study - (Period II)|Withdrawal by Subject|0
111110|NCT00968201|411166|P1|Base Study - (Period II)|Withdrawal by Subject|4
111111|NCT00968201|411164|P3|Base Study - (Period II)|Protocol Violation|12
111112|NCT00968201|411165|P2|Base Study - (Period II)|Protocol Violation|0
111113|NCT00968201|411166|P1|Base Study - (Period II)|Protocol Violation|12
111114|NCT00968201|411164|P3|Base Study - (Period II)|Lost to Follow-up|7
111115|NCT00968201|411165|P2|Base Study - (Period II)|Lost to Follow-up|0
111116|NCT00968201|411166|P1|Base Study - (Period II)|Lost to Follow-up|2
111117|NCT00968201|411164|P3|Base Study - (Period II)|Lack of Efficacy|1
111118|NCT00968201|411165|P2|Base Study - (Period II)|Lack of Efficacy|0
111119|NCT00968201|411166|P1|Base Study - (Period II)|Lack of Efficacy|0
111120|NCT00968201|411164|P3|Base Study - (Period II)|Adverse Event|16
111121|NCT00968201|411165|P2|Base Study - (Period II)|Adverse Event|0
111122|NCT00968201|411166|P1|Base Study - (Period II)|Adverse Event|8
111123|NCT00968149|411227|P2|Overall Study|Withdrawal by Subject|0
111124|NCT00968149|411228|P1|Overall Study|Withdrawal by Subject|2
111125|NCT00968149|411227|P2|Overall Study|Protocol Violation|0
111126|NCT00968149|411228|P1|Overall Study|Protocol Violation|4
111127|NCT00968149|411227|P2|Overall Study|Lost to Follow-up|1
111128|NCT00968149|411228|P1|Overall Study|Lost to Follow-up|0
111129|NCT00968149|411227|P2|Overall Study|Lack of Efficacy|4
111130|NCT00968149|411228|P1|Overall Study|Lack of Efficacy|0
111131|NCT00968149|411227|P2|Overall Study|Adverse Event|1
111132|NCT00968149|411228|P1|Overall Study|Adverse Event|5
111133|NCT00967694|411281|P1|Overall Study|Withdrawal by Subject|6
111134|NCT00967668|411288|P3|Overall Study|Pregnancy|0
111135|NCT00967668|411289|P2|Overall Study|Pregnancy|0
111136|NCT00967668|411290|P1|Overall Study|Pregnancy|1
111137|NCT00967668|411288|P3|Overall Study|Refused 12-mo assessment|9
111138|NCT00967668|411289|P2|Overall Study|Refused 12-mo assessment|1
111139|NCT00967668|411290|P1|Overall Study|Refused 12-mo assessment|3
111140|NCT00967668|411288|P3|Overall Study|Lost to Follow-up|16
111141|NCT00967668|411289|P2|Overall Study|Lost to Follow-up|9
111142|NCT00967668|411290|P1|Overall Study|Lost to Follow-up|15
111143|NCT00967668|411288|P3|Overall Study|Lost to follow-up at 12-mo|26
111144|NCT00967668|411289|P2|Overall Study|Lost to follow-up at 12-mo|29
111145|NCT00967668|411290|P1|Overall Study|Lost to follow-up at 12-mo|27
111146|NCT00967668|411288|P3|Overall Study|Refused Year 2|4
111147|NCT00967668|411289|P2|Overall Study|Refused Year 2|6
111148|NCT00967668|411290|P1|Overall Study|Refused Year 2|11
111149|NCT00967668|411288|P3|Overall Study|Removed due to behavior|2
111150|NCT00967668|411289|P2|Overall Study|Removed due to behavior|1
111151|NCT00967668|411290|P1|Overall Study|Removed due to behavior|1
111152|NCT00967668|411288|P3|Overall Study|Death|4
111153|NCT00967668|411289|P2|Overall Study|Death|2
111154|NCT00967668|411290|P1|Overall Study|Death|0
111155|NCT00967668|411288|P3|Overall Study|Withdrawal by Subject|8
111156|NCT00967668|411289|P2|Overall Study|Withdrawal by Subject|8
111157|NCT00967668|411290|P1|Overall Study|Withdrawal by Subject|13
111158|NCT00967330|411336|P2|Overall Study|Severe protocol deviation|1
111159|NCT00967330|411337|P1|Overall Study|Severe protocol deviation|0
111160|NCT00967330|411336|P2|Overall Study|Death|51
111161|NCT00967330|411337|P1|Overall Study|Death|102
111162|NCT00967330|411336|P2|Overall Study|Lost to Follow-up|1
111163|NCT00967330|411337|P1|Overall Study|Lost to Follow-up|1
111164|NCT00967330|411336|P2|Overall Study|Withdrawal by Subject|0
111165|NCT00967330|411337|P1|Overall Study|Withdrawal by Subject|6
111166|NCT00967330|411336|P2|Overall Study|Regular|3
111167|NCT00967330|411337|P1|Overall Study|Regular|10
111168|NCT00967330|411336|P2|Overall Study|Protocol Violation|4
111169|NCT00967330|411337|P1|Overall Study|Protocol Violation|3
111170|NCT00967226|411367|P2|Overall Study|Physician Decision|1
111171|NCT00967226|411368|P1|Overall Study|Physician Decision|0
111172|NCT00967226|411367|P2|Overall Study|Protocol Violation|0
111173|NCT00967226|411368|P1|Overall Study|Protocol Violation|2
111174|NCT00967226|411367|P2|Overall Study|Adverse Event|5
111175|NCT00967226|411368|P1|Overall Study|Adverse Event|0
111176|NCT00967018|411402|P1|Overall Study|Miscellaneous Reasons|9
111177|NCT00967018|411402|P1|Overall Study|Withdrawal by Subject|1
111178|NCT00967018|411402|P1|Overall Study|Lost to Follow-up|2
111179|NCT00967018|411402|P1|Overall Study|Physician Decision|7
111180|NCT00967018|411402|P1|Overall Study|Adverse Event|2
111181|NCT00967005|411411|P2|Overall Study|Lost to Follow-up|10
111182|NCT00967005|411412|P1|Overall Study|Lost to Follow-up|7
111183|NCT00966940|411498|P2|Period 1, First 6 Weeks|Protocol Violation|0
111184|NCT00966940|411499|P1|Period 1, First 6 Weeks|Protocol Violation|1
111185|NCT00966940|411498|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
111186|NCT00966940|411499|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
111187|NCT00966875|411526|P9|Part B|Entry Criteria|1
111188|NCT00966875|411527|P8|Part B|Entry Criteria|0
111189|NCT00966875|411528|P7|Part B|Entry Criteria|1
111190|NCT00966875|411529|P6|Part B|Entry Criteria|0
111191|NCT00966875|411530|P5|Part B|Entry Criteria|0
111192|NCT00966875|411531|P4|Part B|Entry Criteria|0
111193|NCT00966875|411532|P3|Part B|Entry Criteria|0
111194|NCT00966875|411533|P2|Part B|Entry Criteria|0
111195|NCT00966875|411534|P1|Part B|Entry Criteria|0
111196|NCT00966875|411526|P9|Part B|Withdrawal by Subject|5
111197|NCT00966875|411527|P8|Part B|Withdrawal by Subject|5
111198|NCT00966875|411528|P7|Part B|Withdrawal by Subject|4
111199|NCT00966875|411529|P6|Part B|Withdrawal by Subject|1
111200|NCT00966875|411530|P5|Part B|Withdrawal by Subject|2
111201|NCT00966875|411531|P4|Part B|Withdrawal by Subject|1
111202|NCT00966875|411532|P3|Part B|Withdrawal by Subject|2
111203|NCT00966875|411533|P2|Part B|Withdrawal by Subject|1
111204|NCT00966875|411534|P1|Part B|Withdrawal by Subject|2
111205|NCT00966875|411526|P9|Part B|Sponsor Decision|1
111206|NCT00966875|411527|P8|Part B|Sponsor Decision|2
111207|NCT00966875|411528|P7|Part B|Sponsor Decision|0
111208|NCT00966875|411529|P6|Part B|Sponsor Decision|1
111209|NCT00966875|411530|P5|Part B|Sponsor Decision|0
111210|NCT00966875|411531|P4|Part B|Sponsor Decision|0
111211|NCT00966875|411532|P3|Part B|Sponsor Decision|0
111212|NCT00966875|411533|P2|Part B|Sponsor Decision|0
111213|NCT00966875|411534|P1|Part B|Sponsor Decision|1
111214|NCT00966875|411526|P9|Part B|Physician Decision|2
111215|NCT00966875|411527|P8|Part B|Physician Decision|0
111216|NCT00966875|411528|P7|Part B|Physician Decision|0
111217|NCT00966875|411529|P6|Part B|Physician Decision|1
111218|NCT00966875|411530|P5|Part B|Physician Decision|2
111219|NCT00966875|411531|P4|Part B|Physician Decision|0
111220|NCT00966875|411532|P3|Part B|Physician Decision|1
111221|NCT00966875|411533|P2|Part B|Physician Decision|0
111222|NCT00966875|411534|P1|Part B|Physician Decision|0
111223|NCT00966875|411526|P9|Part B|Lost to Follow-up|1
111224|NCT00966875|411527|P8|Part B|Lost to Follow-up|0
111225|NCT00966875|411528|P7|Part B|Lost to Follow-up|0
111226|NCT00966875|411529|P6|Part B|Lost to Follow-up|0
111227|NCT00966875|411530|P5|Part B|Lost to Follow-up|0
111228|NCT00966875|411531|P4|Part B|Lost to Follow-up|1
111229|NCT00966875|411532|P3|Part B|Lost to Follow-up|0
111230|NCT00966875|411533|P2|Part B|Lost to Follow-up|0
111231|NCT00966875|411534|P1|Part B|Lost to Follow-up|0
111232|NCT00966875|411526|P9|Part B|Lack of Efficacy|6
111233|NCT00966875|411527|P8|Part B|Lack of Efficacy|9
111234|NCT00966875|411528|P7|Part B|Lack of Efficacy|12
111235|NCT00966875|411529|P6|Part B|Lack of Efficacy|3
111236|NCT00966875|411530|P5|Part B|Lack of Efficacy|2
111237|NCT00966875|411531|P4|Part B|Lack of Efficacy|1
111238|NCT00966875|411532|P3|Part B|Lack of Efficacy|1
111239|NCT00966875|411533|P2|Part B|Lack of Efficacy|1
111240|NCT00966875|411534|P1|Part B|Lack of Efficacy|2
111241|NCT00966875|411526|P9|Part B|Death|0
111242|NCT00966875|411527|P8|Part B|Death|1
111243|NCT00966875|411528|P7|Part B|Death|0
111244|NCT00966875|411529|P6|Part B|Death|0
111245|NCT00966875|411530|P5|Part B|Death|0
111246|NCT00966875|411531|P4|Part B|Death|0
111247|NCT00966875|411532|P3|Part B|Death|1
111248|NCT00966875|411533|P2|Part B|Death|0
111249|NCT00966875|411534|P1|Part B|Death|0
111250|NCT00966875|411526|P9|Part B|Adverse Event|2
111251|NCT00966875|411527|P8|Part B|Adverse Event|2
111252|NCT00966875|411528|P7|Part B|Adverse Event|5
111253|NCT00966875|411529|P6|Part B|Adverse Event|0
111254|NCT00966875|411530|P5|Part B|Adverse Event|1
111255|NCT00966875|411531|P4|Part B|Adverse Event|0
111256|NCT00966875|411532|P3|Part B|Adverse Event|1
111257|NCT00966875|411533|P2|Part B|Adverse Event|1
111258|NCT00966875|411534|P1|Part B|Adverse Event|0
111259|NCT00966875|411526|P9|Part A|Protocol Violation|1
111260|NCT00966875|411527|P8|Part A|Protocol Violation|1
111261|NCT00966875|411528|P7|Part A|Protocol Violation|2
111262|NCT00966875|411529|P6|Part A|Protocol Violation|0
111263|NCT00966875|411530|P5|Part A|Protocol Violation|0
111264|NCT00966875|411531|P4|Part A|Protocol Violation|0
111265|NCT00966875|411532|P3|Part A|Protocol Violation|0
111266|NCT00966875|411533|P2|Part A|Protocol Violation|0
111267|NCT00966875|411534|P1|Part A|Protocol Violation|0
111268|NCT00966875|411526|P9|Part A|Withdrawal by Subject|1
111269|NCT00966875|411527|P8|Part A|Withdrawal by Subject|1
111270|NCT00966875|411528|P7|Part A|Withdrawal by Subject|5
111271|NCT00966875|411529|P6|Part A|Withdrawal by Subject|0
111272|NCT00966875|411530|P5|Part A|Withdrawal by Subject|3
111273|NCT00966875|411531|P4|Part A|Withdrawal by Subject|1
111274|NCT00966875|411532|P3|Part A|Withdrawal by Subject|1
111275|NCT00966875|411533|P2|Part A|Withdrawal by Subject|2
111276|NCT00966875|411534|P1|Part A|Withdrawal by Subject|2
111277|NCT00966875|411526|P9|Part A|Sponsor Decision|1
111278|NCT00966875|411527|P8|Part A|Sponsor Decision|2
111279|NCT00966875|411528|P7|Part A|Sponsor Decision|0
111280|NCT00966875|411529|P6|Part A|Sponsor Decision|0
111281|NCT00966875|411530|P5|Part A|Sponsor Decision|1
111282|NCT00966875|411531|P4|Part A|Sponsor Decision|0
111283|NCT00966875|411532|P3|Part A|Sponsor Decision|1
111284|NCT00966875|411533|P2|Part A|Sponsor Decision|0
111285|NCT00966875|411534|P1|Part A|Sponsor Decision|0
111286|NCT00966875|411526|P9|Part A|Physician Decision|2
111287|NCT00966875|411527|P8|Part A|Physician Decision|0
111288|NCT00966875|411528|P7|Part A|Physician Decision|1
111289|NCT00966875|411529|P6|Part A|Physician Decision|0
111290|NCT00966875|411530|P5|Part A|Physician Decision|1
111291|NCT00966875|411531|P4|Part A|Physician Decision|0
111292|NCT00966875|411532|P3|Part A|Physician Decision|0
111293|NCT00966875|411533|P2|Part A|Physician Decision|0
111294|NCT00966875|411534|P1|Part A|Physician Decision|0
111295|NCT00966875|411526|P9|Part A|Parent/Caregiver Decision|0
111296|NCT00966875|411527|P8|Part A|Parent/Caregiver Decision|0
111297|NCT00966875|411528|P7|Part A|Parent/Caregiver Decision|0
111298|NCT00966875|411529|P6|Part A|Parent/Caregiver Decision|0
111299|NCT00966875|411530|P5|Part A|Parent/Caregiver Decision|0
111300|NCT00966875|411531|P4|Part A|Parent/Caregiver Decision|1
111301|NCT00966875|411532|P3|Part A|Parent/Caregiver Decision|0
111302|NCT00966875|411533|P2|Part A|Parent/Caregiver Decision|0
111303|NCT00966875|411534|P1|Part A|Parent/Caregiver Decision|0
111304|NCT00966875|411526|P9|Part A|Lost to Follow-up|0
111305|NCT00966875|411527|P8|Part A|Lost to Follow-up|0
111306|NCT00966875|411528|P7|Part A|Lost to Follow-up|0
111307|NCT00966875|411529|P6|Part A|Lost to Follow-up|1
111308|NCT00966875|411530|P5|Part A|Lost to Follow-up|0
111309|NCT00966875|411531|P4|Part A|Lost to Follow-up|0
111310|NCT00966875|411532|P3|Part A|Lost to Follow-up|0
111311|NCT00966875|411533|P2|Part A|Lost to Follow-up|0
111312|NCT00966875|411534|P1|Part A|Lost to Follow-up|2
111313|NCT00966875|411526|P9|Part A|Lack of Efficacy|0
111314|NCT00966875|411527|P8|Part A|Lack of Efficacy|0
111315|NCT00966875|411528|P7|Part A|Lack of Efficacy|4
111316|NCT00966875|411529|P6|Part A|Lack of Efficacy|0
111317|NCT00966875|411530|P5|Part A|Lack of Efficacy|0
111318|NCT00966875|411531|P4|Part A|Lack of Efficacy|0
111319|NCT00966875|411532|P3|Part A|Lack of Efficacy|0
111320|NCT00966875|411533|P2|Part A|Lack of Efficacy|1
111321|NCT00966875|411534|P1|Part A|Lack of Efficacy|0
111322|NCT00966875|411526|P9|Part A|Entry Criteria|0
111323|NCT00966875|411527|P8|Part A|Entry Criteria|0
111324|NCT00966875|411528|P7|Part A|Entry Criteria|0
111325|NCT00966875|411529|P6|Part A|Entry Criteria|2
111326|NCT00966875|411530|P5|Part A|Entry Criteria|0
111327|NCT00966875|411531|P4|Part A|Entry Criteria|0
111328|NCT00966875|411532|P3|Part A|Entry Criteria|0
111329|NCT00966875|411533|P2|Part A|Entry Criteria|0
111330|NCT00966875|411534|P1|Part A|Entry Criteria|0
111331|NCT00966875|411526|P9|Part A|Adverse Event|3
111332|NCT00966875|411527|P8|Part A|Adverse Event|3
111333|NCT00966875|411528|P7|Part A|Adverse Event|0
111334|NCT00966875|411529|P6|Part A|Adverse Event|1
111335|NCT00966875|411530|P5|Part A|Adverse Event|0
111336|NCT00966875|411531|P4|Part A|Adverse Event|1
111337|NCT00966875|411532|P3|Part A|Adverse Event|0
111338|NCT00966875|411533|P2|Part A|Adverse Event|1
111339|NCT00966875|411534|P1|Part A|Adverse Event|2
111340|NCT00966654|411861|P1|Overall Study|Study was terminated,PI left institution|12
111341|NCT00966355|411907|P3|Overall Study|Lost to Follow-up|3
111342|NCT00966355|411908|P2|Overall Study|Lost to Follow-up|4
111343|NCT00966355|411909|P1|Overall Study|Lost to Follow-up|5
111344|NCT00966355|411907|P3|Overall Study|newly diagnosed advanced HCC|10
111345|NCT00966355|411908|P2|Overall Study|newly diagnosed advanced HCC|12
111346|NCT00966355|411909|P1|Overall Study|newly diagnosed advanced HCC|11
111347|NCT00966355|411907|P3|Overall Study|non-variceal bleeding on endoscopy|71
111348|NCT00966355|411908|P2|Overall Study|non-variceal bleeding on endoscopy|70
111349|NCT00966355|411909|P1|Overall Study|non-variceal bleeding on endoscopy|68
111350|NCT00966277|411922|P2|Overall Study|Treatment Plan Changed|1
111351|NCT00966277|411923|P1|Overall Study|Treatment Plan Changed|0
111352|NCT00966277|411922|P2|Overall Study|Ineligible|3
111353|NCT00966277|411923|P1|Overall Study|Ineligible|1
111354|NCT00966277|411922|P2|Overall Study|Withdrawal by Subject|0
111355|NCT00966277|411923|P1|Overall Study|Withdrawal by Subject|3
111356|NCT00966264|411931|P2|Overall Study|Lost to Follow-up|3
111357|NCT00966264|411932|P1|Overall Study|Lost to Follow-up|4
111358|NCT00965848|411978|P3|Overall Study|Other|1
111359|NCT00965848|411979|P2|Overall Study|Other|0
111360|NCT00965848|411980|P1|Overall Study|Other|5
111361|NCT00965848|411978|P3|Overall Study|Not Clinically Evaluable|1
111362|NCT00965848|411979|P2|Overall Study|Not Clinically Evaluable|1
111363|NCT00965848|411980|P1|Overall Study|Not Clinically Evaluable|7
111364|NCT00965848|411978|P3|Overall Study|Indeterminate Clinical Outcome|1
111365|NCT00965848|411979|P2|Overall Study|Indeterminate Clinical Outcome|0
111366|NCT00965848|411980|P1|Overall Study|Indeterminate Clinical Outcome|2
111367|NCT00965848|411978|P3|Overall Study|Withdrawal by Subject|0
111368|NCT00965848|411979|P2|Overall Study|Withdrawal by Subject|0
111369|NCT00965848|411980|P1|Overall Study|Withdrawal by Subject|1
111370|NCT00965848|411978|P3|Overall Study|Lost to Follow-up|1
111371|NCT00965848|411979|P2|Overall Study|Lost to Follow-up|0
111372|NCT00965848|411980|P1|Overall Study|Lost to Follow-up|0
111373|NCT00965848|411978|P3|Overall Study|Death|5
111374|NCT00965848|411979|P2|Overall Study|Death|1
111375|NCT00965848|411980|P1|Overall Study|Death|11
111376|NCT00965848|411978|P3|Overall Study|Protocol Violation|1
111377|NCT00965848|411979|P2|Overall Study|Protocol Violation|0
111378|NCT00965848|411980|P1|Overall Study|Protocol Violation|3
111379|NCT00965757|411999|P4|Extension Phase|Not Specified|1
111380|NCT00965757|412000|P3|Extension Phase|Not Specified|2
111381|NCT00965757|412001|P2|Extension Phase|Not Specified|0
111382|NCT00965757|412002|P1|Extension Phase|Not Specified|0
111383|NCT00965757|411999|P4|Extension Phase|Protocol Violation|1
111384|NCT00965757|412000|P3|Extension Phase|Protocol Violation|0
111385|NCT00965757|412001|P2|Extension Phase|Protocol Violation|0
111386|NCT00965757|412002|P1|Extension Phase|Protocol Violation|0
111387|NCT00965757|411999|P4|Extension Phase|Ineligible after Taking Study Drug|3
111388|NCT00965757|412000|P3|Extension Phase|Ineligible after Taking Study Drug|3
111389|NCT00965757|412001|P2|Extension Phase|Ineligible after Taking Study Drug|0
111390|NCT00965757|412002|P1|Extension Phase|Ineligible after Taking Study Drug|0
111391|NCT00965757|411999|P4|Extension Phase|Lost to Follow-up|1
111392|NCT00965757|412000|P3|Extension Phase|Lost to Follow-up|0
111393|NCT00965757|412001|P2|Extension Phase|Lost to Follow-up|0
111394|NCT00965757|412002|P1|Extension Phase|Lost to Follow-up|0
111395|NCT00965757|411999|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
111396|NCT00965757|412000|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
111397|NCT00965757|412001|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
111398|NCT00965757|412002|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
111399|NCT00965757|411999|P4|Extension Phase|Lack of Efficacy|12
111400|NCT00965757|412000|P3|Extension Phase|Lack of Efficacy|8
111401|NCT00965757|412001|P2|Extension Phase|Lack of Efficacy|0
111402|NCT00965757|412002|P1|Extension Phase|Lack of Efficacy|0
111403|NCT00965757|411999|P4|Extension Phase|Abnormal Laboratory Value|1
111404|NCT00965757|412000|P3|Extension Phase|Abnormal Laboratory Value|6
111405|NCT00965757|412001|P2|Extension Phase|Abnormal Laboratory Value|0
111406|NCT00965757|412002|P1|Extension Phase|Abnormal Laboratory Value|0
111407|NCT00965757|411999|P4|Extension Phase|Adverse drug reaction|3
111408|NCT00965757|412000|P3|Extension Phase|Adverse drug reaction|6
111409|NCT00965757|412001|P2|Extension Phase|Adverse drug reaction|0
111410|NCT00965757|412002|P1|Extension Phase|Adverse drug reaction|0
111411|NCT00965757|411999|P4|Extension Phase|Progression of concomitant disease|2
111412|NCT00965757|412000|P3|Extension Phase|Progression of concomitant disease|4
111413|NCT00965757|412001|P2|Extension Phase|Progression of concomitant disease|0
111414|NCT00965757|412002|P1|Extension Phase|Progression of concomitant disease|0
111415|NCT00965757|411999|P4|Double-blind Phase|Not specified|0
111416|NCT00965757|412000|P3|Double-blind Phase|Not specified|0
111417|NCT00965757|412001|P2|Double-blind Phase|Not specified|0
111418|NCT00965757|412002|P1|Double-blind Phase|Not specified|1
111419|NCT00965757|411999|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
111420|NCT00965757|412000|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
111421|NCT00965757|412001|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
111422|NCT00965757|412002|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
111423|NCT00965757|411999|P4|Double-blind Phase|Lost to Follow-up|0
111424|NCT00965757|412000|P3|Double-blind Phase|Lost to Follow-up|0
111425|NCT00965757|412001|P2|Double-blind Phase|Lost to Follow-up|1
111426|NCT00965757|412002|P1|Double-blind Phase|Lost to Follow-up|0
111427|NCT00965757|411999|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
111428|NCT00965757|412000|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
111429|NCT00965757|412001|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
111430|NCT00965757|412002|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
111431|NCT00965757|411999|P4|Double-blind Phase|Lack of Efficacy|0
111432|NCT00965757|412000|P3|Double-blind Phase|Lack of Efficacy|0
111433|NCT00965757|412001|P2|Double-blind Phase|Lack of Efficacy|11
111434|NCT00965757|412002|P1|Double-blind Phase|Lack of Efficacy|7
111435|NCT00965757|411999|P4|Double-blind Phase|Abnormal Laboratory Value|0
111436|NCT00965757|412000|P3|Double-blind Phase|Abnormal Laboratory Value|0
111437|NCT00965757|412001|P2|Double-blind Phase|Abnormal Laboratory Value|0
111438|NCT00965757|412002|P1|Double-blind Phase|Abnormal Laboratory Value|2
111439|NCT00965757|411999|P4|Double-blind Phase|Adverse drug reaction|0
111440|NCT00965757|412000|P3|Double-blind Phase|Adverse drug reaction|0
111441|NCT00965757|412001|P2|Double-blind Phase|Adverse drug reaction|1
111442|NCT00965757|412002|P1|Double-blind Phase|Adverse drug reaction|2
111443|NCT00965757|411999|P4|Double-blind Phase|Progression of concomitant disease|0
111444|NCT00965757|412000|P3|Double-blind Phase|Progression of concomitant disease|0
111445|NCT00965757|412001|P2|Double-blind Phase|Progression of concomitant disease|2
111446|NCT00965757|412002|P1|Double-blind Phase|Progression of concomitant disease|1
111447|NCT00965731|412036|P2|Overall Study|Not specified|15
111448|NCT00965731|412037|P1|Overall Study|Not specified|7
111449|NCT00965731|412036|P2|Overall Study|Withdrawal by Subject|1
111450|NCT00965731|412037|P1|Overall Study|Withdrawal by Subject|0
111451|NCT00965731|412036|P2|Overall Study|Death|4
111452|NCT00965731|412037|P1|Overall Study|Death|0
111453|NCT00965718|412101|P1|Overall Study|Withdrawal by Subject|4
111454|NCT00965562|412114|P3|Overall Study|Withdrawal by Subject|0
111455|NCT00965562|412115|P2|Overall Study|Withdrawal by Subject|2
111456|NCT00965562|412116|P1|Overall Study|Withdrawal by Subject|2
111457|NCT00965562|412114|P3|Overall Study|Lost to Follow-up|3
111458|NCT00965562|412115|P2|Overall Study|Lost to Follow-up|2
111459|NCT00965562|412116|P1|Overall Study|Lost to Follow-up|1
111460|NCT00965523|412154|P1|Study 224|Physician Decision|1
111461|NCT00965523|412154|P1|Study 224|Progressive Disease|5
111462|NCT00965523|412154|P1|Study 221|Physician Decision|3
111463|NCT00965523|412154|P1|Study 221|Progressive Disease|4
111464|NCT00965497|412159|P1|Overall Study|Physician Decision|1
111465|NCT00965484|412164|P1|Overall Study|Withdrawal by Subject|1
111466|NCT00965484|412164|P1|Overall Study|Protocol Violation|1
111467|NCT00965458|412173|P2|Overall Study|Withdrawal by Subject|1
111468|NCT00965458|412174|P1|Overall Study|Withdrawal by Subject|0
111469|NCT00965458|412173|P2|Overall Study|Lost to Follow-up|3
111470|NCT00965458|412174|P1|Overall Study|Lost to Follow-up|1
111471|NCT00965458|412173|P2|Overall Study|Adverse Event|0
111472|NCT00965458|412174|P1|Overall Study|Adverse Event|1
111473|NCT00965419|412190|P1|Follow-up Phase|Lack of Efficacy|28
111474|NCT00965419|412190|P1|Follow-up Phase|Parent/Caregiver Decision|9
111475|NCT00965419|412190|P1|Follow-up Phase|Physician Decision|4
111476|NCT00965419|412190|P1|Follow-up Phase|Withdrawal by Subject|8
111477|NCT00965419|412190|P1|Follow-up Phase|Protocol Violation|4
111478|NCT00965419|412190|P1|Follow-up Phase|Adverse Event|9
111479|NCT00965419|412190|P1|Open Label Treatment for Responders|Lost to Follow-up|46
111480|NCT00965419|412190|P1|Open Label Treatment for Responders|Lack of Efficacy|67
111481|NCT00965419|412190|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
111482|NCT00965419|412190|P1|Open Label Treatment for Responders|Sponsor Decision|5
111483|NCT00965419|412190|P1|Open Label Treatment for Responders|Physician Decision|6
111484|NCT00965419|412190|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
111485|NCT00965419|412190|P1|Open Label Treatment for Responders|Protocol Violation|21
111486|NCT00965419|412190|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
111487|NCT00965419|412190|P1|Open Label Treatment for Responders|Adverse Event|33
111488|NCT00965341|412236|P2|Overall Study|Transportation issues|3
111489|NCT00965341|412237|P1|Overall Study|Transportation issues|4
111490|NCT00965341|412236|P2|Overall Study|Lost to Follow-up|0
111491|NCT00965341|412237|P1|Overall Study|Lost to Follow-up|1
111492|NCT00965341|412236|P2|Overall Study|Withdrew consent|5
111493|NCT00965341|412237|P1|Overall Study|Withdrew consent|1
111494|NCT00965263|412247|P2|Overall Study|Protocol Violation|2
111495|NCT00965263|412248|P1|Overall Study|Protocol Violation|0
111496|NCT00965263|412247|P2|Overall Study|Family emergency|1
111497|NCT00965263|412248|P1|Overall Study|Family emergency|0
111498|NCT00965263|412247|P2|Overall Study|Physician Decision|0
111499|NCT00965263|412248|P1|Overall Study|Physician Decision|2
111500|NCT00965185|412308|P2|Overall Study|Withdrawal by Subject|1
111501|NCT00965185|412309|P1|Overall Study|Withdrawal by Subject|0
111502|NCT00965185|412308|P2|Overall Study|Lost to Follow-up|0
111503|NCT00965185|412309|P1|Overall Study|Lost to Follow-up|2
111504|NCT00965146|412329|P1|Overall Study|Overall Study Termination|145
111505|NCT00965146|412329|P1|Overall Study|Revision / Removal of Study Implant|6
111506|NCT00965146|412329|P1|Overall Study|Intercurrent illness|1
111507|NCT00965146|412329|P1|Overall Study|Unwilling to return|11
111508|NCT00965146|412329|P1|Overall Study|Unable to return|1
111509|NCT00965146|412329|P1|Overall Study|Withdrawal by Subject|17
111510|NCT00965146|412329|P1|Overall Study|Lost to Follow-up|22
111511|NCT00965146|412329|P1|Overall Study|Death|7
111512|NCT00965094|412336|P2|Overall Study|Lost to Follow-up|1
111513|NCT00965094|412337|P1|Overall Study|Lost to Follow-up|0
111514|NCT00965094|412336|P2|Overall Study|Adverse Event|0
111515|NCT00965094|412337|P1|Overall Study|Adverse Event|5
111516|NCT00965081|412353|P2|Overall Study|Switched to Rescue Arm|12
111517|NCT00965081|412354|P1|Overall Study|Switched to Rescue Arm|5
111518|NCT00965081|412353|P2|Overall Study|Withdrawal by Subject|7
111519|NCT00965081|412354|P1|Overall Study|Withdrawal by Subject|4
111520|NCT00965081|412353|P2|Overall Study|Sponsor Decision|0
111521|NCT00965081|412354|P1|Overall Study|Sponsor Decision|1
111522|NCT00965081|412353|P2|Overall Study|Protocol Violation|5
111523|NCT00965081|412354|P1|Overall Study|Protocol Violation|2
111524|NCT00965081|412353|P2|Overall Study|Physician Decision|0
111525|NCT00965081|412354|P1|Overall Study|Physician Decision|2
111526|NCT00965081|412353|P2|Overall Study|Lost to Follow-up|5
111527|NCT00965081|412354|P1|Overall Study|Lost to Follow-up|4
111528|NCT00965081|412353|P2|Overall Study|Lack of Efficacy|5
111529|NCT00965081|412354|P1|Overall Study|Lack of Efficacy|2
111530|NCT00965081|412353|P2|Overall Study|Adverse Event|9
111531|NCT00965081|412354|P1|Overall Study|Adverse Event|14
111532|NCT00964886|412381|P4|Overall Study|Protocol Violation|0
111533|NCT00964886|412382|P3|Overall Study|Protocol Violation|0
111534|NCT00964886|412383|P2|Overall Study|Protocol Violation|2
111535|NCT00964886|412384|P1|Overall Study|Protocol Violation|0
111536|NCT00964886|412381|P4|Overall Study|Adverse Event|2
111537|NCT00964886|412382|P3|Overall Study|Adverse Event|5
111538|NCT00964886|412383|P2|Overall Study|Adverse Event|1
111539|NCT00964886|412384|P1|Overall Study|Adverse Event|3
111540|NCT00964886|412381|P4|Overall Study|Withdrawal by Subject|3
111541|NCT00964886|412382|P3|Overall Study|Withdrawal by Subject|5
111542|NCT00964886|412383|P2|Overall Study|Withdrawal by Subject|2
111543|NCT00964886|412384|P1|Overall Study|Withdrawal by Subject|6
111544|NCT00964886|412381|P4|Overall Study|Lost to Follow-up|4
111545|NCT00964886|412382|P3|Overall Study|Lost to Follow-up|6
111546|NCT00964886|412383|P2|Overall Study|Lost to Follow-up|2
111547|NCT00964886|412384|P1|Overall Study|Lost to Follow-up|2
111548|NCT00964860|412400|P2|Overall Study|Withdrawal by Subject|1
111549|NCT00964860|412401|P1|Overall Study|Withdrawal by Subject|0
111550|NCT00964795|412409|P1|Overall Study|Other|23
111551|NCT00964795|412409|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
111552|NCT00964795|412409|P1|Overall Study|Termination of Study by Sponsor|169
111553|NCT00964795|412409|P1|Overall Study|Lost to Follow-up|7
111554|NCT00964795|412409|P1|Overall Study|Death|14
111555|NCT00964795|412409|P1|Overall Study|Adverse Event|12
111556|NCT00964795|412409|P1|Overall Study|Withdrawal by Subject|79
111557|NCT00964743|412416|P1|Overall Study|Neither patient completed 8 weeks of tre|2
111558|NCT00964678|412424|P1|Overall Study|Physician Decision|4
111559|NCT00964392|412488|P2|Overall Study|Not completed|168
111560|NCT00964392|412489|P1|Overall Study|Not completed|44
111561|NCT00964392|412488|P2|Overall Study|Early Termination, non-study arrhythmia|6
111562|NCT00964392|412489|P1|Overall Study|Early Termination, non-study arrhythmia|1
111563|NCT00964392|412488|P2|Overall Study|Lost to Follow-up|10
111564|NCT00964392|412489|P1|Overall Study|Lost to Follow-up|4
111565|NCT00964392|412488|P2|Overall Study|Withdrawal by Subject|6
111566|NCT00964392|412489|P1|Overall Study|Withdrawal by Subject|4
111567|NCT00964366|412499|P2|Overall Study|Withdrawal by Subject|1
111568|NCT00964366|412500|P1|Overall Study|Withdrawal by Subject|0
111569|NCT00964366|412499|P2|Overall Study|Did not qualify at Day 1|0
111570|NCT00964366|412500|P1|Overall Study|Did not qualify at Day 1|1
111571|NCT00964223|412514|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
111572|NCT00964158|412582|P3|Overall Study|Withdrawal by Subject|6
111573|NCT00964158|412583|P2|Overall Study|Withdrawal by Subject|0
111574|NCT00964158|412584|P1|Overall Study|Withdrawal by Subject|0
111575|NCT00964158|412582|P3|Overall Study|Lost to Follow-up|2
111576|NCT00964158|412583|P2|Overall Study|Lost to Follow-up|1
111577|NCT00964158|412584|P1|Overall Study|Lost to Follow-up|0
111578|NCT00964028|412659|P2|Overall Study|Withdrawal by Subject|1
111579|NCT00964028|412660|P1|Overall Study|Withdrawal by Subject|0
111580|NCT00963937|412675|P3|Overall Study|Physician Decision|4
111581|NCT00963937|412676|P2|Overall Study|Physician Decision|10
111582|NCT00963937|412677|P1|Overall Study|Physician Decision|18
111583|NCT00963937|412675|P3|Overall Study|Protocol Violation|0
111584|NCT00963937|412676|P2|Overall Study|Protocol Violation|1
111585|NCT00963937|412677|P1|Overall Study|Protocol Violation|1
111586|NCT00963924|412715|P2|Overall Study|Lost to Follow-up|1
111587|NCT00963924|412716|P1|Overall Study|Lost to Follow-up|0
111588|NCT00963924|412715|P2|Overall Study|Changed antipsychotic|1
111589|NCT00963924|412716|P1|Overall Study|Changed antipsychotic|0
111590|NCT00963924|412715|P2|Overall Study|Withdrawal by Subject|1
111591|NCT00963924|412716|P1|Overall Study|Withdrawal by Subject|0
111592|NCT00963924|412715|P2|Overall Study|Adverse Event|0
111593|NCT00963924|412716|P1|Overall Study|Adverse Event|1
111594|NCT00963820|412790|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
111595|NCT00963820|412791|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
111596|NCT00963820|412792|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
111597|NCT00963820|412793|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
111598|NCT00963820|412794|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
111599|NCT00963820|412795|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
111600|NCT00963820|412796|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
111601|NCT00963820|412797|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
111602|NCT00963820|412798|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
111603|NCT00963820|412799|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
111604|NCT00963820|412800|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
111605|NCT00963820|412801|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
111606|NCT00963820|412790|P12|Expansion Phase|Withdrawal by Subject|1
111607|NCT00963820|412791|P11|Expansion Phase|Withdrawal by Subject|1
111608|NCT00963820|412792|P10|Expansion Phase|Withdrawal by Subject|0
111609|NCT00963820|412793|P9|Expansion Phase|Withdrawal by Subject|1
111610|NCT00963820|412794|P8|Expansion Phase|Withdrawal by Subject|0
111611|NCT00963820|412795|P7|Expansion Phase|Withdrawal by Subject|0
111612|NCT00963820|412796|P6|Expansion Phase|Withdrawal by Subject|0
111613|NCT00963820|412797|P5|Expansion Phase|Withdrawal by Subject|0
111614|NCT00963820|412798|P4|Expansion Phase|Withdrawal by Subject|0
111615|NCT00963820|412799|P3|Expansion Phase|Withdrawal by Subject|0
111616|NCT00963820|412800|P2|Expansion Phase|Withdrawal by Subject|0
111617|NCT00963820|412801|P1|Expansion Phase|Withdrawal by Subject|0
111618|NCT00963820|412790|P12|Expansion Phase|Adverse Event|0
111619|NCT00963820|412791|P11|Expansion Phase|Adverse Event|0
111620|NCT00963820|412792|P10|Expansion Phase|Adverse Event|3
111621|NCT00963820|412793|P9|Expansion Phase|Adverse Event|1
111622|NCT00963820|412794|P8|Expansion Phase|Adverse Event|0
111623|NCT00963820|412795|P7|Expansion Phase|Adverse Event|0
111624|NCT00963820|412796|P6|Expansion Phase|Adverse Event|0
111625|NCT00963820|412797|P5|Expansion Phase|Adverse Event|0
111626|NCT00963820|412798|P4|Expansion Phase|Adverse Event|0
111627|NCT00963820|412799|P3|Expansion Phase|Adverse Event|0
111628|NCT00963820|412800|P2|Expansion Phase|Adverse Event|0
111629|NCT00963820|412801|P1|Expansion Phase|Adverse Event|0
111630|NCT00963820|412790|P12|Expansion Phase|Progressive Disease|2
111631|NCT00963820|412791|P11|Expansion Phase|Progressive Disease|4
111632|NCT00963820|412792|P10|Expansion Phase|Progressive Disease|6
111633|NCT00963820|412793|P9|Expansion Phase|Progressive Disease|8
111634|NCT00963820|412794|P8|Expansion Phase|Progressive Disease|0
111635|NCT00963820|412795|P7|Expansion Phase|Progressive Disease|0
111636|NCT00963820|412796|P6|Expansion Phase|Progressive Disease|0
111637|NCT00963820|412797|P5|Expansion Phase|Progressive Disease|0
111638|NCT00963820|412798|P4|Expansion Phase|Progressive Disease|0
111639|NCT00963820|412799|P3|Expansion Phase|Progressive Disease|0
111640|NCT00963820|412800|P2|Expansion Phase|Progressive Disease|0
111641|NCT00963820|412801|P1|Expansion Phase|Progressive Disease|0
111642|NCT00963820|412790|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111643|NCT00963820|412791|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111644|NCT00963820|412792|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111645|NCT00963820|412793|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111646|NCT00963820|412794|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111647|NCT00963820|412795|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
111648|NCT00963820|412796|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111649|NCT00963820|412797|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111650|NCT00963820|412798|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111651|NCT00963820|412799|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111652|NCT00963820|412800|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111653|NCT00963820|412801|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
111654|NCT00963820|412790|P12|Dose Escalation Phase|Withdrawal by Subject|0
111655|NCT00963820|412791|P11|Dose Escalation Phase|Withdrawal by Subject|0
111656|NCT00963820|412792|P10|Dose Escalation Phase|Withdrawal by Subject|0
111657|NCT00963820|412793|P9|Dose Escalation Phase|Withdrawal by Subject|0
111658|NCT00963820|412794|P8|Dose Escalation Phase|Withdrawal by Subject|2
111659|NCT00963820|412795|P7|Dose Escalation Phase|Withdrawal by Subject|1
111660|NCT00963820|412796|P6|Dose Escalation Phase|Withdrawal by Subject|0
111661|NCT00963820|412797|P5|Dose Escalation Phase|Withdrawal by Subject|0
111662|NCT00963820|412798|P4|Dose Escalation Phase|Withdrawal by Subject|0
111663|NCT00963820|412799|P3|Dose Escalation Phase|Withdrawal by Subject|0
111664|NCT00963820|412800|P2|Dose Escalation Phase|Withdrawal by Subject|0
111665|NCT00963820|412801|P1|Dose Escalation Phase|Withdrawal by Subject|0
111666|NCT00963820|412790|P12|Dose Escalation Phase|Adverse Event|0
111667|NCT00963820|412791|P11|Dose Escalation Phase|Adverse Event|0
111668|NCT00963820|412792|P10|Dose Escalation Phase|Adverse Event|0
111669|NCT00963820|412793|P9|Dose Escalation Phase|Adverse Event|0
111670|NCT00963820|412794|P8|Dose Escalation Phase|Adverse Event|1
111671|NCT00963820|412795|P7|Dose Escalation Phase|Adverse Event|3
111672|NCT00963820|412796|P6|Dose Escalation Phase|Adverse Event|0
111673|NCT00963820|412797|P5|Dose Escalation Phase|Adverse Event|0
111674|NCT00963820|412798|P4|Dose Escalation Phase|Adverse Event|0
111675|NCT00963820|412799|P3|Dose Escalation Phase|Adverse Event|0
111676|NCT00963820|412800|P2|Dose Escalation Phase|Adverse Event|0
111677|NCT00963820|412801|P1|Dose Escalation Phase|Adverse Event|0
111678|NCT00963820|412790|P12|Dose Escalation Phase|Progressive Disease|0
111679|NCT00963820|412791|P11|Dose Escalation Phase|Progressive Disease|0
111680|NCT00963820|412792|P10|Dose Escalation Phase|Progressive Disease|0
111681|NCT00963820|412793|P9|Dose Escalation Phase|Progressive Disease|0
111682|NCT00963820|412794|P8|Dose Escalation Phase|Progressive Disease|2
111683|NCT00963820|412795|P7|Dose Escalation Phase|Progressive Disease|3
111684|NCT00963820|412796|P6|Dose Escalation Phase|Progressive Disease|3
111685|NCT00963820|412797|P5|Dose Escalation Phase|Progressive Disease|4
111686|NCT00963820|412798|P4|Dose Escalation Phase|Progressive Disease|3
111687|NCT00963820|412799|P3|Dose Escalation Phase|Progressive Disease|3
111688|NCT00963820|412800|P2|Dose Escalation Phase|Progressive Disease|3
111689|NCT00963820|412801|P1|Dose Escalation Phase|Progressive Disease|3
111690|NCT00963807|412937|P1|Overall Study|Disease progression|15
111691|NCT00963807|412937|P1|Overall Study|Reaction to study chemotherapy regimen|1
111692|NCT00963807|412937|P1|Overall Study|Physician Decision|2
111693|NCT00963599|412970|P4|Overall Study|Withdrawal by Subject|3
111694|NCT00963599|412971|P3|Overall Study|Withdrawal by Subject|3
111695|NCT00963599|412972|P2|Overall Study|Withdrawal by Subject|1
111696|NCT00963599|412973|P1|Overall Study|Withdrawal by Subject|2
111697|NCT00963599|412970|P4|Overall Study|Protocol Violation|4
111698|NCT00963599|412971|P3|Overall Study|Protocol Violation|3
111699|NCT00963599|412972|P2|Overall Study|Protocol Violation|2
111700|NCT00963599|412973|P1|Overall Study|Protocol Violation|2
111701|NCT00963599|412970|P4|Overall Study|Lost to Follow-up|1
111702|NCT00963599|412971|P3|Overall Study|Lost to Follow-up|1
111703|NCT00963599|412972|P2|Overall Study|Lost to Follow-up|1
111704|NCT00963599|412973|P1|Overall Study|Lost to Follow-up|0
111705|NCT00963599|412970|P4|Overall Study|Lack of Efficacy|4
111706|NCT00963599|412971|P3|Overall Study|Lack of Efficacy|1
111707|NCT00963599|412972|P2|Overall Study|Lack of Efficacy|2
111708|NCT00963599|412973|P1|Overall Study|Lack of Efficacy|0
111709|NCT00963599|412970|P4|Overall Study|Adverse Event|2
111710|NCT00963599|412971|P3|Overall Study|Adverse Event|1
111711|NCT00963599|412972|P2|Overall Study|Adverse Event|0
111712|NCT00963599|412973|P1|Overall Study|Adverse Event|2
111713|NCT00963469|413063|P3|Overall Study|Site closed (local pollen Season ended)|3
111714|NCT00963469|413064|P2|Overall Study|Site closed (local pollen Season ended)|1
111715|NCT00963469|413065|P1|Overall Study|Site closed (local pollen Season ended)|4
111716|NCT00963469|413063|P3|Overall Study|Moved|0
111717|NCT00963469|413064|P2|Overall Study|Moved|0
111718|NCT00963469|413065|P1|Overall Study|Moved|1
111719|NCT00963469|413063|P3|Overall Study|Pre-randomization Adverse Event|0
111720|NCT00963469|413064|P2|Overall Study|Pre-randomization Adverse Event|2
111721|NCT00963469|413065|P1|Overall Study|Pre-randomization Adverse Event|1
111722|NCT00963469|413063|P3|Overall Study|Withdrawal by Subject|1
111723|NCT00963469|413064|P2|Overall Study|Withdrawal by Subject|1
111724|NCT00963469|413065|P1|Overall Study|Withdrawal by Subject|4
111725|NCT00963469|413063|P3|Overall Study|Protocol Violation|3
111726|NCT00963469|413064|P2|Overall Study|Protocol Violation|5
111727|NCT00963469|413065|P1|Overall Study|Protocol Violation|5
111728|NCT00963469|413063|P3|Overall Study|Lost to Follow-up|0
111729|NCT00963469|413064|P2|Overall Study|Lost to Follow-up|1
111730|NCT00963469|413065|P1|Overall Study|Lost to Follow-up|1
111731|NCT00963469|413063|P3|Overall Study|Lack of Efficacy|2
111732|NCT00963469|413064|P2|Overall Study|Lack of Efficacy|7
111733|NCT00963469|413065|P1|Overall Study|Lack of Efficacy|10
111734|NCT00963469|413063|P3|Overall Study|Adverse Event|1
111735|NCT00963469|413064|P2|Overall Study|Adverse Event|11
111736|NCT00963469|413065|P1|Overall Study|Adverse Event|15
111737|NCT00963235|413132|P1|Overall Study|Other|1
111738|NCT00963235|413132|P1|Overall Study|Physician Decision|2
111739|NCT00963235|413132|P1|Overall Study|Adverse Event|5
111740|NCT00963235|413132|P1|Overall Study|Protocol Violation|7
111741|NCT00963235|413132|P1|Overall Study|Failed to return|9
111742|NCT00963235|413132|P1|Overall Study|Lost to Follow-up|14
111743|NCT00963235|413132|P1|Overall Study|Withdrawal by Subject|22
111744|NCT00962780|413375|P2|Overall Study|Other|1
111745|NCT00962780|413376|P1|Overall Study|Other|0
111746|NCT00962780|413375|P2|Overall Study|Withdrawal by Subject|8
111747|NCT00962780|413376|P1|Overall Study|Withdrawal by Subject|1
111748|NCT00962780|413375|P2|Overall Study|Protocol Violation|4
111749|NCT00962780|413376|P1|Overall Study|Protocol Violation|9
111750|NCT00962780|413375|P2|Overall Study|Death|1
111751|NCT00962780|413376|P1|Overall Study|Death|0
111752|NCT00962741|413451|P1|Overall Study|drug ineffective+prohibited drug taken|1
111753|NCT00962741|413451|P1|Overall Study|Lack of Efficacy|1
111754|NCT00962741|413451|P1|Overall Study|Withdrawal by Subject|1
111755|NCT00962741|413451|P1|Overall Study|Lost to Follow-up|2
111756|NCT00962741|413451|P1|Overall Study|Failed to return|3
111757|NCT00962650|413542|P1|Overall Study|Transgastric DP was not completed|2
111758|NCT00962585|413561|P4|Overall Study|Withdrew Consent|0
111759|NCT00962585|413562|P3|Overall Study|Withdrew Consent|0
111760|NCT00962585|413563|P2|Overall Study|Withdrew Consent|0
111761|NCT00962585|413564|P1|Overall Study|Withdrew Consent|2
111762|NCT00962585|413561|P4|Overall Study|Withdrawal by Subject|0
111763|NCT00962585|413562|P3|Overall Study|Withdrawal by Subject|0
111764|NCT00962585|413563|P2|Overall Study|Withdrawal by Subject|0
111765|NCT00962585|413564|P1|Overall Study|Withdrawal by Subject|1
111766|NCT00962585|413561|P4|Overall Study|Protocol Violation|0
111767|NCT00962585|413562|P3|Overall Study|Protocol Violation|1
111768|NCT00962585|413563|P2|Overall Study|Protocol Violation|0
111769|NCT00962585|413564|P1|Overall Study|Protocol Violation|0
111770|NCT00962585|413561|P4|Overall Study|Lost to Follow-up|0
111771|NCT00962585|413562|P3|Overall Study|Lost to Follow-up|1
111772|NCT00962585|413563|P2|Overall Study|Lost to Follow-up|0
111773|NCT00962585|413564|P1|Overall Study|Lost to Follow-up|3
111774|NCT00962585|413561|P4|Overall Study|Adverse Event|0
111775|NCT00962585|413562|P3|Overall Study|Adverse Event|1
111776|NCT00962585|413563|P2|Overall Study|Adverse Event|2
111777|NCT00962585|413564|P1|Overall Study|Adverse Event|0
111778|NCT00962390|413626|P4|Overall Study|Withdrawal by Subject|0
111779|NCT00962390|413627|P3|Overall Study|Withdrawal by Subject|1
111780|NCT00962390|413628|P2|Overall Study|Withdrawal by Subject|1
111781|NCT00962390|413629|P1|Overall Study|Withdrawal by Subject|1
111782|NCT00962390|413626|P4|Overall Study|Protocol Violation|0
111783|NCT00962390|413627|P3|Overall Study|Protocol Violation|0
111784|NCT00962390|413628|P2|Overall Study|Protocol Violation|0
111785|NCT00962390|413629|P1|Overall Study|Protocol Violation|1
111786|NCT00962390|413626|P4|Overall Study|Lost to Follow-up|0
111787|NCT00962390|413627|P3|Overall Study|Lost to Follow-up|0
111788|NCT00962390|413628|P2|Overall Study|Lost to Follow-up|2
111789|NCT00962390|413629|P1|Overall Study|Lost to Follow-up|2
111790|NCT00962390|413626|P4|Overall Study|Adverse Event|1
111791|NCT00962390|413627|P3|Overall Study|Adverse Event|3
111792|NCT00962390|413628|P2|Overall Study|Adverse Event|0
111793|NCT00962390|413629|P1|Overall Study|Adverse Event|0
111794|NCT00962247|413691|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
111795|NCT00962247|413691|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
111796|NCT00962247|413691|P1|Usual Sedentary|Withdrawal by Subject|5
111797|NCT00962247|413691|P1|Usual Sedentary|Protocol Violation|13
111798|NCT00962208|413702|P2|Overall Study|Lost to Follow-up|9
111799|NCT00962208|413703|P1|Overall Study|Lost to Follow-up|0
111800|NCT00962208|413702|P2|Overall Study|Contraindicated to continue study|1
111801|NCT00962208|413703|P1|Overall Study|Contraindicated to continue study|5
111802|NCT00962208|413702|P2|Overall Study|Could not achieve good vision|0
111803|NCT00962208|413703|P1|Overall Study|Could not achieve good vision|9
111804|NCT00962104|413711|P2|Overall Study|Other|0
111805|NCT00962104|413712|P1|Overall Study|Other|2
111806|NCT00962104|413711|P2|Overall Study|Withdrawal by Subject|6
111807|NCT00962104|413712|P1|Overall Study|Withdrawal by Subject|10
111808|NCT00962104|413711|P2|Overall Study|Sponsor Decision|1
111809|NCT00962104|413712|P1|Overall Study|Sponsor Decision|0
111810|NCT00962104|413711|P2|Overall Study|Protocol Violation|8
111811|NCT00962104|413712|P1|Overall Study|Protocol Violation|6
111812|NCT00962104|413711|P2|Overall Study|Physician Decision|0
111813|NCT00962104|413712|P1|Overall Study|Physician Decision|1
111814|NCT00962104|413711|P2|Overall Study|Lost to Follow-up|4
111815|NCT00962104|413712|P1|Overall Study|Lost to Follow-up|10
111816|NCT00962104|413711|P2|Overall Study|Lack of Efficacy|1
111817|NCT00962104|413712|P1|Overall Study|Lack of Efficacy|0
111818|NCT00962104|413711|P2|Overall Study|Entry Criteria Not Met|2
111819|NCT00962104|413712|P1|Overall Study|Entry Criteria Not Met|1
111820|NCT00962104|413711|P2|Overall Study|Adverse Event|3
111821|NCT00962104|413712|P1|Overall Study|Adverse Event|10
111822|NCT00962013|413766|P1|Overall Study|No 5 year evaluation|6
111823|NCT00962013|413766|P1|Overall Study|Site Termination|24
111824|NCT00962013|413766|P1|Overall Study|Removal of study device|3
111825|NCT00962013|413766|P1|Overall Study|Withdrawal by Subject|8
111826|NCT00962013|413766|P1|Overall Study|Unable/Unwilling to return|6
111827|NCT00962013|413766|P1|Overall Study|Lost to Follow-up|12
111828|NCT00962013|413766|P1|Overall Study|Death|8
111829|NCT00962013|413766|P1|Overall Study|Did not have surgery|1
111830|NCT00961896|413789|P3|Overall Study|Abnormal laboratory value|1
111831|NCT00961896|413790|P2|Overall Study|Abnormal laboratory value|0
111832|NCT00961896|413791|P1|Overall Study|Abnormal laboratory value|0
111833|NCT00961649|413858|P4|Overall Study|Study terminated by sponsor|1
111834|NCT00961649|413859|P3|Overall Study|Study terminated by sponsor|4
111835|NCT00961649|413860|P2|Overall Study|Study terminated by sponsor|4
111836|NCT00961649|413861|P1|Overall Study|Study terminated by sponsor|4
111837|NCT00961649|413858|P4|Overall Study|Patient left to Mexico-family emergency|0
111838|NCT00961649|413859|P3|Overall Study|Patient left to Mexico-family emergency|0
111839|NCT00961649|413860|P2|Overall Study|Patient left to Mexico-family emergency|0
111840|NCT00961649|413861|P1|Overall Study|Patient left to Mexico-family emergency|1
111841|NCT00961649|413858|P4|Overall Study|Patient has travel plans during holidays|0
111842|NCT00961649|413859|P3|Overall Study|Patient has travel plans during holidays|1
111843|NCT00961649|413860|P2|Overall Study|Patient has travel plans during holidays|0
111844|NCT00961649|413861|P1|Overall Study|Patient has travel plans during holidays|0
111845|NCT00961649|413858|P4|Overall Study|Inadequate control of IOP|1
111846|NCT00961649|413859|P3|Overall Study|Inadequate control of IOP|0
111847|NCT00961649|413860|P2|Overall Study|Inadequate control of IOP|0
111848|NCT00961649|413861|P1|Overall Study|Inadequate control of IOP|0
111849|NCT00961649|413858|P4|Overall Study|Adverse Event|2
111850|NCT00961649|413859|P3|Overall Study|Adverse Event|0
111851|NCT00961649|413860|P2|Overall Study|Adverse Event|0
111852|NCT00961649|413861|P1|Overall Study|Adverse Event|4
111853|NCT00961636|413875|P3|Overall Study|Withdrawal by Subject|13
111854|NCT00961636|413876|P2|Overall Study|Withdrawal by Subject|22
111855|NCT00961636|413877|P1|Overall Study|Withdrawal by Subject|29
111856|NCT00961636|413875|P3|Overall Study|Protocol Violation|1
111857|NCT00961636|413876|P2|Overall Study|Protocol Violation|5
111858|NCT00961636|413877|P1|Overall Study|Protocol Violation|9
111859|NCT00961636|413875|P3|Overall Study|Physician Decision|1
111860|NCT00961636|413876|P2|Overall Study|Physician Decision|1
111861|NCT00961636|413877|P1|Overall Study|Physician Decision|3
111862|NCT00961636|413875|P3|Overall Study|Lost to Follow-up|1
111863|NCT00961636|413876|P2|Overall Study|Lost to Follow-up|3
111864|NCT00961636|413877|P1|Overall Study|Lost to Follow-up|2
111865|NCT00961636|413875|P3|Overall Study|Flushing Symptoms|3
111866|NCT00961636|413876|P2|Overall Study|Flushing Symptoms|46
111867|NCT00961636|413877|P1|Overall Study|Flushing Symptoms|29
111868|NCT00961636|413875|P3|Overall Study|Adverse Event|13
111869|NCT00961636|413876|P2|Overall Study|Adverse Event|54
111870|NCT00961636|413877|P1|Overall Study|Adverse Event|35
111871|NCT00961571|413888|P1|Overall Study|Physician Decision|39
111872|NCT00961415|413916|P3|Maintenance Treatment Phase|Other reason|3
111873|NCT00961415|413917|P2|Maintenance Treatment Phase|Other reason|1
111874|NCT00961415|413918|P1|Maintenance Treatment Phase|Other reason|0
111875|NCT00961415|413916|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
111876|NCT00961415|413917|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
111877|NCT00961415|413918|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
111878|NCT00961415|413916|P3|Maintenance Treatment Phase|Investigators decision|0
111879|NCT00961415|413917|P2|Maintenance Treatment Phase|Investigators decision|2
112126|NCT00960531|414402|P9|Overall Study|Failed to Return|0
111880|NCT00961415|413918|P1|Maintenance Treatment Phase|Investigators decision|0
111881|NCT00961415|413916|P3|Maintenance Treatment Phase|Death|34
111882|NCT00961415|413917|P2|Maintenance Treatment Phase|Death|42
111883|NCT00961415|413918|P1|Maintenance Treatment Phase|Death|0
111884|NCT00961415|413916|P3|Induction Treatment Phase|Other Reason|0
111885|NCT00961415|413917|P2|Induction Treatment Phase|Other Reason|0
111886|NCT00961415|413918|P1|Induction Treatment Phase|Other Reason|5
111887|NCT00961415|413916|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
111888|NCT00961415|413917|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
111889|NCT00961415|413918|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
111890|NCT00961415|413916|P3|Induction Treatment Phase|Physician Decision|0
111891|NCT00961415|413917|P2|Induction Treatment Phase|Physician Decision|0
111892|NCT00961415|413918|P1|Induction Treatment Phase|Physician Decision|2
111893|NCT00961415|413916|P3|Induction Treatment Phase|Protocol Violation|0
111894|NCT00961415|413917|P2|Induction Treatment Phase|Protocol Violation|0
111895|NCT00961415|413918|P1|Induction Treatment Phase|Protocol Violation|1
111896|NCT00961415|413916|P3|Induction Treatment Phase|Death|0
111897|NCT00961415|413917|P2|Induction Treatment Phase|Death|0
111898|NCT00961415|413918|P1|Induction Treatment Phase|Death|77
111899|NCT00961415|413916|P3|Induction Treatment Phase|Withdrawal by Subject|0
111900|NCT00961415|413917|P2|Induction Treatment Phase|Withdrawal by Subject|0
111901|NCT00961415|413918|P1|Induction Treatment Phase|Withdrawal by Subject|11
111902|NCT00961350|413958|P2|Overall Study|Misc|21
111903|NCT00961350|413959|P1|Overall Study|Misc|16
111904|NCT00961350|413958|P2|Overall Study|Lost to Follow-up|3
111905|NCT00961350|413959|P1|Overall Study|Lost to Follow-up|3
111906|NCT00961350|413958|P2|Overall Study|Withdrawal by Subject|10
111907|NCT00961350|413959|P1|Overall Study|Withdrawal by Subject|10
111908|NCT00961350|413958|P2|Overall Study|Adverse Event|33
111909|NCT00961350|413959|P1|Overall Study|Adverse Event|18
111910|NCT00961298|413980|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
111911|NCT00961298|413980|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
111912|NCT00961298|413980|P1|Two Week Placebo Run in|Withdrawal by Subject|1
111913|NCT00961259|413987|P3|Washout Period of 7 Days|due to concomitant medication used|0
111914|NCT00961259|413988|P2|Washout Period of 7 Days|due to concomitant medication used|1
111915|NCT00961259|413989|P1|Washout Period of 7 Days|due to concomitant medication used|0
111916|NCT00961220|414017|P1|Overall Study|Complete Response prior to 12 courses|1
111917|NCT00961220|414017|P1|Overall Study|O6BG no longer supplied|1
111918|NCT00961220|414017|P1|Overall Study|No IV access for O6BG|1
111919|NCT00961220|414017|P1|Overall Study|Lack of Efficacy|1
111920|NCT00961220|414017|P1|Overall Study|Adverse Event|3
111921|NCT00961181|414033|P1|Overall Study|Lost to Follow-up|1
111922|NCT00961181|414033|P1|Overall Study|Withdrawal by Subject|2
111923|NCT00961181|414033|P1|Overall Study|Death|2
111924|NCT00961116|414046|P2|Washout Period of 7 Days|Protocol Violation|1
111925|NCT00961116|414047|P1|Washout Period of 7 Days|Protocol Violation|0
111926|NCT00961116|414046|P2|Washout Period of 7 Days|Withdrawal by Subject|1
111927|NCT00961116|414047|P1|Washout Period of 7 Days|Withdrawal by Subject|1
111928|NCT00961116|414046|P2|Washout Period of 7 Days|Adverse Event|1
111929|NCT00961116|414047|P1|Washout Period of 7 Days|Adverse Event|1
111930|NCT00960999|414070|P2|Overall Study|RT dose constraints not met|0
111931|NCT00960999|414071|P1|Overall Study|RT dose constraints not met|2
111932|NCT00960999|414070|P2|Overall Study|Protocol Violation|2
111933|NCT00960999|414071|P1|Overall Study|Protocol Violation|5
111934|NCT00960999|414070|P2|Overall Study|Withdrawal by Subject|0
111935|NCT00960999|414071|P1|Overall Study|Withdrawal by Subject|1
111936|NCT00960986|414081|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
111937|NCT00960986|414082|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
111938|NCT00960986|414083|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
111939|NCT00960986|414084|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
111940|NCT00960986|414081|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
111941|NCT00960986|414082|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
111942|NCT00960986|414083|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
111943|NCT00960986|414084|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
111944|NCT00960986|414081|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
111945|NCT00960986|414082|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
111946|NCT00960986|414083|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
111947|NCT00960986|414084|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
111948|NCT00960986|414081|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
111949|NCT00960986|414082|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
111950|NCT00960986|414083|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
111951|NCT00960986|414084|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
111952|NCT00960986|414081|P4|Period 3 (7-week Therapy Period)|Death|0
111953|NCT00960986|414082|P3|Period 3 (7-week Therapy Period)|Death|1
111954|NCT00960986|414083|P2|Period 3 (7-week Therapy Period)|Death|0
111955|NCT00960986|414084|P1|Period 3 (7-week Therapy Period)|Death|0
111956|NCT00960986|414081|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
111957|NCT00960986|414082|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
111958|NCT00960986|414083|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
111959|NCT00960986|414084|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
111960|NCT00960986|414081|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
111961|NCT00960986|414082|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
111962|NCT00960986|414083|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
111963|NCT00960986|414084|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
111964|NCT00960986|414081|P4|Period 1 (Screening and Washout)|Protocol Violation|0
111965|NCT00960986|414082|P3|Period 1 (Screening and Washout)|Protocol Violation|0
111966|NCT00960986|414083|P2|Period 1 (Screening and Washout)|Protocol Violation|0
111967|NCT00960986|414084|P1|Period 1 (Screening and Washout)|Protocol Violation|1
111968|NCT00960986|414081|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
111969|NCT00960986|414082|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
111970|NCT00960986|414083|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
111971|NCT00960986|414084|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
111972|NCT00960986|414081|P4|Period 1 (Screening and Washout)|Adverse Event|1
111973|NCT00960986|414082|P3|Period 1 (Screening and Washout)|Adverse Event|1
111974|NCT00960986|414083|P2|Period 1 (Screening and Washout)|Adverse Event|2
111975|NCT00960986|414084|P1|Period 1 (Screening and Washout)|Adverse Event|1
111976|NCT00960934|414160|P6|Overall Study|Study Terminated by Sponsor|49
111977|NCT00960934|414161|P5|Overall Study|Study Terminated by Sponsor|49
111978|NCT00960934|414162|P4|Overall Study|Study Terminated by Sponsor|50
111979|NCT00960934|414163|P3|Overall Study|Study Terminated by Sponsor|52
111980|NCT00960934|414164|P2|Overall Study|Study Terminated by Sponsor|46
111981|NCT00960934|414165|P1|Overall Study|Study Terminated by Sponsor|50
111982|NCT00960934|414160|P6|Overall Study|Withdrawal by Subject|7
111983|NCT00960934|414161|P5|Overall Study|Withdrawal by Subject|5
111984|NCT00960934|414162|P4|Overall Study|Withdrawal by Subject|5
111985|NCT00960934|414163|P3|Overall Study|Withdrawal by Subject|4
111986|NCT00960934|414164|P2|Overall Study|Withdrawal by Subject|6
111987|NCT00960934|414165|P1|Overall Study|Withdrawal by Subject|5
111988|NCT00960934|414160|P6|Overall Study|Protocol Violation|2
111989|NCT00960934|414161|P5|Overall Study|Protocol Violation|3
111990|NCT00960934|414162|P4|Overall Study|Protocol Violation|3
111991|NCT00960934|414163|P3|Overall Study|Protocol Violation|0
111992|NCT00960934|414164|P2|Overall Study|Protocol Violation|4
111993|NCT00960934|414165|P1|Overall Study|Protocol Violation|3
111994|NCT00960934|414160|P6|Overall Study|Progressive Disease|1
111995|NCT00960934|414161|P5|Overall Study|Progressive Disease|1
111996|NCT00960934|414162|P4|Overall Study|Progressive Disease|0
111997|NCT00960934|414163|P3|Overall Study|Progressive Disease|0
111998|NCT00960934|414164|P2|Overall Study|Progressive Disease|1
111999|NCT00960934|414165|P1|Overall Study|Progressive Disease|1
112000|NCT00960934|414160|P6|Overall Study|Physician Decision|0
112001|NCT00960934|414161|P5|Overall Study|Physician Decision|0
112002|NCT00960934|414162|P4|Overall Study|Physician Decision|0
112003|NCT00960934|414163|P3|Overall Study|Physician Decision|0
112004|NCT00960934|414164|P2|Overall Study|Physician Decision|1
112005|NCT00960934|414165|P1|Overall Study|Physician Decision|0
112006|NCT00960934|414160|P6|Overall Study|Not Specified|2
112007|NCT00960934|414161|P5|Overall Study|Not Specified|2
112008|NCT00960934|414162|P4|Overall Study|Not Specified|4
112009|NCT00960934|414163|P3|Overall Study|Not Specified|5
112010|NCT00960934|414164|P2|Overall Study|Not Specified|1
112011|NCT00960934|414165|P1|Overall Study|Not Specified|2
112012|NCT00960934|414160|P6|Overall Study|Lost to Follow-up|0
112013|NCT00960934|414161|P5|Overall Study|Lost to Follow-up|0
112014|NCT00960934|414162|P4|Overall Study|Lost to Follow-up|0
112015|NCT00960934|414163|P3|Overall Study|Lost to Follow-up|0
112016|NCT00960934|414164|P2|Overall Study|Lost to Follow-up|1
112017|NCT00960934|414165|P1|Overall Study|Lost to Follow-up|0
112018|NCT00960934|414160|P6|Overall Study|Lack of Efficacy|0
112019|NCT00960934|414161|P5|Overall Study|Lack of Efficacy|0
112020|NCT00960934|414162|P4|Overall Study|Lack of Efficacy|0
112021|NCT00960934|414163|P3|Overall Study|Lack of Efficacy|0
112022|NCT00960934|414164|P2|Overall Study|Lack of Efficacy|0
112023|NCT00960934|414165|P1|Overall Study|Lack of Efficacy|1
112024|NCT00960934|414160|P6|Overall Study|Adverse Event|3
112025|NCT00960934|414161|P5|Overall Study|Adverse Event|4
112026|NCT00960934|414162|P4|Overall Study|Adverse Event|2
112027|NCT00960934|414163|P3|Overall Study|Adverse Event|3
112028|NCT00960934|414164|P2|Overall Study|Adverse Event|3
112029|NCT00960934|414165|P1|Overall Study|Adverse Event|2
112030|NCT00960869|414277|P2|Overall Study|Misc|18
112031|NCT00960869|414278|P1|Overall Study|Misc|19
112032|NCT00960869|414277|P2|Overall Study|Lost to Follow-up|4
112033|NCT00960869|414278|P1|Overall Study|Lost to Follow-up|1
112034|NCT00960869|414277|P2|Overall Study|Withdrawal by Subject|14
112035|NCT00960869|414278|P1|Overall Study|Withdrawal by Subject|16
112036|NCT00960869|414277|P2|Overall Study|Adverse Event|26
112037|NCT00960869|414278|P1|Overall Study|Adverse Event|17
112038|NCT00960856|414292|P4|Washout Period of 7 Days|Adverse Event|0
112039|NCT00960856|414293|P3|Washout Period of 7 Days|Adverse Event|1
112040|NCT00960856|414294|P2|Washout Period of 7 Days|Adverse Event|0
112041|NCT00960856|414295|P1|Washout Period of 7 Days|Adverse Event|0
112042|NCT00960856|414292|P4|Washout Period of 7 Days|Withdrawal by Subject|0
112043|NCT00960856|414293|P3|Washout Period of 7 Days|Withdrawal by Subject|0
112044|NCT00960856|414294|P2|Washout Period of 7 Days|Withdrawal by Subject|2
112045|NCT00960856|414295|P1|Washout Period of 7 Days|Withdrawal by Subject|0
112046|NCT00960843|414315|P2|Overall Study|Repeated needle dislodgment|1
112047|NCT00960843|414316|P1|Overall Study|Repeated needle dislodgment|0
112048|NCT00960843|414315|P2|Overall Study|Protocol Violation|4
112049|NCT00960843|414316|P1|Overall Study|Protocol Violation|0
112050|NCT00960843|414315|P2|Overall Study|Lost to Follow-up|0
112051|NCT00960843|414316|P1|Overall Study|Lost to Follow-up|2
112052|NCT00960687|414326|P2|Washout Period of 7 Days|Withdrawal by Subject|1
112053|NCT00960687|414327|P1|Washout Period of 7 Days|Withdrawal by Subject|1
112054|NCT00960687|414326|P2|Washout Period of 7 Days|Adverse Event|2
112055|NCT00960687|414327|P1|Washout Period of 7 Days|Adverse Event|3
112056|NCT00960661|414339|P3|Interventional Phase|Lack of Efficacy|0
112057|NCT00960661|414340|P2|Interventional Phase|Lack of Efficacy|2
112058|NCT00960661|414341|P1|Interventional Phase|Lack of Efficacy|0
112059|NCT00960661|414339|P3|Interventional Phase|sponsor decision|0
112060|NCT00960661|414340|P2|Interventional Phase|sponsor decision|1
112061|NCT00960661|414341|P1|Interventional Phase|sponsor decision|0
112062|NCT00960661|414339|P3|Interventional Phase|Physician Decision|5
112063|NCT00960661|414340|P2|Interventional Phase|Physician Decision|3
112064|NCT00960661|414341|P1|Interventional Phase|Physician Decision|0
112065|NCT00960661|414339|P3|Interventional Phase|Withdrawal by Subject|29
112066|NCT00960661|414340|P2|Interventional Phase|Withdrawal by Subject|18
112067|NCT00960661|414341|P1|Interventional Phase|Withdrawal by Subject|0
112068|NCT00960661|414339|P3|Interventional Phase|Protocol Violation|2
112069|NCT00960661|414340|P2|Interventional Phase|Protocol Violation|7
112070|NCT00960661|414341|P1|Interventional Phase|Protocol Violation|0
112071|NCT00960661|414339|P3|Interventional Phase|entry criteria not met|0
112072|NCT00960661|414340|P2|Interventional Phase|entry criteria not met|3
112073|NCT00960661|414341|P1|Interventional Phase|entry criteria not met|0
112074|NCT00960661|414339|P3|Interventional Phase|Lost to Follow-up|2
112075|NCT00960661|414340|P2|Interventional Phase|Lost to Follow-up|0
112076|NCT00960661|414341|P1|Interventional Phase|Lost to Follow-up|0
112077|NCT00960661|414339|P3|Interventional Phase|Death|0
112078|NCT00960661|414340|P2|Interventional Phase|Death|1
112079|NCT00960661|414341|P1|Interventional Phase|Death|0
112080|NCT00960661|414339|P3|Interventional Phase|Adverse Event|8
112081|NCT00960661|414340|P2|Interventional Phase|Adverse Event|17
112082|NCT00960661|414341|P1|Interventional Phase|Adverse Event|0
112083|NCT00960661|414339|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
112084|NCT00960661|414340|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
112085|NCT00960661|414341|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
112086|NCT00960661|414339|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
112087|NCT00960661|414340|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
112088|NCT00960661|414341|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
112089|NCT00960661|414339|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
112090|NCT00960661|414340|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
112091|NCT00960661|414341|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
112092|NCT00960661|414339|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
112093|NCT00960661|414340|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
112094|NCT00960661|414341|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
112095|NCT00960661|414339|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
112096|NCT00960661|414340|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
112097|NCT00960661|414341|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
112098|NCT00960661|414339|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
112099|NCT00960661|414340|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
112100|NCT00960661|414341|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
112101|NCT00960570|414380|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
112102|NCT00960570|414380|P1|1 Day Period Between Dosing|Adverse Event|2
112103|NCT00960570|414380|P1|21 Day Washout Period|Withdrawal by Subject|1
112104|NCT00960570|414380|P1|21 Day Washout Period|Adverse Event|1
112105|NCT00960531|414401|P10|Overall Study|Reason not Specified|1
112106|NCT00960531|414402|P9|Overall Study|Reason not Specified|8
112107|NCT00960531|414403|P8|Overall Study|Reason not Specified|0
112108|NCT00960531|414404|P7|Overall Study|Reason not Specified|16
112109|NCT00960531|414405|P6|Overall Study|Reason not Specified|0
112110|NCT00960531|414406|P5|Overall Study|Reason not Specified|2
112111|NCT00960531|414407|P4|Overall Study|Reason not Specified|1
112112|NCT00960531|414408|P3|Overall Study|Reason not Specified|13
112113|NCT00960531|414409|P2|Overall Study|Reason not Specified|1
112114|NCT00960531|414410|P1|Overall Study|Reason not Specified|2
112115|NCT00960531|414401|P10|Overall Study|Adverse Event (AE)|0
112116|NCT00960531|414402|P9|Overall Study|Adverse Event (AE)|2
112117|NCT00960531|414403|P8|Overall Study|Adverse Event (AE)|0
112118|NCT00960531|414404|P7|Overall Study|Adverse Event (AE)|2
112119|NCT00960531|414405|P6|Overall Study|Adverse Event (AE)|1
112120|NCT00960531|414406|P5|Overall Study|Adverse Event (AE)|0
112121|NCT00960531|414407|P4|Overall Study|Adverse Event (AE)|0
112122|NCT00960531|414408|P3|Overall Study|Adverse Event (AE)|0
112123|NCT00960531|414409|P2|Overall Study|Adverse Event (AE)|0
112124|NCT00960531|414410|P1|Overall Study|Adverse Event (AE)|2
112125|NCT00960531|414401|P10|Overall Study|Failed to Return|0
112127|NCT00960531|414403|P8|Overall Study|Failed to Return|2
112128|NCT00960531|414404|P7|Overall Study|Failed to Return|0
112129|NCT00960531|414405|P6|Overall Study|Failed to Return|0
112130|NCT00960531|414406|P5|Overall Study|Failed to Return|0
112131|NCT00960531|414407|P4|Overall Study|Failed to Return|0
112132|NCT00960531|414408|P3|Overall Study|Failed to Return|0
112133|NCT00960531|414409|P2|Overall Study|Failed to Return|0
112134|NCT00960531|414410|P1|Overall Study|Failed to Return|2
112135|NCT00960531|414401|P10|Overall Study|Lost to Follow-up|0
112136|NCT00960531|414402|P9|Overall Study|Lost to Follow-up|0
112137|NCT00960531|414403|P8|Overall Study|Lost to Follow-up|0
112138|NCT00960531|414404|P7|Overall Study|Lost to Follow-up|1
112139|NCT00960531|414405|P6|Overall Study|Lost to Follow-up|0
112140|NCT00960531|414406|P5|Overall Study|Lost to Follow-up|0
112141|NCT00960531|414407|P4|Overall Study|Lost to Follow-up|0
112142|NCT00960531|414408|P3|Overall Study|Lost to Follow-up|1
112143|NCT00960531|414409|P2|Overall Study|Lost to Follow-up|0
112144|NCT00960531|414410|P1|Overall Study|Lost to Follow-up|0
112145|NCT00960531|414401|P10|Overall Study|Discontinuation of Study by Sponsor|0
112146|NCT00960531|414402|P9|Overall Study|Discontinuation of Study by Sponsor|0
112147|NCT00960531|414403|P8|Overall Study|Discontinuation of Study by Sponsor|1
112148|NCT00960531|414404|P7|Overall Study|Discontinuation of Study by Sponsor|0
112149|NCT00960531|414405|P6|Overall Study|Discontinuation of Study by Sponsor|0
112150|NCT00960531|414406|P5|Overall Study|Discontinuation of Study by Sponsor|0
112151|NCT00960531|414407|P4|Overall Study|Discontinuation of Study by Sponsor|0
112152|NCT00960531|414408|P3|Overall Study|Discontinuation of Study by Sponsor|0
112153|NCT00960531|414409|P2|Overall Study|Discontinuation of Study by Sponsor|0
112154|NCT00960531|414410|P1|Overall Study|Discontinuation of Study by Sponsor|0
112155|NCT00960531|414401|P10|Overall Study|Investigator Request|0
112156|NCT00960531|414402|P9|Overall Study|Investigator Request|0
112157|NCT00960531|414403|P8|Overall Study|Investigator Request|0
112158|NCT00960531|414404|P7|Overall Study|Investigator Request|0
112159|NCT00960531|414405|P6|Overall Study|Investigator Request|0
112160|NCT00960531|414406|P5|Overall Study|Investigator Request|0
112161|NCT00960531|414407|P4|Overall Study|Investigator Request|0
112162|NCT00960531|414408|P3|Overall Study|Investigator Request|1
112163|NCT00960531|414409|P2|Overall Study|Investigator Request|0
112164|NCT00960531|414410|P1|Overall Study|Investigator Request|0
112165|NCT00960531|414401|P10|Overall Study|Caregiver Request|0
112166|NCT00960531|414402|P9|Overall Study|Caregiver Request|3
112167|NCT00960531|414403|P8|Overall Study|Caregiver Request|1
112168|NCT00960531|414404|P7|Overall Study|Caregiver Request|3
112169|NCT00960531|414405|P6|Overall Study|Caregiver Request|2
112170|NCT00960531|414406|P5|Overall Study|Caregiver Request|0
112171|NCT00960531|414407|P4|Overall Study|Caregiver Request|5
112172|NCT00960531|414408|P3|Overall Study|Caregiver Request|6
112173|NCT00960531|414409|P2|Overall Study|Caregiver Request|0
112174|NCT00960531|414410|P1|Overall Study|Caregiver Request|2
112175|NCT00960531|414401|P10|Overall Study|Withdrawal by Subject|0
112176|NCT00960531|414402|P9|Overall Study|Withdrawal by Subject|1
112177|NCT00960531|414403|P8|Overall Study|Withdrawal by Subject|0
112178|NCT00960531|414404|P7|Overall Study|Withdrawal by Subject|2
112179|NCT00960531|414405|P6|Overall Study|Withdrawal by Subject|0
112180|NCT00960531|414406|P5|Overall Study|Withdrawal by Subject|0
112181|NCT00960531|414407|P4|Overall Study|Withdrawal by Subject|2
112182|NCT00960531|414408|P3|Overall Study|Withdrawal by Subject|5
112183|NCT00960531|414409|P2|Overall Study|Withdrawal by Subject|0
112184|NCT00960531|414410|P1|Overall Study|Withdrawal by Subject|1
112185|NCT00960531|414401|P10|Overall Study|Lack of Efficacy|0
112186|NCT00960531|414402|P9|Overall Study|Lack of Efficacy|0
112187|NCT00960531|414403|P8|Overall Study|Lack of Efficacy|0
112188|NCT00960531|414404|P7|Overall Study|Lack of Efficacy|0
112189|NCT00960531|414405|P6|Overall Study|Lack of Efficacy|0
112190|NCT00960531|414406|P5|Overall Study|Lack of Efficacy|0
112191|NCT00960531|414407|P4|Overall Study|Lack of Efficacy|0
112192|NCT00960531|414408|P3|Overall Study|Lack of Efficacy|0
112193|NCT00960531|414409|P2|Overall Study|Lack of Efficacy|0
112194|NCT00960531|414410|P1|Overall Study|Lack of Efficacy|1
112195|NCT00960440|414458|P4|Overall Study|Other|0
112196|NCT00960440|414459|P3|Overall Study|Other|1
112197|NCT00960440|414460|P2|Overall Study|Other|1
112198|NCT00960440|414461|P1|Overall Study|Other|1
112199|NCT00960440|414458|P4|Overall Study|Withdrawal by Subject|1
112200|NCT00960440|414459|P3|Overall Study|Withdrawal by Subject|2
112201|NCT00960440|414460|P2|Overall Study|Withdrawal by Subject|5
112202|NCT00960440|414461|P1|Overall Study|Withdrawal by Subject|9
112203|NCT00960440|414458|P4|Overall Study|Protocol Violation|4
112204|NCT00960440|414459|P3|Overall Study|Protocol Violation|3
112205|NCT00960440|414460|P2|Overall Study|Protocol Violation|8
112206|NCT00960440|414461|P1|Overall Study|Protocol Violation|2
112207|NCT00960440|414458|P4|Overall Study|Lack of Efficacy|8
112208|NCT00960440|414459|P3|Overall Study|Lack of Efficacy|3
112209|NCT00960440|414460|P2|Overall Study|Lack of Efficacy|5
112210|NCT00960440|414461|P1|Overall Study|Lack of Efficacy|2
112211|NCT00960440|414458|P4|Overall Study|Adverse Event|4
112212|NCT00960440|414459|P3|Overall Study|Adverse Event|4
112213|NCT00960440|414460|P2|Overall Study|Adverse Event|12
112214|NCT00960440|414461|P1|Overall Study|Adverse Event|12
112215|NCT00960440|414458|P4|Overall Study|Death|1
112216|NCT00960440|414459|P3|Overall Study|Death|0
112217|NCT00960440|414460|P2|Overall Study|Death|0
112218|NCT00960440|414461|P1|Overall Study|Death|0
112219|NCT00960375|414633|P2|Overall Study|Lost to Follow-up|22
112220|NCT00960375|414634|P1|Overall Study|Lost to Follow-up|20
112221|NCT00960323|414642|P1|Atorvastatin Alone|Withdrawal by Subject|1
112222|NCT00960297|414653|P1|Overall Study|Disease progression|1
112223|NCT00960297|414653|P1|Overall Study|Venous port infection|1
112224|NCT00960297|414653|P1|Overall Study|Physician Decision|1
112225|NCT00960206|414660|P3|Overall Study|Missing 10 year data|1
112226|NCT00960206|414661|P2|Overall Study|Missing 10 year data|1
112227|NCT00960206|414662|P1|Overall Study|Missing 10 year data|20
112228|NCT00960206|414660|P3|Overall Study|Revision of study component|2
112229|NCT00960206|414661|P2|Overall Study|Revision of study component|2
112230|NCT00960206|414662|P1|Overall Study|Revision of study component|2
112231|NCT00960206|414660|P3|Overall Study|Withdrawal by Subject|0
112232|NCT00960206|414661|P2|Overall Study|Withdrawal by Subject|4
112233|NCT00960206|414662|P1|Overall Study|Withdrawal by Subject|2
112234|NCT00960206|414660|P3|Overall Study|Lost to Follow-up|8
112235|NCT00960206|414661|P2|Overall Study|Lost to Follow-up|14
112236|NCT00960206|414662|P1|Overall Study|Lost to Follow-up|8
112237|NCT00960206|414660|P3|Overall Study|Unwilling/Unable to return|0
112238|NCT00960206|414661|P2|Overall Study|Unwilling/Unable to return|2
112239|NCT00960206|414662|P1|Overall Study|Unwilling/Unable to return|1
112240|NCT00960206|414660|P3|Overall Study|Death|1
112241|NCT00960206|414661|P2|Overall Study|Death|4
112242|NCT00960206|414662|P1|Overall Study|Death|7
112243|NCT00960193|414680|P1|14 Day Washout Period|Withdrawal by Subject|1
112244|NCT00960154|414693|P2|Overall Study|Study termination|25
112245|NCT00960154|414694|P1|Overall Study|Study termination|25
112246|NCT00960141|414705|P3|Overall Study|Withdrawal by Subject|1
112247|NCT00960141|414706|P2|Overall Study|Withdrawal by Subject|2
112248|NCT00960141|414707|P1|Overall Study|Withdrawal by Subject|1
112249|NCT00960141|414705|P3|Overall Study|Protocol Violation|2
112250|NCT00960141|414706|P2|Overall Study|Protocol Violation|3
112251|NCT00960141|414707|P1|Overall Study|Protocol Violation|1
112252|NCT00960141|414705|P3|Overall Study|Lost to Follow-up|0
112253|NCT00960141|414706|P2|Overall Study|Lost to Follow-up|0
112254|NCT00960141|414707|P1|Overall Study|Lost to Follow-up|1
112255|NCT00960141|414705|P3|Overall Study|Lack of Efficacy|2
112256|NCT00960141|414706|P2|Overall Study|Lack of Efficacy|4
112257|NCT00960141|414707|P1|Overall Study|Lack of Efficacy|3
112258|NCT00960141|414705|P3|Overall Study|Adverse Event|2
112259|NCT00960141|414706|P2|Overall Study|Adverse Event|8
112260|NCT00960141|414707|P1|Overall Study|Adverse Event|4
112261|NCT00960115|414732|P2|Overall Study|Ongoing treatment at data cut-off date|15
112262|NCT00960115|414733|P1|Overall Study|Ongoing treatment at data cut-off date|19
112263|NCT00960076|414747|P2|Overall Study|Did not attend the termination visit|1
112264|NCT00960076|414748|P1|Overall Study|Did not attend the termination visit|0
112265|NCT00960076|414747|P2|Overall Study|Hyperglycemia|5
112266|NCT00960076|414748|P1|Overall Study|Hyperglycemia|1
112267|NCT00960076|414747|P2|Overall Study|Severe non-compliance to protocol|2
112268|NCT00960076|414748|P1|Overall Study|Severe non-compliance to protocol|1
112269|NCT00960076|414747|P2|Overall Study|Lost to Follow-up|3
112270|NCT00960076|414748|P1|Overall Study|Lost to Follow-up|3
112271|NCT00960076|414747|P2|Overall Study|Withdrawal by Subject|2
112272|NCT00960076|414748|P1|Overall Study|Withdrawal by Subject|1
112273|NCT00960076|414747|P2|Overall Study|No longer met study criteria|5
112274|NCT00960076|414748|P1|Overall Study|No longer met study criteria|1
112275|NCT00960076|414747|P2|Overall Study|Adverse Event|7
112276|NCT00960076|414748|P1|Overall Study|Adverse Event|1
112277|NCT00960063|414763|P3|Overall Study|Progression of Disease|3
112278|NCT00960063|414764|P2|Overall Study|Progression of Disease|0
112279|NCT00960063|414765|P1|Overall Study|Progression of Disease|0
112280|NCT00960063|414763|P3|Overall Study|Adverse Event|0
112281|NCT00960063|414764|P2|Overall Study|Adverse Event|0
112282|NCT00960063|414765|P1|Overall Study|Adverse Event|1
112283|NCT00959946|414856|P8|Overall Study|Withdrawal by Subject|0
112284|NCT00959946|414857|P7|Overall Study|Withdrawal by Subject|0
112285|NCT00959946|414858|P6|Overall Study|Withdrawal by Subject|1
112286|NCT00959946|414859|P5|Overall Study|Withdrawal by Subject|0
112287|NCT00959946|414860|P4|Overall Study|Withdrawal by Subject|0
112288|NCT00959946|414861|P3|Overall Study|Withdrawal by Subject|0
112289|NCT00959946|414862|P2|Overall Study|Withdrawal by Subject|0
112290|NCT00959946|414863|P1|Overall Study|Withdrawal by Subject|0
112291|NCT00959946|414856|P8|Overall Study|Disease Progression|2
112292|NCT00959946|414857|P7|Overall Study|Disease Progression|2
112293|NCT00959946|414858|P6|Overall Study|Disease Progression|6
112294|NCT00959946|414859|P5|Overall Study|Disease Progression|4
112295|NCT00959946|414860|P4|Overall Study|Disease Progression|4
112296|NCT00959946|414861|P3|Overall Study|Disease Progression|2
112297|NCT00959946|414862|P2|Overall Study|Disease Progression|4
112298|NCT00959946|414863|P1|Overall Study|Disease Progression|2
112299|NCT00959946|414856|P8|Overall Study|Death|0
112300|NCT00959946|414857|P7|Overall Study|Death|0
112301|NCT00959946|414858|P6|Overall Study|Death|1
112302|NCT00959946|414859|P5|Overall Study|Death|0
112303|NCT00959946|414860|P4|Overall Study|Death|0
112304|NCT00959946|414861|P3|Overall Study|Death|0
112305|NCT00959946|414862|P2|Overall Study|Death|0
112306|NCT00959946|414863|P1|Overall Study|Death|0
112307|NCT00959946|414856|P8|Overall Study|Adverse Event|0
112308|NCT00959946|414857|P7|Overall Study|Adverse Event|0
112309|NCT00959946|414858|P6|Overall Study|Adverse Event|1
112310|NCT00959946|414859|P5|Overall Study|Adverse Event|0
112311|NCT00959946|414860|P4|Overall Study|Adverse Event|1
112312|NCT00959946|414861|P3|Overall Study|Adverse Event|2
112313|NCT00959946|414862|P2|Overall Study|Adverse Event|0
112314|NCT00959946|414863|P1|Overall Study|Adverse Event|0
112315|NCT00959907|414927|P2|Overall Study|Withdrawal by Subject|0
112316|NCT00959907|414928|P1|Overall Study|Withdrawal by Subject|2
112317|NCT00959907|414927|P2|Overall Study|Adverse Event|0
112318|NCT00959907|414928|P1|Overall Study|Adverse Event|1
112319|NCT00959907|414927|P2|Overall Study|Protocol Violation|1
112320|NCT00959907|414928|P1|Overall Study|Protocol Violation|0
112321|NCT00959894|414938|P1|Overall Study|Subject moved out of town|1
112322|NCT00959894|414938|P1|Overall Study|Need for contraindicated medication|1
112323|NCT00959894|414938|P1|Overall Study|Withdrawal by Subject|1
112324|NCT00959894|414938|P1|Overall Study|Adverse Event|3
112325|NCT00959894|414938|P1|Overall Study|Lost to Follow-up|10
112326|NCT00959751|414987|P2|Overall Study|No migraine headache without aura|7
112327|NCT00959751|414988|P1|Overall Study|No migraine headache without aura|7
112328|NCT00959751|414987|P2|Overall Study|Non-compliance to Study Procedures|1
112329|NCT00959751|414988|P1|Overall Study|Non-compliance to Study Procedures|0
112330|NCT00959751|414987|P2|Overall Study|Consent Withdrawn|1
112331|NCT00959751|414988|P1|Overall Study|Consent Withdrawn|0
112332|NCT00959751|414987|P2|Overall Study|Lost to Follow-up|3
112333|NCT00959751|414988|P1|Overall Study|Lost to Follow-up|2
112334|NCT00959699|415010|P2|Follow-up Period|Withdrawal by Subject|4
112335|NCT00959699|415011|P1|Follow-up Period|Withdrawal by Subject|3
112336|NCT00959699|415010|P2|Follow-up Period|Lost to Follow-up|2
112337|NCT00959699|415011|P1|Follow-up Period|Lost to Follow-up|3
112338|NCT00959699|415010|P2|Treatment Period|Futility/crossover to boceprevir|0
112339|NCT00959699|415011|P1|Treatment Period|Futility/crossover to boceprevir|4
112340|NCT00959699|415010|P2|Treatment Period|Did not receive treatment|1
112341|NCT00959699|415011|P1|Treatment Period|Did not receive treatment|0
112342|NCT00959699|415010|P2|Treatment Period|Non-Compliance with Protocol|1
112343|NCT00959699|415011|P1|Treatment Period|Non-Compliance with Protocol|0
112344|NCT00959699|415010|P2|Treatment Period|Withdrawal by Subject|3
112345|NCT00959699|415011|P1|Treatment Period|Withdrawal by Subject|1
112346|NCT00959699|415010|P2|Treatment Period|Lost to Follow-up|1
112347|NCT00959699|415011|P1|Treatment Period|Lost to Follow-up|0
112348|NCT00959699|415010|P2|Treatment Period|Lack of Efficacy|6
112349|NCT00959699|415011|P1|Treatment Period|Lack of Efficacy|15
112350|NCT00959699|415010|P2|Treatment Period|Adverse Event|13
112351|NCT00959699|415011|P1|Treatment Period|Adverse Event|3
112352|NCT00959647|415057|P1|Overall Study|Withdrawal by Subject|7
112353|NCT00959647|415057|P1|Overall Study|Study terminated by sponsor|4
112354|NCT00959647|415057|P1|Overall Study|Progressive disease|6
112355|NCT00959647|415057|P1|Overall Study|Adverse Event|2
112356|NCT00959374|415062|P1|Overall Study|Physician Decision|1
112357|NCT00959374|415062|P1|Overall Study|Implant Removed/Not Replaced|4
112358|NCT00959374|415062|P1|Overall Study|Protocol Violation|1
112359|NCT00959374|415062|P1|Overall Study|Death|1
112360|NCT00959374|415062|P1|Overall Study|Lost to Follow-up|14
112361|NCT00959374|415062|P1|Overall Study|Withdrawal by Subject|2
112362|NCT00959192|415076|P4|Overall Study|Caregiver Request|1
112363|NCT00959192|415077|P3|Overall Study|Caregiver Request|2
112364|NCT00959192|415078|P2|Overall Study|Caregiver Request|0
112365|NCT00959192|415079|P1|Overall Study|Caregiver Request|0
112366|NCT00959192|415076|P4|Overall Study|Investigator Request|0
112367|NCT00959192|415077|P3|Overall Study|Investigator Request|0
112368|NCT00959192|415078|P2|Overall Study|Investigator Request|0
112369|NCT00959192|415079|P1|Overall Study|Investigator Request|1
112370|NCT00959192|415076|P4|Overall Study|Adverse Event|0
112371|NCT00959192|415077|P3|Overall Study|Adverse Event|1
112372|NCT00959192|415078|P2|Overall Study|Adverse Event|1
112373|NCT00959192|415079|P1|Overall Study|Adverse Event|1
112374|NCT00959049|415127|P6|Overall Study|Withdrawal by Subject|0
112375|NCT00959049|415128|P5|Overall Study|Withdrawal by Subject|0
112376|NCT00959049|415129|P4|Overall Study|Withdrawal by Subject|0
112377|NCT00959049|415130|P3|Overall Study|Withdrawal by Subject|0
112378|NCT00959049|415131|P2|Overall Study|Withdrawal by Subject|2
112379|NCT00959049|415132|P1|Overall Study|Withdrawal by Subject|0
112380|NCT00959049|415127|P6|Overall Study|Contraindicated medication|0
112381|NCT00959049|415128|P5|Overall Study|Contraindicated medication|0
112382|NCT00959049|415129|P4|Overall Study|Contraindicated medication|1
112383|NCT00959049|415130|P3|Overall Study|Contraindicated medication|0
112384|NCT00959049|415131|P2|Overall Study|Contraindicated medication|0
112385|NCT00959049|415132|P1|Overall Study|Contraindicated medication|0
112386|NCT00959049|415127|P6|Overall Study|Lost to Follow-up|1
112387|NCT00959049|415128|P5|Overall Study|Lost to Follow-up|9
112388|NCT00959049|415129|P4|Overall Study|Lost to Follow-up|10
112389|NCT00959049|415130|P3|Overall Study|Lost to Follow-up|1
112390|NCT00959049|415131|P2|Overall Study|Lost to Follow-up|5
112391|NCT00959049|415132|P1|Overall Study|Lost to Follow-up|17
112392|NCT00959049|415127|P6|Overall Study|Adverse Event|0
112393|NCT00959049|415128|P5|Overall Study|Adverse Event|0
112394|NCT00959049|415129|P4|Overall Study|Adverse Event|0
112395|NCT00959049|415130|P3|Overall Study|Adverse Event|0
112396|NCT00959049|415131|P2|Overall Study|Adverse Event|0
112397|NCT00959049|415132|P1|Overall Study|Adverse Event|1
112398|NCT00958893|415197|P1|Overall Study|Study prematurely terminated|4
112399|NCT00958880|415203|P2|Overall Study|Lost to Follow-up|2
112400|NCT00958880|415204|P1|Overall Study|Lost to Follow-up|2
112401|NCT00958841|415212|P1|Overall Study|Discontinued prior to M*|28
112402|NCT00958841|415212|P1|Overall Study|Completed M6/did not enter extension|27
112403|NCT00958841|415212|P1|Overall Study|Unsatisfactory therapeutic effect|22
112404|NCT00958841|415212|P1|Overall Study|Withdrawal by Subject|1
112405|NCT00958841|415212|P1|Overall Study|New cancer therapy|5
112406|NCT00958841|415212|P1|Overall Study|Adverse Event|8
112407|NCT00958841|415212|P1|Overall Study|Administrative problems|1
112408|NCT00958841|415212|P1|Overall Study|Abnormal test procedure result(s)|3
112409|NCT00958841|415212|P1|Overall Study|Abnormal laboratory value(s)|1
112410|NCT00958828|415230|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
112411|NCT00958828|415231|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
112412|NCT00958828|415230|P2|Period 1, 1 Week of Wear|Randomization break|1
112413|NCT00958828|415231|P1|Period 1, 1 Week of Wear|Randomization break|0
112414|NCT00958789|415237|P1|Overall Study|Revision|8
112415|NCT00958789|415237|P1|Overall Study|Subject terminated|3
112416|NCT00958789|415237|P1|Overall Study|2 yr. Knee Society Score not calculable|2
112417|NCT00958789|415237|P1|Overall Study|No 2 yr. Knee Society Score data|12
112418|NCT00958789|415237|P1|Overall Study|Withdrawal by Subject|16
112419|NCT00958789|415237|P1|Overall Study|Lost to Follow-up|7
112420|NCT00958789|415237|P1|Overall Study|Death|3
112421|NCT00958776|415243|P2|Overall Study|Missing|1
112422|NCT00958776|415244|P1|Overall Study|Missing|1
112423|NCT00958776|415243|P2|Overall Study|Noncompliance; Protocol Deviations|3
112424|NCT00958776|415244|P1|Overall Study|Noncompliance; Protocol Deviations|2
112425|NCT00958776|415243|P2|Overall Study|Death|1
112426|NCT00958776|415244|P1|Overall Study|Death|2
112427|NCT00958776|415243|P2|Overall Study|Protocol Violation|1
112428|NCT00958776|415244|P1|Overall Study|Protocol Violation|1
112429|NCT00958776|415243|P2|Overall Study|Withdrawal by Subject|16
112430|NCT00958776|415244|P1|Overall Study|Withdrawal by Subject|7
112431|NCT00958776|415243|P2|Overall Study|Lost to Follow-up|6
112432|NCT00958776|415244|P1|Overall Study|Lost to Follow-up|2
112433|NCT00958776|415243|P2|Overall Study|Physician Decision|0
112434|NCT00958776|415244|P1|Overall Study|Physician Decision|1
112435|NCT00958776|415243|P2|Overall Study|Adverse Event|1
112436|NCT00958776|415244|P1|Overall Study|Adverse Event|0
112437|NCT00958724|415274|P1|Overall Study|Disease Progression|6
112438|NCT00958568|415303|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
112439|NCT00958568|415304|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
112440|NCT00958568|415305|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
112441|NCT00958568|415306|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
112442|NCT00958568|415303|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
112443|NCT00958568|415304|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
112444|NCT00958568|415305|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
112445|NCT00958568|415306|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
112446|NCT00958568|415303|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
112447|NCT00958568|415304|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
112448|NCT00958568|415305|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
112449|NCT00958568|415306|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
112450|NCT00958568|415303|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
112451|NCT00958568|415304|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
112452|NCT00958568|415305|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
112453|NCT00958568|415306|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
112454|NCT00958568|415303|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
112455|NCT00958568|415304|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
112456|NCT00958568|415305|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
112457|NCT00958568|415306|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
112458|NCT00958568|415303|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
112459|NCT00958568|415304|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
112460|NCT00958568|415305|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
112461|NCT00958568|415306|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
112462|NCT00958568|415303|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
112463|NCT00958568|415304|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
112464|NCT00958568|415305|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
112465|NCT00958568|415306|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
112466|NCT00958568|415303|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
112467|NCT00958568|415304|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
112468|NCT00958568|415305|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
112469|NCT00958568|415306|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
112470|NCT00958568|415303|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
112471|NCT00958568|415304|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
112472|NCT00958568|415305|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
112473|NCT00958568|415306|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
112474|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
112475|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
112476|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
112477|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
112478|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
112479|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
112480|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
112481|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
112482|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
112483|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
112484|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
112485|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
112486|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
112487|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
112488|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
112489|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
112490|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
112491|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
112492|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
112493|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
112494|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
112495|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
112496|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
112497|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
112498|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
112499|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
112500|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
112501|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
112502|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
112503|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
112504|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
112505|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
112506|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
112507|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
112508|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
112509|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
112510|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
112511|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
112512|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
112513|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
112514|NCT00958568|415303|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
112515|NCT00958568|415304|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
112516|NCT00958568|415305|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
112517|NCT00958568|415306|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
112518|NCT00958568|415303|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
112519|NCT00958568|415304|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
112520|NCT00958568|415305|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
112521|NCT00958568|415306|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
112522|NCT00958568|415303|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
112523|NCT00958568|415304|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
112524|NCT00958568|415305|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
112525|NCT00958568|415306|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
112526|NCT00958568|415303|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
112527|NCT00958568|415304|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
112528|NCT00958568|415305|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
112529|NCT00958568|415306|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
112530|NCT00958568|415303|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
112531|NCT00958568|415304|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
112532|NCT00958568|415305|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
112533|NCT00958568|415306|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
112534|NCT00958568|415303|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
112535|NCT00958568|415304|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
112536|NCT00958568|415305|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
112537|NCT00958568|415306|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
112538|NCT00958568|415303|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
112539|NCT00958568|415304|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
112540|NCT00958568|415305|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
112541|NCT00958568|415306|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
112542|NCT00958568|415303|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
112543|NCT00958568|415304|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
112544|NCT00958568|415305|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
112545|NCT00958568|415306|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
112546|NCT00958568|415303|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
112547|NCT00958568|415304|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
112548|NCT00958568|415305|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
112549|NCT00958568|415306|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
112550|NCT00958568|415303|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
112551|NCT00958568|415304|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
112552|NCT00958568|415305|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
112553|NCT00958568|415306|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
112554|NCT00958438|415543|P3|Overall Study|Other than specified above|2
112555|NCT00958438|415544|P2|Overall Study|Other than specified above|3
112556|NCT00958438|415545|P1|Overall Study|Other than specified above|2
112557|NCT00958438|415543|P3|Overall Study|Physician Decision|1
112558|NCT00958438|415544|P2|Overall Study|Physician Decision|0
112559|NCT00958438|415545|P1|Overall Study|Physician Decision|1
112560|NCT00958438|415543|P3|Overall Study|Adverse Event|0
112561|NCT00958438|415544|P2|Overall Study|Adverse Event|3
112562|NCT00958438|415545|P1|Overall Study|Adverse Event|0
112563|NCT00958438|415543|P3|Overall Study|Withdrawal by Subject|1
112564|NCT00958438|415544|P2|Overall Study|Withdrawal by Subject|2
112565|NCT00958438|415545|P1|Overall Study|Withdrawal by Subject|4
112566|NCT00958438|415543|P3|Overall Study|Protocol Violation|2
112567|NCT00958438|415544|P2|Overall Study|Protocol Violation|2
112568|NCT00958438|415545|P1|Overall Study|Protocol Violation|3
112569|NCT00958360|415570|P2|Overall Study|Lost to Follow-up|1
112570|NCT00958360|415571|P1|Overall Study|Lost to Follow-up|0
112571|NCT00958360|415570|P2|Overall Study|Physician Decision|1
112572|NCT00958360|415571|P1|Overall Study|Physician Decision|2
112573|NCT00958360|415570|P2|Overall Study|Death|7
112574|NCT00958360|415571|P1|Overall Study|Death|6
112575|NCT00958360|415570|P2|Overall Study|Withdrawal by Subject|1
112576|NCT00958360|415571|P1|Overall Study|Withdrawal by Subject|3
112577|NCT00958347|415585|P1|Overall Study|study termination|135
112578|NCT00958347|415585|P1|Overall Study|revision/removal|10
112579|NCT00958347|415585|P1|Overall Study|Lost to Follow-up|15
112580|NCT00958347|415585|P1|Overall Study|Withdrawal by Subject|23
112581|NCT00958347|415585|P1|Overall Study|Death|43
112582|NCT00958256|415626|P1|Overall Study|Adverse Event|3
112583|NCT00958243|415636|P6|Overall Study|Lost to Follow-up|5
112584|NCT00958243|415637|P5|Overall Study|Lost to Follow-up|8
112585|NCT00958243|415638|P4|Overall Study|Lost to Follow-up|2
112586|NCT00958243|415639|P3|Overall Study|Lost to Follow-up|11
112587|NCT00958243|415640|P2|Overall Study|Lost to Follow-up|5
112588|NCT00958243|415641|P1|Overall Study|Lost to Follow-up|2
112589|NCT00958243|415636|P6|Overall Study|Withdrawal by Subject|5
112590|NCT00958243|415637|P5|Overall Study|Withdrawal by Subject|1
112591|NCT00958243|415638|P4|Overall Study|Withdrawal by Subject|1
112592|NCT00958243|415639|P3|Overall Study|Withdrawal by Subject|3
112593|NCT00958243|415640|P2|Overall Study|Withdrawal by Subject|1
112594|NCT00958243|415641|P1|Overall Study|Withdrawal by Subject|0
112595|NCT00958217|415699|P2|Overall Study|Inpatient hospitalization|1
112596|NCT00958217|415700|P1|Overall Study|Inpatient hospitalization|0
112597|NCT00958217|415699|P2|Overall Study|Moved out of area|1
112598|NCT00958217|415700|P1|Overall Study|Moved out of area|1
112599|NCT00958217|415699|P2|Overall Study|Lost to Follow-up|19
112600|NCT00958217|415700|P1|Overall Study|Lost to Follow-up|17
112601|NCT00958217|415699|P2|Overall Study|Withdrawal by Subject|3
112602|NCT00958217|415700|P1|Overall Study|Withdrawal by Subject|4
112603|NCT00958217|415699|P2|Overall Study|Death|1
112604|NCT00958217|415700|P1|Overall Study|Death|2
112605|NCT00958191|415711|P1|Overall Study|No 5 yr x-rays|56
112606|NCT00958191|415711|P1|Overall Study|Site termination|11
112607|NCT00958191|415711|P1|Overall Study|Revision of study device|4
112608|NCT00958191|415711|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
112609|NCT00958191|415711|P1|Overall Study|Inadequate 5 yr x-ray quality|10
112610|NCT00958191|415711|P1|Overall Study|Lost to Follow-up|5
112611|NCT00958191|415711|P1|Overall Study|Death|4
112612|NCT00958165|415726|P1|Overall Study|Not eligible|9
112613|NCT00958165|415726|P1|Overall Study|Lost to Follow-up|5
112614|NCT00958126|415738|P8|Overall Study|Other Reason|0
112615|NCT00958126|415739|P7|Overall Study|Other Reason|0
112616|NCT00958126|415740|P6|Overall Study|Other Reason|1
112617|NCT00958126|415741|P5|Overall Study|Other Reason|0
112618|NCT00958126|415742|P4|Overall Study|Other Reason|1
112619|NCT00958126|415743|P3|Overall Study|Other Reason|0
112620|NCT00958126|415744|P2|Overall Study|Other Reason|0
112621|NCT00958126|415745|P1|Overall Study|Other Reason|0
112622|NCT00958126|415738|P8|Overall Study|Sponsor/Investigator decision|0
112623|NCT00958126|415739|P7|Overall Study|Sponsor/Investigator decision|0
112624|NCT00958126|415740|P6|Overall Study|Sponsor/Investigator decision|0
112625|NCT00958126|415741|P5|Overall Study|Sponsor/Investigator decision|0
112626|NCT00958126|415742|P4|Overall Study|Sponsor/Investigator decision|1
112627|NCT00958126|415743|P3|Overall Study|Sponsor/Investigator decision|0
112628|NCT00958126|415744|P2|Overall Study|Sponsor/Investigator decision|0
112629|NCT00958126|415745|P1|Overall Study|Sponsor/Investigator decision|0
112630|NCT00958126|415738|P8|Overall Study|Lost to Follow-up|0
112631|NCT00958126|415739|P7|Overall Study|Lost to Follow-up|0
112632|NCT00958126|415740|P6|Overall Study|Lost to Follow-up|0
112633|NCT00958126|415741|P5|Overall Study|Lost to Follow-up|0
112634|NCT00958126|415742|P4|Overall Study|Lost to Follow-up|8
112635|NCT00958126|415743|P3|Overall Study|Lost to Follow-up|9
112636|NCT00958126|415744|P2|Overall Study|Lost to Follow-up|5
112637|NCT00958126|415745|P1|Overall Study|Lost to Follow-up|1
112638|NCT00958126|415738|P8|Overall Study|Moved away from study area|0
112639|NCT00958126|415739|P7|Overall Study|Moved away from study area|0
112640|NCT00958126|415740|P6|Overall Study|Moved away from study area|0
112641|NCT00958126|415741|P5|Overall Study|Moved away from study area|0
112642|NCT00958126|415742|P4|Overall Study|Moved away from study area|1
112643|NCT00958126|415743|P3|Overall Study|Moved away from study area|1
112644|NCT00958126|415744|P2|Overall Study|Moved away from study area|0
112645|NCT00958126|415745|P1|Overall Study|Moved away from study area|0
112646|NCT00958126|415738|P8|Overall Study|Withdrawal by Subject|0
112647|NCT00958126|415739|P7|Overall Study|Withdrawal by Subject|0
112648|NCT00958126|415740|P6|Overall Study|Withdrawal by Subject|0
112649|NCT00958126|415741|P5|Overall Study|Withdrawal by Subject|0
112650|NCT00958126|415742|P4|Overall Study|Withdrawal by Subject|0
112651|NCT00958126|415743|P3|Overall Study|Withdrawal by Subject|0
112652|NCT00958126|415744|P2|Overall Study|Withdrawal by Subject|2
112653|NCT00958126|415745|P1|Overall Study|Withdrawal by Subject|0
112654|NCT00958126|415738|P8|Overall Study|Serious Adverse Event|0
112655|NCT00958126|415739|P7|Overall Study|Serious Adverse Event|1
112656|NCT00958126|415740|P6|Overall Study|Serious Adverse Event|0
112657|NCT00958126|415741|P5|Overall Study|Serious Adverse Event|0
112658|NCT00958126|415742|P4|Overall Study|Serious Adverse Event|0
112659|NCT00958126|415743|P3|Overall Study|Serious Adverse Event|0
112660|NCT00958126|415744|P2|Overall Study|Serious Adverse Event|2
112661|NCT00958126|415745|P1|Overall Study|Serious Adverse Event|0
112662|NCT00958074|415817|P2|Overall Study|Withdrawal by Subject|1
112663|NCT00958074|415818|P1|Overall Study|Withdrawal by Subject|0
112664|NCT00958009|415833|P1|Overall Study|Subject found device difficult to use|1
112665|NCT00958009|415833|P1|Overall Study|Adverse Event|1
112666|NCT00957996|415840|P2|Overall Study|Noncompliance; Protocol Deviations|6
112667|NCT00957996|415841|P1|Overall Study|Noncompliance; Protocol Deviations|5
112668|NCT00957996|415840|P2|Overall Study|Missing|0
112669|NCT00957996|415841|P1|Overall Study|Missing|1
112670|NCT00957996|415840|P2|Overall Study|Influenza-related complication|1
112671|NCT00957996|415841|P1|Overall Study|Influenza-related complication|0
112672|NCT00957996|415840|P2|Overall Study|Physician Decision|1
112673|NCT00957996|415841|P1|Overall Study|Physician Decision|1
112674|NCT00957996|415840|P2|Overall Study|Adverse Event|1
112675|NCT00957996|415841|P1|Overall Study|Adverse Event|2
112676|NCT00957996|415840|P2|Overall Study|Withdrawal by Subject|2
112677|NCT00957996|415841|P1|Overall Study|Withdrawal by Subject|9
112678|NCT00957996|415840|P2|Overall Study|Lost to Follow-up|7
112679|NCT00957996|415841|P1|Overall Study|Lost to Follow-up|4
112680|NCT00957996|415840|P2|Overall Study|Death|10
112681|NCT00957996|415841|P1|Overall Study|Death|4
112682|NCT00957944|415873|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
112683|NCT00957944|415874|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
112684|NCT00957905|415910|P2|Part B|Protocol Violation|1
112685|NCT00957905|415911|P1|Part B|Protocol Violation|0
112686|NCT00957905|415910|P2|Part B|Death|1
112687|NCT00957905|415911|P1|Part B|Death|0
112688|NCT00957905|415910|P2|Part B|Physician Decision|1
112689|NCT00957905|415911|P1|Part B|Physician Decision|0
112690|NCT00957905|415910|P2|Part B|Not Treated|1
112691|NCT00957905|415911|P1|Part B|Not Treated|0
112692|NCT00957801|415921|P4|Overall Study|Withdrawal by Subject|1
112693|NCT00957801|415922|P3|Overall Study|Withdrawal by Subject|0
112694|NCT00957801|415923|P2|Overall Study|Withdrawal by Subject|0
112695|NCT00957801|415924|P1|Overall Study|Withdrawal by Subject|0
112696|NCT00957723|416090|P1|Overall Study|2yr ROM Data Not Evaluable|25
112697|NCT00957723|416090|P1|Overall Study|Intercurrent Illness|2
112698|NCT00957723|416090|P1|Overall Study|Investigative Site Terminated|55
112699|NCT00957723|416090|P1|Overall Study|Did not undergo surgery|3
112700|NCT00957723|416090|P1|Overall Study|Withdrawal by Subject|23
112701|NCT00957723|416090|P1|Overall Study|Lost to Follow-up|7
112702|NCT00957723|416090|P1|Overall Study|Revision/ Removal of Study Implant|3
112703|NCT00957723|416090|P1|Overall Study|Death|3
112704|NCT00957658|416176|P1|Overall Study|Protocol Violation|5
112705|NCT00957658|416176|P1|Overall Study|surgery cancelled|2
112706|NCT00957658|416176|P1|Overall Study|unwilling/unable to return|2
112707|NCT00957658|416176|P1|Overall Study|Site termination|10
112708|NCT00957658|416176|P1|Overall Study|Incomplete 2 yr data|28
112709|NCT00957658|416176|P1|Overall Study|Revision|1
112710|NCT00957658|416176|P1|Overall Study|Withdrawal by Subject|12
112711|NCT00957658|416176|P1|Overall Study|Lost to Follow-up|4
112712|NCT00957658|416176|P1|Overall Study|Death|1
112713|NCT00957580|416201|P3|Overall Study|Enrolled but not treated|0
112714|NCT00957580|416202|P2|Overall Study|Enrolled but not treated|1
112715|NCT00957580|416203|P1|Overall Study|Enrolled but not treated|0
112716|NCT00957580|416201|P3|Overall Study|Ongoing at data cut-off|0
112717|NCT00957580|416202|P2|Overall Study|Ongoing at data cut-off|1
112718|NCT00957580|416203|P1|Overall Study|Ongoing at data cut-off|0
112719|NCT00957528|416350|P3|Overall Study|Withdrawal by Subject|1
112720|NCT00957528|416351|P2|Overall Study|Withdrawal by Subject|0
112721|NCT00957528|416352|P1|Overall Study|Withdrawal by Subject|0
112722|NCT00957528|416350|P3|Overall Study|Protocol Violation|0
112723|NCT00957528|416351|P2|Overall Study|Protocol Violation|1
112724|NCT00957528|416352|P1|Overall Study|Protocol Violation|0
112725|NCT00957424|416375|P1|Overall Study|Withdrawal by Subject|1
112726|NCT00957424|416375|P1|Overall Study|Protocol Violation|3
112727|NCT00957424|416375|P1|Overall Study|Lost to Follow-up|19
112728|NCT00957372|416385|P4|PART II|Patient non-compliance|4
112729|NCT00957372|416386|P3|PART II|Patient non-compliance|0
112730|NCT00957372|416387|P2|PART II|Patient non-compliance|0
112731|NCT00957372|416388|P1|PART II|Patient non-compliance|0
112732|NCT00957372|416385|P4|PART II|Adverse Event|10
112733|NCT00957372|416386|P3|PART II|Adverse Event|0
112734|NCT00957372|416387|P2|PART II|Adverse Event|0
112735|NCT00957372|416388|P1|PART II|Adverse Event|0
112736|NCT00957372|416385|P4|PART II|Not Know|20
112737|NCT00957372|416386|P3|PART II|Not Know|0
112738|NCT00957372|416387|P2|PART II|Not Know|0
112739|NCT00957372|416388|P1|PART II|Not Know|0
112740|NCT00957372|416385|P4|PART II|Pregnancy|1
112741|NCT00957372|416386|P3|PART II|Pregnancy|0
112742|NCT00957372|416387|P2|PART II|Pregnancy|0
112743|NCT00957372|416388|P1|PART II|Pregnancy|0
112744|NCT00957372|416385|P4|PART II|Physician Decision|1
112745|NCT00957372|416386|P3|PART II|Physician Decision|0
112746|NCT00957372|416387|P2|PART II|Physician Decision|0
112747|NCT00957372|416388|P1|PART II|Physician Decision|0
112748|NCT00957372|416385|P4|PART II|Withdrawal by Subject|8
112749|NCT00957372|416386|P3|PART II|Withdrawal by Subject|0
112750|NCT00957372|416387|P2|PART II|Withdrawal by Subject|0
112751|NCT00957372|416388|P1|PART II|Withdrawal by Subject|0
112752|NCT00957372|416385|P4|PART I|Lost to Follow-up|0
112753|NCT00957372|416386|P3|PART I|Lost to Follow-up|1
112754|NCT00957372|416387|P2|PART I|Lost to Follow-up|0
112755|NCT00957372|416388|P1|PART I|Lost to Follow-up|0
112756|NCT00957268|416413|P5|Overall Study|Voluntary Withdrawal|0
112757|NCT00957268|416414|P4|Overall Study|Voluntary Withdrawal|0
112758|NCT00957268|416415|P3|Overall Study|Voluntary Withdrawal|1
112759|NCT00957268|416416|P2|Overall Study|Voluntary Withdrawal|0
112760|NCT00957268|416417|P1|Overall Study|Voluntary Withdrawal|0
112761|NCT00957034|416539|P3|Overall Study|Withdrawal by Subject|0
112762|NCT00957034|416540|P2|Overall Study|Withdrawal by Subject|2
112763|NCT00957034|416541|P1|Overall Study|Withdrawal by Subject|0
112764|NCT00957034|416539|P3|Overall Study|Sponsor Terminated Study|5
112765|NCT00957034|416540|P2|Overall Study|Sponsor Terminated Study|1
112766|NCT00957034|416541|P1|Overall Study|Sponsor Terminated Study|6
112767|NCT00957034|416539|P3|Overall Study|Adverse Event|1
112768|NCT00957034|416540|P2|Overall Study|Adverse Event|1
112769|NCT00957034|416541|P1|Overall Study|Adverse Event|0
112770|NCT00957021|416564|P1|Overall Study|Termination due to language issue|2
112771|NCT00957021|416564|P1|Overall Study|Surgery Cancelled|9
112772|NCT00957021|416564|P1|Overall Study|Site Termination by the 2 yr visit|16
112773|NCT00957021|416564|P1|Overall Study|Revised study component by 2 yr visit|8
112774|NCT00957021|416564|P1|Overall Study|No 2 yr ROM data|35
112775|NCT00957021|416564|P1|Overall Study|Withdrawal by Subject|34
112776|NCT00957021|416564|P1|Overall Study|Lost to Follow-up|8
112777|NCT00957021|416564|P1|Overall Study|Death|5
112778|NCT00957008|416577|P4|Overall Study|Relocated; Family conflict|3
112779|NCT00957008|416578|P3|Overall Study|Relocated; Family conflict|1
112780|NCT00957008|416579|P2|Overall Study|Relocated; Family conflict|1
112781|NCT00957008|416580|P1|Overall Study|Relocated; Family conflict|4
112782|NCT00957008|416577|P4|Overall Study|Physician Decision|1
112783|NCT00957008|416578|P3|Overall Study|Physician Decision|1
112784|NCT00957008|416579|P2|Overall Study|Physician Decision|0
112785|NCT00957008|416580|P1|Overall Study|Physician Decision|1
112786|NCT00957008|416577|P4|Overall Study|Lost to Follow-up|4
112787|NCT00957008|416578|P3|Overall Study|Lost to Follow-up|3
112788|NCT00957008|416579|P2|Overall Study|Lost to Follow-up|1
112789|NCT00957008|416580|P1|Overall Study|Lost to Follow-up|3
112790|NCT00957008|416577|P4|Overall Study|Withdrawal by Subject|16
112791|NCT00957008|416578|P3|Overall Study|Withdrawal by Subject|12
112792|NCT00957008|416579|P2|Overall Study|Withdrawal by Subject|10
112793|NCT00957008|416580|P1|Overall Study|Withdrawal by Subject|13
112794|NCT00956943|416608|P2|Overall Study|Lost to Follow-up|10
112795|NCT00956943|416609|P1|Overall Study|Lost to Follow-up|9
112796|NCT00956839|416620|P3|Overall Study|Lost to Follow-up|3
112797|NCT00956839|416621|P2|Overall Study|Lost to Follow-up|0
112798|NCT00956839|416622|P1|Overall Study|Lost to Follow-up|3
112799|NCT00956813|416635|P2|Flaxseed and Placebo|Ineligible|1
112800|NCT00956813|416636|P1|Flaxseed and Placebo|Ineligible|3
112801|NCT00956813|416635|P2|Flaxseed and Placebo|Withdrawal by Subject|4
112802|NCT00956813|416636|P1|Flaxseed and Placebo|Withdrawal by Subject|5
112803|NCT00956592|416688|P2|Overall Study|Protocol Violation|3
112804|NCT00956592|416689|P1|Overall Study|Protocol Violation|1
112805|NCT00956293|416724|P3|Follow-up Period|Follow-up period was terminated.|0
112806|NCT00956293|416725|P2|Follow-up Period|Follow-up period was terminated.|32
112807|NCT00956293|416726|P1|Follow-up Period|Follow-up period was terminated.|20
112808|NCT00956293|416724|P3|Main Period (Randomization)|Adverse Event|0
112809|NCT00956293|416725|P2|Main Period (Randomization)|Adverse Event|15
112810|NCT00956293|416726|P1|Main Period (Randomization)|Adverse Event|0
112811|NCT00956293|416724|P3|Main Period (Randomization)|Lack of Efficacy|0
112812|NCT00956293|416725|P2|Main Period (Randomization)|Lack of Efficacy|10
112813|NCT00956293|416726|P1|Main Period (Randomization)|Lack of Efficacy|1
112814|NCT00956293|416724|P3|Main Period (Randomization)|Abnormal laboratory value|0
112815|NCT00956293|416725|P2|Main Period (Randomization)|Abnormal laboratory value|2
112816|NCT00956293|416726|P1|Main Period (Randomization)|Abnormal laboratory value|0
112817|NCT00956293|416724|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
112818|NCT00956293|416725|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
112819|NCT00956293|416726|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
112820|NCT00956293|416724|P3|Main Period (Pre-randomization)|Adverse Event|36
112821|NCT00956293|416725|P2|Main Period (Pre-randomization)|Adverse Event|0
112822|NCT00956293|416726|P1|Main Period (Pre-randomization)|Adverse Event|0
112823|NCT00956293|416724|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
112824|NCT00956293|416725|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
112825|NCT00956293|416726|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
112826|NCT00956293|416724|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
112827|NCT00956293|416725|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
112828|NCT00956293|416726|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
112829|NCT00956293|416724|P3|Main Period (Pre-randomization)|Graft loss|7
112830|NCT00956293|416725|P2|Main Period (Pre-randomization)|Graft loss|0
112831|NCT00956293|416726|P1|Main Period (Pre-randomization)|Graft loss|0
112832|NCT00956293|416724|P3|Main Period (Pre-randomization)|Administrative problems|6
112833|NCT00956293|416725|P2|Main Period (Pre-randomization)|Administrative problems|0
112834|NCT00956293|416726|P1|Main Period (Pre-randomization)|Administrative problems|0
112835|NCT00956293|416724|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
112836|NCT00956293|416725|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
112837|NCT00956293|416726|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
112838|NCT00956293|416724|P3|Main Period (Pre-randomization)|Protocol Violation|1
112839|NCT00956293|416725|P2|Main Period (Pre-randomization)|Protocol Violation|0
112840|NCT00956293|416726|P1|Main Period (Pre-randomization)|Protocol Violation|0
112841|NCT00956293|416724|P3|Main Period (Pre-randomization)|Death|1
112842|NCT00956293|416725|P2|Main Period (Pre-randomization)|Death|0
112843|NCT00956293|416726|P1|Main Period (Pre-randomization)|Death|0
112844|NCT00956293|416724|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
112845|NCT00956293|416725|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
112846|NCT00956293|416726|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
112847|NCT00955968|416781|P2|Overall Study|Site closed|52
112848|NCT00955968|416782|P1|Overall Study|Site closed|55
112849|NCT00955968|416781|P2|Overall Study|Lost to Follow-up|39
112850|NCT00955968|416782|P1|Overall Study|Lost to Follow-up|45
112851|NCT00955968|416781|P2|Overall Study|Withdrawal by Subject|31
112852|NCT00955968|416782|P1|Overall Study|Withdrawal by Subject|35
112853|NCT00955968|416781|P2|Overall Study|Death|4
112854|NCT00955968|416782|P1|Overall Study|Death|2
112855|NCT00955955|416816|P3|Overall Study|Lost to Follow-up|0
112856|NCT00955955|416817|P2|Overall Study|Lost to Follow-up|0
112857|NCT00955955|416818|P1|Overall Study|Lost to Follow-up|2
112858|NCT00955825|416859|P2|Overall Study|Any other reason not above-mentioned|9
112859|NCT00955825|416860|P1|Overall Study|Any other reason not above-mentioned|7
112860|NCT00955825|416859|P2|Overall Study|Withdrawal by Subject|6
112861|NCT00955825|416860|P1|Overall Study|Withdrawal by Subject|4
112862|NCT00955825|416859|P2|Overall Study|Adverse Event|2
112863|NCT00955825|416860|P1|Overall Study|Adverse Event|15
112864|NCT00955721|416877|P2|Overall Study|Withdrawal by Subject|0
112865|NCT00955721|416878|P1|Overall Study|Withdrawal by Subject|1
112866|NCT00955721|416877|P2|Overall Study|Death|0
112867|NCT00955721|416878|P1|Overall Study|Death|1
112868|NCT00955721|416877|P2|Overall Study|Physician Decision|0
112869|NCT00955721|416878|P1|Overall Study|Physician Decision|1
112870|NCT00955617|416888|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
112871|NCT00955617|416889|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
112872|NCT00955617|416888|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
112873|NCT00955617|416889|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
112874|NCT00955617|416888|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
112875|NCT00955617|416889|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
112876|NCT00955617|416888|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
112877|NCT00955617|416889|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
112878|NCT00955474|416953|P2|Overall Study|Physician Decision|5
112879|NCT00955474|416954|P1|Overall Study|Physician Decision|7
112880|NCT00955357|416990|P2|Maintenance Phase|Non compliance to study procedures|0
112881|NCT00955357|416991|P1|Maintenance Phase|Non compliance to study procedures|1
112882|NCT00955357|416990|P2|Maintenance Phase|Patient moving out of area|1
112883|NCT00955357|416991|P1|Maintenance Phase|Patient moving out of area|0
112884|NCT00955357|416990|P2|Maintenance Phase|Withdrawal by Subject|4
112885|NCT00955357|416991|P1|Maintenance Phase|Withdrawal by Subject|4
112886|NCT00955357|416990|P2|Maintenance Phase|Lost to Follow-up|7
112887|NCT00955357|416991|P1|Maintenance Phase|Lost to Follow-up|2
112888|NCT00955357|416990|P2|Maintenance Phase|Protocol Violation|6
112889|NCT00955357|416991|P1|Maintenance Phase|Protocol Violation|2
112890|NCT00955357|416990|P2|Maintenance Phase|Lack of Efficacy|4
112891|NCT00955357|416991|P1|Maintenance Phase|Lack of Efficacy|0
112892|NCT00955357|416990|P2|Maintenance Phase|Adverse Event|23
112893|NCT00955357|416991|P1|Maintenance Phase|Adverse Event|3
112894|NCT00955357|416990|P2|Titration Phase|Non compliance to study procedures|1
112895|NCT00955357|416991|P1|Titration Phase|Non compliance to study procedures|0
112896|NCT00955357|416990|P2|Titration Phase|Study medication not tolerated|1
112897|NCT00955357|416991|P1|Titration Phase|Study medication not tolerated|0
112898|NCT00955357|416990|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
112899|NCT00955357|416991|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
112900|NCT00955357|416990|P2|Titration Phase|Withdrawal by Subject|5
112901|NCT00955357|416991|P1|Titration Phase|Withdrawal by Subject|3
112902|NCT00955357|416990|P2|Titration Phase|Lost to Follow-up|3
112903|NCT00955357|416991|P1|Titration Phase|Lost to Follow-up|1
112904|NCT00955357|416990|P2|Titration Phase|Protocol Violation|7
112905|NCT00955357|416991|P1|Titration Phase|Protocol Violation|3
112906|NCT00955357|416990|P2|Titration Phase|Lack of Efficacy|2
112907|NCT00955357|416991|P1|Titration Phase|Lack of Efficacy|0
112908|NCT00955357|416990|P2|Titration Phase|Adverse Event|46
112909|NCT00955357|416991|P1|Titration Phase|Adverse Event|9
112910|NCT00955305|416999|P2|Overall Study|Ineligible|7
112911|NCT00955305|417000|P1|Overall Study|Ineligible|5
112912|NCT00955305|416999|P2|Overall Study|Never started protocol treatment|5
112913|NCT00955305|417000|P1|Overall Study|Never started protocol treatment|5
112914|NCT00955305|416999|P2|Overall Study|No off-treatment reason submitted|0
112915|NCT00955305|417000|P1|Overall Study|No off-treatment reason submitted|1
112916|NCT00955305|416999|P2|Overall Study|Lost to Follow-up|1
112917|NCT00955305|417000|P1|Overall Study|Lost to Follow-up|0
112918|NCT00955305|416999|P2|Overall Study|Maximum response achieved|1
112919|NCT00955305|417000|P1|Overall Study|Maximum response achieved|0
112920|NCT00955305|416999|P2|Overall Study|Functional decline|0
112921|NCT00955305|417000|P1|Overall Study|Functional decline|2
112922|NCT00955305|416999|P2|Overall Study|Continued presence of residual disease|1
112923|NCT00955305|417000|P1|Overall Study|Continued presence of residual disease|0
112924|NCT00955305|416999|P2|Overall Study|Physician Decision|0
112925|NCT00955305|417000|P1|Overall Study|Physician Decision|1
112926|NCT00955305|416999|P2|Overall Study|Other complicating disease|4
112927|NCT00955305|417000|P1|Overall Study|Other complicating disease|2
112928|NCT00955305|416999|P2|Overall Study|Alternative therapy|0
112929|NCT00955305|417000|P1|Overall Study|Alternative therapy|4
112930|NCT00955305|416999|P2|Overall Study|Withdrawal by Subject|4
112931|NCT00955305|417000|P1|Overall Study|Withdrawal by Subject|5
112932|NCT00955305|416999|P2|Overall Study|Death|1
112933|NCT00955305|417000|P1|Overall Study|Death|2
112934|NCT00955305|416999|P2|Overall Study|Adverse Event|22
112935|NCT00955305|417000|P1|Overall Study|Adverse Event|22
112936|NCT00955305|416999|P2|Overall Study|Disease progression|41
112937|NCT00955305|417000|P1|Overall Study|Disease progression|39
112938|NCT00955279|417013|P3|Overall Study|Withdrawal by Subject|3
112939|NCT00955279|417014|P2|Overall Study|Withdrawal by Subject|0
112940|NCT00955279|417015|P1|Overall Study|Withdrawal by Subject|2
112941|NCT00955279|417013|P3|Overall Study|Lost to Follow-up|1
112942|NCT00955279|417014|P2|Overall Study|Lost to Follow-up|3
112943|NCT00955279|417015|P1|Overall Study|Lost to Follow-up|0
112944|NCT00955279|417013|P3|Overall Study|Death|1
112945|NCT00955279|417014|P2|Overall Study|Death|1
112946|NCT00955279|417015|P1|Overall Study|Death|1
112947|NCT00955279|417013|P3|Overall Study|Other|3
112948|NCT00955279|417014|P2|Overall Study|Other|0
112949|NCT00955279|417015|P1|Overall Study|Other|0
112950|NCT00955110|417052|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
112951|NCT00955110|417052|P1|Treatment Phase|Non-compliance with study restrictions|1
112952|NCT00955110|417052|P1|Treatment Phase|Administrative reasons|2
112953|NCT00955110|417052|P1|Treatment Phase|Adverse Event|2
112954|NCT00955110|417052|P1|Qualification Phase|Did not meet eligibility criteria|24
112955|NCT00954941|417099|P2|Overall Study|Adverse Event|1
112956|NCT00954941|417100|P1|Overall Study|Adverse Event|0
112957|NCT00954941|417099|P2|Overall Study|Ineligible|2
112958|NCT00954941|417100|P1|Overall Study|Ineligible|2
112959|NCT00954941|417099|P2|Overall Study|Physician Decision|2
112960|NCT00954941|417100|P1|Overall Study|Physician Decision|2
112961|NCT00954941|417099|P2|Overall Study|Insurance Denial|2
112962|NCT00954941|417100|P1|Overall Study|Insurance Denial|2
112963|NCT00954941|417099|P2|Overall Study|Withdrawal by Subject|0
112964|NCT00954941|417100|P1|Overall Study|Withdrawal by Subject|1
112965|NCT00954941|417099|P2|Overall Study|Received treatment at home|0
112966|NCT00954941|417100|P1|Overall Study|Received treatment at home|1
112967|NCT00954733|417116|P1|Overall Study|blood gas machine did not work|1
112968|NCT00954707|417120|P1|Overall Study|Lost to Follow-up|33
112969|NCT00954707|417120|P1|Overall Study|Withdrawal by Subject|100
112970|NCT00954707|417120|P1|Overall Study|Death|34
112971|NCT00954538|417142|P6|Part III|Withdrawal by Subject|0
112972|NCT00954538|417143|P5|Part III|Withdrawal by Subject|1
112973|NCT00954538|417144|P4|Part III|Withdrawal by Subject|0
112974|NCT00954538|417145|P3|Part III|Withdrawal by Subject|0
112975|NCT00954538|417146|P2|Part III|Withdrawal by Subject|0
112976|NCT00954538|417147|P1|Part III|Withdrawal by Subject|0
112977|NCT00954512|417164|P6|Overall Study|Progression of Disease|1
112978|NCT00954512|417165|P5|Overall Study|Progression of Disease|1
112979|NCT00954512|417166|P4|Overall Study|Progression of Disease|1
112980|NCT00954512|417167|P3|Overall Study|Progression of Disease|0
112981|NCT00954512|417168|P2|Overall Study|Progression of Disease|1
112982|NCT00954512|417169|P1|Overall Study|Progression of Disease|2
112983|NCT00954512|417164|P6|Overall Study|Symptomatic Deterioration|0
112984|NCT00954512|417165|P5|Overall Study|Symptomatic Deterioration|2
112985|NCT00954512|417166|P4|Overall Study|Symptomatic Deterioration|0
112986|NCT00954512|417167|P3|Overall Study|Symptomatic Deterioration|0
112987|NCT00954512|417168|P2|Overall Study|Symptomatic Deterioration|1
112988|NCT00954512|417169|P1|Overall Study|Symptomatic Deterioration|0
112989|NCT00954512|417164|P6|Overall Study|Physician Decision|0
112990|NCT00954512|417165|P5|Overall Study|Physician Decision|0
112991|NCT00954512|417166|P4|Overall Study|Physician Decision|1
112992|NCT00954512|417167|P3|Overall Study|Physician Decision|0
112993|NCT00954512|417168|P2|Overall Study|Physician Decision|1
112994|NCT00954512|417169|P1|Overall Study|Physician Decision|0
112995|NCT00954512|417164|P6|Overall Study|Adverse Event|2
112996|NCT00954512|417165|P5|Overall Study|Adverse Event|1
112997|NCT00954512|417166|P4|Overall Study|Adverse Event|0
112998|NCT00954512|417167|P3|Overall Study|Adverse Event|0
112999|NCT00954512|417168|P2|Overall Study|Adverse Event|0
113000|NCT00954512|417169|P1|Overall Study|Adverse Event|0
113001|NCT00954512|417164|P6|Overall Study|Withdrawal by Subject|1
113002|NCT00954512|417165|P5|Overall Study|Withdrawal by Subject|0
113003|NCT00954512|417166|P4|Overall Study|Withdrawal by Subject|0
113004|NCT00954512|417167|P3|Overall Study|Withdrawal by Subject|0
113005|NCT00954512|417168|P2|Overall Study|Withdrawal by Subject|0
113006|NCT00954512|417169|P1|Overall Study|Withdrawal by Subject|0
113007|NCT00954447|417190|P2|Overall Study|Other|18
113008|NCT00954447|417191|P1|Overall Study|Other|21
113009|NCT00954447|417190|P2|Overall Study|Withdrawal by Subject|21
113010|NCT00954447|417191|P1|Overall Study|Withdrawal by Subject|26
113011|NCT00954447|417190|P2|Overall Study|Lost to Follow-up|14
113012|NCT00954447|417191|P1|Overall Study|Lost to Follow-up|8
113013|NCT00954447|417190|P2|Overall Study|Protocol Violation|7
113014|NCT00954447|417191|P1|Overall Study|Protocol Violation|5
113015|NCT00954447|417190|P2|Overall Study|Lack of Efficacy|3
113016|NCT00954447|417191|P1|Overall Study|Lack of Efficacy|17
113017|NCT00954447|417190|P2|Overall Study|Adverse Event|25
113018|NCT00954447|417191|P1|Overall Study|Adverse Event|33
113019|NCT00954421|417227|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
113020|NCT00954421|417227|P1|6 Months of DBS|Withdrawal by Subject|1
113021|NCT00954421|417227|P1|Screening|screen failures|3
113022|NCT00954122|417273|P1|Overall Study|Safety Reason|1
113023|NCT00954122|417273|P1|Overall Study|Adverse Event|1
113024|NCT00954122|417273|P1|Overall Study|Withdrawal by Subject|5
113025|NCT00953927|417290|P2|Overall Study|Other study discontinuation|1
113026|NCT00953927|417291|P1|Overall Study|Other study discontinuation|1
113027|NCT00953927|417290|P2|Overall Study|Death|4
113028|NCT00953927|417291|P1|Overall Study|Death|7
113029|NCT00953927|417290|P2|Overall Study|Withdrawal by Subject|25
113030|NCT00953927|417291|P1|Overall Study|Withdrawal by Subject|36
113031|NCT00953927|417290|P2|Overall Study|Lost to Follow-up|65
113032|NCT00953927|417291|P1|Overall Study|Lost to Follow-up|61
113033|NCT00953745|417346|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
113034|NCT00953745|417347|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
113035|NCT00953745|417346|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
113036|NCT00953745|417347|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
113037|NCT00953745|417346|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
113038|NCT00953745|417347|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
113039|NCT00953745|417346|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
113040|NCT00953745|417347|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
113041|NCT00953745|417346|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
113042|NCT00953745|417347|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
113043|NCT00953745|417346|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
113044|NCT00953745|417347|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
113045|NCT00953706|417380|P4|Part B (96-Week Open-Label Extension)|Other|2
113046|NCT00953706|417381|P3|Part B (96-Week Open-Label Extension)|Other|0
113047|NCT00953706|417382|P2|Part B (96-Week Open-Label Extension)|Other|0
113048|NCT00953706|417383|P1|Part B (96-Week Open-Label Extension)|Other|0
113049|NCT00953706|417380|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
113050|NCT00953706|417381|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
113051|NCT00953706|417382|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
113052|NCT00953706|417383|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
113053|NCT00953706|417380|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
113054|NCT00953706|417381|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
113055|NCT00953706|417382|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
113056|NCT00953706|417383|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
113057|NCT00953706|417380|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
113058|NCT00953706|417381|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
113059|NCT00953706|417382|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
113060|NCT00953706|417383|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
113061|NCT00953706|417380|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
113062|NCT00953706|417381|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
113063|NCT00953706|417382|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
113064|NCT00953706|417383|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
113065|NCT00953706|417380|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
113066|NCT00953706|417381|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
113067|NCT00953706|417382|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
113068|NCT00953706|417383|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
113069|NCT00953706|417380|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
113070|NCT00953706|417381|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
113071|NCT00953706|417382|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
113072|NCT00953706|417383|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
113073|NCT00953706|417380|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
113074|NCT00953706|417381|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
113075|NCT00953706|417382|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
113076|NCT00953706|417383|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
113077|NCT00953706|417380|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
113078|NCT00953706|417381|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
113079|NCT00953706|417382|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
113080|NCT00953706|417383|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
113081|NCT00953706|417380|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
113082|NCT00953706|417381|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
113083|NCT00953706|417382|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
113084|NCT00953706|417383|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
113085|NCT00953706|417380|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
113086|NCT00953706|417381|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
113087|NCT00953706|417382|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
113088|NCT00953706|417383|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
113089|NCT00953680|417415|P2|Period 1|Withdrawal by Subject|1
113090|NCT00953680|417416|P1|Period 1|Withdrawal by Subject|0
113091|NCT00953667|417428|P1|Overall Study|poor venous access,unable to draw blood|4
113092|NCT00953667|417428|P1|Overall Study|Adverse Event|10
113093|NCT00953667|417428|P1|Overall Study|Withdrawal by Subject|63
113094|NCT00953667|417428|P1|Overall Study|Physician Decision|35
113095|NCT00953667|417428|P1|Overall Study|Lost to Follow-up|11
113096|NCT00953615|417449|P1|Overall Study|Adverse Event|1
113097|NCT00953524|417460|P4|Overall Study|Withdrawal by Subject|0
113098|NCT00953524|417461|P3|Overall Study|Withdrawal by Subject|1
113099|NCT00953524|417462|P2|Overall Study|Withdrawal by Subject|4
113100|NCT00953524|417463|P1|Overall Study|Withdrawal by Subject|2
113101|NCT00953524|417460|P4|Overall Study|Lost to Follow-up|0
113102|NCT00953524|417461|P3|Overall Study|Lost to Follow-up|1
113103|NCT00953524|417462|P2|Overall Study|Lost to Follow-up|1
113104|NCT00953524|417463|P1|Overall Study|Lost to Follow-up|0
113105|NCT00953524|417460|P4|Overall Study|Protocol Violation|6
113106|NCT00953524|417461|P3|Overall Study|Protocol Violation|11
113107|NCT00953524|417462|P2|Overall Study|Protocol Violation|10
113108|NCT00953524|417463|P1|Overall Study|Protocol Violation|18
113109|NCT00953524|417460|P4|Overall Study|Adverse Event|2
113110|NCT00953524|417461|P3|Overall Study|Adverse Event|1
113111|NCT00953524|417462|P2|Overall Study|Adverse Event|0
113112|NCT00953524|417463|P1|Overall Study|Adverse Event|2
113113|NCT00953407|417506|P5|Overall Study|Lost to Follow-up|0
113114|NCT00953407|417507|P4|Overall Study|Lost to Follow-up|1
113115|NCT00953407|417508|P3|Overall Study|Lost to Follow-up|0
113116|NCT00953407|417509|P2|Overall Study|Lost to Follow-up|0
113117|NCT00953407|417510|P1|Overall Study|Lost to Follow-up|0
113118|NCT00953407|417506|P5|Overall Study|Failed inclusion criteria|1
113119|NCT00953407|417507|P4|Overall Study|Failed inclusion criteria|1
113120|NCT00953407|417508|P3|Overall Study|Failed inclusion criteria|1
113121|NCT00953407|417509|P2|Overall Study|Failed inclusion criteria|1
113122|NCT00953407|417510|P1|Overall Study|Failed inclusion criteria|1
113123|NCT00953329|417522|P1|Overall Study|Lack of Efficacy|1
113124|NCT00953225|417535|P2|Overall Study|Withdrawal by Subject|0
113125|NCT00953225|417536|P1|Overall Study|Withdrawal by Subject|2
113126|NCT00953160|417620|P1|Overall Study|Withdrawal by Subject|4
113127|NCT00953160|417620|P1|Overall Study|Lost to Follow-up|23
113128|NCT00953147|417629|P3|Overall Study|Other|13
113129|NCT00953147|417630|P2|Overall Study|Other|11
113130|NCT00953147|417631|P1|Overall Study|Other|4
113131|NCT00953147|417629|P3|Overall Study|Physician Decision|3
113132|NCT00953147|417630|P2|Overall Study|Physician Decision|7
113133|NCT00953147|417631|P1|Overall Study|Physician Decision|2
113134|NCT00953147|417629|P3|Overall Study|Lost to Follow-up|4
113135|NCT00953147|417630|P2|Overall Study|Lost to Follow-up|9
113136|NCT00953147|417631|P1|Overall Study|Lost to Follow-up|8
113137|NCT00953147|417629|P3|Overall Study|Withdrawal by Subject|12
113138|NCT00953147|417630|P2|Overall Study|Withdrawal by Subject|15
113139|NCT00953147|417631|P1|Overall Study|Withdrawal by Subject|13
113140|NCT00953147|417629|P3|Overall Study|Protocol Violation|4
113141|NCT00953147|417630|P2|Overall Study|Protocol Violation|8
113142|NCT00953147|417631|P1|Overall Study|Protocol Violation|2
113143|NCT00953147|417629|P3|Overall Study|Adverse Event|6
113144|NCT00953147|417630|P2|Overall Study|Adverse Event|16
113145|NCT00953147|417631|P1|Overall Study|Adverse Event|8
113146|NCT00953056|417709|P6|Overall Study|Serious Adverse Event|1
113147|NCT00953056|417710|P5|Overall Study|Serious Adverse Event|0
113148|NCT00953056|417711|P4|Overall Study|Serious Adverse Event|0
113149|NCT00953056|417712|P3|Overall Study|Serious Adverse Event|0
113150|NCT00953056|417713|P2|Overall Study|Serious Adverse Event|0
113151|NCT00953056|417714|P1|Overall Study|Serious Adverse Event|0
113152|NCT00953056|417709|P6|Overall Study|Withdrew Consent|3
113153|NCT00953056|417710|P5|Overall Study|Withdrew Consent|2
113154|NCT00953056|417711|P4|Overall Study|Withdrew Consent|0
113155|NCT00953056|417712|P3|Overall Study|Withdrew Consent|0
113156|NCT00953056|417713|P2|Overall Study|Withdrew Consent|0
113157|NCT00953056|417714|P1|Overall Study|Withdrew Consent|0
113158|NCT00953043|417738|P2|Overall Study|Physician Decision|2
113159|NCT00953043|417739|P1|Overall Study|Physician Decision|0
113160|NCT00953043|417738|P2|Overall Study|Withdrawal by Subject|0
113161|NCT00953043|417739|P1|Overall Study|Withdrawal by Subject|4
113162|NCT00953017|417763|P4|Overall Study|Brown stool prior to procedure|0
113163|NCT00953017|417764|P3|Overall Study|Brown stool prior to procedure|1
113164|NCT00953017|417765|P2|Overall Study|Brown stool prior to procedure|0
113165|NCT00953017|417766|P1|Overall Study|Brown stool prior to procedure|0
113166|NCT00953017|417763|P4|Overall Study|Procedure incomplete due to pain/looping|1
113167|NCT00953017|417764|P3|Overall Study|Procedure incomplete due to pain/looping|0
113168|NCT00953017|417765|P2|Overall Study|Procedure incomplete due to pain/looping|1
113169|NCT00953017|417766|P1|Overall Study|Procedure incomplete due to pain/looping|0
113170|NCT00953017|417763|P4|Overall Study|Incomplete data|0
113171|NCT00953017|417764|P3|Overall Study|Incomplete data|0
113172|NCT00953017|417765|P2|Overall Study|Incomplete data|1
113173|NCT00953017|417766|P1|Overall Study|Incomplete data|1
113174|NCT00953017|417763|P4|Overall Study|DId not show up for colonoscopy|4
113175|NCT00953017|417764|P3|Overall Study|DId not show up for colonoscopy|5
113176|NCT00953017|417765|P2|Overall Study|DId not show up for colonoscopy|4
113177|NCT00953017|417766|P1|Overall Study|DId not show up for colonoscopy|4
113178|NCT00952848|417788|P1|Overall Study|Withdrawal by Subject|4
113179|NCT00952822|417795|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
113180|NCT00952822|417796|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
113181|NCT00952822|417797|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
113182|NCT00952822|417798|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
113183|NCT00952822|417795|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
113184|NCT00952822|417796|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
113185|NCT00952822|417797|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
113186|NCT00952822|417798|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
113187|NCT00952731|417830|P2|Overall Study|Drug supply expired|0
113188|NCT00952731|417831|P1|Overall Study|Drug supply expired|1
113189|NCT00952705|417850|P3|Overall Study|Exclusion criteria not met pre dose|0
113190|NCT00952705|417851|P2|Overall Study|Exclusion criteria not met pre dose|1
113191|NCT00952705|417852|P1|Overall Study|Exclusion criteria not met pre dose|0
113192|NCT00952705|417850|P3|Overall Study|Incarcerated post dose|0
113193|NCT00952705|417851|P2|Overall Study|Incarcerated post dose|0
113194|NCT00952705|417852|P1|Overall Study|Incarcerated post dose|5
113195|NCT00952705|417850|P3|Overall Study|Death|0
113196|NCT00952705|417851|P2|Overall Study|Death|0
113197|NCT00952705|417852|P1|Overall Study|Death|2
113198|NCT00952705|417850|P3|Overall Study|Withdrawal by Subject|1
113199|NCT00952705|417851|P2|Overall Study|Withdrawal by Subject|1
113200|NCT00952705|417852|P1|Overall Study|Withdrawal by Subject|2
113201|NCT00952705|417850|P3|Overall Study|Lost to Follow-up|9
113202|NCT00952705|417851|P2|Overall Study|Lost to Follow-up|8
113203|NCT00952705|417852|P1|Overall Study|Lost to Follow-up|24
113204|NCT00952614|417939|P1|Overall Study|other reason|1
113205|NCT00952614|417939|P1|Overall Study|Lost to Follow-up|3
113206|NCT00952614|417939|P1|Overall Study|Death|3
113207|NCT00952588|417946|P2|Overall Study|Lack of Efficacy|2
113208|NCT00952588|417947|P1|Overall Study|Lack of Efficacy|2
113209|NCT00952588|417946|P2|Overall Study|Physician Decision|1
113210|NCT00952588|417947|P1|Overall Study|Physician Decision|0
113211|NCT00952588|417946|P2|Overall Study|Lost to Follow-up|0
113212|NCT00952588|417947|P1|Overall Study|Lost to Follow-up|2
113213|NCT00952588|417946|P2|Overall Study|Adverse Event|3
113214|NCT00952588|417947|P1|Overall Study|Adverse Event|2
113215|NCT00952588|417946|P2|Overall Study|Withdrawal by Subject|5
113216|NCT00952588|417947|P1|Overall Study|Withdrawal by Subject|2
113217|NCT00952588|417946|P2|Overall Study|Death|13
113218|NCT00952588|417947|P1|Overall Study|Death|28
113219|NCT00952523|417965|P1|Overall Study|Withdrawal by Subject|7
113220|NCT00952484|417974|P3|Overall Study|Withdrawal by Subject|0
113221|NCT00952484|417975|P2|Overall Study|Withdrawal by Subject|1
113222|NCT00952484|417976|P1|Overall Study|Withdrawal by Subject|0
113223|NCT00952419|418003|P3|Overall Study|Withdrawal by Subject|0
113224|NCT00952419|418004|P2|Overall Study|Withdrawal by Subject|3
113225|NCT00952419|418005|P1|Overall Study|Withdrawal by Subject|1
113226|NCT00952419|418003|P3|Overall Study|Protocol Violation|0
113227|NCT00952419|418004|P2|Overall Study|Protocol Violation|7
113228|NCT00952419|418005|P1|Overall Study|Protocol Violation|3
113229|NCT00952419|418003|P3|Overall Study|Adverse Event|0
113230|NCT00952419|418004|P2|Overall Study|Adverse Event|0
113231|NCT00952419|418005|P1|Overall Study|Adverse Event|2
113232|NCT00952367|418041|P1|Overall Study|Protocol Violation|3
113233|NCT00952367|418041|P1|Overall Study|Noncoordination|1
113234|NCT00952367|418041|P1|Overall Study|Withdrawal by Subject|2
113235|NCT00952341|418056|P2|Cycle 2|Progressive Disease|1
113236|NCT00952341|418057|P1|Cycle 2|Progressive Disease|0
113237|NCT00952341|418056|P2|Cycle 2|Physician Decision|1
113238|NCT00952341|418057|P1|Cycle 2|Physician Decision|1
113239|NCT00952341|418056|P2|Cycle 2|Lost to Follow-up|9
113240|NCT00952341|418057|P1|Cycle 2|Lost to Follow-up|6
113241|NCT00952341|418056|P2|Cycle 2|Protocol Violation|0
113242|NCT00952341|418057|P1|Cycle 2|Protocol Violation|1
113243|NCT00952341|418056|P2|Cycle 2|Withdrawal by Subject|1
113244|NCT00952341|418057|P1|Cycle 2|Withdrawal by Subject|1
113245|NCT00952341|418056|P2|Cycle 1|Physician Decision|1
113246|NCT00952341|418057|P1|Cycle 1|Physician Decision|0
113247|NCT00952341|418056|P2|Cycle 1|Lost to Follow-up|2
113248|NCT00952341|418057|P1|Cycle 1|Lost to Follow-up|11
113249|NCT00952341|418056|P2|Cycle 1|Protocol Violation|1
113250|NCT00952341|418057|P1|Cycle 1|Protocol Violation|2
113251|NCT00952341|418056|P2|Cycle 1|Withdrawal by Subject|8
113252|NCT00952341|418057|P1|Cycle 1|Withdrawal by Subject|3
113253|NCT00952341|418056|P2|Cycle 1|Adverse Event|1
113254|NCT00952341|418057|P1|Cycle 1|Adverse Event|4
113255|NCT00952289|418079|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
113256|NCT00952289|418080|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
113257|NCT00952289|418079|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
113258|NCT00952289|418080|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
113259|NCT00952289|418079|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
113260|NCT00952289|418080|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
113261|NCT00952289|418079|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
113262|NCT00952289|418080|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
113263|NCT00952289|418079|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
113264|NCT00952289|418080|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
113265|NCT00952289|418079|P2|All Participants|Data lost during site relocation|1
113266|NCT00952289|418080|P1|All Participants|Data lost during site relocation|0
113267|NCT00952289|418079|P2|All Participants|Withdrawal by Subject|10
113268|NCT00952289|418080|P1|All Participants|Withdrawal by Subject|1
113269|NCT00952289|418079|P2|All Participants|Disease progression|12
113270|NCT00952289|418080|P1|All Participants|Disease progression|3
113271|NCT00952289|418079|P2|All Participants|Adverse Event|8
113272|NCT00952289|418080|P1|All Participants|Adverse Event|8
113273|NCT00952289|418079|P2|All Participants|Death|9
113274|NCT00952289|418080|P1|All Participants|Death|9
113275|NCT00952276|418109|P5|Overall Study|Withdrawal by Subject|0
113276|NCT00952276|418110|P4|Overall Study|Withdrawal by Subject|1
113277|NCT00952276|418111|P3|Overall Study|Withdrawal by Subject|0
113278|NCT00952276|418112|P2|Overall Study|Withdrawal by Subject|0
113279|NCT00952276|418113|P1|Overall Study|Withdrawal by Subject|1
113280|NCT00952068|418199|P1|Overall Study|Withdrawal by Subject|4
113281|NCT00952068|418199|P1|Overall Study|Adverse Event|3
113282|NCT00951912|418210|P3|Overall Study|Other: Stroke|0
113283|NCT00951912|418211|P2|Overall Study|Other: Stroke|1
113284|NCT00951912|418212|P1|Overall Study|Other: Stroke|0
113285|NCT00951912|418210|P3|Overall Study|Other: Colon cancer|0
113286|NCT00951912|418211|P2|Overall Study|Other: Colon cancer|0
113287|NCT00951912|418212|P1|Overall Study|Other: Colon cancer|1
113288|NCT00951912|418210|P3|Overall Study|Other:Depression|0
113289|NCT00951912|418211|P2|Overall Study|Other:Depression|0
113290|NCT00951912|418212|P1|Overall Study|Other:Depression|1
113291|NCT00951912|418210|P3|Overall Study|Withdrawal by Subject|0
113292|NCT00951912|418211|P2|Overall Study|Withdrawal by Subject|1
113293|NCT00951912|418212|P1|Overall Study|Withdrawal by Subject|1
113294|NCT00951912|418210|P3|Overall Study|Physician Decision|1
113295|NCT00951912|418211|P2|Overall Study|Physician Decision|0
113296|NCT00951912|418212|P1|Overall Study|Physician Decision|1
113297|NCT00951912|418210|P3|Overall Study|Lost to Follow-up|0
113298|NCT00951912|418211|P2|Overall Study|Lost to Follow-up|2
113299|NCT00951912|418212|P1|Overall Study|Lost to Follow-up|2
113300|NCT00951912|418210|P3|Overall Study|Adverse Event|1
113301|NCT00951912|418211|P2|Overall Study|Adverse Event|1
113302|NCT00951912|418212|P1|Overall Study|Adverse Event|0
113303|NCT00951912|418210|P3|Overall Study|Lack of Efficacy|0
113304|NCT00951912|418211|P2|Overall Study|Lack of Efficacy|0
113305|NCT00951912|418212|P1|Overall Study|Lack of Efficacy|1
113306|NCT00951665|418312|P6|Phase 2a|Disease Progression|5
113307|NCT00951665|418313|P5|Phase 2a|Disease Progression|6
113308|NCT00951665|418314|P4|Phase 2a|Disease Progression|0
113309|NCT00951665|418315|P3|Phase 2a|Disease Progression|0
113310|NCT00951665|418316|P2|Phase 2a|Disease Progression|0
113311|NCT00951665|418317|P1|Phase 2a|Disease Progression|0
113312|NCT00951665|418312|P6|Phase 2a|Withdrawal by Subject|0
113313|NCT00951665|418313|P5|Phase 2a|Withdrawal by Subject|2
113314|NCT00951665|418314|P4|Phase 2a|Withdrawal by Subject|0
113315|NCT00951665|418315|P3|Phase 2a|Withdrawal by Subject|0
113316|NCT00951665|418316|P2|Phase 2a|Withdrawal by Subject|0
113317|NCT00951665|418317|P1|Phase 2a|Withdrawal by Subject|0
113318|NCT00951665|418312|P6|Phase 2a|Physician Decision|1
113319|NCT00951665|418313|P5|Phase 2a|Physician Decision|0
113320|NCT00951665|418314|P4|Phase 2a|Physician Decision|0
113321|NCT00951665|418315|P3|Phase 2a|Physician Decision|0
113322|NCT00951665|418316|P2|Phase 2a|Physician Decision|0
113323|NCT00951665|418317|P1|Phase 2a|Physician Decision|0
113324|NCT00951665|418312|P6|Phase 2a|Lost to Follow-up|0
113325|NCT00951665|418313|P5|Phase 2a|Lost to Follow-up|1
113326|NCT00951665|418314|P4|Phase 2a|Lost to Follow-up|0
113327|NCT00951665|418315|P3|Phase 2a|Lost to Follow-up|0
113328|NCT00951665|418316|P2|Phase 2a|Lost to Follow-up|0
113329|NCT00951665|418317|P1|Phase 2a|Lost to Follow-up|0
113330|NCT00951665|418312|P6|Phase 2a|Death|1
113331|NCT00951665|418313|P5|Phase 2a|Death|1
113332|NCT00951665|418314|P4|Phase 2a|Death|0
113333|NCT00951665|418315|P3|Phase 2a|Death|0
113334|NCT00951665|418316|P2|Phase 2a|Death|0
113335|NCT00951665|418317|P1|Phase 2a|Death|0
113336|NCT00951665|418312|P6|Phase 2a|Adverse Event|0
113337|NCT00951665|418313|P5|Phase 2a|Adverse Event|2
113338|NCT00951665|418314|P4|Phase 2a|Adverse Event|0
113339|NCT00951665|418315|P3|Phase 2a|Adverse Event|0
113340|NCT00951665|418316|P2|Phase 2a|Adverse Event|0
113341|NCT00951665|418317|P1|Phase 2a|Adverse Event|0
113342|NCT00951665|418312|P6|Phase 1b|Protocol Violation|0
113343|NCT00951665|418313|P5|Phase 1b|Protocol Violation|0
113344|NCT00951665|418314|P4|Phase 1b|Protocol Violation|0
113345|NCT00951665|418315|P3|Phase 1b|Protocol Violation|0
113346|NCT00951665|418316|P2|Phase 1b|Protocol Violation|0
113347|NCT00951665|418317|P1|Phase 1b|Protocol Violation|2
113348|NCT00951665|418312|P6|Phase 1b|Disease Progression|0
113349|NCT00951665|418313|P5|Phase 1b|Disease Progression|0
113350|NCT00951665|418314|P4|Phase 1b|Disease Progression|0
113351|NCT00951665|418315|P3|Phase 1b|Disease Progression|14
113352|NCT00951665|418316|P2|Phase 1b|Disease Progression|2
113353|NCT00951665|418317|P1|Phase 1b|Disease Progression|13
113354|NCT00951665|418312|P6|Phase 1b|Withdrawal by Subject|0
113355|NCT00951665|418313|P5|Phase 1b|Withdrawal by Subject|0
113356|NCT00951665|418314|P4|Phase 1b|Withdrawal by Subject|0
113357|NCT00951665|418315|P3|Phase 1b|Withdrawal by Subject|0
113358|NCT00951665|418316|P2|Phase 1b|Withdrawal by Subject|1
113359|NCT00951665|418317|P1|Phase 1b|Withdrawal by Subject|0
113360|NCT00951665|418312|P6|Phase 1b|Physician Decision|0
113361|NCT00951665|418313|P5|Phase 1b|Physician Decision|0
113362|NCT00951665|418314|P4|Phase 1b|Physician Decision|0
113363|NCT00951665|418315|P3|Phase 1b|Physician Decision|1
113364|NCT00951665|418316|P2|Phase 1b|Physician Decision|0
113365|NCT00951665|418317|P1|Phase 1b|Physician Decision|4
113366|NCT00951665|418312|P6|Phase 1b|Death|0
113367|NCT00951665|418313|P5|Phase 1b|Death|0
113368|NCT00951665|418314|P4|Phase 1b|Death|0
113369|NCT00951665|418315|P3|Phase 1b|Death|2
113370|NCT00951665|418316|P2|Phase 1b|Death|0
113371|NCT00951665|418317|P1|Phase 1b|Death|1
113372|NCT00951665|418312|P6|Phase 1b|Adverse Event|0
113373|NCT00951665|418313|P5|Phase 1b|Adverse Event|0
113374|NCT00951665|418314|P4|Phase 1b|Adverse Event|1
113375|NCT00951665|418315|P3|Phase 1b|Adverse Event|0
113376|NCT00951665|418316|P2|Phase 1b|Adverse Event|1
113377|NCT00951665|418317|P1|Phase 1b|Adverse Event|2
113378|NCT00951509|418426|P1|Overall Study|Withdrawal by Subject|2
113379|NCT00951496|418437|P3|Overall Study|Did not initiate study treatment|13
113380|NCT00951496|418438|P2|Overall Study|Did not initiate study treatment|8
113381|NCT00951496|418439|P1|Overall Study|Did not initiate study treatment|10
113382|NCT00951483|418467|P2|Overall Study|Withdrawal by Subject|0
113383|NCT00951483|418468|P1|Overall Study|Withdrawal by Subject|15
113384|NCT00951483|418467|P2|Overall Study|Physician Decision|0
113385|NCT00951483|418468|P1|Overall Study|Physician Decision|4
113386|NCT00951379|418488|P2|Overall Study|Disease Progression|1
113387|NCT00951379|418489|P1|Overall Study|Disease Progression|0
113388|NCT00951379|418488|P2|Overall Study|Noncompliance|0
113389|NCT00951379|418489|P1|Overall Study|Noncompliance|1
113390|NCT00951379|418488|P2|Overall Study|Withdrawal by Subject|0
113391|NCT00951379|418489|P1|Overall Study|Withdrawal by Subject|1
113392|NCT00951379|418488|P2|Overall Study|Adverse Event|1
113393|NCT00951379|418489|P1|Overall Study|Adverse Event|4
113394|NCT00951275|418531|P1|Overall Study|Protocol Violation|1
113395|NCT00951275|418531|P1|Overall Study|Withdrawal by Subject|4
113396|NCT00951275|418531|P1|Overall Study|Adverse Event|7
113397|NCT00951275|418531|P1|Overall Study|Administrative Reason|1
113398|NCT00951171|418563|P2|Overall Study|Adverse Event|0
113399|NCT00951171|418564|P1|Overall Study|Adverse Event|2
113400|NCT00951015|418598|P5|Open-label Phase|Physician Decision|8
113401|NCT00951015|418599|P4|Open-label Phase|Physician Decision|0
113402|NCT00951015|418600|P3|Open-label Phase|Physician Decision|0
113403|NCT00951015|418601|P2|Open-label Phase|Physician Decision|0
113404|NCT00951015|418602|P1|Open-label Phase|Physician Decision|0
113405|NCT00951015|418598|P5|Open-label Phase|Withdrawal by Subject|14
113406|NCT00951015|418599|P4|Open-label Phase|Withdrawal by Subject|0
113407|NCT00951015|418600|P3|Open-label Phase|Withdrawal by Subject|0
113408|NCT00951015|418601|P2|Open-label Phase|Withdrawal by Subject|0
113409|NCT00951015|418602|P1|Open-label Phase|Withdrawal by Subject|0
113410|NCT00951015|418598|P5|Open-label Phase|Lost to Follow-up|12
113411|NCT00951015|418599|P4|Open-label Phase|Lost to Follow-up|0
113412|NCT00951015|418600|P3|Open-label Phase|Lost to Follow-up|0
113413|NCT00951015|418601|P2|Open-label Phase|Lost to Follow-up|0
113414|NCT00951015|418602|P1|Open-label Phase|Lost to Follow-up|0
113415|NCT00951015|418598|P5|Open-label Phase|Protocol Violation|12
113416|NCT00951015|418599|P4|Open-label Phase|Protocol Violation|0
113417|NCT00951015|418600|P3|Open-label Phase|Protocol Violation|0
113418|NCT00951015|418601|P2|Open-label Phase|Protocol Violation|0
113419|NCT00951015|418602|P1|Open-label Phase|Protocol Violation|0
113420|NCT00951015|418598|P5|Open-label Phase|Lack of Efficacy|1
113421|NCT00951015|418599|P4|Open-label Phase|Lack of Efficacy|0
113422|NCT00951015|418600|P3|Open-label Phase|Lack of Efficacy|0
113423|NCT00951015|418601|P2|Open-label Phase|Lack of Efficacy|0
113424|NCT00951015|418602|P1|Open-label Phase|Lack of Efficacy|0
113425|NCT00951015|418598|P5|Open-label Phase|Adverse Event|3
113426|NCT00951015|418599|P4|Open-label Phase|Adverse Event|0
113427|NCT00951015|418600|P3|Open-label Phase|Adverse Event|0
113428|NCT00951015|418601|P2|Open-label Phase|Adverse Event|0
113429|NCT00951015|418602|P1|Open-label Phase|Adverse Event|0
113430|NCT00951015|418598|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
113431|NCT00951015|418599|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
113432|NCT00951015|418600|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
113433|NCT00951015|418601|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
113434|NCT00951015|418602|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
113435|NCT00951015|418598|P5|Randomization Phase 96 Week|Lost to Follow-up|0
113436|NCT00951015|418599|P4|Randomization Phase 96 Week|Lost to Follow-up|2
113437|NCT00951015|418600|P3|Randomization Phase 96 Week|Lost to Follow-up|1
113438|NCT00951015|418601|P2|Randomization Phase 96 Week|Lost to Follow-up|3
113439|NCT00951015|418602|P1|Randomization Phase 96 Week|Lost to Follow-up|0
113440|NCT00951015|418598|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
113441|NCT00951015|418599|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
113442|NCT00951015|418600|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
113443|NCT00951015|418601|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
113444|NCT00951015|418602|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
113445|NCT00951015|418598|P5|Randomization Phase 96 Week|Protocol Violation|0
113446|NCT00951015|418599|P4|Randomization Phase 96 Week|Protocol Violation|0
113447|NCT00951015|418600|P3|Randomization Phase 96 Week|Protocol Violation|1
113448|NCT00951015|418601|P2|Randomization Phase 96 Week|Protocol Violation|1
113449|NCT00951015|418602|P1|Randomization Phase 96 Week|Protocol Violation|1
113450|NCT00951015|418598|P5|Randomization Phase 96 Week|Lack of Efficacy|0
113451|NCT00951015|418599|P4|Randomization Phase 96 Week|Lack of Efficacy|0
113452|NCT00951015|418600|P3|Randomization Phase 96 Week|Lack of Efficacy|0
113453|NCT00951015|418601|P2|Randomization Phase 96 Week|Lack of Efficacy|1
113454|NCT00951015|418602|P1|Randomization Phase 96 Week|Lack of Efficacy|1
113455|NCT00951015|418598|P5|Randomization Phase 96 Week|Adverse Event|0
113456|NCT00951015|418599|P4|Randomization Phase 96 Week|Adverse Event|5
113457|NCT00951015|418600|P3|Randomization Phase 96 Week|Adverse Event|2
113458|NCT00951015|418601|P2|Randomization Phase 96 Week|Adverse Event|1
113459|NCT00951015|418602|P1|Randomization Phase 96 Week|Adverse Event|1
113460|NCT00950963|418699|P2|Overall Study|Lost to Follow-up|24
113461|NCT00950963|418700|P1|Overall Study|Lost to Follow-up|29
113462|NCT00950911|418735|P2|Overall Study|Poor performance status|1
113463|NCT00950911|418736|P1|Overall Study|Poor performance status|0
113464|NCT00950911|418735|P2|Overall Study|Noncompliance|0
113465|NCT00950911|418736|P1|Overall Study|Noncompliance|1
113466|NCT00950911|418735|P2|Overall Study|Ineligibility determined|0
113467|NCT00950911|418736|P1|Overall Study|Ineligibility determined|1
113468|NCT00950911|418735|P2|Overall Study|Administrative decision|1
113469|NCT00950911|418736|P1|Overall Study|Administrative decision|3
113470|NCT00950911|418735|P2|Overall Study|Consent withdrawn|3
113471|NCT00950911|418736|P1|Overall Study|Consent withdrawn|1
113472|NCT00950911|418735|P2|Overall Study|Disease progression|2
113473|NCT00950911|418736|P1|Overall Study|Disease progression|2
113474|NCT00950911|418735|P2|Overall Study|Death|6
113475|NCT00950911|418736|P1|Overall Study|Death|4
113476|NCT00950911|418735|P2|Overall Study|Adverse Event|2
113477|NCT00950911|418736|P1|Overall Study|Adverse Event|0
113478|NCT00950872|418742|P1|Overall Study|Did not have surgery|2
113479|NCT00950872|418742|P1|Overall Study|Withdrawal by Subject|1
113480|NCT00950859|418751|P2|Overall Study|Lost to Follow-up|3
113481|NCT00950859|418752|P1|Overall Study|Lost to Follow-up|0
113482|NCT00950859|418751|P2|Overall Study|Protocol Violation|1
113483|NCT00950859|418752|P1|Overall Study|Protocol Violation|1
113484|NCT00950859|418751|P2|Overall Study|Insufficient Viral Load Response|3
113485|NCT00950859|418752|P1|Overall Study|Insufficient Viral Load Response|12
113486|NCT00950859|418751|P2|Overall Study|Adverse Event|3
113487|NCT00950859|418752|P1|Overall Study|Adverse Event|3
113488|NCT00950807|418851|P10|Treatment Period 3|Adverse Event|0
113489|NCT00950807|418852|P9|Treatment Period 3|Adverse Event|0
113490|NCT00950807|418853|P8|Treatment Period 3|Adverse Event|0
113491|NCT00950807|418854|P7|Treatment Period 3|Adverse Event|1
113492|NCT00950807|418855|P6|Treatment Period 3|Adverse Event|0
113493|NCT00950807|418856|P5|Treatment Period 3|Adverse Event|0
113494|NCT00950807|418857|P4|Treatment Period 3|Adverse Event|0
113495|NCT00950807|418858|P3|Treatment Period 3|Adverse Event|0
113496|NCT00950807|418859|P2|Treatment Period 3|Adverse Event|0
113497|NCT00950807|418860|P1|Treatment Period 3|Adverse Event|0
113498|NCT00950807|418851|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
113499|NCT00950807|418852|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
113500|NCT00950807|418853|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
113501|NCT00950807|418854|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
113502|NCT00950807|418855|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
113503|NCT00950807|418856|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
113504|NCT00950807|418857|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
113505|NCT00950807|418858|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
113506|NCT00950807|418859|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
113507|NCT00950807|418860|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
113508|NCT00950807|418851|P10|Treatment Period 3|Withdrawal by Subject|1
113509|NCT00950807|418852|P9|Treatment Period 3|Withdrawal by Subject|0
113510|NCT00950807|418853|P8|Treatment Period 3|Withdrawal by Subject|0
113511|NCT00950807|418854|P7|Treatment Period 3|Withdrawal by Subject|0
113512|NCT00950807|418855|P6|Treatment Period 3|Withdrawal by Subject|0
113513|NCT00950807|418856|P5|Treatment Period 3|Withdrawal by Subject|0
113514|NCT00950807|418857|P4|Treatment Period 3|Withdrawal by Subject|0
113515|NCT00950807|418858|P3|Treatment Period 3|Withdrawal by Subject|0
113516|NCT00950807|418859|P2|Treatment Period 3|Withdrawal by Subject|0
113517|NCT00950807|418860|P1|Treatment Period 3|Withdrawal by Subject|0
113518|NCT00950807|418851|P10|Washout Period 2|Adverse Event|0
113519|NCT00950807|418852|P9|Washout Period 2|Adverse Event|0
113520|NCT00950807|418853|P8|Washout Period 2|Adverse Event|0
113521|NCT00950807|418854|P7|Washout Period 2|Adverse Event|0
113522|NCT00950807|418855|P6|Washout Period 2|Adverse Event|0
113523|NCT00950807|418856|P5|Washout Period 2|Adverse Event|0
113524|NCT00950807|418857|P4|Washout Period 2|Adverse Event|1
113525|NCT00950807|418858|P3|Washout Period 2|Adverse Event|0
113526|NCT00950807|418859|P2|Washout Period 2|Adverse Event|0
113527|NCT00950807|418860|P1|Washout Period 2|Adverse Event|3
113528|NCT00950807|418851|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
113529|NCT00950807|418852|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
113530|NCT00950807|418853|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
113531|NCT00950807|418854|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
113532|NCT00950807|418855|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
113533|NCT00950807|418856|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
113534|NCT00950807|418857|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
113535|NCT00950807|418858|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
113536|NCT00950807|418859|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
113537|NCT00950807|418860|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
113538|NCT00950807|418851|P10|Washout Period 2|Lack of Efficacy|0
113539|NCT00950807|418852|P9|Washout Period 2|Lack of Efficacy|0
113540|NCT00950807|418853|P8|Washout Period 2|Lack of Efficacy|0
113541|NCT00950807|418854|P7|Washout Period 2|Lack of Efficacy|0
113542|NCT00950807|418855|P6|Washout Period 2|Lack of Efficacy|0
113543|NCT00950807|418856|P5|Washout Period 2|Lack of Efficacy|0
113544|NCT00950807|418857|P4|Washout Period 2|Lack of Efficacy|0
113545|NCT00950807|418858|P3|Washout Period 2|Lack of Efficacy|0
113546|NCT00950807|418859|P2|Washout Period 2|Lack of Efficacy|0
113547|NCT00950807|418860|P1|Washout Period 2|Lack of Efficacy|1
113548|NCT00950807|418851|P10|Treatment Period 2|Adverse Event|0
113549|NCT00950807|418852|P9|Treatment Period 2|Adverse Event|0
113550|NCT00950807|418853|P8|Treatment Period 2|Adverse Event|1
113551|NCT00950807|418854|P7|Treatment Period 2|Adverse Event|0
113552|NCT00950807|418855|P6|Treatment Period 2|Adverse Event|1
113553|NCT00950807|418856|P5|Treatment Period 2|Adverse Event|0
113554|NCT00950807|418857|P4|Treatment Period 2|Adverse Event|1
113555|NCT00950807|418858|P3|Treatment Period 2|Adverse Event|0
113556|NCT00950807|418859|P2|Treatment Period 2|Adverse Event|1
113557|NCT00950807|418860|P1|Treatment Period 2|Adverse Event|0
113558|NCT00950807|418851|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
113559|NCT00950807|418852|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
113560|NCT00950807|418853|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
113561|NCT00950807|418854|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
113562|NCT00950807|418855|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
113563|NCT00950807|418856|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
113564|NCT00950807|418857|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
113565|NCT00950807|418858|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
113566|NCT00950807|418859|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
113567|NCT00950807|418860|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
113568|NCT00950807|418851|P10|Treatment Period 2|Withdrawal by Subject|0
113569|NCT00950807|418852|P9|Treatment Period 2|Withdrawal by Subject|0
113570|NCT00950807|418853|P8|Treatment Period 2|Withdrawal by Subject|2
113571|NCT00950807|418854|P7|Treatment Period 2|Withdrawal by Subject|1
113572|NCT00950807|418855|P6|Treatment Period 2|Withdrawal by Subject|0
113573|NCT00950807|418856|P5|Treatment Period 2|Withdrawal by Subject|0
113574|NCT00950807|418857|P4|Treatment Period 2|Withdrawal by Subject|0
113575|NCT00950807|418858|P3|Treatment Period 2|Withdrawal by Subject|0
113576|NCT00950807|418859|P2|Treatment Period 2|Withdrawal by Subject|0
113577|NCT00950807|418860|P1|Treatment Period 2|Withdrawal by Subject|0
113578|NCT00950807|418851|P10|Treatment Period 2|Lack of Efficacy|0
113579|NCT00950807|418852|P9|Treatment Period 2|Lack of Efficacy|0
113580|NCT00950807|418853|P8|Treatment Period 2|Lack of Efficacy|0
113581|NCT00950807|418854|P7|Treatment Period 2|Lack of Efficacy|0
113582|NCT00950807|418855|P6|Treatment Period 2|Lack of Efficacy|0
113583|NCT00950807|418856|P5|Treatment Period 2|Lack of Efficacy|0
113584|NCT00950807|418857|P4|Treatment Period 2|Lack of Efficacy|0
113585|NCT00950807|418858|P3|Treatment Period 2|Lack of Efficacy|0
113586|NCT00950807|418859|P2|Treatment Period 2|Lack of Efficacy|0
113587|NCT00950807|418860|P1|Treatment Period 2|Lack of Efficacy|1
113588|NCT00950807|418851|P10|Washout Period 1|Adverse Event|0
113589|NCT00950807|418852|P9|Washout Period 1|Adverse Event|0
113590|NCT00950807|418853|P8|Washout Period 1|Adverse Event|0
113591|NCT00950807|418854|P7|Washout Period 1|Adverse Event|0
113592|NCT00950807|418855|P6|Washout Period 1|Adverse Event|0
113593|NCT00950807|418856|P5|Washout Period 1|Adverse Event|1
113594|NCT00950807|418857|P4|Washout Period 1|Adverse Event|1
113595|NCT00950807|418858|P3|Washout Period 1|Adverse Event|0
113596|NCT00950807|418859|P2|Washout Period 1|Adverse Event|0
113597|NCT00950807|418860|P1|Washout Period 1|Adverse Event|2
113598|NCT00950807|418851|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
113599|NCT00950807|418852|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
113600|NCT00950807|418853|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
113601|NCT00950807|418854|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
113602|NCT00950807|418855|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
113603|NCT00950807|418856|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
113604|NCT00950807|418857|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
113605|NCT00950807|418858|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
113606|NCT00950807|418859|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
113607|NCT00950807|418860|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
113608|NCT00950807|418851|P10|Washout Period 1|Withdrawal by Subject|0
113609|NCT00950807|418852|P9|Washout Period 1|Withdrawal by Subject|1
113610|NCT00950807|418853|P8|Washout Period 1|Withdrawal by Subject|0
113611|NCT00950807|418854|P7|Washout Period 1|Withdrawal by Subject|0
113612|NCT00950807|418855|P6|Washout Period 1|Withdrawal by Subject|0
113613|NCT00950807|418856|P5|Washout Period 1|Withdrawal by Subject|0
113614|NCT00950807|418857|P4|Washout Period 1|Withdrawal by Subject|0
113615|NCT00950807|418858|P3|Washout Period 1|Withdrawal by Subject|0
113616|NCT00950807|418859|P2|Washout Period 1|Withdrawal by Subject|0
113617|NCT00950807|418860|P1|Washout Period 1|Withdrawal by Subject|0
113618|NCT00950807|418851|P10|Washout Period 1|Lack of Efficacy|0
113619|NCT00950807|418852|P9|Washout Period 1|Lack of Efficacy|0
113620|NCT00950807|418853|P8|Washout Period 1|Lack of Efficacy|0
113621|NCT00950807|418854|P7|Washout Period 1|Lack of Efficacy|1
113622|NCT00950807|418855|P6|Washout Period 1|Lack of Efficacy|0
113623|NCT00950807|418856|P5|Washout Period 1|Lack of Efficacy|0
113624|NCT00950807|418857|P4|Washout Period 1|Lack of Efficacy|0
113625|NCT00950807|418858|P3|Washout Period 1|Lack of Efficacy|0
113626|NCT00950807|418859|P2|Washout Period 1|Lack of Efficacy|0
113627|NCT00950807|418860|P1|Washout Period 1|Lack of Efficacy|0
113628|NCT00950807|418851|P10|Treatment Period 1|Adverse Event|0
113629|NCT00950807|418852|P9|Treatment Period 1|Adverse Event|0
113630|NCT00950807|418853|P8|Treatment Period 1|Adverse Event|0
113631|NCT00950807|418854|P7|Treatment Period 1|Adverse Event|0
113632|NCT00950807|418855|P6|Treatment Period 1|Adverse Event|1
113633|NCT00950807|418856|P5|Treatment Period 1|Adverse Event|0
113634|NCT00950807|418857|P4|Treatment Period 1|Adverse Event|0
113635|NCT00950807|418858|P3|Treatment Period 1|Adverse Event|0
113636|NCT00950807|418859|P2|Treatment Period 1|Adverse Event|0
113637|NCT00950807|418860|P1|Treatment Period 1|Adverse Event|0
113638|NCT00950807|418851|P10|Treatment Period 1|Withdrawal by Subject|0
113639|NCT00950807|418852|P9|Treatment Period 1|Withdrawal by Subject|1
113640|NCT00950807|418853|P8|Treatment Period 1|Withdrawal by Subject|0
113641|NCT00950807|418854|P7|Treatment Period 1|Withdrawal by Subject|0
113642|NCT00950807|418855|P6|Treatment Period 1|Withdrawal by Subject|0
113643|NCT00950807|418856|P5|Treatment Period 1|Withdrawal by Subject|1
113644|NCT00950807|418857|P4|Treatment Period 1|Withdrawal by Subject|0
113645|NCT00950807|418858|P3|Treatment Period 1|Withdrawal by Subject|0
113646|NCT00950807|418859|P2|Treatment Period 1|Withdrawal by Subject|0
113647|NCT00950807|418860|P1|Treatment Period 1|Withdrawal by Subject|1
113648|NCT00950807|418851|P10|Treatment Period 1|Lost to Follow-up|0
113649|NCT00950807|418852|P9|Treatment Period 1|Lost to Follow-up|0
113650|NCT00950807|418853|P8|Treatment Period 1|Lost to Follow-up|0
113651|NCT00950807|418854|P7|Treatment Period 1|Lost to Follow-up|0
113652|NCT00950807|418855|P6|Treatment Period 1|Lost to Follow-up|0
113653|NCT00950807|418856|P5|Treatment Period 1|Lost to Follow-up|0
113654|NCT00950807|418857|P4|Treatment Period 1|Lost to Follow-up|0
113655|NCT00950807|418858|P3|Treatment Period 1|Lost to Follow-up|1
113656|NCT00950807|418859|P2|Treatment Period 1|Lost to Follow-up|0
113657|NCT00950807|418860|P1|Treatment Period 1|Lost to Follow-up|0
113658|NCT00950807|418851|P10|Treatment Period 1|Protocol Violation|0
113659|NCT00950807|418852|P9|Treatment Period 1|Protocol Violation|0
113660|NCT00950807|418853|P8|Treatment Period 1|Protocol Violation|0
113661|NCT00950807|418854|P7|Treatment Period 1|Protocol Violation|0
113662|NCT00950807|418855|P6|Treatment Period 1|Protocol Violation|0
113663|NCT00950807|418856|P5|Treatment Period 1|Protocol Violation|0
113664|NCT00950807|418857|P4|Treatment Period 1|Protocol Violation|0
113665|NCT00950807|418858|P3|Treatment Period 1|Protocol Violation|0
113666|NCT00950807|418859|P2|Treatment Period 1|Protocol Violation|0
113667|NCT00950807|418860|P1|Treatment Period 1|Protocol Violation|1
113668|NCT00950807|418851|P10|Treatment Period 1|Lack of Efficacy|0
113669|NCT00950807|418852|P9|Treatment Period 1|Lack of Efficacy|0
113670|NCT00950807|418853|P8|Treatment Period 1|Lack of Efficacy|0
113671|NCT00950807|418854|P7|Treatment Period 1|Lack of Efficacy|0
113672|NCT00950807|418855|P6|Treatment Period 1|Lack of Efficacy|1
113673|NCT00950807|418856|P5|Treatment Period 1|Lack of Efficacy|0
113674|NCT00950807|418857|P4|Treatment Period 1|Lack of Efficacy|0
113675|NCT00950807|418858|P3|Treatment Period 1|Lack of Efficacy|0
113676|NCT00950807|418859|P2|Treatment Period 1|Lack of Efficacy|0
113677|NCT00950807|418860|P1|Treatment Period 1|Lack of Efficacy|1
113678|NCT00950755|418902|P1|Long-Term Follow-Up|Death|8
113679|NCT00950755|418902|P1|Long-Term Follow-Up|Lost to Follow-up|1
113680|NCT00950755|418902|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
113681|NCT00950755|418902|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
113682|NCT00950755|418902|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
113683|NCT00950755|418902|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
113684|NCT00950755|418902|P1|Dosimetric and Therapeutic Treatment|Death|1
113685|NCT00950755|418902|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
113686|NCT00950755|418902|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
113687|NCT00950755|418902|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
113688|NCT00950742|418928|P2|Overall Study|Dose limiting toxicity|0
113689|NCT00950742|418929|P1|Overall Study|Dose limiting toxicity|6
113690|NCT00950742|418928|P2|Overall Study|Progressive Disease|2
113691|NCT00950742|418929|P1|Overall Study|Progressive Disease|6
113692|NCT00950742|418928|P2|Overall Study|Withdrawal by Subject|0
113693|NCT00950742|418929|P1|Overall Study|Withdrawal by Subject|3
113694|NCT00950742|418928|P2|Overall Study|Other Adverse Event|0
113695|NCT00950742|418929|P1|Overall Study|Other Adverse Event|1
113696|NCT00950690|418950|P1|Overall Study|Other|163
113697|NCT00950690|418950|P1|Overall Study|Lost to Follow-up|40
113698|NCT00950690|418950|P1|Overall Study|Lack of Efficacy|22
113699|NCT00950690|418950|P1|Overall Study|Adverse Event|15
113700|NCT00950690|418950|P1|Overall Study|Death|4
113701|NCT00950664|418957|P2|First Intervention|Withdrawal by Subject|2
113702|NCT00950664|418958|P1|First Intervention|Withdrawal by Subject|2
113703|NCT00950664|418957|P2|First Intervention|Lost to Follow-up|3
113704|NCT00950664|418958|P1|First Intervention|Lost to Follow-up|1
113705|NCT00950651|418978|P2|Overall Study|Withdrawal by Subject|9
113706|NCT00950651|418979|P1|Overall Study|Withdrawal by Subject|8
113707|NCT00950651|418978|P2|Overall Study|Protocol Violation|4
113708|NCT00950651|418979|P1|Overall Study|Protocol Violation|3
113709|NCT00950651|418978|P2|Overall Study|Lack of Efficacy|2
113710|NCT00950651|418979|P1|Overall Study|Lack of Efficacy|2
113711|NCT00950651|418978|P2|Overall Study|Death|0
113712|NCT00950651|418979|P1|Overall Study|Death|1
113713|NCT00950651|418978|P2|Overall Study|Adverse Event|20
113714|NCT00950651|418979|P1|Overall Study|Adverse Event|17
113715|NCT00950599|419072|P10|Follow-Up Period|Subject withdrew Consent|1
113716|NCT00950599|419073|P9|Follow-Up Period|Subject withdrew Consent|2
113717|NCT00950599|419074|P8|Follow-Up Period|Subject withdrew Consent|0
113718|NCT00950599|419075|P7|Follow-Up Period|Subject withdrew Consent|0
113719|NCT00950599|419076|P6|Follow-Up Period|Subject withdrew Consent|0
113720|NCT00950599|419077|P5|Follow-Up Period|Subject withdrew Consent|0
113721|NCT00950599|419078|P4|Follow-Up Period|Subject withdrew Consent|0
113722|NCT00950599|419079|P3|Follow-Up Period|Subject withdrew Consent|0
113723|NCT00950599|419080|P2|Follow-Up Period|Subject withdrew Consent|0
113724|NCT00950599|419081|P1|Follow-Up Period|Subject withdrew Consent|0
113725|NCT00950599|419072|P10|Follow-Up Period|Poor/Noncompliance|0
113726|NCT00950599|419073|P9|Follow-Up Period|Poor/Noncompliance|1
113727|NCT00950599|419074|P8|Follow-Up Period|Poor/Noncompliance|0
113728|NCT00950599|419075|P7|Follow-Up Period|Poor/Noncompliance|0
113729|NCT00950599|419076|P6|Follow-Up Period|Poor/Noncompliance|0
113730|NCT00950599|419077|P5|Follow-Up Period|Poor/Noncompliance|0
113731|NCT00950599|419078|P4|Follow-Up Period|Poor/Noncompliance|0
113732|NCT00950599|419079|P3|Follow-Up Period|Poor/Noncompliance|0
113733|NCT00950599|419080|P2|Follow-Up Period|Poor/Noncompliance|0
113734|NCT00950599|419081|P1|Follow-Up Period|Poor/Noncompliance|0
113735|NCT00950599|419072|P10|Follow-Up Period|Physician Decision|0
113736|NCT00950599|419073|P9|Follow-Up Period|Physician Decision|1
113737|NCT00950599|419074|P8|Follow-Up Period|Physician Decision|0
113738|NCT00950599|419075|P7|Follow-Up Period|Physician Decision|0
113739|NCT00950599|419076|P6|Follow-Up Period|Physician Decision|0
113740|NCT00950599|419077|P5|Follow-Up Period|Physician Decision|0
113741|NCT00950599|419078|P4|Follow-Up Period|Physician Decision|0
113742|NCT00950599|419079|P3|Follow-Up Period|Physician Decision|0
113743|NCT00950599|419080|P2|Follow-Up Period|Physician Decision|0
113744|NCT00950599|419081|P1|Follow-Up Period|Physician Decision|0
113745|NCT00950599|419072|P10|Follow-Up Period|Lost to Follow-up|1
113746|NCT00950599|419073|P9|Follow-Up Period|Lost to Follow-up|5
113747|NCT00950599|419074|P8|Follow-Up Period|Lost to Follow-up|0
113748|NCT00950599|419075|P7|Follow-Up Period|Lost to Follow-up|0
113749|NCT00950599|419076|P6|Follow-Up Period|Lost to Follow-up|0
113750|NCT00950599|419077|P5|Follow-Up Period|Lost to Follow-up|0
113751|NCT00950599|419078|P4|Follow-Up Period|Lost to Follow-up|0
113752|NCT00950599|419079|P3|Follow-Up Period|Lost to Follow-up|0
113753|NCT00950599|419080|P2|Follow-Up Period|Lost to Follow-up|0
113754|NCT00950599|419081|P1|Follow-Up Period|Lost to Follow-up|0
113755|NCT00950599|419072|P10|Follow-Up Period|Lack of Efficacy|0
113756|NCT00950599|419073|P9|Follow-Up Period|Lack of Efficacy|3
113757|NCT00950599|419074|P8|Follow-Up Period|Lack of Efficacy|0
113758|NCT00950599|419075|P7|Follow-Up Period|Lack of Efficacy|0
113759|NCT00950599|419076|P6|Follow-Up Period|Lack of Efficacy|0
113760|NCT00950599|419077|P5|Follow-Up Period|Lack of Efficacy|0
113761|NCT00950599|419078|P4|Follow-Up Period|Lack of Efficacy|0
113762|NCT00950599|419079|P3|Follow-Up Period|Lack of Efficacy|0
113763|NCT00950599|419080|P2|Follow-Up Period|Lack of Efficacy|0
113764|NCT00950599|419081|P1|Follow-Up Period|Lack of Efficacy|0
113765|NCT00950599|419072|P10|Follow-Up Period|Adverse Event|0
113766|NCT00950599|419073|P9|Follow-Up Period|Adverse Event|1
113767|NCT00950599|419074|P8|Follow-Up Period|Adverse Event|0
113768|NCT00950599|419075|P7|Follow-Up Period|Adverse Event|0
113769|NCT00950599|419076|P6|Follow-Up Period|Adverse Event|0
113770|NCT00950599|419077|P5|Follow-Up Period|Adverse Event|0
113771|NCT00950599|419078|P4|Follow-Up Period|Adverse Event|0
113772|NCT00950599|419079|P3|Follow-Up Period|Adverse Event|0
113773|NCT00950599|419080|P2|Follow-Up Period|Adverse Event|0
113774|NCT00950599|419081|P1|Follow-Up Period|Adverse Event|0
113775|NCT00950599|419072|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
113776|NCT00950599|419073|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
113777|NCT00950599|419074|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
113778|NCT00950599|419075|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
113779|NCT00950599|419076|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
113780|NCT00950599|419077|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
113781|NCT00950599|419078|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
113782|NCT00950599|419079|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
113783|NCT00950599|419080|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
113784|NCT00950599|419081|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
113785|NCT00950599|419072|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
113786|NCT00950599|419073|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
113787|NCT00950599|419074|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
113788|NCT00950599|419075|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
113789|NCT00950599|419076|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
113790|NCT00950599|419077|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
113791|NCT00950599|419078|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
113792|NCT00950599|419079|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
113793|NCT00950599|419080|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
113794|NCT00950599|419081|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
113795|NCT00950599|419072|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
113796|NCT00950599|419073|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
113797|NCT00950599|419074|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
113798|NCT00950599|419075|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
113799|NCT00950599|419076|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
113800|NCT00950599|419077|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
113801|NCT00950599|419078|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
113802|NCT00950599|419079|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
113803|NCT00950599|419080|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
113804|NCT00950599|419081|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
113805|NCT00950599|419072|P10|Double-Blind Treatment Period|Lost to Follow-up|0
113806|NCT00950599|419073|P9|Double-Blind Treatment Period|Lost to Follow-up|0
113807|NCT00950599|419074|P8|Double-Blind Treatment Period|Lost to Follow-up|1
113808|NCT00950599|419075|P7|Double-Blind Treatment Period|Lost to Follow-up|0
113809|NCT00950599|419076|P6|Double-Blind Treatment Period|Lost to Follow-up|2
113810|NCT00950599|419077|P5|Double-Blind Treatment Period|Lost to Follow-up|1
113811|NCT00950599|419078|P4|Double-Blind Treatment Period|Lost to Follow-up|1
113812|NCT00950599|419079|P3|Double-Blind Treatment Period|Lost to Follow-up|0
113813|NCT00950599|419080|P2|Double-Blind Treatment Period|Lost to Follow-up|0
113814|NCT00950599|419081|P1|Double-Blind Treatment Period|Lost to Follow-up|0
113815|NCT00950599|419072|P10|Double-Blind Treatment Period|Lack of Efficacy|0
113816|NCT00950599|419073|P9|Double-Blind Treatment Period|Lack of Efficacy|0
113817|NCT00950599|419074|P8|Double-Blind Treatment Period|Lack of Efficacy|1
113818|NCT00950599|419075|P7|Double-Blind Treatment Period|Lack of Efficacy|0
113819|NCT00950599|419076|P6|Double-Blind Treatment Period|Lack of Efficacy|6
113820|NCT00950599|419077|P5|Double-Blind Treatment Period|Lack of Efficacy|3
113821|NCT00950599|419078|P4|Double-Blind Treatment Period|Lack of Efficacy|7
113822|NCT00950599|419079|P3|Double-Blind Treatment Period|Lack of Efficacy|5
113823|NCT00950599|419080|P2|Double-Blind Treatment Period|Lack of Efficacy|5
113824|NCT00950599|419081|P1|Double-Blind Treatment Period|Lack of Efficacy|2
113825|NCT00950599|419072|P10|Double-Blind Treatment Period|Adverse Event|0
113826|NCT00950599|419073|P9|Double-Blind Treatment Period|Adverse Event|0
113827|NCT00950599|419074|P8|Double-Blind Treatment Period|Adverse Event|0
113828|NCT00950599|419075|P7|Double-Blind Treatment Period|Adverse Event|0
113829|NCT00950599|419076|P6|Double-Blind Treatment Period|Adverse Event|1
113830|NCT00950599|419077|P5|Double-Blind Treatment Period|Adverse Event|1
113831|NCT00950599|419078|P4|Double-Blind Treatment Period|Adverse Event|1
113832|NCT00950599|419079|P3|Double-Blind Treatment Period|Adverse Event|1
113833|NCT00950599|419080|P2|Double-Blind Treatment Period|Adverse Event|1
113834|NCT00950599|419081|P1|Double-Blind Treatment Period|Adverse Event|0
113835|NCT00950599|419072|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
113836|NCT00950599|419073|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
113837|NCT00950599|419074|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
113838|NCT00950599|419075|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
113839|NCT00950599|419076|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
113840|NCT00950599|419077|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
113841|NCT00950599|419078|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
113842|NCT00950599|419079|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
113843|NCT00950599|419080|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
113844|NCT00950599|419081|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
113845|NCT00950300|419654|P2|SFU Period|Withdrawal by Subject|8
113846|NCT00950300|419655|P1|SFU Period|Withdrawal by Subject|4
113847|NCT00950300|419654|P2|SFU Period|Lost to Follow-up|28
113848|NCT00950300|419655|P1|SFU Period|Lost to Follow-up|30
113849|NCT00950300|419654|P2|SFU Period|Death|42
113850|NCT00950300|419655|P1|SFU Period|Death|44
113851|NCT00950300|419654|P2|TFFU Period|Not Specified|3
113852|NCT00950300|419655|P1|TFFU Period|Not Specified|4
113853|NCT00950300|419654|P2|TFFU Period|Recurrence of Disease|72
113854|NCT00950300|419655|P1|TFFU Period|Recurrence of Disease|63
113855|NCT00950300|419654|P2|TFFU Period|Failure to Return|16
113856|NCT00950300|419655|P1|TFFU Period|Failure to Return|16
113857|NCT00950300|419654|P2|TFFU Period|Refused Treatment|11
113858|NCT00950300|419655|P1|TFFU Period|Refused Treatment|10
113859|NCT00950300|419654|P2|TFFU Period|Death|1
113860|NCT00950300|419655|P1|TFFU Period|Death|4
113861|NCT00950300|419654|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
113862|NCT00950300|419655|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
113863|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
113864|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
113865|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
113866|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
113867|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
113868|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
113869|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
113870|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
113871|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
113872|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
113873|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
113874|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
113875|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
113876|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
113877|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
113878|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
113879|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
113880|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
113881|NCT00950300|419654|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
113968|NCT00949702|419930|P1|Overall Study|Disease progression|7
113882|NCT00950300|419655|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
113883|NCT00949975|419727|P4|Overall Study|Other|0
113884|NCT00949975|419728|P3|Overall Study|Other|0
113885|NCT00949975|419729|P2|Overall Study|Other|0
113886|NCT00949975|419730|P1|Overall Study|Other|1
113887|NCT00949975|419727|P4|Overall Study|Lost to Follow-up|3
113888|NCT00949975|419728|P3|Overall Study|Lost to Follow-up|1
113889|NCT00949975|419729|P2|Overall Study|Lost to Follow-up|0
113890|NCT00949975|419730|P1|Overall Study|Lost to Follow-up|1
113891|NCT00949975|419727|P4|Overall Study|Severe non-compliance|2
113892|NCT00949975|419728|P3|Overall Study|Severe non-compliance|0
113893|NCT00949975|419729|P2|Overall Study|Severe non-compliance|1
113894|NCT00949975|419730|P1|Overall Study|Severe non-compliance|3
113895|NCT00949975|419727|P4|Overall Study|Incorrect enrolment|7
113896|NCT00949975|419728|P3|Overall Study|Incorrect enrolment|4
113897|NCT00949975|419729|P2|Overall Study|Incorrect enrolment|10
113898|NCT00949975|419730|P1|Overall Study|Incorrect enrolment|5
113899|NCT00949975|419727|P4|Overall Study|Study-specific criteria|0
113900|NCT00949975|419728|P3|Overall Study|Study-specific criteria|1
113901|NCT00949975|419729|P2|Overall Study|Study-specific criteria|1
113902|NCT00949975|419730|P1|Overall Study|Study-specific criteria|0
113903|NCT00949975|419727|P4|Overall Study|Safety reason|0
113904|NCT00949975|419728|P3|Overall Study|Safety reason|0
113905|NCT00949975|419729|P2|Overall Study|Safety reason|1
113906|NCT00949975|419730|P1|Overall Study|Safety reason|0
113907|NCT00949975|419727|P4|Overall Study|Adverse Event|10
113908|NCT00949975|419728|P3|Overall Study|Adverse Event|10
113909|NCT00949975|419729|P2|Overall Study|Adverse Event|11
113910|NCT00949975|419730|P1|Overall Study|Adverse Event|11
113911|NCT00949975|419727|P4|Overall Study|Voluntary discontinuation|6
113912|NCT00949975|419728|P3|Overall Study|Voluntary discontinuation|3
113913|NCT00949975|419729|P2|Overall Study|Voluntary discontinuation|5
113914|NCT00949975|419730|P1|Overall Study|Voluntary discontinuation|6
113915|NCT00949910|419848|P1|Overall Study|No Data|9
113916|NCT00949910|419848|P1|Overall Study|Other|4
113917|NCT00949910|419848|P1|Overall Study|Physician/Participant Decision|7
113918|NCT00949910|419848|P1|Overall Study|Serious Adverse Event|6
113919|NCT00949910|419848|P1|Overall Study|Adverse Event|83
113920|NCT00949910|419848|P1|Overall Study|Prolonged Dosing Interruption|4
113921|NCT00949910|419848|P1|Overall Study|Non-Compliance|10
113922|NCT00949910|419848|P1|Overall Study|Logistical Reasons|13
113923|NCT00949910|419848|P1|Overall Study|Violation of Eligibility|23
113924|NCT00949910|419848|P1|Overall Study|Switched to Commercial Treatment|4
113925|NCT00949910|419848|P1|Overall Study|Switched to Compassionate/Other Use|174
113926|NCT00949910|419848|P1|Overall Study|Unspecified Progression/Deterioration|13
113927|NCT00949910|419848|P1|Overall Study|Death from Unknown Cause|5
113928|NCT00949910|419848|P1|Overall Study|Death Due to Toxicity|3
113929|NCT00949910|419848|P1|Overall Study|Death Due to Adverse Event|115
113930|NCT00949910|419848|P1|Overall Study|Death Due to Progression/Deterioration|4
113931|NCT00949910|419848|P1|Overall Study|Death Due to Malignant Disease|456
113932|NCT00949910|419848|P1|Overall Study|Participant Refusal|390
113933|NCT00949910|419848|P1|Overall Study|Study Drug-Related Adverse Event|315
113934|NCT00949910|419848|P1|Overall Study|Lost to Follow-up|100
113935|NCT00949910|419848|P1|Overall Study|Symptomatic Deterioration|1088
113936|NCT00949910|419848|P1|Overall Study|Progressive Disease|3750
113937|NCT00949884|419861|P3|Overall Study|Study terminated by sponsor|1
113938|NCT00949884|419862|P2|Overall Study|Study terminated by sponsor|0
113939|NCT00949884|419863|P1|Overall Study|Study terminated by sponsor|0
113940|NCT00949884|419861|P3|Overall Study|Lack of Efficacy|7
113941|NCT00949884|419862|P2|Overall Study|Lack of Efficacy|2
113942|NCT00949884|419863|P1|Overall Study|Lack of Efficacy|4
113943|NCT00949884|419861|P3|Overall Study|Withdrawal by Subject|16
113944|NCT00949884|419862|P2|Overall Study|Withdrawal by Subject|4
113945|NCT00949884|419863|P1|Overall Study|Withdrawal by Subject|13
113946|NCT00949884|419861|P3|Overall Study|Treatment non-compliance|8
113947|NCT00949884|419862|P2|Overall Study|Treatment non-compliance|0
113948|NCT00949884|419863|P1|Overall Study|Treatment non-compliance|5
113949|NCT00949884|419861|P3|Overall Study|Physician Decision|6
113950|NCT00949884|419862|P2|Overall Study|Physician Decision|0
113951|NCT00949884|419863|P1|Overall Study|Physician Decision|5
113952|NCT00949884|419861|P3|Overall Study|Lost to Follow-up|5
113953|NCT00949884|419862|P2|Overall Study|Lost to Follow-up|5
113954|NCT00949884|419863|P1|Overall Study|Lost to Follow-up|7
113955|NCT00949884|419861|P3|Overall Study|Did not meet inclusion/exclusion|3
113956|NCT00949884|419862|P2|Overall Study|Did not meet inclusion/exclusion|1
113957|NCT00949884|419863|P1|Overall Study|Did not meet inclusion/exclusion|2
113958|NCT00949884|419861|P3|Overall Study|Adverse Event|12
113959|NCT00949884|419862|P2|Overall Study|Adverse Event|3
113960|NCT00949884|419863|P1|Overall Study|Adverse Event|14
113961|NCT00949715|419918|P2|Overall Study|Missing 24 month LVEF measurement|0
113962|NCT00949715|419919|P1|Overall Study|Missing 24 month LVEF measurement|2
113963|NCT00949715|419918|P2|Overall Study|Lost to Follow-up|0
113964|NCT00949715|419919|P1|Overall Study|Lost to Follow-up|1
113965|NCT00949715|419918|P2|Overall Study|Physician Decision|0
113966|NCT00949715|419919|P1|Overall Study|Physician Decision|1
113967|NCT00949702|419930|P1|Overall Study|Withdrawal of consent|1
113969|NCT00949702|419930|P1|Overall Study|Death|40
113970|NCT00949650|419947|P2|Overall Study|Other not specified above|0
113971|NCT00949650|419948|P1|Overall Study|Other not specified above|5
113972|NCT00949650|419947|P2|Overall Study|Not treated|4
113973|NCT00949650|419948|P1|Overall Study|Not treated|1
113974|NCT00949650|419947|P2|Overall Study|Refusal to continue medication|11
113975|NCT00949650|419948|P1|Overall Study|Refusal to continue medication|7
113976|NCT00949650|419947|P2|Overall Study|Protocol Violation|4
113977|NCT00949650|419948|P1|Overall Study|Protocol Violation|1
113978|NCT00949650|419947|P2|Overall Study|Other Adverse Event (AE)|17
113979|NCT00949650|419948|P1|Overall Study|Other Adverse Event (AE)|28
113980|NCT00949650|419947|P2|Overall Study|Completed 6 courses of chemotherapy|60
113981|NCT00949650|419948|P1|Overall Study|Completed 6 courses of chemotherapy|0
113982|NCT00949650|419947|P2|Overall Study|Progressive disease|19
113983|NCT00949650|419948|P1|Overall Study|Progressive disease|188
113984|NCT00949533|419986|P2|Overall Study|Lost to Follow-up|1
113985|NCT00949533|419987|P1|Overall Study|Lost to Follow-up|0
113986|NCT00949117|420005|P2|Overall Study|Adverse Event|1
113987|NCT00949117|420006|P1|Overall Study|Adverse Event|0
113988|NCT00949117|420005|P2|Overall Study|Protocol Violation|1
113989|NCT00949117|420006|P1|Overall Study|Protocol Violation|1
113990|NCT00949117|420005|P2|Overall Study|Lack of Efficacy|3
113991|NCT00949117|420006|P1|Overall Study|Lack of Efficacy|2
113992|NCT00948896|420053|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
113993|NCT00948896|420054|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
113994|NCT00948896|420055|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
113995|NCT00948896|420056|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
113996|NCT00948896|420057|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
113997|NCT00948896|420058|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
113998|NCT00948896|420059|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
113999|NCT00948896|420060|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
114000|NCT00948896|420053|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
114001|NCT00948896|420054|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
114002|NCT00948896|420055|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
114003|NCT00948896|420056|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
114004|NCT00948896|420057|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
114005|NCT00948896|420058|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
114006|NCT00948896|420059|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
114007|NCT00948896|420060|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
114008|NCT00948896|420053|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
114009|NCT00948896|420054|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
114010|NCT00948896|420055|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
114011|NCT00948896|420056|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
114012|NCT00948896|420057|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
114013|NCT00948896|420058|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
114014|NCT00948896|420059|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
114015|NCT00948896|420060|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
114016|NCT00948896|420053|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
114017|NCT00948896|420054|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
114018|NCT00948896|420055|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
114019|NCT00948896|420056|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
114020|NCT00948896|420057|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
114021|NCT00948896|420058|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
114022|NCT00948896|420059|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
114023|NCT00948896|420060|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
114024|NCT00948896|420053|P8|24 Months of Age to 36 Months of Age|Death|0
114025|NCT00948896|420054|P7|24 Months of Age to 36 Months of Age|Death|0
114026|NCT00948896|420055|P6|24 Months of Age to 36 Months of Age|Death|1
114027|NCT00948896|420056|P5|24 Months of Age to 36 Months of Age|Death|0
114028|NCT00948896|420057|P4|24 Months of Age to 36 Months of Age|Death|0
114029|NCT00948896|420058|P3|24 Months of Age to 36 Months of Age|Death|2
114030|NCT00948896|420059|P2|24 Months of Age to 36 Months of Age|Death|2
114031|NCT00948896|420060|P1|24 Months of Age to 36 Months of Age|Death|0
114032|NCT00948896|420053|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
114033|NCT00948896|420054|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
114034|NCT00948896|420055|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
114035|NCT00948896|420056|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
114036|NCT00948896|420057|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
114037|NCT00948896|420058|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
114038|NCT00948896|420059|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
114039|NCT00948896|420060|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
114040|NCT00948896|420053|P8|Randomization to 24 Months of Age|Protocol Violation|1
114041|NCT00948896|420054|P7|Randomization to 24 Months of Age|Protocol Violation|1
114042|NCT00948896|420055|P6|Randomization to 24 Months of Age|Protocol Violation|0
114043|NCT00948896|420056|P5|Randomization to 24 Months of Age|Protocol Violation|0
114044|NCT00948896|420057|P4|Randomization to 24 Months of Age|Protocol Violation|1
114045|NCT00948896|420058|P3|Randomization to 24 Months of Age|Protocol Violation|0
114046|NCT00948896|420059|P2|Randomization to 24 Months of Age|Protocol Violation|1
114047|NCT00948896|420060|P1|Randomization to 24 Months of Age|Protocol Violation|0
114048|NCT00948896|420053|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
114049|NCT00948896|420054|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
114050|NCT00948896|420055|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
114051|NCT00948896|420056|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
114052|NCT00948896|420057|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
114053|NCT00948896|420058|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
114054|NCT00948896|420059|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
114055|NCT00948896|420060|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
114056|NCT00948896|420053|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
114057|NCT00948896|420054|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
114058|NCT00948896|420055|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
114059|NCT00948896|420056|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
114060|NCT00948896|420057|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
114061|NCT00948896|420058|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
114062|NCT00948896|420059|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
114063|NCT00948896|420060|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
114064|NCT00948896|420053|P8|Randomization to 24 Months of Age|Death|1
114065|NCT00948896|420054|P7|Randomization to 24 Months of Age|Death|2
114066|NCT00948896|420055|P6|Randomization to 24 Months of Age|Death|1
114067|NCT00948896|420056|P5|Randomization to 24 Months of Age|Death|2
114068|NCT00948896|420057|P4|Randomization to 24 Months of Age|Death|0
114069|NCT00948896|420058|P3|Randomization to 24 Months of Age|Death|0
114070|NCT00948896|420059|P2|Randomization to 24 Months of Age|Death|0
114071|NCT00948896|420060|P1|Randomization to 24 Months of Age|Death|1
114072|NCT00948857|420096|P2|Overall Study|Lost to Follow-up|0
114073|NCT00948857|420097|P1|Overall Study|Lost to Follow-up|1
114074|NCT00948818|420105|P2|Overall Study|Other Reason|5
114075|NCT00948818|420106|P1|Overall Study|Other Reason|4
114076|NCT00948818|420105|P2|Overall Study|Lack of Efficacy|5
114077|NCT00948818|420106|P1|Overall Study|Lack of Efficacy|4
114078|NCT00948818|420105|P2|Overall Study|Lost to Follow-up|17
114079|NCT00948818|420106|P1|Overall Study|Lost to Follow-up|10
114080|NCT00948818|420105|P2|Overall Study|Withdrawal by Subject|25
114081|NCT00948818|420106|P1|Overall Study|Withdrawal by Subject|25
114082|NCT00948818|420105|P2|Overall Study|Protocol Violation|10
114083|NCT00948818|420106|P1|Overall Study|Protocol Violation|9
114084|NCT00948818|420105|P2|Overall Study|Adverse Event|32
114085|NCT00948818|420106|P1|Overall Study|Adverse Event|10
114086|NCT00948766|420153|P2|Extension Study|Death|0
114087|NCT00948766|420154|P1|Extension Study|Death|4
114088|NCT00948766|420153|P2|Extension Study|Administrative Problems|0
114089|NCT00948766|420154|P1|Extension Study|Administrative Problems|1
114090|NCT00948766|420153|P2|Extension Study|Lost to Follow-up|0
114091|NCT00948766|420154|P1|Extension Study|Lost to Follow-up|8
114092|NCT00948766|420153|P2|Extension Study|Patient Withdrew Consent|0
114093|NCT00948766|420154|P1|Extension Study|Patient Withdrew Consent|32
114094|NCT00948766|420153|P2|Extension Study|Study Drug No Longer Required|0
114095|NCT00948766|420154|P1|Extension Study|Study Drug No Longer Required|1
114096|NCT00948766|420153|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
114097|NCT00948766|420154|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
114098|NCT00948766|420153|P2|Extension Study|Adverse Event|0
114099|NCT00948766|420154|P1|Extension Study|Adverse Event|43
114100|NCT00948766|420153|P2|Core Study|Protocol Deviation|10
114101|NCT00948766|420154|P1|Core Study|Protocol Deviation|8
114102|NCT00948766|420153|P2|Core Study|Death|1
114103|NCT00948766|420154|P1|Core Study|Death|1
114104|NCT00948766|420153|P2|Core Study|Administrative Problems|2
114105|NCT00948766|420154|P1|Core Study|Administrative Problems|2
114106|NCT00948766|420153|P2|Core Study|Lost to Follow-up|2
114107|NCT00948766|420154|P1|Core Study|Lost to Follow-up|3
114108|NCT00948766|420153|P2|Core Study|Patient Withdrew Consent|46
114109|NCT00948766|420154|P1|Core Study|Patient Withdrew Consent|27
114110|NCT00948766|420153|P2|Core Study|Unsatisfactory Therapeutic Effect|14
114111|NCT00948766|420154|P1|Core Study|Unsatisfactory Therapeutic Effect|13
114112|NCT00948766|420153|P2|Core Study|Adverse Event|51
114113|NCT00948766|420154|P1|Core Study|Adverse Event|73
114114|NCT00948688|420170|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
114115|NCT00948688|420171|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
114116|NCT00948688|420170|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
114117|NCT00948688|420171|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
114118|NCT00948688|420170|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
114119|NCT00948688|420171|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
114120|NCT00948675|420185|P2|Overall Study|Treatment ongoing|4
114121|NCT00948675|420186|P1|Overall Study|Treatment ongoing|5
114122|NCT00948675|420185|P2|Overall Study|Lost to Follow-up|0
114123|NCT00948675|420186|P1|Overall Study|Lost to Follow-up|2
114124|NCT00948506|420213|P2|Overall Study|Withdrawal by Subject|1
114125|NCT00948506|420214|P1|Overall Study|Withdrawal by Subject|3
114126|NCT00948441|420225|P2|Overall Study|no longer meet inclusion criteria|4
114127|NCT00948441|420226|P1|Overall Study|no longer meet inclusion criteria|1
114128|NCT00948389|420239|P5|Overall Study|Both Progression and Toxicity|0
114129|NCT00948389|420240|P4|Overall Study|Both Progression and Toxicity|0
114130|NCT00948389|420241|P3|Overall Study|Both Progression and Toxicity|0
114131|NCT00948389|420242|P2|Overall Study|Both Progression and Toxicity|0
114132|NCT00948389|420243|P1|Overall Study|Both Progression and Toxicity|1
114133|NCT00948389|420239|P5|Overall Study|Thrombocytopenia, Grade 4|0
114134|NCT00948389|420240|P4|Overall Study|Thrombocytopenia, Grade 4|1
114135|NCT00948389|420241|P3|Overall Study|Thrombocytopenia, Grade 4|0
114136|NCT00948389|420242|P2|Overall Study|Thrombocytopenia, Grade 4|0
114137|NCT00948389|420243|P1|Overall Study|Thrombocytopenia, Grade 4|2
114138|NCT00948389|420239|P5|Overall Study|Disease Progression/Relapse/Death|1
114139|NCT00948389|420240|P4|Overall Study|Disease Progression/Relapse/Death|8
114140|NCT00948389|420241|P3|Overall Study|Disease Progression/Relapse/Death|7
114141|NCT00948389|420242|P2|Overall Study|Disease Progression/Relapse/Death|3
114142|NCT00948389|420243|P1|Overall Study|Disease Progression/Relapse/Death|3
114143|NCT00948246|420280|P1|Overall Study|Withdrawal by Subject|1
114144|NCT00948246|420280|P1|Overall Study|Death|1
114145|NCT00948246|420280|P1|Overall Study|Adverse Event|11
114146|NCT00948246|420280|P1|Overall Study|Lost to Follow-up|11
114147|NCT00948155|420289|P2|Washout 14 Days|Lost to Follow-up|2
114148|NCT00948155|420290|P1|Washout 14 Days|Lost to Follow-up|1
114149|NCT00948155|420289|P2|First Intervention 21 Days|Lost to Follow-up|2
114150|NCT00948155|420290|P1|First Intervention 21 Days|Lost to Follow-up|2
114151|NCT00948064|420337|P3|Phase II|Withdrawal by Subject|0
114152|NCT00948064|420338|P2|Phase II|Withdrawal by Subject|1
114153|NCT00948064|420339|P1|Phase II|Withdrawal by Subject|0
114154|NCT00948064|420337|P3|Phase II|Physician Decision|1
114155|NCT00948064|420338|P2|Phase II|Physician Decision|0
114156|NCT00948064|420339|P1|Phase II|Physician Decision|0
114157|NCT00948064|420337|P3|Phase I|No treatment received|0
114158|NCT00948064|420338|P2|Phase I|No treatment received|0
114159|NCT00948064|420339|P1|Phase I|No treatment received|1
114160|NCT00947882|420354|P4|Overall Study|Trial Terminated by Sponsor|70
114161|NCT00947882|420355|P3|Overall Study|Trial Terminated by Sponsor|62
114162|NCT00947882|420356|P2|Overall Study|Trial Terminated by Sponsor|61
114163|NCT00947882|420357|P1|Overall Study|Trial Terminated by Sponsor|62
114164|NCT00947882|420354|P4|Overall Study|Other/Unknown|6
114165|NCT00947882|420355|P3|Overall Study|Other/Unknown|3
114166|NCT00947882|420356|P2|Overall Study|Other/Unknown|13
114167|NCT00947882|420357|P1|Overall Study|Other/Unknown|10
114168|NCT00947882|420354|P4|Overall Study|Lost to Follow-up|0
114169|NCT00947882|420355|P3|Overall Study|Lost to Follow-up|1
114170|NCT00947882|420356|P2|Overall Study|Lost to Follow-up|2
114171|NCT00947882|420357|P1|Overall Study|Lost to Follow-up|0
114172|NCT00947882|420354|P4|Overall Study|Protocol Violation|0
114173|NCT00947882|420355|P3|Overall Study|Protocol Violation|1
114174|NCT00947882|420356|P2|Overall Study|Protocol Violation|0
114175|NCT00947882|420357|P1|Overall Study|Protocol Violation|0
114176|NCT00947882|420354|P4|Overall Study|Withdrawal by Subject|2
114177|NCT00947882|420355|P3|Overall Study|Withdrawal by Subject|8
114178|NCT00947882|420356|P2|Overall Study|Withdrawal by Subject|0
114179|NCT00947882|420357|P1|Overall Study|Withdrawal by Subject|2
114180|NCT00947882|420354|P4|Overall Study|Adverse Event|4
114181|NCT00947882|420355|P3|Overall Study|Adverse Event|4
114182|NCT00947882|420356|P2|Overall Study|Adverse Event|1
114183|NCT00947882|420357|P1|Overall Study|Adverse Event|0
114184|NCT00947856|420385|P2|Follow-up Period|Withdrawal by Subject|0
114185|NCT00947856|420386|P1|Follow-up Period|Withdrawal by Subject|1
114186|NCT00947856|420385|P2|Follow-up Period|Patient unavailable for site visits|0
114187|NCT00947856|420386|P1|Follow-up Period|Patient unavailable for site visits|1
114188|NCT00947856|420385|P2|Follow-up Period|Lost to Follow-up|0
114189|NCT00947856|420386|P1|Follow-up Period|Lost to Follow-up|7
114190|NCT00947856|420385|P2|Follow-up Period|Re-enrolled for Retreatment|3
114191|NCT00947856|420386|P1|Follow-up Period|Re-enrolled for Retreatment|2
114192|NCT00947856|420385|P2|Follow-up Period|Study Stopped by Sponsor|20
114193|NCT00947856|420386|P1|Follow-up Period|Study Stopped by Sponsor|40
114194|NCT00947856|420385|P2|Treatment Period|Withdrawal by Subject|1
114195|NCT00947856|420386|P1|Treatment Period|Withdrawal by Subject|12
114196|NCT00947856|420385|P2|Treatment Period|Study Stopped by Sponsor|4
114197|NCT00947856|420386|P1|Treatment Period|Study Stopped by Sponsor|4
114198|NCT00947856|420385|P2|Treatment Period|Physician Decision|6
114199|NCT00947856|420386|P1|Treatment Period|Physician Decision|14
114200|NCT00947856|420385|P2|Treatment Period|Adverse Event|9
114201|NCT00947856|420386|P1|Treatment Period|Adverse Event|15
114202|NCT00947856|420385|P2|Treatment Period|Progressive Disease|12
114203|NCT00947856|420386|P1|Treatment Period|Progressive Disease|33
114204|NCT00947544|420475|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
114205|NCT00947544|420476|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
114206|NCT00947531|420502|P2|Overall Study|Other|1
114207|NCT00947531|420503|P1|Overall Study|Other|1
114208|NCT00947531|420502|P2|Overall Study|Lack of Efficacy|0
114209|NCT00947531|420503|P1|Overall Study|Lack of Efficacy|1
114210|NCT00947531|420502|P2|Overall Study|Adverse Event|2
114211|NCT00947531|420503|P1|Overall Study|Adverse Event|2
114212|NCT00947531|420502|P2|Overall Study|Administrative Reason|1
114213|NCT00947531|420503|P1|Overall Study|Administrative Reason|0
114214|NCT00947531|420502|P2|Overall Study|Withdrawal by Subject|7
114215|NCT00947531|420503|P1|Overall Study|Withdrawal by Subject|10
114216|NCT00947427|420536|P2|Overall Study|Protocol Violation|1
114217|NCT00947427|420537|P1|Overall Study|Protocol Violation|0
114218|NCT00947427|420536|P2|Overall Study|Withdrawal by Subject|3
114219|NCT00947427|420537|P1|Overall Study|Withdrawal by Subject|1
114220|NCT00947349|420547|P4|Overall Study Standard of Care|not specified|1
114221|NCT00947349|420548|P3|Overall Study Standard of Care|not specified|0
114222|NCT00947349|420549|P2|Overall Study Standard of Care|not specified|0
114223|NCT00947349|420550|P1|Overall Study Standard of Care|not specified|0
114224|NCT00947349|420547|P4|Overall Study Standard of Care|Withdrawal by Subject|0
114225|NCT00947349|420548|P3|Overall Study Standard of Care|Withdrawal by Subject|1
114226|NCT00947349|420549|P2|Overall Study Standard of Care|Withdrawal by Subject|0
114227|NCT00947349|420550|P1|Overall Study Standard of Care|Withdrawal by Subject|0
114228|NCT00947349|420547|P4|Overall Study Standard of Care|Lack of Efficacy|1
114229|NCT00947349|420548|P3|Overall Study Standard of Care|Lack of Efficacy|1
114230|NCT00947349|420549|P2|Overall Study Standard of Care|Lack of Efficacy|0
114231|NCT00947349|420550|P1|Overall Study Standard of Care|Lack of Efficacy|0
114232|NCT00947349|420547|P4|Triple Treatment Combination Period|Adverse Event|0
114233|NCT00947349|420548|P3|Triple Treatment Combination Period|Adverse Event|0
114234|NCT00947349|420549|P2|Triple Treatment Combination Period|Adverse Event|1
114235|NCT00947349|420550|P1|Triple Treatment Combination Period|Adverse Event|0
114236|NCT00947154|420764|P1|Overall Study|Lost to Follow-up|1
114237|NCT00947115|420774|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
114238|NCT00947115|420775|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
114239|NCT00947115|420776|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
114240|NCT00947115|420774|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
114241|NCT00947115|420775|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
114242|NCT00947115|420776|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
114243|NCT00947115|420774|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
114244|NCT00947115|420775|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
114245|NCT00947115|420776|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
114246|NCT00947115|420774|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
114247|NCT00947115|420775|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
114248|NCT00947115|420776|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
114249|NCT00947115|420774|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
114250|NCT00947115|420775|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
114251|NCT00947115|420776|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
114252|NCT00947115|420774|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
114253|NCT00947115|420775|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
114254|NCT00947115|420776|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
114255|NCT00947011|420838|P1|Overall Study|Study was terminated,PI left institution|12
114256|NCT00946998|420848|P2|Overall Study|Exited prior to first outcome assessment|3
114257|NCT00946998|420849|P1|Overall Study|Exited prior to first outcome assessment|5
114258|NCT00946985|420863|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
114259|NCT00946985|420863|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
114260|NCT00946985|420863|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
114261|NCT00946985|420863|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
114262|NCT00946985|420863|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
114263|NCT00946985|420863|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
114264|NCT00946985|420863|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
114265|NCT00946985|420863|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
114266|NCT00946985|420863|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
114267|NCT00946920|420869|P2|Overall Study|Miscellaneous reasons|3
114268|NCT00946920|420870|P1|Overall Study|Miscellaneous reasons|18
114269|NCT00946920|420869|P2|Overall Study|Protocol Violation|8
114270|NCT00946920|420870|P1|Overall Study|Protocol Violation|16
114271|NCT00946920|420869|P2|Overall Study|Adverse Event|14
114272|NCT00946920|420870|P1|Overall Study|Adverse Event|41
114273|NCT00946920|420869|P2|Overall Study|Physician Decision|2
114274|NCT00946920|420870|P1|Overall Study|Physician Decision|5
114275|NCT00946920|420869|P2|Overall Study|Lost to Follow-up|2
114276|NCT00946920|420870|P1|Overall Study|Lost to Follow-up|2
114277|NCT00946920|420869|P2|Overall Study|Withdrawal by Subject|15
114278|NCT00946920|420870|P1|Overall Study|Withdrawal by Subject|28
114279|NCT00946881|420885|P1|Retreatment|Withdrawal by Subject|1
114280|NCT00946881|420885|P1|First Treatment|Patient relocated to another state|1
114281|NCT00946881|420885|P1|First Treatment|Withdrawal by Subject|1
114282|NCT00946530|420918|P4|Overall Study|Physician Decision|1
114283|NCT00946530|420919|P3|Overall Study|Physician Decision|1
114284|NCT00946530|420920|P2|Overall Study|Physician Decision|1
114285|NCT00946530|420921|P1|Overall Study|Physician Decision|1
114286|NCT00946530|420918|P4|Overall Study|Withdrawal by Subject|3
114287|NCT00946530|420919|P3|Overall Study|Withdrawal by Subject|0
114288|NCT00946530|420920|P2|Overall Study|Withdrawal by Subject|3
114289|NCT00946530|420921|P1|Overall Study|Withdrawal by Subject|0
114290|NCT00946322|420953|P1|Post-treatment|participant failure to follow up|2
114291|NCT00946322|420953|P1|Pre-treatment|participant failure to follow up|1
114292|NCT00946309|420966|P2|Overall Study|Procedure cancelled/discontinued|3
114293|NCT00946309|420967|P1|Overall Study|Procedure cancelled/discontinued|0
114294|NCT00946309|420966|P2|Overall Study|Lost to Follow-up|1
114295|NCT00946309|420967|P1|Overall Study|Lost to Follow-up|0
114296|NCT00946309|420966|P2|Overall Study|Protocol Violation|0
114297|NCT00946309|420967|P1|Overall Study|Protocol Violation|1
114298|NCT00946296|420985|P2|Overall Study|Physician Decision|0
114299|NCT00946296|420986|P1|Overall Study|Physician Decision|3
114300|NCT00946114|420994|P2|Overall Study|Withdrawal by Subject|0
114301|NCT00946114|420995|P1|Overall Study|Withdrawal by Subject|2
114302|NCT00946114|420994|P2|Overall Study|Other|0
114303|NCT00946114|420995|P1|Overall Study|Other|1
114304|NCT00946114|420994|P2|Overall Study|Death|2
114305|NCT00946114|420995|P1|Overall Study|Death|5
114306|NCT00946101|421003|P2|Overall Study|Physician Decision|1
114307|NCT00946101|421004|P1|Overall Study|Physician Decision|0
114308|NCT00946101|421003|P2|Overall Study|Withdrawal of consent|0
114309|NCT00946101|421004|P1|Overall Study|Withdrawal of consent|2
114310|NCT00946101|421003|P2|Overall Study|Lost to Follow-up|1
114311|NCT00946101|421004|P1|Overall Study|Lost to Follow-up|2
114312|NCT00946088|421070|P2|Overall Study|Withdrawal by Subject|1
114313|NCT00946088|421071|P1|Overall Study|Withdrawal by Subject|0
114314|NCT00945945|421100|P2|Overall Study|Entry Criteria Not Met|1
114315|NCT00945945|421101|P1|Overall Study|Entry Criteria Not Met|0
114316|NCT00945945|421100|P2|Overall Study|Protocol Violation|2
114317|NCT00945945|421101|P1|Overall Study|Protocol Violation|4
114318|NCT00945945|421100|P2|Overall Study|Lack of Efficacy|2
114319|NCT00945945|421101|P1|Overall Study|Lack of Efficacy|6
114320|NCT00945945|421100|P2|Overall Study|Lost to Follow-up|5
114321|NCT00945945|421101|P1|Overall Study|Lost to Follow-up|4
114322|NCT00945945|421100|P2|Overall Study|Withdrawal by Subject|10
114323|NCT00945945|421101|P1|Overall Study|Withdrawal by Subject|7
114324|NCT00945945|421100|P2|Overall Study|Adverse Event|35
114325|NCT00945945|421101|P1|Overall Study|Adverse Event|15
114326|NCT00945906|421127|P1|Overall Study|Moved to another country|2
114327|NCT00945906|421127|P1|Overall Study|Unable to return for last visit|2
114328|NCT00945906|421127|P1|Overall Study|Did not want to return for last visit|2
114329|NCT00945906|421127|P1|Overall Study|Withdrawal by Subject|1
114330|NCT00945893|421138|P2|Overall Study|Withdrawal of consent|2
114331|NCT00945893|421139|P1|Overall Study|Withdrawal of consent|1
114332|NCT00945893|421138|P2|Overall Study|Lost to Follow-up|8
114333|NCT00945893|421139|P1|Overall Study|Lost to Follow-up|2
114334|NCT00945815|421216|P1|Overall Study|Did not begin protocol therapy|1
114335|NCT00945815|421216|P1|Overall Study|Ineligible|3
114336|NCT00945815|421216|P1|Overall Study|Not protocol specified|1
114337|NCT00945815|421216|P1|Overall Study|Death|3
114338|NCT00945555|421245|P1|Overall Study|Other|1
114339|NCT00945555|421245|P1|Overall Study|Death|18
114340|NCT00945555|421245|P1|Overall Study|Participant continued treatment at home|1
114341|NCT00945555|421245|P1|Overall Study|Withdrawal by Subject|2
114342|NCT00945555|421245|P1|Overall Study|Worsening condition, intensive care unit|1
114343|NCT00945555|421245|P1|Overall Study|Referred to another hospital|5
114344|NCT00945477|421256|P1|Overall Study|Withdrawal by Subject|1
114345|NCT00945477|421256|P1|Overall Study|Lack of Efficacy|2
114346|NCT00945477|421256|P1|Overall Study|Adverse Event|3
114347|NCT00945321|421272|P6|Period 4|Lost to Follow-up|1
114348|NCT00945321|421273|P5|Period 4|Lost to Follow-up|0
114349|NCT00945321|421274|P4|Period 4|Lost to Follow-up|0
114350|NCT00945321|421275|P3|Period 4|Lost to Follow-up|0
114351|NCT00945321|421276|P2|Period 4|Lost to Follow-up|0
114352|NCT00945321|421277|P1|Period 4|Lost to Follow-up|0
114353|NCT00945321|421272|P6|Period 1|Adverse Event|0
114354|NCT00945321|421273|P5|Period 1|Adverse Event|1
114355|NCT00945321|421274|P4|Period 1|Adverse Event|0
114356|NCT00945321|421275|P3|Period 1|Adverse Event|0
114357|NCT00945321|421276|P2|Period 1|Adverse Event|0
114358|NCT00945321|421277|P1|Period 1|Adverse Event|0
114359|NCT00945243|421329|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
114360|NCT00944697|421486|P2|Overall Study|Administrative|1
114361|NCT00944697|421487|P1|Overall Study|Administrative|1
114362|NCT00944697|421486|P2|Overall Study|Adverse Event|3
114363|NCT00944697|421487|P1|Overall Study|Adverse Event|0
114364|NCT00944697|421486|P2|Overall Study|Withdrawal by Subject|1
114365|NCT00944697|421487|P1|Overall Study|Withdrawal by Subject|1
114366|NCT00944645|421517|P2|Period 2|Withdrawal by Subject|6
114367|NCT00944645|421518|P1|Period 2|Withdrawal by Subject|7
114368|NCT00944645|421517|P2|Period 2|Lost to Follow-up|3
114369|NCT00944645|421518|P1|Period 2|Lost to Follow-up|0
114370|NCT00944645|421517|P2|Period 2|Adverse Event|0
114371|NCT00944645|421518|P1|Period 2|Adverse Event|1
114372|NCT00944229|421548|P1|Overall Study|Physician Decision|14
114373|NCT00944229|421548|P1|Overall Study|Withdrawal by Subject|11
114374|NCT00944125|421554|P2|6 Months to Study Completion|Withdrawal by Subject|2
114375|NCT00944125|421555|P1|6 Months to Study Completion|Withdrawal by Subject|0
114376|NCT00944125|421554|P2|3 to 6 Months|Withdrawal by Subject|2
114377|NCT00944125|421555|P1|3 to 6 Months|Withdrawal by Subject|0
114378|NCT00944034|421658|P12|Overall Study|Administrative reason|0
114379|NCT00944034|421659|P11|Overall Study|Administrative reason|0
114380|NCT00944034|421660|P10|Overall Study|Administrative reason|0
114381|NCT00944034|421661|P9|Overall Study|Administrative reason|0
114382|NCT00944034|421662|P8|Overall Study|Administrative reason|0
114383|NCT00944034|421663|P7|Overall Study|Administrative reason|1
114384|NCT00944034|421664|P6|Overall Study|Administrative reason|0
114385|NCT00944034|421665|P5|Overall Study|Administrative reason|0
114386|NCT00944034|421666|P4|Overall Study|Administrative reason|0
114387|NCT00944034|421667|P3|Overall Study|Administrative reason|0
114388|NCT00944034|421668|P2|Overall Study|Administrative reason|0
114389|NCT00944034|421669|P1|Overall Study|Administrative reason|0
114390|NCT00944034|421658|P12|Overall Study|Unable to classify|0
114391|NCT00944034|421659|P11|Overall Study|Unable to classify|0
114392|NCT00944034|421660|P10|Overall Study|Unable to classify|0
114393|NCT00944034|421661|P9|Overall Study|Unable to classify|0
114394|NCT00944034|421662|P8|Overall Study|Unable to classify|1
114395|NCT00944034|421663|P7|Overall Study|Unable to classify|1
114396|NCT00944034|421664|P6|Overall Study|Unable to classify|1
114397|NCT00944034|421665|P5|Overall Study|Unable to classify|0
114398|NCT00944034|421666|P4|Overall Study|Unable to classify|0
114399|NCT00944034|421667|P3|Overall Study|Unable to classify|0
114400|NCT00944034|421668|P2|Overall Study|Unable to classify|0
114401|NCT00944034|421669|P1|Overall Study|Unable to classify|0
114402|NCT00944034|421658|P12|Overall Study|Protocol Violation|0
114403|NCT00944034|421659|P11|Overall Study|Protocol Violation|0
114404|NCT00944034|421660|P10|Overall Study|Protocol Violation|4
114405|NCT00944034|421661|P9|Overall Study|Protocol Violation|1
114406|NCT00944034|421662|P8|Overall Study|Protocol Violation|1
114407|NCT00944034|421663|P7|Overall Study|Protocol Violation|0
114408|NCT00944034|421664|P6|Overall Study|Protocol Violation|3
114409|NCT00944034|421665|P5|Overall Study|Protocol Violation|2
114410|NCT00944034|421666|P4|Overall Study|Protocol Violation|1
114411|NCT00944034|421667|P3|Overall Study|Protocol Violation|0
114412|NCT00944034|421668|P2|Overall Study|Protocol Violation|0
114413|NCT00944034|421669|P1|Overall Study|Protocol Violation|2
114414|NCT00944034|421658|P12|Overall Study|Death|0
114415|NCT00944034|421659|P11|Overall Study|Death|0
114416|NCT00944034|421660|P10|Overall Study|Death|0
114417|NCT00944034|421661|P9|Overall Study|Death|0
114418|NCT00944034|421662|P8|Overall Study|Death|0
114419|NCT00944034|421663|P7|Overall Study|Death|0
114420|NCT00944034|421664|P6|Overall Study|Death|0
114421|NCT00944034|421665|P5|Overall Study|Death|0
114422|NCT00944034|421666|P4|Overall Study|Death|0
114423|NCT00944034|421667|P3|Overall Study|Death|1
114424|NCT00944034|421668|P2|Overall Study|Death|0
114425|NCT00944034|421669|P1|Overall Study|Death|0
114426|NCT00944034|421658|P12|Overall Study|Lost to Follow-up|0
114427|NCT00944034|421659|P11|Overall Study|Lost to Follow-up|1
114428|NCT00944034|421660|P10|Overall Study|Lost to Follow-up|1
114429|NCT00944034|421661|P9|Overall Study|Lost to Follow-up|5
114430|NCT00944034|421662|P8|Overall Study|Lost to Follow-up|1
114431|NCT00944034|421663|P7|Overall Study|Lost to Follow-up|0
114432|NCT00944034|421664|P6|Overall Study|Lost to Follow-up|7
114433|NCT00944034|421665|P5|Overall Study|Lost to Follow-up|5
114434|NCT00944034|421666|P4|Overall Study|Lost to Follow-up|0
114435|NCT00944034|421667|P3|Overall Study|Lost to Follow-up|2
114436|NCT00944034|421668|P2|Overall Study|Lost to Follow-up|4
114437|NCT00944034|421669|P1|Overall Study|Lost to Follow-up|0
114438|NCT00944034|421658|P12|Overall Study|Withdrawal by Subject|4
114439|NCT00944034|421659|P11|Overall Study|Withdrawal by Subject|0
114440|NCT00944034|421660|P10|Overall Study|Withdrawal by Subject|4
114441|NCT00944034|421661|P9|Overall Study|Withdrawal by Subject|3
114442|NCT00944034|421662|P8|Overall Study|Withdrawal by Subject|2
114443|NCT00944034|421663|P7|Overall Study|Withdrawal by Subject|2
114444|NCT00944034|421664|P6|Overall Study|Withdrawal by Subject|8
114445|NCT00944034|421665|P5|Overall Study|Withdrawal by Subject|5
114446|NCT00944034|421666|P4|Overall Study|Withdrawal by Subject|2
114447|NCT00944034|421667|P3|Overall Study|Withdrawal by Subject|6
114448|NCT00944034|421668|P2|Overall Study|Withdrawal by Subject|2
114449|NCT00944034|421669|P1|Overall Study|Withdrawal by Subject|3
114450|NCT00944034|421658|P12|Overall Study|Inappropriate enrollment|0
114451|NCT00944034|421659|P11|Overall Study|Inappropriate enrollment|0
114452|NCT00944034|421660|P10|Overall Study|Inappropriate enrollment|1
114453|NCT00944034|421661|P9|Overall Study|Inappropriate enrollment|1
114454|NCT00944034|421662|P8|Overall Study|Inappropriate enrollment|0
114455|NCT00944034|421663|P7|Overall Study|Inappropriate enrollment|0
114456|NCT00944034|421664|P6|Overall Study|Inappropriate enrollment|1
114457|NCT00944034|421665|P5|Overall Study|Inappropriate enrollment|2
114458|NCT00944034|421666|P4|Overall Study|Inappropriate enrollment|1
114459|NCT00944034|421667|P3|Overall Study|Inappropriate enrollment|0
114460|NCT00944034|421668|P2|Overall Study|Inappropriate enrollment|1
114461|NCT00944034|421669|P1|Overall Study|Inappropriate enrollment|0
114462|NCT00943917|421815|P15|Stage II Continuation|A1C elevation|0
114463|NCT00943917|421816|P14|Stage II Continuation|A1C elevation|1
114464|NCT00943917|421817|P13|Stage II Continuation|A1C elevation|0
114465|NCT00943917|421818|P12|Stage II Continuation|A1C elevation|0
114466|NCT00943917|421819|P11|Stage II Continuation|A1C elevation|0
114467|NCT00943917|421820|P10|Stage II Continuation|A1C elevation|0
114468|NCT00943917|421821|P9|Stage II Continuation|A1C elevation|0
114469|NCT00943917|421822|P8|Stage II Continuation|A1C elevation|0
114470|NCT00943917|421823|P7|Stage II Continuation|A1C elevation|0
114471|NCT00943917|421824|P6|Stage II Continuation|A1C elevation|0
114472|NCT00943917|421825|P5|Stage II Continuation|A1C elevation|0
114473|NCT00943917|421826|P4|Stage II Continuation|A1C elevation|0
114474|NCT00943917|421827|P3|Stage II Continuation|A1C elevation|0
114475|NCT00943917|421828|P2|Stage II Continuation|A1C elevation|0
114476|NCT00943917|421829|P1|Stage II Continuation|A1C elevation|0
114477|NCT00943917|421815|P15|Stage II Continuation|hypoglycemia|0
114478|NCT00943917|421816|P14|Stage II Continuation|hypoglycemia|0
114479|NCT00943917|421817|P13|Stage II Continuation|hypoglycemia|1
114480|NCT00943917|421818|P12|Stage II Continuation|hypoglycemia|0
114481|NCT00943917|421819|P11|Stage II Continuation|hypoglycemia|0
114482|NCT00943917|421820|P10|Stage II Continuation|hypoglycemia|0
114483|NCT00943917|421821|P9|Stage II Continuation|hypoglycemia|0
114484|NCT00943917|421822|P8|Stage II Continuation|hypoglycemia|0
114485|NCT00943917|421823|P7|Stage II Continuation|hypoglycemia|0
114486|NCT00943917|421824|P6|Stage II Continuation|hypoglycemia|0
114487|NCT00943917|421825|P5|Stage II Continuation|hypoglycemia|0
114488|NCT00943917|421826|P4|Stage II Continuation|hypoglycemia|0
114489|NCT00943917|421827|P3|Stage II Continuation|hypoglycemia|0
114490|NCT00943917|421828|P2|Stage II Continuation|hypoglycemia|0
114491|NCT00943917|421829|P1|Stage II Continuation|hypoglycemia|0
114492|NCT00943917|421815|P15|Stage II Continuation|Protocol Violation|0
114493|NCT00943917|421816|P14|Stage II Continuation|Protocol Violation|0
114494|NCT00943917|421817|P13|Stage II Continuation|Protocol Violation|0
114495|NCT00943917|421818|P12|Stage II Continuation|Protocol Violation|1
114496|NCT00943917|421819|P11|Stage II Continuation|Protocol Violation|0
114497|NCT00943917|421820|P10|Stage II Continuation|Protocol Violation|1
114498|NCT00943917|421821|P9|Stage II Continuation|Protocol Violation|0
114499|NCT00943917|421822|P8|Stage II Continuation|Protocol Violation|0
114500|NCT00943917|421823|P7|Stage II Continuation|Protocol Violation|0
114501|NCT00943917|421824|P6|Stage II Continuation|Protocol Violation|0
114502|NCT00943917|421825|P5|Stage II Continuation|Protocol Violation|0
114503|NCT00943917|421826|P4|Stage II Continuation|Protocol Violation|0
114504|NCT00943917|421827|P3|Stage II Continuation|Protocol Violation|0
114505|NCT00943917|421828|P2|Stage II Continuation|Protocol Violation|0
114506|NCT00943917|421829|P1|Stage II Continuation|Protocol Violation|0
114507|NCT00943917|421815|P15|Stage II Continuation|Withdrawal by Subject|3
114508|NCT00943917|421816|P14|Stage II Continuation|Withdrawal by Subject|1
114509|NCT00943917|421817|P13|Stage II Continuation|Withdrawal by Subject|0
114510|NCT00943917|421818|P12|Stage II Continuation|Withdrawal by Subject|0
114511|NCT00943917|421819|P11|Stage II Continuation|Withdrawal by Subject|0
114512|NCT00943917|421820|P10|Stage II Continuation|Withdrawal by Subject|0
114513|NCT00943917|421821|P9|Stage II Continuation|Withdrawal by Subject|0
114514|NCT00943917|421822|P8|Stage II Continuation|Withdrawal by Subject|0
114515|NCT00943917|421823|P7|Stage II Continuation|Withdrawal by Subject|0
114516|NCT00943917|421824|P6|Stage II Continuation|Withdrawal by Subject|0
114517|NCT00943917|421825|P5|Stage II Continuation|Withdrawal by Subject|0
114518|NCT00943917|421826|P4|Stage II Continuation|Withdrawal by Subject|0
114519|NCT00943917|421827|P3|Stage II Continuation|Withdrawal by Subject|0
114520|NCT00943917|421828|P2|Stage II Continuation|Withdrawal by Subject|0
114521|NCT00943917|421829|P1|Stage II Continuation|Withdrawal by Subject|0
114522|NCT00943917|421815|P15|Stage II Continuation|Adverse Event|1
114523|NCT00943917|421816|P14|Stage II Continuation|Adverse Event|1
114524|NCT00943917|421817|P13|Stage II Continuation|Adverse Event|2
114525|NCT00943917|421818|P12|Stage II Continuation|Adverse Event|1
114526|NCT00943917|421819|P11|Stage II Continuation|Adverse Event|0
114527|NCT00943917|421820|P10|Stage II Continuation|Adverse Event|0
114528|NCT00943917|421821|P9|Stage II Continuation|Adverse Event|0
114529|NCT00943917|421822|P8|Stage II Continuation|Adverse Event|0
114530|NCT00943917|421823|P7|Stage II Continuation|Adverse Event|0
114531|NCT00943917|421824|P6|Stage II Continuation|Adverse Event|0
114532|NCT00943917|421825|P5|Stage II Continuation|Adverse Event|0
114533|NCT00943917|421826|P4|Stage II Continuation|Adverse Event|0
114534|NCT00943917|421827|P3|Stage II Continuation|Adverse Event|0
114535|NCT00943917|421828|P2|Stage II Continuation|Adverse Event|0
114536|NCT00943917|421829|P1|Stage II Continuation|Adverse Event|0
114537|NCT00943917|421815|P15|Stage II|Pregnancy|0
114538|NCT00943917|421816|P14|Stage II|Pregnancy|0
114539|NCT00943917|421817|P13|Stage II|Pregnancy|0
114540|NCT00943917|421818|P12|Stage II|Pregnancy|0
114541|NCT00943917|421819|P11|Stage II|Pregnancy|0
114542|NCT00943917|421820|P10|Stage II|Pregnancy|0
114543|NCT00943917|421821|P9|Stage II|Pregnancy|0
114544|NCT00943917|421822|P8|Stage II|Pregnancy|0
114545|NCT00943917|421823|P7|Stage II|Pregnancy|0
114546|NCT00943917|421824|P6|Stage II|Pregnancy|1
114547|NCT00943917|421825|P5|Stage II|Pregnancy|0
114548|NCT00943917|421826|P4|Stage II|Pregnancy|0
114549|NCT00943917|421827|P3|Stage II|Pregnancy|0
114550|NCT00943917|421828|P2|Stage II|Pregnancy|0
114551|NCT00943917|421829|P1|Stage II|Pregnancy|0
114552|NCT00943917|421815|P15|Stage II|Withdrawal by Subject|0
114553|NCT00943917|421816|P14|Stage II|Withdrawal by Subject|0
114554|NCT00943917|421817|P13|Stage II|Withdrawal by Subject|0
114555|NCT00943917|421818|P12|Stage II|Withdrawal by Subject|0
114556|NCT00943917|421819|P11|Stage II|Withdrawal by Subject|0
114557|NCT00943917|421820|P10|Stage II|Withdrawal by Subject|0
114558|NCT00943917|421821|P9|Stage II|Withdrawal by Subject|0
114559|NCT00943917|421822|P8|Stage II|Withdrawal by Subject|0
114560|NCT00943917|421823|P7|Stage II|Withdrawal by Subject|0
114561|NCT00943917|421824|P6|Stage II|Withdrawal by Subject|1
114562|NCT00943917|421825|P5|Stage II|Withdrawal by Subject|0
114563|NCT00943917|421826|P4|Stage II|Withdrawal by Subject|0
114564|NCT00943917|421827|P3|Stage II|Withdrawal by Subject|0
114565|NCT00943917|421828|P2|Stage II|Withdrawal by Subject|0
114566|NCT00943917|421829|P1|Stage II|Withdrawal by Subject|0
114567|NCT00943917|421815|P15|Stage II|Adverse Event|0
114568|NCT00943917|421816|P14|Stage II|Adverse Event|0
114569|NCT00943917|421817|P13|Stage II|Adverse Event|0
114570|NCT00943917|421818|P12|Stage II|Adverse Event|0
114571|NCT00943917|421819|P11|Stage II|Adverse Event|0
114572|NCT00943917|421820|P10|Stage II|Adverse Event|0
114573|NCT00943917|421821|P9|Stage II|Adverse Event|1
114574|NCT00943917|421822|P8|Stage II|Adverse Event|0
114575|NCT00943917|421823|P7|Stage II|Adverse Event|3
114576|NCT00943917|421824|P6|Stage II|Adverse Event|1
114577|NCT00943917|421825|P5|Stage II|Adverse Event|0
114578|NCT00943917|421826|P4|Stage II|Adverse Event|0
114579|NCT00943917|421827|P3|Stage II|Adverse Event|0
114580|NCT00943917|421828|P2|Stage II|Adverse Event|0
114581|NCT00943917|421829|P1|Stage II|Adverse Event|0
114582|NCT00943917|421815|P15|Stage I|Withdrawal by Subject|0
114583|NCT00943917|421816|P14|Stage I|Withdrawal by Subject|0
114584|NCT00943917|421817|P13|Stage I|Withdrawal by Subject|0
114585|NCT00943917|421818|P12|Stage I|Withdrawal by Subject|0
114586|NCT00943917|421819|P11|Stage I|Withdrawal by Subject|0
114587|NCT00943917|421820|P10|Stage I|Withdrawal by Subject|0
114588|NCT00943917|421821|P9|Stage I|Withdrawal by Subject|0
114589|NCT00943917|421822|P8|Stage I|Withdrawal by Subject|0
114590|NCT00943917|421823|P7|Stage I|Withdrawal by Subject|0
114591|NCT00943917|421824|P6|Stage I|Withdrawal by Subject|0
114592|NCT00943917|421825|P5|Stage I|Withdrawal by Subject|0
114593|NCT00943917|421826|P4|Stage I|Withdrawal by Subject|0
114594|NCT00943917|421827|P3|Stage I|Withdrawal by Subject|2
114595|NCT00943917|421828|P2|Stage I|Withdrawal by Subject|1
114596|NCT00943917|421829|P1|Stage I|Withdrawal by Subject|2
114597|NCT00943917|421815|P15|Stage I|A1C elevation|0
114598|NCT00943917|421816|P14|Stage I|A1C elevation|0
114599|NCT00943917|421817|P13|Stage I|A1C elevation|0
114600|NCT00943917|421818|P12|Stage I|A1C elevation|0
114601|NCT00943917|421819|P11|Stage I|A1C elevation|0
114602|NCT00943917|421820|P10|Stage I|A1C elevation|0
114603|NCT00943917|421821|P9|Stage I|A1C elevation|0
114604|NCT00943917|421822|P8|Stage I|A1C elevation|0
114605|NCT00943917|421823|P7|Stage I|A1C elevation|0
114606|NCT00943917|421824|P6|Stage I|A1C elevation|0
114607|NCT00943917|421825|P5|Stage I|A1C elevation|0
114608|NCT00943917|421826|P4|Stage I|A1C elevation|0
114609|NCT00943917|421827|P3|Stage I|A1C elevation|0
114610|NCT00943917|421828|P2|Stage I|A1C elevation|0
114611|NCT00943917|421829|P1|Stage I|A1C elevation|1
114612|NCT00943917|421815|P15|Stage I|hyperglycemia|0
114613|NCT00943917|421816|P14|Stage I|hyperglycemia|0
114614|NCT00943917|421817|P13|Stage I|hyperglycemia|0
114615|NCT00943917|421818|P12|Stage I|hyperglycemia|0
114616|NCT00943917|421819|P11|Stage I|hyperglycemia|0
114617|NCT00943917|421820|P10|Stage I|hyperglycemia|0
114618|NCT00943917|421821|P9|Stage I|hyperglycemia|0
114619|NCT00943917|421822|P8|Stage I|hyperglycemia|0
114620|NCT00943917|421823|P7|Stage I|hyperglycemia|0
114621|NCT00943917|421824|P6|Stage I|hyperglycemia|0
114622|NCT00943917|421825|P5|Stage I|hyperglycemia|0
114623|NCT00943917|421826|P4|Stage I|hyperglycemia|0
114624|NCT00943917|421827|P3|Stage I|hyperglycemia|1
114625|NCT00943917|421828|P2|Stage I|hyperglycemia|0
114626|NCT00943917|421829|P1|Stage I|hyperglycemia|0
114627|NCT00943917|421815|P15|Stage I|Lost to Follow-up|0
114628|NCT00943917|421816|P14|Stage I|Lost to Follow-up|0
114629|NCT00943917|421817|P13|Stage I|Lost to Follow-up|0
114630|NCT00943917|421818|P12|Stage I|Lost to Follow-up|0
114631|NCT00943917|421819|P11|Stage I|Lost to Follow-up|0
114632|NCT00943917|421820|P10|Stage I|Lost to Follow-up|0
114633|NCT00943917|421821|P9|Stage I|Lost to Follow-up|0
114634|NCT00943917|421822|P8|Stage I|Lost to Follow-up|0
114635|NCT00943917|421823|P7|Stage I|Lost to Follow-up|0
114636|NCT00943917|421824|P6|Stage I|Lost to Follow-up|0
114637|NCT00943917|421825|P5|Stage I|Lost to Follow-up|0
114638|NCT00943917|421826|P4|Stage I|Lost to Follow-up|0
114639|NCT00943917|421827|P3|Stage I|Lost to Follow-up|1
114640|NCT00943917|421828|P2|Stage I|Lost to Follow-up|0
114641|NCT00943917|421829|P1|Stage I|Lost to Follow-up|0
114642|NCT00943917|421815|P15|Stage I|Adverse Event|0
114643|NCT00943917|421816|P14|Stage I|Adverse Event|0
114644|NCT00943917|421817|P13|Stage I|Adverse Event|0
114645|NCT00943917|421818|P12|Stage I|Adverse Event|0
114646|NCT00943917|421819|P11|Stage I|Adverse Event|0
114647|NCT00943917|421820|P10|Stage I|Adverse Event|0
114648|NCT00943917|421821|P9|Stage I|Adverse Event|0
114649|NCT00943917|421822|P8|Stage I|Adverse Event|0
114650|NCT00943917|421823|P7|Stage I|Adverse Event|0
114651|NCT00943917|421824|P6|Stage I|Adverse Event|0
114652|NCT00943917|421825|P5|Stage I|Adverse Event|0
114653|NCT00943917|421826|P4|Stage I|Adverse Event|0
114654|NCT00943917|421827|P3|Stage I|Adverse Event|2
114655|NCT00943917|421828|P2|Stage I|Adverse Event|2
114656|NCT00943917|421829|P1|Stage I|Adverse Event|1
114657|NCT00943852|422005|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
114658|NCT00943852|422006|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
114659|NCT00943852|422007|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
114660|NCT00943852|422008|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
114661|NCT00943852|422009|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
114662|NCT00943852|422010|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
114663|NCT00943852|422011|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
114664|NCT00943852|422012|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
114665|NCT00943852|422013|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
114666|NCT00943852|422014|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
114667|NCT00943852|422005|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
114668|NCT00943852|422006|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
114669|NCT00943852|422007|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
114670|NCT00943852|422008|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
114671|NCT00943852|422009|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
114672|NCT00943852|422010|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
114673|NCT00943852|422011|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
114674|NCT00943852|422012|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
114675|NCT00943852|422013|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
114676|NCT00943852|422014|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
114677|NCT00943852|422005|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
114678|NCT00943852|422006|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
114679|NCT00943852|422007|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
114680|NCT00943852|422008|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
114681|NCT00943852|422009|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
114682|NCT00943852|422010|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
114683|NCT00943852|422011|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
114684|NCT00943852|422012|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
114685|NCT00943852|422013|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
114686|NCT00943852|422014|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
114687|NCT00943852|422005|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
114688|NCT00943852|422006|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
114689|NCT00943852|422007|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
114690|NCT00943852|422008|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
114691|NCT00943852|422009|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
114692|NCT00943852|422010|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
114693|NCT00943852|422011|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
114694|NCT00943852|422012|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
114695|NCT00943852|422013|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
114696|NCT00943852|422014|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
114697|NCT00943852|422005|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
114698|NCT00943852|422006|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
114699|NCT00943852|422007|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
114700|NCT00943852|422008|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
114701|NCT00943852|422009|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
114702|NCT00943852|422010|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
114703|NCT00943852|422011|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
114704|NCT00943852|422012|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
114705|NCT00943852|422013|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
114706|NCT00943852|422014|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
114707|NCT00943826|422027|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
114708|NCT00943826|422028|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
114709|NCT00943826|422027|P2|After Primary Overall Survival Analysis|Progression of Disease|4
114710|NCT00943826|422028|P1|After Primary Overall Survival Analysis|Progression of Disease|2
114711|NCT00943826|422027|P2|After Primary Overall Survival Analysis|Administrative reasons|16
114712|NCT00943826|422028|P1|After Primary Overall Survival Analysis|Administrative reasons|10
114713|NCT00943826|422027|P2|After Primary Overall Survival Analysis|Adverse Event|0
114714|NCT00943826|422028|P1|After Primary Overall Survival Analysis|Adverse Event|11
114715|NCT00943826|422027|P2|Monotherapy Phase|Failure to return|1
114716|NCT00943826|422028|P1|Monotherapy Phase|Failure to return|2
114717|NCT00943826|422027|P2|Monotherapy Phase|Withdrew Consent|3
114718|NCT00943826|422028|P1|Monotherapy Phase|Withdrew Consent|2
114719|NCT00943826|422027|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
114720|NCT00943826|422028|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
114721|NCT00943826|422027|P2|Monotherapy Phase|Administrative reasons|5
114722|NCT00943826|422028|P1|Monotherapy Phase|Administrative reasons|11
114723|NCT00943826|422027|P2|Monotherapy Phase|Adverse Event|5
114724|NCT00943826|422028|P1|Monotherapy Phase|Adverse Event|42
114725|NCT00943826|422027|P2|Maintenance Phase|Failure to return|1
114726|NCT00943826|422028|P1|Maintenance Phase|Failure to return|0
114727|NCT00943826|422027|P2|Maintenance Phase|Administrative reasons|1
114728|NCT00943826|422028|P1|Maintenance Phase|Administrative reasons|4
114729|NCT00943826|422027|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
114730|NCT00943826|422028|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
114731|NCT00943826|422027|P2|Maintenance Phase|Withdrew consent|4
114732|NCT00943826|422028|P1|Maintenance Phase|Withdrew consent|2
114733|NCT00943826|422027|P2|Maintenance Phase|Adverse Event|30
114734|NCT00943826|422028|P1|Maintenance Phase|Adverse Event|31
114735|NCT00943826|422027|P2|Concurrent Phase|Protocol Violation|0
114736|NCT00943826|422028|P1|Concurrent Phase|Protocol Violation|1
114737|NCT00943826|422027|P2|Concurrent Phase|Administrative reasons|1
114738|NCT00943826|422028|P1|Concurrent Phase|Administrative reasons|2
114739|NCT00943826|422027|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
114740|NCT00943826|422028|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
114741|NCT00943826|422027|P2|Concurrent Phase|Withdrew consent|7
114742|NCT00943826|422028|P1|Concurrent Phase|Withdrew consent|3
114743|NCT00943826|422027|P2|Concurrent Phase|Adverse Event|27
114744|NCT00943826|422028|P1|Concurrent Phase|Adverse Event|50
114745|NCT00943787|422046|P1|Overall Study|Withdrawal by Subject|3
114746|NCT00943787|422046|P1|Overall Study|Physician Decision|4
114747|NCT00943761|422053|P2|Overall Study|Withdrawal by Subject|1
114748|NCT00943761|422054|P1|Overall Study|Withdrawal by Subject|2
114749|NCT00943761|422053|P2|Overall Study|Lost to Follow-up|0
114750|NCT00943761|422054|P1|Overall Study|Lost to Follow-up|2
114751|NCT00943735|422066|P1|Overall Study|Other|3
114752|NCT00943735|422066|P1|Overall Study|Other|8
114753|NCT00943735|422066|P1|Overall Study|Death|1
114754|NCT00943735|422066|P1|Overall Study|Withdrawal by Subject|8
114755|NCT00943735|422066|P1|Overall Study|Adverse Event|12
114756|NCT00943722|422104|P5|Overall Study|Withdrawal by Subject|8
114757|NCT00943722|422105|P4|Overall Study|Withdrawal by Subject|13
114758|NCT00943722|422106|P3|Overall Study|Withdrawal by Subject|2
114759|NCT00943722|422107|P2|Overall Study|Withdrawal by Subject|13
114760|NCT00943722|422108|P1|Overall Study|Withdrawal by Subject|12
114761|NCT00943722|422104|P5|Overall Study|Protocol Violation|2
114762|NCT00943722|422105|P4|Overall Study|Protocol Violation|0
114763|NCT00943722|422106|P3|Overall Study|Protocol Violation|0
114764|NCT00943722|422107|P2|Overall Study|Protocol Violation|1
114765|NCT00943722|422108|P1|Overall Study|Protocol Violation|0
114766|NCT00943722|422104|P5|Overall Study|Pregnancy|0
114767|NCT00943722|422105|P4|Overall Study|Pregnancy|0
114768|NCT00943722|422106|P3|Overall Study|Pregnancy|1
114769|NCT00943722|422107|P2|Overall Study|Pregnancy|0
114770|NCT00943722|422108|P1|Overall Study|Pregnancy|0
114771|NCT00943722|422104|P5|Overall Study|Physician Decision|1
114772|NCT00943722|422105|P4|Overall Study|Physician Decision|0
114773|NCT00943722|422106|P3|Overall Study|Physician Decision|0
114774|NCT00943722|422107|P2|Overall Study|Physician Decision|0
114775|NCT00943722|422108|P1|Overall Study|Physician Decision|1
114776|NCT00943722|422104|P5|Overall Study|Lost to Follow-up|11
114777|NCT00943722|422105|P4|Overall Study|Lost to Follow-up|8
114778|NCT00943722|422106|P3|Overall Study|Lost to Follow-up|10
114779|NCT00943722|422107|P2|Overall Study|Lost to Follow-up|8
114780|NCT00943722|422108|P1|Overall Study|Lost to Follow-up|12
114781|NCT00943722|422104|P5|Overall Study|Adverse Event|0
114782|NCT00943722|422105|P4|Overall Study|Adverse Event|1
114783|NCT00943722|422106|P3|Overall Study|Adverse Event|0
114784|NCT00943722|422107|P2|Overall Study|Adverse Event|0
114785|NCT00943722|422108|P1|Overall Study|Adverse Event|0
114786|NCT00943683|422138|P2|Overall Study|Patient Moved|0
114787|NCT00943683|422139|P1|Overall Study|Patient Moved|1
114788|NCT00943683|422138|P2|Overall Study|Withdrawal by Subject|0
114789|NCT00943683|422139|P1|Overall Study|Withdrawal by Subject|1
114790|NCT00943683|422138|P2|Overall Study|Protocol Violation|2
114791|NCT00943683|422139|P1|Overall Study|Protocol Violation|1
114792|NCT00943683|422138|P2|Overall Study|Lost to Follow-up|1
114793|NCT00943683|422139|P1|Overall Study|Lost to Follow-up|1
114794|NCT00943683|422138|P2|Overall Study|Adverse Event|3
114795|NCT00943683|422139|P1|Overall Study|Adverse Event|3
114796|NCT00943670|422145|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
114797|NCT00943670|422145|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
114798|NCT00943670|422145|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
114799|NCT00943670|422145|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
114800|NCT00943670|422145|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
114801|NCT00943670|422145|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
114802|NCT00943670|422145|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
114803|NCT00943670|422145|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
114804|NCT00943670|422145|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
114805|NCT00943670|422145|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
114806|NCT00943605|422234|P2|Overall Study|Study termination|30
114807|NCT00943605|422235|P1|Overall Study|Study termination|30
114808|NCT00943592|422245|P1|Overall Study|Death|3
114809|NCT00943579|422258|P2|Overall Study|Lack of Efficacy|2
114810|NCT00943579|422259|P1|Overall Study|Lack of Efficacy|2
114811|NCT00943579|422258|P2|Overall Study|Adverse Event|3
114812|NCT00943579|422259|P1|Overall Study|Adverse Event|4
114813|NCT00943397|422360|P2|Overall Study|Site terminated and other|56
114814|NCT00943397|422361|P1|Overall Study|Site terminated and other|12
114815|NCT00943397|422360|P2|Overall Study|Withdrawal by Subject|1
114816|NCT00943397|422361|P1|Overall Study|Withdrawal by Subject|1
114817|NCT00943397|422360|P2|Overall Study|Protocol Violation|5
114818|NCT00943397|422361|P1|Overall Study|Protocol Violation|2
114819|NCT00943397|422360|P2|Overall Study|Lost to Follow-up|4
114820|NCT00943397|422361|P1|Overall Study|Lost to Follow-up|0
114821|NCT00943397|422360|P2|Overall Study|Adverse Event|6
114822|NCT00943397|422361|P1|Overall Study|Adverse Event|0
114823|NCT00943384|422367|P1|Overall Study|Withdrawal by Subject|5
114824|NCT00943384|422367|P1|Overall Study|Lost to Follow-up|16
114825|NCT00943384|422367|P1|Overall Study|Treated off protocol-protocol violation|5
114826|NCT00943384|422367|P1|Overall Study|Dispositioned prior to treatment|23
114827|NCT00943306|422381|P1|Overall Study|Sponsor decision due to non-compliance|1
114828|NCT00943306|422381|P1|Overall Study|Death|1
114829|NCT00943306|422381|P1|Overall Study|Physician Decision|1
114830|NCT00943124|422683|P2|Period 1|Personal Reasons|1
114831|NCT00943124|422684|P1|Period 1|Personal Reasons|0
114832|NCT00943124|422683|P2|Period 1|Did Not Follow Study Procedures|0
114833|NCT00943124|422684|P1|Period 1|Did Not Follow Study Procedures|1
114834|NCT00943124|422683|P2|Period 1|Withdrawal by Subject|1
114835|NCT00943124|422684|P1|Period 1|Withdrawal by Subject|1
114836|NCT00943111|422706|P3|5 Years Long-term Treatment Period|Other than specified above|2
114837|NCT00943111|422707|P2|5 Years Long-term Treatment Period|Other than specified above|0
114838|NCT00943111|422708|P1|5 Years Long-term Treatment Period|Other than specified above|0
114839|NCT00943111|422706|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
114840|NCT00943111|422707|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
114841|NCT00943111|422708|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
114842|NCT00943111|422706|P3|5 Years Long-term Treatment Period|Pregnancy|4
114843|NCT00943111|422707|P2|5 Years Long-term Treatment Period|Pregnancy|0
114844|NCT00943111|422708|P1|5 Years Long-term Treatment Period|Pregnancy|0
114845|NCT00943111|422706|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
114846|NCT00943111|422707|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
114847|NCT00943111|422708|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
114848|NCT00943111|422706|P3|5 Years Long-term Treatment Period|Adverse Event|9
114849|NCT00943111|422707|P2|5 Years Long-term Treatment Period|Adverse Event|0
114850|NCT00943111|422708|P1|5 Years Long-term Treatment Period|Adverse Event|0
114851|NCT00943111|422706|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
114852|NCT00943111|422707|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
114853|NCT00943111|422708|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
114854|NCT00943111|422706|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
114855|NCT00943111|422707|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
114856|NCT00943111|422708|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
114857|NCT00943111|422706|P3|52-Weeks Primary Analysis Period|Adverse Event|0
114858|NCT00943111|422707|P2|52-Weeks Primary Analysis Period|Adverse Event|1
114859|NCT00943111|422708|P1|52-Weeks Primary Analysis Period|Adverse Event|2
114860|NCT00943072|422776|P2|Overall Study|Other|1
114861|NCT00943072|422777|P1|Overall Study|Other|1
114862|NCT00943072|422776|P2|Overall Study|Lack of Efficacy|4
114863|NCT00943072|422777|P1|Overall Study|Lack of Efficacy|0
114864|NCT00943072|422776|P2|Overall Study|Lost to Follow-up|2
114865|NCT00943072|422777|P1|Overall Study|Lost to Follow-up|1
114866|NCT00943072|422776|P2|Overall Study|Protocol Violation|1
114867|NCT00943072|422777|P1|Overall Study|Protocol Violation|0
114868|NCT00943072|422776|P2|Overall Study|Withdrawal by Subject|1
114869|NCT00943072|422777|P1|Overall Study|Withdrawal by Subject|3
114870|NCT00943072|422776|P2|Overall Study|Death|2
114871|NCT00943072|422777|P1|Overall Study|Death|0
114872|NCT00943072|422776|P2|Overall Study|Adverse Event|3
114873|NCT00943072|422777|P1|Overall Study|Adverse Event|0
114874|NCT00942994|422795|P2|Overall Study|Protocol deviation|2
114875|NCT00942994|422796|P1|Overall Study|Protocol deviation|1
114876|NCT00942994|422795|P2|Overall Study|Lost to Follow-up|4
114877|NCT00942994|422796|P1|Overall Study|Lost to Follow-up|1
114878|NCT00942994|422795|P2|Overall Study|Patient withdrew consent|8
114879|NCT00942994|422796|P1|Overall Study|Patient withdrew consent|5
114880|NCT00942994|422795|P2|Overall Study|Unsatisfactory therapeutic effect|1
114881|NCT00942994|422796|P1|Overall Study|Unsatisfactory therapeutic effect|1
114882|NCT00942994|422795|P2|Overall Study|Abnormal laboratory value(s)|0
114883|NCT00942994|422796|P1|Overall Study|Abnormal laboratory value(s)|1
114884|NCT00942994|422795|P2|Overall Study|Adverse Event|4
114885|NCT00942994|422796|P1|Overall Study|Adverse Event|7
114886|NCT00942968|422812|P1|Overall Study|Deep vein thrombosis (DVT)|2
114887|NCT00942968|422812|P1|Overall Study|Participant required pancreatic biopsy|1
114888|NCT00942968|422812|P1|Overall Study|Pulmonary embolism (PE)|1
114889|NCT00942968|422812|P1|Overall Study|Inferior vena cava filter placement|4
114890|NCT00942968|422812|P1|Overall Study|Progression of disease|12
114891|NCT00942968|422812|P1|Overall Study|Physician Decision|11
114892|NCT00942968|422812|P1|Overall Study|Sponsor request|5
114893|NCT00942968|422812|P1|Overall Study|Withdrawal by Subject|44
114894|NCT00942968|422812|P1|Overall Study|Lost to Follow-up|4
114895|NCT00942968|422812|P1|Overall Study|Protocol Violation|9
114896|NCT00942968|422812|P1|Overall Study|Death|76
114897|NCT00942968|422812|P1|Overall Study|Adverse Event|60
114898|NCT00942734|422890|P1|Overall Study|Physician Decision|1
114899|NCT00942734|422890|P1|Overall Study|Disease Progression|2
114900|NCT00942734|422890|P1|Overall Study|Protocol Violation|3
114901|NCT00942734|422890|P1|Overall Study|Adverse Event|2
114902|NCT00942604|422896|P2|Overall Study|Patient relocation|1
114903|NCT00942604|422897|P1|Overall Study|Patient relocation|1
114904|NCT00942604|422896|P2|Overall Study|Withdrawal by Subject|1
114905|NCT00942604|422897|P1|Overall Study|Withdrawal by Subject|0
114906|NCT00942604|422896|P2|Overall Study|Adverse Event|1
114907|NCT00942604|422897|P1|Overall Study|Adverse Event|0
114908|NCT00942604|422896|P2|Overall Study|Protocol Violation|1
114909|NCT00942604|422897|P1|Overall Study|Protocol Violation|1
114910|NCT00942422|422974|P1|Overall Study|Progressive diease|1
114911|NCT00942422|422974|P1|Overall Study|Death|1
114912|NCT00942422|422974|P1|Overall Study|Withdrawal by Subject|1
114913|NCT00942409|422978|P1|Overall Study|study drug unavailable|2
114914|NCT00942409|422978|P1|Overall Study|Lack of Efficacy|1
114915|NCT00942266|422984|P2|Overall Study|medical deterioration (pneumonia)|1
114916|NCT00942266|422985|P1|Overall Study|medical deterioration (pneumonia)|0
114917|NCT00942266|422984|P2|Overall Study|Physician Decision|0
114918|NCT00942266|422985|P1|Overall Study|Physician Decision|2
114919|NCT00942266|422984|P2|Overall Study|Intercurrent illness|1
114920|NCT00942266|422985|P1|Overall Study|Intercurrent illness|0
114921|NCT00942266|422984|P2|Overall Study|Failure to thrive and pt withdrawal|1
114922|NCT00942266|422985|P1|Overall Study|Failure to thrive and pt withdrawal|0
114923|NCT00942266|422984|P2|Overall Study|Disease Progression|11
114924|NCT00942266|422985|P1|Overall Study|Disease Progression|38
114925|NCT00942266|422984|P2|Overall Study|Adverse Event|1
114926|NCT00942266|422985|P1|Overall Study|Adverse Event|2
114927|NCT00942266|422984|P2|Overall Study|Withdrawal by Subject|0
114928|NCT00942266|422985|P1|Overall Study|Withdrawal by Subject|1
114929|NCT00942188|423007|P4|Overall Study|Sponsor Decision|1
114930|NCT00942188|423008|P3|Overall Study|Sponsor Decision|0
114931|NCT00942188|423009|P2|Overall Study|Sponsor Decision|2
114932|NCT00942188|423010|P1|Overall Study|Sponsor Decision|0
114933|NCT00942188|423007|P4|Overall Study|Physician Decision|0
114934|NCT00942188|423008|P3|Overall Study|Physician Decision|1
114935|NCT00942188|423009|P2|Overall Study|Physician Decision|0
114936|NCT00942188|423010|P1|Overall Study|Physician Decision|0
114937|NCT00942188|423007|P4|Overall Study|Withdrawal by Subject|2
114938|NCT00942188|423008|P3|Overall Study|Withdrawal by Subject|4
114939|NCT00942188|423009|P2|Overall Study|Withdrawal by Subject|3
114940|NCT00942188|423010|P1|Overall Study|Withdrawal by Subject|1
114941|NCT00942188|423007|P4|Overall Study|Lost to Follow-up|0
114942|NCT00942188|423008|P3|Overall Study|Lost to Follow-up|2
114943|NCT00942188|423009|P2|Overall Study|Lost to Follow-up|1
114944|NCT00942188|423010|P1|Overall Study|Lost to Follow-up|2
114945|NCT00942188|423007|P4|Overall Study|Protocol Violation|0
114946|NCT00942188|423008|P3|Overall Study|Protocol Violation|0
114947|NCT00942188|423009|P2|Overall Study|Protocol Violation|1
114948|NCT00942188|423010|P1|Overall Study|Protocol Violation|1
114949|NCT00942188|423007|P4|Overall Study|Lack of Efficacy|1
114950|NCT00942188|423008|P3|Overall Study|Lack of Efficacy|0
114951|NCT00942188|423009|P2|Overall Study|Lack of Efficacy|0
114952|NCT00942188|423010|P1|Overall Study|Lack of Efficacy|0
114953|NCT00942188|423007|P4|Overall Study|Adverse Event|0
114954|NCT00942188|423008|P3|Overall Study|Adverse Event|2
114955|NCT00942188|423009|P2|Overall Study|Adverse Event|3
114956|NCT00942188|423010|P1|Overall Study|Adverse Event|0
114957|NCT00942175|423049|P4|Overall Study|Low Platelet Count|0
114958|NCT00942175|423050|P3|Overall Study|Low Platelet Count|0
114959|NCT00942175|423051|P2|Overall Study|Low Platelet Count|2
114960|NCT00942175|423052|P1|Overall Study|Low Platelet Count|0
114961|NCT00942175|423049|P4|Overall Study|Elevated Alanine Amino Transferase|1
114962|NCT00942175|423050|P3|Overall Study|Elevated Alanine Amino Transferase|0
114963|NCT00942175|423051|P2|Overall Study|Elevated Alanine Amino Transferase|0
114964|NCT00942175|423052|P1|Overall Study|Elevated Alanine Amino Transferase|0
114965|NCT00942175|423049|P4|Overall Study|Pregnancy|1
114966|NCT00942175|423050|P3|Overall Study|Pregnancy|0
114967|NCT00942175|423051|P2|Overall Study|Pregnancy|0
114968|NCT00942175|423052|P1|Overall Study|Pregnancy|0
114969|NCT00942175|423049|P4|Overall Study|Protocol Violation|0
114970|NCT00942175|423050|P3|Overall Study|Protocol Violation|2
114971|NCT00942175|423051|P2|Overall Study|Protocol Violation|1
114972|NCT00942175|423052|P1|Overall Study|Protocol Violation|0
114973|NCT00942175|423049|P4|Overall Study|Adverse Event|0
114974|NCT00942175|423050|P3|Overall Study|Adverse Event|0
114975|NCT00942175|423051|P2|Overall Study|Adverse Event|1
114976|NCT00942175|423052|P1|Overall Study|Adverse Event|2
114977|NCT00942084|423106|P1|Overall Study|Death|2
114978|NCT00941928|423123|P1|Overall Study|Disease Progression|1
114979|NCT00941928|423123|P1|Overall Study|Withdrawal by Subject|1
114980|NCT00941863|423141|P5|Continued After PCD|Disease progression, recurrence, relapse|18
114981|NCT00941863|423142|P4|Continued After PCD|Disease progression, recurrence, relapse|0
114982|NCT00941863|423143|P3|Continued After PCD|Disease progression, recurrence, relapse|0
114983|NCT00941863|423144|P2|Continued After PCD|Disease progression, recurrence, relapse|0
114984|NCT00941863|423145|P1|Continued After PCD|Disease progression, recurrence, relapse|0
114985|NCT00941863|423141|P5|Continued After PCD|Withdrawal by Subject|1
114986|NCT00941863|423142|P4|Continued After PCD|Withdrawal by Subject|0
114987|NCT00941863|423143|P3|Continued After PCD|Withdrawal by Subject|0
114988|NCT00941863|423144|P2|Continued After PCD|Withdrawal by Subject|0
114989|NCT00941863|423145|P1|Continued After PCD|Withdrawal by Subject|0
114990|NCT00941863|423141|P5|Until Primary Completion Date (PCD)|Disease progression|73
114991|NCT00941863|423142|P4|Until Primary Completion Date (PCD)|Disease progression|14
114992|NCT00941863|423143|P3|Until Primary Completion Date (PCD)|Disease progression|8
114993|NCT00941863|423144|P2|Until Primary Completion Date (PCD)|Disease progression|1
114994|NCT00941863|423145|P1|Until Primary Completion Date (PCD)|Disease progression|6
114995|NCT00941863|423141|P5|Until Primary Completion Date (PCD)|Death|7
114996|NCT00941863|423142|P4|Until Primary Completion Date (PCD)|Death|2
114997|NCT00941863|423143|P3|Until Primary Completion Date (PCD)|Death|1
114998|NCT00941863|423144|P2|Until Primary Completion Date (PCD)|Death|0
114999|NCT00941863|423145|P1|Until Primary Completion Date (PCD)|Death|0
115000|NCT00941863|423141|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
115001|NCT00941863|423142|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
115002|NCT00941863|423143|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
115003|NCT00941863|423144|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
115004|NCT00941863|423145|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
115005|NCT00941863|423141|P5|Until Primary Completion Date (PCD)|Physician Decision|1
115006|NCT00941863|423142|P4|Until Primary Completion Date (PCD)|Physician Decision|0
115007|NCT00941863|423143|P3|Until Primary Completion Date (PCD)|Physician Decision|0
115008|NCT00941863|423144|P2|Until Primary Completion Date (PCD)|Physician Decision|0
115009|NCT00941863|423145|P1|Until Primary Completion Date (PCD)|Physician Decision|0
115010|NCT00941863|423141|P5|Until Primary Completion Date (PCD)|Adverse Event|5
115011|NCT00941863|423142|P4|Until Primary Completion Date (PCD)|Adverse Event|1
115012|NCT00941863|423143|P3|Until Primary Completion Date (PCD)|Adverse Event|2
115013|NCT00941863|423144|P2|Until Primary Completion Date (PCD)|Adverse Event|2
115014|NCT00941863|423145|P1|Until Primary Completion Date (PCD)|Adverse Event|1
115015|NCT00941798|423172|P2|Overall Study|Death|1
115016|NCT00941798|423173|P1|Overall Study|Death|0
115017|NCT00941798|423172|P2|Overall Study|Abnormal laboratory values|2
115018|NCT00941798|423173|P1|Overall Study|Abnormal laboratory values|1
115019|NCT00941798|423172|P2|Overall Study|Abnormal test procedure results|1
115020|NCT00941798|423173|P1|Overall Study|Abnormal test procedure results|3
115021|NCT00941798|423172|P2|Overall Study|Patient's inability to use device|1
115022|NCT00941798|423173|P1|Overall Study|Patient's inability to use device|6
115023|NCT00941798|423172|P2|Overall Study|Lack of Efficacy|17
115024|NCT00941798|423173|P1|Overall Study|Lack of Efficacy|10
115025|NCT00941798|423172|P2|Overall Study|Administrative problems|23
115026|NCT00941798|423173|P1|Overall Study|Administrative problems|13
115027|NCT00941798|423172|P2|Overall Study|Protocol Violation|20
115028|NCT00941798|423173|P1|Overall Study|Protocol Violation|17
115029|NCT00941798|423172|P2|Overall Study|Lost to Follow-up|23
115030|NCT00941798|423173|P1|Overall Study|Lost to Follow-up|29
115031|NCT00941798|423172|P2|Overall Study|Adverse Event|23
115032|NCT00941798|423173|P1|Overall Study|Adverse Event|43
115033|NCT00941798|423172|P2|Overall Study|Withdrawal by Subject|74
115034|NCT00941798|423173|P1|Overall Study|Withdrawal by Subject|72
115035|NCT00941733|423203|P2|Overall Study|Protocol Violation|6
115036|NCT00941733|423204|P1|Overall Study|Protocol Violation|15
115037|NCT00941733|423203|P2|Overall Study|Lost to Follow-up|2
115038|NCT00941733|423204|P1|Overall Study|Lost to Follow-up|1
115039|NCT00941733|423203|P2|Overall Study|Adverse Event|4
115040|NCT00941733|423204|P1|Overall Study|Adverse Event|20
115041|NCT00941733|423203|P2|Overall Study|Withdrawal by Subject|6
115042|NCT00941733|423204|P1|Overall Study|Withdrawal by Subject|14
115043|NCT00941733|423203|P2|Overall Study|Death|10
115044|NCT00941733|423204|P1|Overall Study|Death|24
115045|NCT00941720|423244|P1|Overall Study|ineligible|2
115046|NCT00941720|423244|P1|Overall Study|Insurance denied participation|11
115047|NCT00941720|423244|P1|Overall Study|Withdrawal by Subject|1
115048|NCT00941655|423291|P2|Overall Study|non-compliant|1
115049|NCT00941655|423292|P1|Overall Study|non-compliant|0
115050|NCT00941655|423291|P2|Overall Study|withdrew consent|1
115051|NCT00941655|423292|P1|Overall Study|withdrew consent|0
115052|NCT00941655|423291|P2|Overall Study|refused further treatment|1
115053|NCT00941655|423292|P1|Overall Study|refused further treatment|0
115054|NCT00941655|423291|P2|Overall Study|progressed while on chemo|2
115055|NCT00941655|423292|P1|Overall Study|progressed while on chemo|0
115056|NCT00941655|423291|P2|Overall Study|not meet criteria for chemo foll surgery|0
115057|NCT00941655|423292|P1|Overall Study|not meet criteria for chemo foll surgery|4
115058|NCT00941655|423291|P2|Overall Study|received some chemo, 4 and 9 cycles|0
115059|NCT00941655|423292|P1|Overall Study|received some chemo, 4 and 9 cycles|1
115060|NCT00941603|423317|P6|Overall Study|Did not meet protocol eligibility|0
115061|NCT00941603|423318|P5|Overall Study|Did not meet protocol eligibility|0
115062|NCT00941603|423319|P4|Overall Study|Did not meet protocol eligibility|0
115063|NCT00941603|423320|P3|Overall Study|Did not meet protocol eligibility|0
115064|NCT00941603|423321|P2|Overall Study|Did not meet protocol eligibility|0
115065|NCT00941603|423322|P1|Overall Study|Did not meet protocol eligibility|1
115066|NCT00941603|423317|P6|Overall Study|Protocol Violation|0
115067|NCT00941603|423318|P5|Overall Study|Protocol Violation|0
115068|NCT00941603|423319|P4|Overall Study|Protocol Violation|0
115069|NCT00941603|423320|P3|Overall Study|Protocol Violation|0
115070|NCT00941603|423321|P2|Overall Study|Protocol Violation|1
115071|NCT00941603|423322|P1|Overall Study|Protocol Violation|0
115072|NCT00941603|423317|P6|Overall Study|Withdrawal by Subject|1
115073|NCT00941603|423318|P5|Overall Study|Withdrawal by Subject|0
115074|NCT00941603|423319|P4|Overall Study|Withdrawal by Subject|2
115075|NCT00941603|423320|P3|Overall Study|Withdrawal by Subject|0
115076|NCT00941603|423321|P2|Overall Study|Withdrawal by Subject|0
115077|NCT00941603|423322|P1|Overall Study|Withdrawal by Subject|0
115078|NCT00941603|423317|P6|Overall Study|Lost to Follow-up|2
115079|NCT00941603|423318|P5|Overall Study|Lost to Follow-up|0
115080|NCT00941603|423319|P4|Overall Study|Lost to Follow-up|1
115081|NCT00941603|423320|P3|Overall Study|Lost to Follow-up|0
115082|NCT00941603|423321|P2|Overall Study|Lost to Follow-up|0
115083|NCT00941603|423322|P1|Overall Study|Lost to Follow-up|0
115084|NCT00941603|423317|P6|Overall Study|Adverse Event|0
115085|NCT00941603|423318|P5|Overall Study|Adverse Event|4
115086|NCT00941603|423319|P4|Overall Study|Adverse Event|1
115087|NCT00941603|423320|P3|Overall Study|Adverse Event|5
115088|NCT00941603|423321|P2|Overall Study|Adverse Event|15
115089|NCT00941603|423322|P1|Overall Study|Adverse Event|10
115090|NCT00941330|423344|P2|Overall Study|Physician Decision|2
115091|NCT00941330|423345|P1|Overall Study|Physician Decision|0
115092|NCT00941330|423344|P2|Overall Study|Other|0
115093|NCT00941330|423345|P1|Overall Study|Other|1
115094|NCT00941304|423358|P5|Overall Study|Lost to Follow-up|0
115095|NCT00941304|423359|P4|Overall Study|Lost to Follow-up|0
115096|NCT00941304|423360|P3|Overall Study|Lost to Follow-up|0
115097|NCT00941304|423361|P2|Overall Study|Lost to Follow-up|0
115098|NCT00941304|423362|P1|Overall Study|Lost to Follow-up|1
115099|NCT00941070|423424|P1|Overall Study|Patient non-compliant|1
115100|NCT00941031|423444|P7|Maintenance Period|Lack of Efficacy|13
115101|NCT00941031|423445|P6|Maintenance Period|Lack of Efficacy|0
115102|NCT00941031|423446|P5|Maintenance Period|Lack of Efficacy|0
115103|NCT00941031|423447|P4|Maintenance Period|Lack of Efficacy|0
115104|NCT00941031|423448|P3|Maintenance Period|Lack of Efficacy|0
115105|NCT00941031|423449|P2|Maintenance Period|Lack of Efficacy|0
115106|NCT00941031|423450|P1|Maintenance Period|Lack of Efficacy|0
115107|NCT00941031|423444|P7|Maintenance Period|Lost to Follow-up|7
115108|NCT00941031|423445|P6|Maintenance Period|Lost to Follow-up|2
115109|NCT00941031|423446|P5|Maintenance Period|Lost to Follow-up|2
115110|NCT00941031|423447|P4|Maintenance Period|Lost to Follow-up|0
115111|NCT00941031|423448|P3|Maintenance Period|Lost to Follow-up|0
115112|NCT00941031|423449|P2|Maintenance Period|Lost to Follow-up|0
115113|NCT00941031|423450|P1|Maintenance Period|Lost to Follow-up|0
115114|NCT00941031|423444|P7|Maintenance Period|Adverse Event|8
115115|NCT00941031|423445|P6|Maintenance Period|Adverse Event|2
115116|NCT00941031|423446|P5|Maintenance Period|Adverse Event|0
115117|NCT00941031|423447|P4|Maintenance Period|Adverse Event|0
115118|NCT00941031|423448|P3|Maintenance Period|Adverse Event|0
115119|NCT00941031|423449|P2|Maintenance Period|Adverse Event|0
115120|NCT00941031|423450|P1|Maintenance Period|Adverse Event|0
115121|NCT00941031|423444|P7|Maintenance Period|Protocol Violation|1
115122|NCT00941031|423445|P6|Maintenance Period|Protocol Violation|0
115123|NCT00941031|423446|P5|Maintenance Period|Protocol Violation|0
115124|NCT00941031|423447|P4|Maintenance Period|Protocol Violation|0
115125|NCT00941031|423448|P3|Maintenance Period|Protocol Violation|0
115126|NCT00941031|423449|P2|Maintenance Period|Protocol Violation|0
115127|NCT00941031|423450|P1|Maintenance Period|Protocol Violation|0
115128|NCT00941031|423444|P7|Maintenance Period|Administrative Problems|1
115129|NCT00941031|423445|P6|Maintenance Period|Administrative Problems|0
115130|NCT00941031|423446|P5|Maintenance Period|Administrative Problems|1
115131|NCT00941031|423447|P4|Maintenance Period|Administrative Problems|0
115132|NCT00941031|423448|P3|Maintenance Period|Administrative Problems|0
115133|NCT00941031|423449|P2|Maintenance Period|Administrative Problems|0
115134|NCT00941031|423450|P1|Maintenance Period|Administrative Problems|0
115135|NCT00941031|423444|P7|Maintenance Period|Withdrawal by Subject|13
115136|NCT00941031|423445|P6|Maintenance Period|Withdrawal by Subject|2
115137|NCT00941031|423446|P5|Maintenance Period|Withdrawal by Subject|6
115138|NCT00941031|423447|P4|Maintenance Period|Withdrawal by Subject|0
115139|NCT00941031|423448|P3|Maintenance Period|Withdrawal by Subject|0
115140|NCT00941031|423449|P2|Maintenance Period|Withdrawal by Subject|0
115141|NCT00941031|423450|P1|Maintenance Period|Withdrawal by Subject|0
115142|NCT00941031|423444|P7|Induction Period|Adverse Event|0
115143|NCT00941031|423445|P6|Induction Period|Adverse Event|0
115144|NCT00941031|423446|P5|Induction Period|Adverse Event|0
115145|NCT00941031|423447|P4|Induction Period|Adverse Event|2
115146|NCT00941031|423448|P3|Induction Period|Adverse Event|3
115147|NCT00941031|423449|P2|Induction Period|Adverse Event|0
115148|NCT00941031|423450|P1|Induction Period|Adverse Event|1
115149|NCT00941031|423444|P7|Induction Period|Adminstative Problems|0
115150|NCT00941031|423445|P6|Induction Period|Adminstative Problems|0
115151|NCT00941031|423446|P5|Induction Period|Adminstative Problems|0
115152|NCT00941031|423447|P4|Induction Period|Adminstative Problems|0
115153|NCT00941031|423448|P3|Induction Period|Adminstative Problems|1
115154|NCT00941031|423449|P2|Induction Period|Adminstative Problems|1
115155|NCT00941031|423450|P1|Induction Period|Adminstative Problems|1
115156|NCT00941031|423444|P7|Induction Period|Withdrawal by Subject|0
115157|NCT00941031|423445|P6|Induction Period|Withdrawal by Subject|0
115158|NCT00941031|423446|P5|Induction Period|Withdrawal by Subject|0
115159|NCT00941031|423447|P4|Induction Period|Withdrawal by Subject|2
115160|NCT00941031|423448|P3|Induction Period|Withdrawal by Subject|2
115161|NCT00941031|423449|P2|Induction Period|Withdrawal by Subject|2
115162|NCT00941031|423450|P1|Induction Period|Withdrawal by Subject|1
115163|NCT00941031|423444|P7|Induction Period|Lack of Efficacy|0
115164|NCT00941031|423445|P6|Induction Period|Lack of Efficacy|0
115165|NCT00941031|423446|P5|Induction Period|Lack of Efficacy|0
115166|NCT00941031|423447|P4|Induction Period|Lack of Efficacy|5
115167|NCT00941031|423448|P3|Induction Period|Lack of Efficacy|0
115168|NCT00941031|423449|P2|Induction Period|Lack of Efficacy|1
115169|NCT00941031|423450|P1|Induction Period|Lack of Efficacy|2
115170|NCT00940992|423476|P3|Overall Study|Lost to Follow-up|1
115171|NCT00940992|423477|P2|Overall Study|Lost to Follow-up|1
115172|NCT00940992|423478|P1|Overall Study|Lost to Follow-up|0
115173|NCT00940992|423476|P3|Overall Study|subject request|0
115174|NCT00940992|423477|P2|Overall Study|subject request|1
115175|NCT00940992|423478|P1|Overall Study|subject request|2
115176|NCT00940992|423476|P3|Overall Study|Adverse Event|1
115177|NCT00940992|423477|P2|Overall Study|Adverse Event|0
115178|NCT00940992|423478|P1|Overall Study|Adverse Event|2
115179|NCT00940888|423507|P1|Overall Study|Lost to Follow-up|6
115180|NCT00940888|423507|P1|Overall Study|Withdrawn - Non-Death|364
115181|NCT00940888|423507|P1|Overall Study|Death|461
115182|NCT00940888|423507|P1|Overall Study|Unsuccessful Implant|4
115183|NCT00940875|423514|P2|Post-Study Treatment|Disease Progression|2
115184|NCT00940875|423515|P1|Post-Study Treatment|Disease Progression|0
115185|NCT00940875|423514|P2|Post-Study Treatment|Death|1
115186|NCT00940875|423515|P1|Post-Study Treatment|Death|0
115187|NCT00940875|423514|P2|Treatment Phase|Physician Decision|0
115188|NCT00940875|423515|P1|Treatment Phase|Physician Decision|1
115189|NCT00940875|423514|P2|Treatment Phase|Disease progression|11
115190|NCT00940875|423515|P1|Treatment Phase|Disease progression|9
115191|NCT00940875|423514|P2|Treatment Phase|Withdrawal by Subject|0
115192|NCT00940875|423515|P1|Treatment Phase|Withdrawal by Subject|3
115193|NCT00940875|423514|P2|Treatment Phase|Lack of Efficacy|0
115194|NCT00940875|423515|P1|Treatment Phase|Lack of Efficacy|1
115195|NCT00940875|423514|P2|Treatment Phase|Death|5
115196|NCT00940875|423515|P1|Treatment Phase|Death|3
115197|NCT00940875|423514|P2|Treatment Phase|Adverse Event|3
115198|NCT00940875|423515|P1|Treatment Phase|Adverse Event|9
115199|NCT00940823|423535|P2|Overall Study|Lost to Follow-up|20
115200|NCT00940823|423536|P1|Overall Study|Lost to Follow-up|27
115201|NCT00940823|423535|P2|Overall Study|Death|12
115202|NCT00940823|423536|P1|Overall Study|Death|8
115203|NCT00940485|423574|P2|Overall Study|Others|1
115204|NCT00940485|423575|P1|Overall Study|Others|1
115205|NCT00940485|423574|P2|Overall Study|Withdrawal by Subject|1
115206|NCT00940485|423575|P1|Overall Study|Withdrawal by Subject|1
115207|NCT00940485|423574|P2|Overall Study|Adverse Event|0
115208|NCT00940485|423575|P1|Overall Study|Adverse Event|8
115209|NCT00940485|423574|P2|Overall Study|Lost to Follow-up|3
115210|NCT00940485|423575|P1|Overall Study|Lost to Follow-up|2
115211|NCT00940485|423574|P2|Overall Study|HBeAb positive at Baseline|2
115212|NCT00940485|423575|P1|Overall Study|HBeAb positive at Baseline|3
115213|NCT00940108|423631|P4|Overall Study|Diagnosed with H1N1|1
115214|NCT00940108|423632|P3|Overall Study|Diagnosed with H1N1|0
115215|NCT00940108|423633|P2|Overall Study|Diagnosed with H1N1|0
115216|NCT00940108|423634|P1|Overall Study|Diagnosed with H1N1|0
115217|NCT00940108|423631|P4|Overall Study|Viral illness after Dose 1|0
115218|NCT00940108|423632|P3|Overall Study|Viral illness after Dose 1|0
115219|NCT00940108|423633|P2|Overall Study|Viral illness after Dose 1|1
115220|NCT00940108|423634|P1|Overall Study|Viral illness after Dose 1|0
115221|NCT00940108|423631|P4|Overall Study|Refused - pyrexia after Dose 1|0
115222|NCT00940108|423632|P3|Overall Study|Refused - pyrexia after Dose 1|0
115223|NCT00940108|423633|P2|Overall Study|Refused - pyrexia after Dose 1|1
115224|NCT00940108|423634|P1|Overall Study|Refused - pyrexia after Dose 1|0
115225|NCT00940108|423631|P4|Overall Study|Declined further vaccination|0
115226|NCT00940108|423632|P3|Overall Study|Declined further vaccination|3
115227|NCT00940108|423633|P2|Overall Study|Declined further vaccination|1
115228|NCT00940108|423634|P1|Overall Study|Declined further vaccination|0
115229|NCT00940108|423631|P4|Overall Study|Dose 2 contraindicated|1
115230|NCT00940108|423632|P3|Overall Study|Dose 2 contraindicated|0
115231|NCT00940108|423633|P2|Overall Study|Dose 2 contraindicated|1
115232|NCT00940108|423634|P1|Overall Study|Dose 2 contraindicated|1
115233|NCT00940108|423631|P4|Overall Study|Withdrew Consent|1
115234|NCT00940108|423632|P3|Overall Study|Withdrew Consent|0
115235|NCT00940108|423633|P2|Overall Study|Withdrew Consent|1
115236|NCT00940108|423634|P1|Overall Study|Withdrew Consent|2
115237|NCT00940108|423631|P4|Overall Study|Adverse Event|2
115238|NCT00940108|423632|P3|Overall Study|Adverse Event|0
115239|NCT00940108|423633|P2|Overall Study|Adverse Event|4
115240|NCT00940108|423634|P1|Overall Study|Adverse Event|2
115241|NCT00940017|423684|P1|Overall Study|Adverse Event|1
115242|NCT00940017|423684|P1|Overall Study|did not meet entrance criteria|3
115243|NCT00939809|423740|P1|Overall Study|Death|1
115244|NCT00939809|423740|P1|Overall Study|Adverse Event|2
115245|NCT00939783|423754|P1|Overall Study|Enrolled but not treated|1
115246|NCT00939783|423754|P1|Overall Study|Protocol Violation|3
115247|NCT00939783|423754|P1|Overall Study|Lost to Follow-up|8
115248|NCT00939783|423754|P1|Overall Study|Other|16
115249|NCT00939783|423754|P1|Overall Study|Withdrawal by Subject|78
115250|NCT00939783|423754|P1|Overall Study|Study Terminated by Sponsor|498
115251|NCT00939783|423754|P1|Overall Study|Adverse Event|39
115252|NCT00939783|423754|P1|Overall Study|Death|6
115253|NCT00939692|423795|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
115254|NCT00939692|423796|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
115255|NCT00939692|423795|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
115256|NCT00939692|423796|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
115257|NCT00939627|423808|P3|Overall Study|No off-tx reason given|0
115258|NCT00939627|423809|P2|Overall Study|No off-tx reason given|2
115259|NCT00939627|423810|P1|Overall Study|No off-tx reason given|0
115260|NCT00939627|423808|P3|Overall Study|Not compliant|0
115261|NCT00939627|423809|P2|Overall Study|Not compliant|0
115262|NCT00939627|423810|P1|Overall Study|Not compliant|2
115263|NCT00939627|423808|P3|Overall Study|Other complicating disease|0
115264|NCT00939627|423809|P2|Overall Study|Other complicating disease|1
115265|NCT00939627|423810|P1|Overall Study|Other complicating disease|1
115266|NCT00939627|423808|P3|Overall Study|Withdrawal by Subject|0
115267|NCT00939627|423809|P2|Overall Study|Withdrawal by Subject|4
115268|NCT00939627|423810|P1|Overall Study|Withdrawal by Subject|2
115269|NCT00939627|423808|P3|Overall Study|Death|0
115270|NCT00939627|423809|P2|Overall Study|Death|2
115271|NCT00939627|423810|P1|Overall Study|Death|0
115272|NCT00939627|423808|P3|Overall Study|Adverse Event|0
115273|NCT00939627|423809|P2|Overall Study|Adverse Event|7
115274|NCT00939627|423810|P1|Overall Study|Adverse Event|6
115275|NCT00939627|423808|P3|Overall Study|Disease Progression|0
115276|NCT00939627|423809|P2|Overall Study|Disease Progression|12
115277|NCT00939627|423810|P1|Overall Study|Disease Progression|16
115278|NCT00939510|423850|P1|Overall Study|Withdrawal by Subject|1
115279|NCT00939484|423859|P3|Overall Study|Progression/Relapse|3
115280|NCT00939484|423860|P2|Overall Study|Progression/Relapse|20
115281|NCT00939484|423861|P1|Overall Study|Progression/Relapse|8
115282|NCT00939393|423887|P2|Overall Study|Lost to Follow-up|0
115283|NCT00939393|423888|P1|Overall Study|Lost to Follow-up|3
115284|NCT00939393|423887|P2|Overall Study|Withdrawal by Subject|0
115285|NCT00939393|423888|P1|Overall Study|Withdrawal by Subject|1
115286|NCT00939341|423919|P1|Overall Study|Incorrect enrolment|8
115287|NCT00939341|423919|P1|Overall Study|Protocol Violation|6
115288|NCT00939341|423919|P1|Overall Study|Withdrawal by Subject|13
115289|NCT00939341|423919|P1|Overall Study|Lost to Follow-up|23
115290|NCT00939341|423919|P1|Overall Study|Pregnancy|1
115291|NCT00939341|423919|P1|Overall Study|Adverse Event|15
115292|NCT00939185|424001|P1|Overall Study|Randomized But Did Not Receive Treatment|10
115293|NCT00939185|424001|P1|Overall Study|Withdrawal by Subject|2
115294|NCT00939185|424001|P1|Overall Study|Other|3
115295|NCT00939185|424001|P1|Overall Study|Lost to Follow-up|6
115296|NCT00939185|424001|P1|Overall Study|Lack of Efficacy|1
115297|NCT00939185|424001|P1|Overall Study|Adverse Event|3
115298|NCT00939107|424039|P2|Overall Study|Lost to Follow-up|12
115299|NCT00939107|424040|P1|Overall Study|Lost to Follow-up|14
115300|NCT00939094|424054|P2|Overall Study|Abnormal ECG findings|0
115301|NCT00939094|424055|P1|Overall Study|Abnormal ECG findings|1
115302|NCT00939094|424054|P2|Overall Study|Study stopped by sponsor|2
115303|NCT00939094|424055|P1|Overall Study|Study stopped by sponsor|0
115304|NCT00939094|424054|P2|Overall Study|Severe non-compliance to protocol|1
115305|NCT00939094|424055|P1|Overall Study|Severe non-compliance to protocol|0
115306|NCT00939094|424054|P2|Overall Study|Eligibility criteria not fulfilled|0
115307|NCT00939094|424055|P1|Overall Study|Eligibility criteria not fulfilled|2
115308|NCT00939094|424054|P2|Overall Study|Lost to Follow-up|1
115309|NCT00939094|424055|P1|Overall Study|Lost to Follow-up|1
115310|NCT00939094|424054|P2|Overall Study|Withdrawal by Subject|6
115311|NCT00939094|424055|P1|Overall Study|Withdrawal by Subject|1
115312|NCT00939094|424054|P2|Overall Study|Adverse Event|0
115313|NCT00939094|424055|P1|Overall Study|Adverse Event|9
115314|NCT00939055|424077|P2|Overall Study|Discontinuation prior to procedure|0
115315|NCT00939055|424078|P1|Overall Study|Discontinuation prior to procedure|4
115316|NCT00939029|424088|P2|Overall Study|Adverse Event|1
115317|NCT00939029|424089|P1|Overall Study|Adverse Event|0
115318|NCT00939029|424088|P2|Overall Study|Lost to Follow-up|4
115319|NCT00939029|424089|P1|Overall Study|Lost to Follow-up|3
115320|NCT00939029|424088|P2|Overall Study|Withdrawal by Subject|7
115321|NCT00939029|424089|P1|Overall Study|Withdrawal by Subject|3
115322|NCT00939003|424101|P2|Open-label Treatment Period|Site Closure|4
115323|NCT00939003|424102|P1|Open-label Treatment Period|Site Closure|3
115324|NCT00939003|424101|P2|Open-label Treatment Period|Exclusion Criteria|0
115325|NCT00939003|424102|P1|Open-label Treatment Period|Exclusion Criteria|1
115326|NCT00939003|424101|P2|Open-label Treatment Period|Pregnancy|1
115327|NCT00939003|424102|P1|Open-label Treatment Period|Pregnancy|1
115328|NCT00939003|424101|P2|Open-label Treatment Period|Lack of Efficacy|9
115329|NCT00939003|424102|P1|Open-label Treatment Period|Lack of Efficacy|6
115330|NCT00939003|424101|P2|Open-label Treatment Period|Withdrawal by Subject|7
115331|NCT00939003|424102|P1|Open-label Treatment Period|Withdrawal by Subject|14
115332|NCT00939003|424101|P2|Open-label Treatment Period|Adverse Event|8
115333|NCT00939003|424102|P1|Open-label Treatment Period|Adverse Event|4
115334|NCT00939003|424101|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
115335|NCT00939003|424102|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
115336|NCT00939003|424101|P2|Double-blind Treatment Period|Pregnancy|1
115337|NCT00939003|424102|P1|Double-blind Treatment Period|Pregnancy|0
115338|NCT00939003|424101|P2|Double-blind Treatment Period|Lack of Efficacy|1
115339|NCT00939003|424102|P1|Double-blind Treatment Period|Lack of Efficacy|0
115340|NCT00939003|424101|P2|Double-blind Treatment Period|Adverse Event|1
115341|NCT00939003|424102|P1|Double-blind Treatment Period|Adverse Event|1
115342|NCT00938964|424139|P2|Overall Study|Found to Meet Exclusion Criteria|4
115343|NCT00938964|424140|P1|Overall Study|Found to Meet Exclusion Criteria|3
115344|NCT00938964|424139|P2|Overall Study|Withdrawal by Subject|18
115345|NCT00938964|424140|P1|Overall Study|Withdrawal by Subject|22
115346|NCT00938964|424139|P2|Overall Study|Lost to Follow-up|3
115347|NCT00938964|424140|P1|Overall Study|Lost to Follow-up|2
115348|NCT00938964|424139|P2|Overall Study|Death|3
115349|NCT00938964|424140|P1|Overall Study|Death|3
115350|NCT00938886|424180|P2|Overall Study|Lost to Follow-up|2
115351|NCT00938886|424181|P1|Overall Study|Lost to Follow-up|3
115352|NCT00938886|424180|P2|Overall Study|Withdrawal by Subject|7
115353|NCT00938886|424181|P1|Overall Study|Withdrawal by Subject|4
115354|NCT00938886|424180|P2|Overall Study|Death|1
115355|NCT00938886|424181|P1|Overall Study|Death|0
115356|NCT00938860|424191|P2|Overall Study|Protocol Violation|1
115357|NCT00938860|424192|P1|Overall Study|Protocol Violation|3
115358|NCT00938860|424191|P2|Overall Study|Death|1
115359|NCT00938860|424192|P1|Overall Study|Death|1
115360|NCT00938860|424191|P2|Overall Study|Administration problems|0
115361|NCT00938860|424192|P1|Overall Study|Administration problems|2
115362|NCT00938860|424191|P2|Overall Study|Lost to Follow-up|4
115363|NCT00938860|424192|P1|Overall Study|Lost to Follow-up|4
115364|NCT00938860|424191|P2|Overall Study|Withdrawal by Subject|8
115365|NCT00938860|424192|P1|Overall Study|Withdrawal by Subject|11
115366|NCT00938860|424191|P2|Overall Study|Abnormal laboratory values|2
115367|NCT00938860|424192|P1|Overall Study|Abnormal laboratory values|2
115368|NCT00938860|424191|P2|Overall Study|Adverse Event|1
115369|NCT00938860|424192|P1|Overall Study|Adverse Event|2
115370|NCT00938717|424225|P2|Overall Study|Other reason|2
115371|NCT00938717|424226|P1|Overall Study|Other reason|5
115372|NCT00938717|424225|P2|Overall Study|Lack of Efficacy|15
115373|NCT00938717|424226|P1|Overall Study|Lack of Efficacy|33
115374|NCT00938717|424225|P2|Overall Study|Lost to Follow-up|18
115375|NCT00938717|424226|P1|Overall Study|Lost to Follow-up|13
115376|NCT00938717|424225|P2|Overall Study|Withdrawal by Subject|24
115377|NCT00938717|424226|P1|Overall Study|Withdrawal by Subject|26
115378|NCT00938717|424225|P2|Overall Study|Protocol Violation|8
115379|NCT00938717|424226|P1|Overall Study|Protocol Violation|11
115380|NCT00938717|424225|P2|Overall Study|Adverse Event|41
115381|NCT00938717|424226|P1|Overall Study|Adverse Event|10
115382|NCT00938639|424277|P2|Overall Study|Participant noncompliance|0
115383|NCT00938639|424278|P1|Overall Study|Participant noncompliance|1
115384|NCT00938639|424277|P2|Overall Study|Family issues|1
115385|NCT00938639|424278|P1|Overall Study|Family issues|1
115386|NCT00938639|424277|P2|Overall Study|Lost to Follow-up|2
115387|NCT00938639|424278|P1|Overall Study|Lost to Follow-up|1
115388|NCT00938639|424277|P2|Overall Study|Moved away from study area|1
115389|NCT00938639|424278|P1|Overall Study|Moved away from study area|0
115390|NCT00938470|424361|P2|Overall Study|Other Reason|1
115391|NCT00938470|424362|P1|Overall Study|Other Reason|0
115392|NCT00938470|424361|P2|Overall Study|Death|2
115393|NCT00938470|424362|P1|Overall Study|Death|3
115394|NCT00938470|424361|P2|Overall Study|Alternate Treatment|0
115395|NCT00938470|424362|P1|Overall Study|Alternate Treatment|1
115396|NCT00938470|424361|P2|Overall Study|Disease Progression|0
115397|NCT00938470|424362|P1|Overall Study|Disease Progression|3
115398|NCT00938431|424392|P3|Overall Study|Reached maximum dose early|1
115399|NCT00938431|424393|P2|Overall Study|Reached maximum dose early|0
115400|NCT00938431|424394|P1|Overall Study|Reached maximum dose early|0
115401|NCT00938431|424392|P3|Overall Study|Dosing compliance issue|1
115402|NCT00938431|424393|P2|Overall Study|Dosing compliance issue|0
115403|NCT00938431|424394|P1|Overall Study|Dosing compliance issue|0
115404|NCT00938431|424392|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
115405|NCT00938431|424393|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
115406|NCT00938431|424394|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
115407|NCT00938431|424392|P3|Overall Study|Lack of Efficacy|0
115408|NCT00938431|424393|P2|Overall Study|Lack of Efficacy|1
115409|NCT00938431|424394|P1|Overall Study|Lack of Efficacy|0
115410|NCT00938431|424392|P3|Overall Study|Adverse Event|6
115411|NCT00938431|424393|P2|Overall Study|Adverse Event|8
115412|NCT00938431|424394|P1|Overall Study|Adverse Event|5
115413|NCT00938392|424421|P2|Overall Study|Lost to Follow-up|2
115414|NCT00938392|424422|P1|Overall Study|Lost to Follow-up|2
115415|NCT00938392|424421|P2|Overall Study|Withdrawal by Subject|1
115416|NCT00938392|424422|P1|Overall Study|Withdrawal by Subject|0
115417|NCT00938392|424421|P2|Overall Study|Adverse Event|1
115418|NCT00938392|424422|P1|Overall Study|Adverse Event|0
115419|NCT00938366|424448|P2|Overall Study|Withdrawal by Subject|0
115420|NCT00938366|424449|P1|Overall Study|Withdrawal by Subject|1
115421|NCT00938327|424469|P1|Overall Study|Vaccine not received as out of stock|9
115422|NCT00938327|424469|P1|Overall Study|2nd dose received outside of the study|7
115423|NCT00938327|424469|P1|Overall Study|Lost to Follow-up|37
115424|NCT00938327|424469|P1|Overall Study|Withdrawal by Subject|4
115425|NCT00938327|424469|P1|Overall Study|Protocol Violation|1
115426|NCT00938327|424469|P1|Overall Study|Adverse Event|2
115427|NCT00938041|424537|P1|Overall Study|Adrenal Insufficiency|3
115428|NCT00938041|424537|P1|Overall Study|Death|12
115429|NCT00938041|424537|P1|Overall Study|Progressive Disease|5
115430|NCT00938041|424537|P1|Overall Study|Received Alternative Therapy|1
115431|NCT00938041|424537|P1|Overall Study|Lost to Follow-up|6
115432|NCT00938015|424546|P1|Overall Study|Reason not related to Etanercept|29
115433|NCT00938015|424546|P1|Overall Study|Non-responder|52
115434|NCT00938015|424546|P1|Overall Study|Adverse Event|32
115435|NCT00938015|424546|P1|Overall Study|Lost to Follow-up|32
115436|NCT00938015|424546|P1|Overall Study|Death|2
115437|NCT00937950|424562|P1|Overall Study|Others|18
115438|NCT00937950|424562|P1|Overall Study|Missing confirmed|4
115439|NCT00937950|424562|P1|Overall Study|Lost to Follow-up|144
115440|NCT00937950|424562|P1|Overall Study|Migrated/moved from study area|27
115441|NCT00937950|424562|P1|Overall Study|Withdrawal by Subject|23
115442|NCT00937937|424578|P1|Overall Study|Not specified|2
115443|NCT00937937|424578|P1|Overall Study|Death|1
115444|NCT00937937|424578|P1|Overall Study|Progression/relapse|61
115445|NCT00937937|424578|P1|Overall Study|Withdrawal by Subject|2
115446|NCT00937937|424578|P1|Overall Study|Adverse Event|6
115447|NCT00937833|424587|P2|Overall Study|Withdrawal by Subject|6
115448|NCT00937833|424588|P1|Overall Study|Withdrawal by Subject|4
115449|NCT00937833|424587|P2|Overall Study|Lost to Follow-up|8
115450|NCT00937833|424588|P1|Overall Study|Lost to Follow-up|10
115451|NCT00937833|424587|P2|Overall Study|Procedure delayed; enrollment closed|1
115452|NCT00937833|424588|P1|Overall Study|Procedure delayed; enrollment closed|0
115453|NCT00937833|424587|P2|Overall Study|Protocol Violation|2
115454|NCT00937833|424588|P1|Overall Study|Protocol Violation|1
115455|NCT00937768|424601|P2|Overall Study|No Further Funding|4
115456|NCT00937768|424602|P1|Overall Study|No Further Funding|4
115457|NCT00937768|424601|P2|Overall Study|Alternate Treatment|1
115458|NCT00937768|424602|P1|Overall Study|Alternate Treatment|0
115459|NCT00937768|424601|P2|Overall Study|Disease Progression|1
115460|NCT00937768|424602|P1|Overall Study|Disease Progression|1
115461|NCT00937768|424601|P2|Overall Study|Refused Further Treatment|2
115462|NCT00937768|424602|P1|Overall Study|Refused Further Treatment|3
115463|NCT00937560|424608|P1|Maintenance Treatment|According to protocol|1
115464|NCT00937560|424608|P1|Maintenance Treatment|Withdraw consent|5
115465|NCT00937560|424608|P1|Maintenance Treatment|Death|12
115466|NCT00937560|424608|P1|Initial Treatment|No end of study page|10
115467|NCT00937560|424608|P1|Initial Treatment|Lost to Follow-up|1
115468|NCT00937560|424608|P1|Initial Treatment|Adverse Event|1
115469|NCT00937560|424608|P1|Initial Treatment|Withdraw consent|3
115470|NCT00937560|424608|P1|Initial Treatment|Death|6
115471|NCT00937547|424619|P3|Overall Study|misdiagnosis|7
115472|NCT00937547|424620|P2|Overall Study|misdiagnosis|6
115473|NCT00937547|424621|P1|Overall Study|misdiagnosis|1
115474|NCT00937521|424658|P8|Booster Phase|Protocol Deviation|0
115475|NCT00937521|424659|P7|Booster Phase|Protocol Deviation|1
115476|NCT00937521|424660|P6|Booster Phase|Protocol Deviation|0
115477|NCT00937521|424661|P5|Booster Phase|Protocol Deviation|0
115478|NCT00937521|424662|P4|Booster Phase|Protocol Deviation|0
115479|NCT00937521|424663|P3|Booster Phase|Protocol Deviation|0
115480|NCT00937521|424664|P2|Booster Phase|Protocol Deviation|0
115481|NCT00937521|424665|P1|Booster Phase|Protocol Deviation|0
115482|NCT00937521|424658|P8|Booster Phase|Administrative Reason|0
115483|NCT00937521|424659|P7|Booster Phase|Administrative Reason|0
115484|NCT00937521|424660|P6|Booster Phase|Administrative Reason|1
115485|NCT00937521|424661|P5|Booster Phase|Administrative Reason|1
115486|NCT00937521|424662|P4|Booster Phase|Administrative Reason|0
115487|NCT00937521|424663|P3|Booster Phase|Administrative Reason|1
115488|NCT00937521|424664|P2|Booster Phase|Administrative Reason|0
115489|NCT00937521|424665|P1|Booster Phase|Administrative Reason|0
115490|NCT00937521|424658|P8|Booster Phase|Lost to Follow-up|0
115491|NCT00937521|424659|P7|Booster Phase|Lost to Follow-up|3
115492|NCT00937521|424660|P6|Booster Phase|Lost to Follow-up|4
115493|NCT00937521|424661|P5|Booster Phase|Lost to Follow-up|4
115494|NCT00937521|424662|P4|Booster Phase|Lost to Follow-up|2
115495|NCT00937521|424663|P3|Booster Phase|Lost to Follow-up|4
115496|NCT00937521|424664|P2|Booster Phase|Lost to Follow-up|2
115497|NCT00937521|424665|P1|Booster Phase|Lost to Follow-up|2
115498|NCT00937521|424658|P8|Booster Phase|Withdrawal by Subject|2
115499|NCT00937521|424659|P7|Booster Phase|Withdrawal by Subject|0
115500|NCT00937521|424660|P6|Booster Phase|Withdrawal by Subject|0
115501|NCT00937521|424661|P5|Booster Phase|Withdrawal by Subject|0
115502|NCT00937521|424662|P4|Booster Phase|Withdrawal by Subject|1
115503|NCT00937521|424663|P3|Booster Phase|Withdrawal by Subject|0
115504|NCT00937521|424664|P2|Booster Phase|Withdrawal by Subject|0
115505|NCT00937521|424665|P1|Booster Phase|Withdrawal by Subject|1
115506|NCT00937521|424658|P8|Booster Phase|Adverse Event|0
115507|NCT00937521|424659|P7|Booster Phase|Adverse Event|1
115508|NCT00937521|424660|P6|Booster Phase|Adverse Event|0
115509|NCT00937521|424661|P5|Booster Phase|Adverse Event|0
115510|NCT00937521|424662|P4|Booster Phase|Adverse Event|0
115511|NCT00937521|424663|P3|Booster Phase|Adverse Event|0
115512|NCT00937521|424664|P2|Booster Phase|Adverse Event|0
115513|NCT00937521|424665|P1|Booster Phase|Adverse Event|0
115514|NCT00937521|424658|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
115515|NCT00937521|424659|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
115516|NCT00937521|424660|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
115517|NCT00937521|424661|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
115518|NCT00937521|424662|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
115519|NCT00937521|424663|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
115520|NCT00937521|424664|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
115521|NCT00937521|424665|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
115522|NCT00937521|424658|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
115523|NCT00937521|424659|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
115524|NCT00937521|424660|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
115525|NCT00937521|424661|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
115526|NCT00937521|424662|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
115527|NCT00937521|424663|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
115528|NCT00937521|424664|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
115529|NCT00937521|424665|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
115530|NCT00937521|424658|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
115531|NCT00937521|424659|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
115532|NCT00937521|424660|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
115533|NCT00937521|424661|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
115534|NCT00937521|424662|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
115535|NCT00937521|424663|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
115536|NCT00937521|424664|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
115537|NCT00937521|424665|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
115538|NCT00937521|424658|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
115539|NCT00937521|424659|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
115540|NCT00937521|424660|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
115541|NCT00937521|424661|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
115542|NCT00937521|424662|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
115543|NCT00937521|424663|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
115544|NCT00937521|424664|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
115545|NCT00937521|424665|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
115546|NCT00937521|424658|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
115547|NCT00937521|424659|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
115548|NCT00937521|424660|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
115549|NCT00937521|424661|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
115550|NCT00937521|424662|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
115551|NCT00937521|424663|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
115552|NCT00937521|424664|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
115553|NCT00937521|424665|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
115554|NCT00937495|424771|P1|Overall Study|Protocol Violation|2
115555|NCT00937391|424779|P1|Stage 2|Withdrawal by Subject|1
115556|NCT00937326|424835|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
115557|NCT00937326|424836|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
115558|NCT00937326|424837|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
115559|NCT00937326|424838|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
115560|NCT00937326|424839|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
115561|NCT00937326|424835|P5|Overall Study|Withdrawal by Subject|3
115562|NCT00937326|424836|P4|Overall Study|Withdrawal by Subject|4
115563|NCT00937326|424837|P3|Overall Study|Withdrawal by Subject|1
115564|NCT00937326|424838|P2|Overall Study|Withdrawal by Subject|4
115565|NCT00937326|424839|P1|Overall Study|Withdrawal by Subject|3
115566|NCT00937326|424835|P5|Overall Study|Death|0
115567|NCT00937326|424836|P4|Overall Study|Death|0
115568|NCT00937326|424837|P3|Overall Study|Death|1
115569|NCT00937326|424838|P2|Overall Study|Death|0
115570|NCT00937326|424839|P1|Overall Study|Death|0
115571|NCT00937326|424835|P5|Overall Study|Adverse Event|2
115572|NCT00937326|424836|P4|Overall Study|Adverse Event|1
115573|NCT00937326|424837|P3|Overall Study|Adverse Event|1
115574|NCT00937326|424838|P2|Overall Study|Adverse Event|3
115575|NCT00937326|424839|P1|Overall Study|Adverse Event|0
115576|NCT00937157|425088|P1|Overall Study|Lost to Follow-up|3
115577|NCT00937157|425088|P1|Overall Study|Pregnancy|1
115578|NCT00937040|425119|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
115579|NCT00937040|425120|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
115580|NCT00937040|425119|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
115581|NCT00937040|425120|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
115582|NCT00937040|425119|P2|Overall Study|Withdrawal by Subject|7
115583|NCT00937040|425120|P1|Overall Study|Withdrawal by Subject|13
115584|NCT00937040|425119|P2|Overall Study|Protocol Violation|0
115585|NCT00937040|425120|P1|Overall Study|Protocol Violation|3
115586|NCT00937040|425119|P2|Overall Study|Lost to Follow-up|12
115587|NCT00937040|425120|P1|Overall Study|Lost to Follow-up|12
115588|NCT00937040|425119|P2|Overall Study|Adverse Event|8
115589|NCT00937040|425120|P1|Overall Study|Adverse Event|5
115590|NCT00936975|425162|P1|Overall Study|Post-Tx scan uninterpretable|2
115591|NCT00936975|425162|P1|Overall Study|Disease progression|3
115592|NCT00936975|425162|P1|Overall Study|Withdrawal by Subject|1
115593|NCT00936910|425171|P1|Overall Study|Lack of Efficacy|3
115594|NCT00936897|425180|P2|Overall Study|Death|1
115595|NCT00936897|425181|P1|Overall Study|Death|0
115596|NCT00936897|425180|P2|Overall Study|Noncompliance|2
115597|NCT00936897|425181|P1|Overall Study|Noncompliance|0
115598|NCT00936897|425180|P2|Overall Study|Ineligibility Determined|3
115599|NCT00936897|425181|P1|Overall Study|Ineligibility Determined|0
115600|NCT00936897|425180|P2|Overall Study|Protocol Violation|1
115601|NCT00936897|425181|P1|Overall Study|Protocol Violation|1
115602|NCT00936897|425180|P2|Overall Study|Administrative Decision|2
115603|NCT00936897|425181|P1|Overall Study|Administrative Decision|1
115604|NCT00936897|425180|P2|Overall Study|Lost to Follow-up|10
115605|NCT00936897|425181|P1|Overall Study|Lost to Follow-up|1
115606|NCT00936897|425180|P2|Overall Study|Other|9
115607|NCT00936897|425181|P1|Overall Study|Other|3
115608|NCT00936897|425180|P2|Overall Study|Adverse Event|13
115609|NCT00936897|425181|P1|Overall Study|Adverse Event|4
115610|NCT00936897|425180|P2|Overall Study|Withdrawal by Subject|19
115611|NCT00936897|425181|P1|Overall Study|Withdrawal by Subject|9
115612|NCT00936715|425198|P1|Overall Study|Safety or Tolerability Reasons|4
115613|NCT00936715|425198|P1|Overall Study|Protocol Violation|1
115614|NCT00936715|425198|P1|Overall Study|Investigators Discretion|1
115615|NCT00936702|425202|P1|Overall Study|Other|1
115616|NCT00936702|425202|P1|Overall Study|Alternative Treatment|1
115617|NCT00936702|425202|P1|Overall Study|Withdrawal by Subject|2
115618|NCT00936702|425202|P1|Overall Study|Adverse Event|8
115619|NCT00936702|425202|P1|Overall Study|Disease progression|34
115620|NCT00936598|425235|P2|Overall Study|Ineligible after consent|0
115621|NCT00936598|425236|P1|Overall Study|Ineligible after consent|1
115622|NCT00936598|425235|P2|Overall Study|Withdrawal by Subject|0
115623|NCT00936598|425236|P1|Overall Study|Withdrawal by Subject|1
115624|NCT00936221|425325|P2|Overall Study|Withdrawal by Subject|1
115625|NCT00936221|425326|P1|Overall Study|Withdrawal by Subject|1
115626|NCT00936208|425340|P2|Overall Study|Protocol Violation|22
115627|NCT00936208|425341|P1|Overall Study|Protocol Violation|37
115628|NCT00936117|425359|P1|Overall Study|Unable to continue oral medication|3
115629|NCT00936117|425359|P1|Overall Study|Adverse Event|7
115630|NCT00936065|425367|P3|Overall Study|Withdrawal by Subject|4
115631|NCT00936065|425368|P2|Overall Study|Withdrawal by Subject|2
115632|NCT00936065|425369|P1|Overall Study|Withdrawal by Subject|0
115633|NCT00936065|425367|P3|Overall Study|Protocol Violation|1
115634|NCT00936065|425368|P2|Overall Study|Protocol Violation|2
115635|NCT00936065|425369|P1|Overall Study|Protocol Violation|1
115636|NCT00936065|425367|P3|Overall Study|Lost to Follow-up|0
115637|NCT00936065|425368|P2|Overall Study|Lost to Follow-up|0
115638|NCT00936065|425369|P1|Overall Study|Lost to Follow-up|1
115639|NCT00936065|425367|P3|Overall Study|Lack of Efficacy|1
115640|NCT00936065|425368|P2|Overall Study|Lack of Efficacy|0
115641|NCT00936065|425369|P1|Overall Study|Lack of Efficacy|1
115642|NCT00936065|425367|P3|Overall Study|Adverse Event|1
115643|NCT00936065|425368|P2|Overall Study|Adverse Event|0
115644|NCT00936065|425369|P1|Overall Study|Adverse Event|1
115645|NCT00935883|425475|P2|Treatment Period|Withdrawal by Subject|2
115646|NCT00935883|425476|P1|Treatment Period|Withdrawal by Subject|0
115647|NCT00935883|425475|P2|Treatment Period|Physician Decision|0
115648|NCT00935883|425476|P1|Treatment Period|Physician Decision|1
115649|NCT00935818|425503|P2|Overall Study|Physician Decision|1
115650|NCT00935818|425504|P1|Overall Study|Physician Decision|0
115651|NCT00935818|425503|P2|Overall Study|Adverse Event|7
115652|NCT00935818|425504|P1|Overall Study|Adverse Event|6
115653|NCT00935818|425503|P2|Overall Study|Lost to Follow-up|42
115654|NCT00935818|425504|P1|Overall Study|Lost to Follow-up|40
115655|NCT00935818|425503|P2|Overall Study|Withdrawal by Subject|50
115656|NCT00935818|425504|P1|Overall Study|Withdrawal by Subject|45
115657|NCT00935701|425555|P1|Overall Study|Failure to Transition to Acupuncture|1
115658|NCT00935584|425572|P2|Overall Study|Provider dropped out of study|4
115659|NCT00935584|425573|P1|Overall Study|Provider dropped out of study|14
115660|NCT00935584|425572|P2|Overall Study|Patient changed provider|0
115661|NCT00935584|425573|P1|Overall Study|Patient changed provider|3
115662|NCT00935584|425572|P2|Overall Study|Relocated|0
115663|NCT00935584|425573|P1|Overall Study|Relocated|3
115664|NCT00935584|425572|P2|Overall Study|No show|0
115665|NCT00935584|425573|P1|Overall Study|No show|9
115666|NCT00935584|425572|P2|Overall Study|Lost to Follow-up|0
115667|NCT00935584|425573|P1|Overall Study|Lost to Follow-up|8
115668|NCT00935584|425572|P2|Overall Study|Death|0
115669|NCT00935584|425573|P1|Overall Study|Death|3
115670|NCT00935584|425572|P2|Overall Study|Withdrawal by Subject|0
115671|NCT00935584|425573|P1|Overall Study|Withdrawal by Subject|9
115672|NCT00935532|425585|P2|Overall Study|Loss Glucose Control|0
115673|NCT00935532|425586|P1|Overall Study|Loss Glucose Control|4
115674|NCT00935532|425585|P2|Overall Study|Sponsor Decision|1
115675|NCT00935532|425586|P1|Overall Study|Sponsor Decision|0
115676|NCT00935532|425585|P2|Overall Study|Subject Decision|1
115677|NCT00935532|425586|P1|Overall Study|Subject Decision|2
115678|NCT00935532|425585|P2|Overall Study|Protocol Violation|1
115679|NCT00935532|425586|P1|Overall Study|Protocol Violation|2
115680|NCT00935532|425585|P2|Overall Study|Physician Decision|2
115681|NCT00935532|425586|P1|Overall Study|Physician Decision|1
115682|NCT00935532|425585|P2|Overall Study|Lost to Follow-up|0
115683|NCT00935532|425586|P1|Overall Study|Lost to Follow-up|1
115684|NCT00935532|425585|P2|Overall Study|Death|0
115685|NCT00935532|425586|P1|Overall Study|Death|1
115686|NCT00935532|425585|P2|Overall Study|Adverse Event|6
115687|NCT00935532|425586|P1|Overall Study|Adverse Event|11
115688|NCT00935493|425615|P3|Overall Study|Treatment Discontinued|0
115689|NCT00935493|425616|P2|Overall Study|Treatment Discontinued|1
115690|NCT00935493|425617|P1|Overall Study|Treatment Discontinued|0
115691|NCT00935493|425615|P3|Overall Study|Lost to Follow-up|1
115692|NCT00935493|425616|P2|Overall Study|Lost to Follow-up|1
115693|NCT00935493|425617|P1|Overall Study|Lost to Follow-up|1
115694|NCT00935272|425655|P2|Overall Study|Protocol Violation|1
115695|NCT00935272|425656|P1|Overall Study|Protocol Violation|0
115696|NCT00935272|425655|P2|Overall Study|Physician Decision|0
115697|NCT00935272|425656|P1|Overall Study|Physician Decision|1
115698|NCT00935272|425655|P2|Overall Study|Withdrawal by Subject|2
115699|NCT00935272|425656|P1|Overall Study|Withdrawal by Subject|8
115700|NCT00935272|425655|P2|Overall Study|Lost to Follow-up|3
115701|NCT00935272|425656|P1|Overall Study|Lost to Follow-up|10
115702|NCT00935259|425665|P2|Period 1|Administrative (scheduling conflict)|1
115703|NCT00935259|425666|P1|Period 1|Administrative (scheduling conflict)|1
115704|NCT00935220|425680|P1|Overall Study|Other reason (not specified)|1
115705|NCT00935220|425680|P1|Overall Study|Adverse Event|1
115706|NCT00934947|425711|P2|Overall Study|Adverse Event|2
115707|NCT00934947|425712|P1|Overall Study|Adverse Event|0
115708|NCT00934856|425741|P6|Extension Part|Non-compliance with drug|1
115709|NCT00934856|425742|P5|Extension Part|Non-compliance with drug|0
115710|NCT00934856|425743|P4|Extension Part|Non-compliance with drug|0
115711|NCT00934856|425744|P3|Extension Part|Non-compliance with drug|0
115712|NCT00934856|425745|P2|Extension Part|Non-compliance with drug|0
115713|NCT00934856|425746|P1|Extension Part|Non-compliance with drug|0
115714|NCT00934856|425741|P6|Extension Part|Progressive disease|0
115715|NCT00934856|425742|P5|Extension Part|Progressive disease|0
115716|NCT00934856|425743|P4|Extension Part|Progressive disease|1
115717|NCT00934856|425744|P3|Extension Part|Progressive disease|0
115718|NCT00934856|425745|P2|Extension Part|Progressive disease|0
115719|NCT00934856|425746|P1|Extension Part|Progressive disease|0
115720|NCT00934856|425741|P6|Extension Part|Adverse Event|4
115721|NCT00934856|425742|P5|Extension Part|Adverse Event|4
115722|NCT00934856|425743|P4|Extension Part|Adverse Event|1
115723|NCT00934856|425744|P3|Extension Part|Adverse Event|0
115724|NCT00934856|425745|P2|Extension Part|Adverse Event|0
115725|NCT00934856|425746|P1|Extension Part|Adverse Event|0
115726|NCT00934856|425741|P6|Feasibility Part|Withdrawal by Subject|1
115727|NCT00934856|425742|P5|Feasibility Part|Withdrawal by Subject|0
115728|NCT00934856|425743|P4|Feasibility Part|Withdrawal by Subject|1
115729|NCT00934856|425744|P3|Feasibility Part|Withdrawal by Subject|0
115730|NCT00934856|425745|P2|Feasibility Part|Withdrawal by Subject|0
115731|NCT00934856|425746|P1|Feasibility Part|Withdrawal by Subject|0
115732|NCT00934856|425741|P6|Feasibility Part|Adverse Event|2
115733|NCT00934856|425742|P5|Feasibility Part|Adverse Event|0
115734|NCT00934856|425743|P4|Feasibility Part|Adverse Event|1
115735|NCT00934856|425744|P3|Feasibility Part|Adverse Event|0
115736|NCT00934856|425745|P2|Feasibility Part|Adverse Event|1
115737|NCT00934856|425746|P1|Feasibility Part|Adverse Event|1
115738|NCT00934856|425741|P6|Feasibility Part|Physician Decision|0
115739|NCT00934856|425742|P5|Feasibility Part|Physician Decision|0
115740|NCT00934856|425743|P4|Feasibility Part|Physician Decision|0
115741|NCT00934856|425744|P3|Feasibility Part|Physician Decision|1
115742|NCT00934856|425745|P2|Feasibility Part|Physician Decision|0
115743|NCT00934856|425746|P1|Feasibility Part|Physician Decision|0
115744|NCT00934856|425741|P6|Feasibility Part|Progressive disease|0
115745|NCT00934856|425742|P5|Feasibility Part|Progressive disease|0
115746|NCT00934856|425743|P4|Feasibility Part|Progressive disease|3
115747|NCT00934856|425744|P3|Feasibility Part|Progressive disease|2
115748|NCT00934856|425745|P2|Feasibility Part|Progressive disease|4
115749|NCT00934856|425746|P1|Feasibility Part|Progressive disease|4
115750|NCT00934843|425844|P2|Overall Study|Protocol Violation|1
115751|NCT00934843|425845|P1|Overall Study|Protocol Violation|0
115752|NCT00934791|425861|P2|Overall Study|Withdrawal by Subject|0
115753|NCT00934791|425862|P1|Overall Study|Withdrawal by Subject|1
115754|NCT00934661|425870|P2|Overall Study|Failure of Combined/Spinal Epidural|0
115755|NCT00934661|425871|P1|Overall Study|Failure of Combined/Spinal Epidural|1
115756|NCT00934648|425891|P1|Overall Study|Withdrawal by Subject|1
115757|NCT00934648|425891|P1|Overall Study|Failure to return|8
115758|NCT00934622|425935|P1|Overall Study|2nd Intraoperative exclusion criteria|1
115759|NCT00934622|425935|P1|Overall Study|Lost to Follow-up|7
115760|NCT00934544|425973|P2|Overall Study|Entered Extension phase INC424|18
115761|NCT00934544|425974|P1|Overall Study|Entered Extension phase INC424|29
115762|NCT00934544|425973|P2|Overall Study|Other Reasons|7
115763|NCT00934544|425974|P1|Overall Study|Other Reasons|7
115764|NCT00934544|425973|P2|Overall Study|Non-compliance with study procedures|1
115765|NCT00934544|425974|P1|Overall Study|Non-compliance with study procedures|0
115766|NCT00934544|425973|P2|Overall Study|Non-compliance with study Medication|0
115767|NCT00934544|425974|P1|Overall Study|Non-compliance with study Medication|2
115768|NCT00934544|425973|P2|Overall Study|Disease Progression|3
115769|NCT00934544|425974|P1|Overall Study|Disease Progression|1
115770|NCT00934544|425973|P2|Overall Study|Protocol Violation|0
115771|NCT00934544|425974|P1|Overall Study|Protocol Violation|2
115772|NCT00934544|425973|P2|Overall Study|Withdrawal by Subject|9
115773|NCT00934544|425974|P1|Overall Study|Withdrawal by Subject|2
115774|NCT00934544|425973|P2|Overall Study|Adverse Event|4
115775|NCT00934544|425974|P1|Overall Study|Adverse Event|12
115776|NCT00934440|425988|P1|Overall Study|Lost to Follow-up|1
115777|NCT00934362|426004|P2|Overall Study|Adverse Event|0
115778|NCT00934362|426005|P1|Overall Study|Adverse Event|1
115779|NCT00934128|426055|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
115780|NCT00934128|426056|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
115781|NCT00934128|426055|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
115782|NCT00934128|426056|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
115783|NCT00934128|426055|P2|Washout Period (1 Hour)|Too tired|0
115784|NCT00934128|426056|P1|Washout Period (1 Hour)|Too tired|1
115785|NCT00934128|426055|P2|Washout Period (1 Hour)|Pain|0
115786|NCT00934128|426056|P1|Washout Period (1 Hour)|Pain|1
115787|NCT00934128|426055|P2|Washout Period (1 Hour)|Patient preference|3
115788|NCT00934128|426056|P1|Washout Period (1 Hour)|Patient preference|1
115789|NCT00934128|426055|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
115790|NCT00934128|426056|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
115791|NCT00934128|426055|P2|First Intervention (2 Hours)|Adverse Event|1
115792|NCT00934128|426056|P1|First Intervention (2 Hours)|Adverse Event|4
115793|NCT00934128|426055|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
115794|NCT00934128|426056|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
115795|NCT00934102|426064|P3|Period 1, One Night of Wear|Personal Reasons|0
115796|NCT00934102|426065|P2|Period 1, One Night of Wear|Personal Reasons|0
115797|NCT00934102|426066|P1|Period 1, One Night of Wear|Personal Reasons|1
115798|NCT00934050|426080|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
115799|NCT00934050|426081|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
115800|NCT00934050|426082|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
115801|NCT00934050|426083|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
115802|NCT00934050|426084|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
115803|NCT00934050|426085|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
115804|NCT00934050|426080|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
115805|NCT00934050|426081|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
115806|NCT00934050|426082|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
115807|NCT00934050|426083|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
115808|NCT00934050|426084|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
115809|NCT00934050|426085|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
115810|NCT00934050|426080|P6|Enrolled After 15 Dec 2009|Death|1
115811|NCT00934050|426081|P5|Enrolled After 15 Dec 2009|Death|0
115812|NCT00934050|426082|P4|Enrolled After 15 Dec 2009|Death|0
115813|NCT00934050|426083|P3|Enrolled After 15 Dec 2009|Death|0
115814|NCT00934050|426084|P2|Enrolled After 15 Dec 2009|Death|0
115815|NCT00934050|426085|P1|Enrolled After 15 Dec 2009|Death|0
115816|NCT00934050|426080|P6|Enrolled After 15 Dec 2009|Adverse Event|0
115817|NCT00934050|426081|P5|Enrolled After 15 Dec 2009|Adverse Event|3
115818|NCT00934050|426082|P4|Enrolled After 15 Dec 2009|Adverse Event|0
115819|NCT00934050|426083|P3|Enrolled After 15 Dec 2009|Adverse Event|0
115820|NCT00934050|426084|P2|Enrolled After 15 Dec 2009|Adverse Event|0
115821|NCT00934050|426085|P1|Enrolled After 15 Dec 2009|Adverse Event|0
115822|NCT00934050|426080|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
115823|NCT00934050|426081|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
115824|NCT00934050|426082|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
115825|NCT00934050|426083|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
115826|NCT00934050|426084|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
115827|NCT00934050|426085|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
115828|NCT00934050|426080|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
115829|NCT00934050|426081|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
115830|NCT00934050|426082|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
115831|NCT00934050|426083|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
115832|NCT00934050|426084|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
115833|NCT00934050|426085|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
115834|NCT00934050|426080|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
115835|NCT00934050|426081|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
115836|NCT00934050|426082|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
115837|NCT00934050|426083|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
115838|NCT00934050|426084|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
115839|NCT00934050|426085|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
115840|NCT00933933|426100|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
115841|NCT00933933|426101|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
115842|NCT00933933|426102|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
115843|NCT00933933|426100|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
115844|NCT00933933|426101|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
115845|NCT00933933|426102|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
115846|NCT00933686|426120|P2|Overall Study|Failure to show up at endpoint visits|2
115847|NCT00933686|426121|P1|Overall Study|Failure to show up at endpoint visits|0
115848|NCT00933686|426120|P2|Overall Study|Physician Decision|0
115849|NCT00933686|426121|P1|Overall Study|Physician Decision|1
115850|NCT00933686|426120|P2|Overall Study|Adverse Event|1
115851|NCT00933686|426121|P1|Overall Study|Adverse Event|1
115852|NCT00933686|426120|P2|Overall Study|Withdrawal by Subject|5
115853|NCT00933686|426121|P1|Overall Study|Withdrawal by Subject|6
115854|NCT00933686|426120|P2|Overall Study|Lost to Follow-up|2
115855|NCT00933686|426121|P1|Overall Study|Lost to Follow-up|2
115856|NCT00933686|426120|P2|Overall Study|Protocol Violation|1
115857|NCT00933686|426121|P1|Overall Study|Protocol Violation|0
115858|NCT00933608|426141|P2|Overall Study|Physician Decision|0
115859|NCT00933608|426142|P1|Overall Study|Physician Decision|1
115860|NCT00933608|426141|P2|Overall Study|Adverse Event|2
115861|NCT00933608|426142|P1|Overall Study|Adverse Event|4
115862|NCT00933543|426150|P2|Overall Study|Other|1
115863|NCT00933543|426151|P1|Overall Study|Other|1
115864|NCT00933543|426150|P2|Overall Study|Lack of Efficacy|3
115865|NCT00933543|426151|P1|Overall Study|Lack of Efficacy|0
115866|NCT00933543|426150|P2|Overall Study|Withdrawal by Subject|1
115867|NCT00933543|426151|P1|Overall Study|Withdrawal by Subject|0
115868|NCT00933543|426150|P2|Overall Study|Lost to Follow-up|1
115869|NCT00933543|426151|P1|Overall Study|Lost to Follow-up|0
115870|NCT00933543|426150|P2|Overall Study|Adverse Event|1
115871|NCT00933543|426151|P1|Overall Study|Adverse Event|2
115872|NCT00933335|426220|P2|Overall Study|Co-morbid Illness|0
115873|NCT00933335|426221|P1|Overall Study|Co-morbid Illness|1
115874|NCT00933335|426220|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
115875|NCT00933335|426221|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
115876|NCT00933335|426220|P2|Overall Study|Progressive Disease|11
115877|NCT00933335|426221|P1|Overall Study|Progressive Disease|0
115878|NCT00933335|426220|P2|Overall Study|Withdrawal by Subject|1
115879|NCT00933335|426221|P1|Overall Study|Withdrawal by Subject|0
115880|NCT00933335|426220|P2|Overall Study|Lost to Follow-up|3
115881|NCT00933335|426221|P1|Overall Study|Lost to Follow-up|1
115882|NCT00933270|426291|P1|Overall Study|Moved or would not return|10
115883|NCT00933270|426291|P1|Overall Study|Death|24
115884|NCT00933270|426291|P1|Overall Study|Missed Visit|2
115885|NCT00933270|426291|P1|Overall Study|Adverse Event|1
115886|NCT00933270|426291|P1|Overall Study|Lost to Follow-up|14
115887|NCT00933270|426291|P1|Overall Study|Insufficient Follow-up|10
115888|NCT00933270|426291|P1|Overall Study|Withdrawal by Subject|26
115889|NCT00933244|426385|P3|Overall Study|Withdrawal by Subject|3
115890|NCT00933244|426386|P2|Overall Study|Withdrawal by Subject|1
115891|NCT00933244|426387|P1|Overall Study|Withdrawal by Subject|5
115892|NCT00933166|426404|P1|Overall Study|Withdrawal by Subject|1
115893|NCT00933166|426404|P1|Overall Study|Unavailable|4
115894|NCT00933166|426404|P1|Overall Study|Lack of Efficacy|9
115895|NCT00933166|426404|P1|Overall Study|Lost to Follow-up|4
115896|NCT00932893|426410|P2|Overall Study|Other|144
115897|NCT00932893|426411|P1|Overall Study|Other|5
115898|NCT00932893|426410|P2|Overall Study|Withdrawal by Subject|2
115899|NCT00932893|426411|P1|Overall Study|Withdrawal by Subject|5
115900|NCT00932893|426410|P2|Overall Study|Lost to Follow-up|0
115901|NCT00932893|426411|P1|Overall Study|Lost to Follow-up|8
115902|NCT00932893|426410|P2|Overall Study|Death|24
115903|NCT00932893|426411|P1|Overall Study|Death|115
115904|NCT00932646|426453|P4|Overall Study|Withdrawal by Subject|0
115905|NCT00932646|426454|P3|Overall Study|Withdrawal by Subject|3
115906|NCT00932646|426455|P2|Overall Study|Withdrawal by Subject|1
115907|NCT00932646|426456|P1|Overall Study|Withdrawal by Subject|1
115908|NCT00932646|426453|P4|Overall Study|Lost to Follow-up|0
115909|NCT00932646|426454|P3|Overall Study|Lost to Follow-up|0
115910|NCT00932646|426455|P2|Overall Study|Lost to Follow-up|1
115911|NCT00932646|426456|P1|Overall Study|Lost to Follow-up|2
115912|NCT00932646|426453|P4|Overall Study|Adverse Event|1
115913|NCT00932646|426454|P3|Overall Study|Adverse Event|1
115914|NCT00932646|426455|P2|Overall Study|Adverse Event|1
115915|NCT00932646|426456|P1|Overall Study|Adverse Event|2
115916|NCT00932451|426543|P1|Overall Study|Other reasons|5
115917|NCT00932451|426543|P1|Overall Study|Death|726
115918|NCT00932451|426543|P1|Overall Study|Lost to Follow-up|22
115919|NCT00932451|426543|P1|Overall Study|Withdrawal by Subject|69
115920|NCT00932425|426567|P2|Overall Study|Withdrawal by Subject|1
115921|NCT00932425|426568|P1|Overall Study|Withdrawal by Subject|0
115922|NCT00932425|426567|P2|Overall Study|Lost to Follow-up|1
115923|NCT00932425|426568|P1|Overall Study|Lost to Follow-up|0
115924|NCT00932373|426601|P11|Overall Study|Lack of Efficacy|0
115925|NCT00932373|426602|P10|Overall Study|Lack of Efficacy|1
115926|NCT00932373|426603|P9|Overall Study|Lack of Efficacy|0
115927|NCT00932373|426604|P8|Overall Study|Lack of Efficacy|0
115928|NCT00932373|426605|P7|Overall Study|Lack of Efficacy|0
115929|NCT00932373|426606|P6|Overall Study|Lack of Efficacy|0
115930|NCT00932373|426607|P5|Overall Study|Lack of Efficacy|0
115931|NCT00932373|426608|P4|Overall Study|Lack of Efficacy|0
115932|NCT00932373|426609|P3|Overall Study|Lack of Efficacy|0
115933|NCT00932373|426610|P2|Overall Study|Lack of Efficacy|0
115934|NCT00932373|426611|P1|Overall Study|Lack of Efficacy|0
115935|NCT00932373|426601|P11|Overall Study|Clinical progression|0
115936|NCT00932373|426602|P10|Overall Study|Clinical progression|0
115937|NCT00932373|426603|P9|Overall Study|Clinical progression|0
115938|NCT00932373|426604|P8|Overall Study|Clinical progression|0
115939|NCT00932373|426605|P7|Overall Study|Clinical progression|1
115940|NCT00932373|426606|P6|Overall Study|Clinical progression|0
115941|NCT00932373|426607|P5|Overall Study|Clinical progression|0
115942|NCT00932373|426608|P4|Overall Study|Clinical progression|0
115943|NCT00932373|426609|P3|Overall Study|Clinical progression|0
115944|NCT00932373|426610|P2|Overall Study|Clinical progression|0
115945|NCT00932373|426611|P1|Overall Study|Clinical progression|0
115946|NCT00932373|426601|P11|Overall Study|Withdrawal by Subject|0
115947|NCT00932373|426602|P10|Overall Study|Withdrawal by Subject|0
115948|NCT00932373|426603|P9|Overall Study|Withdrawal by Subject|1
115949|NCT00932373|426604|P8|Overall Study|Withdrawal by Subject|0
115950|NCT00932373|426605|P7|Overall Study|Withdrawal by Subject|0
115951|NCT00932373|426606|P6|Overall Study|Withdrawal by Subject|0
115952|NCT00932373|426607|P5|Overall Study|Withdrawal by Subject|0
115953|NCT00932373|426608|P4|Overall Study|Withdrawal by Subject|0
115954|NCT00932373|426609|P3|Overall Study|Withdrawal by Subject|0
115955|NCT00932373|426610|P2|Overall Study|Withdrawal by Subject|0
115956|NCT00932373|426611|P1|Overall Study|Withdrawal by Subject|0
115957|NCT00932373|426601|P11|Overall Study|Dose limiting toxicity|0
115958|NCT00932373|426602|P10|Overall Study|Dose limiting toxicity|0
115959|NCT00932373|426603|P9|Overall Study|Dose limiting toxicity|0
115960|NCT00932373|426604|P8|Overall Study|Dose limiting toxicity|0
115961|NCT00932373|426605|P7|Overall Study|Dose limiting toxicity|0
115962|NCT00932373|426606|P6|Overall Study|Dose limiting toxicity|1
115963|NCT00932373|426607|P5|Overall Study|Dose limiting toxicity|0
115964|NCT00932373|426608|P4|Overall Study|Dose limiting toxicity|0
115965|NCT00932373|426609|P3|Overall Study|Dose limiting toxicity|0
115966|NCT00932373|426610|P2|Overall Study|Dose limiting toxicity|0
115967|NCT00932373|426611|P1|Overall Study|Dose limiting toxicity|0
115968|NCT00932373|426601|P11|Overall Study|Physician Decision|0
115969|NCT00932373|426602|P10|Overall Study|Physician Decision|1
115970|NCT00932373|426603|P9|Overall Study|Physician Decision|0
115971|NCT00932373|426604|P8|Overall Study|Physician Decision|0
115972|NCT00932373|426605|P7|Overall Study|Physician Decision|0
115973|NCT00932373|426606|P6|Overall Study|Physician Decision|0
115974|NCT00932373|426607|P5|Overall Study|Physician Decision|2
115975|NCT00932373|426608|P4|Overall Study|Physician Decision|0
115976|NCT00932373|426609|P3|Overall Study|Physician Decision|1
115977|NCT00932373|426610|P2|Overall Study|Physician Decision|0
115978|NCT00932373|426611|P1|Overall Study|Physician Decision|0
115979|NCT00932373|426601|P11|Overall Study|Adverse Event|1
115980|NCT00932373|426602|P10|Overall Study|Adverse Event|2
115981|NCT00932373|426603|P9|Overall Study|Adverse Event|0
115982|NCT00932373|426604|P8|Overall Study|Adverse Event|1
115983|NCT00932373|426605|P7|Overall Study|Adverse Event|0
115984|NCT00932373|426606|P6|Overall Study|Adverse Event|1
115985|NCT00932373|426607|P5|Overall Study|Adverse Event|2
115986|NCT00932373|426608|P4|Overall Study|Adverse Event|0
115987|NCT00932373|426609|P3|Overall Study|Adverse Event|0
115988|NCT00932373|426610|P2|Overall Study|Adverse Event|0
115989|NCT00932373|426611|P1|Overall Study|Adverse Event|0
115990|NCT00932373|426601|P11|Overall Study|Progressive disease|2
115991|NCT00932373|426602|P10|Overall Study|Progressive disease|9
115992|NCT00932373|426603|P9|Overall Study|Progressive disease|1
115993|NCT00932373|426604|P8|Overall Study|Progressive disease|2
115994|NCT00932373|426605|P7|Overall Study|Progressive disease|0
115995|NCT00932373|426606|P6|Overall Study|Progressive disease|1
115996|NCT00932373|426607|P5|Overall Study|Progressive disease|10
115997|NCT00932373|426608|P4|Overall Study|Progressive disease|0
115998|NCT00932373|426609|P3|Overall Study|Progressive disease|0
115999|NCT00932373|426610|P2|Overall Study|Progressive disease|1
116000|NCT00932373|426611|P1|Overall Study|Progressive disease|3
116001|NCT00932165|426739|P1|Overall Study|Lost to Follow-up|1
116002|NCT00932126|426763|P8|Overall Study|Other|2
116003|NCT00932126|426764|P7|Overall Study|Other|1
116004|NCT00932126|426765|P6|Overall Study|Other|0
116005|NCT00932126|426766|P5|Overall Study|Other|1
116006|NCT00932126|426767|P4|Overall Study|Other|0
116007|NCT00932126|426768|P3|Overall Study|Other|0
116008|NCT00932126|426769|P2|Overall Study|Other|0
116009|NCT00932126|426770|P1|Overall Study|Other|0
116010|NCT00932126|426763|P8|Overall Study|Objective progression or relapse|5
116011|NCT00932126|426764|P7|Overall Study|Objective progression or relapse|3
116012|NCT00932126|426765|P6|Overall Study|Objective progression or relapse|3
116013|NCT00932126|426766|P5|Overall Study|Objective progression or relapse|3
116014|NCT00932126|426767|P4|Overall Study|Objective progression or relapse|3
116015|NCT00932126|426768|P3|Overall Study|Objective progression or relapse|2
116016|NCT00932126|426769|P2|Overall Study|Objective progression or relapse|3
116017|NCT00932126|426770|P1|Overall Study|Objective progression or relapse|3
116018|NCT00932126|426763|P8|Overall Study|Withdrawal by Subject|1
116019|NCT00932126|426764|P7|Overall Study|Withdrawal by Subject|0
116020|NCT00932126|426765|P6|Overall Study|Withdrawal by Subject|0
116021|NCT00932126|426766|P5|Overall Study|Withdrawal by Subject|0
116022|NCT00932126|426767|P4|Overall Study|Withdrawal by Subject|0
116023|NCT00932126|426768|P3|Overall Study|Withdrawal by Subject|1
116024|NCT00932126|426769|P2|Overall Study|Withdrawal by Subject|0
116025|NCT00932126|426770|P1|Overall Study|Withdrawal by Subject|0
116026|NCT00932126|426763|P8|Overall Study|Protocol Violation|0
116027|NCT00932126|426764|P7|Overall Study|Protocol Violation|0
116028|NCT00932126|426765|P6|Overall Study|Protocol Violation|0
116029|NCT00932126|426766|P5|Overall Study|Protocol Violation|1
116030|NCT00932126|426767|P4|Overall Study|Protocol Violation|0
116031|NCT00932126|426768|P3|Overall Study|Protocol Violation|0
116032|NCT00932126|426769|P2|Overall Study|Protocol Violation|0
116033|NCT00932126|426770|P1|Overall Study|Protocol Violation|0
116034|NCT00932126|426763|P8|Overall Study|Adverse Event|2
116035|NCT00932126|426764|P7|Overall Study|Adverse Event|1
116036|NCT00932126|426765|P6|Overall Study|Adverse Event|0
116037|NCT00932126|426766|P5|Overall Study|Adverse Event|0
116038|NCT00932126|426767|P4|Overall Study|Adverse Event|0
116039|NCT00932126|426768|P3|Overall Study|Adverse Event|0
116040|NCT00932126|426769|P2|Overall Study|Adverse Event|0
116041|NCT00932126|426770|P1|Overall Study|Adverse Event|0
116042|NCT00932113|426808|P2|Overall Study|Lost to Follow-up|0
116043|NCT00932113|426809|P1|Overall Study|Lost to Follow-up|1
116044|NCT00931918|426861|P2|Overall Study|Did not receive study drug|2
116045|NCT00931918|426862|P1|Overall Study|Did not receive study drug|3
116046|NCT00931918|426861|P2|Overall Study|Other Reason not Specified|4
116047|NCT00931918|426862|P1|Overall Study|Other Reason not Specified|4
116048|NCT00931918|426861|P2|Overall Study|Withdrawal by Patient|4
116049|NCT00931918|426862|P1|Overall Study|Withdrawal by Patient|3
116050|NCT00931918|426861|P2|Overall Study|Symptomatic Deterioration|0
116051|NCT00931918|426862|P1|Overall Study|Symptomatic Deterioration|1
116052|NCT00931918|426861|P2|Overall Study|Progressive Disease|1
116053|NCT00931918|426862|P1|Overall Study|Progressive Disease|2
116054|NCT00931918|426861|P2|Overall Study|Adverse Event|6
116055|NCT00931918|426862|P1|Overall Study|Adverse Event|4
116056|NCT00931801|426914|P3|Overall Study|Confirmed Virologic Failure|3
116057|NCT00931801|426915|P2|Overall Study|Confirmed Virologic Failure|0
116058|NCT00931801|426916|P1|Overall Study|Confirmed Virologic Failure|0
116059|NCT00931801|426914|P3|Overall Study|Withdrawal by Subject|0
116060|NCT00931801|426915|P2|Overall Study|Withdrawal by Subject|0
116061|NCT00931801|426916|P1|Overall Study|Withdrawal by Subject|1
116062|NCT00931801|426914|P3|Overall Study|Lost to Follow-up|0
116063|NCT00931801|426915|P2|Overall Study|Lost to Follow-up|1
116064|NCT00931801|426916|P1|Overall Study|Lost to Follow-up|0
116065|NCT00931801|426914|P3|Overall Study|Adverse Event|1
116066|NCT00931801|426915|P2|Overall Study|Adverse Event|0
116067|NCT00931801|426916|P1|Overall Study|Adverse Event|0
116068|NCT00931723|426939|P2|Overall Study|Late hospital discharge|0
116069|NCT00931723|426940|P1|Overall Study|Late hospital discharge|1
116070|NCT00931723|426939|P2|Overall Study|Sponsor decision|0
116071|NCT00931723|426940|P1|Overall Study|Sponsor decision|1
116072|NCT00931723|426939|P2|Overall Study|Lack or insufficient theraputic response|5
116073|NCT00931723|426940|P1|Overall Study|Lack or insufficient theraputic response|2
116074|NCT00931723|426939|P2|Overall Study|Took prohibited concomitant medication|1
116075|NCT00931723|426940|P1|Overall Study|Took prohibited concomitant medication|0
116076|NCT00931723|426939|P2|Overall Study|Safety reasons|1
116077|NCT00931723|426940|P1|Overall Study|Safety reasons|0
116078|NCT00931723|426939|P2|Overall Study|Severe non-compliance to protocol|0
116079|NCT00931723|426940|P1|Overall Study|Severe non-compliance to protocol|2
116080|NCT00931723|426939|P2|Overall Study|Study-specific discontinuation criteria|1
116081|NCT00931723|426940|P1|Overall Study|Study-specific discontinuation criteria|1
116082|NCT00931723|426939|P2|Overall Study|Lost to Follow-up|2
116083|NCT00931723|426940|P1|Overall Study|Lost to Follow-up|1
116084|NCT00931723|426939|P2|Overall Study|Condition under investigation worsened|2
116085|NCT00931723|426940|P1|Overall Study|Condition under investigation worsened|1
116086|NCT00931723|426939|P2|Overall Study|Lithium found in blood|1
116087|NCT00931723|426940|P1|Overall Study|Lithium found in blood|0
116088|NCT00931723|426939|P2|Overall Study|Adverse Event|13
116089|NCT00931723|426940|P1|Overall Study|Adverse Event|6
116090|NCT00931723|426939|P2|Overall Study|Withdrawal by Subject|13
116091|NCT00931723|426940|P1|Overall Study|Withdrawal by Subject|11
116092|NCT00931710|426988|P2|Overall Study|Protocol deviation|2
116093|NCT00931710|426989|P1|Overall Study|Protocol deviation|1
116094|NCT00931710|426988|P2|Overall Study|Lost to Follow-up|5
116095|NCT00931710|426989|P1|Overall Study|Lost to Follow-up|6
116096|NCT00931710|426988|P2|Overall Study|Patient withdrew consent|9
116097|NCT00931710|426989|P1|Overall Study|Patient withdrew consent|4
116098|NCT00931710|426988|P2|Overall Study|Unsatisfactory therapeutic effects|12
116099|NCT00931710|426989|P1|Overall Study|Unsatisfactory therapeutic effects|5
116100|NCT00931710|426988|P2|Overall Study|Abnormal test procedure results|0
116101|NCT00931710|426989|P1|Overall Study|Abnormal test procedure results|2
116102|NCT00931710|426988|P2|Overall Study|Adverse Event|10
116103|NCT00931710|426989|P1|Overall Study|Adverse Event|16
116104|NCT00931632|427007|P2|Overall Study|Adverse Event|15
116105|NCT00931632|427008|P1|Overall Study|Adverse Event|19
116106|NCT00931632|427007|P2|Overall Study|Withdrawal by Subject|3
116107|NCT00931632|427008|P1|Overall Study|Withdrawal by Subject|2
116108|NCT00931528|427030|P2|Overall Study|Assessment outside of Time Frame|23
116109|NCT00931528|427031|P1|Overall Study|Assessment outside of Time Frame|22
116110|NCT00931528|427030|P2|Overall Study|Lost to Follow-up|13
116111|NCT00931528|427031|P1|Overall Study|Lost to Follow-up|6
116112|NCT00931528|427030|P2|Overall Study|Withdrawal by Subject|12
116113|NCT00931528|427031|P1|Overall Study|Withdrawal by Subject|4
116114|NCT00931528|427030|P2|Overall Study|Protocol Violation|12
116115|NCT00931528|427031|P1|Overall Study|Protocol Violation|9
116116|NCT00931515|427051|P2|Overall Study|Lost to Follow-up|5
116117|NCT00931515|427052|P1|Overall Study|Lost to Follow-up|2
116118|NCT00931463|427082|P2|Overall Study|Lost to Follow-up|1
116119|NCT00931463|427083|P1|Overall Study|Lost to Follow-up|4
116120|NCT00931463|427082|P2|Overall Study|Withdrawal by Subject|0
116121|NCT00931463|427083|P1|Overall Study|Withdrawal by Subject|5
116122|NCT00931463|427082|P2|Overall Study|Death|4
116123|NCT00931463|427083|P1|Overall Study|Death|8
116124|NCT00931411|427099|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
116125|NCT00931411|427100|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
116126|NCT00931411|427099|P2|First Intervention - 42 Days|Lost to Follow-up|0
116127|NCT00931411|427100|P1|First Intervention - 42 Days|Lost to Follow-up|2
116128|NCT00931411|427099|P2|First Intervention - 42 Days|Adverse Event|3
116129|NCT00931411|427100|P1|First Intervention - 42 Days|Adverse Event|2
116130|NCT00931385|427121|P4|Overall Study|Lost to Follow-up|1
116131|NCT00931385|427122|P3|Overall Study|Lost to Follow-up|0
116132|NCT00931385|427123|P2|Overall Study|Lost to Follow-up|0
116133|NCT00931385|427124|P1|Overall Study|Lost to Follow-up|0
116134|NCT00931385|427121|P4|Overall Study|Withdrawal by Subject|1
116135|NCT00931385|427122|P3|Overall Study|Withdrawal by Subject|0
116136|NCT00931385|427123|P2|Overall Study|Withdrawal by Subject|1
116137|NCT00931385|427124|P1|Overall Study|Withdrawal by Subject|0
116138|NCT00931385|427121|P4|Overall Study|Protocol Violation|0
116139|NCT00931385|427122|P3|Overall Study|Protocol Violation|1
116140|NCT00931385|427123|P2|Overall Study|Protocol Violation|0
116141|NCT00931385|427124|P1|Overall Study|Protocol Violation|0
116142|NCT00931385|427121|P4|Overall Study|Adverse Event|3
116143|NCT00931385|427122|P3|Overall Study|Adverse Event|0
116144|NCT00931385|427123|P2|Overall Study|Adverse Event|1
116145|NCT00931385|427124|P1|Overall Study|Adverse Event|2
116146|NCT00931307|427193|P1|Overall Study|Biomicroscopy|1
116147|NCT00931307|427193|P1|Overall Study|Lack of Efficacy|12
116148|NCT00931268|427197|P1|Overall Study|Lost to Follow-up|6
116149|NCT00931255|427209|P2|Overall Study|Follow up biopsy not done|3
116150|NCT00931255|427210|P1|Overall Study|Follow up biopsy not done|2
116151|NCT00930982|427247|P2|Overall Study|Withdrawal by Subject|1
116152|NCT00930982|427248|P1|Overall Study|Withdrawal by Subject|1
116153|NCT00930982|427247|P2|Overall Study|Protocol Violation|5
116154|NCT00930982|427248|P1|Overall Study|Protocol Violation|1
116155|NCT00930982|427247|P2|Overall Study|Adverse Event|23
116156|NCT00930982|427248|P1|Overall Study|Adverse Event|19
116157|NCT00930969|427282|P1|Overall Study|Withdrawal by Subject|19
116158|NCT00930969|427282|P1|Overall Study|Physician Decision|13
116159|NCT00930969|427282|P1|Overall Study|Lost to Follow-up|1
116160|NCT00930969|427282|P1|Overall Study|Death|5
116161|NCT00930930|427292|P2|Overall Study|patients not compliant|1
116162|NCT00930930|427293|P1|Overall Study|patients not compliant|1
116163|NCT00930930|427292|P2|Overall Study|excessive lapse btw txs, not eligible|1
116164|NCT00930930|427293|P1|Overall Study|excessive lapse btw txs, not eligible|0
116165|NCT00930930|427292|P2|Overall Study|Disease progression|3
116166|NCT00930930|427293|P1|Overall Study|Disease progression|2
116167|NCT00930930|427292|P2|Overall Study|Withdrawal by Subject|1
116168|NCT00930930|427293|P1|Overall Study|Withdrawal by Subject|3
116169|NCT00930930|427292|P2|Overall Study|Adverse Event|3
116170|NCT00930930|427293|P1|Overall Study|Adverse Event|13
116171|NCT00930930|427292|P2|Overall Study|Physician Decision|0
116172|NCT00930930|427293|P1|Overall Study|Physician Decision|1
116173|NCT00930930|427292|P2|Overall Study|Death|0
116174|NCT00930930|427293|P1|Overall Study|Death|1
116175|NCT00930813|427307|P2|Overall Study|Lost to Follow-up|4
116176|NCT00930813|427308|P1|Overall Study|Lost to Follow-up|2
116177|NCT00930813|427307|P2|Overall Study|Withdrawal by Subject|5
116178|NCT00930813|427308|P1|Overall Study|Withdrawal by Subject|2
116179|NCT00930813|427307|P2|Overall Study|Death|5
116180|NCT00930813|427308|P1|Overall Study|Death|4
116181|NCT00930774|427329|P4|Overall Study|Withdrawal by Subject|0
116182|NCT00930774|427330|P3|Overall Study|Withdrawal by Subject|2
116183|NCT00930774|427331|P2|Overall Study|Withdrawal by Subject|9
116184|NCT00930774|427332|P1|Overall Study|Withdrawal by Subject|1
116185|NCT00930761|427372|P2|Overall Study|less than 3 music therapy sessions|3
116186|NCT00930761|427373|P1|Overall Study|less than 3 music therapy sessions|0
116187|NCT00930761|427372|P2|Overall Study|3 newborns died; 1 mother quit the study|0
116188|NCT00930761|427373|P1|Overall Study|3 newborns died; 1 mother quit the study|4
116189|NCT00930722|427385|P1|Overall Study|Study terminated by sponsor|2
116190|NCT00930722|427385|P1|Overall Study|No longer willing to participate|9
116191|NCT00930722|427385|P1|Overall Study|Lost to Follow-up|16
116192|NCT00930644|427400|P1|Overall Study|Adverse Event|16
116193|NCT00930644|427400|P1|Overall Study|Death|1
116194|NCT00930644|427400|P1|Overall Study|Physician Decision|2
116195|NCT00930644|427400|P1|Overall Study|Withdrawal by Subject|4
116196|NCT00930553|427413|P1|Overall Study|Other than specified above|28
116197|NCT00930553|427413|P1|Overall Study|Study terminated by sponsor|24
116198|NCT00930553|427413|P1|Overall Study|Death|9
116199|NCT00930553|427413|P1|Overall Study|Lost to Follow-up|25
116200|NCT00930553|427413|P1|Overall Study|Withdrawal by Subject|88
116201|NCT00930553|427413|P1|Overall Study|Pregnancy|1
116202|NCT00930553|427413|P1|Overall Study|Protocol Violation|1
116203|NCT00930553|427413|P1|Overall Study|Physician Decision|39
116204|NCT00930553|427413|P1|Overall Study|Lack of Efficacy|7
116205|NCT00930553|427413|P1|Overall Study|Adverse Event|1
116206|NCT00930176|427490|P1|Overall Study|Death|1
116207|NCT00929864|427507|P2|Overall Study|Non-specified|7
116208|NCT00929864|427508|P1|Overall Study|Non-specified|2
116209|NCT00929864|427507|P2|Overall Study|Administrative reason by Sponsor|1
116210|NCT00929864|427508|P1|Overall Study|Administrative reason by Sponsor|1
116211|NCT00929864|427507|P2|Overall Study|Pregnancy|3
116212|NCT00929864|427508|P1|Overall Study|Pregnancy|0
116213|NCT00929864|427507|P2|Overall Study|Poor or non-compliance|3
116214|NCT00929864|427508|P1|Overall Study|Poor or non-compliance|3
116215|NCT00929864|427507|P2|Overall Study|No longer met criteria|1
116216|NCT00929864|427508|P1|Overall Study|No longer met criteria|2
116217|NCT00929864|427507|P2|Overall Study|Withdrawal by Subject|9
116218|NCT00929864|427508|P1|Overall Study|Withdrawal by Subject|20
116219|NCT00929864|427507|P2|Overall Study|Lost to Follow-up|12
116220|NCT00929864|427508|P1|Overall Study|Lost to Follow-up|7
116221|NCT00929864|427507|P2|Overall Study|Lack of Efficacy|16
116222|NCT00929864|427508|P1|Overall Study|Lack of Efficacy|19
116223|NCT00929864|427507|P2|Overall Study|Adverse Event|30
116224|NCT00929864|427508|P1|Overall Study|Adverse Event|11
116225|NCT00929864|427507|P2|Overall Study|Death|1
116226|NCT00929864|427508|P1|Overall Study|Death|1
116227|NCT00929734|427547|P2|Overall Study|Withdrawal by Subject|2
116228|NCT00929734|427548|P1|Overall Study|Withdrawal by Subject|0
116229|NCT00929734|427547|P2|Overall Study|Lost to Follow-up|1
116230|NCT00929734|427548|P1|Overall Study|Lost to Follow-up|2
116231|NCT00929708|427565|P5|Overall Study|Lost to Follow-up|0
116232|NCT00929708|427566|P4|Overall Study|Lost to Follow-up|1
116233|NCT00929708|427567|P3|Overall Study|Lost to Follow-up|0
116234|NCT00929708|427568|P2|Overall Study|Lost to Follow-up|0
116235|NCT00929708|427569|P1|Overall Study|Lost to Follow-up|0
116236|NCT00929708|427565|P5|Overall Study|Physician Decision|1
116237|NCT00929708|427566|P4|Overall Study|Physician Decision|2
116238|NCT00929708|427567|P3|Overall Study|Physician Decision|2
116239|NCT00929708|427568|P2|Overall Study|Physician Decision|2
116240|NCT00929708|427569|P1|Overall Study|Physician Decision|0
116241|NCT00929708|427565|P5|Overall Study|Adverse Event|3
116242|NCT00929708|427566|P4|Overall Study|Adverse Event|0
116243|NCT00929708|427567|P3|Overall Study|Adverse Event|0
116244|NCT00929708|427568|P2|Overall Study|Adverse Event|0
116245|NCT00929708|427569|P1|Overall Study|Adverse Event|0
116246|NCT00929708|427565|P5|Overall Study|Withdrawal by Subject|1
116247|NCT00929708|427566|P4|Overall Study|Withdrawal by Subject|2
116248|NCT00929708|427567|P3|Overall Study|Withdrawal by Subject|0
116249|NCT00929708|427568|P2|Overall Study|Withdrawal by Subject|0
116250|NCT00929708|427569|P1|Overall Study|Withdrawal by Subject|2
116251|NCT00929708|427565|P5|Overall Study|Protocol Violation|1
116252|NCT00929708|427566|P4|Overall Study|Protocol Violation|1
116253|NCT00929708|427567|P3|Overall Study|Protocol Violation|1
116254|NCT00929708|427568|P2|Overall Study|Protocol Violation|1
116255|NCT00929708|427569|P1|Overall Study|Protocol Violation|2
116256|NCT00929695|427623|P2|Overall Study|incorrect stratification|0
116257|NCT00929695|427624|P1|Overall Study|incorrect stratification|2
116258|NCT00929695|427623|P2|Overall Study|discharge home|3
116259|NCT00929695|427624|P1|Overall Study|discharge home|4
116260|NCT00929695|427623|P2|Overall Study|Withdrawal by Subject|2
116261|NCT00929695|427624|P1|Overall Study|Withdrawal by Subject|0
116262|NCT00929695|427623|P2|Overall Study|Death|1
116263|NCT00929695|427624|P1|Overall Study|Death|2
116264|NCT00929669|427654|P1|Overall Study|elevated glucose levels|1
116265|NCT00929656|427661|P2|Overall Study|Lost to Follow-up|1
116266|NCT00929656|427662|P1|Overall Study|Lost to Follow-up|0
116267|NCT00929643|427676|P1|Overall Study|Protocol Violation|2
116268|NCT00929526|427698|P2|Overall Study|Other|6
116269|NCT00929526|427699|P1|Overall Study|Other|8
116270|NCT00929526|427698|P2|Overall Study|Lost to Follow-up|12
116271|NCT00929526|427699|P1|Overall Study|Lost to Follow-up|8
116272|NCT00929526|427698|P2|Overall Study|Withdrawal by Subject|11
116273|NCT00929526|427699|P1|Overall Study|Withdrawal by Subject|1
116274|NCT00929240|427853|P3|Maintenance Phase|Participant not treated|0
116275|NCT00929240|427854|P2|Maintenance Phase|Participant not treated|2
116276|NCT00929240|427855|P1|Maintenance Phase|Participant not treated|0
116277|NCT00929240|427853|P3|Maintenance Phase|Treatment ongoing at study closure|10
116278|NCT00929240|427854|P2|Maintenance Phase|Treatment ongoing at study closure|0
116279|NCT00929240|427855|P1|Maintenance Phase|Treatment ongoing at study closure|0
116280|NCT00929240|427853|P3|Maintenance Phase|Change of treatment|0
116281|NCT00929240|427854|P2|Maintenance Phase|Change of treatment|4
116282|NCT00929240|427855|P1|Maintenance Phase|Change of treatment|0
116283|NCT00929240|427853|P3|Maintenance Phase|Physician Decision|1
116284|NCT00929240|427854|P2|Maintenance Phase|Physician Decision|2
116285|NCT00929240|427855|P1|Maintenance Phase|Physician Decision|0
116286|NCT00929240|427853|P3|Maintenance Phase|Health authority/Study termination|2
116287|NCT00929240|427854|P2|Maintenance Phase|Health authority/Study termination|1
116288|NCT00929240|427855|P1|Maintenance Phase|Health authority/Study termination|0
116289|NCT00929240|427853|P3|Maintenance Phase|Protocol Violation|0
116290|NCT00929240|427854|P2|Maintenance Phase|Protocol Violation|1
116291|NCT00929240|427855|P1|Maintenance Phase|Protocol Violation|0
116292|NCT00929240|427853|P3|Maintenance Phase|Withdrawal by Subject|6
116293|NCT00929240|427854|P2|Maintenance Phase|Withdrawal by Subject|2
116294|NCT00929240|427855|P1|Maintenance Phase|Withdrawal by Subject|0
116295|NCT00929240|427853|P3|Maintenance Phase|Adverse Event|12
116296|NCT00929240|427854|P2|Maintenance Phase|Adverse Event|9
116297|NCT00929240|427855|P1|Maintenance Phase|Adverse Event|0
116298|NCT00929240|427853|P3|Maintenance Phase|Disease progression|60
116299|NCT00929240|427854|P2|Maintenance Phase|Disease progression|73
116300|NCT00929240|427855|P1|Maintenance Phase|Disease progression|0
116301|NCT00929240|427853|P3|Initial Treatment Phase|Physician Decision|0
116302|NCT00929240|427854|P2|Initial Treatment Phase|Physician Decision|0
116303|NCT00929240|427855|P1|Initial Treatment Phase|Physician Decision|4
116304|NCT00929240|427853|P3|Initial Treatment Phase|Health authority/Study termination|0
116305|NCT00929240|427854|P2|Initial Treatment Phase|Health authority/Study termination|0
116306|NCT00929240|427855|P1|Initial Treatment Phase|Health authority/Study termination|3
116307|NCT00929240|427853|P3|Initial Treatment Phase|Death|0
116308|NCT00929240|427854|P2|Initial Treatment Phase|Death|0
116309|NCT00929240|427855|P1|Initial Treatment Phase|Death|2
116310|NCT00929240|427853|P3|Initial Treatment Phase|Protocol Violation|0
116311|NCT00929240|427854|P2|Initial Treatment Phase|Protocol Violation|0
116312|NCT00929240|427855|P1|Initial Treatment Phase|Protocol Violation|5
116313|NCT00929240|427853|P3|Initial Treatment Phase|Withdrawal by Subject|0
116314|NCT00929240|427854|P2|Initial Treatment Phase|Withdrawal by Subject|0
116315|NCT00929240|427855|P1|Initial Treatment Phase|Withdrawal by Subject|13
116316|NCT00929240|427853|P3|Initial Treatment Phase|Disease progression|0
116317|NCT00929240|427854|P2|Initial Treatment Phase|Disease progression|0
116318|NCT00929240|427855|P1|Initial Treatment Phase|Disease progression|41
116319|NCT00929240|427853|P3|Initial Treatment Phase|Adverse Event|0
116320|NCT00929240|427854|P2|Initial Treatment Phase|Adverse Event|0
116321|NCT00929240|427855|P1|Initial Treatment Phase|Adverse Event|31
116322|NCT00929201|427882|P2|Period 1|Withdrawal by Subject|1
116323|NCT00929201|427883|P1|Period 1|Withdrawal by Subject|0
116324|NCT00929162|427893|P2|Overall Study|Other termination reason|6
116325|NCT00929162|427894|P1|Overall Study|Other termination reason|5
116326|NCT00929162|427893|P2|Overall Study|Protocol Violation|30
116327|NCT00929162|427894|P1|Overall Study|Protocol Violation|32
116328|NCT00929162|427893|P2|Overall Study|Withdrawal by Subject|1
116329|NCT00929162|427894|P1|Overall Study|Withdrawal by Subject|3
116330|NCT00929162|427893|P2|Overall Study|Adverse Event|5
116331|NCT00929162|427894|P1|Overall Study|Adverse Event|8
116332|NCT00929110|427907|P3|Overall Study|Patient inability to use the device|0
116333|NCT00929110|427908|P2|Overall Study|Patient inability to use the device|1
116334|NCT00929110|427909|P1|Overall Study|Patient inability to use the device|0
116335|NCT00929110|427907|P3|Overall Study|Abnormal test procedure result(s)|1
116336|NCT00929110|427908|P2|Overall Study|Abnormal test procedure result(s)|1
116337|NCT00929110|427909|P1|Overall Study|Abnormal test procedure result(s)|0
116338|NCT00929110|427907|P3|Overall Study|Abnormal laboratory value(s)|0
116339|NCT00929110|427908|P2|Overall Study|Abnormal laboratory value(s)|1
116340|NCT00929110|427909|P1|Overall Study|Abnormal laboratory value(s)|0
116341|NCT00929110|427907|P3|Overall Study|Death|2
116342|NCT00929110|427908|P2|Overall Study|Death|2
116343|NCT00929110|427909|P1|Overall Study|Death|2
116344|NCT00929110|427907|P3|Overall Study|Administrative problems|2
116345|NCT00929110|427908|P2|Overall Study|Administrative problems|1
116346|NCT00929110|427909|P1|Overall Study|Administrative problems|4
116347|NCT00929110|427907|P3|Overall Study|Protocol deviation|4
116348|NCT00929110|427908|P2|Overall Study|Protocol deviation|2
116349|NCT00929110|427909|P1|Overall Study|Protocol deviation|5
116350|NCT00929110|427907|P3|Overall Study|Lost to Follow-up|3
116351|NCT00929110|427908|P2|Overall Study|Lost to Follow-up|7
116352|NCT00929110|427909|P1|Overall Study|Lost to Follow-up|7
116353|NCT00929110|427907|P3|Overall Study|Unsatisfactory therapeutic effect|6
116354|NCT00929110|427908|P2|Overall Study|Unsatisfactory therapeutic effect|9
116355|NCT00929110|427909|P1|Overall Study|Unsatisfactory therapeutic effect|20
116356|NCT00929110|427907|P3|Overall Study|Subject withdrew consent|26
116357|NCT00929110|427908|P2|Overall Study|Subject withdrew consent|23
116358|NCT00929110|427909|P1|Overall Study|Subject withdrew consent|40
116359|NCT00929110|427907|P3|Overall Study|Adverse Event|18
116360|NCT00929110|427908|P2|Overall Study|Adverse Event|29
116361|NCT00929110|427909|P1|Overall Study|Adverse Event|40
116362|NCT00928889|427992|P2|Overall Study|Other|0
116363|NCT00928889|427993|P1|Overall Study|Other|1
116364|NCT00928889|427992|P2|Overall Study|Adverse Event|0
116365|NCT00928889|427993|P1|Overall Study|Adverse Event|1
116366|NCT00928889|427992|P2|Overall Study|Protocol Violation|1
116367|NCT00928889|427993|P1|Overall Study|Protocol Violation|0
116368|NCT00928889|427992|P2|Overall Study|Lost to Follow-up|1
116369|NCT00928889|427993|P1|Overall Study|Lost to Follow-up|3
116370|NCT00928746|428039|P1|Overall Study|Other|2
116371|NCT00928746|428039|P1|Overall Study|Withdrawal by Subject|1
116372|NCT00928746|428039|P1|Overall Study|Protocol Violation|1
116373|NCT00928746|428039|P1|Overall Study|Adverse Event|2
116374|NCT00928668|428081|P5|Overall Study|Other reasons not listed above|0
116375|NCT00928668|428082|P4|Overall Study|Other reasons not listed above|1
116376|NCT00928668|428083|P3|Overall Study|Other reasons not listed above|0
116377|NCT00928668|428084|P2|Overall Study|Other reasons not listed above|0
116378|NCT00928668|428085|P1|Overall Study|Other reasons not listed above|0
116379|NCT00928668|428081|P5|Overall Study|Withdrawal by Subject|0
116380|NCT00928668|428082|P4|Overall Study|Withdrawal by Subject|0
116381|NCT00928668|428083|P3|Overall Study|Withdrawal by Subject|1
116382|NCT00928668|428084|P2|Overall Study|Withdrawal by Subject|1
116383|NCT00928668|428085|P1|Overall Study|Withdrawal by Subject|0
116384|NCT00928668|428081|P5|Overall Study|Protocol Violation|1
116385|NCT00928668|428082|P4|Overall Study|Protocol Violation|0
116386|NCT00928668|428083|P3|Overall Study|Protocol Violation|0
116387|NCT00928668|428084|P2|Overall Study|Protocol Violation|0
116388|NCT00928668|428085|P1|Overall Study|Protocol Violation|0
116389|NCT00928668|428081|P5|Overall Study|Adverse Event|0
116390|NCT00928668|428082|P4|Overall Study|Adverse Event|0
116391|NCT00928668|428083|P3|Overall Study|Adverse Event|0
116392|NCT00928668|428084|P2|Overall Study|Adverse Event|0
116393|NCT00928668|428085|P1|Overall Study|Adverse Event|1
116394|NCT00928512|428141|P5|Overall Study|Administrative Problems|0
116395|NCT00928512|428142|P4|Overall Study|Administrative Problems|0
116396|NCT00928512|428143|P3|Overall Study|Administrative Problems|0
116397|NCT00928512|428144|P2|Overall Study|Administrative Problems|1
116398|NCT00928512|428145|P1|Overall Study|Administrative Problems|0
116399|NCT00928512|428141|P5|Overall Study|Lost to Follow-up|3
116400|NCT00928512|428142|P4|Overall Study|Lost to Follow-up|1
116401|NCT00928512|428143|P3|Overall Study|Lost to Follow-up|2
116402|NCT00928512|428144|P2|Overall Study|Lost to Follow-up|1
116403|NCT00928512|428145|P1|Overall Study|Lost to Follow-up|1
116404|NCT00928512|428141|P5|Overall Study|Withdrawal by Subject|0
116405|NCT00928512|428142|P4|Overall Study|Withdrawal by Subject|4
116406|NCT00928512|428143|P3|Overall Study|Withdrawal by Subject|3
116407|NCT00928512|428144|P2|Overall Study|Withdrawal by Subject|0
116408|NCT00928512|428145|P1|Overall Study|Withdrawal by Subject|3
116409|NCT00928512|428141|P5|Overall Study|Protocol Violation|3
116410|NCT00928512|428142|P4|Overall Study|Protocol Violation|1
116411|NCT00928512|428143|P3|Overall Study|Protocol Violation|0
116412|NCT00928512|428144|P2|Overall Study|Protocol Violation|1
116413|NCT00928512|428145|P1|Overall Study|Protocol Violation|0
116414|NCT00928512|428141|P5|Overall Study|Lack of Efficacy|3
116415|NCT00928512|428142|P4|Overall Study|Lack of Efficacy|7
116416|NCT00928512|428143|P3|Overall Study|Lack of Efficacy|4
116417|NCT00928512|428144|P2|Overall Study|Lack of Efficacy|0
116418|NCT00928512|428145|P1|Overall Study|Lack of Efficacy|2
116419|NCT00928512|428141|P5|Overall Study|Adverse Event|6
116420|NCT00928512|428142|P4|Overall Study|Adverse Event|8
116421|NCT00928512|428143|P3|Overall Study|Adverse Event|2
116422|NCT00928512|428144|P2|Overall Study|Adverse Event|3
116423|NCT00928512|428145|P1|Overall Study|Adverse Event|4
116424|NCT00928486|428246|P1|Overall Study|Withdrawal by Subject|1
116425|NCT00928486|428246|P1|Overall Study|Disease Progression|7
116426|NCT00928486|428246|P1|Overall Study|Adverse Event|2
116427|NCT00928434|428255|P3|Overall Study|Other (not meeting above criteria)|2
116428|NCT00928434|428256|P2|Overall Study|Other (not meeting above criteria)|1
116429|NCT00928434|428257|P1|Overall Study|Other (not meeting above criteria)|5
116430|NCT00928434|428255|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
116431|NCT00928434|428256|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
116432|NCT00928434|428257|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
116433|NCT00928434|428255|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
116434|NCT00928434|428256|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
116435|NCT00928434|428257|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
116436|NCT00928434|428255|P3|Overall Study|Withdrawal by Subject|2
116437|NCT00928434|428256|P2|Overall Study|Withdrawal by Subject|3
116438|NCT00928434|428257|P1|Overall Study|Withdrawal by Subject|5
116439|NCT00928434|428255|P3|Overall Study|Lost to Follow-up|3
116440|NCT00928434|428256|P2|Overall Study|Lost to Follow-up|0
116441|NCT00928434|428257|P1|Overall Study|Lost to Follow-up|1
116442|NCT00928434|428255|P3|Overall Study|Physician Decision|3
116443|NCT00928434|428256|P2|Overall Study|Physician Decision|0
116444|NCT00928434|428257|P1|Overall Study|Physician Decision|2
116445|NCT00928434|428255|P3|Overall Study|Protocol Violation|8
116446|NCT00928434|428256|P2|Overall Study|Protocol Violation|0
116447|NCT00928434|428257|P1|Overall Study|Protocol Violation|5
116448|NCT00928434|428255|P3|Overall Study|Adverse Event|18
116449|NCT00928434|428256|P2|Overall Study|Adverse Event|5
116450|NCT00928434|428257|P1|Overall Study|Adverse Event|14
116451|NCT00928408|428333|P1|Overall Study|Lost to Follow-up|12
116452|NCT00928408|428333|P1|Overall Study|Death|5
116453|NCT00928408|428333|P1|Overall Study|Withdrawal by Subject|4
116454|NCT00928408|428333|P1|Overall Study|Other|2
116455|NCT00928252|428379|P1|Overall Study|Physician Decision|3
116456|NCT00928187|428388|P3|Overall Study|Protocol Violation|0
116457|NCT00928187|428389|P2|Overall Study|Protocol Violation|1
116458|NCT00928187|428390|P1|Overall Study|Protocol Violation|0
116459|NCT00928187|428388|P3|Overall Study|Withdrawal by Subject|1
116460|NCT00928187|428389|P2|Overall Study|Withdrawal by Subject|1
116461|NCT00928187|428390|P1|Overall Study|Withdrawal by Subject|0
116462|NCT00928187|428388|P3|Overall Study|Lost to Follow-up|1
116463|NCT00928187|428389|P2|Overall Study|Lost to Follow-up|2
116464|NCT00928187|428390|P1|Overall Study|Lost to Follow-up|1
116465|NCT00928187|428388|P3|Overall Study|Death|3
116466|NCT00928187|428389|P2|Overall Study|Death|2
116467|NCT00928187|428390|P1|Overall Study|Death|1
116468|NCT00928070|428560|P2|Overall Study|Other|5
116469|NCT00928070|428561|P1|Overall Study|Other|5
116470|NCT00928070|428560|P2|Overall Study|Randomized but not treated|2
116471|NCT00928070|428561|P1|Overall Study|Randomized but not treated|2
116472|NCT00928070|428560|P2|Overall Study|Protocol Violation|5
116473|NCT00928070|428561|P1|Overall Study|Protocol Violation|6
116474|NCT00928070|428560|P2|Overall Study|Did not meet entrance criteria|9
116475|NCT00928070|428561|P1|Overall Study|Did not meet entrance criteria|16
116476|NCT00928070|428560|P2|Overall Study|Lack of Efficacy|5
116477|NCT00928070|428561|P1|Overall Study|Lack of Efficacy|9
116478|NCT00928070|428560|P2|Overall Study|Adverse Event|26
116479|NCT00928070|428561|P1|Overall Study|Adverse Event|14
116480|NCT00928070|428560|P2|Overall Study|Withdrawal by Subject|3
116481|NCT00928070|428561|P1|Overall Study|Withdrawal by Subject|10
116482|NCT00928070|428560|P2|Overall Study|Lost to Follow-up|2
116483|NCT00928070|428561|P1|Overall Study|Lost to Follow-up|1
116484|NCT00928057|428619|P2|Overall Study|Protocol Violation|1
116485|NCT00928057|428620|P1|Overall Study|Protocol Violation|0
116486|NCT00928057|428619|P2|Overall Study|Lost to Follow-up|1
116487|NCT00928057|428620|P1|Overall Study|Lost to Follow-up|0
116488|NCT00928057|428619|P2|Overall Study|Withdrawal by Subject|0
116489|NCT00928057|428620|P1|Overall Study|Withdrawal by Subject|1
116490|NCT00928057|428619|P2|Overall Study|Adverse Event|2
116491|NCT00928057|428620|P1|Overall Study|Adverse Event|1
116492|NCT00928018|428645|P2|Overall Study|Withdrawal by Subject|0
116493|NCT00928018|428646|P1|Overall Study|Withdrawal by Subject|1
116494|NCT00927953|428676|P2|Overall Study|Death|1
116495|NCT00927953|428677|P1|Overall Study|Death|2
116496|NCT00927940|428691|P1|Overall Study|Death|1
116497|NCT00927927|428711|P15|Overall Study|Withdrawal by Subject|0
116498|NCT00927927|428712|P14|Overall Study|Withdrawal by Subject|0
116499|NCT00927927|428713|P13|Overall Study|Withdrawal by Subject|0
116500|NCT00927927|428714|P12|Overall Study|Withdrawal by Subject|2
116501|NCT00927927|428715|P11|Overall Study|Withdrawal by Subject|0
116502|NCT00927927|428716|P10|Overall Study|Withdrawal by Subject|0
116503|NCT00927927|428717|P9|Overall Study|Withdrawal by Subject|0
116504|NCT00927927|428718|P8|Overall Study|Withdrawal by Subject|2
116505|NCT00927927|428719|P7|Overall Study|Withdrawal by Subject|0
116506|NCT00927927|428720|P6|Overall Study|Withdrawal by Subject|0
116507|NCT00927927|428721|P5|Overall Study|Withdrawal by Subject|0
116508|NCT00927927|428722|P4|Overall Study|Withdrawal by Subject|0
116509|NCT00927927|428723|P3|Overall Study|Withdrawal by Subject|0
116510|NCT00927927|428724|P2|Overall Study|Withdrawal by Subject|0
116511|NCT00927927|428725|P1|Overall Study|Withdrawal by Subject|0
116512|NCT00927901|428772|P4|Treatment Period 4|Subject withdrew consent|0
116513|NCT00927901|428773|P3|Treatment Period 4|Subject withdrew consent|1
116514|NCT00927901|428774|P2|Treatment Period 4|Subject withdrew consent|0
116515|NCT00927901|428775|P1|Treatment Period 4|Subject withdrew consent|0
116516|NCT00927901|428772|P4|Treatment Period 4|Adverse Event|1
116517|NCT00927901|428773|P3|Treatment Period 4|Adverse Event|0
116518|NCT00927901|428774|P2|Treatment Period 4|Adverse Event|0
116519|NCT00927901|428775|P1|Treatment Period 4|Adverse Event|0
116520|NCT00927901|428772|P4|Treatment Period 1|Subject withdrew consent|0
116521|NCT00927901|428773|P3|Treatment Period 1|Subject withdrew consent|1
116522|NCT00927901|428774|P2|Treatment Period 1|Subject withdrew consent|0
116523|NCT00927901|428775|P1|Treatment Period 1|Subject withdrew consent|0
116524|NCT00927862|428816|P2|Overall Study|Missing data needed for endpt analyses|45
116525|NCT00927862|428817|P1|Overall Study|Missing data needed for endpt analyses|27
116526|NCT00927823|428852|P4|Continuous Dosing Period|Other|3
116527|NCT00927823|428853|P3|Continuous Dosing Period|Other|9
116528|NCT00927823|428854|P2|Continuous Dosing Period|Other|2
116529|NCT00927823|428855|P1|Continuous Dosing Period|Other|1
116530|NCT00927823|428852|P4|Continuous Dosing Period|Withdrawal by Subject|2
116531|NCT00927823|428853|P3|Continuous Dosing Period|Withdrawal by Subject|2
116532|NCT00927823|428854|P2|Continuous Dosing Period|Withdrawal by Subject|0
116533|NCT00927823|428855|P1|Continuous Dosing Period|Withdrawal by Subject|1
116534|NCT00927823|428852|P4|Continuous Dosing Period|Lost to Follow-up|0
116535|NCT00927823|428853|P3|Continuous Dosing Period|Lost to Follow-up|9
116536|NCT00927823|428854|P2|Continuous Dosing Period|Lost to Follow-up|1
116537|NCT00927823|428855|P1|Continuous Dosing Period|Lost to Follow-up|1
116538|NCT00927823|428852|P4|Continuous Dosing Period|Death|0
116539|NCT00927823|428853|P3|Continuous Dosing Period|Death|6
116540|NCT00927823|428854|P2|Continuous Dosing Period|Death|0
116541|NCT00927823|428855|P1|Continuous Dosing Period|Death|0
116542|NCT00927758|428919|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
116543|NCT00927758|428920|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
116544|NCT00927758|428921|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
116545|NCT00927758|428922|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
116546|NCT00927758|428923|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
116547|NCT00927758|428924|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
116548|NCT00927758|428919|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
116549|NCT00927758|428920|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
116550|NCT00927758|428921|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
116551|NCT00927758|428922|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
116552|NCT00927758|428923|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
116553|NCT00927758|428924|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
116554|NCT00927589|428932|P1|Overall Study|Non-compliance|1
116555|NCT00927589|428932|P1|Overall Study|Disease Progression|8
116556|NCT00927589|428932|P1|Overall Study|Adverse Event|2
116557|NCT00927589|428932|P1|Overall Study|Withdrawal by Subject|3
116558|NCT00927589|428932|P1|Overall Study|Physician Decision|1
116559|NCT00927589|428932|P1|Overall Study|Death|1
116560|NCT00927563|428962|P1|Overall Study|Withdrawal by Subject|1
116561|NCT00927563|428962|P1|Overall Study|Lost to Follow-up|1
116562|NCT00927472|428970|P2|Overall Study|Post treatment Assessment out of window|4
116563|NCT00927472|428971|P1|Overall Study|Post treatment Assessment out of window|0
116564|NCT00927472|428970|P2|Overall Study|Protocol Violation|1
116565|NCT00927472|428971|P1|Overall Study|Protocol Violation|0
116566|NCT00927472|428970|P2|Overall Study|Lost to Follow-up|6
116567|NCT00927472|428971|P1|Overall Study|Lost to Follow-up|1
116568|NCT00927472|428970|P2|Overall Study|Withdrawal by Subject|11
116569|NCT00927472|428971|P1|Overall Study|Withdrawal by Subject|10
116570|NCT00927394|428997|P2|Overall Study|Randomized in error|1
116571|NCT00927394|428998|P1|Overall Study|Randomized in error|0
116572|NCT00927394|428997|P2|Overall Study|Protocol deviation|13
116573|NCT00927394|428998|P1|Overall Study|Protocol deviation|16
116574|NCT00927394|428997|P2|Overall Study|Death|1
116575|NCT00927394|428998|P1|Overall Study|Death|1
116576|NCT00927394|428997|P2|Overall Study|Administrative Problem|0
116577|NCT00927394|428998|P1|Overall Study|Administrative Problem|1
116578|NCT00927394|428997|P2|Overall Study|Lost to Follow-up|14
116579|NCT00927394|428998|P1|Overall Study|Lost to Follow-up|8
116580|NCT00927394|428997|P2|Overall Study|Withdrawal by Subject|24
116581|NCT00927394|428998|P1|Overall Study|Withdrawal by Subject|20
116582|NCT00927394|428997|P2|Overall Study|Unsatisfactory therapeutic effect|23
116583|NCT00927394|428998|P1|Overall Study|Unsatisfactory therapeutic effect|17
116584|NCT00927394|428997|P2|Overall Study|Adverse Event|9
116585|NCT00927394|428998|P1|Overall Study|Adverse Event|14
116586|NCT00927368|429029|P3|Overall Study|cancellation of surgery|2
116587|NCT00927368|429030|P2|Overall Study|cancellation of surgery|1
116588|NCT00927368|429031|P1|Overall Study|cancellation of surgery|0
116589|NCT00927368|429029|P3|Overall Study|ineligible post randomization|1
116590|NCT00927368|429030|P2|Overall Study|ineligible post randomization|3
116591|NCT00927368|429031|P1|Overall Study|ineligible post randomization|0
116592|NCT00927368|429029|P3|Overall Study|equipment failure|0
116593|NCT00927368|429030|P2|Overall Study|equipment failure|0
116594|NCT00927368|429031|P1|Overall Study|equipment failure|1
116595|NCT00927368|429029|P3|Overall Study|Lost to Follow-up|0
116596|NCT00927368|429030|P2|Overall Study|Lost to Follow-up|0
116597|NCT00927368|429031|P1|Overall Study|Lost to Follow-up|4
116598|NCT00927368|429029|P3|Overall Study|enrollment in another study|2
116599|NCT00927368|429030|P2|Overall Study|enrollment in another study|1
116600|NCT00927368|429031|P1|Overall Study|enrollment in another study|1
116601|NCT00927355|429050|P2|Overall Study|Adverse Event|1
116602|NCT00927355|429051|P1|Overall Study|Adverse Event|1
116603|NCT00927251|429086|P1|Overall Study|Patients not implanted with 4296 lead|8
116604|NCT00927186|429092|P2|12 Months Primary Study|Withdrawal by Subject|1
116605|NCT00927186|429093|P1|12 Months Primary Study|Withdrawal by Subject|1
116606|NCT00927186|429092|P2|12 Months Primary Study|Protocol Violation|1
116607|NCT00927186|429093|P1|12 Months Primary Study|Protocol Violation|0
116608|NCT00927186|429092|P2|12 Months Primary Study|Lost to Follow-up|0
116609|NCT00927186|429093|P1|12 Months Primary Study|Lost to Follow-up|1
116610|NCT00927186|429092|P2|12 Months Primary Study|Adverse Event|2
116611|NCT00927186|429093|P1|12 Months Primary Study|Adverse Event|5
116612|NCT00927095|429223|P3|Overall Study|Physician Decision|1
116613|NCT00927095|429224|P2|Overall Study|Physician Decision|2
116614|NCT00927095|429225|P1|Overall Study|Physician Decision|1
116615|NCT00927095|429223|P3|Overall Study|Withdrawal by Subject|1
116616|NCT00927095|429224|P2|Overall Study|Withdrawal by Subject|1
116617|NCT00927095|429225|P1|Overall Study|Withdrawal by Subject|2
116618|NCT00927095|429223|P3|Overall Study|Adverse Event|0
116619|NCT00927095|429224|P2|Overall Study|Adverse Event|1
116620|NCT00927095|429225|P1|Overall Study|Adverse Event|3
116621|NCT00927082|429237|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
116622|NCT00927082|429238|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
116623|NCT00927082|429239|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
116624|NCT00927082|429240|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
116625|NCT00927082|429237|P4|Overall Study|Death|0
116626|NCT00927082|429238|P3|Overall Study|Death|1
116627|NCT00927082|429239|P2|Overall Study|Death|0
116628|NCT00927082|429240|P1|Overall Study|Death|0
116629|NCT00927082|429237|P4|Overall Study|Withdrawal by Subject|2
116630|NCT00927082|429238|P3|Overall Study|Withdrawal by Subject|7
116631|NCT00927082|429239|P2|Overall Study|Withdrawal by Subject|2
116632|NCT00927082|429240|P1|Overall Study|Withdrawal by Subject|3
116633|NCT00927082|429237|P4|Overall Study|Lost to Follow-up|16
116634|NCT00927082|429238|P3|Overall Study|Lost to Follow-up|12
116635|NCT00927082|429239|P2|Overall Study|Lost to Follow-up|8
116636|NCT00927082|429240|P1|Overall Study|Lost to Follow-up|9
116637|NCT00927069|429304|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
116638|NCT00927069|429305|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
116639|NCT00927069|429306|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
116640|NCT00927069|429307|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
116641|NCT00927069|429304|P4|Week 12 to Week 24|Withdrawal by Subject|0
116642|NCT00927069|429305|P3|Week 12 to Week 24|Withdrawal by Subject|0
116643|NCT00927069|429306|P2|Week 12 to Week 24|Withdrawal by Subject|0
116644|NCT00927069|429307|P1|Week 12 to Week 24|Withdrawal by Subject|1
116645|NCT00927069|429304|P4|Week 12 to Week 24|Lost to Follow-up|0
116646|NCT00927069|429305|P3|Week 12 to Week 24|Lost to Follow-up|1
116647|NCT00927069|429306|P2|Week 12 to Week 24|Lost to Follow-up|0
116648|NCT00927069|429307|P1|Week 12 to Week 24|Lost to Follow-up|0
116649|NCT00927069|429304|P4|Week 12 to Week 24|Lack of Efficacy|3
116650|NCT00927069|429305|P3|Week 12 to Week 24|Lack of Efficacy|2
116651|NCT00927069|429306|P2|Week 12 to Week 24|Lack of Efficacy|0
116652|NCT00927069|429307|P1|Week 12 to Week 24|Lack of Efficacy|0
116653|NCT00927069|429304|P4|Week 0 to Week 12|Worsening of psoriasis|0
116654|NCT00927069|429305|P3|Week 0 to Week 12|Worsening of psoriasis|0
116655|NCT00927069|429306|P2|Week 0 to Week 12|Worsening of psoriasis|1
116656|NCT00927069|429307|P1|Week 0 to Week 12|Worsening of psoriasis|1
116657|NCT00926796|429344|P2|Overall Study|Withdrawal by Subject|0
116658|NCT00926796|429345|P1|Overall Study|Withdrawal by Subject|1
116659|NCT00926796|429344|P2|Overall Study|Protocol Violation|11
116660|NCT00926796|429345|P1|Overall Study|Protocol Violation|15
116661|NCT00926796|429344|P2|Overall Study|Lost to Follow-up|13
116662|NCT00926796|429345|P1|Overall Study|Lost to Follow-up|22
116663|NCT00926796|429344|P2|Overall Study|Adverse Event|14
116664|NCT00926796|429345|P1|Overall Study|Adverse Event|7
116665|NCT00926796|429344|P2|Overall Study|Ineligible, but positive for gonorrhea|1
116666|NCT00926796|429345|P1|Overall Study|Ineligible, but positive for gonorrhea|1
116667|NCT00926796|429344|P2|Overall Study|Ineligible, negative for gonorrhea|60
116668|NCT00926796|429345|P1|Overall Study|Ineligible, negative for gonorrhea|57
116669|NCT00926796|429344|P2|Overall Study|Did not receive randomized treatment|7
116670|NCT00926796|429345|P1|Overall Study|Did not receive randomized treatment|4
116671|NCT00926783|429366|P2|Overall Study|Incomplete CFAE Procedures|3
116672|NCT00926783|429367|P1|Overall Study|Incomplete CFAE Procedures|3
116673|NCT00926575|429394|P2|Overall Study|Withdrawal by Subject|9
116674|NCT00926575|429395|P1|Overall Study|Withdrawal by Subject|8
116675|NCT00926575|429394|P2|Overall Study|Protocol Violation|0
116676|NCT00926575|429395|P1|Overall Study|Protocol Violation|1
116677|NCT00926575|429394|P2|Overall Study|Physician Decision|2
116678|NCT00926575|429395|P1|Overall Study|Physician Decision|1
116679|NCT00926575|429394|P2|Overall Study|Lost to Follow-up|1
116680|NCT00926575|429395|P1|Overall Study|Lost to Follow-up|1
116681|NCT00926575|429394|P2|Overall Study|Death|4
116682|NCT00926575|429395|P1|Overall Study|Death|4
116683|NCT00926575|429394|P2|Overall Study|Adverse Event|1
116684|NCT00926575|429395|P1|Overall Study|Adverse Event|1
116685|NCT00926536|429407|P2|Overall Study|Physician Decision|2
116686|NCT00926536|429408|P1|Overall Study|Physician Decision|1
116687|NCT00926393|429429|P2|Overall Study|Adverse Event|1
116688|NCT00926393|429430|P1|Overall Study|Adverse Event|1
116689|NCT00926393|429429|P2|Overall Study|Withdrawal by Subject|2
116690|NCT00926393|429430|P1|Overall Study|Withdrawal by Subject|1
116691|NCT00926367|429475|P2|Overall Study|Skin Irritation|2
116692|NCT00926367|429476|P1|Overall Study|Skin Irritation|1
116693|NCT00926367|429475|P2|Overall Study|Lost to Follow-up|0
116694|NCT00926367|429476|P1|Overall Study|Lost to Follow-up|1
116695|NCT00926367|429475|P2|Overall Study|Withdrawal by Subject|1
116696|NCT00926367|429476|P1|Overall Study|Withdrawal by Subject|0
116697|NCT00926328|429518|P2|Overall Study|Lost to Follow-up|14
116698|NCT00926328|429519|P1|Overall Study|Lost to Follow-up|12
116699|NCT00926289|429529|P2|Overall Study|not specified|3
116700|NCT00926289|429530|P1|Overall Study|not specified|1
116701|NCT00926289|429529|P2|Overall Study|Withdrawal by Subject|4
116702|NCT00926289|429530|P1|Overall Study|Withdrawal by Subject|4
116703|NCT00926289|429529|P2|Overall Study|Lost to Follow-up|6
116704|NCT00926289|429530|P1|Overall Study|Lost to Follow-up|3
116705|NCT00926289|429529|P2|Overall Study|Protocol Violation|12
116706|NCT00926289|429530|P1|Overall Study|Protocol Violation|8
116707|NCT00926289|429529|P2|Overall Study|Adverse Event|11
116708|NCT00926289|429530|P1|Overall Study|Adverse Event|9
116709|NCT00926211|429598|P1|Overall Study|Lost to Follow-up|1
116710|NCT00926029|429629|P3|Overall Study|Lost to Follow-up|1
116711|NCT00926029|429630|P2|Overall Study|Lost to Follow-up|1
116712|NCT00926029|429631|P1|Overall Study|Lost to Follow-up|2
116713|NCT00925990|429644|P2|Overall Study|moved out of state, missed medication|2
116714|NCT00925990|429645|P1|Overall Study|moved out of state, missed medication|0
116715|NCT00925990|429644|P2|Overall Study|Physician Decision|1
116716|NCT00925990|429645|P1|Overall Study|Physician Decision|1
116717|NCT00925990|429644|P2|Overall Study|Lost to Follow-up|3
116718|NCT00925990|429645|P1|Overall Study|Lost to Follow-up|1
116719|NCT00925990|429644|P2|Overall Study|Withdrawal by Subject|2
116720|NCT00925990|429645|P1|Overall Study|Withdrawal by Subject|2
116721|NCT00925990|429644|P2|Overall Study|Adverse Event|3
116722|NCT00925990|429645|P1|Overall Study|Adverse Event|1
116723|NCT00925899|429680|P2|Part 1|Withdrawal by Subject|9
116724|NCT00925899|429681|P1|Part 1|Withdrawal by Subject|10
116725|NCT00925899|429680|P2|Part 1|Death|2
116726|NCT00925899|429681|P1|Part 1|Death|1
116727|NCT00925769|429709|P6|Overall Study|Adverse Event|0
116728|NCT00925769|429710|P5|Overall Study|Adverse Event|1
116729|NCT00925769|429711|P4|Overall Study|Adverse Event|0
116730|NCT00925769|429712|P3|Overall Study|Adverse Event|0
116731|NCT00925769|429713|P2|Overall Study|Adverse Event|0
116732|NCT00925769|429714|P1|Overall Study|Adverse Event|0
116733|NCT00925769|429709|P6|Overall Study|Participant is unable to swallow drug|0
116734|NCT00925769|429710|P5|Overall Study|Participant is unable to swallow drug|0
116735|NCT00925769|429711|P4|Overall Study|Participant is unable to swallow drug|1
116736|NCT00925769|429712|P3|Overall Study|Participant is unable to swallow drug|0
116737|NCT00925769|429713|P2|Overall Study|Participant is unable to swallow drug|0
116738|NCT00925769|429714|P1|Overall Study|Participant is unable to swallow drug|0
116739|NCT00925769|429709|P6|Overall Study|End of study visit not done|0
116740|NCT00925769|429710|P5|Overall Study|End of study visit not done|0
116741|NCT00925769|429711|P4|Overall Study|End of study visit not done|0
116742|NCT00925769|429712|P3|Overall Study|End of study visit not done|1
116743|NCT00925769|429713|P2|Overall Study|End of study visit not done|0
116744|NCT00925769|429714|P1|Overall Study|End of study visit not done|0
116745|NCT00925769|429709|P6|Overall Study|Missing documentation|0
116746|NCT00925769|429710|P5|Overall Study|Missing documentation|0
116747|NCT00925769|429711|P4|Overall Study|Missing documentation|0
116748|NCT00925769|429712|P3|Overall Study|Missing documentation|0
116749|NCT00925769|429713|P2|Overall Study|Missing documentation|1
116750|NCT00925769|429714|P1|Overall Study|Missing documentation|0
116751|NCT00925769|429709|P6|Overall Study|Physician Decision|0
116752|NCT00925769|429710|P5|Overall Study|Physician Decision|0
116753|NCT00925769|429711|P4|Overall Study|Physician Decision|0
116754|NCT00925769|429712|P3|Overall Study|Physician Decision|0
116755|NCT00925769|429713|P2|Overall Study|Physician Decision|0
116756|NCT00925769|429714|P1|Overall Study|Physician Decision|1
116757|NCT00925769|429709|P6|Overall Study|Death|0
116758|NCT00925769|429710|P5|Overall Study|Death|0
116759|NCT00925769|429711|P4|Overall Study|Death|0
116760|NCT00925769|429712|P3|Overall Study|Death|1
116761|NCT00925769|429713|P2|Overall Study|Death|0
116762|NCT00925769|429714|P1|Overall Study|Death|0
116763|NCT00925769|429709|P6|Overall Study|Disease progression|3
116764|NCT00925769|429710|P5|Overall Study|Disease progression|2
116765|NCT00925769|429711|P4|Overall Study|Disease progression|4
116766|NCT00925769|429712|P3|Overall Study|Disease progression|3
116767|NCT00925769|429713|P2|Overall Study|Disease progression|5
116768|NCT00925769|429714|P1|Overall Study|Disease progression|4
116769|NCT00925769|429709|P6|Overall Study|Major toxicity|0
116770|NCT00925769|429710|P5|Overall Study|Major toxicity|0
116771|NCT00925769|429711|P4|Overall Study|Major toxicity|1
116772|NCT00925769|429712|P3|Overall Study|Major toxicity|1
116773|NCT00925769|429713|P2|Overall Study|Major toxicity|0
116774|NCT00925769|429714|P1|Overall Study|Major toxicity|1
116775|NCT00925704|429782|P6|Third Intervention|Withdrew consent|1
116776|NCT00925704|429783|P5|Third Intervention|Withdrew consent|0
116777|NCT00925704|429784|P4|Third Intervention|Withdrew consent|0
116778|NCT00925704|429785|P3|Third Intervention|Withdrew consent|0
116779|NCT00925704|429786|P2|Third Intervention|Withdrew consent|0
116780|NCT00925704|429787|P1|Third Intervention|Withdrew consent|0
116781|NCT00925704|429782|P6|Second Intervention|Withdrawal by Subject|0
116782|NCT00925704|429783|P5|Second Intervention|Withdrawal by Subject|1
116783|NCT00925704|429784|P4|Second Intervention|Withdrawal by Subject|0
116784|NCT00925704|429785|P3|Second Intervention|Withdrawal by Subject|0
116785|NCT00925704|429786|P2|Second Intervention|Withdrawal by Subject|0
116786|NCT00925704|429787|P1|Second Intervention|Withdrawal by Subject|1
116787|NCT00925704|429782|P6|First Intervention|Withdrew consent|0
116788|NCT00925704|429783|P5|First Intervention|Withdrew consent|1
116789|NCT00925704|429784|P4|First Intervention|Withdrew consent|1
116790|NCT00925704|429785|P3|First Intervention|Withdrew consent|0
116791|NCT00925704|429786|P2|First Intervention|Withdrew consent|0
116792|NCT00925704|429787|P1|First Intervention|Withdrew consent|0
116793|NCT00925600|429800|P2|Overall Study|Adverse Event|2
116794|NCT00925600|429801|P1|Overall Study|Adverse Event|1
116795|NCT00925600|429800|P2|Overall Study|Other|1
116796|NCT00925600|429801|P1|Overall Study|Other|3
116797|NCT00925600|429800|P2|Overall Study|Requirement for Alternative Therapy|1
116798|NCT00925600|429801|P1|Overall Study|Requirement for Alternative Therapy|0
116799|NCT00925600|429800|P2|Overall Study|Protocol Deviation|1
116800|NCT00925600|429801|P1|Overall Study|Protocol Deviation|0
116801|NCT00925600|429800|P2|Overall Study|Ineligibility Determined|0
116802|NCT00925600|429801|P1|Overall Study|Ineligibility Determined|2
116803|NCT00925600|429800|P2|Overall Study|Noncompliance|0
116804|NCT00925600|429801|P1|Overall Study|Noncompliance|2
116805|NCT00925600|429800|P2|Overall Study|Administrative Decision|1
116806|NCT00925600|429801|P1|Overall Study|Administrative Decision|1
116807|NCT00925600|429800|P2|Overall Study|Disease Progression|3
116808|NCT00925600|429801|P1|Overall Study|Disease Progression|1
116809|NCT00925600|429800|P2|Overall Study|Lost to Follow-up|2
116810|NCT00925600|429801|P1|Overall Study|Lost to Follow-up|2
116811|NCT00925600|429800|P2|Overall Study|Death|3
116812|NCT00925600|429801|P1|Overall Study|Death|4
116813|NCT00925600|429800|P2|Overall Study|Withdrawal by Subject|14
116814|NCT00925600|429801|P1|Overall Study|Withdrawal by Subject|16
116815|NCT00925587|429823|P2|Overall Study|Lost to Follow-up|1
116816|NCT00925587|429824|P1|Overall Study|Lost to Follow-up|0
116817|NCT00925587|429823|P2|Overall Study|Adverse Event|2
116818|NCT00925587|429824|P1|Overall Study|Adverse Event|6
116819|NCT00925587|429823|P2|Overall Study|Death|5
116820|NCT00925587|429824|P1|Overall Study|Death|5
116821|NCT00925587|429823|P2|Overall Study|Withdrawal by Subject|6
116822|NCT00925587|429824|P1|Overall Study|Withdrawal by Subject|9
116823|NCT00925587|429823|P2|Overall Study|Protocol Violation|4
116824|NCT00925587|429824|P1|Overall Study|Protocol Violation|6
116825|NCT00925587|429823|P2|Overall Study|Physician Decision|1
116826|NCT00925587|429824|P1|Overall Study|Physician Decision|4
116827|NCT00925587|429823|P2|Overall Study|Protocol Specified Criteria|6
116828|NCT00925587|429824|P1|Overall Study|Protocol Specified Criteria|6
116829|NCT00925548|429938|P2|Overall Study|Discontinuation of trial by sponsor|5
116830|NCT00925548|429939|P1|Overall Study|Discontinuation of trial by sponsor|10
116831|NCT00925353|429969|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
116832|NCT00925288|429975|P2|Overall Study|Lost to Follow-up|7
116833|NCT00925288|429976|P1|Overall Study|Lost to Follow-up|9
116834|NCT00925132|429988|P5|Overall Study|Removed due to disease progression|4
116835|NCT00925132|429989|P4|Overall Study|Removed due to disease progression|0
116836|NCT00925132|429990|P3|Overall Study|Removed due to disease progression|0
116837|NCT00925132|429991|P2|Overall Study|Removed due to disease progression|0
116838|NCT00925132|429992|P1|Overall Study|Removed due to disease progression|0
116839|NCT00925132|429988|P5|Overall Study|Withdrawal by Subject|1
116840|NCT00925132|429989|P4|Overall Study|Withdrawal by Subject|0
116841|NCT00925132|429990|P3|Overall Study|Withdrawal by Subject|0
116842|NCT00925132|429991|P2|Overall Study|Withdrawal by Subject|0
116843|NCT00925132|429992|P1|Overall Study|Withdrawal by Subject|2
116844|NCT00925015|430011|P3|Overall Study|Withdrawal by Subject|1
116845|NCT00925015|430012|P2|Overall Study|Withdrawal by Subject|0
116846|NCT00925015|430013|P1|Overall Study|Withdrawal by Subject|0
116847|NCT00925015|430011|P3|Overall Study|Progressive Disease|4
116848|NCT00925015|430012|P2|Overall Study|Progressive Disease|3
116849|NCT00925015|430013|P1|Overall Study|Progressive Disease|7
116850|NCT00925015|430011|P3|Overall Study|Physician Decision|0
116851|NCT00925015|430012|P2|Overall Study|Physician Decision|1
116852|NCT00925015|430013|P1|Overall Study|Physician Decision|0
116853|NCT00925015|430011|P3|Overall Study|Adverse Event|1
116854|NCT00925015|430012|P2|Overall Study|Adverse Event|2
116855|NCT00925015|430013|P1|Overall Study|Adverse Event|1
116856|NCT00924950|430069|P1|Overall Study|Lost to Follow-up|2
116857|NCT00924898|430074|P1|Overall Study|Withdrawal by Subject|2
116858|NCT00924781|430110|P2|Overall Study|Study terminated by sponsor|10
116859|NCT00924781|430111|P1|Overall Study|Study terminated by sponsor|12
116860|NCT00924729|430145|P2|Overall Study|Protocol Violation|0
116861|NCT00924729|430146|P1|Overall Study|Protocol Violation|1
116862|NCT00924729|430145|P2|Overall Study|insufficient volume for analysis|0
116863|NCT00924729|430146|P1|Overall Study|insufficient volume for analysis|1
116864|NCT00924651|430156|P2|Overall Study|Incomplete Form|1
116865|NCT00924651|430157|P1|Overall Study|Incomplete Form|2
116866|NCT00924651|430156|P2|Overall Study|Changed Mind|1
116867|NCT00924651|430157|P1|Overall Study|Changed Mind|10
116868|NCT00924651|430156|P2|Overall Study|Medical|3
116869|NCT00924651|430157|P1|Overall Study|Medical|1
116870|NCT00924651|430156|P2|Overall Study|Noncompliant|4
116871|NCT00924651|430157|P1|Overall Study|Noncompliant|1
116872|NCT00924651|430156|P2|Overall Study|Overwhelmed|6
116873|NCT00924651|430157|P1|Overall Study|Overwhelmed|6
116874|NCT00924651|430156|P2|Overall Study|No Reason|7
116875|NCT00924651|430157|P1|Overall Study|No Reason|3
116876|NCT00924651|430156|P2|Overall Study|Chemo started too soon|3
116877|NCT00924651|430157|P1|Overall Study|Chemo started too soon|2
116878|NCT00924638|430165|P2|Overall Study|Physician Decision|3
116879|NCT00924638|430166|P1|Overall Study|Physician Decision|3
116880|NCT00924638|430165|P2|Overall Study|Withdrawal by Subject|7
116881|NCT00924638|430166|P1|Overall Study|Withdrawal by Subject|5
116882|NCT00924638|430165|P2|Overall Study|Lost to Follow-up|1
116883|NCT00924638|430166|P1|Overall Study|Lost to Follow-up|1
116884|NCT00924638|430165|P2|Overall Study|Death|2
116885|NCT00924638|430166|P1|Overall Study|Death|3
116886|NCT00924560|430188|P3|Overall Study|Miscellaneous Reasons|10
116887|NCT00924560|430189|P2|Overall Study|Miscellaneous Reasons|10
116888|NCT00924560|430190|P1|Overall Study|Miscellaneous Reasons|13
116889|NCT00924560|430188|P3|Overall Study|Lost to Follow-up|45
116890|NCT00924560|430189|P2|Overall Study|Lost to Follow-up|94
116891|NCT00924560|430190|P1|Overall Study|Lost to Follow-up|78
116892|NCT00924560|430188|P3|Overall Study|Pregnancy|1
116893|NCT00924560|430189|P2|Overall Study|Pregnancy|7
116894|NCT00924560|430190|P1|Overall Study|Pregnancy|5
116895|NCT00924560|430188|P3|Overall Study|Adverse Event|0
116896|NCT00924560|430189|P2|Overall Study|Adverse Event|33
116897|NCT00924560|430190|P1|Overall Study|Adverse Event|39
116898|NCT00924560|430188|P3|Overall Study|Withdrawal by Subject|18
116899|NCT00924560|430189|P2|Overall Study|Withdrawal by Subject|44
116900|NCT00924560|430190|P1|Overall Study|Withdrawal by Subject|50
116901|NCT00924560|430188|P3|Overall Study|Physician Decision|4
116902|NCT00924560|430189|P2|Overall Study|Physician Decision|3
116903|NCT00924560|430190|P1|Overall Study|Physician Decision|2
116904|NCT00924560|430188|P3|Overall Study|Non Compliance with the Protocol|4
116905|NCT00924560|430189|P2|Overall Study|Non Compliance with the Protocol|15
116906|NCT00924560|430190|P1|Overall Study|Non Compliance with the Protocol|20
116907|NCT00924560|430188|P3|Overall Study|Did Not Meet Protocol Requirements|1
116908|NCT00924560|430189|P2|Overall Study|Did Not Meet Protocol Requirements|2
116909|NCT00924560|430190|P1|Overall Study|Did Not Meet Protocol Requirements|4
116910|NCT00924508|430234|P1|Overall Study|Withdrawal by Subject|3
116911|NCT00924469|430248|P2|Overall Study|Lost to Follow-up|1
116912|NCT00924469|430249|P1|Overall Study|Lost to Follow-up|0
116913|NCT00924469|430248|P2|Overall Study|Withdrawal by Subject|1
116914|NCT00924469|430249|P1|Overall Study|Withdrawal by Subject|0
116915|NCT00924469|430248|P2|Overall Study|Adverse Event|0
116916|NCT00924469|430249|P1|Overall Study|Adverse Event|2
116917|NCT00924443|430271|P1|Overall Study|Protocol Violation|1
116918|NCT00924443|430271|P1|Overall Study|Physician Decision|2
116919|NCT00924404|430281|P2|Overall Study|Lost to Follow-up|4
116920|NCT00924404|430282|P1|Overall Study|Lost to Follow-up|6
116921|NCT00924313|430304|P1|Overall Study|not imaged due to failed tracer imaging|1
116922|NCT00924287|430316|P1|Overall Study|Death|1
116923|NCT00924170|430329|P2|Overall Study|Death|0
116924|NCT00924170|430330|P1|Overall Study|Death|1
116925|NCT00924170|430329|P2|Overall Study|Stopped due to neutralizing antibodies|0
116926|NCT00924170|430330|P1|Overall Study|Stopped due to neutralizing antibodies|3
116927|NCT00924170|430329|P2|Overall Study|Progressive disease|6
116928|NCT00924170|430330|P1|Overall Study|Progressive disease|3
116929|NCT00924170|430329|P2|Overall Study|Physician Decision|1
116930|NCT00924170|430330|P1|Overall Study|Physician Decision|0
116931|NCT00924170|430329|P2|Overall Study|Refused further treatment|1
116932|NCT00924170|430330|P1|Overall Study|Refused further treatment|0
116933|NCT00923975|430455|P1|Overall Study|Did not meet inclusion criteria|1
116934|NCT00923936|430474|P2|Overall Study|Continuing in follow up period|1
116935|NCT00923936|430475|P1|Overall Study|Continuing in follow up period|2
116936|NCT00923936|430474|P2|Overall Study|Lost to follow up|0
116937|NCT00923936|430475|P1|Overall Study|Lost to follow up|2
116938|NCT00923936|430474|P2|Overall Study|Adverse Event|1
116939|NCT00923936|430475|P1|Overall Study|Adverse Event|2
116940|NCT00923936|430474|P2|Overall Study|progressive disease on study|1
116941|NCT00923936|430475|P1|Overall Study|progressive disease on study|2
116942|NCT00923845|430504|P2|Induction Therapy|Poor performance status|2
116943|NCT00923845|430505|P1|Induction Therapy|Poor performance status|0
116944|NCT00923364|430531|P2|Overall Study|Did not go to transplant|0
116945|NCT00923364|430532|P1|Overall Study|Did not go to transplant|1
116946|NCT00923364|430531|P2|Overall Study|Death|0
116947|NCT00923364|430532|P1|Overall Study|Death|3
116948|NCT00923351|430544|P3|Overall Study|no apheresis/adequate tumor sample|12
116949|NCT00923351|430545|P2|Overall Study|no apheresis/adequate tumor sample|0
116950|NCT00923351|430546|P1|Overall Study|no apheresis/adequate tumor sample|0
116951|NCT00923273|430561|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
116952|NCT00923273|430562|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
116953|NCT00923273|430563|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
116954|NCT00923273|430564|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
116955|NCT00923273|430565|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
116956|NCT00923273|430561|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
116957|NCT00923273|430562|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
116958|NCT00923273|430563|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
116959|NCT00923273|430564|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
116960|NCT00923273|430565|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
116961|NCT00923260|430590|P2|Overall Study|Lost to Follow-up|1
116962|NCT00923260|430591|P1|Overall Study|Lost to Follow-up|1
116963|NCT00923195|430754|P2|Overall Study|Death|1
116964|NCT00923195|430755|P1|Overall Study|Death|0
116965|NCT00923156|430766|P3|Overall Study|Lack of Efficacy|1
116966|NCT00923156|430767|P2|Overall Study|Lack of Efficacy|0
116967|NCT00923156|430768|P1|Overall Study|Lack of Efficacy|0
116968|NCT00923156|430766|P3|Overall Study|Death|0
116969|NCT00923156|430767|P2|Overall Study|Death|1
116970|NCT00923156|430768|P1|Overall Study|Death|0
116971|NCT00923156|430766|P3|Overall Study|Withdrawal by Subject|0
116972|NCT00923156|430767|P2|Overall Study|Withdrawal by Subject|1
116973|NCT00923156|430768|P1|Overall Study|Withdrawal by Subject|0
116974|NCT00923156|430766|P3|Overall Study|Abnormal laboratory values|1
116975|NCT00923156|430767|P2|Overall Study|Abnormal laboratory values|0
116976|NCT00923156|430768|P1|Overall Study|Abnormal laboratory values|0
116977|NCT00923156|430766|P3|Overall Study|Adverse Event|1
116978|NCT00923156|430767|P2|Overall Study|Adverse Event|2
116979|NCT00923156|430768|P1|Overall Study|Adverse Event|0
116980|NCT00923130|430794|P1|Overall Study|Refused further treatment|2
116981|NCT00923130|430794|P1|Overall Study|Switched to alternative treatment|2
116982|NCT00923130|430794|P1|Overall Study|Discontinued treatment due to toxicities|3
116983|NCT00923130|430794|P1|Overall Study|Death|1
116984|NCT00923130|430794|P1|Overall Study|Stopped treatment due to progression|17
116985|NCT00923091|430829|P13|Period VI (Open-Label)|Other Reason|0
116986|NCT00923091|430830|P12|Period VI (Open-Label)|Other Reason|0
116987|NCT00923091|430831|P11|Period VI (Open-Label)|Other Reason|0
116988|NCT00923091|430832|P10|Period VI (Open-Label)|Other Reason|0
116989|NCT00923091|430833|P9|Period VI (Open-Label)|Other Reason|0
116990|NCT00923091|430834|P8|Period VI (Open-Label)|Other Reason|0
116991|NCT00923091|430835|P7|Period VI (Open-Label)|Other Reason|0
116992|NCT00923091|430836|P6|Period VI (Open-Label)|Other Reason|0
116993|NCT00923091|430837|P5|Period VI (Open-Label)|Other Reason|1
116994|NCT00923091|430838|P4|Period VI (Open-Label)|Other Reason|1
116995|NCT00923091|430839|P3|Period VI (Open-Label)|Other Reason|0
116996|NCT00923091|430840|P2|Period VI (Open-Label)|Other Reason|0
116997|NCT00923091|430841|P1|Period VI (Open-Label)|Other Reason|0
116998|NCT00923091|430829|P13|Period VI (Open-Label)|Lost to Follow-up|0
116999|NCT00923091|430830|P12|Period VI (Open-Label)|Lost to Follow-up|0
117000|NCT00923091|430831|P11|Period VI (Open-Label)|Lost to Follow-up|0
117001|NCT00923091|430832|P10|Period VI (Open-Label)|Lost to Follow-up|0
117002|NCT00923091|430833|P9|Period VI (Open-Label)|Lost to Follow-up|0
117003|NCT00923091|430834|P8|Period VI (Open-Label)|Lost to Follow-up|0
117004|NCT00923091|430835|P7|Period VI (Open-Label)|Lost to Follow-up|0
117005|NCT00923091|430836|P6|Period VI (Open-Label)|Lost to Follow-up|0
117006|NCT00923091|430837|P5|Period VI (Open-Label)|Lost to Follow-up|0
117007|NCT00923091|430838|P4|Period VI (Open-Label)|Lost to Follow-up|0
117008|NCT00923091|430839|P3|Period VI (Open-Label)|Lost to Follow-up|1
117009|NCT00923091|430840|P2|Period VI (Open-Label)|Lost to Follow-up|0
117010|NCT00923091|430841|P1|Period VI (Open-Label)|Lost to Follow-up|1
117011|NCT00923091|430829|P13|Period VI (Open-Label)|Protocol Violation|0
117012|NCT00923091|430830|P12|Period VI (Open-Label)|Protocol Violation|0
117013|NCT00923091|430831|P11|Period VI (Open-Label)|Protocol Violation|0
117014|NCT00923091|430832|P10|Period VI (Open-Label)|Protocol Violation|0
117015|NCT00923091|430833|P9|Period VI (Open-Label)|Protocol Violation|0
117016|NCT00923091|430834|P8|Period VI (Open-Label)|Protocol Violation|0
117017|NCT00923091|430835|P7|Period VI (Open-Label)|Protocol Violation|0
117018|NCT00923091|430836|P6|Period VI (Open-Label)|Protocol Violation|0
117019|NCT00923091|430837|P5|Period VI (Open-Label)|Protocol Violation|4
117020|NCT00923091|430838|P4|Period VI (Open-Label)|Protocol Violation|1
117021|NCT00923091|430839|P3|Period VI (Open-Label)|Protocol Violation|3
117022|NCT00923091|430840|P2|Period VI (Open-Label)|Protocol Violation|1
117023|NCT00923091|430841|P1|Period VI (Open-Label)|Protocol Violation|6
117024|NCT00923091|430829|P13|Period VI (Open-Label)|Withdrawal by Subject|0
117025|NCT00923091|430830|P12|Period VI (Open-Label)|Withdrawal by Subject|0
117026|NCT00923091|430831|P11|Period VI (Open-Label)|Withdrawal by Subject|0
117027|NCT00923091|430832|P10|Period VI (Open-Label)|Withdrawal by Subject|0
117028|NCT00923091|430833|P9|Period VI (Open-Label)|Withdrawal by Subject|0
117029|NCT00923091|430834|P8|Period VI (Open-Label)|Withdrawal by Subject|0
117030|NCT00923091|430835|P7|Period VI (Open-Label)|Withdrawal by Subject|0
117031|NCT00923091|430836|P6|Period VI (Open-Label)|Withdrawal by Subject|0
117032|NCT00923091|430837|P5|Period VI (Open-Label)|Withdrawal by Subject|1
117033|NCT00923091|430838|P4|Period VI (Open-Label)|Withdrawal by Subject|0
117034|NCT00923091|430839|P3|Period VI (Open-Label)|Withdrawal by Subject|5
117035|NCT00923091|430840|P2|Period VI (Open-Label)|Withdrawal by Subject|7
117036|NCT00923091|430841|P1|Period VI (Open-Label)|Withdrawal by Subject|15
117037|NCT00923091|430829|P13|Period VI (Open-Label)|Adverse Event|0
117038|NCT00923091|430830|P12|Period VI (Open-Label)|Adverse Event|0
117039|NCT00923091|430831|P11|Period VI (Open-Label)|Adverse Event|0
117040|NCT00923091|430832|P10|Period VI (Open-Label)|Adverse Event|0
117041|NCT00923091|430833|P9|Period VI (Open-Label)|Adverse Event|0
117042|NCT00923091|430834|P8|Period VI (Open-Label)|Adverse Event|0
117043|NCT00923091|430835|P7|Period VI (Open-Label)|Adverse Event|0
117044|NCT00923091|430836|P6|Period VI (Open-Label)|Adverse Event|0
117045|NCT00923091|430837|P5|Period VI (Open-Label)|Adverse Event|1
117046|NCT00923091|430838|P4|Period VI (Open-Label)|Adverse Event|1
117047|NCT00923091|430839|P3|Period VI (Open-Label)|Adverse Event|4
117048|NCT00923091|430840|P2|Period VI (Open-Label)|Adverse Event|0
117049|NCT00923091|430841|P1|Period VI (Open-Label)|Adverse Event|17
117050|NCT00923091|430829|P13|Period V (Double -Blind)|Lost to Follow-up|0
117051|NCT00923091|430830|P12|Period V (Double -Blind)|Lost to Follow-up|0
117052|NCT00923091|430831|P11|Period V (Double -Blind)|Lost to Follow-up|1
117053|NCT00923091|430832|P10|Period V (Double -Blind)|Lost to Follow-up|0
117054|NCT00923091|430833|P9|Period V (Double -Blind)|Lost to Follow-up|0
117055|NCT00923091|430834|P8|Period V (Double -Blind)|Lost to Follow-up|0
117056|NCT00923091|430835|P7|Period V (Double -Blind)|Lost to Follow-up|0
117057|NCT00923091|430836|P6|Period V (Double -Blind)|Lost to Follow-up|0
117058|NCT00923091|430837|P5|Period V (Double -Blind)|Lost to Follow-up|0
117059|NCT00923091|430838|P4|Period V (Double -Blind)|Lost to Follow-up|0
117060|NCT00923091|430839|P3|Period V (Double -Blind)|Lost to Follow-up|0
117061|NCT00923091|430840|P2|Period V (Double -Blind)|Lost to Follow-up|0
117062|NCT00923091|430841|P1|Period V (Double -Blind)|Lost to Follow-up|0
117063|NCT00923091|430829|P13|Period V (Double -Blind)|Protocol Violation|1
117064|NCT00923091|430830|P12|Period V (Double -Blind)|Protocol Violation|0
117065|NCT00923091|430831|P11|Period V (Double -Blind)|Protocol Violation|0
117066|NCT00923091|430832|P10|Period V (Double -Blind)|Protocol Violation|0
117067|NCT00923091|430833|P9|Period V (Double -Blind)|Protocol Violation|0
117068|NCT00923091|430834|P8|Period V (Double -Blind)|Protocol Violation|0
117069|NCT00923091|430835|P7|Period V (Double -Blind)|Protocol Violation|0
117070|NCT00923091|430836|P6|Period V (Double -Blind)|Protocol Violation|0
117071|NCT00923091|430837|P5|Period V (Double -Blind)|Protocol Violation|0
117072|NCT00923091|430838|P4|Period V (Double -Blind)|Protocol Violation|0
117073|NCT00923091|430839|P3|Period V (Double -Blind)|Protocol Violation|0
117074|NCT00923091|430840|P2|Period V (Double -Blind)|Protocol Violation|0
117075|NCT00923091|430841|P1|Period V (Double -Blind)|Protocol Violation|0
117076|NCT00923091|430829|P13|Period V (Double -Blind)|Withdrawal by Subject|1
117077|NCT00923091|430830|P12|Period V (Double -Blind)|Withdrawal by Subject|0
117078|NCT00923091|430831|P11|Period V (Double -Blind)|Withdrawal by Subject|0
117079|NCT00923091|430832|P10|Period V (Double -Blind)|Withdrawal by Subject|0
117080|NCT00923091|430833|P9|Period V (Double -Blind)|Withdrawal by Subject|1
117081|NCT00923091|430834|P8|Period V (Double -Blind)|Withdrawal by Subject|0
117082|NCT00923091|430835|P7|Period V (Double -Blind)|Withdrawal by Subject|0
117083|NCT00923091|430836|P6|Period V (Double -Blind)|Withdrawal by Subject|0
117084|NCT00923091|430837|P5|Period V (Double -Blind)|Withdrawal by Subject|0
117085|NCT00923091|430838|P4|Period V (Double -Blind)|Withdrawal by Subject|0
117086|NCT00923091|430839|P3|Period V (Double -Blind)|Withdrawal by Subject|0
117087|NCT00923091|430840|P2|Period V (Double -Blind)|Withdrawal by Subject|0
117088|NCT00923091|430841|P1|Period V (Double -Blind)|Withdrawal by Subject|0
117089|NCT00923091|430829|P13|Period IV (Double-Blind)|Protocol Violation|0
117090|NCT00923091|430830|P12|Period IV (Double-Blind)|Protocol Violation|0
117091|NCT00923091|430831|P11|Period IV (Double-Blind)|Protocol Violation|0
117092|NCT00923091|430832|P10|Period IV (Double-Blind)|Protocol Violation|0
117093|NCT00923091|430833|P9|Period IV (Double-Blind)|Protocol Violation|0
117094|NCT00923091|430834|P8|Period IV (Double-Blind)|Protocol Violation|0
117095|NCT00923091|430835|P7|Period IV (Double-Blind)|Protocol Violation|0
117096|NCT00923091|430836|P6|Period IV (Double-Blind)|Protocol Violation|0
117097|NCT00923091|430837|P5|Period IV (Double-Blind)|Protocol Violation|0
117098|NCT00923091|430838|P4|Period IV (Double-Blind)|Protocol Violation|0
117099|NCT00923091|430839|P3|Period IV (Double-Blind)|Protocol Violation|0
117100|NCT00923091|430840|P2|Period IV (Double-Blind)|Protocol Violation|1
117101|NCT00923091|430841|P1|Period IV (Double-Blind)|Protocol Violation|0
117102|NCT00923091|430829|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
117103|NCT00923091|430830|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
117104|NCT00923091|430831|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
117105|NCT00923091|430832|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
117106|NCT00923091|430833|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
117107|NCT00923091|430834|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
117108|NCT00923091|430835|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
117109|NCT00923091|430836|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
117110|NCT00923091|430837|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
117111|NCT00923091|430838|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
117112|NCT00923091|430839|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
117113|NCT00923091|430840|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
117114|NCT00923091|430841|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
117115|NCT00923091|430829|P13|Period IV (Double-Blind)|Adverse Event|0
117116|NCT00923091|430830|P12|Period IV (Double-Blind)|Adverse Event|0
117117|NCT00923091|430831|P11|Period IV (Double-Blind)|Adverse Event|0
117118|NCT00923091|430832|P10|Period IV (Double-Blind)|Adverse Event|0
117119|NCT00923091|430833|P9|Period IV (Double-Blind)|Adverse Event|0
117120|NCT00923091|430834|P8|Period IV (Double-Blind)|Adverse Event|0
117121|NCT00923091|430835|P7|Period IV (Double-Blind)|Adverse Event|0
117122|NCT00923091|430836|P6|Period IV (Double-Blind)|Adverse Event|0
117123|NCT00923091|430837|P5|Period IV (Double-Blind)|Adverse Event|0
117124|NCT00923091|430838|P4|Period IV (Double-Blind)|Adverse Event|0
117125|NCT00923091|430839|P3|Period IV (Double-Blind)|Adverse Event|0
117126|NCT00923091|430840|P2|Period IV (Double-Blind)|Adverse Event|0
117127|NCT00923091|430841|P1|Period IV (Double-Blind)|Adverse Event|2
117128|NCT00923091|430829|P13|Period III (Single-Blind)|Lost to Follow-up|0
117129|NCT00923091|430830|P12|Period III (Single-Blind)|Lost to Follow-up|0
117130|NCT00923091|430831|P11|Period III (Single-Blind)|Lost to Follow-up|0
117131|NCT00923091|430832|P10|Period III (Single-Blind)|Lost to Follow-up|0
117132|NCT00923091|430833|P9|Period III (Single-Blind)|Lost to Follow-up|0
117133|NCT00923091|430834|P8|Period III (Single-Blind)|Lost to Follow-up|0
117134|NCT00923091|430835|P7|Period III (Single-Blind)|Lost to Follow-up|0
117135|NCT00923091|430836|P6|Period III (Single-Blind)|Lost to Follow-up|0
117136|NCT00923091|430837|P5|Period III (Single-Blind)|Lost to Follow-up|0
117137|NCT00923091|430838|P4|Period III (Single-Blind)|Lost to Follow-up|0
117138|NCT00923091|430839|P3|Period III (Single-Blind)|Lost to Follow-up|0
117139|NCT00923091|430840|P2|Period III (Single-Blind)|Lost to Follow-up|0
117140|NCT00923091|430841|P1|Period III (Single-Blind)|Lost to Follow-up|2
117141|NCT00923091|430829|P13|Period III (Single-Blind)|Protocol Violation|0
117142|NCT00923091|430830|P12|Period III (Single-Blind)|Protocol Violation|0
117143|NCT00923091|430831|P11|Period III (Single-Blind)|Protocol Violation|0
117144|NCT00923091|430832|P10|Period III (Single-Blind)|Protocol Violation|0
117145|NCT00923091|430833|P9|Period III (Single-Blind)|Protocol Violation|0
117146|NCT00923091|430834|P8|Period III (Single-Blind)|Protocol Violation|0
117147|NCT00923091|430835|P7|Period III (Single-Blind)|Protocol Violation|0
117148|NCT00923091|430836|P6|Period III (Single-Blind)|Protocol Violation|0
117149|NCT00923091|430837|P5|Period III (Single-Blind)|Protocol Violation|0
117150|NCT00923091|430838|P4|Period III (Single-Blind)|Protocol Violation|0
117151|NCT00923091|430839|P3|Period III (Single-Blind)|Protocol Violation|0
117152|NCT00923091|430840|P2|Period III (Single-Blind)|Protocol Violation|0
117153|NCT00923091|430841|P1|Period III (Single-Blind)|Protocol Violation|3
117154|NCT00923091|430829|P13|Period III (Single-Blind)|Withdrawal by Subject|0
117155|NCT00923091|430830|P12|Period III (Single-Blind)|Withdrawal by Subject|0
117156|NCT00923091|430831|P11|Period III (Single-Blind)|Withdrawal by Subject|0
117157|NCT00923091|430832|P10|Period III (Single-Blind)|Withdrawal by Subject|0
117158|NCT00923091|430833|P9|Period III (Single-Blind)|Withdrawal by Subject|0
117159|NCT00923091|430834|P8|Period III (Single-Blind)|Withdrawal by Subject|0
117160|NCT00923091|430835|P7|Period III (Single-Blind)|Withdrawal by Subject|0
117161|NCT00923091|430836|P6|Period III (Single-Blind)|Withdrawal by Subject|0
117162|NCT00923091|430837|P5|Period III (Single-Blind)|Withdrawal by Subject|0
117163|NCT00923091|430838|P4|Period III (Single-Blind)|Withdrawal by Subject|0
117164|NCT00923091|430839|P3|Period III (Single-Blind)|Withdrawal by Subject|0
117165|NCT00923091|430840|P2|Period III (Single-Blind)|Withdrawal by Subject|0
117166|NCT00923091|430841|P1|Period III (Single-Blind)|Withdrawal by Subject|10
117167|NCT00923091|430829|P13|Period III (Single-Blind)|Adverse Event|0
117168|NCT00923091|430830|P12|Period III (Single-Blind)|Adverse Event|0
117169|NCT00923091|430831|P11|Period III (Single-Blind)|Adverse Event|0
117170|NCT00923091|430832|P10|Period III (Single-Blind)|Adverse Event|0
117171|NCT00923091|430833|P9|Period III (Single-Blind)|Adverse Event|0
117172|NCT00923091|430834|P8|Period III (Single-Blind)|Adverse Event|0
117173|NCT00923091|430835|P7|Period III (Single-Blind)|Adverse Event|0
117174|NCT00923091|430836|P6|Period III (Single-Blind)|Adverse Event|0
117175|NCT00923091|430837|P5|Period III (Single-Blind)|Adverse Event|0
117176|NCT00923091|430838|P4|Period III (Single-Blind)|Adverse Event|0
117177|NCT00923091|430839|P3|Period III (Single-Blind)|Adverse Event|0
117178|NCT00923091|430840|P2|Period III (Single-Blind)|Adverse Event|0
117179|NCT00923091|430841|P1|Period III (Single-Blind)|Adverse Event|5
117180|NCT00923091|430829|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117181|NCT00923091|430830|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117182|NCT00923091|430831|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117183|NCT00923091|430832|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117184|NCT00923091|430833|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117185|NCT00923091|430834|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117186|NCT00923091|430835|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117187|NCT00923091|430836|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
117188|NCT00923091|430837|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117189|NCT00923091|430838|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
117190|NCT00923091|430839|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117191|NCT00923091|430840|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
117192|NCT00923091|430841|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
117193|NCT00923091|430829|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117194|NCT00923091|430830|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117195|NCT00923091|430831|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117196|NCT00923091|430832|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117197|NCT00923091|430833|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117198|NCT00923091|430834|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117199|NCT00923091|430835|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117200|NCT00923091|430836|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
117201|NCT00923091|430837|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117202|NCT00923091|430838|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117203|NCT00923091|430839|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117204|NCT00923091|430840|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117205|NCT00923091|430841|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
117206|NCT00923091|430829|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
117207|NCT00923091|430830|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
117208|NCT00923091|430831|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
117209|NCT00923091|430832|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
117210|NCT00923091|430833|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
117211|NCT00923091|430834|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
117212|NCT00923091|430835|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
117213|NCT00923091|430836|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
117214|NCT00923091|430837|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
117215|NCT00923091|430838|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
117216|NCT00923091|430839|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
117217|NCT00923091|430840|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
117218|NCT00923091|430841|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
117219|NCT00923091|430829|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
117220|NCT00923091|430830|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
117221|NCT00923091|430831|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
117222|NCT00923091|430832|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
117223|NCT00923091|430833|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
117224|NCT00923091|430834|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
117225|NCT00923091|430835|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
117226|NCT00923091|430836|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
117227|NCT00923091|430837|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
117228|NCT00923091|430838|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
117229|NCT00923091|430839|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
117230|NCT00923091|430840|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
117231|NCT00923091|430841|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
117232|NCT00923091|430829|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
117233|NCT00923091|430830|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
117234|NCT00923091|430831|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
117235|NCT00923091|430832|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
117236|NCT00923091|430833|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
117237|NCT00923091|430834|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
117238|NCT00923091|430835|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
117239|NCT00923091|430836|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
117240|NCT00923091|430837|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
117241|NCT00923091|430838|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
117242|NCT00923091|430839|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
117243|NCT00923091|430840|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
117244|NCT00923091|430841|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
117245|NCT00923078|430891|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
117246|NCT00923078|430892|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
117247|NCT00923078|430893|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
117248|NCT00923078|430891|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
117249|NCT00923078|430892|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
117250|NCT00923078|430893|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
117251|NCT00922987|430912|P1|Overall Study|Adverse Event|1
117252|NCT00922987|430912|P1|Overall Study|Protocol Violation|2
117253|NCT00922987|430912|P1|Overall Study|Insufficient clinical response|1
117254|NCT00922935|430927|P3|Overall Study|Lost to Follow-up|0
117255|NCT00922935|430928|P2|Overall Study|Lost to Follow-up|1
117256|NCT00922935|430929|P1|Overall Study|Lost to Follow-up|0
117257|NCT00922935|430927|P3|Overall Study|Physician Decision|0
117258|NCT00922935|430928|P2|Overall Study|Physician Decision|1
117259|NCT00922935|430929|P1|Overall Study|Physician Decision|1
117260|NCT00922935|430927|P3|Overall Study|Protocol Violation|0
117261|NCT00922935|430928|P2|Overall Study|Protocol Violation|3
117262|NCT00922935|430929|P1|Overall Study|Protocol Violation|0
117263|NCT00922779|430937|P1|Overall Study|Missing|1874
117264|NCT00922779|430937|P1|Overall Study|Other|27
117265|NCT00922779|430937|P1|Overall Study|Lost to Follow-up|44
117266|NCT00922779|430937|P1|Overall Study|Withdrawal by Subject|308
117267|NCT00922779|430937|P1|Overall Study|Pregnancy|7
117268|NCT00922779|430937|P1|Overall Study|Adverse Event|67
117269|NCT00922766|430944|P1|Overall Study|Adverse Event|1
117270|NCT00922766|430944|P1|Overall Study|Other|1
117271|NCT00922766|430944|P1|Overall Study|Withdrawal by Subject|2
117272|NCT00922766|430944|P1|Overall Study|Death|3
117273|NCT00922636|430962|P5|Overall Study|Lost to Follow-up|4
117274|NCT00922636|430963|P4|Overall Study|Lost to Follow-up|2
117275|NCT00922636|430964|P3|Overall Study|Lost to Follow-up|2
117276|NCT00922636|430965|P2|Overall Study|Lost to Follow-up|2
117277|NCT00922636|430966|P1|Overall Study|Lost to Follow-up|1
117278|NCT00922636|430962|P5|Overall Study|Parent/Caregiver Decision|2
117279|NCT00922636|430963|P4|Overall Study|Parent/Caregiver Decision|5
117280|NCT00922636|430964|P3|Overall Study|Parent/Caregiver Decision|3
117281|NCT00922636|430965|P2|Overall Study|Parent/Caregiver Decision|4
117282|NCT00922636|430966|P1|Overall Study|Parent/Caregiver Decision|2
117283|NCT00922636|430962|P5|Overall Study|Entry Criteria Not Met|0
117284|NCT00922636|430963|P4|Overall Study|Entry Criteria Not Met|1
117285|NCT00922636|430964|P3|Overall Study|Entry Criteria Not Met|1
117286|NCT00922636|430965|P2|Overall Study|Entry Criteria Not Met|0
117287|NCT00922636|430966|P1|Overall Study|Entry Criteria Not Met|0
117288|NCT00922636|430962|P5|Overall Study|Protocol Violation|0
117289|NCT00922636|430963|P4|Overall Study|Protocol Violation|2
117290|NCT00922636|430964|P3|Overall Study|Protocol Violation|2
117291|NCT00922636|430965|P2|Overall Study|Protocol Violation|0
117292|NCT00922636|430966|P1|Overall Study|Protocol Violation|0
117293|NCT00922636|430962|P5|Overall Study|Withdrawal by Subject|4
117294|NCT00922636|430963|P4|Overall Study|Withdrawal by Subject|2
117295|NCT00922636|430964|P3|Overall Study|Withdrawal by Subject|5
117296|NCT00922636|430965|P2|Overall Study|Withdrawal by Subject|0
117297|NCT00922636|430966|P1|Overall Study|Withdrawal by Subject|0
117298|NCT00922636|430962|P5|Overall Study|Sponsor Decision|0
117299|NCT00922636|430963|P4|Overall Study|Sponsor Decision|0
117300|NCT00922636|430964|P3|Overall Study|Sponsor Decision|2
117301|NCT00922636|430965|P2|Overall Study|Sponsor Decision|0
117302|NCT00922636|430966|P1|Overall Study|Sponsor Decision|0
117303|NCT00922636|430962|P5|Overall Study|Lack of Efficacy|4
117304|NCT00922636|430963|P4|Overall Study|Lack of Efficacy|2
117305|NCT00922636|430964|P3|Overall Study|Lack of Efficacy|3
117306|NCT00922636|430965|P2|Overall Study|Lack of Efficacy|7
117307|NCT00922636|430966|P1|Overall Study|Lack of Efficacy|1
117308|NCT00922636|430962|P5|Overall Study|Adverse Event|2
117309|NCT00922636|430963|P4|Overall Study|Adverse Event|3
117310|NCT00922636|430964|P3|Overall Study|Adverse Event|2
117311|NCT00922636|430965|P2|Overall Study|Adverse Event|3
117312|NCT00922636|430966|P1|Overall Study|Adverse Event|3
117313|NCT00922623|431113|P1|Overall Study|Lost to Follow-up|1
117314|NCT00922623|431113|P1|Overall Study|Other|4
117315|NCT00922480|431121|P2|Extension Study|Others|1
117316|NCT00922480|431122|P1|Extension Study|Others|0
117317|NCT00922480|431121|P2|Extension Study|Withdrawal by Subject|1
117318|NCT00922480|431122|P1|Extension Study|Withdrawal by Subject|1
117319|NCT00922480|431121|P2|Extension Study|Adverse Event|1
117320|NCT00922480|431122|P1|Extension Study|Adverse Event|1
117321|NCT00922480|431121|P2|Extension Study|Protocol Violation|0
117322|NCT00922480|431122|P1|Extension Study|Protocol Violation|3
117323|NCT00922480|431121|P2|Main Study|Physician Decision|1
117324|NCT00922480|431122|P1|Main Study|Physician Decision|0
117325|NCT00922480|431121|P2|Main Study|Lost to Follow-up|0
117326|NCT00922480|431122|P1|Main Study|Lost to Follow-up|5
117327|NCT00922480|431121|P2|Main Study|Withdrawal by Subject|15
117328|NCT00922480|431122|P1|Main Study|Withdrawal by Subject|20
117329|NCT00922480|431121|P2|Main Study|Lack of Efficacy|0
117330|NCT00922480|431122|P1|Main Study|Lack of Efficacy|3
117331|NCT00922480|431121|P2|Main Study|Adverse Event|7
117332|NCT00922480|431122|P1|Main Study|Adverse Event|6
117333|NCT00922480|431121|P2|Main Study|Protocol Violation|6
117334|NCT00922480|431122|P1|Main Study|Protocol Violation|3
117335|NCT00922441|431133|P3|Overall Study|Withdrawal by Subject|1
117336|NCT00922441|431134|P2|Overall Study|Withdrawal by Subject|0
117337|NCT00922441|431135|P1|Overall Study|Withdrawal by Subject|0
117338|NCT00922441|431133|P3|Overall Study|Protocol Violation|2
117339|NCT00922441|431134|P2|Overall Study|Protocol Violation|0
117340|NCT00922441|431135|P1|Overall Study|Protocol Violation|0
117341|NCT00922428|431143|P1|Overall Study|no medication use or questionable use|13
117342|NCT00922428|431143|P1|Overall Study|retrospective/extremely implausible data|2
117343|NCT00922272|431172|P2|Double-blind Phase|Positive urine drug screen|1
117344|NCT00922272|431173|P1|Double-blind Phase|Positive urine drug screen|1
117345|NCT00922272|431172|P2|Double-blind Phase|Noncompliance|1
117346|NCT00922272|431173|P1|Double-blind Phase|Noncompliance|1
117347|NCT00922272|431172|P2|Double-blind Phase|Withdrawal criteria met|1
117348|NCT00922272|431173|P1|Double-blind Phase|Withdrawal criteria met|1
117349|NCT00922272|431172|P2|Double-blind Phase|Lost to Follow-up|1
117350|NCT00922272|431173|P1|Double-blind Phase|Lost to Follow-up|2
117351|NCT00922272|431172|P2|Double-blind Phase|Withdrawal by Subject|1
117352|NCT00922272|431173|P1|Double-blind Phase|Withdrawal by Subject|1
117353|NCT00922272|431172|P2|Double-blind Phase|Adverse Event|1
117354|NCT00922272|431173|P1|Double-blind Phase|Adverse Event|1
117355|NCT00922272|431172|P2|Open-label Phase|Withdrawal criteria met|0
117356|NCT00922272|431173|P1|Open-label Phase|Withdrawal criteria met|5
117357|NCT00922272|431172|P2|Open-label Phase|Failure to meet randomization criteria|0
117358|NCT00922272|431173|P1|Open-label Phase|Failure to meet randomization criteria|1
117359|NCT00922272|431172|P2|Open-label Phase|Withdrawal by Subject|0
117360|NCT00922272|431173|P1|Open-label Phase|Withdrawal by Subject|11
117361|NCT00922272|431172|P2|Open-label Phase|Protocol Violation|0
117362|NCT00922272|431173|P1|Open-label Phase|Protocol Violation|1
117363|NCT00922272|431172|P2|Open-label Phase|Adverse Event|0
117364|NCT00922272|431173|P1|Open-label Phase|Adverse Event|5
117365|NCT00922207|431238|P3|Overall Study|Abnormality of Laboratory Test|1
117366|NCT00922207|431239|P2|Overall Study|Abnormality of Laboratory Test|1
117367|NCT00922207|431240|P1|Overall Study|Abnormality of Laboratory Test|0
117368|NCT00922207|431238|P3|Overall Study|Withdrew Consent|2
117369|NCT00922207|431239|P2|Overall Study|Withdrew Consent|5
117370|NCT00922207|431240|P1|Overall Study|Withdrew Consent|2
117371|NCT00922207|431238|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
117372|NCT00922207|431239|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
117373|NCT00922207|431240|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
117374|NCT00922207|431238|P3|Overall Study|Violation of Selection Criteria at Entry|0
117375|NCT00922207|431239|P2|Overall Study|Violation of Selection Criteria at Entry|1
117376|NCT00922207|431240|P1|Overall Study|Violation of Selection Criteria at Entry|0
117377|NCT00922207|431238|P3|Overall Study|Insufficient Therapeutic Response|1
117378|NCT00922207|431239|P2|Overall Study|Insufficient Therapeutic Response|0
117379|NCT00922207|431240|P1|Overall Study|Insufficient Therapeutic Response|0
117380|NCT00922207|431238|P3|Overall Study|Adverse Event/Intercurrent Illness|0
117381|NCT00922207|431239|P2|Overall Study|Adverse Event/Intercurrent Illness|0
117382|NCT00922207|431240|P1|Overall Study|Adverse Event/Intercurrent Illness|3
117383|NCT00922116|431276|P1|Overall Study|Other|5
117384|NCT00922116|431276|P1|Overall Study|Withdrawal by Subject|4
117385|NCT00922116|431276|P1|Overall Study|Lost to Follow-up|1
117386|NCT00922116|431276|P1|Overall Study|Death|1
117387|NCT00922116|431276|P1|Overall Study|Adverse Event|4
117388|NCT00921557|431321|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
117389|NCT00921557|431322|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
117390|NCT00921557|431323|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
117391|NCT00921557|431321|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
117392|NCT00921557|431322|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
117393|NCT00921557|431323|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
117394|NCT00921557|431321|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
117395|NCT00921557|431322|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
117396|NCT00921557|431323|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
117397|NCT00921557|431321|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
117398|NCT00921557|431322|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
117399|NCT00921557|431323|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
117400|NCT00921557|431321|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
117401|NCT00921557|431322|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
117402|NCT00921557|431323|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
117403|NCT00921024|431425|P2|Overall Study|Withdrawal by Subject|3
117404|NCT00921024|431426|P1|Overall Study|Withdrawal by Subject|0
117405|NCT00921024|431425|P2|Overall Study|Received concomittant therapy|0
117406|NCT00921024|431426|P1|Overall Study|Received concomittant therapy|2
117407|NCT00921024|431425|P2|Overall Study|Lost to Follow-up|0
117408|NCT00921024|431426|P1|Overall Study|Lost to Follow-up|2
117409|NCT00920907|431436|P2|Maintenance Period|Adverse Event|1
117410|NCT00920907|431437|P1|Maintenance Period|Adverse Event|0
117411|NCT00920907|431436|P2|Maintenance Period|Withdrawal by Subject|0
117412|NCT00920907|431437|P1|Maintenance Period|Withdrawal by Subject|1
117413|NCT00920907|431436|P2|Maintenance Period|Death|1
117414|NCT00920907|431437|P1|Maintenance Period|Death|1
117415|NCT00920907|431436|P2|Maintenance Period|Study Drug Toxicity|2
117416|NCT00920907|431437|P1|Maintenance Period|Study Drug Toxicity|0
117417|NCT00920907|431436|P2|Maintenance Period|Administrative (study closure)|2
117418|NCT00920907|431437|P1|Maintenance Period|Administrative (study closure)|7
117419|NCT00920907|431436|P2|Maintenance Period|Disease Progression|7
117420|NCT00920907|431437|P1|Maintenance Period|Disease Progression|3
117421|NCT00920907|431436|P2|Induction Period|Withdrawal by Subject|1
117422|NCT00920907|431437|P1|Induction Period|Withdrawal by Subject|1
117423|NCT00920907|431436|P2|Induction Period|No longer meets study criteria|1
117424|NCT00920907|431437|P1|Induction Period|No longer meets study criteria|0
117425|NCT00920907|431436|P2|Induction Period|Study Drug Toxicity|6
117426|NCT00920907|431437|P1|Induction Period|Study Drug Toxicity|8
117427|NCT00920907|431436|P2|Induction Period|Disease Progression|11
117428|NCT00920907|431437|P1|Induction Period|Disease Progression|12
117429|NCT00920907|431436|P2|Induction Period|Death|1
117430|NCT00920907|431437|P1|Induction Period|Death|1
117431|NCT00920907|431436|P2|Induction Period|Adverse Event|2
117432|NCT00920907|431437|P1|Induction Period|Adverse Event|0
117433|NCT00920855|431478|P3|Overall Study|Response plateau; started maintenance|1
117434|NCT00920855|431479|P2|Overall Study|Response plateau; started maintenance|0
117435|NCT00920855|431480|P1|Overall Study|Response plateau; started maintenance|0
117436|NCT00920855|431478|P3|Overall Study|Noncompliance to study medication|1
117437|NCT00920855|431479|P2|Overall Study|Noncompliance to study medication|0
117438|NCT00920855|431480|P1|Overall Study|Noncompliance to study medication|0
117439|NCT00920855|431478|P3|Overall Study|Disease progression|10
117440|NCT00920855|431479|P2|Overall Study|Disease progression|1
117441|NCT00920855|431480|P1|Overall Study|Disease progression|2
117442|NCT00920855|431478|P3|Overall Study|Withdrawal by Subject|6
117443|NCT00920855|431479|P2|Overall Study|Withdrawal by Subject|1
117444|NCT00920855|431480|P1|Overall Study|Withdrawal by Subject|2
117445|NCT00920855|431478|P3|Overall Study|Adverse Event|4
117446|NCT00920855|431479|P2|Overall Study|Adverse Event|1
117447|NCT00920855|431480|P1|Overall Study|Adverse Event|1
117448|NCT00920816|431506|P4|Overall Study|Ongoing|36
117449|NCT00920816|431507|P3|Overall Study|Ongoing|70
117450|NCT00920816|431508|P2|Overall Study|Ongoing|56
117451|NCT00920816|431509|P1|Overall Study|Ongoing|106
117452|NCT00920816|431506|P4|Overall Study|Withdrawal by Subject|1
117453|NCT00920816|431507|P3|Overall Study|Withdrawal by Subject|1
117454|NCT00920816|431508|P2|Overall Study|Withdrawal by Subject|2
117455|NCT00920816|431509|P1|Overall Study|Withdrawal by Subject|7
117456|NCT00920816|431506|P4|Overall Study|Objective progression or relapse|0
117457|NCT00920816|431507|P3|Overall Study|Objective progression or relapse|2
117458|NCT00920816|431508|P2|Overall Study|Objective progression or relapse|0
117459|NCT00920816|431509|P1|Overall Study|Objective progression or relapse|0
117460|NCT00920816|431506|P4|Overall Study|Lost to Follow-up|4
117461|NCT00920816|431507|P3|Overall Study|Lost to Follow-up|3
117462|NCT00920816|431508|P2|Overall Study|Lost to Follow-up|2
117463|NCT00920816|431509|P1|Overall Study|Lost to Follow-up|1
117464|NCT00920816|431506|P4|Overall Study|Adverse Event|0
117465|NCT00920816|431507|P3|Overall Study|Adverse Event|1
117466|NCT00920816|431508|P2|Overall Study|Adverse Event|0
117467|NCT00920816|431509|P1|Overall Study|Adverse Event|1
117468|NCT00920816|431506|P4|Overall Study|Death|28
117469|NCT00920816|431507|P3|Overall Study|Death|58
117470|NCT00920816|431508|P2|Overall Study|Death|36
117471|NCT00920816|431509|P1|Overall Study|Death|77
117472|NCT00920790|431547|P1|Overall Study|aggravation of general condition|14
117473|NCT00920699|431559|P3|Overall Study|Lost to Follow-up|2
117474|NCT00920699|431560|P2|Overall Study|Lost to Follow-up|0
117475|NCT00920699|431561|P1|Overall Study|Lost to Follow-up|0
117476|NCT00920699|431559|P3|Overall Study|no longer met eligibility|0
117477|NCT00920699|431560|P2|Overall Study|no longer met eligibility|1
117478|NCT00920699|431561|P1|Overall Study|no longer met eligibility|0
117479|NCT00920699|431559|P3|Overall Study|Withdrawal by Subject|2
117480|NCT00920699|431560|P2|Overall Study|Withdrawal by Subject|0
117481|NCT00920699|431561|P1|Overall Study|Withdrawal by Subject|2
117482|NCT00920686|431578|P3|Overall Study|Study drug dosing criteria not met|12
117483|NCT00920686|431579|P2|Overall Study|Study drug dosing criteria not met|19
117484|NCT00920686|431580|P1|Overall Study|Study drug dosing criteria not met|17
117485|NCT00920686|431578|P3|Overall Study|Lost to Follow-up|1
117486|NCT00920686|431579|P2|Overall Study|Lost to Follow-up|3
117487|NCT00920686|431580|P1|Overall Study|Lost to Follow-up|2
117488|NCT00920621|431659|P4|Overall Study|Blood sample not collected|0
117489|NCT00920621|431660|P3|Overall Study|Blood sample not collected|0
117490|NCT00920621|431661|P2|Overall Study|Blood sample not collected|14
117491|NCT00920621|431662|P1|Overall Study|Blood sample not collected|22
117492|NCT00920621|431659|P4|Overall Study|Fetal/neonatal deaths|14
117493|NCT00920621|431660|P3|Overall Study|Fetal/neonatal deaths|16
117494|NCT00920621|431661|P2|Overall Study|Fetal/neonatal deaths|14
117495|NCT00920621|431662|P1|Overall Study|Fetal/neonatal deaths|16
117496|NCT00920621|431659|P4|Overall Study|Lost to Follow-up|21
117497|NCT00920621|431660|P3|Overall Study|Lost to Follow-up|19
117498|NCT00920621|431661|P2|Overall Study|Lost to Follow-up|17
117499|NCT00920621|431662|P1|Overall Study|Lost to Follow-up|16
117500|NCT00920426|431696|P4|ITZ111451|Adverse Event|0
117501|NCT00920426|431697|P3|ITZ111451|Adverse Event|0
117502|NCT00920426|431698|P2|ITZ111451|Adverse Event|0
117503|NCT00920426|431699|P1|ITZ111451|Adverse Event|1
117504|NCT00920218|431819|P4|Overall Study|Not specified|0
117505|NCT00920218|431820|P3|Overall Study|Not specified|1
117506|NCT00920218|431821|P2|Overall Study|Not specified|0
117507|NCT00920218|431822|P1|Overall Study|Not specified|0
117508|NCT00920218|431819|P4|Overall Study|Transplant failed/malignancy recurrence|3
117509|NCT00920218|431820|P3|Overall Study|Transplant failed/malignancy recurrence|2
117510|NCT00920218|431821|P2|Overall Study|Transplant failed/malignancy recurrence|1
117511|NCT00920218|431822|P1|Overall Study|Transplant failed/malignancy recurrence|0
117512|NCT00920218|431819|P4|Overall Study|Lost to Follow-up|3
117513|NCT00920218|431820|P3|Overall Study|Lost to Follow-up|0
117514|NCT00920218|431821|P2|Overall Study|Lost to Follow-up|1
117515|NCT00920218|431822|P1|Overall Study|Lost to Follow-up|0
117516|NCT00920218|431819|P4|Overall Study|Migrated/moved from study area|0
117517|NCT00920218|431820|P3|Overall Study|Migrated/moved from study area|1
117518|NCT00920218|431821|P2|Overall Study|Migrated/moved from study area|0
117519|NCT00920218|431822|P1|Overall Study|Migrated/moved from study area|0
117520|NCT00920218|431819|P4|Overall Study|Withdrawal by Subject|0
117521|NCT00920218|431820|P3|Overall Study|Withdrawal by Subject|2
117522|NCT00920218|431821|P2|Overall Study|Withdrawal by Subject|3
117523|NCT00920218|431822|P1|Overall Study|Withdrawal by Subject|0
117524|NCT00920218|431819|P4|Overall Study|Serious Adverse Event|1
117525|NCT00920218|431820|P3|Overall Study|Serious Adverse Event|2
117526|NCT00920218|431821|P2|Overall Study|Serious Adverse Event|0
117527|NCT00920218|431822|P1|Overall Study|Serious Adverse Event|2
117528|NCT00920140|431925|P5|Phase 2|Withdrawal by Subject|1
117529|NCT00920140|431926|P4|Phase 2|Withdrawal by Subject|2
117530|NCT00920140|431927|P3|Phase 2|Withdrawal by Subject|4
117531|NCT00920140|431928|P2|Phase 2|Withdrawal by Subject|0
117532|NCT00920140|431929|P1|Phase 2|Withdrawal by Subject|0
117533|NCT00920140|431925|P5|Phase 2|Physician Decision|2
117534|NCT00920140|431926|P4|Phase 2|Physician Decision|3
117535|NCT00920140|431927|P3|Phase 2|Physician Decision|3
117536|NCT00920140|431928|P2|Phase 2|Physician Decision|0
117537|NCT00920140|431929|P1|Phase 2|Physician Decision|0
117538|NCT00920140|431925|P5|Phase 2|Lost to Follow-up|0
117539|NCT00920140|431926|P4|Phase 2|Lost to Follow-up|1
117540|NCT00920140|431927|P3|Phase 2|Lost to Follow-up|0
117541|NCT00920140|431928|P2|Phase 2|Lost to Follow-up|0
117542|NCT00920140|431929|P1|Phase 2|Lost to Follow-up|0
117543|NCT00920140|431925|P5|Phase 2|Lack of Efficacy|5
117544|NCT00920140|431926|P4|Phase 2|Lack of Efficacy|14
117545|NCT00920140|431927|P3|Phase 2|Lack of Efficacy|29
117546|NCT00920140|431928|P2|Phase 2|Lack of Efficacy|0
117547|NCT00920140|431929|P1|Phase 2|Lack of Efficacy|0
117548|NCT00920140|431925|P5|Phase 2|Adverse Event|3
117549|NCT00920140|431926|P4|Phase 2|Adverse Event|2
117550|NCT00920140|431927|P3|Phase 2|Adverse Event|14
117551|NCT00920140|431928|P2|Phase 2|Adverse Event|0
117552|NCT00920140|431929|P1|Phase 2|Adverse Event|0
117553|NCT00920140|431925|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
117554|NCT00920140|431926|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
117555|NCT00920140|431927|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
117556|NCT00920140|431928|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
117557|NCT00920140|431929|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
117558|NCT00920140|431925|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
117559|NCT00920140|431926|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
117560|NCT00920140|431927|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
117561|NCT00920140|431928|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
117562|NCT00920140|431929|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
117563|NCT00920140|431925|P5|Phase 1 (Dose Escalation)|Adverse Event|0
117564|NCT00920140|431926|P4|Phase 1 (Dose Escalation)|Adverse Event|0
117565|NCT00920140|431927|P3|Phase 1 (Dose Escalation)|Adverse Event|0
117566|NCT00920140|431928|P2|Phase 1 (Dose Escalation)|Adverse Event|3
117567|NCT00920140|431929|P1|Phase 1 (Dose Escalation)|Adverse Event|3
117568|NCT00919893|431991|P2|Overall Study|Protocol Violation|9
117569|NCT00919893|431992|P1|Overall Study|Protocol Violation|19
117570|NCT00919867|432004|P6|First Intervention|Physician Decision|1
117571|NCT00919867|432005|P5|First Intervention|Physician Decision|0
117572|NCT00919867|432006|P4|First Intervention|Physician Decision|0
117573|NCT00919867|432007|P3|First Intervention|Physician Decision|0
117574|NCT00919867|432008|P2|First Intervention|Physician Decision|0
117575|NCT00919867|432009|P1|First Intervention|Physician Decision|0
117576|NCT00919867|432004|P6|First Intervention|Withdrawal by Subject|0
117577|NCT00919867|432005|P5|First Intervention|Withdrawal by Subject|0
117578|NCT00919867|432006|P4|First Intervention|Withdrawal by Subject|0
117579|NCT00919867|432007|P3|First Intervention|Withdrawal by Subject|1
117580|NCT00919867|432008|P2|First Intervention|Withdrawal by Subject|0
117581|NCT00919867|432009|P1|First Intervention|Withdrawal by Subject|0
117582|NCT00919854|432030|P1|Overall Study|Adverse Event|1
117583|NCT00919711|432068|P2|Overall Study|Noncompliance|0
117584|NCT00919711|432069|P1|Overall Study|Noncompliance|1
117585|NCT00919711|432068|P2|Overall Study|Death|0
117586|NCT00919711|432069|P1|Overall Study|Death|1
117587|NCT00919711|432068|P2|Overall Study|Lost to Follow-up|0
117588|NCT00919711|432069|P1|Overall Study|Lost to Follow-up|2
117589|NCT00919711|432068|P2|Overall Study|Administrative Decision|1
117590|NCT00919711|432069|P1|Overall Study|Administrative Decision|0
117591|NCT00919711|432068|P2|Overall Study|Other|2
117592|NCT00919711|432069|P1|Overall Study|Other|1
117593|NCT00919711|432068|P2|Overall Study|Adverse Event|3
117594|NCT00919711|432069|P1|Overall Study|Adverse Event|13
117595|NCT00919711|432068|P2|Overall Study|Withdrawal by Subject|7
117596|NCT00919711|432069|P1|Overall Study|Withdrawal by Subject|15
117597|NCT00919633|432085|P4|Overall Study|Viral rebound outside protocol timepoint|0
117598|NCT00919633|432086|P3|Overall Study|Viral rebound outside protocol timepoint|1
117599|NCT00919633|432087|P2|Overall Study|Viral rebound outside protocol timepoint|0
117600|NCT00919633|432088|P1|Overall Study|Viral rebound outside protocol timepoint|0
117601|NCT00919633|432085|P4|Overall Study|Request of withdrawal w/o future contact|0
117602|NCT00919633|432086|P3|Overall Study|Request of withdrawal w/o future contact|1
117603|NCT00919633|432087|P2|Overall Study|Request of withdrawal w/o future contact|0
117604|NCT00919633|432088|P1|Overall Study|Request of withdrawal w/o future contact|0
117605|NCT00919633|432085|P4|Overall Study|Physician Decision|1
117606|NCT00919633|432086|P3|Overall Study|Physician Decision|0
117607|NCT00919633|432087|P2|Overall Study|Physician Decision|0
117608|NCT00919633|432088|P1|Overall Study|Physician Decision|0
117609|NCT00919633|432085|P4|Overall Study|Protocol Violation|1
117610|NCT00919633|432086|P3|Overall Study|Protocol Violation|0
117611|NCT00919633|432087|P2|Overall Study|Protocol Violation|0
117612|NCT00919633|432088|P1|Overall Study|Protocol Violation|0
117613|NCT00919633|432085|P4|Overall Study|Withdraw consent post transition to SOC|1
117614|NCT00919633|432086|P3|Overall Study|Withdraw consent post transition to SOC|1
117615|NCT00919633|432087|P2|Overall Study|Withdraw consent post transition to SOC|0
117616|NCT00919633|432088|P1|Overall Study|Withdraw consent post transition to SOC|0
117617|NCT00919633|432085|P4|Overall Study|Lost to Follow-up|2
117618|NCT00919633|432086|P3|Overall Study|Lost to Follow-up|0
117619|NCT00919633|432087|P2|Overall Study|Lost to Follow-up|1
117620|NCT00919633|432088|P1|Overall Study|Lost to Follow-up|3
117621|NCT00919633|432085|P4|Overall Study|Withdrawal by Subject|3
117622|NCT00919633|432086|P3|Overall Study|Withdrawal by Subject|4
117623|NCT00919633|432087|P2|Overall Study|Withdrawal by Subject|2
117624|NCT00919633|432088|P1|Overall Study|Withdrawal by Subject|1
117625|NCT00919633|432085|P4|Overall Study|Lack of Efficacy|3
117626|NCT00919633|432086|P3|Overall Study|Lack of Efficacy|2
117627|NCT00919633|432087|P2|Overall Study|Lack of Efficacy|3
117628|NCT00919633|432088|P1|Overall Study|Lack of Efficacy|17
117629|NCT00919633|432085|P4|Overall Study|Death|0
117630|NCT00919633|432086|P3|Overall Study|Death|2
117631|NCT00919633|432087|P2|Overall Study|Death|0
117632|NCT00919633|432088|P1|Overall Study|Death|0
117633|NCT00919633|432085|P4|Overall Study|Adverse Event|10
117634|NCT00919633|432086|P3|Overall Study|Adverse Event|12
117635|NCT00919633|432087|P2|Overall Study|Adverse Event|9
117636|NCT00919633|432088|P1|Overall Study|Adverse Event|1
117637|NCT00919061|432173|P1|Overall Study|Withdrawal by Subject|1
117638|NCT00919061|432173|P1|Overall Study|Adverse Event|1
117639|NCT00918957|432186|P2|Overall Study|Withdrawal by Subject|0
117640|NCT00918957|432187|P1|Overall Study|Withdrawal by Subject|1
117641|NCT00918957|432186|P2|Overall Study|Adverse Event|0
117642|NCT00918957|432187|P1|Overall Study|Adverse Event|2
117643|NCT00918879|432220|P2|Overall Study|Severe non-compliance to protocol|1
117644|NCT00918879|432221|P1|Overall Study|Severe non-compliance to protocol|1
117645|NCT00918879|432220|P2|Overall Study|Lost to Follow-up|1
117646|NCT00918879|432221|P1|Overall Study|Lost to Follow-up|1
117647|NCT00918879|432220|P2|Overall Study|Withdrawal by Subject|4
117648|NCT00918879|432221|P1|Overall Study|Withdrawal by Subject|4
117649|NCT00918749|432253|P3|Overall Study|No Study Medication Taken|0
117650|NCT00918749|432254|P2|Overall Study|No Study Medication Taken|0
117651|NCT00918749|432255|P1|Overall Study|No Study Medication Taken|1
117652|NCT00918749|432253|P3|Overall Study|Withdrawal by Subject|5
117653|NCT00918749|432254|P2|Overall Study|Withdrawal by Subject|3
117654|NCT00918749|432255|P1|Overall Study|Withdrawal by Subject|5
117655|NCT00918749|432253|P3|Overall Study|Lost to Follow-up|1
117656|NCT00918749|432254|P2|Overall Study|Lost to Follow-up|0
117657|NCT00918749|432255|P1|Overall Study|Lost to Follow-up|0
117658|NCT00918749|432253|P3|Overall Study|Adverse Event|1
117659|NCT00918749|432254|P2|Overall Study|Adverse Event|0
117660|NCT00918749|432255|P1|Overall Study|Adverse Event|1
117661|NCT00918736|432287|P1|Overall Study|Withdrawal by Subject|4
117662|NCT00918684|432300|P1|Treatment Phase|Withdrawal by Subject|8
117663|NCT00918684|432300|P1|Treatment Phase|Protocol Violation|1
117664|NCT00918684|432300|P1|Treatment Phase|Physician Decision|8
117665|NCT00918684|432300|P1|Treatment Phase|Lost to Follow-up|2
117666|NCT00918684|432300|P1|Treatment Phase|Lack of Efficacy|6
117667|NCT00918684|432300|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
117668|NCT00918645|432311|P1|Overall Study|Withdrawal by Subject|1
117669|NCT00918580|432317|P1|After 6-month FU to 1-year FU|Failed to Return|2
117670|NCT00918580|432317|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
117671|NCT00918580|432317|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
117672|NCT00918580|432317|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
117673|NCT00918580|432317|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
117674|NCT00918580|432317|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
117675|NCT00918580|432317|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
117676|NCT00918385|432337|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
117677|NCT00918385|432338|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
117678|NCT00918385|432337|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
117679|NCT00918385|432338|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
117680|NCT00918385|432337|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
117681|NCT00918385|432338|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
117682|NCT00918385|432337|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
117683|NCT00918385|432338|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
117684|NCT00918385|432337|P2|Monotherapy|Complicating illness|0
117685|NCT00918385|432338|P1|Monotherapy|Complicating illness|1
117686|NCT00918385|432337|P2|Monotherapy|Adverse Event|6
117687|NCT00918385|432338|P1|Monotherapy|Adverse Event|1
117688|NCT00918346|432347|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
117689|NCT00918346|432348|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
117690|NCT00918333|432364|P2|Overall Study|Withdrawal by Subject|1
117691|NCT00918333|432365|P1|Overall Study|Withdrawal by Subject|0
117692|NCT00918333|432364|P2|Overall Study|Ineligible|0
117693|NCT00918333|432365|P1|Overall Study|Ineligible|1
117694|NCT00918333|432364|P2|Overall Study|Inadequate amount of drugs provided|4
117695|NCT00918333|432365|P1|Overall Study|Inadequate amount of drugs provided|1
117696|NCT00918333|432364|P2|Overall Study|Drug not taken per protocol|0
117697|NCT00918333|432365|P1|Overall Study|Drug not taken per protocol|1
117698|NCT00918281|432385|P1|Overall Study|Physician Decision|29
117699|NCT00918255|432395|P3|Overall Study|Investigator discretion|0
117700|NCT00918255|432396|P2|Overall Study|Investigator discretion|0
117701|NCT00918255|432397|P1|Overall Study|Investigator discretion|1
117702|NCT00918255|432395|P3|Overall Study|Non-compliance|0
117703|NCT00918255|432396|P2|Overall Study|Non-compliance|0
117704|NCT00918255|432397|P1|Overall Study|Non-compliance|1
117705|NCT00918255|432395|P3|Overall Study|Exceeded allowed number of interventions|1
117706|NCT00918255|432396|P2|Overall Study|Exceeded allowed number of interventions|0
117707|NCT00918255|432397|P1|Overall Study|Exceeded allowed number of interventions|0
117708|NCT00918255|432395|P3|Overall Study|Lost to Follow-up|2
117709|NCT00918255|432396|P2|Overall Study|Lost to Follow-up|0
117710|NCT00918255|432397|P1|Overall Study|Lost to Follow-up|1
117711|NCT00918255|432395|P3|Overall Study|Lack of Efficacy|0
117712|NCT00918255|432396|P2|Overall Study|Lack of Efficacy|0
117713|NCT00918255|432397|P1|Overall Study|Lack of Efficacy|1
117714|NCT00918255|432395|P3|Overall Study|Withdrawal by Subject|2
117715|NCT00918255|432396|P2|Overall Study|Withdrawal by Subject|0
117716|NCT00918255|432397|P1|Overall Study|Withdrawal by Subject|1
117717|NCT00918255|432395|P3|Overall Study|Adverse Event|0
117718|NCT00918255|432396|P2|Overall Study|Adverse Event|0
117719|NCT00918255|432397|P1|Overall Study|Adverse Event|1
117720|NCT00918203|432425|P3|Crossover to Olaratumab Monotherapy|Other Therapy Started|1
117721|NCT00918203|432426|P2|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
117722|NCT00918203|432427|P1|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
117723|NCT00918203|432425|P3|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|2
117724|NCT00918203|432426|P2|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
117725|NCT00918203|432427|P1|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
117726|NCT00918203|432425|P3|Treatment With or Without Olaratumab|On Treatment|0
117727|NCT00918203|432426|P2|Treatment With or Without Olaratumab|On Treatment|0
117728|NCT00918203|432427|P1|Treatment With or Without Olaratumab|On Treatment|1
117729|NCT00918203|432425|P3|Treatment With or Without Olaratumab|Physician Decision|0
117730|NCT00918203|432426|P2|Treatment With or Without Olaratumab|Physician Decision|1
117731|NCT00918203|432427|P1|Treatment With or Without Olaratumab|Physician Decision|0
117732|NCT00918203|432425|P3|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
117733|NCT00918203|432426|P2|Treatment With or Without Olaratumab|Off Study Treatment/Alive|1
117734|NCT00918203|432427|P1|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
117735|NCT00918203|432425|P3|Treatment With or Without Olaratumab|Never Treated|0
117736|NCT00918203|432426|P2|Treatment With or Without Olaratumab|Never Treated|1
117737|NCT00918203|432427|P1|Treatment With or Without Olaratumab|Never Treated|2
117738|NCT00918203|432425|P3|Treatment With or Without Olaratumab|Adverse Event|0
117739|NCT00918203|432426|P2|Treatment With or Without Olaratumab|Adverse Event|1
117740|NCT00918203|432427|P1|Treatment With or Without Olaratumab|Adverse Event|1
117741|NCT00918203|432425|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
117742|NCT00918203|432426|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
117743|NCT00918203|432427|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
117744|NCT00918203|432425|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
117745|NCT00918203|432426|P2|Treatment With or Without Olaratumab|Lost to Follow-up|0
117746|NCT00918203|432427|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
117747|NCT00918203|432425|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
117748|NCT00918203|432426|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|9
117749|NCT00918203|432427|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|0
117750|NCT00918138|432458|P2|Overall Study|Death|0
117751|NCT00918138|432459|P1|Overall Study|Death|1
117752|NCT00918138|432458|P2|Overall Study|Subject withdrew consent|1
117753|NCT00918138|432459|P1|Overall Study|Subject withdrew consent|1
117754|NCT00917852|432498|P1|Overall Study|Death|6
117755|NCT00917644|432516|P2|Period 2: Second Intervention|family emergency|0
117756|NCT00917644|432517|P1|Period 2: Second Intervention|family emergency|1
117757|NCT00917644|432516|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
117758|NCT00917644|432517|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
117759|NCT00917644|432516|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
117760|NCT00917644|432517|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
117761|NCT00917579|432531|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
117762|NCT00917579|432532|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
117763|NCT00917579|432531|P2|Washout >= 2 Weeks|Adverse Event|0
117764|NCT00917579|432532|P1|Washout >= 2 Weeks|Adverse Event|1
117765|NCT00917501|432548|P2|Overall Study|trouble swollowing capsules|1
117766|NCT00917501|432549|P1|Overall Study|trouble swollowing capsules|0
117767|NCT00917501|432548|P2|Overall Study|Lack of Efficacy|2
117768|NCT00917501|432549|P1|Overall Study|Lack of Efficacy|1
117769|NCT00917501|432548|P2|Overall Study|Withdrawal by Subject|1
117770|NCT00917501|432549|P1|Overall Study|Withdrawal by Subject|3
117771|NCT00917501|432548|P2|Overall Study|Lost to Follow-up|1
117772|NCT00917501|432549|P1|Overall Study|Lost to Follow-up|4
117773|NCT00917384|432557|P2|Overall Study|Withdrawal by Subject|2
117774|NCT00917384|432558|P1|Overall Study|Withdrawal by Subject|10
117775|NCT00917384|432557|P2|Overall Study|Lost to Follow-up|2
117776|NCT00917384|432558|P1|Overall Study|Lost to Follow-up|4
117777|NCT00917267|432582|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
117778|NCT00917267|432583|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
117779|NCT00917267|432582|P2|Overall Study|Sponsor Decision|5
117780|NCT00917267|432583|P1|Overall Study|Sponsor Decision|5
117781|NCT00917267|432582|P2|Overall Study|Entry Criteria Not Met|0
117782|NCT00917267|432583|P1|Overall Study|Entry Criteria Not Met|1
117783|NCT00917267|432582|P2|Overall Study|Lost to follow up|2
117784|NCT00917267|432583|P1|Overall Study|Lost to follow up|0
117785|NCT00917267|432582|P2|Overall Study|Withdrawal by Subject|12
117786|NCT00917267|432583|P1|Overall Study|Withdrawal by Subject|5
117787|NCT00917267|432582|P2|Overall Study|Protocol Violation|18
117788|NCT00917267|432583|P1|Overall Study|Protocol Violation|9
117789|NCT00917267|432582|P2|Overall Study|Physician Decision|4
117790|NCT00917267|432583|P1|Overall Study|Physician Decision|2
117791|NCT00917267|432582|P2|Overall Study|Adverse Event|36
117792|NCT00917267|432583|P1|Overall Study|Adverse Event|15
117793|NCT00917124|432611|P2|Overall Study|Protocol Violation|6
117794|NCT00917124|432612|P1|Overall Study|Protocol Violation|4
117795|NCT00916929|432622|P2|Overall Study|Device unable to process impedance data|7
117796|NCT00916929|432623|P1|Overall Study|Device unable to process impedance data|0
117797|NCT00916929|432622|P2|Overall Study|Moved to another state|1
117798|NCT00916929|432623|P1|Overall Study|Moved to another state|0
117799|NCT00916929|432622|P2|Overall Study|System explant|0
117800|NCT00916929|432623|P1|Overall Study|System explant|1
117801|NCT00916929|432622|P2|Overall Study|Transferred to hospice care|1
117802|NCT00916929|432623|P1|Overall Study|Transferred to hospice care|1
117803|NCT00916929|432622|P2|Overall Study|Left ventricular epicardial lead|2
117804|NCT00916929|432623|P1|Overall Study|Left ventricular epicardial lead|1
117805|NCT00916929|432622|P2|Overall Study|Withdrawal by Subject|5
117806|NCT00916929|432623|P1|Overall Study|Withdrawal by Subject|1
117807|NCT00916929|432622|P2|Overall Study|Death|10
117808|NCT00916929|432623|P1|Overall Study|Death|5
117809|NCT00916929|432622|P2|Overall Study|Lost to Follow-up|3
117810|NCT00916929|432623|P1|Overall Study|Lost to Follow-up|1
117811|NCT00916721|432633|P2|Overall Study|Protocol Violation|4
117812|NCT00916721|432634|P1|Overall Study|Protocol Violation|2
117813|NCT00916721|432633|P2|Overall Study|Withdrawal by Subject|2
117814|NCT00916721|432634|P1|Overall Study|Withdrawal by Subject|2
117815|NCT00916721|432633|P2|Overall Study|Adverse Event|3
117816|NCT00916721|432634|P1|Overall Study|Adverse Event|6
117817|NCT00916721|432633|P2|Overall Study|Lost to Follow-up|1
117818|NCT00916721|432634|P1|Overall Study|Lost to Follow-up|0
117819|NCT00916617|432657|P4|Overall Study|Not specified|2
117820|NCT00916617|432658|P3|Overall Study|Not specified|0
117821|NCT00916617|432659|P2|Overall Study|Not specified|0
117822|NCT00916617|432660|P1|Overall Study|Not specified|2
117823|NCT00916617|432657|P4|Overall Study|Lack of Efficacy|0
117824|NCT00916617|432658|P3|Overall Study|Lack of Efficacy|0
117825|NCT00916617|432659|P2|Overall Study|Lack of Efficacy|0
117826|NCT00916617|432660|P1|Overall Study|Lack of Efficacy|1
117827|NCT00916617|432657|P4|Overall Study|Lost to Follow-up|0
117828|NCT00916617|432658|P3|Overall Study|Lost to Follow-up|0
117829|NCT00916617|432659|P2|Overall Study|Lost to Follow-up|1
117830|NCT00916617|432660|P1|Overall Study|Lost to Follow-up|2
117831|NCT00916617|432657|P4|Overall Study|Discontinuation of Study by Sponsor|1
117832|NCT00916617|432658|P3|Overall Study|Discontinuation of Study by Sponsor|3
117833|NCT00916617|432659|P2|Overall Study|Discontinuation of Study by Sponsor|13
117834|NCT00916617|432660|P1|Overall Study|Discontinuation of Study by Sponsor|8
117835|NCT00916617|432657|P4|Overall Study|Physician Decision|0
117836|NCT00916617|432658|P3|Overall Study|Physician Decision|0
117837|NCT00916617|432659|P2|Overall Study|Physician Decision|1
117838|NCT00916617|432660|P1|Overall Study|Physician Decision|1
117839|NCT00916617|432657|P4|Overall Study|Caregiver Request|0
117840|NCT00916617|432658|P3|Overall Study|Caregiver Request|1
117841|NCT00916617|432659|P2|Overall Study|Caregiver Request|2
117842|NCT00916617|432660|P1|Overall Study|Caregiver Request|3
117843|NCT00916617|432657|P4|Overall Study|Withdrawal by Subject|1
117844|NCT00916617|432658|P3|Overall Study|Withdrawal by Subject|0
117845|NCT00916617|432659|P2|Overall Study|Withdrawal by Subject|2
117846|NCT00916617|432660|P1|Overall Study|Withdrawal by Subject|3
117847|NCT00916617|432657|P4|Overall Study|Adverse Event|3
117848|NCT00916617|432658|P3|Overall Study|Adverse Event|6
117849|NCT00916617|432659|P2|Overall Study|Adverse Event|2
117850|NCT00916617|432660|P1|Overall Study|Adverse Event|3
117851|NCT00916383|432699|P1|Overall Study|Protocol Violation|1
117852|NCT00916383|432699|P1|Overall Study|Death|1
117853|NCT00916383|432699|P1|Overall Study|Adverse Event|1
117854|NCT00916370|432727|P2|Overall Study|Physician Decision|1
117855|NCT00916370|432728|P1|Overall Study|Physician Decision|0
117856|NCT00916370|432727|P2|Overall Study|Withdrawal by Subject|0
117857|NCT00916370|432728|P1|Overall Study|Withdrawal by Subject|2
117858|NCT00916370|432727|P2|Overall Study|Death|1
117859|NCT00916370|432728|P1|Overall Study|Death|3
117860|NCT00916357|432902|P6|Period 2|Weight loss > 3 kilograms (kg)|0
117861|NCT00916357|432903|P5|Period 2|Weight loss > 3 kilograms (kg)|0
117862|NCT00916357|432904|P4|Period 2|Weight loss > 3 kilograms (kg)|1
117863|NCT00916357|432905|P3|Period 2|Weight loss > 3 kilograms (kg)|0
117864|NCT00916357|432906|P2|Period 2|Weight loss > 3 kilograms (kg)|0
117865|NCT00916357|432907|P1|Period 2|Weight loss > 3 kilograms (kg)|0
117866|NCT00916357|432902|P6|Period 1|Withdrawal by Subject|0
117867|NCT00916357|432903|P5|Period 1|Withdrawal by Subject|0
117868|NCT00916357|432904|P4|Period 1|Withdrawal by Subject|0
117869|NCT00916357|432905|P3|Period 1|Withdrawal by Subject|0
117870|NCT00916357|432906|P2|Period 1|Withdrawal by Subject|0
117871|NCT00916357|432907|P1|Period 1|Withdrawal by Subject|1
117872|NCT00916344|432945|P1|Overall Study|Drop-out|5
117873|NCT00916344|432945|P1|Overall Study|ICD upgrade|1
117874|NCT00916344|432945|P1|Overall Study|Death|2
117875|NCT00916305|432952|P2|Overall Study|Withdrawal by Subject|1
117876|NCT00916305|432953|P1|Overall Study|Withdrawal by Subject|0
117877|NCT00916305|432952|P2|Overall Study|Lost to Follow-up|27
117878|NCT00916305|432953|P1|Overall Study|Lost to Follow-up|21
117879|NCT00916279|432961|P1|Overall Study|Lost to Follow-up|2
117880|NCT00916279|432961|P1|Overall Study|Death|2
117881|NCT00916006|433023|P2|Overall Study|Protocol Violation|1
117882|NCT00916006|433024|P1|Overall Study|Protocol Violation|0
117883|NCT00916006|433023|P2|Overall Study|Withdrawal by Subject|5
117884|NCT00916006|433024|P1|Overall Study|Withdrawal by Subject|2
117885|NCT00916006|433023|P2|Overall Study|Adverse Event|1
117886|NCT00916006|433024|P1|Overall Study|Adverse Event|1
117887|NCT00915876|433045|P2|Overall Study|Adverse Event|1
117888|NCT00915876|433046|P1|Overall Study|Adverse Event|0
117889|NCT00915772|433082|P3|Overall Study|Any other reason|7
117890|NCT00915772|433083|P2|Overall Study|Any other reason|7
117891|NCT00915772|433084|P1|Overall Study|Any other reason|4
117892|NCT00915772|433082|P3|Overall Study|Refused to continue trial medication|4
117893|NCT00915772|433083|P2|Overall Study|Refused to continue trial medication|8
117894|NCT00915772|433084|P1|Overall Study|Refused to continue trial medication|6
117895|NCT00915772|433082|P3|Overall Study|Lack of Efficacy|3
117896|NCT00915772|433083|P2|Overall Study|Lack of Efficacy|15
117897|NCT00915772|433084|P1|Overall Study|Lack of Efficacy|9
117898|NCT00915772|433082|P3|Overall Study|Lost to Follow-up|2
117899|NCT00915772|433083|P2|Overall Study|Lost to Follow-up|2
117900|NCT00915772|433084|P1|Overall Study|Lost to Follow-up|1
117901|NCT00915772|433082|P3|Overall Study|Protocol Violation|2
117902|NCT00915772|433083|P2|Overall Study|Protocol Violation|1
117903|NCT00915772|433084|P1|Overall Study|Protocol Violation|4
117904|NCT00915772|433082|P3|Overall Study|Adverse Event|11
117905|NCT00915772|433083|P2|Overall Study|Adverse Event|13
117906|NCT00915772|433084|P1|Overall Study|Adverse Event|12
117907|NCT00915551|433183|P2|Overall Study|Withdrawal by Subject|1
117908|NCT00915551|433184|P1|Overall Study|Withdrawal by Subject|0
117909|NCT00915525|433194|P2|Overall Study|Patient Moved|9
117910|NCT00915525|433195|P1|Overall Study|Patient Moved|15
117911|NCT00915525|433194|P2|Overall Study|Non-Compliance|1
117912|NCT00915525|433195|P1|Overall Study|Non-Compliance|3
117913|NCT00915525|433194|P2|Overall Study|Study Burden|12
117914|NCT00915525|433195|P1|Overall Study|Study Burden|28
117915|NCT00915525|433194|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
117916|NCT00915525|433195|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
117917|NCT00915525|433194|P2|Overall Study|Site Closed|9
117918|NCT00915525|433195|P1|Overall Study|Site Closed|27
117919|NCT00915525|433194|P2|Overall Study|Other Reason|12
117920|NCT00915525|433195|P1|Overall Study|Other Reason|35
117921|NCT00915525|433194|P2|Overall Study|Missing|1
117922|NCT00915525|433195|P1|Overall Study|Missing|12
117923|NCT00915525|433194|P2|Overall Study|Adverse Event|13
117924|NCT00915525|433195|P1|Overall Study|Adverse Event|29
117925|NCT00915525|433194|P2|Overall Study|Lack of Efficacy|32
117926|NCT00915525|433195|P1|Overall Study|Lack of Efficacy|15
117927|NCT00915525|433194|P2|Overall Study|Pregnancy|0
117928|NCT00915525|433195|P1|Overall Study|Pregnancy|2
117929|NCT00915525|433194|P2|Overall Study|Lost to Follow-up|16
117930|NCT00915525|433195|P1|Overall Study|Lost to Follow-up|27
117931|NCT00915525|433194|P2|Overall Study|Withdrawal by Subject|21
117932|NCT00915525|433195|P1|Overall Study|Withdrawal by Subject|59
117933|NCT00915525|433194|P2|Overall Study|Protocol Violation|4
117934|NCT00915525|433195|P1|Overall Study|Protocol Violation|9
117935|NCT00915473|433309|P2|4-week Follow Up|Lost to Follow-up|5
117936|NCT00915473|433310|P1|4-week Follow Up|Lost to Follow-up|1
117937|NCT00915473|433309|P2|Screening|Withdrawal by Subject|0
117938|NCT00915473|433310|P1|Screening|Withdrawal by Subject|1
117939|NCT00915356|433327|P5|Overall Study|Withdrawal by Subject|0
117940|NCT00915356|433328|P4|Overall Study|Withdrawal by Subject|0
117941|NCT00915356|433329|P3|Overall Study|Withdrawal by Subject|0
117942|NCT00915356|433330|P2|Overall Study|Withdrawal by Subject|0
117943|NCT00915356|433331|P1|Overall Study|Withdrawal by Subject|1
117944|NCT00915343|433393|P3|Part B - Open Label Period|Did not attend the last visit|1
117945|NCT00915343|433394|P2|Part B - Open Label Period|Did not attend the last visit|0
117946|NCT00915343|433395|P1|Part B - Open Label Period|Did not attend the last visit|0
117947|NCT00915343|433393|P3|Part B - Open Label Period|Treatment switch|1
117948|NCT00915343|433394|P2|Part B - Open Label Period|Treatment switch|0
117949|NCT00915343|433395|P1|Part B - Open Label Period|Treatment switch|0
117950|NCT00915278|433480|P6|Overall Study|Admission to hospice|0
117951|NCT00915278|433481|P5|Overall Study|Admission to hospice|0
117952|NCT00915278|433482|P4|Overall Study|Admission to hospice|0
117953|NCT00915278|433483|P3|Overall Study|Admission to hospice|1
117954|NCT00915278|433484|P2|Overall Study|Admission to hospice|0
117955|NCT00915278|433485|P1|Overall Study|Admission to hospice|0
117956|NCT00915278|433480|P6|Overall Study|Infusion related AEs|2
117957|NCT00915278|433481|P5|Overall Study|Infusion related AEs|0
117958|NCT00915278|433482|P4|Overall Study|Infusion related AEs|0
117959|NCT00915278|433483|P3|Overall Study|Infusion related AEs|0
117960|NCT00915278|433484|P2|Overall Study|Infusion related AEs|0
117961|NCT00915278|433485|P1|Overall Study|Infusion related AEs|0
117962|NCT00915278|433480|P6|Overall Study|Progressive disease/clinical progression|2
117963|NCT00915278|433481|P5|Overall Study|Progressive disease/clinical progression|1
117964|NCT00915278|433482|P4|Overall Study|Progressive disease/clinical progression|3
117965|NCT00915278|433483|P3|Overall Study|Progressive disease/clinical progression|0
117966|NCT00915278|433484|P2|Overall Study|Progressive disease/clinical progression|0
117967|NCT00915278|433485|P1|Overall Study|Progressive disease/clinical progression|0
117968|NCT00915278|433480|P6|Overall Study|Adverse Event|0
117969|NCT00915278|433481|P5|Overall Study|Adverse Event|0
117970|NCT00915278|433482|P4|Overall Study|Adverse Event|0
117971|NCT00915278|433483|P3|Overall Study|Adverse Event|0
117972|NCT00915278|433484|P2|Overall Study|Adverse Event|1
117973|NCT00915278|433485|P1|Overall Study|Adverse Event|4
117974|NCT00915278|433480|P6|Overall Study|Withdrawal by Subject|4
117975|NCT00915278|433481|P5|Overall Study|Withdrawal by Subject|1
117976|NCT00915278|433482|P4|Overall Study|Withdrawal by Subject|0
117977|NCT00915278|433483|P3|Overall Study|Withdrawal by Subject|0
117978|NCT00915278|433484|P2|Overall Study|Withdrawal by Subject|1
117979|NCT00915278|433485|P1|Overall Study|Withdrawal by Subject|0
117980|NCT00915278|433480|P6|Overall Study|Lost to Follow-up|0
117981|NCT00915278|433481|P5|Overall Study|Lost to Follow-up|0
117982|NCT00915278|433482|P4|Overall Study|Lost to Follow-up|0
117983|NCT00915278|433483|P3|Overall Study|Lost to Follow-up|0
117984|NCT00915278|433484|P2|Overall Study|Lost to Follow-up|1
117985|NCT00915278|433485|P1|Overall Study|Lost to Follow-up|0
117986|NCT00915278|433480|P6|Overall Study|Death|0
117987|NCT00915278|433481|P5|Overall Study|Death|0
117988|NCT00915278|433482|P4|Overall Study|Death|0
117989|NCT00915278|433483|P3|Overall Study|Death|0
117990|NCT00915278|433484|P2|Overall Study|Death|0
117991|NCT00915278|433485|P1|Overall Study|Death|1
117992|NCT00915018|433638|P2|Overall Study|By Sponsor due to Protocol Amendment|105
117993|NCT00915018|433639|P1|Overall Study|By Sponsor due to Protocol Amendment|92
117994|NCT00915018|433638|P2|Overall Study|Withdrawal by Subject|27
117995|NCT00915018|433639|P1|Overall Study|Withdrawal by Subject|38
117996|NCT00915018|433638|P2|Overall Study|Lost to Follow-up|5
117997|NCT00915018|433639|P1|Overall Study|Lost to Follow-up|10
117998|NCT00915018|433638|P2|Overall Study|Death|70
117999|NCT00915018|433639|P1|Overall Study|Death|75
118000|NCT00914966|433653|P1|Step 2: 2000 Units|Withdrawal by Subject|1
118001|NCT00914966|433653|P1|Step 1: 1500 Units|Physician Decision|1
118002|NCT00914966|433653|P1|Step 1: 1500 Units|Withdrawal by Subject|1
118003|NCT00914927|433672|P7|Overall Study|Administrative/Other|0
118004|NCT00914927|433673|P6|Overall Study|Administrative/Other|0
118005|NCT00914927|433674|P5|Overall Study|Administrative/Other|1
118006|NCT00914927|433675|P4|Overall Study|Administrative/Other|0
118007|NCT00914927|433676|P3|Overall Study|Administrative/Other|0
118008|NCT00914927|433677|P2|Overall Study|Administrative/Other|1
118009|NCT00914927|433678|P1|Overall Study|Administrative/Other|2
118010|NCT00914927|433672|P7|Overall Study|Lost to Follow-up|0
118011|NCT00914927|433673|P6|Overall Study|Lost to Follow-up|0
118012|NCT00914927|433674|P5|Overall Study|Lost to Follow-up|0
118013|NCT00914927|433675|P4|Overall Study|Lost to Follow-up|1
118014|NCT00914927|433676|P3|Overall Study|Lost to Follow-up|0
118015|NCT00914927|433677|P2|Overall Study|Lost to Follow-up|0
118016|NCT00914927|433678|P1|Overall Study|Lost to Follow-up|0
118017|NCT00914927|433672|P7|Overall Study|Withdrawal by Subject|0
118018|NCT00914927|433673|P6|Overall Study|Withdrawal by Subject|0
118019|NCT00914927|433674|P5|Overall Study|Withdrawal by Subject|0
118020|NCT00914927|433675|P4|Overall Study|Withdrawal by Subject|1
118021|NCT00914927|433676|P3|Overall Study|Withdrawal by Subject|0
118022|NCT00914927|433677|P2|Overall Study|Withdrawal by Subject|1
118023|NCT00914927|433678|P1|Overall Study|Withdrawal by Subject|0
118024|NCT00914927|433672|P7|Overall Study|Adverse Event|0
118025|NCT00914927|433673|P6|Overall Study|Adverse Event|0
118026|NCT00914927|433674|P5|Overall Study|Adverse Event|1
118027|NCT00914927|433675|P4|Overall Study|Adverse Event|0
118028|NCT00914927|433676|P3|Overall Study|Adverse Event|0
118029|NCT00914927|433677|P2|Overall Study|Adverse Event|0
118030|NCT00914927|433678|P1|Overall Study|Adverse Event|0
118031|NCT00914849|433805|P2|Overall Study|Not eligible|1
118032|NCT00914849|433806|P1|Overall Study|Not eligible|0
118033|NCT00914849|433805|P2|Overall Study|Withdrawal by Subject|0
118034|NCT00914849|433806|P1|Overall Study|Withdrawal by Subject|1
118035|NCT00914810|433840|P2|Overall Study|Hospitalized and unable to follow up.|1
118036|NCT00914810|433841|P1|Overall Study|Hospitalized and unable to follow up.|0
118037|NCT00914810|433840|P2|Overall Study|Relocated out of state|0
118038|NCT00914810|433841|P1|Overall Study|Relocated out of state|1
118039|NCT00914810|433840|P2|Overall Study|Withdrawal by Subject|0
118040|NCT00914810|433841|P1|Overall Study|Withdrawal by Subject|1
118041|NCT00914589|433852|P3|Overall Study|Death|1
118042|NCT00914589|433853|P2|Overall Study|Death|1
118043|NCT00914589|433854|P1|Overall Study|Death|0
118044|NCT00914589|433852|P3|Overall Study|unclassified|7
118045|NCT00914589|433853|P2|Overall Study|unclassified|9
118046|NCT00914589|433854|P1|Overall Study|unclassified|16
118047|NCT00914589|433852|P3|Overall Study|Protocol Violation|3
118048|NCT00914589|433853|P2|Overall Study|Protocol Violation|6
118049|NCT00914589|433854|P1|Overall Study|Protocol Violation|8
118050|NCT00914589|433852|P3|Overall Study|Adverse Event|1
118051|NCT00914589|433853|P2|Overall Study|Adverse Event|0
118052|NCT00914589|433854|P1|Overall Study|Adverse Event|1
118053|NCT00914459|433880|P2|Overall Study|Parent/Legal guardian request|0
118054|NCT00914459|433881|P1|Overall Study|Parent/Legal guardian request|1
118055|NCT00914459|433880|P2|Overall Study|Protocol Violation|1
118056|NCT00914459|433881|P1|Overall Study|Protocol Violation|0
118057|NCT00914316|433911|P4|Phase 2|Withdrawal by Subject|0
118058|NCT00914316|433912|P3|Phase 2|Withdrawal by Subject|1
118059|NCT00914316|433913|P2|Phase 2|Withdrawal by Subject|0
118060|NCT00914316|433914|P1|Phase 2|Withdrawal by Subject|1
118061|NCT00914316|433911|P4|Phase 1|Adverse Event|0
118062|NCT00914316|433912|P3|Phase 1|Adverse Event|0
118063|NCT00914316|433913|P2|Phase 1|Adverse Event|0
118064|NCT00914316|433914|P1|Phase 1|Adverse Event|1
118065|NCT00914316|433911|P4|Phase 1|Withdrawal by Subject|0
118066|NCT00914316|433912|P3|Phase 1|Withdrawal by Subject|4
118067|NCT00914316|433913|P2|Phase 1|Withdrawal by Subject|2
118068|NCT00914316|433914|P1|Phase 1|Withdrawal by Subject|0
118069|NCT00914316|433911|P4|Phase 1|Physician Decision|2
118070|NCT00914316|433912|P3|Phase 1|Physician Decision|1
118071|NCT00914316|433913|P2|Phase 1|Physician Decision|0
118072|NCT00914316|433914|P1|Phase 1|Physician Decision|4
118073|NCT00913835|433993|P2|Lip Dox: Olaratumab Monotherapy|Not Specified|3
118074|NCT00913835|433994|P1|Lip Dox: Olaratumab Monotherapy|Not Specified|0
118075|NCT00913835|433993|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
118076|NCT00913835|433994|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
118077|NCT00913835|433993|P2|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|3
118078|NCT00913835|433994|P1|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|4
118079|NCT00913835|433993|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
118080|NCT00913835|433994|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
118081|NCT00913835|433993|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
118082|NCT00913835|433994|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
118083|NCT00913770|434033|P3|Overall Study|Refused|8
118084|NCT00913770|434034|P2|Overall Study|Refused|10
118085|NCT00913770|434035|P1|Overall Study|Refused|11
118086|NCT00913770|434033|P3|Overall Study|Unable to contact|13
118087|NCT00913770|434034|P2|Overall Study|Unable to contact|19
118088|NCT00913770|434035|P1|Overall Study|Unable to contact|24
118089|NCT00913744|434048|P2|Overall Study|Death|0
118090|NCT00913744|434049|P1|Overall Study|Death|1
118091|NCT00913744|434048|P2|Overall Study|Withdrawal by Subject|1
118092|NCT00913744|434049|P1|Overall Study|Withdrawal by Subject|2
118093|NCT00913744|434048|P2|Overall Study|Adverse Event|0
118094|NCT00913744|434049|P1|Overall Study|Adverse Event|2
118095|NCT00913692|434055|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
118096|NCT00913692|434055|P1|Screening (4 Months)|Not eligible after screening phase.|6
118097|NCT00913692|434055|P1|Screening (4 Months)|Physician Decision|3
118098|NCT00913523|434149|P3|Overall Study|Inadequate Number of Tampons Used|3
118099|NCT00913523|434150|P2|Overall Study|Inadequate Number of Tampons Used|2
118100|NCT00913523|434151|P1|Overall Study|Inadequate Number of Tampons Used|7
118101|NCT00913523|434149|P3|Overall Study|Pregnancy|0
118102|NCT00913523|434150|P2|Overall Study|Pregnancy|3
118103|NCT00913523|434151|P1|Overall Study|Pregnancy|1
118104|NCT00913523|434149|P3|Overall Study|Protocol Violation|8
118105|NCT00913523|434150|P2|Overall Study|Protocol Violation|8
118106|NCT00913523|434151|P1|Overall Study|Protocol Violation|5
118107|NCT00913523|434149|P3|Overall Study|Adverse Event|0
118108|NCT00913523|434150|P2|Overall Study|Adverse Event|0
118109|NCT00913523|434151|P1|Overall Study|Adverse Event|1
118110|NCT00913523|434149|P3|Overall Study|Lost to Follow-up|1
118111|NCT00913523|434150|P2|Overall Study|Lost to Follow-up|1
118112|NCT00913523|434151|P1|Overall Study|Lost to Follow-up|1
118113|NCT00913523|434149|P3|Overall Study|Withdrawal by Subject|2
118114|NCT00913523|434150|P2|Overall Study|Withdrawal by Subject|2
118115|NCT00913523|434151|P1|Overall Study|Withdrawal by Subject|3
118116|NCT00913458|434183|P7|Phase 3|Unsatisfactory Response per Investigator|4
118117|NCT00913458|434184|P6|Phase 3|Unsatisfactory Response per Investigator|11
118118|NCT00913458|434185|P5|Phase 3|Unsatisfactory Response per Investigator|14
118119|NCT00913458|434186|P4|Phase 3|Unsatisfactory Response per Investigator|0
118120|NCT00913458|434187|P3|Phase 3|Unsatisfactory Response per Investigator|0
118121|NCT00913458|434188|P2|Phase 3|Unsatisfactory Response per Investigator|0
118122|NCT00913458|434189|P1|Phase 3|Unsatisfactory Response per Investigator|0
118123|NCT00913458|434183|P7|Phase 3|Withdrawal by Subject|0
118124|NCT00913458|434184|P6|Phase 3|Withdrawal by Subject|2
118125|NCT00913458|434185|P5|Phase 3|Withdrawal by Subject|1
118126|NCT00913458|434186|P4|Phase 3|Withdrawal by Subject|0
118127|NCT00913458|434187|P3|Phase 3|Withdrawal by Subject|0
118128|NCT00913458|434188|P2|Phase 3|Withdrawal by Subject|0
118129|NCT00913458|434189|P1|Phase 3|Withdrawal by Subject|0
118130|NCT00913458|434183|P7|Phase 3|Non-Responder|3
118131|NCT00913458|434184|P6|Phase 3|Non-Responder|1
118132|NCT00913458|434185|P5|Phase 3|Non-Responder|0
118133|NCT00913458|434186|P4|Phase 3|Non-Responder|0
118134|NCT00913458|434187|P3|Phase 3|Non-Responder|0
118135|NCT00913458|434188|P2|Phase 3|Non-Responder|0
118136|NCT00913458|434189|P1|Phase 3|Non-Responder|0
118137|NCT00913458|434183|P7|Phase 3|Lost to Follow-up|0
118138|NCT00913458|434184|P6|Phase 3|Lost to Follow-up|0
118139|NCT00913458|434185|P5|Phase 3|Lost to Follow-up|2
118140|NCT00913458|434186|P4|Phase 3|Lost to Follow-up|0
118141|NCT00913458|434187|P3|Phase 3|Lost to Follow-up|0
118142|NCT00913458|434188|P2|Phase 3|Lost to Follow-up|0
118143|NCT00913458|434189|P1|Phase 3|Lost to Follow-up|0
118144|NCT00913458|434183|P7|Phase 3|Adverse Event|1
118145|NCT00913458|434184|P6|Phase 3|Adverse Event|4
118146|NCT00913458|434185|P5|Phase 3|Adverse Event|5
118147|NCT00913458|434186|P4|Phase 3|Adverse Event|0
118148|NCT00913458|434187|P3|Phase 3|Adverse Event|0
118149|NCT00913458|434188|P2|Phase 3|Adverse Event|0
118150|NCT00913458|434189|P1|Phase 3|Adverse Event|0
118151|NCT00913458|434183|P7|Phase 2|Unsatisfactory Response per Investigator|0
118152|NCT00913458|434184|P6|Phase 2|Unsatisfactory Response per Investigator|0
118153|NCT00913458|434185|P5|Phase 2|Unsatisfactory Response per Investigator|0
118154|NCT00913458|434186|P4|Phase 2|Unsatisfactory Response per Investigator|17
118155|NCT00913458|434187|P3|Phase 2|Unsatisfactory Response per Investigator|11
118156|NCT00913458|434188|P2|Phase 2|Unsatisfactory Response per Investigator|0
118157|NCT00913458|434189|P1|Phase 2|Unsatisfactory Response per Investigator|0
118158|NCT00913458|434183|P7|Phase 2|Protocol Violation|0
118159|NCT00913458|434184|P6|Phase 2|Protocol Violation|0
118160|NCT00913458|434185|P5|Phase 2|Protocol Violation|0
118161|NCT00913458|434186|P4|Phase 2|Protocol Violation|0
118162|NCT00913458|434187|P3|Phase 2|Protocol Violation|0
118163|NCT00913458|434188|P2|Phase 2|Protocol Violation|2
118164|NCT00913458|434189|P1|Phase 2|Protocol Violation|0
118165|NCT00913458|434183|P7|Phase 2|Lost to Follow-up|0
118166|NCT00913458|434184|P6|Phase 2|Lost to Follow-up|0
118167|NCT00913458|434185|P5|Phase 2|Lost to Follow-up|0
118168|NCT00913458|434186|P4|Phase 2|Lost to Follow-up|1
118169|NCT00913458|434187|P3|Phase 2|Lost to Follow-up|0
118170|NCT00913458|434188|P2|Phase 2|Lost to Follow-up|0
118171|NCT00913458|434189|P1|Phase 2|Lost to Follow-up|0
118172|NCT00913458|434183|P7|Phase 2|Adverse Event|0
118173|NCT00913458|434184|P6|Phase 2|Adverse Event|0
118174|NCT00913458|434185|P5|Phase 2|Adverse Event|0
118175|NCT00913458|434186|P4|Phase 2|Adverse Event|1
118176|NCT00913458|434187|P3|Phase 2|Adverse Event|0
118177|NCT00913458|434188|P2|Phase 2|Adverse Event|3
118178|NCT00913458|434189|P1|Phase 2|Adverse Event|0
118179|NCT00913458|434183|P7|Phase 2|Subject Request|0
118180|NCT00913458|434184|P6|Phase 2|Subject Request|0
118181|NCT00913458|434185|P5|Phase 2|Subject Request|0
118182|NCT00913458|434186|P4|Phase 2|Subject Request|2
118183|NCT00913458|434187|P3|Phase 2|Subject Request|1
118184|NCT00913458|434188|P2|Phase 2|Subject Request|0
118185|NCT00913458|434189|P1|Phase 2|Subject Request|0
118186|NCT00913458|434183|P7|Phase 2|Non-Responder|0
118187|NCT00913458|434184|P6|Phase 2|Non-Responder|0
118188|NCT00913458|434185|P5|Phase 2|Non-Responder|0
118189|NCT00913458|434186|P4|Phase 2|Non-Responder|12
118190|NCT00913458|434187|P3|Phase 2|Non-Responder|7
118191|NCT00913458|434188|P2|Phase 2|Non-Responder|5
118192|NCT00913458|434189|P1|Phase 2|Non-Responder|0
118193|NCT00913458|434183|P7|Phase 1|Unsatisfactory Response per Investigator|0
118194|NCT00913458|434184|P6|Phase 1|Unsatisfactory Response per Investigator|0
118195|NCT00913458|434185|P5|Phase 1|Unsatisfactory Response per Investigator|0
118196|NCT00913458|434186|P4|Phase 1|Unsatisfactory Response per Investigator|0
118197|NCT00913458|434187|P3|Phase 1|Unsatisfactory Response per Investigator|0
118198|NCT00913458|434188|P2|Phase 1|Unsatisfactory Response per Investigator|0
118199|NCT00913458|434189|P1|Phase 1|Unsatisfactory Response per Investigator|7
118200|NCT00913458|434183|P7|Phase 1|Sponsor|0
118201|NCT00913458|434184|P6|Phase 1|Sponsor|0
118202|NCT00913458|434185|P5|Phase 1|Sponsor|0
118203|NCT00913458|434186|P4|Phase 1|Sponsor|0
118204|NCT00913458|434187|P3|Phase 1|Sponsor|0
118205|NCT00913458|434188|P2|Phase 1|Sponsor|0
118206|NCT00913458|434189|P1|Phase 1|Sponsor|2
118207|NCT00913458|434183|P7|Phase 1|Protocol Violation|0
118208|NCT00913458|434184|P6|Phase 1|Protocol Violation|0
118209|NCT00913458|434185|P5|Phase 1|Protocol Violation|0
118210|NCT00913458|434186|P4|Phase 1|Protocol Violation|0
118211|NCT00913458|434187|P3|Phase 1|Protocol Violation|0
118212|NCT00913458|434188|P2|Phase 1|Protocol Violation|0
118213|NCT00913458|434189|P1|Phase 1|Protocol Violation|10
118214|NCT00913458|434183|P7|Phase 1|Lost to Follow-up|0
118215|NCT00913458|434184|P6|Phase 1|Lost to Follow-up|0
118216|NCT00913458|434185|P5|Phase 1|Lost to Follow-up|0
118217|NCT00913458|434186|P4|Phase 1|Lost to Follow-up|0
118218|NCT00913458|434187|P3|Phase 1|Lost to Follow-up|0
118219|NCT00913458|434188|P2|Phase 1|Lost to Follow-up|0
118220|NCT00913458|434189|P1|Phase 1|Lost to Follow-up|2
118221|NCT00913458|434183|P7|Phase 1|Adverse Event|0
118222|NCT00913458|434184|P6|Phase 1|Adverse Event|0
118223|NCT00913458|434185|P5|Phase 1|Adverse Event|0
118224|NCT00913458|434186|P4|Phase 1|Adverse Event|0
118225|NCT00913458|434187|P3|Phase 1|Adverse Event|0
118226|NCT00913458|434188|P2|Phase 1|Adverse Event|0
118227|NCT00913458|434189|P1|Phase 1|Adverse Event|20
118228|NCT00913458|434183|P7|Phase 1|Subject Request|0
118229|NCT00913458|434184|P6|Phase 1|Subject Request|0
118230|NCT00913458|434185|P5|Phase 1|Subject Request|0
118231|NCT00913458|434186|P4|Phase 1|Subject Request|0
118232|NCT00913458|434187|P3|Phase 1|Subject Request|0
118233|NCT00913458|434188|P2|Phase 1|Subject Request|0
118234|NCT00913458|434189|P1|Phase 1|Subject Request|17
118235|NCT00913458|434183|P7|Phase 1|Non-Responder|0
118236|NCT00913458|434184|P6|Phase 1|Non-Responder|0
118237|NCT00913458|434185|P5|Phase 1|Non-Responder|0
118238|NCT00913458|434186|P4|Phase 1|Non-Responder|0
118239|NCT00913458|434187|P3|Phase 1|Non-Responder|0
118240|NCT00913458|434188|P2|Phase 1|Non-Responder|0
118241|NCT00913458|434189|P1|Phase 1|Non-Responder|54
118242|NCT00913380|434282|P2|Clinical Outcomes|Lost to Follow-up|6
118243|NCT00913380|434283|P1|Clinical Outcomes|Lost to Follow-up|6
118244|NCT00912964|434349|P3|Overall Study|Randomized but never received study drug|0
118245|NCT00912964|434350|P2|Overall Study|Randomized but never received study drug|1
118246|NCT00912964|434351|P1|Overall Study|Randomized but never received study drug|0
118247|NCT00912964|434349|P3|Overall Study|Violation of exclusion criterion|2
118248|NCT00912964|434350|P2|Overall Study|Violation of exclusion criterion|0
118249|NCT00912964|434351|P1|Overall Study|Violation of exclusion criterion|0
118250|NCT00912964|434349|P3|Overall Study|Non-compliance with study procedures|0
118251|NCT00912964|434350|P2|Overall Study|Non-compliance with study procedures|0
118252|NCT00912964|434351|P1|Overall Study|Non-compliance with study procedures|2
118253|NCT00912964|434349|P3|Overall Study|Medical History|0
118254|NCT00912964|434350|P2|Overall Study|Medical History|0
118255|NCT00912964|434351|P1|Overall Study|Medical History|1
118256|NCT00912964|434349|P3|Overall Study|Taking exclusionary medications|8
118257|NCT00912964|434350|P2|Overall Study|Taking exclusionary medications|4
118258|NCT00912964|434351|P1|Overall Study|Taking exclusionary medications|7
118259|NCT00912964|434349|P3|Overall Study|Protocol Violation|8
118260|NCT00912964|434350|P2|Overall Study|Protocol Violation|3
118261|NCT00912964|434351|P1|Overall Study|Protocol Violation|5
118262|NCT00912964|434349|P3|Overall Study|Lost to Follow-up|3
118263|NCT00912964|434350|P2|Overall Study|Lost to Follow-up|3
118264|NCT00912964|434351|P1|Overall Study|Lost to Follow-up|4
118265|NCT00912964|434349|P3|Overall Study|Withdrawal by Subject|18
118266|NCT00912964|434350|P2|Overall Study|Withdrawal by Subject|12
118267|NCT00912964|434351|P1|Overall Study|Withdrawal by Subject|20
118268|NCT00912964|434349|P3|Overall Study|Lack of Efficacy|3
118269|NCT00912964|434350|P2|Overall Study|Lack of Efficacy|4
118270|NCT00912964|434351|P1|Overall Study|Lack of Efficacy|11
118271|NCT00912964|434349|P3|Overall Study|Adverse Event|12
118272|NCT00912964|434350|P2|Overall Study|Adverse Event|18
118273|NCT00912964|434351|P1|Overall Study|Adverse Event|15
118274|NCT00912964|434349|P3|Overall Study|Eligibility criterion not met|0
118275|NCT00912964|434350|P2|Overall Study|Eligibility criterion not met|1
118276|NCT00912964|434351|P1|Overall Study|Eligibility criterion not met|1
118277|NCT00912912|434494|P1|Overall Study|Disease Progression|3
118278|NCT00912912|434494|P1|Overall Study|Withdrawal by Subject|1
118279|NCT00912808|434500|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
118280|NCT00912808|434501|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
118281|NCT00912808|434500|P2|Second Intervention (6 Weeks)|Adverse Event|1
118282|NCT00912808|434501|P1|Second Intervention (6 Weeks)|Adverse Event|0
118283|NCT00912808|434500|P2|Washout|Withdrawal by Subject|1
118284|NCT00912808|434501|P1|Washout|Withdrawal by Subject|0
118285|NCT00912808|434500|P2|First Intervention (6 Weeks)|Adverse Event|1
118286|NCT00912808|434501|P1|First Intervention (6 Weeks)|Adverse Event|2
118287|NCT00912782|434526|P2|Overall Study|Relocated before study completion|1
118288|NCT00912782|434527|P1|Overall Study|Relocated before study completion|0
118289|NCT00912782|434526|P2|Overall Study|Did not receive vascular access type|2
118290|NCT00912782|434527|P1|Overall Study|Did not receive vascular access type|1
118291|NCT00912782|434526|P2|Overall Study|Lost to Follow-up|1
118292|NCT00912782|434527|P1|Overall Study|Lost to Follow-up|0
118293|NCT00912782|434526|P2|Overall Study|Death|1
118294|NCT00912782|434527|P1|Overall Study|Death|2
118295|NCT00912743|434537|P2|Overall Study|End of treatment form was not collected|0
118296|NCT00912743|434538|P1|Overall Study|End of treatment form was not collected|1
118297|NCT00912743|434537|P2|Overall Study|Toxicity|1
118298|NCT00912743|434538|P1|Overall Study|Toxicity|0
118299|NCT00912743|434537|P2|Overall Study|Lack of Efficacy|18
118300|NCT00912743|434538|P1|Overall Study|Lack of Efficacy|9
118301|NCT00912743|434537|P2|Overall Study|Adverse Event|1
118302|NCT00912743|434538|P1|Overall Study|Adverse Event|3
118303|NCT00912509|434550|P2|Overall Study|Lack of Efficacy|3
118304|NCT00912509|434551|P1|Overall Study|Lack of Efficacy|4
118305|NCT00912509|434550|P2|Overall Study|Lost to Follow-up|0
118306|NCT00912509|434551|P1|Overall Study|Lost to Follow-up|1
118307|NCT00912405|434559|P1|Overall Study|Lost to Follow-up|5
118308|NCT00912288|434593|P2|Overall Study|Other|0
118309|NCT00912288|434594|P1|Overall Study|Other|1
118310|NCT00912288|434593|P2|Overall Study|Study terminated by sponsor|35
118311|NCT00912288|434594|P1|Overall Study|Study terminated by sponsor|34
118312|NCT00912288|434593|P2|Overall Study|Withdrawal by Subject|3
118313|NCT00912288|434594|P1|Overall Study|Withdrawal by Subject|3
118314|NCT00912288|434593|P2|Overall Study|Protocol Violation|0
118315|NCT00912288|434594|P1|Overall Study|Protocol Violation|1
118316|NCT00912288|434593|P2|Overall Study|Lost to Follow-up|0
118317|NCT00912288|434594|P1|Overall Study|Lost to Follow-up|1
118318|NCT00912288|434593|P2|Overall Study|Adverse Event|1
118319|NCT00912288|434594|P1|Overall Study|Adverse Event|1
118320|NCT00912288|434593|P2|Overall Study|Death|1
118321|NCT00912288|434594|P1|Overall Study|Death|0
118322|NCT00912223|434616|P1|Overall Study|Transformed disease|1
118323|NCT00912223|434616|P1|Overall Study|Not transplanted|1
118324|NCT00912223|434616|P1|Overall Study|Withdrawal by Subject|1
118325|NCT00912093|434647|P5|The Controlled Phase|Lost to Follow-up|1
118326|NCT00912093|434648|P4|The Controlled Phase|Lost to Follow-up|0
118327|NCT00912093|434649|P3|The Controlled Phase|Lost to Follow-up|0
118328|NCT00912093|434650|P2|The Controlled Phase|Lost to Follow-up|0
118329|NCT00912093|434651|P1|The Controlled Phase|Lost to Follow-up|0
118330|NCT00912093|434647|P5|The Controlled Phase|Medical Condition|0
118331|NCT00912093|434648|P4|The Controlled Phase|Medical Condition|0
118332|NCT00912093|434649|P3|The Controlled Phase|Medical Condition|0
118333|NCT00912093|434650|P2|The Controlled Phase|Medical Condition|1
118334|NCT00912093|434651|P1|The Controlled Phase|Medical Condition|0
118335|NCT00912093|434647|P5|The Controlled Phase|Death|0
118336|NCT00912093|434648|P4|The Controlled Phase|Death|0
118337|NCT00912093|434649|P3|The Controlled Phase|Death|0
118338|NCT00912093|434650|P2|The Controlled Phase|Death|1
118339|NCT00912093|434651|P1|The Controlled Phase|Death|0
118340|NCT00912028|434670|P5|Overall Study|Withdrawal by Subject|0
118341|NCT00912028|434671|P4|Overall Study|Withdrawal by Subject|0
118342|NCT00912028|434672|P3|Overall Study|Withdrawal by Subject|0
118343|NCT00912028|434673|P2|Overall Study|Withdrawal by Subject|0
118344|NCT00912028|434674|P1|Overall Study|Withdrawal by Subject|3
118345|NCT00912028|434670|P5|Overall Study|Lost to Follow-up|3
118346|NCT00912028|434671|P4|Overall Study|Lost to Follow-up|1
118347|NCT00912028|434672|P3|Overall Study|Lost to Follow-up|0
118348|NCT00912028|434673|P2|Overall Study|Lost to Follow-up|3
118349|NCT00912028|434674|P1|Overall Study|Lost to Follow-up|2
118350|NCT00912015|434703|P4|Overall Study|Adverse Event|1
118351|NCT00912015|434704|P3|Overall Study|Adverse Event|0
118352|NCT00912015|434705|P2|Overall Study|Adverse Event|0
118353|NCT00912015|434706|P1|Overall Study|Adverse Event|6
118354|NCT00912015|434703|P4|Overall Study|Protocol Violation|1
118355|NCT00912015|434704|P3|Overall Study|Protocol Violation|0
118356|NCT00912015|434705|P2|Overall Study|Protocol Violation|0
118357|NCT00912015|434706|P1|Overall Study|Protocol Violation|1
118358|NCT00912015|434703|P4|Overall Study|Withdrawal by Subject|0
118359|NCT00912015|434704|P3|Overall Study|Withdrawal by Subject|3
118360|NCT00912015|434705|P2|Overall Study|Withdrawal by Subject|8
118361|NCT00912015|434706|P1|Overall Study|Withdrawal by Subject|8
118362|NCT00912015|434703|P4|Overall Study|Lack of Efficacy|0
118363|NCT00912015|434704|P3|Overall Study|Lack of Efficacy|0
118364|NCT00912015|434705|P2|Overall Study|Lack of Efficacy|0
118365|NCT00912015|434706|P1|Overall Study|Lack of Efficacy|1
118366|NCT00911989|434722|P1|Overall Study|Adverse Event|1
118367|NCT00911937|434728|P2|Overall Study|Other|5
118368|NCT00911937|434729|P1|Overall Study|Other|9
118369|NCT00911937|434728|P2|Overall Study|Randomized but not treated|13
118370|NCT00911937|434729|P1|Overall Study|Randomized but not treated|13
118371|NCT00911937|434728|P2|Overall Study|Protocol Violation|23
118372|NCT00911937|434729|P1|Overall Study|Protocol Violation|14
118373|NCT00911937|434728|P2|Overall Study|Did not meet inclusion criteria|11
118374|NCT00911937|434729|P1|Overall Study|Did not meet inclusion criteria|9
118375|NCT00911937|434728|P2|Overall Study|Lack of Efficacy|6
118376|NCT00911937|434729|P1|Overall Study|Lack of Efficacy|11
118377|NCT00911937|434728|P2|Overall Study|Adverse Event|25
118378|NCT00911937|434729|P1|Overall Study|Adverse Event|11
118379|NCT00911937|434728|P2|Overall Study|Withdrawn due to pregnancy|0
118380|NCT00911937|434729|P1|Overall Study|Withdrawn due to pregnancy|1
118381|NCT00911937|434728|P2|Overall Study|Withdrawal by Subject|7
118382|NCT00911937|434729|P1|Overall Study|Withdrawal by Subject|10
118383|NCT00911937|434728|P2|Overall Study|Lost to Follow-up|5
118384|NCT00911937|434729|P1|Overall Study|Lost to Follow-up|8
118385|NCT00911937|434728|P2|Overall Study|Death|0
118386|NCT00911937|434729|P1|Overall Study|Death|1
118387|NCT00911859|434796|P3|Follow-up Period|Study terminated by sponsor|27
118388|NCT00911859|434797|P2|Follow-up Period|Study terminated by sponsor|33
118389|NCT00911859|434798|P1|Follow-up Period|Study terminated by sponsor|5
118390|NCT00911859|434796|P3|Follow-up Period|Withdrawal by Subject|4
118391|NCT00911859|434797|P2|Follow-up Period|Withdrawal by Subject|4
118392|NCT00911859|434798|P1|Follow-up Period|Withdrawal by Subject|0
118393|NCT00911859|434796|P3|Follow-up Period|Lost to Follow-up|0
118394|NCT00911859|434797|P2|Follow-up Period|Lost to Follow-up|1
118395|NCT00911859|434798|P1|Follow-up Period|Lost to Follow-up|1
118396|NCT00911859|434796|P3|Follow-up Period|Death|10
118397|NCT00911859|434797|P2|Follow-up Period|Death|8
118398|NCT00911859|434798|P1|Follow-up Period|Death|5
118399|NCT00911859|434796|P3|Maintainance Period|Withdrawal by Subject|3
118400|NCT00911859|434797|P2|Maintainance Period|Withdrawal by Subject|0
118401|NCT00911859|434798|P1|Maintainance Period|Withdrawal by Subject|0
118402|NCT00911859|434796|P3|Maintainance Period|Physician Decision|9
118403|NCT00911859|434797|P2|Maintainance Period|Physician Decision|0
118404|NCT00911859|434798|P1|Maintainance Period|Physician Decision|0
118405|NCT00911859|434796|P3|Maintainance Period|Lack of Efficacy|9
118406|NCT00911859|434797|P2|Maintainance Period|Lack of Efficacy|0
118407|NCT00911859|434798|P1|Maintainance Period|Lack of Efficacy|0
118408|NCT00911859|434796|P3|Treatment Period|Did not receive study treatment|0
118409|NCT00911859|434797|P2|Treatment Period|Did not receive study treatment|1
118410|NCT00911859|434798|P1|Treatment Period|Did not receive study treatment|0
118411|NCT00911859|434796|P3|Treatment Period|Withdrawal by Subject|5
118412|NCT00911859|434797|P2|Treatment Period|Withdrawal by Subject|4
118413|NCT00911859|434798|P1|Treatment Period|Withdrawal by Subject|0
118414|NCT00911859|434796|P3|Treatment Period|Physician Decision|3
118415|NCT00911859|434797|P2|Treatment Period|Physician Decision|3
118416|NCT00911859|434798|P1|Treatment Period|Physician Decision|3
118417|NCT00911859|434796|P3|Treatment Period|Lack of Efficacy|5
118418|NCT00911859|434797|P2|Treatment Period|Lack of Efficacy|7
118419|NCT00911859|434798|P1|Treatment Period|Lack of Efficacy|1
118420|NCT00911859|434796|P3|Treatment Period|Death|5
118421|NCT00911859|434797|P2|Treatment Period|Death|3
118422|NCT00911859|434798|P1|Treatment Period|Death|1
118423|NCT00911859|434796|P3|Treatment Period|Adverse Event|7
118424|NCT00911859|434797|P2|Treatment Period|Adverse Event|3
118425|NCT00911859|434798|P1|Treatment Period|Adverse Event|3
118426|NCT00911820|434824|P2|Overall Study|Withdraw before Receive Treatment|2
118427|NCT00911820|434825|P1|Overall Study|Withdraw before Receive Treatment|0
118428|NCT00911820|434824|P2|Overall Study|Pathology Not Confirmed|0
118429|NCT00911820|434825|P1|Overall Study|Pathology Not Confirmed|1
118430|NCT00911820|434824|P2|Overall Study|Still on Therapy|2
118431|NCT00911820|434825|P1|Overall Study|Still on Therapy|2
118432|NCT00911820|434824|P2|Overall Study|Pursue Radiation|0
118433|NCT00911820|434825|P1|Overall Study|Pursue Radiation|1
118434|NCT00911820|434824|P2|Overall Study|Pursue surgery|1
118435|NCT00911820|434825|P1|Overall Study|Pursue surgery|1
118436|NCT00911820|434824|P2|Overall Study|Death|2
118437|NCT00911820|434825|P1|Overall Study|Death|1
118438|NCT00911820|434824|P2|Overall Study|Withdrawal by Subject|4
118439|NCT00911820|434825|P1|Overall Study|Withdrawal by Subject|3
118440|NCT00911820|434824|P2|Overall Study|Decline in Performance Status|2
118441|NCT00911820|434825|P1|Overall Study|Decline in Performance Status|4
118442|NCT00911820|434824|P2|Overall Study|Physician Decision|9
118443|NCT00911820|434825|P1|Overall Study|Physician Decision|5
118444|NCT00911820|434824|P2|Overall Study|Clinical Progression|5
118445|NCT00911820|434825|P1|Overall Study|Clinical Progression|7
118446|NCT00911820|434824|P2|Overall Study|Adverse Event|8
118447|NCT00911820|434825|P1|Overall Study|Adverse Event|8
118448|NCT00911820|434824|P2|Overall Study|RECIST progression|8
118449|NCT00911820|434825|P1|Overall Study|RECIST progression|12
118450|NCT00911807|434842|P3|Overall Study|Organizational reasons|1
118451|NCT00911807|434843|P2|Overall Study|Organizational reasons|3
118452|NCT00911807|434844|P1|Overall Study|Organizational reasons|1
118453|NCT00911807|434842|P3|Overall Study|Withdrawal by Subject|7
118454|NCT00911807|434843|P2|Overall Study|Withdrawal by Subject|10
118455|NCT00911807|434844|P1|Overall Study|Withdrawal by Subject|8
118456|NCT00911807|434842|P3|Overall Study|Protocol Violation|9
118457|NCT00911807|434843|P2|Overall Study|Protocol Violation|4
118458|NCT00911807|434844|P1|Overall Study|Protocol Violation|6
118459|NCT00911807|434842|P3|Overall Study|Death|1
118460|NCT00911807|434843|P2|Overall Study|Death|0
118461|NCT00911807|434844|P1|Overall Study|Death|0
118462|NCT00911807|434842|P3|Overall Study|Adverse Event|5
118463|NCT00911807|434843|P2|Overall Study|Adverse Event|1
118464|NCT00911807|434844|P1|Overall Study|Adverse Event|2
118465|NCT00911768|434854|P2|Overall Study|Withdrawal by Subject|0
118466|NCT00911768|434855|P1|Overall Study|Withdrawal by Subject|1
118467|NCT00911768|434854|P2|Overall Study|Protocol Violation|4
118468|NCT00911768|434855|P1|Overall Study|Protocol Violation|5
118469|NCT00911625|434884|P2|Overall Study|Lost to Follow-up|0
118470|NCT00911625|434885|P1|Overall Study|Lost to Follow-up|7
118471|NCT00911547|434914|P4|Overall Study|Withdrawal by Subject|8
118472|NCT00911547|434915|P3|Overall Study|Withdrawal by Subject|4
118473|NCT00911547|434916|P2|Overall Study|Withdrawal by Subject|10
118474|NCT00911547|434917|P1|Overall Study|Withdrawal by Subject|3
118475|NCT00911547|434914|P4|Overall Study|Protocol Violation|1
118476|NCT00911547|434915|P3|Overall Study|Protocol Violation|5
118477|NCT00911547|434916|P2|Overall Study|Protocol Violation|5
118478|NCT00911547|434917|P1|Overall Study|Protocol Violation|0
118479|NCT00911547|434914|P4|Overall Study|Lost to Follow-up|1
118480|NCT00911547|434915|P3|Overall Study|Lost to Follow-up|2
118481|NCT00911547|434916|P2|Overall Study|Lost to Follow-up|0
118482|NCT00911547|434917|P1|Overall Study|Lost to Follow-up|0
118483|NCT00911547|434914|P4|Overall Study|Adverse Event|6
118484|NCT00911547|434915|P3|Overall Study|Adverse Event|11
118485|NCT00911547|434916|P2|Overall Study|Adverse Event|27
118486|NCT00911547|434917|P1|Overall Study|Adverse Event|8
118487|NCT00911534|434945|P2|Overall Study|Not specified|2
118488|NCT00911534|434946|P1|Overall Study|Not specified|2
118489|NCT00911534|434945|P2|Overall Study|Withdrawal of consent|4
118490|NCT00911534|434946|P1|Overall Study|Withdrawal of consent|1
118491|NCT00911534|434945|P2|Overall Study|Lack of Efficacy|1
118492|NCT00911534|434946|P1|Overall Study|Lack of Efficacy|4
118493|NCT00911534|434945|P2|Overall Study|Withdrawal by Subject|1
118494|NCT00911534|434946|P1|Overall Study|Withdrawal by Subject|2
118495|NCT00911534|434945|P2|Overall Study|Lost to Follow-up|4
118496|NCT00911534|434946|P1|Overall Study|Lost to Follow-up|2
118497|NCT00911534|434945|P2|Overall Study|Adverse Event|4
118498|NCT00911534|434946|P1|Overall Study|Adverse Event|4
118499|NCT00911300|435001|P2|Overall Study|Randomized; No Study Medication Received|2
118500|NCT00911300|435002|P1|Overall Study|Randomized; No Study Medication Received|0
118501|NCT00911300|435001|P2|Overall Study|Treatment Stopped by Mistake|1
118502|NCT00911300|435002|P1|Overall Study|Treatment Stopped by Mistake|0
118503|NCT00911300|435001|P2|Overall Study|Physician Decision|1
118504|NCT00911300|435002|P1|Overall Study|Physician Decision|0
118505|NCT00911300|435001|P2|Overall Study|Underlying Disease (Myocarditis)|1
118506|NCT00911300|435002|P1|Overall Study|Underlying Disease (Myocarditis)|0
118507|NCT00911300|435001|P2|Overall Study|Participant Refused Hospital Consulation|1
118508|NCT00911300|435002|P1|Overall Study|Participant Refused Hospital Consulation|0
118509|NCT00911300|435001|P2|Overall Study|International Normalized Ratio Too High|1
118510|NCT00911300|435002|P1|Overall Study|International Normalized Ratio Too High|0
118511|NCT00911300|435001|P2|Overall Study|Investigator's Decision; New AF Episode|1
118512|NCT00911300|435002|P1|Overall Study|Investigator's Decision; New AF Episode|0
118513|NCT00911300|435001|P2|Overall Study|Participant Could Not Stay in Hospital|1
118514|NCT00911300|435002|P1|Overall Study|Participant Could Not Stay in Hospital|0
118515|NCT00911300|435001|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
118516|NCT00911300|435002|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
118517|NCT00911300|435001|P2|Overall Study|Nurse Unavailable in Participant's City|0
118518|NCT00911300|435002|P1|Overall Study|Nurse Unavailable in Participant's City|1
118519|NCT00911300|435001|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
118520|NCT00911300|435002|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
118521|NCT00911300|435001|P2|Overall Study|Recurrent Tachyarrhythmia|1
118522|NCT00911300|435002|P1|Overall Study|Recurrent Tachyarrhythmia|1
118523|NCT00911300|435001|P2|Overall Study|Received Commercial Treatment|0
118524|NCT00911300|435002|P1|Overall Study|Received Commercial Treatment|1
118525|NCT00911300|435001|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
118526|NCT00911300|435002|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
118527|NCT00911300|435001|P2|Overall Study|Coronary Angiography Performed|0
118528|NCT00911300|435002|P1|Overall Study|Coronary Angiography Performed|1
118529|NCT00911300|435001|P2|Overall Study|Consent Withdrawn|12
118530|NCT00911300|435002|P1|Overall Study|Consent Withdrawn|4
118531|NCT00911300|435001|P2|Overall Study|Protocol Violation|2
118532|NCT00911300|435002|P1|Overall Study|Protocol Violation|3
118533|NCT00911300|435001|P2|Overall Study|Adverse Event|6
118534|NCT00911300|435002|P1|Overall Study|Adverse Event|14
118535|NCT00911300|435001|P2|Overall Study|Thrombus Persistant in Second TEE|7
118536|NCT00911300|435002|P1|Overall Study|Thrombus Persistant in Second TEE|3
118537|NCT00911300|435001|P2|Overall Study|Death|0
118538|NCT00911300|435002|P1|Overall Study|Death|1
118539|NCT00911300|435001|P2|Overall Study|Primary Endpoint Component Occurred|2
118540|NCT00911300|435002|P1|Overall Study|Primary Endpoint Component Occurred|1
118541|NCT00911170|435039|P2|Long Term Follow-Up|Death|121
118542|NCT00911170|435040|P1|Long Term Follow-Up|Death|116
118543|NCT00911170|435039|P2|Long Term Follow-Up|Lost to Follow-up|7
118544|NCT00911170|435040|P1|Long Term Follow-Up|Lost to Follow-up|8
118545|NCT00911170|435039|P2|Long Term Follow-Up|Physician Decision|4
118546|NCT00911170|435040|P1|Long Term Follow-Up|Physician Decision|5
118547|NCT00911170|435039|P2|Long Term Follow-Up|Withdrawal by Subject|21
118548|NCT00911170|435040|P1|Long Term Follow-Up|Withdrawal by Subject|20
118549|NCT00911170|435039|P2|Long Term Follow-Up|Continuing in study|269
118550|NCT00911170|435040|P1|Long Term Follow-Up|Continuing in study|274
118551|NCT00911170|435039|P2|Treatment Period|Death|9
118552|NCT00911170|435040|P1|Treatment Period|Death|6
118553|NCT00911170|435039|P2|Treatment Period|Lost to Follow-up|1
118554|NCT00911170|435040|P1|Treatment Period|Lost to Follow-up|0
118555|NCT00911170|435039|P2|Treatment Period|Physician Decision|5
118556|NCT00911170|435040|P1|Treatment Period|Physician Decision|5
118557|NCT00911170|435039|P2|Treatment Period|Disease progression|2
118558|NCT00911170|435040|P1|Treatment Period|Disease progression|0
118559|NCT00911170|435039|P2|Treatment Period|Withdrawal by Subject|4
118560|NCT00911170|435040|P1|Treatment Period|Withdrawal by Subject|4
118561|NCT00911170|435039|P2|Treatment Period|Adverse Event|10
118562|NCT00911170|435040|P1|Treatment Period|Adverse Event|9
118563|NCT00911170|435039|P2|Treatment Period|Protocol deviation|2
118564|NCT00911170|435040|P1|Treatment Period|Protocol deviation|1
118565|NCT00911170|435039|P2|Treatment Period|Ineligibility determined|3
118566|NCT00911170|435040|P1|Treatment Period|Ineligibility determined|1
118567|NCT00911170|435039|P2|Treatment Period|Randomized in error|1
118568|NCT00911170|435040|P1|Treatment Period|Randomized in error|1
118569|NCT00911157|435064|P2|Overall Study|Need to treat for lung cancer|0
118570|NCT00911157|435065|P1|Overall Study|Need to treat for lung cancer|1
118571|NCT00911157|435064|P2|Overall Study|Need for prohibited drug (heparin)|0
118572|NCT00911157|435065|P1|Overall Study|Need for prohibited drug (heparin)|1
118573|NCT00911157|435064|P2|Overall Study|Withdrawal by Subject|1
118574|NCT00911157|435065|P1|Overall Study|Withdrawal by Subject|1
118575|NCT00911157|435064|P2|Overall Study|Adverse Event|1
118576|NCT00911157|435065|P1|Overall Study|Adverse Event|4
118577|NCT00911144|435081|P2|Overall Study|Withdrawal by Subject|5
118578|NCT00911144|435082|P1|Overall Study|Withdrawal by Subject|16
118579|NCT00910988|435110|P4|Overall Study|Lost to Follow-up|0
118580|NCT00910988|435111|P3|Overall Study|Lost to Follow-up|3
118581|NCT00910988|435112|P2|Overall Study|Lost to Follow-up|4
118582|NCT00910988|435113|P1|Overall Study|Lost to Follow-up|2
118583|NCT00910962|435158|P3|Overall Study|Reached defined stopping criteria|17
118584|NCT00910962|435159|P2|Overall Study|Reached defined stopping criteria|14
118585|NCT00910962|435160|P1|Overall Study|Reached defined stopping criteria|12
118586|NCT00910962|435158|P3|Overall Study|Withdrawal by Subject|32
118587|NCT00910962|435159|P2|Overall Study|Withdrawal by Subject|32
118588|NCT00910962|435160|P1|Overall Study|Withdrawal by Subject|25
118589|NCT00910962|435158|P3|Overall Study|Physician Decision|6
118590|NCT00910962|435159|P2|Overall Study|Physician Decision|6
118591|NCT00910962|435160|P1|Overall Study|Physician Decision|0
118592|NCT00910962|435158|P3|Overall Study|Lost to Follow-up|1
118593|NCT00910962|435159|P2|Overall Study|Lost to Follow-up|3
118594|NCT00910962|435160|P1|Overall Study|Lost to Follow-up|0
118595|NCT00910962|435158|P3|Overall Study|Protocol Violation|3
118596|NCT00910962|435159|P2|Overall Study|Protocol Violation|3
118597|NCT00910962|435160|P1|Overall Study|Protocol Violation|1
118598|NCT00910962|435158|P3|Overall Study|Adverse Event|17
118599|NCT00910962|435159|P2|Overall Study|Adverse Event|20
118600|NCT00910962|435160|P1|Overall Study|Adverse Event|5
118601|NCT00910910|435252|P2|Overall Study|Untreated before cycle 1|2
118602|NCT00910910|435253|P1|Overall Study|Untreated before cycle 1|1
118603|NCT00910910|435252|P2|Overall Study|Other|32
118604|NCT00910910|435253|P1|Overall Study|Other|114
118605|NCT00910910|435252|P2|Overall Study|Completed 13 cycles of treatment|118
118606|NCT00910910|435253|P1|Overall Study|Completed 13 cycles of treatment|0
118607|NCT00910910|435252|P2|Overall Study|Protocol Violation|2
118608|NCT00910910|435253|P1|Overall Study|Protocol Violation|2
118609|NCT00910910|435252|P2|Overall Study|Death|3
118610|NCT00910910|435253|P1|Overall Study|Death|9
118611|NCT00910910|435252|P2|Overall Study|Lost to Follow-up|2
118612|NCT00910910|435253|P1|Overall Study|Lost to Follow-up|2
118613|NCT00910910|435252|P2|Overall Study|Withdrawal by Subject|5
118614|NCT00910910|435253|P1|Overall Study|Withdrawal by Subject|7
118615|NCT00910910|435252|P2|Overall Study|PD with histologic change|2
118616|NCT00910910|435253|P1|Overall Study|PD with histologic change|0
118617|NCT00910910|435252|P2|Overall Study|PD without histologic change|23
118618|NCT00910910|435253|P1|Overall Study|PD without histologic change|27
118619|NCT00910910|435252|P2|Overall Study|Adverse Event|35
118620|NCT00910910|435253|P1|Overall Study|Adverse Event|63
118621|NCT00910871|435287|P1|Overall Study|Undefined|1
118622|NCT00910871|435287|P1|Overall Study|Subject didn’t meet eligibility criteria|5
118623|NCT00910871|435287|P1|Overall Study|Withdrawal by Subject|12
118624|NCT00910871|435287|P1|Overall Study|Protocol Violation|11
118625|NCT00910871|435287|P1|Overall Study|Lost to Follow-up|8
118626|NCT00910871|435287|P1|Overall Study|Death|12
118627|NCT00910871|435287|P1|Overall Study|Adverse Event|5
118628|NCT00910858|435295|P3|Combined Treatment Phase|Other|1
118629|NCT00910858|435296|P2|Combined Treatment Phase|Other|2
118630|NCT00910858|435297|P1|Combined Treatment Phase|Other|0
118631|NCT00910858|435295|P3|Combined Treatment Phase|Protocol Violation|0
118632|NCT00910858|435296|P2|Combined Treatment Phase|Protocol Violation|0
118633|NCT00910858|435297|P1|Combined Treatment Phase|Protocol Violation|1
118634|NCT00910858|435295|P3|Combined Treatment Phase|Withdrawal by Subject|0
118635|NCT00910858|435296|P2|Combined Treatment Phase|Withdrawal by Subject|2
118636|NCT00910858|435297|P1|Combined Treatment Phase|Withdrawal by Subject|0
118637|NCT00910858|435295|P3|Combined Treatment Phase|Lack of therapeutic effect|3
118638|NCT00910858|435296|P2|Combined Treatment Phase|Lack of therapeutic effect|6
118639|NCT00910858|435297|P1|Combined Treatment Phase|Lack of therapeutic effect|8
118640|NCT00910858|435295|P3|Monotherapy Phase|Other|2
118641|NCT00910858|435296|P2|Monotherapy Phase|Other|4
118642|NCT00910858|435297|P1|Monotherapy Phase|Other|3
118643|NCT00910858|435295|P3|Monotherapy Phase|Protocol Violation|0
118644|NCT00910858|435296|P2|Monotherapy Phase|Protocol Violation|0
118645|NCT00910858|435297|P1|Monotherapy Phase|Protocol Violation|1
118646|NCT00910858|435295|P3|Monotherapy Phase|Withdrawal by Subject|1
118647|NCT00910858|435296|P2|Monotherapy Phase|Withdrawal by Subject|3
118648|NCT00910858|435297|P1|Monotherapy Phase|Withdrawal by Subject|1
118649|NCT00910858|435295|P3|Monotherapy Phase|Lack of therapeutic effect|4
118650|NCT00910858|435296|P2|Monotherapy Phase|Lack of therapeutic effect|6
118651|NCT00910858|435297|P1|Monotherapy Phase|Lack of therapeutic effect|9
118652|NCT00910858|435295|P3|Monotherapy Phase|Adverse Event|0
118653|NCT00910858|435296|P2|Monotherapy Phase|Adverse Event|2
118654|NCT00910858|435297|P1|Monotherapy Phase|Adverse Event|3
118655|NCT00910858|435295|P3|Pharmacokinetic Phase|Adverse Event|0
118656|NCT00910858|435296|P2|Pharmacokinetic Phase|Adverse Event|0
118657|NCT00910858|435297|P1|Pharmacokinetic Phase|Adverse Event|1
118658|NCT00910728|435342|P9|Overall Study|Adverse Event|1
118659|NCT00910728|435343|P8|Overall Study|Adverse Event|1
118660|NCT00910728|435344|P7|Overall Study|Adverse Event|2
118661|NCT00910728|435345|P6|Overall Study|Adverse Event|0
118662|NCT00910728|435346|P5|Overall Study|Adverse Event|0
118663|NCT00910728|435347|P4|Overall Study|Adverse Event|1
118664|NCT00910728|435348|P3|Overall Study|Adverse Event|1
118665|NCT00910728|435349|P2|Overall Study|Adverse Event|0
118666|NCT00910728|435350|P1|Overall Study|Adverse Event|2
118667|NCT00910728|435342|P9|Overall Study|(not specified)|0
118668|NCT00910728|435343|P8|Overall Study|(not specified)|0
118669|NCT00910728|435344|P7|Overall Study|(not specified)|0
118670|NCT00910728|435345|P6|Overall Study|(not specified)|0
118671|NCT00910728|435346|P5|Overall Study|(not specified)|1
118672|NCT00910728|435347|P4|Overall Study|(not specified)|0
118673|NCT00910728|435348|P3|Overall Study|(not specified)|1
118674|NCT00910728|435349|P2|Overall Study|(not specified)|0
118675|NCT00910728|435350|P1|Overall Study|(not specified)|2
118676|NCT00910728|435342|P9|Overall Study|Withdrawal by Subject|0
118677|NCT00910728|435343|P8|Overall Study|Withdrawal by Subject|0
118678|NCT00910728|435344|P7|Overall Study|Withdrawal by Subject|2
118679|NCT00910728|435345|P6|Overall Study|Withdrawal by Subject|1
118680|NCT00910728|435346|P5|Overall Study|Withdrawal by Subject|3
118681|NCT00910728|435347|P4|Overall Study|Withdrawal by Subject|0
118682|NCT00910728|435348|P3|Overall Study|Withdrawal by Subject|0
118683|NCT00910728|435349|P2|Overall Study|Withdrawal by Subject|0
118684|NCT00910728|435350|P1|Overall Study|Withdrawal by Subject|0
118685|NCT00910728|435342|P9|Overall Study|Lack of Efficacy|2
118686|NCT00910728|435343|P8|Overall Study|Lack of Efficacy|2
118687|NCT00910728|435344|P7|Overall Study|Lack of Efficacy|2
118688|NCT00910728|435345|P6|Overall Study|Lack of Efficacy|0
118689|NCT00910728|435346|P5|Overall Study|Lack of Efficacy|1
118690|NCT00910728|435347|P4|Overall Study|Lack of Efficacy|2
118691|NCT00910728|435348|P3|Overall Study|Lack of Efficacy|1
118692|NCT00910728|435349|P2|Overall Study|Lack of Efficacy|3
118693|NCT00910728|435350|P1|Overall Study|Lack of Efficacy|2
118694|NCT00910715|435472|P3|Overall Study|Lost to Follow-up|0
118695|NCT00910715|435473|P2|Overall Study|Lost to Follow-up|26
118696|NCT00910715|435474|P1|Overall Study|Lost to Follow-up|22
118697|NCT00910689|435488|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
118698|NCT00910689|435489|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
118699|NCT00910689|435490|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
118700|NCT00910689|435491|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
118701|NCT00910689|435488|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
118702|NCT00910689|435489|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
118703|NCT00910689|435490|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
118704|NCT00910689|435491|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
118705|NCT00910689|435488|P4|Months 11- 16: Evaluation Period II|Time Demands|0
118706|NCT00910689|435489|P3|Months 11- 16: Evaluation Period II|Time Demands|0
118707|NCT00910689|435490|P2|Months 11- 16: Evaluation Period II|Time Demands|1
118708|NCT00910689|435491|P1|Months 11- 16: Evaluation Period II|Time Demands|2
118709|NCT00910689|435488|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
118710|NCT00910689|435489|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
118711|NCT00910689|435490|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
118712|NCT00910689|435491|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
118713|NCT00910689|435488|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
118714|NCT00910689|435489|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
118715|NCT00910689|435490|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
118716|NCT00910689|435491|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
118717|NCT00910689|435488|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
118718|NCT00910689|435489|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
118719|NCT00910689|435490|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
118720|NCT00910689|435491|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
118721|NCT00910689|435488|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
118722|NCT00910689|435489|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
118723|NCT00910689|435490|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
118724|NCT00910689|435491|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
118725|NCT00910689|435488|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
118726|NCT00910689|435489|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
118727|NCT00910689|435490|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
118728|NCT00910689|435491|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
118729|NCT00910689|435488|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
118730|NCT00910689|435489|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
118731|NCT00910689|435490|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
118732|NCT00910689|435491|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
118733|NCT00910689|435488|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
118734|NCT00910689|435489|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
118735|NCT00910689|435490|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
118736|NCT00910689|435491|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
118737|NCT00910689|435488|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
118738|NCT00910689|435489|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
118906|NCT00909779|435885|P1|Overall Study|Noncompliance|1
118739|NCT00910689|435490|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
118740|NCT00910689|435491|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
118741|NCT00910689|435488|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
118742|NCT00910689|435489|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
118743|NCT00910689|435490|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
118744|NCT00910689|435491|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
118745|NCT00910689|435488|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
118746|NCT00910689|435489|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
118747|NCT00910689|435490|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
118748|NCT00910689|435491|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
118749|NCT00910689|435488|P4|Month 2- 4: Treatment Period|Protocol Violation|0
118750|NCT00910689|435489|P3|Month 2- 4: Treatment Period|Protocol Violation|0
118751|NCT00910689|435490|P2|Month 2- 4: Treatment Period|Protocol Violation|0
118752|NCT00910689|435491|P1|Month 2- 4: Treatment Period|Protocol Violation|1
118753|NCT00910689|435488|P4|Month 2- 4: Treatment Period|Pregnancy|0
118754|NCT00910689|435489|P3|Month 2- 4: Treatment Period|Pregnancy|0
118755|NCT00910689|435490|P2|Month 2- 4: Treatment Period|Pregnancy|2
118756|NCT00910689|435491|P1|Month 2- 4: Treatment Period|Pregnancy|0
118757|NCT00910689|435488|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
118758|NCT00910689|435489|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
118759|NCT00910689|435490|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
118760|NCT00910689|435491|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
118761|NCT00910689|435488|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
118762|NCT00910689|435489|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
118763|NCT00910689|435490|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
118764|NCT00910689|435491|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
118765|NCT00910689|435488|P4|Month 2- 4: Treatment Period|Time Demands|8
118766|NCT00910689|435489|P3|Month 2- 4: Treatment Period|Time Demands|4
118767|NCT00910689|435490|P2|Month 2- 4: Treatment Period|Time Demands|0
118768|NCT00910689|435491|P1|Month 2- 4: Treatment Period|Time Demands|1
118769|NCT00910689|435488|P4|Month 2- 4: Treatment Period|Adverse Event|0
118770|NCT00910689|435489|P3|Month 2- 4: Treatment Period|Adverse Event|2
118771|NCT00910689|435490|P2|Month 2- 4: Treatment Period|Adverse Event|3
118772|NCT00910689|435491|P1|Month 2- 4: Treatment Period|Adverse Event|2
118773|NCT00910689|435488|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
118774|NCT00910689|435489|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
118775|NCT00910689|435490|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
118776|NCT00910689|435491|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
118777|NCT00910689|435488|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
118778|NCT00910689|435489|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
118779|NCT00910689|435490|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
118780|NCT00910689|435491|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
118781|NCT00910663|435523|P2|Period 1|Withdrawal by Subject|1
118782|NCT00910663|435524|P1|Period 1|Withdrawal by Subject|0
118783|NCT00910624|435538|P4|Follow-Up Phase|Administrative|0
118784|NCT00910624|435539|P3|Follow-Up Phase|Administrative|1
118785|NCT00910624|435540|P2|Follow-Up Phase|Administrative|1
118786|NCT00910624|435541|P1|Follow-Up Phase|Administrative|0
118787|NCT00910624|435538|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
118788|NCT00910624|435539|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
118789|NCT00910624|435540|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
118790|NCT00910624|435541|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
118791|NCT00910624|435538|P4|Follow-Up Phase|Withdrawal by Subject|0
118792|NCT00910624|435539|P3|Follow-Up Phase|Withdrawal by Subject|0
118793|NCT00910624|435540|P2|Follow-Up Phase|Withdrawal by Subject|0
118794|NCT00910624|435541|P1|Follow-Up Phase|Withdrawal by Subject|1
118795|NCT00910624|435538|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
118796|NCT00910624|435539|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
118797|NCT00910624|435540|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
118798|NCT00910624|435541|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
118799|NCT00910624|435538|P4|Follow-Up Phase|Lost to Follow-up|0
118800|NCT00910624|435539|P3|Follow-Up Phase|Lost to Follow-up|2
118801|NCT00910624|435540|P2|Follow-Up Phase|Lost to Follow-up|1
118802|NCT00910624|435541|P1|Follow-Up Phase|Lost to Follow-up|3
118803|NCT00910624|435538|P4|Follow-Up Phase|Adverse Event|0
118804|NCT00910624|435539|P3|Follow-Up Phase|Adverse Event|1
118805|NCT00910624|435540|P2|Follow-Up Phase|Adverse Event|0
118806|NCT00910624|435541|P1|Follow-Up Phase|Adverse Event|0
118807|NCT00910624|435538|P4|Treatment Phase|Non-Compliance With Protocol|0
118808|NCT00910624|435539|P3|Treatment Phase|Non-Compliance With Protocol|1
118809|NCT00910624|435540|P2|Treatment Phase|Non-Compliance With Protocol|1
118810|NCT00910624|435541|P1|Treatment Phase|Non-Compliance With Protocol|0
118811|NCT00910624|435538|P4|Treatment Phase|Withdrawal by Subject|0
118812|NCT00910624|435539|P3|Treatment Phase|Withdrawal by Subject|0
118813|NCT00910624|435540|P2|Treatment Phase|Withdrawal by Subject|1
118814|NCT00910624|435541|P1|Treatment Phase|Withdrawal by Subject|2
118815|NCT00910624|435538|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
118816|NCT00910624|435539|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
118817|NCT00910624|435540|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
118818|NCT00910624|435541|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
118819|NCT00910624|435538|P4|Treatment Phase|Lost to Follow-up|0
118820|NCT00910624|435539|P3|Treatment Phase|Lost to Follow-up|1
118821|NCT00910624|435540|P2|Treatment Phase|Lost to Follow-up|0
118822|NCT00910624|435541|P1|Treatment Phase|Lost to Follow-up|0
118823|NCT00910624|435538|P4|Treatment Phase|Treatment Failure|0
118824|NCT00910624|435539|P3|Treatment Phase|Treatment Failure|0
118825|NCT00910624|435540|P2|Treatment Phase|Treatment Failure|10
118826|NCT00910624|435541|P1|Treatment Phase|Treatment Failure|23
118827|NCT00910624|435538|P4|Treatment Phase|Adverse Event|0
118828|NCT00910624|435539|P3|Treatment Phase|Adverse Event|6
118829|NCT00910624|435540|P2|Treatment Phase|Adverse Event|6
118830|NCT00910624|435541|P1|Treatment Phase|Adverse Event|2
118831|NCT00910299|435568|P2|Overall Study|Didn't receive any study drug|1
118832|NCT00910299|435569|P1|Overall Study|Didn't receive any study drug|2
118833|NCT00910299|435568|P2|Overall Study|Sponsor Decision|60
118834|NCT00910299|435569|P1|Overall Study|Sponsor Decision|58
118835|NCT00910299|435568|P2|Overall Study|Withdrawal by Subject|13
118836|NCT00910299|435569|P1|Overall Study|Withdrawal by Subject|16
118837|NCT00910273|435581|P2|Overall Study|Lost to Follow-up|1
118838|NCT00910273|435582|P1|Overall Study|Lost to Follow-up|1
118839|NCT00910273|435581|P2|Overall Study|Protocol Violation|0
118840|NCT00910273|435582|P1|Overall Study|Protocol Violation|1
118841|NCT00910273|435581|P2|Overall Study|Discontinuation of study by sponsor|2
118842|NCT00910273|435582|P1|Overall Study|Discontinuation of study by sponsor|8
118843|NCT00910273|435581|P2|Overall Study|Withdrawal by Subject|0
118844|NCT00910273|435582|P1|Overall Study|Withdrawal by Subject|1
118845|NCT00910273|435581|P2|Overall Study|Adverse Event|1
118846|NCT00910273|435582|P1|Overall Study|Adverse Event|1
118847|NCT00910273|435581|P2|Overall Study|Lack of Efficacy|9
118848|NCT00910273|435582|P1|Overall Study|Lack of Efficacy|6
118849|NCT00910091|435634|P2|Treatment and Survival|Adverse Event|0
118850|NCT00910091|435635|P1|Treatment and Survival|Adverse Event|1
118851|NCT00910091|435634|P2|Treatment and Survival|Withdrawal by Subject|4
118852|NCT00910091|435635|P1|Treatment and Survival|Withdrawal by Subject|3
118853|NCT00910091|435634|P2|Pre-assignment|Withdrawal by Subject|2
118854|NCT00910091|435635|P1|Pre-assignment|Withdrawal by Subject|0
118855|NCT00910039|435663|P1|Overall Study|Physician Decision|1
118856|NCT00910000|435680|P6|Overall Study|Withdrawal by Subject|0
118857|NCT00910000|435681|P5|Overall Study|Withdrawal by Subject|1
118858|NCT00910000|435682|P4|Overall Study|Withdrawal by Subject|0
118859|NCT00910000|435683|P3|Overall Study|Withdrawal by Subject|1
118860|NCT00910000|435684|P2|Overall Study|Withdrawal by Subject|0
118861|NCT00910000|435685|P1|Overall Study|Withdrawal by Subject|0
118862|NCT00910000|435680|P6|Overall Study|Adverse Event|1
118863|NCT00910000|435681|P5|Overall Study|Adverse Event|0
118864|NCT00910000|435682|P4|Overall Study|Adverse Event|2
118865|NCT00910000|435683|P3|Overall Study|Adverse Event|2
118866|NCT00910000|435684|P2|Overall Study|Adverse Event|3
118867|NCT00910000|435685|P1|Overall Study|Adverse Event|0
118868|NCT00909870|435703|P2|Overall Study|Other|5
118869|NCT00909870|435704|P1|Overall Study|Other|1
118870|NCT00909870|435703|P2|Overall Study|Physician Decision|2
118871|NCT00909870|435704|P1|Overall Study|Physician Decision|0
118872|NCT00909870|435703|P2|Overall Study|Lost to Follow-up|3
118873|NCT00909870|435704|P1|Overall Study|Lost to Follow-up|3
118874|NCT00909870|435703|P2|Overall Study|Withdrawal by Subject|8
118875|NCT00909870|435704|P1|Overall Study|Withdrawal by Subject|5
118876|NCT00909870|435703|P2|Overall Study|Protocol Violation|2
118877|NCT00909870|435704|P1|Overall Study|Protocol Violation|1
118878|NCT00909870|435703|P2|Overall Study|Adverse Event|7
118879|NCT00909870|435704|P1|Overall Study|Adverse Event|13
118880|NCT00909857|435716|P2|Overall Study|Did not receive study medication|24
118881|NCT00909857|435717|P1|Overall Study|Did not receive study medication|19
118882|NCT00909857|435716|P2|Overall Study|Other|0
118883|NCT00909857|435717|P1|Overall Study|Other|1
118884|NCT00909857|435716|P2|Overall Study|Pregnancy|0
118885|NCT00909857|435717|P1|Overall Study|Pregnancy|1
118886|NCT00909857|435716|P2|Overall Study|Protocol Violation|1
118887|NCT00909857|435717|P1|Overall Study|Protocol Violation|2
118888|NCT00909857|435716|P2|Overall Study|Lost to Follow-up|5
118889|NCT00909857|435717|P1|Overall Study|Lost to Follow-up|2
118890|NCT00909857|435716|P2|Overall Study|Adverse Event|5
118891|NCT00909857|435717|P1|Overall Study|Adverse Event|5
118892|NCT00909857|435716|P2|Overall Study|Withdrawal by Subject|10
118893|NCT00909857|435717|P1|Overall Study|Withdrawal by Subject|6
118894|NCT00909844|435857|P1|Overall Study|Lost to Follow-up|2
118895|NCT00909844|435857|P1|Overall Study|Withdrawal by Subject|1
118896|NCT00909844|435857|P1|Overall Study|Adverse Event|1
118897|NCT00909792|435875|P2|Period 2|Lost to Follow-up|1
118898|NCT00909792|435876|P1|Period 2|Lost to Follow-up|0
118899|NCT00909792|435875|P2|Period 2|Biomicroscopy|0
118900|NCT00909792|435876|P1|Period 2|Biomicroscopy|1
118901|NCT00909792|435875|P2|Period 1|Did not meet inclusion criteria|1
118902|NCT00909792|435876|P1|Period 1|Did not meet inclusion criteria|0
118903|NCT00909779|435884|P2|Overall Study|Randomized in error|1
118904|NCT00909779|435885|P1|Overall Study|Randomized in error|1
118905|NCT00909779|435884|P2|Overall Study|Noncompliance|1
118907|NCT00909779|435884|P2|Overall Study|Medical Monitor Decision|0
118908|NCT00909779|435885|P1|Overall Study|Medical Monitor Decision|1
118909|NCT00909779|435884|P2|Overall Study|Site Ceasing Operation|2
118910|NCT00909779|435885|P1|Overall Study|Site Ceasing Operation|2
118911|NCT00909779|435884|P2|Overall Study|Withdrawal by Subject|80
118912|NCT00909779|435885|P1|Overall Study|Withdrawal by Subject|116
118913|NCT00909779|435884|P2|Overall Study|Protocol Violation|5
118914|NCT00909779|435885|P1|Overall Study|Protocol Violation|2
118915|NCT00909779|435884|P2|Overall Study|Physician Decision|2
118916|NCT00909779|435885|P1|Overall Study|Physician Decision|8
118917|NCT00909779|435884|P2|Overall Study|Lost to Follow-up|15
118918|NCT00909779|435885|P1|Overall Study|Lost to Follow-up|19
118919|NCT00909779|435884|P2|Overall Study|Lack of Efficacy|4
118920|NCT00909779|435885|P1|Overall Study|Lack of Efficacy|7
118921|NCT00909779|435884|P2|Overall Study|Adverse Event|55
118922|NCT00909779|435885|P1|Overall Study|Adverse Event|53
118923|NCT00909753|435909|P2|Period: Second Intervention|Protocol Violation|0
118924|NCT00909753|435910|P1|Period: Second Intervention|Protocol Violation|1
118925|NCT00909753|435909|P2|Period: Washout of 28 Days|Protocol Violation|3
118926|NCT00909753|435910|P1|Period: Washout of 28 Days|Protocol Violation|2
118927|NCT00909727|435930|P2|Overall Study|Prohibited Medication|0
118928|NCT00909727|435931|P1|Overall Study|Prohibited Medication|1
118929|NCT00909727|435930|P2|Overall Study|Withdrawal of Consent|0
118930|NCT00909727|435931|P1|Overall Study|Withdrawal of Consent|1
118931|NCT00909727|435930|P2|Overall Study|Wrong Genotype|0
118932|NCT00909727|435931|P1|Overall Study|Wrong Genotype|1
118933|NCT00909727|435930|P2|Overall Study|Adverse Event|0
118934|NCT00909727|435931|P1|Overall Study|Adverse Event|1
118935|NCT00909610|435954|P2|Period: Second Intervention|Adverse Event|0
118936|NCT00909610|435955|P1|Period: Second Intervention|Adverse Event|1
118937|NCT00909610|435954|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
118938|NCT00909610|435955|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
118939|NCT00909610|435954|P2|Period: First Intervention|Adverse Event|1
118940|NCT00909610|435955|P1|Period: First Intervention|Adverse Event|0
118941|NCT00909532|436116|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
118942|NCT00909532|436117|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
118943|NCT00909532|436116|P2|Overall Study|Wrong Genotype|0
118944|NCT00909532|436117|P1|Overall Study|Wrong Genotype|1
118945|NCT00909532|436116|P2|Overall Study|Physician Decision|0
118946|NCT00909532|436117|P1|Overall Study|Physician Decision|1
118947|NCT00909532|436116|P2|Overall Study|Noncompliance with Study Requirements|2
118948|NCT00909532|436117|P1|Overall Study|Noncompliance with Study Requirements|0
118949|NCT00909532|436116|P2|Overall Study|Withdrawal of Consent|1
118950|NCT00909532|436117|P1|Overall Study|Withdrawal of Consent|1
118951|NCT00909532|436116|P2|Overall Study|Prohibited Medication|1
118952|NCT00909532|436117|P1|Overall Study|Prohibited Medication|2
118953|NCT00909532|436116|P2|Overall Study|Pregnancy|1
118954|NCT00909532|436117|P1|Overall Study|Pregnancy|0
118955|NCT00909532|436116|P2|Overall Study|Adverse Event|1
118956|NCT00909532|436117|P1|Overall Study|Adverse Event|4
118957|NCT00909480|436135|P2|Overall Study|Unclassified|19
118958|NCT00909480|436136|P1|Overall Study|Unclassified|18
118959|NCT00909480|436135|P2|Overall Study|Withdrawal criteria|11
118960|NCT00909480|436136|P1|Overall Study|Withdrawal criteria|9
118961|NCT00909480|436135|P2|Overall Study|Protocol Violation|8
118962|NCT00909480|436136|P1|Overall Study|Protocol Violation|6
118963|NCT00909480|436135|P2|Overall Study|Adverse Event|3
118964|NCT00909480|436136|P1|Overall Study|Adverse Event|5
118965|NCT00909428|436171|P3|Overall Study|Lost to Follow-up|9
118966|NCT00909428|436172|P2|Overall Study|Lost to Follow-up|10
118967|NCT00909428|436173|P1|Overall Study|Lost to Follow-up|13
118968|NCT00909389|436180|P1|Overall Study|No Information|103
118969|NCT00909389|436180|P1|Overall Study|Lost to Follow-up|4
118970|NCT00909389|436180|P1|Overall Study|Poor Compliance|16
118971|NCT00909389|436180|P1|Overall Study|Death|4
118972|NCT00909389|436180|P1|Overall Study|Adverse Event|6
118973|NCT00909181|436214|P3|Overall Study|Lost to Follow-up|33
118974|NCT00909181|436215|P2|Overall Study|Lost to Follow-up|18
118975|NCT00909181|436216|P1|Overall Study|Lost to Follow-up|39
118976|NCT00909038|436243|P1|Overall Study|Non-evaluable Subjects|230
118977|NCT00909038|436243|P1|Overall Study|Protocol Violation|187
118978|NCT00908960|436255|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
118979|NCT00908960|436256|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
118980|NCT00908960|436257|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
118981|NCT00908895|436279|P2|Overall Study|Adverse Event|1
118982|NCT00908895|436280|P1|Overall Study|Adverse Event|1
118983|NCT00908895|436279|P2|Overall Study|algodystrophy|2
118984|NCT00908895|436280|P1|Overall Study|algodystrophy|2
118985|NCT00908895|436279|P2|Overall Study|Lost to Follow-up|3
118986|NCT00908895|436280|P1|Overall Study|Lost to Follow-up|1
118987|NCT00908596|436353|P4|Overall Study|Withdrawal by Subject|1
118988|NCT00908596|436354|P3|Overall Study|Withdrawal by Subject|3
118989|NCT00908596|436355|P2|Overall Study|Withdrawal by Subject|1
118990|NCT00908596|436356|P1|Overall Study|Withdrawal by Subject|0
118991|NCT00908596|436353|P4|Overall Study|Protocol Violation|0
118992|NCT00908596|436354|P3|Overall Study|Protocol Violation|0
118993|NCT00908596|436355|P2|Overall Study|Protocol Violation|0
119405|NCT00906399|437169|P3|Year 1|Death|1
118994|NCT00908596|436356|P1|Overall Study|Protocol Violation|1
118995|NCT00908596|436353|P4|Overall Study|Death|32
118996|NCT00908596|436354|P3|Overall Study|Death|57
118997|NCT00908596|436355|P2|Overall Study|Death|5
118998|NCT00908596|436356|P1|Overall Study|Death|0
118999|NCT00908596|436353|P4|Overall Study|Lost to Follow-up|4
119000|NCT00908596|436354|P3|Overall Study|Lost to Follow-up|12
119001|NCT00908596|436355|P2|Overall Study|Lost to Follow-up|1
119002|NCT00908596|436356|P1|Overall Study|Lost to Follow-up|0
119003|NCT00908596|436353|P4|Overall Study|Other reasons|0
119004|NCT00908596|436354|P3|Overall Study|Other reasons|2
119005|NCT00908596|436355|P2|Overall Study|Other reasons|6
119006|NCT00908596|436356|P1|Overall Study|Other reasons|46
119007|NCT00908583|436386|P1|Phase 5|Adverse Event|3
119008|NCT00908583|436386|P1|Phase 4|Physician Decision|1
119009|NCT00908583|436386|P1|Phase 4|Adverse Event|1
119010|NCT00908583|436386|P1|Phase 3|Adverse Event|2
119011|NCT00908583|436386|P1|Phase 2|Adverse Event|1
119012|NCT00908583|436386|P1|Phase 2|Physician Decision|1
119013|NCT00908583|436386|P1|Phase 1|Adverse Event|4
119014|NCT00908583|436386|P1|Phase 1|Withdrawal by Subject|1
119015|NCT00908375|436414|P2|Overall Study|Lost to Follow-up|6
119016|NCT00908375|436415|P1|Overall Study|Lost to Follow-up|8
119017|NCT00908375|436414|P2|Overall Study|Withdrawal by Subject|4
119018|NCT00908375|436415|P1|Overall Study|Withdrawal by Subject|2
119019|NCT00908349|436425|P1|Overall Study|Various|6
119020|NCT00908349|436425|P1|Overall Study|Lost to Follow-up|5
119021|NCT00908349|436425|P1|Overall Study|Physician Decision|5
119022|NCT00908349|436425|P1|Overall Study|Withdrawal by Subject|9
119023|NCT00908349|436425|P1|Overall Study|Adverse Event|10
119024|NCT00908310|436429|P1|Overall Study|Other reasons|4
119025|NCT00908310|436429|P1|Overall Study|Screening failure|5
119026|NCT00908310|436429|P1|Overall Study|Lost to Follow-up|7
119027|NCT00908310|436429|P1|Overall Study|Withdrawal by Subject|7
119028|NCT00908310|436429|P1|Overall Study|Death|37
119029|NCT00908232|436433|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
119030|NCT00908232|436434|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
119031|NCT00908232|436435|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
119032|NCT00908232|436436|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
119033|NCT00908232|436433|P4|Randomization (Cycle 5) to Cycle 8|Other|0
119034|NCT00908232|436434|P3|Randomization (Cycle 5) to Cycle 8|Other|0
119035|NCT00908232|436435|P2|Randomization (Cycle 5) to Cycle 8|Other|1
119036|NCT00908232|436436|P1|Randomization (Cycle 5) to Cycle 8|Other|3
119037|NCT00908232|436433|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
119038|NCT00908232|436434|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
119039|NCT00908232|436435|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
119040|NCT00908232|436436|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
119041|NCT00908232|436433|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
119042|NCT00908232|436434|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
119043|NCT00908232|436435|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
119044|NCT00908232|436436|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
119045|NCT00908232|436433|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
119046|NCT00908232|436434|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
119047|NCT00908232|436435|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
119048|NCT00908232|436436|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
119049|NCT00908232|436433|P4|Randomization (Cycle 5) to Cycle 8|Death|0
119050|NCT00908232|436434|P3|Randomization (Cycle 5) to Cycle 8|Death|0
119051|NCT00908232|436435|P2|Randomization (Cycle 5) to Cycle 8|Death|0
119052|NCT00908232|436436|P1|Randomization (Cycle 5) to Cycle 8|Death|2
119053|NCT00908232|436433|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
119054|NCT00908232|436434|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
119055|NCT00908232|436435|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
119056|NCT00908232|436436|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
119057|NCT00908232|436433|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
119058|NCT00908232|436434|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
119059|NCT00908232|436435|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
119060|NCT00908232|436436|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
119061|NCT00908232|436433|P4|Cycle 1 to 4|not specified|0
119062|NCT00908232|436434|P3|Cycle 1 to 4|not specified|0
119063|NCT00908232|436435|P2|Cycle 1 to 4|not specified|0
119064|NCT00908232|436436|P1|Cycle 1 to 4|not specified|1
119065|NCT00908232|436433|P4|Cycle 1 to 4|Adverse Event|0
119066|NCT00908232|436434|P3|Cycle 1 to 4|Adverse Event|0
119067|NCT00908232|436435|P2|Cycle 1 to 4|Adverse Event|0
119068|NCT00908232|436436|P1|Cycle 1 to 4|Adverse Event|12
119069|NCT00908232|436433|P4|Cycle 1 to 4|Progressive Disease|0
119070|NCT00908232|436434|P3|Cycle 1 to 4|Progressive Disease|0
119071|NCT00908232|436435|P2|Cycle 1 to 4|Progressive Disease|0
119072|NCT00908232|436436|P1|Cycle 1 to 4|Progressive Disease|6
119073|NCT00908232|436433|P4|Cycle 1 to 4|Withdrawal by Subject|0
119074|NCT00908232|436434|P3|Cycle 1 to 4|Withdrawal by Subject|0
119075|NCT00908232|436435|P2|Cycle 1 to 4|Withdrawal by Subject|0
119076|NCT00908232|436436|P1|Cycle 1 to 4|Withdrawal by Subject|4
119077|NCT00908232|436433|P4|Cycle 1 to 4|Death|0
119078|NCT00908232|436434|P3|Cycle 1 to 4|Death|0
119079|NCT00908232|436435|P2|Cycle 1 to 4|Death|0
119080|NCT00908232|436436|P1|Cycle 1 to 4|Death|5
119081|NCT00908141|436454|P2|Overall Study|Withdrawal by Subject|1
119082|NCT00908141|436455|P1|Overall Study|Withdrawal by Subject|0
119083|NCT00908115|436472|P1|Overall Study|Other|14
119084|NCT00908076|436480|P2|Overall Study|Lack of Efficacy|1
119085|NCT00908076|436481|P1|Overall Study|Lack of Efficacy|1
119086|NCT00908037|436494|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119087|NCT00908037|436495|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
119088|NCT00908037|436496|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119089|NCT00908037|436497|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119090|NCT00908037|436498|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119091|NCT00908037|436499|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119092|NCT00908037|436500|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119093|NCT00908037|436501|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119094|NCT00908037|436502|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119095|NCT00908037|436503|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119096|NCT00908037|436504|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119097|NCT00908037|436505|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
119098|NCT00908037|436494|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119099|NCT00908037|436495|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119100|NCT00908037|436496|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
119101|NCT00908037|436497|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119102|NCT00908037|436498|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119103|NCT00908037|436499|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119104|NCT00908037|436500|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119105|NCT00908037|436501|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119106|NCT00908037|436502|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119107|NCT00908037|436503|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119108|NCT00908037|436504|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119109|NCT00908037|436505|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
119110|NCT00908037|436494|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119111|NCT00908037|436495|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
119112|NCT00908037|436496|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119113|NCT00908037|436497|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119114|NCT00908037|436498|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119115|NCT00908037|436499|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119116|NCT00908037|436500|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119117|NCT00908037|436501|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119118|NCT00908037|436502|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119119|NCT00908037|436503|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119120|NCT00908037|436504|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119121|NCT00908037|436505|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
119122|NCT00908037|436494|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119123|NCT00908037|436495|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119124|NCT00908037|436496|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
119125|NCT00908037|436497|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119126|NCT00908037|436498|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119127|NCT00908037|436499|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119128|NCT00908037|436500|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119129|NCT00908037|436501|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119130|NCT00908037|436502|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119131|NCT00908037|436503|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119132|NCT00908037|436504|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119133|NCT00908037|436505|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
119134|NCT00908037|436494|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
119135|NCT00908037|436495|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119136|NCT00908037|436496|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
119137|NCT00908037|436497|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119138|NCT00908037|436498|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119139|NCT00908037|436499|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119140|NCT00908037|436500|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119141|NCT00908037|436501|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119142|NCT00908037|436502|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119143|NCT00908037|436503|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119144|NCT00908037|436504|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119145|NCT00908037|436505|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
119146|NCT00908037|436494|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
119147|NCT00908037|436495|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119148|NCT00908037|436496|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119149|NCT00908037|436497|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119150|NCT00908037|436498|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119151|NCT00908037|436499|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119152|NCT00908037|436500|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119153|NCT00908037|436501|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119154|NCT00908037|436502|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119155|NCT00908037|436503|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119156|NCT00908037|436504|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119157|NCT00908037|436505|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
119158|NCT00908037|436494|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119159|NCT00908037|436495|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119160|NCT00908037|436496|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119161|NCT00908037|436497|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119162|NCT00908037|436498|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119163|NCT00908037|436499|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
119164|NCT00908037|436500|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119165|NCT00908037|436501|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119166|NCT00908037|436502|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
119167|NCT00908037|436503|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119168|NCT00908037|436504|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119169|NCT00908037|436505|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
119170|NCT00908037|436494|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119171|NCT00908037|436495|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119172|NCT00908037|436496|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119173|NCT00908037|436497|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
119174|NCT00908037|436498|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119175|NCT00908037|436499|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119176|NCT00908037|436500|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119177|NCT00908037|436501|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
119178|NCT00908037|436502|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119179|NCT00908037|436503|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119180|NCT00908037|436504|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119181|NCT00908037|436505|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
119182|NCT00908037|436494|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
119183|NCT00908037|436495|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
119184|NCT00908037|436496|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
119185|NCT00908037|436497|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
119186|NCT00908037|436498|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
119187|NCT00908037|436499|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
119188|NCT00908037|436500|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
119189|NCT00908037|436501|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
119190|NCT00908037|436502|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
119191|NCT00908037|436503|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
119192|NCT00908037|436504|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
119193|NCT00908037|436505|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
119194|NCT00908011|436654|P2|Overall Study|Withdrawal by Subject|2
119195|NCT00908011|436655|P1|Overall Study|Withdrawal by Subject|2
119196|NCT00907881|436672|P1|Overall Study|Missing discontinuation information|15
119197|NCT00907881|436672|P1|Overall Study|Protocol Violation|1
119198|NCT00907881|436672|P1|Overall Study|Withdrawal by Subject|5
119199|NCT00907881|436672|P1|Overall Study|Noncompliance|5
119200|NCT00907881|436672|P1|Overall Study|Lost to Follow-up|59
119201|NCT00907803|436682|P3|Overall Study|Protocol Violation|0
119202|NCT00907803|436683|P2|Overall Study|Protocol Violation|1
119203|NCT00907803|436684|P1|Overall Study|Protocol Violation|0
119204|NCT00907803|436682|P3|Overall Study|Lost to Follow-up|0
119205|NCT00907803|436683|P2|Overall Study|Lost to Follow-up|1
119206|NCT00907803|436684|P1|Overall Study|Lost to Follow-up|0
119207|NCT00907803|436682|P3|Overall Study|Withdrawal by Subject|0
119208|NCT00907803|436683|P2|Overall Study|Withdrawal by Subject|1
119209|NCT00907803|436684|P1|Overall Study|Withdrawal by Subject|0
119210|NCT00907803|436682|P3|Overall Study|Adverse Event|0
119211|NCT00907803|436683|P2|Overall Study|Adverse Event|0
119212|NCT00907803|436684|P1|Overall Study|Adverse Event|2
119213|NCT00907803|436682|P3|Overall Study|Withdrawal of consent - long commute|0
119214|NCT00907803|436683|P2|Overall Study|Withdrawal of consent - long commute|0
119215|NCT00907803|436684|P1|Overall Study|Withdrawal of consent - long commute|1
119216|NCT00907777|436715|P2|Overall Study|Withdrawal by Subject|1
119217|NCT00907777|436716|P1|Overall Study|Withdrawal by Subject|0
119218|NCT00907738|436743|P5|Overall Study|Disease progression|2
119219|NCT00907738|436744|P4|Overall Study|Disease progression|4
119220|NCT00907738|436745|P3|Overall Study|Disease progression|6
119221|NCT00907738|436746|P2|Overall Study|Disease progression|1
119222|NCT00907738|436747|P1|Overall Study|Disease progression|8
119223|NCT00907738|436743|P5|Overall Study|not specified or withdrew consent|0
119224|NCT00907738|436744|P4|Overall Study|not specified or withdrew consent|0
119225|NCT00907738|436745|P3|Overall Study|not specified or withdrew consent|0
119226|NCT00907738|436746|P2|Overall Study|not specified or withdrew consent|0
119227|NCT00907738|436747|P1|Overall Study|not specified or withdrew consent|3
119228|NCT00907738|436743|P5|Overall Study|Adverse Event|0
119229|NCT00907738|436744|P4|Overall Study|Adverse Event|0
119230|NCT00907738|436745|P3|Overall Study|Adverse Event|1
119231|NCT00907738|436746|P2|Overall Study|Adverse Event|0
119232|NCT00907738|436747|P1|Overall Study|Adverse Event|2
119233|NCT00907621|436765|P2|Overall Study|intercurrent febrile illness|1
119234|NCT00907621|436766|P1|Overall Study|intercurrent febrile illness|1
119235|NCT00907621|436765|P2|Overall Study|Lost to Follow-up|3
119236|NCT00907621|436766|P1|Overall Study|Lost to Follow-up|6
119237|NCT00907517|436779|P5|Overall Study|Symptomatic Deterioration|1
119238|NCT00907517|436780|P4|Overall Study|Symptomatic Deterioration|0
119239|NCT00907517|436781|P3|Overall Study|Symptomatic Deterioration|0
119240|NCT00907517|436782|P2|Overall Study|Symptomatic Deterioration|0
119241|NCT00907517|436783|P1|Overall Study|Symptomatic Deterioration|0
119242|NCT00907517|436779|P5|Overall Study|Progressive Disease|4
119243|NCT00907517|436780|P4|Overall Study|Progressive Disease|4
119244|NCT00907517|436781|P3|Overall Study|Progressive Disease|4
119245|NCT00907517|436782|P2|Overall Study|Progressive Disease|3
119246|NCT00907517|436783|P1|Overall Study|Progressive Disease|3
119247|NCT00907478|436808|P3|Overall Study|Other|1
119248|NCT00907478|436809|P2|Overall Study|Other|0
119249|NCT00907478|436810|P1|Overall Study|Other|3
119250|NCT00907478|436808|P3|Overall Study|Lost to Follow-up|0
119251|NCT00907478|436809|P2|Overall Study|Lost to Follow-up|0
119252|NCT00907478|436810|P1|Overall Study|Lost to Follow-up|1
119253|NCT00907478|436808|P3|Overall Study|Pregnancy|1
119254|NCT00907478|436809|P2|Overall Study|Pregnancy|1
119255|NCT00907478|436810|P1|Overall Study|Pregnancy|0
119256|NCT00907478|436808|P3|Overall Study|Protocol-specified criteria|3
119257|NCT00907478|436809|P2|Overall Study|Protocol-specified criteria|2
119258|NCT00907478|436810|P1|Overall Study|Protocol-specified criteria|5
119259|NCT00907478|436808|P3|Overall Study|Death|1
119260|NCT00907478|436809|P2|Overall Study|Death|2
119261|NCT00907478|436810|P1|Overall Study|Death|4
119262|NCT00907478|436808|P3|Overall Study|Physician Decision|3
119263|NCT00907478|436809|P2|Overall Study|Physician Decision|0
119264|NCT00907478|436810|P1|Overall Study|Physician Decision|2
119265|NCT00907478|436808|P3|Overall Study|Requirement for alternative therapy|3
119266|NCT00907478|436809|P2|Overall Study|Requirement for alternative therapy|2
119267|NCT00907478|436810|P1|Overall Study|Requirement for alternative therapy|1
119268|NCT00907478|436808|P3|Overall Study|Withdrawal by Subject|6
119269|NCT00907478|436809|P2|Overall Study|Withdrawal by Subject|9
119270|NCT00907478|436810|P1|Overall Study|Withdrawal by Subject|8
119271|NCT00907478|436808|P3|Overall Study|Adverse Event|2
119272|NCT00907478|436809|P2|Overall Study|Adverse Event|1
119273|NCT00907478|436810|P1|Overall Study|Adverse Event|3
119274|NCT00907478|436808|P3|Overall Study|Noncompliance|1
119275|NCT00907478|436809|P2|Overall Study|Noncompliance|0
119276|NCT00907478|436810|P1|Overall Study|Noncompliance|0
119277|NCT00907478|436808|P3|Overall Study|Ineligibility determined|1
119278|NCT00907478|436809|P2|Overall Study|Ineligibility determined|0
119279|NCT00907478|436810|P1|Overall Study|Ineligibility determined|0
119280|NCT00907374|436860|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
119281|NCT00907374|436861|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
119282|NCT00907335|436875|P2|Overall Study|Lost to Follow-up|0
119283|NCT00907335|436876|P1|Overall Study|Lost to Follow-up|2
119284|NCT00907335|436875|P2|Overall Study|Adverse Event|1
119285|NCT00907335|436876|P1|Overall Study|Adverse Event|4
119286|NCT00907335|436875|P2|Overall Study|Withdrawal by Subject|0
119287|NCT00907335|436876|P1|Overall Study|Withdrawal by Subject|2
119288|NCT00907257|436894|P2|Overall Study|Personal Reasons|1
119289|NCT00907257|436895|P1|Overall Study|Personal Reasons|6
119290|NCT00907257|436894|P2|Overall Study|Moved|0
119291|NCT00907257|436895|P1|Overall Study|Moved|1
119292|NCT00907257|436894|P2|Overall Study|Per IRB-Subject became vulnerable|0
119293|NCT00907257|436895|P1|Overall Study|Per IRB-Subject became vulnerable|1
119294|NCT00907257|436894|P2|Overall Study|Withdrawal by Subject|2
119295|NCT00907257|436895|P1|Overall Study|Withdrawal by Subject|1
119296|NCT00907257|436894|P2|Overall Study|Lost to Follow-up|3
119297|NCT00907257|436895|P1|Overall Study|Lost to Follow-up|3
119298|NCT00907257|436894|P2|Overall Study|Protocol Violation|2
119299|NCT00907257|436895|P1|Overall Study|Protocol Violation|1
119300|NCT00907257|436894|P2|Overall Study|Adverse Event|4
119301|NCT00907257|436895|P1|Overall Study|Adverse Event|0
119302|NCT00907153|436917|P2|Overall Study|Withdrawal by Subject|3
119303|NCT00907153|436918|P1|Overall Study|Withdrawal by Subject|1
119304|NCT00907153|436917|P2|Overall Study|Lost to Follow-up|1
119305|NCT00907153|436918|P1|Overall Study|Lost to Follow-up|1
119306|NCT00906971|436979|P2|Overall Study|Lost to Follow-up|1
119307|NCT00906971|436980|P1|Overall Study|Lost to Follow-up|0
119308|NCT00906971|436979|P2|Overall Study|Withdrawal by Subject|2
119309|NCT00906971|436980|P1|Overall Study|Withdrawal by Subject|8
119310|NCT00906945|436993|P6|Overall Study|Physician Decision|1
119311|NCT00906945|436994|P5|Overall Study|Physician Decision|0
119312|NCT00906945|436995|P4|Overall Study|Physician Decision|0
119313|NCT00906945|436996|P3|Overall Study|Physician Decision|0
119314|NCT00906945|436997|P2|Overall Study|Physician Decision|0
119315|NCT00906945|436998|P1|Overall Study|Physician Decision|0
119316|NCT00906945|436993|P6|Overall Study|Found to be not eligible|1
119317|NCT00906945|436994|P5|Overall Study|Found to be not eligible|1
119318|NCT00906945|436995|P4|Overall Study|Found to be not eligible|1
119319|NCT00906945|436996|P3|Overall Study|Found to be not eligible|0
119320|NCT00906945|436997|P2|Overall Study|Found to be not eligible|0
119321|NCT00906945|436998|P1|Overall Study|Found to be not eligible|0
119322|NCT00906698|437058|P6|Overall Study|incl. non compliance, lost to follow-up|0
119323|NCT00906698|437059|P5|Overall Study|incl. non compliance, lost to follow-up|0
119324|NCT00906698|437060|P4|Overall Study|incl. non compliance, lost to follow-up|0
119325|NCT00906698|437061|P3|Overall Study|incl. non compliance, lost to follow-up|0
119326|NCT00906698|437062|P2|Overall Study|incl. non compliance, lost to follow-up|1
119327|NCT00906698|437063|P1|Overall Study|incl. non compliance, lost to follow-up|0
119328|NCT00906698|437058|P6|Overall Study|Withdrawal by Subject|0
119329|NCT00906698|437059|P5|Overall Study|Withdrawal by Subject|1
119330|NCT00906698|437060|P4|Overall Study|Withdrawal by Subject|0
119331|NCT00906698|437061|P3|Overall Study|Withdrawal by Subject|0
119332|NCT00906698|437062|P2|Overall Study|Withdrawal by Subject|0
119333|NCT00906698|437063|P1|Overall Study|Withdrawal by Subject|0
119334|NCT00906698|437058|P6|Overall Study|Disease progression|4
119335|NCT00906698|437059|P5|Overall Study|Disease progression|12
119336|NCT00906698|437060|P4|Overall Study|Disease progression|4
119337|NCT00906698|437061|P3|Overall Study|Disease progression|4
119338|NCT00906698|437062|P2|Overall Study|Disease progression|12
119339|NCT00906698|437063|P1|Overall Study|Disease progression|3
119340|NCT00906698|437058|P6|Overall Study|Adverse Event|1
119341|NCT00906698|437059|P5|Overall Study|Adverse Event|4
119342|NCT00906698|437060|P4|Overall Study|Adverse Event|0
119343|NCT00906698|437061|P3|Overall Study|Adverse Event|2
119344|NCT00906698|437062|P2|Overall Study|Adverse Event|0
119345|NCT00906698|437063|P1|Overall Study|Adverse Event|0
119346|NCT00906698|437058|P6|Overall Study|Dose-limiting toxicity (DLT)|0
119347|NCT00906698|437059|P5|Overall Study|Dose-limiting toxicity (DLT)|1
119348|NCT00906698|437060|P4|Overall Study|Dose-limiting toxicity (DLT)|0
119349|NCT00906698|437061|P3|Overall Study|Dose-limiting toxicity (DLT)|0
119350|NCT00906698|437062|P2|Overall Study|Dose-limiting toxicity (DLT)|6
119351|NCT00906698|437063|P1|Overall Study|Dose-limiting toxicity (DLT)|0
119352|NCT00906399|437165|P7|Year 2|Not specified|0
119353|NCT00906399|437166|P6|Year 2|Not specified|1
119354|NCT00906399|437167|P5|Year 2|Not specified|3
119355|NCT00906399|437168|P4|Year 2|Not specified|2
119356|NCT00906399|437169|P3|Year 2|Not specified|0
119357|NCT00906399|437170|P2|Year 2|Not specified|0
119358|NCT00906399|437171|P1|Year 2|Not specified|0
119359|NCT00906399|437165|P7|Year 2|Death|3
119360|NCT00906399|437166|P6|Year 2|Death|0
119361|NCT00906399|437167|P5|Year 2|Death|0
119362|NCT00906399|437168|P4|Year 2|Death|1
119363|NCT00906399|437169|P3|Year 2|Death|0
119364|NCT00906399|437170|P2|Year 2|Death|0
119365|NCT00906399|437171|P1|Year 2|Death|0
119366|NCT00906399|437165|P7|Year 2|Physician Decision|3
119367|NCT00906399|437166|P6|Year 2|Physician Decision|6
119368|NCT00906399|437167|P5|Year 2|Physician Decision|2
119369|NCT00906399|437168|P4|Year 2|Physician Decision|0
119370|NCT00906399|437169|P3|Year 2|Physician Decision|0
119371|NCT00906399|437170|P2|Year 2|Physician Decision|0
119372|NCT00906399|437171|P1|Year 2|Physician Decision|0
119373|NCT00906399|437165|P7|Year 2|Withdrawal by Subject|13
119374|NCT00906399|437166|P6|Year 2|Withdrawal by Subject|27
119375|NCT00906399|437167|P5|Year 2|Withdrawal by Subject|18
119376|NCT00906399|437168|P4|Year 2|Withdrawal by Subject|17
119377|NCT00906399|437169|P3|Year 2|Withdrawal by Subject|0
119378|NCT00906399|437170|P2|Year 2|Withdrawal by Subject|0
119379|NCT00906399|437171|P1|Year 2|Withdrawal by Subject|0
119380|NCT00906399|437165|P7|Year 2|Lost to Follow-up|4
119381|NCT00906399|437166|P6|Year 2|Lost to Follow-up|2
119382|NCT00906399|437167|P5|Year 2|Lost to Follow-up|4
119383|NCT00906399|437168|P4|Year 2|Lost to Follow-up|1
119384|NCT00906399|437169|P3|Year 2|Lost to Follow-up|0
119385|NCT00906399|437170|P2|Year 2|Lost to Follow-up|0
119386|NCT00906399|437171|P1|Year 2|Lost to Follow-up|0
119387|NCT00906399|437165|P7|Year 2|Adverse Event|6
119388|NCT00906399|437166|P6|Year 2|Adverse Event|11
119389|NCT00906399|437167|P5|Year 2|Adverse Event|8
119390|NCT00906399|437168|P4|Year 2|Adverse Event|9
119391|NCT00906399|437169|P3|Year 2|Adverse Event|0
119392|NCT00906399|437170|P2|Year 2|Adverse Event|0
119393|NCT00906399|437171|P1|Year 2|Adverse Event|0
119394|NCT00906399|437165|P7|Year 1|Not specified|0
119395|NCT00906399|437166|P6|Year 1|Not specified|0
119396|NCT00906399|437167|P5|Year 1|Not specified|0
119397|NCT00906399|437168|P4|Year 1|Not specified|0
119398|NCT00906399|437169|P3|Year 1|Not specified|7
119399|NCT00906399|437170|P2|Year 1|Not specified|2
119400|NCT00906399|437171|P1|Year 1|Not specified|4
119401|NCT00906399|437165|P7|Year 1|Death|0
119402|NCT00906399|437166|P6|Year 1|Death|0
119403|NCT00906399|437167|P5|Year 1|Death|0
119404|NCT00906399|437168|P4|Year 1|Death|0
119408|NCT00906399|437165|P7|Year 1|Physician Decision|0
119409|NCT00906399|437166|P6|Year 1|Physician Decision|0
119410|NCT00906399|437167|P5|Year 1|Physician Decision|0
119411|NCT00906399|437168|P4|Year 1|Physician Decision|0
119412|NCT00906399|437169|P3|Year 1|Physician Decision|3
119413|NCT00906399|437170|P2|Year 1|Physician Decision|1
119414|NCT00906399|437171|P1|Year 1|Physician Decision|0
119415|NCT00906399|437165|P7|Year 1|Withdrawal by Subject|0
119416|NCT00906399|437166|P6|Year 1|Withdrawal by Subject|0
119417|NCT00906399|437167|P5|Year 1|Withdrawal by Subject|0
119418|NCT00906399|437168|P4|Year 1|Withdrawal by Subject|0
119419|NCT00906399|437169|P3|Year 1|Withdrawal by Subject|36
119420|NCT00906399|437170|P2|Year 1|Withdrawal by Subject|32
119421|NCT00906399|437171|P1|Year 1|Withdrawal by Subject|30
119422|NCT00906399|437165|P7|Year 1|Lost to Follow-up|0
119423|NCT00906399|437166|P6|Year 1|Lost to Follow-up|0
119424|NCT00906399|437167|P5|Year 1|Lost to Follow-up|0
119425|NCT00906399|437168|P4|Year 1|Lost to Follow-up|0
119426|NCT00906399|437169|P3|Year 1|Lost to Follow-up|2
119427|NCT00906399|437170|P2|Year 1|Lost to Follow-up|4
119428|NCT00906399|437171|P1|Year 1|Lost to Follow-up|4
119429|NCT00906399|437165|P7|Year 1|Adverse Event|0
119430|NCT00906399|437166|P6|Year 1|Adverse Event|0
119431|NCT00906399|437167|P5|Year 1|Adverse Event|0
119432|NCT00906399|437168|P4|Year 1|Adverse Event|0
119433|NCT00906399|437169|P3|Year 1|Adverse Event|24
119434|NCT00906399|437170|P2|Year 1|Adverse Event|22
119435|NCT00906399|437171|P1|Year 1|Adverse Event|4
119436|NCT00906399|437165|P7|Year 1|Randomized But Not Treated|0
119437|NCT00906399|437166|P6|Year 1|Randomized But Not Treated|0
119438|NCT00906399|437167|P5|Year 1|Randomized But Not Treated|0
119439|NCT00906399|437168|P4|Year 1|Randomized But Not Treated|0
119440|NCT00906399|437169|P3|Year 1|Randomized But Not Treated|3
119441|NCT00906399|437170|P2|Year 1|Randomized But Not Treated|1
119442|NCT00906399|437171|P1|Year 1|Randomized But Not Treated|0
119443|NCT00906347|437194|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
119444|NCT00906347|437195|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
119445|NCT00906347|437194|P2|Received Study Drug|Refused study drug|0
119446|NCT00906347|437195|P1|Received Study Drug|Refused study drug|1
119447|NCT00906347|437194|P2|Received Study Drug|Nonreassuring fetal heart rate|1
119448|NCT00906347|437195|P1|Received Study Drug|Nonreassuring fetal heart rate|13
119449|NCT00906347|437194|P2|Received Study Drug|8 cm prior to initiation of study drug|30
119450|NCT00906347|437195|P1|Received Study Drug|8 cm prior to initiation of study drug|18
119451|NCT00906282|437215|P1|Preoperative Chemotherapy|Toxicity|1
119452|NCT00906282|437215|P1|Preoperative Chemotherapy|Progressive disease|6
119453|NCT00906282|437215|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
119454|NCT00906282|437215|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
119455|NCT00906204|437229|P2|Secondary Endpoints (Long-term Safety)|Death|1
119456|NCT00906204|437230|P1|Secondary Endpoints (Long-term Safety)|Death|0
119457|NCT00906204|437229|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
119458|NCT00906204|437230|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
119459|NCT00906204|437229|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
119460|NCT00906204|437230|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
119461|NCT00906204|437229|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
119462|NCT00906204|437230|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
119463|NCT00906204|437229|P2|Primary Endpoint (Early Safety)|Physician Decision|0
119464|NCT00906204|437230|P1|Primary Endpoint (Early Safety)|Physician Decision|1
119465|NCT00906087|437261|P1|Initial Washout|Physician Decision|1
119466|NCT00906087|437261|P1|Initial Washout|Withdrawal by Subject|1
119467|NCT00906035|437298|P3|Overall Study|Withdrawal by Subject|0
119468|NCT00906035|437299|P2|Overall Study|Withdrawal by Subject|3
119469|NCT00906035|437300|P1|Overall Study|Withdrawal by Subject|2
119470|NCT00905840|437314|P1|Overall Study|Adverse Event|1
119471|NCT00905840|437314|P1|Overall Study|Withdrawal by Subject|1
119472|NCT00905840|437314|P1|Overall Study|Death|3
119473|NCT00905840|437314|P1|Overall Study|Lost to Follow-up|11
119474|NCT00905632|437345|P7|Overall Study|Adverse Event|4
119475|NCT00905632|437346|P6|Overall Study|Adverse Event|1
119476|NCT00905632|437347|P5|Overall Study|Adverse Event|0
119477|NCT00905632|437348|P4|Overall Study|Adverse Event|0
119478|NCT00905632|437349|P3|Overall Study|Adverse Event|0
119479|NCT00905632|437350|P2|Overall Study|Adverse Event|0
119480|NCT00905632|437351|P1|Overall Study|Adverse Event|0
119481|NCT00905606|437489|P2|Washout|Withdrawal by Subject|0
119482|NCT00905606|437490|P1|Washout|Withdrawal by Subject|1
119483|NCT00905606|437489|P2|Period 1|Adverse Event|1
119484|NCT00905606|437490|P1|Period 1|Adverse Event|0
119485|NCT00905567|437515|P2|Washout|Withdrawal by Subject|1
119486|NCT00905567|437516|P1|Washout|Withdrawal by Subject|0
119487|NCT00905489|437548|P1|Optional Extension Phase (OEP)|Adverse Event|1
119488|NCT00905489|437548|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
119489|NCT00905489|437548|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
119490|NCT00905437|437597|P2|Overall Study|Other|6
119491|NCT00905437|437598|P1|Overall Study|Other|5
119492|NCT00905437|437597|P2|Overall Study|Withdrawal by Subject|1
119493|NCT00905437|437598|P1|Overall Study|Withdrawal by Subject|0
119494|NCT00905437|437597|P2|Overall Study|Lost to Follow-up|1
119495|NCT00905437|437598|P1|Overall Study|Lost to Follow-up|0
119496|NCT00905437|437597|P2|Overall Study|Adverse Event|2
119497|NCT00905437|437598|P1|Overall Study|Adverse Event|3
119498|NCT00905424|437618|P2|Overall Study|Non-adherence to visit schedule|1
119499|NCT00905424|437619|P1|Overall Study|Non-adherence to visit schedule|0
119500|NCT00905424|437618|P2|Overall Study|Positive urine drug screen|1
119501|NCT00905424|437619|P1|Overall Study|Positive urine drug screen|0
119502|NCT00905424|437618|P2|Overall Study|Sponsor decision|0
119503|NCT00905424|437619|P1|Overall Study|Sponsor decision|1
119504|NCT00905424|437618|P2|Overall Study|Non-compliance with study medication|0
119505|NCT00905424|437619|P1|Overall Study|Non-compliance with study medication|2
119506|NCT00905424|437618|P2|Overall Study|Adverse Event|2
119507|NCT00905424|437619|P1|Overall Study|Adverse Event|4
119508|NCT00905424|437618|P2|Overall Study|Withdrawal by Subject|2
119509|NCT00905424|437619|P1|Overall Study|Withdrawal by Subject|1
119510|NCT00905424|437618|P2|Overall Study|Lost to Follow-up|3
119511|NCT00905424|437619|P1|Overall Study|Lost to Follow-up|3
119512|NCT00905359|437661|P2|Overall Study|Withdrawal consent|6
119513|NCT00905359|437662|P1|Overall Study|Withdrawal consent|5
119514|NCT00905359|437661|P2|Overall Study|Death|0
119515|NCT00905359|437662|P1|Overall Study|Death|2
119516|NCT00905359|437661|P2|Overall Study|Lost to Follow-up|10
119517|NCT00905359|437662|P1|Overall Study|Lost to Follow-up|17
119518|NCT00905346|437698|P2|Period 1|Withdrawal by Subject|0
119519|NCT00905346|437699|P1|Period 1|Withdrawal by Subject|1
119520|NCT00905307|437713|P6|Overall Study|Lack of Efficacy|8
119521|NCT00905307|437714|P5|Overall Study|Lack of Efficacy|4
119522|NCT00905307|437715|P4|Overall Study|Lack of Efficacy|4
119523|NCT00905307|437716|P3|Overall Study|Lack of Efficacy|5
119524|NCT00905307|437717|P2|Overall Study|Lack of Efficacy|3
119525|NCT00905307|437718|P1|Overall Study|Lack of Efficacy|6
119526|NCT00905307|437713|P6|Overall Study|Protocol Violation|0
119527|NCT00905307|437714|P5|Overall Study|Protocol Violation|0
119528|NCT00905307|437715|P4|Overall Study|Protocol Violation|0
119529|NCT00905307|437716|P3|Overall Study|Protocol Violation|1
119530|NCT00905307|437717|P2|Overall Study|Protocol Violation|0
119531|NCT00905307|437718|P1|Overall Study|Protocol Violation|1
119532|NCT00905307|437713|P6|Overall Study|Withdrawal by Subject|13
119533|NCT00905307|437714|P5|Overall Study|Withdrawal by Subject|4
119534|NCT00905307|437715|P4|Overall Study|Withdrawal by Subject|11
119535|NCT00905307|437716|P3|Overall Study|Withdrawal by Subject|15
119536|NCT00905307|437717|P2|Overall Study|Withdrawal by Subject|13
119537|NCT00905307|437718|P1|Overall Study|Withdrawal by Subject|5
119538|NCT00905307|437713|P6|Overall Study|Adverse Event|5
119539|NCT00905307|437714|P5|Overall Study|Adverse Event|3
119540|NCT00905307|437715|P4|Overall Study|Adverse Event|11
119541|NCT00905307|437716|P3|Overall Study|Adverse Event|5
119542|NCT00905307|437717|P2|Overall Study|Adverse Event|4
119543|NCT00905307|437718|P1|Overall Study|Adverse Event|3
119544|NCT00905307|437713|P6|Overall Study|Lost to Follow-up|1
119545|NCT00905307|437714|P5|Overall Study|Lost to Follow-up|1
119546|NCT00905307|437715|P4|Overall Study|Lost to Follow-up|0
119547|NCT00905307|437716|P3|Overall Study|Lost to Follow-up|0
119548|NCT00905307|437717|P2|Overall Study|Lost to Follow-up|0
119549|NCT00905307|437718|P1|Overall Study|Lost to Follow-up|0
119550|NCT00905307|437713|P6|Overall Study|Switched to Open Label Rescue|15
119551|NCT00905307|437714|P5|Overall Study|Switched to Open Label Rescue|4
119552|NCT00905307|437715|P4|Overall Study|Switched to Open Label Rescue|11
119553|NCT00905307|437716|P3|Overall Study|Switched to Open Label Rescue|11
119554|NCT00905307|437717|P2|Overall Study|Switched to Open Label Rescue|17
119555|NCT00905307|437718|P1|Overall Study|Switched to Open Label Rescue|7
119556|NCT00905255|437813|P2|Overall Study|Familial and Personal Reasons|0
119557|NCT00905255|437814|P1|Overall Study|Familial and Personal Reasons|1
119558|NCT00905255|437813|P2|Overall Study|Withdrawal by Subject|4
119559|NCT00905255|437814|P1|Overall Study|Withdrawal by Subject|5
119560|NCT00905255|437813|P2|Overall Study|Adverse Event|5
119561|NCT00905255|437814|P1|Overall Study|Adverse Event|7
119562|NCT00905164|437832|P2|Period 1|Protocol Violation|1
119563|NCT00905164|437833|P1|Period 1|Protocol Violation|0
119564|NCT00905034|437880|P1|Overall Study|Withdrawal by Subject|1
119565|NCT00905021|437884|P1|Overall Study|Adverse Event|2
119566|NCT00904982|437902|P4|Overall Study|Withdrawal by Subject|0
119567|NCT00904982|437903|P3|Overall Study|Withdrawal by Subject|0
119568|NCT00904982|437904|P2|Overall Study|Withdrawal by Subject|0
119569|NCT00904982|437905|P1|Overall Study|Withdrawal by Subject|2
119570|NCT00904969|437915|P1|Overall Study|Case Aborted; Subject Exited|1
119571|NCT00904969|437915|P1|Overall Study|Additional Treatments|11
119572|NCT00904969|437915|P1|Overall Study|Withdrawal by Subject|3
119573|NCT00904969|437915|P1|Overall Study|Lost to Follow-up|4
119574|NCT00904917|437980|P4|Overall Study|Lost to Follow-up|2
119575|NCT00904917|437981|P3|Overall Study|Lost to Follow-up|2
119576|NCT00904917|437982|P2|Overall Study|Lost to Follow-up|2
119577|NCT00904917|437983|P1|Overall Study|Lost to Follow-up|2
119578|NCT00904839|438001|P3|Overall Study|Other than above|7
119579|NCT00904839|438002|P2|Overall Study|Other than above|9
119580|NCT00904839|438003|P1|Overall Study|Other than above|0
119581|NCT00904839|438001|P3|Overall Study|Not treated|1
119582|NCT00904839|438002|P2|Overall Study|Not treated|0
119583|NCT00904839|438003|P1|Overall Study|Not treated|1
119584|NCT00904839|438001|P3|Overall Study|Withdrawal by Subject|0
119585|NCT00904839|438002|P2|Overall Study|Withdrawal by Subject|2
119586|NCT00904839|438003|P1|Overall Study|Withdrawal by Subject|0
119587|NCT00904839|438001|P3|Overall Study|Lost to Follow-up|2
119588|NCT00904839|438002|P2|Overall Study|Lost to Follow-up|1
119589|NCT00904839|438003|P1|Overall Study|Lost to Follow-up|0
119590|NCT00904839|438001|P3|Overall Study|Protocol Violation|1
119591|NCT00904839|438002|P2|Overall Study|Protocol Violation|1
119592|NCT00904839|438003|P1|Overall Study|Protocol Violation|0
119593|NCT00904839|438001|P3|Overall Study|Adverse Event|4
119594|NCT00904839|438002|P2|Overall Study|Adverse Event|5
119595|NCT00904839|438003|P1|Overall Study|Adverse Event|0
119596|NCT00904748|438049|P6|Overall Study|Adverse Event|0
119597|NCT00904748|438050|P5|Overall Study|Adverse Event|1
119598|NCT00904748|438051|P4|Overall Study|Adverse Event|0
119599|NCT00904748|438052|P3|Overall Study|Adverse Event|0
119600|NCT00904748|438053|P2|Overall Study|Adverse Event|0
119601|NCT00904748|438054|P1|Overall Study|Adverse Event|0
119602|NCT00904748|438049|P6|Overall Study|Withdrawal by Subject|0
119603|NCT00904748|438050|P5|Overall Study|Withdrawal by Subject|0
119604|NCT00904748|438051|P4|Overall Study|Withdrawal by Subject|2
119605|NCT00904748|438052|P3|Overall Study|Withdrawal by Subject|1
119606|NCT00904748|438053|P2|Overall Study|Withdrawal by Subject|1
119607|NCT00904748|438054|P1|Overall Study|Withdrawal by Subject|1
119608|NCT00904722|438078|P1|Overall Study|Physician Decision|1
119609|NCT00904670|438083|P2|Open Label Phase|Lost to Follow-up|0
119610|NCT00904670|438084|P1|Open Label Phase|Lost to Follow-up|1
119611|NCT00904670|438083|P2|Open Label Phase|Lack of Efficacy|0
119612|NCT00904670|438084|P1|Open Label Phase|Lack of Efficacy|1
119613|NCT00904670|438083|P2|Open Label Phase|Adverse Event|0
119614|NCT00904670|438084|P1|Open Label Phase|Adverse Event|2
119615|NCT00904670|438083|P2|Open Label Phase|Withdrawal by Subject|0
119616|NCT00904670|438084|P1|Open Label Phase|Withdrawal by Subject|2
119617|NCT00904371|438154|P1|Overall Study|Continued with Tritace|1
119618|NCT00904371|438154|P1|Overall Study|Discontinued at target blood pressure|2
119619|NCT00904371|438154|P1|Overall Study|Lost to Follow-up|4
119620|NCT00904371|438154|P1|Overall Study|Adverse Event|2
119621|NCT00904215|438168|P1|Overall Study|Other|28
119622|NCT00904215|438168|P1|Overall Study|Withdrawal by Subject|9
119623|NCT00904215|438168|P1|Overall Study|Lost to Follow-up|63
119624|NCT00904215|438168|P1|Overall Study|Protocol Violation|10
119625|NCT00904215|438168|P1|Overall Study|Adverse Event|25
119626|NCT00904150|438182|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
119627|NCT00904150|438183|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
119628|NCT00904150|438182|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
119629|NCT00904150|438183|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
119630|NCT00903968|438212|P8|Overall Study|Lack of Efficacy|3
119631|NCT00903968|438213|P7|Overall Study|Lack of Efficacy|0
119632|NCT00903968|438214|P6|Overall Study|Lack of Efficacy|0
119633|NCT00903968|438215|P5|Overall Study|Lack of Efficacy|0
119634|NCT00903968|438216|P4|Overall Study|Lack of Efficacy|0
119635|NCT00903968|438217|P3|Overall Study|Lack of Efficacy|0
119636|NCT00903968|438218|P2|Overall Study|Lack of Efficacy|0
119637|NCT00903968|438219|P1|Overall Study|Lack of Efficacy|0
119638|NCT00903968|438212|P8|Overall Study|Progressive Disease|18
119639|NCT00903968|438213|P7|Overall Study|Progressive Disease|0
119640|NCT00903968|438214|P6|Overall Study|Progressive Disease|3
119641|NCT00903968|438215|P5|Overall Study|Progressive Disease|3
119642|NCT00903968|438216|P4|Overall Study|Progressive Disease|3
119643|NCT00903968|438217|P3|Overall Study|Progressive Disease|2
119644|NCT00903968|438218|P2|Overall Study|Progressive Disease|3
119645|NCT00903968|438219|P1|Overall Study|Progressive Disease|2
119646|NCT00903968|438212|P8|Overall Study|Physician Decision|0
119647|NCT00903968|438213|P7|Overall Study|Physician Decision|0
119648|NCT00903968|438214|P6|Overall Study|Physician Decision|1
119649|NCT00903968|438215|P5|Overall Study|Physician Decision|0
119650|NCT00903968|438216|P4|Overall Study|Physician Decision|0
119651|NCT00903968|438217|P3|Overall Study|Physician Decision|0
119652|NCT00903968|438218|P2|Overall Study|Physician Decision|0
119653|NCT00903968|438219|P1|Overall Study|Physician Decision|0
119654|NCT00903968|438212|P8|Overall Study|Non-Compliance|0
119655|NCT00903968|438213|P7|Overall Study|Non-Compliance|0
119656|NCT00903968|438214|P6|Overall Study|Non-Compliance|1
119657|NCT00903968|438215|P5|Overall Study|Non-Compliance|0
119658|NCT00903968|438216|P4|Overall Study|Non-Compliance|0
119659|NCT00903968|438217|P3|Overall Study|Non-Compliance|0
119660|NCT00903968|438218|P2|Overall Study|Non-Compliance|0
119661|NCT00903968|438219|P1|Overall Study|Non-Compliance|0
119662|NCT00903968|438212|P8|Overall Study|Withdrawal by Subject|4
119663|NCT00903968|438213|P7|Overall Study|Withdrawal by Subject|0
119664|NCT00903968|438214|P6|Overall Study|Withdrawal by Subject|1
119665|NCT00903968|438215|P5|Overall Study|Withdrawal by Subject|1
119666|NCT00903968|438216|P4|Overall Study|Withdrawal by Subject|0
119667|NCT00903968|438217|P3|Overall Study|Withdrawal by Subject|1
119668|NCT00903968|438218|P2|Overall Study|Withdrawal by Subject|0
119669|NCT00903968|438219|P1|Overall Study|Withdrawal by Subject|1
119670|NCT00903968|438212|P8|Overall Study|DLT|0
119671|NCT00903968|438213|P7|Overall Study|DLT|2
119672|NCT00903968|438214|P6|Overall Study|DLT|0
119673|NCT00903968|438215|P5|Overall Study|DLT|0
119674|NCT00903968|438216|P4|Overall Study|DLT|0
119675|NCT00903968|438217|P3|Overall Study|DLT|0
119676|NCT00903968|438218|P2|Overall Study|DLT|0
119677|NCT00903968|438219|P1|Overall Study|DLT|0
119678|NCT00903968|438212|P8|Overall Study|Adverse Event|8
119679|NCT00903968|438213|P7|Overall Study|Adverse Event|1
119680|NCT00903968|438214|P6|Overall Study|Adverse Event|0
119681|NCT00903968|438215|P5|Overall Study|Adverse Event|0
119682|NCT00903968|438216|P4|Overall Study|Adverse Event|0
119683|NCT00903968|438217|P3|Overall Study|Adverse Event|0
119684|NCT00903968|438218|P2|Overall Study|Adverse Event|0
119685|NCT00903968|438219|P1|Overall Study|Adverse Event|0
119686|NCT00903929|438249|P4|Overall Study|Adverse Event|1
119687|NCT00903929|438250|P3|Overall Study|Adverse Event|0
119688|NCT00903929|438251|P2|Overall Study|Adverse Event|0
119689|NCT00903929|438252|P1|Overall Study|Adverse Event|0
119690|NCT00903929|438249|P4|Overall Study|Withdrawal by Subject|2
119691|NCT00903929|438250|P3|Overall Study|Withdrawal by Subject|1
119692|NCT00903929|438251|P2|Overall Study|Withdrawal by Subject|0
119693|NCT00903929|438252|P1|Overall Study|Withdrawal by Subject|0
119694|NCT00903877|438258|P1|Overall Study|Participation put on hold|4
119695|NCT00903877|438258|P1|Overall Study|Lost to Follow-up|1
119696|NCT00903877|438258|P1|Overall Study|Adverse Event|2
119697|NCT00903877|438258|P1|Overall Study|Withdrawal by Subject|3
119698|NCT00903877|438258|P1|Overall Study|Did not meet study criteria|33
119699|NCT00903695|438264|P2|Overall Study|lung cancer|0
119700|NCT00903695|438265|P1|Overall Study|lung cancer|1
119701|NCT00903695|438264|P2|Overall Study|medical exclusion after 1st testing|0
119702|NCT00903695|438265|P1|Overall Study|medical exclusion after 1st testing|1
119703|NCT00903682|438287|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
119704|NCT00903682|438288|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
119705|NCT00903682|438287|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
119706|NCT00903682|438288|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
119707|NCT00903682|438287|P2|Overall Study|Subject Non-Compliant|0
119708|NCT00903682|438288|P1|Overall Study|Subject Non-Compliant|1
119709|NCT00903682|438287|P2|Overall Study|Subject Reached A Virologic Endpoint|1
119710|NCT00903682|438288|P1|Overall Study|Subject Reached A Virologic Endpoint|1
119711|NCT00903682|438287|P2|Overall Study|Pregnancy|1
119712|NCT00903682|438288|P1|Overall Study|Pregnancy|0
119713|NCT00903682|438287|P2|Overall Study|Withdrawal by Subject|0
119714|NCT00903682|438288|P1|Overall Study|Withdrawal by Subject|5
119715|NCT00903682|438287|P2|Overall Study|Lost to Follow-up|0
119716|NCT00903682|438288|P1|Overall Study|Lost to Follow-up|1
119717|NCT00903682|438287|P2|Overall Study|Adverse Event|13
119718|NCT00903682|438288|P1|Overall Study|Adverse Event|6
119719|NCT00903630|438309|P3|Phase 2|Adverse Event|1
119720|NCT00903630|438310|P2|Phase 2|Adverse Event|0
119721|NCT00903630|438311|P1|Phase 2|Adverse Event|0
119722|NCT00903617|438329|P4|Overall Study|Withdrawal by Subject|0
119723|NCT00903617|438330|P3|Overall Study|Withdrawal by Subject|3
119724|NCT00903617|438331|P2|Overall Study|Withdrawal by Subject|2
119725|NCT00903617|438332|P1|Overall Study|Withdrawal by Subject|1
119726|NCT00903617|438329|P4|Overall Study|Lost to Follow-up|1
119727|NCT00903617|438330|P3|Overall Study|Lost to Follow-up|1
119728|NCT00903617|438331|P2|Overall Study|Lost to Follow-up|0
119729|NCT00903617|438332|P1|Overall Study|Lost to Follow-up|2
119730|NCT00903617|438329|P4|Overall Study|Protocol-defined stopping criteria|0
119731|NCT00903617|438330|P3|Overall Study|Protocol-defined stopping criteria|0
119732|NCT00903617|438331|P2|Overall Study|Protocol-defined stopping criteria|2
119733|NCT00903617|438332|P1|Overall Study|Protocol-defined stopping criteria|0
119734|NCT00903617|438329|P4|Overall Study|Adverse Event|0
119735|NCT00903617|438330|P3|Overall Study|Adverse Event|1
119736|NCT00903617|438331|P2|Overall Study|Adverse Event|1
119737|NCT00903617|438332|P1|Overall Study|Adverse Event|0
119738|NCT00903409|438435|P2|Overall Study|Lost to Follow-up|6
119739|NCT00903409|438436|P1|Overall Study|Lost to Follow-up|2
119740|NCT00903409|438435|P2|Overall Study|Not specified|3
119741|NCT00903409|438436|P1|Overall Study|Not specified|2
119742|NCT00903409|438435|P2|Overall Study|Withdrawal by Subject|8
119743|NCT00903409|438436|P1|Overall Study|Withdrawal by Subject|8
119744|NCT00903409|438435|P2|Overall Study|Laboratory Abnormality|0
119745|NCT00903409|438436|P1|Overall Study|Laboratory Abnormality|2
119746|NCT00903409|438435|P2|Overall Study|Non-compliance with Protocol|1
119747|NCT00903409|438436|P1|Overall Study|Non-compliance with Protocol|1
119748|NCT00903409|438435|P2|Overall Study|Adverse Event|9
119749|NCT00903409|438436|P1|Overall Study|Adverse Event|11
119750|NCT00903383|438487|P4|Overall Study|Patient Decision|1
119751|NCT00903383|438488|P3|Overall Study|Patient Decision|0
119752|NCT00903383|438489|P2|Overall Study|Patient Decision|0
119753|NCT00903383|438490|P1|Overall Study|Patient Decision|0
119754|NCT00903383|438487|P4|Overall Study|Patient Decision - Lack of Efficacy|0
119755|NCT00903383|438488|P3|Overall Study|Patient Decision - Lack of Efficacy|0
119756|NCT00903383|438489|P2|Overall Study|Patient Decision - Lack of Efficacy|1
119757|NCT00903383|438490|P1|Overall Study|Patient Decision - Lack of Efficacy|0
119758|NCT00903383|438487|P4|Overall Study|Withdrawal by Subject|2
119759|NCT00903383|438488|P3|Overall Study|Withdrawal by Subject|0
119760|NCT00903383|438489|P2|Overall Study|Withdrawal by Subject|1
119761|NCT00903383|438490|P1|Overall Study|Withdrawal by Subject|4
119762|NCT00903383|438487|P4|Overall Study|Decision of Sponsor|0
119763|NCT00903383|438488|P3|Overall Study|Decision of Sponsor|0
119764|NCT00903383|438489|P2|Overall Study|Decision of Sponsor|0
119765|NCT00903383|438490|P1|Overall Study|Decision of Sponsor|1
119766|NCT00903383|438487|P4|Overall Study|Lost to Follow-up|1
119767|NCT00903383|438488|P3|Overall Study|Lost to Follow-up|0
119768|NCT00903383|438489|P2|Overall Study|Lost to Follow-up|0
119769|NCT00903383|438490|P1|Overall Study|Lost to Follow-up|0
119770|NCT00903383|438487|P4|Overall Study|Physician Decision|0
119771|NCT00903383|438488|P3|Overall Study|Physician Decision|0
119772|NCT00903383|438489|P2|Overall Study|Physician Decision|2
119773|NCT00903383|438490|P1|Overall Study|Physician Decision|1
119774|NCT00903383|438487|P4|Overall Study|Adverse Event|1
119775|NCT00903383|438488|P3|Overall Study|Adverse Event|3
119776|NCT00903383|438489|P2|Overall Study|Adverse Event|2
119777|NCT00903383|438490|P1|Overall Study|Adverse Event|1
119778|NCT00903370|438522|P2|Overall Study|Lost to Follow-up|8
119779|NCT00903370|438523|P1|Overall Study|Lost to Follow-up|6
119780|NCT00903370|438522|P2|Overall Study|Withdrawal by Subject|6
119781|NCT00903370|438523|P1|Overall Study|Withdrawal by Subject|9
119782|NCT00903370|438522|P2|Overall Study|Death|10
119783|NCT00903370|438523|P1|Overall Study|Death|13
119784|NCT00903357|438531|P2|Second Intervention|Lost to Follow-up|0
119785|NCT00903357|438532|P1|Second Intervention|Lost to Follow-up|1
119786|NCT00903357|438531|P2|Wash Out Period of 2 Weeks|Flu|1
119787|NCT00903357|438532|P1|Wash Out Period of 2 Weeks|Flu|0
119788|NCT00903357|438531|P2|First Intervention|Flu|1
119789|NCT00903357|438532|P1|First Intervention|Flu|0
119790|NCT00903357|438531|P2|First Intervention|Withdrawal by Subject|3
119791|NCT00903357|438532|P1|First Intervention|Withdrawal by Subject|5
119792|NCT00903344|438544|P2|Overall Study|Lost to Follow-up|0
119793|NCT00903344|438545|P1|Overall Study|Lost to Follow-up|3
119794|NCT00903344|438544|P2|Overall Study|Pregnancy|3
119795|NCT00903344|438545|P1|Overall Study|Pregnancy|2
119796|NCT00903331|438563|P2|Overall Study|Lung transplant|2
119797|NCT00903331|438564|P1|Overall Study|Lung transplant|0
119798|NCT00903331|438563|P2|Overall Study|Withdrawal of consent|8
119799|NCT00903331|438564|P1|Overall Study|Withdrawal of consent|1
119800|NCT00903331|438563|P2|Overall Study|Death|8
119801|NCT00903331|438564|P1|Overall Study|Death|4
119802|NCT00903201|438575|P3|Overall Study|Withdrawal by Subject|1
119803|NCT00903201|438576|P2|Overall Study|Withdrawal by Subject|0
119804|NCT00903201|438577|P1|Overall Study|Withdrawal by Subject|1
119805|NCT00903201|438575|P3|Overall Study|Physician Decision|1
119806|NCT00903201|438576|P2|Overall Study|Physician Decision|0
119807|NCT00903201|438577|P1|Overall Study|Physician Decision|1
119808|NCT00903201|438575|P3|Overall Study|Lost to Follow-up|0
119809|NCT00903201|438576|P2|Overall Study|Lost to Follow-up|1
119810|NCT00903201|438577|P1|Overall Study|Lost to Follow-up|0
119811|NCT00903201|438575|P3|Overall Study|Protocol Violation|0
119812|NCT00903201|438576|P2|Overall Study|Protocol Violation|1
119813|NCT00903201|438577|P1|Overall Study|Protocol Violation|2
119814|NCT00903201|438575|P3|Overall Study|Adverse Event|0
119815|NCT00903201|438576|P2|Overall Study|Adverse Event|4
119816|NCT00903201|438577|P1|Overall Study|Adverse Event|1
119817|NCT00903175|438635|P2|Period 2 - Second Line|Death|2
119818|NCT00903175|438636|P1|Period 2 - Second Line|Death|5
119819|NCT00903175|438635|P2|Period 2 - Second Line|Administrative problems|9
119820|NCT00903175|438636|P1|Period 2 - Second Line|Administrative problems|19
119821|NCT00903175|438635|P2|Period 2 - Second Line|Lost to Follow-up|0
119822|NCT00903175|438636|P1|Period 2 - Second Line|Lost to Follow-up|1
119823|NCT00903175|438635|P2|Period 2 - Second Line|Withdrawal by Subject|5
119824|NCT00903175|438636|P1|Period 2 - Second Line|Withdrawal by Subject|7
119825|NCT00903175|438635|P2|Period 2 - Second Line|Adverse Event|20
119826|NCT00903175|438636|P1|Period 2 - Second Line|Adverse Event|16
119827|NCT00903175|438635|P2|Period 2 - Second Line|Missing|0
119828|NCT00903175|438636|P1|Period 2 - Second Line|Missing|1
119829|NCT00903175|438635|P2|Period 1 - First Line|Death|10
119830|NCT00903175|438636|P1|Period 1 - First Line|Death|17
119831|NCT00903175|438635|P2|Period 1 - First Line|Administrative problems|13
119832|NCT00903175|438636|P1|Period 1 - First Line|Administrative problems|12
119833|NCT00903175|438635|P2|Period 1 - First Line|Withdrawal by Subject|12
119834|NCT00903175|438636|P1|Period 1 - First Line|Withdrawal by Subject|8
119835|NCT00903175|438635|P2|Period 1 - First Line|Protocol Violation|3
119836|NCT00903175|438636|P1|Period 1 - First Line|Protocol Violation|3
119837|NCT00903175|438635|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
119838|NCT00903175|438636|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
119839|NCT00903175|438635|P2|Period 1 - First Line|Abnormal lab value(s)|1
119840|NCT00903175|438636|P1|Period 1 - First Line|Abnormal lab value(s)|0
119841|NCT00903175|438635|P2|Period 1 - First Line|Adverse Event|50
119842|NCT00903175|438636|P1|Period 1 - First Line|Adverse Event|36
119843|NCT00903032|438674|P2|Overall Study|Lost to Follow-up|2
119844|NCT00903032|438675|P1|Overall Study|Lost to Follow-up|2
119845|NCT00903032|438674|P2|Overall Study|Withdrawal by Subject|3
119846|NCT00903032|438675|P1|Overall Study|Withdrawal by Subject|5
119847|NCT00903006|438685|P4|Overall Study|Progressive Disease|0
119848|NCT00903006|438686|P3|Overall Study|Progressive Disease|1
119849|NCT00903006|438687|P2|Overall Study|Progressive Disease|3
119850|NCT00903006|438688|P1|Overall Study|Progressive Disease|0
119851|NCT00903006|438685|P4|Overall Study|Withdrawal by Subject|0
119852|NCT00903006|438686|P3|Overall Study|Withdrawal by Subject|0
119853|NCT00903006|438687|P2|Overall Study|Withdrawal by Subject|0
119854|NCT00903006|438688|P1|Overall Study|Withdrawal by Subject|2
119855|NCT00902850|438700|P2|Overall Study|Physician Decision|2
119856|NCT00902850|438701|P1|Overall Study|Physician Decision|2
119857|NCT00902746|438707|P1|Overall Study|Physician Decision|2
119858|NCT00902746|438707|P1|Overall Study|Lost to Follow-up|3
119859|NCT00902746|438707|P1|Overall Study|Adverse Event|8
119860|NCT00902746|438707|P1|Overall Study|Withdrawal by Subject|16
119861|NCT00902746|438707|P1|Overall Study|Protocol Violation|7
119862|NCT00902668|438712|P1|Overall Study|Protocol stopped due to slow accrual.|3
119863|NCT00902564|438716|P1|Overall Study|Withdrawal by Subject|2
119864|NCT00902538|438731|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
119865|NCT00902538|438732|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
119866|NCT00902538|438733|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
119867|NCT00902538|438734|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
119868|NCT00902538|438735|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
119869|NCT00902538|438736|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
119870|NCT00902538|438731|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
119871|NCT00902538|438732|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
119872|NCT00902538|438733|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
119873|NCT00902538|438734|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
119874|NCT00902538|438735|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
119875|NCT00902538|438736|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
119876|NCT00902538|438731|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
119877|NCT00902538|438732|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
119878|NCT00902538|438733|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
119879|NCT00902538|438734|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
119880|NCT00902538|438735|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
119881|NCT00902538|438736|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
119882|NCT00902538|438731|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
119883|NCT00902538|438732|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
119884|NCT00902538|438733|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
119885|NCT00902538|438734|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
119886|NCT00902538|438735|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
119887|NCT00902538|438736|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
119888|NCT00902538|438731|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
119889|NCT00902538|438732|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
119890|NCT00902538|438733|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
119891|NCT00902538|438734|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
119892|NCT00902538|438735|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
119893|NCT00902538|438736|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
119894|NCT00902538|438731|P6|3-Single-blind, Single Treatment|Protocol Violation|0
119895|NCT00902538|438732|P5|3-Single-blind, Single Treatment|Protocol Violation|0
119896|NCT00902538|438733|P4|3-Single-blind, Single Treatment|Protocol Violation|0
119897|NCT00902538|438734|P3|3-Single-blind, Single Treatment|Protocol Violation|0
119898|NCT00902538|438735|P2|3-Single-blind, Single Treatment|Protocol Violation|5
119899|NCT00902538|438736|P1|3-Single-blind, Single Treatment|Protocol Violation|0
119900|NCT00902538|438731|P6|3-Single-blind, Single Treatment|Adverse Event|0
119901|NCT00902538|438732|P5|3-Single-blind, Single Treatment|Adverse Event|0
119902|NCT00902538|438733|P4|3-Single-blind, Single Treatment|Adverse Event|0
119903|NCT00902538|438734|P3|3-Single-blind, Single Treatment|Adverse Event|0
119904|NCT00902538|438735|P2|3-Single-blind, Single Treatment|Adverse Event|5
119905|NCT00902538|438736|P1|3-Single-blind, Single Treatment|Adverse Event|0
119906|NCT00902538|438731|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
119907|NCT00902538|438732|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
119908|NCT00902538|438733|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
119909|NCT00902538|438734|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
119910|NCT00902538|438735|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
119911|NCT00902538|438736|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
119912|NCT00902538|438731|P6|2-Randomized Double-blind 3 Treatments|Other|0
119913|NCT00902538|438732|P5|2-Randomized Double-blind 3 Treatments|Other|0
119914|NCT00902538|438733|P4|2-Randomized Double-blind 3 Treatments|Other|0
119915|NCT00902538|438734|P3|2-Randomized Double-blind 3 Treatments|Other|0
119916|NCT00902538|438735|P2|2-Randomized Double-blind 3 Treatments|Other|1
119917|NCT00902538|438736|P1|2-Randomized Double-blind 3 Treatments|Other|2
119918|NCT00902538|438731|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
119919|NCT00902538|438732|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
119920|NCT00902538|438733|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
119921|NCT00902538|438734|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
119922|NCT00902538|438735|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
119923|NCT00902538|438736|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
119924|NCT00902538|438731|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
119925|NCT00902538|438732|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
119926|NCT00902538|438733|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
119927|NCT00902538|438734|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
119928|NCT00902538|438735|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
119929|NCT00902538|438736|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
119930|NCT00902538|438731|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
119931|NCT00902538|438732|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
119932|NCT00902538|438733|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
119933|NCT00902538|438734|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
119934|NCT00902538|438735|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
119935|NCT00902538|438736|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
119936|NCT00902538|438731|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
119937|NCT00902538|438732|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
119938|NCT00902538|438733|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
119939|NCT00902538|438734|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
119940|NCT00902538|438735|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
119941|NCT00902538|438736|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
119942|NCT00902538|438731|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
119943|NCT00902538|438732|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
119944|NCT00902538|438733|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
119945|NCT00902538|438734|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
119946|NCT00902538|438735|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
119947|NCT00902538|438736|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
119948|NCT00902538|438731|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
119949|NCT00902538|438732|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
119950|NCT00902538|438733|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
119951|NCT00902538|438734|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
119952|NCT00902538|438735|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
119953|NCT00902538|438736|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
119954|NCT00902538|438731|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
119955|NCT00902538|438732|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
119956|NCT00902538|438733|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
119957|NCT00902538|438734|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
119958|NCT00902538|438735|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
119959|NCT00902538|438736|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
119960|NCT00902538|438731|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
119961|NCT00902538|438732|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
119962|NCT00902538|438733|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
119963|NCT00902538|438734|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
119964|NCT00902538|438735|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
119965|NCT00902538|438736|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
119966|NCT00902330|438768|P2|Overall Study|No post baseline data|0
119967|NCT00902330|438769|P1|Overall Study|No post baseline data|1
119968|NCT00902330|438768|P2|Overall Study|Adverse Event|0
119969|NCT00902330|438769|P1|Overall Study|Adverse Event|1
119970|NCT00902330|438768|P2|Overall Study|Too overwhelmed by treatment|5
119971|NCT00902330|438769|P1|Overall Study|Too overwhelmed by treatment|2
119972|NCT00902304|438806|P3|Overall Study|includes pregnancy|2
119973|NCT00902304|438807|P2|Overall Study|includes pregnancy|9
119974|NCT00902304|438808|P1|Overall Study|includes pregnancy|3
119975|NCT00902304|438806|P3|Overall Study|Withdrawal by Subject|43
119976|NCT00902304|438807|P2|Overall Study|Withdrawal by Subject|22
119977|NCT00902304|438808|P1|Overall Study|Withdrawal by Subject|32
119978|NCT00902304|438806|P3|Overall Study|Protocol Violation|20
119979|NCT00902304|438807|P2|Overall Study|Protocol Violation|18
119980|NCT00902304|438808|P1|Overall Study|Protocol Violation|9
119981|NCT00902304|438806|P3|Overall Study|Lost to Follow-up|7
119982|NCT00902304|438807|P2|Overall Study|Lost to Follow-up|7
119983|NCT00902304|438808|P1|Overall Study|Lost to Follow-up|7
119984|NCT00902304|438806|P3|Overall Study|Investigator discretion|13
119985|NCT00902304|438807|P2|Overall Study|Investigator discretion|5
119986|NCT00902304|438808|P1|Overall Study|Investigator discretion|3
119987|NCT00902304|438806|P3|Overall Study|Adverse Event|25
119988|NCT00902304|438807|P2|Overall Study|Adverse Event|10
119989|NCT00902304|438808|P1|Overall Study|Adverse Event|4
119990|NCT00902278|438858|P5|Overall Study|Lost to Follow-up|1
119991|NCT00902278|438859|P4|Overall Study|Lost to Follow-up|0
119992|NCT00902278|438860|P3|Overall Study|Lost to Follow-up|3
119993|NCT00902278|438861|P2|Overall Study|Lost to Follow-up|2
119994|NCT00902278|438862|P1|Overall Study|Lost to Follow-up|3
119995|NCT00902278|438858|P5|Overall Study|Physician Decision|1
119996|NCT00902278|438859|P4|Overall Study|Physician Decision|0
119997|NCT00902278|438860|P3|Overall Study|Physician Decision|2
119998|NCT00902278|438861|P2|Overall Study|Physician Decision|0
119999|NCT00902278|438862|P1|Overall Study|Physician Decision|1
120000|NCT00902265|438879|P1|Overall Study|Protocol Violation|1
120001|NCT00902265|438879|P1|Overall Study|Lack of Efficacy|2
120002|NCT00902265|438879|P1|Overall Study|Adverse Event|2
120003|NCT00902265|438879|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
120004|NCT00902174|438903|P2|Overall Study|Administration problem|1
120005|NCT00902174|438904|P1|Overall Study|Administration problem|0
120006|NCT00902174|438903|P2|Overall Study|Protocol Violation|1
120007|NCT00902174|438904|P1|Overall Study|Protocol Violation|1
120008|NCT00902174|438903|P2|Overall Study|Abnormal labs|1
120009|NCT00902174|438904|P1|Overall Study|Abnormal labs|1
120010|NCT00902174|438903|P2|Overall Study|Withdrawal by Subject|1
120011|NCT00902174|438904|P1|Overall Study|Withdrawal by Subject|2
120012|NCT00902174|438903|P2|Overall Study|Death|2
120013|NCT00902174|438904|P1|Overall Study|Death|2
120014|NCT00902174|438903|P2|Overall Study|Lack of Efficacy|5
120015|NCT00902174|438904|P1|Overall Study|Lack of Efficacy|1
120016|NCT00902174|438903|P2|Overall Study|Adverse Event|7
120017|NCT00902174|438904|P1|Overall Study|Adverse Event|27
120018|NCT00901901|438961|P2|Follow-up Period|Lost to Follow-up|8
120019|NCT00901901|438962|P1|Follow-up Period|Lost to Follow-up|12
120020|NCT00901901|438961|P2|Follow-up Period|Withdrawal by Subject|9
120021|NCT00901901|438962|P1|Follow-up Period|Withdrawal by Subject|6
120022|NCT00901901|438961|P2|Follow-up Period|Protocol driven decision point|35
120023|NCT00901901|438962|P1|Follow-up Period|Protocol driven decision point|47
120024|NCT00901901|438961|P2|Follow-up Period|Death|207
120025|NCT00901901|438962|P1|Follow-up Period|Death|181
120026|NCT00901901|438961|P2|Treatment Period|Never treated|3
120027|NCT00901901|438962|P1|Treatment Period|Never treated|0
120028|NCT00901901|438961|P2|Treatment Period|Missing|1
120029|NCT00901901|438962|P1|Treatment Period|Missing|1
120030|NCT00901901|438961|P2|Treatment Period|Protocol Violation|9
120031|NCT00901901|438962|P1|Treatment Period|Protocol Violation|4
120032|NCT00901901|438961|P2|Treatment Period|Noncompliance with study medication|1
120033|NCT00901901|438962|P1|Treatment Period|Noncompliance with study medication|4
120034|NCT00901901|438961|P2|Treatment Period|Lost to Follow-up|5
120035|NCT00901901|438962|P1|Treatment Period|Lost to Follow-up|3
120036|NCT00901901|438961|P2|Treatment Period|Physician Decision|2
120037|NCT00901901|438962|P1|Treatment Period|Physician Decision|2
120038|NCT00901901|438961|P2|Treatment Period|Withdrawal by Subject|24
120039|NCT00901901|438962|P1|Treatment Period|Withdrawal by Subject|26
120040|NCT00901901|438961|P2|Treatment Period|Adverse Event|123
120041|NCT00901901|438962|P1|Treatment Period|Adverse Event|117
120042|NCT00901628|438984|P2|Overall Study|peroneal nerve palsy|1
120043|NCT00901628|438985|P1|Overall Study|peroneal nerve palsy|0
120044|NCT00901628|438984|P2|Overall Study|disconnection of drain|1
120045|NCT00901628|438985|P1|Overall Study|disconnection of drain|0
120046|NCT00901628|438984|P2|Overall Study|disconnection of catheter|8
120047|NCT00901628|438985|P1|Overall Study|disconnection of catheter|4
120048|NCT00901576|439007|P6|Second Intervention|Physician Decision|0
120049|NCT00901576|439008|P5|Second Intervention|Physician Decision|0
120050|NCT00901576|439009|P4|Second Intervention|Physician Decision|0
120051|NCT00901576|439010|P3|Second Intervention|Physician Decision|0
120052|NCT00901576|439011|P2|Second Intervention|Physician Decision|0
120053|NCT00901576|439012|P1|Second Intervention|Physician Decision|1
120054|NCT00901576|439007|P6|Second Intervention|Withdrawal by Subject|1
120055|NCT00901576|439008|P5|Second Intervention|Withdrawal by Subject|0
120056|NCT00901576|439009|P4|Second Intervention|Withdrawal by Subject|1
120057|NCT00901576|439010|P3|Second Intervention|Withdrawal by Subject|0
120058|NCT00901576|439011|P2|Second Intervention|Withdrawal by Subject|0
120059|NCT00901576|439012|P1|Second Intervention|Withdrawal by Subject|0
120060|NCT00901459|439033|P1|Overall Study|Withdrawal by Subject|6
120061|NCT00901342|439044|P1|Overall Study|Withdrawal by Subject|9
120062|NCT00901342|439044|P1|Overall Study|Disease progression|1
120063|NCT00901342|439044|P1|Overall Study|Death|4
120064|NCT00901342|439044|P1|Overall Study|Adverse Event|1
120065|NCT00901186|439068|P2|Overall Study|Protocol deviations|4
120066|NCT00901186|439069|P1|Overall Study|Protocol deviations|5
120067|NCT00901186|439068|P2|Overall Study|Administration problems|1
120068|NCT00901186|439069|P1|Overall Study|Administration problems|0
120069|NCT00901186|439068|P2|Overall Study|Adverse Event|4
120070|NCT00901186|439069|P1|Overall Study|Adverse Event|2
120071|NCT00901186|439068|P2|Overall Study|Lost to Follow-up|0
120072|NCT00901186|439069|P1|Overall Study|Lost to Follow-up|2
120073|NCT00901186|439068|P2|Overall Study|Abnormal laboratory values|1
120074|NCT00901186|439069|P1|Overall Study|Abnormal laboratory values|0
120075|NCT00901186|439068|P2|Overall Study|Lack of Efficacy|1
120076|NCT00901186|439069|P1|Overall Study|Lack of Efficacy|0
120077|NCT00900796|439109|P1|Phase 2|Lost to Follow-up|5
120078|NCT00900796|439109|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
120079|NCT00900796|439109|P1|Phase 1|Missing information at Week 16|7
120080|NCT00900796|439109|P1|Phase 1|Lacked sufficient information|4
120081|NCT00900757|439119|P1|Overall Study|screen failure|19
120082|NCT00900731|439129|P2|Overall Study|Death|2
120083|NCT00900731|439130|P1|Overall Study|Death|0
120084|NCT00900731|439129|P2|Overall Study|Lack of Efficacy|3
120085|NCT00900731|439130|P1|Overall Study|Lack of Efficacy|1
120086|NCT00900731|439129|P2|Overall Study|Lost to Follow-up|3
120087|NCT00900731|439130|P1|Overall Study|Lost to Follow-up|2
120088|NCT00900731|439129|P2|Overall Study|Abnormal Laboratory Value(s)|4
120089|NCT00900731|439130|P1|Overall Study|Abnormal Laboratory Value(s)|2
120090|NCT00900731|439129|P2|Overall Study|Abnormal Test Procedure Result(s)|0
120091|NCT00900731|439130|P1|Overall Study|Abnormal Test Procedure Result(s)|3
120092|NCT00900731|439129|P2|Overall Study|Administrative Problems|4
120093|NCT00900731|439130|P1|Overall Study|Administrative Problems|5
120094|NCT00900731|439129|P2|Overall Study|Protocol Deviation|11
120095|NCT00900731|439130|P1|Overall Study|Protocol Deviation|8
120096|NCT00900731|439129|P2|Overall Study|Withdrawal by Subject|7
120097|NCT00900731|439130|P1|Overall Study|Withdrawal by Subject|8
120098|NCT00900731|439129|P2|Overall Study|Adverse Event|27
120099|NCT00900731|439130|P1|Overall Study|Adverse Event|31
120100|NCT00900627|439167|P6|Overall Study|Death|24
120101|NCT00900627|439168|P5|Overall Study|Death|28
120102|NCT00900627|439169|P4|Overall Study|Death|0
120103|NCT00900627|439170|P3|Overall Study|Death|0
120104|NCT00900627|439171|P2|Overall Study|Death|0
120105|NCT00900627|439172|P1|Overall Study|Death|0
120106|NCT00900627|439167|P6|Overall Study|Adverse Event|0
120107|NCT00900627|439168|P5|Overall Study|Adverse Event|0
120108|NCT00900627|439169|P4|Overall Study|Adverse Event|3
120109|NCT00900627|439170|P3|Overall Study|Adverse Event|0
120110|NCT00900627|439171|P2|Overall Study|Adverse Event|2
120111|NCT00900627|439172|P1|Overall Study|Adverse Event|1
120112|NCT00900627|439167|P6|Overall Study|Withdrawal by Subject|2
120113|NCT00900627|439168|P5|Overall Study|Withdrawal by Subject|1
120114|NCT00900627|439169|P4|Overall Study|Withdrawal by Subject|0
120115|NCT00900627|439170|P3|Overall Study|Withdrawal by Subject|1
120116|NCT00900627|439171|P2|Overall Study|Withdrawal by Subject|0
120117|NCT00900627|439172|P1|Overall Study|Withdrawal by Subject|1
120118|NCT00900627|439167|P6|Overall Study|Condition under investigation worsened|0
120119|NCT00900627|439168|P5|Overall Study|Condition under investigation worsened|0
120120|NCT00900627|439169|P4|Overall Study|Condition under investigation worsened|3
120121|NCT00900627|439170|P3|Overall Study|Condition under investigation worsened|5
120122|NCT00900627|439171|P2|Overall Study|Condition under investigation worsened|0
120123|NCT00900627|439172|P1|Overall Study|Condition under investigation worsened|4
120124|NCT00900601|439190|P1|Overall Study|Physician Decision|1
120125|NCT00900159|439209|P2|Second Intervention|disempanelled for inappropriate behavior|0
120126|NCT00900159|439210|P1|Second Intervention|disempanelled for inappropriate behavior|1
120127|NCT00900146|439229|P5|Intermediate: Period III|Administrative problems|163
120128|NCT00900146|439230|P4|Intermediate: Period III|Administrative problems|90
120129|NCT00900146|439231|P3|Intermediate: Period III|Administrative problems|84
120130|NCT00900146|439232|P2|Intermediate: Period III|Administrative problems|92
120131|NCT00900146|439233|P1|Intermediate: Period III|Administrative problems|85
120132|NCT00900146|439229|P5|Intermediate: Period III|Lost to Follow-up|1
120133|NCT00900146|439230|P4|Intermediate: Period III|Lost to Follow-up|0
120134|NCT00900146|439231|P3|Intermediate: Period III|Lost to Follow-up|0
120135|NCT00900146|439232|P2|Intermediate: Period III|Lost to Follow-up|0
120136|NCT00900146|439233|P1|Intermediate: Period III|Lost to Follow-up|2
120137|NCT00900146|439229|P5|Intermediate: Period III|Withdrawal by Subject|3
120138|NCT00900146|439230|P4|Intermediate: Period III|Withdrawal by Subject|0
120139|NCT00900146|439231|P3|Intermediate: Period III|Withdrawal by Subject|0
120140|NCT00900146|439232|P2|Intermediate: Period III|Withdrawal by Subject|1
120141|NCT00900146|439233|P1|Intermediate: Period III|Withdrawal by Subject|0
120142|NCT00900146|439229|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
120143|NCT00900146|439230|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
120144|NCT00900146|439231|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
120145|NCT00900146|439232|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
120146|NCT00900146|439233|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
120147|NCT00900146|439229|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
120148|NCT00900146|439230|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
120149|NCT00900146|439231|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
120150|NCT00900146|439232|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
120151|NCT00900146|439233|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
120152|NCT00900146|439229|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
120153|NCT00900146|439230|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
120154|NCT00900146|439231|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
120155|NCT00900146|439232|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
120156|NCT00900146|439233|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
120157|NCT00900029|439350|P5|Overall Study|Death|0
120158|NCT00900029|439351|P4|Overall Study|Death|1
120159|NCT00900029|439352|P3|Overall Study|Death|0
120160|NCT00900029|439353|P2|Overall Study|Death|0
120161|NCT00900029|439354|P1|Overall Study|Death|1
120162|NCT00900029|439350|P5|Overall Study|Adverse Event|1
120163|NCT00900029|439351|P4|Overall Study|Adverse Event|1
120164|NCT00900029|439352|P3|Overall Study|Adverse Event|1
120165|NCT00900029|439353|P2|Overall Study|Adverse Event|0
120166|NCT00900029|439354|P1|Overall Study|Adverse Event|0
120167|NCT00900029|439350|P5|Overall Study|Withdrawal by Subject|1
120168|NCT00900029|439351|P4|Overall Study|Withdrawal by Subject|1
120169|NCT00900029|439352|P3|Overall Study|Withdrawal by Subject|1
120170|NCT00900029|439353|P2|Overall Study|Withdrawal by Subject|2
120171|NCT00900029|439354|P1|Overall Study|Withdrawal by Subject|2
120172|NCT00900029|439350|P5|Overall Study|Lost to Follow-up|4
120173|NCT00900029|439351|P4|Overall Study|Lost to Follow-up|4
120174|NCT00900029|439352|P3|Overall Study|Lost to Follow-up|1
120175|NCT00900029|439353|P2|Overall Study|Lost to Follow-up|2
120176|NCT00900029|439354|P1|Overall Study|Lost to Follow-up|0
120177|NCT00899847|439371|P1|Overall Study|Lack of suitable allogeneic donor|2
120178|NCT00899678|439402|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
120179|NCT00899678|439403|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
120180|NCT00899678|439404|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
120181|NCT00899678|439402|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
120182|NCT00899678|439403|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
120183|NCT00899678|439404|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
120184|NCT00899678|439402|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
120185|NCT00899678|439403|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
120186|NCT00899678|439404|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
120187|NCT00899678|439402|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
120188|NCT00899678|439403|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
120189|NCT00899678|439404|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
120190|NCT00899678|439402|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
120191|NCT00899678|439403|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
120192|NCT00899678|439404|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
120193|NCT00899678|439402|P3|Induction Period (Weeks 0 to 6)|Other reason|0
120194|NCT00899678|439403|P2|Induction Period (Weeks 0 to 6)|Other reason|0
120195|NCT00899678|439404|P1|Induction Period (Weeks 0 to 6)|Other reason|1
120196|NCT00899678|439402|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
120197|NCT00899678|439403|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
120198|NCT00899678|439404|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
120199|NCT00899678|439402|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
120200|NCT00899678|439403|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
120201|NCT00899678|439404|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
120202|NCT00899678|439402|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
120203|NCT00899678|439403|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
120204|NCT00899678|439404|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
120205|NCT00899392|439527|P2|Overall Study|Subject didn't finish/partial pilot data|24
120206|NCT00899392|439528|P1|Overall Study|Subject didn't finish/partial pilot data|21
120207|NCT00899379|439545|P5|Overall Study|Inc/Exc Criteria Not Met|0
120208|NCT00899379|439546|P4|Overall Study|Inc/Exc Criteria Not Met|0
120209|NCT00899379|439547|P3|Overall Study|Inc/Exc Criteria Not Met|1
120210|NCT00899379|439548|P2|Overall Study|Inc/Exc Criteria Not Met|0
120211|NCT00899379|439549|P1|Overall Study|Inc/Exc Criteria Not Met|0
120212|NCT00899379|439545|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
120213|NCT00899379|439546|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
120214|NCT00899379|439547|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
120215|NCT00899379|439548|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
120216|NCT00899379|439549|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
120217|NCT00899379|439545|P5|Overall Study|No Attack Pretreatment|4
120218|NCT00899379|439546|P4|Overall Study|No Attack Pretreatment|6
120219|NCT00899379|439547|P3|Overall Study|No Attack Pretreatment|5
120220|NCT00899379|439548|P2|Overall Study|No Attack Pretreatment|5
120221|NCT00899379|439549|P1|Overall Study|No Attack Pretreatment|3
120222|NCT00899379|439545|P5|Overall Study|Abnormal Baseline ECG|0
120223|NCT00899379|439546|P4|Overall Study|Abnormal Baseline ECG|1
120224|NCT00899379|439547|P3|Overall Study|Abnormal Baseline ECG|1
120225|NCT00899379|439548|P2|Overall Study|Abnormal Baseline ECG|0
120226|NCT00899379|439549|P1|Overall Study|Abnormal Baseline ECG|0
120227|NCT00899379|439545|P5|Overall Study|Abnormal Prestudy Labs|2
120228|NCT00899379|439546|P4|Overall Study|Abnormal Prestudy Labs|0
120229|NCT00899379|439547|P3|Overall Study|Abnormal Prestudy Labs|0
120230|NCT00899379|439548|P2|Overall Study|Abnormal Prestudy Labs|0
120231|NCT00899379|439549|P1|Overall Study|Abnormal Prestudy Labs|0
120232|NCT00899379|439545|P5|Overall Study|Patient Uncooperative|0
120233|NCT00899379|439546|P4|Overall Study|Patient Uncooperative|1
120234|NCT00899379|439547|P3|Overall Study|Patient Uncooperative|0
120235|NCT00899379|439548|P2|Overall Study|Patient Uncooperative|0
120236|NCT00899379|439549|P1|Overall Study|Patient Uncooperative|0
120237|NCT00899379|439545|P5|Overall Study|Pregnancy|0
120238|NCT00899379|439546|P4|Overall Study|Pregnancy|0
120239|NCT00899379|439547|P3|Overall Study|Pregnancy|0
120240|NCT00899379|439548|P2|Overall Study|Pregnancy|0
120241|NCT00899379|439549|P1|Overall Study|Pregnancy|1
120242|NCT00899379|439545|P5|Overall Study|Withdrawal by Subject|2
120243|NCT00899379|439546|P4|Overall Study|Withdrawal by Subject|7
120244|NCT00899379|439547|P3|Overall Study|Withdrawal by Subject|4
120245|NCT00899379|439548|P2|Overall Study|Withdrawal by Subject|7
120246|NCT00899379|439549|P1|Overall Study|Withdrawal by Subject|4
120247|NCT00899379|439545|P5|Overall Study|Lost to Follow-up|5
120248|NCT00899379|439546|P4|Overall Study|Lost to Follow-up|2
120249|NCT00899379|439547|P3|Overall Study|Lost to Follow-up|0
120250|NCT00899379|439548|P2|Overall Study|Lost to Follow-up|1
120251|NCT00899379|439549|P1|Overall Study|Lost to Follow-up|3
120252|NCT00899379|439545|P5|Overall Study|Study Terminated|1
120253|NCT00899379|439546|P4|Overall Study|Study Terminated|3
120254|NCT00899379|439547|P3|Overall Study|Study Terminated|3
120255|NCT00899379|439548|P2|Overall Study|Study Terminated|0
120256|NCT00899379|439549|P1|Overall Study|Study Terminated|3
120257|NCT00899379|439545|P5|Overall Study|Not Completed/Entered Extn|3
120258|NCT00899379|439546|P4|Overall Study|Not Completed/Entered Extn|4
120259|NCT00899379|439547|P3|Overall Study|Not Completed/Entered Extn|6
120260|NCT00899379|439548|P2|Overall Study|Not Completed/Entered Extn|1
120261|NCT00899379|439549|P1|Overall Study|Not Completed/Entered Extn|5
120262|NCT00899379|439545|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
120263|NCT00899379|439546|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
120264|NCT00899379|439547|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
120265|NCT00899379|439548|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
120266|NCT00899379|439549|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
120267|NCT00899379|439545|P5|Overall Study|Abnormal Baseline ECG|0
120268|NCT00899379|439546|P4|Overall Study|Abnormal Baseline ECG|1
120269|NCT00899379|439547|P3|Overall Study|Abnormal Baseline ECG|0
120270|NCT00899379|439548|P2|Overall Study|Abnormal Baseline ECG|0
120271|NCT00899379|439549|P1|Overall Study|Abnormal Baseline ECG|0
120272|NCT00899379|439545|P5|Overall Study|Patient Uncooperative|2
120273|NCT00899379|439546|P4|Overall Study|Patient Uncooperative|1
120274|NCT00899379|439547|P3|Overall Study|Patient Uncooperative|0
120275|NCT00899379|439548|P2|Overall Study|Patient Uncooperative|1
120276|NCT00899379|439549|P1|Overall Study|Patient Uncooperative|0
120277|NCT00899379|439545|P5|Overall Study|Pregnancy|1
120278|NCT00899379|439546|P4|Overall Study|Pregnancy|0
120279|NCT00899379|439547|P3|Overall Study|Pregnancy|1
120280|NCT00899379|439548|P2|Overall Study|Pregnancy|0
120281|NCT00899379|439549|P1|Overall Study|Pregnancy|0
120282|NCT00899379|439545|P5|Overall Study|Withdrawal by Subject|6
120283|NCT00899379|439546|P4|Overall Study|Withdrawal by Subject|3
120284|NCT00899379|439547|P3|Overall Study|Withdrawal by Subject|2
120285|NCT00899379|439548|P2|Overall Study|Withdrawal by Subject|4
120286|NCT00899379|439549|P1|Overall Study|Withdrawal by Subject|2
120287|NCT00899379|439545|P5|Overall Study|Protocol Violation|0
120288|NCT00899379|439546|P4|Overall Study|Protocol Violation|1
120289|NCT00899379|439547|P3|Overall Study|Protocol Violation|1
120290|NCT00899379|439548|P2|Overall Study|Protocol Violation|0
120291|NCT00899379|439549|P1|Overall Study|Protocol Violation|0
120292|NCT00899379|439545|P5|Overall Study|Lost to Follow-up|2
120293|NCT00899379|439546|P4|Overall Study|Lost to Follow-up|6
120294|NCT00899379|439547|P3|Overall Study|Lost to Follow-up|0
120295|NCT00899379|439548|P2|Overall Study|Lost to Follow-up|3
120296|NCT00899379|439549|P1|Overall Study|Lost to Follow-up|9
120297|NCT00899379|439545|P5|Overall Study|Lack of Efficacy|1
120298|NCT00899379|439546|P4|Overall Study|Lack of Efficacy|0
120299|NCT00899379|439547|P3|Overall Study|Lack of Efficacy|3
120300|NCT00899379|439548|P2|Overall Study|Lack of Efficacy|4
120301|NCT00899379|439549|P1|Overall Study|Lack of Efficacy|0
120302|NCT00899379|439545|P5|Overall Study|Adverse Event|2
120303|NCT00899379|439546|P4|Overall Study|Adverse Event|1
120304|NCT00899379|439547|P3|Overall Study|Adverse Event|1
120305|NCT00899379|439548|P2|Overall Study|Adverse Event|2
120306|NCT00899379|439549|P1|Overall Study|Adverse Event|2
120307|NCT00899353|439561|P1|Overall Study|Withdrawal by Subject|2
120308|NCT00899353|439561|P1|Overall Study|Lost to Follow-up|1
120309|NCT00899353|439561|P1|Overall Study|Adverse Event|2
120310|NCT00898807|439597|P2|Overall Study|Death|1
120311|NCT00898807|439598|P1|Overall Study|Death|0
120312|NCT00898807|439597|P2|Overall Study|Lost to Follow-up|3
120313|NCT00898807|439598|P1|Overall Study|Lost to Follow-up|1
120314|NCT00898807|439597|P2|Overall Study|Family pressure to discontinue|2
120315|NCT00898807|439598|P1|Overall Study|Family pressure to discontinue|2
120316|NCT00898807|439597|P2|Overall Study|Withdrawal by Subject|3
120317|NCT00898807|439598|P1|Overall Study|Withdrawal by Subject|5
120318|NCT00898677|439614|P4|Overall Study|Not Treated: Other (Not Specified)|0
120319|NCT00898677|439615|P3|Overall Study|Not Treated: Other (Not Specified)|2
120320|NCT00898677|439616|P2|Overall Study|Not Treated: Other (Not Specified)|0
120321|NCT00898677|439617|P1|Overall Study|Not Treated: Other (Not Specified)|0
120322|NCT00898677|439614|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
120323|NCT00898677|439615|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
120324|NCT00898677|439616|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
120325|NCT00898677|439617|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
120326|NCT00898677|439614|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
120327|NCT00898677|439615|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
120328|NCT00898677|439616|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
120329|NCT00898677|439617|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
120330|NCT00898677|439614|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
120331|NCT00898677|439615|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
120332|NCT00898677|439616|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
120333|NCT00898677|439617|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
120334|NCT00898677|439614|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
120335|NCT00898677|439615|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
120336|NCT00898677|439616|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
120337|NCT00898677|439617|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
120338|NCT00898677|439614|P4|Overall Study|Not Treated: Patient uncooperative|0
120339|NCT00898677|439615|P3|Overall Study|Not Treated: Patient uncooperative|1
120340|NCT00898677|439616|P2|Overall Study|Not Treated: Patient uncooperative|3
120341|NCT00898677|439617|P1|Overall Study|Not Treated: Patient uncooperative|2
120342|NCT00898677|439614|P4|Overall Study|Not Treated: Withdraw by Subject|3
120343|NCT00898677|439615|P3|Overall Study|Not Treated: Withdraw by Subject|11
120344|NCT00898677|439616|P2|Overall Study|Not Treated: Withdraw by Subject|16
120345|NCT00898677|439617|P1|Overall Study|Not Treated: Withdraw by Subject|2
120346|NCT00898677|439614|P4|Overall Study|Not Treated: Protocol Violation|0
120347|NCT00898677|439615|P3|Overall Study|Not Treated: Protocol Violation|2
120348|NCT00898677|439616|P2|Overall Study|Not Treated: Protocol Violation|0
120349|NCT00898677|439617|P1|Overall Study|Not Treated: Protocol Violation|2
120350|NCT00898677|439614|P4|Overall Study|Not Treated: Pregnancy|0
120351|NCT00898677|439615|P3|Overall Study|Not Treated: Pregnancy|1
120352|NCT00898677|439616|P2|Overall Study|Not Treated: Pregnancy|0
120353|NCT00898677|439617|P1|Overall Study|Not Treated: Pregnancy|0
120354|NCT00898677|439614|P4|Overall Study|Not Treated: Lost to Follow-Up|2
120355|NCT00898677|439615|P3|Overall Study|Not Treated: Lost to Follow-Up|5
120356|NCT00898677|439616|P2|Overall Study|Not Treated: Lost to Follow-Up|5
120357|NCT00898677|439617|P1|Overall Study|Not Treated: Lost to Follow-Up|0
120358|NCT00898677|439614|P4|Overall Study|Not Treated: Adverse Event|0
120359|NCT00898677|439615|P3|Overall Study|Not Treated: Adverse Event|1
120360|NCT00898677|439616|P2|Overall Study|Not Treated: Adverse Event|2
120361|NCT00898677|439617|P1|Overall Study|Not Treated: Adverse Event|0
120362|NCT00898677|439614|P4|Overall Study|Withdrawal by Subject|1
120363|NCT00898677|439615|P3|Overall Study|Withdrawal by Subject|0
120364|NCT00898677|439616|P2|Overall Study|Withdrawal by Subject|0
120365|NCT00898677|439617|P1|Overall Study|Withdrawal by Subject|0
120366|NCT00898677|439614|P4|Overall Study|Protocol Violation|0
120367|NCT00898677|439615|P3|Overall Study|Protocol Violation|2
120368|NCT00898677|439616|P2|Overall Study|Protocol Violation|1
120369|NCT00898677|439617|P1|Overall Study|Protocol Violation|1
120370|NCT00898677|439614|P4|Overall Study|Lost to Follow-up|0
120371|NCT00898677|439615|P3|Overall Study|Lost to Follow-up|2
120372|NCT00898677|439616|P2|Overall Study|Lost to Follow-up|0
120373|NCT00898677|439617|P1|Overall Study|Lost to Follow-up|0
120374|NCT00898677|439614|P4|Overall Study|Adverse Event|0
120375|NCT00898677|439615|P3|Overall Study|Adverse Event|1
120376|NCT00898677|439616|P2|Overall Study|Adverse Event|0
120377|NCT00898677|439617|P1|Overall Study|Adverse Event|0
120378|NCT00898443|439655|P2|Overall Study|Withdrawal by Subject|0
120379|NCT00898443|439656|P1|Overall Study|Withdrawal by Subject|1
120380|NCT00897949|439671|P3|Overall Study|Did not take study drug|4
120381|NCT00897949|439672|P2|Overall Study|Did not take study drug|3
120382|NCT00897949|439673|P1|Overall Study|Did not take study drug|9
120383|NCT00897949|439671|P3|Overall Study|Lack of Migraine Attack|19
120384|NCT00897949|439672|P2|Overall Study|Lack of Migraine Attack|30
120385|NCT00897949|439673|P1|Overall Study|Lack of Migraine Attack|29
120386|NCT00897949|439671|P3|Overall Study|Need for Concom. Med.|1
120387|NCT00897949|439672|P2|Overall Study|Need for Concom. Med.|1
120388|NCT00897949|439673|P1|Overall Study|Need for Concom. Med.|0
120389|NCT00897949|439671|P3|Overall Study|Abnormal Baseline ECG|4
120390|NCT00897949|439672|P2|Overall Study|Abnormal Baseline ECG|2
120391|NCT00897949|439673|P1|Overall Study|Abnormal Baseline ECG|2
120392|NCT00897949|439671|P3|Overall Study|Abnormal Prestudy Labs|4
120393|NCT00897949|439672|P2|Overall Study|Abnormal Prestudy Labs|3
120394|NCT00897949|439673|P1|Overall Study|Abnormal Prestudy Labs|2
120395|NCT00897949|439671|P3|Overall Study|Withdrawal by Subject|17
120396|NCT00897949|439672|P2|Overall Study|Withdrawal by Subject|31
120397|NCT00897949|439673|P1|Overall Study|Withdrawal by Subject|24
120398|NCT00897949|439671|P3|Overall Study|Lost to Follow-up|17
120399|NCT00897949|439672|P2|Overall Study|Lost to Follow-up|23
120400|NCT00897949|439673|P1|Overall Study|Lost to Follow-up|30
120401|NCT00897949|439671|P3|Overall Study|Patient Uncoorperative|1
120402|NCT00897949|439672|P2|Overall Study|Patient Uncoorperative|2
120403|NCT00897949|439673|P1|Overall Study|Patient Uncoorperative|0
120404|NCT00897949|439671|P3|Overall Study|Withdrawal by Subject|0
120405|NCT00897949|439672|P2|Overall Study|Withdrawal by Subject|2
120406|NCT00897949|439673|P1|Overall Study|Withdrawal by Subject|1
120407|NCT00897949|439671|P3|Overall Study|Protocol Violation|1
120408|NCT00897949|439672|P2|Overall Study|Protocol Violation|3
120409|NCT00897949|439673|P1|Overall Study|Protocol Violation|6
120410|NCT00897949|439671|P3|Overall Study|Lost to Follow-up|1
120411|NCT00897949|439672|P2|Overall Study|Lost to Follow-up|2
120412|NCT00897949|439673|P1|Overall Study|Lost to Follow-up|0
120413|NCT00897949|439671|P3|Overall Study|Adverse Event|0
120414|NCT00897949|439672|P2|Overall Study|Adverse Event|1
120415|NCT00897949|439673|P1|Overall Study|Adverse Event|1
120416|NCT00897715|439707|P2|Overall Study|increased risk of infection|0
120417|NCT00897715|439708|P1|Overall Study|increased risk of infection|1
120418|NCT00897715|439707|P2|Overall Study|Physician Decision|0
120419|NCT00897715|439708|P1|Overall Study|Physician Decision|1
120420|NCT00897715|439707|P2|Overall Study|Lost to Follow-up|1
120421|NCT00897715|439708|P1|Overall Study|Lost to Follow-up|0
120422|NCT00897390|439733|P1|Overall Study|Did not Return for the Clinic Visit|2
120423|NCT00897390|439733|P1|Overall Study|Personal Reasons|1
120424|NCT00897390|439733|P1|Overall Study|No Longer Met Study Criteria|1
120425|NCT00897390|439733|P1|Overall Study|Adverse Event|2
120426|NCT00897104|439823|P3|Overall Study|Withdrawal by Subject|1
120427|NCT00897104|439824|P2|Overall Study|Withdrawal by Subject|0
120428|NCT00897104|439825|P1|Overall Study|Withdrawal by Subject|0
120429|NCT00897104|439823|P3|Overall Study|Protocol Violation|0
120430|NCT00897104|439824|P2|Overall Study|Protocol Violation|0
120431|NCT00897104|439825|P1|Overall Study|Protocol Violation|1
120432|NCT00897104|439823|P3|Overall Study|Not Specified|0
120433|NCT00897104|439824|P2|Overall Study|Not Specified|0
120434|NCT00897104|439825|P1|Overall Study|Not Specified|3
120435|NCT00897104|439823|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
120436|NCT00897104|439824|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
120437|NCT00897104|439825|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
120438|NCT00897104|439823|P3|Overall Study|Lack of Migraine Attack|1
120439|NCT00897104|439824|P2|Overall Study|Lack of Migraine Attack|22
120440|NCT00897104|439825|P1|Overall Study|Lack of Migraine Attack|20
120441|NCT00897104|439823|P3|Overall Study|Need for Concom. Med.|1
120442|NCT00897104|439824|P2|Overall Study|Need for Concom. Med.|1
120443|NCT00897104|439825|P1|Overall Study|Need for Concom. Med.|0
120444|NCT00897104|439823|P3|Overall Study|Abnormal Baseline ECG|0
120445|NCT00897104|439824|P2|Overall Study|Abnormal Baseline ECG|2
120446|NCT00897104|439825|P1|Overall Study|Abnormal Baseline ECG|2
120447|NCT00897104|439823|P3|Overall Study|Abnormal Prestudy Labs|0
120448|NCT00897104|439824|P2|Overall Study|Abnormal Prestudy Labs|0
120449|NCT00897104|439825|P1|Overall Study|Abnormal Prestudy Labs|2
120450|NCT00897104|439823|P3|Overall Study|Withdrawal by Subject|3
120451|NCT00897104|439824|P2|Overall Study|Withdrawal by Subject|27
120452|NCT00897104|439825|P1|Overall Study|Withdrawal by Subject|23
120453|NCT00897104|439823|P3|Overall Study|Protocol Violation|0
120454|NCT00897104|439824|P2|Overall Study|Protocol Violation|1
120455|NCT00897104|439825|P1|Overall Study|Protocol Violation|0
120456|NCT00897104|439823|P3|Overall Study|Pregnancy|0
120457|NCT00897104|439824|P2|Overall Study|Pregnancy|1
120458|NCT00897104|439825|P1|Overall Study|Pregnancy|0
120459|NCT00897104|439823|P3|Overall Study|Lost to Follow-up|2
120460|NCT00897104|439824|P2|Overall Study|Lost to Follow-up|17
120461|NCT00897104|439825|P1|Overall Study|Lost to Follow-up|12
120462|NCT00896649|439860|P1|Overall Study|technical difficulties|2
120463|NCT00896649|439860|P1|Overall Study|missing documentation|1
120464|NCT00896649|439860|P1|Overall Study|Pregnancy|1
120465|NCT00896649|439860|P1|Overall Study|Physician Decision|1
120466|NCT00896454|439865|P1|Overall Study|Withdrawal by Subject|1
120467|NCT00896454|439865|P1|Overall Study|Ongoing in study|2
120468|NCT00896454|439865|P1|Overall Study|Requirement for alternative therapy|3
120469|NCT00896454|439865|P1|Overall Study|Other|4
120470|NCT00896454|439865|P1|Overall Study|Disease Progression|5
120471|NCT00896454|439865|P1|Overall Study|Adverse Event|8
120472|NCT00896454|439865|P1|Overall Study|Death|10
120473|NCT00896363|439904|P3|Overall Study|Withdrawal by Subject|5
120474|NCT00896363|439905|P2|Overall Study|Withdrawal by Subject|5
120475|NCT00896363|439906|P1|Overall Study|Withdrawal by Subject|3
120476|NCT00896363|439904|P3|Overall Study|Lack of Efficacy|1
120477|NCT00896363|439905|P2|Overall Study|Lack of Efficacy|2
120478|NCT00896363|439906|P1|Overall Study|Lack of Efficacy|0
120479|NCT00896363|439904|P3|Overall Study|Adverse Event|2
120480|NCT00896363|439905|P2|Overall Study|Adverse Event|4
120481|NCT00896363|439906|P1|Overall Study|Adverse Event|3
120482|NCT00896337|439958|P1|Overall Study|Lost to Follow-up|11
120483|NCT00896337|439958|P1|Overall Study|Withdrawal by Subject|7
120484|NCT00896337|439958|P1|Overall Study|Death|7
120485|NCT00896233|440025|P1|Overall Study|Claustrophobia during MRI|1
120486|NCT00896168|440038|P2|Overall Study|Other|1
120487|NCT00896168|440039|P1|Overall Study|Other|1
120488|NCT00896168|440038|P2|Overall Study|Lost to Follow-up|1
120489|NCT00896168|440039|P1|Overall Study|Lost to Follow-up|1
120490|NCT00896168|440038|P2|Overall Study|Treatment failure|10
120491|NCT00896168|440039|P1|Overall Study|Treatment failure|8
120492|NCT00896168|440038|P2|Overall Study|Adverse Event|7
120493|NCT00896168|440039|P1|Overall Study|Adverse Event|4
120494|NCT00896051|440100|P2|Overall Study|Not specified|1
120495|NCT00896051|440101|P1|Overall Study|Not specified|1
120496|NCT00896051|440100|P2|Overall Study|Subject noncompliant|3
120497|NCT00896051|440101|P1|Overall Study|Subject noncompliant|1
120498|NCT00896051|440100|P2|Overall Study|Withdrawal by Subject|2
120499|NCT00896051|440101|P1|Overall Study|Withdrawal by Subject|3
120500|NCT00896051|440100|P2|Overall Study|Lost to Follow-up|2
120501|NCT00896051|440101|P1|Overall Study|Lost to Follow-up|3
120502|NCT00896051|440100|P2|Overall Study|Adverse Event|1
120503|NCT00896051|440101|P1|Overall Study|Adverse Event|2
120504|NCT00895947|440188|P2|Overall Study|Withdrawal by Subject|0
120505|NCT00895947|440189|P1|Overall Study|Withdrawal by Subject|2
120506|NCT00895947|440188|P2|Overall Study|Protocol Violation|2
120507|NCT00895947|440189|P1|Overall Study|Protocol Violation|4
120508|NCT00895947|440188|P2|Overall Study|Lost to Follow-up|4
120509|NCT00895947|440189|P1|Overall Study|Lost to Follow-up|3
120510|NCT00895947|440188|P2|Overall Study|Adverse Event|4
120511|NCT00895947|440189|P1|Overall Study|Adverse Event|3
120512|NCT00895934|440207|P2|Overall Study|ineligible|0
120513|NCT00895934|440208|P1|Overall Study|ineligible|1
120514|NCT00895934|440207|P2|Overall Study|Death|1
120515|NCT00895934|440208|P1|Overall Study|Death|0
120516|NCT00895934|440207|P2|Overall Study|Lack of Efficacy|24
120517|NCT00895934|440208|P1|Overall Study|Lack of Efficacy|5
120518|NCT00895895|440219|P5|Period 2|unsatisfactory response-efficacy|0
120519|NCT00895895|440220|P4|Period 2|unsatisfactory response-efficacy|0
120520|NCT00895895|440221|P3|Period 2|unsatisfactory response-efficacy|0
120521|NCT00895895|440222|P2|Period 2|unsatisfactory response-efficacy|1
120522|NCT00895895|440223|P1|Period 2|unsatisfactory response-efficacy|2
120523|NCT00895895|440219|P5|Period 2|Withdrawal by Subject|5
120524|NCT00895895|440220|P4|Period 2|Withdrawal by Subject|3
120525|NCT00895895|440221|P3|Period 2|Withdrawal by Subject|0
120526|NCT00895895|440222|P2|Period 2|Withdrawal by Subject|2
120527|NCT00895895|440223|P1|Period 2|Withdrawal by Subject|0
120528|NCT00895895|440219|P5|Period 2|Protocol Violation|1
120529|NCT00895895|440220|P4|Period 2|Protocol Violation|1
120530|NCT00895895|440221|P3|Period 2|Protocol Violation|1
120531|NCT00895895|440222|P2|Period 2|Protocol Violation|0
120532|NCT00895895|440223|P1|Period 2|Protocol Violation|1
120533|NCT00895895|440219|P5|Period 2|Other|1
120534|NCT00895895|440220|P4|Period 2|Other|1
120535|NCT00895895|440221|P3|Period 2|Other|3
120536|NCT00895895|440222|P2|Period 2|Other|1
120537|NCT00895895|440223|P1|Period 2|Other|1
120538|NCT00895895|440219|P5|Period 2|Lost to Follow-up|0
120539|NCT00895895|440220|P4|Period 2|Lost to Follow-up|1
120540|NCT00895895|440221|P3|Period 2|Lost to Follow-up|1
120541|NCT00895895|440222|P2|Period 2|Lost to Follow-up|2
120542|NCT00895895|440223|P1|Period 2|Lost to Follow-up|1
120543|NCT00895895|440219|P5|Period 2|investigator request|0
120544|NCT00895895|440220|P4|Period 2|investigator request|0
120545|NCT00895895|440221|P3|Period 2|investigator request|0
120546|NCT00895895|440222|P2|Period 2|investigator request|0
120547|NCT00895895|440223|P1|Period 2|investigator request|2
120548|NCT00895895|440219|P5|Period 2|failed to return|0
120549|NCT00895895|440220|P4|Period 2|failed to return|0
120550|NCT00895895|440221|P3|Period 2|failed to return|0
120551|NCT00895895|440222|P2|Period 2|failed to return|0
120552|NCT00895895|440223|P1|Period 2|failed to return|2
120553|NCT00895895|440219|P5|Period 2|discontinued by sponsor|37
120554|NCT00895895|440220|P4|Period 2|discontinued by sponsor|46
120555|NCT00895895|440221|P3|Period 2|discontinued by sponsor|38
120556|NCT00895895|440222|P2|Period 2|discontinued by sponsor|44
120557|NCT00895895|440223|P1|Period 2|discontinued by sponsor|44
120558|NCT00895895|440219|P5|Period 2|Death|0
120559|NCT00895895|440220|P4|Period 2|Death|0
120560|NCT00895895|440221|P3|Period 2|Death|1
120561|NCT00895895|440222|P2|Period 2|Death|0
120562|NCT00895895|440223|P1|Period 2|Death|0
120563|NCT00895895|440219|P5|Period 2|Adverse Event|5
120564|NCT00895895|440220|P4|Period 2|Adverse Event|2
120565|NCT00895895|440221|P3|Period 2|Adverse Event|5
120566|NCT00895895|440222|P2|Period 2|Adverse Event|3
120567|NCT00895895|440223|P1|Period 2|Adverse Event|3
120568|NCT00895895|440219|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
120569|NCT00895895|440220|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
120570|NCT00895895|440221|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
120571|NCT00895895|440222|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
120572|NCT00895895|440223|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
120573|NCT00895895|440219|P5|After Period 1, Prior to Period 2|Protocol Violation|1
120574|NCT00895895|440220|P4|After Period 1, Prior to Period 2|Protocol Violation|0
120575|NCT00895895|440221|P3|After Period 1, Prior to Period 2|Protocol Violation|0
120576|NCT00895895|440222|P2|After Period 1, Prior to Period 2|Protocol Violation|0
120577|NCT00895895|440223|P1|After Period 1, Prior to Period 2|Protocol Violation|0
120578|NCT00895895|440219|P5|After Period 1, Prior to Period 2|Other|0
120579|NCT00895895|440220|P4|After Period 1, Prior to Period 2|Other|0
120580|NCT00895895|440221|P3|After Period 1, Prior to Period 2|Other|1
120581|NCT00895895|440222|P2|After Period 1, Prior to Period 2|Other|0
120582|NCT00895895|440223|P1|After Period 1, Prior to Period 2|Other|0
120583|NCT00895895|440219|P5|After Period 1, Prior to Period 2|Adverse Event|0
120584|NCT00895895|440220|P4|After Period 1, Prior to Period 2|Adverse Event|0
120585|NCT00895895|440221|P3|After Period 1, Prior to Period 2|Adverse Event|1
120586|NCT00895895|440222|P2|After Period 1, Prior to Period 2|Adverse Event|0
120587|NCT00895895|440223|P1|After Period 1, Prior to Period 2|Adverse Event|0
120588|NCT00895895|440219|P5|Period 1|randomized and not treated|2
120589|NCT00895895|440220|P4|Period 1|randomized and not treated|1
120590|NCT00895895|440221|P3|Period 1|randomized and not treated|1
120591|NCT00895895|440222|P2|Period 1|randomized and not treated|3
120592|NCT00895895|440223|P1|Period 1|randomized and not treated|1
120593|NCT00895895|440219|P5|Period 1|unsatisfactory response-efficacy|0
120594|NCT00895895|440220|P4|Period 1|unsatisfactory response-efficacy|0
120595|NCT00895895|440221|P3|Period 1|unsatisfactory response-efficacy|0
120596|NCT00895895|440222|P2|Period 1|unsatisfactory response-efficacy|0
120597|NCT00895895|440223|P1|Period 1|unsatisfactory response-efficacy|2
120598|NCT00895895|440219|P5|Period 1|Withdrawal by Subject|4
120599|NCT00895895|440220|P4|Period 1|Withdrawal by Subject|2
120600|NCT00895895|440221|P3|Period 1|Withdrawal by Subject|8
120601|NCT00895895|440222|P2|Period 1|Withdrawal by Subject|6
120602|NCT00895895|440223|P1|Period 1|Withdrawal by Subject|6
120603|NCT00895895|440219|P5|Period 1|Protocol Violation|0
120604|NCT00895895|440220|P4|Period 1|Protocol Violation|0
120605|NCT00895895|440221|P3|Period 1|Protocol Violation|0
120606|NCT00895895|440222|P2|Period 1|Protocol Violation|1
120607|NCT00895895|440223|P1|Period 1|Protocol Violation|0
120608|NCT00895895|440219|P5|Period 1|Other|1
120609|NCT00895895|440220|P4|Period 1|Other|1
120610|NCT00895895|440221|P3|Period 1|Other|1
120611|NCT00895895|440222|P2|Period 1|Other|2
120612|NCT00895895|440223|P1|Period 1|Other|1
120613|NCT00895895|440219|P5|Period 1|Lost to Follow-up|3
120614|NCT00895895|440220|P4|Period 1|Lost to Follow-up|2
120615|NCT00895895|440221|P3|Period 1|Lost to Follow-up|3
120616|NCT00895895|440222|P2|Period 1|Lost to Follow-up|1
120617|NCT00895895|440223|P1|Period 1|Lost to Follow-up|2
120618|NCT00895895|440219|P5|Period 1|investigator request|0
120619|NCT00895895|440220|P4|Period 1|investigator request|0
120620|NCT00895895|440221|P3|Period 1|investigator request|0
120621|NCT00895895|440222|P2|Period 1|investigator request|1
120622|NCT00895895|440223|P1|Period 1|investigator request|0
120623|NCT00895895|440219|P5|Period 1|failed to return|1
120624|NCT00895895|440220|P4|Period 1|failed to return|0
120625|NCT00895895|440221|P3|Period 1|failed to return|1
120626|NCT00895895|440222|P2|Period 1|failed to return|0
120627|NCT00895895|440223|P1|Period 1|failed to return|0
120628|NCT00895895|440219|P5|Period 1|discontinued by sponsor|1
120629|NCT00895895|440220|P4|Period 1|discontinued by sponsor|1
120630|NCT00895895|440221|P3|Period 1|discontinued by sponsor|2
120631|NCT00895895|440222|P2|Period 1|discontinued by sponsor|1
120632|NCT00895895|440223|P1|Period 1|discontinued by sponsor|2
120633|NCT00895895|440219|P5|Period 1|Death|1
120634|NCT00895895|440220|P4|Period 1|Death|0
120635|NCT00895895|440221|P3|Period 1|Death|0
120636|NCT00895895|440222|P2|Period 1|Death|0
120637|NCT00895895|440223|P1|Period 1|Death|0
120638|NCT00895895|440219|P5|Period 1|Adverse Event|7
120639|NCT00895895|440220|P4|Period 1|Adverse Event|6
120640|NCT00895895|440221|P3|Period 1|Adverse Event|4
120641|NCT00895895|440222|P2|Period 1|Adverse Event|6
120642|NCT00895895|440223|P1|Period 1|Adverse Event|7
120643|NCT00895843|440337|P2|Overall Study|Protocol Violation|12
120644|NCT00895843|440338|P1|Overall Study|Protocol Violation|12
120645|NCT00895661|440385|P1|Overall Study|reason unknown|2
120646|NCT00895661|440385|P1|Overall Study|Death|1
120647|NCT00895622|440395|P3|Overall Study|Protocol Violation|4
120648|NCT00895622|440396|P2|Overall Study|Protocol Violation|4
120649|NCT00895622|440397|P1|Overall Study|Protocol Violation|5
120650|NCT00895583|440420|P2|Overall Study|Not specified|1
120651|NCT00895583|440421|P1|Overall Study|Not specified|0
120652|NCT00895583|440420|P2|Overall Study|Lack of Efficacy|0
120653|NCT00895583|440421|P1|Overall Study|Lack of Efficacy|5
120654|NCT00895583|440420|P2|Overall Study|Withdrawal by Subject|2
120655|NCT00895583|440421|P1|Overall Study|Withdrawal by Subject|4
120656|NCT00895583|440420|P2|Overall Study|Protocol Violation|0
120657|NCT00895583|440421|P1|Overall Study|Protocol Violation|1
120658|NCT00895583|440420|P2|Overall Study|Lost to Follow-up|3
120659|NCT00895583|440421|P1|Overall Study|Lost to Follow-up|1
120660|NCT00895583|440420|P2|Overall Study|Physician Decision|1
120661|NCT00895583|440421|P1|Overall Study|Physician Decision|3
120662|NCT00895583|440420|P2|Overall Study|Death|1
120663|NCT00895583|440421|P1|Overall Study|Death|2
120664|NCT00895583|440420|P2|Overall Study|Adverse Event|4
120665|NCT00895583|440421|P1|Overall Study|Adverse Event|28
120666|NCT00895453|440511|P3|Overall Study|Lost to Follow-up|23
120667|NCT00895453|440512|P2|Overall Study|Lost to Follow-up|25
120668|NCT00895453|440513|P1|Overall Study|Lost to Follow-up|25
120669|NCT00895310|440521|P1|Overall Study|Withdrawal by Subject|1
120670|NCT00895245|440537|P1|Overall Study|Lack of Efficacy|6
120671|NCT00895011|440616|P3|Overall Study|schedule conflict|0
120672|NCT00895011|440617|P2|Overall Study|schedule conflict|0
120673|NCT00895011|440618|P1|Overall Study|schedule conflict|1
120674|NCT00895011|440616|P3|Overall Study|Adverse Event|2
120675|NCT00895011|440617|P2|Overall Study|Adverse Event|2
120676|NCT00895011|440618|P1|Overall Study|Adverse Event|1
120677|NCT00895011|440616|P3|Overall Study|Protocol Violation|3
120678|NCT00895011|440617|P2|Overall Study|Protocol Violation|1
120679|NCT00895011|440618|P1|Overall Study|Protocol Violation|3
120680|NCT00895011|440616|P3|Overall Study|Lost to Follow-up|1
120681|NCT00895011|440617|P2|Overall Study|Lost to Follow-up|4
120682|NCT00895011|440618|P1|Overall Study|Lost to Follow-up|5
120683|NCT00895011|440616|P3|Overall Study|Withdrawal by Subject|2
120684|NCT00895011|440617|P2|Overall Study|Withdrawal by Subject|7
120685|NCT00895011|440618|P1|Overall Study|Withdrawal by Subject|14
120686|NCT00894933|440632|P1|Overall Study|Did not meeting incl/excl criteria|1
120687|NCT00894933|440632|P1|Overall Study|Cancelled Procedure|1
120688|NCT00894933|440632|P1|Overall Study|Lost to Follow-up|2
120689|NCT00894803|440650|P2|Overall Study|Lost to Follow-up|1
120690|NCT00894803|440651|P1|Overall Study|Lost to Follow-up|0
120691|NCT00894803|440650|P2|Overall Study|Death|4
120692|NCT00894803|440651|P1|Overall Study|Death|20
120693|NCT00894790|440687|P2|Overall Study|Did not meet entrance criteria|0
120694|NCT00894790|440688|P1|Overall Study|Did not meet entrance criteria|1
120695|NCT00894790|440687|P2|Overall Study|Lost to Follow-up|1
120696|NCT00894790|440688|P1|Overall Study|Lost to Follow-up|0
120697|NCT00894790|440687|P2|Overall Study|Protocol Violation|1
120698|NCT00894790|440688|P1|Overall Study|Protocol Violation|0
120699|NCT00894647|440721|P2|Overall Study|Other, not due to AE|2
120700|NCT00894647|440722|P1|Overall Study|Other, not due to AE|1
120701|NCT00894647|440721|P2|Overall Study|Non-compliance with study procedures|2
120702|NCT00894647|440722|P1|Overall Study|Non-compliance with study procedures|0
120703|NCT00894647|440721|P2|Overall Study|Lost to Follow-up|2
120704|NCT00894647|440722|P1|Overall Study|Lost to Follow-up|0
120705|NCT00894647|440721|P2|Overall Study|Withdrawal by Subject|4
120706|NCT00894647|440722|P1|Overall Study|Withdrawal by Subject|4
120707|NCT00894647|440721|P2|Overall Study|Adverse Event|4
120708|NCT00894647|440722|P1|Overall Study|Adverse Event|5
120709|NCT00894556|440735|P4|Treatment Phase|Lack of Qualifying Event|0
120710|NCT00894556|440736|P3|Treatment Phase|Lack of Qualifying Event|0
120711|NCT00894556|440737|P2|Treatment Phase|Lack of Qualifying Event|1
120712|NCT00894556|440738|P1|Treatment Phase|Lack of Qualifying Event|2
120713|NCT00894556|440735|P4|Treatment Phase|Lost to Follow-up|0
120714|NCT00894556|440736|P3|Treatment Phase|Lost to Follow-up|1
120715|NCT00894556|440737|P2|Treatment Phase|Lost to Follow-up|3
120716|NCT00894556|440738|P1|Treatment Phase|Lost to Follow-up|2
120717|NCT00894556|440735|P4|Baseline Phase|Did not meet Randomization Criteria|85
120718|NCT00894556|440736|P3|Baseline Phase|Did not meet Randomization Criteria|0
120719|NCT00894556|440737|P2|Baseline Phase|Did not meet Randomization Criteria|0
120720|NCT00894556|440738|P1|Baseline Phase|Did not meet Randomization Criteria|0
120721|NCT00894543|440749|P2|Week 4 to Week 8|No diary or lost or withdrew|2
120722|NCT00894543|440750|P1|Week 4 to Week 8|No diary or lost or withdrew|4
120723|NCT00894543|440749|P2|Baseline to Week 4|No diary or lost or withdrew|2
120724|NCT00894543|440750|P1|Baseline to Week 4|No diary or lost or withdrew|3
120725|NCT00894387|440816|P2|Overall Study|GCP non-compliance|2
120726|NCT00894387|440817|P1|Overall Study|GCP non-compliance|0
120727|NCT00894387|440816|P2|Overall Study|Mis-randomized|9
120728|NCT00894387|440817|P1|Overall Study|Mis-randomized|13
120729|NCT00894387|440816|P2|Overall Study|Other (Missing)|3
120730|NCT00894387|440817|P1|Overall Study|Other (Missing)|5
120731|NCT00894387|440816|P2|Overall Study|Patient's request|30
120732|NCT00894387|440817|P1|Overall Study|Patient's request|25
120733|NCT00894387|440816|P2|Overall Study|Protocol Deviation|0
120734|NCT00894387|440817|P1|Overall Study|Protocol Deviation|4
120735|NCT00894387|440816|P2|Overall Study|Death|76
120736|NCT00894387|440817|P1|Overall Study|Death|77
120737|NCT00894387|440816|P2|Overall Study|Administrative problems|2
120738|NCT00894387|440817|P1|Overall Study|Administrative problems|2
120739|NCT00894387|440816|P2|Overall Study|Lost to Follow-up|5
120740|NCT00894387|440817|P1|Overall Study|Lost to Follow-up|3
120741|NCT00894387|440816|P2|Overall Study|Unsatisfactory therapeutic effect|1
120742|NCT00894387|440817|P1|Overall Study|Unsatisfactory therapeutic effect|0
120743|NCT00894387|440816|P2|Overall Study|Abnormal Laboratory values|2
120744|NCT00894387|440817|P1|Overall Study|Abnormal Laboratory values|2
120745|NCT00894387|440816|P2|Overall Study|Adverse Event|45
120746|NCT00894387|440817|P1|Overall Study|Adverse Event|44
120747|NCT00894361|440837|P2|Overall Study|deaths and less than 2 yr followup|64
120748|NCT00894361|440838|P1|Overall Study|deaths and less than 2 yr followup|24
120749|NCT00894322|440847|P3|Overall Study|Withdrawal by Subject|0
120750|NCT00894322|440848|P2|Overall Study|Withdrawal by Subject|0
120751|NCT00894322|440849|P1|Overall Study|Withdrawal by Subject|1
120752|NCT00894166|440900|P8|Overall Study|Death|0
120753|NCT00894166|440901|P7|Overall Study|Death|0
120754|NCT00894166|440902|P6|Overall Study|Death|0
120755|NCT00894166|440903|P5|Overall Study|Death|0
120756|NCT00894166|440904|P4|Overall Study|Death|1
120757|NCT00894166|440905|P3|Overall Study|Death|0
120758|NCT00894166|440906|P2|Overall Study|Death|0
120759|NCT00894166|440907|P1|Overall Study|Death|0
120760|NCT00894166|440900|P8|Overall Study|Withdrew or Lost to Follow-Up|34
120761|NCT00894166|440901|P7|Overall Study|Withdrew or Lost to Follow-Up|16
120762|NCT00894166|440902|P6|Overall Study|Withdrew or Lost to Follow-Up|16
120763|NCT00894166|440903|P5|Overall Study|Withdrew or Lost to Follow-Up|24
120764|NCT00894166|440904|P4|Overall Study|Withdrew or Lost to Follow-Up|68
120765|NCT00894166|440905|P3|Overall Study|Withdrew or Lost to Follow-Up|62
120766|NCT00894166|440906|P2|Overall Study|Withdrew or Lost to Follow-Up|63
120767|NCT00894166|440907|P1|Overall Study|Withdrew or Lost to Follow-Up|61
120768|NCT00893971|440946|P1|Overall Study|Physician Decision|3
120769|NCT00893789|441064|P4|Overall Study|Lost to Follow-up|1
120770|NCT00893789|441065|P3|Overall Study|Lost to Follow-up|0
120771|NCT00893789|441066|P2|Overall Study|Lost to Follow-up|0
120772|NCT00893789|441067|P1|Overall Study|Lost to Follow-up|0
120773|NCT00893789|441064|P4|Overall Study|Protocol Violation|4
120774|NCT00893789|441065|P3|Overall Study|Protocol Violation|1
120775|NCT00893789|441066|P2|Overall Study|Protocol Violation|1
120776|NCT00893789|441067|P1|Overall Study|Protocol Violation|0
120777|NCT00893789|441064|P4|Overall Study|Adverse Event|5
120778|NCT00893789|441065|P3|Overall Study|Adverse Event|1
120779|NCT00893789|441066|P2|Overall Study|Adverse Event|2
120780|NCT00893789|441067|P1|Overall Study|Adverse Event|0
120781|NCT00893789|441064|P4|Overall Study|Taking Excluded Concomitant Medication|0
120782|NCT00893789|441065|P3|Overall Study|Taking Excluded Concomitant Medication|1
120783|NCT00893789|441066|P2|Overall Study|Taking Excluded Concomitant Medication|0
120784|NCT00893789|441067|P1|Overall Study|Taking Excluded Concomitant Medication|1
120785|NCT00893789|441064|P4|Overall Study|Noncompliance With Study Procedures|0
120786|NCT00893789|441065|P3|Overall Study|Noncompliance With Study Procedures|0
120787|NCT00893789|441066|P2|Overall Study|Noncompliance With Study Procedures|0
120788|NCT00893789|441067|P1|Overall Study|Noncompliance With Study Procedures|1
120789|NCT00893789|441064|P4|Overall Study|Noncompliance With Study Drug|2
120790|NCT00893789|441065|P3|Overall Study|Noncompliance With Study Drug|1
120791|NCT00893789|441066|P2|Overall Study|Noncompliance With Study Drug|0
120792|NCT00893789|441067|P1|Overall Study|Noncompliance With Study Drug|1
120793|NCT00893789|441064|P4|Overall Study|Withdrawal by Subject|1
120794|NCT00893789|441065|P3|Overall Study|Withdrawal by Subject|3
120795|NCT00893789|441066|P2|Overall Study|Withdrawal by Subject|1
120796|NCT00893789|441067|P1|Overall Study|Withdrawal by Subject|3
120797|NCT00893763|441151|P2|Overall Study|extubated|110
120798|NCT00893763|441152|P1|Overall Study|extubated|110
120799|NCT00893737|441160|P1|Overall Study|Lost to Follow-up|6
120800|NCT00893737|441160|P1|Overall Study|Withdrawal by Subject|2
120801|NCT00893737|441160|P1|Overall Study|Adverse Event|4
120802|NCT00893464|441174|P8|Overall Study|Did not complete therapy/experience PD|2
120803|NCT00893464|441175|P7|Overall Study|Did not complete therapy/experience PD|2
120804|NCT00893464|441176|P6|Overall Study|Did not complete therapy/experience PD|0
120805|NCT00893464|441177|P5|Overall Study|Did not complete therapy/experience PD|0
120806|NCT00893464|441178|P4|Overall Study|Did not complete therapy/experience PD|0
120807|NCT00893464|441179|P3|Overall Study|Did not complete therapy/experience PD|0
120808|NCT00893464|441180|P2|Overall Study|Did not complete therapy/experience PD|0
120809|NCT00893464|441181|P1|Overall Study|Did not complete therapy/experience PD|0
120810|NCT00893113|441308|P2|Overall Study|Withdrew Consent|7
120811|NCT00893113|441309|P1|Overall Study|Withdrew Consent|8
120812|NCT00893113|441308|P2|Overall Study|Early Termination|1
120813|NCT00893113|441309|P1|Overall Study|Early Termination|1
120814|NCT00893113|441308|P2|Overall Study|Lost to Follow-up|8
120815|NCT00893113|441309|P1|Overall Study|Lost to Follow-up|4
120816|NCT00892957|441339|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
120817|NCT00892957|441340|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
120818|NCT00892957|441339|P2|Between Postoperative Day 1 and Day 14|Death|2
120819|NCT00892957|441340|P1|Between Postoperative Day 1 and Day 14|Death|0
120820|NCT00892775|441428|P2|Overall Study|Lost to Follow-up|0
120821|NCT00892775|441429|P1|Overall Study|Lost to Follow-up|1
120822|NCT00892775|441428|P2|Overall Study|Withdrawal by Subject|1
120823|NCT00892775|441429|P1|Overall Study|Withdrawal by Subject|0
120824|NCT00892775|441428|P2|Overall Study|Migrated/ moved from study area|0
120825|NCT00892775|441429|P1|Overall Study|Migrated/ moved from study area|1
120826|NCT00892775|441428|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
120827|NCT00892775|441429|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
120828|NCT00892775|441428|P2|Overall Study|Subject difficulties with blood drawing|0
120829|NCT00892775|441429|P1|Overall Study|Subject difficulties with blood drawing|1
120830|NCT00892775|441428|P2|Overall Study|Protocol Violation|0
120831|NCT00892775|441429|P1|Overall Study|Protocol Violation|1
120832|NCT00892723|441456|P3|Overall Study|Withdrawal by Subject|1
120833|NCT00892723|441457|P2|Overall Study|Withdrawal by Subject|1
120834|NCT00892723|441458|P1|Overall Study|Withdrawal by Subject|1
120835|NCT00892723|441456|P3|Overall Study|Lost to Follow-up|1
120836|NCT00892723|441457|P2|Overall Study|Lost to Follow-up|3
120837|NCT00892723|441458|P1|Overall Study|Lost to Follow-up|1
120838|NCT00892437|441547|P2|Open-Label Extension Phase|Withdrew Consent|1
120839|NCT00892437|441548|P1|Open-Label Extension Phase|Withdrew Consent|3
120840|NCT00892437|441547|P2|Open-Label Extension Phase|Investigator's Discretion|0
120841|NCT00892437|441548|P1|Open-Label Extension Phase|Investigator's Discretion|1
120842|NCT00892437|441547|P2|Open-Label Extension Phase|Lost to Follow-up|1
120843|NCT00892437|441548|P1|Open-Label Extension Phase|Lost to Follow-up|3
120844|NCT00892437|441547|P2|Open-Label Extension Phase|Lack of Efficacy|0
120845|NCT00892437|441548|P1|Open-Label Extension Phase|Lack of Efficacy|1
120846|NCT00892437|441547|P2|Open-Label Extension Phase|Adverse Event|2
120847|NCT00892437|441548|P1|Open-Label Extension Phase|Adverse Event|4
120848|NCT00892437|441547|P2|Randomized Phase|Withdrew Consent|0
120849|NCT00892437|441548|P1|Randomized Phase|Withdrew Consent|1
120850|NCT00892437|441547|P2|Randomized Phase|Investigator’s Discretion|0
120851|NCT00892437|441548|P1|Randomized Phase|Investigator’s Discretion|1
120852|NCT00892437|441547|P2|Randomized Phase|Lost to Follow-up|3
120853|NCT00892437|441548|P1|Randomized Phase|Lost to Follow-up|1
120854|NCT00892437|441547|P2|Randomized Phase|Adverse Event|2
120855|NCT00892437|441548|P1|Randomized Phase|Adverse Event|2
120856|NCT00892437|441547|P2|Randomized Phase|Randomized but not treated|0
120857|NCT00892437|441548|P1|Randomized Phase|Randomized but not treated|6
120858|NCT00892281|441567|P2|Overall Study|Visit 4 date out of window|0
120859|NCT00892281|441568|P1|Overall Study|Visit 4 date out of window|1
120860|NCT00892281|441567|P2|Overall Study|Rash on hand|0
120861|NCT00892281|441568|P1|Overall Study|Rash on hand|1
120862|NCT00892281|441567|P2|Overall Study|Subject had history of drug abuse|0
120863|NCT00892281|441568|P1|Overall Study|Subject had history of drug abuse|1
120864|NCT00892281|441567|P2|Overall Study|Non-compliant with visits as scheduled|0
120865|NCT00892281|441568|P1|Overall Study|Non-compliant with visits as scheduled|1
120866|NCT00892281|441567|P2|Overall Study|Missed visits rescheduled out of window|0
120867|NCT00892281|441568|P1|Overall Study|Missed visits rescheduled out of window|1
120868|NCT00892281|441567|P2|Overall Study|Missed multiple visits|0
120869|NCT00892281|441568|P1|Overall Study|Missed multiple visits|1
120870|NCT00892281|441567|P2|Overall Study|No show Visit 2; prescription not filled|0
120871|NCT00892281|441568|P1|Overall Study|No show Visit 2; prescription not filled|1
120872|NCT00892281|441567|P2|Overall Study|Subject not seen by PI at final visit|0
120873|NCT00892281|441568|P1|Overall Study|Subject not seen by PI at final visit|1
120874|NCT00892281|441567|P2|Overall Study|Lack of efficacy of study product|0
120875|NCT00892281|441568|P1|Overall Study|Lack of efficacy of study product|2
120876|NCT00892281|441567|P2|Overall Study|Death in family|0
120877|NCT00892281|441568|P1|Overall Study|Death in family|1
120878|NCT00892281|441567|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
120879|NCT00892281|441568|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
120880|NCT00892281|441567|P2|Overall Study|Subject lost interest in program|1
120881|NCT00892281|441568|P1|Overall Study|Subject lost interest in program|0
120882|NCT00892281|441567|P2|Overall Study|PI complained of inadequate compensation|0
120883|NCT00892281|441568|P1|Overall Study|PI complained of inadequate compensation|3
120884|NCT00892281|441567|P2|Overall Study|Scheduled for knee replacement|1
120885|NCT00892281|441568|P1|Overall Study|Scheduled for knee replacement|0
120886|NCT00892281|441567|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
120887|NCT00892281|441568|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
120888|NCT00892281|441567|P2|Overall Study|Subject missed several visits/lost meds|0
120889|NCT00892281|441568|P1|Overall Study|Subject missed several visits/lost meds|1
120890|NCT00892281|441567|P2|Overall Study|Subject did not return for any visits|0
120891|NCT00892281|441568|P1|Overall Study|Subject did not return for any visits|1
120892|NCT00892281|441567|P2|Overall Study|Subject not good candidate for study|0
120893|NCT00892281|441568|P1|Overall Study|Subject not good candidate for study|1
120894|NCT00892281|441567|P2|Overall Study|Unable to redeem the drug voucher|0
120895|NCT00892281|441568|P1|Overall Study|Unable to redeem the drug voucher|1
120896|NCT00892281|441567|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
120897|NCT00892281|441568|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
120898|NCT00892281|441567|P2|Overall Study|Did not meet incl/excl criteria|0
120899|NCT00892281|441568|P1|Overall Study|Did not meet incl/excl criteria|1
120900|NCT00892281|441567|P2|Overall Study|Last visit not done - death in family|0
120901|NCT00892281|441568|P1|Overall Study|Last visit not done - death in family|1
120902|NCT00892281|441567|P2|Overall Study|Family emergency|0
120903|NCT00892281|441568|P1|Overall Study|Family emergency|1
120904|NCT00892281|441567|P2|Overall Study|Subject completed day after study closed|0
120905|NCT00892281|441568|P1|Overall Study|Subject completed day after study closed|1
120906|NCT00892281|441567|P2|Overall Study|Final visit completed 4 weeks late|1
120907|NCT00892281|441568|P1|Overall Study|Final visit completed 4 weeks late|0
120908|NCT00892281|441567|P2|Overall Study|Subject unable to keep follow-up visits|0
120909|NCT00892281|441568|P1|Overall Study|Subject unable to keep follow-up visits|1
120910|NCT00892281|441567|P2|Overall Study|Subject failed to return for final visit|0
120911|NCT00892281|441568|P1|Overall Study|Subject failed to return for final visit|2
120912|NCT00892281|441567|P2|Overall Study|Withdrawal by Subject|14
120913|NCT00892281|441568|P1|Overall Study|Withdrawal by Subject|86
120914|NCT00892281|441567|P2|Overall Study|Protocol Violation|2
120915|NCT00892281|441568|P1|Overall Study|Protocol Violation|7
120916|NCT00892281|441567|P2|Overall Study|Pregnancy|0
120917|NCT00892281|441568|P1|Overall Study|Pregnancy|1
120918|NCT00892281|441567|P2|Overall Study|Lost to Follow-up|8
120919|NCT00892281|441568|P1|Overall Study|Lost to Follow-up|81
120920|NCT00892281|441567|P2|Overall Study|Adverse Event|8
120921|NCT00892281|441568|P1|Overall Study|Adverse Event|65
120922|NCT00892177|441581|P6|Phase II|Withdrawal by Subject|1
120923|NCT00892177|441582|P5|Phase II|Withdrawal by Subject|4
120924|NCT00892177|441583|P4|Phase II|Withdrawal by Subject|0
120925|NCT00892177|441584|P3|Phase II|Withdrawal by Subject|0
120926|NCT00892177|441585|P2|Phase II|Withdrawal by Subject|0
120927|NCT00892177|441586|P1|Phase II|Withdrawal by Subject|0
120928|NCT00892177|441581|P6|Phase II|Ineligible|1
120929|NCT00892177|441582|P5|Phase II|Ineligible|1
120930|NCT00892177|441583|P4|Phase II|Ineligible|0
120931|NCT00892177|441584|P3|Phase II|Ineligible|0
120932|NCT00892177|441585|P2|Phase II|Ineligible|0
120933|NCT00892177|441586|P1|Phase II|Ineligible|0
120934|NCT00892151|441611|P1|Overall Study|Protocol Violation|1
120935|NCT00892099|441620|P3|Overall Study|Lost to Follow-up|1
120936|NCT00892099|441621|P2|Overall Study|Lost to Follow-up|0
120937|NCT00892099|441622|P1|Overall Study|Lost to Follow-up|0
120938|NCT00892099|441620|P3|Overall Study|investigator decision|1
120939|NCT00892099|441621|P2|Overall Study|investigator decision|0
120940|NCT00892099|441622|P1|Overall Study|investigator decision|0
120941|NCT00892099|441620|P3|Overall Study|kidney function recovered|0
120942|NCT00892099|441621|P2|Overall Study|kidney function recovered|1
120943|NCT00892099|441622|P1|Overall Study|kidney function recovered|0
120944|NCT00892099|441620|P3|Overall Study|no further details|1
120945|NCT00892099|441621|P2|Overall Study|no further details|0
120946|NCT00892099|441622|P1|Overall Study|no further details|1
120947|NCT00892099|441620|P3|Overall Study|Prolonged hospitalization|1
120948|NCT00892099|441621|P2|Overall Study|Prolonged hospitalization|0
120949|NCT00892099|441622|P1|Overall Study|Prolonged hospitalization|1
120950|NCT00892099|441620|P3|Overall Study|replocated|2
120951|NCT00892099|441621|P2|Overall Study|replocated|0
120952|NCT00892099|441622|P1|Overall Study|replocated|1
120953|NCT00892099|441620|P3|Overall Study|Adverse Event|0
120954|NCT00892099|441621|P2|Overall Study|Adverse Event|0
120955|NCT00892099|441622|P1|Overall Study|Adverse Event|1
120956|NCT00892099|441620|P3|Overall Study|Death|1
120957|NCT00892099|441621|P2|Overall Study|Death|0
120958|NCT00892099|441622|P1|Overall Study|Death|1
120959|NCT00892047|441647|P2|Overall Study|Lack of Efficacy|2
120960|NCT00892047|441648|P1|Overall Study|Lack of Efficacy|0
120961|NCT00892047|441647|P2|Overall Study|subject burden|3
120962|NCT00892047|441648|P1|Overall Study|subject burden|2
120963|NCT00892047|441647|P2|Overall Study|Adverse Event|2
120964|NCT00892047|441648|P1|Overall Study|Adverse Event|2
120965|NCT00892008|441664|P1|Overall Study|Adverse Event|37
120966|NCT00892008|441664|P1|Overall Study|Other|378
120967|NCT00892008|441664|P1|Overall Study|Lost to Follow-up|142
120968|NCT00892008|441664|P1|Overall Study|Lack of Efficacy|3
120969|NCT00892008|441664|P1|Overall Study|Death|5
120970|NCT00891930|441750|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
120971|NCT00891930|441750|P1|Part 2: Panitumumab + Ganitumab|Death|30
120972|NCT00891930|441750|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
120973|NCT00891930|441750|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
120974|NCT00891930|441750|P1|Part 1: Panitumumab +Irinotecan|Death|38
120975|NCT00891904|441771|P1|Overall Study|Adverse Event|1
120976|NCT00891904|441771|P1|Overall Study|Death|1
120977|NCT00891839|441778|P1|Overall Study|Disease progression|3
120978|NCT00891839|441778|P1|Overall Study|Withdrawal by Subject|2
120979|NCT00891839|441778|P1|Overall Study|Adverse Event|2
120980|NCT00891813|441787|P1|Overall Study|Protocol Violation|2
120981|NCT00891813|441787|P1|Overall Study|Patient Noncompliance|6
120982|NCT00891813|441787|P1|Overall Study|Withdrawal by Subject|1
120983|NCT00891813|441787|P1|Overall Study|Adverse Event|3
120984|NCT00891774|441793|P1|Overall Study|Protocol Violation|4
120985|NCT00891774|441793|P1|Overall Study|Withdrawal by Subject|2
120986|NCT00891774|441793|P1|Overall Study|Illness (Self/Mother)|3
120987|NCT00891774|441793|P1|Overall Study|Lost to Follow-up|5
120988|NCT00891735|441801|P4|Overall Study|Patient's decision to withdraw|8
120989|NCT00891735|441802|P3|Overall Study|Patient's decision to withdraw|4
120990|NCT00891735|441803|P2|Overall Study|Patient's decision to withdraw|9
120991|NCT00891735|441804|P1|Overall Study|Patient's decision to withdraw|4
120992|NCT00891735|441801|P4|Overall Study|Physician's decision to withdraw patient|0
120993|NCT00891735|441802|P3|Overall Study|Physician's decision to withdraw patient|0
120994|NCT00891735|441803|P2|Overall Study|Physician's decision to withdraw patient|0
120995|NCT00891735|441804|P1|Overall Study|Physician's decision to withdraw patient|1
120996|NCT00891735|441801|P4|Overall Study|Lost to Follow-up|2
120997|NCT00891735|441802|P3|Overall Study|Lost to Follow-up|2
120998|NCT00891735|441803|P2|Overall Study|Lost to Follow-up|2
120999|NCT00891735|441804|P1|Overall Study|Lost to Follow-up|2
121000|NCT00891735|441801|P4|Overall Study|Death|5
121001|NCT00891735|441802|P3|Overall Study|Death|4
121002|NCT00891735|441803|P2|Overall Study|Death|5
121003|NCT00891735|441804|P1|Overall Study|Death|8
121004|NCT00891735|441801|P4|Overall Study|Adverse Event|0
121005|NCT00891735|441802|P3|Overall Study|Adverse Event|2
121006|NCT00891735|441803|P2|Overall Study|Adverse Event|0
121007|NCT00891735|441804|P1|Overall Study|Adverse Event|2
121008|NCT00891657|441844|P2|Overall Study|Withdrawal by Subject|1
121009|NCT00891657|441845|P1|Overall Study|Withdrawal by Subject|1
121010|NCT00891618|441857|P1|Overall Study|Withdrawal by Subject|1
121011|NCT00891527|441861|P1|Overall Study|Withdrawal by Subject|2
121012|NCT00891462|441870|P3|Overall Study|Lost to Follow-up|0
121013|NCT00891462|441871|P2|Overall Study|Lost to Follow-up|2
121014|NCT00891462|441872|P1|Overall Study|Lost to Follow-up|0
121015|NCT00891462|441870|P3|Overall Study|Inclusion/exclusion criteria|2
121016|NCT00891462|441871|P2|Overall Study|Inclusion/exclusion criteria|2
121017|NCT00891462|441872|P1|Overall Study|Inclusion/exclusion criteria|0
121018|NCT00891462|441870|P3|Overall Study|Protocol Violation|3
121019|NCT00891462|441871|P2|Overall Study|Protocol Violation|1
121020|NCT00891462|441872|P1|Overall Study|Protocol Violation|2
121021|NCT00891462|441870|P3|Overall Study|Other Reason|3
121022|NCT00891462|441871|P2|Overall Study|Other Reason|5
121023|NCT00891462|441872|P1|Overall Study|Other Reason|2
121024|NCT00891462|441870|P3|Overall Study|COPD exacerbation|1
121025|NCT00891462|441871|P2|Overall Study|COPD exacerbation|4
121026|NCT00891462|441872|P1|Overall Study|COPD exacerbation|7
121027|NCT00891462|441870|P3|Overall Study|Lack of Efficacy|1
121028|NCT00891462|441871|P2|Overall Study|Lack of Efficacy|5
121029|NCT00891462|441872|P1|Overall Study|Lack of Efficacy|10
121030|NCT00891462|441870|P3|Overall Study|Adverse Event|7
121031|NCT00891462|441871|P2|Overall Study|Adverse Event|8
121032|NCT00891462|441872|P1|Overall Study|Adverse Event|7
121033|NCT00891462|441870|P3|Overall Study|Withdrawal by Subject|7
121034|NCT00891462|441871|P2|Overall Study|Withdrawal by Subject|6
121035|NCT00891462|441872|P1|Overall Study|Withdrawal by Subject|9
121036|NCT00891371|441894|P1|Treatment|Lost to Follow-up|1
121037|NCT00891371|441894|P1|Treatment|Death|1
121038|NCT00891371|441894|P1|Treatment|Adverse Event|2
121039|NCT00891371|441894|P1|Treatment|Lack of Efficacy|5
121040|NCT00891371|441894|P1|Pre-assignment|Consent withdrawal|1
121041|NCT00891371|441894|P1|Pre-assignment|Inclusion/exclusion|5
121042|NCT00891293|441916|P1|Overall Study|Sponsor termination|62
121043|NCT00891293|441916|P1|Overall Study|Subject withdrew consent|7
121044|NCT00891293|441916|P1|Overall Study|Lost to Follow-up|7
121045|NCT00891293|441916|P1|Overall Study|Laboratory abnormality|4
121046|NCT00891293|441916|P1|Overall Study|Protocol Violation|2
121047|NCT00891293|441916|P1|Overall Study|Adverse Event|2
121048|NCT00891228|441931|P3|Overall Study|Pregnancy|0
121049|NCT00891228|441932|P2|Overall Study|Pregnancy|1
121050|NCT00891228|441933|P1|Overall Study|Pregnancy|0
121051|NCT00891228|441931|P3|Overall Study|Lost to Follow-up|5
121052|NCT00891228|441932|P2|Overall Study|Lost to Follow-up|4
121053|NCT00891228|441933|P1|Overall Study|Lost to Follow-up|4
121054|NCT00891228|441931|P3|Overall Study|Physician Decision|0
121055|NCT00891228|441932|P2|Overall Study|Physician Decision|1
121056|NCT00891228|441933|P1|Overall Study|Physician Decision|2
121057|NCT00891228|441931|P3|Overall Study|Protocol Violation|2
121058|NCT00891228|441932|P2|Overall Study|Protocol Violation|1
121059|NCT00891228|441933|P1|Overall Study|Protocol Violation|3
121060|NCT00891228|441931|P3|Overall Study|Withdrawal by Subject|5
121061|NCT00891228|441932|P2|Overall Study|Withdrawal by Subject|4
121062|NCT00891228|441933|P1|Overall Study|Withdrawal by Subject|2
121063|NCT00891228|441931|P3|Overall Study|Adverse Event|3
121064|NCT00891228|441932|P2|Overall Study|Adverse Event|2
121065|NCT00891228|441933|P1|Overall Study|Adverse Event|0
121066|NCT00891202|441955|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
121067|NCT00891202|441956|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
121068|NCT00891202|441957|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
121069|NCT00891202|441958|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
121070|NCT00891202|441955|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
121071|NCT00891202|441956|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
121072|NCT00891202|441957|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
121073|NCT00891202|441958|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
121074|NCT00891202|441955|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
121075|NCT00891202|441956|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
121076|NCT00891202|441957|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
121077|NCT00891202|441958|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
121078|NCT00891202|441955|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
121079|NCT00891202|441956|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
121080|NCT00891202|441957|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
121081|NCT00891202|441958|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
121082|NCT00891046|442134|P5|Overall Study|Lost to Follow-up|1
121083|NCT00891046|442135|P4|Overall Study|Lost to Follow-up|0
121084|NCT00891046|442136|P3|Overall Study|Lost to Follow-up|0
121085|NCT00891046|442137|P2|Overall Study|Lost to Follow-up|0
121086|NCT00891046|442138|P1|Overall Study|Lost to Follow-up|0
121087|NCT00891046|442134|P5|Overall Study|Withdrawal by Subject|1
121088|NCT00891046|442135|P4|Overall Study|Withdrawal by Subject|1
121089|NCT00891046|442136|P3|Overall Study|Withdrawal by Subject|2
121090|NCT00891046|442137|P2|Overall Study|Withdrawal by Subject|1
121091|NCT00891046|442138|P1|Overall Study|Withdrawal by Subject|2
121092|NCT00891046|442134|P5|Overall Study|Adverse Event|14
121093|NCT00891046|442135|P4|Overall Study|Adverse Event|0
121094|NCT00891046|442136|P3|Overall Study|Adverse Event|2
121095|NCT00891046|442137|P2|Overall Study|Adverse Event|3
121096|NCT00891046|442138|P1|Overall Study|Adverse Event|4
121097|NCT00891046|442134|P5|Overall Study|Participant no longer required drug|1
121098|NCT00891046|442135|P4|Overall Study|Participant no longer required drug|0
121099|NCT00891046|442136|P3|Overall Study|Participant no longer required drug|0
121100|NCT00891046|442137|P2|Overall Study|Participant no longer required drug|2
121101|NCT00891046|442138|P1|Overall Study|Participant no longer required drug|0
121102|NCT00891046|442134|P5|Overall Study|Administrative problems|1
121103|NCT00891046|442135|P4|Overall Study|Administrative problems|0
121104|NCT00891046|442136|P3|Overall Study|Administrative problems|0
121105|NCT00891046|442137|P2|Overall Study|Administrative problems|0
121106|NCT00891046|442138|P1|Overall Study|Administrative problems|0
121107|NCT00891046|442134|P5|Overall Study|Unsatisfactory therapeutic effect|20
121108|NCT00891046|442135|P4|Overall Study|Unsatisfactory therapeutic effect|2
121109|NCT00891046|442136|P3|Overall Study|Unsatisfactory therapeutic effect|19
121110|NCT00891046|442137|P2|Overall Study|Unsatisfactory therapeutic effect|2
121111|NCT00891046|442138|P1|Overall Study|Unsatisfactory therapeutic effect|5
121112|NCT00891046|442134|P5|Overall Study|Protocol Violation|1
121113|NCT00891046|442135|P4|Overall Study|Protocol Violation|0
121114|NCT00891046|442136|P3|Overall Study|Protocol Violation|0
121115|NCT00891046|442137|P2|Overall Study|Protocol Violation|1
121116|NCT00891046|442138|P1|Overall Study|Protocol Violation|1
121117|NCT00891020|442214|P3|Long-term Extension Period|Administrative|2
121118|NCT00891020|442215|P2|Long-term Extension Period|Administrative|2
121119|NCT00891020|442216|P1|Long-term Extension Period|Administrative|1
121120|NCT00891020|442214|P3|Long-term Extension Period|Failure to return|3
121121|NCT00891020|442215|P2|Long-term Extension Period|Failure to return|2
121122|NCT00891020|442216|P1|Long-term Extension Period|Failure to return|0
121123|NCT00891020|442214|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
121124|NCT00891020|442215|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
121125|NCT00891020|442216|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
121126|NCT00891020|442214|P3|Long-term Extension Period|Protocol Violation|1
121127|NCT00891020|442215|P2|Long-term Extension Period|Protocol Violation|1
121128|NCT00891020|442216|P1|Long-term Extension Period|Protocol Violation|0
121129|NCT00891020|442214|P3|Long-term Extension Period|Insufficient therapeutic response|2
121130|NCT00891020|442215|P2|Long-term Extension Period|Insufficient therapeutic response|2
121131|NCT00891020|442216|P1|Long-term Extension Period|Insufficient therapeutic response|3
121132|NCT00891020|442214|P3|Long-term Extension Period|Death|1
121133|NCT00891020|442215|P2|Long-term Extension Period|Death|0
121134|NCT00891020|442216|P1|Long-term Extension Period|Death|0
121135|NCT00891020|442214|P3|Long-term Extension Period|Adverse Event|10
121136|NCT00891020|442215|P2|Long-term Extension Period|Adverse Event|11
121137|NCT00891020|442216|P1|Long-term Extension Period|Adverse Event|1
121138|NCT00891020|442214|P3|24 Week Treatment Period|Administrative/Other|1
121139|NCT00891020|442215|P2|24 Week Treatment Period|Administrative/Other|6
121140|NCT00891020|442216|P1|24 Week Treatment Period|Administrative/Other|5
121141|NCT00891020|442214|P3|24 Week Treatment Period|Withdrew consent|15
121142|NCT00891020|442215|P2|24 Week Treatment Period|Withdrew consent|3
121143|NCT00891020|442216|P1|24 Week Treatment Period|Withdrew consent|6
121144|NCT00891020|442214|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
121145|NCT00891020|442215|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
121146|NCT00891020|442216|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
121147|NCT00891020|442214|P3|24 Week Treatment Period|Other protocol violation|2
121148|NCT00891020|442215|P2|24 Week Treatment Period|Other protocol violation|1
121149|NCT00891020|442216|P1|24 Week Treatment Period|Other protocol violation|1
121150|NCT00891020|442214|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
121151|NCT00891020|442215|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
121152|NCT00891020|442216|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
121153|NCT00891020|442214|P3|24 Week Treatment Period|Failure to return|5
121154|NCT00891020|442215|P2|24 Week Treatment Period|Failure to return|5
121155|NCT00891020|442216|P1|24 Week Treatment Period|Failure to return|4
121156|NCT00891020|442214|P3|24 Week Treatment Period|Insufficient therapeutic response|15
121157|NCT00891020|442215|P2|24 Week Treatment Period|Insufficient therapeutic response|9
121158|NCT00891020|442216|P1|24 Week Treatment Period|Insufficient therapeutic response|6
121159|NCT00891020|442214|P3|24 Week Treatment Period|Death|0
121160|NCT00891020|442215|P2|24 Week Treatment Period|Death|2
121161|NCT00891020|442216|P1|24 Week Treatment Period|Death|0
121162|NCT00891020|442214|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
121163|NCT00891020|442215|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
121164|NCT00891020|442216|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
121165|NCT00890929|442280|P1|Overall Study|Physician Decision|1
121166|NCT00890929|442280|P1|Overall Study|Withdrawal by Subject|3
121167|NCT00890929|442280|P1|Overall Study|Death before treatment|2
121168|NCT00890695|442307|P2|Overall Study|Protocol Violation|0
121169|NCT00890695|442308|P1|Overall Study|Protocol Violation|1
121170|NCT00890591|442337|P1|Overall Study|Lack of Efficacy|20
121171|NCT00890552|442343|P1|On-treatment|Early prog disease/ death|10
121172|NCT00890552|442343|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
121173|NCT00890409|442352|P2|Overall Study|Lost to Follow-up|21
121174|NCT00890409|442353|P1|Overall Study|Lost to Follow-up|20
121175|NCT00890201|442363|P2|Overall Study|Protocol Violation|56
121176|NCT00890201|442364|P1|Overall Study|Protocol Violation|5
121177|NCT00890097|442373|P3|Overall Study|Protocol Deviation|1
121178|NCT00890097|442374|P2|Overall Study|Protocol Deviation|1
121179|NCT00890097|442375|P1|Overall Study|Protocol Deviation|1
121180|NCT00890097|442373|P3|Overall Study|Subject Moved|0
121181|NCT00890097|442374|P2|Overall Study|Subject Moved|4
121182|NCT00890097|442375|P1|Overall Study|Subject Moved|0
121183|NCT00890097|442373|P3|Overall Study|Transportation|0
121184|NCT00890097|442374|P2|Overall Study|Transportation|2
121185|NCT00890097|442375|P1|Overall Study|Transportation|0
121186|NCT00890097|442373|P3|Overall Study|Failed inclusion criteria|0
121187|NCT00890097|442374|P2|Overall Study|Failed inclusion criteria|4
121188|NCT00890097|442375|P1|Overall Study|Failed inclusion criteria|3
121189|NCT00890097|442373|P3|Overall Study|Randomization Error|0
121190|NCT00890097|442374|P2|Overall Study|Randomization Error|0
121191|NCT00890097|442375|P1|Overall Study|Randomization Error|2
121192|NCT00890097|442373|P3|Overall Study|Subject Decision|6
121193|NCT00890097|442374|P2|Overall Study|Subject Decision|2
121194|NCT00890097|442375|P1|Overall Study|Subject Decision|3
121195|NCT00890097|442373|P3|Overall Study|Did not attend final visit|0
121196|NCT00890097|442374|P2|Overall Study|Did not attend final visit|3
121197|NCT00890097|442375|P1|Overall Study|Did not attend final visit|2
121198|NCT00890097|442373|P3|Overall Study|Sponsor Decision|7
121199|NCT00890097|442374|P2|Overall Study|Sponsor Decision|11
121200|NCT00890097|442375|P1|Overall Study|Sponsor Decision|7
121201|NCT00890097|442373|P3|Overall Study|Noncompliance|4
121202|NCT00890097|442374|P2|Overall Study|Noncompliance|4
121203|NCT00890097|442375|P1|Overall Study|Noncompliance|0
121204|NCT00890097|442373|P3|Overall Study|Lost to Follow-up|5
121205|NCT00890097|442374|P2|Overall Study|Lost to Follow-up|5
121206|NCT00890097|442375|P1|Overall Study|Lost to Follow-up|5
121207|NCT00890097|442373|P3|Overall Study|Withdrew Consent|9
121208|NCT00890097|442374|P2|Overall Study|Withdrew Consent|6
121209|NCT00890097|442375|P1|Overall Study|Withdrew Consent|9
121210|NCT00890097|442373|P3|Overall Study|Decision Unrelated to an Adverse Event|17
121211|NCT00890097|442374|P2|Overall Study|Decision Unrelated to an Adverse Event|12
121212|NCT00890097|442375|P1|Overall Study|Decision Unrelated to an Adverse Event|15
121213|NCT00890097|442373|P3|Overall Study|Adverse Event|28
121214|NCT00890097|442374|P2|Overall Study|Adverse Event|32
121215|NCT00890097|442375|P1|Overall Study|Adverse Event|21
121216|NCT00890084|442383|P1|Overall Study|Lost to Follow-up|126
121217|NCT00890084|442383|P1|Overall Study|Adverse Event|16
121218|NCT00889863|442423|P2|Part II: Randomized Double Blind|Protocol deviation|1
121219|NCT00889863|442424|P1|Part II: Randomized Double Blind|Protocol deviation|0
121220|NCT00889863|442423|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
121221|NCT00889863|442424|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
121222|NCT00889863|442423|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
121223|NCT00889863|442424|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
121224|NCT00889863|442423|P2|Part II: Randomized Double Blind|Adverse Event|4
121225|NCT00889863|442424|P1|Part II: Randomized Double Blind|Adverse Event|0
121226|NCT00889863|442423|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
121227|NCT00889863|442424|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
121228|NCT00889863|442423|P2|Part I: Open Label|Adverse Event|0
121229|NCT00889863|442424|P1|Part I: Open Label|Adverse Event|4
121230|NCT00889863|442423|P2|Part I: Open Label|Death|0
121231|NCT00889863|442424|P1|Part I: Open Label|Death|1
121232|NCT00889720|442450|P1|Overall Study|Other|4
121233|NCT00889720|442450|P1|Overall Study|Withdrawal by Subject|4
121234|NCT00889707|442477|P2|Overall Study|Lack of Efficacy|5
121235|NCT00889707|442478|P1|Overall Study|Lack of Efficacy|2
121236|NCT00889707|442477|P2|Overall Study|Lost to Follow-up|2
121237|NCT00889707|442478|P1|Overall Study|Lost to Follow-up|0
121238|NCT00889707|442477|P2|Overall Study|Withdrawal by Subject|3
121239|NCT00889707|442478|P1|Overall Study|Withdrawal by Subject|4
121240|NCT00889707|442477|P2|Overall Study|Adverse Event|0
121241|NCT00889707|442478|P1|Overall Study|Adverse Event|1
121242|NCT00889681|442486|P1|Overall Study|Insurance disapproval|1
121243|NCT00889681|442486|P1|Overall Study|Not meeting qualification Criteria|2
121244|NCT00889603|442493|P1|Overall Study|Not Specified|4
121245|NCT00889603|442493|P1|Overall Study|No longer willing to participant in stud|4
121246|NCT00889603|442493|P1|Overall Study|Lost to Follow-up|19
121247|NCT00889603|442493|P1|Overall Study|Death|3
121248|NCT00889603|442493|P1|Overall Study|Adverse Event|7
121249|NCT00889421|442515|P1|Overall Study|Lack of Efficacy|3
121250|NCT00889265|442556|P1|Overall Study|Protocol Violation|1
121251|NCT00889265|442556|P1|Overall Study|Lost to Follow-up|5
121252|NCT00889265|442556|P1|Overall Study|Adverse Event|1
121253|NCT00889252|442563|P2|Overall Study|Protocol Violation|0
121254|NCT00889252|442564|P1|Overall Study|Protocol Violation|2
121255|NCT00889252|442563|P2|Overall Study|Withdrawal by Subject|0
121256|NCT00889252|442564|P1|Overall Study|Withdrawal by Subject|3
121257|NCT00889252|442563|P2|Overall Study|Adverse Event|4
121258|NCT00889252|442564|P1|Overall Study|Adverse Event|2
121259|NCT00888940|442636|P2|Overall Study|Randomized Not Treated|13
121260|NCT00888940|442637|P1|Overall Study|Randomized Not Treated|11
121261|NCT00888940|442636|P2|Overall Study|Lost to Follow-up|5
121262|NCT00888940|442637|P1|Overall Study|Lost to Follow-up|5
121263|NCT00888940|442636|P2|Overall Study|Adverse Event|3
121264|NCT00888940|442637|P1|Overall Study|Adverse Event|12
121265|NCT00888849|442647|P2|Overall Study|Lost to Follow-up|2
121266|NCT00888849|442648|P1|Overall Study|Lost to Follow-up|1
121267|NCT00888849|442647|P2|Overall Study|Death|7
121268|NCT00888849|442648|P1|Overall Study|Death|4
121269|NCT00888654|442658|P1|Overall Study|Stopped meds due to headaches|1
121270|NCT00888654|442658|P1|Overall Study|Change in surg date|1
121271|NCT00888654|442658|P1|Overall Study|Inelig. due to contraindication of med|1
121272|NCT00888654|442658|P1|Overall Study|Withdrawal by Subject|1
121273|NCT00888654|442658|P1|Overall Study|Surgery aborted|2
121274|NCT00888654|442658|P1|Overall Study|Not enough oral meds before surgery|3
121275|NCT00888654|442658|P1|Overall Study|Problems swallowing oral meds.|1
121276|NCT00888433|442687|P2|Overall Study|Missed Visit|1
121277|NCT00888433|442688|P1|Overall Study|Missed Visit|2
121278|NCT00888433|442687|P2|Overall Study|Withdrawal by Subject|2
121279|NCT00888433|442688|P1|Overall Study|Withdrawal by Subject|1
121280|NCT00888381|442696|P2|Overall Study|Lost to Follow-up|1
121281|NCT00888381|442697|P1|Overall Study|Lost to Follow-up|0
121282|NCT00888355|442717|P4|Overall Study|Withdrawal by Subject|3
121283|NCT00888355|442718|P3|Overall Study|Withdrawal by Subject|1
121284|NCT00888355|442719|P2|Overall Study|Withdrawal by Subject|3
121285|NCT00888355|442720|P1|Overall Study|Withdrawal by Subject|0
121286|NCT00888355|442717|P4|Overall Study|Protocol Violation|2
121287|NCT00888355|442718|P3|Overall Study|Protocol Violation|1
121288|NCT00888355|442719|P2|Overall Study|Protocol Violation|2
121289|NCT00888355|442720|P1|Overall Study|Protocol Violation|3
121290|NCT00888355|442717|P4|Overall Study|Lost to Follow-up|0
121291|NCT00888355|442718|P3|Overall Study|Lost to Follow-up|2
121292|NCT00888355|442719|P2|Overall Study|Lost to Follow-up|2
121293|NCT00888355|442720|P1|Overall Study|Lost to Follow-up|0
121294|NCT00888355|442717|P4|Overall Study|Lack of Efficacy|2
121295|NCT00888355|442718|P3|Overall Study|Lack of Efficacy|5
121296|NCT00888355|442719|P2|Overall Study|Lack of Efficacy|2
121297|NCT00888355|442720|P1|Overall Study|Lack of Efficacy|9
121298|NCT00888355|442717|P4|Overall Study|Adverse Event|3
121299|NCT00888355|442718|P3|Overall Study|Adverse Event|3
121300|NCT00888355|442719|P2|Overall Study|Adverse Event|0
121301|NCT00888355|442720|P1|Overall Study|Adverse Event|10
121302|NCT00888329|442776|P2|Overall Study|Physician Decision|9
121303|NCT00888329|442777|P1|Overall Study|Physician Decision|6
121304|NCT00888238|442783|P3|Washout Period After Period 2|Adverse Event|1
121305|NCT00888238|442784|P2|Washout Period After Period 2|Adverse Event|0
121306|NCT00888238|442785|P1|Washout Period After Period 2|Adverse Event|0
121307|NCT00888173|442793|P1|Overall Study|Ineligible: required test not done|1
121308|NCT00888173|442793|P1|Overall Study|Wrong Primary|1
121309|NCT00888134|442801|P1|Follow-up|being followed for long-term survival|1
121310|NCT00888134|442801|P1|Treatment With Study Drug|Withdrawal by Subject|1
121311|NCT00887978|442811|P2|Overall Study|Lost to Follow-up|1
121312|NCT00887978|442812|P1|Overall Study|Lost to Follow-up|0
121313|NCT00887978|442811|P2|Overall Study|Withdrawal by Subject|2
121314|NCT00887978|442812|P1|Overall Study|Withdrawal by Subject|1
121315|NCT00887978|442811|P2|Overall Study|Death|3
121316|NCT00887978|442812|P1|Overall Study|Death|2
121317|NCT00887978|442811|P2|Overall Study|Clinical Worsening|4
121318|NCT00887978|442812|P1|Overall Study|Clinical Worsening|4
121319|NCT00887978|442811|P2|Overall Study|Adverse Event|5
121320|NCT00887978|442812|P1|Overall Study|Adverse Event|18
121321|NCT00887913|442878|P1|Overall Study|Withdrawal by Subject|6
121322|NCT00887822|442886|P2|Overall Study|Randomized but not treated|1
121323|NCT00887822|442887|P1|Overall Study|Randomized but not treated|0
121324|NCT00887822|442886|P2|Overall Study|Protocol Violation|1
121325|NCT00887822|442887|P1|Overall Study|Protocol Violation|0
121326|NCT00887822|442886|P2|Overall Study|Death|3
121327|NCT00887822|442887|P1|Overall Study|Death|2
121328|NCT00887822|442886|P2|Overall Study|Administrative/Other than specified|4
121329|NCT00887822|442887|P1|Overall Study|Administrative/Other than specified|5
121330|NCT00887822|442886|P2|Overall Study|Refused treatment/Did not cooperate|10
121331|NCT00887822|442887|P1|Overall Study|Refused treatment/Did not cooperate|12
121332|NCT00887822|442886|P2|Overall Study|Failure to return|11
121333|NCT00887822|442887|P1|Overall Study|Failure to return|11
121334|NCT00887822|442886|P2|Overall Study|Adverse Event|17
121335|NCT00887822|442887|P1|Overall Study|Adverse Event|14
121336|NCT00887822|442886|P2|Overall Study|Insufficient therapeutic response|55
121337|NCT00887822|442887|P1|Overall Study|Insufficient therapeutic response|53
121338|NCT00887809|442919|P2|Overall Study|Death|0
121339|NCT00887809|442920|P1|Overall Study|Death|1
121340|NCT00887809|442919|P2|Overall Study|Patient Not Treated|0
121341|NCT00887809|442920|P1|Overall Study|Patient Not Treated|3
121342|NCT00887744|442926|P1|Overall Study|Various reasons|9
121343|NCT00887744|442926|P1|Overall Study|Withdrawal by Subject|18
121344|NCT00887744|442926|P1|Overall Study|Lost to Follow-up|3
121345|NCT00887744|442926|P1|Overall Study|Death|1
121346|NCT00887744|442926|P1|Overall Study|Adverse Event|3
121347|NCT00887679|442935|P1|Overall Study|Physician Decision|5
121348|NCT00887679|442935|P1|Overall Study|Lost to Follow-up|4
121349|NCT00887679|442935|P1|Overall Study|Withdrawal by Subject|1
121350|NCT00887588|442965|P2|Extension Period|Lost to Follow-up|0
121351|NCT00887588|442966|P1|Extension Period|Lost to Follow-up|1
121352|NCT00887588|442965|P2|Extension Period|Protocol deviation|0
121353|NCT00887588|442966|P1|Extension Period|Protocol deviation|1
121354|NCT00887588|442965|P2|Extension Period|Death|1
121355|NCT00887588|442966|P1|Extension Period|Death|0
121356|NCT00887588|442965|P2|Extension Period|Adverse Event|4
121357|NCT00887588|442966|P1|Extension Period|Adverse Event|4
121358|NCT00887588|442965|P2|Core Period|Adverse Event|11
121359|NCT00887588|442966|P1|Core Period|Adverse Event|9
121360|NCT00887588|442965|P2|Core Period|Withdrawal by Subject|8
121361|NCT00887588|442966|P1|Core Period|Withdrawal by Subject|6
121362|NCT00887588|442965|P2|Core Period|Lost to Follow-up|1
121363|NCT00887588|442966|P1|Core Period|Lost to Follow-up|3
121364|NCT00887588|442965|P2|Core Period|Death|1
121365|NCT00887588|442966|P1|Core Period|Death|1
121366|NCT00887549|443047|P1|Maintenance Therapy|Death due to adverse event|1
121367|NCT00887549|443047|P1|Maintenance Therapy|Progressive Disease|25
121368|NCT00887549|443047|P1|Maintenance Therapy|Physician Decision|1
121369|NCT00887549|443047|P1|Maintenance Therapy|Adverse Event|16
121370|NCT00887549|443047|P1|Induction Therapy|Death due to Study Drug Toxicity|1
121371|NCT00887549|443047|P1|Induction Therapy|Death due to Study Disease|4
121372|NCT00887549|443047|P1|Induction Therapy|Progressive Disease|13
121373|NCT00887549|443047|P1|Induction Therapy|Physician Decision|1
121374|NCT00887549|443047|P1|Induction Therapy|Adverse Event|8
121375|NCT00887484|443065|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
121376|NCT00887484|443065|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
121377|NCT00887484|443065|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
121378|NCT00887354|443153|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
121379|NCT00887354|443154|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
121380|NCT00887354|443153|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
121381|NCT00887354|443154|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
121382|NCT00887354|443153|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
121383|NCT00887354|443154|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
121384|NCT00887354|443153|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
121385|NCT00887354|443154|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
121386|NCT00887354|443153|P2|Open Label Phase (Week 26 to Week 78)|Death|2
121387|NCT00887354|443154|P1|Open Label Phase (Week 26 to Week 78)|Death|0
121388|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
121389|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
121390|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
121391|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
121392|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
121393|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
121394|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
121395|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
121396|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
121397|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
121398|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
121399|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
121400|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
121401|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
121402|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
121403|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
121404|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
121405|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
121406|NCT00887354|443153|P2|Treatment Phase (Week 0 to Week 26)|Death|1
121407|NCT00887354|443154|P1|Treatment Phase (Week 0 to Week 26)|Death|0
121408|NCT00887341|443174|P2|Overall Study|Lost to Follow-up|1
121409|NCT00887341|443175|P1|Overall Study|Lost to Follow-up|0
121410|NCT00887341|443174|P2|Overall Study|Adverse Event|1
121411|NCT00887341|443175|P1|Overall Study|Adverse Event|0
121412|NCT00887341|443174|P2|Overall Study|Withdrawal by Subject|1
121413|NCT00887341|443175|P1|Overall Study|Withdrawal by Subject|1
121414|NCT00887341|443174|P2|Overall Study|Refused treatment|0
121415|NCT00887341|443175|P1|Overall Study|Refused treatment|1
121416|NCT00887315|443211|P2|Overall Study|Study termination|4
121417|NCT00887315|443212|P1|Overall Study|Study termination|7
121418|NCT00887289|443220|P1|Overall Study|not specified|20
121419|NCT00887289|443220|P1|Overall Study|Lost to Follow-up|8
121420|NCT00887289|443220|P1|Overall Study|Withdrawal by Subject|26
121421|NCT00887289|443220|P1|Overall Study|Adverse Event|27
121422|NCT00887289|443220|P1|Overall Study|Lack of Efficacy|14
121423|NCT00887250|443232|P3|Overall Study|Patient uncooperative|1
121424|NCT00887250|443233|P2|Overall Study|Patient uncooperative|0
121425|NCT00887250|443234|P1|Overall Study|Patient uncooperative|0
121426|NCT00887250|443232|P3|Overall Study|Withdrawal by Subject|2
121427|NCT00887250|443233|P2|Overall Study|Withdrawal by Subject|1
121428|NCT00887250|443234|P1|Overall Study|Withdrawal by Subject|2
121429|NCT00887250|443232|P3|Overall Study|Protocol Violation|1
121430|NCT00887250|443233|P2|Overall Study|Protocol Violation|2
121431|NCT00887250|443234|P1|Overall Study|Protocol Violation|2
121432|NCT00887250|443232|P3|Overall Study|Lost to Follow-up|1
121433|NCT00887250|443233|P2|Overall Study|Lost to Follow-up|3
121434|NCT00887250|443234|P1|Overall Study|Lost to Follow-up|2
121435|NCT00887250|443232|P3|Overall Study|Lack of Efficacy|1
121436|NCT00887250|443233|P2|Overall Study|Lack of Efficacy|6
121437|NCT00887250|443234|P1|Overall Study|Lack of Efficacy|9
121438|NCT00887250|443232|P3|Overall Study|Adverse Event|7
121439|NCT00887250|443233|P2|Overall Study|Adverse Event|0
121440|NCT00887250|443234|P1|Overall Study|Adverse Event|3
121441|NCT00887224|443257|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
121442|NCT00887224|443258|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
121443|NCT00887224|443259|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
121444|NCT00887224|443257|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
121445|NCT00887224|443258|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
121446|NCT00887224|443259|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
121447|NCT00887224|443257|P3|DB Taper Phase / Post Study Follow Up|Other|12
121448|NCT00887224|443258|P2|DB Taper Phase / Post Study Follow Up|Other|11
121449|NCT00887224|443259|P1|DB Taper Phase / Post Study Follow Up|Other|0
121450|NCT00887224|443257|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
121451|NCT00887224|443258|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
121452|NCT00887224|443259|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
121453|NCT00887224|443257|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
121454|NCT00887224|443258|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
121455|NCT00887224|443259|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
121456|NCT00887224|443257|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
121457|NCT00887224|443258|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
121458|NCT00887224|443259|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
121459|NCT00887224|443257|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
121460|NCT00887224|443258|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
121461|NCT00887224|443259|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
121462|NCT00887224|443257|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
121463|NCT00887224|443258|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
121464|NCT00887224|443259|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
121465|NCT00887224|443257|P3|Double-blind (DB) Phase|Protocol Violation|5
121466|NCT00887224|443258|P2|Double-blind (DB) Phase|Protocol Violation|8
121467|NCT00887224|443259|P1|Double-blind (DB) Phase|Protocol Violation|0
121468|NCT00887224|443257|P3|Double-blind (DB) Phase|Other|0
121469|NCT00887224|443258|P2|Double-blind (DB) Phase|Other|2
121470|NCT00887224|443259|P1|Double-blind (DB) Phase|Other|0
121471|NCT00887224|443257|P3|Double-blind (DB) Phase|Lost to Follow-up|8
121472|NCT00887224|443258|P2|Double-blind (DB) Phase|Lost to Follow-up|8
121473|NCT00887224|443259|P1|Double-blind (DB) Phase|Lost to Follow-up|0
121474|NCT00887224|443257|P3|Double-blind (DB) Phase|Lack of Efficacy|33
121475|NCT00887224|443258|P2|Double-blind (DB) Phase|Lack of Efficacy|67
121476|NCT00887224|443259|P1|Double-blind (DB) Phase|Lack of Efficacy|0
121477|NCT00887224|443257|P3|Double-blind (DB) Phase|Failed to return|2
121478|NCT00887224|443258|P2|Double-blind (DB) Phase|Failed to return|2
121479|NCT00887224|443259|P1|Double-blind (DB) Phase|Failed to return|0
121480|NCT00887224|443257|P3|Double-blind (DB) Phase|Adverse Event|2
121481|NCT00887224|443258|P2|Double-blind (DB) Phase|Adverse Event|7
121482|NCT00887224|443259|P1|Double-blind (DB) Phase|Adverse Event|0
121483|NCT00887224|443257|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
121484|NCT00887224|443258|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
121485|NCT00887224|443259|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
121486|NCT00887224|443257|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
121487|NCT00887224|443258|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
121488|NCT00887224|443259|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
121489|NCT00887224|443257|P3|OL Taper Phase / OL Follow Up|Other|0
121490|NCT00887224|443258|P2|OL Taper Phase / OL Follow Up|Other|0
121491|NCT00887224|443259|P1|OL Taper Phase / OL Follow Up|Other|30
121492|NCT00887224|443257|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
121493|NCT00887224|443258|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
121494|NCT00887224|443259|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
121495|NCT00887224|443257|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
121496|NCT00887224|443258|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
121497|NCT00887224|443259|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
121498|NCT00887224|443257|P3|OL Taper Phase / OL Follow Up|Failed to return|0
121499|NCT00887224|443258|P2|OL Taper Phase / OL Follow Up|Failed to return|0
121500|NCT00887224|443259|P1|OL Taper Phase / OL Follow Up|Failed to return|17
121501|NCT00887224|443257|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
121502|NCT00887224|443258|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
121503|NCT00887224|443259|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
121504|NCT00887224|443257|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
121505|NCT00887224|443258|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
121506|NCT00887224|443259|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
121507|NCT00887224|443257|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
121508|NCT00887224|443258|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
121509|NCT00887224|443259|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
121510|NCT00887224|443257|P3|Open-label Stability (OLS) Phase|Other|0
121511|NCT00887224|443258|P2|Open-label Stability (OLS) Phase|Other|0
121512|NCT00887224|443259|P1|Open-label Stability (OLS) Phase|Other|1
121513|NCT00887224|443257|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
121514|NCT00887224|443258|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
121515|NCT00887224|443259|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
121516|NCT00887224|443257|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
121517|NCT00887224|443258|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
121518|NCT00887224|443259|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
121519|NCT00887224|443257|P3|Open-label Stability (OLS) Phase|Failed to return|0
121520|NCT00887224|443258|P2|Open-label Stability (OLS) Phase|Failed to return|0
121521|NCT00887224|443259|P1|Open-label Stability (OLS) Phase|Failed to return|3
121522|NCT00887224|443257|P3|Open-label Stability (OLS) Phase|Adverse Event|0
121523|NCT00887224|443258|P2|Open-label Stability (OLS) Phase|Adverse Event|0
121524|NCT00887224|443259|P1|Open-label Stability (OLS) Phase|Adverse Event|22
121525|NCT00887224|443257|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
121526|NCT00887224|443258|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
121527|NCT00887224|443259|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
121528|NCT00887224|443257|P3|Open-label Response (OLR) Phase|Protocol Violation|0
121529|NCT00887224|443258|P2|Open-label Response (OLR) Phase|Protocol Violation|0
121530|NCT00887224|443259|P1|Open-label Response (OLR) Phase|Protocol Violation|12
121531|NCT00887224|443257|P3|Open-label Response (OLR) Phase|Other|0
121532|NCT00887224|443258|P2|Open-label Response (OLR) Phase|Other|0
121533|NCT00887224|443259|P1|Open-label Response (OLR) Phase|Other|1
121534|NCT00887224|443257|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
121535|NCT00887224|443258|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
121536|NCT00887224|443259|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
121537|NCT00887224|443257|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
121538|NCT00887224|443258|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
121539|NCT00887224|443259|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
121540|NCT00887224|443257|P3|Open-label Response (OLR) Phase|Failed to return|0
121541|NCT00887224|443258|P2|Open-label Response (OLR) Phase|Failed to return|0
121542|NCT00887224|443259|P1|Open-label Response (OLR) Phase|Failed to return|6
121543|NCT00887224|443257|P3|Open-label Response (OLR) Phase|Adverse Event|0
121544|NCT00887224|443258|P2|Open-label Response (OLR) Phase|Adverse Event|0
121545|NCT00887224|443259|P1|Open-label Response (OLR) Phase|Adverse Event|46
121546|NCT00887198|443286|P2|Overall Study|Lost to Follow-up|3
121547|NCT00887198|443287|P1|Overall Study|Lost to Follow-up|4
121548|NCT00887198|443286|P2|Overall Study|Withdrawal by Subject|41
121549|NCT00887198|443287|P1|Overall Study|Withdrawal by Subject|28
121550|NCT00887198|443286|P2|Overall Study|Death|387
121551|NCT00887198|443287|P1|Overall Study|Death|352
121552|NCT00887159|443318|P3|Overall Study|Never started assigned therapy|4
121553|NCT00887159|443319|P2|Overall Study|Never started assigned therapy|3
121554|NCT00887159|443320|P1|Overall Study|Never started assigned therapy|3
121555|NCT00887159|443318|P3|Overall Study|Ineligible|0
121556|NCT00887159|443319|P2|Overall Study|Ineligible|1
121557|NCT00887159|443320|P1|Overall Study|Ineligible|5
121558|NCT00887159|443318|P3|Overall Study|Received more tx instead of observation|0
121559|NCT00887159|443319|P2|Overall Study|Received more tx instead of observation|0
121560|NCT00887159|443320|P1|Overall Study|Received more tx instead of observation|1
121561|NCT00887159|443318|P3|Overall Study|Pt had PD but was SD when re-measured|0
121562|NCT00887159|443319|P2|Overall Study|Pt had PD but was SD when re-measured|1
121563|NCT00887159|443320|P1|Overall Study|Pt had PD but was SD when re-measured|0
121564|NCT00887159|443318|P3|Overall Study|Treatment delayed|0
121565|NCT00887159|443319|P2|Overall Study|Treatment delayed|1
121566|NCT00887159|443320|P1|Overall Study|Treatment delayed|1
121567|NCT00887159|443318|P3|Overall Study|Sympomatic deterioration|0
121568|NCT00887159|443319|P2|Overall Study|Sympomatic deterioration|0
121569|NCT00887159|443320|P1|Overall Study|Sympomatic deterioration|1
121570|NCT00887159|443318|P3|Overall Study|Physician Decision|0
121571|NCT00887159|443319|P2|Overall Study|Physician Decision|1
121572|NCT00887159|443320|P1|Overall Study|Physician Decision|1
121573|NCT00887159|443318|P3|Overall Study|Alternative therapy|0
121574|NCT00887159|443319|P2|Overall Study|Alternative therapy|0
121575|NCT00887159|443320|P1|Overall Study|Alternative therapy|2
121576|NCT00887159|443318|P3|Overall Study|Withdrawal by Subject|2
121577|NCT00887159|443319|P2|Overall Study|Withdrawal by Subject|4
121578|NCT00887159|443320|P1|Overall Study|Withdrawal by Subject|4
121579|NCT00887159|443318|P3|Overall Study|Death|0
121580|NCT00887159|443319|P2|Overall Study|Death|2
121581|NCT00887159|443320|P1|Overall Study|Death|2
121582|NCT00887159|443318|P3|Overall Study|Adverse Event|17
121583|NCT00887159|443319|P2|Overall Study|Adverse Event|4
121584|NCT00887159|443320|P1|Overall Study|Adverse Event|3
121585|NCT00887159|443318|P3|Overall Study|Disease progression|33
121586|NCT00887159|443319|P2|Overall Study|Disease progression|39
121587|NCT00887159|443320|P1|Overall Study|Disease progression|6
121588|NCT00886938|443336|P1|Overall Study|Withdrawal by Subject|1
121589|NCT00886938|443336|P1|Overall Study|Adverse Event|1
121590|NCT00886834|443349|P2|Overall Study|Protocol Violation|3
121591|NCT00886834|443350|P1|Overall Study|Protocol Violation|0
121592|NCT00886821|443372|P14|Stage 2|Lost to Follow-up|1
121593|NCT00886821|443373|P13|Stage 2|Lost to Follow-up|2
121594|NCT00886821|443374|P12|Stage 2|Lost to Follow-up|0
121595|NCT00886821|443375|P11|Stage 2|Lost to Follow-up|0
121596|NCT00886821|443376|P10|Stage 2|Lost to Follow-up|0
121597|NCT00886821|443377|P9|Stage 2|Lost to Follow-up|0
121598|NCT00886821|443378|P8|Stage 2|Lost to Follow-up|0
121599|NCT00886821|443379|P7|Stage 2|Lost to Follow-up|0
121600|NCT00886821|443380|P6|Stage 2|Lost to Follow-up|0
121601|NCT00886821|443381|P5|Stage 2|Lost to Follow-up|0
121602|NCT00886821|443382|P4|Stage 2|Lost to Follow-up|0
121603|NCT00886821|443383|P3|Stage 2|Lost to Follow-up|0
121604|NCT00886821|443384|P2|Stage 2|Lost to Follow-up|0
121605|NCT00886821|443385|P1|Stage 2|Lost to Follow-up|0
121606|NCT00886821|443372|P14|Stage 2|Adverse Event|0
121607|NCT00886821|443373|P13|Stage 2|Adverse Event|3
121608|NCT00886821|443374|P12|Stage 2|Adverse Event|1
121609|NCT00886821|443375|P11|Stage 2|Adverse Event|0
121610|NCT00886821|443376|P10|Stage 2|Adverse Event|0
121611|NCT00886821|443377|P9|Stage 2|Adverse Event|0
121612|NCT00886821|443378|P8|Stage 2|Adverse Event|0
121613|NCT00886821|443379|P7|Stage 2|Adverse Event|0
121614|NCT00886821|443380|P6|Stage 2|Adverse Event|0
121615|NCT00886821|443381|P5|Stage 2|Adverse Event|0
121616|NCT00886821|443382|P4|Stage 2|Adverse Event|0
121617|NCT00886821|443383|P3|Stage 2|Adverse Event|0
121618|NCT00886821|443384|P2|Stage 2|Adverse Event|0
121619|NCT00886821|443385|P1|Stage 2|Adverse Event|0
121620|NCT00886795|443610|P1|Overall Study|Lack of Efficacy|1
121621|NCT00886769|443617|P2|Overall Study|Unsatisfactory therapeutic effect|37
121622|NCT00886769|443618|P1|Overall Study|Unsatisfactory therapeutic effect|6
121623|NCT00886743|443642|P1|Overall Study|Other|1
121624|NCT00886743|443642|P1|Overall Study|Adverse Event|3
121625|NCT00886639|443661|P1|Overall Study|non-compliance|2
121626|NCT00886639|443661|P1|Overall Study|acute exacerbation|14
121627|NCT00886613|443675|P3|Overall Study|Subject withdrew consent (Part A)|2
121628|NCT00886613|443676|P2|Overall Study|Subject withdrew consent (Part A)|0
121629|NCT00886613|443677|P1|Overall Study|Subject withdrew consent (Part A)|0
121630|NCT00886613|443675|P3|Overall Study|Lost to follow-up (Part B)|1
121631|NCT00886613|443676|P2|Overall Study|Lost to follow-up (Part B)|0
121632|NCT00886613|443677|P1|Overall Study|Lost to follow-up (Part B)|1
121633|NCT00886613|443675|P3|Overall Study|Protocol deviation (Part B)|0
121634|NCT00886613|443676|P2|Overall Study|Protocol deviation (Part B)|0
121635|NCT00886613|443677|P1|Overall Study|Protocol deviation (Part B)|1
121636|NCT00886600|443699|P4|Combination Therapy Period|Protocol Violation|0
121637|NCT00886600|443700|P3|Combination Therapy Period|Protocol Violation|1
121638|NCT00886600|443701|P2|Combination Therapy Period|Protocol Violation|0
121639|NCT00886600|443702|P1|Combination Therapy Period|Protocol Violation|0
121640|NCT00886600|443699|P4|Combination Therapy Period|Adverse Event|0
121641|NCT00886600|443700|P3|Combination Therapy Period|Adverse Event|1
121642|NCT00886600|443701|P2|Combination Therapy Period|Adverse Event|0
121643|NCT00886600|443702|P1|Combination Therapy Period|Adverse Event|0
121644|NCT00886600|443699|P4|Double-blind Monotherapy|Withdrawal by Subject|0
121645|NCT00886600|443700|P3|Double-blind Monotherapy|Withdrawal by Subject|0
121646|NCT00886600|443701|P2|Double-blind Monotherapy|Withdrawal by Subject|0
121647|NCT00886600|443702|P1|Double-blind Monotherapy|Withdrawal by Subject|1
121648|NCT00886600|443699|P4|Double-blind Monotherapy|Protocol Violation|1
121649|NCT00886600|443700|P3|Double-blind Monotherapy|Protocol Violation|0
121650|NCT00886600|443701|P2|Double-blind Monotherapy|Protocol Violation|0
121651|NCT00886600|443702|P1|Double-blind Monotherapy|Protocol Violation|0
121652|NCT00886600|443699|P4|Double-blind Monotherapy|Adverse Event|1
121653|NCT00886600|443700|P3|Double-blind Monotherapy|Adverse Event|1
121654|NCT00886600|443701|P2|Double-blind Monotherapy|Adverse Event|1
121655|NCT00886600|443702|P1|Double-blind Monotherapy|Adverse Event|1
121656|NCT00886587|443726|P2|Overall Study|Withdrawal by Subject|1
121657|NCT00886587|443727|P1|Overall Study|Withdrawal by Subject|0
121658|NCT00886587|443726|P2|Overall Study|Protocol Violation|0
121659|NCT00886587|443727|P1|Overall Study|Protocol Violation|2
121660|NCT00886587|443726|P2|Overall Study|Adverse Event|1
121661|NCT00886587|443727|P1|Overall Study|Adverse Event|2
121662|NCT00886483|443741|P2|Overall Study|Distance to center, poor grades|0
121663|NCT00886483|443742|P1|Overall Study|Distance to center, poor grades|1
121664|NCT00886483|443741|P2|Overall Study|Pursue medications|2
121665|NCT00886483|443742|P1|Overall Study|Pursue medications|1
121666|NCT00886483|443741|P2|Overall Study|Lost to Follow-up|1
121667|NCT00886483|443742|P1|Overall Study|Lost to Follow-up|0
121668|NCT00886340|443760|P2|Overall Study|Withdrawal by Subject|7
121669|NCT00886340|443761|P1|Overall Study|Withdrawal by Subject|0
121670|NCT00886288|443769|P2|Overall Study|Lost to Follow-up|0
121671|NCT00886288|443770|P1|Overall Study|Lost to Follow-up|86
121672|NCT00886288|443769|P2|Overall Study|no respect of the 12 weeks period|227
121673|NCT00886288|443770|P1|Overall Study|no respect of the 12 weeks period|657
121674|NCT00886119|443792|P2|Period 1|Did not meet inclusion criteria|0
121675|NCT00886119|443793|P1|Period 1|Did not meet inclusion criteria|1
121676|NCT00886015|443801|P2|Overall Study|Death|2
121677|NCT00886015|443802|P1|Overall Study|Death|0
121678|NCT00885846|443821|P3|Overall Study|Withdrawal by Subject|2
121679|NCT00885846|443822|P2|Overall Study|Withdrawal by Subject|5
121680|NCT00885846|443823|P1|Overall Study|Withdrawal by Subject|2
121681|NCT00885755|443838|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
121682|NCT00885755|443839|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
121683|NCT00885755|443840|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
121684|NCT00885755|443838|P3|Part I: Trastuzumab+Taxane|Death|1
121685|NCT00885755|443839|P2|Part I: Trastuzumab+Taxane|Death|0
121686|NCT00885755|443840|P1|Part I: Trastuzumab+Taxane|Death|0
121687|NCT00885755|443838|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
121688|NCT00885755|443839|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
121689|NCT00885755|443840|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
121690|NCT00885755|443838|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
121691|NCT00885755|443839|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
121692|NCT00885755|443840|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
121693|NCT00885755|443838|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
121694|NCT00885755|443839|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
121695|NCT00885755|443840|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
121696|NCT00885703|443883|P7|Overall Study|Ineligible (no CM)|1
121697|NCT00885703|443884|P6|Overall Study|Ineligible (no CM)|3
121698|NCT00885703|443885|P5|Overall Study|Ineligible (no CM)|2
121699|NCT00885703|443886|P4|Overall Study|Ineligible (no CM)|1
121700|NCT00885703|443887|P3|Overall Study|Ineligible (no CM)|2
121701|NCT00885703|443888|P2|Overall Study|Ineligible (no CM)|3
121702|NCT00885703|443889|P1|Overall Study|Ineligible (no CM)|1
121703|NCT00885703|443883|P7|Overall Study|Withdrawal by Subject|1
121704|NCT00885703|443884|P6|Overall Study|Withdrawal by Subject|1
121705|NCT00885703|443885|P5|Overall Study|Withdrawal by Subject|3
121706|NCT00885703|443886|P4|Overall Study|Withdrawal by Subject|1
121707|NCT00885703|443887|P3|Overall Study|Withdrawal by Subject|0
121708|NCT00885703|443888|P2|Overall Study|Withdrawal by Subject|0
121709|NCT00885703|443889|P1|Overall Study|Withdrawal by Subject|0
121710|NCT00885703|443883|P7|Overall Study|Lost to Follow-up|0
121711|NCT00885703|443884|P6|Overall Study|Lost to Follow-up|1
121712|NCT00885703|443885|P5|Overall Study|Lost to Follow-up|0
121713|NCT00885703|443886|P4|Overall Study|Lost to Follow-up|0
121714|NCT00885703|443887|P3|Overall Study|Lost to Follow-up|1
121715|NCT00885703|443888|P2|Overall Study|Lost to Follow-up|0
121716|NCT00885703|443889|P1|Overall Study|Lost to Follow-up|0
121717|NCT00885703|443883|P7|Overall Study|Death|4
121718|NCT00885703|443884|P6|Overall Study|Death|8
121719|NCT00885703|443885|P5|Overall Study|Death|7
121720|NCT00885703|443886|P4|Overall Study|Death|7
121721|NCT00885703|443887|P3|Overall Study|Death|8
121722|NCT00885703|443888|P2|Overall Study|Death|7
121723|NCT00885703|443889|P1|Overall Study|Death|9
121724|NCT00885677|443947|P2|Overall Study|Inclusion/exclusion not met|27
121725|NCT00885677|443948|P1|Overall Study|Inclusion/exclusion not met|25
121726|NCT00885677|443947|P2|Overall Study|Heart transplantation|0
121727|NCT00885677|443948|P1|Overall Study|Heart transplantation|1
121728|NCT00885677|443947|P2|Overall Study|device/lead revision or replacement|6
121729|NCT00885677|443948|P1|Overall Study|device/lead revision or replacement|7
121730|NCT00885677|443947|P2|Overall Study|premature study closure|44
121731|NCT00885677|443948|P1|Overall Study|premature study closure|41
121732|NCT00885677|443947|P2|Overall Study|Protocol Violation|54
121733|NCT00885677|443948|P1|Overall Study|Protocol Violation|54
121734|NCT00885677|443947|P2|Overall Study|Lost to Follow-up|13
121735|NCT00885677|443948|P1|Overall Study|Lost to Follow-up|15
121736|NCT00885677|443947|P2|Overall Study|Death|34
121737|NCT00885677|443948|P1|Overall Study|Death|40
121738|NCT00885534|443964|P1|Overall Study|Patient deemed ineligible|1
121739|NCT00885482|443968|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
121740|NCT00885482|443968|P1|Overall Study|Death|1
121741|NCT00885482|443968|P1|Overall Study|Lack of Efficacy|1
121742|NCT00885482|443968|P1|Overall Study|Pregnancy|1
121743|NCT00885378|443974|P2|Overall Study|Protocol Violation|0
121744|NCT00885378|443975|P1|Overall Study|Protocol Violation|2
121745|NCT00885378|443974|P2|Overall Study|Poor/Noncompliance|2
121746|NCT00885378|443975|P1|Overall Study|Poor/Noncompliance|2
121747|NCT00885378|443974|P2|Overall Study|Lost to Follow-up|2
121748|NCT00885378|443975|P1|Overall Study|Lost to Follow-up|1
121749|NCT00885378|443974|P2|Overall Study|Withdrawal by Subject|2
121750|NCT00885378|443975|P1|Overall Study|Withdrawal by Subject|1
121751|NCT00885378|443974|P2|Overall Study|Lack of Efficacy|2
121752|NCT00885378|443975|P1|Overall Study|Lack of Efficacy|2
121753|NCT00885365|444005|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
121754|NCT00885365|444006|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
121755|NCT00885365|444005|P2|4 Weeks ON Treatment|Protocol Violation|2
121756|NCT00885365|444006|P1|4 Weeks ON Treatment|Protocol Violation|1
121757|NCT00885365|444005|P2|4 Weeks ON Treatment|Adverse Event|4
121758|NCT00885365|444006|P1|4 Weeks ON Treatment|Adverse Event|2
121759|NCT00885352|444042|P2|Overall Study|Lab abnormalities|1
121760|NCT00885352|444043|P1|Overall Study|Lab abnormalities|1
121761|NCT00885352|444042|P2|Overall Study|Excluded medication|2
121762|NCT00885352|444043|P1|Overall Study|Excluded medication|2
121763|NCT00885352|444042|P2|Overall Study|Contradiction to study medication|2
121764|NCT00885352|444043|P1|Overall Study|Contradiction to study medication|0
121765|NCT00885352|444042|P2|Overall Study|Withdrawal by Subject|5
121766|NCT00885352|444043|P1|Overall Study|Withdrawal by Subject|1
121767|NCT00885352|444042|P2|Overall Study|Protocol Violation|2
121768|NCT00885352|444043|P1|Overall Study|Protocol Violation|0
121769|NCT00885352|444042|P2|Overall Study|Physician Decision|3
121770|NCT00885352|444043|P1|Overall Study|Physician Decision|0
121771|NCT00885352|444042|P2|Overall Study|Lost to Follow-up|2
121772|NCT00885352|444043|P1|Overall Study|Lost to Follow-up|2
121773|NCT00885352|444042|P2|Overall Study|Adverse Event|3
121774|NCT00885352|444043|P1|Overall Study|Adverse Event|2
121775|NCT00885170|444055|P2|Overall Study|Withdrawal by Subject|13
121776|NCT00885170|444056|P1|Overall Study|Withdrawal by Subject|13
121777|NCT00885170|444055|P2|Overall Study|Protocol Violation|1
121778|NCT00885170|444056|P1|Overall Study|Protocol Violation|3
121779|NCT00885170|444055|P2|Overall Study|Physician Decision|1
121780|NCT00885170|444056|P1|Overall Study|Physician Decision|2
121781|NCT00885170|444055|P2|Overall Study|Lost to Follow-up|1
121782|NCT00885170|444056|P1|Overall Study|Lost to Follow-up|2
121783|NCT00885170|444055|P2|Overall Study|Excessive bone loss|3
121784|NCT00885170|444056|P1|Overall Study|Excessive bone loss|6
121785|NCT00885170|444055|P2|Overall Study|Adverse Event|4
121786|NCT00885170|444056|P1|Overall Study|Adverse Event|12
121787|NCT00885118|444115|P5|Overall Study|Other reason not defined above|0
121788|NCT00885118|444116|P4|Overall Study|Other reason not defined above|0
121789|NCT00885118|444117|P3|Overall Study|Other reason not defined above|1
121790|NCT00885118|444118|P2|Overall Study|Other reason not defined above|0
121791|NCT00885118|444119|P1|Overall Study|Other reason not defined above|0
121792|NCT00885118|444115|P5|Overall Study|Withdrawal by Subject|1
121793|NCT00885118|444116|P4|Overall Study|Withdrawal by Subject|0
121794|NCT00885118|444117|P3|Overall Study|Withdrawal by Subject|0
121795|NCT00885118|444118|P2|Overall Study|Withdrawal by Subject|0
121796|NCT00885118|444119|P1|Overall Study|Withdrawal by Subject|0
121797|NCT00885118|444115|P5|Overall Study|Adverse Event|0
121798|NCT00885118|444116|P4|Overall Study|Adverse Event|0
121799|NCT00885118|444117|P3|Overall Study|Adverse Event|0
121800|NCT00885118|444118|P2|Overall Study|Adverse Event|0
121801|NCT00885118|444119|P1|Overall Study|Adverse Event|1
121802|NCT00885105|444258|P2|Overall Study|Protocol Violation|2
121803|NCT00885105|444259|P1|Overall Study|Protocol Violation|0
121804|NCT00885105|444258|P2|Overall Study|Adverse Event|0
121805|NCT00885105|444259|P1|Overall Study|Adverse Event|1
121806|NCT00885105|444258|P2|Overall Study|Withdrawal by Subject|8
121807|NCT00885105|444259|P1|Overall Study|Withdrawal by Subject|0
121808|NCT00884949|444299|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
121809|NCT00884949|444299|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
121810|NCT00884832|444334|P2|Overall Study|Withdrawal by Subject|1
121811|NCT00884832|444335|P1|Overall Study|Withdrawal by Subject|0
121812|NCT00884793|444370|P1|Overall Study|Withdrawal by Subject|1
121813|NCT00884741|444389|P4|Randomization|Protocol Violation|8
121814|NCT00884741|444390|P3|Randomization|Protocol Violation|8
121815|NCT00884741|444391|P2|Randomization|Protocol Violation|0
121816|NCT00884741|444392|P1|Randomization|Protocol Violation|0
121817|NCT00884741|444389|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
121818|NCT00884741|444390|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
121819|NCT00884741|444391|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
121820|NCT00884741|444392|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
121821|NCT00884741|444389|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
121822|NCT00884741|444390|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
121823|NCT00884741|444391|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
121824|NCT00884741|444392|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
121825|NCT00884741|444389|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
121826|NCT00884741|444390|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
121827|NCT00884741|444391|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
121828|NCT00884741|444392|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
121829|NCT00884741|444389|P4|Step 2 Registration: Tissue Analysis|Death|0
121830|NCT00884741|444390|P3|Step 2 Registration: Tissue Analysis|Death|0
121831|NCT00884741|444391|P2|Step 2 Registration: Tissue Analysis|Death|1
121832|NCT00884741|444392|P1|Step 2 Registration: Tissue Analysis|Death|0
121833|NCT00884741|444389|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
121834|NCT00884741|444390|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
121835|NCT00884741|444391|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
121836|NCT00884741|444392|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
121837|NCT00884741|444389|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
121838|NCT00884741|444390|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
121839|NCT00884741|444391|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
121840|NCT00884741|444392|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
121841|NCT00884741|444389|P4|Step 1 Registration: Tissue Screening|Disease progression|0
121842|NCT00884741|444390|P3|Step 1 Registration: Tissue Screening|Disease progression|0
121843|NCT00884741|444391|P2|Step 1 Registration: Tissue Screening|Disease progression|0
121844|NCT00884741|444392|P1|Step 1 Registration: Tissue Screening|Disease progression|12
121845|NCT00884741|444389|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
121846|NCT00884741|444390|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
121847|NCT00884741|444391|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
121848|NCT00884741|444392|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
121849|NCT00884741|444389|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
121850|NCT00884741|444390|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
121851|NCT00884741|444391|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
121852|NCT00884741|444392|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
121853|NCT00884741|444389|P4|Step 1 Registration: Tissue Screening|Death|0
121854|NCT00884741|444390|P3|Step 1 Registration: Tissue Screening|Death|0
121855|NCT00884741|444391|P2|Step 1 Registration: Tissue Screening|Death|0
121856|NCT00884741|444392|P1|Step 1 Registration: Tissue Screening|Death|3
121857|NCT00884741|444389|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
121858|NCT00884741|444390|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
121859|NCT00884741|444391|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
121860|NCT00884741|444392|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
121861|NCT00884390|444442|P2|Overall Study|Not specified|1
121862|NCT00884390|444443|P1|Overall Study|Not specified|11
121863|NCT00884390|444442|P2|Overall Study|Discontinuation of Study by Sponsor|2
121864|NCT00884390|444443|P1|Overall Study|Discontinuation of Study by Sponsor|2
121865|NCT00884390|444442|P2|Overall Study|Withdrawal by Subject|1
121866|NCT00884390|444443|P1|Overall Study|Withdrawal by Subject|4
121867|NCT00884390|444442|P2|Overall Study|Protocol Violation|1
121868|NCT00884390|444443|P1|Overall Study|Protocol Violation|4
121869|NCT00884390|444442|P2|Overall Study|Physician Decision|1
121870|NCT00884390|444443|P1|Overall Study|Physician Decision|2
121871|NCT00884390|444442|P2|Overall Study|Lost to Follow-up|1
121872|NCT00884390|444443|P1|Overall Study|Lost to Follow-up|0
121873|NCT00884390|444442|P2|Overall Study|Adverse Event|1
121874|NCT00884390|444443|P1|Overall Study|Adverse Event|0
121875|NCT00884377|444461|P2|Overall Study|Physician Decision|1
121876|NCT00884377|444462|P1|Overall Study|Physician Decision|0
121877|NCT00884377|444461|P2|Overall Study|Could not confirm diagnosis|0
121878|NCT00884377|444462|P1|Overall Study|Could not confirm diagnosis|1
121879|NCT00884377|444461|P2|Overall Study|Withdrawal by Subject|0
121880|NCT00884377|444462|P1|Overall Study|Withdrawal by Subject|1
121881|NCT00884325|444484|P2|Overall Study|Not provided|0
121882|NCT00884325|444485|P1|Overall Study|Not provided|1
121883|NCT00884325|444484|P2|Overall Study|Withdrawal by Subject|1
121884|NCT00884325|444485|P1|Overall Study|Withdrawal by Subject|1
121885|NCT00884325|444484|P2|Overall Study|Lack of Efficacy|1
121886|NCT00884325|444485|P1|Overall Study|Lack of Efficacy|0
121887|NCT00884325|444484|P2|Overall Study|Lost to Follow-up|2
121888|NCT00884325|444485|P1|Overall Study|Lost to Follow-up|1
121889|NCT00884312|444495|P2|Overall Study|Did Not Receive Study Drug|1
121890|NCT00884312|444496|P1|Overall Study|Did Not Receive Study Drug|0
121891|NCT00884312|444495|P2|Overall Study|Other|4
121892|NCT00884312|444496|P1|Overall Study|Other|0
121893|NCT00884312|444495|P2|Overall Study|Physician Decision|1
121894|NCT00884312|444496|P1|Overall Study|Physician Decision|0
121895|NCT00884312|444495|P2|Overall Study|Withdrawal by Subject|6
121896|NCT00884312|444496|P1|Overall Study|Withdrawal by Subject|0
121897|NCT00884312|444495|P2|Overall Study|Fatal Adverse Event|4
121898|NCT00884312|444496|P1|Overall Study|Fatal Adverse Event|1
121899|NCT00884312|444495|P2|Overall Study|Non-fatal Adverse Event|0
121900|NCT00884312|444496|P1|Overall Study|Non-fatal Adverse Event|1
121901|NCT00884312|444495|P2|Overall Study|Fatal Progressive Disease|1
121902|NCT00884312|444496|P1|Overall Study|Fatal Progressive Disease|0
121903|NCT00884312|444495|P2|Overall Study|Non-fatal Progressive Disease|8
121904|NCT00884312|444496|P1|Overall Study|Non-fatal Progressive Disease|0
121905|NCT00884286|444512|P2|Overall Study|Comprised lung carcinoma|1
121906|NCT00884286|444513|P1|Overall Study|Comprised lung carcinoma|0
121907|NCT00884286|444512|P2|Overall Study|Not treated|1
121908|NCT00884286|444513|P1|Overall Study|Not treated|2
121909|NCT00884286|444512|P2|Overall Study|Thrombus in right auricle|0
121910|NCT00884286|444513|P1|Overall Study|Thrombus in right auricle|1
121911|NCT00884286|444512|P2|Overall Study|Septic shock|0
121912|NCT00884286|444513|P1|Overall Study|Septic shock|1
121913|NCT00884286|444512|P2|Overall Study|Physician Decision|0
121914|NCT00884286|444513|P1|Overall Study|Physician Decision|1
121915|NCT00884286|444512|P2|Overall Study|Death|2
121916|NCT00884286|444513|P1|Overall Study|Death|2
121917|NCT00884286|444512|P2|Overall Study|Toxicity|1
121918|NCT00884286|444513|P1|Overall Study|Toxicity|4
121919|NCT00884286|444512|P2|Overall Study|Progressive disease|28
121920|NCT00884286|444513|P1|Overall Study|Progressive disease|21
121921|NCT00884273|444527|P2|Overall Study|Practical reasons|0
121922|NCT00884273|444528|P1|Overall Study|Practical reasons|1
121923|NCT00884273|444527|P2|Overall Study|Protocol Violation|3
121924|NCT00884273|444528|P1|Overall Study|Protocol Violation|1
121925|NCT00884273|444527|P2|Overall Study|Adverse Event|2
121926|NCT00884273|444528|P1|Overall Study|Adverse Event|0
121927|NCT00884221|444554|P2|Overall Study|Cancellation of Cycle and Other Reason|13
121928|NCT00884221|444555|P1|Overall Study|Cancellation of Cycle and Other Reason|12
121929|NCT00884221|444554|P2|Overall Study|Protocol Violation|13
121930|NCT00884221|444555|P1|Overall Study|Protocol Violation|16
121931|NCT00884221|444554|P2|Overall Study|Adverse Event|3
121932|NCT00884221|444555|P1|Overall Study|Adverse Event|6
121933|NCT00884221|444554|P2|Overall Study|Withdrawal by Subject|3
121934|NCT00884221|444555|P1|Overall Study|Withdrawal by Subject|0
121935|NCT00884117|444591|P1|Overall Study|Not Specified|12
121936|NCT00884117|444591|P1|Overall Study|Lost to Follow-up|143
121937|NCT00884117|444591|P1|Overall Study|Death|3
121938|NCT00884117|444591|P1|Overall Study|Withdrawal by Subject|89
121939|NCT00884117|444591|P1|Overall Study|Adverse Event|2
121940|NCT00884039|444654|P2|Overall Study|Lack of Efficacy|0
121941|NCT00884039|444655|P1|Overall Study|Lack of Efficacy|2
121942|NCT00884039|444654|P2|Overall Study|Withdrawal by Subject|1
121943|NCT00884039|444655|P1|Overall Study|Withdrawal by Subject|0
121944|NCT00883779|444663|P2|Off-study Phase|Other|21
121945|NCT00883779|444664|P1|Off-study Phase|Other|18
121946|NCT00883779|444663|P2|Off-study Phase|Failure to return|6
121947|NCT00883779|444664|P1|Off-study Phase|Failure to return|5
121948|NCT00883779|444663|P2|Off-study Phase|Refused treatment|1
121949|NCT00883779|444664|P1|Off-study Phase|Refused treatment|1
121950|NCT00883779|444663|P2|Off-study Phase|Death|174
121951|NCT00883779|444664|P1|Off-study Phase|Death|185
121952|NCT00883779|444663|P2|Post-Study Treatment Phase|Ongoing in the study|6
121953|NCT00883779|444664|P1|Post-Study Treatment Phase|Ongoing in the study|0
121954|NCT00883779|444663|P2|Post-Study Treatment Phase|Other|0
121955|NCT00883779|444664|P1|Post-Study Treatment Phase|Other|3
121956|NCT00883779|444663|P2|Post-Study Treatment Phase|Disease progression|122
121957|NCT00883779|444664|P1|Post-Study Treatment Phase|Disease progression|103
121958|NCT00883779|444663|P2|Post-Study Treatment Phase|Refused Treatment|0
121959|NCT00883779|444664|P1|Post-Study Treatment Phase|Refused Treatment|3
121960|NCT00883779|444663|P2|Post-Study Treatment Phase|Protocol Violation|1
121961|NCT00883779|444664|P1|Post-Study Treatment Phase|Protocol Violation|0
121962|NCT00883779|444663|P2|Post-Study Treatment Phase|Death|3
121963|NCT00883779|444664|P1|Post-Study Treatment Phase|Death|1
121964|NCT00883779|444663|P2|Post-Study Treatment Phase|Adverse Event|3
121965|NCT00883779|444664|P1|Post-Study Treatment Phase|Adverse Event|2
121966|NCT00883779|444663|P2|Primary Study Treatment Phase|Other|0
121967|NCT00883779|444664|P1|Primary Study Treatment Phase|Other|3
121968|NCT00883779|444663|P2|Primary Study Treatment Phase|Refused Treatment|4
121969|NCT00883779|444664|P1|Primary Study Treatment Phase|Refused Treatment|5
121970|NCT00883779|444663|P2|Primary Study Treatment Phase|Death|3
121971|NCT00883779|444664|P1|Primary Study Treatment Phase|Death|2
121972|NCT00883779|444663|P2|Primary Study Treatment Phase|Adverse Event|16
121973|NCT00883779|444664|P1|Primary Study Treatment Phase|Adverse Event|16
121974|NCT00883779|444663|P2|Primary Study Treatment Phase|Disease progression|59
121975|NCT00883779|444664|P1|Primary Study Treatment Phase|Disease progression|75
121976|NCT00883779|444663|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
121977|NCT00883779|444664|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
121978|NCT00883753|444700|P1|Overall Study|Administrative/Other|8
121979|NCT00883753|444700|P1|Overall Study|Investigator's decision|17
121980|NCT00883753|444700|P1|Overall Study|Withdrew consent|10
121981|NCT00883753|444700|P1|Overall Study|Refused treatment|4
121982|NCT00883753|444700|P1|Overall Study|Protocol Violation|2
121983|NCT00883753|444700|P1|Overall Study|Violation of selection criteria at entry|7
121984|NCT00883753|444700|P1|Overall Study|Lost to Follow-up|4
121985|NCT00883753|444700|P1|Overall Study|Insufficient therapeutic response|16
121986|NCT00883753|444700|P1|Overall Study|Death|2
121987|NCT00883753|444700|P1|Overall Study|Adverse Event|37
121988|NCT00883740|444740|P2|Second Intervention|No longer willing to participate|1
121989|NCT00883740|444741|P1|Second Intervention|No longer willing to participate|0
121990|NCT00883740|444740|P2|Second Intervention|Protocol Violation|0
121991|NCT00883740|444741|P1|Second Intervention|Protocol Violation|1
121992|NCT00883740|444740|P2|First Intervention|Adverse Event|2
121993|NCT00883740|444741|P1|First Intervention|Adverse Event|1
121994|NCT00883740|444740|P2|First Intervention|Protocol Violation|6
121995|NCT00883740|444741|P1|First Intervention|Protocol Violation|3
121996|NCT00883740|444740|P2|First Intervention|No longer willing to participate|0
121997|NCT00883740|444741|P1|First Intervention|No longer willing to participate|2
121998|NCT00883740|444740|P2|First Intervention|Lost to Follow-up|0
121999|NCT00883740|444741|P1|First Intervention|Lost to Follow-up|1
122000|NCT00883558|444785|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
122001|NCT00883558|444786|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
122002|NCT00883558|444787|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
122003|NCT00883558|444785|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
122004|NCT00883558|444786|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
122005|NCT00883558|444787|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
122006|NCT00883558|444785|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
122007|NCT00883558|444786|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
122008|NCT00883558|444787|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
122009|NCT00883558|444785|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
122010|NCT00883558|444786|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
122011|NCT00883558|444787|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
122012|NCT00883558|444785|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
122013|NCT00883558|444786|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
122014|NCT00883558|444787|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
122015|NCT00883493|444799|P2|Overall Study|Not specified|3
122016|NCT00883493|444800|P1|Overall Study|Not specified|5
122017|NCT00883493|444799|P2|Overall Study|Study specific disc. criteria|0
122018|NCT00883493|444800|P1|Overall Study|Study specific disc. criteria|2
122019|NCT00883493|444799|P2|Overall Study|Eligibility Criteria not fullfilled|6
122020|NCT00883493|444800|P1|Overall Study|Eligibility Criteria not fullfilled|6
122021|NCT00883493|444799|P2|Overall Study|Withdrawal by Subject|20
122022|NCT00883493|444800|P1|Overall Study|Withdrawal by Subject|11
122023|NCT00883493|444799|P2|Overall Study|Lost to Follow-up|6
122024|NCT00883493|444800|P1|Overall Study|Lost to Follow-up|7
122025|NCT00883493|444799|P2|Overall Study|Lack of Efficacy|3
122026|NCT00883493|444800|P1|Overall Study|Lack of Efficacy|4
122027|NCT00883493|444799|P2|Overall Study|Adverse Event|12
122028|NCT00883493|444800|P1|Overall Study|Adverse Event|11
122029|NCT00883337|444831|P3|Extension Treatment Period|Other than above|5
122030|NCT00883337|444832|P2|Extension Treatment Period|Other than above|9
122031|NCT00883337|444833|P1|Extension Treatment Period|Other than above|10
122032|NCT00883337|444831|P3|Extension Treatment Period|Lost to Follow-up|0
122033|NCT00883337|444832|P2|Extension Treatment Period|Lost to Follow-up|0
122034|NCT00883337|444833|P1|Extension Treatment Period|Lost to Follow-up|1
122035|NCT00883337|444831|P3|Extension Treatment Period|Poor compliance to protocol|1
122036|NCT00883337|444832|P2|Extension Treatment Period|Poor compliance to protocol|1
122122|NCT00882908|445210|P4|Overall Study|Withdrawal by Subject|5
122037|NCT00883337|444833|P1|Extension Treatment Period|Poor compliance to protocol|1
122038|NCT00883337|444831|P3|Extension Treatment Period|Lack of Efficacy|8
122039|NCT00883337|444832|P2|Extension Treatment Period|Lack of Efficacy|8
122040|NCT00883337|444833|P1|Extension Treatment Period|Lack of Efficacy|8
122041|NCT00883337|444831|P3|Extension Treatment Period|Adverse Event|5
122042|NCT00883337|444832|P2|Extension Treatment Period|Adverse Event|5
122043|NCT00883337|444833|P1|Extension Treatment Period|Adverse Event|8
122044|NCT00883337|444831|P3|Core Treatment Period|Other than above|1
122045|NCT00883337|444832|P2|Core Treatment Period|Other than above|1
122046|NCT00883337|444833|P1|Core Treatment Period|Other than above|0
122047|NCT00883337|444831|P3|Core Treatment Period|Poor compliance to protocol|1
122048|NCT00883337|444832|P2|Core Treatment Period|Poor compliance to protocol|0
122049|NCT00883337|444833|P1|Core Treatment Period|Poor compliance to protocol|0
122050|NCT00883337|444831|P3|Core Treatment Period|Wish to be pregnant|1
122051|NCT00883337|444832|P2|Core Treatment Period|Wish to be pregnant|2
122052|NCT00883337|444833|P1|Core Treatment Period|Wish to be pregnant|1
122053|NCT00883337|444831|P3|Core Treatment Period|Withdrawal by Subject|6
122054|NCT00883337|444832|P2|Core Treatment Period|Withdrawal by Subject|2
122055|NCT00883337|444833|P1|Core Treatment Period|Withdrawal by Subject|2
122056|NCT00883337|444831|P3|Core Treatment Period|Lost to Follow-up|0
122057|NCT00883337|444832|P2|Core Treatment Period|Lost to Follow-up|1
122058|NCT00883337|444833|P1|Core Treatment Period|Lost to Follow-up|1
122059|NCT00883337|444831|P3|Core Treatment Period|Lack of Efficacy|2
122060|NCT00883337|444832|P2|Core Treatment Period|Lack of Efficacy|4
122061|NCT00883337|444833|P1|Core Treatment Period|Lack of Efficacy|7
122062|NCT00883337|444831|P3|Core Treatment Period|Adverse Event|22
122063|NCT00883337|444832|P2|Core Treatment Period|Adverse Event|12
122064|NCT00883337|444833|P1|Core Treatment Period|Adverse Event|9
122065|NCT00883181|444900|P1|Overall Study|Noncompliance|3
122066|NCT00883181|444900|P1|Overall Study|Protocol Deviation|3
122067|NCT00883181|444900|P1|Overall Study|Other|38
122068|NCT00883181|444900|P1|Overall Study|Death|31
122069|NCT00883181|444900|P1|Overall Study|Withdrawal by Subject|4
122070|NCT00883181|444900|P1|Overall Study|Administrative Reason|24
122071|NCT00883181|444900|P1|Overall Study|Disease Progression|94
122072|NCT00883181|444900|P1|Overall Study|Non-hematological Adverse Event|55
122073|NCT00883181|444900|P1|Overall Study|Hematological Adverse Event|26
122074|NCT00883129|445136|P2|Overall Study|Defined Treatment Failure|2
122075|NCT00883129|445137|P1|Overall Study|Defined Treatment Failure|0
122076|NCT00883129|445136|P2|Overall Study|Death|2
122077|NCT00883129|445137|P1|Overall Study|Death|1
122078|NCT00883129|445136|P2|Overall Study|Lost to Follow-up|2
122079|NCT00883129|445137|P1|Overall Study|Lost to Follow-up|1
122080|NCT00883129|445136|P2|Overall Study|Non-compliance|6
122081|NCT00883129|445137|P1|Overall Study|Non-compliance|3
122082|NCT00883129|445136|P2|Overall Study|Withdrawal by Subject|9
122083|NCT00883129|445137|P1|Overall Study|Withdrawal by Subject|8
122084|NCT00883129|445136|P2|Overall Study|Adverse Event|15
122085|NCT00883129|445137|P1|Overall Study|Adverse Event|7
122086|NCT00883116|445161|P2|Overall Study|No longer meets study criteria|2
122087|NCT00883116|445162|P1|Overall Study|No longer meets study criteria|2
122088|NCT00883116|445161|P2|Overall Study|Withdrawal by Subject|8
122089|NCT00883116|445162|P1|Overall Study|Withdrawal by Subject|14
122090|NCT00883116|445161|P2|Overall Study|Study drug toxicity|16
122091|NCT00883116|445162|P1|Overall Study|Study drug toxicity|36
122092|NCT00883116|445161|P2|Overall Study|Not identified|6
122093|NCT00883116|445162|P1|Overall Study|Not identified|3
122094|NCT00883116|445161|P2|Overall Study|Maximum clinical benefit|46
122095|NCT00883116|445162|P1|Overall Study|Maximum clinical benefit|13
122096|NCT00883116|445161|P2|Overall Study|Lost to Follow-up|1
122097|NCT00883116|445162|P1|Overall Study|Lost to Follow-up|0
122098|NCT00883116|445161|P2|Overall Study|Disease progression|128
122099|NCT00883116|445162|P1|Overall Study|Disease progression|130
122100|NCT00883116|445161|P2|Overall Study|Death|2
122101|NCT00883116|445162|P1|Overall Study|Death|6
122102|NCT00883116|445161|P2|Overall Study|Adverse event unrelated to study drug|10
122103|NCT00883116|445162|P1|Overall Study|Adverse event unrelated to study drug|5
122104|NCT00883090|445184|P1|Overall Study|Withdrawal by Subject|1
122105|NCT00883090|445184|P1|Overall Study|Sponsor's decision|1
122106|NCT00882921|445199|P1|Overall Study|Withdrawal Of Consent|1
122107|NCT00882921|445199|P1|Overall Study|Termination By Investigator|3
122108|NCT00882921|445199|P1|Overall Study|Lost to Follow-up|2
122109|NCT00882921|445199|P1|Overall Study|Not specified|3
122110|NCT00882921|445199|P1|Overall Study|Death|2
122111|NCT00882908|445209|P5|Overall Study|Study terminated in error|0
122112|NCT00882908|445210|P4|Overall Study|Study terminated in error|1
122113|NCT00882908|445211|P3|Overall Study|Study terminated in error|0
122114|NCT00882908|445212|P2|Overall Study|Study terminated in error|0
122115|NCT00882908|445213|P1|Overall Study|Study terminated in error|0
122116|NCT00882908|445209|P5|Overall Study|Subject reached a virologic endpoint|1
122117|NCT00882908|445210|P4|Overall Study|Subject reached a virologic endpoint|0
122118|NCT00882908|445211|P3|Overall Study|Subject reached a virologic endpoint|0
122119|NCT00882908|445212|P2|Overall Study|Subject reached a virologic endpoint|0
122120|NCT00882908|445213|P1|Overall Study|Subject reached a virologic endpoint|0
122121|NCT00882908|445209|P5|Overall Study|Withdrawal by Subject|2
122123|NCT00882908|445211|P3|Overall Study|Withdrawal by Subject|3
122124|NCT00882908|445212|P2|Overall Study|Withdrawal by Subject|0
122125|NCT00882908|445213|P1|Overall Study|Withdrawal by Subject|0
122126|NCT00882908|445209|P5|Overall Study|Protocol Violation|0
122127|NCT00882908|445210|P4|Overall Study|Protocol Violation|0
122128|NCT00882908|445211|P3|Overall Study|Protocol Violation|0
122129|NCT00882908|445212|P2|Overall Study|Protocol Violation|1
122130|NCT00882908|445213|P1|Overall Study|Protocol Violation|0
122131|NCT00882908|445209|P5|Overall Study|Lost to Follow-up|2
122132|NCT00882908|445210|P4|Overall Study|Lost to Follow-up|1
122133|NCT00882908|445211|P3|Overall Study|Lost to Follow-up|3
122134|NCT00882908|445212|P2|Overall Study|Lost to Follow-up|5
122135|NCT00882908|445213|P1|Overall Study|Lost to Follow-up|3
122136|NCT00882908|445209|P5|Overall Study|Adverse Event|1
122137|NCT00882908|445210|P4|Overall Study|Adverse Event|0
122138|NCT00882908|445211|P3|Overall Study|Adverse Event|1
122139|NCT00882908|445212|P2|Overall Study|Adverse Event|0
122140|NCT00882908|445213|P1|Overall Study|Adverse Event|0
122141|NCT00882713|445319|P1|Overall Study|Other - Reasons|2
122142|NCT00882713|445319|P1|Overall Study|Failure to return|2
122143|NCT00882713|445319|P1|Overall Study|Insufficient therapeutic response|3
122144|NCT00882713|445319|P1|Overall Study|Blood transfusion|2
122145|NCT00882713|445319|P1|Overall Study|refused treatment/withdrew consent|4
122146|NCT00882713|445319|P1|Overall Study|Administrative reasons|4
122147|NCT00882713|445319|P1|Overall Study|Death|3
122148|NCT00882713|445319|P1|Overall Study|Adverse Event|2
122149|NCT00882583|445412|P2|Overall Study|Adverse Event|1
122150|NCT00882583|445413|P1|Overall Study|Adverse Event|0
122151|NCT00882583|445412|P2|Overall Study|Physician Decision|0
122152|NCT00882583|445413|P1|Overall Study|Physician Decision|1
122153|NCT00882557|445421|P2|Overall Study|Randomized Not Treated|1
122154|NCT00882557|445422|P1|Overall Study|Randomized Not Treated|0
122155|NCT00882557|445421|P2|Overall Study|Trouble with Vein Access|0
122156|NCT00882557|445422|P1|Overall Study|Trouble with Vein Access|1
122157|NCT00882557|445421|P2|Overall Study|Withdrawal by Subject|0
122158|NCT00882557|445422|P1|Overall Study|Withdrawal by Subject|1
122159|NCT00882518|445442|P2|Overall Study|Allocating random number by mistake|1
122160|NCT00882518|445443|P1|Overall Study|Allocating random number by mistake|0
122161|NCT00882518|445442|P2|Overall Study|Central lab closure for National day|0
122162|NCT00882518|445443|P1|Overall Study|Central lab closure for National day|1
122163|NCT00882518|445442|P2|Overall Study|Incorrect enrolment|2
122164|NCT00882518|445443|P1|Overall Study|Incorrect enrolment|4
122165|NCT00882518|445442|P2|Overall Study|Severe non-compliance to protocol|1
122166|NCT00882518|445443|P1|Overall Study|Severe non-compliance to protocol|3
122167|NCT00882518|445442|P2|Overall Study|Lack of Efficacy|9
122168|NCT00882518|445443|P1|Overall Study|Lack of Efficacy|12
122169|NCT00882518|445442|P2|Overall Study|Withdrawal by Subject|13
122170|NCT00882518|445443|P1|Overall Study|Withdrawal by Subject|9
122171|NCT00882518|445442|P2|Overall Study|Adverse Event|18
122172|NCT00882518|445443|P1|Overall Study|Adverse Event|9
122173|NCT00882440|445472|P7|Overall Study|Patient Uncooperative|0
122174|NCT00882440|445473|P6|Overall Study|Patient Uncooperative|0
122175|NCT00882440|445474|P5|Overall Study|Patient Uncooperative|1
122176|NCT00882440|445475|P4|Overall Study|Patient Uncooperative|0
122177|NCT00882440|445476|P3|Overall Study|Patient Uncooperative|0
122178|NCT00882440|445477|P2|Overall Study|Patient Uncooperative|0
122179|NCT00882440|445478|P1|Overall Study|Patient Uncooperative|2
122180|NCT00882440|445472|P7|Overall Study|Withdrawal by Subject|1
122181|NCT00882440|445473|P6|Overall Study|Withdrawal by Subject|0
122182|NCT00882440|445474|P5|Overall Study|Withdrawal by Subject|6
122183|NCT00882440|445475|P4|Overall Study|Withdrawal by Subject|0
122184|NCT00882440|445476|P3|Overall Study|Withdrawal by Subject|1
122185|NCT00882440|445477|P2|Overall Study|Withdrawal by Subject|1
122186|NCT00882440|445478|P1|Overall Study|Withdrawal by Subject|2
122187|NCT00882440|445472|P7|Overall Study|Protocol Violation|0
122188|NCT00882440|445473|P6|Overall Study|Protocol Violation|0
122189|NCT00882440|445474|P5|Overall Study|Protocol Violation|1
122190|NCT00882440|445475|P4|Overall Study|Protocol Violation|1
122191|NCT00882440|445476|P3|Overall Study|Protocol Violation|1
122192|NCT00882440|445477|P2|Overall Study|Protocol Violation|0
122193|NCT00882440|445478|P1|Overall Study|Protocol Violation|0
122194|NCT00882440|445472|P7|Overall Study|Lost to Follow-up|1
122195|NCT00882440|445473|P6|Overall Study|Lost to Follow-up|0
122196|NCT00882440|445474|P5|Overall Study|Lost to Follow-up|1
122197|NCT00882440|445475|P4|Overall Study|Lost to Follow-up|1
122198|NCT00882440|445476|P3|Overall Study|Lost to Follow-up|1
122199|NCT00882440|445477|P2|Overall Study|Lost to Follow-up|0
122200|NCT00882440|445478|P1|Overall Study|Lost to Follow-up|2
122201|NCT00882440|445472|P7|Overall Study|Lack of Efficacy|0
122202|NCT00882440|445473|P6|Overall Study|Lack of Efficacy|3
122203|NCT00882440|445474|P5|Overall Study|Lack of Efficacy|0
122204|NCT00882440|445475|P4|Overall Study|Lack of Efficacy|0
122205|NCT00882440|445476|P3|Overall Study|Lack of Efficacy|2
122206|NCT00882440|445477|P2|Overall Study|Lack of Efficacy|5
122207|NCT00882440|445478|P1|Overall Study|Lack of Efficacy|3
122208|NCT00882440|445472|P7|Overall Study|Adverse Event|2
122209|NCT00882440|445473|P6|Overall Study|Adverse Event|4
122210|NCT00882440|445474|P5|Overall Study|Adverse Event|1
122211|NCT00882440|445475|P4|Overall Study|Adverse Event|1
122212|NCT00882440|445476|P3|Overall Study|Adverse Event|2
122213|NCT00882440|445477|P2|Overall Study|Adverse Event|2
122214|NCT00882440|445478|P1|Overall Study|Adverse Event|2
122215|NCT00882362|445503|P2|Overall Study|change of residence or other commitments|0
122216|NCT00882362|445504|P1|Overall Study|change of residence or other commitments|5
122217|NCT00882362|445503|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
122218|NCT00882362|445504|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
122219|NCT00882362|445503|P2|Overall Study|Physician Decision|1
122220|NCT00882362|445504|P1|Overall Study|Physician Decision|5
122221|NCT00882362|445503|P2|Overall Study|Pregnancy|0
122222|NCT00882362|445504|P1|Overall Study|Pregnancy|1
122223|NCT00882362|445503|P2|Overall Study|Protocol Violation|2
122224|NCT00882362|445504|P1|Overall Study|Protocol Violation|7
122225|NCT00882362|445503|P2|Overall Study|Lack of Efficacy|0
122226|NCT00882362|445504|P1|Overall Study|Lack of Efficacy|3
122227|NCT00882362|445503|P2|Overall Study|Withdrawal by Subject|10
122228|NCT00882362|445504|P1|Overall Study|Withdrawal by Subject|13
122229|NCT00882362|445503|P2|Overall Study|Adverse Event|10
122230|NCT00882362|445504|P1|Overall Study|Adverse Event|13
122231|NCT00882310|445510|P1|Overall Study|Adverse Event|1
122232|NCT00882310|445510|P1|Overall Study|Progression of disease|4
122233|NCT00882310|445510|P1|Overall Study|Death|6
122234|NCT00882310|445510|P1|Overall Study|Never received treatment|1
122235|NCT00882310|445510|P1|Overall Study|Screen Failure|10
122236|NCT00881959|445529|P2|Overall Study|Lost to Follow-up|4
122237|NCT00881959|445530|P1|Overall Study|Lost to Follow-up|2
122238|NCT00881894|445538|P2|Overall Study|Other reasons for premature termination|2
122239|NCT00881894|445539|P1|Overall Study|Other reasons for premature termination|1
122240|NCT00881894|445538|P2|Overall Study|Consent withdrawn|1
122241|NCT00881894|445539|P1|Overall Study|Consent withdrawn|0
122242|NCT00881868|445571|P2|Overall Study|Protocol Violation|0
122243|NCT00881868|445572|P1|Overall Study|Protocol Violation|2
122244|NCT00881868|445571|P2|Overall Study|Physician Decision|0
122245|NCT00881868|445572|P1|Overall Study|Physician Decision|4
122246|NCT00881868|445571|P2|Overall Study|Lost to Follow-up|1
122247|NCT00881868|445572|P1|Overall Study|Lost to Follow-up|2
122248|NCT00881868|445571|P2|Overall Study|Adverse Event|1
122249|NCT00881868|445572|P1|Overall Study|Adverse Event|0
122250|NCT00881751|445586|P2|Overall Study|Withdrawal by Subject|2
122251|NCT00881751|445587|P1|Overall Study|Withdrawal by Subject|0
122252|NCT00881751|445586|P2|Overall Study|Adverse Event|2
122253|NCT00881751|445587|P1|Overall Study|Adverse Event|0
122254|NCT00881751|445586|P2|Overall Study|Physician Decision|1
122255|NCT00881751|445587|P1|Overall Study|Physician Decision|0
122256|NCT00881712|445602|P3|Overall Study|Withdrawal by Subject|0
122257|NCT00881712|445603|P2|Overall Study|Withdrawal by Subject|0
122258|NCT00881712|445604|P1|Overall Study|Withdrawal by Subject|1
122259|NCT00881712|445602|P3|Overall Study|Death|0
122260|NCT00881712|445603|P2|Overall Study|Death|0
122261|NCT00881712|445604|P1|Overall Study|Death|1
122262|NCT00881621|445637|P1|Overall Study|Physician Decision|34
122263|NCT00881608|445649|P1|Overall Study|Study prematurely terminated|11
122264|NCT00881530|445672|P6|Overall Study|Other reason not defined above|2
122265|NCT00881530|445673|P5|Overall Study|Other reason not defined above|0
122266|NCT00881530|445674|P4|Overall Study|Other reason not defined above|0
122267|NCT00881530|445675|P3|Overall Study|Other reason not defined above|2
122268|NCT00881530|445676|P2|Overall Study|Other reason not defined above|1
122269|NCT00881530|445677|P1|Overall Study|Other reason not defined above|1
122270|NCT00881530|445672|P6|Overall Study|Refused to continue medication|0
122271|NCT00881530|445673|P5|Overall Study|Refused to continue medication|0
122272|NCT00881530|445674|P4|Overall Study|Refused to continue medication|2
122273|NCT00881530|445675|P3|Overall Study|Refused to continue medication|1
122274|NCT00881530|445676|P2|Overall Study|Refused to continue medication|2
122275|NCT00881530|445677|P1|Overall Study|Refused to continue medication|7
122276|NCT00881530|445672|P6|Overall Study|Lost to Follow-up|0
122277|NCT00881530|445673|P5|Overall Study|Lost to Follow-up|1
122278|NCT00881530|445674|P4|Overall Study|Lost to Follow-up|3
122279|NCT00881530|445675|P3|Overall Study|Lost to Follow-up|1
122280|NCT00881530|445676|P2|Overall Study|Lost to Follow-up|1
122281|NCT00881530|445677|P1|Overall Study|Lost to Follow-up|0
122282|NCT00881530|445672|P6|Overall Study|Not compliant with the protocol|0
122283|NCT00881530|445673|P5|Overall Study|Not compliant with the protocol|2
122284|NCT00881530|445674|P4|Overall Study|Not compliant with the protocol|0
122285|NCT00881530|445675|P3|Overall Study|Not compliant with the protocol|0
122286|NCT00881530|445676|P2|Overall Study|Not compliant with the protocol|0
122287|NCT00881530|445677|P1|Overall Study|Not compliant with the protocol|0
122288|NCT00881530|445672|P6|Overall Study|Lack of Efficacy|1
122289|NCT00881530|445673|P5|Overall Study|Lack of Efficacy|1
122290|NCT00881530|445674|P4|Overall Study|Lack of Efficacy|0
122291|NCT00881530|445675|P3|Overall Study|Lack of Efficacy|0
122292|NCT00881530|445676|P2|Overall Study|Lack of Efficacy|0
122293|NCT00881530|445677|P1|Overall Study|Lack of Efficacy|1
122294|NCT00881530|445672|P6|Overall Study|Adverse Event|2
122295|NCT00881530|445673|P5|Overall Study|Adverse Event|10
122296|NCT00881530|445674|P4|Overall Study|Adverse Event|4
122297|NCT00881530|445675|P3|Overall Study|Adverse Event|1
122298|NCT00881530|445676|P2|Overall Study|Adverse Event|1
122299|NCT00881530|445677|P1|Overall Study|Adverse Event|5
122300|NCT00881504|445733|P1|Overall Study|Withdrawal by Subject|1
122301|NCT00881335|445753|P2|Overall Study|Lost to Follow-up|2
122302|NCT00881335|445754|P1|Overall Study|Lost to Follow-up|3
122303|NCT00881205|445774|P2|Overall Study|Condition no longer requires drug|0
122304|NCT00881205|445775|P1|Overall Study|Condition no longer requires drug|1
122305|NCT00881205|445774|P2|Overall Study|Administrative problems|1
122306|NCT00881205|445775|P1|Overall Study|Administrative problems|1
122307|NCT00881205|445774|P2|Overall Study|Lost to Follow-up|1
122308|NCT00881205|445775|P1|Overall Study|Lost to Follow-up|0
122309|NCT00881205|445774|P2|Overall Study|Withdrawal by Subject|2
122310|NCT00881205|445775|P1|Overall Study|Withdrawal by Subject|1
122311|NCT00881205|445774|P2|Overall Study|Adverse Event|3
122312|NCT00881205|445775|P1|Overall Study|Adverse Event|8
122313|NCT00880906|445821|P2|Overall Study|Did not meet criteria following patholog|6
122314|NCT00880906|445822|P1|Overall Study|Did not meet criteria following patholog|12
122315|NCT00880906|445821|P2|Overall Study|Lost to Follow-up|1
122316|NCT00880906|445822|P1|Overall Study|Lost to Follow-up|0
122317|NCT00880763|445834|P4|Extension Period (Part 2)|Lack of Efficacy|1
122318|NCT00880763|445835|P3|Extension Period (Part 2)|Lack of Efficacy|0
122319|NCT00880763|445836|P2|Extension Period (Part 2)|Lack of Efficacy|0
122320|NCT00880763|445837|P1|Extension Period (Part 2)|Lack of Efficacy|0
122321|NCT00880763|445834|P4|Extension Period (Part 2)|Physician Decision|0
122322|NCT00880763|445835|P3|Extension Period (Part 2)|Physician Decision|1
122323|NCT00880763|445836|P2|Extension Period (Part 2)|Physician Decision|1
122324|NCT00880763|445837|P1|Extension Period (Part 2)|Physician Decision|0
122325|NCT00880763|445834|P4|Extension Period (Part 2)|Withdrawal by Subject|1
122326|NCT00880763|445835|P3|Extension Period (Part 2)|Withdrawal by Subject|1
122327|NCT00880763|445836|P2|Extension Period (Part 2)|Withdrawal by Subject|2
122328|NCT00880763|445837|P1|Extension Period (Part 2)|Withdrawal by Subject|0
122329|NCT00880763|445834|P4|Extension Period (Part 2)|Adverse Event|1
122330|NCT00880763|445835|P3|Extension Period (Part 2)|Adverse Event|1
122331|NCT00880763|445836|P2|Extension Period (Part 2)|Adverse Event|0
122332|NCT00880763|445837|P1|Extension Period (Part 2)|Adverse Event|0
122333|NCT00880750|445869|P2|Second Intervention|Unable to collect urine|0
122334|NCT00880750|445870|P1|Second Intervention|Unable to collect urine|1
122335|NCT00880750|445869|P2|Second Intervention|Protocol Violation|0
122336|NCT00880750|445870|P1|Second Intervention|Protocol Violation|1
122337|NCT00880750|445869|P2|Second Intervention|Withdrawal by Subject|2
122338|NCT00880750|445870|P1|Second Intervention|Withdrawal by Subject|2
122339|NCT00880750|445869|P2|First Intervention|Lost to Follow-up|0
122340|NCT00880750|445870|P1|First Intervention|Lost to Follow-up|2
122341|NCT00880750|445869|P2|First Intervention|Withdrawal by Subject|0
122342|NCT00880750|445870|P1|First Intervention|Withdrawal by Subject|2
122343|NCT00880750|445869|P2|First Intervention|Non-compliance with meals|1
122344|NCT00880750|445870|P1|First Intervention|Non-compliance with meals|0
122345|NCT00880750|445869|P2|First Intervention|Unable to collect urine|0
122346|NCT00880750|445870|P1|First Intervention|Unable to collect urine|4
122347|NCT00880750|445869|P2|First Intervention|Adverse Event|0
122348|NCT00880750|445870|P1|First Intervention|Adverse Event|1
122349|NCT00880698|445888|P4|Overall Study|Lost to Follow-up|1
122350|NCT00880698|445889|P3|Overall Study|Lost to Follow-up|0
122351|NCT00880698|445890|P2|Overall Study|Lost to Follow-up|3
122352|NCT00880698|445891|P1|Overall Study|Lost to Follow-up|1
122353|NCT00880698|445888|P4|Overall Study|Death|2
122354|NCT00880698|445889|P3|Overall Study|Death|1
122355|NCT00880698|445890|P2|Overall Study|Death|0
122356|NCT00880698|445891|P1|Overall Study|Death|0
122357|NCT00880685|445917|P1|Memantine 20mg|Withdrawal by Subject|1
122358|NCT00880685|445917|P1|Memantine 10mg|Lost to Follow-up|2
122359|NCT00880620|445929|P4|Overall Study|Not specified|2
122360|NCT00880620|445930|P3|Overall Study|Not specified|2
122361|NCT00880620|445931|P2|Overall Study|Not specified|1
122362|NCT00880620|445932|P1|Overall Study|Not specified|1
122363|NCT00880620|445929|P4|Overall Study|Noncompliance|1
122364|NCT00880620|445930|P3|Overall Study|Noncompliance|1
122365|NCT00880620|445931|P2|Overall Study|Noncompliance|0
122366|NCT00880620|445932|P1|Overall Study|Noncompliance|0
122367|NCT00880620|445929|P4|Overall Study|Withdrawal by Subject|3
122368|NCT00880620|445930|P3|Overall Study|Withdrawal by Subject|1
122369|NCT00880620|445931|P2|Overall Study|Withdrawal by Subject|3
122370|NCT00880620|445932|P1|Overall Study|Withdrawal by Subject|4
122371|NCT00880620|445929|P4|Overall Study|Protocol Violation|2
122372|NCT00880620|445930|P3|Overall Study|Protocol Violation|0
122373|NCT00880620|445931|P2|Overall Study|Protocol Violation|1
122374|NCT00880620|445932|P1|Overall Study|Protocol Violation|0
122375|NCT00880620|445929|P4|Overall Study|Lost to Follow-up|0
122376|NCT00880620|445930|P3|Overall Study|Lost to Follow-up|1
122377|NCT00880620|445931|P2|Overall Study|Lost to Follow-up|1
122378|NCT00880620|445932|P1|Overall Study|Lost to Follow-up|0
122379|NCT00880620|445929|P4|Overall Study|Lack of Efficacy|1
122380|NCT00880620|445930|P3|Overall Study|Lack of Efficacy|0
122381|NCT00880620|445931|P2|Overall Study|Lack of Efficacy|4
122382|NCT00880620|445932|P1|Overall Study|Lack of Efficacy|12
122383|NCT00880620|445929|P4|Overall Study|Death|0
122384|NCT00880620|445930|P3|Overall Study|Death|1
122385|NCT00880620|445931|P2|Overall Study|Death|0
122386|NCT00880620|445932|P1|Overall Study|Death|0
122387|NCT00880620|445929|P4|Overall Study|Adverse Event|15
122388|NCT00880620|445930|P3|Overall Study|Adverse Event|15
122389|NCT00880620|445931|P2|Overall Study|Adverse Event|5
122390|NCT00880620|445932|P1|Overall Study|Adverse Event|4
122391|NCT00880568|445960|P9|Overall Study|Withdrawal by Subject|0
122392|NCT00880568|445961|P8|Overall Study|Withdrawal by Subject|1
122393|NCT00880568|445962|P7|Overall Study|Withdrawal by Subject|0
122394|NCT00880568|445963|P6|Overall Study|Withdrawal by Subject|0
122395|NCT00880568|445964|P5|Overall Study|Withdrawal by Subject|0
122396|NCT00880568|445965|P4|Overall Study|Withdrawal by Subject|0
122397|NCT00880568|445966|P3|Overall Study|Withdrawal by Subject|0
122398|NCT00880568|445967|P2|Overall Study|Withdrawal by Subject|0
122399|NCT00880568|445968|P1|Overall Study|Withdrawal by Subject|0
122400|NCT00880568|445960|P9|Overall Study|Adverse Event|0
122401|NCT00880568|445961|P8|Overall Study|Adverse Event|1
122402|NCT00880568|445962|P7|Overall Study|Adverse Event|1
122403|NCT00880568|445963|P6|Overall Study|Adverse Event|0
122404|NCT00880568|445964|P5|Overall Study|Adverse Event|0
122405|NCT00880568|445965|P4|Overall Study|Adverse Event|0
122406|NCT00880568|445966|P3|Overall Study|Adverse Event|0
122407|NCT00880568|445967|P2|Overall Study|Adverse Event|0
122408|NCT00880568|445968|P1|Overall Study|Adverse Event|0
122409|NCT00880568|445960|P9|Overall Study|Disease progression|3
122410|NCT00880568|445961|P8|Overall Study|Disease progression|0
122411|NCT00880568|445962|P7|Overall Study|Disease progression|5
122412|NCT00880568|445963|P6|Overall Study|Disease progression|3
122413|NCT00880568|445964|P5|Overall Study|Disease progression|3
122414|NCT00880568|445965|P4|Overall Study|Disease progression|1
122415|NCT00880568|445966|P3|Overall Study|Disease progression|3
122416|NCT00880568|445967|P2|Overall Study|Disease progression|3
122417|NCT00880568|445968|P1|Overall Study|Disease progression|3
122418|NCT00880555|446014|P6|Overall Study|Lost to Follow-up|0
122419|NCT00880555|446015|P5|Overall Study|Lost to Follow-up|0
122420|NCT00880555|446016|P4|Overall Study|Lost to Follow-up|0
122421|NCT00880555|446017|P3|Overall Study|Lost to Follow-up|0
122422|NCT00880555|446018|P2|Overall Study|Lost to Follow-up|1
122423|NCT00880555|446019|P1|Overall Study|Lost to Follow-up|0
122424|NCT00880555|446014|P6|Overall Study|Death|1
122425|NCT00880555|446015|P5|Overall Study|Death|0
122426|NCT00880555|446016|P4|Overall Study|Death|0
122427|NCT00880555|446017|P3|Overall Study|Death|0
122428|NCT00880555|446018|P2|Overall Study|Death|0
122429|NCT00880555|446019|P1|Overall Study|Death|0
122430|NCT00880555|446014|P6|Overall Study|Lack of resources (hired rater)|0
122431|NCT00880555|446015|P5|Overall Study|Lack of resources (hired rater)|0
122432|NCT00880555|446016|P4|Overall Study|Lack of resources (hired rater)|0
122433|NCT00880555|446017|P3|Overall Study|Lack of resources (hired rater)|5
122434|NCT00880555|446018|P2|Overall Study|Lack of resources (hired rater)|7
122435|NCT00880555|446019|P1|Overall Study|Lack of resources (hired rater)|9
122436|NCT00880555|446014|P6|Overall Study|Withdrawal by Subject|0
122437|NCT00880555|446015|P5|Overall Study|Withdrawal by Subject|0
122438|NCT00880555|446016|P4|Overall Study|Withdrawal by Subject|0
122439|NCT00880555|446017|P3|Overall Study|Withdrawal by Subject|0
122440|NCT00880555|446018|P2|Overall Study|Withdrawal by Subject|1
122441|NCT00880555|446019|P1|Overall Study|Withdrawal by Subject|1
122442|NCT00880555|446014|P6|Overall Study|Physician Decision|0
122443|NCT00880555|446015|P5|Overall Study|Physician Decision|1
122444|NCT00880555|446016|P4|Overall Study|Physician Decision|2
122445|NCT00880555|446017|P3|Overall Study|Physician Decision|0
122446|NCT00880555|446018|P2|Overall Study|Physician Decision|8
122447|NCT00880555|446019|P1|Overall Study|Physician Decision|0
122448|NCT00880542|446030|P1|REP: Surgical Resection|progressive disease|1
122449|NCT00880542|446030|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
122450|NCT00880542|446030|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
122451|NCT00880399|446047|P3|Overall Study|Withdrawal by Subject|3
122452|NCT00880399|446048|P2|Overall Study|Withdrawal by Subject|3
122453|NCT00880399|446049|P1|Overall Study|Withdrawal by Subject|6
122454|NCT00880399|446047|P3|Overall Study|Physician Decision|3
122455|NCT00880399|446048|P2|Overall Study|Physician Decision|0
122456|NCT00880399|446049|P1|Overall Study|Physician Decision|5
122457|NCT00880399|446047|P3|Overall Study|Lost to Follow-up|3
122458|NCT00880399|446048|P2|Overall Study|Lost to Follow-up|5
122459|NCT00880399|446049|P1|Overall Study|Lost to Follow-up|8
122460|NCT00880399|446047|P3|Overall Study|Study closed/terminated|4
122461|NCT00880399|446048|P2|Overall Study|Study closed/terminated|7
122462|NCT00880399|446049|P1|Overall Study|Study closed/terminated|3
122463|NCT00880399|446047|P3|Overall Study|Protocol Violation|6
122464|NCT00880399|446048|P2|Overall Study|Protocol Violation|4
122465|NCT00880399|446049|P1|Overall Study|Protocol Violation|4
122466|NCT00880399|446047|P3|Overall Study|Lack of Efficacy|2
122467|NCT00880399|446048|P2|Overall Study|Lack of Efficacy|4
122468|NCT00880399|446049|P1|Overall Study|Lack of Efficacy|1
122469|NCT00880399|446047|P3|Overall Study|Adverse Event|5
122470|NCT00880399|446048|P2|Overall Study|Adverse Event|6
122471|NCT00880399|446049|P1|Overall Study|Adverse Event|4
122472|NCT00880334|446112|P2|Overall Study|Brain Metastasis|1
122473|NCT00880334|446113|P1|Overall Study|Brain Metastasis|0
122474|NCT00880334|446112|P2|Overall Study|Inadequate Labs|1
122475|NCT00880334|446113|P1|Overall Study|Inadequate Labs|1
122476|NCT00880334|446112|P2|Overall Study|Withdrawal by Subject|1
122477|NCT00880334|446113|P1|Overall Study|Withdrawal by Subject|2
122478|NCT00880334|446112|P2|Overall Study|Physician Decision|0
122479|NCT00880334|446113|P1|Overall Study|Physician Decision|1
122480|NCT00880269|446129|P2|Overall Study|Adverse Event|9
122481|NCT00880269|446130|P1|Overall Study|Adverse Event|10
122482|NCT00880269|446129|P2|Overall Study|Withdrawal by Subject|4
122483|NCT00880269|446130|P1|Overall Study|Withdrawal by Subject|3
122484|NCT00880269|446129|P2|Overall Study|Lost to Follow-up|1
122485|NCT00880269|446130|P1|Overall Study|Lost to Follow-up|0
122486|NCT00880269|446129|P2|Overall Study|Death|2
122487|NCT00880269|446130|P1|Overall Study|Death|4
122488|NCT00880269|446129|P2|Overall Study|New Cancer Therapy|0
122489|NCT00880269|446130|P1|Overall Study|New Cancer Therapy|1
122490|NCT00880269|446129|P2|Overall Study|Disease Progression|11
122491|NCT00880269|446130|P1|Overall Study|Disease Progression|13
122492|NCT00880269|446129|P2|Overall Study|Protocol Violation|0
122493|NCT00880269|446130|P1|Overall Study|Protocol Violation|1
122494|NCT00880256|446146|P1|Overall Study|Lost to Follow-up|28
122495|NCT00880191|446173|P2|Overall Study|Hospitalization/efficacy|1
122496|NCT00880191|446174|P1|Overall Study|Hospitalization/efficacy|1
122497|NCT00880191|446173|P2|Overall Study|Adverse Event|6
122498|NCT00880191|446174|P1|Overall Study|Adverse Event|8
122499|NCT00880191|446173|P2|Overall Study|Refused further treatment|1
122500|NCT00880191|446174|P1|Overall Study|Refused further treatment|4
122501|NCT00880165|446194|P2|Overall Study|Lost to follow|15
122502|NCT00880165|446195|P1|Overall Study|Lost to follow|9
122503|NCT00880165|446194|P2|Overall Study|Required BIPAP or oxygen treatment|4
122504|NCT00880165|446195|P1|Overall Study|Required BIPAP or oxygen treatment|12
122505|NCT00880165|446194|P2|Overall Study|Not diagnosed with OSA|8
122506|NCT00880165|446195|P1|Overall Study|Not diagnosed with OSA|14
122507|NCT00880165|446194|P2|Overall Study|Withdrawal by Subject|23
122508|NCT00880165|446195|P1|Overall Study|Withdrawal by Subject|27
122509|NCT00880100|446205|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
122510|NCT00880100|446205|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
122511|NCT00880100|446205|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
122512|NCT00880048|446219|P3|Overall Study|Study closed/terminated|6
122513|NCT00880048|446220|P2|Overall Study|Study closed/terminated|7
122514|NCT00880048|446221|P1|Overall Study|Study closed/terminated|9
122515|NCT00880048|446219|P3|Overall Study|Withdrawal by Subject|5
122516|NCT00880048|446220|P2|Overall Study|Withdrawal by Subject|8
122517|NCT00880048|446221|P1|Overall Study|Withdrawal by Subject|5
122518|NCT00880048|446219|P3|Overall Study|Physician Decision|7
122519|NCT00880048|446220|P2|Overall Study|Physician Decision|1
122520|NCT00880048|446221|P1|Overall Study|Physician Decision|1
122521|NCT00880048|446219|P3|Overall Study|Lost to Follow-up|5
122522|NCT00880048|446220|P2|Overall Study|Lost to Follow-up|6
122523|NCT00880048|446221|P1|Overall Study|Lost to Follow-up|6
122524|NCT00880048|446219|P3|Overall Study|Protocol Violation|5
122525|NCT00880048|446220|P2|Overall Study|Protocol Violation|6
122526|NCT00880048|446221|P1|Overall Study|Protocol Violation|4
122527|NCT00880048|446219|P3|Overall Study|Lack of Efficacy|2
122528|NCT00880048|446220|P2|Overall Study|Lack of Efficacy|2
122529|NCT00880048|446221|P1|Overall Study|Lack of Efficacy|1
122530|NCT00880048|446219|P3|Overall Study|Adverse Event|5
122531|NCT00880048|446220|P2|Overall Study|Adverse Event|3
122532|NCT00880048|446221|P1|Overall Study|Adverse Event|2
122533|NCT00880009|446288|P1|Overall Study|Protocol Violation|1
122534|NCT00880009|446288|P1|Overall Study|Withdrawal by Subject|1
122535|NCT00880009|446288|P1|Overall Study|Study terminated by sponsor|14
122536|NCT00879996|446312|P2|Overall Study|put on parole|0
122537|NCT00879996|446313|P1|Overall Study|put on parole|1
122538|NCT00879996|446312|P2|Overall Study|psychiatric problem|1
122539|NCT00879996|446313|P1|Overall Study|psychiatric problem|0
122540|NCT00879996|446312|P2|Overall Study|Physician Decision|2
122541|NCT00879996|446313|P1|Overall Study|Physician Decision|1
122542|NCT00879996|446312|P2|Overall Study|non-compliance|4
122543|NCT00879996|446313|P1|Overall Study|non-compliance|6
122544|NCT00879996|446312|P2|Overall Study|Lost to Follow-up|6
122545|NCT00879996|446313|P1|Overall Study|Lost to Follow-up|7
122546|NCT00879970|446328|P5|Period 2 Vitamin D Randomization|Death|0
122547|NCT00879970|446329|P4|Period 2 Vitamin D Randomization|Death|2
122548|NCT00879970|446330|P3|Period 2 Vitamin D Randomization|Death|0
122549|NCT00879970|446331|P2|Period 2 Vitamin D Randomization|Death|0
122550|NCT00879970|446332|P1|Period 2 Vitamin D Randomization|Death|0
122551|NCT00879970|446328|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
122552|NCT00879970|446329|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
122553|NCT00879970|446330|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
122554|NCT00879970|446331|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
122555|NCT00879970|446332|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
122556|NCT00879970|446328|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
122557|NCT00879970|446329|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
122558|NCT00879970|446330|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
122641|NCT00879684|446570|P7|Stage 1: Dose Escalation|Death|0
122559|NCT00879970|446331|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
122560|NCT00879970|446332|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
122561|NCT00879970|446328|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
122562|NCT00879970|446329|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
122563|NCT00879970|446330|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
122564|NCT00879970|446331|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
122565|NCT00879970|446332|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
122566|NCT00879970|446328|P5|Period 1 TZD Randomization|Death|0
122567|NCT00879970|446329|P4|Period 1 TZD Randomization|Death|0
122568|NCT00879970|446330|P3|Period 1 TZD Randomization|Death|0
122569|NCT00879970|446331|P2|Period 1 TZD Randomization|Death|1
122570|NCT00879970|446332|P1|Period 1 TZD Randomization|Death|2
122571|NCT00879970|446328|P5|Period 1 TZD Randomization|Lost to Follow-up|0
122572|NCT00879970|446329|P4|Period 1 TZD Randomization|Lost to Follow-up|0
122573|NCT00879970|446330|P3|Period 1 TZD Randomization|Lost to Follow-up|1
122574|NCT00879970|446331|P2|Period 1 TZD Randomization|Lost to Follow-up|0
122575|NCT00879970|446332|P1|Period 1 TZD Randomization|Lost to Follow-up|1
122576|NCT00879970|446328|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
122577|NCT00879970|446329|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
122578|NCT00879970|446330|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
122579|NCT00879970|446331|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
122580|NCT00879970|446332|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
122581|NCT00879879|446414|P1|Overall Study|Physician Decision|1
122582|NCT00879879|446414|P1|Overall Study|Withdrawal by Subject|1
122583|NCT00879879|446414|P1|Overall Study|Death|1
122584|NCT00879814|446422|P4|Overall Study|Other|0
122585|NCT00879814|446423|P3|Overall Study|Other|1
122586|NCT00879814|446424|P2|Overall Study|Other|0
122587|NCT00879814|446425|P1|Overall Study|Other|0
122588|NCT00879814|446422|P4|Overall Study|Physician Decision|0
122589|NCT00879814|446423|P3|Overall Study|Physician Decision|1
122590|NCT00879814|446424|P2|Overall Study|Physician Decision|0
122591|NCT00879814|446425|P1|Overall Study|Physician Decision|0
122592|NCT00879814|446422|P4|Overall Study|Withdrawal by Subject|2
122593|NCT00879814|446423|P3|Overall Study|Withdrawal by Subject|1
122594|NCT00879814|446424|P2|Overall Study|Withdrawal by Subject|1
122595|NCT00879814|446425|P1|Overall Study|Withdrawal by Subject|3
122596|NCT00879814|446422|P4|Overall Study|Participant Failed to Return|1
122597|NCT00879814|446423|P3|Overall Study|Participant Failed to Return|0
122598|NCT00879814|446424|P2|Overall Study|Participant Failed to Return|0
122599|NCT00879814|446425|P1|Overall Study|Participant Failed to Return|0
122600|NCT00879814|446422|P4|Overall Study|Lost to Follow-up|2
122601|NCT00879814|446423|P3|Overall Study|Lost to Follow-up|0
122602|NCT00879814|446424|P2|Overall Study|Lost to Follow-up|0
122603|NCT00879814|446425|P1|Overall Study|Lost to Follow-up|1
122604|NCT00879814|446422|P4|Overall Study|Adverse Event|0
122605|NCT00879814|446423|P3|Overall Study|Adverse Event|0
122606|NCT00879814|446424|P2|Overall Study|Adverse Event|1
122607|NCT00879814|446425|P1|Overall Study|Adverse Event|0
122608|NCT00879775|446533|P2|Overall Study|Lost to Follow-up|1
122609|NCT00879775|446534|P1|Overall Study|Lost to Follow-up|2
122610|NCT00879710|446550|P4|Phase 1 - 6 Weeks|Adverse Event|0
122611|NCT00879710|446551|P3|Phase 1 - 6 Weeks|Adverse Event|1
122612|NCT00879710|446552|P2|Phase 1 - 6 Weeks|Adverse Event|0
122613|NCT00879710|446553|P1|Phase 1 - 6 Weeks|Adverse Event|0
122614|NCT00879710|446550|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
122615|NCT00879710|446551|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
122616|NCT00879710|446552|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
122617|NCT00879710|446553|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
122618|NCT00879697|446563|P2|Overall Study|Physician Decision|2
122619|NCT00879697|446564|P1|Overall Study|Physician Decision|2
122620|NCT00879684|446570|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
122621|NCT00879684|446571|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
122622|NCT00879684|446572|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
122623|NCT00879684|446573|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
122624|NCT00879684|446574|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
122625|NCT00879684|446575|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
122626|NCT00879684|446576|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
122627|NCT00879684|446570|P7|Stage 2: Expanded Cohort|Progressive Disease|11
122628|NCT00879684|446571|P6|Stage 2: Expanded Cohort|Progressive Disease|0
122629|NCT00879684|446572|P5|Stage 2: Expanded Cohort|Progressive Disease|0
122630|NCT00879684|446573|P4|Stage 2: Expanded Cohort|Progressive Disease|0
122631|NCT00879684|446574|P3|Stage 2: Expanded Cohort|Progressive Disease|0
122632|NCT00879684|446575|P2|Stage 2: Expanded Cohort|Progressive Disease|0
122633|NCT00879684|446576|P1|Stage 2: Expanded Cohort|Progressive Disease|0
122634|NCT00879684|446570|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
122635|NCT00879684|446571|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
122636|NCT00879684|446572|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
122637|NCT00879684|446573|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
122638|NCT00879684|446574|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
122639|NCT00879684|446575|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
122640|NCT00879684|446576|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
122642|NCT00879684|446571|P6|Stage 1: Dose Escalation|Death|0
122643|NCT00879684|446572|P5|Stage 1: Dose Escalation|Death|0
122644|NCT00879684|446573|P4|Stage 1: Dose Escalation|Death|0
122645|NCT00879684|446574|P3|Stage 1: Dose Escalation|Death|1
122646|NCT00879684|446575|P2|Stage 1: Dose Escalation|Death|0
122647|NCT00879684|446576|P1|Stage 1: Dose Escalation|Death|0
122648|NCT00879684|446570|P7|Stage 1: Dose Escalation|Investigator declined participation|0
122649|NCT00879684|446571|P6|Stage 1: Dose Escalation|Investigator declined participation|0
122650|NCT00879684|446572|P5|Stage 1: Dose Escalation|Investigator declined participation|0
122651|NCT00879684|446573|P4|Stage 1: Dose Escalation|Investigator declined participation|2
122652|NCT00879684|446574|P3|Stage 1: Dose Escalation|Investigator declined participation|2
122653|NCT00879684|446575|P2|Stage 1: Dose Escalation|Investigator declined participation|0
122654|NCT00879684|446576|P1|Stage 1: Dose Escalation|Investigator declined participation|0
122655|NCT00879684|446570|P7|Stage 1: Dose Escalation|Progressive Disease|0
122656|NCT00879684|446571|P6|Stage 1: Dose Escalation|Progressive Disease|3
122657|NCT00879684|446572|P5|Stage 1: Dose Escalation|Progressive Disease|3
122658|NCT00879684|446573|P4|Stage 1: Dose Escalation|Progressive Disease|4
122659|NCT00879684|446574|P3|Stage 1: Dose Escalation|Progressive Disease|0
122660|NCT00879684|446575|P2|Stage 1: Dose Escalation|Progressive Disease|3
122661|NCT00879684|446576|P1|Stage 1: Dose Escalation|Progressive Disease|2
122662|NCT00879684|446570|P7|Stage 1: Dose Escalation|Adverse Event|0
122663|NCT00879684|446571|P6|Stage 1: Dose Escalation|Adverse Event|0
122664|NCT00879684|446572|P5|Stage 1: Dose Escalation|Adverse Event|0
122665|NCT00879684|446573|P4|Stage 1: Dose Escalation|Adverse Event|0
122666|NCT00879684|446574|P3|Stage 1: Dose Escalation|Adverse Event|0
122667|NCT00879684|446575|P2|Stage 1: Dose Escalation|Adverse Event|0
122668|NCT00879684|446576|P1|Stage 1: Dose Escalation|Adverse Event|1
122669|NCT00879645|446642|P4|Overall Study|Adverse Event|0
122670|NCT00879645|446643|P3|Overall Study|Adverse Event|0
122671|NCT00879645|446644|P2|Overall Study|Adverse Event|0
122672|NCT00879645|446645|P1|Overall Study|Adverse Event|1
122673|NCT00879411|446672|P1|Overall Study|lost to follow-up (non-AE)|162
122674|NCT00879398|446678|P1|Overall Study|Other Reasons|171
122675|NCT00879398|446678|P1|Overall Study|Adverse Event|41
122676|NCT00879398|446678|P1|Overall Study|Lack of Efficacy|64
122677|NCT00879398|446678|P1|Overall Study|Visit Stop|399
122678|NCT00879333|446696|P2|Overall Study|Protocol Violation|1
122679|NCT00879333|446697|P1|Overall Study|Protocol Violation|1
122680|NCT00879333|446696|P2|Overall Study|Disease Progression|169
122681|NCT00879333|446697|P1|Overall Study|Disease Progression|292
122682|NCT00879333|446696|P2|Overall Study|Death|5
122683|NCT00879333|446697|P1|Overall Study|Death|16
122684|NCT00879333|446696|P2|Overall Study|Administrative Problems|0
122685|NCT00879333|446697|P1|Overall Study|Administrative Problems|2
122686|NCT00879333|446696|P2|Overall Study|Lost to Follow-up|1
122687|NCT00879333|446697|P1|Overall Study|Lost to Follow-up|2
122688|NCT00879333|446696|P2|Overall Study|Withdrawal by Subject|7
122689|NCT00879333|446697|P1|Overall Study|Withdrawal by Subject|20
122690|NCT00879333|446696|P2|Overall Study|Abnormal Laboratory Value|0
122691|NCT00879333|446697|P1|Overall Study|Abnormal Laboratory Value|1
122692|NCT00879333|446696|P2|Overall Study|Adverse Event|34
122693|NCT00879333|446697|P1|Overall Study|Adverse Event|94
122694|NCT00879229|446730|P2|Overall Study|Other|0
122695|NCT00879229|446731|P1|Overall Study|Other|1
122696|NCT00879229|446730|P2|Overall Study|Clinical status did not improve|0
122697|NCT00879229|446731|P1|Overall Study|Clinical status did not improve|1
122698|NCT00879229|446730|P2|Overall Study|Withdrawal by Subject|0
122699|NCT00879229|446731|P1|Overall Study|Withdrawal by Subject|1
122700|NCT00879229|446730|P2|Overall Study|Adverse Event|0
122701|NCT00879229|446731|P1|Overall Study|Adverse Event|2
122702|NCT00879229|446730|P2|Overall Study|Death|2
122703|NCT00879229|446731|P1|Overall Study|Death|4
122704|NCT00879229|446730|P2|Overall Study|Study terminated by Sponsor|12
122705|NCT00879229|446731|P1|Overall Study|Study terminated by Sponsor|13
122706|NCT00878995|446779|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
122707|NCT00878995|446780|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
122708|NCT00878969|446881|P3|Overall Study|Pregnancy|0
122709|NCT00878969|446882|P2|Overall Study|Pregnancy|1
122710|NCT00878969|446883|P1|Overall Study|Pregnancy|0
122711|NCT00878969|446881|P3|Overall Study|Death|2
122712|NCT00878969|446882|P2|Overall Study|Death|0
122713|NCT00878969|446883|P1|Overall Study|Death|0
122714|NCT00878969|446881|P3|Overall Study|Protocol Violation|0
122715|NCT00878969|446882|P2|Overall Study|Protocol Violation|0
122716|NCT00878969|446883|P1|Overall Study|Protocol Violation|2
122717|NCT00878969|446881|P3|Overall Study|Lost to Follow-up|0
122718|NCT00878969|446882|P2|Overall Study|Lost to Follow-up|1
122719|NCT00878969|446883|P1|Overall Study|Lost to Follow-up|2
122720|NCT00878969|446881|P3|Overall Study|Adverse Event|2
122721|NCT00878969|446882|P2|Overall Study|Adverse Event|1
122722|NCT00878969|446883|P1|Overall Study|Adverse Event|3
122723|NCT00878969|446881|P3|Overall Study|kidney transplant|2
122724|NCT00878969|446882|P2|Overall Study|kidney transplant|3
122725|NCT00878969|446883|P1|Overall Study|kidney transplant|2
122726|NCT00878969|446881|P3|Overall Study|Withdrawal by Subject|3
122727|NCT00878969|446882|P2|Overall Study|Withdrawal by Subject|6
122728|NCT00878969|446883|P1|Overall Study|Withdrawal by Subject|1
122729|NCT00878969|446881|P3|Overall Study|Physician Decision|2
122730|NCT00878969|446882|P2|Overall Study|Physician Decision|3
122731|NCT00878969|446883|P1|Overall Study|Physician Decision|5
122732|NCT00878800|446931|P5|Overall Study|Other|1
122733|NCT00878800|446932|P4|Overall Study|Other|0
122734|NCT00878800|446933|P3|Overall Study|Other|0
122735|NCT00878800|446934|P2|Overall Study|Other|1
122736|NCT00878800|446935|P1|Overall Study|Other|1
122737|NCT00878800|446931|P5|Overall Study|Death|0
122738|NCT00878800|446932|P4|Overall Study|Death|0
122739|NCT00878800|446933|P3|Overall Study|Death|1
122740|NCT00878800|446934|P2|Overall Study|Death|0
122741|NCT00878800|446935|P1|Overall Study|Death|0
122742|NCT00878800|446931|P5|Overall Study|Withdrew consent|1
122743|NCT00878800|446932|P4|Overall Study|Withdrew consent|1
122744|NCT00878800|446933|P3|Overall Study|Withdrew consent|0
122745|NCT00878800|446934|P2|Overall Study|Withdrew consent|1
122746|NCT00878800|446935|P1|Overall Study|Withdrew consent|1
122747|NCT00878800|446931|P5|Overall Study|Progressive disease|13
122748|NCT00878800|446932|P4|Overall Study|Progressive disease|5
122749|NCT00878800|446933|P3|Overall Study|Progressive disease|6
122750|NCT00878800|446934|P2|Overall Study|Progressive disease|5
122751|NCT00878800|446935|P1|Overall Study|Progressive disease|1
122752|NCT00878800|446931|P5|Overall Study|Adverse Event|1
122753|NCT00878800|446932|P4|Overall Study|Adverse Event|0
122754|NCT00878800|446933|P3|Overall Study|Adverse Event|2
122755|NCT00878800|446934|P2|Overall Study|Adverse Event|0
122756|NCT00878800|446935|P1|Overall Study|Adverse Event|0
122757|NCT00878722|446970|P8|Overall Study|Relapse|0
122758|NCT00878722|446971|P7|Overall Study|Relapse|0
122759|NCT00878722|446972|P6|Overall Study|Relapse|0
122760|NCT00878722|446973|P5|Overall Study|Relapse|0
122761|NCT00878722|446974|P4|Overall Study|Relapse|1
122762|NCT00878722|446975|P3|Overall Study|Relapse|0
122763|NCT00878722|446976|P2|Overall Study|Relapse|0
122764|NCT00878722|446977|P1|Overall Study|Relapse|0
122765|NCT00878722|446970|P8|Overall Study|Withdrawal by Subject|2
122766|NCT00878722|446971|P7|Overall Study|Withdrawal by Subject|0
122767|NCT00878722|446972|P6|Overall Study|Withdrawal by Subject|0
122768|NCT00878722|446973|P5|Overall Study|Withdrawal by Subject|0
122769|NCT00878722|446974|P4|Overall Study|Withdrawal by Subject|0
122770|NCT00878722|446975|P3|Overall Study|Withdrawal by Subject|0
122771|NCT00878722|446976|P2|Overall Study|Withdrawal by Subject|0
122772|NCT00878722|446977|P1|Overall Study|Withdrawal by Subject|0
122773|NCT00878722|446970|P8|Overall Study|Adverse Event|0
122774|NCT00878722|446971|P7|Overall Study|Adverse Event|2
122775|NCT00878722|446972|P6|Overall Study|Adverse Event|0
122776|NCT00878722|446973|P5|Overall Study|Adverse Event|0
122777|NCT00878722|446974|P4|Overall Study|Adverse Event|0
122778|NCT00878722|446975|P3|Overall Study|Adverse Event|0
122779|NCT00878722|446976|P2|Overall Study|Adverse Event|0
122780|NCT00878722|446977|P1|Overall Study|Adverse Event|0
122781|NCT00878722|446970|P8|Overall Study|Death|2
122782|NCT00878722|446971|P7|Overall Study|Death|0
122783|NCT00878722|446972|P6|Overall Study|Death|1
122784|NCT00878722|446973|P5|Overall Study|Death|0
122785|NCT00878722|446974|P4|Overall Study|Death|1
122786|NCT00878722|446975|P3|Overall Study|Death|0
122787|NCT00878722|446976|P2|Overall Study|Death|0
122788|NCT00878722|446977|P1|Overall Study|Death|0
122789|NCT00878722|446970|P8|Overall Study|Progressive disease|3
122790|NCT00878722|446971|P7|Overall Study|Progressive disease|4
122791|NCT00878722|446972|P6|Overall Study|Progressive disease|1
122792|NCT00878722|446973|P5|Overall Study|Progressive disease|7
122793|NCT00878722|446974|P4|Overall Study|Progressive disease|7
122794|NCT00878722|446975|P3|Overall Study|Progressive disease|3
122795|NCT00878722|446976|P2|Overall Study|Progressive disease|3
122796|NCT00878722|446977|P1|Overall Study|Progressive disease|3
122797|NCT00878709|447062|P2|Overall Study|Other Reasons|84
122798|NCT00878709|447063|P1|Overall Study|Other Reasons|93
122799|NCT00878709|447062|P2|Overall Study|Lost to Follow-up|33
122800|NCT00878709|447063|P1|Overall Study|Lost to Follow-up|35
122801|NCT00878709|447062|P2|Overall Study|Withdrawal by Subject|120
122802|NCT00878709|447063|P1|Overall Study|Withdrawal by Subject|197
122803|NCT00878553|447123|P5|PK Study|Withdrawal by Subject|0
122804|NCT00878553|447124|P4|PK Study|Withdrawal by Subject|1
122805|NCT00878553|447125|P3|PK Study|Withdrawal by Subject|0
122806|NCT00878553|447126|P2|PK Study|Withdrawal by Subject|0
122807|NCT00878553|447127|P1|PK Study|Withdrawal by Subject|0
122808|NCT00878553|447123|P5|Sleep Study|family emergency|0
122809|NCT00878553|447124|P4|Sleep Study|family emergency|0
122810|NCT00878553|447125|P3|Sleep Study|family emergency|0
122811|NCT00878553|447126|P2|Sleep Study|family emergency|0
122812|NCT00878553|447127|P1|Sleep Study|family emergency|1
122813|NCT00878553|447123|P5|Sleep Study|car accident|0
122814|NCT00878553|447124|P4|Sleep Study|car accident|0
122815|NCT00878553|447125|P3|Sleep Study|car accident|0
122816|NCT00878553|447126|P2|Sleep Study|car accident|0
122817|NCT00878553|447127|P1|Sleep Study|car accident|1
122818|NCT00878553|447123|P5|Sleep Study|Lost to Follow-up|0
122819|NCT00878553|447124|P4|Sleep Study|Lost to Follow-up|0
122820|NCT00878553|447125|P3|Sleep Study|Lost to Follow-up|0
122821|NCT00878553|447126|P2|Sleep Study|Lost to Follow-up|0
122822|NCT00878553|447127|P1|Sleep Study|Lost to Follow-up|1
122823|NCT00878553|447123|P5|Sleep Study|Withdrawal by Subject|0
122824|NCT00878553|447124|P4|Sleep Study|Withdrawal by Subject|0
122825|NCT00878553|447125|P3|Sleep Study|Withdrawal by Subject|0
122826|NCT00878553|447126|P2|Sleep Study|Withdrawal by Subject|0
122827|NCT00878553|447127|P1|Sleep Study|Withdrawal by Subject|2
122828|NCT00878501|447186|P3|Overall Study|Administrative|1
122829|NCT00878501|447187|P2|Overall Study|Administrative|0
122830|NCT00878501|447188|P1|Overall Study|Administrative|0
122831|NCT00878501|447186|P3|Overall Study|Mis-randomisation of patient|0
122832|NCT00878501|447187|P2|Overall Study|Mis-randomisation of patient|0
122833|NCT00878501|447188|P1|Overall Study|Mis-randomisation of patient|1
122834|NCT00878501|447186|P3|Overall Study|Intake of prohibited concom. medication|1
122835|NCT00878501|447187|P2|Overall Study|Intake of prohibited concom. medication|0
122836|NCT00878501|447188|P1|Overall Study|Intake of prohibited concom. medication|0
122837|NCT00878501|447186|P3|Overall Study|Incorrect enrolment|0
122838|NCT00878501|447187|P2|Overall Study|Incorrect enrolment|2
122839|NCT00878501|447188|P1|Overall Study|Incorrect enrolment|1
122840|NCT00878501|447186|P3|Overall Study|Protocol Violation|1
122841|NCT00878501|447187|P2|Overall Study|Protocol Violation|0
122842|NCT00878501|447188|P1|Overall Study|Protocol Violation|0
122843|NCT00878501|447186|P3|Overall Study|Withdrawal by Subject|2
122844|NCT00878501|447187|P2|Overall Study|Withdrawal by Subject|1
122845|NCT00878501|447188|P1|Overall Study|Withdrawal by Subject|2
122846|NCT00878501|447186|P3|Overall Study|Lack of Efficacy|0
122847|NCT00878501|447187|P2|Overall Study|Lack of Efficacy|1
122848|NCT00878501|447188|P1|Overall Study|Lack of Efficacy|2
122849|NCT00878501|447186|P3|Overall Study|Adverse Event|3
122850|NCT00878501|447187|P2|Overall Study|Adverse Event|3
122851|NCT00878501|447188|P1|Overall Study|Adverse Event|11
122852|NCT00878215|447237|P4|Overall Study|Determined to be ineligible|0
122853|NCT00878215|447238|P3|Overall Study|Determined to be ineligible|0
122854|NCT00878215|447239|P2|Overall Study|Determined to be ineligible|10
122855|NCT00878215|447240|P1|Overall Study|Determined to be ineligible|0
122856|NCT00877929|447252|P2|Overall Study|Other reason (not specified)|6
122857|NCT00877929|447253|P1|Overall Study|Other reason (not specified)|2
122858|NCT00877929|447252|P2|Overall Study|Lack of Efficacy|1
122859|NCT00877929|447253|P1|Overall Study|Lack of Efficacy|0
122860|NCT00877929|447252|P2|Overall Study|Withdrawal by Subject|4
122861|NCT00877929|447253|P1|Overall Study|Withdrawal by Subject|4
122862|NCT00877929|447252|P2|Overall Study|Lost to Follow-up|1
122863|NCT00877929|447253|P1|Overall Study|Lost to Follow-up|0
122864|NCT00877929|447252|P2|Overall Study|Protocol Violation|3
122865|NCT00877929|447253|P1|Overall Study|Protocol Violation|3
122866|NCT00877929|447252|P2|Overall Study|Adverse Event|20
122867|NCT00877929|447253|P1|Overall Study|Adverse Event|11
122868|NCT00877890|447341|P2|Overall Study|Loss of Glucose Control|4
122869|NCT00877890|447342|P1|Overall Study|Loss of Glucose Control|3
122870|NCT00877890|447341|P2|Overall Study|Investigator Decision|2
122871|NCT00877890|447342|P1|Overall Study|Investigator Decision|0
122872|NCT00877890|447341|P2|Overall Study|Withdrawal of Consent|12
122873|NCT00877890|447342|P1|Overall Study|Withdrawal of Consent|6
122874|NCT00877890|447341|P2|Overall Study|Protocol Violation|1
122875|NCT00877890|447342|P1|Overall Study|Protocol Violation|0
122876|NCT00877890|447341|P2|Overall Study|Lost to Follow-up|5
122877|NCT00877890|447342|P1|Overall Study|Lost to Follow-up|5
122878|NCT00877890|447341|P2|Overall Study|Adverse Event|6
122879|NCT00877890|447342|P1|Overall Study|Adverse Event|6
122880|NCT00877799|447407|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
122881|NCT00877799|447408|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
122882|NCT00877799|447409|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
122883|NCT00877799|447410|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
122884|NCT00877799|447411|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
122885|NCT00877799|447407|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
122886|NCT00877799|447408|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
122887|NCT00877799|447409|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
122888|NCT00877799|447410|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
122889|NCT00877799|447411|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
122890|NCT00877799|447407|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
122891|NCT00877799|447408|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
122892|NCT00877799|447409|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
122893|NCT00877799|447410|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
122894|NCT00877799|447411|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
122895|NCT00877799|447407|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
122896|NCT00877799|447408|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
122897|NCT00877799|447409|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
122898|NCT00877799|447410|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
122899|NCT00877799|447411|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
122900|NCT00877799|447407|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
122901|NCT00877799|447408|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
122902|NCT00877799|447409|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
122903|NCT00877799|447410|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
122904|NCT00877799|447411|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
122905|NCT00877773|447426|P1|Overall Study|Disease Progression|44
122906|NCT00877487|447439|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
122907|NCT00877487|447440|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
122908|NCT00877487|447439|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
122909|NCT00877487|447440|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
122910|NCT00877487|447439|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
122911|NCT00877487|447440|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
122912|NCT00877487|447439|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
122913|NCT00877487|447440|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
122914|NCT00877487|447439|P2|Open-label Treatment Phase|Out of country for business|0
122915|NCT00877487|447440|P1|Open-label Treatment Phase|Out of country for business|1
122916|NCT00877487|447439|P2|Open-label Treatment Phase|Lost to Follow-up|0
122917|NCT00877487|447440|P1|Open-label Treatment Phase|Lost to Follow-up|1
122918|NCT00877487|447439|P2|Open-label Treatment Phase|Withdrawal by Subject|0
122919|NCT00877487|447440|P1|Open-label Treatment Phase|Withdrawal by Subject|1
122920|NCT00877487|447439|P2|Open-label Treatment Phase|Protocol Violation|0
122921|NCT00877487|447440|P1|Open-label Treatment Phase|Protocol Violation|3
122922|NCT00877487|447439|P2|Open-label Treatment Phase|Adverse Event|0
122923|NCT00877487|447440|P1|Open-label Treatment Phase|Adverse Event|1
122924|NCT00877383|447488|P2|Overall Study|Death|2
122925|NCT00877383|447489|P1|Overall Study|Death|1
122926|NCT00877383|447488|P2|Overall Study|Unsatisfactory therapeutic effect|0
122927|NCT00877383|447489|P1|Overall Study|Unsatisfactory therapeutic effect|1
122928|NCT00877383|447488|P2|Overall Study|Protocol deviation|6
122929|NCT00877383|447489|P1|Overall Study|Protocol deviation|2
122930|NCT00877383|447488|P2|Overall Study|Administrative problems|0
122931|NCT00877383|447489|P1|Overall Study|Administrative problems|2
122932|NCT00877383|447488|P2|Overall Study|Subject no longer requires study drug|0
122933|NCT00877383|447489|P1|Overall Study|Subject no longer requires study drug|2
122934|NCT00877383|447488|P2|Overall Study|Subject withdrew consent|12
122935|NCT00877383|447489|P1|Overall Study|Subject withdrew consent|3
122936|NCT00877383|447488|P2|Overall Study|Lost to Follow-up|3
122937|NCT00877383|447489|P1|Overall Study|Lost to Follow-up|5
122938|NCT00877383|447488|P2|Overall Study|Adverse Event|14
122939|NCT00877383|447489|P1|Overall Study|Adverse Event|13
122940|NCT00877071|447509|P1|Overall Study|disease progression|2
122941|NCT00877032|447542|P7|Overall Study|Did not meet entrance criteria|2
122942|NCT00877032|447543|P6|Overall Study|Did not meet entrance criteria|0
122943|NCT00877032|447544|P5|Overall Study|Did not meet entrance criteria|0
122944|NCT00877032|447545|P4|Overall Study|Did not meet entrance criteria|1
122945|NCT00877032|447546|P3|Overall Study|Did not meet entrance criteria|0
122946|NCT00877032|447547|P2|Overall Study|Did not meet entrance criteria|0
122947|NCT00877032|447548|P1|Overall Study|Did not meet entrance criteria|0
122948|NCT00877006|447649|P2|Long-Term Follow-up Period|Not specified|9
122949|NCT00877006|447650|P1|Long-Term Follow-up Period|Not specified|7
122950|NCT00877006|447649|P2|Long-Term Follow-up Period|Death|18
122951|NCT00877006|447650|P1|Long-Term Follow-up Period|Death|26
122952|NCT00877006|447649|P2|Long-Term Follow-up Period|Lost to Follow-up|9
122953|NCT00877006|447650|P1|Long-Term Follow-up Period|Lost to Follow-up|8
122954|NCT00877006|447649|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
122955|NCT00877006|447650|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
122956|NCT00877006|447649|P2|Treatment Period|Randomized but Not Treated|8
122957|NCT00877006|447650|P1|Treatment Period|Randomized but Not Treated|3
122958|NCT00877006|447649|P2|Treatment Period|Not Specified|4
122959|NCT00877006|447650|P1|Treatment Period|Not Specified|4
122960|NCT00877006|447649|P2|Treatment Period|Started New Treatment Regimen|5
122961|NCT00877006|447650|P1|Treatment Period|Started New Treatment Regimen|2
122962|NCT00877006|447649|P2|Treatment Period|Disease Progression|2
122963|NCT00877006|447650|P1|Treatment Period|Disease Progression|1
122964|NCT00877006|447649|P2|Treatment Period|Lost to Follow-up|1
122965|NCT00877006|447650|P1|Treatment Period|Lost to Follow-up|0
122966|NCT00877006|447649|P2|Treatment Period|Protocol Violation|0
122967|NCT00877006|447650|P1|Treatment Period|Protocol Violation|1
122968|NCT00877006|447649|P2|Treatment Period|Withdrawal by Subject|3
122969|NCT00877006|447650|P1|Treatment Period|Withdrawal by Subject|2
122970|NCT00877006|447649|P2|Treatment Period|Adverse Event|3
122971|NCT00877006|447650|P1|Treatment Period|Adverse Event|10
122972|NCT00877006|447649|P2|Treatment Period|Death|1
122973|NCT00877006|447650|P1|Treatment Period|Death|2
122974|NCT00876928|447690|P2|Overall Study|Hypokalemia-affects insulin secretion|0
122975|NCT00876928|447691|P1|Overall Study|Hypokalemia-affects insulin secretion|1
122976|NCT00876928|447690|P2|Overall Study|Lost to Follow-up|5
122977|NCT00876928|447691|P1|Overall Study|Lost to Follow-up|2
122978|NCT00876733|447728|P4|Overall Study|Data not available|1
122979|NCT00876733|447729|P3|Overall Study|Data not available|7
122980|NCT00876733|447730|P2|Overall Study|Data not available|3
122981|NCT00876733|447731|P1|Overall Study|Data not available|14
122982|NCT00876733|447728|P4|Overall Study|Lost to Follow-up|2
122983|NCT00876733|447729|P3|Overall Study|Lost to Follow-up|3
122984|NCT00876733|447730|P2|Overall Study|Lost to Follow-up|10
122985|NCT00876733|447731|P1|Overall Study|Lost to Follow-up|26
122986|NCT00876733|447728|P4|Overall Study|Lack of Efficacy|1
122987|NCT00876733|447729|P3|Overall Study|Lack of Efficacy|10
122988|NCT00876733|447730|P2|Overall Study|Lack of Efficacy|9
122989|NCT00876733|447731|P1|Overall Study|Lack of Efficacy|17
122990|NCT00876733|447728|P4|Overall Study|Adverse Event|3
122991|NCT00876733|447729|P3|Overall Study|Adverse Event|10
122992|NCT00876733|447730|P2|Overall Study|Adverse Event|20
122993|NCT00876733|447731|P1|Overall Study|Adverse Event|34
122994|NCT00876694|447839|P2|Overall Study|Death|0
122995|NCT00876694|447840|P1|Overall Study|Death|1
122996|NCT00876694|447839|P2|Overall Study|Administrative problems|1
122997|NCT00876694|447840|P1|Overall Study|Administrative problems|1
122998|NCT00876694|447839|P2|Overall Study|Abnormal test procedure result(s)|0
122999|NCT00876694|447840|P1|Overall Study|Abnormal test procedure result(s)|1
123000|NCT00876694|447839|P2|Overall Study|Unsatisfactory therapeutic effect|0
123001|NCT00876694|447840|P1|Overall Study|Unsatisfactory therapeutic effect|2
123002|NCT00876694|447839|P2|Overall Study|Subject withdrew consent|4
123003|NCT00876694|447840|P1|Overall Study|Subject withdrew consent|6
123004|NCT00876694|447839|P2|Overall Study|Adverse Event|7
123005|NCT00876694|447840|P1|Overall Study|Adverse Event|10
123006|NCT00876460|447866|P8|Mono Therapy Phase|Adverse Event|0
123007|NCT00876460|447867|P7|Mono Therapy Phase|Adverse Event|0
123008|NCT00876460|447868|P6|Mono Therapy Phase|Adverse Event|0
123009|NCT00876460|447869|P5|Mono Therapy Phase|Adverse Event|0
123010|NCT00876460|447870|P4|Mono Therapy Phase|Adverse Event|1
123011|NCT00876460|447871|P3|Mono Therapy Phase|Adverse Event|0
123012|NCT00876460|447872|P2|Mono Therapy Phase|Adverse Event|0
123013|NCT00876460|447873|P1|Mono Therapy Phase|Adverse Event|0
123014|NCT00876460|447866|P8|Mono Therapy Phase|Withdrawal by Subject|0
123015|NCT00876460|447867|P7|Mono Therapy Phase|Withdrawal by Subject|0
123016|NCT00876460|447868|P6|Mono Therapy Phase|Withdrawal by Subject|0
123017|NCT00876460|447869|P5|Mono Therapy Phase|Withdrawal by Subject|0
123018|NCT00876460|447870|P4|Mono Therapy Phase|Withdrawal by Subject|0
123019|NCT00876460|447871|P3|Mono Therapy Phase|Withdrawal by Subject|0
123020|NCT00876460|447872|P2|Mono Therapy Phase|Withdrawal by Subject|1
123021|NCT00876460|447873|P1|Mono Therapy Phase|Withdrawal by Subject|0
123022|NCT00876460|447866|P8|Mono Therapy Phase|Progressive disease|3
123023|NCT00876460|447867|P7|Mono Therapy Phase|Progressive disease|1
123024|NCT00876460|447868|P6|Mono Therapy Phase|Progressive disease|0
123025|NCT00876460|447869|P5|Mono Therapy Phase|Progressive disease|2
123026|NCT00876460|447870|P4|Mono Therapy Phase|Progressive disease|0
123027|NCT00876460|447871|P3|Mono Therapy Phase|Progressive disease|0
123028|NCT00876460|447872|P2|Mono Therapy Phase|Progressive disease|0
123029|NCT00876460|447873|P1|Mono Therapy Phase|Progressive disease|0
123030|NCT00876460|447866|P8|Combination Therapy Phase|Not treated|0
123031|NCT00876460|447867|P7|Combination Therapy Phase|Not treated|1
123032|NCT00876460|447868|P6|Combination Therapy Phase|Not treated|0
123033|NCT00876460|447869|P5|Combination Therapy Phase|Not treated|0
123034|NCT00876460|447870|P4|Combination Therapy Phase|Not treated|0
123035|NCT00876460|447871|P3|Combination Therapy Phase|Not treated|0
123036|NCT00876460|447872|P2|Combination Therapy Phase|Not treated|0
123037|NCT00876460|447873|P1|Combination Therapy Phase|Not treated|0
123038|NCT00876460|447866|P8|Combination Therapy Phase|Other reason not defined above|2
123039|NCT00876460|447867|P7|Combination Therapy Phase|Other reason not defined above|1
123040|NCT00876460|447868|P6|Combination Therapy Phase|Other reason not defined above|0
123041|NCT00876460|447869|P5|Combination Therapy Phase|Other reason not defined above|0
123042|NCT00876460|447870|P4|Combination Therapy Phase|Other reason not defined above|0
123043|NCT00876460|447871|P3|Combination Therapy Phase|Other reason not defined above|0
123044|NCT00876460|447872|P2|Combination Therapy Phase|Other reason not defined above|0
123045|NCT00876460|447873|P1|Combination Therapy Phase|Other reason not defined above|0
123046|NCT00876460|447866|P8|Combination Therapy Phase|Withdrawal by Subject|0
123047|NCT00876460|447867|P7|Combination Therapy Phase|Withdrawal by Subject|0
123048|NCT00876460|447868|P6|Combination Therapy Phase|Withdrawal by Subject|0
123049|NCT00876460|447869|P5|Combination Therapy Phase|Withdrawal by Subject|1
123050|NCT00876460|447870|P4|Combination Therapy Phase|Withdrawal by Subject|0
123051|NCT00876460|447871|P3|Combination Therapy Phase|Withdrawal by Subject|0
123052|NCT00876460|447872|P2|Combination Therapy Phase|Withdrawal by Subject|1
123053|NCT00876460|447873|P1|Combination Therapy Phase|Withdrawal by Subject|1
123054|NCT00876460|447866|P8|Combination Therapy Phase|Adverse Event|2
123055|NCT00876460|447867|P7|Combination Therapy Phase|Adverse Event|3
123056|NCT00876460|447868|P6|Combination Therapy Phase|Adverse Event|0
123057|NCT00876460|447869|P5|Combination Therapy Phase|Adverse Event|2
123058|NCT00876460|447870|P4|Combination Therapy Phase|Adverse Event|2
123059|NCT00876460|447871|P3|Combination Therapy Phase|Adverse Event|0
123060|NCT00876460|447872|P2|Combination Therapy Phase|Adverse Event|2
123061|NCT00876460|447873|P1|Combination Therapy Phase|Adverse Event|0
123062|NCT00876460|447866|P8|Combination Therapy Phase|Dose limiting toxicity|1
123063|NCT00876460|447867|P7|Combination Therapy Phase|Dose limiting toxicity|2
123064|NCT00876460|447868|P6|Combination Therapy Phase|Dose limiting toxicity|2
123065|NCT00876460|447869|P5|Combination Therapy Phase|Dose limiting toxicity|1
123066|NCT00876460|447870|P4|Combination Therapy Phase|Dose limiting toxicity|1
123067|NCT00876460|447871|P3|Combination Therapy Phase|Dose limiting toxicity|0
123068|NCT00876460|447872|P2|Combination Therapy Phase|Dose limiting toxicity|1
123069|NCT00876460|447873|P1|Combination Therapy Phase|Dose limiting toxicity|0
123070|NCT00876460|447866|P8|Combination Therapy Phase|Progressive disease|1
123071|NCT00876460|447867|P7|Combination Therapy Phase|Progressive disease|1
123072|NCT00876460|447868|P6|Combination Therapy Phase|Progressive disease|1
123073|NCT00876460|447869|P5|Combination Therapy Phase|Progressive disease|3
123074|NCT00876460|447870|P4|Combination Therapy Phase|Progressive disease|3
123075|NCT00876460|447871|P3|Combination Therapy Phase|Progressive disease|3
123076|NCT00876460|447872|P2|Combination Therapy Phase|Progressive disease|3
123077|NCT00876460|447873|P1|Combination Therapy Phase|Progressive disease|2
123078|NCT00876447|447945|P2|Overall Study|Adverse Event|8
123079|NCT00876447|447946|P1|Overall Study|Adverse Event|4
123080|NCT00876447|447945|P2|Overall Study|Lack of Efficacy|3
123081|NCT00876447|447946|P1|Overall Study|Lack of Efficacy|5
123082|NCT00876447|447945|P2|Overall Study|Pregnancy|2
123083|NCT00876447|447946|P1|Overall Study|Pregnancy|4
123084|NCT00876447|447945|P2|Overall Study|Lost to Follow-up|15
123085|NCT00876447|447946|P1|Overall Study|Lost to Follow-up|6
123086|NCT00876447|447945|P2|Overall Study|Personal reasons|28
123087|NCT00876447|447946|P1|Overall Study|Personal reasons|30
123088|NCT00876447|447945|P2|Overall Study|Protocol Violation|3
123089|NCT00876447|447946|P1|Overall Study|Protocol Violation|9
123090|NCT00876447|447945|P2|Overall Study|Site closure|14
123091|NCT00876447|447946|P1|Overall Study|Site closure|19
123092|NCT00876447|447945|P2|Overall Study|Other miscellaneous reasons|8
123093|NCT00876447|447946|P1|Overall Study|Other miscellaneous reasons|3
123094|NCT00876343|448007|P3|Overall Study|Change of residence or other commitments|3
123095|NCT00876343|448008|P2|Overall Study|Change of residence or other commitments|2
123096|NCT00876343|448009|P1|Overall Study|Change of residence or other commitments|2
123097|NCT00876343|448007|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
123098|NCT00876343|448008|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
123099|NCT00876343|448009|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
123100|NCT00876343|448007|P3|Overall Study|Physician Decision|1
123101|NCT00876343|448008|P2|Overall Study|Physician Decision|1
123102|NCT00876343|448009|P1|Overall Study|Physician Decision|0
123103|NCT00876343|448007|P3|Overall Study|Protocol Violation|1
123104|NCT00876343|448008|P2|Overall Study|Protocol Violation|1
123105|NCT00876343|448009|P1|Overall Study|Protocol Violation|4
123106|NCT00876343|448007|P3|Overall Study|Lack of Efficacy|1
123107|NCT00876343|448008|P2|Overall Study|Lack of Efficacy|0
123108|NCT00876343|448009|P1|Overall Study|Lack of Efficacy|0
123109|NCT00876343|448007|P3|Overall Study|Withdrawal by Subject|3
123110|NCT00876343|448008|P2|Overall Study|Withdrawal by Subject|4
123111|NCT00876343|448009|P1|Overall Study|Withdrawal by Subject|4
123112|NCT00876343|448007|P3|Overall Study|Adverse Event|2
123113|NCT00876343|448008|P2|Overall Study|Adverse Event|8
123114|NCT00876343|448009|P1|Overall Study|Adverse Event|7
123115|NCT00876265|448023|P1|Overall Study|Withdrawal by Subject|2
123116|NCT00876265|448023|P1|Overall Study|Lost to Follow-up|6
123117|NCT00876265|448023|P1|Overall Study|Miscellaneous reasons|4
123118|NCT00876018|448032|P3|Overall Study|Withdrew Consent due to Adverse Event|2
123119|NCT00876018|448033|P2|Overall Study|Withdrew Consent due to Adverse Event|4
123120|NCT00876018|448034|P1|Overall Study|Withdrew Consent due to Adverse Event|5
123121|NCT00876018|448032|P3|Overall Study|Lost to Follow-up|1
123122|NCT00876018|448033|P2|Overall Study|Lost to Follow-up|1
123123|NCT00876018|448034|P1|Overall Study|Lost to Follow-up|0
123124|NCT00875979|448089|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
123125|NCT00875979|448090|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
123126|NCT00875979|448089|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
123127|NCT00875979|448090|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
123128|NCT00875979|448089|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
123129|NCT00875979|448090|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
123130|NCT00875979|448089|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
123131|NCT00875979|448090|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
123132|NCT00875979|448089|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
123133|NCT00875979|448090|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
123134|NCT00875979|448089|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
123135|NCT00875979|448090|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
123136|NCT00875979|448089|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
123137|NCT00875979|448090|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
123138|NCT00875979|448089|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
123139|NCT00875979|448090|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
123140|NCT00875979|448089|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
123141|NCT00875979|448090|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
123142|NCT00875810|448113|P1|Overall Study|Device explanted|1
123143|NCT00875810|448113|P1|Overall Study|Patient enroled but not implanted|2
123144|NCT00875810|448113|P1|Overall Study|Lost to Follow-up|39
123145|NCT00875810|448113|P1|Overall Study|Physician Decision|3
123146|NCT00875810|448113|P1|Overall Study|Withdrawal by Subject|1
123147|NCT00875797|448122|P2|Overall Study|Protocol Violation|3
123148|NCT00875797|448123|P1|Overall Study|Protocol Violation|6
123149|NCT00875706|448136|P3|Overall Study|Withdrawal by Subject|0
123150|NCT00875706|448137|P2|Overall Study|Withdrawal by Subject|0
123151|NCT00875706|448138|P1|Overall Study|Withdrawal by Subject|1
123152|NCT00875615|448155|P1|Overall Study|Withdrawal by Subject|1
123153|NCT00875563|448169|P1|Overall Study|Still be eligible for follow-up|7
123154|NCT00875563|448169|P1|Overall Study|No long-term (3-5 year) consent|6
123155|NCT00875563|448169|P1|Overall Study|Withdrawal by Subject|7
123156|NCT00875563|448169|P1|Overall Study|Death|4
123157|NCT00875485|448194|P2|Challenge Dose Epoch|Pregnancy|0
123158|NCT00875485|448195|P1|Challenge Dose Epoch|Pregnancy|1
123159|NCT00875433|448235|P1|Overall Study|Not specified|3
123160|NCT00875433|448235|P1|Overall Study|Withdrawal by Subject|2
123161|NCT00875433|448235|P1|Overall Study|Other Adverse Event|14
123162|NCT00875433|448235|P1|Overall Study|Progressive disease|41
123163|NCT00875420|448265|P5|Overall Study|Withdrawal by Subject|0
123164|NCT00875420|448266|P4|Overall Study|Withdrawal by Subject|0
123165|NCT00875420|448267|P3|Overall Study|Withdrawal by Subject|1
123166|NCT00875420|448268|P2|Overall Study|Withdrawal by Subject|0
123167|NCT00875420|448269|P1|Overall Study|Withdrawal by Subject|0
123168|NCT00875420|448265|P5|Overall Study|Sponsor decision|0
123169|NCT00875420|448266|P4|Overall Study|Sponsor decision|0
123170|NCT00875420|448267|P3|Overall Study|Sponsor decision|0
123171|NCT00875420|448268|P2|Overall Study|Sponsor decision|1
123172|NCT00875420|448269|P1|Overall Study|Sponsor decision|0
123173|NCT00875420|448265|P5|Overall Study|Prohibited medication|0
123174|NCT00875420|448266|P4|Overall Study|Prohibited medication|1
123175|NCT00875420|448267|P3|Overall Study|Prohibited medication|0
123176|NCT00875420|448268|P2|Overall Study|Prohibited medication|0
123177|NCT00875420|448269|P1|Overall Study|Prohibited medication|0
123178|NCT00875420|448265|P5|Overall Study|Personal reason|1
123179|NCT00875420|448266|P4|Overall Study|Personal reason|0
123180|NCT00875420|448267|P3|Overall Study|Personal reason|0
123181|NCT00875420|448268|P2|Overall Study|Personal reason|0
123182|NCT00875420|448269|P1|Overall Study|Personal reason|0
123183|NCT00875420|448265|P5|Overall Study|Lost to Follow-up|0
123184|NCT00875420|448266|P4|Overall Study|Lost to Follow-up|0
123185|NCT00875420|448267|P3|Overall Study|Lost to Follow-up|0
123186|NCT00875420|448268|P2|Overall Study|Lost to Follow-up|0
123187|NCT00875420|448269|P1|Overall Study|Lost to Follow-up|1
123188|NCT00875420|448265|P5|Overall Study|Inability to complete study procedures|1
123189|NCT00875420|448266|P4|Overall Study|Inability to complete study procedures|1
123190|NCT00875420|448267|P3|Overall Study|Inability to complete study procedures|1
123191|NCT00875420|448268|P2|Overall Study|Inability to complete study procedures|0
123192|NCT00875420|448269|P1|Overall Study|Inability to complete study procedures|1
123193|NCT00875420|448265|P5|Overall Study|Adverse Event|0
123194|NCT00875420|448266|P4|Overall Study|Adverse Event|0
123195|NCT00875420|448267|P3|Overall Study|Adverse Event|1
123196|NCT00875420|448268|P2|Overall Study|Adverse Event|1
123197|NCT00875420|448269|P1|Overall Study|Adverse Event|0
123198|NCT00875017|448330|P6|Fourth Intervention|Inability to comply with fasting|1
123199|NCT00875017|448331|P5|Fourth Intervention|Inability to comply with fasting|0
123200|NCT00875017|448332|P4|Fourth Intervention|Inability to comply with fasting|0
123201|NCT00875017|448333|P3|Fourth Intervention|Inability to comply with fasting|0
123202|NCT00875017|448334|P2|Fourth Intervention|Inability to comply with fasting|0
123203|NCT00875017|448335|P1|Fourth Intervention|Inability to comply with fasting|0
123204|NCT00875017|448330|P6|Washout|Withdrawal by Subject|0
123205|NCT00875017|448331|P5|Washout|Withdrawal by Subject|1
123206|NCT00875017|448332|P4|Washout|Withdrawal by Subject|0
123207|NCT00875017|448333|P3|Washout|Withdrawal by Subject|0
123208|NCT00875017|448334|P2|Washout|Withdrawal by Subject|0
123209|NCT00875017|448335|P1|Washout|Withdrawal by Subject|0
123210|NCT00875017|448330|P6|Third Intervention|Adverse Event|0
123211|NCT00875017|448331|P5|Third Intervention|Adverse Event|0
123212|NCT00875017|448332|P4|Third Intervention|Adverse Event|0
123213|NCT00875017|448333|P3|Third Intervention|Adverse Event|1
123214|NCT00875017|448334|P2|Third Intervention|Adverse Event|1
123215|NCT00875017|448335|P1|Third Intervention|Adverse Event|0
123216|NCT00875017|448330|P6|Washout|Problems collecting rectal effluent|0
123217|NCT00875017|448331|P5|Washout|Problems collecting rectal effluent|0
123218|NCT00875017|448332|P4|Washout|Problems collecting rectal effluent|0
123219|NCT00875017|448333|P3|Washout|Problems collecting rectal effluent|0
123220|NCT00875017|448334|P2|Washout|Problems collecting rectal effluent|1
123221|NCT00875017|448335|P1|Washout|Problems collecting rectal effluent|0
123222|NCT00875017|448330|P6|Second Intervention|Adverse Event|0
123223|NCT00875017|448331|P5|Second Intervention|Adverse Event|0
123224|NCT00875017|448332|P4|Second Intervention|Adverse Event|1
123225|NCT00875017|448333|P3|Second Intervention|Adverse Event|0
123226|NCT00875017|448334|P2|Second Intervention|Adverse Event|0
123227|NCT00875017|448335|P1|Second Intervention|Adverse Event|0
123228|NCT00875017|448330|P6|Washout|Problem collecting rectal effluent|0
123229|NCT00875017|448331|P5|Washout|Problem collecting rectal effluent|0
123230|NCT00875017|448332|P4|Washout|Problem collecting rectal effluent|0
123231|NCT00875017|448333|P3|Washout|Problem collecting rectal effluent|1
123232|NCT00875017|448334|P2|Washout|Problem collecting rectal effluent|0
123233|NCT00875017|448335|P1|Washout|Problem collecting rectal effluent|0
123234|NCT00875017|448330|P6|First Intervention|Intolerance to nasogastric tube|0
123235|NCT00875017|448331|P5|First Intervention|Intolerance to nasogastric tube|1
123236|NCT00875017|448332|P4|First Intervention|Intolerance to nasogastric tube|0
123237|NCT00875017|448333|P3|First Intervention|Intolerance to nasogastric tube|0
123238|NCT00875017|448334|P2|First Intervention|Intolerance to nasogastric tube|0
123239|NCT00875017|448335|P1|First Intervention|Intolerance to nasogastric tube|0
123240|NCT00875017|448330|P6|First Intervention|Problems collecting rectal effluent|0
123241|NCT00875017|448331|P5|First Intervention|Problems collecting rectal effluent|0
123242|NCT00875017|448332|P4|First Intervention|Problems collecting rectal effluent|0
123243|NCT00875017|448333|P3|First Intervention|Problems collecting rectal effluent|0
123244|NCT00875017|448334|P2|First Intervention|Problems collecting rectal effluent|0
123245|NCT00875017|448335|P1|First Intervention|Problems collecting rectal effluent|1
123246|NCT00875017|448330|P6|First Intervention|Adverse Event|0
123247|NCT00875017|448331|P5|First Intervention|Adverse Event|0
123248|NCT00875017|448332|P4|First Intervention|Adverse Event|1
123249|NCT00875017|448333|P3|First Intervention|Adverse Event|0
123250|NCT00875017|448334|P2|First Intervention|Adverse Event|0
123251|NCT00875017|448335|P1|First Intervention|Adverse Event|0
123252|NCT00875017|448330|P6|First Intervention|Withdrawal by Subject|0
123253|NCT00875017|448331|P5|First Intervention|Withdrawal by Subject|0
123254|NCT00875017|448332|P4|First Intervention|Withdrawal by Subject|0
123255|NCT00875017|448333|P3|First Intervention|Withdrawal by Subject|1
123256|NCT00875017|448334|P2|First Intervention|Withdrawal by Subject|0
123257|NCT00875017|448335|P1|First Intervention|Withdrawal by Subject|1
123258|NCT00874939|448349|P1|Overall Study|Study terminated|4
123259|NCT00874848|448382|P2|Overall Study|Physician Decision|2
123260|NCT00874848|448383|P1|Overall Study|Physician Decision|0
123261|NCT00874848|448382|P2|Overall Study|Failure to comply with protocol|1
123262|NCT00874848|448383|P1|Overall Study|Failure to comply with protocol|0
123263|NCT00874848|448382|P2|Overall Study|Noncompliance|1
123264|NCT00874848|448383|P1|Overall Study|Noncompliance|1
123265|NCT00874848|448382|P2|Overall Study|Withdrawal by Subject|4
123266|NCT00874848|448383|P1|Overall Study|Withdrawal by Subject|7
123267|NCT00874848|448382|P2|Overall Study|Progressive neoplastic disease|18
123268|NCT00874848|448383|P1|Overall Study|Progressive neoplastic disease|38
123269|NCT00874848|448382|P2|Overall Study|Adverse Event|2
123270|NCT00874848|448383|P1|Overall Study|Adverse Event|13
123271|NCT00874822|448399|P1|Overall Study|excluded by criteria|8
123272|NCT00874770|448407|P4|Overall Study|Subject no Longer Meets Study Criteria|0
123273|NCT00874770|448408|P3|Overall Study|Subject no Longer Meets Study Criteria|0
123274|NCT00874770|448409|P2|Overall Study|Subject no Longer Meets Study Criteria|0
123275|NCT00874770|448410|P1|Overall Study|Subject no Longer Meets Study Criteria|1
123276|NCT00874770|448407|P4|Overall Study|Lost to Follow-up|1
123277|NCT00874770|448408|P3|Overall Study|Lost to Follow-up|0
123278|NCT00874770|448409|P2|Overall Study|Lost to Follow-up|0
123279|NCT00874770|448410|P1|Overall Study|Lost to Follow-up|1
123280|NCT00874770|448407|P4|Overall Study|Adverse Event|2
123281|NCT00874770|448408|P3|Overall Study|Adverse Event|4
123282|NCT00874770|448409|P2|Overall Study|Adverse Event|1
123283|NCT00874770|448410|P1|Overall Study|Adverse Event|1
123284|NCT00874770|448407|P4|Overall Study|Lack of Efficacy|2
123285|NCT00874770|448408|P3|Overall Study|Lack of Efficacy|0
123286|NCT00874770|448409|P2|Overall Study|Lack of Efficacy|0
123287|NCT00874770|448410|P1|Overall Study|Lack of Efficacy|2
123288|NCT00874549|448448|P4|Overall Study|Withdrawal by Subject|1
123289|NCT00874549|448449|P3|Overall Study|Withdrawal by Subject|0
123290|NCT00874549|448450|P2|Overall Study|Withdrawal by Subject|1
123291|NCT00874549|448451|P1|Overall Study|Withdrawal by Subject|0
123292|NCT00874549|448448|P4|Overall Study|Lost to Follow-up|0
123293|NCT00874549|448449|P3|Overall Study|Lost to Follow-up|1
123294|NCT00874549|448450|P2|Overall Study|Lost to Follow-up|0
123295|NCT00874549|448451|P1|Overall Study|Lost to Follow-up|0
123296|NCT00874549|448448|P4|Overall Study|Protocol Violation|1
123297|NCT00874549|448449|P3|Overall Study|Protocol Violation|2
123298|NCT00874549|448450|P2|Overall Study|Protocol Violation|0
123299|NCT00874549|448451|P1|Overall Study|Protocol Violation|1
123300|NCT00874549|448448|P4|Overall Study|Adverse Event|0
123301|NCT00874549|448449|P3|Overall Study|Adverse Event|1
123302|NCT00874549|448450|P2|Overall Study|Adverse Event|0
123303|NCT00874549|448451|P1|Overall Study|Adverse Event|0
123304|NCT00874497|448528|P2|Overall Study|Withdrawal by Subject|4
123305|NCT00874497|448529|P1|Overall Study|Withdrawal by Subject|5
123306|NCT00874497|448528|P2|Overall Study|Physician Decision|1
123307|NCT00874497|448529|P1|Overall Study|Physician Decision|1
123308|NCT00874497|448528|P2|Overall Study|Met Withdrawal Criteria|2
123309|NCT00874497|448529|P1|Overall Study|Met Withdrawal Criteria|4
123310|NCT00874497|448528|P2|Overall Study|Sponsor Discontinued Trial|3
123311|NCT00874497|448529|P1|Overall Study|Sponsor Discontinued Trial|7
123312|NCT00874497|448528|P2|Overall Study|Adverse Event|4
123313|NCT00874497|448529|P1|Overall Study|Adverse Event|9
123314|NCT00874497|448528|P2|Overall Study|Lost to Follow-up|4
123315|NCT00874497|448529|P1|Overall Study|Lost to Follow-up|2
123316|NCT00874276|448569|P2|Overall Study|Withdrawal by Subject|1
123317|NCT00874276|448570|P1|Overall Study|Withdrawal by Subject|1
123318|NCT00874120|448592|P2|Second Intervention|Protocol Violation|0
123319|NCT00874120|448593|P1|Second Intervention|Protocol Violation|1
123320|NCT00874120|448592|P2|Second Intervention|Withdrawal by Subject|0
123321|NCT00874120|448593|P1|Second Intervention|Withdrawal by Subject|1
123322|NCT00874120|448592|P2|First Intervention|positive drug test|0
123323|NCT00874120|448593|P1|First Intervention|positive drug test|1
123324|NCT00874120|448592|P2|First Intervention|Protocol Violation|0
123325|NCT00874120|448593|P1|First Intervention|Protocol Violation|3
123326|NCT00874120|448592|P2|First Intervention|Lost to Follow-up|1
123327|NCT00874120|448593|P1|First Intervention|Lost to Follow-up|0
123328|NCT00874120|448592|P2|First Intervention|Withdrawal by Subject|0
123329|NCT00874120|448593|P1|First Intervention|Withdrawal by Subject|2
123330|NCT00874120|448592|P2|First Intervention|Adverse Event|1
123331|NCT00874120|448593|P1|First Intervention|Adverse Event|0
123332|NCT00874029|448606|P1|Overall Study|Lost to Follow-up|5
123333|NCT00874029|448606|P1|Overall Study|Adverse Event|1
123334|NCT00874029|448606|P1|Overall Study|Physician Decision|1
123335|NCT00874029|448606|P1|Overall Study|Pregnancy|4
123336|NCT00874029|448606|P1|Overall Study|Withdrawal by Subject|10
123337|NCT00873912|448622|P2|Overall Study|Lost to Follow-up|0
123338|NCT00873912|448623|P1|Overall Study|Lost to Follow-up|2
123339|NCT00873912|448622|P2|Overall Study|Withdrawal by Subject|0
123340|NCT00873912|448623|P1|Overall Study|Withdrawal by Subject|1
123341|NCT00873860|448662|P4|Overall Study|Other|0
123342|NCT00873860|448663|P3|Overall Study|Other|1
123343|NCT00873860|448664|P2|Overall Study|Other|0
123344|NCT00873860|448665|P1|Overall Study|Other|1
123345|NCT00873860|448662|P4|Overall Study|Death|0
123346|NCT00873860|448663|P3|Overall Study|Death|0
123347|NCT00873860|448664|P2|Overall Study|Death|0
123348|NCT00873860|448665|P1|Overall Study|Death|1
123349|NCT00873860|448662|P4|Overall Study|Withdrawal by Subject|0
123350|NCT00873860|448663|P3|Overall Study|Withdrawal by Subject|2
123351|NCT00873860|448664|P2|Overall Study|Withdrawal by Subject|0
123352|NCT00873860|448665|P1|Overall Study|Withdrawal by Subject|1
123353|NCT00873860|448662|P4|Overall Study|Lost to Follow-up|1
123354|NCT00873860|448663|P3|Overall Study|Lost to Follow-up|0
123355|NCT00873860|448664|P2|Overall Study|Lost to Follow-up|0
123356|NCT00873860|448665|P1|Overall Study|Lost to Follow-up|1
123357|NCT00873730|448753|P2|Overall Study|Sponsor decision|0
123358|NCT00873730|448754|P1|Overall Study|Sponsor decision|1
123359|NCT00873730|448753|P2|Overall Study|Withdrawal by Subject|1
123360|NCT00873730|448754|P1|Overall Study|Withdrawal by Subject|0
123361|NCT00873730|448753|P2|Overall Study|Adverse Event|2
123362|NCT00873730|448754|P1|Overall Study|Adverse Event|0
123363|NCT00873730|448753|P2|Overall Study|Protocol Deviation|2
123364|NCT00873730|448754|P1|Overall Study|Protocol Deviation|5
123365|NCT00873366|448797|P1|Overall Study|Refused to continue DM-BT testing|3
123366|NCT00873366|448797|P1|Overall Study|Off tamoxifen due to side effects|2
123367|NCT00873366|448797|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
123368|NCT00873119|448822|P2|Overall Study|Not treated|0
123369|NCT00873119|448823|P1|Overall Study|Not treated|2
123370|NCT00873119|448822|P2|Overall Study|Other|5
123371|NCT00873119|448823|P1|Overall Study|Other|2
123372|NCT00873119|448822|P2|Overall Study|Death|1
123373|NCT00873119|448823|P1|Overall Study|Death|2
123374|NCT00873119|448822|P2|Overall Study|Progressive disease|18
123375|NCT00873119|448823|P1|Overall Study|Progressive disease|26
123376|NCT00873119|448822|P2|Overall Study|Adverse Event|0
123377|NCT00873119|448823|P1|Overall Study|Adverse Event|8
123378|NCT00873119|448822|P2|Overall Study|Patient request|2
123379|NCT00873119|448823|P1|Overall Study|Patient request|4
123380|NCT00873093|448844|P5|Overall Study|Ineligible|0
123381|NCT00873093|448845|P4|Overall Study|Ineligible|1
123382|NCT00873093|448846|P3|Overall Study|Ineligible|0
123383|NCT00873093|448847|P2|Overall Study|Ineligible|1
123384|NCT00873093|448848|P1|Overall Study|Ineligible|0
123385|NCT00873093|448844|P5|Overall Study|Withdrawal by Subject|0
123386|NCT00873093|448845|P4|Overall Study|Withdrawal by Subject|0
123387|NCT00873093|448846|P3|Overall Study|Withdrawal by Subject|4
123388|NCT00873093|448847|P2|Overall Study|Withdrawal by Subject|4
123389|NCT00873093|448848|P1|Overall Study|Withdrawal by Subject|1
123390|NCT00873093|448844|P5|Overall Study|Physician Decision|2
123391|NCT00873093|448845|P4|Overall Study|Physician Decision|10
123392|NCT00873093|448846|P3|Overall Study|Physician Decision|10
123393|NCT00873093|448847|P2|Overall Study|Physician Decision|17
123394|NCT00873093|448848|P1|Overall Study|Physician Decision|0
123395|NCT00873093|448844|P5|Overall Study|Death|0
123396|NCT00873093|448845|P4|Overall Study|Death|0
123397|NCT00873093|448846|P3|Overall Study|Death|2
123398|NCT00873093|448847|P2|Overall Study|Death|3
123399|NCT00873093|448848|P1|Overall Study|Death|0
123400|NCT00873093|448844|P5|Overall Study|Adverse Event|0
123401|NCT00873093|448845|P4|Overall Study|Adverse Event|0
123402|NCT00873093|448846|P3|Overall Study|Adverse Event|0
123403|NCT00873093|448847|P2|Overall Study|Adverse Event|2
123404|NCT00873093|448848|P1|Overall Study|Adverse Event|0
123405|NCT00873041|448905|P3|Extension Study|Administrative reasons|1
123406|NCT00873041|448906|P2|Extension Study|Administrative reasons|0
123407|NCT00873041|448907|P1|Extension Study|Administrative reasons|0
123408|NCT00873041|448905|P3|Extension Study|Adverse Event|1
123409|NCT00873041|448906|P2|Extension Study|Adverse Event|0
123410|NCT00873041|448907|P1|Extension Study|Adverse Event|1
123411|NCT00873041|448905|P3|Core Study|Protocol deviation|1
123412|NCT00873041|448906|P2|Core Study|Protocol deviation|0
123413|NCT00873041|448907|P1|Core Study|Protocol deviation|1
123414|NCT00873041|448905|P3|Core Study|Abnormal laboratory value|1
123415|NCT00873041|448906|P2|Core Study|Abnormal laboratory value|0
123416|NCT00873041|448907|P1|Core Study|Abnormal laboratory value|0
123417|NCT00873041|448905|P3|Core Study|Lost to Follow-up|0
123418|NCT00873041|448906|P2|Core Study|Lost to Follow-up|1
123419|NCT00873041|448907|P1|Core Study|Lost to Follow-up|3
123420|NCT00873041|448905|P3|Core Study|Withdrawal by Subject|2
123421|NCT00873041|448906|P2|Core Study|Withdrawal by Subject|2
123422|NCT00873041|448907|P1|Core Study|Withdrawal by Subject|1
123423|NCT00873041|448905|P3|Core Study|Adverse Event|1
123424|NCT00873041|448906|P2|Core Study|Adverse Event|3
123425|NCT00873041|448907|P1|Core Study|Adverse Event|2
123426|NCT00873015|448965|P4|Overall Study|Withdrawal by Subject|0
123427|NCT00873015|448966|P3|Overall Study|Withdrawal by Subject|0
123428|NCT00873015|448967|P2|Overall Study|Withdrawal by Subject|1
123429|NCT00873015|448968|P1|Overall Study|Withdrawal by Subject|0
123430|NCT00872989|448977|P2|Overall Study|Not protocol specified|8
123431|NCT00872989|448978|P1|Overall Study|Not protocol specified|3
123432|NCT00872989|448977|P2|Overall Study|Progression/relapse|35
123433|NCT00872989|448978|P1|Overall Study|Progression/relapse|47
123434|NCT00872989|448977|P2|Overall Study|Withdrawal by Subject|5
123435|NCT00872989|448978|P1|Overall Study|Withdrawal by Subject|8
123436|NCT00872989|448977|P2|Overall Study|Adverse Event|15
123437|NCT00872989|448978|P1|Overall Study|Adverse Event|7
123438|NCT00872898|448997|P2|Part Two - Double Blind|Other reasons|0
123439|NCT00872898|448998|P1|Part Two - Double Blind|Other reasons|2
123440|NCT00872898|448997|P2|Part Two - Double Blind|Lost to Follow-up|2
123441|NCT00872898|448998|P1|Part Two - Double Blind|Lost to Follow-up|0
123442|NCT00872898|448997|P2|Part Two - Double Blind|Withdrawal by Subject|1
123443|NCT00872898|448998|P1|Part Two - Double Blind|Withdrawal by Subject|3
123444|NCT00872898|448997|P2|Part Two - Double Blind|Protocol Violation|0
123445|NCT00872898|448998|P1|Part Two - Double Blind|Protocol Violation|1
123446|NCT00872898|448997|P2|Part Two - Double Blind|Lack of Efficacy|0
123447|NCT00872898|448998|P1|Part Two - Double Blind|Lack of Efficacy|1
123448|NCT00872898|448997|P2|Part Two - Double Blind|Adverse Event|3
123449|NCT00872898|448998|P1|Part Two - Double Blind|Adverse Event|4
123450|NCT00872599|449072|P2|Second Washout Period|Adverse Event|1
123451|NCT00872599|449073|P1|Second Washout Period|Adverse Event|1
123452|NCT00872521|449093|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
123453|NCT00872521|449094|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
123454|NCT00872521|449095|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
123455|NCT00872521|449093|P3|Completed 3-month Follow up|Physician Decision|0
123456|NCT00872521|449094|P2|Completed 3-month Follow up|Physician Decision|1
123457|NCT00872521|449095|P1|Completed 3-month Follow up|Physician Decision|0
123458|NCT00872521|449093|P3|Completed 3-month Follow up|Not specified|0
123459|NCT00872521|449094|P2|Completed 3-month Follow up|Not specified|2
123460|NCT00872521|449095|P1|Completed 3-month Follow up|Not specified|0
123461|NCT00872521|449093|P3|Primary Endpoint Analysis|Patient response missing|1
123462|NCT00872521|449094|P2|Primary Endpoint Analysis|Patient response missing|0
123463|NCT00872521|449095|P1|Primary Endpoint Analysis|Patient response missing|0
123464|NCT00872521|449093|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
123465|NCT00872521|449094|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
123466|NCT00872521|449095|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
123467|NCT00872521|449093|P3|Primary Endpoint Analysis|Patient choice|0
123468|NCT00872521|449094|P2|Primary Endpoint Analysis|Patient choice|1
123469|NCT00872521|449095|P1|Primary Endpoint Analysis|Patient choice|0
123470|NCT00872521|449093|P3|Primary Endpoint Analysis|Not specified|0
123471|NCT00872521|449094|P2|Primary Endpoint Analysis|Not specified|2
123472|NCT00872521|449095|P1|Primary Endpoint Analysis|Not specified|1
123473|NCT00872521|449093|P3|Completed PAD Induction|Death|0
123474|NCT00872521|449094|P2|Completed PAD Induction|Death|1
123475|NCT00872521|449095|P1|Completed PAD Induction|Death|1
123476|NCT00872521|449093|P3|Completed PAD Induction|Adverse Event|0
123477|NCT00872521|449094|P2|Completed PAD Induction|Adverse Event|0
123478|NCT00872521|449095|P1|Completed PAD Induction|Adverse Event|4
123479|NCT00872521|449093|P3|Completed PAD Induction|Disease progression|0
123480|NCT00872521|449094|P2|Completed PAD Induction|Disease progression|2
123481|NCT00872521|449095|P1|Completed PAD Induction|Disease progression|0
123482|NCT00872521|449093|P3|Completed PAD Induction|Patient choice|0
123483|NCT00872521|449094|P2|Completed PAD Induction|Patient choice|1
123484|NCT00872521|449095|P1|Completed PAD Induction|Patient choice|0
123485|NCT00872170|449166|P2|Overall Study|Adverse Event|0
123486|NCT00872170|449167|P1|Overall Study|Adverse Event|1
123487|NCT00872001|449197|P2|Overall Study|Administrative|15
123488|NCT00872001|449198|P1|Overall Study|Administrative|23
123489|NCT00872001|449197|P2|Overall Study|Did Not Meet Protocol Eligibility|36
123490|NCT00872001|449198|P1|Overall Study|Did Not Meet Protocol Eligibility|38
123491|NCT00872001|449197|P2|Overall Study|Protocol Violation|8
123492|NCT00872001|449198|P1|Overall Study|Protocol Violation|5
123493|NCT00872001|449197|P2|Overall Study|Withdrawal by Subject|30
123494|NCT00872001|449198|P1|Overall Study|Withdrawal by Subject|18
123495|NCT00872001|449197|P2|Overall Study|Lost to Follow-up|12
123496|NCT00872001|449198|P1|Overall Study|Lost to Follow-up|13
123497|NCT00872001|449197|P2|Overall Study|Protocol Defined Clinical Event|7
123498|NCT00872001|449198|P1|Overall Study|Protocol Defined Clinical Event|5
123499|NCT00872001|449197|P2|Overall Study|Adverse Event|23
123500|NCT00872001|449198|P1|Overall Study|Adverse Event|34
123501|NCT00871975|449206|P1|Overall Study|Motion artifact, tracing uninterpretable|5
123502|NCT00871975|449206|P1|Overall Study|Patient unable to void/insufficient vol|13
123503|NCT00871975|449206|P1|Overall Study|Catheters could not be inserted|1
123504|NCT00871975|449206|P1|Overall Study|Technical difficulty w155-1ith equipment|3
123505|NCT00871871|449212|P4|Part II|Protocol Violation|1
123506|NCT00871871|449213|P3|Part II|Protocol Violation|0
123507|NCT00871871|449214|P2|Part II|Protocol Violation|0
123508|NCT00871871|449215|P1|Part II|Protocol Violation|0
123509|NCT00871871|449212|P4|Part II|Adverse Event|2
123510|NCT00871871|449213|P3|Part II|Adverse Event|1
123511|NCT00871871|449214|P2|Part II|Adverse Event|0
123512|NCT00871871|449215|P1|Part II|Adverse Event|0
123513|NCT00871871|449212|P4|Part II|Withdrawal by Subject|1
123514|NCT00871871|449213|P3|Part II|Withdrawal by Subject|2
123515|NCT00871871|449214|P2|Part II|Withdrawal by Subject|0
123516|NCT00871871|449215|P1|Part II|Withdrawal by Subject|0
123517|NCT00871871|449212|P4|Part II|Lack of Efficacy|0
123518|NCT00871871|449213|P3|Part II|Lack of Efficacy|1
123519|NCT00871871|449214|P2|Part II|Lack of Efficacy|0
123520|NCT00871871|449215|P1|Part II|Lack of Efficacy|0
123521|NCT00871871|449212|P4|Part I|Laboratory abnormality|0
123522|NCT00871871|449213|P3|Part I|Laboratory abnormality|0
123523|NCT00871871|449214|P2|Part I|Laboratory abnormality|1
123524|NCT00871871|449215|P1|Part I|Laboratory abnormality|0
123525|NCT00871871|449212|P4|Part I|Withdrawal by Subject|0
123526|NCT00871871|449213|P3|Part I|Withdrawal by Subject|0
123527|NCT00871871|449214|P2|Part I|Withdrawal by Subject|0
123528|NCT00871871|449215|P1|Part I|Withdrawal by Subject|3
123529|NCT00871871|449212|P4|Part I|Adverse Event|0
123530|NCT00871871|449213|P3|Part I|Adverse Event|0
123531|NCT00871871|449214|P2|Part I|Adverse Event|2
123532|NCT00871871|449215|P1|Part I|Adverse Event|0
123533|NCT00871780|449239|P1|Overall Study|Physician Decision|1
123534|NCT00871780|449239|P1|Overall Study|Death|1
123535|NCT00871780|449239|P1|Overall Study|Voluntary Discontinuation|4
123536|NCT00871780|449239|P1|Overall Study|Adverse Event|6
123537|NCT00871780|449239|P1|Overall Study|Withdrawal by Subject|9
123538|NCT00871780|449239|P1|Overall Study|Enrolled But Not Treated|6
123539|NCT00871741|449259|P2|Overall Study|Premature study termination|7
123540|NCT00871741|449260|P1|Overall Study|Premature study termination|9
123541|NCT00871728|449274|P1|Overall Study|Withdrawal of Informed Consent|5
123542|NCT00871728|449274|P1|Overall Study|Participant Non-compliance|1
123543|NCT00871728|449274|P1|Overall Study|Failed to Visit Hospital|4
123544|NCT00871728|449274|P1|Overall Study|Lost to Follow-up|2
123545|NCT00871728|449274|P1|Overall Study|Protocol Violation|7
123546|NCT00871728|449274|P1|Overall Study|Adverse Event|1
123547|NCT00871715|449287|P3|Overall Study|Lost to Follow-up|9
123548|NCT00871715|449288|P2|Overall Study|Lost to Follow-up|6
123549|NCT00871715|449289|P1|Overall Study|Lost to Follow-up|3
123550|NCT00871715|449287|P3|Overall Study|Physician Decision|2
123551|NCT00871715|449288|P2|Overall Study|Physician Decision|0
123552|NCT00871715|449289|P1|Overall Study|Physician Decision|6
123553|NCT00871715|449287|P3|Overall Study|Withdrawal by Subject|15
123554|NCT00871715|449288|P2|Overall Study|Withdrawal by Subject|10
123555|NCT00871715|449289|P1|Overall Study|Withdrawal by Subject|6
123556|NCT00871572|449333|P4|Overall Study|Withdrawal by Subject|1
123557|NCT00871572|449334|P3|Overall Study|Withdrawal by Subject|3
123558|NCT00871572|449335|P2|Overall Study|Withdrawal by Subject|2
123559|NCT00871572|449336|P1|Overall Study|Withdrawal by Subject|1
123560|NCT00871572|449333|P4|Overall Study|Sponsor Decision|0
123561|NCT00871572|449334|P3|Overall Study|Sponsor Decision|0
123562|NCT00871572|449335|P2|Overall Study|Sponsor Decision|0
123563|NCT00871572|449336|P1|Overall Study|Sponsor Decision|1
123564|NCT00871572|449333|P4|Overall Study|Protocol Violation|1
123565|NCT00871572|449334|P3|Overall Study|Protocol Violation|1
123566|NCT00871572|449335|P2|Overall Study|Protocol Violation|0
123567|NCT00871572|449336|P1|Overall Study|Protocol Violation|0
123568|NCT00871572|449333|P4|Overall Study|Lost to Follow-up|1
123569|NCT00871572|449334|P3|Overall Study|Lost to Follow-up|0
123570|NCT00871572|449335|P2|Overall Study|Lost to Follow-up|1
123571|NCT00871572|449336|P1|Overall Study|Lost to Follow-up|0
123572|NCT00871572|449333|P4|Overall Study|Investigator Decision|1
123573|NCT00871572|449334|P3|Overall Study|Investigator Decision|0
123574|NCT00871572|449335|P2|Overall Study|Investigator Decision|1
123575|NCT00871572|449336|P1|Overall Study|Investigator Decision|0
123576|NCT00871572|449333|P4|Overall Study|Adverse Event|3
123577|NCT00871572|449334|P3|Overall Study|Adverse Event|0
123578|NCT00871572|449335|P2|Overall Study|Adverse Event|2
123579|NCT00871572|449336|P1|Overall Study|Adverse Event|0
123580|NCT00871494|449406|P1|Overall Study|Lost to Follow-up|1
123581|NCT00871494|449406|P1|Overall Study|Adverse Event|4
123582|NCT00871494|449406|P1|Overall Study|Lack of Efficacy|4
123583|NCT00871494|449406|P1|Overall Study|Protocol Violation|5
123584|NCT00871429|449413|P1|Overall Study|Questionnaire not completed|1
123585|NCT00871429|449413|P1|Overall Study|Withdrawal by Subject|17
123586|NCT00871429|449413|P1|Overall Study|Lost to Follow-up|6
123587|NCT00871403|449424|P3|Monotherapy Treatment Phase|Adverse Event|0
123588|NCT00871403|449425|P2|Monotherapy Treatment Phase|Adverse Event|4
123589|NCT00871403|449426|P1|Monotherapy Treatment Phase|Adverse Event|0
123590|NCT00871403|449424|P3|Monotherapy Treatment Phase|Disease Progression|1
123591|NCT00871403|449425|P2|Monotherapy Treatment Phase|Disease Progression|9
123592|NCT00871403|449426|P1|Monotherapy Treatment Phase|Disease Progression|0
123593|NCT00871403|449424|P3|Combination Treatment Phase|Physician Decision|3
123594|NCT00871403|449425|P2|Combination Treatment Phase|Physician Decision|1
123595|NCT00871403|449426|P1|Combination Treatment Phase|Physician Decision|0
123596|NCT00871403|449424|P3|Combination Treatment Phase|Withdrawal by Subject|1
123597|NCT00871403|449425|P2|Combination Treatment Phase|Withdrawal by Subject|3
123598|NCT00871403|449426|P1|Combination Treatment Phase|Withdrawal by Subject|0
123599|NCT00871403|449424|P3|Combination Treatment Phase|Disease Progression|5
123600|NCT00871403|449425|P2|Combination Treatment Phase|Disease Progression|8
123601|NCT00871403|449426|P1|Combination Treatment Phase|Disease Progression|0
123602|NCT00871403|449424|P3|Combination Treatment Phase|Adverse Event|2
123603|NCT00871403|449425|P2|Combination Treatment Phase|Adverse Event|17
123604|NCT00871403|449426|P1|Combination Treatment Phase|Adverse Event|0
123605|NCT00871403|449424|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
123606|NCT00871403|449425|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
123607|NCT00871403|449426|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
123608|NCT00871403|449424|P3|Combination Treatment Phase|Randomized but Not Treated|1
123609|NCT00871403|449425|P2|Combination Treatment Phase|Randomized but Not Treated|1
123610|NCT00871403|449426|P1|Combination Treatment Phase|Randomized but Not Treated|1
123611|NCT00871377|449439|P6|Third Intervention (10 Weeks)|Death|0
123612|NCT00871377|449440|P5|Third Intervention (10 Weeks)|Death|0
123613|NCT00871377|449441|P4|Third Intervention (10 Weeks)|Death|1
123614|NCT00871377|449442|P3|Third Intervention (10 Weeks)|Death|0
123615|NCT00871377|449443|P2|Third Intervention (10 Weeks)|Death|0
123616|NCT00871377|449444|P1|Third Intervention (10 Weeks)|Death|0
123617|NCT00871377|449439|P6|Washout (6 Weeks)|Withdrawal by Subject|1
123618|NCT00871377|449440|P5|Washout (6 Weeks)|Withdrawal by Subject|0
123619|NCT00871377|449441|P4|Washout (6 Weeks)|Withdrawal by Subject|0
123620|NCT00871377|449442|P3|Washout (6 Weeks)|Withdrawal by Subject|0
123621|NCT00871377|449443|P2|Washout (6 Weeks)|Withdrawal by Subject|0
123622|NCT00871377|449444|P1|Washout (6 Weeks)|Withdrawal by Subject|0
123623|NCT00871377|449439|P6|Washout (6 Weeks)|Withdrawal by Subject|0
123624|NCT00871377|449440|P5|Washout (6 Weeks)|Withdrawal by Subject|0
123625|NCT00871377|449441|P4|Washout (6 Weeks)|Withdrawal by Subject|0
123626|NCT00871377|449442|P3|Washout (6 Weeks)|Withdrawal by Subject|0
123627|NCT00871377|449443|P2|Washout (6 Weeks)|Withdrawal by Subject|0
123628|NCT00871377|449444|P1|Washout (6 Weeks)|Withdrawal by Subject|1
123629|NCT00871377|449439|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
123630|NCT00871377|449440|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
123631|NCT00871377|449441|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
123632|NCT00871377|449442|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
123633|NCT00871377|449443|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
123634|NCT00871377|449444|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
123635|NCT00871377|449439|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
123636|NCT00871377|449440|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
123637|NCT00871377|449441|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
123638|NCT00871377|449442|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
123639|NCT00871377|449443|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
123640|NCT00871377|449444|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
123641|NCT00871351|449455|P3|Overall Study|Adverse Event|0
123642|NCT00871351|449456|P2|Overall Study|Adverse Event|1
123643|NCT00871351|449457|P1|Overall Study|Adverse Event|3
123644|NCT00871351|449455|P3|Overall Study|Withdrawal by Subject|0
123645|NCT00871351|449456|P2|Overall Study|Withdrawal by Subject|0
123646|NCT00871351|449457|P1|Overall Study|Withdrawal by Subject|1
123647|NCT00871338|449479|P2|Prior to Booster|Lost to Follow-up|0
123648|NCT00871338|449480|P1|Prior to Booster|Lost to Follow-up|1
123649|NCT00871338|449479|P2|Prior to Booster|Withdrawal by Subject|3
123650|NCT00871338|449480|P1|Prior to Booster|Withdrawal by Subject|1
123651|NCT00871234|449569|P1|Overall Study|Lost to Follow-up|3
123652|NCT00871234|449569|P1|Overall Study|Adverse Event|2
123653|NCT00871169|449573|P1|Overall Study|Patient did not receive study treatment|2
123654|NCT00871169|449573|P1|Overall Study|Protocol Violation|1
123655|NCT00871117|449601|P2|Overall Study|Lost to Follow-up|10
123656|NCT00871117|449602|P1|Overall Study|Lost to Follow-up|5
123657|NCT00871000|449634|P2|Overall Study|Withdrawal by Subject|0
123658|NCT00871000|449635|P1|Overall Study|Withdrawal by Subject|1
123659|NCT00870740|449689|P6|Overall Study|Not Specified|5
123660|NCT00870740|449690|P5|Overall Study|Not Specified|3
123661|NCT00870740|449691|P4|Overall Study|Not Specified|4
123662|NCT00870740|449692|P3|Overall Study|Not Specified|2
123663|NCT00870740|449693|P2|Overall Study|Not Specified|5
123664|NCT00870740|449694|P1|Overall Study|Not Specified|2
123665|NCT00870740|449689|P6|Overall Study|Death|0
123666|NCT00870740|449690|P5|Overall Study|Death|1
123667|NCT00870740|449691|P4|Overall Study|Death|0
123668|NCT00870740|449692|P3|Overall Study|Death|0
123669|NCT00870740|449693|P2|Overall Study|Death|0
123670|NCT00870740|449694|P1|Overall Study|Death|0
123671|NCT00870740|449689|P6|Overall Study|Subject Non-compliance|1
123672|NCT00870740|449690|P5|Overall Study|Subject Non-compliance|0
123673|NCT00870740|449691|P4|Overall Study|Subject Non-compliance|0
123674|NCT00870740|449692|P3|Overall Study|Subject Non-compliance|0
123675|NCT00870740|449693|P2|Overall Study|Subject Non-compliance|0
123676|NCT00870740|449694|P1|Overall Study|Subject Non-compliance|0
123677|NCT00870740|449689|P6|Overall Study|Investigator Decision|0
123678|NCT00870740|449690|P5|Overall Study|Investigator Decision|0
123679|NCT00870740|449691|P4|Overall Study|Investigator Decision|0
123680|NCT00870740|449692|P3|Overall Study|Investigator Decision|1
123681|NCT00870740|449693|P2|Overall Study|Investigator Decision|0
123682|NCT00870740|449694|P1|Overall Study|Investigator Decision|2
123683|NCT00870740|449689|P6|Overall Study|Consent Withdrawn|5
123684|NCT00870740|449690|P5|Overall Study|Consent Withdrawn|6
123685|NCT00870740|449691|P4|Overall Study|Consent Withdrawn|6
123686|NCT00870740|449692|P3|Overall Study|Consent Withdrawn|4
123687|NCT00870740|449693|P2|Overall Study|Consent Withdrawn|3
123688|NCT00870740|449694|P1|Overall Study|Consent Withdrawn|6
123689|NCT00870740|449689|P6|Overall Study|Adverse Event|6
123690|NCT00870740|449690|P5|Overall Study|Adverse Event|1
123691|NCT00870740|449691|P4|Overall Study|Adverse Event|2
123692|NCT00870740|449692|P3|Overall Study|Adverse Event|3
123693|NCT00870740|449693|P2|Overall Study|Adverse Event|1
123694|NCT00870740|449694|P1|Overall Study|Adverse Event|2
123695|NCT00870688|449768|P1|Overall Study|Granules in the Stools|1
123696|NCT00870688|449768|P1|Overall Study|Death, Unrelated|1
123697|NCT00870688|449768|P1|Overall Study|Lost to Follow-up|2
123698|NCT00870584|449773|P2|Overall Study|Protocol Deviation|2
123699|NCT00870584|449774|P1|Overall Study|Protocol Deviation|2
123700|NCT00870584|449773|P2|Overall Study|Lost to Follow-up|1
123701|NCT00870584|449774|P1|Overall Study|Lost to Follow-up|5
123702|NCT00870584|449773|P2|Overall Study|Withdrawal by Subject|7
123703|NCT00870584|449774|P1|Overall Study|Withdrawal by Subject|6
123704|NCT00870584|449773|P2|Overall Study|Adverse Event|3
123705|NCT00870584|449774|P1|Overall Study|Adverse Event|3
123706|NCT00870194|449885|P2|Overall Study|Subject Decision|2
123707|NCT00870194|449886|P1|Overall Study|Subject Decision|7
123708|NCT00870194|449885|P2|Overall Study|Entry Criteria Not Met|2
123709|NCT00870194|449886|P1|Overall Study|Entry Criteria Not Met|1
123710|NCT00870194|449885|P2|Overall Study|Protocol Violation|3
123711|NCT00870194|449886|P1|Overall Study|Protocol Violation|3
123712|NCT00870194|449885|P2|Overall Study|Physician Decision|1
123713|NCT00870194|449886|P1|Overall Study|Physician Decision|3
123714|NCT00870194|449885|P2|Overall Study|Lost to Follow-up|0
123715|NCT00870194|449886|P1|Overall Study|Lost to Follow-up|2
123716|NCT00870194|449885|P2|Overall Study|Lack of Efficacy|1
123717|NCT00870194|449886|P1|Overall Study|Lack of Efficacy|0
123718|NCT00870194|449885|P2|Overall Study|Adverse Event|5
123719|NCT00870194|449886|P1|Overall Study|Adverse Event|10
123720|NCT00870103|449924|P1|Overall Study|Lost to Follow-up|2
123721|NCT00870103|449924|P1|Overall Study|Physician Decision|2
123722|NCT00869999|449929|P1|Overall Study|removed prior to starting therapy|1
123723|NCT00869999|449929|P1|Overall Study|Withdrawal by Subject|1
123724|NCT00869960|449935|P1|Overall Study|Lost to Follow-up|2
123725|NCT00869778|449984|P3|Overall Study|Unblinding|0
123726|NCT00869778|449985|P2|Overall Study|Unblinding|0
123727|NCT00869778|449986|P1|Overall Study|Unblinding|1
123728|NCT00869778|449984|P3|Overall Study|Protocol Violation|5
123729|NCT00869778|449985|P2|Overall Study|Protocol Violation|3
123730|NCT00869778|449986|P1|Overall Study|Protocol Violation|5
123731|NCT00869778|449984|P3|Overall Study|Pregnancy|0
123732|NCT00869778|449985|P2|Overall Study|Pregnancy|0
123733|NCT00869778|449986|P1|Overall Study|Pregnancy|1
123734|NCT00869778|449984|P3|Overall Study|Withdrawal by Subject|5
123735|NCT00869778|449985|P2|Overall Study|Withdrawal by Subject|4
123736|NCT00869778|449986|P1|Overall Study|Withdrawal by Subject|3
123737|NCT00869778|449984|P3|Overall Study|Adverse Event|0
123738|NCT00869778|449985|P2|Overall Study|Adverse Event|0
123739|NCT00869778|449986|P1|Overall Study|Adverse Event|2
123740|NCT00869557|450061|P2|Extension Phase|Withdrew Consent|0
123741|NCT00869557|450062|P1|Extension Phase|Withdrew Consent|2
123742|NCT00869557|450061|P2|Extension Phase|Investigator's Discretion|0
123743|NCT00869557|450062|P1|Extension Phase|Investigator's Discretion|2
123744|NCT00869557|450061|P2|Extension Phase|Lost to Follow-up|1
123745|NCT00869557|450062|P1|Extension Phase|Lost to Follow-up|3
123746|NCT00869557|450061|P2|Extension Phase|Lack of Efficacy|0
123747|NCT00869557|450062|P1|Extension Phase|Lack of Efficacy|1
123748|NCT00869557|450061|P2|Extension Phase|Adverse Event|2
123749|NCT00869557|450062|P1|Extension Phase|Adverse Event|2
123750|NCT00869557|450061|P2|Randomized Phase|Withdrew Consent|1
123751|NCT00869557|450062|P1|Randomized Phase|Withdrew Consent|0
123752|NCT00869557|450061|P2|Randomized Phase|Investigator's Discretion|0
123753|NCT00869557|450062|P1|Randomized Phase|Investigator's Discretion|1
123754|NCT00869557|450061|P2|Randomized Phase|Lost to Follow-up|1
123755|NCT00869557|450062|P1|Randomized Phase|Lost to Follow-up|2
123756|NCT00869518|450081|P2|Overall Study|Lost to Follow-up|1
123757|NCT00869518|450082|P1|Overall Study|Lost to Follow-up|1
123758|NCT00869401|450110|P5|Overall Study|Withdrawal by Subject|3
123759|NCT00869401|450111|P4|Overall Study|Withdrawal by Subject|5
123760|NCT00869401|450112|P3|Overall Study|Withdrawal by Subject|0
123761|NCT00869401|450113|P2|Overall Study|Withdrawal by Subject|0
123762|NCT00869401|450114|P1|Overall Study|Withdrawal by Subject|0
123763|NCT00869362|450143|P2|Overall Study|Lost to Follow-up|3
123764|NCT00869362|450144|P1|Overall Study|Lost to Follow-up|1
123765|NCT00869362|450143|P2|Overall Study|Death|2
123766|NCT00869362|450144|P1|Overall Study|Death|0
123767|NCT00869323|450165|P1|Maintenance Therapy|concurrent illness|1
123768|NCT00869258|450173|P1|Overall Study|Physician Decision|1
123769|NCT00869128|450207|P2|Overall Study|lack of Compliance|6
123770|NCT00869128|450208|P1|Overall Study|lack of Compliance|6
123771|NCT00869089|450212|P1|Overall Study|Screen Fail|1
123772|NCT00869089|450212|P1|Overall Study|Withdrawal by Subject|1
123773|NCT00869089|450212|P1|Overall Study|Lost to Follow-up|1
123774|NCT00869050|450216|P1|Overall Study|Screen Failure|3
123775|NCT00868998|450221|P1|Overall Study|Death|1
123776|NCT00868998|450221|P1|Overall Study|Progression of disease|2
123777|NCT00868998|450221|P1|Overall Study|Withdrawal by Subject|1
123778|NCT00868998|450221|P1|Overall Study|Screen Failure|1
123779|NCT00868790|450232|P14|Post-study|Excluded Medication|0
123780|NCT00868790|450233|P13|Post-study|Excluded Medication|0
123781|NCT00868790|450234|P12|Post-study|Excluded Medication|0
123782|NCT00868790|450235|P11|Post-study|Excluded Medication|0
123783|NCT00868790|450236|P10|Post-study|Excluded Medication|1
123784|NCT00868790|450237|P9|Post-study|Excluded Medication|0
123785|NCT00868790|450238|P8|Post-study|Excluded Medication|2
123786|NCT00868790|450239|P7|Post-study|Excluded Medication|0
123787|NCT00868790|450240|P6|Post-study|Excluded Medication|0
123788|NCT00868790|450241|P5|Post-study|Excluded Medication|0
123789|NCT00868790|450242|P4|Post-study|Excluded Medication|0
123790|NCT00868790|450243|P3|Post-study|Excluded Medication|0
123791|NCT00868790|450244|P2|Post-study|Excluded Medication|0
123792|NCT00868790|450245|P1|Post-study|Excluded Medication|0
123793|NCT00868790|450232|P14|Post-study|Withdrawal by Subject|0
123794|NCT00868790|450233|P13|Post-study|Withdrawal by Subject|0
123795|NCT00868790|450234|P12|Post-study|Withdrawal by Subject|0
123796|NCT00868790|450235|P11|Post-study|Withdrawal by Subject|0
123797|NCT00868790|450236|P10|Post-study|Withdrawal by Subject|0
123798|NCT00868790|450237|P9|Post-study|Withdrawal by Subject|0
123799|NCT00868790|450238|P8|Post-study|Withdrawal by Subject|0
123800|NCT00868790|450239|P7|Post-study|Withdrawal by Subject|0
123801|NCT00868790|450240|P6|Post-study|Withdrawal by Subject|0
123802|NCT00868790|450241|P5|Post-study|Withdrawal by Subject|1
123803|NCT00868790|450242|P4|Post-study|Withdrawal by Subject|0
123804|NCT00868790|450243|P3|Post-study|Withdrawal by Subject|0
123805|NCT00868790|450244|P2|Post-study|Withdrawal by Subject|0
123806|NCT00868790|450245|P1|Post-study|Withdrawal by Subject|0
123807|NCT00868790|450232|P14|Period 4|Abnormal ALT/AST|0
123808|NCT00868790|450233|P13|Period 4|Abnormal ALT/AST|0
123809|NCT00868790|450234|P12|Period 4|Abnormal ALT/AST|0
123810|NCT00868790|450235|P11|Period 4|Abnormal ALT/AST|0
123811|NCT00868790|450236|P10|Period 4|Abnormal ALT/AST|0
123812|NCT00868790|450237|P9|Period 4|Abnormal ALT/AST|0
123813|NCT00868790|450238|P8|Period 4|Abnormal ALT/AST|0
123814|NCT00868790|450239|P7|Period 4|Abnormal ALT/AST|0
123815|NCT00868790|450240|P6|Period 4|Abnormal ALT/AST|0
123816|NCT00868790|450241|P5|Period 4|Abnormal ALT/AST|0
123817|NCT00868790|450242|P4|Period 4|Abnormal ALT/AST|0
123818|NCT00868790|450243|P3|Period 4|Abnormal ALT/AST|1
123819|NCT00868790|450244|P2|Period 4|Abnormal ALT/AST|0
123820|NCT00868790|450245|P1|Period 4|Abnormal ALT/AST|0
123821|NCT00868790|450232|P14|Period 4|Study Terminated by Sponsor|1
123822|NCT00868790|450233|P13|Period 4|Study Terminated by Sponsor|0
123823|NCT00868790|450234|P12|Period 4|Study Terminated by Sponsor|1
123824|NCT00868790|450235|P11|Period 4|Study Terminated by Sponsor|2
123825|NCT00868790|450236|P10|Period 4|Study Terminated by Sponsor|0
123826|NCT00868790|450237|P9|Period 4|Study Terminated by Sponsor|2
123827|NCT00868790|450238|P8|Period 4|Study Terminated by Sponsor|1
123828|NCT00868790|450239|P7|Period 4|Study Terminated by Sponsor|0
123829|NCT00868790|450240|P6|Period 4|Study Terminated by Sponsor|0
123830|NCT00868790|450241|P5|Period 4|Study Terminated by Sponsor|0
123831|NCT00868790|450242|P4|Period 4|Study Terminated by Sponsor|0
123832|NCT00868790|450243|P3|Period 4|Study Terminated by Sponsor|0
123833|NCT00868790|450244|P2|Period 4|Study Terminated by Sponsor|0
123834|NCT00868790|450245|P1|Period 4|Study Terminated by Sponsor|2
123835|NCT00868790|450232|P14|Period 4|Lost to Follow-up|0
123836|NCT00868790|450233|P13|Period 4|Lost to Follow-up|0
123837|NCT00868790|450234|P12|Period 4|Lost to Follow-up|0
123838|NCT00868790|450235|P11|Period 4|Lost to Follow-up|0
123839|NCT00868790|450236|P10|Period 4|Lost to Follow-up|0
123840|NCT00868790|450237|P9|Period 4|Lost to Follow-up|0
123841|NCT00868790|450238|P8|Period 4|Lost to Follow-up|1
123842|NCT00868790|450239|P7|Period 4|Lost to Follow-up|0
123843|NCT00868790|450240|P6|Period 4|Lost to Follow-up|0
123844|NCT00868790|450241|P5|Period 4|Lost to Follow-up|0
123845|NCT00868790|450242|P4|Period 4|Lost to Follow-up|0
123846|NCT00868790|450243|P3|Period 4|Lost to Follow-up|0
123847|NCT00868790|450244|P2|Period 4|Lost to Follow-up|0
123848|NCT00868790|450245|P1|Period 4|Lost to Follow-up|0
123849|NCT00868790|450232|P14|Period 4|Adverse Event|0
123850|NCT00868790|450233|P13|Period 4|Adverse Event|1
123851|NCT00868790|450234|P12|Period 4|Adverse Event|0
123852|NCT00868790|450235|P11|Period 4|Adverse Event|1
123853|NCT00868790|450236|P10|Period 4|Adverse Event|0
123854|NCT00868790|450237|P9|Period 4|Adverse Event|0
123855|NCT00868790|450238|P8|Period 4|Adverse Event|1
123856|NCT00868790|450239|P7|Period 4|Adverse Event|0
123857|NCT00868790|450240|P6|Period 4|Adverse Event|0
123858|NCT00868790|450241|P5|Period 4|Adverse Event|0
123859|NCT00868790|450242|P4|Period 4|Adverse Event|0
123860|NCT00868790|450243|P3|Period 4|Adverse Event|0
123861|NCT00868790|450244|P2|Period 4|Adverse Event|0
123862|NCT00868790|450245|P1|Period 4|Adverse Event|0
123863|NCT00868790|450232|P14|Period 3|Study Terminated by Sponsor|0
123864|NCT00868790|450233|P13|Period 3|Study Terminated by Sponsor|0
123865|NCT00868790|450234|P12|Period 3|Study Terminated by Sponsor|0
123866|NCT00868790|450235|P11|Period 3|Study Terminated by Sponsor|0
123867|NCT00868790|450236|P10|Period 3|Study Terminated by Sponsor|0
123868|NCT00868790|450237|P9|Period 3|Study Terminated by Sponsor|0
123869|NCT00868790|450238|P8|Period 3|Study Terminated by Sponsor|0
123870|NCT00868790|450239|P7|Period 3|Study Terminated by Sponsor|0
123871|NCT00868790|450240|P6|Period 3|Study Terminated by Sponsor|0
123872|NCT00868790|450241|P5|Period 3|Study Terminated by Sponsor|0
123873|NCT00868790|450242|P4|Period 3|Study Terminated by Sponsor|1
123874|NCT00868790|450243|P3|Period 3|Study Terminated by Sponsor|0
123875|NCT00868790|450244|P2|Period 3|Study Terminated by Sponsor|0
123876|NCT00868790|450245|P1|Period 3|Study Terminated by Sponsor|0
123877|NCT00868790|450232|P14|Period 3|Protocol Violation|0
123878|NCT00868790|450233|P13|Period 3|Protocol Violation|0
123879|NCT00868790|450234|P12|Period 3|Protocol Violation|0
123880|NCT00868790|450235|P11|Period 3|Protocol Violation|1
123881|NCT00868790|450236|P10|Period 3|Protocol Violation|0
123882|NCT00868790|450237|P9|Period 3|Protocol Violation|0
123883|NCT00868790|450238|P8|Period 3|Protocol Violation|0
123884|NCT00868790|450239|P7|Period 3|Protocol Violation|0
123885|NCT00868790|450240|P6|Period 3|Protocol Violation|0
123886|NCT00868790|450241|P5|Period 3|Protocol Violation|0
123887|NCT00868790|450242|P4|Period 3|Protocol Violation|0
123888|NCT00868790|450243|P3|Period 3|Protocol Violation|0
123889|NCT00868790|450244|P2|Period 3|Protocol Violation|0
123890|NCT00868790|450245|P1|Period 3|Protocol Violation|0
123891|NCT00868790|450232|P14|Period 3|Adverse Event|0
123892|NCT00868790|450233|P13|Period 3|Adverse Event|0
123893|NCT00868790|450234|P12|Period 3|Adverse Event|0
123894|NCT00868790|450235|P11|Period 3|Adverse Event|0
123895|NCT00868790|450236|P10|Period 3|Adverse Event|1
123896|NCT00868790|450237|P9|Period 3|Adverse Event|0
123897|NCT00868790|450238|P8|Period 3|Adverse Event|0
123898|NCT00868790|450239|P7|Period 3|Adverse Event|0
123899|NCT00868790|450240|P6|Period 3|Adverse Event|0
123900|NCT00868790|450241|P5|Period 3|Adverse Event|0
123901|NCT00868790|450242|P4|Period 3|Adverse Event|0
123902|NCT00868790|450243|P3|Period 3|Adverse Event|0
123903|NCT00868790|450244|P2|Period 3|Adverse Event|0
123904|NCT00868790|450245|P1|Period 3|Adverse Event|0
123905|NCT00868790|450232|P14|Period 2|Withdrawal by Subject|1
123906|NCT00868790|450233|P13|Period 2|Withdrawal by Subject|0
123907|NCT00868790|450234|P12|Period 2|Withdrawal by Subject|0
123908|NCT00868790|450235|P11|Period 2|Withdrawal by Subject|0
123909|NCT00868790|450236|P10|Period 2|Withdrawal by Subject|0
123910|NCT00868790|450237|P9|Period 2|Withdrawal by Subject|1
123911|NCT00868790|450238|P8|Period 2|Withdrawal by Subject|0
123912|NCT00868790|450239|P7|Period 2|Withdrawal by Subject|0
123913|NCT00868790|450240|P6|Period 2|Withdrawal by Subject|0
123914|NCT00868790|450241|P5|Period 2|Withdrawal by Subject|0
123915|NCT00868790|450242|P4|Period 2|Withdrawal by Subject|0
123916|NCT00868790|450243|P3|Period 2|Withdrawal by Subject|0
123917|NCT00868790|450244|P2|Period 2|Withdrawal by Subject|0
123918|NCT00868790|450245|P1|Period 2|Withdrawal by Subject|0
123919|NCT00868790|450232|P14|Period 2|Lost to Follow-up|0
123920|NCT00868790|450233|P13|Period 2|Lost to Follow-up|0
123921|NCT00868790|450234|P12|Period 2|Lost to Follow-up|0
123922|NCT00868790|450235|P11|Period 2|Lost to Follow-up|0
123923|NCT00868790|450236|P10|Period 2|Lost to Follow-up|0
123924|NCT00868790|450237|P9|Period 2|Lost to Follow-up|0
123925|NCT00868790|450238|P8|Period 2|Lost to Follow-up|0
123926|NCT00868790|450239|P7|Period 2|Lost to Follow-up|0
123927|NCT00868790|450240|P6|Period 2|Lost to Follow-up|1
123928|NCT00868790|450241|P5|Period 2|Lost to Follow-up|0
123929|NCT00868790|450242|P4|Period 2|Lost to Follow-up|0
123930|NCT00868790|450243|P3|Period 2|Lost to Follow-up|0
123931|NCT00868790|450244|P2|Period 2|Lost to Follow-up|1
123932|NCT00868790|450245|P1|Period 2|Lost to Follow-up|0
123933|NCT00868790|450232|P14|Period 2|Adverse Event|0
123934|NCT00868790|450233|P13|Period 2|Adverse Event|0
123935|NCT00868790|450234|P12|Period 2|Adverse Event|0
123936|NCT00868790|450235|P11|Period 2|Adverse Event|0
123937|NCT00868790|450236|P10|Period 2|Adverse Event|0
123938|NCT00868790|450237|P9|Period 2|Adverse Event|1
123939|NCT00868790|450238|P8|Period 2|Adverse Event|0
123940|NCT00868790|450239|P7|Period 2|Adverse Event|0
123941|NCT00868790|450240|P6|Period 2|Adverse Event|0
123942|NCT00868790|450241|P5|Period 2|Adverse Event|0
123943|NCT00868790|450242|P4|Period 2|Adverse Event|0
123944|NCT00868790|450243|P3|Period 2|Adverse Event|0
123945|NCT00868790|450244|P2|Period 2|Adverse Event|0
123946|NCT00868790|450245|P1|Period 2|Adverse Event|0
123947|NCT00868790|450232|P14|Period 1|Lost to Follow-up|0
123948|NCT00868790|450233|P13|Period 1|Lost to Follow-up|0
123949|NCT00868790|450234|P12|Period 1|Lost to Follow-up|0
123950|NCT00868790|450235|P11|Period 1|Lost to Follow-up|0
123951|NCT00868790|450236|P10|Period 1|Lost to Follow-up|0
123952|NCT00868790|450237|P9|Period 1|Lost to Follow-up|0
123953|NCT00868790|450238|P8|Period 1|Lost to Follow-up|0
123954|NCT00868790|450239|P7|Period 1|Lost to Follow-up|0
123955|NCT00868790|450240|P6|Period 1|Lost to Follow-up|1
123956|NCT00868790|450241|P5|Period 1|Lost to Follow-up|0
123957|NCT00868790|450242|P4|Period 1|Lost to Follow-up|0
123958|NCT00868790|450243|P3|Period 1|Lost to Follow-up|0
123959|NCT00868790|450244|P2|Period 1|Lost to Follow-up|0
123960|NCT00868790|450245|P1|Period 1|Lost to Follow-up|0
123961|NCT00868790|450232|P14|Period 1|Abnormal Triglycerides|0
123962|NCT00868790|450233|P13|Period 1|Abnormal Triglycerides|0
123963|NCT00868790|450234|P12|Period 1|Abnormal Triglycerides|0
123964|NCT00868790|450235|P11|Period 1|Abnormal Triglycerides|0
123965|NCT00868790|450236|P10|Period 1|Abnormal Triglycerides|0
123966|NCT00868790|450237|P9|Period 1|Abnormal Triglycerides|0
123967|NCT00868790|450238|P8|Period 1|Abnormal Triglycerides|0
123968|NCT00868790|450239|P7|Period 1|Abnormal Triglycerides|0
123969|NCT00868790|450240|P6|Period 1|Abnormal Triglycerides|0
123970|NCT00868790|450241|P5|Period 1|Abnormal Triglycerides|1
123971|NCT00868790|450242|P4|Period 1|Abnormal Triglycerides|0
123972|NCT00868790|450243|P3|Period 1|Abnormal Triglycerides|0
123973|NCT00868790|450244|P2|Period 1|Abnormal Triglycerides|0
123974|NCT00868790|450245|P1|Period 1|Abnormal Triglycerides|0
123975|NCT00868790|450232|P14|Period 1|Withdrawal by Subject|1
123976|NCT00868790|450233|P13|Period 1|Withdrawal by Subject|0
123977|NCT00868790|450234|P12|Period 1|Withdrawal by Subject|0
123978|NCT00868790|450235|P11|Period 1|Withdrawal by Subject|0
123979|NCT00868790|450236|P10|Period 1|Withdrawal by Subject|0
123980|NCT00868790|450237|P9|Period 1|Withdrawal by Subject|0
123981|NCT00868790|450238|P8|Period 1|Withdrawal by Subject|0
123982|NCT00868790|450239|P7|Period 1|Withdrawal by Subject|0
123983|NCT00868790|450240|P6|Period 1|Withdrawal by Subject|0
123984|NCT00868790|450241|P5|Period 1|Withdrawal by Subject|0
123985|NCT00868790|450242|P4|Period 1|Withdrawal by Subject|0
123986|NCT00868790|450243|P3|Period 1|Withdrawal by Subject|0
123987|NCT00868790|450244|P2|Period 1|Withdrawal by Subject|1
123988|NCT00868790|450245|P1|Period 1|Withdrawal by Subject|0
123989|NCT00868790|450232|P14|Period 1|Protocol Violation|0
123990|NCT00868790|450233|P13|Period 1|Protocol Violation|0
123991|NCT00868790|450234|P12|Period 1|Protocol Violation|0
123992|NCT00868790|450235|P11|Period 1|Protocol Violation|0
123993|NCT00868790|450236|P10|Period 1|Protocol Violation|0
123994|NCT00868790|450237|P9|Period 1|Protocol Violation|0
123995|NCT00868790|450238|P8|Period 1|Protocol Violation|0
123996|NCT00868790|450239|P7|Period 1|Protocol Violation|0
123997|NCT00868790|450240|P6|Period 1|Protocol Violation|0
123998|NCT00868790|450241|P5|Period 1|Protocol Violation|0
123999|NCT00868790|450242|P4|Period 1|Protocol Violation|0
124000|NCT00868790|450243|P3|Period 1|Protocol Violation|0
124001|NCT00868790|450244|P2|Period 1|Protocol Violation|0
124002|NCT00868790|450245|P1|Period 1|Protocol Violation|1
124003|NCT00868790|450232|P14|Period 1|Adverse Event|1
124004|NCT00868790|450233|P13|Period 1|Adverse Event|0
124005|NCT00868790|450234|P12|Period 1|Adverse Event|0
124006|NCT00868790|450235|P11|Period 1|Adverse Event|0
124007|NCT00868790|450236|P10|Period 1|Adverse Event|0
124008|NCT00868790|450237|P9|Period 1|Adverse Event|1
124009|NCT00868790|450238|P8|Period 1|Adverse Event|3
124010|NCT00868790|450239|P7|Period 1|Adverse Event|0
124011|NCT00868790|450240|P6|Period 1|Adverse Event|0
124012|NCT00868790|450241|P5|Period 1|Adverse Event|0
124013|NCT00868790|450242|P4|Period 1|Adverse Event|0
124014|NCT00868790|450243|P3|Period 1|Adverse Event|0
124015|NCT00868790|450244|P2|Period 1|Adverse Event|0
124016|NCT00868790|450245|P1|Period 1|Adverse Event|1
124017|NCT00868608|450328|P3|Overall Study|Other - Unspecified|0
124018|NCT00868608|450329|P2|Overall Study|Other - Unspecified|0
124019|NCT00868608|450330|P1|Overall Study|Other - Unspecified|1
124020|NCT00868608|450328|P3|Overall Study|Death|4
124021|NCT00868608|450329|P2|Overall Study|Death|2
124022|NCT00868608|450330|P1|Overall Study|Death|16
124023|NCT00868608|450328|P3|Overall Study|Lost to Follow-up|1
124024|NCT00868608|450329|P2|Overall Study|Lost to Follow-up|0
124025|NCT00868608|450330|P1|Overall Study|Lost to Follow-up|3
124026|NCT00868608|450328|P3|Overall Study|Withdrawal by Subject|0
124027|NCT00868608|450329|P2|Overall Study|Withdrawal by Subject|1
124028|NCT00868608|450330|P1|Overall Study|Withdrawal by Subject|3
124029|NCT00868530|450354|P1|Overall Study|Lost to Follow-up|1
124030|NCT00868530|450354|P1|Overall Study|Adverse Event|3
124031|NCT00868517|450369|P3|Overall Study|Protocol Violation|0
124032|NCT00868517|450370|P2|Overall Study|Protocol Violation|1
124033|NCT00868517|450371|P1|Overall Study|Protocol Violation|1
124034|NCT00868517|450369|P3|Overall Study|Withdrawal by Subject|2
124035|NCT00868517|450370|P2|Overall Study|Withdrawal by Subject|3
124036|NCT00868517|450371|P1|Overall Study|Withdrawal by Subject|3
124037|NCT00868439|450409|P2|Overall Study|Withdrawal by Subject|1
124038|NCT00868439|450410|P1|Overall Study|Withdrawal by Subject|0
124039|NCT00868439|450409|P2|Overall Study|Physician Decision|0
124040|NCT00868439|450410|P1|Overall Study|Physician Decision|1
124041|NCT00868439|450409|P2|Overall Study|Protocol Violation|1
124042|NCT00868439|450410|P1|Overall Study|Protocol Violation|1
124043|NCT00868439|450409|P2|Overall Study|Death|1
124044|NCT00868439|450410|P1|Overall Study|Death|0
124045|NCT00868439|450409|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
124046|NCT00868439|450410|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
124047|NCT00868439|450409|P2|Overall Study|Adverse Event|3
124048|NCT00868439|450410|P1|Overall Study|Adverse Event|4
124049|NCT00868296|450467|P2|Overall Study|Withdrawal by Subject|1
124050|NCT00868296|450468|P1|Overall Study|Withdrawal by Subject|0
124051|NCT00868296|450467|P2|Overall Study|Adverse Event|2
124052|NCT00868296|450468|P1|Overall Study|Adverse Event|0
124053|NCT00868231|450476|P6|Treatment Period 3|Adverse Event|0
124054|NCT00868231|450477|P5|Treatment Period 3|Adverse Event|0
124055|NCT00868231|450478|P4|Treatment Period 3|Adverse Event|0
124056|NCT00868231|450479|P3|Treatment Period 3|Adverse Event|1
124057|NCT00868231|450480|P2|Treatment Period 3|Adverse Event|0
124058|NCT00868231|450481|P1|Treatment Period 3|Adverse Event|0
124059|NCT00868231|450476|P6|Treatment Period 2|Adverse Event|0
124060|NCT00868231|450477|P5|Treatment Period 2|Adverse Event|0
124061|NCT00868231|450478|P4|Treatment Period 2|Adverse Event|0
124062|NCT00868231|450479|P3|Treatment Period 2|Adverse Event|0
124063|NCT00868231|450480|P2|Treatment Period 2|Adverse Event|0
124064|NCT00868231|450481|P1|Treatment Period 2|Adverse Event|1
124065|NCT00868231|450476|P6|Treatment Period 1|Adverse Event|0
124066|NCT00868231|450477|P5|Treatment Period 1|Adverse Event|1
124067|NCT00868231|450478|P4|Treatment Period 1|Adverse Event|0
124068|NCT00868231|450479|P3|Treatment Period 1|Adverse Event|0
124069|NCT00868231|450480|P2|Treatment Period 1|Adverse Event|0
124070|NCT00868231|450481|P1|Treatment Period 1|Adverse Event|0
124071|NCT00868192|450547|P1|Overall Study|Ineligible|4
124072|NCT00867568|450601|P1|Overall Study|Withdrawal by Subject|1
124073|NCT00867568|450601|P1|Overall Study|Adverse Event|4
124074|NCT00867568|450601|P1|Overall Study|Lack of Efficacy|10
124075|NCT00867503|450618|P1|Overall Study|Withdrawal by Subject|1
124076|NCT00867490|450624|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
124077|NCT00867490|450624|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
124078|NCT00867490|450624|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
124079|NCT00867490|450624|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
124080|NCT00867490|450624|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
124081|NCT00867360|450666|P2|Overall Study|Physician Decision|1
124082|NCT00867360|450667|P1|Overall Study|Physician Decision|0
124083|NCT00867360|450666|P2|Overall Study|Withdrawal by Subject|0
124084|NCT00867360|450667|P1|Overall Study|Withdrawal by Subject|1
124085|NCT00867165|450714|P2|Overall Study|Withdrawal by Subject|0
124086|NCT00867165|450715|P1|Overall Study|Withdrawal by Subject|1
124087|NCT00867165|450714|P2|Overall Study|Adverse Event|0
124088|NCT00867165|450715|P1|Overall Study|Adverse Event|3
124089|NCT00867113|450863|P1|Post Treatment After Survival Follow-up|Administrative problems|4
124090|NCT00867113|450863|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
124091|NCT00867113|450863|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
124092|NCT00867113|450863|P1|Post Treatment After Survival Follow-up|Death|1
124093|NCT00867113|450863|P1|Treatment Period|Protocol Violation|4
124094|NCT00867113|450863|P1|Treatment Period|Disease progression/relapse|1
124095|NCT00867113|450863|P1|Treatment Period|Administrative problems|1
124096|NCT00867113|450863|P1|Treatment Period|Lost to Follow-up|3
124097|NCT00867113|450863|P1|Treatment Period|Withdrawal by Subject|19
124098|NCT00867113|450863|P1|Treatment Period|Death|2
124099|NCT00867113|450863|P1|Treatment Period|Adverse Event|15
124100|NCT00867087|450870|P1|Overall Study|Death|37
124101|NCT00867087|450870|P1|Overall Study|Withdrawal by Subject|4
124102|NCT00867087|450870|P1|Overall Study|Other|1
124103|NCT00867035|450886|P2|Baseline to 1 Week|Withdrawal by Subject|0
124104|NCT00867035|450887|P1|Baseline to 1 Week|Withdrawal by Subject|1
124105|NCT00867035|450886|P2|Baseline to 1 Hour|Withdrawal by Subject|1
124106|NCT00867035|450887|P1|Baseline to 1 Hour|Withdrawal by Subject|1
124107|NCT00867009|450913|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
124108|NCT00867009|450913|P1|Induction Period|Progressive Disease (PD)|25
124109|NCT00867009|450913|P1|Induction Period|Physician Decision|3
124110|NCT00867009|450913|P1|Induction Period|Withdrawal by Subject|8
124111|NCT00867009|450913|P1|Induction Period|Protocol Violation|1
124112|NCT00867009|450913|P1|Induction Period|Death due to Study Disease|4
124113|NCT00867009|450913|P1|Induction Period|Death due to serious adverse event|6
124114|NCT00867009|450913|P1|Induction Period|Serious Adverse Event|10
124115|NCT00867009|450913|P1|Induction Period|Nonserious Adverse Event|5
124116|NCT00866918|450922|P2|Overall Study|Secondary malignancy|0
124117|NCT00866918|450923|P1|Overall Study|Secondary malignancy|1
124118|NCT00866918|450922|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
124119|NCT00866918|450923|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
124120|NCT00866918|450922|P2|Overall Study|Ineligible|4
124121|NCT00866918|450923|P1|Overall Study|Ineligible|2
124122|NCT00866918|450922|P2|Overall Study|Physician Decision|2
124123|NCT00866918|450923|P1|Overall Study|Physician Decision|10
124124|NCT00866918|450922|P2|Overall Study|Lack of Efficacy|1
124125|NCT00866918|450923|P1|Overall Study|Lack of Efficacy|1
124126|NCT00866918|450922|P2|Overall Study|Death|5
124127|NCT00866918|450923|P1|Overall Study|Death|1
124128|NCT00866814|450940|P1|Overall Study|Moved to area without study site|1
124129|NCT00866814|450940|P1|Overall Study|Unable to meet follow-up requirements|2
124130|NCT00866814|450940|P1|Overall Study|No longer wished to participate|1
124131|NCT00866814|450940|P1|Overall Study|Death|1
124132|NCT00866814|450940|P1|Overall Study|Physician Decision|1
124133|NCT00866814|450940|P1|Overall Study|Adverse Event|2
124134|NCT00866814|450940|P1|Overall Study|Lost to Follow-up|12
124135|NCT00866788|450953|P4|Overall Study|Physician Decision|1
124136|NCT00866788|450954|P3|Overall Study|Physician Decision|1
124137|NCT00866788|450955|P2|Overall Study|Physician Decision|0
124138|NCT00866788|450956|P1|Overall Study|Physician Decision|0
124139|NCT00866788|450953|P4|Overall Study|Disease progression|0
124140|NCT00866788|450954|P3|Overall Study|Disease progression|1
124141|NCT00866788|450955|P2|Overall Study|Disease progression|1
124142|NCT00866788|450956|P1|Overall Study|Disease progression|3
124143|NCT00866788|450953|P4|Overall Study|Pregnancy|0
124144|NCT00866788|450954|P3|Overall Study|Pregnancy|0
124145|NCT00866788|450955|P2|Overall Study|Pregnancy|1
124146|NCT00866788|450956|P1|Overall Study|Pregnancy|0
124147|NCT00866788|450953|P4|Overall Study|Withdrawal by Subject|1
124148|NCT00866788|450954|P3|Overall Study|Withdrawal by Subject|0
124149|NCT00866788|450955|P2|Overall Study|Withdrawal by Subject|1
124150|NCT00866788|450956|P1|Overall Study|Withdrawal by Subject|2
124151|NCT00866788|450953|P4|Overall Study|Lost to Follow-up|2
124152|NCT00866788|450954|P3|Overall Study|Lost to Follow-up|0
124153|NCT00866788|450955|P2|Overall Study|Lost to Follow-up|1
124154|NCT00866788|450956|P1|Overall Study|Lost to Follow-up|1
124155|NCT00866788|450953|P4|Overall Study|Adverse Event|1
124156|NCT00866788|450954|P3|Overall Study|Adverse Event|0
124157|NCT00866788|450955|P2|Overall Study|Adverse Event|2
124158|NCT00866788|450956|P1|Overall Study|Adverse Event|0
124159|NCT00866775|451004|P2|Overall Study|discontinued due to communication error|1
124160|NCT00866775|451005|P1|Overall Study|discontinued due to communication error|0
124161|NCT00866775|451004|P2|Overall Study|met exit criteria|17
124162|NCT00866775|451005|P1|Overall Study|met exit criteria|23
124163|NCT00866775|451004|P2|Overall Study|Withdrawal by Subject|4
124164|NCT00866775|451005|P1|Overall Study|Withdrawal by Subject|4
124165|NCT00866775|451004|P2|Overall Study|Protocol Violation|4
124166|NCT00866775|451005|P1|Overall Study|Protocol Violation|3
124167|NCT00866775|451004|P2|Overall Study|Physician Decision|3
124168|NCT00866775|451005|P1|Overall Study|Physician Decision|0
124169|NCT00866775|451004|P2|Overall Study|Lost to Follow-up|4
124170|NCT00866775|451005|P1|Overall Study|Lost to Follow-up|0
124171|NCT00866775|451004|P2|Overall Study|Death|0
124172|NCT00866775|451005|P1|Overall Study|Death|1
124173|NCT00866775|451004|P2|Overall Study|Adverse Event|19
124174|NCT00866775|451005|P1|Overall Study|Adverse Event|5
124175|NCT00866723|451041|P1|Overall Study|Disease Progression|4
124176|NCT00866723|451041|P1|Overall Study|Withdrawal by Subject|1
124177|NCT00866697|451048|P2|Overall Study|Ongoing|312
124178|NCT00866697|451049|P1|Overall Study|Ongoing|335
124179|NCT00866697|451048|P2|Overall Study|Withdrawal by Subject|53
124180|NCT00866697|451049|P1|Overall Study|Withdrawal by Subject|28
124181|NCT00866697|451048|P2|Overall Study|Physician Decision|4
124182|NCT00866697|451049|P1|Overall Study|Physician Decision|3
124183|NCT00866697|451048|P2|Overall Study|Lost to Follow-up|8
124184|NCT00866697|451049|P1|Overall Study|Lost to Follow-up|7
124185|NCT00866658|451093|P2|Overall Study|Familial and Personal Reasons|5
124186|NCT00866658|451094|P1|Overall Study|Familial and Personal Reasons|4
124187|NCT00866658|451093|P2|Overall Study|Protocol Violation|1
124188|NCT00866658|451094|P1|Overall Study|Protocol Violation|1
124189|NCT00866658|451093|P2|Overall Study|Withdrawal by Subject|0
124190|NCT00866658|451094|P1|Overall Study|Withdrawal by Subject|1
124191|NCT00866658|451093|P2|Overall Study|Lack of Efficacy|1
124192|NCT00866658|451094|P1|Overall Study|Lack of Efficacy|2
124193|NCT00866658|451093|P2|Overall Study|Adverse Event|14
124194|NCT00866658|451094|P1|Overall Study|Adverse Event|5
124195|NCT00866606|451122|P1|Overall Study|Adverse Event|1
124196|NCT00866606|451122|P1|Overall Study|Lost to Follow-up|3
124197|NCT00866359|451136|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
124198|NCT00866359|451137|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
124199|NCT00866359|451138|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
124200|NCT00866359|451139|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
124201|NCT00866359|451136|P4|Treatment Phase (Days 1 to 85)|Other|0
124202|NCT00866359|451137|P3|Treatment Phase (Days 1 to 85)|Other|0
124203|NCT00866359|451138|P2|Treatment Phase (Days 1 to 85)|Other|0
124204|NCT00866359|451139|P1|Treatment Phase (Days 1 to 85)|Other|1
124205|NCT00866359|451136|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
124206|NCT00866359|451137|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
124207|NCT00866359|451138|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
124208|NCT00866359|451139|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
124209|NCT00866359|451136|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
124210|NCT00866359|451137|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
124211|NCT00866359|451138|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
124212|NCT00866359|451139|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
124213|NCT00866359|451136|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
124214|NCT00866359|451137|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
124215|NCT00866359|451138|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
124216|NCT00866359|451139|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
124217|NCT00866359|451136|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
124218|NCT00866359|451137|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
124219|NCT00866359|451138|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
124220|NCT00866359|451139|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
124221|NCT00866320|451192|P1|Overall Study|Death|2
124222|NCT00866320|451192|P1|Overall Study|Withdrawal by Subject|4
124223|NCT00866307|451199|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
124224|NCT00866307|451200|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
124225|NCT00866307|451201|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
124226|NCT00866307|451199|P3|Consolidation/Maintenance|Non-compliance|1
124227|NCT00866307|451200|P2|Consolidation/Maintenance|Non-compliance|0
124228|NCT00866307|451201|P1|Consolidation/Maintenance|Non-compliance|0
124229|NCT00866307|451199|P3|Consolidation/Maintenance|Therapy error|0
124230|NCT00866307|451200|P2|Consolidation/Maintenance|Therapy error|1
124231|NCT00866307|451201|P1|Consolidation/Maintenance|Therapy error|0
124232|NCT00866307|451199|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
124233|NCT00866307|451200|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
124234|NCT00866307|451201|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
124235|NCT00866307|451199|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
124236|NCT00866307|451200|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
124237|NCT00866307|451201|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
124238|NCT00866307|451199|P3|Consolidation/Maintenance|Withdrawal by Subject|1
124239|NCT00866307|451200|P2|Consolidation/Maintenance|Withdrawal by Subject|1
124240|NCT00866307|451201|P1|Consolidation/Maintenance|Withdrawal by Subject|0
124241|NCT00866307|451199|P3|Consolidation/Maintenance|Physician Decision|2
124242|NCT00866307|451200|P2|Consolidation/Maintenance|Physician Decision|3
124243|NCT00866307|451201|P1|Consolidation/Maintenance|Physician Decision|0
124244|NCT00866307|451199|P3|Consolidation/Maintenance|Death|1
124245|NCT00866307|451200|P2|Consolidation/Maintenance|Death|0
124246|NCT00866307|451201|P1|Consolidation/Maintenance|Death|0
124247|NCT00866307|451199|P3|Consolidation/Maintenance|Adverse Event|8
124248|NCT00866307|451200|P2|Consolidation/Maintenance|Adverse Event|0
124249|NCT00866307|451201|P1|Consolidation/Maintenance|Adverse Event|0
124250|NCT00866307|451199|P3|Induction|Study was closed at the time|0
124251|NCT00866307|451200|P2|Induction|Study was closed at the time|0
124252|NCT00866307|451201|P1|Induction|Study was closed at the time|1
124253|NCT00866307|451199|P3|Induction|Improper post-induction consent|0
124254|NCT00866307|451200|P2|Induction|Improper post-induction consent|0
124255|NCT00866307|451201|P1|Induction|Improper post-induction consent|2
124256|NCT00866307|451199|P3|Induction|Inadequate cytognetic samples th|0
124257|NCT00866307|451200|P2|Induction|Inadequate cytognetic samples th|0
124258|NCT00866307|451201|P1|Induction|Inadequate cytognetic samples th|1
124259|NCT00866307|451199|P3|Induction|Identification of Patients with Day 29 M|0
124260|NCT00866307|451200|P2|Induction|Identification of Patients with Day 29 M|0
124261|NCT00866307|451201|P1|Induction|Identification of Patients with Day 29 M|3
124262|NCT00866307|451199|P3|Induction|Progressive Disease|0
124263|NCT00866307|451200|P2|Induction|Progressive Disease|0
124264|NCT00866307|451201|P1|Induction|Progressive Disease|1
124265|NCT00866307|451199|P3|Induction|Physician Decision|0
124266|NCT00866307|451200|P2|Induction|Physician Decision|0
124267|NCT00866307|451201|P1|Induction|Physician Decision|5
124268|NCT00866307|451199|P3|Induction|Death|0
124269|NCT00866307|451200|P2|Induction|Death|0
124270|NCT00866307|451201|P1|Induction|Death|2
124271|NCT00866307|451199|P3|Induction|Adverse Event|0
124272|NCT00866307|451200|P2|Induction|Adverse Event|0
124273|NCT00866307|451201|P1|Induction|Adverse Event|5
124274|NCT00866294|451211|P3|Overall Study|Physician Decision|1
124275|NCT00866294|451212|P2|Overall Study|Physician Decision|2
124276|NCT00866294|451213|P1|Overall Study|Physician Decision|6
124277|NCT00866294|451211|P3|Overall Study|Lost to Follow-up|0
124278|NCT00866294|451212|P2|Overall Study|Lost to Follow-up|3
124279|NCT00866294|451213|P1|Overall Study|Lost to Follow-up|1
124280|NCT00866294|451211|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
124281|NCT00866294|451212|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
124282|NCT00866294|451213|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
124283|NCT00866294|451211|P3|Overall Study|Protocol Violation|0
124284|NCT00866294|451212|P2|Overall Study|Protocol Violation|0
124285|NCT00866294|451213|P1|Overall Study|Protocol Violation|2
124286|NCT00866294|451211|P3|Overall Study|Lack of Efficacy|0
124287|NCT00866294|451212|P2|Overall Study|Lack of Efficacy|1
124288|NCT00866294|451213|P1|Overall Study|Lack of Efficacy|7
124289|NCT00866294|451211|P3|Overall Study|Adverse Event|9
124290|NCT00866294|451212|P2|Overall Study|Adverse Event|13
124291|NCT00866294|451213|P1|Overall Study|Adverse Event|12
124292|NCT00866281|451242|P2|Overall Study|New cancer therapy|4
124293|NCT00866281|451243|P1|Overall Study|New cancer therapy|0
124294|NCT00866281|451242|P2|Overall Study|Disease progression|11
124295|NCT00866281|451243|P1|Overall Study|Disease progression|3
124296|NCT00866281|451242|P2|Overall Study|Withdrawal by participants|0
124297|NCT00866281|451243|P1|Overall Study|Withdrawal by participants|3
124298|NCT00866281|451242|P2|Overall Study|Adverse Event|0
124299|NCT00866281|451243|P1|Overall Study|Adverse Event|1
124300|NCT00866177|451259|P1|Overall Study|Not Treated|151
124301|NCT00866177|451259|P1|Overall Study|Withdrawal by Subject|1
124302|NCT00866047|451263|P1|Follow-up Period|Lost to Follow-up|5
124303|NCT00866047|451263|P1|Treatment Period|Withdrawal by Subject|5
124304|NCT00866047|451263|P1|Treatment Period|Physician Decision|14
124305|NCT00866047|451263|P1|Treatment Period|Adverse Event|16
124306|NCT00866047|451263|P1|Treatment Period|Progressive disease|13
124307|NCT00865904|451295|P5|Overall Study|Randomized but not Treated|1
124308|NCT00865904|451296|P4|Overall Study|Randomized but not Treated|1
124309|NCT00865904|451297|P3|Overall Study|Randomized but not Treated|0
124310|NCT00865904|451298|P2|Overall Study|Randomized but not Treated|0
124311|NCT00865904|451299|P1|Overall Study|Randomized but not Treated|2
124312|NCT00865709|451356|P2|Treatment|Surgery|3
124313|NCT00865709|451357|P1|Treatment|Surgery|8
124314|NCT00865709|451356|P2|Treatment|Physician Decision|2
124315|NCT00865709|451357|P1|Treatment|Physician Decision|3
124316|NCT00865709|451356|P2|Treatment|Withdrawal by Subject|7
124317|NCT00865709|451357|P1|Treatment|Withdrawal by Subject|10
124318|NCT00865709|451356|P2|Treatment|Adverse Event|6
124319|NCT00865709|451357|P1|Treatment|Adverse Event|9
124320|NCT00865514|451373|P1|Overall Study|Infusion cost exceeded funding|2
124321|NCT00865345|451378|P1|Overall Study|Withdrawal by Subject|2
124322|NCT00865306|451385|P2|Controlled Trial|Withdrawal by Subject|1
124323|NCT00865306|451386|P1|Controlled Trial|Withdrawal by Subject|0
124324|NCT00865306|451385|P2|Controlled Trial|Sought treatment for conduct disorder|0
124325|NCT00865306|451386|P1|Controlled Trial|Sought treatment for conduct disorder|1
124326|NCT00865306|451385|P2|Controlled Trial|Improved btw baseline and first session|0
124327|NCT00865306|451386|P1|Controlled Trial|Improved btw baseline and first session|1
124328|NCT00865306|451385|P2|Controlled Trial|Difficulty commuting|0
124329|NCT00865306|451386|P1|Controlled Trial|Difficulty commuting|2
124330|NCT00865306|451385|P2|Controlled Trial|Lost to Follow-up|1
124331|NCT00865306|451386|P1|Controlled Trial|Lost to Follow-up|1
124332|NCT00865189|451415|P2|Overall Study|Withdrawal by Subject|0
124333|NCT00865189|451416|P1|Overall Study|Withdrawal by Subject|1
124334|NCT00865189|451415|P2|Overall Study|Lost to Follow-up|6
124335|NCT00865189|451416|P1|Overall Study|Lost to Follow-up|6
124336|NCT00865189|451415|P2|Overall Study|Death|11
124337|NCT00865189|451416|P1|Overall Study|Death|4
124338|NCT00865189|451415|P2|Overall Study|Other|2
124339|NCT00865189|451416|P1|Overall Study|Other|1
124340|NCT00865124|451444|P3|Overall Study|Withdrawn consent|0
124341|NCT00865124|451445|P2|Overall Study|Withdrawn consent|0
124342|NCT00865124|451446|P1|Overall Study|Withdrawn consent|2
124343|NCT00865124|451444|P3|Overall Study|Physician Decision|0
124344|NCT00865124|451445|P2|Overall Study|Physician Decision|1
124345|NCT00865124|451446|P1|Overall Study|Physician Decision|2
124346|NCT00865098|451463|P1|Overall Study|Progressive disease|1
124347|NCT00865046|451475|P3|Overall Study|Withdrawal by Subject|0
124348|NCT00865046|451476|P2|Overall Study|Withdrawal by Subject|0
124349|NCT00865046|451477|P1|Overall Study|Withdrawal by Subject|5
124350|NCT00865046|451475|P3|Overall Study|Death|1
124351|NCT00865046|451476|P2|Overall Study|Death|1
124352|NCT00865046|451477|P1|Overall Study|Death|0
124353|NCT00865046|451475|P3|Overall Study|Lost to Follow-up|0
124354|NCT00865046|451476|P2|Overall Study|Lost to Follow-up|4
124355|NCT00865046|451477|P1|Overall Study|Lost to Follow-up|1
124356|NCT00865020|451487|P2|Overall Study|Randomized but discontinued|4
124357|NCT00865020|451488|P1|Overall Study|Randomized but discontinued|2
124358|NCT00865020|451487|P2|Overall Study|Death|1
124359|NCT00865020|451488|P1|Overall Study|Death|0
124360|NCT00865020|451487|P2|Overall Study|Abnormal laboratory value(s)|1
124361|NCT00865020|451488|P1|Overall Study|Abnormal laboratory value(s)|0
124362|NCT00865020|451487|P2|Overall Study|Administrative problems|2
124363|NCT00865020|451488|P1|Overall Study|Administrative problems|0
124364|NCT00865020|451487|P2|Overall Study|Protocol deviation|1
124365|NCT00865020|451488|P1|Overall Study|Protocol deviation|4
124366|NCT00865020|451487|P2|Overall Study|Lost to Follow-up|4
124367|NCT00865020|451488|P1|Overall Study|Lost to Follow-up|6
124368|NCT00865020|451487|P2|Overall Study|Abnormal test procedure result(s)|8
124369|NCT00865020|451488|P1|Overall Study|Abnormal test procedure result(s)|6
124370|NCT00865020|451487|P2|Overall Study|Adverse Event|14
124371|NCT00865020|451488|P1|Overall Study|Adverse Event|9
124372|NCT00865020|451487|P2|Overall Study|Withdrawal by Subject|16
124373|NCT00865020|451488|P1|Overall Study|Withdrawal by Subject|22
124374|NCT00864916|451504|P2|Overall Study|Withdrawal by Subject|0
124375|NCT00864916|451505|P1|Overall Study|Withdrawal by Subject|1
124376|NCT00864916|451504|P2|Overall Study|Protocol Violation|0
124377|NCT00864916|451505|P1|Overall Study|Protocol Violation|1
124378|NCT00864916|451504|P2|Overall Study|Lost to Follow-up|4
124379|NCT00864916|451505|P1|Overall Study|Lost to Follow-up|4
124380|NCT00864851|451514|P3|Overall Study|Patient uncooperative|0
124381|NCT00864851|451515|P2|Overall Study|Patient uncooperative|0
124382|NCT00864851|451516|P1|Overall Study|Patient uncooperative|1
124383|NCT00864851|451514|P3|Overall Study|Death|0
124384|NCT00864851|451515|P2|Overall Study|Death|0
124385|NCT00864851|451516|P1|Overall Study|Death|1
124386|NCT00864851|451514|P3|Overall Study|Physician Decision|0
124387|NCT00864851|451515|P2|Overall Study|Physician Decision|0
124388|NCT00864851|451516|P1|Overall Study|Physician Decision|1
124389|NCT00864851|451514|P3|Overall Study|Withdrawal by Subject|0
124390|NCT00864851|451515|P2|Overall Study|Withdrawal by Subject|1
124391|NCT00864851|451516|P1|Overall Study|Withdrawal by Subject|0
124392|NCT00864682|451562|P3|Overall Study|Protocol Violation|2
124393|NCT00864682|451563|P2|Overall Study|Protocol Violation|1
124394|NCT00864682|451564|P1|Overall Study|Protocol Violation|2
124395|NCT00864513|451603|P1|Overall Study|Withdrawal by Subject|3
124396|NCT00864253|451649|P2|Overall Study|Untreated|7
124397|NCT00864253|451650|P1|Overall Study|Untreated|7
124398|NCT00864253|451649|P2|Overall Study|Ongoing|3
124399|NCT00864253|451650|P1|Overall Study|Ongoing|2
124400|NCT00864253|451649|P2|Overall Study|Death|0
124401|NCT00864253|451650|P1|Overall Study|Death|1
124402|NCT00864253|451649|P2|Overall Study|Withdrawal by Subject|18
124403|NCT00864253|451650|P1|Overall Study|Withdrawal by Subject|18
124404|NCT00864253|451649|P2|Overall Study|Lost to Follow-up|1
124405|NCT00864253|451650|P1|Overall Study|Lost to Follow-up|1
124406|NCT00864253|451649|P2|Overall Study|Protocol Violation|2
124407|NCT00864253|451650|P1|Overall Study|Protocol Violation|0
124408|NCT00864253|451649|P2|Overall Study|Physician Decision|15
124409|NCT00864253|451650|P1|Overall Study|Physician Decision|11
124410|NCT00864253|451649|P2|Overall Study|Unrelated Adverse Event|1
124411|NCT00864253|451650|P1|Overall Study|Unrelated Adverse Event|3
124412|NCT00864253|451649|P2|Overall Study|Adverse Event|11
124413|NCT00864253|451650|P1|Overall Study|Adverse Event|56
124414|NCT00864227|451680|P1|Overall Study|Disease Relapse/Progression|3
124415|NCT00864227|451680|P1|Overall Study|Withdrawal by Subject|1
124416|NCT00863798|451742|P3|Overall Study|Randomized not treated|3
124417|NCT00863798|451743|P2|Overall Study|Randomized not treated|2
124418|NCT00863798|451744|P1|Overall Study|Randomized not treated|4
124419|NCT00863798|451742|P3|Overall Study|Withdrawal by Subject|4
124420|NCT00863798|451743|P2|Overall Study|Withdrawal by Subject|7
124421|NCT00863798|451744|P1|Overall Study|Withdrawal by Subject|8
124422|NCT00863798|451742|P3|Overall Study|Protocol Violation|1
124423|NCT00863798|451743|P2|Overall Study|Protocol Violation|1
124424|NCT00863798|451744|P1|Overall Study|Protocol Violation|0
124425|NCT00863798|451742|P3|Overall Study|Other|1
124426|NCT00863798|451743|P2|Overall Study|Other|3
124427|NCT00863798|451744|P1|Overall Study|Other|2
124428|NCT00863798|451742|P3|Overall Study|Lost to Follow-up|5
124429|NCT00863798|451743|P2|Overall Study|Lost to Follow-up|9
124430|NCT00863798|451744|P1|Overall Study|Lost to Follow-up|6
124431|NCT00863798|451742|P3|Overall Study|Lack of Efficacy|6
124432|NCT00863798|451743|P2|Overall Study|Lack of Efficacy|3
124433|NCT00863798|451744|P1|Overall Study|Lack of Efficacy|4
124434|NCT00863798|451742|P3|Overall Study|Investigator request|1
124435|NCT00863798|451743|P2|Overall Study|Investigator request|2
124436|NCT00863798|451744|P1|Overall Study|Investigator request|1
124437|NCT00863798|451742|P3|Overall Study|Participant failed to return|0
124438|NCT00863798|451743|P2|Overall Study|Participant failed to return|1
124439|NCT00863798|451744|P1|Overall Study|Participant failed to return|2
124440|NCT00863798|451742|P3|Overall Study|Adverse Event|4
124441|NCT00863798|451743|P2|Overall Study|Adverse Event|2
124442|NCT00863798|451744|P1|Overall Study|Adverse Event|5
124443|NCT00863746|451796|P2|Survival Follow up|Consent Withdrawn|8
124444|NCT00863746|451797|P1|Survival Follow up|Consent Withdrawn|7
124445|NCT00863746|451796|P2|Survival Follow up|Lost to Follow-up|1
124446|NCT00863746|451797|P1|Survival Follow up|Lost to Follow-up|2
124447|NCT00863746|451796|P2|Survival Follow up|Death|271
124448|NCT00863746|451797|P1|Survival Follow up|Death|244
124449|NCT00863746|451796|P2|Treatment|not available|0
124450|NCT00863746|451797|P1|Treatment|not available|1
124451|NCT00863746|451796|P2|Treatment|Protocol Violation|3
124452|NCT00863746|451797|P1|Treatment|Protocol Violation|5
124453|NCT00863746|451796|P2|Treatment|Lost to Follow-up|0
124454|NCT00863746|451797|P1|Treatment|Lost to Follow-up|1
124455|NCT00863746|451796|P2|Treatment|Consent withdrawn|14
124456|NCT00863746|451797|P1|Treatment|Consent withdrawn|15
124457|NCT00863746|451796|P2|Treatment|non-compliant with study medication|0
124458|NCT00863746|451797|P1|Treatment|non-compliant with study medication|4
124459|NCT00863746|451796|P2|Treatment|Adverse Event|16
124460|NCT00863746|451797|P1|Treatment|Adverse Event|41
124461|NCT00863746|451796|P2|Treatment|Not treated|2
124462|NCT00863746|451797|P1|Treatment|Not treated|4
124463|NCT00863707|451823|P2|Overall Study|Randomized, but drug not received|3
124464|NCT00863707|451824|P1|Overall Study|Randomized, but drug not received|4
124465|NCT00863655|451832|P2|Overall Study|Treatment completed as per protocol|1
124466|NCT00863655|451833|P1|Overall Study|Treatment completed as per protocol|5
124467|NCT00863655|451832|P2|Overall Study|Disease progression|221
124468|NCT00863655|451833|P1|Overall Study|Disease progression|364
124469|NCT00863655|451832|P2|Overall Study|New cancer therapy|1
124470|NCT00863655|451833|P1|Overall Study|New cancer therapy|5
124471|NCT00863655|451832|P2|Overall Study|Death|1
124472|NCT00863655|451833|P1|Overall Study|Death|7
124473|NCT00863655|451832|P2|Overall Study|Administrative problems|0
124474|NCT00863655|451833|P1|Overall Study|Administrative problems|1
124475|NCT00863655|451832|P2|Overall Study|Withdrawal by Subject|7
124476|NCT00863655|451833|P1|Overall Study|Withdrawal by Subject|47
124477|NCT00863655|451832|P2|Overall Study|Adverse Event|8
124478|NCT00863655|451833|P1|Overall Study|Adverse Event|52
124479|NCT00863655|451832|P2|Overall Study|Protocol Violation|0
124480|NCT00863655|451833|P1|Overall Study|Protocol Violation|4
124481|NCT00863512|451870|P2|Overall Study|Physician Decision|0
124482|NCT00863512|451871|P1|Overall Study|Physician Decision|1
124483|NCT00863512|451870|P2|Overall Study|Withdrawal by Subject|0
124484|NCT00863512|451871|P1|Overall Study|Withdrawal by Subject|11
124485|NCT00863512|451870|P2|Overall Study|Adverse Event|0
124486|NCT00863512|451871|P1|Overall Study|Adverse Event|2
124487|NCT00863330|451902|P1|Overall Study|study terminated early due to administra|6
124488|NCT00863317|451908|P2|Overall Study|Lost to Follow-up|9
124489|NCT00863317|451909|P1|Overall Study|Lost to Follow-up|8
124490|NCT00863057|451932|P4|Period 2 (Weeks 6-10)|Physician Decision|1
124491|NCT00863057|451933|P3|Period 2 (Weeks 6-10)|Physician Decision|0
124492|NCT00863057|451934|P2|Period 2 (Weeks 6-10)|Physician Decision|0
124493|NCT00863057|451935|P1|Period 2 (Weeks 6-10)|Physician Decision|0
124494|NCT00863057|451932|P4|Period 2 (Weeks 6-10)|Adverse Event|0
124495|NCT00863057|451933|P3|Period 2 (Weeks 6-10)|Adverse Event|1
124496|NCT00863057|451934|P2|Period 2 (Weeks 6-10)|Adverse Event|1
124497|NCT00863057|451935|P1|Period 2 (Weeks 6-10)|Adverse Event|0
124498|NCT00863057|451932|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
124499|NCT00863057|451933|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
124500|NCT00863057|451934|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
124501|NCT00863057|451935|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
124502|NCT00863057|451932|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
124503|NCT00863057|451933|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
124504|NCT00863057|451934|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
124505|NCT00863057|451935|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
124506|NCT00862940|451985|P2|Overall Study|Administrative or other reason(s)|3
124507|NCT00862940|451986|P1|Overall Study|Administrative or other reason(s)|4
124508|NCT00862940|451985|P2|Overall Study|Lost to Follow-up|1
124509|NCT00862940|451986|P1|Overall Study|Lost to Follow-up|0
124510|NCT00862940|451985|P2|Overall Study|Non-compliance|0
124511|NCT00862940|451986|P1|Overall Study|Non-compliance|4
124512|NCT00862940|451985|P2|Overall Study|Withdrawal by Subject|6
124513|NCT00862940|451986|P1|Overall Study|Withdrawal by Subject|4
124514|NCT00862940|451985|P2|Overall Study|Protocol Violation|5
124515|NCT00862940|451986|P1|Overall Study|Protocol Violation|2
124516|NCT00862940|451985|P2|Overall Study|Lack of Efficacy|3
124517|NCT00862940|451986|P1|Overall Study|Lack of Efficacy|1
124518|NCT00862940|451985|P2|Overall Study|Adverse Event|12
124519|NCT00862940|451986|P1|Overall Study|Adverse Event|15
124520|NCT00862849|451998|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
124521|NCT00862849|451999|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
124522|NCT00862849|452000|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
124523|NCT00862849|452001|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
124524|NCT00862849|452002|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
124525|NCT00862849|452003|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
124526|NCT00862849|451998|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
124527|NCT00862849|451999|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
124528|NCT00862849|452000|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
124529|NCT00862849|452001|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
124530|NCT00862849|452002|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
124531|NCT00862849|452003|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
124532|NCT00862836|452026|P1|Overall Study|Withdrawal by Subject|1
124533|NCT00862823|452037|P2|First Intervention|Withdrawal by Subject|1
124534|NCT00862823|452038|P1|First Intervention|Withdrawal by Subject|1
124535|NCT00862719|452087|P4|Overall Study|Veno-Occlusive Disease|0
124536|NCT00862719|452088|P3|Overall Study|Veno-Occlusive Disease|1
124537|NCT00862719|452089|P2|Overall Study|Veno-Occlusive Disease|0
124538|NCT00862719|452090|P1|Overall Study|Veno-Occlusive Disease|0
124539|NCT00862719|452087|P4|Overall Study|Engraftment failure|0
124540|NCT00862719|452088|P3|Overall Study|Engraftment failure|1
124541|NCT00862719|452089|P2|Overall Study|Engraftment failure|0
124542|NCT00862719|452090|P1|Overall Study|Engraftment failure|0
124543|NCT00862719|452087|P4|Overall Study|Death|1
124544|NCT00862719|452088|P3|Overall Study|Death|1
124545|NCT00862719|452089|P2|Overall Study|Death|6
124546|NCT00862719|452090|P1|Overall Study|Death|5
124547|NCT00862719|452087|P4|Overall Study|Disease Progression|0
124548|NCT00862719|452088|P3|Overall Study|Disease Progression|1
124549|NCT00862719|452089|P2|Overall Study|Disease Progression|0
124550|NCT00862719|452090|P1|Overall Study|Disease Progression|5
124551|NCT00862654|452113|P4|Overall Study|Included after end of inclusions|0
124552|NCT00862654|452114|P3|Overall Study|Included after end of inclusions|1
124553|NCT00862654|452115|P2|Overall Study|Included after end of inclusions|0
124554|NCT00862654|452116|P1|Overall Study|Included after end of inclusions|0
124555|NCT00862654|452113|P4|Overall Study|Never used study drugs|0
124556|NCT00862654|452114|P3|Overall Study|Never used study drugs|0
124557|NCT00862654|452115|P2|Overall Study|Never used study drugs|0
124558|NCT00862654|452116|P1|Overall Study|Never used study drugs|1
124559|NCT00862654|452113|P4|Overall Study|Familly constraint|0
124560|NCT00862654|452114|P3|Overall Study|Familly constraint|0
124561|NCT00862654|452115|P2|Overall Study|Familly constraint|1
124562|NCT00862654|452116|P1|Overall Study|Familly constraint|0
124563|NCT00862654|452113|P4|Overall Study|Subject mistake|0
124564|NCT00862654|452114|P3|Overall Study|Subject mistake|0
124565|NCT00862654|452115|P2|Overall Study|Subject mistake|1
124566|NCT00862654|452116|P1|Overall Study|Subject mistake|0
124567|NCT00862654|452113|P4|Overall Study|Withdrawal by Subject|3
124568|NCT00862654|452114|P3|Overall Study|Withdrawal by Subject|2
124569|NCT00862654|452115|P2|Overall Study|Withdrawal by Subject|2
124570|NCT00862654|452116|P1|Overall Study|Withdrawal by Subject|2
124571|NCT00862654|452113|P4|Overall Study|Pregnancy|0
124572|NCT00862654|452114|P3|Overall Study|Pregnancy|0
124573|NCT00862654|452115|P2|Overall Study|Pregnancy|1
124574|NCT00862654|452116|P1|Overall Study|Pregnancy|1
124575|NCT00862654|452113|P4|Overall Study|Adverse Event|0
124576|NCT00862654|452114|P3|Overall Study|Adverse Event|1
124577|NCT00862654|452115|P2|Overall Study|Adverse Event|1
124578|NCT00862654|452116|P1|Overall Study|Adverse Event|0
124579|NCT00862654|452113|P4|Overall Study|Lost to Follow-up|3
124580|NCT00862654|452114|P3|Overall Study|Lost to Follow-up|1
124581|NCT00862654|452115|P2|Overall Study|Lost to Follow-up|2
124582|NCT00862654|452116|P1|Overall Study|Lost to Follow-up|1
124583|NCT00862654|452113|P4|Overall Study|Lack of Efficacy|0
124584|NCT00862654|452114|P3|Overall Study|Lack of Efficacy|1
124585|NCT00862654|452115|P2|Overall Study|Lack of Efficacy|0
124586|NCT00862654|452116|P1|Overall Study|Lack of Efficacy|1
124587|NCT00862641|452130|P4|Overall Study|Randomized, but drug not received|4
124588|NCT00862641|452131|P3|Overall Study|Randomized, but drug not received|1
124589|NCT00862641|452132|P2|Overall Study|Randomized, but drug not received|4
124590|NCT00862641|452133|P1|Overall Study|Randomized, but drug not received|1
124591|NCT00862459|452227|P3|Overall Study|Administrative problems|0
124592|NCT00862459|452228|P2|Overall Study|Administrative problems|1
124593|NCT00862459|452229|P1|Overall Study|Administrative problems|0
124594|NCT00862459|452227|P3|Overall Study|Inclusion/exclusion criteria not met|0
124595|NCT00862459|452228|P2|Overall Study|Inclusion/exclusion criteria not met|1
124596|NCT00862459|452229|P1|Overall Study|Inclusion/exclusion criteria not met|0
124597|NCT00862459|452227|P3|Overall Study|Unable to hold still for imaging|0
124598|NCT00862459|452228|P2|Overall Study|Unable to hold still for imaging|1
124599|NCT00862459|452229|P1|Overall Study|Unable to hold still for imaging|0
124600|NCT00862459|452227|P3|Overall Study|Intravenous (IV) site problems|1
124601|NCT00862459|452228|P2|Overall Study|Intravenous (IV) site problems|0
124602|NCT00862459|452229|P1|Overall Study|Intravenous (IV) site problems|1
124603|NCT00862459|452227|P3|Overall Study|Operation|0
124604|NCT00862459|452228|P2|Overall Study|Operation|1
124605|NCT00862459|452229|P1|Overall Study|Operation|1
124606|NCT00862459|452227|P3|Overall Study|Personal reasons|0
124607|NCT00862459|452228|P2|Overall Study|Personal reasons|0
124608|NCT00862459|452229|P1|Overall Study|Personal reasons|1
124609|NCT00862459|452227|P3|Overall Study|Adverse Event|0
124610|NCT00862459|452228|P2|Overall Study|Adverse Event|1
124611|NCT00862459|452229|P1|Overall Study|Adverse Event|0
124612|NCT00862459|452227|P3|Overall Study|Withdrawal by Subject|3
124613|NCT00862459|452228|P2|Overall Study|Withdrawal by Subject|1
124614|NCT00862459|452229|P1|Overall Study|Withdrawal by Subject|1
124615|NCT00862459|452227|P3|Overall Study|Protocol Violation|0
124616|NCT00862459|452228|P2|Overall Study|Protocol Violation|0
124617|NCT00862459|452229|P1|Overall Study|Protocol Violation|1
124618|NCT00862459|452227|P3|Overall Study|Lost to Follow-up|2
124619|NCT00862459|452228|P2|Overall Study|Lost to Follow-up|2
124620|NCT00862459|452229|P1|Overall Study|Lost to Follow-up|1
124621|NCT00862277|452376|P3|Overall Study|Protocol Violation|5
124622|NCT00862277|452377|P2|Overall Study|Protocol Violation|2
124623|NCT00862277|452378|P1|Overall Study|Protocol Violation|1
124624|NCT00862251|452392|P3|Overall Study|Withdrawal by Subject|6
124625|NCT00862251|452393|P2|Overall Study|Withdrawal by Subject|2
124626|NCT00862251|452394|P1|Overall Study|Withdrawal by Subject|9
124627|NCT00862251|452392|P3|Overall Study|Protocol Violation|1
124628|NCT00862251|452393|P2|Overall Study|Protocol Violation|0
124629|NCT00862251|452394|P1|Overall Study|Protocol Violation|2
124630|NCT00862251|452392|P3|Overall Study|Lost to Follow-up|1
124631|NCT00862251|452393|P2|Overall Study|Lost to Follow-up|0
124632|NCT00862251|452394|P1|Overall Study|Lost to Follow-up|0
124633|NCT00862251|452392|P3|Overall Study|Adverse Event|1
124634|NCT00862251|452393|P2|Overall Study|Adverse Event|3
124635|NCT00862251|452394|P1|Overall Study|Adverse Event|8
124636|NCT00862134|452454|P2|Overall Study|Withdrew prior to dosing|0
124637|NCT00862134|452455|P1|Overall Study|Withdrew prior to dosing|2
124638|NCT00862134|452454|P2|Overall Study|Adverse Event|2
124639|NCT00862134|452455|P1|Overall Study|Adverse Event|2
124640|NCT00862134|452454|P2|Overall Study|Sponsor terminated study|7
124641|NCT00862134|452455|P1|Overall Study|Sponsor terminated study|5
124642|NCT00862134|452454|P2|Overall Study|Withdrawal by Subject|2
124643|NCT00862134|452455|P1|Overall Study|Withdrawal by Subject|1
124644|NCT00862134|452454|P2|Overall Study|Physician Decision|1
124645|NCT00862134|452455|P1|Overall Study|Physician Decision|0
124646|NCT00862134|452454|P2|Overall Study|Death|0
124647|NCT00862134|452455|P1|Overall Study|Death|1
124648|NCT00862121|452467|P2|Overall Study|Incorrect randomisation|1
124649|NCT00862121|452468|P1|Overall Study|Incorrect randomisation|0
124650|NCT00862121|452467|P2|Overall Study|Exclusion criterion violation|1
124651|NCT00862121|452468|P1|Overall Study|Exclusion criterion violation|0
124652|NCT00862121|452467|P2|Overall Study|Protocol Violation|1
124653|NCT00862121|452468|P1|Overall Study|Protocol Violation|0
124654|NCT00862121|452467|P2|Overall Study|Lack of Efficacy|3
124655|NCT00862121|452468|P1|Overall Study|Lack of Efficacy|0
124656|NCT00862121|452467|P2|Overall Study|Adverse Event|2
124657|NCT00862121|452468|P1|Overall Study|Adverse Event|1
124658|NCT00862082|452486|P2|Overall Study|Withdrawal by Subject|1
124659|NCT00862082|452487|P1|Overall Study|Withdrawal by Subject|0
124660|NCT00862082|452486|P2|Overall Study|Sponsor decision to terminate the study|0
124661|NCT00862082|452487|P1|Overall Study|Sponsor decision to terminate the study|5
124662|NCT00861757|452542|P4|Overall Study|Withdrawal by Subject|2
124663|NCT00861757|452543|P3|Overall Study|Withdrawal by Subject|5
124664|NCT00861757|452544|P2|Overall Study|Withdrawal by Subject|5
124665|NCT00861757|452545|P1|Overall Study|Withdrawal by Subject|1
124666|NCT00861757|452542|P4|Overall Study|Protocol Violation|1
124667|NCT00861757|452543|P3|Overall Study|Protocol Violation|4
124668|NCT00861757|452544|P2|Overall Study|Protocol Violation|2
124669|NCT00861757|452545|P1|Overall Study|Protocol Violation|2
124670|NCT00861757|452542|P4|Overall Study|Physician Decision|1
124671|NCT00861757|452543|P3|Overall Study|Physician Decision|0
124672|NCT00861757|452544|P2|Overall Study|Physician Decision|0
124673|NCT00861757|452545|P1|Overall Study|Physician Decision|0
124674|NCT00861757|452542|P4|Overall Study|Lost to Follow-up|1
124675|NCT00861757|452543|P3|Overall Study|Lost to Follow-up|1
124676|NCT00861757|452544|P2|Overall Study|Lost to Follow-up|0
124677|NCT00861757|452545|P1|Overall Study|Lost to Follow-up|1
124678|NCT00861757|452542|P4|Overall Study|Lack of Efficacy|1
124679|NCT00861757|452543|P3|Overall Study|Lack of Efficacy|0
124680|NCT00861757|452544|P2|Overall Study|Lack of Efficacy|1
124681|NCT00861757|452545|P1|Overall Study|Lack of Efficacy|3
124682|NCT00861757|452542|P4|Overall Study|Entry Criteria Not Met|1
124683|NCT00861757|452543|P3|Overall Study|Entry Criteria Not Met|1
124684|NCT00861757|452544|P2|Overall Study|Entry Criteria Not Met|2
124685|NCT00861757|452545|P1|Overall Study|Entry Criteria Not Met|1
124686|NCT00861757|452542|P4|Overall Study|Adverse Event|2
124687|NCT00861757|452543|P3|Overall Study|Adverse Event|7
124688|NCT00861757|452544|P2|Overall Study|Adverse Event|5
124689|NCT00861757|452545|P1|Overall Study|Adverse Event|1
124690|NCT00861744|452603|P4|Overall Study|Blood draws|1
124691|NCT00861744|452604|P3|Overall Study|Blood draws|0
124692|NCT00861744|452605|P2|Overall Study|Blood draws|0
124693|NCT00861744|452606|P1|Overall Study|Blood draws|0
124694|NCT00861744|452603|P4|Overall Study|Migration from study area|0
124695|NCT00861744|452604|P3|Overall Study|Migration from study area|1
124696|NCT00861744|452605|P2|Overall Study|Migration from study area|3
124697|NCT00861744|452606|P1|Overall Study|Migration from study area|0
124698|NCT00861744|452603|P4|Overall Study|Protocol Violation|0
124699|NCT00861744|452604|P3|Overall Study|Protocol Violation|0
124700|NCT00861744|452605|P2|Overall Study|Protocol Violation|1
124701|NCT00861744|452606|P1|Overall Study|Protocol Violation|0
124702|NCT00861744|452603|P4|Overall Study|Withdrawal by Subject|19
124703|NCT00861744|452604|P3|Overall Study|Withdrawal by Subject|6
124704|NCT00861744|452605|P2|Overall Study|Withdrawal by Subject|6
124705|NCT00861744|452606|P1|Overall Study|Withdrawal by Subject|10
124706|NCT00861744|452603|P4|Overall Study|Lost to Follow-up|12
124707|NCT00861744|452604|P3|Overall Study|Lost to Follow-up|17
124708|NCT00861744|452605|P2|Overall Study|Lost to Follow-up|19
124709|NCT00861744|452606|P1|Overall Study|Lost to Follow-up|7
124710|NCT00861744|452603|P4|Overall Study|Adverse Event|1
124711|NCT00861744|452604|P3|Overall Study|Adverse Event|0
124712|NCT00861744|452605|P2|Overall Study|Adverse Event|0
124713|NCT00861744|452606|P1|Overall Study|Adverse Event|0
124714|NCT00861705|452788|P4|Overall Study|Never Began Treatment|1
124715|NCT00861705|452789|P3|Overall Study|Never Began Treatment|0
124716|NCT00861705|452790|P2|Overall Study|Never Began Treatment|3
124717|NCT00861705|452791|P1|Overall Study|Never Began Treatment|7
124718|NCT00861692|452807|P1|Overall Study|Death|6
124719|NCT00861614|452819|P2|Overall Study|Other|22
124720|NCT00861614|452820|P1|Overall Study|Other|17
124721|NCT00861614|452819|P2|Overall Study|Withdrawal by Subject|35
124722|NCT00861614|452820|P1|Overall Study|Withdrawal by Subject|34
124723|NCT00861614|452819|P2|Overall Study|Adverse Event|23
124724|NCT00861614|452820|P1|Overall Study|Adverse Event|27
124725|NCT00861614|452819|P2|Overall Study|Death|19
124726|NCT00861614|452820|P1|Overall Study|Death|32
124727|NCT00861614|452819|P2|Overall Study|Study Drug Toxicity|6
124728|NCT00861614|452820|P1|Overall Study|Study Drug Toxicity|79
124729|NCT00861614|452819|P2|Overall Study|Disease Progression|263
124730|NCT00861614|452820|P1|Overall Study|Disease Progression|182
124731|NCT00861471|452905|P1|Overall Study|Physician Decision|2
124732|NCT00861471|452905|P1|Overall Study|treatment for lumbar laminectomy|1
124733|NCT00861471|452905|P1|Overall Study|Lack of Efficacy|3
124734|NCT00861471|452905|P1|Overall Study|Adverse Event|2
124735|NCT00861471|452905|P1|Overall Study|Withdrawal by Subject|1
124736|NCT00861341|452913|P1|Overall Study|Withdrawal by Subject|2
124737|NCT00861198|452922|P1|Overall Study|SpyGlass Failed|5
124738|NCT00860951|452939|P1|Overall Study|Lost to Follow-up|5
124739|NCT00860951|452939|P1|Overall Study|Withdrawal by Subject|2
124740|NCT00860743|452981|P2|Overall Study|Withdrawal by Subject|0
124741|NCT00860743|452982|P1|Overall Study|Withdrawal by Subject|3
124742|NCT00860470|452995|P2|Overall Study|Lost to Follow-up|39
124743|NCT00860470|452996|P1|Overall Study|Lost to Follow-up|34
124744|NCT00860470|452995|P2|Overall Study|Moved away|10
124745|NCT00860470|452996|P1|Overall Study|Moved away|8
124746|NCT00860470|452995|P2|Overall Study|Death|10
124747|NCT00860470|452996|P1|Overall Study|Death|6
124748|NCT00860405|453026|P2|Overall Study|Main reason: Follow-up data not complete|4
124749|NCT00860405|453027|P1|Overall Study|Main reason: Follow-up data not complete|5
124750|NCT00860262|453067|P3|Overall Study|Not Specified|1
124751|NCT00860262|453068|P2|Overall Study|Not Specified|3
124752|NCT00860262|453069|P1|Overall Study|Not Specified|5
124753|NCT00860262|453067|P3|Overall Study|Lack of Efficacy|3
124754|NCT00860262|453068|P2|Overall Study|Lack of Efficacy|4
124755|NCT00860262|453069|P1|Overall Study|Lack of Efficacy|0
124756|NCT00860262|453067|P3|Overall Study|Withdrawal by Subject|6
124757|NCT00860262|453068|P2|Overall Study|Withdrawal by Subject|8
124758|NCT00860262|453069|P1|Overall Study|Withdrawal by Subject|4
124759|NCT00860262|453067|P3|Overall Study|Lost to Follow-up|1
124760|NCT00860262|453068|P2|Overall Study|Lost to Follow-up|0
124761|NCT00860262|453069|P1|Overall Study|Lost to Follow-up|2
124762|NCT00860262|453067|P3|Overall Study|Protocol Violation|0
124763|NCT00860262|453068|P2|Overall Study|Protocol Violation|1
124764|NCT00860262|453069|P1|Overall Study|Protocol Violation|0
124765|NCT00860262|453067|P3|Overall Study|Adverse Event|7
124766|NCT00860262|453068|P2|Overall Study|Adverse Event|6
124767|NCT00860262|453069|P1|Overall Study|Adverse Event|9
124768|NCT00860249|453182|P3|Overall Study|trial was terminated prior to completion|21
124769|NCT00860249|453183|P2|Overall Study|trial was terminated prior to completion|18
124770|NCT00860249|453184|P1|Overall Study|trial was terminated prior to completion|21
124771|NCT00860158|453202|P1|Overall Study|Study Terminated|1
124772|NCT00860067|453214|P3|Overall Study|Pregnancy|0
124773|NCT00860067|453215|P2|Overall Study|Pregnancy|0
124774|NCT00860067|453216|P1|Overall Study|Pregnancy|1
124775|NCT00860067|453214|P3|Overall Study|Withdrawal by Subject|0
124776|NCT00860067|453215|P2|Overall Study|Withdrawal by Subject|0
124777|NCT00860067|453216|P1|Overall Study|Withdrawal by Subject|4
124778|NCT00860067|453214|P3|Overall Study|Lost to Follow-up|9
124779|NCT00860067|453215|P2|Overall Study|Lost to Follow-up|9
124780|NCT00860067|453216|P1|Overall Study|Lost to Follow-up|46
124781|NCT00860028|453276|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
124782|NCT00860028|453277|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
124783|NCT00859937|453298|P2|Overall Study|Protocol Violation|0
124784|NCT00859937|453299|P1|Overall Study|Protocol Violation|1
124785|NCT00859898|453314|P3|Overall Study|non-specified|1
124786|NCT00859898|453315|P2|Overall Study|non-specified|1
124787|NCT00859898|453316|P1|Overall Study|non-specified|1
124788|NCT00859898|453314|P3|Overall Study|No longer meets criteria|0
124789|NCT00859898|453315|P2|Overall Study|No longer meets criteria|1
124790|NCT00859898|453316|P1|Overall Study|No longer meets criteria|0
124791|NCT00859898|453314|P3|Overall Study|poor/non-compliance|0
124792|NCT00859898|453315|P2|Overall Study|poor/non-compliance|0
124793|NCT00859898|453316|P1|Overall Study|poor/non-compliance|2
124794|NCT00859898|453314|P3|Overall Study|Lost to Follow-up|5
124795|NCT00859898|453315|P2|Overall Study|Lost to Follow-up|11
124796|NCT00859898|453316|P1|Overall Study|Lost to Follow-up|10
124797|NCT00859898|453314|P3|Overall Study|Death|1
124798|NCT00859898|453315|P2|Overall Study|Death|0
124799|NCT00859898|453316|P1|Overall Study|Death|0
124800|NCT00859898|453314|P3|Overall Study|Withdrawal by Subject|11
124801|NCT00859898|453315|P2|Overall Study|Withdrawal by Subject|8
124802|NCT00859898|453316|P1|Overall Study|Withdrawal by Subject|11
124803|NCT00859898|453314|P3|Overall Study|Adverse Event|8
124804|NCT00859898|453315|P2|Overall Study|Adverse Event|9
124805|NCT00859898|453316|P1|Overall Study|Adverse Event|4
124806|NCT00859898|453314|P3|Overall Study|Lack of Efficacy|1
124807|NCT00859898|453315|P2|Overall Study|Lack of Efficacy|1
124808|NCT00859898|453316|P1|Overall Study|Lack of Efficacy|0
124809|NCT00859638|453375|P2|Overall Study|Ill health|1
124810|NCT00859638|453376|P1|Overall Study|Ill health|1
124811|NCT00859638|453375|P2|Overall Study|Withdrawal by Subject|2
124812|NCT00859638|453376|P1|Overall Study|Withdrawal by Subject|3
124813|NCT00859638|453375|P2|Overall Study|Lost to Follow-up|1
124814|NCT00859638|453376|P1|Overall Study|Lost to Follow-up|6
124815|NCT00859586|453382|P1|Overall Study|Donors|4
124816|NCT00859573|453388|P2|Overall Study|Physician Decision|1
124817|NCT00859573|453389|P1|Overall Study|Physician Decision|1
124818|NCT00859573|453388|P2|Overall Study|Withdrawal by Subject|1
124819|NCT00859573|453389|P1|Overall Study|Withdrawal by Subject|4
124820|NCT00859547|453395|P1|Overall Study|Parent withdrew consent|1
124821|NCT00859547|453395|P1|Overall Study|Lost to Follow-up|1
124822|NCT00859521|453408|P2|Washout|Withdrawal by Subject|1
124823|NCT00859521|453409|P1|Washout|Withdrawal by Subject|0
124824|NCT00859469|453426|P1|Overall Study|Death|16
124825|NCT00859469|453426|P1|Overall Study|Withdrawal by Subject|1
124826|NCT00859469|453426|P1|Overall Study|Lack of Efficacy|9
124827|NCT00859469|453426|P1|Overall Study|Adverse Event|2
124828|NCT00859430|453434|P2|First Intervention|Withdrawal by Subject|1
124829|NCT00859430|453435|P1|First Intervention|Withdrawal by Subject|0
124830|NCT00859313|453451|P1|Overall Study|staff error|1
124831|NCT00859313|453451|P1|Overall Study|Adverse Event|1
124832|NCT00859313|453451|P1|Overall Study|Lack of Efficacy|2
124833|NCT00859222|453458|P5|Overall Study|DLT|0
124834|NCT00859222|453459|P4|Overall Study|DLT|0
124835|NCT00859222|453460|P3|Overall Study|DLT|0
124836|NCT00859222|453461|P2|Overall Study|DLT|0
124837|NCT00859222|453462|P1|Overall Study|DLT|1
124838|NCT00859222|453458|P5|Overall Study|Adverse Event|15
124839|NCT00859222|453459|P4|Overall Study|Adverse Event|24
124840|NCT00859222|453460|P3|Overall Study|Adverse Event|6
124841|NCT00859222|453461|P2|Overall Study|Adverse Event|3
124842|NCT00859222|453462|P1|Overall Study|Adverse Event|2
124843|NCT00859014|453584|P1|Overall Study|Lost to Follow-up|1
124844|NCT00859014|453584|P1|Overall Study|Death|4
124845|NCT00858845|453599|P2|Overall Study|Patient underwent heart transplant.|1
124846|NCT00858845|453600|P1|Overall Study|Patient underwent heart transplant.|0
124847|NCT00858832|453612|P2|Overall Study|Adverse Event|1
124848|NCT00858832|453613|P1|Overall Study|Adverse Event|0
124849|NCT00858832|453612|P2|Overall Study|became ineligible: delivered vaginally|0
124850|NCT00858832|453613|P1|Overall Study|became ineligible: delivered vaginally|1
124851|NCT00858780|453619|P5|OL Re-Treatment (Failure to Week 48)|Other|1
124852|NCT00858780|453620|P4|OL Re-Treatment (Failure to Week 48)|Other|0
124853|NCT00858780|453621|P3|OL Re-Treatment (Failure to Week 48)|Other|0
124854|NCT00858780|453622|P2|OL Re-Treatment (Failure to Week 48)|Other|0
124855|NCT00858780|453623|P1|OL Re-Treatment (Failure to Week 48)|Other|0
124856|NCT00858780|453619|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
124857|NCT00858780|453620|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
124858|NCT00858780|453621|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
124859|NCT00858780|453622|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
124860|NCT00858780|453623|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
124861|NCT00858780|453619|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
124862|NCT00858780|453620|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
124863|NCT00858780|453621|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
124864|NCT00858780|453622|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
124865|NCT00858780|453623|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
124866|NCT00858780|453619|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
124867|NCT00858780|453620|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
124868|NCT00858780|453621|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
124869|NCT00858780|453622|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
124870|NCT00858780|453623|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
124871|NCT00858780|453619|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
124872|NCT00858780|453620|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
124873|NCT00858780|453621|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
124874|NCT00858780|453622|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
124875|NCT00858780|453623|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
124876|NCT00858780|453619|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
124877|NCT00858780|453620|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
124878|NCT00858780|453621|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
124879|NCT00858780|453622|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
124880|NCT00858780|453623|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
124881|NCT00858702|453698|P2|Overall Study|Withdrawal by Subject|0
124882|NCT00858702|453699|P1|Overall Study|Withdrawal by Subject|1
124883|NCT00858702|453698|P2|Overall Study|Other|1
124884|NCT00858702|453699|P1|Overall Study|Other|2
124885|NCT00858702|453698|P2|Overall Study|Protocol Violation|1
124886|NCT00858702|453699|P1|Overall Study|Protocol Violation|1
124887|NCT00858702|453698|P2|Overall Study|Lack of Efficacy|0
124888|NCT00858702|453699|P1|Overall Study|Lack of Efficacy|1
124889|NCT00858637|453714|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
124890|NCT00858637|453715|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
124891|NCT00858637|453716|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
124892|NCT00858637|453717|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
124893|NCT00858637|453718|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
124894|NCT00858637|453719|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
124895|NCT00858637|453714|P6|Placebo-controlled Withdrawal Phase|Death|0
124896|NCT00858637|453715|P5|Placebo-controlled Withdrawal Phase|Death|1
124897|NCT00858637|453716|P4|Placebo-controlled Withdrawal Phase|Death|0
124898|NCT00858637|453717|P3|Placebo-controlled Withdrawal Phase|Death|1
124899|NCT00858637|453718|P2|Placebo-controlled Withdrawal Phase|Death|0
124900|NCT00858637|453719|P1|Placebo-controlled Withdrawal Phase|Death|0
124901|NCT00858637|453714|P6|Active Comparison Phase|Other Reasons|0
124902|NCT00858637|453715|P5|Active Comparison Phase|Other Reasons|0
124903|NCT00858637|453716|P4|Active Comparison Phase|Other Reasons|1
124904|NCT00858637|453717|P3|Active Comparison Phase|Other Reasons|0
124905|NCT00858637|453718|P2|Active Comparison Phase|Other Reasons|0
124906|NCT00858637|453719|P1|Active Comparison Phase|Other Reasons|1
124907|NCT00858637|453714|P6|Active Comparison Phase|Withdrawal by Subject|0
124908|NCT00858637|453715|P5|Active Comparison Phase|Withdrawal by Subject|0
124909|NCT00858637|453716|P4|Active Comparison Phase|Withdrawal by Subject|6
124910|NCT00858637|453717|P3|Active Comparison Phase|Withdrawal by Subject|0
124911|NCT00858637|453718|P2|Active Comparison Phase|Withdrawal by Subject|0
124912|NCT00858637|453719|P1|Active Comparison Phase|Withdrawal by Subject|7
124913|NCT00858637|453714|P6|Active Comparison Phase|Physician Decision|0
124914|NCT00858637|453715|P5|Active Comparison Phase|Physician Decision|0
124915|NCT00858637|453716|P4|Active Comparison Phase|Physician Decision|1
124916|NCT00858637|453717|P3|Active Comparison Phase|Physician Decision|0
124917|NCT00858637|453718|P2|Active Comparison Phase|Physician Decision|0
124918|NCT00858637|453719|P1|Active Comparison Phase|Physician Decision|1
124919|NCT00858637|453714|P6|Active Comparison Phase|Death|0
124920|NCT00858637|453715|P5|Active Comparison Phase|Death|0
124921|NCT00858637|453716|P4|Active Comparison Phase|Death|1
124922|NCT00858637|453717|P3|Active Comparison Phase|Death|0
124923|NCT00858637|453718|P2|Active Comparison Phase|Death|0
124924|NCT00858637|453719|P1|Active Comparison Phase|Death|1
124925|NCT00858637|453714|P6|Active Comparison Phase|Adverse Event|0
124926|NCT00858637|453715|P5|Active Comparison Phase|Adverse Event|0
124927|NCT00858637|453716|P4|Active Comparison Phase|Adverse Event|9
124928|NCT00858637|453717|P3|Active Comparison Phase|Adverse Event|0
124929|NCT00858637|453718|P2|Active Comparison Phase|Adverse Event|0
124930|NCT00858637|453719|P1|Active Comparison Phase|Adverse Event|14
124931|NCT00858442|453760|P2|Compression:Start to Finish|Lost to Follow-up|3
124932|NCT00858442|453761|P1|Compression:Start to Finish|Lost to Follow-up|1
124933|NCT00858403|453771|P1|Overall Study|Disease Progression|1
124934|NCT00858403|453771|P1|Overall Study|Death|3
124935|NCT00858403|453771|P1|Overall Study|Withdrawal by Subject|1
124936|NCT00858247|453792|P2|Week 12 Follow-up|Withdrawal by Subject|1
124937|NCT00858247|453793|P1|Week 12 Follow-up|Withdrawal by Subject|0
124938|NCT00858247|453792|P2|Baseline Assessment|Protocol Violation|1
124939|NCT00858247|453793|P1|Baseline Assessment|Protocol Violation|0
124940|NCT00858247|453792|P2|Baseline Assessment|Poor IV access|0
124941|NCT00858247|453793|P1|Baseline Assessment|Poor IV access|1
124942|NCT00858247|453792|P2|Baseline Assessment|Withdrawal by Subject|1
124943|NCT00858247|453793|P1|Baseline Assessment|Withdrawal by Subject|1
124944|NCT00858208|453809|P1|Overall Study|Other|10
124945|NCT00858208|453809|P1|Overall Study|Participant refused|40
124946|NCT00858208|453809|P1|Overall Study|Lost to Follow-up|26
124947|NCT00858208|453809|P1|Overall Study|Adverse Event|3
124948|NCT00858143|453826|P1|Overall Study|Other|23
124949|NCT00858143|453826|P1|Overall Study|Death|7
124950|NCT00858143|453826|P1|Overall Study|Lack of Efficacy|4
124951|NCT00858143|453826|P1|Overall Study|Adverse Event|16
124952|NCT00857948|453938|P4|Overall Study|Protocol Violation|0
124953|NCT00857948|453939|P3|Overall Study|Protocol Violation|1
124954|NCT00857948|453940|P2|Overall Study|Protocol Violation|0
124955|NCT00857948|453941|P1|Overall Study|Protocol Violation|1
124956|NCT00857948|453938|P4|Overall Study|Withdrawal by Subject|0
124957|NCT00857948|453939|P3|Overall Study|Withdrawal by Subject|0
124958|NCT00857948|453940|P2|Overall Study|Withdrawal by Subject|0
124959|NCT00857948|453941|P1|Overall Study|Withdrawal by Subject|2
124960|NCT00857896|453963|P1|Baseline to Week 4|Withdrawal by Subject|1
124961|NCT00857818|454119|P2|Overall Study|Investigator decision|0
124962|NCT00857818|454120|P1|Overall Study|Investigator decision|1
124963|NCT00857818|454119|P2|Overall Study|Sponsor terminated study|4
124964|NCT00857818|454120|P1|Overall Study|Sponsor terminated study|6
124965|NCT00857818|454119|P2|Overall Study|Withdrawal by Subject|4
124966|NCT00857818|454120|P1|Overall Study|Withdrawal by Subject|0
124967|NCT00857818|454119|P2|Overall Study|Adverse Event|0
124968|NCT00857818|454120|P1|Overall Study|Adverse Event|3
124969|NCT00857818|454119|P2|Overall Study|Lack of Efficacy|0
124970|NCT00857818|454120|P1|Overall Study|Lack of Efficacy|1
124971|NCT00857792|454148|P1|Overall Study|inadequate image quality for analysis|12
124972|NCT00857766|454154|P2|Overall Study|Participant Withdrew Consent|4
124973|NCT00857766|454155|P1|Overall Study|Participant Withdrew Consent|4
124974|NCT00857766|454154|P2|Overall Study|Investigator Discretion|3
124975|NCT00857766|454155|P1|Overall Study|Investigator Discretion|2
124976|NCT00857766|454154|P2|Overall Study|Lost to Follow-up|0
124977|NCT00857766|454155|P1|Overall Study|Lost to Follow-up|1
124978|NCT00857766|454154|P2|Overall Study|Protocol Violation|11
124979|NCT00857766|454155|P1|Overall Study|Protocol Violation|11
124980|NCT00857766|454154|P2|Overall Study|Adverse Event|12
124981|NCT00857766|454155|P1|Overall Study|Adverse Event|13
124982|NCT00857649|454172|P2|Overall Study|Other Reasons|3
124983|NCT00857649|454173|P1|Overall Study|Other Reasons|1
124984|NCT00857649|454172|P2|Overall Study|Nursing Home Placement|9
124985|NCT00857649|454173|P1|Overall Study|Nursing Home Placement|2
124986|NCT00857649|454172|P2|Overall Study|Withdrawal of Consent|7
124987|NCT00857649|454173|P1|Overall Study|Withdrawal of Consent|10
124988|NCT00857649|454172|P2|Overall Study|Protocol Violation|2
124989|NCT00857649|454173|P1|Overall Study|Protocol Violation|2
124990|NCT00857649|454172|P2|Overall Study|Non-compliance|1
124991|NCT00857649|454173|P1|Overall Study|Non-compliance|1
124992|NCT00857649|454172|P2|Overall Study|Adverse Event|10
124993|NCT00857649|454173|P1|Overall Study|Adverse Event|15
124994|NCT00857623|454189|P2|Overall Study|Positive for HEP C|1
124995|NCT00857623|454190|P1|Overall Study|Positive for HEP C|0
124996|NCT00857623|454189|P2|Overall Study|Intake of prohibited medication|1
124997|NCT00857623|454190|P1|Overall Study|Intake of prohibited medication|0
124998|NCT00857623|454189|P2|Overall Study|Severe non-compliance to protocol|1
124999|NCT00857623|454190|P1|Overall Study|Severe non-compliance to protocol|1
125000|NCT00857623|454189|P2|Overall Study|Lack of Efficacy|1
125001|NCT00857623|454190|P1|Overall Study|Lack of Efficacy|1
125002|NCT00857623|454189|P2|Overall Study|Withdrawal by Subject|1
125003|NCT00857623|454190|P1|Overall Study|Withdrawal by Subject|2
125004|NCT00857623|454189|P2|Overall Study|Study-specific discontinuation criteria|3
125005|NCT00857623|454190|P1|Overall Study|Study-specific discontinuation criteria|5
125006|NCT00857623|454189|P2|Overall Study|Adverse Event|2
125007|NCT00857623|454190|P1|Overall Study|Adverse Event|5
125008|NCT00857584|454214|P2|Overall Study|Physician Decision|1
125009|NCT00857584|454215|P1|Overall Study|Physician Decision|1
125010|NCT00857584|454214|P2|Overall Study|Adverse Event|2
125011|NCT00857584|454215|P1|Overall Study|Adverse Event|2
125012|NCT00857584|454214|P2|Overall Study|Lack of Efficacy|2
125013|NCT00857584|454215|P1|Overall Study|Lack of Efficacy|1
125014|NCT00857454|454307|P1|Overall Study|MTE09 enrollment criteria not met|6
125015|NCT00857454|454307|P1|Overall Study|Total Testosterone <300 ng/dL|8
125016|NCT00857454|454307|P1|Overall Study|Total Testosterone >1050 ng/dL|1
125017|NCT00857454|454307|P1|Overall Study|Adverse Event|2
125018|NCT00857454|454307|P1|Overall Study|Lost to Follow-up|1
125019|NCT00857454|454307|P1|Overall Study|Withdrawal by Subject|2
125020|NCT00857415|454320|P2|Overall Study|Deceased with no autopsy|0
125021|NCT00857415|454321|P1|Overall Study|Deceased with no autopsy|2
125022|NCT00857415|454320|P2|Overall Study|Subject still living at end of study|0
125023|NCT00857415|454321|P1|Overall Study|Subject still living at end of study|110
125024|NCT00857415|454320|P2|Overall Study|Invalid image or not imaged|0
125025|NCT00857415|454321|P1|Overall Study|Invalid image or not imaged|3
125026|NCT00857415|454320|P2|Overall Study|Image acquisition failure|0
125027|NCT00857415|454321|P1|Overall Study|Image acquisition failure|2
125028|NCT00857311|454332|P4|Overall Study|Lost to Follow-up|0
125029|NCT00857311|454333|P3|Overall Study|Lost to Follow-up|0
125030|NCT00857311|454334|P2|Overall Study|Lost to Follow-up|0
125031|NCT00857311|454335|P1|Overall Study|Lost to Follow-up|1
125032|NCT00857285|454347|P2|Overall Study|Randomization criteria not met|1
125033|NCT00857285|454348|P1|Overall Study|Randomization criteria not met|1
125034|NCT00857285|454347|P2|Overall Study|Withdrawal by Subject|0
125035|NCT00857285|454348|P1|Overall Study|Withdrawal by Subject|4
125036|NCT00857285|454347|P2|Overall Study|Protocol Violation|1
125037|NCT00857285|454348|P1|Overall Study|Protocol Violation|3
125038|NCT00857285|454347|P2|Overall Study|Lack of Efficacy|2
125039|NCT00857285|454348|P1|Overall Study|Lack of Efficacy|0
125040|NCT00857285|454347|P2|Overall Study|Adverse Event|2
125041|NCT00857285|454348|P1|Overall Study|Adverse Event|4
125042|NCT00857259|454364|P3|Overall Study|Protocol Violation|1
125043|NCT00857259|454365|P2|Overall Study|Protocol Violation|0
125044|NCT00857259|454366|P1|Overall Study|Protocol Violation|1
125045|NCT00857246|454376|P1|ChemoRT|Adverse Event|2
125046|NCT00857246|454376|P1|ChemoRT|Withdrawal by Subject|1
125047|NCT00857246|454376|P1|Surgery (Curative)|disease progression|6
125048|NCT00857246|454376|P1|Induction Regimen|Withdrawal by Subject|1
125049|NCT00857246|454376|P1|Induction Regimen|disease-related complications|1
125050|NCT00857246|454376|P1|Induction Regimen|Adverse Event|1
125051|NCT00857233|454386|P1|Overall Study|Other Reasons|2
125052|NCT00857233|454386|P1|Overall Study|Nursing Home Placement|14
125053|NCT00857233|454386|P1|Overall Study|Lost to Follow-up|4
125054|NCT00857233|454386|P1|Overall Study|Withdrawal of Consent|9
125055|NCT00857233|454386|P1|Overall Study|Non-compliance|1
125056|NCT00857233|454386|P1|Overall Study|Lack of Efficacy|1
125057|NCT00857233|454386|P1|Overall Study|Adverse Event|24
125058|NCT00857220|454395|P1|Overall Study|Miscellaneous|8
125059|NCT00857220|454395|P1|Overall Study|Site Closed|5
125060|NCT00857220|454395|P1|Overall Study|Clinical Hold|6
125061|NCT00857220|454395|P1|Overall Study|Withdrawal by Subject|67
125062|NCT00857220|454395|P1|Overall Study|Protocol Violation|16
125063|NCT00857220|454395|P1|Overall Study|Physician Decision|4
125064|NCT00857220|454395|P1|Overall Study|Lost to Follow-up|30
125065|NCT00857220|454395|P1|Overall Study|Lack of Efficacy|11
125066|NCT00857220|454395|P1|Overall Study|Death|1
125067|NCT00857220|454395|P1|Overall Study|Adverse Event|35
125068|NCT00856986|454417|P5|Extension Period, Weeks 26-52|Unclassified|0
125069|NCT00856986|454418|P4|Extension Period, Weeks 26-52|Unclassified|0
125070|NCT00856986|454419|P3|Extension Period, Weeks 26-52|Unclassified|11
125071|NCT00856986|454420|P2|Extension Period, Weeks 26-52|Unclassified|2
125072|NCT00856986|454421|P1|Extension Period, Weeks 26-52|Unclassified|4
125073|NCT00856986|454417|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
125074|NCT00856986|454418|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
125075|NCT00856986|454419|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
125076|NCT00856986|454420|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
125077|NCT00856986|454421|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
125078|NCT00856986|454417|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
125079|NCT00856986|454418|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
125080|NCT00856986|454419|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
125081|NCT00856986|454420|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
125082|NCT00856986|454421|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
125083|NCT00856986|454417|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
125084|NCT00856986|454418|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
125085|NCT00856986|454419|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
125086|NCT00856986|454420|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
125087|NCT00856986|454421|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
125088|NCT00856986|454417|P5|Extension Period, Weeks 26-52|Protocol Violation|0
125089|NCT00856986|454418|P4|Extension Period, Weeks 26-52|Protocol Violation|0
125090|NCT00856986|454419|P3|Extension Period, Weeks 26-52|Protocol Violation|5
125091|NCT00856986|454420|P2|Extension Period, Weeks 26-52|Protocol Violation|2
125092|NCT00856986|454421|P1|Extension Period, Weeks 26-52|Protocol Violation|6
125093|NCT00856986|454417|P5|Extension Period, Weeks 26-52|Adverse Event|0
125094|NCT00856986|454418|P4|Extension Period, Weeks 26-52|Adverse Event|0
125095|NCT00856986|454419|P3|Extension Period, Weeks 26-52|Adverse Event|10
125096|NCT00856986|454420|P2|Extension Period, Weeks 26-52|Adverse Event|3
125097|NCT00856986|454421|P1|Extension Period, Weeks 26-52|Adverse Event|3
125098|NCT00856986|454417|P5|Main Period, Weeks 0-26|Unclassified|0
125099|NCT00856986|454418|P4|Main Period, Weeks 0-26|Unclassified|0
125100|NCT00856986|454419|P3|Main Period, Weeks 0-26|Unclassified|7
125101|NCT00856986|454420|P2|Main Period, Weeks 0-26|Unclassified|6
125102|NCT00856986|454421|P1|Main Period, Weeks 0-26|Unclassified|7
125103|NCT00856986|454417|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
125104|NCT00856986|454418|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
125105|NCT00856986|454419|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
125106|NCT00856986|454420|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
125107|NCT00856986|454421|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
125108|NCT00856986|454417|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
125109|NCT00856986|454418|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
125110|NCT00856986|454419|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
125111|NCT00856986|454420|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
125112|NCT00856986|454421|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
125113|NCT00856986|454417|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
125114|NCT00856986|454418|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
125115|NCT00856986|454419|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
125116|NCT00856986|454420|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
125117|NCT00856986|454421|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
125118|NCT00856986|454417|P5|Main Period, Weeks 0-26|Protocol Violation|0
125119|NCT00856986|454418|P4|Main Period, Weeks 0-26|Protocol Violation|0
125120|NCT00856986|454419|P3|Main Period, Weeks 0-26|Protocol Violation|7
125121|NCT00856986|454420|P2|Main Period, Weeks 0-26|Protocol Violation|5
125122|NCT00856986|454421|P1|Main Period, Weeks 0-26|Protocol Violation|4
125123|NCT00856986|454417|P5|Main Period, Weeks 0-26|Adverse Event|0
125124|NCT00856986|454418|P4|Main Period, Weeks 0-26|Adverse Event|0
125125|NCT00856986|454419|P3|Main Period, Weeks 0-26|Adverse Event|9
125126|NCT00856986|454420|P2|Main Period, Weeks 0-26|Adverse Event|4
125127|NCT00856986|454421|P1|Main Period, Weeks 0-26|Adverse Event|6
125128|NCT00856986|454417|P5|Run-in Period, Weeks -12-0|Unclassified|0
125129|NCT00856986|454418|P4|Run-in Period, Weeks -12-0|Unclassified|24
125130|NCT00856986|454419|P3|Run-in Period, Weeks -12-0|Unclassified|0
125131|NCT00856986|454420|P2|Run-in Period, Weeks -12-0|Unclassified|0
125132|NCT00856986|454421|P1|Run-in Period, Weeks -12-0|Unclassified|0
125133|NCT00856986|454417|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
125134|NCT00856986|454418|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
125135|NCT00856986|454419|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
125136|NCT00856986|454420|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
125137|NCT00856986|454421|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
125138|NCT00856986|454417|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
125139|NCT00856986|454418|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
125140|NCT00856986|454419|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
125141|NCT00856986|454420|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
125142|NCT00856986|454421|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
125143|NCT00856986|454417|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
125144|NCT00856986|454418|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
125145|NCT00856986|454419|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
125146|NCT00856986|454420|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
125147|NCT00856986|454421|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
125148|NCT00856986|454417|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
125149|NCT00856986|454418|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
125150|NCT00856986|454419|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
125151|NCT00856986|454420|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
125152|NCT00856986|454421|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
125153|NCT00856986|454417|P5|Run-in Period, Weeks -12-0|Adverse Event|0
125154|NCT00856986|454418|P4|Run-in Period, Weeks -12-0|Adverse Event|92
125155|NCT00856986|454419|P3|Run-in Period, Weeks -12-0|Adverse Event|0
125156|NCT00856986|454420|P2|Run-in Period, Weeks -12-0|Adverse Event|0
125157|NCT00856986|454421|P1|Run-in Period, Weeks -12-0|Adverse Event|0
125158|NCT00856973|454591|P3|Overall Study|Other|13
125159|NCT00856973|454592|P2|Overall Study|Other|12
125160|NCT00856973|454593|P1|Overall Study|Other|11
125161|NCT00856973|454591|P3|Overall Study|Withdrawal by Subject|15
125162|NCT00856973|454592|P2|Overall Study|Withdrawal by Subject|16
125163|NCT00856973|454593|P1|Overall Study|Withdrawal by Subject|13
125164|NCT00856973|454591|P3|Overall Study|Protocol Violation|1
125165|NCT00856973|454592|P2|Overall Study|Protocol Violation|2
125166|NCT00856973|454593|P1|Overall Study|Protocol Violation|1
125167|NCT00856973|454591|P3|Overall Study|Physician Decision|1
125168|NCT00856973|454592|P2|Overall Study|Physician Decision|3
125169|NCT00856973|454593|P1|Overall Study|Physician Decision|0
125170|NCT00856973|454591|P3|Overall Study|Lost to Follow-up|5
125171|NCT00856973|454592|P2|Overall Study|Lost to Follow-up|3
125172|NCT00856973|454593|P1|Overall Study|Lost to Follow-up|6
125173|NCT00856973|454591|P3|Overall Study|Adverse Event|3
125174|NCT00856973|454592|P2|Overall Study|Adverse Event|5
125175|NCT00856973|454593|P1|Overall Study|Adverse Event|5
125176|NCT00856908|454673|P2|Overall Study|Lost to Follow-up|0
125177|NCT00856908|454674|P1|Overall Study|Lost to Follow-up|1
125178|NCT00856843|454701|P2|Overall Study|Lack of Efficacy|0
125179|NCT00856843|454702|P1|Overall Study|Lack of Efficacy|1
125180|NCT00856843|454701|P2|Overall Study|Withdrawal by Subject|5
125181|NCT00856843|454702|P1|Overall Study|Withdrawal by Subject|1
125182|NCT00856830|454738|P4|Irinotecan & Bendamustine|Physician Decision|1
125183|NCT00856830|454739|P3|Irinotecan & Bendamustine|Physician Decision|0
125184|NCT00856830|454740|P2|Irinotecan & Bendamustine|Physician Decision|0
125185|NCT00856830|454741|P1|Irinotecan & Bendamustine|Physician Decision|0
125186|NCT00856830|454738|P4|Irinotecan & Bendamustine|Death|2
125187|NCT00856830|454739|P3|Irinotecan & Bendamustine|Death|0
125188|NCT00856830|454740|P2|Irinotecan & Bendamustine|Death|0
125189|NCT00856830|454741|P1|Irinotecan & Bendamustine|Death|0
125190|NCT00856778|454752|P1|Overall Study|Lost to Follow-up|5
125191|NCT00856778|454752|P1|Overall Study|Study deviation|2
125192|NCT00856778|454752|P1|Overall Study|Withdrawal by Subject|10
125193|NCT00856778|454752|P1|Overall Study|Adverse Event|7
125194|NCT00856661|454795|P2|Overall Study|Physician Judgement|5
125195|NCT00856661|454796|P1|Overall Study|Physician Judgement|8
125196|NCT00856661|454795|P2|Overall Study|Lost to Follow-up|3
125197|NCT00856661|454796|P1|Overall Study|Lost to Follow-up|1
125198|NCT00856661|454795|P2|Overall Study|Withdrawal by Subject|2
125199|NCT00856661|454796|P1|Overall Study|Withdrawal by Subject|1
125200|NCT00856661|454795|P2|Overall Study|Protocol Violation|1
125201|NCT00856661|454796|P1|Overall Study|Protocol Violation|2
125202|NCT00856661|454795|P2|Overall Study|Death|18
125203|NCT00856661|454796|P1|Overall Study|Death|15
125204|NCT00856635|454810|P2|Overall Study|Discontinued at Randomization|2
125205|NCT00856635|454811|P1|Overall Study|Discontinued at Randomization|2
125206|NCT00856635|454810|P2|Overall Study|Other|0
125207|NCT00856635|454811|P1|Overall Study|Other|1
125208|NCT00856635|454810|P2|Overall Study|Serious Adverse Event|0
125209|NCT00856635|454811|P1|Overall Study|Serious Adverse Event|1
125210|NCT00856635|454810|P2|Overall Study|Withdrawal by Subject|1
125211|NCT00856635|454811|P1|Overall Study|Withdrawal by Subject|3
125212|NCT00856635|454810|P2|Overall Study|Pregnancy|0
125213|NCT00856635|454811|P1|Overall Study|Pregnancy|1
125214|NCT00856635|454810|P2|Overall Study|Lost to Follow-up|5
125215|NCT00856635|454811|P1|Overall Study|Lost to Follow-up|2
125216|NCT00856609|454821|P2|Overall Study|Adverse Event|0
125217|NCT00856609|454822|P1|Overall Study|Adverse Event|1
125218|NCT00856583|454834|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
125219|NCT00856583|454835|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
125220|NCT00856583|454834|P2|Overall Study|Other|104
125221|NCT00856583|454835|P1|Overall Study|Other|92
125222|NCT00856583|454834|P2|Overall Study|Pregnancy|5
125223|NCT00856583|454835|P1|Overall Study|Pregnancy|14
125224|NCT00856583|454834|P2|Overall Study|Physician Decision|82
125225|NCT00856583|454835|P1|Overall Study|Physician Decision|59
125226|NCT00856583|454834|P2|Overall Study|Withdrawal by Subject|919
125227|NCT00856583|454835|P1|Overall Study|Withdrawal by Subject|1092
125228|NCT00856583|454834|P2|Overall Study|Non-compliance|262
125229|NCT00856583|454835|P1|Overall Study|Non-compliance|305
125230|NCT00856583|454834|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
125231|NCT00856583|454835|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
125232|NCT00856583|454834|P2|Overall Study|Serious Adverse Event (SAE)|65
125233|NCT00856583|454835|P1|Overall Study|Serious Adverse Event (SAE)|99
125234|NCT00856583|454834|P2|Overall Study|Lack of Efficacy|377
125235|NCT00856583|454835|P1|Overall Study|Lack of Efficacy|389
125236|NCT00856557|454865|P2|Overall Study|No patients with contextual flags|16
125237|NCT00856557|454866|P1|Overall Study|No patients with contextual flags|12
125238|NCT00856544|454880|P4|Overall Study|Withdrawal by Subject|1
125239|NCT00856544|454881|P3|Overall Study|Withdrawal by Subject|0
125240|NCT00856544|454882|P2|Overall Study|Withdrawal by Subject|5
125241|NCT00856544|454883|P1|Overall Study|Withdrawal by Subject|8
125242|NCT00856544|454880|P4|Overall Study|Lost to Follow-up|0
125243|NCT00856544|454881|P3|Overall Study|Lost to Follow-up|2
125244|NCT00856544|454882|P2|Overall Study|Lost to Follow-up|2
125245|NCT00856544|454883|P1|Overall Study|Lost to Follow-up|1
125246|NCT00856544|454880|P4|Overall Study|Other|6
125247|NCT00856544|454881|P3|Overall Study|Other|1
125248|NCT00856544|454882|P2|Overall Study|Other|16
125249|NCT00856544|454883|P1|Overall Study|Other|9
125250|NCT00856544|454880|P4|Overall Study|Lack of Efficacy|3
125251|NCT00856544|454881|P3|Overall Study|Lack of Efficacy|3
125252|NCT00856544|454882|P2|Overall Study|Lack of Efficacy|12
125253|NCT00856544|454883|P1|Overall Study|Lack of Efficacy|16
125254|NCT00856544|454880|P4|Overall Study|Adverse Event|3
125255|NCT00856544|454881|P3|Overall Study|Adverse Event|2
125256|NCT00856544|454882|P2|Overall Study|Adverse Event|29
125257|NCT00856544|454883|P1|Overall Study|Adverse Event|20
125258|NCT00856544|454880|P4|Overall Study|Death|0
125259|NCT00856544|454881|P3|Overall Study|Death|0
125260|NCT00856544|454882|P2|Overall Study|Death|2
125261|NCT00856544|454883|P1|Overall Study|Death|0
125262|NCT00856544|454880|P4|Overall Study|Randomized but not treated|0
125263|NCT00856544|454881|P3|Overall Study|Randomized but not treated|0
125264|NCT00856544|454882|P2|Overall Study|Randomized but not treated|0
125265|NCT00856544|454883|P1|Overall Study|Randomized but not treated|3
125266|NCT00856518|455062|P2|Overall Study|Lost to Follow-up|2
125267|NCT00856518|455063|P1|Overall Study|Lost to Follow-up|4
125268|NCT00856492|455076|P3|Overall Study|Ineligible or withdrew consent|2
125269|NCT00856492|455077|P2|Overall Study|Ineligible or withdrew consent|1
125270|NCT00856492|455078|P1|Overall Study|Ineligible or withdrew consent|1
125271|NCT00856388|455100|P1|Overall Study|Not Specified|1
125272|NCT00856349|455111|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
125273|NCT00856349|455111|P1|Overall Study|Site closure|78
125274|NCT00856349|455111|P1|Overall Study|Device explant|33
125275|NCT00856349|455111|P1|Overall Study|Subject relocation|104
125276|NCT00856349|455111|P1|Overall Study|Physician Decision|13
125277|NCT00856349|455111|P1|Overall Study|Protocol Violation|38
125278|NCT00856349|455111|P1|Overall Study|Lost to Follow-up|91
125279|NCT00856349|455111|P1|Overall Study|Withdrawal by Subject|116
125280|NCT00856349|455111|P1|Overall Study|Death|418
125281|NCT00856323|455120|P1|Overall Study|Withdrawal by Subject|2
125282|NCT00856297|455132|P5|Overall Study|Unable to classify|0
125283|NCT00856297|455133|P4|Overall Study|Unable to classify|0
125284|NCT00856297|455134|P3|Overall Study|Unable to classify|0
125285|NCT00856297|455135|P2|Overall Study|Unable to classify|0
125286|NCT00856297|455136|P1|Overall Study|Unable to classify|2
125287|NCT00856284|455169|P3|Overall Study|Randomized in error|1
125288|NCT00856284|455170|P2|Overall Study|Randomized in error|0
125289|NCT00856284|455171|P1|Overall Study|Randomized in error|0
125290|NCT00856284|455169|P3|Overall Study|Other|14
125291|NCT00856284|455170|P2|Overall Study|Other|17
125292|NCT00856284|455171|P1|Overall Study|Other|15
125293|NCT00856284|455169|P3|Overall Study|Investigator discretion|10
125294|NCT00856284|455170|P2|Overall Study|Investigator discretion|8
125295|NCT00856284|455171|P1|Overall Study|Investigator discretion|9
125296|NCT00856284|455169|P3|Overall Study|Pregnancy|0
125297|NCT00856284|455170|P2|Overall Study|Pregnancy|2
125298|NCT00856284|455171|P1|Overall Study|Pregnancy|1
125299|NCT00856284|455169|P3|Overall Study|Voluntary withdrawal|62
125300|NCT00856284|455170|P2|Overall Study|Voluntary withdrawal|52
125301|NCT00856284|455171|P1|Overall Study|Voluntary withdrawal|48
125302|NCT00856284|455169|P3|Overall Study|Lost to Follow-up|28
125303|NCT00856284|455170|P2|Overall Study|Lost to Follow-up|22
125304|NCT00856284|455171|P1|Overall Study|Lost to Follow-up|20
125305|NCT00856284|455169|P3|Overall Study|Major protocol deviation|15
125306|NCT00856284|455170|P2|Overall Study|Major protocol deviation|16
125307|NCT00856284|455171|P1|Overall Study|Major protocol deviation|24
125308|NCT00856284|455169|P3|Overall Study|Adverse Event|82
125309|NCT00856284|455170|P2|Overall Study|Adverse Event|74
125310|NCT00856284|455171|P1|Overall Study|Adverse Event|60
125311|NCT00856284|455169|P3|Overall Study|Hyperglycemic rescue|235
125312|NCT00856284|455170|P2|Overall Study|Hyperglycemic rescue|201
125313|NCT00856284|455171|P1|Overall Study|Hyperglycemic rescue|231
125314|NCT00856245|455197|P1|Overall Study|Was not transplanted|5
125315|NCT00856206|455220|P2|Overall Study|Other than specified above|10
125316|NCT00856206|455221|P1|Overall Study|Other than specified above|3
125317|NCT00856206|455220|P2|Overall Study|Decision by the Sponsor|8
125318|NCT00856206|455221|P1|Overall Study|Decision by the Sponsor|4
125319|NCT00856206|455220|P2|Overall Study|Death|2
125320|NCT00856206|455221|P1|Overall Study|Death|2
125321|NCT00856206|455220|P2|Overall Study|Lost to Follow-up|39
125322|NCT00856206|455221|P1|Overall Study|Lost to Follow-up|13
125323|NCT00856206|455220|P2|Overall Study|Withdrawal by Subject|36
125324|NCT00856206|455221|P1|Overall Study|Withdrawal by Subject|15
125325|NCT00856206|455220|P2|Overall Study|Lack of Efficacy|2
125326|NCT00856206|455221|P1|Overall Study|Lack of Efficacy|1
125327|NCT00856206|455220|P2|Overall Study|Adverse Event|46
125328|NCT00856206|455221|P1|Overall Study|Adverse Event|10
125329|NCT00856206|455220|P2|Overall Study|Protocol Violation|18
125330|NCT00856206|455221|P1|Overall Study|Protocol Violation|6
125331|NCT00856193|455235|P2|Period 2|Lost to Follow-up|1
125332|NCT00856193|455236|P1|Period 2|Lost to Follow-up|0
125333|NCT00856193|455235|P2|Period 2|Abnormal test procedure results|1
125334|NCT00856193|455236|P1|Period 2|Abnormal test procedure results|0
125335|NCT00856180|455248|P1|Overall Study|Progressive Disease|16
125336|NCT00856180|455248|P1|Overall Study|Adverse Event|4
125337|NCT00855959|455273|P1|Overall Study|Incorrect enrolment|1
125338|NCT00855959|455273|P1|Overall Study|Pregnancy|1
125339|NCT00855959|455273|P1|Overall Study|Withdrawal by Subject|3
125340|NCT00855959|455273|P1|Overall Study|Lost to Follow-up|2
125341|NCT00855959|455273|P1|Overall Study|Adverse Event|2
125342|NCT00855933|455290|P2|Overall Study|Withdrawal by Subject|1
125343|NCT00855933|455291|P1|Overall Study|Withdrawal by Subject|0
125344|NCT00855920|455300|P3|Overall Study|Other than specified above|1
125345|NCT00855920|455301|P2|Overall Study|Other than specified above|1
125346|NCT00855920|455302|P1|Overall Study|Other than specified above|1
125347|NCT00855920|455300|P3|Overall Study|Decision by the sponsor|1
125348|NCT00855920|455301|P2|Overall Study|Decision by the sponsor|1
125349|NCT00855920|455302|P1|Overall Study|Decision by the sponsor|0
125350|NCT00855920|455300|P3|Overall Study|Death|0
125351|NCT00855920|455301|P2|Overall Study|Death|1
125352|NCT00855920|455302|P1|Overall Study|Death|0
125353|NCT00855920|455300|P3|Overall Study|Lost to Follow-up|2
125354|NCT00855920|455301|P2|Overall Study|Lost to Follow-up|0
125355|NCT00855920|455302|P1|Overall Study|Lost to Follow-up|1
125356|NCT00855920|455300|P3|Overall Study|Withdrawal by Subject|2
125357|NCT00855920|455301|P2|Overall Study|Withdrawal by Subject|3
125358|NCT00855920|455302|P1|Overall Study|Withdrawal by Subject|2
125359|NCT00855920|455300|P3|Overall Study|Lack of Efficacy|2
125360|NCT00855920|455301|P2|Overall Study|Lack of Efficacy|2
125361|NCT00855920|455302|P1|Overall Study|Lack of Efficacy|2
125362|NCT00855920|455300|P3|Overall Study|Adverse Event|1
125363|NCT00855920|455301|P2|Overall Study|Adverse Event|1
125364|NCT00855920|455302|P1|Overall Study|Adverse Event|2
125365|NCT00855920|455300|P3|Overall Study|Protocol Violation|2
125366|NCT00855920|455301|P2|Overall Study|Protocol Violation|0
125367|NCT00855920|455302|P1|Overall Study|Protocol Violation|0
125368|NCT00855894|455319|P1|Overall Study|Disease progression|1
125369|NCT00855894|455319|P1|Overall Study|Patient's decision|1
125370|NCT00855894|455319|P1|Overall Study|Death|31
125371|NCT00855816|455342|P2|Overall Study|Became ineligible|1
125372|NCT00855816|455343|P1|Overall Study|Became ineligible|0
125373|NCT00855816|455342|P2|Overall Study|Death|0
125374|NCT00855816|455343|P1|Overall Study|Death|1
125375|NCT00855816|455342|P2|Overall Study|Lost to Follow-up|5
125376|NCT00855816|455343|P1|Overall Study|Lost to Follow-up|3
125377|NCT00855816|455342|P2|Overall Study|Withdrawal by Subject|15
125378|NCT00855816|455343|P1|Overall Study|Withdrawal by Subject|22
125379|NCT00855738|455349|P1|Overall Study|Death|1
125380|NCT00855738|455349|P1|Overall Study|Subject Defaulted|1
125381|NCT00855738|455349|P1|Overall Study|Adverse Event|1
125382|NCT00855738|455349|P1|Overall Study|Lost to Follow-up|2
125383|NCT00855595|455377|P2|Overall Study|patient left country|1
125384|NCT00855595|455378|P1|Overall Study|patient left country|0
125385|NCT00855595|455377|P2|Overall Study|patient moved out of state|0
125386|NCT00855595|455378|P1|Overall Study|patient moved out of state|1
125387|NCT00855595|455377|P2|Overall Study|Adverse Event|1
125388|NCT00855595|455378|P1|Overall Study|Adverse Event|1
125389|NCT00855595|455377|P2|Overall Study|Lost to Follow-up|3
125390|NCT00855595|455378|P1|Overall Study|Lost to Follow-up|3
125391|NCT00855595|455377|P2|Overall Study|Withdrawal by Subject|2
125392|NCT00855595|455378|P1|Overall Study|Withdrawal by Subject|1
125393|NCT00855582|455417|P3|Overall Study|Withdrawal by Subject|8
125394|NCT00855582|455418|P2|Overall Study|Withdrawal by Subject|4
125395|NCT00855582|455419|P1|Overall Study|Withdrawal by Subject|7
125396|NCT00855582|455417|P3|Overall Study|Entry Criteria Not Met|3
125397|NCT00855582|455418|P2|Overall Study|Entry Criteria Not Met|6
125398|NCT00855582|455419|P1|Overall Study|Entry Criteria Not Met|8
125399|NCT00855582|455417|P3|Overall Study|Protocol Violation|6
125400|NCT00855582|455418|P2|Overall Study|Protocol Violation|2
125401|NCT00855582|455419|P1|Overall Study|Protocol Violation|6
125402|NCT00855582|455417|P3|Overall Study|Physician Decision|1
125403|NCT00855582|455418|P2|Overall Study|Physician Decision|0
125404|NCT00855582|455419|P1|Overall Study|Physician Decision|0
125405|NCT00855582|455417|P3|Overall Study|Lost to Follow-up|1
125406|NCT00855582|455418|P2|Overall Study|Lost to Follow-up|3
125407|NCT00855582|455419|P1|Overall Study|Lost to Follow-up|1
125408|NCT00855582|455417|P3|Overall Study|Lack of Efficacy|8
125409|NCT00855582|455418|P2|Overall Study|Lack of Efficacy|3
125410|NCT00855582|455419|P1|Overall Study|Lack of Efficacy|1
125411|NCT00855582|455417|P3|Overall Study|Death|0
125412|NCT00855582|455418|P2|Overall Study|Death|0
125413|NCT00855582|455419|P1|Overall Study|Death|1
125414|NCT00855582|455417|P3|Overall Study|Adverse Event|3
125415|NCT00855582|455418|P2|Overall Study|Adverse Event|6
125416|NCT00855582|455419|P1|Overall Study|Adverse Event|2
125417|NCT00855465|455508|P2|Follow-up Period (FUP)|Missing|0
125418|NCT00855465|455509|P1|Follow-up Period (FUP)|Missing|1
125419|NCT00855465|455508|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
125420|NCT00855465|455509|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
125421|NCT00855465|455508|P2|Follow-up Period (FUP)|Lost to Follow-up|0
125422|NCT00855465|455509|P1|Follow-up Period (FUP)|Lost to Follow-up|3
125423|NCT00855465|455508|P2|Follow-up Period (FUP)|Death|1
125424|NCT00855465|455509|P1|Follow-up Period (FUP)|Death|0
125425|NCT00855465|455508|P2|Follow-up Period (FUP)|Adverse Event|1
125426|NCT00855465|455509|P1|Follow-up Period (FUP)|Adverse Event|0
125427|NCT00855465|455508|P2|Treatment Period|Not treated|0
125428|NCT00855465|455509|P1|Treatment Period|Not treated|1
125429|NCT00855465|455508|P2|Treatment Period|Withdrawal by Subject|0
125430|NCT00855465|455509|P1|Treatment Period|Withdrawal by Subject|2
125431|NCT00855465|455508|P2|Treatment Period|Protocol Violation|0
125432|NCT00855465|455509|P1|Treatment Period|Protocol Violation|2
125433|NCT00855465|455508|P2|Treatment Period|Non-compliance|0
125434|NCT00855465|455509|P1|Treatment Period|Non-compliance|1
125435|NCT00855465|455508|P2|Treatment Period|Lack of Efficacy|1
125436|NCT00855465|455509|P1|Treatment Period|Lack of Efficacy|2
125437|NCT00855465|455508|P2|Treatment Period|Death|2
125438|NCT00855465|455509|P1|Treatment Period|Death|2
125439|NCT00855465|455508|P2|Treatment Period|Adverse Event|2
125440|NCT00855465|455509|P1|Treatment Period|Adverse Event|4
125441|NCT00855439|455599|P2|Overall Study|Pregnancy|0
125442|NCT00855439|455600|P1|Overall Study|Pregnancy|1
125443|NCT00855439|455599|P2|Overall Study|Withdrawal by Subject|0
125444|NCT00855439|455600|P1|Overall Study|Withdrawal by Subject|2
125445|NCT00855335|455658|P5|Overall Study|Other|1
125446|NCT00855335|455659|P4|Overall Study|Other|5
125447|NCT00855335|455660|P3|Overall Study|Other|2
125448|NCT00855335|455661|P2|Overall Study|Other|1
125449|NCT00855335|455662|P1|Overall Study|Other|2
125450|NCT00855335|455658|P5|Overall Study|Physician Decision|0
125451|NCT00855335|455659|P4|Overall Study|Physician Decision|0
125452|NCT00855335|455660|P3|Overall Study|Physician Decision|0
125453|NCT00855335|455661|P2|Overall Study|Physician Decision|1
125454|NCT00855335|455662|P1|Overall Study|Physician Decision|1
125455|NCT00855335|455658|P5|Overall Study|Adverse Event|0
125456|NCT00855335|455659|P4|Overall Study|Adverse Event|0
125457|NCT00855335|455660|P3|Overall Study|Adverse Event|0
125458|NCT00855335|455661|P2|Overall Study|Adverse Event|0
125459|NCT00855335|455662|P1|Overall Study|Adverse Event|2
125460|NCT00855335|455658|P5|Overall Study|Withdrawal by Subject|0
125461|NCT00855335|455659|P4|Overall Study|Withdrawal by Subject|1
125462|NCT00855335|455660|P3|Overall Study|Withdrawal by Subject|0
125463|NCT00855335|455661|P2|Overall Study|Withdrawal by Subject|0
125464|NCT00855335|455662|P1|Overall Study|Withdrawal by Subject|0
125465|NCT00855335|455658|P5|Overall Study|Lost to Follow-up|0
125466|NCT00855335|455659|P4|Overall Study|Lost to Follow-up|1
125467|NCT00855335|455660|P3|Overall Study|Lost to Follow-up|3
125468|NCT00855335|455661|P2|Overall Study|Lost to Follow-up|0
125469|NCT00855335|455662|P1|Overall Study|Lost to Follow-up|0
125470|NCT00855309|455749|P2|Overall Study|patient never recieved drug|0
125471|NCT00855309|455750|P1|Overall Study|patient never recieved drug|1
125472|NCT00855218|455758|P2|Overall Study|Clinical endpoint reached|13
125473|NCT00855218|455759|P1|Overall Study|Clinical endpoint reached|10
125474|NCT00855218|455758|P2|Overall Study|Progression measurement proven|15
125475|NCT00855218|455759|P1|Overall Study|Progression measurement proven|7
125476|NCT00855218|455758|P2|Overall Study|Second malignancy|1
125477|NCT00855218|455759|P1|Overall Study|Second malignancy|0
125478|NCT00855218|455758|P2|Overall Study|Untreatable disease progression|67
125479|NCT00855218|455759|P1|Overall Study|Untreatable disease progression|54
125480|NCT00855218|455758|P2|Overall Study|Still treated with study medication|1
125481|NCT00855218|455759|P1|Overall Study|Still treated with study medication|0
125482|NCT00855218|455758|P2|Overall Study|technical problems|1
125483|NCT00855218|455759|P1|Overall Study|technical problems|2
125484|NCT00855218|455758|P2|Overall Study|patient convenience|0
125485|NCT00855218|455759|P1|Overall Study|patient convenience|2
125486|NCT00855218|455758|P2|Overall Study|non-compliant with study drug|1
125487|NCT00855218|455759|P1|Overall Study|non-compliant with study drug|3
125488|NCT00855218|455758|P2|Overall Study|Protocol Violation|9
125489|NCT00855218|455759|P1|Overall Study|Protocol Violation|5
125490|NCT00855218|455758|P2|Overall Study|Lost to Follow-up|1
125491|NCT00855218|455759|P1|Overall Study|Lost to Follow-up|0
125492|NCT00855218|455758|P2|Overall Study|Physician Decision|11
125493|NCT00855218|455759|P1|Overall Study|Physician Decision|18
125494|NCT00855218|455758|P2|Overall Study|Withdrawal by Subject|6
125495|NCT00855218|455759|P1|Overall Study|Withdrawal by Subject|10
125496|NCT00855218|455758|P2|Overall Study|Adverse Event|27
125497|NCT00855218|455759|P1|Overall Study|Adverse Event|43
125498|NCT00855166|455777|P2|Overall Study|Subject no longer meets study criteria|1
125499|NCT00855166|455778|P1|Overall Study|Subject no longer meets study criteria|1
125500|NCT00855166|455777|P2|Overall Study|Administrative reasons by sponsor|0
125501|NCT00855166|455778|P1|Overall Study|Administrative reasons by sponsor|1
125502|NCT00855166|455777|P2|Overall Study|Poor/non-compliance|0
125503|NCT00855166|455778|P1|Overall Study|Poor/non-compliance|2
125504|NCT00855166|455777|P2|Overall Study|Withdrawal by Subject|4
125505|NCT00855166|455778|P1|Overall Study|Withdrawal by Subject|1
125506|NCT00855166|455777|P2|Overall Study|Death|1
125507|NCT00855166|455778|P1|Overall Study|Death|0
125508|NCT00855166|455777|P2|Overall Study|Adverse Event|2
125509|NCT00855166|455778|P1|Overall Study|Adverse Event|0
125510|NCT00855062|455798|P2|Step2|Initiation of antiretroviral therapy/ART|1
125511|NCT00855062|455799|P1|Step2|Initiation of antiretroviral therapy/ART|0
125512|NCT00855062|455798|P2|Step2|Adverse Event|3
125513|NCT00855062|455799|P1|Step2|Adverse Event|0
125514|NCT00855062|455798|P2|Step2|Early Study Closure|2
125515|NCT00855062|455799|P1|Step2|Early Study Closure|6
125516|NCT00855062|455798|P2|Step1|Withdrawal by Subject|3
125517|NCT00855062|455799|P1|Step1|Withdrawal by Subject|2
125518|NCT00855062|455798|P2|Step1|Pregnancy|0
125519|NCT00855062|455799|P1|Step1|Pregnancy|1
125520|NCT00855062|455798|P2|Step1|Protocol Violation|0
125521|NCT00855062|455799|P1|Step1|Protocol Violation|1
125522|NCT00855062|455798|P2|Step1|Adverse Event|1
125523|NCT00855062|455799|P1|Step1|Adverse Event|1
125524|NCT00855062|455798|P2|Step1|Early Study Closure|7
125525|NCT00855062|455799|P1|Step1|Early Study Closure|5
125526|NCT00854906|455848|P1|Overall Study|One person had no ocular history|1
125527|NCT00854724|455857|P2|Second Intervention|Physician Decision|1
125528|NCT00854724|455858|P1|Second Intervention|Physician Decision|0
125529|NCT00854724|455857|P2|Second Intervention|Protocol Violation|0
125530|NCT00854724|455858|P1|Second Intervention|Protocol Violation|1
125531|NCT00854724|455857|P2|Washout|Withdrawal by Subject|1
125532|NCT00854724|455858|P1|Washout|Withdrawal by Subject|0
125533|NCT00854724|455857|P2|Washout|Protocol Violation|0
125534|NCT00854724|455858|P1|Washout|Protocol Violation|1
125535|NCT00854724|455857|P2|First Intervention|Withdrawal by Subject|1
125536|NCT00854724|455858|P1|First Intervention|Withdrawal by Subject|1
125537|NCT00854620|455864|P1|Overall Study|Adverse Event|1
125538|NCT00854607|455868|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
125539|NCT00854581|455916|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
125540|NCT00854581|455916|P1|Induction (Up to Day 21)|Physician Decision|1
125541|NCT00854581|455916|P1|Induction (Up to Day 21)|Death|1
125542|NCT00854581|455916|P1|Induction (Up to Day 21)|Lack of Efficacy|4
125543|NCT00854373|455931|P2|Overall Study|Forgot to take study drug|1
125544|NCT00854373|455932|P1|Overall Study|Forgot to take study drug|1
125545|NCT00854373|455931|P2|Overall Study|Withdrawal by Subject|3
125546|NCT00854373|455932|P1|Overall Study|Withdrawal by Subject|1
125547|NCT00854360|455946|P4|Overall Study|Other|3
125548|NCT00854360|455947|P3|Overall Study|Other|0
125549|NCT00854360|455948|P2|Overall Study|Other|0
125550|NCT00854360|455949|P1|Overall Study|Other|0
125551|NCT00854360|455946|P4|Overall Study|Lack of Efficacy|0
125552|NCT00854360|455947|P3|Overall Study|Lack of Efficacy|0
125553|NCT00854360|455948|P2|Overall Study|Lack of Efficacy|1
125554|NCT00854360|455949|P1|Overall Study|Lack of Efficacy|2
125555|NCT00854360|455946|P4|Overall Study|Pregnancy|0
125556|NCT00854360|455947|P3|Overall Study|Pregnancy|0
125557|NCT00854360|455948|P2|Overall Study|Pregnancy|1
125558|NCT00854360|455949|P1|Overall Study|Pregnancy|0
125559|NCT00854360|455946|P4|Overall Study|Withdrawal by Subject|1
125560|NCT00854360|455947|P3|Overall Study|Withdrawal by Subject|0
125561|NCT00854360|455948|P2|Overall Study|Withdrawal by Subject|0
125562|NCT00854360|455949|P1|Overall Study|Withdrawal by Subject|0
125563|NCT00854360|455946|P4|Overall Study|Adverse Event|6
125564|NCT00854360|455947|P3|Overall Study|Adverse Event|2
125565|NCT00854360|455948|P2|Overall Study|Adverse Event|1
125566|NCT00854360|455949|P1|Overall Study|Adverse Event|0
125567|NCT00854308|455981|P2|Overall Study|Sponsor's decision to terminate study|1
125568|NCT00854308|455982|P1|Overall Study|Sponsor's decision to terminate study|0
125569|NCT00854308|455981|P2|Overall Study|Withdrawal by Subject|2
125570|NCT00854308|455982|P1|Overall Study|Withdrawal by Subject|4
125571|NCT00854308|455981|P2|Overall Study|Physician Decision|6
125572|NCT00854308|455982|P1|Overall Study|Physician Decision|6
125573|NCT00854308|455981|P2|Overall Study|Death|5
125574|NCT00854308|455982|P1|Overall Study|Death|2
125575|NCT00854308|455981|P2|Overall Study|Adverse Event|3
125576|NCT00854308|455982|P1|Overall Study|Adverse Event|8
125577|NCT00854308|455981|P2|Overall Study|Disease progression|50
125578|NCT00854308|455982|P1|Overall Study|Disease progression|42
125579|NCT00854113|456007|P11|Overall Study|Withdrawal by Subject|0
125580|NCT00854113|456008|P10|Overall Study|Withdrawal by Subject|0
125581|NCT00854113|456009|P9|Overall Study|Withdrawal by Subject|1
125582|NCT00854113|456010|P8|Overall Study|Withdrawal by Subject|1
125583|NCT00854113|456011|P7|Overall Study|Withdrawal by Subject|0
125584|NCT00854113|456012|P6|Overall Study|Withdrawal by Subject|0
125585|NCT00854113|456013|P5|Overall Study|Withdrawal by Subject|0
125586|NCT00854113|456014|P4|Overall Study|Withdrawal by Subject|0
125587|NCT00854113|456015|P3|Overall Study|Withdrawal by Subject|0
125588|NCT00854113|456016|P2|Overall Study|Withdrawal by Subject|0
125589|NCT00854113|456017|P1|Overall Study|Withdrawal by Subject|0
125590|NCT00854113|456007|P11|Overall Study|Adverse Event|0
125591|NCT00854113|456008|P10|Overall Study|Adverse Event|0
125592|NCT00854113|456009|P9|Overall Study|Adverse Event|0
125593|NCT00854113|456010|P8|Overall Study|Adverse Event|2
125594|NCT00854113|456011|P7|Overall Study|Adverse Event|0
125595|NCT00854113|456012|P6|Overall Study|Adverse Event|0
125596|NCT00854113|456013|P5|Overall Study|Adverse Event|0
125597|NCT00854113|456014|P4|Overall Study|Adverse Event|0
125598|NCT00854113|456015|P3|Overall Study|Adverse Event|0
125599|NCT00854113|456016|P2|Overall Study|Adverse Event|0
125600|NCT00854113|456017|P1|Overall Study|Adverse Event|0
125601|NCT00853970|456139|P2|Overall Study|Cancelled surgery|2
125602|NCT00853970|456140|P1|Overall Study|Cancelled surgery|4
125603|NCT00853970|456139|P2|Overall Study|Withdrawal by Subject|1
125604|NCT00853970|456140|P1|Overall Study|Withdrawal by Subject|2
125605|NCT00853957|456150|P2|Overall Study|Protocol deviation|3
125606|NCT00853957|456151|P1|Overall Study|Protocol deviation|0
125607|NCT00853957|456150|P2|Overall Study|Lost to Follow-up|6
125608|NCT00853957|456151|P1|Overall Study|Lost to Follow-up|1
125609|NCT00853957|456150|P2|Overall Study|Subject withdrew consent|5
125610|NCT00853957|456151|P1|Overall Study|Subject withdrew consent|4
125611|NCT00853957|456150|P2|Overall Study|Unsatisfactory therapeutic effect|2
125612|NCT00853957|456151|P1|Overall Study|Unsatisfactory therapeutic effect|0
125613|NCT00853957|456150|P2|Overall Study|Adverse Event|3
125614|NCT00853957|456151|P1|Overall Study|Adverse Event|9
125615|NCT00853905|456169|P2|Overall Study|never had surgery|0
125616|NCT00853905|456170|P1|Overall Study|never had surgery|1
125617|NCT00853905|456169|P2|Overall Study|Withdrawal by Subject|1
125618|NCT00853905|456170|P1|Overall Study|Withdrawal by Subject|0
125619|NCT00853905|456169|P2|Overall Study|Lost to Follow-up|3
125620|NCT00853905|456170|P1|Overall Study|Lost to Follow-up|1
125621|NCT00853827|456194|P2|Double Blind Period (103 Weeks)|Death|6
125622|NCT00853827|456195|P1|Double Blind Period (103 Weeks)|Death|1
125623|NCT00853827|456194|P2|Double Blind Period (103 Weeks)|Administrative problems|56
125624|NCT00853827|456195|P1|Double Blind Period (103 Weeks)|Administrative problems|45
125625|NCT00853827|456194|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
125626|NCT00853827|456195|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
125627|NCT00853827|456194|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
125628|NCT00853827|456195|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
125629|NCT00853827|456194|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
125630|NCT00853827|456195|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
125631|NCT00853827|456194|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
125632|NCT00853827|456195|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
125633|NCT00853827|456194|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
125634|NCT00853827|456195|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
125635|NCT00853827|456194|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
125636|NCT00853827|456195|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
125637|NCT00853827|456194|P2|Double Blind Period (103 Weeks)|Adverse Event|14
125638|NCT00853827|456195|P1|Double Blind Period (103 Weeks)|Adverse Event|25
125639|NCT00853827|456194|P2|Single Blind Period (1 Week)|Protocol Violation|0
125640|NCT00853827|456195|P1|Single Blind Period (1 Week)|Protocol Violation|12
125641|NCT00853827|456194|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
125642|NCT00853827|456195|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
125643|NCT00853827|456194|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
125644|NCT00853827|456195|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
125645|NCT00853827|456194|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
125646|NCT00853827|456195|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
125647|NCT00853827|456194|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
125648|NCT00853827|456195|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
125649|NCT00853827|456194|P2|Single Blind Period (1 Week)|Adverse Event|0
125650|NCT00853827|456195|P1|Single Blind Period (1 Week)|Adverse Event|9
125651|NCT00853827|456194|P2|Single Blind Period (1 Week)|Other|0
125652|NCT00853827|456195|P1|Single Blind Period (1 Week)|Other|4
125653|NCT00853762|456211|P4|Overall Study|Randomised but not Treated|0
125654|NCT00853762|456212|P3|Overall Study|Randomised but not Treated|2
125655|NCT00853762|456213|P2|Overall Study|Randomised but not Treated|2
125656|NCT00853762|456214|P1|Overall Study|Randomised but not Treated|0
125657|NCT00853762|456211|P4|Overall Study|Other|0
125658|NCT00853762|456212|P3|Overall Study|Other|0
125659|NCT00853762|456213|P2|Overall Study|Other|2
125660|NCT00853762|456214|P1|Overall Study|Other|0
125661|NCT00853762|456211|P4|Overall Study|Withdrawal by Subject|0
125662|NCT00853762|456212|P3|Overall Study|Withdrawal by Subject|1
125663|NCT00853762|456213|P2|Overall Study|Withdrawal by Subject|0
125664|NCT00853762|456214|P1|Overall Study|Withdrawal by Subject|0
125665|NCT00853762|456211|P4|Overall Study|Protocol Violation|1
125666|NCT00853762|456212|P3|Overall Study|Protocol Violation|0
125667|NCT00853762|456213|P2|Overall Study|Protocol Violation|0
125668|NCT00853762|456214|P1|Overall Study|Protocol Violation|0
125669|NCT00853762|456211|P4|Overall Study|Premature Termination|21
125670|NCT00853762|456212|P3|Overall Study|Premature Termination|14
125671|NCT00853762|456213|P2|Overall Study|Premature Termination|15
125672|NCT00853762|456214|P1|Overall Study|Premature Termination|16
125673|NCT00853749|456282|P2|Overall Study|Lost to Follow-up|1
125674|NCT00853749|456283|P1|Overall Study|Lost to Follow-up|0
125675|NCT00853723|456304|P3|Overall Study|Protocol Violation|1
125676|NCT00853723|456305|P2|Overall Study|Protocol Violation|2
125677|NCT00853723|456306|P1|Overall Study|Protocol Violation|1
125678|NCT00853723|456304|P3|Overall Study|Withdrawal by Subject|0
125679|NCT00853723|456305|P2|Overall Study|Withdrawal by Subject|1
125680|NCT00853723|456306|P1|Overall Study|Withdrawal by Subject|2
125681|NCT00853723|456304|P3|Overall Study|Adverse Event|1
125682|NCT00853723|456305|P2|Overall Study|Adverse Event|4
125683|NCT00853723|456306|P1|Overall Study|Adverse Event|3
125684|NCT00853658|456353|P3|Overall Study|Missing study completion information|6
125685|NCT00853658|456354|P2|Overall Study|Missing study completion information|4
125686|NCT00853658|456355|P1|Overall Study|Missing study completion information|5
125687|NCT00853658|456353|P3|Overall Study|Patient's request|11
125688|NCT00853658|456354|P2|Overall Study|Patient's request|17
125689|NCT00853658|456355|P1|Overall Study|Patient's request|21
125690|NCT00853658|456353|P3|Overall Study|Vital Status at study end N/A|10
125691|NCT00853658|456354|P2|Overall Study|Vital Status at study end N/A|10
125692|NCT00853658|456355|P1|Overall Study|Vital Status at study end N/A|8
125693|NCT00853658|456353|P3|Overall Study|Vital Status unknown at study end|0
125694|NCT00853658|456354|P2|Overall Study|Vital Status unknown at study end|1
125695|NCT00853658|456355|P1|Overall Study|Vital Status unknown at study end|1
125696|NCT00853658|456353|P3|Overall Study|Vital Status known (alive) at study end|3
125697|NCT00853658|456354|P2|Overall Study|Vital Status known (alive) at study end|3
125698|NCT00853658|456355|P1|Overall Study|Vital Status known (alive) at study end|2
125699|NCT00853658|456353|P3|Overall Study|IRB request|2
125700|NCT00853658|456354|P2|Overall Study|IRB request|0
125701|NCT00853658|456355|P1|Overall Study|IRB request|0
125702|NCT00853658|456353|P3|Overall Study|H.A. Request|19
125703|NCT00853658|456354|P2|Overall Study|H.A. Request|23
125704|NCT00853658|456355|P1|Overall Study|H.A. Request|26
125705|NCT00853658|456353|P3|Overall Study|Lost to Follow-up|11
125706|NCT00853658|456354|P2|Overall Study|Lost to Follow-up|6
125707|NCT00853658|456355|P1|Overall Study|Lost to Follow-up|11
125708|NCT00853658|456353|P3|Overall Study|Death|753
125709|NCT00853658|456354|P2|Overall Study|Death|768
125710|NCT00853658|456355|P1|Overall Study|Death|713
125711|NCT00853593|456375|P1|Overall Study|Implant not attempted|4
125712|NCT00853593|456375|P1|Overall Study|Model 4396 lead not attempted|29
125713|NCT00853593|456375|P1|Overall Study|Subjects did not receive a 4396 lead|12
125714|NCT00853580|456402|P2|Overall Study|Commenced contraindicated therapy|2
125715|NCT00853580|456403|P1|Overall Study|Commenced contraindicated therapy|0
125716|NCT00853580|456402|P2|Overall Study|Withdrawal by Subject|8
125717|NCT00853580|456403|P1|Overall Study|Withdrawal by Subject|2
125718|NCT00853580|456402|P2|Overall Study|Protocol Violation|1
125719|NCT00853580|456403|P1|Overall Study|Protocol Violation|2
125720|NCT00853580|456402|P2|Overall Study|Lost to Follow-up|5
125721|NCT00853580|456403|P1|Overall Study|Lost to Follow-up|3
125722|NCT00853567|456450|P1|Overall Study|Study prematurely terminated|71
125723|NCT00853489|456460|P2|Overall Study|Lost to Follow-up|2
125724|NCT00853489|456461|P1|Overall Study|Lost to Follow-up|5
125725|NCT00853385|456476|P5|Overall Study|Other|12
125726|NCT00853385|456477|P4|Overall Study|Other|4
125727|NCT00853385|456478|P3|Overall Study|Other|4
125728|NCT00853385|456479|P2|Overall Study|Other|9
125729|NCT00853385|456480|P1|Overall Study|Other|18
125730|NCT00853385|456476|P5|Overall Study|Withdrawal by Subject|1
125731|NCT00853385|456477|P4|Overall Study|Withdrawal by Subject|1
125732|NCT00853385|456478|P3|Overall Study|Withdrawal by Subject|0
125733|NCT00853385|456479|P2|Overall Study|Withdrawal by Subject|2
125734|NCT00853385|456480|P1|Overall Study|Withdrawal by Subject|4
125735|NCT00853385|456476|P5|Overall Study|Lost to Follow-up|0
125736|NCT00853385|456477|P4|Overall Study|Lost to Follow-up|0
125737|NCT00853385|456478|P3|Overall Study|Lost to Follow-up|0
125738|NCT00853385|456479|P2|Overall Study|Lost to Follow-up|1
125739|NCT00853385|456480|P1|Overall Study|Lost to Follow-up|2
125740|NCT00853385|456476|P5|Overall Study|Lack of Efficacy|6
125741|NCT00853385|456477|P4|Overall Study|Lack of Efficacy|3
125742|NCT00853385|456478|P3|Overall Study|Lack of Efficacy|3
125743|NCT00853385|456479|P2|Overall Study|Lack of Efficacy|7
125744|NCT00853385|456480|P1|Overall Study|Lack of Efficacy|6
125745|NCT00853385|456476|P5|Overall Study|Adverse Event|22
125746|NCT00853385|456477|P4|Overall Study|Adverse Event|5
125747|NCT00853385|456478|P3|Overall Study|Adverse Event|2
125748|NCT00853385|456479|P2|Overall Study|Adverse Event|24
125749|NCT00853385|456480|P1|Overall Study|Adverse Event|24
125750|NCT00853385|456476|P5|Overall Study|Death|1
125751|NCT00853385|456477|P4|Overall Study|Death|0
125752|NCT00853385|456478|P3|Overall Study|Death|0
125753|NCT00853385|456479|P2|Overall Study|Death|0
125754|NCT00853385|456480|P1|Overall Study|Death|0
125755|NCT00853307|456708|P2|Overall Study|Reason Not Specified|1
125756|NCT00853307|456709|P1|Overall Study|Reason Not Specified|0
125757|NCT00853307|456708|P2|Overall Study|Withdrawal by Subject|2
125758|NCT00853307|456709|P1|Overall Study|Withdrawal by Subject|1
125759|NCT00853307|456708|P2|Overall Study|Adverse Event|2
125760|NCT00853307|456709|P1|Overall Study|Adverse Event|1
125761|NCT00853242|456736|P7|Overall Study|Other|2
125762|NCT00853242|456737|P6|Overall Study|Other|1
125763|NCT00853242|456738|P5|Overall Study|Other|0
125764|NCT00853242|456739|P4|Overall Study|Other|0
125765|NCT00853242|456740|P3|Overall Study|Other|2
125766|NCT00853242|456741|P2|Overall Study|Other|0
125767|NCT00853242|456742|P1|Overall Study|Other|2
125768|NCT00853242|456736|P7|Overall Study|Withdrawal by Subject|2
125769|NCT00853242|456737|P6|Overall Study|Withdrawal by Subject|0
125770|NCT00853242|456738|P5|Overall Study|Withdrawal by Subject|0
125771|NCT00853242|456739|P4|Overall Study|Withdrawal by Subject|4
125772|NCT00853242|456740|P3|Overall Study|Withdrawal by Subject|0
125773|NCT00853242|456741|P2|Overall Study|Withdrawal by Subject|2
125774|NCT00853242|456742|P1|Overall Study|Withdrawal by Subject|1
125775|NCT00853242|456736|P7|Overall Study|Noncompliant|0
125776|NCT00853242|456737|P6|Overall Study|Noncompliant|0
125777|NCT00853242|456738|P5|Overall Study|Noncompliant|1
125778|NCT00853242|456739|P4|Overall Study|Noncompliant|0
125779|NCT00853242|456740|P3|Overall Study|Noncompliant|0
125780|NCT00853242|456741|P2|Overall Study|Noncompliant|0
125781|NCT00853242|456742|P1|Overall Study|Noncompliant|0
125782|NCT00853242|456736|P7|Overall Study|Adverse Event|1
125783|NCT00853242|456737|P6|Overall Study|Adverse Event|1
125784|NCT00853242|456738|P5|Overall Study|Adverse Event|3
125785|NCT00853242|456739|P4|Overall Study|Adverse Event|0
125786|NCT00853242|456740|P3|Overall Study|Adverse Event|1
125787|NCT00853242|456741|P2|Overall Study|Adverse Event|1
125788|NCT00853242|456742|P1|Overall Study|Adverse Event|0
125789|NCT00853229|456784|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
125790|NCT00853229|456785|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
125791|NCT00853151|456795|P4|Overall Study|Sponsor Decision|0
125792|NCT00853151|456796|P3|Overall Study|Sponsor Decision|0
125793|NCT00853151|456797|P2|Overall Study|Sponsor Decision|3
125794|NCT00853151|456798|P1|Overall Study|Sponsor Decision|0
125795|NCT00853151|456795|P4|Overall Study|Physician Decision|0
125796|NCT00853151|456796|P3|Overall Study|Physician Decision|1
125797|NCT00853151|456797|P2|Overall Study|Physician Decision|2
125798|NCT00853151|456798|P1|Overall Study|Physician Decision|0
125799|NCT00853151|456795|P4|Overall Study|Withdrawal by Subject|1
125800|NCT00853151|456796|P3|Overall Study|Withdrawal by Subject|2
125801|NCT00853151|456797|P2|Overall Study|Withdrawal by Subject|4
125802|NCT00853151|456798|P1|Overall Study|Withdrawal by Subject|5
125803|NCT00853151|456795|P4|Overall Study|Protocol Violation|1
125804|NCT00853151|456796|P3|Overall Study|Protocol Violation|0
125805|NCT00853151|456797|P2|Overall Study|Protocol Violation|0
125806|NCT00853151|456798|P1|Overall Study|Protocol Violation|0
125807|NCT00853151|456795|P4|Overall Study|Death|1
125808|NCT00853151|456796|P3|Overall Study|Death|0
125809|NCT00853151|456797|P2|Overall Study|Death|0
125810|NCT00853151|456798|P1|Overall Study|Death|1
125811|NCT00853151|456795|P4|Overall Study|Lost to Follow-up|0
125812|NCT00853151|456796|P3|Overall Study|Lost to Follow-up|3
125813|NCT00853151|456797|P2|Overall Study|Lost to Follow-up|0
125814|NCT00853151|456798|P1|Overall Study|Lost to Follow-up|2
125815|NCT00853151|456795|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
125816|NCT00853151|456796|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
125817|NCT00853151|456797|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
125818|NCT00853151|456798|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
125819|NCT00853151|456795|P4|Overall Study|Adverse Event|0
125820|NCT00853151|456796|P3|Overall Study|Adverse Event|2
125821|NCT00853151|456797|P2|Overall Study|Adverse Event|4
125822|NCT00853151|456798|P1|Overall Study|Adverse Event|1
125823|NCT00853112|456947|P7|Overall Study|Randomized but not treated|1
125824|NCT00853112|456948|P6|Overall Study|Randomized but not treated|0
125825|NCT00853112|456949|P5|Overall Study|Randomized but not treated|0
125826|NCT00853112|456950|P4|Overall Study|Randomized but not treated|2
125827|NCT00853112|456951|P3|Overall Study|Randomized but not treated|0
125828|NCT00853112|456952|P2|Overall Study|Randomized but not treated|1
125829|NCT00853112|456953|P1|Overall Study|Randomized but not treated|0
125830|NCT00853099|457063|P4|Double-blind + Open-label Periods|Not Specified|6
125831|NCT00853099|457064|P3|Double-blind + Open-label Periods|Not Specified|0
125832|NCT00853099|457065|P2|Double-blind + Open-label Periods|Not Specified|0
125833|NCT00853099|457066|P1|Double-blind + Open-label Periods|Not Specified|0
125834|NCT00853099|457063|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
125835|NCT00853099|457064|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
125836|NCT00853099|457065|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
125837|NCT00853099|457066|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
125838|NCT00853099|457063|P4|Double-blind + Open-label Periods|Adverse Event|47
125839|NCT00853099|457064|P3|Double-blind + Open-label Periods|Adverse Event|0
125840|NCT00853099|457065|P2|Double-blind + Open-label Periods|Adverse Event|0
125841|NCT00853099|457066|P1|Double-blind + Open-label Periods|Adverse Event|0
125842|NCT00853099|457063|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
125843|NCT00853099|457064|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
125844|NCT00853099|457065|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
125845|NCT00853099|457066|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
125846|NCT00853099|457063|P4|Double-blind Period|Mistreated with rescue study drug|0
125847|NCT00853099|457064|P3|Double-blind Period|Mistreated with rescue study drug|1
125848|NCT00853099|457065|P2|Double-blind Period|Mistreated with rescue study drug|0
125849|NCT00853099|457066|P1|Double-blind Period|Mistreated with rescue study drug|0
125850|NCT00853099|457063|P4|Double-blind Period|Not Specified|0
125851|NCT00853099|457064|P3|Double-blind Period|Not Specified|1
125852|NCT00853099|457065|P2|Double-blind Period|Not Specified|0
125853|NCT00853099|457066|P1|Double-blind Period|Not Specified|0
125854|NCT00853099|457063|P4|Double-blind Period|Lack of Efficacy|0
125855|NCT00853099|457064|P3|Double-blind Period|Lack of Efficacy|16
125856|NCT00853099|457065|P2|Double-blind Period|Lack of Efficacy|17
125857|NCT00853099|457066|P1|Double-blind Period|Lack of Efficacy|14
125858|NCT00853099|457063|P4|Double-blind Period|Withdrawal by Subject|0
125859|NCT00853099|457064|P3|Double-blind Period|Withdrawal by Subject|0
125860|NCT00853099|457065|P2|Double-blind Period|Withdrawal by Subject|3
125861|NCT00853099|457066|P1|Double-blind Period|Withdrawal by Subject|2
125862|NCT00853099|457063|P4|Double-blind Period|Adverse Event|0
125863|NCT00853099|457064|P3|Double-blind Period|Adverse Event|13
125864|NCT00853099|457065|P2|Double-blind Period|Adverse Event|9
125865|NCT00853099|457066|P1|Double-blind Period|Adverse Event|7
125866|NCT00853073|457108|P2|Overall Study|Withdrawal by Subject|2
125867|NCT00853073|457109|P1|Overall Study|Withdrawal by Subject|3
125868|NCT00853021|457117|P1|Overall Study|Death|1
125869|NCT00853021|457117|P1|Overall Study|Withdrawal by Subject|2
125870|NCT00853021|457117|P1|Overall Study|Adverse Event|2
125871|NCT00852995|457129|P5|Overall Study|Moved Out of Area|0
125872|NCT00852995|457130|P4|Overall Study|Moved Out of Area|0
125873|NCT00852995|457131|P3|Overall Study|Moved Out of Area|0
125874|NCT00852995|457132|P2|Overall Study|Moved Out of Area|0
125875|NCT00852995|457133|P1|Overall Study|Moved Out of Area|1
125876|NCT00852995|457129|P5|Overall Study|Protocol Violation|1
125877|NCT00852995|457130|P4|Overall Study|Protocol Violation|0
125878|NCT00852995|457131|P3|Overall Study|Protocol Violation|0
125879|NCT00852995|457132|P2|Overall Study|Protocol Violation|0
125880|NCT00852995|457133|P1|Overall Study|Protocol Violation|0
125881|NCT00852995|457129|P5|Overall Study|Physician Decision|0
125882|NCT00852995|457130|P4|Overall Study|Physician Decision|0
125883|NCT00852995|457131|P3|Overall Study|Physician Decision|0
125884|NCT00852995|457132|P2|Overall Study|Physician Decision|0
125885|NCT00852995|457133|P1|Overall Study|Physician Decision|1
125886|NCT00852995|457129|P5|Overall Study|Progressive Disease|1
125887|NCT00852995|457130|P4|Overall Study|Progressive Disease|2
125888|NCT00852995|457131|P3|Overall Study|Progressive Disease|0
125889|NCT00852995|457132|P2|Overall Study|Progressive Disease|0
125890|NCT00852995|457133|P1|Overall Study|Progressive Disease|1
125891|NCT00852995|457129|P5|Overall Study|Non-Compliance|0
125892|NCT00852995|457130|P4|Overall Study|Non-Compliance|2
125893|NCT00852995|457131|P3|Overall Study|Non-Compliance|0
125894|NCT00852995|457132|P2|Overall Study|Non-Compliance|0
125895|NCT00852995|457133|P1|Overall Study|Non-Compliance|0
125896|NCT00852995|457129|P5|Overall Study|Withdrawal by Subject|2
125897|NCT00852995|457130|P4|Overall Study|Withdrawal by Subject|1
125898|NCT00852995|457131|P3|Overall Study|Withdrawal by Subject|0
125899|NCT00852995|457132|P2|Overall Study|Withdrawal by Subject|0
125900|NCT00852995|457133|P1|Overall Study|Withdrawal by Subject|4
125901|NCT00852995|457129|P5|Overall Study|Lost to Follow-up|0
125902|NCT00852995|457130|P4|Overall Study|Lost to Follow-up|0
125903|NCT00852995|457131|P3|Overall Study|Lost to Follow-up|1
125904|NCT00852995|457132|P2|Overall Study|Lost to Follow-up|1
125905|NCT00852995|457133|P1|Overall Study|Lost to Follow-up|0
125906|NCT00852995|457129|P5|Overall Study|Adverse Event|0
125907|NCT00852995|457130|P4|Overall Study|Adverse Event|0
125908|NCT00852995|457131|P3|Overall Study|Adverse Event|4
125909|NCT00852995|457132|P2|Overall Study|Adverse Event|0
125910|NCT00852995|457133|P1|Overall Study|Adverse Event|1
125911|NCT00852969|457177|P2|Overall Study|Lost to Follow-up|1
125912|NCT00852969|457178|P1|Overall Study|Lost to Follow-up|0
125913|NCT00852969|457177|P2|Overall Study|Adverse Event|1
125914|NCT00852969|457178|P1|Overall Study|Adverse Event|0
125915|NCT00852930|457189|P3|Overall Study|Physician Decision|1
125916|NCT00852930|457190|P2|Overall Study|Physician Decision|0
125917|NCT00852930|457191|P1|Overall Study|Physician Decision|0
125918|NCT00852930|457189|P3|Overall Study|Withdrawal by Subject|1
125919|NCT00852930|457190|P2|Overall Study|Withdrawal by Subject|1
125920|NCT00852930|457191|P1|Overall Study|Withdrawal by Subject|1
125921|NCT00852917|457212|P4|Overall Study|Death|1
125922|NCT00852917|457213|P3|Overall Study|Death|0
125923|NCT00852917|457214|P2|Overall Study|Death|0
125924|NCT00852917|457215|P1|Overall Study|Death|0
125925|NCT00852917|457212|P4|Overall Study|Physician Decision|19
125926|NCT00852917|457213|P3|Overall Study|Physician Decision|2
125927|NCT00852917|457214|P2|Overall Study|Physician Decision|7
125928|NCT00852917|457215|P1|Overall Study|Physician Decision|6
125929|NCT00852917|457212|P4|Overall Study|Withdrawal by Subject|9
125930|NCT00852917|457213|P3|Overall Study|Withdrawal by Subject|10
125931|NCT00852917|457214|P2|Overall Study|Withdrawal by Subject|8
125932|NCT00852917|457215|P1|Overall Study|Withdrawal by Subject|4
125933|NCT00852917|457212|P4|Overall Study|Lack of Efficacy|47
125934|NCT00852917|457213|P3|Overall Study|Lack of Efficacy|11
125935|NCT00852917|457214|P2|Overall Study|Lack of Efficacy|11
125936|NCT00852917|457215|P1|Overall Study|Lack of Efficacy|21
125937|NCT00852917|457212|P4|Overall Study|Adverse Event|17
125938|NCT00852917|457213|P3|Overall Study|Adverse Event|35
125939|NCT00852917|457214|P2|Overall Study|Adverse Event|20
125940|NCT00852917|457215|P1|Overall Study|Adverse Event|13
125941|NCT00852540|457343|P2|Overall Study|Did Not Receive Study Drug|3
125942|NCT00852540|457344|P1|Overall Study|Did Not Receive Study Drug|3
125943|NCT00852540|457343|P2|Overall Study|Withdrawal by Subject|1
125944|NCT00852540|457344|P1|Overall Study|Withdrawal by Subject|3
125945|NCT00852540|457343|P2|Overall Study|Investigator Discretion|3
125946|NCT00852540|457344|P1|Overall Study|Investigator Discretion|2
125947|NCT00852540|457343|P2|Overall Study|Lost to Follow-up|3
125948|NCT00852540|457344|P1|Overall Study|Lost to Follow-up|2
125949|NCT00852540|457343|P2|Overall Study|Protocol Violation|2
125950|NCT00852540|457344|P1|Overall Study|Protocol Violation|1
125951|NCT00852540|457343|P2|Overall Study|Lack of Efficacy|3
125952|NCT00852540|457344|P1|Overall Study|Lack of Efficacy|15
125953|NCT00852540|457343|P2|Overall Study|Adverse Event|3
125954|NCT00852540|457344|P1|Overall Study|Adverse Event|10
125955|NCT00852475|457378|P2|Overall Study|Lost to Follow-up|4
125956|NCT00852475|457379|P1|Overall Study|Lost to Follow-up|3
125957|NCT00852397|457390|P3|Overall Study|Protocol Violation|1
125958|NCT00852397|457391|P2|Overall Study|Protocol Violation|0
125959|NCT00852397|457392|P1|Overall Study|Protocol Violation|0
125960|NCT00852397|457390|P3|Overall Study|Difficulty in study site visit|0
125961|NCT00852397|457391|P2|Overall Study|Difficulty in study site visit|0
125962|NCT00852397|457392|P1|Overall Study|Difficulty in study site visit|1
125963|NCT00852397|457390|P3|Overall Study|Study terminated by sponsor|6
125964|NCT00852397|457391|P2|Overall Study|Study terminated by sponsor|1
125965|NCT00852397|457392|P1|Overall Study|Study terminated by sponsor|2
125966|NCT00852397|457390|P3|Overall Study|Withdrawal by Subject|2
125967|NCT00852397|457391|P2|Overall Study|Withdrawal by Subject|1
125968|NCT00852397|457392|P1|Overall Study|Withdrawal by Subject|4
125969|NCT00852397|457390|P3|Overall Study|Death|1
125970|NCT00852397|457391|P2|Overall Study|Death|0
125971|NCT00852397|457392|P1|Overall Study|Death|0
125972|NCT00852397|457390|P3|Overall Study|Adverse Event|4
125973|NCT00852397|457391|P2|Overall Study|Adverse Event|6
125974|NCT00852397|457392|P1|Overall Study|Adverse Event|4
125975|NCT00852241|457421|P1|Overall Study|Physician Decision|18
125976|NCT00851903|457456|P1|Overall Study|Withdrawal by Subject|2
125977|NCT00851890|457470|P4|Overall Study|Lost to Follow-up|1
125978|NCT00851890|457471|P3|Overall Study|Lost to Follow-up|0
125979|NCT00851890|457472|P2|Overall Study|Lost to Follow-up|1
125980|NCT00851890|457473|P1|Overall Study|Lost to Follow-up|0
125981|NCT00851799|457533|P3|Overall Study|Completed protocol due to pregnancy|1
125982|NCT00851799|457534|P2|Overall Study|Completed protocol due to pregnancy|0
125983|NCT00851799|457535|P1|Overall Study|Completed protocol due to pregnancy|0
125984|NCT00851799|457533|P3|Overall Study|Severe Debilitation|0
125985|NCT00851799|457534|P2|Overall Study|Severe Debilitation|1
125986|NCT00851799|457535|P1|Overall Study|Severe Debilitation|0
125987|NCT00851799|457533|P3|Overall Study|Withdrew consent prior study completion|1
125988|NCT00851799|457534|P2|Overall Study|Withdrew consent prior study completion|2
125989|NCT00851799|457535|P1|Overall Study|Withdrew consent prior study completion|1
125990|NCT00851799|457533|P3|Overall Study|Not willing to adhere to requirements|2
125991|NCT00851799|457534|P2|Overall Study|Not willing to adhere to requirements|2
125992|NCT00851799|457535|P1|Overall Study|Not willing to adhere to requirements|1
125993|NCT00851799|457533|P3|Overall Study|Not able to get to clinic|9
125994|NCT00851799|457534|P2|Overall Study|Not able to get to clinic|5
125995|NCT00851799|457535|P1|Overall Study|Not able to get to clinic|8
125996|NCT00851799|457533|P3|Overall Study|Lost to Follow-up|10
125997|NCT00851799|457534|P2|Overall Study|Lost to Follow-up|3
125998|NCT00851799|457535|P1|Overall Study|Lost to Follow-up|5
125999|NCT00851799|457533|P3|Overall Study|Death|1
126000|NCT00851799|457534|P2|Overall Study|Death|0
126001|NCT00851799|457535|P1|Overall Study|Death|1
126002|NCT00851786|457623|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
126003|NCT00851786|457624|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
126004|NCT00851786|457623|P2|Overall Study|Site Closure|0
126005|NCT00851786|457624|P1|Overall Study|Site Closure|1
126006|NCT00851786|457623|P2|Overall Study|Incarceration|0
126007|NCT00851786|457624|P1|Overall Study|Incarceration|1
126008|NCT00851786|457623|P2|Overall Study|Lost to Follow-up|0
126009|NCT00851786|457624|P1|Overall Study|Lost to Follow-up|1
126010|NCT00851786|457623|P2|Overall Study|Protocol Violation|1
126011|NCT00851786|457624|P1|Overall Study|Protocol Violation|0
126012|NCT00851786|457623|P2|Overall Study|Withdrawal by Subject|1
126013|NCT00851786|457624|P1|Overall Study|Withdrawal by Subject|0
126014|NCT00851747|457637|P3|Overall Study|Physician Decision|6
126015|NCT00851747|457638|P2|Overall Study|Physician Decision|6
126016|NCT00851747|457639|P1|Overall Study|Physician Decision|6
126017|NCT00851721|457648|P2|Overall Study|Adverse Event|1
126018|NCT00851721|457649|P1|Overall Study|Adverse Event|0
126019|NCT00851721|457648|P2|Overall Study|Death|0
126020|NCT00851721|457649|P1|Overall Study|Death|1
126021|NCT00851721|457648|P2|Overall Study|planned surgery|0
126022|NCT00851721|457649|P1|Overall Study|planned surgery|1
126023|NCT00851682|457739|P2|Overall Study|screen failure|0
126024|NCT00851682|457740|P1|Overall Study|screen failure|5
126025|NCT00851643|457754|P6|Extension Study (Up to 36 Months)|Moved|1
126026|NCT00851643|457755|P5|Extension Study (Up to 36 Months)|Moved|0
126027|NCT00851643|457756|P4|Extension Study (Up to 36 Months)|Moved|1
126028|NCT00851643|457757|P3|Extension Study (Up to 36 Months)|Moved|1
126029|NCT00851643|457758|P2|Extension Study (Up to 36 Months)|Moved|2
126030|NCT00851643|457759|P1|Extension Study (Up to 36 Months)|Moved|0
126031|NCT00851643|457754|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
126032|NCT00851643|457755|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
126033|NCT00851643|457756|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
126034|NCT00851643|457757|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
126035|NCT00851643|457758|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
126036|NCT00851643|457759|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
126037|NCT00851643|457754|P6|Base Study (Up to 12 Months)|Other|1
126038|NCT00851643|457755|P5|Base Study (Up to 12 Months)|Other|0
126039|NCT00851643|457756|P4|Base Study (Up to 12 Months)|Other|0
126040|NCT00851643|457757|P3|Base Study (Up to 12 Months)|Other|0
126041|NCT00851643|457758|P2|Base Study (Up to 12 Months)|Other|0
126042|NCT00851643|457759|P1|Base Study (Up to 12 Months)|Other|0
126043|NCT00851643|457754|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
126044|NCT00851643|457755|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
126045|NCT00851643|457756|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
126046|NCT00851643|457757|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
126047|NCT00851643|457758|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
126048|NCT00851643|457759|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
126049|NCT00851630|457780|P2|Overall Study|Clinical failure|1
126050|NCT00851630|457781|P1|Overall Study|Clinical failure|0
126051|NCT00851630|457780|P2|Overall Study|Death|1
126052|NCT00851630|457781|P1|Overall Study|Death|2
126053|NCT00851591|457795|P2|Overall Study|Withdrawal by Subject|0
126054|NCT00851591|457796|P1|Overall Study|Withdrawal by Subject|2
126055|NCT00851552|457802|P1|Overall Study|Disease Progression|4
126056|NCT00851552|457802|P1|Overall Study|Adverse Event|1
126057|NCT00851552|457802|P1|Overall Study|Death|2
126058|NCT00851318|457816|P4|Overall Study|Physician Decision|1
126059|NCT00851318|457817|P3|Overall Study|Physician Decision|1
126060|NCT00851318|457818|P2|Overall Study|Physician Decision|0
126061|NCT00851318|457819|P1|Overall Study|Physician Decision|0
126062|NCT00851318|457816|P4|Overall Study|Non-compliance with Study Procedures|0
126063|NCT00851318|457817|P3|Overall Study|Non-compliance with Study Procedures|1
126064|NCT00851318|457818|P2|Overall Study|Non-compliance with Study Procedures|0
126065|NCT00851318|457819|P1|Overall Study|Non-compliance with Study Procedures|2
126066|NCT00851318|457816|P4|Overall Study|Lack of Efficacy|2
126067|NCT00851318|457817|P3|Overall Study|Lack of Efficacy|4
126068|NCT00851318|457818|P2|Overall Study|Lack of Efficacy|2
126069|NCT00851318|457819|P1|Overall Study|Lack of Efficacy|8
126070|NCT00851318|457816|P4|Overall Study|Pregnancy|1
126071|NCT00851318|457817|P3|Overall Study|Pregnancy|1
126072|NCT00851318|457818|P2|Overall Study|Pregnancy|0
126073|NCT00851318|457819|P1|Overall Study|Pregnancy|0
126074|NCT00851318|457816|P4|Overall Study|Adverse Event|12
126075|NCT00851318|457817|P3|Overall Study|Adverse Event|9
126076|NCT00851318|457818|P2|Overall Study|Adverse Event|2
126077|NCT00851318|457819|P1|Overall Study|Adverse Event|13
126078|NCT00851318|457816|P4|Overall Study|Withdrawal by Subject|3
126079|NCT00851318|457817|P3|Overall Study|Withdrawal by Subject|5
126080|NCT00851318|457818|P2|Overall Study|Withdrawal by Subject|1
126081|NCT00851318|457819|P1|Overall Study|Withdrawal by Subject|7
126082|NCT00851253|457855|P2|Overall Study|Disease Progression|0
126083|NCT00851253|457856|P1|Overall Study|Disease Progression|1
126084|NCT00851084|457866|P2|Overall Study|Not specified|1
126085|NCT00851084|457867|P1|Overall Study|Not specified|7
126086|NCT00851084|457866|P2|Overall Study|Metastatic surgery|6
126087|NCT00851084|457867|P1|Overall Study|Metastatic surgery|6
126088|NCT00851084|457866|P2|Overall Study|Withdrawal by Subject|12
126089|NCT00851084|457867|P1|Overall Study|Withdrawal by Subject|11
126090|NCT00851084|457866|P2|Overall Study|Consent withdrawn|2
126091|NCT00851084|457867|P1|Overall Study|Consent withdrawn|0
126092|NCT00851084|457866|P2|Overall Study|Physician Decision|14
126093|NCT00851084|457867|P1|Overall Study|Physician Decision|13
126094|NCT00851084|457866|P2|Overall Study|Poor compliance to protocol|1
126095|NCT00851084|457867|P1|Overall Study|Poor compliance to protocol|1
126096|NCT00851084|457866|P2|Overall Study|Disease progression|47
126097|NCT00851084|457867|P1|Overall Study|Disease progression|52
126098|NCT00851084|457866|P2|Overall Study|Adverse Event|36
126099|NCT00851084|457867|P1|Overall Study|Adverse Event|26
126100|NCT00851084|457866|P2|Overall Study|Randomized but not treated|0
126101|NCT00851084|457867|P1|Overall Study|Randomized but not treated|1
126102|NCT00850759|457927|P4|Overall Study|Lost to Follow-up|3
126103|NCT00850759|457928|P3|Overall Study|Lost to Follow-up|5
126104|NCT00850759|457929|P2|Overall Study|Lost to Follow-up|5
126105|NCT00850759|457930|P1|Overall Study|Lost to Follow-up|7
126106|NCT00850564|458011|P1|Overall Study|Withdrawal by Subject|2
126107|NCT00850538|458016|P1|Overall Study|Protocol Violation|2
126108|NCT00850538|458016|P1|Overall Study|radiology error|2
126109|NCT00850538|458016|P1|Overall Study|Withdrawal by Subject|3
126110|NCT00850538|458016|P1|Overall Study|specimen unusable|7
126111|NCT00850538|458016|P1|Overall Study|specimen missed due to scheduling error|14
126112|NCT00850538|458016|P1|Overall Study|unable/unwilling to complete MRI|13
126113|NCT00850499|458022|P2|Overall Study|Lack of Efficacy|1
126114|NCT00850499|458023|P1|Overall Study|Lack of Efficacy|0
126115|NCT00850499|458022|P2|Overall Study|Adverse Event|1
126116|NCT00850499|458023|P1|Overall Study|Adverse Event|3
126117|NCT00850460|458033|P2|Overall Study|Lost to Follow-up|4
126118|NCT00850460|458034|P1|Overall Study|Lost to Follow-up|4
126119|NCT00850395|458046|P1|Overall Study|Other|5
126120|NCT00850395|458046|P1|Overall Study|Insufficient clinical response|3
126121|NCT00850395|458046|P1|Overall Study|Adverse Event|1
126122|NCT00850395|458046|P1|Overall Study|Death|1
126123|NCT00850343|458066|P4|Overall Study|Physician Decision|1
126124|NCT00850343|458067|P3|Overall Study|Physician Decision|1
126125|NCT00850343|458068|P2|Overall Study|Physician Decision|1
126126|NCT00850343|458069|P1|Overall Study|Physician Decision|2
126127|NCT00850343|458066|P4|Overall Study|Non-compliance with Study Procedures|1
126128|NCT00850343|458067|P3|Overall Study|Non-compliance with Study Procedures|1
126129|NCT00850343|458068|P2|Overall Study|Non-compliance with Study Procedures|0
126130|NCT00850343|458069|P1|Overall Study|Non-compliance with Study Procedures|1
126131|NCT00850343|458066|P4|Overall Study|Lack of Efficacy|2
126132|NCT00850343|458067|P3|Overall Study|Lack of Efficacy|3
126133|NCT00850343|458068|P2|Overall Study|Lack of Efficacy|0
126134|NCT00850343|458069|P1|Overall Study|Lack of Efficacy|17
126135|NCT00850343|458066|P4|Overall Study|Pregnancy|1
126136|NCT00850343|458067|P3|Overall Study|Pregnancy|0
126137|NCT00850343|458068|P2|Overall Study|Pregnancy|0
126138|NCT00850343|458069|P1|Overall Study|Pregnancy|0
126139|NCT00850343|458066|P4|Overall Study|Adverse Event|6
126140|NCT00850343|458067|P3|Overall Study|Adverse Event|6
126141|NCT00850343|458068|P2|Overall Study|Adverse Event|2
126142|NCT00850343|458069|P1|Overall Study|Adverse Event|15
126143|NCT00850343|458066|P4|Overall Study|Withdrawal by Subject|2
126144|NCT00850343|458067|P3|Overall Study|Withdrawal by Subject|3
126145|NCT00850343|458068|P2|Overall Study|Withdrawal by Subject|0
126146|NCT00850343|458069|P1|Overall Study|Withdrawal by Subject|11
126147|NCT00850200|458099|P1|Overall Study|Withdrawal by Subject|1
126148|NCT00850174|458107|P2|Second Intervention|Withdrawal by Subject|0
126149|NCT00850174|458108|P1|Second Intervention|Withdrawal by Subject|1
126150|NCT00850174|458107|P2|Washout: One Week|Withdrawal by Subject|2
126151|NCT00850174|458108|P1|Washout: One Week|Withdrawal by Subject|0
126152|NCT00850135|458122|P1|Overall Study|Physician Decision|1
126153|NCT00850070|458141|P2|Overall Study|Adverse Event|0
126154|NCT00850070|458142|P1|Overall Study|Adverse Event|2
126155|NCT00850070|458141|P2|Overall Study|Lack of Efficacy|1
126156|NCT00850070|458142|P1|Overall Study|Lack of Efficacy|1
126157|NCT00849940|458171|P1|Overall Study|Physician Decision|4
126158|NCT00849901|458182|P3|Extension Phase|Lack of Efficacy|1
126159|NCT00849901|458183|P2|Extension Phase|Lack of Efficacy|4
126160|NCT00849901|458184|P1|Extension Phase|Lack of Efficacy|2
126161|NCT00849901|458182|P3|Extension Phase|Physician Decision|0
126162|NCT00849901|458183|P2|Extension Phase|Physician Decision|2
126163|NCT00849901|458184|P1|Extension Phase|Physician Decision|1
126164|NCT00849901|458182|P3|Extension Phase|Parent or Caregiver Decision|4
126165|NCT00849901|458183|P2|Extension Phase|Parent or Caregiver Decision|4
126166|NCT00849901|458184|P1|Extension Phase|Parent or Caregiver Decision|10
126167|NCT00849901|458182|P3|Extension Phase|Withdrawal by Subject|3
126168|NCT00849901|458183|P2|Extension Phase|Withdrawal by Subject|6
126169|NCT00849901|458184|P1|Extension Phase|Withdrawal by Subject|7
126170|NCT00849901|458182|P3|Extension Phase|Protocol Violation|4
126171|NCT00849901|458183|P2|Extension Phase|Protocol Violation|2
126172|NCT00849901|458184|P1|Extension Phase|Protocol Violation|2
126173|NCT00849901|458182|P3|Extension Phase|Lost to Follow-up|1
126174|NCT00849901|458183|P2|Extension Phase|Lost to Follow-up|0
126175|NCT00849901|458184|P1|Extension Phase|Lost to Follow-up|3
126176|NCT00849901|458182|P3|Extension Phase|Adverse Event|4
126177|NCT00849901|458183|P2|Extension Phase|Adverse Event|8
126178|NCT00849901|458184|P1|Extension Phase|Adverse Event|2
126179|NCT00849901|458182|P3|Acute Treatment Phase|Lack of Efficacy|2
126180|NCT00849901|458183|P2|Acute Treatment Phase|Lack of Efficacy|3
126181|NCT00849901|458184|P1|Acute Treatment Phase|Lack of Efficacy|2
126182|NCT00849901|458182|P3|Acute Treatment Phase|Sponsor Decision|0
126183|NCT00849901|458183|P2|Acute Treatment Phase|Sponsor Decision|0
126184|NCT00849901|458184|P1|Acute Treatment Phase|Sponsor Decision|1
126185|NCT00849901|458182|P3|Acute Treatment Phase|Physician Decision|1
126186|NCT00849901|458183|P2|Acute Treatment Phase|Physician Decision|1
126187|NCT00849901|458184|P1|Acute Treatment Phase|Physician Decision|1
126188|NCT00849901|458182|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
126189|NCT00849901|458183|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
126190|NCT00849901|458184|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
126191|NCT00849901|458182|P3|Acute Treatment Phase|Withdrawal by Subject|4
126192|NCT00849901|458183|P2|Acute Treatment Phase|Withdrawal by Subject|10
126193|NCT00849901|458184|P1|Acute Treatment Phase|Withdrawal by Subject|4
126194|NCT00849901|458182|P3|Acute Treatment Phase|Protocol Violation|1
126195|NCT00849901|458183|P2|Acute Treatment Phase|Protocol Violation|2
126196|NCT00849901|458184|P1|Acute Treatment Phase|Protocol Violation|0
126197|NCT00849901|458182|P3|Acute Treatment Phase|Lost to Follow-up|1
126198|NCT00849901|458183|P2|Acute Treatment Phase|Lost to Follow-up|4
126199|NCT00849901|458184|P1|Acute Treatment Phase|Lost to Follow-up|2
126200|NCT00849901|458182|P3|Acute Treatment Phase|Adverse Event|3
126201|NCT00849901|458183|P2|Acute Treatment Phase|Adverse Event|1
126202|NCT00849901|458184|P1|Acute Treatment Phase|Adverse Event|9
126203|NCT00849875|458231|P1|Overall Study|Lost to Follow-up|2
126204|NCT00849875|458231|P1|Overall Study|Others|6
126205|NCT00849875|458231|P1|Overall Study|Ongoing (unknown completion status)|11
126206|NCT00849875|458231|P1|Overall Study|Death|28
126207|NCT00849797|458328|P2|Washout: One Week|Withdrawal by Subject|2
126208|NCT00849797|458329|P1|Washout: One Week|Withdrawal by Subject|0
126209|NCT00849797|458328|P2|First Intervention|Adverse Event|1
126210|NCT00849797|458329|P1|First Intervention|Adverse Event|0
126211|NCT00849797|458328|P2|First Intervention|bad veins|0
126212|NCT00849797|458329|P1|First Intervention|bad veins|1
126213|NCT00849693|458347|P4|Extension Phase|Lack of Efficacy|1
126214|NCT00849693|458348|P3|Extension Phase|Lack of Efficacy|2
126215|NCT00849693|458349|P2|Extension Phase|Lack of Efficacy|2
126216|NCT00849693|458350|P1|Extension Phase|Lack of Efficacy|2
126217|NCT00849693|458347|P4|Extension Phase|Sponsor decision|1
126218|NCT00849693|458348|P3|Extension Phase|Sponsor decision|0
126219|NCT00849693|458349|P2|Extension Phase|Sponsor decision|0
126220|NCT00849693|458350|P1|Extension Phase|Sponsor decision|1
126221|NCT00849693|458347|P4|Extension Phase|Physician Decision|0
126222|NCT00849693|458348|P3|Extension Phase|Physician Decision|2
126223|NCT00849693|458349|P2|Extension Phase|Physician Decision|1
126224|NCT00849693|458350|P1|Extension Phase|Physician Decision|1
126225|NCT00849693|458347|P4|Extension Phase|Parent or caregiver decision|5
126226|NCT00849693|458348|P3|Extension Phase|Parent or caregiver decision|10
126227|NCT00849693|458349|P2|Extension Phase|Parent or caregiver decision|4
126228|NCT00849693|458350|P1|Extension Phase|Parent or caregiver decision|9
126229|NCT00849693|458347|P4|Extension Phase|Withdrawal by Subject|15
126230|NCT00849693|458348|P3|Extension Phase|Withdrawal by Subject|10
126231|NCT00849693|458349|P2|Extension Phase|Withdrawal by Subject|9
126232|NCT00849693|458350|P1|Extension Phase|Withdrawal by Subject|6
126233|NCT00849693|458347|P4|Extension Phase|Protocol Violation|3
126234|NCT00849693|458348|P3|Extension Phase|Protocol Violation|2
126235|NCT00849693|458349|P2|Extension Phase|Protocol Violation|3
126236|NCT00849693|458350|P1|Extension Phase|Protocol Violation|0
126237|NCT00849693|458347|P4|Extension Phase|Lost to Follow-up|6
126238|NCT00849693|458348|P3|Extension Phase|Lost to Follow-up|6
126239|NCT00849693|458349|P2|Extension Phase|Lost to Follow-up|5
126240|NCT00849693|458350|P1|Extension Phase|Lost to Follow-up|7
126241|NCT00849693|458347|P4|Extension Phase|Adverse Event|7
126242|NCT00849693|458348|P3|Extension Phase|Adverse Event|3
126243|NCT00849693|458349|P2|Extension Phase|Adverse Event|6
126244|NCT00849693|458350|P1|Extension Phase|Adverse Event|4
126245|NCT00849693|458347|P4|Acute Treatment Phase|Lack of Efficacy|2
126246|NCT00849693|458348|P3|Acute Treatment Phase|Lack of Efficacy|1
126247|NCT00849693|458349|P2|Acute Treatment Phase|Lack of Efficacy|3
126248|NCT00849693|458350|P1|Acute Treatment Phase|Lack of Efficacy|1
126249|NCT00849693|458347|P4|Acute Treatment Phase|Sponsor decision|0
126250|NCT00849693|458348|P3|Acute Treatment Phase|Sponsor decision|1
126251|NCT00849693|458349|P2|Acute Treatment Phase|Sponsor decision|0
126252|NCT00849693|458350|P1|Acute Treatment Phase|Sponsor decision|0
126253|NCT00849693|458347|P4|Acute Treatment Phase|Physician Decision|1
126254|NCT00849693|458348|P3|Acute Treatment Phase|Physician Decision|2
126255|NCT00849693|458349|P2|Acute Treatment Phase|Physician Decision|1
126256|NCT00849693|458350|P1|Acute Treatment Phase|Physician Decision|2
126257|NCT00849693|458347|P4|Acute Treatment Phase|Parent or caregiver decision|7
126258|NCT00849693|458348|P3|Acute Treatment Phase|Parent or caregiver decision|7
126259|NCT00849693|458349|P2|Acute Treatment Phase|Parent or caregiver decision|6
126260|NCT00849693|458350|P1|Acute Treatment Phase|Parent or caregiver decision|7
126261|NCT00849693|458347|P4|Acute Treatment Phase|Withdrawal by Subject|8
126262|NCT00849693|458348|P3|Acute Treatment Phase|Withdrawal by Subject|3
126263|NCT00849693|458349|P2|Acute Treatment Phase|Withdrawal by Subject|5
126264|NCT00849693|458350|P1|Acute Treatment Phase|Withdrawal by Subject|5
126265|NCT00849693|458347|P4|Acute Treatment Phase|Protocol Violation|6
126266|NCT00849693|458348|P3|Acute Treatment Phase|Protocol Violation|2
126267|NCT00849693|458349|P2|Acute Treatment Phase|Protocol Violation|5
126268|NCT00849693|458350|P1|Acute Treatment Phase|Protocol Violation|1
126269|NCT00849693|458347|P4|Acute Treatment Phase|Lost to Follow-up|9
126270|NCT00849693|458348|P3|Acute Treatment Phase|Lost to Follow-up|11
126271|NCT00849693|458349|P2|Acute Treatment Phase|Lost to Follow-up|8
126272|NCT00849693|458350|P1|Acute Treatment Phase|Lost to Follow-up|5
126273|NCT00849693|458347|P4|Acute Treatment Phase|Adverse Event|4
126274|NCT00849693|458348|P3|Acute Treatment Phase|Adverse Event|6
126275|NCT00849693|458349|P2|Acute Treatment Phase|Adverse Event|7
126276|NCT00849693|458350|P1|Acute Treatment Phase|Adverse Event|12
126277|NCT00849680|458417|P8|Overall Study|Subject unable to comply with protocol|0
126278|NCT00849680|458418|P7|Overall Study|Subject unable to comply with protocol|0
126279|NCT00849680|458419|P6|Overall Study|Subject unable to comply with protocol|0
126280|NCT00849680|458420|P5|Overall Study|Subject unable to comply with protocol|0
126281|NCT00849680|458421|P4|Overall Study|Subject unable to comply with protocol|0
126282|NCT00849680|458422|P3|Overall Study|Subject unable to comply with protocol|0
126283|NCT00849680|458423|P2|Overall Study|Subject unable to comply with protocol|0
126284|NCT00849680|458424|P1|Overall Study|Subject unable to comply with protocol|1
126285|NCT00849680|458417|P8|Overall Study|Withdrawal by Subject|1
126286|NCT00849680|458418|P7|Overall Study|Withdrawal by Subject|1
126287|NCT00849680|458419|P6|Overall Study|Withdrawal by Subject|2
126288|NCT00849680|458420|P5|Overall Study|Withdrawal by Subject|2
126289|NCT00849680|458421|P4|Overall Study|Withdrawal by Subject|2
126290|NCT00849680|458422|P3|Overall Study|Withdrawal by Subject|0
126291|NCT00849680|458423|P2|Overall Study|Withdrawal by Subject|0
126292|NCT00849680|458424|P1|Overall Study|Withdrawal by Subject|2
126293|NCT00849680|458417|P8|Overall Study|Subject moved|2
126294|NCT00849680|458418|P7|Overall Study|Subject moved|2
126295|NCT00849680|458419|P6|Overall Study|Subject moved|2
126296|NCT00849680|458420|P5|Overall Study|Subject moved|0
126297|NCT00849680|458421|P4|Overall Study|Subject moved|1
126298|NCT00849680|458422|P3|Overall Study|Subject moved|3
126299|NCT00849680|458423|P2|Overall Study|Subject moved|0
126300|NCT00849680|458424|P1|Overall Study|Subject moved|1
126301|NCT00849680|458417|P8|Overall Study|Lost to Follow-up|5
126302|NCT00849680|458418|P7|Overall Study|Lost to Follow-up|12
126303|NCT00849680|458419|P6|Overall Study|Lost to Follow-up|11
126304|NCT00849680|458420|P5|Overall Study|Lost to Follow-up|8
126305|NCT00849680|458421|P4|Overall Study|Lost to Follow-up|11
126306|NCT00849680|458422|P3|Overall Study|Lost to Follow-up|12
126307|NCT00849680|458423|P2|Overall Study|Lost to Follow-up|3
126308|NCT00849680|458424|P1|Overall Study|Lost to Follow-up|7
126309|NCT00849680|458417|P8|Overall Study|Adverse Event|0
126310|NCT00849680|458418|P7|Overall Study|Adverse Event|2
126311|NCT00849680|458419|P6|Overall Study|Adverse Event|0
126312|NCT00849680|458420|P5|Overall Study|Adverse Event|0
126313|NCT00849680|458421|P4|Overall Study|Adverse Event|0
126314|NCT00849680|458422|P3|Overall Study|Adverse Event|0
126315|NCT00849680|458423|P2|Overall Study|Adverse Event|0
126316|NCT00849680|458424|P1|Overall Study|Adverse Event|0
126317|NCT00849524|458466|P1|Overall Study|Lack of Efficacy|3
126318|NCT00849472|458483|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
126319|NCT00849472|458483|P1|Pazopanib Postsurgery Treatment|Moved|1
126320|NCT00849472|458483|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
126321|NCT00849472|458483|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
126322|NCT00849472|458483|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
126323|NCT00849472|458483|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
126324|NCT00849472|458483|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
126325|NCT00849472|458483|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
126326|NCT00849472|458483|P1|Weekly Paclitaxel|Physician Decision|3
126327|NCT00849472|458483|P1|Weekly Paclitaxel|Withdrawal by Subject|1
126328|NCT00849472|458483|P1|Weekly Paclitaxel|Adverse Event|11
126329|NCT00849472|458483|P1|Weekly Paclitaxel|Disease Progression|1
126330|NCT00849472|458483|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
126331|NCT00849472|458483|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
126332|NCT00849472|458483|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
126333|NCT00849472|458483|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
126334|NCT00849472|458483|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
126335|NCT00849381|458497|P1|Overall Study|Other|4
126336|NCT00849381|458497|P1|Overall Study|Withdrawal by Subject|6
126337|NCT00849381|458497|P1|Overall Study|Protocol Violation|5
126338|NCT00849381|458497|P1|Overall Study|Lost to Follow-up|129
126339|NCT00849381|458497|P1|Overall Study|Adverse Event|1
126340|NCT00849290|458503|P1|Overall Study|Disease Progression|20
126341|NCT00849290|458503|P1|Overall Study|Protocol Violation|5
126342|NCT00849290|458503|P1|Overall Study|Lost to Follow-up|2
126343|NCT00849290|458503|P1|Overall Study|Withdrawal by Subject|11
126344|NCT00849290|458503|P1|Overall Study|Death|14
126345|NCT00849290|458503|P1|Overall Study|Adverse Event|3
126346|NCT00849212|458514|P1|Overall Study|Miscellaneous|1
126347|NCT00849212|458514|P1|Overall Study|Adverse Event|2
126348|NCT00849212|458514|P1|Overall Study|Withdrawal by Subject|3
126349|NCT00849212|458514|P1|Overall Study|Lack of Efficacy|1
126350|NCT00849186|458519|P1|Overall Study|Other|1
126351|NCT00849186|458519|P1|Overall Study|not treated|6
126352|NCT00849186|458519|P1|Overall Study|Withdrawal by Subject|1
126353|NCT00849186|458519|P1|Overall Study|Adverse Event|2
126354|NCT00849147|458525|P1|Overall Study|Disease Relapse/Progression|2
126355|NCT00849147|458525|P1|Overall Study|Protocol Violation|2
126356|NCT00849147|458525|P1|Overall Study|Withdrawal by Subject|1
126357|NCT00849108|458558|P2|Cohort 2 Efficacy|Not specified|9
126358|NCT00849108|458559|P1|Cohort 2 Efficacy|Not specified|0
126359|NCT00849108|458558|P2|Cohort 2 Efficacy|Adverse Event|1
126360|NCT00849108|458559|P1|Cohort 2 Efficacy|Adverse Event|0
126361|NCT00849108|458558|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
126362|NCT00849108|458559|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
126363|NCT00849056|458569|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
126364|NCT00849056|458570|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
126365|NCT00849056|458569|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
126366|NCT00849056|458570|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
126367|NCT00849056|458569|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
126368|NCT00849056|458570|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
126369|NCT00849056|458569|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
126370|NCT00849056|458570|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
126371|NCT00849056|458569|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
126372|NCT00849056|458570|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
126373|NCT00849056|458569|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
126374|NCT00849056|458570|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
126375|NCT00849056|458569|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
126376|NCT00849056|458570|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
126377|NCT00849056|458569|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
126378|NCT00849056|458570|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
126379|NCT00849056|458569|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
126380|NCT00849056|458570|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
126381|NCT00849056|458569|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
126382|NCT00849056|458570|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
126383|NCT00849056|458569|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
126384|NCT00849056|458570|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
126385|NCT00849056|458569|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
126386|NCT00849056|458570|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
126387|NCT00849056|458569|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
126388|NCT00849056|458570|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
126389|NCT00849056|458569|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
126390|NCT00849056|458570|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
126391|NCT00849056|458569|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
126392|NCT00849056|458570|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
126393|NCT00849056|458569|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
126394|NCT00849056|458570|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
126395|NCT00849017|458595|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
126396|NCT00849017|458596|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
126397|NCT00849017|458597|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
126398|NCT00849017|458595|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
126399|NCT00849017|458596|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
126400|NCT00849017|458597|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
126401|NCT00849017|458595|P3|Follow-up Period (8 Weeks)|Physician Decision|1
126402|NCT00849017|458596|P2|Follow-up Period (8 Weeks)|Physician Decision|1
126403|NCT00849017|458597|P1|Follow-up Period (8 Weeks)|Physician Decision|0
126404|NCT00849017|458595|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
126405|NCT00849017|458596|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
126406|NCT00849017|458597|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
126407|NCT00849017|458595|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
126408|NCT00849017|458596|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
126409|NCT00849017|458597|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
126410|NCT00849017|458595|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
126411|NCT00849017|458596|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
126412|NCT00849017|458597|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
126413|NCT00849017|458595|P3|Follow-up Period (8 Weeks)|Noncompliance|0
126414|NCT00849017|458596|P2|Follow-up Period (8 Weeks)|Noncompliance|1
126415|NCT00849017|458597|P1|Follow-up Period (8 Weeks)|Noncompliance|2
126416|NCT00849017|458595|P3|Follow-up Period (8 Weeks)|Adverse Event|0
126417|NCT00849017|458596|P2|Follow-up Period (8 Weeks)|Adverse Event|0
126418|NCT00849017|458597|P1|Follow-up Period (8 Weeks)|Adverse Event|1
126419|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
126420|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
126421|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
126422|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Pregnancy|1
126423|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Pregnancy|0
126424|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Pregnancy|1
126425|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
126426|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
126427|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
126428|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
126429|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
126430|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
126431|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
126432|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
126433|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
126434|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
126435|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
126436|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
126437|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Physician Decision|1
126438|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Physician Decision|2
126439|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Physician Decision|0
126440|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
126441|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
126442|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
126443|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
126444|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
126445|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
126446|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Noncompliance|4
126447|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Noncompliance|3
126448|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Noncompliance|3
126449|NCT00849017|458595|P3|Treatment Period (156 Weeks)|Adverse Event|15
126450|NCT00849017|458596|P2|Treatment Period (156 Weeks)|Adverse Event|6
126451|NCT00849017|458597|P1|Treatment Period (156 Weeks)|Adverse Event|5
126452|NCT00848965|458640|P1|Overall Study|Withdrawal by Subject|1
126453|NCT00848965|458640|P1|Overall Study|Adverse Event|1
126454|NCT00848926|458682|P1|Follow-up Period|Not specified|2
126455|NCT00848926|458682|P1|Follow-up Period|Withdrawal by Subject|3
126456|NCT00848926|458682|P1|Follow-up Period|Lost to Follow-up|7
126457|NCT00848926|458682|P1|Treatment Period|Withdrawal by Subject|7
126458|NCT00848926|458682|P1|Treatment Period|Physician Decision|12
126459|NCT00848926|458682|P1|Treatment Period|Adverse Event|20
126460|NCT00848926|458682|P1|Treatment Period|Progressive disease|45
126461|NCT00848549|458721|P2|E2090-E044-314 (Extension Study)|Not Specified|6
126462|NCT00848549|458722|P1|E2090-E044-314 (Extension Study)|Not Specified|5
126463|NCT00848549|458721|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
126464|NCT00848549|458722|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
126465|NCT00848549|458721|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
126466|NCT00848549|458722|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
126467|NCT00848549|458721|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
126468|NCT00848549|458722|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
126469|NCT00848549|458721|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
126470|NCT00848549|458722|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
126471|NCT00848549|458721|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
126472|NCT00848549|458722|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
126473|NCT00848549|458721|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
126474|NCT00848549|458722|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
126475|NCT00848549|458721|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
126476|NCT00848549|458722|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
126477|NCT00848549|458721|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
126478|NCT00848549|458722|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
126479|NCT00848549|458721|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
126480|NCT00848549|458722|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
126481|NCT00848549|458721|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
126482|NCT00848549|458722|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
126483|NCT00848549|458721|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
126484|NCT00848549|458722|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
126485|NCT00848549|458721|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
126486|NCT00848549|458722|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
126487|NCT00848549|458721|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
126488|NCT00848549|458722|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
126489|NCT00848536|458740|P2|Overall Study|Patient Moved|2
126490|NCT00848536|458741|P1|Overall Study|Patient Moved|0
126491|NCT00848536|458740|P2|Overall Study|Inadequate Control of IOP|1
126492|NCT00848536|458741|P1|Overall Study|Inadequate Control of IOP|1
126493|NCT00848536|458740|P2|Overall Study|Noncompliance|0
126494|NCT00848536|458741|P1|Overall Study|Noncompliance|1
126495|NCT00848536|458740|P2|Overall Study|Protocol Violation|1
126496|NCT00848536|458741|P1|Overall Study|Protocol Violation|0
126497|NCT00848536|458740|P2|Overall Study|Withdrawal by Subject|1
126498|NCT00848536|458741|P1|Overall Study|Withdrawal by Subject|0
126499|NCT00848536|458740|P2|Overall Study|Adverse Event|2
126500|NCT00848536|458741|P1|Overall Study|Adverse Event|2
126501|NCT00848497|458806|P2|Overall Study|Withdrawal by Subject|1
126502|NCT00848497|458807|P1|Overall Study|Withdrawal by Subject|0
126503|NCT00848497|458806|P2|Overall Study|Screen failure|0
126504|NCT00848497|458807|P1|Overall Study|Screen failure|2
126505|NCT00848484|458821|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
126506|NCT00848484|458822|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
126507|NCT00848484|458821|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
126508|NCT00848484|458822|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
126509|NCT00848484|458821|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
126510|NCT00848484|458822|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
126511|NCT00848484|458821|P2|First Intervention (Treatment Period 1)|Physician Decision|1
126512|NCT00848484|458822|P1|First Intervention (Treatment Period 1)|Physician Decision|0
126513|NCT00848484|458821|P2|First Intervention (Treatment Period 1)|Adverse Event|1
126514|NCT00848484|458822|P1|First Intervention (Treatment Period 1)|Adverse Event|2
126515|NCT00848354|458851|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
126516|NCT00848354|458852|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
126517|NCT00848354|458851|P2|Phase 2 Year 2|Subject Request|1
126518|NCT00848354|458852|P1|Phase 2 Year 2|Subject Request|1
126519|NCT00848354|458851|P2|Phase 2 Year 2|Protocol Violation|1
126520|NCT00848354|458852|P1|Phase 2 Year 2|Protocol Violation|1
126521|NCT00848354|458851|P2|Phase 2 Year 2|Unspecified Reason|0
126522|NCT00848354|458852|P1|Phase 2 Year 2|Unspecified Reason|1
126523|NCT00848354|458851|P2|Phase 2 Year 2|Lost to Follow-up|3
126524|NCT00848354|458852|P1|Phase 2 Year 2|Lost to Follow-up|1
126525|NCT00848354|458851|P2|Phase 2 Year 2|Failed to return|0
126526|NCT00848354|458852|P1|Phase 2 Year 2|Failed to return|3
126527|NCT00848354|458851|P2|Phase 2 Year 2|Death|0
126528|NCT00848354|458852|P1|Phase 2 Year 2|Death|2
126529|NCT00848354|458851|P2|Phase 2 Year 2|Adverse Event|2
126530|NCT00848354|458852|P1|Phase 2 Year 2|Adverse Event|12
126531|NCT00848354|458851|P2|Phase 2 Year 1|Subject Request|2
126532|NCT00848354|458852|P1|Phase 2 Year 1|Subject Request|1
126533|NCT00848354|458851|P2|Phase 2 Year 1|Protocol Violation|1
126534|NCT00848354|458852|P1|Phase 2 Year 1|Protocol Violation|4
126535|NCT00848354|458851|P2|Phase 2 Year 1|Unspecified Reason|0
126536|NCT00848354|458852|P1|Phase 2 Year 1|Unspecified Reason|3
126537|NCT00848354|458851|P2|Phase 2 Year 1|Lost to Follow-up|0
126538|NCT00848354|458852|P1|Phase 2 Year 1|Lost to Follow-up|1
126539|NCT00848354|458851|P2|Phase 2 Year 1|Failed to Return|1
126540|NCT00848354|458852|P1|Phase 2 Year 1|Failed to Return|1
126541|NCT00848354|458851|P2|Phase 2 Year 1|Death|0
126542|NCT00848354|458852|P1|Phase 2 Year 1|Death|1
126543|NCT00848354|458851|P2|Phase 2 Year 1|Adverse Event|2
126544|NCT00848354|458852|P1|Phase 2 Year 1|Adverse Event|7
126545|NCT00848354|458851|P2|Phase 1|Lack of Efficacy|1
126546|NCT00848354|458852|P1|Phase 1|Lack of Efficacy|0
126547|NCT00848354|458851|P2|Phase 1|Withdrawal by Subject|4
126548|NCT00848354|458852|P1|Phase 1|Withdrawal by Subject|2
126549|NCT00848354|458851|P2|Phase 1|Protocol Violation|1
126550|NCT00848354|458852|P1|Phase 1|Protocol Violation|1
126551|NCT00848354|458851|P2|Phase 1|Unspecified Reason|1
126552|NCT00848354|458852|P1|Phase 1|Unspecified Reason|1
126553|NCT00848354|458851|P2|Phase 1|Lost to Follow-up|1
126554|NCT00848354|458852|P1|Phase 1|Lost to Follow-up|1
126555|NCT00848354|458851|P2|Phase 1|Failed to return|1
126556|NCT00848354|458852|P1|Phase 1|Failed to return|0
126557|NCT00848354|458851|P2|Phase 1|Discontinuation of study by sponsor|1
126558|NCT00848354|458852|P1|Phase 1|Discontinuation of study by sponsor|2
126559|NCT00848354|458851|P2|Phase 1|Adverse Event|4
126560|NCT00848354|458852|P1|Phase 1|Adverse Event|5
126561|NCT00848250|459004|P2|Overall Study|surgery was completed without cardiopulm|1
126562|NCT00848250|459005|P1|Overall Study|surgery was completed without cardiopulm|0
126563|NCT00848211|459036|P4|Overall Study|Adverse Event|0
126564|NCT00848211|459037|P3|Overall Study|Adverse Event|0
126565|NCT00848211|459038|P2|Overall Study|Adverse Event|0
126566|NCT00848211|459039|P1|Overall Study|Adverse Event|0
126567|NCT00848211|459036|P4|Overall Study|Protocol Violation|0
126568|NCT00848211|459037|P3|Overall Study|Protocol Violation|1
126569|NCT00848211|459038|P2|Overall Study|Protocol Violation|1
126570|NCT00848211|459039|P1|Overall Study|Protocol Violation|0
126571|NCT00848198|459057|P1|Overall Study|Incomplete Case Report Forms|15
126572|NCT00848120|459122|P1|Overall Study|Adverse Event|1
126573|NCT00848107|459134|P1|Overall Study|Pregnancy|1
126574|NCT00848107|459134|P1|Overall Study|Death|1
126575|NCT00848107|459134|P1|Overall Study|Adverse Event|9
126576|NCT00848107|459134|P1|Overall Study|Withdrawal by Subject|8
126577|NCT00848107|459134|P1|Overall Study|Lost to Follow-up|2
126578|NCT00848081|459144|P2|Overall Study|Withdrawal by Subject|3
126579|NCT00848081|459145|P1|Overall Study|Withdrawal by Subject|5
126580|NCT00848081|459144|P2|Overall Study|Physician Decision|3
126581|NCT00848081|459145|P1|Overall Study|Physician Decision|0
126582|NCT00848081|459144|P2|Overall Study|Lost to Follow-up|0
126583|NCT00848081|459145|P1|Overall Study|Lost to Follow-up|1
126584|NCT00848081|459144|P2|Overall Study|Protocol Violation|5
126585|NCT00848081|459145|P1|Overall Study|Protocol Violation|8
126586|NCT00848081|459144|P2|Overall Study|Adverse Event|7
126587|NCT00848081|459145|P1|Overall Study|Adverse Event|6
126588|NCT00848042|459162|P3|Overall Study|Other Therapy|0
126589|NCT00848042|459163|P2|Overall Study|Other Therapy|0
126590|NCT00848042|459164|P1|Overall Study|Other Therapy|3
126591|NCT00848042|459162|P3|Overall Study|Death|0
126592|NCT00848042|459163|P2|Overall Study|Death|2
126593|NCT00848042|459164|P1|Overall Study|Death|1
126594|NCT00847912|459183|P2|Overall Study|Withdrawal by Subject|6
126595|NCT00847912|459184|P1|Overall Study|Withdrawal by Subject|3
126596|NCT00847912|459183|P2|Overall Study|Protocol Violation|7
126597|NCT00847912|459184|P1|Overall Study|Protocol Violation|6
126598|NCT00847886|459194|P2|Overall Study|Adverse Event|1
126599|NCT00847886|459195|P1|Overall Study|Adverse Event|0
126600|NCT00847808|459221|P1|Overall Study|Participant Took Excluded Medication|1
126601|NCT00847808|459221|P1|Overall Study|Participant Reported Lack of Efficacy|1
126602|NCT00847808|459221|P1|Overall Study|Withdrawal by Subject|4
126603|NCT00847808|459221|P1|Overall Study|Lost to Follow-up|1
126604|NCT00847808|459221|P1|Overall Study|Protocol Violation|1
126605|NCT00847808|459221|P1|Overall Study|Adverse Event|7
126606|NCT00847704|459238|P1|Overall Study|Withdrawal by Subject|1
126607|NCT00847665|459249|P2|Overall Study|Withdrawal by Subject|0
126608|NCT00847665|459250|P1|Overall Study|Withdrawal by Subject|1
126609|NCT00847626|459273|P11|Overall Study|Other|3
126610|NCT00847626|459274|P10|Overall Study|Other|1
126611|NCT00847626|459275|P9|Overall Study|Other|1
126612|NCT00847626|459276|P8|Overall Study|Other|3
126613|NCT00847626|459277|P7|Overall Study|Other|2
126614|NCT00847626|459278|P6|Overall Study|Other|2
126615|NCT00847626|459279|P5|Overall Study|Other|2
126616|NCT00847626|459280|P4|Overall Study|Other|1
126617|NCT00847626|459281|P3|Overall Study|Other|4
126618|NCT00847626|459282|P2|Overall Study|Other|5
126619|NCT00847626|459283|P1|Overall Study|Other|1
126620|NCT00847626|459273|P11|Overall Study|Lack of Efficacy|7
126621|NCT00847626|459274|P10|Overall Study|Lack of Efficacy|1
126622|NCT00847626|459275|P9|Overall Study|Lack of Efficacy|5
126623|NCT00847626|459276|P8|Overall Study|Lack of Efficacy|2
126624|NCT00847626|459277|P7|Overall Study|Lack of Efficacy|6
126625|NCT00847626|459278|P6|Overall Study|Lack of Efficacy|0
126626|NCT00847626|459279|P5|Overall Study|Lack of Efficacy|2
126627|NCT00847626|459280|P4|Overall Study|Lack of Efficacy|1
126628|NCT00847626|459281|P3|Overall Study|Lack of Efficacy|0
126629|NCT00847626|459282|P2|Overall Study|Lack of Efficacy|1
126630|NCT00847626|459283|P1|Overall Study|Lack of Efficacy|3
126631|NCT00847626|459273|P11|Overall Study|Withdrawal by Subject|2
126632|NCT00847626|459274|P10|Overall Study|Withdrawal by Subject|5
126633|NCT00847626|459275|P9|Overall Study|Withdrawal by Subject|4
126634|NCT00847626|459276|P8|Overall Study|Withdrawal by Subject|4
126635|NCT00847626|459277|P7|Overall Study|Withdrawal by Subject|8
126636|NCT00847626|459278|P6|Overall Study|Withdrawal by Subject|9
126637|NCT00847626|459279|P5|Overall Study|Withdrawal by Subject|12
126638|NCT00847626|459280|P4|Overall Study|Withdrawal by Subject|8
126639|NCT00847626|459281|P3|Overall Study|Withdrawal by Subject|3
126640|NCT00847626|459282|P2|Overall Study|Withdrawal by Subject|5
126641|NCT00847626|459283|P1|Overall Study|Withdrawal by Subject|5
126642|NCT00847626|459273|P11|Overall Study|Lost to Follow-up|1
126643|NCT00847626|459274|P10|Overall Study|Lost to Follow-up|0
126644|NCT00847626|459275|P9|Overall Study|Lost to Follow-up|1
126645|NCT00847626|459276|P8|Overall Study|Lost to Follow-up|3
126646|NCT00847626|459277|P7|Overall Study|Lost to Follow-up|1
126647|NCT00847626|459278|P6|Overall Study|Lost to Follow-up|3
126648|NCT00847626|459279|P5|Overall Study|Lost to Follow-up|0
126649|NCT00847626|459280|P4|Overall Study|Lost to Follow-up|1
126650|NCT00847626|459281|P3|Overall Study|Lost to Follow-up|1
126651|NCT00847626|459282|P2|Overall Study|Lost to Follow-up|1
126652|NCT00847626|459283|P1|Overall Study|Lost to Follow-up|0
126653|NCT00847626|459273|P11|Overall Study|Protocol Violation|1
126654|NCT00847626|459274|P10|Overall Study|Protocol Violation|1
126655|NCT00847626|459275|P9|Overall Study|Protocol Violation|0
126656|NCT00847626|459276|P8|Overall Study|Protocol Violation|1
126657|NCT00847626|459277|P7|Overall Study|Protocol Violation|1
126658|NCT00847626|459278|P6|Overall Study|Protocol Violation|1
126659|NCT00847626|459279|P5|Overall Study|Protocol Violation|1
126660|NCT00847626|459280|P4|Overall Study|Protocol Violation|1
126661|NCT00847626|459281|P3|Overall Study|Protocol Violation|2
126662|NCT00847626|459282|P2|Overall Study|Protocol Violation|1
126663|NCT00847626|459283|P1|Overall Study|Protocol Violation|2
126664|NCT00847626|459273|P11|Overall Study|Adverse Event|6
126665|NCT00847626|459274|P10|Overall Study|Adverse Event|6
126666|NCT00847626|459275|P9|Overall Study|Adverse Event|3
126667|NCT00847626|459276|P8|Overall Study|Adverse Event|6
126668|NCT00847626|459277|P7|Overall Study|Adverse Event|4
126669|NCT00847626|459278|P6|Overall Study|Adverse Event|22
126670|NCT00847626|459279|P5|Overall Study|Adverse Event|11
126671|NCT00847626|459280|P4|Overall Study|Adverse Event|19
126672|NCT00847626|459281|P3|Overall Study|Adverse Event|6
126673|NCT00847626|459282|P2|Overall Study|Adverse Event|10
126674|NCT00847626|459283|P1|Overall Study|Adverse Event|10
126675|NCT00847613|459482|P4|Overall Study|Other|0
126676|NCT00847613|459483|P3|Overall Study|Other|2
126677|NCT00847613|459484|P2|Overall Study|Other|1
126678|NCT00847613|459485|P1|Overall Study|Other|1
126679|NCT00847613|459482|P4|Overall Study|Randomized, but not treated|0
126680|NCT00847613|459483|P3|Overall Study|Randomized, but not treated|0
126681|NCT00847613|459484|P2|Overall Study|Randomized, but not treated|3
126682|NCT00847613|459485|P1|Overall Study|Randomized, but not treated|0
126683|NCT00847613|459482|P4|Overall Study|Sponsor request|0
126684|NCT00847613|459483|P3|Overall Study|Sponsor request|0
126685|NCT00847613|459484|P2|Overall Study|Sponsor request|1
126686|NCT00847613|459485|P1|Overall Study|Sponsor request|0
126687|NCT00847613|459482|P4|Overall Study|Participant moved|0
126688|NCT00847613|459483|P3|Overall Study|Participant moved|0
126689|NCT00847613|459484|P2|Overall Study|Participant moved|1
126690|NCT00847613|459485|P1|Overall Study|Participant moved|4
126691|NCT00847613|459482|P4|Overall Study|Withdrawal by Subject|2
126692|NCT00847613|459483|P3|Overall Study|Withdrawal by Subject|2
126693|NCT00847613|459484|P2|Overall Study|Withdrawal by Subject|11
126694|NCT00847613|459485|P1|Overall Study|Withdrawal by Subject|8
126695|NCT00847613|459482|P4|Overall Study|Site closure|1
126696|NCT00847613|459483|P3|Overall Study|Site closure|0
126697|NCT00847613|459484|P2|Overall Study|Site closure|0
126698|NCT00847613|459485|P1|Overall Study|Site closure|1
126699|NCT00847613|459482|P4|Overall Study|Pregnancy|0
126700|NCT00847613|459483|P3|Overall Study|Pregnancy|0
126701|NCT00847613|459484|P2|Overall Study|Pregnancy|1
126702|NCT00847613|459485|P1|Overall Study|Pregnancy|1
126703|NCT00847613|459482|P4|Overall Study|Protocol Violation|1
126704|NCT00847613|459483|P3|Overall Study|Protocol Violation|3
126705|NCT00847613|459484|P2|Overall Study|Protocol Violation|6
126706|NCT00847613|459485|P1|Overall Study|Protocol Violation|6
126707|NCT00847613|459482|P4|Overall Study|Lost to Follow-up|3
126708|NCT00847613|459483|P3|Overall Study|Lost to Follow-up|0
126709|NCT00847613|459484|P2|Overall Study|Lost to Follow-up|0
126710|NCT00847613|459485|P1|Overall Study|Lost to Follow-up|5
126711|NCT00847613|459482|P4|Overall Study|Study terminated by Sponsor|1
126712|NCT00847613|459483|P3|Overall Study|Study terminated by Sponsor|2
126713|NCT00847613|459484|P2|Overall Study|Study terminated by Sponsor|0
126714|NCT00847613|459485|P1|Overall Study|Study terminated by Sponsor|1
126715|NCT00847613|459482|P4|Overall Study|Lack of Efficacy|1
126716|NCT00847613|459483|P3|Overall Study|Lack of Efficacy|3
126717|NCT00847613|459484|P2|Overall Study|Lack of Efficacy|3
126718|NCT00847613|459485|P1|Overall Study|Lack of Efficacy|7
126719|NCT00847613|459482|P4|Overall Study|Adverse Event|6
126720|NCT00847613|459483|P3|Overall Study|Adverse Event|5
126721|NCT00847613|459484|P2|Overall Study|Adverse Event|26
126722|NCT00847613|459485|P1|Overall Study|Adverse Event|36
126723|NCT00847613|459482|P4|Overall Study|Death|0
126724|NCT00847613|459483|P3|Overall Study|Death|0
126725|NCT00847613|459484|P2|Overall Study|Death|1
126726|NCT00847613|459485|P1|Overall Study|Death|1
126727|NCT00847613|459482|P4|Overall Study|Ongoing at cut-off date|64
126728|NCT00847613|459483|P3|Overall Study|Ongoing at cut-off date|64
126729|NCT00847613|459484|P2|Overall Study|Ongoing at cut-off date|265
126730|NCT00847613|459485|P1|Overall Study|Ongoing at cut-off date|250
126731|NCT00847561|459736|P2|Overall Study|Unable to schedule|1
126732|NCT00847561|459737|P1|Overall Study|Unable to schedule|9
126733|NCT00847561|459736|P2|Overall Study|Withdrawal by Subject|3
126734|NCT00847561|459737|P1|Overall Study|Withdrawal by Subject|4
126735|NCT00847535|459743|P3|Overall Study|Lost to Follow-up|0
126736|NCT00847535|459744|P2|Overall Study|Lost to Follow-up|1
126737|NCT00847535|459745|P1|Overall Study|Lost to Follow-up|0
126738|NCT00847535|459743|P3|Overall Study|Withdrawal by Subject|1
126739|NCT00847535|459744|P2|Overall Study|Withdrawal by Subject|1
126740|NCT00847535|459745|P1|Overall Study|Withdrawal by Subject|2
126741|NCT00847405|459764|P2|Washout of 7 Days|Withdrawal by Subject|0
126742|NCT00847405|459765|P1|Washout of 7 Days|Withdrawal by Subject|1
126743|NCT00847405|459764|P2|First Intervention|Adverse Event|1
126744|NCT00847405|459765|P1|First Intervention|Adverse Event|0
126745|NCT00847301|459773|P1|Overall Study|Other reason not defined above|1
126746|NCT00847301|459773|P1|Overall Study|No prescription after hospital discharge|1
126747|NCT00847301|459773|P1|Overall Study|Lost to Follow-up|1
126748|NCT00847301|459773|P1|Overall Study|Switch to other anticoagulants|16
126749|NCT00847301|459773|P1|Overall Study|Adverse Event|35
126750|NCT00847197|459821|P2|Overall Study|Withdrawal by Subject|1
126751|NCT00847197|459822|P1|Overall Study|Withdrawal by Subject|3
126752|NCT00847197|459821|P2|Overall Study|Protocol Violation|1
126753|NCT00847197|459822|P1|Overall Study|Protocol Violation|0
126754|NCT00847197|459821|P2|Overall Study|Adverse Event|3
126755|NCT00847197|459822|P1|Overall Study|Adverse Event|21
126756|NCT00847145|459840|P8|Overall Study|Protocol Violation|1
126757|NCT00847145|459841|P7|Overall Study|Protocol Violation|0
126758|NCT00847145|459842|P6|Overall Study|Protocol Violation|0
126759|NCT00847145|459843|P5|Overall Study|Protocol Violation|1
126760|NCT00847145|459844|P4|Overall Study|Protocol Violation|0
126761|NCT00847145|459845|P3|Overall Study|Protocol Violation|3
126762|NCT00847145|459846|P2|Overall Study|Protocol Violation|0
126763|NCT00847145|459847|P1|Overall Study|Protocol Violation|0
126764|NCT00847145|459840|P8|Overall Study|Inappropriate enrollment|0
126765|NCT00847145|459841|P7|Overall Study|Inappropriate enrollment|0
126766|NCT00847145|459842|P6|Overall Study|Inappropriate enrollment|0
126767|NCT00847145|459843|P5|Overall Study|Inappropriate enrollment|1
126768|NCT00847145|459844|P4|Overall Study|Inappropriate enrollment|0
126769|NCT00847145|459845|P3|Overall Study|Inappropriate enrollment|0
126770|NCT00847145|459846|P2|Overall Study|Inappropriate enrollment|0
126771|NCT00847145|459847|P1|Overall Study|Inappropriate enrollment|0
126772|NCT00847145|459840|P8|Overall Study|Lost to Follow-up|2
126773|NCT00847145|459841|P7|Overall Study|Lost to Follow-up|8
126774|NCT00847145|459842|P6|Overall Study|Lost to Follow-up|4
126775|NCT00847145|459843|P5|Overall Study|Lost to Follow-up|4
126776|NCT00847145|459844|P4|Overall Study|Lost to Follow-up|0
126777|NCT00847145|459845|P3|Overall Study|Lost to Follow-up|1
126778|NCT00847145|459846|P2|Overall Study|Lost to Follow-up|1
126779|NCT00847145|459847|P1|Overall Study|Lost to Follow-up|3
126780|NCT00847145|459840|P8|Overall Study|Withdrawal by Subject|1
126781|NCT00847145|459841|P7|Overall Study|Withdrawal by Subject|1
126782|NCT00847145|459842|P6|Overall Study|Withdrawal by Subject|0
126783|NCT00847145|459843|P5|Overall Study|Withdrawal by Subject|0
126784|NCT00847145|459844|P4|Overall Study|Withdrawal by Subject|1
126785|NCT00847145|459845|P3|Overall Study|Withdrawal by Subject|6
126786|NCT00847145|459846|P2|Overall Study|Withdrawal by Subject|4
126787|NCT00847145|459847|P1|Overall Study|Withdrawal by Subject|3
126788|NCT00847145|459840|P8|Overall Study|AE or Death|0
126789|NCT00847145|459841|P7|Overall Study|AE or Death|0
126790|NCT00847145|459842|P6|Overall Study|AE or Death|0
126791|NCT00847145|459843|P5|Overall Study|AE or Death|0
126792|NCT00847145|459844|P4|Overall Study|AE or Death|0
126793|NCT00847145|459845|P3|Overall Study|AE or Death|1
126794|NCT00847145|459846|P2|Overall Study|AE or Death|1
126795|NCT00847145|459847|P1|Overall Study|AE or Death|0
126796|NCT00847132|459897|P2|Overall Study|Death|1
126797|NCT00847132|459898|P1|Overall Study|Death|1
126798|NCT00847015|459906|P1|Overall Study|partial cystectomy vs radical cystectomy|1
126799|NCT00847015|459906|P1|Overall Study|declined any surgery|1
126800|NCT00847015|459906|P1|Overall Study|Withdrawal by Subject|1
126801|NCT00846846|459934|P1|Overall Study|Withdrawal by Subject|19
126802|NCT00846846|459934|P1|Overall Study|Death|56
126803|NCT00846807|459939|P1|Overall Study|Other|60
126804|NCT00846807|459939|P1|Overall Study|No prescription after hospital discharge|56
126805|NCT00846807|459939|P1|Overall Study|Switch to other anticoagulants|89
126806|NCT00846807|459939|P1|Overall Study|Non compliant with European label|7
126807|NCT00846807|459939|P1|Overall Study|Withdrawal by Subject|56
126808|NCT00846807|459939|P1|Overall Study|Lost to Follow-up|94
126809|NCT00846807|459939|P1|Overall Study|Adverse Event|270
126810|NCT00846768|459947|P4|Overall Study|Adverse Event|0
126811|NCT00846768|459948|P3|Overall Study|Adverse Event|0
126812|NCT00846768|459949|P2|Overall Study|Adverse Event|1
126813|NCT00846768|459950|P1|Overall Study|Adverse Event|0
126814|NCT00846586|460041|P2|Overall Study|Unsatisfactory therapeutic effect|1
126815|NCT00846586|460042|P1|Overall Study|Unsatisfactory therapeutic effect|0
126816|NCT00846586|460041|P2|Overall Study|Lost to Follow-up|4
126817|NCT00846586|460042|P1|Overall Study|Lost to Follow-up|1
126818|NCT00846586|460041|P2|Overall Study|Abnormal test procedure result(s)|0
126819|NCT00846586|460042|P1|Overall Study|Abnormal test procedure result(s)|1
126820|NCT00846586|460041|P2|Overall Study|Protocol deviation|6
126821|NCT00846586|460042|P1|Overall Study|Protocol deviation|2
126822|NCT00846586|460041|P2|Overall Study|Death|0
126823|NCT00846586|460042|P1|Overall Study|Death|2
126824|NCT00846586|460041|P2|Overall Study|Administrative problems|4
126825|NCT00846586|460042|P1|Overall Study|Administrative problems|5
126826|NCT00846586|460041|P2|Overall Study|Subject withdrew consent|10
126827|NCT00846586|460042|P1|Overall Study|Subject withdrew consent|8
126828|NCT00846586|460041|P2|Overall Study|Adverse Event|10
126829|NCT00846586|460042|P1|Overall Study|Adverse Event|20
126830|NCT00846521|460076|P1|Overall Study|Protocol Violation|1
126831|NCT00846521|460076|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
126832|NCT00846521|460076|P1|Overall Study|Withdrawal by Subject|5
126833|NCT00846495|460083|P2|Overall Study|Physician Decision|0
126834|NCT00846495|460084|P1|Overall Study|Physician Decision|1
126835|NCT00846495|460083|P2|Overall Study|Lack of Efficacy|2
126836|NCT00846495|460084|P1|Overall Study|Lack of Efficacy|1
126837|NCT00846495|460083|P2|Overall Study|Adverse Event|1
126838|NCT00846495|460084|P1|Overall Study|Adverse Event|5
126839|NCT00846495|460083|P2|Overall Study|Lost to Follow-up|0
126840|NCT00846495|460084|P1|Overall Study|Lost to Follow-up|1
126841|NCT00846391|460107|P3|Overall Study|Study Terminated by Sponsor|2
126842|NCT00846391|460108|P2|Overall Study|Study Terminated by Sponsor|2
126843|NCT00846391|460109|P1|Overall Study|Study Terminated by Sponsor|1
126844|NCT00846391|460107|P3|Overall Study|Physician Decision|1
126845|NCT00846391|460108|P2|Overall Study|Physician Decision|0
126846|NCT00846391|460109|P1|Overall Study|Physician Decision|0
126847|NCT00846365|460120|P3|Overall Study|Other|6
126848|NCT00846365|460121|P2|Overall Study|Other|1
126849|NCT00846365|460122|P1|Overall Study|Other|9
126850|NCT00846365|460120|P3|Overall Study|Lack of Efficacy|2
126851|NCT00846365|460121|P2|Overall Study|Lack of Efficacy|1
126852|NCT00846365|460122|P1|Overall Study|Lack of Efficacy|1
126853|NCT00846365|460120|P3|Overall Study|Pregnancy|0
126854|NCT00846365|460121|P2|Overall Study|Pregnancy|0
126855|NCT00846365|460122|P1|Overall Study|Pregnancy|1
126856|NCT00846365|460120|P3|Overall Study|Withdrawal by Subject|9
126857|NCT00846365|460121|P2|Overall Study|Withdrawal by Subject|11
126858|NCT00846365|460122|P1|Overall Study|Withdrawal by Subject|11
126859|NCT00846365|460120|P3|Overall Study|Lost to Follow-up|5
126860|NCT00846365|460121|P2|Overall Study|Lost to Follow-up|2
126861|NCT00846365|460122|P1|Overall Study|Lost to Follow-up|8
126862|NCT00846365|460120|P3|Overall Study|Protocol Violation|0
126863|NCT00846365|460121|P2|Overall Study|Protocol Violation|4
126864|NCT00846365|460122|P1|Overall Study|Protocol Violation|5
126865|NCT00846365|460120|P3|Overall Study|Adverse Event|11
126866|NCT00846365|460121|P2|Overall Study|Adverse Event|30
126867|NCT00846365|460122|P1|Overall Study|Adverse Event|20
126868|NCT00846027|460201|P1|Overall Study|Subject Not Treated|7
126869|NCT00846027|460201|P1|Overall Study|Protocol Violation|2
126870|NCT00846027|460201|P1|Overall Study|Investigator Discretion|29
126871|NCT00846027|460201|P1|Overall Study|Patient Decision|7
126872|NCT00846027|460201|P1|Overall Study|Toxicity|12
126873|NCT00846027|460201|P1|Overall Study|Disease Progression|30
126874|NCT00846027|460201|P1|Overall Study|Death|3
126875|NCT00845897|460224|P3|Overall Study|Too ill to participate|0
126876|NCT00845897|460225|P2|Overall Study|Too ill to participate|1
126877|NCT00845897|460226|P1|Overall Study|Too ill to participate|0
126878|NCT00845897|460224|P3|Overall Study|Ulcer did not heal|1
126879|NCT00845897|460225|P2|Overall Study|Ulcer did not heal|0
126880|NCT00845897|460226|P1|Overall Study|Ulcer did not heal|1
126881|NCT00845897|460224|P3|Overall Study|Withdrawal by Subject|2
126882|NCT00845897|460225|P2|Overall Study|Withdrawal by Subject|3
126883|NCT00845897|460226|P1|Overall Study|Withdrawal by Subject|0
126884|NCT00845897|460224|P3|Overall Study|Lost to Follow-up|0
126885|NCT00845897|460225|P2|Overall Study|Lost to Follow-up|1
126886|NCT00845897|460226|P1|Overall Study|Lost to Follow-up|1
126887|NCT00845858|460240|P3|Overall Study|not eligible|2
126888|NCT00845858|460241|P2|Overall Study|not eligible|3
126889|NCT00845858|460242|P1|Overall Study|not eligible|0
126890|NCT00845858|460240|P3|Overall Study|Protocol Violation|1
126891|NCT00845858|460241|P2|Overall Study|Protocol Violation|0
126892|NCT00845858|460242|P1|Overall Study|Protocol Violation|0
126893|NCT00845858|460240|P3|Overall Study|Adverse Event|4
126894|NCT00845858|460241|P2|Overall Study|Adverse Event|8
126895|NCT00845858|460242|P1|Overall Study|Adverse Event|3
126896|NCT00845858|460240|P3|Overall Study|Withdrawal by Subject|1
126897|NCT00845858|460241|P2|Overall Study|Withdrawal by Subject|1
126898|NCT00845858|460242|P1|Overall Study|Withdrawal by Subject|5
126899|NCT00845845|460255|P2|Overall Study|Lost to Follow-up|4
126900|NCT00845845|460256|P1|Overall Study|Lost to Follow-up|0
126901|NCT00845832|460267|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
126902|NCT00845832|460268|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
126903|NCT00845832|460269|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
126904|NCT00845832|460267|P3|Safety Follow-Up|Withdrawal by Subject|0
126905|NCT00845832|460268|P2|Safety Follow-Up|Withdrawal by Subject|0
126906|NCT00845832|460269|P1|Safety Follow-Up|Withdrawal by Subject|1
126907|NCT00845832|460267|P3|Treatment Period|Protocol Violation|0
126908|NCT00845832|460268|P2|Treatment Period|Protocol Violation|1
126909|NCT00845832|460269|P1|Treatment Period|Protocol Violation|1
126910|NCT00845832|460267|P3|Treatment Period|Adverse Event|0
126911|NCT00845832|460268|P2|Treatment Period|Adverse Event|2
126912|NCT00845832|460269|P1|Treatment Period|Adverse Event|0
126913|NCT00845728|460315|P2|Overall Study|Withdrawal by Subject|108
126914|NCT00845728|460316|P1|Overall Study|Withdrawal by Subject|105
126915|NCT00845728|460315|P2|Overall Study|Adverse Event|96
126916|NCT00845728|460316|P1|Overall Study|Adverse Event|101
126917|NCT00845728|460315|P2|Overall Study|Lack of Efficacy|39
126918|NCT00845728|460316|P1|Overall Study|Lack of Efficacy|51
126919|NCT00845728|460315|P2|Overall Study|Protocol Violation|24
126920|NCT00845728|460316|P1|Overall Study|Protocol Violation|36
126921|NCT00845728|460315|P2|Overall Study|Administrative Problems|26
126922|NCT00845728|460316|P1|Overall Study|Administrative Problems|34
126923|NCT00845728|460315|P2|Overall Study|Death|26
126924|NCT00845728|460316|P1|Overall Study|Death|24
126925|NCT00845728|460315|P2|Overall Study|Lost to Follow-up|13
126926|NCT00845728|460316|P1|Overall Study|Lost to Follow-up|22
126927|NCT00845728|460315|P2|Overall Study|Abnormal test procedure result (s)|2
126928|NCT00845728|460316|P1|Overall Study|Abnormal test procedure result (s)|7
126929|NCT00845728|460315|P2|Overall Study|Patient's inability to use the device|6
126930|NCT00845728|460316|P1|Overall Study|Patient's inability to use the device|4
126931|NCT00845728|460315|P2|Overall Study|Abnormal laboratory value (s)|2
126932|NCT00845728|460316|P1|Overall Study|Abnormal laboratory value (s)|2
126933|NCT00845676|460330|P1|Overall Study|Adverse Event|1
126934|NCT00845676|460330|P1|Overall Study|Virologic breakthrough at week 20|1
126935|NCT00845429|460408|P3|Overall Study|Serious adverse event|1
126936|NCT00845429|460409|P2|Overall Study|Serious adverse event|0
126937|NCT00845429|460410|P1|Overall Study|Serious adverse event|0
126938|NCT00845429|460408|P3|Overall Study|Withdrawal by Subject|2
126939|NCT00845429|460409|P2|Overall Study|Withdrawal by Subject|2
126940|NCT00845429|460410|P1|Overall Study|Withdrawal by Subject|2
126941|NCT00845429|460408|P3|Overall Study|Lost to Follow-up|10
126942|NCT00845429|460409|P2|Overall Study|Lost to Follow-up|9
126943|NCT00845429|460410|P1|Overall Study|Lost to Follow-up|7
126944|NCT00845429|460408|P3|Overall Study|Protocol Violation|7
126945|NCT00845429|460409|P2|Overall Study|Protocol Violation|4
126946|NCT00845429|460410|P1|Overall Study|Protocol Violation|5
126947|NCT00845182|460445|P3|Overall Study|Physician Decision|1
126948|NCT00845182|460446|P2|Overall Study|Physician Decision|0
126949|NCT00845182|460447|P1|Overall Study|Physician Decision|0
126950|NCT00845182|460445|P3|Overall Study|Adverse Event|1
126951|NCT00845182|460446|P2|Overall Study|Adverse Event|1
126952|NCT00845182|460447|P1|Overall Study|Adverse Event|0
126953|NCT00845182|460445|P3|Overall Study|Lost to Follow-up|4
126954|NCT00845182|460446|P2|Overall Study|Lost to Follow-up|3
126955|NCT00845182|460447|P1|Overall Study|Lost to Follow-up|3
126956|NCT00845065|460472|P2|Overall Study|Non-Medical Reasons|11
126957|NCT00845065|460473|P1|Overall Study|Non-Medical Reasons|1
126958|NCT00845065|460472|P2|Overall Study|Lack of Efficacy|21
126959|NCT00845065|460473|P1|Overall Study|Lack of Efficacy|43
126960|NCT00845065|460472|P2|Overall Study|Adverse Event|23
126961|NCT00845065|460473|P1|Overall Study|Adverse Event|3
126962|NCT00844896|460517|P2|Overall Study|Parents did not have time to complete|1
126963|NCT00844896|460518|P1|Overall Study|Parents did not have time to complete|0
126964|NCT00844896|460517|P2|Overall Study|Lost to Follow-up|16
126965|NCT00844896|460518|P1|Overall Study|Lost to Follow-up|12
126966|NCT00844883|460540|P1|Overall Study|Bridged to resection|1
126967|NCT00844883|460540|P1|Overall Study|Bridged to liver transplant|3
126968|NCT00844857|460552|P2|Overall Study|Good Clinical Practice Violations|11
126969|NCT00844857|460553|P1|Overall Study|Good Clinical Practice Violations|21
126970|NCT00844857|460552|P2|Overall Study|Did Not Take Study Drug|1
126971|NCT00844857|460553|P1|Overall Study|Did Not Take Study Drug|3
126972|NCT00844857|460552|P2|Overall Study|Lost to Follow-up|3
126973|NCT00844857|460553|P1|Overall Study|Lost to Follow-up|2
126974|NCT00844857|460552|P2|Overall Study|Entry Criteria Not Met|1
126975|NCT00844857|460553|P1|Overall Study|Entry Criteria Not Met|0
126976|NCT00844857|460552|P2|Overall Study|Clinical Relapse|1
126977|NCT00844857|460553|P1|Overall Study|Clinical Relapse|0
126978|NCT00844857|460552|P2|Overall Study|Lack of Efficacy|5
126979|NCT00844857|460553|P1|Overall Study|Lack of Efficacy|5
126980|NCT00844857|460552|P2|Overall Study|Protocol Violation|0
126981|NCT00844857|460553|P1|Overall Study|Protocol Violation|6
126982|NCT00844857|460552|P2|Overall Study|Withdrawal by Subject|7
126983|NCT00844857|460553|P1|Overall Study|Withdrawal by Subject|8
126984|NCT00844857|460552|P2|Overall Study|Parent/Caregiver Decision|2
126985|NCT00844857|460553|P1|Overall Study|Parent/Caregiver Decision|6
126986|NCT00844857|460552|P2|Overall Study|Physician Decision|0
126987|NCT00844857|460553|P1|Overall Study|Physician Decision|2
126988|NCT00844857|460552|P2|Overall Study|Sponsor Decision|1
126989|NCT00844857|460553|P1|Overall Study|Sponsor Decision|1
126990|NCT00844857|460552|P2|Overall Study|Adverse Event|5
126991|NCT00844857|460553|P1|Overall Study|Adverse Event|24
126992|NCT00844844|460597|P1|Post Treatment Period|Withdrawal by Subject|1
126993|NCT00844844|460597|P1|Extension Treatment Period|Adverse Event|2
126994|NCT00844844|460597|P1|Treatment Period (26 Weeks)|Protocol Violation|1
126995|NCT00844844|460597|P1|Treatment Period (26 Weeks)|Adverse Event|1
126996|NCT00844831|460611|P1|Overall Study|Physician Decision|1
126997|NCT00844831|460611|P1|Overall Study|Adverse Event|1
126998|NCT00844831|460611|P1|Overall Study|Withdrawal by Subject|4
126999|NCT00844805|460621|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
127000|NCT00844805|460622|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
127001|NCT00844805|460623|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
127002|NCT00844805|460624|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
127003|NCT00844805|460621|P4|Follow-Up Phase|Relapse/Recurrence|4
127004|NCT00844805|460622|P3|Follow-Up Phase|Relapse/Recurrence|2
127005|NCT00844805|460623|P2|Follow-Up Phase|Relapse/Recurrence|0
127006|NCT00844805|460624|P1|Follow-Up Phase|Relapse/Recurrence|0
127007|NCT00844805|460621|P4|Follow-Up Phase|Noncompliance With Protocol|1
127008|NCT00844805|460622|P3|Follow-Up Phase|Noncompliance With Protocol|0
127009|NCT00844805|460623|P2|Follow-Up Phase|Noncompliance With Protocol|0
127010|NCT00844805|460624|P1|Follow-Up Phase|Noncompliance With Protocol|0
127011|NCT00844805|460621|P4|Follow-Up Phase|Withdrawal by Subject|3
127012|NCT00844805|460622|P3|Follow-Up Phase|Withdrawal by Subject|6
127013|NCT00844805|460623|P2|Follow-Up Phase|Withdrawal by Subject|0
127014|NCT00844805|460624|P1|Follow-Up Phase|Withdrawal by Subject|0
127015|NCT00844805|460621|P4|Follow-Up Phase|Adverse Event|0
127016|NCT00844805|460622|P3|Follow-Up Phase|Adverse Event|1
127017|NCT00844805|460623|P2|Follow-Up Phase|Adverse Event|0
127018|NCT00844805|460624|P1|Follow-Up Phase|Adverse Event|0
127019|NCT00844805|460621|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
127020|NCT00844805|460622|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
127021|NCT00844805|460623|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
127022|NCT00844805|460624|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
127023|NCT00844805|460621|P4|Treatment Phase|Noncompliance With Protocol|0
127024|NCT00844805|460622|P3|Treatment Phase|Noncompliance With Protocol|0
127025|NCT00844805|460623|P2|Treatment Phase|Noncompliance With Protocol|0
127026|NCT00844805|460624|P1|Treatment Phase|Noncompliance With Protocol|1
127027|NCT00844805|460621|P4|Treatment Phase|Withdrawal by Subject|0
127028|NCT00844805|460622|P3|Treatment Phase|Withdrawal by Subject|0
127029|NCT00844805|460623|P2|Treatment Phase|Withdrawal by Subject|4
127030|NCT00844805|460624|P1|Treatment Phase|Withdrawal by Subject|3
127031|NCT00844805|460621|P4|Treatment Phase|Adverse Event|0
127032|NCT00844805|460622|P3|Treatment Phase|Adverse Event|0
127033|NCT00844805|460623|P2|Treatment Phase|Adverse Event|1
127034|NCT00844805|460624|P1|Treatment Phase|Adverse Event|5
127035|NCT00844753|460668|P4|Overall Study|Withdrawal by Subject|3
127036|NCT00844753|460669|P3|Overall Study|Withdrawal by Subject|0
127037|NCT00844753|460670|P2|Overall Study|Withdrawal by Subject|0
127038|NCT00844753|460671|P1|Overall Study|Withdrawal by Subject|1
127039|NCT00844753|460668|P4|Overall Study|could not swallow medication|0
127040|NCT00844753|460669|P3|Overall Study|could not swallow medication|0
127041|NCT00844753|460670|P2|Overall Study|could not swallow medication|0
127042|NCT00844753|460671|P1|Overall Study|could not swallow medication|2
127043|NCT00844753|460668|P4|Overall Study|Lost to Follow-up|1
127044|NCT00844753|460669|P3|Overall Study|Lost to Follow-up|0
127045|NCT00844753|460670|P2|Overall Study|Lost to Follow-up|1
127046|NCT00844753|460671|P1|Overall Study|Lost to Follow-up|1
127047|NCT00844753|460668|P4|Overall Study|Adverse Event|5
127048|NCT00844753|460669|P3|Overall Study|Adverse Event|5
127049|NCT00844753|460670|P2|Overall Study|Adverse Event|2
127050|NCT00844753|460671|P1|Overall Study|Adverse Event|3
127051|NCT00844753|460668|P4|Overall Study|Lack of Efficacy|2
127052|NCT00844753|460669|P3|Overall Study|Lack of Efficacy|2
127053|NCT00844753|460670|P2|Overall Study|Lack of Efficacy|0
127054|NCT00844753|460671|P1|Overall Study|Lack of Efficacy|1
127055|NCT00844649|460689|P2|Overall Study|Withdrew prior to starting treatment|27
127056|NCT00844649|460690|P1|Overall Study|Withdrew prior to starting treatment|11
127057|NCT00844649|460689|P2|Overall Study|Other|10
127058|NCT00844649|460690|P1|Overall Study|Other|7
127059|NCT00844649|460689|P2|Overall Study|Withdrawal by Subject|39
127060|NCT00844649|460690|P1|Overall Study|Withdrawal by Subject|28
127061|NCT00844649|460689|P2|Overall Study|Protocol Violation|6
127062|NCT00844649|460690|P1|Overall Study|Protocol Violation|10
127063|NCT00844649|460689|P2|Overall Study|Physician Decision|18
127064|NCT00844649|460690|P1|Overall Study|Physician Decision|25
127065|NCT00844649|460689|P2|Overall Study|Adverse Event|73
127066|NCT00844649|460690|P1|Overall Study|Adverse Event|128
127067|NCT00844649|460689|P2|Overall Study|Progressive Disease|245
127068|NCT00844649|460690|P1|Overall Study|Progressive Disease|196
127069|NCT00844597|460714|P6|Overall Study|Adverse Event|0
127070|NCT00844597|460715|P5|Overall Study|Adverse Event|0
127071|NCT00844597|460716|P4|Overall Study|Adverse Event|1
127072|NCT00844597|460717|P3|Overall Study|Adverse Event|0
127073|NCT00844597|460718|P2|Overall Study|Adverse Event|0
127074|NCT00844597|460719|P1|Overall Study|Adverse Event|0
127075|NCT00844558|460739|P2|Overall Study|Physician Decision|0
127076|NCT00844558|460740|P1|Overall Study|Physician Decision|1
127077|NCT00844558|460739|P2|Overall Study|Lost to Follow-up|1
127078|NCT00844558|460740|P1|Overall Study|Lost to Follow-up|0
127079|NCT00844558|460739|P2|Overall Study|Protocol Violation|1
127080|NCT00844558|460740|P1|Overall Study|Protocol Violation|1
127081|NCT00844558|460739|P2|Overall Study|Death|0
127082|NCT00844558|460740|P1|Overall Study|Death|1
127083|NCT00844558|460739|P2|Overall Study|Withdrawal by Subject|2
127084|NCT00844558|460740|P1|Overall Study|Withdrawal by Subject|9
127085|NCT00844545|460756|P1|Post Treatment Period|Withdrawal by Subject|1
127086|NCT00844545|460756|P1|Extension Treatment Period|Adverse Event|2
127087|NCT00844545|460756|P1|Treatment Period (26 Weeks)|Protocol Violation|1
127088|NCT00844545|460756|P1|Treatment Period (26 Weeks)|Adverse Event|1
127089|NCT00844532|460770|P1|Overall Study|Lost to Follow-up|7
127090|NCT00844532|460770|P1|Overall Study|Withdrawal by Subject|16
127091|NCT00844532|460770|P1|Overall Study|Death|16
127092|NCT00844519|460856|P2|Overall Study|Adverse Event|0
127093|NCT00844519|460857|P1|Overall Study|Adverse Event|1
127094|NCT00844519|460856|P2|Overall Study|Withdrawal by Subject|1
127095|NCT00844519|460857|P1|Overall Study|Withdrawal by Subject|1
127096|NCT00844480|460865|P2|Overall Study|Withdrawal by Subject|3
127097|NCT00844480|460866|P1|Overall Study|Withdrawal by Subject|2
127098|NCT00844428|460874|P1|Post Treatment Period (Patients Who Disc|Death|1
127099|NCT00844428|460874|P1|Extension Treatment Period|Death|1
127100|NCT00844428|460874|P1|Screening Period|Screen Failure|3
127101|NCT00844415|460890|P1|Overall Study|Withdrawal by Subject|1
127102|NCT00844376|460904|P2|Period 1: First Intervention|Withdrawal by Subject|0
127103|NCT00844376|460905|P1|Period 1: First Intervention|Withdrawal by Subject|1
127104|NCT00844194|460929|P2|Overall Study|Other reason (not specified)|0
127105|NCT00844194|460930|P1|Overall Study|Other reason (not specified)|1
127106|NCT00844194|460929|P2|Overall Study|Lack of Efficacy|0
127107|NCT00844194|460930|P1|Overall Study|Lack of Efficacy|3
127108|NCT00844194|460929|P2|Overall Study|Withdrawal by Subject|1
127109|NCT00844194|460930|P1|Overall Study|Withdrawal by Subject|2
127110|NCT00844194|460929|P2|Overall Study|Lost to Follow-up|1
127111|NCT00844194|460930|P1|Overall Study|Lost to Follow-up|1
127112|NCT00844194|460929|P2|Overall Study|Protocol Violation|1
127113|NCT00844194|460930|P1|Overall Study|Protocol Violation|1
127114|NCT00844194|460929|P2|Overall Study|Adverse Event|5
127115|NCT00844194|460930|P1|Overall Study|Adverse Event|17
127116|NCT00843843|461185|P2|Overall Study|Protocol Violation|1
127117|NCT00843843|461186|P1|Overall Study|Protocol Violation|1
127118|NCT00843843|461185|P2|Overall Study|Physician Decision|1
127119|NCT00843843|461186|P1|Overall Study|Physician Decision|1
127120|NCT00843778|461199|P1|Overall Study|Withdrawal by Subject|4
127121|NCT00843778|461199|P1|Overall Study|Loss of efficacy|2
127122|NCT00843778|461199|P1|Overall Study|Lack of Efficacy|14
127123|NCT00843778|461199|P1|Overall Study|Adverse Event|15
127124|NCT00843635|461244|P3|Overall Study|Adverse Event|0
127125|NCT00843635|461245|P2|Overall Study|Adverse Event|2
127126|NCT00843635|461246|P1|Overall Study|Adverse Event|2
127127|NCT00843518|461275|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
127128|NCT00843518|461276|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
127129|NCT00843518|461275|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
127130|NCT00843518|461276|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
127131|NCT00843518|461275|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
127132|NCT00843518|461276|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
127133|NCT00843518|461275|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
127134|NCT00843518|461276|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
127135|NCT00843518|461275|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
127136|NCT00843518|461276|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
127137|NCT00843518|461275|P2|Period 2 (Double-blind Treatment)|Death|1
127138|NCT00843518|461276|P1|Period 2 (Double-blind Treatment)|Death|0
127139|NCT00843518|461275|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
127140|NCT00843518|461276|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
127141|NCT00843492|461306|P2|Overall Study|Deep-vein Thrombosis|0
127142|NCT00843492|461307|P1|Overall Study|Deep-vein Thrombosis|1
127143|NCT00843492|461306|P2|Overall Study|Visit Not Performed|0
127144|NCT00843492|461307|P1|Overall Study|Visit Not Performed|1
127145|NCT00843492|461306|P2|Overall Study|Orthopedic Surgery|2
127146|NCT00843492|461307|P1|Overall Study|Orthopedic Surgery|0
127147|NCT00843492|461306|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
127148|NCT00843492|461307|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
127149|NCT00843492|461306|P2|Overall Study|Immobilization Stopped|0
127150|NCT00843492|461307|P1|Overall Study|Immobilization Stopped|1
127151|NCT00843492|461306|P2|Overall Study|Withdrawal by Subject|4
127152|NCT00843492|461307|P1|Overall Study|Withdrawal by Subject|0
127153|NCT00843492|461306|P2|Overall Study|Lost to Follow-up|4
127154|NCT00843492|461307|P1|Overall Study|Lost to Follow-up|4
127155|NCT00843492|461306|P2|Overall Study|Adverse Event|3
127156|NCT00843492|461307|P1|Overall Study|Adverse Event|0
127157|NCT00843284|461378|P1|Overall Study|Death|3
127158|NCT00843284|461378|P1|Overall Study|Withdrawal by Subject|4
127159|NCT00843284|461378|P1|Overall Study|Other|10
127160|NCT00843284|461378|P1|Overall Study|Lost to Follow-up|11
127161|NCT00843284|461378|P1|Overall Study|Lack of Efficacy|5
127162|NCT00843284|461378|P1|Overall Study|Adverse Event|39
127163|NCT00843193|461388|P2|Overall Study|Withdrawal by Subject|3
127164|NCT00843193|461389|P1|Overall Study|Withdrawal by Subject|3
127165|NCT00843193|461388|P2|Overall Study|Physician Decision|1
127166|NCT00843193|461389|P1|Overall Study|Physician Decision|0
127167|NCT00843193|461388|P2|Overall Study|Lost to Follow-up|0
127168|NCT00843193|461389|P1|Overall Study|Lost to Follow-up|1
127169|NCT00843193|461388|P2|Overall Study|Protocol Violation|2
127170|NCT00843193|461389|P1|Overall Study|Protocol Violation|1
127171|NCT00843193|461388|P2|Overall Study|Lack of Efficacy|1
127172|NCT00843193|461389|P1|Overall Study|Lack of Efficacy|1
127173|NCT00843193|461388|P2|Overall Study|Adverse Event|4
127174|NCT00843193|461389|P1|Overall Study|Adverse Event|2
127175|NCT00843167|461440|P2|Treatment Period|Withdrawal by Subject|3
127176|NCT00843167|461441|P1|Treatment Period|Withdrawal by Subject|2
127177|NCT00843167|461440|P2|Treatment Period|Adverse Event|5
127178|NCT00843167|461441|P1|Treatment Period|Adverse Event|1
127179|NCT00843115|461454|P1|Overall Study|Syndrome De Glissement|1
127180|NCT00843115|461454|P1|Overall Study|week 12 not done|1
127181|NCT00843115|461454|P1|Overall Study|hospitalized due to deterioration|1
127182|NCT00843115|461454|P1|Overall Study|patient never took the medication|1
127183|NCT00843115|461454|P1|Overall Study|patient took for 2 days then stopped|1
127184|NCT00843115|461454|P1|Overall Study|Family discontinued meds|1
127185|NCT00843115|461454|P1|Overall Study|Physician Decision|1
127186|NCT00843115|461454|P1|Overall Study|Does not meet entrance criteria|1
127187|NCT00843115|461454|P1|Overall Study|Patient forgot to take meds|1
127188|NCT00843115|461454|P1|Overall Study|Family does not want continuation|1
127189|NCT00843115|461454|P1|Overall Study|Family wanted meds stopped|1
127190|NCT00843115|461454|P1|Overall Study|Withdrawal by Subject|17
127191|NCT00843115|461454|P1|Overall Study|Lost to Follow-up|4
127192|NCT00843115|461454|P1|Overall Study|Adverse Event|30
127193|NCT00843115|461454|P1|Overall Study|Death|4
127194|NCT00843024|461510|P6|Double-blind Treatment Phase|Lack of Efficacy|0
127195|NCT00843024|461511|P5|Double-blind Treatment Phase|Lack of Efficacy|1
127196|NCT00843024|461512|P4|Double-blind Treatment Phase|Lack of Efficacy|0
127197|NCT00843024|461513|P3|Double-blind Treatment Phase|Lack of Efficacy|0
127198|NCT00843024|461514|P2|Double-blind Treatment Phase|Lack of Efficacy|0
127199|NCT00843024|461515|P1|Double-blind Treatment Phase|Lack of Efficacy|0
127200|NCT00843024|461510|P6|Double-blind Treatment Phase|Adverse Event|1
127201|NCT00843024|461511|P5|Double-blind Treatment Phase|Adverse Event|1
127202|NCT00843024|461512|P4|Double-blind Treatment Phase|Adverse Event|0
127203|NCT00843024|461513|P3|Double-blind Treatment Phase|Adverse Event|0
127204|NCT00843024|461514|P2|Double-blind Treatment Phase|Adverse Event|0
127205|NCT00843024|461515|P1|Double-blind Treatment Phase|Adverse Event|0
127206|NCT00843024|461510|P6|Double-blind Treatment Phase|Physician Decision|1
127207|NCT00843024|461511|P5|Double-blind Treatment Phase|Physician Decision|1
127208|NCT00843024|461512|P4|Double-blind Treatment Phase|Physician Decision|3
127209|NCT00843024|461513|P3|Double-blind Treatment Phase|Physician Decision|0
127210|NCT00843024|461514|P2|Double-blind Treatment Phase|Physician Decision|0
127211|NCT00843024|461515|P1|Double-blind Treatment Phase|Physician Decision|0
127212|NCT00843024|461510|P6|Double-blind Treatment Phase|Protocol Violation|3
127213|NCT00843024|461511|P5|Double-blind Treatment Phase|Protocol Violation|0
127214|NCT00843024|461512|P4|Double-blind Treatment Phase|Protocol Violation|0
127215|NCT00843024|461513|P3|Double-blind Treatment Phase|Protocol Violation|3
127216|NCT00843024|461514|P2|Double-blind Treatment Phase|Protocol Violation|0
127217|NCT00843024|461515|P1|Double-blind Treatment Phase|Protocol Violation|0
127218|NCT00843024|461510|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
127219|NCT00843024|461511|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
127220|NCT00843024|461512|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
127221|NCT00843024|461513|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
127222|NCT00843024|461514|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
127223|NCT00843024|461515|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
127224|NCT00843024|461510|P6|Double-blind Treatment Phase|Lost to Follow-up|4
127225|NCT00843024|461511|P5|Double-blind Treatment Phase|Lost to Follow-up|4
127226|NCT00843024|461512|P4|Double-blind Treatment Phase|Lost to Follow-up|4
127227|NCT00843024|461513|P3|Double-blind Treatment Phase|Lost to Follow-up|8
127228|NCT00843024|461514|P2|Double-blind Treatment Phase|Lost to Follow-up|0
127229|NCT00843024|461515|P1|Double-blind Treatment Phase|Lost to Follow-up|0
127230|NCT00843024|461510|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
127231|NCT00843024|461511|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
127232|NCT00843024|461512|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
127233|NCT00843024|461513|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
127234|NCT00843024|461514|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
127235|NCT00843024|461515|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
127236|NCT00843024|461510|P6|Single-blind Placebo Run-In Phase|Other|0
127237|NCT00843024|461511|P5|Single-blind Placebo Run-In Phase|Other|0
127238|NCT00843024|461512|P4|Single-blind Placebo Run-In Phase|Other|0
127239|NCT00843024|461513|P3|Single-blind Placebo Run-In Phase|Other|0
127240|NCT00843024|461514|P2|Single-blind Placebo Run-In Phase|Other|1
127241|NCT00843024|461515|P1|Single-blind Placebo Run-In Phase|Other|0
127242|NCT00843024|461510|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
127243|NCT00843024|461511|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
127244|NCT00843024|461512|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
127245|NCT00843024|461513|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
127246|NCT00843024|461514|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
127247|NCT00843024|461515|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
127248|NCT00843024|461510|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
127249|NCT00843024|461511|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
127250|NCT00843024|461512|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
127251|NCT00843024|461513|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
127252|NCT00843024|461514|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
127253|NCT00843024|461515|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
127254|NCT00843024|461510|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
127255|NCT00843024|461511|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
127256|NCT00843024|461512|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
127257|NCT00843024|461513|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
127258|NCT00843024|461514|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
127259|NCT00843024|461515|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
127260|NCT00843024|461510|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
127261|NCT00843024|461511|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
127262|NCT00843024|461512|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
127263|NCT00843024|461513|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
127264|NCT00843024|461514|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
127265|NCT00843024|461515|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
127266|NCT00843024|461510|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
127267|NCT00843024|461511|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
127268|NCT00843024|461512|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
127269|NCT00843024|461513|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
127270|NCT00843024|461514|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
127271|NCT00843024|461515|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
127272|NCT00843024|461510|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
127273|NCT00843024|461511|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
127274|NCT00843024|461512|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
127275|NCT00843024|461513|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
127276|NCT00843024|461514|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
127277|NCT00843024|461515|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
127278|NCT00842985|461580|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
127279|NCT00842985|461580|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
127280|NCT00842985|461580|P1|First Intervention|Protocol Violation|3
127281|NCT00842985|461580|P1|First Intervention|Withdrawal by Subject|3
127282|NCT00842985|461580|P1|Screening|Did not meet entrance requirements|27
127283|NCT00842829|461598|P3|Continuation Period|Non-compliance to study drug|1
127284|NCT00842829|461599|P2|Continuation Period|Non-compliance to study drug|0
127285|NCT00842829|461600|P1|Continuation Period|Non-compliance to study drug|0
127286|NCT00842829|461598|P3|Continuation Period|Non-compliance to study procedures|2
127287|NCT00842829|461599|P2|Continuation Period|Non-compliance to study procedures|0
127288|NCT00842829|461600|P1|Continuation Period|Non-compliance to study procedures|0
127289|NCT00842829|461598|P3|Continuation Period|Not specified|7
127290|NCT00842829|461599|P2|Continuation Period|Not specified|0
127291|NCT00842829|461600|P1|Continuation Period|Not specified|0
127292|NCT00842829|461598|P3|Continuation Period|Withdrawal by Subject|10
127293|NCT00842829|461599|P2|Continuation Period|Withdrawal by Subject|0
127294|NCT00842829|461600|P1|Continuation Period|Withdrawal by Subject|0
127295|NCT00842829|461598|P3|Continuation Period|Unstable persistent cancer pain|3
127296|NCT00842829|461599|P2|Continuation Period|Unstable persistent cancer pain|0
127297|NCT00842829|461600|P1|Continuation Period|Unstable persistent cancer pain|0
127298|NCT00842829|461598|P3|Continuation Period|Lack of Efficacy|6
127299|NCT00842829|461599|P2|Continuation Period|Lack of Efficacy|0
127300|NCT00842829|461600|P1|Continuation Period|Lack of Efficacy|0
127301|NCT00842829|461598|P3|Continuation Period|Adverse Event|32
127302|NCT00842829|461599|P2|Continuation Period|Adverse Event|0
127303|NCT00842829|461600|P1|Continuation Period|Adverse Event|0
127304|NCT00842829|461598|P3|Treatment Period|Unclear completion status|1
127305|NCT00842829|461599|P2|Treatment Period|Unclear completion status|0
127306|NCT00842829|461600|P1|Treatment Period|Unclear completion status|0
127307|NCT00842829|461598|P3|Treatment Period|Non-compliance to study procedures|4
127308|NCT00842829|461599|P2|Treatment Period|Non-compliance to study procedures|0
127309|NCT00842829|461600|P1|Treatment Period|Non-compliance to study procedures|0
127310|NCT00842829|461598|P3|Treatment Period|Not specified|18
127311|NCT00842829|461599|P2|Treatment Period|Not specified|0
127312|NCT00842829|461600|P1|Treatment Period|Not specified|0
127313|NCT00842829|461598|P3|Treatment Period|Protocol Violation|2
127314|NCT00842829|461599|P2|Treatment Period|Protocol Violation|0
127315|NCT00842829|461600|P1|Treatment Period|Protocol Violation|0
127316|NCT00842829|461598|P3|Treatment Period|Consistently >4 BTP episodes daily|1
127317|NCT00842829|461599|P2|Treatment Period|Consistently >4 BTP episodes daily|0
127318|NCT00842829|461600|P1|Treatment Period|Consistently >4 BTP episodes daily|0
127319|NCT00842829|461598|P3|Treatment Period|Withdrawal by Subject|11
127320|NCT00842829|461599|P2|Treatment Period|Withdrawal by Subject|0
127321|NCT00842829|461600|P1|Treatment Period|Withdrawal by Subject|0
127322|NCT00842829|461598|P3|Treatment Period|Unstable persistent cancer pain|5
127323|NCT00842829|461599|P2|Treatment Period|Unstable persistent cancer pain|0
127324|NCT00842829|461600|P1|Treatment Period|Unstable persistent cancer pain|0
127325|NCT00842829|461598|P3|Treatment Period|Lack of Efficacy|6
127326|NCT00842829|461599|P2|Treatment Period|Lack of Efficacy|0
127327|NCT00842829|461600|P1|Treatment Period|Lack of Efficacy|0
127328|NCT00842829|461598|P3|Treatment Period|Adverse Event|15
127329|NCT00842829|461599|P2|Treatment Period|Adverse Event|0
127330|NCT00842829|461600|P1|Treatment Period|Adverse Event|0
127331|NCT00842829|461598|P3|Dose Titration Period|Non-compliance to study drug|0
127332|NCT00842829|461599|P2|Dose Titration Period|Non-compliance to study drug|1
127333|NCT00842829|461600|P1|Dose Titration Period|Non-compliance to study drug|2
127334|NCT00842829|461598|P3|Dose Titration Period|Non-compliance to study procedures|0
127335|NCT00842829|461599|P2|Dose Titration Period|Non-compliance to study procedures|1
127336|NCT00842829|461600|P1|Dose Titration Period|Non-compliance to study procedures|1
127337|NCT00842829|461598|P3|Dose Titration Period|Not specified|0
127338|NCT00842829|461599|P2|Dose Titration Period|Not specified|4
127339|NCT00842829|461600|P1|Dose Titration Period|Not specified|5
127340|NCT00842829|461598|P3|Dose Titration Period|Withdrawal by Subject|0
127341|NCT00842829|461599|P2|Dose Titration Period|Withdrawal by Subject|6
127342|NCT00842829|461600|P1|Dose Titration Period|Withdrawal by Subject|2
127343|NCT00842829|461598|P3|Dose Titration Period|Unstable persistent cancer pain|0
127344|NCT00842829|461599|P2|Dose Titration Period|Unstable persistent cancer pain|0
127345|NCT00842829|461600|P1|Dose Titration Period|Unstable persistent cancer pain|1
127346|NCT00842829|461598|P3|Dose Titration Period|Lack of Efficacy|0
127347|NCT00842829|461599|P2|Dose Titration Period|Lack of Efficacy|1
127348|NCT00842829|461600|P1|Dose Titration Period|Lack of Efficacy|4
127349|NCT00842829|461598|P3|Dose Titration Period|Adverse Event|0
127350|NCT00842829|461599|P2|Dose Titration Period|Adverse Event|10
127351|NCT00842829|461600|P1|Dose Titration Period|Adverse Event|11
127352|NCT00842712|461655|P7|Randomized Part|Ongoing at cut-off date|2
127353|NCT00842712|461656|P6|Randomized Part|Ongoing at cut-off date|0
127354|NCT00842712|461657|P5|Randomized Part|Ongoing at cut-off date|0
127355|NCT00842712|461658|P4|Randomized Part|Ongoing at cut-off date|0
127356|NCT00842712|461659|P3|Randomized Part|Ongoing at cut-off date|0
127357|NCT00842712|461660|P2|Randomized Part|Ongoing at cut-off date|0
127358|NCT00842712|461661|P1|Randomized Part|Ongoing at cut-off date|0
127359|NCT00842712|461655|P7|Randomized Part|Randomized but not treated|4
127360|NCT00842712|461656|P6|Randomized Part|Randomized but not treated|1
127361|NCT00842712|461657|P5|Randomized Part|Randomized but not treated|0
127362|NCT00842712|461658|P4|Randomized Part|Randomized but not treated|0
127363|NCT00842712|461659|P3|Randomized Part|Randomized but not treated|0
127364|NCT00842712|461660|P2|Randomized Part|Randomized but not treated|0
127365|NCT00842712|461661|P1|Randomized Part|Randomized but not treated|0
127366|NCT00842712|461655|P7|Safety Run-in Part|Progressive disease|0
127367|NCT00842712|461656|P6|Safety Run-in Part|Progressive disease|0
127368|NCT00842712|461657|P5|Safety Run-in Part|Progressive disease|0
127369|NCT00842712|461658|P4|Safety Run-in Part|Progressive disease|1
127370|NCT00842712|461659|P3|Safety Run-in Part|Progressive disease|0
127371|NCT00842712|461660|P2|Safety Run-in Part|Progressive disease|1
127372|NCT00842712|461661|P1|Safety Run-in Part|Progressive disease|3
127373|NCT00842712|461655|P7|Safety Run-in Part|Adverse Event|0
127374|NCT00842712|461656|P6|Safety Run-in Part|Adverse Event|0
127375|NCT00842712|461657|P5|Safety Run-in Part|Adverse Event|0
127376|NCT00842712|461658|P4|Safety Run-in Part|Adverse Event|0
127377|NCT00842712|461659|P3|Safety Run-in Part|Adverse Event|0
127378|NCT00842712|461660|P2|Safety Run-in Part|Adverse Event|1
127379|NCT00842712|461661|P1|Safety Run-in Part|Adverse Event|0
127380|NCT00842543|461718|P4|Overall Study|Withdrawal by Subject|4
127381|NCT00842543|461719|P3|Overall Study|Withdrawal by Subject|3
127382|NCT00842543|461720|P2|Overall Study|Withdrawal by Subject|0
127383|NCT00842543|461721|P1|Overall Study|Withdrawal by Subject|2
127384|NCT00842361|461735|P2|Overall Study|Unclassified|2
127385|NCT00842361|461736|P1|Overall Study|Unclassified|0
127386|NCT00842361|461735|P2|Overall Study|Protocol Violation|0
127387|NCT00842361|461736|P1|Overall Study|Protocol Violation|1
127388|NCT00842348|461756|P2|Study 729|Surgical resection|0
127389|NCT00842348|461757|P1|Study 729|Surgical resection|1
127390|NCT00842348|461756|P2|Study 729|Sponsor's decision|0
127391|NCT00842348|461757|P1|Study 729|Sponsor's decision|1
127392|NCT00842348|461756|P2|Study 729|Due to non-availability of IP|1
127393|NCT00842348|461757|P1|Study 729|Due to non-availability of IP|0
127394|NCT00842348|461756|P2|Study 729|Due to Sponsor stopping the study|1
127395|NCT00842348|461757|P1|Study 729|Due to Sponsor stopping the study|1
127396|NCT00842348|461756|P2|Study 729|Withdrawal by Subject|4
127397|NCT00842348|461757|P1|Study 729|Withdrawal by Subject|2
127398|NCT00842348|461756|P2|Study 729|Protocol Violation|1
127399|NCT00842348|461757|P1|Study 729|Protocol Violation|1
127400|NCT00842348|461756|P2|Study 729|Adverse Event|1
127401|NCT00842348|461757|P1|Study 729|Adverse Event|1
127402|NCT00842348|461756|P2|Study 729|Disease progression/death|30
127403|NCT00842348|461757|P1|Study 729|Disease progression/death|19
127404|NCT00842348|461756|P2|Patients Randomised in Study 726|Did not enter Study 729|56
127405|NCT00842348|461757|P1|Patients Randomised in Study 726|Did not enter Study 729|59
127406|NCT00842257|461800|P1|Overall Study|Adverse Event|1
127407|NCT00842244|461807|P1|Overall Study|Other|17
127408|NCT00842244|461807|P1|Overall Study|Withdrawal by Subject|1
127409|NCT00842244|461807|P1|Overall Study|Death|3
127410|NCT00842153|461834|P2|Overall Study|Lost to Follow-up|2
127411|NCT00842153|461835|P1|Overall Study|Lost to Follow-up|1
127412|NCT00842153|461834|P2|Overall Study|Adverse Event|1
127413|NCT00842153|461835|P1|Overall Study|Adverse Event|0
127414|NCT00841906|461910|P2|Overall Study|Withdrawal by Subject|0
127415|NCT00841906|461911|P1|Overall Study|Withdrawal by Subject|2
127416|NCT00841815|461925|P2|Washout|Withdrawal by Subject|1
127417|NCT00841815|461926|P1|Washout|Withdrawal by Subject|0
127418|NCT00841776|461936|P2|Overall Study|Withdrawal by Subject|1
127419|NCT00841776|461937|P1|Overall Study|Withdrawal by Subject|0
127420|NCT00841776|461936|P2|Overall Study|Lost to Follow-up|1
127421|NCT00841776|461937|P1|Overall Study|Lost to Follow-up|2
127422|NCT00841776|461936|P2|Overall Study|Lack of Efficacy|1
127423|NCT00841776|461937|P1|Overall Study|Lack of Efficacy|0
127424|NCT00841763|461955|P4|Overall Study|Unable to Classify|0
127425|NCT00841763|461956|P3|Overall Study|Unable to Classify|0
127426|NCT00841763|461957|P2|Overall Study|Unable to Classify|1
127427|NCT00841763|461958|P1|Overall Study|Unable to Classify|7
127428|NCT00841763|461955|P4|Overall Study|Administrative Reasons|0
127429|NCT00841763|461956|P3|Overall Study|Administrative Reasons|0
127430|NCT00841763|461957|P2|Overall Study|Administrative Reasons|1
127431|NCT00841763|461958|P1|Overall Study|Administrative Reasons|3
127432|NCT00841763|461955|P4|Overall Study|Protocol Violation|0
127433|NCT00841763|461956|P3|Overall Study|Protocol Violation|1
127434|NCT00841763|461957|P2|Overall Study|Protocol Violation|3
127435|NCT00841763|461958|P1|Overall Study|Protocol Violation|20
127436|NCT00841763|461955|P4|Overall Study|Lost to Follow-up|0
127437|NCT00841763|461956|P3|Overall Study|Lost to Follow-up|0
127438|NCT00841763|461957|P2|Overall Study|Lost to Follow-up|25
127439|NCT00841763|461958|P1|Overall Study|Lost to Follow-up|63
127440|NCT00841763|461955|P4|Overall Study|Adverse Event|2
127441|NCT00841763|461956|P3|Overall Study|Adverse Event|3
127442|NCT00841763|461957|P2|Overall Study|Adverse Event|10
127443|NCT00841763|461958|P1|Overall Study|Adverse Event|9
127444|NCT00841763|461955|P4|Overall Study|Withdrawal by Subject|1
127445|NCT00841763|461956|P3|Overall Study|Withdrawal by Subject|4
127446|NCT00841763|461957|P2|Overall Study|Withdrawal by Subject|17
127447|NCT00841763|461958|P1|Overall Study|Withdrawal by Subject|60
127448|NCT00841698|462020|P2|First Intervention|Withdrawal by Subject|0
127449|NCT00841698|462021|P1|First Intervention|Withdrawal by Subject|1
127450|NCT00841672|462031|P2|Overall Study|Protocol Deviation|1
127451|NCT00841672|462032|P1|Overall Study|Protocol Deviation|0
127452|NCT00841672|462031|P2|Overall Study|Misrandomized|0
127453|NCT00841672|462032|P1|Overall Study|Misrandomized|1
127454|NCT00841672|462031|P2|Overall Study|Administrative problems|9
127455|NCT00841672|462032|P1|Overall Study|Administrative problems|9
127456|NCT00841672|462031|P2|Overall Study|Lost to Follow-up|1
127457|NCT00841672|462032|P1|Overall Study|Lost to Follow-up|1
127458|NCT00841672|462031|P2|Overall Study|Subject withdrew consent|4
127459|NCT00841672|462032|P1|Overall Study|Subject withdrew consent|2
127460|NCT00841672|462031|P2|Overall Study|Abnormal test procedure result(s)|1
127461|NCT00841672|462032|P1|Overall Study|Abnormal test procedure result(s)|0
127462|NCT00841672|462031|P2|Overall Study|Adverse Event|16
127463|NCT00841672|462032|P1|Overall Study|Adverse Event|7
127464|NCT00841659|462048|P2|Washout: 2 Weeks|Protocol Violation|0
127465|NCT00841659|462049|P1|Washout: 2 Weeks|Protocol Violation|1
127466|NCT00841542|462072|P2|Period 1|Adverse Event|0
127467|NCT00841542|462073|P1|Period 1|Adverse Event|1
127468|NCT00841321|462088|P2|Overall Study|Adverse Event|2
127469|NCT00841321|462089|P1|Overall Study|Adverse Event|0
127470|NCT00841321|462088|P2|Overall Study|Lost to Follow-up|1
127471|NCT00841321|462089|P1|Overall Study|Lost to Follow-up|1
127472|NCT00841035|462157|P1|Phase 1 Overall Study|Physician Decision|13
127473|NCT00840996|462164|P2|Overall Study|Withdrawal by Subject|0
127474|NCT00840996|462165|P1|Overall Study|Withdrawal by Subject|1
127475|NCT00840879|462185|P2|Second Intervention|Withdrawal by Subject|0
127476|NCT00840879|462186|P1|Second Intervention|Withdrawal by Subject|1
127477|NCT00840658|462226|P4|Overall Study|Lost to Follow-up|1
127478|NCT00840658|462227|P3|Overall Study|Lost to Follow-up|2
127479|NCT00840658|462228|P2|Overall Study|Lost to Follow-up|1
127480|NCT00840658|462229|P1|Overall Study|Lost to Follow-up|3
127481|NCT00840658|462226|P4|Overall Study|Death|3
127482|NCT00840658|462227|P3|Overall Study|Death|3
127483|NCT00840658|462228|P2|Overall Study|Death|2
127484|NCT00840658|462229|P1|Overall Study|Death|2
127485|NCT00840632|462241|P2|Washout|Withdrawal by Subject|1
127486|NCT00840632|462242|P1|Washout|Withdrawal by Subject|1
127487|NCT00840632|462241|P2|First Intervention|Withdrawal by Subject|1
127488|NCT00840632|462242|P1|First Intervention|Withdrawal by Subject|0
127489|NCT00840450|462267|P1|Overall Study|Lack of Efficacy|2
127490|NCT00840450|462267|P1|Overall Study|Adverse Event|1
127491|NCT00840411|462275|P2|Washout|Withdrawal by Subject|0
127492|NCT00840411|462276|P1|Washout|Withdrawal by Subject|1
127493|NCT00840411|462275|P2|First Intervention|Adverse Event|0
127494|NCT00840411|462276|P1|First Intervention|Adverse Event|1
127495|NCT00840294|462290|P2|Overall Study|Illness|1
127496|NCT00840294|462291|P1|Overall Study|Illness|0
127497|NCT00840294|462290|P2|Overall Study|Protocol Violation|3
127498|NCT00840294|462291|P1|Overall Study|Protocol Violation|1
127499|NCT00840294|462290|P2|Overall Study|Withdrawal by Subject|1
127500|NCT00840294|462291|P1|Overall Study|Withdrawal by Subject|2
127501|NCT00840216|462312|P2|Washout: 7 Days|Withdrawal by Subject|0
127502|NCT00840216|462313|P1|Washout: 7 Days|Withdrawal by Subject|1
127503|NCT00840203|462323|P2|Washout|Protocol Violation|0
127504|NCT00840203|462324|P1|Washout|Protocol Violation|1
127505|NCT00840203|462323|P2|First Intervention|Protocol Violation|1
127506|NCT00840203|462324|P1|First Intervention|Protocol Violation|1
127507|NCT00840086|462355|P1|Overall Study|Lost to Follow-up|1
127508|NCT00840086|462355|P1|Overall Study|Protocol Violation|2
127509|NCT00840086|462355|P1|Overall Study|Adverse Event|1
127510|NCT00840073|462364|P2|Second Intervention|Missed 72 hour blood draw|1
127511|NCT00840073|462365|P1|Second Intervention|Missed 72 hour blood draw|1
127512|NCT00840060|462379|P2|Overall Study|Change in emotional/behavioral status|1
127513|NCT00840060|462380|P1|Overall Study|Change in emotional/behavioral status|0
127514|NCT00840060|462379|P2|Overall Study|Withdrawal by Subject|0
127515|NCT00840060|462380|P1|Overall Study|Withdrawal by Subject|1
127516|NCT00840034|462390|P2|Taper Phase|Withdrawal by Subject|1
127517|NCT00840034|462391|P1|Taper Phase|Withdrawal by Subject|1
127518|NCT00840034|462390|P2|Taper Phase|Lost to Follow-up|1
127519|NCT00840034|462391|P1|Taper Phase|Lost to Follow-up|1
127520|NCT00840034|462390|P2|Taper Phase|Adverse Event|0
127521|NCT00840034|462391|P1|Taper Phase|Adverse Event|1
127522|NCT00840034|462390|P2|Acute Treatment Phase|Withdrawal by Subject|11
127523|NCT00840034|462391|P1|Acute Treatment Phase|Withdrawal by Subject|6
127524|NCT00840034|462390|P2|Acute Treatment Phase|Protocol Violation|4
127525|NCT00840034|462391|P1|Acute Treatment Phase|Protocol Violation|2
127526|NCT00840034|462390|P2|Acute Treatment Phase|Physician Decision|1
127527|NCT00840034|462391|P1|Acute Treatment Phase|Physician Decision|0
127528|NCT00840034|462390|P2|Acute Treatment Phase|Lost to Follow-up|12
127529|NCT00840034|462391|P1|Acute Treatment Phase|Lost to Follow-up|5
127530|NCT00840034|462390|P2|Acute Treatment Phase|Lack of Efficacy|0
127531|NCT00840034|462391|P1|Acute Treatment Phase|Lack of Efficacy|2
127532|NCT00840034|462390|P2|Acute Treatment Phase|Adverse Event|8
127533|NCT00840034|462391|P1|Acute Treatment Phase|Adverse Event|6
127534|NCT00839956|462444|P1|Overall Study|Withdrawal by Subject|3
127535|NCT00839956|462444|P1|Overall Study|Physician Decision|1
127536|NCT00839956|462444|P1|Overall Study|Lack of Efficacy|6
127537|NCT00839956|462444|P1|Overall Study|Adverse Event|2
127538|NCT00839917|462464|P2|Overall Study|Did not receive vaccine|1
127539|NCT00839917|462465|P1|Overall Study|Did not receive vaccine|0
127540|NCT00839917|462464|P2|Overall Study|Lost to Follow-up|0
127541|NCT00839917|462465|P1|Overall Study|Lost to Follow-up|1
127542|NCT00839800|462503|P2|Overall Study|Severe Non-Compliance to Protocol|7
127543|NCT00839800|462504|P1|Overall Study|Severe Non-Compliance to Protocol|7
127544|NCT00839800|462503|P2|Overall Study|Not Specified|14
127545|NCT00839800|462504|P1|Overall Study|Not Specified|8
127546|NCT00839800|462503|P2|Overall Study|Safety Reasons|1
127547|NCT00839800|462504|P1|Overall Study|Safety Reasons|2
127548|NCT00839800|462503|P2|Overall Study|Study-Specific Discontinuation Criteria|13
127549|NCT00839800|462504|P1|Overall Study|Study-Specific Discontinuation Criteria|6
127550|NCT00839800|462503|P2|Overall Study|Incorrect Enrolment|3
127551|NCT00839800|462504|P1|Overall Study|Incorrect Enrolment|3
127552|NCT00839800|462503|P2|Overall Study|Withdrawal by Subject|34
127553|NCT00839800|462504|P1|Overall Study|Withdrawal by Subject|28
127554|NCT00839800|462503|P2|Overall Study|Lost to Follow-up|26
127555|NCT00839800|462504|P1|Overall Study|Lost to Follow-up|31
127556|NCT00839800|462503|P2|Overall Study|Adverse Event|12
127557|NCT00839800|462504|P1|Overall Study|Adverse Event|8
127558|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
127559|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
127560|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
127561|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
127562|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
127563|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
127564|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
127565|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
127566|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
127567|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
127568|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
127569|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
127570|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
127571|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
127572|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
127573|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
127574|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
127575|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
127576|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
127577|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
127578|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
127579|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
127580|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
127581|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
127582|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
127583|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
127584|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
127585|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
127586|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
127587|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
127588|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
127589|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
127590|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
127591|NCT00839527|462550|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
127592|NCT00839527|462551|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
127593|NCT00839527|462552|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
127594|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
127595|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
127596|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
127597|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
127598|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
127599|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
127600|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
127601|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
127602|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
127603|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
127604|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
127605|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
127606|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Missing|0
127607|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Missing|1
127608|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Missing|0
127609|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
127610|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
127611|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
127612|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
127613|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
127614|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
127615|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
127616|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
127617|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
127618|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
127619|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
127620|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
127621|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
127622|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
127623|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
127624|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
127625|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
127626|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
127627|NCT00839527|462550|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
127628|NCT00839527|462551|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
127629|NCT00839527|462552|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
127630|NCT00839436|462587|P3|Overall Study|Study drug no longer available|1
127631|NCT00839436|462588|P2|Overall Study|Study drug no longer available|0
127632|NCT00839436|462589|P1|Overall Study|Study drug no longer available|0
127633|NCT00839436|462587|P3|Overall Study|Withdrawal by Subject|0
127634|NCT00839436|462588|P2|Overall Study|Withdrawal by Subject|1
127635|NCT00839436|462589|P1|Overall Study|Withdrawal by Subject|0
127636|NCT00839436|462587|P3|Overall Study|Developed exclusionary condition|0
127637|NCT00839436|462588|P2|Overall Study|Developed exclusionary condition|0
127638|NCT00839436|462589|P1|Overall Study|Developed exclusionary condition|1
127639|NCT00839423|462601|P4|Overall Study|Administrative or other reasons|0
127640|NCT00839423|462602|P3|Overall Study|Administrative or other reasons|1
127641|NCT00839423|462603|P2|Overall Study|Administrative or other reasons|0
127642|NCT00839423|462604|P1|Overall Study|Administrative or other reasons|3
127643|NCT00839423|462601|P4|Overall Study|Lost to Follow-up|0
127644|NCT00839423|462602|P3|Overall Study|Lost to Follow-up|1
127645|NCT00839423|462603|P2|Overall Study|Lost to Follow-up|0
127646|NCT00839423|462604|P1|Overall Study|Lost to Follow-up|1
127647|NCT00839423|462601|P4|Overall Study|Withdrawal of consent|1
127648|NCT00839423|462602|P3|Overall Study|Withdrawal of consent|4
127649|NCT00839423|462603|P2|Overall Study|Withdrawal of consent|0
127650|NCT00839423|462604|P1|Overall Study|Withdrawal of consent|4
127651|NCT00839423|462601|P4|Overall Study|Protocol Violation|0
127652|NCT00839423|462602|P3|Overall Study|Protocol Violation|2
127653|NCT00839423|462603|P2|Overall Study|Protocol Violation|1
127654|NCT00839423|462604|P1|Overall Study|Protocol Violation|0
127655|NCT00839423|462601|P4|Overall Study|Non-compliance|1
127656|NCT00839423|462602|P3|Overall Study|Non-compliance|0
127657|NCT00839423|462603|P2|Overall Study|Non-compliance|0
127658|NCT00839423|462604|P1|Overall Study|Non-compliance|0
127659|NCT00839423|462601|P4|Overall Study|Lack of Efficacy|2
127660|NCT00839423|462602|P3|Overall Study|Lack of Efficacy|3
127661|NCT00839423|462603|P2|Overall Study|Lack of Efficacy|6
127662|NCT00839423|462604|P1|Overall Study|Lack of Efficacy|6
127663|NCT00839423|462601|P4|Overall Study|Adverse Event|16
127664|NCT00839423|462602|P3|Overall Study|Adverse Event|7
127665|NCT00839423|462603|P2|Overall Study|Adverse Event|3
127666|NCT00839423|462604|P1|Overall Study|Adverse Event|4
127667|NCT00839332|462645|P3|Phase 2|Lost to Follow-up|1
127668|NCT00839332|462646|P2|Phase 2|Lost to Follow-up|0
127669|NCT00839332|462647|P1|Phase 2|Lost to Follow-up|0
127670|NCT00839332|462645|P3|Phase 2|Physician Decision|1
127671|NCT00839332|462646|P2|Phase 2|Physician Decision|4
127672|NCT00839332|462647|P1|Phase 2|Physician Decision|0
127673|NCT00839332|462645|P3|Phase 2|Withdrawal by Subject|8
127674|NCT00839332|462646|P2|Phase 2|Withdrawal by Subject|5
127675|NCT00839332|462647|P1|Phase 2|Withdrawal by Subject|0
127676|NCT00839332|462645|P3|Phase 2|Death|2
127677|NCT00839332|462646|P2|Phase 2|Death|4
127678|NCT00839332|462647|P1|Phase 2|Death|0
127679|NCT00839332|462645|P3|Phase 2|Adverse Event|6
127680|NCT00839332|462646|P2|Phase 2|Adverse Event|8
127681|NCT00839332|462647|P1|Phase 2|Adverse Event|0
127682|NCT00839332|462645|P3|Phase 2|Disease Progression|21
127683|NCT00839332|462646|P2|Phase 2|Disease Progression|46
127684|NCT00839332|462647|P1|Phase 2|Disease Progression|0
127685|NCT00839332|462645|P3|Phase 2|Protocol Violation|0
127686|NCT00839332|462646|P2|Phase 2|Protocol Violation|1
127687|NCT00839332|462647|P1|Phase 2|Protocol Violation|0
127688|NCT00839332|462645|P3|Phase 1|Physician Decision|0
127689|NCT00839332|462646|P2|Phase 1|Physician Decision|0
127690|NCT00839332|462647|P1|Phase 1|Physician Decision|2
127691|NCT00839332|462645|P3|Phase 1|Withdrawal by Subject|0
127692|NCT00839332|462646|P2|Phase 1|Withdrawal by Subject|0
127693|NCT00839332|462647|P1|Phase 1|Withdrawal by Subject|4
127694|NCT00839332|462645|P3|Phase 1|Adverse Event|0
127695|NCT00839332|462646|P2|Phase 1|Adverse Event|0
127696|NCT00839332|462647|P1|Phase 1|Adverse Event|6
127697|NCT00839332|462645|P3|Phase 1|Disease Progression|0
127698|NCT00839332|462646|P2|Phase 1|Disease Progression|0
127699|NCT00839332|462647|P1|Phase 1|Disease Progression|38
127700|NCT00839306|462708|P2|Overall Study|Not specified|18
127701|NCT00839306|462709|P1|Overall Study|Not specified|6
127702|NCT00839306|462708|P2|Overall Study|Lack of Efficacy|4
127703|NCT00839306|462709|P1|Overall Study|Lack of Efficacy|5
127704|NCT00839306|462708|P2|Overall Study|Withdrawal by Subject|7
127705|NCT00839306|462709|P1|Overall Study|Withdrawal by Subject|5
127706|NCT00839306|462708|P2|Overall Study|Lost to Follow-up|9
127707|NCT00839306|462709|P1|Overall Study|Lost to Follow-up|6
127708|NCT00839306|462708|P2|Overall Study|Adverse Event|5
127709|NCT00839306|462709|P1|Overall Study|Adverse Event|3
127710|NCT00839098|462807|P3|Overall Study|Withdrawal by Subject|7
127711|NCT00839098|462808|P2|Overall Study|Withdrawal by Subject|1
127712|NCT00839098|462809|P1|Overall Study|Withdrawal by Subject|2
127713|NCT00839072|462835|P2|Second Intervention Period|Withdrawal by Subject|0
127714|NCT00839072|462836|P1|Second Intervention Period|Withdrawal by Subject|1
127715|NCT00839072|462835|P2|First Intervention Period|Adverse Event|1
127716|NCT00839072|462836|P1|First Intervention Period|Adverse Event|1
127866|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Noncompliance|9
127717|NCT00839072|462835|P2|First Intervention Period|Withdrawal by Subject|0
127718|NCT00839072|462836|P1|First Intervention Period|Withdrawal by Subject|1
127719|NCT00838929|462880|P3|Overall Study|Disease progression|1
127720|NCT00838929|462881|P2|Overall Study|Disease progression|2
127721|NCT00838929|462882|P1|Overall Study|Disease progression|0
127722|NCT00838929|462880|P3|Overall Study|Protocol Violation|0
127723|NCT00838929|462881|P2|Overall Study|Protocol Violation|1
127724|NCT00838929|462882|P1|Overall Study|Protocol Violation|0
127725|NCT00838916|462890|P2|Follow-up Period (8 Weeks)|Missing|0
127726|NCT00838916|462891|P1|Follow-up Period (8 Weeks)|Missing|3
127727|NCT00838916|462890|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
127728|NCT00838916|462891|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
127729|NCT00838916|462890|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
127730|NCT00838916|462891|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
127731|NCT00838916|462890|P2|Follow-up Period (8 Weeks)|Physician Decision|0
127732|NCT00838916|462891|P1|Follow-up Period (8 Weeks)|Physician Decision|2
127733|NCT00838916|462890|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
127734|NCT00838916|462891|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
127735|NCT00838916|462890|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
127736|NCT00838916|462891|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
127737|NCT00838916|462890|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
127738|NCT00838916|462891|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
127739|NCT00838916|462890|P2|Follow-up Period (8 Weeks)|Noncompliance|5
127740|NCT00838916|462891|P1|Follow-up Period (8 Weeks)|Noncompliance|6
127741|NCT00838916|462890|P2|Follow-up Period (8 Weeks)|Adverse Event|5
127742|NCT00838916|462891|P1|Follow-up Period (8 Weeks)|Adverse Event|10
127743|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Pregnancy|0
127744|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Pregnancy|2
127745|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Missing|1
127746|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Missing|3
127747|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
127748|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
127749|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Physician Decision|1
127750|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Physician Decision|6
127751|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
127752|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
127753|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
127754|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
127755|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
127756|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
127757|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Noncompliance|14
127758|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Noncompliance|21
127759|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Protocol Violation|3
127760|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Protocol Violation|12
127761|NCT00838916|462890|P2|Treatment Period (156 Weeks)|Adverse Event|11
127762|NCT00838916|462891|P1|Treatment Period (156 Weeks)|Adverse Event|50
127763|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Missing|1
127764|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Missing|1
127765|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Missing|2
127766|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Missing|1
127767|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
127768|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
127769|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
127770|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
127771|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
127772|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
127773|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
127774|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
127775|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
127776|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
127777|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
127778|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
127779|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
127780|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
127781|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
127782|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
127783|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Physician Decision|1
127784|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Physician Decision|1
127785|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Physician Decision|1
127786|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Physician Decision|1
127787|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
127788|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
127789|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
127790|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
127791|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
127792|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
127793|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
127794|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
127795|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
127796|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
127797|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
127798|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
127799|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Noncompliance|5
127800|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Noncompliance|5
127801|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Noncompliance|8
127802|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Noncompliance|2
127803|NCT00838903|462920|P4|Follow-up Period (8 Weeks)|Adverse Event|1
127804|NCT00838903|462921|P3|Follow-up Period (8 Weeks)|Adverse Event|3
127805|NCT00838903|462922|P2|Follow-up Period (8 Weeks)|Adverse Event|0
127806|NCT00838903|462923|P1|Follow-up Period (8 Weeks)|Adverse Event|0
127807|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
127808|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
127809|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
127810|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
127811|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
127812|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
127813|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
127814|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
127815|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
127816|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
127817|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
127818|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
127819|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Site closed|0
127820|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Site closed|1
127821|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Site closed|0
127822|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Site closed|0
127823|NCT00838903|462920|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
127824|NCT00838903|462921|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
127825|NCT00838903|462922|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
127826|NCT00838903|462923|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
127827|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Pregnancy|0
127828|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Pregnancy|1
127829|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Pregnancy|0
127830|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Pregnancy|0
127831|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
127832|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
127833|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
127834|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
127835|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
127836|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
127837|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
127838|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
127839|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
127840|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
127841|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
127842|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
127843|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
127844|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
127845|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
127846|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
127847|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Physician Decision|2
127848|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Physician Decision|1
127849|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Physician Decision|2
127850|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Physician Decision|1
127851|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
127852|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
127853|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
127854|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
127855|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
127856|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
127857|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
127858|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
127859|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
127860|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
127861|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
127862|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
127863|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Noncompliance|6
127864|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Noncompliance|12
127865|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Noncompliance|13
127867|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Protocol Violation|5
127868|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Protocol Violation|6
127869|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Protocol Violation|6
127870|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Protocol Violation|1
127871|NCT00838903|462920|P4|Treatment Period (156 Weeks)|Adverse Event|25
127872|NCT00838903|462921|P3|Treatment Period (156 Weeks)|Adverse Event|17
127873|NCT00838903|462922|P2|Treatment Period (156 Weeks)|Adverse Event|13
127874|NCT00838903|462923|P1|Treatment Period (156 Weeks)|Adverse Event|5
127875|NCT00838682|462967|P2|Overall Study|Withdrawal by Subject|1
127876|NCT00838682|462968|P1|Overall Study|Withdrawal by Subject|0
127877|NCT00838682|462967|P2|Overall Study|Protocol Violation|1
127878|NCT00838682|462968|P1|Overall Study|Protocol Violation|0
127879|NCT00838682|462967|P2|Overall Study|detection of exclusion criteria|3
127880|NCT00838682|462968|P1|Overall Study|detection of exclusion criteria|4
127881|NCT00838682|462967|P2|Overall Study|Lost to Follow-up|14
127882|NCT00838682|462968|P1|Overall Study|Lost to Follow-up|21
127883|NCT00838630|462986|P2|Washout: 7 Days|Protocol Violation|0
127884|NCT00838630|462987|P1|Washout: 7 Days|Protocol Violation|1
127885|NCT00838630|462986|P2|First Intervention|Adverse Event|0
127886|NCT00838630|462987|P1|First Intervention|Adverse Event|1
127887|NCT00838578|462995|P1|Overall Study|Protocol Violation|2
127888|NCT00838539|463015|P12|Overall Study|Symptomatic Deterioration|0
127889|NCT00838539|463016|P11|Overall Study|Symptomatic Deterioration|0
127890|NCT00838539|463017|P10|Overall Study|Symptomatic Deterioration|1
127891|NCT00838539|463018|P9|Overall Study|Symptomatic Deterioration|0
127892|NCT00838539|463019|P8|Overall Study|Symptomatic Deterioration|0
127893|NCT00838539|463020|P7|Overall Study|Symptomatic Deterioration|0
127894|NCT00838539|463021|P6|Overall Study|Symptomatic Deterioration|1
127895|NCT00838539|463022|P5|Overall Study|Symptomatic Deterioration|0
127896|NCT00838539|463023|P4|Overall Study|Symptomatic Deterioration|1
127897|NCT00838539|463024|P3|Overall Study|Symptomatic Deterioration|1
127898|NCT00838539|463025|P2|Overall Study|Symptomatic Deterioration|0
127899|NCT00838539|463026|P1|Overall Study|Symptomatic Deterioration|0
127900|NCT00838539|463015|P12|Overall Study|Clinical Progression|0
127901|NCT00838539|463016|P11|Overall Study|Clinical Progression|0
127902|NCT00838539|463017|P10|Overall Study|Clinical Progression|0
127903|NCT00838539|463018|P9|Overall Study|Clinical Progression|0
127904|NCT00838539|463019|P8|Overall Study|Clinical Progression|0
127905|NCT00838539|463020|P7|Overall Study|Clinical Progression|1
127906|NCT00838539|463021|P6|Overall Study|Clinical Progression|0
127907|NCT00838539|463022|P5|Overall Study|Clinical Progression|0
127908|NCT00838539|463023|P4|Overall Study|Clinical Progression|0
127909|NCT00838539|463024|P3|Overall Study|Clinical Progression|0
127910|NCT00838539|463025|P2|Overall Study|Clinical Progression|0
127911|NCT00838539|463026|P1|Overall Study|Clinical Progression|0
127912|NCT00838539|463015|P12|Overall Study|Physician Decision|0
127913|NCT00838539|463016|P11|Overall Study|Physician Decision|0
127914|NCT00838539|463017|P10|Overall Study|Physician Decision|0
127915|NCT00838539|463018|P9|Overall Study|Physician Decision|1
127916|NCT00838539|463019|P8|Overall Study|Physician Decision|0
127917|NCT00838539|463020|P7|Overall Study|Physician Decision|0
127918|NCT00838539|463021|P6|Overall Study|Physician Decision|0
127919|NCT00838539|463022|P5|Overall Study|Physician Decision|0
127920|NCT00838539|463023|P4|Overall Study|Physician Decision|0
127921|NCT00838539|463024|P3|Overall Study|Physician Decision|0
127922|NCT00838539|463025|P2|Overall Study|Physician Decision|0
127923|NCT00838539|463026|P1|Overall Study|Physician Decision|0
127924|NCT00838539|463015|P12|Overall Study|Death|0
127925|NCT00838539|463016|P11|Overall Study|Death|0
127926|NCT00838539|463017|P10|Overall Study|Death|0
127927|NCT00838539|463018|P9|Overall Study|Death|0
127928|NCT00838539|463019|P8|Overall Study|Death|0
127929|NCT00838539|463020|P7|Overall Study|Death|1
127930|NCT00838539|463021|P6|Overall Study|Death|0
127931|NCT00838539|463022|P5|Overall Study|Death|0
127932|NCT00838539|463023|P4|Overall Study|Death|0
127933|NCT00838539|463024|P3|Overall Study|Death|0
127934|NCT00838539|463025|P2|Overall Study|Death|0
127935|NCT00838539|463026|P1|Overall Study|Death|0
127936|NCT00838539|463015|P12|Overall Study|Withdrawal by Subject|0
127937|NCT00838539|463016|P11|Overall Study|Withdrawal by Subject|2
127938|NCT00838539|463017|P10|Overall Study|Withdrawal by Subject|1
127939|NCT00838539|463018|P9|Overall Study|Withdrawal by Subject|0
127940|NCT00838539|463019|P8|Overall Study|Withdrawal by Subject|0
127941|NCT00838539|463020|P7|Overall Study|Withdrawal by Subject|0
127942|NCT00838539|463021|P6|Overall Study|Withdrawal by Subject|0
127943|NCT00838539|463022|P5|Overall Study|Withdrawal by Subject|0
127944|NCT00838539|463023|P4|Overall Study|Withdrawal by Subject|0
127945|NCT00838539|463024|P3|Overall Study|Withdrawal by Subject|0
127946|NCT00838539|463025|P2|Overall Study|Withdrawal by Subject|1
127947|NCT00838539|463026|P1|Overall Study|Withdrawal by Subject|0
127948|NCT00838539|463015|P12|Overall Study|Adverse Event|0
127949|NCT00838539|463016|P11|Overall Study|Adverse Event|2
127950|NCT00838539|463017|P10|Overall Study|Adverse Event|1
127951|NCT00838539|463018|P9|Overall Study|Adverse Event|0
127952|NCT00838539|463019|P8|Overall Study|Adverse Event|2
127953|NCT00838539|463020|P7|Overall Study|Adverse Event|0
127954|NCT00838539|463021|P6|Overall Study|Adverse Event|1
127955|NCT00838539|463022|P5|Overall Study|Adverse Event|0
127956|NCT00838539|463023|P4|Overall Study|Adverse Event|1
127957|NCT00838539|463024|P3|Overall Study|Adverse Event|1
127958|NCT00838539|463025|P2|Overall Study|Adverse Event|0
127959|NCT00838539|463026|P1|Overall Study|Adverse Event|1
127960|NCT00838539|463015|P12|Overall Study|Disease Progression|4
127961|NCT00838539|463016|P11|Overall Study|Disease Progression|1
127962|NCT00838539|463017|P10|Overall Study|Disease Progression|5
127963|NCT00838539|463018|P9|Overall Study|Disease Progression|4
127964|NCT00838539|463019|P8|Overall Study|Disease Progression|4
127965|NCT00838539|463020|P7|Overall Study|Disease Progression|3
127966|NCT00838539|463021|P6|Overall Study|Disease Progression|2
127967|NCT00838539|463022|P5|Overall Study|Disease Progression|4
127968|NCT00838539|463023|P4|Overall Study|Disease Progression|2
127969|NCT00838539|463024|P3|Overall Study|Disease Progression|3
127970|NCT00838539|463025|P2|Overall Study|Disease Progression|4
127971|NCT00838539|463026|P1|Overall Study|Disease Progression|2
127972|NCT00838526|463064|P2|Overall Study|Not specified|7
127973|NCT00838526|463065|P1|Overall Study|Not specified|11
127974|NCT00838526|463064|P2|Overall Study|Lack of Efficacy|3
127975|NCT00838526|463065|P1|Overall Study|Lack of Efficacy|2
127976|NCT00838526|463064|P2|Overall Study|Withdrawal by Subject|5
127977|NCT00838526|463065|P1|Overall Study|Withdrawal by Subject|4
127978|NCT00838526|463064|P2|Overall Study|Lost to Follow-up|12
127979|NCT00838526|463065|P1|Overall Study|Lost to Follow-up|4
127980|NCT00838526|463064|P2|Overall Study|Adverse Event|12
127981|NCT00838526|463065|P1|Overall Study|Adverse Event|3
127982|NCT00838513|463073|P1|Post Treatment Period (Patients Who Disc|Death|1
127983|NCT00838513|463073|P1|Extension Treatment Period|Death|1
127984|NCT00838513|463073|P1|Screening Period|Screen Failure|3
127985|NCT00838331|463089|P1|Aged Blood Transfusion|Withdrawal by Subject|9
127986|NCT00838279|463095|P2|Washout|Withdrawal by Subject|1
127987|NCT00838279|463096|P1|Washout|Withdrawal by Subject|0
127988|NCT00838279|463095|P2|Washout|Protocol Violation|0
127989|NCT00838279|463096|P1|Washout|Protocol Violation|1
127990|NCT00838201|463106|P2|Overall Study|Death|13
127991|NCT00838201|463107|P1|Overall Study|Death|11
127992|NCT00838201|463106|P2|Overall Study|Adverse Event|9
127993|NCT00838201|463107|P1|Overall Study|Adverse Event|5
127994|NCT00838201|463106|P2|Overall Study|Lost to Follow-up|3
127995|NCT00838201|463107|P1|Overall Study|Lost to Follow-up|4
127996|NCT00838201|463106|P2|Overall Study|Consetn withdrawn|19
127997|NCT00838201|463107|P1|Overall Study|Consetn withdrawn|16
127998|NCT00838201|463106|P2|Overall Study|Disease progression|3
127999|NCT00838201|463107|P1|Overall Study|Disease progression|3
128000|NCT00838201|463106|P2|Overall Study|Administrative decision|2
128001|NCT00838201|463107|P1|Overall Study|Administrative decision|1
128002|NCT00838201|463106|P2|Overall Study|Noncompliance|1
128003|NCT00838201|463107|P1|Overall Study|Noncompliance|0
128004|NCT00838201|463106|P2|Overall Study|Investigator decision, or other reasons|3
128005|NCT00838201|463107|P1|Overall Study|Investigator decision, or other reasons|2
128006|NCT00838110|463175|P4|Overall Study|Randomized but not treated|0
128007|NCT00838110|463176|P3|Overall Study|Randomized but not treated|0
128008|NCT00838110|463177|P2|Overall Study|Randomized but not treated|1
128009|NCT00838110|463178|P1|Overall Study|Randomized but not treated|0
128010|NCT00838110|463175|P4|Overall Study|Did not meet eligibility criteria|2
128011|NCT00838110|463176|P3|Overall Study|Did not meet eligibility criteria|1
128012|NCT00838110|463177|P2|Overall Study|Did not meet eligibility criteria|0
128013|NCT00838110|463178|P1|Overall Study|Did not meet eligibility criteria|0
128014|NCT00838110|463175|P4|Overall Study|Lost to Follow-up|0
128015|NCT00838110|463176|P3|Overall Study|Lost to Follow-up|0
128016|NCT00838110|463177|P2|Overall Study|Lost to Follow-up|0
128017|NCT00838110|463178|P1|Overall Study|Lost to Follow-up|3
128018|NCT00838110|463175|P4|Overall Study|Protocol Violation|1
128019|NCT00838110|463176|P3|Overall Study|Protocol Violation|1
128020|NCT00838110|463177|P2|Overall Study|Protocol Violation|2
128021|NCT00838110|463178|P1|Overall Study|Protocol Violation|0
128022|NCT00838110|463175|P4|Overall Study|Other|2
128023|NCT00838110|463176|P3|Overall Study|Other|3
128024|NCT00838110|463177|P2|Overall Study|Other|3
128025|NCT00838110|463178|P1|Overall Study|Other|3
128026|NCT00838110|463175|P4|Overall Study|Withdrawal by Subject|4
128027|NCT00838110|463176|P3|Overall Study|Withdrawal by Subject|3
128028|NCT00838110|463177|P2|Overall Study|Withdrawal by Subject|6
128029|NCT00838110|463178|P1|Overall Study|Withdrawal by Subject|5
128030|NCT00838110|463175|P4|Overall Study|Adverse Event|7
128031|NCT00838110|463176|P3|Overall Study|Adverse Event|8
128032|NCT00838110|463177|P2|Overall Study|Adverse Event|10
128033|NCT00838110|463178|P1|Overall Study|Adverse Event|11
128034|NCT00838110|463175|P4|Overall Study|Death|2
128035|NCT00838110|463176|P3|Overall Study|Death|1
128036|NCT00838110|463177|P2|Overall Study|Death|0
128037|NCT00838110|463178|P1|Overall Study|Death|0
128038|NCT00838097|463198|P1|Overall Study|Protocol-specified criteria|142
128039|NCT00838097|463198|P1|Overall Study|Death|6
128040|NCT00838097|463198|P1|Overall Study|Lost to Follow-up|11
128041|NCT00838097|463198|P1|Overall Study|Physician Decision|4
128042|NCT00838097|463198|P1|Overall Study|Requirement for alternative therapy|2
128043|NCT00838097|463198|P1|Overall Study|Withdrawal by Subject|3
128044|NCT00838097|463198|P1|Overall Study|Adverse Event|2
128045|NCT00838097|463198|P1|Overall Study|Ineligibility determined|6
128046|NCT00837967|463206|P2|Washout Period of 7 - 14 Days|Adverse Event|0
128047|NCT00837967|463207|P1|Washout Period of 7 - 14 Days|Adverse Event|2
128048|NCT00837876|463223|P1|Overall Study|disease progression|24
128049|NCT00837876|463223|P1|Overall Study|Withdrawal by Subject|3
128050|NCT00837876|463223|P1|Overall Study|Physician Decision|1
128051|NCT00837876|463223|P1|Overall Study|Adverse Event|7
128052|NCT00837876|463223|P1|Overall Study|Death|2
128053|NCT00837811|463245|P3|Overall Study|Sponsor Decision|0
128054|NCT00837811|463246|P2|Overall Study|Sponsor Decision|2
128055|NCT00837811|463247|P1|Overall Study|Sponsor Decision|0
128056|NCT00837811|463245|P3|Overall Study|Withdrawal by Subject|0
128057|NCT00837811|463246|P2|Overall Study|Withdrawal by Subject|9
128058|NCT00837811|463247|P1|Overall Study|Withdrawal by Subject|1
128059|NCT00837811|463245|P3|Overall Study|Physician Decision|1
128060|NCT00837811|463246|P2|Overall Study|Physician Decision|2
128061|NCT00837811|463247|P1|Overall Study|Physician Decision|0
128062|NCT00837811|463245|P3|Overall Study|Lost to Follow-up|0
128063|NCT00837811|463246|P2|Overall Study|Lost to Follow-up|3
128064|NCT00837811|463247|P1|Overall Study|Lost to Follow-up|1
128065|NCT00837811|463245|P3|Overall Study|Lack of Efficacy|0
128066|NCT00837811|463246|P2|Overall Study|Lack of Efficacy|11
128067|NCT00837811|463247|P1|Overall Study|Lack of Efficacy|0
128068|NCT00837811|463245|P3|Overall Study|Death|0
128069|NCT00837811|463246|P2|Overall Study|Death|1
128070|NCT00837811|463247|P1|Overall Study|Death|1
128071|NCT00837811|463245|P3|Overall Study|Adverse Event|0
128072|NCT00837811|463246|P2|Overall Study|Adverse Event|6
128073|NCT00837811|463247|P1|Overall Study|Adverse Event|4
128074|NCT00837759|463332|P1|Overall Study|Lost to Follow-up|1
128075|NCT00837759|463332|P1|Overall Study|Protocol Violation|3
128076|NCT00837616|463343|P2|Overall Study|Withdrawal by Subject|1
128077|NCT00837616|463344|P1|Overall Study|Withdrawal by Subject|0
128078|NCT00837577|463370|P2|Open-label Period|Other Reason|1
128079|NCT00837577|463371|P1|Open-label Period|Other Reason|1
128080|NCT00837577|463370|P2|Open-label Period|Withdrawal by Subject|2
128081|NCT00837577|463371|P1|Open-label Period|Withdrawal by Subject|1
128082|NCT00837577|463370|P2|Open-label Period|Lack of Efficacy|3
128083|NCT00837577|463371|P1|Open-label Period|Lack of Efficacy|4
128084|NCT00837577|463370|P2|Open-label Period|Laboratory Adverse Event|1
128085|NCT00837577|463371|P1|Open-label Period|Laboratory Adverse Event|0
128086|NCT00837577|463370|P2|Open-label Period|Clinical Adverse Event|2
128087|NCT00837577|463371|P1|Open-label Period|Clinical Adverse Event|2
128088|NCT00837577|463370|P2|Double-blind Period|Withdrawal by Subject|0
128089|NCT00837577|463371|P1|Double-blind Period|Withdrawal by Subject|1
128090|NCT00837577|463370|P2|Double-blind Period|Clinical Adverse Event|0
128091|NCT00837577|463371|P1|Double-blind Period|Clinical Adverse Event|1
128092|NCT00837486|463391|P2|Long-term Follow-up Phase - Open Label|Death|0
128093|NCT00837486|463392|P1|Long-term Follow-up Phase - Open Label|Death|1
128094|NCT00837486|463391|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
128095|NCT00837486|463392|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
128096|NCT00837486|463391|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
128097|NCT00837486|463392|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
128098|NCT00837486|463391|P2|Blinded-treatment Phase|Physician Decision|0
128099|NCT00837486|463392|P1|Blinded-treatment Phase|Physician Decision|1
128100|NCT00837473|463404|P1|Overall Study|Withdrawal by Subject|2
128101|NCT00837473|463404|P1|Overall Study|Lost to Follow-up|1
128102|NCT00837434|463424|P2|Overall Study|Unable to obtain study drug|0
128103|NCT00837434|463425|P1|Overall Study|Unable to obtain study drug|1
128104|NCT00837434|463424|P2|Overall Study|Baseline assessments not done in time|0
128105|NCT00837434|463425|P1|Overall Study|Baseline assessments not done in time|1
128106|NCT00837434|463424|P2|Overall Study|Noncompliant|0
128107|NCT00837434|463425|P1|Overall Study|Noncompliant|2
128108|NCT00837434|463424|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
128109|NCT00837434|463425|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
128110|NCT00837434|463424|P2|Overall Study|Lost to Follow-up|1
128111|NCT00837434|463425|P1|Overall Study|Lost to Follow-up|1
128112|NCT00837434|463424|P2|Overall Study|Physician Decision|0
128113|NCT00837434|463425|P1|Overall Study|Physician Decision|3
128114|NCT00837330|463445|P2|Overall Study|Lost to Follow-up|3
128115|NCT00837330|463446|P1|Overall Study|Lost to Follow-up|1
128116|NCT00837213|463469|P2|Overall Study|not stated|1
128117|NCT00837213|463470|P1|Overall Study|not stated|1
128118|NCT00837213|463469|P2|Overall Study|Withdrawal by Subject|2
128119|NCT00837213|463470|P1|Overall Study|Withdrawal by Subject|2
128120|NCT00837213|463469|P2|Overall Study|Lost to Follow-up|2
128121|NCT00837213|463470|P1|Overall Study|Lost to Follow-up|3
128122|NCT00837161|463496|P1|Overall Study|refused hysterectomy|2
128123|NCT00837148|463504|P1|Overall Study|Death|1
128124|NCT00837148|463504|P1|Overall Study|Adverse Event|1
128125|NCT00836953|463514|P1|Overall Study|Lost to Follow-up|1
128126|NCT00836953|463514|P1|Overall Study|Withdrawal by Subject|1
128127|NCT00836927|463525|P5|Overall Study|Withdrawal by Subject|0
128128|NCT00836927|463526|P4|Overall Study|Withdrawal by Subject|0
128129|NCT00836927|463527|P3|Overall Study|Withdrawal by Subject|0
128130|NCT00836927|463528|P2|Overall Study|Withdrawal by Subject|0
128131|NCT00836927|463529|P1|Overall Study|Withdrawal by Subject|1
128221|NCT00835731|463999|P1|Overall Study|Physician Decision|1
128132|NCT00836927|463525|P5|Overall Study|Study drug terminated by sponsor|0
128133|NCT00836927|463526|P4|Overall Study|Study drug terminated by sponsor|0
128134|NCT00836927|463527|P3|Overall Study|Study drug terminated by sponsor|1
128135|NCT00836927|463528|P2|Overall Study|Study drug terminated by sponsor|1
128136|NCT00836927|463529|P1|Overall Study|Study drug terminated by sponsor|0
128137|NCT00836927|463525|P5|Overall Study|Progressive disease|1
128138|NCT00836927|463526|P4|Overall Study|Progressive disease|1
128139|NCT00836927|463527|P3|Overall Study|Progressive disease|0
128140|NCT00836927|463528|P2|Overall Study|Progressive disease|0
128141|NCT00836927|463529|P1|Overall Study|Progressive disease|2
128142|NCT00836901|463563|P2|First Intervention|Withdrawal by Subject|0
128143|NCT00836901|463564|P1|First Intervention|Withdrawal by Subject|1
128144|NCT00836875|463580|P2|Overall Study|Withdrawal by Subject|1
128145|NCT00836875|463581|P1|Overall Study|Withdrawal by Subject|0
128146|NCT00836875|463580|P2|Overall Study|Death|2
128147|NCT00836875|463581|P1|Overall Study|Death|3
128148|NCT00836810|463597|P2|Overall Study|New diagnosis|0
128149|NCT00836810|463598|P1|Overall Study|New diagnosis|1
128150|NCT00836745|463614|P1|Overall Study|Other|2
128151|NCT00836745|463614|P1|Overall Study|Objective progression or relapse|4
128152|NCT00836745|463614|P1|Overall Study|Adverse Event|3
128153|NCT00836745|463614|P1|Overall Study|Lost to Follow-up|10
128154|NCT00836745|463614|P1|Overall Study|Death|2
128155|NCT00836706|463628|P2|Washout: 7 Days|Withdrawal by Subject|1
128156|NCT00836706|463629|P1|Washout: 7 Days|Withdrawal by Subject|0
128157|NCT00836693|463639|P2|Overall Study|Lost to Follow-up|0
128158|NCT00836693|463640|P1|Overall Study|Lost to Follow-up|1
128159|NCT00836693|463639|P2|Overall Study|Protocol Violation|0
128160|NCT00836693|463640|P1|Overall Study|Protocol Violation|1
128161|NCT00836693|463639|P2|Overall Study|Withdrawal by Subject|4
128162|NCT00836693|463640|P1|Overall Study|Withdrawal by Subject|9
128163|NCT00836693|463639|P2|Overall Study|Physician Decision|0
128164|NCT00836693|463640|P1|Overall Study|Physician Decision|2
128165|NCT00836693|463639|P2|Overall Study|Sponsor Decision|1
128166|NCT00836693|463640|P1|Overall Study|Sponsor Decision|0
128167|NCT00836693|463639|P2|Overall Study|Adverse Event|1
128168|NCT00836693|463640|P1|Overall Study|Adverse Event|4
128169|NCT00836498|463692|P2|Overall Study|Withdrawal by Subject|1
128170|NCT00836498|463693|P1|Overall Study|Withdrawal by Subject|2
128171|NCT00836498|463692|P2|Overall Study|Lost to Follow-up|0
128172|NCT00836498|463693|P1|Overall Study|Lost to Follow-up|1
128173|NCT00836498|463692|P2|Overall Study|Adverse Event|0
128174|NCT00836498|463693|P1|Overall Study|Adverse Event|1
128175|NCT00836472|463725|P2|Washout|Withdrawal by Subject|1
128176|NCT00836472|463726|P1|Washout|Withdrawal by Subject|1
128177|NCT00836472|463725|P2|Washout|Adverse Event|2
128178|NCT00836472|463726|P1|Washout|Adverse Event|1
128179|NCT00836277|463803|P1|Overall Study|Not evaluable for response|6
128180|NCT00836095|463813|P2|Overall Study|Physician Decision|3
128181|NCT00836095|463814|P1|Overall Study|Physician Decision|0
128182|NCT00836056|463824|P2|First Intervention|Adverse Event|0
128183|NCT00836056|463825|P1|First Intervention|Adverse Event|1
128184|NCT00835991|463854|P2|Washout|Withdrawal by Subject|1
128185|NCT00835991|463855|P1|Washout|Withdrawal by Subject|3
128186|NCT00835991|463854|P2|Washout|Protocol Violation|2
128187|NCT00835991|463855|P1|Washout|Protocol Violation|0
128188|NCT00835991|463854|P2|First Intervention|Adverse Event|1
128189|NCT00835991|463855|P1|First Intervention|Adverse Event|0
128190|NCT00835978|463873|P4|Overall Study|Study terminated by sponsor|0
128191|NCT00835978|463874|P3|Overall Study|Study terminated by sponsor|30
128192|NCT00835978|463875|P2|Overall Study|Study terminated by sponsor|8
128193|NCT00835978|463876|P1|Overall Study|Study terminated by sponsor|12
128194|NCT00835978|463873|P4|Overall Study|Withdrawal by Subject|5
128195|NCT00835978|463874|P3|Overall Study|Withdrawal by Subject|0
128196|NCT00835978|463875|P2|Overall Study|Withdrawal by Subject|3
128197|NCT00835978|463876|P1|Overall Study|Withdrawal by Subject|0
128198|NCT00835978|463873|P4|Overall Study|Adverse Event|0
128199|NCT00835978|463874|P3|Overall Study|Adverse Event|1
128200|NCT00835978|463875|P2|Overall Study|Adverse Event|0
128201|NCT00835978|463876|P1|Overall Study|Adverse Event|1
128202|NCT00835978|463873|P4|Overall Study|Objective progression or relapse|0
128203|NCT00835978|463874|P3|Overall Study|Objective progression or relapse|1
128204|NCT00835978|463875|P2|Overall Study|Objective progression or relapse|0
128205|NCT00835978|463876|P1|Overall Study|Objective progression or relapse|2
128206|NCT00835978|463873|P4|Overall Study|Not Specified|0
128207|NCT00835978|463874|P3|Overall Study|Not Specified|8
128208|NCT00835978|463875|P2|Overall Study|Not Specified|1
128209|NCT00835978|463876|P1|Overall Study|Not Specified|5
128210|NCT00835978|463873|P4|Overall Study|Lost to Follow-up|1
128211|NCT00835978|463874|P3|Overall Study|Lost to Follow-up|2
128212|NCT00835978|463875|P2|Overall Study|Lost to Follow-up|4
128213|NCT00835978|463876|P1|Overall Study|Lost to Follow-up|3
128214|NCT00835978|463873|P4|Overall Study|Death|4
128215|NCT00835978|463874|P3|Overall Study|Death|49
128216|NCT00835978|463875|P2|Overall Study|Death|40
128217|NCT00835978|463876|P1|Overall Study|Death|33
128218|NCT00835796|463987|P2|First Intervention|Withdrawal by Subject|1
128219|NCT00835796|463988|P1|First Intervention|Withdrawal by Subject|0
128220|NCT00835731|463998|P2|Overall Study|Physician Decision|1
128222|NCT00835731|463998|P2|Overall Study|Withdrawal by Subject|0
128223|NCT00835731|463999|P1|Overall Study|Withdrawal by Subject|1
128224|NCT00835705|464019|P2|Second Intervention|Difficulty with vein|0
128225|NCT00835705|464020|P1|Second Intervention|Difficulty with vein|1
128226|NCT00835705|464019|P2|First Intervention|Difficulty with vein|0
128227|NCT00835705|464020|P1|First Intervention|Difficulty with vein|1
128228|NCT00835692|464036|P2|First Intervention|Withdrawal by Subject|0
128229|NCT00835692|464037|P1|First Intervention|Withdrawal by Subject|1
128230|NCT00835679|464049|P4|Overall Study|Withdrawal by Subject|0
128231|NCT00835679|464050|P3|Overall Study|Withdrawal by Subject|0
128232|NCT00835679|464051|P2|Overall Study|Withdrawal by Subject|0
128233|NCT00835679|464052|P1|Overall Study|Withdrawal by Subject|1
128234|NCT00835666|464076|P2|Washout|Withdrawal by Subject|0
128235|NCT00835666|464077|P1|Washout|Withdrawal by Subject|1
128236|NCT00835666|464076|P2|Washout|Protocol Violation|0
128237|NCT00835666|464077|P1|Washout|Protocol Violation|1
128238|NCT00835640|464087|P2|Second Intervention|Protocol Violation|0
128239|NCT00835640|464088|P1|Second Intervention|Protocol Violation|1
128240|NCT00835575|464120|P2|Washout of 14 Days|Withdrawal by Subject|0
128241|NCT00835575|464121|P1|Washout of 14 Days|Withdrawal by Subject|1
128242|NCT00835549|464131|P2|Washout of 7 Days|Withdrawal by Subject|0
128243|NCT00835549|464132|P1|Washout of 7 Days|Withdrawal by Subject|2
128244|NCT00835536|464142|P2|Washout of 5 Weeks|Withdrawal by Subject|0
128245|NCT00835536|464143|P1|Washout of 5 Weeks|Withdrawal by Subject|1
128246|NCT00835406|464204|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
128247|NCT00835406|464205|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
128248|NCT00835406|464204|P2|Period: First Intervention|Withdrawal by Subject|0
128249|NCT00835406|464205|P1|Period: First Intervention|Withdrawal by Subject|2
128250|NCT00835406|464204|P2|Period: First Intervention|Adverse Event|1
128251|NCT00835406|464205|P1|Period: First Intervention|Adverse Event|0
128252|NCT00835380|464211|P1|Overall Study|Withdrawal by Subject|2
128253|NCT00835367|464218|P2|Second Intervention|Adverse Event|1
128254|NCT00835367|464219|P1|Second Intervention|Adverse Event|1
128255|NCT00835367|464218|P2|Washout|Withdrawal by Subject|0
128256|NCT00835367|464219|P1|Washout|Withdrawal by Subject|1
128257|NCT00835367|464218|P2|Washout|Adverse Event|0
128258|NCT00835367|464219|P1|Washout|Adverse Event|2
128259|NCT00835354|464241|P2|First Intervention|Adverse Event|1
128260|NCT00835354|464242|P1|First Intervention|Adverse Event|0
128261|NCT00835341|464252|P2|Overall Study|Lost to Follow-up|12
128262|NCT00835341|464253|P1|Overall Study|Lost to Follow-up|3
128263|NCT00835263|464272|P2|Second Intervention|Adverse Event|0
128264|NCT00835263|464273|P1|Second Intervention|Adverse Event|1
128265|NCT00835237|464283|P2|Overall Study|Withdrawal by Subject|0
128266|NCT00835237|464284|P1|Overall Study|Withdrawal by Subject|2
128267|NCT00835237|464283|P2|Overall Study|Lost to Follow-up|0
128268|NCT00835237|464284|P1|Overall Study|Lost to Follow-up|4
128269|NCT00835211|464324|P2|Washout: 7 Days|Withdrawal by Subject|0
128270|NCT00835211|464325|P1|Washout: 7 Days|Withdrawal by Subject|1
128271|NCT00835211|464324|P2|Washout: 7 Days|Adverse Event|1
128272|NCT00835211|464325|P1|Washout: 7 Days|Adverse Event|2
128273|NCT00835211|464324|P2|First Intervention|Withdrawal by Subject|1
128274|NCT00835211|464325|P1|First Intervention|Withdrawal by Subject|0
128275|NCT00835172|464371|P2|Washout|Protocol Violation|1
128276|NCT00835172|464372|P1|Washout|Protocol Violation|0
128277|NCT00835120|464398|P1|Overall Study|Withdrawal by Subject|2
128278|NCT00835120|464398|P1|Overall Study|Adverse Event|2
128279|NCT00835120|464398|P1|Overall Study|Lost to Follow-up|3
128280|NCT00835120|464398|P1|Overall Study|Lack of Efficacy|1
128281|NCT00835081|464408|P2|Washout of 7 Days|Withdrawal by Subject|0
128282|NCT00835081|464409|P1|Washout of 7 Days|Withdrawal by Subject|1
128283|NCT00835068|464419|P2|Overall Study|Withdrawal by Subject|0
128284|NCT00835068|464420|P1|Overall Study|Withdrawal by Subject|1
128285|NCT00835068|464419|P2|Overall Study|Other|0
128286|NCT00835068|464420|P1|Overall Study|Other|8
128287|NCT00835068|464419|P2|Overall Study|Adverse Event|1
128288|NCT00835068|464420|P1|Overall Study|Adverse Event|0
128289|NCT00835068|464419|P2|Overall Study|Death|0
128290|NCT00835068|464420|P1|Overall Study|Death|1
128291|NCT00835042|464440|P2|Washout of 21 Days|Withdrawal by Subject|2
128292|NCT00835042|464441|P1|Washout of 21 Days|Withdrawal by Subject|0
128293|NCT00835042|464440|P2|First Intervention|Adverse Event|2
128294|NCT00835042|464441|P1|First Intervention|Adverse Event|1
128295|NCT00835042|464440|P2|First Intervention|Withdrawal by Subject|0
128296|NCT00835042|464441|P1|First Intervention|Withdrawal by Subject|3
128297|NCT00834912|464527|P6|Treatment Period 2|Withdrawal by Subject|0
128298|NCT00834912|464528|P5|Treatment Period 2|Withdrawal by Subject|1
128299|NCT00834912|464529|P4|Treatment Period 2|Withdrawal by Subject|0
128300|NCT00834912|464530|P3|Treatment Period 2|Withdrawal by Subject|1
128301|NCT00834912|464531|P2|Treatment Period 2|Withdrawal by Subject|0
128302|NCT00834912|464532|P1|Treatment Period 2|Withdrawal by Subject|0
128303|NCT00834912|464527|P6|Treatment Period 1|Adverse Event|0
128304|NCT00834912|464528|P5|Treatment Period 1|Adverse Event|0
128305|NCT00834912|464529|P4|Treatment Period 1|Adverse Event|1
128306|NCT00834912|464530|P3|Treatment Period 1|Adverse Event|0
128307|NCT00834912|464531|P2|Treatment Period 1|Adverse Event|1
128308|NCT00834912|464532|P1|Treatment Period 1|Adverse Event|0
128309|NCT00834899|464554|P2|Overall Study|Withdrawal by Subject|1
128310|NCT00834899|464555|P1|Overall Study|Withdrawal by Subject|1
128311|NCT00834873|464594|P2|First Intervention|Adverse Event|1
128312|NCT00834873|464595|P1|First Intervention|Adverse Event|0
128313|NCT00834834|464605|P2|Overall Study|Withdrawal by Subject|3
128314|NCT00834834|464606|P1|Overall Study|Withdrawal by Subject|4
128315|NCT00834795|464641|P2|Second Intervention|Adverse Event|0
128316|NCT00834795|464642|P1|Second Intervention|Adverse Event|1
128317|NCT00834795|464641|P2|Washout: 7 Days|Withdrawal by Subject|1
128318|NCT00834795|464642|P1|Washout: 7 Days|Withdrawal by Subject|0
128319|NCT00834756|464652|P2|Washout: 21 Days|Withdrawal by Subject|0
128320|NCT00834756|464653|P1|Washout: 21 Days|Withdrawal by Subject|1
128321|NCT00834756|464652|P2|First Intervention|Adverse Event|0
128322|NCT00834756|464653|P1|First Intervention|Adverse Event|1
128323|NCT00834743|464663|P2|Second Intervention|Withdrawal by Subject|0
128324|NCT00834743|464664|P1|Second Intervention|Withdrawal by Subject|1
128325|NCT00834717|464674|P2|First Intervention|Withdrawal by Subject|1
128326|NCT00834717|464675|P1|First Intervention|Withdrawal by Subject|0
128327|NCT00834717|464674|P2|First Intervention|Adverse Event|0
128328|NCT00834717|464675|P1|First Intervention|Adverse Event|1
128329|NCT00834639|464706|P2|Second Intervention|Physician Decision|2
128330|NCT00834639|464707|P1|Second Intervention|Physician Decision|0
128331|NCT00834613|464724|P2|First Intervention|Protocol Violation|0
128332|NCT00834613|464725|P1|First Intervention|Protocol Violation|1
128333|NCT00834587|464735|P2|Washout: 7 Days|Withdrawal by Subject|0
128334|NCT00834587|464736|P1|Washout: 7 Days|Withdrawal by Subject|1
128335|NCT00834522|464785|P2|Washout|Withdrawal by Subject|1
128336|NCT00834522|464786|P1|Washout|Withdrawal by Subject|2
128337|NCT00834522|464785|P2|Washout|Adverse Event|0
128338|NCT00834522|464786|P1|Washout|Adverse Event|1
128339|NCT00834444|464809|P2|Second Intervention|Adverse Event|0
128340|NCT00834444|464810|P1|Second Intervention|Adverse Event|1
128341|NCT00834444|464809|P2|Washout of 7 Days|Withdrawal by Subject|1
128342|NCT00834444|464810|P1|Washout of 7 Days|Withdrawal by Subject|0
128343|NCT00834444|464809|P2|First Intervention|Intolerance to Venopuncture|1
128344|NCT00834444|464810|P1|First Intervention|Intolerance to Venopuncture|0
128345|NCT00834444|464809|P2|First Intervention|Adverse Event|0
128346|NCT00834444|464810|P1|First Intervention|Adverse Event|1
128347|NCT00834431|464820|P2|Washout of 7 Days|Withdrawal by Subject|1
128348|NCT00834431|464821|P1|Washout of 7 Days|Withdrawal by Subject|0
128349|NCT00834431|464820|P2|First Intervention|Adverse Event|1
128350|NCT00834431|464821|P1|First Intervention|Adverse Event|0
128351|NCT00834418|464831|P2|Overall Study|Adverse Event|2
128352|NCT00834418|464832|P1|Overall Study|Adverse Event|0
128353|NCT00834366|464849|P2|Treatment Period 1|Adverse Event|1
128354|NCT00834366|464850|P1|Treatment Period 1|Adverse Event|1
128355|NCT00834340|464866|P2|Washout|Withdrawal by Subject|0
128356|NCT00834340|464867|P1|Washout|Withdrawal by Subject|1
128357|NCT00834340|464866|P2|Washout|Adverse Event|0
128358|NCT00834340|464867|P1|Washout|Adverse Event|1
128359|NCT00834249|464911|P2|Second Intervention|Adverse Event|0
128360|NCT00834249|464912|P1|Second Intervention|Adverse Event|1
128361|NCT00834249|464911|P2|Washout: 7 Days|Withdrawal by Subject|1
128362|NCT00834249|464912|P1|Washout: 7 Days|Withdrawal by Subject|1
128363|NCT00834080|465008|P1|Overall Study|Subject Relocated|1
128364|NCT00834080|465008|P1|Overall Study|Physician Decision|1
128365|NCT00834080|465008|P1|Overall Study|Other - False positive tests of the UDS|1
128366|NCT00834080|465008|P1|Overall Study|Other - Pregnancy|1
128367|NCT00834080|465008|P1|Overall Study|Withdrawal by Subject|5
128368|NCT00834080|465008|P1|Overall Study|Lost to Follow-up|7
128369|NCT00834080|465008|P1|Overall Study|Adverse Event|7
128370|NCT00834067|465014|P2|Washout of 21 Days|Protocol Violation|1
128371|NCT00834067|465015|P1|Washout of 21 Days|Protocol Violation|0
128372|NCT00834041|465037|P2|Overall Study|Lost to Follow-up|1
128373|NCT00834041|465038|P1|Overall Study|Lost to Follow-up|0
128374|NCT00834041|465037|P2|Overall Study|Withdrawal by Subject|0
128375|NCT00834041|465038|P1|Overall Study|Withdrawal by Subject|1
128376|NCT00833989|465056|P4|Overall Study|Withdrawal by Subject|1
128377|NCT00833989|465057|P3|Overall Study|Withdrawal by Subject|1
128378|NCT00833989|465058|P2|Overall Study|Withdrawal by Subject|0
128379|NCT00833989|465059|P1|Overall Study|Withdrawal by Subject|3
128380|NCT00833989|465056|P4|Overall Study|Physician Decision|1
128381|NCT00833989|465057|P3|Overall Study|Physician Decision|0
128382|NCT00833989|465058|P2|Overall Study|Physician Decision|0
128383|NCT00833989|465059|P1|Overall Study|Physician Decision|0
128384|NCT00833976|465163|P1|Overall Study|Physician Decision|1
128385|NCT00833976|465163|P1|Overall Study|Did not meet eligibility criteria|41
128386|NCT00833976|465163|P1|Overall Study|Lost to Follow-up|4
128387|NCT00833976|465163|P1|Overall Study|Withdrawal by Subject|5
128388|NCT00833937|465171|P2|Washout|Withdrawal by Subject|0
128389|NCT00833937|465172|P1|Washout|Withdrawal by Subject|1
128390|NCT00833924|465180|P1|Overall Study|In study follow-up|71
128391|NCT00833924|465180|P1|Overall Study|Withdrawal by Subject|13
128392|NCT00833924|465180|P1|Overall Study|Lost to Follow-up|2
128393|NCT00833924|465180|P1|Overall Study|Conversion|2
128394|NCT00833924|465180|P1|Overall Study|Death|21
128395|NCT00833911|465185|P1|Maintenance Phase II|Lack of Efficacy|1
128396|NCT00833911|465185|P1|Maintenance Phase II|Withdrawal by Subject|1
128397|NCT00833911|465185|P1|Maintenance Phase II|Physician Decision|2
128398|NCT00833911|465185|P1|Maintenance Phase II|Adverse Event|6
128399|NCT00833911|465185|P1|Maintenance Phase I|Lack of Efficacy|4
128400|NCT00833911|465185|P1|Maintenance Phase I|Physician Decision|10
128401|NCT00833911|465185|P1|Maintenance Phase I|Withdrawal by Subject|11
128402|NCT00833911|465185|P1|Maintenance Phase I|Adverse Event|73
128403|NCT00833911|465185|P1|Titration|Withdrawal by Subject|3
128404|NCT00833911|465185|P1|Titration|Adverse Event|18
128405|NCT00833898|465195|P2|Overall Study|Patient did not receive transplant|2
128406|NCT00833898|465196|P1|Overall Study|Patient did not receive transplant|0
128407|NCT00833898|465195|P2|Overall Study|Lost to Follow-up|7
128408|NCT00833898|465196|P1|Overall Study|Lost to Follow-up|7
128409|NCT00833898|465195|P2|Overall Study|Withdrawal by Subject|27
128410|NCT00833898|465196|P1|Overall Study|Withdrawal by Subject|33
128411|NCT00833833|465255|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
128412|NCT00833833|465256|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
128413|NCT00833833|465257|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
128414|NCT00833833|465258|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
128415|NCT00833833|465259|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
128416|NCT00833833|465260|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
128417|NCT00833833|465255|P6|Phase 2 (as of 01 April 2011)|Other|3
128418|NCT00833833|465256|P5|Phase 2 (as of 01 April 2011)|Other|4
128419|NCT00833833|465257|P4|Phase 2 (as of 01 April 2011)|Other|0
128420|NCT00833833|465258|P3|Phase 2 (as of 01 April 2011)|Other|0
128421|NCT00833833|465259|P2|Phase 2 (as of 01 April 2011)|Other|0
128422|NCT00833833|465260|P1|Phase 2 (as of 01 April 2011)|Other|0
128423|NCT00833833|465255|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
128424|NCT00833833|465256|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
128425|NCT00833833|465257|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
128426|NCT00833833|465258|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
128427|NCT00833833|465259|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
128428|NCT00833833|465260|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
128429|NCT00833833|465255|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
128430|NCT00833833|465256|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
128431|NCT00833833|465257|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
128432|NCT00833833|465258|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
128433|NCT00833833|465259|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
128434|NCT00833833|465260|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
128435|NCT00833833|465255|P6|Phase 2 (as of 01 April 2011)|Death|9
128436|NCT00833833|465256|P5|Phase 2 (as of 01 April 2011)|Death|8
128437|NCT00833833|465257|P4|Phase 2 (as of 01 April 2011)|Death|0
128438|NCT00833833|465258|P3|Phase 2 (as of 01 April 2011)|Death|0
128439|NCT00833833|465259|P2|Phase 2 (as of 01 April 2011)|Death|0
128440|NCT00833833|465260|P1|Phase 2 (as of 01 April 2011)|Death|0
128441|NCT00833833|465255|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
128442|NCT00833833|465256|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
128443|NCT00833833|465257|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
128444|NCT00833833|465258|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
128445|NCT00833833|465259|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
128446|NCT00833833|465260|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
128447|NCT00833833|465255|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
128448|NCT00833833|465256|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
128449|NCT00833833|465257|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
128450|NCT00833833|465258|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
128451|NCT00833833|465259|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
128452|NCT00833833|465260|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
128453|NCT00833833|465255|P6|Phase 1 (as of 01 April 2011)|Other|0
128454|NCT00833833|465256|P5|Phase 1 (as of 01 April 2011)|Other|0
128455|NCT00833833|465257|P4|Phase 1 (as of 01 April 2011)|Other|1
128456|NCT00833833|465258|P3|Phase 1 (as of 01 April 2011)|Other|0
128457|NCT00833833|465259|P2|Phase 1 (as of 01 April 2011)|Other|3
128458|NCT00833833|465260|P1|Phase 1 (as of 01 April 2011)|Other|1
128459|NCT00833833|465255|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
128460|NCT00833833|465256|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
128461|NCT00833833|465257|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
128462|NCT00833833|465258|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
128463|NCT00833833|465259|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
128464|NCT00833833|465260|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
128465|NCT00833833|465255|P6|Phase 1 (as of 01 April 2011)|Death|0
128466|NCT00833833|465256|P5|Phase 1 (as of 01 April 2011)|Death|0
128467|NCT00833833|465257|P4|Phase 1 (as of 01 April 2011)|Death|0
128468|NCT00833833|465258|P3|Phase 1 (as of 01 April 2011)|Death|2
128469|NCT00833833|465259|P2|Phase 1 (as of 01 April 2011)|Death|1
128470|NCT00833833|465260|P1|Phase 1 (as of 01 April 2011)|Death|0
128471|NCT00833833|465255|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
128472|NCT00833833|465256|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
128473|NCT00833833|465257|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
128474|NCT00833833|465258|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
128475|NCT00833833|465259|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
128476|NCT00833833|465260|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
128477|NCT00833833|465255|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
128478|NCT00833833|465256|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
128479|NCT00833833|465257|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
128480|NCT00833833|465258|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
128481|NCT00833833|465259|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
128482|NCT00833833|465260|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
128483|NCT00833833|465255|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
128484|NCT00833833|465256|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
128485|NCT00833833|465257|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
128486|NCT00833833|465258|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
128487|NCT00833833|465259|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
128488|NCT00833833|465260|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
128489|NCT00833794|465300|P2|Double-blind Phase|Administrative reason|3
128490|NCT00833794|465301|P1|Double-blind Phase|Administrative reason|1
128491|NCT00833794|465300|P2|Double-blind Phase|Physician Decision|7
128492|NCT00833794|465301|P1|Double-blind Phase|Physician Decision|4
128493|NCT00833794|465300|P2|Double-blind Phase|Withdrawal by Subject|6
128494|NCT00833794|465301|P1|Double-blind Phase|Withdrawal by Subject|23
128495|NCT00833794|465300|P2|Double-blind Phase|Lack of Efficacy|22
128496|NCT00833794|465301|P1|Double-blind Phase|Lack of Efficacy|34
128497|NCT00833794|465300|P2|Double-blind Phase|Adverse Event|11
128498|NCT00833794|465301|P1|Double-blind Phase|Adverse Event|44
128499|NCT00833794|465300|P2|Open-label Phase|enrolled in error (immediately D/C)|0
128500|NCT00833794|465301|P1|Open-label Phase|enrolled in error (immediately D/C)|1
128501|NCT00833794|465300|P2|Open-label Phase|Did not complete wash-out period|0
128502|NCT00833794|465301|P1|Open-label Phase|Did not complete wash-out period|12
128503|NCT00833794|465300|P2|Open-label Phase|Protocol Violation|0
128504|NCT00833794|465301|P1|Open-label Phase|Protocol Violation|47
128505|NCT00833794|465300|P2|Open-label Phase|Administrative reason|0
128506|NCT00833794|465301|P1|Open-label Phase|Administrative reason|1
128507|NCT00833794|465300|P2|Open-label Phase|Physician Decision|0
128508|NCT00833794|465301|P1|Open-label Phase|Physician Decision|20
128509|NCT00833794|465300|P2|Open-label Phase|Withdrawal by Subject|0
128510|NCT00833794|465301|P1|Open-label Phase|Withdrawal by Subject|48
128511|NCT00833794|465300|P2|Open-label Phase|Lack of Efficacy|0
128512|NCT00833794|465301|P1|Open-label Phase|Lack of Efficacy|28
128513|NCT00833794|465300|P2|Open-label Phase|Adverse Event|0
128514|NCT00833794|465301|P1|Open-label Phase|Adverse Event|225
128515|NCT00833755|465345|P4|Overall Study|Subject had scheduling issues|0
128516|NCT00833755|465346|P3|Overall Study|Subject had scheduling issues|0
128517|NCT00833755|465347|P2|Overall Study|Subject had scheduling issues|1
128518|NCT00833755|465348|P1|Overall Study|Subject had scheduling issues|0
128519|NCT00833755|465345|P4|Overall Study|Physician Decision|6
128520|NCT00833755|465346|P3|Overall Study|Physician Decision|2
128521|NCT00833755|465347|P2|Overall Study|Physician Decision|4
128522|NCT00833755|465348|P1|Overall Study|Physician Decision|4
128523|NCT00833703|465368|P2|Overall Study|Parent(s)/guardian(s)'s request|1
128524|NCT00833703|465369|P1|Overall Study|Parent(s)/guardian(s)'s request|0
128525|NCT00833690|465382|P3|Overall Study|Discontinued study drug|0
128526|NCT00833690|465383|P2|Overall Study|Discontinued study drug|2
128527|NCT00833690|465384|P1|Overall Study|Discontinued study drug|3
128528|NCT00833690|465382|P3|Overall Study|Withdrawal by Subject|0
128529|NCT00833690|465383|P2|Overall Study|Withdrawal by Subject|0
128530|NCT00833690|465384|P1|Overall Study|Withdrawal by Subject|1
128531|NCT00833638|465520|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
128532|NCT00833638|465521|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
128533|NCT00833638|465522|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
128534|NCT00833638|465520|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
128535|NCT00833638|465521|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
128536|NCT00833638|465522|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
128537|NCT00833638|465520|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
128538|NCT00833638|465521|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
128539|NCT00833638|465522|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
128540|NCT00833638|465520|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
128541|NCT00833638|465521|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
128542|NCT00833638|465522|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
128543|NCT00833638|465520|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
128544|NCT00833638|465521|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
128545|NCT00833638|465522|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
128546|NCT00833638|465520|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
128547|NCT00833638|465521|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
128548|NCT00833638|465522|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
128549|NCT00833638|465520|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
128550|NCT00833638|465521|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
128551|NCT00833638|465522|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
128552|NCT00833638|465520|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
128553|NCT00833638|465521|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
128554|NCT00833638|465522|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
128555|NCT00833638|465520|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
128556|NCT00833638|465521|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
128557|NCT00833638|465522|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
128558|NCT00833560|465573|P1|Overall Study|Not specified|5
128559|NCT00833560|465573|P1|Overall Study|Pregression of other disease|1
128560|NCT00833560|465573|P1|Overall Study|Death|2
128561|NCT00833560|465573|P1|Overall Study|Lack of Efficacy|4
128562|NCT00833560|465573|P1|Overall Study|Protocol Violation|6
128563|NCT00833560|465573|P1|Overall Study|Adverse Event|11
128564|NCT00833560|465573|P1|Overall Study|Toxicity|13
128565|NCT00833547|465582|P2|Overall Study|Withdrawal by Subject|2
128566|NCT00833547|465583|P1|Overall Study|Withdrawal by Subject|2
128567|NCT00833482|465604|P6|Days 21-30|Withdrawal by Subject|0
128568|NCT00833482|465605|P5|Days 21-30|Withdrawal by Subject|1
128569|NCT00833482|465606|P4|Days 21-30|Withdrawal by Subject|0
128570|NCT00833482|465607|P3|Days 21-30|Withdrawal by Subject|0
128571|NCT00833482|465608|P2|Days 21-30|Withdrawal by Subject|0
128572|NCT00833482|465609|P1|Days 21-30|Withdrawal by Subject|0
128573|NCT00833482|465604|P6|Days 21-30|Adverse Event|0
128574|NCT00833482|465605|P5|Days 21-30|Adverse Event|0
128575|NCT00833482|465606|P4|Days 21-30|Adverse Event|0
128576|NCT00833482|465607|P3|Days 21-30|Adverse Event|1
128577|NCT00833482|465608|P2|Days 21-30|Adverse Event|0
128578|NCT00833482|465609|P1|Days 21-30|Adverse Event|0
128579|NCT00833482|465604|P6|Days 11-20|Withdrawal by Subject|0
128580|NCT00833482|465605|P5|Days 11-20|Withdrawal by Subject|0
128581|NCT00833482|465606|P4|Days 11-20|Withdrawal by Subject|0
128582|NCT00833482|465607|P3|Days 11-20|Withdrawal by Subject|0
128583|NCT00833482|465608|P2|Days 11-20|Withdrawal by Subject|1
128584|NCT00833482|465609|P1|Days 11-20|Withdrawal by Subject|0
128585|NCT00833482|465604|P6|Days 11-20|Adverse Event|0
128586|NCT00833482|465605|P5|Days 11-20|Adverse Event|0
128587|NCT00833482|465606|P4|Days 11-20|Adverse Event|0
128588|NCT00833482|465607|P3|Days 11-20|Adverse Event|0
128589|NCT00833482|465608|P2|Days 11-20|Adverse Event|2
128590|NCT00833482|465609|P1|Days 11-20|Adverse Event|0
128591|NCT00833469|465665|P1|Overall Study|Lost to Follow-up|1
128592|NCT00833469|465665|P1|Overall Study|Withdrawal by Subject|1
128593|NCT00833417|465688|P2|Overall Study|Reason Not Specified|1
128594|NCT00833417|465689|P1|Overall Study|Reason Not Specified|0
128595|NCT00833417|465688|P2|Overall Study|Disease Progression|17
128596|NCT00833417|465689|P1|Overall Study|Disease Progression|18
128597|NCT00833417|465688|P2|Overall Study|Sponsor Decision to Terminate Study|2
128598|NCT00833417|465689|P1|Overall Study|Sponsor Decision to Terminate Study|1
128599|NCT00833417|465688|P2|Overall Study|Patient Decision to Withdraw|23
128600|NCT00833417|465689|P1|Overall Study|Patient Decision to Withdraw|4
128601|NCT00833417|465688|P2|Overall Study|Physician Decision to Withdraw Patient|7
128602|NCT00833417|465689|P1|Overall Study|Physician Decision to Withdraw Patient|3
128603|NCT00833417|465688|P2|Overall Study|Lost to Follow-up|2
128604|NCT00833417|465689|P1|Overall Study|Lost to Follow-up|1
128605|NCT00833417|465688|P2|Overall Study|Death|3
128606|NCT00833417|465689|P1|Overall Study|Death|1
128607|NCT00833417|465688|P2|Overall Study|Adverse Event|16
128608|NCT00833417|465689|P1|Overall Study|Adverse Event|5
128609|NCT00833248|465715|P2|Overall Study|Withdrawal by Subject|1
128610|NCT00833248|465716|P1|Overall Study|Withdrawal by Subject|0
128611|NCT00833248|465715|P2|Overall Study|Protocol Violation|2
128612|NCT00833248|465716|P1|Overall Study|Protocol Violation|1
128613|NCT00833248|465715|P2|Overall Study|Adverse Event|0
128614|NCT00833248|465716|P1|Overall Study|Adverse Event|3
128615|NCT00833092|465740|P2|Overall Study|constipation|1
128616|NCT00833092|465741|P1|Overall Study|constipation|0
128617|NCT00833092|465740|P2|Overall Study|Diarrhea|2
128618|NCT00833092|465741|P1|Overall Study|Diarrhea|0
128619|NCT00833092|465740|P2|Overall Study|Protocol Violation|1
128620|NCT00833092|465741|P1|Overall Study|Protocol Violation|2
128621|NCT00833092|465740|P2|Overall Study|Withdrawal by Subject|3
128622|NCT00833092|465741|P1|Overall Study|Withdrawal by Subject|2
128623|NCT00833053|465749|P2|Overall Study|Protocol Violation|1
128624|NCT00833053|465750|P1|Overall Study|Protocol Violation|2
128625|NCT00833053|465749|P2|Overall Study|Withdrawal by Subject|1
128626|NCT00833053|465750|P1|Overall Study|Withdrawal by Subject|0
128627|NCT00833053|465749|P2|Overall Study|Treatment Failure|1
128628|NCT00833053|465750|P1|Overall Study|Treatment Failure|3
128629|NCT00833053|465749|P2|Overall Study|Adverse Event|0
128630|NCT00833053|465750|P1|Overall Study|Adverse Event|4
128631|NCT00833040|465768|P6|Overall Study|Adverse Event|1
128632|NCT00833040|465769|P5|Overall Study|Adverse Event|0
128633|NCT00833040|465770|P4|Overall Study|Adverse Event|0
128634|NCT00833040|465771|P3|Overall Study|Adverse Event|0
128635|NCT00833040|465772|P2|Overall Study|Adverse Event|0
128636|NCT00833040|465773|P1|Overall Study|Adverse Event|0
128637|NCT00833027|465778|P1|Overall Study|Missing|10
128638|NCT00833027|465778|P1|Overall Study|Withdrawal by Subject|16
128639|NCT00833027|465778|P1|Overall Study|Protocol Violation|115
128640|NCT00833027|465778|P1|Overall Study|Lost to Follow-up|24
128641|NCT00833027|465778|P1|Overall Study|Lack of Efficacy|12
128642|NCT00833027|465778|P1|Overall Study|Death|1
128643|NCT00833027|465778|P1|Overall Study|Adverse Event|33
128644|NCT00832975|465783|P1|Overall Study|Other reasons|14
128645|NCT00832975|465783|P1|Overall Study|Withdrawal by Subject|3
128646|NCT00832975|465783|P1|Overall Study|Physician Decision|4
128647|NCT00832975|465783|P1|Overall Study|Death|5
128648|NCT00832975|465783|P1|Overall Study|Protocol Violation|6
128649|NCT00832975|465783|P1|Overall Study|Lost to Follow-up|7
128650|NCT00832819|465797|P3|Overall Study|Protocol Violation|1
128651|NCT00832819|465798|P2|Overall Study|Protocol Violation|0
128652|NCT00832819|465799|P1|Overall Study|Protocol Violation|0
128653|NCT00832819|465797|P3|Overall Study|Adverse Event|0
128654|NCT00832819|465798|P2|Overall Study|Adverse Event|1
128655|NCT00832819|465799|P1|Overall Study|Adverse Event|0
128656|NCT00832780|465805|P1|Overall Study|Physician Decision|1
128657|NCT00832780|465805|P1|Overall Study|other complicating condition|2
128658|NCT00832780|465805|P1|Overall Study|no reason given|2
128659|NCT00832780|465805|P1|Overall Study|Lost to Follow-up|4
128660|NCT00832780|465805|P1|Overall Study|Death|16
128661|NCT00832650|465847|P3|Overall Study|Randomized but not treated|1
128662|NCT00832650|465848|P2|Overall Study|Randomized but not treated|0
128663|NCT00832650|465849|P1|Overall Study|Randomized but not treated|0
128664|NCT00832624|465889|P1|Overall Study|Study Terminated|10
128665|NCT00832585|465899|P1|Overall Study|Lost to Follow-up|1
128666|NCT00832585|465899|P1|Overall Study|Withdrawal by Subject|1
128667|NCT00832455|465924|P1|Overall Study|Patient moved|1
128668|NCT00832455|465924|P1|Overall Study|No improvement|3
128669|NCT00832455|465924|P1|Overall Study|Parent dissatisfied|1
128670|NCT00832455|465924|P1|Overall Study|Parent misunderstood study|1
128671|NCT00832455|465924|P1|Overall Study|Stopped Medication|4
128672|NCT00832455|465924|P1|Overall Study|Screening Failure|2
128673|NCT00832455|465924|P1|Overall Study|Withdrawal by Subject|17
128674|NCT00832455|465924|P1|Overall Study|Protocol Violation|4
128675|NCT00832455|465924|P1|Overall Study|Lost to Follow-up|26
128676|NCT00832455|465924|P1|Overall Study|Adverse Event|13
128677|NCT00832416|465948|P4|Overall Study|Death|0
128678|NCT00832416|465949|P3|Overall Study|Death|0
128679|NCT00832416|465950|P2|Overall Study|Death|0
128680|NCT00832416|465951|P1|Overall Study|Death|1
128681|NCT00832416|465948|P4|Overall Study|Adverse Event|10
128682|NCT00832416|465949|P3|Overall Study|Adverse Event|41
128683|NCT00832416|465950|P2|Overall Study|Adverse Event|19
128684|NCT00832416|465951|P1|Overall Study|Adverse Event|21
128685|NCT00832416|465948|P4|Overall Study|Administrative|1
128686|NCT00832416|465949|P3|Overall Study|Administrative|0
128687|NCT00832416|465950|P2|Overall Study|Administrative|0
128688|NCT00832416|465951|P1|Overall Study|Administrative|0
128689|NCT00832416|465948|P4|Overall Study|Physician Decision|10
128690|NCT00832416|465949|P3|Overall Study|Physician Decision|5
128691|NCT00832416|465950|P2|Overall Study|Physician Decision|12
128692|NCT00832416|465951|P1|Overall Study|Physician Decision|2
128693|NCT00832416|465948|P4|Overall Study|Withdrawal by Subject|10
128694|NCT00832416|465949|P3|Overall Study|Withdrawal by Subject|2
128695|NCT00832416|465950|P2|Overall Study|Withdrawal by Subject|7
128696|NCT00832416|465951|P1|Overall Study|Withdrawal by Subject|5
128697|NCT00832416|465948|P4|Overall Study|Lack of Efficacy|52
128698|NCT00832416|465949|P3|Overall Study|Lack of Efficacy|13
128699|NCT00832416|465950|P2|Overall Study|Lack of Efficacy|15
128700|NCT00832416|465951|P1|Overall Study|Lack of Efficacy|17
128701|NCT00832377|466002|P1|Overall Study|Protocol Violation|1
128702|NCT00832117|466048|P1|Overall Study|Disease Progression|11
128703|NCT00832117|466048|P1|Overall Study|Death|1
128704|NCT00832091|466067|P2|Overall Study|Prohibited Medication|0
128705|NCT00832091|466068|P1|Overall Study|Prohibited Medication|1
128706|NCT00832091|466067|P2|Overall Study|Withdrawal by Subject|1
128707|NCT00832091|466068|P1|Overall Study|Withdrawal by Subject|2
128708|NCT00832091|466067|P2|Overall Study|Protocol Violation|0
128709|NCT00832091|466068|P1|Overall Study|Protocol Violation|1
128710|NCT00832091|466067|P2|Overall Study|Adverse Event|1
128711|NCT00832091|466068|P1|Overall Study|Adverse Event|1
128712|NCT00832078|466076|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
128713|NCT00832078|466077|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
128714|NCT00832078|466076|P2|Test Day 1-2 Period|Lack of Efficacy|2
128715|NCT00832078|466077|P1|Test Day 1-2 Period|Lack of Efficacy|0
128716|NCT00832000|466083|P2|Overall Study|No calls to IVR in period 2|0
128717|NCT00832000|466084|P1|Overall Study|No calls to IVR in period 2|2
128718|NCT00832000|466083|P2|Overall Study|No calls to IVR in either period|1
128719|NCT00832000|466084|P1|Overall Study|No calls to IVR in either period|1
128720|NCT00832000|466083|P2|Overall Study|Withdrawal by Subject|0
128721|NCT00832000|466084|P1|Overall Study|Withdrawal by Subject|1
128722|NCT00832000|466083|P2|Overall Study|Adverse Event|0
128723|NCT00832000|466084|P1|Overall Study|Adverse Event|2
128724|NCT00831844|466145|P10|Overall Study|Ineligible|0
128725|NCT00831844|466146|P9|Overall Study|Ineligible|0
128726|NCT00831844|466147|P8|Overall Study|Ineligible|0
128727|NCT00831844|466148|P7|Overall Study|Ineligible|0
128728|NCT00831844|466149|P6|Overall Study|Ineligible|0
128729|NCT00831844|466150|P5|Overall Study|Ineligible|1
128730|NCT00831844|466151|P4|Overall Study|Ineligible|0
128731|NCT00831844|466152|P3|Overall Study|Ineligible|1
128732|NCT00831844|466153|P2|Overall Study|Ineligible|1
128733|NCT00831844|466154|P1|Overall Study|Ineligible|0
128734|NCT00831844|466145|P10|Overall Study|Withdrawal by Subject|0
128735|NCT00831844|466146|P9|Overall Study|Withdrawal by Subject|1
128736|NCT00831844|466147|P8|Overall Study|Withdrawal by Subject|1
128737|NCT00831844|466148|P7|Overall Study|Withdrawal by Subject|0
128738|NCT00831844|466149|P6|Overall Study|Withdrawal by Subject|0
128739|NCT00831844|466150|P5|Overall Study|Withdrawal by Subject|0
128740|NCT00831844|466151|P4|Overall Study|Withdrawal by Subject|0
128741|NCT00831844|466152|P3|Overall Study|Withdrawal by Subject|1
128742|NCT00831844|466153|P2|Overall Study|Withdrawal by Subject|0
128743|NCT00831844|466154|P1|Overall Study|Withdrawal by Subject|0
128744|NCT00831844|466145|P10|Overall Study|Physician Decision|0
128745|NCT00831844|466146|P9|Overall Study|Physician Decision|1
128746|NCT00831844|466147|P8|Overall Study|Physician Decision|0
128747|NCT00831844|466148|P7|Overall Study|Physician Decision|0
128748|NCT00831844|466149|P6|Overall Study|Physician Decision|1
128749|NCT00831844|466150|P5|Overall Study|Physician Decision|1
128750|NCT00831844|466151|P4|Overall Study|Physician Decision|1
128751|NCT00831844|466152|P3|Overall Study|Physician Decision|3
128752|NCT00831844|466153|P2|Overall Study|Physician Decision|1
128753|NCT00831844|466154|P1|Overall Study|Physician Decision|0
128754|NCT00831844|466145|P10|Overall Study|Lack of Efficacy|0
128755|NCT00831844|466146|P9|Overall Study|Lack of Efficacy|7
128756|NCT00831844|466147|P8|Overall Study|Lack of Efficacy|9
128757|NCT00831844|466148|P7|Overall Study|Lack of Efficacy|8
128758|NCT00831844|466149|P6|Overall Study|Lack of Efficacy|17
128759|NCT00831844|466150|P5|Overall Study|Lack of Efficacy|11
128760|NCT00831844|466151|P4|Overall Study|Lack of Efficacy|8
128761|NCT00831844|466152|P3|Overall Study|Lack of Efficacy|15
128762|NCT00831844|466153|P2|Overall Study|Lack of Efficacy|10
128763|NCT00831844|466154|P1|Overall Study|Lack of Efficacy|8
128764|NCT00831844|466145|P10|Overall Study|Death|0
128765|NCT00831844|466146|P9|Overall Study|Death|0
128766|NCT00831844|466147|P8|Overall Study|Death|0
128767|NCT00831844|466148|P7|Overall Study|Death|0
128768|NCT00831844|466149|P6|Overall Study|Death|0
128769|NCT00831844|466150|P5|Overall Study|Death|0
128770|NCT00831844|466151|P4|Overall Study|Death|1
128771|NCT00831844|466152|P3|Overall Study|Death|0
128772|NCT00831844|466153|P2|Overall Study|Death|0
128773|NCT00831844|466154|P1|Overall Study|Death|0
128774|NCT00831844|466145|P10|Overall Study|Adverse Event|0
128775|NCT00831844|466146|P9|Overall Study|Adverse Event|0
128776|NCT00831844|466147|P8|Overall Study|Adverse Event|0
128777|NCT00831844|466148|P7|Overall Study|Adverse Event|2
128778|NCT00831844|466149|P6|Overall Study|Adverse Event|1
128779|NCT00831844|466150|P5|Overall Study|Adverse Event|1
128780|NCT00831844|466151|P4|Overall Study|Adverse Event|0
128781|NCT00831844|466152|P3|Overall Study|Adverse Event|0
128782|NCT00831844|466153|P2|Overall Study|Adverse Event|0
128783|NCT00831844|466154|P1|Overall Study|Adverse Event|2
128784|NCT00831779|466178|P2|Overall Study|No longer met criteria|1
128785|NCT00831779|466179|P1|Overall Study|No longer met criteria|0
128786|NCT00831779|466178|P2|Overall Study|Lost to Follow-up|0
128787|NCT00831779|466179|P1|Overall Study|Lost to Follow-up|1
128788|NCT00831701|466213|P2|Overall Study|Lost to Follow-up|3
128789|NCT00831701|466214|P1|Overall Study|Lost to Follow-up|1
128790|NCT00831701|466213|P2|Overall Study|Stone expulsion before first medication|2
128791|NCT00831701|466214|P1|Overall Study|Stone expulsion before first medication|2
128792|NCT00831701|466213|P2|Overall Study|Withdrawal by Subject|0
128793|NCT00831701|466214|P1|Overall Study|Withdrawal by Subject|2
128794|NCT00831493|466243|P1|Overall Study|Intractable nausea and vomiting|1
128795|NCT00831441|466253|P2|Follow Up (30 Days)|missing end of study status|1
128796|NCT00831441|466254|P1|Follow Up (30 Days)|missing end of study status|0
128797|NCT00831441|466253|P2|Follow Up (30 Days)|non-specified|26
128798|NCT00831441|466254|P1|Follow Up (30 Days)|non-specified|16
128799|NCT00831441|466253|P2|Follow Up (30 Days)|Death|86
128800|NCT00831441|466254|P1|Follow Up (30 Days)|Death|63
128801|NCT00831441|466253|P2|Follow Up (30 Days)|Lost to Follow-up|27
128802|NCT00831441|466254|P1|Follow Up (30 Days)|Lost to Follow-up|13
128803|NCT00831441|466253|P2|Follow Up (30 Days)|Withdrawal by Subject|34
128804|NCT00831441|466254|P1|Follow Up (30 Days)|Withdrawal by Subject|41
128805|NCT00831441|466253|P2|Randomized|non-specified|266
128806|NCT00831441|466254|P1|Randomized|non-specified|276
128807|NCT00831441|466253|P2|Randomized|poor/non-compliance|38
128808|NCT00831441|466254|P1|Randomized|poor/non-compliance|30
128809|NCT00831441|466253|P2|Randomized|Administrative reason by sponsor|2671
128810|NCT00831441|466254|P1|Randomized|Administrative reason by sponsor|2780
128811|NCT00831441|466253|P2|Randomized|Lost to Follow-up|35
128812|NCT00831441|466254|P1|Randomized|Lost to Follow-up|26
128813|NCT00831441|466253|P2|Randomized|Withdrawal by Subject|212
128814|NCT00831441|466254|P1|Randomized|Withdrawal by Subject|178
128815|NCT00831441|466253|P2|Randomized|No longer met criteria|19
128816|NCT00831441|466254|P1|Randomized|No longer met criteria|13
128817|NCT00831441|466253|P2|Randomized|Physician Decision|35
128818|NCT00831441|466254|P1|Randomized|Physician Decision|26
128819|NCT00831441|466253|P2|Randomized|Elective procedure|25
128820|NCT00831441|466254|P1|Randomized|Elective procedure|26
128821|NCT00831441|466253|P2|Randomized|Emergency procedure|2
128822|NCT00831441|466254|P1|Randomized|Emergency procedure|2
128823|NCT00831441|466253|P2|Randomized|Adverse Event|321
128824|NCT00831441|466254|P1|Randomized|Adverse Event|248
128825|NCT00831441|466253|P2|Randomized|Death|81
128826|NCT00831441|466254|P1|Randomized|Death|82
128827|NCT00831415|466286|P1|Overall Study|Death|1
128828|NCT00831415|466286|P1|Overall Study|Unsatisfactory response - Efficacy|4
128829|NCT00831415|466286|P1|Overall Study|Withdrawal by Subject|35
128830|NCT00831415|466286|P1|Overall Study|Protocol Violation|3
128831|NCT00831415|466286|P1|Overall Study|Lost to Follow-up|9
128832|NCT00831415|466286|P1|Overall Study|Physician Decision|6
128833|NCT00831415|466286|P1|Overall Study|Failed to return|3
128834|NCT00831415|466286|P1|Overall Study|Adverse Event|14
128835|NCT00831389|466295|P2|Overall Study|Withdrawal by Subject|1
128836|NCT00831389|466296|P1|Overall Study|Withdrawal by Subject|0
128837|NCT00831311|466322|P2|Overall Study|Withdrawal by Subject|4
128838|NCT00831311|466323|P1|Overall Study|Withdrawal by Subject|6
128839|NCT00831311|466322|P2|Overall Study|Physician Decision|1
128840|NCT00831311|466323|P1|Overall Study|Physician Decision|0
128841|NCT00831311|466322|P2|Overall Study|Lost to Follow-up|0
128842|NCT00831311|466323|P1|Overall Study|Lost to Follow-up|3
128843|NCT00831311|466322|P2|Overall Study|Definitive Contraindication|3
128844|NCT00831311|466323|P1|Overall Study|Definitive Contraindication|3
128845|NCT00831233|466360|P2|Overall Study|Selection Criteria Not Met|0
128846|NCT00831233|466361|P1|Overall Study|Selection Criteria Not Met|2
128847|NCT00831233|466360|P2|Overall Study|Protocol Violation|0
128848|NCT00831233|466361|P1|Overall Study|Protocol Violation|1
128849|NCT00831233|466360|P2|Overall Study|Adverse Event|1
128850|NCT00831233|466361|P1|Overall Study|Adverse Event|0
128851|NCT00831181|466385|P1|Overall Study|Adverse Event|12
128852|NCT00831129|466398|P2|Overall Study|9 lost to follow-up reasons uknown|9
128853|NCT00831129|466399|P1|Overall Study|9 lost to follow-up reasons uknown|0
128854|NCT00831129|466398|P2|Overall Study|Adverse Event|1
128855|NCT00831129|466399|P1|Overall Study|Adverse Event|0
128856|NCT00830960|466441|P6|Overall Study|No study drug received|7
128857|NCT00830960|466442|P5|Overall Study|No study drug received|5
128858|NCT00830960|466443|P4|Overall Study|No study drug received|3
128859|NCT00830960|466444|P3|Overall Study|No study drug received|4
128860|NCT00830960|466445|P2|Overall Study|No study drug received|2
128861|NCT00830960|466446|P1|Overall Study|No study drug received|7
128862|NCT00830960|466441|P6|Overall Study|Sponsor Decision|7
128863|NCT00830960|466442|P5|Overall Study|Sponsor Decision|5
128864|NCT00830960|466443|P4|Overall Study|Sponsor Decision|4
128865|NCT00830960|466444|P3|Overall Study|Sponsor Decision|3
128866|NCT00830960|466445|P2|Overall Study|Sponsor Decision|2
128867|NCT00830960|466446|P1|Overall Study|Sponsor Decision|1
128868|NCT00830960|466441|P6|Overall Study|Withdrawal by Subject|21
128869|NCT00830960|466442|P5|Overall Study|Withdrawal by Subject|16
128870|NCT00830960|466443|P4|Overall Study|Withdrawal by Subject|23
128871|NCT00830960|466444|P3|Overall Study|Withdrawal by Subject|18
128872|NCT00830960|466445|P2|Overall Study|Withdrawal by Subject|19
128873|NCT00830960|466446|P1|Overall Study|Withdrawal by Subject|19
128874|NCT00830960|466441|P6|Overall Study|Lost to Follow-up|1
128875|NCT00830960|466442|P5|Overall Study|Lost to Follow-up|0
128876|NCT00830960|466443|P4|Overall Study|Lost to Follow-up|0
128877|NCT00830960|466444|P3|Overall Study|Lost to Follow-up|1
128878|NCT00830960|466445|P2|Overall Study|Lost to Follow-up|1
128879|NCT00830960|466446|P1|Overall Study|Lost to Follow-up|1
128880|NCT00830960|466441|P6|Overall Study|Death|1
128881|NCT00830960|466442|P5|Overall Study|Death|6
128882|NCT00830960|466443|P4|Overall Study|Death|2
128883|NCT00830960|466444|P3|Overall Study|Death|3
128884|NCT00830960|466445|P2|Overall Study|Death|4
128885|NCT00830960|466446|P1|Overall Study|Death|5
128886|NCT00830947|466562|P2|Overall Study|Lost to Follow-up|4
128887|NCT00830947|466563|P1|Overall Study|Lost to Follow-up|4
128888|NCT00830804|466569|P1|Overall Study|Unwilling to adhere to study requirement|1
128889|NCT00830804|466569|P1|Overall Study|Consent withdrawn|2
128890|NCT00830804|466569|P1|Overall Study|Unable to get to clinic|7
128891|NCT00830804|466569|P1|Overall Study|Death|1
128892|NCT00830804|466569|P1|Overall Study|Lost to Follow-up|4
128893|NCT00830765|466649|P2|Overall Study|Protocol Violation|2
128894|NCT00830765|466650|P1|Overall Study|Protocol Violation|3
128895|NCT00830518|466683|P2|Overall Study|Reason not Specified|1
128896|NCT00830518|466684|P1|Overall Study|Reason not Specified|8
128897|NCT00830518|466683|P2|Overall Study|Withdrawal by Patient|0
128898|NCT00830518|466684|P1|Overall Study|Withdrawal by Patient|2
128899|NCT00830518|466683|P2|Overall Study|Adverse Event|1
128900|NCT00830518|466684|P1|Overall Study|Adverse Event|14
128901|NCT00830518|466683|P2|Overall Study|Symptomatic Deterioration|1
128902|NCT00830518|466684|P1|Overall Study|Symptomatic Deterioration|4
128903|NCT00830518|466683|P2|Overall Study|Progressive Disease|8
128904|NCT00830518|466684|P1|Overall Study|Progressive Disease|18
128905|NCT00830440|466703|P2|Overall Study|Adverse Event|0
128906|NCT00830440|466704|P1|Overall Study|Adverse Event|2
128907|NCT00830440|466703|P2|Overall Study|unsuccessful procedure|0
128908|NCT00830440|466704|P1|Overall Study|unsuccessful procedure|4
128909|NCT00830440|466703|P2|Overall Study|Withdrawal by Subject|0
128910|NCT00830440|466704|P1|Overall Study|Withdrawal by Subject|1
128911|NCT00830440|466703|P2|Overall Study|Protocol Violation|0
128912|NCT00830440|466704|P1|Overall Study|Protocol Violation|1
128913|NCT00830375|466719|P1|Overall Study|Lost to Follow-up|1
128914|NCT00830336|466734|P2|Washout: 21 Days|Withdrawal by Subject|0
128915|NCT00830336|466735|P1|Washout: 21 Days|Withdrawal by Subject|1
128916|NCT00830258|466762|P2|Washout: 7 Days|Protocol Violation|0
128917|NCT00830258|466763|P1|Washout: 7 Days|Protocol Violation|1
128918|NCT00830258|466762|P2|First Intervention|Adverse Event|0
128919|NCT00830258|466763|P1|First Intervention|Adverse Event|1
128920|NCT00830219|466782|P2|Washout of 7 Days|Withdrawal by Subject|1
128921|NCT00830219|466783|P1|Washout of 7 Days|Withdrawal by Subject|1
128922|NCT00830206|466793|P2|Washout: 21 Days|Withdrawal by Subject|1
128923|NCT00830206|466794|P1|Washout: 21 Days|Withdrawal by Subject|1
128924|NCT00830167|466804|P2|Overall Study|Other|2
128925|NCT00830167|466805|P1|Overall Study|Other|2
128926|NCT00830167|466804|P2|Overall Study|Protocol Violation|1
128927|NCT00830167|466805|P1|Overall Study|Protocol Violation|0
128928|NCT00830167|466804|P2|Overall Study|Lost to Follow-up|1
128929|NCT00830167|466805|P1|Overall Study|Lost to Follow-up|0
128930|NCT00830167|466804|P2|Overall Study|Withdrawal by Subject|0
128931|NCT00830167|466805|P1|Overall Study|Withdrawal by Subject|2
128932|NCT00830167|466804|P2|Overall Study|Not meeting entrance criteria|5
128933|NCT00830167|466805|P1|Overall Study|Not meeting entrance criteria|2
128934|NCT00830167|466804|P2|Overall Study|Adverse Event|24
128935|NCT00830167|466805|P1|Overall Study|Adverse Event|8
128936|NCT00830167|466804|P2|Overall Study|Lack of Efficacy|10
128937|NCT00830167|466805|P1|Overall Study|Lack of Efficacy|26
128938|NCT00830128|466875|P1|Overall Study|Operating a vehicle|1
128939|NCT00830128|466875|P1|Overall Study|Work obligation|1
128940|NCT00830128|466875|P1|Overall Study|Relocation|1
128941|NCT00830128|466875|P1|Overall Study|Family obligation|1
128942|NCT00830128|466875|P1|Overall Study|Withdrawal by Subject|2
128943|NCT00830128|466875|P1|Overall Study|Protocol Violation|1
128944|NCT00830128|466875|P1|Overall Study|Lack of Efficacy|7
128945|NCT00830128|466875|P1|Overall Study|Adverse Event|5
128946|NCT00830115|466890|P1|Overall Study|Improvement/recovery|1
128947|NCT00830115|466890|P1|Overall Study|Adverse Event|2
128948|NCT00830037|466917|P2|Overall Study|Active when terminated by DSMB|14
128949|NCT00830037|466918|P1|Overall Study|Active when terminated by DSMB|15
128950|NCT00830037|466917|P2|Overall Study|Lost to Follow-up|2
128951|NCT00830037|466918|P1|Overall Study|Lost to Follow-up|1
128952|NCT00830037|466917|P2|Overall Study|Withdrawal by Subject|3
128953|NCT00830037|466918|P1|Overall Study|Withdrawal by Subject|2
128954|NCT00830024|466928|P2|Washout: 7 Days|Withdrawal by Subject|0
128955|NCT00830024|466929|P1|Washout: 7 Days|Withdrawal by Subject|1
128956|NCT00829998|466939|P2|Washout|Adverse Event|1
128957|NCT00829998|466940|P1|Washout|Adverse Event|0
128958|NCT00829933|466969|P4|Overall Study|withdrew before treatment started|9
128959|NCT00829933|466970|P3|Overall Study|withdrew before treatment started|2
128960|NCT00829933|466971|P2|Overall Study|withdrew before treatment started|1
128961|NCT00829933|466972|P1|Overall Study|withdrew before treatment started|5
128962|NCT00829933|466969|P4|Overall Study|Protocol Violation|0
128963|NCT00829933|466970|P3|Overall Study|Protocol Violation|0
128964|NCT00829933|466971|P2|Overall Study|Protocol Violation|1
128965|NCT00829933|466972|P1|Overall Study|Protocol Violation|2
128966|NCT00829933|466969|P4|Overall Study|Pregnancy|2
128967|NCT00829933|466970|P3|Overall Study|Pregnancy|0
128968|NCT00829933|466971|P2|Overall Study|Pregnancy|0
128969|NCT00829933|466972|P1|Overall Study|Pregnancy|0
128970|NCT00829933|466969|P4|Overall Study|Physician Decision|1
128971|NCT00829933|466970|P3|Overall Study|Physician Decision|8
128972|NCT00829933|466971|P2|Overall Study|Physician Decision|7
128973|NCT00829933|466972|P1|Overall Study|Physician Decision|5
128974|NCT00829933|466969|P4|Overall Study|Lack of Efficacy|0
128975|NCT00829933|466970|P3|Overall Study|Lack of Efficacy|0
128976|NCT00829933|466971|P2|Overall Study|Lack of Efficacy|1
128977|NCT00829933|466972|P1|Overall Study|Lack of Efficacy|0
128978|NCT00829933|466969|P4|Overall Study|Death|1
128979|NCT00829933|466970|P3|Overall Study|Death|1
128980|NCT00829933|466971|P2|Overall Study|Death|0
128981|NCT00829933|466972|P1|Overall Study|Death|0
128982|NCT00829933|466969|P4|Overall Study|Adverse Event|1
128983|NCT00829933|466970|P3|Overall Study|Adverse Event|2
128984|NCT00829933|466971|P2|Overall Study|Adverse Event|3
128985|NCT00829933|466972|P1|Overall Study|Adverse Event|2
128986|NCT00829868|466984|P2|Washout|Physician Decision|0
128987|NCT00829868|466985|P1|Washout|Physician Decision|1
128988|NCT00829829|466996|P3|Overall Study|Other than specified above|1
128989|NCT00829829|466997|P2|Overall Study|Other than specified above|2
128990|NCT00829829|466998|P1|Overall Study|Other than specified above|2
128991|NCT00829829|466996|P3|Overall Study|Lost to Follow-up|3
128992|NCT00829829|466997|P2|Overall Study|Lost to Follow-up|3
128993|NCT00829829|466998|P1|Overall Study|Lost to Follow-up|7
128994|NCT00829829|466996|P3|Overall Study|Decision by the Sponsor|2
128995|NCT00829829|466997|P2|Overall Study|Decision by the Sponsor|0
128996|NCT00829829|466998|P1|Overall Study|Decision by the Sponsor|1
128997|NCT00829829|466996|P3|Overall Study|Withdrawal by Subject|2
128998|NCT00829829|466997|P2|Overall Study|Withdrawal by Subject|4
128999|NCT00829829|466998|P1|Overall Study|Withdrawal by Subject|8
129000|NCT00829829|466996|P3|Overall Study|Adverse Event|3
129001|NCT00829829|466997|P2|Overall Study|Adverse Event|4
129002|NCT00829829|466998|P1|Overall Study|Adverse Event|4
129003|NCT00829829|466996|P3|Overall Study|Protocol Violation|0
129004|NCT00829829|466997|P2|Overall Study|Protocol Violation|3
129005|NCT00829829|466998|P1|Overall Study|Protocol Violation|0
129006|NCT00829790|467023|P2|Washout of 14 Days|Withdrawal by Subject|1
129007|NCT00829790|467024|P1|Washout of 14 Days|Withdrawal by Subject|0
129008|NCT00829764|467034|P2|First Intervention|Withdrawal by Subject|1
129009|NCT00829764|467035|P1|First Intervention|Withdrawal by Subject|1
129010|NCT00829764|467034|P2|First Intervention|Adverse Event|0
129011|NCT00829764|467035|P1|First Intervention|Adverse Event|1
129012|NCT00829712|467061|P2|Washout of 7 Days|Withdrawal by Subject|1
129013|NCT00829712|467062|P1|Washout of 7 Days|Withdrawal by Subject|0
129014|NCT00829673|467081|P2|Washout of 7 Days|Withdrawal by Subject|0
129015|NCT00829673|467082|P1|Washout of 7 Days|Withdrawal by Subject|1
129016|NCT00829621|467092|P2|Overall Study|Lost to Follow-up|4
129017|NCT00829621|467093|P1|Overall Study|Lost to Follow-up|3
129018|NCT00829621|467092|P2|Overall Study|Death|0
129019|NCT00829621|467093|P1|Overall Study|Death|1
129020|NCT00829530|467101|P2|Second Intervention|Intolerance to Venopuncture|0
129021|NCT00829530|467102|P1|Second Intervention|Intolerance to Venopuncture|1
129022|NCT00829530|467101|P2|First Intervention|Intolerance to Venopuncture|1
129023|NCT00829530|467102|P1|First Intervention|Intolerance to Venopuncture|0
129024|NCT00829530|467101|P2|First Intervention|Adverse Event|1
129025|NCT00829530|467102|P1|First Intervention|Adverse Event|0
129026|NCT00829504|467116|P2|Second Intervention|Physician Decision|0
129027|NCT00829504|467117|P1|Second Intervention|Physician Decision|1
129028|NCT00829504|467116|P2|Washout of 7 Days|Withdrawal by Subject|0
129029|NCT00829504|467117|P1|Washout of 7 Days|Withdrawal by Subject|1
129030|NCT00829504|467116|P2|First Intervention|Adverse Event|0
129031|NCT00829504|467117|P1|First Intervention|Adverse Event|1
129032|NCT00829452|467127|P2|Second Intervention|Physician Decision|1
129033|NCT00829452|467128|P1|Second Intervention|Physician Decision|0
129034|NCT00829452|467127|P2|Washout of 42 Days|Withdrawal by Subject|1
129035|NCT00829452|467128|P1|Washout of 42 Days|Withdrawal by Subject|0
129036|NCT00829452|467127|P2|First Intervention|Withdrawal by Subject|1
129037|NCT00829452|467128|P1|First Intervention|Withdrawal by Subject|0
129038|NCT00829439|467140|P4|Overall Study|Adverse Event|0
129039|NCT00829439|467141|P3|Overall Study|Adverse Event|1
129040|NCT00829439|467142|P2|Overall Study|Adverse Event|0
129041|NCT00829439|467143|P1|Overall Study|Adverse Event|0
129042|NCT00829426|467149|P2|Washout: 7 Days|Withdrawal by Subject|0
129043|NCT00829426|467150|P1|Washout: 7 Days|Withdrawal by Subject|1
129044|NCT00829387|467160|P2|Overall Study|Disqualified by PI|0
129045|NCT00829387|467161|P1|Overall Study|Disqualified by PI|1
129046|NCT00829387|467160|P2|Overall Study|Withdrawal by Subject|3
129047|NCT00829387|467161|P1|Overall Study|Withdrawal by Subject|2
129048|NCT00829309|467179|P2|Washout: 7 Days|Protocol Violation|0
129049|NCT00829309|467180|P1|Washout: 7 Days|Protocol Violation|1
129050|NCT00829296|467190|P2|Overall Study|Adverse Event|4
129051|NCT00829296|467191|P1|Overall Study|Adverse Event|5
129052|NCT00829283|467205|P2|Overall Study|Lost to Follow-up|25
129053|NCT00829283|467206|P1|Overall Study|Lost to Follow-up|7
129054|NCT00829244|467216|P2|Overall Study|No embryo cleavage|2
129055|NCT00829244|467217|P1|Overall Study|No embryo cleavage|0
129056|NCT00829244|467216|P2|Overall Study|All embryos discarded|3
129057|NCT00829244|467217|P1|Overall Study|All embryos discarded|0
129058|NCT00829244|467216|P2|Overall Study|No fertilization|2
129059|NCT00829244|467217|P1|Overall Study|No fertilization|2
129060|NCT00829244|467216|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
129061|NCT00829244|467217|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
129062|NCT00829244|467216|P2|Overall Study|Lack of ovarian response to stimulation|5
129063|NCT00829244|467217|P1|Overall Study|Lack of ovarian response to stimulation|9
129064|NCT00829244|467216|P2|Overall Study|Protocol Violation|0
129065|NCT00829244|467217|P1|Overall Study|Protocol Violation|1
129066|NCT00829244|467216|P2|Overall Study|Adverse Event|3
129067|NCT00829244|467217|P1|Overall Study|Adverse Event|1
129068|NCT00829179|467247|P1|Overall Study|Withdrawal by Subject|1
129069|NCT00829166|467253|P2|Overall Study|Reason Not Specified|3
129070|NCT00829166|467254|P1|Overall Study|Reason Not Specified|3
129071|NCT00829166|467253|P2|Overall Study|Sponsor’s Decision|98
129072|NCT00829166|467254|P1|Overall Study|Sponsor’s Decision|137
129073|NCT00829166|467253|P2|Overall Study|Subject's Decision|55
129074|NCT00829166|467254|P1|Overall Study|Subject's Decision|41
129075|NCT00829166|467253|P2|Overall Study|Physician's Decision|3
129076|NCT00829166|467254|P1|Overall Study|Physician's Decision|4
129077|NCT00829166|467253|P2|Overall Study|Lost to Follow-up|4
129078|NCT00829166|467254|P1|Overall Study|Lost to Follow-up|5
129079|NCT00829166|467253|P2|Overall Study|Death|333
129080|NCT00829166|467254|P1|Overall Study|Death|305
129081|NCT00829010|467317|P5|Overall Study|Migrated/Moved from study area|0
129082|NCT00829010|467318|P4|Overall Study|Migrated/Moved from study area|5
129083|NCT00829010|467319|P3|Overall Study|Migrated/Moved from study area|0
129084|NCT00829010|467320|P2|Overall Study|Migrated/Moved from study area|4
129085|NCT00829010|467321|P1|Overall Study|Migrated/Moved from study area|3
129086|NCT00829010|467317|P5|Overall Study|Fatality|0
129087|NCT00829010|467318|P4|Overall Study|Fatality|3
129088|NCT00829010|467319|P3|Overall Study|Fatality|0
129089|NCT00829010|467320|P2|Overall Study|Fatality|4
129090|NCT00829010|467321|P1|Overall Study|Fatality|5
129091|NCT00829010|467317|P5|Overall Study|Lost to Follow-up|0
129092|NCT00829010|467318|P4|Overall Study|Lost to Follow-up|0
129093|NCT00829010|467319|P3|Overall Study|Lost to Follow-up|2
129094|NCT00829010|467320|P2|Overall Study|Lost to Follow-up|0
129095|NCT00829010|467321|P1|Overall Study|Lost to Follow-up|1
129096|NCT00829010|467317|P5|Overall Study|Withdrawal by Subject|2
129097|NCT00829010|467318|P4|Overall Study|Withdrawal by Subject|0
129098|NCT00829010|467319|P3|Overall Study|Withdrawal by Subject|1
129099|NCT00829010|467320|P2|Overall Study|Withdrawal by Subject|1
129100|NCT00829010|467321|P1|Overall Study|Withdrawal by Subject|0
129101|NCT00829010|467317|P5|Overall Study|Adverse Event|0
129102|NCT00829010|467318|P4|Overall Study|Adverse Event|0
129103|NCT00829010|467319|P3|Overall Study|Adverse Event|0
129104|NCT00829010|467320|P2|Overall Study|Adverse Event|0
129105|NCT00829010|467321|P1|Overall Study|Adverse Event|1
129106|NCT00828984|467486|P3|Overall Study|ConMed|1
129107|NCT00828984|467487|P2|Overall Study|ConMed|1
129108|NCT00828984|467488|P1|Overall Study|ConMed|1
129109|NCT00828984|467486|P3|Overall Study|Noncompliant|3
129110|NCT00828984|467487|P2|Overall Study|Noncompliant|2
129111|NCT00828984|467488|P1|Overall Study|Noncompliant|1
129112|NCT00828984|467486|P3|Overall Study|Medical Contraindication|0
129113|NCT00828984|467487|P2|Overall Study|Medical Contraindication|1
129114|NCT00828984|467488|P1|Overall Study|Medical Contraindication|0
129115|NCT00828984|467486|P3|Overall Study|Ineligable|0
129116|NCT00828984|467487|P2|Overall Study|Ineligable|2
129117|NCT00828984|467488|P1|Overall Study|Ineligable|1
129118|NCT00828984|467486|P3|Overall Study|Withdrawal by Subject|4
129119|NCT00828984|467487|P2|Overall Study|Withdrawal by Subject|4
129120|NCT00828984|467488|P1|Overall Study|Withdrawal by Subject|4
129121|NCT00828984|467486|P3|Overall Study|Lost to Follow-up|1
129122|NCT00828984|467487|P2|Overall Study|Lost to Follow-up|3
129123|NCT00828984|467488|P1|Overall Study|Lost to Follow-up|5
129124|NCT00828984|467486|P3|Overall Study|Adverse Event|0
129125|NCT00828984|467487|P2|Overall Study|Adverse Event|3
129126|NCT00828984|467488|P1|Overall Study|Adverse Event|2
129127|NCT00828945|467511|P1|Overall Study|Other|36
129128|NCT00828945|467511|P1|Overall Study|Participant was missing|1
129129|NCT00828945|467511|P1|Overall Study|Death|4
129130|NCT00828750|467543|P1|Overall Study|Normal PC Remained While No Treatment|1
129131|NCT00828750|467543|P1|Overall Study|Lack of Efficacy|3
129132|NCT00828711|467557|P3|Overall Study|Lost to Follow-up|0
129133|NCT00828711|467558|P2|Overall Study|Lost to Follow-up|0
129134|NCT00828711|467559|P1|Overall Study|Lost to Follow-up|1
129135|NCT00828568|467591|P3|Treated - Received at Least One Dose|Protocol Violation|3
129136|NCT00828568|467592|P2|Treated - Received at Least One Dose|Protocol Violation|5
129137|NCT00828568|467593|P1|Treated - Received at Least One Dose|Protocol Violation|9
129138|NCT00828568|467591|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
129139|NCT00828568|467592|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
129140|NCT00828568|467593|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
129141|NCT00828568|467591|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
129142|NCT00828568|467592|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
129143|NCT00828568|467593|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
129144|NCT00828568|467591|P3|Treated - Received at Least One Dose|Adverse Event|1
129145|NCT00828568|467592|P2|Treated - Received at Least One Dose|Adverse Event|8
129146|NCT00828568|467593|P1|Treated - Received at Least One Dose|Adverse Event|11
129147|NCT00828568|467591|P3|Randomized|Withdrawal by Subject|2
129148|NCT00828568|467592|P2|Randomized|Withdrawal by Subject|0
129149|NCT00828568|467593|P1|Randomized|Withdrawal by Subject|1
129150|NCT00828516|467615|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
129151|NCT00828464|467620|P1|Overall Study|Withdrawal by Subject|1
129152|NCT00828451|467637|P1|Overall Study|Deterioration in clinical status|1
129153|NCT00828451|467637|P1|Overall Study|Withdrawal by Subject|1
129154|NCT00828451|467637|P1|Overall Study|Lack of intravenous line|7
129155|NCT00828451|467637|P1|Overall Study|Death|2
129156|NCT00828321|467663|P2|Second Intervention|Protocol Violation|1
129157|NCT00828321|467664|P1|Second Intervention|Protocol Violation|0
129158|NCT00828321|467663|P2|Washout of 42 Days|Withdrawal by Subject|0
129159|NCT00828321|467664|P1|Washout of 42 Days|Withdrawal by Subject|2
129160|NCT00828204|467693|P2|Extension Study|Physician Decision|2
129161|NCT00828204|467694|P1|Extension Study|Physician Decision|0
129162|NCT00828204|467693|P2|Extension Study|Lost to Follow-up|1
129163|NCT00828204|467694|P1|Extension Study|Lost to Follow-up|0
129164|NCT00828204|467693|P2|Main Study: After Study Restart|Noncompliance|1
129165|NCT00828204|467694|P1|Main Study: After Study Restart|Noncompliance|0
129166|NCT00828204|467693|P2|Main Study: After Study Restart|Adverse Event|2
129167|NCT00828204|467694|P1|Main Study: After Study Restart|Adverse Event|0
129168|NCT00828204|467693|P2|Main Study: Prior to Study Suspension|Study Suspension|0
129169|NCT00828204|467694|P1|Main Study: Prior to Study Suspension|Study Suspension|11
129170|NCT00828204|467693|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
129171|NCT00828204|467694|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
129172|NCT00828204|467693|P2|Main Study: Prior to Study Suspension|Adverse Event|0
129173|NCT00828204|467694|P1|Main Study: Prior to Study Suspension|Adverse Event|1
129174|NCT00828139|467741|P4|Overall Study|Not specified|2
129175|NCT00828139|467742|P3|Overall Study|Not specified|5
129176|NCT00828139|467743|P2|Overall Study|Not specified|2
129177|NCT00828139|467744|P1|Overall Study|Not specified|4
129178|NCT00828139|467741|P4|Overall Study|Disease Progression|39
129179|NCT00828139|467742|P3|Overall Study|Disease Progression|35
129180|NCT00828139|467743|P2|Overall Study|Disease Progression|33
129181|NCT00828139|467744|P1|Overall Study|Disease Progression|24
129182|NCT00828139|467741|P4|Overall Study|Refusal unrelated to toxicity|3
129183|NCT00828139|467742|P3|Overall Study|Refusal unrelated to toxicity|5
129184|NCT00828139|467743|P2|Overall Study|Refusal unrelated to toxicity|4
129185|NCT00828139|467744|P1|Overall Study|Refusal unrelated to toxicity|3
129186|NCT00828139|467741|P4|Overall Study|Death|2
129187|NCT00828139|467742|P3|Overall Study|Death|0
129188|NCT00828139|467743|P2|Overall Study|Death|1
129189|NCT00828139|467744|P1|Overall Study|Death|2
129190|NCT00828139|467741|P4|Overall Study|Adverse Event|5
129191|NCT00828139|467742|P3|Overall Study|Adverse Event|10
129192|NCT00828139|467743|P2|Overall Study|Adverse Event|1
129193|NCT00828139|467744|P1|Overall Study|Adverse Event|8
129194|NCT00828113|467764|P2|Overall Study|Lost to Follow-up|5
129195|NCT00828113|467765|P1|Overall Study|Lost to Follow-up|3
129196|NCT00828113|467764|P2|Overall Study|Withdrawal by Subject|26
129197|NCT00828113|467765|P1|Overall Study|Withdrawal by Subject|27
129198|NCT00827931|467839|P2|Overall Study|Other|0
129199|NCT00827931|467840|P1|Overall Study|Other|1
129200|NCT00827931|467839|P2|Overall Study|Withdrawal by Subject|1
129201|NCT00827931|467840|P1|Overall Study|Withdrawal by Subject|0
129202|NCT00827931|467839|P2|Overall Study|Lost to Follow-up|0
129203|NCT00827931|467840|P1|Overall Study|Lost to Follow-up|1
129204|NCT00827931|467839|P2|Overall Study|Adverse Event|0
129205|NCT00827931|467840|P1|Overall Study|Adverse Event|1
129206|NCT00827931|467839|P2|Overall Study|Death|5
129207|NCT00827931|467840|P1|Overall Study|Death|3
129208|NCT00827918|467861|P3|Overall Study|Withdrawal by Subject|6
129209|NCT00827918|467862|P2|Overall Study|Withdrawal by Subject|2
129210|NCT00827918|467863|P1|Overall Study|Withdrawal by Subject|6
129211|NCT00827918|467861|P3|Overall Study|Protocol Violation|0
129212|NCT00827918|467862|P2|Overall Study|Protocol Violation|1
129213|NCT00827918|467863|P1|Overall Study|Protocol Violation|0
129214|NCT00827918|467861|P3|Overall Study|Progressive Disease|0
129215|NCT00827918|467862|P2|Overall Study|Progressive Disease|1
129216|NCT00827918|467863|P1|Overall Study|Progressive Disease|1
129217|NCT00827918|467861|P3|Overall Study|Pregnancy|0
129218|NCT00827918|467862|P2|Overall Study|Pregnancy|1
129219|NCT00827918|467863|P1|Overall Study|Pregnancy|0
129220|NCT00827918|467861|P3|Overall Study|Physician Decision|0
129221|NCT00827918|467862|P2|Overall Study|Physician Decision|0
129222|NCT00827918|467863|P1|Overall Study|Physician Decision|1
129223|NCT00827918|467861|P3|Overall Study|Lack of Efficacy|15
129224|NCT00827918|467862|P2|Overall Study|Lack of Efficacy|4
129225|NCT00827918|467863|P1|Overall Study|Lack of Efficacy|16
129226|NCT00827918|467861|P3|Overall Study|Adverse Event|0
129227|NCT00827918|467862|P2|Overall Study|Adverse Event|0
129228|NCT00827918|467863|P1|Overall Study|Adverse Event|4
129229|NCT00827827|467891|P2|Overall Study|Burned with water at home|0
129230|NCT00827827|467892|P1|Overall Study|Burned with water at home|1
129231|NCT00827827|467891|P2|Overall Study|Transportation issues|0
129232|NCT00827827|467892|P1|Overall Study|Transportation issues|1
129233|NCT00827827|467891|P2|Overall Study|Gout|0
129234|NCT00827827|467892|P1|Overall Study|Gout|1
129235|NCT00827827|467891|P2|Overall Study|Another cerebrovascular accident (CVA)|0
129236|NCT00827827|467892|P1|Overall Study|Another cerebrovascular accident (CVA)|1
129237|NCT00827827|467891|P2|Overall Study|Fall at home- hospitalization|0
129238|NCT00827827|467892|P1|Overall Study|Fall at home- hospitalization|1
129239|NCT00827827|467891|P2|Overall Study|Lost to Follow-up|0
129240|NCT00827827|467892|P1|Overall Study|Lost to Follow-up|3
129241|NCT00827632|467936|P2|Overall Study|Early withdrawal|11
129242|NCT00827632|467937|P1|Overall Study|Early withdrawal|14
129243|NCT00827632|467936|P2|Overall Study|Lost to Follow-up|12
129244|NCT00827632|467937|P1|Overall Study|Lost to Follow-up|8
129245|NCT00827606|467945|P2|Overall Study|Adverse Event|2
129246|NCT00827606|467946|P1|Overall Study|Adverse Event|4
129247|NCT00827606|467945|P2|Overall Study|LDL below 2.59 mmol/L|12
129248|NCT00827606|467946|P1|Overall Study|LDL below 2.59 mmol/L|4
129249|NCT00827606|467945|P2|Overall Study|Not specified|13
129250|NCT00827606|467946|P1|Overall Study|Not specified|5
129251|NCT00827606|467945|P2|Overall Study|Pregnancy|1
129252|NCT00827606|467946|P1|Overall Study|Pregnancy|0
129253|NCT00827606|467945|P2|Overall Study|Withdrawal by Subject|6
129254|NCT00827606|467946|P1|Overall Study|Withdrawal by Subject|7
129255|NCT00827606|467945|P2|Overall Study|Lost to Follow-up|1
129256|NCT00827606|467946|P1|Overall Study|Lost to Follow-up|3
129257|NCT00827606|467945|P2|Overall Study|Protocol Violation|3
129258|NCT00827606|467946|P1|Overall Study|Protocol Violation|4
129259|NCT00827567|468007|P1|Overall Study|Progression of Disease/Screen Failure|4
129260|NCT00827541|468013|P2|Overall Study|Lack of effectiveness|0
129261|NCT00827541|468014|P1|Overall Study|Lack of effectiveness|1
129262|NCT00827541|468013|P2|Overall Study|Pathogen not susceptible|0
129263|NCT00827541|468014|P1|Overall Study|Pathogen not susceptible|1
129264|NCT00827541|468013|P2|Overall Study|Other|3
129265|NCT00827541|468014|P1|Overall Study|Other|1
129266|NCT00827541|468013|P2|Overall Study|Exitus|8
129267|NCT00827541|468014|P1|Overall Study|Exitus|1
129268|NCT00827502|468026|P1|Overall Study|Withdrawal by Subject|5
129269|NCT00827502|468026|P1|Overall Study|Lost to Follow-up|4
129270|NCT00827502|468026|P1|Overall Study|Adverse Event|1
129271|NCT00827502|468026|P1|Overall Study|randomized but not treated|11
129272|NCT00827372|468032|P1|Overall Study|Lack of Efficacy|3
129273|NCT00827372|468032|P1|Overall Study|Adverse Event|5
129274|NCT00827242|468047|P2|Overall Study|Lack of Efficacy|0
129275|NCT00827242|468048|P1|Overall Study|Lack of Efficacy|1
129276|NCT00827242|468047|P2|Overall Study|Death|0
129277|NCT00827242|468048|P1|Overall Study|Death|1
129278|NCT00827242|468047|P2|Overall Study|Physician Decision|0
129279|NCT00827242|468048|P1|Overall Study|Physician Decision|2
129280|NCT00827242|468047|P2|Overall Study|Entry Criteria Not Met|1
129281|NCT00827242|468048|P1|Overall Study|Entry Criteria Not Met|4
129282|NCT00827242|468047|P2|Overall Study|Adverse Event Excluding Death|1
129283|NCT00827242|468048|P1|Overall Study|Adverse Event Excluding Death|2
129284|NCT00827242|468047|P2|Overall Study|Lost to Follow-up|3
129285|NCT00827242|468048|P1|Overall Study|Lost to Follow-up|0
129286|NCT00827242|468047|P2|Overall Study|Protocol Violation|3
129287|NCT00827242|468048|P1|Overall Study|Protocol Violation|1
129288|NCT00827242|468047|P2|Overall Study|Withdrawal by Subject|4
129289|NCT00827242|468048|P1|Overall Study|Withdrawal by Subject|2
129290|NCT00827112|468086|P2|Overall Study|Other|3
129291|NCT00827112|468087|P1|Overall Study|Other|1
129292|NCT00827112|468086|P2|Overall Study|Randomized but not treated|3
129293|NCT00827112|468087|P1|Overall Study|Randomized but not treated|5
129294|NCT00827112|468086|P2|Overall Study|Withdrawal by Subject|1
129295|NCT00827112|468087|P1|Overall Study|Withdrawal by Subject|2
129296|NCT00827112|468086|P2|Overall Study|Protocol Violation|2
129297|NCT00827112|468087|P1|Overall Study|Protocol Violation|0
129298|NCT00827112|468086|P2|Overall Study|Pregnancy|1
129299|NCT00827112|468087|P1|Overall Study|Pregnancy|0
129300|NCT00827112|468086|P2|Overall Study|Lost to Follow-up|2
129301|NCT00827112|468087|P1|Overall Study|Lost to Follow-up|3
129302|NCT00827112|468086|P2|Overall Study|Lack of Efficacy|0
129303|NCT00827112|468087|P1|Overall Study|Lack of Efficacy|2
129304|NCT00827112|468086|P2|Overall Study|Adverse Event|0
129305|NCT00827112|468087|P1|Overall Study|Adverse Event|2
129306|NCT00826943|468140|P6|Overall Study|Withdrawal by Subject|0
129307|NCT00826943|468141|P5|Overall Study|Withdrawal by Subject|1
129308|NCT00826943|468142|P4|Overall Study|Withdrawal by Subject|0
129309|NCT00826943|468143|P3|Overall Study|Withdrawal by Subject|0
129310|NCT00826943|468144|P2|Overall Study|Withdrawal by Subject|0
129311|NCT00826943|468145|P1|Overall Study|Withdrawal by Subject|0
129312|NCT00826748|468166|P3|Overall Study|Samples Did Not pass QC|1
129313|NCT00826748|468167|P2|Overall Study|Samples Did Not pass QC|0
129314|NCT00826748|468168|P1|Overall Study|Samples Did Not pass QC|0
129315|NCT00826748|468166|P3|Overall Study|Physician Decision|1
129316|NCT00826748|468167|P2|Overall Study|Physician Decision|0
129317|NCT00826748|468168|P1|Overall Study|Physician Decision|0
129318|NCT00826748|468166|P3|Overall Study|Withdrawal by Subject|2
129319|NCT00826748|468167|P2|Overall Study|Withdrawal by Subject|0
129320|NCT00826748|468168|P1|Overall Study|Withdrawal by Subject|0
129321|NCT00826618|468176|P1|Overall Study|Withdrawal by Subject|1
129322|NCT00826540|468180|P1|Overall Study|Withdrawal by Subject|1
129323|NCT00826540|468180|P1|Overall Study|ineligible|3
129324|NCT00826449|468186|P1|Overall Study|Withdrawal by Subject|1
129325|NCT00826449|468186|P1|Overall Study|Disease Progression|4
129326|NCT00826280|468195|P3|Overall Study|One or more non-interpretable scan|1
129327|NCT00826280|468196|P2|Overall Study|One or more non-interpretable scan|1
129328|NCT00826280|468197|P1|Overall Study|One or more non-interpretable scan|0
129329|NCT00826280|468195|P3|Overall Study|Machine Failure|0
129330|NCT00826280|468196|P2|Overall Study|Machine Failure|1
129331|NCT00826280|468197|P1|Overall Study|Machine Failure|1
129332|NCT00826280|468195|P3|Overall Study|Interpretation Failure|0
129333|NCT00826280|468196|P2|Overall Study|Interpretation Failure|0
129334|NCT00826280|468197|P1|Overall Study|Interpretation Failure|1
129335|NCT00826280|468195|P3|Overall Study|Reversible ischemic defect not present|44
129336|NCT00826280|468196|P2|Overall Study|Reversible ischemic defect not present|40
129337|NCT00826280|468197|P1|Overall Study|Reversible ischemic defect not present|43
129338|NCT00826280|468195|P3|Overall Study|Sponsor discontinued subject or study|0
129339|NCT00826280|468196|P2|Overall Study|Sponsor discontinued subject or study|0
129340|NCT00826280|468197|P1|Overall Study|Sponsor discontinued subject or study|1
129341|NCT00826280|468195|P3|Overall Study|Lost to Follow-up|0
129342|NCT00826280|468196|P2|Overall Study|Lost to Follow-up|1
129343|NCT00826280|468197|P1|Overall Study|Lost to Follow-up|0
129344|NCT00826280|468195|P3|Overall Study|Adverse Event|0
129345|NCT00826280|468196|P2|Overall Study|Adverse Event|3
129346|NCT00826280|468197|P1|Overall Study|Adverse Event|1
129347|NCT00826280|468195|P3|Overall Study|Randomized but drug not received|1
129348|NCT00826280|468196|P2|Overall Study|Randomized but drug not received|0
129349|NCT00826280|468197|P1|Overall Study|Randomized but drug not received|1
129350|NCT00826267|468226|P3|Overall Study|Other Adverse Event|0
129351|NCT00826267|468227|P2|Overall Study|Other Adverse Event|0
129352|NCT00826267|468228|P1|Overall Study|Other Adverse Event|1
129353|NCT00826228|468246|P1|Overall Study|Withdrawal by Subject|1
129354|NCT00826176|468268|P2|Overall Study|Administrative|0
129355|NCT00826176|468269|P1|Overall Study|Administrative|9
129356|NCT00826176|468268|P2|Overall Study|Subject Withdrew Consent|0
129357|NCT00826176|468269|P1|Overall Study|Subject Withdrew Consent|3
129358|NCT00826176|468268|P2|Overall Study|Lost to Follow-up|0
129359|NCT00826176|468269|P1|Overall Study|Lost to Follow-up|1
129360|NCT00826111|468281|P2|Overall Study|Physician Decision|1
129361|NCT00826111|468282|P1|Overall Study|Physician Decision|1
129362|NCT00826111|468281|P2|Overall Study|Withdrawal by Subject|0
129363|NCT00826111|468282|P1|Overall Study|Withdrawal by Subject|5
129364|NCT00826111|468281|P2|Overall Study|Protocol Violation|0
129365|NCT00826111|468282|P1|Overall Study|Protocol Violation|1
129366|NCT00826111|468281|P2|Overall Study|Lost to Follow-up|1
129367|NCT00826111|468282|P1|Overall Study|Lost to Follow-up|0
129368|NCT00825994|468312|P1|Overall Study|Placebo Responder at V2|1
129369|NCT00825994|468312|P1|Overall Study|Protocol Violation|1
129370|NCT00825994|468312|P1|Overall Study|Lost to Follow-up|1
129371|NCT00825994|468312|P1|Overall Study|Withdrawal by Subject|2
129372|NCT00825916|468320|P3|Overall Study|Lost to Follow-up|1
129373|NCT00825916|468321|P2|Overall Study|Lost to Follow-up|2
129374|NCT00825916|468322|P1|Overall Study|Lost to Follow-up|4
129375|NCT00825825|468363|P6|Third Medication Period (14 Days)|poor data quality|0
129376|NCT00825825|468364|P5|Third Medication Period (14 Days)|poor data quality|0
129377|NCT00825825|468365|P4|Third Medication Period (14 Days)|poor data quality|0
129378|NCT00825825|468366|P3|Third Medication Period (14 Days)|poor data quality|0
129379|NCT00825825|468367|P2|Third Medication Period (14 Days)|poor data quality|1
129380|NCT00825825|468368|P1|Third Medication Period (14 Days)|poor data quality|0
129381|NCT00825825|468363|P6|Third Medication Period (14 Days)|Protocol Violation|2
129382|NCT00825825|468364|P5|Third Medication Period (14 Days)|Protocol Violation|0
129383|NCT00825825|468365|P4|Third Medication Period (14 Days)|Protocol Violation|0
129384|NCT00825825|468366|P3|Third Medication Period (14 Days)|Protocol Violation|0
129385|NCT00825825|468367|P2|Third Medication Period (14 Days)|Protocol Violation|0
129386|NCT00825825|468368|P1|Third Medication Period (14 Days)|Protocol Violation|0
129387|NCT00825825|468363|P6|Third Medication Period (14 Days)|Adverse Event|0
129388|NCT00825825|468364|P5|Third Medication Period (14 Days)|Adverse Event|0
129389|NCT00825825|468365|P4|Third Medication Period (14 Days)|Adverse Event|0
129390|NCT00825825|468366|P3|Third Medication Period (14 Days)|Adverse Event|0
129391|NCT00825825|468367|P2|Third Medication Period (14 Days)|Adverse Event|1
129392|NCT00825825|468368|P1|Third Medication Period (14 Days)|Adverse Event|0
129393|NCT00825825|468363|P6|Second Medication Period (14 Days)|Protocol Violation|0
129394|NCT00825825|468364|P5|Second Medication Period (14 Days)|Protocol Violation|1
129395|NCT00825825|468365|P4|Second Medication Period (14 Days)|Protocol Violation|0
129396|NCT00825825|468366|P3|Second Medication Period (14 Days)|Protocol Violation|0
129397|NCT00825825|468367|P2|Second Medication Period (14 Days)|Protocol Violation|0
129398|NCT00825825|468368|P1|Second Medication Period (14 Days)|Protocol Violation|1
129399|NCT00825825|468363|P6|Second Medication Period (14 Days)|Physician Decision|0
129400|NCT00825825|468364|P5|Second Medication Period (14 Days)|Physician Decision|0
129401|NCT00825825|468365|P4|Second Medication Period (14 Days)|Physician Decision|2
129402|NCT00825825|468366|P3|Second Medication Period (14 Days)|Physician Decision|0
129403|NCT00825825|468367|P2|Second Medication Period (14 Days)|Physician Decision|0
129404|NCT00825825|468368|P1|Second Medication Period (14 Days)|Physician Decision|1
129405|NCT00825825|468363|P6|First Medication Period (14 Days)|Physician Decision|1
129406|NCT00825825|468364|P5|First Medication Period (14 Days)|Physician Decision|0
129407|NCT00825825|468365|P4|First Medication Period (14 Days)|Physician Decision|0
129408|NCT00825825|468366|P3|First Medication Period (14 Days)|Physician Decision|1
129409|NCT00825825|468367|P2|First Medication Period (14 Days)|Physician Decision|0
129410|NCT00825825|468368|P1|First Medication Period (14 Days)|Physician Decision|2
129411|NCT00825825|468363|P6|First Medication Period (14 Days)|Adverse Event|1
129412|NCT00825825|468364|P5|First Medication Period (14 Days)|Adverse Event|0
129413|NCT00825825|468365|P4|First Medication Period (14 Days)|Adverse Event|0
129414|NCT00825825|468366|P3|First Medication Period (14 Days)|Adverse Event|0
129415|NCT00825825|468367|P2|First Medication Period (14 Days)|Adverse Event|0
129416|NCT00825825|468368|P1|First Medication Period (14 Days)|Adverse Event|1
129417|NCT00825812|468384|P4|Overall Study|Administrative|5
129418|NCT00825812|468385|P3|Overall Study|Administrative|3
129419|NCT00825812|468386|P2|Overall Study|Administrative|1
129420|NCT00825812|468387|P1|Overall Study|Administrative|0
129421|NCT00825812|468384|P4|Overall Study|Non-compliance with protocol|1
129422|NCT00825812|468385|P3|Overall Study|Non-compliance with protocol|0
129423|NCT00825812|468386|P2|Overall Study|Non-compliance with protocol|0
129424|NCT00825812|468387|P1|Overall Study|Non-compliance with protocol|0
129425|NCT00825812|468384|P4|Overall Study|Subject withdrew consent|2
129426|NCT00825812|468385|P3|Overall Study|Subject withdrew consent|3
129427|NCT00825812|468386|P2|Overall Study|Subject withdrew consent|0
129428|NCT00825812|468387|P1|Overall Study|Subject withdrew consent|0
129429|NCT00825812|468384|P4|Overall Study|Adverse Event|1
129430|NCT00825812|468385|P3|Overall Study|Adverse Event|0
129431|NCT00825812|468386|P2|Overall Study|Adverse Event|0
129432|NCT00825812|468387|P1|Overall Study|Adverse Event|0
129433|NCT00825812|468384|P4|Overall Study|Never entered follow up|1
129434|NCT00825812|468385|P3|Overall Study|Never entered follow up|0
129435|NCT00825812|468386|P2|Overall Study|Never entered follow up|0
129436|NCT00825812|468387|P1|Overall Study|Never entered follow up|0
129437|NCT00825682|468434|P2|Overall Study|personal reasons/ inconvenience|5
129438|NCT00825682|468435|P1|Overall Study|personal reasons/ inconvenience|13
129439|NCT00825305|468526|P2|Overall Study|Can not be classified|1
129440|NCT00825305|468527|P1|Overall Study|Can not be classified|0
129441|NCT00825305|468526|P2|Overall Study|Protocol Violation|9
129442|NCT00825305|468527|P1|Overall Study|Protocol Violation|9
129443|NCT00825305|468526|P2|Overall Study|Inappropriate inclusion|0
129444|NCT00825305|468527|P1|Overall Study|Inappropriate inclusion|1
129445|NCT00825305|468526|P2|Overall Study|Withdrawal by Subject|12
129446|NCT00825305|468527|P1|Overall Study|Withdrawal by Subject|6
129447|NCT00825305|468526|P2|Overall Study|Adverse Event|1
129448|NCT00825305|468527|P1|Overall Study|Adverse Event|1
129449|NCT00825175|468567|P2|Overall Study|Withdrawal by Subject|5
129450|NCT00825175|468568|P1|Overall Study|Withdrawal by Subject|0
129451|NCT00825162|468577|P3|Overall Study|Unable to attend the study visit|0
129452|NCT00825162|468578|P2|Overall Study|Unable to attend the study visit|2
129453|NCT00825162|468579|P1|Overall Study|Unable to attend the study visit|5
129454|NCT00825162|468577|P3|Overall Study|Move away from the study area|0
129455|NCT00825162|468578|P2|Overall Study|Move away from the study area|0
129456|NCT00825162|468579|P1|Overall Study|Move away from the study area|1
129457|NCT00825162|468577|P3|Overall Study|Physician Decision|0
129458|NCT00825162|468578|P2|Overall Study|Physician Decision|0
129459|NCT00825162|468579|P1|Overall Study|Physician Decision|2
129460|NCT00825162|468577|P3|Overall Study|Lost to Follow-up|3
129461|NCT00825162|468578|P2|Overall Study|Lost to Follow-up|6
129462|NCT00825162|468579|P1|Overall Study|Lost to Follow-up|9
129463|NCT00825162|468577|P3|Overall Study|Withdrawal by Subject|3
129464|NCT00825162|468578|P2|Overall Study|Withdrawal by Subject|13
129465|NCT00825162|468579|P1|Overall Study|Withdrawal by Subject|11
129466|NCT00824993|468605|P2|Overall Study|Death|3
129467|NCT00824993|468606|P1|Overall Study|Death|0
129468|NCT00824993|468605|P2|Overall Study|Insurance Issue|1
129469|NCT00824993|468606|P1|Overall Study|Insurance Issue|2
129470|NCT00824993|468605|P2|Overall Study|Non-Compliant|1
129471|NCT00824993|468606|P1|Overall Study|Non-Compliant|2
129472|NCT00824993|468605|P2|Overall Study|Rapid Bone Loss|1
129473|NCT00824993|468606|P1|Overall Study|Rapid Bone Loss|0
129474|NCT00824993|468605|P2|Overall Study|Malignancy Relapse|10
129475|NCT00824993|468606|P1|Overall Study|Malignancy Relapse|9
129476|NCT00824993|468605|P2|Overall Study|Withdrawal by Subject|1
129477|NCT00824993|468606|P1|Overall Study|Withdrawal by Subject|1
129478|NCT00824850|468614|P2|Overall Study|Withdrawal by Subject|1
129479|NCT00824850|468615|P1|Overall Study|Withdrawal by Subject|0
129480|NCT00824772|468668|P1|Overall Study|Withdrawal by Subject|8
129481|NCT00824720|468688|P3|Overall Study|Protocol Violation|1
129482|NCT00824720|468689|P2|Overall Study|Protocol Violation|0
129483|NCT00824720|468690|P1|Overall Study|Protocol Violation|0
129484|NCT00824720|468688|P3|Overall Study|failed plug insertion|0
129485|NCT00824720|468689|P2|Overall Study|failed plug insertion|1
129486|NCT00824720|468690|P1|Overall Study|failed plug insertion|3
129487|NCT00824655|468706|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
129488|NCT00824655|468707|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
129489|NCT00824655|468706|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
129490|NCT00824655|468707|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
129491|NCT00824616|468727|P2|Overall Study|Withdrawal by Subject|1
129492|NCT00824616|468728|P1|Overall Study|Withdrawal by Subject|1
129493|NCT00824616|468727|P2|Overall Study|Lost to Follow-up|1
129494|NCT00824616|468728|P1|Overall Study|Lost to Follow-up|0
129495|NCT00824616|468727|P2|Overall Study|Lack of Efficacy|1
129496|NCT00824616|468728|P1|Overall Study|Lack of Efficacy|2
129497|NCT00824616|468727|P2|Overall Study|Hyperglycemia|1
129498|NCT00824616|468728|P1|Overall Study|Hyperglycemia|1
129499|NCT00824616|468727|P2|Overall Study|Creatinine/Creatinine Clearance|2
129500|NCT00824616|468728|P1|Overall Study|Creatinine/Creatinine Clearance|0
129501|NCT00824616|468727|P2|Overall Study|Adverse Event|1
129502|NCT00824616|468728|P1|Overall Study|Adverse Event|2
129503|NCT00824564|468738|P2|Overall Study|Randomized, but not treated|0
129504|NCT00824564|468739|P1|Overall Study|Randomized, but not treated|1
129505|NCT00824564|468738|P2|Overall Study|Other|2
129506|NCT00824564|468739|P1|Overall Study|Other|1
129507|NCT00824564|468738|P2|Overall Study|Withdrawal by Subject|1
129508|NCT00824564|468739|P1|Overall Study|Withdrawal by Subject|1
129509|NCT00824564|468738|P2|Overall Study|Lost to Follow-up|7
129510|NCT00824564|468739|P1|Overall Study|Lost to Follow-up|5
129511|NCT00824473|468818|P2|Overall Study|Other|1
129512|NCT00824473|468819|P1|Overall Study|Other|1
129513|NCT00824473|468818|P2|Overall Study|Withdrawal by Subject|3
129514|NCT00824473|468819|P1|Overall Study|Withdrawal by Subject|2
129515|NCT00824473|468818|P2|Overall Study|Non-Compliance|2
129516|NCT00824473|468819|P1|Overall Study|Non-Compliance|4
129517|NCT00824473|468818|P2|Overall Study|Protocol Violation|0
129518|NCT00824473|468819|P1|Overall Study|Protocol Violation|2
129519|NCT00824473|468818|P2|Overall Study|Lack of Efficacy|2
129520|NCT00824473|468819|P1|Overall Study|Lack of Efficacy|2
129521|NCT00824473|468818|P2|Overall Study|Adverse Event|5
129522|NCT00824473|468819|P1|Overall Study|Adverse Event|4
129523|NCT00824421|468900|P3|Overall Study|Other|0
129524|NCT00824421|468901|P2|Overall Study|Other|1
129525|NCT00824421|468902|P1|Overall Study|Other|0
129526|NCT00824421|468900|P3|Overall Study|Randomized but not Treated|0
129527|NCT00824421|468901|P2|Overall Study|Randomized but not Treated|1
129528|NCT00824421|468902|P1|Overall Study|Randomized but not Treated|1
129529|NCT00824421|468900|P3|Overall Study|Withdrawal by Subject|3
129530|NCT00824421|468901|P2|Overall Study|Withdrawal by Subject|3
129531|NCT00824421|468902|P1|Overall Study|Withdrawal by Subject|2
129532|NCT00824421|468900|P3|Overall Study|Pregnancy|1
129533|NCT00824421|468901|P2|Overall Study|Pregnancy|0
129534|NCT00824421|468902|P1|Overall Study|Pregnancy|1
129535|NCT00824421|468900|P3|Overall Study|Lost to Follow-up|0
129536|NCT00824421|468901|P2|Overall Study|Lost to Follow-up|3
129537|NCT00824421|468902|P1|Overall Study|Lost to Follow-up|2
129538|NCT00824421|468900|P3|Overall Study|Lack of Efficacy|4
129539|NCT00824421|468901|P2|Overall Study|Lack of Efficacy|7
129540|NCT00824421|468902|P1|Overall Study|Lack of Efficacy|5
129541|NCT00824421|468900|P3|Overall Study|Death|0
129542|NCT00824421|468901|P2|Overall Study|Death|1
129543|NCT00824421|468902|P1|Overall Study|Death|0
129544|NCT00824421|468900|P3|Overall Study|Adverse Event|6
129545|NCT00824421|468901|P2|Overall Study|Adverse Event|6
129546|NCT00824421|468902|P1|Overall Study|Adverse Event|6
129547|NCT00824408|468953|P5|Randomized Phase|Other reason not defined above|4
129548|NCT00824408|468954|P4|Randomized Phase|Other reason not defined above|2
129549|NCT00824408|468955|P3|Randomized Phase|Other reason not defined above|4
129550|NCT00824408|468956|P2|Randomized Phase|Other reason not defined above|0
129551|NCT00824408|468957|P1|Randomized Phase|Other reason not defined above|0
129552|NCT00824408|468953|P5|Randomized Phase|Refused to continue medication|2
129553|NCT00824408|468954|P4|Randomized Phase|Refused to continue medication|2
129554|NCT00824408|468955|P3|Randomized Phase|Refused to continue medication|2
129555|NCT00824408|468956|P2|Randomized Phase|Refused to continue medication|0
129556|NCT00824408|468957|P1|Randomized Phase|Refused to continue medication|0
129557|NCT00824408|468953|P5|Randomized Phase|Adverse Event|5
129558|NCT00824408|468954|P4|Randomized Phase|Adverse Event|5
129559|NCT00824408|468955|P3|Randomized Phase|Adverse Event|4
129560|NCT00824408|468956|P2|Randomized Phase|Adverse Event|0
129561|NCT00824408|468957|P1|Randomized Phase|Adverse Event|0
129562|NCT00824408|468953|P5|Randomized Phase|Progressive disease|34
129563|NCT00824408|468954|P4|Randomized Phase|Progressive disease|36
129564|NCT00824408|468955|P3|Randomized Phase|Progressive disease|25
129565|NCT00824408|468956|P2|Randomized Phase|Progressive disease|0
129566|NCT00824408|468957|P1|Randomized Phase|Progressive disease|0
129567|NCT00824408|468953|P5|Randomized Phase|Not treated|1
129568|NCT00824408|468954|P4|Randomized Phase|Not treated|1
129569|NCT00824408|468955|P3|Randomized Phase|Not treated|1
129570|NCT00824408|468956|P2|Randomized Phase|Not treated|0
129571|NCT00824408|468957|P1|Randomized Phase|Not treated|0
129572|NCT00824408|468953|P5|Run-in Phase|Other reason not defined above|0
129573|NCT00824408|468954|P4|Run-in Phase|Other reason not defined above|0
129574|NCT00824408|468955|P3|Run-in Phase|Other reason not defined above|0
129575|NCT00824408|468956|P2|Run-in Phase|Other reason not defined above|1
129576|NCT00824408|468957|P1|Run-in Phase|Other reason not defined above|0
129577|NCT00824408|468953|P5|Run-in Phase|Refused to continue medication|0
129578|NCT00824408|468954|P4|Run-in Phase|Refused to continue medication|0
129579|NCT00824408|468955|P3|Run-in Phase|Refused to continue medication|0
129580|NCT00824408|468956|P2|Run-in Phase|Refused to continue medication|0
129581|NCT00824408|468957|P1|Run-in Phase|Refused to continue medication|1
129582|NCT00824408|468953|P5|Run-in Phase|Adverse Event|0
129583|NCT00824408|468954|P4|Run-in Phase|Adverse Event|0
129584|NCT00824408|468955|P3|Run-in Phase|Adverse Event|0
129585|NCT00824408|468956|P2|Run-in Phase|Adverse Event|1
129586|NCT00824408|468957|P1|Run-in Phase|Adverse Event|1
129587|NCT00824408|468953|P5|Run-in Phase|Progressive disease|0
129588|NCT00824408|468954|P4|Run-in Phase|Progressive disease|0
129589|NCT00824408|468955|P3|Run-in Phase|Progressive disease|0
129590|NCT00824408|468956|P2|Run-in Phase|Progressive disease|4
129591|NCT00824408|468957|P1|Run-in Phase|Progressive disease|4
129592|NCT00824382|469009|P4|Overall Study|Investigator's decision|0
129593|NCT00824382|469010|P3|Overall Study|Investigator's decision|2
129594|NCT00824382|469011|P2|Overall Study|Investigator's decision|1
129595|NCT00824382|469012|P1|Overall Study|Investigator's decision|0
129596|NCT00824382|469009|P4|Overall Study|Protocol Violation|1
129597|NCT00824382|469010|P3|Overall Study|Protocol Violation|0
129598|NCT00824382|469011|P2|Overall Study|Protocol Violation|0
129599|NCT00824382|469012|P1|Overall Study|Protocol Violation|1
129600|NCT00824382|469009|P4|Overall Study|Adverse Event|4
129601|NCT00824382|469010|P3|Overall Study|Adverse Event|1
129602|NCT00824382|469011|P2|Overall Study|Adverse Event|1
129603|NCT00824382|469012|P1|Overall Study|Adverse Event|4
129604|NCT00824369|469088|P6|Overall Study|Lost to Follow-up|0
129605|NCT00824369|469089|P5|Overall Study|Lost to Follow-up|1
129606|NCT00824369|469090|P4|Overall Study|Lost to Follow-up|0
129607|NCT00824369|469091|P3|Overall Study|Lost to Follow-up|0
129608|NCT00824369|469092|P2|Overall Study|Lost to Follow-up|0
129609|NCT00824369|469093|P1|Overall Study|Lost to Follow-up|0
129610|NCT00824369|469088|P6|Overall Study|Nolonger willing to participate in study|1
129611|NCT00824369|469089|P5|Overall Study|Nolonger willing to participate in study|0
129612|NCT00824369|469090|P4|Overall Study|Nolonger willing to participate in study|2
129613|NCT00824369|469091|P3|Overall Study|Nolonger willing to participate in study|1
129614|NCT00824369|469092|P2|Overall Study|Nolonger willing to participate in study|0
129615|NCT00824369|469093|P1|Overall Study|Nolonger willing to participate in study|1
129616|NCT00824291|469133|P2|Overall Study|Participant on prohibited medication|0
129617|NCT00824291|469134|P1|Overall Study|Participant on prohibited medication|1
129618|NCT00824291|469133|P2|Overall Study|Lack of Efficacy|8
129619|NCT00824291|469134|P1|Overall Study|Lack of Efficacy|7
129620|NCT00824291|469133|P2|Overall Study|Withdrawal by Subject|8
129621|NCT00824291|469134|P1|Overall Study|Withdrawal by Subject|14
129622|NCT00824291|469133|P2|Overall Study|Protocol Violation|1
129623|NCT00824291|469134|P1|Overall Study|Protocol Violation|4
129624|NCT00824291|469133|P2|Overall Study|Non-compliance|1
129625|NCT00824291|469134|P1|Overall Study|Non-compliance|1
129626|NCT00824291|469133|P2|Overall Study|Lost to Follow-up|9
129627|NCT00824291|469134|P1|Overall Study|Lost to Follow-up|11
129628|NCT00824291|469133|P2|Overall Study|Discontinuation of Study by Sponsor|2
129629|NCT00824291|469134|P1|Overall Study|Discontinuation of Study by Sponsor|1
129630|NCT00824291|469133|P2|Overall Study|Adverse Event|6
129631|NCT00824291|469134|P1|Overall Study|Adverse Event|15
129632|NCT00824265|469156|P2|Overall Study|Withdrawal by Subject|15
129633|NCT00824265|469157|P1|Overall Study|Withdrawal by Subject|6
129634|NCT00824265|469156|P2|Overall Study|Physician Decision|12
129635|NCT00824265|469157|P1|Overall Study|Physician Decision|6
129636|NCT00824265|469156|P2|Overall Study|Lost to Follow-up|1
129637|NCT00824265|469157|P1|Overall Study|Lost to Follow-up|1
129638|NCT00824265|469156|P2|Overall Study|Protocol Violation|0
129639|NCT00824265|469157|P1|Overall Study|Protocol Violation|1
129640|NCT00824265|469156|P2|Overall Study|Adverse Event,non-fatal|52
129641|NCT00824265|469157|P1|Overall Study|Adverse Event,non-fatal|50
129642|NCT00824161|469216|P1|Overall Study|Screen Failure|1
129643|NCT00824161|469216|P1|Overall Study|Withdrawal by Subject|1
129644|NCT00824005|469282|P2|Overall Study|Lost to Follow-up|1
129645|NCT00824005|469283|P1|Overall Study|Lost to Follow-up|0
129646|NCT00824005|469282|P2|Overall Study|Death|1
129647|NCT00824005|469283|P1|Overall Study|Death|0
129648|NCT00823979|469318|P3|Overall Study|Study Terminated by Sponsor|7
129649|NCT00823979|469319|P2|Overall Study|Study Terminated by Sponsor|5
129650|NCT00823979|469320|P1|Overall Study|Study Terminated by Sponsor|5
129651|NCT00823979|469318|P3|Overall Study|Randomized but not Treated|1
129652|NCT00823979|469319|P2|Overall Study|Randomized but not Treated|3
129653|NCT00823979|469320|P1|Overall Study|Randomized but not Treated|4
129654|NCT00823979|469318|P3|Overall Study|Other|1
129655|NCT00823979|469319|P2|Overall Study|Other|0
129656|NCT00823979|469320|P1|Overall Study|Other|2
129657|NCT00823979|469318|P3|Overall Study|Adverse Event|4
129658|NCT00823979|469319|P2|Overall Study|Adverse Event|2
129659|NCT00823979|469320|P1|Overall Study|Adverse Event|0
129660|NCT00823979|469318|P3|Overall Study|Pregnancy|0
129661|NCT00823979|469319|P2|Overall Study|Pregnancy|1
129662|NCT00823979|469320|P1|Overall Study|Pregnancy|0
129663|NCT00823979|469318|P3|Overall Study|Protocol Violation|0
129664|NCT00823979|469319|P2|Overall Study|Protocol Violation|1
129665|NCT00823979|469320|P1|Overall Study|Protocol Violation|1
129666|NCT00823979|469318|P3|Overall Study|Withdrawal by Subject|2
129667|NCT00823979|469319|P2|Overall Study|Withdrawal by Subject|3
129668|NCT00823979|469320|P1|Overall Study|Withdrawal by Subject|2
129669|NCT00823979|469318|P3|Overall Study|Lost to Follow-up|0
129670|NCT00823979|469319|P2|Overall Study|Lost to Follow-up|1
129671|NCT00823979|469320|P1|Overall Study|Lost to Follow-up|2
129672|NCT00823979|469318|P3|Overall Study|Lack of Efficacy|9
129673|NCT00823979|469319|P2|Overall Study|Lack of Efficacy|16
129674|NCT00823979|469320|P1|Overall Study|Lack of Efficacy|13
129675|NCT00823901|469365|P2|Overall Study|Lost to Follow-up|1
129676|NCT00823901|469366|P1|Overall Study|Lost to Follow-up|2
129677|NCT00823901|469365|P2|Overall Study|Lack of Efficacy|0
129678|NCT00823901|469366|P1|Overall Study|Lack of Efficacy|1
129679|NCT00823901|469365|P2|Overall Study|Adverse Event|1
129680|NCT00823901|469366|P1|Overall Study|Adverse Event|1
129681|NCT00823836|469374|P2|Long-term Phase|Withdrawal by Subject|1
129682|NCT00823836|469375|P1|Long-term Phase|Withdrawal by Subject|1
129683|NCT00823836|469374|P2|Long-term Phase|Physician Decision|2
129684|NCT00823836|469375|P1|Long-term Phase|Physician Decision|1
129685|NCT00823836|469374|P2|Long-term Phase|Adverse Event|2
129686|NCT00823836|469375|P1|Long-term Phase|Adverse Event|3
129687|NCT00823836|469374|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
129688|NCT00823836|469375|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
129689|NCT00823836|469374|P2|NV and PR/XR Switching Phases|Physician Decision|2
129690|NCT00823836|469375|P1|NV and PR/XR Switching Phases|Physician Decision|5
129691|NCT00823836|469374|P2|NV and PR/XR Switching Phases|Protocol Violation|1
129692|NCT00823836|469375|P1|NV and PR/XR Switching Phases|Protocol Violation|1
129693|NCT00823836|469374|P2|NV and PR/XR Switching Phases|Adverse Event|21
129694|NCT00823836|469375|P1|NV and PR/XR Switching Phases|Adverse Event|22
129695|NCT00823823|469481|P2|Overall Study|Protocol Violation|5
129696|NCT00823823|469482|P1|Overall Study|Protocol Violation|5
129697|NCT00823823|469481|P2|Overall Study|Lost to Follow-up|1
129698|NCT00823823|469482|P1|Overall Study|Lost to Follow-up|3
129699|NCT00823719|469506|P2|Overall Study|Disease Progression|4
129700|NCT00823719|469507|P1|Overall Study|Disease Progression|4
129701|NCT00823719|469506|P2|Overall Study|Withdrawal by Subject|1
129702|NCT00823719|469507|P1|Overall Study|Withdrawal by Subject|0
129703|NCT00823719|469506|P2|Overall Study|Physician Decision|4
129704|NCT00823719|469507|P1|Overall Study|Physician Decision|1
129705|NCT00823719|469506|P2|Overall Study|Adverse Event|2
129706|NCT00823719|469507|P1|Overall Study|Adverse Event|1
129707|NCT00823615|469560|P2|Period 2|Time/Job Conflict|2
129708|NCT00823615|469561|P1|Period 2|Time/Job Conflict|1
129709|NCT00823615|469560|P2|Period 2|Lost to Follow-up|0
129710|NCT00823615|469561|P1|Period 2|Lost to Follow-up|2
129711|NCT00823472|469571|P2|Overall Study|Physician Decision|28
129712|NCT00823472|469572|P1|Overall Study|Physician Decision|24
129713|NCT00823264|469591|P2|Overall Study|Protocol Violation|0
129714|NCT00823264|469592|P1|Overall Study|Protocol Violation|2
129715|NCT00823212|469600|P2|Overall Study|Missed 12-month visit|21
129716|NCT00823212|469601|P1|Overall Study|Missed 12-month visit|21
129717|NCT00823212|469600|P2|Overall Study|Incarcerated|1
129718|NCT00823212|469601|P1|Overall Study|Incarcerated|0
129719|NCT00823212|469600|P2|Overall Study|Withdrawal by Subject|1
129720|NCT00823212|469601|P1|Overall Study|Withdrawal by Subject|6
129721|NCT00823212|469600|P2|Overall Study|Death|10
129722|NCT00823212|469601|P1|Overall Study|Death|8
129723|NCT00823199|469683|P1|Overall Study|Withdrawal by Subject|2
129724|NCT00822926|469752|P2|Second Injection Visit|Withdrawal by Subject|1
129725|NCT00822926|469753|P1|Second Injection Visit|Withdrawal by Subject|0
129726|NCT00822926|469752|P2|Second Injection Visit|Lost to Follow-up|0
129727|NCT00822926|469753|P1|Second Injection Visit|Lost to Follow-up|1
129728|NCT00822900|469767|P2|Overall Study|Became a ward of the state|1
129729|NCT00822900|469768|P1|Overall Study|Became a ward of the state|2
129730|NCT00822900|469767|P2|Overall Study|Death|69
129731|NCT00822900|469768|P1|Overall Study|Death|83
129732|NCT00822900|469767|P2|Overall Study|Lost to Follow-up|9
129733|NCT00822900|469768|P1|Overall Study|Lost to Follow-up|9
129734|NCT00822900|469767|P2|Overall Study|Withdrawal by Subject|14
129735|NCT00822900|469768|P1|Overall Study|Withdrawal by Subject|14
129736|NCT00822692|469815|P2|Overall Study|Lost to Follow-up|25
129737|NCT00822692|469816|P1|Overall Study|Lost to Follow-up|17
129738|NCT00822237|469954|P2|Dose 2 Vaccination|Lost to Follow-up|9
129739|NCT00822237|469955|P1|Dose 2 Vaccination|Lost to Follow-up|2
129740|NCT00822237|469954|P2|Dose 2 Vaccination|Withdrawal by Subject|2
129741|NCT00822237|469955|P1|Dose 2 Vaccination|Withdrawal by Subject|2
129742|NCT00822237|469954|P2|Dose 1 Vaccination|Lost to Follow-up|12
129743|NCT00822237|469955|P1|Dose 1 Vaccination|Lost to Follow-up|9
129744|NCT00822237|469954|P2|Dose 1 Vaccination|Withdrawal by Subject|14
129745|NCT00822237|469955|P1|Dose 1 Vaccination|Withdrawal by Subject|13
129746|NCT00822237|469954|P2|Dose 1 Vaccination|Not vaccinated|0
129747|NCT00822237|469955|P1|Dose 1 Vaccination|Not vaccinated|3
129748|NCT00822172|470036|P2|Overall Study|Other|1
129749|NCT00822172|470037|P1|Overall Study|Other|0
129750|NCT00822172|470036|P2|Overall Study|site closed|1
129751|NCT00822172|470037|P1|Overall Study|site closed|0
129752|NCT00822172|470036|P2|Overall Study|Withdrawal by Subject|4
129753|NCT00822172|470037|P1|Overall Study|Withdrawal by Subject|1
129754|NCT00822172|470036|P2|Overall Study|Lost to Follow-up|1
129755|NCT00822172|470037|P1|Overall Study|Lost to Follow-up|3
129756|NCT00822172|470036|P2|Overall Study|Death|0
129757|NCT00822172|470037|P1|Overall Study|Death|1
129758|NCT00822172|470036|P2|Overall Study|Adverse Event|12
129759|NCT00822172|470037|P1|Overall Study|Adverse Event|10
129760|NCT00822120|470045|P6|PET-directed Therapy|Protocol Violation|0
129761|NCT00822120|470046|P5|PET-directed Therapy|Protocol Violation|0
129762|NCT00822120|470047|P4|PET-directed Therapy|Protocol Violation|6
129763|NCT00822120|470048|P3|PET-directed Therapy|Protocol Violation|0
129764|NCT00822120|470049|P2|PET-directed Therapy|Protocol Violation|0
129765|NCT00822120|470050|P1|PET-directed Therapy|Protocol Violation|0
129766|NCT00822120|470045|P6|PET-directed Therapy|Death|0
129767|NCT00822120|470046|P5|PET-directed Therapy|Death|0
129768|NCT00822120|470047|P4|PET-directed Therapy|Death|2
129769|NCT00822120|470048|P3|PET-directed Therapy|Death|0
129770|NCT00822120|470049|P2|PET-directed Therapy|Death|0
129771|NCT00822120|470050|P1|PET-directed Therapy|Death|0
129772|NCT00822120|470045|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
129773|NCT00822120|470046|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
129774|NCT00822120|470047|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
129775|NCT00822120|470048|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
129776|NCT00822120|470049|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
129777|NCT00822120|470050|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
129778|NCT00822120|470045|P6|PET-directed Therapy|Adverse Event|0
129779|NCT00822120|470046|P5|PET-directed Therapy|Adverse Event|0
129780|NCT00822120|470047|P4|PET-directed Therapy|Adverse Event|1
129781|NCT00822120|470048|P3|PET-directed Therapy|Adverse Event|0
129782|NCT00822120|470049|P2|PET-directed Therapy|Adverse Event|0
129783|NCT00822120|470050|P1|PET-directed Therapy|Adverse Event|0
129784|NCT00822120|470045|P6|Initial Registration|Ineligible|0
129785|NCT00822120|470046|P5|Initial Registration|Ineligible|0
129786|NCT00822120|470047|P4|Initial Registration|Ineligible|0
129787|NCT00822120|470048|P3|Initial Registration|Ineligible|0
129788|NCT00822120|470049|P2|Initial Registration|Ineligible|1
129789|NCT00822120|470050|P1|Initial Registration|Ineligible|22
129790|NCT00822120|470045|P6|Initial Registration|Reasons not Protocol Specified|0
129791|NCT00822120|470046|P5|Initial Registration|Reasons not Protocol Specified|0
129792|NCT00822120|470047|P4|Initial Registration|Reasons not Protocol Specified|0
129793|NCT00822120|470048|P3|Initial Registration|Reasons not Protocol Specified|0
129794|NCT00822120|470049|P2|Initial Registration|Reasons not Protocol Specified|0
129795|NCT00822120|470050|P1|Initial Registration|Reasons not Protocol Specified|2
129796|NCT00822120|470045|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
129797|NCT00822120|470046|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
129798|NCT00822120|470047|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
129799|NCT00822120|470048|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
129800|NCT00822120|470049|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
129801|NCT00822120|470050|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
129802|NCT00822120|470045|P6|Initial Registration|Adverse Event|0
129803|NCT00822120|470046|P5|Initial Registration|Adverse Event|0
129804|NCT00822120|470047|P4|Initial Registration|Adverse Event|0
129805|NCT00822120|470048|P3|Initial Registration|Adverse Event|0
129806|NCT00822120|470049|P2|Initial Registration|Adverse Event|0
129807|NCT00822120|470050|P1|Initial Registration|Adverse Event|1
129808|NCT00821873|470112|P1|Overall Study|Lost to Follow-up|4
129809|NCT00821678|470133|P2|Overall Study|Death|2
129810|NCT00821678|470134|P1|Overall Study|Death|0
129811|NCT00821678|470133|P2|Overall Study|Lost to Follow-up|12
129812|NCT00821678|470134|P1|Overall Study|Lost to Follow-up|13
129813|NCT00821678|470133|P2|Overall Study|Withdrawal by Subject|0
129814|NCT00821678|470134|P1|Overall Study|Withdrawal by Subject|8
129815|NCT00821587|470152|P2|Overall Study|Physician Decision|1
129816|NCT00821587|470153|P1|Overall Study|Physician Decision|0
129817|NCT00821509|470162|P3|Overall Study|Withdrawal by Subject|34
129818|NCT00821509|470163|P2|Overall Study|Withdrawal by Subject|11
129819|NCT00821509|470164|P1|Overall Study|Withdrawal by Subject|12
129820|NCT00821431|470177|P2|Overall Study|Physician Decision|1
129821|NCT00821431|470178|P1|Overall Study|Physician Decision|0
129822|NCT00821431|470177|P2|Overall Study|Protocol Violation|1
129823|NCT00821431|470178|P1|Overall Study|Protocol Violation|3
129824|NCT00821431|470177|P2|Overall Study|Lost to Follow-up|0
129825|NCT00821431|470178|P1|Overall Study|Lost to Follow-up|1
129826|NCT00821431|470177|P2|Overall Study|Withdrawal by Subject|0
129827|NCT00821431|470178|P1|Overall Study|Withdrawal by Subject|5
129828|NCT00821431|470177|P2|Overall Study|Adverse Event|3
129829|NCT00821431|470178|P1|Overall Study|Adverse Event|6
129830|NCT00821327|470186|P1|Overall Study|Other/Unknown|5
129831|NCT00821327|470186|P1|Overall Study|Disease Progression|13
129832|NCT00821327|470186|P1|Overall Study|Sponsor Request|1
129833|NCT00821327|470186|P1|Overall Study|Investigator Request|2
129834|NCT00821327|470186|P1|Overall Study|Patient Request|1
129835|NCT00821327|470186|P1|Overall Study|Adverse Event|13
129836|NCT00821236|470195|P1|Overall Study|Lost to Follow-up|3
129837|NCT00821093|470235|P2|Overall Study|Administrative problems|2
129838|NCT00821093|470236|P1|Overall Study|Administrative problems|1
129839|NCT00821093|470235|P2|Overall Study|Abnormal test procedure result(s)|1
129840|NCT00821093|470236|P1|Overall Study|Abnormal test procedure result(s)|1
129841|NCT00821093|470235|P2|Overall Study|Death|1
129842|NCT00821093|470236|P1|Overall Study|Death|2
129843|NCT00821093|470235|P2|Overall Study|Lack of Efficacy|2
129844|NCT00821093|470236|P1|Overall Study|Lack of Efficacy|2
129845|NCT00821093|470235|P2|Overall Study|Abnormal laboratory value(s)|0
129846|NCT00821093|470236|P1|Overall Study|Abnormal laboratory value(s)|2
129847|NCT00821093|470235|P2|Overall Study|Protocol deviation|6
129848|NCT00821093|470236|P1|Overall Study|Protocol deviation|3
129849|NCT00821093|470235|P2|Overall Study|Lost to Follow-up|3
129850|NCT00821093|470236|P1|Overall Study|Lost to Follow-up|9
129851|NCT00821093|470235|P2|Overall Study|Withdrawal by Subject|13
129852|NCT00821093|470236|P1|Overall Study|Withdrawal by Subject|9
129853|NCT00821093|470235|P2|Overall Study|Adverse Event|12
129854|NCT00821093|470236|P1|Overall Study|Adverse Event|20
129855|NCT00820898|470255|P1|Overall Study|Inelgible - wrong primary site|1
129856|NCT00820755|470269|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
129857|NCT00820755|470270|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
129858|NCT00820755|470271|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
129859|NCT00820755|470269|P3|Period 1: Combination Therapy Phase|Other|0
129860|NCT00820755|470270|P2|Period 1: Combination Therapy Phase|Other|0
129861|NCT00820755|470271|P1|Period 1: Combination Therapy Phase|Other|11
129862|NCT00820755|470269|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
129863|NCT00820755|470270|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
129864|NCT00820755|470271|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
129865|NCT00820755|470269|P3|Period 1: Combination Therapy Phase|Progressive disease|0
129866|NCT00820755|470270|P2|Period 1: Combination Therapy Phase|Progressive disease|0
129867|NCT00820755|470271|P1|Period 1: Combination Therapy Phase|Progressive disease|114
129868|NCT00820755|470269|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
129869|NCT00820755|470270|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
129870|NCT00820755|470271|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
129871|NCT00820755|470269|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
129872|NCT00820755|470270|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
129873|NCT00820755|470271|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
129874|NCT00820755|470269|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
129875|NCT00820755|470270|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
129876|NCT00820755|470271|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
129877|NCT00820755|470269|P3|Period 1: Combination Therapy Phase|Death|0
129878|NCT00820755|470270|P2|Period 1: Combination Therapy Phase|Death|0
129879|NCT00820755|470271|P1|Period 1: Combination Therapy Phase|Death|28
129880|NCT00820755|470269|P3|Period 1: Combination Therapy Phase|Adverse Event|0
129881|NCT00820755|470270|P2|Period 1: Combination Therapy Phase|Adverse Event|0
129882|NCT00820755|470271|P1|Period 1: Combination Therapy Phase|Adverse Event|77
129883|NCT00820248|470364|P2|Overall Study|No treated|1
129884|NCT00820248|470365|P1|Overall Study|No treated|4
129885|NCT00820222|470375|P2|Overall Study|Ongoing|191
129886|NCT00820222|470376|P1|Overall Study|Ongoing|185
129887|NCT00820222|470375|P2|Overall Study|Sponsor Terminated Study|1
129888|NCT00820222|470376|P1|Overall Study|Sponsor Terminated Study|0
129889|NCT00820222|470375|P2|Overall Study|Physician Decision|6
129890|NCT00820222|470376|P1|Overall Study|Physician Decision|4
129891|NCT00820222|470375|P2|Overall Study|Withdrawal by Subject|9
129892|NCT00820222|470376|P1|Overall Study|Withdrawal by Subject|8
129893|NCT00820222|470375|P2|Overall Study|Lost to Follow-up|4
129894|NCT00820222|470376|P1|Overall Study|Lost to Follow-up|4
129895|NCT00819910|470406|P4|Overall Study|Lost to Follow-up|0
129896|NCT00819910|470407|P3|Overall Study|Lost to Follow-up|0
129897|NCT00819910|470408|P2|Overall Study|Lost to Follow-up|0
129898|NCT00819910|470409|P1|Overall Study|Lost to Follow-up|1
129899|NCT00819910|470406|P4|Overall Study|Withdrawal by Subject|0
129900|NCT00819910|470407|P3|Overall Study|Withdrawal by Subject|1
129901|NCT00819910|470408|P2|Overall Study|Withdrawal by Subject|1
129902|NCT00819910|470409|P1|Overall Study|Withdrawal by Subject|1
129903|NCT00819910|470406|P4|Overall Study|Adverse Event|1
129904|NCT00819910|470407|P3|Overall Study|Adverse Event|2
129905|NCT00819910|470408|P2|Overall Study|Adverse Event|0
129906|NCT00819910|470409|P1|Overall Study|Adverse Event|0
129907|NCT00819832|470441|P6|Overall Study|Sponsor Termination of Study|0
129908|NCT00819832|470442|P5|Overall Study|Sponsor Termination of Study|0
129909|NCT00819832|470443|P4|Overall Study|Sponsor Termination of Study|0
129910|NCT00819832|470444|P3|Overall Study|Sponsor Termination of Study|0
129911|NCT00819832|470445|P2|Overall Study|Sponsor Termination of Study|0
129912|NCT00819832|470446|P1|Overall Study|Sponsor Termination of Study|3
129913|NCT00819780|470462|P2|Overall Study|Still in treatment|17
129914|NCT00819780|470463|P1|Overall Study|Still in treatment|25
129915|NCT00819780|470462|P2|Overall Study|Did not receive study drug|4
129916|NCT00819780|470463|P1|Overall Study|Did not receive study drug|3
129917|NCT00819767|470497|P2|Overall Study|Unsatisfactory therapeutic effect|2
129918|NCT00819767|470498|P1|Overall Study|Unsatisfactory therapeutic effect|1
129919|NCT00819741|470510|P2|Overall Study|Reasons unknown|3
129920|NCT00819741|470511|P1|Overall Study|Reasons unknown|3
129921|NCT00819741|470510|P2|Overall Study|Unclassified|0
129922|NCT00819741|470511|P1|Overall Study|Unclassified|6
129923|NCT00819741|470510|P2|Overall Study|Withdrawal by Subject|2
129924|NCT00819741|470511|P1|Overall Study|Withdrawal by Subject|2
129925|NCT00819741|470510|P2|Overall Study|Protocol Violation|4
129926|NCT00819741|470511|P1|Overall Study|Protocol Violation|3
129927|NCT00819741|470510|P2|Overall Study|Lost to Follow-up|1
129928|NCT00819741|470511|P1|Overall Study|Lost to Follow-up|3
129929|NCT00819741|470510|P2|Overall Study|Lack of Efficacy|2
129930|NCT00819741|470511|P1|Overall Study|Lack of Efficacy|0
129931|NCT00819741|470510|P2|Overall Study|Adverse Event|2
129932|NCT00819741|470511|P1|Overall Study|Adverse Event|5
129933|NCT00819585|470565|P7|Overall Study|Protocol Violation|3
129934|NCT00819585|470566|P6|Overall Study|Protocol Violation|1
129935|NCT00819585|470567|P5|Overall Study|Protocol Violation|0
129936|NCT00819585|470568|P4|Overall Study|Protocol Violation|0
129937|NCT00819585|470569|P3|Overall Study|Protocol Violation|1
129938|NCT00819585|470570|P2|Overall Study|Protocol Violation|0
129939|NCT00819585|470571|P1|Overall Study|Protocol Violation|0
129940|NCT00819585|470565|P7|Overall Study|Death|1
129941|NCT00819585|470566|P6|Overall Study|Death|0
129942|NCT00819585|470567|P5|Overall Study|Death|0
129943|NCT00819585|470568|P4|Overall Study|Death|0
129944|NCT00819585|470569|P3|Overall Study|Death|0
129945|NCT00819585|470570|P2|Overall Study|Death|0
129946|NCT00819585|470571|P1|Overall Study|Death|0
129947|NCT00819585|470565|P7|Overall Study|Administrative problems|2
129948|NCT00819585|470566|P6|Overall Study|Administrative problems|0
129949|NCT00819585|470567|P5|Overall Study|Administrative problems|0
129950|NCT00819585|470568|P4|Overall Study|Administrative problems|0
129951|NCT00819585|470569|P3|Overall Study|Administrative problems|0
129952|NCT00819585|470570|P2|Overall Study|Administrative problems|0
129953|NCT00819585|470571|P1|Overall Study|Administrative problems|0
129954|NCT00819585|470565|P7|Overall Study|Lost to Follow-up|1
129955|NCT00819585|470566|P6|Overall Study|Lost to Follow-up|1
129956|NCT00819585|470567|P5|Overall Study|Lost to Follow-up|1
129957|NCT00819585|470568|P4|Overall Study|Lost to Follow-up|0
129958|NCT00819585|470569|P3|Overall Study|Lost to Follow-up|2
129959|NCT00819585|470570|P2|Overall Study|Lost to Follow-up|1
129960|NCT00819585|470571|P1|Overall Study|Lost to Follow-up|2
129961|NCT00819585|470565|P7|Overall Study|Subject withdrew consent|3
129962|NCT00819585|470566|P6|Overall Study|Subject withdrew consent|0
129963|NCT00819585|470567|P5|Overall Study|Subject withdrew consent|0
129964|NCT00819585|470568|P4|Overall Study|Subject withdrew consent|1
129965|NCT00819585|470569|P3|Overall Study|Subject withdrew consent|2
129966|NCT00819585|470570|P2|Overall Study|Subject withdrew consent|3
129967|NCT00819585|470571|P1|Overall Study|Subject withdrew consent|0
129968|NCT00819585|470565|P7|Overall Study|Subject no longer requires study drug|0
129969|NCT00819585|470566|P6|Overall Study|Subject no longer requires study drug|0
129970|NCT00819585|470567|P5|Overall Study|Subject no longer requires study drug|1
129971|NCT00819585|470568|P4|Overall Study|Subject no longer requires study drug|0
129972|NCT00819585|470569|P3|Overall Study|Subject no longer requires study drug|0
129973|NCT00819585|470570|P2|Overall Study|Subject no longer requires study drug|0
129974|NCT00819585|470571|P1|Overall Study|Subject no longer requires study drug|0
129975|NCT00819585|470565|P7|Overall Study|Unsatisfactory therapeutic effect|1
129976|NCT00819585|470566|P6|Overall Study|Unsatisfactory therapeutic effect|0
129977|NCT00819585|470567|P5|Overall Study|Unsatisfactory therapeutic effect|0
129978|NCT00819585|470568|P4|Overall Study|Unsatisfactory therapeutic effect|0
129979|NCT00819585|470569|P3|Overall Study|Unsatisfactory therapeutic effect|0
129980|NCT00819585|470570|P2|Overall Study|Unsatisfactory therapeutic effect|1
129981|NCT00819585|470571|P1|Overall Study|Unsatisfactory therapeutic effect|0
129982|NCT00819585|470565|P7|Overall Study|Abnormal laboratory value(s)|0
129983|NCT00819585|470566|P6|Overall Study|Abnormal laboratory value(s)|0
129984|NCT00819585|470567|P5|Overall Study|Abnormal laboratory value(s)|0
129985|NCT00819585|470568|P4|Overall Study|Abnormal laboratory value(s)|0
129986|NCT00819585|470569|P3|Overall Study|Abnormal laboratory value(s)|0
129987|NCT00819585|470570|P2|Overall Study|Abnormal laboratory value(s)|0
129988|NCT00819585|470571|P1|Overall Study|Abnormal laboratory value(s)|2
129989|NCT00819585|470565|P7|Overall Study|Adverse Event|2
129990|NCT00819585|470566|P6|Overall Study|Adverse Event|0
129991|NCT00819585|470567|P5|Overall Study|Adverse Event|1
129992|NCT00819585|470568|P4|Overall Study|Adverse Event|4
129993|NCT00819585|470569|P3|Overall Study|Adverse Event|1
129994|NCT00819585|470570|P2|Overall Study|Adverse Event|1
129995|NCT00819585|470571|P1|Overall Study|Adverse Event|2
129996|NCT00819390|470648|P4|Overall Study|Adverse Event|0
129997|NCT00819390|470649|P3|Overall Study|Adverse Event|1
129998|NCT00819390|470650|P2|Overall Study|Adverse Event|0
129999|NCT00819390|470651|P1|Overall Study|Adverse Event|0
130000|NCT00819390|470648|P4|Overall Study|Withdrawal by Subject|0
130001|NCT00819390|470649|P3|Overall Study|Withdrawal by Subject|0
130002|NCT00819390|470650|P2|Overall Study|Withdrawal by Subject|0
130003|NCT00819390|470651|P1|Overall Study|Withdrawal by Subject|2
130004|NCT00819390|470648|P4|Overall Study|Lost to Follow-up|0
130005|NCT00819390|470649|P3|Overall Study|Lost to Follow-up|0
130006|NCT00819390|470650|P2|Overall Study|Lost to Follow-up|1
130007|NCT00819390|470651|P1|Overall Study|Lost to Follow-up|1
130008|NCT00819247|470787|P3|Overall Study|not specified|0
130009|NCT00819247|470788|P2|Overall Study|not specified|0
130010|NCT00819247|470789|P1|Overall Study|not specified|1
130011|NCT00819247|470787|P3|Overall Study|Bad prostate-specific antigen response|0
130012|NCT00819247|470788|P2|Overall Study|Bad prostate-specific antigen response|2
130013|NCT00819247|470789|P1|Overall Study|Bad prostate-specific antigen response|3
130014|NCT00819247|470787|P3|Overall Study|Mistakenly withdrawn|0
130015|NCT00819247|470788|P2|Overall Study|Mistakenly withdrawn|1
130016|NCT00819247|470789|P1|Overall Study|Mistakenly withdrawn|0
130017|NCT00819247|470787|P3|Overall Study|Protocol Violation|1
130018|NCT00819247|470788|P2|Overall Study|Protocol Violation|0
130019|NCT00819247|470789|P1|Overall Study|Protocol Violation|1
130020|NCT00819247|470787|P3|Overall Study|Withdrawal by Subject|0
130021|NCT00819247|470788|P2|Overall Study|Withdrawal by Subject|0
130022|NCT00819247|470789|P1|Overall Study|Withdrawal by Subject|1
130023|NCT00819247|470787|P3|Overall Study|Insufficient testosterone response|10
130024|NCT00819247|470788|P2|Overall Study|Insufficient testosterone response|8
130025|NCT00819247|470789|P1|Overall Study|Insufficient testosterone response|5
130026|NCT00819247|470787|P3|Overall Study|Adverse Event|3
130027|NCT00819247|470788|P2|Overall Study|Adverse Event|5
130028|NCT00819247|470789|P1|Overall Study|Adverse Event|0
130029|NCT00819234|470815|P10|Overall Study|Lost to Follow-up|2
130030|NCT00819234|470816|P9|Overall Study|Lost to Follow-up|1
130031|NCT00819234|470817|P8|Overall Study|Lost to Follow-up|1
130032|NCT00819234|470818|P7|Overall Study|Lost to Follow-up|1
130033|NCT00819234|470819|P6|Overall Study|Lost to Follow-up|1
130034|NCT00819234|470820|P5|Overall Study|Lost to Follow-up|1
130035|NCT00819234|470821|P4|Overall Study|Lost to Follow-up|2
130036|NCT00819234|470822|P3|Overall Study|Lost to Follow-up|0
130037|NCT00819234|470823|P2|Overall Study|Lost to Follow-up|2
130038|NCT00819234|470824|P1|Overall Study|Lost to Follow-up|2
130039|NCT00819234|470815|P10|Overall Study|Protocol Violation|0
130040|NCT00819234|470816|P9|Overall Study|Protocol Violation|0
130041|NCT00819234|470817|P8|Overall Study|Protocol Violation|0
130042|NCT00819234|470818|P7|Overall Study|Protocol Violation|0
130043|NCT00819234|470819|P6|Overall Study|Protocol Violation|0
130044|NCT00819234|470820|P5|Overall Study|Protocol Violation|0
130045|NCT00819234|470821|P4|Overall Study|Protocol Violation|0
130046|NCT00819234|470822|P3|Overall Study|Protocol Violation|1
130047|NCT00819234|470823|P2|Overall Study|Protocol Violation|0
130048|NCT00819234|470824|P1|Overall Study|Protocol Violation|0
130049|NCT00819234|470815|P10|Overall Study|Physician Decision|2
130050|NCT00819234|470816|P9|Overall Study|Physician Decision|0
130051|NCT00819234|470817|P8|Overall Study|Physician Decision|0
130052|NCT00819234|470818|P7|Overall Study|Physician Decision|0
130053|NCT00819234|470819|P6|Overall Study|Physician Decision|0
130054|NCT00819234|470820|P5|Overall Study|Physician Decision|0
130055|NCT00819234|470821|P4|Overall Study|Physician Decision|1
130056|NCT00819234|470822|P3|Overall Study|Physician Decision|0
130057|NCT00819234|470823|P2|Overall Study|Physician Decision|0
130058|NCT00819234|470824|P1|Overall Study|Physician Decision|0
130059|NCT00819234|470815|P10|Overall Study|Adverse Event|0
130060|NCT00819234|470816|P9|Overall Study|Adverse Event|0
130061|NCT00819234|470817|P8|Overall Study|Adverse Event|0
130062|NCT00819234|470818|P7|Overall Study|Adverse Event|0
130063|NCT00819234|470819|P6|Overall Study|Adverse Event|2
130064|NCT00819234|470820|P5|Overall Study|Adverse Event|0
130065|NCT00819234|470821|P4|Overall Study|Adverse Event|0
130066|NCT00819234|470822|P3|Overall Study|Adverse Event|1
130067|NCT00819234|470823|P2|Overall Study|Adverse Event|0
130068|NCT00819234|470824|P1|Overall Study|Adverse Event|0
130069|NCT00819234|470815|P10|Overall Study|Withdrawal by Subject|3
130070|NCT00819234|470816|P9|Overall Study|Withdrawal by Subject|5
130071|NCT00819234|470817|P8|Overall Study|Withdrawal by Subject|8
130072|NCT00819234|470818|P7|Overall Study|Withdrawal by Subject|4
130073|NCT00819234|470819|P6|Overall Study|Withdrawal by Subject|4
130074|NCT00819234|470820|P5|Overall Study|Withdrawal by Subject|0
130075|NCT00819234|470821|P4|Overall Study|Withdrawal by Subject|3
130076|NCT00819234|470822|P3|Overall Study|Withdrawal by Subject|6
130077|NCT00819234|470823|P2|Overall Study|Withdrawal by Subject|13
130078|NCT00819234|470824|P1|Overall Study|Withdrawal by Subject|8
130079|NCT00819156|471023|P6|Overall Study|Prostate-specific antigen progression|0
130080|NCT00819156|471024|P5|Overall Study|Prostate-specific antigen progression|1
130081|NCT00819156|471025|P4|Overall Study|Prostate-specific antigen progression|0
130082|NCT00819156|471026|P3|Overall Study|Prostate-specific antigen progression|0
130083|NCT00819156|471027|P2|Overall Study|Prostate-specific antigen progression|0
130084|NCT00819156|471028|P1|Overall Study|Prostate-specific antigen progression|0
130085|NCT00819156|471023|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
130086|NCT00819156|471024|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
130087|NCT00819156|471025|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
130088|NCT00819156|471026|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
130089|NCT00819156|471027|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
130090|NCT00819156|471028|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
130091|NCT00819156|471023|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
130092|NCT00819156|471024|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
130093|NCT00819156|471025|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
130094|NCT00819156|471026|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
130095|NCT00819156|471027|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
130096|NCT00819156|471028|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
130097|NCT00819156|471023|P6|Overall Study|Lost to Follow-up|2
130098|NCT00819156|471024|P5|Overall Study|Lost to Follow-up|0
130099|NCT00819156|471025|P4|Overall Study|Lost to Follow-up|0
130100|NCT00819156|471026|P3|Overall Study|Lost to Follow-up|0
130101|NCT00819156|471027|P2|Overall Study|Lost to Follow-up|1
130102|NCT00819156|471028|P1|Overall Study|Lost to Follow-up|0
130103|NCT00819156|471023|P6|Overall Study|Protocol Violation|1
130104|NCT00819156|471024|P5|Overall Study|Protocol Violation|0
130105|NCT00819156|471025|P4|Overall Study|Protocol Violation|0
130106|NCT00819156|471026|P3|Overall Study|Protocol Violation|1
130107|NCT00819156|471027|P2|Overall Study|Protocol Violation|0
130108|NCT00819156|471028|P1|Overall Study|Protocol Violation|1
130109|NCT00819156|471023|P6|Overall Study|Withdrawal by Subject|0
130110|NCT00819156|471024|P5|Overall Study|Withdrawal by Subject|1
130111|NCT00819156|471025|P4|Overall Study|Withdrawal by Subject|0
130112|NCT00819156|471026|P3|Overall Study|Withdrawal by Subject|2
130113|NCT00819156|471027|P2|Overall Study|Withdrawal by Subject|3
130114|NCT00819156|471028|P1|Overall Study|Withdrawal by Subject|0
130115|NCT00819156|471023|P6|Overall Study|Adverse Event|3
130116|NCT00819156|471024|P5|Overall Study|Adverse Event|2
130117|NCT00819156|471025|P4|Overall Study|Adverse Event|1
130118|NCT00819156|471026|P3|Overall Study|Adverse Event|2
130119|NCT00819156|471027|P2|Overall Study|Adverse Event|4
130120|NCT00819156|471028|P1|Overall Study|Adverse Event|1
130121|NCT00819091|471118|P2|Overall Study|Not Specified|2
130122|NCT00819091|471119|P1|Overall Study|Not Specified|1
130123|NCT00819091|471118|P2|Overall Study|Withdrawal by Subject|2
130124|NCT00819091|471119|P1|Overall Study|Withdrawal by Subject|1
130125|NCT00819091|471118|P2|Overall Study|Lost to Follow-up|0
130126|NCT00819091|471119|P1|Overall Study|Lost to Follow-up|2
130127|NCT00819091|471118|P2|Overall Study|Protocol Violation|1
130128|NCT00819091|471119|P1|Overall Study|Protocol Violation|0
130129|NCT00819091|471118|P2|Overall Study|Adverse Event|5
130130|NCT00819091|471119|P1|Overall Study|Adverse Event|3
130131|NCT00819052|471145|P2|Overall Study|Death or events leading to death|0
130132|NCT00819052|471146|P1|Overall Study|Death or events leading to death|1
130133|NCT00819052|471145|P2|Overall Study|Pregnancy|2
130134|NCT00819052|471146|P1|Overall Study|Pregnancy|1
130135|NCT00819052|471145|P2|Overall Study|Lack of Efficacy|1
130136|NCT00819052|471146|P1|Overall Study|Lack of Efficacy|1
130137|NCT00819052|471145|P2|Overall Study|Withdrawal by Subject|2
130138|NCT00819052|471146|P1|Overall Study|Withdrawal by Subject|1
130139|NCT00819052|471145|P2|Overall Study|Lost to Follow-up|2
130140|NCT00819052|471146|P1|Overall Study|Lost to Follow-up|1
130141|NCT00819052|471145|P2|Overall Study|Protocol Violation|2
130142|NCT00819052|471146|P1|Overall Study|Protocol Violation|1
130143|NCT00819052|471145|P2|Overall Study|Adverse Event|5
130144|NCT00819052|471146|P1|Overall Study|Adverse Event|0
130145|NCT00819039|471261|P3|Overall Study|Protocol Violation|0
130146|NCT00819039|471262|P2|Overall Study|Protocol Violation|0
130147|NCT00819039|471263|P1|Overall Study|Protocol Violation|1
130148|NCT00819039|471261|P3|Overall Study|Physician Decision|1
130149|NCT00819039|471262|P2|Overall Study|Physician Decision|0
130150|NCT00819039|471263|P1|Overall Study|Physician Decision|1
130151|NCT00819013|471293|P4|Overall Study|Death|1
130152|NCT00819013|471294|P3|Overall Study|Death|0
130153|NCT00819013|471295|P2|Overall Study|Death|0
130154|NCT00819013|471296|P1|Overall Study|Death|0
130155|NCT00819013|471293|P4|Overall Study|Lost to Follow-up|2
130156|NCT00819013|471294|P3|Overall Study|Lost to Follow-up|1
130157|NCT00819013|471295|P2|Overall Study|Lost to Follow-up|0
130158|NCT00819013|471296|P1|Overall Study|Lost to Follow-up|0
130159|NCT00819013|471293|P4|Overall Study|Withdrawal by Subject|0
130160|NCT00819013|471294|P3|Overall Study|Withdrawal by Subject|1
130161|NCT00819013|471295|P2|Overall Study|Withdrawal by Subject|0
130162|NCT00819013|471296|P1|Overall Study|Withdrawal by Subject|1
130163|NCT00819013|471293|P4|Overall Study|Adverse Event|0
130164|NCT00819013|471294|P3|Overall Study|Adverse Event|1
130165|NCT00819013|471295|P2|Overall Study|Adverse Event|0
130166|NCT00819013|471296|P1|Overall Study|Adverse Event|0
130167|NCT00819013|471293|P4|Overall Study|Not meeting continuing study eligibility|1
130168|NCT00819013|471294|P3|Overall Study|Not meeting continuing study eligibility|2
130169|NCT00819013|471295|P2|Overall Study|Not meeting continuing study eligibility|1
130170|NCT00819013|471296|P1|Overall Study|Not meeting continuing study eligibility|2
130171|NCT00818883|471362|P2|Overall Study|Other|7
130172|NCT00818883|471363|P1|Overall Study|Other|2
130173|NCT00818883|471362|P2|Overall Study|Lack of Efficacy|2
130174|NCT00818883|471363|P1|Overall Study|Lack of Efficacy|0
130175|NCT00818883|471362|P2|Overall Study|Withdrawal by Subject|14
130176|NCT00818883|471363|P1|Overall Study|Withdrawal by Subject|16
130177|NCT00818883|471362|P2|Overall Study|Lost to Follow-up|2
130178|NCT00818883|471363|P1|Overall Study|Lost to Follow-up|3
130179|NCT00818883|471362|P2|Overall Study|Protocol Violation|2
130180|NCT00818883|471363|P1|Overall Study|Protocol Violation|2
130181|NCT00818883|471362|P2|Overall Study|Adverse Event|19
130182|NCT00818883|471363|P1|Overall Study|Adverse Event|28
130183|NCT00818779|471410|P2|Overall Study|Adverse Event|1
130184|NCT00818779|471411|P1|Overall Study|Adverse Event|4
130185|NCT00818779|471410|P2|Overall Study|Lost to Follow-up|0
130186|NCT00818779|471411|P1|Overall Study|Lost to Follow-up|1
130187|NCT00818779|471410|P2|Overall Study|Protocol Violation|0
130188|NCT00818779|471411|P1|Overall Study|Protocol Violation|1
130189|NCT00818766|471427|P2|Overall Study|Did not Receive Allocated Intervention|0
130190|NCT00818766|471428|P1|Overall Study|Did not Receive Allocated Intervention|3
130191|NCT00818766|471427|P2|Overall Study|Death|0
130192|NCT00818766|471428|P1|Overall Study|Death|1
130193|NCT00818766|471427|P2|Overall Study|Could not be Contacted on Day 28|10
130194|NCT00818766|471428|P1|Overall Study|Could not be Contacted on Day 28|11
130195|NCT00818753|471457|P3|Overall Study|Randomised and not treated|0
130196|NCT00818753|471458|P2|Overall Study|Randomised and not treated|0
130197|NCT00818753|471459|P1|Overall Study|Randomised and not treated|2
130198|NCT00818753|471457|P3|Overall Study|Other reason (not specified)|1
130199|NCT00818753|471458|P2|Overall Study|Other reason (not specified)|0
130200|NCT00818753|471459|P1|Overall Study|Other reason (not specified)|0
130201|NCT00818753|471457|P3|Overall Study|Protocol Violation|0
130202|NCT00818753|471458|P2|Overall Study|Protocol Violation|0
130203|NCT00818753|471459|P1|Overall Study|Protocol Violation|1
130204|NCT00818662|471483|P4|Overall Study|Admitted to long term nursing care|0
130289|NCT00818623|471592|P2|Overall Study|Lack of trial drug at site|0
130205|NCT00818662|471484|P3|Overall Study|Admitted to long term nursing care|0
130206|NCT00818662|471485|P2|Overall Study|Admitted to long term nursing care|1
130207|NCT00818662|471486|P1|Overall Study|Admitted to long term nursing care|0
130208|NCT00818662|471483|P4|Overall Study|Study partner decision|1
130209|NCT00818662|471484|P3|Overall Study|Study partner decision|0
130210|NCT00818662|471485|P2|Overall Study|Study partner decision|0
130211|NCT00818662|471486|P1|Overall Study|Study partner decision|0
130212|NCT00818662|471483|P4|Overall Study|Change in living situation|1
130213|NCT00818662|471484|P3|Overall Study|Change in living situation|0
130214|NCT00818662|471485|P2|Overall Study|Change in living situation|0
130215|NCT00818662|471486|P1|Overall Study|Change in living situation|0
130216|NCT00818662|471483|P4|Overall Study|Declined move to another study site|0
130217|NCT00818662|471484|P3|Overall Study|Declined move to another study site|0
130218|NCT00818662|471485|P2|Overall Study|Declined move to another study site|0
130219|NCT00818662|471486|P1|Overall Study|Declined move to another study site|1
130220|NCT00818662|471483|P4|Overall Study|Moving out of state|1
130221|NCT00818662|471484|P3|Overall Study|Moving out of state|0
130222|NCT00818662|471485|P2|Overall Study|Moving out of state|0
130223|NCT00818662|471486|P1|Overall Study|Moving out of state|0
130224|NCT00818662|471483|P4|Overall Study|Caregiver to pursue other treatment|0
130225|NCT00818662|471484|P3|Overall Study|Caregiver to pursue other treatment|0
130226|NCT00818662|471485|P2|Overall Study|Caregiver to pursue other treatment|1
130227|NCT00818662|471486|P1|Overall Study|Caregiver to pursue other treatment|0
130228|NCT00818662|471483|P4|Overall Study|Participant's health declined|1
130229|NCT00818662|471484|P3|Overall Study|Participant's health declined|0
130230|NCT00818662|471485|P2|Overall Study|Participant's health declined|0
130231|NCT00818662|471486|P1|Overall Study|Participant's health declined|0
130232|NCT00818662|471483|P4|Overall Study|Study Partner Unwilling or Unable|1
130233|NCT00818662|471484|P3|Overall Study|Study Partner Unwilling or Unable|1
130234|NCT00818662|471485|P2|Overall Study|Study Partner Unwilling or Unable|2
130235|NCT00818662|471486|P1|Overall Study|Study Partner Unwilling or Unable|3
130236|NCT00818662|471483|P4|Overall Study|Safety Risk|1
130237|NCT00818662|471484|P3|Overall Study|Safety Risk|0
130238|NCT00818662|471485|P2|Overall Study|Safety Risk|1
130239|NCT00818662|471486|P1|Overall Study|Safety Risk|1
130240|NCT00818662|471483|P4|Overall Study|Requires a Prohibited Medication|0
130241|NCT00818662|471484|P3|Overall Study|Requires a Prohibited Medication|0
130242|NCT00818662|471485|P2|Overall Study|Requires a Prohibited Medication|0
130243|NCT00818662|471486|P1|Overall Study|Requires a Prohibited Medication|1
130244|NCT00818662|471483|P4|Overall Study|Protocol Violation|0
130245|NCT00818662|471484|P3|Overall Study|Protocol Violation|0
130246|NCT00818662|471485|P2|Overall Study|Protocol Violation|1
130247|NCT00818662|471486|P1|Overall Study|Protocol Violation|1
130248|NCT00818662|471483|P4|Overall Study|Unwilling or Unable to Participate|4
130249|NCT00818662|471484|P3|Overall Study|Unwilling or Unable to Participate|2
130250|NCT00818662|471485|P2|Overall Study|Unwilling or Unable to Participate|6
130251|NCT00818662|471486|P1|Overall Study|Unwilling or Unable to Participate|4
130252|NCT00818662|471483|P4|Overall Study|Lost to Follow-up|1
130253|NCT00818662|471484|P3|Overall Study|Lost to Follow-up|0
130254|NCT00818662|471485|P2|Overall Study|Lost to Follow-up|0
130255|NCT00818662|471486|P1|Overall Study|Lost to Follow-up|0
130256|NCT00818662|471483|P4|Overall Study|Physician Decision|0
130257|NCT00818662|471484|P3|Overall Study|Physician Decision|0
130258|NCT00818662|471485|P2|Overall Study|Physician Decision|0
130259|NCT00818662|471486|P1|Overall Study|Physician Decision|1
130260|NCT00818662|471483|P4|Overall Study|Death|0
130261|NCT00818662|471484|P3|Overall Study|Death|0
130262|NCT00818662|471485|P2|Overall Study|Death|3
130263|NCT00818662|471486|P1|Overall Study|Death|1
130264|NCT00818662|471483|P4|Overall Study|Withdrawal by Subject|2
130265|NCT00818662|471484|P3|Overall Study|Withdrawal by Subject|2
130266|NCT00818662|471485|P2|Overall Study|Withdrawal by Subject|4
130267|NCT00818662|471486|P1|Overall Study|Withdrawal by Subject|5
130268|NCT00818662|471483|P4|Overall Study|Adverse Event|3
130269|NCT00818662|471484|P3|Overall Study|Adverse Event|4
130270|NCT00818662|471485|P2|Overall Study|Adverse Event|14
130271|NCT00818662|471486|P1|Overall Study|Adverse Event|5
130272|NCT00818649|471572|P1|Overall Study|Adverse Event|1
130273|NCT00818649|471572|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
130274|NCT00818649|471572|P1|Overall Study|Declining performance status|2
130275|NCT00818623|471586|P8|Overall Study|Disease progression|0
130276|NCT00818623|471587|P7|Overall Study|Disease progression|1
130277|NCT00818623|471588|P6|Overall Study|Disease progression|0
130278|NCT00818623|471589|P5|Overall Study|Disease progression|0
130279|NCT00818623|471590|P4|Overall Study|Disease progression|0
130280|NCT00818623|471591|P3|Overall Study|Disease progression|0
130281|NCT00818623|471592|P2|Overall Study|Disease progression|0
130282|NCT00818623|471593|P1|Overall Study|Disease progression|0
130283|NCT00818623|471586|P8|Overall Study|Lack of trial drug at site|0
130284|NCT00818623|471587|P7|Overall Study|Lack of trial drug at site|1
130285|NCT00818623|471588|P6|Overall Study|Lack of trial drug at site|0
130286|NCT00818623|471589|P5|Overall Study|Lack of trial drug at site|2
130287|NCT00818623|471590|P4|Overall Study|Lack of trial drug at site|0
130288|NCT00818623|471591|P3|Overall Study|Lack of trial drug at site|0
130290|NCT00818623|471593|P1|Overall Study|Lack of trial drug at site|0
130291|NCT00818623|471586|P8|Overall Study|Need of additional treatment|0
130292|NCT00818623|471587|P7|Overall Study|Need of additional treatment|0
130293|NCT00818623|471588|P6|Overall Study|Need of additional treatment|0
130294|NCT00818623|471589|P5|Overall Study|Need of additional treatment|1
130295|NCT00818623|471590|P4|Overall Study|Need of additional treatment|0
130296|NCT00818623|471591|P3|Overall Study|Need of additional treatment|0
130297|NCT00818623|471592|P2|Overall Study|Need of additional treatment|0
130298|NCT00818623|471593|P1|Overall Study|Need of additional treatment|0
130299|NCT00818623|471586|P8|Overall Study|Protocol Violation|0
130300|NCT00818623|471587|P7|Overall Study|Protocol Violation|1
130301|NCT00818623|471588|P6|Overall Study|Protocol Violation|0
130302|NCT00818623|471589|P5|Overall Study|Protocol Violation|1
130303|NCT00818623|471590|P4|Overall Study|Protocol Violation|0
130304|NCT00818623|471591|P3|Overall Study|Protocol Violation|0
130305|NCT00818623|471592|P2|Overall Study|Protocol Violation|0
130306|NCT00818623|471593|P1|Overall Study|Protocol Violation|1
130307|NCT00818623|471586|P8|Overall Study|Withdrawal by Subject|1
130308|NCT00818623|471587|P7|Overall Study|Withdrawal by Subject|1
130309|NCT00818623|471588|P6|Overall Study|Withdrawal by Subject|1
130310|NCT00818623|471589|P5|Overall Study|Withdrawal by Subject|0
130311|NCT00818623|471590|P4|Overall Study|Withdrawal by Subject|0
130312|NCT00818623|471591|P3|Overall Study|Withdrawal by Subject|1
130313|NCT00818623|471592|P2|Overall Study|Withdrawal by Subject|1
130314|NCT00818623|471593|P1|Overall Study|Withdrawal by Subject|0
130315|NCT00818623|471586|P8|Overall Study|Bad prostate specific antigen response|0
130316|NCT00818623|471587|P7|Overall Study|Bad prostate specific antigen response|0
130317|NCT00818623|471588|P6|Overall Study|Bad prostate specific antigen response|1
130318|NCT00818623|471589|P5|Overall Study|Bad prostate specific antigen response|0
130319|NCT00818623|471590|P4|Overall Study|Bad prostate specific antigen response|5
130320|NCT00818623|471591|P3|Overall Study|Bad prostate specific antigen response|2
130321|NCT00818623|471592|P2|Overall Study|Bad prostate specific antigen response|3
130322|NCT00818623|471593|P1|Overall Study|Bad prostate specific antigen response|0
130323|NCT00818623|471586|P8|Overall Study|Adverse Event|0
130324|NCT00818623|471587|P7|Overall Study|Adverse Event|0
130325|NCT00818623|471588|P6|Overall Study|Adverse Event|1
130326|NCT00818623|471589|P5|Overall Study|Adverse Event|0
130327|NCT00818623|471590|P4|Overall Study|Adverse Event|0
130328|NCT00818623|471591|P3|Overall Study|Adverse Event|1
130329|NCT00818623|471592|P2|Overall Study|Adverse Event|0
130330|NCT00818623|471593|P1|Overall Study|Adverse Event|1
130331|NCT00818519|471669|P2|Overall Study|participant will leave for long tme|0
130332|NCT00818519|471670|P1|Overall Study|participant will leave for long tme|1
130333|NCT00818519|471669|P2|Overall Study|participant recovered completely|0
130334|NCT00818519|471670|P1|Overall Study|participant recovered completely|1
130335|NCT00818519|471669|P2|Overall Study|Withdrawal by Subject|9
130336|NCT00818519|471670|P1|Overall Study|Withdrawal by Subject|4
130337|NCT00818519|471669|P2|Overall Study|Pregnancy|1
130338|NCT00818519|471670|P1|Overall Study|Pregnancy|0
130339|NCT00818519|471669|P2|Overall Study|Protocol Violation|1
130340|NCT00818519|471670|P1|Overall Study|Protocol Violation|2
130341|NCT00818519|471669|P2|Overall Study|Lost to Follow-up|6
130342|NCT00818519|471670|P1|Overall Study|Lost to Follow-up|4
130343|NCT00818519|471669|P2|Overall Study|Adverse Event|2
130344|NCT00818519|471670|P1|Overall Study|Adverse Event|2
130345|NCT00818454|471700|P4|Treatment Period 3|Adverse Event|1
130346|NCT00818454|471701|P3|Treatment Period 3|Adverse Event|0
130347|NCT00818454|471702|P2|Treatment Period 3|Adverse Event|0
130348|NCT00818454|471703|P1|Treatment Period 3|Adverse Event|0
130349|NCT00818454|471700|P4|Treatment Period 2|not specified|0
130350|NCT00818454|471701|P3|Treatment Period 2|not specified|0
130351|NCT00818454|471702|P2|Treatment Period 2|not specified|1
130352|NCT00818454|471703|P1|Treatment Period 2|not specified|2
130353|NCT00818454|471700|P4|Washout Period of 1 Week|not specified|0
130354|NCT00818454|471701|P3|Washout Period of 1 Week|not specified|0
130355|NCT00818454|471702|P2|Washout Period of 1 Week|not specified|2
130356|NCT00818454|471703|P1|Washout Period of 1 Week|not specified|1
130357|NCT00818454|471700|P4|Washout Period of 1 Week|Protocol Violation|0
130358|NCT00818454|471701|P3|Washout Period of 1 Week|Protocol Violation|0
130359|NCT00818454|471702|P2|Washout Period of 1 Week|Protocol Violation|0
130360|NCT00818454|471703|P1|Washout Period of 1 Week|Protocol Violation|2
130361|NCT00818454|471700|P4|Washout Period of 1 Week|Adverse Event|0
130362|NCT00818454|471701|P3|Washout Period of 1 Week|Adverse Event|0
130363|NCT00818454|471702|P2|Washout Period of 1 Week|Adverse Event|1
130364|NCT00818454|471703|P1|Washout Period of 1 Week|Adverse Event|1
130365|NCT00818454|471700|P4|Treatment Period 1|not specified|0
130366|NCT00818454|471701|P3|Treatment Period 1|not specified|0
130367|NCT00818454|471702|P2|Treatment Period 1|not specified|0
130368|NCT00818454|471703|P1|Treatment Period 1|not specified|3
130369|NCT00818454|471700|P4|Treatment Period 1|Adverse Event|0
130370|NCT00818454|471701|P3|Treatment Period 1|Adverse Event|0
130371|NCT00818454|471702|P2|Treatment Period 1|Adverse Event|1
130372|NCT00818454|471703|P1|Treatment Period 1|Adverse Event|0
130373|NCT00818441|471731|P2|Overall Study|Study terminated by sponsor|2
130374|NCT00818441|471732|P1|Overall Study|Study terminated by sponsor|11
130375|NCT00818441|471731|P2|Overall Study|Adverse Event|1
130376|NCT00818441|471732|P1|Overall Study|Adverse Event|0
130377|NCT00818441|471731|P2|Overall Study|Withdrawal by Subject|0
130378|NCT00818441|471732|P1|Overall Study|Withdrawal by Subject|2
130379|NCT00818441|471731|P2|Overall Study|Lost to Follow-up|1
130380|NCT00818441|471732|P1|Overall Study|Lost to Follow-up|2
130381|NCT00818441|471731|P2|Overall Study|Other|0
130382|NCT00818441|471732|P1|Overall Study|Other|5
130383|NCT00818441|471731|P2|Overall Study|Death|26
130384|NCT00818441|471732|P1|Overall Study|Death|69
130385|NCT00818389|471754|P2|Overall Study|Adverse Event|1
130386|NCT00818389|471755|P1|Overall Study|Adverse Event|0
130387|NCT00818389|471754|P2|Overall Study|Withdrawal by Subject|2
130388|NCT00818389|471755|P1|Overall Study|Withdrawal by Subject|2
130389|NCT00818389|471754|P2|Overall Study|ALS Disease Progression|0
130390|NCT00818389|471755|P1|Overall Study|ALS Disease Progression|1
130391|NCT00818389|471754|P2|Overall Study|Death|3
130392|NCT00818389|471755|P1|Overall Study|Death|1
130393|NCT00818259|471790|P9|Part V|Adverse Event|0
130394|NCT00818259|471791|P8|Part V|Adverse Event|1
130395|NCT00818259|471792|P7|Part V|Adverse Event|0
130396|NCT00818259|471793|P6|Part V|Adverse Event|0
130397|NCT00818259|471794|P5|Part V|Adverse Event|0
130398|NCT00818259|471795|P4|Part V|Adverse Event|0
130399|NCT00818259|471796|P3|Part V|Adverse Event|0
130400|NCT00818259|471797|P2|Part V|Adverse Event|0
130401|NCT00818259|471798|P1|Part V|Adverse Event|0
130402|NCT00818259|471790|P9|Part IV|Physician Decision|0
130403|NCT00818259|471791|P8|Part IV|Physician Decision|0
130404|NCT00818259|471792|P7|Part IV|Physician Decision|0
130405|NCT00818259|471793|P6|Part IV|Physician Decision|1
130406|NCT00818259|471794|P5|Part IV|Physician Decision|0
130407|NCT00818259|471795|P4|Part IV|Physician Decision|0
130408|NCT00818259|471796|P3|Part IV|Physician Decision|0
130409|NCT00818259|471797|P2|Part IV|Physician Decision|0
130410|NCT00818259|471798|P1|Part IV|Physician Decision|0
130411|NCT00818259|471790|P9|Part II|Not Treated|0
130412|NCT00818259|471791|P8|Part II|Not Treated|0
130413|NCT00818259|471792|P7|Part II|Not Treated|0
130414|NCT00818259|471793|P6|Part II|Not Treated|0
130415|NCT00818259|471794|P5|Part II|Not Treated|0
130416|NCT00818259|471795|P4|Part II|Not Treated|1
130417|NCT00818259|471796|P3|Part II|Not Treated|0
130418|NCT00818259|471797|P2|Part II|Not Treated|0
130419|NCT00818259|471798|P1|Part II|Not Treated|0
130420|NCT00818259|471790|P9|Part II|Lack of Efficacy|0
130421|NCT00818259|471791|P8|Part II|Lack of Efficacy|0
130422|NCT00818259|471792|P7|Part II|Lack of Efficacy|0
130423|NCT00818259|471793|P6|Part II|Lack of Efficacy|0
130424|NCT00818259|471794|P5|Part II|Lack of Efficacy|0
130425|NCT00818259|471795|P4|Part II|Lack of Efficacy|1
130426|NCT00818259|471796|P3|Part II|Lack of Efficacy|0
130427|NCT00818259|471797|P2|Part II|Lack of Efficacy|0
130428|NCT00818259|471798|P1|Part II|Lack of Efficacy|0
130429|NCT00818259|471790|P9|Part II|Physician Decision|0
130430|NCT00818259|471791|P8|Part II|Physician Decision|0
130431|NCT00818259|471792|P7|Part II|Physician Decision|0
130432|NCT00818259|471793|P6|Part II|Physician Decision|0
130433|NCT00818259|471794|P5|Part II|Physician Decision|0
130434|NCT00818259|471795|P4|Part II|Physician Decision|0
130435|NCT00818259|471796|P3|Part II|Physician Decision|1
130436|NCT00818259|471797|P2|Part II|Physician Decision|0
130437|NCT00818259|471798|P1|Part II|Physician Decision|0
130438|NCT00818259|471790|P9|Part I|Withdrawal by Subject|0
130439|NCT00818259|471791|P8|Part I|Withdrawal by Subject|0
130440|NCT00818259|471792|P7|Part I|Withdrawal by Subject|0
130441|NCT00818259|471793|P6|Part I|Withdrawal by Subject|0
130442|NCT00818259|471794|P5|Part I|Withdrawal by Subject|0
130443|NCT00818259|471795|P4|Part I|Withdrawal by Subject|0
130444|NCT00818259|471796|P3|Part I|Withdrawal by Subject|0
130445|NCT00818259|471797|P2|Part I|Withdrawal by Subject|0
130446|NCT00818259|471798|P1|Part I|Withdrawal by Subject|1
130447|NCT00818246|471870|P1|Overall Study|Impossible to match pictures|5
130448|NCT00818207|471879|P2|Overall Study|Death|5
130449|NCT00818207|471880|P1|Overall Study|Death|3
130450|NCT00818207|471879|P2|Overall Study|Withdrawal by Subject|104
130451|NCT00818207|471880|P1|Overall Study|Withdrawal by Subject|42
130452|NCT00818207|471879|P2|Overall Study|Multiple reasons|12
130453|NCT00818207|471880|P1|Overall Study|Multiple reasons|11
130454|NCT00818207|471879|P2|Overall Study|Lost to Follow-up|146
130455|NCT00818207|471880|P1|Overall Study|Lost to Follow-up|160
130456|NCT00818207|471879|P2|Overall Study|Adverse Event|0
130457|NCT00818207|471880|P1|Overall Study|Adverse Event|6
130458|NCT00818168|471894|P1|Overall Study|Participant Moved|2
130459|NCT00818168|471894|P1|Overall Study|Reason for Non-completion Not reported|6
130460|NCT00818168|471894|P1|Overall Study|Adverse Event|19
130461|NCT00818168|471894|P1|Overall Study|Lost to Follow-up|7
130462|NCT00818168|471894|P1|Overall Study|Withdrawal by Subject|16
130463|NCT00818168|471894|P1|Overall Study|Pregnancy|2
130464|NCT00818168|471894|P1|Overall Study|Lack of Efficacy|18
130465|NCT00817778|471934|P2|Overall Study|Poor venous access|0
130466|NCT00817778|471935|P1|Overall Study|Poor venous access|1
130467|NCT00817778|471934|P2|Overall Study|Study-specific discontinuation criteria|1
130468|NCT00817778|471935|P1|Overall Study|Study-specific discontinuation criteria|0
130469|NCT00817778|471934|P2|Overall Study|Protocol Violation|1
130470|NCT00817778|471935|P1|Overall Study|Protocol Violation|0
130471|NCT00817778|471934|P2|Overall Study|Withdrawal by Subject|1
130472|NCT00817778|471935|P1|Overall Study|Withdrawal by Subject|1
130473|NCT00817778|471934|P2|Overall Study|Adverse Event|0
130474|NCT00817778|471935|P1|Overall Study|Adverse Event|1
130475|NCT00817531|471964|P1|Overall Study|Lack of Efficacy|1
130476|NCT00817531|471964|P1|Overall Study|Adverse Event|1
130477|NCT00817479|471970|P2|Overall Study|Physician Decision|1
130478|NCT00817479|471971|P1|Overall Study|Physician Decision|1
130479|NCT00817336|471981|P2|Overall Study|Withdrawal by Subject|1
130480|NCT00817336|471982|P1|Overall Study|Withdrawal by Subject|1
130481|NCT00817206|472008|P2|Overall Study|Physician Decision|0
130482|NCT00817206|472009|P1|Overall Study|Physician Decision|2
130483|NCT00817206|472008|P2|Overall Study|Withdrawal by Subject|3
130484|NCT00817206|472009|P1|Overall Study|Withdrawal by Subject|7
130485|NCT00817206|472008|P2|Overall Study|Death|0
130486|NCT00817206|472009|P1|Overall Study|Death|2
130487|NCT00817206|472008|P2|Overall Study|Lost to Follow-up|1
130488|NCT00817206|472009|P1|Overall Study|Lost to Follow-up|0
130489|NCT00817206|472008|P2|Overall Study|Protocol Violation|2
130490|NCT00817206|472009|P1|Overall Study|Protocol Violation|0
130491|NCT00817206|472008|P2|Overall Study|Adverse Event|3
130492|NCT00817206|472009|P1|Overall Study|Adverse Event|10
130493|NCT00817063|472017|P2|Overall Study|Abnormality of Laboratory Test|1
130494|NCT00817063|472018|P1|Overall Study|Abnormality of Laboratory Test|2
130495|NCT00817063|472017|P2|Overall Study|Administrative|4
130496|NCT00817063|472018|P1|Overall Study|Administrative|10
130497|NCT00817063|472017|P2|Overall Study|Early Improvement|4
130498|NCT00817063|472018|P1|Overall Study|Early Improvement|19
130499|NCT00817063|472017|P2|Overall Study|Withdrawal by Subject|37
130500|NCT00817063|472018|P1|Overall Study|Withdrawal by Subject|17
130501|NCT00817063|472017|P2|Overall Study|Protocol Violation|8
130502|NCT00817063|472018|P1|Overall Study|Protocol Violation|3
130503|NCT00817063|472017|P2|Overall Study|Violation of Selection at Entry|4
130504|NCT00817063|472018|P1|Overall Study|Violation of Selection at Entry|7
130505|NCT00817063|472017|P2|Overall Study|Failure to Return|12
130506|NCT00817063|472018|P1|Overall Study|Failure to Return|13
130507|NCT00817063|472017|P2|Overall Study|Lack of Efficacy|86
130508|NCT00817063|472018|P1|Overall Study|Lack of Efficacy|33
130509|NCT00817063|472017|P2|Overall Study|Death|1
130510|NCT00817063|472018|P1|Overall Study|Death|1
130511|NCT00817063|472017|P2|Overall Study|Adverse Event|13
130512|NCT00817063|472018|P1|Overall Study|Adverse Event|32
130513|NCT00816595|472121|P2|Overall Study|Withdrawal by Subject|0
130514|NCT00816595|472122|P1|Overall Study|Withdrawal by Subject|2
130515|NCT00816556|472135|P3|Overall Study|Lost to Follow-up|1
130516|NCT00816556|472136|P2|Overall Study|Lost to Follow-up|0
130517|NCT00816556|472137|P1|Overall Study|Lost to Follow-up|0
130518|NCT00816556|472135|P3|Overall Study|Withdrawal by Subject|1
130519|NCT00816556|472136|P2|Overall Study|Withdrawal by Subject|1
130520|NCT00816556|472137|P1|Overall Study|Withdrawal by Subject|1
130521|NCT00816556|472135|P3|Overall Study|Adverse Event|1
130522|NCT00816556|472136|P2|Overall Study|Adverse Event|1
130523|NCT00816556|472137|P1|Overall Study|Adverse Event|1
130524|NCT00816400|472160|P9|Overall Study|In hospice care at the end of the study|0
130525|NCT00816400|472161|P8|Overall Study|In hospice care at the end of the study|0
130526|NCT00816400|472162|P7|Overall Study|In hospice care at the end of the study|0
130527|NCT00816400|472163|P6|Overall Study|In hospice care at the end of the study|0
130528|NCT00816400|472164|P5|Overall Study|In hospice care at the end of the study|0
130529|NCT00816400|472165|P4|Overall Study|In hospice care at the end of the study|0
130530|NCT00816400|472166|P3|Overall Study|In hospice care at the end of the study|2
130531|NCT00816400|472167|P2|Overall Study|In hospice care at the end of the study|0
130532|NCT00816400|472168|P1|Overall Study|In hospice care at the end of the study|0
130533|NCT00816400|472160|P9|Overall Study|Death|6
130534|NCT00816400|472161|P8|Overall Study|Death|5
130535|NCT00816400|472162|P7|Overall Study|Death|2
130536|NCT00816400|472163|P6|Overall Study|Death|3
130537|NCT00816400|472164|P5|Overall Study|Death|2
130538|NCT00816400|472165|P4|Overall Study|Death|3
130539|NCT00816400|472166|P3|Overall Study|Death|3
130540|NCT00816400|472167|P2|Overall Study|Death|3
130541|NCT00816400|472168|P1|Overall Study|Death|2
130542|NCT00816166|472358|P2|Overall Study|Death|2
130543|NCT00816166|472359|P1|Overall Study|Death|4
130544|NCT00816166|472358|P2|Overall Study|Lost to Follow-up|10
130545|NCT00816166|472359|P1|Overall Study|Lost to Follow-up|6
130546|NCT00816036|472391|P2|Overall Study|Withdrawal by Subject|23
130547|NCT00816036|472392|P1|Overall Study|Withdrawal by Subject|54
130548|NCT00816036|472391|P2|Overall Study|Lost to Follow-up|57
130549|NCT00816036|472392|P1|Overall Study|Lost to Follow-up|75
130550|NCT00816036|472391|P2|Overall Study|Death|28
130551|NCT00816036|472392|P1|Overall Study|Death|47
130552|NCT00816023|472406|P4|Overall Study|Randomized Not Treated|11
130553|NCT00816023|472407|P3|Overall Study|Randomized Not Treated|6
130554|NCT00816023|472408|P2|Overall Study|Randomized Not Treated|4
130555|NCT00816023|472409|P1|Overall Study|Randomized Not Treated|6
130556|NCT00816023|472406|P4|Overall Study|assessments complete prior to window|1
130557|NCT00816023|472407|P3|Overall Study|assessments complete prior to window|2
130558|NCT00816023|472408|P2|Overall Study|assessments complete prior to window|1
130559|NCT00816023|472409|P1|Overall Study|assessments complete prior to window|1
130560|NCT00816023|472406|P4|Overall Study|Physician Decision|0
130561|NCT00816023|472407|P3|Overall Study|Physician Decision|1
130562|NCT00816023|472408|P2|Overall Study|Physician Decision|0
130563|NCT00816023|472409|P1|Overall Study|Physician Decision|0
130564|NCT00816023|472406|P4|Overall Study|Withdrawal by Subject|0
130565|NCT00816023|472407|P3|Overall Study|Withdrawal by Subject|0
130566|NCT00816023|472408|P2|Overall Study|Withdrawal by Subject|0
130567|NCT00816023|472409|P1|Overall Study|Withdrawal by Subject|1
130568|NCT00816023|472406|P4|Overall Study|Lost to Follow-up|0
130569|NCT00816023|472407|P3|Overall Study|Lost to Follow-up|0
130570|NCT00816023|472408|P2|Overall Study|Lost to Follow-up|1
130571|NCT00816023|472409|P1|Overall Study|Lost to Follow-up|1
130572|NCT00815919|472423|P1|Overall Study|Lack of Efficacy|2
130573|NCT00815919|472423|P1|Overall Study|AML Relapse|1
130574|NCT00815919|472423|P1|Overall Study|Unrelated Fungal Infection|1
130575|NCT00815659|472466|P1|Overall Study|Protocol Violation|1
130576|NCT00815659|472466|P1|Overall Study|Lost to Follow-up|4
130577|NCT00815659|472466|P1|Overall Study|Withdrawal by Subject|9
130578|NCT00815659|472466|P1|Overall Study|Adverse Event|9
130579|NCT00815633|472509|P1|Overall Study|study terminated|1
130580|NCT00815516|472516|P2|Overall Study|Physician Decision|0
130581|NCT00815516|472517|P1|Overall Study|Physician Decision|1
130582|NCT00815516|472516|P2|Overall Study|Death|1
130583|NCT00815516|472517|P1|Overall Study|Death|3
130584|NCT00815308|472582|P1|Overall Study|Protocol Violation|6
130585|NCT00815308|472582|P1|Overall Study|Withdrawal by Subject|0
130586|NCT00815308|472582|P1|Overall Study|Adverse Event|4
130587|NCT00815295|472591|P3|Overall Study|Cetuximab hypersensitivity reaction|3
130588|NCT00815295|472592|P2|Overall Study|Cetuximab hypersensitivity reaction|1
130589|NCT00815295|472593|P1|Overall Study|Cetuximab hypersensitivity reaction|0
130590|NCT00815191|472605|P2|Overall Study|Protocol Violation|1
130591|NCT00815191|472606|P1|Overall Study|Protocol Violation|1
130592|NCT00814983|472643|P2|Overall Study|Graft failure|0
130593|NCT00814983|472644|P1|Overall Study|Graft failure|1
130594|NCT00814983|472643|P2|Overall Study|Withdrawal by Subject|0
130595|NCT00814983|472644|P1|Overall Study|Withdrawal by Subject|1
130596|NCT00814983|472643|P2|Overall Study|Screen failure|0
130597|NCT00814983|472644|P1|Overall Study|Screen failure|1
130598|NCT00814892|472675|P1|Overall Study|Study Termination|1
130599|NCT00814892|472675|P1|Overall Study|Disease Progression|1
130600|NCT00814879|472687|P2|By Week 48|Death|1
130601|NCT00814879|472688|P1|By Week 48|Death|0
130602|NCT00814879|472687|P2|By Week 48|Lost to Follow-up|2
130603|NCT00814879|472688|P1|By Week 48|Lost to Follow-up|2
130604|NCT00814879|472687|P2|By Week 24|Incarceration|1
130605|NCT00814879|472688|P1|By Week 24|Incarceration|0
130606|NCT00814879|472687|P2|By Week 24|Cancer Diagnosis|0
130607|NCT00814879|472688|P1|By Week 24|Cancer Diagnosis|1
130608|NCT00814801|472707|P3|Overall Study|Not specified|4
130609|NCT00814801|472708|P2|Overall Study|Not specified|6
130610|NCT00814801|472709|P1|Overall Study|Not specified|2
130611|NCT00814801|472707|P3|Overall Study|Non-compliance|1
130612|NCT00814801|472708|P2|Overall Study|Non-compliance|1
130613|NCT00814801|472709|P1|Overall Study|Non-compliance|0
130614|NCT00814801|472707|P3|Overall Study|Missing or change of caregiver|4
130615|NCT00814801|472708|P2|Overall Study|Missing or change of caregiver|2
130616|NCT00814801|472709|P1|Overall Study|Missing or change of caregiver|6
130617|NCT00814801|472707|P3|Overall Study|Change of patients for CIBIC plus-J|0
130618|NCT00814801|472708|P2|Overall Study|Change of patients for CIBIC plus-J|1
130619|NCT00814801|472709|P1|Overall Study|Change of patients for CIBIC plus-J|1
130620|NCT00814801|472707|P3|Overall Study|Inappropriate as a subject|1
130621|NCT00814801|472708|P2|Overall Study|Inappropriate as a subject|1
130622|NCT00814801|472709|P1|Overall Study|Inappropriate as a subject|1
130623|NCT00814801|472707|P3|Overall Study|Withdrawal by Subject|14
130624|NCT00814801|472708|P2|Overall Study|Withdrawal by Subject|11
130625|NCT00814801|472709|P1|Overall Study|Withdrawal by Subject|9
130626|NCT00814801|472707|P3|Overall Study|Adverse Event|19
130627|NCT00814801|472708|P2|Overall Study|Adverse Event|16
130628|NCT00814801|472709|P1|Overall Study|Adverse Event|15
130629|NCT00814710|472748|P2|Overall Study|Lost to Follow-up|3
130630|NCT00814710|472749|P1|Overall Study|Lost to Follow-up|7
130631|NCT00814710|472748|P2|Overall Study|Adverse Event|0
130632|NCT00814710|472749|P1|Overall Study|Adverse Event|1
130633|NCT00814658|472817|P2|Overall Study|Adverse Event|3
130634|NCT00814658|472818|P1|Overall Study|Adverse Event|3
130635|NCT00814658|472817|P2|Overall Study|Physician Decision|0
130636|NCT00814658|472818|P1|Overall Study|Physician Decision|1
130637|NCT00814658|472817|P2|Overall Study|Lost to Follow-up|1
130638|NCT00814658|472818|P1|Overall Study|Lost to Follow-up|0
130639|NCT00814632|472884|P1|Overall Study|Lack of Efficacy|2
130640|NCT00814580|472890|P2|Overall Study|Did Not Take Drug|2
130641|NCT00814580|472891|P1|Overall Study|Did Not Take Drug|2
130642|NCT00814580|472890|P2|Overall Study|Other|3
130643|NCT00814580|472891|P1|Overall Study|Other|1
130644|NCT00814580|472890|P2|Overall Study|Withdrawal by Subject|2
130645|NCT00814580|472891|P1|Overall Study|Withdrawal by Subject|2
130646|NCT00814580|472890|P2|Overall Study|Protocol Violation|0
130647|NCT00814580|472891|P1|Overall Study|Protocol Violation|2
130648|NCT00814580|472890|P2|Overall Study|Lack of Efficacy|25
130649|NCT00814580|472891|P1|Overall Study|Lack of Efficacy|18
130650|NCT00814580|472890|P2|Overall Study|Adverse Event|15
130651|NCT00814580|472891|P1|Overall Study|Adverse Event|6
130652|NCT00814502|473021|P2|Overall Study|Withdrawal by Subject|2
130653|NCT00814502|473022|P1|Overall Study|Withdrawal by Subject|0
130654|NCT00814502|473021|P2|Overall Study|Adverse Event|0
130655|NCT00814502|473022|P1|Overall Study|Adverse Event|1
130656|NCT00814489|473035|P3|Overall Study|Other|1
130657|NCT00814489|473036|P2|Overall Study|Other|0
130658|NCT00814489|473037|P1|Overall Study|Other|2
130659|NCT00814463|473069|P1|Overall Study|Lost to Follow-up|1
130660|NCT00814346|473075|P2|Open Phase (17 Months)|Not otherwise specified|0
130661|NCT00814346|473076|P1|Open Phase (17 Months)|Not otherwise specified|1
130662|NCT00814346|473075|P2|Open Phase (17 Months)|Lost to Follow-up|0
130663|NCT00814346|473076|P1|Open Phase (17 Months)|Lost to Follow-up|2
130664|NCT00814346|473075|P2|Open Phase (17 Months)|Consent|0
130665|NCT00814346|473076|P1|Open Phase (17 Months)|Consent|2
130666|NCT00814346|473075|P2|Open Phase (17 Months)|Adverse Event|0
130667|NCT00814346|473076|P1|Open Phase (17 Months)|Adverse Event|5
130668|NCT00814346|473075|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
130669|NCT00814346|473076|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
130670|NCT00814346|473075|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
130671|NCT00814346|473076|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
130672|NCT00814333|473142|P2|Enrollment|Lost to Follow-up|0
130673|NCT00814333|473143|P1|Enrollment|Lost to Follow-up|1
130674|NCT00814320|473151|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
130675|NCT00814320|473152|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
130676|NCT00814320|473151|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
130677|NCT00814320|473152|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
130678|NCT00814320|473151|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
130679|NCT00814320|473152|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
130680|NCT00814320|473151|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
130681|NCT00814320|473152|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
130682|NCT00814320|473151|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
130683|NCT00814320|473152|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
130684|NCT00814320|473151|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
130685|NCT00814320|473152|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
130686|NCT00814320|473151|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
130687|NCT00814320|473152|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
130688|NCT00814320|473151|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
130689|NCT00814320|473152|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
130690|NCT00814320|473151|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
130691|NCT00814320|473152|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
130692|NCT00814320|473151|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
130693|NCT00814320|473152|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
130694|NCT00814307|473284|P4|Overall Study|Death|0
130695|NCT00814307|473285|P3|Overall Study|Death|0
130696|NCT00814307|473286|P2|Overall Study|Death|1
130697|NCT00814307|473287|P1|Overall Study|Death|0
130698|NCT00814307|473284|P4|Overall Study|Withdrawal by Subject|2
130699|NCT00814307|473285|P3|Overall Study|Withdrawal by Subject|0
130700|NCT00814307|473286|P2|Overall Study|Withdrawal by Subject|6
130701|NCT00814307|473287|P1|Overall Study|Withdrawal by Subject|4
130702|NCT00814307|473284|P4|Overall Study|Protocol Violation|1
130703|NCT00814307|473285|P3|Overall Study|Protocol Violation|1
130704|NCT00814307|473286|P2|Overall Study|Protocol Violation|8
130705|NCT00814307|473287|P1|Overall Study|Protocol Violation|2
130706|NCT00814307|473284|P4|Overall Study|Other|1
130707|NCT00814307|473285|P3|Overall Study|Other|0
130708|NCT00814307|473286|P2|Overall Study|Other|2
130709|NCT00814307|473287|P1|Overall Study|Other|1
130710|NCT00814307|473284|P4|Overall Study|Lack of Efficacy|4
130711|NCT00814307|473285|P3|Overall Study|Lack of Efficacy|3
130712|NCT00814307|473286|P2|Overall Study|Lack of Efficacy|1
130713|NCT00814307|473287|P1|Overall Study|Lack of Efficacy|1
130714|NCT00814307|473284|P4|Overall Study|Adverse Event|2
130715|NCT00814307|473285|P3|Overall Study|Adverse Event|3
130716|NCT00814307|473286|P2|Overall Study|Adverse Event|9
130717|NCT00814307|473287|P1|Overall Study|Adverse Event|3
130718|NCT00814307|473284|P4|Overall Study|Randomized but not treated|0
130719|NCT00814307|473285|P3|Overall Study|Randomized but not treated|0
130720|NCT00814307|473286|P2|Overall Study|Randomized but not treated|0
130721|NCT00814307|473287|P1|Overall Study|Randomized but not treated|1
130722|NCT00814164|473483|P1|Overall Study|Death|5
130723|NCT00814164|473483|P1|Overall Study|not stated|7
130724|NCT00814164|473483|P1|Overall Study|Progression|7
130725|NCT00813995|473517|P2|Overall Study|Withdrawal by Subject|5
130726|NCT00813995|473518|P1|Overall Study|Withdrawal by Subject|0
130727|NCT00813995|473517|P2|Overall Study|Subject moved|0
130728|NCT00813995|473518|P1|Overall Study|Subject moved|4
130729|NCT00813995|473517|P2|Overall Study|Protocol Violation|2
130730|NCT00813995|473518|P1|Overall Study|Protocol Violation|3
130731|NCT00813995|473517|P2|Overall Study|Other reason|2
130732|NCT00813995|473518|P1|Overall Study|Other reason|2
130733|NCT00813995|473517|P2|Overall Study|Lost to Follow-up|2
130734|NCT00813995|473518|P1|Overall Study|Lost to Follow-up|4
130735|NCT00813995|473517|P2|Overall Study|Lack of Efficacy|0
130736|NCT00813995|473518|P1|Overall Study|Lack of Efficacy|1
130737|NCT00813995|473517|P2|Overall Study|Laboratory adverse event|2
130738|NCT00813995|473518|P1|Overall Study|Laboratory adverse event|0
130739|NCT00813995|473517|P2|Overall Study|Clinical adverse event|3
130740|NCT00813995|473518|P1|Overall Study|Clinical adverse event|9
130741|NCT00813943|473541|P3|Overall Study|Ongoing at cut-off date|3
130742|NCT00813943|473542|P2|Overall Study|Ongoing at cut-off date|5
130743|NCT00813943|473543|P1|Overall Study|Ongoing at cut-off date|5
130744|NCT00813917|473573|P2|Overall Study|Lost to Follow-up|1
130745|NCT00813917|473574|P1|Overall Study|Lost to Follow-up|3
130746|NCT00813917|473573|P2|Overall Study|Withdrawal by Subject|4
130747|NCT00813917|473574|P1|Overall Study|Withdrawal by Subject|3
130748|NCT00813917|473573|P2|Overall Study|Adverse Event|1
130749|NCT00813917|473574|P1|Overall Study|Adverse Event|0
130750|NCT00813904|473580|P1|Overall Study|Death|1
130751|NCT00813813|473588|P2|Overall Study|Other|1
130752|NCT00813813|473589|P1|Overall Study|Other|0
130753|NCT00813813|473588|P2|Overall Study|Lost to Follow-up|7
130754|NCT00813813|473589|P1|Overall Study|Lost to Follow-up|2
130755|NCT00813813|473588|P2|Overall Study|Withdrawal by Subject|1
130756|NCT00813813|473589|P1|Overall Study|Withdrawal by Subject|1
130757|NCT00813800|473605|P1|Overall Study|Physician Decision|1
130758|NCT00813800|473605|P1|Overall Study|Worsening of depression|2
130759|NCT00813800|473605|P1|Overall Study|Adverse Event|1
130760|NCT00813800|473605|P1|Overall Study|Screen Failure after Consent|2
130761|NCT00813761|473613|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
130762|NCT00813761|473614|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
130763|NCT00813761|473615|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
130764|NCT00813761|473616|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
130765|NCT00813761|473613|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
130766|NCT00813761|473614|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
130767|NCT00813761|473615|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
130768|NCT00813761|473616|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
130769|NCT00813761|473613|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
130770|NCT00813761|473614|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
130771|NCT00813761|473615|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
130772|NCT00813761|473616|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
130773|NCT00813761|473613|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
130774|NCT00813761|473614|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
130775|NCT00813761|473615|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
130776|NCT00813761|473616|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
130777|NCT00813761|473613|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
130778|NCT00813761|473614|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
130779|NCT00813761|473615|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
130780|NCT00813761|473616|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
130781|NCT00813761|473613|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
130782|NCT00813761|473614|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
130783|NCT00813761|473615|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
130784|NCT00813761|473616|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
130785|NCT00813761|473613|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
130786|NCT00813761|473614|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
130787|NCT00813761|473615|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
130788|NCT00813761|473616|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
130789|NCT00813761|473613|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
130790|NCT00813761|473614|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
130791|NCT00813761|473615|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
130792|NCT00813761|473616|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
130793|NCT00813761|473613|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
130794|NCT00813761|473614|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
130795|NCT00813761|473615|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
130796|NCT00813761|473616|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
130797|NCT00813761|473613|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
130798|NCT00813761|473614|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
130799|NCT00813761|473615|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
130800|NCT00813761|473616|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
130801|NCT00813761|473613|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
130802|NCT00813761|473614|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
130803|NCT00813761|473615|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
130804|NCT00813761|473616|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
130805|NCT00813761|473613|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
130806|NCT00813761|473614|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
130807|NCT00813761|473615|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
130808|NCT00813761|473616|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
130809|NCT00813748|473666|P2|Skin Test Substudy|Physician Decision|1
130810|NCT00813748|473667|P1|Skin Test Substudy|Physician Decision|0
130811|NCT00813709|473696|P6|Open Label Period|Other|6
130812|NCT00813709|473697|P5|Open Label Period|Other|5
130813|NCT00813709|473698|P4|Open Label Period|Other|11
130814|NCT00813709|473699|P3|Open Label Period|Other|0
130815|NCT00813709|473700|P2|Open Label Period|Other|0
130816|NCT00813709|473701|P1|Open Label Period|Other|0
130817|NCT00813709|473696|P6|Open Label Period|Randomized but not treated|1
130818|NCT00813709|473697|P5|Open Label Period|Randomized but not treated|0
130819|NCT00813709|473698|P4|Open Label Period|Randomized but not treated|1
130820|NCT00813709|473699|P3|Open Label Period|Randomized but not treated|0
130821|NCT00813709|473700|P2|Open Label Period|Randomized but not treated|0
130822|NCT00813709|473701|P1|Open Label Period|Randomized but not treated|0
130823|NCT00813709|473696|P6|Open Label Period|Lack of Efficacy|1
130824|NCT00813709|473697|P5|Open Label Period|Lack of Efficacy|1
130825|NCT00813709|473698|P4|Open Label Period|Lack of Efficacy|3
130826|NCT00813709|473699|P3|Open Label Period|Lack of Efficacy|0
130827|NCT00813709|473700|P2|Open Label Period|Lack of Efficacy|0
130828|NCT00813709|473701|P1|Open Label Period|Lack of Efficacy|0
130829|NCT00813709|473696|P6|Open Label Period|Adverse Event|3
130830|NCT00813709|473697|P5|Open Label Period|Adverse Event|4
130831|NCT00813709|473698|P4|Open Label Period|Adverse Event|5
130832|NCT00813709|473699|P3|Open Label Period|Adverse Event|0
130833|NCT00813709|473700|P2|Open Label Period|Adverse Event|0
130834|NCT00813709|473701|P1|Open Label Period|Adverse Event|0
130835|NCT00813709|473696|P6|Double Blind Period|Other|0
130836|NCT00813709|473697|P5|Double Blind Period|Other|0
130837|NCT00813709|473698|P4|Double Blind Period|Other|0
130838|NCT00813709|473699|P3|Double Blind Period|Other|6
130839|NCT00813709|473700|P2|Double Blind Period|Other|9
130840|NCT00813709|473701|P1|Double Blind Period|Other|14
130841|NCT00813709|473696|P6|Double Blind Period|Randomized but not treated|0
130842|NCT00813709|473697|P5|Double Blind Period|Randomized but not treated|0
130843|NCT00813709|473698|P4|Double Blind Period|Randomized but not treated|0
130844|NCT00813709|473699|P3|Double Blind Period|Randomized but not treated|1
130845|NCT00813709|473700|P2|Double Blind Period|Randomized but not treated|3
130846|NCT00813709|473701|P1|Double Blind Period|Randomized but not treated|1
130847|NCT00813709|473696|P6|Double Blind Period|Switched to open label phase|0
130848|NCT00813709|473697|P5|Double Blind Period|Switched to open label phase|0
130849|NCT00813709|473698|P4|Double Blind Period|Switched to open label phase|0
130850|NCT00813709|473699|P3|Double Blind Period|Switched to open label phase|18
130851|NCT00813709|473700|P2|Double Blind Period|Switched to open label phase|26
130852|NCT00813709|473701|P1|Double Blind Period|Switched to open label phase|9
130853|NCT00813709|473696|P6|Double Blind Period|Lost to Follow-up|0
130854|NCT00813709|473697|P5|Double Blind Period|Lost to Follow-up|0
130855|NCT00813709|473698|P4|Double Blind Period|Lost to Follow-up|0
130856|NCT00813709|473699|P3|Double Blind Period|Lost to Follow-up|2
130857|NCT00813709|473700|P2|Double Blind Period|Lost to Follow-up|2
130858|NCT00813709|473701|P1|Double Blind Period|Lost to Follow-up|3
130859|NCT00813709|473696|P6|Double Blind Period|Adverse Event|0
130860|NCT00813709|473697|P5|Double Blind Period|Adverse Event|0
130861|NCT00813709|473698|P4|Double Blind Period|Adverse Event|0
130862|NCT00813709|473699|P3|Double Blind Period|Adverse Event|4
130863|NCT00813709|473700|P2|Double Blind Period|Adverse Event|1
130864|NCT00813709|473701|P1|Double Blind Period|Adverse Event|4
130865|NCT00813592|473781|P1|Overall Study|Disease assessment was not completed per|2
130866|NCT00813488|473790|P2|Open-label Extension|Not specified|0
130867|NCT00813488|473791|P1|Open-label Extension|Not specified|1
130868|NCT00813488|473790|P2|Open-label Extension|Non-compliance study procedures|1
130869|NCT00813488|473791|P1|Open-label Extension|Non-compliance study procedures|2
130870|NCT00813488|473790|P2|Open-label Extension|Non-compliance study medication|0
130871|NCT00813488|473791|P1|Open-label Extension|Non-compliance study medication|4
130872|NCT00813488|473790|P2|Open-label Extension|Protocol Violation|2
130873|NCT00813488|473791|P1|Open-label Extension|Protocol Violation|1
130874|NCT00813488|473790|P2|Open-label Extension|Withdrawal by Subject|2
130875|NCT00813488|473791|P1|Open-label Extension|Withdrawal by Subject|0
130876|NCT00813488|473790|P2|Open-label Extension|Lack of Efficacy|0
130877|NCT00813488|473791|P1|Open-label Extension|Lack of Efficacy|3
130878|NCT00813488|473790|P2|Open-label Extension|Adverse Event|2
130879|NCT00813488|473791|P1|Open-label Extension|Adverse Event|1
130880|NCT00813488|473790|P2|Double-blind Treatment Period 2|Not Specified|0
130881|NCT00813488|473791|P1|Double-blind Treatment Period 2|Not Specified|1
130882|NCT00813488|473790|P2|Double-blind Treatment Period 2|Protocol Violation|0
130883|NCT00813488|473791|P1|Double-blind Treatment Period 2|Protocol Violation|2
130884|NCT00813488|473790|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
130885|NCT00813488|473791|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
130886|NCT00813488|473790|P2|Double-blind Treatment Period 2|Adverse Event|0
130887|NCT00813488|473791|P1|Double-blind Treatment Period 2|Adverse Event|1
130888|NCT00813488|473790|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
130889|NCT00813488|473791|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
130890|NCT00813488|473790|P2|Double-blind Treatment Period 1|Protocol Violation|2
130891|NCT00813488|473791|P1|Double-blind Treatment Period 1|Protocol Violation|0
130892|NCT00813488|473790|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
130893|NCT00813488|473791|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
130894|NCT00813488|473790|P2|Double-blind Treatment Period 1|Adverse Event|1
130895|NCT00813488|473791|P1|Double-blind Treatment Period 1|Adverse Event|1
130896|NCT00813488|473790|P2|Titration Period 2|Non-compliance with study procedures|1
130897|NCT00813488|473791|P1|Titration Period 2|Non-compliance with study procedures|2
130898|NCT00813488|473790|P2|Titration Period 2|Lost to Follow-up|0
130899|NCT00813488|473791|P1|Titration Period 2|Lost to Follow-up|1
130900|NCT00813488|473790|P2|Titration Period 2|Protocol Violation|2
130901|NCT00813488|473791|P1|Titration Period 2|Protocol Violation|3
130902|NCT00813488|473790|P2|Titration Period 2|Lack of Efficacy|4
130903|NCT00813488|473791|P1|Titration Period 2|Lack of Efficacy|8
130904|NCT00813488|473790|P2|Titration Period 2|Adverse Event|3
130905|NCT00813488|473791|P1|Titration Period 2|Adverse Event|2
130906|NCT00813488|473790|P2|Titration Period 1|Technical Difficulties|1
130907|NCT00813488|473791|P1|Titration Period 1|Technical Difficulties|0
130908|NCT00813488|473790|P2|Titration Period 1|Non-compliance to study procedures|2
130909|NCT00813488|473791|P1|Titration Period 1|Non-compliance to study procedures|2
130910|NCT00813488|473790|P2|Titration Period 1|Non-compliance to study medication|1
130911|NCT00813488|473791|P1|Titration Period 1|Non-compliance to study medication|4
130912|NCT00813488|473790|P2|Titration Period 1|Protocol Violation|3
130913|NCT00813488|473791|P1|Titration Period 1|Protocol Violation|4
130914|NCT00813488|473790|P2|Titration Period 1|Withdrawal by Subject|2
130915|NCT00813488|473791|P1|Titration Period 1|Withdrawal by Subject|2
130916|NCT00813488|473790|P2|Titration Period 1|Lack of Efficacy|7
130917|NCT00813488|473791|P1|Titration Period 1|Lack of Efficacy|9
130918|NCT00813488|473790|P2|Titration Period 1|Adverse Event|1
130919|NCT00813488|473791|P1|Titration Period 1|Adverse Event|6
130920|NCT00813150|473902|P2|Long Term Follow-up|Progression/Relapse|24
130921|NCT00813150|473903|P1|Long Term Follow-up|Progression/Relapse|22
130922|NCT00813150|473902|P2|Long Term Follow-up|Lost to Follow-up|0
130923|NCT00813150|473903|P1|Long Term Follow-up|Lost to Follow-up|2
130924|NCT00813150|473902|P2|Long Term Follow-up|Not specified|3
130925|NCT00813150|473903|P1|Long Term Follow-up|Not specified|0
130926|NCT00813150|473902|P2|Long Term Follow-up|Death|4
130927|NCT00813150|473903|P1|Long Term Follow-up|Death|0
130928|NCT00813150|473902|P2|Treatment Period|Data not available|2
130929|NCT00813150|473903|P1|Treatment Period|Data not available|1
130930|NCT00813150|473902|P2|Treatment Period|Reason not specified|4
130931|NCT00813150|473903|P1|Treatment Period|Reason not specified|3
130932|NCT00813150|473902|P2|Treatment Period|Non compliance|1
130933|NCT00813150|473903|P1|Treatment Period|Non compliance|0
130934|NCT00813150|473902|P2|Treatment Period|Withdrawal by Subject|3
130935|NCT00813150|473903|P1|Treatment Period|Withdrawal by Subject|5
130936|NCT00813150|473902|P2|Treatment Period|Protocol Violation|4
130937|NCT00813150|473903|P1|Treatment Period|Protocol Violation|3
130938|NCT00813150|473902|P2|Treatment Period|Stable disease|2
130939|NCT00813150|473903|P1|Treatment Period|Stable disease|1
130940|NCT00813150|473902|P2|Treatment Period|Complete response|1
130941|NCT00813150|473903|P1|Treatment Period|Complete response|0
130942|NCT00813150|473902|P2|Treatment Period|Progressive disease|0
130943|NCT00813150|473903|P1|Treatment Period|Progressive disease|1
130944|NCT00813150|473902|P2|Treatment Period|Death|0
130945|NCT00813150|473903|P1|Treatment Period|Death|2
130946|NCT00813150|473902|P2|Treatment Period|Adverse Event|15
130947|NCT00813150|473903|P1|Treatment Period|Adverse Event|16
130948|NCT00813098|473927|P3|Overall Study|Withdrew Consent|0
130949|NCT00813098|473928|P2|Overall Study|Withdrew Consent|1
130950|NCT00813098|473929|P1|Overall Study|Withdrew Consent|0
130951|NCT00813098|473927|P3|Overall Study|Principal Investigator decision|0
130952|NCT00813098|473928|P2|Overall Study|Principal Investigator decision|1
130953|NCT00813098|473929|P1|Overall Study|Principal Investigator decision|0
130954|NCT00813098|473927|P3|Overall Study|Protocol Violation|1
130955|NCT00813098|473928|P2|Overall Study|Protocol Violation|0
130956|NCT00813098|473929|P1|Overall Study|Protocol Violation|0
130957|NCT00813098|473927|P3|Overall Study|Lost to Follow-up|0
130958|NCT00813098|473928|P2|Overall Study|Lost to Follow-up|1
130959|NCT00813098|473929|P1|Overall Study|Lost to Follow-up|0
130960|NCT00813098|473927|P3|Overall Study|Inability to complete study procedures|0
130961|NCT00813098|473928|P2|Overall Study|Inability to complete study procedures|0
130962|NCT00813098|473929|P1|Overall Study|Inability to complete study procedures|1
130963|NCT00813098|473927|P3|Overall Study|Withdrawal by Subject|0
130964|NCT00813098|473928|P2|Overall Study|Withdrawal by Subject|1
130965|NCT00813098|473929|P1|Overall Study|Withdrawal by Subject|0
130966|NCT00813098|473927|P3|Overall Study|Adverse Event|1
130967|NCT00813098|473928|P2|Overall Study|Adverse Event|4
130968|NCT00813098|473929|P1|Overall Study|Adverse Event|2
130969|NCT00812981|473954|P2|Overall Study|Other|1
130970|NCT00812981|473955|P1|Overall Study|Other|0
130971|NCT00812968|473993|P1|Overall Study|Study closed due to marketing approval|3
130972|NCT00812968|473993|P1|Overall Study|No further treatment required|1
130973|NCT00812968|473993|P1|Overall Study|Disease progression|1
130974|NCT00812968|473993|P1|Overall Study|Relapse after erythroid response|6
130975|NCT00812955|474028|P4|Overall Study|randomized in error|0
130976|NCT00812955|474029|P3|Overall Study|randomized in error|1
130977|NCT00812955|474030|P2|Overall Study|randomized in error|0
130978|NCT00812955|474031|P1|Overall Study|randomized in error|0
130979|NCT00812955|474028|P4|Overall Study|Withdrawal by Subject|2
130980|NCT00812955|474029|P3|Overall Study|Withdrawal by Subject|1
130981|NCT00812955|474030|P2|Overall Study|Withdrawal by Subject|0
130982|NCT00812955|474031|P1|Overall Study|Withdrawal by Subject|1
130983|NCT00812955|474028|P4|Overall Study|Lost to Follow-up|2
130984|NCT00812955|474029|P3|Overall Study|Lost to Follow-up|1
130985|NCT00812955|474030|P2|Overall Study|Lost to Follow-up|1
130986|NCT00812955|474031|P1|Overall Study|Lost to Follow-up|2
130987|NCT00812955|474028|P4|Overall Study|Adverse Event|4
130988|NCT00812955|474029|P3|Overall Study|Adverse Event|3
130989|NCT00812955|474030|P2|Overall Study|Adverse Event|6
130990|NCT00812955|474031|P1|Overall Study|Adverse Event|7
130991|NCT00812929|474051|P10|Washout Period 3 (7 Days)|Adverse Event|0
130992|NCT00812929|474052|P9|Washout Period 3 (7 Days)|Adverse Event|0
130993|NCT00812929|474053|P8|Washout Period 3 (7 Days)|Adverse Event|0
130994|NCT00812929|474054|P7|Washout Period 3 (7 Days)|Adverse Event|0
130995|NCT00812929|474055|P6|Washout Period 3 (7 Days)|Adverse Event|1
130996|NCT00812929|474056|P5|Washout Period 3 (7 Days)|Adverse Event|0
130997|NCT00812929|474057|P4|Washout Period 3 (7 Days)|Adverse Event|0
130998|NCT00812929|474058|P3|Washout Period 3 (7 Days)|Adverse Event|0
130999|NCT00812929|474059|P2|Washout Period 3 (7 Days)|Adverse Event|0
131000|NCT00812929|474060|P1|Washout Period 3 (7 Days)|Adverse Event|0
131001|NCT00812929|474051|P10|Washout Period 2 (7 Days)|Physician Decision|1
131002|NCT00812929|474052|P9|Washout Period 2 (7 Days)|Physician Decision|0
131003|NCT00812929|474053|P8|Washout Period 2 (7 Days)|Physician Decision|0
131004|NCT00812929|474054|P7|Washout Period 2 (7 Days)|Physician Decision|0
131005|NCT00812929|474055|P6|Washout Period 2 (7 Days)|Physician Decision|0
131006|NCT00812929|474056|P5|Washout Period 2 (7 Days)|Physician Decision|0
131007|NCT00812929|474057|P4|Washout Period 2 (7 Days)|Physician Decision|0
131008|NCT00812929|474058|P3|Washout Period 2 (7 Days)|Physician Decision|0
131009|NCT00812929|474059|P2|Washout Period 2 (7 Days)|Physician Decision|0
131010|NCT00812929|474060|P1|Washout Period 2 (7 Days)|Physician Decision|0
131011|NCT00812929|474051|P10|Washout Period 1 (7 Days)|Physician Decision|0
131012|NCT00812929|474052|P9|Washout Period 1 (7 Days)|Physician Decision|0
131013|NCT00812929|474053|P8|Washout Period 1 (7 Days)|Physician Decision|0
131014|NCT00812929|474054|P7|Washout Period 1 (7 Days)|Physician Decision|0
131015|NCT00812929|474055|P6|Washout Period 1 (7 Days)|Physician Decision|0
131016|NCT00812929|474056|P5|Washout Period 1 (7 Days)|Physician Decision|0
131017|NCT00812929|474057|P4|Washout Period 1 (7 Days)|Physician Decision|0
131018|NCT00812929|474058|P3|Washout Period 1 (7 Days)|Physician Decision|1
131019|NCT00812929|474059|P2|Washout Period 1 (7 Days)|Physician Decision|0
131020|NCT00812929|474060|P1|Washout Period 1 (7 Days)|Physician Decision|0
131021|NCT00812812|474198|P2|Overall Study|Withdrawal by Subject|2
131022|NCT00812812|474199|P1|Overall Study|Withdrawal by Subject|0
131023|NCT00812812|474198|P2|Overall Study|Lost to Follow-up|1
131024|NCT00812812|474199|P1|Overall Study|Lost to Follow-up|0
131025|NCT00812812|474198|P2|Overall Study|Lack of Efficacy|0
131026|NCT00812812|474199|P1|Overall Study|Lack of Efficacy|1
131027|NCT00812812|474198|P2|Overall Study|Adverse Event|1
131028|NCT00812812|474199|P1|Overall Study|Adverse Event|2
131029|NCT00812565|474231|P8|Overall Study|Reason Not Specified|0
131030|NCT00812565|474232|P7|Overall Study|Reason Not Specified|0
131031|NCT00812565|474233|P6|Overall Study|Reason Not Specified|1
131032|NCT00812565|474234|P5|Overall Study|Reason Not Specified|0
131033|NCT00812565|474235|P4|Overall Study|Reason Not Specified|0
131034|NCT00812565|474236|P3|Overall Study|Reason Not Specified|0
131035|NCT00812565|474237|P2|Overall Study|Reason Not Specified|0
131036|NCT00812565|474238|P1|Overall Study|Reason Not Specified|0
131037|NCT00812565|474231|P8|Overall Study|Withdrawal of Consent|0
131038|NCT00812565|474232|P7|Overall Study|Withdrawal of Consent|0
131039|NCT00812565|474233|P6|Overall Study|Withdrawal of Consent|0
131040|NCT00812565|474234|P5|Overall Study|Withdrawal of Consent|1
131041|NCT00812565|474235|P4|Overall Study|Withdrawal of Consent|0
131042|NCT00812565|474236|P3|Overall Study|Withdrawal of Consent|0
131043|NCT00812565|474237|P2|Overall Study|Withdrawal of Consent|0
131044|NCT00812565|474238|P1|Overall Study|Withdrawal of Consent|1
131045|NCT00812565|474231|P8|Overall Study|Did Not Come to Study Visit|0
131046|NCT00812565|474232|P7|Overall Study|Did Not Come to Study Visit|0
131047|NCT00812565|474233|P6|Overall Study|Did Not Come to Study Visit|0
131048|NCT00812565|474234|P5|Overall Study|Did Not Come to Study Visit|0
131049|NCT00812565|474235|P4|Overall Study|Did Not Come to Study Visit|0
131050|NCT00812565|474236|P3|Overall Study|Did Not Come to Study Visit|0
131051|NCT00812565|474237|P2|Overall Study|Did Not Come to Study Visit|0
131052|NCT00812565|474238|P1|Overall Study|Did Not Come to Study Visit|1
131053|NCT00812565|474231|P8|Overall Study|Adverse Event|1
131054|NCT00812565|474232|P7|Overall Study|Adverse Event|0
131055|NCT00812565|474233|P6|Overall Study|Adverse Event|0
131056|NCT00812565|474234|P5|Overall Study|Adverse Event|0
131057|NCT00812565|474235|P4|Overall Study|Adverse Event|2
131058|NCT00812565|474236|P3|Overall Study|Adverse Event|0
131059|NCT00812565|474237|P2|Overall Study|Adverse Event|0
131060|NCT00812565|474238|P1|Overall Study|Adverse Event|0
131061|NCT00812565|474231|P8|Overall Study|Did Not Receive Study Medication|0
131062|NCT00812565|474232|P7|Overall Study|Did Not Receive Study Medication|0
131063|NCT00812565|474233|P6|Overall Study|Did Not Receive Study Medication|0
131064|NCT00812565|474234|P5|Overall Study|Did Not Receive Study Medication|0
131065|NCT00812565|474235|P4|Overall Study|Did Not Receive Study Medication|0
131066|NCT00812565|474236|P3|Overall Study|Did Not Receive Study Medication|0
131067|NCT00812565|474237|P2|Overall Study|Did Not Receive Study Medication|1
131068|NCT00812565|474238|P1|Overall Study|Did Not Receive Study Medication|1
131069|NCT00812487|474362|P2|Overall Study|Protocol Violation|1
131070|NCT00812487|474363|P1|Overall Study|Protocol Violation|0
131071|NCT00812487|474362|P2|Overall Study|Transfer to ICU prior to intervention|0
131072|NCT00812487|474363|P1|Overall Study|Transfer to ICU prior to intervention|1
131073|NCT00812487|474362|P2|Overall Study|Withdrawal by Subject|2
131074|NCT00812487|474363|P1|Overall Study|Withdrawal by Subject|3
131075|NCT00812487|474362|P2|Overall Study|Lost to Follow-up|0
131076|NCT00812487|474363|P1|Overall Study|Lost to Follow-up|2
131077|NCT00812461|474389|P2|All Treated Patients|Other Reason|21
131078|NCT00812461|474390|P1|All Treated Patients|Other Reason|13
131079|NCT00812461|474389|P2|All Treated Patients|Lost to Follow-up|14
131080|NCT00812461|474390|P1|All Treated Patients|Lost to Follow-up|11
131081|NCT00812461|474389|P2|All Treated Patients|Withdrawal by Subject|54
131082|NCT00812461|474390|P1|All Treated Patients|Withdrawal by Subject|45
131083|NCT00812461|474389|P2|All Treated Patients|Protocol Violation|27
131084|NCT00812461|474390|P1|All Treated Patients|Protocol Violation|36
131085|NCT00812461|474389|P2|All Treated Patients|Non-compliance|9
131086|NCT00812461|474390|P1|All Treated Patients|Non-compliance|6
131087|NCT00812461|474389|P2|All Treated Patients|Lack of Efficacy|7
131088|NCT00812461|474390|P1|All Treated Patients|Lack of Efficacy|13
131089|NCT00812461|474389|P2|All Treated Patients|Adverse Event|15
131090|NCT00812461|474390|P1|All Treated Patients|Adverse Event|8
131091|NCT00812461|474389|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
131092|NCT00812461|474390|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
131093|NCT00812331|474413|P5|Overall Study|Adverse Event|0
131094|NCT00812331|474414|P4|Overall Study|Adverse Event|0
131095|NCT00812331|474415|P3|Overall Study|Adverse Event|0
131096|NCT00812331|474416|P2|Overall Study|Adverse Event|0
131097|NCT00812331|474417|P1|Overall Study|Adverse Event|1
131098|NCT00812253|474492|P2|Overall Study|Lost to Follow-up|0
131099|NCT00812253|474493|P1|Overall Study|Lost to Follow-up|2
131100|NCT00812253|474492|P2|Overall Study|Protocol Violation|1
131101|NCT00812253|474493|P1|Overall Study|Protocol Violation|1
131102|NCT00812253|474492|P2|Overall Study|Withdrawal by Subject|2
131103|NCT00812253|474493|P1|Overall Study|Withdrawal by Subject|3
131104|NCT00812097|474518|P4|Overall Study|Unknown reasons and patient/doctor moves|5
131105|NCT00812097|474519|P3|Overall Study|Unknown reasons and patient/doctor moves|15
131106|NCT00812097|474520|P2|Overall Study|Unknown reasons and patient/doctor moves|24
131107|NCT00812097|474521|P1|Overall Study|Unknown reasons and patient/doctor moves|111
131108|NCT00812097|474518|P4|Overall Study|Explantation of study device(s)|20
131109|NCT00812097|474519|P3|Overall Study|Explantation of study device(s)|14
131110|NCT00812097|474520|P2|Overall Study|Explantation of study device(s)|29
131111|NCT00812097|474521|P1|Overall Study|Explantation of study device(s)|27
131112|NCT00812097|474518|P4|Overall Study|Lost to Follow-up|5
131113|NCT00812097|474519|P3|Overall Study|Lost to Follow-up|17
131114|NCT00812097|474520|P2|Overall Study|Lost to Follow-up|14
131115|NCT00812097|474521|P1|Overall Study|Lost to Follow-up|90
131116|NCT00812097|474518|P4|Overall Study|Withdrawal by Subject|2
131117|NCT00812097|474519|P3|Overall Study|Withdrawal by Subject|8
131118|NCT00812097|474520|P2|Overall Study|Withdrawal by Subject|12
131119|NCT00812097|474521|P1|Overall Study|Withdrawal by Subject|14
131120|NCT00812097|474518|P4|Overall Study|Death|3
131121|NCT00812097|474519|P3|Overall Study|Death|3
131122|NCT00812097|474520|P2|Overall Study|Death|10
131123|NCT00812097|474521|P1|Overall Study|Death|3
131124|NCT00812006|474550|P3|Overall Study|Lack of Qualifying Event|2
131125|NCT00812006|474551|P2|Overall Study|Lack of Qualifying Event|2
131126|NCT00812006|474552|P1|Overall Study|Lack of Qualifying Event|4
131127|NCT00812006|474550|P3|Overall Study|Withdrawal by Subject|1
131128|NCT00812006|474551|P2|Overall Study|Withdrawal by Subject|1
131129|NCT00812006|474552|P1|Overall Study|Withdrawal by Subject|2
131130|NCT00812006|474550|P3|Overall Study|Physician Decision|1
131131|NCT00812006|474551|P2|Overall Study|Physician Decision|0
131132|NCT00812006|474552|P1|Overall Study|Physician Decision|0
131133|NCT00812006|474550|P3|Overall Study|Lost to Follow-up|2
131134|NCT00812006|474551|P2|Overall Study|Lost to Follow-up|0
131135|NCT00812006|474552|P1|Overall Study|Lost to Follow-up|0
131136|NCT00811954|474569|P3|Overall Study|Complete Protocol: No follow-up|1
131137|NCT00811954|474570|P2|Overall Study|Complete Protocol: No follow-up|0
131138|NCT00811954|474571|P1|Overall Study|Complete Protocol: No follow-up|0
131139|NCT00811954|474569|P3|Overall Study|Severe Debilitation|1
131140|NCT00811954|474570|P2|Overall Study|Severe Debilitation|0
131141|NCT00811954|474571|P1|Overall Study|Severe Debilitation|2
131142|NCT00811954|474569|P3|Overall Study|Site Closure|1
131143|NCT00811954|474570|P2|Overall Study|Site Closure|0
131144|NCT00811954|474571|P1|Overall Study|Site Closure|4
131145|NCT00811954|474569|P3|Overall Study|Withdraw consent prior study completion|5
131146|NCT00811954|474570|P2|Overall Study|Withdraw consent prior study completion|6
131147|NCT00811954|474571|P1|Overall Study|Withdraw consent prior study completion|4
131148|NCT00811954|474569|P3|Overall Study|Not willing to adhere to requirements|16
131149|NCT00811954|474570|P2|Overall Study|Not willing to adhere to requirements|2
131150|NCT00811954|474571|P1|Overall Study|Not willing to adhere to requirements|12
131151|NCT00811954|474569|P3|Overall Study|Not able to get to clinic|30
131152|NCT00811954|474570|P2|Overall Study|Not able to get to clinic|35
131153|NCT00811954|474571|P1|Overall Study|Not able to get to clinic|28
131154|NCT00811954|474569|P3|Overall Study|Lost to Follow-up|34
131155|NCT00811954|474570|P2|Overall Study|Lost to Follow-up|23
131156|NCT00811954|474571|P1|Overall Study|Lost to Follow-up|29
131157|NCT00811954|474569|P3|Overall Study|Death|13
131158|NCT00811954|474570|P2|Overall Study|Death|6
131159|NCT00811954|474571|P1|Overall Study|Death|10
131160|NCT00811941|474635|P2|All Treated Patients|Other Reason|14
131161|NCT00811941|474636|P1|All Treated Patients|Other Reason|4
131162|NCT00811941|474635|P2|All Treated Patients|Lost to Follow-up|12
131163|NCT00811941|474636|P1|All Treated Patients|Lost to Follow-up|3
131164|NCT00811941|474635|P2|All Treated Patients|Withdrawal by Subject|94
131165|NCT00811941|474636|P1|All Treated Patients|Withdrawal by Subject|35
131166|NCT00811941|474635|P2|All Treated Patients|Protocol Violation|17
131167|NCT00811941|474636|P1|All Treated Patients|Protocol Violation|5
131168|NCT00811941|474635|P2|All Treated Patients|Non-compliance|8
131169|NCT00811941|474636|P1|All Treated Patients|Non-compliance|1
131170|NCT00811941|474635|P2|All Treated Patients|Lack of Efficacy|3
131171|NCT00811941|474636|P1|All Treated Patients|Lack of Efficacy|2
131172|NCT00811941|474635|P2|All Treated Patients|Adverse Event|43
131173|NCT00811941|474636|P1|All Treated Patients|Adverse Event|2
131174|NCT00811941|474635|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
131175|NCT00811941|474636|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
131176|NCT00811928|474674|P2|Overall Study|Poor Compliance|5
131177|NCT00811928|474675|P1|Overall Study|Poor Compliance|2
131178|NCT00811928|474674|P2|Overall Study|Investigator Decision|1
131179|NCT00811928|474675|P1|Overall Study|Investigator Decision|2
131180|NCT00811928|474674|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
131181|NCT00811928|474675|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
131182|NCT00811928|474674|P2|Overall Study|Did Not Take Study Drug|0
131183|NCT00811928|474675|P1|Overall Study|Did Not Take Study Drug|3
131184|NCT00811928|474674|P2|Overall Study|Withdrawal by Subject|12
131185|NCT00811928|474675|P1|Overall Study|Withdrawal by Subject|18
131186|NCT00811928|474674|P2|Overall Study|AEs and SAEs Including Death|11
131187|NCT00811928|474675|P1|Overall Study|AEs and SAEs Including Death|7
131188|NCT00811733|474719|P2|Overall Study|Withdrawal by Subject|2
131189|NCT00811733|474720|P1|Overall Study|Withdrawal by Subject|1
131190|NCT00811733|474719|P2|Overall Study|Investigator Discretion|8
131191|NCT00811733|474720|P1|Overall Study|Investigator Discretion|10
131192|NCT00811720|474768|P2|All Treated Patients|Other Reason|4
131193|NCT00811720|474769|P1|All Treated Patients|Other Reason|7
131194|NCT00811720|474768|P2|All Treated Patients|Lost to Follow-up|16
131195|NCT00811720|474769|P1|All Treated Patients|Lost to Follow-up|10
131196|NCT00811720|474768|P2|All Treated Patients|Withdrawal by Subject|34
131197|NCT00811720|474769|P1|All Treated Patients|Withdrawal by Subject|28
131198|NCT00811720|474768|P2|All Treated Patients|Protocol Violation|16
131199|NCT00811720|474769|P1|All Treated Patients|Protocol Violation|9
131200|NCT00811720|474768|P2|All Treated Patients|Non-compliance|14
131201|NCT00811720|474769|P1|All Treated Patients|Non-compliance|0
131202|NCT00811720|474768|P2|All Treated Patients|Lack of Efficacy|18
131203|NCT00811720|474769|P1|All Treated Patients|Lack of Efficacy|22
131204|NCT00811720|474768|P2|All Treated Patients|Adverse Event|62
131205|NCT00811720|474769|P1|All Treated Patients|Adverse Event|20
131206|NCT00811720|474768|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
131207|NCT00811720|474769|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
131208|NCT00811655|474787|P1|Overall Study|Physician Decision|1
131209|NCT00811642|474799|P1|Overall Study|Cumulative use of antifungal agent|2
131210|NCT00811642|474799|P1|Overall Study|Withdrawal by Subject|7
131211|NCT00811642|474799|P1|Overall Study|Death|2
131212|NCT00811642|474799|P1|Overall Study|Protocol Violation|1
131213|NCT00811642|474799|P1|Overall Study|Adverse Event|3
131214|NCT00811577|474815|P2|Overall Study|Withdrawal by Subject|0
131215|NCT00811577|474816|P1|Overall Study|Withdrawal by Subject|3
131216|NCT00811577|474815|P2|Overall Study|Lost to Follow-up|1
131217|NCT00811577|474816|P1|Overall Study|Lost to Follow-up|7
131218|NCT00811473|474876|P2|Overall Study|Safety Reasons|0
131219|NCT00811473|474877|P1|Overall Study|Safety Reasons|1
131220|NCT00811473|474876|P2|Overall Study|Incorrect Enrollment|0
131221|NCT00811473|474877|P1|Overall Study|Incorrect Enrollment|1
131222|NCT00811473|474876|P2|Overall Study|Other 2|1
131223|NCT00811473|474877|P1|Overall Study|Other 2|4
131224|NCT00811473|474876|P2|Overall Study|Condition under investigation worsened|3
131225|NCT00811473|474877|P1|Overall Study|Condition under investigation worsened|1
131226|NCT00811473|474876|P2|Overall Study|Lack of therapeutic response|1
131227|NCT00811473|474877|P1|Overall Study|Lack of therapeutic response|4
131228|NCT00811473|474876|P2|Overall Study|Severe non-compliance to protocol|4
131229|NCT00811473|474877|P1|Overall Study|Severe non-compliance to protocol|2
131230|NCT00811473|474876|P2|Overall Study|Withdrawal by Subject|4
131231|NCT00811473|474877|P1|Overall Study|Withdrawal by Subject|2
131232|NCT00811473|474876|P2|Overall Study|Lost to Follow-up|1
131233|NCT00811473|474877|P1|Overall Study|Lost to Follow-up|5
131234|NCT00811473|474876|P2|Overall Study|Adverse Event|12
131235|NCT00811473|474877|P1|Overall Study|Adverse Event|3
131236|NCT00811395|474908|P6|Extension Treatment|Other than above|0
131237|NCT00811395|474909|P5|Extension Treatment|Other than above|0
131238|NCT00811395|474910|P4|Extension Treatment|Other than above|0
131239|NCT00811395|474911|P3|Extension Treatment|Other than above|1
131240|NCT00811395|474912|P2|Extension Treatment|Other than above|0
131241|NCT00811395|474913|P1|Extension Treatment|Other than above|0
131242|NCT00811395|474908|P6|Extension Treatment|Participant did not wish to continue|1
131243|NCT00811395|474909|P5|Extension Treatment|Participant did not wish to continue|0
131244|NCT00811395|474910|P4|Extension Treatment|Participant did not wish to continue|1
131245|NCT00811395|474911|P3|Extension Treatment|Participant did not wish to continue|0
131246|NCT00811395|474912|P2|Extension Treatment|Participant did not wish to continue|3
131247|NCT00811395|474913|P1|Extension Treatment|Participant did not wish to continue|0
131248|NCT00811395|474908|P6|Extension Treatment|Progressive disease|0
131249|NCT00811395|474909|P5|Extension Treatment|Progressive disease|0
131250|NCT00811395|474910|P4|Extension Treatment|Progressive disease|0
131251|NCT00811395|474911|P3|Extension Treatment|Progressive disease|0
131252|NCT00811395|474912|P2|Extension Treatment|Progressive disease|1
131253|NCT00811395|474913|P1|Extension Treatment|Progressive disease|1
131254|NCT00811395|474908|P6|Extension Treatment|Adverse Event|1
131255|NCT00811395|474909|P5|Extension Treatment|Adverse Event|0
131256|NCT00811395|474910|P4|Extension Treatment|Adverse Event|2
131257|NCT00811395|474911|P3|Extension Treatment|Adverse Event|2
131258|NCT00811395|474912|P2|Extension Treatment|Adverse Event|2
131259|NCT00811395|474913|P1|Extension Treatment|Adverse Event|1
131260|NCT00811252|475019|P3|Overall Study|Administrative or Other Reasons|2
131261|NCT00811252|475020|P2|Overall Study|Administrative or Other Reasons|3
131262|NCT00811252|475021|P1|Overall Study|Administrative or Other Reasons|0
131263|NCT00811252|475019|P3|Overall Study|Lost to Follow-up|2
131264|NCT00811252|475020|P2|Overall Study|Lost to Follow-up|0
131265|NCT00811252|475021|P1|Overall Study|Lost to Follow-up|0
131266|NCT00811252|475019|P3|Overall Study|Withdrawal of Consent|2
131267|NCT00811252|475020|P2|Overall Study|Withdrawal of Consent|2
131268|NCT00811252|475021|P1|Overall Study|Withdrawal of Consent|1
131269|NCT00811252|475019|P3|Overall Study|Protocol Violation|2
131270|NCT00811252|475020|P2|Overall Study|Protocol Violation|3
131271|NCT00811252|475021|P1|Overall Study|Protocol Violation|3
131272|NCT00811252|475019|P3|Overall Study|Lack of Efficacy|0
131273|NCT00811252|475020|P2|Overall Study|Lack of Efficacy|2
131274|NCT00811252|475021|P1|Overall Study|Lack of Efficacy|7
131275|NCT00811252|475019|P3|Overall Study|Adverse Event|15
131276|NCT00811252|475020|P2|Overall Study|Adverse Event|10
131277|NCT00811252|475021|P1|Overall Study|Adverse Event|6
131278|NCT00811174|475065|P1|Overall Study|Sponsors Decision|1
131279|NCT00811174|475065|P1|Overall Study|Protocol Violation|2
131280|NCT00811135|475076|P1|Overall Study|Ongoing|59
131281|NCT00811135|475076|P1|Overall Study|Administrative/Other Unspecified|11
131282|NCT00811135|475076|P1|Overall Study|Withdrawal by Subject|3
131283|NCT00811135|475076|P1|Overall Study|Refused Treatment|1
131284|NCT00811135|475076|P1|Overall Study|Violation of Selection Criteria|1
131285|NCT00811135|475076|P1|Overall Study|Protocol Violation|2
131286|NCT00811135|475076|P1|Overall Study|Death|3
131287|NCT00811135|475076|P1|Overall Study|Adverse Event/Intercurrent Illness|8
131288|NCT00811070|475094|P6|Overall Study|Physician Decision|1
131289|NCT00811070|475095|P5|Overall Study|Physician Decision|0
131290|NCT00811070|475096|P4|Overall Study|Physician Decision|0
131291|NCT00811070|475097|P3|Overall Study|Physician Decision|0
131292|NCT00811070|475098|P2|Overall Study|Physician Decision|0
131293|NCT00811070|475099|P1|Overall Study|Physician Decision|0
131294|NCT00811070|475094|P6|Overall Study|Withdrawal by Subject|0
131295|NCT00811070|475095|P5|Overall Study|Withdrawal by Subject|0
131296|NCT00811070|475096|P4|Overall Study|Withdrawal by Subject|0
131297|NCT00811070|475097|P3|Overall Study|Withdrawal by Subject|0
131298|NCT00811070|475098|P2|Overall Study|Withdrawal by Subject|1
131299|NCT00811070|475099|P1|Overall Study|Withdrawal by Subject|0
131300|NCT00811070|475094|P6|Overall Study|Other|0
131301|NCT00811070|475095|P5|Overall Study|Other|0
131302|NCT00811070|475096|P4|Overall Study|Other|0
131303|NCT00811070|475097|P3|Overall Study|Other|0
131304|NCT00811070|475098|P2|Overall Study|Other|0
131305|NCT00811070|475099|P1|Overall Study|Other|1
131306|NCT00811070|475094|P6|Overall Study|Death|0
131307|NCT00811070|475095|P5|Overall Study|Death|5
131308|NCT00811070|475096|P4|Overall Study|Death|2
131309|NCT00811070|475097|P3|Overall Study|Death|0
131310|NCT00811070|475098|P2|Overall Study|Death|0
131311|NCT00811070|475099|P1|Overall Study|Death|0
131312|NCT00811057|475159|P3|Overall Study|Protocol Violation|10
131313|NCT00811057|475160|P2|Overall Study|Protocol Violation|10
131314|NCT00811057|475161|P1|Overall Study|Protocol Violation|5
131315|NCT00811018|475172|P1|Overall Study|Other|26
131316|NCT00811018|475172|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
131317|NCT00811018|475172|P1|Overall Study|Withdrawal by Subject|70
131318|NCT00811018|475172|P1|Overall Study|Sponsor Decision|450
131319|NCT00811018|475172|P1|Overall Study|Pregnancy|6
131320|NCT00811018|475172|P1|Overall Study|Lost to Follow-up|19
131321|NCT00811018|475172|P1|Overall Study|Investigator Decision|57
131322|NCT00811018|475172|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
131323|NCT00811018|475172|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
131324|NCT00811018|475172|P1|Overall Study|Death|147
131325|NCT00811018|475172|P1|Overall Study|Adverse Event|79
131326|NCT00811018|475172|P1|Overall Study|Additional Chronic Treatment|31
131327|NCT00810901|475190|P2|Overall Study|Lost to Follow-up|58
131328|NCT00810901|475191|P1|Overall Study|Lost to Follow-up|88
131329|NCT00810810|475237|P4|Overall Study|Physician Decision|5
131330|NCT00810810|475238|P3|Overall Study|Physician Decision|1
131331|NCT00810810|475239|P2|Overall Study|Physician Decision|3
131332|NCT00810810|475240|P1|Overall Study|Physician Decision|0
131333|NCT00810810|475237|P4|Overall Study|Withdrawal by Subject|8
131334|NCT00810810|475238|P3|Overall Study|Withdrawal by Subject|10
131335|NCT00810810|475239|P2|Overall Study|Withdrawal by Subject|8
131336|NCT00810810|475240|P1|Overall Study|Withdrawal by Subject|0
131337|NCT00810693|475288|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
131338|NCT00810693|475289|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
131339|NCT00810693|475290|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
131340|NCT00810693|475288|P3|Follow-up Period (FUP)|Protocol Violation|0
131341|NCT00810693|475289|P2|Follow-up Period (FUP)|Protocol Violation|1
131342|NCT00810693|475290|P1|Follow-up Period (FUP)|Protocol Violation|0
131343|NCT00810693|475288|P3|Follow-up Period (FUP)|Lost to Follow-up|2
131344|NCT00810693|475289|P2|Follow-up Period (FUP)|Lost to Follow-up|0
131345|NCT00810693|475290|P1|Follow-up Period (FUP)|Lost to Follow-up|1
131346|NCT00810693|475288|P3|Follow-up Period (FUP)|Death|1
131347|NCT00810693|475289|P2|Follow-up Period (FUP)|Death|0
131348|NCT00810693|475290|P1|Follow-up Period (FUP)|Death|2
131349|NCT00810693|475288|P3|Follow-up Period (FUP)|Adverse Event|1
131350|NCT00810693|475289|P2|Follow-up Period (FUP)|Adverse Event|1
131351|NCT00810693|475290|P1|Follow-up Period (FUP)|Adverse Event|3
131352|NCT00810693|475288|P3|Treatment Period|Not treated|1
131353|NCT00810693|475289|P2|Treatment Period|Not treated|1
131354|NCT00810693|475290|P1|Treatment Period|Not treated|0
131355|NCT00810693|475288|P3|Treatment Period|Withdrawal by Subject|3
131356|NCT00810693|475289|P2|Treatment Period|Withdrawal by Subject|2
131357|NCT00810693|475290|P1|Treatment Period|Withdrawal by Subject|6
131358|NCT00810693|475288|P3|Treatment Period|Protocol Violation|2
131359|NCT00810693|475289|P2|Treatment Period|Protocol Violation|2
131360|NCT00810693|475290|P1|Treatment Period|Protocol Violation|1
131361|NCT00810693|475288|P3|Treatment Period|Non-compliance|0
131362|NCT00810693|475289|P2|Treatment Period|Non-compliance|0
131363|NCT00810693|475290|P1|Treatment Period|Non-compliance|1
131364|NCT00810693|475288|P3|Treatment Period|Lost to Follow-up|0
131365|NCT00810693|475289|P2|Treatment Period|Lost to Follow-up|0
131366|NCT00810693|475290|P1|Treatment Period|Lost to Follow-up|1
131367|NCT00810693|475288|P3|Treatment Period|Lack of Efficacy|1
131368|NCT00810693|475289|P2|Treatment Period|Lack of Efficacy|0
131369|NCT00810693|475290|P1|Treatment Period|Lack of Efficacy|0
131370|NCT00810693|475288|P3|Treatment Period|Death|2
131371|NCT00810693|475289|P2|Treatment Period|Death|1
131372|NCT00810693|475290|P1|Treatment Period|Death|0
131373|NCT00810693|475288|P3|Treatment Period|Adverse Event|7
131374|NCT00810693|475289|P2|Treatment Period|Adverse Event|1
131375|NCT00810693|475290|P1|Treatment Period|Adverse Event|8
131376|NCT00810641|475322|P3|Overall Study|Withdrawal by Subject|2
131377|NCT00810641|475323|P2|Overall Study|Withdrawal by Subject|1
131378|NCT00810641|475324|P1|Overall Study|Withdrawal by Subject|0
131379|NCT00810602|475332|P2|Overall Study|Withdrawal by Subject|3
131380|NCT00810602|475333|P1|Overall Study|Withdrawal by Subject|8
131381|NCT00810511|475346|P2|Overall Study|deposits on contact lens|1
131382|NCT00810511|475347|P1|Overall Study|deposits on contact lens|0
131383|NCT00810511|475346|P2|Overall Study|Lost to Follow-up|0
131384|NCT00810511|475347|P1|Overall Study|Lost to Follow-up|1
131385|NCT00810511|475346|P2|Overall Study|death in the family|1
131386|NCT00810511|475347|P1|Overall Study|death in the family|0
131387|NCT00810511|475346|P2|Overall Study|Lack of Efficacy|1
131388|NCT00810511|475347|P1|Overall Study|Lack of Efficacy|9
131389|NCT00810511|475346|P2|Overall Study|Protocol Violation|1
131390|NCT00810511|475347|P1|Overall Study|Protocol Violation|0
131391|NCT00810394|475353|P1|Overall Study|Withdrawal by Subject|3
131392|NCT00810368|475361|P2|Overall Study|Lack of Efficacy|0
131393|NCT00810368|475362|P1|Overall Study|Lack of Efficacy|2
131394|NCT00810368|475361|P2|Overall Study|Lost to Follow-up|2
131395|NCT00810368|475362|P1|Overall Study|Lost to Follow-up|4
131396|NCT00810355|475383|P3|Overall Study|Withdrawal by Subject|0
131397|NCT00810355|475384|P2|Overall Study|Withdrawal by Subject|0
131398|NCT00810355|475385|P1|Overall Study|Withdrawal by Subject|1
131399|NCT00810355|475383|P3|Overall Study|Lost to Follow-up|11
131400|NCT00810355|475384|P2|Overall Study|Lost to Follow-up|17
131401|NCT00810355|475385|P1|Overall Study|Lost to Follow-up|13
131402|NCT00810342|475401|P2|12-month Followup|Lost to Follow-up|1
131403|NCT00810342|475402|P1|12-month Followup|Lost to Follow-up|3
131404|NCT00810342|475401|P2|12-month Followup|Pregnancy|10
131405|NCT00810342|475402|P1|12-month Followup|Pregnancy|9
131406|NCT00810342|475401|P2|6-month Follow-up|Pregnancy|2
131407|NCT00810342|475402|P1|6-month Follow-up|Pregnancy|6
131408|NCT00810342|475401|P2|6-month Follow-up|Lost to Follow-up|6
131409|NCT00810342|475402|P1|6-month Follow-up|Lost to Follow-up|18
131410|NCT00810342|475401|P2|Month 1 Follow-up|Pregnancy|0
131411|NCT00810342|475402|P1|Month 1 Follow-up|Pregnancy|1
131412|NCT00810342|475401|P2|Month 1 Follow-up|Lost to Follow-up|2
131413|NCT00810342|475402|P1|Month 1 Follow-up|Lost to Follow-up|4
131414|NCT00810277|475435|P1|Overall Study|Adverse Event|1
131415|NCT00810199|475450|P2|Overall Study|Did not receive study drug|1
131416|NCT00810199|475451|P1|Overall Study|Did not receive study drug|2
131417|NCT00810199|475450|P2|Overall Study|Failure to return|4
131418|NCT00810199|475451|P1|Overall Study|Failure to return|1
131419|NCT00810199|475450|P2|Overall Study|Protocol Violation|6
131420|NCT00810199|475451|P1|Overall Study|Protocol Violation|2
131421|NCT00810199|475450|P2|Overall Study|Administrative/Other|6
131422|NCT00810199|475451|P1|Overall Study|Administrative/Other|5
131423|NCT00810199|475450|P2|Overall Study|Refused treatment/Did not cooperate|7
131424|NCT00810199|475451|P1|Overall Study|Refused treatment/Did not cooperate|7
131425|NCT00810199|475450|P2|Overall Study|Insufficient therapeutic response|14
131426|NCT00810199|475451|P1|Overall Study|Insufficient therapeutic response|5
131427|NCT00810199|475450|P2|Overall Study|Withdrew consent|12
131428|NCT00810199|475451|P1|Overall Study|Withdrew consent|9
131429|NCT00810199|475450|P2|Overall Study|Death|6
131430|NCT00810199|475451|P1|Overall Study|Death|4
131431|NCT00810199|475450|P2|Overall Study|Adverse Event|26
131432|NCT00810199|475451|P1|Overall Study|Adverse Event|24
131433|NCT00810108|475529|P2|Overall Study|Withdrawal by Subject|0
131434|NCT00810108|475530|P1|Overall Study|Withdrawal by Subject|1
131435|NCT00810082|475544|P2|Overall Study|Lost to Follow-up|4
131436|NCT00810082|475545|P1|Overall Study|Lost to Follow-up|0
131437|NCT00810069|475553|P3|Double-Blind Period II|Protocol Violation|6
131438|NCT00810069|475554|P2|Double-Blind Period II|Protocol Violation|7
131439|NCT00810069|475555|P1|Double-Blind Period II|Protocol Violation|0
131440|NCT00810069|475553|P3|Double-Blind Period II|Clinical relapse|0
131441|NCT00810069|475554|P2|Double-Blind Period II|Clinical relapse|3
131442|NCT00810069|475555|P1|Double-Blind Period II|Clinical relapse|0
131443|NCT00810069|475553|P3|Double-Blind Period II|Protocol entry criterion not met|1
131444|NCT00810069|475554|P2|Double-Blind Period II|Protocol entry criterion not met|0
131445|NCT00810069|475555|P1|Double-Blind Period II|Protocol entry criterion not met|0
131446|NCT00810069|475553|P3|Double-Blind Period II|Withdrawal by Subject|35
131447|NCT00810069|475554|P2|Double-Blind Period II|Withdrawal by Subject|21
131448|NCT00810069|475555|P1|Double-Blind Period II|Withdrawal by Subject|0
131449|NCT00810069|475553|P3|Double-Blind Period II|Physician Decision|1
131450|NCT00810069|475554|P2|Double-Blind Period II|Physician Decision|0
131451|NCT00810069|475555|P1|Double-Blind Period II|Physician Decision|0
131452|NCT00810069|475553|P3|Double-Blind Period II|Lost to Follow-up|9
131453|NCT00810069|475554|P2|Double-Blind Period II|Lost to Follow-up|9
131454|NCT00810069|475555|P1|Double-Blind Period II|Lost to Follow-up|0
131455|NCT00810069|475553|P3|Double-Blind Period II|Lack of Efficacy|12
131456|NCT00810069|475554|P2|Double-Blind Period II|Lack of Efficacy|7
131457|NCT00810069|475555|P1|Double-Blind Period II|Lack of Efficacy|0
131458|NCT00810069|475553|P3|Double-Blind Period II|Adverse Event|8
131459|NCT00810069|475554|P2|Double-Blind Period II|Adverse Event|9
131460|NCT00810069|475555|P1|Double-Blind Period II|Adverse Event|0
131461|NCT00810069|475553|P3|Lead-in Period I|Randomization criteria not met|0
131462|NCT00810069|475554|P2|Lead-in Period I|Randomization criteria not met|0
131463|NCT00810069|475555|P1|Lead-in Period I|Randomization criteria not met|158
131464|NCT00810069|475553|P3|Lead-in Period I|Protocol entry criterion not met|0
131465|NCT00810069|475554|P2|Lead-in Period I|Protocol entry criterion not met|0
131466|NCT00810069|475555|P1|Lead-in Period I|Protocol entry criterion not met|5
131467|NCT00810069|475553|P3|Lead-in Period I|Withdrawal by Subject|0
131468|NCT00810069|475554|P2|Lead-in Period I|Withdrawal by Subject|0
131469|NCT00810069|475555|P1|Lead-in Period I|Withdrawal by Subject|46
131470|NCT00810069|475553|P3|Lead-in Period I|Protocol Violation|0
131471|NCT00810069|475554|P2|Lead-in Period I|Protocol Violation|0
131472|NCT00810069|475555|P1|Lead-in Period I|Protocol Violation|1
131473|NCT00810069|475553|P3|Lead-in Period I|Physician Decision|0
131474|NCT00810069|475554|P2|Lead-in Period I|Physician Decision|0
131475|NCT00810069|475555|P1|Lead-in Period I|Physician Decision|1
131476|NCT00810069|475553|P3|Lead-in Period I|Lost to Follow-up|0
131477|NCT00810069|475554|P2|Lead-in Period I|Lost to Follow-up|0
131478|NCT00810069|475555|P1|Lead-in Period I|Lost to Follow-up|19
131479|NCT00810069|475553|P3|Lead-in Period I|Lack of Efficacy|0
131480|NCT00810069|475554|P2|Lead-in Period I|Lack of Efficacy|0
131481|NCT00810069|475555|P1|Lead-in Period I|Lack of Efficacy|1
131482|NCT00810069|475553|P3|Lead-in Period I|Adverse Event|0
131483|NCT00810069|475554|P2|Lead-in Period I|Adverse Event|0
131484|NCT00810069|475555|P1|Lead-in Period I|Adverse Event|43
131485|NCT00810043|475600|P3|Overall Study|No longer met enrollment criteria|3
131486|NCT00810043|475601|P2|Overall Study|No longer met enrollment criteria|0
131487|NCT00810043|475602|P1|Overall Study|No longer met enrollment criteria|0
131488|NCT00810043|475600|P3|Overall Study|Non-medical problem|1
131489|NCT00810043|475601|P2|Overall Study|Non-medical problem|0
131490|NCT00810043|475602|P1|Overall Study|Non-medical problem|0
131491|NCT00810043|475600|P3|Overall Study|Unrelated medical problem|0
131492|NCT00810043|475601|P2|Overall Study|Unrelated medical problem|1
131493|NCT00810043|475602|P1|Overall Study|Unrelated medical problem|0
131494|NCT00810043|475600|P3|Overall Study|Death|0
131495|NCT00810043|475601|P2|Overall Study|Death|0
131496|NCT00810043|475602|P1|Overall Study|Death|2
131497|NCT00810043|475600|P3|Overall Study|Physician Decision|2
131498|NCT00810043|475601|P2|Overall Study|Physician Decision|0
131499|NCT00810043|475602|P1|Overall Study|Physician Decision|0
131500|NCT00810043|475600|P3|Overall Study|Lost to Follow-up|0
131501|NCT00810043|475601|P2|Overall Study|Lost to Follow-up|0
131502|NCT00810043|475602|P1|Overall Study|Lost to Follow-up|1
131503|NCT00810043|475600|P3|Overall Study|Withdrawal by Subject|2
131504|NCT00810043|475601|P2|Overall Study|Withdrawal by Subject|0
131505|NCT00810043|475602|P1|Overall Study|Withdrawal by Subject|1
131506|NCT00809965|475624|P3|Overall Study|Other Reason|189
131507|NCT00809965|475625|P2|Overall Study|Other Reason|170
131508|NCT00809965|475626|P1|Overall Study|Other Reason|167
131509|NCT00809965|475624|P3|Overall Study|Withdrawal by Subject|441
131510|NCT00809965|475625|P2|Overall Study|Withdrawal by Subject|448
131511|NCT00809965|475626|P1|Overall Study|Withdrawal by Subject|405
131512|NCT00809965|475624|P3|Overall Study|Lost to Follow-up|18
131513|NCT00809965|475625|P2|Overall Study|Lost to Follow-up|10
131514|NCT00809965|475626|P1|Overall Study|Lost to Follow-up|17
131515|NCT00809965|475624|P3|Overall Study|Death|196
131516|NCT00809965|475625|P2|Overall Study|Death|147
131517|NCT00809965|475626|P1|Overall Study|Death|194
131518|NCT00809926|475648|P2|Overall Study|Protocol deviation|2
131519|NCT00809926|475649|P1|Overall Study|Protocol deviation|0
131520|NCT00809926|475648|P2|Overall Study|Administrative Problems|1
131521|NCT00809926|475649|P1|Overall Study|Administrative Problems|0
131522|NCT00809926|475648|P2|Overall Study|Lost to Follow-up|1
131523|NCT00809926|475649|P1|Overall Study|Lost to Follow-up|2
131524|NCT00809926|475648|P2|Overall Study|Patient withdrew consent|6
131525|NCT00809926|475649|P1|Overall Study|Patient withdrew consent|8
131526|NCT00809926|475648|P2|Overall Study|Unsatisfactory therapeutic effect|3
131527|NCT00809926|475649|P1|Overall Study|Unsatisfactory therapeutic effect|3
131528|NCT00809926|475648|P2|Overall Study|Adverse Event|10
131529|NCT00809926|475649|P1|Overall Study|Adverse Event|18
131530|NCT00809835|475703|P4|Overall Study|Withdrawal by Subject|0
131531|NCT00809835|475704|P3|Overall Study|Withdrawal by Subject|1
131532|NCT00809835|475705|P2|Overall Study|Withdrawal by Subject|1
131533|NCT00809835|475706|P1|Overall Study|Withdrawal by Subject|1
131534|NCT00809835|475703|P4|Overall Study|Lost to Follow-up|2
131535|NCT00809835|475704|P3|Overall Study|Lost to Follow-up|10
131536|NCT00809835|475705|P2|Overall Study|Lost to Follow-up|6
131537|NCT00809835|475706|P1|Overall Study|Lost to Follow-up|7
131538|NCT00809757|475736|P3|Overall Study|Noncompliance with Medication|1
131539|NCT00809757|475737|P2|Overall Study|Noncompliance with Medication|0
131540|NCT00809757|475738|P1|Overall Study|Noncompliance with Medication|0
131541|NCT00809757|475736|P3|Overall Study|Subject Uncooperative|2
131542|NCT00809757|475737|P2|Overall Study|Subject Uncooperative|0
131543|NCT00809757|475738|P1|Overall Study|Subject Uncooperative|1
131544|NCT00809757|475736|P3|Overall Study|Withdrawal by Subject|3
131545|NCT00809757|475737|P2|Overall Study|Withdrawal by Subject|1
131546|NCT00809757|475738|P1|Overall Study|Withdrawal by Subject|2
131547|NCT00809757|475736|P3|Overall Study|Protocol Violation|1
131548|NCT00809757|475737|P2|Overall Study|Protocol Violation|1
131549|NCT00809757|475738|P1|Overall Study|Protocol Violation|1
131550|NCT00809757|475736|P3|Overall Study|Lost to Follow-up|1
131551|NCT00809757|475737|P2|Overall Study|Lost to Follow-up|0
131552|NCT00809757|475738|P1|Overall Study|Lost to Follow-up|0
131553|NCT00809757|475736|P3|Overall Study|Adverse Event|3
131554|NCT00809757|475737|P2|Overall Study|Adverse Event|3
131555|NCT00809757|475738|P1|Overall Study|Adverse Event|2
131556|NCT00809614|475823|P2|Overall Study|Withdrawal by Subject|1
131557|NCT00809614|475824|P1|Overall Study|Withdrawal by Subject|1
131558|NCT00809614|475823|P2|Overall Study|Lack of Efficacy|3
131559|NCT00809614|475824|P1|Overall Study|Lack of Efficacy|2
131560|NCT00809471|475868|P3|Overall Study|Requirement for restricted medication|0
131561|NCT00809471|475869|P2|Overall Study|Requirement for restricted medication|1
131562|NCT00809471|475870|P1|Overall Study|Requirement for restricted medication|1
131563|NCT00809471|475868|P3|Overall Study|Adverse Event|2
131564|NCT00809471|475869|P2|Overall Study|Adverse Event|2
131565|NCT00809471|475870|P1|Overall Study|Adverse Event|0
131566|NCT00809471|475868|P3|Overall Study|Lost to Follow-up|9
131567|NCT00809471|475869|P2|Overall Study|Lost to Follow-up|2
131568|NCT00809471|475870|P1|Overall Study|Lost to Follow-up|4
131569|NCT00809471|475868|P3|Overall Study|Protocol non-compliance|6
131570|NCT00809471|475869|P2|Overall Study|Protocol non-compliance|15
131571|NCT00809471|475870|P1|Overall Study|Protocol non-compliance|15
131572|NCT00809445|475900|P3|6 Month Follow-up|Withdrew consent|1
131573|NCT00809445|475901|P2|6 Month Follow-up|Withdrew consent|0
131574|NCT00809445|475902|P1|6 Month Follow-up|Withdrew consent|0
131575|NCT00809445|475900|P3|6 Month Follow-up|Incarcerated|8
131576|NCT00809445|475901|P2|6 Month Follow-up|Incarcerated|8
131577|NCT00809445|475902|P1|6 Month Follow-up|Incarcerated|6
131578|NCT00809445|475900|P3|6 Month Follow-up|Death|1
131579|NCT00809445|475901|P2|6 Month Follow-up|Death|1
131580|NCT00809445|475902|P1|6 Month Follow-up|Death|2
131581|NCT00809445|475900|P3|6 Month Follow-up|Lost contact|14
131582|NCT00809445|475901|P2|6 Month Follow-up|Lost contact|14
131583|NCT00809445|475902|P1|6 Month Follow-up|Lost contact|16
131584|NCT00809445|475900|P3|1 Month Follow-up|Incarcerated|1
131585|NCT00809445|475901|P2|1 Month Follow-up|Incarcerated|0
131586|NCT00809445|475902|P1|1 Month Follow-up|Incarcerated|0
131587|NCT00809445|475900|P3|1 Month Follow-up|Death|1
131588|NCT00809445|475901|P2|1 Month Follow-up|Death|1
131589|NCT00809445|475902|P1|1 Month Follow-up|Death|0
131590|NCT00809445|475900|P3|1 Month Follow-up|Withdrew consent|1
131591|NCT00809445|475901|P2|1 Month Follow-up|Withdrew consent|1
131592|NCT00809445|475902|P1|1 Month Follow-up|Withdrew consent|1
131593|NCT00809445|475900|P3|1 Month Follow-up|Lost contact|1
131594|NCT00809445|475901|P2|1 Month Follow-up|Lost contact|2
131595|NCT00809445|475902|P1|1 Month Follow-up|Lost contact|1
131596|NCT00809328|475919|P1|Overall Study|Withdrawal by Subject|2
131597|NCT00809328|475919|P1|Overall Study|Protocol Violation|3
131598|NCT00809328|475919|P1|Overall Study|Adverse Event|6
131599|NCT00809328|475919|P1|Overall Study|Lack of Efficacy|18
131600|NCT00809159|475939|P6|Part 1 and 2|Withdrawal by Subject|1
131601|NCT00809159|475940|P5|Part 1 and 2|Withdrawal by Subject|0
131602|NCT00809159|475941|P4|Part 1 and 2|Withdrawal by Subject|0
131603|NCT00809159|475942|P3|Part 1 and 2|Withdrawal by Subject|4
131604|NCT00809159|475943|P2|Part 1 and 2|Withdrawal by Subject|0
131605|NCT00809159|475944|P1|Part 1 and 2|Withdrawal by Subject|0
131606|NCT00809159|475939|P6|Part 1 and 2|Lost to Follow-up|0
131607|NCT00809159|475940|P5|Part 1 and 2|Lost to Follow-up|0
131608|NCT00809159|475941|P4|Part 1 and 2|Lost to Follow-up|1
131609|NCT00809159|475942|P3|Part 1 and 2|Lost to Follow-up|1
131610|NCT00809159|475943|P2|Part 1 and 2|Lost to Follow-up|0
131611|NCT00809159|475944|P1|Part 1 and 2|Lost to Follow-up|0
131612|NCT00809159|475939|P6|Part 1 and 2|Adverse Event|1
131613|NCT00809159|475940|P5|Part 1 and 2|Adverse Event|1
131614|NCT00809159|475941|P4|Part 1 and 2|Adverse Event|0
131615|NCT00809159|475942|P3|Part 1 and 2|Adverse Event|1
131616|NCT00809159|475943|P2|Part 1 and 2|Adverse Event|0
131617|NCT00809159|475944|P1|Part 1 and 2|Adverse Event|0
131618|NCT00809159|475939|P6|Part 1 and 2|Administrative problems|0
131619|NCT00809159|475940|P5|Part 1 and 2|Administrative problems|0
131620|NCT00809159|475941|P4|Part 1 and 2|Administrative problems|1
131621|NCT00809159|475942|P3|Part 1 and 2|Administrative problems|0
131622|NCT00809159|475943|P2|Part 1 and 2|Administrative problems|0
131623|NCT00809159|475944|P1|Part 1 and 2|Administrative problems|0
131624|NCT00809159|475939|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
131625|NCT00809159|475940|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
131626|NCT00809159|475941|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
131627|NCT00809159|475942|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
131628|NCT00809159|475943|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
131629|NCT00809159|475944|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
131630|NCT00809159|475939|P6|Part 1|Unsatisfactory therapeutic effect|0
131631|NCT00809159|475940|P5|Part 1|Unsatisfactory therapeutic effect|0
131632|NCT00809159|475941|P4|Part 1|Unsatisfactory therapeutic effect|0
131633|NCT00809159|475942|P3|Part 1|Unsatisfactory therapeutic effect|0
131634|NCT00809159|475943|P2|Part 1|Unsatisfactory therapeutic effect|1
131635|NCT00809159|475944|P1|Part 1|Unsatisfactory therapeutic effect|3
131636|NCT00809159|475939|P6|Part 1|Withdrawal by Subject|0
131637|NCT00809159|475940|P5|Part 1|Withdrawal by Subject|0
131638|NCT00809159|475941|P4|Part 1|Withdrawal by Subject|0
131639|NCT00809159|475942|P3|Part 1|Withdrawal by Subject|0
131640|NCT00809159|475943|P2|Part 1|Withdrawal by Subject|1
131641|NCT00809159|475944|P1|Part 1|Withdrawal by Subject|3
131642|NCT00809159|475939|P6|Part 1|Lost to Follow-up|0
131643|NCT00809159|475940|P5|Part 1|Lost to Follow-up|0
131644|NCT00809159|475941|P4|Part 1|Lost to Follow-up|0
131645|NCT00809159|475942|P3|Part 1|Lost to Follow-up|0
131646|NCT00809159|475943|P2|Part 1|Lost to Follow-up|0
131647|NCT00809159|475944|P1|Part 1|Lost to Follow-up|1
131648|NCT00809159|475939|P6|Part 1|Adverse Event|0
131649|NCT00809159|475940|P5|Part 1|Adverse Event|0
131650|NCT00809159|475941|P4|Part 1|Adverse Event|0
131651|NCT00809159|475942|P3|Part 1|Adverse Event|0
131652|NCT00809159|475943|P2|Part 1|Adverse Event|1
131653|NCT00809159|475944|P1|Part 1|Adverse Event|1
131654|NCT00809133|476049|P14|Overall Study|Other not mentioned above|0
131655|NCT00809133|476050|P13|Overall Study|Other not mentioned above|0
131656|NCT00809133|476051|P12|Overall Study|Other not mentioned above|0
131657|NCT00809133|476052|P11|Overall Study|Other not mentioned above|0
131658|NCT00809133|476053|P10|Overall Study|Other not mentioned above|0
131659|NCT00809133|476054|P9|Overall Study|Other not mentioned above|0
131660|NCT00809133|476055|P8|Overall Study|Other not mentioned above|0
131661|NCT00809133|476056|P7|Overall Study|Other not mentioned above|0
131662|NCT00809133|476057|P6|Overall Study|Other not mentioned above|1
131663|NCT00809133|476058|P5|Overall Study|Other not mentioned above|0
131664|NCT00809133|476059|P4|Overall Study|Other not mentioned above|0
131665|NCT00809133|476060|P3|Overall Study|Other not mentioned above|0
131666|NCT00809133|476061|P2|Overall Study|Other not mentioned above|1
131667|NCT00809133|476062|P1|Overall Study|Other not mentioned above|0
131668|NCT00809133|476049|P14|Overall Study|Consent withdrawn|0
131669|NCT00809133|476050|P13|Overall Study|Consent withdrawn|0
131670|NCT00809133|476051|P12|Overall Study|Consent withdrawn|0
131671|NCT00809133|476052|P11|Overall Study|Consent withdrawn|0
131672|NCT00809133|476053|P10|Overall Study|Consent withdrawn|0
131673|NCT00809133|476054|P9|Overall Study|Consent withdrawn|0
131674|NCT00809133|476055|P8|Overall Study|Consent withdrawn|0
131675|NCT00809133|476056|P7|Overall Study|Consent withdrawn|0
131676|NCT00809133|476057|P6|Overall Study|Consent withdrawn|0
131677|NCT00809133|476058|P5|Overall Study|Consent withdrawn|1
131678|NCT00809133|476059|P4|Overall Study|Consent withdrawn|0
131679|NCT00809133|476060|P3|Overall Study|Consent withdrawn|0
131680|NCT00809133|476061|P2|Overall Study|Consent withdrawn|0
131681|NCT00809133|476062|P1|Overall Study|Consent withdrawn|0
131682|NCT00809133|476049|P14|Overall Study|Lost to Follow-up|0
131683|NCT00809133|476050|P13|Overall Study|Lost to Follow-up|0
131684|NCT00809133|476051|P12|Overall Study|Lost to Follow-up|0
131685|NCT00809133|476052|P11|Overall Study|Lost to Follow-up|0
131686|NCT00809133|476053|P10|Overall Study|Lost to Follow-up|0
131687|NCT00809133|476054|P9|Overall Study|Lost to Follow-up|0
131688|NCT00809133|476055|P8|Overall Study|Lost to Follow-up|0
131689|NCT00809133|476056|P7|Overall Study|Lost to Follow-up|0
131690|NCT00809133|476057|P6|Overall Study|Lost to Follow-up|1
131691|NCT00809133|476058|P5|Overall Study|Lost to Follow-up|0
131692|NCT00809133|476059|P4|Overall Study|Lost to Follow-up|0
131693|NCT00809133|476060|P3|Overall Study|Lost to Follow-up|0
131694|NCT00809133|476061|P2|Overall Study|Lost to Follow-up|0
131695|NCT00809133|476062|P1|Overall Study|Lost to Follow-up|0
131696|NCT00809133|476049|P14|Overall Study|Other adverse event|1
131697|NCT00809133|476050|P13|Overall Study|Other adverse event|0
131698|NCT00809133|476051|P12|Overall Study|Other adverse event|1
131699|NCT00809133|476052|P11|Overall Study|Other adverse event|1
131700|NCT00809133|476053|P10|Overall Study|Other adverse event|0
131701|NCT00809133|476054|P9|Overall Study|Other adverse event|0
131702|NCT00809133|476055|P8|Overall Study|Other adverse event|4
131703|NCT00809133|476056|P7|Overall Study|Other adverse event|2
131704|NCT00809133|476057|P6|Overall Study|Other adverse event|3
131705|NCT00809133|476058|P5|Overall Study|Other adverse event|0
131706|NCT00809133|476059|P4|Overall Study|Other adverse event|0
131707|NCT00809133|476060|P3|Overall Study|Other adverse event|1
131708|NCT00809133|476061|P2|Overall Study|Other adverse event|1
131709|NCT00809133|476062|P1|Overall Study|Other adverse event|1
131710|NCT00809133|476049|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
131711|NCT00809133|476050|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
131712|NCT00809133|476051|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
131713|NCT00809133|476052|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
131714|NCT00809133|476053|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
131715|NCT00809133|476054|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
131716|NCT00809133|476055|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
131717|NCT00809133|476056|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
131718|NCT00809133|476057|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
131719|NCT00809133|476058|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
131720|NCT00809133|476059|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
131721|NCT00809133|476060|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
131722|NCT00809133|476061|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
131723|NCT00809133|476062|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
131724|NCT00809133|476049|P14|Overall Study|Progressive disease|4
131725|NCT00809133|476050|P13|Overall Study|Progressive disease|5
131726|NCT00809133|476051|P12|Overall Study|Progressive disease|7
131727|NCT00809133|476052|P11|Overall Study|Progressive disease|5
131728|NCT00809133|476053|P10|Overall Study|Progressive disease|9
131729|NCT00809133|476054|P9|Overall Study|Progressive disease|3
131730|NCT00809133|476055|P8|Overall Study|Progressive disease|3
131731|NCT00809133|476056|P7|Overall Study|Progressive disease|3
131732|NCT00809133|476057|P6|Overall Study|Progressive disease|1
131733|NCT00809133|476058|P5|Overall Study|Progressive disease|4
131734|NCT00809133|476059|P4|Overall Study|Progressive disease|3
131735|NCT00809133|476060|P3|Overall Study|Progressive disease|5
131736|NCT00809133|476061|P2|Overall Study|Progressive disease|5
131737|NCT00809133|476062|P1|Overall Study|Progressive disease|2
131738|NCT00809094|476216|P2|Overall Study|Lost to Follow-up|1
131739|NCT00809094|476217|P1|Overall Study|Lost to Follow-up|0
131740|NCT00808899|476262|P1|Overall Study|Physician Decision|3
131741|NCT00808899|476262|P1|Overall Study|Death|1
131742|NCT00808808|476276|P3|Overall Study|Employee was not vaccinated.|2255
131743|NCT00808808|476277|P2|Overall Study|Employee was not vaccinated.|2268
131744|NCT00808808|476278|P1|Overall Study|Employee was not vaccinated.|2686
131745|NCT00808808|476276|P3|Overall Study|Vaccinated; survey not completed|302
131746|NCT00808808|476277|P2|Overall Study|Vaccinated; survey not completed|169
131747|NCT00808808|476278|P1|Overall Study|Vaccinated; survey not completed|131
131748|NCT00808665|476313|P2|Overall Study|Medication stopped by resident|1
131749|NCT00808665|476314|P1|Overall Study|Medication stopped by resident|0
131750|NCT00808665|476313|P2|Overall Study|Physician Decision|1
131751|NCT00808665|476314|P1|Overall Study|Physician Decision|3
131752|NCT00808665|476313|P2|Overall Study|required an additional procedure|1
131753|NCT00808665|476314|P1|Overall Study|required an additional procedure|0
131754|NCT00808665|476313|P2|Overall Study|surgery cancelled|0
131755|NCT00808665|476314|P1|Overall Study|surgery cancelled|1
131756|NCT00808665|476313|P2|Overall Study|only required minimally invasive surgery|0
131757|NCT00808665|476314|P1|Overall Study|only required minimally invasive surgery|1
131758|NCT00808665|476313|P2|Overall Study|Withdrawal by Subject|0
131759|NCT00808665|476314|P1|Overall Study|Withdrawal by Subject|1
131760|NCT00808639|476320|P1|Overall Study|Disease progression before surgery.|1
131761|NCT00808509|476328|P2|Randomized Phase|Patient refused rescue therapy|3
131762|NCT00808509|476329|P1|Randomized Phase|Patient refused rescue therapy|0
131763|NCT00808509|476328|P2|Randomized Phase|Reduced methotrexate dose|2
131764|NCT00808509|476329|P1|Randomized Phase|Reduced methotrexate dose|1
131765|NCT00808509|476328|P2|Randomized Phase|Did not meet eligibility criteria|0
131766|NCT00808509|476329|P1|Randomized Phase|Did not meet eligibility criteria|1
131767|NCT00808483|476427|P2|From 5 Months to 12 Months|Lack of Efficacy|0
131768|NCT00808483|476428|P1|From 5 Months to 12 Months|Lack of Efficacy|1
131769|NCT00808483|476427|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
131770|NCT00808483|476428|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
131771|NCT00808483|476427|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
131772|NCT00808483|476428|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
131773|NCT00808444|476465|P2|Overall Study|Lost to Follow-up|1
131774|NCT00808444|476466|P1|Overall Study|Lost to Follow-up|0
131775|NCT00808444|476465|P2|Overall Study|Withdrawal by Subject|0
131776|NCT00808444|476466|P1|Overall Study|Withdrawal by Subject|1
131777|NCT00808249|476541|P4|Overall Study|All other reasons|1
131778|NCT00808249|476542|P3|Overall Study|All other reasons|3
131779|NCT00808249|476543|P2|Overall Study|All other reasons|1
131780|NCT00808249|476544|P1|Overall Study|All other reasons|2
131781|NCT00808249|476541|P4|Overall Study|study specific discontinuation criteria|0
131782|NCT00808249|476542|P3|Overall Study|study specific discontinuation criteria|1
131783|NCT00808249|476543|P2|Overall Study|study specific discontinuation criteria|0
131784|NCT00808249|476544|P1|Overall Study|study specific discontinuation criteria|1
131785|NCT00808249|476541|P4|Overall Study|Lack of Efficacy|0
131786|NCT00808249|476542|P3|Overall Study|Lack of Efficacy|0
131787|NCT00808249|476543|P2|Overall Study|Lack of Efficacy|1
131788|NCT00808249|476544|P1|Overall Study|Lack of Efficacy|1
131789|NCT00808249|476541|P4|Overall Study|Protocol Violation|0
131790|NCT00808249|476542|P3|Overall Study|Protocol Violation|3
131791|NCT00808249|476543|P2|Overall Study|Protocol Violation|3
131792|NCT00808249|476544|P1|Overall Study|Protocol Violation|3
131793|NCT00808249|476541|P4|Overall Study|Withdrawal by Subject|4
131794|NCT00808249|476542|P3|Overall Study|Withdrawal by Subject|2
131795|NCT00808249|476543|P2|Overall Study|Withdrawal by Subject|0
131796|NCT00808249|476544|P1|Overall Study|Withdrawal by Subject|4
131797|NCT00808249|476541|P4|Overall Study|Lost to Follow-up|5
131798|NCT00808249|476542|P3|Overall Study|Lost to Follow-up|3
131799|NCT00808249|476543|P2|Overall Study|Lost to Follow-up|3
131800|NCT00808249|476544|P1|Overall Study|Lost to Follow-up|2
131801|NCT00808249|476541|P4|Overall Study|Adverse Event|6
131802|NCT00808249|476542|P3|Overall Study|Adverse Event|10
131803|NCT00808249|476543|P2|Overall Study|Adverse Event|7
131804|NCT00808249|476544|P1|Overall Study|Adverse Event|4
131805|NCT00808236|476572|P2|Overall Study|Death|30
131806|NCT00808236|476573|P1|Overall Study|Death|18
131807|NCT00808236|476572|P2|Overall Study|Physician Decision|1
131808|NCT00808236|476573|P1|Overall Study|Physician Decision|0
131809|NCT00808236|476572|P2|Overall Study|Lost to Follow-up|1
131810|NCT00808236|476573|P1|Overall Study|Lost to Follow-up|1
131811|NCT00808236|476572|P2|Overall Study|Pre-defined exclusion|3
131812|NCT00808236|476573|P1|Overall Study|Pre-defined exclusion|13
131813|NCT00808236|476572|P2|Overall Study|Was not resuscitated|56
131814|NCT00808236|476573|P1|Overall Study|Was not resuscitated|50
131815|NCT00808132|476606|P5|Overall Study|Unsatisfactory response|12
131816|NCT00808132|476607|P4|Overall Study|Unsatisfactory response|4
131817|NCT00808132|476608|P3|Overall Study|Unsatisfactory response|6
131818|NCT00808132|476609|P2|Overall Study|Unsatisfactory response|6
131819|NCT00808132|476610|P1|Overall Study|Unsatisfactory response|5
131820|NCT00808132|476606|P5|Overall Study|Randomized, but not treated|9
131821|NCT00808132|476607|P4|Overall Study|Randomized, but not treated|8
131822|NCT00808132|476608|P3|Overall Study|Randomized, but not treated|9
131823|NCT00808132|476609|P2|Overall Study|Randomized, but not treated|7
131824|NCT00808132|476610|P1|Overall Study|Randomized, but not treated|10
131825|NCT00808132|476606|P5|Overall Study|Other|15
131826|NCT00808132|476607|P4|Overall Study|Other|2
131827|NCT00808132|476608|P3|Overall Study|Other|6
131828|NCT00808132|476609|P2|Overall Study|Other|4
131829|NCT00808132|476610|P1|Overall Study|Other|6
131830|NCT00808132|476606|P5|Overall Study|Withdrawal by Subject|16
131831|NCT00808132|476607|P4|Overall Study|Withdrawal by Subject|7
131832|NCT00808132|476608|P3|Overall Study|Withdrawal by Subject|2
131833|NCT00808132|476609|P2|Overall Study|Withdrawal by Subject|18
131834|NCT00808132|476610|P1|Overall Study|Withdrawal by Subject|27
131835|NCT00808132|476606|P5|Overall Study|Protocol Violation|5
131836|NCT00808132|476607|P4|Overall Study|Protocol Violation|9
131837|NCT00808132|476608|P3|Overall Study|Protocol Violation|4
131838|NCT00808132|476609|P2|Overall Study|Protocol Violation|9
131839|NCT00808132|476610|P1|Overall Study|Protocol Violation|8
131840|NCT00808132|476606|P5|Overall Study|Lost to Follow-up|9
131841|NCT00808132|476607|P4|Overall Study|Lost to Follow-up|8
131842|NCT00808132|476608|P3|Overall Study|Lost to Follow-up|11
131843|NCT00808132|476609|P2|Overall Study|Lost to Follow-up|10
131844|NCT00808132|476610|P1|Overall Study|Lost to Follow-up|8
131845|NCT00808132|476606|P5|Overall Study|Physician Decision|0
131846|NCT00808132|476607|P4|Overall Study|Physician Decision|0
131847|NCT00808132|476608|P3|Overall Study|Physician Decision|0
131848|NCT00808132|476609|P2|Overall Study|Physician Decision|1
131849|NCT00808132|476610|P1|Overall Study|Physician Decision|0
131850|NCT00808132|476606|P5|Overall Study|Death|1
131851|NCT00808132|476607|P4|Overall Study|Death|0
131852|NCT00808132|476608|P3|Overall Study|Death|0
131853|NCT00808132|476609|P2|Overall Study|Death|0
131854|NCT00808132|476610|P1|Overall Study|Death|0
131855|NCT00808132|476606|P5|Overall Study|Adverse Event|33
131856|NCT00808132|476607|P4|Overall Study|Adverse Event|31
131857|NCT00808132|476608|P3|Overall Study|Adverse Event|16
131858|NCT00808132|476609|P2|Overall Study|Adverse Event|33
131859|NCT00808132|476610|P1|Overall Study|Adverse Event|34
131860|NCT00808080|476682|P1|Overall Study|Patients Became Ineligible for infusion|6
131861|NCT00808067|476688|P2|Overall Study|Excluded from analysis|19
131862|NCT00808067|476689|P1|Overall Study|Excluded from analysis|13
131863|NCT00808067|476688|P2|Overall Study|Other reason not defined above|5
131864|NCT00808067|476689|P1|Overall Study|Other reason not defined above|5
131865|NCT00808067|476688|P2|Overall Study|Site closed for cause|19
131866|NCT00808067|476689|P1|Overall Study|Site closed for cause|19
131867|NCT00808067|476688|P2|Overall Study|Patient elected|9
131868|NCT00808067|476689|P1|Overall Study|Patient elected|7
131869|NCT00808067|476688|P2|Overall Study|Protocol Violation|11
131870|NCT00808067|476689|P1|Overall Study|Protocol Violation|3
131871|NCT00808067|476688|P2|Overall Study|Physician Decision|38
131872|NCT00808067|476689|P1|Overall Study|Physician Decision|47
131873|NCT00808067|476688|P2|Overall Study|Site closed|3
131874|NCT00808067|476689|P1|Overall Study|Site closed|4
131875|NCT00808067|476688|P2|Overall Study|Withdrawal by Subject|25
131876|NCT00808067|476689|P1|Overall Study|Withdrawal by Subject|21
131877|NCT00808067|476688|P2|Overall Study|Procedure|7
131878|NCT00808067|476689|P1|Overall Study|Procedure|6
131879|NCT00808067|476688|P2|Overall Study|Death|1
131880|NCT00808067|476689|P1|Overall Study|Death|1
131881|NCT00808067|476688|P2|Overall Study|Missing|0
131882|NCT00808067|476689|P1|Overall Study|Missing|1
131883|NCT00808067|476688|P2|Overall Study|Patient refused to take study medication|76
131884|NCT00808067|476689|P1|Overall Study|Patient refused to take study medication|65
131885|NCT00808067|476688|P2|Overall Study|Elevated LFT results|3
131886|NCT00808067|476689|P1|Overall Study|Elevated LFT results|7
131887|NCT00808067|476688|P2|Overall Study|Reduced creatinine clearance|55
131888|NCT00808067|476689|P1|Overall Study|Reduced creatinine clearance|53
131889|NCT00808067|476688|P2|Overall Study|Hospitalization due to surgery|40
131890|NCT00808067|476689|P1|Overall Study|Hospitalization due to surgery|37
131891|NCT00808067|476688|P2|Overall Study|Hospitalization (not including surgery)|17
131892|NCT00808067|476689|P1|Overall Study|Hospitalization (not including surgery)|18
131893|NCT00808067|476688|P2|Overall Study|Adverse Event|121
131894|NCT00808067|476689|P1|Overall Study|Adverse Event|111
131895|NCT00808067|476688|P2|Overall Study|Outcome event - other|25
131896|NCT00808067|476689|P1|Overall Study|Outcome event - other|33
131897|NCT00808067|476688|P2|Overall Study|Major/minor bleed|44
131898|NCT00808067|476689|P1|Overall Study|Major/minor bleed|30
131899|NCT00808028|476725|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
131900|NCT00808028|476726|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
131901|NCT00808028|476727|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
131902|NCT00808028|476728|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
131903|NCT00808028|476725|P4|Stage 2 (Followed up to 48 Months )|Death|0
131904|NCT00808028|476726|P3|Stage 2 (Followed up to 48 Months )|Death|1
131905|NCT00808028|476727|P2|Stage 2 (Followed up to 48 Months )|Death|0
131906|NCT00808028|476728|P1|Stage 2 (Followed up to 48 Months )|Death|0
131907|NCT00808028|476725|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
131908|NCT00808028|476726|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
131909|NCT00808028|476727|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
131910|NCT00808028|476728|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
131911|NCT00808028|476725|P4|Stage 2 (Followed up to 48 Months )|Other|1
131912|NCT00808028|476726|P3|Stage 2 (Followed up to 48 Months )|Other|1
131913|NCT00808028|476727|P2|Stage 2 (Followed up to 48 Months )|Other|0
131914|NCT00808028|476728|P1|Stage 2 (Followed up to 48 Months )|Other|0
131915|NCT00808028|476725|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
131916|NCT00808028|476726|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
131917|NCT00808028|476727|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
131918|NCT00808028|476728|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
131919|NCT00808028|476725|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
131920|NCT00808028|476726|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
131921|NCT00808028|476727|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
131922|NCT00808028|476728|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
131923|NCT00808028|476725|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
131924|NCT00808028|476726|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
131925|NCT00808028|476727|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
131926|NCT00808028|476728|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
131927|NCT00808028|476725|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
131928|NCT00808028|476726|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
131929|NCT00808028|476727|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
131930|NCT00808028|476728|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
131931|NCT00808028|476725|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
131932|NCT00808028|476726|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
131933|NCT00808028|476727|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
131934|NCT00808028|476728|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
131935|NCT00808028|476725|P4|Stage 1 (6 Months)|Protocol Violation|1
131936|NCT00808028|476726|P3|Stage 1 (6 Months)|Protocol Violation|0
131937|NCT00808028|476727|P2|Stage 1 (6 Months)|Protocol Violation|0
131938|NCT00808028|476728|P1|Stage 1 (6 Months)|Protocol Violation|0
131939|NCT00808028|476725|P4|Stage 1 (6 Months)|Lost to Follow-up|0
131940|NCT00808028|476726|P3|Stage 1 (6 Months)|Lost to Follow-up|1
131941|NCT00808028|476727|P2|Stage 1 (6 Months)|Lost to Follow-up|0
131942|NCT00808028|476728|P1|Stage 1 (6 Months)|Lost to Follow-up|1
131943|NCT00808028|476725|P4|Stage 1 (6 Months)|Adverse Event|2
131944|NCT00808028|476726|P3|Stage 1 (6 Months)|Adverse Event|1
131945|NCT00808028|476727|P2|Stage 1 (6 Months)|Adverse Event|0
131946|NCT00808028|476728|P1|Stage 1 (6 Months)|Adverse Event|0
131947|NCT00808028|476725|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
131948|NCT00808028|476726|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
131949|NCT00808028|476727|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
131950|NCT00808028|476728|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
131951|NCT00808028|476725|P4|Stage 1 (6 Months)|Other|4
131952|NCT00808028|476726|P3|Stage 1 (6 Months)|Other|2
131953|NCT00808028|476727|P2|Stage 1 (6 Months)|Other|0
131954|NCT00808028|476728|P1|Stage 1 (6 Months)|Other|1
131955|NCT00808028|476725|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
131956|NCT00808028|476726|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
131957|NCT00808028|476727|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
131958|NCT00808028|476728|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
131959|NCT00808015|476764|P1|Overall Study|Enrolled but not treated|4
131960|NCT00808015|476764|P1|Overall Study|Other|25
131961|NCT00808015|476764|P1|Overall Study|Adverse Event|22
131962|NCT00808015|476764|P1|Overall Study|Participants not willing to participate|158
131963|NCT00808015|476764|P1|Overall Study|Lost to Follow-up|76
131964|NCT00808015|476764|P1|Overall Study|Lack of Efficacy|58
131965|NCT00808015|476764|P1|Overall Study|Death|1
131966|NCT00807937|476793|P4|Overall Study|All other reasons (not provided)|1
131967|NCT00807937|476794|P3|Overall Study|All other reasons (not provided)|0
131968|NCT00807937|476795|P2|Overall Study|All other reasons (not provided)|4
131969|NCT00807937|476796|P1|Overall Study|All other reasons (not provided)|2
131970|NCT00807937|476793|P4|Overall Study|Intake of prohibited medicine|0
131971|NCT00807937|476794|P3|Overall Study|Intake of prohibited medicine|2
131972|NCT00807937|476795|P2|Overall Study|Intake of prohibited medicine|0
131973|NCT00807937|476796|P1|Overall Study|Intake of prohibited medicine|0
131974|NCT00807937|476793|P4|Overall Study|Lack of Efficacy|2
131975|NCT00807937|476794|P3|Overall Study|Lack of Efficacy|1
131976|NCT00807937|476795|P2|Overall Study|Lack of Efficacy|0
131977|NCT00807937|476796|P1|Overall Study|Lack of Efficacy|0
131978|NCT00807937|476793|P4|Overall Study|Lost to Follow-up|1
131979|NCT00807937|476794|P3|Overall Study|Lost to Follow-up|2
131980|NCT00807937|476795|P2|Overall Study|Lost to Follow-up|0
131981|NCT00807937|476796|P1|Overall Study|Lost to Follow-up|4
131982|NCT00807937|476793|P4|Overall Study|Withdrawal by Subject|4
131983|NCT00807937|476794|P3|Overall Study|Withdrawal by Subject|1
131984|NCT00807937|476795|P2|Overall Study|Withdrawal by Subject|4
131985|NCT00807937|476796|P1|Overall Study|Withdrawal by Subject|5
131986|NCT00807937|476793|P4|Overall Study|Protocol Violation|3
131987|NCT00807937|476794|P3|Overall Study|Protocol Violation|3
131988|NCT00807937|476795|P2|Overall Study|Protocol Violation|5
131989|NCT00807937|476796|P1|Overall Study|Protocol Violation|4
131990|NCT00807937|476793|P4|Overall Study|Adverse Event|4
131991|NCT00807937|476794|P3|Overall Study|Adverse Event|5
131992|NCT00807937|476795|P2|Overall Study|Adverse Event|12
131993|NCT00807937|476796|P1|Overall Study|Adverse Event|12
131994|NCT00807885|476831|P9|Overall Study|Lost to Follow-up|0
131995|NCT00807885|476832|P8|Overall Study|Lost to Follow-up|0
131996|NCT00807885|476833|P7|Overall Study|Lost to Follow-up|0
131997|NCT00807885|476834|P6|Overall Study|Lost to Follow-up|1
131998|NCT00807885|476835|P5|Overall Study|Lost to Follow-up|0
131999|NCT00807885|476836|P4|Overall Study|Lost to Follow-up|0
132000|NCT00807885|476837|P3|Overall Study|Lost to Follow-up|0
132001|NCT00807885|476838|P2|Overall Study|Lost to Follow-up|0
132002|NCT00807885|476839|P1|Overall Study|Lost to Follow-up|0
132003|NCT00807846|476888|P2|Overall Study|Not Specified|2
132004|NCT00807846|476889|P1|Overall Study|Not Specified|1
132005|NCT00807846|476888|P2|Overall Study|Withdrawal by Subject|1
132006|NCT00807846|476889|P1|Overall Study|Withdrawal by Subject|2
132007|NCT00807846|476888|P2|Overall Study|Protocol Violation|1
132008|NCT00807846|476889|P1|Overall Study|Protocol Violation|2
132009|NCT00807846|476888|P2|Overall Study|Lack of Efficacy|0
132010|NCT00807846|476889|P1|Overall Study|Lack of Efficacy|2
132011|NCT00807846|476888|P2|Overall Study|Adverse Event|0
132012|NCT00807846|476889|P1|Overall Study|Adverse Event|5
132013|NCT00807573|476953|P1|Overall Study|Adverse Event|1
132014|NCT00807573|476953|P1|Overall Study|Withdrawal by Subject|1
132015|NCT00807495|476999|P5|Overall Study|Reason Not Specified|3
132016|NCT00807495|477000|P4|Overall Study|Reason Not Specified|0
132017|NCT00807495|477001|P3|Overall Study|Reason Not Specified|2
132018|NCT00807495|477002|P2|Overall Study|Reason Not Specified|3
132019|NCT00807495|477003|P1|Overall Study|Reason Not Specified|0
132020|NCT00807495|476999|P5|Overall Study|Withdrawal by Patient|0
132021|NCT00807495|477000|P4|Overall Study|Withdrawal by Patient|0
132022|NCT00807495|477001|P3|Overall Study|Withdrawal by Patient|1
132023|NCT00807495|477002|P2|Overall Study|Withdrawal by Patient|0
132024|NCT00807495|477003|P1|Overall Study|Withdrawal by Patient|2
132025|NCT00807495|476999|P5|Overall Study|Adverse Event|2
132026|NCT00807495|477000|P4|Overall Study|Adverse Event|1
132027|NCT00807495|477001|P3|Overall Study|Adverse Event|1
132028|NCT00807495|477002|P2|Overall Study|Adverse Event|3
132029|NCT00807495|477003|P1|Overall Study|Adverse Event|6
132030|NCT00807365|477049|P1|Overall Study|Study Terminated|5
132031|NCT00807248|477057|P4|Overall Study|Other Reason|0
132032|NCT00807248|477058|P3|Overall Study|Other Reason|2
132033|NCT00807248|477059|P2|Overall Study|Other Reason|0
132034|NCT00807248|477060|P1|Overall Study|Other Reason|0
132035|NCT00807248|477057|P4|Overall Study|Lost to Follow-up|0
132036|NCT00807248|477058|P3|Overall Study|Lost to Follow-up|0
132037|NCT00807248|477059|P2|Overall Study|Lost to Follow-up|0
132038|NCT00807248|477060|P1|Overall Study|Lost to Follow-up|1
132039|NCT00807248|477057|P4|Overall Study|Withdrawal of Consent|5
132040|NCT00807248|477058|P3|Overall Study|Withdrawal of Consent|5
132041|NCT00807248|477059|P2|Overall Study|Withdrawal of Consent|5
132042|NCT00807248|477060|P1|Overall Study|Withdrawal of Consent|5
132043|NCT00807248|477057|P4|Overall Study|Protocol Violation|0
132044|NCT00807248|477058|P3|Overall Study|Protocol Violation|1
132045|NCT00807248|477059|P2|Overall Study|Protocol Violation|1
132046|NCT00807248|477060|P1|Overall Study|Protocol Violation|0
132047|NCT00807248|477057|P4|Overall Study|Lack of Efficacy|3
132048|NCT00807248|477058|P3|Overall Study|Lack of Efficacy|8
132049|NCT00807248|477059|P2|Overall Study|Lack of Efficacy|4
132050|NCT00807248|477060|P1|Overall Study|Lack of Efficacy|14
132051|NCT00807248|477057|P4|Overall Study|Adverse Event|6
132052|NCT00807248|477058|P3|Overall Study|Adverse Event|2
132053|NCT00807248|477059|P2|Overall Study|Adverse Event|2
132054|NCT00807248|477060|P1|Overall Study|Adverse Event|1
132055|NCT00807235|477104|P2|Overall Study|Adverse Event|0
132056|NCT00807235|477105|P1|Overall Study|Adverse Event|1
132057|NCT00807092|477150|P2|Overall Study|CGMS data collection failed|1
132058|NCT00807092|477151|P1|Overall Study|CGMS data collection failed|0
132059|NCT00807092|477150|P2|Overall Study|Withdrawal by Subject|0
132060|NCT00807092|477151|P1|Overall Study|Withdrawal by Subject|1
132061|NCT00807092|477150|P2|Overall Study|Protocol Violation|2
132062|NCT00807092|477151|P1|Overall Study|Protocol Violation|0
132063|NCT00807092|477150|P2|Overall Study|Adverse Event|1
132064|NCT00807092|477151|P1|Overall Study|Adverse Event|0
132065|NCT00807040|477181|P2|Overall Study|Lost to Follow-up|6
132066|NCT00807040|477182|P1|Overall Study|Lost to Follow-up|4
132067|NCT00807040|477181|P2|Overall Study|Withdrawal by Subject|6
132068|NCT00807040|477182|P1|Overall Study|Withdrawal by Subject|8
132069|NCT00807040|477181|P2|Overall Study|Death|29
132070|NCT00807040|477182|P1|Overall Study|Death|24
132071|NCT00807014|477192|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
132072|NCT00807014|477193|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
132073|NCT00807014|477192|P2|Overall Study|Recovery|0
132074|NCT00807014|477193|P1|Overall Study|Recovery|1
132075|NCT00807014|477192|P2|Overall Study|Lost to Follow-up|7
132076|NCT00807014|477193|P1|Overall Study|Lost to Follow-up|9
132077|NCT00807014|477192|P2|Overall Study|Adverse Event|2
132078|NCT00807014|477193|P1|Overall Study|Adverse Event|0
132079|NCT00807014|477192|P2|Overall Study|Protocol Violation|8
132080|NCT00807014|477193|P1|Overall Study|Protocol Violation|2
132081|NCT00807014|477192|P2|Overall Study|Participant Considered Disease Not Cured|7
132082|NCT00807014|477193|P1|Overall Study|Participant Considered Disease Not Cured|2
132083|NCT00807014|477192|P2|Overall Study|Participant Considered Disease Cured|2
132084|NCT00807014|477193|P1|Overall Study|Participant Considered Disease Cured|13
132085|NCT00807001|477224|P5|Overall Study|Non-compliance|0
132086|NCT00807001|477225|P4|Overall Study|Non-compliance|0
132087|NCT00807001|477226|P3|Overall Study|Non-compliance|0
132088|NCT00807001|477227|P2|Overall Study|Non-compliance|1
132089|NCT00807001|477228|P1|Overall Study|Non-compliance|0
132090|NCT00806988|477247|P2|Overall Study|Lost to Follow-up|19
132091|NCT00806988|477248|P1|Overall Study|Lost to Follow-up|4
132092|NCT00806988|477247|P2|Overall Study|Withdrawal by Subject|8
132093|NCT00806988|477248|P1|Overall Study|Withdrawal by Subject|8
132094|NCT00806988|477247|P2|Overall Study|Death|16
132095|NCT00806988|477248|P1|Overall Study|Death|15
132096|NCT00806819|477258|P2|Overall Study|Reasons other than stated above|41
132097|NCT00806819|477259|P1|Overall Study|Reasons other than stated above|25
132098|NCT00806819|477258|P2|Overall Study|Not treated|3
132099|NCT00806819|477259|P1|Overall Study|Not treated|6
132100|NCT00806819|477258|P2|Overall Study|Withdrawal by Subject|29
132101|NCT00806819|477259|P1|Overall Study|Withdrawal by Subject|32
132102|NCT00806819|477258|P2|Overall Study|Lost to Follow-up|0
132103|NCT00806819|477259|P1|Overall Study|Lost to Follow-up|1
132104|NCT00806819|477258|P2|Overall Study|Protocol Violation|4
132105|NCT00806819|477259|P1|Overall Study|Protocol Violation|9
132106|NCT00806819|477258|P2|Overall Study|Other AE|40
132107|NCT00806819|477259|P1|Overall Study|Other AE|38
132108|NCT00806819|477258|P2|Overall Study|Worsening or AE of underlying disease|25
132109|NCT00806819|477259|P1|Overall Study|Worsening or AE of underlying disease|18
132110|NCT00806819|477258|P2|Overall Study|progressive disease (modified RECIST )|216
132111|NCT00806819|477259|P1|Overall Study|progressive disease (modified RECIST )|217
132112|NCT00806624|477328|P3|Overall Study|discontinued before start of treatment|1
132113|NCT00806624|477329|P2|Overall Study|discontinued before start of treatment|0
132114|NCT00806624|477330|P1|Overall Study|discontinued before start of treatment|0
132115|NCT00806624|477328|P3|Overall Study|Withdrawal by Subject|3
132116|NCT00806624|477329|P2|Overall Study|Withdrawal by Subject|3
132117|NCT00806624|477330|P1|Overall Study|Withdrawal by Subject|6
132118|NCT00806624|477328|P3|Overall Study|Lost to Follow-up|1
132119|NCT00806624|477329|P2|Overall Study|Lost to Follow-up|0
132120|NCT00806624|477330|P1|Overall Study|Lost to Follow-up|1
132121|NCT00806624|477328|P3|Overall Study|Death|1
132122|NCT00806624|477329|P2|Overall Study|Death|1
132123|NCT00806624|477330|P1|Overall Study|Death|0
132124|NCT00806624|477328|P3|Overall Study|Adverse Event|0
132125|NCT00806624|477329|P2|Overall Study|Adverse Event|8
132126|NCT00806624|477330|P1|Overall Study|Adverse Event|2
132127|NCT00806585|477347|P5|Overall Study|Completion status unknown|12
132128|NCT00806585|477348|P4|Overall Study|Completion status unknown|4
132129|NCT00806585|477349|P3|Overall Study|Completion status unknown|12
132130|NCT00806585|477350|P2|Overall Study|Completion status unknown|14
132131|NCT00806585|477351|P1|Overall Study|Completion status unknown|15
132132|NCT00806585|477347|P5|Overall Study|Withdrawal by Subject|11
132133|NCT00806585|477348|P4|Overall Study|Withdrawal by Subject|3
132134|NCT00806585|477349|P3|Overall Study|Withdrawal by Subject|9
132135|NCT00806585|477350|P2|Overall Study|Withdrawal by Subject|8
132136|NCT00806585|477351|P1|Overall Study|Withdrawal by Subject|10
132137|NCT00806585|477347|P5|Overall Study|Adverse Event|2
132138|NCT00806585|477348|P4|Overall Study|Adverse Event|4
132139|NCT00806585|477349|P3|Overall Study|Adverse Event|3
132140|NCT00806585|477350|P2|Overall Study|Adverse Event|5
132141|NCT00806585|477351|P1|Overall Study|Adverse Event|1
132142|NCT00806585|477347|P5|Overall Study|Lack of Efficacy|0
132143|NCT00806585|477348|P4|Overall Study|Lack of Efficacy|0
132144|NCT00806585|477349|P3|Overall Study|Lack of Efficacy|0
132145|NCT00806585|477350|P2|Overall Study|Lack of Efficacy|0
132146|NCT00806585|477351|P1|Overall Study|Lack of Efficacy|1
132147|NCT00806585|477347|P5|Overall Study|Lost to Follow-up|5
132148|NCT00806585|477348|P4|Overall Study|Lost to Follow-up|2
132149|NCT00806585|477349|P3|Overall Study|Lost to Follow-up|2
132150|NCT00806585|477350|P2|Overall Study|Lost to Follow-up|1
132151|NCT00806585|477351|P1|Overall Study|Lost to Follow-up|2
132152|NCT00806585|477347|P5|Overall Study|Physician Decision|1
132153|NCT00806585|477348|P4|Overall Study|Physician Decision|0
132154|NCT00806585|477349|P3|Overall Study|Physician Decision|3
132155|NCT00806585|477350|P2|Overall Study|Physician Decision|2
132156|NCT00806585|477351|P1|Overall Study|Physician Decision|0
132157|NCT00806585|477347|P5|Overall Study|Protocol Violation|0
132158|NCT00806585|477348|P4|Overall Study|Protocol Violation|0
132159|NCT00806585|477349|P3|Overall Study|Protocol Violation|2
132160|NCT00806585|477350|P2|Overall Study|Protocol Violation|1
132161|NCT00806585|477351|P1|Overall Study|Protocol Violation|3
132162|NCT00806585|477347|P5|Overall Study|Study terminated by Sponsor|0
132163|NCT00806585|477348|P4|Overall Study|Study terminated by Sponsor|2
132164|NCT00806585|477349|P3|Overall Study|Study terminated by Sponsor|1
132165|NCT00806585|477350|P2|Overall Study|Study terminated by Sponsor|0
132166|NCT00806585|477351|P1|Overall Study|Study terminated by Sponsor|0
132167|NCT00806546|477383|P1|Overall Study|Various|42
132168|NCT00806546|477383|P1|Overall Study|Protocol Violation|49
132169|NCT00806546|477383|P1|Overall Study|Withdrawal by Subject|75
132170|NCT00806546|477383|P1|Overall Study|Adverse Event|74
132171|NCT00806546|477383|P1|Overall Study|Lost to Follow-up|32
132172|NCT00806546|477383|P1|Overall Study|Enrolled, not treated|35
132173|NCT00806494|477387|P1|Overall Study|Withdrawal by Subject|5
132174|NCT00806494|477387|P1|Overall Study|Other|30
132175|NCT00806494|477387|P1|Overall Study|Lost to Follow-up|10
132176|NCT00806494|477387|P1|Overall Study|Lack of Efficacy|6
132177|NCT00806494|477387|P1|Overall Study|Adverse Event|29
132178|NCT00806442|477411|P2|Overall Study|Withdrawal by Subject|5
132179|NCT00806442|477412|P1|Overall Study|Withdrawal by Subject|1
132180|NCT00806442|477411|P2|Overall Study|Lost to Follow-up|2
132181|NCT00806442|477412|P1|Overall Study|Lost to Follow-up|3
132182|NCT00806416|477434|P4|Period 1 - Part II|Withdrawal by Subject|2
132183|NCT00806416|477435|P3|Period 1 - Part II|Withdrawal by Subject|0
132184|NCT00806416|477436|P2|Period 1 - Part II|Withdrawal by Subject|0
132185|NCT00806416|477437|P1|Period 1 - Part II|Withdrawal by Subject|0
132186|NCT00806416|477434|P4|Period 1 - Part I|Withdrawal by Subject|0
132187|NCT00806416|477435|P3|Period 1 - Part I|Withdrawal by Subject|0
132188|NCT00806416|477436|P2|Period 1 - Part I|Withdrawal by Subject|1
132189|NCT00806416|477437|P1|Period 1 - Part I|Withdrawal by Subject|3
132190|NCT00806416|477434|P4|Period 1 - Part I|Lost to Follow-up|0
132191|NCT00806416|477435|P3|Period 1 - Part I|Lost to Follow-up|0
132192|NCT00806416|477436|P2|Period 1 - Part I|Lost to Follow-up|2
132193|NCT00806416|477437|P1|Period 1 - Part I|Lost to Follow-up|0
132194|NCT00806416|477434|P4|Period 1 - Part I|Adverse Event|0
132195|NCT00806416|477435|P3|Period 1 - Part I|Adverse Event|0
132196|NCT00806416|477436|P2|Period 1 - Part I|Adverse Event|1
132197|NCT00806416|477437|P1|Period 1 - Part I|Adverse Event|0
132198|NCT00806403|477450|P2|Overall Study|Death|3
132199|NCT00806403|477451|P1|Overall Study|Death|4
132200|NCT00806351|477474|P2|Overall Study|Death|4
132201|NCT00806351|477475|P1|Overall Study|Death|5
132202|NCT00806260|477512|P6|Period 3|Pregnancy|0
132203|NCT00806260|477513|P5|Period 3|Pregnancy|0
132204|NCT00806260|477514|P4|Period 3|Pregnancy|0
132205|NCT00806260|477515|P3|Period 3|Pregnancy|0
132206|NCT00806260|477516|P2|Period 3|Pregnancy|0
132207|NCT00806260|477517|P1|Period 3|Pregnancy|1
132208|NCT00806260|477512|P6|Period 3|Protocol Violation|0
132209|NCT00806260|477513|P5|Period 3|Protocol Violation|0
132210|NCT00806260|477514|P4|Period 3|Protocol Violation|0
132211|NCT00806260|477515|P3|Period 3|Protocol Violation|1
132212|NCT00806260|477516|P2|Period 3|Protocol Violation|1
132213|NCT00806260|477517|P1|Period 3|Protocol Violation|0
132214|NCT00806260|477512|P6|Period 2|sponsor request|0
132215|NCT00806260|477513|P5|Period 2|sponsor request|0
132216|NCT00806260|477514|P4|Period 2|sponsor request|1
132217|NCT00806260|477515|P3|Period 2|sponsor request|1
132218|NCT00806260|477516|P2|Period 2|sponsor request|0
132219|NCT00806260|477517|P1|Period 2|sponsor request|0
132220|NCT00806260|477512|P6|Period 2|Need to take concomitant medication|0
132221|NCT00806260|477513|P5|Period 2|Need to take concomitant medication|0
132222|NCT00806260|477514|P4|Period 2|Need to take concomitant medication|0
132223|NCT00806260|477515|P3|Period 2|Need to take concomitant medication|0
132224|NCT00806260|477516|P2|Period 2|Need to take concomitant medication|0
132225|NCT00806260|477517|P1|Period 2|Need to take concomitant medication|1
132226|NCT00806260|477512|P6|Period 2|Protocol Violation|0
132227|NCT00806260|477513|P5|Period 2|Protocol Violation|0
132228|NCT00806260|477514|P4|Period 2|Protocol Violation|0
132229|NCT00806260|477515|P3|Period 2|Protocol Violation|1
132230|NCT00806260|477516|P2|Period 2|Protocol Violation|0
132231|NCT00806260|477517|P1|Period 2|Protocol Violation|1
132232|NCT00806260|477512|P6|Period 2|Adverse Event|0
132233|NCT00806260|477513|P5|Period 2|Adverse Event|0
132234|NCT00806260|477514|P4|Period 2|Adverse Event|1
132235|NCT00806260|477515|P3|Period 2|Adverse Event|0
132236|NCT00806260|477516|P2|Period 2|Adverse Event|0
132237|NCT00806260|477517|P1|Period 2|Adverse Event|0
132238|NCT00806260|477512|P6|Period 1 (1 Day)|Adverse Event|0
132239|NCT00806260|477513|P5|Period 1 (1 Day)|Adverse Event|3
132240|NCT00806260|477514|P4|Period 1 (1 Day)|Adverse Event|0
132241|NCT00806260|477515|P3|Period 1 (1 Day)|Adverse Event|0
132242|NCT00806260|477516|P2|Period 1 (1 Day)|Adverse Event|0
132243|NCT00806260|477517|P1|Period 1 (1 Day)|Adverse Event|0
132244|NCT00806195|477562|P4|Overall Study|Protocol Violation|9
132245|NCT00806195|477563|P3|Overall Study|Protocol Violation|26
132246|NCT00806195|477564|P2|Overall Study|Protocol Violation|24
132247|NCT00806195|477565|P1|Overall Study|Protocol Violation|34
132248|NCT00806195|477562|P4|Overall Study|Administrative Reason|26
132249|NCT00806195|477563|P3|Overall Study|Administrative Reason|66
132250|NCT00806195|477564|P2|Overall Study|Administrative Reason|35
132251|NCT00806195|477565|P1|Overall Study|Administrative Reason|113
132252|NCT00806195|477562|P4|Overall Study|Inappropriate Enrollment|0
132253|NCT00806195|477563|P3|Overall Study|Inappropriate Enrollment|0
132254|NCT00806195|477564|P2|Overall Study|Inappropriate Enrollment|1
132255|NCT00806195|477565|P1|Overall Study|Inappropriate Enrollment|0
132256|NCT00806195|477562|P4|Overall Study|Lost to Follow-up|34
132257|NCT00806195|477563|P3|Overall Study|Lost to Follow-up|90
132258|NCT00806195|477564|P2|Overall Study|Lost to Follow-up|66
132259|NCT00806195|477565|P1|Overall Study|Lost to Follow-up|217
132260|NCT00806195|477562|P4|Overall Study|Withdrawal by Subject|35
132261|NCT00806195|477563|P3|Overall Study|Withdrawal by Subject|76
132262|NCT00806195|477564|P2|Overall Study|Withdrawal by Subject|31
132263|NCT00806195|477565|P1|Overall Study|Withdrawal by Subject|119
132264|NCT00806195|477562|P4|Overall Study|Adverse Event|2
132265|NCT00806195|477563|P3|Overall Study|Adverse Event|11
132266|NCT00806195|477564|P2|Overall Study|Adverse Event|5
132267|NCT00806195|477565|P1|Overall Study|Adverse Event|25
132268|NCT00806195|477562|P4|Overall Study|Death|0
132269|NCT00806195|477563|P3|Overall Study|Death|1
132270|NCT00806195|477564|P2|Overall Study|Death|0
132271|NCT00806195|477565|P1|Overall Study|Death|6
132272|NCT00806026|477596|P6|Overall Study|Adverse Event|9
132273|NCT00806026|477597|P5|Overall Study|Adverse Event|9
132274|NCT00806026|477598|P4|Overall Study|Adverse Event|17
132275|NCT00806026|477599|P3|Overall Study|Adverse Event|44
132276|NCT00806026|477600|P2|Overall Study|Adverse Event|35
132277|NCT00806026|477601|P1|Overall Study|Adverse Event|52
132278|NCT00806026|477596|P6|Overall Study|Protocol Violation|3
132279|NCT00806026|477597|P5|Overall Study|Protocol Violation|2
132280|NCT00806026|477598|P4|Overall Study|Protocol Violation|0
132281|NCT00806026|477599|P3|Overall Study|Protocol Violation|9
132282|NCT00806026|477600|P2|Overall Study|Protocol Violation|9
132283|NCT00806026|477601|P1|Overall Study|Protocol Violation|6
132284|NCT00806026|477596|P6|Overall Study|Other|4
132285|NCT00806026|477597|P5|Overall Study|Other|0
132286|NCT00806026|477598|P4|Overall Study|Other|2
132287|NCT00806026|477599|P3|Overall Study|Other|8
132288|NCT00806026|477600|P2|Overall Study|Other|6
132289|NCT00806026|477601|P1|Overall Study|Other|3
132290|NCT00806026|477596|P6|Overall Study|Withdrawal by Subject|3
132291|NCT00806026|477597|P5|Overall Study|Withdrawal by Subject|5
132292|NCT00806026|477598|P4|Overall Study|Withdrawal by Subject|2
132293|NCT00806026|477599|P3|Overall Study|Withdrawal by Subject|9
132294|NCT00806026|477600|P2|Overall Study|Withdrawal by Subject|17
132295|NCT00806026|477601|P1|Overall Study|Withdrawal by Subject|14
132296|NCT00806026|477596|P6|Overall Study|Lost to Follow-up|6
132297|NCT00806026|477597|P5|Overall Study|Lost to Follow-up|6
132298|NCT00806026|477598|P4|Overall Study|Lost to Follow-up|2
132299|NCT00806026|477599|P3|Overall Study|Lost to Follow-up|8
132300|NCT00806026|477600|P2|Overall Study|Lost to Follow-up|15
132301|NCT00806026|477601|P1|Overall Study|Lost to Follow-up|8
132302|NCT00806026|477596|P6|Overall Study|Lack of Efficacy|7
132303|NCT00806026|477597|P5|Overall Study|Lack of Efficacy|8
132304|NCT00806026|477598|P4|Overall Study|Lack of Efficacy|4
132305|NCT00806026|477599|P3|Overall Study|Lack of Efficacy|13
132306|NCT00806026|477600|P2|Overall Study|Lack of Efficacy|18
132307|NCT00806026|477601|P1|Overall Study|Lack of Efficacy|5
132308|NCT00806026|477596|P6|Overall Study|Did not meet entrance criteria|0
132309|NCT00806026|477597|P5|Overall Study|Did not meet entrance criteria|0
132310|NCT00806026|477598|P4|Overall Study|Did not meet entrance criteria|1
132311|NCT00806026|477599|P3|Overall Study|Did not meet entrance criteria|2
132312|NCT00806026|477600|P2|Overall Study|Did not meet entrance criteria|1
132313|NCT00806026|477601|P1|Overall Study|Did not meet entrance criteria|4
132314|NCT00806026|477596|P6|Overall Study|Death|0
132315|NCT00806026|477597|P5|Overall Study|Death|0
132316|NCT00806026|477598|P4|Overall Study|Death|1
132317|NCT00806026|477599|P3|Overall Study|Death|0
132318|NCT00806026|477600|P2|Overall Study|Death|0
132319|NCT00806026|477601|P1|Overall Study|Death|0
132320|NCT00805961|477696|P1|Maintenance Treatment|Withdrawn Consent|1
132321|NCT00805961|477696|P1|Maintenance Treatment|Symptomatic Deterioration|2
132322|NCT00805961|477696|P1|Maintenance Treatment|Withdrawal by Subject|5
132323|NCT00805961|477696|P1|Maintenance Treatment|Adverse Event|6
132324|NCT00805961|477696|P1|Maintenance Treatment|Intercurrent Illness|7
132325|NCT00805961|477696|P1|Maintenance Treatment|Lack of Efficacy|13
132326|NCT00805961|477696|P1|Treatment-Free Interval|Lack of Efficacy|1
132327|NCT00805961|477696|P1|Treatment-Free Interval|Physician Decision|1
132328|NCT00805961|477696|P1|Treatment-Free Interval|Intercurrent Illness|2
132329|NCT00805961|477696|P1|Treatment-Free Interval|Adverse Event|3
132330|NCT00805961|477696|P1|Modality Therapy|Disease Progression|2
132331|NCT00805961|477696|P1|Modality Therapy|Adverse Event|1
132332|NCT00805961|477696|P1|Modality Therapy|Withdrawal by Subject|1
132333|NCT00805935|477706|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
132334|NCT00805935|477707|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
132335|NCT00805935|477708|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
132336|NCT00805935|477709|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
132337|NCT00805935|477706|P4|Overall Study|Ectopic pregnancy|0
132338|NCT00805935|477707|P3|Overall Study|Ectopic pregnancy|1
132339|NCT00805935|477708|P2|Overall Study|Ectopic pregnancy|0
132340|NCT00805935|477709|P1|Overall Study|Ectopic pregnancy|0
132341|NCT00805935|477706|P4|Overall Study|Chemical pregnancy|2
132342|NCT00805935|477707|P3|Overall Study|Chemical pregnancy|3
132343|NCT00805935|477708|P2|Overall Study|Chemical pregnancy|5
132344|NCT00805935|477709|P1|Overall Study|Chemical pregnancy|0
132345|NCT00805935|477706|P4|Overall Study|Biochemical pregnancy|0
132346|NCT00805935|477707|P3|Overall Study|Biochemical pregnancy|0
132347|NCT00805935|477708|P2|Overall Study|Biochemical pregnancy|1
132348|NCT00805935|477709|P1|Overall Study|Biochemical pregnancy|0
132349|NCT00805935|477706|P4|Overall Study|Pregnancy loss/miscarriage|0
132350|NCT00805935|477707|P3|Overall Study|Pregnancy loss/miscarriage|0
132351|NCT00805935|477708|P2|Overall Study|Pregnancy loss/miscarriage|0
132352|NCT00805935|477709|P1|Overall Study|Pregnancy loss/miscarriage|2
132353|NCT00805935|477706|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
132354|NCT00805935|477707|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
132355|NCT00805935|477708|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
132356|NCT00805935|477709|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
132357|NCT00805935|477706|P4|Overall Study|No positive serum pregnancy|5
132358|NCT00805935|477707|P3|Overall Study|No positive serum pregnancy|6
132359|NCT00805935|477708|P2|Overall Study|No positive serum pregnancy|7
132360|NCT00805935|477709|P1|Overall Study|No positive serum pregnancy|8
132361|NCT00805935|477706|P4|Overall Study|Lost to Follow-up|0
132362|NCT00805935|477707|P3|Overall Study|Lost to Follow-up|0
132363|NCT00805935|477708|P2|Overall Study|Lost to Follow-up|0
132364|NCT00805935|477709|P1|Overall Study|Lost to Follow-up|1
132365|NCT00805935|477706|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
132366|NCT00805935|477707|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
132367|NCT00805935|477708|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
132458|NCT00805441|477942|P2|Overall Study|Protocol Violation|8
132368|NCT00805935|477709|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
132369|NCT00805935|477706|P4|Overall Study|Cycle cancellation for risk of OHSS|0
132370|NCT00805935|477707|P3|Overall Study|Cycle cancellation for risk of OHSS|1
132371|NCT00805935|477708|P2|Overall Study|Cycle cancellation for risk of OHSS|0
132372|NCT00805935|477709|P1|Overall Study|Cycle cancellation for risk of OHSS|1
132373|NCT00805935|477706|P4|Overall Study|Cycle cancelled|0
132374|NCT00805935|477707|P3|Overall Study|Cycle cancelled|2
132375|NCT00805935|477708|P2|Overall Study|Cycle cancelled|0
132376|NCT00805935|477709|P1|Overall Study|Cycle cancelled|0
132377|NCT00805935|477706|P4|Overall Study|Stimulation Failure|2
132378|NCT00805935|477707|P3|Overall Study|Stimulation Failure|2
132379|NCT00805935|477708|P2|Overall Study|Stimulation Failure|5
132380|NCT00805935|477709|P1|Overall Study|Stimulation Failure|1
132381|NCT00805792|477776|P1|Overall Study|Lost to Follow-up|2
132382|NCT00805792|477776|P1|Overall Study|Death|3
132383|NCT00805766|477784|P1|Increased Dose Period|Withdrawal by Subject|1
132384|NCT00805766|477784|P1|Increased Dose Period|Pregnancy|1
132385|NCT00805766|477784|P1|Increased Dose Period|Lack of Efficacy|7
132386|NCT00805766|477784|P1|Increased Dose Period|Adverse Event|4
132387|NCT00805766|477784|P1|Screening Period|Responder|2
132388|NCT00805766|477784|P1|Screening Period|Pregnancy|1
132389|NCT00805766|477784|P1|Screening Period|Lack of Efficacy|2
132390|NCT00805766|477784|P1|Screening Period|Adverse Event|1
132391|NCT00805740|477798|P2|Overall Study|Randomized, but not treated|0
132392|NCT00805740|477799|P1|Overall Study|Randomized, but not treated|2
132393|NCT00805740|477798|P2|Overall Study|Lost to Follow-up|0
132394|NCT00805740|477799|P1|Overall Study|Lost to Follow-up|1
132395|NCT00805740|477798|P2|Overall Study|Withdrawal by Subject|0
132396|NCT00805740|477799|P1|Overall Study|Withdrawal by Subject|1
132397|NCT00805740|477798|P2|Overall Study|Death|4
132398|NCT00805740|477799|P1|Overall Study|Death|7
132399|NCT00805675|477824|P3|Overall Study|Adverse Event|1
132400|NCT00805675|477825|P2|Overall Study|Adverse Event|0
132401|NCT00805675|477826|P1|Overall Study|Adverse Event|0
132402|NCT00805545|477860|P2|Overall Study|Protocol Violation|1
132403|NCT00805545|477861|P1|Overall Study|Protocol Violation|3
132404|NCT00805545|477860|P2|Overall Study|Protocol Violation|2
132405|NCT00805545|477861|P1|Overall Study|Protocol Violation|3
132406|NCT00805480|477887|P4|Overall Study|Adverse Event|0
132407|NCT00805480|477888|P3|Overall Study|Adverse Event|1
132408|NCT00805480|477889|P2|Overall Study|Adverse Event|0
132409|NCT00805480|477890|P1|Overall Study|Adverse Event|0
132410|NCT00805480|477887|P4|Overall Study|Lost to Follow-up|0
132411|NCT00805480|477888|P3|Overall Study|Lost to Follow-up|0
132412|NCT00805480|477889|P2|Overall Study|Lost to Follow-up|2
132413|NCT00805480|477890|P1|Overall Study|Lost to Follow-up|1
132414|NCT00805480|477887|P4|Overall Study|Withdrawal by Subject|5
132415|NCT00805480|477888|P3|Overall Study|Withdrawal by Subject|11
132416|NCT00805480|477889|P2|Overall Study|Withdrawal by Subject|5
132417|NCT00805480|477890|P1|Overall Study|Withdrawal by Subject|13
132418|NCT00805467|477919|P4|Overall Study|Not reported|7
132419|NCT00805467|477920|P3|Overall Study|Not reported|3
132420|NCT00805467|477921|P2|Overall Study|Not reported|0
132421|NCT00805467|477922|P1|Overall Study|Not reported|0
132422|NCT00805467|477919|P4|Overall Study|Physician Decision|6
132423|NCT00805467|477920|P3|Overall Study|Physician Decision|2
132424|NCT00805467|477921|P2|Overall Study|Physician Decision|1
132425|NCT00805467|477922|P1|Overall Study|Physician Decision|0
132426|NCT00805467|477919|P4|Overall Study|Death|5
132427|NCT00805467|477920|P3|Overall Study|Death|7
132428|NCT00805467|477921|P2|Overall Study|Death|2
132429|NCT00805467|477922|P1|Overall Study|Death|0
132430|NCT00805467|477919|P4|Overall Study|Adverse Event|57
132431|NCT00805467|477920|P3|Overall Study|Adverse Event|26
132432|NCT00805467|477921|P2|Overall Study|Adverse Event|13
132433|NCT00805467|477922|P1|Overall Study|Adverse Event|0
132434|NCT00805467|477919|P4|Overall Study|Protocol Violation|5
132435|NCT00805467|477920|P3|Overall Study|Protocol Violation|0
132436|NCT00805467|477921|P2|Overall Study|Protocol Violation|3
132437|NCT00805467|477922|P1|Overall Study|Protocol Violation|0
132438|NCT00805467|477919|P4|Overall Study|Withdrawal by Subject|50
132439|NCT00805467|477920|P3|Overall Study|Withdrawal by Subject|45
132440|NCT00805467|477921|P2|Overall Study|Withdrawal by Subject|6
132441|NCT00805467|477922|P1|Overall Study|Withdrawal by Subject|0
132442|NCT00805467|477919|P4|Overall Study|Lost to Follow-up|21
132443|NCT00805467|477920|P3|Overall Study|Lost to Follow-up|7
132444|NCT00805467|477921|P2|Overall Study|Lost to Follow-up|1
132445|NCT00805467|477922|P1|Overall Study|Lost to Follow-up|0
132446|NCT00805467|477919|P4|Overall Study|Lack of Efficacy|86
132447|NCT00805467|477920|P3|Overall Study|Lack of Efficacy|13
132448|NCT00805467|477921|P2|Overall Study|Lack of Efficacy|8
132449|NCT00805467|477922|P1|Overall Study|Lack of Efficacy|0
132450|NCT00805441|477942|P2|Overall Study|Acute Alcohol Withdrawal|1
132451|NCT00805441|477943|P1|Overall Study|Acute Alcohol Withdrawal|0
132452|NCT00805441|477942|P2|Overall Study|Physician Decision|1
132453|NCT00805441|477943|P1|Overall Study|Physician Decision|0
132454|NCT00805441|477942|P2|Overall Study|Withdrawal by Subject|9
132455|NCT00805441|477943|P1|Overall Study|Withdrawal by Subject|15
132456|NCT00805441|477942|P2|Overall Study|Lost to Follow-up|13
132457|NCT00805441|477943|P1|Overall Study|Lost to Follow-up|10
132459|NCT00805441|477943|P1|Overall Study|Protocol Violation|4
132460|NCT00805441|477942|P2|Overall Study|Lack of Efficacy|2
132461|NCT00805441|477943|P1|Overall Study|Lack of Efficacy|0
132462|NCT00805441|477942|P2|Overall Study|Adverse Event|2
132463|NCT00805441|477943|P1|Overall Study|Adverse Event|5
132464|NCT00805389|477978|P5|Overall Study|Withdrawal by Subject|4
132465|NCT00805389|477979|P4|Overall Study|Withdrawal by Subject|5
132466|NCT00805389|477980|P3|Overall Study|Withdrawal by Subject|4
132467|NCT00805389|477981|P2|Overall Study|Withdrawal by Subject|2
132468|NCT00805389|477982|P1|Overall Study|Withdrawal by Subject|3
132469|NCT00805389|477978|P5|Overall Study|Protocol Violation|0
132470|NCT00805389|477979|P4|Overall Study|Protocol Violation|0
132471|NCT00805389|477980|P3|Overall Study|Protocol Violation|1
132472|NCT00805389|477981|P2|Overall Study|Protocol Violation|0
132473|NCT00805389|477982|P1|Overall Study|Protocol Violation|0
132474|NCT00805389|477978|P5|Overall Study|Lost to Follow-up|9
132475|NCT00805389|477979|P4|Overall Study|Lost to Follow-up|10
132476|NCT00805389|477980|P3|Overall Study|Lost to Follow-up|6
132477|NCT00805389|477981|P2|Overall Study|Lost to Follow-up|3
132478|NCT00805389|477982|P1|Overall Study|Lost to Follow-up|4
132479|NCT00805389|477978|P5|Overall Study|Adverse Event|0
132480|NCT00805389|477979|P4|Overall Study|Adverse Event|2
132481|NCT00805389|477980|P3|Overall Study|Adverse Event|1
132482|NCT00805389|477981|P2|Overall Study|Adverse Event|0
132483|NCT00805389|477982|P1|Overall Study|Adverse Event|0
132484|NCT00805285|478224|P1|Overall Study|Lack of Efficacy|1
132485|NCT00805194|478234|P2|Overall Study|Reasons other than stated above|16
132486|NCT00805194|478235|P1|Overall Study|Reasons other than stated above|20
132487|NCT00805194|478234|P2|Overall Study|Not treated|4
132488|NCT00805194|478235|P1|Overall Study|Not treated|3
132489|NCT00805194|478234|P2|Overall Study|Withdrawal by Subject|42
132490|NCT00805194|478235|P1|Overall Study|Withdrawal by Subject|60
132491|NCT00805194|478234|P2|Overall Study|Lost to Follow-up|5
132492|NCT00805194|478235|P1|Overall Study|Lost to Follow-up|5
132493|NCT00805194|478234|P2|Overall Study|Protocol Violation|9
132494|NCT00805194|478235|P1|Overall Study|Protocol Violation|9
132495|NCT00805194|478234|P2|Overall Study|Other AE|73
132496|NCT00805194|478235|P1|Overall Study|Other AE|84
132497|NCT00805194|478234|P2|Overall Study|Worsening or AE of underlying disease|70
132498|NCT00805194|478235|P1|Overall Study|Worsening or AE of underlying disease|64
132499|NCT00805194|478234|P2|Overall Study|Progressive disease (modified RECIST)|435
132500|NCT00805194|478235|P1|Overall Study|Progressive disease (modified RECIST)|404
132501|NCT00805142|478269|P2|Maintenance Period|Other|1
132502|NCT00805142|478270|P1|Maintenance Period|Other|0
132503|NCT00805142|478269|P2|Maintenance Period|Adverse Event|1
132504|NCT00805142|478270|P1|Maintenance Period|Adverse Event|0
132505|NCT00805142|478269|P2|Titration Period|Other|3
132506|NCT00805142|478270|P1|Titration Period|Other|0
132507|NCT00805142|478269|P2|Titration Period|Withdrawal of consent|1
132508|NCT00805142|478270|P1|Titration Period|Withdrawal of consent|0
132509|NCT00805142|478269|P2|Titration Period|Disease Progression|1
132510|NCT00805142|478270|P1|Titration Period|Disease Progression|2
132511|NCT00805142|478269|P2|Titration Period|Lost to Follow-up|1
132512|NCT00805142|478270|P1|Titration Period|Lost to Follow-up|0
132513|NCT00805142|478269|P2|Titration Period|Lack of Efficacy|1
132514|NCT00805142|478270|P1|Titration Period|Lack of Efficacy|1
132515|NCT00805142|478269|P2|Titration Period|Adverse Event|3
132516|NCT00805142|478270|P1|Titration Period|Adverse Event|3
132517|NCT00805025|478303|P1|Overall Study|Physician Decision|1
132518|NCT00805025|478303|P1|Overall Study|Withdrawal by Subject|2
132519|NCT00805025|478303|P1|Overall Study|Adverse Event|4
132520|NCT00805025|478303|P1|Overall Study|Screened but not enrolled/treated|42
132521|NCT00804986|478332|P6|Overall Study|Physician Decision|0
132522|NCT00804986|478333|P5|Overall Study|Physician Decision|0
132523|NCT00804986|478334|P4|Overall Study|Physician Decision|0
132524|NCT00804986|478335|P3|Overall Study|Physician Decision|0
132525|NCT00804986|478336|P2|Overall Study|Physician Decision|0
132526|NCT00804986|478337|P1|Overall Study|Physician Decision|1
132527|NCT00804986|478332|P6|Overall Study|Sponsor Decision|0
132528|NCT00804986|478333|P5|Overall Study|Sponsor Decision|0
132529|NCT00804986|478334|P4|Overall Study|Sponsor Decision|0
132530|NCT00804986|478335|P3|Overall Study|Sponsor Decision|0
132531|NCT00804986|478336|P2|Overall Study|Sponsor Decision|1
132532|NCT00804986|478337|P1|Overall Study|Sponsor Decision|0
132533|NCT00804986|478332|P6|Overall Study|Inclusion/Exclusion criteria not met|1
132534|NCT00804986|478333|P5|Overall Study|Inclusion/Exclusion criteria not met|0
132535|NCT00804986|478334|P4|Overall Study|Inclusion/Exclusion criteria not met|1
132536|NCT00804986|478335|P3|Overall Study|Inclusion/Exclusion criteria not met|0
132537|NCT00804986|478336|P2|Overall Study|Inclusion/Exclusion criteria not met|2
132538|NCT00804986|478337|P1|Overall Study|Inclusion/Exclusion criteria not met|0
132539|NCT00804986|478332|P6|Overall Study|Withdrawal by Subject|3
132540|NCT00804986|478333|P5|Overall Study|Withdrawal by Subject|5
132541|NCT00804986|478334|P4|Overall Study|Withdrawal by Subject|3
132542|NCT00804986|478335|P3|Overall Study|Withdrawal by Subject|0
132543|NCT00804986|478336|P2|Overall Study|Withdrawal by Subject|3
132544|NCT00804986|478337|P1|Overall Study|Withdrawal by Subject|0
132545|NCT00804986|478332|P6|Overall Study|Protocol Violation|0
132546|NCT00804986|478333|P5|Overall Study|Protocol Violation|0
132547|NCT00804986|478334|P4|Overall Study|Protocol Violation|1
132548|NCT00804986|478335|P3|Overall Study|Protocol Violation|0
132549|NCT00804986|478336|P2|Overall Study|Protocol Violation|1
132550|NCT00804986|478337|P1|Overall Study|Protocol Violation|0
132551|NCT00804986|478332|P6|Overall Study|Lost to Follow-up|3
132552|NCT00804986|478333|P5|Overall Study|Lost to Follow-up|1
132553|NCT00804986|478334|P4|Overall Study|Lost to Follow-up|1
132554|NCT00804986|478335|P3|Overall Study|Lost to Follow-up|0
132555|NCT00804986|478336|P2|Overall Study|Lost to Follow-up|0
132556|NCT00804986|478337|P1|Overall Study|Lost to Follow-up|0
132557|NCT00804986|478332|P6|Overall Study|Lack of Efficacy|3
132558|NCT00804986|478333|P5|Overall Study|Lack of Efficacy|0
132559|NCT00804986|478334|P4|Overall Study|Lack of Efficacy|1
132560|NCT00804986|478335|P3|Overall Study|Lack of Efficacy|0
132561|NCT00804986|478336|P2|Overall Study|Lack of Efficacy|0
132562|NCT00804986|478337|P1|Overall Study|Lack of Efficacy|0
132563|NCT00804986|478332|P6|Overall Study|Adverse Event|0
132564|NCT00804986|478333|P5|Overall Study|Adverse Event|3
132565|NCT00804986|478334|P4|Overall Study|Adverse Event|1
132566|NCT00804986|478335|P3|Overall Study|Adverse Event|2
132567|NCT00804986|478336|P2|Overall Study|Adverse Event|1
132568|NCT00804986|478337|P1|Overall Study|Adverse Event|0
132569|NCT00804908|478432|P3|Overall Study|Not specified|114
132570|NCT00804908|478433|P2|Overall Study|Not specified|116
132571|NCT00804908|478434|P1|Overall Study|Not specified|115
132572|NCT00804843|478465|P2|Overall Study|Withdrawal by Subject|2
132573|NCT00804843|478466|P1|Overall Study|Withdrawal by Subject|1
132574|NCT00804843|478465|P2|Overall Study|Adverse Event|5
132575|NCT00804843|478466|P1|Overall Study|Adverse Event|8
132576|NCT00804843|478465|P2|Overall Study|Protocol Violation|0
132577|NCT00804843|478466|P1|Overall Study|Protocol Violation|1
132578|NCT00804687|478484|P6|Period 5: Treatment Period|Positive drug test|0
132579|NCT00804687|478485|P5|Period 5: Treatment Period|Positive drug test|0
132580|NCT00804687|478486|P4|Period 5: Treatment Period|Positive drug test|0
132581|NCT00804687|478487|P3|Period 5: Treatment Period|Positive drug test|0
132582|NCT00804687|478488|P2|Period 5: Treatment Period|Positive drug test|0
132583|NCT00804687|478489|P1|Period 5: Treatment Period|Positive drug test|1
132584|NCT00804687|478484|P6|Period 5: Treatment Period|Positive drugs of abuse|0
132585|NCT00804687|478485|P5|Period 5: Treatment Period|Positive drugs of abuse|0
132586|NCT00804687|478486|P4|Period 5: Treatment Period|Positive drugs of abuse|0
132587|NCT00804687|478487|P3|Period 5: Treatment Period|Positive drugs of abuse|1
132588|NCT00804687|478488|P2|Period 5: Treatment Period|Positive drugs of abuse|0
132589|NCT00804687|478489|P1|Period 5: Treatment Period|Positive drugs of abuse|0
132590|NCT00804687|478484|P6|Period 5: Treatment Period|Withdrawal by Subject|0
132591|NCT00804687|478485|P5|Period 5: Treatment Period|Withdrawal by Subject|1
132592|NCT00804687|478486|P4|Period 5: Treatment Period|Withdrawal by Subject|0
132593|NCT00804687|478487|P3|Period 5: Treatment Period|Withdrawal by Subject|0
132594|NCT00804687|478488|P2|Period 5: Treatment Period|Withdrawal by Subject|0
132595|NCT00804687|478489|P1|Period 5: Treatment Period|Withdrawal by Subject|0
132596|NCT00804687|478484|P6|Period 3: Treatment Period|Positive Drug screen|0
132597|NCT00804687|478485|P5|Period 3: Treatment Period|Positive Drug screen|0
132598|NCT00804687|478486|P4|Period 3: Treatment Period|Positive Drug screen|1
132599|NCT00804687|478487|P3|Period 3: Treatment Period|Positive Drug screen|0
132600|NCT00804687|478488|P2|Period 3: Treatment Period|Positive Drug screen|0
132601|NCT00804687|478489|P1|Period 3: Treatment Period|Positive Drug screen|0
132602|NCT00804570|478568|P2|Overall Study|Withdrawal by Subject|38
132603|NCT00804570|478569|P1|Overall Study|Withdrawal by Subject|21
132604|NCT00804570|478568|P2|Overall Study|Sponsor decision|4
132605|NCT00804570|478569|P1|Overall Study|Sponsor decision|1
132606|NCT00804570|478568|P2|Overall Study|Physician Decision|2
132607|NCT00804570|478569|P1|Overall Study|Physician Decision|1
132608|NCT00804570|478568|P2|Overall Study|Protocol Violation|16
132609|NCT00804570|478569|P1|Overall Study|Protocol Violation|12
132610|NCT00804570|478568|P2|Overall Study|Entry criteria not met|5
132611|NCT00804570|478569|P1|Overall Study|Entry criteria not met|5
132612|NCT00804570|478568|P2|Overall Study|Lost to Follow-up|21
132613|NCT00804570|478569|P1|Overall Study|Lost to Follow-up|18
132614|NCT00804570|478568|P2|Overall Study|Lack of Efficacy|1
132615|NCT00804570|478569|P1|Overall Study|Lack of Efficacy|0
132616|NCT00804570|478568|P2|Overall Study|Adverse Event|7
132617|NCT00804570|478569|P1|Overall Study|Adverse Event|14
132618|NCT00804193|478628|P3|Overall Study|Withdrawal by Subject|2
132619|NCT00804193|478629|P2|Overall Study|Withdrawal by Subject|1
132620|NCT00804193|478630|P1|Overall Study|Withdrawal by Subject|3
132621|NCT00804193|478628|P3|Overall Study|Lost to Follow-up|4
132622|NCT00804193|478629|P2|Overall Study|Lost to Follow-up|3
132623|NCT00804193|478630|P1|Overall Study|Lost to Follow-up|3
132624|NCT00804193|478628|P3|Overall Study|Protocol Violation|2
132625|NCT00804193|478629|P2|Overall Study|Protocol Violation|8
132626|NCT00804193|478630|P1|Overall Study|Protocol Violation|0
132627|NCT00804193|478628|P3|Overall Study|Lack of Efficacy|3
132628|NCT00804193|478629|P2|Overall Study|Lack of Efficacy|1
132629|NCT00804193|478630|P1|Overall Study|Lack of Efficacy|1
132630|NCT00804193|478628|P3|Overall Study|Adverse Event|2
132631|NCT00804193|478629|P2|Overall Study|Adverse Event|0
132632|NCT00804193|478630|P1|Overall Study|Adverse Event|0
132633|NCT00804193|478628|P3|Overall Study|Lack of baseline fungus|19
132634|NCT00804193|478629|P2|Overall Study|Lack of baseline fungus|31
132635|NCT00804193|478630|P1|Overall Study|Lack of baseline fungus|32
132636|NCT00803790|478679|P4|Period 2|Positive Drug Screen or Personal Reasons|0
132637|NCT00803790|478680|P3|Period 2|Positive Drug Screen or Personal Reasons|0
132638|NCT00803790|478681|P2|Period 2|Positive Drug Screen or Personal Reasons|0
132639|NCT00803790|478682|P1|Period 2|Positive Drug Screen or Personal Reasons|1
132640|NCT00803790|478679|P4|Period 2|Withdrawal by Subject|0
132641|NCT00803790|478680|P3|Period 2|Withdrawal by Subject|0
132642|NCT00803790|478681|P2|Period 2|Withdrawal by Subject|0
132643|NCT00803790|478682|P1|Period 2|Withdrawal by Subject|1
132644|NCT00803790|478679|P4|Period 2|Adverse Event|1
132645|NCT00803790|478680|P3|Period 2|Adverse Event|1
132646|NCT00803790|478681|P2|Period 2|Adverse Event|0
132647|NCT00803790|478682|P1|Period 2|Adverse Event|0
132648|NCT00803790|478679|P4|Period 1|Protocol Violation|0
132649|NCT00803790|478680|P3|Period 1|Protocol Violation|1
132650|NCT00803790|478681|P2|Period 1|Protocol Violation|0
132651|NCT00803790|478682|P1|Period 1|Protocol Violation|0
132652|NCT00803790|478679|P4|Period 1|positive drug screen or personal reasons|4
132653|NCT00803790|478680|P3|Period 1|positive drug screen or personal reasons|0
132654|NCT00803790|478681|P2|Period 1|positive drug screen or personal reasons|3
132655|NCT00803790|478682|P1|Period 1|positive drug screen or personal reasons|0
132656|NCT00803790|478679|P4|Period 1|Withdrawal by Subject|0
132657|NCT00803790|478680|P3|Period 1|Withdrawal by Subject|0
132658|NCT00803790|478681|P2|Period 1|Withdrawal by Subject|6
132659|NCT00803790|478682|P1|Period 1|Withdrawal by Subject|8
132660|NCT00803790|478679|P4|Period 1|Lost to Follow-up|0
132661|NCT00803790|478680|P3|Period 1|Lost to Follow-up|0
132662|NCT00803790|478681|P2|Period 1|Lost to Follow-up|2
132663|NCT00803790|478682|P1|Period 1|Lost to Follow-up|1
132664|NCT00803790|478679|P4|Period 1|Adverse Event|0
132665|NCT00803790|478680|P3|Period 1|Adverse Event|0
132666|NCT00803790|478681|P2|Period 1|Adverse Event|1
132667|NCT00803790|478682|P1|Period 1|Adverse Event|0
132668|NCT00803738|478722|P2|Overall Study|Positive Results for STD or abnormal PAP|8
132669|NCT00803738|478723|P1|Overall Study|Positive Results for STD or abnormal PAP|2
132670|NCT00803738|478722|P2|Overall Study|Negative Baseline Culture of Candida|63
132671|NCT00803738|478723|P1|Overall Study|Negative Baseline Culture of Candida|56
132672|NCT00803738|478722|P2|Overall Study|Lack of Efficacy|16
132673|NCT00803738|478723|P1|Overall Study|Lack of Efficacy|10
132674|NCT00803738|478722|P2|Overall Study|Withdrawal by Subject|4
132675|NCT00803738|478723|P1|Overall Study|Withdrawal by Subject|1
132676|NCT00803738|478722|P2|Overall Study|Protocol Violation|10
132677|NCT00803738|478723|P1|Overall Study|Protocol Violation|18
132678|NCT00803738|478722|P2|Overall Study|Lost to Follow-up|4
132679|NCT00803738|478723|P1|Overall Study|Lost to Follow-up|4
132680|NCT00803738|478722|P2|Overall Study|Adverse Event|5
132681|NCT00803738|478723|P1|Overall Study|Adverse Event|3
132682|NCT00803712|478735|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
132683|NCT00803712|478736|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
132684|NCT00803712|478735|P2|Overall Study|Administrative decision|3
132685|NCT00803712|478736|P1|Overall Study|Administrative decision|2
132686|NCT00803712|478735|P2|Overall Study|Protocol criteria (renal transplant)|8
132687|NCT00803712|478736|P1|Overall Study|Protocol criteria (renal transplant)|12
132688|NCT00803712|478735|P2|Overall Study|Protocol criteria (other)|2
132689|NCT00803712|478736|P1|Overall Study|Protocol criteria (other)|0
132690|NCT00803712|478735|P2|Overall Study|"Other in electronic Case Report Form"|1
132691|NCT00803712|478736|P1|Overall Study|"Other in electronic Case Report Form"|0
132692|NCT00803712|478735|P2|Overall Study|Withdrawal by Subject|4
132693|NCT00803712|478736|P1|Overall Study|Withdrawal by Subject|2
132694|NCT00803712|478735|P2|Overall Study|Lost to Follow-up|1
132695|NCT00803712|478736|P1|Overall Study|Lost to Follow-up|3
132696|NCT00803712|478735|P2|Overall Study|Death|7
132697|NCT00803712|478736|P1|Overall Study|Death|8
132698|NCT00803712|478735|P2|Overall Study|Adverse Event|0
132699|NCT00803712|478736|P1|Overall Study|Adverse Event|5
132700|NCT00803712|478735|P2|Overall Study|Noncompliance|0
132701|NCT00803712|478736|P1|Overall Study|Noncompliance|3
132702|NCT00803634|478835|P2|Overall Study|Death|2
132703|NCT00803634|478836|P1|Overall Study|Death|3
132704|NCT00803634|478835|P2|Overall Study|Lost to Follow-up|3
132705|NCT00803634|478836|P1|Overall Study|Lost to Follow-up|2
132706|NCT00803634|478835|P2|Overall Study|Withdrew Consent|0
132707|NCT00803634|478836|P1|Overall Study|Withdrew Consent|1
132708|NCT00803595|478865|P3|Overall Study|Withdrawal by Subject|3
132709|NCT00803595|478866|P2|Overall Study|Withdrawal by Subject|2
132710|NCT00803595|478867|P1|Overall Study|Withdrawal by Subject|5
132711|NCT00803595|478865|P3|Overall Study|Protocol Violation|12
132712|NCT00803595|478866|P2|Overall Study|Protocol Violation|2
132713|NCT00803595|478867|P1|Overall Study|Protocol Violation|7
132714|NCT00803595|478865|P3|Overall Study|Adverse Event|1
132715|NCT00803595|478866|P2|Overall Study|Adverse Event|4
132716|NCT00803595|478867|P1|Overall Study|Adverse Event|3
132717|NCT00803452|478904|P2|Overall Study|Lost to Follow-up|3
132718|NCT00803452|478905|P1|Overall Study|Lost to Follow-up|0
132719|NCT00803452|478904|P2|Overall Study|Adverse Event|2
132720|NCT00803452|478905|P1|Overall Study|Adverse Event|0
132721|NCT00803361|478943|P2|Overall Study|Withdrawal by Subject|6
132722|NCT00803361|478944|P1|Overall Study|Withdrawal by Subject|5
132723|NCT00803361|478943|P2|Overall Study|Protocol Violation|4
132724|NCT00803361|478944|P1|Overall Study|Protocol Violation|2
132725|NCT00803361|478943|P2|Overall Study|Physician Decision|0
132726|NCT00803361|478944|P1|Overall Study|Physician Decision|1
132727|NCT00803361|478943|P2|Overall Study|Lost to Follow-up|2
132728|NCT00803361|478944|P1|Overall Study|Lost to Follow-up|1
132729|NCT00803361|478943|P2|Overall Study|Lack of Efficacy|13
132730|NCT00803361|478944|P1|Overall Study|Lack of Efficacy|4
132731|NCT00803361|478943|P2|Overall Study|Adverse Event|3
132732|NCT00803361|478944|P1|Overall Study|Adverse Event|13
132733|NCT00803270|478991|P2|Overall Study|Lost to Follow-up|2
132734|NCT00803270|478992|P1|Overall Study|Lost to Follow-up|1
132735|NCT00803244|479002|P2|Overall Study|Any other reason not above-mentioned|10
132736|NCT00803244|479003|P1|Overall Study|Any other reason not above-mentioned|4
132737|NCT00803244|479002|P2|Overall Study|Withdrawal by Subject|3
132738|NCT00803244|479003|P1|Overall Study|Withdrawal by Subject|2
132739|NCT00803244|479002|P2|Overall Study|Adverse Event|2
132740|NCT00803244|479003|P1|Overall Study|Adverse Event|1
132741|NCT00803179|479011|P1|Overall Study|Lost to Follow-up|3
132742|NCT00803101|479030|P2|Overall Study|Patient did not have surgery|1
132743|NCT00803101|479031|P1|Overall Study|Patient did not have surgery|1
132744|NCT00803101|479030|P2|Overall Study|Patient did not attend scheduled visit|1
132745|NCT00803101|479031|P1|Overall Study|Patient did not attend scheduled visit|2
132746|NCT00803101|479030|P2|Overall Study|Patient died outside SAE report period|0
132747|NCT00803101|479031|P1|Overall Study|Patient died outside SAE report period|1
132748|NCT00803101|479030|P2|Overall Study|Surgery finished outside protocol window|1
132749|NCT00803101|479031|P1|Overall Study|Surgery finished outside protocol window|1
132750|NCT00803101|479030|P2|Overall Study|Protocol Violation|7
132751|NCT00803101|479031|P1|Overall Study|Protocol Violation|1
132752|NCT00803101|479030|P2|Overall Study|Lost to Follow-up|2
132753|NCT00803101|479031|P1|Overall Study|Lost to Follow-up|2
132754|NCT00803101|479030|P2|Overall Study|Withdrawal by Subject|4
132755|NCT00803101|479031|P1|Overall Study|Withdrawal by Subject|6
132756|NCT00803101|479030|P2|Overall Study|Death / Serious Adverse Event|6
132757|NCT00803101|479031|P1|Overall Study|Death / Serious Adverse Event|4
132758|NCT00803049|479082|P4|Overall Study|Other than Specified Above|5
132759|NCT00803049|479083|P3|Overall Study|Other than Specified Above|2
132760|NCT00803049|479084|P2|Overall Study|Other than Specified Above|9
132761|NCT00803049|479085|P1|Overall Study|Other than Specified Above|3
132762|NCT00803049|479082|P4|Overall Study|Randomized and Not Treated|2
132763|NCT00803049|479083|P3|Overall Study|Randomized and Not Treated|0
132764|NCT00803049|479084|P2|Overall Study|Randomized and Not Treated|0
132765|NCT00803049|479085|P1|Overall Study|Randomized and Not Treated|0
132766|NCT00803049|479082|P4|Overall Study|Protocol Violation|0
132767|NCT00803049|479083|P3|Overall Study|Protocol Violation|1
132768|NCT00803049|479084|P2|Overall Study|Protocol Violation|1
132769|NCT00803049|479085|P1|Overall Study|Protocol Violation|0
132770|NCT00803049|479082|P4|Overall Study|Withdrawal by Subject|44
132771|NCT00803049|479083|P3|Overall Study|Withdrawal by Subject|16
132772|NCT00803049|479084|P2|Overall Study|Withdrawal by Subject|43
132773|NCT00803049|479085|P1|Overall Study|Withdrawal by Subject|19
132774|NCT00803049|479082|P4|Overall Study|Progressive Disease|6
132775|NCT00803049|479083|P3|Overall Study|Progressive Disease|6
132776|NCT00803049|479084|P2|Overall Study|Progressive Disease|10
132777|NCT00803049|479085|P1|Overall Study|Progressive Disease|6
132778|NCT00803049|479082|P4|Overall Study|Death|2
132779|NCT00803049|479083|P3|Overall Study|Death|0
132780|NCT00803049|479084|P2|Overall Study|Death|1
132781|NCT00803049|479085|P1|Overall Study|Death|2
132782|NCT00803049|479082|P4|Overall Study|Lost to Follow-up|3
132783|NCT00803049|479083|P3|Overall Study|Lost to Follow-up|0
132784|NCT00803049|479084|P2|Overall Study|Lost to Follow-up|2
132785|NCT00803049|479085|P1|Overall Study|Lost to Follow-up|0
132786|NCT00803049|479082|P4|Overall Study|Lack of Efficacy|13
132787|NCT00803049|479083|P3|Overall Study|Lack of Efficacy|6
132788|NCT00803049|479084|P2|Overall Study|Lack of Efficacy|19
132789|NCT00803049|479085|P1|Overall Study|Lack of Efficacy|10
132790|NCT00803049|479082|P4|Overall Study|Adverse Event|27
132791|NCT00803049|479083|P3|Overall Study|Adverse Event|13
132792|NCT00803049|479084|P2|Overall Study|Adverse Event|33
132793|NCT00803049|479085|P1|Overall Study|Adverse Event|21
132794|NCT00803023|479119|P4|Overall Study|Lack of Efficacy|1
132795|NCT00803023|479120|P3|Overall Study|Lack of Efficacy|1
132796|NCT00803023|479121|P2|Overall Study|Lack of Efficacy|1
132797|NCT00803023|479122|P1|Overall Study|Lack of Efficacy|0
132798|NCT00803023|479119|P4|Overall Study|Lost to Follow-up|1
132799|NCT00803023|479120|P3|Overall Study|Lost to Follow-up|2
132800|NCT00803023|479121|P2|Overall Study|Lost to Follow-up|1
132801|NCT00803023|479122|P1|Overall Study|Lost to Follow-up|0
132802|NCT00803023|479119|P4|Overall Study|Withdrawal by Subject|0
132803|NCT00803023|479120|P3|Overall Study|Withdrawal by Subject|0
132804|NCT00803023|479121|P2|Overall Study|Withdrawal by Subject|2
132805|NCT00803023|479122|P1|Overall Study|Withdrawal by Subject|0
132806|NCT00803023|479119|P4|Overall Study|Adverse Event|6
132807|NCT00803023|479120|P3|Overall Study|Adverse Event|8
132808|NCT00803023|479121|P2|Overall Study|Adverse Event|4
132809|NCT00803023|479122|P1|Overall Study|Adverse Event|5
132810|NCT00802893|479173|P1|Overall Study|study terminated|3
132811|NCT00802867|479197|P1|Overall Study|Withdrawal by Subject|1
132812|NCT00802867|479197|P1|Overall Study|Protocol Violation|6
132813|NCT00802867|479197|P1|Overall Study|Lost to Follow-up|6
132814|NCT00802841|479220|P2|Overall Study|Treatment duration completed|76
132815|NCT00802841|479221|P1|Overall Study|Treatment duration completed|66
132816|NCT00802841|479220|P2|Overall Study|Protocol deviation|6
132817|NCT00802841|479221|P1|Overall Study|Protocol deviation|2
132818|NCT00802841|479220|P2|Overall Study|Withdrawal by Subject|5
132819|NCT00802841|479221|P1|Overall Study|Withdrawal by Subject|9
132820|NCT00802841|479220|P2|Overall Study|Disease progression|3
132821|NCT00802841|479221|P1|Overall Study|Disease progression|7
132822|NCT00802841|479220|P2|Overall Study|Adverse Event|2
132823|NCT00802841|479221|P1|Overall Study|Adverse Event|8
132824|NCT00802841|479220|P2|Overall Study|Death|2
132825|NCT00802841|479221|P1|Overall Study|Death|1
132826|NCT00802841|479220|P2|Overall Study|Lost to Follow-up|1
132827|NCT00802841|479221|P1|Overall Study|Lost to Follow-up|2
132828|NCT00802841|479220|P2|Overall Study|Administrative problems|0
132829|NCT00802841|479221|P1|Overall Study|Administrative problems|1
132830|NCT00802737|479246|P3|Overall Study|Participant too Unwell|0
132831|NCT00802737|479247|P2|Overall Study|Participant too Unwell|2
132832|NCT00802737|479248|P1|Overall Study|Participant too Unwell|0
132833|NCT00802737|479246|P3|Overall Study|Ongoing CLL-Treatment|0
132834|NCT00802737|479247|P2|Overall Study|Ongoing CLL-Treatment|1
132835|NCT00802737|479248|P1|Overall Study|Ongoing CLL-Treatment|0
132836|NCT00802737|479246|P3|Overall Study|Received Prohibited Therapy|0
132837|NCT00802737|479247|P2|Overall Study|Received Prohibited Therapy|0
132838|NCT00802737|479248|P1|Overall Study|Received Prohibited Therapy|1
132839|NCT00802737|479246|P3|Overall Study|Adverse Event|0
132840|NCT00802737|479247|P2|Overall Study|Adverse Event|0
132841|NCT00802737|479248|P1|Overall Study|Adverse Event|1
132842|NCT00802737|479246|P3|Overall Study|Death|1
132843|NCT00802737|479247|P2|Overall Study|Death|5
132844|NCT00802737|479248|P1|Overall Study|Death|6
132845|NCT00802737|479246|P3|Overall Study|Withdrawn due to Disease Progression|0
132846|NCT00802737|479247|P2|Overall Study|Withdrawn due to Disease Progression|3
132847|NCT00802737|479248|P1|Overall Study|Withdrawn due to Disease Progression|9
132848|NCT00802672|479308|P3|Overall Study|other|2
132849|NCT00802672|479309|P2|Overall Study|other|1
132850|NCT00802672|479310|P1|Overall Study|other|3
132851|NCT00802672|479308|P3|Overall Study|Withdrawal by Subject|2
132852|NCT00802672|479309|P2|Overall Study|Withdrawal by Subject|1
132853|NCT00802672|479310|P1|Overall Study|Withdrawal by Subject|1
132854|NCT00802672|479308|P3|Overall Study|Lost to Follow-up|3
132855|NCT00802672|479309|P2|Overall Study|Lost to Follow-up|5
132856|NCT00802672|479310|P1|Overall Study|Lost to Follow-up|5
132857|NCT00802672|479308|P3|Overall Study|Protocol Violation|1
132858|NCT00802672|479309|P2|Overall Study|Protocol Violation|1
132859|NCT00802672|479310|P1|Overall Study|Protocol Violation|2
132860|NCT00802672|479308|P3|Overall Study|Adverse Event|1
132861|NCT00802672|479309|P2|Overall Study|Adverse Event|1
132862|NCT00802672|479310|P1|Overall Study|Adverse Event|1
132863|NCT00802672|479308|P3|Overall Study|Lack of fungal pathogen at baseline|25
132864|NCT00802672|479309|P2|Overall Study|Lack of fungal pathogen at baseline|43
132865|NCT00802672|479310|P1|Overall Study|Lack of fungal pathogen at baseline|56
132866|NCT00802659|479328|P4|Overall Study|Physician Decision|0
132867|NCT00802659|479329|P3|Overall Study|Physician Decision|0
132868|NCT00802659|479330|P2|Overall Study|Physician Decision|1
132869|NCT00802659|479331|P1|Overall Study|Physician Decision|0
132870|NCT00802529|479370|P2|Overall Study|Lost to Follow-up|1
132871|NCT00802529|479371|P1|Overall Study|Lost to Follow-up|0
132872|NCT00802464|479410|P4|Month 8 - Month 14|Lost to Follow-up|0
132873|NCT00802464|479411|P3|Month 8 - Month 14|Lost to Follow-up|1
132874|NCT00802464|479412|P2|Month 8 - Month 14|Lost to Follow-up|0
132875|NCT00802464|479413|P1|Month 8 - Month 14|Lost to Follow-up|0
132876|NCT00802464|479410|P4|Month 8 - Month 14|Withdrawal by Subject|0
132877|NCT00802464|479411|P3|Month 8 - Month 14|Withdrawal by Subject|0
132878|NCT00802464|479412|P2|Month 8 - Month 14|Withdrawal by Subject|1
132879|NCT00802464|479413|P1|Month 8 - Month 14|Withdrawal by Subject|1
132880|NCT00802464|479410|P4|Month 8 - Month 14|Adverse Event|0
132881|NCT00802464|479411|P3|Month 8 - Month 14|Adverse Event|0
132882|NCT00802464|479412|P2|Month 8 - Month 14|Adverse Event|1
132883|NCT00802464|479413|P1|Month 8 - Month 14|Adverse Event|0
132884|NCT00802464|479410|P4|Month 0 - Month 8|Not specified|0
132885|NCT00802464|479411|P3|Month 0 - Month 8|Not specified|1
132886|NCT00802464|479412|P2|Month 0 - Month 8|Not specified|0
132887|NCT00802464|479413|P1|Month 0 - Month 8|Not specified|0
132888|NCT00802464|479410|P4|Month 0 - Month 8|Lost to Follow-up|2
132889|NCT00802464|479411|P3|Month 0 - Month 8|Lost to Follow-up|2
132890|NCT00802464|479412|P2|Month 0 - Month 8|Lost to Follow-up|1
132891|NCT00802464|479413|P1|Month 0 - Month 8|Lost to Follow-up|0
132892|NCT00802464|479410|P4|Month 0 - Month 8|Withdrawal by Subject|5
132893|NCT00802464|479411|P3|Month 0 - Month 8|Withdrawal by Subject|2
132894|NCT00802464|479412|P2|Month 0 - Month 8|Withdrawal by Subject|1
132895|NCT00802464|479413|P1|Month 0 - Month 8|Withdrawal by Subject|0
132896|NCT00802464|479410|P4|Month 0 - Month 8|Protocol Violation|0
132897|NCT00802464|479411|P3|Month 0 - Month 8|Protocol Violation|1
132898|NCT00802464|479412|P2|Month 0 - Month 8|Protocol Violation|0
132899|NCT00802464|479413|P1|Month 0 - Month 8|Protocol Violation|0
132900|NCT00802464|479410|P4|Month 0 - Month 8|Adverse Event|2
132901|NCT00802464|479411|P3|Month 0 - Month 8|Adverse Event|1
132902|NCT00802464|479412|P2|Month 0 - Month 8|Adverse Event|1
132903|NCT00802464|479413|P1|Month 0 - Month 8|Adverse Event|0
132904|NCT00802438|479499|P1|Overall Study|Physician Decision|1
132905|NCT00802438|479499|P1|Overall Study|Withdrawal by Subject|7
132906|NCT00802438|479499|P1|Overall Study|Screen Failure|20
132907|NCT00802360|479519|P4|Overall Study|Other|3
132908|NCT00802360|479520|P3|Overall Study|Other|6
132909|NCT00802360|479521|P2|Overall Study|Other|3
132910|NCT00802360|479522|P1|Overall Study|Other|2
132911|NCT00802360|479519|P4|Overall Study|Pregnancy loss/miscarriage|3
132912|NCT00802360|479520|P3|Overall Study|Pregnancy loss/miscarriage|0
132913|NCT00802360|479521|P2|Overall Study|Pregnancy loss/miscarriage|2
132914|NCT00802360|479522|P1|Overall Study|Pregnancy loss/miscarriage|0
132915|NCT00802360|479519|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
132916|NCT00802360|479520|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
132917|NCT00802360|479521|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
132918|NCT00802360|479522|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
132919|NCT00802360|479519|P4|Overall Study|No positive serum pregnancy|10
132920|NCT00802360|479520|P3|Overall Study|No positive serum pregnancy|14
132921|NCT00802360|479521|P2|Overall Study|No positive serum pregnancy|20
132922|NCT00802360|479522|P1|Overall Study|No positive serum pregnancy|17
132923|NCT00802360|479519|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
132924|NCT00802360|479520|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
132925|NCT00802360|479521|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
132926|NCT00802360|479522|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
132927|NCT00802360|479519|P4|Overall Study|Cycle cancelled|1
132928|NCT00802360|479520|P3|Overall Study|Cycle cancelled|1
132929|NCT00802360|479521|P2|Overall Study|Cycle cancelled|1
132930|NCT00802360|479522|P1|Overall Study|Cycle cancelled|0
132931|NCT00802360|479519|P4|Overall Study|Inadequate number of oocytes retrieved|1
132932|NCT00802360|479520|P3|Overall Study|Inadequate number of oocytes retrieved|0
132933|NCT00802360|479521|P2|Overall Study|Inadequate number of oocytes retrieved|0
132934|NCT00802360|479522|P1|Overall Study|Inadequate number of oocytes retrieved|0
132935|NCT00802360|479519|P4|Overall Study|Stimulation failure|3
132936|NCT00802360|479520|P3|Overall Study|Stimulation failure|3
132937|NCT00802360|479521|P2|Overall Study|Stimulation failure|0
132938|NCT00802360|479522|P1|Overall Study|Stimulation failure|4
132939|NCT00802178|479589|P1|Overall Study|Patients wish and other reason|1
132940|NCT00802178|479589|P1|Overall Study|IT and patient wish|8
132941|NCT00802178|479589|P1|Overall Study|Lack of efficacy and patient wish|1
132942|NCT00802178|479589|P1|Overall Study|Other|32
132943|NCT00802178|479589|P1|Overall Study|Withdrawal by Subject|18
132944|NCT00802178|479589|P1|Overall Study|Insufficient tolerability (IT)|17
132945|NCT00802178|479589|P1|Overall Study|Lack of Efficacy|36
132946|NCT00802074|479616|P6|Overall Study|Withdrawal by Subject|0
132947|NCT00802074|479617|P5|Overall Study|Withdrawal by Subject|0
132948|NCT00802074|479618|P4|Overall Study|Withdrawal by Subject|0
132949|NCT00802074|479619|P3|Overall Study|Withdrawal by Subject|0
132950|NCT00802074|479620|P2|Overall Study|Withdrawal by Subject|0
132951|NCT00802074|479621|P1|Overall Study|Withdrawal by Subject|1
132952|NCT00802074|479616|P6|Overall Study|Adverse Event|0
132953|NCT00802074|479617|P5|Overall Study|Adverse Event|0
132954|NCT00802074|479618|P4|Overall Study|Adverse Event|0
132955|NCT00802074|479619|P3|Overall Study|Adverse Event|1
132956|NCT00802074|479620|P2|Overall Study|Adverse Event|1
132957|NCT00802074|479621|P1|Overall Study|Adverse Event|1
132958|NCT00801983|479655|P2|Period 2|Withdrawal by Subject|1
132959|NCT00801983|479656|P1|Period 2|Withdrawal by Subject|2
132960|NCT00801983|479655|P2|Period 1|Withdrawal by Subject|8
132961|NCT00801983|479656|P1|Period 1|Withdrawal by Subject|2
132962|NCT00801983|479655|P2|Period 1|Lost to Follow-up|0
132963|NCT00801983|479656|P1|Period 1|Lost to Follow-up|2
132964|NCT00801892|479664|P2|Sham Crossover Period|Lost to Follow-up|2
132965|NCT00801892|479665|P1|Sham Crossover Period|Lost to Follow-up|0
132966|NCT00801892|479664|P2|Main Study Period|Withdrawal by Subject|1
132967|NCT00801892|479665|P1|Main Study Period|Withdrawal by Subject|0
132968|NCT00801632|479712|P1|Overall Study|Re-transplant|1
132969|NCT00801242|479723|P1|Overall Study|Miscellaneous reasons|20
132970|NCT00801242|479723|P1|Overall Study|Lost to Follow-up|1
132971|NCT00801242|479723|P1|Overall Study|Physician Decision|3
132972|NCT00801242|479723|P1|Overall Study|Protocol Violation|5
132973|NCT00801242|479723|P1|Overall Study|Withdrawal by Subject|13
132974|NCT00801242|479723|P1|Overall Study|Adverse Event|10
132975|NCT00801229|479736|P2|Received Study Drug/Placebo|Adverse Event|1
132976|NCT00801229|479737|P1|Received Study Drug/Placebo|Adverse Event|1
132977|NCT00801229|479736|P2|Received Study Drug/Placebo|Lost to Follow-up|1
132978|NCT00801229|479737|P1|Received Study Drug/Placebo|Lost to Follow-up|0
133065|NCT00799617|480093|P1|Sexual Funtion Trial|No Baseline Data|4
132979|NCT00801229|479736|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
132980|NCT00801229|479737|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
132981|NCT00801229|479736|P2|Received Study Drug/Placebo|Simulator sickness|1
132982|NCT00801229|479737|P1|Received Study Drug/Placebo|Simulator sickness|1
132983|NCT00801229|479736|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
132984|NCT00801229|479737|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
132985|NCT00801229|479736|P2|Received Study Drug/Placebo|Elevated SGOT level|0
132986|NCT00801229|479737|P1|Received Study Drug/Placebo|Elevated SGOT level|1
132987|NCT00801229|479736|P2|Signed Consent|Found Ineligible|1
132988|NCT00801229|479737|P1|Signed Consent|Found Ineligible|1
132989|NCT00801229|479736|P2|Signed Consent|Withdrawal by Subject|2
132990|NCT00801229|479737|P1|Signed Consent|Withdrawal by Subject|2
132991|NCT00801099|479772|P1|Overall Study|Lost to Follow-up|101
132992|NCT00800982|479778|P2|Overall Study|Patient moved out of state|0
132993|NCT00800982|479779|P1|Overall Study|Patient moved out of state|1
132994|NCT00800982|479778|P2|Overall Study|Withdrawal by Subject|1
132995|NCT00800982|479779|P1|Overall Study|Withdrawal by Subject|0
132996|NCT00800982|479778|P2|Overall Study|Lost to Follow-up|2
132997|NCT00800982|479779|P1|Overall Study|Lost to Follow-up|1
132998|NCT00800735|479805|P1|Overall Study|Withdrew Consent|3
132999|NCT00800735|479805|P1|Overall Study|Violation of Selection Criteria at Entry|7
133000|NCT00800735|479805|P1|Overall Study|Insufficient Therapeutic Response|2
133001|NCT00800735|479805|P1|Overall Study|Administrative/Other|2
133002|NCT00800683|479811|P2|Overall Study|Not specified|2
133003|NCT00800683|479812|P1|Overall Study|Not specified|1
133004|NCT00800683|479811|P2|Overall Study|Lack of Efficacy|1
133005|NCT00800683|479812|P1|Overall Study|Lack of Efficacy|1
133006|NCT00800683|479811|P2|Overall Study|Withdrawal by Subject|7
133007|NCT00800683|479812|P1|Overall Study|Withdrawal by Subject|1
133008|NCT00800683|479811|P2|Overall Study|Lost to Follow-up|1
133009|NCT00800683|479812|P1|Overall Study|Lost to Follow-up|3
133010|NCT00800683|479811|P2|Overall Study|Adverse Event|8
133011|NCT00800683|479812|P1|Overall Study|Adverse Event|11
133012|NCT00800540|479858|P2|Period 2: 6 Weeks|Adverse Event|1
133013|NCT00800540|479859|P1|Period 2: 6 Weeks|Adverse Event|0
133014|NCT00800540|479858|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
133015|NCT00800540|479859|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
133016|NCT00800540|479858|P2|Period One: 6 Weeks|Noncompliance|0
133017|NCT00800540|479859|P1|Period One: 6 Weeks|Noncompliance|1
133018|NCT00800436|479894|P7|Overall Study|Withdrawal by Subject|0
133019|NCT00800436|479895|P6|Overall Study|Withdrawal by Subject|0
133020|NCT00800436|479896|P5|Overall Study|Withdrawal by Subject|0
133021|NCT00800436|479897|P4|Overall Study|Withdrawal by Subject|1
133022|NCT00800436|479898|P3|Overall Study|Withdrawal by Subject|1
133023|NCT00800436|479899|P2|Overall Study|Withdrawal by Subject|0
133024|NCT00800436|479900|P1|Overall Study|Withdrawal by Subject|0
133025|NCT00800384|479946|P2|Overall Study|Lost to Follow-up|26
133026|NCT00800384|479947|P1|Overall Study|Lost to Follow-up|17
133027|NCT00800384|479946|P2|Overall Study|Withdrawal by Subject|17
133028|NCT00800384|479947|P1|Overall Study|Withdrawal by Subject|24
133029|NCT00800202|479985|P2|Overall Study|Disease Progression|18
133030|NCT00800202|479986|P1|Overall Study|Disease Progression|54
133031|NCT00800202|479985|P2|Overall Study|Other|0
133032|NCT00800202|479986|P1|Overall Study|Other|5
133033|NCT00800202|479985|P2|Overall Study|Death|0
133034|NCT00800202|479986|P1|Overall Study|Death|1
133035|NCT00800202|479985|P2|Overall Study|Adverse Event|6
133036|NCT00800202|479986|P1|Overall Study|Adverse Event|7
133037|NCT00799903|480006|P2|Overall Study|Lost to Follow-up|80
133038|NCT00799903|480007|P1|Overall Study|Lost to Follow-up|69
133039|NCT00799903|480006|P2|Overall Study|Withdrawal by Subject|175
133040|NCT00799903|480007|P1|Overall Study|Withdrawal by Subject|179
133041|NCT00799903|480006|P2|Overall Study|Investigator Site Closed|23
133042|NCT00799903|480007|P1|Overall Study|Investigator Site Closed|25
133043|NCT00799825|480027|P1|Overall Study|Pregnancy|3
133044|NCT00799825|480027|P1|Overall Study|Lost to Follow-up|38
133045|NCT00799825|480027|P1|Overall Study|Withdrawal by Subject|6
133046|NCT00799825|480027|P1|Overall Study|Adverse Event|1
133047|NCT00799708|480067|P3|Overall Study|non-compliance|0
133048|NCT00799708|480068|P2|Overall Study|non-compliance|0
133049|NCT00799708|480069|P1|Overall Study|non-compliance|1
133050|NCT00799617|480092|P2|Anemia Trial|Withdrawal by Subject|3
133051|NCT00799617|480093|P1|Anemia Trial|Withdrawal by Subject|3
133052|NCT00799617|480092|P2|Cognitive Function Trial|Lost to Follow-up|1
133053|NCT00799617|480093|P1|Cognitive Function Trial|Lost to Follow-up|0
133054|NCT00799617|480092|P2|Bone Trial|Month 12 scan not available|16
133055|NCT00799617|480093|P1|Bone Trial|Month 12 scan not available|6
133056|NCT00799617|480092|P2|Cardiovascular Trial|Baseline scan not analyzable|2
133057|NCT00799617|480093|P1|Cardiovascular Trial|Baseline scan not analyzable|0
133058|NCT00799617|480092|P2|Cardiovascular Trial|Month 12 scan not available|15
133059|NCT00799617|480093|P1|Cardiovascular Trial|Month 12 scan not available|15
133060|NCT00799617|480092|P2|Vitality Trial|Lost to Follow-up|22
133061|NCT00799617|480093|P1|Vitality Trial|Lost to Follow-up|7
133062|NCT00799617|480092|P2|Physical Function Trial|Lost to Follow-up|11
133063|NCT00799617|480093|P1|Physical Function Trial|Lost to Follow-up|6
133064|NCT00799617|480092|P2|Sexual Funtion Trial|No Baseline Data|7
133066|NCT00799617|480092|P2|Sexual Funtion Trial|Lost to Follow-up|14
133067|NCT00799617|480093|P1|Sexual Funtion Trial|Lost to Follow-up|12
133068|NCT00799617|480092|P2|Main Testosterone Trial|Lost to Follow-up|20
133069|NCT00799617|480093|P1|Main Testosterone Trial|Lost to Follow-up|18
133070|NCT00799617|480092|P2|Main Testosterone Trial|Randomized in error|1
133071|NCT00799617|480093|P1|Main Testosterone Trial|Randomized in error|1
133072|NCT00799591|480200|P1|Overall Study|Infectious origin not probable|1
133073|NCT00799591|480200|P1|Overall Study|Antibiotic changed, no apparent reason|1
133074|NCT00799591|480200|P1|Overall Study|Persistance of fever undetermined origin|1
133075|NCT00799591|480200|P1|Overall Study|Resistance germ and technical failure|2
133076|NCT00799591|480200|P1|Overall Study|New infection|4
133077|NCT00799591|480200|P1|Overall Study|Resistant germ|11
133078|NCT00799591|480200|P1|Overall Study|Technical failure|12
133079|NCT00799591|480200|P1|Overall Study|Death|14
133080|NCT00799591|480200|P1|Overall Study|De-escalation of doses|20
133081|NCT00799487|480218|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
133082|NCT00799487|480219|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
133083|NCT00799487|480220|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
133084|NCT00799487|480218|P3|Double-Blind Assessment Period|Subject was out of the state|1
133085|NCT00799487|480219|P2|Double-Blind Assessment Period|Subject was out of the state|0
133086|NCT00799487|480220|P1|Double-Blind Assessment Period|Subject was out of the state|0
133087|NCT00799487|480218|P3|Double-Blind Assessment Period|Lost to Follow-up|1
133088|NCT00799487|480219|P2|Double-Blind Assessment Period|Lost to Follow-up|0
133089|NCT00799487|480220|P1|Double-Blind Assessment Period|Lost to Follow-up|0
133090|NCT00799487|480218|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
133091|NCT00799487|480219|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
133092|NCT00799487|480220|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
133093|NCT00799487|480218|P3|Dose Adjustment Period|Missed laboratory day 1|0
133094|NCT00799487|480219|P2|Dose Adjustment Period|Missed laboratory day 1|0
133095|NCT00799487|480220|P1|Dose Adjustment Period|Missed laboratory day 1|1
133096|NCT00799487|480218|P3|Dose Adjustment Period|Child too young (exclusion)|0
133097|NCT00799487|480219|P2|Dose Adjustment Period|Child too young (exclusion)|0
133098|NCT00799487|480220|P1|Dose Adjustment Period|Child too young (exclusion)|1
133099|NCT00799487|480218|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
133100|NCT00799487|480219|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
133101|NCT00799487|480220|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
133102|NCT00799487|480218|P3|Dose Adjustment Period|Withdrawal by Subject|0
133103|NCT00799487|480219|P2|Dose Adjustment Period|Withdrawal by Subject|0
133104|NCT00799487|480220|P1|Dose Adjustment Period|Withdrawal by Subject|3
133105|NCT00799487|480218|P3|Dose Adjustment Period|Investigator Discretion|0
133106|NCT00799487|480219|P2|Dose Adjustment Period|Investigator Discretion|0
133107|NCT00799487|480220|P1|Dose Adjustment Period|Investigator Discretion|2
133108|NCT00799487|480218|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
133109|NCT00799487|480219|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
133110|NCT00799487|480220|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
133111|NCT00799487|480218|P3|Dose Adjustment Period|Adverse Event|0
133112|NCT00799487|480219|P2|Dose Adjustment Period|Adverse Event|0
133113|NCT00799487|480220|P1|Dose Adjustment Period|Adverse Event|2
133114|NCT00799487|480218|P3|Dose Adjustment Period|Lost to Follow-up|0
133115|NCT00799487|480219|P2|Dose Adjustment Period|Lost to Follow-up|0
133116|NCT00799487|480220|P1|Dose Adjustment Period|Lost to Follow-up|1
133117|NCT00799422|480315|P6|First Week of Wear|Adverse Event|0
133118|NCT00799422|480316|P5|First Week of Wear|Adverse Event|0
133119|NCT00799422|480317|P4|First Week of Wear|Adverse Event|1
133120|NCT00799422|480318|P3|First Week of Wear|Adverse Event|0
133121|NCT00799422|480319|P2|First Week of Wear|Adverse Event|0
133122|NCT00799422|480320|P1|First Week of Wear|Adverse Event|0
133123|NCT00799422|480315|P6|First Week of Wear|Lost to Follow-up|0
133124|NCT00799422|480316|P5|First Week of Wear|Lost to Follow-up|0
133125|NCT00799422|480317|P4|First Week of Wear|Lost to Follow-up|0
133126|NCT00799422|480318|P3|First Week of Wear|Lost to Follow-up|1
133127|NCT00799422|480319|P2|First Week of Wear|Lost to Follow-up|0
133128|NCT00799422|480320|P1|First Week of Wear|Lost to Follow-up|0
133129|NCT00799409|480337|P3|Overall Study|medication compliance|0
133130|NCT00799409|480338|P2|Overall Study|medication compliance|0
133131|NCT00799409|480339|P1|Overall Study|medication compliance|1
133132|NCT00799409|480337|P3|Overall Study|Did not attend lab school day 1|0
133133|NCT00799409|480338|P2|Overall Study|Did not attend lab school day 1|0
133134|NCT00799409|480339|P1|Overall Study|Did not attend lab school day 1|1
133135|NCT00799409|480337|P3|Overall Study|Failure to follow study protocol)|0
133136|NCT00799409|480338|P2|Overall Study|Failure to follow study protocol)|0
133137|NCT00799409|480339|P1|Overall Study|Failure to follow study protocol)|1
133138|NCT00799409|480337|P3|Overall Study|Optimal Dose Not Achieved|0
133139|NCT00799409|480338|P2|Overall Study|Optimal Dose Not Achieved|0
133140|NCT00799409|480339|P1|Overall Study|Optimal Dose Not Achieved|2
133141|NCT00799409|480337|P3|Overall Study|Lost to Follow-up|0
133142|NCT00799409|480338|P2|Overall Study|Lost to Follow-up|0
133143|NCT00799409|480339|P1|Overall Study|Lost to Follow-up|1
133144|NCT00799409|480337|P3|Overall Study|Withdrawal by Subject|0
133145|NCT00799409|480338|P2|Overall Study|Withdrawal by Subject|0
133146|NCT00799409|480339|P1|Overall Study|Withdrawal by Subject|1
133147|NCT00799396|480419|P1|Clopidogrel Plus Aspirin|Physician Decision|4
133148|NCT00799396|480419|P1|Clopidogrel Plus Aspirin|Adverse Event|2
133149|NCT00799396|480419|P1|Clopidogrel Treatment|Withdrawal by Subject|2
133150|NCT00799396|480419|P1|Clopidogrel Treatment|Physician Decision|5
133151|NCT00799396|480419|P1|Clopidogrel Treatment|Adverse Event|6
133152|NCT00799383|480426|P2|Overall Study|Withdrawal by Subject|1
133153|NCT00799383|480427|P1|Overall Study|Withdrawal by Subject|0
133154|NCT00799383|480426|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
133155|NCT00799383|480427|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
133156|NCT00799383|480426|P2|Overall Study|Lost to Follow-up|2
133157|NCT00799383|480427|P1|Overall Study|Lost to Follow-up|1
133158|NCT00799383|480426|P2|Overall Study|Adverse Event|1
133159|NCT00799383|480427|P1|Overall Study|Adverse Event|0
133160|NCT00799383|480426|P2|Overall Study|Protocol Violation|1
133161|NCT00799383|480427|P1|Overall Study|Protocol Violation|1
133162|NCT00798967|480463|P2|Overall Study|Randomized in error by site|0
133163|NCT00798967|480464|P1|Overall Study|Randomized in error by site|1
133164|NCT00798967|480463|P2|Overall Study|Physician Decision|0
133165|NCT00798967|480464|P1|Overall Study|Physician Decision|1
133166|NCT00798967|480463|P2|Overall Study|Withdrawal by Subject|1
133167|NCT00798967|480464|P1|Overall Study|Withdrawal by Subject|0
133168|NCT00798967|480463|P2|Overall Study|Adverse Event|3
133169|NCT00798967|480464|P1|Overall Study|Adverse Event|2
133170|NCT00798889|480472|P1|Overall Study|Enrolled, Not treated|3
133171|NCT00798889|480472|P1|Overall Study|Decision of Sponsor|11
133172|NCT00798889|480472|P1|Overall Study|Lack of Efficacy|213
133173|NCT00798889|480472|P1|Overall Study|Lost to Follow-up|1
133174|NCT00798889|480472|P1|Overall Study|Withdrawal by Subject|31
133175|NCT00798889|480472|P1|Overall Study|Protocol Violation|2
133176|NCT00798889|480472|P1|Overall Study|Adverse Event|53
133177|NCT00798759|480478|P2|Overall Study|Not specified|1
133178|NCT00798759|480479|P1|Overall Study|Not specified|0
133179|NCT00798759|480478|P2|Overall Study|Protocol Violation|8
133180|NCT00798759|480479|P1|Overall Study|Protocol Violation|4
133181|NCT00798759|480478|P2|Overall Study|Lost to Follow-up|1
133182|NCT00798759|480479|P1|Overall Study|Lost to Follow-up|1
133183|NCT00798759|480478|P2|Overall Study|Adverse Event|3
133184|NCT00798759|480479|P1|Overall Study|Adverse Event|3
133185|NCT00798707|480497|P3|Overall Study|Randomized not treated|1
133186|NCT00798707|480498|P2|Overall Study|Randomized not treated|5
133187|NCT00798707|480499|P1|Overall Study|Randomized not treated|4
133188|NCT00798707|480497|P3|Overall Study|Withdrawal by Subject|2
133189|NCT00798707|480498|P2|Overall Study|Withdrawal by Subject|8
133190|NCT00798707|480499|P1|Overall Study|Withdrawal by Subject|3
133191|NCT00798707|480497|P3|Overall Study|Protocol Violation|2
133192|NCT00798707|480498|P2|Overall Study|Protocol Violation|0
133193|NCT00798707|480499|P1|Overall Study|Protocol Violation|4
133194|NCT00798707|480497|P3|Overall Study|Other|0
133195|NCT00798707|480498|P2|Overall Study|Other|1
133196|NCT00798707|480499|P1|Overall Study|Other|0
133197|NCT00798707|480497|P3|Overall Study|Lost to Follow-up|6
133198|NCT00798707|480498|P2|Overall Study|Lost to Follow-up|6
133199|NCT00798707|480499|P1|Overall Study|Lost to Follow-up|5
133200|NCT00798707|480497|P3|Overall Study|Lack of Efficacy|1
133201|NCT00798707|480498|P2|Overall Study|Lack of Efficacy|2
133202|NCT00798707|480499|P1|Overall Study|Lack of Efficacy|2
133203|NCT00798707|480497|P3|Overall Study|Investigator|2
133204|NCT00798707|480498|P2|Overall Study|Investigator|1
133205|NCT00798707|480499|P1|Overall Study|Investigator|0
133206|NCT00798707|480497|P3|Overall Study|Failed to return|0
133207|NCT00798707|480498|P2|Overall Study|Failed to return|2
133208|NCT00798707|480499|P1|Overall Study|Failed to return|2
133209|NCT00798707|480497|P3|Overall Study|Adverse Event|8
133210|NCT00798707|480498|P2|Overall Study|Adverse Event|8
133211|NCT00798707|480499|P1|Overall Study|Adverse Event|6
133212|NCT00798655|480549|P1|Overall Study|Did not receive at least one dose of pan|2
133213|NCT00798603|480554|P1|Overall Study|Lack of insurance coverage|1
133214|NCT00798603|480554|P1|Overall Study|Physician Decision|1
133215|NCT00798603|480554|P1|Overall Study|Adverse Event|22
133216|NCT00798603|480554|P1|Overall Study|Withdrawal by Subject|10
133217|NCT00798603|480554|P1|Overall Study|Still on treatment as of 11/6/2012|1
133218|NCT00798590|480576|P2|Overall Study|P.I, Left institution. Study terminated|8
133219|NCT00798590|480577|P1|Overall Study|P.I, Left institution. Study terminated|11
133220|NCT00798434|480611|P2|Open-Label|Not Treated|1
133221|NCT00798434|480612|P1|Open-Label|Not Treated|0
133222|NCT00798434|480611|P2|Open-Label|Not Specified|2
133223|NCT00798434|480612|P1|Open-Label|Not Specified|1
133224|NCT00798434|480611|P2|Open-Label|Protocol Violation|0
133225|NCT00798434|480612|P1|Open-Label|Protocol Violation|1
133226|NCT00798434|480611|P2|Open-Label|Withdrawal by Subject|7
133227|NCT00798434|480612|P1|Open-Label|Withdrawal by Subject|2
133228|NCT00798434|480611|P2|Open-Label|Lack of Efficacy|11
133229|NCT00798434|480612|P1|Open-Label|Lack of Efficacy|5
133230|NCT00798434|480611|P2|Open-Label|Adverse Event|11
133231|NCT00798434|480612|P1|Open-Label|Adverse Event|33
133232|NCT00798434|480611|P2|Double-Blind|Not Treated|6
133233|NCT00798434|480612|P1|Double-Blind|Not Treated|3
133234|NCT00798434|480611|P2|Double-Blind|Not Specified|0
133235|NCT00798434|480612|P1|Double-Blind|Not Specified|1
133236|NCT00798434|480611|P2|Double-Blind|Did Not Meet Entrance Criteria|1
133237|NCT00798434|480612|P1|Double-Blind|Did Not Meet Entrance Criteria|2
133238|NCT00798434|480611|P2|Double-Blind|Protocol Violation|4
133239|NCT00798434|480612|P1|Double-Blind|Protocol Violation|1
133240|NCT00798434|480611|P2|Double-Blind|Withdrawal by Subject|14
133241|NCT00798434|480612|P1|Double-Blind|Withdrawal by Subject|17
133242|NCT00798434|480611|P2|Double-Blind|Lack of Efficacy|12
133243|NCT00798434|480612|P1|Double-Blind|Lack of Efficacy|8
133244|NCT00798434|480611|P2|Double-Blind|Lost to Follow-up|0
133245|NCT00798434|480612|P1|Double-Blind|Lost to Follow-up|1
133246|NCT00798434|480611|P2|Double-Blind|Death|1
133247|NCT00798434|480612|P1|Double-Blind|Death|0
133248|NCT00798434|480611|P2|Double-Blind|Adverse Event|46
133249|NCT00798434|480612|P1|Double-Blind|Adverse Event|22
133250|NCT00798369|480698|P6|Overall Study|Adminstrative problems|1
133251|NCT00798369|480699|P5|Overall Study|Adminstrative problems|0
133252|NCT00798369|480700|P4|Overall Study|Adminstrative problems|0
133253|NCT00798369|480701|P3|Overall Study|Adminstrative problems|0
133254|NCT00798369|480702|P2|Overall Study|Adminstrative problems|0
133255|NCT00798369|480703|P1|Overall Study|Adminstrative problems|0
133256|NCT00798369|480698|P6|Overall Study|Lost to Follow-up|0
133257|NCT00798369|480699|P5|Overall Study|Lost to Follow-up|1
133258|NCT00798369|480700|P4|Overall Study|Lost to Follow-up|0
133259|NCT00798369|480701|P3|Overall Study|Lost to Follow-up|1
133260|NCT00798369|480702|P2|Overall Study|Lost to Follow-up|1
133261|NCT00798369|480703|P1|Overall Study|Lost to Follow-up|1
133262|NCT00798369|480698|P6|Overall Study|Subject withdrew consent|2
133263|NCT00798369|480699|P5|Overall Study|Subject withdrew consent|0
133264|NCT00798369|480700|P4|Overall Study|Subject withdrew consent|1
133265|NCT00798369|480701|P3|Overall Study|Subject withdrew consent|1
133266|NCT00798369|480702|P2|Overall Study|Subject withdrew consent|0
133267|NCT00798369|480703|P1|Overall Study|Subject withdrew consent|0
133268|NCT00798317|480750|P2|Overall Study|Death|0
133269|NCT00798317|480751|P1|Overall Study|Death|1
133270|NCT00798317|480750|P2|Overall Study|Adverse Event|0
133271|NCT00798317|480751|P1|Overall Study|Adverse Event|2
133272|NCT00798317|480750|P2|Overall Study|Lost to Follow-up|2
133273|NCT00798317|480751|P1|Overall Study|Lost to Follow-up|2
133274|NCT00798317|480750|P2|Overall Study|Withdrawal by Subject|4
133275|NCT00798317|480751|P1|Overall Study|Withdrawal by Subject|5
133276|NCT00798317|480750|P2|Overall Study|Physician Decision|1
133277|NCT00798317|480751|P1|Overall Study|Physician Decision|0
133278|NCT00798304|480762|P3|Overall Study|Discontinuation by Sponsor|9
133279|NCT00798304|480763|P2|Overall Study|Discontinuation by Sponsor|21
133280|NCT00798304|480764|P1|Overall Study|Discontinuation by Sponsor|14
133281|NCT00798304|480762|P3|Overall Study|Adverse Event|1
133282|NCT00798304|480763|P2|Overall Study|Adverse Event|1
133283|NCT00798304|480764|P1|Overall Study|Adverse Event|0
133284|NCT00798161|480797|P7|Overall Study|Other reason (incl. lack of efficacy)|5
133285|NCT00798161|480798|P6|Overall Study|Other reason (incl. lack of efficacy)|4
133286|NCT00798161|480799|P5|Overall Study|Other reason (incl. lack of efficacy)|2
133287|NCT00798161|480800|P4|Overall Study|Other reason (incl. lack of efficacy)|5
133288|NCT00798161|480801|P3|Overall Study|Other reason (incl. lack of efficacy)|3
133289|NCT00798161|480802|P2|Overall Study|Other reason (incl. lack of efficacy)|5
133290|NCT00798161|480803|P1|Overall Study|Other reason (incl. lack of efficacy)|7
133291|NCT00798161|480797|P7|Overall Study|Withdrawal by Subject|1
133292|NCT00798161|480798|P6|Overall Study|Withdrawal by Subject|3
133293|NCT00798161|480799|P5|Overall Study|Withdrawal by Subject|2
133294|NCT00798161|480800|P4|Overall Study|Withdrawal by Subject|4
133295|NCT00798161|480801|P3|Overall Study|Withdrawal by Subject|5
133296|NCT00798161|480802|P2|Overall Study|Withdrawal by Subject|4
133297|NCT00798161|480803|P1|Overall Study|Withdrawal by Subject|5
133298|NCT00798161|480797|P7|Overall Study|Lost to Follow-up|0
133299|NCT00798161|480798|P6|Overall Study|Lost to Follow-up|0
133300|NCT00798161|480799|P5|Overall Study|Lost to Follow-up|4
133301|NCT00798161|480800|P4|Overall Study|Lost to Follow-up|3
133302|NCT00798161|480801|P3|Overall Study|Lost to Follow-up|4
133303|NCT00798161|480802|P2|Overall Study|Lost to Follow-up|3
133304|NCT00798161|480803|P1|Overall Study|Lost to Follow-up|1
133305|NCT00798161|480797|P7|Overall Study|Protocol Violation|0
133306|NCT00798161|480798|P6|Overall Study|Protocol Violation|2
133307|NCT00798161|480799|P5|Overall Study|Protocol Violation|3
133308|NCT00798161|480800|P4|Overall Study|Protocol Violation|3
133309|NCT00798161|480801|P3|Overall Study|Protocol Violation|3
133310|NCT00798161|480802|P2|Overall Study|Protocol Violation|1
133311|NCT00798161|480803|P1|Overall Study|Protocol Violation|2
133312|NCT00798161|480797|P7|Overall Study|Adverse Event|4
133313|NCT00798161|480798|P6|Overall Study|Adverse Event|2
133314|NCT00798161|480799|P5|Overall Study|Adverse Event|5
133315|NCT00798161|480800|P4|Overall Study|Adverse Event|6
133316|NCT00798161|480801|P3|Overall Study|Adverse Event|6
133317|NCT00798161|480802|P2|Overall Study|Adverse Event|4
133318|NCT00798161|480803|P1|Overall Study|Adverse Event|3
133319|NCT00798135|480910|P1|Overall Study|Physician Decision|1
133320|NCT00798135|480910|P1|Overall Study|Disease progression, refractory|1
133321|NCT00798135|480910|P1|Overall Study|Disease progression, relapse|11
133322|NCT00798096|480916|P1|Overall Study|Ongoing|2
133323|NCT00797966|480944|P6|Phase A+|Protocol deviation|4
133324|NCT00797966|480945|P5|Phase A+|Protocol deviation|0
133325|NCT00797966|480946|P4|Phase A+|Protocol deviation|0
133326|NCT00797966|480947|P3|Phase A+|Protocol deviation|0
133327|NCT00797966|480948|P2|Phase A+|Protocol deviation|0
133328|NCT00797966|480949|P1|Phase A+|Protocol deviation|0
133329|NCT00797966|480944|P6|Phase A+|Adverse Event|4
133330|NCT00797966|480945|P5|Phase A+|Adverse Event|0
133331|NCT00797966|480946|P4|Phase A+|Adverse Event|0
133332|NCT00797966|480947|P3|Phase A+|Adverse Event|0
133333|NCT00797966|480948|P2|Phase A+|Adverse Event|0
133334|NCT00797966|480949|P1|Phase A+|Adverse Event|0
133335|NCT00797966|480944|P6|Phase A+|Withdrawal by Subject|6
133336|NCT00797966|480945|P5|Phase A+|Withdrawal by Subject|0
133337|NCT00797966|480946|P4|Phase A+|Withdrawal by Subject|0
133338|NCT00797966|480947|P3|Phase A+|Withdrawal by Subject|0
133339|NCT00797966|480948|P2|Phase A+|Withdrawal by Subject|0
133340|NCT00797966|480949|P1|Phase A+|Withdrawal by Subject|0
133341|NCT00797966|480944|P6|Phase A+|Met withdrawal criteria|5
133342|NCT00797966|480945|P5|Phase A+|Met withdrawal criteria|0
133343|NCT00797966|480946|P4|Phase A+|Met withdrawal criteria|0
133344|NCT00797966|480947|P3|Phase A+|Met withdrawal criteria|0
133345|NCT00797966|480948|P2|Phase A+|Met withdrawal criteria|0
133346|NCT00797966|480949|P1|Phase A+|Met withdrawal criteria|0
133347|NCT00797966|480944|P6|Phase A+|Lost to Follow-up|9
133348|NCT00797966|480945|P5|Phase A+|Lost to Follow-up|0
133349|NCT00797966|480946|P4|Phase A+|Lost to Follow-up|0
133350|NCT00797966|480947|P3|Phase A+|Lost to Follow-up|0
133351|NCT00797966|480948|P2|Phase A+|Lost to Follow-up|0
133352|NCT00797966|480949|P1|Phase A+|Lost to Follow-up|0
133353|NCT00797966|480944|P6|Phase B|Lack of Efficacy|0
133354|NCT00797966|480945|P5|Phase B|Lack of Efficacy|0
133355|NCT00797966|480946|P4|Phase B|Lack of Efficacy|4
133356|NCT00797966|480947|P3|Phase B|Lack of Efficacy|1
133357|NCT00797966|480948|P2|Phase B|Lack of Efficacy|1
133358|NCT00797966|480949|P1|Phase B|Lack of Efficacy|0
133359|NCT00797966|480944|P6|Phase B|Protocol Deviation|0
133360|NCT00797966|480945|P5|Phase B|Protocol Deviation|0
133361|NCT00797966|480946|P4|Phase B|Protocol Deviation|6
133362|NCT00797966|480947|P3|Phase B|Protocol Deviation|2
133363|NCT00797966|480948|P2|Phase B|Protocol Deviation|8
133364|NCT00797966|480949|P1|Phase B|Protocol Deviation|4
133365|NCT00797966|480944|P6|Phase B|Withdrawal by Subject|0
133366|NCT00797966|480945|P5|Phase B|Withdrawal by Subject|0
133367|NCT00797966|480946|P4|Phase B|Withdrawal by Subject|3
133368|NCT00797966|480947|P3|Phase B|Withdrawal by Subject|3
133369|NCT00797966|480948|P2|Phase B|Withdrawal by Subject|4
133370|NCT00797966|480949|P1|Phase B|Withdrawal by Subject|1
133371|NCT00797966|480944|P6|Phase B|Physician Decision|0
133372|NCT00797966|480945|P5|Phase B|Physician Decision|0
133373|NCT00797966|480946|P4|Phase B|Physician Decision|1
133374|NCT00797966|480947|P3|Phase B|Physician Decision|3
133375|NCT00797966|480948|P2|Phase B|Physician Decision|0
133376|NCT00797966|480949|P1|Phase B|Physician Decision|1
133377|NCT00797966|480944|P6|Phase B|Met Withdrawal Criteria|0
133378|NCT00797966|480945|P5|Phase B|Met Withdrawal Criteria|0
133379|NCT00797966|480946|P4|Phase B|Met Withdrawal Criteria|1
133380|NCT00797966|480947|P3|Phase B|Met Withdrawal Criteria|6
133381|NCT00797966|480948|P2|Phase B|Met Withdrawal Criteria|3
133382|NCT00797966|480949|P1|Phase B|Met Withdrawal Criteria|3
133383|NCT00797966|480944|P6|Phase B|Adverse Event|0
133384|NCT00797966|480945|P5|Phase B|Adverse Event|0
133385|NCT00797966|480946|P4|Phase B|Adverse Event|1
133386|NCT00797966|480947|P3|Phase B|Adverse Event|3
133387|NCT00797966|480948|P2|Phase B|Adverse Event|1
133388|NCT00797966|480949|P1|Phase B|Adverse Event|2
133389|NCT00797966|480944|P6|Phase B|Lost to Follow-up|0
133390|NCT00797966|480945|P5|Phase B|Lost to Follow-up|0
133391|NCT00797966|480946|P4|Phase B|Lost to Follow-up|0
133392|NCT00797966|480947|P3|Phase B|Lost to Follow-up|3
133393|NCT00797966|480948|P2|Phase B|Lost to Follow-up|1
133394|NCT00797966|480949|P1|Phase B|Lost to Follow-up|0
133395|NCT00797966|480944|P6|Phase A|Protocol deviation|0
133396|NCT00797966|480945|P5|Phase A|Protocol deviation|56
133397|NCT00797966|480946|P4|Phase A|Protocol deviation|0
133398|NCT00797966|480947|P3|Phase A|Protocol deviation|0
133399|NCT00797966|480948|P2|Phase A|Protocol deviation|0
133400|NCT00797966|480949|P1|Phase A|Protocol deviation|0
133401|NCT00797966|480944|P6|Phase A|Withdrawal by Subject|0
133402|NCT00797966|480945|P5|Phase A|Withdrawal by Subject|33
133403|NCT00797966|480946|P4|Phase A|Withdrawal by Subject|0
133404|NCT00797966|480947|P3|Phase A|Withdrawal by Subject|0
133405|NCT00797966|480948|P2|Phase A|Withdrawal by Subject|0
133406|NCT00797966|480949|P1|Phase A|Withdrawal by Subject|0
133407|NCT00797966|480944|P6|Phase A|Physician Decision|0
133408|NCT00797966|480945|P5|Phase A|Physician Decision|13
133409|NCT00797966|480946|P4|Phase A|Physician Decision|0
133410|NCT00797966|480947|P3|Phase A|Physician Decision|0
133411|NCT00797966|480948|P2|Phase A|Physician Decision|0
133412|NCT00797966|480949|P1|Phase A|Physician Decision|0
133413|NCT00797966|480944|P6|Phase A|Met withdrawal criteria|0
133414|NCT00797966|480945|P5|Phase A|Met withdrawal criteria|4
133415|NCT00797966|480946|P4|Phase A|Met withdrawal criteria|0
133416|NCT00797966|480947|P3|Phase A|Met withdrawal criteria|0
133417|NCT00797966|480948|P2|Phase A|Met withdrawal criteria|0
133418|NCT00797966|480949|P1|Phase A|Met withdrawal criteria|0
133419|NCT00797966|480944|P6|Phase A|Adverse Event|0
133420|NCT00797966|480945|P5|Phase A|Adverse Event|46
133421|NCT00797966|480946|P4|Phase A|Adverse Event|0
133422|NCT00797966|480947|P3|Phase A|Adverse Event|0
133423|NCT00797966|480948|P2|Phase A|Adverse Event|0
133424|NCT00797966|480949|P1|Phase A|Adverse Event|0
133425|NCT00797966|480944|P6|Phase A|Lost to Follow-up|0
133426|NCT00797966|480945|P5|Phase A|Lost to Follow-up|33
133427|NCT00797966|480946|P4|Phase A|Lost to Follow-up|0
133428|NCT00797966|480947|P3|Phase A|Lost to Follow-up|0
133429|NCT00797966|480948|P2|Phase A|Lost to Follow-up|0
133430|NCT00797966|480949|P1|Phase A|Lost to Follow-up|0
133431|NCT00797862|481014|P3|Overall Study|Mis-randomized|1
133432|NCT00797862|481015|P2|Overall Study|Mis-randomized|3
133433|NCT00797862|481016|P1|Overall Study|Mis-randomized|3
133434|NCT00797862|481014|P3|Overall Study|Protocol Violation|8
133435|NCT00797862|481015|P2|Overall Study|Protocol Violation|6
133436|NCT00797862|481016|P1|Overall Study|Protocol Violation|4
133437|NCT00797862|481014|P3|Overall Study|Administrative Problem|0
133438|NCT00797862|481015|P2|Overall Study|Administrative Problem|0
133439|NCT00797862|481016|P1|Overall Study|Administrative Problem|4
133440|NCT00797862|481014|P3|Overall Study|Lost to Follow-up|5
133441|NCT00797862|481015|P2|Overall Study|Lost to Follow-up|0
133442|NCT00797862|481016|P1|Overall Study|Lost to Follow-up|11
133443|NCT00797862|481014|P3|Overall Study|Withdrawal by Subject|7
133444|NCT00797862|481015|P2|Overall Study|Withdrawal by Subject|7
133445|NCT00797862|481016|P1|Overall Study|Withdrawal by Subject|14
133446|NCT00797862|481014|P3|Overall Study|No longer required study medication|0
133447|NCT00797862|481015|P2|Overall Study|No longer required study medication|0
133448|NCT00797862|481016|P1|Overall Study|No longer required study medication|1
133449|NCT00797862|481014|P3|Overall Study|Lack of Efficacy|6
133450|NCT00797862|481015|P2|Overall Study|Lack of Efficacy|7
133451|NCT00797862|481016|P1|Overall Study|Lack of Efficacy|1
133452|NCT00797862|481014|P3|Overall Study|Abnormal Test Procedure Result|1
133453|NCT00797862|481015|P2|Overall Study|Abnormal Test Procedure Result|1
133454|NCT00797862|481016|P1|Overall Study|Abnormal Test Procedure Result|0
133455|NCT00797862|481014|P3|Overall Study|Adverse Event|58
133456|NCT00797862|481015|P2|Overall Study|Adverse Event|44
133457|NCT00797862|481016|P1|Overall Study|Adverse Event|86
133458|NCT00797823|481045|P3|First Period (Initial Randomization)|Physician Decision|0
133459|NCT00797823|481046|P2|First Period (Initial Randomization)|Physician Decision|0
133460|NCT00797823|481047|P1|First Period (Initial Randomization)|Physician Decision|1
133461|NCT00797732|481069|P3|Overall Study|Refused to Participate|123
133462|NCT00797732|481070|P2|Overall Study|Refused to Participate|0
133463|NCT00797732|481071|P1|Overall Study|Refused to Participate|0
133464|NCT00797732|481069|P3|Overall Study|Excluded due to time constraints|24
133465|NCT00797732|481070|P2|Overall Study|Excluded due to time constraints|0
133466|NCT00797732|481071|P1|Overall Study|Excluded due to time constraints|0
133467|NCT00797732|481069|P3|Overall Study|Not meet inclusion criteria|7
133468|NCT00797732|481070|P2|Overall Study|Not meet inclusion criteria|0
133469|NCT00797732|481071|P1|Overall Study|Not meet inclusion criteria|0
133470|NCT00797732|481069|P3|Overall Study|Death|0
133471|NCT00797732|481070|P2|Overall Study|Death|0
133472|NCT00797732|481071|P1|Overall Study|Death|1
133473|NCT00797732|481069|P3|Overall Study|Lost to Follow-up|0
133474|NCT00797732|481070|P2|Overall Study|Lost to Follow-up|0
133475|NCT00797732|481071|P1|Overall Study|Lost to Follow-up|1
133476|NCT00797732|481069|P3|Overall Study|Withdrawal by Subject|0
133477|NCT00797732|481070|P2|Overall Study|Withdrawal by Subject|3
133478|NCT00797732|481071|P1|Overall Study|Withdrawal by Subject|3
133479|NCT00797667|481086|P3|Overall Study|Adverse Event|8
133480|NCT00797667|481087|P2|Overall Study|Adverse Event|8
133481|NCT00797667|481088|P1|Overall Study|Adverse Event|19
133482|NCT00797667|481086|P3|Overall Study|Withdrawal by Subject|2
133483|NCT00797667|481087|P2|Overall Study|Withdrawal by Subject|14
133484|NCT00797667|481088|P1|Overall Study|Withdrawal by Subject|9
133485|NCT00797667|481086|P3|Overall Study|Study Terminated by Sponsor|115
133486|NCT00797667|481087|P2|Overall Study|Study Terminated by Sponsor|216
133487|NCT00797667|481088|P1|Overall Study|Study Terminated by Sponsor|217
133488|NCT00797667|481086|P3|Overall Study|Protocol Violation|0
133489|NCT00797667|481087|P2|Overall Study|Protocol Violation|7
133490|NCT00797667|481088|P1|Overall Study|Protocol Violation|2
133491|NCT00797667|481086|P3|Overall Study|Pregnancy|0
133492|NCT00797667|481087|P2|Overall Study|Pregnancy|0
133493|NCT00797667|481088|P1|Overall Study|Pregnancy|2
133494|NCT00797667|481086|P3|Overall Study|Physician Decision|0
133495|NCT00797667|481087|P2|Overall Study|Physician Decision|1
133496|NCT00797667|481088|P1|Overall Study|Physician Decision|3
133497|NCT00797667|481086|P3|Overall Study|Lost to Follow-up|2
133498|NCT00797667|481087|P2|Overall Study|Lost to Follow-up|12
133499|NCT00797667|481088|P1|Overall Study|Lost to Follow-up|8
133500|NCT00797667|481086|P3|Overall Study|Lack of Efficacy|0
133501|NCT00797667|481087|P2|Overall Study|Lack of Efficacy|1
133502|NCT00797667|481088|P1|Overall Study|Lack of Efficacy|0
133503|NCT00797563|481114|P1|Overall Study|Adverse Event|1
134806|NCT00788957|485754|P1|Part 2|Death|0
133504|NCT00797511|481120|P1|Overall Study|Withdrawal by Subject|1
133505|NCT00797316|481138|P2|Overall Study|Unsatisfactory therapeutic effect|13
133506|NCT00797316|481139|P1|Overall Study|Unsatisfactory therapeutic effect|0
133507|NCT00797316|481138|P2|Overall Study|Patient withdrew consent|6
133508|NCT00797316|481139|P1|Overall Study|Patient withdrew consent|12
133509|NCT00797316|481138|P2|Overall Study|Protocol Deviation|2
133510|NCT00797316|481139|P1|Overall Study|Protocol Deviation|1
133511|NCT00797316|481138|P2|Overall Study|Lost to Follow-up|8
133512|NCT00797316|481139|P1|Overall Study|Lost to Follow-up|4
133513|NCT00797316|481138|P2|Overall Study|Adverse Event|3
133514|NCT00797316|481139|P1|Overall Study|Adverse Event|5
133515|NCT00797316|481138|P2|Overall Study|Administrative problems|0
133516|NCT00797316|481139|P1|Overall Study|Administrative problems|1
133517|NCT00797108|481173|P3|Overall Study|Randomized but not Treated|0
133518|NCT00797108|481174|P2|Overall Study|Randomized but not Treated|0
133519|NCT00797108|481175|P1|Overall Study|Randomized but not Treated|2
133520|NCT00797108|481173|P3|Overall Study|Other|2
133521|NCT00797108|481174|P2|Overall Study|Other|0
133522|NCT00797108|481175|P1|Overall Study|Other|0
133523|NCT00797108|481173|P3|Overall Study|Lack of Efficacy|1
133524|NCT00797108|481174|P2|Overall Study|Lack of Efficacy|0
133525|NCT00797108|481175|P1|Overall Study|Lack of Efficacy|1
133526|NCT00797108|481173|P3|Overall Study|Global Deterioration of Health Status|0
133527|NCT00797108|481174|P2|Overall Study|Global Deterioration of Health Status|1
133528|NCT00797108|481175|P1|Overall Study|Global Deterioration of Health Status|0
133529|NCT00797108|481173|P3|Overall Study|Did Not Meet Entrance Criteria|0
133530|NCT00797108|481174|P2|Overall Study|Did Not Meet Entrance Criteria|1
133531|NCT00797108|481175|P1|Overall Study|Did Not Meet Entrance Criteria|0
133532|NCT00797108|481173|P3|Overall Study|Adverse Event|3
133533|NCT00797108|481174|P2|Overall Study|Adverse Event|0
133534|NCT00797108|481175|P1|Overall Study|Adverse Event|1
133535|NCT00796991|481210|P3|Overall Study|Withdrawal by Subject|1
133536|NCT00796991|481211|P2|Overall Study|Withdrawal by Subject|0
133537|NCT00796991|481212|P1|Overall Study|Withdrawal by Subject|0
133538|NCT00796991|481210|P3|Overall Study|Study Drug Toxicity|5
133539|NCT00796991|481211|P2|Overall Study|Study Drug Toxicity|3
133540|NCT00796991|481212|P1|Overall Study|Study Drug Toxicity|3
133541|NCT00796991|481210|P3|Overall Study|Disease Progression|7
133542|NCT00796991|481211|P2|Overall Study|Disease Progression|9
133543|NCT00796991|481212|P1|Overall Study|Disease Progression|10
133544|NCT00796991|481210|P3|Overall Study|Death|0
133545|NCT00796991|481211|P2|Overall Study|Death|0
133546|NCT00796991|481212|P1|Overall Study|Death|2
133547|NCT00796991|481210|P3|Overall Study|Adverse Event|1
133548|NCT00796991|481211|P2|Overall Study|Adverse Event|0
133549|NCT00796991|481212|P1|Overall Study|Adverse Event|0
133550|NCT00796861|481319|P1|Overall Study|Death|2
133551|NCT00796861|481319|P1|Overall Study|Withdrawal by Subject|2
133552|NCT00796822|481325|P2|Overall Study|Adverse Event|0
133553|NCT00796822|481326|P1|Overall Study|Adverse Event|1
133554|NCT00796822|481325|P2|Overall Study|Lost to Follow-up|0
133555|NCT00796822|481326|P1|Overall Study|Lost to Follow-up|2
133556|NCT00796757|481334|P1|Overall Study|Not specified|7
133557|NCT00796757|481334|P1|Overall Study|Investigator's decision|2
133558|NCT00796757|481334|P1|Overall Study|Participant noncompliance|1
133559|NCT00796757|481334|P1|Overall Study|Protocol Violation|1
133560|NCT00796757|481334|P1|Overall Study|Death|61
133561|NCT00796757|481334|P1|Overall Study|Withdrawal by Subject|14
133562|NCT00796718|481368|P1|Overall Study|Withdrawal by Informed Consent|1
133563|NCT00796718|481368|P1|Overall Study|Lost to Follow-up|5
133564|NCT00796718|481368|P1|Overall Study|Exclusion Criteria|1
133565|NCT00796718|481368|P1|Overall Study|Adverse Event|2
133566|NCT00796666|481420|P2|Overall Study|Randomized and not treated|0
133567|NCT00796666|481421|P1|Overall Study|Randomized and not treated|1
133568|NCT00796666|481420|P2|Overall Study|Terminated by sponsor|55
133569|NCT00796666|481421|P1|Overall Study|Terminated by sponsor|53
133570|NCT00796666|481420|P2|Overall Study|Other|0
133571|NCT00796666|481421|P1|Overall Study|Other|1
133572|NCT00796666|481420|P2|Overall Study|Protocol Violation|0
133573|NCT00796666|481421|P1|Overall Study|Protocol Violation|1
133574|NCT00796666|481420|P2|Overall Study|Adverse Event|5
133575|NCT00796666|481421|P1|Overall Study|Adverse Event|7
133576|NCT00796666|481420|P2|Overall Study|Withdrawal by Subject|0
133577|NCT00796666|481421|P1|Overall Study|Withdrawal by Subject|2
133578|NCT00796666|481420|P2|Overall Study|Death|4
133579|NCT00796666|481421|P1|Overall Study|Death|2
133580|NCT00796653|481455|P4|Overall Study|Other reason not described above|4
133581|NCT00796653|481456|P3|Overall Study|Other reason not described above|7
133582|NCT00796653|481457|P2|Overall Study|Other reason not described above|9
133583|NCT00796653|481458|P1|Overall Study|Other reason not described above|4
133584|NCT00796653|481455|P4|Overall Study|Non compliance with protocol|2
133585|NCT00796653|481456|P3|Overall Study|Non compliance with protocol|0
133586|NCT00796653|481457|P2|Overall Study|Non compliance with protocol|2
133587|NCT00796653|481458|P1|Overall Study|Non compliance with protocol|2
133588|NCT00796653|481455|P4|Overall Study|Lack of Efficacy|2
133589|NCT00796653|481456|P3|Overall Study|Lack of Efficacy|3
133590|NCT00796653|481457|P2|Overall Study|Lack of Efficacy|1
133591|NCT00796653|481458|P1|Overall Study|Lack of Efficacy|8
133592|NCT00796653|481455|P4|Overall Study|Withdrawal by Subject|13
133593|NCT00796653|481456|P3|Overall Study|Withdrawal by Subject|8
133594|NCT00796653|481457|P2|Overall Study|Withdrawal by Subject|8
133595|NCT00796653|481458|P1|Overall Study|Withdrawal by Subject|16
133596|NCT00796653|481455|P4|Overall Study|Lost to Follow-up|3
133597|NCT00796653|481456|P3|Overall Study|Lost to Follow-up|2
133598|NCT00796653|481457|P2|Overall Study|Lost to Follow-up|1
133599|NCT00796653|481458|P1|Overall Study|Lost to Follow-up|2
133600|NCT00796653|481455|P4|Overall Study|Adverse Event|16
133601|NCT00796653|481456|P3|Overall Study|Adverse Event|16
133602|NCT00796653|481457|P2|Overall Study|Adverse Event|16
133603|NCT00796653|481458|P1|Overall Study|Adverse Event|19
133604|NCT00796614|481743|P4|Overall Study|Other than stated|0
133605|NCT00796614|481744|P3|Overall Study|Other than stated|0
133606|NCT00796614|481745|P2|Overall Study|Other than stated|0
133607|NCT00796614|481746|P1|Overall Study|Other than stated|1
133608|NCT00796614|481743|P4|Overall Study|Withdrawal by Subject|1
133609|NCT00796614|481744|P3|Overall Study|Withdrawal by Subject|0
133610|NCT00796614|481745|P2|Overall Study|Withdrawal by Subject|0
133611|NCT00796614|481746|P1|Overall Study|Withdrawal by Subject|1
133612|NCT00796614|481743|P4|Overall Study|Lost to Follow-up|0
133613|NCT00796614|481744|P3|Overall Study|Lost to Follow-up|1
133614|NCT00796614|481745|P2|Overall Study|Lost to Follow-up|2
133615|NCT00796614|481746|P1|Overall Study|Lost to Follow-up|2
133616|NCT00796614|481743|P4|Overall Study|Protocol Violation|0
133617|NCT00796614|481744|P3|Overall Study|Protocol Violation|2
133618|NCT00796614|481745|P2|Overall Study|Protocol Violation|0
133619|NCT00796614|481746|P1|Overall Study|Protocol Violation|0
133620|NCT00796614|481743|P4|Overall Study|Adverse Event|0
133621|NCT00796614|481744|P3|Overall Study|Adverse Event|0
133622|NCT00796614|481745|P2|Overall Study|Adverse Event|2
133623|NCT00796614|481746|P1|Overall Study|Adverse Event|1
133624|NCT00796549|481788|P1|Overall Study|Progressive disease|56
133625|NCT00796549|481788|P1|Overall Study|Other|2
133626|NCT00796549|481788|P1|Overall Study|not entered|149
133627|NCT00796549|481788|P1|Overall Study|Adverse Event|11
133628|NCT00796523|481805|P2|Overall Study|Lost to Follow-up|7
133629|NCT00796523|481806|P1|Overall Study|Lost to Follow-up|9
133630|NCT00796510|481816|P2|Overall Study|Study Terminated|0
133631|NCT00796510|481817|P1|Overall Study|Study Terminated|2
133632|NCT00796510|481816|P2|Overall Study|Death|0
133633|NCT00796510|481817|P1|Overall Study|Death|1
133634|NCT00796419|481829|P2|Overall Study|Death|1
133635|NCT00796419|481830|P1|Overall Study|Death|0
133636|NCT00796367|481843|P3|Overall Study|other|3
133637|NCT00796367|481844|P2|Overall Study|other|4
133638|NCT00796367|481845|P1|Overall Study|other|2
133639|NCT00796367|481843|P3|Overall Study|Requirement for restricted medication|2
133640|NCT00796367|481844|P2|Overall Study|Requirement for restricted medication|0
133641|NCT00796367|481845|P1|Overall Study|Requirement for restricted medication|2
133642|NCT00796367|481843|P3|Overall Study|Pregnancy|1
133643|NCT00796367|481844|P2|Overall Study|Pregnancy|0
133644|NCT00796367|481845|P1|Overall Study|Pregnancy|1
133645|NCT00796367|481843|P3|Overall Study|non compliance|1
133646|NCT00796367|481844|P2|Overall Study|non compliance|1
133647|NCT00796367|481845|P1|Overall Study|non compliance|3
133648|NCT00796367|481843|P3|Overall Study|Lack of Efficacy|0
133649|NCT00796367|481844|P2|Overall Study|Lack of Efficacy|1
133650|NCT00796367|481845|P1|Overall Study|Lack of Efficacy|2
133651|NCT00796367|481843|P3|Overall Study|Withdrawal by Subject|12
133652|NCT00796367|481844|P2|Overall Study|Withdrawal by Subject|11
133653|NCT00796367|481845|P1|Overall Study|Withdrawal by Subject|9
133654|NCT00796367|481843|P3|Overall Study|Lost to Follow-up|21
133655|NCT00796367|481844|P2|Overall Study|Lost to Follow-up|4
133656|NCT00796367|481845|P1|Overall Study|Lost to Follow-up|5
133657|NCT00796367|481843|P3|Overall Study|Adverse Event|7
133658|NCT00796367|481844|P2|Overall Study|Adverse Event|4
133659|NCT00796367|481845|P1|Overall Study|Adverse Event|6
133660|NCT00796328|481856|P1|Overall Study|experienced hypotension requiring tx|6
133661|NCT00796315|481860|P3|Overall Study|Protocol Violation|0
133662|NCT00796315|481861|P2|Overall Study|Protocol Violation|1
133663|NCT00796315|481862|P1|Overall Study|Protocol Violation|0
133664|NCT00796224|481890|P2|Overall Study|Protocol Violation|1
133665|NCT00796224|481891|P1|Overall Study|Protocol Violation|0
133666|NCT00796224|481890|P2|Overall Study|Adverse Event|0
133667|NCT00796224|481891|P1|Overall Study|Adverse Event|1
133668|NCT00796120|481911|P2|Overall Study|Randomized but not treated|3
133669|NCT00796120|481912|P1|Overall Study|Randomized but not treated|0
133670|NCT00796120|481911|P2|Overall Study|Physician Decision|17
133671|NCT00796120|481912|P1|Overall Study|Physician Decision|16
133672|NCT00796120|481911|P2|Overall Study|Other|17
133673|NCT00796120|481912|P1|Overall Study|Other|6
133674|NCT00796120|481911|P2|Overall Study|Participant refusal|4
133675|NCT00796120|481912|P1|Overall Study|Participant refusal|3
133676|NCT00796120|481911|P2|Overall Study|Progressive disease|13
133677|NCT00796120|481912|P1|Overall Study|Progressive disease|22
133678|NCT00796120|481911|P2|Overall Study|Adverse Event|6
133679|NCT00796120|481912|P1|Overall Study|Adverse Event|11
133680|NCT00796120|481911|P2|Overall Study|Death|0
133681|NCT00796120|481912|P1|Overall Study|Death|3
133682|NCT00796003|481928|P2|Overall Study|Participants Not treated|2
133683|NCT00796003|481929|P1|Overall Study|Participants Not treated|0
133684|NCT00796003|481928|P2|Overall Study|Other|1
133685|NCT00796003|481929|P1|Overall Study|Other|0
133686|NCT00796003|481928|P2|Overall Study|Withdrawal by Subject|1
133687|NCT00796003|481929|P1|Overall Study|Withdrawal by Subject|0
133688|NCT00796003|481928|P2|Overall Study|Physician Decision|4
133689|NCT00796003|481929|P1|Overall Study|Physician Decision|0
133690|NCT00796003|481928|P2|Overall Study|Specified organ function not met|1
133691|NCT00796003|481929|P1|Overall Study|Specified organ function not met|0
133692|NCT00796003|481928|P2|Overall Study|Adverse Event|7
133693|NCT00796003|481929|P1|Overall Study|Adverse Event|1
133694|NCT00796003|481928|P2|Overall Study|Disease Progression|13
133695|NCT00796003|481929|P1|Overall Study|Disease Progression|2
133696|NCT00795951|481950|P1|Overall Study|Withdrawal by Subject|1
133697|NCT00795951|481950|P1|Overall Study|Lost to Follow-up|1
133698|NCT00795886|481987|P1|Overall Study|Death|10
133699|NCT00795821|481995|P2|Taper Phase|Withdrawal by Subject|0
133700|NCT00795821|481996|P1|Taper Phase|Withdrawal by Subject|4
133701|NCT00795821|481995|P2|Taper Phase|Physician Decision|0
133702|NCT00795821|481996|P1|Taper Phase|Physician Decision|2
133703|NCT00795821|481995|P2|Taper Phase|Lost to Follow-up|0
133704|NCT00795821|481996|P1|Taper Phase|Lost to Follow-up|1
133705|NCT00795821|481995|P2|Taper Phase|Adverse Event|0
133706|NCT00795821|481996|P1|Taper Phase|Adverse Event|2
133707|NCT00795821|481995|P2|Long-term Extension Phase|Withdrawal by Subject|25
133708|NCT00795821|481996|P1|Long-term Extension Phase|Withdrawal by Subject|25
133709|NCT00795821|481995|P2|Long-term Extension Phase|Protocol Violation|5
133710|NCT00795821|481996|P1|Long-term Extension Phase|Protocol Violation|3
133711|NCT00795821|481995|P2|Long-term Extension Phase|Physician Decision|2
133712|NCT00795821|481996|P1|Long-term Extension Phase|Physician Decision|1
133713|NCT00795821|481995|P2|Long-term Extension Phase|Lost to Follow-up|16
133714|NCT00795821|481996|P1|Long-term Extension Phase|Lost to Follow-up|20
133715|NCT00795821|481995|P2|Long-term Extension Phase|Lack of Efficacy|12
133716|NCT00795821|481996|P1|Long-term Extension Phase|Lack of Efficacy|16
133717|NCT00795821|481995|P2|Long-term Extension Phase|Adverse Event|32
133718|NCT00795821|481996|P1|Long-term Extension Phase|Adverse Event|25
133719|NCT00795821|481995|P2|Acute Treatment Phase|Withdrawal by Subject|10
133720|NCT00795821|481996|P1|Acute Treatment Phase|Withdrawal by Subject|16
133721|NCT00795821|481995|P2|Acute Treatment Phase|Protocol Violation|2
133722|NCT00795821|481996|P1|Acute Treatment Phase|Protocol Violation|1
133723|NCT00795821|481995|P2|Acute Treatment Phase|Physician Decision|1
133724|NCT00795821|481996|P1|Acute Treatment Phase|Physician Decision|1
133725|NCT00795821|481995|P2|Acute Treatment Phase|Lost to Follow-up|12
133726|NCT00795821|481996|P1|Acute Treatment Phase|Lost to Follow-up|9
133727|NCT00795821|481995|P2|Acute Treatment Phase|Lack of Efficacy|2
133728|NCT00795821|481996|P1|Acute Treatment Phase|Lack of Efficacy|5
133729|NCT00795821|481995|P2|Acute Treatment Phase|Death|0
133730|NCT00795821|481996|P1|Acute Treatment Phase|Death|1
133731|NCT00795821|481995|P2|Acute Treatment Phase|Adverse Event|4
133732|NCT00795821|481996|P1|Acute Treatment Phase|Adverse Event|23
133733|NCT00795717|482071|P2|Phase II|too busy|1
133734|NCT00795717|482072|P1|Phase II|too busy|0
133735|NCT00795717|482071|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
133736|NCT00795717|482072|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
133737|NCT00795717|482071|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
133738|NCT00795717|482072|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
133739|NCT00795717|482071|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
133740|NCT00795717|482072|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
133741|NCT00795704|482084|P2|Overall Study|Adverse Event|1
133742|NCT00795704|482085|P1|Overall Study|Adverse Event|1
133743|NCT00795704|482084|P2|Overall Study|Withdrawal by Subject|2
133744|NCT00795704|482085|P1|Overall Study|Withdrawal by Subject|3
133745|NCT00795639|482097|P2|Overall Study|Randomized and not treated|1
133746|NCT00795639|482098|P1|Overall Study|Randomized and not treated|0
133747|NCT00795639|482097|P2|Overall Study|Terminated by sponsor|12
133748|NCT00795639|482098|P1|Overall Study|Terminated by sponsor|13
133749|NCT00795639|482097|P2|Overall Study|Other|2
133750|NCT00795639|482098|P1|Overall Study|Other|0
133751|NCT00795639|482097|P2|Overall Study|Adverse Event|2
133752|NCT00795639|482098|P1|Overall Study|Adverse Event|5
133753|NCT00795639|482097|P2|Overall Study|Pregnancy|0
133754|NCT00795639|482098|P1|Overall Study|Pregnancy|1
133755|NCT00795639|482097|P2|Overall Study|Withdrawal by Subject|3
133756|NCT00795639|482098|P1|Overall Study|Withdrawal by Subject|1
133757|NCT00795639|482097|P2|Overall Study|Death|6
133758|NCT00795639|482098|P1|Overall Study|Death|1
133759|NCT00795600|482110|P2|Overall Study|Unclassified|1
133760|NCT00795600|482111|P1|Overall Study|Unclassified|1
133761|NCT00795600|482110|P2|Overall Study|Withdrawal by Subject|0
133762|NCT00795600|482111|P1|Overall Study|Withdrawal by Subject|1
133763|NCT00795600|482110|P2|Overall Study|Protocol Violation|2
133764|NCT00795600|482111|P1|Overall Study|Protocol Violation|1
133765|NCT00795600|482110|P2|Overall Study|Adverse Event|1
133766|NCT00795600|482111|P1|Overall Study|Adverse Event|1
133767|NCT00795535|482231|P1|Overall Study|incomplete data and technical problems|20
133768|NCT00795509|482238|P1|Overall Study|Protocol Violation|31
133769|NCT00795184|482294|P2|Overall Study|Tissue sampling incomplete/conclusive|13
133770|NCT00795184|482295|P1|Overall Study|Tissue sampling incomplete/conclusive|8
133771|NCT00795132|482356|P1|Overall Study|Relapse|2
133772|NCT00795132|482356|P1|Overall Study|Death|1
133773|NCT00794963|482379|P2|Overall Study|Withdrawal by Subject|4
133774|NCT00794963|482380|P1|Overall Study|Withdrawal by Subject|1
133775|NCT00794924|482388|P2|Overall Study|Adverse Event|2
133776|NCT00794924|482389|P1|Overall Study|Adverse Event|6
133777|NCT00794924|482388|P2|Overall Study|Withdrawal by Subject|60
133778|NCT00794924|482389|P1|Overall Study|Withdrawal by Subject|48
133779|NCT00794924|482388|P2|Overall Study|Lost to Follow-up|8
133780|NCT00794924|482389|P1|Overall Study|Lost to Follow-up|6
133781|NCT00794820|482393|P1|Overall Study|Ineligible/Screen Failure|1
133782|NCT00794820|482393|P1|Overall Study|Resistant Disease|2
133783|NCT00794820|482393|P1|Overall Study|Secondary Malignancies|2
133784|NCT00794820|482393|P1|Overall Study|Adverse Event|11
133785|NCT00794677|482401|P2|First Intervention|Withdrawal by Subject|0
133786|NCT00794677|482402|P1|First Intervention|Withdrawal by Subject|2
133787|NCT00794664|482424|P2|Follow-up Period|Protocol non-compliance|1
133788|NCT00794664|482425|P1|Follow-up Period|Protocol non-compliance|0
133789|NCT00794664|482424|P2|Follow-up Period|Withdrawal by Subject|2
133790|NCT00794664|482425|P1|Follow-up Period|Withdrawal by Subject|0
133791|NCT00794664|482424|P2|Follow-up Period|Not specified|2
133792|NCT00794664|482425|P1|Follow-up Period|Not specified|1
133793|NCT00794664|482424|P2|Treatment Period|Adverse Event|8
133794|NCT00794664|482425|P1|Treatment Period|Adverse Event|1
133795|NCT00794664|482424|P2|Treatment Period|Not specified|1
133796|NCT00794664|482425|P1|Treatment Period|Not specified|0
133797|NCT00794664|482424|P2|Treatment Period|Protocol non-compliance|1
133798|NCT00794664|482425|P1|Treatment Period|Protocol non-compliance|0
133799|NCT00794664|482424|P2|Treatment Period|Withdrawal by Subject|2
133800|NCT00794664|482425|P1|Treatment Period|Withdrawal by Subject|0
133801|NCT00794365|482510|P1|Overall Study|Lack of Efficacy|3
133802|NCT00794365|482510|P1|Overall Study|Adverse Event|10
133803|NCT00794365|482510|P1|Overall Study|Poor Compliance|11
133804|NCT00794365|482510|P1|Overall Study|Other|17
133805|NCT00794365|482510|P1|Overall Study|Lost to Follow-up|38
133806|NCT00794196|482531|P2|Overall Study|Lost to Follow-up|23
133807|NCT00794196|482532|P1|Overall Study|Lost to Follow-up|5
133808|NCT00794157|482552|P3|Overall Study|Protocol deviation|1
133809|NCT00794157|482553|P2|Overall Study|Protocol deviation|1
133810|NCT00794157|482554|P1|Overall Study|Protocol deviation|0
133811|NCT00794157|482552|P3|Overall Study|Abnormal test procedure result(s)|0
133812|NCT00794157|482553|P2|Overall Study|Abnormal test procedure result(s)|1
133813|NCT00794157|482554|P1|Overall Study|Abnormal test procedure result(s)|0
133814|NCT00794157|482552|P3|Overall Study|Administrative problems|4
133815|NCT00794157|482553|P2|Overall Study|Administrative problems|7
133816|NCT00794157|482554|P1|Overall Study|Administrative problems|1
133817|NCT00794157|482552|P3|Overall Study|Unsatisfactory therapeutic effect|2
133818|NCT00794157|482553|P2|Overall Study|Unsatisfactory therapeutic effect|0
133819|NCT00794157|482554|P1|Overall Study|Unsatisfactory therapeutic effect|1
133820|NCT00794157|482552|P3|Overall Study|Lost to Follow-up|1
133821|NCT00794157|482553|P2|Overall Study|Lost to Follow-up|0
133822|NCT00794157|482554|P1|Overall Study|Lost to Follow-up|2
133823|NCT00794157|482552|P3|Overall Study|Subject withdrew consent|3
133824|NCT00794157|482553|P2|Overall Study|Subject withdrew consent|0
133825|NCT00794157|482554|P1|Overall Study|Subject withdrew consent|2
133826|NCT00794157|482552|P3|Overall Study|Adverse Event|8
133827|NCT00794157|482553|P2|Overall Study|Adverse Event|1
133828|NCT00794157|482554|P1|Overall Study|Adverse Event|4
133829|NCT00794118|482583|P1|Overall Study|Changed hospital center|2
133830|NCT00794118|482583|P1|Overall Study|Withdrawal by Subject|9
133831|NCT00794118|482583|P1|Overall Study|Lost to Follow-up|16
133832|NCT00793910|482641|P2|Overall Study|Withdrawal by Subject|1
133833|NCT00793910|482642|P1|Overall Study|Withdrawal by Subject|0
133834|NCT00793910|482641|P2|Overall Study|decided to undergo LASIK instead of PRK|1
133835|NCT00793910|482642|P1|Overall Study|decided to undergo LASIK instead of PRK|2
133836|NCT00793910|482641|P2|Overall Study|ineligible based on entry criteria|3
133837|NCT00793910|482642|P1|Overall Study|ineligible based on entry criteria|2
133838|NCT00793910|482641|P2|Overall Study|did not pick up medications|1
133839|NCT00793910|482642|P1|Overall Study|did not pick up medications|1
133840|NCT00793910|482641|P2|Overall Study|discarded study pills|1
133841|NCT00793910|482642|P1|Overall Study|discarded study pills|0
133842|NCT00793871|482656|P1|Overall Study|Study terminated by the Sponsor|7
133843|NCT00793871|482656|P1|Overall Study|Lost to Follow-up|3
133844|NCT00793871|482656|P1|Overall Study|Death|50
133845|NCT00793819|482670|P2|Overall Study|Lost to Follow-up|1
133846|NCT00793819|482671|P1|Overall Study|Lost to Follow-up|1
133847|NCT00793819|482670|P2|Overall Study|Withdrawal by Subject|3
133848|NCT00793819|482671|P1|Overall Study|Withdrawal by Subject|4
133849|NCT00793819|482670|P2|Overall Study|Lack of Efficacy|1
133850|NCT00793819|482671|P1|Overall Study|Lack of Efficacy|1
133851|NCT00793819|482670|P2|Overall Study|Adverse Event|4
133852|NCT00793819|482671|P1|Overall Study|Adverse Event|8
133853|NCT00793793|482689|P12|Overall Study|reason not specified|4
133854|NCT00793793|482690|P11|Overall Study|reason not specified|2
133855|NCT00793793|482691|P10|Overall Study|reason not specified|6
133856|NCT00793793|482692|P9|Overall Study|reason not specified|7
133857|NCT00793793|482693|P8|Overall Study|reason not specified|0
133858|NCT00793793|482694|P7|Overall Study|reason not specified|2
133859|NCT00793793|482695|P6|Overall Study|reason not specified|1
133860|NCT00793793|482696|P5|Overall Study|reason not specified|1
133861|NCT00793793|482697|P4|Overall Study|reason not specified|1
133862|NCT00793793|482698|P3|Overall Study|reason not specified|0
133863|NCT00793793|482699|P2|Overall Study|reason not specified|1
133864|NCT00793793|482700|P1|Overall Study|reason not specified|0
133865|NCT00793793|482689|P12|Overall Study|Withdrawal by Subject|0
133866|NCT00793793|482690|P11|Overall Study|Withdrawal by Subject|0
133867|NCT00793793|482691|P10|Overall Study|Withdrawal by Subject|0
133868|NCT00793793|482692|P9|Overall Study|Withdrawal by Subject|1
133869|NCT00793793|482693|P8|Overall Study|Withdrawal by Subject|0
133870|NCT00793793|482694|P7|Overall Study|Withdrawal by Subject|0
133871|NCT00793793|482695|P6|Overall Study|Withdrawal by Subject|0
133872|NCT00793793|482696|P5|Overall Study|Withdrawal by Subject|1
133873|NCT00793793|482697|P4|Overall Study|Withdrawal by Subject|0
133874|NCT00793793|482698|P3|Overall Study|Withdrawal by Subject|0
133875|NCT00793793|482699|P2|Overall Study|Withdrawal by Subject|0
133876|NCT00793793|482700|P1|Overall Study|Withdrawal by Subject|0
133877|NCT00793793|482689|P12|Overall Study|Lost to Follow-up|0
133878|NCT00793793|482690|P11|Overall Study|Lost to Follow-up|1
133879|NCT00793793|482691|P10|Overall Study|Lost to Follow-up|3
133880|NCT00793793|482692|P9|Overall Study|Lost to Follow-up|1
133881|NCT00793793|482693|P8|Overall Study|Lost to Follow-up|0
133882|NCT00793793|482694|P7|Overall Study|Lost to Follow-up|0
133883|NCT00793793|482695|P6|Overall Study|Lost to Follow-up|0
133884|NCT00793793|482696|P5|Overall Study|Lost to Follow-up|0
133885|NCT00793793|482697|P4|Overall Study|Lost to Follow-up|0
133886|NCT00793793|482698|P3|Overall Study|Lost to Follow-up|1
133887|NCT00793793|482699|P2|Overall Study|Lost to Follow-up|0
133888|NCT00793793|482700|P1|Overall Study|Lost to Follow-up|0
133889|NCT00793793|482689|P12|Overall Study|Protocol Violation|0
133890|NCT00793793|482690|P11|Overall Study|Protocol Violation|0
133891|NCT00793793|482691|P10|Overall Study|Protocol Violation|0
133892|NCT00793793|482692|P9|Overall Study|Protocol Violation|0
133893|NCT00793793|482693|P8|Overall Study|Protocol Violation|0
133894|NCT00793793|482694|P7|Overall Study|Protocol Violation|0
133895|NCT00793793|482695|P6|Overall Study|Protocol Violation|0
133896|NCT00793793|482696|P5|Overall Study|Protocol Violation|0
133897|NCT00793793|482697|P4|Overall Study|Protocol Violation|1
133898|NCT00793793|482698|P3|Overall Study|Protocol Violation|0
133899|NCT00793793|482699|P2|Overall Study|Protocol Violation|0
133900|NCT00793793|482700|P1|Overall Study|Protocol Violation|0
133901|NCT00793793|482689|P12|Overall Study|Adverse Event|2
133902|NCT00793793|482690|P11|Overall Study|Adverse Event|0
133903|NCT00793793|482691|P10|Overall Study|Adverse Event|0
133904|NCT00793793|482692|P9|Overall Study|Adverse Event|0
133905|NCT00793793|482693|P8|Overall Study|Adverse Event|0
133906|NCT00793793|482694|P7|Overall Study|Adverse Event|2
133907|NCT00793793|482695|P6|Overall Study|Adverse Event|1
133908|NCT00793793|482696|P5|Overall Study|Adverse Event|0
133909|NCT00793793|482697|P4|Overall Study|Adverse Event|1
133910|NCT00793793|482698|P3|Overall Study|Adverse Event|1
133911|NCT00793793|482699|P2|Overall Study|Adverse Event|0
133912|NCT00793793|482700|P1|Overall Study|Adverse Event|0
133913|NCT00793780|483075|P2|Overall Study|Withdrawal by Subject|1
133914|NCT00793780|483076|P1|Overall Study|Withdrawal by Subject|2
133915|NCT00793624|483107|P4|Overall Study|Other reason not described above|3
133916|NCT00793624|483108|P3|Overall Study|Other reason not described above|6
133917|NCT00793624|483109|P2|Overall Study|Other reason not described above|4
133918|NCT00793624|483110|P1|Overall Study|Other reason not described above|6
133919|NCT00793624|483107|P4|Overall Study|Non compliance with protocol|3
133920|NCT00793624|483108|P3|Overall Study|Non compliance with protocol|2
133921|NCT00793624|483109|P2|Overall Study|Non compliance with protocol|3
133922|NCT00793624|483110|P1|Overall Study|Non compliance with protocol|2
133923|NCT00793624|483107|P4|Overall Study|Lack of Efficacy|3
133924|NCT00793624|483108|P3|Overall Study|Lack of Efficacy|1
133925|NCT00793624|483109|P2|Overall Study|Lack of Efficacy|2
133926|NCT00793624|483110|P1|Overall Study|Lack of Efficacy|9
133927|NCT00793624|483107|P4|Overall Study|Withdrawal by Subject|14
133928|NCT00793624|483108|P3|Overall Study|Withdrawal by Subject|11
133929|NCT00793624|483109|P2|Overall Study|Withdrawal by Subject|9
133930|NCT00793624|483110|P1|Overall Study|Withdrawal by Subject|20
133931|NCT00793624|483107|P4|Overall Study|Lost to Follow-up|0
133932|NCT00793624|483108|P3|Overall Study|Lost to Follow-up|4
133933|NCT00793624|483109|P2|Overall Study|Lost to Follow-up|2
133934|NCT00793624|483110|P1|Overall Study|Lost to Follow-up|2
133935|NCT00793624|483107|P4|Overall Study|Adverse Event|20
133936|NCT00793624|483108|P3|Overall Study|Adverse Event|15
133937|NCT00793624|483109|P2|Overall Study|Adverse Event|16
133938|NCT00793624|483110|P1|Overall Study|Adverse Event|18
133939|NCT00793585|483391|P2|Overall Study|Protocol Violation|2
133940|NCT00793585|483392|P1|Overall Study|Protocol Violation|1
133941|NCT00793585|483391|P2|Overall Study|Adverse Event|1
133942|NCT00793585|483392|P1|Overall Study|Adverse Event|1
133943|NCT00793546|483411|P2|Overall Study|Other|0
133944|NCT00793546|483412|P1|Overall Study|Other|1
133945|NCT00793546|483411|P2|Overall Study|Study Terminated by Sponsor|27
133946|NCT00793546|483412|P1|Overall Study|Study Terminated by Sponsor|8
133947|NCT00793546|483411|P2|Overall Study|Withdrawal by Subject|1
133948|NCT00793546|483412|P1|Overall Study|Withdrawal by Subject|1
133949|NCT00793546|483411|P2|Overall Study|Lost to Follow-up|0
133950|NCT00793546|483412|P1|Overall Study|Lost to Follow-up|1
133951|NCT00793546|483411|P2|Overall Study|Death|0
133952|NCT00793546|483412|P1|Overall Study|Death|3
133953|NCT00793403|483462|P1|Overall Study|Other|73
133954|NCT00793325|483509|P1|Overall Study|Lost to Follow-up|1
133955|NCT00793325|483509|P1|Overall Study|Protocol Violation|18
133956|NCT00793104|483541|P1|Overall Study|Lost to Follow-up|1
133957|NCT00792948|483549|P1|Overall Study|Protocol Violation|1
133958|NCT00792948|483549|P1|Overall Study|Physician Decision|11
133959|NCT00792948|483549|P1|Overall Study|Insurance denial - not treated|1
133960|NCT00792948|483549|P1|Overall Study|Ineligible|2
133961|NCT00792948|483549|P1|Overall Study|Withdrawal by Subject|3
133962|NCT00792948|483549|P1|Overall Study|Death|4
133963|NCT00792948|483549|P1|Overall Study|Adverse Event|6
133964|NCT00792935|483560|P2|Overall Study|Withdrawal by Subject|1
133965|NCT00792935|483561|P1|Overall Study|Withdrawal by Subject|0
133966|NCT00792935|483560|P2|Overall Study|Protocol Violation|0
133967|NCT00792935|483561|P1|Overall Study|Protocol Violation|2
133968|NCT00792935|483560|P2|Overall Study|Lost to Follow-up|1
133969|NCT00792935|483561|P1|Overall Study|Lost to Follow-up|0
133970|NCT00792935|483560|P2|Overall Study|Adverse Event|1
133971|NCT00792935|483561|P1|Overall Study|Adverse Event|2
133972|NCT00792909|483593|P3|Overall Study|Withdrawal by Subject|0
133973|NCT00792909|483594|P2|Overall Study|Withdrawal by Subject|1
133974|NCT00792909|483595|P1|Overall Study|Withdrawal by Subject|0
133975|NCT00792805|483651|P3|Overall Study|Protocol deviation|1
133976|NCT00792805|483652|P2|Overall Study|Protocol deviation|1
133977|NCT00792805|483653|P1|Overall Study|Protocol deviation|0
133978|NCT00792805|483651|P3|Overall Study|Abnormal laboratory value(s)|1
133979|NCT00792805|483652|P2|Overall Study|Abnormal laboratory value(s)|0
133980|NCT00792805|483653|P1|Overall Study|Abnormal laboratory value(s)|0
133981|NCT00792805|483651|P3|Overall Study|Lost to Follow-up|6
133982|NCT00792805|483652|P2|Overall Study|Lost to Follow-up|1
133983|NCT00792805|483653|P1|Overall Study|Lost to Follow-up|1
133984|NCT00792805|483651|P3|Overall Study|Unsatisfactory therapeutic effect|6
133985|NCT00792805|483652|P2|Overall Study|Unsatisfactory therapeutic effect|6
133986|NCT00792805|483653|P1|Overall Study|Unsatisfactory therapeutic effect|1
133987|NCT00792805|483651|P3|Overall Study|Abnormal test procedure result(s)|0
133988|NCT00792805|483652|P2|Overall Study|Abnormal test procedure result(s)|2
133989|NCT00792805|483653|P1|Overall Study|Abnormal test procedure result(s)|1
133990|NCT00792805|483651|P3|Overall Study|Administrative problems|4
133991|NCT00792805|483652|P2|Overall Study|Administrative problems|0
133992|NCT00792805|483653|P1|Overall Study|Administrative problems|2
133993|NCT00792805|483651|P3|Overall Study|Subject withdrew consent|5
133994|NCT00792805|483652|P2|Overall Study|Subject withdrew consent|6
133995|NCT00792805|483653|P1|Overall Study|Subject withdrew consent|5
133996|NCT00792805|483651|P3|Overall Study|Adverse Event|10
133997|NCT00792805|483652|P2|Overall Study|Adverse Event|10
133998|NCT00792805|483653|P1|Overall Study|Adverse Event|12
133999|NCT00792701|483663|P2|Overall Study|Not protocol specified|0
134000|NCT00792701|483664|P1|Overall Study|Not protocol specified|17
134001|NCT00792701|483663|P2|Overall Study|Withdrawal by Subject|19
134002|NCT00792701|483664|P1|Overall Study|Withdrawal by Subject|1
134003|NCT00792701|483663|P2|Overall Study|Ineligible|3
134004|NCT00792701|483664|P1|Overall Study|Ineligible|1
134005|NCT00792701|483663|P2|Overall Study|Adverse Event|22
134006|NCT00792701|483664|P1|Overall Study|Adverse Event|0
134007|NCT00792636|483694|P3|Overall Study|Investigator Discretion|2
134008|NCT00792636|483695|P2|Overall Study|Investigator Discretion|0
134009|NCT00792636|483696|P1|Overall Study|Investigator Discretion|2
134010|NCT00792636|483694|P3|Overall Study|Adverse Event|3
134011|NCT00792636|483695|P2|Overall Study|Adverse Event|2
134012|NCT00792636|483696|P1|Overall Study|Adverse Event|4
134013|NCT00792636|483694|P3|Overall Study|Lack of Efficacy|13
134014|NCT00792636|483695|P2|Overall Study|Lack of Efficacy|4
134015|NCT00792636|483696|P1|Overall Study|Lack of Efficacy|3
134016|NCT00792636|483694|P3|Overall Study|Withdrew Consent|9
134017|NCT00792636|483695|P2|Overall Study|Withdrew Consent|13
134018|NCT00792636|483696|P1|Overall Study|Withdrew Consent|10
134019|NCT00792636|483694|P3|Overall Study|Lost to Follow-up|14
134020|NCT00792636|483695|P2|Overall Study|Lost to Follow-up|19
134021|NCT00792636|483696|P1|Overall Study|Lost to Follow-up|13
134022|NCT00792636|483694|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
134023|NCT00792636|483695|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
134024|NCT00792636|483696|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
134025|NCT00792636|483694|P3|Overall Study|Protocol Violation|20
134026|NCT00792636|483695|P2|Overall Study|Protocol Violation|23
134027|NCT00792636|483696|P1|Overall Study|Protocol Violation|17
134028|NCT00792623|483733|P1|Overall Study|Withdrawal by Subject|5
134029|NCT00792623|483733|P1|Overall Study|Adverse Event|2
134030|NCT00792298|483761|P8|Treatment Period 2|Withdrawal by Subject|2
134031|NCT00792298|483762|P7|Treatment Period 2|Withdrawal by Subject|0
134032|NCT00792298|483763|P6|Treatment Period 2|Withdrawal by Subject|0
134033|NCT00792298|483764|P5|Treatment Period 2|Withdrawal by Subject|1
134034|NCT00792298|483765|P4|Treatment Period 2|Withdrawal by Subject|2
134035|NCT00792298|483766|P3|Treatment Period 2|Withdrawal by Subject|0
134036|NCT00792298|483767|P2|Treatment Period 2|Withdrawal by Subject|1
134037|NCT00792298|483768|P1|Treatment Period 2|Withdrawal by Subject|1
134038|NCT00792298|483761|P8|Treatment Period 2|Pregnancy|0
134039|NCT00792298|483762|P7|Treatment Period 2|Pregnancy|0
134040|NCT00792298|483763|P6|Treatment Period 2|Pregnancy|0
134041|NCT00792298|483764|P5|Treatment Period 2|Pregnancy|0
134042|NCT00792298|483765|P4|Treatment Period 2|Pregnancy|0
134043|NCT00792298|483766|P3|Treatment Period 2|Pregnancy|1
134044|NCT00792298|483767|P2|Treatment Period 2|Pregnancy|0
134045|NCT00792298|483768|P1|Treatment Period 2|Pregnancy|0
134046|NCT00792298|483761|P8|Treatment Period 2|Physician Decision|0
134047|NCT00792298|483762|P7|Treatment Period 2|Physician Decision|1
134048|NCT00792298|483763|P6|Treatment Period 2|Physician Decision|0
134049|NCT00792298|483764|P5|Treatment Period 2|Physician Decision|0
134050|NCT00792298|483765|P4|Treatment Period 2|Physician Decision|0
134051|NCT00792298|483766|P3|Treatment Period 2|Physician Decision|0
134052|NCT00792298|483767|P2|Treatment Period 2|Physician Decision|0
134053|NCT00792298|483768|P1|Treatment Period 2|Physician Decision|0
134054|NCT00792298|483761|P8|Treatment Period 2|Lack of Efficacy|0
134055|NCT00792298|483762|P7|Treatment Period 2|Lack of Efficacy|0
134056|NCT00792298|483763|P6|Treatment Period 2|Lack of Efficacy|0
134057|NCT00792298|483764|P5|Treatment Period 2|Lack of Efficacy|1
134058|NCT00792298|483765|P4|Treatment Period 2|Lack of Efficacy|0
134059|NCT00792298|483766|P3|Treatment Period 2|Lack of Efficacy|0
134060|NCT00792298|483767|P2|Treatment Period 2|Lack of Efficacy|0
134061|NCT00792298|483768|P1|Treatment Period 2|Lack of Efficacy|0
134062|NCT00792298|483761|P8|Washout|Withdrawal by Subject|0
134063|NCT00792298|483762|P7|Washout|Withdrawal by Subject|0
134064|NCT00792298|483763|P6|Washout|Withdrawal by Subject|1
134065|NCT00792298|483764|P5|Washout|Withdrawal by Subject|0
134066|NCT00792298|483765|P4|Washout|Withdrawal by Subject|0
134067|NCT00792298|483766|P3|Washout|Withdrawal by Subject|1
134068|NCT00792298|483767|P2|Washout|Withdrawal by Subject|0
134069|NCT00792298|483768|P1|Washout|Withdrawal by Subject|0
134070|NCT00792298|483761|P8|Washout|Adverse Event|0
134071|NCT00792298|483762|P7|Washout|Adverse Event|0
134072|NCT00792298|483763|P6|Washout|Adverse Event|1
134073|NCT00792298|483764|P5|Washout|Adverse Event|0
134074|NCT00792298|483765|P4|Washout|Adverse Event|0
134075|NCT00792298|483766|P3|Washout|Adverse Event|0
134076|NCT00792298|483767|P2|Washout|Adverse Event|0
134077|NCT00792298|483768|P1|Washout|Adverse Event|0
134078|NCT00792298|483761|P8|Treatment Period 1|Protocol Violation|1
134079|NCT00792298|483762|P7|Treatment Period 1|Protocol Violation|0
134080|NCT00792298|483763|P6|Treatment Period 1|Protocol Violation|0
134081|NCT00792298|483764|P5|Treatment Period 1|Protocol Violation|0
134082|NCT00792298|483765|P4|Treatment Period 1|Protocol Violation|0
134083|NCT00792298|483766|P3|Treatment Period 1|Protocol Violation|0
134084|NCT00792298|483767|P2|Treatment Period 1|Protocol Violation|0
134085|NCT00792298|483768|P1|Treatment Period 1|Protocol Violation|0
134086|NCT00792298|483761|P8|Treatment Period 1|Physician Decision|0
134087|NCT00792298|483762|P7|Treatment Period 1|Physician Decision|1
134088|NCT00792298|483763|P6|Treatment Period 1|Physician Decision|0
134089|NCT00792298|483764|P5|Treatment Period 1|Physician Decision|0
134090|NCT00792298|483765|P4|Treatment Period 1|Physician Decision|1
134091|NCT00792298|483766|P3|Treatment Period 1|Physician Decision|0
134092|NCT00792298|483767|P2|Treatment Period 1|Physician Decision|0
134093|NCT00792298|483768|P1|Treatment Period 1|Physician Decision|0
134094|NCT00792298|483761|P8|Treatment Period 1|Lost to Follow-up|0
134095|NCT00792298|483762|P7|Treatment Period 1|Lost to Follow-up|1
134096|NCT00792298|483763|P6|Treatment Period 1|Lost to Follow-up|0
134097|NCT00792298|483764|P5|Treatment Period 1|Lost to Follow-up|0
134098|NCT00792298|483765|P4|Treatment Period 1|Lost to Follow-up|0
134099|NCT00792298|483766|P3|Treatment Period 1|Lost to Follow-up|0
134100|NCT00792298|483767|P2|Treatment Period 1|Lost to Follow-up|0
134101|NCT00792298|483768|P1|Treatment Period 1|Lost to Follow-up|0
134102|NCT00792298|483761|P8|Treatment Period 1|Withdrawal by Subject|0
134103|NCT00792298|483762|P7|Treatment Period 1|Withdrawal by Subject|1
134104|NCT00792298|483763|P6|Treatment Period 1|Withdrawal by Subject|2
134105|NCT00792298|483764|P5|Treatment Period 1|Withdrawal by Subject|0
134106|NCT00792298|483765|P4|Treatment Period 1|Withdrawal by Subject|2
134107|NCT00792298|483766|P3|Treatment Period 1|Withdrawal by Subject|1
134108|NCT00792298|483767|P2|Treatment Period 1|Withdrawal by Subject|0
134109|NCT00792298|483768|P1|Treatment Period 1|Withdrawal by Subject|1
134110|NCT00792298|483761|P8|Treatment Period 1|Lack of Efficacy|0
134111|NCT00792298|483762|P7|Treatment Period 1|Lack of Efficacy|0
134112|NCT00792298|483763|P6|Treatment Period 1|Lack of Efficacy|0
134113|NCT00792298|483764|P5|Treatment Period 1|Lack of Efficacy|0
134114|NCT00792298|483765|P4|Treatment Period 1|Lack of Efficacy|0
134115|NCT00792298|483766|P3|Treatment Period 1|Lack of Efficacy|1
134116|NCT00792298|483767|P2|Treatment Period 1|Lack of Efficacy|0
134117|NCT00792298|483768|P1|Treatment Period 1|Lack of Efficacy|0
134118|NCT00792298|483761|P8|Treatment Period 1|Adverse Event|0
134119|NCT00792298|483762|P7|Treatment Period 1|Adverse Event|1
134120|NCT00792298|483763|P6|Treatment Period 1|Adverse Event|1
134121|NCT00792298|483764|P5|Treatment Period 1|Adverse Event|0
134122|NCT00792298|483765|P4|Treatment Period 1|Adverse Event|1
134123|NCT00792298|483766|P3|Treatment Period 1|Adverse Event|0
134124|NCT00792298|483767|P2|Treatment Period 1|Adverse Event|1
134125|NCT00792298|483768|P1|Treatment Period 1|Adverse Event|0
134126|NCT00792259|483798|P3|Overall Study|Poor Quality Scans|0
134127|NCT00792259|483799|P2|Overall Study|Poor Quality Scans|0
134128|NCT00792259|483800|P1|Overall Study|Poor Quality Scans|1
134129|NCT00792116|483810|P2|Overall Study|Discontnued intervention|0
134130|NCT00792116|483811|P1|Overall Study|Discontnued intervention|1
134131|NCT00792116|483810|P2|Overall Study|Lost to Follow-up|1
134132|NCT00792116|483811|P1|Overall Study|Lost to Follow-up|0
134133|NCT00792103|483821|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
134134|NCT00792103|483821|P1|Overall Study|Protocol Violation|10
134135|NCT00792103|483821|P1|Overall Study|Withdrawal by Subject|52
134136|NCT00792103|483821|P1|Overall Study|Adverse Event|25
134137|NCT00792103|483821|P1|Overall Study|Lost to Follow-up|17
134138|NCT00792103|483821|P1|Overall Study|Enrolled, not treated|15
134139|NCT00791999|483833|P4|Overall Study|Reason other than those above|0
134140|NCT00791999|483834|P3|Overall Study|Reason other than those above|1
134141|NCT00791999|483835|P2|Overall Study|Reason other than those above|0
134142|NCT00791999|483836|P1|Overall Study|Reason other than those above|1
134143|NCT00791999|483833|P4|Overall Study|Lack of Efficacy|2
134144|NCT00791999|483834|P3|Overall Study|Lack of Efficacy|0
134145|NCT00791999|483835|P2|Overall Study|Lack of Efficacy|1
134146|NCT00791999|483836|P1|Overall Study|Lack of Efficacy|0
134147|NCT00791999|483833|P4|Overall Study|Adverse Event|3
134148|NCT00791999|483834|P3|Overall Study|Adverse Event|7
134149|NCT00791999|483835|P2|Overall Study|Adverse Event|3
134150|NCT00791999|483836|P1|Overall Study|Adverse Event|3
134151|NCT00791999|483833|P4|Overall Study|Protocol Violation|0
134152|NCT00791999|483834|P3|Overall Study|Protocol Violation|1
134153|NCT00791999|483835|P2|Overall Study|Protocol Violation|0
134154|NCT00791999|483836|P1|Overall Study|Protocol Violation|3
134155|NCT00791999|483833|P4|Overall Study|Withdrawal by Subject|2
134156|NCT00791999|483834|P3|Overall Study|Withdrawal by Subject|0
134157|NCT00791999|483835|P2|Overall Study|Withdrawal by Subject|1
134158|NCT00791999|483836|P1|Overall Study|Withdrawal by Subject|0
134159|NCT00791999|483833|P4|Overall Study|Protocol planed withdrawal|45
134160|NCT00791999|483834|P3|Overall Study|Protocol planed withdrawal|11
134161|NCT00791999|483835|P2|Overall Study|Protocol planed withdrawal|11
134162|NCT00791999|483836|P1|Overall Study|Protocol planed withdrawal|14
134163|NCT00791934|483861|P1|Overall Study|Did not consent for extended follow-up|13
134164|NCT00791934|483861|P1|Overall Study|Withdrawal by Subject|2
134165|NCT00791921|483871|P2|Overall Study|Reason other than those above|1
134166|NCT00791921|483872|P1|Overall Study|Reason other than those above|0
134167|NCT00791921|483871|P2|Overall Study|Lack of study drug administration|1
134168|NCT00791921|483872|P1|Overall Study|Lack of study drug administration|1
134169|NCT00791921|483871|P2|Overall Study|Lack of Efficacy|2
134170|NCT00791921|483872|P1|Overall Study|Lack of Efficacy|0
134171|NCT00791921|483871|P2|Overall Study|Adverse Event|2
134172|NCT00791921|483872|P1|Overall Study|Adverse Event|8
134173|NCT00791921|483871|P2|Overall Study|Withdrawal by Subject|2
134174|NCT00791921|483872|P1|Overall Study|Withdrawal by Subject|1
134175|NCT00791921|483871|P2|Overall Study|Protocol planed|88
134176|NCT00791921|483872|P1|Overall Study|Protocol planed|24
134177|NCT00791778|483899|P2|Follow-up|Lost to Follow-up|1
134178|NCT00791778|483900|P1|Follow-up|Lost to Follow-up|2
134179|NCT00791778|483899|P2|Follow-up|Withdrawal by Subject|0
134180|NCT00791778|483900|P1|Follow-up|Withdrawal by Subject|3
134181|NCT00791778|483899|P2|Double-blind Treatment|Non-compliant with study medication|0
134182|NCT00791778|483900|P1|Double-blind Treatment|Non-compliant with study medication|2
134183|NCT00791778|483899|P2|Double-blind Treatment|Withdrawal by Subject|9
134184|NCT00791778|483900|P1|Double-blind Treatment|Withdrawal by Subject|20
134185|NCT00791778|483899|P2|Double-blind Treatment|Protocol Violation|4
134186|NCT00791778|483900|P1|Double-blind Treatment|Protocol Violation|0
134187|NCT00791778|483899|P2|Double-blind Treatment|Physician Decision|26
134188|NCT00791778|483900|P1|Double-blind Treatment|Physician Decision|6
134189|NCT00791778|483899|P2|Double-blind Treatment|Adverse Event|9
134190|NCT00791778|483900|P1|Double-blind Treatment|Adverse Event|49
134191|NCT00791765|483954|P2|Weeks 13 to 24|Other|1
134192|NCT00791765|483955|P1|Weeks 13 to 24|Other|0
134193|NCT00791765|483954|P2|Weeks 13 to 24|Lost to Follow-up|2
134194|NCT00791765|483955|P1|Weeks 13 to 24|Lost to Follow-up|1
134195|NCT00791765|483954|P2|Weeks 13 to 24|Disease progression|1
134196|NCT00791765|483955|P1|Weeks 13 to 24|Disease progression|0
134197|NCT00791765|483954|P2|Weeks 13 to 24|Withdrawal by Subject|1
134198|NCT00791765|483955|P1|Weeks 13 to 24|Withdrawal by Subject|2
134199|NCT00791765|483954|P2|Weeks 13 to 24|Adverse Event|3
134200|NCT00791765|483955|P1|Weeks 13 to 24|Adverse Event|0
134201|NCT00791765|483954|P2|Weeks 13 to 24|Protocol deviation|0
134202|NCT00791765|483955|P1|Weeks 13 to 24|Protocol deviation|2
134203|NCT00791765|483954|P2|Weeks 1 to 12|Ineligibility determined|3
134204|NCT00791765|483955|P1|Weeks 1 to 12|Ineligibility determined|0
134205|NCT00791765|483954|P2|Weeks 1 to 12|Disease progression|0
134206|NCT00791765|483955|P1|Weeks 1 to 12|Disease progression|3
134207|NCT00791765|483954|P2|Weeks 1 to 12|Physician Decision|0
134208|NCT00791765|483955|P1|Weeks 1 to 12|Physician Decision|1
134209|NCT00791765|483954|P2|Weeks 1 to 12|Withdrawal by Subject|0
134210|NCT00791765|483955|P1|Weeks 1 to 12|Withdrawal by Subject|3
134211|NCT00791765|483954|P2|Weeks 1 to 12|Lost to Follow-up|0
134212|NCT00791765|483955|P1|Weeks 1 to 12|Lost to Follow-up|1
134213|NCT00791765|483954|P2|Weeks 1 to 12|Adverse Event|1
134214|NCT00791765|483955|P1|Weeks 1 to 12|Adverse Event|0
134215|NCT00791700|483970|P4|Overall Study|Blood sampling not done before Stage 1|1
134216|NCT00791700|483971|P3|Overall Study|Blood sampling not done before Stage 1|0
134217|NCT00791700|483972|P2|Overall Study|Blood sampling not done before Stage 1|0
134218|NCT00791700|483973|P1|Overall Study|Blood sampling not done before Stage 1|0
134219|NCT00791700|483970|P4|Overall Study|Non-compliance with study treatment|2
134220|NCT00791700|483971|P3|Overall Study|Non-compliance with study treatment|0
134221|NCT00791700|483972|P2|Overall Study|Non-compliance with study treatment|0
134222|NCT00791700|483973|P1|Overall Study|Non-compliance with study treatment|1
134223|NCT00791700|483970|P4|Overall Study|No longer willing to participate|1
134224|NCT00791700|483971|P3|Overall Study|No longer willing to participate|0
134225|NCT00791700|483972|P2|Overall Study|No longer willing to participate|1
134226|NCT00791700|483973|P1|Overall Study|No longer willing to participate|0
134227|NCT00791700|483970|P4|Overall Study|Adverse Event|1
134228|NCT00791700|483971|P3|Overall Study|Adverse Event|1
134229|NCT00791700|483972|P2|Overall Study|Adverse Event|0
134230|NCT00791700|483973|P1|Overall Study|Adverse Event|0
134231|NCT00791700|483970|P4|Overall Study|Insufficient clinical response|13
134232|NCT00791700|483971|P3|Overall Study|Insufficient clinical response|3
134233|NCT00791700|483972|P2|Overall Study|Insufficient clinical response|4
134234|NCT00791700|483973|P1|Overall Study|Insufficient clinical response|3
134235|NCT00791661|484061|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
134236|NCT00791661|484062|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
134237|NCT00791661|484063|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
134238|NCT00791661|484061|P3|7 Day Wash-out|Adverse Event|1
134239|NCT00791661|484062|P2|7 Day Wash-out|Adverse Event|0
134240|NCT00791661|484063|P1|7 Day Wash-out|Adverse Event|0
134241|NCT00791648|484156|P2|Overall Study|Withdrawal by Subject|1
134242|NCT00791648|484157|P1|Overall Study|Withdrawal by Subject|0
134243|NCT00791648|484156|P2|Overall Study|Physician Decision|1
134244|NCT00791648|484157|P1|Overall Study|Physician Decision|0
134245|NCT00791557|484173|P1|Overall Study|Adverse Event|1
134246|NCT00791518|484177|P1|Overall Study|Protocol Violation|93
134247|NCT00791492|484205|P2|Overall Study|Liver transplantation|1
134248|NCT00791492|484206|P1|Overall Study|Liver transplantation|5
134249|NCT00791492|484205|P2|Overall Study|Withdrawal by Subject|2
134250|NCT00791492|484206|P1|Overall Study|Withdrawal by Subject|1
134251|NCT00791479|484254|P6|Overall Study|Withdrawal by Subject|1
134252|NCT00791479|484255|P5|Overall Study|Withdrawal by Subject|0
134253|NCT00791479|484256|P4|Overall Study|Withdrawal by Subject|1
134254|NCT00791479|484257|P3|Overall Study|Withdrawal by Subject|0
134255|NCT00791479|484258|P2|Overall Study|Withdrawal by Subject|0
134256|NCT00791479|484259|P1|Overall Study|Withdrawal by Subject|0
134257|NCT00791479|484254|P6|Overall Study|Protocol Violation|0
134258|NCT00791479|484255|P5|Overall Study|Protocol Violation|0
134259|NCT00791479|484256|P4|Overall Study|Protocol Violation|1
134260|NCT00791479|484257|P3|Overall Study|Protocol Violation|0
134261|NCT00791479|484258|P2|Overall Study|Protocol Violation|1
134262|NCT00791479|484259|P1|Overall Study|Protocol Violation|2
134263|NCT00791479|484254|P6|Overall Study|Lost to Follow-up|1
134264|NCT00791479|484255|P5|Overall Study|Lost to Follow-up|0
134265|NCT00791479|484256|P4|Overall Study|Lost to Follow-up|0
134266|NCT00791479|484257|P3|Overall Study|Lost to Follow-up|0
134267|NCT00791479|484258|P2|Overall Study|Lost to Follow-up|1
134268|NCT00791479|484259|P1|Overall Study|Lost to Follow-up|0
134269|NCT00791479|484254|P6|Overall Study|Adverse Event|1
134270|NCT00791479|484255|P5|Overall Study|Adverse Event|0
134271|NCT00791479|484256|P4|Overall Study|Adverse Event|2
134272|NCT00791479|484257|P3|Overall Study|Adverse Event|0
134273|NCT00791479|484258|P2|Overall Study|Adverse Event|1
134274|NCT00791479|484259|P1|Overall Study|Adverse Event|0
134275|NCT00791479|484254|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
134276|NCT00791479|484255|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
134277|NCT00791479|484256|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
134278|NCT00791479|484257|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
134279|NCT00791479|484258|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
134280|NCT00791479|484259|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
134281|NCT00791388|484358|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
134282|NCT00791388|484359|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
134283|NCT00791388|484360|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
134284|NCT00791388|484361|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
134285|NCT00791388|484362|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
134286|NCT00791388|484358|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
134287|NCT00791388|484359|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
134288|NCT00791388|484360|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
134289|NCT00791388|484361|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
134290|NCT00791388|484362|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
134291|NCT00791388|484358|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
134292|NCT00791388|484359|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
134293|NCT00791388|484360|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
134294|NCT00791388|484361|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
134295|NCT00791388|484362|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
134296|NCT00791258|484404|P1|Overall Study|Lack of Efficacy|1
134297|NCT00791258|484404|P1|Overall Study|Subject required restricted medication|1
134298|NCT00791258|484404|P1|Overall Study|Subject incarcerated|1
134299|NCT00791258|484404|P1|Overall Study|non-compliance|3
134300|NCT00791258|484404|P1|Overall Study|subject left area|2
134301|NCT00791258|484404|P1|Overall Study|Did not take medication for >3 days|1
134302|NCT00791258|484404|P1|Overall Study|Withdrawal by Subject|40
134303|NCT00791258|484404|P1|Overall Study|Protocol Violation|109
134304|NCT00791258|484404|P1|Overall Study|Lost to Follow-up|18
134305|NCT00791258|484404|P1|Overall Study|Adverse Event|87
134306|NCT00791128|484466|P1|Overall Study|abdominal tumor, unrelated to device|1
134307|NCT00791128|484466|P1|Overall Study|non-compliance by subject|2
134308|NCT00791128|484466|P1|Overall Study|Device migration|2
134309|NCT00791128|484466|P1|Overall Study|Adverse Event|4
134310|NCT00791076|484497|P1|Overall Study|Study was terminated,PI left institution|8
134311|NCT00790907|484515|P3|Overall Study|Did Not Receive Study Drug|0
134312|NCT00790907|484516|P2|Overall Study|Did Not Receive Study Drug|0
134313|NCT00790907|484517|P1|Overall Study|Did Not Receive Study Drug|10
134314|NCT00790907|484515|P3|Overall Study|Verbatim Reason on the Case Report Form|29
134315|NCT00790907|484516|P2|Overall Study|Verbatim Reason on the Case Report Form|20
134316|NCT00790907|484517|P1|Overall Study|Verbatim Reason on the Case Report Form|74
134317|NCT00790907|484515|P3|Overall Study|Qualifying Condition Not Present|16
134318|NCT00790907|484516|P2|Overall Study|Qualifying Condition Not Present|14
134319|NCT00790907|484517|P1|Overall Study|Qualifying Condition Not Present|29
134320|NCT00790907|484515|P3|Overall Study|Required Protocol-prohibited Therapy|7
134321|NCT00790907|484516|P2|Overall Study|Required Protocol-prohibited Therapy|5
134322|NCT00790907|484517|P1|Overall Study|Required Protocol-prohibited Therapy|17
134323|NCT00790907|484515|P3|Overall Study|Bleeding Event|21
134324|NCT00790907|484516|P2|Overall Study|Bleeding Event|16
134325|NCT00790907|484517|P1|Overall Study|Bleeding Event|11
134326|NCT00790907|484515|P3|Overall Study|Withdrawal by Subject|5
134327|NCT00790907|484516|P2|Overall Study|Withdrawal by Subject|7
134328|NCT00790907|484517|P1|Overall Study|Withdrawal by Subject|1
134329|NCT00790907|484515|P3|Overall Study|Physician Decision|255
134330|NCT00790907|484516|P2|Overall Study|Physician Decision|271
134331|NCT00790907|484517|P1|Overall Study|Physician Decision|304
134332|NCT00790907|484515|P3|Overall Study|Adverse Event|6
134333|NCT00790907|484516|P2|Overall Study|Adverse Event|7
134334|NCT00790907|484517|P1|Overall Study|Adverse Event|9
134335|NCT00790868|484540|P2|Overall Study|Lost to Follow-up|12
134336|NCT00790868|484541|P1|Overall Study|Lost to Follow-up|2
134337|NCT00790868|484540|P2|Overall Study|Withdrawal by Subject|5
134338|NCT00790868|484541|P1|Overall Study|Withdrawal by Subject|4
134339|NCT00790790|484571|P3|Study Period 2: Therapy Phase|Physician Decision|0
134340|NCT00790790|484572|P2|Study Period 2: Therapy Phase|Physician Decision|1
134341|NCT00790790|484573|P1|Study Period 2: Therapy Phase|Physician Decision|0
134342|NCT00790790|484571|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
134343|NCT00790790|484572|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
134344|NCT00790790|484573|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
134345|NCT00790790|484571|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
134346|NCT00790790|484572|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
134347|NCT00790790|484573|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
134348|NCT00790790|484571|P3|Study Period 2: Therapy Phase|Protocol Violation|0
134349|NCT00790790|484572|P2|Study Period 2: Therapy Phase|Protocol Violation|1
134350|NCT00790790|484573|P1|Study Period 2: Therapy Phase|Protocol Violation|1
134351|NCT00790790|484571|P3|Study Period 2: Therapy Phase|Adverse Event|16
134352|NCT00790790|484572|P2|Study Period 2: Therapy Phase|Adverse Event|16
134353|NCT00790790|484573|P1|Study Period 2: Therapy Phase|Adverse Event|3
134354|NCT00790751|484650|P4|Overall Study|Physician Decision|1
134355|NCT00790751|484651|P3|Overall Study|Physician Decision|0
134356|NCT00790751|484652|P2|Overall Study|Physician Decision|0
134357|NCT00790751|484653|P1|Overall Study|Physician Decision|0
134358|NCT00790751|484650|P4|Overall Study|Death|0
134359|NCT00790751|484651|P3|Overall Study|Death|1
134360|NCT00790751|484652|P2|Overall Study|Death|0
134361|NCT00790751|484653|P1|Overall Study|Death|0
134362|NCT00790751|484650|P4|Overall Study|Requirement for restricted medication|0
134363|NCT00790751|484651|P3|Overall Study|Requirement for restricted medication|0
134364|NCT00790751|484652|P2|Overall Study|Requirement for restricted medication|2
134365|NCT00790751|484653|P1|Overall Study|Requirement for restricted medication|0
134366|NCT00790751|484650|P4|Overall Study|Adverse Event|4
134367|NCT00790751|484651|P3|Overall Study|Adverse Event|5
134368|NCT00790751|484652|P2|Overall Study|Adverse Event|3
134369|NCT00790751|484653|P1|Overall Study|Adverse Event|5
134370|NCT00790751|484650|P4|Overall Study|Lost to Follow-up|5
134371|NCT00790751|484651|P3|Overall Study|Lost to Follow-up|4
134372|NCT00790751|484652|P2|Overall Study|Lost to Follow-up|9
134373|NCT00790751|484653|P1|Overall Study|Lost to Follow-up|4
134374|NCT00790751|484650|P4|Overall Study|Protocol non-compliance|11
134375|NCT00790751|484651|P3|Overall Study|Protocol non-compliance|10
134376|NCT00790751|484652|P2|Overall Study|Protocol non-compliance|16
134377|NCT00790751|484653|P1|Overall Study|Protocol non-compliance|16
134378|NCT00790647|484701|P1|Overall Study|Adverse Event|1
134379|NCT00790569|484711|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
134380|NCT00790569|484712|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
134381|NCT00790569|484713|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
134382|NCT00790569|484711|P3|End of Treatment (6 Month Interview)|Incarcerated|3
134383|NCT00790569|484712|P2|End of Treatment (6 Month Interview)|Incarcerated|0
134384|NCT00790569|484713|P1|End of Treatment (6 Month Interview)|Incarcerated|0
134385|NCT00790569|484711|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
134386|NCT00790569|484712|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
134387|NCT00790569|484713|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
134388|NCT00790569|484711|P3|End of Treatment (6 Month Interview)|Hospitalized|0
134389|NCT00790569|484712|P2|End of Treatment (6 Month Interview)|Hospitalized|0
134390|NCT00790569|484713|P1|End of Treatment (6 Month Interview)|Hospitalized|2
134391|NCT00790569|484711|P3|End of Treatment (6 Month Interview)|Death|1
134392|NCT00790569|484712|P2|End of Treatment (6 Month Interview)|Death|2
134393|NCT00790569|484713|P1|End of Treatment (6 Month Interview)|Death|0
134394|NCT00790569|484711|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
134395|NCT00790569|484712|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
134396|NCT00790569|484713|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
134397|NCT00790556|484736|P2|Treatment Period 1|Withdrawal by Subject|0
134398|NCT00790556|484737|P1|Treatment Period 1|Withdrawal by Subject|1
134399|NCT00790556|484736|P2|Treatment Period 1|Physician Decision|0
134400|NCT00790556|484737|P1|Treatment Period 1|Physician Decision|1
134401|NCT00790452|484749|P2|Overall Study|Drug supply issue|0
134402|NCT00790452|484750|P1|Overall Study|Drug supply issue|1
134403|NCT00790400|484758|P2|Everolimus Period (Core or Extension)|New treatment|0
134404|NCT00790400|484759|P1|Everolimus Period (Core or Extension)|New treatment|2
134405|NCT00790400|484758|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
134406|NCT00790400|484759|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
134407|NCT00790400|484758|P2|Everolimus Period (Core or Extension)|Disease progression|0
134408|NCT00790400|484759|P1|Everolimus Period (Core or Extension)|Disease progression|5
134409|NCT00790400|484758|P2|Everolimus Period (Core or Extension)|Death|0
134410|NCT00790400|484759|P1|Everolimus Period (Core or Extension)|Death|1
134411|NCT00790400|484758|P2|Everolimus Period (Core or Extension)|Administrative problems|0
134412|NCT00790400|484759|P1|Everolimus Period (Core or Extension)|Administrative problems|2
134413|NCT00790400|484758|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
134414|NCT00790400|484759|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
134415|NCT00790400|484758|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
134416|NCT00790400|484759|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
134417|NCT00790400|484758|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
134418|NCT00790400|484759|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
134419|NCT00790400|484758|P2|Everolimus Period (Core or Extension)|Adverse Event|0
134420|NCT00790400|484759|P1|Everolimus Period (Core or Extension)|Adverse Event|9
134421|NCT00790400|484758|P2|Double-blind Period (Core Phase)|Death|0
134422|NCT00790400|484759|P1|Double-blind Period (Core Phase)|Death|1
134423|NCT00790400|484758|P2|Double-blind Period (Core Phase)|Administrative problems|0
134424|NCT00790400|484759|P1|Double-blind Period (Core Phase)|Administrative problems|1
134425|NCT00790400|484758|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
134426|NCT00790400|484759|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
134427|NCT00790400|484758|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
134428|NCT00790400|484759|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
134429|NCT00790400|484758|P2|Double-blind Period (Core Phase)|Adverse Event|4
134430|NCT00790400|484759|P1|Double-blind Period (Core Phase)|Adverse Event|2
134431|NCT00790400|484758|P2|Double-blind Period (Core Phase)|Progressive disease|9
134432|NCT00790400|484759|P1|Double-blind Period (Core Phase)|Progressive disease|0
134433|NCT00790400|484758|P2|Double-blind Period (Core Phase)|Protocol Violation|0
134434|NCT00790400|484759|P1|Double-blind Period (Core Phase)|Protocol Violation|1
134435|NCT00790296|484849|P2|Overall Study|Adverse Event|1
134436|NCT00790296|484850|P1|Overall Study|Adverse Event|0
134437|NCT00790296|484849|P2|Overall Study|Did not meet study eligibility criteria|1
134438|NCT00790296|484850|P1|Overall Study|Did not meet study eligibility criteria|1
134439|NCT00790218|484872|P3|Overall Study|Death|0
134440|NCT00790218|484873|P2|Overall Study|Death|0
134441|NCT00790218|484874|P1|Overall Study|Death|1
134442|NCT00790205|484884|P2|Overall Study|Withdrawal by Subject|363
134443|NCT00790205|484885|P1|Overall Study|Withdrawal by Subject|299
134444|NCT00790205|484884|P2|Overall Study|Lost to Follow-up|71
134445|NCT00790205|484885|P1|Overall Study|Lost to Follow-up|61
134446|NCT00790036|484982|P2|Overall Study|Subject/guardian decision|7
134447|NCT00790036|484983|P1|Overall Study|Subject/guardian decision|20
134448|NCT00790036|484982|P2|Overall Study|Withdrawal by Subject|7
134449|NCT00790036|484983|P1|Overall Study|Withdrawal by Subject|18
134450|NCT00790036|484982|P2|Overall Study|Protocol Violation|2
134451|NCT00790036|484983|P1|Overall Study|Protocol Violation|10
134452|NCT00790036|484982|P2|Overall Study|Lost to Follow-up|2
134453|NCT00790036|484983|P1|Overall Study|Lost to Follow-up|1
134454|NCT00790036|484982|P2|Overall Study|Disease progression|48
134455|NCT00790036|484983|P1|Overall Study|Disease progression|24
134456|NCT00790036|484982|P2|Overall Study|Death|0
134457|NCT00790036|484983|P1|Overall Study|Death|1
134458|NCT00790036|484982|P2|Overall Study|Adverse Event|44
134459|NCT00790036|484983|P1|Overall Study|Adverse Event|113
134460|NCT00790036|484982|P2|Overall Study|Administrative problems|9
134461|NCT00790036|484983|P1|Overall Study|Administrative problems|5
134462|NCT00790036|484982|P2|Overall Study|Abnormal lab values|2
134463|NCT00790036|484983|P1|Overall Study|Abnormal lab values|3
134464|NCT00790023|484997|P3|Overall Study|Not specified|8
134465|NCT00790023|484998|P2|Overall Study|Not specified|5
134466|NCT00790023|484999|P1|Overall Study|Not specified|5
134467|NCT00790023|484997|P3|Overall Study|Lost to Follow-up|1
134468|NCT00790023|484998|P2|Overall Study|Lost to Follow-up|0
134469|NCT00790023|484999|P1|Overall Study|Lost to Follow-up|0
134470|NCT00790023|484997|P3|Overall Study|Withdrawal by Subject|6
134471|NCT00790023|484998|P2|Overall Study|Withdrawal by Subject|0
134472|NCT00790023|484999|P1|Overall Study|Withdrawal by Subject|2
134473|NCT00790023|484997|P3|Overall Study|Protocol Violation|2
134474|NCT00790023|484998|P2|Overall Study|Protocol Violation|4
134475|NCT00790023|484999|P1|Overall Study|Protocol Violation|2
134476|NCT00790023|484997|P3|Overall Study|Adverse Event|4
134477|NCT00790023|484998|P2|Overall Study|Adverse Event|1
134478|NCT00790023|484999|P1|Overall Study|Adverse Event|2
134479|NCT00789958|485098|P1|Overall Study|Not eligible/not analyzable|26
134480|NCT00789958|485098|P1|Overall Study|not protocol specified|1
134481|NCT00789958|485098|P1|Overall Study|Progression|3
134482|NCT00789958|485098|P1|Overall Study|Withdrawal by Subject|4
134483|NCT00789958|485098|P1|Overall Study|Adverse Event|3
134484|NCT00789880|485117|P6|Overall Study|Withdrawal by Subject|0
134485|NCT00789880|485118|P5|Overall Study|Withdrawal by Subject|2
134486|NCT00789880|485119|P4|Overall Study|Withdrawal by Subject|0
134487|NCT00789880|485120|P3|Overall Study|Withdrawal by Subject|0
134488|NCT00789880|485121|P2|Overall Study|Withdrawal by Subject|0
134489|NCT00789880|485122|P1|Overall Study|Withdrawal by Subject|1
134490|NCT00789880|485117|P6|Overall Study|Protocol Violation|0
134491|NCT00789880|485118|P5|Overall Study|Protocol Violation|0
134492|NCT00789880|485119|P4|Overall Study|Protocol Violation|1
134493|NCT00789880|485120|P3|Overall Study|Protocol Violation|0
134494|NCT00789880|485121|P2|Overall Study|Protocol Violation|1
134495|NCT00789880|485122|P1|Overall Study|Protocol Violation|0
134496|NCT00789880|485117|P6|Overall Study|Adverse Event|0
134497|NCT00789880|485118|P5|Overall Study|Adverse Event|1
134498|NCT00789880|485119|P4|Overall Study|Adverse Event|0
134499|NCT00789880|485120|P3|Overall Study|Adverse Event|0
134500|NCT00789880|485121|P2|Overall Study|Adverse Event|0
134501|NCT00789880|485122|P1|Overall Study|Adverse Event|0
134502|NCT00789854|485151|P3|Overall Study|Other|5
134503|NCT00789854|485152|P2|Overall Study|Other|0
134504|NCT00789854|485153|P1|Overall Study|Other|6
134505|NCT00789854|485151|P3|Overall Study|Safety reasons|2
134506|NCT00789854|485152|P2|Overall Study|Safety reasons|0
134507|NCT00789854|485153|P1|Overall Study|Safety reasons|0
134508|NCT00789854|485151|P3|Overall Study|Severe non-compliance to the protocol|0
134509|NCT00789854|485152|P2|Overall Study|Severe non-compliance to the protocol|0
134510|NCT00789854|485153|P1|Overall Study|Severe non-compliance to the protocol|3
134511|NCT00789854|485151|P3|Overall Study|Eligibility criteria not fulfilled|1
134512|NCT00789854|485152|P2|Overall Study|Eligibility criteria not fulfilled|5
134513|NCT00789854|485153|P1|Overall Study|Eligibility criteria not fulfilled|2
134514|NCT00789854|485151|P3|Overall Study|Withdrawal by Subject|17
134515|NCT00789854|485152|P2|Overall Study|Withdrawal by Subject|6
134516|NCT00789854|485153|P1|Overall Study|Withdrawal by Subject|9
134517|NCT00789854|485151|P3|Overall Study|Lost to Follow-up|4
134518|NCT00789854|485152|P2|Overall Study|Lost to Follow-up|1
134519|NCT00789854|485153|P1|Overall Study|Lost to Follow-up|1
134520|NCT00789854|485151|P3|Overall Study|Adverse Event|18
134521|NCT00789854|485152|P2|Overall Study|Adverse Event|23
134522|NCT00789854|485153|P1|Overall Study|Adverse Event|28
134523|NCT00789828|485250|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
134524|NCT00789828|485251|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
134525|NCT00789828|485250|P2|Open-label Extension Period (4 Years)|Disease progression|0
134526|NCT00789828|485251|P1|Open-label Extension Period (4 Years)|Disease progression|1
134527|NCT00789828|485250|P2|Open-label Extension Period (4 Years)|Death|0
134528|NCT00789828|485251|P1|Open-label Extension Period (4 Years)|Death|1
134529|NCT00789828|485250|P2|Open-label Extension Period (4 Years)|Administrative problems|0
134530|NCT00789828|485251|P1|Open-label Extension Period (4 Years)|Administrative problems|7
134531|NCT00789828|485250|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
134532|NCT00789828|485251|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
134533|NCT00789828|485250|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
134534|NCT00789828|485251|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
134535|NCT00789828|485250|P2|Open-label Extension Period (4 Years)|Adverse Event|0
134536|NCT00789828|485251|P1|Open-label Extension Period (4 Years)|Adverse Event|10
134537|NCT00789828|485250|P2|Core Period (48 Weeks)|Lost to Follow-up|1
134538|NCT00789828|485251|P1|Core Period (48 Weeks)|Lost to Follow-up|0
134539|NCT00789828|485250|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
134540|NCT00789828|485251|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
134541|NCT00789828|485250|P2|Core Period (48 Weeks)|Administrative problems|1
134542|NCT00789828|485251|P1|Core Period (48 Weeks)|Administrative problems|0
134543|NCT00789815|485285|P2|Overall Study|Intubation due to massive bleeding|0
134544|NCT00789815|485286|P1|Overall Study|Intubation due to massive bleeding|1
134545|NCT00789815|485285|P2|Overall Study|Protocol Violation|1
134546|NCT00789815|485286|P1|Overall Study|Protocol Violation|6
134547|NCT00789737|485375|P2|Overall Study|not specified|7
134548|NCT00789737|485376|P1|Overall Study|not specified|11
134549|NCT00789737|485375|P2|Overall Study|hyperglycemia that met protocol-specifie|4
134550|NCT00789737|485376|P1|Overall Study|hyperglycemia that met protocol-specifie|0
134551|NCT00789737|485375|P2|Overall Study|Lack of Efficacy|0
134552|NCT00789737|485376|P1|Overall Study|Lack of Efficacy|3
134553|NCT00789737|485375|P2|Overall Study|Protocol Violation|0
134554|NCT00789737|485376|P1|Overall Study|Protocol Violation|3
134555|NCT00789737|485375|P2|Overall Study|Adverse Event|8
134556|NCT00789737|485376|P1|Overall Study|Adverse Event|8
134557|NCT00789737|485375|P2|Overall Study|Lost to Follow-up|14
134558|NCT00789737|485376|P1|Overall Study|Lost to Follow-up|10
134559|NCT00789737|485375|P2|Overall Study|Withdrawal by Subject|22
134560|NCT00789737|485376|P1|Overall Study|Withdrawal by Subject|13
134561|NCT00789698|485419|P4|Overall Study|Administrative|1
134562|NCT00789698|485420|P3|Overall Study|Administrative|3
134563|NCT00789698|485421|P2|Overall Study|Administrative|3
134564|NCT00789698|485422|P1|Overall Study|Administrative|0
134565|NCT00789698|485419|P4|Overall Study|Withdrawal by Subject|19
134566|NCT00789698|485420|P3|Overall Study|Withdrawal by Subject|12
134567|NCT00789698|485421|P2|Overall Study|Withdrawal by Subject|15
134568|NCT00789698|485422|P1|Overall Study|Withdrawal by Subject|14
134569|NCT00789698|485419|P4|Overall Study|Protocol Violation|1
134570|NCT00789698|485420|P3|Overall Study|Protocol Violation|2
134571|NCT00789698|485421|P2|Overall Study|Protocol Violation|1
134572|NCT00789698|485422|P1|Overall Study|Protocol Violation|6
134573|NCT00789698|485419|P4|Overall Study|Lost to Follow-up|9
134574|NCT00789698|485420|P3|Overall Study|Lost to Follow-up|2
134575|NCT00789698|485421|P2|Overall Study|Lost to Follow-up|5
134576|NCT00789698|485422|P1|Overall Study|Lost to Follow-up|5
134577|NCT00789698|485419|P4|Overall Study|Adverse Event|4
134578|NCT00789698|485420|P3|Overall Study|Adverse Event|3
134579|NCT00789698|485421|P2|Overall Study|Adverse Event|5
134580|NCT00789698|485422|P1|Overall Study|Adverse Event|5
134581|NCT00789698|485419|P4|Overall Study|Lack of Efficacy|18
134582|NCT00789698|485420|P3|Overall Study|Lack of Efficacy|5
134583|NCT00789698|485421|P2|Overall Study|Lack of Efficacy|4
134584|NCT00789698|485422|P1|Overall Study|Lack of Efficacy|10
134585|NCT00789581|485477|P2|Adjuvant Therapy|Not Specified|1
134586|NCT00789581|485478|P1|Adjuvant Therapy|Not Specified|0
134587|NCT00789581|485477|P2|Adjuvant Therapy|Protocol Violation|1
134588|NCT00789581|485478|P1|Adjuvant Therapy|Protocol Violation|1
134589|NCT00789581|485477|P2|Adjuvant Therapy|Intercurrent Illness|3
134590|NCT00789581|485478|P1|Adjuvant Therapy|Intercurrent Illness|1
134591|NCT00789581|485477|P2|Adjuvant Therapy|Disease recurrence|1
134592|NCT00789581|485478|P1|Adjuvant Therapy|Disease recurrence|2
134593|NCT00789581|485477|P2|Adjuvant Therapy|Withdrawal by Subject|5
134594|NCT00789581|485478|P1|Adjuvant Therapy|Withdrawal by Subject|14
134595|NCT00789581|485477|P2|Adjuvant Therapy|Adverse Event|44
134596|NCT00789581|485478|P1|Adjuvant Therapy|Adverse Event|20
134597|NCT00789581|485477|P2|Adjuvant Therapy|Never treated|2
134598|NCT00789581|485478|P1|Adjuvant Therapy|Never treated|2
134599|NCT00789581|485477|P2|AC Therapy|Not specified|2
134600|NCT00789581|485478|P1|AC Therapy|Not specified|0
134601|NCT00789581|485477|P2|AC Therapy|Never Treated|4
134602|NCT00789581|485478|P1|AC Therapy|Never Treated|1
134603|NCT00789581|485477|P2|AC Therapy|Intercurrent Illness|0
134604|NCT00789581|485478|P1|AC Therapy|Intercurrent Illness|1
134605|NCT00789581|485477|P2|AC Therapy|Disease recurrence|1
134606|NCT00789581|485478|P1|AC Therapy|Disease recurrence|3
134607|NCT00789581|485477|P2|AC Therapy|Withdrawal by Subject|7
134608|NCT00789581|485478|P1|AC Therapy|Withdrawal by Subject|4
134609|NCT00789581|485477|P2|AC Therapy|Adverse Event|3
134610|NCT00789581|485478|P1|AC Therapy|Adverse Event|2
134611|NCT00789555|485489|P3|Overall Study|Protocol Violation|13
134612|NCT00789555|485490|P2|Overall Study|Protocol Violation|9
134613|NCT00789555|485491|P1|Overall Study|Protocol Violation|6
134614|NCT00789555|485489|P3|Overall Study|Treatment failure|12
134615|NCT00789555|485490|P2|Overall Study|Treatment failure|8
134616|NCT00789555|485491|P1|Overall Study|Treatment failure|11
134617|NCT00789555|485489|P3|Overall Study|Patient decision unnrelated to adv event|26
134618|NCT00789555|485490|P2|Overall Study|Patient decision unnrelated to adv event|29
134619|NCT00789555|485491|P1|Overall Study|Patient decision unnrelated to adv event|38
134620|NCT00789555|485489|P3|Overall Study|Lost to Follow-up|18
134621|NCT00789555|485490|P2|Overall Study|Lost to Follow-up|10
134622|NCT00789555|485491|P1|Overall Study|Lost to Follow-up|9
134623|NCT00789555|485489|P3|Overall Study|Adverse Event|10
134624|NCT00789555|485490|P2|Overall Study|Adverse Event|7
134625|NCT00789555|485491|P1|Overall Study|Adverse Event|17
134626|NCT00789555|485489|P3|Overall Study|Protocol Amendment|80
134627|NCT00789555|485490|P2|Overall Study|Protocol Amendment|76
134628|NCT00789555|485491|P1|Overall Study|Protocol Amendment|78
134629|NCT00789529|485516|P2|Overall Study|Other Reason|0
134630|NCT00789529|485517|P1|Overall Study|Other Reason|1
134631|NCT00789529|485516|P2|Overall Study|Withdrawal by Subject|1
134632|NCT00789529|485517|P1|Overall Study|Withdrawal by Subject|0
134633|NCT00789477|485530|P5|Overall Study|Other|0
134634|NCT00789477|485531|P4|Overall Study|Other|3
134635|NCT00789477|485532|P3|Overall Study|Other|1
134636|NCT00789477|485533|P2|Overall Study|Other|0
134637|NCT00789477|485534|P1|Overall Study|Other|2
134638|NCT00789477|485530|P5|Overall Study|Lack of Efficacy|0
134639|NCT00789477|485531|P4|Overall Study|Lack of Efficacy|0
134640|NCT00789477|485532|P3|Overall Study|Lack of Efficacy|0
134641|NCT00789477|485533|P2|Overall Study|Lack of Efficacy|0
134642|NCT00789477|485534|P1|Overall Study|Lack of Efficacy|2
134643|NCT00789477|485530|P5|Overall Study|Lost to Follow-up|4
134644|NCT00789477|485531|P4|Overall Study|Lost to Follow-up|2
134645|NCT00789477|485532|P3|Overall Study|Lost to Follow-up|4
134646|NCT00789477|485533|P2|Overall Study|Lost to Follow-up|1
134647|NCT00789477|485534|P1|Overall Study|Lost to Follow-up|0
134648|NCT00789477|485530|P5|Overall Study|Death|0
134649|NCT00789477|485531|P4|Overall Study|Death|2
134650|NCT00789477|485532|P3|Overall Study|Death|2
134651|NCT00789477|485533|P2|Overall Study|Death|1
134652|NCT00789477|485534|P1|Overall Study|Death|1
134653|NCT00789477|485530|P5|Overall Study|Adverse Event|0
134654|NCT00789477|485531|P4|Overall Study|Adverse Event|0
134655|NCT00789477|485532|P3|Overall Study|Adverse Event|1
134656|NCT00789477|485533|P2|Overall Study|Adverse Event|3
134657|NCT00789477|485534|P1|Overall Study|Adverse Event|3
134658|NCT00789477|485530|P5|Overall Study|Protocol Violation|0
134659|NCT00789477|485531|P4|Overall Study|Protocol Violation|1
134660|NCT00789477|485532|P3|Overall Study|Protocol Violation|0
134661|NCT00789477|485533|P2|Overall Study|Protocol Violation|0
134662|NCT00789477|485534|P1|Overall Study|Protocol Violation|1
134663|NCT00789477|485530|P5|Overall Study|Withdrawal by Subject|3
134664|NCT00789477|485531|P4|Overall Study|Withdrawal by Subject|2
134665|NCT00789477|485532|P3|Overall Study|Withdrawal by Subject|3
134666|NCT00789477|485533|P2|Overall Study|Withdrawal by Subject|1
134667|NCT00789477|485534|P1|Overall Study|Withdrawal by Subject|2
134668|NCT00789373|485579|P3|Maintenance|Participants On-Going at Data Cut-Off|0
134669|NCT00789373|485580|P2|Maintenance|Participants On-Going at Data Cut-Off|4
134670|NCT00789373|485581|P1|Maintenance|Participants On-Going at Data Cut-Off|0
134671|NCT00789373|485579|P3|Maintenance|Sponsor Decision|2
134672|NCT00789373|485580|P2|Maintenance|Sponsor Decision|0
134673|NCT00789373|485581|P1|Maintenance|Sponsor Decision|0
134674|NCT00789373|485579|P3|Maintenance|Withdrawal by Subject|8
134675|NCT00789373|485580|P2|Maintenance|Withdrawal by Subject|21
134676|NCT00789373|485581|P1|Maintenance|Withdrawal by Subject|0
134677|NCT00789373|485579|P3|Maintenance|Progressive Disease|152
134678|NCT00789373|485580|P2|Maintenance|Progressive Disease|253
134679|NCT00789373|485581|P1|Maintenance|Progressive Disease|0
134680|NCT00789373|485579|P3|Maintenance|Lost to Follow-up|0
134681|NCT00789373|485580|P2|Maintenance|Lost to Follow-up|2
134682|NCT00789373|485581|P1|Maintenance|Lost to Follow-up|0
134683|NCT00789373|485579|P3|Maintenance|Protocol entry criteria not met|0
134684|NCT00789373|485580|P2|Maintenance|Protocol entry criteria not met|2
134685|NCT00789373|485581|P1|Maintenance|Protocol entry criteria not met|0
134686|NCT00789373|485579|P3|Maintenance|Investigator Decision|2
134687|NCT00789373|485580|P2|Maintenance|Investigator Decision|4
134688|NCT00789373|485581|P1|Maintenance|Investigator Decision|0
134689|NCT00789373|485579|P3|Maintenance|Death due to toxicity|2
134690|NCT00789373|485580|P2|Maintenance|Death due to toxicity|1
134691|NCT00789373|485581|P1|Maintenance|Death due to toxicity|0
134692|NCT00789373|485579|P3|Maintenance|Death due to adverse event|1
134693|NCT00789373|485580|P2|Maintenance|Death due to adverse event|4
134694|NCT00789373|485581|P1|Maintenance|Death due to adverse event|0
134695|NCT00789373|485579|P3|Maintenance|Death due to study disease|1
134696|NCT00789373|485580|P2|Maintenance|Death due to study disease|3
134697|NCT00789373|485581|P1|Maintenance|Death due to study disease|0
134698|NCT00789373|485579|P3|Maintenance|Adverse Event|12
134699|NCT00789373|485580|P2|Maintenance|Adverse Event|65
134700|NCT00789373|485581|P1|Maintenance|Adverse Event|0
134701|NCT00789373|485579|P3|Induction|Withdrawal by Subject|0
134702|NCT00789373|485580|P2|Induction|Withdrawal by Subject|0
134703|NCT00789373|485581|P1|Induction|Withdrawal by Subject|37
134704|NCT00789373|485579|P3|Induction|Progressive Disease|0
134705|NCT00789373|485580|P2|Induction|Progressive Disease|0
134706|NCT00789373|485581|P1|Induction|Progressive Disease|220
134707|NCT00789373|485579|P3|Induction|Protocol Violation|0
134708|NCT00789373|485580|P2|Induction|Protocol Violation|0
134709|NCT00789373|485581|P1|Induction|Protocol Violation|1
134710|NCT00789373|485579|P3|Induction|Lost to Follow-up|0
134711|NCT00789373|485580|P2|Induction|Lost to Follow-up|0
134712|NCT00789373|485581|P1|Induction|Lost to Follow-up|6
134713|NCT00789373|485579|P3|Induction|Protocol entry criteria not met|0
134714|NCT00789373|485580|P2|Induction|Protocol entry criteria not met|0
134715|NCT00789373|485581|P1|Induction|Protocol entry criteria not met|9
134716|NCT00789373|485579|P3|Induction|Investigator decision|0
134717|NCT00789373|485580|P2|Induction|Investigator decision|0
134718|NCT00789373|485581|P1|Induction|Investigator decision|7
134719|NCT00789373|485579|P3|Induction|Death due to procedure|0
134720|NCT00789373|485580|P2|Induction|Death due to procedure|0
134721|NCT00789373|485581|P1|Induction|Death due to procedure|1
134722|NCT00789373|485579|P3|Induction|Death due to toxicity|0
134723|NCT00789373|485580|P2|Induction|Death due to toxicity|0
134724|NCT00789373|485581|P1|Induction|Death due to toxicity|11
134725|NCT00789373|485579|P3|Induction|Death due to adverse event|0
134726|NCT00789373|485580|P2|Induction|Death due to adverse event|0
134727|NCT00789373|485581|P1|Induction|Death due to adverse event|19
134728|NCT00789373|485579|P3|Induction|Death Due to study disease|0
134729|NCT00789373|485580|P2|Induction|Death Due to study disease|0
134730|NCT00789373|485581|P1|Induction|Death Due to study disease|24
134731|NCT00789373|485579|P3|Induction|Adverse Event|0
134732|NCT00789373|485580|P2|Induction|Adverse Event|0
134733|NCT00789373|485581|P1|Induction|Adverse Event|64
134734|NCT00789321|485608|P2|Overall Study|Adverse Event|1
134735|NCT00789321|485609|P1|Overall Study|Adverse Event|0
134736|NCT00789191|485628|P2|Overall Study|Unclassified|3
134737|NCT00789191|485629|P1|Overall Study|Unclassified|5
134738|NCT00789191|485628|P2|Overall Study|Withdrawal Criteria|4
134739|NCT00789191|485629|P1|Overall Study|Withdrawal Criteria|2
134740|NCT00789191|485628|P2|Overall Study|Protocol Violation|3
134741|NCT00789191|485629|P1|Overall Study|Protocol Violation|5
134742|NCT00789191|485628|P2|Overall Study|Lack of Efficacy|5
134743|NCT00789191|485629|P1|Overall Study|Lack of Efficacy|0
134744|NCT00789191|485628|P2|Overall Study|Adverse Event|4
134745|NCT00789191|485629|P1|Overall Study|Adverse Event|2
134746|NCT00789035|485686|P5|Overall Study|Other reason not defined above|1
134747|NCT00789035|485687|P4|Overall Study|Other reason not defined above|0
134748|NCT00789035|485688|P3|Overall Study|Other reason not defined above|1
134749|NCT00789035|485689|P2|Overall Study|Other reason not defined above|3
134750|NCT00789035|485690|P1|Overall Study|Other reason not defined above|2
134751|NCT00789035|485686|P5|Overall Study|Withdrawal by Subject|0
134752|NCT00789035|485687|P4|Overall Study|Withdrawal by Subject|0
134753|NCT00789035|485688|P3|Overall Study|Withdrawal by Subject|0
134754|NCT00789035|485689|P2|Overall Study|Withdrawal by Subject|2
134755|NCT00789035|485690|P1|Overall Study|Withdrawal by Subject|0
134756|NCT00789035|485686|P5|Overall Study|Protocol Violation|0
134757|NCT00789035|485687|P4|Overall Study|Protocol Violation|0
134758|NCT00789035|485688|P3|Overall Study|Protocol Violation|0
134759|NCT00789035|485689|P2|Overall Study|Protocol Violation|0
134760|NCT00789035|485690|P1|Overall Study|Protocol Violation|1
134761|NCT00789035|485686|P5|Overall Study|Lack of Efficacy|2
134762|NCT00789035|485687|P4|Overall Study|Lack of Efficacy|0
134763|NCT00789035|485688|P3|Overall Study|Lack of Efficacy|0
134764|NCT00789035|485689|P2|Overall Study|Lack of Efficacy|0
134765|NCT00789035|485690|P1|Overall Study|Lack of Efficacy|3
134766|NCT00789035|485686|P5|Overall Study|Adverse Event|3
134767|NCT00789035|485687|P4|Overall Study|Adverse Event|1
134768|NCT00789035|485688|P3|Overall Study|Adverse Event|0
134769|NCT00789035|485689|P2|Overall Study|Adverse Event|2
134770|NCT00789035|485690|P1|Overall Study|Adverse Event|0
134771|NCT00788957|485749|P6|Part 3|On-study at time of data cut-off|0
134772|NCT00788957|485750|P5|Part 3|On-study at time of data cut-off|1
134773|NCT00788957|485751|P4|Part 3|On-study at time of data cut-off|0
134774|NCT00788957|485752|P3|Part 3|On-study at time of data cut-off|0
134775|NCT00788957|485753|P2|Part 3|On-study at time of data cut-off|0
134776|NCT00788957|485754|P1|Part 3|On-study at time of data cut-off|0
134777|NCT00788957|485749|P6|Part 3|Death|9
134778|NCT00788957|485750|P5|Part 3|Death|8
134779|NCT00788957|485751|P4|Part 3|Death|0
134780|NCT00788957|485752|P3|Part 3|Death|0
134781|NCT00788957|485753|P2|Part 3|Death|0
134782|NCT00788957|485754|P1|Part 3|Death|0
134783|NCT00788957|485749|P6|Part 3|Withdrawal by Subject|2
134784|NCT00788957|485750|P5|Part 3|Withdrawal by Subject|0
134785|NCT00788957|485751|P4|Part 3|Withdrawal by Subject|0
134786|NCT00788957|485752|P3|Part 3|Withdrawal by Subject|0
134787|NCT00788957|485753|P2|Part 3|Withdrawal by Subject|0
134788|NCT00788957|485754|P1|Part 3|Withdrawal by Subject|0
134789|NCT00788957|485749|P6|Part 2|On-study at time of data cut-off|0
134790|NCT00788957|485750|P5|Part 2|On-study at time of data cut-off|0
134791|NCT00788957|485751|P4|Part 2|On-study at time of data cut-off|1
134792|NCT00788957|485752|P3|Part 2|On-study at time of data cut-off|1
134793|NCT00788957|485753|P2|Part 2|On-study at time of data cut-off|1
134794|NCT00788957|485754|P1|Part 2|On-study at time of data cut-off|0
134795|NCT00788957|485749|P6|Part 2|Lost to Follow-up|0
134796|NCT00788957|485750|P5|Part 2|Lost to Follow-up|0
134797|NCT00788957|485751|P4|Part 2|Lost to Follow-up|0
134798|NCT00788957|485752|P3|Part 2|Lost to Follow-up|3
134799|NCT00788957|485753|P2|Part 2|Lost to Follow-up|0
134800|NCT00788957|485754|P1|Part 2|Lost to Follow-up|0
134801|NCT00788957|485749|P6|Part 2|Death|0
134802|NCT00788957|485750|P5|Part 2|Death|0
134803|NCT00788957|485751|P4|Part 2|Death|37
134804|NCT00788957|485752|P3|Part 2|Death|35
134805|NCT00788957|485753|P2|Part 2|Death|32
134807|NCT00788957|485749|P6|Part 2|Withdrawal by Subject|0
134808|NCT00788957|485750|P5|Part 2|Withdrawal by Subject|0
134809|NCT00788957|485751|P4|Part 2|Withdrawal by Subject|3
134810|NCT00788957|485752|P3|Part 2|Withdrawal by Subject|5
134811|NCT00788957|485753|P2|Part 2|Withdrawal by Subject|9
134812|NCT00788957|485754|P1|Part 2|Withdrawal by Subject|0
134813|NCT00788957|485749|P6|Part 1|Lost to Follow-up|0
134814|NCT00788957|485750|P5|Part 1|Lost to Follow-up|0
134815|NCT00788957|485751|P4|Part 1|Lost to Follow-up|0
134816|NCT00788957|485752|P3|Part 1|Lost to Follow-up|0
134817|NCT00788957|485753|P2|Part 1|Lost to Follow-up|0
134818|NCT00788957|485754|P1|Part 1|Lost to Follow-up|1
134819|NCT00788957|485749|P6|Part 1|Death|0
134820|NCT00788957|485750|P5|Part 1|Death|0
134821|NCT00788957|485751|P4|Part 1|Death|0
134822|NCT00788957|485752|P3|Part 1|Death|0
134823|NCT00788957|485753|P2|Part 1|Death|0
134824|NCT00788957|485754|P1|Part 1|Death|8
134825|NCT00788775|485829|P2|Overall Study|Patient's measurable disease resected.|0
134826|NCT00788775|485830|P1|Overall Study|Patient's measurable disease resected.|1
134827|NCT00788775|485829|P2|Overall Study|Patient Non-Compliance|0
134828|NCT00788775|485830|P1|Overall Study|Patient Non-Compliance|1
134829|NCT00788775|485829|P2|Overall Study|Withdrawal by Subject|2
134830|NCT00788775|485830|P1|Overall Study|Withdrawal by Subject|0
134831|NCT00788775|485829|P2|Overall Study|Progressive Disease|6
134832|NCT00788775|485830|P1|Overall Study|Progressive Disease|8
134833|NCT00788710|485845|P3|Overall Study|Withdrawal by Subject|0
134834|NCT00788710|485846|P2|Overall Study|Withdrawal by Subject|2
134835|NCT00788710|485847|P1|Overall Study|Withdrawal by Subject|2
134836|NCT00788710|485845|P3|Overall Study|Protocol Violation|1
134837|NCT00788710|485846|P2|Overall Study|Protocol Violation|1
134838|NCT00788710|485847|P1|Overall Study|Protocol Violation|0
134839|NCT00788710|485845|P3|Overall Study|Physician Decision|0
134840|NCT00788710|485846|P2|Overall Study|Physician Decision|1
134841|NCT00788710|485847|P1|Overall Study|Physician Decision|2
134842|NCT00788710|485845|P3|Overall Study|Lost to Follow-up|0
134843|NCT00788710|485846|P2|Overall Study|Lost to Follow-up|1
134844|NCT00788710|485847|P1|Overall Study|Lost to Follow-up|0
134845|NCT00788710|485845|P3|Overall Study|Lack of Efficacy|1
134846|NCT00788710|485846|P2|Overall Study|Lack of Efficacy|0
134847|NCT00788710|485847|P1|Overall Study|Lack of Efficacy|0
134848|NCT00788710|485845|P3|Overall Study|Adverse Event|4
134849|NCT00788710|485846|P2|Overall Study|Adverse Event|3
134850|NCT00788710|485847|P1|Overall Study|Adverse Event|1
134851|NCT00788697|485861|P1|Overall Study|Indeterminate diagnosis from truth stand|17
134852|NCT00788697|485861|P1|Overall Study|Technically inadequate truth standard|1
134853|NCT00788697|485861|P1|Overall Study|no truth standard procedure available|5
134854|NCT00788697|485861|P1|Overall Study|Training Patients|74
134855|NCT00788697|485861|P1|Overall Study|No study drug administered|12
134856|NCT00788593|485908|P3|Second Intervention Period|Other|1
134857|NCT00788593|485909|P2|Second Intervention Period|Other|0
134858|NCT00788593|485910|P1|Second Intervention Period|Other|0
134859|NCT00788593|485908|P3|Second Intervention Period|Lost to Follow-up|0
134860|NCT00788593|485909|P2|Second Intervention Period|Lost to Follow-up|1
134861|NCT00788593|485910|P1|Second Intervention Period|Lost to Follow-up|0
134862|NCT00788593|485908|P3|First Intervention Period|Adverse Event|0
134863|NCT00788593|485909|P2|First Intervention Period|Adverse Event|1
134864|NCT00788593|485910|P1|First Intervention Period|Adverse Event|0
134865|NCT00788593|485908|P3|Placebo Run-in Phase|Protocol Violation|0
134866|NCT00788593|485909|P2|Placebo Run-in Phase|Protocol Violation|0
134867|NCT00788593|485910|P1|Placebo Run-in Phase|Protocol Violation|2
134868|NCT00788593|485908|P3|Placebo Run-in Phase|Withdrawal by Subject|0
134869|NCT00788593|485909|P2|Placebo Run-in Phase|Withdrawal by Subject|0
134870|NCT00788593|485910|P1|Placebo Run-in Phase|Withdrawal by Subject|2
134871|NCT00788593|485908|P3|Placebo Run-in Phase|Adverse Event|0
134872|NCT00788593|485909|P2|Placebo Run-in Phase|Adverse Event|0
134873|NCT00788593|485910|P1|Placebo Run-in Phase|Adverse Event|2
134874|NCT00788372|485927|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
134875|NCT00788372|485927|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
134876|NCT00788372|485927|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
134877|NCT00788372|485927|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
134878|NCT00788372|485927|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
134879|NCT00788372|485927|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
134880|NCT00788372|485927|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
134881|NCT00788073|485956|P2|Placebo Then STX209|Protocol Violation|1
134882|NCT00788073|485957|P1|Placebo Then STX209|Protocol Violation|0
134883|NCT00788073|485956|P2|Placebo Then STX209|Adverse Event|0
134884|NCT00788073|485957|P1|Placebo Then STX209|Adverse Event|2
134885|NCT00788073|485956|P2|STX209 Then Placebo|unable to return due to travel|1
134886|NCT00788073|485957|P1|STX209 Then Placebo|unable to return due to travel|0
134887|NCT00788073|485956|P2|STX209 Then Placebo|Withdrawal by Subject|1
134888|NCT00788073|485957|P1|STX209 Then Placebo|Withdrawal by Subject|0
134889|NCT00788073|485956|P2|STX209 Then Placebo|Lost to Follow-up|1
134890|NCT00788073|485957|P1|STX209 Then Placebo|Lost to Follow-up|0
134891|NCT00788073|485956|P2|STX209 Then Placebo|Adverse Event|0
134892|NCT00788073|485957|P1|STX209 Then Placebo|Adverse Event|1
134893|NCT00787930|485982|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
134894|NCT00787917|485997|P2|Open Label|Administrative problems|0
134895|NCT00787917|485998|P1|Open Label|Administrative problems|3
134896|NCT00787917|485997|P2|Open Label|Unsatisfactory therapeutic effect|0
134897|NCT00787917|485998|P1|Open Label|Unsatisfactory therapeutic effect|1
134898|NCT00787917|485997|P2|Blinded Treatment|Administrative problems|2
134899|NCT00787917|485998|P1|Blinded Treatment|Administrative problems|3
134900|NCT00787917|485997|P2|Blinded Treatment|Lack of Efficacy|0
134901|NCT00787917|485998|P1|Blinded Treatment|Lack of Efficacy|1
134902|NCT00787917|485997|P2|Blinded Treatment|Adverse Event|0
134903|NCT00787917|485998|P1|Blinded Treatment|Adverse Event|1
134904|NCT00787891|486028|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
134905|NCT00787891|486029|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
134906|NCT00787891|486028|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
134907|NCT00787891|486029|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
134908|NCT00787891|486028|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
134909|NCT00787891|486029|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
134910|NCT00787891|486028|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
134911|NCT00787891|486029|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
134912|NCT00787891|486028|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
134913|NCT00787891|486029|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
134914|NCT00787891|486028|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
134915|NCT00787891|486029|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
134916|NCT00787891|486028|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
134917|NCT00787891|486029|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
134918|NCT00787891|486028|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
134919|NCT00787891|486029|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
134920|NCT00787891|486028|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
134921|NCT00787891|486029|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
134922|NCT00787891|486028|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
134923|NCT00787891|486029|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
134924|NCT00787839|486056|P1|Overall Study|Failure to have the OGTT was most common|404
134925|NCT00787800|486079|P2|Overall Study|Death|2
134926|NCT00787800|486080|P1|Overall Study|Death|0
134927|NCT00787800|486079|P2|Overall Study|Withdrawal by Subject|5
134928|NCT00787800|486080|P1|Overall Study|Withdrawal by Subject|3
134929|NCT00787787|486096|P1|Overall Study|Adverse Event|3
134930|NCT00787787|486096|P1|Overall Study|Lack of Efficacy|4
134931|NCT00787644|486115|P2|Overall Study|Withdrawal by Subject|1
134932|NCT00787644|486116|P1|Overall Study|Withdrawal by Subject|1
134933|NCT00787644|486115|P2|Overall Study|Lost to Follow-up|1
134934|NCT00787644|486116|P1|Overall Study|Lost to Follow-up|1
134935|NCT00787605|486137|P2|Overall Study|Lack of Efficacy|9
134936|NCT00787605|486138|P1|Overall Study|Lack of Efficacy|13
134937|NCT00787605|486137|P2|Overall Study|Withdrawal by Subject|13
134938|NCT00787605|486138|P1|Overall Study|Withdrawal by Subject|6
134939|NCT00787605|486137|P2|Overall Study|Protocol Violation|3
134940|NCT00787605|486138|P1|Overall Study|Protocol Violation|7
134941|NCT00787605|486137|P2|Overall Study|Lost to Follow-up|6
134942|NCT00787605|486138|P1|Overall Study|Lost to Follow-up|3
134943|NCT00787605|486137|P2|Overall Study|Adverse Event|25
134944|NCT00787605|486138|P1|Overall Study|Adverse Event|14
134945|NCT00787605|486137|P2|Overall Study|Administrative Problems|0
134946|NCT00787605|486138|P1|Overall Study|Administrative Problems|3
134947|NCT00787566|486157|P3|Overall Study|AE related to chemotherapy|0
134948|NCT00787566|486158|P2|Overall Study|AE related to chemotherapy|1
134949|NCT00787566|486159|P1|Overall Study|AE related to chemotherapy|0
134950|NCT00787527|486167|P1|Overall Study|Toxicity|3
134951|NCT00787319|486184|P1|Overall Study|Inactive disease|5
134952|NCT00787319|486184|P1|Overall Study|Stabilized disease findings|3
134953|NCT00787319|486184|P1|Overall Study|No health insurance reimbursement|2
134954|NCT00787319|486184|P1|Overall Study|Unresponsiveness to visit invitation|1
134955|NCT00787319|486184|P1|Overall Study|Budget exhausted/exceeded|1
134956|NCT00787319|486184|P1|Overall Study|Lack of Efficacy|1
134957|NCT00787319|486184|P1|Overall Study|Objective progression or relapse|30
134958|NCT00787319|486184|P1|Overall Study|Adverse Event|3
134959|NCT00787319|486184|P1|Overall Study|Withdrawal by Subject|15
134960|NCT00787319|486184|P1|Overall Study|Lost to Follow-up|2
134961|NCT00787267|486196|P1|Overall Study|Withdrawal by Subject|1
134962|NCT00787267|486196|P1|Overall Study|No Reason Provided|1
134963|NCT00787267|486196|P1|Overall Study|Screen failure/Ineligible|10
134964|NCT00787254|486206|P2|Overall Study|Physician Decision|8
134965|NCT00787254|486207|P1|Overall Study|Physician Decision|4
134966|NCT00787254|486206|P2|Overall Study|Institution closed|0
134967|NCT00787254|486207|P1|Overall Study|Institution closed|1
134968|NCT00787254|486206|P2|Overall Study|NSAIDs discontinuation|2
134969|NCT00787254|486207|P1|Overall Study|NSAIDs discontinuation|1
134970|NCT00787254|486206|P2|Overall Study|Lack of Efficacy|15
134971|NCT00787254|486207|P1|Overall Study|Lack of Efficacy|4
134972|NCT00787254|486206|P2|Overall Study|Withdrawal by Subject|11
134973|NCT00787254|486207|P1|Overall Study|Withdrawal by Subject|16
134974|NCT00787254|486206|P2|Overall Study|Protocol Violation|23
134975|NCT00787254|486207|P1|Overall Study|Protocol Violation|26
134976|NCT00787254|486206|P2|Overall Study|Adverse Event|23
134977|NCT00787254|486207|P1|Overall Study|Adverse Event|24
134978|NCT00787202|486331|P5|Overall Study|Randomized, not treated|0
134979|NCT00787202|486332|P4|Overall Study|Randomized, not treated|0
134980|NCT00787202|486333|P3|Overall Study|Randomized, not treated|0
134981|NCT00787202|486334|P2|Overall Study|Randomized, not treated|0
134982|NCT00787202|486335|P1|Overall Study|Randomized, not treated|1
134983|NCT00787202|486331|P5|Overall Study|Protocol Violation|1
134984|NCT00787202|486332|P4|Overall Study|Protocol Violation|0
134985|NCT00787202|486333|P3|Overall Study|Protocol Violation|0
134986|NCT00787202|486334|P2|Overall Study|Protocol Violation|1
134987|NCT00787202|486335|P1|Overall Study|Protocol Violation|2
134988|NCT00787202|486331|P5|Overall Study|Withdrawal by Subject|0
134989|NCT00787202|486332|P4|Overall Study|Withdrawal by Subject|0
134990|NCT00787202|486333|P3|Overall Study|Withdrawal by Subject|2
134991|NCT00787202|486334|P2|Overall Study|Withdrawal by Subject|2
134992|NCT00787202|486335|P1|Overall Study|Withdrawal by Subject|2
134993|NCT00787202|486331|P5|Overall Study|Lost to Follow-up|0
134994|NCT00787202|486332|P4|Overall Study|Lost to Follow-up|0
134995|NCT00787202|486333|P3|Overall Study|Lost to Follow-up|0
134996|NCT00787202|486334|P2|Overall Study|Lost to Follow-up|0
134997|NCT00787202|486335|P1|Overall Study|Lost to Follow-up|1
134998|NCT00787202|486331|P5|Overall Study|Lack of Efficacy|1
134999|NCT00787202|486332|P4|Overall Study|Lack of Efficacy|2
135000|NCT00787202|486333|P3|Overall Study|Lack of Efficacy|5
135001|NCT00787202|486334|P2|Overall Study|Lack of Efficacy|6
135002|NCT00787202|486335|P1|Overall Study|Lack of Efficacy|5
135003|NCT00787202|486331|P5|Overall Study|Adverse Event|2
135004|NCT00787202|486332|P4|Overall Study|Adverse Event|0
135005|NCT00787202|486333|P3|Overall Study|Adverse Event|0
135006|NCT00787202|486334|P2|Overall Study|Adverse Event|2
135007|NCT00787202|486335|P1|Overall Study|Adverse Event|3
135008|NCT00787189|486388|P2|Overall Study|Lost to Follow-up|2
135009|NCT00787189|486389|P1|Overall Study|Lost to Follow-up|2
135010|NCT00787150|486398|P3|Overall Study|Dosing incorrect study durg|0
135011|NCT00787150|486399|P2|Overall Study|Dosing incorrect study durg|0
135012|NCT00787150|486400|P1|Overall Study|Dosing incorrect study durg|2
135013|NCT00787150|486398|P3|Overall Study|Withdrawal by Subject|0
135014|NCT00787150|486399|P2|Overall Study|Withdrawal by Subject|1
135015|NCT00787150|486400|P1|Overall Study|Withdrawal by Subject|2
135016|NCT00787150|486398|P3|Overall Study|Physician Decision|1
135017|NCT00787150|486399|P2|Overall Study|Physician Decision|2
135018|NCT00787150|486400|P1|Overall Study|Physician Decision|1
135019|NCT00787150|486398|P3|Overall Study|Adverse Event|4
135020|NCT00787150|486399|P2|Overall Study|Adverse Event|4
135021|NCT00787150|486400|P1|Overall Study|Adverse Event|4
135022|NCT00787137|486445|P3|Overall Study|Study Termination|1
135023|NCT00787137|486446|P2|Overall Study|Study Termination|0
135024|NCT00787137|486447|P1|Overall Study|Study Termination|0
135025|NCT00786864|486522|P2|Overall Study|Sustained serious back injury|0
135026|NCT00786864|486523|P1|Overall Study|Sustained serious back injury|1
135027|NCT00786864|486522|P2|Overall Study|Lost to Follow-up|1
135028|NCT00786864|486523|P1|Overall Study|Lost to Follow-up|0
135029|NCT00786838|486535|P1|Overall Study|Withdrawal by Subject|4
135030|NCT00786838|486535|P1|Overall Study|Progressive disease|31
135031|NCT00786838|486535|P1|Overall Study|Adverse Event|6
135032|NCT00786838|486535|P1|Overall Study|Death|4
135033|NCT00786838|486535|P1|Overall Study|Physician Decision|4
135034|NCT00786799|486562|P2|Overall Study|Lost to Follow-up|1
135035|NCT00786799|486563|P1|Overall Study|Lost to Follow-up|1
135036|NCT00786565|486593|P1|Post Surgery|Adapt AO implanted posterior side up|1
135037|NCT00786565|486593|P1|Post Surgery|Abnormal macular pucker|1
135038|NCT00786565|486593|P1|Enrollment Prior to Surgery|Protocol Violation|3
135039|NCT00786565|486593|P1|Enrollment Prior to Surgery|Site Closed|3
135040|NCT00786474|486650|P2|Overall Study|Not Specified|4
135041|NCT00786474|486651|P1|Overall Study|Not Specified|4
135042|NCT00786474|486650|P2|Overall Study|Physician Decision|1
135043|NCT00786474|486651|P1|Overall Study|Physician Decision|2
135044|NCT00786474|486650|P2|Overall Study|Lost to Follow-up|3
135045|NCT00786474|486651|P1|Overall Study|Lost to Follow-up|3
135046|NCT00786474|486650|P2|Overall Study|Withdrawal by Subject|31
135047|NCT00786474|486651|P1|Overall Study|Withdrawal by Subject|23
135048|NCT00786474|486650|P2|Overall Study|Death|4
135049|NCT00786474|486651|P1|Overall Study|Death|5
135050|NCT00786422|486663|P1|Follow-up Period|End-of-study done up to 4 days early|2
135051|NCT00786422|486663|P1|Follow-up Period|Death|1
135052|NCT00786422|486663|P1|Rivaroxaban Treatment|Adverse Event|2
135053|NCT00786422|486663|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
135054|NCT00786422|486663|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
135055|NCT00786422|486663|P1|Rivaroxaban Treatment|Physician Decision|1
135056|NCT00786422|486663|P1|Rivaroxaban Treatment|Lack of Efficacy|1
135057|NCT00786422|486663|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
135058|NCT00786422|486663|P1|Rivaroxaban Treatment|Death|2
135059|NCT00786409|486679|P1|Overall Study|Lost to Follow-up|1
135060|NCT00786409|486679|P1|Overall Study|Pregnancy|2
135061|NCT00786409|486679|P1|Overall Study|Adverse Event|2
135062|NCT00786409|486679|P1|Overall Study|Withdrawal by Subject|2
135063|NCT00786188|486696|P2|Overall Study|Withdrawal by Subject|0
135064|NCT00786188|486697|P1|Overall Study|Withdrawal by Subject|2
135065|NCT00786188|486696|P2|Overall Study|Adverse Event|1
135066|NCT00786188|486697|P1|Overall Study|Adverse Event|3
135067|NCT00786032|486723|P1|Overall Study|Did not complete in the timeframe|6
135068|NCT00786032|486723|P1|Overall Study|Withdrawal by Subject|14
135069|NCT00786032|486723|P1|Overall Study|Death|4
135070|NCT00785980|486733|P1|7 Day Washout Period|Protocol Violation|3
135071|NCT00785785|486751|P2|Optional Extension Phase|Study terminated by sponsor|37
135072|NCT00785785|486752|P1|Optional Extension Phase|Study terminated by sponsor|3
135073|NCT00785785|486751|P2|Optional Extension Phase|Protocol deviation|2
135074|NCT00785785|486752|P1|Optional Extension Phase|Protocol deviation|0
135075|NCT00785785|486751|P2|Optional Extension Phase|Disease progression|70
135076|NCT00785785|486752|P1|Optional Extension Phase|Disease progression|22
135077|NCT00785785|486751|P2|Optional Extension Phase|Death|5
135078|NCT00785785|486752|P1|Optional Extension Phase|Death|1
135079|NCT00785785|486751|P2|Optional Extension Phase|Administrative problems|0
135080|NCT00785785|486752|P1|Optional Extension Phase|Administrative problems|2
135081|NCT00785785|486751|P2|Optional Extension Phase|Lost to Follow-up|0
135082|NCT00785785|486752|P1|Optional Extension Phase|Lost to Follow-up|1
135083|NCT00785785|486751|P2|Optional Extension Phase|Withdrawal by Subject|6
135084|NCT00785785|486752|P1|Optional Extension Phase|Withdrawal by Subject|6
135085|NCT00785785|486751|P2|Optional Extension Phase|Adverse Event|5
135086|NCT00785785|486752|P1|Optional Extension Phase|Adverse Event|4
135087|NCT00785785|486751|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
135088|NCT00785785|486752|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
135089|NCT00785785|486751|P2|Core Phase up to 36 Months|Protocol deviation|6
135090|NCT00785785|486752|P1|Core Phase up to 36 Months|Protocol deviation|5
135091|NCT00785785|486751|P2|Core Phase up to 36 Months|Disease progression|119
135092|NCT00785785|486752|P1|Core Phase up to 36 Months|Disease progression|139
135093|NCT00785785|486751|P2|Core Phase up to 36 Months|Death|8
135094|NCT00785785|486752|P1|Core Phase up to 36 Months|Death|5
135095|NCT00785785|486751|P2|Core Phase up to 36 Months|Administrative problems|3
135096|NCT00785785|486752|P1|Core Phase up to 36 Months|Administrative problems|3
135097|NCT00785785|486751|P2|Core Phase up to 36 Months|Lost to Follow-up|7
135098|NCT00785785|486752|P1|Core Phase up to 36 Months|Lost to Follow-up|3
135099|NCT00785785|486751|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
135100|NCT00785785|486752|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
135101|NCT00785785|486751|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
135102|NCT00785785|486752|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
135103|NCT00785785|486751|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
135104|NCT00785785|486752|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
135105|NCT00785785|486751|P2|Core Phase up to 36 Months|Adverse Event|21
135106|NCT00785785|486752|P1|Core Phase up to 36 Months|Adverse Event|31
135107|NCT00785785|486751|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
135108|NCT00785785|486752|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
135109|NCT00785707|486766|P1|Overall Study|Lost to Follow-up|7
135110|NCT00785629|486775|P4|Overall Study|Withdrawal by Subject|2
135111|NCT00785629|486776|P3|Overall Study|Withdrawal by Subject|2
135112|NCT00785629|486777|P2|Overall Study|Withdrawal by Subject|1
135113|NCT00785629|486778|P1|Overall Study|Withdrawal by Subject|0
135114|NCT00785629|486775|P4|Overall Study|administrative decision|4
135115|NCT00785629|486776|P3|Overall Study|administrative decision|3
135116|NCT00785629|486777|P2|Overall Study|administrative decision|1
135117|NCT00785629|486778|P1|Overall Study|administrative decision|5
135118|NCT00785629|486775|P4|Overall Study|Protocol Violation|5
135119|NCT00785629|486776|P3|Overall Study|Protocol Violation|4
135120|NCT00785629|486777|P2|Overall Study|Protocol Violation|2
135121|NCT00785629|486778|P1|Overall Study|Protocol Violation|1
135122|NCT00785629|486775|P4|Overall Study|Adverse Event|5
135123|NCT00785629|486776|P3|Overall Study|Adverse Event|1
135124|NCT00785629|486777|P2|Overall Study|Adverse Event|1
135125|NCT00785629|486778|P1|Overall Study|Adverse Event|2
135126|NCT00785577|486791|P5|Study Period 3: 1-Week Washout Phase|Death|1
135127|NCT00785577|486792|P4|Study Period 3: 1-Week Washout Phase|Death|0
135128|NCT00785577|486793|P3|Study Period 3: 1-Week Washout Phase|Death|0
135129|NCT00785577|486794|P2|Study Period 3: 1-Week Washout Phase|Death|0
135130|NCT00785577|486795|P1|Study Period 3: 1-Week Washout Phase|Death|0
135131|NCT00785577|486791|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
135132|NCT00785577|486792|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
135133|NCT00785577|486793|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
135134|NCT00785577|486794|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
135135|NCT00785577|486795|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
135136|NCT00785577|486791|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
135137|NCT00785577|486792|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
135138|NCT00785577|486793|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
135139|NCT00785577|486794|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
135140|NCT00785577|486795|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
135141|NCT00785577|486791|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
135142|NCT00785577|486792|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
135143|NCT00785577|486793|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
135144|NCT00785577|486794|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
135145|NCT00785577|486795|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
135146|NCT00785577|486791|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
135147|NCT00785577|486792|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
135148|NCT00785577|486793|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
135149|NCT00785577|486794|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
135150|NCT00785577|486795|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
135151|NCT00785577|486791|P5|Study Period 2: Therapy Phase|Protocol Violation|1
135152|NCT00785577|486792|P4|Study Period 2: Therapy Phase|Protocol Violation|0
135153|NCT00785577|486793|P3|Study Period 2: Therapy Phase|Protocol Violation|1
135154|NCT00785577|486794|P2|Study Period 2: Therapy Phase|Protocol Violation|1
135155|NCT00785577|486795|P1|Study Period 2: Therapy Phase|Protocol Violation|1
135156|NCT00785577|486791|P5|Study Period 2: Therapy Phase|Physician Decision|0
135157|NCT00785577|486792|P4|Study Period 2: Therapy Phase|Physician Decision|0
135158|NCT00785577|486793|P3|Study Period 2: Therapy Phase|Physician Decision|0
135159|NCT00785577|486794|P2|Study Period 2: Therapy Phase|Physician Decision|0
135160|NCT00785577|486795|P1|Study Period 2: Therapy Phase|Physician Decision|1
135161|NCT00785577|486791|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
135162|NCT00785577|486792|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
135163|NCT00785577|486793|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
135164|NCT00785577|486794|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
135165|NCT00785577|486795|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
135166|NCT00785577|486791|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
135167|NCT00785577|486792|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
135168|NCT00785577|486793|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
135169|NCT00785577|486794|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
135170|NCT00785577|486795|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
135171|NCT00785577|486791|P5|Study Period 2: Therapy Phase|Adverse Event|17
135172|NCT00785577|486792|P4|Study Period 2: Therapy Phase|Adverse Event|10
135173|NCT00785577|486793|P3|Study Period 2: Therapy Phase|Adverse Event|14
135174|NCT00785577|486794|P2|Study Period 2: Therapy Phase|Adverse Event|7
135175|NCT00785577|486795|P1|Study Period 2: Therapy Phase|Adverse Event|5
135176|NCT00785512|486933|P2|Overall Study|Lack of compliance|1
135177|NCT00785512|486934|P1|Overall Study|Lack of compliance|0
135178|NCT00785512|486933|P2|Overall Study|Physician Decision|0
135179|NCT00785512|486934|P1|Overall Study|Physician Decision|0
135180|NCT00785512|486933|P2|Overall Study|IVRS Programing Error|0
135181|NCT00785512|486934|P1|Overall Study|IVRS Programing Error|0
135182|NCT00785512|486933|P2|Overall Study|Precedure Refused|0
135183|NCT00785512|486934|P1|Overall Study|Precedure Refused|0
135184|NCT00785512|486933|P2|Overall Study|Lost to Follow-up|0
135185|NCT00785512|486934|P1|Overall Study|Lost to Follow-up|3
135186|NCT00785512|486933|P2|Overall Study|Withdrawal by Subject|1
135187|NCT00785512|486934|P1|Overall Study|Withdrawal by Subject|0
135188|NCT00785512|486933|P2|Overall Study|Lack of Efficacy|2
135189|NCT00785512|486934|P1|Overall Study|Lack of Efficacy|0
135190|NCT00785512|486933|P2|Overall Study|Adverse Event|0
135191|NCT00785512|486934|P1|Overall Study|Adverse Event|0
135192|NCT00785512|486933|P2|Overall Study|Inclusion/Exclusion not meet|0
135193|NCT00785512|486934|P1|Overall Study|Inclusion/Exclusion not meet|0
135194|NCT00785486|486943|P1|Midazolam Alone|Withdrawal by Subject|1
135195|NCT00785356|486967|P1|Overall Study|Study prematurely terminated|8
135196|NCT00785291|486978|P3|Overall Study|Other Medical Reasons|15
135197|NCT00785291|486979|P2|Overall Study|Other Medical Reasons|25
135198|NCT00785291|486980|P1|Overall Study|Other Medical Reasons|29
135199|NCT00785291|486978|P3|Overall Study|Complicating illness|4
135200|NCT00785291|486979|P2|Overall Study|Complicating illness|4
135201|NCT00785291|486980|P1|Overall Study|Complicating illness|6
135202|NCT00785291|486978|P3|Overall Study|Alternative Therapy|7
135203|NCT00785291|486979|P2|Overall Study|Alternative Therapy|6
135204|NCT00785291|486980|P1|Overall Study|Alternative Therapy|12
135205|NCT00785291|486978|P3|Overall Study|Withdrawal by Subject|17
135206|NCT00785291|486979|P2|Overall Study|Withdrawal by Subject|36
135207|NCT00785291|486980|P1|Overall Study|Withdrawal by Subject|35
135208|NCT00785291|486978|P3|Overall Study|Death|3
135209|NCT00785291|486979|P2|Overall Study|Death|4
135210|NCT00785291|486980|P1|Overall Study|Death|7
135211|NCT00785291|486978|P3|Overall Study|Adverse Event|56
135212|NCT00785291|486979|P2|Overall Study|Adverse Event|70
135213|NCT00785291|486980|P1|Overall Study|Adverse Event|39
135214|NCT00785291|486978|P3|Overall Study|Never began treatment|4
135215|NCT00785291|486979|P2|Overall Study|Never began treatment|4
135216|NCT00785291|486980|P1|Overall Study|Never began treatment|8
135217|NCT00785213|487000|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
135218|NCT00785213|487000|P1|Quinine Sulfate Alone|Adverse Event|4
135219|NCT00785044|487011|P1|Overall Study|Withdrawal by Subject|1
135220|NCT00785044|487011|P1|Overall Study|Lost to Follow-up|266
135221|NCT00785044|487011|P1|Overall Study|Death|77
135222|NCT00785044|487011|P1|Overall Study|Dosed at non-participating sites|152
135223|NCT00784979|487016|P1|Overall Study|incomplete data|6
135224|NCT00784927|487020|P1|Overall Study|Ineligible|1
135225|NCT00784927|487020|P1|Overall Study|Protocol Violation|1
135226|NCT00784927|487020|P1|Overall Study|Cancel Prior to Initiating Treatment|1
135227|NCT00784875|487032|P4|Period D|Lost to Follow-up|1
135228|NCT00784875|487033|P3|Period D|Lost to Follow-up|1
135229|NCT00784875|487034|P2|Period D|Lost to Follow-up|0
135230|NCT00784875|487035|P1|Period D|Lost to Follow-up|1
135231|NCT00784875|487032|P4|Period D|Sponsor Decision|0
135232|NCT00784875|487033|P3|Period D|Sponsor Decision|1
135233|NCT00784875|487034|P2|Period D|Sponsor Decision|1
135234|NCT00784875|487035|P1|Period D|Sponsor Decision|1
135235|NCT00784875|487032|P4|Period D|Physician Decision|0
135236|NCT00784875|487033|P3|Period D|Physician Decision|0
135237|NCT00784875|487034|P2|Period D|Physician Decision|1
135238|NCT00784875|487035|P1|Period D|Physician Decision|0
135239|NCT00784875|487032|P4|Period D|Withdrawal by Subject|0
135240|NCT00784875|487033|P3|Period D|Withdrawal by Subject|2
135241|NCT00784875|487034|P2|Period D|Withdrawal by Subject|0
135242|NCT00784875|487035|P1|Period D|Withdrawal by Subject|2
135243|NCT00784875|487032|P4|Period D|Protocol Violation|0
135244|NCT00784875|487033|P3|Period D|Protocol Violation|0
135245|NCT00784875|487034|P2|Period D|Protocol Violation|0
135246|NCT00784875|487035|P1|Period D|Protocol Violation|1
135247|NCT00784875|487032|P4|Period D|Adverse Event|0
135248|NCT00784875|487033|P3|Period D|Adverse Event|2
135249|NCT00784875|487034|P2|Period D|Adverse Event|2
135250|NCT00784875|487035|P1|Period D|Adverse Event|0
135251|NCT00784875|487032|P4|Period C|Sponsor Decision|2
135252|NCT00784875|487033|P3|Period C|Sponsor Decision|4
135253|NCT00784875|487034|P2|Period C|Sponsor Decision|5
135254|NCT00784875|487035|P1|Period C|Sponsor Decision|5
135255|NCT00784875|487032|P4|Period C|Physician Decision|1
135256|NCT00784875|487033|P3|Period C|Physician Decision|1
135257|NCT00784875|487034|P2|Period C|Physician Decision|0
135258|NCT00784875|487035|P1|Period C|Physician Decision|0
135259|NCT00784875|487032|P4|Period C|Withdrawal by Subject|0
135260|NCT00784875|487033|P3|Period C|Withdrawal by Subject|2
135261|NCT00784875|487034|P2|Period C|Withdrawal by Subject|1
135262|NCT00784875|487035|P1|Period C|Withdrawal by Subject|1
135263|NCT00784875|487032|P4|Period C|Lack of Efficacy|0
135264|NCT00784875|487033|P3|Period C|Lack of Efficacy|1
135265|NCT00784875|487034|P2|Period C|Lack of Efficacy|0
135266|NCT00784875|487035|P1|Period C|Lack of Efficacy|0
135267|NCT00784875|487032|P4|Period C|Protocol Violation|2
135268|NCT00784875|487033|P3|Period C|Protocol Violation|1
135269|NCT00784875|487034|P2|Period C|Protocol Violation|0
135270|NCT00784875|487035|P1|Period C|Protocol Violation|0
135271|NCT00784875|487032|P4|Period C|Adverse Event|2
135272|NCT00784875|487033|P3|Period C|Adverse Event|4
135273|NCT00784875|487034|P2|Period C|Adverse Event|0
135274|NCT00784875|487035|P1|Period C|Adverse Event|1
135275|NCT00784875|487032|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
135276|NCT00784875|487033|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
135277|NCT00784875|487034|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
135278|NCT00784875|487035|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
135279|NCT00784875|487032|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
135280|NCT00784875|487033|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
135281|NCT00784875|487034|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
135282|NCT00784875|487035|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
135283|NCT00784875|487032|P4|Period B - Efficacy Endpoint|Physician Decision|0
135284|NCT00784875|487033|P3|Period B - Efficacy Endpoint|Physician Decision|1
135285|NCT00784875|487034|P2|Period B - Efficacy Endpoint|Physician Decision|0
135286|NCT00784875|487035|P1|Period B - Efficacy Endpoint|Physician Decision|0
135287|NCT00784875|487032|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
135288|NCT00784875|487033|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
135289|NCT00784875|487034|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
135290|NCT00784875|487035|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
135291|NCT00784875|487032|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
135292|NCT00784875|487033|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
135293|NCT00784875|487034|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
135294|NCT00784875|487035|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
135295|NCT00784875|487032|P4|Period B - Efficacy Endpoint|Protocol Violation|3
135296|NCT00784875|487033|P3|Period B - Efficacy Endpoint|Protocol Violation|2
135297|NCT00784875|487034|P2|Period B - Efficacy Endpoint|Protocol Violation|1
135298|NCT00784875|487035|P1|Period B - Efficacy Endpoint|Protocol Violation|1
135299|NCT00784875|487032|P4|Period B - Efficacy Endpoint|Adverse Event|1
135300|NCT00784875|487033|P3|Period B - Efficacy Endpoint|Adverse Event|2
135301|NCT00784875|487034|P2|Period B - Efficacy Endpoint|Adverse Event|3
135302|NCT00784875|487035|P1|Period B - Efficacy Endpoint|Adverse Event|0
135303|NCT00784875|487032|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
135304|NCT00784875|487033|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
135305|NCT00784875|487034|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
135306|NCT00784875|487035|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
135307|NCT00784875|487032|P4|Period A - Baseline|Lost to Follow-up|2
135308|NCT00784875|487033|P3|Period A - Baseline|Lost to Follow-up|0
135309|NCT00784875|487034|P2|Period A - Baseline|Lost to Follow-up|0
135310|NCT00784875|487035|P1|Period A - Baseline|Lost to Follow-up|0
135311|NCT00784875|487032|P4|Period A - Baseline|Sponsor Decision|113
135312|NCT00784875|487033|P3|Period A - Baseline|Sponsor Decision|0
135313|NCT00784875|487034|P2|Period A - Baseline|Sponsor Decision|0
135314|NCT00784875|487035|P1|Period A - Baseline|Sponsor Decision|0
135315|NCT00784875|487032|P4|Period A - Baseline|Physician Decision|2
135316|NCT00784875|487033|P3|Period A - Baseline|Physician Decision|0
135317|NCT00784875|487034|P2|Period A - Baseline|Physician Decision|0
135318|NCT00784875|487035|P1|Period A - Baseline|Physician Decision|0
135319|NCT00784875|487032|P4|Period A - Baseline|Withdrawal by Subject|27
135320|NCT00784875|487033|P3|Period A - Baseline|Withdrawal by Subject|0
135321|NCT00784875|487034|P2|Period A - Baseline|Withdrawal by Subject|0
135322|NCT00784875|487035|P1|Period A - Baseline|Withdrawal by Subject|0
135323|NCT00784875|487032|P4|Period A - Baseline|Protocol Violation|25
135324|NCT00784875|487033|P3|Period A - Baseline|Protocol Violation|0
135325|NCT00784875|487034|P2|Period A - Baseline|Protocol Violation|0
135326|NCT00784875|487035|P1|Period A - Baseline|Protocol Violation|0
135327|NCT00784875|487032|P4|Period A - Baseline|Adverse Event|8
135328|NCT00784875|487033|P3|Period A - Baseline|Adverse Event|0
135329|NCT00784875|487034|P2|Period A - Baseline|Adverse Event|0
135330|NCT00784875|487035|P1|Period A - Baseline|Adverse Event|0
135331|NCT00784875|487032|P4|Period A - Baseline|Entry Criteria Not Met|5
135332|NCT00784875|487033|P3|Period A - Baseline|Entry Criteria Not Met|0
135333|NCT00784875|487034|P2|Period A - Baseline|Entry Criteria Not Met|0
135334|NCT00784875|487035|P1|Period A - Baseline|Entry Criteria Not Met|0
135335|NCT00784836|487155|P1|Overall Study|Early Study Termination|3
135336|NCT00784810|487162|P2|Overall Study|Lost to Follow-up|1
135337|NCT00784810|487163|P1|Overall Study|Lost to Follow-up|1
135338|NCT00784810|487162|P2|Overall Study|Administrative|8
135339|NCT00784810|487163|P1|Overall Study|Administrative|5
135340|NCT00784810|487162|P2|Overall Study|Withdrawal by Subject|9
135341|NCT00784810|487163|P1|Overall Study|Withdrawal by Subject|11
135342|NCT00784810|487162|P2|Overall Study|Lack of Efficacy|11
135343|NCT00784810|487163|P1|Overall Study|Lack of Efficacy|14
135344|NCT00784810|487162|P2|Overall Study|Adverse Event|20
135345|NCT00784810|487163|P1|Overall Study|Adverse Event|32
135346|NCT00784784|487173|P2|Overall Study|Withdrawal by Subject|2
135347|NCT00784784|487174|P1|Overall Study|Withdrawal by Subject|2
135348|NCT00784719|487189|P7|Overall Study|Withdrawal by Subject|1
135349|NCT00784719|487190|P6|Overall Study|Withdrawal by Subject|0
135350|NCT00784719|487191|P5|Overall Study|Withdrawal by Subject|2
135351|NCT00784719|487192|P4|Overall Study|Withdrawal by Subject|0
135352|NCT00784719|487193|P3|Overall Study|Withdrawal by Subject|0
135353|NCT00784719|487194|P2|Overall Study|Withdrawal by Subject|0
135354|NCT00784719|487195|P1|Overall Study|Withdrawal by Subject|1
135355|NCT00784719|487189|P7|Overall Study|Other|3
135356|NCT00784719|487190|P6|Overall Study|Other|1
135357|NCT00784719|487191|P5|Overall Study|Other|2
135358|NCT00784719|487192|P4|Overall Study|Other|0
135359|NCT00784719|487193|P3|Overall Study|Other|1
135360|NCT00784719|487194|P2|Overall Study|Other|1
135361|NCT00784719|487195|P1|Overall Study|Other|2
135362|NCT00784719|487189|P7|Overall Study|Lost to Follow-up|0
135363|NCT00784719|487190|P6|Overall Study|Lost to Follow-up|1
135364|NCT00784719|487191|P5|Overall Study|Lost to Follow-up|1
135365|NCT00784719|487192|P4|Overall Study|Lost to Follow-up|0
135366|NCT00784719|487193|P3|Overall Study|Lost to Follow-up|0
135367|NCT00784719|487194|P2|Overall Study|Lost to Follow-up|0
135368|NCT00784719|487195|P1|Overall Study|Lost to Follow-up|0
135369|NCT00784719|487189|P7|Overall Study|Adverse Event|1
135370|NCT00784719|487190|P6|Overall Study|Adverse Event|1
135371|NCT00784719|487191|P5|Overall Study|Adverse Event|1
135372|NCT00784719|487192|P4|Overall Study|Adverse Event|0
135373|NCT00784719|487193|P3|Overall Study|Adverse Event|0
135374|NCT00784719|487194|P2|Overall Study|Adverse Event|2
135375|NCT00784719|487195|P1|Overall Study|Adverse Event|0
135376|NCT00784654|487365|P3|Randomized Withdrawal Period|Family reasons|1
135377|NCT00784654|487366|P2|Randomized Withdrawal Period|Family reasons|0
135378|NCT00784654|487367|P1|Randomized Withdrawal Period|Family reasons|0
135379|NCT00784654|487365|P3|Randomized Withdrawal Period|Did not complete a visit|0
135380|NCT00784654|487366|P2|Randomized Withdrawal Period|Did not complete a visit|1
135381|NCT00784654|487367|P1|Randomized Withdrawal Period|Did not complete a visit|0
135382|NCT00784654|487365|P3|Randomized Withdrawal Period|Adverse Event|1
135383|NCT00784654|487366|P2|Randomized Withdrawal Period|Adverse Event|1
135384|NCT00784654|487367|P1|Randomized Withdrawal Period|Adverse Event|0
135385|NCT00784654|487365|P3|Randomized Withdrawal Period|Protocol Violation|1
135386|NCT00784654|487366|P2|Randomized Withdrawal Period|Protocol Violation|2
135387|NCT00784654|487367|P1|Randomized Withdrawal Period|Protocol Violation|0
135388|NCT00784654|487365|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
135389|NCT00784654|487366|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
135390|NCT00784654|487367|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
135391|NCT00784654|487365|P3|Randomized Withdrawal Period|Lack of Efficacy|18
135392|NCT00784654|487366|P2|Randomized Withdrawal Period|Lack of Efficacy|5
135393|NCT00784654|487367|P1|Randomized Withdrawal Period|Lack of Efficacy|0
135394|NCT00784654|487365|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
135395|NCT00784654|487366|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
135396|NCT00784654|487367|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
135397|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
135398|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
135399|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
135400|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
135401|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
135402|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
135403|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
135404|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
135405|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
135406|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
135407|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
135408|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
135409|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
135410|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
135411|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
135412|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
135413|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
135414|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
135415|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
135416|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
135417|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
135418|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
135419|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
135420|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
135421|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
135422|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
135423|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
135424|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
135425|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
135426|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
135427|NCT00784654|487365|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
135428|NCT00784654|487366|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
135429|NCT00784654|487367|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
135430|NCT00784563|487402|P3|Year 3|Adverse Event|1
135431|NCT00784563|487403|P2|Year 3|Adverse Event|0
135432|NCT00784563|487404|P1|Year 3|Adverse Event|0
135433|NCT00784563|487402|P3|Year 3|Withdrawal by Subject|2
135434|NCT00784563|487403|P2|Year 3|Withdrawal by Subject|0
135435|NCT00784563|487404|P1|Year 3|Withdrawal by Subject|0
135436|NCT00784563|487402|P3|Years 1 & 2|Adverse Event|0
135437|NCT00784563|487403|P2|Years 1 & 2|Adverse Event|3
135438|NCT00784563|487404|P1|Years 1 & 2|Adverse Event|0
135439|NCT00784563|487402|P3|Years 1 & 2|Withdrawal by Subject|0
135440|NCT00784563|487403|P2|Years 1 & 2|Withdrawal by Subject|2
135441|NCT00784563|487404|P1|Years 1 & 2|Withdrawal by Subject|3
135442|NCT00784550|487422|P2|Overall Study|Withdrawal by Subject|13
135443|NCT00784550|487423|P1|Overall Study|Withdrawal by Subject|4
135444|NCT00784550|487422|P2|Overall Study|Physician Decision|3
135445|NCT00784550|487423|P1|Overall Study|Physician Decision|2
135446|NCT00784550|487422|P2|Overall Study|Lost to Follow-up|5
135447|NCT00784550|487423|P1|Overall Study|Lost to Follow-up|8
135448|NCT00784550|487422|P2|Overall Study|Protocol Violation|10
135449|NCT00784550|487423|P1|Overall Study|Protocol Violation|10
135450|NCT00784550|487422|P2|Overall Study|Lack of Efficacy|1
135451|NCT00784550|487423|P1|Overall Study|Lack of Efficacy|0
135452|NCT00784550|487422|P2|Overall Study|Adverse Event|10
135453|NCT00784550|487423|P1|Overall Study|Adverse Event|12
135454|NCT00784459|487441|P2|Overall Study|Adverse Event|2
135455|NCT00784459|487442|P1|Overall Study|Adverse Event|0
135456|NCT00784368|487453|P3|Overall Study|Withdrawal of informed consent|0
135457|NCT00784368|487454|P2|Overall Study|Withdrawal of informed consent|1
135458|NCT00784368|487455|P1|Overall Study|Withdrawal of informed consent|0
135459|NCT00784368|487453|P3|Overall Study|Worsening of symptoms|0
135460|NCT00784368|487454|P2|Overall Study|Worsening of symptoms|1
135461|NCT00784368|487455|P1|Overall Study|Worsening of symptoms|0
135462|NCT00784368|487453|P3|Overall Study|Worsening of complications|1
135463|NCT00784368|487454|P2|Overall Study|Worsening of complications|0
135464|NCT00784368|487455|P1|Overall Study|Worsening of complications|0
135465|NCT00784368|487453|P3|Overall Study|Diagnosis of fever|1
135466|NCT00784368|487454|P2|Overall Study|Diagnosis of fever|0
135467|NCT00784368|487455|P1|Overall Study|Diagnosis of fever|0
135468|NCT00784368|487453|P3|Overall Study|Adverse Event|2
135469|NCT00784368|487454|P2|Overall Study|Adverse Event|9
135470|NCT00784368|487455|P1|Overall Study|Adverse Event|6
135471|NCT00784368|487453|P3|Overall Study|Lack of Efficacy|1
135472|NCT00784368|487454|P2|Overall Study|Lack of Efficacy|0
135473|NCT00784368|487455|P1|Overall Study|Lack of Efficacy|2
135474|NCT00784368|487453|P3|Overall Study|Physician Decision|6
135475|NCT00784368|487454|P2|Overall Study|Physician Decision|0
135476|NCT00784368|487455|P1|Overall Study|Physician Decision|0
135477|NCT00784277|487493|P7|ER Treatment|Other|2
135478|NCT00784277|487494|P6|ER Treatment|Other|3
135479|NCT00784277|487495|P5|ER Treatment|Other|1
135480|NCT00784277|487496|P4|ER Treatment|Other|0
135481|NCT00784277|487497|P3|ER Treatment|Other|0
135482|NCT00784277|487498|P2|ER Treatment|Other|0
135483|NCT00784277|487499|P1|ER Treatment|Other|0
135484|NCT00784277|487493|P7|ER Treatment|Study Medication Non-Compliant|3
135485|NCT00784277|487494|P6|ER Treatment|Study Medication Non-Compliant|3
135486|NCT00784277|487495|P5|ER Treatment|Study Medication Non-Compliant|2
135487|NCT00784277|487496|P4|ER Treatment|Study Medication Non-Compliant|0
135488|NCT00784277|487497|P3|ER Treatment|Study Medication Non-Compliant|0
135489|NCT00784277|487498|P2|ER Treatment|Study Medication Non-Compliant|0
135490|NCT00784277|487499|P1|ER Treatment|Study Medication Non-Compliant|0
135491|NCT00784277|487493|P7|ER Treatment|Withdrawal by Subject|3
135492|NCT00784277|487494|P6|ER Treatment|Withdrawal by Subject|5
135493|NCT00784277|487495|P5|ER Treatment|Withdrawal by Subject|2
135494|NCT00784277|487496|P4|ER Treatment|Withdrawal by Subject|0
135495|NCT00784277|487497|P3|ER Treatment|Withdrawal by Subject|0
135496|NCT00784277|487498|P2|ER Treatment|Withdrawal by Subject|0
135497|NCT00784277|487499|P1|ER Treatment|Withdrawal by Subject|0
135498|NCT00784277|487493|P7|ER Treatment|Lost to Follow-up|0
135499|NCT00784277|487494|P6|ER Treatment|Lost to Follow-up|2
135500|NCT00784277|487495|P5|ER Treatment|Lost to Follow-up|0
135501|NCT00784277|487496|P4|ER Treatment|Lost to Follow-up|0
135502|NCT00784277|487497|P3|ER Treatment|Lost to Follow-up|0
135503|NCT00784277|487498|P2|ER Treatment|Lost to Follow-up|0
135504|NCT00784277|487499|P1|ER Treatment|Lost to Follow-up|0
135505|NCT00784277|487493|P7|ER Treatment|Lack of Efficacy|0
135506|NCT00784277|487494|P6|ER Treatment|Lack of Efficacy|4
135507|NCT00784277|487495|P5|ER Treatment|Lack of Efficacy|3
135508|NCT00784277|487496|P4|ER Treatment|Lack of Efficacy|0
135509|NCT00784277|487497|P3|ER Treatment|Lack of Efficacy|0
135510|NCT00784277|487498|P2|ER Treatment|Lack of Efficacy|0
135511|NCT00784277|487499|P1|ER Treatment|Lack of Efficacy|0
135512|NCT00784277|487493|P7|ER Treatment|Adverse Event|7
135513|NCT00784277|487494|P6|ER Treatment|Adverse Event|7
135514|NCT00784277|487495|P5|ER Treatment|Adverse Event|1
135515|NCT00784277|487496|P4|ER Treatment|Adverse Event|0
135516|NCT00784277|487497|P3|ER Treatment|Adverse Event|0
135517|NCT00784277|487498|P2|ER Treatment|Adverse Event|0
135518|NCT00784277|487499|P1|ER Treatment|Adverse Event|0
135519|NCT00784277|487493|P7|IR Treatment|Other|0
135520|NCT00784277|487494|P6|IR Treatment|Other|0
135521|NCT00784277|487495|P5|IR Treatment|Other|0
135522|NCT00784277|487496|P4|IR Treatment|Other|2
135523|NCT00784277|487497|P3|IR Treatment|Other|3
135524|NCT00784277|487498|P2|IR Treatment|Other|3
135525|NCT00784277|487499|P1|IR Treatment|Other|2
135526|NCT00784277|487493|P7|IR Treatment|Resolution Of Pain|0
135527|NCT00784277|487494|P6|IR Treatment|Resolution Of Pain|0
135528|NCT00784277|487495|P5|IR Treatment|Resolution Of Pain|0
135529|NCT00784277|487496|P4|IR Treatment|Resolution Of Pain|0
135530|NCT00784277|487497|P3|IR Treatment|Resolution Of Pain|0
135531|NCT00784277|487498|P2|IR Treatment|Resolution Of Pain|1
135532|NCT00784277|487499|P1|IR Treatment|Resolution Of Pain|0
135533|NCT00784277|487493|P7|IR Treatment|Withdrawal by Subject|0
135534|NCT00784277|487494|P6|IR Treatment|Withdrawal by Subject|0
135535|NCT00784277|487495|P5|IR Treatment|Withdrawal by Subject|0
135536|NCT00784277|487496|P4|IR Treatment|Withdrawal by Subject|6
135537|NCT00784277|487497|P3|IR Treatment|Withdrawal by Subject|4
135538|NCT00784277|487498|P2|IR Treatment|Withdrawal by Subject|1
135539|NCT00784277|487499|P1|IR Treatment|Withdrawal by Subject|5
135540|NCT00784277|487493|P7|IR Treatment|Lost to Follow-up|0
135541|NCT00784277|487494|P6|IR Treatment|Lost to Follow-up|0
135542|NCT00784277|487495|P5|IR Treatment|Lost to Follow-up|0
135543|NCT00784277|487496|P4|IR Treatment|Lost to Follow-up|0
135544|NCT00784277|487497|P3|IR Treatment|Lost to Follow-up|1
135545|NCT00784277|487498|P2|IR Treatment|Lost to Follow-up|0
135546|NCT00784277|487499|P1|IR Treatment|Lost to Follow-up|1
135547|NCT00784277|487493|P7|IR Treatment|Lack of Efficacy|0
135548|NCT00784277|487494|P6|IR Treatment|Lack of Efficacy|0
135549|NCT00784277|487495|P5|IR Treatment|Lack of Efficacy|0
135550|NCT00784277|487496|P4|IR Treatment|Lack of Efficacy|0
135551|NCT00784277|487497|P3|IR Treatment|Lack of Efficacy|1
135552|NCT00784277|487498|P2|IR Treatment|Lack of Efficacy|4
135553|NCT00784277|487499|P1|IR Treatment|Lack of Efficacy|4
135554|NCT00784277|487493|P7|IR Treatment|Adverse Event|0
135555|NCT00784277|487494|P6|IR Treatment|Adverse Event|0
135556|NCT00784277|487495|P5|IR Treatment|Adverse Event|0
135557|NCT00784277|487496|P4|IR Treatment|Adverse Event|35
135558|NCT00784277|487497|P3|IR Treatment|Adverse Event|19
135559|NCT00784277|487498|P2|IR Treatment|Adverse Event|8
135560|NCT00784277|487499|P1|IR Treatment|Adverse Event|4
135561|NCT00784238|487516|P1|Overall Study|Other|14
135562|NCT00784238|487516|P1|Overall Study|Withdrawal by Subject|26
135563|NCT00784238|487516|P1|Overall Study|Pregnancy|1
135564|NCT00784238|487516|P1|Overall Study|Lost to Follow-up|29
135565|NCT00784238|487516|P1|Overall Study|Lack of Efficacy|33
135566|NCT00784238|487516|P1|Overall Study|Death|2
135567|NCT00784238|487516|P1|Overall Study|Adverse Event|14
135568|NCT00784147|487559|P2|Overall Study|Death|0
135569|NCT00784147|487560|P1|Overall Study|Death|2
135570|NCT00784147|487559|P2|Overall Study|Protocol Violation|1
135571|NCT00784147|487560|P1|Overall Study|Protocol Violation|1
135572|NCT00784147|487559|P2|Overall Study|Physician Decision|1
135573|NCT00784147|487560|P1|Overall Study|Physician Decision|2
135574|NCT00784147|487559|P2|Overall Study|Withdrawal by Subject|3
135575|NCT00784147|487560|P1|Overall Study|Withdrawal by Subject|1
135576|NCT00784147|487559|P2|Overall Study|Lost to Follow-up|4
135577|NCT00784147|487560|P1|Overall Study|Lost to Follow-up|2
135578|NCT00784134|487580|P2|Overall Study|Lost to Follow-up|6
135579|NCT00784134|487581|P1|Overall Study|Lost to Follow-up|3
135580|NCT00784043|487704|P2|Overall Study|Protocol Terminated|1
135581|NCT00784043|487705|P1|Overall Study|Protocol Terminated|23
135582|NCT00784043|487704|P2|Overall Study|Withdrawal by Subject|5
135583|NCT00784043|487705|P1|Overall Study|Withdrawal by Subject|8
135584|NCT00783835|487740|P1|Overall Study|Participant not Adherent|3
135585|NCT00783835|487740|P1|Overall Study|Lost to Follow-up|1
135586|NCT00783835|487740|P1|Overall Study|Withdrawal by Subject|2
135587|NCT00783835|487740|P1|Overall Study|Medical Criteria|1
135588|NCT00783835|487740|P1|Overall Study|Adverse Event|3
135589|NCT00783796|487752|P1|Overall Study|Received commercial XIENCE V stent|1
135590|NCT00783796|487752|P1|Overall Study|Received non-XIENCE V stent|1
135591|NCT00783796|487752|P1|Overall Study|Did not receive any stent|4
135592|NCT00783718|487857|P7|Maintenance Phase|Lost to Follow-up|2
135593|NCT00783718|487858|P6|Maintenance Phase|Lost to Follow-up|0
135594|NCT00783718|487859|P5|Maintenance Phase|Lost to Follow-up|2
135595|NCT00783718|487860|P4|Maintenance Phase|Lost to Follow-up|0
135596|NCT00783718|487861|P3|Maintenance Phase|Lost to Follow-up|0
135597|NCT00783718|487862|P2|Maintenance Phase|Lost to Follow-up|0
135598|NCT00783718|487863|P1|Maintenance Phase|Lost to Follow-up|3
135599|NCT00783718|487857|P7|Maintenance Phase|Withdrawal by Subject|20
135600|NCT00783718|487858|P6|Maintenance Phase|Withdrawal by Subject|2
135601|NCT00783718|487859|P5|Maintenance Phase|Withdrawal by Subject|5
135602|NCT00783718|487860|P4|Maintenance Phase|Withdrawal by Subject|2
135603|NCT00783718|487861|P3|Maintenance Phase|Withdrawal by Subject|0
135604|NCT00783718|487862|P2|Maintenance Phase|Withdrawal by Subject|0
135605|NCT00783718|487863|P1|Maintenance Phase|Withdrawal by Subject|6
135606|NCT00783718|487857|P7|Maintenance Phase|Lack of Efficacy|155
135607|NCT00783718|487858|P6|Maintenance Phase|Lack of Efficacy|33
135608|NCT00783718|487859|P5|Maintenance Phase|Lack of Efficacy|31
135609|NCT00783718|487860|P4|Maintenance Phase|Lack of Efficacy|61
135610|NCT00783718|487861|P3|Maintenance Phase|Lack of Efficacy|0
135611|NCT00783718|487862|P2|Maintenance Phase|Lack of Efficacy|0
135612|NCT00783718|487863|P1|Maintenance Phase|Lack of Efficacy|83
135613|NCT00783718|487857|P7|Maintenance Phase|Protocol Violation|2
135614|NCT00783718|487858|P6|Maintenance Phase|Protocol Violation|0
135615|NCT00783718|487859|P5|Maintenance Phase|Protocol Violation|0
135616|NCT00783718|487860|P4|Maintenance Phase|Protocol Violation|0
135617|NCT00783718|487861|P3|Maintenance Phase|Protocol Violation|0
135618|NCT00783718|487862|P2|Maintenance Phase|Protocol Violation|0
135619|NCT00783718|487863|P1|Maintenance Phase|Protocol Violation|1
135620|NCT00783718|487857|P7|Maintenance Phase|Adverse Event|16
135621|NCT00783718|487858|P6|Maintenance Phase|Adverse Event|6
135622|NCT00783718|487859|P5|Maintenance Phase|Adverse Event|7
135623|NCT00783718|487860|P4|Maintenance Phase|Adverse Event|15
135624|NCT00783718|487861|P3|Maintenance Phase|Adverse Event|0
135625|NCT00783718|487862|P2|Maintenance Phase|Adverse Event|0
135626|NCT00783718|487863|P1|Maintenance Phase|Adverse Event|12
135627|NCT00783718|487857|P7|Induction Phase|Lost to Follow-up|0
135628|NCT00783718|487858|P6|Induction Phase|Lost to Follow-up|0
135629|NCT00783718|487859|P5|Induction Phase|Lost to Follow-up|0
135630|NCT00783718|487860|P4|Induction Phase|Lost to Follow-up|0
135631|NCT00783718|487861|P3|Induction Phase|Lost to Follow-up|1
135632|NCT00783718|487862|P2|Induction Phase|Lost to Follow-up|0
135633|NCT00783718|487863|P1|Induction Phase|Lost to Follow-up|1
135634|NCT00783718|487857|P7|Induction Phase|Withdrawal by Subject|0
135635|NCT00783718|487858|P6|Induction Phase|Withdrawal by Subject|0
135636|NCT00783718|487859|P5|Induction Phase|Withdrawal by Subject|0
135637|NCT00783718|487860|P4|Induction Phase|Withdrawal by Subject|0
135638|NCT00783718|487861|P3|Induction Phase|Withdrawal by Subject|8
135639|NCT00783718|487862|P2|Induction Phase|Withdrawal by Subject|4
135640|NCT00783718|487863|P1|Induction Phase|Withdrawal by Subject|3
135641|NCT00783718|487857|P7|Induction Phase|Lack of Efficacy|0
135642|NCT00783718|487858|P6|Induction Phase|Lack of Efficacy|0
135643|NCT00783718|487859|P5|Induction Phase|Lack of Efficacy|0
135644|NCT00783718|487860|P4|Induction Phase|Lack of Efficacy|0
135645|NCT00783718|487861|P3|Induction Phase|Lack of Efficacy|14
135646|NCT00783718|487862|P2|Induction Phase|Lack of Efficacy|2
135647|NCT00783718|487863|P1|Induction Phase|Lack of Efficacy|5
135648|NCT00783718|487857|P7|Induction Phase|Protocol Violation|0
135649|NCT00783718|487858|P6|Induction Phase|Protocol Violation|0
135650|NCT00783718|487859|P5|Induction Phase|Protocol Violation|0
135651|NCT00783718|487860|P4|Induction Phase|Protocol Violation|0
135652|NCT00783718|487861|P3|Induction Phase|Protocol Violation|6
135653|NCT00783718|487862|P2|Induction Phase|Protocol Violation|1
135654|NCT00783718|487863|P1|Induction Phase|Protocol Violation|1
135655|NCT00783718|487857|P7|Induction Phase|Adverse Event|0
135656|NCT00783718|487858|P6|Induction Phase|Adverse Event|0
135657|NCT00783718|487859|P5|Induction Phase|Adverse Event|0
135658|NCT00783718|487860|P4|Induction Phase|Adverse Event|0
135659|NCT00783718|487861|P3|Induction Phase|Adverse Event|7
135660|NCT00783718|487862|P2|Induction Phase|Adverse Event|0
135661|NCT00783718|487863|P1|Induction Phase|Adverse Event|4
135662|NCT00783705|487891|P2|Overall Study|Lost to Follow-up|3
135663|NCT00783705|487892|P1|Overall Study|Lost to Follow-up|1
135664|NCT00783705|487891|P2|Overall Study|Withdrawal by Subject|2
135665|NCT00783705|487892|P1|Overall Study|Withdrawal by Subject|3
135666|NCT00783705|487891|P2|Overall Study|Adverse Event|0
135667|NCT00783705|487892|P1|Overall Study|Adverse Event|2
135668|NCT00783692|487939|P7|Maintenance Phase|Other|1
135669|NCT00783692|487940|P6|Maintenance Phase|Other|1
135670|NCT00783692|487941|P5|Maintenance Phase|Other|0
135671|NCT00783692|487942|P4|Maintenance Phase|Other|1
135672|NCT00783692|487943|P3|Maintenance Phase|Other|0
135673|NCT00783692|487944|P2|Maintenance Phase|Other|0
135674|NCT00783692|487945|P1|Maintenance Phase|Other|0
135675|NCT00783692|487939|P7|Maintenance Phase|Lost to Follow-up|5
135676|NCT00783692|487940|P6|Maintenance Phase|Lost to Follow-up|2
135677|NCT00783692|487941|P5|Maintenance Phase|Lost to Follow-up|3
135678|NCT00783692|487942|P4|Maintenance Phase|Lost to Follow-up|1
135679|NCT00783692|487943|P3|Maintenance Phase|Lost to Follow-up|0
135680|NCT00783692|487944|P2|Maintenance Phase|Lost to Follow-up|0
135681|NCT00783692|487945|P1|Maintenance Phase|Lost to Follow-up|2
135682|NCT00783692|487939|P7|Maintenance Phase|Withdrawal by Subject|24
135683|NCT00783692|487940|P6|Maintenance Phase|Withdrawal by Subject|9
135684|NCT00783692|487941|P5|Maintenance Phase|Withdrawal by Subject|6
135685|NCT00783692|487942|P4|Maintenance Phase|Withdrawal by Subject|7
135686|NCT00783692|487943|P3|Maintenance Phase|Withdrawal by Subject|0
135687|NCT00783692|487944|P2|Maintenance Phase|Withdrawal by Subject|0
135688|NCT00783692|487945|P1|Maintenance Phase|Withdrawal by Subject|7
135689|NCT00783692|487939|P7|Maintenance Phase|Lack of Efficacy|177
135690|NCT00783692|487940|P6|Maintenance Phase|Lack of Efficacy|48
135691|NCT00783692|487941|P5|Maintenance Phase|Lack of Efficacy|58
135692|NCT00783692|487942|P4|Maintenance Phase|Lack of Efficacy|64
135693|NCT00783692|487943|P3|Maintenance Phase|Lack of Efficacy|0
135694|NCT00783692|487944|P2|Maintenance Phase|Lack of Efficacy|0
135695|NCT00783692|487945|P1|Maintenance Phase|Lack of Efficacy|79
135696|NCT00783692|487939|P7|Maintenance Phase|Protocol Violation|4
135697|NCT00783692|487940|P6|Maintenance Phase|Protocol Violation|3
135698|NCT00783692|487941|P5|Maintenance Phase|Protocol Violation|2
135699|NCT00783692|487942|P4|Maintenance Phase|Protocol Violation|1
135700|NCT00783692|487943|P3|Maintenance Phase|Protocol Violation|0
135701|NCT00783692|487944|P2|Maintenance Phase|Protocol Violation|0
135702|NCT00783692|487945|P1|Maintenance Phase|Protocol Violation|0
135703|NCT00783692|487939|P7|Maintenance Phase|Adverse Event|38
135704|NCT00783692|487940|P6|Maintenance Phase|Adverse Event|9
135705|NCT00783692|487941|P5|Maintenance Phase|Adverse Event|12
135706|NCT00783692|487942|P4|Maintenance Phase|Adverse Event|15
135707|NCT00783692|487943|P3|Maintenance Phase|Adverse Event|0
135708|NCT00783692|487944|P2|Maintenance Phase|Adverse Event|0
135709|NCT00783692|487945|P1|Maintenance Phase|Adverse Event|7
135710|NCT00783692|487939|P7|Induction Phase|Other|0
135711|NCT00783692|487940|P6|Induction Phase|Other|0
135712|NCT00783692|487941|P5|Induction Phase|Other|0
135713|NCT00783692|487942|P4|Induction Phase|Other|0
135714|NCT00783692|487943|P3|Induction Phase|Other|2
135715|NCT00783692|487944|P2|Induction Phase|Other|0
135716|NCT00783692|487945|P1|Induction Phase|Other|0
135717|NCT00783692|487939|P7|Induction Phase|Lost to Follow-up|0
135718|NCT00783692|487940|P6|Induction Phase|Lost to Follow-up|0
135719|NCT00783692|487941|P5|Induction Phase|Lost to Follow-up|0
135720|NCT00783692|487942|P4|Induction Phase|Lost to Follow-up|0
135721|NCT00783692|487943|P3|Induction Phase|Lost to Follow-up|3
135722|NCT00783692|487944|P2|Induction Phase|Lost to Follow-up|0
135723|NCT00783692|487945|P1|Induction Phase|Lost to Follow-up|0
135724|NCT00783692|487939|P7|Induction Phase|Withdrawal by Subject|0
135725|NCT00783692|487940|P6|Induction Phase|Withdrawal by Subject|0
135726|NCT00783692|487941|P5|Induction Phase|Withdrawal by Subject|0
135727|NCT00783692|487942|P4|Induction Phase|Withdrawal by Subject|0
135728|NCT00783692|487943|P3|Induction Phase|Withdrawal by Subject|16
135729|NCT00783692|487944|P2|Induction Phase|Withdrawal by Subject|9
135730|NCT00783692|487945|P1|Induction Phase|Withdrawal by Subject|3
135731|NCT00783692|487939|P7|Induction Phase|Lack of Efficacy|0
135732|NCT00783692|487940|P6|Induction Phase|Lack of Efficacy|0
135733|NCT00783692|487941|P5|Induction Phase|Lack of Efficacy|0
135734|NCT00783692|487942|P4|Induction Phase|Lack of Efficacy|0
135735|NCT00783692|487943|P3|Induction Phase|Lack of Efficacy|28
135736|NCT00783692|487944|P2|Induction Phase|Lack of Efficacy|3
135737|NCT00783692|487945|P1|Induction Phase|Lack of Efficacy|1
135738|NCT00783692|487939|P7|Induction Phase|Protocol Violation|0
135739|NCT00783692|487940|P6|Induction Phase|Protocol Violation|0
135740|NCT00783692|487941|P5|Induction Phase|Protocol Violation|0
135741|NCT00783692|487942|P4|Induction Phase|Protocol Violation|0
135742|NCT00783692|487943|P3|Induction Phase|Protocol Violation|1
135743|NCT00783692|487944|P2|Induction Phase|Protocol Violation|0
135744|NCT00783692|487945|P1|Induction Phase|Protocol Violation|0
135745|NCT00783692|487939|P7|Induction Phase|Adverse Event|0
135746|NCT00783692|487940|P6|Induction Phase|Adverse Event|0
135747|NCT00783692|487941|P5|Induction Phase|Adverse Event|0
135748|NCT00783692|487942|P4|Induction Phase|Adverse Event|0
135749|NCT00783692|487943|P3|Induction Phase|Adverse Event|24
135750|NCT00783692|487944|P2|Induction Phase|Adverse Event|9
135751|NCT00783692|487945|P1|Induction Phase|Adverse Event|7
135752|NCT00783432|487991|P2|Overall Study|Protocol Violation|9
135753|NCT00783432|487992|P1|Overall Study|Protocol Violation|6
135754|NCT00783432|487991|P2|Overall Study|subject moved|5
135755|NCT00783432|487992|P1|Overall Study|subject moved|3
135756|NCT00783432|487991|P2|Overall Study|Withdrawal by Subject|20
135757|NCT00783432|487992|P1|Overall Study|Withdrawal by Subject|23
135758|NCT00783432|487991|P2|Overall Study|Lost to Follow-up|6
135759|NCT00783432|487992|P1|Overall Study|Lost to Follow-up|11
135760|NCT00783432|487991|P2|Overall Study|Lack of Efficacy|21
135761|NCT00783432|487992|P1|Overall Study|Lack of Efficacy|20
135762|NCT00783432|487991|P2|Overall Study|Adverse Event|17
135763|NCT00783432|487992|P1|Overall Study|Adverse Event|22
135764|NCT00783302|488002|P1|Overall Study|Withdrawal by Subject|3
135765|NCT00783302|488002|P1|Overall Study|Physician Decision|1
135766|NCT00783302|488002|P1|Overall Study|Protocol Violation|3
135767|NCT00783302|488002|P1|Overall Study|Technical Problems|11
135768|NCT00783302|488002|P1|Overall Study|Lost to Follow-up|17
135769|NCT00783263|488024|P4|Overall Study|Withdrawal by Subject|2
135770|NCT00783263|488025|P3|Overall Study|Withdrawal by Subject|1
135771|NCT00783263|488026|P2|Overall Study|Withdrawal by Subject|1
135772|NCT00783263|488027|P1|Overall Study|Withdrawal by Subject|0
135773|NCT00783263|488024|P4|Overall Study|Lost to Follow-up|0
135774|NCT00783263|488025|P3|Overall Study|Lost to Follow-up|0
135775|NCT00783263|488026|P2|Overall Study|Lost to Follow-up|1
135776|NCT00783263|488027|P1|Overall Study|Lost to Follow-up|1
135777|NCT00783263|488024|P4|Overall Study|Adverse Event|1
135778|NCT00783263|488025|P3|Overall Study|Adverse Event|2
135779|NCT00783263|488026|P2|Overall Study|Adverse Event|0
135780|NCT00783263|488027|P1|Overall Study|Adverse Event|3
135781|NCT00783224|488057|P4|Overall Study|Inappropriate as a study subject|1
135782|NCT00783224|488058|P3|Overall Study|Inappropriate as a study subject|0
135783|NCT00783224|488059|P2|Overall Study|Inappropriate as a study subject|0
135784|NCT00783224|488060|P1|Overall Study|Inappropriate as a study subject|0
135785|NCT00783224|488057|P4|Overall Study|Discarded the Investigational Drug Used|1
135786|NCT00783224|488058|P3|Overall Study|Discarded the Investigational Drug Used|0
135787|NCT00783224|488059|P2|Overall Study|Discarded the Investigational Drug Used|0
135788|NCT00783224|488060|P1|Overall Study|Discarded the Investigational Drug Used|0
135789|NCT00783224|488057|P4|Overall Study|Adverse Event|0
135790|NCT00783224|488058|P3|Overall Study|Adverse Event|1
135791|NCT00783224|488059|P2|Overall Study|Adverse Event|0
135792|NCT00783224|488060|P1|Overall Study|Adverse Event|0
135793|NCT00783198|488072|P3|Overall Study|Administrative|2
135794|NCT00783198|488073|P2|Overall Study|Administrative|1
135795|NCT00783198|488074|P1|Overall Study|Administrative|2
135796|NCT00783198|488072|P3|Overall Study|Did not meet protocol eligibility|0
135797|NCT00783198|488073|P2|Overall Study|Did not meet protocol eligibility|1
135798|NCT00783198|488074|P1|Overall Study|Did not meet protocol eligibility|0
135799|NCT00783198|488072|P3|Overall Study|Noncompliance with protocol|10
135800|NCT00783198|488073|P2|Overall Study|Noncompliance with protocol|7
135801|NCT00783198|488074|P1|Overall Study|Noncompliance with protocol|7
135802|NCT00783198|488072|P3|Overall Study|Withdrawal by Subject|20
135803|NCT00783198|488073|P2|Overall Study|Withdrawal by Subject|14
135804|NCT00783198|488074|P1|Overall Study|Withdrawal by Subject|22
135805|NCT00783198|488072|P3|Overall Study|Lost to Follow-up|7
135806|NCT00783198|488073|P2|Overall Study|Lost to Follow-up|1
135807|NCT00783198|488074|P1|Overall Study|Lost to Follow-up|11
135808|NCT00783198|488072|P3|Overall Study|Adverse Event|3
135809|NCT00783198|488073|P2|Overall Study|Adverse Event|19
135810|NCT00783198|488074|P1|Overall Study|Adverse Event|15
135811|NCT00783094|488097|P3|Open-Label Extension Period|Lack of Efficacy|0
135812|NCT00783094|488098|P2|Open-Label Extension Period|Lack of Efficacy|4
135813|NCT00783094|488099|P1|Open-Label Extension Period|Lack of Efficacy|1
135814|NCT00783094|488097|P3|Open-Label Extension Period|Physician Decision|3
135815|NCT00783094|488098|P2|Open-Label Extension Period|Physician Decision|2
135816|NCT00783094|488099|P1|Open-Label Extension Period|Physician Decision|4
135817|NCT00783094|488097|P3|Open-Label Extension Period|Withdrawal by Subject|3
135818|NCT00783094|488098|P2|Open-Label Extension Period|Withdrawal by Subject|1
135819|NCT00783094|488099|P1|Open-Label Extension Period|Withdrawal by Subject|1
135820|NCT00783094|488097|P3|Open-Label Extension Period|Protocol Violation|7
135821|NCT00783094|488098|P2|Open-Label Extension Period|Protocol Violation|5
135822|NCT00783094|488099|P1|Open-Label Extension Period|Protocol Violation|4
135823|NCT00783094|488097|P3|Open-Label Extension Period|Death|1
135824|NCT00783094|488098|P2|Open-Label Extension Period|Death|0
135825|NCT00783094|488099|P1|Open-Label Extension Period|Death|0
135826|NCT00783094|488097|P3|Open-Label Extension Period|Adverse Event|16
135827|NCT00783094|488098|P2|Open-Label Extension Period|Adverse Event|7
135828|NCT00783094|488099|P1|Open-Label Extension Period|Adverse Event|12
135829|NCT00783094|488097|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
135830|NCT00783094|488098|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
135831|NCT00783094|488099|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
135832|NCT00783094|488097|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
135833|NCT00783094|488098|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
135834|NCT00783094|488099|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
135835|NCT00783094|488097|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
135836|NCT00783094|488098|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
135837|NCT00783094|488099|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
135838|NCT00783094|488097|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
135839|NCT00783094|488098|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
135840|NCT00783094|488099|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
135841|NCT00783094|488097|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
135842|NCT00783094|488098|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
135843|NCT00783094|488099|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
135844|NCT00782834|488175|P1|Treatment Phase|fibrous tumor not GIST|1
135845|NCT00782795|488215|P2|Overall Study|Withdrawal by Subject|2
135846|NCT00782795|488216|P1|Overall Study|Withdrawal by Subject|1
135847|NCT00782717|488256|P2|Overall Study|Exited in error|2
135848|NCT00782717|488257|P1|Overall Study|Exited in error|0
135849|NCT00782717|488256|P2|Overall Study|Did not meet entrance criteria|3
135850|NCT00782717|488257|P1|Overall Study|Did not meet entrance criteria|1
135851|NCT00782717|488256|P2|Overall Study|Enrollment close prior to surgery|0
135852|NCT00782717|488257|P1|Overall Study|Enrollment close prior to surgery|1
135853|NCT00782717|488256|P2|Overall Study|Treatment failure|14
135854|NCT00782717|488257|P1|Overall Study|Treatment failure|3
135855|NCT00782717|488256|P2|Overall Study|Noncompliance|1
135856|NCT00782717|488257|P1|Overall Study|Noncompliance|2
135857|NCT00782717|488256|P2|Overall Study|Patient decision unrelated to AE|3
135858|NCT00782717|488257|P1|Overall Study|Patient decision unrelated to AE|6
135859|NCT00782717|488256|P2|Overall Study|Adverse Event|5
135860|NCT00782717|488257|P1|Overall Study|Adverse Event|2
135861|NCT00782626|488284|P1|Overall Study|Other Complicating Disease|1
135862|NCT00782626|488284|P1|Overall Study|Progressive Disease|5
135863|NCT00782626|488284|P1|Overall Study|Adverse Event|1
135864|NCT00782509|488291|P3|Overall Study|Lack of Efficacy|2
135865|NCT00782509|488292|P2|Overall Study|Lack of Efficacy|5
135866|NCT00782509|488293|P1|Overall Study|Lack of Efficacy|10
135867|NCT00782509|488291|P3|Overall Study|Other reasons not stated above|3
135868|NCT00782509|488292|P2|Overall Study|Other reasons not stated above|2
135869|NCT00782509|488293|P1|Overall Study|Other reasons not stated above|5
135870|NCT00782509|488291|P3|Overall Study|Non compliance with protocol|0
135871|NCT00782509|488292|P2|Overall Study|Non compliance with protocol|0
135872|NCT00782509|488293|P1|Overall Study|Non compliance with protocol|2
135873|NCT00782509|488291|P3|Overall Study|Withdrawal by Subject|8
135874|NCT00782509|488292|P2|Overall Study|Withdrawal by Subject|5
135875|NCT00782509|488293|P1|Overall Study|Withdrawal by Subject|3
135876|NCT00782509|488291|P3|Overall Study|Lost to Follow-up|3
135877|NCT00782509|488292|P2|Overall Study|Lost to Follow-up|2
135878|NCT00782509|488293|P1|Overall Study|Lost to Follow-up|1
135879|NCT00782509|488291|P3|Overall Study|Adverse Event|20
135880|NCT00782509|488292|P2|Overall Study|Adverse Event|10
135881|NCT00782509|488293|P1|Overall Study|Adverse Event|20
135882|NCT00782496|488486|P2|Overall Study|Lost to Follow-up|15
135883|NCT00782496|488487|P1|Overall Study|Lost to Follow-up|14
135884|NCT00782483|488494|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
135885|NCT00782418|488498|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
135886|NCT00782418|488499|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
135887|NCT00782418|488500|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
135888|NCT00782418|488501|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
135889|NCT00782418|488502|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
135890|NCT00782418|488503|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
135891|NCT00782418|488504|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
135892|NCT00782418|488498|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
135893|NCT00782418|488499|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
135894|NCT00782418|488500|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
135895|NCT00782418|488501|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
135896|NCT00782418|488502|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
135897|NCT00782418|488503|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
135898|NCT00782418|488504|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
135899|NCT00782340|488541|P3|Open Label Titration|Randomized in error|0
135900|NCT00782340|488542|P2|Open Label Titration|Randomized in error|0
135901|NCT00782340|488543|P1|Open Label Titration|Randomized in error|6
135902|NCT00782340|488541|P3|Open Label Titration|Lost to Follow-up|0
135903|NCT00782340|488542|P2|Open Label Titration|Lost to Follow-up|0
135904|NCT00782340|488543|P1|Open Label Titration|Lost to Follow-up|5
135905|NCT00782340|488541|P3|Open Label Titration|Did not meet responder criteria|0
135906|NCT00782340|488542|P2|Open Label Titration|Did not meet responder criteria|0
135907|NCT00782340|488543|P1|Open Label Titration|Did not meet responder criteria|2
135908|NCT00782340|488541|P3|Open Label Titration|Enrollment capped|0
135909|NCT00782340|488542|P2|Open Label Titration|Enrollment capped|0
135910|NCT00782340|488543|P1|Open Label Titration|Enrollment capped|16
135911|NCT00782340|488541|P3|Open Label Titration|Withdrawal by Subject|0
135912|NCT00782340|488542|P2|Open Label Titration|Withdrawal by Subject|0
135913|NCT00782340|488543|P1|Open Label Titration|Withdrawal by Subject|5
135914|NCT00782340|488541|P3|Open Label Titration|Protocol Violation|0
135915|NCT00782340|488542|P2|Open Label Titration|Protocol Violation|0
135916|NCT00782340|488543|P1|Open Label Titration|Protocol Violation|5
135917|NCT00782340|488541|P3|Open Label Titration|Treatment failure|0
135918|NCT00782340|488542|P2|Open Label Titration|Treatment failure|0
135919|NCT00782340|488543|P1|Open Label Titration|Treatment failure|50
135920|NCT00782340|488541|P3|Open Label Titration|Adverse Event|0
135921|NCT00782340|488542|P2|Open Label Titration|Adverse Event|0
135922|NCT00782340|488543|P1|Open Label Titration|Adverse Event|12
135923|NCT00782275|488613|P1|Overall Study|Other|3
135924|NCT00782275|488613|P1|Overall Study|Not started treatment|1
135925|NCT00782275|488613|P1|Overall Study|Physician Decision|4
135926|NCT00782275|488613|P1|Overall Study|Progressive Disease|21
135927|NCT00782275|488613|P1|Overall Study|Withdrawal by Subject|1
135928|NCT00782275|488613|P1|Overall Study|Adverse Event|11
135929|NCT00782210|488622|P3|Overall Study|Other reason not described above|3
135930|NCT00782210|488623|P2|Overall Study|Other reason not described above|2
135931|NCT00782210|488624|P1|Overall Study|Other reason not described above|3
135932|NCT00782210|488622|P3|Overall Study|Lack of Efficacy|1
135933|NCT00782210|488623|P2|Overall Study|Lack of Efficacy|4
135934|NCT00782210|488624|P1|Overall Study|Lack of Efficacy|13
135935|NCT00782210|488622|P3|Overall Study|Non compliance with protocol|2
135936|NCT00782210|488623|P2|Overall Study|Non compliance with protocol|3
135937|NCT00782210|488624|P1|Overall Study|Non compliance with protocol|0
135938|NCT00782210|488622|P3|Overall Study|Withdrawal by Subject|11
135939|NCT00782210|488623|P2|Overall Study|Withdrawal by Subject|8
135940|NCT00782210|488624|P1|Overall Study|Withdrawal by Subject|11
135941|NCT00782210|488622|P3|Overall Study|Lost to Follow-up|2
135942|NCT00782210|488623|P2|Overall Study|Lost to Follow-up|1
135943|NCT00782210|488624|P1|Overall Study|Lost to Follow-up|2
135944|NCT00782210|488622|P3|Overall Study|Adverse Event|16
135945|NCT00782210|488623|P2|Overall Study|Adverse Event|17
135946|NCT00782210|488624|P1|Overall Study|Adverse Event|21
135947|NCT00782184|488817|P2|Overall Study|Withdrawal by Subject|2
135948|NCT00782184|488818|P1|Overall Study|Withdrawal by Subject|3
135949|NCT00782184|488817|P2|Overall Study|Protocol Violation|1
135950|NCT00782184|488818|P1|Overall Study|Protocol Violation|0
135951|NCT00782184|488817|P2|Overall Study|Adverse Event|2
135952|NCT00782184|488818|P1|Overall Study|Adverse Event|1
135953|NCT00782171|488855|P2|Overall Study|not eligible|6
135954|NCT00782171|488856|P1|Overall Study|not eligible|8
135955|NCT00782171|488855|P2|Overall Study|others|9
135956|NCT00782171|488856|P1|Overall Study|others|7
135957|NCT00782171|488855|P2|Overall Study|complications|1
135958|NCT00782171|488856|P1|Overall Study|complications|3
135959|NCT00782171|488855|P2|Overall Study|Withdrawal by Subject|1
135960|NCT00782171|488856|P1|Overall Study|Withdrawal by Subject|2
135961|NCT00782171|488855|P2|Overall Study|Lost to Follow-up|2
135962|NCT00782171|488856|P1|Overall Study|Lost to Follow-up|2
135963|NCT00782067|488888|P1|Overall Study|Disease progression|44
135964|NCT00782067|488888|P1|Overall Study|Withdrawal by Subject|10
135965|NCT00782067|488888|P1|Overall Study|Adverse Event|28
135966|NCT00782067|488888|P1|Overall Study|Death|8
135967|NCT00782067|488888|P1|Overall Study|Protocol deviation|2
135968|NCT00782067|488888|P1|Overall Study|Lost to Follow-up|1
135969|NCT00782067|488888|P1|Overall Study|Administrative problems|1
135970|NCT00782067|488888|P1|Overall Study|Abnormal procedure results|1
135971|NCT00781963|488898|P3|Overall Study|Refused follow-up|0
135972|NCT00781963|488899|P2|Overall Study|Refused follow-up|5
135973|NCT00781963|488900|P1|Overall Study|Refused follow-up|4
135974|NCT00781963|488898|P3|Overall Study|Withdrawal by Subject|1
135975|NCT00781963|488899|P2|Overall Study|Withdrawal by Subject|3
135976|NCT00781963|488900|P1|Overall Study|Withdrawal by Subject|0
135977|NCT00781963|488898|P3|Overall Study|Lost to Follow-up|1
135978|NCT00781963|488899|P2|Overall Study|Lost to Follow-up|1
135979|NCT00781963|488900|P1|Overall Study|Lost to Follow-up|1
135980|NCT00781963|488898|P3|Overall Study|Death|0
135981|NCT00781963|488899|P2|Overall Study|Death|0
135982|NCT00781963|488900|P1|Overall Study|Death|3
135983|NCT00781937|488921|P2|Follow up Period (Week 56-68)|Unclassified|4
135984|NCT00781937|488922|P1|Follow up Period (Week 56-68)|Unclassified|5
135985|NCT00781937|488921|P2|Follow up Period (Week 56-68)|Protocol Violation|1
135986|NCT00781937|488922|P1|Follow up Period (Week 56-68)|Protocol Violation|1
135987|NCT00781937|488921|P2|Main Trial Period Through Week 56|Unclassified|15
135988|NCT00781937|488922|P1|Main Trial Period Through Week 56|Unclassified|10
135989|NCT00781937|488921|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
135990|NCT00781937|488922|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
135991|NCT00781937|488921|P2|Main Trial Period Through Week 56|Protocol Violation|5
135992|NCT00781937|488922|P1|Main Trial Period Through Week 56|Protocol Violation|8
135993|NCT00781937|488921|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
135994|NCT00781937|488922|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
135995|NCT00781937|488921|P2|Main Trial Period Through Week 56|Adverse Event|18
135996|NCT00781937|488922|P1|Main Trial Period Through Week 56|Adverse Event|18
135997|NCT00781911|488980|P2|Overall Study|Sponsor Decision|0
135998|NCT00781911|488981|P1|Overall Study|Sponsor Decision|1
135999|NCT00781911|488980|P2|Overall Study|Physician Decision|2
136000|NCT00781911|488981|P1|Overall Study|Physician Decision|0
136001|NCT00781911|488980|P2|Overall Study|Withdrawal by Subject|2
136002|NCT00781911|488981|P1|Overall Study|Withdrawal by Subject|1
136003|NCT00781911|488980|P2|Overall Study|Adverse Event|4
136004|NCT00781911|488981|P1|Overall Study|Adverse Event|4
136005|NCT00781859|489018|P2|Overall Study|Death|0
136006|NCT00781859|489019|P1|Overall Study|Death|3
136007|NCT00781859|489018|P2|Overall Study|Lost to Follow-up|3
136008|NCT00781859|489019|P1|Overall Study|Lost to Follow-up|6
136009|NCT00781859|489018|P2|Overall Study|Withdrawal by Subject|4
136010|NCT00781859|489019|P1|Overall Study|Withdrawal by Subject|8
136011|NCT00781859|489018|P2|Overall Study|Adverse Event|2
136012|NCT00781859|489019|P1|Overall Study|Adverse Event|2
136013|NCT00781599|489029|P2|Overall Study|Lost to Follow-up|4
136014|NCT00781599|489030|P1|Overall Study|Lost to Follow-up|7
136015|NCT00781456|489055|P2|Overall Study|Other Reason, Unknown|1
136016|NCT00781456|489056|P1|Overall Study|Other Reason, Unknown|0
136017|NCT00781456|489055|P2|Overall Study|Lost to Follow-up|5
136018|NCT00781456|489056|P1|Overall Study|Lost to Follow-up|10
136019|NCT00781456|489055|P2|Overall Study|Noncompliance With Protocol|1
136020|NCT00781456|489056|P1|Overall Study|Noncompliance With Protocol|1
136021|NCT00781456|489055|P2|Overall Study|Protocol Violation|1
136022|NCT00781456|489056|P1|Overall Study|Protocol Violation|4
136023|NCT00781456|489055|P2|Overall Study|Withdrawal by Subject|5
136024|NCT00781456|489056|P1|Overall Study|Withdrawal by Subject|3
136025|NCT00781456|489055|P2|Overall Study|Adverse Event|3
136026|NCT00781456|489056|P1|Overall Study|Adverse Event|3
136027|NCT00781391|489079|P3|Overall Study|Lost to Follow-up|1
136028|NCT00781391|489080|P2|Overall Study|Lost to Follow-up|0
136029|NCT00781391|489081|P1|Overall Study|Lost to Follow-up|0
136030|NCT00781391|489079|P3|Overall Study|Withdrawal by Subject|25
136031|NCT00781391|489080|P2|Overall Study|Withdrawal by Subject|37
136032|NCT00781391|489081|P1|Overall Study|Withdrawal by Subject|47
136033|NCT00781391|489079|P3|Overall Study|Death|706
136034|NCT00781391|489080|P2|Overall Study|Death|730
136035|NCT00781391|489081|P1|Overall Study|Death|789
136036|NCT00781391|489079|P3|Overall Study|Protocol Violation|20
136037|NCT00781391|489080|P2|Overall Study|Protocol Violation|17
136038|NCT00781391|489081|P1|Overall Study|Protocol Violation|19
136039|NCT00781391|489079|P3|Overall Study|never received study drug|32
136040|NCT00781391|489080|P2|Overall Study|never received study drug|23
136041|NCT00781391|489081|P1|Overall Study|never received study drug|24
136042|NCT00781365|489115|P2|Overall Study|Language barrier|0
136043|NCT00781365|489116|P1|Overall Study|Language barrier|1
136044|NCT00781365|489115|P2|Overall Study|Did Not Attend Visit|28
136045|NCT00781365|489116|P1|Overall Study|Did Not Attend Visit|20
136046|NCT00781365|489115|P2|Overall Study|Withdrawal by Subject|8
136047|NCT00781365|489116|P1|Overall Study|Withdrawal by Subject|13
136048|NCT00781326|489126|P1|Phase I|Physician Decision|2
136049|NCT00781326|489126|P1|Phase I|Withdrawal by Subject|1
136050|NCT00781326|489126|P1|Phase I|Adverse Event|1
136051|NCT00781274|489130|P1|Overall Study|Withdrawal by Subject|2
136052|NCT00780910|489154|P1|Overall Study|Adverse Event|2
136053|NCT00780416|489250|P2|Overall Study|Withdrawal by Subject|6
136054|NCT00780416|489251|P1|Overall Study|Withdrawal by Subject|8
136055|NCT00780416|489250|P2|Overall Study|Protocol Violation|0
136056|NCT00780416|489251|P1|Overall Study|Protocol Violation|1
136057|NCT00780416|489250|P2|Overall Study|Physician Decision|3
136058|NCT00780416|489251|P1|Overall Study|Physician Decision|3
136059|NCT00780273|489296|P1|Overall Study|Lost to Follow-up|1
136060|NCT00780273|489296|P1|Overall Study|Death|1
136061|NCT00779909|489330|P4|Overall Study|Withdrawal by Subject|0
136062|NCT00779909|489331|P3|Overall Study|Withdrawal by Subject|0
136063|NCT00779909|489332|P2|Overall Study|Withdrawal by Subject|1
136064|NCT00779909|489333|P1|Overall Study|Withdrawal by Subject|0
136065|NCT00779909|489330|P4|Overall Study|Lost to Follow-up|1
136066|NCT00779909|489331|P3|Overall Study|Lost to Follow-up|0
136067|NCT00779909|489332|P2|Overall Study|Lost to Follow-up|0
136068|NCT00779909|489333|P1|Overall Study|Lost to Follow-up|1
136069|NCT00779857|489375|P1|Overall Study|Missed Visit|2
136070|NCT00779857|489375|P1|Overall Study|Withdrawal by Subject|3
136071|NCT00779857|489375|P1|Overall Study|Death|1
136072|NCT00779779|489380|P1|Overall Study|Lost to Follow-up|5
136073|NCT00779779|489380|P1|Overall Study|Withdrawal by Subject|4
136074|NCT00779779|489380|P1|Overall Study|Protocol Violation|14
136075|NCT00779779|489380|P1|Overall Study|Adverse Event|1
136076|NCT00779766|489389|P2|Overall Study|Withdrawal by Subject|67
136077|NCT00779766|489390|P1|Overall Study|Withdrawal by Subject|84
136078|NCT00779766|489389|P2|Overall Study|Protocol Violation|1
136079|NCT00779766|489390|P1|Overall Study|Protocol Violation|1
136080|NCT00779675|489472|P1|Extended Treatment Period|Lost to Follow-up|6
136081|NCT00779675|489472|P1|Extended Treatment Period|Protocol defined clinical event|1
136082|NCT00779675|489472|P1|Extended Treatment Period|Treatment Failure|11
136083|NCT00779675|489472|P1|Extended Treatment Period|Adverse Event|6
136084|NCT00779675|489472|P1|Extended Treatment Period|Protocol Violation|13
136085|NCT00779675|489472|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
136086|NCT00779675|489472|P1|Treatment Period|Administrative|3
136087|NCT00779675|489472|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
136088|NCT00779675|489472|P1|Treatment Period|Protocol Violation|54
136089|NCT00779675|489472|P1|Treatment Period|Withdrawal by Subject|46
136090|NCT00779675|489472|P1|Treatment Period|Lost to Follow-up|23
136091|NCT00779675|489472|P1|Treatment Period|Transferred to Another Study|38
136092|NCT00779675|489472|P1|Treatment Period|Treatment Failure|80
136093|NCT00779675|489472|P1|Treatment Period|Adverse Event|87
136094|NCT00779584|489500|P9|Overall Study|Ongoing in Study|0
136095|NCT00779584|489501|P8|Overall Study|Ongoing in Study|0
136096|NCT00779584|489502|P7|Overall Study|Ongoing in Study|0
136097|NCT00779584|489503|P6|Overall Study|Ongoing in Study|1
136098|NCT00779584|489504|P5|Overall Study|Ongoing in Study|1
136099|NCT00779584|489505|P4|Overall Study|Ongoing in Study|0
136100|NCT00779584|489506|P3|Overall Study|Ongoing in Study|0
136101|NCT00779584|489507|P2|Overall Study|Ongoing in Study|0
136102|NCT00779584|489508|P1|Overall Study|Ongoing in Study|0
136103|NCT00779584|489500|P9|Overall Study|Symptomatic Deterioration|0
136104|NCT00779584|489501|P8|Overall Study|Symptomatic Deterioration|0
136105|NCT00779584|489502|P7|Overall Study|Symptomatic Deterioration|1
136106|NCT00779584|489503|P6|Overall Study|Symptomatic Deterioration|1
136107|NCT00779584|489504|P5|Overall Study|Symptomatic Deterioration|0
136108|NCT00779584|489505|P4|Overall Study|Symptomatic Deterioration|0
136109|NCT00779584|489506|P3|Overall Study|Symptomatic Deterioration|1
136110|NCT00779584|489507|P2|Overall Study|Symptomatic Deterioration|1
136111|NCT00779584|489508|P1|Overall Study|Symptomatic Deterioration|1
136112|NCT00779584|489500|P9|Overall Study|Adverse Event|1
136113|NCT00779584|489501|P8|Overall Study|Adverse Event|1
136114|NCT00779584|489502|P7|Overall Study|Adverse Event|2
136115|NCT00779584|489503|P6|Overall Study|Adverse Event|0
136116|NCT00779584|489504|P5|Overall Study|Adverse Event|0
136117|NCT00779584|489505|P4|Overall Study|Adverse Event|0
136118|NCT00779584|489506|P3|Overall Study|Adverse Event|2
136119|NCT00779584|489507|P2|Overall Study|Adverse Event|0
136120|NCT00779584|489508|P1|Overall Study|Adverse Event|1
136121|NCT00779584|489500|P9|Overall Study|Progression of Disease|1
136122|NCT00779584|489501|P8|Overall Study|Progression of Disease|2
136123|NCT00779584|489502|P7|Overall Study|Progression of Disease|4
136124|NCT00779584|489503|P6|Overall Study|Progression of Disease|1
136125|NCT00779584|489504|P5|Overall Study|Progression of Disease|5
136126|NCT00779584|489505|P4|Overall Study|Progression of Disease|6
136127|NCT00779584|489506|P3|Overall Study|Progression of Disease|2
136128|NCT00779584|489507|P2|Overall Study|Progression of Disease|1
136129|NCT00779584|489508|P1|Overall Study|Progression of Disease|0
136130|NCT00779584|489500|P9|Overall Study|Lost to Follow-up|0
136131|NCT00779584|489501|P8|Overall Study|Lost to Follow-up|0
136132|NCT00779584|489502|P7|Overall Study|Lost to Follow-up|0
136133|NCT00779584|489503|P6|Overall Study|Lost to Follow-up|0
136134|NCT00779584|489504|P5|Overall Study|Lost to Follow-up|1
136135|NCT00779584|489505|P4|Overall Study|Lost to Follow-up|0
136136|NCT00779584|489506|P3|Overall Study|Lost to Follow-up|0
136137|NCT00779584|489507|P2|Overall Study|Lost to Follow-up|0
136138|NCT00779584|489508|P1|Overall Study|Lost to Follow-up|0
136139|NCT00779584|489500|P9|Overall Study|Withdrawal by Subject|0
136140|NCT00779584|489501|P8|Overall Study|Withdrawal by Subject|0
136141|NCT00779584|489502|P7|Overall Study|Withdrawal by Subject|1
136142|NCT00779584|489503|P6|Overall Study|Withdrawal by Subject|2
136143|NCT00779584|489504|P5|Overall Study|Withdrawal by Subject|0
136144|NCT00779584|489505|P4|Overall Study|Withdrawal by Subject|0
136145|NCT00779584|489506|P3|Overall Study|Withdrawal by Subject|2
136146|NCT00779584|489507|P2|Overall Study|Withdrawal by Subject|1
136147|NCT00779584|489508|P1|Overall Study|Withdrawal by Subject|1
136148|NCT00779584|489500|P9|Overall Study|Protocol Violation|0
136149|NCT00779584|489501|P8|Overall Study|Protocol Violation|0
136150|NCT00779584|489502|P7|Overall Study|Protocol Violation|0
136151|NCT00779584|489503|P6|Overall Study|Protocol Violation|1
136152|NCT00779584|489504|P5|Overall Study|Protocol Violation|0
136153|NCT00779584|489505|P4|Overall Study|Protocol Violation|0
136154|NCT00779584|489506|P3|Overall Study|Protocol Violation|0
136155|NCT00779584|489507|P2|Overall Study|Protocol Violation|0
136156|NCT00779584|489508|P1|Overall Study|Protocol Violation|0
136157|NCT00779506|489599|P1|Overall Study|Lost to Follow-up|1
136158|NCT00779506|489599|P1|Overall Study|Withdrawal by Subject|6
136159|NCT00779506|489599|P1|Overall Study|Protocol Violation|5
136160|NCT00779506|489599|P1|Overall Study|Lack of Efficacy|11
136161|NCT00779506|489599|P1|Overall Study|Adverse Event|4
136162|NCT00779506|489599|P1|Overall Study|Screening Failed|2
136163|NCT00779467|489613|P4|Overall Study|unavailable research staff|1
136164|NCT00779467|489614|P3|Overall Study|unavailable research staff|0
136165|NCT00779467|489615|P2|Overall Study|unavailable research staff|0
136166|NCT00779467|489616|P1|Overall Study|unavailable research staff|0
136167|NCT00779467|489613|P4|Overall Study|technical issue|1
136168|NCT00779467|489614|P3|Overall Study|technical issue|2
136169|NCT00779467|489615|P2|Overall Study|technical issue|0
136170|NCT00779467|489616|P1|Overall Study|technical issue|0
136171|NCT00779467|489613|P4|Overall Study|missing data|4
136172|NCT00779467|489614|P3|Overall Study|missing data|1
136173|NCT00779467|489615|P2|Overall Study|missing data|0
136174|NCT00779467|489616|P1|Overall Study|missing data|1
136175|NCT00779467|489613|P4|Overall Study|failed inclusion criteria|2
136176|NCT00779467|489614|P3|Overall Study|failed inclusion criteria|1
136177|NCT00779467|489615|P2|Overall Study|failed inclusion criteria|3
136178|NCT00779467|489616|P1|Overall Study|failed inclusion criteria|3
136179|NCT00779467|489613|P4|Overall Study|Lack of Efficacy|11
136180|NCT00779467|489614|P3|Overall Study|Lack of Efficacy|6
136181|NCT00779467|489615|P2|Overall Study|Lack of Efficacy|2
136182|NCT00779467|489616|P1|Overall Study|Lack of Efficacy|11
136183|NCT00779402|489656|P2|Long-term Follow-up|Completed Protocol Visits|2
136184|NCT00779402|489657|P1|Long-term Follow-up|Completed Protocol Visits|6
136185|NCT00779402|489656|P2|Long-term Follow-up|Closure of Study|4
136186|NCT00779402|489657|P1|Long-term Follow-up|Closure of Study|8
136187|NCT00779402|489656|P2|Long-term Follow-up|Not specified|0
136188|NCT00779402|489657|P1|Long-term Follow-up|Not specified|5
136189|NCT00779402|489656|P2|Long-term Follow-up|Patient refused to continue|0
136190|NCT00779402|489657|P1|Long-term Follow-up|Patient refused to continue|2
136191|NCT00779402|489656|P2|Surveillance Phase|Completed Protocol Visits|2
136192|NCT00779402|489657|P1|Surveillance Phase|Completed Protocol Visits|3
136193|NCT00779402|489656|P2|Surveillance Phase|Closure of study|6
136194|NCT00779402|489657|P1|Surveillance Phase|Closure of study|5
136195|NCT00779402|489656|P2|Surveillance Phase|Withdrawal by Subject|1
136196|NCT00779402|489657|P1|Surveillance Phase|Withdrawal by Subject|4
136197|NCT00779402|489656|P2|Surveillance Phase|Not specified|5
136198|NCT00779402|489657|P1|Surveillance Phase|Not specified|5
136199|NCT00779402|489656|P2|Surveillance Phase|Intercurrent Illness|0
136200|NCT00779402|489657|P1|Surveillance Phase|Intercurrent Illness|2
136201|NCT00779402|489656|P2|Surveillance Phase|Death|1
136202|NCT00779402|489657|P1|Surveillance Phase|Death|0
136203|NCT00779402|489656|P2|Surveillance Phase|Lost to Follow-up|1
136204|NCT00779402|489657|P1|Surveillance Phase|Lost to Follow-up|2
136205|NCT00779402|489656|P2|Surveillance Phase|Patient refused to continue|14
136206|NCT00779402|489657|P1|Surveillance Phase|Patient refused to continue|22
136207|NCT00779402|489656|P2|Surveillance Phase|Protocol Violation|1
136208|NCT00779402|489657|P1|Surveillance Phase|Protocol Violation|0
136209|NCT00779402|489656|P2|Treatment Phase 1|Completed Protocol Visits|6
136210|NCT00779402|489657|P1|Treatment Phase 1|Completed Protocol Visits|3
136211|NCT00779402|489656|P2|Treatment Phase 1|Closure of Study|2
136212|NCT00779402|489657|P1|Treatment Phase 1|Closure of Study|3
136213|NCT00779402|489656|P2|Treatment Phase 1|Not Specified|2
136214|NCT00779402|489657|P1|Treatment Phase 1|Not Specified|4
136215|NCT00779402|489656|P2|Treatment Phase 1|Withdrawal by Subject|0
136216|NCT00779402|489657|P1|Treatment Phase 1|Withdrawal by Subject|1
136217|NCT00779402|489656|P2|Treatment Phase 1|Intercurrent Illness|1
136218|NCT00779402|489657|P1|Treatment Phase 1|Intercurrent Illness|1
136219|NCT00779402|489656|P2|Treatment Phase 1|Death|1
136220|NCT00779402|489657|P1|Treatment Phase 1|Death|0
136221|NCT00779402|489656|P2|Treatment Phase 1|Lost to Follow-up|1
136222|NCT00779402|489657|P1|Treatment Phase 1|Lost to Follow-up|0
136223|NCT00779402|489656|P2|Treatment Phase 1|Patient Refused to Continue|2
136224|NCT00779402|489657|P1|Treatment Phase 1|Patient Refused to Continue|17
136225|NCT00779402|489656|P2|Treatment Phase 1|Protocol Violation|0
136226|NCT00779402|489657|P1|Treatment Phase 1|Protocol Violation|1
136227|NCT00779402|489656|P2|Treatment Phase 1|Adverse Event|0
136228|NCT00779402|489657|P1|Treatment Phase 1|Adverse Event|2
136229|NCT00779402|489656|P2|Treatment Phase 1|Disease Progression|0
136230|NCT00779402|489657|P1|Treatment Phase 1|Disease Progression|1
136231|NCT00779259|489700|P1|Quinine Alone|Adverse Event|2
136232|NCT00779246|489721|P2|Overall Study|Missing sufficient data for analysis|53
136233|NCT00779246|489722|P1|Overall Study|Missing sufficient data for analysis|33
136234|NCT00779142|489741|P1|Overall Study|Screen Failures|3
136235|NCT00779038|489755|P1|Overall Study|Study Prematurely Terminated|13
136236|NCT00779025|489764|P1|Overall Study|Withdrawal by Subject|1
136237|NCT00778999|489775|P2|Overall Study|Did not receive recFSH|20
136238|NCT00778999|489776|P1|Overall Study|Did not receive recFSH|14
136239|NCT00778999|489775|P2|Overall Study|Discontinuation: no embryo transfer|14
136240|NCT00778999|489776|P1|Overall Study|Discontinuation: no embryo transfer|14
136241|NCT00778921|489785|P3|Overall Study|Not treated|2
136242|NCT00778921|489786|P2|Overall Study|Not treated|2
136243|NCT00778921|489787|P1|Overall Study|Not treated|0
136244|NCT00778921|489785|P3|Overall Study|Protocol Violation|2
136245|NCT00778921|489786|P2|Overall Study|Protocol Violation|0
136246|NCT00778921|489787|P1|Overall Study|Protocol Violation|3
136247|NCT00778921|489785|P3|Overall Study|Administrative Problems|0
136248|NCT00778921|489786|P2|Overall Study|Administrative Problems|2
136249|NCT00778921|489787|P1|Overall Study|Administrative Problems|1
136250|NCT00778921|489785|P3|Overall Study|Lost to Follow-up|1
136251|NCT00778921|489786|P2|Overall Study|Lost to Follow-up|2
136252|NCT00778921|489787|P1|Overall Study|Lost to Follow-up|0
136253|NCT00778921|489785|P3|Overall Study|Patient withdrew request|6
136254|NCT00778921|489786|P2|Overall Study|Patient withdrew request|1
136255|NCT00778921|489787|P1|Overall Study|Patient withdrew request|3
136256|NCT00778921|489785|P3|Overall Study|Patient No Longer Requires Study Drug|0
136257|NCT00778921|489786|P2|Overall Study|Patient No Longer Requires Study Drug|1
136258|NCT00778921|489787|P1|Overall Study|Patient No Longer Requires Study Drug|0
136259|NCT00778921|489785|P3|Overall Study|Unsatisfactory therapeutic response|1
136260|NCT00778921|489786|P2|Overall Study|Unsatisfactory therapeutic response|1
136261|NCT00778921|489787|P1|Overall Study|Unsatisfactory therapeutic response|1
136262|NCT00778921|489785|P3|Overall Study|Abnormal Test Procedure Result(s)|2
136263|NCT00778921|489786|P2|Overall Study|Abnormal Test Procedure Result(s)|0
136264|NCT00778921|489787|P1|Overall Study|Abnormal Test Procedure Result(s)|0
136265|NCT00778921|489785|P3|Overall Study|Abnormal Laboratory Value(s)|0
136266|NCT00778921|489786|P2|Overall Study|Abnormal Laboratory Value(s)|0
136267|NCT00778921|489787|P1|Overall Study|Abnormal Laboratory Value(s)|1
136268|NCT00778921|489785|P3|Overall Study|Adverse Event|14
136269|NCT00778921|489786|P2|Overall Study|Adverse Event|10
136270|NCT00778921|489787|P1|Overall Study|Adverse Event|9
136271|NCT00778895|489804|P3|ESFU Phase|Other|0
136272|NCT00778895|489805|P2|ESFU Phase|Other|0
136273|NCT00778895|489806|P1|ESFU Phase|Other|2
136274|NCT00778895|489804|P3|ESFU Phase|Lost to Follow-up|2
136275|NCT00778895|489805|P2|ESFU Phase|Lost to Follow-up|7
136276|NCT00778895|489806|P1|ESFU Phase|Lost to Follow-up|6
136277|NCT00778895|489804|P3|ESFU Phase|Withdrawal by Subject|0
136278|NCT00778895|489805|P2|ESFU Phase|Withdrawal by Subject|4
136279|NCT00778895|489806|P1|ESFU Phase|Withdrawal by Subject|1
136280|NCT00778895|489804|P3|ESFU Phase|Adverse Event|0
136281|NCT00778895|489805|P2|ESFU Phase|Adverse Event|1
136282|NCT00778895|489806|P1|ESFU Phase|Adverse Event|2
136283|NCT00778895|489804|P3|Active Phase|Other|0
136284|NCT00778895|489805|P2|Active Phase|Other|0
136285|NCT00778895|489806|P1|Active Phase|Other|2
136286|NCT00778895|489804|P3|Active Phase|Lost to Follow-up|0
136287|NCT00778895|489805|P2|Active Phase|Lost to Follow-up|1
136288|NCT00778895|489806|P1|Active Phase|Lost to Follow-up|1
136289|NCT00778895|489804|P3|Active Phase|Withdrawal by Subject|0
136290|NCT00778895|489805|P2|Active Phase|Withdrawal by Subject|4
136291|NCT00778895|489806|P1|Active Phase|Withdrawal by Subject|1
136292|NCT00778895|489804|P3|Active Phase|Adverse Event|0
136293|NCT00778895|489805|P2|Active Phase|Adverse Event|1
136294|NCT00778895|489806|P1|Active Phase|Adverse Event|3
136295|NCT00778830|489850|P2|Overall Study|Ongoing at data cut-off|1
136296|NCT00778830|489851|P1|Overall Study|Ongoing at data cut-off|0
136297|NCT00778817|489863|P1|Overall Study|Withdrawal by Subject|2
136298|NCT00778817|489863|P1|Overall Study|Adverse Event|2
136299|NCT00778622|489890|P3|Overall Study|Other|1
136300|NCT00778622|489891|P2|Overall Study|Other|0
136301|NCT00778622|489892|P1|Overall Study|Other|1
136302|NCT00778622|489890|P3|Overall Study|immigration|0
136303|NCT00778622|489891|P2|Overall Study|immigration|0
136304|NCT00778622|489892|P1|Overall Study|immigration|1
136305|NCT00778622|489890|P3|Overall Study|Lack of Efficacy|0
136306|NCT00778622|489891|P2|Overall Study|Lack of Efficacy|0
136307|NCT00778622|489892|P1|Overall Study|Lack of Efficacy|2
136308|NCT00778622|489890|P3|Overall Study|Protocol Violation|0
136309|NCT00778622|489891|P2|Overall Study|Protocol Violation|3
136310|NCT00778622|489892|P1|Overall Study|Protocol Violation|0
136311|NCT00778622|489890|P3|Overall Study|Lost to Follow-up|2
136312|NCT00778622|489891|P2|Overall Study|Lost to Follow-up|3
136313|NCT00778622|489892|P1|Overall Study|Lost to Follow-up|3
136314|NCT00778622|489890|P3|Overall Study|Withdrawal by Subject|5
136315|NCT00778622|489891|P2|Overall Study|Withdrawal by Subject|5
136316|NCT00778622|489892|P1|Overall Study|Withdrawal by Subject|4
136317|NCT00778622|489890|P3|Overall Study|Adverse Event|7
136318|NCT00778622|489891|P2|Overall Study|Adverse Event|4
136319|NCT00778622|489892|P1|Overall Study|Adverse Event|5
136320|NCT00778375|489945|P1|Overall Study|Ineligible|3
136321|NCT00778336|489959|P4|3 Month Follow Up|Death|0
136322|NCT00778336|489960|P3|3 Month Follow Up|Death|2
136323|NCT00778336|489961|P2|3 Month Follow Up|Death|3
136324|NCT00778336|489962|P1|3 Month Follow Up|Death|8
136325|NCT00778336|489959|P4|3 Month Follow Up|Lost to Follow-up|0
136326|NCT00778336|489960|P3|3 Month Follow Up|Lost to Follow-up|3
136327|NCT00778336|489961|P2|3 Month Follow Up|Lost to Follow-up|20
136328|NCT00778336|489962|P1|3 Month Follow Up|Lost to Follow-up|15
136329|NCT00778336|489959|P4|Index Procedure-Discharge|Death|0
136330|NCT00778336|489960|P3|Index Procedure-Discharge|Death|2
136331|NCT00778336|489961|P2|Index Procedure-Discharge|Death|3
136332|NCT00778336|489962|P1|Index Procedure-Discharge|Death|6
136333|NCT00778258|490000|P9|Overall Study|Other|0
136334|NCT00778258|490001|P8|Overall Study|Other|0
136335|NCT00778258|490002|P7|Overall Study|Other|1
136336|NCT00778258|490003|P6|Overall Study|Other|0
136337|NCT00778258|490004|P5|Overall Study|Other|0
136338|NCT00778258|490005|P4|Overall Study|Other|0
136339|NCT00778258|490006|P3|Overall Study|Other|0
136340|NCT00778258|490007|P2|Overall Study|Other|0
136341|NCT00778258|490008|P1|Overall Study|Other|0
136342|NCT00778258|490000|P9|Overall Study|Non-compliance|0
136343|NCT00778258|490001|P8|Overall Study|Non-compliance|0
136344|NCT00778258|490002|P7|Overall Study|Non-compliance|0
136345|NCT00778258|490003|P6|Overall Study|Non-compliance|0
136346|NCT00778258|490004|P5|Overall Study|Non-compliance|0
136347|NCT00778258|490005|P4|Overall Study|Non-compliance|1
136348|NCT00778258|490006|P3|Overall Study|Non-compliance|0
136349|NCT00778258|490007|P2|Overall Study|Non-compliance|0
136350|NCT00778258|490008|P1|Overall Study|Non-compliance|0
136351|NCT00778258|490000|P9|Overall Study|New Contraindication|0
136352|NCT00778258|490001|P8|Overall Study|New Contraindication|1
136353|NCT00778258|490002|P7|Overall Study|New Contraindication|0
136354|NCT00778258|490003|P6|Overall Study|New Contraindication|0
136355|NCT00778258|490004|P5|Overall Study|New Contraindication|0
136356|NCT00778258|490005|P4|Overall Study|New Contraindication|0
136357|NCT00778258|490006|P3|Overall Study|New Contraindication|0
136358|NCT00778258|490007|P2|Overall Study|New Contraindication|0
136359|NCT00778258|490008|P1|Overall Study|New Contraindication|0
136360|NCT00778258|490000|P9|Overall Study|Withdrawal by Subject|4
136361|NCT00778258|490001|P8|Overall Study|Withdrawal by Subject|12
136362|NCT00778258|490002|P7|Overall Study|Withdrawal by Subject|12
136363|NCT00778258|490003|P6|Overall Study|Withdrawal by Subject|6
136364|NCT00778258|490004|P5|Overall Study|Withdrawal by Subject|0
136365|NCT00778258|490005|P4|Overall Study|Withdrawal by Subject|2
136366|NCT00778258|490006|P3|Overall Study|Withdrawal by Subject|8
136367|NCT00778258|490007|P2|Overall Study|Withdrawal by Subject|2
136368|NCT00778258|490008|P1|Overall Study|Withdrawal by Subject|6
136369|NCT00778258|490000|P9|Overall Study|Lost to Follow-up|0
136370|NCT00778258|490001|P8|Overall Study|Lost to Follow-up|2
136371|NCT00778258|490002|P7|Overall Study|Lost to Follow-up|2
136372|NCT00778258|490003|P6|Overall Study|Lost to Follow-up|3
136373|NCT00778258|490004|P5|Overall Study|Lost to Follow-up|0
136374|NCT00778258|490005|P4|Overall Study|Lost to Follow-up|0
136375|NCT00778258|490006|P3|Overall Study|Lost to Follow-up|2
136376|NCT00778258|490007|P2|Overall Study|Lost to Follow-up|0
136377|NCT00778258|490008|P1|Overall Study|Lost to Follow-up|0
136378|NCT00778258|490000|P9|Overall Study|Adverse Event|0
136379|NCT00778258|490001|P8|Overall Study|Adverse Event|0
136380|NCT00778258|490002|P7|Overall Study|Adverse Event|0
136381|NCT00778258|490003|P6|Overall Study|Adverse Event|1
136382|NCT00778258|490004|P5|Overall Study|Adverse Event|0
136383|NCT00778258|490005|P4|Overall Study|Adverse Event|0
136384|NCT00778258|490006|P3|Overall Study|Adverse Event|0
136385|NCT00778258|490007|P2|Overall Study|Adverse Event|0
136386|NCT00778258|490008|P1|Overall Study|Adverse Event|1
136387|NCT00778102|490075|P2|Overall Study|Administrative Reason|10
136388|NCT00778102|490076|P1|Overall Study|Administrative Reason|7
136389|NCT00778102|490075|P2|Overall Study|Withdrawal by Subject|1
136390|NCT00778102|490076|P1|Overall Study|Withdrawal by Subject|1
136391|NCT00778102|490075|P2|Overall Study|Refused Treatment|3
136392|NCT00778102|490076|P1|Overall Study|Refused Treatment|2
136393|NCT00778102|490075|P2|Overall Study|Protocol Violation|1
136394|NCT00778102|490076|P1|Overall Study|Protocol Violation|0
136395|NCT00778102|490075|P2|Overall Study|Violation of Selection Criteria|1
136396|NCT00778102|490076|P1|Overall Study|Violation of Selection Criteria|1
136397|NCT00778102|490075|P2|Overall Study|Lost to Follow-up|0
136398|NCT00778102|490076|P1|Overall Study|Lost to Follow-up|1
136399|NCT00778102|490075|P2|Overall Study|Death|1
136400|NCT00778102|490076|P1|Overall Study|Death|1
136401|NCT00778102|490075|P2|Overall Study|Adverse Event|5
136402|NCT00778102|490076|P1|Overall Study|Adverse Event|8
136403|NCT00777946|490111|P3|Overall Study|Randomized in error|0
136404|NCT00777946|490112|P2|Overall Study|Randomized in error|1
136405|NCT00777946|490113|P1|Overall Study|Randomized in error|1
136406|NCT00777946|490111|P3|Overall Study|Protocol deviation|1
136407|NCT00777946|490112|P2|Overall Study|Protocol deviation|1
136408|NCT00777946|490113|P1|Overall Study|Protocol deviation|2
136409|NCT00777946|490111|P3|Overall Study|Lost to Follow-up|0
136410|NCT00777946|490112|P2|Overall Study|Lost to Follow-up|1
136411|NCT00777946|490113|P1|Overall Study|Lost to Follow-up|3
136412|NCT00777946|490111|P3|Overall Study|Patient withdrew consent|3
136413|NCT00777946|490112|P2|Overall Study|Patient withdrew consent|2
136414|NCT00777946|490113|P1|Overall Study|Patient withdrew consent|3
136415|NCT00777946|490111|P3|Overall Study|Condition no longer required study drug|0
136416|NCT00777946|490112|P2|Overall Study|Condition no longer required study drug|0
136417|NCT00777946|490113|P1|Overall Study|Condition no longer required study drug|1
136418|NCT00777946|490111|P3|Overall Study|Lack of Efficacy|9
136419|NCT00777946|490112|P2|Overall Study|Lack of Efficacy|0
136420|NCT00777946|490113|P1|Overall Study|Lack of Efficacy|0
136421|NCT00777946|490111|P3|Overall Study|Adverse Event|3
136422|NCT00777946|490112|P2|Overall Study|Adverse Event|1
136423|NCT00777946|490113|P1|Overall Study|Adverse Event|11
136424|NCT00777803|490148|P2|Overall Study|Non-compliance|2
136425|NCT00777803|490149|P1|Overall Study|Non-compliance|2
136426|NCT00777803|490148|P2|Overall Study|Adverse Event|0
136427|NCT00777803|490149|P1|Overall Study|Adverse Event|1
136428|NCT00777803|490148|P2|Overall Study|Lost to Follow-up|5
136429|NCT00777803|490149|P1|Overall Study|Lost to Follow-up|12
136430|NCT00777608|490228|P2|Overall Study|Investigator Decision|2
136431|NCT00777608|490229|P1|Overall Study|Investigator Decision|1
136432|NCT00777608|490228|P2|Overall Study|Protocol Violation|0
136433|NCT00777608|490229|P1|Overall Study|Protocol Violation|1
136434|NCT00777608|490228|P2|Overall Study|Withdrawal by Subject|3
136435|NCT00777608|490229|P1|Overall Study|Withdrawal by Subject|1
136436|NCT00777608|490228|P2|Overall Study|Lost to Follow-up|1
136437|NCT00777608|490229|P1|Overall Study|Lost to Follow-up|1
136438|NCT00777556|490239|P1|Overall Study|Did not complete all 3 follow-up visits|20
136439|NCT00777556|490239|P1|Overall Study|Dispensed but did not use product|12
136440|NCT00777556|490239|P1|Overall Study|Inappropriate self-selection|34
136441|NCT00777257|490260|P3|Overall Study|Withdrawal by Subject|5
136442|NCT00777257|490261|P2|Overall Study|Withdrawal by Subject|6
136443|NCT00777257|490262|P1|Overall Study|Withdrawal by Subject|3
136444|NCT00777257|490260|P3|Overall Study|Protocol Violation|2
136445|NCT00777257|490261|P2|Overall Study|Protocol Violation|2
136446|NCT00777257|490262|P1|Overall Study|Protocol Violation|2
136447|NCT00777257|490260|P3|Overall Study|Lost to Follow-up|2
136448|NCT00777257|490261|P2|Overall Study|Lost to Follow-up|3
136449|NCT00777257|490262|P1|Overall Study|Lost to Follow-up|3
136450|NCT00777257|490260|P3|Overall Study|Adverse Event|0
136451|NCT00777257|490261|P2|Overall Study|Adverse Event|1
136452|NCT00777257|490262|P1|Overall Study|Adverse Event|3
136453|NCT00777205|490281|P2|Overall Study|Protocol Violation|56
136454|NCT00777205|490282|P1|Overall Study|Protocol Violation|0
136455|NCT00777205|490281|P2|Overall Study|Death|2
136456|NCT00777205|490282|P1|Overall Study|Death|0
136457|NCT00777205|490281|P2|Overall Study|Withdrawal by Subject|4
136458|NCT00777205|490282|P1|Overall Study|Withdrawal by Subject|6
136459|NCT00777205|490281|P2|Overall Study|Lost to Follow-up|9
136460|NCT00777205|490282|P1|Overall Study|Lost to Follow-up|25
136461|NCT00777153|490316|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
136462|NCT00777153|490317|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
136463|NCT00777153|490318|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
136464|NCT00777153|490316|P3|Overall Study|Withdrawal by Subject|3
136465|NCT00777153|490317|P2|Overall Study|Withdrawal by Subject|4
136466|NCT00777153|490318|P1|Overall Study|Withdrawal by Subject|3
136467|NCT00777153|490316|P3|Overall Study|Death|33
136468|NCT00777153|490317|P2|Overall Study|Death|73
136469|NCT00777153|490318|P1|Overall Study|Death|85
136470|NCT00777153|490316|P3|Overall Study|Lost to Follow-up|0
136471|NCT00777153|490317|P2|Overall Study|Lost to Follow-up|1
136472|NCT00777153|490318|P1|Overall Study|Lost to Follow-up|1
136473|NCT00777101|490343|P2|Overall Study|Failed to Return|1
136474|NCT00777101|490344|P1|Overall Study|Failed to Return|0
136475|NCT00777101|490343|P2|Overall Study|Discontinuation of Study by Sponsor|0
136476|NCT00777101|490344|P1|Overall Study|Discontinuation of Study by Sponsor|1
136477|NCT00777101|490343|P2|Overall Study|Lost to Follow-up|1
136478|NCT00777101|490344|P1|Overall Study|Lost to Follow-up|2
136479|NCT00777101|490343|P2|Overall Study|Withdrawal by Subject|6
136480|NCT00777101|490344|P1|Overall Study|Withdrawal by Subject|11
136481|NCT00777101|490343|P2|Overall Study|Death|43
136482|NCT00777101|490344|P1|Overall Study|Death|48
136483|NCT00777049|490375|P2|Overall Study|No treatment (elevated liver enzymes)|1
136484|NCT00777049|490376|P1|Overall Study|No treatment (elevated liver enzymes)|0
136485|NCT00777049|490375|P2|Overall Study|Withdrawal by Subject|0
136486|NCT00777049|490376|P1|Overall Study|Withdrawal by Subject|1
136487|NCT00777036|490385|P3|Follow-Up|Death|0
136488|NCT00777036|490386|P2|Follow-Up|Death|8
136489|NCT00777036|490387|P1|Follow-Up|Death|1
136490|NCT00777036|490385|P3|Follow-Up|Withdrawal by Subject|4
136491|NCT00777036|490386|P2|Follow-Up|Withdrawal by Subject|0
136492|NCT00777036|490387|P1|Follow-Up|Withdrawal by Subject|1
136493|NCT00777036|490385|P3|Follow-Up|Reason Not Specified|0
136494|NCT00777036|490386|P2|Follow-Up|Reason Not Specified|0
136495|NCT00777036|490387|P1|Follow-Up|Reason Not Specified|2
136496|NCT00777036|490385|P3|Follow-Up|Lost to Follow-up|0
136497|NCT00777036|490386|P2|Follow-Up|Lost to Follow-up|0
136498|NCT00777036|490387|P1|Follow-Up|Lost to Follow-up|1
136499|NCT00777036|490385|P3|On Treatment|Progressive Disease|6
136500|NCT00777036|490386|P2|On Treatment|Progressive Disease|4
136501|NCT00777036|490387|P1|On Treatment|Progressive Disease|5
136502|NCT00777036|490385|P3|On Treatment|Study Drug Toxicity|1
136503|NCT00777036|490386|P2|On Treatment|Study Drug Toxicity|0
136504|NCT00777036|490387|P1|On Treatment|Study Drug Toxicity|0
136505|NCT00777036|490385|P3|On Treatment|Death|0
136506|NCT00777036|490386|P2|On Treatment|Death|2
136507|NCT00777036|490387|P1|On Treatment|Death|0
136508|NCT00777036|490385|P3|On Treatment|Withdrawal by Subject|3
136509|NCT00777036|490386|P2|On Treatment|Withdrawal by Subject|2
136510|NCT00777036|490387|P1|On Treatment|Withdrawal by Subject|3
136511|NCT00777036|490385|P3|On Treatment|Maximum Clinical Benefit|1
136512|NCT00777036|490386|P2|On Treatment|Maximum Clinical Benefit|0
136513|NCT00777036|490387|P1|On Treatment|Maximum Clinical Benefit|2
136514|NCT00777036|490385|P3|On Treatment|Non-compliance with Study Drug|0
136515|NCT00777036|490386|P2|On Treatment|Non-compliance with Study Drug|0
136516|NCT00777036|490387|P1|On Treatment|Non-compliance with Study Drug|1
136517|NCT00777036|490385|P3|On Treatment|Failure to Meet Study Criteria|0
136518|NCT00777036|490386|P2|On Treatment|Failure to Meet Study Criteria|1
136519|NCT00777036|490387|P1|On Treatment|Failure to Meet Study Criteria|0
136520|NCT00777036|490385|P3|On Treatment|Reason Not Specified|12
136521|NCT00777036|490386|P2|On Treatment|Reason Not Specified|7
136522|NCT00777036|490387|P1|On Treatment|Reason Not Specified|4
136523|NCT00777023|490483|P3|Overall Study|Last dose date unknown|1
136524|NCT00777023|490484|P2|Overall Study|Last dose date unknown|3
136525|NCT00777023|490485|P1|Overall Study|Last dose date unknown|3
136526|NCT00777023|490483|P3|Overall Study|Reasons not specified|2
136527|NCT00777023|490484|P2|Overall Study|Reasons not specified|4
136528|NCT00777023|490485|P1|Overall Study|Reasons not specified|4
136529|NCT00777023|490483|P3|Overall Study|Missing data|0
136530|NCT00777023|490484|P2|Overall Study|Missing data|1
136531|NCT00777023|490485|P1|Overall Study|Missing data|1
136532|NCT00777023|490483|P3|Overall Study|Withdrawal by Subject|8
136533|NCT00777023|490484|P2|Overall Study|Withdrawal by Subject|7
136534|NCT00777023|490485|P1|Overall Study|Withdrawal by Subject|7
136535|NCT00777023|490483|P3|Overall Study|Death|0
136536|NCT00777023|490484|P2|Overall Study|Death|1
136537|NCT00777023|490485|P1|Overall Study|Death|0
136538|NCT00777023|490483|P3|Overall Study|Lost to Follow-up|3
136539|NCT00777023|490484|P2|Overall Study|Lost to Follow-up|3
136540|NCT00777023|490485|P1|Overall Study|Lost to Follow-up|2
136541|NCT00777023|490483|P3|Overall Study|Protocol Violation|1
136542|NCT00777023|490484|P2|Overall Study|Protocol Violation|1
136543|NCT00777023|490485|P1|Overall Study|Protocol Violation|2
136544|NCT00777023|490483|P3|Overall Study|Lack of Efficacy|14
136545|NCT00777023|490484|P2|Overall Study|Lack of Efficacy|0
136546|NCT00777023|490485|P1|Overall Study|Lack of Efficacy|1
136547|NCT00777023|490483|P3|Overall Study|Adverse Event|8
136548|NCT00777023|490484|P2|Overall Study|Adverse Event|21
136549|NCT00777023|490485|P1|Overall Study|Adverse Event|15
136550|NCT00776997|490502|P1|Overall Study|Adverse Event|2
136551|NCT00776984|490511|P2|Overall Study|Other|9
136552|NCT00776984|490512|P1|Overall Study|Other|5
136553|NCT00776984|490511|P2|Overall Study|Lack of Efficacy|1
136554|NCT00776984|490512|P1|Overall Study|Lack of Efficacy|0
136555|NCT00776984|490511|P2|Overall Study|Withdrawal by Subject|7
136556|NCT00776984|490512|P1|Overall Study|Withdrawal by Subject|12
136557|NCT00776984|490511|P2|Overall Study|Lost to Follow-up|0
136558|NCT00776984|490512|P1|Overall Study|Lost to Follow-up|2
136559|NCT00776984|490511|P2|Overall Study|Protocol Violation|2
136560|NCT00776984|490512|P1|Overall Study|Protocol Violation|4
136561|NCT00776984|490511|P2|Overall Study|Adverse Event|2
136562|NCT00776984|490512|P1|Overall Study|Adverse Event|8
136563|NCT00776919|490586|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
136564|NCT00776919|490587|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
136565|NCT00776919|490588|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
136566|NCT00776919|490589|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
136567|NCT00776919|490586|P4|Overall Study|Protocol Violation|1
136568|NCT00776919|490587|P3|Overall Study|Protocol Violation|0
136569|NCT00776919|490588|P2|Overall Study|Protocol Violation|2
136570|NCT00776919|490589|P1|Overall Study|Protocol Violation|1
136571|NCT00776919|490586|P4|Overall Study|Adverse Event|2
136572|NCT00776919|490587|P3|Overall Study|Adverse Event|2
136573|NCT00776919|490588|P2|Overall Study|Adverse Event|0
136574|NCT00776919|490589|P1|Overall Study|Adverse Event|1
136575|NCT00776919|490586|P4|Overall Study|Lost to Follow-up|8
136576|NCT00776919|490587|P3|Overall Study|Lost to Follow-up|11
136577|NCT00776919|490588|P2|Overall Study|Lost to Follow-up|12
136578|NCT00776919|490589|P1|Overall Study|Lost to Follow-up|8
136579|NCT00776919|490586|P4|Overall Study|Withdrawal by Subject|26
136580|NCT00776919|490587|P3|Overall Study|Withdrawal by Subject|15
136581|NCT00776919|490588|P2|Overall Study|Withdrawal by Subject|14
136582|NCT00776919|490589|P1|Overall Study|Withdrawal by Subject|16
136583|NCT00776789|490653|P2|Overall Study|Poor quality video|1
136584|NCT00776789|490654|P1|Overall Study|Poor quality video|1
136585|NCT00776789|490653|P2|Overall Study|Consent refusal|2
136586|NCT00776789|490654|P1|Overall Study|Consent refusal|2
136587|NCT00776659|490666|P1|Overall Study|Study Terminated by Sponsor|1
136588|NCT00776659|490666|P1|Overall Study|Withdrawal by Subject|10
136589|NCT00776659|490666|P1|Overall Study|Lost to Follow-up|15
136590|NCT00776555|490693|P2|Overall Study|Study terminated|0
136591|NCT00776555|490694|P1|Overall Study|Study terminated|3
136592|NCT00776230|490712|P3|Overall Study|Subject missed Visit 4|0
136593|NCT00776230|490713|P2|Overall Study|Subject missed Visit 4|1
136594|NCT00776230|490714|P1|Overall Study|Subject missed Visit 4|0
136595|NCT00776230|490712|P3|Overall Study|Withdrawal by Subject|0
136596|NCT00776230|490713|P2|Overall Study|Withdrawal by Subject|1
136597|NCT00776230|490714|P1|Overall Study|Withdrawal by Subject|0
136598|NCT00776230|490712|P3|Overall Study|Not vaccinated at Day 0|0
136599|NCT00776230|490713|P2|Overall Study|Not vaccinated at Day 0|0
136600|NCT00776230|490714|P1|Overall Study|Not vaccinated at Day 0|1
136601|NCT00776230|490712|P3|Overall Study|Lost to Follow-up|5
136602|NCT00776230|490713|P2|Overall Study|Lost to Follow-up|1
136603|NCT00776230|490714|P1|Overall Study|Lost to Follow-up|2
136604|NCT00776100|490724|P2|Overall Study|Disease Progression|0
136605|NCT00776100|490725|P1|Overall Study|Disease Progression|1
136606|NCT00776009|490747|P6|Period 3: Third Intervention|Withdrawal by Subject|0
136607|NCT00776009|490748|P5|Period 3: Third Intervention|Withdrawal by Subject|0
136608|NCT00776009|490749|P4|Period 3: Third Intervention|Withdrawal by Subject|0
136609|NCT00776009|490750|P3|Period 3: Third Intervention|Withdrawal by Subject|0
136610|NCT00776009|490751|P2|Period 3: Third Intervention|Withdrawal by Subject|0
136611|NCT00776009|490752|P1|Period 3: Third Intervention|Withdrawal by Subject|1
136612|NCT00776009|490747|P6|Period 2: Second Intervention|Protocol Violation|0
136613|NCT00776009|490748|P5|Period 2: Second Intervention|Protocol Violation|0
136614|NCT00776009|490749|P4|Period 2: Second Intervention|Protocol Violation|0
136615|NCT00776009|490750|P3|Period 2: Second Intervention|Protocol Violation|1
136616|NCT00776009|490751|P2|Period 2: Second Intervention|Protocol Violation|0
136617|NCT00776009|490752|P1|Period 2: Second Intervention|Protocol Violation|1
136618|NCT00776009|490747|P6|Period 2: Second Intervention|Withdrawal by Subject|1
136619|NCT00776009|490748|P5|Period 2: Second Intervention|Withdrawal by Subject|0
136620|NCT00776009|490749|P4|Period 2: Second Intervention|Withdrawal by Subject|0
136621|NCT00776009|490750|P3|Period 2: Second Intervention|Withdrawal by Subject|0
136622|NCT00776009|490751|P2|Period 2: Second Intervention|Withdrawal by Subject|0
136623|NCT00776009|490752|P1|Period 2: Second Intervention|Withdrawal by Subject|0
136624|NCT00776009|490747|P6|Period 1: First Intervention|Protocol Violation|0
136625|NCT00776009|490748|P5|Period 1: First Intervention|Protocol Violation|1
136626|NCT00776009|490749|P4|Period 1: First Intervention|Protocol Violation|0
136627|NCT00776009|490750|P3|Period 1: First Intervention|Protocol Violation|0
136628|NCT00776009|490751|P2|Period 1: First Intervention|Protocol Violation|1
136629|NCT00776009|490752|P1|Period 1: First Intervention|Protocol Violation|0
136630|NCT00776009|490747|P6|Period 1: First Intervention|Withdrawal by Subject|0
136631|NCT00776009|490748|P5|Period 1: First Intervention|Withdrawal by Subject|1
136632|NCT00776009|490749|P4|Period 1: First Intervention|Withdrawal by Subject|0
136633|NCT00776009|490750|P3|Period 1: First Intervention|Withdrawal by Subject|1
136634|NCT00776009|490751|P2|Period 1: First Intervention|Withdrawal by Subject|0
136635|NCT00776009|490752|P1|Period 1: First Intervention|Withdrawal by Subject|0
136636|NCT00775983|490774|P2|Overall Study|Protocol Violation|2
136637|NCT00775983|490775|P1|Overall Study|Protocol Violation|1
136638|NCT00775606|490886|P2|Overall Study|Study sponsor terminated funding|0
136639|NCT00775606|490887|P1|Overall Study|Study sponsor terminated funding|3
136640|NCT00775593|490897|P1|Overall Study|Death|1
136641|NCT00775593|490897|P1|Overall Study|Unmet eligibility criteria|6
136642|NCT00775528|490904|P1|Overall Study|Protocol Violation|1
136643|NCT00775463|490913|P2|Overall Study|Lack of Efficacy|1
136644|NCT00775463|490914|P1|Overall Study|Lack of Efficacy|1
136645|NCT00775463|490913|P2|Overall Study|Lost to Follow-up|0
136646|NCT00775463|490914|P1|Overall Study|Lost to Follow-up|1
136647|NCT00775463|490913|P2|Overall Study|Protocol Violation|2
136648|NCT00775463|490914|P1|Overall Study|Protocol Violation|2
136649|NCT00775463|490913|P2|Overall Study|Adverse Event|9
136650|NCT00775463|490914|P1|Overall Study|Adverse Event|7
136651|NCT00775463|490913|P2|Overall Study|Withdrawal by Subject|1
136652|NCT00775463|490914|P1|Overall Study|Withdrawal by Subject|0
136653|NCT00775450|490951|P5|Overall Study|Withdrawal by Subject|1
136654|NCT00775450|490952|P4|Overall Study|Withdrawal by Subject|0
136655|NCT00775450|490953|P3|Overall Study|Withdrawal by Subject|0
136656|NCT00775450|490954|P2|Overall Study|Withdrawal by Subject|0
136657|NCT00775450|490955|P1|Overall Study|Withdrawal by Subject|1
136658|NCT00775450|490951|P5|Overall Study|Protocol Violation|1
136659|NCT00775450|490952|P4|Overall Study|Protocol Violation|0
136660|NCT00775450|490953|P3|Overall Study|Protocol Violation|0
136661|NCT00775450|490954|P2|Overall Study|Protocol Violation|0
136662|NCT00775450|490955|P1|Overall Study|Protocol Violation|0
136663|NCT00775450|490951|P5|Overall Study|Serious Adverse Event|0
136664|NCT00775450|490952|P4|Overall Study|Serious Adverse Event|0
136665|NCT00775450|490953|P3|Overall Study|Serious Adverse Event|0
136666|NCT00775450|490954|P2|Overall Study|Serious Adverse Event|0
136667|NCT00775450|490955|P1|Overall Study|Serious Adverse Event|2
136668|NCT00775437|490982|P1|Overall Study|Lost to Follow-up|1
136669|NCT00775437|490982|P1|Overall Study|Withdrawal by Subject|3
136670|NCT00775437|490982|P1|Overall Study|Loss of efficacy|2
136671|NCT00775203|491057|P2|Overall Study|Physician Decision|1
136672|NCT00775203|491058|P1|Overall Study|Physician Decision|0
136673|NCT00775203|491057|P2|Overall Study|Entered other study|0
136674|NCT00775203|491058|P1|Overall Study|Entered other study|1
136675|NCT00775203|491057|P2|Overall Study|Protocol Violation|1
136676|NCT00775203|491058|P1|Overall Study|Protocol Violation|0
136677|NCT00775203|491057|P2|Overall Study|Noncompliance|2
136678|NCT00775203|491058|P1|Overall Study|Noncompliance|4
136679|NCT00775203|491057|P2|Overall Study|Administrative reason|0
136680|NCT00775203|491058|P1|Overall Study|Administrative reason|2
136681|NCT00775203|491057|P2|Overall Study|Lost to Follow-up|15
136682|NCT00775203|491058|P1|Overall Study|Lost to Follow-up|11
136683|NCT00775203|491057|P2|Overall Study|Withdrawal by Subject|9
136684|NCT00775203|491058|P1|Overall Study|Withdrawal by Subject|11
136685|NCT00775203|491057|P2|Overall Study|Lack of Efficacy|9
136686|NCT00775203|491058|P1|Overall Study|Lack of Efficacy|8
136687|NCT00775203|491057|P2|Overall Study|Adverse Event|6
136688|NCT00775203|491058|P1|Overall Study|Adverse Event|25
136689|NCT00775190|491092|P2|Overall Study|Protocol Violation|0
136690|NCT00775190|491093|P1|Overall Study|Protocol Violation|1
136691|NCT00775190|491092|P2|Overall Study|Withdrawal by Subject|2
136692|NCT00775190|491093|P1|Overall Study|Withdrawal by Subject|1
136693|NCT00775190|491092|P2|Overall Study|Lost to Follow-up|3
136694|NCT00775190|491093|P1|Overall Study|Lost to Follow-up|2
136695|NCT00775021|491115|P2|Second Intervention|Adverse Event|1
136696|NCT00775021|491116|P1|Second Intervention|Adverse Event|0
136697|NCT00775021|491115|P2|First Intervention|Lost to Follow-up|0
136698|NCT00775021|491116|P1|First Intervention|Lost to Follow-up|1
136699|NCT00774995|491134|P4|Overall Study|Protocol Violation|0
136700|NCT00774995|491135|P3|Overall Study|Protocol Violation|1
136701|NCT00774995|491136|P2|Overall Study|Protocol Violation|0
136702|NCT00774995|491137|P1|Overall Study|Protocol Violation|0
136703|NCT00774930|491177|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
136704|NCT00774930|491178|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
136705|NCT00774930|491177|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
136706|NCT00774930|491178|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
136707|NCT00774930|491177|P2|LTOLE Phase|Disease Progression|5
136708|NCT00774930|491178|P1|LTOLE Phase|Disease Progression|2
136709|NCT00774930|491177|P2|LTOLE Phase|Sponsor decision|1
136710|NCT00774930|491178|P1|LTOLE Phase|Sponsor decision|2
136711|NCT00774930|491177|P2|LTOLE Phase|Physician Decision|1
136712|NCT00774930|491178|P1|LTOLE Phase|Physician Decision|4
136713|NCT00774930|491177|P2|LTOLE Phase|Subject decision|5
136714|NCT00774930|491178|P1|LTOLE Phase|Subject decision|0
136715|NCT00774930|491177|P2|LTOLE Phase|Adverse Event|3
136716|NCT00774930|491178|P1|LTOLE Phase|Adverse Event|7
136717|NCT00774930|491177|P2|IOL Phase|Brain radiation|1
136718|NCT00774930|491178|P1|IOL Phase|Brain radiation|0
136719|NCT00774930|491177|P2|IOL Phase|Other|0
136720|NCT00774930|491178|P1|IOL Phase|Other|1
136721|NCT00774930|491177|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
136722|NCT00774930|491178|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
136723|NCT00774930|491177|P2|IOL Phase|Subject Consumed Prohibited Medication|0
136724|NCT00774930|491178|P1|IOL Phase|Subject Consumed Prohibited Medication|1
136725|NCT00774930|491177|P2|IOL Phase|Disease Progression|1
136726|NCT00774930|491178|P1|IOL Phase|Disease Progression|2
136727|NCT00774930|491177|P2|IOL Phase|Sponsor Decision|0
136728|NCT00774930|491178|P1|IOL Phase|Sponsor Decision|1
136729|NCT00774930|491177|P2|IOL Phase|Physician Decision|2
136730|NCT00774930|491178|P1|IOL Phase|Physician Decision|3
136731|NCT00774930|491177|P2|IOL Phase|Subject Decision|3
136732|NCT00774930|491178|P1|IOL Phase|Subject Decision|4
136733|NCT00774930|491177|P2|IOL Phase|Adverse Event|1
136734|NCT00774930|491178|P1|IOL Phase|Adverse Event|1
136735|NCT00774930|491177|P2|DB Phase|Started Nonprotocol Radiation therapy|1
136736|NCT00774930|491178|P1|DB Phase|Started Nonprotocol Radiation therapy|0
136737|NCT00774930|491177|P2|DB Phase|Disease Progression|1
136738|NCT00774930|491178|P1|DB Phase|Disease Progression|1
136739|NCT00774930|491177|P2|DB Phase|Sponsor Decision|1
136740|NCT00774930|491178|P1|DB Phase|Sponsor Decision|0
136741|NCT00774930|491177|P2|DB Phase|Subject Decision|5
136742|NCT00774930|491178|P1|DB Phase|Subject Decision|1
136743|NCT00774930|491177|P2|DB Phase|Adverse Event|2
136744|NCT00774930|491178|P1|DB Phase|Adverse Event|1
136745|NCT00774930|491177|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
136746|NCT00774930|491178|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
136747|NCT00774852|491206|P2|Overall Study|Subject received prohibited medication|0
136748|NCT00774852|491207|P1|Overall Study|Subject received prohibited medication|1
136749|NCT00774852|491206|P2|Overall Study|Protocol Violation|0
136750|NCT00774852|491207|P1|Overall Study|Protocol Violation|1
136751|NCT00774852|491206|P2|Overall Study|Subject non-compliance|1
136752|NCT00774852|491207|P1|Overall Study|Subject non-compliance|0
136753|NCT00774852|491206|P2|Overall Study|Non-responder|11
136754|NCT00774852|491207|P1|Overall Study|Non-responder|15
136755|NCT00774852|491206|P2|Overall Study|Withdrawal by Subject|2
136756|NCT00774852|491207|P1|Overall Study|Withdrawal by Subject|2
136757|NCT00774852|491206|P2|Overall Study|Pregnancy|2
136758|NCT00774852|491207|P1|Overall Study|Pregnancy|1
136759|NCT00774852|491206|P2|Overall Study|Physician Decision|6
136760|NCT00774852|491207|P1|Overall Study|Physician Decision|2
136761|NCT00774852|491206|P2|Overall Study|Lost to Follow-up|5
136762|NCT00774852|491207|P1|Overall Study|Lost to Follow-up|9
136763|NCT00774852|491206|P2|Overall Study|Lack of Efficacy|7
136764|NCT00774852|491207|P1|Overall Study|Lack of Efficacy|3
136765|NCT00774852|491206|P2|Overall Study|Death|1
136766|NCT00774852|491207|P1|Overall Study|Death|2
136767|NCT00774852|491206|P2|Overall Study|Adverse Event|6
136768|NCT00774852|491207|P1|Overall Study|Adverse Event|9
136769|NCT00774800|491255|P1|Intervention 4|Withdrawal by Subject|1
136770|NCT00774787|491277|P1|Overall Study|Lost to Follow-up|1
136771|NCT00774748|491284|P1|Overall Study|Lost to Follow-up|3
136772|NCT00774397|491299|P7|Overall Study|Other than those stated above|1
136773|NCT00774397|491300|P6|Overall Study|Other than those stated above|0
136774|NCT00774397|491301|P5|Overall Study|Other than those stated above|2
136775|NCT00774397|491302|P4|Overall Study|Other than those stated above|2
136776|NCT00774397|491303|P3|Overall Study|Other than those stated above|3
136777|NCT00774397|491304|P2|Overall Study|Other than those stated above|1
136778|NCT00774397|491305|P1|Overall Study|Other than those stated above|1
136779|NCT00774397|491299|P7|Overall Study|Not treated|1
136780|NCT00774397|491300|P6|Overall Study|Not treated|0
136781|NCT00774397|491301|P5|Overall Study|Not treated|1
136782|NCT00774397|491302|P4|Overall Study|Not treated|0
136783|NCT00774397|491303|P3|Overall Study|Not treated|0
136784|NCT00774397|491304|P2|Overall Study|Not treated|0
136785|NCT00774397|491305|P1|Overall Study|Not treated|0
136786|NCT00774397|491299|P7|Overall Study|Refused to continue trial medication|3
136787|NCT00774397|491300|P6|Overall Study|Refused to continue trial medication|2
136788|NCT00774397|491301|P5|Overall Study|Refused to continue trial medication|6
136789|NCT00774397|491302|P4|Overall Study|Refused to continue trial medication|2
136790|NCT00774397|491303|P3|Overall Study|Refused to continue trial medication|2
136791|NCT00774397|491304|P2|Overall Study|Refused to continue trial medication|3
136792|NCT00774397|491305|P1|Overall Study|Refused to continue trial medication|1
136793|NCT00774397|491299|P7|Overall Study|Lost to Follow-up|0
136794|NCT00774397|491300|P6|Overall Study|Lost to Follow-up|1
136795|NCT00774397|491301|P5|Overall Study|Lost to Follow-up|0
136796|NCT00774397|491302|P4|Overall Study|Lost to Follow-up|1
136797|NCT00774397|491303|P3|Overall Study|Lost to Follow-up|1
136798|NCT00774397|491304|P2|Overall Study|Lost to Follow-up|1
136799|NCT00774397|491305|P1|Overall Study|Lost to Follow-up|0
136800|NCT00774397|491299|P7|Overall Study|Protocol Violation|0
136801|NCT00774397|491300|P6|Overall Study|Protocol Violation|1
136802|NCT00774397|491301|P5|Overall Study|Protocol Violation|2
136803|NCT00774397|491302|P4|Overall Study|Protocol Violation|1
136804|NCT00774397|491303|P3|Overall Study|Protocol Violation|3
136805|NCT00774397|491304|P2|Overall Study|Protocol Violation|1
136806|NCT00774397|491305|P1|Overall Study|Protocol Violation|0
136807|NCT00774397|491299|P7|Overall Study|Lack of Efficacy|9
136808|NCT00774397|491300|P6|Overall Study|Lack of Efficacy|15
136809|NCT00774397|491301|P5|Overall Study|Lack of Efficacy|27
136810|NCT00774397|491302|P4|Overall Study|Lack of Efficacy|3
136811|NCT00774397|491303|P3|Overall Study|Lack of Efficacy|5
136812|NCT00774397|491304|P2|Overall Study|Lack of Efficacy|4
136813|NCT00774397|491305|P1|Overall Study|Lack of Efficacy|11
136814|NCT00774397|491299|P7|Overall Study|Adverse Event|16
136815|NCT00774397|491300|P6|Overall Study|Adverse Event|3
136816|NCT00774397|491301|P5|Overall Study|Adverse Event|8
136817|NCT00774397|491302|P4|Overall Study|Adverse Event|8
136818|NCT00774397|491303|P3|Overall Study|Adverse Event|16
136819|NCT00774397|491304|P2|Overall Study|Adverse Event|3
136820|NCT00774397|491305|P1|Overall Study|Adverse Event|1
136821|NCT00774306|491541|P4|Overall Study|Death|0
136822|NCT00774306|491542|P3|Overall Study|Death|0
136823|NCT00774306|491543|P2|Overall Study|Death|1
136824|NCT00774306|491544|P1|Overall Study|Death|1
136825|NCT00774306|491541|P4|Overall Study|Lost to Follow-up|5
136826|NCT00774306|491542|P3|Overall Study|Lost to Follow-up|4
136827|NCT00774306|491543|P2|Overall Study|Lost to Follow-up|0
136828|NCT00774306|491544|P1|Overall Study|Lost to Follow-up|6
136829|NCT00774306|491541|P4|Overall Study|Withdrawal by Subject|0
136830|NCT00774306|491542|P3|Overall Study|Withdrawal by Subject|1
136831|NCT00774306|491543|P2|Overall Study|Withdrawal by Subject|1
136832|NCT00774306|491544|P1|Overall Study|Withdrawal by Subject|6
136833|NCT00774306|491541|P4|Overall Study|Protocol Violation|0
136834|NCT00774306|491542|P3|Overall Study|Protocol Violation|3
136835|NCT00774306|491543|P2|Overall Study|Protocol Violation|0
136836|NCT00774306|491544|P1|Overall Study|Protocol Violation|2
136837|NCT00774306|491541|P4|Overall Study|Adverse Event|0
136838|NCT00774306|491542|P3|Overall Study|Adverse Event|0
136839|NCT00774306|491543|P2|Overall Study|Adverse Event|0
136840|NCT00774306|491544|P1|Overall Study|Adverse Event|3
136841|NCT00774046|491612|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
136842|NCT00774046|491612|P1|Enrollment|Desired other therapy/refused|28
136843|NCT00774046|491612|P1|Screening|Not eligible|56
136844|NCT00773968|491622|P1|Overall Study|Other|8
136845|NCT00773968|491622|P1|Overall Study|Screen Failure|17
136846|NCT00773968|491622|P1|Overall Study|Withdrawal by Subject|11
136847|NCT00773968|491622|P1|Overall Study|Protocol Violation|1
136848|NCT00773968|491622|P1|Overall Study|Lack of Efficacy|3
136849|NCT00773968|491622|P1|Overall Study|Failure to Return|2
136850|NCT00773968|491622|P1|Overall Study|Death|1
136851|NCT00773968|491622|P1|Overall Study|Adverse Event|2
136852|NCT00773734|491653|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
136853|NCT00773734|491654|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
136854|NCT00773734|491655|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
136855|NCT00773734|491656|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
136856|NCT00773734|491657|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
136857|NCT00773734|491658|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
136858|NCT00773734|491653|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
136859|NCT00773734|491654|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
136860|NCT00773734|491655|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
136861|NCT00773734|491656|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
136862|NCT00773734|491657|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
136863|NCT00773734|491658|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
136864|NCT00773734|491653|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
136865|NCT00773734|491654|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
136866|NCT00773734|491655|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
136867|NCT00773734|491656|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
136868|NCT00773734|491657|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
136869|NCT00773734|491658|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
136870|NCT00773734|491653|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
136871|NCT00773734|491654|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
136872|NCT00773734|491655|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
136873|NCT00773734|491656|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
136874|NCT00773734|491657|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
136875|NCT00773734|491658|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
136876|NCT00773734|491653|P6|Extension: Active Treatment Week 24-52|Other|1
136877|NCT00773734|491654|P5|Extension: Active Treatment Week 24-52|Other|0
136878|NCT00773734|491655|P4|Extension: Active Treatment Week 24-52|Other|2
136879|NCT00773734|491656|P3|Extension: Active Treatment Week 24-52|Other|1
136880|NCT00773734|491657|P2|Extension: Active Treatment Week 24-52|Other|0
136881|NCT00773734|491658|P1|Extension: Active Treatment Week 24-52|Other|0
136882|NCT00773734|491653|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
136883|NCT00773734|491654|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
136884|NCT00773734|491655|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
136885|NCT00773734|491656|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
136886|NCT00773734|491657|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
136887|NCT00773734|491658|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
136888|NCT00773734|491653|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
136889|NCT00773734|491654|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
136890|NCT00773734|491655|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
136891|NCT00773734|491656|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
136892|NCT00773734|491657|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
136893|NCT00773734|491658|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
136894|NCT00773734|491653|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
136895|NCT00773734|491654|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
136896|NCT00773734|491655|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
136897|NCT00773734|491656|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
136898|NCT00773734|491657|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
136899|NCT00773734|491658|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
136900|NCT00773734|491653|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
136901|NCT00773734|491654|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
136902|NCT00773734|491655|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
136903|NCT00773734|491656|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
136904|NCT00773734|491657|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
136905|NCT00773734|491658|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
136906|NCT00773734|491653|P6|Core: Active Treatment Phase Week 16-24|Other|0
136907|NCT00773734|491654|P5|Core: Active Treatment Phase Week 16-24|Other|0
136908|NCT00773734|491655|P4|Core: Active Treatment Phase Week 16-24|Other|0
136909|NCT00773734|491656|P3|Core: Active Treatment Phase Week 16-24|Other|0
136910|NCT00773734|491657|P2|Core: Active Treatment Phase Week 16-24|Other|1
136911|NCT00773734|491658|P1|Core: Active Treatment Phase Week 16-24|Other|0
136912|NCT00773734|491653|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
136913|NCT00773734|491654|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
136914|NCT00773734|491655|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
136915|NCT00773734|491656|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
136916|NCT00773734|491657|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
136917|NCT00773734|491658|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
136918|NCT00773734|491653|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
136919|NCT00773734|491654|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
136920|NCT00773734|491655|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
136921|NCT00773734|491656|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
136922|NCT00773734|491657|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
136923|NCT00773734|491658|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
136924|NCT00773734|491653|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
136925|NCT00773734|491654|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
136926|NCT00773734|491655|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
136927|NCT00773734|491656|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
136928|NCT00773734|491657|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
136929|NCT00773734|491658|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
136930|NCT00773734|491653|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
136931|NCT00773734|491654|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
136932|NCT00773734|491655|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
136933|NCT00773734|491656|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
136934|NCT00773734|491657|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
136935|NCT00773734|491658|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
136936|NCT00773734|491653|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
136937|NCT00773734|491654|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
136938|NCT00773734|491655|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
136939|NCT00773734|491656|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
136940|NCT00773734|491657|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
136941|NCT00773734|491658|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
136942|NCT00773734|491653|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
136943|NCT00773734|491654|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
136944|NCT00773734|491655|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
136945|NCT00773734|491656|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
136946|NCT00773734|491657|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
136947|NCT00773734|491658|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
136948|NCT00773734|491653|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
136949|NCT00773734|491654|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
136950|NCT00773734|491655|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
136951|NCT00773734|491656|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
136952|NCT00773734|491657|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
136953|NCT00773734|491658|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
136954|NCT00773734|491653|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
136955|NCT00773734|491654|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
136956|NCT00773734|491655|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
136957|NCT00773734|491656|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
136958|NCT00773734|491657|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
136959|NCT00773734|491658|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
136960|NCT00773734|491653|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
136961|NCT00773734|491654|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
136962|NCT00773734|491655|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
136963|NCT00773734|491656|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
136964|NCT00773734|491657|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
136965|NCT00773734|491658|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
136966|NCT00773734|491653|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
136967|NCT00773734|491654|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
136968|NCT00773734|491655|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
136969|NCT00773734|491656|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
136970|NCT00773734|491657|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
136971|NCT00773734|491658|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
136972|NCT00773734|491653|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
136973|NCT00773734|491654|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
136974|NCT00773734|491655|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
136975|NCT00773734|491656|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
136976|NCT00773734|491657|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
136977|NCT00773734|491658|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
136978|NCT00773734|491653|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
136979|NCT00773734|491654|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
136980|NCT00773734|491655|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
136981|NCT00773734|491656|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
136982|NCT00773734|491657|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
136983|NCT00773734|491658|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
136984|NCT00773461|492229|P2|Overall Study|Withdrawal by Subject|1
136985|NCT00773461|492230|P1|Overall Study|Withdrawal by Subject|4
136986|NCT00773461|492229|P2|Overall Study|Adverse Event|3
136987|NCT00773461|492230|P1|Overall Study|Adverse Event|1
136988|NCT00773383|492284|P1|Overall Study|No study dose received|1
136989|NCT00773383|492284|P1|Overall Study|not specified|2
136990|NCT00773383|492284|P1|Overall Study|Progression of Disease|23
136991|NCT00773383|492284|P1|Overall Study|Death|1
136992|NCT00773383|492284|P1|Overall Study|Adverse Event|4
136993|NCT00773279|492319|P2|Period 2|Unclassified|2
136994|NCT00773279|492320|P1|Period 2|Unclassified|2
136995|NCT00773279|492319|P2|Period 2|Protocol Violation|3
136996|NCT00773279|492320|P1|Period 2|Protocol Violation|0
136997|NCT00773279|492319|P2|Period 2|Lack of Efficacy|0
136998|NCT00773279|492320|P1|Period 2|Lack of Efficacy|1
136999|NCT00773279|492319|P2|Period 2|Adverse Event|1
137000|NCT00773279|492320|P1|Period 2|Adverse Event|0
137001|NCT00773279|492319|P2|Period 1|Unclassified|1
137002|NCT00773279|492320|P1|Period 1|Unclassified|5
137003|NCT00773279|492319|P2|Period 1|Lack of Efficacy|2
137004|NCT00773279|492320|P1|Period 1|Lack of Efficacy|0
137005|NCT00773279|492319|P2|Period 1|Adverse Event|1
137006|NCT00773279|492320|P1|Period 1|Adverse Event|2
137007|NCT00773253|492341|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
137008|NCT00773253|492342|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
137009|NCT00773136|492348|P1|Overall Study|Physician Decision|2
137010|NCT00773097|492353|P1|Overall Study|Physician Decision|6
137011|NCT00773097|492353|P1|Overall Study|Withdrawal by Subject|1
137012|NCT00772967|492359|P6|Crossover Treatment 3|Adverse Event|0
137013|NCT00772967|492360|P5|Crossover Treatment 3|Adverse Event|1
137014|NCT00772967|492361|P4|Crossover Treatment 3|Adverse Event|0
137015|NCT00772967|492362|P3|Crossover Treatment 3|Adverse Event|0
137016|NCT00772967|492363|P2|Crossover Treatment 3|Adverse Event|0
137017|NCT00772967|492364|P1|Crossover Treatment 3|Adverse Event|0
137018|NCT00772967|492359|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
137019|NCT00772967|492360|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
137020|NCT00772967|492361|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
137021|NCT00772967|492362|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
137022|NCT00772967|492363|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
137023|NCT00772967|492364|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
137024|NCT00772967|492359|P6|Crossover Treatment 1|Adverse Event (Pain)|0
137025|NCT00772967|492360|P5|Crossover Treatment 1|Adverse Event (Pain)|0
137026|NCT00772967|492361|P4|Crossover Treatment 1|Adverse Event (Pain)|1
137027|NCT00772967|492362|P3|Crossover Treatment 1|Adverse Event (Pain)|0
137028|NCT00772967|492363|P2|Crossover Treatment 1|Adverse Event (Pain)|0
137029|NCT00772967|492364|P1|Crossover Treatment 1|Adverse Event (Pain)|0
137030|NCT00772954|492384|P3|Overall Study|Adverse Event|1
137031|NCT00772954|492385|P2|Overall Study|Adverse Event|0
137032|NCT00772954|492386|P1|Overall Study|Adverse Event|0
137033|NCT00772941|492394|P1|Overall Study|GPSP Violation|90
137034|NCT00772941|492394|P1|Overall Study|Poor Compliance|7
137035|NCT00772941|492394|P1|Overall Study|Missed Visits|374
137036|NCT00772941|492394|P1|Overall Study|Study not completed|16
137037|NCT00772941|492394|P1|Overall Study|CRFs not available|195
137038|NCT00772928|492425|P2|Overall Study|Did not receive vaccine|1
137039|NCT00772928|492426|P1|Overall Study|Did not receive vaccine|0
137040|NCT00772928|492425|P2|Overall Study|Withdrawal by Subject|22
137041|NCT00772928|492426|P1|Overall Study|Withdrawal by Subject|25
137042|NCT00772928|492425|P2|Overall Study|Protocol Violation|12
137043|NCT00772928|492426|P1|Overall Study|Protocol Violation|10
137044|NCT00772928|492425|P2|Overall Study|Lost to Follow-up|6
137045|NCT00772928|492426|P1|Overall Study|Lost to Follow-up|9
137046|NCT00772889|492443|P3|Overall Study|Lost to Follow-up|7
137047|NCT00772889|492444|P2|Overall Study|Lost to Follow-up|6
137048|NCT00772889|492445|P1|Overall Study|Lost to Follow-up|6
137049|NCT00772889|492443|P3|Overall Study|Withdrawal by Subject|9
137050|NCT00772889|492444|P2|Overall Study|Withdrawal by Subject|8
137051|NCT00772889|492445|P1|Overall Study|Withdrawal by Subject|9
137052|NCT00772889|492443|P3|Overall Study|Adverse Event|0
137053|NCT00772889|492444|P2|Overall Study|Adverse Event|4
137054|NCT00772889|492445|P1|Overall Study|Adverse Event|7
137055|NCT00772707|492503|P1|Overall Study|Withdrawn|3
137056|NCT00772668|492508|P1|Overall Study|Physician Decision|3
137057|NCT00772629|492517|P2|Overall Study|Subject was not vaccinated|0
137058|NCT00772629|492518|P1|Overall Study|Subject was not vaccinated|1
137059|NCT00772603|492527|P3|Overall Study|Other|2
137060|NCT00772603|492528|P2|Overall Study|Other|0
137061|NCT00772603|492529|P1|Overall Study|Other|2
137062|NCT00772603|492527|P3|Overall Study|Physician Decision|1
137063|NCT00772603|492528|P2|Overall Study|Physician Decision|0
137064|NCT00772603|492529|P1|Overall Study|Physician Decision|0
137065|NCT00772603|492527|P3|Overall Study|Lost to Follow-up|2
137066|NCT00772603|492528|P2|Overall Study|Lost to Follow-up|5
137067|NCT00772603|492529|P1|Overall Study|Lost to Follow-up|1
137068|NCT00772603|492527|P3|Overall Study|Protocol Violation|1
137069|NCT00772603|492528|P2|Overall Study|Protocol Violation|1
137070|NCT00772603|492529|P1|Overall Study|Protocol Violation|0
137071|NCT00772603|492527|P3|Overall Study|Subject Non-compliance|4
137072|NCT00772603|492528|P2|Overall Study|Subject Non-compliance|6
137073|NCT00772603|492529|P1|Overall Study|Subject Non-compliance|1
137074|NCT00772603|492527|P3|Overall Study|Adverse Event|10
137075|NCT00772603|492528|P2|Overall Study|Adverse Event|18
137076|NCT00772603|492529|P1|Overall Study|Adverse Event|37
137077|NCT00772603|492527|P3|Overall Study|Withdrawal by Subject|6
137078|NCT00772603|492528|P2|Overall Study|Withdrawal by Subject|10
137079|NCT00772603|492529|P1|Overall Study|Withdrawal by Subject|11
137080|NCT00772577|492568|P2|Overall Study|Protocol Deviation|2
137081|NCT00772577|492569|P1|Overall Study|Protocol Deviation|3
137082|NCT00772577|492568|P2|Overall Study|Administrative problems|1
137083|NCT00772577|492569|P1|Overall Study|Administrative problems|2
137084|NCT00772577|492568|P2|Overall Study|Lost to Follow-up|3
137085|NCT00772577|492569|P1|Overall Study|Lost to Follow-up|4
137086|NCT00772577|492568|P2|Overall Study|Patient withdrew consent|5
137087|NCT00772577|492569|P1|Overall Study|Patient withdrew consent|8
137088|NCT00772577|492568|P2|Overall Study|Unsatisfactory therapeutic effect|8
137089|NCT00772577|492569|P1|Overall Study|Unsatisfactory therapeutic effect|0
137090|NCT00772577|492568|P2|Overall Study|Abnormal laboratory values|1
137091|NCT00772577|492569|P1|Overall Study|Abnormal laboratory values|0
137092|NCT00772577|492568|P2|Overall Study|Adverse Event|3
137093|NCT00772577|492569|P1|Overall Study|Adverse Event|6
137094|NCT00772538|492585|P2|Overall Study|Other|7
137095|NCT00772538|492586|P1|Overall Study|Other|7
137096|NCT00772538|492585|P2|Overall Study|Lack of Efficacy|1
137097|NCT00772538|492586|P1|Overall Study|Lack of Efficacy|0
137098|NCT00772538|492585|P2|Overall Study|Withdrawal by Subject|8
137099|NCT00772538|492586|P1|Overall Study|Withdrawal by Subject|3
137100|NCT00772538|492585|P2|Overall Study|Lost to Follow-up|1
137101|NCT00772538|492586|P1|Overall Study|Lost to Follow-up|1
137102|NCT00772538|492585|P2|Overall Study|Protocol Violation|3
137103|NCT00772538|492586|P1|Overall Study|Protocol Violation|3
137104|NCT00772538|492585|P2|Overall Study|Adverse Event|6
137105|NCT00772538|492586|P1|Overall Study|Adverse Event|6
137106|NCT00772447|492658|P2|Overall Study|all others|2
137107|NCT00772447|492659|P1|Overall Study|all others|2
137108|NCT00772447|492658|P2|Overall Study|Protocol Violation|1
137109|NCT00772447|492659|P1|Overall Study|Protocol Violation|0
137110|NCT00772447|492658|P2|Overall Study|incorrect enrolment|4
137111|NCT00772447|492659|P1|Overall Study|incorrect enrolment|3
137112|NCT00772447|492658|P2|Overall Study|Lost to Follow-up|4
137113|NCT00772447|492659|P1|Overall Study|Lost to Follow-up|2
137114|NCT00772447|492658|P2|Overall Study|Physician Decision|8
137115|NCT00772447|492659|P1|Overall Study|Physician Decision|4
137116|NCT00772447|492658|P2|Overall Study|Withdrawal by Subject|5
137117|NCT00772447|492659|P1|Overall Study|Withdrawal by Subject|9
137118|NCT00772382|492687|P1|Overall Study|Other Reasons|10
137119|NCT00772382|492687|P1|Overall Study|Withdrawal by Subject|10
137120|NCT00772382|492687|P1|Overall Study|Protocol Violation|1
137121|NCT00772382|492687|P1|Overall Study|Physician Decision|5
137122|NCT00772382|492687|P1|Overall Study|Lack of Efficacy|4
137123|NCT00772382|492687|P1|Overall Study|Death|6
137124|NCT00772382|492687|P1|Overall Study|Adverse Event|19
137125|NCT00772369|492692|P1|Overall Study|Did not return record release form|1
137126|NCT00772148|492703|P2|Maintenance Phase (Week 52)|Administrative/other|2
137127|NCT00772148|492704|P1|Maintenance Phase (Week 52)|Administrative/other|1
137128|NCT00772148|492703|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
137129|NCT00772148|492704|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
137130|NCT00772148|492703|P2|Maintenance Phase (Week 52)|Adverse Event|0
137131|NCT00772148|492704|P1|Maintenance Phase (Week 52)|Adverse Event|1
137132|NCT00772148|492703|P2|Maintenance Phase (Week 52)|Death|2
137133|NCT00772148|492704|P1|Maintenance Phase (Week 52)|Death|2
137134|NCT00772148|492703|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
137135|NCT00772148|492704|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
137136|NCT00772148|492703|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
137137|NCT00772148|492704|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
137138|NCT00772148|492703|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
137139|NCT00772148|492704|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
137140|NCT00772109|492724|P4|Overall Study|Withdrawal by Subject|16
137141|NCT00772109|492725|P3|Overall Study|Withdrawal by Subject|6
137142|NCT00772109|492726|P2|Overall Study|Withdrawal by Subject|8
137143|NCT00772109|492727|P1|Overall Study|Withdrawal by Subject|8
137144|NCT00772109|492724|P4|Overall Study|Lost to Follow-up|9
137145|NCT00772109|492725|P3|Overall Study|Lost to Follow-up|5
137146|NCT00772109|492726|P2|Overall Study|Lost to Follow-up|3
137147|NCT00772109|492727|P1|Overall Study|Lost to Follow-up|7
137148|NCT00772109|492724|P4|Overall Study|Protocol Violation|6
137149|NCT00772109|492725|P3|Overall Study|Protocol Violation|7
137150|NCT00772109|492726|P2|Overall Study|Protocol Violation|8
137151|NCT00772109|492727|P1|Overall Study|Protocol Violation|5
137152|NCT00772109|492724|P4|Overall Study|Serious adverse event|0
137153|NCT00772109|492725|P3|Overall Study|Serious adverse event|1
137154|NCT00772109|492726|P2|Overall Study|Serious adverse event|0
137155|NCT00772109|492727|P1|Overall Study|Serious adverse event|1
137156|NCT00772070|492751|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
137157|NCT00772070|492752|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
137158|NCT00772070|492751|P2|Overall Study|Withdrawal by Subject|2
137159|NCT00772070|492752|P1|Overall Study|Withdrawal by Subject|0
137160|NCT00772070|492751|P2|Overall Study|Lost to Follow-up|8
137161|NCT00772070|492752|P1|Overall Study|Lost to Follow-up|0
137162|NCT00772031|492764|P2|Overall Study|Lost to Follow-up|33
137163|NCT00772031|492765|P1|Overall Study|Lost to Follow-up|20
137164|NCT00772031|492764|P2|Overall Study|Early termination of trial|10
137165|NCT00772031|492765|P1|Overall Study|Early termination of trial|12
137166|NCT00772005|492791|P4|Overall Study|Non-compliance with drug administration|1
137167|NCT00772005|492792|P3|Overall Study|Non-compliance with drug administration|1
137168|NCT00772005|492793|P2|Overall Study|Non-compliance with drug administration|0
137169|NCT00772005|492794|P1|Overall Study|Non-compliance with drug administration|3
137170|NCT00772005|492791|P4|Overall Study|Non-compliance with study procedures|1
137171|NCT00772005|492792|P3|Overall Study|Non-compliance with study procedures|0
137172|NCT00772005|492793|P2|Overall Study|Non-compliance with study procedures|1
137173|NCT00772005|492794|P1|Overall Study|Non-compliance with study procedures|1
137174|NCT00772005|492791|P4|Overall Study|Lost to Follow-up|3
137175|NCT00772005|492792|P3|Overall Study|Lost to Follow-up|6
137176|NCT00772005|492793|P2|Overall Study|Lost to Follow-up|3
137177|NCT00772005|492794|P1|Overall Study|Lost to Follow-up|7
137178|NCT00772005|492791|P4|Overall Study|Protocol Violation|6
137179|NCT00772005|492792|P3|Overall Study|Protocol Violation|1
137180|NCT00772005|492793|P2|Overall Study|Protocol Violation|4
137181|NCT00772005|492794|P1|Overall Study|Protocol Violation|2
137182|NCT00772005|492791|P4|Overall Study|Withdrawal by Subject|2
137183|NCT00772005|492792|P3|Overall Study|Withdrawal by Subject|10
137184|NCT00772005|492793|P2|Overall Study|Withdrawal by Subject|7
137185|NCT00772005|492794|P1|Overall Study|Withdrawal by Subject|3
137186|NCT00772005|492791|P4|Overall Study|Lack of Efficacy|0
137187|NCT00772005|492792|P3|Overall Study|Lack of Efficacy|0
137188|NCT00772005|492793|P2|Overall Study|Lack of Efficacy|1
137189|NCT00772005|492794|P1|Overall Study|Lack of Efficacy|0
137190|NCT00772005|492791|P4|Overall Study|Adverse Event|13
137191|NCT00772005|492792|P3|Overall Study|Adverse Event|10
137192|NCT00772005|492793|P2|Overall Study|Adverse Event|14
137193|NCT00772005|492794|P1|Overall Study|Adverse Event|9
137194|NCT00771953|493482|P2|Overall Study|Withdrawal by Subject|3
137195|NCT00771953|493483|P1|Overall Study|Withdrawal by Subject|0
137196|NCT00771953|493482|P2|Overall Study|Other complicating disease|0
137197|NCT00771953|493483|P1|Overall Study|Other complicating disease|1
137198|NCT00771953|493482|P2|Overall Study|Sponsor decision|0
137199|NCT00771953|493483|P1|Overall Study|Sponsor decision|1
137200|NCT00771953|493482|P2|Overall Study|Progression before active Tx|2
137201|NCT00771953|493483|P1|Overall Study|Progression before active Tx|1
137202|NCT00771953|493482|P2|Overall Study|Death|2
137203|NCT00771953|493483|P1|Overall Study|Death|2
137204|NCT00771953|493482|P2|Overall Study|Adverse Event|3
137205|NCT00771953|493483|P1|Overall Study|Adverse Event|5
137206|NCT00771927|493493|P2|Overall Study|Other reason|27
137207|NCT00771927|493494|P1|Overall Study|Other reason|23
137208|NCT00771927|493493|P2|Overall Study|Withdrawal by Subject|17
137209|NCT00771927|493494|P1|Overall Study|Withdrawal by Subject|16
137210|NCT00771927|493493|P2|Overall Study|Lost to Follow-up|46
137211|NCT00771927|493494|P1|Overall Study|Lost to Follow-up|46
137212|NCT00771927|493493|P2|Overall Study|Lack of Efficacy|42
137213|NCT00771927|493494|P1|Overall Study|Lack of Efficacy|70
137214|NCT00771927|493493|P2|Overall Study|Adverse Event|105
137215|NCT00771927|493494|P1|Overall Study|Adverse Event|100
137216|NCT00771914|493506|P4|Overall Study|Lost to Follow-up|1
137217|NCT00771914|493507|P3|Overall Study|Lost to Follow-up|0
137218|NCT00771914|493508|P2|Overall Study|Lost to Follow-up|0
137219|NCT00771914|493509|P1|Overall Study|Lost to Follow-up|0
137220|NCT00771914|493506|P4|Overall Study|Physician Decision|1
137221|NCT00771914|493507|P3|Overall Study|Physician Decision|0
137222|NCT00771914|493508|P2|Overall Study|Physician Decision|0
137223|NCT00771914|493509|P1|Overall Study|Physician Decision|0
137224|NCT00771901|493522|P3|Overall Study|Dissat w/# of study medication (40/day)|4
137225|NCT00771901|493523|P2|Overall Study|Dissat w/# of study medication (40/day)|0
137226|NCT00771901|493524|P1|Overall Study|Dissat w/# of study medication (40/day)|0
137227|NCT00771849|493571|P2|Overall Study|Not vaccinated|1
137228|NCT00771849|493572|P1|Overall Study|Not vaccinated|0
137229|NCT00771849|493571|P2|Overall Study|Withdrawal by Subject|1
137230|NCT00771849|493572|P1|Overall Study|Withdrawal by Subject|1
137231|NCT00771849|493571|P2|Overall Study|Lost to Follow-up|2
137232|NCT00771849|493572|P1|Overall Study|Lost to Follow-up|1
137233|NCT00771810|493583|P3|Overall Study|Other|1
137234|NCT00771810|493584|P2|Overall Study|Other|0
137235|NCT00771810|493585|P1|Overall Study|Other|0
137236|NCT00771810|493583|P3|Overall Study|Withdrawal by Subject|0
137237|NCT00771810|493584|P2|Overall Study|Withdrawal by Subject|2
137238|NCT00771810|493585|P1|Overall Study|Withdrawal by Subject|1
137239|NCT00771810|493583|P3|Overall Study|Protocol Violation|1
137240|NCT00771810|493584|P2|Overall Study|Protocol Violation|1
137241|NCT00771810|493585|P1|Overall Study|Protocol Violation|0
137242|NCT00771810|493583|P3|Overall Study|Physician Decision|2
137243|NCT00771810|493584|P2|Overall Study|Physician Decision|2
137244|NCT00771810|493585|P1|Overall Study|Physician Decision|1
137245|NCT00771810|493583|P3|Overall Study|Lost to Follow-up|1
137246|NCT00771810|493584|P2|Overall Study|Lost to Follow-up|0
137247|NCT00771810|493585|P1|Overall Study|Lost to Follow-up|0
137248|NCT00771810|493583|P3|Overall Study|Adverse Event|2
137249|NCT00771810|493584|P2|Overall Study|Adverse Event|0
137250|NCT00771810|493585|P1|Overall Study|Adverse Event|3
137251|NCT00771758|493623|P3|Overall Study|Other|0
137252|NCT00771758|493624|P2|Overall Study|Other|2
137253|NCT00771758|493625|P1|Overall Study|Other|3
137254|NCT00771758|493623|P3|Overall Study|Withdrawal by Subject|0
137255|NCT00771758|493624|P2|Overall Study|Withdrawal by Subject|0
137256|NCT00771758|493625|P1|Overall Study|Withdrawal by Subject|1
137257|NCT00771758|493623|P3|Overall Study|Protocol Violation|0
137258|NCT00771758|493624|P2|Overall Study|Protocol Violation|0
137259|NCT00771758|493625|P1|Overall Study|Protocol Violation|1
137260|NCT00771758|493623|P3|Overall Study|Lost to Follow-up|0
137261|NCT00771758|493624|P2|Overall Study|Lost to Follow-up|0
137262|NCT00771758|493625|P1|Overall Study|Lost to Follow-up|1
137263|NCT00771758|493623|P3|Overall Study|Lack of Efficacy|1
137264|NCT00771758|493624|P2|Overall Study|Lack of Efficacy|2
137265|NCT00771758|493625|P1|Overall Study|Lack of Efficacy|0
137266|NCT00771758|493623|P3|Overall Study|Adverse Event|1
137267|NCT00771758|493624|P2|Overall Study|Adverse Event|8
137268|NCT00771758|493625|P1|Overall Study|Adverse Event|2
137269|NCT00771667|493786|P10|Maintenance Phase|Other|3
137270|NCT00771667|493787|P9|Maintenance Phase|Other|3
137271|NCT00771667|493788|P8|Maintenance Phase|Other|2
137272|NCT00771667|493789|P7|Maintenance Phase|Other|2
137273|NCT00771667|493790|P6|Maintenance Phase|Other|1
137274|NCT00771667|493791|P5|Maintenance Phase|Other|0
137275|NCT00771667|493792|P4|Maintenance Phase|Other|0
137276|NCT00771667|493793|P3|Maintenance Phase|Other|0
137277|NCT00771667|493794|P2|Maintenance Phase|Other|0
137278|NCT00771667|493795|P1|Maintenance Phase|Other|0
137279|NCT00771667|493786|P10|Maintenance Phase|Lack of Efficacy|7
137280|NCT00771667|493787|P9|Maintenance Phase|Lack of Efficacy|11
137281|NCT00771667|493788|P8|Maintenance Phase|Lack of Efficacy|2
137282|NCT00771667|493789|P7|Maintenance Phase|Lack of Efficacy|3
137283|NCT00771667|493790|P6|Maintenance Phase|Lack of Efficacy|3
137284|NCT00771667|493791|P5|Maintenance Phase|Lack of Efficacy|1
137285|NCT00771667|493792|P4|Maintenance Phase|Lack of Efficacy|0
137286|NCT00771667|493793|P3|Maintenance Phase|Lack of Efficacy|0
137287|NCT00771667|493794|P2|Maintenance Phase|Lack of Efficacy|0
137288|NCT00771667|493795|P1|Maintenance Phase|Lack of Efficacy|0
137289|NCT00771667|493786|P10|Maintenance Phase|Adverse Event|7
137290|NCT00771667|493787|P9|Maintenance Phase|Adverse Event|8
137291|NCT00771667|493788|P8|Maintenance Phase|Adverse Event|1
137292|NCT00771667|493789|P7|Maintenance Phase|Adverse Event|5
137293|NCT00771667|493790|P6|Maintenance Phase|Adverse Event|3
137294|NCT00771667|493791|P5|Maintenance Phase|Adverse Event|1
137295|NCT00771667|493792|P4|Maintenance Phase|Adverse Event|0
137296|NCT00771667|493793|P3|Maintenance Phase|Adverse Event|0
137297|NCT00771667|493794|P2|Maintenance Phase|Adverse Event|0
137298|NCT00771667|493795|P1|Maintenance Phase|Adverse Event|0
137299|NCT00771667|493786|P10|Induction Phase|Other|0
137300|NCT00771667|493787|P9|Induction Phase|Other|0
137301|NCT00771667|493788|P8|Induction Phase|Other|0
137302|NCT00771667|493789|P7|Induction Phase|Other|0
137303|NCT00771667|493790|P6|Induction Phase|Other|0
137304|NCT00771667|493791|P5|Induction Phase|Other|0
137305|NCT00771667|493792|P4|Induction Phase|Other|4
137306|NCT00771667|493793|P3|Induction Phase|Other|3
137307|NCT00771667|493794|P2|Induction Phase|Other|6
137308|NCT00771667|493795|P1|Induction Phase|Other|4
137309|NCT00771667|493786|P10|Induction Phase|Lost to Follow-up|0
137310|NCT00771667|493787|P9|Induction Phase|Lost to Follow-up|0
137311|NCT00771667|493788|P8|Induction Phase|Lost to Follow-up|0
137312|NCT00771667|493789|P7|Induction Phase|Lost to Follow-up|0
137313|NCT00771667|493790|P6|Induction Phase|Lost to Follow-up|0
137314|NCT00771667|493791|P5|Induction Phase|Lost to Follow-up|0
137315|NCT00771667|493792|P4|Induction Phase|Lost to Follow-up|0
137316|NCT00771667|493793|P3|Induction Phase|Lost to Follow-up|1
137317|NCT00771667|493794|P2|Induction Phase|Lost to Follow-up|0
137318|NCT00771667|493795|P1|Induction Phase|Lost to Follow-up|1
137319|NCT00771667|493786|P10|Induction Phase|Lack of Efficacy|0
137320|NCT00771667|493787|P9|Induction Phase|Lack of Efficacy|0
137321|NCT00771667|493788|P8|Induction Phase|Lack of Efficacy|0
137322|NCT00771667|493789|P7|Induction Phase|Lack of Efficacy|0
137323|NCT00771667|493790|P6|Induction Phase|Lack of Efficacy|0
137324|NCT00771667|493791|P5|Induction Phase|Lack of Efficacy|0
137325|NCT00771667|493792|P4|Induction Phase|Lack of Efficacy|3
137326|NCT00771667|493793|P3|Induction Phase|Lack of Efficacy|4
137327|NCT00771667|493794|P2|Induction Phase|Lack of Efficacy|2
137328|NCT00771667|493795|P1|Induction Phase|Lack of Efficacy|9
137329|NCT00771667|493786|P10|Induction Phase|Adverse Event|0
137330|NCT00771667|493787|P9|Induction Phase|Adverse Event|0
137331|NCT00771667|493788|P8|Induction Phase|Adverse Event|0
137332|NCT00771667|493789|P7|Induction Phase|Adverse Event|0
137333|NCT00771667|493790|P6|Induction Phase|Adverse Event|0
137334|NCT00771667|493791|P5|Induction Phase|Adverse Event|0
137335|NCT00771667|493792|P4|Induction Phase|Adverse Event|1
137336|NCT00771667|493793|P3|Induction Phase|Adverse Event|4
137337|NCT00771667|493794|P2|Induction Phase|Adverse Event|2
137338|NCT00771667|493795|P1|Induction Phase|Adverse Event|5
137339|NCT00771615|493840|P9|Overall Study|Lost to Follow-up|0
137340|NCT00771615|493841|P8|Overall Study|Lost to Follow-up|0
137341|NCT00771615|493842|P7|Overall Study|Lost to Follow-up|1
137342|NCT00771615|493843|P6|Overall Study|Lost to Follow-up|1
137343|NCT00771615|493844|P5|Overall Study|Lost to Follow-up|0
137344|NCT00771615|493845|P4|Overall Study|Lost to Follow-up|1
137345|NCT00771615|493846|P3|Overall Study|Lost to Follow-up|1
137346|NCT00771615|493847|P2|Overall Study|Lost to Follow-up|1
137347|NCT00771615|493848|P1|Overall Study|Lost to Follow-up|1
137348|NCT00771615|493840|P9|Overall Study|Withdrawal by Subject|0
137349|NCT00771615|493841|P8|Overall Study|Withdrawal by Subject|1
137350|NCT00771615|493842|P7|Overall Study|Withdrawal by Subject|0
137351|NCT00771615|493843|P6|Overall Study|Withdrawal by Subject|0
137352|NCT00771615|493844|P5|Overall Study|Withdrawal by Subject|0
137353|NCT00771615|493845|P4|Overall Study|Withdrawal by Subject|0
137354|NCT00771615|493846|P3|Overall Study|Withdrawal by Subject|0
137355|NCT00771615|493847|P2|Overall Study|Withdrawal by Subject|1
137356|NCT00771615|493848|P1|Overall Study|Withdrawal by Subject|0
137357|NCT00771472|494109|P2|Overall Study|Protocol Violation|0
137358|NCT00771472|494110|P1|Overall Study|Protocol Violation|1
137359|NCT00771472|494109|P2|Overall Study|Progressive Disease|1
137360|NCT00771472|494110|P1|Overall Study|Progressive Disease|3
137361|NCT00771472|494109|P2|Overall Study|Physician Decision|3
137362|NCT00771472|494110|P1|Overall Study|Physician Decision|2
137363|NCT00771316|494130|P2|Overall Study|Discontinued due to early termination|0
137364|NCT00771316|494131|P1|Overall Study|Discontinued due to early termination|1
137365|NCT00771316|494130|P2|Overall Study|Patient withdrew consent|0
137366|NCT00771316|494131|P1|Overall Study|Patient withdrew consent|1
137367|NCT00771316|494130|P2|Overall Study|Adverse Event|1
137368|NCT00771316|494131|P1|Overall Study|Adverse Event|0
137369|NCT00770991|494183|P2|Overall Study|Pregnancy|0
137370|NCT00770991|494184|P1|Overall Study|Pregnancy|1
137371|NCT00770991|494183|P2|Overall Study|Adverse Event|5
137372|NCT00770991|494184|P1|Overall Study|Adverse Event|1
137373|NCT00770991|494183|P2|Overall Study|Withdrawal by Subject|0
137374|NCT00770991|494184|P1|Overall Study|Withdrawal by Subject|1
137375|NCT00770991|494183|P2|Overall Study|Physician Decision|0
137376|NCT00770991|494184|P1|Overall Study|Physician Decision|2
137377|NCT00770965|494200|P4|Excluded Set|Withdrawal by Subject|3
137378|NCT00770965|494201|P3|Excluded Set|Withdrawal by Subject|2
137379|NCT00770965|494202|P2|Excluded Set|Withdrawal by Subject|1
137380|NCT00770965|494203|P1|Excluded Set|Withdrawal by Subject|1
137381|NCT00770965|494200|P4|Excluded Set|Administrative problems|10
137382|NCT00770965|494201|P3|Excluded Set|Administrative problems|12
137383|NCT00770965|494202|P2|Excluded Set|Administrative problems|12
137384|NCT00770965|494203|P1|Excluded Set|Administrative problems|14
137385|NCT00770965|494200|P4|Safety Set|Protocol deviation|0
137386|NCT00770965|494201|P3|Safety Set|Protocol deviation|1
137387|NCT00770965|494202|P2|Safety Set|Protocol deviation|0
137388|NCT00770965|494203|P1|Safety Set|Protocol deviation|0
137389|NCT00770965|494200|P4|Safety Set|Withdrawal by Subject|1
137390|NCT00770965|494201|P3|Safety Set|Withdrawal by Subject|0
137391|NCT00770965|494202|P2|Safety Set|Withdrawal by Subject|0
137392|NCT00770965|494203|P1|Safety Set|Withdrawal by Subject|0
137393|NCT00770913|494224|P3|Overall Study|Incorrect drug was allocated|0
137394|NCT00770913|494225|P2|Overall Study|Incorrect drug was allocated|0
137395|NCT00770913|494226|P1|Overall Study|Incorrect drug was allocated|1
137396|NCT00770913|494224|P3|Overall Study|Protocol Violation|1
137397|NCT00770913|494225|P2|Overall Study|Protocol Violation|0
137398|NCT00770913|494226|P1|Overall Study|Protocol Violation|3
137399|NCT00770913|494224|P3|Overall Study|Physician Decision|1
137400|NCT00770913|494225|P2|Overall Study|Physician Decision|1
137401|NCT00770913|494226|P1|Overall Study|Physician Decision|0
137402|NCT00770913|494224|P3|Overall Study|Refusal to continue participation|5
137403|NCT00770913|494225|P2|Overall Study|Refusal to continue participation|4
137404|NCT00770913|494226|P1|Overall Study|Refusal to continue participation|6
137405|NCT00770913|494224|P3|Overall Study|Adverse Event|6
137406|NCT00770913|494225|P2|Overall Study|Adverse Event|3
137407|NCT00770913|494226|P1|Overall Study|Adverse Event|1
137408|NCT00770809|494248|P3|Overall Study|Other Medical Reasons|3
137409|NCT00770809|494249|P2|Overall Study|Other Medical Reasons|4
137410|NCT00770809|494250|P1|Overall Study|Other Medical Reasons|2
137411|NCT00770809|494248|P3|Overall Study|Complicating illness|1
137412|NCT00770809|494249|P2|Overall Study|Complicating illness|0
137413|NCT00770809|494250|P1|Overall Study|Complicating illness|0
137414|NCT00770809|494248|P3|Overall Study|Progression|0
137415|NCT00770809|494249|P2|Overall Study|Progression|2
137416|NCT00770809|494250|P1|Overall Study|Progression|2
137417|NCT00770809|494248|P3|Overall Study|Withdrawal by Subject|7
137418|NCT00770809|494249|P2|Overall Study|Withdrawal by Subject|3
137419|NCT00770809|494250|P1|Overall Study|Withdrawal by Subject|3
137420|NCT00770809|494248|P3|Overall Study|Death|0
137421|NCT00770809|494249|P2|Overall Study|Death|0
137422|NCT00770809|494250|P1|Overall Study|Death|1
137423|NCT00770809|494248|P3|Overall Study|Adverse Event|12
137424|NCT00770809|494249|P2|Overall Study|Adverse Event|1
137425|NCT00770809|494250|P1|Overall Study|Adverse Event|9
137426|NCT00770770|494260|P2|Overall Study|Study Terminated|0
137427|NCT00770770|494261|P1|Overall Study|Study Terminated|8
137428|NCT00770770|494260|P2|Overall Study|Death|1
137429|NCT00770770|494261|P1|Overall Study|Death|0
137430|NCT00770770|494260|P2|Overall Study|Withdrawal by Subject|0
137431|NCT00770770|494261|P1|Overall Study|Withdrawal by Subject|1
137432|NCT00770770|494260|P2|Overall Study|Lost to Follow-up|0
137433|NCT00770770|494261|P1|Overall Study|Lost to Follow-up|1
137434|NCT00770692|494279|P4|Overall Study|Investigator judgment|1
137435|NCT00770692|494280|P3|Overall Study|Investigator judgment|1
137436|NCT00770692|494281|P2|Overall Study|Investigator judgment|0
137437|NCT00770692|494282|P1|Overall Study|Investigator judgment|2
137438|NCT00770692|494279|P4|Overall Study|Adverse Event|4
137439|NCT00770692|494280|P3|Overall Study|Adverse Event|4
137440|NCT00770692|494281|P2|Overall Study|Adverse Event|0
137441|NCT00770692|494282|P1|Overall Study|Adverse Event|3
137442|NCT00770692|494279|P4|Overall Study|Withdrawal by Subject|6
137443|NCT00770692|494280|P3|Overall Study|Withdrawal by Subject|9
137444|NCT00770692|494281|P2|Overall Study|Withdrawal by Subject|9
137445|NCT00770692|494282|P1|Overall Study|Withdrawal by Subject|7
137446|NCT00770679|494308|P1|Overall Study|Follow-up LDL measurement not collected|3
137447|NCT00770679|494308|P1|Overall Study|Lost to Follow-up|3
137448|NCT00770653|494316|P2|Overall Study|Physician Decision|0
137449|NCT00770653|494317|P1|Overall Study|Physician Decision|1
137450|NCT00770653|494316|P2|Overall Study|Lost to Follow-up|2
137451|NCT00770653|494317|P1|Overall Study|Lost to Follow-up|1
137452|NCT00770653|494316|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
137453|NCT00770653|494317|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
137454|NCT00770653|494316|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
137455|NCT00770653|494317|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
137456|NCT00770653|494316|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
137457|NCT00770653|494317|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
137458|NCT00770653|494316|P2|Overall Study|Lack of Compliance|4
137459|NCT00770653|494317|P1|Overall Study|Lack of Compliance|1
137460|NCT00770653|494316|P2|Overall Study|Withdrawal by Subject|7
137461|NCT00770653|494317|P1|Overall Study|Withdrawal by Subject|4
137462|NCT00770653|494316|P2|Overall Study|Protocol Violation|6
137463|NCT00770653|494317|P1|Overall Study|Protocol Violation|8
137464|NCT00770653|494316|P2|Overall Study|Adverse Event|5
137465|NCT00770653|494317|P1|Overall Study|Adverse Event|13
137466|NCT00770588|494387|P2|Overall Study|Withdrawal by Subject|1
137467|NCT00770588|494388|P1|Overall Study|Withdrawal by Subject|1
137468|NCT00770588|494387|P2|Overall Study|Lost to Follow-up|1
137469|NCT00770588|494388|P1|Overall Study|Lost to Follow-up|1
137470|NCT00770588|494387|P2|Overall Study|Death caused by progression of disease|91
137471|NCT00770588|494388|P1|Overall Study|Death caused by progression of disease|70
137472|NCT00770588|494387|P2|Overall Study|Adverse Event|2
137473|NCT00770588|494388|P1|Overall Study|Adverse Event|9
137474|NCT00770562|494404|P2|Overall Study|Did not take treatment|1
137475|NCT00770562|494405|P1|Overall Study|Did not take treatment|1
137476|NCT00770510|494416|P1|Overall Study|Withdrawal by Subject|2
137477|NCT00770510|494416|P1|Overall Study|Pregnancy|1
137478|NCT00770510|494416|P1|Overall Study|Lost to Follow-up|2
137479|NCT00770484|494455|P2|Overall Study|Withdrawal by Subject|0
137480|NCT00770484|494456|P1|Overall Study|Withdrawal by Subject|1
137481|NCT00770432|494464|P2|Overall Study|Non-compliance|1
137482|NCT00770432|494465|P1|Overall Study|Non-compliance|0
137483|NCT00770432|494464|P2|Overall Study|Not specified|6
137484|NCT00770432|494465|P1|Overall Study|Not specified|4
137485|NCT00770367|494473|P2|Second Intervention|Lost to Follow-up|0
137486|NCT00770367|494474|P1|Second Intervention|Lost to Follow-up|2
137487|NCT00770367|494473|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
137488|NCT00770367|494474|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
137489|NCT00770367|494473|P2|First Intervention|Withdrawal by Subject|2
137490|NCT00770367|494474|P1|First Intervention|Withdrawal by Subject|0
137491|NCT00770341|494483|P3|Overall Study|Not treated|0
137492|NCT00770341|494484|P2|Overall Study|Not treated|0
137493|NCT00770341|494485|P1|Overall Study|Not treated|1
137494|NCT00770341|494483|P3|Overall Study|Not specified|0
137495|NCT00770341|494484|P2|Overall Study|Not specified|0
137496|NCT00770341|494485|P1|Overall Study|Not specified|1
137497|NCT00770341|494483|P3|Overall Study|Lack of Efficacy|1
137498|NCT00770341|494484|P2|Overall Study|Lack of Efficacy|0
137499|NCT00770341|494485|P1|Overall Study|Lack of Efficacy|3
137500|NCT00770341|494483|P3|Overall Study|Laboratory adverse event|0
137501|NCT00770341|494484|P2|Overall Study|Laboratory adverse event|3
137502|NCT00770341|494485|P1|Overall Study|Laboratory adverse event|3
137503|NCT00770341|494483|P3|Overall Study|Clinical Adverse Event|2
137504|NCT00770341|494484|P2|Overall Study|Clinical Adverse Event|1
137505|NCT00770341|494485|P1|Overall Study|Clinical Adverse Event|3
137506|NCT00770341|494483|P3|Overall Study|Withdrawal by Subject|0
137507|NCT00770341|494484|P2|Overall Study|Withdrawal by Subject|1
137508|NCT00770341|494485|P1|Overall Study|Withdrawal by Subject|0
137509|NCT00770341|494483|P3|Overall Study|Did not meet eligibility criteria|0
137510|NCT00770341|494484|P2|Overall Study|Did not meet eligibility criteria|0
137511|NCT00770341|494485|P1|Overall Study|Did not meet eligibility criteria|1
137512|NCT00770328|494511|P2|Overall Study|Lost to Follow-up|2
137513|NCT00770328|494512|P1|Overall Study|Lost to Follow-up|2
137514|NCT00770328|494511|P2|Overall Study|Adverse Event|2
137515|NCT00770328|494512|P1|Overall Study|Adverse Event|11
137516|NCT00770315|494528|P4|Overall Study|Noncompliance with Protocol|9
137517|NCT00770315|494529|P3|Overall Study|Noncompliance with Protocol|7
137518|NCT00770315|494530|P2|Overall Study|Noncompliance with Protocol|4
137519|NCT00770315|494531|P1|Overall Study|Noncompliance with Protocol|7
137520|NCT00770315|494528|P4|Overall Study|Withdrawal by Subject|20
137521|NCT00770315|494529|P3|Overall Study|Withdrawal by Subject|24
137522|NCT00770315|494530|P2|Overall Study|Withdrawal by Subject|17
137523|NCT00770315|494531|P1|Overall Study|Withdrawal by Subject|13
137524|NCT00770315|494528|P4|Overall Study|Lost to Follow-up|3
137525|NCT00770315|494529|P3|Overall Study|Lost to Follow-up|10
137526|NCT00770315|494530|P2|Overall Study|Lost to Follow-up|5
137527|NCT00770315|494531|P1|Overall Study|Lost to Follow-up|9
137528|NCT00770315|494528|P4|Overall Study|Adverse Event|6
137529|NCT00770315|494529|P3|Overall Study|Adverse Event|16
137530|NCT00770315|494530|P2|Overall Study|Adverse Event|17
137531|NCT00770315|494531|P1|Overall Study|Adverse Event|11
137532|NCT00770289|494557|P1|Overall Study|Other|6
137533|NCT00770211|494568|P2|Overall Study|Withdrawal by Subject|2
137534|NCT00770211|494569|P1|Overall Study|Withdrawal by Subject|0
137535|NCT00770211|494568|P2|Overall Study|Lost to Follow-up|0
137536|NCT00770211|494569|P1|Overall Study|Lost to Follow-up|1
137537|NCT00770146|494585|P2|Follow-up Period|Other|5
137538|NCT00770146|494586|P1|Follow-up Period|Other|4
137539|NCT00770146|494585|P2|Follow-up Period|Adverse Event|2
137540|NCT00770146|494586|P1|Follow-up Period|Adverse Event|0
137541|NCT00770146|494585|P2|Follow-up Period|Withdrawal by Subject|13
137542|NCT00770146|494586|P1|Follow-up Period|Withdrawal by Subject|7
137543|NCT00770146|494585|P2|Treatment Period|Protocol non-compliance|1
137544|NCT00770146|494586|P1|Treatment Period|Protocol non-compliance|0
137545|NCT00770146|494585|P2|Treatment Period|Other|5
137546|NCT00770146|494586|P1|Treatment Period|Other|1
137547|NCT00770146|494585|P2|Treatment Period|Adverse Event|26
137548|NCT00770146|494586|P1|Treatment Period|Adverse Event|2
137549|NCT00770146|494585|P2|Treatment Period|Withdrawal by Subject|13
137550|NCT00770146|494586|P1|Treatment Period|Withdrawal by Subject|6
137551|NCT00770120|494630|P1|Overall Study|Reason under Review|1
137552|NCT00770120|494630|P1|Overall Study|Never Received Treatment/Not Analyzable|1
137553|NCT00770120|494630|P1|Overall Study|Ineligible|1
137554|NCT00770120|494630|P1|Overall Study|Withdrawal by Subject|2
137555|NCT00770120|494630|P1|Overall Study|Death|3
137556|NCT00770120|494630|P1|Overall Study|Not Protocol Specified|11
137557|NCT00770120|494630|P1|Overall Study|Adverse Event|11
137558|NCT00770120|494630|P1|Overall Study|Progression|31
137559|NCT00770029|494639|P2|Overall Study|Adverse Event|0
137560|NCT00770029|494640|P1|Overall Study|Adverse Event|1
137561|NCT00770029|494639|P2|Overall Study|Withdrawal by Subject|3
137562|NCT00770029|494640|P1|Overall Study|Withdrawal by Subject|3
137563|NCT00770029|494639|P2|Overall Study|Lost to Follow-up|0
137564|NCT00770029|494640|P1|Overall Study|Lost to Follow-up|2
137565|NCT00769860|494656|P2|Overall Study|Withdrawal by Subject|0
137566|NCT00769860|494657|P1|Overall Study|Withdrawal by Subject|2
137567|NCT00769704|494685|P2|Overall Study|Other|2
137568|NCT00769704|494686|P1|Overall Study|Other|1
137569|NCT00769704|494685|P2|Overall Study|Withdrawal by Subject|5
137570|NCT00769704|494686|P1|Overall Study|Withdrawal by Subject|12
137571|NCT00769704|494685|P2|Overall Study|Death|190
137572|NCT00769704|494686|P1|Overall Study|Death|95
137573|NCT00769704|494685|P2|Overall Study|Lost to Follow-up|2
137574|NCT00769704|494686|P1|Overall Study|Lost to Follow-up|3
137575|NCT00769561|494719|P2|Overall Study|Lost to Follow-up|3
137576|NCT00769561|494720|P1|Overall Study|Lost to Follow-up|1
137577|NCT00769561|494719|P2|Overall Study|Withdrawal by Subject|2
137578|NCT00769561|494720|P1|Overall Study|Withdrawal by Subject|2
137579|NCT00769184|494769|P2|No Treatment (6 Weeks)|Adverse Event|1
137580|NCT00769184|494770|P1|No Treatment (6 Weeks)|Adverse Event|1
137581|NCT00769184|494769|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
137582|NCT00769184|494770|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
137583|NCT00769184|494769|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
137584|NCT00769184|494770|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
137585|NCT00769132|494778|P4|Period 4|Withdrawal by Subject|0
137586|NCT00769132|494779|P3|Period 4|Withdrawal by Subject|0
137587|NCT00769132|494780|P2|Period 4|Withdrawal by Subject|1
137588|NCT00769132|494781|P1|Period 4|Withdrawal by Subject|0
137589|NCT00769132|494778|P4|Period 3|Withdrawal by Subject|0
137590|NCT00769132|494779|P3|Period 3|Withdrawal by Subject|0
137591|NCT00769132|494780|P2|Period 3|Withdrawal by Subject|0
137592|NCT00769132|494781|P1|Period 3|Withdrawal by Subject|1
137593|NCT00769132|494778|P4|Period 2|Withdrawal by Subject|1
137594|NCT00769132|494779|P3|Period 2|Withdrawal by Subject|0
137595|NCT00769132|494780|P2|Period 2|Withdrawal by Subject|0
137596|NCT00769132|494781|P1|Period 2|Withdrawal by Subject|0
137597|NCT00769132|494778|P4|Period 1|Adverse Event|1
137598|NCT00769132|494779|P3|Period 1|Adverse Event|0
137599|NCT00769132|494780|P2|Period 1|Adverse Event|0
137600|NCT00769132|494781|P1|Period 1|Adverse Event|1
137601|NCT00769119|494797|P2|Overall Study|Disallowed medication|0
137602|NCT00769119|494798|P1|Overall Study|Disallowed medication|1
137603|NCT00769119|494797|P2|Overall Study|Adverse Event|1
137604|NCT00769119|494798|P1|Overall Study|Adverse Event|1
137605|NCT00769119|494797|P2|Overall Study|Voluntary discontinuation|2
137606|NCT00769119|494798|P1|Overall Study|Voluntary discontinuation|0
137607|NCT00769067|494844|P2|Overall Study|Withdrawal by Subject|1
137608|NCT00769067|494845|P1|Overall Study|Withdrawal by Subject|0
137609|NCT00769067|494844|P2|Overall Study|Other|3
137610|NCT00769067|494845|P1|Overall Study|Other|1
137611|NCT00769067|494844|P2|Overall Study|Study terminated by sponsor|3
137612|NCT00769067|494845|P1|Overall Study|Study terminated by sponsor|1
137613|NCT00769067|494844|P2|Overall Study|Lost to Follow-up|1
137614|NCT00769067|494845|P1|Overall Study|Lost to Follow-up|3
137615|NCT00769067|494844|P2|Overall Study|Death|86
137616|NCT00769067|494845|P1|Overall Study|Death|89
137617|NCT00768989|494893|P2|On or After Week 36|Sponsor Termination|26
137618|NCT00768989|494894|P1|On or After Week 36|Sponsor Termination|45
137619|NCT00768989|494893|P2|On or After Week 36|Did not attend termination visit|0
137620|NCT00768989|494894|P1|On or After Week 36|Did not attend termination visit|2
137621|NCT00768989|494893|P2|On or After Week 36|Protocol Violation|0
137622|NCT00768989|494894|P1|On or After Week 36|Protocol Violation|1
137623|NCT00768989|494893|P2|On or After Week 36|Poor Compliance|0
137624|NCT00768989|494894|P1|On or After Week 36|Poor Compliance|1
137625|NCT00768989|494893|P2|On or After Week 36|Lost to Follow-up|0
137626|NCT00768989|494894|P1|On or After Week 36|Lost to Follow-up|1
137627|NCT00768989|494893|P2|On or After Week 36|Adverse Event|1
137628|NCT00768989|494894|P1|On or After Week 36|Adverse Event|0
137629|NCT00768989|494893|P2|On or After Week 36|Lack of Efficacy|0
137630|NCT00768989|494894|P1|On or After Week 36|Lack of Efficacy|1
137631|NCT00768989|494893|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
137632|NCT00768989|494894|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
137633|NCT00768989|494893|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
137634|NCT00768989|494894|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
137635|NCT00768989|494893|P2|Week 24 to Prior to Week 36|Adverse Event|0
137636|NCT00768989|494894|P1|Week 24 to Prior to Week 36|Adverse Event|1
137637|NCT00768989|494893|P2|Prior to Week 24|Protocol Violation|2
137638|NCT00768989|494894|P1|Prior to Week 24|Protocol Violation|0
137639|NCT00768989|494893|P2|Prior to Week 24|Lost to Follow-up|1
137640|NCT00768989|494894|P1|Prior to Week 24|Lost to Follow-up|0
137641|NCT00768989|494893|P2|Prior to Week 24|Adverse Event|0
137642|NCT00768989|494894|P1|Prior to Week 24|Adverse Event|3
137643|NCT00768989|494893|P2|Prior to Week 24|Withdrawal by Subject|0
137644|NCT00768989|494894|P1|Prior to Week 24|Withdrawal by Subject|1
137645|NCT00768898|494942|P1|Overall Study|Headache|1
137646|NCT00768898|494942|P1|Overall Study|Unrelated injury|1
137647|NCT00768755|494966|P4|Phase 2|Randomized but not treated|2
137648|NCT00768755|494967|P3|Phase 2|Randomized but not treated|0
137649|NCT00768755|494968|P2|Phase 2|Randomized but not treated|0
137650|NCT00768755|494969|P1|Phase 2|Randomized but not treated|0
137651|NCT00768755|494966|P4|Phase 2|Study Terminated by Sponsor|14
137652|NCT00768755|494967|P3|Phase 2|Study Terminated by Sponsor|7
137653|NCT00768755|494968|P2|Phase 2|Study Terminated by Sponsor|13
137654|NCT00768755|494969|P1|Phase 2|Study Terminated by Sponsor|0
137655|NCT00768755|494966|P4|Phase 2|Other|4
137656|NCT00768755|494967|P3|Phase 2|Other|2
137657|NCT00768755|494968|P2|Phase 2|Other|1
137658|NCT00768755|494969|P1|Phase 2|Other|0
137659|NCT00768755|494966|P4|Phase 2|Withdrawal by Subject|1
137660|NCT00768755|494967|P3|Phase 2|Withdrawal by Subject|0
137661|NCT00768755|494968|P2|Phase 2|Withdrawal by Subject|1
137662|NCT00768755|494969|P1|Phase 2|Withdrawal by Subject|0
137663|NCT00768755|494966|P4|Phase 2|Lost to Follow-up|4
137664|NCT00768755|494967|P3|Phase 2|Lost to Follow-up|1
137665|NCT00768755|494968|P2|Phase 2|Lost to Follow-up|1
137666|NCT00768755|494969|P1|Phase 2|Lost to Follow-up|0
137667|NCT00768755|494966|P4|Phase 2|Protocol Violation|1
137668|NCT00768755|494967|P3|Phase 2|Protocol Violation|0
137669|NCT00768755|494968|P2|Phase 2|Protocol Violation|2
137670|NCT00768755|494969|P1|Phase 2|Protocol Violation|0
137671|NCT00768755|494966|P4|Phase 2|Death|31
137672|NCT00768755|494967|P3|Phase 2|Death|48
137673|NCT00768755|494968|P2|Phase 2|Death|37
137674|NCT00768755|494969|P1|Phase 2|Death|0
137675|NCT00768755|494966|P4|Phase 1|Other|0
137676|NCT00768755|494967|P3|Phase 1|Other|0
137677|NCT00768755|494968|P2|Phase 1|Other|0
137678|NCT00768755|494969|P1|Phase 1|Other|4
137679|NCT00768755|494966|P4|Phase 1|Death|0
137680|NCT00768755|494967|P3|Phase 1|Death|0
137681|NCT00768755|494968|P2|Phase 1|Death|0
137682|NCT00768755|494969|P1|Phase 1|Death|6
137683|NCT00768651|494993|P1|Overall Study|Withdrawal by Subject|1
137684|NCT00768560|495032|P6|Intervention Set 1|Adverse Event|0
137685|NCT00768560|495033|P5|Intervention Set 1|Adverse Event|0
137686|NCT00768560|495034|P4|Intervention Set 1|Adverse Event|0
137687|NCT00768560|495035|P3|Intervention Set 1|Adverse Event|0
137688|NCT00768560|495036|P2|Intervention Set 1|Adverse Event|1
137689|NCT00768560|495037|P1|Intervention Set 1|Adverse Event|0
137690|NCT00768430|495074|P2|7 Day Endpoint|Withdrawal by Subject|3
137691|NCT00768430|495075|P1|7 Day Endpoint|Withdrawal by Subject|2
137692|NCT00768300|495083|P2|Overall Study|Missing data|0
137693|NCT00768300|495084|P1|Overall Study|Missing data|1
137694|NCT00768300|495083|P2|Overall Study|Treated but never dosed with Study drug|0
137695|NCT00768300|495084|P1|Overall Study|Treated but never dosed with Study drug|1
137696|NCT00768300|495083|P2|Overall Study|Began prohibited concomitant medication|1
137697|NCT00768300|495084|P1|Overall Study|Began prohibited concomitant medication|0
137698|NCT00768300|495083|P2|Overall Study|Lost to Follow-up|1
137699|NCT00768300|495084|P1|Overall Study|Lost to Follow-up|0
137700|NCT00768300|495083|P2|Overall Study|Received lung transplant|1
137701|NCT00768300|495084|P1|Overall Study|Received lung transplant|1
137702|NCT00768300|495083|P2|Overall Study|Screen failure following randomization|0
137703|NCT00768300|495084|P1|Overall Study|Screen failure following randomization|1
137704|NCT00768300|495083|P2|Overall Study|Subject moved to pursue lung transplant|1
137705|NCT00768300|495084|P1|Overall Study|Subject moved to pursue lung transplant|1
137706|NCT00768300|495083|P2|Overall Study|Death|5
137707|NCT00768300|495084|P1|Overall Study|Death|21
137708|NCT00768300|495083|P2|Overall Study|Study discontinued by Sponsor|140
137709|NCT00768300|495084|P1|Overall Study|Study discontinued by Sponsor|271
137710|NCT00768300|495083|P2|Overall Study|Physician Decision|3
137711|NCT00768300|495084|P1|Overall Study|Physician Decision|2
137712|NCT00768300|495083|P2|Overall Study|Withdrawal by Subject|7
137713|NCT00768300|495084|P1|Overall Study|Withdrawal by Subject|13
137714|NCT00768300|495083|P2|Overall Study|Protocol Violation|1
137715|NCT00768300|495084|P1|Overall Study|Protocol Violation|6
137716|NCT00768300|495083|P2|Overall Study|Adverse Event|2
137717|NCT00768300|495084|P1|Overall Study|Adverse Event|10
137718|NCT00768300|495083|P2|Overall Study|Randomized but not treated|1
137719|NCT00768300|495084|P1|Overall Study|Randomized but not treated|1
137720|NCT00768222|495108|P2|Overall Study|Protocol Violation|2
137721|NCT00768222|495109|P1|Overall Study|Protocol Violation|0
137722|NCT00768222|495108|P2|Overall Study|Withdrawal by Subject|1
137723|NCT00768222|495109|P1|Overall Study|Withdrawal by Subject|3
137724|NCT00768222|495108|P2|Overall Study|Lost to Follow-up|1
137725|NCT00768222|495109|P1|Overall Study|Lost to Follow-up|1
137726|NCT00768144|495131|P1|Overall Study|Pt Withdrew Consent|1
137727|NCT00768144|495131|P1|Overall Study|Patient or MD Decision to End Treatment|1
137728|NCT00768144|495131|P1|Overall Study|Progressive Disease|21
137729|NCT00768144|495131|P1|Overall Study|Adverse Event|13
137730|NCT00768066|495144|P3|Overall Study|Did not receive study product injection.|0
137731|NCT00768066|495145|P2|Overall Study|Did not receive study product injection.|3
137732|NCT00768066|495146|P1|Overall Study|Did not receive study product injection.|3
137733|NCT00768053|495178|P1|Overall Study|Lost to Follow-up|1
137734|NCT00768053|495178|P1|Overall Study|Adverse Event|10
137735|NCT00768040|495209|P2|Overall Study|Abnormal laboratory value|1
137736|NCT00768040|495210|P1|Overall Study|Abnormal laboratory value|1
137737|NCT00768040|495209|P2|Overall Study|Adverse Event|2
137738|NCT00768040|495210|P1|Overall Study|Adverse Event|3
137739|NCT00767806|495218|P2|Overall Study|Sponsor Decision|1
137740|NCT00767806|495219|P1|Overall Study|Sponsor Decision|0
137741|NCT00767806|495218|P2|Overall Study|Entry Criteria Not Met|1
137742|NCT00767806|495219|P1|Overall Study|Entry Criteria Not Met|1
137743|NCT00767806|495218|P2|Overall Study|Lost to Follow-up|4
137744|NCT00767806|495219|P1|Overall Study|Lost to Follow-up|1
137745|NCT00767806|495218|P2|Overall Study|Physician Decision|3
137746|NCT00767806|495219|P1|Overall Study|Physician Decision|4
137747|NCT00767806|495218|P2|Overall Study|Lack of Efficacy|9
137748|NCT00767806|495219|P1|Overall Study|Lack of Efficacy|1
137749|NCT00767806|495218|P2|Overall Study|Protocol Violation|5
137750|NCT00767806|495219|P1|Overall Study|Protocol Violation|6
137751|NCT00767806|495218|P2|Overall Study|Withdrawal by Subject|13
137752|NCT00767806|495219|P1|Overall Study|Withdrawal by Subject|8
137753|NCT00767806|495218|P2|Overall Study|Adverse Event|11
137754|NCT00767806|495219|P1|Overall Study|Adverse Event|30
137755|NCT00767676|495296|P1|Overall Study|Investigator error|54
137756|NCT00767520|495319|P2|Overall Study|Randomized in error and Never treated|2
137757|NCT00767520|495320|P1|Overall Study|Randomized in error and Never treated|0
137758|NCT00767520|495319|P2|Overall Study|Participants still on treatment|15
137759|NCT00767520|495320|P1|Overall Study|Participants still on treatment|11
137760|NCT00767455|495373|P1|Overall Study|Investigator error|19
137761|NCT00767325|495407|P1|Overall Study|Missed visit due to family reasons|1
137762|NCT00767325|495407|P1|Overall Study|No longer met study criteria|2
137763|NCT00767325|495407|P1|Overall Study|Lost to Follow-up|3
137764|NCT00767325|495407|P1|Overall Study|Adverse Event|7
137765|NCT00767325|495407|P1|Overall Study|Lack of Efficacy|2
137766|NCT00767104|495418|P2|Overall Study|Lost to Follow-up|2
137767|NCT00767104|495419|P1|Overall Study|Lost to Follow-up|1
137768|NCT00767039|495429|P2|Overall Study|Death|2
137769|NCT00767039|495430|P1|Overall Study|Death|5
137770|NCT00767000|495461|P5|Optional 104-week Extension|Study terminated by sponsor|4
137771|NCT00767000|495462|P4|Optional 104-week Extension|Study terminated by sponsor|2
137772|NCT00767000|495463|P3|Optional 104-week Extension|Study terminated by sponsor|7
137773|NCT00767000|495464|P2|Optional 104-week Extension|Study terminated by sponsor|3
137774|NCT00767000|495465|P1|Optional 104-week Extension|Study terminated by sponsor|7
137775|NCT00767000|495461|P5|54-week Study|Reason not reported|0
137776|NCT00767000|495462|P4|54-week Study|Reason not reported|1
137777|NCT00767000|495463|P3|54-week Study|Reason not reported|0
137778|NCT00767000|495464|P2|54-week Study|Reason not reported|0
137779|NCT00767000|495465|P1|54-week Study|Reason not reported|0
137780|NCT00767000|495461|P5|54-week Study|Study terminated by sponsor|194
137781|NCT00767000|495462|P4|54-week Study|Study terminated by sponsor|196
137782|NCT00767000|495463|P3|54-week Study|Study terminated by sponsor|89
137783|NCT00767000|495464|P2|54-week Study|Study terminated by sponsor|102
137784|NCT00767000|495465|P1|54-week Study|Study terminated by sponsor|90
137785|NCT00767000|495461|P5|54-week Study|Withdrawal by Subject|13
137786|NCT00767000|495462|P4|54-week Study|Withdrawal by Subject|11
137787|NCT00767000|495463|P3|54-week Study|Withdrawal by Subject|5
137788|NCT00767000|495464|P2|54-week Study|Withdrawal by Subject|3
137789|NCT00767000|495465|P1|54-week Study|Withdrawal by Subject|2
137790|NCT00767000|495461|P5|54-week Study|Protocol Violation|0
137791|NCT00767000|495462|P4|54-week Study|Protocol Violation|2
137792|NCT00767000|495463|P3|54-week Study|Protocol Violation|1
137793|NCT00767000|495464|P2|54-week Study|Protocol Violation|0
137794|NCT00767000|495465|P1|54-week Study|Protocol Violation|0
137795|NCT00767000|495461|P5|54-week Study|Progressive disease|0
137796|NCT00767000|495462|P4|54-week Study|Progressive disease|0
137797|NCT00767000|495463|P3|54-week Study|Progressive disease|1
137798|NCT00767000|495464|P2|54-week Study|Progressive disease|0
137799|NCT00767000|495465|P1|54-week Study|Progressive disease|0
137800|NCT00767000|495461|P5|54-week Study|Physician Decision|1
137801|NCT00767000|495462|P4|54-week Study|Physician Decision|1
137802|NCT00767000|495463|P3|54-week Study|Physician Decision|1
137803|NCT00767000|495464|P2|54-week Study|Physician Decision|0
137804|NCT00767000|495465|P1|54-week Study|Physician Decision|4
137805|NCT00767000|495461|P5|54-week Study|Lost to Follow-up|2
137806|NCT00767000|495462|P4|54-week Study|Lost to Follow-up|4
137807|NCT00767000|495463|P3|54-week Study|Lost to Follow-up|1
137808|NCT00767000|495464|P2|54-week Study|Lost to Follow-up|0
137809|NCT00767000|495465|P1|54-week Study|Lost to Follow-up|4
137810|NCT00767000|495461|P5|54-week Study|Lack of Efficacy|5
137811|NCT00767000|495462|P4|54-week Study|Lack of Efficacy|0
137812|NCT00767000|495463|P3|54-week Study|Lack of Efficacy|1
137813|NCT00767000|495464|P2|54-week Study|Lack of Efficacy|0
137814|NCT00767000|495465|P1|54-week Study|Lack of Efficacy|2
137815|NCT00767000|495461|P5|54-week Study|Interruption of study medication|0
138058|NCT00765817|495868|P1|Overall Study|Adverse Event|13
137816|NCT00767000|495462|P4|54-week Study|Interruption of study medication|0
137817|NCT00767000|495463|P3|54-week Study|Interruption of study medication|1
137818|NCT00767000|495464|P2|54-week Study|Interruption of study medication|0
137819|NCT00767000|495465|P1|54-week Study|Interruption of study medication|0
137820|NCT00767000|495461|P5|54-week Study|Hypoglycemia|0
137821|NCT00767000|495462|P4|54-week Study|Hypoglycemia|0
137822|NCT00767000|495463|P3|54-week Study|Hypoglycemia|0
137823|NCT00767000|495464|P2|54-week Study|Hypoglycemia|1
137824|NCT00767000|495465|P1|54-week Study|Hypoglycemia|0
137825|NCT00767000|495461|P5|54-week Study|Hyperglycemia|1
137826|NCT00767000|495462|P4|54-week Study|Hyperglycemia|0
137827|NCT00767000|495463|P3|54-week Study|Hyperglycemia|1
137828|NCT00767000|495464|P2|54-week Study|Hyperglycemia|0
137829|NCT00767000|495465|P1|54-week Study|Hyperglycemia|0
137830|NCT00767000|495461|P5|54-week Study|Creaninine/creatinine clearance|4
137831|NCT00767000|495462|P4|54-week Study|Creaninine/creatinine clearance|2
137832|NCT00767000|495463|P3|54-week Study|Creaninine/creatinine clearance|2
137833|NCT00767000|495464|P2|54-week Study|Creaninine/creatinine clearance|1
137834|NCT00767000|495465|P1|54-week Study|Creaninine/creatinine clearance|2
137835|NCT00767000|495461|P5|54-week Study|Adverse Event|4
137836|NCT00767000|495462|P4|54-week Study|Adverse Event|8
137837|NCT00767000|495463|P3|54-week Study|Adverse Event|6
137838|NCT00767000|495464|P2|54-week Study|Adverse Event|6
137839|NCT00767000|495465|P1|54-week Study|Adverse Event|4
137840|NCT00766831|495507|P1|Overall Study|Not specified|28
137841|NCT00766831|495507|P1|Overall Study|Non cooperation by participants|14
137842|NCT00766831|495507|P1|Overall Study|Withdrawal of consent|26
137843|NCT00766831|495507|P1|Overall Study|Physician Decision|5
137844|NCT00766831|495507|P1|Overall Study|Protocol Violation|15
137845|NCT00766831|495507|P1|Overall Study|Adverse Event|20
137846|NCT00766831|495507|P1|Overall Study|Lost to Follow-up|3
137847|NCT00766831|495507|P1|Overall Study|Withdrawal by Subject|4
137848|NCT00766675|495537|P1|Overall Study|Insufficient therapy|1
137849|NCT00766675|495537|P1|Overall Study|Receive other anti-neoplastic treatment|1
137850|NCT00766675|495537|P1|Overall Study|Participant took prohibited medication|1
137851|NCT00766675|495537|P1|Overall Study|Protocol Violation|8
137852|NCT00766675|495537|P1|Overall Study|Withdrawal by Subject|11
137853|NCT00766675|495537|P1|Overall Study|Lost to Follow-up|2
137854|NCT00766675|495537|P1|Overall Study|Adverse Event|16
137855|NCT00766636|495564|P2|Overall Study|Disease Progression|0
137856|NCT00766636|495565|P1|Overall Study|Disease Progression|1
137857|NCT00766636|495564|P2|Overall Study|Adverse Event|0
137858|NCT00766636|495565|P1|Overall Study|Adverse Event|1
137859|NCT00766636|495564|P2|Overall Study|Incomplete Treatment|1
137860|NCT00766636|495565|P1|Overall Study|Incomplete Treatment|0
137861|NCT00766636|495564|P2|Overall Study|Withdrawal by Subject|1
137862|NCT00766636|495565|P1|Overall Study|Withdrawal by Subject|1
137863|NCT00766597|495571|P1|Overall Study|Without CCR5-tropic virus|5
137864|NCT00766597|495571|P1|Overall Study|Unexpected closure of study|4
137865|NCT00766532|495583|P1|Overall Study|Protocol Violation|2
137866|NCT00766506|495589|P2|Overall Study|Other|2
137867|NCT00766506|495590|P1|Overall Study|Other|2
137868|NCT00766506|495589|P2|Overall Study|Use rescue medication after 3 hours|0
137869|NCT00766506|495590|P1|Overall Study|Use rescue medication after 3 hours|3
137870|NCT00766493|495614|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
137871|NCT00766493|495614|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
137872|NCT00766493|495614|P1|30 Days Post-Procedure|Discontinued|7
137873|NCT00766467|495624|P2|Overall Study|Physician Decision|0
137874|NCT00766467|495625|P1|Overall Study|Physician Decision|1
137875|NCT00766467|495624|P2|Overall Study|Tumor Progression on Study|1
137876|NCT00766467|495625|P1|Overall Study|Tumor Progression on Study|0
137877|NCT00766467|495624|P2|Overall Study|Protocol Violation|4
137878|NCT00766467|495625|P1|Overall Study|Protocol Violation|2
137879|NCT00766467|495624|P2|Overall Study|Adverse Event|1
137880|NCT00766467|495625|P1|Overall Study|Adverse Event|1
137881|NCT00766467|495624|P2|Overall Study|Withdrawal by Subject|2
137882|NCT00766467|495625|P1|Overall Study|Withdrawal by Subject|7
137883|NCT00766415|495637|P2|Overall Study|Withdrawal by Subject|1
137884|NCT00766415|495638|P1|Overall Study|Withdrawal by Subject|0
137885|NCT00766376|495686|P1|Overall Study|Withdrawal by Subject|27
137886|NCT00766363|495695|P4|Overall Study|Adverse Event Prior to Randomization|0
137887|NCT00766363|495696|P3|Overall Study|Adverse Event Prior to Randomization|0
137888|NCT00766363|495697|P2|Overall Study|Adverse Event Prior to Randomization|1
137889|NCT00766363|495698|P1|Overall Study|Adverse Event Prior to Randomization|0
137890|NCT00766363|495695|P4|Overall Study|Withdrawal by Subject|0
137891|NCT00766363|495696|P3|Overall Study|Withdrawal by Subject|0
137892|NCT00766363|495697|P2|Overall Study|Withdrawal by Subject|0
137893|NCT00766363|495698|P1|Overall Study|Withdrawal by Subject|1
137894|NCT00766090|495737|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137895|NCT00766090|495738|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137896|NCT00766090|495739|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137897|NCT00766090|495740|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137898|NCT00766090|495741|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137899|NCT00766090|495742|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137900|NCT00766090|495743|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137901|NCT00766090|495744|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
137902|NCT00766090|495745|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137903|NCT00766090|495746|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137904|NCT00766090|495747|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137905|NCT00766090|495748|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
137906|NCT00766090|495737|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
137907|NCT00766090|495738|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
137908|NCT00766090|495739|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
137909|NCT00766090|495740|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
137910|NCT00766090|495741|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
137911|NCT00766090|495742|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
137912|NCT00766090|495743|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
137913|NCT00766090|495744|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
137914|NCT00766090|495745|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
137915|NCT00766090|495746|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
137916|NCT00766090|495747|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
137917|NCT00766090|495748|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
137918|NCT00766090|495737|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
137919|NCT00766090|495738|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
137920|NCT00766090|495739|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
137921|NCT00766090|495740|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
137922|NCT00766090|495741|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
137923|NCT00766090|495742|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
137924|NCT00766090|495743|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
137925|NCT00766090|495744|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
137926|NCT00766090|495745|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
137927|NCT00766090|495746|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
137928|NCT00766090|495747|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
137929|NCT00766090|495748|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
137930|NCT00766090|495737|P12|Washout Period 2 (14 Days)|Physician Decision|0
137931|NCT00766090|495738|P11|Washout Period 2 (14 Days)|Physician Decision|0
137932|NCT00766090|495739|P10|Washout Period 2 (14 Days)|Physician Decision|0
137933|NCT00766090|495740|P9|Washout Period 2 (14 Days)|Physician Decision|0
137934|NCT00766090|495741|P8|Washout Period 2 (14 Days)|Physician Decision|0
137935|NCT00766090|495742|P7|Washout Period 2 (14 Days)|Physician Decision|0
137936|NCT00766090|495743|P6|Washout Period 2 (14 Days)|Physician Decision|0
137937|NCT00766090|495744|P5|Washout Period 2 (14 Days)|Physician Decision|0
137938|NCT00766090|495745|P4|Washout Period 2 (14 Days)|Physician Decision|0
137939|NCT00766090|495746|P3|Washout Period 2 (14 Days)|Physician Decision|1
137940|NCT00766090|495747|P2|Washout Period 2 (14 Days)|Physician Decision|0
137941|NCT00766090|495748|P1|Washout Period 2 (14 Days)|Physician Decision|0
137942|NCT00766090|495737|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137943|NCT00766090|495738|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137944|NCT00766090|495739|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137945|NCT00766090|495740|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137946|NCT00766090|495741|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137947|NCT00766090|495742|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137948|NCT00766090|495743|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137949|NCT00766090|495744|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137950|NCT00766090|495745|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137951|NCT00766090|495746|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
137952|NCT00766090|495747|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137953|NCT00766090|495748|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
137954|NCT00766090|495737|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137955|NCT00766090|495738|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137956|NCT00766090|495739|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137957|NCT00766090|495740|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137958|NCT00766090|495741|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137959|NCT00766090|495742|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137960|NCT00766090|495743|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137961|NCT00766090|495744|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
137962|NCT00766090|495745|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137963|NCT00766090|495746|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137964|NCT00766090|495747|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137965|NCT00766090|495748|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
137966|NCT00766090|495737|P12|Washout Period 1 (14 Days)|Protocol Violation|0
137967|NCT00766090|495738|P11|Washout Period 1 (14 Days)|Protocol Violation|0
137968|NCT00766090|495739|P10|Washout Period 1 (14 Days)|Protocol Violation|0
137969|NCT00766090|495740|P9|Washout Period 1 (14 Days)|Protocol Violation|0
137970|NCT00766090|495741|P8|Washout Period 1 (14 Days)|Protocol Violation|0
137971|NCT00766090|495742|P7|Washout Period 1 (14 Days)|Protocol Violation|0
137972|NCT00766090|495743|P6|Washout Period 1 (14 Days)|Protocol Violation|0
137973|NCT00766090|495744|P5|Washout Period 1 (14 Days)|Protocol Violation|0
137974|NCT00766090|495745|P4|Washout Period 1 (14 Days)|Protocol Violation|0
137975|NCT00766090|495746|P3|Washout Period 1 (14 Days)|Protocol Violation|1
137976|NCT00766090|495747|P2|Washout Period 1 (14 Days)|Protocol Violation|0
137977|NCT00766090|495748|P1|Washout Period 1 (14 Days)|Protocol Violation|0
137978|NCT00766090|495737|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137979|NCT00766090|495738|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137980|NCT00766090|495739|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137981|NCT00766090|495740|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137982|NCT00766090|495741|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137983|NCT00766090|495742|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137984|NCT00766090|495743|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137985|NCT00766090|495744|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137986|NCT00766090|495745|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
137987|NCT00766090|495746|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137988|NCT00766090|495747|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
137989|NCT00766090|495748|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
137990|NCT00766090|495737|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
137991|NCT00766090|495738|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
137992|NCT00766090|495739|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
137993|NCT00766090|495740|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
137994|NCT00766090|495741|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
137995|NCT00766090|495742|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
137996|NCT00766090|495743|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
137997|NCT00766090|495744|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
137998|NCT00766090|495745|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
137999|NCT00766090|495746|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
138000|NCT00766090|495747|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
138001|NCT00766090|495748|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
138002|NCT00766090|495737|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138003|NCT00766090|495738|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138004|NCT00766090|495739|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138005|NCT00766090|495740|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
138006|NCT00766090|495741|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138007|NCT00766090|495742|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138008|NCT00766090|495743|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138009|NCT00766090|495744|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138010|NCT00766090|495745|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138011|NCT00766090|495746|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138012|NCT00766090|495747|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138013|NCT00766090|495748|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
138014|NCT00766051|495789|P2|Overall Study|Withdrawal by Subject|0
138015|NCT00766051|495790|P1|Overall Study|Withdrawal by Subject|2
138016|NCT00765882|495821|P3|Overall Study|Other Reason|2
138017|NCT00765882|495822|P2|Overall Study|Other Reason|1
138018|NCT00765882|495823|P1|Overall Study|Other Reason|3
138019|NCT00765882|495821|P3|Overall Study|Lost to Follow-up|6
138020|NCT00765882|495822|P2|Overall Study|Lost to Follow-up|9
138021|NCT00765882|495823|P1|Overall Study|Lost to Follow-up|1
138022|NCT00765882|495821|P3|Overall Study|Withdrawal by Subject|6
138023|NCT00765882|495822|P2|Overall Study|Withdrawal by Subject|6
138024|NCT00765882|495823|P1|Overall Study|Withdrawal by Subject|2
138025|NCT00765882|495821|P3|Overall Study|Protocol Violation|1
138026|NCT00765882|495822|P2|Overall Study|Protocol Violation|3
138027|NCT00765882|495823|P1|Overall Study|Protocol Violation|4
138028|NCT00765882|495821|P3|Overall Study|Lack of Efficacy|1
138029|NCT00765882|495822|P2|Overall Study|Lack of Efficacy|0
138030|NCT00765882|495823|P1|Overall Study|Lack of Efficacy|4
138031|NCT00765882|495821|P3|Overall Study|Adverse Event|20
138032|NCT00765882|495822|P2|Overall Study|Adverse Event|21
138033|NCT00765882|495823|P1|Overall Study|Adverse Event|10
138034|NCT00765843|495855|P3|Overall Study|Adverse Event|1
138035|NCT00765843|495856|P2|Overall Study|Adverse Event|0
138036|NCT00765843|495857|P1|Overall Study|Adverse Event|0
138037|NCT00765843|495855|P3|Overall Study|did not return to receive intervention|0
138038|NCT00765843|495856|P2|Overall Study|did not return to receive intervention|1
138039|NCT00765843|495857|P1|Overall Study|did not return to receive intervention|0
138040|NCT00765843|495855|P3|Overall Study|Lost to Follow-up|2
138041|NCT00765843|495856|P2|Overall Study|Lost to Follow-up|3
138042|NCT00765843|495857|P1|Overall Study|Lost to Follow-up|1
138043|NCT00765817|495867|P2|Overall Study|Subject decision|11
138044|NCT00765817|495868|P1|Overall Study|Subject decision|7
138045|NCT00765817|495867|P2|Overall Study|Protocol Violation|1
138046|NCT00765817|495868|P1|Overall Study|Protocol Violation|1
138047|NCT00765817|495867|P2|Overall Study|Physician Decision|1
138048|NCT00765817|495868|P1|Overall Study|Physician Decision|2
138049|NCT00765817|495867|P2|Overall Study|Lost to Follow-up|3
138050|NCT00765817|495868|P1|Overall Study|Lost to Follow-up|1
138051|NCT00765817|495867|P2|Overall Study|Loss of glucose control|2
138052|NCT00765817|495868|P1|Overall Study|Loss of glucose control|0
138053|NCT00765817|495867|P2|Overall Study|Entry criteria not met|2
138054|NCT00765817|495868|P1|Overall Study|Entry criteria not met|2
138055|NCT00765817|495867|P2|Overall Study|Death|1
138056|NCT00765817|495868|P1|Overall Study|Death|0
138057|NCT00765817|495867|P2|Overall Study|Adverse Event|1
138059|NCT00765726|495916|P1|Overall Study|Discontinuation of study by sponsor|8
138060|NCT00765726|495916|P1|Overall Study|Withdrawal by Subject|1
138061|NCT00765674|495924|P4|Overall Study|Randomized in Error - No Study Drug|1
138062|NCT00765674|495925|P3|Overall Study|Randomized in Error - No Study Drug|0
138063|NCT00765674|495926|P2|Overall Study|Randomized in Error - No Study Drug|1
138064|NCT00765674|495927|P1|Overall Study|Randomized in Error - No Study Drug|0
138065|NCT00765674|495924|P4|Overall Study|Lost to Follow-up|1
138066|NCT00765674|495925|P3|Overall Study|Lost to Follow-up|2
138067|NCT00765674|495926|P2|Overall Study|Lost to Follow-up|6
138068|NCT00765674|495927|P1|Overall Study|Lost to Follow-up|4
138069|NCT00765674|495924|P4|Overall Study|Withdrawal by Subject|8
138070|NCT00765674|495925|P3|Overall Study|Withdrawal by Subject|3
138071|NCT00765674|495926|P2|Overall Study|Withdrawal by Subject|7
138072|NCT00765674|495927|P1|Overall Study|Withdrawal by Subject|5
138073|NCT00765674|495924|P4|Overall Study|Protocol Violation|0
138074|NCT00765674|495925|P3|Overall Study|Protocol Violation|1
138075|NCT00765674|495926|P2|Overall Study|Protocol Violation|0
138076|NCT00765674|495927|P1|Overall Study|Protocol Violation|2
138077|NCT00765674|495924|P4|Overall Study|Lack of Efficacy|2
138078|NCT00765674|495925|P3|Overall Study|Lack of Efficacy|1
138079|NCT00765674|495926|P2|Overall Study|Lack of Efficacy|3
138080|NCT00765674|495927|P1|Overall Study|Lack of Efficacy|2
138081|NCT00765674|495924|P4|Overall Study|Abnormal Test Procedure Result(s)|2
138082|NCT00765674|495925|P3|Overall Study|Abnormal Test Procedure Result(s)|1
138083|NCT00765674|495926|P2|Overall Study|Abnormal Test Procedure Result(s)|3
138084|NCT00765674|495927|P1|Overall Study|Abnormal Test Procedure Result(s)|1
138085|NCT00765674|495924|P4|Overall Study|Abnormal Laboratory Value(s)|0
138086|NCT00765674|495925|P3|Overall Study|Abnormal Laboratory Value(s)|1
138087|NCT00765674|495926|P2|Overall Study|Abnormal Laboratory Value(s)|0
138088|NCT00765674|495927|P1|Overall Study|Abnormal Laboratory Value(s)|0
138089|NCT00765674|495924|P4|Overall Study|Adverse Event|11
138090|NCT00765674|495925|P3|Overall Study|Adverse Event|8
138091|NCT00765674|495926|P2|Overall Study|Adverse Event|2
138092|NCT00765674|495927|P1|Overall Study|Adverse Event|7
138093|NCT00765388|495994|P2|Period 1|Hip operation|1
138094|NCT00765388|495995|P1|Period 1|Hip operation|0
138095|NCT00765388|495994|P2|Period 1|Herpes Zoster|1
138096|NCT00765388|495995|P1|Period 1|Herpes Zoster|0
138097|NCT00765388|495994|P2|Period 1|Lost to Follow-up|1
138098|NCT00765388|495995|P1|Period 1|Lost to Follow-up|0
138099|NCT00765388|495994|P2|Period 1|Lack of Efficacy|2
138100|NCT00765388|495995|P1|Period 1|Lack of Efficacy|1
138101|NCT00765362|496029|P1|Overall Study|Lost to Follow-up|95
138102|NCT00765362|496029|P1|Overall Study|Withdrawal by Subject|13
138103|NCT00765362|496029|P1|Overall Study|Protocol Violation|18
138104|NCT00765362|496029|P1|Overall Study|Adverse Event|2
138105|NCT00765362|496029|P1|Overall Study|Death|9
138106|NCT00765336|496037|P2|Overall Study|Adverse Event|1
138107|NCT00765336|496038|P1|Overall Study|Adverse Event|2
138108|NCT00765336|496037|P2|Overall Study|Lost to Follow-up|9
138109|NCT00765336|496038|P1|Overall Study|Lost to Follow-up|7
138110|NCT00765336|496037|P2|Overall Study|Withdrawal by Subject|4
138111|NCT00765336|496038|P1|Overall Study|Withdrawal by Subject|6
138112|NCT00765336|496037|P2|Overall Study|Protocol Violation|2
138113|NCT00765336|496038|P1|Overall Study|Protocol Violation|4
138114|NCT00765245|496046|P2|Overall Study|Death|0
138115|NCT00765245|496047|P1|Overall Study|Death|1
138116|NCT00765245|496046|P2|Overall Study|Physician Decision|0
138117|NCT00765245|496047|P1|Overall Study|Physician Decision|1
138118|NCT00765245|496046|P2|Overall Study|Adverse Event|0
138119|NCT00765245|496047|P1|Overall Study|Adverse Event|5
138120|NCT00765245|496046|P2|Overall Study|Withdrawal by Subject|0
138121|NCT00765245|496047|P1|Overall Study|Withdrawal by Subject|3
138122|NCT00765245|496046|P2|Overall Study|disease progression|2
138123|NCT00765245|496047|P1|Overall Study|disease progression|3
138124|NCT00765102|496093|P1|Overall Study|Protocol Violation|1
138125|NCT00765102|496093|P1|Overall Study|Withdrawal by Subject|2
138126|NCT00765102|496093|P1|Overall Study|Physician Decision|4
138127|NCT00765102|496093|P1|Overall Study|Adverse Event|6
138128|NCT00765102|496093|P1|Overall Study|Progressive disease|18
138129|NCT00765076|496118|P3|Overall Study|Withdrawal by Subject|1
138130|NCT00765076|496119|P2|Overall Study|Withdrawal by Subject|0
138131|NCT00765076|496120|P1|Overall Study|Withdrawal by Subject|0
138132|NCT00765076|496118|P3|Overall Study|Adverse Event|0
138133|NCT00765076|496119|P2|Overall Study|Adverse Event|0
138134|NCT00765076|496120|P1|Overall Study|Adverse Event|1
138135|NCT00765063|496173|P1|Overall Study|Adverse Event|4
138136|NCT00765063|496173|P1|Overall Study|Protocol Violation|6
138137|NCT00765063|496173|P1|Overall Study|Other|16
138138|NCT00765063|496173|P1|Overall Study|Withdrawal by Subject|1
138139|NCT00765063|496173|P1|Overall Study|Lack of Efficacy|5
138140|NCT00765037|496189|P1|Overall Study|Adverse Event|1
138141|NCT00765037|496189|P1|Overall Study|Lost to Follow-up|5
138142|NCT00764946|496196|P3|Overall Study|Never Treated|1
138143|NCT00764946|496197|P2|Overall Study|Never Treated|1
138144|NCT00764946|496198|P1|Overall Study|Never Treated|1
138145|NCT00764946|496196|P3|Overall Study|Withdrawal by Subject|2
138146|NCT00764946|496197|P2|Overall Study|Withdrawal by Subject|6
138147|NCT00764946|496198|P1|Overall Study|Withdrawal by Subject|3
138148|NCT00764946|496196|P3|Overall Study|Adverse Event|1
138149|NCT00764946|496197|P2|Overall Study|Adverse Event|2
138150|NCT00764946|496198|P1|Overall Study|Adverse Event|3
138151|NCT00764946|496196|P3|Overall Study|Physician Decision|0
138152|NCT00764946|496197|P2|Overall Study|Physician Decision|4
138153|NCT00764946|496198|P1|Overall Study|Physician Decision|2
138154|NCT00764946|496196|P3|Overall Study|Lost to Follow-up|0
138155|NCT00764946|496197|P2|Overall Study|Lost to Follow-up|4
138156|NCT00764946|496198|P1|Overall Study|Lost to Follow-up|3
138157|NCT00764946|496196|P3|Overall Study|Lack of Efficacy|0
138158|NCT00764946|496197|P2|Overall Study|Lack of Efficacy|0
138159|NCT00764946|496198|P1|Overall Study|Lack of Efficacy|1
138160|NCT00764881|496226|P2|Overall Study|no treatment or no observation|2
138161|NCT00764881|496227|P1|Overall Study|no treatment or no observation|2
138162|NCT00764881|496226|P2|Overall Study|Possibly noncompliant (study drug)|2
138163|NCT00764881|496227|P1|Overall Study|Possibly noncompliant (study drug)|0
138164|NCT00764881|496226|P2|Overall Study|Carcinoma detected|0
138165|NCT00764881|496227|P1|Overall Study|Carcinoma detected|1
138166|NCT00764881|496226|P2|Overall Study|Wished to become pregnant|0
138167|NCT00764881|496227|P1|Overall Study|Wished to become pregnant|1
138168|NCT00764881|496226|P2|Overall Study|Accidentally discontinued study drug|0
138169|NCT00764881|496227|P1|Overall Study|Accidentally discontinued study drug|1
138170|NCT00764881|496226|P2|Overall Study|Noncompliant|0
138171|NCT00764881|496227|P1|Overall Study|Noncompliant|1
138172|NCT00764881|496226|P2|Overall Study|Lost to Follow-up|0
138173|NCT00764881|496227|P1|Overall Study|Lost to Follow-up|2
138174|NCT00764881|496226|P2|Overall Study|Protocol Violation|2
138175|NCT00764881|496227|P1|Overall Study|Protocol Violation|2
138176|NCT00764881|496226|P2|Overall Study|Withdrawal by Subject|3
138177|NCT00764881|496227|P1|Overall Study|Withdrawal by Subject|1
138178|NCT00764881|496226|P2|Overall Study|Adverse Event|1
138179|NCT00764881|496227|P1|Overall Study|Adverse Event|5
138180|NCT00764868|496451|P1|Overall Study|Sponsor requested withdrawal|1
138181|NCT00764868|496451|P1|Overall Study|Positive drug screen|2
138182|NCT00764868|496451|P1|Overall Study|Met an exclusion criteria|1
138183|NCT00764868|496451|P1|Overall Study|Subject sent to boarding school|1
138184|NCT00764868|496451|P1|Overall Study|Misuse and compliance of study drug|1
138185|NCT00764868|496451|P1|Overall Study|Out of town|1
138186|NCT00764868|496451|P1|Overall Study|Prohibited medication|1
138187|NCT00764868|496451|P1|Overall Study|Pregnancy|3
138188|NCT00764868|496451|P1|Overall Study|Subject moved|7
138189|NCT00764868|496451|P1|Overall Study|Lack of Efficacy|5
138190|NCT00764868|496451|P1|Overall Study|Lost to Follow-up|25
138191|NCT00764868|496451|P1|Overall Study|Non-compliance|16
138192|NCT00764868|496451|P1|Overall Study|Withdrawal by Subject|31
138193|NCT00764868|496451|P1|Overall Study|Adverse Event|18
138194|NCT00764790|496460|P3|Overall Study|Lost to Follow-up|23
138195|NCT00764790|496461|P2|Overall Study|Lost to Follow-up|29
138196|NCT00764790|496462|P1|Overall Study|Lost to Follow-up|28
138197|NCT00764790|496460|P3|Overall Study|Withdrawal by Subject|6
138198|NCT00764790|496461|P2|Overall Study|Withdrawal by Subject|12
138199|NCT00764790|496462|P1|Overall Study|Withdrawal by Subject|10
138200|NCT00764790|496460|P3|Overall Study|Protocol Violation|1
138201|NCT00764790|496461|P2|Overall Study|Protocol Violation|0
138202|NCT00764790|496462|P1|Overall Study|Protocol Violation|0
138203|NCT00764699|496494|P1|Overall Study|PI left and study terminated|3
138204|NCT00764673|496498|P1|Overall Study|Revision of Device|2
138205|NCT00764673|496498|P1|Overall Study|Withdrawal by Subject|6
138206|NCT00764673|496498|P1|Overall Study|Lost to Follow-up|3
138207|NCT00764673|496498|P1|Overall Study|Death|1
138208|NCT00764660|496508|P2|Overall Study|Did Not Meet Protocol Eligibility|0
138209|NCT00764660|496509|P1|Overall Study|Did Not Meet Protocol Eligibility|1
138210|NCT00764660|496508|P2|Overall Study|Noncompliance With Protocol|1
138211|NCT00764660|496509|P1|Overall Study|Noncompliance With Protocol|5
138212|NCT00764660|496508|P2|Overall Study|Withdrawal by Subject|3
138213|NCT00764660|496509|P1|Overall Study|Withdrawal by Subject|7
138214|NCT00764660|496508|P2|Overall Study|Lost to Follow-up|4
138215|NCT00764660|496509|P1|Overall Study|Lost to Follow-up|3
138216|NCT00764660|496508|P2|Overall Study|Adverse Event|3
138217|NCT00764660|496509|P1|Overall Study|Adverse Event|6
138218|NCT00764517|496543|P2|Overall Study|Physician Decision|0
138219|NCT00764517|496544|P1|Overall Study|Physician Decision|3
138220|NCT00764517|496543|P2|Overall Study|Death|11
138221|NCT00764517|496544|P1|Overall Study|Death|3
138222|NCT00764517|496543|P2|Overall Study|Adverse Event|3
138223|NCT00764517|496544|P1|Overall Study|Adverse Event|9
138224|NCT00764504|496565|P3|Overall Study|Lost to Follow-up|72
138225|NCT00764504|496566|P2|Overall Study|Lost to Follow-up|34
138226|NCT00764504|496567|P1|Overall Study|Lost to Follow-up|40
138227|NCT00764504|496565|P3|Overall Study|Withdrawal by Subject|4
138228|NCT00764504|496566|P2|Overall Study|Withdrawal by Subject|7
138229|NCT00764504|496567|P1|Overall Study|Withdrawal by Subject|1
138230|NCT00764504|496565|P3|Overall Study|Physician Decision|0
138231|NCT00764504|496566|P2|Overall Study|Physician Decision|0
138232|NCT00764504|496567|P1|Overall Study|Physician Decision|1
138233|NCT00764504|496565|P3|Overall Study|Revision of Device|14
138234|NCT00764504|496566|P2|Overall Study|Revision of Device|23
138235|NCT00764504|496567|P1|Overall Study|Revision of Device|12
138236|NCT00764504|496565|P3|Overall Study|Death|13
138237|NCT00764504|496566|P2|Overall Study|Death|6
138238|NCT00764504|496567|P1|Overall Study|Death|12
138239|NCT00764478|496596|P3|Overall Study|Protocol Violation|1
138240|NCT00764478|496597|P2|Overall Study|Protocol Violation|1
138241|NCT00764478|496598|P1|Overall Study|Protocol Violation|0
138242|NCT00764478|496596|P3|Overall Study|Lost to Follow-up|5
138243|NCT00764478|496597|P2|Overall Study|Lost to Follow-up|8
138244|NCT00764478|496598|P1|Overall Study|Lost to Follow-up|7
138245|NCT00764478|496596|P3|Overall Study|Withdrawal by Subject|1
138246|NCT00764478|496597|P2|Overall Study|Withdrawal by Subject|12
138247|NCT00764478|496598|P1|Overall Study|Withdrawal by Subject|7
138248|NCT00764478|496596|P3|Overall Study|Adverse Event|1
138249|NCT00764478|496597|P2|Overall Study|Adverse Event|1
138250|NCT00764478|496598|P1|Overall Study|Adverse Event|1
138251|NCT00764465|496678|P6|Overall Study|Withdrawal by Subject|0
138252|NCT00764465|496679|P5|Overall Study|Withdrawal by Subject|0
138253|NCT00764465|496680|P4|Overall Study|Withdrawal by Subject|0
138254|NCT00764465|496681|P3|Overall Study|Withdrawal by Subject|1
138255|NCT00764465|496682|P2|Overall Study|Withdrawal by Subject|1
138256|NCT00764465|496683|P1|Overall Study|Withdrawal by Subject|0
138257|NCT00764465|496678|P6|Overall Study|Adverse Event|1
138258|NCT00764465|496679|P5|Overall Study|Adverse Event|1
138259|NCT00764465|496680|P4|Overall Study|Adverse Event|1
138260|NCT00764465|496681|P3|Overall Study|Adverse Event|0
138261|NCT00764465|496682|P2|Overall Study|Adverse Event|0
138262|NCT00764465|496683|P1|Overall Study|Adverse Event|2
138263|NCT00764361|496711|P2|Overall Study|Adverse Event|1
138264|NCT00764361|496712|P1|Overall Study|Adverse Event|0
138265|NCT00764361|496711|P2|Overall Study|Withdrawal by Subject|3
138266|NCT00764361|496712|P1|Overall Study|Withdrawal by Subject|2
138267|NCT00764322|496720|P1|Overall Study|No CYP2D6 genotyping|9
138268|NCT00764322|496720|P1|Overall Study|Withdrawal by Subject|11
138269|NCT00763971|496747|P3|Overall Study|Participation in 489-326 required|0
138270|NCT00763971|496748|P2|Overall Study|Participation in 489-326 required|0
138271|NCT00763971|496749|P1|Overall Study|Participation in 489-326 required|1
138272|NCT00763971|496747|P3|Overall Study|Performed final visit on phone|0
138273|NCT00763971|496748|P2|Overall Study|Performed final visit on phone|1
138274|NCT00763971|496749|P1|Overall Study|Performed final visit on phone|0
138275|NCT00763971|496747|P3|Overall Study|Lack of availability|0
138276|NCT00763971|496748|P2|Overall Study|Lack of availability|1
138277|NCT00763971|496749|P1|Overall Study|Lack of availability|0
138278|NCT00763971|496747|P3|Overall Study|Subject wanted dose reduction|0
138279|NCT00763971|496748|P2|Overall Study|Subject wanted dose reduction|1
138280|NCT00763971|496749|P1|Overall Study|Subject wanted dose reduction|0
138281|NCT00763971|496747|P3|Overall Study|Moved to another country|0
138282|NCT00763971|496748|P2|Overall Study|Moved to another country|1
138283|NCT00763971|496749|P1|Overall Study|Moved to another country|0
138284|NCT00763971|496747|P3|Overall Study|Medical monitor decision|1
138285|NCT00763971|496748|P2|Overall Study|Medical monitor decision|0
138286|NCT00763971|496749|P1|Overall Study|Medical monitor decision|0
138287|NCT00763971|496747|P3|Overall Study|Randomization error|1
138288|NCT00763971|496748|P2|Overall Study|Randomization error|0
138289|NCT00763971|496749|P1|Overall Study|Randomization error|0
138290|NCT00763971|496747|P3|Overall Study|Due to holiday season|1
138291|NCT00763971|496748|P2|Overall Study|Due to holiday season|0
138292|NCT00763971|496749|P1|Overall Study|Due to holiday season|2
138293|NCT00763971|496747|P3|Overall Study|Sponsor decision|0
138294|NCT00763971|496748|P2|Overall Study|Sponsor decision|0
138295|NCT00763971|496749|P1|Overall Study|Sponsor decision|1
138296|NCT00763971|496747|P3|Overall Study|Exclusion criteria met|0
138297|NCT00763971|496748|P2|Overall Study|Exclusion criteria met|0
138298|NCT00763971|496749|P1|Overall Study|Exclusion criteria met|1
138299|NCT00763971|496747|P3|Overall Study|Personal reason|0
138300|NCT00763971|496748|P2|Overall Study|Personal reason|0
138301|NCT00763971|496749|P1|Overall Study|Personal reason|3
138302|NCT00763971|496747|P3|Overall Study|Unable to swallow capsule|1
138303|NCT00763971|496748|P2|Overall Study|Unable to swallow capsule|1
138304|NCT00763971|496749|P1|Overall Study|Unable to swallow capsule|2
138305|NCT00763971|496747|P3|Overall Study|Lack of Efficacy|54
138306|NCT00763971|496748|P2|Overall Study|Lack of Efficacy|22
138307|NCT00763971|496749|P1|Overall Study|Lack of Efficacy|11
138308|NCT00763971|496747|P3|Overall Study|Lost to Follow-up|0
138309|NCT00763971|496748|P2|Overall Study|Lost to Follow-up|1
138310|NCT00763971|496749|P1|Overall Study|Lost to Follow-up|0
138311|NCT00763971|496747|P3|Overall Study|Withdrawal by Subject|5
138312|NCT00763971|496748|P2|Overall Study|Withdrawal by Subject|5
138313|NCT00763971|496749|P1|Overall Study|Withdrawal by Subject|4
138314|NCT00763971|496747|P3|Overall Study|Protocol Violation|2
138315|NCT00763971|496748|P2|Overall Study|Protocol Violation|3
138316|NCT00763971|496749|P1|Overall Study|Protocol Violation|3
138317|NCT00763971|496747|P3|Overall Study|Adverse Event|4
138318|NCT00763971|496748|P2|Overall Study|Adverse Event|2
138319|NCT00763971|496749|P1|Overall Study|Adverse Event|5
138320|NCT00763958|496780|P2|Overall Study|Believed they were receiving placebo|5
138321|NCT00763958|496781|P1|Overall Study|Believed they were receiving placebo|0
138322|NCT00763958|496780|P2|Overall Study|Lost to Follow-up|2
138323|NCT00763958|496781|P1|Overall Study|Lost to Follow-up|10
138324|NCT00763958|496780|P2|Overall Study|did not meet final criteria|4
138325|NCT00763958|496781|P1|Overall Study|did not meet final criteria|4
138326|NCT00763815|496916|P2|Overall Study|Sponsor's Decision|1
138327|NCT00763815|496917|P1|Overall Study|Sponsor's Decision|0
138328|NCT00763815|496916|P2|Overall Study|Protocol Violation|5
138329|NCT00763815|496917|P1|Overall Study|Protocol Violation|2
138330|NCT00763815|496916|P2|Overall Study|Withdrawal by Subject|12
138331|NCT00763815|496917|P1|Overall Study|Withdrawal by Subject|7
138332|NCT00763815|496916|P2|Overall Study|Physician Decision|0
138333|NCT00763815|496917|P1|Overall Study|Physician Decision|1
138334|NCT00763815|496916|P2|Overall Study|Familial and Personal Reasons|16
138335|NCT00763815|496917|P1|Overall Study|Familial and Personal Reasons|9
138336|NCT00763815|496916|P2|Overall Study|Early Termination|0
138337|NCT00763815|496917|P1|Overall Study|Early Termination|1
138338|NCT00763815|496916|P2|Overall Study|Lost to Follow-up|4
138339|NCT00763815|496917|P1|Overall Study|Lost to Follow-up|2
138340|NCT00763815|496916|P2|Overall Study|Poor Compliance to Protocol|6
138341|NCT00763815|496917|P1|Overall Study|Poor Compliance to Protocol|6
138342|NCT00763815|496916|P2|Overall Study|Lack of Efficacy|11
138343|NCT00763815|496917|P1|Overall Study|Lack of Efficacy|10
138344|NCT00763815|496916|P2|Overall Study|Adverse Event|29
138345|NCT00763815|496917|P1|Overall Study|Adverse Event|14
138346|NCT00763698|496945|P1|Overall Study|Withdrawal by Subject|1
138347|NCT00763698|496945|P1|Overall Study|Death|4
138348|NCT00763698|496945|P1|Overall Study|Unsuccessful Implant|5
138349|NCT00763451|496962|P4|Overall Study|Study Site Reason|1
138350|NCT00763451|496963|P3|Overall Study|Study Site Reason|1
138351|NCT00763451|496964|P2|Overall Study|Study Site Reason|1
138352|NCT00763451|496965|P1|Overall Study|Study Site Reason|0
138353|NCT00763451|496962|P4|Overall Study|Randomized but not Treated|0
138354|NCT00763451|496963|P3|Overall Study|Randomized but not Treated|0
138355|NCT00763451|496964|P2|Overall Study|Randomized but not Treated|1
138356|NCT00763451|496965|P1|Overall Study|Randomized but not Treated|1
138357|NCT00763451|496962|P4|Overall Study|Familial and Personal Reasons|4
138358|NCT00763451|496963|P3|Overall Study|Familial and Personal Reasons|5
138359|NCT00763451|496964|P2|Overall Study|Familial and Personal Reasons|3
138360|NCT00763451|496965|P1|Overall Study|Familial and Personal Reasons|5
138361|NCT00763451|496962|P4|Overall Study|Poor Compliance to Protocol|2
138362|NCT00763451|496963|P3|Overall Study|Poor Compliance to Protocol|2
138363|NCT00763451|496964|P2|Overall Study|Poor Compliance to Protocol|1
138364|NCT00763451|496965|P1|Overall Study|Poor Compliance to Protocol|1
138365|NCT00763451|496962|P4|Overall Study|Protocol Violation|0
138366|NCT00763451|496963|P3|Overall Study|Protocol Violation|1
138367|NCT00763451|496964|P2|Overall Study|Protocol Violation|0
138368|NCT00763451|496965|P1|Overall Study|Protocol Violation|0
138369|NCT00763451|496962|P4|Overall Study|Withdrawal by Subject|7
138370|NCT00763451|496963|P3|Overall Study|Withdrawal by Subject|9
138371|NCT00763451|496964|P2|Overall Study|Withdrawal by Subject|6
138372|NCT00763451|496965|P1|Overall Study|Withdrawal by Subject|1
138373|NCT00763451|496962|P4|Overall Study|Lack of Efficacy|2
138374|NCT00763451|496963|P3|Overall Study|Lack of Efficacy|3
138375|NCT00763451|496964|P2|Overall Study|Lack of Efficacy|4
138376|NCT00763451|496965|P1|Overall Study|Lack of Efficacy|1
138377|NCT00763451|496962|P4|Overall Study|Adverse Event|14
138378|NCT00763451|496963|P3|Overall Study|Adverse Event|19
138379|NCT00763451|496964|P2|Overall Study|Adverse Event|6
138380|NCT00763451|496965|P1|Overall Study|Adverse Event|4
138381|NCT00763386|497024|P2|Overall Study|Study Prosthesis Removed|0
138382|NCT00763386|497025|P1|Overall Study|Study Prosthesis Removed|1
138383|NCT00763386|497024|P2|Overall Study|CRF missing|1
138384|NCT00763386|497025|P1|Overall Study|CRF missing|0
138385|NCT00763386|497024|P2|Overall Study|Withdrawal by Subject|1
138386|NCT00763386|497025|P1|Overall Study|Withdrawal by Subject|0
138387|NCT00763386|497024|P2|Overall Study|Lost to Follow-up|3
138388|NCT00763386|497025|P1|Overall Study|Lost to Follow-up|3
138389|NCT00763386|497024|P2|Overall Study|Death|2
138390|NCT00763386|497025|P1|Overall Study|Death|1
138391|NCT00763386|497024|P2|Overall Study|Adverse Event|33
138392|NCT00763386|497025|P1|Overall Study|Adverse Event|43
138393|NCT00763321|497058|P3|Double-blind Period|Not specified|3
138394|NCT00763321|497059|P2|Double-blind Period|Not specified|2
138395|NCT00763321|497060|P1|Double-blind Period|Not specified|0
138396|NCT00763321|497058|P3|Double-blind Period|Withdrawal by Subject|3
138397|NCT00763321|497059|P2|Double-blind Period|Withdrawal by Subject|2
138398|NCT00763321|497060|P1|Double-blind Period|Withdrawal by Subject|0
138399|NCT00763321|497058|P3|Double-blind Period|Lost to Follow-up|2
138400|NCT00763321|497059|P2|Double-blind Period|Lost to Follow-up|4
138401|NCT00763321|497060|P1|Double-blind Period|Lost to Follow-up|0
138402|NCT00763321|497058|P3|Double-blind Period|Adverse Event|4
138403|NCT00763321|497059|P2|Double-blind Period|Adverse Event|4
138404|NCT00763321|497060|P1|Double-blind Period|Adverse Event|0
138405|NCT00763321|497058|P3|Double-blind Period|Lack of Efficacy|17
138406|NCT00763321|497059|P2|Double-blind Period|Lack of Efficacy|9
138407|NCT00763321|497060|P1|Double-blind Period|Lack of Efficacy|0
138408|NCT00763321|497058|P3|Open-label Period|Not specified|0
138409|NCT00763321|497059|P2|Open-label Period|Not specified|0
138410|NCT00763321|497060|P1|Open-label Period|Not specified|4
138411|NCT00763321|497058|P3|Open-label Period|Lack of Efficacy|0
138412|NCT00763321|497059|P2|Open-label Period|Lack of Efficacy|0
138413|NCT00763321|497060|P1|Open-label Period|Lack of Efficacy|2
138414|NCT00763321|497058|P3|Open-label Period|Did not meet DB randomization criteria|0
138415|NCT00763321|497059|P2|Open-label Period|Did not meet DB randomization criteria|0
138416|NCT00763321|497060|P1|Open-label Period|Did not meet DB randomization criteria|5
138417|NCT00763321|497058|P3|Open-label Period|Subject noncompliant|0
138418|NCT00763321|497059|P2|Open-label Period|Subject noncompliant|0
138419|NCT00763321|497060|P1|Open-label Period|Subject noncompliant|7
138420|NCT00763321|497058|P3|Open-label Period|Withdrawal by Subject|0
138421|NCT00763321|497059|P2|Open-label Period|Withdrawal by Subject|0
138422|NCT00763321|497060|P1|Open-label Period|Withdrawal by Subject|7
138423|NCT00763321|497058|P3|Open-label Period|Lost to Follow-up|0
138424|NCT00763321|497059|P2|Open-label Period|Lost to Follow-up|0
138425|NCT00763321|497060|P1|Open-label Period|Lost to Follow-up|14
138426|NCT00763321|497058|P3|Open-label Period|Adverse Event|0
138427|NCT00763321|497059|P2|Open-label Period|Adverse Event|0
138428|NCT00763321|497060|P1|Open-label Period|Adverse Event|24
138429|NCT00763282|497071|P2|Overall Study|Lost to Follow-up|26
138430|NCT00763282|497072|P1|Overall Study|Lost to Follow-up|22
138431|NCT00763282|497071|P2|Overall Study|Death|3
138432|NCT00763282|497072|P1|Overall Study|Death|4
138433|NCT00763282|497071|P2|Overall Study|Withdrawal by Subject|5
138434|NCT00763282|497072|P1|Overall Study|Withdrawal by Subject|6
138435|NCT00763269|497088|P2|Overall Study|Lost to Follow-up|13
138436|NCT00763269|497089|P1|Overall Study|Lost to Follow-up|12
138437|NCT00763256|497103|P2|Overall Study|Didn't return for appointments|10
138438|NCT00763256|497104|P1|Overall Study|Didn't return for appointments|7
138439|NCT00763139|497140|P2|Overall Study|med change not allowed by protocol|0
138440|NCT00763139|497141|P1|Overall Study|med change not allowed by protocol|1
138441|NCT00763139|497140|P2|Overall Study|Withdrawal by Subject|1
138442|NCT00763139|497141|P1|Overall Study|Withdrawal by Subject|0
138443|NCT00763139|497140|P2|Overall Study|Adverse Event|2
138444|NCT00763139|497141|P1|Overall Study|Adverse Event|4
138445|NCT00763009|497203|P1|Overall Study|Coronary Anatomy unsuitable|1
138446|NCT00762996|497208|P4|Period One|Withdrawal by Subject|0
138447|NCT00762996|497209|P3|Period One|Withdrawal by Subject|1
138448|NCT00762996|497210|P2|Period One|Withdrawal by Subject|0
138449|NCT00762996|497211|P1|Period One|Withdrawal by Subject|0
138450|NCT00762996|497208|P4|Period One|Adverse Event|0
138451|NCT00762996|497209|P3|Period One|Adverse Event|1
138452|NCT00762996|497210|P2|Period One|Adverse Event|0
138453|NCT00762996|497211|P1|Period One|Adverse Event|0
138454|NCT00762996|497208|P4|Period One|ineligible|1
138455|NCT00762996|497209|P3|Period One|ineligible|1
138456|NCT00762996|497210|P2|Period One|ineligible|0
138457|NCT00762996|497211|P1|Period One|ineligible|0
138458|NCT00762996|497208|P4|Period One|Protocol Violation|0
138459|NCT00762996|497209|P3|Period One|Protocol Violation|1
138460|NCT00762996|497210|P2|Period One|Protocol Violation|0
138461|NCT00762996|497211|P1|Period One|Protocol Violation|0
138462|NCT00762970|497224|P3|Overall Study|Difficulty of handling lens|0
138463|NCT00762970|497225|P2|Overall Study|Difficulty of handling lens|2
138464|NCT00762970|497226|P1|Overall Study|Difficulty of handling lens|1
138465|NCT00762970|497224|P3|Overall Study|Lost to Follow-up|0
138466|NCT00762970|497225|P2|Overall Study|Lost to Follow-up|2
138467|NCT00762970|497226|P1|Overall Study|Lost to Follow-up|1
138468|NCT00762970|497224|P3|Overall Study|Protocol Violation|1
138469|NCT00762970|497225|P2|Overall Study|Protocol Violation|1
138470|NCT00762970|497226|P1|Overall Study|Protocol Violation|3
138471|NCT00762970|497224|P3|Overall Study|Withdrawal by Subject|0
138472|NCT00762970|497225|P2|Overall Study|Withdrawal by Subject|4
138473|NCT00762970|497226|P1|Overall Study|Withdrawal by Subject|7
138474|NCT00762892|497244|P2|Overall Study|Incarceration|0
138475|NCT00762892|497245|P1|Overall Study|Incarceration|1
138476|NCT00762892|497244|P2|Overall Study|Pregnancy|0
138477|NCT00762892|497245|P1|Overall Study|Pregnancy|1
138478|NCT00762892|497244|P2|Overall Study|Death|0
138479|NCT00762892|497245|P1|Overall Study|Death|1
138480|NCT00762892|497244|P2|Overall Study|Withdrawal by Subject|1
138481|NCT00762892|497245|P1|Overall Study|Withdrawal by Subject|0
138482|NCT00762892|497244|P2|Overall Study|Lost to Follow-up|5
138483|NCT00762892|497245|P1|Overall Study|Lost to Follow-up|2
138484|NCT00762788|497274|P6|Overall Study|Lost to Follow-up|21
138485|NCT00762788|497275|P5|Overall Study|Lost to Follow-up|13
138486|NCT00762788|497276|P4|Overall Study|Lost to Follow-up|26
138487|NCT00762788|497277|P3|Overall Study|Lost to Follow-up|21
138488|NCT00762788|497278|P2|Overall Study|Lost to Follow-up|37
138489|NCT00762788|497279|P1|Overall Study|Lost to Follow-up|26
138490|NCT00762762|497301|P2|Overall Study|Did not report for appointments|10
138491|NCT00762762|497302|P1|Overall Study|Did not report for appointments|8
138492|NCT00762723|497319|P3|Overall Study|Study Terminated slow enrollement|3
138493|NCT00762723|497320|P2|Overall Study|Study Terminated slow enrollement|5
138494|NCT00762723|497321|P1|Overall Study|Study Terminated slow enrollement|5
138495|NCT00762606|497485|P2|Overall Study|Lost to Follow-up|13
138496|NCT00762606|497486|P1|Overall Study|Lost to Follow-up|18
138497|NCT00762502|497531|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
138498|NCT00762502|497532|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
138499|NCT00762502|497533|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
138500|NCT00762502|497531|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
138501|NCT00762502|497532|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
138502|NCT00762502|497533|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
138503|NCT00762502|497531|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
138504|NCT00762502|497532|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
138505|NCT00762502|497533|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
138506|NCT00762476|497547|P2|Overall Study|Seasonal allergies|0
138507|NCT00762476|497548|P1|Overall Study|Seasonal allergies|1
138508|NCT00762476|497547|P2|Overall Study|non-compliance with study visits|2
138509|NCT00762476|497548|P1|Overall Study|non-compliance with study visits|0
138510|NCT00762476|497547|P2|Overall Study|antibiotic use|1
138511|NCT00762476|497548|P1|Overall Study|antibiotic use|0
138512|NCT00762476|497547|P2|Overall Study|Withdrawal by Subject|12
138513|NCT00762476|497548|P1|Overall Study|Withdrawal by Subject|6
138514|NCT00762476|497547|P2|Overall Study|Physician Decision|14
138515|NCT00762476|497548|P1|Overall Study|Physician Decision|2
138516|NCT00762476|497547|P2|Overall Study|Protocol Violation|6
138517|NCT00762476|497548|P1|Overall Study|Protocol Violation|5
138518|NCT00762476|497547|P2|Overall Study|Lost to Follow-up|0
138519|NCT00762476|497548|P1|Overall Study|Lost to Follow-up|2
138520|NCT00762476|497547|P2|Overall Study|Adverse Event|1
138521|NCT00762476|497548|P1|Overall Study|Adverse Event|7
138522|NCT00762463|497560|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
138523|NCT00762463|497561|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
138524|NCT00762463|497562|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
138525|NCT00762463|497563|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
138526|NCT00762463|497560|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
138527|NCT00762463|497561|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
138528|NCT00762463|497562|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
138529|NCT00762463|497563|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
138530|NCT00762463|497560|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
138531|NCT00762463|497561|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
138532|NCT00762463|497562|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
138533|NCT00762463|497563|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
138534|NCT00762463|497560|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
138535|NCT00762463|497561|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
138536|NCT00762463|497562|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
138537|NCT00762463|497563|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
138538|NCT00762463|497560|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
138539|NCT00762463|497561|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
138540|NCT00762463|497562|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
138541|NCT00762463|497563|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
138542|NCT00762463|497560|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
138543|NCT00762463|497561|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
138544|NCT00762463|497562|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
138545|NCT00762463|497563|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
138546|NCT00762463|497560|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
138547|NCT00762463|497561|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
138548|NCT00762463|497562|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
138549|NCT00762463|497563|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
138550|NCT00762463|497560|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
138551|NCT00762463|497561|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
138552|NCT00762463|497562|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
138553|NCT00762463|497563|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
138554|NCT00762411|497669|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
138555|NCT00762411|497670|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
138556|NCT00762411|497669|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
138557|NCT00762411|497670|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
138558|NCT00762411|497669|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
138559|NCT00762411|497670|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
138560|NCT00762411|497669|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
138561|NCT00762411|497670|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
138562|NCT00762411|497669|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
138563|NCT00762411|497670|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
138564|NCT00762411|497669|P2|Safety Follow Up (SFU)-Optional|Death|8
138565|NCT00762411|497670|P1|Safety Follow Up (SFU)-Optional|Death|1
138566|NCT00762411|497669|P2|Delayed Start|Caregiver Decision|1
138567|NCT00762411|497670|P1|Delayed Start|Caregiver Decision|1
138568|NCT00762411|497669|P2|Delayed Start|Sponsor Decision|20
138569|NCT00762411|497670|P1|Delayed Start|Sponsor Decision|16
138570|NCT00762411|497669|P2|Delayed Start|Protocol Violation|1
138571|NCT00762411|497670|P1|Delayed Start|Protocol Violation|0
138572|NCT00762411|497669|P2|Delayed Start|Adverse Event|4
138573|NCT00762411|497670|P1|Delayed Start|Adverse Event|0
138574|NCT00762411|497669|P2|Initial Treatment|Entry Criteria Exclusion|1
138575|NCT00762411|497670|P1|Initial Treatment|Entry Criteria Exclusion|0
138576|NCT00762411|497669|P2|Initial Treatment|Abnormal Lab/ECG Result|4
138577|NCT00762411|497670|P1|Initial Treatment|Abnormal Lab/ECG Result|6
138578|NCT00762411|497669|P2|Initial Treatment|Caregiver Decision|16
138579|NCT00762411|497670|P1|Initial Treatment|Caregiver Decision|21
138580|NCT00762411|497669|P2|Initial Treatment|Lost to Follow-up|0
138581|NCT00762411|497670|P1|Initial Treatment|Lost to Follow-up|5
138582|NCT00762411|497669|P2|Initial Treatment|Sponsor Decision|401
138583|NCT00762411|497670|P1|Initial Treatment|Sponsor Decision|293
138584|NCT00762411|497669|P2|Initial Treatment|Physician Decision|0
138585|NCT00762411|497670|P1|Initial Treatment|Physician Decision|1
138586|NCT00762411|497669|P2|Initial Treatment|Withdrawal by Subject|52
138587|NCT00762411|497670|P1|Initial Treatment|Withdrawal by Subject|65
138588|NCT00762411|497669|P2|Initial Treatment|Protocol Violation|1
138589|NCT00762411|497670|P1|Initial Treatment|Protocol Violation|4
138590|NCT00762411|497669|P2|Initial Treatment|Adverse Event|40
138591|NCT00762411|497670|P1|Initial Treatment|Adverse Event|132
138592|NCT00762411|497669|P2|Initial Treatment|Death|6
138593|NCT00762411|497670|P1|Initial Treatment|Death|7
138594|NCT00762385|497734|P2|Second Intervention|Protocol Violation|3
138595|NCT00762385|497735|P1|Second Intervention|Protocol Violation|3
138596|NCT00762385|497734|P2|First Intervention|Protocol Violation|1
138597|NCT00762385|497735|P1|First Intervention|Protocol Violation|0
138598|NCT00762385|497734|P2|First Intervention|Ineligible|0
138599|NCT00762385|497735|P1|First Intervention|Ineligible|1
138600|NCT00762385|497734|P2|First Intervention|Lost to Follow-up|2
138601|NCT00762385|497735|P1|First Intervention|Lost to Follow-up|0
138602|NCT00762385|497734|P2|First Intervention|Lens Issue|1
138603|NCT00762385|497735|P1|First Intervention|Lens Issue|1
138604|NCT00762359|497747|P2|Overall Study|Withdrew consent|0
138605|NCT00762359|497748|P1|Overall Study|Withdrew consent|1
138606|NCT00762359|497747|P2|Overall Study|Removal|1
138607|NCT00762359|497748|P1|Overall Study|Removal|0
138608|NCT00762359|497747|P2|Overall Study|Physician Decision|3
138609|NCT00762359|497748|P1|Overall Study|Physician Decision|2
138610|NCT00762359|497747|P2|Overall Study|Institution closed|3
138611|NCT00762359|497748|P1|Overall Study|Institution closed|2
138612|NCT00762359|497747|P2|Overall Study|Lack of Efficacy|4
138613|NCT00762359|497748|P1|Overall Study|Lack of Efficacy|0
138614|NCT00762359|497747|P2|Overall Study|Withdrawal by Subject|10
138615|NCT00762359|497748|P1|Overall Study|Withdrawal by Subject|13
138616|NCT00762359|497747|P2|Overall Study|Protocol Violation|13
138617|NCT00762359|497748|P1|Overall Study|Protocol Violation|21
138618|NCT00762359|497747|P2|Overall Study|Adverse Event|23
138619|NCT00762359|497748|P1|Overall Study|Adverse Event|20
138620|NCT00762268|497865|P2|Overall Study|Protocol Violation|2
138621|NCT00762268|497866|P1|Overall Study|Protocol Violation|1
138622|NCT00762229|497874|P2|Overall Study|did not recveive intervention|1
138623|NCT00762229|497875|P1|Overall Study|did not recveive intervention|0
138624|NCT00762229|497874|P2|Overall Study|Lost to Follow-up|1
138625|NCT00762229|497875|P1|Overall Study|Lost to Follow-up|1
138626|NCT00762164|497972|P2|Overall Study|Withdrawal by Subject|1
138627|NCT00762164|497973|P1|Overall Study|Withdrawal by Subject|0
138628|NCT00762164|497972|P2|Overall Study|Discontinued medication|0
138629|NCT00762164|497973|P1|Overall Study|Discontinued medication|2
138630|NCT00762164|497972|P2|Overall Study|Lost to Follow-up|1
138631|NCT00762164|497973|P1|Overall Study|Lost to Follow-up|1
138632|NCT00762086|497983|P2|Overall Study|Ineligible to participate in the study|0
138633|NCT00762086|497984|P1|Overall Study|Ineligible to participate in the study|1
138634|NCT00762086|497983|P2|Overall Study|Withdrawal by Subject|2
138635|NCT00762086|497984|P1|Overall Study|Withdrawal by Subject|2
138636|NCT00762086|497983|P2|Overall Study|Non compliance|0
138637|NCT00762086|497984|P1|Overall Study|Non compliance|1
138638|NCT00762086|497983|P2|Overall Study|Lost to Follow-up|2
138639|NCT00762086|497984|P1|Overall Study|Lost to Follow-up|0
138640|NCT00762086|497983|P2|Overall Study|Adverse Event|0
138641|NCT00762086|497984|P1|Overall Study|Adverse Event|2
138642|NCT00762073|497994|P4|Overall Study|Not on treatment for >/= 77 days|0
138643|NCT00762073|497995|P3|Overall Study|Not on treatment for >/= 77 days|0
138644|NCT00762073|497996|P2|Overall Study|Not on treatment for >/= 77 days|0
138645|NCT00762073|497997|P1|Overall Study|Not on treatment for >/= 77 days|1
138646|NCT00762073|497994|P4|Overall Study|Withdrawal by Subject|1
138647|NCT00762073|497995|P3|Overall Study|Withdrawal by Subject|1
138648|NCT00762073|497996|P2|Overall Study|Withdrawal by Subject|2
138649|NCT00762073|497997|P1|Overall Study|Withdrawal by Subject|1
138650|NCT00762073|497994|P4|Overall Study|Significant Subject Noncompliance|1
138651|NCT00762073|497995|P3|Overall Study|Significant Subject Noncompliance|0
138652|NCT00762073|497996|P2|Overall Study|Significant Subject Noncompliance|1
138653|NCT00762073|497997|P1|Overall Study|Significant Subject Noncompliance|0
138654|NCT00762073|497994|P4|Overall Study|Adverse Event|1
138655|NCT00762073|497995|P3|Overall Study|Adverse Event|1
138656|NCT00762073|497996|P2|Overall Study|Adverse Event|0
138657|NCT00762073|497997|P1|Overall Study|Adverse Event|1
138658|NCT00762073|497994|P4|Overall Study|Lack of Efficacy|0
138659|NCT00762073|497995|P3|Overall Study|Lack of Efficacy|0
138660|NCT00762073|497996|P2|Overall Study|Lack of Efficacy|1
138661|NCT00762073|497997|P1|Overall Study|Lack of Efficacy|1
138662|NCT00762034|498061|P2|Maintenance Period|Other|1
138663|NCT00762034|498062|P1|Maintenance Period|Other|1
138664|NCT00762034|498061|P2|Maintenance Period|Death due to study disease|3
138665|NCT00762034|498062|P1|Maintenance Period|Death due to study disease|3
138666|NCT00762034|498061|P2|Maintenance Period|Death not due to study disease|5
138667|NCT00762034|498062|P1|Maintenance Period|Death not due to study disease|2
138668|NCT00762034|498061|P2|Maintenance Period|Withdrawal by Subject|14
138669|NCT00762034|498062|P1|Maintenance Period|Withdrawal by Subject|34
138670|NCT00762034|498061|P2|Maintenance Period|Physician Decision|20
138671|NCT00762034|498062|P1|Maintenance Period|Physician Decision|25
138672|NCT00762034|498061|P2|Maintenance Period|Progressive Disease|224
138673|NCT00762034|498062|P1|Maintenance Period|Progressive Disease|186
138674|NCT00762034|498061|P2|Maintenance Period|Adverse Event|26
138675|NCT00762034|498062|P1|Maintenance Period|Adverse Event|42
138676|NCT00762034|498061|P2|Maintenance Period|Entry Criterion Not Met|2
138677|NCT00762034|498062|P1|Maintenance Period|Entry Criterion Not Met|0
138678|NCT00762034|498061|P2|Maintenance Period|Protocol Violation|3
138679|NCT00762034|498062|P1|Maintenance Period|Protocol Violation|1
138680|NCT00762034|498061|P2|Induction Period|Deaths Due to Study Disease|9
138681|NCT00762034|498062|P1|Induction Period|Deaths Due to Study Disease|9
138682|NCT00762034|498061|P2|Induction Period|Deaths Not Due to Study Disease|14
138683|NCT00762034|498062|P1|Induction Period|Deaths Not Due to Study Disease|19
138684|NCT00762034|498061|P2|Induction Period|Withdrawal by Subject|19
138685|NCT00762034|498062|P1|Induction Period|Withdrawal by Subject|15
138686|NCT00762034|498061|P2|Induction Period|Physician Decision|20
138687|NCT00762034|498062|P1|Induction Period|Physician Decision|21
138688|NCT00762034|498061|P2|Induction Period|Progressive Disease|55
138689|NCT00762034|498062|P1|Induction Period|Progressive Disease|73
138690|NCT00762034|498061|P2|Induction Period|Lost to Follow-up|1
138691|NCT00762034|498062|P1|Induction Period|Lost to Follow-up|1
138692|NCT00762034|498061|P2|Induction Period|Adverse Event|38
138693|NCT00762034|498062|P1|Induction Period|Adverse Event|27
138694|NCT00762034|498061|P2|Induction Period|Entry Criterion Not Met|11
138695|NCT00762034|498062|P1|Induction Period|Entry Criterion Not Met|12
138696|NCT00762034|498061|P2|Induction Period|Protocol Violation|2
138697|NCT00762034|498062|P1|Induction Period|Protocol Violation|1
138698|NCT00761969|498134|P2|Overall Study|Lost to Follow-up|93
138699|NCT00761969|498135|P1|Overall Study|Lost to Follow-up|88
138700|NCT00761969|498134|P2|Overall Study|Death|47
138701|NCT00761969|498135|P1|Overall Study|Death|112
138702|NCT00761956|498145|P2|Overall Study|Adverse Event|34
138703|NCT00761956|498146|P1|Overall Study|Adverse Event|26
138704|NCT00761956|498145|P2|Overall Study|Death|1
138705|NCT00761956|498146|P1|Overall Study|Death|0
138706|NCT00761956|498145|P2|Overall Study|Withdrawal by Subject|8
138707|NCT00761956|498146|P1|Overall Study|Withdrawal by Subject|3
138708|NCT00761956|498145|P2|Overall Study|Lost to Follow-up|11
138709|NCT00761956|498146|P1|Overall Study|Lost to Follow-up|6
138710|NCT00761865|498175|P2|Overall Study|Lost to Follow-up|7
138711|NCT00761865|498176|P1|Overall Study|Lost to Follow-up|8
138712|NCT00761774|498197|P1|Overall Study|IP stopped by hospital physician|1
138713|NCT00761774|498197|P1|Overall Study|Subject IP non-compliance|1
138714|NCT00761774|498197|P1|Overall Study|Coordinator leaving site|1
138715|NCT00761774|498197|P1|Overall Study|Patient moved out of study area|1
138716|NCT00761774|498197|P1|Overall Study|Investigator clinical judgement|1
138717|NCT00761774|498197|P1|Overall Study|Sponsor decision|1
138718|NCT00761774|498197|P1|Overall Study|Medical decision to read SUSAR reports|1
138719|NCT00761774|498197|P1|Overall Study|Reclassification of seizures|1
138720|NCT00761774|498197|P1|Overall Study|End of study|2
138721|NCT00761774|498197|P1|Overall Study|Non-compliance|4
138722|NCT00761774|498197|P1|Overall Study|Withdrawal by Subject|9
138723|NCT00761774|498197|P1|Overall Study|Lost to Follow-up|2
138724|NCT00761774|498197|P1|Overall Study|Lack of Efficacy|37
138725|NCT00761774|498197|P1|Overall Study|Adverse Event|17
138726|NCT00761761|498208|P2|Overall Study|Withdrawal by Subject|0
138727|NCT00761761|498209|P1|Overall Study|Withdrawal by Subject|3
138728|NCT00761761|498208|P2|Overall Study|Lost to Follow-up|1
138729|NCT00761761|498209|P1|Overall Study|Lost to Follow-up|3
138730|NCT00761748|498221|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
138731|NCT00761748|498222|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
138732|NCT00761748|498221|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
138733|NCT00761748|498222|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
138734|NCT00761735|498228|P1|Overall Study|Administrative|1
138735|NCT00761735|498228|P1|Overall Study|Non-compliance with protocol|1
138736|NCT00761735|498228|P1|Overall Study|Withdrawal by Subject|6
138737|NCT00761735|498228|P1|Overall Study|Lost to Follow-up|6
138738|NCT00761631|498244|P6|Overall Study|Other|1
138739|NCT00761631|498245|P5|Overall Study|Other|1
138740|NCT00761631|498246|P4|Overall Study|Other|0
138741|NCT00761631|498247|P3|Overall Study|Other|0
138742|NCT00761631|498248|P2|Overall Study|Other|0
138743|NCT00761631|498249|P1|Overall Study|Other|0
138744|NCT00761631|498244|P6|Overall Study|Physician Decision|0
138745|NCT00761631|498245|P5|Overall Study|Physician Decision|0
138746|NCT00761631|498246|P4|Overall Study|Physician Decision|0
138747|NCT00761631|498247|P3|Overall Study|Physician Decision|0
138748|NCT00761631|498248|P2|Overall Study|Physician Decision|0
138749|NCT00761631|498249|P1|Overall Study|Physician Decision|1
138750|NCT00761631|498244|P6|Overall Study|Failed to return|2
138751|NCT00761631|498245|P5|Overall Study|Failed to return|5
138752|NCT00761631|498246|P4|Overall Study|Failed to return|1
138753|NCT00761631|498247|P3|Overall Study|Failed to return|1
138754|NCT00761631|498248|P2|Overall Study|Failed to return|0
138755|NCT00761631|498249|P1|Overall Study|Failed to return|1
138756|NCT00761631|498244|P6|Overall Study|Randomized, not treated|0
138757|NCT00761631|498245|P5|Overall Study|Randomized, not treated|0
138758|NCT00761631|498246|P4|Overall Study|Randomized, not treated|0
138759|NCT00761631|498247|P3|Overall Study|Randomized, not treated|0
138760|NCT00761631|498248|P2|Overall Study|Randomized, not treated|0
138761|NCT00761631|498249|P1|Overall Study|Randomized, not treated|1
138762|NCT00761631|498244|P6|Overall Study|Protocol Violation|1
138763|NCT00761631|498245|P5|Overall Study|Protocol Violation|5
138764|NCT00761631|498246|P4|Overall Study|Protocol Violation|1
138765|NCT00761631|498247|P3|Overall Study|Protocol Violation|0
138766|NCT00761631|498248|P2|Overall Study|Protocol Violation|0
138767|NCT00761631|498249|P1|Overall Study|Protocol Violation|2
138768|NCT00761631|498244|P6|Overall Study|Lost to Follow-up|1
138769|NCT00761631|498245|P5|Overall Study|Lost to Follow-up|6
138770|NCT00761631|498246|P4|Overall Study|Lost to Follow-up|1
138771|NCT00761631|498247|P3|Overall Study|Lost to Follow-up|7
138772|NCT00761631|498248|P2|Overall Study|Lost to Follow-up|4
138773|NCT00761631|498249|P1|Overall Study|Lost to Follow-up|2
138774|NCT00761631|498244|P6|Overall Study|Parent/legal guardian request|0
138775|NCT00761631|498245|P5|Overall Study|Parent/legal guardian request|5
138776|NCT00761631|498246|P4|Overall Study|Parent/legal guardian request|0
138777|NCT00761631|498247|P3|Overall Study|Parent/legal guardian request|8
138778|NCT00761631|498248|P2|Overall Study|Parent/legal guardian request|3
138779|NCT00761631|498249|P1|Overall Study|Parent/legal guardian request|8
138780|NCT00761605|498284|P1|Overall Study|Other|21
138781|NCT00761605|498284|P1|Overall Study|Withdrawal by Subject|37
138782|NCT00761605|498284|P1|Overall Study|Lost to Follow-up|29
138783|NCT00761605|498284|P1|Overall Study|Lack of Efficacy|26
138784|NCT00761605|498284|P1|Overall Study|Death|2
138785|NCT00761605|498284|P1|Overall Study|Adverse Event|26
138786|NCT00761579|498328|P1|Overall Study|Intake of prohibited concomitant drug|1
138787|NCT00761579|498328|P1|Overall Study|Lost survey form|1
138788|NCT00761579|498328|P1|Overall Study|Aggravation of symptoms by changing drug|1
138789|NCT00761579|498328|P1|Overall Study|Aggravation of depression|1
138790|NCT00761579|498328|P1|Overall Study|Drug overdose|1
138791|NCT00761579|498328|P1|Overall Study|Protocol deviation|1
138792|NCT00761579|498328|P1|Overall Study|Lack of compliance|2
138793|NCT00761579|498328|P1|Overall Study|Withdrawal by Subject|34
138794|NCT00761579|498328|P1|Overall Study|Pregnancy|1
138795|NCT00761579|498328|P1|Overall Study|Lost to Follow-up|16
138796|NCT00761579|498328|P1|Overall Study|Lack of Efficacy|21
138797|NCT00761579|498328|P1|Overall Study|Death|2
138798|NCT00761579|498328|P1|Overall Study|Adverse Event|10
138799|NCT00761527|498361|P1|Overall Study|Unknown reason|2
138800|NCT00761527|498361|P1|Overall Study|Lost to Follow-up|9
138801|NCT00761527|498361|P1|Overall Study|Poor Compliance|8
138802|NCT00761527|498361|P1|Overall Study|Adverse Event|3
138803|NCT00761514|498368|P1|Overall Study|Unable to pay for medications|1
138804|NCT00761514|498368|P1|Overall Study|Problem complying with study visit|1
138805|NCT00761514|498368|P1|Overall Study|Health insurance didn't cover study drug|1
138806|NCT00761514|498368|P1|Overall Study|Lost to Follow-up|1
138807|NCT00761514|498368|P1|Overall Study|Withdrawal by Subject|2
138808|NCT00761514|498368|P1|Overall Study|Adverse Event|1
138809|NCT00761462|498375|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
138810|NCT00761462|498376|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
138811|NCT00761462|498375|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
138812|NCT00761462|498376|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
138813|NCT00761462|498375|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
138814|NCT00761462|498376|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
138815|NCT00761462|498375|P2|Treatment|Subjects never received study medication|12
138816|NCT00761462|498376|P1|Treatment|Subjects never received study medication|23
138817|NCT00761319|498390|P2|Overall Study|Missing|0
138818|NCT00761319|498391|P1|Overall Study|Missing|1
138819|NCT00761319|498390|P2|Overall Study|Nonspecified|2
138820|NCT00761319|498391|P1|Overall Study|Nonspecified|2
138821|NCT00761319|498390|P2|Overall Study|Lost to Follow-up|1
138822|NCT00761319|498391|P1|Overall Study|Lost to Follow-up|1
138823|NCT00761319|498390|P2|Overall Study|Noncompliance|3
138824|NCT00761319|498391|P1|Overall Study|Noncompliance|4
138825|NCT00761319|498390|P2|Overall Study|Withdrawal by Subject|7
138826|NCT00761319|498391|P1|Overall Study|Withdrawal by Subject|8
138827|NCT00761319|498390|P2|Overall Study|Adverse Event|7
138828|NCT00761319|498391|P1|Overall Study|Adverse Event|11
138829|NCT00761319|498390|P2|Overall Study|Protocol Violation|14
138830|NCT00761319|498391|P1|Overall Study|Protocol Violation|21
138831|NCT00761306|498399|P1|Overall Study|Administrative or Other Reasons|5
138832|NCT00761306|498399|P1|Overall Study|Lost to Follow-up|1
138833|NCT00761306|498399|P1|Overall Study|Withdrawal of Consent|3
138834|NCT00761306|498399|P1|Overall Study|Protocol Violation|2
138835|NCT00761306|498399|P1|Overall Study|Lack of Efficacy|4
138836|NCT00761306|498399|P1|Overall Study|Adverse Event|5
138837|NCT00761280|498410|P2|First Dose to End of Study|Lost to Follow-up|1
138838|NCT00761280|498411|P1|First Dose to End of Study|Lost to Follow-up|0
138839|NCT00761280|498410|P2|First Dose to End of Study|Death|0
138840|NCT00761280|498411|P1|First Dose to End of Study|Death|1
138841|NCT00761280|498410|P2|First Dose to End of Study|Sponsor decision|2
138842|NCT00761280|498411|P1|First Dose to End of Study|Sponsor decision|1
138843|NCT00761280|498410|P2|First Dose to End of Study|Progressive disease|3
138844|NCT00761280|498411|P1|First Dose to End of Study|Progressive disease|5
138845|NCT00761280|498410|P2|First Dose to End of Study|End of trial|5
138846|NCT00761280|498411|P1|First Dose to End of Study|End of trial|5
138847|NCT00761280|498410|P2|Randomization to First Dose|Other|0
138848|NCT00761280|498411|P1|Randomization to First Dose|Other|1
138849|NCT00761280|498410|P2|Randomization to First Dose|Sponsor decision|0
138850|NCT00761280|498411|P1|Randomization to First Dose|Sponsor decision|1
138851|NCT00761280|498410|P2|Randomization to First Dose|Withdrawal by Subject|2
138852|NCT00761280|498411|P1|Randomization to First Dose|Withdrawal by Subject|0
138853|NCT00761215|498442|P3|Overall Study|Bacteremia|0
138854|NCT00761215|498443|P2|Overall Study|Bacteremia|0
138855|NCT00761215|498444|P1|Overall Study|Bacteremia|1
138856|NCT00761215|498442|P3|Overall Study|Withdrawal by Subject|0
138857|NCT00761215|498443|P2|Overall Study|Withdrawal by Subject|0
138858|NCT00761215|498444|P1|Overall Study|Withdrawal by Subject|1
138859|NCT00761215|498442|P3|Overall Study|Lost to Follow-up|6
138860|NCT00761215|498443|P2|Overall Study|Lost to Follow-up|3
138861|NCT00761215|498444|P1|Overall Study|Lost to Follow-up|6
138862|NCT00761215|498442|P3|Overall Study|Randomized but didn't receive drug|2
138863|NCT00761215|498443|P2|Overall Study|Randomized but didn't receive drug|1
138864|NCT00761215|498444|P1|Overall Study|Randomized but didn't receive drug|1
138865|NCT00761189|498486|P1|Overall Study|Other|13
138866|NCT00761189|498486|P1|Overall Study|Withdrawal by Subject|49
138867|NCT00761189|498486|P1|Overall Study|Lost to Follow-up|36
138868|NCT00761189|498486|P1|Overall Study|Lack of Efficacy|45
138869|NCT00761189|498486|P1|Overall Study|Adverse Event|42
138870|NCT00761176|498503|P2|Overall Study|Withdrawal by Subject|1
138871|NCT00761176|498504|P1|Overall Study|Withdrawal by Subject|1
138872|NCT00761176|498503|P2|Overall Study|Death|0
138873|NCT00761176|498504|P1|Overall Study|Death|1
138874|NCT00761150|498513|P3|Double-blind Period|Not specified|3
138875|NCT00761150|498514|P2|Double-blind Period|Not specified|3
138876|NCT00761150|498515|P1|Double-blind Period|Not specified|0
138877|NCT00761150|498513|P3|Double-blind Period|Noncompliance|0
138878|NCT00761150|498514|P2|Double-blind Period|Noncompliance|1
138879|NCT00761150|498515|P1|Double-blind Period|Noncompliance|0
138880|NCT00761150|498513|P3|Double-blind Period|Did not meet DB randomization criteria|1
138881|NCT00761150|498514|P2|Double-blind Period|Did not meet DB randomization criteria|0
138882|NCT00761150|498515|P1|Double-blind Period|Did not meet DB randomization criteria|0
138883|NCT00761150|498513|P3|Double-blind Period|Lost to Follow-up|1
138884|NCT00761150|498514|P2|Double-blind Period|Lost to Follow-up|2
138885|NCT00761150|498515|P1|Double-blind Period|Lost to Follow-up|0
138886|NCT00761150|498513|P3|Double-blind Period|Withdrawal by Subject|2
138887|NCT00761150|498514|P2|Double-blind Period|Withdrawal by Subject|3
138888|NCT00761150|498515|P1|Double-blind Period|Withdrawal by Subject|0
138889|NCT00761150|498513|P3|Double-blind Period|Adverse Event|3
138890|NCT00761150|498514|P2|Double-blind Period|Adverse Event|3
138891|NCT00761150|498515|P1|Double-blind Period|Adverse Event|0
138892|NCT00761150|498513|P3|Double-blind Period|Lack of Efficacy|19
138893|NCT00761150|498514|P2|Double-blind Period|Lack of Efficacy|2
138894|NCT00761150|498515|P1|Double-blind Period|Lack of Efficacy|0
138895|NCT00761150|498513|P3|Open-label Period|Not specified|0
138896|NCT00761150|498514|P2|Open-label Period|Not specified|0
138897|NCT00761150|498515|P1|Open-label Period|Not specified|5
138898|NCT00761150|498513|P3|Open-label Period|Noncompliance|0
138899|NCT00761150|498514|P2|Open-label Period|Noncompliance|0
138900|NCT00761150|498515|P1|Open-label Period|Noncompliance|2
138901|NCT00761150|498513|P3|Open-label Period|Withdrawal by Subject|0
138902|NCT00761150|498514|P2|Open-label Period|Withdrawal by Subject|0
138903|NCT00761150|498515|P1|Open-label Period|Withdrawal by Subject|5
138904|NCT00761150|498513|P3|Open-label Period|Lack of Efficacy|0
138905|NCT00761150|498514|P2|Open-label Period|Lack of Efficacy|0
138906|NCT00761150|498515|P1|Open-label Period|Lack of Efficacy|4
138907|NCT00761150|498513|P3|Open-label Period|Lost to Follow-up|0
138908|NCT00761150|498514|P2|Open-label Period|Lost to Follow-up|0
138909|NCT00761150|498515|P1|Open-label Period|Lost to Follow-up|7
138910|NCT00761150|498513|P3|Open-label Period|Did not meet DB randomization criteria|0
138911|NCT00761150|498514|P2|Open-label Period|Did not meet DB randomization criteria|0
138912|NCT00761150|498515|P1|Open-label Period|Did not meet DB randomization criteria|11
138913|NCT00761150|498513|P3|Open-label Period|Adverse Event|0
138914|NCT00761150|498514|P2|Open-label Period|Adverse Event|0
138915|NCT00761150|498515|P1|Open-label Period|Adverse Event|36
138916|NCT00760877|498566|P2|Overall Study|Treatment failure|0
138917|NCT00760877|498567|P1|Overall Study|Treatment failure|1
138918|NCT00760877|498566|P2|Overall Study|Participants transferred to AMN107A2408|1
138919|NCT00760877|498567|P1|Overall Study|Participants transferred to AMN107A2408|11
138920|NCT00760877|498566|P2|Overall Study|Physician Decision|2
138921|NCT00760877|498567|P1|Overall Study|Physician Decision|1
138922|NCT00760877|498566|P2|Overall Study|Participant not eligible to cross-over|1
138923|NCT00760877|498567|P1|Overall Study|Participant not eligible to cross-over|0
138924|NCT00760877|498566|P2|Overall Study|Participant diagnosed with AML|1
138925|NCT00760877|498567|P1|Overall Study|Participant diagnosed with AML|0
138926|NCT00760877|498566|P2|Overall Study|Adverse Event|12
138927|NCT00760877|498567|P1|Overall Study|Adverse Event|19
138928|NCT00760877|498566|P2|Overall Study|Withdrawal by Subject|3
138929|NCT00760877|498567|P1|Overall Study|Withdrawal by Subject|7
138930|NCT00760877|498566|P2|Overall Study|Death|1
138931|NCT00760877|498567|P1|Overall Study|Death|2
138932|NCT00760877|498566|P2|Overall Study|Pregnancy|4
138933|NCT00760877|498567|P1|Overall Study|Pregnancy|1
138934|NCT00760877|498566|P2|Overall Study|Non-compliance with protocol treatment|1
138935|NCT00760877|498567|P1|Overall Study|Non-compliance with protocol treatment|2
138936|NCT00760877|498566|P2|Overall Study|Protocol Violation|0
138937|NCT00760877|498567|P1|Overall Study|Protocol Violation|1
138938|NCT00760838|498585|P2|Overall Study|Withdrawal by Subject|1
138939|NCT00760838|498586|P1|Overall Study|Withdrawal by Subject|1
138940|NCT00760838|498585|P2|Overall Study|Lost to Follow-up|0
138941|NCT00760838|498586|P1|Overall Study|Lost to Follow-up|2
138942|NCT00760838|498585|P2|Overall Study|Lack of Efficacy|0
138943|NCT00760838|498586|P1|Overall Study|Lack of Efficacy|1
138944|NCT00760838|498585|P2|Overall Study|Adverse Event|1
138945|NCT00760838|498586|P1|Overall Study|Adverse Event|1
138946|NCT00760747|498604|P2|Study Period III|Physician Decision|1
138947|NCT00760747|498605|P1|Study Period III|Physician Decision|0
138948|NCT00760747|498604|P2|Study Period III|Protocol Violation|1
138949|NCT00760747|498605|P1|Study Period III|Protocol Violation|1
138950|NCT00760747|498604|P2|Study Period III|Parent/Caregiver Decision|1
138951|NCT00760747|498605|P1|Study Period III|Parent/Caregiver Decision|0
138952|NCT00760747|498604|P2|Study Period III|Lack of Efficacy|0
138953|NCT00760747|498605|P1|Study Period III|Lack of Efficacy|1
138954|NCT00760747|498604|P2|Study Period III|Adverse Event|0
138955|NCT00760747|498605|P1|Study Period III|Adverse Event|1
138956|NCT00760747|498604|P2|Study Period II|No drug administered|1
138957|NCT00760747|498605|P1|Study Period II|No drug administered|0
138958|NCT00760747|498604|P2|Study Period II|Withdrawal by Subject|0
138959|NCT00760747|498605|P1|Study Period II|Withdrawal by Subject|1
138960|NCT00760747|498604|P2|Study Period II|Protocol Violation|3
138961|NCT00760747|498605|P1|Study Period II|Protocol Violation|6
138962|NCT00760747|498604|P2|Study Period II|Parent/Caregiver Decision|0
138963|NCT00760747|498605|P1|Study Period II|Parent/Caregiver Decision|3
138964|NCT00760747|498604|P2|Study Period II|Lack of Efficacy|6
138965|NCT00760747|498605|P1|Study Period II|Lack of Efficacy|0
138966|NCT00760747|498604|P2|Study Period II|Adverse Event|4
138967|NCT00760747|498605|P1|Study Period II|Adverse Event|3
138968|NCT00760669|498633|P1|Overall Study|Took drug before entering in contract|5
138969|NCT00760669|498633|P1|Overall Study|Participants with overlapping cases|1
138970|NCT00760669|498633|P1|Overall Study|Participants missing efficacy assessment|6
138971|NCT00760669|498633|P1|Overall Study|Not assessed for overall improvement|18
138972|NCT00760617|498650|P3|Overall Study|Lost to Follow-up|5
138973|NCT00760617|498651|P2|Overall Study|Lost to Follow-up|0
138974|NCT00760617|498652|P1|Overall Study|Lost to Follow-up|0
138975|NCT00760617|498650|P3|Overall Study|Adverse Event|0
138976|NCT00760617|498651|P2|Overall Study|Adverse Event|2
138977|NCT00760617|498652|P1|Overall Study|Adverse Event|5
138978|NCT00760552|498766|P2|Overall Study|Lost to Follow-up|10
138979|NCT00760552|498767|P1|Overall Study|Lost to Follow-up|11
138980|NCT00760552|498766|P2|Overall Study|Death|0
138981|NCT00760552|498767|P1|Overall Study|Death|2
138982|NCT00760487|498801|P1|Overall Study|Unilateral implantation|3
138983|NCT00760474|498807|P2|Period 2 (P2)|Adverse Event|1
138984|NCT00760474|498808|P1|Period 2 (P2)|Adverse Event|0
138985|NCT00760474|498807|P2|Period 2 (P2)|Lost to Follow-up|0
138986|NCT00760474|498808|P1|Period 2 (P2)|Lost to Follow-up|1
138987|NCT00760474|498807|P2|Placebo Washout Period|Other|1
138988|NCT00760474|498808|P1|Placebo Washout Period|Other|0
138989|NCT00760474|498807|P2|Period 1 (P1)|Discontinued then re-entered|1
138990|NCT00760474|498808|P1|Period 1 (P1)|Discontinued then re-entered|1
138991|NCT00760383|498865|P2|Overall Study|moved away; withdrew; medical reasons|7
138992|NCT00760383|498866|P1|Overall Study|moved away; withdrew; medical reasons|5
138993|NCT00760266|498878|P2|Overall Study|Administrative Problems|1
138994|NCT00760266|498879|P1|Overall Study|Administrative Problems|0
138995|NCT00760266|498878|P2|Overall Study|Lost to Follow-up|1
138996|NCT00760266|498879|P1|Overall Study|Lost to Follow-up|2
138997|NCT00760266|498878|P2|Overall Study|Patient withdrew consent|3
138998|NCT00760266|498879|P1|Overall Study|Patient withdrew consent|3
138999|NCT00760266|498878|P2|Overall Study|Protocol deviation|4
139000|NCT00760266|498879|P1|Overall Study|Protocol deviation|2
139001|NCT00760266|498878|P2|Overall Study|Lack of Efficacy|2
139002|NCT00760266|498879|P1|Overall Study|Lack of Efficacy|2
139003|NCT00760266|498878|P2|Overall Study|Abnormal test procedure result(s)|0
139004|NCT00760266|498879|P1|Overall Study|Abnormal test procedure result(s)|1
139005|NCT00760266|498878|P2|Overall Study|Abnormal laboratory value(s)|0
139006|NCT00760266|498879|P1|Overall Study|Abnormal laboratory value(s)|1
139007|NCT00760266|498878|P2|Overall Study|Adverse Event|7
139008|NCT00760266|498879|P1|Overall Study|Adverse Event|13
139009|NCT00760214|498896|P3|Overall Study|Other|6
139010|NCT00760214|498897|P2|Overall Study|Other|4
139011|NCT00760214|498898|P1|Overall Study|Other|3
139012|NCT00760214|498896|P3|Overall Study|Physician Decision|1
139013|NCT00760214|498897|P2|Overall Study|Physician Decision|1
139014|NCT00760214|498898|P1|Overall Study|Physician Decision|1
139015|NCT00760214|498896|P3|Overall Study|Pregnancy|1
139016|NCT00760214|498897|P2|Overall Study|Pregnancy|0
139017|NCT00760214|498898|P1|Overall Study|Pregnancy|0
139018|NCT00760214|498896|P3|Overall Study|Lack of Efficacy|4
139019|NCT00760214|498897|P2|Overall Study|Lack of Efficacy|2
139020|NCT00760214|498898|P1|Overall Study|Lack of Efficacy|3
139021|NCT00760214|498896|P3|Overall Study|Withdrawal by Subject|13
139022|NCT00760214|498897|P2|Overall Study|Withdrawal by Subject|14
139023|NCT00760214|498898|P1|Overall Study|Withdrawal by Subject|12
139024|NCT00760214|498896|P3|Overall Study|Lost to Follow-up|1
139025|NCT00760214|498897|P2|Overall Study|Lost to Follow-up|0
139026|NCT00760214|498898|P1|Overall Study|Lost to Follow-up|0
139027|NCT00760214|498896|P3|Overall Study|Protocol Violation|3
139028|NCT00760214|498897|P2|Overall Study|Protocol Violation|0
139029|NCT00760214|498898|P1|Overall Study|Protocol Violation|3
139030|NCT00760214|498896|P3|Overall Study|Adverse Event|12
139031|NCT00760214|498897|P2|Overall Study|Adverse Event|9
139032|NCT00760214|498898|P1|Overall Study|Adverse Event|8
139033|NCT00760084|498939|P1|Overall Study|Progressive Disease|3
139034|NCT00760084|498939|P1|Overall Study|Withdrawal by Subject|2
139035|NCT00760084|498939|P1|Overall Study|Physician Decision|5
139036|NCT00759954|498982|P2|Overall Study|Adverse Event|2
139037|NCT00759954|498983|P1|Overall Study|Adverse Event|1
139038|NCT00759954|498982|P2|Overall Study|Personal reason|0
139039|NCT00759954|498983|P1|Overall Study|Personal reason|1
139040|NCT00759941|498997|P2|Overall Study|Exited in error by site|1
139041|NCT00759941|498998|P1|Overall Study|Exited in error by site|1
139042|NCT00759941|498997|P2|Overall Study|Adverse Event|0
139043|NCT00759941|498998|P1|Overall Study|Adverse Event|1
139044|NCT00759941|498997|P2|Overall Study|Use of medication|0
139045|NCT00759941|498998|P1|Overall Study|Use of medication|1
139046|NCT00759915|499012|P2|Overall Study|Adverse Event|1
139047|NCT00759915|499013|P1|Overall Study|Adverse Event|0
139048|NCT00759915|499012|P2|Overall Study|Withdrawal by Subject|0
139049|NCT00759915|499013|P1|Overall Study|Withdrawal by Subject|1
139050|NCT00759902|499027|P2|Overall Study|Adverse Event|1
139051|NCT00759902|499028|P1|Overall Study|Adverse Event|0
139052|NCT00759863|499042|P2|Overall Study|Death, moved, or lost contact|18
139053|NCT00759863|499043|P1|Overall Study|Death, moved, or lost contact|20
139054|NCT00759785|499064|P2|Overall Study|Withdrawal by Subject|1
139055|NCT00759785|499065|P1|Overall Study|Withdrawal by Subject|0
139056|NCT00759785|499064|P2|Overall Study|Physician Decision|1
139057|NCT00759785|499065|P1|Overall Study|Physician Decision|0
139058|NCT00759785|499064|P2|Overall Study|Protocol Violation|0
139059|NCT00759785|499065|P1|Overall Study|Protocol Violation|1
139060|NCT00759785|499064|P2|Overall Study|Participant sample lost|1
139061|NCT00759785|499065|P1|Overall Study|Participant sample lost|0
139062|NCT00759785|499064|P2|Overall Study|Participant sample not evaluable|2
139063|NCT00759785|499065|P1|Overall Study|Participant sample not evaluable|11
139064|NCT00759759|499088|P2|Overall Study|Withdrawal by Subject|1
139065|NCT00759759|499089|P1|Overall Study|Withdrawal by Subject|2
139066|NCT00759759|499088|P2|Overall Study|Didn't receive drug in period 2|0
139067|NCT00759759|499089|P1|Overall Study|Didn't receive drug in period 2|1
139068|NCT00759759|499088|P2|Overall Study|didn't return for period 2|0
139069|NCT00759759|499089|P1|Overall Study|didn't return for period 2|1
139070|NCT00759681|499107|P2|Overall Study|Lost to Follow-up|5
139071|NCT00759681|499108|P1|Overall Study|Lost to Follow-up|8
139072|NCT00759681|499107|P2|Overall Study|Death|5
139073|NCT00759681|499108|P1|Overall Study|Death|2
139074|NCT00759655|499135|P1|Overall Study|Termination of the study by sponsor|1
139075|NCT00759564|499163|P5|Washout Period (at Least 14 Days)|Adverse Event|1
139076|NCT00759564|499164|P4|Washout Period (at Least 14 Days)|Adverse Event|0
139077|NCT00759564|499165|P3|Washout Period (at Least 14 Days)|Adverse Event|0
139078|NCT00759564|499166|P2|Washout Period (at Least 14 Days)|Adverse Event|0
139079|NCT00759564|499167|P1|Washout Period (at Least 14 Days)|Adverse Event|0
139080|NCT00759395|499337|P2|Overall Study|Lack of Efficacy|2
139081|NCT00759395|499338|P1|Overall Study|Lack of Efficacy|0
139082|NCT00759395|499337|P2|Overall Study|Withdrawal by Subject|0
139083|NCT00759395|499338|P1|Overall Study|Withdrawal by Subject|1
139084|NCT00759395|499337|P2|Overall Study|Adverse Event|0
139085|NCT00759395|499338|P1|Overall Study|Adverse Event|1
139086|NCT00759356|499354|P2|Overall Study|Subject was unable to return|0
139087|NCT00759356|499355|P1|Overall Study|Subject was unable to return|1
139088|NCT00759356|499354|P2|Overall Study|Withdrawal by Subject|2
139089|NCT00759356|499355|P1|Overall Study|Withdrawal by Subject|0
139090|NCT00759356|499354|P2|Overall Study|Adverse Event|1
139091|NCT00759356|499355|P1|Overall Study|Adverse Event|0
139092|NCT00759174|499435|P2|Overall Study|Other|2
139093|NCT00759174|499436|P1|Overall Study|Other|0
139094|NCT00759148|499460|P2|Overall Study|Reason not given|0
139095|NCT00759148|499461|P1|Overall Study|Reason not given|1
139096|NCT00759148|499460|P2|Overall Study|Treatment Failure|10
139097|NCT00759148|499461|P1|Overall Study|Treatment Failure|6
139098|NCT00759148|499460|P2|Overall Study|Lost to Follow-up|9
139099|NCT00759148|499461|P1|Overall Study|Lost to Follow-up|3
139100|NCT00759148|499460|P2|Overall Study|Withdrawal by Subject|7
139101|NCT00759148|499461|P1|Overall Study|Withdrawal by Subject|3
139102|NCT00759148|499460|P2|Overall Study|Adverse Event|6
139103|NCT00759148|499461|P1|Overall Study|Adverse Event|1
139104|NCT00759109|499471|P2|Overall Study|Lost during study|0
139105|NCT00759109|499472|P1|Overall Study|Lost during study|1
139106|NCT00759109|499471|P2|Overall Study|Participant had a liver transplant|1
139107|NCT00759109|499472|P1|Overall Study|Participant had a liver transplant|0
139108|NCT00759109|499471|P2|Overall Study|Participant moved to a different city|1
139109|NCT00759109|499472|P1|Overall Study|Participant moved to a different city|0
139110|NCT00759109|499471|P2|Overall Study|HCV RNA negative|0
139111|NCT00759109|499472|P1|Overall Study|HCV RNA negative|1
139112|NCT00759109|499471|P2|Overall Study|Started new therapy|6
139113|NCT00759109|499472|P1|Overall Study|Started new therapy|2
139114|NCT00759109|499471|P2|Overall Study|Lost to Follow-up|6
139115|NCT00759109|499472|P1|Overall Study|Lost to Follow-up|4
139116|NCT00759109|499471|P2|Overall Study|Death|3
139117|NCT00759109|499472|P1|Overall Study|Death|4
139118|NCT00759109|499471|P2|Overall Study|Withdrawal by Subject|5
139119|NCT00759109|499472|P1|Overall Study|Withdrawal by Subject|9
139120|NCT00759109|499471|P2|Overall Study|Inability to comply|1
139121|NCT00759109|499472|P1|Overall Study|Inability to comply|1
139122|NCT00759109|499471|P2|Overall Study|Adverse Event|12
139123|NCT00759109|499472|P1|Overall Study|Adverse Event|17
139124|NCT00759031|499494|P2|First Intervention (1 Day)|Screening failure|0
139125|NCT00759031|499495|P1|First Intervention (1 Day)|Screening failure|1
139126|NCT00759031|499494|P2|First Intervention (1 Day)|Withdrawal by Subject|1
139127|NCT00759031|499495|P1|First Intervention (1 Day)|Withdrawal by Subject|0
139128|NCT00759031|499494|P2|First Intervention (1 Day)|Physician Decision|0
139129|NCT00759031|499495|P1|First Intervention (1 Day)|Physician Decision|1
139130|NCT00758771|499532|P2|Overall Study|Did not meet eligibility criteria|4
139131|NCT00758771|499533|P1|Overall Study|Did not meet eligibility criteria|2
139132|NCT00758771|499532|P2|Overall Study|Withdrawal by Subject|1
139133|NCT00758771|499533|P1|Overall Study|Withdrawal by Subject|1
139134|NCT00758706|499591|P2|Overall Study|Adverse Event|4
139135|NCT00758706|499592|P1|Overall Study|Adverse Event|4
139136|NCT00758680|499628|P10|Overall Study|Withdrawal by Subject|0
139137|NCT00758680|499629|P9|Overall Study|Withdrawal by Subject|1
139138|NCT00758680|499630|P8|Overall Study|Withdrawal by Subject|0
139139|NCT00758680|499631|P7|Overall Study|Withdrawal by Subject|1
139140|NCT00758680|499632|P6|Overall Study|Withdrawal by Subject|0
139141|NCT00758680|499633|P5|Overall Study|Withdrawal by Subject|0
139142|NCT00758680|499634|P4|Overall Study|Withdrawal by Subject|0
139143|NCT00758680|499635|P3|Overall Study|Withdrawal by Subject|0
139144|NCT00758680|499636|P2|Overall Study|Withdrawal by Subject|0
139145|NCT00758680|499637|P1|Overall Study|Withdrawal by Subject|0
139146|NCT00758680|499628|P10|Overall Study|Laboratory Adverse Event|0
139147|NCT00758680|499629|P9|Overall Study|Laboratory Adverse Event|1
139148|NCT00758680|499630|P8|Overall Study|Laboratory Adverse Event|0
139149|NCT00758680|499631|P7|Overall Study|Laboratory Adverse Event|0
139150|NCT00758680|499632|P6|Overall Study|Laboratory Adverse Event|0
139151|NCT00758680|499633|P5|Overall Study|Laboratory Adverse Event|0
139152|NCT00758680|499634|P4|Overall Study|Laboratory Adverse Event|0
139153|NCT00758680|499635|P3|Overall Study|Laboratory Adverse Event|0
139154|NCT00758680|499636|P2|Overall Study|Laboratory Adverse Event|0
139155|NCT00758680|499637|P1|Overall Study|Laboratory Adverse Event|0
139156|NCT00758680|499628|P10|Overall Study|Adverse Event|1
139157|NCT00758680|499629|P9|Overall Study|Adverse Event|0
139158|NCT00758680|499630|P8|Overall Study|Adverse Event|1
139159|NCT00758680|499631|P7|Overall Study|Adverse Event|0
139160|NCT00758680|499632|P6|Overall Study|Adverse Event|0
139161|NCT00758680|499633|P5|Overall Study|Adverse Event|0
139162|NCT00758680|499634|P4|Overall Study|Adverse Event|0
139163|NCT00758680|499635|P3|Overall Study|Adverse Event|0
139164|NCT00758680|499636|P2|Overall Study|Adverse Event|0
139165|NCT00758680|499637|P1|Overall Study|Adverse Event|0
139166|NCT00758602|499690|P2|Overall Study|Reason not specified|3
139167|NCT00758602|499691|P1|Overall Study|Reason not specified|3
139168|NCT00758602|499690|P2|Overall Study|Death|1
139169|NCT00758602|499691|P1|Overall Study|Death|0
139170|NCT00758602|499690|P2|Overall Study|Protocol Violation|2
139171|NCT00758602|499691|P1|Overall Study|Protocol Violation|0
139172|NCT00758602|499690|P2|Overall Study|Withdrawal by Subject|3
139173|NCT00758602|499691|P1|Overall Study|Withdrawal by Subject|1
139174|NCT00758602|499690|P2|Overall Study|Lost to Follow-up|3
139175|NCT00758602|499691|P1|Overall Study|Lost to Follow-up|4
139176|NCT00758602|499690|P2|Overall Study|Adverse Event|10
139177|NCT00758602|499691|P1|Overall Study|Adverse Event|11
139178|NCT00758589|499717|P4|Overall Study|Palm stopped to work|1
139179|NCT00758589|499718|P3|Overall Study|Palm stopped to work|0
139180|NCT00758589|499719|P2|Overall Study|Palm stopped to work|0
139181|NCT00758589|499720|P1|Overall Study|Palm stopped to work|0
139182|NCT00758589|499717|P4|Overall Study|Withdrawal by Subject|1
139183|NCT00758589|499718|P3|Overall Study|Withdrawal by Subject|1
139184|NCT00758589|499719|P2|Overall Study|Withdrawal by Subject|1
139185|NCT00758589|499720|P1|Overall Study|Withdrawal by Subject|0
139186|NCT00758589|499717|P4|Overall Study|Adverse Event|4
139187|NCT00758589|499718|P3|Overall Study|Adverse Event|5
139188|NCT00758589|499719|P2|Overall Study|Adverse Event|2
139189|NCT00758589|499720|P1|Overall Study|Adverse Event|3
139190|NCT00758498|499813|P3|Overall Study|Noncompliance to study procedures|1
139191|NCT00758498|499814|P2|Overall Study|Noncompliance to study procedures|0
139192|NCT00758498|499815|P1|Overall Study|Noncompliance to study procedures|0
139193|NCT00758498|499813|P3|Overall Study|Withdrawal by Subject|1
139194|NCT00758498|499814|P2|Overall Study|Withdrawal by Subject|0
139195|NCT00758498|499815|P1|Overall Study|Withdrawal by Subject|0
139196|NCT00758498|499813|P3|Overall Study|Subject legally detained out of state|0
139197|NCT00758498|499814|P2|Overall Study|Subject legally detained out of state|0
139198|NCT00758498|499815|P1|Overall Study|Subject legally detained out of state|1
139199|NCT00758498|499813|P3|Overall Study|Adverse Event|3
139200|NCT00758498|499814|P2|Overall Study|Adverse Event|2
139201|NCT00758498|499815|P1|Overall Study|Adverse Event|2
139202|NCT00758485|499900|P2|Overall Study|Not Treated|2
139203|NCT00758485|499901|P1|Overall Study|Not Treated|1
139204|NCT00758485|499900|P2|Overall Study|Lost to Follow-up|1
139205|NCT00758485|499901|P1|Overall Study|Lost to Follow-up|0
139206|NCT00758459|499913|P2|Overall Study|Withdrawal by Subject|1
139207|NCT00758459|499914|P1|Overall Study|Withdrawal by Subject|0
139208|NCT00758459|499913|P2|Overall Study|Protocol Violation|1
139209|NCT00758459|499914|P1|Overall Study|Protocol Violation|0
139210|NCT00758459|499913|P2|Overall Study|Adverse Event|2
139211|NCT00758459|499914|P1|Overall Study|Adverse Event|3
139212|NCT00758394|499959|P4|3rd Intervention|Lost to Follow-up|1
139213|NCT00758394|499960|P3|3rd Intervention|Lost to Follow-up|0
139214|NCT00758394|499961|P2|3rd Intervention|Lost to Follow-up|0
139215|NCT00758394|499962|P1|3rd Intervention|Lost to Follow-up|1
139216|NCT00758394|499959|P4|2nd Intervention Order|Lost to Follow-up|0
139217|NCT00758394|499960|P3|2nd Intervention Order|Lost to Follow-up|0
139218|NCT00758394|499961|P2|2nd Intervention Order|Lost to Follow-up|1
139219|NCT00758394|499962|P1|2nd Intervention Order|Lost to Follow-up|0
139220|NCT00758264|499991|P3|Active Phase|Not specified|4
139221|NCT00758264|499992|P2|Active Phase|Not specified|0
139222|NCT00758264|499993|P1|Active Phase|Not specified|0
139223|NCT00758264|499991|P3|Active Phase|Lost to Follow-up|0
139224|NCT00758264|499992|P2|Active Phase|Lost to Follow-up|0
139225|NCT00758264|499993|P1|Active Phase|Lost to Follow-up|1
139226|NCT00758264|499991|P3|Active Phase|Withdrawal by Subject|1
139227|NCT00758264|499992|P2|Active Phase|Withdrawal by Subject|0
139228|NCT00758264|499993|P1|Active Phase|Withdrawal by Subject|0
139229|NCT00758160|500052|P1|Overall Study|Withdrawal by Subject|8
139230|NCT00758160|500052|P1|Overall Study|Protocol Violation|12
139231|NCT00758160|500052|P1|Overall Study|Lost to Follow-up|14
139232|NCT00758160|500052|P1|Overall Study|Lack of Efficacy|10
139233|NCT00758160|500052|P1|Overall Study|Adverse Event|15
139234|NCT00758160|500052|P1|Overall Study|Administration Problems|3
139235|NCT00758160|500052|P1|Overall Study|No Longer Requires Study Medication|4
139236|NCT00758069|500073|P3|Overall Study|Incorrect Study Drug|0
139237|NCT00758069|500074|P2|Overall Study|Incorrect Study Drug|0
139238|NCT00758069|500075|P1|Overall Study|Incorrect Study Drug|1
139239|NCT00758069|500073|P3|Overall Study|Lack of Efficacy|1
139240|NCT00758069|500074|P2|Overall Study|Lack of Efficacy|0
139241|NCT00758069|500075|P1|Overall Study|Lack of Efficacy|0
139242|NCT00758043|500090|P4|Overall Study|Other Reasons|5
139243|NCT00758043|500091|P3|Overall Study|Other Reasons|0
139244|NCT00758043|500092|P2|Overall Study|Other Reasons|1
139245|NCT00758043|500093|P1|Overall Study|Other Reasons|0
139246|NCT00758043|500090|P4|Overall Study|Non-Compliant With study Drug|1
139247|NCT00758043|500091|P3|Overall Study|Non-Compliant With study Drug|0
139248|NCT00758043|500092|P2|Overall Study|Non-Compliant With study Drug|0
139249|NCT00758043|500093|P1|Overall Study|Non-Compliant With study Drug|0
139250|NCT00758043|500090|P4|Overall Study|Required Prohibited Medication|3
139251|NCT00758043|500091|P3|Overall Study|Required Prohibited Medication|1
139252|NCT00758043|500092|P2|Overall Study|Required Prohibited Medication|0
139253|NCT00758043|500093|P1|Overall Study|Required Prohibited Medication|0
139254|NCT00758043|500090|P4|Overall Study|Withdrawal by Subject|4
139255|NCT00758043|500091|P3|Overall Study|Withdrawal by Subject|1
139256|NCT00758043|500092|P2|Overall Study|Withdrawal by Subject|1
139257|NCT00758043|500093|P1|Overall Study|Withdrawal by Subject|0
139258|NCT00758043|500090|P4|Overall Study|Lost to Follow-up|5
139259|NCT00758043|500091|P3|Overall Study|Lost to Follow-up|2
139260|NCT00758043|500092|P2|Overall Study|Lost to Follow-up|2
139261|NCT00758043|500093|P1|Overall Study|Lost to Follow-up|0
139262|NCT00758043|500090|P4|Overall Study|Refused Further Treatment|8
139263|NCT00758043|500091|P3|Overall Study|Refused Further Treatment|5
139264|NCT00758043|500092|P2|Overall Study|Refused Further Treatment|11
139265|NCT00758043|500093|P1|Overall Study|Refused Further Treatment|0
139266|NCT00758043|500090|P4|Overall Study|Lack of Efficacy|12
139267|NCT00758043|500091|P3|Overall Study|Lack of Efficacy|18
139268|NCT00758043|500092|P2|Overall Study|Lack of Efficacy|6
139269|NCT00758043|500093|P1|Overall Study|Lack of Efficacy|0
139270|NCT00758043|500090|P4|Overall Study|Adverse Event|62
139271|NCT00758043|500091|P3|Overall Study|Adverse Event|12
139272|NCT00758043|500092|P2|Overall Study|Adverse Event|20
139273|NCT00758043|500093|P1|Overall Study|Adverse Event|1
139274|NCT00757848|500121|P2|Overall Study|Incorrect enrolment|0
139275|NCT00757848|500122|P1|Overall Study|Incorrect enrolment|1
139276|NCT00757848|500121|P2|Overall Study|Adverse Event|2
139277|NCT00757848|500122|P1|Overall Study|Adverse Event|1
139278|NCT00757848|500121|P2|Overall Study|Voluntary discontinuation|0
139279|NCT00757848|500122|P1|Overall Study|Voluntary discontinuation|1
139280|NCT00757783|500191|P2|Overall Study|Other|2
139281|NCT00757783|500192|P1|Overall Study|Other|1
139282|NCT00757783|500191|P2|Overall Study|Withdrawal by Subject|1
139283|NCT00757783|500192|P1|Overall Study|Withdrawal by Subject|2
139284|NCT00757783|500191|P2|Overall Study|Protocol Violation|0
139285|NCT00757783|500192|P1|Overall Study|Protocol Violation|1
139286|NCT00757783|500191|P2|Overall Study|Lost to Follow-up|1
139287|NCT00757783|500192|P1|Overall Study|Lost to Follow-up|1
139288|NCT00757783|500191|P2|Overall Study|Adverse Event|2
139289|NCT00757783|500192|P1|Overall Study|Adverse Event|0
139290|NCT00757705|500228|P1|Overall Study|Other|18
139291|NCT00757705|500228|P1|Overall Study|Non-compliant|9
139292|NCT00757705|500228|P1|Overall Study|Ineligible to continue|8
139293|NCT00757705|500228|P1|Overall Study|Insufficient Response|26
139294|NCT00757705|500228|P1|Overall Study|Withdrawal by Subject|25
139295|NCT00757705|500228|P1|Overall Study|Lost to Follow-up|16
139296|NCT00757705|500228|P1|Overall Study|Adverse Event|19
139297|NCT00757627|500257|P1|Overall Study|Other|1
139298|NCT00757627|500257|P1|Overall Study|Withdrawal by Subject|27
139299|NCT00757627|500257|P1|Overall Study|Lost to Follow-up|28
139300|NCT00757627|500257|P1|Overall Study|Lack of Efficacy|10
139301|NCT00757627|500257|P1|Overall Study|Adverse Event|15
139302|NCT00757588|500392|P2|Period 2: Long-term (52-week) Phase|Not specified|0
139303|NCT00757588|500393|P1|Period 2: Long-term (52-week) Phase|Not specified|1
139304|NCT00757588|500392|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
139305|NCT00757588|500393|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
139306|NCT00757588|500392|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
139307|NCT00757588|500393|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
139308|NCT00757588|500392|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
139309|NCT00757588|500393|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
139310|NCT00757588|500392|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
139311|NCT00757588|500393|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
139312|NCT00757588|500392|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
139313|NCT00757588|500393|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
139314|NCT00757588|500392|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
139315|NCT00757588|500393|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
139316|NCT00757588|500392|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
139317|NCT00757588|500393|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
139318|NCT00757588|500392|P2|Period 1: Short-term (24-week) Phase|Not specified|1
139319|NCT00757588|500393|P1|Period 1: Short-term (24-week) Phase|Not specified|0
139320|NCT00757588|500392|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
139321|NCT00757588|500393|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
139322|NCT00757588|500392|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
139323|NCT00757588|500393|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
139324|NCT00757588|500392|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
139325|NCT00757588|500393|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
139326|NCT00757588|500392|P2|Period 1: Short-term (24-week) Phase|Death|0
139327|NCT00757588|500393|P1|Period 1: Short-term (24-week) Phase|Death|1
139328|NCT00757588|500392|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
139329|NCT00757588|500393|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
139330|NCT00757588|500392|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
139331|NCT00757588|500393|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
139332|NCT00757588|500392|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
139333|NCT00757588|500393|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
139334|NCT00757237|500434|P2|Overall Study|Other|2
139335|NCT00757237|500435|P1|Overall Study|Other|0
139336|NCT00757237|500434|P2|Overall Study|Safety or Tolerability|5
139337|NCT00757237|500435|P1|Overall Study|Safety or Tolerability|3
139338|NCT00757237|500434|P2|Overall Study|Withdrawal by Subject|12
139339|NCT00757237|500435|P1|Overall Study|Withdrawal by Subject|8
139340|NCT00757237|500434|P2|Overall Study|Physician Decision|3
139341|NCT00757237|500435|P1|Overall Study|Physician Decision|2
139342|NCT00757237|500434|P2|Overall Study|Protocol Violation|2
139343|NCT00757237|500435|P1|Overall Study|Protocol Violation|0
139344|NCT00757237|500434|P2|Overall Study|Lost to Follow-up|1
139345|NCT00757237|500435|P1|Overall Study|Lost to Follow-up|0
139346|NCT00757172|500463|P1|Overall Study|Progression|4
139347|NCT00757172|500463|P1|Overall Study|Physician Decision|3
139348|NCT00757172|500463|P1|Overall Study|Withdrawal by Subject|4
139349|NCT00757003|500471|P1|Overall Study|Not implanted|1
139350|NCT00757003|500471|P1|Overall Study|Surgically explanted|2
139351|NCT00757003|500471|P1|Overall Study|Withdrawal by Subject|4
139352|NCT00757003|500471|P1|Overall Study|Lost to Follow-up|9
139353|NCT00757003|500471|P1|Overall Study|Death|33
139354|NCT00756938|500518|P4|Optional Extension|Adverse Event|1
139355|NCT00756938|500519|P3|Optional Extension|Adverse Event|0
139356|NCT00756938|500520|P2|Optional Extension|Adverse Event|0
139357|NCT00756938|500521|P1|Optional Extension|Adverse Event|0
139358|NCT00756938|500518|P4|Optional Extension|Withdrawal by Subject|10
139359|NCT00756938|500519|P3|Optional Extension|Withdrawal by Subject|0
139360|NCT00756938|500520|P2|Optional Extension|Withdrawal by Subject|0
139361|NCT00756938|500521|P1|Optional Extension|Withdrawal by Subject|0
139362|NCT00756938|500518|P4|Optional Extension|Protocol Violation|1
139363|NCT00756938|500519|P3|Optional Extension|Protocol Violation|0
139364|NCT00756938|500520|P2|Optional Extension|Protocol Violation|0
139365|NCT00756938|500521|P1|Optional Extension|Protocol Violation|0
139366|NCT00756938|500518|P4|Optional Extension|Lost to Follow-up|1
139367|NCT00756938|500519|P3|Optional Extension|Lost to Follow-up|0
139368|NCT00756938|500520|P2|Optional Extension|Lost to Follow-up|0
139369|NCT00756938|500521|P1|Optional Extension|Lost to Follow-up|0
139370|NCT00756938|500518|P4|Optional Extension|Physician Decision|3
139371|NCT00756938|500519|P3|Optional Extension|Physician Decision|0
139372|NCT00756938|500520|P2|Optional Extension|Physician Decision|0
139373|NCT00756938|500521|P1|Optional Extension|Physician Decision|0
139374|NCT00756938|500518|P4|Optional Extension|Protocol-specific criteria met|9
139375|NCT00756938|500519|P3|Optional Extension|Protocol-specific criteria met|0
139376|NCT00756938|500520|P2|Optional Extension|Protocol-specific criteria met|0
139377|NCT00756938|500521|P1|Optional Extension|Protocol-specific criteria met|0
139378|NCT00756938|500518|P4|Optional Extension|End of Study|11
139379|NCT00756938|500519|P3|Optional Extension|End of Study|0
139380|NCT00756938|500520|P2|Optional Extension|End of Study|0
139381|NCT00756938|500521|P1|Optional Extension|End of Study|0
139382|NCT00756938|500518|P4|Optional Extension|Lack of Efficacy|1
139383|NCT00756938|500519|P3|Optional Extension|Lack of Efficacy|0
139384|NCT00756938|500520|P2|Optional Extension|Lack of Efficacy|0
139385|NCT00756938|500521|P1|Optional Extension|Lack of Efficacy|0
139386|NCT00756938|500518|P4|12-week Base Study|Lost to Follow-up|0
139387|NCT00756938|500519|P3|12-week Base Study|Lost to Follow-up|0
139388|NCT00756938|500520|P2|12-week Base Study|Lost to Follow-up|0
139389|NCT00756938|500521|P1|12-week Base Study|Lost to Follow-up|1
139390|NCT00756938|500518|P4|12-week Base Study|Protocol Violation|0
139391|NCT00756938|500519|P3|12-week Base Study|Protocol Violation|1
139392|NCT00756938|500520|P2|12-week Base Study|Protocol Violation|0
139393|NCT00756938|500521|P1|12-week Base Study|Protocol Violation|0
139394|NCT00756938|500518|P4|12-week Base Study|Protocol-specific Criteria Met|0
139395|NCT00756938|500519|P3|12-week Base Study|Protocol-specific Criteria Met|1
139396|NCT00756938|500520|P2|12-week Base Study|Protocol-specific Criteria Met|0
139397|NCT00756938|500521|P1|12-week Base Study|Protocol-specific Criteria Met|1
139398|NCT00756886|500549|P2|Overall Study|Ineligible|4
139399|NCT00756886|500550|P1|Overall Study|Ineligible|9
139400|NCT00756886|500549|P2|Overall Study|Lack of Efficacy|0
139401|NCT00756886|500550|P1|Overall Study|Lack of Efficacy|1
139402|NCT00756886|500549|P2|Overall Study|Adverse Event|3
139403|NCT00756886|500550|P1|Overall Study|Adverse Event|0
139404|NCT00756886|500549|P2|Overall Study|Lost to Follow-up|0
139405|NCT00756886|500550|P1|Overall Study|Lost to Follow-up|1
139406|NCT00756730|500558|P2|Overall Study|persistent low-level viremmia|1
139407|NCT00756730|500559|P1|Overall Study|persistent low-level viremmia|0
139408|NCT00756730|500558|P2|Overall Study|discontinued due to rash prior to week 4|1
139409|NCT00756730|500559|P1|Overall Study|discontinued due to rash prior to week 4|0
139410|NCT00756574|500592|P2|Overall Study|Lost to Follow-up|4
139411|NCT00756574|500593|P1|Overall Study|Lost to Follow-up|4
139412|NCT00756574|500592|P2|Overall Study|Withdrawal by Subject|7
139413|NCT00756574|500593|P1|Overall Study|Withdrawal by Subject|9
139414|NCT00756470|500637|P1|Overall Study|Adverse Event|4
139415|NCT00756470|500637|P1|Overall Study|Withdrawal by Subject|1
139416|NCT00756457|500644|P2|Overall Study|Lost to Follow-up|2
139417|NCT00756457|500645|P1|Overall Study|Lost to Follow-up|1
139418|NCT00756444|500675|P2|Overall Study|Ineligibility Determined|0
139419|NCT00756444|500676|P1|Overall Study|Ineligibility Determined|1
139420|NCT00756444|500675|P2|Overall Study|Disease Progression|7
139421|NCT00756444|500676|P1|Overall Study|Disease Progression|2
139422|NCT00756444|500675|P2|Overall Study|Death|4
139423|NCT00756444|500676|P1|Overall Study|Death|5
139424|NCT00756444|500675|P2|Overall Study|Lost to Follow-up|1
139425|NCT00756444|500676|P1|Overall Study|Lost to Follow-up|0
139426|NCT00756444|500675|P2|Overall Study|Withdrawal by Subject|8
139427|NCT00756444|500676|P1|Overall Study|Withdrawal by Subject|6
139428|NCT00756444|500675|P2|Overall Study|Adverse Event|1
139429|NCT00756444|500676|P1|Overall Study|Adverse Event|1
139430|NCT00756314|500687|P2|Overall Study|Lost to Follow-up|59
139431|NCT00756314|500688|P1|Overall Study|Lost to Follow-up|2
139432|NCT00756275|500704|P2|Overall Study|Withdrawal by Subject|7
139433|NCT00756275|500705|P1|Overall Study|Withdrawal by Subject|4
139434|NCT00756275|500704|P2|Overall Study|Lost to Follow-up|21
139435|NCT00756275|500705|P1|Overall Study|Lost to Follow-up|25
139436|NCT00756002|500757|P2|Double-Blind Treatment Period|Not Specified|2
139437|NCT00756002|500758|P1|Double-Blind Treatment Period|Not Specified|2
139438|NCT00756002|500757|P2|Double-Blind Treatment Period|Protocol Violation|5
139439|NCT00756002|500758|P1|Double-Blind Treatment Period|Protocol Violation|6
139440|NCT00756002|500757|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
139441|NCT00756002|500758|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
139442|NCT00756002|500757|P2|Double-Blind Treatment Period|Lost to Follow-up|1
139443|NCT00756002|500758|P1|Double-Blind Treatment Period|Lost to Follow-up|0
139444|NCT00756002|500757|P2|Double-Blind Treatment Period|Lack of Efficacy|1
139445|NCT00756002|500758|P1|Double-Blind Treatment Period|Lack of Efficacy|1
139446|NCT00755937|500852|P1|Observational Follow-up|Lost to Follow-up|148
139447|NCT00755937|500852|P1|Recruitment|Unknown if infliximab received|164
139448|NCT00755846|500879|P6|Overall Study|Participant Non-compliance|0
139449|NCT00755846|500880|P5|Overall Study|Participant Non-compliance|1
139450|NCT00755846|500881|P4|Overall Study|Participant Non-compliance|0
139451|NCT00755846|500882|P3|Overall Study|Participant Non-compliance|0
139452|NCT00755846|500883|P2|Overall Study|Participant Non-compliance|0
139453|NCT00755846|500884|P1|Overall Study|Participant Non-compliance|0
139454|NCT00755846|500879|P6|Overall Study|Administrative Error|0
139455|NCT00755846|500880|P5|Overall Study|Administrative Error|0
139456|NCT00755846|500881|P4|Overall Study|Administrative Error|0
139457|NCT00755846|500882|P3|Overall Study|Administrative Error|0
139458|NCT00755846|500883|P2|Overall Study|Administrative Error|1
139459|NCT00755846|500884|P1|Overall Study|Administrative Error|0
139460|NCT00755846|500879|P6|Overall Study|Physician Decision|1
139461|NCT00755846|500880|P5|Overall Study|Physician Decision|0
139462|NCT00755846|500881|P4|Overall Study|Physician Decision|1
139463|NCT00755846|500882|P3|Overall Study|Physician Decision|0
139464|NCT00755846|500883|P2|Overall Study|Physician Decision|3
139465|NCT00755846|500884|P1|Overall Study|Physician Decision|1
139466|NCT00755846|500879|P6|Overall Study|Hyperglycemic Rescue|7
139467|NCT00755846|500880|P5|Overall Study|Hyperglycemic Rescue|8
139468|NCT00755846|500881|P4|Overall Study|Hyperglycemic Rescue|8
139469|NCT00755846|500882|P3|Overall Study|Hyperglycemic Rescue|5
139470|NCT00755846|500883|P2|Overall Study|Hyperglycemic Rescue|7
139471|NCT00755846|500884|P1|Overall Study|Hyperglycemic Rescue|21
139472|NCT00755846|500879|P6|Overall Study|Withdrawal by Subject|1
139473|NCT00755846|500880|P5|Overall Study|Withdrawal by Subject|0
139474|NCT00755846|500881|P4|Overall Study|Withdrawal by Subject|2
139475|NCT00755846|500882|P3|Overall Study|Withdrawal by Subject|5
139476|NCT00755846|500883|P2|Overall Study|Withdrawal by Subject|3
139477|NCT00755846|500884|P1|Overall Study|Withdrawal by Subject|2
139478|NCT00755846|500879|P6|Overall Study|Lost to Follow-up|2
139479|NCT00755846|500880|P5|Overall Study|Lost to Follow-up|4
139480|NCT00755846|500881|P4|Overall Study|Lost to Follow-up|0
139481|NCT00755846|500882|P3|Overall Study|Lost to Follow-up|1
139482|NCT00755846|500883|P2|Overall Study|Lost to Follow-up|2
139483|NCT00755846|500884|P1|Overall Study|Lost to Follow-up|0
139484|NCT00755846|500879|P6|Overall Study|Protocol Violation|1
139485|NCT00755846|500880|P5|Overall Study|Protocol Violation|1
139486|NCT00755846|500881|P4|Overall Study|Protocol Violation|1
139487|NCT00755846|500882|P3|Overall Study|Protocol Violation|1
139488|NCT00755846|500883|P2|Overall Study|Protocol Violation|1
139489|NCT00755846|500884|P1|Overall Study|Protocol Violation|1
139490|NCT00755846|500879|P6|Overall Study|Adverse Event|2
139491|NCT00755846|500880|P5|Overall Study|Adverse Event|3
139492|NCT00755846|500881|P4|Overall Study|Adverse Event|1
139493|NCT00755846|500882|P3|Overall Study|Adverse Event|0
139494|NCT00755846|500883|P2|Overall Study|Adverse Event|0
139495|NCT00755846|500884|P1|Overall Study|Adverse Event|0
139496|NCT00755807|500984|P2|Open-label Extension Phase|Sponsor Decision|1
139497|NCT00755807|500985|P1|Open-label Extension Phase|Sponsor Decision|0
139498|NCT00755807|500984|P2|Open-label Extension Phase|Lost to Follow-up|0
139499|NCT00755807|500985|P1|Open-label Extension Phase|Lost to Follow-up|2
139500|NCT00755807|500984|P2|Open-label Extension Phase|Withdrawal by Subject|3
139501|NCT00755807|500985|P1|Open-label Extension Phase|Withdrawal by Subject|1
139502|NCT00755807|500984|P2|Open-label Extension Phase|Lack of Efficacy|3
139503|NCT00755807|500985|P1|Open-label Extension Phase|Lack of Efficacy|3
139504|NCT00755807|500984|P2|Open-label Extension Phase|Protocol Violation|2
139505|NCT00755807|500985|P1|Open-label Extension Phase|Protocol Violation|5
139506|NCT00755807|500984|P2|Open-label Extension Phase|Adverse Event|7
139507|NCT00755807|500985|P1|Open-label Extension Phase|Adverse Event|7
139508|NCT00755807|500984|P2|Acute Phase|Physician Decision|1
139509|NCT00755807|500985|P1|Acute Phase|Physician Decision|0
139510|NCT00755807|500984|P2|Acute Phase|Lack of Efficacy|1
139511|NCT00755807|500985|P1|Acute Phase|Lack of Efficacy|0
139512|NCT00755807|500984|P2|Acute Phase|Withdrawal by Subject|2
139513|NCT00755807|500985|P1|Acute Phase|Withdrawal by Subject|1
139514|NCT00755807|500984|P2|Acute Phase|Protocol Violation|3
139515|NCT00755807|500985|P1|Acute Phase|Protocol Violation|1
139516|NCT00755807|500984|P2|Acute Phase|Adverse Event|5
139517|NCT00755807|500985|P1|Acute Phase|Adverse Event|16
139518|NCT00755716|501065|P3|Overall Study|work schedule issues|1
139519|NCT00755716|501066|P2|Overall Study|work schedule issues|1
139520|NCT00755716|501067|P1|Overall Study|work schedule issues|0
139521|NCT00755716|501065|P3|Overall Study|Lost to Follow-up|1
139522|NCT00755716|501066|P2|Overall Study|Lost to Follow-up|3
139523|NCT00755716|501067|P1|Overall Study|Lost to Follow-up|5
139524|NCT00755716|501065|P3|Overall Study|Lack of Efficacy|0
139525|NCT00755716|501066|P2|Overall Study|Lack of Efficacy|0
139526|NCT00755716|501067|P1|Overall Study|Lack of Efficacy|2
139527|NCT00755716|501065|P3|Overall Study|Adverse Event|1
139528|NCT00755716|501066|P2|Overall Study|Adverse Event|4
139529|NCT00755716|501067|P1|Overall Study|Adverse Event|1
139530|NCT00755417|501081|P3|Overall Study|Not specified or missing data|12
139531|NCT00755417|501082|P2|Overall Study|Not specified or missing data|18
139532|NCT00755417|501083|P1|Overall Study|Not specified or missing data|9
139533|NCT00755417|501081|P3|Overall Study|Withdrawal by Subject|12
139534|NCT00755417|501082|P2|Overall Study|Withdrawal by Subject|12
139535|NCT00755417|501083|P1|Overall Study|Withdrawal by Subject|12
139536|NCT00755417|501081|P3|Overall Study|Lost to Follow-up|1
139537|NCT00755417|501082|P2|Overall Study|Lost to Follow-up|0
139538|NCT00755417|501083|P1|Overall Study|Lost to Follow-up|3
139539|NCT00755417|501081|P3|Overall Study|Protocol Violation|1
139540|NCT00755417|501082|P2|Overall Study|Protocol Violation|1
139541|NCT00755417|501083|P1|Overall Study|Protocol Violation|2
139542|NCT00755417|501081|P3|Overall Study|Lack of Efficacy|9
139543|NCT00755417|501082|P2|Overall Study|Lack of Efficacy|4
139544|NCT00755417|501083|P1|Overall Study|Lack of Efficacy|8
139545|NCT00755417|501081|P3|Overall Study|Adverse Event|7
139546|NCT00755417|501082|P2|Overall Study|Adverse Event|20
139547|NCT00755417|501083|P1|Overall Study|Adverse Event|28
139548|NCT00755222|501140|P2|Overall Study|Protocol Violation|0
139549|NCT00755222|501141|P1|Overall Study|Protocol Violation|2
139550|NCT00755222|501140|P2|Overall Study|Adverse Event|0
139551|NCT00755222|501141|P1|Overall Study|Adverse Event|2
139552|NCT00755222|501140|P2|Overall Study|Withdrawal by Subject|2
139553|NCT00755222|501141|P1|Overall Study|Withdrawal by Subject|4
139554|NCT00755196|501155|P1|Overall Study|Lack of Efficiency|1
139555|NCT00755196|501155|P1|Overall Study|Lost to Follow-up|1
139556|NCT00755105|501176|P3|Overall Study|Withdrawal by Subject|4
139557|NCT00755105|501177|P2|Overall Study|Withdrawal by Subject|11
139558|NCT00755105|501178|P1|Overall Study|Withdrawal by Subject|9
139559|NCT00755079|501188|P2|Overall Study|Withdrawal by Subject|2
139560|NCT00755079|501189|P1|Overall Study|Withdrawal by Subject|0
139561|NCT00755079|501188|P2|Overall Study|Adverse Event|1
139562|NCT00755079|501189|P1|Overall Study|Adverse Event|0
139563|NCT00755079|501188|P2|Overall Study|Lost to Follow-up|3
139564|NCT00755079|501189|P1|Overall Study|Lost to Follow-up|1
139565|NCT00754793|501226|P2|Overall Study|voluntary withdrawn from study|1
139566|NCT00754793|501227|P1|Overall Study|voluntary withdrawn from study|0
139567|NCT00754741|501245|P3|Overall Study|Died or disenrolled|54
139568|NCT00754741|501246|P2|Overall Study|Died or disenrolled|69
139569|NCT00754741|501247|P1|Overall Study|Died or disenrolled|57
139570|NCT00754650|501294|P1|Overall Study|Disease Progression|2
139571|NCT00754624|501299|P1|Overall Study|Lost to Follow-up|3
139572|NCT00754624|501299|P1|Overall Study|Various|12
139573|NCT00754624|501299|P1|Overall Study|Withdrawal by Subject|28
139574|NCT00754624|501299|P1|Overall Study|Protocol Violation|1
139575|NCT00754624|501299|P1|Overall Study|Physician Decision|8
139576|NCT00754624|501299|P1|Overall Study|Death|1
139577|NCT00754624|501299|P1|Overall Study|Adverse Event|16
139578|NCT00754572|501309|P1|Overall Study|Lost to Follow-up|1
139579|NCT00754572|501309|P1|Overall Study|Administrative Reason|3
139580|NCT00754572|501309|P1|Overall Study|Death|1
139581|NCT00754572|501309|P1|Overall Study|Lack of Efficacy|2
139582|NCT00754572|501309|P1|Overall Study|Withdrawal by Subject|3
139583|NCT00754572|501309|P1|Overall Study|Protocol Violation|3
139584|NCT00754572|501309|P1|Overall Study|Other|39
139585|NCT00754572|501309|P1|Overall Study|Adverse Event|19
139586|NCT00754559|501336|P1|Overall Study|Withdrawal by Subject|3
139587|NCT00754559|501336|P1|Overall Study|Other|5
139588|NCT00754559|501336|P1|Overall Study|Administrative reason|1
139589|NCT00754559|501336|P1|Overall Study|Lost to Follow-up|2
139590|NCT00754559|501336|P1|Overall Study|Lack of Efficacy|10
139591|NCT00754559|501336|P1|Overall Study|Protocol Violation|11
139592|NCT00754559|501336|P1|Overall Study|Adverse Event|15
139593|NCT00754442|501436|P2|Overall Study|Withdrawal by Subject|3
139594|NCT00754442|501437|P1|Overall Study|Withdrawal by Subject|5
139595|NCT00754390|501444|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
139596|NCT00754390|501444|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
139597|NCT00754390|501444|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
139598|NCT00754390|501444|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
139599|NCT00754338|501466|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
139600|NCT00754338|501467|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
139601|NCT00754338|501468|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
139602|NCT00754338|501469|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
139603|NCT00754338|501466|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
139604|NCT00754338|501467|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
139605|NCT00754338|501468|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
139606|NCT00754338|501469|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
139607|NCT00754325|501501|P2|Initial Treatment|Disease Progression|35
139608|NCT00754325|501502|P1|Initial Treatment|Disease Progression|35
139609|NCT00754325|501501|P2|Initial Treatment|Sponsor Request|1
139610|NCT00754325|501502|P1|Initial Treatment|Sponsor Request|0
139611|NCT00754325|501501|P2|Initial Treatment|Physician Decision|0
139612|NCT00754325|501502|P1|Initial Treatment|Physician Decision|2
139613|NCT00754325|501501|P2|Initial Treatment|Withdrawal by Subject|2
139614|NCT00754325|501502|P1|Initial Treatment|Withdrawal by Subject|2
139615|NCT00754325|501501|P2|Initial Treatment|Adverse Event|6
139616|NCT00754325|501502|P1|Initial Treatment|Adverse Event|7
139617|NCT00754325|501501|P2|Initial Treatment|Continuing Active Treatment|5
139618|NCT00754325|501502|P1|Initial Treatment|Continuing Active Treatment|4
139619|NCT00754234|501521|P1|Overall Study|Withdrawal by Subject|3
139620|NCT00754065|501607|P2|Overall Study|Reason not specified or unknown, etc.|27
139621|NCT00754065|501608|P1|Overall Study|Reason not specified or unknown, etc.|21
139622|NCT00754065|501607|P2|Overall Study|Pregnancy|0
139623|NCT00754065|501608|P1|Overall Study|Pregnancy|6
139624|NCT00754065|501607|P2|Overall Study|Withdrawal by Subject|5
139625|NCT00754065|501608|P1|Overall Study|Withdrawal by Subject|4
139626|NCT00754065|501607|P2|Overall Study|Protocol Violation|10
139627|NCT00754065|501608|P1|Overall Study|Protocol Violation|12
139628|NCT00754065|501607|P2|Overall Study|Lost to Follow-up|11
139629|NCT00754065|501608|P1|Overall Study|Lost to Follow-up|7
139630|NCT00754065|501607|P2|Overall Study|Adverse Event|25
139631|NCT00754065|501608|P1|Overall Study|Adverse Event|19
139632|NCT00754065|501607|P2|Overall Study|Never received treatment|2
139633|NCT00754065|501608|P1|Overall Study|Never received treatment|12
139634|NCT00754052|501848|P2|Overall Study|Study terminated by Sponsor|3
139635|NCT00754052|501849|P1|Overall Study|Study terminated by Sponsor|5
139636|NCT00754013|501863|P2|Overall Study|didn't return after study termed|4
139637|NCT00754013|501864|P1|Overall Study|didn't return after study termed|3
139638|NCT00754013|501863|P2|Overall Study|Lost to Follow-up|1
139639|NCT00754013|501864|P1|Overall Study|Lost to Follow-up|1
139640|NCT00753922|501898|P4|Overall Study|Discontinuation Due to Explantation|4
139641|NCT00753922|501899|P3|Overall Study|Discontinuation Due to Explantation|14
139642|NCT00753922|501900|P2|Overall Study|Discontinuation Due to Explantation|14
139643|NCT00753922|501901|P1|Overall Study|Discontinuation Due to Explantation|14
139644|NCT00753922|501898|P4|Overall Study|Death|1
139645|NCT00753922|501899|P3|Overall Study|Death|2
139646|NCT00753922|501900|P2|Overall Study|Death|23
139647|NCT00753922|501901|P1|Overall Study|Death|2
139648|NCT00753922|501898|P4|Overall Study|Patients Not Completing Visit|0
139649|NCT00753922|501899|P3|Overall Study|Patients Not Completing Visit|1
139650|NCT00753922|501900|P2|Overall Study|Patients Not Completing Visit|0
139651|NCT00753922|501901|P1|Overall Study|Patients Not Completing Visit|11
139652|NCT00753922|501898|P4|Overall Study|Patient Non-compliance|11
139653|NCT00753922|501899|P3|Overall Study|Patient Non-compliance|14
139654|NCT00753922|501900|P2|Overall Study|Patient Non-compliance|22
139655|NCT00753922|501901|P1|Overall Study|Patient Non-compliance|55
139656|NCT00753922|501898|P4|Overall Study|Withdrawal by Subject|2
139657|NCT00753922|501899|P3|Overall Study|Withdrawal by Subject|4
139658|NCT00753922|501900|P2|Overall Study|Withdrawal by Subject|11
139659|NCT00753922|501901|P1|Overall Study|Withdrawal by Subject|9
139660|NCT00753922|501898|P4|Overall Study|Lost to Follow-up|5
139661|NCT00753922|501899|P3|Overall Study|Lost to Follow-up|28
139662|NCT00753922|501900|P2|Overall Study|Lost to Follow-up|24
139663|NCT00753922|501901|P1|Overall Study|Lost to Follow-up|155
139664|NCT00753896|501931|P1|Overall Study|Entry Criteria Not Met|4
139665|NCT00753896|501931|P1|Overall Study|Withdrawal by Subject|4
139666|NCT00753896|501931|P1|Overall Study|Protocol Violation|1
139667|NCT00753896|501931|P1|Overall Study|Lost to Follow-up|2
139668|NCT00753896|501931|P1|Overall Study|Death|1
139669|NCT00753896|501931|P1|Overall Study|Adverse Event|4
139670|NCT00753766|501947|P2|Overall Study|Physician Decision|0
139671|NCT00753766|501948|P1|Overall Study|Physician Decision|1
139672|NCT00753714|501958|P2|Overall Study|not specified|5
139673|NCT00753714|501959|P1|Overall Study|not specified|7
139674|NCT00753714|501958|P2|Overall Study|Death|3
139675|NCT00753714|501959|P1|Overall Study|Death|3
139676|NCT00753714|501958|P2|Overall Study|Withdrawal by Subject|1
139677|NCT00753714|501959|P1|Overall Study|Withdrawal by Subject|2
139678|NCT00753714|501958|P2|Overall Study|Lost to Follow-up|1
139679|NCT00753714|501959|P1|Overall Study|Lost to Follow-up|0
139680|NCT00753714|501958|P2|Overall Study|Protocol Violation|0
139681|NCT00753714|501959|P1|Overall Study|Protocol Violation|1
139682|NCT00753714|501958|P2|Overall Study|Adverse Event|18
139683|NCT00753714|501959|P1|Overall Study|Adverse Event|26
139684|NCT00753714|501958|P2|Overall Study|Lack of Efficacy|34
139685|NCT00753714|501959|P1|Overall Study|Lack of Efficacy|21
139686|NCT00753688|501975|P2|Overall Study|Adverse Event|1
139687|NCT00753688|501976|P1|Overall Study|Adverse Event|0
139688|NCT00753688|501975|P2|Overall Study|Ongoing - in Follow-up|31
139689|NCT00753688|501976|P1|Overall Study|Ongoing - in Follow-up|15
139690|NCT00753688|501975|P2|Overall Study|Participant Withdrew Consent|2
139691|NCT00753688|501976|P1|Overall Study|Participant Withdrew Consent|2
139692|NCT00753688|501975|P2|Overall Study|Missing|9
139693|NCT00753688|501976|P1|Overall Study|Missing|4
139694|NCT00753688|501975|P2|Overall Study|Death|203
139695|NCT00753688|501976|P1|Overall Study|Death|102
139696|NCT00753675|502005|P3|Overall Study|Lost to Follow-up|0
139697|NCT00753675|502006|P2|Overall Study|Lost to Follow-up|0
139698|NCT00753675|502007|P1|Overall Study|Lost to Follow-up|1
139699|NCT00753675|502005|P3|Overall Study|Withdrawal by Subject|0
139700|NCT00753675|502006|P2|Overall Study|Withdrawal by Subject|1
139701|NCT00753675|502007|P1|Overall Study|Withdrawal by Subject|0
139702|NCT00753675|502005|P3|Overall Study|Objective progression of disease|35
139703|NCT00753675|502006|P2|Overall Study|Objective progression of disease|35
139704|NCT00753675|502007|P1|Overall Study|Objective progression of disease|35
139705|NCT00753675|502005|P3|Overall Study|Adverse Event|4
139706|NCT00753675|502006|P2|Overall Study|Adverse Event|9
139707|NCT00753675|502007|P1|Overall Study|Adverse Event|11
139708|NCT00753675|502005|P3|Overall Study|Death|4
139709|NCT00753675|502006|P2|Overall Study|Death|2
139710|NCT00753675|502007|P1|Overall Study|Death|1
139711|NCT00753675|502005|P3|Overall Study|other reason|13
139712|NCT00753675|502006|P2|Overall Study|other reason|12
139713|NCT00753675|502007|P1|Overall Study|other reason|11
139714|NCT00753649|502029|P2|Overall Study|Protocol Violation|0
139715|NCT00753649|502030|P1|Overall Study|Protocol Violation|2
139716|NCT00753649|502029|P2|Overall Study|Lost to follow-up-complete vaccination|0
139717|NCT00753649|502030|P1|Overall Study|Lost to follow-up-complete vaccination|1
139718|NCT00753649|502029|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
139719|NCT00753649|502030|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
139720|NCT00753649|502029|P2|Overall Study|Migrated/moved from study area|0
139721|NCT00753649|502030|P1|Overall Study|Migrated/moved from study area|1
139722|NCT00753623|502062|P2|Phase II (14 Days)|Physician Decision|1
139723|NCT00753623|502063|P1|Phase II (14 Days)|Physician Decision|0
139724|NCT00753623|502062|P2|Washout (7 Days)|Physician Decision|0
139725|NCT00753623|502063|P1|Washout (7 Days)|Physician Decision|1
139726|NCT00753623|502062|P2|Phase I (14 Days)|Adverse Event|1
139727|NCT00753623|502063|P1|Phase I (14 Days)|Adverse Event|0
139728|NCT00753623|502062|P2|Phase I (14 Days)|Physician Decision|2
139729|NCT00753623|502063|P1|Phase I (14 Days)|Physician Decision|1
139730|NCT00753623|502062|P2|Phase I (14 Days)|Withdrawal by Subject|1
139731|NCT00753623|502063|P1|Phase I (14 Days)|Withdrawal by Subject|1
139732|NCT00753545|502071|P2|Overall Study|Voluntary Discontinuation of Patient|3
139733|NCT00753545|502072|P1|Overall Study|Voluntary Discontinuation of Patient|7
139734|NCT00753545|502071|P2|Overall Study|Protocol Violation|0
139735|NCT00753545|502072|P1|Overall Study|Protocol Violation|1
139736|NCT00753545|502071|P2|Overall Study|Lost to Follow-up|3
139737|NCT00753545|502072|P1|Overall Study|Lost to Follow-up|2
139738|NCT00753545|502071|P2|Overall Study|Death|112
139739|NCT00753545|502072|P1|Overall Study|Death|98
139740|NCT00753519|502110|P2|Overall Study|Withdrawal by Subject|2
139741|NCT00753519|502111|P1|Overall Study|Withdrawal by Subject|0
139742|NCT00753506|502133|P2|Overall Study|Other reason|1
139743|NCT00753506|502134|P1|Overall Study|Other reason|1
139744|NCT00753506|502133|P2|Overall Study|Lost to Follow-up|0
139745|NCT00753506|502134|P1|Overall Study|Lost to Follow-up|2
139746|NCT00753506|502133|P2|Overall Study|Withdrawal by Subject|1
139747|NCT00753506|502134|P1|Overall Study|Withdrawal by Subject|4
139748|NCT00753454|502140|P1|Overall Study|Investigator Decision|1
139749|NCT00753454|502140|P1|Overall Study|Withdrawal by Subject|5
139750|NCT00753454|502140|P1|Overall Study|Lost to Follow-up|3
139751|NCT00753454|502140|P1|Overall Study|Lack of Efficacy|1
139752|NCT00753454|502140|P1|Overall Study|Adverse Event|4
139753|NCT00753415|502174|P10|Part B|Disease progression|1
139754|NCT00753415|502175|P9|Part B|Disease progression|2
139755|NCT00753415|502176|P8|Part B|Disease progression|0
139756|NCT00753415|502177|P7|Part B|Disease progression|0
139757|NCT00753415|502178|P6|Part B|Disease progression|0
139758|NCT00753415|502179|P5|Part B|Disease progression|0
139759|NCT00753415|502180|P4|Part B|Disease progression|0
139760|NCT00753415|502181|P3|Part B|Disease progression|0
139761|NCT00753415|502182|P2|Part B|Disease progression|0
139762|NCT00753415|502183|P1|Part B|Disease progression|0
139763|NCT00753415|502174|P10|Part B|Lost to Follow-up|0
139764|NCT00753415|502175|P9|Part B|Lost to Follow-up|1
139765|NCT00753415|502176|P8|Part B|Lost to Follow-up|1
139766|NCT00753415|502177|P7|Part B|Lost to Follow-up|0
139767|NCT00753415|502178|P6|Part B|Lost to Follow-up|0
139768|NCT00753415|502179|P5|Part B|Lost to Follow-up|0
139769|NCT00753415|502180|P4|Part B|Lost to Follow-up|0
139770|NCT00753415|502181|P3|Part B|Lost to Follow-up|0
139771|NCT00753415|502182|P2|Part B|Lost to Follow-up|0
139772|NCT00753415|502183|P1|Part B|Lost to Follow-up|0
139773|NCT00753415|502174|P10|Part A|Withdrawal by Subject|0
139774|NCT00753415|502175|P9|Part A|Withdrawal by Subject|0
139775|NCT00753415|502176|P8|Part A|Withdrawal by Subject|0
139776|NCT00753415|502177|P7|Part A|Withdrawal by Subject|0
139777|NCT00753415|502178|P6|Part A|Withdrawal by Subject|0
139778|NCT00753415|502179|P5|Part A|Withdrawal by Subject|0
139779|NCT00753415|502180|P4|Part A|Withdrawal by Subject|0
139780|NCT00753415|502181|P3|Part A|Withdrawal by Subject|1
139781|NCT00753415|502182|P2|Part A|Withdrawal by Subject|0
139782|NCT00753415|502183|P1|Part A|Withdrawal by Subject|0
139783|NCT00753415|502174|P10|Part A|Disease progression|0
139784|NCT00753415|502175|P9|Part A|Disease progression|0
139785|NCT00753415|502176|P8|Part A|Disease progression|0
139786|NCT00753415|502177|P7|Part A|Disease progression|0
139787|NCT00753415|502178|P6|Part A|Disease progression|0
139788|NCT00753415|502179|P5|Part A|Disease progression|0
139789|NCT00753415|502180|P4|Part A|Disease progression|2
139790|NCT00753415|502181|P3|Part A|Disease progression|1
139791|NCT00753415|502182|P2|Part A|Disease progression|0
139792|NCT00753415|502183|P1|Part A|Disease progression|1
139793|NCT00753272|502273|P2|Overall Study|Other|1088
139794|NCT00753272|502274|P1|Overall Study|Other|1104
139795|NCT00753272|502273|P2|Overall Study|Lost to Follow-up|497
139796|NCT00753272|502274|P1|Overall Study|Lost to Follow-up|491
139797|NCT00753272|502273|P2|Overall Study|Withdrawal by Subject|2407
139798|NCT00753272|502274|P1|Overall Study|Withdrawal by Subject|2481
139799|NCT00753272|502273|P2|Overall Study|Protocol Violation|46
139800|NCT00753272|502274|P1|Overall Study|Protocol Violation|28
139801|NCT00753272|502273|P2|Overall Study|Adverse Event|869
139802|NCT00753272|502274|P1|Overall Study|Adverse Event|878
139803|NCT00753012|502359|P2|Overall Study|Confounded endpoint data|0
139804|NCT00753012|502360|P1|Overall Study|Confounded endpoint data|1
139805|NCT00753012|502359|P2|Overall Study|Lost to Follow-up|0
139806|NCT00753012|502360|P1|Overall Study|Lost to Follow-up|4
139807|NCT00753012|502359|P2|Overall Study|Withdrawal by Subject|1
139808|NCT00753012|502360|P1|Overall Study|Withdrawal by Subject|0
139809|NCT00753012|502359|P2|Overall Study|Adverse Event|0
139810|NCT00753012|502360|P1|Overall Study|Adverse Event|2
139811|NCT00753012|502359|P2|Overall Study|Ineligible, abnormal cardiac histo|0
139812|NCT00753012|502360|P1|Overall Study|Ineligible, abnormal cardiac histo|1
139813|NCT00752986|502373|P3|Overall Study|Protocol Violation|0
139814|NCT00752986|502374|P2|Overall Study|Protocol Violation|0
139815|NCT00752986|502375|P1|Overall Study|Protocol Violation|3
139816|NCT00752986|502373|P3|Overall Study|Withdrawal by Subject|2
139817|NCT00752986|502374|P2|Overall Study|Withdrawal by Subject|1
139818|NCT00752986|502375|P1|Overall Study|Withdrawal by Subject|2
139819|NCT00752895|502404|P2|Overall Study|Withdrawal by Subject|3
139820|NCT00752895|502405|P1|Overall Study|Withdrawal by Subject|8
139821|NCT00752791|502413|P1|Overall Study|Protocol deviation|1
139822|NCT00752791|502413|P1|Overall Study|Switched to hemodialysis|2
139823|NCT00752791|502413|P1|Overall Study|Renal transplant|3
139824|NCT00752791|502413|P1|Overall Study|Death|1
139825|NCT00752791|502413|P1|Overall Study|Physician Decision|1
139826|NCT00752791|502413|P1|Overall Study|Withdrawal by Subject|1
139827|NCT00752791|502413|P1|Overall Study|Adverse Event|7
139828|NCT00752726|502425|P2|Overall Study|Other Reason|2
139829|NCT00752726|502426|P1|Overall Study|Other Reason|1
139830|NCT00752726|502425|P2|Overall Study|Withdrawal by Subject|10
139831|NCT00752726|502426|P1|Overall Study|Withdrawal by Subject|5
139832|NCT00752726|502425|P2|Overall Study|Adverse Event|0
139833|NCT00752726|502426|P1|Overall Study|Adverse Event|3
139834|NCT00752726|502425|P2|Overall Study|Lost to Follow-up|1
139835|NCT00752726|502426|P1|Overall Study|Lost to Follow-up|2
139836|NCT00752622|502451|P1|Interventional Phase|Premature Study Termination|5
139837|NCT00752622|502451|P1|Interventional Phase|Physician Decision|1
139838|NCT00752622|502451|P1|Interventional Phase|Non-responder|2
139839|NCT00752622|502451|P1|Observational Phase|Other|2
139840|NCT00752622|502451|P1|Observational Phase|Adverse Event|1
139841|NCT00752622|502451|P1|Observational Phase|Withdrawal by Subject|2
139842|NCT00752622|502451|P1|Observational Phase|Non-responder|2
139843|NCT00752622|502451|P1|Observational Phase|Premature Study Termination|36
139844|NCT00752622|502451|P1|Induction Phase|Premature study termination|14
139845|NCT00752622|502451|P1|Induction Phase|Withdrawal by Subject|1
139846|NCT00752622|502451|P1|Induction Phase|Non-responder|14
139847|NCT00752622|502451|P1|Induction Phase|Other|3
139848|NCT00752622|502451|P1|Induction Phase|Adverse Event|3
139849|NCT00752609|502464|P2|Overall Study|Received Aranesp in error|0
139850|NCT00752609|502465|P1|Overall Study|Received Aranesp in error|1
139851|NCT00752609|502464|P2|Overall Study|Met exclusion criteria|0
139852|NCT00752609|502465|P1|Overall Study|Met exclusion criteria|1
139853|NCT00752609|502464|P2|Overall Study|Death|0
139854|NCT00752609|502465|P1|Overall Study|Death|1
139855|NCT00752609|502464|P2|Overall Study|Physician Decision|0
139856|NCT00752609|502465|P1|Overall Study|Physician Decision|1
139857|NCT00752609|502464|P2|Overall Study|Withdrawal by Subject|0
139858|NCT00752609|502465|P1|Overall Study|Withdrawal by Subject|3
139859|NCT00752609|502464|P2|Overall Study|Adverse Event|2
139860|NCT00752609|502465|P1|Overall Study|Adverse Event|2
139861|NCT00752232|502491|P7|Overall Study|Caregiver could not attend the subject|0
139862|NCT00752232|502492|P6|Overall Study|Caregiver could not attend the subject|0
139863|NCT00752232|502493|P5|Overall Study|Caregiver could not attend the subject|1
139864|NCT00752232|502494|P4|Overall Study|Caregiver could not attend the subject|0
139865|NCT00752232|502495|P3|Overall Study|Caregiver could not attend the subject|0
139866|NCT00752232|502496|P2|Overall Study|Caregiver could not attend the subject|0
139867|NCT00752232|502497|P1|Overall Study|Caregiver could not attend the subject|0
139868|NCT00752232|502491|P7|Overall Study|Group home admission|0
139869|NCT00752232|502492|P6|Overall Study|Group home admission|0
139870|NCT00752232|502493|P5|Overall Study|Group home admission|0
139871|NCT00752232|502494|P4|Overall Study|Group home admission|1
139872|NCT00752232|502495|P3|Overall Study|Group home admission|0
139873|NCT00752232|502496|P2|Overall Study|Group home admission|0
139874|NCT00752232|502497|P1|Overall Study|Group home admission|0
139875|NCT00752232|502491|P7|Overall Study|Subject request|0
139876|NCT00752232|502492|P6|Overall Study|Subject request|0
139877|NCT00752232|502493|P5|Overall Study|Subject request|0
139878|NCT00752232|502494|P4|Overall Study|Subject request|0
139879|NCT00752232|502495|P3|Overall Study|Subject request|1
139880|NCT00752232|502496|P2|Overall Study|Subject request|0
139881|NCT00752232|502497|P1|Overall Study|Subject request|0
139882|NCT00752232|502491|P7|Overall Study|Investigator request|0
139883|NCT00752232|502492|P6|Overall Study|Investigator request|0
139884|NCT00752232|502493|P5|Overall Study|Investigator request|1
139885|NCT00752232|502494|P4|Overall Study|Investigator request|0
139886|NCT00752232|502495|P3|Overall Study|Investigator request|0
139887|NCT00752232|502496|P2|Overall Study|Investigator request|0
139888|NCT00752232|502497|P1|Overall Study|Investigator request|0
139889|NCT00752232|502491|P7|Overall Study|Caregiver request|0
139890|NCT00752232|502492|P6|Overall Study|Caregiver request|0
139891|NCT00752232|502493|P5|Overall Study|Caregiver request|1
139892|NCT00752232|502494|P4|Overall Study|Caregiver request|0
139893|NCT00752232|502495|P3|Overall Study|Caregiver request|0
139894|NCT00752232|502496|P2|Overall Study|Caregiver request|0
139895|NCT00752232|502497|P1|Overall Study|Caregiver request|2
139896|NCT00752232|502491|P7|Overall Study|Protocol Violation|0
139897|NCT00752232|502492|P6|Overall Study|Protocol Violation|1
139898|NCT00752232|502493|P5|Overall Study|Protocol Violation|0
139899|NCT00752232|502494|P4|Overall Study|Protocol Violation|0
139900|NCT00752232|502495|P3|Overall Study|Protocol Violation|0
139901|NCT00752232|502496|P2|Overall Study|Protocol Violation|0
139902|NCT00752232|502497|P1|Overall Study|Protocol Violation|0
139903|NCT00752128|502569|P1|Overall Study|Withdrawal by Subject|4
139904|NCT00752089|502583|P1|Overall Study|Cannot continue the study|1
139905|NCT00752089|502583|P1|Overall Study|Not capable of wearing partial denture|1
139906|NCT00752089|502583|P1|Overall Study|Could not attend visit 9|1
139907|NCT00752089|502583|P1|Overall Study|Protocol Deviation|2
139908|NCT00752089|502583|P1|Overall Study|Adverse Event|1
139909|NCT00751998|502597|P1|Overall Study|Withdrawal by Subject|2
139910|NCT00751998|502597|P1|Overall Study|Death|11
139911|NCT00751998|502597|P1|Overall Study|Lost to Follow-up|7
139912|NCT00751933|502616|P4|Overall Study|Physician Decision|1
139913|NCT00751933|502617|P3|Overall Study|Physician Decision|1
139914|NCT00751933|502618|P2|Overall Study|Physician Decision|0
139915|NCT00751933|502619|P1|Overall Study|Physician Decision|0
139916|NCT00751933|502616|P4|Overall Study|Withdrawal by Subject|0
139917|NCT00751933|502617|P3|Overall Study|Withdrawal by Subject|0
139918|NCT00751933|502618|P2|Overall Study|Withdrawal by Subject|1
139919|NCT00751933|502619|P1|Overall Study|Withdrawal by Subject|0
139920|NCT00751881|502627|P3|Extension Study Period|Other than specified above|18
139921|NCT00751881|502628|P2|Extension Study Period|Other than specified above|30
139922|NCT00751881|502629|P1|Extension Study Period|Other than specified above|26
139923|NCT00751881|502627|P3|Extension Study Period|Poor Compliance to Protocol|1
139924|NCT00751881|502628|P2|Extension Study Period|Poor Compliance to Protocol|2
139925|NCT00751881|502629|P1|Extension Study Period|Poor Compliance to Protocol|3
139926|NCT00751881|502627|P3|Extension Study Period|Lost to Follow-up|6
139927|NCT00751881|502628|P2|Extension Study Period|Lost to Follow-up|9
139928|NCT00751881|502629|P1|Extension Study Period|Lost to Follow-up|4
139929|NCT00751881|502627|P3|Extension Study Period|Lack of Efficacy|20
139930|NCT00751881|502628|P2|Extension Study Period|Lack of Efficacy|10
139931|NCT00751881|502629|P1|Extension Study Period|Lack of Efficacy|14
139932|NCT00751881|502627|P3|Extension Study Period|Adverse Event|21
139933|NCT00751881|502628|P2|Extension Study Period|Adverse Event|20
139934|NCT00751881|502629|P1|Extension Study Period|Adverse Event|18
139935|NCT00751881|502627|P3|Core Treatment Period|Other:participant's decision/unspecified|16
139936|NCT00751881|502628|P2|Core Treatment Period|Other:participant's decision/unspecified|22
139937|NCT00751881|502629|P1|Core Treatment Period|Other:participant's decision/unspecified|19
139938|NCT00751881|502627|P3|Core Treatment Period|Other: tolerability complaints|0
139939|NCT00751881|502628|P2|Core Treatment Period|Other: tolerability complaints|0
139940|NCT00751881|502629|P1|Core Treatment Period|Other: tolerability complaints|2
139941|NCT00751881|502627|P3|Core Treatment Period|Other: MS treatment change|4
139942|NCT00751881|502628|P2|Core Treatment Period|Other: MS treatment change|4
139943|NCT00751881|502629|P1|Core Treatment Period|Other: MS treatment change|6
139944|NCT00751881|502627|P3|Core Treatment Period|Other: personal/family constraints|10
139945|NCT00751881|502628|P2|Core Treatment Period|Other: personal/family constraints|7
139946|NCT00751881|502629|P1|Core Treatment Period|Other: personal/family constraints|6
139947|NCT00751881|502627|P3|Core Treatment Period|Other: wish to parent|4
139948|NCT00751881|502628|P2|Core Treatment Period|Other: wish to parent|7
139949|NCT00751881|502629|P1|Core Treatment Period|Other: wish to parent|5
139950|NCT00751881|502627|P3|Core Treatment Period|Other: protocol deviation|7
139951|NCT00751881|502628|P2|Core Treatment Period|Other: protocol deviation|3
139952|NCT00751881|502629|P1|Core Treatment Period|Other: protocol deviation|3
139953|NCT00751881|502627|P3|Core Treatment Period|Lost to Follow-up|3
139954|NCT00751881|502628|P2|Core Treatment Period|Lost to Follow-up|4
139955|NCT00751881|502629|P1|Core Treatment Period|Lost to Follow-up|6
139956|NCT00751881|502627|P3|Core Treatment Period|Poor compliance to protocol|4
139957|NCT00751881|502628|P2|Core Treatment Period|Poor compliance to protocol|3
139958|NCT00751881|502629|P1|Core Treatment Period|Poor compliance to protocol|15
139959|NCT00751881|502627|P3|Core Treatment Period|Lack of Efficacy|20
139960|NCT00751881|502628|P2|Core Treatment Period|Lack of Efficacy|30
139961|NCT00751881|502629|P1|Core Treatment Period|Lack of Efficacy|37
139962|NCT00751881|502627|P3|Core Treatment Period|Adverse Event|58
139963|NCT00751881|502628|P2|Core Treatment Period|Adverse Event|54
139964|NCT00751881|502629|P1|Core Treatment Period|Adverse Event|26
139965|NCT00751881|502627|P3|Core Treatment Period|Not treated|2
139966|NCT00751881|502628|P2|Core Treatment Period|Not treated|1
139967|NCT00751881|502629|P1|Core Treatment Period|Not treated|1
139968|NCT00751790|502676|P1|Overall Study|Withdrawal by Subject|1
139969|NCT00751790|502676|P1|Overall Study|Death|3
139970|NCT00751790|502676|P1|Overall Study|Lost to Follow-up|1
139971|NCT00751621|502701|P1|Overall Study|Poor adherence to asthma treatment|1
139972|NCT00751621|502701|P1|Overall Study|Subject moved to another country|1
139973|NCT00751621|502701|P1|Overall Study|Withdrawal by Subject|1
139974|NCT00751621|502701|P1|Overall Study|Adverse Event|1
139975|NCT00751400|502735|P1|Overall Study|Lost to Follow-up|10
139976|NCT00751348|502750|P2|Overall Study|Migration from study area|0
139977|NCT00751348|502751|P1|Overall Study|Migration from study area|1
139978|NCT00751348|502750|P2|Overall Study|Withdrawal by Subject|2
139979|NCT00751348|502751|P1|Overall Study|Withdrawal by Subject|5
139980|NCT00751296|502773|P1|Overall Study|Adverse Event|2
139981|NCT00751140|502801|P1|Overall Study|benign angioma excluded from analysis|1
139982|NCT00751114|502811|P2|Overall Study|Move to another city|0
139983|NCT00751114|502812|P1|Overall Study|Move to another city|1
139984|NCT00751114|502811|P2|Overall Study|Out of country for 2 months|0
139985|NCT00751114|502812|P1|Overall Study|Out of country for 2 months|1
139986|NCT00751114|502811|P2|Overall Study|Not Treated|1
139987|NCT00751114|502812|P1|Overall Study|Not Treated|13
139988|NCT00751114|502811|P2|Overall Study|Lack of Efficacy|7
139989|NCT00751114|502812|P1|Overall Study|Lack of Efficacy|0
139990|NCT00751114|502811|P2|Overall Study|Lost to Follow-up|7
139991|NCT00751114|502812|P1|Overall Study|Lost to Follow-up|4
139992|NCT00751114|502811|P2|Overall Study|Withdrawal by Subject|4
139993|NCT00751114|502812|P1|Overall Study|Withdrawal by Subject|9
139994|NCT00751114|502811|P2|Overall Study|Protocol Violation|9
139995|NCT00751114|502812|P1|Overall Study|Protocol Violation|8
139996|NCT00751114|502811|P2|Overall Study|Adverse Event|4
139997|NCT00751114|502812|P1|Overall Study|Adverse Event|2
139998|NCT00751036|502837|P2|Overall Study|Missing end of Treatment Page|3
139999|NCT00751036|502838|P1|Overall Study|Missing end of Treatment Page|2
140000|NCT00751036|502837|P2|Overall Study|Protocol Violation|0
140001|NCT00751036|502838|P1|Overall Study|Protocol Violation|1
140002|NCT00751036|502837|P2|Overall Study|Lost to Follow-up|1
140003|NCT00751036|502838|P1|Overall Study|Lost to Follow-up|0
140004|NCT00751036|502837|P2|Overall Study|Death|3
140005|NCT00751036|502838|P1|Overall Study|Death|3
140006|NCT00751036|502837|P2|Overall Study|Withdrawal by Subject|2
140007|NCT00751036|502838|P1|Overall Study|Withdrawal by Subject|5
140008|NCT00751036|502837|P2|Overall Study|Administrative Problems|4
140009|NCT00751036|502838|P1|Overall Study|Administrative Problems|3
140010|NCT00751036|502837|P2|Overall Study|Adverse Event|4
140011|NCT00751036|502838|P1|Overall Study|Adverse Event|6
140012|NCT00751036|502837|P2|Overall Study|Disease Progression|29
140013|NCT00751036|502838|P1|Overall Study|Disease Progression|28
140014|NCT00750919|502850|P1|Overall Study|Other|36
140015|NCT00750919|502850|P1|Overall Study|Could not cooperate, unrelated to trial|4
140016|NCT00750919|502850|P1|Overall Study|Lack of Efficacy|8
140017|NCT00750919|502850|P1|Overall Study|Withdrawal by Subject|1
140018|NCT00750919|502850|P1|Overall Study|Adverse Event|9
140019|NCT00750893|502858|P1|Overall Study|Other|17
140020|NCT00750893|502858|P1|Overall Study|Lost to Follow-up|510
140021|NCT00750893|502858|P1|Overall Study|Withdrawal by Subject|10
140022|NCT00750893|502858|P1|Overall Study|Adverse Event|5
140023|NCT00750880|502873|P1|Overall Study|Administrative|11
140024|NCT00750880|502873|P1|Overall Study|Physician Decision|20
140025|NCT00750880|502873|P1|Overall Study|Withdrawal by Subject|33
140026|NCT00750880|502873|P1|Overall Study|Protocol Violation|15
140027|NCT00750880|502873|P1|Overall Study|Lost to Follow-up|10
140028|NCT00750880|502873|P1|Overall Study|Lack of Efficacy|46
140029|NCT00750880|502873|P1|Overall Study|Death|4
140030|NCT00750880|502873|P1|Overall Study|Adverse Event|76
140031|NCT00750867|502896|P1|Overall Study|Adverse Event|2
140032|NCT00750737|502917|P2|Overall Study|Withdrawal by Subject|3
140033|NCT00750737|502918|P1|Overall Study|Withdrawal by Subject|3
140034|NCT00750308|502978|P12|Third Treatment|Withdrawal by Subject|0
140035|NCT00750308|502979|P11|Third Treatment|Withdrawal by Subject|0
140036|NCT00750308|502980|P10|Third Treatment|Withdrawal by Subject|0
140037|NCT00750308|502981|P9|Third Treatment|Withdrawal by Subject|0
140038|NCT00750308|502982|P8|Third Treatment|Withdrawal by Subject|0
140039|NCT00750308|502983|P7|Third Treatment|Withdrawal by Subject|0
140040|NCT00750308|502984|P6|Third Treatment|Withdrawal by Subject|0
140041|NCT00750308|502985|P5|Third Treatment|Withdrawal by Subject|0
140042|NCT00750308|502986|P4|Third Treatment|Withdrawal by Subject|0
140043|NCT00750308|502987|P3|Third Treatment|Withdrawal by Subject|0
140044|NCT00750308|502988|P2|Third Treatment|Withdrawal by Subject|1
140045|NCT00750308|502989|P1|Third Treatment|Withdrawal by Subject|0
140046|NCT00750308|502978|P12|Second Treatment|Withdrawal by Subject|0
140047|NCT00750308|502979|P11|Second Treatment|Withdrawal by Subject|0
140048|NCT00750308|502980|P10|Second Treatment|Withdrawal by Subject|0
140049|NCT00750308|502981|P9|Second Treatment|Withdrawal by Subject|0
140050|NCT00750308|502982|P8|Second Treatment|Withdrawal by Subject|0
140051|NCT00750308|502983|P7|Second Treatment|Withdrawal by Subject|0
140052|NCT00750308|502984|P6|Second Treatment|Withdrawal by Subject|0
140053|NCT00750308|502985|P5|Second Treatment|Withdrawal by Subject|1
140054|NCT00750308|502986|P4|Second Treatment|Withdrawal by Subject|0
140055|NCT00750308|502987|P3|Second Treatment|Withdrawal by Subject|0
140056|NCT00750308|502988|P2|Second Treatment|Withdrawal by Subject|0
140057|NCT00750308|502989|P1|Second Treatment|Withdrawal by Subject|0
140058|NCT00750308|502978|P12|Second Treatment|Adverse Event|0
140059|NCT00750308|502979|P11|Second Treatment|Adverse Event|0
140060|NCT00750308|502980|P10|Second Treatment|Adverse Event|0
140061|NCT00750308|502981|P9|Second Treatment|Adverse Event|1
140062|NCT00750308|502982|P8|Second Treatment|Adverse Event|0
140063|NCT00750308|502983|P7|Second Treatment|Adverse Event|0
140064|NCT00750308|502984|P6|Second Treatment|Adverse Event|1
140065|NCT00750308|502985|P5|Second Treatment|Adverse Event|0
140066|NCT00750308|502986|P4|Second Treatment|Adverse Event|0
140067|NCT00750308|502987|P3|Second Treatment|Adverse Event|0
140068|NCT00750308|502988|P2|Second Treatment|Adverse Event|0
140069|NCT00750308|502989|P1|Second Treatment|Adverse Event|0
140070|NCT00750308|502978|P12|First Treatment|Withdrawal by Subject|0
140071|NCT00750308|502979|P11|First Treatment|Withdrawal by Subject|0
140072|NCT00750308|502980|P10|First Treatment|Withdrawal by Subject|0
140073|NCT00750308|502981|P9|First Treatment|Withdrawal by Subject|0
140074|NCT00750308|502982|P8|First Treatment|Withdrawal by Subject|1
140075|NCT00750308|502983|P7|First Treatment|Withdrawal by Subject|0
140076|NCT00750308|502984|P6|First Treatment|Withdrawal by Subject|0
140077|NCT00750308|502985|P5|First Treatment|Withdrawal by Subject|0
140078|NCT00750308|502986|P4|First Treatment|Withdrawal by Subject|1
140079|NCT00750308|502987|P3|First Treatment|Withdrawal by Subject|0
140080|NCT00750308|502988|P2|First Treatment|Withdrawal by Subject|0
140081|NCT00750308|502989|P1|First Treatment|Withdrawal by Subject|0
140082|NCT00750308|502978|P12|First Treatment|Adverse Event|1
140083|NCT00750308|502979|P11|First Treatment|Adverse Event|1
140084|NCT00750308|502980|P10|First Treatment|Adverse Event|0
140085|NCT00750308|502981|P9|First Treatment|Adverse Event|0
140086|NCT00750308|502982|P8|First Treatment|Adverse Event|0
140087|NCT00750308|502983|P7|First Treatment|Adverse Event|0
140088|NCT00750308|502984|P6|First Treatment|Adverse Event|0
140089|NCT00750308|502985|P5|First Treatment|Adverse Event|0
140090|NCT00750308|502986|P4|First Treatment|Adverse Event|0
140091|NCT00750308|502987|P3|First Treatment|Adverse Event|0
140092|NCT00750308|502988|P2|First Treatment|Adverse Event|1
140093|NCT00750308|502989|P1|First Treatment|Adverse Event|0
140094|NCT00750269|503039|P5|Overall Study|Fiducials could not be placed|1
140095|NCT00750269|503040|P4|Overall Study|Fiducials could not be placed|0
140096|NCT00750269|503041|P3|Overall Study|Fiducials could not be placed|0
140097|NCT00750269|503042|P2|Overall Study|Fiducials could not be placed|0
140098|NCT00750269|503043|P1|Overall Study|Fiducials could not be placed|0
140099|NCT00750269|503039|P5|Overall Study|SBRT plan could not be drawn|1
140100|NCT00750269|503040|P4|Overall Study|SBRT plan could not be drawn|0
140101|NCT00750269|503041|P3|Overall Study|SBRT plan could not be drawn|0
140102|NCT00750269|503042|P2|Overall Study|SBRT plan could not be drawn|0
140103|NCT00750269|503043|P1|Overall Study|SBRT plan could not be drawn|0
140104|NCT00750269|503039|P5|Overall Study|Site error|0
140105|NCT00750269|503040|P4|Overall Study|Site error|1
140106|NCT00750269|503041|P3|Overall Study|Site error|0
140107|NCT00750269|503042|P2|Overall Study|Site error|0
140108|NCT00750269|503043|P1|Overall Study|Site error|0
140109|NCT00750269|503039|P5|Overall Study|Patient too large for positioning|0
140110|NCT00750269|503040|P4|Overall Study|Patient too large for positioning|0
140111|NCT00750269|503041|P3|Overall Study|Patient too large for positioning|1
140112|NCT00750269|503042|P2|Overall Study|Patient too large for positioning|0
140113|NCT00750269|503043|P1|Overall Study|Patient too large for positioning|0
140114|NCT00750269|503039|P5|Overall Study|Physician Decision|2
140115|NCT00750269|503040|P4|Overall Study|Physician Decision|0
140116|NCT00750269|503041|P3|Overall Study|Physician Decision|0
140117|NCT00750269|503042|P2|Overall Study|Physician Decision|0
140118|NCT00750269|503043|P1|Overall Study|Physician Decision|0
140119|NCT00750269|503039|P5|Overall Study|Withdrawal by Subject|2
140120|NCT00750269|503040|P4|Overall Study|Withdrawal by Subject|2
140121|NCT00750269|503041|P3|Overall Study|Withdrawal by Subject|2
140122|NCT00750269|503042|P2|Overall Study|Withdrawal by Subject|0
140123|NCT00750269|503043|P1|Overall Study|Withdrawal by Subject|0
140124|NCT00750269|503039|P5|Overall Study|Protocol Violation|4
140125|NCT00750269|503040|P4|Overall Study|Protocol Violation|2
140126|NCT00750269|503041|P3|Overall Study|Protocol Violation|1
140127|NCT00750269|503042|P2|Overall Study|Protocol Violation|1
140128|NCT00750269|503043|P1|Overall Study|Protocol Violation|0
140129|NCT00750204|503090|P2|Overall Study|study halted prematurely|1
140130|NCT00750204|503091|P1|Overall Study|study halted prematurely|1
140131|NCT00750152|503114|P2|Overall Study|Not specified|8
140132|NCT00750152|503115|P1|Overall Study|Not specified|7
140133|NCT00750152|503114|P2|Overall Study|Termination by sponsor|0
140134|NCT00750152|503115|P1|Overall Study|Termination by sponsor|1
140135|NCT00750152|503114|P2|Overall Study|Non-compliance|1
140136|NCT00750152|503115|P1|Overall Study|Non-compliance|0
140137|NCT00750152|503114|P2|Overall Study|Physician Decision|1
140138|NCT00750152|503115|P1|Overall Study|Physician Decision|1
140139|NCT00750152|503114|P2|Overall Study|Withdrawal by Subject|3
140140|NCT00750152|503115|P1|Overall Study|Withdrawal by Subject|3
140141|NCT00750152|503114|P2|Overall Study|Lost to Follow-up|13
140142|NCT00750152|503115|P1|Overall Study|Lost to Follow-up|8
140143|NCT00750152|503114|P2|Overall Study|Adverse Event|1
140144|NCT00750152|503115|P1|Overall Study|Adverse Event|2
140145|NCT00750139|503127|P4|Overall Study|Non-specific|33
140146|NCT00750139|503128|P3|Overall Study|Non-specific|79
140147|NCT00750139|503129|P2|Overall Study|Non-specific|42
140148|NCT00750139|503130|P1|Overall Study|Non-specific|62
140149|NCT00750139|503127|P4|Overall Study|Termination by sponsor|1
140150|NCT00750139|503128|P3|Overall Study|Termination by sponsor|0
140151|NCT00750139|503129|P2|Overall Study|Termination by sponsor|0
140152|NCT00750139|503130|P1|Overall Study|Termination by sponsor|4
140153|NCT00750139|503127|P4|Overall Study|Non-compliance|3
140154|NCT00750139|503128|P3|Overall Study|Non-compliance|1
140155|NCT00750139|503129|P2|Overall Study|Non-compliance|0
140156|NCT00750139|503130|P1|Overall Study|Non-compliance|1
140157|NCT00750139|503127|P4|Overall Study|Physician Decision|0
140158|NCT00750139|503128|P3|Overall Study|Physician Decision|0
140159|NCT00750139|503129|P2|Overall Study|Physician Decision|1
140160|NCT00750139|503130|P1|Overall Study|Physician Decision|1
140161|NCT00750139|503127|P4|Overall Study|Withdrawal by Subject|2
140162|NCT00750139|503128|P3|Overall Study|Withdrawal by Subject|6
140163|NCT00750139|503129|P2|Overall Study|Withdrawal by Subject|2
140164|NCT00750139|503130|P1|Overall Study|Withdrawal by Subject|3
140165|NCT00750139|503127|P4|Overall Study|Lost to Follow-up|6
140166|NCT00750139|503128|P3|Overall Study|Lost to Follow-up|15
140167|NCT00750139|503129|P2|Overall Study|Lost to Follow-up|12
140168|NCT00750139|503130|P1|Overall Study|Lost to Follow-up|17
140169|NCT00750139|503127|P4|Overall Study|Adverse Event|1
140170|NCT00750139|503128|P3|Overall Study|Adverse Event|0
140171|NCT00750139|503129|P2|Overall Study|Adverse Event|2
140172|NCT00750139|503130|P1|Overall Study|Adverse Event|1
140173|NCT00750061|503146|P2|Overall Study|Physician Decision|1
140174|NCT00750061|503147|P1|Overall Study|Physician Decision|0
140175|NCT00750061|503146|P2|Overall Study|Withdrawal by Subject|1
140176|NCT00750061|503147|P1|Overall Study|Withdrawal by Subject|0
140177|NCT00750061|503146|P2|Overall Study|Adverse Event|0
140178|NCT00750061|503147|P1|Overall Study|Adverse Event|2
140179|NCT00749996|503157|P2|Overall Study|Death|0
140180|NCT00749996|503158|P1|Overall Study|Death|1
140181|NCT00749996|503157|P2|Overall Study|Adverse Event|0
140182|NCT00749996|503158|P1|Overall Study|Adverse Event|1
140183|NCT00749996|503157|P2|Overall Study|Pregnancy|2
140184|NCT00749996|503158|P1|Overall Study|Pregnancy|0
140185|NCT00749996|503157|P2|Overall Study|Physician Decision|0
140186|NCT00749996|503158|P1|Overall Study|Physician Decision|2
140187|NCT00749996|503157|P2|Overall Study|Protocol Violation|3
140188|NCT00749996|503158|P1|Overall Study|Protocol Violation|2
140189|NCT00749996|503157|P2|Overall Study|Withdrawal by Subject|4
140190|NCT00749996|503158|P1|Overall Study|Withdrawal by Subject|5
140191|NCT00749996|503157|P2|Overall Study|Lost to Follow-up|4
140192|NCT00749996|503158|P1|Overall Study|Lost to Follow-up|7
140193|NCT00749944|503181|P2|Overall Study|Withdrawal by Subject|0
140194|NCT00749944|503182|P1|Overall Study|Withdrawal by Subject|2
140195|NCT00749944|503181|P2|Overall Study|Not specified|0
140196|NCT00749944|503182|P1|Overall Study|Not specified|1
140197|NCT00749944|503181|P2|Overall Study|Lost to Follow-up|1
140198|NCT00749944|503182|P1|Overall Study|Lost to Follow-up|2
140199|NCT00749775|503261|P1|Overall Study|No drug administration|3
140200|NCT00749775|503261|P1|Overall Study|No visit after first day of treatment|44
140201|NCT00749775|503261|P1|Overall Study|Lost to Follow-up|36
140202|NCT00749775|503261|P1|Overall Study|Protocol Violation|24
140203|NCT00749684|503277|P1|Overall Study|Missing|9
140204|NCT00749684|503277|P1|Overall Study|AE+discontinuation on participants wish|1
140205|NCT00749684|503277|P1|Overall Study|Therapy according to protocol + AE|2
140206|NCT00749684|503277|P1|Overall Study|Progressive Desease|31
140207|NCT00749684|503277|P1|Overall Study|Not Documented|1
140208|NCT00749684|503277|P1|Overall Study|Participant's Wish|10
140209|NCT00749684|503277|P1|Overall Study|Adverse Event|27
140210|NCT00749684|503277|P1|Overall Study|Death|1
140211|NCT00749580|503316|P2|Overall Study|Adverse Event|1
140212|NCT00749580|503317|P1|Overall Study|Adverse Event|0
140213|NCT00749580|503316|P2|Overall Study|Lost to Follow-up|8
140214|NCT00749580|503317|P1|Overall Study|Lost to Follow-up|4
140215|NCT00749463|503332|P3|Overall Study|Withdrawal by Subject|0
140216|NCT00749463|503333|P2|Overall Study|Withdrawal by Subject|0
140217|NCT00749463|503334|P1|Overall Study|Withdrawal by Subject|1
140218|NCT00749463|503332|P3|Overall Study|Adverse Event|1
140219|NCT00749463|503333|P2|Overall Study|Adverse Event|4
140220|NCT00749463|503334|P1|Overall Study|Adverse Event|0
140221|NCT00749398|503360|P1|Overall Study|Unknown reason|1
140222|NCT00749398|503360|P1|Overall Study|Reason not specified|2
140223|NCT00749398|503360|P1|Overall Study|Lost to Follow-up|11
140224|NCT00749398|503360|P1|Overall Study|Withdrawal by Subject|17
140225|NCT00749398|503360|P1|Overall Study|Serious adverse event|11
140226|NCT00749398|503360|P1|Overall Study|Adverse Event|4
140227|NCT00749398|503360|P1|Overall Study|Lack of Efficacy|7
140228|NCT00749203|503403|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
140229|NCT00749203|503404|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
140230|NCT00749203|503403|P2|Second Infusion at 2 Weeks|Protocol Violation|1
140231|NCT00749203|503404|P1|Second Infusion at 2 Weeks|Protocol Violation|0
140232|NCT00749203|503403|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
140233|NCT00749203|503404|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
140234|NCT00749203|503403|P2|no Infusion at Week 1|delayed-onset sedation|1
140235|NCT00749203|503404|P1|no Infusion at Week 1|delayed-onset sedation|0
140236|NCT00749203|503403|P2|no Infusion at Week 1|Withdrawal by Subject|1
140237|NCT00749203|503404|P1|no Infusion at Week 1|Withdrawal by Subject|0
140238|NCT00749203|503403|P2|no Infusion at Week 1|Lost to Follow-up|1
140239|NCT00749203|503404|P1|no Infusion at Week 1|Lost to Follow-up|0
140240|NCT00749190|503425|P7|Overall Study|Other reason not defined above|0
140241|NCT00749190|503426|P6|Overall Study|Other reason not defined above|0
140242|NCT00749190|503427|P5|Overall Study|Other reason not defined above|0
140243|NCT00749190|503428|P4|Overall Study|Other reason not defined above|1
140244|NCT00749190|503429|P3|Overall Study|Other reason not defined above|0
140245|NCT00749190|503430|P2|Overall Study|Other reason not defined above|0
140246|NCT00749190|503431|P1|Overall Study|Other reason not defined above|0
140247|NCT00749190|503425|P7|Overall Study|Protocol Violation|1
140248|NCT00749190|503426|P6|Overall Study|Protocol Violation|0
140249|NCT00749190|503427|P5|Overall Study|Protocol Violation|0
140250|NCT00749190|503428|P4|Overall Study|Protocol Violation|0
140251|NCT00749190|503429|P3|Overall Study|Protocol Violation|0
140252|NCT00749190|503430|P2|Overall Study|Protocol Violation|1
140253|NCT00749190|503431|P1|Overall Study|Protocol Violation|0
140254|NCT00749190|503425|P7|Overall Study|Withdrawal by Subject|0
140255|NCT00749190|503426|P6|Overall Study|Withdrawal by Subject|1
140256|NCT00749190|503427|P5|Overall Study|Withdrawal by Subject|0
140257|NCT00749190|503428|P4|Overall Study|Withdrawal by Subject|0
140258|NCT00749190|503429|P3|Overall Study|Withdrawal by Subject|0
140259|NCT00749190|503430|P2|Overall Study|Withdrawal by Subject|1
140260|NCT00749190|503431|P1|Overall Study|Withdrawal by Subject|2
140261|NCT00749190|503425|P7|Overall Study|Lack of Efficacy|0
140262|NCT00749190|503426|P6|Overall Study|Lack of Efficacy|1
140263|NCT00749190|503427|P5|Overall Study|Lack of Efficacy|0
140264|NCT00749190|503428|P4|Overall Study|Lack of Efficacy|0
140265|NCT00749190|503429|P3|Overall Study|Lack of Efficacy|1
140266|NCT00749190|503430|P2|Overall Study|Lack of Efficacy|1
140267|NCT00749190|503431|P1|Overall Study|Lack of Efficacy|3
140268|NCT00749190|503425|P7|Overall Study|Adverse Event|0
140269|NCT00749190|503426|P6|Overall Study|Adverse Event|3
140270|NCT00749190|503427|P5|Overall Study|Adverse Event|0
140271|NCT00749190|503428|P4|Overall Study|Adverse Event|4
140272|NCT00749190|503429|P3|Overall Study|Adverse Event|0
140273|NCT00749190|503430|P2|Overall Study|Adverse Event|2
140274|NCT00749190|503431|P1|Overall Study|Adverse Event|0
140275|NCT00748969|503531|P2|Overall Study|Withdrawal by Subject|1
140276|NCT00748969|503532|P1|Overall Study|Withdrawal by Subject|0
140277|NCT00748969|503531|P2|Overall Study|Withdrawal by Subject|0
140278|NCT00748969|503532|P1|Overall Study|Withdrawal by Subject|1
140279|NCT00748709|503580|P1|Overall Study|Other Reasons|1
140280|NCT00748709|503580|P1|Overall Study|Withdrawal by Subject|1
140281|NCT00748709|503580|P1|Overall Study|Other Adverse Event|1
140282|NCT00748709|503580|P1|Overall Study|Drug reducing Toxity|2
140283|NCT00748709|503580|P1|Overall Study|Progressive disease|15
140284|NCT00748566|503607|P1|Overall Study|Other|9
140285|NCT00748566|503607|P1|Overall Study|Study terminated by sponsor|5
140286|NCT00748566|503607|P1|Overall Study|Withdrawal by Subject|22
140287|NCT00748566|503607|P1|Overall Study|Protocol Violation|13
140288|NCT00748566|503607|P1|Overall Study|Lost to Follow-up|1
140289|NCT00748566|503607|P1|Overall Study|Lack of Efficacy|12
140290|NCT00748566|503607|P1|Overall Study|Death|1
140291|NCT00748566|503607|P1|Overall Study|Adverse Event|49
140292|NCT00748553|503637|P2|Overall Study|noncompliance|0
140293|NCT00748553|503638|P1|Overall Study|noncompliance|1
140294|NCT00748553|503637|P2|Overall Study|disease progression|0
140295|NCT00748553|503638|P1|Overall Study|disease progression|2
140296|NCT00748553|503637|P2|Overall Study|Adverse Event|1
140297|NCT00748553|503638|P1|Overall Study|Adverse Event|0
140298|NCT00748241|503664|P1|Overall Study|Death|2
140299|NCT00748241|503664|P1|Overall Study|Lost to Follow-up|5
140300|NCT00748241|503664|P1|Overall Study|Implant failure|1
140301|NCT00748189|503674|P2|Overall Study|Ongoing|162
140302|NCT00748189|503675|P1|Overall Study|Ongoing|155
140303|NCT00748189|503674|P2|Overall Study|Study terminated by Sponsor|1
140304|NCT00748189|503675|P1|Overall Study|Study terminated by Sponsor|0
140305|NCT00748189|503674|P2|Overall Study|Lost to Follow-up|4
140306|NCT00748189|503675|P1|Overall Study|Lost to Follow-up|2
140307|NCT00748189|503674|P2|Overall Study|Physician Decision|4
140308|NCT00748189|503675|P1|Overall Study|Physician Decision|13
140309|NCT00748189|503674|P2|Overall Study|Withdrawal by Subject|16
140310|NCT00748189|503675|P1|Overall Study|Withdrawal by Subject|15
140311|NCT00748189|503674|P2|Overall Study|Death|34
140312|NCT00748189|503675|P1|Overall Study|Death|40
140313|NCT00748098|503729|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
140314|NCT00748098|503730|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
140315|NCT00748098|503729|P2|Second Treatment Intervention Period|Lost to Follow-up|1
140316|NCT00748098|503730|P1|Second Treatment Intervention Period|Lost to Follow-up|1
140317|NCT00748098|503729|P2|Second Treatment Intervention Period|Adverse Event|1
140318|NCT00748098|503730|P1|Second Treatment Intervention Period|Adverse Event|4
140319|NCT00748098|503729|P2|1-Week Washout Period|Withdrawal by Subject|0
140320|NCT00748098|503730|P1|1-Week Washout Period|Withdrawal by Subject|2
140321|NCT00748098|503729|P2|1-Week Washout Period|Adverse Event|1
140322|NCT00748098|503730|P1|1-Week Washout Period|Adverse Event|0
140323|NCT00748098|503729|P2|First Taper Period|Protocol Stopping Criteria Met|1
140324|NCT00748098|503730|P1|First Taper Period|Protocol Stopping Criteria Met|0
140325|NCT00748098|503729|P2|First Taper Period|Withdrawal by Subject|0
140326|NCT00748098|503730|P1|First Taper Period|Withdrawal by Subject|2
140327|NCT00748098|503729|P2|First Taper Period|Protocol Violation|0
140328|NCT00748098|503730|P1|First Taper Period|Protocol Violation|1
140329|NCT00748098|503729|P2|First Treatment Intervention Period|Withdrawal by Subject|0
140330|NCT00748098|503730|P1|First Treatment Intervention Period|Withdrawal by Subject|2
140331|NCT00748098|503729|P2|First Treatment Intervention Period|Lost to Follow-up|0
140332|NCT00748098|503730|P1|First Treatment Intervention Period|Lost to Follow-up|1
140333|NCT00748098|503729|P2|First Treatment Intervention Period|Protocol Violation|0
140334|NCT00748098|503730|P1|First Treatment Intervention Period|Protocol Violation|1
140335|NCT00748098|503729|P2|First Treatment Intervention Period|Adverse Event|1
140336|NCT00748098|503730|P1|First Treatment Intervention Period|Adverse Event|1
140337|NCT00747812|503811|P2|Overall Study|Research Site Staff Relocation|3
140338|NCT00747812|503812|P1|Overall Study|Research Site Staff Relocation|5
140339|NCT00747643|503850|P2|Overall Study|Withdrawal by Subject|27
140340|NCT00747643|503851|P1|Overall Study|Withdrawal by Subject|36
140341|NCT00747617|503865|P2|Overall Study|Lost to Follow-up|1
140342|NCT00747617|503866|P1|Overall Study|Lost to Follow-up|3
140343|NCT00747565|503874|P2|Overall Study|Lost to Follow-up|1
140344|NCT00747565|503875|P1|Overall Study|Lost to Follow-up|4
140345|NCT00747565|503874|P2|Overall Study|Withdrawal by Subject|6
140346|NCT00747565|503875|P1|Overall Study|Withdrawal by Subject|10
140347|NCT00747474|503888|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140348|NCT00747474|503889|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140349|NCT00747474|503890|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140350|NCT00747474|503891|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140351|NCT00747474|503892|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
140352|NCT00747474|503893|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140353|NCT00747474|503894|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140354|NCT00747474|503895|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140355|NCT00747474|503896|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140356|NCT00747474|503897|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140357|NCT00747474|503898|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140358|NCT00747474|503899|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
140359|NCT00747461|503925|P1|Overall Study|study terminated by sponsor|5
140360|NCT00747435|503930|P1|Overall Study|Still undergoing follow up|1
140361|NCT00747435|503930|P1|Overall Study|Withdrawal by Subject|3
140362|NCT00747435|503930|P1|Overall Study|Lost to Follow-up|2
140363|NCT00747344|503940|P4|After Controlled Period|Adverse Event|1
140364|NCT00747344|503941|P3|After Controlled Period|Adverse Event|0
140365|NCT00747344|503942|P2|After Controlled Period|Adverse Event|0
140366|NCT00747344|503943|P1|After Controlled Period|Adverse Event|0
140367|NCT00747344|503940|P4|Controlled Period|Other|0
140368|NCT00747344|503941|P3|Controlled Period|Other|0
140369|NCT00747344|503942|P2|Controlled Period|Other|3
140370|NCT00747344|503943|P1|Controlled Period|Other|0
140371|NCT00747344|503940|P4|Controlled Period|Lack of Efficacy|0
140372|NCT00747344|503941|P3|Controlled Period|Lack of Efficacy|0
140373|NCT00747344|503942|P2|Controlled Period|Lack of Efficacy|1
140374|NCT00747344|503943|P1|Controlled Period|Lack of Efficacy|2
140375|NCT00747344|503940|P4|Controlled Period|Adverse Event|0
140376|NCT00747344|503941|P3|Controlled Period|Adverse Event|0
140377|NCT00747344|503942|P2|Controlled Period|Adverse Event|0
140378|NCT00747344|503943|P1|Controlled Period|Adverse Event|3
140379|NCT00747227|503957|P2|Overall Study|Illness|1
140380|NCT00747227|503958|P1|Overall Study|Illness|1
140381|NCT00747227|503957|P2|Overall Study|Lost to Follow-up|2
140382|NCT00747227|503958|P1|Overall Study|Lost to Follow-up|1
140383|NCT00747227|503957|P2|Overall Study|Withdrawal by Subject|0
140384|NCT00747227|503958|P1|Overall Study|Withdrawal by Subject|1
140385|NCT00747227|503957|P2|Overall Study|Death|1
140386|NCT00747227|503958|P1|Overall Study|Death|3
140387|NCT00747149|503987|P2|Overall Study|Not reported|4
140388|NCT00747149|503988|P1|Overall Study|Not reported|1
140389|NCT00747149|503987|P2|Overall Study|Severe non-compliance to protocol|1
140390|NCT00747149|503988|P1|Overall Study|Severe non-compliance to protocol|0
140391|NCT00747149|503987|P2|Overall Study|Incorrect enrollment|6
140392|NCT00747149|503988|P1|Overall Study|Incorrect enrollment|0
140393|NCT00747149|503987|P2|Overall Study|Did not receive treatment|1
140394|NCT00747149|503988|P1|Overall Study|Did not receive treatment|0
140395|NCT00747149|503987|P2|Overall Study|Withdrawal by Subject|6
140396|NCT00747149|503988|P1|Overall Study|Withdrawal by Subject|0
140397|NCT00747149|503987|P2|Overall Study|Lost to Follow-up|10
140398|NCT00747149|503988|P1|Overall Study|Lost to Follow-up|0
140399|NCT00747149|503987|P2|Overall Study|Adverse Event|15
140400|NCT00747149|503988|P1|Overall Study|Adverse Event|0
140401|NCT00747006|504003|P3|Overall Study|Physician Decision|1
140402|NCT00747006|504004|P2|Overall Study|Physician Decision|0
140403|NCT00747006|504005|P1|Overall Study|Physician Decision|2
140404|NCT00747006|504003|P3|Overall Study|Lost to Follow-up|0
140405|NCT00747006|504004|P2|Overall Study|Lost to Follow-up|1
140406|NCT00747006|504005|P1|Overall Study|Lost to Follow-up|0
140407|NCT00747006|504003|P3|Overall Study|Adverse Event|0
140408|NCT00747006|504004|P2|Overall Study|Adverse Event|0
140409|NCT00747006|504005|P1|Overall Study|Adverse Event|1
140410|NCT00746941|504083|P4|Overall Study|Adverse Event|1
140411|NCT00746941|504084|P3|Overall Study|Adverse Event|0
140412|NCT00746941|504085|P2|Overall Study|Adverse Event|0
140413|NCT00746941|504086|P1|Overall Study|Adverse Event|0
140414|NCT00746941|504083|P4|Overall Study|Other, reason not provided|4
140415|NCT00746941|504084|P3|Overall Study|Other, reason not provided|0
140416|NCT00746941|504085|P2|Overall Study|Other, reason not provided|4
140417|NCT00746941|504086|P1|Overall Study|Other, reason not provided|2
140418|NCT00746941|504083|P4|Overall Study|Withdrawal by Subject|2
140419|NCT00746941|504084|P3|Overall Study|Withdrawal by Subject|0
140420|NCT00746941|504085|P2|Overall Study|Withdrawal by Subject|0
140421|NCT00746941|504086|P1|Overall Study|Withdrawal by Subject|3
140422|NCT00746941|504083|P4|Overall Study|Physician Decision|0
140423|NCT00746941|504084|P3|Overall Study|Physician Decision|2
140424|NCT00746941|504085|P2|Overall Study|Physician Decision|0
140425|NCT00746941|504086|P1|Overall Study|Physician Decision|0
140426|NCT00746941|504083|P4|Overall Study|Death|6
140427|NCT00746941|504084|P3|Overall Study|Death|0
140428|NCT00746941|504085|P2|Overall Study|Death|0
140429|NCT00746941|504086|P1|Overall Study|Death|2
140430|NCT00746798|504144|P4|Overall Study|Participant unable to return for visit|0
140431|NCT00746798|504145|P3|Overall Study|Participant unable to return for visit|0
140432|NCT00746798|504146|P2|Overall Study|Participant unable to return for visit|0
140433|NCT00746798|504147|P1|Overall Study|Participant unable to return for visit|1
140434|NCT00746798|504144|P4|Overall Study|Death|0
140435|NCT00746798|504145|P3|Overall Study|Death|2
140436|NCT00746798|504146|P2|Overall Study|Death|0
140437|NCT00746798|504147|P1|Overall Study|Death|0
140438|NCT00746798|504144|P4|Overall Study|Withdrawal by Subject|0
140439|NCT00746798|504145|P3|Overall Study|Withdrawal by Subject|1
140440|NCT00746798|504146|P2|Overall Study|Withdrawal by Subject|1
140441|NCT00746798|504147|P1|Overall Study|Withdrawal by Subject|0
140442|NCT00746798|504144|P4|Overall Study|Protocol Violation|0
140443|NCT00746798|504145|P3|Overall Study|Protocol Violation|0
140444|NCT00746798|504146|P2|Overall Study|Protocol Violation|1
140445|NCT00746798|504147|P1|Overall Study|Protocol Violation|0
140446|NCT00746785|504172|P3|Overall Study|Lost to Follow-up|27
140447|NCT00746785|504173|P2|Overall Study|Lost to Follow-up|25
140448|NCT00746785|504174|P1|Overall Study|Lost to Follow-up|29
140449|NCT00746733|504182|P2|Third Intervention|Withdrawal by Subject|1
140450|NCT00746733|504183|P1|Third Intervention|Withdrawal by Subject|1
140451|NCT00746733|504182|P2|Second Intervention|Adverse Event|0
140452|NCT00746733|504183|P1|Second Intervention|Adverse Event|1
140453|NCT00746590|504267|P1|Overall Study|Death|1
140454|NCT00746564|504271|P1|Overall Study|Required Pacemaker/ICD Implant|2
140455|NCT00746551|504286|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
140456|NCT00746551|504287|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
140457|NCT00746551|504286|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
140458|NCT00746551|504287|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
140459|NCT00746551|504286|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
140460|NCT00746551|504287|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
140461|NCT00746356|504338|P2|Overall Study|Patient relocated|0
140462|NCT00746356|504339|P1|Overall Study|Patient relocated|1
140463|NCT00746356|504338|P2|Overall Study|Removal of Device|1
140464|NCT00746356|504339|P1|Overall Study|Removal of Device|0
140465|NCT00746356|504338|P2|Overall Study|Lost to Follow-up|0
140466|NCT00746356|504339|P1|Overall Study|Lost to Follow-up|1
140467|NCT00746356|504338|P2|Overall Study|Death|3
140468|NCT00746356|504339|P1|Overall Study|Death|7
140469|NCT00746356|504338|P2|Overall Study|Withdrawal by Subject|3
140470|NCT00746356|504339|P1|Overall Study|Withdrawal by Subject|2
140471|NCT00746330|504351|P4|Period 1|Abnormal test procedure result|0
140472|NCT00746330|504352|P3|Period 1|Abnormal test procedure result|1
140473|NCT00746330|504353|P2|Period 1|Abnormal test procedure result|0
140474|NCT00746330|504354|P1|Period 1|Abnormal test procedure result|0
140475|NCT00746252|504384|P2|Overall Study|weight gain >7.5 %|2
140476|NCT00746252|504385|P1|Overall Study|weight gain >7.5 %|1
140477|NCT00746096|504407|P2|Overall Study|No study drug treatment|1
140478|NCT00746096|504408|P1|Overall Study|No study drug treatment|1
140479|NCT00746096|504407|P2|Overall Study|Protocol Violation|0
140480|NCT00746096|504408|P1|Overall Study|Protocol Violation|1
140481|NCT00746096|504407|P2|Overall Study|Lost to Follow-up|1
140482|NCT00746096|504408|P1|Overall Study|Lost to Follow-up|2
140483|NCT00746096|504407|P2|Overall Study|Withdrawal by Subject|1
140484|NCT00746096|504408|P1|Overall Study|Withdrawal by Subject|5
140485|NCT00746096|504407|P2|Overall Study|Adverse Event|0
140486|NCT00746096|504408|P1|Overall Study|Adverse Event|1
140487|NCT00745901|504439|P2|Overall Study|Patient didn't take any study medication|3
140488|NCT00745901|504440|P1|Overall Study|Patient didn't take any study medication|7
140489|NCT00745901|504439|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
140490|NCT00745901|504440|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
140491|NCT00745901|504439|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
140492|NCT00745901|504440|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
140493|NCT00745901|504439|P2|Overall Study|Patient's next menses did not start with|0
140494|NCT00745901|504440|P1|Overall Study|Patient's next menses did not start with|1
140495|NCT00745901|504439|P2|Overall Study|Lack of compliance|2
140496|NCT00745901|504440|P1|Overall Study|Lack of compliance|2
140497|NCT00745901|504439|P2|Overall Study|Pregnancy|4
140498|NCT00745901|504440|P1|Overall Study|Pregnancy|2
140499|NCT00745901|504439|P2|Overall Study|Lost to Follow-up|4
140500|NCT00745901|504440|P1|Overall Study|Lost to Follow-up|7
140501|NCT00745901|504439|P2|Overall Study|Withdrawal by Subject|0
140502|NCT00745901|504440|P1|Overall Study|Withdrawal by Subject|1
140503|NCT00745901|504439|P2|Overall Study|Protocol Violation|1
140504|NCT00745901|504440|P1|Overall Study|Protocol Violation|0
140505|NCT00745901|504439|P2|Overall Study|Adverse Event|4
140506|NCT00745901|504440|P1|Overall Study|Adverse Event|3
140507|NCT00745875|504486|P2|Overall Study|Continuing study treatment|4
140508|NCT00745875|504487|P1|Overall Study|Continuing study treatment|4
140509|NCT00745823|504497|P2|Overall Study|Study Terminated by Sponsor|349
140510|NCT00745823|504498|P1|Overall Study|Study Terminated by Sponsor|326
140511|NCT00745823|504497|P2|Overall Study|Withdrawal by Subject|8
140512|NCT00745823|504498|P1|Overall Study|Withdrawal by Subject|14
140513|NCT00745823|504497|P2|Overall Study|Pregnancy|4
140514|NCT00745823|504498|P1|Overall Study|Pregnancy|0
140515|NCT00745823|504497|P2|Overall Study|Physician Decision|5
140516|NCT00745823|504498|P1|Overall Study|Physician Decision|10
140517|NCT00745823|504497|P2|Overall Study|Lost to Follow-up|11
140518|NCT00745823|504498|P1|Overall Study|Lost to Follow-up|10
140519|NCT00745823|504497|P2|Overall Study|Lack of Efficacy|6
140520|NCT00745823|504498|P1|Overall Study|Lack of Efficacy|20
140521|NCT00745823|504497|P2|Overall Study|Adverse Event|3
140522|NCT00745823|504498|P1|Overall Study|Adverse Event|5
140523|NCT00745498|504525|P3|Overall Study|Edophthalmitis after preoperative IVB|0
140524|NCT00745498|504526|P2|Overall Study|Edophthalmitis after preoperative IVB|0
140525|NCT00745498|504527|P1|Overall Study|Edophthalmitis after preoperative IVB|1
140526|NCT00745498|504525|P3|Overall Study|Non-PDR related VH|1
140527|NCT00745498|504526|P2|Overall Study|Non-PDR related VH|1
140528|NCT00745498|504527|P1|Overall Study|Non-PDR related VH|0
140529|NCT00745498|504525|P3|Overall Study|Injection of intravitreal silicone oil o|4
140530|NCT00745498|504526|P2|Overall Study|Injection of intravitreal silicone oil o|4
140531|NCT00745498|504527|P1|Overall Study|Injection of intravitreal silicone oil o|3
140532|NCT00745498|504525|P3|Overall Study|Lost to Follow-up|3
140533|NCT00745498|504526|P2|Overall Study|Lost to Follow-up|1
140534|NCT00745498|504527|P1|Overall Study|Lost to Follow-up|1
140535|NCT00745420|504541|P1|Overall Study|Ineligible|1
140536|NCT00745368|504558|P1|Overall Study|Unable to provide sample|3
140537|NCT00745251|504580|P2|Overall Study|Withdrawal by Subject|1
140538|NCT00745251|504581|P1|Overall Study|Withdrawal by Subject|1
140539|NCT00745251|504580|P2|Overall Study|Adverse Event|2
140540|NCT00745251|504581|P1|Overall Study|Adverse Event|1
140541|NCT00745095|504595|P6|Overall Study|Ineligible due to GFR criteria|28
140542|NCT00745095|504596|P5|Overall Study|Ineligible due to GFR criteria|30
140543|NCT00745095|504597|P4|Overall Study|Ineligible due to GFR criteria|3
140544|NCT00745095|504598|P3|Overall Study|Ineligible due to GFR criteria|3
140545|NCT00745095|504599|P2|Overall Study|Ineligible due to GFR criteria|2
140546|NCT00745095|504600|P1|Overall Study|Ineligible due to GFR criteria|0
140547|NCT00745095|504595|P6|Overall Study|Declined to participate|95
140548|NCT00745095|504596|P5|Overall Study|Declined to participate|92
140549|NCT00745095|504597|P4|Overall Study|Declined to participate|0
140550|NCT00745095|504598|P3|Overall Study|Declined to participate|0
140551|NCT00745095|504599|P2|Overall Study|Declined to participate|0
140552|NCT00745095|504600|P1|Overall Study|Declined to participate|1
140553|NCT00744978|504631|P2|Period 2|Adverse Event|1
140554|NCT00744978|504632|P1|Period 2|Adverse Event|0
140555|NCT00744978|504631|P2|Period 1|Randomized but not Treated|1
140556|NCT00744978|504632|P1|Period 1|Randomized but not Treated|1
140557|NCT00744978|504631|P2|Period 1|Adverse Event|0
140558|NCT00744978|504632|P1|Period 1|Adverse Event|4
140559|NCT00744978|504631|P2|Period 1|Other|2
140560|NCT00744978|504632|P1|Period 1|Other|0
140561|NCT00744978|504631|P2|Period 1|Withdrawal by Subject|2
140562|NCT00744978|504632|P1|Period 1|Withdrawal by Subject|0
140563|NCT00744978|504631|P2|Period 1|Lost to Follow-up|0
140564|NCT00744978|504632|P1|Period 1|Lost to Follow-up|1
140565|NCT00744939|504684|P1|Overall Study|incorrect race|1
140566|NCT00744939|504684|P1|Overall Study|coma|1
140567|NCT00744939|504684|P1|Overall Study|Failed inclusion/exclusion criteria|19
140568|NCT00744939|504684|P1|Overall Study|Did not receive Magnevist|7
140569|NCT00744939|504684|P1|Overall Study|Medical history exclusionary|1
140570|NCT00744939|504684|P1|Overall Study|Lost to Follow-up|12
140571|NCT00744939|504684|P1|Overall Study|distance|4
140572|NCT00744939|504684|P1|Overall Study|Death|24
140573|NCT00744939|504684|P1|Overall Study|Protocol Violation|13
140574|NCT00744939|504684|P1|Overall Study|Withdrawal by Subject|9
140575|NCT00744874|504720|P1|Overall Study|Unable to accomodate schedule|1
140576|NCT00744874|504720|P1|Overall Study|Study Device not available at procedure|1
140577|NCT00744874|504720|P1|Overall Study|Withdrawal by Subject|1
140578|NCT00744874|504720|P1|Overall Study|Lost to Follow-up|1
140579|NCT00744757|504745|P1|Overall Study|Adverse Event|2
140580|NCT00744757|504745|P1|Overall Study|Death|6
140581|NCT00744757|504745|P1|Overall Study|Withdrawal by Subject|1
140582|NCT00744757|504745|P1|Overall Study|Physician Decision|5
140583|NCT00744757|504745|P1|Overall Study|Objective disease progression|7
140584|NCT00744653|504770|P1|Overall Study|Physician Decision|3
140585|NCT00744653|504770|P1|Overall Study|Lost to Follow-up|1
140586|NCT00744653|504770|P1|Overall Study|Death|1
140587|NCT00744653|504770|P1|Overall Study|antineoplastic treatment|11
140588|NCT00744627|504778|P2|Overall Study|Other|0
140589|NCT00744627|504779|P1|Overall Study|Other|1
140590|NCT00744627|504778|P2|Overall Study|Lost to Follow-up|1
140591|NCT00744627|504779|P1|Overall Study|Lost to Follow-up|2
140592|NCT00744627|504778|P2|Overall Study|Voluntary Withdrawal|6
140593|NCT00744627|504779|P1|Overall Study|Voluntary Withdrawal|9
140594|NCT00744627|504778|P2|Overall Study|Protocol Deviations|2
140595|NCT00744627|504779|P1|Overall Study|Protocol Deviations|0
140596|NCT00744627|504778|P2|Overall Study|Noncompliance|1
140597|NCT00744627|504779|P1|Overall Study|Noncompliance|0
140598|NCT00744627|504778|P2|Overall Study|Lack of Efficacy|3
140599|NCT00744627|504779|P1|Overall Study|Lack of Efficacy|7
140600|NCT00744627|504778|P2|Overall Study|Adverse Event|9
140601|NCT00744627|504779|P1|Overall Study|Adverse Event|6
140602|NCT00744523|504835|P2|30 Days After the Procedure|Insufficient follow-up|5
140603|NCT00744523|504836|P1|30 Days After the Procedure|Insufficient follow-up|0
140604|NCT00744497|504856|P2|Overall Study|Not defined|13
140605|NCT00744497|504857|P1|Overall Study|Not defined|19
140606|NCT00744497|504856|P2|Overall Study|Maximum clinical benefit|142
140607|NCT00744497|504857|P1|Overall Study|Maximum clinical benefit|141
140608|NCT00744497|504856|P2|Overall Study|Patient requested to stop study drug|80
140609|NCT00744497|504857|P1|Overall Study|Patient requested to stop study drug|65
140610|NCT00744497|504856|P2|Overall Study|Adverse event unrelated to study drug|122
140611|NCT00744497|504857|P1|Overall Study|Adverse event unrelated to study drug|78
140612|NCT00744497|504856|P2|Overall Study|Study drug toxicity|141
140613|NCT00744497|504857|P1|Overall Study|Study drug toxicity|68
140614|NCT00744497|504856|P2|Overall Study|Disease progression|219
140615|NCT00744497|504857|P1|Overall Study|Disease progression|312
140616|NCT00744497|504856|P2|Overall Study|Administrative Reason By Sponsor|8
140617|NCT00744497|504857|P1|Overall Study|Administrative Reason By Sponsor|25
140618|NCT00744497|504856|P2|Overall Study|No longer meets study criteria|3
140619|NCT00744497|504857|P1|Overall Study|No longer meets study criteria|7
140620|NCT00744497|504856|P2|Overall Study|Poor compliance/noncompliance|5
140621|NCT00744497|504857|P1|Overall Study|Poor compliance/noncompliance|9
140622|NCT00744497|504856|P2|Overall Study|Lost to Follow-up|2
140623|NCT00744497|504857|P1|Overall Study|Lost to Follow-up|4
140624|NCT00744497|504856|P2|Overall Study|Death|9
140625|NCT00744497|504857|P1|Overall Study|Death|11
140626|NCT00744497|504856|P2|Overall Study|Withdrawal by Subject|18
140627|NCT00744497|504857|P1|Overall Study|Withdrawal by Subject|21
140628|NCT00744328|504917|P3|Overall Study|Found ineligible after randomization|1
140629|NCT00744328|504918|P2|Overall Study|Found ineligible after randomization|0
140630|NCT00744328|504919|P1|Overall Study|Found ineligible after randomization|0
140631|NCT00744328|504917|P3|Overall Study|Withdrawal by Subject|4
140632|NCT00744328|504918|P2|Overall Study|Withdrawal by Subject|3
140633|NCT00744328|504919|P1|Overall Study|Withdrawal by Subject|5
140634|NCT00744328|504917|P3|Overall Study|Lost to Follow-up|3
140635|NCT00744328|504918|P2|Overall Study|Lost to Follow-up|5
140636|NCT00744328|504919|P1|Overall Study|Lost to Follow-up|2
140637|NCT00744263|504929|P2|Overall Study|Other|2
140638|NCT00744263|504930|P1|Overall Study|Other|2
140639|NCT00744263|504929|P2|Overall Study|Adverse Event|0
140640|NCT00744263|504930|P1|Overall Study|Adverse Event|1
140641|NCT00744263|504929|P2|Overall Study|Protocol Violation|5
140642|NCT00744263|504930|P1|Overall Study|Protocol Violation|3
140643|NCT00744263|504929|P2|Overall Study|Physician Decision|23
140644|NCT00744263|504930|P1|Overall Study|Physician Decision|20
140645|NCT00744263|504929|P2|Overall Study|Withdrawal by Subject|150
140646|NCT00744263|504930|P1|Overall Study|Withdrawal by Subject|166
140647|NCT00744263|504929|P2|Overall Study|Lost to Follow-up|2135
140648|NCT00744263|504930|P1|Overall Study|Lost to Follow-up|2038
140649|NCT00744263|504929|P2|Overall Study|Death|3005
140650|NCT00744263|504930|P1|Overall Study|Death|3006
140651|NCT00744237|504953|P3|Overall Study|Adverse Event|5
140652|NCT00744237|504954|P2|Overall Study|Adverse Event|13
140653|NCT00744237|504955|P1|Overall Study|Adverse Event|9
140654|NCT00744237|504953|P3|Overall Study|Administrative. Site Closed|1
140655|NCT00744237|504954|P2|Overall Study|Administrative. Site Closed|1
140656|NCT00744237|504955|P1|Overall Study|Administrative. Site Closed|1
140657|NCT00744237|504953|P3|Overall Study|Poor Compliance|0
140658|NCT00744237|504954|P2|Overall Study|Poor Compliance|2
140659|NCT00744237|504955|P1|Overall Study|Poor Compliance|0
140660|NCT00744237|504953|P3|Overall Study|Prohibited Concomitant Medication|1
140661|NCT00744237|504954|P2|Overall Study|Prohibited Concomitant Medication|0
140662|NCT00744237|504955|P1|Overall Study|Prohibited Concomitant Medication|0
140663|NCT00744237|504953|P3|Overall Study|Study Drug Error|0
140664|NCT00744237|504954|P2|Overall Study|Study Drug Error|0
140665|NCT00744237|504955|P1|Overall Study|Study Drug Error|1
140666|NCT00744237|504953|P3|Overall Study|Dosing Error|1
140667|NCT00744237|504954|P2|Overall Study|Dosing Error|0
140668|NCT00744237|504955|P1|Overall Study|Dosing Error|1
140669|NCT00744237|504953|P3|Overall Study|Inclusion/Exclusion criteria not met|0
140670|NCT00744237|504954|P2|Overall Study|Inclusion/Exclusion criteria not met|0
140671|NCT00744237|504955|P1|Overall Study|Inclusion/Exclusion criteria not met|1
140672|NCT00744237|504953|P3|Overall Study|Protocol Violation|3
140673|NCT00744237|504954|P2|Overall Study|Protocol Violation|4
140674|NCT00744237|504955|P1|Overall Study|Protocol Violation|3
140675|NCT00744237|504953|P3|Overall Study|Lost to Follow-up|1
140676|NCT00744237|504954|P2|Overall Study|Lost to Follow-up|1
140677|NCT00744237|504955|P1|Overall Study|Lost to Follow-up|1
140678|NCT00744237|504953|P3|Overall Study|Withdrawal by Subject|3
140679|NCT00744237|504954|P2|Overall Study|Withdrawal by Subject|5
140680|NCT00744237|504955|P1|Overall Study|Withdrawal by Subject|9
140681|NCT00744237|504953|P3|Overall Study|Lack of Efficacy|0
140682|NCT00744237|504954|P2|Overall Study|Lack of Efficacy|1
140683|NCT00744237|504955|P1|Overall Study|Lack of Efficacy|1
140684|NCT00744055|504989|P2|Overall Study|Lost to Follow-up|1
140685|NCT00744055|504990|P1|Overall Study|Lost to Follow-up|0
140686|NCT00744055|504989|P2|Overall Study|Protocol Violation|1
140687|NCT00744055|504990|P1|Overall Study|Protocol Violation|1
140688|NCT00744055|504989|P2|Overall Study|Physician Decision|2
140689|NCT00744055|504990|P1|Overall Study|Physician Decision|0
140690|NCT00744055|504989|P2|Overall Study|Lack of Efficacy|1
140691|NCT00744055|504990|P1|Overall Study|Lack of Efficacy|0
140692|NCT00744055|504989|P2|Overall Study|Withdrawal by Subject|9
140693|NCT00744055|504990|P1|Overall Study|Withdrawal by Subject|6
140694|NCT00744042|504998|P1|Overall Study|Withdrawal by Subject|1
140695|NCT00743652|505041|P5|Overall Study|Lost to Follow-up|0
140696|NCT00743652|505042|P4|Overall Study|Lost to Follow-up|0
140697|NCT00743652|505043|P3|Overall Study|Lost to Follow-up|0
140698|NCT00743652|505044|P2|Overall Study|Lost to Follow-up|0
140699|NCT00743652|505045|P1|Overall Study|Lost to Follow-up|1
140700|NCT00743652|505041|P5|Overall Study|Other|0
140701|NCT00743652|505042|P4|Overall Study|Other|0
140702|NCT00743652|505043|P3|Overall Study|Other|0
140703|NCT00743652|505044|P2|Overall Study|Other|1
140704|NCT00743652|505045|P1|Overall Study|Other|1
140705|NCT00743652|505041|P5|Overall Study|Investigator Request|0
140706|NCT00743652|505042|P4|Overall Study|Investigator Request|2
140707|NCT00743652|505043|P3|Overall Study|Investigator Request|0
140708|NCT00743652|505044|P2|Overall Study|Investigator Request|0
140709|NCT00743652|505045|P1|Overall Study|Investigator Request|0
140710|NCT00743652|505041|P5|Overall Study|Death|0
140711|NCT00743652|505042|P4|Overall Study|Death|0
140712|NCT00743652|505043|P3|Overall Study|Death|0
140713|NCT00743652|505044|P2|Overall Study|Death|0
140714|NCT00743652|505045|P1|Overall Study|Death|2
140715|NCT00743652|505041|P5|Overall Study|Adverse Event|0
140716|NCT00743652|505042|P4|Overall Study|Adverse Event|0
140717|NCT00743652|505043|P3|Overall Study|Adverse Event|0
140718|NCT00743652|505044|P2|Overall Study|Adverse Event|0
140719|NCT00743652|505045|P1|Overall Study|Adverse Event|3
140720|NCT00743652|505041|P5|Overall Study|Parent/Legal Guardian Request|0
140721|NCT00743652|505042|P4|Overall Study|Parent/Legal Guardian Request|2
140722|NCT00743652|505043|P3|Overall Study|Parent/Legal Guardian Request|2
140723|NCT00743652|505044|P2|Overall Study|Parent/Legal Guardian Request|2
140724|NCT00743652|505045|P1|Overall Study|Parent/Legal Guardian Request|3
140725|NCT00743509|505129|P1|Overall Study|Withdrawal by Subject|2
140726|NCT00743483|505134|P1|Treatment Period|Adverse Event|1
140727|NCT00743483|505134|P1|Baseline Period|Physician Decision|1
140728|NCT00743444|505138|P2|Washout Period|Adverse Event|1
140729|NCT00743444|505139|P1|Washout Period|Adverse Event|0
140730|NCT00743444|505138|P2|First Intervention|Catheter placement problems|1
140731|NCT00743444|505139|P1|First Intervention|Catheter placement problems|0
140732|NCT00743431|505148|P1|Overall Study|No documentation available|13
140733|NCT00743431|505148|P1|Overall Study|Reason for discontinuation not specified|29
140734|NCT00743431|505148|P1|Overall Study|Death|9
140735|NCT00743431|505148|P1|Overall Study|Withdrawal by Subject|13
140736|NCT00743431|505148|P1|Overall Study|Tumor progression|56
140737|NCT00743431|505148|P1|Overall Study|Toxicity|6
140738|NCT00743366|505152|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
140739|NCT00743366|505153|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
140740|NCT00743340|505159|P1|Overall Study|Participant Relocated|1
140741|NCT00743340|505159|P1|Overall Study|Rolled over to other Gilead Study|23
140742|NCT00743340|505159|P1|Overall Study|Pregnancy|1
140743|NCT00743340|505159|P1|Overall Study|Virologic failure|8
140744|NCT00743340|505159|P1|Overall Study|Protocol Violation|1
140745|NCT00743340|505159|P1|Overall Study|Withdrawal from the Study|5
140746|NCT00743340|505159|P1|Overall Study|Lost to Follow-up|1
140747|NCT00743340|505159|P1|Overall Study|Study medication non-compliance|1
140748|NCT00743288|505163|P7|Overall Study|Worsening of condition (Not PD)|0
140749|NCT00743288|505164|P6|Overall Study|Worsening of condition (Not PD)|0
140750|NCT00743288|505165|P5|Overall Study|Worsening of condition (Not PD)|0
140751|NCT00743288|505166|P4|Overall Study|Worsening of condition (Not PD)|1
140752|NCT00743288|505167|P3|Overall Study|Worsening of condition (Not PD)|1
140753|NCT00743288|505168|P2|Overall Study|Worsening of condition (Not PD)|2
140754|NCT00743288|505169|P1|Overall Study|Worsening of condition (Not PD)|0
140755|NCT00743288|505163|P7|Overall Study|Progressive disease (PD)|6
140756|NCT00743288|505164|P6|Overall Study|Progressive disease (PD)|3
140757|NCT00743288|505165|P5|Overall Study|Progressive disease (PD)|5
140758|NCT00743288|505166|P4|Overall Study|Progressive disease (PD)|4
140759|NCT00743288|505167|P3|Overall Study|Progressive disease (PD)|1
140760|NCT00743288|505168|P2|Overall Study|Progressive disease (PD)|0
140761|NCT00743288|505169|P1|Overall Study|Progressive disease (PD)|2
140762|NCT00743288|505163|P7|Overall Study|Withdrawal by Subject|1
140763|NCT00743288|505164|P6|Overall Study|Withdrawal by Subject|1
140764|NCT00743288|505165|P5|Overall Study|Withdrawal by Subject|0
140765|NCT00743288|505166|P4|Overall Study|Withdrawal by Subject|0
140766|NCT00743288|505167|P3|Overall Study|Withdrawal by Subject|1
140767|NCT00743288|505168|P2|Overall Study|Withdrawal by Subject|0
140768|NCT00743288|505169|P1|Overall Study|Withdrawal by Subject|0
140769|NCT00743288|505163|P7|Overall Study|Adverse Event|2
140770|NCT00743288|505164|P6|Overall Study|Adverse Event|1
140771|NCT00743288|505165|P5|Overall Study|Adverse Event|1
140772|NCT00743288|505166|P4|Overall Study|Adverse Event|2
140773|NCT00743288|505167|P3|Overall Study|Adverse Event|2
140774|NCT00743288|505168|P2|Overall Study|Adverse Event|1
140775|NCT00743288|505169|P1|Overall Study|Adverse Event|1
140776|NCT00743275|505183|P2|Overall Study|Protocol Violation|1
140777|NCT00743275|505184|P1|Overall Study|Protocol Violation|0
140778|NCT00743249|505204|P2|Overall Study|Unsuccessful insertion of stent|1
140779|NCT00743249|505205|P1|Overall Study|Unsuccessful insertion of stent|2
140780|NCT00743249|505204|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
140781|NCT00743249|505205|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
140782|NCT00743249|505204|P2|Overall Study|Adverse Event|4
140783|NCT00743249|505205|P1|Overall Study|Adverse Event|0
140784|NCT00743197|505215|P2|Overall Study|Study terminated due to departure of PI.|2
140785|NCT00743197|505216|P1|Overall Study|Study terminated due to departure of PI.|1
140786|NCT00743119|505222|P1|Overall Study|Withdrawal by Subject|1
140787|NCT00743119|505222|P1|Overall Study|unreliable|3
140788|NCT00743106|505236|P2|Overall Study|Met intraoperative exclusion criterion|5
140789|NCT00743106|505237|P1|Overall Study|Met intraoperative exclusion criterion|8
140790|NCT00742924|505264|P4|Overall Study|Withdrawal by Subject|0
140791|NCT00742924|505265|P3|Overall Study|Withdrawal by Subject|1
140792|NCT00742924|505266|P2|Overall Study|Withdrawal by Subject|1
140793|NCT00742924|505267|P1|Overall Study|Withdrawal by Subject|0
140794|NCT00742924|505264|P4|Overall Study|Physician Decision|1
140795|NCT00742924|505265|P3|Overall Study|Physician Decision|0
140796|NCT00742924|505266|P2|Overall Study|Physician Decision|0
140797|NCT00742924|505267|P1|Overall Study|Physician Decision|0
140798|NCT00742924|505264|P4|Overall Study|Lack of Efficacy|4
140799|NCT00742924|505265|P3|Overall Study|Lack of Efficacy|2
140800|NCT00742924|505266|P2|Overall Study|Lack of Efficacy|1
140801|NCT00742924|505267|P1|Overall Study|Lack of Efficacy|5
140802|NCT00742924|505264|P4|Overall Study|Adverse Event|1
140803|NCT00742924|505265|P3|Overall Study|Adverse Event|1
140804|NCT00742924|505266|P2|Overall Study|Adverse Event|0
140805|NCT00742924|505267|P1|Overall Study|Adverse Event|0
140806|NCT00742885|505279|P2|Overall Study|Lost to Follow-up|0
140807|NCT00742885|505280|P1|Overall Study|Lost to Follow-up|1
140808|NCT00742859|505339|P4|Overall Study|Site error|1
140809|NCT00742859|505340|P3|Overall Study|Site error|1
140810|NCT00742859|505341|P2|Overall Study|Site error|0
140811|NCT00742859|505342|P1|Overall Study|Site error|0
140812|NCT00742859|505339|P4|Overall Study|Sponsor request patient out of town|1
140813|NCT00742859|505340|P3|Overall Study|Sponsor request patient out of town|1
140814|NCT00742859|505341|P2|Overall Study|Sponsor request patient out of town|0
140815|NCT00742859|505342|P1|Overall Study|Sponsor request patient out of town|0
140816|NCT00742859|505339|P4|Overall Study|Sponsor req visit schedule noncompliance|1
140817|NCT00742859|505340|P3|Overall Study|Sponsor req visit schedule noncompliance|0
140818|NCT00742859|505341|P2|Overall Study|Sponsor req visit schedule noncompliance|0
140819|NCT00742859|505342|P1|Overall Study|Sponsor req visit schedule noncompliance|0
140820|NCT00742859|505339|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
140821|NCT00742859|505340|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
140822|NCT00742859|505341|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
140823|NCT00742859|505342|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
140824|NCT00742859|505339|P4|Overall Study|Endpoint|2
140825|NCT00742859|505340|P3|Overall Study|Endpoint|1
140826|NCT00742859|505341|P2|Overall Study|Endpoint|1
140827|NCT00742859|505342|P1|Overall Study|Endpoint|0
140828|NCT00742859|505339|P4|Overall Study|Withdrawal by Subject|1
140829|NCT00742859|505340|P3|Overall Study|Withdrawal by Subject|4
140830|NCT00742859|505341|P2|Overall Study|Withdrawal by Subject|2
140831|NCT00742859|505342|P1|Overall Study|Withdrawal by Subject|4
140832|NCT00742859|505339|P4|Overall Study|Physician Decision|0
140833|NCT00742859|505340|P3|Overall Study|Physician Decision|0
140834|NCT00742859|505341|P2|Overall Study|Physician Decision|2
140835|NCT00742859|505342|P1|Overall Study|Physician Decision|1
140836|NCT00742859|505339|P4|Overall Study|Death|1
140837|NCT00742859|505340|P3|Overall Study|Death|0
140838|NCT00742859|505341|P2|Overall Study|Death|0
140839|NCT00742859|505342|P1|Overall Study|Death|1
140840|NCT00742859|505339|P4|Overall Study|Adverse Event|1
140841|NCT00742859|505340|P3|Overall Study|Adverse Event|3
140842|NCT00742859|505341|P2|Overall Study|Adverse Event|6
140843|NCT00742859|505342|P1|Overall Study|Adverse Event|5
140844|NCT00742781|505356|P1|Overall Study|Withdrawal by Subject|3
140845|NCT00742625|505365|P1|Consolidation|Non protocol therapy|13
140846|NCT00742625|505365|P1|Consolidation|Refused|1
140847|NCT00742625|505365|P1|Consolidation|Death|1
140848|NCT00742625|505365|P1|Consolidation|Adverse Event|1
140849|NCT00742625|505365|P1|Consolidation|Progression|5
140850|NCT00742625|505365|P1|Remission Induction|Other, not specified|5
140851|NCT00742625|505365|P1|Remission Induction|Non protocol treatment|17
140852|NCT00742625|505365|P1|Remission Induction|Refusal|5
140853|NCT00742625|505365|P1|Remission Induction|Death|10
140854|NCT00742625|505365|P1|Remission Induction|Adverse Event|3
140855|NCT00742625|505365|P1|Remission Induction|Failed induction|8
140856|NCT00742625|505365|P1|Remission Induction|Progression|6
140857|NCT00742560|505379|P5|Overall Study|MIssing|1
140858|NCT00742560|505380|P4|Overall Study|MIssing|0
140859|NCT00742560|505381|P3|Overall Study|MIssing|0
140860|NCT00742560|505382|P2|Overall Study|MIssing|0
140861|NCT00742560|505383|P1|Overall Study|MIssing|0
140862|NCT00742560|505379|P5|Overall Study|Not Specified|9
140863|NCT00742560|505380|P4|Overall Study|Not Specified|9
140864|NCT00742560|505381|P3|Overall Study|Not Specified|8
140865|NCT00742560|505382|P2|Overall Study|Not Specified|1
140866|NCT00742560|505383|P1|Overall Study|Not Specified|0
140867|NCT00742560|505379|P5|Overall Study|New Multiple Myeloma Therapy|4
140868|NCT00742560|505380|P4|Overall Study|New Multiple Myeloma Therapy|3
140869|NCT00742560|505381|P3|Overall Study|New Multiple Myeloma Therapy|2
140870|NCT00742560|505382|P2|Overall Study|New Multiple Myeloma Therapy|0
140871|NCT00742560|505383|P1|Overall Study|New Multiple Myeloma Therapy|1
140872|NCT00742560|505379|P5|Overall Study|Disease Progression|16
140873|NCT00742560|505380|P4|Overall Study|Disease Progression|17
140874|NCT00742560|505381|P3|Overall Study|Disease Progression|5
140875|NCT00742560|505382|P2|Overall Study|Disease Progression|0
140876|NCT00742560|505383|P1|Overall Study|Disease Progression|1
140877|NCT00742560|505379|P5|Overall Study|Investigator's Decision|0
140878|NCT00742560|505380|P4|Overall Study|Investigator's Decision|1
140879|NCT00742560|505381|P3|Overall Study|Investigator's Decision|4
140880|NCT00742560|505382|P2|Overall Study|Investigator's Decision|0
140881|NCT00742560|505383|P1|Overall Study|Investigator's Decision|0
140882|NCT00742560|505379|P5|Overall Study|Subject's Decision|3
140883|NCT00742560|505380|P4|Overall Study|Subject's Decision|3
140884|NCT00742560|505381|P3|Overall Study|Subject's Decision|2
140885|NCT00742560|505382|P2|Overall Study|Subject's Decision|0
140886|NCT00742560|505383|P1|Overall Study|Subject's Decision|1
140887|NCT00742560|505379|P5|Overall Study|Death|3
140888|NCT00742560|505380|P4|Overall Study|Death|2
140889|NCT00742560|505381|P3|Overall Study|Death|0
140890|NCT00742560|505382|P2|Overall Study|Death|2
140891|NCT00742560|505383|P1|Overall Study|Death|0
140892|NCT00742560|505379|P5|Overall Study|Adverse Event|1
140893|NCT00742560|505380|P4|Overall Study|Adverse Event|1
140894|NCT00742560|505381|P3|Overall Study|Adverse Event|1
140895|NCT00742560|505382|P2|Overall Study|Adverse Event|0
140896|NCT00742560|505383|P1|Overall Study|Adverse Event|0
140897|NCT00742508|505457|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
140898|NCT00742508|505458|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
140899|NCT00742508|505457|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
140900|NCT00742508|505458|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
140901|NCT00742508|505457|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
140902|NCT00742508|505458|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
140903|NCT00742508|505457|P2|8-Week Primary Evaluation Period|Protocol Violation|0
140904|NCT00742508|505458|P1|8-Week Primary Evaluation Period|Protocol Violation|1
140905|NCT00742508|505457|P2|8-Week Primary Evaluation Period|Adverse Event|4
140906|NCT00742508|505458|P1|8-Week Primary Evaluation Period|Adverse Event|2
140907|NCT00742417|505522|P2|Intensive Period|Adverse Event|0
140908|NCT00742417|505523|P1|Intensive Period|Adverse Event|2
140909|NCT00742417|505522|P2|Intensive Period|Withdrawal by Subject|1
140910|NCT00742417|505523|P1|Intensive Period|Withdrawal by Subject|1
140911|NCT00742417|505522|P2|Randomized|Physician Decision|0
140912|NCT00742417|505523|P1|Randomized|Physician Decision|1
140913|NCT00742417|505522|P2|Randomized|Withdrawal by Subject|0
140914|NCT00742417|505523|P1|Randomized|Withdrawal by Subject|1
140915|NCT00742417|505522|P2|Randomized|Withdrawal by legal representative|1
140916|NCT00742417|505523|P1|Randomized|Withdrawal by legal representative|0
140917|NCT00742391|505547|P2|Overall Study|Protocol Violation|0
140918|NCT00742391|505548|P1|Overall Study|Protocol Violation|1
140919|NCT00742391|505547|P2|Overall Study|Lost to Follow-up|0
140920|NCT00742391|505548|P1|Overall Study|Lost to Follow-up|1
140921|NCT00742391|505547|P2|Overall Study|Adverse Event|1
140922|NCT00742391|505548|P1|Overall Study|Adverse Event|2
140923|NCT00742326|505558|P2|Overall Study|Physician Decision|1
140924|NCT00742326|505559|P1|Overall Study|Physician Decision|0
140925|NCT00742274|505578|P2|Overall Study|Removed for medical reasons|1
140926|NCT00742274|505579|P1|Overall Study|Removed for medical reasons|1
140927|NCT00742274|505578|P2|Overall Study|Withdrawal by Subject|2
140928|NCT00742274|505579|P1|Overall Study|Withdrawal by Subject|1
140929|NCT00742274|505578|P2|Overall Study|Death|0
140930|NCT00742274|505579|P1|Overall Study|Death|1
140931|NCT00742235|505587|P2|Overall Study|Lost to Follow-up|31
140932|NCT00742235|505588|P1|Overall Study|Lost to Follow-up|0
140933|NCT00742209|505601|P5|Overall Study|Investigator Discretion|1
140934|NCT00742209|505602|P4|Overall Study|Investigator Discretion|1
140935|NCT00742209|505603|P3|Overall Study|Investigator Discretion|5
140936|NCT00742209|505604|P2|Overall Study|Investigator Discretion|0
140937|NCT00742209|505605|P1|Overall Study|Investigator Discretion|0
140938|NCT00742209|505601|P5|Overall Study|Lack of Efficacy|1
140939|NCT00742209|505602|P4|Overall Study|Lack of Efficacy|3
140940|NCT00742209|505603|P3|Overall Study|Lack of Efficacy|1
140941|NCT00742209|505604|P2|Overall Study|Lack of Efficacy|1
140942|NCT00742209|505605|P1|Overall Study|Lack of Efficacy|6
140943|NCT00742209|505601|P5|Overall Study|Lost to Follow-up|3
140944|NCT00742209|505602|P4|Overall Study|Lost to Follow-up|5
140945|NCT00742209|505603|P3|Overall Study|Lost to Follow-up|5
140946|NCT00742209|505604|P2|Overall Study|Lost to Follow-up|4
140947|NCT00742209|505605|P1|Overall Study|Lost to Follow-up|3
140948|NCT00742209|505601|P5|Overall Study|Protocol Violation|3
140949|NCT00742209|505602|P4|Overall Study|Protocol Violation|5
140950|NCT00742209|505603|P3|Overall Study|Protocol Violation|4
140951|NCT00742209|505604|P2|Overall Study|Protocol Violation|5
140952|NCT00742209|505605|P1|Overall Study|Protocol Violation|6
140953|NCT00742209|505601|P5|Overall Study|Participant Withdrew Consent|4
140954|NCT00742209|505602|P4|Overall Study|Participant Withdrew Consent|7
140955|NCT00742209|505603|P3|Overall Study|Participant Withdrew Consent|14
140956|NCT00742209|505604|P2|Overall Study|Participant Withdrew Consent|4
140957|NCT00742209|505605|P1|Overall Study|Participant Withdrew Consent|8
140958|NCT00742209|505601|P5|Overall Study|Adverse Event|13
140959|NCT00742209|505602|P4|Overall Study|Adverse Event|16
140960|NCT00742209|505603|P3|Overall Study|Adverse Event|17
140961|NCT00742209|505604|P2|Overall Study|Adverse Event|4
140962|NCT00742209|505605|P1|Overall Study|Adverse Event|11
140963|NCT00742183|505708|P2|Overall Study|Lack of Efficacy|3
140964|NCT00742183|505709|P1|Overall Study|Lack of Efficacy|0
140965|NCT00742183|505708|P2|Overall Study|Withdrawal by Subject|0
140966|NCT00742183|505709|P1|Overall Study|Withdrawal by Subject|1
140967|NCT00742183|505708|P2|Overall Study|Required skin-graft|1
140968|NCT00742183|505709|P1|Overall Study|Required skin-graft|1
140969|NCT00742183|505708|P2|Overall Study|Lost to Follow-up|4
140970|NCT00742183|505709|P1|Overall Study|Lost to Follow-up|4
140971|NCT00742183|505708|P2|Overall Study|Physician Decision|2
140972|NCT00742183|505709|P1|Overall Study|Physician Decision|0
140973|NCT00742183|505708|P2|Overall Study|Death|0
140974|NCT00742183|505709|P1|Overall Study|Death|1
140975|NCT00742183|505708|P2|Overall Study|Adverse Event|2
140976|NCT00742183|505709|P1|Overall Study|Adverse Event|2
140977|NCT00742079|505728|P2|Overall Study|Lost to Follow-up|1
140978|NCT00742079|505729|P1|Overall Study|Lost to Follow-up|0
140979|NCT00741988|505749|P2|Overall Study|Lack of Efficacy|0
140980|NCT00741988|505750|P1|Overall Study|Lack of Efficacy|2
140981|NCT00741988|505749|P2|Overall Study|Adverse Event|4
140982|NCT00741988|505750|P1|Overall Study|Adverse Event|2
140983|NCT00741936|505762|P2|Overall Study|Low compliance|0
140984|NCT00741936|505763|P1|Overall Study|Low compliance|3
140985|NCT00741936|505762|P2|Overall Study|Lack of Efficacy|2
140986|NCT00741936|505763|P1|Overall Study|Lack of Efficacy|0
140987|NCT00741936|505762|P2|Overall Study|Protocol Violation|0
140988|NCT00741936|505763|P1|Overall Study|Protocol Violation|2
140989|NCT00741936|505762|P2|Overall Study|Pregnancy|1
140990|NCT00741936|505763|P1|Overall Study|Pregnancy|0
140991|NCT00741936|505762|P2|Overall Study|Adverse Event|4
140992|NCT00741936|505763|P1|Overall Study|Adverse Event|3
140993|NCT00741936|505762|P2|Overall Study|Lost to Follow-up|1
140994|NCT00741936|505763|P1|Overall Study|Lost to Follow-up|1
140995|NCT00741819|505798|P1|Overall Study|Disease progression|1
140996|NCT00741819|505798|P1|Overall Study|Death|1
140997|NCT00741819|505798|P1|Overall Study|Withdrawal by Subject|3
140998|NCT00741819|505798|P1|Overall Study|Adverse Event|3
140999|NCT00741611|505812|P3|Overall Study|Withdrawal by Subject|2
141000|NCT00741611|505813|P2|Overall Study|Withdrawal by Subject|2
141001|NCT00741611|505814|P1|Overall Study|Withdrawal by Subject|0
141002|NCT00741611|505812|P3|Overall Study|Death|1
141003|NCT00741611|505813|P2|Overall Study|Death|0
141004|NCT00741611|505814|P1|Overall Study|Death|0
141005|NCT00741598|505833|P2|Overall Study|Withdrawal by Subject|2
141006|NCT00741598|505834|P1|Overall Study|Withdrawal by Subject|3
141007|NCT00741598|505833|P2|Overall Study|Pregnancy|0
141008|NCT00741598|505834|P1|Overall Study|Pregnancy|1
141009|NCT00741598|505833|P2|Overall Study|Physician Decision|1
141010|NCT00741598|505834|P1|Overall Study|Physician Decision|1
141011|NCT00741598|505833|P2|Overall Study|Lack of Efficacy|2
141012|NCT00741598|505834|P1|Overall Study|Lack of Efficacy|1
141013|NCT00741598|505833|P2|Overall Study|Lost to Follow-up|4
141014|NCT00741598|505834|P1|Overall Study|Lost to Follow-up|3
141015|NCT00741338|505880|P2|Overall Study|Adverse Event|1
141016|NCT00741338|505881|P1|Overall Study|Adverse Event|0
141017|NCT00741286|505891|P2|Overall Study|Primary Outcome|1
141018|NCT00741286|505892|P1|Overall Study|Primary Outcome|1
141019|NCT00741286|505891|P2|Overall Study|Protocol Violation|2
141020|NCT00741286|505892|P1|Overall Study|Protocol Violation|3
141021|NCT00741286|505891|P2|Overall Study|Adverse Event|6
141022|NCT00741286|505892|P1|Overall Study|Adverse Event|1
141023|NCT00741286|505891|P2|Overall Study|Lost to Follow-up|10
141024|NCT00741286|505892|P1|Overall Study|Lost to Follow-up|15
141025|NCT00741260|505926|P7|Overall Study|Not Specified|1
141026|NCT00741260|505927|P6|Overall Study|Not Specified|3
141027|NCT00741260|505928|P5|Overall Study|Not Specified|1
141028|NCT00741260|505929|P4|Overall Study|Not Specified|2
141029|NCT00741260|505930|P3|Overall Study|Not Specified|1
141030|NCT00741260|505931|P2|Overall Study|Not Specified|1
141031|NCT00741260|505932|P1|Overall Study|Not Specified|2
141032|NCT00741260|505926|P7|Overall Study|Physician Decision|0
141033|NCT00741260|505927|P6|Overall Study|Physician Decision|0
141034|NCT00741260|505928|P5|Overall Study|Physician Decision|0
141035|NCT00741260|505929|P4|Overall Study|Physician Decision|0
141036|NCT00741260|505930|P3|Overall Study|Physician Decision|0
141037|NCT00741260|505931|P2|Overall Study|Physician Decision|1
141038|NCT00741260|505932|P1|Overall Study|Physician Decision|1
141039|NCT00741260|505926|P7|Overall Study|Withdrawal by Subject|1
141040|NCT00741260|505927|P6|Overall Study|Withdrawal by Subject|3
141041|NCT00741260|505928|P5|Overall Study|Withdrawal by Subject|1
141042|NCT00741260|505929|P4|Overall Study|Withdrawal by Subject|0
141043|NCT00741260|505930|P3|Overall Study|Withdrawal by Subject|0
141044|NCT00741260|505931|P2|Overall Study|Withdrawal by Subject|0
141045|NCT00741260|505932|P1|Overall Study|Withdrawal by Subject|0
141046|NCT00741260|505926|P7|Overall Study|Death|1
141047|NCT00741260|505927|P6|Overall Study|Death|2
141048|NCT00741260|505928|P5|Overall Study|Death|2
141049|NCT00741260|505929|P4|Overall Study|Death|1
141050|NCT00741260|505930|P3|Overall Study|Death|0
141051|NCT00741260|505931|P2|Overall Study|Death|1
141052|NCT00741260|505932|P1|Overall Study|Death|0
141053|NCT00741260|505926|P7|Overall Study|Disease Progression|4
141054|NCT00741260|505927|P6|Overall Study|Disease Progression|37
141055|NCT00741260|505928|P5|Overall Study|Disease Progression|5
141056|NCT00741260|505929|P4|Overall Study|Disease Progression|3
141057|NCT00741260|505930|P3|Overall Study|Disease Progression|3
141058|NCT00741260|505931|P2|Overall Study|Disease Progression|5
141059|NCT00741260|505932|P1|Overall Study|Disease Progression|3
141060|NCT00741091|505979|P1|Overall Study|Missed Visit|22
141061|NCT00741091|505979|P1|Overall Study|Withdrawal by Subject|6
141062|NCT00741091|505979|P1|Overall Study|Lost to Follow-up|16
141063|NCT00741091|505979|P1|Overall Study|Death|13
141064|NCT00741039|505989|P2|Overall Study|Patient non-compliance|0
141065|NCT00741039|505990|P1|Overall Study|Patient non-compliance|2
141066|NCT00741013|506027|P3|Overall Study|Discovered failed screen after enrolled|0
141067|NCT00741013|506028|P2|Overall Study|Discovered failed screen after enrolled|2
141068|NCT00741013|506029|P1|Overall Study|Discovered failed screen after enrolled|0
141069|NCT00741013|506027|P3|Overall Study|Withdrawal by Subject|1
141070|NCT00741013|506028|P2|Overall Study|Withdrawal by Subject|0
141071|NCT00741013|506029|P1|Overall Study|Withdrawal by Subject|0
141072|NCT00741013|506027|P3|Overall Study|Adverse Event|0
141073|NCT00741013|506028|P2|Overall Study|Adverse Event|0
141074|NCT00741013|506029|P1|Overall Study|Adverse Event|1
141075|NCT00740870|506040|P1|Overall Study|Further testing contraindicated implant|17
141076|NCT00740870|506040|P1|Overall Study|Not Catheterized|4
141077|NCT00740857|506055|P3|Overall Study|Withdrawal by Subject|0
141078|NCT00740857|506056|P2|Overall Study|Withdrawal by Subject|0
141079|NCT00740857|506057|P1|Overall Study|Withdrawal by Subject|1
141080|NCT00740792|506112|P4|Overall Study|administrative|2
141081|NCT00740792|506113|P3|Overall Study|administrative|8
141082|NCT00740792|506114|P2|Overall Study|administrative|3
141083|NCT00740792|506115|P1|Overall Study|administrative|3
141084|NCT00740792|506112|P4|Overall Study|Withdrawal by Subject|0
141085|NCT00740792|506113|P3|Overall Study|Withdrawal by Subject|0
141086|NCT00740792|506114|P2|Overall Study|Withdrawal by Subject|1
141087|NCT00740792|506115|P1|Overall Study|Withdrawal by Subject|1
141088|NCT00740792|506112|P4|Overall Study|Protocol Violation|2
141089|NCT00740792|506113|P3|Overall Study|Protocol Violation|0
141090|NCT00740792|506114|P2|Overall Study|Protocol Violation|1
141091|NCT00740792|506115|P1|Overall Study|Protocol Violation|0
141092|NCT00740792|506112|P4|Overall Study|Lost to Follow-up|0
141093|NCT00740792|506113|P3|Overall Study|Lost to Follow-up|0
141094|NCT00740792|506114|P2|Overall Study|Lost to Follow-up|1
141095|NCT00740792|506115|P1|Overall Study|Lost to Follow-up|2
141096|NCT00740792|506112|P4|Overall Study|Lack of Efficacy|3
141097|NCT00740792|506113|P3|Overall Study|Lack of Efficacy|0
141098|NCT00740792|506114|P2|Overall Study|Lack of Efficacy|1
141099|NCT00740792|506115|P1|Overall Study|Lack of Efficacy|1
141100|NCT00740792|506112|P4|Overall Study|Adverse Event|3
141101|NCT00740792|506113|P3|Overall Study|Adverse Event|1
141102|NCT00740792|506114|P2|Overall Study|Adverse Event|1
141103|NCT00740792|506115|P1|Overall Study|Adverse Event|3
141104|NCT00740779|506136|P3|Overall Study|Lost to Follow-up|5
141105|NCT00740779|506137|P2|Overall Study|Lost to Follow-up|3
141106|NCT00740779|506138|P1|Overall Study|Lost to Follow-up|2
141107|NCT00740779|506136|P3|Overall Study|Withdrawal by Subject|2
141108|NCT00740779|506137|P2|Overall Study|Withdrawal by Subject|4
141109|NCT00740779|506138|P1|Overall Study|Withdrawal by Subject|2
141110|NCT00740779|506136|P3|Overall Study|Lack of Efficacy|2
141111|NCT00740779|506137|P2|Overall Study|Lack of Efficacy|0
141112|NCT00740779|506138|P1|Overall Study|Lack of Efficacy|0
141113|NCT00740779|506136|P3|Overall Study|Protocol Violation|1
141114|NCT00740779|506137|P2|Overall Study|Protocol Violation|1
141115|NCT00740779|506138|P1|Overall Study|Protocol Violation|1
141116|NCT00740779|506136|P3|Overall Study|Adverse Event|3
141117|NCT00740779|506137|P2|Overall Study|Adverse Event|6
141118|NCT00740779|506138|P1|Overall Study|Adverse Event|4
141119|NCT00740714|506155|P3|Overall Study|Withdrawal by Subject|29
141120|NCT00740714|506156|P2|Overall Study|Withdrawal by Subject|19
141121|NCT00740714|506157|P1|Overall Study|Withdrawal by Subject|17
141122|NCT00740636|506233|P2|Overall Study|Death|0
141123|NCT00740636|506234|P1|Overall Study|Death|1
141124|NCT00740636|506233|P2|Overall Study|Progressive Disease|0
141125|NCT00740636|506234|P1|Overall Study|Progressive Disease|1
141126|NCT00740636|506233|P2|Overall Study|Patient Not Treated|1
141127|NCT00740636|506234|P1|Overall Study|Patient Not Treated|0
141128|NCT00740636|506233|P2|Overall Study|Patient Ineligible|1
141129|NCT00740636|506234|P1|Overall Study|Patient Ineligible|0
141130|NCT00740636|506233|P2|Overall Study|Adverse Event|2
141131|NCT00740636|506234|P1|Overall Study|Adverse Event|0
141132|NCT00740597|506240|P1|Overall Study|insurance would not cover treatment|1
141133|NCT00740584|506244|P1|Overall Study|Withdrawal by Subject|1
141134|NCT00740480|506248|P1|Overall Study|Physician Decision|1
141135|NCT00740480|506248|P1|Overall Study|Adverse Event|1
141136|NCT00740220|506252|P1|Overall Study|screen failures (non-COPD patients)|9
141137|NCT00740051|506277|P2|Overall Study|Other reason (not specified)|1
141138|NCT00740051|506278|P1|Overall Study|Other reason (not specified)|4
141139|NCT00740051|506277|P2|Overall Study|Withdrawal by Subject|8
141140|NCT00740051|506278|P1|Overall Study|Withdrawal by Subject|6
141141|NCT00740051|506277|P2|Overall Study|Lost to Follow-up|8
141142|NCT00740051|506278|P1|Overall Study|Lost to Follow-up|3
141143|NCT00740051|506277|P2|Overall Study|Protocol Violation|6
141144|NCT00740051|506278|P1|Overall Study|Protocol Violation|2
141145|NCT00740051|506277|P2|Overall Study|Adverse Event|4
141146|NCT00740051|506278|P1|Overall Study|Adverse Event|1
141147|NCT00740051|506277|P2|Overall Study|Lack of Efficacy|5
141148|NCT00740051|506278|P1|Overall Study|Lack of Efficacy|2
141149|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
141150|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
141151|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
141152|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
141153|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
141154|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
141155|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
141156|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
141157|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
141158|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
141159|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
141160|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
141161|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
141162|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
141163|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
141164|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
141165|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
141166|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
141167|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
141168|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
141169|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
141170|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
141171|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
141172|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
141173|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
141174|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
141175|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
141176|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
141177|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
141178|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
141179|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
141180|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
141181|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
141182|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
141183|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
141184|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
141185|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
141186|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
141187|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
141188|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
141189|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
141190|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
141191|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
141192|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
141193|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
141194|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
141195|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
141196|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
141197|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
141198|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
141199|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
141200|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
141201|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
141202|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
141203|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
141204|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
141205|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
141206|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
141207|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
141208|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
141209|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
141210|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
141211|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
141212|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
141213|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
141214|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
141215|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
141216|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
141217|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
141218|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
141219|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
141220|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
141221|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
141222|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
141223|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
141224|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
141225|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
141226|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
141227|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
141228|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
141229|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
141230|NCT00739973|506381|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
141231|NCT00739973|506382|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
141232|NCT00739973|506383|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
141233|NCT00739973|506384|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
141234|NCT00739973|506385|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
141235|NCT00739973|506386|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
141236|NCT00739973|506387|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
141237|NCT00739973|506388|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
141238|NCT00739973|506389|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
141239|NCT00739973|506381|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
141240|NCT00739973|506382|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
141241|NCT00739973|506383|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
141242|NCT00739973|506384|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
141243|NCT00739973|506385|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
141244|NCT00739973|506386|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
141245|NCT00739973|506387|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
141246|NCT00739973|506388|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
141247|NCT00739973|506389|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
141248|NCT00739973|506381|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
141249|NCT00739973|506382|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
141250|NCT00739973|506383|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
141251|NCT00739973|506384|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
141252|NCT00739973|506385|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
141253|NCT00739973|506386|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
141254|NCT00739973|506387|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
141255|NCT00739973|506388|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
141256|NCT00739973|506389|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
141257|NCT00739973|506381|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
141258|NCT00739973|506382|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
141259|NCT00739973|506383|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
141260|NCT00739973|506384|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
141261|NCT00739973|506385|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
141262|NCT00739973|506386|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
141263|NCT00739973|506387|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
141264|NCT00739973|506388|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
141265|NCT00739973|506389|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
141266|NCT00739973|506381|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
141267|NCT00739973|506382|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
141268|NCT00739973|506383|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
141269|NCT00739973|506384|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
141270|NCT00739973|506385|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
141271|NCT00739973|506386|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
141272|NCT00739973|506387|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
141273|NCT00739973|506388|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
141274|NCT00739973|506389|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
141275|NCT00739973|506381|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
141276|NCT00739973|506382|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
141277|NCT00739973|506383|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
141278|NCT00739973|506384|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
141279|NCT00739973|506385|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
141280|NCT00739973|506386|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
141281|NCT00739973|506387|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
141282|NCT00739973|506388|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
141283|NCT00739973|506389|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
141284|NCT00739973|506381|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
141285|NCT00739973|506382|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
141286|NCT00739973|506383|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
141287|NCT00739973|506384|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
141288|NCT00739973|506385|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
141289|NCT00739973|506386|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
141290|NCT00739973|506387|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
141291|NCT00739973|506388|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
141292|NCT00739973|506389|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
141293|NCT00739973|506381|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
141294|NCT00739973|506382|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
141295|NCT00739973|506383|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
141296|NCT00739973|506384|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
141297|NCT00739973|506385|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
141298|NCT00739973|506386|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
141299|NCT00739973|506387|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
141300|NCT00739973|506388|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
141301|NCT00739973|506389|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
141302|NCT00739934|506475|P1|Voriconazole Oral|Other|3
141303|NCT00739934|506475|P1|Voriconazole IV|Adverse Event|6
141304|NCT00739908|506497|P2|Overall Study|Relocation|1
141305|NCT00739908|506498|P1|Overall Study|Relocation|0
141306|NCT00739908|506497|P2|Overall Study|Lack of Efficacy|1
141307|NCT00739908|506498|P1|Overall Study|Lack of Efficacy|0
141308|NCT00739908|506497|P2|Overall Study|Non-Compliance With Study Medication|3
141309|NCT00739908|506498|P1|Overall Study|Non-Compliance With Study Medication|0
141310|NCT00739908|506497|P2|Overall Study|Non-Compliance With Study Procedures|3
141311|NCT00739908|506498|P1|Overall Study|Non-Compliance With Study Procedures|2
141312|NCT00739908|506497|P2|Overall Study|Lost to Follow-up|9
141313|NCT00739908|506498|P1|Overall Study|Lost to Follow-up|14
141314|NCT00739908|506497|P2|Overall Study|Withdrawal by Subject|2
141315|NCT00739908|506498|P1|Overall Study|Withdrawal by Subject|4
141316|NCT00739908|506497|P2|Overall Study|Adverse Event|6
141317|NCT00739908|506498|P1|Overall Study|Adverse Event|5
141318|NCT00739882|506518|P2|Open-label Period|Other|5
141319|NCT00739882|506519|P1|Open-label Period|Other|9
141320|NCT00739882|506518|P2|Open-label Period|Adverse Event|0
141321|NCT00739882|506519|P1|Open-label Period|Adverse Event|1
141322|NCT00739882|506518|P2|Double-blind Period|Not specified|8
141323|NCT00739882|506519|P1|Double-blind Period|Not specified|16
141324|NCT00739882|506518|P2|Double-blind Period|Lack of Efficacy|1
141325|NCT00739882|506519|P1|Double-blind Period|Lack of Efficacy|1
141326|NCT00739882|506518|P2|Double-blind Period|Protocol Violation|0
141327|NCT00739882|506519|P1|Double-blind Period|Protocol Violation|1
141328|NCT00739882|506518|P2|Double-blind Period|Adverse Event|2
141329|NCT00739882|506519|P1|Double-blind Period|Adverse Event|1
141330|NCT00739674|506580|P2|Overall Study|Erectile dysfunction|1
141331|NCT00739674|506581|P1|Overall Study|Erectile dysfunction|0
141332|NCT00739674|506580|P2|Overall Study|Home monitoring off meds|0
141333|NCT00739674|506581|P1|Overall Study|Home monitoring off meds|1
141334|NCT00739674|506580|P2|Overall Study|Unable to attend visit|1
141335|NCT00739674|506581|P1|Overall Study|Unable to attend visit|3
141336|NCT00739674|506580|P2|Overall Study|Non compliant|0
141337|NCT00739674|506581|P1|Overall Study|Non compliant|4
141338|NCT00739674|506580|P2|Overall Study|Patient moved|2
141339|NCT00739674|506581|P1|Overall Study|Patient moved|3
141340|NCT00739674|506580|P2|Overall Study|Clinic closed|4
141341|NCT00739674|506581|P1|Overall Study|Clinic closed|6
141342|NCT00739674|506580|P2|Overall Study|Reason missing|0
141343|NCT00739674|506581|P1|Overall Study|Reason missing|2
141344|NCT00739674|506580|P2|Overall Study|Withdrawal by Subject|9
141345|NCT00739674|506581|P1|Overall Study|Withdrawal by Subject|9
141346|NCT00739674|506580|P2|Overall Study|Protocol Violation|5
141347|NCT00739674|506581|P1|Overall Study|Protocol Violation|5
141348|NCT00739674|506580|P2|Overall Study|Lost to Follow-up|30
141349|NCT00739674|506581|P1|Overall Study|Lost to Follow-up|52
141350|NCT00739674|506580|P2|Overall Study|Lack of Efficacy|0
141351|NCT00739674|506581|P1|Overall Study|Lack of Efficacy|1
141352|NCT00739674|506580|P2|Overall Study|Death|0
141353|NCT00739674|506581|P1|Overall Study|Death|1
141354|NCT00739674|506580|P2|Overall Study|Adverse Event|13
141355|NCT00739674|506581|P1|Overall Study|Adverse Event|22
141356|NCT00739674|506580|P2|Overall Study|Dietician consultation >30 days|9
141357|NCT00739674|506581|P1|Overall Study|Dietician consultation >30 days|1
141358|NCT00739674|506580|P2|Overall Study|No follow-up data|18
141359|NCT00739674|506581|P1|Overall Study|No follow-up data|33
141360|NCT00739674|506580|P2|Overall Study|Site 212 removal|13
141361|NCT00739674|506581|P1|Overall Study|Site 212 removal|19
141362|NCT00739674|506580|P2|Overall Study|Screening failures|17
141363|NCT00739674|506581|P1|Overall Study|Screening failures|19
141364|NCT00739661|506609|P2|Overall Study|Reason for discontinuation not available|1
141365|NCT00739661|506610|P1|Overall Study|Reason for discontinuation not available|1
141366|NCT00739661|506609|P2|Overall Study|Disease progression, radiographic|37
141367|NCT00739661|506610|P1|Overall Study|Disease progression, radiographic|33
141368|NCT00739661|506609|P2|Overall Study|Patient decision to withdraw|4
141369|NCT00739661|506610|P1|Overall Study|Patient decision to withdraw|9
141370|NCT00739661|506609|P2|Overall Study|Physician decision to withdraw patient|0
141371|NCT00739661|506610|P1|Overall Study|Physician decision to withdraw patient|1
141372|NCT00739661|506609|P2|Overall Study|Adverse Event|0
141373|NCT00739661|506610|P1|Overall Study|Adverse Event|2
141374|NCT00739648|506622|P2|Overall Study|Do not know|6
141375|NCT00739648|506623|P1|Overall Study|Do not know|4
141376|NCT00739648|506622|P2|Overall Study|Death|0
141377|NCT00739648|506623|P1|Overall Study|Death|2
141378|NCT00739648|506622|P2|Overall Study|Lost to Follow-up|7
141379|NCT00739648|506623|P1|Overall Study|Lost to Follow-up|4
141380|NCT00739648|506622|P2|Overall Study|Withdrawal by Subject|25
141381|NCT00739648|506623|P1|Overall Study|Withdrawal by Subject|13
141382|NCT00739648|506622|P2|Overall Study|Adverse Event|15
141383|NCT00739648|506623|P1|Overall Study|Adverse Event|3
141384|NCT00739596|506637|P2|Overall Study|Protocol Deviation|1
141385|NCT00739596|506638|P1|Overall Study|Protocol Deviation|1
141386|NCT00739596|506637|P2|Overall Study|Lost to Follow-up|2
141387|NCT00739596|506638|P1|Overall Study|Lost to Follow-up|0
141388|NCT00739596|506637|P2|Overall Study|Patient Withdrew Consent|8
141389|NCT00739596|506638|P1|Overall Study|Patient Withdrew Consent|8
141390|NCT00739596|506637|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
141391|NCT00739596|506638|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
141392|NCT00739596|506637|P2|Overall Study|Adverse Event|6
141393|NCT00739596|506638|P1|Overall Study|Adverse Event|12
141394|NCT00739310|506680|P1|Overall Study|Lost to Follow-up|2
141395|NCT00739310|506680|P1|Overall Study|Withdrawal by Subject|1
141396|NCT00739310|506680|P1|Overall Study|Poor adherance to prescribed therapy|4
141397|NCT00739297|506685|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
141398|NCT00739297|506686|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
141399|NCT00739297|506687|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
141400|NCT00739297|506688|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
141401|NCT00739297|506689|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
141402|NCT00739297|506690|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
141403|NCT00739297|506691|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
141404|NCT00739297|506685|P7|First Washout Period of 4-7 Days|Adverse Event|2
141405|NCT00739297|506686|P6|First Washout Period of 4-7 Days|Adverse Event|0
141406|NCT00739297|506687|P5|First Washout Period of 4-7 Days|Adverse Event|0
141407|NCT00739297|506688|P4|First Washout Period of 4-7 Days|Adverse Event|2
141408|NCT00739297|506689|P3|First Washout Period of 4-7 Days|Adverse Event|0
141409|NCT00739297|506690|P2|First Washout Period of 4-7 Days|Adverse Event|0
141410|NCT00739297|506691|P1|First Washout Period of 4-7 Days|Adverse Event|0
141411|NCT00739102|506719|P1|Overall Study|Withdrawal by Subject|10
141412|NCT00739102|506719|P1|Overall Study|Death|5
141413|NCT00739063|506735|P1|Overall Study|Screen failures|8
141414|NCT00738881|506780|P2|Overall Study|Withdrawal by Subject|2
141415|NCT00738881|506781|P1|Overall Study|Withdrawal by Subject|0
141416|NCT00738699|506795|P2|Overall Study|Not specified|0
141417|NCT00738699|506796|P1|Overall Study|Not specified|2
141418|NCT00738699|506795|P2|Overall Study|Discontinuation of study by Sponsor|72
141419|NCT00738699|506796|P1|Overall Study|Discontinuation of study by Sponsor|123
141420|NCT00738699|506795|P2|Overall Study|Death|68
141421|NCT00738699|506796|P1|Overall Study|Death|144
141422|NCT00738699|506795|P2|Overall Study|Lost to Follow-up|0
141423|NCT00738699|506796|P1|Overall Study|Lost to Follow-up|1
141424|NCT00738699|506795|P2|Overall Study|Withdrawal by Subject|0
141425|NCT00738699|506796|P1|Overall Study|Withdrawal by Subject|5
141426|NCT00738673|506814|P2|Overall Study|Withdrawal by Subject|1
141427|NCT00738673|506815|P1|Overall Study|Withdrawal by Subject|3
141428|NCT00738673|506814|P2|Overall Study|Protocol Violation|2
141429|NCT00738673|506815|P1|Overall Study|Protocol Violation|1
141430|NCT00738673|506814|P2|Overall Study|Lack of Efficacy|8
141431|NCT00738673|506815|P1|Overall Study|Lack of Efficacy|19
141432|NCT00738673|506814|P2|Overall Study|Adverse Event|0
141433|NCT00738673|506815|P1|Overall Study|Adverse Event|1
141434|NCT00738530|506853|P2|Overall Study|Withdrawal by Subject|8
141435|NCT00738530|506854|P1|Overall Study|Withdrawal by Subject|6
141436|NCT00738530|506853|P2|Overall Study|Lost to Follow-up|6
141437|NCT00738530|506854|P1|Overall Study|Lost to Follow-up|8
141438|NCT00738530|506853|P2|Overall Study|Death|224
141439|NCT00738530|506854|P1|Overall Study|Death|220
141440|NCT00738400|506889|P2|Overall Study|Non-compliant with study medication|1
141441|NCT00738400|506890|P1|Overall Study|Non-compliant with study medication|0
141442|NCT00738400|506889|P2|Overall Study|Protocol Violation|0
141443|NCT00738400|506890|P1|Overall Study|Protocol Violation|1
141444|NCT00738400|506889|P2|Overall Study|Lost to Follow-up|3
141445|NCT00738400|506890|P1|Overall Study|Lost to Follow-up|0
141446|NCT00738400|506889|P2|Overall Study|Lack of Efficacy|1
141447|NCT00738400|506890|P1|Overall Study|Lack of Efficacy|0
141448|NCT00738400|506889|P2|Overall Study|Withdrawal by Subject|1
141449|NCT00738400|506890|P1|Overall Study|Withdrawal by Subject|0
141450|NCT00738400|506889|P2|Overall Study|Adverse Event|1
141451|NCT00738400|506890|P1|Overall Study|Adverse Event|3
141452|NCT00738374|506911|P4|Maintenance Treatment/Observation Phase|Not Specified|0
141453|NCT00738374|506912|P3|Maintenance Treatment/Observation Phase|Not Specified|0
141454|NCT00738374|506913|P2|Maintenance Treatment/Observation Phase|Not Specified|1
141455|NCT00738374|506914|P1|Maintenance Treatment/Observation Phase|Not Specified|0
141456|NCT00738374|506911|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
141457|NCT00738374|506912|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
141458|NCT00738374|506913|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
141459|NCT00738374|506914|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
141460|NCT00738374|506911|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
141461|NCT00738374|506912|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
141462|NCT00738374|506913|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
141463|NCT00738374|506914|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
141464|NCT00738374|506911|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
141465|NCT00738374|506912|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
141466|NCT00738374|506913|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
141467|NCT00738374|506914|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
141468|NCT00738374|506911|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
141469|NCT00738374|506912|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
141470|NCT00738374|506913|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
141471|NCT00738374|506914|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
141472|NCT00738374|506911|P4|Induction Treatment Phase|Withdrawal by Subject|0
141473|NCT00738374|506912|P3|Induction Treatment Phase|Withdrawal by Subject|0
141474|NCT00738374|506913|P2|Induction Treatment Phase|Withdrawal by Subject|0
141475|NCT00738374|506914|P1|Induction Treatment Phase|Withdrawal by Subject|1
141476|NCT00738374|506911|P4|Induction Treatment Phase|Non-compliance|0
141477|NCT00738374|506912|P3|Induction Treatment Phase|Non-compliance|0
141478|NCT00738374|506913|P2|Induction Treatment Phase|Non-compliance|0
141479|NCT00738374|506914|P1|Induction Treatment Phase|Non-compliance|1
141480|NCT00738374|506911|P4|Induction Treatment Phase|Protocol Violation|0
141481|NCT00738374|506912|P3|Induction Treatment Phase|Protocol Violation|0
141482|NCT00738374|506913|P2|Induction Treatment Phase|Protocol Violation|0
141483|NCT00738374|506914|P1|Induction Treatment Phase|Protocol Violation|2
141484|NCT00738374|506911|P4|Induction Treatment Phase|Physician Decision|0
141485|NCT00738374|506912|P3|Induction Treatment Phase|Physician Decision|0
141486|NCT00738374|506913|P2|Induction Treatment Phase|Physician Decision|0
141487|NCT00738374|506914|P1|Induction Treatment Phase|Physician Decision|2
141488|NCT00738374|506911|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
141489|NCT00738374|506912|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
141490|NCT00738374|506913|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
141491|NCT00738374|506914|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
141492|NCT00738374|506911|P4|Induction Treatment Phase|Adverse Event|0
141493|NCT00738374|506912|P3|Induction Treatment Phase|Adverse Event|0
141494|NCT00738374|506913|P2|Induction Treatment Phase|Adverse Event|0
141495|NCT00738374|506914|P1|Induction Treatment Phase|Adverse Event|14
141496|NCT00738283|506952|P1|Overall Study|Discharge home prior to end of study|1
141497|NCT00738283|506952|P1|Overall Study|Transfer to another facility|2
141498|NCT00738283|506952|P1|Overall Study|Death|1
141499|NCT00738062|506959|P3|Open-Label Extension|Study Terminated|0
141500|NCT00738062|506960|P2|Open-Label Extension|Study Terminated|0
141501|NCT00738062|506961|P1|Open-Label Extension|Study Terminated|2
141502|NCT00738062|506959|P3|Open-Label Extension|Protocol Violation|0
141503|NCT00738062|506960|P2|Open-Label Extension|Protocol Violation|0
141504|NCT00738062|506961|P1|Open-Label Extension|Protocol Violation|1
141505|NCT00738062|506959|P3|Open-Label Extension|Withdrawal by Subject|0
141506|NCT00738062|506960|P2|Open-Label Extension|Withdrawal by Subject|0
141507|NCT00738062|506961|P1|Open-Label Extension|Withdrawal by Subject|6
141508|NCT00738062|506959|P3|Open-Label Extension|Lack of Efficacy|0
141509|NCT00738062|506960|P2|Open-Label Extension|Lack of Efficacy|0
141510|NCT00738062|506961|P1|Open-Label Extension|Lack of Efficacy|2
141511|NCT00738062|506959|P3|Open-Label Extension|Physician Decision|0
141512|NCT00738062|506960|P2|Open-Label Extension|Physician Decision|0
141513|NCT00738062|506961|P1|Open-Label Extension|Physician Decision|1
141514|NCT00738062|506959|P3|Open-Label Extension|Adverse Event|0
141515|NCT00738062|506960|P2|Open-Label Extension|Adverse Event|0
141516|NCT00738062|506961|P1|Open-Label Extension|Adverse Event|5
141517|NCT00738062|506959|P3|Open Label Treatment|Investigator Decision|0
141518|NCT00738062|506960|P2|Open Label Treatment|Investigator Decision|0
141519|NCT00738062|506961|P1|Open Label Treatment|Investigator Decision|1
141520|NCT00738062|506959|P3|Open Label Treatment|Withdrawal by Subject|0
141521|NCT00738062|506960|P2|Open Label Treatment|Withdrawal by Subject|0
141522|NCT00738062|506961|P1|Open Label Treatment|Withdrawal by Subject|9
141523|NCT00738062|506959|P3|Open Label Treatment|Protocol Violation|0
141524|NCT00738062|506960|P2|Open Label Treatment|Protocol Violation|0
141525|NCT00738062|506961|P1|Open Label Treatment|Protocol Violation|2
141526|NCT00738062|506959|P3|Open Label Treatment|Adverse Event|0
141527|NCT00738062|506960|P2|Open Label Treatment|Adverse Event|0
141528|NCT00738062|506961|P1|Open Label Treatment|Adverse Event|11
141529|NCT00738062|506959|P3|Open Label Treatment|Lack of Efficacy|0
141530|NCT00738062|506960|P2|Open Label Treatment|Lack of Efficacy|0
141531|NCT00738062|506961|P1|Open Label Treatment|Lack of Efficacy|5
141532|NCT00737711|507023|P1|Overall Study|Other|5
141533|NCT00737711|507023|P1|Overall Study|Blood transfusion|6
141534|NCT00737711|507023|P1|Overall Study|Withdrawal by Subject|5
141535|NCT00737711|507023|P1|Overall Study|Protocol Violation|1
141536|NCT00737711|507023|P1|Overall Study|Failure to return|4
141537|NCT00737711|507023|P1|Overall Study|Death|8
141538|NCT00737711|507023|P1|Overall Study|Adverse Event|2
141539|NCT00737672|507056|P2|Overall Study|Physician Decision|2
141540|NCT00737672|507057|P1|Overall Study|Physician Decision|0
141541|NCT00737672|507056|P2|Overall Study|Miscellaneous|1
141542|NCT00737672|507057|P1|Overall Study|Miscellaneous|7
141543|NCT00737672|507056|P2|Overall Study|Lost to Follow-up|0
141544|NCT00737672|507057|P1|Overall Study|Lost to Follow-up|1
141545|NCT00737672|507056|P2|Overall Study|Withdrawal by Subject|2
141546|NCT00737672|507057|P1|Overall Study|Withdrawal by Subject|1
141547|NCT00737672|507056|P2|Overall Study|Death|22
141548|NCT00737672|507057|P1|Overall Study|Death|23
141549|NCT00737672|507056|P2|Overall Study|Graft Abandonment|56
141550|NCT00737672|507057|P1|Overall Study|Graft Abandonment|48
141551|NCT00737633|507095|P2|Overall Study|protocol non-compliance|1
141552|NCT00737633|507096|P1|Overall Study|protocol non-compliance|0
141553|NCT00737633|507095|P2|Overall Study|Lost to Follow-up|1
141554|NCT00737633|507096|P1|Overall Study|Lost to Follow-up|0
141555|NCT00737633|507095|P2|Overall Study|Study terminated by sponsor|55
141556|NCT00737633|507096|P1|Overall Study|Study terminated by sponsor|44
141557|NCT00737568|507119|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
141558|NCT00737568|507120|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
141559|NCT00737568|507119|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
141560|NCT00737568|507120|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
141561|NCT00737568|507119|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
141562|NCT00737568|507120|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
141563|NCT00737568|507119|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
141564|NCT00737568|507120|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
141565|NCT00737568|507119|P2|Treatment Period Through Week 240|Protocol Violation|3
141566|NCT00737568|507120|P1|Treatment Period Through Week 240|Protocol Violation|2
141567|NCT00737568|507119|P2|Treatment Period Through Week 240|Lost to Follow-up|3
141568|NCT00737568|507120|P1|Treatment Period Through Week 240|Lost to Follow-up|3
141569|NCT00737568|507119|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
141570|NCT00737568|507120|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
141571|NCT00737568|507119|P2|Treatment Period Through Week 240|Withdrew Consent|6
141572|NCT00737568|507120|P1|Treatment Period Through Week 240|Withdrew Consent|5
141573|NCT00737568|507119|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
141574|NCT00737568|507120|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
141575|NCT00737529|507150|P1|Overall Study|Other|2
141576|NCT00737529|507150|P1|Overall Study|Protocol Violation|1
141577|NCT00737529|507150|P1|Overall Study|Death|3
141578|NCT00737529|507150|P1|Overall Study|Withdrawal by Subject|3
141579|NCT00737529|507150|P1|Overall Study|Adverse Event|23
141580|NCT00737529|507150|P1|Overall Study|Disease Progression|80
141581|NCT00737477|507164|P1|Overall Study|Not Specified|4
141582|NCT00737477|507164|P1|Overall Study|Renal Transplantation|10
141583|NCT00737477|507164|P1|Overall Study|Withdrawal by Subject|1
141584|NCT00737477|507164|P1|Overall Study|Treatment Refusal|1
141585|NCT00737477|507164|P1|Overall Study|Death|9
141586|NCT00737477|507164|P1|Overall Study|Adverse Event|9
141587|NCT00737464|507180|P1|Overall Study|Other reasons|4
141588|NCT00737464|507180|P1|Overall Study|Refused Treatment / Withdrew Consent|6
141589|NCT00737464|507180|P1|Overall Study|Other - Failure to Return|1
141590|NCT00737464|507180|P1|Overall Study|Death|6
141591|NCT00737464|507180|P1|Overall Study|Adverse Event|1
141592|NCT00737438|507201|P1|Overall Study|Patient ineligible|1
141593|NCT00737438|507201|P1|Overall Study|Withdrawal by Subject|2
141594|NCT00737282|507214|P1|Overall Study|Study prematurely terminated|175
141595|NCT00737100|507257|P3|Overall Study|Reason discontinued not explained above|1
141596|NCT00737100|507258|P2|Overall Study|Reason discontinued not explained above|1
141597|NCT00737100|507259|P1|Overall Study|Reason discontinued not explained above|1
141598|NCT00737100|507257|P3|Overall Study|Withdrawal by Subject|3
141599|NCT00737100|507258|P2|Overall Study|Withdrawal by Subject|0
141600|NCT00737100|507259|P1|Overall Study|Withdrawal by Subject|0
141601|NCT00737100|507257|P3|Overall Study|Lost to Follow-up|0
141602|NCT00737100|507258|P2|Overall Study|Lost to Follow-up|1
141603|NCT00737100|507259|P1|Overall Study|Lost to Follow-up|0
141604|NCT00737100|507257|P3|Overall Study|Adverse Event|3
141605|NCT00737100|507258|P2|Overall Study|Adverse Event|5
141606|NCT00737100|507259|P1|Overall Study|Adverse Event|6
141607|NCT00737061|507303|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
141608|NCT00737061|507303|P1|1 Year Wearing Period|Discontinued reilance|3
141609|NCT00737061|507303|P1|1 Year Wearing Period|Withdrawal by Subject|2
141610|NCT00737061|507303|P1|1 Year Wearing Period|Lost to Follow-up|11
141611|NCT00737061|507303|P1|Waiting Period|Elected surgical tubal ligation|5
141612|NCT00737061|507303|P1|Waiting Period|Alternative contraception failure|3
141613|NCT00737061|507303|P1|Waiting Period|Deemed patent following HSG|26
141614|NCT00737061|507303|P1|Waiting Period|Bilateral placement failure|34
141615|NCT00737061|507303|P1|Waiting Period|Withdrawal by Subject|1
141616|NCT00737061|507303|P1|Waiting Period|Lost to Follow-up|6
141617|NCT00737048|507320|P3|Overall Study|Worsening of the symptoms|3
141618|NCT00737048|507321|P2|Overall Study|Worsening of the symptoms|5
141619|NCT00737048|507322|P1|Overall Study|Worsening of the symptoms|3
141620|NCT00737048|507320|P3|Overall Study|Adverse Event|0
141621|NCT00737048|507321|P2|Overall Study|Adverse Event|1
141622|NCT00737048|507322|P1|Overall Study|Adverse Event|0
141623|NCT00737048|507320|P3|Overall Study|Physician Decision|1
141624|NCT00737048|507321|P2|Overall Study|Physician Decision|0
141625|NCT00737048|507322|P1|Overall Study|Physician Decision|0
141626|NCT00736996|507366|P3|Overall Study|Lost to Follow-up|2
141627|NCT00736996|507367|P2|Overall Study|Lost to Follow-up|9
141628|NCT00736996|507368|P1|Overall Study|Lost to Follow-up|1
141629|NCT00736957|507382|P1|Overall Study|Physician Decision|5
141630|NCT00736957|507382|P1|Overall Study|not eligible for Treatment Period I|22
141631|NCT00736957|507382|P1|Overall Study|did not attend hospital appointments|1
141632|NCT00736957|507382|P1|Overall Study|violation of eligibility criteria|2
141633|NCT00736957|507382|P1|Overall Study|Withdrawal by Subject|49
141634|NCT00736957|507382|P1|Overall Study|Adverse Event|43
141635|NCT00736944|507392|P1|Definitive Treatment|Physician Decision|1
141636|NCT00736944|507392|P1|Induction|Death|1
141637|NCT00736879|507423|P4|Follow up Period - No Drug Treatment|non-specified|0
141638|NCT00736879|507424|P3|Follow up Period - No Drug Treatment|non-specified|0
141639|NCT00736879|507425|P2|Follow up Period - No Drug Treatment|non-specified|2
141640|NCT00736879|507426|P1|Follow up Period - No Drug Treatment|non-specified|1
141641|NCT00736879|507423|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
141642|NCT00736879|507424|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
141643|NCT00736879|507425|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
141644|NCT00736879|507426|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
141645|NCT00736879|507423|P4|Double Blind Treatment Period|non-specified|0
141646|NCT00736879|507424|P3|Double Blind Treatment Period|non-specified|0
141647|NCT00736879|507425|P2|Double Blind Treatment Period|non-specified|1
141648|NCT00736879|507426|P1|Double Blind Treatment Period|non-specified|0
141649|NCT00736879|507423|P4|Double Blind Treatment Period|No longer met criteria|0
141650|NCT00736879|507424|P3|Double Blind Treatment Period|No longer met criteria|0
141651|NCT00736879|507425|P2|Double Blind Treatment Period|No longer met criteria|1
141652|NCT00736879|507426|P1|Double Blind Treatment Period|No longer met criteria|0
141653|NCT00736879|507423|P4|Double Blind Treatment Period|Poor non-compliance|1
141654|NCT00736879|507424|P3|Double Blind Treatment Period|Poor non-compliance|1
141655|NCT00736879|507425|P2|Double Blind Treatment Period|Poor non-compliance|0
141656|NCT00736879|507426|P1|Double Blind Treatment Period|Poor non-compliance|0
141657|NCT00736879|507423|P4|Double Blind Treatment Period|Lost to Follow-up|1
141658|NCT00736879|507424|P3|Double Blind Treatment Period|Lost to Follow-up|2
141659|NCT00736879|507425|P2|Double Blind Treatment Period|Lost to Follow-up|0
141660|NCT00736879|507426|P1|Double Blind Treatment Period|Lost to Follow-up|0
141661|NCT00736879|507423|P4|Double Blind Treatment Period|Withdrawal by Subject|3
141662|NCT00736879|507424|P3|Double Blind Treatment Period|Withdrawal by Subject|3
141663|NCT00736879|507425|P2|Double Blind Treatment Period|Withdrawal by Subject|1
141664|NCT00736879|507426|P1|Double Blind Treatment Period|Withdrawal by Subject|2
141665|NCT00736879|507423|P4|Double Blind Treatment Period|Adverse Event|0
141666|NCT00736879|507424|P3|Double Blind Treatment Period|Adverse Event|1
141667|NCT00736879|507425|P2|Double Blind Treatment Period|Adverse Event|1
141668|NCT00736879|507426|P1|Double Blind Treatment Period|Adverse Event|0
141669|NCT00736879|507423|P4|Double Blind Treatment Period|Lack of Efficacy|0
141670|NCT00736879|507424|P3|Double Blind Treatment Period|Lack of Efficacy|0
141671|NCT00736879|507425|P2|Double Blind Treatment Period|Lack of Efficacy|0
141672|NCT00736879|507426|P1|Double Blind Treatment Period|Lack of Efficacy|1
141673|NCT00736853|507480|P3|Double-Blind Period|Ineligible to participate the study|0
141674|NCT00736853|507481|P2|Double-Blind Period|Ineligible to participate the study|1
141675|NCT00736853|507482|P1|Double-Blind Period|Ineligible to participate the study|0
141676|NCT00736853|507480|P3|Double-Blind Period|Withdrawal by Subject|4
141677|NCT00736853|507481|P2|Double-Blind Period|Withdrawal by Subject|1
141678|NCT00736853|507482|P1|Double-Blind Period|Withdrawal by Subject|0
141679|NCT00736853|507480|P3|Double-Blind Period|Adverse Event|2
141680|NCT00736853|507481|P2|Double-Blind Period|Adverse Event|3
141681|NCT00736853|507482|P1|Double-Blind Period|Adverse Event|0
141682|NCT00736853|507480|P3|Double-Blind Period|Lack of Efficacy|42
141683|NCT00736853|507481|P2|Double-Blind Period|Lack of Efficacy|19
141684|NCT00736853|507482|P1|Double-Blind Period|Lack of Efficacy|0
141685|NCT00736853|507480|P3|Open-Label Period|Unable to attend hospital appointments|0
141686|NCT00736853|507481|P2|Open-Label Period|Unable to attend hospital appointments|0
141687|NCT00736853|507482|P1|Open-Label Period|Unable to attend hospital appointments|1
141688|NCT00736853|507480|P3|Open-Label Period|Failed to meet the transfer criteria|0
141689|NCT00736853|507481|P2|Open-Label Period|Failed to meet the transfer criteria|0
141690|NCT00736853|507482|P1|Open-Label Period|Failed to meet the transfer criteria|40
141691|NCT00736853|507480|P3|Open-Label Period|Started but not treated|0
141692|NCT00736853|507481|P2|Open-Label Period|Started but not treated|0
141693|NCT00736853|507482|P1|Open-Label Period|Started but not treated|42
141694|NCT00736853|507480|P3|Open-Label Period|Withdrawal by Subject|0
141695|NCT00736853|507481|P2|Open-Label Period|Withdrawal by Subject|0
141696|NCT00736853|507482|P1|Open-Label Period|Withdrawal by Subject|16
141697|NCT00736853|507480|P3|Open-Label Period|Adverse Event|0
141698|NCT00736853|507481|P2|Open-Label Period|Adverse Event|0
141699|NCT00736853|507482|P1|Open-Label Period|Adverse Event|31
141700|NCT00736853|507480|P3|Open-Label Period|Physician Decision|0
141701|NCT00736853|507481|P2|Open-Label Period|Physician Decision|0
141702|NCT00736853|507482|P1|Open-Label Period|Physician Decision|2
141703|NCT00736840|507522|P1|Overall Study|Lost to Follow-up|13
141704|NCT00736723|507529|P2|Overall Study|Withdrawal by Subject|3
141705|NCT00736723|507530|P1|Overall Study|Withdrawal by Subject|4
141706|NCT00736645|507540|P4|Overall Study|Adverse Event|0
141707|NCT00736645|507541|P3|Overall Study|Adverse Event|0
141708|NCT00736645|507542|P2|Overall Study|Adverse Event|2
141709|NCT00736645|507543|P1|Overall Study|Adverse Event|0
141710|NCT00736502|507566|P1|Overall Study|Lost to Follow-up|27
141711|NCT00736502|507566|P1|Overall Study|Lack of Efficacy|16
141712|NCT00736502|507566|P1|Overall Study|Adverse Event|22
141713|NCT00736489|507572|P6|Period 1|Withdrawal by Subject|1
141714|NCT00736489|507573|P5|Period 1|Withdrawal by Subject|0
141715|NCT00736489|507574|P4|Period 1|Withdrawal by Subject|0
141716|NCT00736489|507575|P3|Period 1|Withdrawal by Subject|0
141717|NCT00736489|507576|P2|Period 1|Withdrawal by Subject|0
141718|NCT00736489|507577|P1|Period 1|Withdrawal by Subject|0
141719|NCT00736489|507572|P6|Period 1|Lost to Follow-up|0
141720|NCT00736489|507573|P5|Period 1|Lost to Follow-up|0
141721|NCT00736489|507574|P4|Period 1|Lost to Follow-up|0
141722|NCT00736489|507575|P3|Period 1|Lost to Follow-up|0
141723|NCT00736489|507576|P2|Period 1|Lost to Follow-up|0
141724|NCT00736489|507577|P1|Period 1|Lost to Follow-up|1
141725|NCT00736476|507731|P2|Overall Study|Adverse Event|0
141726|NCT00736476|507732|P1|Overall Study|Adverse Event|1
141727|NCT00736385|507754|P2|Overall Study|Adverse Event|1
141728|NCT00736385|507755|P1|Overall Study|Adverse Event|0
141729|NCT00736385|507754|P2|Overall Study|Withdrawal by Subject|2
141730|NCT00736385|507755|P1|Overall Study|Withdrawal by Subject|2
141731|NCT00736333|507767|P1|Overall Study|Not Specified|4
141732|NCT00736333|507767|P1|Overall Study|Death|7
141733|NCT00736333|507767|P1|Overall Study|Withdrawal by Subject|10
141734|NCT00736333|507767|P1|Overall Study|Toxicity|6
141735|NCT00736333|507767|P1|Overall Study|Tumor Progression|75
141736|NCT00736333|507767|P1|Overall Study|Data Missing|2
141737|NCT00736333|507767|P1|Overall Study|Did Not Receive Drug or Not Documented|7
141738|NCT00736255|507778|P2|Overall Study|Non-compliance|1
141739|NCT00736255|507779|P1|Overall Study|Non-compliance|1
141740|NCT00736255|507778|P2|Overall Study|Physician Decision|0
141741|NCT00736255|507779|P1|Overall Study|Physician Decision|1
141742|NCT00736255|507778|P2|Overall Study|Adverse Event|0
141743|NCT00736255|507779|P1|Overall Study|Adverse Event|1
141744|NCT00736190|507818|P1|Overall Study|Adverse Event|1
141745|NCT00736190|507818|P1|Overall Study|Withdrawal by Subject|1
141746|NCT00736190|507818|P1|Overall Study|Pregnancy|1
141747|NCT00736099|507844|P2|Overall Study|Other reason|10
141748|NCT00736099|507845|P1|Overall Study|Other reason|43
141749|NCT00736099|507844|P2|Overall Study|Lack of Efficacy|8
141750|NCT00736099|507845|P1|Overall Study|Lack of Efficacy|15
141751|NCT00736099|507844|P2|Overall Study|Withdrawal by Subject|13
141752|NCT00736099|507845|P1|Overall Study|Withdrawal by Subject|42
141753|NCT00736099|507844|P2|Overall Study|Lost to Follow-up|5
141754|NCT00736099|507845|P1|Overall Study|Lost to Follow-up|12
141755|NCT00736099|507844|P2|Overall Study|Protocol Violation|4
141756|NCT00736099|507845|P1|Overall Study|Protocol Violation|10
141757|NCT00736099|507844|P2|Overall Study|Adverse Event|18
141758|NCT00736099|507845|P1|Overall Study|Adverse Event|61
141759|NCT00736034|507954|P1|Overall Study|Adverse Event|2
141760|NCT00735943|507962|P1|Overall Study|Adverse Event|1
141761|NCT00735943|507962|P1|Overall Study|Lost to Follow-up|1
141762|NCT00735904|507987|P1|Overall Study|Other|8
141763|NCT00735904|507987|P1|Overall Study|Study Terminated by Sponsor|5
141764|NCT00735904|507987|P1|Overall Study|Withdrawal by Subject|1
141765|NCT00735904|507987|P1|Overall Study|Protocol Violation|1
141766|NCT00735904|507987|P1|Overall Study|Death|20
141767|NCT00735904|507987|P1|Overall Study|Adverse Event|3
141768|NCT00735709|508056|P4|Overall Study|Excluded medication|1
141769|NCT00735709|508057|P3|Overall Study|Excluded medication|0
141770|NCT00735709|508058|P2|Overall Study|Excluded medication|0
141771|NCT00735709|508059|P1|Overall Study|Excluded medication|1
141772|NCT00735709|508056|P4|Overall Study|Lost to Follow-up|1
141773|NCT00735709|508057|P3|Overall Study|Lost to Follow-up|1
141774|NCT00735709|508058|P2|Overall Study|Lost to Follow-up|1
141775|NCT00735709|508059|P1|Overall Study|Lost to Follow-up|0
141776|NCT00735709|508056|P4|Overall Study|Voluntary Withdrawal|7
141777|NCT00735709|508057|P3|Overall Study|Voluntary Withdrawal|5
141778|NCT00735709|508058|P2|Overall Study|Voluntary Withdrawal|3
141779|NCT00735709|508059|P1|Overall Study|Voluntary Withdrawal|1
141780|NCT00735709|508056|P4|Overall Study|Protocol deviations|1
141781|NCT00735709|508057|P3|Overall Study|Protocol deviations|1
141782|NCT00735709|508058|P2|Overall Study|Protocol deviations|2
141783|NCT00735709|508059|P1|Overall Study|Protocol deviations|1
141784|NCT00735709|508056|P4|Overall Study|Noncompliance|0
141785|NCT00735709|508057|P3|Overall Study|Noncompliance|1
141786|NCT00735709|508058|P2|Overall Study|Noncompliance|0
141787|NCT00735709|508059|P1|Overall Study|Noncompliance|0
141788|NCT00735709|508056|P4|Overall Study|Lack of Efficacy|3
141789|NCT00735709|508057|P3|Overall Study|Lack of Efficacy|2
141790|NCT00735709|508058|P2|Overall Study|Lack of Efficacy|4
141791|NCT00735709|508059|P1|Overall Study|Lack of Efficacy|8
141792|NCT00735709|508056|P4|Overall Study|Adverse Event|5
141793|NCT00735709|508057|P3|Overall Study|Adverse Event|1
141794|NCT00735709|508058|P2|Overall Study|Adverse Event|3
141795|NCT00735709|508059|P1|Overall Study|Adverse Event|2
141796|NCT00735696|508169|P1|Overall Study|Enrolled but never Treated|1
141797|NCT00735696|508169|P1|Overall Study|Withdrawal by Subject|1
141798|NCT00735644|508197|P5|Overall Study|Withdrawal by Subject|0
141799|NCT00735644|508198|P4|Overall Study|Withdrawal by Subject|1
141800|NCT00735644|508199|P3|Overall Study|Withdrawal by Subject|1
141801|NCT00735644|508200|P2|Overall Study|Withdrawal by Subject|1
141802|NCT00735644|508201|P1|Overall Study|Withdrawal by Subject|0
141803|NCT00735644|508197|P5|Overall Study|Did not receive study vaccine|0
141804|NCT00735644|508198|P4|Overall Study|Did not receive study vaccine|0
141805|NCT00735644|508199|P3|Overall Study|Did not receive study vaccine|0
141806|NCT00735644|508200|P2|Overall Study|Did not receive study vaccine|1
141807|NCT00735644|508201|P1|Overall Study|Did not receive study vaccine|0
141808|NCT00735553|508245|P1|Overall Study|Study prematurely terminated|77
141809|NCT00735475|508255|P2|Overall Study|Withdrawal by Subject|5
141810|NCT00735475|508256|P1|Overall Study|Withdrawal by Subject|4
141811|NCT00735475|508255|P2|Overall Study|Physician Decision|1
141812|NCT00735475|508256|P1|Overall Study|Physician Decision|0
141813|NCT00735475|508255|P2|Overall Study|Lost to Follow-up|3
141814|NCT00735475|508256|P1|Overall Study|Lost to Follow-up|3
141815|NCT00735475|508255|P2|Overall Study|Death|1
141816|NCT00735475|508256|P1|Overall Study|Death|1
141817|NCT00735475|508255|P2|Overall Study|Adverse Event|1
141818|NCT00735475|508256|P1|Overall Study|Adverse Event|0
141819|NCT00735397|508316|P1|Overall Study|Administrative/Other|502
141820|NCT00735397|508316|P1|Overall Study|Inadequate therapeutic effect|202
141821|NCT00735397|508316|P1|Overall Study|Participant choice|252
141822|NCT00735397|508316|P1|Overall Study|Lost to Follow-up|33
141823|NCT00735397|508316|P1|Overall Study|Adverse Event|194
141824|NCT00735371|508330|P4|Overall Study|Exclusion criteria|0
141825|NCT00735371|508331|P3|Overall Study|Exclusion criteria|0
141826|NCT00735371|508332|P2|Overall Study|Exclusion criteria|0
141827|NCT00735371|508333|P1|Overall Study|Exclusion criteria|1
141828|NCT00735371|508330|P4|Overall Study|Prior Vyvanse Exposure|0
141829|NCT00735371|508331|P3|Overall Study|Prior Vyvanse Exposure|0
141830|NCT00735371|508332|P2|Overall Study|Prior Vyvanse Exposure|1
141831|NCT00735371|508333|P1|Overall Study|Prior Vyvanse Exposure|1
141832|NCT00735371|508330|P4|Overall Study|Protocol Violation|0
141833|NCT00735371|508331|P3|Overall Study|Protocol Violation|2
141834|NCT00735371|508332|P2|Overall Study|Protocol Violation|1
141835|NCT00735371|508333|P1|Overall Study|Protocol Violation|0
141836|NCT00735371|508330|P4|Overall Study|Sponsor Decision|1
141837|NCT00735371|508331|P3|Overall Study|Sponsor Decision|0
141838|NCT00735371|508332|P2|Overall Study|Sponsor Decision|1
141839|NCT00735371|508333|P1|Overall Study|Sponsor Decision|3
141840|NCT00735371|508330|P4|Overall Study|Lack of Efficacy|4
141841|NCT00735371|508331|P3|Overall Study|Lack of Efficacy|0
141842|NCT00735371|508332|P2|Overall Study|Lack of Efficacy|2
141843|NCT00735371|508333|P1|Overall Study|Lack of Efficacy|4
141844|NCT00735371|508330|P4|Overall Study|Lost to Follow-up|1
141845|NCT00735371|508331|P3|Overall Study|Lost to Follow-up|3
141846|NCT00735371|508332|P2|Overall Study|Lost to Follow-up|1
141847|NCT00735371|508333|P1|Overall Study|Lost to Follow-up|1
141848|NCT00735371|508330|P4|Overall Study|Withdrawal by Subject|0
141849|NCT00735371|508331|P3|Overall Study|Withdrawal by Subject|2
141850|NCT00735371|508332|P2|Overall Study|Withdrawal by Subject|2
141851|NCT00735371|508333|P1|Overall Study|Withdrawal by Subject|0
141852|NCT00735371|508330|P4|Overall Study|Protocol Violation|3
141853|NCT00735371|508331|P3|Overall Study|Protocol Violation|0
141854|NCT00735371|508332|P2|Overall Study|Protocol Violation|2
141855|NCT00735371|508333|P1|Overall Study|Protocol Violation|2
141856|NCT00735371|508330|P4|Overall Study|Adverse Event|1
141857|NCT00735371|508331|P3|Overall Study|Adverse Event|4
141858|NCT00735371|508332|P2|Overall Study|Adverse Event|3
141859|NCT00735371|508333|P1|Overall Study|Adverse Event|3
141860|NCT00735254|508361|P4|Overall Study|Protocol Violation|0
141861|NCT00735254|508362|P3|Overall Study|Protocol Violation|1
141862|NCT00735254|508363|P2|Overall Study|Protocol Violation|1
141863|NCT00735254|508364|P1|Overall Study|Protocol Violation|1
141864|NCT00735072|508376|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
141865|NCT00735072|508377|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
141866|NCT00735072|508376|P2|Overall Study|interrupted study med during ARV change|0
141867|NCT00735072|508377|P1|Overall Study|interrupted study med during ARV change|1
141868|NCT00735007|508383|P1|Overall Study|Protocol Violation|1
141869|NCT00735007|508383|P1|Overall Study|Adverse Event|4
141870|NCT00734994|508408|P1|Overall Study|Withdrawal by Subject|1
141871|NCT00734929|508428|P2|Overall Study|No intervention/ screen fail|3
141872|NCT00734929|508429|P1|Overall Study|No intervention/ screen fail|5
141873|NCT00734929|508428|P2|Overall Study|Lost to Follow-up|2
141874|NCT00734929|508429|P1|Overall Study|Lost to Follow-up|1
141875|NCT00734851|508457|P1|Overall Study|Physician Decision|18
141876|NCT00734851|508457|P1|Overall Study|Lost to Follow-up|1
141877|NCT00734851|508457|P1|Overall Study|Withdrawal by Subject|2
141878|NCT00734747|508478|P1|6 Month Follow-up|Did not meet inclusion criteria|3
141879|NCT00734747|508478|P1|SRS Procedure|No staples placed|3
141880|NCT00734656|508492|P4|Lab Session 4|Withdrawal by Subject|1
141881|NCT00734656|508493|P3|Lab Session 4|Withdrawal by Subject|0
141882|NCT00734656|508494|P2|Lab Session 4|Withdrawal by Subject|0
141883|NCT00734656|508495|P1|Lab Session 4|Withdrawal by Subject|0
141884|NCT00734656|508492|P4|Washout 3|Withdrawal by Subject|1
141885|NCT00734656|508493|P3|Washout 3|Withdrawal by Subject|0
141886|NCT00734656|508494|P2|Washout 3|Withdrawal by Subject|0
141887|NCT00734656|508495|P1|Washout 3|Withdrawal by Subject|1
141888|NCT00734656|508492|P4|Washout 2|Withdrawal by Subject|0
141889|NCT00734656|508493|P3|Washout 2|Withdrawal by Subject|1
141890|NCT00734656|508494|P2|Washout 2|Withdrawal by Subject|1
141891|NCT00734656|508495|P1|Washout 2|Withdrawal by Subject|1
141892|NCT00734656|508492|P4|Lab Session 2|Withdrawal by Subject|1
141893|NCT00734656|508493|P3|Lab Session 2|Withdrawal by Subject|0
141894|NCT00734656|508494|P2|Lab Session 2|Withdrawal by Subject|0
141895|NCT00734656|508495|P1|Lab Session 2|Withdrawal by Subject|1
141896|NCT00734656|508492|P4|Washout 1|Withdrawal by Subject|3
141897|NCT00734656|508493|P3|Washout 1|Withdrawal by Subject|2
141898|NCT00734656|508494|P2|Washout 1|Withdrawal by Subject|5
141899|NCT00734656|508495|P1|Washout 1|Withdrawal by Subject|1
141900|NCT00734656|508492|P4|Lab Session 1|Withdrawal by Subject|0
141901|NCT00734656|508493|P3|Lab Session 1|Withdrawal by Subject|0
141902|NCT00734656|508494|P2|Lab Session 1|Withdrawal by Subject|0
141903|NCT00734656|508495|P1|Lab Session 1|Withdrawal by Subject|2
141904|NCT00734630|508519|P2|Overall Study|Poor Compliance|1
141905|NCT00734630|508520|P1|Overall Study|Poor Compliance|1
141906|NCT00734630|508519|P2|Overall Study|Tested Positive for Illegal Drug Use|1
141907|NCT00734630|508520|P1|Overall Study|Tested Positive for Illegal Drug Use|1
141908|NCT00734630|508519|P2|Overall Study|Randomized in Error|1
141909|NCT00734630|508520|P1|Overall Study|Randomized in Error|0
141910|NCT00734630|508519|P2|Overall Study|Adverse Event|6
141911|NCT00734630|508520|P1|Overall Study|Adverse Event|3
141912|NCT00734630|508519|P2|Overall Study|Inclusion/Exclusion criteria not met|1
141913|NCT00734630|508520|P1|Overall Study|Inclusion/Exclusion criteria not met|0
141914|NCT00734630|508519|P2|Overall Study|Protocol Violation|3
141915|NCT00734630|508520|P1|Overall Study|Protocol Violation|0
141916|NCT00734630|508519|P2|Overall Study|Lost to Follow-up|7
141917|NCT00734630|508520|P1|Overall Study|Lost to Follow-up|13
141918|NCT00734630|508519|P2|Overall Study|Withdrawal by Subject|9
141919|NCT00734630|508520|P1|Overall Study|Withdrawal by Subject|7
141920|NCT00734630|508519|P2|Overall Study|Lack of Efficacy|4
141921|NCT00734630|508520|P1|Overall Study|Lack of Efficacy|4
141922|NCT00734617|508530|P2|Overall Study|Withdrawal by Subject|95
141923|NCT00734617|508531|P1|Overall Study|Withdrawal by Subject|103
141924|NCT00734617|508530|P2|Overall Study|Adverse Event|7
141925|NCT00734617|508531|P1|Overall Study|Adverse Event|4
141926|NCT00734604|508543|P6|Overall Study|Lack of Efficacy|0
141927|NCT00734604|508544|P5|Overall Study|Lack of Efficacy|0
141928|NCT00734604|508545|P4|Overall Study|Lack of Efficacy|0
141929|NCT00734604|508546|P3|Overall Study|Lack of Efficacy|1
141930|NCT00734604|508547|P2|Overall Study|Lack of Efficacy|1
141931|NCT00734604|508548|P1|Overall Study|Lack of Efficacy|0
141932|NCT00734604|508543|P6|Overall Study|Withdrawal by Subject|1
141933|NCT00734604|508544|P5|Overall Study|Withdrawal by Subject|2
141934|NCT00734604|508545|P4|Overall Study|Withdrawal by Subject|1
141935|NCT00734604|508546|P3|Overall Study|Withdrawal by Subject|0
141936|NCT00734604|508547|P2|Overall Study|Withdrawal by Subject|2
141937|NCT00734604|508548|P1|Overall Study|Withdrawal by Subject|0
141938|NCT00734604|508543|P6|Overall Study|Sponsor Decision|0
141939|NCT00734604|508544|P5|Overall Study|Sponsor Decision|2
141940|NCT00734604|508545|P4|Overall Study|Sponsor Decision|0
141941|NCT00734604|508546|P3|Overall Study|Sponsor Decision|1
141942|NCT00734604|508547|P2|Overall Study|Sponsor Decision|2
141943|NCT00734604|508548|P1|Overall Study|Sponsor Decision|1
141944|NCT00734604|508543|P6|Overall Study|Protocol Violation|0
141945|NCT00734604|508544|P5|Overall Study|Protocol Violation|1
141946|NCT00734604|508545|P4|Overall Study|Protocol Violation|0
141947|NCT00734604|508546|P3|Overall Study|Protocol Violation|0
141948|NCT00734604|508547|P2|Overall Study|Protocol Violation|2
141949|NCT00734604|508548|P1|Overall Study|Protocol Violation|0
141950|NCT00734604|508543|P6|Overall Study|Physician Decision|0
141951|NCT00734604|508544|P5|Overall Study|Physician Decision|0
141952|NCT00734604|508545|P4|Overall Study|Physician Decision|0
141953|NCT00734604|508546|P3|Overall Study|Physician Decision|1
141954|NCT00734604|508547|P2|Overall Study|Physician Decision|1
141955|NCT00734604|508548|P1|Overall Study|Physician Decision|0
141956|NCT00734604|508543|P6|Overall Study|Lost to Follow-up|3
141957|NCT00734604|508544|P5|Overall Study|Lost to Follow-up|2
141958|NCT00734604|508545|P4|Overall Study|Lost to Follow-up|4
141959|NCT00734604|508546|P3|Overall Study|Lost to Follow-up|2
141960|NCT00734604|508547|P2|Overall Study|Lost to Follow-up|2
141961|NCT00734604|508548|P1|Overall Study|Lost to Follow-up|1
141962|NCT00734604|508543|P6|Overall Study|Serious Adverse Event|1
141963|NCT00734604|508544|P5|Overall Study|Serious Adverse Event|0
141964|NCT00734604|508545|P4|Overall Study|Serious Adverse Event|2
141965|NCT00734604|508546|P3|Overall Study|Serious Adverse Event|1
141966|NCT00734604|508547|P2|Overall Study|Serious Adverse Event|0
141967|NCT00734604|508548|P1|Overall Study|Serious Adverse Event|1
141968|NCT00734604|508543|P6|Overall Study|Adverse Event|1
141969|NCT00734604|508544|P5|Overall Study|Adverse Event|1
141970|NCT00734604|508545|P4|Overall Study|Adverse Event|2
141971|NCT00734604|508546|P3|Overall Study|Adverse Event|0
141972|NCT00734604|508547|P2|Overall Study|Adverse Event|2
141973|NCT00734604|508548|P1|Overall Study|Adverse Event|0
141974|NCT00734591|508598|P2|Prospective Period|Other|2
141975|NCT00734591|508599|P1|Prospective Period|Other|2
141976|NCT00734591|508598|P2|Prospective Period|Study Terminated|0
141977|NCT00734591|508599|P1|Prospective Period|Study Terminated|1
141978|NCT00734591|508598|P2|Prospective Period|Lost to Follow-up|33
141979|NCT00734591|508599|P1|Prospective Period|Lost to Follow-up|37
141980|NCT00734591|508598|P2|Prospective Period|Withdrawal by Subject|9
141981|NCT00734591|508599|P1|Prospective Period|Withdrawal by Subject|11
141982|NCT00734591|508598|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
141983|NCT00734591|508599|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
141984|NCT00734591|508598|P2|Screening for Prospective Period|Site did not participate|1488
141985|NCT00734591|508599|P1|Screening for Prospective Period|Site did not participate|1604
141986|NCT00734578|508614|P3|Overall Study|Exclusion criteria|0
141987|NCT00734578|508615|P2|Overall Study|Exclusion criteria|0
141988|NCT00734578|508616|P1|Overall Study|Exclusion criteria|1
141989|NCT00734578|508614|P3|Overall Study|Randomized in error|0
141990|NCT00734578|508615|P2|Overall Study|Randomized in error|0
141991|NCT00734578|508616|P1|Overall Study|Randomized in error|1
141992|NCT00734578|508614|P3|Overall Study|Lack of Efficacy|5
141993|NCT00734578|508615|P2|Overall Study|Lack of Efficacy|2
141994|NCT00734578|508616|P1|Overall Study|Lack of Efficacy|3
141995|NCT00734578|508614|P3|Overall Study|Lost to Follow-up|5
141996|NCT00734578|508615|P2|Overall Study|Lost to Follow-up|3
141997|NCT00734578|508616|P1|Overall Study|Lost to Follow-up|9
141998|NCT00734578|508614|P3|Overall Study|Withdrawal by Subject|11
141999|NCT00734578|508615|P2|Overall Study|Withdrawal by Subject|8
142000|NCT00734578|508616|P1|Overall Study|Withdrawal by Subject|7
142001|NCT00734578|508614|P3|Overall Study|Protocol Violation|3
142002|NCT00734578|508615|P2|Overall Study|Protocol Violation|6
142003|NCT00734578|508616|P1|Overall Study|Protocol Violation|8
142004|NCT00734578|508614|P3|Overall Study|Adverse Event|1
142005|NCT00734578|508615|P2|Overall Study|Adverse Event|6
142006|NCT00734578|508616|P1|Overall Study|Adverse Event|4
142007|NCT00734539|508650|P2|Main Study|Enrolled in error; ineligible|0
142008|NCT00734539|508651|P1|Main Study|Enrolled in error; ineligible|1
142009|NCT00734539|508650|P2|Main Study|Withdrawal by Subject|3
142010|NCT00734539|508651|P1|Main Study|Withdrawal by Subject|1
142011|NCT00734539|508650|P2|Main Study|Physician Decision|0
142012|NCT00734539|508651|P1|Main Study|Physician Decision|2
142013|NCT00734539|508650|P2|Main Study|Death|32
142014|NCT00734539|508651|P1|Main Study|Death|33
142015|NCT00734474|508693|P9|Overall Study|Lack of Efficacy|6
142016|NCT00734474|508694|P8|Overall Study|Lack of Efficacy|4
142017|NCT00734474|508695|P7|Overall Study|Lack of Efficacy|0
142018|NCT00734474|508696|P6|Overall Study|Lack of Efficacy|0
142019|NCT00734474|508697|P5|Overall Study|Lack of Efficacy|0
142020|NCT00734474|508698|P4|Overall Study|Lack of Efficacy|0
142021|NCT00734474|508699|P3|Overall Study|Lack of Efficacy|4
142022|NCT00734474|508700|P2|Overall Study|Lack of Efficacy|0
142023|NCT00734474|508701|P1|Overall Study|Lack of Efficacy|0
142024|NCT00734474|508693|P9|Overall Study|Death|1
142025|NCT00734474|508694|P8|Overall Study|Death|2
142026|NCT00734474|508695|P7|Overall Study|Death|0
142027|NCT00734474|508696|P6|Overall Study|Death|0
142028|NCT00734474|508697|P5|Overall Study|Death|0
142029|NCT00734474|508698|P4|Overall Study|Death|0
142030|NCT00734474|508699|P3|Overall Study|Death|1
142031|NCT00734474|508700|P2|Overall Study|Death|0
142032|NCT00734474|508701|P1|Overall Study|Death|0
142033|NCT00734474|508693|P9|Overall Study|Sponsor Decision|0
142034|NCT00734474|508694|P8|Overall Study|Sponsor Decision|0
142035|NCT00734474|508695|P7|Overall Study|Sponsor Decision|0
142036|NCT00734474|508696|P6|Overall Study|Sponsor Decision|0
142037|NCT00734474|508697|P5|Overall Study|Sponsor Decision|2
142038|NCT00734474|508698|P4|Overall Study|Sponsor Decision|0
142039|NCT00734474|508699|P3|Overall Study|Sponsor Decision|0
142040|NCT00734474|508700|P2|Overall Study|Sponsor Decision|0
142041|NCT00734474|508701|P1|Overall Study|Sponsor Decision|0
142042|NCT00734474|508693|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
142043|NCT00734474|508694|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
142044|NCT00734474|508695|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
142045|NCT00734474|508696|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
142046|NCT00734474|508697|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
142047|NCT00734474|508698|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
142048|NCT00734474|508699|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
142049|NCT00734474|508700|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
142050|NCT00734474|508701|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
142051|NCT00734474|508693|P9|Overall Study|Protocol Violation|1
142052|NCT00734474|508694|P8|Overall Study|Protocol Violation|3
142053|NCT00734474|508695|P7|Overall Study|Protocol Violation|0
142054|NCT00734474|508696|P6|Overall Study|Protocol Violation|0
142055|NCT00734474|508697|P5|Overall Study|Protocol Violation|3
142056|NCT00734474|508698|P4|Overall Study|Protocol Violation|0
142057|NCT00734474|508699|P3|Overall Study|Protocol Violation|4
142058|NCT00734474|508700|P2|Overall Study|Protocol Violation|0
142059|NCT00734474|508701|P1|Overall Study|Protocol Violation|0
142060|NCT00734474|508693|P9|Overall Study|Adverse Event|39
142061|NCT00734474|508694|P8|Overall Study|Adverse Event|65
142062|NCT00734474|508695|P7|Overall Study|Adverse Event|1
142063|NCT00734474|508696|P6|Overall Study|Adverse Event|0
142064|NCT00734474|508697|P5|Overall Study|Adverse Event|64
142065|NCT00734474|508698|P4|Overall Study|Adverse Event|1
142066|NCT00734474|508699|P3|Overall Study|Adverse Event|63
142067|NCT00734474|508700|P2|Overall Study|Adverse Event|4
142068|NCT00734474|508701|P1|Overall Study|Adverse Event|4
142069|NCT00734474|508693|P9|Overall Study|Physician Decision|9
142070|NCT00734474|508694|P8|Overall Study|Physician Decision|9
142071|NCT00734474|508695|P7|Overall Study|Physician Decision|0
142072|NCT00734474|508696|P6|Overall Study|Physician Decision|0
142073|NCT00734474|508697|P5|Overall Study|Physician Decision|11
142074|NCT00734474|508698|P4|Overall Study|Physician Decision|1
142075|NCT00734474|508699|P3|Overall Study|Physician Decision|4
142076|NCT00734474|508700|P2|Overall Study|Physician Decision|0
142077|NCT00734474|508701|P1|Overall Study|Physician Decision|0
142078|NCT00734474|508693|P9|Overall Study|Withdrawal by Subject|21
142079|NCT00734474|508694|P8|Overall Study|Withdrawal by Subject|36
142080|NCT00734474|508695|P7|Overall Study|Withdrawal by Subject|0
142081|NCT00734474|508696|P6|Overall Study|Withdrawal by Subject|2
142082|NCT00734474|508697|P5|Overall Study|Withdrawal by Subject|24
142083|NCT00734474|508698|P4|Overall Study|Withdrawal by Subject|0
142084|NCT00734474|508699|P3|Overall Study|Withdrawal by Subject|18
142085|NCT00734474|508700|P2|Overall Study|Withdrawal by Subject|1
142086|NCT00734474|508701|P1|Overall Study|Withdrawal by Subject|2
142087|NCT00734474|508693|P9|Overall Study|Lost to Follow-up|4
142088|NCT00734474|508694|P8|Overall Study|Lost to Follow-up|9
142089|NCT00734474|508695|P7|Overall Study|Lost to Follow-up|0
142090|NCT00734474|508696|P6|Overall Study|Lost to Follow-up|1
142091|NCT00734474|508697|P5|Overall Study|Lost to Follow-up|11
142092|NCT00734474|508698|P4|Overall Study|Lost to Follow-up|0
142093|NCT00734474|508699|P3|Overall Study|Lost to Follow-up|13
142094|NCT00734474|508700|P2|Overall Study|Lost to Follow-up|0
142095|NCT00734474|508701|P1|Overall Study|Lost to Follow-up|1
142096|NCT00734474|508693|P9|Overall Study|Entry Criteria Not Met|1
142097|NCT00734474|508694|P8|Overall Study|Entry Criteria Not Met|1
142098|NCT00734474|508695|P7|Overall Study|Entry Criteria Not Met|0
142099|NCT00734474|508696|P6|Overall Study|Entry Criteria Not Met|1
142100|NCT00734474|508697|P5|Overall Study|Entry Criteria Not Met|3
142101|NCT00734474|508698|P4|Overall Study|Entry Criteria Not Met|0
142102|NCT00734474|508699|P3|Overall Study|Entry Criteria Not Met|5
142103|NCT00734474|508700|P2|Overall Study|Entry Criteria Not Met|0
142104|NCT00734474|508701|P1|Overall Study|Entry Criteria Not Met|0
142105|NCT00734214|508991|P2|Overall Study|MD withdrawal|0
142106|NCT00734214|508992|P1|Overall Study|MD withdrawal|1
142107|NCT00734214|508991|P2|Overall Study|Withdrawal by Subject|4
142108|NCT00734214|508992|P1|Overall Study|Withdrawal by Subject|3
142109|NCT00734162|509002|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
142110|NCT00734162|509003|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
142111|NCT00734162|509004|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
142112|NCT00734162|509005|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
142113|NCT00734162|509002|P4|Open-Label Phase|Lost to Follow-up|1
142114|NCT00734162|509003|P3|Open-Label Phase|Lost to Follow-up|0
142115|NCT00734162|509004|P2|Open-Label Phase|Lost to Follow-up|2
142116|NCT00734162|509005|P1|Open-Label Phase|Lost to Follow-up|1
142117|NCT00734162|509002|P4|Open-Label Phase|Withdrew Consent|1
142118|NCT00734162|509003|P3|Open-Label Phase|Withdrew Consent|1
142119|NCT00734162|509004|P2|Open-Label Phase|Withdrew Consent|0
142120|NCT00734162|509005|P1|Open-Label Phase|Withdrew Consent|1
142121|NCT00734162|509002|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
142122|NCT00734162|509003|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
142123|NCT00734162|509004|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
142124|NCT00734162|509005|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
142125|NCT00734162|509002|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
142126|NCT00734162|509003|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
142127|NCT00734162|509004|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
142128|NCT00734162|509005|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
142129|NCT00734162|509002|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
142130|NCT00734162|509003|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
142131|NCT00734162|509004|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
142132|NCT00734162|509005|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
142133|NCT00734149|509229|P1|Overall Study|Withdrawal by Subject|1
142134|NCT00734097|509236|P1|Open Label|Protocol Violation|4
142135|NCT00734097|509236|P1|Open Label|Withdrawal by Subject|5
142136|NCT00734097|509236|P1|Open Label|Lost to Follow-up|7
142137|NCT00734097|509236|P1|Screening|Unconfirmed pregnancy|1
142138|NCT00734097|509236|P1|Screening|Lost to Follow-up|2
142139|NCT00734097|509236|P1|Screening|Withdrawal by Subject|5
142140|NCT00734097|509236|P1|Screening|Protocol Violation|12
142141|NCT00734071|509253|P2|Overall Study|Other|2
142142|NCT00734071|509254|P1|Overall Study|Other|1
142143|NCT00734071|509253|P2|Overall Study|Lost to Follow-up|8
142144|NCT00734071|509254|P1|Overall Study|Lost to Follow-up|16
142145|NCT00734071|509253|P2|Overall Study|Voluntary Withdrawal|7
142146|NCT00734071|509254|P1|Overall Study|Voluntary Withdrawal|9
142147|NCT00734071|509253|P2|Overall Study|Protocol Deviations|4
142148|NCT00734071|509254|P1|Overall Study|Protocol Deviations|3
142149|NCT00734071|509253|P2|Overall Study|Noncompliance|2
142150|NCT00734071|509254|P1|Overall Study|Noncompliance|2
142151|NCT00734071|509253|P2|Overall Study|Lack of Efficacy|1
142152|NCT00734071|509254|P1|Overall Study|Lack of Efficacy|3
142153|NCT00734071|509253|P2|Overall Study|Adverse Event|3
142154|NCT00734071|509254|P1|Overall Study|Adverse Event|4
142155|NCT00734032|509312|P4|Overall Study|Adverse Event|0
142156|NCT00734032|509313|P3|Overall Study|Adverse Event|0
142157|NCT00734032|509314|P2|Overall Study|Adverse Event|1
142158|NCT00734032|509315|P1|Overall Study|Adverse Event|0
142159|NCT00733980|509371|P2|Overall Study|Withdrawal by Subject|2
142160|NCT00733980|509372|P1|Overall Study|Withdrawal by Subject|6
142161|NCT00733980|509371|P2|Overall Study|Physician Decision|3
142162|NCT00733980|509372|P1|Overall Study|Physician Decision|2
142163|NCT00733980|509371|P2|Overall Study|Lost to Follow-up|11
142164|NCT00733980|509372|P1|Overall Study|Lost to Follow-up|6
142165|NCT00733980|509371|P2|Overall Study|Protocol defined stopping criteria reach|1
142166|NCT00733980|509372|P1|Overall Study|Protocol defined stopping criteria reach|1
142167|NCT00733980|509371|P2|Overall Study|Protocol Violation|1
142168|NCT00733980|509372|P1|Overall Study|Protocol Violation|2
142169|NCT00733980|509371|P2|Overall Study|Lack of Efficacy|1
142170|NCT00733980|509372|P1|Overall Study|Lack of Efficacy|0
142171|NCT00733980|509371|P2|Overall Study|Adverse Event|2
142172|NCT00733980|509372|P1|Overall Study|Adverse Event|5
142173|NCT00733954|509416|P2|Overall Study|Withdrawal by Subject|0
142174|NCT00733954|509417|P1|Overall Study|Withdrawal by Subject|2
142175|NCT00733954|509416|P2|Overall Study|Protocol Violation|0
142176|NCT00733954|509417|P1|Overall Study|Protocol Violation|1
142177|NCT00733954|509416|P2|Overall Study|Lost to Follow-up|2
142178|NCT00733954|509417|P1|Overall Study|Lost to Follow-up|5
142179|NCT00733824|509464|P5|Phase I|Withdrawal by Subject|0
142180|NCT00733824|509465|P4|Phase I|Withdrawal by Subject|0
142181|NCT00733824|509466|P3|Phase I|Withdrawal by Subject|0
142182|NCT00733824|509467|P2|Phase I|Withdrawal by Subject|0
142183|NCT00733824|509468|P1|Phase I|Withdrawal by Subject|1
142184|NCT00733746|509487|P1|Overall Study|Ineligible|5
142185|NCT00733499|509502|P2|24 Months Follow-up|Death|1
142186|NCT00733499|509503|P1|24 Months Follow-up|Death|0
142187|NCT00733499|509502|P2|12 Months Follow-up|Death|1
142188|NCT00733499|509503|P1|12 Months Follow-up|Death|2
142189|NCT00733499|509502|P2|6 Months Follow-up|Adverse Event|1
142190|NCT00733499|509503|P1|6 Months Follow-up|Adverse Event|0
142191|NCT00733499|509502|P2|6 Months Follow-up|Death|2
142192|NCT00733499|509503|P1|6 Months Follow-up|Death|0
142193|NCT00733499|509502|P2|3 Months Follow-up|Death|2
142194|NCT00733499|509503|P1|3 Months Follow-up|Death|1
142195|NCT00733499|509502|P2|Pre-operative|Protocol Violation|1
142196|NCT00733499|509503|P1|Pre-operative|Protocol Violation|0
142197|NCT00733421|509511|P2|Overall Study|Withdrawal by Subject|1
142198|NCT00733421|509512|P1|Overall Study|Withdrawal by Subject|1
142199|NCT00733369|509536|P2|Overall Study|Protocol Violation|4
142200|NCT00733369|509537|P1|Overall Study|Protocol Violation|4
142201|NCT00733369|509536|P2|Overall Study|Adverse Event|4
142202|NCT00733369|509537|P1|Overall Study|Adverse Event|4
142203|NCT00733369|509536|P2|Overall Study|Lost to Follow-up|1
142204|NCT00733369|509537|P1|Overall Study|Lost to Follow-up|2
142205|NCT00733304|509745|P3|Overall Study|Withdrawal by Subject|0
142206|NCT00733304|509746|P2|Overall Study|Withdrawal by Subject|1
142207|NCT00733304|509747|P1|Overall Study|Withdrawal by Subject|1
142208|NCT00733304|509745|P3|Overall Study|Physician Decision|3
142209|NCT00733304|509746|P2|Overall Study|Physician Decision|1
142210|NCT00733304|509747|P1|Overall Study|Physician Decision|3
142211|NCT00733304|509745|P3|Overall Study|Lost to Follow-up|0
142212|NCT00733304|509746|P2|Overall Study|Lost to Follow-up|1
142213|NCT00733304|509747|P1|Overall Study|Lost to Follow-up|0
142214|NCT00733304|509745|P3|Overall Study|Lack of Efficacy|2
142215|NCT00733304|509746|P2|Overall Study|Lack of Efficacy|0
142216|NCT00733304|509747|P1|Overall Study|Lack of Efficacy|0
142217|NCT00733304|509745|P3|Overall Study|Adverse Event|0
142218|NCT00733304|509746|P2|Overall Study|Adverse Event|0
142219|NCT00733304|509747|P1|Overall Study|Adverse Event|3
142220|NCT00733291|509829|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
142221|NCT00733291|509830|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
142222|NCT00733291|509831|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
142223|NCT00733291|509832|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
142224|NCT00733226|509861|P2|Overall Study|moved to another place|0
142225|NCT00733226|509862|P1|Overall Study|moved to another place|2
142226|NCT00733226|509861|P2|Overall Study|Lost to Follow-up|0
142227|NCT00733226|509862|P1|Overall Study|Lost to Follow-up|2
142228|NCT00733226|509861|P2|Overall Study|Withdrawal by Subject|0
142229|NCT00733226|509862|P1|Overall Study|Withdrawal by Subject|1
142230|NCT00733005|509911|P2|Overall Study|Protocol Violation|0
142231|NCT00733005|509912|P1|Overall Study|Protocol Violation|2
142232|NCT00733005|509911|P2|Overall Study|Withdrawal by Subject|1
142233|NCT00733005|509912|P1|Overall Study|Withdrawal by Subject|0
142234|NCT00733005|509911|P2|Overall Study|Treatment Failure|1
142235|NCT00733005|509912|P1|Overall Study|Treatment Failure|0
142236|NCT00733005|509911|P2|Overall Study|Adverse Event|1
142237|NCT00733005|509912|P1|Overall Study|Adverse Event|0
142238|NCT00732992|509922|P2|Overall Study|Withdrawal by Subject|0
142239|NCT00732992|509923|P1|Overall Study|Withdrawal by Subject|1
142240|NCT00732992|509922|P2|Overall Study|Global Deterioration of Health Status|0
142241|NCT00732992|509923|P1|Overall Study|Global Deterioration of Health Status|1
142242|NCT00732992|509922|P2|Overall Study|Objective Progression or Relapse|5
142243|NCT00732992|509923|P1|Overall Study|Objective Progression or Relapse|3
142244|NCT00732992|509922|P2|Overall Study|Adverse Event|1
142245|NCT00732992|509923|P1|Overall Study|Adverse Event|1
142246|NCT00732940|509942|P2|Overall Study|Lost to Follow-up|0
142247|NCT00732940|509943|P1|Overall Study|Lost to Follow-up|1
142248|NCT00732940|509942|P2|Overall Study|Adverse Event|1
142249|NCT00732940|509943|P1|Overall Study|Adverse Event|0
142250|NCT00732940|509942|P2|Overall Study|Withdrawal by Subject|2
142251|NCT00732940|509943|P1|Overall Study|Withdrawal by Subject|1
142252|NCT00732875|510024|P1|Overall Study|Lack of Efficacy|13
142253|NCT00732875|510024|P1|Overall Study|Withdrawal by Subject|6
142254|NCT00732875|510024|P1|Overall Study|Adverse Event|16
142255|NCT00732758|510032|P2|Overall Study|Lost to Follow-up|16
142256|NCT00732758|510033|P1|Overall Study|Lost to Follow-up|8
142257|NCT00732641|510073|P2|Overall Study|Not Specified|5
142258|NCT00732641|510074|P1|Overall Study|Not Specified|18
142259|NCT00732641|510073|P2|Overall Study|Unable to Complete|1
142260|NCT00732641|510074|P1|Overall Study|Unable to Complete|1
142261|NCT00732641|510073|P2|Overall Study|Withdrawal by Subject|2
142262|NCT00732641|510074|P1|Overall Study|Withdrawal by Subject|4
142263|NCT00732641|510073|P2|Overall Study|Physician Decision|0
142264|NCT00732641|510074|P1|Overall Study|Physician Decision|6
142265|NCT00732641|510073|P2|Overall Study|Serious Adverse Events|3
142266|NCT00732641|510074|P1|Overall Study|Serious Adverse Events|12
142267|NCT00732641|510073|P2|Overall Study|Relapse or Progressive Disease|101
142268|NCT00732641|510074|P1|Overall Study|Relapse or Progressive Disease|65
142269|NCT00732615|510094|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
142270|NCT00732615|510095|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
142271|NCT00732615|510094|P2|Overall Study|Physician Decision|0
142272|NCT00732615|510095|P1|Overall Study|Physician Decision|3
142273|NCT00732615|510094|P2|Overall Study|Adverse Event|2
142274|NCT00732615|510095|P1|Overall Study|Adverse Event|0
142275|NCT00732615|510094|P2|Overall Study|Lost to Follow-up|1
142276|NCT00732615|510095|P1|Overall Study|Lost to Follow-up|0
142277|NCT00732615|510094|P2|Overall Study|Withdrawal by Subject|1
142278|NCT00732615|510095|P1|Overall Study|Withdrawal by Subject|3
142279|NCT00732472|510111|P4|Overall Study|Withdrawal by Subject|1
142280|NCT00732472|510112|P3|Overall Study|Withdrawal by Subject|0
142281|NCT00732472|510113|P2|Overall Study|Withdrawal by Subject|2
142282|NCT00732472|510114|P1|Overall Study|Withdrawal by Subject|0
142283|NCT00732472|510111|P4|Overall Study|Protocol Violation|1
142284|NCT00732472|510112|P3|Overall Study|Protocol Violation|0
142285|NCT00732472|510113|P2|Overall Study|Protocol Violation|0
142286|NCT00732472|510114|P1|Overall Study|Protocol Violation|0
142287|NCT00732472|510111|P4|Overall Study|Adverse Event|1
142288|NCT00732472|510112|P3|Overall Study|Adverse Event|1
142289|NCT00732472|510113|P2|Overall Study|Adverse Event|1
142290|NCT00732472|510114|P1|Overall Study|Adverse Event|0
142291|NCT00732381|510214|P2|Overall Study|Treatment Failure|1
142292|NCT00732381|510215|P1|Overall Study|Treatment Failure|1
142293|NCT00732381|510214|P2|Overall Study|Adverse Event|0
142294|NCT00732381|510215|P1|Overall Study|Adverse Event|1
142295|NCT00732303|510223|P1|Overall Study|Study Terminated|2
142296|NCT00732251|510229|P1|Overall Study|Early Term due to Site Closure|1
142297|NCT00732251|510229|P1|Overall Study|Withdrawal by Subject|3
142298|NCT00732251|510229|P1|Overall Study|Lost to Follow-up|3
142299|NCT00732238|510235|P2|Overall Study|Asymptomatic bacteriuria|0
142300|NCT00732238|510236|P1|Overall Study|Asymptomatic bacteriuria|1
142301|NCT00732238|510235|P2|Overall Study|Bacteremia|1
142302|NCT00732238|510236|P1|Overall Study|Bacteremia|4
142303|NCT00732199|510337|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
142304|NCT00732199|510338|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
142305|NCT00732199|510337|P2|Overall Study|Withdrawal by Subject|18
142306|NCT00732199|510338|P1|Overall Study|Withdrawal by Subject|25
142307|NCT00732160|510353|P4|Overall Study|scheduling|1
142308|NCT00732160|510354|P3|Overall Study|scheduling|2
142309|NCT00732160|510355|P2|Overall Study|scheduling|4
142310|NCT00732160|510356|P1|Overall Study|scheduling|4
142311|NCT00732160|510353|P4|Overall Study|Adverse Event|1
142312|NCT00732160|510354|P3|Overall Study|Adverse Event|1
142313|NCT00732160|510355|P2|Overall Study|Adverse Event|0
142314|NCT00732160|510356|P1|Overall Study|Adverse Event|1
142315|NCT00732069|510370|P6|Washout After First Study Drug|Adverse Event|0
142316|NCT00732069|510371|P5|Washout After First Study Drug|Adverse Event|0
142317|NCT00732069|510372|P4|Washout After First Study Drug|Adverse Event|0
142318|NCT00732069|510373|P3|Washout After First Study Drug|Adverse Event|0
142319|NCT00732069|510374|P2|Washout After First Study Drug|Adverse Event|0
142320|NCT00732069|510375|P1|Washout After First Study Drug|Adverse Event|1
142321|NCT00731939|510393|P1|Overall Study|Did not meet enrollment criteria|2
142322|NCT00731939|510393|P1|Overall Study|Withdrawal by Subject|2
142323|NCT00731939|510393|P1|Overall Study|Not implanted with study device|9
142324|NCT00731939|510393|P1|Overall Study|Lost to Follow-up|15
142325|NCT00731939|510393|P1|Overall Study|Adverse Event|6
142326|NCT00731822|510454|P2|Overall Study|Lost to Follow-up|0
142327|NCT00731822|510455|P1|Overall Study|Lost to Follow-up|1
142328|NCT00731822|510454|P2|Overall Study|Protocol Violation|0
142329|NCT00731822|510455|P1|Overall Study|Protocol Violation|1
142330|NCT00731822|510454|P2|Overall Study|Adverse Event|1
142331|NCT00731822|510455|P1|Overall Study|Adverse Event|2
142332|NCT00731783|510469|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
142333|NCT00731783|510470|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
142334|NCT00731783|510469|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
142335|NCT00731783|510470|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
142336|NCT00731783|510469|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
142337|NCT00731783|510470|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
142338|NCT00731783|510469|P2|One Month Follow-Up Visit|Lost to Follow-up|22
142339|NCT00731783|510470|P1|One Month Follow-Up Visit|Lost to Follow-up|14
142340|NCT00731731|510493|P3|Overall Study|Cancel prior to treatment|2
142341|NCT00731731|510494|P2|Overall Study|Cancel prior to treatment|0
142342|NCT00731731|510495|P1|Overall Study|Cancel prior to treatment|0
142343|NCT00731731|510493|P3|Overall Study|Protocol Violation|1
142344|NCT00731731|510494|P2|Overall Study|Protocol Violation|0
142345|NCT00731731|510495|P1|Overall Study|Protocol Violation|0
142346|NCT00731692|510513|P3|Extension Phase|Adverse Event|15
142347|NCT00731692|510514|P2|Extension Phase|Adverse Event|1
142348|NCT00731692|510515|P1|Extension Phase|Adverse Event|1
142349|NCT00731692|510513|P3|Extension Phase|Withdrawal by Subject|3
142350|NCT00731692|510514|P2|Extension Phase|Withdrawal by Subject|5
142351|NCT00731692|510515|P1|Extension Phase|Withdrawal by Subject|4
142352|NCT00731692|510513|P3|Extension Phase|Lost to Follow-up|4
142353|NCT00731692|510514|P2|Extension Phase|Lost to Follow-up|1
142354|NCT00731692|510515|P1|Extension Phase|Lost to Follow-up|0
142355|NCT00731692|510513|P3|Extension Phase|Abnormal lab values|1
142356|NCT00731692|510514|P2|Extension Phase|Abnormal lab values|0
142357|NCT00731692|510515|P1|Extension Phase|Abnormal lab values|0
142358|NCT00731692|510513|P3|Extension Phase|Abnormal test procedure|1
142359|NCT00731692|510514|P2|Extension Phase|Abnormal test procedure|0
142360|NCT00731692|510515|P1|Extension Phase|Abnormal test procedure|0
142361|NCT00731692|510513|P3|Extension Phase|Admin Problems: Terminated # patients|277
142362|NCT00731692|510514|P2|Extension Phase|Admin Problems: Terminated # patients|189
142363|NCT00731692|510515|P1|Extension Phase|Admin Problems: Terminated # patients|69
142364|NCT00731692|510513|P3|Core Study (36 Months)|Withdrawal by Subject|46
142365|NCT00731692|510514|P2|Core Study (36 Months)|Withdrawal by Subject|32
142366|NCT00731692|510515|P1|Core Study (36 Months)|Withdrawal by Subject|12
142367|NCT00731692|510513|P3|Core Study (36 Months)|Adverse Event|29
142368|NCT00731692|510514|P2|Core Study (36 Months)|Adverse Event|28
142369|NCT00731692|510515|P1|Core Study (36 Months)|Adverse Event|25
142370|NCT00731692|510513|P3|Core Study (36 Months)|Abnormal Lab values|5
142371|NCT00731692|510514|P2|Core Study (36 Months)|Abnormal Lab values|19
142372|NCT00731692|510515|P1|Core Study (36 Months)|Abnormal Lab values|6
142373|NCT00731692|510513|P3|Core Study (36 Months)|Protocol Violation|8
142374|NCT00731692|510514|P2|Core Study (36 Months)|Protocol Violation|5
142375|NCT00731692|510515|P1|Core Study (36 Months)|Protocol Violation|4
142376|NCT00731692|510513|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
142377|NCT00731692|510514|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
142378|NCT00731692|510515|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
142379|NCT00731692|510513|P3|Core Study (36 Months)|Administrative|6
142380|NCT00731692|510514|P2|Core Study (36 Months)|Administrative|2
142381|NCT00731692|510515|P1|Core Study (36 Months)|Administrative|2
142382|NCT00731692|510513|P3|Core Study (36 Months)|Lost to Follow-up|3
142383|NCT00731692|510514|P2|Core Study (36 Months)|Lost to Follow-up|3
142384|NCT00731692|510515|P1|Core Study (36 Months)|Lost to Follow-up|1
142385|NCT00731692|510513|P3|Core Study (36 Months)|Death|2
142386|NCT00731692|510514|P2|Core Study (36 Months)|Death|1
142387|NCT00731692|510515|P1|Core Study (36 Months)|Death|2
142388|NCT00731692|510513|P3|Core Study (36 Months)|Physician Decision|2
142389|NCT00731692|510514|P2|Core Study (36 Months)|Physician Decision|0
142390|NCT00731692|510515|P1|Core Study (36 Months)|Physician Decision|1
142391|NCT00731692|510513|P3|Core Study (36 Months)|Lack of Efficacy|64
142392|NCT00731692|510514|P2|Core Study (36 Months)|Lack of Efficacy|23
142393|NCT00731692|510515|P1|Core Study (36 Months)|Lack of Efficacy|11
142394|NCT00731679|510561|P2|Overall Study|Pregnancy|1
142395|NCT00731679|510562|P1|Overall Study|Pregnancy|0
142396|NCT00731679|510561|P2|Overall Study|Noncompliance|1
142397|NCT00731679|510562|P1|Overall Study|Noncompliance|0
142398|NCT00731679|510561|P2|Overall Study|Lost to Follow-up|8
142399|NCT00731679|510562|P1|Overall Study|Lost to Follow-up|7
142400|NCT00731679|510561|P2|Overall Study|Withdrawal by Subject|8
142401|NCT00731679|510562|P1|Overall Study|Withdrawal by Subject|8
142402|NCT00731679|510561|P2|Overall Study|Adverse Event|8
142403|NCT00731679|510562|P1|Overall Study|Adverse Event|7
142404|NCT00731666|510570|P1|Overall Study|Withdrawal by Subject|2
142405|NCT00731666|510570|P1|Overall Study|Lost to Follow-up|8
142406|NCT00731666|510570|P1|Overall Study|Adverse Event|2
142407|NCT00731549|510604|P1|Overall Study|Lack of efficacy without AE|6
142408|NCT00731549|510604|P1|Overall Study|Lack of efficacy with AE|37
142409|NCT00731549|510604|P1|Overall Study|Adverse Event|31
142410|NCT00731549|510604|P1|Overall Study|Protocol deviation|1
142411|NCT00731549|510604|P1|Overall Study|Withdrawal by Subject|89
142412|NCT00731549|510604|P1|Overall Study|Physician Decision|16
142413|NCT00731549|510604|P1|Overall Study|Met withdrawal criteria|24
142414|NCT00731549|510604|P1|Overall Study|Lost to Follow-up|19
142415|NCT00731133|510644|P1|Overall Study|Withdrawal by Subject|10
142416|NCT00731120|510652|P3|Overall Study|Other|1
142417|NCT00731120|510653|P2|Overall Study|Other|0
142418|NCT00731120|510654|P1|Overall Study|Other|4
142419|NCT00731120|510652|P3|Overall Study|Lost to Follow-up|17
142420|NCT00731120|510653|P2|Overall Study|Lost to Follow-up|15
142421|NCT00731120|510654|P1|Overall Study|Lost to Follow-up|10
142422|NCT00731120|510652|P3|Overall Study|Withdrawal of Consent|4
142423|NCT00731120|510653|P2|Overall Study|Withdrawal of Consent|8
142424|NCT00731120|510654|P1|Overall Study|Withdrawal of Consent|13
142425|NCT00731120|510652|P3|Overall Study|Protocol Deviations|1
142426|NCT00731120|510653|P2|Overall Study|Protocol Deviations|6
142427|NCT00731120|510654|P1|Overall Study|Protocol Deviations|1
142428|NCT00731120|510652|P3|Overall Study|Noncompliance with Study Drug|1
142429|NCT00731120|510653|P2|Overall Study|Noncompliance with Study Drug|3
142430|NCT00731120|510654|P1|Overall Study|Noncompliance with Study Drug|3
142431|NCT00731120|510652|P3|Overall Study|Lack of Efficacy|4
142432|NCT00731120|510653|P2|Overall Study|Lack of Efficacy|5
142433|NCT00731120|510654|P1|Overall Study|Lack of Efficacy|4
142434|NCT00731120|510652|P3|Overall Study|Adverse Event|8
142435|NCT00731120|510653|P2|Overall Study|Adverse Event|6
142436|NCT00731120|510654|P1|Overall Study|Adverse Event|7
142437|NCT00731042|510771|P2|Second Intervention|Did not meet inclusion criteria|2
142438|NCT00731042|510772|P1|Second Intervention|Did not meet inclusion criteria|0
142439|NCT00730925|510783|P1|Overall Study|Other|1
142440|NCT00730925|510783|P1|Overall Study|Switch to combination therapy|8
142441|NCT00730925|510783|P1|Overall Study|Withdrawal by Subject|1
142442|NCT00730925|510783|P1|Overall Study|Protocol Violation|1
142443|NCT00730925|510783|P1|Overall Study|Other Averse Event|7
142444|NCT00730925|510783|P1|Overall Study|Dose reducing Event|2
142445|NCT00730925|510783|P1|Overall Study|Progressive Disease|21
142446|NCT00730912|510793|P3|Overall Study|Discontinued|1
142447|NCT00730912|510794|P2|Overall Study|Discontinued|0
142448|NCT00730912|510795|P1|Overall Study|Discontinued|0
142449|NCT00730847|510806|P1|Overall Study|Other|24
142450|NCT00730847|510806|P1|Overall Study|Unknown completion status|21
142451|NCT00730847|510806|P1|Overall Study|Lost to Follow-up|67
142452|NCT00730847|510806|P1|Overall Study|Withdrawal by Subject|16
142453|NCT00730847|510806|P1|Overall Study|Protocol Violation|2
142454|NCT00730847|510806|P1|Overall Study|Adverse Event|1
142455|NCT00730756|510815|P2|Overall Study|Withdrew Consent|1
142456|NCT00730756|510816|P1|Overall Study|Withdrew Consent|0
142457|NCT00730756|510815|P2|Overall Study|Lost to Follow-up|1
142458|NCT00730756|510816|P1|Overall Study|Lost to Follow-up|0
142459|NCT00730756|510815|P2|Overall Study|Protocol Deviation|2
142460|NCT00730756|510816|P1|Overall Study|Protocol Deviation|1
142461|NCT00730756|510815|P2|Overall Study|Lack of Efficacy|1
142462|NCT00730756|510816|P1|Overall Study|Lack of Efficacy|1
142463|NCT00730756|510815|P2|Overall Study|Adverse Event|0
142464|NCT00730756|510816|P1|Overall Study|Adverse Event|2
142465|NCT00730691|510850|P5|Overall Study|Other|2
142466|NCT00730691|510851|P4|Overall Study|Other|2
142467|NCT00730691|510852|P3|Overall Study|Other|1
142468|NCT00730691|510853|P2|Overall Study|Other|1
142469|NCT00730691|510854|P1|Overall Study|Other|1
142470|NCT00730691|510850|P5|Overall Study|Lost to Follow-up|13
142471|NCT00730691|510851|P4|Overall Study|Lost to Follow-up|15
142472|NCT00730691|510852|P3|Overall Study|Lost to Follow-up|13
142473|NCT00730691|510853|P2|Overall Study|Lost to Follow-up|8
142474|NCT00730691|510854|P1|Overall Study|Lost to Follow-up|11
142475|NCT00730691|510850|P5|Overall Study|Withdrawal of Consent|3
142476|NCT00730691|510851|P4|Overall Study|Withdrawal of Consent|6
142477|NCT00730691|510852|P3|Overall Study|Withdrawal of Consent|3
142478|NCT00730691|510853|P2|Overall Study|Withdrawal of Consent|9
142479|NCT00730691|510854|P1|Overall Study|Withdrawal of Consent|7
142480|NCT00730691|510850|P5|Overall Study|Protocol Deviations|5
142481|NCT00730691|510851|P4|Overall Study|Protocol Deviations|7
142482|NCT00730691|510852|P3|Overall Study|Protocol Deviations|3
142483|NCT00730691|510853|P2|Overall Study|Protocol Deviations|5
142484|NCT00730691|510854|P1|Overall Study|Protocol Deviations|3
142485|NCT00730691|510850|P5|Overall Study|Non-compliance with Study Drug|3
142486|NCT00730691|510851|P4|Overall Study|Non-compliance with Study Drug|3
142487|NCT00730691|510852|P3|Overall Study|Non-compliance with Study Drug|6
142488|NCT00730691|510853|P2|Overall Study|Non-compliance with Study Drug|1
142489|NCT00730691|510854|P1|Overall Study|Non-compliance with Study Drug|6
142490|NCT00730691|510850|P5|Overall Study|Lack of Efficacy|1
142491|NCT00730691|510851|P4|Overall Study|Lack of Efficacy|1
142492|NCT00730691|510852|P3|Overall Study|Lack of Efficacy|2
142493|NCT00730691|510853|P2|Overall Study|Lack of Efficacy|4
142494|NCT00730691|510854|P1|Overall Study|Lack of Efficacy|4
142495|NCT00730691|510850|P5|Overall Study|Adverse Event|23
142496|NCT00730691|510851|P4|Overall Study|Adverse Event|11
142497|NCT00730691|510852|P3|Overall Study|Adverse Event|11
142498|NCT00730691|510853|P2|Overall Study|Adverse Event|8
142499|NCT00730691|510854|P1|Overall Study|Adverse Event|4
142500|NCT00730639|510946|P5|Overall Study|Treatment on-going|4
142501|NCT00730639|510947|P4|Overall Study|Treatment on-going|4
142502|NCT00730639|510948|P3|Overall Study|Treatment on-going|5
142503|NCT00730639|510949|P2|Overall Study|Treatment on-going|5
142504|NCT00730639|510950|P1|Overall Study|Treatment on-going|2
142505|NCT00730639|510946|P5|Overall Study|Withdrawal by Subject|4
142506|NCT00730639|510947|P4|Overall Study|Withdrawal by Subject|3
142507|NCT00730639|510948|P3|Overall Study|Withdrawal by Subject|6
142508|NCT00730639|510949|P2|Overall Study|Withdrawal by Subject|0
142509|NCT00730639|510950|P1|Overall Study|Withdrawal by Subject|0
142510|NCT00730639|510946|P5|Overall Study|Protocol Violation|0
142511|NCT00730639|510947|P4|Overall Study|Protocol Violation|0
142512|NCT00730639|510948|P3|Overall Study|Protocol Violation|1
142513|NCT00730639|510949|P2|Overall Study|Protocol Violation|0
142514|NCT00730639|510950|P1|Overall Study|Protocol Violation|0
142515|NCT00730639|510946|P5|Overall Study|non-specified|3
142516|NCT00730639|510947|P4|Overall Study|non-specified|2
142517|NCT00730639|510948|P3|Overall Study|non-specified|4
142518|NCT00730639|510949|P2|Overall Study|non-specified|0
142519|NCT00730639|510950|P1|Overall Study|non-specified|0
142520|NCT00730639|510946|P5|Overall Study|Disease Progression|88
142521|NCT00730639|510947|P4|Overall Study|Disease Progression|32
142522|NCT00730639|510948|P3|Overall Study|Disease Progression|48
142523|NCT00730639|510949|P2|Overall Study|Disease Progression|13
142524|NCT00730639|510950|P1|Overall Study|Disease Progression|12
142525|NCT00730639|510946|P5|Overall Study|Death|2
142526|NCT00730639|510947|P4|Overall Study|Death|0
142527|NCT00730639|510948|P3|Overall Study|Death|0
142528|NCT00730639|510949|P2|Overall Study|Death|0
142529|NCT00730639|510950|P1|Overall Study|Death|0
142530|NCT00730639|510946|P5|Overall Study|Completed Maximum Cycles|6
142531|NCT00730639|510947|P4|Overall Study|Completed Maximum Cycles|3
142532|NCT00730639|510948|P3|Overall Study|Completed Maximum Cycles|11
142533|NCT00730639|510949|P2|Overall Study|Completed Maximum Cycles|0
142534|NCT00730639|510950|P1|Overall Study|Completed Maximum Cycles|0
142535|NCT00730639|510946|P5|Overall Study|Complete Response|1
142536|NCT00730639|510947|P4|Overall Study|Complete Response|2
142537|NCT00730639|510948|P3|Overall Study|Complete Response|2
142538|NCT00730639|510949|P2|Overall Study|Complete Response|0
142539|NCT00730639|510950|P1|Overall Study|Complete Response|0
142540|NCT00730639|510946|P5|Overall Study|Adverse Event|23
142541|NCT00730639|510947|P4|Overall Study|Adverse Event|8
142542|NCT00730639|510948|P3|Overall Study|Adverse Event|9
142543|NCT00730639|510949|P2|Overall Study|Adverse Event|0
142544|NCT00730639|510950|P1|Overall Study|Adverse Event|3
142545|NCT00730405|511027|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
142546|NCT00730405|511028|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
142547|NCT00730405|511029|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
142548|NCT00730405|511030|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
142549|NCT00730405|511031|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
142550|NCT00730405|511027|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
142551|NCT00730405|511028|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
142552|NCT00730405|511029|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
142553|NCT00730405|511030|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
142554|NCT00730405|511031|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
142555|NCT00730405|511027|P5|Overall Study-follow-up Phase|Other Protocol violation|0
142556|NCT00730405|511028|P4|Overall Study-follow-up Phase|Other Protocol violation|0
142557|NCT00730405|511029|P3|Overall Study-follow-up Phase|Other Protocol violation|1
142558|NCT00730405|511030|P2|Overall Study-follow-up Phase|Other Protocol violation|0
142559|NCT00730405|511031|P1|Overall Study-follow-up Phase|Other Protocol violation|0
142560|NCT00730405|511027|P5|Overall Study-follow-up Phase|Mis-randomized|0
142561|NCT00730405|511028|P4|Overall Study-follow-up Phase|Mis-randomized|0
142562|NCT00730405|511029|P3|Overall Study-follow-up Phase|Mis-randomized|0
142563|NCT00730405|511030|P2|Overall Study-follow-up Phase|Mis-randomized|1
142564|NCT00730405|511031|P1|Overall Study-follow-up Phase|Mis-randomized|0
142565|NCT00730405|511027|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
142566|NCT00730405|511028|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
142567|NCT00730405|511029|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
142568|NCT00730405|511030|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
142569|NCT00730405|511031|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
142570|NCT00730405|511027|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
142571|NCT00730405|511028|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
142572|NCT00730405|511029|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
142573|NCT00730405|511030|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
142574|NCT00730405|511031|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
142575|NCT00730405|511027|P5|Overall Study-follow-up Phase|Missing|0
142576|NCT00730405|511028|P4|Overall Study-follow-up Phase|Missing|0
142577|NCT00730405|511029|P3|Overall Study-follow-up Phase|Missing|2
142578|NCT00730405|511030|P2|Overall Study-follow-up Phase|Missing|0
142579|NCT00730405|511031|P1|Overall Study-follow-up Phase|Missing|0
142580|NCT00730405|511027|P5|Overall Study-follow-up Phase|Non-compliance|0
142581|NCT00730405|511028|P4|Overall Study-follow-up Phase|Non-compliance|0
142582|NCT00730405|511029|P3|Overall Study-follow-up Phase|Non-compliance|2
142583|NCT00730405|511030|P2|Overall Study-follow-up Phase|Non-compliance|0
142584|NCT00730405|511031|P1|Overall Study-follow-up Phase|Non-compliance|1
142585|NCT00730405|511027|P5|Overall Study-follow-up Phase|Use of restricted medication|0
142586|NCT00730405|511028|P4|Overall Study-follow-up Phase|Use of restricted medication|0
142587|NCT00730405|511029|P3|Overall Study-follow-up Phase|Use of restricted medication|0
142588|NCT00730405|511030|P2|Overall Study-follow-up Phase|Use of restricted medication|1
142589|NCT00730405|511031|P1|Overall Study-follow-up Phase|Use of restricted medication|0
142590|NCT00730405|511027|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
142591|NCT00730405|511028|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
142592|NCT00730405|511029|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
142593|NCT00730405|511030|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
142594|NCT00730405|511031|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
142595|NCT00730405|511027|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
142596|NCT00730405|511028|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
142597|NCT00730405|511029|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
142598|NCT00730405|511030|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
142599|NCT00730405|511031|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
142600|NCT00730405|511027|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
142601|NCT00730405|511028|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
142602|NCT00730405|511029|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
142603|NCT00730405|511030|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
142604|NCT00730405|511031|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
142605|NCT00730405|511027|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
142606|NCT00730405|511028|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
142607|NCT00730405|511029|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
142608|NCT00730405|511030|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
142609|NCT00730405|511031|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
142610|NCT00730405|511027|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
142611|NCT00730405|511028|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
142612|NCT00730405|511029|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
142613|NCT00730405|511030|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
142614|NCT00730405|511031|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
142615|NCT00730405|511027|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
142616|NCT00730405|511028|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
142617|NCT00730405|511029|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
142618|NCT00730405|511030|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
142619|NCT00730405|511031|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
142620|NCT00730405|511027|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
142621|NCT00730405|511028|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
142622|NCT00730405|511029|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
142623|NCT00730405|511030|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
142624|NCT00730405|511031|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
142625|NCT00730405|511027|P5|Overall Study-follow-up Phase|Did not met eligibility|0
142626|NCT00730405|511028|P4|Overall Study-follow-up Phase|Did not met eligibility|0
142627|NCT00730405|511029|P3|Overall Study-follow-up Phase|Did not met eligibility|1
142628|NCT00730405|511030|P2|Overall Study-follow-up Phase|Did not met eligibility|0
142629|NCT00730405|511031|P1|Overall Study-follow-up Phase|Did not met eligibility|0
142630|NCT00730405|511027|P5|Overall Study-follow-up Phase|Change of location|0
142631|NCT00730405|511028|P4|Overall Study-follow-up Phase|Change of location|1
142632|NCT00730405|511029|P3|Overall Study-follow-up Phase|Change of location|0
142633|NCT00730405|511030|P2|Overall Study-follow-up Phase|Change of location|1
142634|NCT00730405|511031|P1|Overall Study-follow-up Phase|Change of location|1
142635|NCT00730405|511027|P5|Overall Study-follow-up Phase|Death|0
142636|NCT00730405|511028|P4|Overall Study-follow-up Phase|Death|1
142637|NCT00730405|511029|P3|Overall Study-follow-up Phase|Death|0
142638|NCT00730405|511030|P2|Overall Study-follow-up Phase|Death|1
142639|NCT00730405|511031|P1|Overall Study-follow-up Phase|Death|0
142640|NCT00730405|511027|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
142641|NCT00730405|511028|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
142642|NCT00730405|511029|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
142643|NCT00730405|511030|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
142644|NCT00730405|511031|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
142645|NCT00730405|511027|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
142646|NCT00730405|511028|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
142647|NCT00730405|511029|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
142648|NCT00730405|511030|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
142649|NCT00730405|511031|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
142650|NCT00730405|511027|P5|Overall Study-follow-up Phase|Adverse Event|4
142651|NCT00730405|511028|P4|Overall Study-follow-up Phase|Adverse Event|3
142652|NCT00730405|511029|P3|Overall Study-follow-up Phase|Adverse Event|2
142653|NCT00730405|511030|P2|Overall Study-follow-up Phase|Adverse Event|6
142654|NCT00730405|511031|P1|Overall Study-follow-up Phase|Adverse Event|2
142655|NCT00730405|511027|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
142656|NCT00730405|511028|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
142657|NCT00730405|511029|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
142658|NCT00730405|511030|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
142659|NCT00730405|511031|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
142660|NCT00730405|511027|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
142661|NCT00730405|511028|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
142662|NCT00730405|511029|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
142663|NCT00730405|511030|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
142664|NCT00730405|511031|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
142665|NCT00730405|511027|P5|Overall Study-Treatment Phase|Pregnancy|0
142666|NCT00730405|511028|P4|Overall Study-Treatment Phase|Pregnancy|0
142667|NCT00730405|511029|P3|Overall Study-Treatment Phase|Pregnancy|0
142668|NCT00730405|511030|P2|Overall Study-Treatment Phase|Pregnancy|1
142669|NCT00730405|511031|P1|Overall Study-Treatment Phase|Pregnancy|0
142670|NCT00730405|511027|P5|Overall Study-Treatment Phase|Change of location|0
142671|NCT00730405|511028|P4|Overall Study-Treatment Phase|Change of location|1
142672|NCT00730405|511029|P3|Overall Study-Treatment Phase|Change of location|0
142673|NCT00730405|511030|P2|Overall Study-Treatment Phase|Change of location|0
142674|NCT00730405|511031|P1|Overall Study-Treatment Phase|Change of location|0
142675|NCT00730405|511027|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
142676|NCT00730405|511028|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
142677|NCT00730405|511029|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
142678|NCT00730405|511030|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
142679|NCT00730405|511031|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
142680|NCT00730405|511027|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
142681|NCT00730405|511028|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
142682|NCT00730405|511029|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
142683|NCT00730405|511030|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
142684|NCT00730405|511031|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
142685|NCT00730405|511027|P5|Overall Study-Treatment Phase|Study drug interrupted|0
142686|NCT00730405|511028|P4|Overall Study-Treatment Phase|Study drug interrupted|0
142687|NCT00730405|511029|P3|Overall Study-Treatment Phase|Study drug interrupted|0
142688|NCT00730405|511030|P2|Overall Study-Treatment Phase|Study drug interrupted|1
142689|NCT00730405|511031|P1|Overall Study-Treatment Phase|Study drug interrupted|0
142690|NCT00730405|511027|P5|Overall Study-Treatment Phase|Misrandomized|0
142691|NCT00730405|511028|P4|Overall Study-Treatment Phase|Misrandomized|0
142692|NCT00730405|511029|P3|Overall Study-Treatment Phase|Misrandomized|0
142693|NCT00730405|511030|P2|Overall Study-Treatment Phase|Misrandomized|1
142694|NCT00730405|511031|P1|Overall Study-Treatment Phase|Misrandomized|0
142695|NCT00730405|511027|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
142696|NCT00730405|511028|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
142697|NCT00730405|511029|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
142698|NCT00730405|511030|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
142699|NCT00730405|511031|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
142700|NCT00730405|511027|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
142701|NCT00730405|511028|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
142702|NCT00730405|511029|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
142703|NCT00730405|511030|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
142704|NCT00730405|511031|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
142705|NCT00730405|511027|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
142706|NCT00730405|511028|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
142707|NCT00730405|511029|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
142708|NCT00730405|511030|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
142709|NCT00730405|511031|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
142710|NCT00730405|511027|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
142711|NCT00730405|511028|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
142712|NCT00730405|511029|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
142713|NCT00730405|511030|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
142714|NCT00730405|511031|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
142715|NCT00730405|511027|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
142716|NCT00730405|511028|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
142717|NCT00730405|511029|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
142718|NCT00730405|511030|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
142719|NCT00730405|511031|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
142720|NCT00730405|511027|P5|Overall Study-Treatment Phase|Did not met eligibility|0
142721|NCT00730405|511028|P4|Overall Study-Treatment Phase|Did not met eligibility|0
142722|NCT00730405|511029|P3|Overall Study-Treatment Phase|Did not met eligibility|1
142723|NCT00730405|511030|P2|Overall Study-Treatment Phase|Did not met eligibility|0
142724|NCT00730405|511031|P1|Overall Study-Treatment Phase|Did not met eligibility|0
142725|NCT00730405|511027|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
142726|NCT00730405|511028|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
142727|NCT00730405|511029|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
142728|NCT00730405|511030|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
142729|NCT00730405|511031|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
142730|NCT00730405|511027|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
142731|NCT00730405|511028|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
142732|NCT00730405|511029|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
142733|NCT00730405|511030|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
142734|NCT00730405|511031|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
142735|NCT00730405|511027|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
142736|NCT00730405|511028|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
142737|NCT00730405|511029|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
142738|NCT00730405|511030|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
142739|NCT00730405|511031|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
142740|NCT00730405|511027|P5|Overall Study-Treatment Phase|Adverse Event|4
142741|NCT00730405|511028|P4|Overall Study-Treatment Phase|Adverse Event|8
142742|NCT00730405|511029|P3|Overall Study-Treatment Phase|Adverse Event|4
142743|NCT00730405|511030|P2|Overall Study-Treatment Phase|Adverse Event|10
142744|NCT00730405|511031|P1|Overall Study-Treatment Phase|Adverse Event|5
142745|NCT00730327|511078|P2|Overall Study|Subject withdrew (reason not specified)|7
142746|NCT00730327|511079|P1|Overall Study|Subject withdrew (reason not specified)|2
142747|NCT00730327|511078|P2|Overall Study|Withdrawal by Subject|13
142748|NCT00730327|511079|P1|Overall Study|Withdrawal by Subject|3
142749|NCT00730327|511078|P2|Overall Study|Adverse Event|1
142750|NCT00730327|511079|P1|Overall Study|Adverse Event|8
142751|NCT00730327|511078|P2|Overall Study|Lost to Follow-up|16
142752|NCT00730327|511079|P1|Overall Study|Lost to Follow-up|14
142753|NCT00730275|511104|P4|Overall Study|Withdrawal by Subject|1
142754|NCT00730275|511105|P3|Overall Study|Withdrawal by Subject|0
142755|NCT00730275|511106|P2|Overall Study|Withdrawal by Subject|0
142756|NCT00730275|511107|P1|Overall Study|Withdrawal by Subject|0
142757|NCT00730236|511133|P1|Overall Study|Non-compliance|1
142758|NCT00730236|511133|P1|Overall Study|Withdrawal by Subject|1
142759|NCT00730236|511133|P1|Overall Study|Adverse Event|4
142760|NCT00730171|511148|P1|Overall Study|Not Specified|61
142761|NCT00730171|511148|P1|Overall Study|Insufficient Therapeutic Response|141
142762|NCT00730171|511148|P1|Overall Study|Lost to Follow-up|121
142763|NCT00730171|511148|P1|Overall Study|Withdrawal by Subject|202
142764|NCT00730171|511148|P1|Overall Study|Protocol Violation|48
142765|NCT00730171|511148|P1|Overall Study|Adverse Event|193
142766|NCT00730171|511148|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
142767|NCT00730132|511156|P1|Overall Study|Death|1
142768|NCT00730132|511156|P1|Overall Study|Protocol Violation|154
142769|NCT00730041|511174|P2|Overall Study|Lost to Follow-up|2
142770|NCT00730041|511175|P1|Overall Study|Lost to Follow-up|0
142771|NCT00730028|511198|P5|Overall Study|Randomization Error|2
142772|NCT00730028|511199|P4|Overall Study|Randomization Error|0
142773|NCT00730028|511200|P3|Overall Study|Randomization Error|0
142774|NCT00730028|511201|P2|Overall Study|Randomization Error|0
142775|NCT00730028|511202|P1|Overall Study|Randomization Error|1
142776|NCT00730028|511198|P5|Overall Study|Treatment Failure|1
142777|NCT00730028|511199|P4|Overall Study|Treatment Failure|0
142778|NCT00730028|511200|P3|Overall Study|Treatment Failure|0
142779|NCT00730028|511201|P2|Overall Study|Treatment Failure|5
142780|NCT00730028|511202|P1|Overall Study|Treatment Failure|5
142781|NCT00730028|511198|P5|Overall Study|Physician Decision|2
142782|NCT00730028|511199|P4|Overall Study|Physician Decision|3
142783|NCT00730028|511200|P3|Overall Study|Physician Decision|2
142784|NCT00730028|511201|P2|Overall Study|Physician Decision|3
142785|NCT00730028|511202|P1|Overall Study|Physician Decision|3
142786|NCT00730028|511198|P5|Overall Study|Withdrawal by Subject|9
142787|NCT00730028|511199|P4|Overall Study|Withdrawal by Subject|5
142788|NCT00730028|511200|P3|Overall Study|Withdrawal by Subject|4
142789|NCT00730028|511201|P2|Overall Study|Withdrawal by Subject|5
142790|NCT00730028|511202|P1|Overall Study|Withdrawal by Subject|9
142791|NCT00730028|511198|P5|Overall Study|Protocol Violation|0
142792|NCT00730028|511199|P4|Overall Study|Protocol Violation|2
142793|NCT00730028|511200|P3|Overall Study|Protocol Violation|1
142794|NCT00730028|511201|P2|Overall Study|Protocol Violation|1
142795|NCT00730028|511202|P1|Overall Study|Protocol Violation|6
142796|NCT00730028|511198|P5|Overall Study|Lost to Follow-up|25
142797|NCT00730028|511199|P4|Overall Study|Lost to Follow-up|26
142798|NCT00730028|511200|P3|Overall Study|Lost to Follow-up|22
142799|NCT00730028|511201|P2|Overall Study|Lost to Follow-up|26
142800|NCT00730028|511202|P1|Overall Study|Lost to Follow-up|13
142801|NCT00730028|511198|P5|Overall Study|Adverse Event|43
142802|NCT00730028|511199|P4|Overall Study|Adverse Event|20
142803|NCT00730028|511200|P3|Overall Study|Adverse Event|16
142804|NCT00730028|511201|P2|Overall Study|Adverse Event|26
142805|NCT00730028|511202|P1|Overall Study|Adverse Event|23
142806|NCT00730015|511252|P3|Overall Study|Other Reason|1
142807|NCT00730015|511253|P2|Overall Study|Other Reason|0
142808|NCT00730015|511254|P1|Overall Study|Other Reason|1
142809|NCT00730015|511252|P3|Overall Study|Lack of Efficacy|8
142810|NCT00730015|511253|P2|Overall Study|Lack of Efficacy|2
142811|NCT00730015|511254|P1|Overall Study|Lack of Efficacy|1
142812|NCT00730015|511252|P3|Overall Study|Lost to Follow-up|3
142813|NCT00730015|511253|P2|Overall Study|Lost to Follow-up|10
142814|NCT00730015|511254|P1|Overall Study|Lost to Follow-up|4
142815|NCT00730015|511252|P3|Overall Study|Withdrawal by Subject|8
142816|NCT00730015|511253|P2|Overall Study|Withdrawal by Subject|12
142817|NCT00730015|511254|P1|Overall Study|Withdrawal by Subject|12
142818|NCT00730015|511252|P3|Overall Study|Protocol Violation|4
142819|NCT00730015|511253|P2|Overall Study|Protocol Violation|6
142820|NCT00730015|511254|P1|Overall Study|Protocol Violation|2
142821|NCT00730015|511252|P3|Overall Study|Adverse Event|8
142822|NCT00730015|511253|P2|Overall Study|Adverse Event|10
142823|NCT00730015|511254|P1|Overall Study|Adverse Event|11
142824|NCT00729937|511294|P6|Overall Study|Incarcerated|0
142825|NCT00729937|511295|P5|Overall Study|Incarcerated|0
142826|NCT00729937|511296|P4|Overall Study|Incarcerated|1
142827|NCT00729937|511297|P3|Overall Study|Incarcerated|1
142828|NCT00729937|511298|P2|Overall Study|Incarcerated|2
142829|NCT00729937|511299|P1|Overall Study|Incarcerated|0
142830|NCT00729937|511294|P6|Overall Study|Did not meet eligibility criteria|0
142831|NCT00729937|511295|P5|Overall Study|Did not meet eligibility criteria|0
142832|NCT00729937|511296|P4|Overall Study|Did not meet eligibility criteria|0
142833|NCT00729937|511297|P3|Overall Study|Did not meet eligibility criteria|0
142834|NCT00729937|511298|P2|Overall Study|Did not meet eligibility criteria|1
142835|NCT00729937|511299|P1|Overall Study|Did not meet eligibility criteria|2
142836|NCT00729937|511294|P6|Overall Study|Randomized but not treated|3
142837|NCT00729937|511295|P5|Overall Study|Randomized but not treated|1
142838|NCT00729937|511296|P4|Overall Study|Randomized but not treated|0
142839|NCT00729937|511297|P3|Overall Study|Randomized but not treated|1
142840|NCT00729937|511298|P2|Overall Study|Randomized but not treated|6
142841|NCT00729937|511299|P1|Overall Study|Randomized but not treated|12
142842|NCT00729937|511294|P6|Overall Study|Withdrawal by Subject|2
142843|NCT00729937|511295|P5|Overall Study|Withdrawal by Subject|4
142844|NCT00729937|511296|P4|Overall Study|Withdrawal by Subject|0
142845|NCT00729937|511297|P3|Overall Study|Withdrawal by Subject|6
142846|NCT00729937|511298|P2|Overall Study|Withdrawal by Subject|5
142847|NCT00729937|511299|P1|Overall Study|Withdrawal by Subject|3
142848|NCT00729937|511294|P6|Overall Study|Death|1
142849|NCT00729937|511295|P5|Overall Study|Death|0
142850|NCT00729937|511296|P4|Overall Study|Death|0
142851|NCT00729937|511297|P3|Overall Study|Death|1
142852|NCT00729937|511298|P2|Overall Study|Death|0
142853|NCT00729937|511299|P1|Overall Study|Death|1
142854|NCT00729937|511294|P6|Overall Study|Physician Decision|8
142855|NCT00729937|511295|P5|Overall Study|Physician Decision|5
142856|NCT00729937|511296|P4|Overall Study|Physician Decision|0
142857|NCT00729937|511297|P3|Overall Study|Physician Decision|2
142858|NCT00729937|511298|P2|Overall Study|Physician Decision|16
142859|NCT00729937|511299|P1|Overall Study|Physician Decision|7
142860|NCT00729937|511294|P6|Overall Study|Lost to Follow-up|23
142861|NCT00729937|511295|P5|Overall Study|Lost to Follow-up|18
142862|NCT00729937|511296|P4|Overall Study|Lost to Follow-up|33
142863|NCT00729937|511297|P3|Overall Study|Lost to Follow-up|18
142864|NCT00729937|511298|P2|Overall Study|Lost to Follow-up|58
142865|NCT00729937|511299|P1|Overall Study|Lost to Follow-up|49
142866|NCT00729859|511503|P3|Overall Study|Withdrawal by Subject|0
142867|NCT00729859|511504|P2|Overall Study|Withdrawal by Subject|1
142868|NCT00729859|511505|P1|Overall Study|Withdrawal by Subject|0
142869|NCT00729859|511503|P3|Overall Study|Adverse Event|0
142870|NCT00729859|511504|P2|Overall Study|Adverse Event|1
142871|NCT00729859|511505|P1|Overall Study|Adverse Event|0
142872|NCT00729833|511549|P4|Overall Study|Unspecified Reasons|1
142873|NCT00729833|511550|P3|Overall Study|Unspecified Reasons|5
142874|NCT00729833|511551|P2|Overall Study|Unspecified Reasons|5
142875|NCT00729833|511552|P1|Overall Study|Unspecified Reasons|11
142876|NCT00729833|511549|P4|Overall Study|Withdrawal by Subject|0
142877|NCT00729833|511550|P3|Overall Study|Withdrawal by Subject|3
142878|NCT00729833|511551|P2|Overall Study|Withdrawal by Subject|1
142879|NCT00729833|511552|P1|Overall Study|Withdrawal by Subject|3
142880|NCT00729833|511549|P4|Overall Study|Lost to Follow-up|0
142881|NCT00729833|511550|P3|Overall Study|Lost to Follow-up|0
142882|NCT00729833|511551|P2|Overall Study|Lost to Follow-up|0
142883|NCT00729833|511552|P1|Overall Study|Lost to Follow-up|1
142884|NCT00729833|511549|P4|Overall Study|Study Terminated by Sponsor|0
142885|NCT00729833|511550|P3|Overall Study|Study Terminated by Sponsor|1
142886|NCT00729833|511551|P2|Overall Study|Study Terminated by Sponsor|0
142887|NCT00729833|511552|P1|Overall Study|Study Terminated by Sponsor|0
142888|NCT00729833|511549|P4|Overall Study|Death|5
142889|NCT00729833|511550|P3|Overall Study|Death|3
142890|NCT00729833|511551|P2|Overall Study|Death|1
142891|NCT00729833|511552|P1|Overall Study|Death|5
142892|NCT00729690|511604|P3|Overall Study|IT Catheter Malfunction|2
142893|NCT00729690|511605|P2|Overall Study|IT Catheter Malfunction|2
142894|NCT00729690|511606|P1|Overall Study|IT Catheter Malfunction|0
142895|NCT00729651|511636|P2|Overall Study|Subject’s private reason|0
142896|NCT00729651|511637|P1|Overall Study|Subject’s private reason|2
142897|NCT00729651|511636|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
142898|NCT00729651|511637|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
142899|NCT00729651|511636|P2|Overall Study|Adverse Event|3
142900|NCT00729651|511637|P1|Overall Study|Adverse Event|7
142901|NCT00729651|511636|P2|Overall Study|Protocol Violation|1
142902|NCT00729651|511637|P1|Overall Study|Protocol Violation|0
142903|NCT00729651|511636|P2|Overall Study|Lost to Follow-up|4
142904|NCT00729651|511637|P1|Overall Study|Lost to Follow-up|5
142905|NCT00729651|511636|P2|Overall Study|Withdrawal by Subject|6
142906|NCT00729651|511637|P1|Overall Study|Withdrawal by Subject|5
142907|NCT00729612|511649|P1|Overall Study|Non evaluable for response|10
142908|NCT00729560|511656|P1|Overall Study|Withdrawal by Subject|3
142909|NCT00729469|511682|P2|Overall Study|Other-Not mentioned|4
142910|NCT00729469|511683|P1|Overall Study|Other-Not mentioned|9
142911|NCT00729469|511682|P2|Overall Study|Withdrawal by Subject|8
142912|NCT00729469|511683|P1|Overall Study|Withdrawal by Subject|19
142913|NCT00729469|511682|P2|Overall Study|Protocol Violation|1
142914|NCT00729469|511683|P1|Overall Study|Protocol Violation|2
142915|NCT00729469|511682|P2|Overall Study|Lost to Follow-up|9
142916|NCT00729469|511683|P1|Overall Study|Lost to Follow-up|9
142917|NCT00729469|511682|P2|Overall Study|Adverse Event|25
142918|NCT00729469|511683|P1|Overall Study|Adverse Event|14
142919|NCT00729378|511736|P2|36-months|Lost to Follow-up|6
142920|NCT00729378|511737|P1|36-months|Lost to Follow-up|15
142921|NCT00729378|511736|P2|24-months|Lost to Follow-up|51
142922|NCT00729378|511737|P1|24-months|Lost to Follow-up|72
142923|NCT00729378|511736|P2|12-months|Lost to Follow-up|65
142924|NCT00729378|511737|P1|12-months|Lost to Follow-up|100
142925|NCT00729378|511736|P2|Baseline|Withdrawal by Subject|59
142926|NCT00729378|511737|P1|Baseline|Withdrawal by Subject|66
142927|NCT00729378|511736|P2|Baseline|Did not complete study measurements|33
142928|NCT00729378|511737|P1|Baseline|Did not complete study measurements|72
142929|NCT00729365|511936|P3|Overall Study|Physician Decision|7
142930|NCT00729365|511937|P2|Overall Study|Physician Decision|6
142931|NCT00729365|511938|P1|Overall Study|Physician Decision|33
142932|NCT00729326|511951|P2|Overall Study|Sponsor Decision|2
142933|NCT00729326|511952|P1|Overall Study|Sponsor Decision|1
142934|NCT00729326|511951|P2|Overall Study|Subject Decision|4
142935|NCT00729326|511952|P1|Overall Study|Subject Decision|4
142936|NCT00729326|511951|P2|Overall Study|Protocol Violation|2
142937|NCT00729326|511952|P1|Overall Study|Protocol Violation|3
142938|NCT00729326|511951|P2|Overall Study|Physician Decision|1
142939|NCT00729326|511952|P1|Overall Study|Physician Decision|0
142940|NCT00729326|511951|P2|Overall Study|Lost to Follow-up|0
142941|NCT00729326|511952|P1|Overall Study|Lost to Follow-up|2
142942|NCT00729248|511994|P1|Overall Study|Physician Decision|2
142943|NCT00729183|512001|P2|Overall Study|Withdrawal by Subject|7
142944|NCT00729183|512002|P1|Overall Study|Withdrawal by Subject|9
142945|NCT00729183|512001|P2|Overall Study|Protocol Violation|0
142946|NCT00729183|512002|P1|Overall Study|Protocol Violation|1
142947|NCT00729183|512001|P2|Overall Study|Physician Decision|1
142948|NCT00729183|512002|P1|Overall Study|Physician Decision|1
142949|NCT00729183|512001|P2|Overall Study|Lost to Follow-up|1
142950|NCT00729183|512002|P1|Overall Study|Lost to Follow-up|3
142951|NCT00729183|512001|P2|Overall Study|Lack of Efficacy|1
142952|NCT00729183|512002|P1|Overall Study|Lack of Efficacy|0
142953|NCT00729183|512001|P2|Overall Study|Adverse Event|5
142954|NCT00729183|512002|P1|Overall Study|Adverse Event|11
142955|NCT00729157|512034|P1|Overall Study|Withdrawal by Subject|1
142956|NCT00728988|512044|P2|Overall Study|Withdrawal by Subject|6
142957|NCT00728988|512045|P1|Overall Study|Withdrawal by Subject|2
142958|NCT00728988|512044|P2|Overall Study|Other|77
142959|NCT00728988|512045|P1|Overall Study|Other|85
142960|NCT00728988|512044|P2|Overall Study|Adverse Event|2
142961|NCT00728988|512045|P1|Overall Study|Adverse Event|3
142962|NCT00728988|512044|P2|Overall Study|Death|1
142963|NCT00728988|512045|P1|Overall Study|Death|1
142964|NCT00728988|512044|P2|Overall Study|Not Treated|2
142965|NCT00728988|512045|P1|Overall Study|Not Treated|2
142966|NCT00728962|512063|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
142967|NCT00728962|512063|P1|Permanent Prosthesis Placement|Adverse Event|3
142968|NCT00728962|512063|P1|Implant Placement Surgery|Protocol Violation|1
142969|NCT00728962|512063|P1|Implant Placement Surgery|Lost to Follow-up|1
142970|NCT00728962|512063|P1|Implant Placement Surgery|Adverse Event|8
142971|NCT00728884|512084|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
142972|NCT00728884|512084|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
142973|NCT00728754|512120|P2|One Year Post Placement Follow-up|Adverse Event|0
142974|NCT00728754|512121|P1|One Year Post Placement Follow-up|Adverse Event|1
142975|NCT00728754|512120|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
142976|NCT00728754|512121|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
142977|NCT00728754|512120|P2|Permanent Prosthesis Placement|Adverse Event|1
142978|NCT00728754|512121|P1|Permanent Prosthesis Placement|Adverse Event|1
142979|NCT00728689|512150|P2|Washout Period (Days 4 - 10)|Death in family|0
142980|NCT00728689|512151|P1|Washout Period (Days 4 - 10)|Death in family|1
142981|NCT00728494|512180|P2|Overall Study|No data available|1
142982|NCT00728494|512181|P1|Overall Study|No data available|0
142983|NCT00728494|512180|P2|Overall Study|Lack of Efficacy|4
142984|NCT00728494|512181|P1|Overall Study|Lack of Efficacy|2
142985|NCT00728494|512180|P2|Overall Study|Withdrawal by Subject|2
142986|NCT00728494|512181|P1|Overall Study|Withdrawal by Subject|0
142987|NCT00728494|512180|P2|Overall Study|Adverse Event|0
142988|NCT00728494|512181|P1|Overall Study|Adverse Event|7
142989|NCT00728481|512199|P2|Overall Study|Incorrectly assigned to opposite arm|0
142990|NCT00728481|512200|P1|Overall Study|Incorrectly assigned to opposite arm|1
142991|NCT00728481|512199|P2|Overall Study|Study medication non-compliance|2
142992|NCT00728481|512200|P1|Overall Study|Study medication non-compliance|0
142993|NCT00728481|512199|P2|Overall Study|Adverse Event|1
142994|NCT00728481|512200|P1|Overall Study|Adverse Event|0
142995|NCT00728481|512199|P2|Overall Study|Withdrawal by Subject|1
142996|NCT00728481|512200|P1|Overall Study|Withdrawal by Subject|0
142997|NCT00728468|512216|P1|Overall Study|Study terminated by sponsor|1
142998|NCT00728468|512216|P1|Overall Study|Objective progression or relapse|9
142999|NCT00728468|512216|P1|Overall Study|Protocol Violation|4
143000|NCT00728468|512216|P1|Overall Study|Death|1
143001|NCT00728468|512216|P1|Overall Study|Enrolled but not treated|1
143002|NCT00728416|512240|P2|Overall Study|Withdrawal by Subject|0
143003|NCT00728416|512241|P1|Overall Study|Withdrawal by Subject|1
143004|NCT00728416|512240|P2|Overall Study|Treatment Failure|1
143005|NCT00728416|512241|P1|Overall Study|Treatment Failure|0
143006|NCT00728416|512240|P2|Overall Study|Adverse Event|1
143007|NCT00728416|512241|P1|Overall Study|Adverse Event|1
143008|NCT00728182|512257|P2|Overall Study|Protocol Noncompliance|1
143009|NCT00728182|512258|P1|Overall Study|Protocol Noncompliance|0
143010|NCT00728182|512257|P2|Overall Study|Death|2
143011|NCT00728182|512258|P1|Overall Study|Death|0
143012|NCT00728182|512257|P2|Overall Study|Lost to Follow-up|0
143013|NCT00728182|512258|P1|Overall Study|Lost to Follow-up|2
143014|NCT00728182|512257|P2|Overall Study|Adverse Event|0
143015|NCT00728182|512258|P1|Overall Study|Adverse Event|1
143016|NCT00728130|512286|P1|Overall Study|Physician Decision|1
143017|NCT00728130|512286|P1|Overall Study|Paperwork not completed in time|1
143018|NCT00728130|512286|P1|Overall Study|Withdrawal by Subject|1
143019|NCT00727961|512291|P1|Overall Study|Progression|30
143020|NCT00727961|512291|P1|Overall Study|Patient's refusal|2
143021|NCT00727961|512291|P1|Overall Study|Adverse Event|4
143022|NCT00727961|512291|P1|Overall Study|Lost to Follow-up|1
143023|NCT00727909|512301|P4|Overall Study|Death|0
143024|NCT00727909|512302|P3|Overall Study|Death|1
143025|NCT00727909|512303|P2|Overall Study|Death|0
143026|NCT00727909|512304|P1|Overall Study|Death|0
143027|NCT00727909|512301|P4|Overall Study|Withdrawal by Subject|5
143028|NCT00727909|512302|P3|Overall Study|Withdrawal by Subject|8
143029|NCT00727909|512303|P2|Overall Study|Withdrawal by Subject|11
143030|NCT00727909|512304|P1|Overall Study|Withdrawal by Subject|5
143031|NCT00727844|512401|P4|Initial Randomization|Physician Decision|0
143032|NCT00727844|512402|P3|Initial Randomization|Physician Decision|0
143033|NCT00727844|512403|P2|Initial Randomization|Physician Decision|0
143034|NCT00727844|512404|P1|Initial Randomization|Physician Decision|2
143035|NCT00727714|512418|P1|Overall Study|Lost to Follow-up|2
143036|NCT00727649|512428|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
143037|NCT00727649|512429|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
143038|NCT00727649|512428|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
143039|NCT00727649|512429|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
143040|NCT00727649|512428|P2|Second Intervention (4-weeks)|Death|0
143041|NCT00727649|512429|P1|Second Intervention (4-weeks)|Death|1
143042|NCT00727649|512428|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
143043|NCT00727649|512429|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
143044|NCT00727649|512428|P2|Wash-out (2-weeks)|Lost to Follow-up|1
143045|NCT00727649|512429|P1|Wash-out (2-weeks)|Lost to Follow-up|3
143046|NCT00727649|512428|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
143047|NCT00727649|512429|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
143048|NCT00727649|512428|P2|First Intervention (4-weeks)|Lost to Follow-up|2
143049|NCT00727649|512429|P1|First Intervention (4-weeks)|Lost to Follow-up|1
143050|NCT00727571|512471|P4|Overall Study|Other|0
143051|NCT00727571|512472|P3|Overall Study|Other|6
143052|NCT00727571|512473|P2|Overall Study|Other|4
143053|NCT00727571|512474|P1|Overall Study|Other|0
143054|NCT00727571|512471|P4|Overall Study|AE not leading to hospitalization|0
143055|NCT00727571|512472|P3|Overall Study|AE not leading to hospitalization|2
143056|NCT00727571|512473|P2|Overall Study|AE not leading to hospitalization|0
143057|NCT00727571|512474|P1|Overall Study|AE not leading to hospitalization|0
143058|NCT00727571|512471|P4|Overall Study|Hospitalization|1
143059|NCT00727571|512472|P3|Overall Study|Hospitalization|0
143060|NCT00727571|512473|P2|Overall Study|Hospitalization|1
143061|NCT00727571|512474|P1|Overall Study|Hospitalization|0
143062|NCT00727571|512471|P4|Overall Study|Dismissed from nursing home|0
143063|NCT00727571|512472|P3|Overall Study|Dismissed from nursing home|5
143064|NCT00727571|512473|P2|Overall Study|Dismissed from nursing home|9
143065|NCT00727571|512474|P1|Overall Study|Dismissed from nursing home|0
143066|NCT00727571|512471|P4|Overall Study|Subject Non Compliance|4
143067|NCT00727571|512472|P3|Overall Study|Subject Non Compliance|0
143068|NCT00727571|512473|P2|Overall Study|Subject Non Compliance|6
143069|NCT00727571|512474|P1|Overall Study|Subject Non Compliance|0
143070|NCT00727571|512471|P4|Overall Study|Withdrawal by Subject|0
143071|NCT00727571|512472|P3|Overall Study|Withdrawal by Subject|11
143072|NCT00727571|512473|P2|Overall Study|Withdrawal by Subject|10
143073|NCT00727571|512474|P1|Overall Study|Withdrawal by Subject|0
143074|NCT00727571|512471|P4|Overall Study|Physician Decision|0
143075|NCT00727571|512472|P3|Overall Study|Physician Decision|0
143076|NCT00727571|512473|P2|Overall Study|Physician Decision|5
143077|NCT00727571|512474|P1|Overall Study|Physician Decision|0
143078|NCT00727571|512471|P4|Overall Study|Death|1
143079|NCT00727571|512472|P3|Overall Study|Death|5
143080|NCT00727571|512473|P2|Overall Study|Death|19
143081|NCT00727571|512474|P1|Overall Study|Death|0
143082|NCT00727571|512471|P4|Overall Study|Ineligibility determined|0
143083|NCT00727571|512472|P3|Overall Study|Ineligibility determined|1
143084|NCT00727571|512473|P2|Overall Study|Ineligibility determined|1
143085|NCT00727571|512474|P1|Overall Study|Ineligibility determined|1
143086|NCT00727558|512501|P2|Overall Study|Lost to Follow-up|0
143087|NCT00727558|512502|P1|Overall Study|Lost to Follow-up|1
143088|NCT00727558|512501|P2|Overall Study|Subject unable to return for follow-up|1
143089|NCT00727558|512502|P1|Overall Study|Subject unable to return for follow-up|1
143090|NCT00727558|512501|P2|Overall Study|Adverse Event|1
143091|NCT00727558|512502|P1|Overall Study|Adverse Event|0
143092|NCT00727558|512501|P2|Overall Study|Lens issue|1
143093|NCT00727558|512502|P1|Overall Study|Lens issue|0
143094|NCT00727506|512526|P6|Overall Study|Other reason not described above|1
143095|NCT00727506|512527|P5|Overall Study|Other reason not described above|1
143096|NCT00727506|512528|P4|Overall Study|Other reason not described above|4
143097|NCT00727506|512529|P3|Overall Study|Other reason not described above|1
143098|NCT00727506|512530|P2|Overall Study|Other reason not described above|0
143099|NCT00727506|512531|P1|Overall Study|Other reason not described above|0
143100|NCT00727506|512526|P6|Overall Study|Refused to continue medication|2
143101|NCT00727506|512527|P5|Overall Study|Refused to continue medication|1
143102|NCT00727506|512528|P4|Overall Study|Refused to continue medication|3
143103|NCT00727506|512529|P3|Overall Study|Refused to continue medication|2
143104|NCT00727506|512530|P2|Overall Study|Refused to continue medication|1
143105|NCT00727506|512531|P1|Overall Study|Refused to continue medication|0
143106|NCT00727506|512526|P6|Overall Study|Progressive disease|28
143107|NCT00727506|512527|P5|Overall Study|Progressive disease|38
143108|NCT00727506|512528|P4|Overall Study|Progressive disease|28
143109|NCT00727506|512529|P3|Overall Study|Progressive disease|9
143110|NCT00727506|512530|P2|Overall Study|Progressive disease|7
143111|NCT00727506|512531|P1|Overall Study|Progressive disease|4
143112|NCT00727506|512526|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
143113|NCT00727506|512527|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
143114|NCT00727506|512528|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
143115|NCT00727506|512529|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
143116|NCT00727506|512530|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
143117|NCT00727506|512531|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
143118|NCT00727506|512526|P6|Overall Study|Adverse Event|8
143119|NCT00727506|512527|P5|Overall Study|Adverse Event|1
143120|NCT00727506|512528|P4|Overall Study|Adverse Event|4
143121|NCT00727506|512529|P3|Overall Study|Adverse Event|4
143122|NCT00727506|512530|P2|Overall Study|Adverse Event|0
143123|NCT00727506|512531|P1|Overall Study|Adverse Event|0
143124|NCT00727402|512624|P1|Overall Study|Physician Decision|116
143125|NCT00727311|512645|P1|Overall Study|Multiple reasons|39
143126|NCT00727311|512645|P1|Overall Study|not specified|97
143127|NCT00727311|512645|P1|Overall Study|Withdrawal by Subject|77
143128|NCT00727311|512645|P1|Overall Study|Lost to Follow-up|73
143129|NCT00727311|512645|P1|Overall Study|Lack of Efficacy|242
143130|NCT00727311|512645|P1|Overall Study|Adverse Event|58
143131|NCT00727311|512645|P1|Overall Study|Missing end of therapy data|205
143132|NCT00727311|512645|P1|Overall Study|Did not receive drug|316
143133|NCT00727272|512658|P3|Washout Period B|Withdrawal by Subject|1
143134|NCT00727272|512659|P2|Washout Period B|Withdrawal by Subject|0
143135|NCT00727272|512660|P1|Washout Period B|Withdrawal by Subject|0
143136|NCT00727272|512658|P3|Washout Period A|Adverse Event|1
143137|NCT00727272|512659|P2|Washout Period A|Adverse Event|0
143138|NCT00727272|512660|P1|Washout Period A|Adverse Event|0
143139|NCT00727259|512677|P1|Overall Study|Not all questionnaires completed|1055
143140|NCT00727246|512686|P4|Overall Study|withdrawn|0
143141|NCT00727246|512687|P3|Overall Study|withdrawn|1
143142|NCT00727246|512688|P2|Overall Study|withdrawn|0
143143|NCT00727246|512689|P1|Overall Study|withdrawn|0
143144|NCT00727246|512686|P4|Overall Study|incidental finding|1
143145|NCT00727246|512687|P3|Overall Study|incidental finding|0
143146|NCT00727246|512688|P2|Overall Study|incidental finding|0
143147|NCT00727246|512689|P1|Overall Study|incidental finding|0
143148|NCT00727246|512686|P4|Overall Study|could not complete MRI|1
143149|NCT00727246|512687|P3|Overall Study|could not complete MRI|0
143150|NCT00727246|512688|P2|Overall Study|could not complete MRI|1
143151|NCT00727246|512689|P1|Overall Study|could not complete MRI|0
143152|NCT00727194|512712|P3|Treatment Period 2|Lack of Efficacy|0
143153|NCT00727194|512713|P2|Treatment Period 2|Lack of Efficacy|1
143154|NCT00727194|512714|P1|Treatment Period 2|Lack of Efficacy|0
143155|NCT00727194|512712|P3|Screening Period|History of thymoma|1
143156|NCT00727194|512713|P2|Screening Period|History of thymoma|0
143157|NCT00727194|512714|P1|Screening Period|History of thymoma|0
143158|NCT00727194|512712|P3|Screening Period|Severe infections|2
143159|NCT00727194|512713|P2|Screening Period|Severe infections|0
143160|NCT00727194|512714|P1|Screening Period|Severe infections|0
143161|NCT00727194|512712|P3|Screening Period|Not stable on concomitant MG therapy|2
143162|NCT00727194|512713|P2|Screening Period|Not stable on concomitant MG therapy|0
143163|NCT00727194|512714|P1|Screening Period|Not stable on concomitant MG therapy|0
143164|NCT00727194|512712|P3|Screening Period|Lacked AChR antibodies|5
143165|NCT00727194|512713|P2|Screening Period|Lacked AChR antibodies|0
143166|NCT00727194|512714|P1|Screening Period|Lacked AChR antibodies|0
143167|NCT00727194|512712|P3|Screening Period|Low QMG scores|6
143168|NCT00727194|512713|P2|Screening Period|Low QMG scores|0
143169|NCT00727194|512714|P1|Screening Period|Low QMG scores|0
143170|NCT00727025|512786|P1|Overall Study|Physician Decision|23
143171|NCT00726999|512798|P2|Overall Study|Protocol Violation|0
143172|NCT00726999|512799|P1|Overall Study|Protocol Violation|1
143173|NCT00726999|512798|P2|Overall Study|Withdrawal by Subject|0
143174|NCT00726999|512799|P1|Overall Study|Withdrawal by Subject|2
143175|NCT00726999|512798|P2|Overall Study|Physician Decision|1
143176|NCT00726999|512799|P1|Overall Study|Physician Decision|0
143177|NCT00726986|512809|P1|Maintenance Phase|Lack of Efficacy|2
143178|NCT00726986|512809|P1|Maintenance Phase|Adverse Event|1
143179|NCT00726986|512809|P1|Induction Phase|Secondary Disease|2
143180|NCT00726986|512809|P1|Induction Phase|Lack of Efficacy|5
143181|NCT00726986|512809|P1|Induction Phase|Death|2
143182|NCT00726986|512809|P1|Induction Phase|Withdrawal by Subject|2
143183|NCT00726986|512809|P1|Induction Phase|Adverse Event|4
143184|NCT00726895|512816|P2|Washout Period of 7 Days|Withdrawal by Subject|1
143185|NCT00726895|512817|P1|Washout Period of 7 Days|Withdrawal by Subject|0
143186|NCT00726882|512830|P1|Overall Study|Not Specified|10
143187|NCT00726882|512830|P1|Overall Study|Lost to Follow-up|7
143188|NCT00726882|512830|P1|Overall Study|Withdrawal by Subject|5
143189|NCT00726752|512845|P1|Overall Study|Lack of Efficacy|6
143190|NCT00726661|512907|P2|Overall Study|Not specified|35
143191|NCT00726661|512908|P1|Overall Study|Not specified|47
143192|NCT00726661|512907|P2|Overall Study|Physician Decision|13
143193|NCT00726661|512908|P1|Overall Study|Physician Decision|25
143194|NCT00726661|512907|P2|Overall Study|Death|159
143195|NCT00726661|512908|P1|Overall Study|Death|475
143196|NCT00726661|512907|P2|Overall Study|Trial terminated by sponsor|187
143197|NCT00726661|512908|P1|Overall Study|Trial terminated by sponsor|214
143198|NCT00726661|512907|P2|Overall Study|Withdrawal by Subject|13
143199|NCT00726661|512908|P1|Overall Study|Withdrawal by Subject|17
143200|NCT00726661|512907|P2|Overall Study|Lost to Follow-up|11
143201|NCT00726661|512908|P1|Overall Study|Lost to Follow-up|36
143202|NCT00726622|512925|P2|Overall Study|Metastasis|0
143203|NCT00726622|512926|P1|Overall Study|Metastasis|2
143204|NCT00726622|512925|P2|Overall Study|Physician Decision|1
143205|NCT00726622|512926|P1|Overall Study|Physician Decision|0
143206|NCT00726622|512925|P2|Overall Study|Withdrawal by Subject|2
143207|NCT00726622|512926|P1|Overall Study|Withdrawal by Subject|16
143208|NCT00726609|512944|P1|Overall Study|Other|3
143209|NCT00726609|512944|P1|Overall Study|Missing|42
143210|NCT00726609|512944|P1|Overall Study|Not specified|16
143211|NCT00726609|512944|P1|Overall Study|Lack of Efficacy|25
143212|NCT00726609|512944|P1|Overall Study|Withdrawal by Subject|2
143213|NCT00726609|512944|P1|Overall Study|Adverse Event|10
143214|NCT00726557|512948|P1|Overall Study|Inclusion criteria not met|15
143215|NCT00726557|512948|P1|Overall Study|Treatment less than 3 months|17
143216|NCT00726557|512948|P1|Overall Study|No follow-up documentation available|55
143217|NCT00726557|512948|P1|Overall Study|No end of treatment documentation|37
143218|NCT00726557|512948|P1|Overall Study|Screening failure|4
143219|NCT00726453|512955|P2|38 mm Length Group|Death|3
143220|NCT00726453|512956|P1|38 mm Length Group|Death|0
143221|NCT00726453|512955|P2|Primary Enrollment Group|Withdrawal by Subject|0
143222|NCT00726453|512956|P1|Primary Enrollment Group|Withdrawal by Subject|13
143223|NCT00726453|512955|P2|Primary Enrollment Group|Death|0
143224|NCT00726453|512956|P1|Primary Enrollment Group|Death|18
143225|NCT00726323|512984|P2|Overall Study|Metastatic lesions inferred cyst|1
143226|NCT00726323|512985|P1|Overall Study|Metastatic lesions inferred cyst|0
143227|NCT00726323|512984|P2|Overall Study|Participant wished to discontinue|1
143228|NCT00726323|512985|P1|Overall Study|Participant wished to discontinue|0
143229|NCT00726323|512984|P2|Overall Study|Death|0
143230|NCT00726323|512985|P1|Overall Study|Death|1
143231|NCT00726323|512984|P2|Overall Study|Adverse Event|9
143232|NCT00726323|512985|P1|Overall Study|Adverse Event|9
143233|NCT00726323|512984|P2|Overall Study|Clinical progression|3
143234|NCT00726323|512985|P1|Overall Study|Clinical progression|0
143235|NCT00726323|512984|P2|Overall Study|Progressive disease|16
143236|NCT00726323|512985|P1|Overall Study|Progressive disease|23
143237|NCT00726323|512984|P2|Overall Study|Physician Decision|0
143238|NCT00726323|512985|P1|Overall Study|Physician Decision|1
143239|NCT00726323|512984|P2|Overall Study|Withdrawal by Subject|1
143240|NCT00726323|512985|P1|Overall Study|Withdrawal by Subject|3
143241|NCT00726232|513015|P6|Overall Study|No response|1
143242|NCT00726232|513016|P5|Overall Study|No response|3
143243|NCT00726232|513017|P4|Overall Study|No response|0
143244|NCT00726232|513018|P3|Overall Study|No response|0
143245|NCT00726232|513019|P2|Overall Study|No response|0
143246|NCT00726232|513020|P1|Overall Study|No response|1
143247|NCT00726232|513015|P6|Overall Study|Disease progression|0
143248|NCT00726232|513016|P5|Overall Study|Disease progression|0
143249|NCT00726232|513017|P4|Overall Study|Disease progression|0
143250|NCT00726232|513018|P3|Overall Study|Disease progression|0
143251|NCT00726232|513019|P2|Overall Study|Disease progression|0
143252|NCT00726232|513020|P1|Overall Study|Disease progression|1
143253|NCT00726232|513015|P6|Overall Study|Adverse Event|1
143254|NCT00726232|513016|P5|Overall Study|Adverse Event|2
143255|NCT00726232|513017|P4|Overall Study|Adverse Event|1
143256|NCT00726232|513018|P3|Overall Study|Adverse Event|0
143257|NCT00726232|513019|P2|Overall Study|Adverse Event|1
143258|NCT00726232|513020|P1|Overall Study|Adverse Event|1
143259|NCT00726232|513015|P6|Overall Study|Withdrawal by Subject|2
143260|NCT00726232|513016|P5|Overall Study|Withdrawal by Subject|0
143261|NCT00726232|513017|P4|Overall Study|Withdrawal by Subject|0
143262|NCT00726232|513018|P3|Overall Study|Withdrawal by Subject|0
143263|NCT00726232|513019|P2|Overall Study|Withdrawal by Subject|0
143264|NCT00726232|513020|P1|Overall Study|Withdrawal by Subject|2
143265|NCT00726063|513070|P2|Overall Study|Adverse Event|7
143266|NCT00726063|513071|P1|Overall Study|Adverse Event|9
143267|NCT00725985|513085|P12|LTFU (No Cladribine Treatment)|Other|14
143268|NCT00725985|513086|P11|LTFU (No Cladribine Treatment)|Other|36
143269|NCT00725985|513087|P10|LTFU (No Cladribine Treatment)|Other|34
143270|NCT00725985|513088|P9|LTFU (No Cladribine Treatment)|Other|0
143271|NCT00725985|513089|P8|LTFU (No Cladribine Treatment)|Other|0
143272|NCT00725985|513090|P7|LTFU (No Cladribine Treatment)|Other|0
143273|NCT00725985|513091|P6|LTFU (No Cladribine Treatment)|Other|0
143274|NCT00725985|513092|P5|LTFU (No Cladribine Treatment)|Other|0
143275|NCT00725985|513093|P4|LTFU (No Cladribine Treatment)|Other|0
143276|NCT00725985|513094|P3|LTFU (No Cladribine Treatment)|Other|0
143277|NCT00725985|513095|P2|LTFU (No Cladribine Treatment)|Other|0
143278|NCT00725985|513096|P1|LTFU (No Cladribine Treatment)|Other|0
143279|NCT00725985|513085|P12|LTFU (With Cladribine Treatment)|Other|0
143280|NCT00725985|513086|P11|LTFU (With Cladribine Treatment)|Other|0
143281|NCT00725985|513087|P10|LTFU (With Cladribine Treatment)|Other|0
143282|NCT00725985|513088|P9|LTFU (With Cladribine Treatment)|Other|16
143283|NCT00725985|513089|P8|LTFU (With Cladribine Treatment)|Other|8
143284|NCT00725985|513090|P7|LTFU (With Cladribine Treatment)|Other|9
143285|NCT00725985|513091|P6|LTFU (With Cladribine Treatment)|Other|0
143286|NCT00725985|513092|P5|LTFU (With Cladribine Treatment)|Other|0
143287|NCT00725985|513093|P4|LTFU (With Cladribine Treatment)|Other|0
143288|NCT00725985|513094|P3|LTFU (With Cladribine Treatment)|Other|0
143289|NCT00725985|513095|P2|LTFU (With Cladribine Treatment)|Other|0
143290|NCT00725985|513096|P1|LTFU (With Cladribine Treatment)|Other|0
143291|NCT00725985|513085|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143292|NCT00725985|513086|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143293|NCT00725985|513087|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143294|NCT00725985|513088|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
143295|NCT00725985|513089|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143296|NCT00725985|513090|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143297|NCT00725985|513091|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143298|NCT00725985|513092|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143299|NCT00725985|513093|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143300|NCT00725985|513094|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143301|NCT00725985|513095|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143302|NCT00725985|513096|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
143303|NCT00725985|513085|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
143304|NCT00725985|513086|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
143305|NCT00725985|513087|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
143306|NCT00725985|513088|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
143307|NCT00725985|513089|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
143308|NCT00725985|513090|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
143309|NCT00725985|513091|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
143310|NCT00725985|513092|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
143311|NCT00725985|513093|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
143312|NCT00725985|513094|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
143313|NCT00725985|513095|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
143314|NCT00725985|513096|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
143315|NCT00725985|513085|P12|OLMP|Other|0
143316|NCT00725985|513086|P11|OLMP|Other|0
143317|NCT00725985|513087|P10|OLMP|Other|0
143318|NCT00725985|513088|P9|OLMP|Other|0
143319|NCT00725985|513089|P8|OLMP|Other|0
143320|NCT00725985|513090|P7|OLMP|Other|0
143321|NCT00725985|513091|P6|OLMP|Other|44
143322|NCT00725985|513092|P5|OLMP|Other|20
143323|NCT00725985|513093|P4|OLMP|Other|15
143324|NCT00725985|513094|P3|OLMP|Other|0
143325|NCT00725985|513095|P2|OLMP|Other|0
143326|NCT00725985|513096|P1|OLMP|Other|0
143327|NCT00725985|513085|P12|OLMP|Disease progression|0
143328|NCT00725985|513086|P11|OLMP|Disease progression|0
143329|NCT00725985|513087|P10|OLMP|Disease progression|0
143330|NCT00725985|513088|P9|OLMP|Disease progression|0
143331|NCT00725985|513089|P8|OLMP|Disease progression|0
143332|NCT00725985|513090|P7|OLMP|Disease progression|0
143333|NCT00725985|513091|P6|OLMP|Disease progression|4
143334|NCT00725985|513092|P5|OLMP|Disease progression|0
143335|NCT00725985|513093|P4|OLMP|Disease progression|0
143336|NCT00725985|513094|P3|OLMP|Disease progression|0
143337|NCT00725985|513095|P2|OLMP|Disease progression|0
143338|NCT00725985|513096|P1|OLMP|Disease progression|0
143339|NCT00725985|513085|P12|OLMP|Lost to Follow-up|0
143340|NCT00725985|513086|P11|OLMP|Lost to Follow-up|0
143341|NCT00725985|513087|P10|OLMP|Lost to Follow-up|0
143342|NCT00725985|513088|P9|OLMP|Lost to Follow-up|0
143343|NCT00725985|513089|P8|OLMP|Lost to Follow-up|0
143344|NCT00725985|513090|P7|OLMP|Lost to Follow-up|0
143345|NCT00725985|513091|P6|OLMP|Lost to Follow-up|0
143346|NCT00725985|513092|P5|OLMP|Lost to Follow-up|0
143347|NCT00725985|513093|P4|OLMP|Lost to Follow-up|1
143348|NCT00725985|513094|P3|OLMP|Lost to Follow-up|0
143349|NCT00725985|513095|P2|OLMP|Lost to Follow-up|0
143350|NCT00725985|513096|P1|OLMP|Lost to Follow-up|0
143351|NCT00725985|513085|P12|OLMP|Death|0
143352|NCT00725985|513086|P11|OLMP|Death|0
143353|NCT00725985|513087|P10|OLMP|Death|0
143354|NCT00725985|513088|P9|OLMP|Death|0
143355|NCT00725985|513089|P8|OLMP|Death|0
143356|NCT00725985|513090|P7|OLMP|Death|0
143357|NCT00725985|513091|P6|OLMP|Death|0
143358|NCT00725985|513092|P5|OLMP|Death|1
143359|NCT00725985|513093|P4|OLMP|Death|0
143360|NCT00725985|513094|P3|OLMP|Death|0
143361|NCT00725985|513095|P2|OLMP|Death|0
143362|NCT00725985|513096|P1|OLMP|Death|0
143363|NCT00725985|513085|P12|OLMP|Adverse Event|0
143364|NCT00725985|513086|P11|OLMP|Adverse Event|0
143365|NCT00725985|513087|P10|OLMP|Adverse Event|0
143366|NCT00725985|513088|P9|OLMP|Adverse Event|0
143367|NCT00725985|513089|P8|OLMP|Adverse Event|0
143368|NCT00725985|513090|P7|OLMP|Adverse Event|0
143369|NCT00725985|513091|P6|OLMP|Adverse Event|5
143370|NCT00725985|513092|P5|OLMP|Adverse Event|2
143371|NCT00725985|513093|P4|OLMP|Adverse Event|2
143372|NCT00725985|513094|P3|OLMP|Adverse Event|0
143373|NCT00725985|513095|P2|OLMP|Adverse Event|0
143374|NCT00725985|513096|P1|OLMP|Adverse Event|0
143375|NCT00725985|513085|P12|ITP (Up to 96 Weeks)|Other|0
143376|NCT00725985|513086|P11|ITP (Up to 96 Weeks)|Other|0
143377|NCT00725985|513087|P10|ITP (Up to 96 Weeks)|Other|0
143378|NCT00725985|513088|P9|ITP (Up to 96 Weeks)|Other|0
143379|NCT00725985|513089|P8|ITP (Up to 96 Weeks)|Other|0
143380|NCT00725985|513090|P7|ITP (Up to 96 Weeks)|Other|0
143381|NCT00725985|513091|P6|ITP (Up to 96 Weeks)|Other|0
143382|NCT00725985|513092|P5|ITP (Up to 96 Weeks)|Other|0
143383|NCT00725985|513093|P4|ITP (Up to 96 Weeks)|Other|0
143384|NCT00725985|513094|P3|ITP (Up to 96 Weeks)|Other|24
143385|NCT00725985|513095|P2|ITP (Up to 96 Weeks)|Other|38
143386|NCT00725985|513096|P1|ITP (Up to 96 Weeks)|Other|50
143387|NCT00725985|513085|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
143388|NCT00725985|513086|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
143389|NCT00725985|513087|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
143390|NCT00725985|513088|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
143391|NCT00725985|513089|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
143392|NCT00725985|513090|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
143393|NCT00725985|513091|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
143394|NCT00725985|513092|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
143395|NCT00725985|513093|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
143396|NCT00725985|513094|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
143397|NCT00725985|513095|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
143398|NCT00725985|513096|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
143399|NCT00725985|513085|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
143400|NCT00725985|513086|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
143401|NCT00725985|513087|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
143402|NCT00725985|513088|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
143403|NCT00725985|513089|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
143404|NCT00725985|513090|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
143405|NCT00725985|513091|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
143406|NCT00725985|513092|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
143407|NCT00725985|513093|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
143408|NCT00725985|513094|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
143409|NCT00725985|513095|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
143410|NCT00725985|513096|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
143411|NCT00725985|513085|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143412|NCT00725985|513086|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143413|NCT00725985|513087|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143414|NCT00725985|513088|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143415|NCT00725985|513089|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143416|NCT00725985|513090|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143417|NCT00725985|513091|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143418|NCT00725985|513092|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143419|NCT00725985|513093|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143420|NCT00725985|513094|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
143421|NCT00725985|513095|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143422|NCT00725985|513096|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
143423|NCT00725985|513085|P12|ITP (Up to 96 Weeks)|Adverse Event|0
143424|NCT00725985|513086|P11|ITP (Up to 96 Weeks)|Adverse Event|0
143425|NCT00725985|513087|P10|ITP (Up to 96 Weeks)|Adverse Event|0
143426|NCT00725985|513088|P9|ITP (Up to 96 Weeks)|Adverse Event|0
143427|NCT00725985|513089|P8|ITP (Up to 96 Weeks)|Adverse Event|0
143428|NCT00725985|513090|P7|ITP (Up to 96 Weeks)|Adverse Event|0
143429|NCT00725985|513091|P6|ITP (Up to 96 Weeks)|Adverse Event|0
143430|NCT00725985|513092|P5|ITP (Up to 96 Weeks)|Adverse Event|0
143431|NCT00725985|513093|P4|ITP (Up to 96 Weeks)|Adverse Event|0
143432|NCT00725985|513094|P3|ITP (Up to 96 Weeks)|Adverse Event|5
143433|NCT00725985|513095|P2|ITP (Up to 96 Weeks)|Adverse Event|10
143434|NCT00725985|513096|P1|ITP (Up to 96 Weeks)|Adverse Event|20
143435|NCT00725920|513133|P2|Overall Study|Lack of Efficacy|6
143436|NCT00725920|513134|P1|Overall Study|Lack of Efficacy|3
143437|NCT00725842|513140|P1|Overall Study|No Visit 1 data|1
143438|NCT00725842|513140|P1|Overall Study|Inclusion criterion not met|1
143439|NCT00725842|513140|P1|Overall Study|Consent date prior to study start date|5
143440|NCT00725842|513140|P1|Overall Study|Positive HCV-RNA at Visit 2|13
143441|NCT00725842|513140|P1|Overall Study|Death|1
143442|NCT00725842|513140|P1|Overall Study|Lost to Follow-up|19
143443|NCT00725764|513147|P1|Overall Study|Decline in performance status|1
143444|NCT00725764|513147|P1|Overall Study|Participant non compliant with protocol|1
143445|NCT00725764|513147|P1|Overall Study|Death|1
143446|NCT00725764|513147|P1|Overall Study|Lost to Follow-up|1
143447|NCT00725764|513147|P1|Overall Study|Progressive Disease|7
143448|NCT00725764|513147|P1|Overall Study|Physician Decision|1
143449|NCT00725764|513147|P1|Overall Study|Withdrawal by Subject|2
143450|NCT00725725|513180|P3|Overall Study|Protocol Violation|0
143451|NCT00725725|513181|P2|Overall Study|Protocol Violation|1
143452|NCT00725725|513182|P1|Overall Study|Protocol Violation|0
143453|NCT00725725|513180|P3|Overall Study|Withdrawal by Subject|1
143454|NCT00725725|513181|P2|Overall Study|Withdrawal by Subject|0
143455|NCT00725725|513182|P1|Overall Study|Withdrawal by Subject|1
143456|NCT00725725|513180|P3|Overall Study|Lost to Follow-up|2
143457|NCT00725725|513181|P2|Overall Study|Lost to Follow-up|0
143458|NCT00725725|513182|P1|Overall Study|Lost to Follow-up|2
143459|NCT00725725|513180|P3|Overall Study|Adverse Event|2
143460|NCT00725725|513181|P2|Overall Study|Adverse Event|3
143461|NCT00725725|513182|P1|Overall Study|Adverse Event|1
143462|NCT00725712|513225|P2|Overall Study|Hospitalized, unable to continue|1
143463|NCT00725712|513226|P1|Overall Study|Hospitalized, unable to continue|0
143464|NCT00725712|513225|P2|Overall Study|Other: Death|0
143465|NCT00725712|513226|P1|Overall Study|Other: Death|1
143466|NCT00725712|513225|P2|Overall Study|Death|0
143467|NCT00725712|513226|P1|Overall Study|Death|2
143468|NCT00725712|513225|P2|Overall Study|Adverse Event|5
143469|NCT00725712|513226|P1|Overall Study|Adverse Event|5
143470|NCT00725712|513225|P2|Overall Study|Clinical progression not based on RECIST|3
143471|NCT00725712|513226|P1|Overall Study|Clinical progression not based on RECIST|0
143472|NCT00725712|513225|P2|Overall Study|Progressive disease|16
143473|NCT00725712|513226|P1|Overall Study|Progressive disease|37
143474|NCT00725712|513225|P2|Overall Study|Protocol Violation|0
143475|NCT00725712|513226|P1|Overall Study|Protocol Violation|1
143476|NCT00725712|513225|P2|Overall Study|Withdrawal by Subject|1
143477|NCT00725712|513226|P1|Overall Study|Withdrawal by Subject|2
143478|NCT00725621|513262|P1|Overall Study|Reason not specified|55
143479|NCT00725621|513262|P1|Overall Study|Prepared for elective surgery|1
143480|NCT00725621|513262|P1|Overall Study|Switched to other drug|1
143481|NCT00725621|513262|P1|Overall Study|Switched to other study|1
143482|NCT00725621|513262|P1|Overall Study|Continued treatment by other physician|6
143483|NCT00725621|513262|P1|Overall Study|Non-compliance|8
143484|NCT00725621|513262|P1|Overall Study|Lost to Follow-up|52
143485|NCT00725621|513262|P1|Overall Study|Physician Decision|19
143486|NCT00725621|513262|P1|Overall Study|Withdrawal by Subject|57
143487|NCT00725621|513262|P1|Overall Study|Lack of Efficacy|46
143488|NCT00725621|513262|P1|Overall Study|Adverse Event|25
143489|NCT00725608|513285|P1|Overall Study|Other|7
143490|NCT00725608|513285|P1|Overall Study|Individual reasons|86
143491|NCT00725608|513285|P1|Overall Study|Adverse Event|14
143492|NCT00725608|513285|P1|Overall Study|Lost to Follow-up|60
143493|NCT00725543|513291|P1|Overall Study|Not specified|119
143494|NCT00725543|513291|P1|Overall Study|Non-compliance|2
143495|NCT00725543|513291|P1|Overall Study|Lost to Follow-up|4
143496|NCT00725543|513291|P1|Overall Study|Physician Decision|5
143497|NCT00725543|513291|P1|Overall Study|Withdrawal by Subject|10
143498|NCT00725543|513291|P1|Overall Study|Lack of Efficacy|3
143499|NCT00725543|513291|P1|Overall Study|Adverse Event|10
143500|NCT00725491|513316|P2|Overall Study|No/too few embryos/ bad quality embryos|2
143501|NCT00725491|513317|P1|Overall Study|No/too few embryos/ bad quality embryos|3
143502|NCT00725491|513316|P2|Overall Study|Fertilization failure|1
143503|NCT00725491|513317|P1|Overall Study|Fertilization failure|0
143504|NCT00725491|513316|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
143505|NCT00725491|513317|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
143506|NCT00725491|513316|P2|Overall Study|Risk for hyperstimulation|9
143507|NCT00725491|513317|P1|Overall Study|Risk for hyperstimulation|2
143508|NCT00725491|513316|P2|Overall Study|Pregnancy|3
143509|NCT00725491|513317|P1|Overall Study|Pregnancy|0
143510|NCT00725491|513316|P2|Overall Study|Adverse Event|2
143511|NCT00725491|513317|P1|Overall Study|Adverse Event|3
143512|NCT00725452|513323|P1|Overall Study|Lost to Follow-up|1
143513|NCT00725452|513323|P1|Overall Study|Withdrawal by Subject|3
143514|NCT00725452|513323|P1|Overall Study|Physician Decision|1
143515|NCT00725452|513323|P1|Overall Study|Reason not specified|1
143516|NCT00725452|513323|P1|Overall Study|Lack of Efficacy|2
143517|NCT00725452|513323|P1|Overall Study|Adverse Event|3
143518|NCT00725322|513342|P2|Washout (28 Days)|Protocol Violation|1
143519|NCT00725322|513343|P1|Washout (28 Days)|Protocol Violation|0
143520|NCT00725322|513342|P2|Washout (28 Days)|Withdrawal by Subject|0
143521|NCT00725322|513343|P1|Washout (28 Days)|Withdrawal by Subject|2
143522|NCT00725296|513351|P1|Overall Study|Not Specified|38
143523|NCT00725296|513351|P1|Overall Study|Lost to Follow-up|1
143524|NCT00725296|513351|P1|Overall Study|Non-Compliance|2
143525|NCT00725296|513351|P1|Overall Study|Withdrawal by Subject|3
143526|NCT00725296|513351|P1|Overall Study|Lack of Efficacy|7
143527|NCT00725296|513351|P1|Overall Study|Adverse Event|11
143528|NCT00725205|513371|P1|Overall Study|Treatment Failure|41
143529|NCT00725205|513371|P1|Overall Study|Protocol Defined Clinical Event|1
143530|NCT00725205|513371|P1|Overall Study|Other|8
143531|NCT00725205|513371|P1|Overall Study|Non-compliance With Protocol|14
143532|NCT00725205|513371|P1|Overall Study|Investigator Discontinued|1
143533|NCT00725205|513371|P1|Overall Study|Adverse Event|22
143534|NCT00725101|513384|P1|Overall Study|not specified/no reason given|11
143535|NCT00725101|513384|P1|Overall Study|Withdrawal by Subject|127
143536|NCT00725101|513384|P1|Overall Study|Protocol Violation|1
143537|NCT00725101|513384|P1|Overall Study|Lost to Follow-up|353
143538|NCT00725101|513384|P1|Overall Study|Death|3
143539|NCT00725075|513407|P3|Overall Study|Other|0
143540|NCT00725075|513408|P2|Overall Study|Other|0
143541|NCT00725075|513409|P1|Overall Study|Other|1
143542|NCT00725075|513407|P3|Overall Study|Inclusion/Exclusion Criteria|1
143543|NCT00725075|513408|P2|Overall Study|Inclusion/Exclusion Criteria|0
143544|NCT00725075|513409|P1|Overall Study|Inclusion/Exclusion Criteria|1
143545|NCT00725075|513407|P3|Overall Study|Worsening of Disease|2
143546|NCT00725075|513408|P2|Overall Study|Worsening of Disease|1
143547|NCT00725075|513409|P1|Overall Study|Worsening of Disease|2
143548|NCT00725075|513407|P3|Overall Study|Adverse Event|1
143549|NCT00725075|513408|P2|Overall Study|Adverse Event|1
143550|NCT00725075|513409|P1|Overall Study|Adverse Event|2
143551|NCT00725075|513407|P3|Overall Study|Withdrawal by Subject|4
143552|NCT00725075|513408|P2|Overall Study|Withdrawal by Subject|5
143553|NCT00725075|513409|P1|Overall Study|Withdrawal by Subject|4
143554|NCT00725075|513407|P3|Overall Study|Lost to Follow-up|0
143555|NCT00725075|513408|P2|Overall Study|Lost to Follow-up|0
143556|NCT00725075|513409|P1|Overall Study|Lost to Follow-up|1
143557|NCT00725075|513407|P3|Overall Study|Protocol Violation|1
143558|NCT00725075|513408|P2|Overall Study|Protocol Violation|0
143559|NCT00725075|513409|P1|Overall Study|Protocol Violation|0
143560|NCT00725075|513407|P3|Overall Study|Use of Excluded Medication|0
143561|NCT00725075|513408|P2|Overall Study|Use of Excluded Medication|1
143562|NCT00725075|513409|P1|Overall Study|Use of Excluded Medication|0
143563|NCT00725010|513462|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
143564|NCT00725010|513462|P1|Overall Study|No further documentation|1
143565|NCT00725010|513462|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
143566|NCT00725010|513462|P1|Overall Study|Hepatopathy probably not Temodal-related|1
143567|NCT00725010|513462|P1|Overall Study|Lost to Follow-up|1
143568|NCT00725010|513462|P1|Overall Study|Death|1
143569|NCT00725010|513462|P1|Overall Study|Withdrawal by Subject|2
143570|NCT00725010|513462|P1|Overall Study|Tumor Progression|7
143571|NCT00725010|513462|P1|Overall Study|Toxicity|9
143572|NCT00724958|513495|P1|Overall Study|No documentation for end of therapy|13
143573|NCT00724958|513495|P1|Overall Study|Other Reason|76
143574|NCT00724958|513495|P1|Overall Study|Remission|7
143575|NCT00724958|513495|P1|Overall Study|No Response|18
143576|NCT00724958|513495|P1|Overall Study|Loss of Response|40
143577|NCT00724958|513495|P1|Overall Study|Adverse Event|28
143578|NCT00724945|513504|P2|Period 2|lens physiology issue|0
143579|NCT00724945|513505|P1|Period 2|lens physiology issue|1
143580|NCT00724945|513504|P2|Period 2|lens comfort issue|0
143581|NCT00724945|513505|P1|Period 2|lens comfort issue|3
143582|NCT00724945|513504|P2|Period 1|Lost to Follow-up|0
143583|NCT00724945|513505|P1|Period 1|Lost to Follow-up|1
143584|NCT00724945|513504|P2|Period 1|Adverse Event|1
143585|NCT00724945|513505|P1|Period 1|Adverse Event|1
143586|NCT00724945|513504|P2|Period 1|non-compliance|0
143587|NCT00724945|513505|P1|Period 1|non-compliance|1
143588|NCT00724932|513517|P2|Overall Study|Not treated|3
143589|NCT00724932|513518|P1|Overall Study|Not treated|4
143590|NCT00724932|513517|P2|Overall Study|Lost to Follow-up|0
143591|NCT00724932|513518|P1|Overall Study|Lost to Follow-up|1
143592|NCT00724893|513589|P2|Overall Study|Unknown, missing data|1
143593|NCT00724893|513590|P1|Overall Study|Unknown, missing data|1
143594|NCT00724893|513589|P2|Overall Study|Lost to Follow-up|52
143595|NCT00724893|513590|P1|Overall Study|Lost to Follow-up|0
143596|NCT00724893|513589|P2|Overall Study|Assigned shorter treatment|2
143597|NCT00724893|513590|P1|Overall Study|Assigned shorter treatment|0
143598|NCT00724893|513589|P2|Overall Study|Financial reasons|2
143599|NCT00724893|513590|P1|Overall Study|Financial reasons|0
143600|NCT00724893|513589|P2|Overall Study|Substance abuse|3
143601|NCT00724893|513590|P1|Overall Study|Substance abuse|0
143602|NCT00724893|513589|P2|Overall Study|Incarceration|9
143603|NCT00724893|513590|P1|Overall Study|Incarceration|0
143604|NCT00724893|513589|P2|Overall Study|Geographic reasons|11
143605|NCT00724893|513590|P1|Overall Study|Geographic reasons|0
143606|NCT00724893|513589|P2|Overall Study|Patient choice|26
143607|NCT00724893|513590|P1|Overall Study|Patient choice|0
143608|NCT00724893|513589|P2|Overall Study|Reason not specified|7
143609|NCT00724893|513590|P1|Overall Study|Reason not specified|193
143610|NCT00724893|513589|P2|Overall Study|Lack of virologic response|202
143611|NCT00724893|513590|P1|Overall Study|Lack of virologic response|94
143612|NCT00724893|513589|P2|Overall Study|Withdrawal by Subject|1
143613|NCT00724893|513590|P1|Overall Study|Withdrawal by Subject|0
143614|NCT00724893|513589|P2|Overall Study|Adverse Event|142
143615|NCT00724893|513590|P1|Overall Study|Adverse Event|76
143616|NCT00724867|513658|P1|Overall Study|Elected to exit due to site closure|2
143617|NCT00724867|513658|P1|Overall Study|Subject moved out of state|1
143618|NCT00724867|513658|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
143619|NCT00724867|513658|P1|Overall Study|Subject incarcerated|1
143620|NCT00724867|513658|P1|Overall Study|Sponsor decision to end study|14
143621|NCT00724867|513658|P1|Overall Study|Withdrawal by Subject|31
143622|NCT00724867|513658|P1|Overall Study|Protocol Violation|1
143623|NCT00724867|513658|P1|Overall Study|Physician Decision|17
143624|NCT00724867|513658|P1|Overall Study|Non-compliance with study drug|6
143625|NCT00724867|513658|P1|Overall Study|Lost to Follow-up|12
143626|NCT00724867|513658|P1|Overall Study|Lack of Efficacy|14
143627|NCT00724867|513658|P1|Overall Study|Adverse Event|25
143628|NCT00724854|513698|P2|Overall Study|Adverse event + lack of efficacy|1
143629|NCT00724854|513699|P1|Overall Study|Adverse event + lack of efficacy|2
143630|NCT00724854|513698|P2|Overall Study|Withdrawal by Subject|0
143631|NCT00724854|513699|P1|Overall Study|Withdrawal by Subject|5
143632|NCT00724854|513698|P2|Overall Study|Change of treatment|0
143633|NCT00724854|513699|P1|Overall Study|Change of treatment|7
143634|NCT00724854|513698|P2|Overall Study|Death|0
143635|NCT00724854|513699|P1|Overall Study|Death|11
143636|NCT00724854|513698|P2|Overall Study|Not specified|3
143637|NCT00724854|513699|P1|Overall Study|Not specified|42
143638|NCT00724854|513698|P2|Overall Study|Adverse Event|4
143639|NCT00724854|513699|P1|Overall Study|Adverse Event|62
143640|NCT00724854|513698|P2|Overall Study|Lost to Follow-up|10
143641|NCT00724854|513699|P1|Overall Study|Lost to Follow-up|87
143642|NCT00724854|513698|P2|Overall Study|Lack of Efficacy|13
143643|NCT00724854|513699|P1|Overall Study|Lack of Efficacy|187
143644|NCT00724815|513716|P2|Overall Study|Other Various|5
143645|NCT00724815|513717|P1|Overall Study|Other Various|3
143646|NCT00724815|513716|P2|Overall Study|Lost to Follow-up|1
143647|NCT00724815|513717|P1|Overall Study|Lost to Follow-up|4
143648|NCT00724815|513716|P2|Overall Study|Adverse Event|3
143649|NCT00724815|513717|P1|Overall Study|Adverse Event|5
143650|NCT00724815|513716|P2|Overall Study|Randomized, not treated|30
143651|NCT00724815|513717|P1|Overall Study|Randomized, not treated|31
143652|NCT00724711|513750|P2|Overall Study|Protocol Violation|0
143653|NCT00724711|513751|P1|Overall Study|Protocol Violation|1
143654|NCT00724711|513750|P2|Overall Study|Lost to Follow-up|5
143655|NCT00724711|513751|P1|Overall Study|Lost to Follow-up|4
143656|NCT00724711|513750|P2|Overall Study|Withdrawal by Subject|4
143657|NCT00724711|513751|P1|Overall Study|Withdrawal by Subject|5
143658|NCT00724711|513750|P2|Overall Study|Physician Decision|3
143659|NCT00724711|513751|P1|Overall Study|Physician Decision|0
143660|NCT00724711|513750|P2|Overall Study|Lack of Efficacy|1
143661|NCT00724711|513751|P1|Overall Study|Lack of Efficacy|0
143662|NCT00724711|513750|P2|Overall Study|Pregnancy|1
143663|NCT00724711|513751|P1|Overall Study|Pregnancy|0
143664|NCT00724711|513750|P2|Overall Study|Adverse Event|3
143665|NCT00724711|513751|P1|Overall Study|Adverse Event|7
143666|NCT00724698|513783|P1|Overall Study|No Info|25
143667|NCT00724698|513783|P1|Overall Study|Lost to Follow-up|36
143668|NCT00724698|513783|P1|Overall Study|Poor Compliance|16
143669|NCT00724698|513783|P1|Overall Study|Failure of Therapy|4
143670|NCT00724698|513783|P1|Overall Study|Adverse Event|9
143671|NCT00724451|513838|P1|Overall Study|Investigator + Participant Decision|13
143672|NCT00724451|513838|P1|Overall Study|Withdrawal by Subject|45
143673|NCT00724451|513838|P1|Overall Study|Physician Decision|116
143674|NCT00724451|513838|P1|Overall Study|Unknown; No Data Sources Available|9
143675|NCT00724451|513838|P1|Overall Study|Never Started Treatment|89
143676|NCT00724451|513838|P1|Overall Study|Participant Refused Treatment|89
143677|NCT00724451|513838|P1|Overall Study|Not Eligible for Treatment|431
143678|NCT00724451|513838|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
143679|NCT00724451|513838|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
143680|NCT00724373|513844|P1|Overall Study|Tolerability|23
143681|NCT00724373|513844|P1|Overall Study|Drug Relapse|1
143682|NCT00724373|513844|P1|Overall Study|Acute HCV infection|1
143683|NCT00724373|513844|P1|Overall Study|Viral Relapse|1
143684|NCT00724373|513844|P1|Overall Study|Only to have 24 week regimen|1
143685|NCT00724373|513844|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
143686|NCT00724373|513844|P1|Overall Study|Participant moved away|1
143687|NCT00724373|513844|P1|Overall Study|HCV RNA negative after 4 weeks|9
143688|NCT00724373|513844|P1|Overall Study|Non-compliance|2
143689|NCT00724373|513844|P1|Overall Study|Lost to Follow-up|7
143690|NCT00724373|513844|P1|Overall Study|Lack of Efficacy|82
143691|NCT00724373|513844|P1|Overall Study|Adverse Event|41
143692|NCT00724282|513861|P1|Overall Study|Physician Decision|1
143693|NCT00724282|513861|P1|Overall Study|Withdrawal by Subject|3
143694|NCT00724243|513865|P1|Overall Study|Adverse Event|5
143695|NCT00724243|513865|P1|Overall Study|Lack of Efficacy|10
143696|NCT00724152|513875|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
143697|NCT00724152|513876|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
143698|NCT00724152|513877|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
143699|NCT00724152|513875|P3|Two-arm Study Period|Withdrawal by Subject|0
143700|NCT00724152|513876|P2|Two-arm Study Period|Withdrawal by Subject|2
143701|NCT00724152|513877|P1|Two-arm Study Period|Withdrawal by Subject|3
143702|NCT00724126|513894|P2|Overall Study|Subject had to leave vicinity of site|1
143703|NCT00724126|513895|P1|Overall Study|Subject had to leave vicinity of site|0
143704|NCT00724126|513894|P2|Overall Study|Subject randomized although ineligible|1
143705|NCT00724126|513895|P1|Overall Study|Subject randomized although ineligible|1
143706|NCT00724126|513894|P2|Overall Study|Noncompliance|1
143707|NCT00724126|513895|P1|Overall Study|Noncompliance|2
143708|NCT00724126|513894|P2|Overall Study|Lost to Follow-up|6
143709|NCT00724126|513895|P1|Overall Study|Lost to Follow-up|6
143710|NCT00724126|513894|P2|Overall Study|Withdrawal by Subject|6
143711|NCT00724126|513895|P1|Overall Study|Withdrawal by Subject|8
143712|NCT00724126|513894|P2|Overall Study|Adverse Event|0
143713|NCT00724126|513895|P1|Overall Study|Adverse Event|2
143714|NCT00724061|513903|P1|Dose Escalation Phase|Disease Progression|3
143715|NCT00724061|513903|P1|Dose Escalation Phase|Adverse Event|2
143716|NCT00723957|513920|P2|Overall Study|Never received treatment|3
143717|NCT00723957|513921|P1|Overall Study|Never received treatment|3
143718|NCT00723957|513920|P2|Overall Study|Reason not analyzed|0
143719|NCT00723957|513921|P1|Overall Study|Reason not analyzed|1
143720|NCT00723957|513920|P2|Overall Study|Withdrawal by Subject|5
143721|NCT00723957|513921|P1|Overall Study|Withdrawal by Subject|7
143722|NCT00723957|513920|P2|Overall Study|Study drug toxicity|6
143723|NCT00723957|513921|P1|Overall Study|Study drug toxicity|4
143724|NCT00723957|513920|P2|Overall Study|Investigator decision|1
143725|NCT00723957|513921|P1|Overall Study|Investigator decision|1
143726|NCT00723957|513920|P2|Overall Study|Maximum clinical benefit|5
143727|NCT00723957|513921|P1|Overall Study|Maximum clinical benefit|4
143728|NCT00723957|513920|P2|Overall Study|Disease progression|25
143729|NCT00723957|513921|P1|Overall Study|Disease progression|27
143730|NCT00723957|513920|P2|Overall Study|Death|4
143731|NCT00723957|513921|P1|Overall Study|Death|3
143732|NCT00723957|513920|P2|Overall Study|Adverse event unrelated to study drug|4
143733|NCT00723957|513921|P1|Overall Study|Adverse event unrelated to study drug|1
143734|NCT00723944|513945|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
143735|NCT00723944|513946|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
143736|NCT00723944|513945|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
143737|NCT00723944|513946|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
143738|NCT00723944|513945|P2|Permanent Prosthesis Placement|Adverse Event|7
143739|NCT00723944|513946|P1|Permanent Prosthesis Placement|Adverse Event|1
143740|NCT00723892|513959|P2|Overall Study|Drug addiction|0
143741|NCT00723892|513960|P1|Overall Study|Drug addiction|1
143742|NCT00723892|513959|P2|Overall Study|Intercurrent infection|0
143743|NCT00723892|513960|P1|Overall Study|Intercurrent infection|2
143744|NCT00723892|513959|P2|Overall Study|Alcohol abuse|1
143745|NCT00723892|513960|P1|Overall Study|Alcohol abuse|0
143746|NCT00723892|513959|P2|Overall Study|Weight loss|3
143747|NCT00723892|513960|P1|Overall Study|Weight loss|1
143748|NCT00723892|513959|P2|Overall Study|Study end|3
143749|NCT00723892|513960|P1|Overall Study|Study end|1
143750|NCT00723892|513959|P2|Overall Study|Not specified|3
143751|NCT00723892|513960|P1|Overall Study|Not specified|6
143752|NCT00723892|513959|P2|Overall Study|Multiple reasons|12
143753|NCT00723892|513960|P1|Overall Study|Multiple reasons|17
143754|NCT00723892|513959|P2|Overall Study|Bad tolerance|5
143755|NCT00723892|513960|P1|Overall Study|Bad tolerance|5
143756|NCT00723892|513959|P2|Overall Study|End planned|7
143757|NCT00723892|513960|P1|Overall Study|End planned|11
143758|NCT00723892|513959|P2|Overall Study|Withdrawal by Subject|9
143759|NCT00723892|513960|P1|Overall Study|Withdrawal by Subject|6
143760|NCT00723892|513959|P2|Overall Study|Virological criterion|9
143761|NCT00723892|513960|P1|Overall Study|Virological criterion|24
143762|NCT00723892|513959|P2|Overall Study|Participant not tracked|35
143763|NCT00723892|513960|P1|Overall Study|Participant not tracked|33
143764|NCT00723840|513967|P1|Overall Study|Unspecified reason|2
143765|NCT00723840|513967|P1|Overall Study|Other Medical Event|2
143766|NCT00723840|513967|P1|Overall Study|Serious Adverse Events|3
143767|NCT00723840|513967|P1|Overall Study|Withdrawal by Subject|55
143768|NCT00723840|513967|P1|Overall Study|Failure to return|18
143769|NCT00723840|513967|P1|Overall Study|Lost to Follow-up|2
143770|NCT00723801|513988|P2|Overall Study|Protocol Violation|1
143771|NCT00723801|513989|P1|Overall Study|Protocol Violation|2
143772|NCT00723801|513988|P2|Overall Study|Lost to Follow-up|2
143773|NCT00723801|513989|P1|Overall Study|Lost to Follow-up|1
143774|NCT00723710|514014|P1|Overall Study|Physician Decision|2
143775|NCT00723710|514014|P1|Overall Study|Withdrawal by Subject|36
143776|NCT00723710|514014|P1|Overall Study|Adverse Event|88
143777|NCT00723710|514014|P1|Overall Study|Disease progression|48
143778|NCT00723697|514018|P1|Overall Study|Other exclusion criteria applied|6
143779|NCT00723697|514018|P1|Overall Study|Missing Informed Consent Form|10
143780|NCT00723697|514018|P1|Overall Study|Physician questionnaires not received|2
143781|NCT00723606|514039|P2|Overall Study|Withdrawal by Subject|2
143782|NCT00723606|514040|P1|Overall Study|Withdrawal by Subject|0
143783|NCT00723606|514039|P2|Overall Study|Other|0
143784|NCT00723606|514040|P1|Overall Study|Other|2
143785|NCT00723606|514039|P2|Overall Study|Adverse Event|5
143786|NCT00723606|514040|P1|Overall Study|Adverse Event|2
143787|NCT00723554|514060|P1|Overall Study|Non-compliance|1
143788|NCT00723554|514060|P1|Overall Study|Lost to Follow-up|1
143789|NCT00723554|514060|P1|Overall Study|Not specified|3
143790|NCT00723554|514060|P1|Overall Study|Withdrawal of consent|3
143791|NCT00723554|514060|P1|Overall Study|Inhaled medication other than iloprost|4
143792|NCT00723554|514060|P1|Overall Study|Investigator's judgement|5
143793|NCT00723554|514060|P1|Overall Study|Adverse Event|12
143794|NCT00723528|514110|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
143795|NCT00723528|514111|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
143796|NCT00723528|514112|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
143797|NCT00723528|514113|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
143798|NCT00723528|514114|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
143799|NCT00723528|514115|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
143800|NCT00723528|514116|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
143801|NCT00723528|514110|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
143802|NCT00723528|514111|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
143803|NCT00723528|514112|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
143804|NCT00723528|514113|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
143805|NCT00723528|514114|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
143806|NCT00723528|514115|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
143807|NCT00723528|514116|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
143808|NCT00723528|514110|P7|Period 2: After Controlled Period|Adverse Event|1
143809|NCT00723528|514111|P6|Period 2: After Controlled Period|Adverse Event|0
143810|NCT00723528|514112|P5|Period 2: After Controlled Period|Adverse Event|1
143811|NCT00723528|514113|P4|Period 2: After Controlled Period|Adverse Event|0
143812|NCT00723528|514114|P3|Period 2: After Controlled Period|Adverse Event|0
143813|NCT00723528|514115|P2|Period 2: After Controlled Period|Adverse Event|0
143814|NCT00723528|514116|P1|Period 2: After Controlled Period|Adverse Event|0
143815|NCT00723528|514110|P7|Period 2: After Controlled Period|Other|0
143816|NCT00723528|514111|P6|Period 2: After Controlled Period|Other|4
143817|NCT00723528|514112|P5|Period 2: After Controlled Period|Other|1
143818|NCT00723528|514113|P4|Period 2: After Controlled Period|Other|0
143819|NCT00723528|514114|P3|Period 2: After Controlled Period|Other|0
143820|NCT00723528|514115|P2|Period 2: After Controlled Period|Other|0
143821|NCT00723528|514116|P1|Period 2: After Controlled Period|Other|0
143822|NCT00723528|514110|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
143823|NCT00723528|514111|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
143824|NCT00723528|514112|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
143825|NCT00723528|514113|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
143826|NCT00723528|514114|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
143827|NCT00723528|514115|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
143828|NCT00723528|514116|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
143829|NCT00723528|514110|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
143830|NCT00723528|514111|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
143831|NCT00723528|514112|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
143832|NCT00723528|514113|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
143833|NCT00723528|514114|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
143834|NCT00723528|514115|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
143835|NCT00723528|514116|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
143836|NCT00723528|514110|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
143837|NCT00723528|514111|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
143838|NCT00723528|514112|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
143839|NCT00723528|514113|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
143840|NCT00723528|514114|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
143841|NCT00723528|514115|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
143842|NCT00723528|514116|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
143843|NCT00723528|514110|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
143844|NCT00723528|514111|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
143845|NCT00723528|514112|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
143846|NCT00723528|514113|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
143847|NCT00723528|514114|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
143848|NCT00723528|514115|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
143849|NCT00723528|514116|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
143850|NCT00723528|514110|P7|Period 1: Controlled Period (CP)|Physician Decision|0
143851|NCT00723528|514111|P6|Period 1: Controlled Period (CP)|Physician Decision|0
143852|NCT00723528|514112|P5|Period 1: Controlled Period (CP)|Physician Decision|0
143853|NCT00723528|514113|P4|Period 1: Controlled Period (CP)|Physician Decision|0
143854|NCT00723528|514114|P3|Period 1: Controlled Period (CP)|Physician Decision|1
143855|NCT00723528|514115|P2|Period 1: Controlled Period (CP)|Physician Decision|0
143856|NCT00723528|514116|P1|Period 1: Controlled Period (CP)|Physician Decision|0
143857|NCT00723528|514110|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
143858|NCT00723528|514111|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
143859|NCT00723528|514112|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
143860|NCT00723528|514113|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
143861|NCT00723528|514114|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
143862|NCT00723528|514115|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
143863|NCT00723528|514116|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
143864|NCT00723528|514110|P7|Period 1: Controlled Period (CP)|Adverse Event|0
143865|NCT00723528|514111|P6|Period 1: Controlled Period (CP)|Adverse Event|0
143866|NCT00723528|514112|P5|Period 1: Controlled Period (CP)|Adverse Event|0
143867|NCT00723528|514113|P4|Period 1: Controlled Period (CP)|Adverse Event|0
143868|NCT00723528|514114|P3|Period 1: Controlled Period (CP)|Adverse Event|1
143869|NCT00723528|514115|P2|Period 1: Controlled Period (CP)|Adverse Event|0
143870|NCT00723528|514116|P1|Period 1: Controlled Period (CP)|Adverse Event|0
143871|NCT00723489|514178|P4|Overall Study|Samples Collected Out of Window|0
143872|NCT00723489|514179|P3|Overall Study|Samples Collected Out of Window|0
143873|NCT00723489|514180|P2|Overall Study|Samples Collected Out of Window|3
143874|NCT00723489|514181|P1|Overall Study|Samples Collected Out of Window|0
143875|NCT00723489|514178|P4|Overall Study|Prohibited Medication|1
143876|NCT00723489|514179|P3|Overall Study|Prohibited Medication|0
143877|NCT00723489|514180|P2|Overall Study|Prohibited Medication|0
143878|NCT00723489|514181|P1|Overall Study|Prohibited Medication|0
143879|NCT00723489|514178|P4|Overall Study|Seropositive at baseline|0
143880|NCT00723489|514179|P3|Overall Study|Seropositive at baseline|0
143881|NCT00723489|514180|P2|Overall Study|Seropositive at baseline|0
143882|NCT00723489|514181|P1|Overall Study|Seropositive at baseline|1
143883|NCT00723489|514178|P4|Overall Study|Withdrawal by Subject|1
143884|NCT00723489|514179|P3|Overall Study|Withdrawal by Subject|0
143885|NCT00723489|514180|P2|Overall Study|Withdrawal by Subject|0
143886|NCT00723489|514181|P1|Overall Study|Withdrawal by Subject|0
143887|NCT00723489|514178|P4|Overall Study|Pregnancy|1
143888|NCT00723489|514179|P3|Overall Study|Pregnancy|0
143889|NCT00723489|514180|P2|Overall Study|Pregnancy|0
143890|NCT00723489|514181|P1|Overall Study|Pregnancy|0
143891|NCT00723489|514178|P4|Overall Study|Physician Decision|0
143892|NCT00723489|514179|P3|Overall Study|Physician Decision|0
143893|NCT00723489|514180|P2|Overall Study|Physician Decision|1
143894|NCT00723489|514181|P1|Overall Study|Physician Decision|0
143895|NCT00723450|514209|P3|Randomized Phase|Withdrawal by Subject|22
143896|NCT00723450|514210|P2|Randomized Phase|Withdrawal by Subject|14
143897|NCT00723450|514211|P1|Randomized Phase|Withdrawal by Subject|0
143898|NCT00723450|514209|P3|Randomized Phase|Physician Decision|1
143899|NCT00723450|514210|P2|Randomized Phase|Physician Decision|3
143900|NCT00723450|514211|P1|Randomized Phase|Physician Decision|0
143901|NCT00723450|514209|P3|Randomized Phase|Lost to Follow-up|3
143902|NCT00723450|514210|P2|Randomized Phase|Lost to Follow-up|2
143903|NCT00723450|514211|P1|Randomized Phase|Lost to Follow-up|0
143904|NCT00723450|514209|P3|Randomized Phase|Protocol Violation|13
143905|NCT00723450|514210|P2|Randomized Phase|Protocol Violation|9
143906|NCT00723450|514211|P1|Randomized Phase|Protocol Violation|0
143907|NCT00723450|514209|P3|Randomized Phase|Lack of Efficacy|11
143908|NCT00723450|514210|P2|Randomized Phase|Lack of Efficacy|11
143909|NCT00723450|514211|P1|Randomized Phase|Lack of Efficacy|0
143910|NCT00723450|514209|P3|Randomized Phase|Adverse Event|17
143911|NCT00723450|514210|P2|Randomized Phase|Adverse Event|26
143912|NCT00723450|514211|P1|Randomized Phase|Adverse Event|0
143913|NCT00723450|514209|P3|Open-Label Phase|Withdrawal by Subject|0
143914|NCT00723450|514210|P2|Open-Label Phase|Withdrawal by Subject|0
143915|NCT00723450|514211|P1|Open-Label Phase|Withdrawal by Subject|37
143916|NCT00723450|514209|P3|Open-Label Phase|Physician Decision|0
143917|NCT00723450|514210|P2|Open-Label Phase|Physician Decision|0
143918|NCT00723450|514211|P1|Open-Label Phase|Physician Decision|2
143919|NCT00723450|514209|P3|Open-Label Phase|Lost to Follow-up|0
143920|NCT00723450|514210|P2|Open-Label Phase|Lost to Follow-up|0
143921|NCT00723450|514211|P1|Open-Label Phase|Lost to Follow-up|7
143922|NCT00723450|514209|P3|Open-Label Phase|Protocol Violation|0
143923|NCT00723450|514210|P2|Open-Label Phase|Protocol Violation|0
143924|NCT00723450|514211|P1|Open-Label Phase|Protocol Violation|35
143925|NCT00723450|514209|P3|Open-Label Phase|Lack of Efficacy|0
143926|NCT00723450|514210|P2|Open-Label Phase|Lack of Efficacy|0
143927|NCT00723450|514211|P1|Open-Label Phase|Lack of Efficacy|18
143928|NCT00723450|514209|P3|Open-Label Phase|Adverse Event|0
143929|NCT00723450|514210|P2|Open-Label Phase|Adverse Event|0
143930|NCT00723450|514211|P1|Open-Label Phase|Adverse Event|26
143931|NCT00723294|514252|P1|Overall Study|No treatment due to probe failure|1
143932|NCT00723294|514252|P1|Overall Study|Withdrawal by Subject|1
143933|NCT00723294|514252|P1|Overall Study|Benign lesion|1
143934|NCT00723294|514252|P1|Overall Study|Treated by non-credentialed surgeon|1
143935|NCT00723294|514252|P1|Overall Study|Treated prior to registration|1
143936|NCT00723294|514252|P1|Overall Study|Did not undergo surgery|1
143937|NCT00723294|514252|P1|Overall Study|No cryoabalation|2
143938|NCT00723294|514252|P1|Overall Study|1.0-Tesla MRI|1
143939|NCT00723294|514252|P1|Overall Study|No MRI tumor enhancement|1
143940|NCT00723294|514252|P1|Overall Study|>25% intraductal component|1
143941|NCT00723294|514252|P1|Overall Study|Lobular histology|2
143942|NCT00723255|514257|P1|Overall Study|Ineligible: Wrong Primary|2
143943|NCT00723255|514257|P1|Overall Study|Ineligible: Second primary|1
143944|NCT00723255|514257|P1|Overall Study|Ineligible: Inadequate pathology|1
143945|NCT00723229|514284|P2|First Intervention|Lost to Follow-up|3
143946|NCT00723229|514285|P1|First Intervention|Lost to Follow-up|7
143947|NCT00723203|514297|P1|Overall Study|Withdrawal by Subject|3
143948|NCT00723190|514301|P1|Overall Study|Other-Not included in safety population|2
143949|NCT00723190|514301|P1|Overall Study|Other-Premature Discontinuation|9
143950|NCT00723190|514301|P1|Overall Study|Protocol Violation|15
143951|NCT00723190|514301|P1|Overall Study|Lack of Efficacy|16
143952|NCT00723190|514301|P1|Overall Study|Adverse Event|18
143953|NCT00723190|514301|P1|Overall Study|Lost to Follow-up|37
143954|NCT00723190|514301|P1|Overall Study|Withdrawal by Subject|45
143955|NCT00723125|514334|P2|Overall Study|Adverse Event|0
143956|NCT00723125|514335|P1|Overall Study|Adverse Event|2
143957|NCT00723125|514334|P2|Overall Study|Withdrawal by Subject|6
143958|NCT00723125|514335|P1|Overall Study|Withdrawal by Subject|15
143959|NCT00723125|514334|P2|Overall Study|Met Dx|0
143960|NCT00723125|514335|P1|Overall Study|Met Dx|1
143961|NCT00723021|514372|P5|Intervention Period 4|Adverse Event|1
143962|NCT00723021|514373|P4|Intervention Period 4|Adverse Event|0
143963|NCT00723021|514374|P3|Intervention Period 4|Adverse Event|0
143964|NCT00723021|514375|P2|Intervention Period 4|Adverse Event|0
143965|NCT00723021|514376|P1|Intervention Period 4|Adverse Event|0
143966|NCT00723008|514430|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
143967|NCT00723008|514431|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
143968|NCT00723008|514430|P2|4-Week Unblinded Treatment|Adverse Event|0
143969|NCT00723008|514431|P1|4-Week Unblinded Treatment|Adverse Event|1
143970|NCT00723008|514430|P2|4-Week Double Blinded|Lost to Follow-up|3
143971|NCT00723008|514431|P1|4-Week Double Blinded|Lost to Follow-up|4
143972|NCT00723008|514430|P2|4-Week Double Blinded|Withdrawal by Subject|1
143973|NCT00723008|514431|P1|4-Week Double Blinded|Withdrawal by Subject|1
143974|NCT00723008|514430|P2|4-Week Double Blinded|Lack of Efficacy|1
143975|NCT00723008|514431|P1|4-Week Double Blinded|Lack of Efficacy|0
143976|NCT00723008|514430|P2|Enrollment|Lost to Follow-up|0
143977|NCT00723008|514431|P1|Enrollment|Lost to Follow-up|1
143978|NCT00722800|514463|P2|Overall Study|Physician Decision|0
143979|NCT00722800|514464|P1|Overall Study|Physician Decision|1
143980|NCT00722800|514463|P2|Overall Study|Withdrawal by Subject|0
143981|NCT00722800|514464|P1|Overall Study|Withdrawal by Subject|1
143982|NCT00722761|514476|P2|Overall Study|Withdrawal by Subject|2
143983|NCT00722761|514477|P1|Overall Study|Withdrawal by Subject|5
143984|NCT00722761|514476|P2|Overall Study|Lost to Follow-up|4
143985|NCT00722761|514477|P1|Overall Study|Lost to Follow-up|1
143986|NCT00722423|514534|P2|Overall Study|Protocol Violation|1
143987|NCT00722423|514535|P1|Overall Study|Protocol Violation|0
143988|NCT00722371|514550|P7|Overall Study|Withdrawal by Subject|26
143989|NCT00722371|514551|P6|Overall Study|Withdrawal by Subject|18
143990|NCT00722371|514552|P5|Overall Study|Withdrawal by Subject|19
143991|NCT00722371|514553|P4|Overall Study|Withdrawal by Subject|23
143992|NCT00722371|514554|P3|Overall Study|Withdrawal by Subject|19
143993|NCT00722371|514555|P2|Overall Study|Withdrawal by Subject|27
143994|NCT00722371|514556|P1|Overall Study|Withdrawal by Subject|18
143995|NCT00722371|514550|P7|Overall Study|Protocol Violation|1
143996|NCT00722371|514551|P6|Overall Study|Protocol Violation|2
143997|NCT00722371|514552|P5|Overall Study|Protocol Violation|4
143998|NCT00722371|514553|P4|Overall Study|Protocol Violation|1
143999|NCT00722371|514554|P3|Overall Study|Protocol Violation|0
144000|NCT00722371|514555|P2|Overall Study|Protocol Violation|1
144001|NCT00722371|514556|P1|Overall Study|Protocol Violation|6
144002|NCT00722371|514550|P7|Overall Study|Pregnancy|0
144003|NCT00722371|514551|P6|Overall Study|Pregnancy|1
144004|NCT00722371|514552|P5|Overall Study|Pregnancy|0
144005|NCT00722371|514553|P4|Overall Study|Pregnancy|0
144006|NCT00722371|514554|P3|Overall Study|Pregnancy|0
144007|NCT00722371|514555|P2|Overall Study|Pregnancy|1
144008|NCT00722371|514556|P1|Overall Study|Pregnancy|1
144009|NCT00722371|514550|P7|Overall Study|Physician Decision|4
144010|NCT00722371|514551|P6|Overall Study|Physician Decision|3
144011|NCT00722371|514552|P5|Overall Study|Physician Decision|2
144012|NCT00722371|514553|P4|Overall Study|Physician Decision|5
144013|NCT00722371|514554|P3|Overall Study|Physician Decision|2
144014|NCT00722371|514555|P2|Overall Study|Physician Decision|2
144015|NCT00722371|514556|P1|Overall Study|Physician Decision|5
144016|NCT00722371|514550|P7|Overall Study|Lost to Follow-up|13
144017|NCT00722371|514551|P6|Overall Study|Lost to Follow-up|16
144018|NCT00722371|514552|P5|Overall Study|Lost to Follow-up|8
144019|NCT00722371|514553|P4|Overall Study|Lost to Follow-up|13
144020|NCT00722371|514554|P3|Overall Study|Lost to Follow-up|21
144021|NCT00722371|514555|P2|Overall Study|Lost to Follow-up|14
144022|NCT00722371|514556|P1|Overall Study|Lost to Follow-up|11
144023|NCT00722371|514550|P7|Overall Study|Lack of Efficacy|0
144024|NCT00722371|514551|P6|Overall Study|Lack of Efficacy|3
144025|NCT00722371|514552|P5|Overall Study|Lack of Efficacy|2
144026|NCT00722371|514553|P4|Overall Study|Lack of Efficacy|6
144027|NCT00722371|514554|P3|Overall Study|Lack of Efficacy|6
144028|NCT00722371|514555|P2|Overall Study|Lack of Efficacy|6
144029|NCT00722371|514556|P1|Overall Study|Lack of Efficacy|4
144030|NCT00722371|514550|P7|Overall Study|Hypoglycemia|0
144031|NCT00722371|514551|P6|Overall Study|Hypoglycemia|0
144032|NCT00722371|514552|P5|Overall Study|Hypoglycemia|0
144033|NCT00722371|514553|P4|Overall Study|Hypoglycemia|0
144034|NCT00722371|514554|P3|Overall Study|Hypoglycemia|0
144035|NCT00722371|514555|P2|Overall Study|Hypoglycemia|0
144036|NCT00722371|514556|P1|Overall Study|Hypoglycemia|1
144037|NCT00722371|514550|P7|Overall Study|Hyperglycemia|1
144038|NCT00722371|514551|P6|Overall Study|Hyperglycemia|1
144039|NCT00722371|514552|P5|Overall Study|Hyperglycemia|5
144040|NCT00722371|514553|P4|Overall Study|Hyperglycemia|2
144041|NCT00722371|514554|P3|Overall Study|Hyperglycemia|4
144042|NCT00722371|514555|P2|Overall Study|Hyperglycemia|6
144043|NCT00722371|514556|P1|Overall Study|Hyperglycemia|2
144044|NCT00722371|514550|P7|Overall Study|Excluded medication|1
144045|NCT00722371|514551|P6|Overall Study|Excluded medication|0
144046|NCT00722371|514552|P5|Overall Study|Excluded medication|0
144047|NCT00722371|514553|P4|Overall Study|Excluded medication|0
144048|NCT00722371|514554|P3|Overall Study|Excluded medication|1
144049|NCT00722371|514555|P2|Overall Study|Excluded medication|1
144050|NCT00722371|514556|P1|Overall Study|Excluded medication|0
144051|NCT00722371|514550|P7|Overall Study|Creatinine / Creatinine clearance|1
144052|NCT00722371|514551|P6|Overall Study|Creatinine / Creatinine clearance|1
144053|NCT00722371|514552|P5|Overall Study|Creatinine / Creatinine clearance|2
144054|NCT00722371|514553|P4|Overall Study|Creatinine / Creatinine clearance|3
144055|NCT00722371|514554|P3|Overall Study|Creatinine / Creatinine clearance|2
144056|NCT00722371|514555|P2|Overall Study|Creatinine / Creatinine clearance|1
144057|NCT00722371|514556|P1|Overall Study|Creatinine / Creatinine clearance|2
144058|NCT00722371|514550|P7|Overall Study|Contraindication|0
144059|NCT00722371|514551|P6|Overall Study|Contraindication|0
144060|NCT00722371|514552|P5|Overall Study|Contraindication|0
144061|NCT00722371|514553|P4|Overall Study|Contraindication|0
144062|NCT00722371|514554|P3|Overall Study|Contraindication|1
144063|NCT00722371|514555|P2|Overall Study|Contraindication|0
144064|NCT00722371|514556|P1|Overall Study|Contraindication|0
144065|NCT00722371|514550|P7|Overall Study|Adverse Event|4
144066|NCT00722371|514551|P6|Overall Study|Adverse Event|8
144067|NCT00722371|514552|P5|Overall Study|Adverse Event|6
144068|NCT00722371|514553|P4|Overall Study|Adverse Event|10
144069|NCT00722371|514554|P3|Overall Study|Adverse Event|9
144070|NCT00722371|514555|P2|Overall Study|Adverse Event|13
144071|NCT00722371|514556|P1|Overall Study|Adverse Event|6
144072|NCT00722137|514609|P2|Overall Study|Randomized But Not Treated|2
144073|NCT00722137|514610|P1|Overall Study|Randomized But Not Treated|3
144074|NCT00722137|514609|P2|Overall Study|Other Reason Uknown|3
144075|NCT00722137|514610|P1|Overall Study|Other Reason Uknown|4
144076|NCT00722137|514609|P2|Overall Study|Withdrawal by Subject|6
144077|NCT00722137|514610|P1|Overall Study|Withdrawal by Subject|9
144078|NCT00722137|514609|P2|Overall Study|Death|12
144079|NCT00722137|514610|P1|Overall Study|Death|7
144080|NCT00722137|514609|P2|Overall Study|Adverse Event|17
144081|NCT00722137|514610|P1|Overall Study|Adverse Event|21
144082|NCT00722137|514609|P2|Overall Study|Overt Disease Progression|5
144083|NCT00722137|514610|P1|Overall Study|Overt Disease Progression|4
144084|NCT00721968|514678|P2|Overall Study|Lost to Follow-up|0
144085|NCT00721968|514679|P1|Overall Study|Lost to Follow-up|2
144086|NCT00721955|514690|P3|Overall Study|Adverse Event|2
144087|NCT00721955|514691|P2|Overall Study|Adverse Event|0
144088|NCT00721955|514692|P1|Overall Study|Adverse Event|0
144089|NCT00721799|514706|P1|Overall Study|withdraw by subject after scan 1|1
144090|NCT00721799|514706|P1|Overall Study|Withdrawal by Subject|7
144091|NCT00721734|514746|P5|Overall Study|Other|0
144092|NCT00721734|514747|P4|Overall Study|Other|1
144093|NCT00721734|514748|P3|Overall Study|Other|0
144094|NCT00721734|514749|P2|Overall Study|Other|0
144095|NCT00721734|514750|P1|Overall Study|Other|0
144096|NCT00721734|514746|P5|Overall Study|Withdrawal by Subject|1
144097|NCT00721734|514747|P4|Overall Study|Withdrawal by Subject|0
144098|NCT00721734|514748|P3|Overall Study|Withdrawal by Subject|0
144099|NCT00721734|514749|P2|Overall Study|Withdrawal by Subject|1
144100|NCT00721734|514750|P1|Overall Study|Withdrawal by Subject|2
144101|NCT00721734|514746|P5|Overall Study|Adverse Event|3
144102|NCT00721734|514747|P4|Overall Study|Adverse Event|0
144103|NCT00721734|514748|P3|Overall Study|Adverse Event|4
144104|NCT00721734|514749|P2|Overall Study|Adverse Event|1
144105|NCT00721734|514750|P1|Overall Study|Adverse Event|3
144106|NCT00721734|514746|P5|Overall Study|Progressive Disease|2
144107|NCT00721734|514747|P4|Overall Study|Progressive Disease|5
144108|NCT00721734|514748|P3|Overall Study|Progressive Disease|4
144109|NCT00721734|514749|P2|Overall Study|Progressive Disease|10
144110|NCT00721734|514750|P1|Overall Study|Progressive Disease|3
144111|NCT00721630|514862|P1|Overall Study|Participant found to be ineligible|1
144112|NCT00721578|514891|P2|Overall Study|Withdrawal by Subject|1
144113|NCT00721578|514892|P1|Overall Study|Withdrawal by Subject|1
144114|NCT00721578|514891|P2|Overall Study|Death|1
144115|NCT00721578|514892|P1|Overall Study|Death|1
144116|NCT00721409|514935|P3|Overall Study|Death|0
144117|NCT00721409|514936|P2|Overall Study|Death|1
144118|NCT00721409|514937|P1|Overall Study|Death|0
144119|NCT00721409|514935|P3|Overall Study|Adverse Event|2
144120|NCT00721409|514936|P2|Overall Study|Adverse Event|11
144121|NCT00721409|514937|P1|Overall Study|Adverse Event|0
144122|NCT00721409|514935|P3|Overall Study|Reason not specified|5
144123|NCT00721409|514936|P2|Overall Study|Reason not specified|1
144124|NCT00721409|514937|P1|Overall Study|Reason not specified|0
144125|NCT00721409|514935|P3|Overall Study|Withdrawal by Subject|6
144126|NCT00721409|514936|P2|Overall Study|Withdrawal by Subject|5
144127|NCT00721409|514937|P1|Overall Study|Withdrawal by Subject|1
144128|NCT00721409|514935|P3|Overall Study|Objective progression or relapse|57
144129|NCT00721409|514936|P2|Overall Study|Objective progression or relapse|42
144130|NCT00721409|514937|P1|Overall Study|Objective progression or relapse|7
144131|NCT00721409|514935|P3|Overall Study|Global deterioration of health status|3
144132|NCT00721409|514936|P2|Overall Study|Global deterioration of health status|5
144133|NCT00721409|514937|P1|Overall Study|Global deterioration of health status|2
144134|NCT00721409|514935|P3|Overall Study|Ongoing at date of cutoff|8
144135|NCT00721409|514936|P2|Overall Study|Ongoing at date of cutoff|19
144136|NCT00721409|514937|P1|Overall Study|Ongoing at date of cutoff|2
144137|NCT00721396|515064|P4|Overall Study|Administrative reason|0
144138|NCT00721396|515065|P3|Overall Study|Administrative reason|1
144139|NCT00721396|515066|P2|Overall Study|Administrative reason|0
144140|NCT00721396|515067|P1|Overall Study|Administrative reason|3
144141|NCT00721396|515064|P4|Overall Study|Inappropriate enrollment|0
144142|NCT00721396|515065|P3|Overall Study|Inappropriate enrollment|0
144143|NCT00721396|515066|P2|Overall Study|Inappropriate enrollment|2
144144|NCT00721396|515067|P1|Overall Study|Inappropriate enrollment|0
144145|NCT00721396|515064|P4|Overall Study|Protocol Violation|0
144146|NCT00721396|515065|P3|Overall Study|Protocol Violation|1
144147|NCT00721396|515066|P2|Overall Study|Protocol Violation|3
144148|NCT00721396|515067|P1|Overall Study|Protocol Violation|4
144149|NCT00721396|515064|P4|Overall Study|Lost to Follow-up|3
144150|NCT00721396|515065|P3|Overall Study|Lost to Follow-up|3
144151|NCT00721396|515066|P2|Overall Study|Lost to Follow-up|9
144152|NCT00721396|515067|P1|Overall Study|Lost to Follow-up|7
144153|NCT00721396|515064|P4|Overall Study|Withdrawal by Subject|7
144154|NCT00721396|515065|P3|Overall Study|Withdrawal by Subject|3
144155|NCT00721396|515066|P2|Overall Study|Withdrawal by Subject|15
144156|NCT00721396|515067|P1|Overall Study|Withdrawal by Subject|12
144157|NCT00721396|515064|P4|Overall Study|Adverse Event|0
144158|NCT00721396|515065|P3|Overall Study|Adverse Event|2
144159|NCT00721396|515066|P2|Overall Study|Adverse Event|7
144160|NCT00721396|515067|P1|Overall Study|Adverse Event|4
144161|NCT00721279|515114|P2|Overall Study|Other|16
144162|NCT00721279|515115|P1|Overall Study|Other|12
144163|NCT00721279|515114|P2|Overall Study|Withdrawal by Subject|3
144164|NCT00721279|515115|P1|Overall Study|Withdrawal by Subject|13
144165|NCT00721279|515114|P2|Overall Study|Tolerability insufficient|2
144166|NCT00721279|515115|P1|Overall Study|Tolerability insufficient|5
144167|NCT00721279|515114|P2|Overall Study|Lack of Efficacy|3
144168|NCT00721279|515115|P1|Overall Study|Lack of Efficacy|6
144169|NCT00721227|515143|P2|Overall Study|Noncompliance with scheduled visits.|0
144170|NCT00721227|515144|P1|Overall Study|Noncompliance with scheduled visits.|1
144171|NCT00721227|515143|P2|Overall Study|Lost to Follow-up|0
144172|NCT00721227|515144|P1|Overall Study|Lost to Follow-up|3
144173|NCT00721214|515154|P1|Overall Study|Death|3
144174|NCT00721214|515154|P1|Overall Study|Chose another center for transplant|1
144175|NCT00721149|515204|P1|Overall Study|Physician Decision|1
144176|NCT00721123|515238|P1|Overall Study|Withdrawal by Subject|5
144177|NCT00721123|515238|P1|Overall Study|Failure to Return|9
144178|NCT00721123|515238|P1|Overall Study|Refused Treatment|41
144179|NCT00721123|515238|P1|Overall Study|Protocol Violation|1
144180|NCT00721123|515238|P1|Overall Study|Insufficient Therapeutic Response|21
144181|NCT00721123|515238|P1|Overall Study|Death|10
144182|NCT00721123|515238|P1|Overall Study|Adverse Event|96
144183|NCT00721110|515316|P4|Overall Study|vertical incision|0
144184|NCT00721110|515317|P3|Overall Study|vertical incision|1
144185|NCT00721110|515318|P2|Overall Study|vertical incision|0
144186|NCT00721110|515319|P1|Overall Study|vertical incision|0
144187|NCT00721110|515316|P4|Overall Study|Ultram use|0
144188|NCT00721110|515317|P3|Overall Study|Ultram use|0
144189|NCT00721110|515318|P2|Overall Study|Ultram use|0
144190|NCT00721110|515319|P1|Overall Study|Ultram use|1
144191|NCT00720941|515347|P2|Overall Study|Ongoing|23
144192|NCT00720941|515348|P1|Overall Study|Ongoing|34
144193|NCT00720941|515347|P2|Overall Study|Withdrawal by Subject|35
144194|NCT00720941|515348|P1|Overall Study|Withdrawal by Subject|27
144195|NCT00720941|515347|P2|Overall Study|Physician Decision|5
144196|NCT00720941|515348|P1|Overall Study|Physician Decision|1
144197|NCT00720941|515347|P2|Overall Study|Lost to Follow-up|15
144198|NCT00720941|515348|P1|Overall Study|Lost to Follow-up|17
144199|NCT00720941|515347|P2|Overall Study|Protocol Violation|2
144200|NCT00720941|515348|P1|Overall Study|Protocol Violation|0
144201|NCT00720941|515347|P2|Overall Study|Death|335
144202|NCT00720941|515348|P1|Overall Study|Death|334
144203|NCT00720798|515388|P1|Overall Study|Reason not Specified|83
144204|NCT00720798|515388|P1|Overall Study|Failure to Return|46
144205|NCT00720798|515388|P1|Overall Study|Refused Treatment|151
144206|NCT00720798|515388|P1|Overall Study|Protocol Violation|4
144207|NCT00720798|515388|P1|Overall Study|Insufficient Therapeutic Response|129
144208|NCT00720798|515388|P1|Overall Study|Death|39
144209|NCT00720798|515388|P1|Overall Study|Adverse Event|304
144210|NCT00720759|515411|P4|Overall Study|Lost to Follow-up|0
144211|NCT00720759|515412|P3|Overall Study|Lost to Follow-up|1
144212|NCT00720759|515413|P2|Overall Study|Lost to Follow-up|1
144213|NCT00720759|515414|P1|Overall Study|Lost to Follow-up|0
144214|NCT00720499|515434|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
144215|NCT00720499|515435|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
144216|NCT00720499|515434|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
144217|NCT00720499|515435|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
144218|NCT00720499|515434|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
144219|NCT00720499|515435|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
144220|NCT00720434|515528|P4|Open-Label Period (Week 5-72)|Other|2
144221|NCT00720434|515529|P3|Open-Label Period (Week 5-72)|Other|3
144222|NCT00720434|515530|P2|Open-Label Period (Week 5-72)|Other|3
144223|NCT00720434|515531|P1|Open-Label Period (Week 5-72)|Other|4
144224|NCT00720434|515528|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
144225|NCT00720434|515529|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
144226|NCT00720434|515530|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
144227|NCT00720434|515531|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
144228|NCT00720434|515528|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
144229|NCT00720434|515529|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
144230|NCT00720434|515530|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
144231|NCT00720434|515531|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
144232|NCT00720434|515528|P4|Open-Label Period (Week 5-72)|Adverse Event|2
144233|NCT00720434|515529|P3|Open-Label Period (Week 5-72)|Adverse Event|0
144234|NCT00720434|515530|P2|Open-Label Period (Week 5-72)|Adverse Event|0
144235|NCT00720434|515531|P1|Open-Label Period (Week 5-72)|Adverse Event|0
144236|NCT00720434|515528|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
144237|NCT00720434|515529|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
144238|NCT00720434|515530|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
144239|NCT00720434|515531|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
144240|NCT00720382|515555|P2|Overall Study|administrative|5
144241|NCT00720382|515556|P1|Overall Study|administrative|14
144242|NCT00720382|515555|P2|Overall Study|Lost to Follow-up|14
144243|NCT00720382|515556|P1|Overall Study|Lost to Follow-up|28
144244|NCT00720382|515555|P2|Overall Study|Withdrawal by Subject|11
144245|NCT00720382|515556|P1|Overall Study|Withdrawal by Subject|47
144246|NCT00720382|515555|P2|Overall Study|Non-Compliance|5
144247|NCT00720382|515556|P1|Overall Study|Non-Compliance|15
144248|NCT00720382|515555|P2|Overall Study|Lack of Efficacy|7
144249|NCT00720382|515556|P1|Overall Study|Lack of Efficacy|18
144250|NCT00720382|515555|P2|Overall Study|Adverse Event|17
144251|NCT00720382|515556|P1|Overall Study|Adverse Event|54
144252|NCT00720343|515575|P1|Overall Study|No data|3
144253|NCT00720343|515575|P1|Overall Study|Physician Decision|3
144254|NCT00720278|515609|P3|Overall Study|eligibility criteria violation|1
144255|NCT00720278|515610|P2|Overall Study|eligibility criteria violation|0
144256|NCT00720278|515611|P1|Overall Study|eligibility criteria violation|1
144257|NCT00720278|515609|P3|Overall Study|Non-compliance|0
144258|NCT00720278|515610|P2|Overall Study|Non-compliance|0
144259|NCT00720278|515611|P1|Overall Study|Non-compliance|1
144260|NCT00720278|515609|P3|Overall Study|Lost to Follow-up|1
144261|NCT00720278|515610|P2|Overall Study|Lost to Follow-up|0
144262|NCT00720278|515611|P1|Overall Study|Lost to Follow-up|0
144263|NCT00720278|515609|P3|Overall Study|Withdrawal by Subject|0
144264|NCT00720278|515610|P2|Overall Study|Withdrawal by Subject|1
144265|NCT00720278|515611|P1|Overall Study|Withdrawal by Subject|0
144266|NCT00720278|515609|P3|Overall Study|Adverse Event|4
144267|NCT00720278|515610|P2|Overall Study|Adverse Event|3
144268|NCT00720278|515611|P1|Overall Study|Adverse Event|5
144269|NCT00720226|515633|P2|Overall Study|Withdrawal by Subject|4
144270|NCT00720226|515634|P1|Overall Study|Withdrawal by Subject|7
144271|NCT00720122|515642|P1|Overall Study|Withdrawal by Subject|7
144272|NCT00720122|515642|P1|Overall Study|Physician Decision|1
144273|NCT00720122|515642|P1|Overall Study|Lost to Follow-up|1
144274|NCT00720109|515646|P3|Risk Stratification Period|Development of second malignant neoplasm|0
144275|NCT00720109|515647|P2|Risk Stratification Period|Development of second malignant neoplasm|1
144276|NCT00720109|515648|P1|Risk Stratification Period|Development of second malignant neoplasm|0
144277|NCT00720109|515646|P3|Risk Stratification Period|Disease progression or relapse|0
144278|NCT00720109|515647|P2|Risk Stratification Period|Disease progression or relapse|2
144279|NCT00720109|515648|P1|Risk Stratification Period|Disease progression or relapse|0
144280|NCT00720109|515646|P3|Risk Stratification Period|Bone marrow transplant|7
144281|NCT00720109|515647|P2|Risk Stratification Period|Bone marrow transplant|9
144282|NCT00720109|515648|P1|Risk Stratification Period|Bone marrow transplant|0
144283|NCT00720109|515646|P3|Risk Stratification Period|Physician Decision|1
144284|NCT00720109|515647|P2|Risk Stratification Period|Physician Decision|2
144285|NCT00720109|515648|P1|Risk Stratification Period|Physician Decision|0
144286|NCT00720109|515646|P3|Risk Stratification Period|Adverse Event|0
144287|NCT00720109|515647|P2|Risk Stratification Period|Adverse Event|1
144288|NCT00720109|515648|P1|Risk Stratification Period|Adverse Event|0
144289|NCT00720109|515646|P3|Induction Period|Physician Decision|0
144290|NCT00720109|515647|P2|Induction Period|Physician Decision|0
144291|NCT00720109|515648|P1|Induction Period|Physician Decision|1
144292|NCT00720109|515646|P3|Induction Period|Bone Marrow Transplant|0
144293|NCT00720109|515647|P2|Induction Period|Bone Marrow Transplant|0
144294|NCT00720109|515648|P1|Induction Period|Bone Marrow Transplant|2
144295|NCT00720109|515646|P3|Induction Period|Did not meet eligibility criteria|0
144296|NCT00720109|515647|P2|Induction Period|Did not meet eligibility criteria|0
144297|NCT00720109|515648|P1|Induction Period|Did not meet eligibility criteria|3
144298|NCT00720096|515668|P2|Overall Study|Withdrawal by Subject|2
144299|NCT00720096|515669|P1|Overall Study|Withdrawal by Subject|0
144300|NCT00720083|515681|P2|Overall Study|Ineligible|2
144301|NCT00720083|515682|P1|Overall Study|Ineligible|1
144302|NCT00720057|515690|P2|Overall Study|Withdrawal by Subject|1
144303|NCT00720057|515691|P1|Overall Study|Withdrawal by Subject|0
144304|NCT00720057|515690|P2|Overall Study|Protocol Violation|0
144305|NCT00720057|515691|P1|Overall Study|Protocol Violation|1
144306|NCT00720057|515690|P2|Overall Study|Lost to Follow-up|2
144307|NCT00720057|515691|P1|Overall Study|Lost to Follow-up|0
144308|NCT00719953|515707|P1|Overall Study|Adverse Event|4
144309|NCT00719901|515720|P1|Overall Study|Availability of Study Drug|1
144310|NCT00719901|515720|P1|Overall Study|Disease Progression|3
144311|NCT00719901|515720|P1|Overall Study|Alternate Treatment|1
144312|NCT00719901|515720|P1|Overall Study|Withdrawal by Subject|1
144313|NCT00719901|515720|P1|Overall Study|Adverse Event|5
144314|NCT00719862|515732|P2|Overall Study|Other|3
144315|NCT00719862|515733|P1|Overall Study|Other|2
144316|NCT00719862|515732|P2|Overall Study|Lost to Follow-up|1
144317|NCT00719862|515733|P1|Overall Study|Lost to Follow-up|0
144318|NCT00719862|515732|P2|Overall Study|Withdrawal by Subject|0
144319|NCT00719862|515733|P1|Overall Study|Withdrawal by Subject|1
144320|NCT00719862|515732|P2|Overall Study|Non-Compliance|0
144321|NCT00719862|515733|P1|Overall Study|Non-Compliance|1
144322|NCT00719862|515732|P2|Overall Study|Lack of Efficacy|0
144323|NCT00719862|515733|P1|Overall Study|Lack of Efficacy|3
144324|NCT00719862|515732|P2|Overall Study|Adverse Event|2
144325|NCT00719862|515733|P1|Overall Study|Adverse Event|1
144326|NCT00719849|515751|P2|Overall Study|Death|1
144327|NCT00719849|515752|P1|Overall Study|Death|0
144328|NCT00719810|515791|P3|Overall Study|Withdrawal by Subject|2
144329|NCT00719810|515792|P2|Overall Study|Withdrawal by Subject|1
144330|NCT00719810|515793|P1|Overall Study|Withdrawal by Subject|1
144331|NCT00719810|515791|P3|Overall Study|Physician Decision|0
144332|NCT00719810|515792|P2|Overall Study|Physician Decision|1
144333|NCT00719810|515793|P1|Overall Study|Physician Decision|0
144334|NCT00719810|515791|P3|Overall Study|Lost to Follow-up|3
144335|NCT00719810|515792|P2|Overall Study|Lost to Follow-up|0
144336|NCT00719810|515793|P1|Overall Study|Lost to Follow-up|2
144337|NCT00719810|515791|P3|Overall Study|Adverse Event|3
144338|NCT00719810|515792|P2|Overall Study|Adverse Event|2
144339|NCT00719810|515793|P1|Overall Study|Adverse Event|0
144340|NCT00719732|515804|P1|Overall Study|Illness not associated with device|1
144341|NCT00719732|515804|P1|Overall Study|Unilateral (not bilateral) implantation|1
144342|NCT00719732|515804|P1|Overall Study|Lost to Follow-up|20
144343|NCT00719706|515810|P2|Overall Study|Protocol Violation|0
144344|NCT00719706|515811|P1|Overall Study|Protocol Violation|3
144345|NCT00719706|515810|P2|Overall Study|Withdrawal by Subject|2
144346|NCT00719706|515811|P1|Overall Study|Withdrawal by Subject|1
144347|NCT00719706|515810|P2|Overall Study|Adverse Event|4
144348|NCT00719706|515811|P1|Overall Study|Adverse Event|5
144349|NCT00719680|515825|P1|Overall Study|Withdrawal by Subject|3
144350|NCT00719680|515825|P1|Overall Study|Lost to Follow-up|1
144351|NCT00719680|515825|P1|Overall Study|Adverse Event|1
144352|NCT00719563|515881|P2|Overall Study|Lost to Follow-up|3
144353|NCT00719563|515882|P1|Overall Study|Lost to Follow-up|5
144354|NCT00719563|515881|P2|Overall Study|Noncompliant|1
144355|NCT00719563|515882|P1|Overall Study|Noncompliant|1
144356|NCT00719563|515881|P2|Overall Study|Unknown reasons|6
144357|NCT00719563|515882|P1|Overall Study|Unknown reasons|4
144358|NCT00719563|515881|P2|Overall Study|Personal reasons|7
144359|NCT00719563|515882|P1|Overall Study|Personal reasons|6
144360|NCT00719563|515881|P2|Overall Study|Lack of Efficacy|7
144361|NCT00719563|515882|P1|Overall Study|Lack of Efficacy|3
144362|NCT00719563|515881|P2|Overall Study|Medical condition changed|5
144363|NCT00719563|515882|P1|Overall Study|Medical condition changed|3
144364|NCT00719563|515881|P2|Overall Study|Adverse Event|13
144365|NCT00719563|515882|P1|Overall Study|Adverse Event|16
144366|NCT00719537|515914|P2|Overall Study|Lost to Follow-up|1
144367|NCT00719537|515915|P1|Overall Study|Lost to Follow-up|0
144368|NCT00719537|515914|P2|Overall Study|Withdrawal by Subject|0
144369|NCT00719537|515915|P1|Overall Study|Withdrawal by Subject|1
144370|NCT00719472|515921|P1|Received Cycle 2 Treatment|Various Reasons|25
144371|NCT00719472|515921|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
144372|NCT00719472|515921|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
144373|NCT00719472|515921|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
144374|NCT00719472|515921|P1|Received Cycle 2 Treatment|Disease progression|3
144375|NCT00719472|515921|P1|Received Cycle 2 Treatment|Death|6
144376|NCT00719472|515921|P1|Received Cycle 2 Treatment|Adverse Event|12
144377|NCT00719472|515921|P1|Received Cycle 1 Treatment|Various Reasons|13
144378|NCT00719472|515921|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
144379|NCT00719472|515921|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
144380|NCT00719472|515921|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
144381|NCT00719472|515921|P1|Received Cycle 1 Treatment|Death|5
144382|NCT00719472|515921|P1|Received Cycle 1 Treatment|Adverse Event|8
144383|NCT00719472|515921|P1|Enrolled in Study|Various Reasons|17
144384|NCT00719472|515921|P1|Enrolled in Study|Subject decision to withdraw|8
144385|NCT00719472|515921|P1|Enrolled in Study|Physician decision to withdraw patient|1
144386|NCT00719355|515932|P2|Overall Study|Moved|1
144387|NCT00719355|515933|P1|Overall Study|Moved|0
144388|NCT00719355|515932|P2|Overall Study|Compliance|6
144389|NCT00719355|515933|P1|Overall Study|Compliance|4
144390|NCT00719355|515932|P2|Overall Study|Medical|5
144391|NCT00719355|515933|P1|Overall Study|Medical|14
144392|NCT00719355|515932|P2|Overall Study|Death|1
144393|NCT00719355|515933|P1|Overall Study|Death|0
144394|NCT00719264|515962|P2|Overall Study|Disease Progression|107
144395|NCT00719264|515963|P1|Overall Study|Disease Progression|104
144396|NCT00719264|515962|P2|Overall Study|New Cancer Therapy|2
144397|NCT00719264|515963|P1|Overall Study|New Cancer Therapy|4
144398|NCT00719264|515962|P2|Overall Study|Protocol Deviation|3
144399|NCT00719264|515963|P1|Overall Study|Protocol Deviation|1
144400|NCT00719264|515962|P2|Overall Study|Withdrawal by Subject|7
144401|NCT00719264|515963|P1|Overall Study|Withdrawal by Subject|12
144402|NCT00719264|515962|P2|Overall Study|Lost to Follow-up|1
144403|NCT00719264|515963|P1|Overall Study|Lost to Follow-up|1
144404|NCT00719264|515962|P2|Overall Study|Administrative Problems|4
144405|NCT00719264|515963|P1|Overall Study|Administrative Problems|6
144406|NCT00719264|515962|P2|Overall Study|Death|10
144407|NCT00719264|515963|P1|Overall Study|Death|13
144408|NCT00719264|515962|P2|Overall Study|Adverse Event|49
144409|NCT00719264|515963|P1|Overall Study|Adverse Event|41
144410|NCT00719212|515982|P1|Overall Study|Withdrawal by Subject|1
144411|NCT00719212|515982|P1|Overall Study|Lost to Follow-up|2
144412|NCT00719212|515982|P1|Overall Study|Death|41
144413|NCT00719043|516030|P7|Overall Study|Withdrawal by Subject|14
144414|NCT00719043|516031|P6|Overall Study|Withdrawal by Subject|18
144415|NCT00719043|516032|P5|Overall Study|Withdrawal by Subject|16
144416|NCT00719043|516033|P4|Overall Study|Withdrawal by Subject|10
144417|NCT00719043|516034|P3|Overall Study|Withdrawal by Subject|9
144418|NCT00719043|516035|P2|Overall Study|Withdrawal by Subject|14
144419|NCT00719043|516036|P1|Overall Study|Withdrawal by Subject|12
144420|NCT00719043|516030|P7|Overall Study|Other|1
144421|NCT00719043|516031|P6|Overall Study|Other|2
144422|NCT00719043|516032|P5|Overall Study|Other|0
144423|NCT00719043|516033|P4|Overall Study|Other|2
144424|NCT00719043|516034|P3|Overall Study|Other|1
144425|NCT00719043|516035|P2|Overall Study|Other|0
144426|NCT00719043|516036|P1|Overall Study|Other|1
144427|NCT00719043|516030|P7|Overall Study|Protocol Violation|0
144428|NCT00719043|516031|P6|Overall Study|Protocol Violation|1
144429|NCT00719043|516032|P5|Overall Study|Protocol Violation|0
144430|NCT00719043|516033|P4|Overall Study|Protocol Violation|0
144431|NCT00719043|516034|P3|Overall Study|Protocol Violation|0
144432|NCT00719043|516035|P2|Overall Study|Protocol Violation|0
144433|NCT00719043|516036|P1|Overall Study|Protocol Violation|0
144434|NCT00719043|516030|P7|Overall Study|Lost to Follow-up|9
144435|NCT00719043|516031|P6|Overall Study|Lost to Follow-up|9
144436|NCT00719043|516032|P5|Overall Study|Lost to Follow-up|10
144437|NCT00719043|516033|P4|Overall Study|Lost to Follow-up|9
144438|NCT00719043|516034|P3|Overall Study|Lost to Follow-up|8
144439|NCT00719043|516035|P2|Overall Study|Lost to Follow-up|10
144440|NCT00719043|516036|P1|Overall Study|Lost to Follow-up|14
144441|NCT00719043|516030|P7|Overall Study|Adverse Event|4
144442|NCT00719043|516031|P6|Overall Study|Adverse Event|4
144443|NCT00719043|516032|P5|Overall Study|Adverse Event|1
144444|NCT00719043|516033|P4|Overall Study|Adverse Event|2
144445|NCT00719043|516034|P3|Overall Study|Adverse Event|2
144446|NCT00719043|516035|P2|Overall Study|Adverse Event|1
144447|NCT00719043|516036|P1|Overall Study|Adverse Event|5
144448|NCT00718887|516160|P2|Overall Study|Not identified|7
144449|NCT00718887|516161|P1|Overall Study|Not identified|2
144450|NCT00718887|516160|P2|Overall Study|Withdrawal by Subject|2
144451|NCT00718887|516161|P1|Overall Study|Withdrawal by Subject|3
144452|NCT00718861|516185|P2|Overall Study|Death|5
144453|NCT00718861|516186|P1|Overall Study|Death|1
144454|NCT00718861|516185|P2|Overall Study|Administrative Problems|1
144455|NCT00718861|516186|P1|Overall Study|Administrative Problems|1
144456|NCT00718861|516185|P2|Overall Study|Lost to Follow-up|1
144457|NCT00718861|516186|P1|Overall Study|Lost to Follow-up|2
144458|NCT00718861|516185|P2|Overall Study|Adverse Event|1
144459|NCT00718861|516186|P1|Overall Study|Adverse Event|2
144460|NCT00718861|516185|P2|Overall Study|Withdrawal by Subject|10
144461|NCT00718861|516186|P1|Overall Study|Withdrawal by Subject|15
144462|NCT00718809|516214|P2|Overall Study|Noncompliance|0
144463|NCT00718809|516215|P1|Overall Study|Noncompliance|1
144464|NCT00718809|516214|P2|Overall Study|Lost to Follow-up|0
144465|NCT00718809|516215|P1|Overall Study|Lost to Follow-up|1
144466|NCT00718809|516214|P2|Overall Study|Withdrawal by Subject|1
144467|NCT00718809|516215|P1|Overall Study|Withdrawal by Subject|0
144468|NCT00718809|516214|P2|Overall Study|Adverse Event|1
144469|NCT00718809|516215|P1|Overall Study|Adverse Event|1
144470|NCT00718809|516214|P2|Overall Study|Disease progression|7
144471|NCT00718809|516215|P1|Overall Study|Disease progression|9
144472|NCT00718770|516229|P1|Overall Study|Adverse Event|1
144473|NCT00718770|516229|P1|Overall Study|Lack of Efficacy|1
144474|NCT00718770|516229|P1|Overall Study|Adverse Event|1
144475|NCT00718770|516229|P1|Overall Study|Lack of Efficacy|1
144476|NCT00718770|516229|P1|Overall Study|Adverse Event|1
144477|NCT00718770|516229|P1|Overall Study|Lack of Efficacy|1
144478|NCT00718770|516229|P1|Overall Study|Lack of Efficacy|1
144479|NCT00718770|516229|P1|Overall Study|Adverse Event|1
144480|NCT00718718|516240|P10|Week 12 to End of Study|Other|0
144481|NCT00718718|516241|P9|Week 12 to End of Study|Other|0
144482|NCT00718718|516242|P8|Week 12 to End of Study|Other|0
144483|NCT00718718|516243|P7|Week 12 to End of Study|Other|1
144484|NCT00718718|516244|P6|Week 12 to End of Study|Other|0
144485|NCT00718718|516245|P5|Week 12 to End of Study|Other|0
144486|NCT00718718|516246|P4|Week 12 to End of Study|Other|1
144487|NCT00718718|516247|P3|Week 12 to End of Study|Other|0
144488|NCT00718718|516248|P2|Week 12 to End of Study|Other|1
144489|NCT00718718|516249|P1|Week 12 to End of Study|Other|0
144490|NCT00718718|516240|P10|Week 12 to End of Study|Lost to Follow-up|0
144491|NCT00718718|516241|P9|Week 12 to End of Study|Lost to Follow-up|1
144492|NCT00718718|516242|P8|Week 12 to End of Study|Lost to Follow-up|0
144493|NCT00718718|516243|P7|Week 12 to End of Study|Lost to Follow-up|0
144494|NCT00718718|516244|P6|Week 12 to End of Study|Lost to Follow-up|0
144495|NCT00718718|516245|P5|Week 12 to End of Study|Lost to Follow-up|0
144496|NCT00718718|516246|P4|Week 12 to End of Study|Lost to Follow-up|0
144497|NCT00718718|516247|P3|Week 12 to End of Study|Lost to Follow-up|0
144498|NCT00718718|516248|P2|Week 12 to End of Study|Lost to Follow-up|0
144499|NCT00718718|516249|P1|Week 12 to End of Study|Lost to Follow-up|0
144500|NCT00718718|516240|P10|Week 12 to End of Study|Withdrawal by Subject|0
144501|NCT00718718|516241|P9|Week 12 to End of Study|Withdrawal by Subject|0
144502|NCT00718718|516242|P8|Week 12 to End of Study|Withdrawal by Subject|0
144503|NCT00718718|516243|P7|Week 12 to End of Study|Withdrawal by Subject|1
144504|NCT00718718|516244|P6|Week 12 to End of Study|Withdrawal by Subject|2
144505|NCT00718718|516245|P5|Week 12 to End of Study|Withdrawal by Subject|0
144506|NCT00718718|516246|P4|Week 12 to End of Study|Withdrawal by Subject|0
144507|NCT00718718|516247|P3|Week 12 to End of Study|Withdrawal by Subject|0
144508|NCT00718718|516248|P2|Week 12 to End of Study|Withdrawal by Subject|0
144509|NCT00718718|516249|P1|Week 12 to End of Study|Withdrawal by Subject|0
144510|NCT00718718|516240|P10|Week 12 to End of Study|Death|0
144511|NCT00718718|516241|P9|Week 12 to End of Study|Death|0
144512|NCT00718718|516242|P8|Week 12 to End of Study|Death|0
144513|NCT00718718|516243|P7|Week 12 to End of Study|Death|0
144514|NCT00718718|516244|P6|Week 12 to End of Study|Death|1
144515|NCT00718718|516245|P5|Week 12 to End of Study|Death|0
144516|NCT00718718|516246|P4|Week 12 to End of Study|Death|0
144517|NCT00718718|516247|P3|Week 12 to End of Study|Death|0
144518|NCT00718718|516248|P2|Week 12 to End of Study|Death|0
144519|NCT00718718|516249|P1|Week 12 to End of Study|Death|0
144520|NCT00718718|516240|P10|Week 12 to End of Study|Adverse Event|0
144521|NCT00718718|516241|P9|Week 12 to End of Study|Adverse Event|0
144522|NCT00718718|516242|P8|Week 12 to End of Study|Adverse Event|1
144523|NCT00718718|516243|P7|Week 12 to End of Study|Adverse Event|0
144524|NCT00718718|516244|P6|Week 12 to End of Study|Adverse Event|0
144525|NCT00718718|516245|P5|Week 12 to End of Study|Adverse Event|0
144526|NCT00718718|516246|P4|Week 12 to End of Study|Adverse Event|0
144527|NCT00718718|516247|P3|Week 12 to End of Study|Adverse Event|0
144528|NCT00718718|516248|P2|Week 12 to End of Study|Adverse Event|0
144529|NCT00718718|516249|P1|Week 12 to End of Study|Adverse Event|0
144530|NCT00718718|516240|P10|Prior to Week 12|Other|0
144531|NCT00718718|516241|P9|Prior to Week 12|Other|0
144532|NCT00718718|516242|P8|Prior to Week 12|Other|0
144533|NCT00718718|516243|P7|Prior to Week 12|Other|0
144534|NCT00718718|516244|P6|Prior to Week 12|Other|0
144535|NCT00718718|516245|P5|Prior to Week 12|Other|0
144536|NCT00718718|516246|P4|Prior to Week 12|Other|0
144537|NCT00718718|516247|P3|Prior to Week 12|Other|1
144538|NCT00718718|516248|P2|Prior to Week 12|Other|0
144539|NCT00718718|516249|P1|Prior to Week 12|Other|1
144540|NCT00718718|516240|P10|Prior to Week 12|Withdrawal by Subject|0
144541|NCT00718718|516241|P9|Prior to Week 12|Withdrawal by Subject|1
144542|NCT00718718|516242|P8|Prior to Week 12|Withdrawal by Subject|1
144543|NCT00718718|516243|P7|Prior to Week 12|Withdrawal by Subject|1
144544|NCT00718718|516244|P6|Prior to Week 12|Withdrawal by Subject|0
144545|NCT00718718|516245|P5|Prior to Week 12|Withdrawal by Subject|3
144546|NCT00718718|516246|P4|Prior to Week 12|Withdrawal by Subject|0
144547|NCT00718718|516247|P3|Prior to Week 12|Withdrawal by Subject|0
144548|NCT00718718|516248|P2|Prior to Week 12|Withdrawal by Subject|0
144549|NCT00718718|516249|P1|Prior to Week 12|Withdrawal by Subject|0
144550|NCT00718718|516240|P10|Prior to Week 12|Adverse Event|0
144551|NCT00718718|516241|P9|Prior to Week 12|Adverse Event|1
144552|NCT00718718|516242|P8|Prior to Week 12|Adverse Event|1
144553|NCT00718718|516243|P7|Prior to Week 12|Adverse Event|0
144554|NCT00718718|516244|P6|Prior to Week 12|Adverse Event|0
144555|NCT00718718|516245|P5|Prior to Week 12|Adverse Event|0
144556|NCT00718718|516246|P4|Prior to Week 12|Adverse Event|0
144557|NCT00718718|516247|P3|Prior to Week 12|Adverse Event|0
144558|NCT00718718|516248|P2|Prior to Week 12|Adverse Event|0
144559|NCT00718718|516249|P1|Prior to Week 12|Adverse Event|0
144560|NCT00718640|516289|P1|Overall Study|Unresolved toxicity after 2 weeks|2
144561|NCT00718640|516289|P1|Overall Study|Death|1
144562|NCT00718640|516289|P1|Overall Study|Adverse Event|4
144563|NCT00718523|516303|P2|Overall Study|Death|17
144564|NCT00718523|516304|P1|Overall Study|Death|13
144565|NCT00718523|516303|P2|Overall Study|Withdrawal by Subject|7
144566|NCT00718523|516304|P1|Overall Study|Withdrawal by Subject|5
144567|NCT00718510|516316|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
144568|NCT00718510|516317|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
144569|NCT00718510|516316|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
144570|NCT00718510|516317|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
144571|NCT00718328|516329|P2|Overall Study|Lost to Follow-up|0
144572|NCT00718328|516330|P1|Overall Study|Lost to Follow-up|1
144573|NCT00718315|516339|P3|Overall Study|Use of ATB and Corticoids|2
144574|NCT00718315|516340|P2|Overall Study|Use of ATB and Corticoids|1
144575|NCT00718315|516341|P1|Overall Study|Use of ATB and Corticoids|0
144576|NCT00718315|516339|P3|Overall Study|Other|1
144577|NCT00718315|516340|P2|Overall Study|Other|0
144578|NCT00718315|516341|P1|Overall Study|Other|0
144579|NCT00718315|516339|P3|Overall Study|Disease progression|1
144580|NCT00718315|516340|P2|Overall Study|Disease progression|1
144581|NCT00718315|516341|P1|Overall Study|Disease progression|0
144582|NCT00718315|516339|P3|Overall Study|Use of Minocyclin|1
144583|NCT00718315|516340|P2|Overall Study|Use of Minocyclin|1
144584|NCT00718315|516341|P1|Overall Study|Use of Minocyclin|1
144585|NCT00718315|516339|P3|Overall Study|Erlotinib dose decreased|1
144586|NCT00718315|516340|P2|Overall Study|Erlotinib dose decreased|3
144587|NCT00718315|516341|P1|Overall Study|Erlotinib dose decreased|4
144588|NCT00718315|516339|P3|Overall Study|Protocol Violation|3
144589|NCT00718315|516340|P2|Overall Study|Protocol Violation|5
144590|NCT00718315|516341|P1|Overall Study|Protocol Violation|5
144591|NCT00718315|516339|P3|Overall Study|Lost to Follow-up|4
144592|NCT00718315|516340|P2|Overall Study|Lost to Follow-up|3
144593|NCT00718315|516341|P1|Overall Study|Lost to Follow-up|2
144594|NCT00718315|516339|P3|Overall Study|Death|5
144595|NCT00718315|516340|P2|Overall Study|Death|6
144596|NCT00718315|516341|P1|Overall Study|Death|6
144597|NCT00718315|516339|P3|Overall Study|Adverse Event|3
144598|NCT00718315|516340|P2|Overall Study|Adverse Event|2
144599|NCT00718315|516341|P1|Overall Study|Adverse Event|1
144600|NCT00718237|516392|P2|Overall Study|Withdrawal by Subject|10
144601|NCT00718237|516393|P1|Overall Study|Withdrawal by Subject|9
144602|NCT00718237|516392|P2|Overall Study|Physician Decision|0
144603|NCT00718237|516393|P1|Overall Study|Physician Decision|1
144604|NCT00718237|516392|P2|Overall Study|Lost to Follow-up|2
144605|NCT00718237|516393|P1|Overall Study|Lost to Follow-up|2
144606|NCT00718237|516392|P2|Overall Study|Adverse Event|3
144607|NCT00718237|516393|P1|Overall Study|Adverse Event|1
144608|NCT00718081|516436|P3|Overall Study|Lack of Efficacy|21
144609|NCT00718081|516437|P2|Overall Study|Lack of Efficacy|3
144610|NCT00718081|516438|P1|Overall Study|Lack of Efficacy|7
144611|NCT00718081|516436|P3|Overall Study|Adverse Event|0
144612|NCT00718081|516437|P2|Overall Study|Adverse Event|1
144613|NCT00718081|516438|P1|Overall Study|Adverse Event|0
144614|NCT00718042|516455|P6|Donor Follow-up|Lost to Follow-up|0
144615|NCT00718042|516456|P5|Donor Follow-up|Lost to Follow-up|19
144616|NCT00718042|516457|P4|Donor Follow-up|Lost to Follow-up|0
144617|NCT00718042|516458|P3|Donor Follow-up|Lost to Follow-up|0
144618|NCT00718042|516459|P2|Donor Follow-up|Lost to Follow-up|0
144619|NCT00718042|516460|P1|Donor Follow-up|Lost to Follow-up|13
144620|NCT00718042|516455|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
144621|NCT00718042|516456|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
144622|NCT00718042|516457|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
144623|NCT00718042|516458|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
144624|NCT00718042|516459|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
144625|NCT00718042|516460|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
144626|NCT00718042|516455|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
144627|NCT00718042|516456|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
144628|NCT00718042|516457|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
144629|NCT00718042|516458|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
144630|NCT00718042|516459|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
144631|NCT00718042|516460|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
144632|NCT00718042|516455|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
144633|NCT00718042|516456|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
144634|NCT00718042|516457|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
144635|NCT00718042|516458|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
144636|NCT00718042|516459|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
144637|NCT00718042|516460|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
144638|NCT00718042|516455|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
144639|NCT00718042|516456|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
144640|NCT00718042|516457|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
144641|NCT00718042|516458|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
144642|NCT00718042|516459|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
144643|NCT00718042|516460|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
144644|NCT00717886|516516|P1|Overall Study|Treatment Failure|1
144645|NCT00717886|516516|P1|Overall Study|Withdrawal by Subject|3
144646|NCT00717860|516531|P2|Overall Study|Withdrew consent|3
144647|NCT00717860|516532|P1|Overall Study|Withdrew consent|7
144648|NCT00717860|516531|P2|Overall Study|Discontinued for other reason|1
144649|NCT00717860|516532|P1|Overall Study|Discontinued for other reason|6
144650|NCT00717860|516531|P2|Overall Study|Lack of Efficacy|13
144651|NCT00717860|516532|P1|Overall Study|Lack of Efficacy|7
144652|NCT00717860|516531|P2|Overall Study|Laboratory adverse experience|2
144653|NCT00717860|516532|P1|Overall Study|Laboratory adverse experience|2
144654|NCT00717860|516531|P2|Overall Study|Clinical adverse experience|9
144655|NCT00717860|516532|P1|Overall Study|Clinical adverse experience|5
144656|NCT00717756|516542|P1|Overall Study|Withdrawal by Subject|1
144657|NCT00717522|516555|P1|Overall Study|Death|1
144658|NCT00717522|516555|P1|Overall Study|Adverse Event|1
144659|NCT00717522|516555|P1|Overall Study|Disease Progression|5
144660|NCT00717366|516591|P2|Extension Period (52 Weeks)|Withdrew consent|1
144661|NCT00717366|516592|P1|Extension Period (52 Weeks)|Withdrew consent|1
144662|NCT00717366|516591|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
144663|NCT00717366|516592|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
144664|NCT00717366|516591|P2|Extension Period (52 Weeks)|Renal transplant|13
144665|NCT00717366|516592|P1|Extension Period (52 Weeks)|Renal transplant|3
144666|NCT00717366|516591|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
144667|NCT00717366|516592|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
144668|NCT00717366|516591|P2|Core Study Period (20 Weeks)|Death|1
144669|NCT00717366|516592|P1|Core Study Period (20 Weeks)|Death|0
144670|NCT00717366|516591|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
144671|NCT00717366|516592|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
144672|NCT00717366|516591|P2|Core Study Period (20 Weeks)|Renal transplant|9
144673|NCT00717366|516592|P1|Core Study Period (20 Weeks)|Renal transplant|4
144674|NCT00717314|516616|P2|Overall Study|Withdrawal by Subject|3
144675|NCT00717314|516617|P1|Overall Study|Withdrawal by Subject|1
144676|NCT00717314|516616|P2|Overall Study|Lost to Follow-up|5
144677|NCT00717314|516617|P1|Overall Study|Lost to Follow-up|1
144678|NCT00717314|516616|P2|Overall Study|Protocol Violation|0
144679|NCT00717314|516617|P1|Overall Study|Protocol Violation|1
144680|NCT00717314|516616|P2|Overall Study|Adverse Event|2
144681|NCT00717314|516617|P1|Overall Study|Adverse Event|3
144682|NCT00717275|516654|P1|Overall Study|Premature study termination.|3
144683|NCT00717249|516660|P2|Overall Study|Headaches|0
144684|NCT00717249|516661|P1|Overall Study|Headaches|1
144685|NCT00717249|516660|P2|Overall Study|Subject relocated|0
144686|NCT00717249|516661|P1|Overall Study|Subject relocated|1
144687|NCT00717249|516660|P2|Overall Study|Diagnosed with Multiple Scletosis|0
144688|NCT00717249|516661|P1|Overall Study|Diagnosed with Multiple Scletosis|1
144689|NCT00717249|516660|P2|Overall Study|Diagnosed with Diabetes|0
144690|NCT00717249|516661|P1|Overall Study|Diagnosed with Diabetes|1
144691|NCT00717249|516660|P2|Overall Study|Gastric Surgery|1
144692|NCT00717249|516661|P1|Overall Study|Gastric Surgery|0
144693|NCT00717249|516660|P2|Overall Study|Unsatisfactory Physiological Response|1
144694|NCT00717249|516661|P1|Overall Study|Unsatisfactory Physiological Response|0
144695|NCT00717249|516660|P2|Overall Study|Subject became Ineligible|1
144696|NCT00717249|516661|P1|Overall Study|Subject became Ineligible|1
144697|NCT00717249|516660|P2|Overall Study|Protocol Violation|2
144698|NCT00717249|516661|P1|Overall Study|Protocol Violation|0
144699|NCT00717249|516660|P2|Overall Study|Pregnancy|3
144700|NCT00717249|516661|P1|Overall Study|Pregnancy|6
144701|NCT00717249|516660|P2|Overall Study|Withdrawal by Subject|2
144702|NCT00717249|516661|P1|Overall Study|Withdrawal by Subject|1
144703|NCT00717249|516660|P2|Overall Study|Lost to Follow-up|0
144704|NCT00717249|516661|P1|Overall Study|Lost to Follow-up|2
144705|NCT00717249|516660|P2|Overall Study|Adverse Event|2
144706|NCT00717249|516661|P1|Overall Study|Adverse Event|4
144707|NCT00717249|516660|P2|Overall Study|Unsatisfactory visual Response|2
144708|NCT00717249|516661|P1|Overall Study|Unsatisfactory visual Response|0
144709|NCT00717249|516660|P2|Overall Study|Lens Discomfort|1
144710|NCT00717249|516661|P1|Overall Study|Lens Discomfort|4
144711|NCT00717236|516675|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
144712|NCT00717236|516676|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
144713|NCT00717236|516675|P2|Open-Label Period|Other: Completion Accidently Performed|0
144714|NCT00717236|516676|P1|Open-Label Period|Other: Completion Accidently Performed|1
144715|NCT00717236|516675|P2|Open-Label Period|Other: Administration of Golimumab|0
144716|NCT00717236|516676|P1|Open-Label Period|Other: Administration of Golimumab|1
144717|NCT00717236|516675|P2|Open-Label Period|Other: Cataract Surgery|0
144718|NCT00717236|516676|P1|Open-Label Period|Other: Cataract Surgery|1
144719|NCT00717236|516675|P2|Open-Label Period|Other: Sponsor Request|0
144720|NCT00717236|516676|P1|Open-Label Period|Other: Sponsor Request|3
144721|NCT00717236|516675|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
144722|NCT00717236|516676|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
144723|NCT00717236|516675|P2|Open-Label Period|Other: Investigator Decision|0
144724|NCT00717236|516676|P1|Open-Label Period|Other: Investigator Decision|1
144725|NCT00717236|516675|P2|Open-Label Period|Other: Moved|0
144726|NCT00717236|516676|P1|Open-Label Period|Other: Moved|1
144727|NCT00717236|516675|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
144728|NCT00717236|516676|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
144729|NCT00717236|516675|P2|Open-Label Period|Other: Lack of Compliance|1
144730|NCT00717236|516676|P1|Open-Label Period|Other: Lack of Compliance|1
144731|NCT00717236|516675|P2|Open-Label Period|Other: Peripheral Neuropathy|1
144732|NCT00717236|516676|P1|Open-Label Period|Other: Peripheral Neuropathy|0
144733|NCT00717236|516675|P2|Open-Label Period|Loss of Efficacy|1
144734|NCT00717236|516676|P1|Open-Label Period|Loss of Efficacy|6
144735|NCT00717236|516675|P2|Open-Label Period|Withdrawal by Subject|2
144736|NCT00717236|516676|P1|Open-Label Period|Withdrawal by Subject|20
144737|NCT00717236|516675|P2|Open-Label Period|Lost to Follow-up|4
144738|NCT00717236|516676|P1|Open-Label Period|Lost to Follow-up|28
144739|NCT00717236|516675|P2|Open-Label Period|Lack of Efficacy|8
144740|NCT00717236|516676|P1|Open-Label Period|Lack of Efficacy|30
144741|NCT00717236|516675|P2|Open-Label Period|Adverse Event|4
144742|NCT00717236|516676|P1|Open-Label Period|Adverse Event|29
144743|NCT00717236|516675|P2|Double-Blind Period|Other: Investigator Decision|1
144744|NCT00717236|516676|P1|Double-Blind Period|Other: Investigator Decision|0
144745|NCT00717236|516675|P2|Double-Blind Period|Other: Transportation problems|1
144746|NCT00717236|516676|P1|Double-Blind Period|Other: Transportation problems|0
144747|NCT00717236|516675|P2|Double-Blind Period|Other: Prohibited medication taken|2
144748|NCT00717236|516676|P1|Double-Blind Period|Other: Prohibited medication taken|2
144749|NCT00717236|516675|P2|Double-Blind Period|Other: Stopped taking DMARD|0
144750|NCT00717236|516676|P1|Double-Blind Period|Other: Stopped taking DMARD|1
144751|NCT00717236|516675|P2|Double-Blind Period|Other: Subject moved|1
144752|NCT00717236|516676|P1|Double-Blind Period|Other: Subject moved|1
144753|NCT00717236|516675|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
144754|NCT00717236|516676|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
144755|NCT00717236|516675|P2|Double-Blind Period|Other: Inappropriate randomization|0
144756|NCT00717236|516676|P1|Double-Blind Period|Other: Inappropriate randomization|1
144757|NCT00717236|516675|P2|Double-Blind Period|Other: Sponsor request|0
144758|NCT00717236|516676|P1|Double-Blind Period|Other: Sponsor request|1
144759|NCT00717236|516675|P2|Double-Blind Period|Other: History of cancer|0
144760|NCT00717236|516676|P1|Double-Blind Period|Other: History of cancer|1
144761|NCT00717236|516675|P2|Double-Blind Period|Other: History of adenoid grown|0
144762|NCT00717236|516676|P1|Double-Blind Period|Other: History of adenoid grown|1
144763|NCT00717236|516675|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
144764|NCT00717236|516676|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
144765|NCT00717236|516675|P2|Double-Blind Period|Other: subject withdrew consent|1
144766|NCT00717236|516676|P1|Double-Blind Period|Other: subject withdrew consent|1
144767|NCT00717236|516675|P2|Double-Blind Period|Other: Screening failure|0
144768|NCT00717236|516676|P1|Double-Blind Period|Other: Screening failure|1
144769|NCT00717236|516675|P2|Double-Blind Period|Other: Site withdrew|0
144770|NCT00717236|516676|P1|Double-Blind Period|Other: Site withdrew|2
144771|NCT00717236|516675|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
144772|NCT00717236|516676|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
144773|NCT00717236|516675|P2|Double-Blind Period|Other: Protocol Violation|0
144774|NCT00717236|516676|P1|Double-Blind Period|Other: Protocol Violation|2
144775|NCT00717236|516675|P2|Double-Blind Period|Other: Pregnancy|0
144776|NCT00717236|516676|P1|Double-Blind Period|Other: Pregnancy|1
144777|NCT00717236|516675|P2|Double-Blind Period|Other: Death|0
144778|NCT00717236|516676|P1|Double-Blind Period|Other: Death|1
144779|NCT00717236|516675|P2|Double-Blind Period|Loss of efficacy|0
144780|NCT00717236|516676|P1|Double-Blind Period|Loss of efficacy|3
144781|NCT00717236|516675|P2|Double-Blind Period|Withdrawal by Subject|2
144782|NCT00717236|516676|P1|Double-Blind Period|Withdrawal by Subject|10
144783|NCT00717236|516675|P2|Double-Blind Period|Lost to Follow-up|5
144784|NCT00717236|516676|P1|Double-Blind Period|Lost to Follow-up|3
144785|NCT00717236|516675|P2|Double-Blind Period|Lack of Efficacy|6
144786|NCT00717236|516676|P1|Double-Blind Period|Lack of Efficacy|6
144787|NCT00717236|516675|P2|Double-Blind Period|Adverse Event|6
144788|NCT00717236|516676|P1|Double-Blind Period|Adverse Event|33
144789|NCT00717197|516745|P1|Overall Study|Physician Decision|1
144790|NCT00717197|516745|P1|Overall Study|Tumor Progression|1
144791|NCT00717197|516745|P1|Overall Study|Unable to purchase study drug|5
144792|NCT00717093|516751|P2|Overall Study|Randomized but not treated|0
144793|NCT00717093|516752|P1|Overall Study|Randomized but not treated|1
144794|NCT00717093|516751|P2|Overall Study|Other|1
144795|NCT00717093|516752|P1|Overall Study|Other|0
144796|NCT00717093|516751|P2|Overall Study|Withdrawal by Subject|19
144797|NCT00717093|516752|P1|Overall Study|Withdrawal by Subject|12
144798|NCT00717093|516751|P2|Overall Study|Lost to Follow-up|6
144799|NCT00717093|516752|P1|Overall Study|Lost to Follow-up|9
144800|NCT00717093|516751|P2|Overall Study|Lack of Efficacy|13
144801|NCT00717093|516752|P1|Overall Study|Lack of Efficacy|3
144802|NCT00717093|516751|P2|Overall Study|Adverse Event|9
144803|NCT00717093|516752|P1|Overall Study|Adverse Event|19
144804|NCT00717067|516769|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
144805|NCT00717067|516770|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
144806|NCT00717067|516771|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
144807|NCT00717067|516772|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
144808|NCT00717067|516773|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
144809|NCT00716976|516880|P2|Overall Study|Ineligibles|2
144810|NCT00716976|516881|P1|Overall Study|Ineligibles|4
144811|NCT00716976|516880|P2|Overall Study|Radiation during protocol|0
144812|NCT00716976|516881|P1|Overall Study|Radiation during protocol|1
144813|NCT00716976|516880|P2|Overall Study|Premature discontinuation cisplatin|4
144814|NCT00716976|516881|P1|Overall Study|Premature discontinuation cisplatin|5
144815|NCT00716976|516880|P2|Overall Study|Withdrawal by Subject|1
144816|NCT00716976|516881|P1|Overall Study|Withdrawal by Subject|5
144817|NCT00716976|516880|P2|Overall Study|Physician Decision|2
144818|NCT00716976|516881|P1|Overall Study|Physician Decision|2
144819|NCT00716976|516880|P2|Overall Study|Death|0
144820|NCT00716976|516881|P1|Overall Study|Death|1
144821|NCT00716976|516880|P2|Overall Study|Adverse Event|0
144822|NCT00716976|516881|P1|Overall Study|Adverse Event|2
144823|NCT00716859|516919|P2|Overall Study|Not treated|1
144824|NCT00716859|516920|P1|Overall Study|Not treated|1
144825|NCT00716859|516919|P2|Overall Study|Withdrawal by Subject|3
144826|NCT00716859|516920|P1|Overall Study|Withdrawal by Subject|1
144827|NCT00716859|516919|P2|Overall Study|Lack of Efficacy|0
144828|NCT00716859|516920|P1|Overall Study|Lack of Efficacy|3
144829|NCT00716859|516919|P2|Overall Study|Adverse Event|1
144830|NCT00716859|516920|P1|Overall Study|Adverse Event|4
144831|NCT00716625|517005|P1|Overall Study|Safety was not Assessable|1
144832|NCT00716482|517030|P1|Overall Study|inclusion/exclusion criteria not met|25
144833|NCT00716482|517030|P1|Overall Study|technical/machine error|28
144834|NCT00716482|517030|P1|Overall Study|no pathology obtained|10
144835|NCT00716482|517030|P1|Overall Study|Inadequate acquisition or analysis|50
144836|NCT00716482|517030|P1|Overall Study|Lost to Follow-up|6
144837|NCT00716456|517043|P3|Overall Study|Adverse Event|0
144838|NCT00716456|517044|P2|Overall Study|Adverse Event|2
144839|NCT00716456|517045|P1|Overall Study|Adverse Event|0
144840|NCT00716417|517096|P10|Overall Study|On patient request due to toxicities|0
144841|NCT00716417|517097|P9|Overall Study|On patient request due to toxicities|0
144842|NCT00716417|517098|P8|Overall Study|On patient request due to toxicities|1
144843|NCT00716417|517099|P7|Overall Study|On patient request due to toxicities|0
144844|NCT00716417|517100|P6|Overall Study|On patient request due to toxicities|0
144845|NCT00716417|517101|P5|Overall Study|On patient request due to toxicities|0
144846|NCT00716417|517102|P4|Overall Study|On patient request due to toxicities|0
144847|NCT00716417|517103|P3|Overall Study|On patient request due to toxicities|0
144848|NCT00716417|517104|P2|Overall Study|On patient request due to toxicities|0
144849|NCT00716417|517105|P1|Overall Study|On patient request due to toxicities|0
144850|NCT00716417|517096|P10|Overall Study|Dose limiting toxicity (DLT)|0
144851|NCT00716417|517097|P9|Overall Study|Dose limiting toxicity (DLT)|0
144852|NCT00716417|517098|P8|Overall Study|Dose limiting toxicity (DLT)|0
144853|NCT00716417|517099|P7|Overall Study|Dose limiting toxicity (DLT)|0
144854|NCT00716417|517100|P6|Overall Study|Dose limiting toxicity (DLT)|0
144855|NCT00716417|517101|P5|Overall Study|Dose limiting toxicity (DLT)|1
144856|NCT00716417|517102|P4|Overall Study|Dose limiting toxicity (DLT)|0
144857|NCT00716417|517103|P3|Overall Study|Dose limiting toxicity (DLT)|0
144858|NCT00716417|517104|P2|Overall Study|Dose limiting toxicity (DLT)|0
144859|NCT00716417|517105|P1|Overall Study|Dose limiting toxicity (DLT)|0
144860|NCT00716417|517096|P10|Overall Study|Progressive disease|0
144861|NCT00716417|517097|P9|Overall Study|Progressive disease|5
144862|NCT00716417|517098|P8|Overall Study|Progressive disease|1
144863|NCT00716417|517099|P7|Overall Study|Progressive disease|3
144864|NCT00716417|517100|P6|Overall Study|Progressive disease|3
144865|NCT00716417|517101|P5|Overall Study|Progressive disease|0
144866|NCT00716417|517102|P4|Overall Study|Progressive disease|8
144867|NCT00716417|517103|P3|Overall Study|Progressive disease|3
144868|NCT00716417|517104|P2|Overall Study|Progressive disease|5
144869|NCT00716417|517105|P1|Overall Study|Progressive disease|3
144870|NCT00716417|517096|P10|Overall Study|Withdrawal by Subject|0
144871|NCT00716417|517097|P9|Overall Study|Withdrawal by Subject|0
144872|NCT00716417|517098|P8|Overall Study|Withdrawal by Subject|0
144873|NCT00716417|517099|P7|Overall Study|Withdrawal by Subject|1
144874|NCT00716417|517100|P6|Overall Study|Withdrawal by Subject|0
144875|NCT00716417|517101|P5|Overall Study|Withdrawal by Subject|0
144876|NCT00716417|517102|P4|Overall Study|Withdrawal by Subject|2
144877|NCT00716417|517103|P3|Overall Study|Withdrawal by Subject|0
144878|NCT00716417|517104|P2|Overall Study|Withdrawal by Subject|1
144879|NCT00716417|517105|P1|Overall Study|Withdrawal by Subject|0
144880|NCT00716417|517096|P10|Overall Study|Adverse Event|3
144881|NCT00716417|517097|P9|Overall Study|Adverse Event|0
144882|NCT00716417|517098|P8|Overall Study|Adverse Event|1
144883|NCT00716417|517099|P7|Overall Study|Adverse Event|3
144884|NCT00716417|517100|P6|Overall Study|Adverse Event|0
144885|NCT00716417|517101|P5|Overall Study|Adverse Event|0
144886|NCT00716417|517102|P4|Overall Study|Adverse Event|1
144887|NCT00716417|517103|P3|Overall Study|Adverse Event|2
144888|NCT00716417|517104|P2|Overall Study|Adverse Event|0
144889|NCT00716417|517105|P1|Overall Study|Adverse Event|0
144890|NCT00716274|517152|P6|Study Period III (16-Weeks)|Adverse Event|0
144891|NCT00716274|517153|P5|Study Period III (16-Weeks)|Adverse Event|1
144892|NCT00716274|517154|P4|Study Period III (16-Weeks)|Adverse Event|0
144893|NCT00716274|517155|P3|Study Period III (16-Weeks)|Adverse Event|0
144894|NCT00716274|517156|P2|Study Period III (16-Weeks)|Adverse Event|0
144895|NCT00716274|517157|P1|Study Period III (16-Weeks)|Adverse Event|0
144896|NCT00716274|517152|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
144897|NCT00716274|517153|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
144898|NCT00716274|517154|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
144899|NCT00716274|517155|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
144900|NCT00716274|517156|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
144901|NCT00716274|517157|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
144902|NCT00716274|517152|P6|Study Period III (16-Weeks)|Physician Decision|0
144903|NCT00716274|517153|P5|Study Period III (16-Weeks)|Physician Decision|1
144904|NCT00716274|517154|P4|Study Period III (16-Weeks)|Physician Decision|0
144905|NCT00716274|517155|P3|Study Period III (16-Weeks)|Physician Decision|0
144906|NCT00716274|517156|P2|Study Period III (16-Weeks)|Physician Decision|0
144907|NCT00716274|517157|P1|Study Period III (16-Weeks)|Physician Decision|0
144908|NCT00716274|517152|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
144909|NCT00716274|517153|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
144910|NCT00716274|517154|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
144911|NCT00716274|517155|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
144912|NCT00716274|517156|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
144913|NCT00716274|517157|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
144914|NCT00716274|517152|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
144915|NCT00716274|517153|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
144916|NCT00716274|517154|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
144917|NCT00716274|517155|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
144918|NCT00716274|517156|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
144919|NCT00716274|517157|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
144920|NCT00716274|517152|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
144921|NCT00716274|517153|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
144922|NCT00716274|517154|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
144923|NCT00716274|517155|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
144924|NCT00716274|517156|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
144925|NCT00716274|517157|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
144926|NCT00716274|517152|P6|Study Period II (16-Weeks)|Physician Decision|1
144927|NCT00716274|517153|P5|Study Period II (16-Weeks)|Physician Decision|0
144928|NCT00716274|517154|P4|Study Period II (16-Weeks)|Physician Decision|0
144929|NCT00716274|517155|P3|Study Period II (16-Weeks)|Physician Decision|0
144930|NCT00716274|517156|P2|Study Period II (16-Weeks)|Physician Decision|1
144931|NCT00716274|517157|P1|Study Period II (16-Weeks)|Physician Decision|3
144932|NCT00716274|517152|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
144933|NCT00716274|517153|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
144934|NCT00716274|517154|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
144935|NCT00716274|517155|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
144936|NCT00716274|517156|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
144937|NCT00716274|517157|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
144938|NCT00716274|517152|P6|Study Period II (16-Weeks)|Protocol Violation|1
144939|NCT00716274|517153|P5|Study Period II (16-Weeks)|Protocol Violation|0
144940|NCT00716274|517154|P4|Study Period II (16-Weeks)|Protocol Violation|0
144941|NCT00716274|517155|P3|Study Period II (16-Weeks)|Protocol Violation|0
144942|NCT00716274|517156|P2|Study Period II (16-Weeks)|Protocol Violation|3
144943|NCT00716274|517157|P1|Study Period II (16-Weeks)|Protocol Violation|0
144944|NCT00716274|517152|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
144945|NCT00716274|517153|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
144946|NCT00716274|517154|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
144947|NCT00716274|517155|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
144948|NCT00716274|517156|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
144949|NCT00716274|517157|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
144950|NCT00716144|517291|P4|Overall Study|Clinical Depression|0
144951|NCT00716144|517292|P3|Overall Study|Clinical Depression|0
144952|NCT00716144|517293|P2|Overall Study|Clinical Depression|1
144953|NCT00716144|517294|P1|Overall Study|Clinical Depression|0
144954|NCT00716144|517291|P4|Overall Study|Adverse event: left foot pain|0
144955|NCT00716144|517292|P3|Overall Study|Adverse event: left foot pain|0
144956|NCT00716144|517293|P2|Overall Study|Adverse event: left foot pain|1
144957|NCT00716144|517294|P1|Overall Study|Adverse event: left foot pain|0
144958|NCT00716144|517291|P4|Overall Study|Withdrew consent, allowed use of data|0
144959|NCT00716144|517292|P3|Overall Study|Withdrew consent, allowed use of data|1
144960|NCT00716144|517293|P2|Overall Study|Withdrew consent, allowed use of data|0
144961|NCT00716144|517294|P1|Overall Study|Withdrew consent, allowed use of data|0
144962|NCT00716144|517291|P4|Overall Study|Intercurrent illness|0
144963|NCT00716144|517292|P3|Overall Study|Intercurrent illness|1
144964|NCT00716144|517293|P2|Overall Study|Intercurrent illness|0
144965|NCT00716144|517294|P1|Overall Study|Intercurrent illness|0
144966|NCT00716144|517291|P4|Overall Study|Physician Decision|2
144967|NCT00716144|517292|P3|Overall Study|Physician Decision|2
144968|NCT00716144|517293|P2|Overall Study|Physician Decision|1
144969|NCT00716144|517294|P1|Overall Study|Physician Decision|0
144970|NCT00716144|517291|P4|Overall Study|Protocol Violation|0
144971|NCT00716144|517292|P3|Overall Study|Protocol Violation|1
144972|NCT00716144|517293|P2|Overall Study|Protocol Violation|0
144973|NCT00716144|517294|P1|Overall Study|Protocol Violation|2
144974|NCT00716144|517291|P4|Overall Study|Non-compliance|0
144975|NCT00716144|517292|P3|Overall Study|Non-compliance|0
144976|NCT00716144|517293|P2|Overall Study|Non-compliance|0
144977|NCT00716144|517294|P1|Overall Study|Non-compliance|1
144978|NCT00716144|517291|P4|Overall Study|Adverse Event|2
144979|NCT00716144|517292|P3|Overall Study|Adverse Event|0
144980|NCT00716144|517293|P2|Overall Study|Adverse Event|0
144981|NCT00716144|517294|P1|Overall Study|Adverse Event|0
144982|NCT00716144|517291|P4|Overall Study|Lost to Follow-up|2
144983|NCT00716144|517292|P3|Overall Study|Lost to Follow-up|1
144984|NCT00716144|517293|P2|Overall Study|Lost to Follow-up|2
144985|NCT00716144|517294|P1|Overall Study|Lost to Follow-up|2
144986|NCT00716144|517291|P4|Overall Study|Withdrawal by Subject|6
144987|NCT00716144|517292|P3|Overall Study|Withdrawal by Subject|6
144988|NCT00716144|517293|P2|Overall Study|Withdrawal by Subject|2
144989|NCT00716144|517294|P1|Overall Study|Withdrawal by Subject|4
144990|NCT00716092|517319|P3|Overall Study|Other incl. Lack of Efficacy|0
144991|NCT00716092|517320|P2|Overall Study|Other incl. Lack of Efficacy|1
144992|NCT00716092|517321|P1|Overall Study|Other incl. Lack of Efficacy|2
144993|NCT00715949|517374|P1|Overall Study|could not finish first test|4
144994|NCT00715910|517382|P6|Booster and ESFU Phase|Other|0
144995|NCT00715910|517383|P5|Booster and ESFU Phase|Other|1
144996|NCT00715910|517384|P4|Booster and ESFU Phase|Other|5
144997|NCT00715910|517385|P3|Booster and ESFU Phase|Other|0
144998|NCT00715910|517386|P2|Booster and ESFU Phase|Other|0
144999|NCT00715910|517387|P1|Booster and ESFU Phase|Other|0
145000|NCT00715910|517382|P6|Booster and ESFU Phase|Lost to Follow-up|13
145001|NCT00715910|517383|P5|Booster and ESFU Phase|Lost to Follow-up|1
145002|NCT00715910|517384|P4|Booster and ESFU Phase|Lost to Follow-up|6
145003|NCT00715910|517385|P3|Booster and ESFU Phase|Lost to Follow-up|0
145004|NCT00715910|517386|P2|Booster and ESFU Phase|Lost to Follow-up|0
145005|NCT00715910|517387|P1|Booster and ESFU Phase|Lost to Follow-up|0
145006|NCT00715793|517506|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
145007|NCT00715793|517507|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
145008|NCT00715793|517506|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
145009|NCT00715793|517507|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
145010|NCT00715676|517557|P3|Overall Study|Elevated Blood Glucose|0
145011|NCT00715676|517558|P2|Overall Study|Elevated Blood Glucose|1
145012|NCT00715676|517559|P1|Overall Study|Elevated Blood Glucose|0
145013|NCT00715676|517557|P3|Overall Study|Use of Exclusionary Medication|1
145014|NCT00715676|517558|P2|Overall Study|Use of Exclusionary Medication|0
145015|NCT00715676|517559|P1|Overall Study|Use of Exclusionary Medication|0
145016|NCT00715676|517557|P3|Overall Study|Did Not Meet Entry Criteria|1
145017|NCT00715676|517558|P2|Overall Study|Did Not Meet Entry Criteria|0
145018|NCT00715676|517559|P1|Overall Study|Did Not Meet Entry Criteria|0
145019|NCT00715676|517557|P3|Overall Study|Terminated by Sponsor|0
145020|NCT00715676|517558|P2|Overall Study|Terminated by Sponsor|0
145021|NCT00715676|517559|P1|Overall Study|Terminated by Sponsor|1
145022|NCT00715676|517557|P3|Overall Study|Lost to Follow-up|1
145023|NCT00715676|517558|P2|Overall Study|Lost to Follow-up|2
145024|NCT00715676|517559|P1|Overall Study|Lost to Follow-up|1
145025|NCT00715676|517557|P3|Overall Study|Withdrawal by Subject|8
145026|NCT00715676|517558|P2|Overall Study|Withdrawal by Subject|3
145027|NCT00715676|517559|P1|Overall Study|Withdrawal by Subject|1
145028|NCT00715676|517557|P3|Overall Study|Adverse Event|21
145029|NCT00715676|517558|P2|Overall Study|Adverse Event|5
145030|NCT00715676|517559|P1|Overall Study|Adverse Event|3
145031|NCT00715624|517602|P2|Overall Study|Other|1
145032|NCT00715624|517603|P1|Overall Study|Other|0
145033|NCT00715624|517602|P2|Overall Study|Incorrect randomization (not treated)|1
145034|NCT00715624|517603|P1|Overall Study|Incorrect randomization (not treated)|0
145035|NCT00715624|517602|P2|Overall Study|Sponsor decision|4
145036|NCT00715624|517603|P1|Overall Study|Sponsor decision|0
145037|NCT00715624|517602|P2|Overall Study|Poor compliance|13
145038|NCT00715624|517603|P1|Overall Study|Poor compliance|6
145039|NCT00715624|517602|P2|Overall Study|Familial and personal reasons|22
145040|NCT00715624|517603|P1|Overall Study|Familial and personal reasons|10
145041|NCT00715624|517602|P2|Overall Study|Withdrawal by Subject|25
145042|NCT00715624|517603|P1|Overall Study|Withdrawal by Subject|11
145043|NCT00715624|517602|P2|Overall Study|Protocol Violation|0
145044|NCT00715624|517603|P1|Overall Study|Protocol Violation|1
145045|NCT00715624|517602|P2|Overall Study|Lost to Follow-up|2
145046|NCT00715624|517603|P1|Overall Study|Lost to Follow-up|1
145047|NCT00715624|517602|P2|Overall Study|Lack of Efficacy|11
145048|NCT00715624|517603|P1|Overall Study|Lack of Efficacy|11
145049|NCT00715624|517602|P2|Overall Study|Adverse Event|37
145050|NCT00715624|517603|P1|Overall Study|Adverse Event|12
145051|NCT00715559|517631|P1|Overall Study|medication not tolerated - nausea|1
145052|NCT00715520|517641|P3|Overall Study|Withdrawal by Subject|1
145053|NCT00715520|517642|P2|Overall Study|Withdrawal by Subject|0
145054|NCT00715520|517643|P1|Overall Study|Withdrawal by Subject|2
145055|NCT00715520|517641|P3|Overall Study|Screen failure|1
145056|NCT00715520|517642|P2|Overall Study|Screen failure|1
145057|NCT00715520|517643|P1|Overall Study|Screen failure|8
145058|NCT00715403|517663|P7|Overall Study|Other reason not defined above|0
145059|NCT00715403|517664|P6|Overall Study|Other reason not defined above|1
145060|NCT00715403|517665|P5|Overall Study|Other reason not defined above|1
145061|NCT00715403|517666|P4|Overall Study|Other reason not defined above|0
145062|NCT00715403|517667|P3|Overall Study|Other reason not defined above|1
145063|NCT00715403|517668|P2|Overall Study|Other reason not defined above|0
145064|NCT00715403|517669|P1|Overall Study|Other reason not defined above|0
145065|NCT00715403|517663|P7|Overall Study|Protocol Violation|0
145066|NCT00715403|517664|P6|Overall Study|Protocol Violation|1
145067|NCT00715403|517665|P5|Overall Study|Protocol Violation|0
145068|NCT00715403|517666|P4|Overall Study|Protocol Violation|0
145069|NCT00715403|517667|P3|Overall Study|Protocol Violation|0
145070|NCT00715403|517668|P2|Overall Study|Protocol Violation|0
145071|NCT00715403|517669|P1|Overall Study|Protocol Violation|0
145072|NCT00715403|517663|P7|Overall Study|Other Adverse Event than DLT|0
145073|NCT00715403|517664|P6|Overall Study|Other Adverse Event than DLT|2
145074|NCT00715403|517665|P5|Overall Study|Other Adverse Event than DLT|0
145075|NCT00715403|517666|P4|Overall Study|Other Adverse Event than DLT|0
145076|NCT00715403|517667|P3|Overall Study|Other Adverse Event than DLT|0
145077|NCT00715403|517668|P2|Overall Study|Other Adverse Event than DLT|0
145078|NCT00715403|517669|P1|Overall Study|Other Adverse Event than DLT|1
145079|NCT00715403|517663|P7|Overall Study|Dose limiting Toxicity (DLT)|0
145080|NCT00715403|517664|P6|Overall Study|Dose limiting Toxicity (DLT)|1
145081|NCT00715403|517665|P5|Overall Study|Dose limiting Toxicity (DLT)|0
145082|NCT00715403|517666|P4|Overall Study|Dose limiting Toxicity (DLT)|0
145083|NCT00715403|517667|P3|Overall Study|Dose limiting Toxicity (DLT)|0
145084|NCT00715403|517668|P2|Overall Study|Dose limiting Toxicity (DLT)|0
145085|NCT00715403|517669|P1|Overall Study|Dose limiting Toxicity (DLT)|0
145086|NCT00715403|517663|P7|Overall Study|Progressive disease|1
145087|NCT00715403|517664|P6|Overall Study|Progressive disease|14
145088|NCT00715403|517665|P5|Overall Study|Progressive disease|5
145089|NCT00715403|517666|P4|Overall Study|Progressive disease|9
145090|NCT00715403|517667|P3|Overall Study|Progressive disease|3
145091|NCT00715403|517668|P2|Overall Study|Progressive disease|1
145092|NCT00715403|517669|P1|Overall Study|Progressive disease|0
145093|NCT00715299|517808|P1|Overall Study|failed the pre-screen exercise test|2
145094|NCT00715299|517808|P1|Overall Study|Adverse Event|3
145095|NCT00715299|517808|P1|Overall Study|Withdrawal by Subject|1
145096|NCT00715208|517814|P2|Overall Study|Lack of Efficacy|2
145097|NCT00715208|517815|P1|Overall Study|Lack of Efficacy|0
145098|NCT00715208|517814|P2|Overall Study|Adverse Event|6
145099|NCT00715208|517815|P1|Overall Study|Adverse Event|0
145100|NCT00715208|517814|P2|Overall Study|Withdrawal by Subject|1
145101|NCT00715208|517815|P1|Overall Study|Withdrawal by Subject|1
145102|NCT00715117|517831|P2|Overall Study|Crohn's flare and rescue with steroids|1
145103|NCT00715117|517832|P1|Overall Study|Crohn's flare and rescue with steroids|0
145104|NCT00715078|517900|P3|Overall Study|Unable to start due to disease prog.|1
145105|NCT00715078|517901|P2|Overall Study|Unable to start due to disease prog.|0
145106|NCT00715078|517902|P1|Overall Study|Unable to start due to disease prog.|0
145107|NCT00715078|517900|P3|Overall Study|Withdrawal by Subject|1
145108|NCT00715078|517901|P2|Overall Study|Withdrawal by Subject|0
145109|NCT00715078|517902|P1|Overall Study|Withdrawal by Subject|1
145110|NCT00715078|517900|P3|Overall Study|Death|36
145111|NCT00715078|517901|P2|Overall Study|Death|36
145112|NCT00715078|517902|P1|Overall Study|Death|29
145113|NCT00715026|517910|P1|Overall Study|Surgery done on non-study consented hip|1
145114|NCT00715026|517910|P1|Overall Study|Protocol Violation|1
145115|NCT00715026|517910|P1|Overall Study|Lost to Follow-up|3
145116|NCT00715026|517910|P1|Overall Study|Withdrawal by Subject|5
145117|NCT00714948|517915|P1|Overall Study|Adverse Event|2
145118|NCT00714870|517921|P2|Overall Study|did not attend minimum of 4 sessions|0
145119|NCT00714870|517922|P1|Overall Study|did not attend minimum of 4 sessions|4
145120|NCT00714870|517921|P2|Overall Study|patient unable to come b/c back pain|0
145121|NCT00714870|517922|P1|Overall Study|patient unable to come b/c back pain|1
145122|NCT00714870|517921|P2|Overall Study|Lost to Follow-up|5
145123|NCT00714870|517922|P1|Overall Study|Lost to Follow-up|22
145124|NCT00714714|517937|P1|Overall Study|Adverse Event|1
145125|NCT00714688|517946|P3|Overall Study|Other|5
145126|NCT00714688|517947|P2|Overall Study|Other|6
145127|NCT00714688|517948|P1|Overall Study|Other|1
145128|NCT00714688|517946|P3|Overall Study|Sponsor's Decision|0
145129|NCT00714688|517947|P2|Overall Study|Sponsor's Decision|2
145130|NCT00714688|517948|P1|Overall Study|Sponsor's Decision|0
145131|NCT00714688|517946|P3|Overall Study|Ineligible to Continue the Study|1
145132|NCT00714688|517947|P2|Overall Study|Ineligible to Continue the Study|1
145133|NCT00714688|517948|P1|Overall Study|Ineligible to Continue the Study|0
145134|NCT00714688|517946|P3|Overall Study|Subject Non-compliant|5
145135|NCT00714688|517947|P2|Overall Study|Subject Non-compliant|5
145136|NCT00714688|517948|P1|Overall Study|Subject Non-compliant|3
145137|NCT00714688|517946|P3|Overall Study|Adverse Event|19
145138|NCT00714688|517947|P2|Overall Study|Adverse Event|15
145139|NCT00714688|517948|P1|Overall Study|Adverse Event|2
145140|NCT00714688|517946|P3|Overall Study|Lost to Follow-up|0
145141|NCT00714688|517947|P2|Overall Study|Lost to Follow-up|2
145142|NCT00714688|517948|P1|Overall Study|Lost to Follow-up|5
145143|NCT00714688|517946|P3|Overall Study|Withdrawal by Subject|3
145144|NCT00714688|517947|P2|Overall Study|Withdrawal by Subject|3
145145|NCT00714688|517948|P1|Overall Study|Withdrawal by Subject|4
145146|NCT00714688|517946|P3|Overall Study|Lack of Efficacy|4
145147|NCT00714688|517947|P2|Overall Study|Lack of Efficacy|1
145148|NCT00714688|517948|P1|Overall Study|Lack of Efficacy|14
145149|NCT00714493|517990|P1|Overall Study|OTHER|2
145150|NCT00714493|517990|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
145151|NCT00714493|517990|P1|Overall Study|Protocol Violation|12
145152|NCT00714493|517990|P1|Overall Study|Lost to Follow-up|3
145153|NCT00714493|517990|P1|Overall Study|Lack of Efficacy|10
145154|NCT00714493|517990|P1|Overall Study|Death|3
145155|NCT00714493|517990|P1|Overall Study|Adverse Event|11
145156|NCT00714285|518018|P4|Overall Study|Migrated/moved from study area|0
145157|NCT00714285|518019|P3|Overall Study|Migrated/moved from study area|0
145158|NCT00714285|518020|P2|Overall Study|Migrated/moved from study area|1
145159|NCT00714285|518021|P1|Overall Study|Migrated/moved from study area|0
145160|NCT00714285|518018|P4|Overall Study|Lost to Follow-up|1
145161|NCT00714285|518019|P3|Overall Study|Lost to Follow-up|0
145162|NCT00714285|518020|P2|Overall Study|Lost to Follow-up|2
145163|NCT00714285|518021|P1|Overall Study|Lost to Follow-up|0
145164|NCT00714259|518071|P1|Overall Study|Death|2
145165|NCT00714168|518117|P2|Overall Study|Non-study medical condition|2
145166|NCT00714168|518118|P1|Overall Study|Non-study medical condition|3
145167|NCT00714168|518117|P2|Overall Study|Relocation|3
145168|NCT00714168|518118|P1|Overall Study|Relocation|4
145169|NCT00714168|518117|P2|Overall Study|Lost to Follow-up|50
145170|NCT00714168|518118|P1|Overall Study|Lost to Follow-up|32
145171|NCT00714168|518117|P2|Overall Study|Pregnancy|4
145172|NCT00714168|518118|P1|Overall Study|Pregnancy|5
145173|NCT00714051|518134|P2|Overall Study|Death|1
145174|NCT00714051|518135|P1|Overall Study|Death|0
145175|NCT00714051|518134|P2|Overall Study|Withdrawal by Subject|0
145176|NCT00714051|518135|P1|Overall Study|Withdrawal by Subject|1
145177|NCT00713830|518143|P2|Overall Study|Sponsor Decision|10
145178|NCT00713830|518144|P1|Overall Study|Sponsor Decision|4
145179|NCT00713830|518143|P2|Overall Study|Familial and Personal Reasons|34
145180|NCT00713830|518144|P1|Overall Study|Familial and Personal Reasons|9
145181|NCT00713830|518143|P2|Overall Study|Poor Compliance to Protocol|14
145182|NCT00713830|518144|P1|Overall Study|Poor Compliance to Protocol|7
145183|NCT00713830|518143|P2|Overall Study|Withdrawal by Subject|23
145184|NCT00713830|518144|P1|Overall Study|Withdrawal by Subject|13
145185|NCT00713830|518143|P2|Overall Study|Lost to Follow-up|9
145186|NCT00713830|518144|P1|Overall Study|Lost to Follow-up|2
145187|NCT00713830|518143|P2|Overall Study|Lack of Efficacy|16
145188|NCT00713830|518144|P1|Overall Study|Lack of Efficacy|24
145189|NCT00713830|518143|P2|Overall Study|Adverse Event|71
145190|NCT00713830|518144|P1|Overall Study|Adverse Event|23
145191|NCT00713700|518201|P1|Overall Study|Withdrawal by Subject|1
145192|NCT00713700|518201|P1|Overall Study|Lost to Follow-up|3
145193|NCT00713648|518227|P1|Overall Study|Development of antibodies|3
145194|NCT00713648|518227|P1|Overall Study|According to Protocol|2
145195|NCT00713648|518227|P1|Overall Study|Unclassified|2
145196|NCT00713648|518227|P1|Overall Study|Adverse Event|1
145197|NCT00713609|518240|P6|Overall Study|Protocol Violation|0
145198|NCT00713609|518241|P5|Overall Study|Protocol Violation|2
145199|NCT00713609|518242|P4|Overall Study|Protocol Violation|1
145200|NCT00713609|518243|P3|Overall Study|Protocol Violation|1
145201|NCT00713609|518244|P2|Overall Study|Protocol Violation|3
145202|NCT00713609|518245|P1|Overall Study|Protocol Violation|6
145203|NCT00713609|518240|P6|Overall Study|Withdrawal by Subject|7
145204|NCT00713609|518241|P5|Overall Study|Withdrawal by Subject|5
145205|NCT00713609|518242|P4|Overall Study|Withdrawal by Subject|1
145206|NCT00713609|518243|P3|Overall Study|Withdrawal by Subject|5
145207|NCT00713609|518244|P2|Overall Study|Withdrawal by Subject|1
145208|NCT00713609|518245|P1|Overall Study|Withdrawal by Subject|6
145209|NCT00713609|518240|P6|Overall Study|Non-Compliance with Study Treatment|0
145210|NCT00713609|518241|P5|Overall Study|Non-Compliance with Study Treatment|1
145211|NCT00713609|518242|P4|Overall Study|Non-Compliance with Study Treatment|0
145212|NCT00713609|518243|P3|Overall Study|Non-Compliance with Study Treatment|2
145213|NCT00713609|518244|P2|Overall Study|Non-Compliance with Study Treatment|1
145214|NCT00713609|518245|P1|Overall Study|Non-Compliance with Study Treatment|1
145215|NCT00713609|518240|P6|Overall Study|Lack of Efficacy|0
145216|NCT00713609|518241|P5|Overall Study|Lack of Efficacy|1
145217|NCT00713609|518242|P4|Overall Study|Lack of Efficacy|0
145218|NCT00713609|518243|P3|Overall Study|Lack of Efficacy|0
145219|NCT00713609|518244|P2|Overall Study|Lack of Efficacy|3
145220|NCT00713609|518245|P1|Overall Study|Lack of Efficacy|1
145221|NCT00713609|518240|P6|Overall Study|Lost to Follow-up|0
145222|NCT00713609|518241|P5|Overall Study|Lost to Follow-up|7
145223|NCT00713609|518242|P4|Overall Study|Lost to Follow-up|5
145224|NCT00713609|518243|P3|Overall Study|Lost to Follow-up|5
145225|NCT00713609|518244|P2|Overall Study|Lost to Follow-up|7
145226|NCT00713609|518245|P1|Overall Study|Lost to Follow-up|5
145227|NCT00713609|518240|P6|Overall Study|Adverse Event|1
145228|NCT00713609|518241|P5|Overall Study|Adverse Event|3
145229|NCT00713609|518242|P4|Overall Study|Adverse Event|2
145230|NCT00713609|518243|P3|Overall Study|Adverse Event|2
145231|NCT00713609|518244|P2|Overall Study|Adverse Event|0
145232|NCT00713609|518245|P1|Overall Study|Adverse Event|2
145233|NCT00713596|518280|P3|Overall Study|Study was terminated|2
145234|NCT00713596|518281|P2|Overall Study|Study was terminated|3
145235|NCT00713596|518282|P1|Overall Study|Study was terminated|2
145236|NCT00713544|518308|P6|Overall Study|Hepatotoxicity - not an AE|0
145237|NCT00713544|518309|P5|Overall Study|Hepatotoxicity - not an AE|1
145238|NCT00713544|518310|P4|Overall Study|Hepatotoxicity - not an AE|0
145239|NCT00713544|518311|P3|Overall Study|Hepatotoxicity - not an AE|0
145240|NCT00713544|518312|P2|Overall Study|Hepatotoxicity - not an AE|0
145241|NCT00713544|518313|P1|Overall Study|Hepatotoxicity - not an AE|0
145242|NCT00713544|518308|P6|Overall Study|Incorrect enrollment|0
145243|NCT00713544|518309|P5|Overall Study|Incorrect enrollment|0
145244|NCT00713544|518310|P4|Overall Study|Incorrect enrollment|0
145245|NCT00713544|518311|P3|Overall Study|Incorrect enrollment|0
145246|NCT00713544|518312|P2|Overall Study|Incorrect enrollment|1
145247|NCT00713544|518313|P1|Overall Study|Incorrect enrollment|0
145248|NCT00713544|518308|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
145249|NCT00713544|518309|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
145250|NCT00713544|518310|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
145251|NCT00713544|518311|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
145252|NCT00713544|518312|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
145253|NCT00713544|518313|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
145254|NCT00713544|518308|P6|Overall Study|Lost to Follow-up|0
145255|NCT00713544|518309|P5|Overall Study|Lost to Follow-up|0
145256|NCT00713544|518310|P4|Overall Study|Lost to Follow-up|0
145257|NCT00713544|518311|P3|Overall Study|Lost to Follow-up|1
145258|NCT00713544|518312|P2|Overall Study|Lost to Follow-up|0
145259|NCT00713544|518313|P1|Overall Study|Lost to Follow-up|0
145260|NCT00713544|518308|P6|Overall Study|Lack of Efficacy|0
145261|NCT00713544|518309|P5|Overall Study|Lack of Efficacy|1
145262|NCT00713544|518310|P4|Overall Study|Lack of Efficacy|1
145263|NCT00713544|518311|P3|Overall Study|Lack of Efficacy|0
145264|NCT00713544|518312|P2|Overall Study|Lack of Efficacy|1
145265|NCT00713544|518313|P1|Overall Study|Lack of Efficacy|0
145266|NCT00713544|518308|P6|Overall Study|Physician Decision|2
145267|NCT00713544|518309|P5|Overall Study|Physician Decision|0
145268|NCT00713544|518310|P4|Overall Study|Physician Decision|0
145269|NCT00713544|518311|P3|Overall Study|Physician Decision|0
145270|NCT00713544|518312|P2|Overall Study|Physician Decision|0
145271|NCT00713544|518313|P1|Overall Study|Physician Decision|0
145272|NCT00713544|518308|P6|Overall Study|Protocol Violation|1
145273|NCT00713544|518309|P5|Overall Study|Protocol Violation|0
145274|NCT00713544|518310|P4|Overall Study|Protocol Violation|0
145275|NCT00713544|518311|P3|Overall Study|Protocol Violation|0
145276|NCT00713544|518312|P2|Overall Study|Protocol Violation|0
145277|NCT00713544|518313|P1|Overall Study|Protocol Violation|0
145278|NCT00713544|518308|P6|Overall Study|Withdrawal by Subject|1
145279|NCT00713544|518309|P5|Overall Study|Withdrawal by Subject|3
145280|NCT00713544|518310|P4|Overall Study|Withdrawal by Subject|2
145281|NCT00713544|518311|P3|Overall Study|Withdrawal by Subject|3
145282|NCT00713544|518312|P2|Overall Study|Withdrawal by Subject|0
145283|NCT00713544|518313|P1|Overall Study|Withdrawal by Subject|2
145284|NCT00713544|518308|P6|Overall Study|Adverse Event|5
145285|NCT00713544|518309|P5|Overall Study|Adverse Event|3
145286|NCT00713544|518310|P4|Overall Study|Adverse Event|7
145287|NCT00713544|518311|P3|Overall Study|Adverse Event|7
145288|NCT00713544|518312|P2|Overall Study|Adverse Event|3
145289|NCT00713544|518313|P1|Overall Study|Adverse Event|5
145290|NCT00713349|518364|P1|Overall Study|Protocol Violation|1
145291|NCT00713323|518370|P1|Overall Study|Treatment that may interact with Sativex|1
145292|NCT00713323|518370|P1|Overall Study|Subject travelling to Dominica Republic|1
145293|NCT00713323|518370|P1|Overall Study|Subject travelling to USA|1
145294|NCT00713323|518370|P1|Overall Study|Pain resolved|1
145295|NCT00713323|518370|P1|Overall Study|Non-compliance|1
145296|NCT00713323|518370|P1|Overall Study|Pain free|1
145297|NCT00713323|518370|P1|Overall Study|Surgery cured allodynic pain|1
145298|NCT00713323|518370|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
145299|NCT00713323|518370|P1|Overall Study|Low creatine clearance at screening|1
145300|NCT00713323|518370|P1|Overall Study|Lack of Efficacy|36
145301|NCT00713323|518370|P1|Overall Study|Lost to Follow-up|11
145302|NCT00713323|518370|P1|Overall Study|Withdrawal by Subject|15
145303|NCT00713323|518370|P1|Overall Study|Adverse Event|75
145304|NCT00713310|518383|P2|Overall Study|Withdrawal by Subject|2
145305|NCT00713310|518384|P1|Overall Study|Withdrawal by Subject|0
145306|NCT00713310|518383|P2|Overall Study|Lack of Efficacy|2
145307|NCT00713310|518384|P1|Overall Study|Lack of Efficacy|0
145308|NCT00713310|518383|P2|Overall Study|Adverse Event|2
145309|NCT00713310|518384|P1|Overall Study|Adverse Event|5
145310|NCT00713258|518394|P2|Overall Study|Other|1
145311|NCT00713258|518395|P1|Overall Study|Other|1
145312|NCT00713258|518394|P2|Overall Study|Non-Compliance|1
145313|NCT00713258|518395|P1|Overall Study|Non-Compliance|2
145314|NCT00713258|518394|P2|Overall Study|Adverse Event|4
145315|NCT00713258|518395|P1|Overall Study|Adverse Event|2
145316|NCT00713219|518403|P1|Overall Study|Protocol Violation|1
145317|NCT00713219|518403|P1|Overall Study|Death|1
145318|NCT00713206|518409|P2|Overall Study|Adverse Event|1
145319|NCT00713206|518410|P1|Overall Study|Adverse Event|2
145320|NCT00713206|518409|P2|Overall Study|Lost to Follow-up|2
145321|NCT00713206|518410|P1|Overall Study|Lost to Follow-up|5
145322|NCT00712985|518416|P1|Overall Study|Lack of Efficacy|3
145323|NCT00712985|518416|P1|Overall Study|1 patient moved out of state|1
145324|NCT00712985|518416|P1|Overall Study|1 withdrew prior to start of drug|1
145325|NCT00712959|518422|P2|Overall Study|Withdrawal by Subject|0
145326|NCT00712959|518423|P1|Overall Study|Withdrawal by Subject|3
145327|NCT00712959|518422|P2|Overall Study|Lost to Follow-up|2
145328|NCT00712959|518423|P1|Overall Study|Lost to Follow-up|13
145329|NCT00712959|518422|P2|Overall Study|Protocol Violation|1
145330|NCT00712959|518423|P1|Overall Study|Protocol Violation|3
145331|NCT00712933|518441|P1|Overall Study|Withdrawal by Subject|151
145332|NCT00712933|518441|P1|Overall Study|Protocol Violation|4
145333|NCT00712933|518441|P1|Overall Study|Physician Decision|36
145334|NCT00712933|518441|P1|Overall Study|Participant received medication|1
145335|NCT00712933|518441|P1|Overall Study|Not committed to contraception|1
145336|NCT00712933|518441|P1|Overall Study|Other Physician decision|1
145337|NCT00712933|518441|P1|Overall Study|Death of patient|1
145338|NCT00712933|518441|P1|Overall Study|Participant travelled overseas|2
145339|NCT00712933|518441|P1|Overall Study|Participant hospitalized|1
145340|NCT00712933|518441|P1|Overall Study|Involved in Clinical research|3
145341|NCT00712933|518441|P1|Overall Study|Hip replacement surgery|1
145342|NCT00712933|518441|P1|Overall Study|Withdrew consent|4
145343|NCT00712933|518441|P1|Overall Study|Sponsor decision|14
145344|NCT00712933|518441|P1|Overall Study|Other Pregnancy|37
145345|NCT00712933|518441|P1|Overall Study|Non-compliance with study drug|13
145346|NCT00712933|518441|P1|Overall Study|Lost to Follow-up|22
145347|NCT00712933|518441|P1|Overall Study|Lack of Efficacy|6
145348|NCT00712933|518441|P1|Overall Study|Adverse Event|69
145349|NCT00712920|518471|P3|Overall Study|Non-compliance|0
145350|NCT00712920|518472|P2|Overall Study|Non-compliance|0
145351|NCT00712920|518473|P1|Overall Study|Non-compliance|3
145352|NCT00712920|518471|P3|Overall Study|Other|3
145353|NCT00712920|518472|P2|Overall Study|Other|7
145354|NCT00712920|518473|P1|Overall Study|Other|5
145355|NCT00712920|518471|P3|Overall Study|Lack of Efficacy|1
145356|NCT00712920|518472|P2|Overall Study|Lack of Efficacy|0
145357|NCT00712920|518473|P1|Overall Study|Lack of Efficacy|1
145358|NCT00712920|518471|P3|Overall Study|Lost to Follow-up|0
145359|NCT00712920|518472|P2|Overall Study|Lost to Follow-up|4
145360|NCT00712920|518473|P1|Overall Study|Lost to Follow-up|1
145361|NCT00712920|518471|P3|Overall Study|Withdrawal by Subject|1
145362|NCT00712920|518472|P2|Overall Study|Withdrawal by Subject|2
145363|NCT00712920|518473|P1|Overall Study|Withdrawal by Subject|4
145364|NCT00712920|518471|P3|Overall Study|Adverse Event|7
145365|NCT00712920|518472|P2|Overall Study|Adverse Event|4
145366|NCT00712920|518473|P1|Overall Study|Adverse Event|3
145367|NCT00712725|518501|P8|Overall Study|Protocol Specified Criteria|1
145368|NCT00712725|518502|P7|Overall Study|Protocol Specified Criteria|2
145369|NCT00712725|518503|P6|Overall Study|Protocol Specified Criteria|0
145370|NCT00712725|518504|P5|Overall Study|Protocol Specified Criteria|1
145371|NCT00712725|518505|P4|Overall Study|Protocol Specified Criteria|2
145372|NCT00712725|518506|P3|Overall Study|Protocol Specified Criteria|1
145373|NCT00712725|518507|P2|Overall Study|Protocol Specified Criteria|0
145374|NCT00712725|518508|P1|Overall Study|Protocol Specified Criteria|3
145375|NCT00712725|518501|P8|Overall Study|Lack of Qualifying Event|6
145376|NCT00712725|518502|P7|Overall Study|Lack of Qualifying Event|11
145377|NCT00712725|518503|P6|Overall Study|Lack of Qualifying Event|13
145378|NCT00712725|518504|P5|Overall Study|Lack of Qualifying Event|11
145379|NCT00712725|518505|P4|Overall Study|Lack of Qualifying Event|8
145380|NCT00712725|518506|P3|Overall Study|Lack of Qualifying Event|6
145381|NCT00712725|518507|P2|Overall Study|Lack of Qualifying Event|2
145382|NCT00712725|518508|P1|Overall Study|Lack of Qualifying Event|16
145383|NCT00712725|518501|P8|Overall Study|Withdrawal by Subject|2
145384|NCT00712725|518502|P7|Overall Study|Withdrawal by Subject|1
145385|NCT00712725|518503|P6|Overall Study|Withdrawal by Subject|1
145386|NCT00712725|518504|P5|Overall Study|Withdrawal by Subject|1
145387|NCT00712725|518505|P4|Overall Study|Withdrawal by Subject|2
145388|NCT00712725|518506|P3|Overall Study|Withdrawal by Subject|1
145389|NCT00712725|518507|P2|Overall Study|Withdrawal by Subject|1
145390|NCT00712725|518508|P1|Overall Study|Withdrawal by Subject|2
145391|NCT00712725|518501|P8|Overall Study|Protocol Violation|1
145392|NCT00712725|518502|P7|Overall Study|Protocol Violation|1
145393|NCT00712725|518503|P6|Overall Study|Protocol Violation|0
145394|NCT00712725|518504|P5|Overall Study|Protocol Violation|2
145395|NCT00712725|518505|P4|Overall Study|Protocol Violation|3
145396|NCT00712725|518506|P3|Overall Study|Protocol Violation|1
145397|NCT00712725|518507|P2|Overall Study|Protocol Violation|0
145398|NCT00712725|518508|P1|Overall Study|Protocol Violation|2
145399|NCT00712725|518501|P8|Overall Study|Pregnancy|0
145400|NCT00712725|518502|P7|Overall Study|Pregnancy|2
145401|NCT00712725|518503|P6|Overall Study|Pregnancy|0
145402|NCT00712725|518504|P5|Overall Study|Pregnancy|1
145403|NCT00712725|518505|P4|Overall Study|Pregnancy|0
145404|NCT00712725|518506|P3|Overall Study|Pregnancy|0
145405|NCT00712725|518507|P2|Overall Study|Pregnancy|1
145406|NCT00712725|518508|P1|Overall Study|Pregnancy|0
145407|NCT00712725|518501|P8|Overall Study|Physician Decision|0
145408|NCT00712725|518502|P7|Overall Study|Physician Decision|2
145409|NCT00712725|518503|P6|Overall Study|Physician Decision|0
145410|NCT00712725|518504|P5|Overall Study|Physician Decision|1
145411|NCT00712725|518505|P4|Overall Study|Physician Decision|0
145412|NCT00712725|518506|P3|Overall Study|Physician Decision|0
145413|NCT00712725|518507|P2|Overall Study|Physician Decision|0
145414|NCT00712725|518508|P1|Overall Study|Physician Decision|2
145415|NCT00712725|518501|P8|Overall Study|Lost to Follow-up|1
145416|NCT00712725|518502|P7|Overall Study|Lost to Follow-up|3
145417|NCT00712725|518503|P6|Overall Study|Lost to Follow-up|2
145418|NCT00712725|518504|P5|Overall Study|Lost to Follow-up|2
145419|NCT00712725|518505|P4|Overall Study|Lost to Follow-up|1
145420|NCT00712725|518506|P3|Overall Study|Lost to Follow-up|1
145421|NCT00712725|518507|P2|Overall Study|Lost to Follow-up|2
145422|NCT00712725|518508|P1|Overall Study|Lost to Follow-up|3
145423|NCT00712725|518501|P8|Overall Study|Adverse Event|0
145424|NCT00712725|518502|P7|Overall Study|Adverse Event|0
145425|NCT00712725|518503|P6|Overall Study|Adverse Event|0
145426|NCT00712725|518504|P5|Overall Study|Adverse Event|0
145427|NCT00712725|518505|P4|Overall Study|Adverse Event|1
145428|NCT00712725|518506|P3|Overall Study|Adverse Event|0
145429|NCT00712725|518507|P2|Overall Study|Adverse Event|0
145430|NCT00712725|518508|P1|Overall Study|Adverse Event|1
145431|NCT00712673|518569|P4|Overall Study|Protocol Violation|0
145432|NCT00712673|518570|P3|Overall Study|Protocol Violation|2
145433|NCT00712673|518571|P2|Overall Study|Protocol Violation|0
145434|NCT00712673|518572|P1|Overall Study|Protocol Violation|0
145435|NCT00712673|518569|P4|Overall Study|Investigator's Decision|0
145436|NCT00712673|518570|P3|Overall Study|Investigator's Decision|0
145437|NCT00712673|518571|P2|Overall Study|Investigator's Decision|0
145438|NCT00712673|518572|P1|Overall Study|Investigator's Decision|1
145439|NCT00712673|518569|P4|Overall Study|Familial and Personal Reasons|2
145440|NCT00712673|518570|P3|Overall Study|Familial and Personal Reasons|5
145441|NCT00712673|518571|P2|Overall Study|Familial and Personal Reasons|0
145442|NCT00712673|518572|P1|Overall Study|Familial and Personal Reasons|5
145443|NCT00712673|518569|P4|Overall Study|Withdrawal by Subject|20
145444|NCT00712673|518570|P3|Overall Study|Withdrawal by Subject|15
145445|NCT00712673|518571|P2|Overall Study|Withdrawal by Subject|7
145446|NCT00712673|518572|P1|Overall Study|Withdrawal by Subject|6
145447|NCT00712673|518569|P4|Overall Study|Lost to Follow-up|0
145448|NCT00712673|518570|P3|Overall Study|Lost to Follow-up|2
145449|NCT00712673|518571|P2|Overall Study|Lost to Follow-up|0
145450|NCT00712673|518572|P1|Overall Study|Lost to Follow-up|1
145451|NCT00712673|518569|P4|Overall Study|Poor Compliance to Protocol|16
145452|NCT00712673|518570|P3|Overall Study|Poor Compliance to Protocol|4
145453|NCT00712673|518571|P2|Overall Study|Poor Compliance to Protocol|3
145454|NCT00712673|518572|P1|Overall Study|Poor Compliance to Protocol|3
145455|NCT00712673|518569|P4|Overall Study|Lack of Efficacy|6
145456|NCT00712673|518570|P3|Overall Study|Lack of Efficacy|8
145457|NCT00712673|518571|P2|Overall Study|Lack of Efficacy|8
145458|NCT00712673|518572|P1|Overall Study|Lack of Efficacy|2
145459|NCT00712673|518569|P4|Overall Study|Adverse Event|26
145460|NCT00712673|518570|P3|Overall Study|Adverse Event|21
145461|NCT00712673|518571|P2|Overall Study|Adverse Event|3
145462|NCT00712673|518572|P1|Overall Study|Adverse Event|3
145463|NCT00712543|518636|P2|Day 8-14|Lost to Follow-up|2
145464|NCT00712543|518637|P1|Day 8-14|Lost to Follow-up|0
145465|NCT00712348|518671|P1|Overall Study|Withdrawal by Subject|1
145466|NCT00712335|518683|P5|Overall Study|Other Reason|0
145467|NCT00712335|518684|P4|Overall Study|Other Reason|0
145468|NCT00712335|518685|P3|Overall Study|Other Reason|1
145469|NCT00712335|518686|P2|Overall Study|Other Reason|3
145470|NCT00712335|518687|P1|Overall Study|Other Reason|0
145471|NCT00712335|518683|P5|Overall Study|Lack of Efficacy|0
145472|NCT00712335|518684|P4|Overall Study|Lack of Efficacy|1
145473|NCT00712335|518685|P3|Overall Study|Lack of Efficacy|1
145474|NCT00712335|518686|P2|Overall Study|Lack of Efficacy|0
145475|NCT00712335|518687|P1|Overall Study|Lack of Efficacy|0
145476|NCT00712335|518683|P5|Overall Study|Protocol Violation|0
145477|NCT00712335|518684|P4|Overall Study|Protocol Violation|0
145478|NCT00712335|518685|P3|Overall Study|Protocol Violation|1
145479|NCT00712335|518686|P2|Overall Study|Protocol Violation|2
145480|NCT00712335|518687|P1|Overall Study|Protocol Violation|1
145481|NCT00712335|518683|P5|Overall Study|Lost to Follow-up|0
145482|NCT00712335|518684|P4|Overall Study|Lost to Follow-up|1
145483|NCT00712335|518685|P3|Overall Study|Lost to Follow-up|0
145484|NCT00712335|518686|P2|Overall Study|Lost to Follow-up|5
145485|NCT00712335|518687|P1|Overall Study|Lost to Follow-up|2
145486|NCT00712335|518683|P5|Overall Study|Withdrawal by Subject|0
145487|NCT00712335|518684|P4|Overall Study|Withdrawal by Subject|3
145488|NCT00712335|518685|P3|Overall Study|Withdrawal by Subject|2
145489|NCT00712335|518686|P2|Overall Study|Withdrawal by Subject|7
145490|NCT00712335|518687|P1|Overall Study|Withdrawal by Subject|0
145491|NCT00712166|518784|P2|Overall Study|Noncompliance|1
145492|NCT00712166|518785|P1|Overall Study|Noncompliance|0
145493|NCT00712010|518828|P1|Washout (7 Days)|Withdrawal by Subject|1
145494|NCT00711971|518867|P3|Overall Study|Lost to Follow-up|1
145495|NCT00711971|518868|P2|Overall Study|Lost to Follow-up|4
145496|NCT00711971|518869|P1|Overall Study|Lost to Follow-up|3
145497|NCT00711958|518903|P2|Overall Study|Progression of disease|0
145498|NCT00711958|518904|P1|Overall Study|Progression of disease|1
145499|NCT00711958|518903|P2|Overall Study|Death|5
145500|NCT00711958|518904|P1|Overall Study|Death|10
145501|NCT00711958|518903|P2|Overall Study|Lost to Follow-up|2
145502|NCT00711958|518904|P1|Overall Study|Lost to Follow-up|2
145503|NCT00711958|518903|P2|Overall Study|Protocol Violation|0
145504|NCT00711958|518904|P1|Overall Study|Protocol Violation|1
145505|NCT00711958|518903|P2|Overall Study|Adverse Event|7
145506|NCT00711958|518904|P1|Overall Study|Adverse Event|9
145507|NCT00711958|518903|P2|Overall Study|Clinical deterioration|0
145508|NCT00711958|518904|P1|Overall Study|Clinical deterioration|1
145509|NCT00711958|518903|P2|Overall Study|Lack of Efficacy|1
145510|NCT00711958|518904|P1|Overall Study|Lack of Efficacy|3
145511|NCT00711958|518903|P2|Overall Study|Withdrawal by Subject|8
145512|NCT00711958|518904|P1|Overall Study|Withdrawal by Subject|6
145513|NCT00711880|518912|P2|Overall Study|Lack of Efficacy|5
145514|NCT00711880|518913|P1|Overall Study|Lack of Efficacy|1
145515|NCT00711880|518912|P2|Overall Study|Patient non-compliance|0
145516|NCT00711880|518913|P1|Overall Study|Patient non-compliance|1
145517|NCT00711880|518912|P2|Overall Study|Adverse Event|2
145518|NCT00711880|518913|P1|Overall Study|Adverse Event|11
145519|NCT00711802|518975|P8|Overall Study|Reason not reported|0
145520|NCT00711802|518976|P7|Overall Study|Reason not reported|1
145521|NCT00711802|518977|P6|Overall Study|Reason not reported|0
145522|NCT00711802|518978|P5|Overall Study|Reason not reported|1
145523|NCT00711802|518979|P4|Overall Study|Reason not reported|0
145524|NCT00711802|518980|P3|Overall Study|Reason not reported|1
145525|NCT00711802|518981|P2|Overall Study|Reason not reported|1
145526|NCT00711802|518982|P1|Overall Study|Reason not reported|0
145527|NCT00711802|518975|P8|Overall Study|Lost to Follow-up|2
145528|NCT00711802|518976|P7|Overall Study|Lost to Follow-up|4
145529|NCT00711802|518977|P6|Overall Study|Lost to Follow-up|6
145530|NCT00711802|518978|P5|Overall Study|Lost to Follow-up|10
145531|NCT00711802|518979|P4|Overall Study|Lost to Follow-up|1
145532|NCT00711802|518980|P3|Overall Study|Lost to Follow-up|3
145533|NCT00711802|518981|P2|Overall Study|Lost to Follow-up|0
145534|NCT00711802|518982|P1|Overall Study|Lost to Follow-up|0
145535|NCT00711802|518975|P8|Overall Study|Withdrawal by Subject|0
145536|NCT00711802|518976|P7|Overall Study|Withdrawal by Subject|0
145537|NCT00711802|518977|P6|Overall Study|Withdrawal by Subject|0
145538|NCT00711802|518978|P5|Overall Study|Withdrawal by Subject|0
145539|NCT00711802|518979|P4|Overall Study|Withdrawal by Subject|1
145540|NCT00711802|518980|P3|Overall Study|Withdrawal by Subject|0
145541|NCT00711802|518981|P2|Overall Study|Withdrawal by Subject|1
145542|NCT00711802|518982|P1|Overall Study|Withdrawal by Subject|0
145543|NCT00711802|518975|P8|Overall Study|Physician Decision|0
145544|NCT00711802|518976|P7|Overall Study|Physician Decision|0
145545|NCT00711802|518977|P6|Overall Study|Physician Decision|0
145546|NCT00711802|518978|P5|Overall Study|Physician Decision|0
145547|NCT00711802|518979|P4|Overall Study|Physician Decision|0
145548|NCT00711802|518980|P3|Overall Study|Physician Decision|0
145549|NCT00711802|518981|P2|Overall Study|Physician Decision|2
145550|NCT00711802|518982|P1|Overall Study|Physician Decision|0
145551|NCT00711802|518975|P8|Overall Study|Protocol Violation|0
145552|NCT00711802|518976|P7|Overall Study|Protocol Violation|0
145553|NCT00711802|518977|P6|Overall Study|Protocol Violation|0
145554|NCT00711802|518978|P5|Overall Study|Protocol Violation|0
145555|NCT00711802|518979|P4|Overall Study|Protocol Violation|1
145556|NCT00711802|518980|P3|Overall Study|Protocol Violation|0
145557|NCT00711802|518981|P2|Overall Study|Protocol Violation|0
145558|NCT00711802|518982|P1|Overall Study|Protocol Violation|0
145559|NCT00711802|518975|P8|Overall Study|Microbiological failure|0
145560|NCT00711802|518976|P7|Overall Study|Microbiological failure|0
145561|NCT00711802|518977|P6|Overall Study|Microbiological failure|1
145562|NCT00711802|518978|P5|Overall Study|Microbiological failure|0
145563|NCT00711802|518979|P4|Overall Study|Microbiological failure|0
145564|NCT00711802|518980|P3|Overall Study|Microbiological failure|0
145565|NCT00711802|518981|P2|Overall Study|Microbiological failure|1
145566|NCT00711802|518982|P1|Overall Study|Microbiological failure|0
145567|NCT00711802|518975|P8|Overall Study|Adverse Event|0
145568|NCT00711802|518976|P7|Overall Study|Adverse Event|0
145569|NCT00711802|518977|P6|Overall Study|Adverse Event|1
145570|NCT00711802|518978|P5|Overall Study|Adverse Event|1
145571|NCT00711802|518979|P4|Overall Study|Adverse Event|0
145572|NCT00711802|518980|P3|Overall Study|Adverse Event|0
145573|NCT00711802|518981|P2|Overall Study|Adverse Event|0
145574|NCT00711802|518982|P1|Overall Study|Adverse Event|0
145575|NCT00711802|518975|P8|Overall Study|Not treated (no further detail)|0
145576|NCT00711802|518976|P7|Overall Study|Not treated (no further detail)|0
145577|NCT00711802|518977|P6|Overall Study|Not treated (no further detail)|0
145578|NCT00711802|518978|P5|Overall Study|Not treated (no further detail)|2
145579|NCT00711802|518979|P4|Overall Study|Not treated (no further detail)|0
145580|NCT00711802|518980|P3|Overall Study|Not treated (no further detail)|2
145581|NCT00711802|518981|P2|Overall Study|Not treated (no further detail)|1
145582|NCT00711802|518982|P1|Overall Study|Not treated (no further detail)|2
145583|NCT00711646|519014|P2|Overall Study|patient non-compliance|0
145584|NCT00711646|519015|P1|Overall Study|patient non-compliance|1
145585|NCT00711646|519014|P2|Overall Study|administrative decision|1
145586|NCT00711646|519015|P1|Overall Study|administrative decision|0
145587|NCT00711646|519014|P2|Overall Study|Lost to Follow-up|0
145588|NCT00711646|519015|P1|Overall Study|Lost to Follow-up|1
145589|NCT00711646|519014|P2|Overall Study|Protocol Violation|1
145590|NCT00711646|519015|P1|Overall Study|Protocol Violation|0
145591|NCT00711646|519014|P2|Overall Study|Withdrawal by Subject|0
145592|NCT00711646|519015|P1|Overall Study|Withdrawal by Subject|4
145593|NCT00711646|519014|P2|Overall Study|Adverse Event|1
145594|NCT00711646|519015|P1|Overall Study|Adverse Event|6
145595|NCT00711594|519037|P4|Overall Study|Withdrawal by Subject|2
145596|NCT00711594|519038|P3|Overall Study|Withdrawal by Subject|0
145597|NCT00711594|519039|P2|Overall Study|Withdrawal by Subject|1
145598|NCT00711594|519040|P1|Overall Study|Withdrawal by Subject|0
145599|NCT00711594|519037|P4|Overall Study|Other Adverse Event|16
145600|NCT00711594|519038|P3|Overall Study|Other Adverse Event|0
145601|NCT00711594|519039|P2|Overall Study|Other Adverse Event|0
145602|NCT00711594|519040|P1|Overall Study|Other Adverse Event|1
145603|NCT00711594|519037|P4|Overall Study|Progressive disease|44
145604|NCT00711594|519038|P3|Overall Study|Progressive disease|6
145605|NCT00711594|519039|P2|Overall Study|Progressive disease|2
145606|NCT00711594|519040|P1|Overall Study|Progressive disease|2
145607|NCT00711555|519077|P1|Overall Study|Adverse Event|3
145608|NCT00711529|519086|P2|Overall Study|Withdrawal by Subject|6
145609|NCT00711529|519087|P1|Overall Study|Withdrawal by Subject|2
145610|NCT00711529|519086|P2|Overall Study|Protocol Violation|0
145611|NCT00711529|519087|P1|Overall Study|Protocol Violation|2
145612|NCT00711516|519111|P2|Overall Study|Protocol Violation|1
145613|NCT00711516|519112|P1|Overall Study|Protocol Violation|0
145614|NCT00711516|519111|P2|Overall Study|Withdrawal by Subject|1
145615|NCT00711516|519112|P1|Overall Study|Withdrawal by Subject|0
145616|NCT00711516|519111|P2|Overall Study|Adverse Event|1
145617|NCT00711516|519112|P1|Overall Study|Adverse Event|1
145618|NCT00711477|519219|P2|Overall Study|Noncompliance|1
145619|NCT00711477|519220|P1|Overall Study|Noncompliance|0
145620|NCT00711477|519219|P2|Overall Study|Lost to Follow-up|1
145621|NCT00711477|519220|P1|Overall Study|Lost to Follow-up|0
145622|NCT00711477|519219|P2|Overall Study|Adverse Event|1
145623|NCT00711477|519220|P1|Overall Study|Adverse Event|3
145624|NCT00711425|519266|P1|Overall Study|Lost to Follow-up|1
145625|NCT00711425|519266|P1|Overall Study|Death|2
145626|NCT00711425|519266|P1|Overall Study|Protocol Violation|1
145627|NCT00711191|519294|P3|Overall Study|Withdrawal by Subject|3
145628|NCT00711191|519295|P2|Overall Study|Withdrawal by Subject|1
145629|NCT00711191|519296|P1|Overall Study|Withdrawal by Subject|0
145630|NCT00711191|519294|P3|Overall Study|Objective progression or relapse|7
145631|NCT00711191|519295|P2|Overall Study|Objective progression or relapse|3
145632|NCT00711191|519296|P1|Overall Study|Objective progression or relapse|2
145633|NCT00711191|519294|P3|Overall Study|Adverse Event|2
145634|NCT00711191|519295|P2|Overall Study|Adverse Event|1
145635|NCT00711191|519296|P1|Overall Study|Adverse Event|1
145636|NCT00711113|519333|P1|Overall Study|Implant lost|2
145637|NCT00711113|519333|P1|Overall Study|Lost to Follow-up|9
145638|NCT00711100|519339|P1|Overall Study|Withdrawal by Subject|8
145639|NCT00711100|519339|P1|Overall Study|Lack of Efficacy|5
145640|NCT00711087|519357|P2|Overall Study|Lost to Follow-up|0
145641|NCT00711087|519358|P1|Overall Study|Lost to Follow-up|1
145642|NCT00711009|519370|P2|Overall Study|Dose adjustment|0
145643|NCT00711009|519371|P1|Overall Study|Dose adjustment|1
145644|NCT00711009|519370|P2|Overall Study|Site closing|1
145645|NCT00711009|519371|P1|Overall Study|Site closing|0
145646|NCT00711009|519370|P2|Overall Study|Pregnancy|0
145647|NCT00711009|519371|P1|Overall Study|Pregnancy|1
145648|NCT00711009|519370|P2|Overall Study|Virologic Failure|1
145649|NCT00711009|519371|P1|Overall Study|Virologic Failure|2
145650|NCT00711009|519370|P2|Overall Study|Participant Noncompliant|1
145651|NCT00711009|519371|P1|Overall Study|Participant Noncompliant|0
145652|NCT00711009|519370|P2|Overall Study|Lost to Follow-up|9
145653|NCT00711009|519371|P1|Overall Study|Lost to Follow-up|3
145654|NCT00711009|519370|P2|Overall Study|Withdrawal by Subject|2
145655|NCT00711009|519371|P1|Overall Study|Withdrawal by Subject|4
145656|NCT00711009|519370|P2|Overall Study|Adverse Event/HIV-Related Event|5
145657|NCT00711009|519371|P1|Overall Study|Adverse Event/HIV-Related Event|4
145658|NCT00710970|519552|P1|Overall Study|Never took drug|2
145659|NCT00710970|519552|P1|Overall Study|Lost to Follow-up|8
145660|NCT00710879|519579|P2|Overall Study|Protocol Violation|3
145661|NCT00710879|519580|P1|Overall Study|Protocol Violation|0
145662|NCT00710879|519579|P2|Overall Study|Lost to Follow-up|1
145663|NCT00710879|519580|P1|Overall Study|Lost to Follow-up|2
145664|NCT00710866|519592|P2|Overall Study|Failed to meet eligibility|1
145665|NCT00710866|519593|P1|Overall Study|Failed to meet eligibility|1
145666|NCT00710866|519592|P2|Overall Study|Lost to Follow-up|0
145667|NCT00710866|519593|P1|Overall Study|Lost to Follow-up|1
145668|NCT00710866|519592|P2|Overall Study|Withdrawal by Subject|1
145669|NCT00710866|519593|P1|Overall Study|Withdrawal by Subject|2
145670|NCT00710866|519592|P2|Overall Study|Protocol Violation|4
145671|NCT00710866|519593|P1|Overall Study|Protocol Violation|5
145672|NCT00710762|519639|P2|Overall Study|Reason other than listed above|2
145673|NCT00710762|519640|P1|Overall Study|Reason other than listed above|2
145674|NCT00710762|519639|P2|Overall Study|Lost to Follow-up|0
145675|NCT00710762|519640|P1|Overall Study|Lost to Follow-up|1
145676|NCT00710762|519639|P2|Overall Study|Other Adverse Event|7
145677|NCT00710762|519640|P1|Overall Study|Other Adverse Event|7
145678|NCT00710762|519639|P2|Overall Study|Adverse Event other disease worsening|1
145679|NCT00710762|519640|P1|Overall Study|Adverse Event other disease worsening|2
145680|NCT00710762|519639|P2|Overall Study|Progressive disease|30
145681|NCT00710762|519640|P1|Overall Study|Progressive disease|27
145682|NCT00710749|519656|P2|First Intervention|Withdrawal by Subject|0
145683|NCT00710749|519657|P1|First Intervention|Withdrawal by Subject|1
145684|NCT00710684|519668|P3|Overall Study|Did not continue after week 24|16
145685|NCT00710684|519669|P2|Overall Study|Did not continue after week 24|21
145686|NCT00710684|519670|P1|Overall Study|Did not continue after week 24|25
145687|NCT00710684|519668|P3|Overall Study|Missing|0
145688|NCT00710684|519669|P2|Overall Study|Missing|0
145689|NCT00710684|519670|P1|Overall Study|Missing|1
145690|NCT00710684|519668|P3|Overall Study|Withdrawal by Subject|11
145691|NCT00710684|519669|P2|Overall Study|Withdrawal by Subject|18
145692|NCT00710684|519670|P1|Overall Study|Withdrawal by Subject|24
145693|NCT00710684|519668|P3|Overall Study|Physician Decision|4
145694|NCT00710684|519669|P2|Overall Study|Physician Decision|2
145695|NCT00710684|519670|P1|Overall Study|Physician Decision|0
145696|NCT00710684|519668|P3|Overall Study|Lost to Follow-up|7
145697|NCT00710684|519669|P2|Overall Study|Lost to Follow-up|6
145698|NCT00710684|519670|P1|Overall Study|Lost to Follow-up|4
145699|NCT00710684|519668|P3|Overall Study|Protocol Violation|5
145700|NCT00710684|519669|P2|Overall Study|Protocol Violation|5
145701|NCT00710684|519670|P1|Overall Study|Protocol Violation|5
145702|NCT00710684|519668|P3|Overall Study|Lack of Efficacy|5
145703|NCT00710684|519669|P2|Overall Study|Lack of Efficacy|3
145704|NCT00710684|519670|P1|Overall Study|Lack of Efficacy|4
145705|NCT00710684|519668|P3|Overall Study|Adverse Event|16
145706|NCT00710684|519669|P2|Overall Study|Adverse Event|19
145707|NCT00710684|519670|P1|Overall Study|Adverse Event|11
145708|NCT00710606|519727|P2|Overall Study|Adverse Event|2
145709|NCT00710606|519728|P1|Overall Study|Adverse Event|0
145710|NCT00710593|519740|P2|Overall Study|Prem disc vaccine, completed all visits|2
145711|NCT00710593|519741|P1|Overall Study|Prem disc vaccine, completed all visits|6
145712|NCT00710593|519740|P2|Overall Study|Protocol Violation|1
145713|NCT00710593|519741|P1|Overall Study|Protocol Violation|1
145714|NCT00710593|519740|P2|Overall Study|Failure to adhere or complete study eval|1
145715|NCT00710593|519741|P1|Overall Study|Failure to adhere or complete study eval|1
145716|NCT00710593|519740|P2|Overall Study|Moved out of area|0
145717|NCT00710593|519741|P1|Overall Study|Moved out of area|1
145718|NCT00710593|519740|P2|Overall Study|Lost to Follow-up|1
145719|NCT00710593|519741|P1|Overall Study|Lost to Follow-up|3
145720|NCT00710593|519740|P2|Overall Study|Unable to complete Wk 48 within window|0
145721|NCT00710593|519741|P1|Overall Study|Unable to complete Wk 48 within window|2
145722|NCT00710593|519740|P2|Overall Study|Incarceration|0
145723|NCT00710593|519741|P1|Overall Study|Incarceration|1
145724|NCT00710554|519784|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
145725|NCT00710554|519785|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
145726|NCT00710554|519784|P2|Overall Study|Lack of Efficacy|12
145727|NCT00710554|519785|P1|Overall Study|Lack of Efficacy|11
145728|NCT00710554|519784|P2|Overall Study|Lost to Follow-up|1
145729|NCT00710554|519785|P1|Overall Study|Lost to Follow-up|7
145730|NCT00710554|519784|P2|Overall Study|Withdrawal by Subject|3
145731|NCT00710554|519785|P1|Overall Study|Withdrawal by Subject|7
145732|NCT00710554|519784|P2|Overall Study|Adverse Event|7
145733|NCT00710554|519785|P1|Overall Study|Adverse Event|24
145734|NCT00710424|519813|P2|Overall Study|Felt good so stopped treatment|1
145735|NCT00710424|519814|P1|Overall Study|Felt good so stopped treatment|0
145736|NCT00710424|519813|P2|Overall Study|Subject preferred paracetamol|1
145737|NCT00710424|519814|P1|Overall Study|Subject preferred paracetamol|0
145738|NCT00710424|519813|P2|Overall Study|Ceased treatment due to travel|0
145739|NCT00710424|519814|P1|Overall Study|Ceased treatment due to travel|1
145740|NCT00710424|519813|P2|Overall Study|Subject thought medication changed|0
145741|NCT00710424|519814|P1|Overall Study|Subject thought medication changed|1
145742|NCT00710424|519813|P2|Overall Study|Did not meet entry criteria at visit 1|0
145743|NCT00710424|519814|P1|Overall Study|Did not meet entry criteria at visit 1|1
145744|NCT00710424|519813|P2|Overall Study|Non-compliance with stable analgesia|0
145745|NCT00710424|519814|P1|Overall Study|Non-compliance with stable analgesia|1
145746|NCT00710424|519813|P2|Overall Study|Refused medication, no side effects|0
145747|NCT00710424|519814|P1|Overall Study|Refused medication, no side effects|1
145748|NCT00710424|519813|P2|Overall Study|Lost to Follow-up|1
145749|NCT00710424|519814|P1|Overall Study|Lost to Follow-up|0
145750|NCT00710424|519813|P2|Overall Study|Withdrawal by Subject|3
145751|NCT00710424|519814|P1|Overall Study|Withdrawal by Subject|5
145752|NCT00710424|519813|P2|Overall Study|Lack of Efficacy|5
145753|NCT00710424|519814|P1|Overall Study|Lack of Efficacy|4
145754|NCT00710424|519813|P2|Overall Study|Adverse Event|12
145755|NCT00710424|519814|P1|Overall Study|Adverse Event|30
145756|NCT00710385|519838|P1|Overall Study|Undisclosed excessive methadone use|1
145757|NCT00710385|519838|P1|Overall Study|Physician Decision|1
145758|NCT00710385|519838|P1|Overall Study|Undisclosed back pain|1
145759|NCT00710385|519838|P1|Overall Study|Withdrawal by Subject|1
145760|NCT00710385|519838|P1|Overall Study|Did not qualify|1
145761|NCT00710034|519883|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
145762|NCT00710034|519884|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
145763|NCT00710034|519883|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
145764|NCT00710034|519884|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
145765|NCT00710034|519883|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
145766|NCT00710034|519884|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
145767|NCT00710034|519883|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
145768|NCT00710034|519884|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
145769|NCT00710034|519883|P2|Completed 12 Weeks of Treatment|Adverse Event|1
145770|NCT00710034|519884|P1|Completed 12 Weeks of Treatment|Adverse Event|0
145771|NCT00710034|519883|P2|Completed 6 Weeks of Treatment|Physician Decision|0
145772|NCT00710034|519884|P1|Completed 6 Weeks of Treatment|Physician Decision|1
145773|NCT00710034|519883|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
145774|NCT00710034|519884|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
145775|NCT00710034|519883|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
145776|NCT00710034|519884|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
145777|NCT00710034|519883|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
145778|NCT00710034|519884|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
145779|NCT00710034|519883|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
145780|NCT00710034|519884|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
145781|NCT00710034|519883|P2|Completed 6 Weeks of Treatment|Adverse Event|12
145782|NCT00710034|519884|P1|Completed 6 Weeks of Treatment|Adverse Event|5
145783|NCT00710021|519901|P3|Overall Study|Physician Decision|0
145784|NCT00710021|519902|P2|Overall Study|Physician Decision|1
145785|NCT00710021|519903|P1|Overall Study|Physician Decision|0
145786|NCT00710021|519901|P3|Overall Study|Subject misrandomized|1
145787|NCT00710021|519902|P2|Overall Study|Subject misrandomized|1
145788|NCT00710021|519903|P1|Overall Study|Subject misrandomized|0
145789|NCT00710021|519901|P3|Overall Study|Subject's Decision|0
145790|NCT00710021|519902|P2|Overall Study|Subject's Decision|1
145791|NCT00710021|519903|P1|Overall Study|Subject's Decision|0
145792|NCT00710021|519901|P3|Overall Study|Lost to Follow-up|0
145793|NCT00710021|519902|P2|Overall Study|Lost to Follow-up|0
145794|NCT00710021|519903|P1|Overall Study|Lost to Follow-up|1
145795|NCT00709956|520018|P2|Overall Study|Inclusion/exclusion criteria violation|3
145796|NCT00709956|520019|P1|Overall Study|Inclusion/exclusion criteria violation|2
145797|NCT00709956|520018|P2|Overall Study|Withdrawal by Subject|1
145798|NCT00709956|520019|P1|Overall Study|Withdrawal by Subject|1
145799|NCT00709852|520049|P2|Period 2|No 72-hour follow-up|0
145800|NCT00709852|520050|P1|Period 2|No 72-hour follow-up|3
145801|NCT00709852|520049|P2|Period 2|Lost to Follow-up|0
145802|NCT00709852|520050|P1|Period 2|Lost to Follow-up|1
145803|NCT00709852|520049|P2|Period 2|Adverse Event|1
145804|NCT00709852|520050|P1|Period 2|Adverse Event|1
145805|NCT00709852|520049|P2|Period 2|Protocol Violation|1
145806|NCT00709852|520050|P1|Period 2|Protocol Violation|4
145807|NCT00709852|520049|P2|Period 1|Lost to Follow-up|0
145808|NCT00709852|520050|P1|Period 1|Lost to Follow-up|1
145809|NCT00709852|520049|P2|Period 1|Defective scanner|1
145810|NCT00709852|520050|P1|Period 1|Defective scanner|0
145811|NCT00709852|520049|P2|Period 1|Protocol Violation|0
145812|NCT00709852|520050|P1|Period 1|Protocol Violation|1
145813|NCT00709852|520049|P2|Period 1|Withdrawal by Subject|2
145814|NCT00709852|520050|P1|Period 1|Withdrawal by Subject|4
145815|NCT00709852|520049|P2|Period 1|Adverse Event|0
145816|NCT00709852|520050|P1|Period 1|Adverse Event|2
145817|NCT00709761|520214|P1|Overall Study|Ongoing|40
145818|NCT00709761|520214|P1|Overall Study|Withdrawal by Subject|7
145819|NCT00709735|520225|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
145820|NCT00709735|520226|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
145821|NCT00709735|520225|P2|Overall Study|Relapse into Opioid Abuse|1
145822|NCT00709735|520226|P1|Overall Study|Relapse into Opioid Abuse|0
145823|NCT00709735|520225|P2|Overall Study|Lost to Follow-up|1
145824|NCT00709735|520226|P1|Overall Study|Lost to Follow-up|1
145825|NCT00709722|520234|P1|Overall Study|Adverse Event|1
145826|NCT00709618|520249|P1|Overall Study|Study Closed/Terminated|25
145827|NCT00709618|520249|P1|Overall Study|Lost to Follow-up|1
145828|NCT00709618|520249|P1|Overall Study|Withdrawal by Subject|4
145829|NCT00709592|520261|P2|Overall Study|Unable to proceed to transplant|1
145830|NCT00709592|520262|P1|Overall Study|Unable to proceed to transplant|0
145831|NCT00709319|520282|P1|Overall Study|Withdrawal by Subject|2
145832|NCT00709319|520282|P1|Overall Study|Death|4
145833|NCT00709228|520311|P1|Overall Study|Non-compliance|5
145834|NCT00709228|520311|P1|Overall Study|Lost to Follow-up|6
145835|NCT00709228|520311|P1|Overall Study|Disease progression|1
145836|NCT00709228|520311|P1|Overall Study|Discontinued follow-up|5
145837|NCT00709228|520311|P1|Overall Study|Did not enter follow-up|4
145838|NCT00709228|520311|P1|Overall Study|Discontinued treatment|14
145839|NCT00709228|520311|P1|Overall Study|Adverse events|2
145840|NCT00709228|520311|P1|Overall Study|Eligibility criteria not met|281
145841|NCT00709228|520311|P1|Overall Study|Not treated|14
145842|NCT00709124|520317|P2|Overall Study|encephalopathy; can't do assessment|0
145843|NCT00709124|520318|P1|Overall Study|encephalopathy; can't do assessment|1
145844|NCT00709124|520317|P2|Overall Study|Death|1
145845|NCT00709124|520318|P1|Overall Study|Death|3
145846|NCT00709111|520352|P1|Overall Study|Unable to attend clinic visits|1
145847|NCT00709111|520352|P1|Overall Study|Withdrawal by Subject|1
145848|NCT00709098|520393|P3|Open-label Period|Lost to Follow-up|1
145849|NCT00709098|520394|P2|Open-label Period|Lost to Follow-up|0
145850|NCT00709098|520395|P1|Open-label Period|Lost to Follow-up|0
145851|NCT00709098|520393|P3|Open-label Period|Death|1
145852|NCT00709098|520394|P2|Open-label Period|Death|0
145853|NCT00709098|520395|P1|Open-label Period|Death|0
145854|NCT00709098|520393|P3|Open-label Period|Administrative reason|5
145855|NCT00709098|520394|P2|Open-label Period|Administrative reason|0
145856|NCT00709098|520395|P1|Open-label Period|Administrative reason|0
145857|NCT00709098|520393|P3|Open-label Period|Withdrawal of consent|7
145858|NCT00709098|520394|P2|Open-label Period|Withdrawal of consent|0
145859|NCT00709098|520395|P1|Open-label Period|Withdrawal of consent|0
145860|NCT00709098|520393|P3|Double-blind Period|Lost to Follow-up|0
145861|NCT00709098|520394|P2|Double-blind Period|Lost to Follow-up|1
145862|NCT00709098|520395|P1|Double-blind Period|Lost to Follow-up|1
145863|NCT00709098|520393|P3|Double-blind Period|Death|0
145864|NCT00709098|520394|P2|Double-blind Period|Death|1
145865|NCT00709098|520395|P1|Double-blind Period|Death|1
145866|NCT00709098|520393|P3|Double-blind Period|Administrative reason|0
145867|NCT00709098|520394|P2|Double-blind Period|Administrative reason|3
145868|NCT00709098|520395|P1|Double-blind Period|Administrative reason|1
145869|NCT00709098|520393|P3|Double-blind Period|Withdrawal of consent|0
145870|NCT00709098|520394|P2|Double-blind Period|Withdrawal of consent|3
145871|NCT00709098|520395|P1|Double-blind Period|Withdrawal of consent|3
145872|NCT00709059|520414|P1|Overall Study|Serious side effects|11
145873|NCT00709059|520414|P1|Overall Study|Side effects|20
145874|NCT00709059|520414|P1|Overall Study|Disease complication|3
145875|NCT00709059|520414|P1|Overall Study|Physician Decision|7
145876|NCT00709059|520414|P1|Overall Study|Withdrawal by Subject|19
145877|NCT00709059|520414|P1|Overall Study|Lost to Follow-up|34
145878|NCT00708734|520461|P1|Overall Study|leg fracture|1
145879|NCT00708734|520461|P1|Overall Study|vertigo|1
145880|NCT00708734|520461|P1|Overall Study|knee replacement|1
145881|NCT00708734|520461|P1|Overall Study|leg injury|1
145882|NCT00708734|520461|P1|Overall Study|moved|1
145883|NCT00708734|520461|P1|Overall Study|scheduling conflict|2
145884|NCT00708708|520481|P1|Overall Study|Missing values|392
145885|NCT00708708|520481|P1|Overall Study|Adverse Event|3
145886|NCT00708708|520481|P1|Overall Study|Pregnancy|3
145887|NCT00708708|520481|P1|Overall Study|Lack of compliance|3
145888|NCT00708708|520481|P1|Overall Study|Lack of effectiveness|4
145889|NCT00708708|520481|P1|Overall Study|Administrative reasons|7
145890|NCT00708708|520481|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
145891|NCT00708708|520481|P1|Overall Study|Good effectiveness|9
145892|NCT00708708|520481|P1|Overall Study|Other unspecified|11
145893|NCT00708708|520481|P1|Overall Study|Another therapy along with Enbrel|15
145894|NCT00708708|520481|P1|Overall Study|Intolerance|42
145895|NCT00708708|520481|P1|Overall Study|Withdrawal by Subject|51
145896|NCT00708708|520481|P1|Overall Study|Lost to Follow-up|52
145897|NCT00708708|520481|P1|Overall Study|Another therapy instead of Enbrel|141
145898|NCT00708682|520529|P1|Toddler Dose|Failed to Return|4
145899|NCT00708682|520529|P1|Toddler Dose|Lost to Follow-up|3
145900|NCT00708682|520529|P1|Toddler Dose|Parent/Legal Guardian Request|1
145901|NCT00708682|520529|P1|After Infant Series|Parent/Legal Guardian Request|1
145902|NCT00708682|520529|P1|Infant Series|Not Specified|19
145903|NCT00708682|520529|P1|Infant Series|Failed to return|2
145904|NCT00708682|520529|P1|Infant Series|Parent/legal guardian request|6
145905|NCT00708682|520529|P1|Infant Series|Protocol Violation|1
145906|NCT00708682|520529|P1|Infant Series|Lost to Follow-up|4
145907|NCT00708682|520529|P1|Infant Series|Adverse Event|1
145908|NCT00708643|520550|P2|Overall Study|Adverse Event|1
145909|NCT00708643|520551|P1|Overall Study|Adverse Event|0
145910|NCT00708552|520571|P4|Overall Study|Withdrawal by Subject|10
145911|NCT00708552|520572|P3|Overall Study|Withdrawal by Subject|8
145912|NCT00708552|520573|P2|Overall Study|Withdrawal by Subject|7
145913|NCT00708552|520574|P1|Overall Study|Withdrawal by Subject|12
145914|NCT00708552|520571|P4|Overall Study|Physician Decision|0
145915|NCT00708552|520572|P3|Overall Study|Physician Decision|0
145916|NCT00708552|520573|P2|Overall Study|Physician Decision|2
145917|NCT00708552|520574|P1|Overall Study|Physician Decision|1
145918|NCT00708552|520571|P4|Overall Study|Lost to Follow-up|1
145919|NCT00708552|520572|P3|Overall Study|Lost to Follow-up|0
145920|NCT00708552|520573|P2|Overall Study|Lost to Follow-up|2
145921|NCT00708552|520574|P1|Overall Study|Lost to Follow-up|4
145922|NCT00708552|520571|P4|Overall Study|Protocol Violation|4
145923|NCT00708552|520572|P3|Overall Study|Protocol Violation|2
145924|NCT00708552|520573|P2|Overall Study|Protocol Violation|0
145925|NCT00708552|520574|P1|Overall Study|Protocol Violation|0
145926|NCT00708552|520571|P4|Overall Study|Lack of Efficacy|0
145927|NCT00708552|520572|P3|Overall Study|Lack of Efficacy|1
145928|NCT00708552|520573|P2|Overall Study|Lack of Efficacy|4
145929|NCT00708552|520574|P1|Overall Study|Lack of Efficacy|0
145930|NCT00708552|520571|P4|Overall Study|Adverse Event|6
145931|NCT00708552|520572|P3|Overall Study|Adverse Event|4
145932|NCT00708552|520573|P2|Overall Study|Adverse Event|3
145933|NCT00708552|520574|P1|Overall Study|Adverse Event|10
145934|NCT00708500|520736|P3|FOLLOWUP|Non-compliance with protocol|1
145935|NCT00708500|520737|P2|FOLLOWUP|Non-compliance with protocol|0
145936|NCT00708500|520738|P1|FOLLOWUP|Non-compliance with protocol|5
145937|NCT00708500|520736|P3|FOLLOWUP|Subject withdrew consent|5
145938|NCT00708500|520737|P2|FOLLOWUP|Subject withdrew consent|4
145939|NCT00708500|520738|P1|FOLLOWUP|Subject withdrew consent|31
145940|NCT00708500|520736|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
145941|NCT00708500|520737|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
145942|NCT00708500|520738|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
145943|NCT00708500|520736|P3|FOLLOWUP|Lost to Follow-up|4
145944|NCT00708500|520737|P2|FOLLOWUP|Lost to Follow-up|6
145945|NCT00708500|520738|P1|FOLLOWUP|Lost to Follow-up|1
145946|NCT00708500|520736|P3|FOLLOWUP|Adverse Event|0
145947|NCT00708500|520737|P2|FOLLOWUP|Adverse Event|1
145948|NCT00708500|520738|P1|FOLLOWUP|Adverse Event|0
145949|NCT00708500|520736|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
145950|NCT00708500|520737|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
145951|NCT00708500|520738|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
145952|NCT00708500|520736|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
145953|NCT00708500|520737|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
145954|NCT00708500|520738|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
145955|NCT00708500|520736|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
145956|NCT00708500|520737|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
145957|NCT00708500|520738|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
145958|NCT00708500|520736|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
145959|NCT00708500|520737|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
145960|NCT00708500|520738|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
145961|NCT00708500|520736|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
145962|NCT00708500|520737|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
145963|NCT00708500|520738|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
145964|NCT00708500|520736|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
145965|NCT00708500|520737|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
145966|NCT00708500|520738|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
145967|NCT00708500|520736|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
145968|NCT00708500|520737|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
145969|NCT00708500|520738|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
145970|NCT00708500|520736|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
145971|NCT00708500|520737|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
145972|NCT00708500|520738|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
145973|NCT00708500|520736|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
145974|NCT00708500|520737|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
145975|NCT00708500|520738|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
145976|NCT00708500|520736|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
145977|NCT00708500|520737|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
145978|NCT00708500|520738|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
145979|NCT00708500|520736|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
145980|NCT00708500|520737|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
145981|NCT00708500|520738|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
145982|NCT00708500|520736|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
145983|NCT00708500|520737|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
145984|NCT00708500|520738|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
145985|NCT00708500|520736|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
145986|NCT00708500|520737|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
145987|NCT00708500|520738|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
145988|NCT00708461|520757|P2|Overall Study|left workforce|180
145989|NCT00708461|520758|P1|Overall Study|left workforce|115
145990|NCT00708461|520757|P2|Overall Study|Withdrawal by Subject|9
145991|NCT00708461|520758|P1|Overall Study|Withdrawal by Subject|8
145992|NCT00708461|520757|P2|Overall Study|Lost to Follow-up|11
145993|NCT00708461|520758|P1|Overall Study|Lost to Follow-up|18
145994|NCT00708435|520766|P2|Overall Study|Refused hospitalization|0
145995|NCT00708435|520767|P1|Overall Study|Refused hospitalization|1
145996|NCT00708435|520766|P2|Overall Study|Intervention by primary care physician|0
145997|NCT00708435|520767|P1|Overall Study|Intervention by primary care physician|1
145998|NCT00708435|520766|P2|Overall Study|Protocol Violation|1
145999|NCT00708435|520767|P1|Overall Study|Protocol Violation|0
146000|NCT00708435|520766|P2|Overall Study|Adverse Event|0
146001|NCT00708435|520767|P1|Overall Study|Adverse Event|1
146002|NCT00708435|520766|P2|Overall Study|Withdrawal by Subject|7
146003|NCT00708435|520767|P1|Overall Study|Withdrawal by Subject|3
146004|NCT00708435|520766|P2|Overall Study|Lost to Follow-up|4
146005|NCT00708435|520767|P1|Overall Study|Lost to Follow-up|9
146006|NCT00708435|520766|P2|Overall Study|Death / Serious Adverse Event|5
146007|NCT00708435|520767|P1|Overall Study|Death / Serious Adverse Event|10
146008|NCT00708422|520794|P2|Overall Study|Withdrawal by Subject|0
146009|NCT00708422|520795|P1|Overall Study|Withdrawal by Subject|1
146010|NCT00708422|520794|P2|Overall Study|Adverse Event|1
146011|NCT00708422|520795|P1|Overall Study|Adverse Event|3
146012|NCT00708305|520803|P4|Period 3|Other Reason|0
146013|NCT00708305|520804|P3|Period 3|Other Reason|0
146014|NCT00708305|520805|P2|Period 3|Other Reason|0
146015|NCT00708305|520806|P1|Period 3|Other Reason|1
146016|NCT00708305|520803|P4|Period 3|Protocol Violation|0
146017|NCT00708305|520804|P3|Period 3|Protocol Violation|0
146018|NCT00708305|520805|P2|Period 3|Protocol Violation|2
146019|NCT00708305|520806|P1|Period 3|Protocol Violation|0
146020|NCT00708305|520803|P4|Period 2|Other Reason|1
146021|NCT00708305|520804|P3|Period 2|Other Reason|0
146022|NCT00708305|520805|P2|Period 2|Other Reason|0
146023|NCT00708305|520806|P1|Period 2|Other Reason|1
146024|NCT00708305|520803|P4|Period 2|Protocol Violation|0
146025|NCT00708305|520804|P3|Period 2|Protocol Violation|0
146026|NCT00708305|520805|P2|Period 2|Protocol Violation|1
146027|NCT00708305|520806|P1|Period 2|Protocol Violation|0
146028|NCT00708305|520803|P4|Period 2|Lost to Follow-up|0
146029|NCT00708305|520804|P3|Period 2|Lost to Follow-up|0
146030|NCT00708305|520805|P2|Period 2|Lost to Follow-up|1
146031|NCT00708305|520806|P1|Period 2|Lost to Follow-up|0
146032|NCT00708305|520803|P4|Period 1|Other Reason|2
146033|NCT00708305|520804|P3|Period 1|Other Reason|0
146034|NCT00708305|520805|P2|Period 1|Other Reason|0
146035|NCT00708305|520806|P1|Period 1|Other Reason|0
146036|NCT00708305|520803|P4|Period 1|Protocol Violation|0
146037|NCT00708305|520804|P3|Period 1|Protocol Violation|1
146038|NCT00708305|520805|P2|Period 1|Protocol Violation|0
146039|NCT00708305|520806|P1|Period 1|Protocol Violation|1
146040|NCT00708227|520842|P4|Overall Study|Withdrawal by Subject|1
146041|NCT00708227|520843|P3|Overall Study|Withdrawal by Subject|0
146042|NCT00708227|520844|P2|Overall Study|Withdrawal by Subject|2
146043|NCT00708227|520845|P1|Overall Study|Withdrawal by Subject|1
146044|NCT00708227|520842|P4|Overall Study|Physician Decision|2
146045|NCT00708227|520843|P3|Overall Study|Physician Decision|1
146046|NCT00708227|520844|P2|Overall Study|Physician Decision|3
146047|NCT00708227|520845|P1|Overall Study|Physician Decision|0
146048|NCT00708214|520878|P3|Overall Study|Progressive Disease|5
146049|NCT00708214|520879|P2|Overall Study|Progressive Disease|6
146050|NCT00708214|520880|P1|Overall Study|Progressive Disease|4
146051|NCT00708214|520878|P3|Overall Study|Other|1
146052|NCT00708214|520879|P2|Overall Study|Other|1
146053|NCT00708214|520880|P1|Overall Study|Other|0
146054|NCT00708214|520878|P3|Overall Study|Other Adverse Event|2
146055|NCT00708214|520879|P2|Overall Study|Other Adverse Event|6
146056|NCT00708214|520880|P1|Overall Study|Other Adverse Event|3
146057|NCT00708201|520923|P2|Overall Study|Protocol Violation|1
146058|NCT00708201|520924|P1|Overall Study|Protocol Violation|0
146059|NCT00708201|520923|P2|Overall Study|Lost to Follow-up|0
146060|NCT00708201|520924|P1|Overall Study|Lost to Follow-up|2
146061|NCT00708201|520923|P2|Overall Study|Withdrawal by Subject|1
146062|NCT00708201|520924|P1|Overall Study|Withdrawal by Subject|1
146063|NCT00708201|520923|P2|Overall Study|Adverse Event|4
146064|NCT00708201|520924|P1|Overall Study|Adverse Event|4
146065|NCT00708175|520948|P2|Overall Study|BMD loss >7%|3
146066|NCT00708175|520949|P1|Overall Study|BMD loss >7%|2
146067|NCT00708175|520948|P2|Overall Study|Withdrawal by Subject|7
146068|NCT00708175|520949|P1|Overall Study|Withdrawal by Subject|5
146069|NCT00708175|520948|P2|Overall Study|Lost to Follow-up|3
146070|NCT00708175|520949|P1|Overall Study|Lost to Follow-up|5
146071|NCT00708175|520948|P2|Overall Study|Protocol Violation|3
146072|NCT00708175|520949|P1|Overall Study|Protocol Violation|2
146073|NCT00708175|520948|P2|Overall Study|Adverse Event|5
146074|NCT00708175|520949|P1|Overall Study|Adverse Event|4
146075|NCT00708162|520965|P2|Open-Label Phase|Other|0
146076|NCT00708162|520966|P1|Open-Label Phase|Other|1
146077|NCT00708162|520965|P2|Open-Label Phase|Adverse Event|2
146078|NCT00708162|520966|P1|Open-Label Phase|Adverse Event|1
146079|NCT00708162|520965|P2|Open-Label Phase|Death|1
146080|NCT00708162|520966|P1|Open-Label Phase|Death|3
146081|NCT00708162|520965|P2|Open-Label Phase|Investigator's Discretion|2
146082|NCT00708162|520966|P1|Open-Label Phase|Investigator's Discretion|3
146083|NCT00708162|520965|P2|Open-Label Phase|Lack of Efficacy|4
146084|NCT00708162|520966|P1|Open-Label Phase|Lack of Efficacy|7
146085|NCT00708162|520965|P2|Open-Label Phase|Participant Noncompliance|7
146086|NCT00708162|520966|P1|Open-Label Phase|Participant Noncompliance|7
146087|NCT00708162|520965|P2|Open-Label Phase|Withdrew Consent|6
146088|NCT00708162|520966|P1|Open-Label Phase|Withdrew Consent|12
146089|NCT00708162|520965|P2|Open-Label Phase|Lost to Follow-up|8
146090|NCT00708162|520966|P1|Open-Label Phase|Lost to Follow-up|10
146091|NCT00708162|520965|P2|Randomized Phase|Pregnancy|0
146092|NCT00708162|520966|P1|Randomized Phase|Pregnancy|3
146093|NCT00708162|520965|P2|Randomized Phase|Death|9
146094|NCT00708162|520966|P1|Randomized Phase|Death|2
146095|NCT00708162|520965|P2|Randomized Phase|Investigator’s Discretion|10
146096|NCT00708162|520966|P1|Randomized Phase|Investigator’s Discretion|7
146097|NCT00708162|520965|P2|Randomized Phase|Adverse Event|12
146098|NCT00708162|520966|P1|Randomized Phase|Adverse Event|8
146099|NCT00708162|520965|P2|Randomized Phase|Protocol Violation|11
146100|NCT00708162|520966|P1|Randomized Phase|Protocol Violation|10
146101|NCT00708162|520965|P2|Randomized Phase|Lack of Efficacy|19
146102|NCT00708162|520966|P1|Randomized Phase|Lack of Efficacy|14
146103|NCT00708162|520965|P2|Randomized Phase|Withdrew Consent|22
146104|NCT00708162|520966|P1|Randomized Phase|Withdrew Consent|31
146105|NCT00708162|520965|P2|Randomized Phase|Lost to Follow-up|34
146106|NCT00708162|520966|P1|Randomized Phase|Lost to Follow-up|34
146107|NCT00708162|520965|P2|Randomized Phase|Participant Noncompliance|32
146108|NCT00708162|520966|P1|Randomized Phase|Participant Noncompliance|40
146109|NCT00708162|520965|P2|Randomized Phase|Randomized but Not Treated|5
146110|NCT00708162|520966|P1|Randomized Phase|Randomized but Not Treated|7
146111|NCT00708123|521007|P5|Period 4|Protocol Violation|0
146112|NCT00708123|521008|P4|Period 4|Protocol Violation|0
146113|NCT00708123|521009|P3|Period 4|Protocol Violation|0
146114|NCT00708123|521010|P2|Period 4|Protocol Violation|1
146115|NCT00708123|521011|P1|Period 4|Protocol Violation|0
146116|NCT00708123|521007|P5|Period 3|Lost to Follow-up|0
146117|NCT00708123|521008|P4|Period 3|Lost to Follow-up|1
146118|NCT00708123|521009|P3|Period 3|Lost to Follow-up|1
146119|NCT00708123|521010|P2|Period 3|Lost to Follow-up|0
146120|NCT00708123|521011|P1|Period 3|Lost to Follow-up|0
146121|NCT00708123|521007|P5|Period 2|Other Reason|0
146122|NCT00708123|521008|P4|Period 2|Other Reason|0
146123|NCT00708123|521009|P3|Period 2|Other Reason|0
146124|NCT00708123|521010|P2|Period 2|Other Reason|0
146125|NCT00708123|521011|P1|Period 2|Other Reason|1
146126|NCT00708123|521007|P5|Period 2|Protocol Violation|0
146127|NCT00708123|521008|P4|Period 2|Protocol Violation|1
146128|NCT00708123|521009|P3|Period 2|Protocol Violation|0
146129|NCT00708123|521010|P2|Period 2|Protocol Violation|0
146130|NCT00708123|521011|P1|Period 2|Protocol Violation|0
146131|NCT00708123|521007|P5|Period 1|Adverse Event|0
146132|NCT00708123|521008|P4|Period 1|Adverse Event|0
146133|NCT00708123|521009|P3|Period 1|Adverse Event|1
146134|NCT00708123|521010|P2|Period 1|Adverse Event|0
146135|NCT00708123|521011|P1|Period 1|Adverse Event|0
146136|NCT00708123|521007|P5|Period 1|Protocol Violation|0
146137|NCT00708123|521008|P4|Period 1|Protocol Violation|1
146138|NCT00708123|521009|P3|Period 1|Protocol Violation|0
146139|NCT00708123|521010|P2|Period 1|Protocol Violation|1
146140|NCT00708123|521011|P1|Period 1|Protocol Violation|0
146141|NCT00708097|521144|P5|Period 2|Protocol Violation|0
146142|NCT00708097|521145|P4|Period 2|Protocol Violation|1
146143|NCT00708097|521146|P3|Period 2|Protocol Violation|1
146144|NCT00708097|521147|P2|Period 2|Protocol Violation|1
146145|NCT00708097|521148|P1|Period 2|Protocol Violation|0
146146|NCT00708097|521144|P5|Period 1|Other Reason|1
146147|NCT00708097|521145|P4|Period 1|Other Reason|0
146148|NCT00708097|521146|P3|Period 1|Other Reason|0
146149|NCT00708097|521147|P2|Period 1|Other Reason|0
146150|NCT00708097|521148|P1|Period 1|Other Reason|0
146151|NCT00708097|521144|P5|Period 1|Protocol Violation|0
146152|NCT00708097|521145|P4|Period 1|Protocol Violation|2
146153|NCT00708097|521146|P3|Period 1|Protocol Violation|0
146154|NCT00708097|521147|P2|Period 1|Protocol Violation|1
146155|NCT00708097|521148|P1|Period 1|Protocol Violation|0
146156|NCT00708032|521258|P2|Overall Study|Withdrawal by Subject|1
146157|NCT00708032|521259|P1|Overall Study|Withdrawal by Subject|0
146158|NCT00708032|521258|P2|Overall Study|Protocol Violation|1
146159|NCT00708032|521259|P1|Overall Study|Protocol Violation|4
146160|NCT00708032|521258|P2|Overall Study|Did not meet protocol criteria|2
146161|NCT00708032|521259|P1|Overall Study|Did not meet protocol criteria|1
146162|NCT00708032|521258|P2|Overall Study|Visit out of range at month 12|1
146163|NCT00708032|521259|P1|Overall Study|Visit out of range at month 12|4
146164|NCT00708032|521258|P2|Overall Study|Poor vision|6
146165|NCT00708032|521259|P1|Overall Study|Poor vision|0
146166|NCT00708032|521258|P2|Overall Study|Pregnancy|1
146167|NCT00708032|521259|P1|Overall Study|Pregnancy|0
146168|NCT00708032|521258|P2|Overall Study|Lost to Follow-up|2
146169|NCT00708032|521259|P1|Overall Study|Lost to Follow-up|1
146170|NCT00708032|521258|P2|Overall Study|Adverse Event|2
146171|NCT00708032|521259|P1|Overall Study|Adverse Event|0
146172|NCT00707993|521286|P2|Overall Study|Other|0
146173|NCT00707993|521287|P1|Overall Study|Other|2
146174|NCT00707993|521286|P2|Overall Study|Hyperglycemic Rescue|47
146175|NCT00707993|521287|P1|Overall Study|Hyperglycemic Rescue|55
146176|NCT00707993|521286|P2|Overall Study|Withdrawal by Subject|16
146177|NCT00707993|521287|P1|Overall Study|Withdrawal by Subject|12
146178|NCT00707993|521286|P2|Overall Study|Lost to Follow-up|4
146179|NCT00707993|521287|P1|Overall Study|Lost to Follow-up|0
146180|NCT00707993|521286|P2|Overall Study|Protocol Violation|7
146181|NCT00707993|521287|P1|Overall Study|Protocol Violation|4
146182|NCT00707993|521286|P2|Overall Study|Adverse Event|20
146183|NCT00707993|521287|P1|Overall Study|Adverse Event|16
146184|NCT00707980|521329|P1|Overall Study|Other|39
146185|NCT00707980|521329|P1|Overall Study|Lost to Follow-up|59
146186|NCT00707980|521329|P1|Overall Study|Withdrawal of Consent|81
146187|NCT00707980|521329|P1|Overall Study|Protocol Deviations|19
146188|NCT00707980|521329|P1|Overall Study|Non-Compliance with Study Drug|28
146189|NCT00707980|521329|P1|Overall Study|Lack of Efficacy|35
146190|NCT00707980|521329|P1|Overall Study|Adverse Event|49
146191|NCT00707954|521413|P5|Overall Study|Physician Decision|1
146192|NCT00707954|521414|P4|Overall Study|Physician Decision|0
146193|NCT00707954|521415|P3|Overall Study|Physician Decision|0
146194|NCT00707954|521416|P2|Overall Study|Physician Decision|0
146195|NCT00707954|521417|P1|Overall Study|Physician Decision|0
146196|NCT00707746|521458|P2|Treatment Period|Ineligibility|1
146197|NCT00707746|521459|P1|Treatment Period|Ineligibility|0
146198|NCT00707746|521458|P2|Treatment Period|Adverse Event|4
146199|NCT00707746|521459|P1|Treatment Period|Adverse Event|2
146200|NCT00707577|521520|P2|Overall Study|Pregnancy|1
146201|NCT00707577|521521|P1|Overall Study|Pregnancy|4
146202|NCT00707577|521520|P2|Overall Study|Left employment|10
146203|NCT00707577|521521|P1|Overall Study|Left employment|13
146204|NCT00707577|521520|P2|Overall Study|Lost to Follow-up|25
146205|NCT00707577|521521|P1|Overall Study|Lost to Follow-up|34
146206|NCT00707577|521520|P2|Overall Study|Withdrawal by Subject|2
146207|NCT00707577|521521|P1|Overall Study|Withdrawal by Subject|3
146208|NCT00707486|521527|P1|Overall Study|Withdrawal by Subject|1
146209|NCT00707239|521570|P3|Overall Study|Other|5
146210|NCT00707239|521571|P2|Overall Study|Other|3
146211|NCT00707239|521572|P1|Overall Study|Other|8
146212|NCT00707239|521570|P3|Overall Study|Randomized, but not treated|1
146213|NCT00707239|521571|P2|Overall Study|Randomized, but not treated|1
146214|NCT00707239|521572|P1|Overall Study|Randomized, but not treated|1
146215|NCT00707239|521570|P3|Overall Study|Lack of Efficacy|0
146216|NCT00707239|521571|P2|Overall Study|Lack of Efficacy|2
146217|NCT00707239|521572|P1|Overall Study|Lack of Efficacy|1
146218|NCT00707239|521570|P3|Overall Study|Protocol Violation|1
146219|NCT00707239|521571|P2|Overall Study|Protocol Violation|0
146220|NCT00707239|521572|P1|Overall Study|Protocol Violation|0
146221|NCT00707239|521570|P3|Overall Study|Physician Decision|2
146222|NCT00707239|521571|P2|Overall Study|Physician Decision|1
146223|NCT00707239|521572|P1|Overall Study|Physician Decision|1
146224|NCT00707239|521570|P3|Overall Study|Death|3
146225|NCT00707239|521571|P2|Overall Study|Death|1
146226|NCT00707239|521572|P1|Overall Study|Death|3
146227|NCT00707239|521570|P3|Overall Study|Adverse Event|2
146228|NCT00707239|521571|P2|Overall Study|Adverse Event|3
146229|NCT00707239|521572|P1|Overall Study|Adverse Event|5
146230|NCT00707174|521620|P2|Overall Study|Withdrawal by Subject|1
146231|NCT00707174|521621|P1|Overall Study|Withdrawal by Subject|4
146232|NCT00707174|521620|P2|Overall Study|Adverse Event|6
146233|NCT00707174|521621|P1|Overall Study|Adverse Event|1
146234|NCT00707161|521627|P1|Overall Study|Physician Decision|6
146235|NCT00707057|521633|P2|Overall Study|Dosed incorrectly|1
146236|NCT00707057|521634|P1|Overall Study|Dosed incorrectly|0
146237|NCT00707057|521633|P2|Overall Study|Withdrawal by Subject|3
146238|NCT00707057|521634|P1|Overall Study|Withdrawal by Subject|8
146239|NCT00707031|521668|P2|Overall Study|Sponsor Decision|8
146240|NCT00707031|521669|P1|Overall Study|Sponsor Decision|9
146241|NCT00707031|521668|P2|Overall Study|Serious Noncompliance|3
146242|NCT00707031|521669|P1|Overall Study|Serious Noncompliance|2
146243|NCT00707031|521668|P2|Overall Study|Familial or Personal Reasons|15
146244|NCT00707031|521669|P1|Overall Study|Familial or Personal Reasons|12
146245|NCT00707031|521668|P2|Overall Study|Poor Compliance to Protocol|13
146246|NCT00707031|521669|P1|Overall Study|Poor Compliance to Protocol|7
146247|NCT00707031|521668|P2|Overall Study|Withdrawal by Subject|8
146248|NCT00707031|521669|P1|Overall Study|Withdrawal by Subject|7
146249|NCT00707031|521668|P2|Overall Study|Protocol Violation|0
146250|NCT00707031|521669|P1|Overall Study|Protocol Violation|1
146251|NCT00707031|521668|P2|Overall Study|Lost to Follow-up|1
146252|NCT00707031|521669|P1|Overall Study|Lost to Follow-up|2
146253|NCT00707031|521668|P2|Overall Study|Lack of Efficacy|6
146254|NCT00707031|521669|P1|Overall Study|Lack of Efficacy|19
146255|NCT00707031|521668|P2|Overall Study|Adverse Event|45
146256|NCT00707031|521669|P1|Overall Study|Adverse Event|45
146257|NCT00706992|521698|P7|Overall Study|Disease progression before treatment|0
146258|NCT00706992|521699|P6|Overall Study|Disease progression before treatment|0
146259|NCT00706992|521700|P5|Overall Study|Disease progression before treatment|1
146260|NCT00706992|521701|P4|Overall Study|Disease progression before treatment|0
146261|NCT00706992|521702|P3|Overall Study|Disease progression before treatment|0
146262|NCT00706992|521703|P2|Overall Study|Disease progression before treatment|0
146263|NCT00706992|521704|P1|Overall Study|Disease progression before treatment|0
146264|NCT00706992|521698|P7|Overall Study|Study termination|3
146265|NCT00706992|521699|P6|Overall Study|Study termination|2
146266|NCT00706992|521700|P5|Overall Study|Study termination|3
146267|NCT00706992|521701|P4|Overall Study|Study termination|2
146268|NCT00706992|521702|P3|Overall Study|Study termination|6
146269|NCT00706992|521703|P2|Overall Study|Study termination|5
146270|NCT00706992|521704|P1|Overall Study|Study termination|5
146271|NCT00706966|521736|P1|Overall Study|Adverse Event|1
146272|NCT00706914|521772|P3|Overall Study|Protocol Violation|1
146273|NCT00706914|521773|P2|Overall Study|Protocol Violation|1
146274|NCT00706914|521774|P1|Overall Study|Protocol Violation|3
146275|NCT00706914|521772|P3|Overall Study|Adverse Event|0
146276|NCT00706914|521773|P2|Overall Study|Adverse Event|2
146277|NCT00706914|521774|P1|Overall Study|Adverse Event|2
146278|NCT00706914|521772|P3|Overall Study|Lost to Follow-up|0
146279|NCT00706914|521773|P2|Overall Study|Lost to Follow-up|0
146280|NCT00706914|521774|P1|Overall Study|Lost to Follow-up|1
146281|NCT00706914|521772|P3|Overall Study|Lack of Efficacy|0
146282|NCT00706914|521773|P2|Overall Study|Lack of Efficacy|1
146283|NCT00706914|521774|P1|Overall Study|Lack of Efficacy|0
146284|NCT00706901|521797|P3|Overall Study|Death|0
146285|NCT00706901|521798|P2|Overall Study|Death|0
146286|NCT00706901|521799|P1|Overall Study|Death|1
146287|NCT00706901|521797|P3|Overall Study|In Jail|1
146288|NCT00706901|521798|P2|Overall Study|In Jail|0
146289|NCT00706901|521799|P1|Overall Study|In Jail|1
146290|NCT00706901|521797|P3|Overall Study|Withdrawal by Subject|5
146291|NCT00706901|521798|P2|Overall Study|Withdrawal by Subject|2
146292|NCT00706901|521799|P1|Overall Study|Withdrawal by Subject|4
146293|NCT00706901|521797|P3|Overall Study|Lost to Follow-up|2
146294|NCT00706901|521798|P2|Overall Study|Lost to Follow-up|3
146295|NCT00706901|521799|P1|Overall Study|Lost to Follow-up|2
146296|NCT00706849|521824|P2|Follow-up Period|Protocol non-compliance|1
146297|NCT00706849|521825|P1|Follow-up Period|Protocol non-compliance|0
146298|NCT00706849|521824|P2|Follow-up Period|Withdrawal by Subject|2
146299|NCT00706849|521825|P1|Follow-up Period|Withdrawal by Subject|0
146300|NCT00706849|521824|P2|Treatment Period|Other|1
146301|NCT00706849|521825|P1|Treatment Period|Other|0
146302|NCT00706849|521824|P2|Treatment Period|Adverse Event|9
146303|NCT00706849|521825|P1|Treatment Period|Adverse Event|0
146304|NCT00706797|521903|P2|Overall Study|Other|0
146305|NCT00706797|521904|P1|Overall Study|Other|1
146306|NCT00706797|521903|P2|Overall Study|Lost to Follow-up|2
146307|NCT00706797|521904|P1|Overall Study|Lost to Follow-up|1
146308|NCT00706797|521903|P2|Overall Study|Protocol Violation|2
146309|NCT00706797|521904|P1|Overall Study|Protocol Violation|3
146310|NCT00706797|521903|P2|Overall Study|Discontinuation of study by sponsor|63
146311|NCT00706797|521904|P1|Overall Study|Discontinuation of study by sponsor|52
146312|NCT00706797|521903|P2|Overall Study|Death|0
146313|NCT00706797|521904|P1|Overall Study|Death|1
146314|NCT00706797|521903|P2|Overall Study|Withdrawal by Subject|1
146315|NCT00706797|521904|P1|Overall Study|Withdrawal by Subject|8
146316|NCT00706797|521903|P2|Overall Study|Adverse Event|3
146317|NCT00706797|521904|P1|Overall Study|Adverse Event|0
146318|NCT00706797|521903|P2|Overall Study|Lack of Efficacy|0
146319|NCT00706797|521904|P1|Overall Study|Lack of Efficacy|3
146320|NCT00706706|521973|P1|Overall Study|Study endpoint had reached|45
146321|NCT00706706|521973|P1|Overall Study|Lost to Follow-up|7
146322|NCT00706706|521973|P1|Overall Study|Death|53
146323|NCT00706654|521983|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
146324|NCT00706654|521984|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
146325|NCT00706654|521985|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
146326|NCT00706654|521986|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
146327|NCT00706654|521983|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
146328|NCT00706654|521984|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
146329|NCT00706654|521985|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
146330|NCT00706654|521986|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
146331|NCT00706654|521983|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
146332|NCT00706654|521984|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
146333|NCT00706654|521985|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
146334|NCT00706654|521986|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
146335|NCT00706654|521983|P4|Depot Maintenance Phase|Protocol Deviation|1
146336|NCT00706654|521984|P3|Depot Maintenance Phase|Protocol Deviation|3
146337|NCT00706654|521985|P2|Depot Maintenance Phase|Protocol Deviation|2
146338|NCT00706654|521986|P1|Depot Maintenance Phase|Protocol Deviation|0
146339|NCT00706654|521983|P4|Depot Maintenance Phase|Withdrew Consent|14
146340|NCT00706654|521984|P3|Depot Maintenance Phase|Withdrew Consent|29
146341|NCT00706654|521985|P2|Depot Maintenance Phase|Withdrew Consent|21
146342|NCT00706654|521986|P1|Depot Maintenance Phase|Withdrew Consent|0
146343|NCT00706654|521983|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
146344|NCT00706654|521984|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
146345|NCT00706654|521985|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
146346|NCT00706654|521986|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
146347|NCT00706654|521983|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
146348|NCT00706654|521984|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
146349|NCT00706654|521985|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
146350|NCT00706654|521986|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
146351|NCT00706654|521983|P4|Depot Maintenance Phase|Lost to Follow-up|6
146352|NCT00706654|521984|P3|Depot Maintenance Phase|Lost to Follow-up|10
146353|NCT00706654|521985|P2|Depot Maintenance Phase|Lost to Follow-up|4
146354|NCT00706654|521986|P1|Depot Maintenance Phase|Lost to Follow-up|0
146355|NCT00706654|521983|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
146356|NCT00706654|521984|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
146437|NCT00706628|522022|P1|Overall Study|Progressive disease|20
146357|NCT00706654|521985|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
146358|NCT00706654|521986|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
146359|NCT00706654|521983|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
146360|NCT00706654|521984|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
146361|NCT00706654|521985|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
146362|NCT00706654|521986|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
146363|NCT00706654|521983|P4|Oral Stabilization Phase|Adverse Event|0
146364|NCT00706654|521984|P3|Oral Stabilization Phase|Adverse Event|0
146365|NCT00706654|521985|P2|Oral Stabilization Phase|Adverse Event|0
146366|NCT00706654|521986|P1|Oral Stabilization Phase|Adverse Event|21
146367|NCT00706654|521983|P4|Oral Stabilization Phase|Protocol Deviation|0
146368|NCT00706654|521984|P3|Oral Stabilization Phase|Protocol Deviation|0
146369|NCT00706654|521985|P2|Oral Stabilization Phase|Protocol Deviation|0
146370|NCT00706654|521986|P1|Oral Stabilization Phase|Protocol Deviation|2
146371|NCT00706654|521983|P4|Oral Stabilization Phase|Withdrew consent|0
146372|NCT00706654|521984|P3|Oral Stabilization Phase|Withdrew consent|0
146373|NCT00706654|521985|P2|Oral Stabilization Phase|Withdrew consent|0
146374|NCT00706654|521986|P1|Oral Stabilization Phase|Withdrew consent|55
146375|NCT00706654|521983|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
146376|NCT00706654|521984|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
146377|NCT00706654|521985|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
146378|NCT00706654|521986|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
146379|NCT00706654|521983|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
146380|NCT00706654|521984|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
146381|NCT00706654|521985|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
146382|NCT00706654|521986|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
146383|NCT00706654|521983|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
146384|NCT00706654|521984|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
146385|NCT00706654|521985|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
146386|NCT00706654|521986|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
146387|NCT00706654|521983|P4|Oral Stabilization Phase|Lost to Follow-up|0
146388|NCT00706654|521984|P3|Oral Stabilization Phase|Lost to Follow-up|0
146389|NCT00706654|521985|P2|Oral Stabilization Phase|Lost to Follow-up|0
146390|NCT00706654|521986|P1|Oral Stabilization Phase|Lost to Follow-up|17
146391|NCT00706654|521983|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
146392|NCT00706654|521984|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
146393|NCT00706654|521985|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
146394|NCT00706654|521986|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
146395|NCT00706654|521983|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
146396|NCT00706654|521984|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
146397|NCT00706654|521985|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
146398|NCT00706654|521986|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
146399|NCT00706654|521983|P4|Conversion Phase|Adverse Event|0
146400|NCT00706654|521984|P3|Conversion Phase|Adverse Event|0
146401|NCT00706654|521985|P2|Conversion Phase|Adverse Event|0
146402|NCT00706654|521986|P1|Conversion Phase|Adverse Event|18
146403|NCT00706654|521983|P4|Conversion Phase|Withdrew Consent|0
146404|NCT00706654|521984|P3|Conversion Phase|Withdrew Consent|0
146405|NCT00706654|521985|P2|Conversion Phase|Withdrew Consent|0
146406|NCT00706654|521986|P1|Conversion Phase|Withdrew Consent|38
146407|NCT00706654|521983|P4|Conversion Phase|Withdrawn by Investigator|0
146408|NCT00706654|521984|P3|Conversion Phase|Withdrawn by Investigator|0
146409|NCT00706654|521985|P2|Conversion Phase|Withdrawn by Investigator|0
146410|NCT00706654|521986|P1|Conversion Phase|Withdrawn by Investigator|14
146411|NCT00706654|521983|P4|Conversion Phase|Met Withdrawal Criteria|0
146412|NCT00706654|521984|P3|Conversion Phase|Met Withdrawal Criteria|0
146413|NCT00706654|521985|P2|Conversion Phase|Met Withdrawal Criteria|0
146414|NCT00706654|521986|P1|Conversion Phase|Met Withdrawal Criteria|2
146415|NCT00706654|521983|P4|Conversion Phase|Sponsor Discontinued Trial|0
146416|NCT00706654|521984|P3|Conversion Phase|Sponsor Discontinued Trial|0
146417|NCT00706654|521985|P2|Conversion Phase|Sponsor Discontinued Trial|0
146418|NCT00706654|521986|P1|Conversion Phase|Sponsor Discontinued Trial|8
146419|NCT00706654|521983|P4|Conversion Phase|Lost to Follow-up|0
146420|NCT00706654|521984|P3|Conversion Phase|Lost to Follow-up|0
146421|NCT00706654|521985|P2|Conversion Phase|Lost to Follow-up|0
146422|NCT00706654|521986|P1|Conversion Phase|Lost to Follow-up|4
146423|NCT00706641|522005|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
146424|NCT00706641|522005|P1|Dasatinib Administration|Ineligible after start of therapy|1
146425|NCT00706641|522005|P1|Dasatinib Administration|Withdrawal by Subject|1
146426|NCT00706628|522019|P4|Overall Study|Not treated|0
146427|NCT00706628|522020|P3|Overall Study|Not treated|0
146428|NCT00706628|522021|P2|Overall Study|Not treated|1
146429|NCT00706628|522022|P1|Overall Study|Not treated|1
146430|NCT00706628|522019|P4|Overall Study|Other than those stated above|0
146431|NCT00706628|522020|P3|Overall Study|Other than those stated above|0
146432|NCT00706628|522021|P2|Overall Study|Other than those stated above|0
146433|NCT00706628|522022|P1|Overall Study|Other than those stated above|4
146434|NCT00706628|522019|P4|Overall Study|Progressive disease|1
146435|NCT00706628|522020|P3|Overall Study|Progressive disease|8
146436|NCT00706628|522021|P2|Overall Study|Progressive disease|13
146438|NCT00706628|522019|P4|Overall Study|Consent withdrawn|0
146439|NCT00706628|522020|P3|Overall Study|Consent withdrawn|3
146440|NCT00706628|522021|P2|Overall Study|Consent withdrawn|1
146441|NCT00706628|522022|P1|Overall Study|Consent withdrawn|6
146442|NCT00706628|522019|P4|Overall Study|Non compliant with protocol|0
146443|NCT00706628|522020|P3|Overall Study|Non compliant with protocol|0
146444|NCT00706628|522021|P2|Overall Study|Non compliant with protocol|1
146445|NCT00706628|522022|P1|Overall Study|Non compliant with protocol|0
146446|NCT00706628|522019|P4|Overall Study|Other Adverse Event|2
146447|NCT00706628|522020|P3|Overall Study|Other Adverse Event|5
146448|NCT00706628|522021|P2|Overall Study|Other Adverse Event|5
146449|NCT00706628|522022|P1|Overall Study|Other Adverse Event|16
146450|NCT00706433|522182|P4|Overall Study|new job|1
146451|NCT00706433|522183|P3|Overall Study|new job|0
146452|NCT00706433|522184|P2|Overall Study|new job|0
146453|NCT00706433|522185|P1|Overall Study|new job|0
146454|NCT00706433|522182|P4|Overall Study|Protocol Violation|0
146455|NCT00706433|522183|P3|Overall Study|Protocol Violation|0
146456|NCT00706433|522184|P2|Overall Study|Protocol Violation|0
146457|NCT00706433|522185|P1|Overall Study|Protocol Violation|1
146458|NCT00706433|522182|P4|Overall Study|Adverse Event|0
146459|NCT00706433|522183|P3|Overall Study|Adverse Event|1
146460|NCT00706433|522184|P2|Overall Study|Adverse Event|0
146461|NCT00706433|522185|P1|Overall Study|Adverse Event|0
146462|NCT00706433|522182|P4|Overall Study|Withdrawal by Subject|1
146463|NCT00706433|522183|P3|Overall Study|Withdrawal by Subject|3
146464|NCT00706433|522184|P2|Overall Study|Withdrawal by Subject|2
146465|NCT00706433|522185|P1|Overall Study|Withdrawal by Subject|1
146466|NCT00706433|522182|P4|Overall Study|Lost to Follow-up|0
146467|NCT00706433|522183|P3|Overall Study|Lost to Follow-up|6
146468|NCT00706433|522184|P2|Overall Study|Lost to Follow-up|1
146469|NCT00706433|522185|P1|Overall Study|Lost to Follow-up|3
146470|NCT00706355|522512|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
146471|NCT00706355|522513|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
146472|NCT00706355|522514|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
146473|NCT00706355|522515|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
146474|NCT00706355|522512|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
146475|NCT00706355|522513|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
146476|NCT00706355|522514|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
146477|NCT00706355|522515|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
146478|NCT00706355|522512|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
146479|NCT00706355|522513|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
146480|NCT00706355|522514|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
146481|NCT00706355|522515|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
146482|NCT00706355|522512|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
146483|NCT00706355|522513|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
146484|NCT00706355|522514|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
146485|NCT00706355|522515|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
146486|NCT00706355|522512|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
146487|NCT00706355|522513|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
146488|NCT00706355|522514|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
146489|NCT00706355|522515|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
146490|NCT00706355|522512|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
146491|NCT00706355|522513|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
146492|NCT00706355|522514|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
146493|NCT00706355|522515|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
146494|NCT00706355|522512|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
146495|NCT00706355|522513|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
146496|NCT00706355|522514|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
146497|NCT00706355|522515|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
146498|NCT00706355|522512|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
146499|NCT00706355|522513|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
146500|NCT00706355|522514|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
146501|NCT00706355|522515|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
146502|NCT00706355|522512|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
146503|NCT00706355|522513|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
146504|NCT00706355|522514|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
146505|NCT00706355|522515|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
146506|NCT00706342|522567|P1|Overall Study|WIthdrawal of consent|1
146507|NCT00706342|522567|P1|Overall Study|Ongoing|6
146508|NCT00706342|522567|P1|Overall Study|Non-responder Week 12|1
146509|NCT00706342|522567|P1|Overall Study|Investigator discretion|2
146510|NCT00706342|522567|P1|Overall Study|Withdrew from the study on his own.|1
146511|NCT00706342|522567|P1|Overall Study|Death|1
146512|NCT00706342|522567|P1|Overall Study|Withdrawn due to failure to respond|1
146513|NCT00706342|522567|P1|Overall Study|Not responding to treatment|2
146514|NCT00706342|522567|P1|Overall Study|Adverse Event|3
146515|NCT00706134|522584|P4|Overall Study|Did not meet study criteria|0
146516|NCT00706134|522585|P3|Overall Study|Did not meet study criteria|0
146517|NCT00706134|522586|P2|Overall Study|Did not meet study criteria|0
146518|NCT00706134|522587|P1|Overall Study|Did not meet study criteria|2
146519|NCT00706134|522584|P4|Overall Study|Unsatisfactory therapeutic effect|5
146520|NCT00706134|522585|P3|Overall Study|Unsatisfactory therapeutic effect|3
146521|NCT00706134|522586|P2|Overall Study|Unsatisfactory therapeutic effect|3
146522|NCT00706134|522587|P1|Overall Study|Unsatisfactory therapeutic effect|9
146523|NCT00706134|522584|P4|Overall Study|Withdrawal by Subject|0
146524|NCT00706134|522585|P3|Overall Study|Withdrawal by Subject|1
146525|NCT00706134|522586|P2|Overall Study|Withdrawal by Subject|2
146526|NCT00706134|522587|P1|Overall Study|Withdrawal by Subject|1
146527|NCT00706134|522584|P4|Overall Study|Protocol Violation|3
146528|NCT00706134|522585|P3|Overall Study|Protocol Violation|0
146529|NCT00706134|522586|P2|Overall Study|Protocol Violation|6
146530|NCT00706134|522587|P1|Overall Study|Protocol Violation|0
146531|NCT00706134|522584|P4|Overall Study|Lost to Follow-up|0
146532|NCT00706134|522585|P3|Overall Study|Lost to Follow-up|0
146533|NCT00706134|522586|P2|Overall Study|Lost to Follow-up|1
146534|NCT00706134|522587|P1|Overall Study|Lost to Follow-up|0
146535|NCT00706134|522584|P4|Overall Study|Adverse Event|3
146536|NCT00706134|522585|P3|Overall Study|Adverse Event|2
146537|NCT00706134|522586|P2|Overall Study|Adverse Event|7
146538|NCT00706134|522587|P1|Overall Study|Adverse Event|8
146539|NCT00706095|522653|P3|Overall Study|Withdrawal by Subject|0
146540|NCT00706095|522654|P2|Overall Study|Withdrawal by Subject|0
146541|NCT00706095|522655|P1|Overall Study|Withdrawal by Subject|1
146542|NCT00706095|522653|P3|Overall Study|Clinical Progression|2
146543|NCT00706095|522654|P2|Overall Study|Clinical Progression|2
146544|NCT00706095|522655|P1|Overall Study|Clinical Progression|1
146545|NCT00706095|522653|P3|Overall Study|Progressive Disease|3
146546|NCT00706095|522654|P2|Overall Study|Progressive Disease|5
146547|NCT00706095|522655|P1|Overall Study|Progressive Disease|4
146548|NCT00706030|522673|P4|Overall Study|Death|0
146549|NCT00706030|522674|P3|Overall Study|Death|1
146550|NCT00706030|522675|P2|Overall Study|Death|0
146551|NCT00706030|522676|P1|Overall Study|Death|0
146552|NCT00706030|522673|P4|Overall Study|No treatment received|1
146553|NCT00706030|522674|P3|Overall Study|No treatment received|0
146554|NCT00706030|522675|P2|Overall Study|No treatment received|0
146555|NCT00706030|522676|P1|Overall Study|No treatment received|0
146556|NCT00706030|522673|P4|Overall Study|Symptomatic Deterioration|0
146557|NCT00706030|522674|P3|Overall Study|Symptomatic Deterioration|1
146558|NCT00706030|522675|P2|Overall Study|Symptomatic Deterioration|0
146559|NCT00706030|522676|P1|Overall Study|Symptomatic Deterioration|0
146560|NCT00706030|522673|P4|Overall Study|Failed to return|0
146561|NCT00706030|522674|P3|Overall Study|Failed to return|1
146562|NCT00706030|522675|P2|Overall Study|Failed to return|0
146563|NCT00706030|522676|P1|Overall Study|Failed to return|0
146564|NCT00706030|522673|P4|Overall Study|Protocol Violation|1
146565|NCT00706030|522674|P3|Overall Study|Protocol Violation|1
146566|NCT00706030|522675|P2|Overall Study|Protocol Violation|0
146567|NCT00706030|522676|P1|Overall Study|Protocol Violation|0
146568|NCT00706030|522673|P4|Overall Study|Not recorded|0
146569|NCT00706030|522674|P3|Overall Study|Not recorded|2
146570|NCT00706030|522675|P2|Overall Study|Not recorded|0
146571|NCT00706030|522676|P1|Overall Study|Not recorded|0
146572|NCT00706030|522673|P4|Overall Study|Physician Decision|0
146573|NCT00706030|522674|P3|Overall Study|Physician Decision|2
146574|NCT00706030|522675|P2|Overall Study|Physician Decision|0
146575|NCT00706030|522676|P1|Overall Study|Physician Decision|0
146576|NCT00706030|522673|P4|Overall Study|Withdrawal by Subject|0
146577|NCT00706030|522674|P3|Overall Study|Withdrawal by Subject|2
146578|NCT00706030|522675|P2|Overall Study|Withdrawal by Subject|0
146579|NCT00706030|522676|P1|Overall Study|Withdrawal by Subject|1
146580|NCT00706030|522673|P4|Overall Study|Adverse Event|2
146581|NCT00706030|522674|P3|Overall Study|Adverse Event|4
146582|NCT00706030|522675|P2|Overall Study|Adverse Event|0
146583|NCT00706030|522676|P1|Overall Study|Adverse Event|1
146584|NCT00706030|522673|P4|Overall Study|Disease Progression|12
146585|NCT00706030|522674|P3|Overall Study|Disease Progression|46
146586|NCT00706030|522675|P2|Overall Study|Disease Progression|6
146587|NCT00706030|522676|P1|Overall Study|Disease Progression|4
146588|NCT00706004|522691|P1|Overall Study|Did not meet eligibility criteria|2
146589|NCT00705939|522719|P3|Overall Study|Physician Decision|0
146590|NCT00705939|522720|P2|Overall Study|Physician Decision|1
146591|NCT00705939|522721|P1|Overall Study|Physician Decision|0
146592|NCT00705939|522719|P3|Overall Study|Withdrawal by Subject|3
146593|NCT00705939|522720|P2|Overall Study|Withdrawal by Subject|1
146594|NCT00705939|522721|P1|Overall Study|Withdrawal by Subject|0
146595|NCT00705939|522719|P3|Overall Study|Protocol Violation|1
146596|NCT00705939|522720|P2|Overall Study|Protocol Violation|0
146597|NCT00705939|522721|P1|Overall Study|Protocol Violation|0
146598|NCT00705783|522775|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
146599|NCT00705783|522776|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
146600|NCT00705783|522777|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
146601|NCT00705783|522775|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
146602|NCT00705783|522776|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
146603|NCT00705783|522777|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
146604|NCT00705783|522775|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
146605|NCT00705783|522776|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
146606|NCT00705783|522777|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
146607|NCT00705783|522775|P3|Depot Maintenance Phase|Protocol Deviation|0
146608|NCT00705783|522776|P2|Depot Maintenance Phase|Protocol Deviation|2
146609|NCT00705783|522777|P1|Depot Maintenance Phase|Protocol Deviation|0
146610|NCT00705783|522775|P3|Depot Maintenance Phase|Withdrew Consent|4
146611|NCT00705783|522776|P2|Depot Maintenance Phase|Withdrew Consent|14
146612|NCT00705783|522777|P1|Depot Maintenance Phase|Withdrew Consent|0
146613|NCT00705783|522775|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
146614|NCT00705783|522776|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
146615|NCT00705783|522777|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
146616|NCT00705783|522775|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
146617|NCT00705783|522776|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
146618|NCT00705783|522777|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
146619|NCT00705783|522775|P3|Depot Maintenance Phase|Lost to Follow-up|3
146620|NCT00705783|522776|P2|Depot Maintenance Phase|Lost to Follow-up|5
146621|NCT00705783|522777|P1|Depot Maintenance Phase|Lost to Follow-up|0
146622|NCT00705783|522775|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
146623|NCT00705783|522776|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
146624|NCT00705783|522777|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
146625|NCT00705783|522775|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
146626|NCT00705783|522776|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
146627|NCT00705783|522777|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
146628|NCT00705783|522775|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
146629|NCT00705783|522776|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
146630|NCT00705783|522777|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
146631|NCT00705783|522775|P3|Depot Stabilization Phase|Adverse Event|0
146632|NCT00705783|522776|P2|Depot Stabilization Phase|Adverse Event|0
146633|NCT00705783|522777|P1|Depot Stabilization Phase|Adverse Event|17
146634|NCT00705783|522775|P3|Depot Stabilization Phase|Withdrew Consent|0
146635|NCT00705783|522776|P2|Depot Stabilization Phase|Withdrew Consent|0
146636|NCT00705783|522777|P1|Depot Stabilization Phase|Withdrew Consent|29
146637|NCT00705783|522775|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
146638|NCT00705783|522776|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
146639|NCT00705783|522777|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
146640|NCT00705783|522775|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
146641|NCT00705783|522776|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
146642|NCT00705783|522777|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
146643|NCT00705783|522775|P3|Depot Stabilization Phase|Lost to Follow-up|0
146644|NCT00705783|522776|P2|Depot Stabilization Phase|Lost to Follow-up|0
146645|NCT00705783|522777|P1|Depot Stabilization Phase|Lost to Follow-up|11
146646|NCT00705783|522775|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
146647|NCT00705783|522776|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
146648|NCT00705783|522777|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
146649|NCT00705783|522775|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
146650|NCT00705783|522776|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
146651|NCT00705783|522777|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
146652|NCT00705783|522775|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
146653|NCT00705783|522776|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
146654|NCT00705783|522777|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
146655|NCT00705783|522775|P3|Oral Stabilization Phase|Adverse Event|0
146656|NCT00705783|522776|P2|Oral Stabilization Phase|Adverse Event|0
146657|NCT00705783|522777|P1|Oral Stabilization Phase|Adverse Event|14
146658|NCT00705783|522775|P3|Oral Stabilization Phase|Withdrew Consent|0
146659|NCT00705783|522776|P2|Oral Stabilization Phase|Withdrew Consent|0
146660|NCT00705783|522777|P1|Oral Stabilization Phase|Withdrew Consent|29
146661|NCT00705783|522775|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
146662|NCT00705783|522776|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
146663|NCT00705783|522777|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
146664|NCT00705783|522775|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
146665|NCT00705783|522776|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
146666|NCT00705783|522777|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
146667|NCT00705783|522775|P3|Oral Stabilization Phase|Lost to Follow-up|0
146668|NCT00705783|522776|P2|Oral Stabilization Phase|Lost to Follow-up|0
146669|NCT00705783|522777|P1|Oral Stabilization Phase|Lost to Follow-up|7
146670|NCT00705783|522775|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
146671|NCT00705783|522776|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
146672|NCT00705783|522777|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
146673|NCT00705783|522775|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
146674|NCT00705783|522776|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
146675|NCT00705783|522777|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
146676|NCT00705783|522775|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
146677|NCT00705783|522776|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
146678|NCT00705783|522777|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
146679|NCT00705783|522775|P3|Conversion Phase|Adverse Event|0
146680|NCT00705783|522776|P2|Conversion Phase|Adverse Event|0
146681|NCT00705783|522777|P1|Conversion Phase|Adverse Event|11
146682|NCT00705783|522775|P3|Conversion Phase|Protocol Deviation|0
146683|NCT00705783|522776|P2|Conversion Phase|Protocol Deviation|0
146684|NCT00705783|522777|P1|Conversion Phase|Protocol Deviation|2
146685|NCT00705783|522775|P3|Conversion Phase|Withdrew Consent|0
146686|NCT00705783|522776|P2|Conversion Phase|Withdrew Consent|0
146687|NCT00705783|522777|P1|Conversion Phase|Withdrew Consent|24
146688|NCT00705783|522775|P3|Conversion Phase|Withdrawn by Investigator|0
146689|NCT00705783|522776|P2|Conversion Phase|Withdrawn by Investigator|0
146690|NCT00705783|522777|P1|Conversion Phase|Withdrawn by Investigator|4
146691|NCT00705783|522775|P3|Conversion Phase|Met Withdrawal Criteria|0
146692|NCT00705783|522776|P2|Conversion Phase|Met Withdrawal Criteria|0
146693|NCT00705783|522777|P1|Conversion Phase|Met Withdrawal Criteria|4
146694|NCT00705783|522775|P3|Conversion Phase|Lost to Follow-up|0
146695|NCT00705783|522776|P2|Conversion Phase|Lost to Follow-up|0
146696|NCT00705783|522777|P1|Conversion Phase|Lost to Follow-up|13
146697|NCT00705783|522775|P3|Conversion Phase|Sponsor Discontinued Study|0
146698|NCT00705783|522776|P2|Conversion Phase|Sponsor Discontinued Study|0
146699|NCT00705783|522777|P1|Conversion Phase|Sponsor Discontinued Study|54
146700|NCT00705757|522807|P3|Overall Study|Withdrawal by Subject|2
146701|NCT00705757|522808|P2|Overall Study|Withdrawal by Subject|1
146702|NCT00705757|522809|P1|Overall Study|Withdrawal by Subject|1
146703|NCT00705757|522807|P3|Overall Study|Lost to Follow-up|6
146704|NCT00705757|522808|P2|Overall Study|Lost to Follow-up|6
146705|NCT00705757|522809|P1|Overall Study|Lost to Follow-up|7
146706|NCT00705757|522807|P3|Overall Study|Lack of Efficacy|3
146707|NCT00705757|522808|P2|Overall Study|Lack of Efficacy|1
146708|NCT00705757|522809|P1|Overall Study|Lack of Efficacy|5
146709|NCT00705718|522819|P2|Overall Study|Follow up not done|4
146710|NCT00705718|522820|P1|Overall Study|Follow up not done|1
146711|NCT00705718|522819|P2|Overall Study|Not due for Visit|12
146712|NCT00705718|522820|P1|Overall Study|Not due for Visit|0
146713|NCT00705718|522819|P2|Overall Study|Death|6
146714|NCT00705718|522820|P1|Overall Study|Death|6
146715|NCT00705679|522841|P5|Overall Study|Withdrawal by Subject|33
146716|NCT00705679|522842|P4|Overall Study|Withdrawal by Subject|47
146717|NCT00705679|522843|P3|Overall Study|Withdrawal by Subject|68
146718|NCT00705679|522844|P2|Overall Study|Withdrawal by Subject|77
146719|NCT00705679|522845|P1|Overall Study|Withdrawal by Subject|32
146720|NCT00705679|522841|P5|Overall Study|Physician Decision|0
146721|NCT00705679|522842|P4|Overall Study|Physician Decision|1
146722|NCT00705679|522843|P3|Overall Study|Physician Decision|0
146723|NCT00705679|522844|P2|Overall Study|Physician Decision|1
146724|NCT00705679|522845|P1|Overall Study|Physician Decision|0
146725|NCT00705679|522841|P5|Overall Study|Lost to Follow-up|35
146726|NCT00705679|522842|P4|Overall Study|Lost to Follow-up|30
146727|NCT00705679|522843|P3|Overall Study|Lost to Follow-up|44
146728|NCT00705679|522844|P2|Overall Study|Lost to Follow-up|60
146729|NCT00705679|522845|P1|Overall Study|Lost to Follow-up|32
146730|NCT00705679|522841|P5|Overall Study|Death|1
146731|NCT00705679|522842|P4|Overall Study|Death|2
146732|NCT00705679|522843|P3|Overall Study|Death|3
146733|NCT00705679|522844|P2|Overall Study|Death|0
146734|NCT00705679|522845|P1|Overall Study|Death|0
146735|NCT00705679|522841|P5|Overall Study|Adverse Event|0
146736|NCT00705679|522842|P4|Overall Study|Adverse Event|0
146737|NCT00705679|522843|P3|Overall Study|Adverse Event|0
146738|NCT00705679|522844|P2|Overall Study|Adverse Event|1
146739|NCT00705679|522845|P1|Overall Study|Adverse Event|1
146740|NCT00705666|522880|P1|Overall Study|Untreated|5
146741|NCT00705666|522880|P1|Overall Study|Lack of data|3
146742|NCT00705666|522880|P1|Overall Study|Other|2
146743|NCT00705666|522880|P1|Overall Study|Not specified|12
146744|NCT00705666|522880|P1|Overall Study|Adverse Event|4
146745|NCT00705666|522880|P1|Overall Study|Death|1
146746|NCT00705666|522880|P1|Overall Study|Lost to Follow-up|5
146747|NCT00705666|522880|P1|Overall Study|Physician Decision|7
146748|NCT00705666|522880|P1|Overall Study|Withdrawal by Subject|21
146749|NCT00705666|522880|P1|Overall Study|No post-treatment questionnaire|279
146750|NCT00705614|522891|P2|Switch to Remicade|Administrative Reason|9
146751|NCT00705614|522892|P1|Switch to Remicade|Administrative Reason|0
146752|NCT00705614|522891|P2|Switch to Remicade|Withdrawal by Subject|12
146753|NCT00705614|522892|P1|Switch to Remicade|Withdrawal by Subject|0
146754|NCT00705614|522891|P2|Switch to Remicade|Lost to Follow-up|23
146755|NCT00705614|522892|P1|Switch to Remicade|Lost to Follow-up|0
146756|NCT00705614|522891|P2|Switch to Remicade|Adverse Event|5
146757|NCT00705614|522892|P1|Switch to Remicade|Adverse Event|0
146758|NCT00705614|522891|P2|Initial Intervention|Status completion unknown|0
146759|NCT00705614|522892|P1|Initial Intervention|Status completion unknown|3
146760|NCT00705614|522891|P2|Initial Intervention|Administrative Reason|38
146761|NCT00705614|522892|P1|Initial Intervention|Administrative Reason|51
146762|NCT00705614|522891|P2|Initial Intervention|Withdrawal by Subject|71
146763|NCT00705614|522892|P1|Initial Intervention|Withdrawal by Subject|114
146764|NCT00705614|522891|P2|Initial Intervention|Lost to Follow-up|191
146765|NCT00705614|522892|P1|Initial Intervention|Lost to Follow-up|310
146766|NCT00705614|522891|P2|Initial Intervention|Adverse Event|21
146767|NCT00705614|522892|P1|Initial Intervention|Adverse Event|40
146768|NCT00705575|522941|P2|Overall Study|Withdrawal by Subject|10
146769|NCT00705575|522942|P1|Overall Study|Withdrawal by Subject|5
146770|NCT00705575|522941|P2|Overall Study|Protocol Violation|2
146771|NCT00705575|522942|P1|Overall Study|Protocol Violation|2
146772|NCT00705575|522941|P2|Overall Study|Lost to Follow-up|4
146773|NCT00705575|522942|P1|Overall Study|Lost to Follow-up|3
146774|NCT00705575|522941|P2|Overall Study|Adverse Event|15
146775|NCT00705575|522942|P1|Overall Study|Adverse Event|11
146776|NCT00705575|522941|P2|Overall Study|Abnormal test procedure result(s)|12
146777|NCT00705575|522942|P1|Overall Study|Abnormal test procedure result(s)|2
146778|NCT00705575|522941|P2|Overall Study|Abnormal laboratory value(s)|3
146779|NCT00705575|522942|P1|Overall Study|Abnormal laboratory value(s)|0
146780|NCT00705536|522956|P4|Start Period 1|Withdrawal by Subject|1
146781|NCT00705536|522957|P3|Start Period 1|Withdrawal by Subject|0
146782|NCT00705536|522958|P2|Start Period 1|Withdrawal by Subject|0
146783|NCT00705536|522959|P1|Start Period 1|Withdrawal by Subject|0
146784|NCT00705523|523020|P2|Overall Study|Lost to Follow-up|3
146785|NCT00705523|523021|P1|Overall Study|Lost to Follow-up|2
146786|NCT00705432|523035|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
146787|NCT00705432|523036|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
146788|NCT00705432|523037|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
146789|NCT00705432|523038|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
146790|NCT00705432|523039|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
146791|NCT00705432|523040|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
146792|NCT00705432|523035|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
146793|NCT00705432|523036|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
146794|NCT00705432|523037|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
146795|NCT00705432|523038|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
146796|NCT00705432|523039|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
146797|NCT00705432|523040|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
146798|NCT00705432|523035|P6|Treatment Period|Non medical reason|7
146799|NCT00705432|523036|P5|Treatment Period|Non medical reason|7
146800|NCT00705432|523037|P4|Treatment Period|Non medical reason|4
146801|NCT00705432|523038|P3|Treatment Period|Non medical reason|37
146802|NCT00705432|523039|P2|Treatment Period|Non medical reason|32
146803|NCT00705432|523040|P1|Treatment Period|Non medical reason|26
146804|NCT00705432|523035|P6|Treatment Period|Treatment failure|14
146805|NCT00705432|523036|P5|Treatment Period|Treatment failure|13
146806|NCT00705432|523037|P4|Treatment Period|Treatment failure|25
146807|NCT00705432|523038|P3|Treatment Period|Treatment failure|33
146808|NCT00705432|523039|P2|Treatment Period|Treatment failure|42
146809|NCT00705432|523040|P1|Treatment Period|Treatment failure|92
146810|NCT00705432|523035|P6|Treatment Period|Adverse Event|9
146811|NCT00705432|523036|P5|Treatment Period|Adverse Event|8
146812|NCT00705432|523037|P4|Treatment Period|Adverse Event|12
146813|NCT00705432|523038|P3|Treatment Period|Adverse Event|51
146814|NCT00705432|523039|P2|Treatment Period|Adverse Event|37
146815|NCT00705432|523040|P1|Treatment Period|Adverse Event|45
146816|NCT00705406|523077|P2|Overall Study|Did not receive study drug|2
146817|NCT00705406|523078|P1|Overall Study|Did not receive study drug|1
146818|NCT00705406|523077|P2|Overall Study|Lost to Follow-up|3
146819|NCT00705406|523078|P1|Overall Study|Lost to Follow-up|3
146820|NCT00705367|523102|P2|Long-term Extension Period|Administrative reason by sponsor|0
146821|NCT00705367|523103|P1|Long-term Extension Period|Administrative reason by sponsor|3
146822|NCT00705367|523102|P2|Long-term Extension Period|No longer met study criteria|0
146823|NCT00705367|523103|P1|Long-term Extension Period|No longer met study criteria|1
146824|NCT00705367|523102|P2|Long-term Extension Period|Lack of Efficacy|0
146825|NCT00705367|523103|P1|Long-term Extension Period|Lack of Efficacy|1
146826|NCT00705367|523102|P2|Long-term Extension Period|Withdrawal by Subject|0
146827|NCT00705367|523103|P1|Long-term Extension Period|Withdrawal by Subject|2
146828|NCT00705367|523102|P2|Long-term Extension Period|Adverse Event|0
146829|NCT00705367|523103|P1|Long-term Extension Period|Adverse Event|2
146830|NCT00705341|523130|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
146831|NCT00705341|523131|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
146832|NCT00705341|523132|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
146833|NCT00705341|523133|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
146834|NCT00705341|523130|P4|Phase 2: Trial|Withdrawal by Subject|4
146835|NCT00705341|523131|P3|Phase 2: Trial|Withdrawal by Subject|6
146836|NCT00705341|523132|P2|Phase 2: Trial|Withdrawal by Subject|0
146837|NCT00705341|523133|P1|Phase 2: Trial|Withdrawal by Subject|0
146838|NCT00705289|523141|P1|Overall Study|Subject or treating physician's choice|131
146839|NCT00705263|523165|P1|Overall Study|Withdrawal by Subject|2
146840|NCT00705250|523169|P1|Overall Study|Patient died in car accident|1
146841|NCT00705250|523169|P1|Overall Study|Withdrawal by Subject|1
146842|NCT00705224|523173|P1|Overall Study|Lost to Follow-up|5
146843|NCT00705224|523173|P1|Overall Study|Withdrawal by Subject|3
146844|NCT00705224|523173|P1|Overall Study|Lack of Efficacy|2
146845|NCT00705224|523173|P1|Overall Study|Adverse Event|1
146846|NCT00705159|523189|P4|Overall Study|Screen Failure|1
146847|NCT00705159|523190|P3|Overall Study|Screen Failure|0
146848|NCT00705159|523191|P2|Overall Study|Screen Failure|0
146849|NCT00705159|523192|P1|Overall Study|Screen Failure|0
146850|NCT00705159|523189|P4|Overall Study|Lost to Follow-up|2
146851|NCT00705159|523190|P3|Overall Study|Lost to Follow-up|3
146852|NCT00705159|523191|P2|Overall Study|Lost to Follow-up|0
146853|NCT00705159|523192|P1|Overall Study|Lost to Follow-up|0
146854|NCT00705159|523189|P4|Overall Study|Adverse Event|0
146855|NCT00705159|523190|P3|Overall Study|Adverse Event|1
146856|NCT00705159|523191|P2|Overall Study|Adverse Event|0
146857|NCT00705159|523192|P1|Overall Study|Adverse Event|0
146858|NCT00705159|523189|P4|Overall Study|Protocol Violation|0
146859|NCT00705159|523190|P3|Overall Study|Protocol Violation|0
146860|NCT00705159|523191|P2|Overall Study|Protocol Violation|1
146861|NCT00705159|523192|P1|Overall Study|Protocol Violation|0
146862|NCT00705159|523189|P4|Overall Study|Withdrawal by Subject|1
146863|NCT00705159|523190|P3|Overall Study|Withdrawal by Subject|1
146864|NCT00705159|523191|P2|Overall Study|Withdrawal by Subject|1
146865|NCT00705159|523192|P1|Overall Study|Withdrawal by Subject|0
146866|NCT00705146|523212|P2|Overall Study|Lost to Follow-up|1
146867|NCT00705146|523213|P1|Overall Study|Lost to Follow-up|1
146868|NCT00705016|523242|P3|Overall Study|Other|6
146869|NCT00705016|523243|P2|Overall Study|Other|6
146870|NCT00705016|523244|P1|Overall Study|Other|9
146871|NCT00705016|523242|P3|Overall Study|Symptomatic Deterioration|1
146872|NCT00705016|523243|P2|Overall Study|Symptomatic Deterioration|1
146873|NCT00705016|523244|P1|Overall Study|Symptomatic Deterioration|3
146874|NCT00705016|523242|P3|Overall Study|Progressive Disease|33
146875|NCT00705016|523243|P2|Overall Study|Progressive Disease|29
146876|NCT00705016|523244|P1|Overall Study|Progressive Disease|33
146877|NCT00705016|523242|P3|Overall Study|Withdrawal by Subject|2
146878|NCT00705016|523243|P2|Overall Study|Withdrawal by Subject|3
146879|NCT00705016|523244|P1|Overall Study|Withdrawal by Subject|4
146880|NCT00705016|523242|P3|Overall Study|Protocol Violation|1
146881|NCT00705016|523243|P2|Overall Study|Protocol Violation|1
146882|NCT00705016|523244|P1|Overall Study|Protocol Violation|0
146883|NCT00705016|523242|P3|Overall Study|Death|5
146884|NCT00705016|523243|P2|Overall Study|Death|7
146885|NCT00705016|523244|P1|Overall Study|Death|5
146886|NCT00705016|523242|P3|Overall Study|Adverse Event|10
146887|NCT00705016|523243|P2|Overall Study|Adverse Event|11
146888|NCT00705016|523244|P1|Overall Study|Adverse Event|6
146889|NCT00704964|523295|P1|Overall Study|Not completed on time|328
146890|NCT00704808|523344|P1|Overall Study|Treatment change|1
146891|NCT00704808|523344|P1|Overall Study|Lost to Follow-up|1
146892|NCT00704808|523344|P1|Overall Study|Adverse Event|1
146893|NCT00704808|523344|P1|Overall Study|Early therapy discontinuation|16
146894|NCT00704808|523344|P1|Overall Study|Patient's decision|11
146895|NCT00704808|523344|P1|Overall Study|Tumor progression|80
146896|NCT00704808|523344|P1|Overall Study|Death|7
146897|NCT00704808|523344|P1|Overall Study|Discontinued prior to starting treatment|14
146898|NCT00704730|523355|P2|Overall Study|Withdrawal by Subject|13
146899|NCT00704730|523356|P1|Overall Study|Withdrawal by Subject|9
146900|NCT00704730|523355|P2|Overall Study|data unavailable|0
146901|NCT00704730|523356|P1|Overall Study|data unavailable|1
146902|NCT00704730|523355|P2|Overall Study|Disease progression per PI|67
146903|NCT00704730|523356|P1|Overall Study|Disease progression per PI|58
146904|NCT00704730|523355|P2|Overall Study|Did not receive drug|2
146905|NCT00704730|523356|P1|Overall Study|Did not receive drug|5
146906|NCT00704730|523355|P2|Overall Study|Physician Decision|0
146907|NCT00704730|523356|P1|Overall Study|Physician Decision|2
146908|NCT00704730|523355|P2|Overall Study|Death|5
146909|NCT00704730|523356|P1|Overall Study|Death|11
146910|NCT00704730|523355|P2|Overall Study|Adverse Event|9
146911|NCT00704730|523356|P1|Overall Study|Adverse Event|35
146912|NCT00704535|523376|P1|Overall Study|Completed status not on Case Report Form|124
146913|NCT00704535|523376|P1|Overall Study|Protocol Violation|10
146914|NCT00704535|523376|P1|Overall Study|Lost to Follow-up|8
146915|NCT00704535|523376|P1|Overall Study|Death|2
146916|NCT00704535|523376|P1|Overall Study|Adverse Event|2
146917|NCT00704522|523389|P2|Overall Study|No information on therapy end|2
146918|NCT00704522|523390|P1|Overall Study|No information on therapy end|27
146919|NCT00704522|523389|P2|Overall Study|Undefined causes|7
146920|NCT00704522|523390|P1|Overall Study|Undefined causes|9
146921|NCT00704522|523389|P2|Overall Study|Adverse Event|1
146922|NCT00704522|523390|P1|Overall Study|Adverse Event|9
146923|NCT00704522|523389|P2|Overall Study|Withdrawal by Subject|8
146924|NCT00704522|523390|P1|Overall Study|Withdrawal by Subject|17
146925|NCT00704522|523389|P2|Overall Study|Failure to appear again at hospital|10
146926|NCT00704522|523390|P1|Overall Study|Failure to appear again at hospital|56
146927|NCT00704522|523389|P2|Overall Study|Lack of Efficacy|17
146928|NCT00704522|523390|P1|Overall Study|Lack of Efficacy|65
146929|NCT00704418|523410|P2|Overall Study|Over-enrolled/surgery postponed|6
146930|NCT00704418|523411|P1|Overall Study|Over-enrolled/surgery postponed|3
146931|NCT00704418|523410|P2|Overall Study|Withdrawal by Subject|0
146932|NCT00704418|523411|P1|Overall Study|Withdrawal by Subject|2
146933|NCT00704405|523424|P5|Overall Study (C Population)|Lost to Follow-up|0
146934|NCT00704405|523425|P4|Overall Study (C Population)|Lost to Follow-up|0
146935|NCT00704405|523426|P3|Overall Study (C Population)|Lost to Follow-up|0
146936|NCT00704405|523427|P2|Overall Study (C Population)|Lost to Follow-up|2
146937|NCT00704405|523428|P1|Overall Study (C Population)|Lost to Follow-up|0
146938|NCT00704405|523424|P5|Overall Study (C Population)|Withdrawal by Subject|0
146939|NCT00704405|523425|P4|Overall Study (C Population)|Withdrawal by Subject|1
146940|NCT00704405|523426|P3|Overall Study (C Population)|Withdrawal by Subject|1
146941|NCT00704405|523427|P2|Overall Study (C Population)|Withdrawal by Subject|1
146942|NCT00704405|523428|P1|Overall Study (C Population)|Withdrawal by Subject|1
146943|NCT00704405|523424|P5|Overall Study (NC Population)|Other|1
146944|NCT00704405|523425|P4|Overall Study (NC Population)|Other|0
146945|NCT00704405|523426|P3|Overall Study (NC Population)|Other|0
146946|NCT00704405|523427|P2|Overall Study (NC Population)|Other|0
146947|NCT00704405|523428|P1|Overall Study (NC Population)|Other|0
146948|NCT00704405|523424|P5|Overall Study (NC Population)|Withdrawal by Subject|2
146949|NCT00704405|523425|P4|Overall Study (NC Population)|Withdrawal by Subject|2
146950|NCT00704405|523426|P3|Overall Study (NC Population)|Withdrawal by Subject|2
146951|NCT00704405|523427|P2|Overall Study (NC Population)|Withdrawal by Subject|3
146952|NCT00704405|523428|P1|Overall Study (NC Population)|Withdrawal by Subject|2
146953|NCT00704405|523424|P5|Overall Study (NC Population)|Lost to Follow-up|2
146954|NCT00704405|523425|P4|Overall Study (NC Population)|Lost to Follow-up|2
146955|NCT00704405|523426|P3|Overall Study (NC Population)|Lost to Follow-up|1
146956|NCT00704405|523427|P2|Overall Study (NC Population)|Lost to Follow-up|1
146957|NCT00704405|523428|P1|Overall Study (NC Population)|Lost to Follow-up|2
146958|NCT00704405|523424|P5|Overall Study (NC Population)|Adverse Event|0
146959|NCT00704405|523425|P4|Overall Study (NC Population)|Adverse Event|0
146960|NCT00704405|523426|P3|Overall Study (NC Population)|Adverse Event|0
146961|NCT00704405|523427|P2|Overall Study (NC Population)|Adverse Event|0
146962|NCT00704405|523428|P1|Overall Study (NC Population)|Adverse Event|1
146963|NCT00704340|523486|P2|Overall Study|Death|1
146964|NCT00704340|523487|P1|Overall Study|Death|0
146965|NCT00704340|523486|P2|Overall Study|Lost to Follow-up|1
146966|NCT00704340|523487|P1|Overall Study|Lost to Follow-up|2
146967|NCT00704184|523502|P5|Open-Label Treatment|Withdrawal by Subject|0
146968|NCT00704184|523503|P4|Open-Label Treatment|Withdrawal by Subject|3
146969|NCT00704184|523504|P3|Open-Label Treatment|Withdrawal by Subject|0
146970|NCT00704184|523505|P2|Open-Label Treatment|Withdrawal by Subject|0
146971|NCT00704184|523506|P1|Open-Label Treatment|Withdrawal by Subject|1
146972|NCT00704184|523502|P5|Open-Label Treatment|Physician Decision|1
146973|NCT00704184|523503|P4|Open-Label Treatment|Physician Decision|0
146974|NCT00704184|523504|P3|Open-Label Treatment|Physician Decision|0
146975|NCT00704184|523505|P2|Open-Label Treatment|Physician Decision|0
146976|NCT00704184|523506|P1|Open-Label Treatment|Physician Decision|0
146977|NCT00704184|523502|P5|Open-Label Treatment|Lack of Efficacy|1
146978|NCT00704184|523503|P4|Open-Label Treatment|Lack of Efficacy|2
146979|NCT00704184|523504|P3|Open-Label Treatment|Lack of Efficacy|2
146980|NCT00704184|523505|P2|Open-Label Treatment|Lack of Efficacy|2
146981|NCT00704184|523506|P1|Open-Label Treatment|Lack of Efficacy|0
146982|NCT00704184|523502|P5|Open-Label Treatment|Adverse Event|1
146983|NCT00704184|523503|P4|Open-Label Treatment|Adverse Event|0
146984|NCT00704184|523504|P3|Open-Label Treatment|Adverse Event|2
146985|NCT00704184|523505|P2|Open-Label Treatment|Adverse Event|0
146986|NCT00704184|523506|P1|Open-Label Treatment|Adverse Event|0
146987|NCT00704184|523502|P5|Double-Blind Treatment|Withdrawal by Subject|0
146988|NCT00704184|523503|P4|Double-Blind Treatment|Withdrawal by Subject|0
146989|NCT00704184|523504|P3|Double-Blind Treatment|Withdrawal by Subject|0
146990|NCT00704184|523505|P2|Double-Blind Treatment|Withdrawal by Subject|0
146991|NCT00704184|523506|P1|Double-Blind Treatment|Withdrawal by Subject|1
146992|NCT00704171|523545|P2|Overall Study|Withdrawal by Subject|0
146993|NCT00704171|523546|P1|Overall Study|Withdrawal by Subject|1
146994|NCT00704132|523564|P2|Overall Study|Withdrawal by Subject|1
146995|NCT00704132|523565|P1|Overall Study|Withdrawal by Subject|0
146996|NCT00704132|523564|P2|Overall Study|Lack of Efficacy|1
146997|NCT00704132|523565|P1|Overall Study|Lack of Efficacy|0
146998|NCT00704132|523564|P2|Overall Study|Clinical Adverse Experience|0
146999|NCT00704132|523565|P1|Overall Study|Clinical Adverse Experience|1
147000|NCT00703963|523593|P2|Overall Study|Physician Decision|1
147001|NCT00703963|523594|P1|Overall Study|Physician Decision|0
147002|NCT00703963|523593|P2|Overall Study|Withdrawal by Subject|13
147003|NCT00703963|523594|P1|Overall Study|Withdrawal by Subject|7
147004|NCT00703924|523615|P2|Overall Study|Withdrawal by Subject|1
147005|NCT00703924|523616|P1|Overall Study|Withdrawal by Subject|1
147006|NCT00703911|523632|P1|Overall Study|Withdrawal by Subject|2
147007|NCT00703911|523632|P1|Overall Study|Lost to Follow-up|1
147008|NCT00703911|523632|P1|Overall Study|Physician Decision|6
147009|NCT00703911|523632|P1|Overall Study|Death|1
147010|NCT00703846|523665|P1|Overall Study|Did Not Receive Study Drug|2
147011|NCT00703846|523665|P1|Overall Study|Other|14
147012|NCT00703846|523665|P1|Overall Study|Death|1
147013|NCT00703846|523665|P1|Overall Study|Withdrawal by Subject|40
147014|NCT00703846|523665|P1|Overall Study|Noncompliance with Study Treatment|2
147015|NCT00703846|523665|P1|Overall Study|Lack of Efficacy|15
147016|NCT00703846|523665|P1|Overall Study|Lost to Follow-up|55
147017|NCT00703846|523665|P1|Overall Study|Adverse Event|8
147018|NCT00703820|523681|P2|Overall Study|Withdrawal by Subject|1
147019|NCT00703820|523682|P1|Overall Study|Withdrawal by Subject|2
147020|NCT00703820|523681|P2|Overall Study|Physician Decision|5
147021|NCT00703820|523682|P1|Overall Study|Physician Decision|4
147022|NCT00703820|523681|P2|Overall Study|Received non-protocol therapy|0
147023|NCT00703820|523682|P1|Overall Study|Received non-protocol therapy|1
147024|NCT00703820|523681|P2|Overall Study|Lack of Efficacy|11
147025|NCT00703820|523682|P1|Overall Study|Lack of Efficacy|11
147026|NCT00703820|523681|P2|Overall Study|Death|0
147027|NCT00703820|523682|P1|Overall Study|Death|5
147028|NCT00703820|523681|P2|Overall Study|Adverse Event|17
147029|NCT00703820|523682|P1|Overall Study|Adverse Event|12
147030|NCT00703781|523691|P2|Overall Study|Cancelled surgery|0
147031|NCT00703781|523692|P1|Overall Study|Cancelled surgery|1
147032|NCT00703781|523691|P2|Overall Study|Withdrawal by Subject|2
147033|NCT00703781|523692|P1|Overall Study|Withdrawal by Subject|1
147034|NCT00703677|523737|P1|Overall Study|Dropout-withdrawal not related to drug|3
147035|NCT00703534|523752|P2|Overall Study|Severe Non Compliance|5
147036|NCT00703534|523753|P1|Overall Study|Severe Non Compliance|1
147037|NCT00703534|523752|P2|Overall Study|Lost to Follow-up|4
147038|NCT00703534|523753|P1|Overall Study|Lost to Follow-up|1
147039|NCT00703534|523752|P2|Overall Study|Incorrect Enrollment|6
147040|NCT00703534|523753|P1|Overall Study|Incorrect Enrollment|6
147041|NCT00703534|523752|P2|Overall Study|Withdrawal by Subject|7
147042|NCT00703534|523753|P1|Overall Study|Withdrawal by Subject|8
147043|NCT00703534|523752|P2|Overall Study|Adverse Event|3
147044|NCT00703534|523753|P1|Overall Study|Adverse Event|14
147045|NCT00703326|523825|P2|Overall Study|Withdrawal by Subject|20
147046|NCT00703326|523826|P1|Overall Study|Withdrawal by Subject|42
147047|NCT00703326|523825|P2|Overall Study|Lost to Follow-up|8
147048|NCT00703326|523826|P1|Overall Study|Lost to Follow-up|25
147049|NCT00703326|523825|P2|Overall Study|Still on study|197
147050|NCT00703326|523826|P1|Overall Study|Still on study|380
147051|NCT00703157|523858|P2|Overall Study|source data permanently lost/ other|1
147052|NCT00703157|523859|P1|Overall Study|source data permanently lost/ other|4
147053|NCT00703157|523858|P2|Overall Study|Lost to Follow-up|1
147054|NCT00703157|523859|P1|Overall Study|Lost to Follow-up|0
147055|NCT00703118|523893|P3|Overall Study|Not specified|1
147056|NCT00703118|523894|P2|Overall Study|Not specified|0
147057|NCT00703118|523895|P1|Overall Study|Not specified|0
147058|NCT00703118|523893|P3|Overall Study|Withdrawal by Subject|13
147059|NCT00703118|523894|P2|Overall Study|Withdrawal by Subject|7
147060|NCT00703118|523895|P1|Overall Study|Withdrawal by Subject|8
147061|NCT00703118|523893|P3|Overall Study|Lost to Follow-up|4
147062|NCT00703118|523894|P2|Overall Study|Lost to Follow-up|4
147063|NCT00703118|523895|P1|Overall Study|Lost to Follow-up|6
147064|NCT00703118|523893|P3|Overall Study|Subject Ineligible To Continue The Trial|2
147065|NCT00703118|523894|P2|Overall Study|Subject Ineligible To Continue The Trial|3
147066|NCT00703118|523895|P1|Overall Study|Subject Ineligible To Continue The Trial|6
147067|NCT00703118|523893|P3|Overall Study|Adverse Event|2
147068|NCT00703118|523894|P2|Overall Study|Adverse Event|2
147069|NCT00703118|523895|P1|Overall Study|Adverse Event|1
147070|NCT00703092|523926|P1|Overall Study|Withdrawal by Subject|2
147071|NCT00703014|524134|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
147072|NCT00703014|524135|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
147073|NCT00703014|524136|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
147074|NCT00703014|524137|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
147075|NCT00703014|524134|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
147076|NCT00703014|524135|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
147077|NCT00703014|524136|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
147078|NCT00703014|524137|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
147079|NCT00702949|524158|P3|Overall Study|Other Medical Reason/unknown|3
147080|NCT00702949|524159|P2|Overall Study|Other Medical Reason/unknown|1
147081|NCT00702949|524160|P1|Overall Study|Other Medical Reason/unknown|1
147082|NCT00702949|524158|P3|Overall Study|Adverse Event|3
147083|NCT00702949|524159|P2|Overall Study|Adverse Event|6
147084|NCT00702949|524160|P1|Overall Study|Adverse Event|1
147085|NCT00702949|524158|P3|Overall Study|Refusal|2
147086|NCT00702949|524159|P2|Overall Study|Refusal|2
147087|NCT00702949|524160|P1|Overall Study|Refusal|3
147088|NCT00702923|524185|P1|Overall Study|Adverse Event|1
147089|NCT00702845|524208|P2|Overall Study|Not randomized|1
147090|NCT00702845|524209|P1|Overall Study|Not randomized|0
147091|NCT00702845|524208|P2|Overall Study|Patient's decision|1
147092|NCT00702845|524209|P1|Overall Study|Patient's decision|2
147093|NCT00702845|524208|P2|Overall Study|No or abnormal fertilization|2
147094|NCT00702845|524209|P1|Overall Study|No or abnormal fertilization|4
147095|NCT00702845|524208|P2|Overall Study|No/too few/bad quality embryos retrieved|1
147096|NCT00702845|524209|P1|Overall Study|No/too few/bad quality embryos retrieved|7
147097|NCT00702845|524208|P2|Overall Study|Insufficient ovarian response|0
147098|NCT00702845|524209|P1|Overall Study|Insufficient ovarian response|1
147099|NCT00702845|524208|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
147100|NCT00702845|524209|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
147101|NCT00702845|524208|P2|Overall Study|Too high ovarian response|1
147102|NCT00702845|524209|P1|Overall Study|Too high ovarian response|5
147103|NCT00702845|524208|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
147104|NCT00702845|524209|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
147105|NCT00702715|524271|P2|Overall Study|Lost to Follow-up|0
147106|NCT00702715|524272|P1|Overall Study|Lost to Follow-up|1
147107|NCT00702702|524285|P1|Overall Study|Study prematurely terminated|56
147108|NCT00702689|524293|P1|Overall Study|Adverse Event|1
147109|NCT00702689|524293|P1|Overall Study|Recurrent malignancy|1
147110|NCT00702689|524293|P1|Overall Study|Withdrawal by Subject|4
147111|NCT00702650|524304|P1|Overall Study|Adverse Event|3
147112|NCT00702650|524304|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
147113|NCT00702650|524304|P1|Overall Study|Sponsor Request|1
147114|NCT00702650|524304|P1|Overall Study|Non-Compliance with Site Directives|1
147115|NCT00702650|524304|P1|Overall Study|Lost to Follow-up|2
147116|NCT00702650|524304|P1|Overall Study|Non-Compliance of Study Drug|3
147117|NCT00702650|524304|P1|Overall Study|Withdrawal by Subject|9
147118|NCT00702520|524366|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
147119|NCT00702520|524367|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
147120|NCT00702520|524368|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
147121|NCT00702520|524369|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
147122|NCT00702520|524366|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
147123|NCT00702520|524367|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
147124|NCT00702520|524368|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
147125|NCT00702520|524369|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
147126|NCT00702520|524366|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
147127|NCT00702520|524367|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
147128|NCT00702520|524368|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
147129|NCT00702520|524369|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
147130|NCT00702507|524385|P1|Follow-up Phase|Late Enrollment|1
147131|NCT00702507|524385|P1|Follow-up Phase|Lost to Follow-up|23
147132|NCT00702507|524385|P1|Follow-up Phase|Protocol Violation|2
147133|NCT00702507|524385|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
147134|NCT00702507|524385|P1|Initial Treatment Phase|Negative Candida Culture|34
147135|NCT00702507|524385|P1|Initial Treatment Phase|Lost to Follow-up|2
147136|NCT00702507|524385|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
147137|NCT00702507|524385|P1|Initial Treatment Phase|Adverse Event|2
147138|NCT00702403|524422|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
147139|NCT00702403|524422|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
147140|NCT00702403|524422|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
147141|NCT00702403|524422|P1|From Engraftment to Study Completion|Suicide|1
147142|NCT00702403|524422|P1|From Engraftment to Study Completion|Liver GVHD|1
147143|NCT00702403|524422|P1|From Engraftment to Study Completion|Adenocarcinoma|1
147144|NCT00702403|524422|P1|From Engraftment to Study Completion|Non-compliance|2
147145|NCT00702403|524422|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
147146|NCT00702403|524422|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
147147|NCT00702403|524422|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
147148|NCT00702403|524422|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
147149|NCT00702403|524422|P1|From Consent to Engraftment|Myocardial infarction|1
147150|NCT00702403|524422|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
147151|NCT00702403|524422|P1|From Consent to Engraftment|Critically ill|2
147152|NCT00702403|524422|P1|From Consent to Engraftment|Progressive leukemia|6
147153|NCT00702325|524476|P2|Overall Study|Incorrectly Discontinued|1
147154|NCT00702325|524477|P1|Overall Study|Incorrectly Discontinued|0
147155|NCT00702325|524476|P2|Overall Study|Withdrew consent|1
147156|NCT00702325|524477|P1|Overall Study|Withdrew consent|0
147157|NCT00702325|524476|P2|Overall Study|Didn't follow study medication dosage|2
147158|NCT00702325|524477|P1|Overall Study|Didn't follow study medication dosage|0
147159|NCT00702325|524476|P2|Overall Study|Termination due to lab results|0
147160|NCT00702325|524477|P1|Overall Study|Termination due to lab results|1
147161|NCT00702325|524476|P2|Overall Study|Severe noncompliance to protocol|3
147162|NCT00702325|524477|P1|Overall Study|Severe noncompliance to protocol|3
147163|NCT00702325|524476|P2|Overall Study|Developed study discontinuation criteria|28
147164|NCT00702325|524477|P1|Overall Study|Developed study discontinuation criteria|18
147165|NCT00702325|524476|P2|Overall Study|Incorrect enrollment|7
147166|NCT00702325|524477|P1|Overall Study|Incorrect enrollment|5
147167|NCT00702325|524476|P2|Overall Study|Lost to Follow-up|4
147168|NCT00702325|524477|P1|Overall Study|Lost to Follow-up|3
147169|NCT00702325|524476|P2|Overall Study|Withdrawal by Subject|7
147170|NCT00702325|524477|P1|Overall Study|Withdrawal by Subject|7
147171|NCT00702325|524476|P2|Overall Study|Adverse Event|0
147172|NCT00702325|524477|P1|Overall Study|Adverse Event|1
147173|NCT00702221|524573|P2|Overall Study|Adverse Event|3
147174|NCT00702221|524574|P1|Overall Study|Adverse Event|4
147175|NCT00702208|524580|P1|Overall Study|Unsatisfactory colposcopy|2
147176|NCT00702208|524580|P1|Overall Study|Did not self-lavage|1
147177|NCT00702208|524580|P1|Overall Study|Lost to Follow-up|28
147178|NCT00702143|524589|P3|Overall Study|Lost to Follow-up|1
147179|NCT00702143|524590|P2|Overall Study|Lost to Follow-up|0
147180|NCT00702143|524591|P1|Overall Study|Lost to Follow-up|0
147181|NCT00701805|524640|P4|Overall Study|Resumption criteria were not met|0
147182|NCT00701805|524641|P3|Overall Study|Resumption criteria were not met|0
147183|NCT00701805|524642|P2|Overall Study|Resumption criteria were not met|1
147184|NCT00701805|524643|P1|Overall Study|Resumption criteria were not met|0
147185|NCT00701805|524640|P4|Overall Study|Difficult to travel to dialysis site|0
147186|NCT00701805|524641|P3|Overall Study|Difficult to travel to dialysis site|1
147187|NCT00701805|524642|P2|Overall Study|Difficult to travel to dialysis site|0
147188|NCT00701805|524643|P1|Overall Study|Difficult to travel to dialysis site|0
147189|NCT00701805|524640|P4|Overall Study|Physician decision, change of therapy|1
147190|NCT00701805|524641|P3|Overall Study|Physician decision, change of therapy|0
147191|NCT00701805|524642|P2|Overall Study|Physician decision, change of therapy|0
147192|NCT00701805|524643|P1|Overall Study|Physician decision, change of therapy|0
147193|NCT00701805|524640|P4|Overall Study|Admitted to hospital for 2 weeks|0
147194|NCT00701805|524641|P3|Overall Study|Admitted to hospital for 2 weeks|1
147195|NCT00701805|524642|P2|Overall Study|Admitted to hospital for 2 weeks|0
147196|NCT00701805|524643|P1|Overall Study|Admitted to hospital for 2 weeks|0
147197|NCT00701805|524640|P4|Overall Study|Missed 7 consecutive doses|0
147198|NCT00701805|524641|P3|Overall Study|Missed 7 consecutive doses|0
147199|NCT00701805|524642|P2|Overall Study|Missed 7 consecutive doses|1
147200|NCT00701805|524643|P1|Overall Study|Missed 7 consecutive doses|0
147201|NCT00701805|524640|P4|Overall Study|Adverse Event|0
147202|NCT00701805|524641|P3|Overall Study|Adverse Event|1
147203|NCT00701805|524642|P2|Overall Study|Adverse Event|1
147204|NCT00701805|524643|P1|Overall Study|Adverse Event|0
147205|NCT00701805|524640|P4|Overall Study|Withdrawal by Subject|3
147206|NCT00701805|524641|P3|Overall Study|Withdrawal by Subject|4
147207|NCT00701805|524642|P2|Overall Study|Withdrawal by Subject|1
147208|NCT00701805|524643|P1|Overall Study|Withdrawal by Subject|3
147209|NCT00701779|524693|P1|Overall Study|Withdrawal by Subject|2
147210|NCT00701779|524693|P1|Overall Study|Lost to Follow-up|1
147211|NCT00701779|524693|P1|Overall Study|Adverse Event|6
147212|NCT00701727|524702|P2|Second Treatment Period|Withdrawal by Subject|0
147213|NCT00701727|524703|P1|Second Treatment Period|Withdrawal by Subject|2
147214|NCT00701727|524702|P2|First Treatment Period|Lost to Follow-up|1
147215|NCT00701727|524703|P1|First Treatment Period|Lost to Follow-up|0
147216|NCT00701727|524702|P2|First Treatment Period|sponsor decision|1
147217|NCT00701727|524703|P1|First Treatment Period|sponsor decision|0
147218|NCT00701727|524702|P2|First Treatment Period|Withdrawal by Subject|0
147219|NCT00701727|524703|P1|First Treatment Period|Withdrawal by Subject|1
147220|NCT00701727|524702|P2|First Treatment Period|Adverse Event|0
147221|NCT00701727|524703|P1|First Treatment Period|Adverse Event|0
147222|NCT00701662|524749|P1|Overall Study|Lack of Efficacy|1
147223|NCT00701558|524774|P1|Overall Study|Lost to Follow-up|8
147224|NCT00701558|524774|P1|Overall Study|Death|7
147225|NCT00701441|524782|P2|Overall Study|failure in cpap compliance|4
147226|NCT00701441|524783|P1|Overall Study|failure in cpap compliance|0
147227|NCT00701415|524795|P2|Overall Study|Social/family issues and needle phobia|0
147228|NCT00701415|524796|P1|Overall Study|Social/family issues and needle phobia|1
147229|NCT00701415|524795|P2|Overall Study|Adverse Event|1
147230|NCT00701415|524796|P1|Overall Study|Adverse Event|0
147231|NCT00701363|524831|P4|Treatment Phase 2|Withdrawal by Subject|0
147232|NCT00701363|524832|P3|Treatment Phase 2|Withdrawal by Subject|1
147233|NCT00701363|524833|P2|Treatment Phase 2|Withdrawal by Subject|0
147234|NCT00701363|524834|P1|Treatment Phase 2|Withdrawal by Subject|0
147235|NCT00701363|524831|P4|Treatment Phase 2|Adverse Event|0
147236|NCT00701363|524832|P3|Treatment Phase 2|Adverse Event|1
147237|NCT00701363|524833|P2|Treatment Phase 2|Adverse Event|0
147238|NCT00701363|524834|P1|Treatment Phase 2|Adverse Event|0
147239|NCT00701363|524831|P4|Treatment Phase 1|Lack of Efficacy|0
147240|NCT00701363|524832|P3|Treatment Phase 1|Lack of Efficacy|0
147241|NCT00701363|524833|P2|Treatment Phase 1|Lack of Efficacy|0
147242|NCT00701363|524834|P1|Treatment Phase 1|Lack of Efficacy|1
147243|NCT00701363|524831|P4|Treatment Phase 1|Withdrawal by Subject|0
147244|NCT00701363|524832|P3|Treatment Phase 1|Withdrawal by Subject|0
147245|NCT00701363|524833|P2|Treatment Phase 1|Withdrawal by Subject|0
147246|NCT00701363|524834|P1|Treatment Phase 1|Withdrawal by Subject|5
147247|NCT00701363|524831|P4|Treatment Phase 1|Protocol Violation|0
147248|NCT00701363|524832|P3|Treatment Phase 1|Protocol Violation|0
147249|NCT00701363|524833|P2|Treatment Phase 1|Protocol Violation|0
147250|NCT00701363|524834|P1|Treatment Phase 1|Protocol Violation|1
147251|NCT00701363|524831|P4|Treatment Phase 1|Adverse Event|0
147252|NCT00701363|524832|P3|Treatment Phase 1|Adverse Event|0
147253|NCT00701363|524833|P2|Treatment Phase 1|Adverse Event|0
147254|NCT00701363|524834|P1|Treatment Phase 1|Adverse Event|7
147255|NCT00701363|524831|P4|Treatment Phase 1|Does not meet entry Criteria|0
147256|NCT00701363|524832|P3|Treatment Phase 1|Does not meet entry Criteria|0
147257|NCT00701363|524833|P2|Treatment Phase 1|Does not meet entry Criteria|0
147258|NCT00701363|524834|P1|Treatment Phase 1|Does not meet entry Criteria|1
147259|NCT00701363|524831|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
147260|NCT00701363|524832|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
147261|NCT00701363|524833|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
147262|NCT00701363|524834|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
147263|NCT00701311|524874|P1|Overall Study|Withdrawal by Subject|2
147264|NCT00701311|524874|P1|Overall Study|Adverse Event|3
147265|NCT00701311|524874|P1|Overall Study|Lack of Efficacy|3
147266|NCT00701129|524878|P1|Overall Study|Death|2
147267|NCT00701103|524900|P11|Overall Study|Other|0
147268|NCT00701103|524901|P10|Overall Study|Other|1
147269|NCT00701103|524902|P9|Overall Study|Other|1
147270|NCT00701103|524903|P8|Overall Study|Other|0
147271|NCT00701103|524904|P7|Overall Study|Other|0
147272|NCT00701103|524905|P6|Overall Study|Other|0
147273|NCT00701103|524906|P5|Overall Study|Other|0
147274|NCT00701103|524907|P4|Overall Study|Other|0
147275|NCT00701103|524908|P3|Overall Study|Other|0
147276|NCT00701103|524909|P2|Overall Study|Other|0
147277|NCT00701103|524910|P1|Overall Study|Other|0
147278|NCT00701103|524900|P11|Overall Study|Withdrawal by Subject|0
147279|NCT00701103|524901|P10|Overall Study|Withdrawal by Subject|0
147280|NCT00701103|524902|P9|Overall Study|Withdrawal by Subject|0
147281|NCT00701103|524903|P8|Overall Study|Withdrawal by Subject|0
147282|NCT00701103|524904|P7|Overall Study|Withdrawal by Subject|0
147283|NCT00701103|524905|P6|Overall Study|Withdrawal by Subject|0
147284|NCT00701103|524906|P5|Overall Study|Withdrawal by Subject|0
147285|NCT00701103|524907|P4|Overall Study|Withdrawal by Subject|0
147286|NCT00701103|524908|P3|Overall Study|Withdrawal by Subject|1
147287|NCT00701103|524909|P2|Overall Study|Withdrawal by Subject|1
147288|NCT00701103|524910|P1|Overall Study|Withdrawal by Subject|0
147289|NCT00701103|524900|P11|Overall Study|Progressive Disease|11
147290|NCT00701103|524901|P10|Overall Study|Progressive Disease|8
147291|NCT00701103|524902|P9|Overall Study|Progressive Disease|8
147292|NCT00701103|524903|P8|Overall Study|Progressive Disease|7
147293|NCT00701103|524904|P7|Overall Study|Progressive Disease|7
147294|NCT00701103|524905|P6|Overall Study|Progressive Disease|5
147295|NCT00701103|524906|P5|Overall Study|Progressive Disease|6
147296|NCT00701103|524907|P4|Overall Study|Progressive Disease|5
147297|NCT00701103|524908|P3|Overall Study|Progressive Disease|6
147298|NCT00701103|524909|P2|Overall Study|Progressive Disease|2
147299|NCT00701103|524910|P1|Overall Study|Progressive Disease|5
147300|NCT00701103|524900|P11|Overall Study|Adverse Event|0
147301|NCT00701103|524901|P10|Overall Study|Adverse Event|2
147302|NCT00701103|524902|P9|Overall Study|Adverse Event|0
147303|NCT00701103|524903|P8|Overall Study|Adverse Event|0
147304|NCT00701103|524904|P7|Overall Study|Adverse Event|1
147305|NCT00701103|524905|P6|Overall Study|Adverse Event|1
147306|NCT00701103|524906|P5|Overall Study|Adverse Event|0
147307|NCT00701103|524907|P4|Overall Study|Adverse Event|1
147308|NCT00701103|524908|P3|Overall Study|Adverse Event|1
147309|NCT00701103|524909|P2|Overall Study|Adverse Event|0
147310|NCT00701103|524910|P1|Overall Study|Adverse Event|0
147311|NCT00701090|525016|P2|Overall Study|Other|12
147312|NCT00701090|525017|P1|Overall Study|Other|7
147313|NCT00701090|525016|P2|Overall Study|Withdrawal by Subject|16
147314|NCT00701090|525017|P1|Overall Study|Withdrawal by Subject|11
147315|NCT00701090|525016|P2|Overall Study|Protocol Violation|3
147316|NCT00701090|525017|P1|Overall Study|Protocol Violation|2
147317|NCT00701090|525016|P2|Overall Study|Physician Decision|4
147318|NCT00701090|525017|P1|Overall Study|Physician Decision|3
147319|NCT00701090|525016|P2|Overall Study|Lost to Follow-up|9
147320|NCT00701090|525017|P1|Overall Study|Lost to Follow-up|9
147321|NCT00701090|525016|P2|Overall Study|Lack of Efficacy|4
147322|NCT00701090|525017|P1|Overall Study|Lack of Efficacy|5
147323|NCT00701090|525016|P2|Overall Study|Death|1
147324|NCT00701090|525017|P1|Overall Study|Death|0
147325|NCT00701090|525016|P2|Overall Study|Adverse Event|2
147326|NCT00701090|525017|P1|Overall Study|Adverse Event|11
147327|NCT00701064|525035|P2|Overall Study|initiated other PTSD treatment|2
147328|NCT00701064|525036|P1|Overall Study|initiated other PTSD treatment|2
147329|NCT00701064|525035|P2|Overall Study|Withdrawal by Subject|1
147330|NCT00701064|525036|P1|Overall Study|Withdrawal by Subject|1
147331|NCT00701064|525035|P2|Overall Study|Protocol Violation|1
147332|NCT00701064|525036|P1|Overall Study|Protocol Violation|1
147333|NCT00701051|525044|P3|Exercise Intervention|time conflict; non-study related illness|3
147334|NCT00701051|525045|P2|Exercise Intervention|time conflict; non-study related illness|5
147335|NCT00701051|525046|P1|Exercise Intervention|time conflict; non-study related illness|0
147336|NCT00701051|525044|P3|Screening|Time conflicts|0
147337|NCT00701051|525045|P2|Screening|Time conflicts|0
147338|NCT00701051|525046|P1|Screening|Time conflicts|19
147339|NCT00701051|525044|P3|Screening|Failed Screening|0
147340|NCT00701051|525045|P2|Screening|Failed Screening|0
147341|NCT00701051|525046|P1|Screening|Failed Screening|40
147342|NCT00701038|525064|P2|Overall Study|study amended pilot group of patients|4
147343|NCT00701038|525065|P1|Overall Study|study amended pilot group of patients|4
147344|NCT00700999|525073|P2|Overall Study|Withdrawal by Subject|1
147345|NCT00700999|525074|P1|Overall Study|Withdrawal by Subject|8
147346|NCT00700999|525073|P2|Overall Study|Excluded - did not meet study criteria|1
147347|NCT00700999|525074|P1|Overall Study|Excluded - did not meet study criteria|0
147348|NCT00700999|525073|P2|Overall Study|Lost to Follow-up|7
147349|NCT00700999|525074|P1|Overall Study|Lost to Follow-up|7
147350|NCT00700817|525094|P5|Week 52-78 (Extension Period 2)|Unclassified|1
147351|NCT00700817|525095|P4|Week 52-78 (Extension Period 2)|Unclassified|0
147352|NCT00700817|525096|P3|Week 52-78 (Extension Period 2)|Unclassified|0
147353|NCT00700817|525097|P2|Week 52-78 (Extension Period 2)|Unclassified|4
147354|NCT00700817|525098|P1|Week 52-78 (Extension Period 2)|Unclassified|2
147355|NCT00700817|525094|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
147356|NCT00700817|525095|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
147357|NCT00700817|525096|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
147358|NCT00700817|525097|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
147359|NCT00700817|525098|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
147360|NCT00700817|525094|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
147361|NCT00700817|525095|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
147362|NCT00700817|525096|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
147363|NCT00700817|525097|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
147364|NCT00700817|525098|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
147365|NCT00700817|525094|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
147366|NCT00700817|525095|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
147367|NCT00700817|525096|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
147368|NCT00700817|525097|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
147369|NCT00700817|525098|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
147370|NCT00700817|525094|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
147371|NCT00700817|525095|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
147372|NCT00700817|525096|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
147373|NCT00700817|525097|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
147374|NCT00700817|525098|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
147375|NCT00700817|525094|P5|Week 26-52 (Extension Period 1)|Unclassified|0
147376|NCT00700817|525095|P4|Week 26-52 (Extension Period 1)|Unclassified|0
147377|NCT00700817|525096|P3|Week 26-52 (Extension Period 1)|Unclassified|1
147378|NCT00700817|525097|P2|Week 26-52 (Extension Period 1)|Unclassified|3
147379|NCT00700817|525098|P1|Week 26-52 (Extension Period 1)|Unclassified|4
147380|NCT00700817|525094|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
147381|NCT00700817|525095|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
147382|NCT00700817|525096|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
147383|NCT00700817|525097|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
147384|NCT00700817|525098|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
147385|NCT00700817|525094|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
147386|NCT00700817|525095|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
147387|NCT00700817|525096|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
147388|NCT00700817|525097|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
147389|NCT00700817|525098|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
147390|NCT00700817|525094|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
147391|NCT00700817|525095|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
147392|NCT00700817|525096|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
147393|NCT00700817|525097|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
147394|NCT00700817|525098|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
147395|NCT00700817|525094|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
147396|NCT00700817|525095|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
147397|NCT00700817|525096|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
147398|NCT00700817|525097|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
147399|NCT00700817|525098|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
147400|NCT00700817|525094|P5|Week 0-26 (Main Period)|Unclassified|0
147401|NCT00700817|525095|P4|Week 0-26 (Main Period)|Unclassified|0
147402|NCT00700817|525096|P3|Week 0-26 (Main Period)|Unclassified|8
147403|NCT00700817|525097|P2|Week 0-26 (Main Period)|Unclassified|4
147404|NCT00700817|525098|P1|Week 0-26 (Main Period)|Unclassified|14
147405|NCT00700817|525094|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
147406|NCT00700817|525095|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
147407|NCT00700817|525096|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
147408|NCT00700817|525097|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
147409|NCT00700817|525098|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
147410|NCT00700817|525094|P5|Week 0-26 (Main Period)|Protocol Violation|0
147411|NCT00700817|525095|P4|Week 0-26 (Main Period)|Protocol Violation|0
147412|NCT00700817|525096|P3|Week 0-26 (Main Period)|Protocol Violation|4
147413|NCT00700817|525097|P2|Week 0-26 (Main Period)|Protocol Violation|4
147414|NCT00700817|525098|P1|Week 0-26 (Main Period)|Protocol Violation|14
147415|NCT00700817|525094|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
147416|NCT00700817|525095|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
147417|NCT00700817|525096|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
147418|NCT00700817|525097|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
147419|NCT00700817|525098|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
147420|NCT00700817|525094|P5|Week 0-26 (Main Period)|Adverse Event|0
147421|NCT00700817|525095|P4|Week 0-26 (Main Period)|Adverse Event|0
147422|NCT00700817|525096|P3|Week 0-26 (Main Period)|Adverse Event|4
147423|NCT00700817|525097|P2|Week 0-26 (Main Period)|Adverse Event|15
147424|NCT00700817|525098|P1|Week 0-26 (Main Period)|Adverse Event|14
147425|NCT00700804|525480|P2|Overall Study|Loose Stools|1
147426|NCT00700804|525481|P1|Overall Study|Loose Stools|1
147427|NCT00700804|525480|P2|Overall Study|Protocol Violation|1
147428|NCT00700804|525481|P1|Overall Study|Protocol Violation|1
147429|NCT00700804|525480|P2|Overall Study|Withdrawal by Subject|2
147430|NCT00700804|525481|P1|Overall Study|Withdrawal by Subject|1
147431|NCT00700752|525489|P2|First Intervention|Withdrawal by Subject|2
147432|NCT00700752|525490|P1|First Intervention|Withdrawal by Subject|0
147433|NCT00700739|525498|P2|Overall Study|Lost to Follow-up|4
147434|NCT00700739|525499|P1|Overall Study|Lost to Follow-up|4
147435|NCT00700713|525538|P3|Overall Study|Withdrawal by Subject|1
147436|NCT00700713|525539|P2|Overall Study|Withdrawal by Subject|0
147437|NCT00700713|525540|P1|Overall Study|Withdrawal by Subject|0
147438|NCT00700713|525538|P3|Overall Study|Protocol Violation|1
147439|NCT00700713|525539|P2|Overall Study|Protocol Violation|0
147440|NCT00700713|525540|P1|Overall Study|Protocol Violation|1
147441|NCT00700635|525557|P3|Overall Study|Withdrawal by Subject|1
147442|NCT00700635|525558|P2|Overall Study|Withdrawal by Subject|3
147443|NCT00700635|525559|P1|Overall Study|Withdrawal by Subject|7
147444|NCT00700635|525557|P3|Overall Study|Protocol Violation|0
147445|NCT00700635|525558|P2|Overall Study|Protocol Violation|2
147446|NCT00700635|525559|P1|Overall Study|Protocol Violation|2
147447|NCT00700635|525557|P3|Overall Study|Lost to Follow-up|0
147448|NCT00700635|525558|P2|Overall Study|Lost to Follow-up|3
147449|NCT00700635|525559|P1|Overall Study|Lost to Follow-up|1
147450|NCT00700635|525557|P3|Overall Study|Adverse Event|0
147451|NCT00700635|525558|P2|Overall Study|Adverse Event|0
147452|NCT00700635|525559|P1|Overall Study|Adverse Event|1
147453|NCT00700622|525581|P2|Overall Study|Other|1
147454|NCT00700622|525582|P1|Overall Study|Other|3
147455|NCT00700622|525581|P2|Overall Study|Withdrawal by Subject|1
147456|NCT00700622|525582|P1|Overall Study|Withdrawal by Subject|4
147457|NCT00700622|525581|P2|Overall Study|Protocol Violation|1
147458|NCT00700622|525582|P1|Overall Study|Protocol Violation|0
147459|NCT00700622|525581|P2|Overall Study|Physician Decision|1
147460|NCT00700622|525582|P1|Overall Study|Physician Decision|2
147461|NCT00700622|525581|P2|Overall Study|Lost to Follow-up|1
147462|NCT00700622|525582|P1|Overall Study|Lost to Follow-up|0
147463|NCT00700622|525581|P2|Overall Study|Adverse Event|0
147464|NCT00700622|525582|P1|Overall Study|Adverse Event|4
147465|NCT00700570|525590|P2|Overall Study|Withdrawal by Subject|6
147466|NCT00700570|525591|P1|Overall Study|Withdrawal by Subject|1
147467|NCT00700570|525590|P2|Overall Study|Disease Progression|11
147468|NCT00700570|525591|P1|Overall Study|Disease Progression|8
147469|NCT00700570|525590|P2|Overall Study|Discretion of Investigator or Sponsor|3
147470|NCT00700570|525591|P1|Overall Study|Discretion of Investigator or Sponsor|0
147471|NCT00700570|525590|P2|Overall Study|Adverse Event|6
147472|NCT00700570|525591|P1|Overall Study|Adverse Event|2
147473|NCT00700427|525607|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
147474|NCT00700427|525608|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
147475|NCT00700427|525609|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
147476|NCT00700427|525610|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
147477|NCT00700427|525611|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
147478|NCT00700427|525607|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
147479|NCT00700427|525608|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
147480|NCT00700427|525609|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
147481|NCT00700427|525610|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
147482|NCT00700427|525611|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
147483|NCT00700427|525607|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
147484|NCT00700427|525608|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
147485|NCT00700427|525609|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
147486|NCT00700427|525610|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
147487|NCT00700427|525611|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
147488|NCT00700427|525607|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
147489|NCT00700427|525608|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
147490|NCT00700427|525609|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
147491|NCT00700427|525610|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
147492|NCT00700427|525611|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
147493|NCT00700427|525607|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
147494|NCT00700427|525608|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
147495|NCT00700427|525609|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
147496|NCT00700427|525610|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
147497|NCT00700427|525611|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
147498|NCT00700427|525607|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
147499|NCT00700427|525608|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
147500|NCT00700427|525609|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
147501|NCT00700427|525610|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
147502|NCT00700427|525611|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
147503|NCT00700427|525607|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
147504|NCT00700427|525608|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
147505|NCT00700427|525609|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
147506|NCT00700427|525610|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
147507|NCT00700427|525611|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
147508|NCT00700427|525607|P5|Study Period 4 (Open-Label Extension)|Death|1
147509|NCT00700427|525608|P4|Study Period 4 (Open-Label Extension)|Death|0
147510|NCT00700427|525609|P3|Study Period 4 (Open-Label Extension)|Death|0
147511|NCT00700427|525610|P2|Study Period 4 (Open-Label Extension)|Death|0
147512|NCT00700427|525611|P1|Study Period 4 (Open-Label Extension)|Death|0
147513|NCT00700427|525607|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
147514|NCT00700427|525608|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
147515|NCT00700427|525609|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
147516|NCT00700427|525610|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
147517|NCT00700427|525611|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
147518|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Death|0
147519|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Death|0
147520|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Death|1
147521|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Death|0
147522|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Death|0
147523|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
147524|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
147525|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
147526|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
147527|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
147528|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
147529|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
147530|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
147531|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
147532|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
147533|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
147534|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
147535|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
147536|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
147537|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
147538|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
147539|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
147540|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
147541|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
147542|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
147543|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
147544|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
147545|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
147546|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
147547|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
147548|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
147549|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
147550|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
147551|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
147552|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
147553|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
147554|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
147555|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
147556|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
147557|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
147558|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
147559|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
147560|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
147561|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
147562|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
147563|NCT00700427|525607|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
147564|NCT00700427|525608|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
147565|NCT00700427|525609|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
147566|NCT00700427|525610|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
147567|NCT00700427|525611|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
147568|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
147569|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
147570|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
147571|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
147572|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
147573|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
147574|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
147575|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
147576|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
147577|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
147578|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
147579|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
147580|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
147581|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
147582|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
147583|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
147584|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
147585|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
147586|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
147587|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
147588|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
147589|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
147590|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
147591|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
147592|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
147593|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
147594|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
147595|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
147596|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
147597|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
147598|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
147599|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
147600|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
147601|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
147602|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
147603|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
147604|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
147605|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
147606|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
147607|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
147608|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
147609|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
147610|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
147611|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
147612|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
147613|NCT00700427|525607|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
147614|NCT00700427|525608|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
147615|NCT00700427|525609|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
147616|NCT00700427|525610|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
147617|NCT00700427|525611|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
147618|NCT00700427|525607|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
147619|NCT00700427|525608|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
147620|NCT00700427|525609|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
147621|NCT00700427|525610|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
147622|NCT00700427|525611|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
147623|NCT00700427|525607|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
147624|NCT00700427|525608|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
147625|NCT00700427|525609|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
147626|NCT00700427|525610|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
147627|NCT00700427|525611|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
147628|NCT00700427|525607|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
147629|NCT00700427|525608|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
147630|NCT00700427|525609|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
147631|NCT00700427|525610|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
147632|NCT00700427|525611|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
147633|NCT00700427|525607|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
147634|NCT00700427|525608|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
147635|NCT00700427|525609|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
147636|NCT00700427|525610|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
147637|NCT00700427|525611|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
147638|NCT00700427|525607|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
147639|NCT00700427|525608|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
147640|NCT00700427|525609|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
147641|NCT00700427|525610|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
147642|NCT00700427|525611|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
147643|NCT00700427|525607|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
147644|NCT00700427|525608|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
147645|NCT00700427|525609|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
147646|NCT00700427|525610|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
147647|NCT00700427|525611|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
147648|NCT00700427|525607|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
147649|NCT00700427|525608|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
147650|NCT00700427|525609|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
147651|NCT00700427|525610|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
147652|NCT00700427|525611|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
147653|NCT00700427|525607|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
147654|NCT00700427|525608|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
147655|NCT00700427|525609|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
147656|NCT00700427|525610|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
147657|NCT00700427|525611|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
147658|NCT00700427|525607|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
147659|NCT00700427|525608|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
147660|NCT00700427|525609|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
147661|NCT00700427|525610|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
147662|NCT00700427|525611|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
147663|NCT00700401|525633|P1|Overall Study|Withdrawal by Subject|2
147664|NCT00700401|525633|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
147665|NCT00700401|525633|P1|Overall Study|Treatment never started|1
147666|NCT00700401|525633|P1|Overall Study|Lost to Follow-up|1
147667|NCT00700401|525633|P1|Overall Study|Refused Treatment|2
147668|NCT00700401|525633|P1|Overall Study|Adverse Event|5
147669|NCT00700401|525633|P1|Overall Study|Detectable HCV RNA after Week 4|82
147670|NCT00700310|525657|P4|Overall Study|Randomized, Not Treated|2
147671|NCT00700310|525658|P3|Overall Study|Randomized, Not Treated|2
147672|NCT00700310|525659|P2|Overall Study|Randomized, Not Treated|0
147673|NCT00700310|525660|P1|Overall Study|Randomized, Not Treated|2
147674|NCT00700310|525657|P4|Overall Study|Administrative/Other|3
147675|NCT00700310|525658|P3|Overall Study|Administrative/Other|1
147676|NCT00700310|525659|P2|Overall Study|Administrative/Other|3
147677|NCT00700310|525660|P1|Overall Study|Administrative/Other|1
147678|NCT00700310|525657|P4|Overall Study|Lack of Efficacy|1
147679|NCT00700310|525658|P3|Overall Study|Lack of Efficacy|0
147680|NCT00700310|525659|P2|Overall Study|Lack of Efficacy|3
147681|NCT00700310|525660|P1|Overall Study|Lack of Efficacy|0
147682|NCT00700310|525657|P4|Overall Study|Withdrawal by Subject|8
147683|NCT00700310|525658|P3|Overall Study|Withdrawal by Subject|8
147684|NCT00700310|525659|P2|Overall Study|Withdrawal by Subject|9
147685|NCT00700310|525660|P1|Overall Study|Withdrawal by Subject|8
147686|NCT00700310|525657|P4|Overall Study|Lost to Follow-up|1
147687|NCT00700310|525658|P3|Overall Study|Lost to Follow-up|0
147688|NCT00700310|525659|P2|Overall Study|Lost to Follow-up|1
147689|NCT00700310|525660|P1|Overall Study|Lost to Follow-up|4
147690|NCT00700310|525657|P4|Overall Study|Adverse Event|11
147691|NCT00700310|525658|P3|Overall Study|Adverse Event|5
147692|NCT00700310|525659|P2|Overall Study|Adverse Event|10
147693|NCT00700310|525660|P1|Overall Study|Adverse Event|6
147694|NCT00700271|525680|P2|Overall Study|Lost to Follow-up|2
147695|NCT00700271|525681|P1|Overall Study|Lost to Follow-up|2
147696|NCT00700271|525680|P2|Overall Study|Withdrawal by Subject|4
147697|NCT00700271|525681|P1|Overall Study|Withdrawal by Subject|6
147698|NCT00700271|525680|P2|Overall Study|Administrative Reasons|0
147699|NCT00700271|525681|P1|Overall Study|Administrative Reasons|1
147700|NCT00700271|525680|P2|Overall Study|Protocol Violation|0
147701|NCT00700271|525681|P1|Overall Study|Protocol Violation|1
147702|NCT00700271|525680|P2|Overall Study|Adverse Event|6
147703|NCT00700271|525681|P1|Overall Study|Adverse Event|4
147704|NCT00700180|525709|P2|Overall Study|Lost to Follow-up|5
147705|NCT00700180|525710|P1|Overall Study|Lost to Follow-up|4
147706|NCT00700180|525709|P2|Overall Study|Alive in follow-up|27
147707|NCT00700180|525710|P1|Overall Study|Alive in follow-up|46
147708|NCT00700180|525709|P2|Overall Study|Alive on treatment|3
147709|NCT00700180|525710|P1|Overall Study|Alive on treatment|5
147710|NCT00700180|525709|P2|Overall Study|Death|114
147711|NCT00700180|525710|P1|Overall Study|Death|99
147712|NCT00700115|525739|P2|Overall Study|Lost to Follow-up|1
147713|NCT00700115|525740|P1|Overall Study|Lost to Follow-up|0
147714|NCT00700115|525739|P2|Overall Study|Withdrawal by Subject|0
147715|NCT00700115|525740|P1|Overall Study|Withdrawal by Subject|1
147716|NCT00700102|525750|P2|Overall Study|Lost to Follow-up|10
147717|NCT00700102|525751|P1|Overall Study|Lost to Follow-up|8
147718|NCT00700102|525750|P2|Overall Study|Died|385
147719|NCT00700102|525751|P1|Overall Study|Died|394
147720|NCT00700011|525890|P2|Overall Study|Death|1
147721|NCT00700011|525891|P1|Overall Study|Death|0
147722|NCT00699998|525907|P4|Overall Study|Lost to Follow-up|1
147723|NCT00699998|525908|P3|Overall Study|Lost to Follow-up|3
147724|NCT00699998|525909|P2|Overall Study|Lost to Follow-up|1
147725|NCT00699998|525910|P1|Overall Study|Lost to Follow-up|2
147726|NCT00699998|525907|P4|Overall Study|Physician Decision|1
147727|NCT00699998|525908|P3|Overall Study|Physician Decision|1
147728|NCT00699998|525909|P2|Overall Study|Physician Decision|2
147729|NCT00699998|525910|P1|Overall Study|Physician Decision|3
147730|NCT00699998|525907|P4|Overall Study|Withdrawal by Subject|80
147731|NCT00699998|525908|P3|Overall Study|Withdrawal by Subject|202
147732|NCT00699998|525909|P2|Overall Study|Withdrawal by Subject|83
147733|NCT00699998|525910|P1|Overall Study|Withdrawal by Subject|194
147734|NCT00699972|525955|P3|Overall Study|Randomized, Not Treated|1
147735|NCT00699972|525956|P2|Overall Study|Randomized, Not Treated|0
147736|NCT00699972|525957|P1|Overall Study|Randomized, Not Treated|1
147737|NCT00699972|525955|P3|Overall Study|Administrative/Other|4
147738|NCT00699972|525956|P2|Overall Study|Administrative/Other|1
147739|NCT00699972|525957|P1|Overall Study|Administrative/Other|3
147740|NCT00699972|525955|P3|Overall Study|Lack of Efficacy|2
147741|NCT00699972|525956|P2|Overall Study|Lack of Efficacy|0
147742|NCT00699972|525957|P1|Overall Study|Lack of Efficacy|2
147743|NCT00699972|525955|P3|Overall Study|Withdrawal by Subject|4
147744|NCT00699972|525956|P2|Overall Study|Withdrawal by Subject|7
147745|NCT00699972|525957|P1|Overall Study|Withdrawal by Subject|3
147746|NCT00699972|525955|P3|Overall Study|Lost to Follow-up|0
147747|NCT00699972|525956|P2|Overall Study|Lost to Follow-up|2
147748|NCT00699972|525957|P1|Overall Study|Lost to Follow-up|0
147749|NCT00699972|525955|P3|Overall Study|Adverse Event|24
147750|NCT00699972|525956|P2|Overall Study|Adverse Event|9
147751|NCT00699972|525957|P1|Overall Study|Adverse Event|7
147752|NCT00699907|525974|P3|Overall Study|No usable sample|8
147753|NCT00699907|525975|P2|Overall Study|No usable sample|9
147754|NCT00699907|525976|P1|Overall Study|No usable sample|0
147755|NCT00699907|525974|P3|Overall Study|Withdrawal by Subject|0
147756|NCT00699907|525975|P2|Overall Study|Withdrawal by Subject|1
147757|NCT00699907|525976|P1|Overall Study|Withdrawal by Subject|2
147758|NCT00699842|526011|P3|Overall Study|Death|0
147759|NCT00699842|526012|P2|Overall Study|Death|1
147760|NCT00699842|526013|P1|Overall Study|Death|0
147761|NCT00699816|526026|P2|Overall Study|Protocol Violation|3
147762|NCT00699816|526027|P1|Overall Study|Protocol Violation|1
147763|NCT00699751|526045|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
147764|NCT00699751|526046|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
147765|NCT00699751|526045|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
147766|NCT00699751|526046|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
147767|NCT00699751|526045|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
147768|NCT00699751|526046|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
147769|NCT00699751|526045|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
147770|NCT00699751|526046|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
147771|NCT00699751|526045|P2|Period 1: Without/Before Drug Switch|Other|20
147772|NCT00699751|526046|P1|Period 1: Without/Before Drug Switch|Other|30
147773|NCT00699751|526045|P2|Period 1: Without/Before Drug Switch|Subject Request|23
147774|NCT00699751|526046|P1|Period 1: Without/Before Drug Switch|Subject Request|43
147775|NCT00699751|526045|P2|Period 1: Without/Before Drug Switch|Death|29
147776|NCT00699751|526046|P1|Period 1: Without/Before Drug Switch|Death|28
147777|NCT00699751|526045|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
147778|NCT00699751|526046|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
147779|NCT00699699|526131|P1|Overall Study|Individual different reasons|21
147780|NCT00699699|526131|P1|Overall Study|Adverse Event|36
147781|NCT00699660|526140|P2|Overall Study|missing reports and recording failures|6
147782|NCT00699660|526141|P1|Overall Study|missing reports and recording failures|10
147783|NCT00699660|526140|P2|Overall Study|Lost to Follow-up|2
147784|NCT00699660|526141|P1|Overall Study|Lost to Follow-up|4
147785|NCT00699608|526153|P6|Second Intervention|Withdrawal by Subject|0
147786|NCT00699608|526154|P5|Second Intervention|Withdrawal by Subject|0
147787|NCT00699608|526155|P4|Second Intervention|Withdrawal by Subject|1
147788|NCT00699608|526156|P3|Second Intervention|Withdrawal by Subject|0
147789|NCT00699608|526157|P2|Second Intervention|Withdrawal by Subject|0
147790|NCT00699608|526158|P1|Second Intervention|Withdrawal by Subject|0
147791|NCT00699608|526153|P6|Second Intervention|Adverse Event|0
147792|NCT00699608|526154|P5|Second Intervention|Adverse Event|0
147793|NCT00699608|526155|P4|Second Intervention|Adverse Event|0
147794|NCT00699608|526156|P3|Second Intervention|Adverse Event|1
147795|NCT00699608|526157|P2|Second Intervention|Adverse Event|0
147796|NCT00699608|526158|P1|Second Intervention|Adverse Event|0
147797|NCT00699608|526153|P6|First Intervention|Protocol Violation|0
147798|NCT00699608|526154|P5|First Intervention|Protocol Violation|1
147799|NCT00699608|526155|P4|First Intervention|Protocol Violation|0
147800|NCT00699608|526156|P3|First Intervention|Protocol Violation|0
147801|NCT00699608|526157|P2|First Intervention|Protocol Violation|0
147802|NCT00699608|526158|P1|First Intervention|Protocol Violation|0
147803|NCT00699608|526153|P6|First Intervention|Withdrawal by Subject|0
147804|NCT00699608|526154|P5|First Intervention|Withdrawal by Subject|0
147805|NCT00699608|526155|P4|First Intervention|Withdrawal by Subject|0
147806|NCT00699608|526156|P3|First Intervention|Withdrawal by Subject|1
147807|NCT00699608|526157|P2|First Intervention|Withdrawal by Subject|0
147808|NCT00699608|526158|P1|First Intervention|Withdrawal by Subject|0
147809|NCT00699582|526211|P3|Overall Study|Randomized, Not Treated|0
147810|NCT00699582|526212|P2|Overall Study|Randomized, Not Treated|1
147811|NCT00699582|526213|P1|Overall Study|Randomized, Not Treated|2
147812|NCT00699582|526211|P3|Overall Study|Administrative/Other|0
147813|NCT00699582|526212|P2|Overall Study|Administrative/Other|3
147814|NCT00699582|526213|P1|Overall Study|Administrative/Other|4
147815|NCT00699582|526211|P3|Overall Study|Progressive Disease|0
147816|NCT00699582|526212|P2|Overall Study|Progressive Disease|0
147817|NCT00699582|526213|P1|Overall Study|Progressive Disease|1
147818|NCT00699582|526211|P3|Overall Study|Lack of Efficacy|1
147819|NCT00699582|526212|P2|Overall Study|Lack of Efficacy|0
147820|NCT00699582|526213|P1|Overall Study|Lack of Efficacy|1
147821|NCT00699582|526211|P3|Overall Study|Withdrawal by Subject|4
147822|NCT00699582|526212|P2|Overall Study|Withdrawal by Subject|7
147823|NCT00699582|526213|P1|Overall Study|Withdrawal by Subject|6
147824|NCT00699582|526211|P3|Overall Study|Adverse Event|23
147825|NCT00699582|526212|P2|Overall Study|Adverse Event|11
147826|NCT00699582|526213|P1|Overall Study|Adverse Event|4
147827|NCT00699374|526317|P2|Overall Study|Died 28 days after last dose|9
147828|NCT00699374|526318|P1|Overall Study|Died 28 days after last dose|5
147829|NCT00699374|526317|P2|Overall Study|Randomized but not treated|2
147830|NCT00699374|526318|P1|Overall Study|Randomized but not treated|4
147831|NCT00699374|526317|P2|Overall Study|Study terminated by sponsor|28
147832|NCT00699374|526318|P1|Overall Study|Study terminated by sponsor|13
147833|NCT00699374|526317|P2|Overall Study|Protocol Violation|6
147834|NCT00699374|526318|P1|Overall Study|Protocol Violation|2
147835|NCT00699374|526317|P2|Overall Study|Other|15
147836|NCT00699374|526318|P1|Overall Study|Other|18
147837|NCT00699374|526317|P2|Overall Study|Objective progression or relapse|277
147838|NCT00699374|526318|P1|Overall Study|Objective progression or relapse|281
147839|NCT00699374|526317|P2|Overall Study|Withdrawal by Subject|44
147840|NCT00699374|526318|P1|Overall Study|Withdrawal by Subject|34
147841|NCT00699374|526317|P2|Overall Study|Lost to Follow-up|5
147842|NCT00699374|526318|P1|Overall Study|Lost to Follow-up|3
147843|NCT00699374|526317|P2|Overall Study|Global deterioration of health status|8
147844|NCT00699374|526318|P1|Overall Study|Global deterioration of health status|7
147845|NCT00699374|526317|P2|Overall Study|Adverse Event|67
147846|NCT00699374|526318|P1|Overall Study|Adverse Event|70
147847|NCT00699374|526317|P2|Overall Study|Death|83
147848|NCT00699374|526318|P1|Overall Study|Death|93
147849|NCT00699348|526330|P1|Overall Study|Other|5
147850|NCT00699348|526330|P1|Overall Study|Renal transplantation|10
147851|NCT00699348|526330|P1|Overall Study|Blood transfusion|24
147852|NCT00699348|526330|P1|Overall Study|Failure to return|1
147853|NCT00699348|526330|P1|Overall Study|Lack of Efficacy|8
147854|NCT00699348|526330|P1|Overall Study|Protocol Violation|10
147855|NCT00699348|526330|P1|Overall Study|Withdrawal by Subject|11
147856|NCT00699348|526330|P1|Overall Study|Adverse Event|15
147857|NCT00699348|526330|P1|Overall Study|Death|6
147858|NCT00699335|526339|P1|Overall Study|Missing data|52
147859|NCT00699335|526339|P1|Overall Study|Combination of multiple reasons|176
147860|NCT00699283|526372|P2|Overall Study|AE of unknown type|0
147861|NCT00699283|526373|P1|Overall Study|AE of unknown type|1
147862|NCT00699283|526372|P2|Overall Study|AE, non-serious non-fatal|1
147863|NCT00699283|526373|P1|Overall Study|AE, non-serious non-fatal|8
147864|NCT00699283|526372|P2|Overall Study|SAE, non-fatal|1
147865|NCT00699283|526373|P1|Overall Study|SAE, non-fatal|1
147866|NCT00699283|526372|P2|Overall Study|Other Reason|1
147867|NCT00699283|526373|P1|Overall Study|Other Reason|5
147868|NCT00699283|526372|P2|Overall Study|Withdrawal by Subject|0
147869|NCT00699283|526373|P1|Overall Study|Withdrawal by Subject|1
147870|NCT00699283|526372|P2|Overall Study|Lost to Follow-up|0
147871|NCT00699283|526373|P1|Overall Study|Lost to Follow-up|2
147872|NCT00699283|526372|P2|Overall Study|Lack of Efficacy|5
147873|NCT00699283|526373|P1|Overall Study|Lack of Efficacy|15
147874|NCT00699192|526381|P3|Overall Study|Protocol Violation|0
147875|NCT00699192|526382|P2|Overall Study|Protocol Violation|2
147876|NCT00699192|526383|P1|Overall Study|Protocol Violation|2
147877|NCT00699192|526381|P3|Overall Study|Administrative problems|1
147878|NCT00699192|526382|P2|Overall Study|Administrative problems|3
147879|NCT00699192|526383|P1|Overall Study|Administrative problems|1
147880|NCT00699192|526381|P3|Overall Study|Withdrawal by Subject|4
147881|NCT00699192|526382|P2|Overall Study|Withdrawal by Subject|2
147882|NCT00699192|526383|P1|Overall Study|Withdrawal by Subject|3
147883|NCT00699192|526381|P3|Overall Study|Lack of Efficacy|1
147884|NCT00699192|526382|P2|Overall Study|Lack of Efficacy|0
147885|NCT00699192|526383|P1|Overall Study|Lack of Efficacy|0
147886|NCT00699192|526381|P3|Overall Study|Abnormal test procedure result(s)|1
147887|NCT00699192|526382|P2|Overall Study|Abnormal test procedure result(s)|0
147888|NCT00699192|526383|P1|Overall Study|Abnormal test procedure result(s)|0
147889|NCT00699192|526381|P3|Overall Study|Adverse Event|3
147890|NCT00699192|526382|P2|Overall Study|Adverse Event|4
147891|NCT00699192|526383|P1|Overall Study|Adverse Event|9
147892|NCT00699192|526381|P3|Overall Study|Missing|1
147893|NCT00699192|526382|P2|Overall Study|Missing|1
147894|NCT00699192|526383|P1|Overall Study|Missing|1
147895|NCT00699153|526405|P2|Overall Study|Travel Problem|0
147896|NCT00699153|526406|P1|Overall Study|Travel Problem|1
147897|NCT00699153|526405|P2|Overall Study|Protocol Violation|0
147898|NCT00699153|526406|P1|Overall Study|Protocol Violation|1
147899|NCT00699153|526405|P2|Overall Study|Adverse Event|2
147900|NCT00699153|526406|P1|Overall Study|Adverse Event|0
147901|NCT00699153|526405|P2|Overall Study|Lost to Follow-up|0
147902|NCT00699153|526406|P1|Overall Study|Lost to Follow-up|1
147903|NCT00698932|526432|P2|Overall Study|Death|0
147904|NCT00698932|526433|P1|Overall Study|Death|1
147905|NCT00698932|526432|P2|Overall Study|Safety reasons|2
147906|NCT00698932|526433|P1|Overall Study|Safety reasons|0
147907|NCT00698932|526432|P2|Overall Study|Severe non-compliance to protocol|2
147908|NCT00698932|526433|P1|Overall Study|Severe non-compliance to protocol|1
147909|NCT00698932|526432|P2|Overall Study|Lost to Follow-up|1
147910|NCT00698932|526433|P1|Overall Study|Lost to Follow-up|6
147911|NCT00698932|526432|P2|Overall Study|Withdrawal by Subject|23
147912|NCT00698932|526433|P1|Overall Study|Withdrawal by Subject|11
147913|NCT00698932|526432|P2|Overall Study|Study specific discontinuation criteria|4
147914|NCT00698932|526433|P1|Overall Study|Study specific discontinuation criteria|3
147915|NCT00698932|526432|P2|Overall Study|Incorrect enrollment|2
147916|NCT00698932|526433|P1|Overall Study|Incorrect enrollment|0
147917|NCT00698932|526432|P2|Overall Study|Adverse Event|2
147918|NCT00698932|526433|P1|Overall Study|Adverse Event|0
147919|NCT00698841|526459|P1|Overall Study|Other|2
147920|NCT00698841|526459|P1|Overall Study|Study drug toxicity|2
147921|NCT00698841|526459|P1|Overall Study|Failure to meet eligibility criteria|2
147922|NCT00698841|526459|P1|Overall Study|Disease progression|7
147923|NCT00698841|526459|P1|Overall Study|Adverse Event|3
147924|NCT00698841|526459|P1|Overall Study|Withdrawal by Subject|2
147925|NCT00698815|526473|P3|Overall Study|Did not receive protocol treatment|2
147926|NCT00698815|526474|P2|Overall Study|Did not receive protocol treatment|2
147927|NCT00698815|526475|P1|Overall Study|Did not receive protocol treatment|1
147928|NCT00698815|526473|P3|Overall Study|MD discretion|2
147929|NCT00698815|526474|P2|Overall Study|MD discretion|7
147930|NCT00698815|526475|P1|Overall Study|MD discretion|2
147931|NCT00698815|526473|P3|Overall Study|Withdrawal by Subject|2
147932|NCT00698815|526474|P2|Overall Study|Withdrawal by Subject|3
147933|NCT00698815|526475|P1|Overall Study|Withdrawal by Subject|6
147934|NCT00698815|526473|P3|Overall Study|Death|4
147935|NCT00698815|526474|P2|Overall Study|Death|2
147936|NCT00698815|526475|P1|Overall Study|Death|1
147937|NCT00698685|526492|P1|Overall Study|Off study pre transplant by clinic MD|1
147938|NCT00698685|526492|P1|Overall Study|Sister withdrew as donor|1
147939|NCT00698646|526500|P3|Overall Study|Administrative problems|1
147940|NCT00698646|526501|P2|Overall Study|Administrative problems|0
147941|NCT00698646|526502|P1|Overall Study|Administrative problems|1
147942|NCT00698646|526500|P3|Overall Study|Lost to Follow-up|2
147943|NCT00698646|526501|P2|Overall Study|Lost to Follow-up|0
147944|NCT00698646|526502|P1|Overall Study|Lost to Follow-up|0
147945|NCT00698646|526500|P3|Overall Study|Withdrawal by Subject|8
147946|NCT00698646|526501|P2|Overall Study|Withdrawal by Subject|11
147947|NCT00698646|526502|P1|Overall Study|Withdrawal by Subject|10
147948|NCT00698646|526500|P3|Overall Study|Protocol Deviation|3
147949|NCT00698646|526501|P2|Overall Study|Protocol Deviation|2
147950|NCT00698646|526502|P1|Overall Study|Protocol Deviation|6
147951|NCT00698646|526500|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
147952|NCT00698646|526501|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
147953|NCT00698646|526502|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
147954|NCT00698646|526500|P3|Overall Study|Adverse Event|8
147955|NCT00698646|526501|P2|Overall Study|Adverse Event|7
147956|NCT00698646|526502|P1|Overall Study|Adverse Event|8
147957|NCT00698581|526527|P2|Overall Study|AE of unknown type|0
147958|NCT00698581|526528|P1|Overall Study|AE of unknown type|1
147959|NCT00698581|526527|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
147960|NCT00698581|526528|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
147961|NCT00698581|526527|P2|Overall Study|AE, non-serious non-fatal|0
147962|NCT00698581|526528|P1|Overall Study|AE, non-serious non-fatal|4
147963|NCT00698581|526527|P2|Overall Study|SAE, non-fatal|0
147964|NCT00698581|526528|P1|Overall Study|SAE, non-fatal|1
147965|NCT00698581|526527|P2|Overall Study|Other reason|1
147966|NCT00698581|526528|P1|Overall Study|Other reason|9
147967|NCT00698581|526527|P2|Overall Study|Withdrawal by Subject|0
147968|NCT00698581|526528|P1|Overall Study|Withdrawal by Subject|6
147969|NCT00698581|526527|P2|Overall Study|Lack of Efficacy|11
147970|NCT00698581|526528|P1|Overall Study|Lack of Efficacy|23
147971|NCT00698516|526539|P1|Overall Study|Withdrawal by Subject|3
147972|NCT00698516|526539|P1|Overall Study|Study Termination|2
147973|NCT00698451|526557|P1|Overall Study|Disease progression|3
147974|NCT00698451|526557|P1|Overall Study|Withdrawal by Subject|6
147975|NCT00698451|526557|P1|Overall Study|Protocol Violation|6
147976|NCT00698451|526557|P1|Overall Study|Physician Decision|2
147977|NCT00698451|526557|P1|Overall Study|Adverse Event|22
147978|NCT00698204|526564|P2|Overall Study|Withdrawal by Subject|0
147979|NCT00698204|526565|P1|Overall Study|Withdrawal by Subject|1
147980|NCT00698009|526625|P1|Overall Study|Withdrawal by Subject|1
147981|NCT00697827|526631|P2|Overall Study|enrolled but not treated|1
147982|NCT00697827|526632|P1|Overall Study|enrolled but not treated|2
147983|NCT00697788|526659|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
147984|NCT00697788|526660|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
147985|NCT00697788|526661|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
147986|NCT00697788|526662|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
147987|NCT00697788|526663|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
147988|NCT00697788|526664|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
147989|NCT00697788|526665|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
147990|NCT00697788|526666|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
147991|NCT00697788|526659|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
147992|NCT00697788|526660|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
147993|NCT00697788|526661|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
147994|NCT00697788|526662|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
147995|NCT00697788|526663|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
148078|NCT00696787|527012|P2|Overall Study|Lost to Follow-up|0
147996|NCT00697788|526664|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
147997|NCT00697788|526665|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
147998|NCT00697788|526666|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
147999|NCT00697619|526721|P2|Overall Study|Adverse Event|6
148000|NCT00697619|526722|P1|Overall Study|Adverse Event|4
148001|NCT00697619|526721|P2|Overall Study|Lack of Efficacy|2
148002|NCT00697619|526722|P1|Overall Study|Lack of Efficacy|2
148003|NCT00697593|526728|P1|Overall Study|Suspension of the study by sponsor|12
148004|NCT00697593|526728|P1|Overall Study|Lack of Efficacy|3
148005|NCT00697593|526728|P1|Overall Study|Protocol Violation|1
148006|NCT00697593|526728|P1|Overall Study|Adverse Event|3
148007|NCT00697515|526772|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
148008|NCT00697515|526773|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
148009|NCT00697515|526772|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
148010|NCT00697515|526773|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
148011|NCT00697515|526772|P2|First Intervention (Crossover Period)|Adverse Event|2
148012|NCT00697515|526773|P1|First Intervention (Crossover Period)|Adverse Event|0
148013|NCT00697515|526772|P2|First Intervention (Crossover Period)|Natural disaster|9
148014|NCT00697515|526773|P1|First Intervention (Crossover Period)|Natural disaster|8
148015|NCT00697515|526772|P2|Dose Optimization Period|elevated QTc|0
148016|NCT00697515|526773|P1|Dose Optimization Period|elevated QTc|1
148017|NCT00697515|526772|P2|Dose Optimization Period|called to active duty|0
148018|NCT00697515|526773|P1|Dose Optimization Period|called to active duty|1
148019|NCT00697515|526772|P2|Dose Optimization Period|sponsor request|0
148020|NCT00697515|526773|P1|Dose Optimization Period|sponsor request|2
148021|NCT00697515|526772|P2|Dose Optimization Period|Lost to Follow-up|0
148022|NCT00697515|526773|P1|Dose Optimization Period|Lost to Follow-up|2
148023|NCT00697515|526772|P2|Dose Optimization Period|Withdrawal by Subject|0
148024|NCT00697515|526773|P1|Dose Optimization Period|Withdrawal by Subject|5
148025|NCT00697515|526772|P2|Dose Optimization Period|Adverse Event|0
148026|NCT00697515|526773|P1|Dose Optimization Period|Adverse Event|4
148027|NCT00697255|526803|P2|Stage 1b|Insufficient ovarian response|1
148028|NCT00697255|526804|P1|Stage 1b|Insufficient ovarian response|0
148029|NCT00697255|526803|P2|Stage 1b|Not growing of dominant follicle|1
148030|NCT00697255|526804|P1|Stage 1b|Not growing of dominant follicle|0
148031|NCT00697255|526803|P2|Stage 1a|Not growing of dominant follicle|0
148032|NCT00697255|526804|P1|Stage 1a|Not growing of dominant follicle|1
148033|NCT00697255|526803|P2|Stage 1a|Multifollicular growth|0
148034|NCT00697255|526804|P1|Stage 1a|Multifollicular growth|1
148035|NCT00697255|526803|P2|Stage 1a|Insufficient ovarian response|0
148036|NCT00697255|526804|P1|Stage 1a|Insufficient ovarian response|1
148037|NCT00697112|526855|P1|Overall Study|Did not meet inclusion criteria|1
148038|NCT00697112|526855|P1|Overall Study|Lost to Follow-up|1
148039|NCT00697112|526855|P1|Overall Study|Adverse Event|8
148040|NCT00697073|526879|P1|Overall Study|non compliance and other|6
148041|NCT00697073|526879|P1|Overall Study|Pregnancy|1
148042|NCT00697073|526879|P1|Overall Study|Withdrawal by Subject|2
148043|NCT00696878|526883|P1|Overall Study|Other reason (not specified)|55
148044|NCT00696878|526883|P1|Overall Study|Trial stopped|32
148045|NCT00696878|526883|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
148046|NCT00696878|526883|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
148047|NCT00696878|526883|P1|Overall Study|Withdrawal by Subject|87
148048|NCT00696878|526883|P1|Overall Study|Adverse Event|8
148049|NCT00696800|526957|P2|Overall Study|Not treated|2
148050|NCT00696800|526958|P1|Overall Study|Not treated|1
148051|NCT00696800|526957|P2|Overall Study|Other Reasons|3
148052|NCT00696800|526958|P1|Overall Study|Other Reasons|5
148053|NCT00696800|526957|P2|Overall Study|No/too few/bad quality embryos|18
148054|NCT00696800|526958|P1|Overall Study|No/too few/bad quality embryos|24
148055|NCT00696800|526957|P2|Overall Study|No/abnormal fertilization|13
148056|NCT00696800|526958|P1|Overall Study|No/abnormal fertilization|11
148057|NCT00696800|526957|P2|Overall Study|No/too few/bad quality oocytes|3
148058|NCT00696800|526958|P1|Overall Study|No/too few/bad quality oocytes|4
148059|NCT00696800|526957|P2|Overall Study|Too high ovarian response|1
148060|NCT00696800|526958|P1|Overall Study|Too high ovarian response|6
148061|NCT00696800|526957|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
148062|NCT00696800|526958|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
148063|NCT00696800|526957|P2|Overall Study|Insufficient ovarian response|1
148064|NCT00696800|526958|P1|Overall Study|Insufficient ovarian response|4
148065|NCT00696800|526957|P2|Overall Study|Insufficient ovarian response on Day 8|1
148066|NCT00696800|526958|P1|Overall Study|Insufficient ovarian response on Day 8|4
148067|NCT00696800|526957|P2|Overall Study|Insufficient compliance with medication|1
148068|NCT00696800|526958|P1|Overall Study|Insufficient compliance with medication|2
148069|NCT00696800|526957|P2|Overall Study|Adverse Event|3
148070|NCT00696800|526958|P1|Overall Study|Adverse Event|16
148071|NCT00696787|527011|P3|Overall Study|Failed to return|1
148072|NCT00696787|527012|P2|Overall Study|Failed to return|3
148073|NCT00696787|527013|P1|Overall Study|Failed to return|1
148074|NCT00696787|527011|P3|Overall Study|Withdrawal by Subject|2
148075|NCT00696787|527012|P2|Overall Study|Withdrawal by Subject|3
148076|NCT00696787|527013|P1|Overall Study|Withdrawal by Subject|0
148077|NCT00696787|527011|P3|Overall Study|Lost to Follow-up|3
148079|NCT00696787|527013|P1|Overall Study|Lost to Follow-up|4
148080|NCT00696787|527011|P3|Overall Study|Lack of Efficacy|0
148081|NCT00696787|527012|P2|Overall Study|Lack of Efficacy|1
148082|NCT00696787|527013|P1|Overall Study|Lack of Efficacy|0
148083|NCT00696787|527011|P3|Overall Study|Discontinuation by Sponsor|14
148084|NCT00696787|527012|P2|Overall Study|Discontinuation by Sponsor|13
148085|NCT00696787|527013|P1|Overall Study|Discontinuation by Sponsor|9
148086|NCT00696787|527011|P3|Overall Study|Adverse Event|6
148087|NCT00696787|527012|P2|Overall Study|Adverse Event|0
148088|NCT00696787|527013|P1|Overall Study|Adverse Event|1
148089|NCT00696774|527027|P3|Period III|Lack of Efficacy|0
148090|NCT00696774|527028|P2|Period III|Lack of Efficacy|2
148091|NCT00696774|527029|P1|Period III|Lack of Efficacy|0
148092|NCT00696774|527027|P3|Period III|Sponsor Decision|0
148093|NCT00696774|527028|P2|Period III|Sponsor Decision|0
148094|NCT00696774|527029|P1|Period III|Sponsor Decision|2
148095|NCT00696774|527027|P3|Period III|Withdrawal by Subject|0
148096|NCT00696774|527028|P2|Period III|Withdrawal by Subject|2
148097|NCT00696774|527029|P1|Period III|Withdrawal by Subject|1
148098|NCT00696774|527027|P3|Period III|Protocol Violation|0
148099|NCT00696774|527028|P2|Period III|Protocol Violation|1
148100|NCT00696774|527029|P1|Period III|Protocol Violation|1
148101|NCT00696774|527027|P3|Period III|Lost to Follow-up|0
148102|NCT00696774|527028|P2|Period III|Lost to Follow-up|1
148103|NCT00696774|527029|P1|Period III|Lost to Follow-up|2
148104|NCT00696774|527027|P3|Period III|Adverse Event|0
148105|NCT00696774|527028|P2|Period III|Adverse Event|1
148106|NCT00696774|527029|P1|Period III|Adverse Event|1
148107|NCT00696774|527027|P3|Period II|Lack of Efficacy|2
148108|NCT00696774|527028|P2|Period II|Lack of Efficacy|0
148109|NCT00696774|527029|P1|Period II|Lack of Efficacy|0
148110|NCT00696774|527027|P3|Period II|Sponsor Decision|0
148111|NCT00696774|527028|P2|Period II|Sponsor Decision|0
148112|NCT00696774|527029|P1|Period II|Sponsor Decision|0
148113|NCT00696774|527027|P3|Period II|Withdrawal by Subject|4
148114|NCT00696774|527028|P2|Period II|Withdrawal by Subject|0
148115|NCT00696774|527029|P1|Period II|Withdrawal by Subject|0
148116|NCT00696774|527027|P3|Period II|Protocol Violation|11
148117|NCT00696774|527028|P2|Period II|Protocol Violation|0
148118|NCT00696774|527029|P1|Period II|Protocol Violation|0
148119|NCT00696774|527027|P3|Period II|Lost to Follow-up|4
148120|NCT00696774|527028|P2|Period II|Lost to Follow-up|0
148121|NCT00696774|527029|P1|Period II|Lost to Follow-up|0
148122|NCT00696774|527027|P3|Period II|Adverse Event|15
148123|NCT00696774|527028|P2|Period II|Adverse Event|0
148124|NCT00696774|527029|P1|Period II|Adverse Event|0
148125|NCT00696696|527084|P1|Overall Study|Death|3
148126|NCT00696696|527084|P1|Overall Study|Physician Decision|2
148127|NCT00696696|527084|P1|Overall Study|Withdrawal by Subject|8
148128|NCT00696696|527084|P1|Overall Study|Adverse Event|5
148129|NCT00696436|527135|P5|Overall Study|Missing|0
148130|NCT00696436|527136|P4|Overall Study|Missing|0
148131|NCT00696436|527137|P3|Overall Study|Missing|1
148132|NCT00696436|527138|P2|Overall Study|Missing|1
148133|NCT00696436|527139|P1|Overall Study|Missing|0
148134|NCT00696436|527135|P5|Overall Study|Administrative Decision|0
148135|NCT00696436|527136|P4|Overall Study|Administrative Decision|0
148136|NCT00696436|527137|P3|Overall Study|Administrative Decision|0
148137|NCT00696436|527138|P2|Overall Study|Administrative Decision|0
148138|NCT00696436|527139|P1|Overall Study|Administrative Decision|1
148139|NCT00696436|527135|P5|Overall Study|Participant Non-compliance|0
148140|NCT00696436|527136|P4|Overall Study|Participant Non-compliance|2
148141|NCT00696436|527137|P3|Overall Study|Participant Non-compliance|1
148142|NCT00696436|527138|P2|Overall Study|Participant Non-compliance|0
148143|NCT00696436|527139|P1|Overall Study|Participant Non-compliance|0
148144|NCT00696436|527135|P5|Overall Study|Administrative Error|0
148145|NCT00696436|527136|P4|Overall Study|Administrative Error|0
148146|NCT00696436|527137|P3|Overall Study|Administrative Error|2
148147|NCT00696436|527138|P2|Overall Study|Administrative Error|0
148148|NCT00696436|527139|P1|Overall Study|Administrative Error|2
148149|NCT00696436|527135|P5|Overall Study|Participant Unavailability|0
148150|NCT00696436|527136|P4|Overall Study|Participant Unavailability|1
148151|NCT00696436|527137|P3|Overall Study|Participant Unavailability|2
148152|NCT00696436|527138|P2|Overall Study|Participant Unavailability|0
148153|NCT00696436|527139|P1|Overall Study|Participant Unavailability|2
148154|NCT00696436|527135|P5|Overall Study|Lack of Efficacy|4
148155|NCT00696436|527136|P4|Overall Study|Lack of Efficacy|2
148156|NCT00696436|527137|P3|Overall Study|Lack of Efficacy|5
148157|NCT00696436|527138|P2|Overall Study|Lack of Efficacy|1
148158|NCT00696436|527139|P1|Overall Study|Lack of Efficacy|3
148159|NCT00696436|527135|P5|Overall Study|Withdrawal by Subject|1
148160|NCT00696436|527136|P4|Overall Study|Withdrawal by Subject|7
148161|NCT00696436|527137|P3|Overall Study|Withdrawal by Subject|5
148162|NCT00696436|527138|P2|Overall Study|Withdrawal by Subject|11
148163|NCT00696436|527139|P1|Overall Study|Withdrawal by Subject|4
148164|NCT00696436|527135|P5|Overall Study|Lost to Follow-up|3
148165|NCT00696436|527136|P4|Overall Study|Lost to Follow-up|4
148166|NCT00696436|527137|P3|Overall Study|Lost to Follow-up|2
148167|NCT00696436|527138|P2|Overall Study|Lost to Follow-up|6
148168|NCT00696436|527139|P1|Overall Study|Lost to Follow-up|1
148169|NCT00696436|527135|P5|Overall Study|Protocol Violation|1
148170|NCT00696436|527136|P4|Overall Study|Protocol Violation|0
148171|NCT00696436|527137|P3|Overall Study|Protocol Violation|2
148172|NCT00696436|527138|P2|Overall Study|Protocol Violation|2
148173|NCT00696436|527139|P1|Overall Study|Protocol Violation|3
148174|NCT00696436|527135|P5|Overall Study|Adverse Event|4
148175|NCT00696436|527136|P4|Overall Study|Adverse Event|6
148176|NCT00696436|527137|P3|Overall Study|Adverse Event|8
148177|NCT00696436|527138|P2|Overall Study|Adverse Event|9
148178|NCT00696436|527139|P1|Overall Study|Adverse Event|7
148179|NCT00696423|527223|P2|Overall Study|Lost to Follow-up|5
148180|NCT00696423|527224|P1|Overall Study|Lost to Follow-up|0
148181|NCT00696410|527256|P2|Overall Study|Physician Decision|0
148182|NCT00696410|527257|P1|Overall Study|Physician Decision|3
148183|NCT00696410|527256|P2|Overall Study|Withdrawal by Subject|0
148184|NCT00696410|527257|P1|Overall Study|Withdrawal by Subject|8
148185|NCT00696410|527256|P2|Overall Study|Lost to Follow-up|0
148186|NCT00696410|527257|P1|Overall Study|Lost to Follow-up|2
148187|NCT00696384|527271|P3|Double Blind Phase|Physician Decision|0
148188|NCT00696384|527272|P2|Double Blind Phase|Physician Decision|2
148189|NCT00696384|527273|P1|Double Blind Phase|Physician Decision|0
148190|NCT00696384|527271|P3|Double Blind Phase|Lack of Efficacy|0
148191|NCT00696384|527272|P2|Double Blind Phase|Lack of Efficacy|1
148192|NCT00696384|527273|P1|Double Blind Phase|Lack of Efficacy|0
148193|NCT00696384|527271|P3|Double Blind Phase|Withdrawal by Subject|3
148194|NCT00696384|527272|P2|Double Blind Phase|Withdrawal by Subject|4
148195|NCT00696384|527273|P1|Double Blind Phase|Withdrawal by Subject|0
148196|NCT00696384|527271|P3|Double Blind Phase|Lost to Follow-up|1
148197|NCT00696384|527272|P2|Double Blind Phase|Lost to Follow-up|2
148198|NCT00696384|527273|P1|Double Blind Phase|Lost to Follow-up|0
148199|NCT00696384|527271|P3|Double Blind Phase|Adverse Event|2
148200|NCT00696384|527272|P2|Double Blind Phase|Adverse Event|2
148201|NCT00696384|527273|P1|Double Blind Phase|Adverse Event|0
148202|NCT00696384|527271|P3|Open Label Phase|Physician Decision|0
148203|NCT00696384|527272|P2|Open Label Phase|Physician Decision|0
148204|NCT00696384|527273|P1|Open Label Phase|Physician Decision|4
148205|NCT00696384|527271|P3|Open Label Phase|Lack of Efficacy|0
148206|NCT00696384|527272|P2|Open Label Phase|Lack of Efficacy|0
148207|NCT00696384|527273|P1|Open Label Phase|Lack of Efficacy|3
148208|NCT00696384|527271|P3|Open Label Phase|Other|0
148209|NCT00696384|527272|P2|Open Label Phase|Other|0
148210|NCT00696384|527273|P1|Open Label Phase|Other|6
148211|NCT00696384|527271|P3|Open Label Phase|Withdrawal by Subject|0
148212|NCT00696384|527272|P2|Open Label Phase|Withdrawal by Subject|0
148213|NCT00696384|527273|P1|Open Label Phase|Withdrawal by Subject|37
148214|NCT00696384|527271|P3|Open Label Phase|Lost to Follow-up|0
148215|NCT00696384|527272|P2|Open Label Phase|Lost to Follow-up|0
148216|NCT00696384|527273|P1|Open Label Phase|Lost to Follow-up|24
148217|NCT00696384|527271|P3|Open Label Phase|Protocol Violation|0
148218|NCT00696384|527272|P2|Open Label Phase|Protocol Violation|0
148219|NCT00696384|527273|P1|Open Label Phase|Protocol Violation|18
148220|NCT00696384|527271|P3|Open Label Phase|Adverse Event|0
148221|NCT00696384|527272|P2|Open Label Phase|Adverse Event|0
148222|NCT00696384|527273|P1|Open Label Phase|Adverse Event|27
148223|NCT00696241|527297|P5|Overall Study|Other|1
148224|NCT00696241|527298|P4|Overall Study|Other|2
148225|NCT00696241|527299|P3|Overall Study|Other|5
148226|NCT00696241|527300|P2|Overall Study|Other|1
148227|NCT00696241|527301|P1|Overall Study|Other|6
148228|NCT00696241|527297|P5|Overall Study|Lack of Efficacy|3
148229|NCT00696241|527298|P4|Overall Study|Lack of Efficacy|5
148230|NCT00696241|527299|P3|Overall Study|Lack of Efficacy|4
148231|NCT00696241|527300|P2|Overall Study|Lack of Efficacy|5
148232|NCT00696241|527301|P1|Overall Study|Lack of Efficacy|1
148233|NCT00696241|527297|P5|Overall Study|Withdrawal by Subject|0
148234|NCT00696241|527298|P4|Overall Study|Withdrawal by Subject|1
148235|NCT00696241|527299|P3|Overall Study|Withdrawal by Subject|6
148236|NCT00696241|527300|P2|Overall Study|Withdrawal by Subject|8
148237|NCT00696241|527301|P1|Overall Study|Withdrawal by Subject|4
148238|NCT00696241|527297|P5|Overall Study|Lost to Follow-up|0
148239|NCT00696241|527298|P4|Overall Study|Lost to Follow-up|2
148240|NCT00696241|527299|P3|Overall Study|Lost to Follow-up|1
148241|NCT00696241|527300|P2|Overall Study|Lost to Follow-up|4
148242|NCT00696241|527301|P1|Overall Study|Lost to Follow-up|1
148243|NCT00696241|527297|P5|Overall Study|Protocol Violation|3
148244|NCT00696241|527298|P4|Overall Study|Protocol Violation|0
148245|NCT00696241|527299|P3|Overall Study|Protocol Violation|2
148246|NCT00696241|527300|P2|Overall Study|Protocol Violation|1
148247|NCT00696241|527301|P1|Overall Study|Protocol Violation|1
148248|NCT00696241|527297|P5|Overall Study|Adverse Event|5
148249|NCT00696241|527298|P4|Overall Study|Adverse Event|4
148250|NCT00696241|527299|P3|Overall Study|Adverse Event|6
148251|NCT00696241|527300|P2|Overall Study|Adverse Event|3
148252|NCT00696241|527301|P1|Overall Study|Adverse Event|11
148253|NCT00696072|527385|P2|Overall Study|Non-specified|2
148254|NCT00696072|527386|P1|Overall Study|Non-specified|1
148255|NCT00696072|527385|P2|Overall Study|Disease Progression|30
148256|NCT00696072|527386|P1|Overall Study|Disease Progression|32
148257|NCT00696072|527385|P2|Overall Study|Sponsor Request|1
148258|NCT00696072|527386|P1|Overall Study|Sponsor Request|0
148259|NCT00696072|527385|P2|Overall Study|Investigator Request|4
148260|NCT00696072|527386|P1|Overall Study|Investigator Request|1
148261|NCT00696072|527385|P2|Overall Study|Patient Request|7
148262|NCT00696072|527386|P1|Overall Study|Patient Request|3
148263|NCT00696072|527385|P2|Overall Study|Adverse Event|6
148264|NCT00696072|527386|P1|Overall Study|Adverse Event|10
148265|NCT00696072|527385|P2|Overall Study|continuing active treatment|13
148266|NCT00696072|527386|P1|Overall Study|continuing active treatment|10
148267|NCT00696020|527407|P4|Overall Study|Other not stated above|1
148268|NCT00696020|527408|P3|Overall Study|Other not stated above|1
148269|NCT00696020|527409|P2|Overall Study|Other not stated above|0
148270|NCT00696020|527410|P1|Overall Study|Other not stated above|0
148271|NCT00696020|527407|P4|Overall Study|Withdrawal by Subject|1
148272|NCT00696020|527408|P3|Overall Study|Withdrawal by Subject|0
148273|NCT00696020|527409|P2|Overall Study|Withdrawal by Subject|1
148274|NCT00696020|527410|P1|Overall Study|Withdrawal by Subject|0
148275|NCT00696020|527407|P4|Overall Study|Protocol Violation|1
148276|NCT00696020|527408|P3|Overall Study|Protocol Violation|0
148277|NCT00696020|527409|P2|Overall Study|Protocol Violation|0
148278|NCT00696020|527410|P1|Overall Study|Protocol Violation|0
148279|NCT00696020|527407|P4|Overall Study|Lack of Efficacy|0
148280|NCT00696020|527408|P3|Overall Study|Lack of Efficacy|0
148281|NCT00696020|527409|P2|Overall Study|Lack of Efficacy|0
148282|NCT00696020|527410|P1|Overall Study|Lack of Efficacy|1
148283|NCT00696020|527407|P4|Overall Study|Adverse Event|1
148284|NCT00696020|527408|P3|Overall Study|Adverse Event|2
148285|NCT00696020|527409|P2|Overall Study|Adverse Event|1
148286|NCT00696020|527410|P1|Overall Study|Adverse Event|3
148287|NCT00695955|527518|P1|Cohort 2|Other|5
148288|NCT00695955|527518|P1|Cohort 2|Lack of Efficacy|4
148289|NCT00695955|527518|P1|Cohort 2|Withdrawal by Subject|28
148290|NCT00695955|527518|P1|Cohort 2|Lost to Follow-up|38
148291|NCT00695955|527518|P1|Cohort 2|Protocol Violation|5
148292|NCT00695955|527518|P1|Cohort 2|Adverse Event|24
148293|NCT00695955|527518|P1|Cohort 1|Other|16
148294|NCT00695955|527518|P1|Cohort 1|Lack of Efficacy|3
148295|NCT00695955|527518|P1|Cohort 1|Withdrawal by Subject|25
148296|NCT00695955|527518|P1|Cohort 1|Lost to Follow-up|30
148297|NCT00695955|527518|P1|Cohort 1|Protocol Violation|2
148298|NCT00695955|527518|P1|Cohort 1|Adverse Event|26
148299|NCT00695903|527530|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
148300|NCT00695903|527531|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
148301|NCT00695903|527530|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
148302|NCT00695903|527531|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
148303|NCT00695903|527530|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
148304|NCT00695903|527531|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
148305|NCT00695903|527530|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
148306|NCT00695903|527531|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
148307|NCT00695903|527530|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
148308|NCT00695903|527531|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
148309|NCT00695903|527530|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
148310|NCT00695903|527531|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
148311|NCT00695903|527530|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
148312|NCT00695903|527531|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
148313|NCT00695903|527530|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
148314|NCT00695903|527531|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
148315|NCT00695903|527530|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
148316|NCT00695903|527531|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
148317|NCT00695864|527543|P1|Placebo|Physician Decision|4
148318|NCT00695864|527543|P1|Placebo|Withdrawal by Subject|1
148319|NCT00695669|527553|P4|Overall Study|Lost to Follow-up|4
148320|NCT00695669|527554|P3|Overall Study|Lost to Follow-up|1
148321|NCT00695669|527555|P2|Overall Study|Lost to Follow-up|4
148322|NCT00695669|527556|P1|Overall Study|Lost to Follow-up|4
148323|NCT00695669|527553|P4|Overall Study|Adverse Event|0
148324|NCT00695669|527554|P3|Overall Study|Adverse Event|2
148325|NCT00695669|527555|P2|Overall Study|Adverse Event|0
148326|NCT00695669|527556|P1|Overall Study|Adverse Event|0
148327|NCT00695565|527632|P2|Overall Study|Subject did not follow instructions|1
148328|NCT00695565|527633|P1|Overall Study|Subject did not follow instructions|1
148329|NCT00695565|527632|P2|Overall Study|Lack of Efficacy|1
148330|NCT00695565|527633|P1|Overall Study|Lack of Efficacy|1
148331|NCT00695565|527632|P2|Overall Study|Withdrawal by Subject|1
148332|NCT00695565|527633|P1|Overall Study|Withdrawal by Subject|1
148333|NCT00695565|527632|P2|Overall Study|Protocol Violation|1
148334|NCT00695565|527633|P1|Overall Study|Protocol Violation|3
148335|NCT00695565|527632|P2|Overall Study|Adverse Event|1
148336|NCT00695565|527633|P1|Overall Study|Adverse Event|3
148337|NCT00695565|527632|P2|Overall Study|Lost to Follow-up|4
148338|NCT00695565|527633|P1|Overall Study|Lost to Follow-up|4
148339|NCT00695396|527694|P3|Overall Study|Withdrawal by Subject|0
148340|NCT00695396|527695|P2|Overall Study|Withdrawal by Subject|2
148341|NCT00695396|527696|P1|Overall Study|Withdrawal by Subject|2
148342|NCT00695396|527694|P3|Overall Study|Study Closed Prematurely|8
148343|NCT00695396|527695|P2|Overall Study|Study Closed Prematurely|6
148344|NCT00695396|527696|P1|Overall Study|Study Closed Prematurely|5
148345|NCT00695318|527712|P2|Overall Study|Study Terminated|0
148346|NCT00695318|527713|P1|Overall Study|Study Terminated|1
148347|NCT00695318|527712|P2|Overall Study|Death|1
148348|NCT00695318|527713|P1|Overall Study|Death|1
148349|NCT00695318|527712|P2|Overall Study|Withdrawal by Subject|0
148350|NCT00695318|527713|P1|Overall Study|Withdrawal by Subject|2
148351|NCT00695318|527712|P2|Overall Study|Lost to Follow-up|0
148352|NCT00695318|527713|P1|Overall Study|Lost to Follow-up|1
148353|NCT00695136|527738|P1|Overall Study|unrelated adverse event|1
148354|NCT00695136|527738|P1|Overall Study|Withdrawal by Subject|1
148355|NCT00695019|527754|P3|Overall Study|Various|4
148356|NCT00695019|527755|P2|Overall Study|Various|5
148357|NCT00695019|527756|P1|Overall Study|Various|4
148358|NCT00695019|527754|P3|Overall Study|Lack of Efficacy|1
148359|NCT00695019|527755|P2|Overall Study|Lack of Efficacy|0
148360|NCT00695019|527756|P1|Overall Study|Lack of Efficacy|0
148361|NCT00695019|527754|P3|Overall Study|Protocol Violation|1
148362|NCT00695019|527755|P2|Overall Study|Protocol Violation|3
148363|NCT00695019|527756|P1|Overall Study|Protocol Violation|1
148364|NCT00695019|527754|P3|Overall Study|Withdrawal by Subject|4
148365|NCT00695019|527755|P2|Overall Study|Withdrawal by Subject|6
148366|NCT00695019|527756|P1|Overall Study|Withdrawal by Subject|8
148367|NCT00694551|527797|P3|Overall Study|Disease Progression|1
148368|NCT00694551|527798|P2|Overall Study|Disease Progression|0
148369|NCT00694551|527799|P1|Overall Study|Disease Progression|1
148370|NCT00694369|527828|P5|Overall Study|Withdrawal by Subject|2
148371|NCT00694369|527829|P4|Overall Study|Withdrawal by Subject|1
148372|NCT00694369|527830|P3|Overall Study|Withdrawal by Subject|1
148373|NCT00694369|527831|P2|Overall Study|Withdrawal by Subject|1
148374|NCT00694369|527832|P1|Overall Study|Withdrawal by Subject|1
148375|NCT00694369|527828|P5|Overall Study|Protocol Violation|0
148376|NCT00694369|527829|P4|Overall Study|Protocol Violation|0
148377|NCT00694369|527830|P3|Overall Study|Protocol Violation|0
148378|NCT00694369|527831|P2|Overall Study|Protocol Violation|1
148379|NCT00694369|527832|P1|Overall Study|Protocol Violation|0
148380|NCT00694369|527828|P5|Overall Study|Physician Decision|1
148381|NCT00694369|527829|P4|Overall Study|Physician Decision|0
148382|NCT00694369|527830|P3|Overall Study|Physician Decision|0
148383|NCT00694369|527831|P2|Overall Study|Physician Decision|0
148384|NCT00694369|527832|P1|Overall Study|Physician Decision|0
148385|NCT00694369|527828|P5|Overall Study|Lost to Follow-up|0
148386|NCT00694369|527829|P4|Overall Study|Lost to Follow-up|1
148387|NCT00694369|527830|P3|Overall Study|Lost to Follow-up|1
148388|NCT00694369|527831|P2|Overall Study|Lost to Follow-up|0
148389|NCT00694369|527832|P1|Overall Study|Lost to Follow-up|0
148390|NCT00694369|527828|P5|Overall Study|Adverse Event|3
148391|NCT00694369|527829|P4|Overall Study|Adverse Event|1
148392|NCT00694369|527830|P3|Overall Study|Adverse Event|0
148393|NCT00694369|527831|P2|Overall Study|Adverse Event|1
148394|NCT00694369|527832|P1|Overall Study|Adverse Event|0
148395|NCT00694356|527852|P3|Overall Study|Progressive Disease|6
148396|NCT00694356|527853|P2|Overall Study|Progressive Disease|6
148397|NCT00694356|527854|P1|Overall Study|Progressive Disease|2
148398|NCT00694356|527852|P3|Overall Study|Adverse Event|0
148399|NCT00694356|527853|P2|Overall Study|Adverse Event|0
148400|NCT00694356|527854|P1|Overall Study|Adverse Event|1
148401|NCT00694304|527889|P1|Overall Study|Administrative or Other Reasons|32
148402|NCT00694304|527889|P1|Overall Study|Lost to Follow-up|15
148403|NCT00694304|527889|P1|Overall Study|Withdrawal of Consent|61
148404|NCT00694304|527889|P1|Overall Study|Protocol Violation|6
148405|NCT00694304|527889|P1|Overall Study|Non-compliance With Study Product|16
148406|NCT00694304|527889|P1|Overall Study|Lack of Efficacy|35
148407|NCT00694304|527889|P1|Overall Study|Adverse Event|42
148408|NCT00694161|527902|P1|Part 2 (After Week 6 up to Month 12)|Death|1
148409|NCT00694161|527902|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
148410|NCT00694161|527902|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
148411|NCT00694122|527941|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
148412|NCT00694122|527942|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
148413|NCT00694122|527941|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
148414|NCT00694122|527942|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
148415|NCT00694122|527941|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
148416|NCT00694122|527942|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
148417|NCT00694109|527958|P1|Overall Study|Consented but no additional treatment|3
148418|NCT00694109|527958|P1|Overall Study|Other|2
148419|NCT00694109|527958|P1|Overall Study|Enrolled but not treated|1
148420|NCT00694109|527958|P1|Overall Study|Pregnancy|1
148421|NCT00694109|527958|P1|Overall Study|Withdrawal by Subject|13
148422|NCT00694109|527958|P1|Overall Study|Lack of Efficacy|2
148423|NCT00694109|527958|P1|Overall Study|Not consent of more 2 years of treatment|18
148424|NCT00694109|527958|P1|Overall Study|Adverse Event|74
148425|NCT00694109|527958|P1|Overall Study|Physician Decision|3
148426|NCT00694096|527982|P1|Overall Study|Withdrawal by Subject|5
148427|NCT00693784|528022|P1|Overall Study|Withdrawal by Subject|2
148428|NCT00693784|528022|P1|Overall Study|Lost to Follow-up|2
148429|NCT00693706|528035|P2|Overall Study|Protocol Violation|1
148430|NCT00693706|528036|P1|Overall Study|Protocol Violation|0
148431|NCT00693693|528063|P3|Overall Study|Lost to Follow-up|2
148432|NCT00693693|528064|P2|Overall Study|Lost to Follow-up|1
148433|NCT00693693|528065|P1|Overall Study|Lost to Follow-up|1
148434|NCT00693472|528124|P4|Part 2|Withdrew - reason unrelated to treatment|2
148435|NCT00693472|528125|P3|Part 2|Withdrew - reason unrelated to treatment|1
148436|NCT00693472|528126|P2|Part 2|Withdrew - reason unrelated to treatment|0
148437|NCT00693472|528127|P1|Part 2|Withdrew - reason unrelated to treatment|0
148438|NCT00693472|528124|P4|Part 2|Adverse Event|0
148439|NCT00693472|528125|P3|Part 2|Adverse Event|1
148440|NCT00693472|528126|P2|Part 2|Adverse Event|0
148441|NCT00693472|528127|P1|Part 2|Adverse Event|0
148442|NCT00693472|528124|P4|Part 1|Withdrew - reason unrelated to treatment|0
148443|NCT00693472|528125|P3|Part 1|Withdrew - reason unrelated to treatment|0
148444|NCT00693472|528126|P2|Part 1|Withdrew - reason unrelated to treatment|2
148445|NCT00693472|528127|P1|Part 1|Withdrew - reason unrelated to treatment|5
148446|NCT00693472|528124|P4|Part 1|Lost to Follow-up|0
148447|NCT00693472|528125|P3|Part 1|Lost to Follow-up|0
148448|NCT00693472|528126|P2|Part 1|Lost to Follow-up|1
148449|NCT00693472|528127|P1|Part 1|Lost to Follow-up|0
148450|NCT00693472|528124|P4|Part 1|Adverse Event|0
148451|NCT00693472|528125|P3|Part 1|Adverse Event|0
148452|NCT00693472|528126|P2|Part 1|Adverse Event|1
148453|NCT00693472|528127|P1|Part 1|Adverse Event|1
148454|NCT00693420|528147|P2|Overall Study|Personal Reasons|4
148455|NCT00693420|528148|P1|Overall Study|Personal Reasons|1
148456|NCT00693420|528147|P2|Overall Study|Sponsor Request - Conflict of Interest|2
148457|NCT00693420|528148|P1|Overall Study|Sponsor Request - Conflict of Interest|0
148458|NCT00693420|528147|P2|Overall Study|Protocol Violation|2
148459|NCT00693420|528148|P1|Overall Study|Protocol Violation|0
148460|NCT00693420|528147|P2|Overall Study|Withdrawal by Subject|0
148461|NCT00693420|528148|P1|Overall Study|Withdrawal by Subject|1
148462|NCT00693420|528147|P2|Overall Study|Lost to Follow-up|3
148463|NCT00693420|528148|P1|Overall Study|Lost to Follow-up|0
148464|NCT00693420|528147|P2|Overall Study|Adverse Event|4
148465|NCT00693420|528148|P1|Overall Study|Adverse Event|4
148466|NCT00693225|528187|P2|Overall Study|Adverse Event|3
148467|NCT00693225|528188|P1|Overall Study|Adverse Event|1
148468|NCT00693225|528187|P2|Overall Study|Lost to Follow-up|2
148469|NCT00693225|528188|P1|Overall Study|Lost to Follow-up|1
148470|NCT00693017|528211|P2|Overall Study|Death|1
148471|NCT00693017|528212|P1|Overall Study|Death|0
148472|NCT00693017|528211|P2|Overall Study|Sponsor Decision|1
148473|NCT00693017|528212|P1|Overall Study|Sponsor Decision|2
148474|NCT00692913|528222|P2|Overall Study|Withdrawal by Subject|20
148475|NCT00692913|528223|P1|Overall Study|Withdrawal by Subject|15
148476|NCT00692913|528222|P2|Overall Study|Protocol Violation|1
148477|NCT00692913|528223|P1|Overall Study|Protocol Violation|1
148478|NCT00692913|528222|P2|Overall Study|Physician Decision|0
148479|NCT00692913|528223|P1|Overall Study|Physician Decision|2
148480|NCT00692913|528222|P2|Overall Study|Lost to Follow-up|5
148481|NCT00692913|528223|P1|Overall Study|Lost to Follow-up|3
148482|NCT00692913|528222|P2|Overall Study|Adverse Event|4
148483|NCT00692913|528223|P1|Overall Study|Adverse Event|8
148484|NCT00692770|528245|P2|Overall Study|Randomized but not treated|4
148485|NCT00692770|528246|P1|Overall Study|Randomized but not treated|3
148486|NCT00692770|528245|P2|Overall Study|Study terminated by sponsor|2
148487|NCT00692770|528246|P1|Overall Study|Study terminated by sponsor|2
148488|NCT00692770|528245|P2|Overall Study|Clinical endpoint reached|43
148489|NCT00692770|528246|P1|Overall Study|Clinical endpoint reached|16
148490|NCT00692770|528245|P2|Overall Study|Radiological and clinical progression|8
148491|NCT00692770|528246|P1|Overall Study|Radiological and clinical progression|8
148492|NCT00692770|528245|P2|Overall Study|Completed all planned assessments|101
148493|NCT00692770|528246|P1|Overall Study|Completed all planned assessments|79
148494|NCT00692770|528245|P2|Overall Study|Protocol driven decision point|7
148495|NCT00692770|528246|P1|Overall Study|Protocol driven decision point|3
148496|NCT00692770|528245|P2|Overall Study|Disease progression, recurrence/relapse|279
148497|NCT00692770|528246|P1|Overall Study|Disease progression, recurrence/relapse|170
148498|NCT00692770|528245|P2|Overall Study|Physician decision not protocol driven|14
148499|NCT00692770|528246|P1|Overall Study|Physician decision not protocol driven|10
148500|NCT00692770|528245|P2|Overall Study|Progression by clinical judgment|3
148501|NCT00692770|528246|P1|Overall Study|Progression by clinical judgment|2
148502|NCT00692770|528245|P2|Overall Study|Non-compliant with study medication|5
148503|NCT00692770|528246|P1|Overall Study|Non-compliant with study medication|11
148504|NCT00692770|528245|P2|Overall Study|Lost to Follow-up|3
148505|NCT00692770|528246|P1|Overall Study|Lost to Follow-up|7
148506|NCT00692770|528245|P2|Overall Study|Death|5
148507|NCT00692770|528246|P1|Overall Study|Death|10
148508|NCT00692770|528245|P2|Overall Study|Adverse Event|41
148509|NCT00692770|528246|P1|Overall Study|Adverse Event|136
148510|NCT00692770|528245|P2|Overall Study|Withdrawal by Subject|36
148511|NCT00692770|528246|P1|Overall Study|Withdrawal by Subject|97
148512|NCT00692770|528245|P2|Overall Study|Protocol Violation|7
148513|NCT00692770|528246|P1|Overall Study|Protocol Violation|2
148514|NCT00692406|528292|P1|Overall Study|PI dropped, bad data|57
148515|NCT00692237|528354|P2|Overall Study|Adverse Event|1
148516|NCT00692237|528355|P1|Overall Study|Adverse Event|0
148517|NCT00692237|528354|P2|Overall Study|Withdrawal by Subject|3
148518|NCT00692237|528355|P1|Overall Study|Withdrawal by Subject|1
148519|NCT00692003|528419|P2|Overall Study|Sponsor Decision|1
148520|NCT00692003|528420|P1|Overall Study|Sponsor Decision|5
148521|NCT00691938|528435|P7|Overall Study|QTc prolongation|0
148522|NCT00691938|528436|P6|Overall Study|QTc prolongation|0
148523|NCT00691938|528437|P5|Overall Study|QTc prolongation|0
148524|NCT00691938|528438|P4|Overall Study|QTc prolongation|0
148525|NCT00691938|528439|P3|Overall Study|QTc prolongation|0
148526|NCT00691938|528440|P2|Overall Study|QTc prolongation|0
148527|NCT00691938|528441|P1|Overall Study|QTc prolongation|1
148528|NCT00691704|528508|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
148529|NCT00691704|528508|P1|Two Years of Maintenance Therapy|Physician Decision|4
148530|NCT00691704|528508|P1|Two Years of Maintenance Therapy|Disease Progression|8
148531|NCT00691704|528508|P1|Induction Therapy|Active Hepatitis|1
148532|NCT00691704|528508|P1|Induction Therapy|Disease Progression|1
148533|NCT00691483|528537|P2|Overall Study|Randomized by not treated|1
148534|NCT00691483|528538|P1|Overall Study|Randomized by not treated|7
148535|NCT00691483|528537|P2|Overall Study|Other known cause|1
148536|NCT00691483|528538|P1|Overall Study|Other known cause|6
148537|NCT00691483|528537|P2|Overall Study|Withdrawal by Subject|7
148538|NCT00691483|528538|P1|Overall Study|Withdrawal by Subject|24
148539|NCT00691483|528537|P2|Overall Study|Lost to Follow-up|10
148540|NCT00691483|528538|P1|Overall Study|Lost to Follow-up|17
148541|NCT00691483|528537|P2|Overall Study|Adverse Event|6
148542|NCT00691483|528538|P1|Overall Study|Adverse Event|14
148543|NCT00691301|528565|P1|Overall Study|Did not initiate study treatment|1
148544|NCT00691301|528565|P1|Overall Study|other reason|3
148545|NCT00691301|528565|P1|Overall Study|Concurrent illness|2
148546|NCT00691301|528565|P1|Overall Study|Withdrawal by Subject|4
148547|NCT00691301|528565|P1|Overall Study|Lack of Efficacy|32
148548|NCT00691301|528565|P1|Overall Study|Death|2
148549|NCT00691301|528565|P1|Overall Study|Adverse Event|10
148550|NCT00691210|528585|P8|Overall Study|Lack of Efficacy|0
148551|NCT00691210|528586|P7|Overall Study|Lack of Efficacy|0
148552|NCT00691210|528587|P6|Overall Study|Lack of Efficacy|1
148553|NCT00691210|528588|P5|Overall Study|Lack of Efficacy|0
148554|NCT00691210|528589|P4|Overall Study|Lack of Efficacy|1
148555|NCT00691210|528590|P3|Overall Study|Lack of Efficacy|0
148556|NCT00691210|528591|P2|Overall Study|Lack of Efficacy|0
148557|NCT00691210|528592|P1|Overall Study|Lack of Efficacy|0
148558|NCT00691210|528585|P8|Overall Study|Progression of Disease|0
148559|NCT00691210|528586|P7|Overall Study|Progression of Disease|0
148560|NCT00691210|528587|P6|Overall Study|Progression of Disease|0
148561|NCT00691210|528588|P5|Overall Study|Progression of Disease|0
148562|NCT00691210|528589|P4|Overall Study|Progression of Disease|2
148563|NCT00691210|528590|P3|Overall Study|Progression of Disease|0
148564|NCT00691210|528591|P2|Overall Study|Progression of Disease|0
148565|NCT00691210|528592|P1|Overall Study|Progression of Disease|0
148566|NCT00691132|528627|P2|Overall Study|Withdrawal by Subject|10
148567|NCT00691132|528628|P1|Overall Study|Withdrawal by Subject|10
148568|NCT00691132|528627|P2|Overall Study|Adverse Event|3
148569|NCT00691132|528628|P1|Overall Study|Adverse Event|2
148570|NCT00691093|528647|P1|Overall Study|Ongoing at Date of Cut-Off|4
148571|NCT00691093|528647|P1|Overall Study|Lack of Efficacy|1
148572|NCT00691093|528647|P1|Overall Study|Lost to Follow-up|1
148573|NCT00691093|528647|P1|Overall Study|Adverse Event|1
148574|NCT00691054|528681|P1|Overall Study|Withdrawal by Subject|1
148575|NCT00691028|528693|P4|Double-blind Period|not come to a hospital.|0
148576|NCT00691028|528694|P3|Double-blind Period|not come to a hospital.|0
148577|NCT00691028|528695|P2|Double-blind Period|not come to a hospital.|1
148578|NCT00691028|528696|P1|Double-blind Period|not come to a hospital.|0
148579|NCT00691028|528693|P4|Double-blind Period|Withdrawal by Subject|0
148580|NCT00691028|528694|P3|Double-blind Period|Withdrawal by Subject|1
148581|NCT00691028|528695|P2|Double-blind Period|Withdrawal by Subject|0
148582|NCT00691028|528696|P1|Double-blind Period|Withdrawal by Subject|1
148583|NCT00691028|528693|P4|Double-blind Period|Lack of Efficacy|0
148584|NCT00691028|528694|P3|Double-blind Period|Lack of Efficacy|2
148585|NCT00691028|528695|P2|Double-blind Period|Lack of Efficacy|3
148586|NCT00691028|528696|P1|Double-blind Period|Lack of Efficacy|4
148587|NCT00691028|528693|P4|Double-blind Period|Adverse Event|0
148588|NCT00691028|528694|P3|Double-blind Period|Adverse Event|6
148589|NCT00691028|528695|P2|Double-blind Period|Adverse Event|9
148590|NCT00691028|528696|P1|Double-blind Period|Adverse Event|8
148591|NCT00691028|528693|P4|Open-label Period|not come to a hospital|1
148592|NCT00691028|528694|P3|Open-label Period|not come to a hospital|0
148593|NCT00691028|528695|P2|Open-label Period|not come to a hospital|0
148594|NCT00691028|528696|P1|Open-label Period|not come to a hospital|0
148595|NCT00691028|528693|P4|Open-label Period|Withdrawal by Subject|3
148596|NCT00691028|528694|P3|Open-label Period|Withdrawal by Subject|0
148597|NCT00691028|528695|P2|Open-label Period|Withdrawal by Subject|0
148598|NCT00691028|528696|P1|Open-label Period|Withdrawal by Subject|0
148599|NCT00691028|528693|P4|Open-label Period|Adverse Event|16
148600|NCT00691028|528694|P3|Open-label Period|Adverse Event|0
148601|NCT00691028|528695|P2|Open-label Period|Adverse Event|0
148602|NCT00691028|528696|P1|Open-label Period|Adverse Event|0
148603|NCT00691015|528729|P1|Overall Study|Refused further treatment|1
148604|NCT00690898|528744|P1|TREATMENT|Other (not otherwise specified)|1
148605|NCT00690898|528744|P1|TREATMENT|Withdrawal by Subject|4
148606|NCT00690898|528744|P1|TREATMENT|Lack of Efficacy|18
148607|NCT00690898|528744|P1|TREATMENT|Adverse Event|3
148608|NCT00690898|528744|P1|SCREENING|Screen failure|18
148609|NCT00690820|528764|P2|Period 1|Withdrawal by Subject|1
148610|NCT00690820|528765|P1|Period 1|Withdrawal by Subject|0
148611|NCT00690794|528787|P2|Overall Study|Other not specified|3
148612|NCT00690794|528788|P1|Overall Study|Other not specified|1
148613|NCT00690794|528787|P2|Overall Study|Noncompliance|2
148614|NCT00690794|528788|P1|Overall Study|Noncompliance|1
148615|NCT00690794|528787|P2|Overall Study|Protocol Violation|7
148616|NCT00690794|528788|P1|Overall Study|Protocol Violation|6
148617|NCT00690794|528787|P2|Overall Study|Withdrawal by Subject|9
148618|NCT00690794|528788|P1|Overall Study|Withdrawal by Subject|0
148619|NCT00690794|528787|P2|Overall Study|Lost to Follow-up|4
148620|NCT00690794|528788|P1|Overall Study|Lost to Follow-up|1
148621|NCT00690794|528787|P2|Overall Study|Adverse Event|10
148622|NCT00690794|528788|P1|Overall Study|Adverse Event|12
148623|NCT00690755|528803|P7|Overall Study|Physician Decision|0
148624|NCT00690755|528804|P6|Overall Study|Physician Decision|4
148625|NCT00690755|528805|P5|Overall Study|Physician Decision|0
148626|NCT00690755|528806|P4|Overall Study|Physician Decision|5
148627|NCT00690755|528807|P3|Overall Study|Physician Decision|46
148628|NCT00690755|528808|P2|Overall Study|Physician Decision|0
148629|NCT00690755|528809|P1|Overall Study|Physician Decision|2
148630|NCT00690612|528825|P1|Overall Study|Withdrawal by Subject|2
148631|NCT00690612|528825|P1|Overall Study|Adverse Event|1
148632|NCT00690573|528830|P1|Overall Study|Withdrawal by Subject|1
148633|NCT00690573|528830|P1|Overall Study|Lack of Efficacy|8
148634|NCT00690482|528849|P2|Overall Study|withdrew consent at rand.day|1
148635|NCT00690482|528850|P1|Overall Study|withdrew consent at rand.day|0
148636|NCT00690482|528849|P2|Overall Study|Intake of prohibited medicine|0
148637|NCT00690482|528850|P1|Overall Study|Intake of prohibited medicine|1
148638|NCT00690482|528849|P2|Overall Study|Study-specific discontinuation criteria|0
148639|NCT00690482|528850|P1|Overall Study|Study-specific discontinuation criteria|1
148640|NCT00690482|528849|P2|Overall Study|Incorrect enrolment|1
148641|NCT00690482|528850|P1|Overall Study|Incorrect enrolment|0
148642|NCT00690482|528849|P2|Overall Study|Adverse Event|1
148643|NCT00690482|528850|P1|Overall Study|Adverse Event|2
148644|NCT00690443|528884|P2|Overall Study|Adverse Event|2
148645|NCT00690443|528885|P1|Overall Study|Adverse Event|1
148646|NCT00690430|528895|P3|Extension Phase|Early Termination|3
148647|NCT00690430|528896|P2|Extension Phase|Early Termination|1
148648|NCT00690430|528897|P1|Extension Phase|Early Termination|10
148649|NCT00690430|528895|P3|Extension Phase|Withdrawal by Subject|2
148650|NCT00690430|528896|P2|Extension Phase|Withdrawal by Subject|0
148651|NCT00690430|528897|P1|Extension Phase|Withdrawal by Subject|0
148652|NCT00690430|528895|P3|Extension Phase|Death|1
148653|NCT00690430|528896|P2|Extension Phase|Death|1
148654|NCT00690430|528897|P1|Extension Phase|Death|1
148655|NCT00690430|528895|P3|Extension Phase|Adverse Event|2
148656|NCT00690430|528896|P2|Extension Phase|Adverse Event|1
148657|NCT00690430|528897|P1|Extension Phase|Adverse Event|2
148658|NCT00690430|528895|P3|Extension Phase|Administrative Problems|1
148659|NCT00690430|528896|P2|Extension Phase|Administrative Problems|1
148660|NCT00690430|528897|P1|Extension Phase|Administrative Problems|0
148661|NCT00690430|528895|P3|Extension Phase|Abnormal test procedure results|0
148662|NCT00690430|528896|P2|Extension Phase|Abnormal test procedure results|0
148663|NCT00690430|528897|P1|Extension Phase|Abnormal test procedure results|1
148664|NCT00690430|528895|P3|Extension Phase|Abnormal Lab Values|0
148665|NCT00690430|528896|P2|Extension Phase|Abnormal Lab Values|0
148666|NCT00690430|528897|P1|Extension Phase|Abnormal Lab Values|1
148667|NCT00690430|528895|P3|Extension Phase|Lack of Efficacy|4
148668|NCT00690430|528896|P2|Extension Phase|Lack of Efficacy|1
148669|NCT00690430|528897|P1|Extension Phase|Lack of Efficacy|3
148670|NCT00690430|528895|P3|Core Phase|Early Termination|0
148671|NCT00690430|528896|P2|Core Phase|Early Termination|5
148672|NCT00690430|528897|P1|Core Phase|Early Termination|0
148673|NCT00690430|528895|P3|Core Phase|Administrative Problems|0
148674|NCT00690430|528896|P2|Core Phase|Administrative Problems|1
148675|NCT00690430|528897|P1|Core Phase|Administrative Problems|0
148676|NCT00690430|528895|P3|Core Phase|Lack of Efficacy|0
148677|NCT00690430|528896|P2|Core Phase|Lack of Efficacy|10
148678|NCT00690430|528897|P1|Core Phase|Lack of Efficacy|8
148679|NCT00690430|528895|P3|Core Phase|Subject no longer requires study drug|0
148680|NCT00690430|528896|P2|Core Phase|Subject no longer requires study drug|0
148681|NCT00690430|528897|P1|Core Phase|Subject no longer requires study drug|1
148682|NCT00690430|528895|P3|Core Phase|Withdrawal by Subject|0
148683|NCT00690430|528896|P2|Core Phase|Withdrawal by Subject|3
148684|NCT00690430|528897|P1|Core Phase|Withdrawal by Subject|3
148685|NCT00690430|528895|P3|Core Phase|Protocol Violation|0
148686|NCT00690430|528896|P2|Core Phase|Protocol Violation|0
148687|NCT00690430|528897|P1|Core Phase|Protocol Violation|1
148688|NCT00690430|528895|P3|Core Phase|Death|0
148689|NCT00690430|528896|P2|Core Phase|Death|2
148690|NCT00690430|528897|P1|Core Phase|Death|0
148691|NCT00690430|528895|P3|Core Phase|Adverse Event|0
148692|NCT00690430|528896|P2|Core Phase|Adverse Event|1
148693|NCT00690430|528897|P1|Core Phase|Adverse Event|5
148694|NCT00690430|528895|P3|Core Phase|Abnormal Laboratory value|0
148695|NCT00690430|528896|P2|Core Phase|Abnormal Laboratory value|1
148696|NCT00690430|528897|P1|Core Phase|Abnormal Laboratory value|0
148697|NCT00690378|528926|P2|Overall Study|Social problem|0
148698|NCT00690378|528927|P1|Overall Study|Social problem|1
148699|NCT00690378|528926|P2|Overall Study|Did not meet inc/exc criteria|11
148700|NCT00690378|528927|P1|Overall Study|Did not meet inc/exc criteria|13
148701|NCT00690378|528926|P2|Overall Study|Lost to Follow-up|3
148702|NCT00690378|528927|P1|Overall Study|Lost to Follow-up|2
148703|NCT00690378|528926|P2|Overall Study|Protocol Violation|0
148704|NCT00690378|528927|P1|Overall Study|Protocol Violation|1
148705|NCT00690378|528926|P2|Overall Study|Withdrawal by Subject|0
148706|NCT00690378|528927|P1|Overall Study|Withdrawal by Subject|2
148707|NCT00690378|528926|P2|Overall Study|Adverse Event|0
148708|NCT00690378|528927|P1|Overall Study|Adverse Event|1
148709|NCT00689936|529004|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
148710|NCT00689936|529005|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
148711|NCT00689936|529006|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
148712|NCT00689936|529004|P3|Active Treatment Phase|Miscellaneous|47
148713|NCT00689936|529005|P2|Active Treatment Phase|Miscellaneous|34
148714|NCT00689936|529006|P1|Active Treatment Phase|Miscellaneous|52
148715|NCT00689936|529004|P3|Active Treatment Phase|Study Close Out|21
148716|NCT00689936|529005|P2|Active Treatment Phase|Study Close Out|26
148717|NCT00689936|529006|P1|Active Treatment Phase|Study Close Out|64
148718|NCT00689936|529004|P3|Active Treatment Phase|Protocol Violation|4
148719|NCT00689936|529005|P2|Active Treatment Phase|Protocol Violation|2
148720|NCT00689936|529006|P1|Active Treatment Phase|Protocol Violation|2
148721|NCT00689936|529004|P3|Active Treatment Phase|Lost to Follow-up|2
148722|NCT00689936|529005|P2|Active Treatment Phase|Lost to Follow-up|2
148723|NCT00689936|529006|P1|Active Treatment Phase|Lost to Follow-up|0
148724|NCT00689936|529004|P3|Active Treatment Phase|Death|37
148725|NCT00689936|529005|P2|Active Treatment Phase|Death|28
148726|NCT00689936|529006|P1|Active Treatment Phase|Death|60
148727|NCT00689936|529004|P3|Active Treatment Phase|Withdrawal by Subject|21
148728|NCT00689936|529005|P2|Active Treatment Phase|Withdrawal by Subject|16
148729|NCT00689936|529006|P1|Active Treatment Phase|Withdrawal by Subject|16
148730|NCT00689936|529004|P3|Active Treatment Phase|Disease Progression|339
148731|NCT00689936|529005|P2|Active Treatment Phase|Disease Progression|362
148732|NCT00689936|529006|P1|Active Treatment Phase|Disease Progression|273
148733|NCT00689936|529004|P3|Active Treatment Phase|Adverse Event|76
148734|NCT00689936|529005|P2|Active Treatment Phase|Adverse Event|71
148735|NCT00689936|529006|P1|Active Treatment Phase|Adverse Event|68
148736|NCT00689871|529155|P4|Overall Study|Physician Decision|0
148737|NCT00689871|529156|P3|Overall Study|Physician Decision|1
148738|NCT00689871|529157|P2|Overall Study|Physician Decision|1
148739|NCT00689871|529158|P1|Overall Study|Physician Decision|2
148740|NCT00689871|529155|P4|Overall Study|Death|2
148741|NCT00689871|529156|P3|Overall Study|Death|2
148742|NCT00689871|529157|P2|Overall Study|Death|10
148743|NCT00689871|529158|P1|Overall Study|Death|1
148744|NCT00689871|529155|P4|Overall Study|Withdrawal by Subject|1
148745|NCT00689871|529156|P3|Overall Study|Withdrawal by Subject|4
148746|NCT00689871|529157|P2|Overall Study|Withdrawal by Subject|3
148747|NCT00689871|529158|P1|Overall Study|Withdrawal by Subject|13
148748|NCT00689871|529155|P4|Overall Study|Explanted of All Study Devices|3
148749|NCT00689871|529156|P3|Overall Study|Explanted of All Study Devices|29
148750|NCT00689871|529157|P2|Overall Study|Explanted of All Study Devices|25
148751|NCT00689871|529158|P1|Overall Study|Explanted of All Study Devices|36
148752|NCT00689871|529155|P4|Overall Study|Lost to Follow-up|1
148753|NCT00689871|529156|P3|Overall Study|Lost to Follow-up|37
148754|NCT00689871|529157|P2|Overall Study|Lost to Follow-up|13
148755|NCT00689871|529158|P1|Overall Study|Lost to Follow-up|123
148756|NCT00689793|529185|P2|Overall Study|Lost to Follow-up|5
148757|NCT00689793|529186|P1|Overall Study|Lost to Follow-up|4
148758|NCT00689611|529204|P2|Overall Study|Lost to Follow-up|28
148759|NCT00689611|529205|P1|Overall Study|Lost to Follow-up|27
148760|NCT00689611|529204|P2|Overall Study|Withdrawal by Subject|9
148761|NCT00689611|529205|P1|Overall Study|Withdrawal by Subject|8
148762|NCT00689611|529204|P2|Overall Study|Death|9
148763|NCT00689611|529205|P1|Overall Study|Death|6
148764|NCT00689481|529215|P2|Overall Study|Subject early term, left on vacation|1
148765|NCT00689481|529216|P1|Overall Study|Subject early term, left on vacation|0
148766|NCT00689481|529215|P2|Overall Study|Excluded medication started during study|1
148767|NCT00689481|529216|P1|Overall Study|Excluded medication started during study|0
148768|NCT00689481|529215|P2|Overall Study|Withdrawal by Subject|4
148769|NCT00689481|529216|P1|Overall Study|Withdrawal by Subject|8
148770|NCT00689481|529215|P2|Overall Study|Non-compliance with study treatment|1
148771|NCT00689481|529216|P1|Overall Study|Non-compliance with study treatment|1
148772|NCT00689481|529215|P2|Overall Study|Lack of Efficacy|3
148773|NCT00689481|529216|P1|Overall Study|Lack of Efficacy|4
148774|NCT00689481|529215|P2|Overall Study|Lost to Follow-up|3
148775|NCT00689481|529216|P1|Overall Study|Lost to Follow-up|4
148776|NCT00689481|529215|P2|Overall Study|Adverse Event|1
148777|NCT00689481|529216|P1|Overall Study|Adverse Event|7
148778|NCT00689390|529234|P2|Overall Study|Administrative|0
148779|NCT00689390|529235|P1|Overall Study|Administrative|37
148780|NCT00689390|529234|P2|Overall Study|Did Not Meet Protocol Eligibility|0
148781|NCT00689390|529235|P1|Overall Study|Did Not Meet Protocol Eligibility|1
148782|NCT00689390|529234|P2|Overall Study|Non-Compliance With Protocol|0
148783|NCT00689390|529235|P1|Overall Study|Non-Compliance With Protocol|21
148784|NCT00689390|529234|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
148785|NCT00689390|529235|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
148786|NCT00689390|529234|P2|Overall Study|Withdrawal by Subject|3
148787|NCT00689390|529235|P1|Overall Study|Withdrawal by Subject|117
148788|NCT00689390|529234|P2|Overall Study|Lost to Follow-up|7
148789|NCT00689390|529235|P1|Overall Study|Lost to Follow-up|179
148790|NCT00689390|529234|P2|Overall Study|Adverse Event|0
148791|NCT00689390|529235|P1|Overall Study|Adverse Event|19
148792|NCT00689351|529253|P2|After Infant Series|Parent/legal guardian request|0
148793|NCT00689351|529254|P1|After Infant Series|Parent/legal guardian request|1
148794|NCT00689351|529253|P2|Infant Series of Dosing|Lost to Follow-up|1
148795|NCT00689351|529254|P1|Infant Series of Dosing|Lost to Follow-up|0
148796|NCT00689351|529253|P2|Infant Series of Dosing|Adverse Event|0
148797|NCT00689351|529254|P1|Infant Series of Dosing|Adverse Event|1
148798|NCT00689351|529253|P2|Infant Series of Dosing|Parent/legal guardian request|0
148799|NCT00689351|529254|P1|Infant Series of Dosing|Parent/legal guardian request|5
148800|NCT00689338|529286|P1|Overall Study|Protocol Violation|15
148801|NCT00689338|529286|P1|Overall Study|Withdrawal by Subject|3
148802|NCT00689338|529286|P1|Overall Study|Lost to Follow-up|5
148803|NCT00689338|529286|P1|Overall Study|Did not Meet Entrance Criteria|27
148804|NCT00689338|529286|P1|Overall Study|Other|8
148805|NCT00689338|529286|P1|Overall Study|Lack of Efficacy|6
148806|NCT00689338|529286|P1|Overall Study|Insufficient Clinical Response|1
148807|NCT00689338|529286|P1|Overall Study|Adverse Event|13
148808|NCT00689338|529286|P1|Overall Study|Death|65
148809|NCT00689299|529299|P3|Overall Study|Protocol Violation|0
148810|NCT00689299|529300|P2|Overall Study|Protocol Violation|0
148811|NCT00689299|529301|P1|Overall Study|Protocol Violation|1
148812|NCT00689299|529299|P3|Overall Study|Withdrawal by Subject|3
148813|NCT00689299|529300|P2|Overall Study|Withdrawal by Subject|1
148814|NCT00689299|529301|P1|Overall Study|Withdrawal by Subject|4
148815|NCT00689299|529299|P3|Overall Study|Lost to Follow-up|1
148816|NCT00689299|529300|P2|Overall Study|Lost to Follow-up|1
148817|NCT00689299|529301|P1|Overall Study|Lost to Follow-up|0
148818|NCT00689299|529299|P3|Overall Study|Adverse Event|1
148819|NCT00689299|529300|P2|Overall Study|Adverse Event|1
148820|NCT00689299|529301|P1|Overall Study|Adverse Event|2
148821|NCT00689221|529330|P2|Overall Study|Ongoing at cut-off date|36
148822|NCT00689221|529331|P1|Overall Study|Ongoing at cut-off date|39
148823|NCT00689117|529360|P4|Overall Study|Dispensing Error|0
148824|NCT00689117|529361|P3|Overall Study|Dispensing Error|0
148825|NCT00689117|529362|P2|Overall Study|Dispensing Error|1
148826|NCT00689117|529363|P1|Overall Study|Dispensing Error|0
148827|NCT00689117|529360|P4|Overall Study|Personal Reason|0
148828|NCT00689117|529361|P3|Overall Study|Personal Reason|0
148829|NCT00689117|529362|P2|Overall Study|Personal Reason|1
148830|NCT00689117|529363|P1|Overall Study|Personal Reason|0
148831|NCT00689117|529360|P4|Overall Study|Patient Withdrew from Study|1
148832|NCT00689117|529361|P3|Overall Study|Patient Withdrew from Study|0
148833|NCT00689117|529362|P2|Overall Study|Patient Withdrew from Study|0
148834|NCT00689117|529363|P1|Overall Study|Patient Withdrew from Study|0
148835|NCT00689117|529360|P4|Overall Study|Transportation|0
148836|NCT00689117|529361|P3|Overall Study|Transportation|0
148837|NCT00689117|529362|P2|Overall Study|Transportation|0
148838|NCT00689117|529363|P1|Overall Study|Transportation|1
148839|NCT00689117|529360|P4|Overall Study|Fear of Birth Defects|0
148840|NCT00689117|529361|P3|Overall Study|Fear of Birth Defects|1
148841|NCT00689117|529362|P2|Overall Study|Fear of Birth Defects|0
148842|NCT00689117|529363|P1|Overall Study|Fear of Birth Defects|0
148843|NCT00689117|529360|P4|Overall Study|Incarceration|0
148844|NCT00689117|529361|P3|Overall Study|Incarceration|0
148845|NCT00689117|529362|P2|Overall Study|Incarceration|0
148846|NCT00689117|529363|P1|Overall Study|Incarceration|2
148847|NCT00689117|529360|P4|Overall Study|Pregnancy|2
148848|NCT00689117|529361|P3|Overall Study|Pregnancy|0
148849|NCT00689117|529362|P2|Overall Study|Pregnancy|2
148850|NCT00689117|529363|P1|Overall Study|Pregnancy|0
148851|NCT00689117|529360|P4|Overall Study|Use of Prohibitive Medication|0
148852|NCT00689117|529361|P3|Overall Study|Use of Prohibitive Medication|3
148853|NCT00689117|529362|P2|Overall Study|Use of Prohibitive Medication|1
148854|NCT00689117|529363|P1|Overall Study|Use of Prohibitive Medication|2
148855|NCT00689117|529360|P4|Overall Study|Change/Discontinuation of Birth Control|0
148856|NCT00689117|529361|P3|Overall Study|Change/Discontinuation of Birth Control|1
148857|NCT00689117|529362|P2|Overall Study|Change/Discontinuation of Birth Control|1
148858|NCT00689117|529363|P1|Overall Study|Change/Discontinuation of Birth Control|1
148859|NCT00689117|529360|P4|Overall Study|Non-compliance with Treatment Regimen|0
148860|NCT00689117|529361|P3|Overall Study|Non-compliance with Treatment Regimen|0
148861|NCT00689117|529362|P2|Overall Study|Non-compliance with Treatment Regimen|1
148862|NCT00689117|529363|P1|Overall Study|Non-compliance with Treatment Regimen|0
148863|NCT00689117|529360|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
148864|NCT00689117|529361|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
148865|NCT00689117|529362|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
148866|NCT00689117|529363|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
148867|NCT00689117|529360|P4|Overall Study|Unable to Comply with Visit Schedule|1
148868|NCT00689117|529361|P3|Overall Study|Unable to Comply with Visit Schedule|1
148869|NCT00689117|529362|P2|Overall Study|Unable to Comply with Visit Schedule|0
148870|NCT00689117|529363|P1|Overall Study|Unable to Comply with Visit Schedule|0
148871|NCT00689117|529360|P4|Overall Study|Withdrawal by Subject|13
148872|NCT00689117|529361|P3|Overall Study|Withdrawal by Subject|26
148873|NCT00689117|529362|P2|Overall Study|Withdrawal by Subject|18
148874|NCT00689117|529363|P1|Overall Study|Withdrawal by Subject|19
148875|NCT00689117|529360|P4|Overall Study|Non-Compliance with Study Treatment|1
148876|NCT00689117|529361|P3|Overall Study|Non-Compliance with Study Treatment|3
148877|NCT00689117|529362|P2|Overall Study|Non-Compliance with Study Treatment|3
148878|NCT00689117|529363|P1|Overall Study|Non-Compliance with Study Treatment|3
148879|NCT00689117|529360|P4|Overall Study|Lack of Efficacy|2
148880|NCT00689117|529361|P3|Overall Study|Lack of Efficacy|2
148881|NCT00689117|529362|P2|Overall Study|Lack of Efficacy|2
148882|NCT00689117|529363|P1|Overall Study|Lack of Efficacy|1
148883|NCT00689117|529360|P4|Overall Study|Lost to Follow-up|11
148884|NCT00689117|529361|P3|Overall Study|Lost to Follow-up|17
148885|NCT00689117|529362|P2|Overall Study|Lost to Follow-up|19
148886|NCT00689117|529363|P1|Overall Study|Lost to Follow-up|26
148887|NCT00689117|529360|P4|Overall Study|Adverse Event|0
148888|NCT00689117|529361|P3|Overall Study|Adverse Event|5
148889|NCT00689117|529362|P2|Overall Study|Adverse Event|0
148890|NCT00689117|529363|P1|Overall Study|Adverse Event|6
148891|NCT00689104|529393|P4|Overall Study|Non-compliance with study procedures|0
148892|NCT00689104|529394|P3|Overall Study|Non-compliance with study procedures|1
148893|NCT00689104|529395|P2|Overall Study|Non-compliance with study procedures|0
148894|NCT00689104|529396|P1|Overall Study|Non-compliance with study procedures|0
148895|NCT00689104|529393|P4|Overall Study|Physician Decision|0
148896|NCT00689104|529394|P3|Overall Study|Physician Decision|0
148897|NCT00689104|529395|P2|Overall Study|Physician Decision|0
148898|NCT00689104|529396|P1|Overall Study|Physician Decision|1
148899|NCT00689104|529393|P4|Overall Study|Randomized but never received study drug|0
148900|NCT00689104|529394|P3|Overall Study|Randomized but never received study drug|1
148901|NCT00689104|529395|P2|Overall Study|Randomized but never received study drug|1
148902|NCT00689104|529396|P1|Overall Study|Randomized but never received study drug|2
148903|NCT00689104|529393|P4|Overall Study|Protocol Violation|3
148904|NCT00689104|529394|P3|Overall Study|Protocol Violation|5
148905|NCT00689104|529395|P2|Overall Study|Protocol Violation|3
148906|NCT00689104|529396|P1|Overall Study|Protocol Violation|2
148907|NCT00689104|529393|P4|Overall Study|Lost to Follow-up|5
148908|NCT00689104|529394|P3|Overall Study|Lost to Follow-up|2
148909|NCT00689104|529395|P2|Overall Study|Lost to Follow-up|3
148910|NCT00689104|529396|P1|Overall Study|Lost to Follow-up|4
148911|NCT00689104|529393|P4|Overall Study|Withdrawal by Subject|11
148912|NCT00689104|529394|P3|Overall Study|Withdrawal by Subject|18
148913|NCT00689104|529395|P2|Overall Study|Withdrawal by Subject|11
148914|NCT00689104|529396|P1|Overall Study|Withdrawal by Subject|12
148915|NCT00689104|529393|P4|Overall Study|Lack of Efficacy|3
148916|NCT00689104|529394|P3|Overall Study|Lack of Efficacy|2
148917|NCT00689104|529395|P2|Overall Study|Lack of Efficacy|6
148918|NCT00689104|529396|P1|Overall Study|Lack of Efficacy|5
148919|NCT00689104|529393|P4|Overall Study|Adverse Event|24
148920|NCT00689104|529394|P3|Overall Study|Adverse Event|16
148921|NCT00689104|529395|P2|Overall Study|Adverse Event|25
148922|NCT00689104|529396|P1|Overall Study|Adverse Event|13
148923|NCT00689104|529393|P4|Overall Study|Eligibility criterion not met|4
148924|NCT00689104|529394|P3|Overall Study|Eligibility criterion not met|0
148925|NCT00689104|529395|P2|Overall Study|Eligibility criterion not met|8
148926|NCT00689104|529396|P1|Overall Study|Eligibility criterion not met|5
148927|NCT00689052|529549|P2|Overall Study|Early termination of the trial|24
148928|NCT00689052|529550|P1|Overall Study|Early termination of the trial|22
148929|NCT00689052|529549|P2|Overall Study|Withdrawal by Subject|0
148930|NCT00689052|529550|P1|Overall Study|Withdrawal by Subject|2
148931|NCT00689052|529549|P2|Overall Study|Lost to Follow-up|0
148932|NCT00689052|529550|P1|Overall Study|Lost to Follow-up|2
148933|NCT00689052|529549|P2|Overall Study|Protocol Violation|0
148934|NCT00689052|529550|P1|Overall Study|Protocol Violation|1
148935|NCT00689052|529549|P2|Overall Study|Adverse Event|6
148936|NCT00689052|529550|P1|Overall Study|Adverse Event|4
148937|NCT00689026|529582|P2|Overall Study|Withdrawal by Subject|6
148938|NCT00689026|529583|P1|Overall Study|Withdrawal by Subject|13
148939|NCT00688870|529591|P2|Infant Series|Parent or legal guardian request|0
148940|NCT00688870|529592|P1|Infant Series|Parent or legal guardian request|4
148941|NCT00688844|529624|P1|Overall Study|Lost to Follow-up|10
148942|NCT00688753|529634|P1|Overall Study|Lost to Follow-up|3
148943|NCT00688753|529634|P1|Overall Study|Protocol Violation|1
148944|NCT00688753|529634|P1|Overall Study|Adverse Event|20
148945|NCT00688753|529634|P1|Overall Study|Withdrawal by Subject|3
148946|NCT00688753|529634|P1|Overall Study|Death|9
148947|NCT00688753|529634|P1|Overall Study|Missing|1
148948|NCT00688753|529634|P1|Overall Study|Disease progression|55
148949|NCT00688740|529645|P2|Overall Study|Violation of Inclusion Criteria|3
148950|NCT00688740|529646|P1|Overall Study|Violation of Inclusion Criteria|1
148951|NCT00688740|529645|P2|Overall Study|Breast Cancer Relapse|4
148952|NCT00688740|529646|P1|Overall Study|Breast Cancer Relapse|1
148953|NCT00688740|529645|P2|Overall Study|Consent Withdrawn|17
148954|NCT00688740|529646|P1|Overall Study|Consent Withdrawn|17
148955|NCT00688740|529645|P2|Overall Study|Lost to Follow-up|1
148956|NCT00688740|529646|P1|Overall Study|Lost to Follow-up|0
148957|NCT00688740|529645|P2|Overall Study|Death|2
148958|NCT00688740|529646|P1|Overall Study|Death|2
148959|NCT00688740|529645|P2|Overall Study|Adverse Event|8
148960|NCT00688740|529646|P1|Overall Study|Adverse Event|45
148961|NCT00688701|529659|P4|Overall Study|Poor compliance to protocol|0
148962|NCT00688701|529660|P3|Overall Study|Poor compliance to protocol|1
148963|NCT00688701|529661|P2|Overall Study|Poor compliance to protocol|1
148964|NCT00688701|529662|P1|Overall Study|Poor compliance to protocol|0
148965|NCT00688701|529659|P4|Overall Study|Withdrawal by Subject|8
148966|NCT00688701|529660|P3|Overall Study|Withdrawal by Subject|4
148967|NCT00688701|529661|P2|Overall Study|Withdrawal by Subject|3
148968|NCT00688701|529662|P1|Overall Study|Withdrawal by Subject|3
148969|NCT00688701|529659|P4|Overall Study|Lack of Efficacy|0
148970|NCT00688701|529660|P3|Overall Study|Lack of Efficacy|0
148971|NCT00688701|529661|P2|Overall Study|Lack of Efficacy|1
148972|NCT00688701|529662|P1|Overall Study|Lack of Efficacy|0
148973|NCT00688701|529659|P4|Overall Study|Adverse Event|3
148974|NCT00688701|529660|P3|Overall Study|Adverse Event|5
148975|NCT00688701|529661|P2|Overall Study|Adverse Event|0
148976|NCT00688701|529662|P1|Overall Study|Adverse Event|1
148977|NCT00688688|529703|P3|Overall Study|Violation of exclusion criterion|0
148978|NCT00688688|529704|P2|Overall Study|Violation of exclusion criterion|1
148979|NCT00688688|529705|P1|Overall Study|Violation of exclusion criterion|0
148980|NCT00688688|529703|P3|Overall Study|Site closure|0
148981|NCT00688688|529704|P2|Overall Study|Site closure|1
148982|NCT00688688|529705|P1|Overall Study|Site closure|0
148983|NCT00688688|529703|P3|Overall Study|Taking exclusionary medications|0
148984|NCT00688688|529704|P2|Overall Study|Taking exclusionary medications|0
148985|NCT00688688|529705|P1|Overall Study|Taking exclusionary medications|1
148986|NCT00688688|529703|P3|Overall Study|Non-compliance with study procedures|4
148987|NCT00688688|529704|P2|Overall Study|Non-compliance with study procedures|3
148988|NCT00688688|529705|P1|Overall Study|Non-compliance with study procedures|5
148989|NCT00688688|529703|P3|Overall Study|Randomized but never received study drug|0
148990|NCT00688688|529704|P2|Overall Study|Randomized but never received study drug|0
148991|NCT00688688|529705|P1|Overall Study|Randomized but never received study drug|1
148992|NCT00688688|529703|P3|Overall Study|Protocol Violation|11
148993|NCT00688688|529704|P2|Overall Study|Protocol Violation|9
148994|NCT00688688|529705|P1|Overall Study|Protocol Violation|6
148995|NCT00688688|529703|P3|Overall Study|Lost to Follow-up|7
148996|NCT00688688|529704|P2|Overall Study|Lost to Follow-up|7
148997|NCT00688688|529705|P1|Overall Study|Lost to Follow-up|14
148998|NCT00688688|529703|P3|Overall Study|Withdrawal by Subject|65
148999|NCT00688688|529704|P2|Overall Study|Withdrawal by Subject|75
149000|NCT00688688|529705|P1|Overall Study|Withdrawal by Subject|66
149001|NCT00688688|529703|P3|Overall Study|Lack of Efficacy|45
149002|NCT00688688|529704|P2|Overall Study|Lack of Efficacy|25
149003|NCT00688688|529705|P1|Overall Study|Lack of Efficacy|34
149004|NCT00688688|529703|P3|Overall Study|Adverse Event|50
149005|NCT00688688|529704|P2|Overall Study|Adverse Event|51
149006|NCT00688688|529705|P1|Overall Study|Adverse Event|52
149007|NCT00688688|529703|P3|Overall Study|Eligibility criterion not met|10
149008|NCT00688688|529704|P2|Overall Study|Eligibility criterion not met|7
149009|NCT00688688|529705|P1|Overall Study|Eligibility criterion not met|7
149010|NCT00688636|529807|P2|Overall Study|Adverse Event|1
149011|NCT00688636|529808|P1|Overall Study|Adverse Event|2
149012|NCT00688545|529824|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
149013|NCT00688545|529825|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
149014|NCT00688545|529824|P2|Overall Study|Withdrawal by Subject|3
149015|NCT00688545|529825|P1|Overall Study|Withdrawal by Subject|2
149016|NCT00688545|529824|P2|Overall Study|Insurance/cost of drug|1
149017|NCT00688545|529825|P1|Overall Study|Insurance/cost of drug|0
149018|NCT00688545|529824|P2|Overall Study|Lost to Follow-up|4
149019|NCT00688545|529825|P1|Overall Study|Lost to Follow-up|1
149020|NCT00688519|529835|P2|Overall Study|Pregnancy|1
149021|NCT00688519|529836|P1|Overall Study|Pregnancy|0
149022|NCT00688519|529835|P2|Overall Study|Subject moved out of area|0
149023|NCT00688519|529836|P1|Overall Study|Subject moved out of area|1
149024|NCT00688519|529835|P2|Overall Study|Investigator decision|0
149025|NCT00688519|529836|P1|Overall Study|Investigator decision|1
149026|NCT00688519|529835|P2|Overall Study|Subject moved out of state|0
149027|NCT00688519|529836|P1|Overall Study|Subject moved out of state|1
149028|NCT00688519|529835|P2|Overall Study|Non-compliance|1
149029|NCT00688519|529836|P1|Overall Study|Non-compliance|0
149030|NCT00688519|529835|P2|Overall Study|Prohibited medication|0
149031|NCT00688519|529836|P1|Overall Study|Prohibited medication|1
149032|NCT00688519|529835|P2|Overall Study|Withdrawal by Subject|6
149033|NCT00688519|529836|P1|Overall Study|Withdrawal by Subject|7
149034|NCT00688519|529835|P2|Overall Study|Lack of Efficacy|1
149035|NCT00688519|529836|P1|Overall Study|Lack of Efficacy|3
149036|NCT00688519|529835|P2|Overall Study|Lost to Follow-up|3
149037|NCT00688519|529836|P1|Overall Study|Lost to Follow-up|3
149038|NCT00688519|529835|P2|Overall Study|Adverse Event|3
149039|NCT00688519|529836|P1|Overall Study|Adverse Event|2
149040|NCT00688467|529854|P2|Treatment Period 2|Adverse Event|1
149041|NCT00688467|529855|P1|Treatment Period 2|Adverse Event|0
149042|NCT00688467|529854|P2|Treatment Period 2|Protocol Violation|1
149043|NCT00688467|529855|P1|Treatment Period 2|Protocol Violation|0
149044|NCT00688467|529854|P2|Treatment Period 1|Did not meet protocol eligibility|1
149045|NCT00688467|529855|P1|Treatment Period 1|Did not meet protocol eligibility|0
149046|NCT00688467|529854|P2|Treatment Period 1|Adverse Event|1
149047|NCT00688467|529855|P1|Treatment Period 1|Adverse Event|2
149048|NCT00688324|529885|P1|Overall Study|Lost to Follow-up|1
149049|NCT00688324|529885|P1|Overall Study|Physician Decision|5
149050|NCT00688324|529885|P1|Overall Study|Withdrawal by Subject|2
149051|NCT00688259|529930|P2|Overall Study|Hospitalized at Follow-up|1
149052|NCT00688259|529931|P1|Overall Study|Hospitalized at Follow-up|0
149053|NCT00688259|529930|P2|Overall Study|Declined Interview|3
149054|NCT00688259|529931|P1|Overall Study|Declined Interview|2
149055|NCT00688259|529930|P2|Overall Study|Withdrawal by Subject|0
149056|NCT00688259|529931|P1|Overall Study|Withdrawal by Subject|2
149057|NCT00688259|529930|P2|Overall Study|Physician Decision|0
149058|NCT00688259|529931|P1|Overall Study|Physician Decision|1
149059|NCT00688259|529930|P2|Overall Study|Lost to Follow-up|4
149060|NCT00688259|529931|P1|Overall Study|Lost to Follow-up|2
149061|NCT00688155|529951|P4|Overall Study|Withdrawal by Subject|1
149062|NCT00688155|529952|P3|Overall Study|Withdrawal by Subject|1
149063|NCT00688155|529953|P2|Overall Study|Withdrawal by Subject|2
149064|NCT00688155|529954|P1|Overall Study|Withdrawal by Subject|2
149065|NCT00688103|529974|P2|Overall Study|complex reasons|9
149066|NCT00688103|529975|P1|Overall Study|complex reasons|11
149067|NCT00688103|529974|P2|Overall Study|Withdrawal by Subject|2
149068|NCT00688103|529975|P1|Overall Study|Withdrawal by Subject|4
149069|NCT00688103|529974|P2|Overall Study|Lack of Efficacy|1
149070|NCT00688103|529975|P1|Overall Study|Lack of Efficacy|11
149071|NCT00688103|529974|P2|Overall Study|Adverse Event|1
149072|NCT00688103|529975|P1|Overall Study|Adverse Event|4
149073|NCT00688064|529987|P2|Overall Study|Any other reasons|3
149074|NCT00688064|529988|P1|Overall Study|Any other reasons|1
149075|NCT00688064|529987|P2|Overall Study|Pregnancy|0
149076|NCT00688064|529988|P1|Overall Study|Pregnancy|1
149077|NCT00688064|529987|P2|Overall Study|Lack of Efficacy|1
149078|NCT00688064|529988|P1|Overall Study|Lack of Efficacy|0
149079|NCT00688064|529987|P2|Overall Study|Lost to Follow-up|10
149080|NCT00688064|529988|P1|Overall Study|Lost to Follow-up|10
149081|NCT00688064|529987|P2|Overall Study|Withdrawal by Subject|7
149082|NCT00688064|529988|P1|Overall Study|Withdrawal by Subject|7
149083|NCT00688064|529987|P2|Overall Study|Adverse Event|4
149084|NCT00688064|529988|P1|Overall Study|Adverse Event|2
149085|NCT00688064|529987|P2|Overall Study|Protocol Violation|1
149086|NCT00688064|529988|P1|Overall Study|Protocol Violation|0
149087|NCT00687973|530004|P2|Overall Study|Withdrawal by Subject|3
149088|NCT00687973|530005|P1|Overall Study|Withdrawal by Subject|3
149089|NCT00687973|530004|P2|Overall Study|Administrative Reasons|2
149090|NCT00687973|530005|P1|Overall Study|Administrative Reasons|0
149091|NCT00687973|530004|P2|Overall Study|Protocol Violation|2
149092|NCT00687973|530005|P1|Overall Study|Protocol Violation|1
149093|NCT00687973|530004|P2|Overall Study|Lack of Efficacy|3
149094|NCT00687973|530005|P1|Overall Study|Lack of Efficacy|2
149095|NCT00687973|530004|P2|Overall Study|Adverse Event|28
149096|NCT00687973|530005|P1|Overall Study|Adverse Event|18
149097|NCT00687804|530067|P3|Open-Label Extension Study|Death|3
149098|NCT00687804|530068|P2|Open-Label Extension Study|Death|3
149099|NCT00687804|530069|P1|Open-Label Extension Study|Death|2
149100|NCT00687804|530067|P3|Open-Label Extension Study|Administrative problems|0
149101|NCT00687804|530068|P2|Open-Label Extension Study|Administrative problems|1
149102|NCT00687804|530069|P1|Open-Label Extension Study|Administrative problems|1
149103|NCT00687804|530067|P3|Open-Label Extension Study|Lost to Follow-up|2
149104|NCT00687804|530068|P2|Open-Label Extension Study|Lost to Follow-up|1
149105|NCT00687804|530069|P1|Open-Label Extension Study|Lost to Follow-up|2
149106|NCT00687804|530067|P3|Open-Label Extension Study|Subject withdrew consent|4
149107|NCT00687804|530068|P2|Open-Label Extension Study|Subject withdrew consent|4
149108|NCT00687804|530069|P1|Open-Label Extension Study|Subject withdrew consent|3
149109|NCT00687804|530067|P3|Open-Label Extension Study|Adverse Event|2
149110|NCT00687804|530068|P2|Open-Label Extension Study|Adverse Event|2
149111|NCT00687804|530069|P1|Open-Label Extension Study|Adverse Event|2
149112|NCT00687804|530067|P3|Core Study|Protocol Violation|0
149113|NCT00687804|530068|P2|Core Study|Protocol Violation|1
149114|NCT00687804|530069|P1|Core Study|Protocol Violation|1
149115|NCT00687804|530067|P3|Core Study|Death|2
149116|NCT00687804|530068|P2|Core Study|Death|2
149117|NCT00687804|530069|P1|Core Study|Death|2
149118|NCT00687804|530067|P3|Core Study|Lost to Follow-up|0
149119|NCT00687804|530068|P2|Core Study|Lost to Follow-up|1
149120|NCT00687804|530069|P1|Core Study|Lost to Follow-up|0
149121|NCT00687804|530067|P3|Core Study|Withdrawal by Subject|7
149122|NCT00687804|530068|P2|Core Study|Withdrawal by Subject|7
149123|NCT00687804|530069|P1|Core Study|Withdrawal by Subject|4
149124|NCT00687804|530067|P3|Core Study|Lack of Efficacy|1
149125|NCT00687804|530068|P2|Core Study|Lack of Efficacy|1
149126|NCT00687804|530069|P1|Core Study|Lack of Efficacy|1
149127|NCT00687804|530067|P3|Core Study|Abnormal laboratory value(s)|0
149128|NCT00687804|530068|P2|Core Study|Abnormal laboratory value(s)|0
149129|NCT00687804|530069|P1|Core Study|Abnormal laboratory value(s)|1
149130|NCT00687804|530067|P3|Core Study|Adverse Event|3
149131|NCT00687804|530068|P2|Core Study|Adverse Event|3
149132|NCT00687804|530069|P1|Core Study|Adverse Event|5
149133|NCT00687609|530130|P1|Overall Study|Withdrawal by Subject|2
149134|NCT00687609|530130|P1|Overall Study|Physician Decision|1
149135|NCT00687531|530153|P1|Overall Study|Lost to Follow-up|26
149136|NCT00687531|530153|P1|Overall Study|Adverse Event|5
149137|NCT00687531|530153|P1|Overall Study|Did not meet protocol eligibility|104
149138|NCT00687440|530176|P1|Overall Study|Missing|1
149139|NCT00687440|530176|P1|Overall Study|Not specified|1
149140|NCT00687440|530176|P1|Overall Study|Death|2
149141|NCT00687440|530176|P1|Overall Study|Lack of Efficacy|2
149142|NCT00687440|530176|P1|Overall Study|Lost to Follow-up|3
149143|NCT00687440|530176|P1|Overall Study|Adverse Event|3
149144|NCT00687401|530180|P1|Overall Study|For reasons different from those above|4
149145|NCT00687401|530180|P1|Overall Study|Did not return for visit|3
149146|NCT00687401|530180|P1|Overall Study|Withdrawal by Subject|4
149147|NCT00687401|530180|P1|Overall Study|Lack of Efficacy|6
149148|NCT00687401|530180|P1|Overall Study|Adverse Event|6
149149|NCT00687401|530180|P1|Overall Study|Protocol Violation|7
149150|NCT00687362|530185|P1|Overall Study|Withdrawal by Subject|1
149151|NCT00687362|530185|P1|Overall Study|Protocol Violation|2
149152|NCT00687323|530189|P1|Overall Study|Screen failure|148
149153|NCT00687323|530189|P1|Overall Study|Excluded from efficacy evaluations|6
149154|NCT00687323|530189|P1|Overall Study|Withdrawal by Subject|1
149155|NCT00687323|530189|P1|Overall Study|Death|25
149156|NCT00687297|530205|P2|Induction|Other|1
149157|NCT00687297|530206|P1|Induction|Other|0
149158|NCT00687297|530205|P2|Induction|Physician Decision|2
149159|NCT00687297|530206|P1|Induction|Physician Decision|0
149160|NCT00687297|530205|P2|Induction|Patient Noncompliance|0
149161|NCT00687297|530206|P1|Induction|Patient Noncompliance|1
149162|NCT00687297|530205|P2|Induction|Ineligible|1
149163|NCT00687297|530206|P1|Induction|Ineligible|0
149164|NCT00687297|530205|P2|Induction|Lack of Efficacy|21
149165|NCT00687297|530206|P1|Induction|Lack of Efficacy|17
149166|NCT00687297|530205|P2|Induction|Death|11
149167|NCT00687297|530206|P1|Induction|Death|7
149168|NCT00687297|530205|P2|Induction|Adverse Event|15
149169|NCT00687297|530206|P1|Induction|Adverse Event|16
149170|NCT00687297|530205|P2|Induction|Withdrawal by Subject|4
149171|NCT00687297|530206|P1|Induction|Withdrawal by Subject|4
149172|NCT00687297|530205|P2|Randomization|Withdrew before treatment, ineligible|1
149173|NCT00687297|530206|P1|Randomization|Withdrew before treatment, ineligible|1
149174|NCT00687297|530205|P2|Randomization|Withdrawal by Subject|0
149175|NCT00687297|530206|P1|Randomization|Withdrawal by Subject|2
149176|NCT00687219|530216|P1|Overall Study|Lack of Efficacy|1
149177|NCT00687219|530216|P1|Overall Study|Withdrawal by Subject|1
149178|NCT00687219|530216|P1|Overall Study|HCV-RNA positive conversion|34
149179|NCT00687219|530216|P1|Overall Study|Discontinuance criteria met|7
149180|NCT00687219|530216|P1|Overall Study|Adverse Event|8
149181|NCT00687193|530228|P6|Overall Study|Protocol Violation|0
149182|NCT00687193|530229|P5|Overall Study|Protocol Violation|2
149183|NCT00687193|530230|P4|Overall Study|Protocol Violation|1
149184|NCT00687193|530231|P3|Overall Study|Protocol Violation|0
149185|NCT00687193|530232|P2|Overall Study|Protocol Violation|2
149186|NCT00687193|530233|P1|Overall Study|Protocol Violation|1
149187|NCT00687193|530228|P6|Overall Study|Lack of Efficacy|2
149188|NCT00687193|530229|P5|Overall Study|Lack of Efficacy|0
149189|NCT00687193|530230|P4|Overall Study|Lack of Efficacy|0
149190|NCT00687193|530231|P3|Overall Study|Lack of Efficacy|0
149191|NCT00687193|530232|P2|Overall Study|Lack of Efficacy|1
149192|NCT00687193|530233|P1|Overall Study|Lack of Efficacy|1
149193|NCT00687193|530228|P6|Overall Study|Adverse Event|2
149194|NCT00687193|530229|P5|Overall Study|Adverse Event|0
149195|NCT00687193|530230|P4|Overall Study|Adverse Event|3
149196|NCT00687193|530231|P3|Overall Study|Adverse Event|2
149197|NCT00687193|530232|P2|Overall Study|Adverse Event|1
149198|NCT00687193|530233|P1|Overall Study|Adverse Event|0
149199|NCT00686998|530443|P3|Overall Study|Safety Reasons|0
149200|NCT00686998|530444|P2|Overall Study|Safety Reasons|0
149201|NCT00686998|530445|P1|Overall Study|Safety Reasons|1
149202|NCT00686998|530443|P3|Overall Study|Not specified|1
149203|NCT00686998|530444|P2|Overall Study|Not specified|0
149204|NCT00686998|530445|P1|Overall Study|Not specified|0
149205|NCT00686998|530443|P3|Overall Study|Lack of Efficacy|0
149206|NCT00686998|530444|P2|Overall Study|Lack of Efficacy|5
149207|NCT00686998|530445|P1|Overall Study|Lack of Efficacy|7
149208|NCT00686998|530443|P3|Overall Study|Withdrawal by Subject|2
149209|NCT00686998|530444|P2|Overall Study|Withdrawal by Subject|1
149210|NCT00686998|530445|P1|Overall Study|Withdrawal by Subject|2
149211|NCT00686998|530443|P3|Overall Study|Adverse Event|1
149212|NCT00686998|530444|P2|Overall Study|Adverse Event|2
149213|NCT00686998|530445|P1|Overall Study|Adverse Event|3
149214|NCT00686972|530453|P1|Overall Study|P.I, Left institution. Study terminated|51
149215|NCT00686959|530459|P2|Overall Study|Participants censored (no death events)|117
149216|NCT00686959|530460|P1|Overall Study|Participants censored (no death events)|124
149217|NCT00686894|530478|P1|Overall Study|Protocol Violation|4
149218|NCT00686894|530478|P1|Overall Study|Relapse|2
149219|NCT00686881|530484|P2|Overall Study|Never received study drug|6
149220|NCT00686881|530485|P1|Overall Study|Never received study drug|2
149221|NCT00686881|530484|P2|Overall Study|Study discontinuation|32
149222|NCT00686881|530485|P1|Overall Study|Study discontinuation|35
149223|NCT00686881|530484|P2|Overall Study|Irregular visits|0
149224|NCT00686881|530485|P1|Overall Study|Irregular visits|1
149225|NCT00686881|530484|P2|Overall Study|Did not meet protocol eligibility|0
149226|NCT00686881|530485|P1|Overall Study|Did not meet protocol eligibility|1
149227|NCT00686881|530484|P2|Overall Study|Circumstances of site|1
149228|NCT00686881|530485|P1|Overall Study|Circumstances of site|1
149229|NCT00686881|530484|P2|Overall Study|Physician Decision|0
149230|NCT00686881|530485|P1|Overall Study|Physician Decision|1
149231|NCT00686881|530484|P2|Overall Study|Lack of Efficacy|3
149232|NCT00686881|530485|P1|Overall Study|Lack of Efficacy|4
149233|NCT00686881|530484|P2|Overall Study|Onset of malignant tumor|11
149234|NCT00686881|530485|P1|Overall Study|Onset of malignant tumor|11
149235|NCT00686881|530484|P2|Overall Study|Met discontinuation criteria|0
149236|NCT00686881|530485|P1|Overall Study|Met discontinuation criteria|5
149237|NCT00686881|530484|P2|Overall Study|Treatment-related adverse event|9
149238|NCT00686881|530485|P1|Overall Study|Treatment-related adverse event|10
149239|NCT00686881|530484|P2|Overall Study|Lost to Follow-up|1
149240|NCT00686881|530485|P1|Overall Study|Lost to Follow-up|0
149241|NCT00686881|530484|P2|Overall Study|Withdrawal by Subject|18
149242|NCT00686881|530485|P1|Overall Study|Withdrawal by Subject|11
149243|NCT00686855|530497|P2|Overall Study|Progressive GVHD|1
149244|NCT00686855|530498|P1|Overall Study|Progressive GVHD|0
149245|NCT00686855|530497|P2|Overall Study|Lost to Follow-up|0
149246|NCT00686855|530498|P1|Overall Study|Lost to Follow-up|1
149247|NCT00686790|530524|P1|Overall Study|Lost to Follow-up|12
149248|NCT00686790|530524|P1|Overall Study|Death|1
149249|NCT00686790|530524|P1|Overall Study|Withdrawal by Subject|1
149250|NCT00686790|530524|P1|Overall Study|Adverse Event|2
149251|NCT00686777|530532|P1|Overall Study|No Visit|1
149252|NCT00686777|530532|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
149253|NCT00686777|530532|P1|Overall Study|Withdrawal by Subject|2
149254|NCT00686777|530532|P1|Overall Study|Pregnancy|1
149255|NCT00686777|530532|P1|Overall Study|Adverse Event|2
149256|NCT00686725|530540|P2|Overall Study|Not Specified|3
149257|NCT00686725|530541|P1|Overall Study|Not Specified|1
149258|NCT00686725|530540|P2|Overall Study|Protocol Violation|3
149259|NCT00686725|530541|P1|Overall Study|Protocol Violation|1
149260|NCT00686725|530540|P2|Overall Study|Withdrawal by Subject|4
149261|NCT00686725|530541|P1|Overall Study|Withdrawal by Subject|13
149262|NCT00686725|530540|P2|Overall Study|Death|3
149263|NCT00686725|530541|P1|Overall Study|Death|6
149264|NCT00686725|530540|P2|Overall Study|Lost to Follow-up|5
149265|NCT00686725|530541|P1|Overall Study|Lost to Follow-up|7
149266|NCT00686725|530540|P2|Overall Study|Progressive Disease|23
149267|NCT00686725|530541|P1|Overall Study|Progressive Disease|17
149268|NCT00686725|530540|P2|Overall Study|Adverse Event|1
149269|NCT00686725|530541|P1|Overall Study|Adverse Event|1
149270|NCT00686712|530566|P3|Overall Study|Adverse Event|0
149271|NCT00686712|530567|P2|Overall Study|Adverse Event|1
149272|NCT00686712|530568|P1|Overall Study|Adverse Event|1
149273|NCT00686712|530566|P3|Overall Study|Lost to Follow-up|3
149274|NCT00686712|530567|P2|Overall Study|Lost to Follow-up|2
149275|NCT00686712|530568|P1|Overall Study|Lost to Follow-up|1
149276|NCT00686712|530566|P3|Overall Study|Protocol Violation|10
149277|NCT00686712|530567|P2|Overall Study|Protocol Violation|8
149278|NCT00686712|530568|P1|Overall Study|Protocol Violation|8
149279|NCT00686699|530596|P2|Treatment Period 1|Adverse Event|2
149280|NCT00686699|530597|P1|Treatment Period 1|Adverse Event|0
149281|NCT00686686|530621|P1|Overall Study|Lost to Follow-up|3
149282|NCT00686686|530621|P1|Overall Study|Adverse Event|2
149283|NCT00686686|530621|P1|Overall Study|Non-compliance|1
149284|NCT00686647|530629|P1|Overall Study|Death|1
149285|NCT00686647|530629|P1|Overall Study|Lost to Follow-up|1
149286|NCT00686634|530635|P1|Overall Study|Protocol Violation|6
149287|NCT00686595|530642|P1|Overall Study|Poor Compliance|1
149288|NCT00686595|530642|P1|Overall Study|Lack of Efficacy|1
149289|NCT00686595|530642|P1|Overall Study|Lost to Follow-up|1
149290|NCT00686595|530642|P1|Overall Study|Protocol Violation|1
149291|NCT00686595|530642|P1|Overall Study|Adverse Event|3
149292|NCT00686543|530671|P4|Overall Study|Protocol Violation|1
149293|NCT00686543|530672|P3|Overall Study|Protocol Violation|2
149294|NCT00686543|530673|P2|Overall Study|Protocol Violation|0
149295|NCT00686543|530674|P1|Overall Study|Protocol Violation|3
149296|NCT00686543|530671|P4|Overall Study|Withdrawal by Subject|0
149297|NCT00686543|530672|P3|Overall Study|Withdrawal by Subject|0
149298|NCT00686543|530673|P2|Overall Study|Withdrawal by Subject|0
149299|NCT00686543|530674|P1|Overall Study|Withdrawal by Subject|2
149300|NCT00686543|530671|P4|Overall Study|Adverse Event|2
149301|NCT00686543|530672|P3|Overall Study|Adverse Event|3
149302|NCT00686543|530673|P2|Overall Study|Adverse Event|1
149303|NCT00686543|530674|P1|Overall Study|Adverse Event|9
149304|NCT00686517|530695|P3|Treatment|Protocol Violation|0
149305|NCT00686517|530696|P2|Treatment|Protocol Violation|1
149306|NCT00686517|530697|P1|Treatment|Protocol Violation|2
149307|NCT00686517|530695|P3|Treatment|Poor Protocol Compliance|0
149308|NCT00686517|530696|P2|Treatment|Poor Protocol Compliance|0
149309|NCT00686517|530697|P1|Treatment|Poor Protocol Compliance|1
149310|NCT00686517|530695|P3|Treatment|Adverse Event|0
149311|NCT00686517|530696|P2|Treatment|Adverse Event|0
149312|NCT00686517|530697|P1|Treatment|Adverse Event|2
149313|NCT00686517|530695|P3|Treatment|Serious Adverse Event|1
149314|NCT00686517|530696|P2|Treatment|Serious Adverse Event|2
149315|NCT00686517|530697|P1|Treatment|Serious Adverse Event|1
149316|NCT00686374|530720|P1|Overall Study|Other, not specified|4
149317|NCT00686374|530720|P1|Overall Study|Missing reason|33
149318|NCT00686374|530720|P1|Overall Study|Lost to Follow-up|1
149319|NCT00686374|530720|P1|Overall Study|Withdrew consent|5
149320|NCT00686374|530720|P1|Overall Study|Adverse Event|8
149321|NCT00686374|530720|P1|Overall Study|Lack of Efficacy|10
149322|NCT00686335|530731|P1|Run-in Period|violation of inclusion/exclusion criteri|3
149323|NCT00686335|530731|P1|Run-in Period|asthma exacerbation|1
149324|NCT00686335|530731|P1|Run-in Period|Adverse Event|1
149325|NCT00686205|530761|P2|Overall Study|Specimens not confirmed HIV positive|981
149326|NCT00686205|530762|P1|Overall Study|Specimens not confirmed HIV positive|0
149327|NCT00686205|530761|P2|Overall Study|Specimen handling procedure altered|0
149328|NCT00686205|530762|P1|Overall Study|Specimen handling procedure altered|5878
149329|NCT00686205|530761|P2|Overall Study|Withdrawal by Subject|0
149330|NCT00686205|530762|P1|Overall Study|Withdrawal by Subject|2
149331|NCT00686205|530761|P2|Overall Study|Protocol Violation|0
149332|NCT00686205|530762|P1|Overall Study|Protocol Violation|127
149333|NCT00686166|530768|P1|Overall Study|Did not begin protocol therapy|4
149334|NCT00686166|530768|P1|Overall Study|Ineligible|5
149335|NCT00686166|530768|P1|Overall Study|Not Protocol Specified|1
149336|NCT00686166|530768|P1|Overall Study|Death|1
149337|NCT00686166|530768|P1|Overall Study|Progression/Relapse|1
149338|NCT00686166|530768|P1|Overall Study|Withdrawal by Subject|1
149339|NCT00686166|530768|P1|Overall Study|Adverse Event|7
149340|NCT00686127|530780|P2|Overall Study|Withdrawal by Subject|6
149341|NCT00686127|530781|P1|Overall Study|Withdrawal by Subject|14
149342|NCT00686075|530797|P10|Overall Study|Other|1
149343|NCT00686075|530798|P9|Overall Study|Other|0
149344|NCT00686075|530799|P8|Overall Study|Other|0
149345|NCT00686075|530800|P7|Overall Study|Other|0
149346|NCT00686075|530801|P6|Overall Study|Other|0
149347|NCT00686075|530802|P5|Overall Study|Other|0
149348|NCT00686075|530803|P4|Overall Study|Other|0
149349|NCT00686075|530804|P3|Overall Study|Other|0
149350|NCT00686075|530805|P2|Overall Study|Other|1
149351|NCT00686075|530806|P1|Overall Study|Other|1
149352|NCT00686075|530797|P10|Overall Study|Lost to Follow-up|3
149353|NCT00686075|530798|P9|Overall Study|Lost to Follow-up|2
149354|NCT00686075|530799|P8|Overall Study|Lost to Follow-up|0
149355|NCT00686075|530800|P7|Overall Study|Lost to Follow-up|0
149356|NCT00686075|530801|P6|Overall Study|Lost to Follow-up|3
149357|NCT00686075|530802|P5|Overall Study|Lost to Follow-up|3
149358|NCT00686075|530803|P4|Overall Study|Lost to Follow-up|2
149359|NCT00686075|530804|P3|Overall Study|Lost to Follow-up|3
149360|NCT00686075|530805|P2|Overall Study|Lost to Follow-up|6
149361|NCT00686075|530806|P1|Overall Study|Lost to Follow-up|3
149362|NCT00686075|530797|P10|Overall Study|Withdrawal by Subject|6
149363|NCT00686075|530798|P9|Overall Study|Withdrawal by Subject|4
149364|NCT00686075|530799|P8|Overall Study|Withdrawal by Subject|2
149365|NCT00686075|530800|P7|Overall Study|Withdrawal by Subject|0
149366|NCT00686075|530801|P6|Overall Study|Withdrawal by Subject|0
149367|NCT00686075|530802|P5|Overall Study|Withdrawal by Subject|1
149368|NCT00686075|530803|P4|Overall Study|Withdrawal by Subject|7
149369|NCT00686075|530804|P3|Overall Study|Withdrawal by Subject|3
149370|NCT00686075|530805|P2|Overall Study|Withdrawal by Subject|3
149371|NCT00686075|530806|P1|Overall Study|Withdrawal by Subject|4
149372|NCT00686036|531000|P2|Overall Study|Other reasons not identified|4
149373|NCT00686036|531001|P1|Overall Study|Other reasons not identified|0
149374|NCT00686036|531000|P2|Overall Study|PSA ≥ 10ng/mL|0
149375|NCT00686036|531001|P1|Overall Study|PSA ≥ 10ng/mL|1
149376|NCT00686036|531000|P2|Overall Study|Study terminated by AstraZeneca|1
149377|NCT00686036|531001|P1|Overall Study|Study terminated by AstraZeneca|2
149378|NCT00686036|531000|P2|Overall Study|Withdrawal by Subject|1
149379|NCT00686036|531001|P1|Overall Study|Withdrawal by Subject|3
149380|NCT00686036|531000|P2|Overall Study|Adverse Event|0
149381|NCT00686036|531001|P1|Overall Study|Adverse Event|3
149382|NCT00685945|531013|P1|L-NMMA + Bradykinin|Physician Decision|1
149383|NCT00685802|531048|P2|Washout Period of 7 Days|Withdrawal by Subject|1
149384|NCT00685802|531049|P1|Washout Period of 7 Days|Withdrawal by Subject|0
149385|NCT00685802|531048|P2|Washout Period of 7 Days|Protocol Violation|0
149386|NCT00685802|531049|P1|Washout Period of 7 Days|Protocol Violation|2
149387|NCT00685763|531059|P1|Overall Study|Protocol Violation|1
149388|NCT00685763|531059|P1|Overall Study|Intercurrent death-incomplete treatment|1
149389|NCT00685698|531063|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
149390|NCT00685698|531063|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
149391|NCT00685698|531063|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
149392|NCT00685698|531063|P1|Overall Study|Adverse Event|3
149393|NCT00685698|531063|P1|Overall Study|Protocol Violation|6
149394|NCT00685698|531063|P1|Overall Study|Withdrawal by Subject|1
149395|NCT00685685|531098|P2|Washout Period of 7 Days|Withdrawal by Subject|1
149396|NCT00685685|531099|P1|Washout Period of 7 Days|Withdrawal by Subject|0
149397|NCT00685685|531098|P2|Washout Period of 7 Days|Adverse Event|0
149398|NCT00685685|531099|P1|Washout Period of 7 Days|Adverse Event|2
149399|NCT00685399|531252|P8|Extension|Adverse Event|0
149400|NCT00685399|531253|P7|Extension|Adverse Event|0
149401|NCT00685399|531254|P6|Extension|Adverse Event|0
149402|NCT00685399|531255|P5|Extension|Adverse Event|0
149403|NCT00685399|531256|P4|Extension|Adverse Event|2
149404|NCT00685399|531257|P3|Extension|Adverse Event|0
149405|NCT00685399|531258|P2|Extension|Adverse Event|0
149406|NCT00685399|531259|P1|Extension|Adverse Event|0
149407|NCT00685399|531252|P8|Extension|Lack of Efficacy|0
149408|NCT00685399|531253|P7|Extension|Lack of Efficacy|0
149409|NCT00685399|531254|P6|Extension|Lack of Efficacy|0
149410|NCT00685399|531255|P5|Extension|Lack of Efficacy|0
149411|NCT00685399|531256|P4|Extension|Lack of Efficacy|2
149412|NCT00685399|531257|P3|Extension|Lack of Efficacy|0
149413|NCT00685399|531258|P2|Extension|Lack of Efficacy|0
149414|NCT00685399|531259|P1|Extension|Lack of Efficacy|0
149415|NCT00685399|531252|P8|Extension|Protocol Violation|0
149416|NCT00685399|531253|P7|Extension|Protocol Violation|0
149417|NCT00685399|531254|P6|Extension|Protocol Violation|0
149418|NCT00685399|531255|P5|Extension|Protocol Violation|0
149419|NCT00685399|531256|P4|Extension|Protocol Violation|1
149420|NCT00685399|531257|P3|Extension|Protocol Violation|0
149421|NCT00685399|531258|P2|Extension|Protocol Violation|0
149422|NCT00685399|531259|P1|Extension|Protocol Violation|0
149423|NCT00685399|531252|P8|Extension|Withdrawal by Subject|0
149424|NCT00685399|531253|P7|Extension|Withdrawal by Subject|0
149425|NCT00685399|531254|P6|Extension|Withdrawal by Subject|0
149426|NCT00685399|531255|P5|Extension|Withdrawal by Subject|0
149427|NCT00685399|531256|P4|Extension|Withdrawal by Subject|1
149428|NCT00685399|531257|P3|Extension|Withdrawal by Subject|0
149429|NCT00685399|531258|P2|Extension|Withdrawal by Subject|0
149430|NCT00685399|531259|P1|Extension|Withdrawal by Subject|0
149431|NCT00685399|531252|P8|Extension|Administrative Issues|0
149432|NCT00685399|531253|P7|Extension|Administrative Issues|0
149433|NCT00685399|531254|P6|Extension|Administrative Issues|0
149434|NCT00685399|531255|P5|Extension|Administrative Issues|0
149435|NCT00685399|531256|P4|Extension|Administrative Issues|1
149436|NCT00685399|531257|P3|Extension|Administrative Issues|0
149437|NCT00685399|531258|P2|Extension|Administrative Issues|0
149438|NCT00685399|531259|P1|Extension|Administrative Issues|0
149439|NCT00685399|531252|P8|Treatment Period 2|Lack of Efficacy|0
149440|NCT00685399|531253|P7|Treatment Period 2|Lack of Efficacy|0
149441|NCT00685399|531254|P6|Treatment Period 2|Lack of Efficacy|1
149442|NCT00685399|531255|P5|Treatment Period 2|Lack of Efficacy|0
149443|NCT00685399|531256|P4|Treatment Period 2|Lack of Efficacy|0
149444|NCT00685399|531257|P3|Treatment Period 2|Lack of Efficacy|2
149445|NCT00685399|531258|P2|Treatment Period 2|Lack of Efficacy|10
149446|NCT00685399|531259|P1|Treatment Period 2|Lack of Efficacy|0
149447|NCT00685399|531252|P8|Treatment Period 2|Adverse Event|0
149448|NCT00685399|531253|P7|Treatment Period 2|Adverse Event|0
149449|NCT00685399|531254|P6|Treatment Period 2|Adverse Event|1
149450|NCT00685399|531255|P5|Treatment Period 2|Adverse Event|0
149451|NCT00685399|531256|P4|Treatment Period 2|Adverse Event|0
149452|NCT00685399|531257|P3|Treatment Period 2|Adverse Event|0
149453|NCT00685399|531258|P2|Treatment Period 2|Adverse Event|0
149454|NCT00685399|531259|P1|Treatment Period 2|Adverse Event|0
149455|NCT00685399|531252|P8|Treatment Period 2|Withdrawal by Subject|2
149456|NCT00685399|531253|P7|Treatment Period 2|Withdrawal by Subject|0
149457|NCT00685399|531254|P6|Treatment Period 2|Withdrawal by Subject|0
149458|NCT00685399|531255|P5|Treatment Period 2|Withdrawal by Subject|0
149459|NCT00685399|531256|P4|Treatment Period 2|Withdrawal by Subject|0
149460|NCT00685399|531257|P3|Treatment Period 2|Withdrawal by Subject|0
149461|NCT00685399|531258|P2|Treatment Period 2|Withdrawal by Subject|0
149462|NCT00685399|531259|P1|Treatment Period 2|Withdrawal by Subject|0
149463|NCT00685399|531252|P8|Treatment Period 2|Administrative Problems|0
149464|NCT00685399|531253|P7|Treatment Period 2|Administrative Problems|0
149465|NCT00685399|531254|P6|Treatment Period 2|Administrative Problems|0
149466|NCT00685399|531255|P5|Treatment Period 2|Administrative Problems|0
149467|NCT00685399|531256|P4|Treatment Period 2|Administrative Problems|0
149468|NCT00685399|531257|P3|Treatment Period 2|Administrative Problems|1
149469|NCT00685399|531258|P2|Treatment Period 2|Administrative Problems|2
149470|NCT00685399|531259|P1|Treatment Period 2|Administrative Problems|0
149471|NCT00685399|531252|P8|Treatment Period 1|Lack of Efficacy|0
149472|NCT00685399|531253|P7|Treatment Period 1|Lack of Efficacy|0
149473|NCT00685399|531254|P6|Treatment Period 1|Lack of Efficacy|0
149474|NCT00685399|531255|P5|Treatment Period 1|Lack of Efficacy|0
149475|NCT00685399|531256|P4|Treatment Period 1|Lack of Efficacy|0
149476|NCT00685399|531257|P3|Treatment Period 1|Lack of Efficacy|0
149477|NCT00685399|531258|P2|Treatment Period 1|Lack of Efficacy|0
149478|NCT00685399|531259|P1|Treatment Period 1|Lack of Efficacy|1
149479|NCT00685399|531252|P8|Treatment Period 1|Administrative|0
149480|NCT00685399|531253|P7|Treatment Period 1|Administrative|0
149481|NCT00685399|531254|P6|Treatment Period 1|Administrative|0
149482|NCT00685399|531255|P5|Treatment Period 1|Administrative|0
149483|NCT00685399|531256|P4|Treatment Period 1|Administrative|0
149484|NCT00685399|531257|P3|Treatment Period 1|Administrative|0
149485|NCT00685399|531258|P2|Treatment Period 1|Administrative|0
149486|NCT00685399|531259|P1|Treatment Period 1|Administrative|2
149487|NCT00685399|531252|P8|Treatment Period 1|Protocol Violation|0
149488|NCT00685399|531253|P7|Treatment Period 1|Protocol Violation|0
149489|NCT00685399|531254|P6|Treatment Period 1|Protocol Violation|0
149490|NCT00685399|531255|P5|Treatment Period 1|Protocol Violation|0
149491|NCT00685399|531256|P4|Treatment Period 1|Protocol Violation|0
149492|NCT00685399|531257|P3|Treatment Period 1|Protocol Violation|0
149493|NCT00685399|531258|P2|Treatment Period 1|Protocol Violation|0
149494|NCT00685399|531259|P1|Treatment Period 1|Protocol Violation|1
149495|NCT00685399|531252|P8|Treatment Period 1|Withdrawal by Subject|0
149496|NCT00685399|531253|P7|Treatment Period 1|Withdrawal by Subject|0
149497|NCT00685399|531254|P6|Treatment Period 1|Withdrawal by Subject|0
149498|NCT00685399|531255|P5|Treatment Period 1|Withdrawal by Subject|0
149499|NCT00685399|531256|P4|Treatment Period 1|Withdrawal by Subject|0
149500|NCT00685399|531257|P3|Treatment Period 1|Withdrawal by Subject|0
149501|NCT00685399|531258|P2|Treatment Period 1|Withdrawal by Subject|0
149502|NCT00685399|531259|P1|Treatment Period 1|Withdrawal by Subject|2
149503|NCT00685373|531292|P1|Overall Study|Protocol Violation|1
149504|NCT00685373|531292|P1|Overall Study|Lost to Follow-up|2
149505|NCT00685373|531292|P1|Overall Study|Condition no longer requires study drug|1
149506|NCT00685373|531292|P1|Overall Study|Lack of Efficacy|3
149507|NCT00685373|531292|P1|Overall Study|Withdrawal by Subject|5
149508|NCT00685373|531292|P1|Overall Study|Adverse Event|3
149509|NCT00685334|531301|P2|Overall Study|Chose to enter hospital|1
149510|NCT00685334|531302|P1|Overall Study|Chose to enter hospital|1
149511|NCT00685334|531301|P2|Overall Study|Lost to Follow-up|0
149512|NCT00685334|531302|P1|Overall Study|Lost to Follow-up|4
149513|NCT00685334|531301|P2|Overall Study|Withdrawal by Subject|6
149514|NCT00685334|531302|P1|Overall Study|Withdrawal by Subject|5
149515|NCT00685178|531327|P4|Overall Study|Pregnancy|1
149516|NCT00685178|531328|P3|Overall Study|Pregnancy|0
149517|NCT00685178|531329|P2|Overall Study|Pregnancy|0
149518|NCT00685178|531330|P1|Overall Study|Pregnancy|0
149519|NCT00685178|531327|P4|Overall Study|administrative (disciplinary) discharge|2
149520|NCT00685178|531328|P3|Overall Study|administrative (disciplinary) discharge|0
149521|NCT00685178|531329|P2|Overall Study|administrative (disciplinary) discharge|1
149522|NCT00685178|531330|P1|Overall Study|administrative (disciplinary) discharge|0
149523|NCT00685178|531327|P4|Overall Study|incarcerated|0
149524|NCT00685178|531328|P3|Overall Study|incarcerated|7
149525|NCT00685178|531329|P2|Overall Study|incarcerated|3
149526|NCT00685178|531330|P1|Overall Study|incarcerated|1
149527|NCT00685178|531327|P4|Overall Study|voluntary study discharge|1
149528|NCT00685178|531328|P3|Overall Study|voluntary study discharge|1
149529|NCT00685178|531329|P2|Overall Study|voluntary study discharge|5
149530|NCT00685178|531330|P1|Overall Study|voluntary study discharge|4
149531|NCT00685178|531327|P4|Overall Study|missed 3 consecutive methadone clin days|6
149532|NCT00685178|531328|P3|Overall Study|missed 3 consecutive methadone clin days|2
149533|NCT00685178|531329|P2|Overall Study|missed 3 consecutive methadone clin days|5
149534|NCT00685178|531330|P1|Overall Study|missed 3 consecutive methadone clin days|7
149535|NCT00685178|531327|P4|Overall Study|Adverse Event|4
149536|NCT00685178|531328|P3|Overall Study|Adverse Event|2
149537|NCT00685178|531329|P2|Overall Study|Adverse Event|5
149538|NCT00685178|531330|P1|Overall Study|Adverse Event|1
149539|NCT00685165|531344|P2|Washout Period of 14 Days|Adverse Event|0
149540|NCT00685165|531345|P1|Washout Period of 14 Days|Adverse Event|1
149541|NCT00685035|531364|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
149542|NCT00685035|531365|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
149543|NCT00684996|531389|P1|Overall Study|Other reasons not protocol specified|1
149544|NCT00684996|531389|P1|Overall Study|Progression/relapse|2
149545|NCT00684996|531389|P1|Overall Study|Refusal unrelated to adverse event|1
149546|NCT00684996|531389|P1|Overall Study|Adverse Event|1
149547|NCT00684814|531421|P2|Second Intervention|Adverse Event|0
149548|NCT00684814|531422|P1|Second Intervention|Adverse Event|1
149549|NCT00684814|531421|P2|Washout Period of 7 Days|Withdrawal by Subject|2
149550|NCT00684814|531422|P1|Washout Period of 7 Days|Withdrawal by Subject|1
149551|NCT00684814|531421|P2|Washout Period of 7 Days|Adverse Event|2
149552|NCT00684814|531422|P1|Washout Period of 7 Days|Adverse Event|1
149553|NCT00684762|531474|P2|Washout Period of 7 Days|Withdrawal by Subject|2
149554|NCT00684762|531475|P1|Washout Period of 7 Days|Withdrawal by Subject|2
149555|NCT00684671|531503|P3|Overall Study|Alcoholic dependance|0
149556|NCT00684671|531504|P2|Overall Study|Alcoholic dependance|0
149557|NCT00684671|531505|P1|Overall Study|Alcoholic dependance|1
149558|NCT00684671|531503|P3|Overall Study|Lost to Follow-up|0
149559|NCT00684671|531504|P2|Overall Study|Lost to Follow-up|0
149560|NCT00684671|531505|P1|Overall Study|Lost to Follow-up|1
149561|NCT00684671|531503|P3|Overall Study|Adverse Event|0
149562|NCT00684671|531504|P2|Overall Study|Adverse Event|0
149563|NCT00684671|531505|P1|Overall Study|Adverse Event|1
149564|NCT00684645|531534|P1|Overall Study|Not specified|15
149565|NCT00684645|531534|P1|Overall Study|Lost to Follow-up|3
149566|NCT00684645|531534|P1|Overall Study|Adverse Event|27
149567|NCT00684645|531534|P1|Overall Study|Progressive disease|67
149568|NCT00684645|531534|P1|Overall Study|Death|2
149569|NCT00684593|531554|P2|Overall Study|Adverse Event|2
149570|NCT00684593|531555|P1|Overall Study|Adverse Event|0
149571|NCT00684567|531567|P1|Monotherapy Period|Progression of primary disease|11
149572|NCT00684567|531567|P1|Monotherapy Period|Death|1
149573|NCT00684567|531567|P1|Monotherapy Period|Adverse Event|2
149574|NCT00684567|531567|P1|Concomitant Radiotherapy Period|Adverse Event|2
149575|NCT00684515|531600|P3|Overall Study|Protocol-Defined Clinical Event|0
149576|NCT00684515|531601|P2|Overall Study|Protocol-Defined Clinical Event|0
149577|NCT00684515|531602|P1|Overall Study|Protocol-Defined Clinical Event|1
149578|NCT00684515|531600|P3|Overall Study|Adverse Event|1
149579|NCT00684515|531601|P2|Overall Study|Adverse Event|3
149580|NCT00684515|531602|P1|Overall Study|Adverse Event|3
149581|NCT00684424|531625|P1|Overall Study|Not Specified|2
149582|NCT00684424|531625|P1|Overall Study|Lost to Follow-up|2
149583|NCT00684424|531625|P1|Overall Study|Adverse Event|1
149584|NCT00684411|531640|P1|Overall Study|Adverse Event|1
149585|NCT00684411|531640|P1|Overall Study|Disease Progression|10
149586|NCT00684411|531640|P1|Overall Study|New Primary Cancer|1
149587|NCT00684307|531662|P5|Overall Study|Criteria from the CSR|3
149588|NCT00684307|531663|P4|Overall Study|Criteria from the CSR|3
149589|NCT00684307|531664|P3|Overall Study|Criteria from the CSR|1
149590|NCT00684307|531665|P2|Overall Study|Criteria from the CSR|0
149591|NCT00684307|531666|P1|Overall Study|Criteria from the CSR|0
149592|NCT00684307|531662|P5|Overall Study|Participant not willing to continue|8
149593|NCT00684307|531663|P4|Overall Study|Participant not willing to continue|5
149594|NCT00684307|531664|P3|Overall Study|Participant not willing to continue|11
149595|NCT00684307|531665|P2|Overall Study|Participant not willing to continue|10
149596|NCT00684307|531666|P1|Overall Study|Participant not willing to continue|7
149597|NCT00684307|531662|P5|Overall Study|Severe non compliance to protocol|2
149598|NCT00684307|531663|P4|Overall Study|Severe non compliance to protocol|1
149599|NCT00684307|531664|P3|Overall Study|Severe non compliance to protocol|0
149600|NCT00684307|531665|P2|Overall Study|Severe non compliance to protocol|0
149601|NCT00684307|531666|P1|Overall Study|Severe non compliance to protocol|1
149602|NCT00684307|531662|P5|Overall Study|Interupted IP for more than 7 days|3
149603|NCT00684307|531663|P4|Overall Study|Interupted IP for more than 7 days|3
149604|NCT00684307|531664|P3|Overall Study|Interupted IP for more than 7 days|1
149605|NCT00684307|531665|P2|Overall Study|Interupted IP for more than 7 days|4
149606|NCT00684307|531666|P1|Overall Study|Interupted IP for more than 7 days|0
149607|NCT00684307|531662|P5|Overall Study|Incorrect enrolment or randomization|0
149608|NCT00684307|531663|P4|Overall Study|Incorrect enrolment or randomization|0
149609|NCT00684307|531664|P3|Overall Study|Incorrect enrolment or randomization|0
149610|NCT00684307|531665|P2|Overall Study|Incorrect enrolment or randomization|0
149611|NCT00684307|531666|P1|Overall Study|Incorrect enrolment or randomization|4
149612|NCT00684307|531662|P5|Overall Study|Fullfillment of exclusion criteria|1
149613|NCT00684307|531663|P4|Overall Study|Fullfillment of exclusion criteria|3
149614|NCT00684307|531664|P3|Overall Study|Fullfillment of exclusion criteria|0
149615|NCT00684307|531665|P2|Overall Study|Fullfillment of exclusion criteria|0
149616|NCT00684307|531666|P1|Overall Study|Fullfillment of exclusion criteria|1
149617|NCT00684307|531662|P5|Overall Study|Development of increasing Liver Function|0
149618|NCT00684307|531663|P4|Overall Study|Development of increasing Liver Function|1
149619|NCT00684307|531664|P3|Overall Study|Development of increasing Liver Function|0
149620|NCT00684307|531665|P2|Overall Study|Development of increasing Liver Function|2
149621|NCT00684307|531666|P1|Overall Study|Development of increasing Liver Function|0
149622|NCT00684307|531662|P5|Overall Study|Adverse Event|8
149623|NCT00684307|531663|P4|Overall Study|Adverse Event|16
149624|NCT00684307|531664|P3|Overall Study|Adverse Event|15
149625|NCT00684307|531665|P2|Overall Study|Adverse Event|6
149626|NCT00684307|531666|P1|Overall Study|Adverse Event|11
149627|NCT00684203|531748|P6|Overall Study|Did not meet protocol eligibility|0
149628|NCT00684203|531749|P5|Overall Study|Did not meet protocol eligibility|0
149629|NCT00684203|531750|P4|Overall Study|Did not meet protocol eligibility|0
149630|NCT00684203|531751|P3|Overall Study|Did not meet protocol eligibility|0
149631|NCT00684203|531752|P2|Overall Study|Did not meet protocol eligibility|1
149632|NCT00684203|531753|P1|Overall Study|Did not meet protocol eligibility|0
149633|NCT00684203|531748|P6|Overall Study|Withdrawal by Subject|0
149634|NCT00684203|531749|P5|Overall Study|Withdrawal by Subject|0
149635|NCT00684203|531750|P4|Overall Study|Withdrawal by Subject|0
149636|NCT00684203|531751|P3|Overall Study|Withdrawal by Subject|1
149637|NCT00684203|531752|P2|Overall Study|Withdrawal by Subject|2
149638|NCT00684203|531753|P1|Overall Study|Withdrawal by Subject|0
149639|NCT00684203|531748|P6|Overall Study|Protocol-defined clinical event|0
149640|NCT00684203|531749|P5|Overall Study|Protocol-defined clinical event|0
149641|NCT00684203|531750|P4|Overall Study|Protocol-defined clinical event|0
149642|NCT00684203|531751|P3|Overall Study|Protocol-defined clinical event|0
149643|NCT00684203|531752|P2|Overall Study|Protocol-defined clinical event|1
149644|NCT00684203|531753|P1|Overall Study|Protocol-defined clinical event|3
149645|NCT00684203|531748|P6|Overall Study|Adverse Event|0
149646|NCT00684203|531749|P5|Overall Study|Adverse Event|0
149647|NCT00684203|531750|P4|Overall Study|Adverse Event|0
149648|NCT00684203|531751|P3|Overall Study|Adverse Event|8
149649|NCT00684203|531752|P2|Overall Study|Adverse Event|4
149650|NCT00684203|531753|P1|Overall Study|Adverse Event|6
149651|NCT00684177|531814|P2|Overall Study|Other|2
149652|NCT00684177|531815|P1|Overall Study|Other|1
149653|NCT00684177|531814|P2|Overall Study|Withdrawal by Subject|2
149654|NCT00684177|531815|P1|Overall Study|Withdrawal by Subject|1
149655|NCT00684177|531814|P2|Overall Study|Physician Decision|0
149656|NCT00684177|531815|P1|Overall Study|Physician Decision|2
149657|NCT00684177|531814|P2|Overall Study|Lost to Follow-up|1
149658|NCT00684177|531815|P1|Overall Study|Lost to Follow-up|2
149659|NCT00684177|531814|P2|Overall Study|Protocol Violation|0
149660|NCT00684177|531815|P1|Overall Study|Protocol Violation|1
149661|NCT00684177|531814|P2|Overall Study|Lack of Efficacy|15
149662|NCT00684177|531815|P1|Overall Study|Lack of Efficacy|10
149663|NCT00684177|531814|P2|Overall Study|Adverse Event|3
149664|NCT00684177|531815|P1|Overall Study|Adverse Event|4
149665|NCT00684073|531850|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
149666|NCT00684073|531850|P1|Selection|request of the sponsor|1
149667|NCT00684073|531850|P1|Selection|Lost to Follow-up|1
149668|NCT00684073|531850|P1|Selection|noncompliance|1
149669|NCT00684073|531850|P1|Selection|Death|1
149670|NCT00684073|531850|P1|Selection|Selection/non-selection criteria|3
149671|NCT00684060|531860|P2|Overall Study|Death|1
149672|NCT00684060|531861|P1|Overall Study|Death|0
149673|NCT00684060|531860|P2|Overall Study|Unable to collect MRI|2
149674|NCT00684060|531861|P1|Overall Study|Unable to collect MRI|1
149675|NCT00684060|531860|P2|Overall Study|New stenosis identified|0
149676|NCT00684060|531861|P1|Overall Study|New stenosis identified|1
149677|NCT00684060|531860|P2|Overall Study|Lost to Follow-up|0
149678|NCT00684060|531861|P1|Overall Study|Lost to Follow-up|1
149679|NCT00684021|531900|P4|Overall Study|Death|0
149680|NCT00684021|531901|P3|Overall Study|Death|0
149681|NCT00684021|531902|P2|Overall Study|Death|0
149682|NCT00684021|531903|P1|Overall Study|Death|1
149683|NCT00684021|531900|P4|Overall Study|MRI not performed|2
149684|NCT00684021|531901|P3|Overall Study|MRI not performed|1
149685|NCT00684021|531902|P2|Overall Study|MRI not performed|1
149686|NCT00684021|531903|P1|Overall Study|MRI not performed|0
149687|NCT00684021|531900|P4|Overall Study|MRI Contraindicated|0
149688|NCT00684021|531901|P3|Overall Study|MRI Contraindicated|1
149689|NCT00684021|531902|P2|Overall Study|MRI Contraindicated|1
149690|NCT00684021|531903|P1|Overall Study|MRI Contraindicated|1
149691|NCT00683917|531964|P1|Overall Study|Study prematurely terminated|10
149692|NCT00683904|531974|P2|Dose Level 2|Adverse Event|2
149693|NCT00683904|531975|P1|Dose Level 2|Adverse Event|0
149694|NCT00683904|531974|P2|Dose Level 1|Adverse Event|0
149695|NCT00683904|531975|P1|Dose Level 1|Adverse Event|1
149696|NCT00683904|531974|P2|Dose Level 1|Disease progression|0
149697|NCT00683904|531975|P1|Dose Level 1|Disease progression|2
149698|NCT00683878|532011|P3|Overall Study|Non-compliance, not met criteria etc.|0
149699|NCT00683878|532012|P2|Overall Study|Non-compliance, not met criteria etc.|2
149700|NCT00683878|532013|P1|Overall Study|Non-compliance, not met criteria etc.|3
149701|NCT00683878|532011|P3|Overall Study|Lost to Follow-up|4
149702|NCT00683878|532012|P2|Overall Study|Lost to Follow-up|2
149703|NCT00683878|532013|P1|Overall Study|Lost to Follow-up|4
149704|NCT00683878|532011|P3|Overall Study|Death|0
149705|NCT00683878|532012|P2|Overall Study|Death|1
149706|NCT00683878|532013|P1|Overall Study|Death|0
149707|NCT00683878|532011|P3|Overall Study|Withdrawal by Subject|6
149708|NCT00683878|532012|P2|Overall Study|Withdrawal by Subject|8
149709|NCT00683878|532013|P1|Overall Study|Withdrawal by Subject|9
149710|NCT00683878|532011|P3|Overall Study|Adverse Event|3
149711|NCT00683878|532012|P2|Overall Study|Adverse Event|3
149712|NCT00683878|532013|P1|Overall Study|Adverse Event|4
149713|NCT00683878|532011|P3|Overall Study|Lack of Efficacy|1
149714|NCT00683878|532012|P2|Overall Study|Lack of Efficacy|0
149715|NCT00683878|532013|P1|Overall Study|Lack of Efficacy|3
149716|NCT00683800|532087|P2|Overall Study|Randomized, not treated|33
149717|NCT00683800|532088|P1|Overall Study|Randomized, not treated|35
149718|NCT00683800|532087|P2|Overall Study|Lack of Efficacy|104
149719|NCT00683800|532088|P1|Overall Study|Lack of Efficacy|61
149720|NCT00683800|532087|P2|Overall Study|Withdrawal by Subject|64
149721|NCT00683800|532088|P1|Overall Study|Withdrawal by Subject|66
149722|NCT00683800|532087|P2|Overall Study|Protocol Violation|16
149723|NCT00683800|532088|P1|Overall Study|Protocol Violation|13
149724|NCT00683800|532087|P2|Overall Study|Other|2
149725|NCT00683800|532088|P1|Overall Study|Other|5
149726|NCT00683800|532087|P2|Overall Study|Lost to Follow-up|44
149727|NCT00683800|532088|P1|Overall Study|Lost to Follow-up|57
149728|NCT00683800|532087|P2|Overall Study|Death|1
149729|NCT00683800|532088|P1|Overall Study|Death|0
149730|NCT00683800|532087|P2|Overall Study|Adverse Event|102
149731|NCT00683800|532088|P1|Overall Study|Adverse Event|195
149732|NCT00683787|532155|P3|Overall Study|Adverse Event|2
149733|NCT00683787|532156|P2|Overall Study|Adverse Event|0
149734|NCT00683787|532157|P1|Overall Study|Adverse Event|0
149735|NCT00683787|532155|P3|Overall Study|Progression|0
149736|NCT00683787|532156|P2|Overall Study|Progression|3
149737|NCT00683787|532157|P1|Overall Study|Progression|3
149738|NCT00683774|532176|P2|Overall Study|Physician Decision|0
149739|NCT00683774|532177|P1|Overall Study|Physician Decision|3
149740|NCT00683774|532176|P2|Overall Study|Withdrawal by Subject|1
149741|NCT00683774|532177|P1|Overall Study|Withdrawal by Subject|0
149742|NCT00683696|532187|P2|Overall Study|Death|30
149743|NCT00683696|532188|P1|Overall Study|Death|46
149744|NCT00683696|532187|P2|Overall Study|Vital status follow-up only|3
149745|NCT00683696|532188|P1|Overall Study|Vital status follow-up only|3
149746|NCT00683696|532187|P2|Overall Study|Lost to Follow-up|6
149747|NCT00683696|532188|P1|Overall Study|Lost to Follow-up|5
149748|NCT00683696|532187|P2|Overall Study|Withdrawn prior to study closure|28
149749|NCT00683696|532188|P1|Overall Study|Withdrawn prior to study closure|13
149750|NCT00683696|532187|P2|Overall Study|Withdrawn due to study closure|338
149751|NCT00683696|532188|P1|Overall Study|Withdrawn due to study closure|337
149752|NCT00683657|532207|P2|Overall Study|Subject Withdrew Consent|0
149753|NCT00683657|532208|P1|Overall Study|Subject Withdrew Consent|1
149754|NCT00683657|532207|P2|Overall Study|Adverse Event|1
149755|NCT00683657|532208|P1|Overall Study|Adverse Event|0
149756|NCT00683644|532224|P2|Overall Study|Low copper, other health problems,|6
149757|NCT00683644|532225|P1|Overall Study|Low copper, other health problems,|7
149758|NCT00683644|532224|P2|Overall Study|Adverse Event|2
149759|NCT00683644|532225|P1|Overall Study|Adverse Event|1
149760|NCT00683644|532224|P2|Overall Study|Lost to Follow-up|4
149761|NCT00683644|532225|P1|Overall Study|Lost to Follow-up|1
149762|NCT00683644|532224|P2|Overall Study|Withdrawal by Subject|2
149763|NCT00683644|532225|P1|Overall Study|Withdrawal by Subject|4
149764|NCT00683618|532238|P3|Extension Treatment Period|Protocol Violation|0
149765|NCT00683618|532239|P2|Extension Treatment Period|Protocol Violation|0
149766|NCT00683618|532240|P1|Extension Treatment Period|Protocol Violation|1
149767|NCT00683618|532238|P3|Extension Treatment Period|Adverse Event|0
149768|NCT00683618|532239|P2|Extension Treatment Period|Adverse Event|0
149769|NCT00683618|532240|P1|Extension Treatment Period|Adverse Event|1
149770|NCT00683618|532238|P3|Extension Treatment Period|Withdrawal by Subject|0
149771|NCT00683618|532239|P2|Extension Treatment Period|Withdrawal by Subject|0
149772|NCT00683618|532240|P1|Extension Treatment Period|Withdrawal by Subject|1
149773|NCT00683618|532238|P3|Randomised Treatment Period|Reason not provided|2
149774|NCT00683618|532239|P2|Randomised Treatment Period|Reason not provided|0
149775|NCT00683618|532240|P1|Randomised Treatment Period|Reason not provided|0
149776|NCT00683618|532238|P3|Randomised Treatment Period|Adverse Event|2
149777|NCT00683618|532239|P2|Randomised Treatment Period|Adverse Event|0
149778|NCT00683618|532240|P1|Randomised Treatment Period|Adverse Event|2
149779|NCT00683618|532238|P3|Randomised Treatment Period|Protocol Violation|0
149780|NCT00683618|532239|P2|Randomised Treatment Period|Protocol Violation|1
149781|NCT00683618|532240|P1|Randomised Treatment Period|Protocol Violation|0
149782|NCT00683618|532238|P3|Randomised Treatment Period|Withdrawal by Subject|2
149783|NCT00683618|532239|P2|Randomised Treatment Period|Withdrawal by Subject|1
149784|NCT00683618|532240|P1|Randomised Treatment Period|Withdrawal by Subject|4
149785|NCT00683592|532290|P2|Overall Study|Other|1
149786|NCT00683592|532291|P1|Overall Study|Other|1
149787|NCT00683592|532290|P2|Overall Study|Non-compliance|5
149788|NCT00683592|532291|P1|Overall Study|Non-compliance|3
149789|NCT00683592|532290|P2|Overall Study|Physician Decision|1
149790|NCT00683592|532291|P1|Overall Study|Physician Decision|0
149791|NCT00683592|532290|P2|Overall Study|Lack of Efficacy|7
149792|NCT00683592|532291|P1|Overall Study|Lack of Efficacy|3
149793|NCT00683592|532290|P2|Overall Study|Lost to Follow-up|17
149794|NCT00683592|532291|P1|Overall Study|Lost to Follow-up|17
149795|NCT00683592|532290|P2|Overall Study|Withdrawal by Subject|11
149796|NCT00683592|532291|P1|Overall Study|Withdrawal by Subject|11
149797|NCT00683592|532290|P2|Overall Study|Adverse Event|4
149798|NCT00683592|532291|P1|Overall Study|Adverse Event|12
149799|NCT00683475|532309|P2|Overall Study|Never Treated: Progressive Disease|0
149800|NCT00683475|532310|P1|Overall Study|Never Treated: Progressive Disease|1
149801|NCT00683475|532309|P2|Overall Study|Never Treated: Adverse Event|3
149802|NCT00683475|532310|P1|Overall Study|Never Treated: Adverse Event|2
149803|NCT00683475|532309|P2|Overall Study|Withdrawal by Subject|0
149804|NCT00683475|532310|P1|Overall Study|Withdrawal by Subject|1
149805|NCT00683449|532345|P5|Overall Study|Lost to Follow-up|0
149806|NCT00683449|532346|P4|Overall Study|Lost to Follow-up|0
149807|NCT00683449|532347|P3|Overall Study|Lost to Follow-up|0
149808|NCT00683449|532348|P2|Overall Study|Lost to Follow-up|1
149809|NCT00683449|532349|P1|Overall Study|Lost to Follow-up|0
149810|NCT00683384|532375|P1|Overall Study|Adverse Event|1
149811|NCT00683384|532375|P1|Overall Study|Death|1
149812|NCT00683293|532385|P2|Overall Study|Withdrawal by Subject|3
149813|NCT00683293|532386|P1|Overall Study|Withdrawal by Subject|2
149814|NCT00682929|532449|P3|Overall Study|lag in DEA renewal|0
149815|NCT00682929|532450|P2|Overall Study|lag in DEA renewal|0
149816|NCT00682929|532451|P1|Overall Study|lag in DEA renewal|1
149817|NCT00682929|532449|P3|Overall Study|dosing compliance < 80%|0
149818|NCT00682929|532450|P2|Overall Study|dosing compliance < 80%|2
149819|NCT00682929|532451|P1|Overall Study|dosing compliance < 80%|0
149820|NCT00682929|532449|P3|Overall Study|Withdrawal by Subject|1
149821|NCT00682929|532450|P2|Overall Study|Withdrawal by Subject|2
149822|NCT00682929|532451|P1|Overall Study|Withdrawal by Subject|1
149823|NCT00682929|532449|P3|Overall Study|Adverse Event|1
149824|NCT00682929|532450|P2|Overall Study|Adverse Event|1
149825|NCT00682929|532451|P1|Overall Study|Adverse Event|4
149826|NCT00682890|532620|P2|Overall Study|heavy menstrual bleeding|0
149827|NCT00682890|532621|P1|Overall Study|heavy menstrual bleeding|1
149828|NCT00682890|532620|P2|Overall Study|subject moved away|1
149829|NCT00682890|532621|P1|Overall Study|subject moved away|0
149830|NCT00682890|532620|P2|Overall Study|Lost to Follow-up|1
149831|NCT00682890|532621|P1|Overall Study|Lost to Follow-up|1
149832|NCT00682786|532663|P2|Overall Study|Did not receive irinotecan|1
149833|NCT00682786|532664|P1|Overall Study|Did not receive irinotecan|0
149834|NCT00682786|532663|P2|Overall Study|Withdrawal by Subject|2
149835|NCT00682786|532664|P1|Overall Study|Withdrawal by Subject|2
149836|NCT00682643|532713|P2|Overall Study|Did Not Receive Study Drug|1
149837|NCT00682643|532714|P1|Overall Study|Did Not Receive Study Drug|1
149838|NCT00682643|532713|P2|Overall Study|Withdrawal by Subject|53
149839|NCT00682643|532714|P1|Overall Study|Withdrawal by Subject|19
149840|NCT00682643|532713|P2|Overall Study|Physician Decision|6
149841|NCT00682643|532714|P1|Overall Study|Physician Decision|2
149842|NCT00682643|532713|P2|Overall Study|Lost to Follow-up|6
149843|NCT00682643|532714|P1|Overall Study|Lost to Follow-up|1
149844|NCT00682643|532713|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
149845|NCT00682643|532714|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
149846|NCT00682643|532713|P2|Overall Study|Protocol Violation|76
149847|NCT00682643|532714|P1|Overall Study|Protocol Violation|38
149848|NCT00682643|532713|P2|Overall Study|Lack of Efficacy|0
149849|NCT00682643|532714|P1|Overall Study|Lack of Efficacy|2
149850|NCT00682643|532713|P2|Overall Study|Adverse Event|23
149851|NCT00682643|532714|P1|Overall Study|Adverse Event|12
149852|NCT00682539|532775|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
149853|NCT00682539|532776|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
149854|NCT00682539|532777|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
149855|NCT00682539|532775|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
149856|NCT00682539|532776|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
149857|NCT00682539|532777|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
149858|NCT00682461|532790|P2|Overall Study|Withdrawal by Subject|19
149859|NCT00682461|532791|P1|Overall Study|Withdrawal by Subject|12
149860|NCT00682461|532790|P2|Overall Study|Lost to Follow-up|5
149861|NCT00682461|532791|P1|Overall Study|Lost to Follow-up|8
149862|NCT00682461|532790|P2|Overall Study|Adverse Event|7
149863|NCT00682461|532791|P1|Overall Study|Adverse Event|5
149864|NCT00681863|532831|P1|Overall Study|not specified|18
149865|NCT00681863|532831|P1|Overall Study|Lack of Efficacy|2
149866|NCT00681863|532831|P1|Overall Study|Lost to Follow-up|2
149867|NCT00681863|532831|P1|Overall Study|Adverse Event|1
149868|NCT00681824|532879|P3|Overall Study|Death|0
149869|NCT00681824|532880|P2|Overall Study|Death|1
149870|NCT00681824|532881|P1|Overall Study|Death|0
149871|NCT00681824|532879|P3|Overall Study|scheduling conflict|0
149872|NCT00681824|532880|P2|Overall Study|scheduling conflict|0
149873|NCT00681824|532881|P1|Overall Study|scheduling conflict|1
149874|NCT00681824|532879|P3|Overall Study|withdrawn by investigator|1
149875|NCT00681824|532880|P2|Overall Study|withdrawn by investigator|0
149876|NCT00681824|532881|P1|Overall Study|withdrawn by investigator|0
149877|NCT00681811|532899|P2|Overall Study|Non-compliance|1
149878|NCT00681811|532900|P1|Overall Study|Non-compliance|0
149879|NCT00681811|532899|P2|Overall Study|Withdrawal by Subject|2
149880|NCT00681811|532900|P1|Overall Study|Withdrawal by Subject|2
149881|NCT00681811|532899|P2|Overall Study|Adverse Event|1
149882|NCT00681811|532900|P1|Overall Study|Adverse Event|1
149883|NCT00681668|532928|P1|Overall Study|Withdrawal by Subject|1
149884|NCT00681668|532928|P1|Overall Study|Protocol Violation|1
149885|NCT00681629|532937|P2|Overall Study|Adverse Event|0
149886|NCT00681629|532938|P1|Overall Study|Adverse Event|1
149887|NCT00681629|532937|P2|Overall Study|Study termination|2
149888|NCT00681629|532938|P1|Overall Study|Study termination|4
149889|NCT00681590|532984|P2|Overall Study|Withdrawal by Subject|12
149890|NCT00681590|532985|P1|Overall Study|Withdrawal by Subject|2
149891|NCT00681564|532995|P2|Overall Study|Death|1
149892|NCT00681564|532996|P1|Overall Study|Death|0
149893|NCT00681564|532995|P2|Overall Study|Withdrawal by Subject|1
149894|NCT00681564|532996|P1|Overall Study|Withdrawal by Subject|0
149895|NCT00681564|532995|P2|Overall Study|Lost to Follow-up|6
149896|NCT00681564|532996|P1|Overall Study|Lost to Follow-up|6
149897|NCT00681187|533088|P2|Overall Study|Adverse Event|1
149898|NCT00681187|533089|P1|Overall Study|Adverse Event|0
149899|NCT00681187|533088|P2|Overall Study|Death|1
149900|NCT00681187|533089|P1|Overall Study|Death|0
149901|NCT00681187|533088|P2|Overall Study|Withdrawal by Subject|0
149902|NCT00681187|533089|P1|Overall Study|Withdrawal by Subject|1
149903|NCT00681109|533124|P3|Overall Study|Lost to Follow-up|0
149904|NCT00681109|533125|P2|Overall Study|Lost to Follow-up|6
149905|NCT00681109|533126|P1|Overall Study|Lost to Follow-up|2
149906|NCT00680914|533176|P2|Overall Study|serious adverse event (SAE)|1
149907|NCT00680914|533177|P1|Overall Study|serious adverse event (SAE)|0
149908|NCT00680914|533176|P2|Overall Study|Lost to Follow-up|0
149909|NCT00680914|533177|P1|Overall Study|Lost to Follow-up|4
149910|NCT00680914|533176|P2|Overall Study|Consent withdrawal|3
149911|NCT00680914|533177|P1|Overall Study|Consent withdrawal|6
149912|NCT00680901|533211|P2|Overall Study|Ongoing: In Follow Up|41
149913|NCT00680901|533212|P1|Overall Study|Ongoing: In Follow Up|45
149914|NCT00680901|533211|P2|Overall Study|Ongoing: On Study Treatment|13
149915|NCT00680901|533212|P1|Overall Study|Ongoing: On Study Treatment|16
149916|NCT00680901|533211|P2|Overall Study|Physician Decision|1
149917|NCT00680901|533212|P1|Overall Study|Physician Decision|0
149918|NCT00680901|533211|P2|Overall Study|Withdrawal by Subject|13
149919|NCT00680901|533212|P1|Overall Study|Withdrawal by Subject|4
149920|NCT00680901|533211|P2|Overall Study|Lost to Follow-up|8
149921|NCT00680901|533212|P1|Overall Study|Lost to Follow-up|8
149922|NCT00680836|533250|P2|Overall Study|Physician Decision|1
149923|NCT00680836|533251|P1|Overall Study|Physician Decision|2
149924|NCT00680836|533250|P2|Overall Study|Lost to Follow-up|1
149925|NCT00680836|533251|P1|Overall Study|Lost to Follow-up|3
149926|NCT00680836|533250|P2|Overall Study|Withdrawal by Subject|0
149927|NCT00680836|533251|P1|Overall Study|Withdrawal by Subject|3
149928|NCT00680771|533305|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
149929|NCT00680771|533306|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
149930|NCT00680771|533305|P2|Overall Study|Sleep Apnea suspected after PSG|0
149931|NCT00680771|533306|P1|Overall Study|Sleep Apnea suspected after PSG|1
149932|NCT00680771|533305|P2|Overall Study|Withdrawal by Subject|0
149933|NCT00680771|533306|P1|Overall Study|Withdrawal by Subject|1
149934|NCT00680745|533316|P4|Overall Study|False Treatment|0
149935|NCT00680745|533317|P3|Overall Study|False Treatment|3
149936|NCT00680745|533318|P2|Overall Study|False Treatment|1
149937|NCT00680745|533319|P1|Overall Study|False Treatment|0
149938|NCT00680745|533316|P4|Overall Study|Subject No Longer Meets Study Criteria|2
149939|NCT00680745|533317|P3|Overall Study|Subject No Longer Meets Study Criteria|0
149940|NCT00680745|533318|P2|Overall Study|Subject No Longer Meets Study Criteria|2
149941|NCT00680745|533319|P1|Overall Study|Subject No Longer Meets Study Criteria|0
149942|NCT00680745|533316|P4|Overall Study|Poor/Non-compliance|0
149943|NCT00680745|533317|P3|Overall Study|Poor/Non-compliance|0
149944|NCT00680745|533318|P2|Overall Study|Poor/Non-compliance|3
149945|NCT00680745|533319|P1|Overall Study|Poor/Non-compliance|0
149946|NCT00680745|533316|P4|Overall Study|Adverse Event|3
149947|NCT00680745|533317|P3|Overall Study|Adverse Event|3
149948|NCT00680745|533318|P2|Overall Study|Adverse Event|3
149949|NCT00680745|533319|P1|Overall Study|Adverse Event|5
149950|NCT00680745|533316|P4|Overall Study|Death|0
149951|NCT00680745|533317|P3|Overall Study|Death|1
149952|NCT00680745|533318|P2|Overall Study|Death|0
149953|NCT00680745|533319|P1|Overall Study|Death|1
149954|NCT00680745|533316|P4|Overall Study|Lost to Follow-up|0
149955|NCT00680745|533317|P3|Overall Study|Lost to Follow-up|1
149956|NCT00680745|533318|P2|Overall Study|Lost to Follow-up|1
149957|NCT00680745|533319|P1|Overall Study|Lost to Follow-up|0
149958|NCT00680745|533316|P4|Overall Study|Withdrawal by Subject|8
149959|NCT00680745|533317|P3|Overall Study|Withdrawal by Subject|2
149960|NCT00680745|533318|P2|Overall Study|Withdrawal by Subject|3
149961|NCT00680745|533319|P1|Overall Study|Withdrawal by Subject|8
149962|NCT00680407|533393|P3|Overall Study|Withdrawal by Subject|2
149963|NCT00680407|533394|P2|Overall Study|Withdrawal by Subject|2
149964|NCT00680407|533395|P1|Overall Study|Withdrawal by Subject|5
149965|NCT00680407|533393|P3|Overall Study|Lost to Follow-up|1
149966|NCT00680407|533394|P2|Overall Study|Lost to Follow-up|3
149967|NCT00680407|533395|P1|Overall Study|Lost to Follow-up|3
149968|NCT00680368|533409|P1|Overall Study|not supervised, not eligible|15
149969|NCT00680186|533437|P2|Overall Study|Other|1
149970|NCT00680186|533438|P1|Overall Study|Other|4
149971|NCT00680186|533437|P2|Overall Study|Withdrawal by Subject|39
149972|NCT00680186|533438|P1|Overall Study|Withdrawal by Subject|32
149973|NCT00680186|533437|P2|Overall Study|Lost to Follow-up|6
149974|NCT00680186|533438|P1|Overall Study|Lost to Follow-up|11
149975|NCT00680186|533437|P2|Overall Study|Protocol Violation|26
149976|NCT00680186|533438|P1|Overall Study|Protocol Violation|31
149977|NCT00680186|533437|P2|Overall Study|Adverse Event|44
149978|NCT00680186|533438|P1|Overall Study|Adverse Event|47
149979|NCT00680121|533464|P2|Overall Study|Lost to Follow-up|23
149980|NCT00680121|533465|P1|Overall Study|Lost to Follow-up|27
149981|NCT00680056|533479|P2|Second Intervention|Protocol Violation|1
149982|NCT00680056|533480|P1|Second Intervention|Protocol Violation|3
149983|NCT00680056|533479|P2|First Intervention|Mainly Exacerbation of COPD|2
149984|NCT00680056|533480|P1|First Intervention|Mainly Exacerbation of COPD|1
149985|NCT00680043|533491|P3|Overall Study|Renal Transplant|4
149986|NCT00680043|533492|P2|Overall Study|Renal Transplant|0
149987|NCT00680043|533493|P1|Overall Study|Renal Transplant|1
149988|NCT00680043|533491|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
149989|NCT00680043|533492|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
149990|NCT00680043|533493|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
149991|NCT00680043|533491|P3|Overall Study|Withdrawal by Subject|0
149992|NCT00680043|533492|P2|Overall Study|Withdrawal by Subject|0
149993|NCT00680043|533493|P1|Overall Study|Withdrawal by Subject|1
149994|NCT00680017|533509|P2|Overall Study|Lost to Follow-up|0
149995|NCT00680017|533510|P1|Overall Study|Lost to Follow-up|2
149996|NCT00680017|533509|P2|Overall Study|Withdrawal by Subject|5
149997|NCT00680017|533510|P1|Overall Study|Withdrawal by Subject|2
149998|NCT00680017|533509|P2|Overall Study|Adverse Event|7
149999|NCT00680017|533510|P1|Overall Study|Adverse Event|13
150000|NCT00679939|533529|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
150001|NCT00679939|533530|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
150002|NCT00679939|533529|P2|24-Week Open-Label (OL) Period|Physician Decision|0
150003|NCT00679939|533530|P1|24-Week Open-Label (OL) Period|Physician Decision|1
150004|NCT00679939|533529|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
150005|NCT00679939|533530|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
150006|NCT00679939|533529|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
150007|NCT00679939|533530|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
150008|NCT00679939|533529|P2|24-Week Open-Label (OL) Period|Adverse Event|1
150009|NCT00679939|533530|P1|24-Week Open-Label (OL) Period|Adverse Event|0
150010|NCT00679939|533529|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
150011|NCT00679939|533530|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
150012|NCT00679939|533529|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
150013|NCT00679939|533530|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
150014|NCT00679939|533529|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
150015|NCT00679939|533530|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
150016|NCT00679939|533529|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
150017|NCT00679939|533530|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
150018|NCT00679939|533529|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
150019|NCT00679939|533530|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
150020|NCT00679913|533681|P2|Overall Study|Protocol Violation|13
150021|NCT00679913|533682|P1|Overall Study|Protocol Violation|18
150022|NCT00679783|533697|P7|Overall Study|Ongoing at data cut-off|0
150023|NCT00679783|533698|P6|Overall Study|Ongoing at data cut-off|0
150024|NCT00679783|533699|P5|Overall Study|Ongoing at data cut-off|1
150025|NCT00679783|533700|P4|Overall Study|Ongoing at data cut-off|9
150026|NCT00679783|533701|P3|Overall Study|Ongoing at data cut-off|0
150027|NCT00679783|533702|P2|Overall Study|Ongoing at data cut-off|2
150028|NCT00679783|533703|P1|Overall Study|Ongoing at data cut-off|2
150029|NCT00679783|533697|P7|Overall Study|Not Captured|0
150030|NCT00679783|533698|P6|Overall Study|Not Captured|0
150031|NCT00679783|533699|P5|Overall Study|Not Captured|0
150032|NCT00679783|533700|P4|Overall Study|Not Captured|5
150033|NCT00679783|533701|P3|Overall Study|Not Captured|0
150034|NCT00679783|533702|P2|Overall Study|Not Captured|0
150035|NCT00679783|533703|P1|Overall Study|Not Captured|0
150036|NCT00679783|533697|P7|Overall Study|Withdrawal by Subject|0
150037|NCT00679783|533698|P6|Overall Study|Withdrawal by Subject|0
150038|NCT00679783|533699|P5|Overall Study|Withdrawal by Subject|0
150039|NCT00679783|533700|P4|Overall Study|Withdrawal by Subject|1
150040|NCT00679783|533701|P3|Overall Study|Withdrawal by Subject|1
150041|NCT00679783|533702|P2|Overall Study|Withdrawal by Subject|0
150042|NCT00679783|533703|P1|Overall Study|Withdrawal by Subject|0
150043|NCT00679783|533697|P7|Overall Study|Lack of Efficacy|0
150044|NCT00679783|533698|P6|Overall Study|Lack of Efficacy|0
150045|NCT00679783|533699|P5|Overall Study|Lack of Efficacy|0
150046|NCT00679783|533700|P4|Overall Study|Lack of Efficacy|2
150047|NCT00679783|533701|P3|Overall Study|Lack of Efficacy|0
150048|NCT00679783|533702|P2|Overall Study|Lack of Efficacy|1
150049|NCT00679783|533703|P1|Overall Study|Lack of Efficacy|0
150050|NCT00679783|533697|P7|Overall Study|Adverse Event|1
150051|NCT00679783|533698|P6|Overall Study|Adverse Event|0
150052|NCT00679783|533699|P5|Overall Study|Adverse Event|0
150053|NCT00679783|533700|P4|Overall Study|Adverse Event|3
150054|NCT00679783|533701|P3|Overall Study|Adverse Event|0
150055|NCT00679783|533702|P2|Overall Study|Adverse Event|0
150056|NCT00679783|533703|P1|Overall Study|Adverse Event|0
150057|NCT00679627|533756|P2|Overall Study|Early Study Closure|405
150058|NCT00679627|533757|P1|Overall Study|Early Study Closure|425
150059|NCT00679627|533756|P2|Overall Study|Lost to Follow-up|26
150060|NCT00679627|533757|P1|Overall Study|Lost to Follow-up|22
150061|NCT00679627|533756|P2|Overall Study|Withdrawal by Subject|172
150062|NCT00679627|533757|P1|Overall Study|Withdrawal by Subject|168
150063|NCT00679627|533756|P2|Overall Study|Adverse Event|53
150064|NCT00679627|533757|P1|Overall Study|Adverse Event|43
150065|NCT00679627|533756|P2|Overall Study|Death|29
150066|NCT00679627|533757|P1|Overall Study|Death|41
150067|NCT00679432|533783|P4|Overall Study|Randomization error, return to prior Rx|0
150068|NCT00679432|533784|P3|Overall Study|Randomization error, return to prior Rx|3
150069|NCT00679432|533785|P2|Overall Study|Randomization error, return to prior Rx|0
150070|NCT00679432|533786|P1|Overall Study|Randomization error, return to prior Rx|0
150071|NCT00679432|533783|P4|Overall Study|Infectious colitis, normal histology|3
150072|NCT00679432|533784|P3|Overall Study|Infectious colitis, normal histology|8
150073|NCT00679432|533785|P2|Overall Study|Infectious colitis, normal histology|4
150074|NCT00679432|533786|P1|Overall Study|Infectious colitis, normal histology|5
150075|NCT00679432|533783|P4|Overall Study|Lack of Efficacy|8
150076|NCT00679432|533784|P3|Overall Study|Lack of Efficacy|14
150077|NCT00679432|533785|P2|Overall Study|Lack of Efficacy|9
150078|NCT00679432|533786|P1|Overall Study|Lack of Efficacy|13
150079|NCT00679432|533783|P4|Overall Study|Sponsor decision|0
150080|NCT00679432|533784|P3|Overall Study|Sponsor decision|0
150081|NCT00679432|533785|P2|Overall Study|Sponsor decision|0
150082|NCT00679432|533786|P1|Overall Study|Sponsor decision|1
150083|NCT00679432|533783|P4|Overall Study|Physician Decision|2
150084|NCT00679432|533784|P3|Overall Study|Physician Decision|2
150085|NCT00679432|533785|P2|Overall Study|Physician Decision|2
150086|NCT00679432|533786|P1|Overall Study|Physician Decision|3
150087|NCT00679432|533783|P4|Overall Study|Lost to Follow-up|2
150088|NCT00679432|533784|P3|Overall Study|Lost to Follow-up|4
150089|NCT00679432|533785|P2|Overall Study|Lost to Follow-up|5
150090|NCT00679432|533786|P1|Overall Study|Lost to Follow-up|1
150091|NCT00679432|533783|P4|Overall Study|Withdrawal by Subject|9
150092|NCT00679432|533784|P3|Overall Study|Withdrawal by Subject|10
150093|NCT00679432|533785|P2|Overall Study|Withdrawal by Subject|11
150094|NCT00679432|533786|P1|Overall Study|Withdrawal by Subject|8
150095|NCT00679432|533783|P4|Overall Study|Protocol Violation|1
150096|NCT00679432|533784|P3|Overall Study|Protocol Violation|2
150097|NCT00679432|533785|P2|Overall Study|Protocol Violation|1
150098|NCT00679432|533786|P1|Overall Study|Protocol Violation|1
150099|NCT00679432|533783|P4|Overall Study|Adverse Event|7
150100|NCT00679432|533784|P3|Overall Study|Adverse Event|10
150101|NCT00679432|533785|P2|Overall Study|Adverse Event|6
150102|NCT00679432|533786|P1|Overall Study|Adverse Event|5
150103|NCT00679367|533829|P1|Overall Study|Withdrawal by Subject|1
150104|NCT00679367|533829|P1|Overall Study|Lack of Efficacy|3
150105|NCT00679367|533829|P1|Overall Study|inability to swallow oral drugs|1
150106|NCT00679367|533829|P1|Overall Study|Adverse Event|7
150107|NCT00679354|533835|P1|Overall Study|Ineligible|1
150108|NCT00679354|533835|P1|Overall Study|Physician Decision|4
150109|NCT00679354|533835|P1|Overall Study|Lack of Efficacy|22
150110|NCT00679354|533835|P1|Overall Study|Death|3
150111|NCT00679341|533841|P2|Overall Study|Physician/patient decision to withdraw|6
150112|NCT00679341|533842|P1|Overall Study|Physician/patient decision to withdraw|0
150113|NCT00679341|533841|P2|Overall Study|Not treated|2
150114|NCT00679341|533842|P1|Overall Study|Not treated|0
150115|NCT00679341|533841|P2|Overall Study|Physician Decision|0
150116|NCT00679341|533842|P1|Overall Study|Physician Decision|1
150117|NCT00679341|533841|P2|Overall Study|Not specified|0
150118|NCT00679341|533842|P1|Overall Study|Not specified|1
150119|NCT00679341|533841|P2|Overall Study|Death|1
150120|NCT00679341|533842|P1|Overall Study|Death|1
150121|NCT00679341|533841|P2|Overall Study|Subject/guardian decision to discontinue|0
150122|NCT00679341|533842|P1|Overall Study|Subject/guardian decision to discontinue|3
150123|NCT00679341|533841|P2|Overall Study|Adverse Event|6
150124|NCT00679341|533842|P1|Overall Study|Adverse Event|5
150125|NCT00679341|533841|P2|Overall Study|Disease progression|36
150126|NCT00679341|533842|P1|Overall Study|Disease progression|42
150127|NCT00679302|533862|P2|Overall Study|Lost to Follow-up|4
150128|NCT00679302|533863|P1|Overall Study|Lost to Follow-up|8
150129|NCT00679289|533874|P3|Overall Study|Physician Decision|1
150130|NCT00679289|533875|P2|Overall Study|Physician Decision|0
150131|NCT00679289|533876|P1|Overall Study|Physician Decision|1
150132|NCT00679289|533874|P3|Overall Study|Adverse Event|3
150133|NCT00679289|533875|P2|Overall Study|Adverse Event|0
150134|NCT00679289|533876|P1|Overall Study|Adverse Event|0
150135|NCT00679289|533874|P3|Overall Study|Withdrawal by Subject|1
150136|NCT00679289|533875|P2|Overall Study|Withdrawal by Subject|1
150137|NCT00679289|533876|P1|Overall Study|Withdrawal by Subject|0
150138|NCT00679289|533874|P3|Overall Study|Progressive disease|18
150139|NCT00679289|533875|P2|Overall Study|Progressive disease|5
150140|NCT00679289|533876|P1|Overall Study|Progressive disease|4
150141|NCT00679263|533898|P3|Visit 2/Dose 1|subject not compliance|0
150142|NCT00679263|533899|P2|Visit 2/Dose 1|subject not compliance|1
150143|NCT00679263|533900|P1|Visit 2/Dose 1|subject not compliance|1
150144|NCT00679263|533898|P3|Visit 2/Dose 1|Adverse Event|0
150145|NCT00679263|533899|P2|Visit 2/Dose 1|Adverse Event|0
150146|NCT00679263|533900|P1|Visit 2/Dose 1|Adverse Event|1
150147|NCT00679211|533911|P1|Overall Study|Other|1
150148|NCT00679211|533911|P1|Overall Study|Transferred to extension study TDM4529g|12
150149|NCT00679211|533911|P1|Overall Study|Refused to undergo protocol procedures|1
150150|NCT00679211|533911|P1|Overall Study|Physician Decision|5
150151|NCT00679211|533911|P1|Overall Study|Withdrawal by Subject|2
150152|NCT00679211|533911|P1|Overall Study|Adverse Event|7
150153|NCT00679211|533911|P1|Overall Study|Progressive disease|82
150154|NCT00679172|533928|P5|Overall Study|Other not specified|0
150155|NCT00679172|533929|P4|Overall Study|Other not specified|0
150156|NCT00679172|533930|P3|Overall Study|Other not specified|1
150157|NCT00679172|533931|P2|Overall Study|Other not specified|0
150158|NCT00679172|533932|P1|Overall Study|Other not specified|0
150159|NCT00679172|533928|P5|Overall Study|Non-compliance|0
150160|NCT00679172|533929|P4|Overall Study|Non-compliance|1
150161|NCT00679172|533930|P3|Overall Study|Non-compliance|0
150162|NCT00679172|533931|P2|Overall Study|Non-compliance|1
150163|NCT00679172|533932|P1|Overall Study|Non-compliance|1
150164|NCT00679081|533995|P1|Overall Study|Lost to Follow-up|1
150165|NCT00679055|534005|P2|Overall Study|Study Terminated|1
150166|NCT00679055|534006|P1|Overall Study|Study Terminated|2
150167|NCT00679055|534005|P2|Overall Study|Other|3
150168|NCT00679055|534006|P1|Overall Study|Other|0
150169|NCT00679055|534005|P2|Overall Study|Adverse Event|1
150170|NCT00679055|534006|P1|Overall Study|Adverse Event|0
150171|NCT00678899|534016|P1|Overall Study|Adverse Event|1
150172|NCT00678886|534025|P4|Overall Study|Other|0
150173|NCT00678886|534026|P3|Overall Study|Other|1
150174|NCT00678886|534027|P2|Overall Study|Other|0
150175|NCT00678886|534028|P1|Overall Study|Other|0
150176|NCT00678886|534025|P4|Overall Study|Lost to Follow-up|2
150177|NCT00678886|534026|P3|Overall Study|Lost to Follow-up|3
150178|NCT00678886|534027|P2|Overall Study|Lost to Follow-up|0
150179|NCT00678886|534028|P1|Overall Study|Lost to Follow-up|0
150180|NCT00678886|534025|P4|Overall Study|Physician Decision|1
150181|NCT00678886|534026|P3|Overall Study|Physician Decision|1
150182|NCT00678886|534027|P2|Overall Study|Physician Decision|0
150183|NCT00678886|534028|P1|Overall Study|Physician Decision|0
150184|NCT00678886|534025|P4|Overall Study|Withdrawal by Subject|6
150185|NCT00678886|534026|P3|Overall Study|Withdrawal by Subject|4
150186|NCT00678886|534027|P2|Overall Study|Withdrawal by Subject|0
150187|NCT00678886|534028|P1|Overall Study|Withdrawal by Subject|0
150188|NCT00678795|534097|P2|Overall Study|Lack of Efficacy|1
150189|NCT00678795|534098|P1|Overall Study|Lack of Efficacy|1
150190|NCT00678795|534097|P2|Overall Study|Lost to Follow-up|1
150191|NCT00678795|534098|P1|Overall Study|Lost to Follow-up|0
150192|NCT00678795|534097|P2|Overall Study|Protocol Violation|1
150193|NCT00678795|534098|P1|Overall Study|Protocol Violation|0
150194|NCT00678795|534097|P2|Overall Study|Withdrawal by Subject|0
150195|NCT00678795|534098|P1|Overall Study|Withdrawal by Subject|3
150196|NCT00678795|534097|P2|Overall Study|Adverse Event|3
150197|NCT00678795|534098|P1|Overall Study|Adverse Event|7
150198|NCT00678691|534120|P2|Overall Study|Adverse Event|4
150199|NCT00678691|534121|P1|Overall Study|Adverse Event|6
150200|NCT00678652|534131|P4|Overall Study|Relocation|0
150201|NCT00678652|534132|P3|Overall Study|Relocation|0
150202|NCT00678652|534133|P2|Overall Study|Relocation|0
150203|NCT00678652|534134|P1|Overall Study|Relocation|1
150204|NCT00678652|534131|P4|Overall Study|Pregnancy|0
150205|NCT00678652|534132|P3|Overall Study|Pregnancy|1
150206|NCT00678652|534133|P2|Overall Study|Pregnancy|0
150207|NCT00678652|534134|P1|Overall Study|Pregnancy|0
150208|NCT00678652|534131|P4|Overall Study|Protocol Violation|0
150209|NCT00678652|534132|P3|Overall Study|Protocol Violation|0
150210|NCT00678652|534133|P2|Overall Study|Protocol Violation|0
150211|NCT00678652|534134|P1|Overall Study|Protocol Violation|2
150212|NCT00678639|534158|P2|Overall Study|Lost to Follow-up at 30 days|0
150213|NCT00678639|534159|P1|Overall Study|Lost to Follow-up at 30 days|2
150214|NCT00678587|534174|P2|Overall Study|Withdrew Consent|3
150215|NCT00678587|534175|P1|Overall Study|Withdrew Consent|8
150216|NCT00678587|534174|P2|Overall Study|Investigator Discretion|6
150217|NCT00678587|534175|P1|Overall Study|Investigator Discretion|2
150218|NCT00678587|534174|P2|Overall Study|Lost to Follow-up|5
150219|NCT00678587|534175|P1|Overall Study|Lost to Follow-up|3
150220|NCT00678587|534174|P2|Overall Study|Study Closed/Terminated|0
150221|NCT00678587|534175|P1|Overall Study|Study Closed/Terminated|1
150222|NCT00678587|534174|P2|Overall Study|Protocol Violation|1
150223|NCT00678587|534175|P1|Overall Study|Protocol Violation|2
150224|NCT00678587|534174|P2|Overall Study|Lack of Efficacy|0
150225|NCT00678587|534175|P1|Overall Study|Lack of Efficacy|1
150226|NCT00678587|534174|P2|Overall Study|Adverse Event|3
150227|NCT00678587|534175|P1|Overall Study|Adverse Event|3
150228|NCT00678392|534258|P2|Overall Study|Other|53
150229|NCT00678392|534259|P1|Overall Study|Other|56
150230|NCT00678392|534258|P2|Overall Study|Randomized But Not Treated|7
150231|NCT00678392|534259|P1|Overall Study|Randomized But Not Treated|2
150232|NCT00678392|534258|P2|Overall Study|Withdrawal by Subject|4
150233|NCT00678392|534259|P1|Overall Study|Withdrawal by Subject|4
150234|NCT00678392|534258|P2|Overall Study|Sponsor's Decision|2
150235|NCT00678392|534259|P1|Overall Study|Sponsor's Decision|1
150236|NCT00678392|534258|P2|Overall Study|Objective Progression or Relapse|8
150237|NCT00678392|534259|P1|Overall Study|Objective Progression or Relapse|3
150238|NCT00678392|534258|P2|Overall Study|Lost to Follow-up|13
150239|NCT00678392|534259|P1|Overall Study|Lost to Follow-up|15
150240|NCT00678392|534258|P2|Overall Study|Death|269
150241|NCT00678392|534259|P1|Overall Study|Death|280
150242|NCT00678392|534258|P2|Overall Study|Adverse Event|6
150243|NCT00678392|534259|P1|Overall Study|Adverse Event|0
150244|NCT00678379|534294|P3|Overall Study|Incomplete Data|3
150245|NCT00678379|534295|P2|Overall Study|Incomplete Data|3
150246|NCT00678379|534296|P1|Overall Study|Incomplete Data|4
150247|NCT00678379|534294|P3|Overall Study|Injection performed after tonsillectomy|1
150248|NCT00678379|534295|P2|Overall Study|Injection performed after tonsillectomy|0
150249|NCT00678379|534296|P1|Overall Study|Injection performed after tonsillectomy|2
150250|NCT00678301|534324|P2|Overall Study|Lost to Follow-up|1
150251|NCT00678301|534325|P1|Overall Study|Lost to Follow-up|3
150252|NCT00678301|534324|P2|Overall Study|Withdrawal by Subject|0
150253|NCT00678301|534325|P1|Overall Study|Withdrawal by Subject|4
150254|NCT00678301|534324|P2|Overall Study|Adverse Event|0
150255|NCT00678301|534325|P1|Overall Study|Adverse Event|1
150256|NCT00678301|534324|P2|Overall Study|Non-compliance with study procedures|1
150257|NCT00678301|534325|P1|Overall Study|Non-compliance with study procedures|0
150258|NCT00678288|534383|P2|Overall Study|Disease progression/recurrence/relapse|1
150259|NCT00678288|534384|P1|Overall Study|Disease progression/recurrence/relapse|6
150260|NCT00678288|534383|P2|Overall Study|Reason not reported|0
150261|NCT00678288|534384|P1|Overall Study|Reason not reported|1
150262|NCT00678288|534383|P2|Overall Study|Switch to commercial drug|1
150263|NCT00678288|534384|P1|Overall Study|Switch to commercial drug|0
150264|NCT00678288|534383|P2|Overall Study|Not compliant with study medication|1
150265|NCT00678288|534384|P1|Overall Study|Not compliant with study medication|0
150266|NCT00678288|534383|P2|Overall Study|Study terminated by the sponsor|0
150267|NCT00678288|534384|P1|Overall Study|Study terminated by the sponsor|2
150268|NCT00678288|534383|P2|Overall Study|Withdrawal by Subject|1
150269|NCT00678288|534384|P1|Overall Study|Withdrawal by Subject|1
150270|NCT00678288|534383|P2|Overall Study|Adverse Event|2
150271|NCT00678288|534384|P1|Overall Study|Adverse Event|0
150272|NCT00678210|534439|P4|Overall Study|Other|0
150273|NCT00678210|534440|P3|Overall Study|Other|1
150274|NCT00678210|534441|P2|Overall Study|Other|0
150275|NCT00678210|534442|P1|Overall Study|Other|1
150276|NCT00678210|534439|P4|Overall Study|Withdrawal by Subject|7
150277|NCT00678210|534440|P3|Overall Study|Withdrawal by Subject|1
150278|NCT00678210|534441|P2|Overall Study|Withdrawal by Subject|4
150279|NCT00678210|534442|P1|Overall Study|Withdrawal by Subject|3
150280|NCT00678210|534439|P4|Overall Study|Lost to Follow-up|1
150281|NCT00678210|534440|P3|Overall Study|Lost to Follow-up|0
150282|NCT00678210|534441|P2|Overall Study|Lost to Follow-up|2
150283|NCT00678210|534442|P1|Overall Study|Lost to Follow-up|4
150284|NCT00678210|534439|P4|Overall Study|Lack of Efficacy|9
150285|NCT00678210|534440|P3|Overall Study|Lack of Efficacy|1
150286|NCT00678210|534441|P2|Overall Study|Lack of Efficacy|3
150287|NCT00678210|534442|P1|Overall Study|Lack of Efficacy|2
150288|NCT00678210|534439|P4|Overall Study|Adverse Event|3
150289|NCT00678210|534440|P3|Overall Study|Adverse Event|3
150290|NCT00678210|534441|P2|Overall Study|Adverse Event|2
150291|NCT00678210|534442|P1|Overall Study|Adverse Event|1
150292|NCT00678041|534478|P2|Overall Study|Physician Decision|5
150293|NCT00678041|534479|P1|Overall Study|Physician Decision|5
150294|NCT00677833|534532|P4|Overall Study|Lost to Follow-up|0
150295|NCT00677833|534533|P3|Overall Study|Lost to Follow-up|1
150296|NCT00677833|534534|P2|Overall Study|Lost to Follow-up|0
150297|NCT00677833|534535|P1|Overall Study|Lost to Follow-up|0
150298|NCT00677833|534532|P4|Overall Study|Withdrawal by Subject|3
150299|NCT00677833|534533|P3|Overall Study|Withdrawal by Subject|1
150300|NCT00677833|534534|P2|Overall Study|Withdrawal by Subject|0
150301|NCT00677833|534535|P1|Overall Study|Withdrawal by Subject|4
150302|NCT00677820|534585|P2|Overall Study|Lost to Follow-up|0
150303|NCT00677820|534586|P1|Overall Study|Lost to Follow-up|1
150304|NCT00677807|534607|P3|Overall Study|Protocol Deviation|0
150305|NCT00677807|534608|P2|Overall Study|Protocol Deviation|3
150306|NCT00677807|534609|P1|Overall Study|Protocol Deviation|1
150307|NCT00677807|534607|P3|Overall Study|Death|1
150308|NCT00677807|534608|P2|Overall Study|Death|1
150309|NCT00677807|534609|P1|Overall Study|Death|0
150310|NCT00677807|534607|P3|Overall Study|Administrative problems|2
150311|NCT00677807|534608|P2|Overall Study|Administrative problems|1
150312|NCT00677807|534609|P1|Overall Study|Administrative problems|1
150313|NCT00677807|534607|P3|Overall Study|Lost to Follow-up|2
150314|NCT00677807|534608|P2|Overall Study|Lost to Follow-up|2
150315|NCT00677807|534609|P1|Overall Study|Lost to Follow-up|2
150316|NCT00677807|534607|P3|Overall Study|Withdrawal by Subject|6
150317|NCT00677807|534608|P2|Overall Study|Withdrawal by Subject|3
150318|NCT00677807|534609|P1|Overall Study|Withdrawal by Subject|10
150319|NCT00677807|534607|P3|Overall Study|Participant no longer needs study drug|1
150320|NCT00677807|534608|P2|Overall Study|Participant no longer needs study drug|0
150321|NCT00677807|534609|P1|Overall Study|Participant no longer needs study drug|0
150322|NCT00677807|534607|P3|Overall Study|Lack of Efficacy|2
150323|NCT00677807|534608|P2|Overall Study|Lack of Efficacy|0
150324|NCT00677807|534609|P1|Overall Study|Lack of Efficacy|0
150325|NCT00677807|534607|P3|Overall Study|Adverse Event|6
150326|NCT00677807|534608|P2|Overall Study|Adverse Event|1
150327|NCT00677807|534609|P1|Overall Study|Adverse Event|4
150328|NCT00677534|534655|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
150329|NCT00677534|534655|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
150330|NCT00677534|534655|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
150331|NCT00677365|534663|P4|Overall Study|Other reason|1
150332|NCT00677365|534664|P3|Overall Study|Other reason|0
150333|NCT00677365|534665|P2|Overall Study|Other reason|0
150334|NCT00677365|534666|P1|Overall Study|Other reason|0
150335|NCT00677365|534663|P4|Overall Study|Withdrawal by Subject|0
150336|NCT00677365|534664|P3|Overall Study|Withdrawal by Subject|1
150337|NCT00677365|534665|P2|Overall Study|Withdrawal by Subject|0
150338|NCT00677365|534666|P1|Overall Study|Withdrawal by Subject|0
150339|NCT00677365|534663|P4|Overall Study|Adverse Event|2
150340|NCT00677365|534664|P3|Overall Study|Adverse Event|1
150341|NCT00677365|534665|P2|Overall Study|Adverse Event|1
150342|NCT00677365|534666|P1|Overall Study|Adverse Event|2
150343|NCT00677352|534698|P2|Tapering Phase|Job transfer|1
150344|NCT00677352|534699|P1|Tapering Phase|Job transfer|0
150345|NCT00677352|534698|P2|Tapering Phase|Pregnancy|1
150346|NCT00677352|534699|P1|Tapering Phase|Pregnancy|0
150347|NCT00677352|534698|P2|Tapering Phase|Withdrawal by Subject|3
150348|NCT00677352|534699|P1|Tapering Phase|Withdrawal by Subject|5
150349|NCT00677352|534698|P2|Tapering Phase|Adverse Event|5
150350|NCT00677352|534699|P1|Tapering Phase|Adverse Event|1
150351|NCT00677352|534698|P2|Treatment Phase|Not treated|2
150352|NCT00677352|534699|P1|Treatment Phase|Not treated|0
150353|NCT00677352|534698|P2|Treatment Phase|Transference or work related matter|5
150354|NCT00677352|534699|P1|Treatment Phase|Transference or work related matter|0
150355|NCT00677352|534698|P2|Treatment Phase|Protocol Violation|1
150356|NCT00677352|534699|P1|Treatment Phase|Protocol Violation|1
150357|NCT00677352|534698|P2|Treatment Phase|Pregnancy|1
150358|NCT00677352|534699|P1|Treatment Phase|Pregnancy|0
150359|NCT00677352|534698|P2|Treatment Phase|Physician Decision|0
150360|NCT00677352|534699|P1|Treatment Phase|Physician Decision|1
150361|NCT00677352|534698|P2|Treatment Phase|Withdrawal by Subject|7
150362|NCT00677352|534699|P1|Treatment Phase|Withdrawal by Subject|7
150363|NCT00677352|534698|P2|Treatment Phase|Lost to Follow-up|1
150364|NCT00677352|534699|P1|Treatment Phase|Lost to Follow-up|0
150365|NCT00677352|534698|P2|Treatment Phase|Lack of Efficacy|3
150366|NCT00677352|534699|P1|Treatment Phase|Lack of Efficacy|2
150367|NCT00677352|534698|P2|Treatment Phase|Adverse Event|22
150368|NCT00677352|534699|P1|Treatment Phase|Adverse Event|14
150369|NCT00677235|534719|P2|Overall Study|Adverse Experience|0
150370|NCT00677235|534720|P1|Overall Study|Adverse Experience|1
150371|NCT00677235|534719|P2|Overall Study|Death|36
150372|NCT00677235|534720|P1|Overall Study|Death|37
150373|NCT00677235|534719|P2|Overall Study|Lost to Follow-up|1
150374|NCT00677235|534720|P1|Overall Study|Lost to Follow-up|2
150375|NCT00677235|534719|P2|Overall Study|Withdrawal by Subject|1
150376|NCT00677235|534720|P1|Overall Study|Withdrawal by Subject|1
150377|NCT00677092|534760|P1|Overall Study|Death Prior to Receiving Treatment|1
150378|NCT00677092|534760|P1|Overall Study|Withdrawal by Subject|3
150379|NCT00677092|534760|P1|Overall Study|Lost to Follow-up|1
150380|NCT00677092|534760|P1|Overall Study|Adverse Event|1
150381|NCT00677014|534772|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
150382|NCT00677014|534773|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
150383|NCT00677014|534774|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
150384|NCT00677014|534772|P3|Overall Study|Death|7
150385|NCT00677014|534773|P2|Overall Study|Death|15
150386|NCT00677014|534774|P1|Overall Study|Death|6
150387|NCT00677014|534772|P3|Overall Study|Lost to Follow-up|24
150388|NCT00677014|534773|P2|Overall Study|Lost to Follow-up|12
150389|NCT00677014|534774|P1|Overall Study|Lost to Follow-up|20
150390|NCT00676715|534827|P4|Overall Study|Participants Ongoing|24
150391|NCT00676715|534828|P3|Overall Study|Participants Ongoing|17
150392|NCT00676715|534829|P2|Overall Study|Participants Ongoing|29
150393|NCT00676715|534830|P1|Overall Study|Participants Ongoing|29
150394|NCT00676715|534827|P4|Overall Study|Adverse Event|0
150395|NCT00676715|534828|P3|Overall Study|Adverse Event|2
150396|NCT00676715|534829|P2|Overall Study|Adverse Event|1
150397|NCT00676715|534830|P1|Overall Study|Adverse Event|0
150398|NCT00676715|534827|P4|Overall Study|Death|0
150399|NCT00676715|534828|P3|Overall Study|Death|1
150400|NCT00676715|534829|P2|Overall Study|Death|1
150401|NCT00676715|534830|P1|Overall Study|Death|1
150402|NCT00676715|534827|P4|Overall Study|Lost to Follow-up|3
150403|NCT00676715|534828|P3|Overall Study|Lost to Follow-up|7
150404|NCT00676715|534829|P2|Overall Study|Lost to Follow-up|1
150405|NCT00676715|534830|P1|Overall Study|Lost to Follow-up|1
150406|NCT00676715|534827|P4|Overall Study|Other|3
150407|NCT00676715|534828|P3|Overall Study|Other|4
150408|NCT00676715|534829|P2|Overall Study|Other|6
150409|NCT00676715|534830|P1|Overall Study|Other|2
150410|NCT00676715|534827|P4|Overall Study|Withdrawal by Subject|10
150411|NCT00676715|534828|P3|Overall Study|Withdrawal by Subject|10
150412|NCT00676715|534829|P2|Overall Study|Withdrawal by Subject|9
150413|NCT00676715|534830|P1|Overall Study|Withdrawal by Subject|7
150414|NCT00676689|534860|P1|Overall Study|Continuing FU|49
150415|NCT00676689|534860|P1|Overall Study|Withdrawal by Subject|3
150416|NCT00676689|534860|P1|Overall Study|Physician Decision|1
150417|NCT00676689|534860|P1|Overall Study|Lost to Follow-up|4
150418|NCT00676689|534860|P1|Overall Study|Death|2
150419|NCT00676689|534860|P1|Overall Study|Screen Failure|2
150420|NCT00676650|534872|P2|Overall Study|Randomized but not treated|4
150421|NCT00676650|534873|P1|Overall Study|Randomized but not treated|3
150422|NCT00676650|534872|P2|Overall Study|Withdrawal by Subject|24
150423|NCT00676650|534873|P1|Overall Study|Withdrawal by Subject|48
150424|NCT00676650|534872|P2|Overall Study|Study terminated by sponsor|43
150425|NCT00676650|534873|P1|Overall Study|Study terminated by sponsor|57
150426|NCT00676650|534872|P2|Overall Study|Protocol Violation|1
150427|NCT00676650|534873|P1|Overall Study|Protocol Violation|3
150428|NCT00676650|534872|P2|Overall Study|Other|10
150429|NCT00676650|534873|P1|Overall Study|Other|14
150430|NCT00676650|534872|P2|Overall Study|Objective progression or relapse|140
150431|NCT00676650|534873|P1|Overall Study|Objective progression or relapse|189
150432|NCT00676650|534872|P2|Overall Study|Lost to Follow-up|1
150433|NCT00676650|534873|P1|Overall Study|Lost to Follow-up|0
150434|NCT00676650|534872|P2|Overall Study|Global deterioration of health status|31
150435|NCT00676650|534873|P1|Overall Study|Global deterioration of health status|66
150436|NCT00676650|534872|P2|Overall Study|Adverse Event|21
150437|NCT00676650|534873|P1|Overall Study|Adverse Event|159
150438|NCT00676650|534872|P2|Overall Study|Death|14
150439|NCT00676650|534873|P1|Overall Study|Death|45
150440|NCT00676520|534904|P1|Overall Study|Other Reason|18
150441|NCT00676520|534904|P1|Overall Study|Ineligible for Randomization to DAPT|209
150442|NCT00676520|534904|P1|Overall Study|Physician Decision|20
150443|NCT00676520|534904|P1|Overall Study|Death|159
150444|NCT00676520|534904|P1|Overall Study|Lost to Follow-up|162
150445|NCT00676520|534904|P1|Overall Study|Withdrawal by Subject|163
150446|NCT00676494|534961|P1|Overall Study|Withdrawal by Subject|6
150447|NCT00676494|534961|P1|Overall Study|Missed Visit|8
150448|NCT00676403|534978|P6|Overall Study|Withdrawal by Subject|1
150449|NCT00676403|534979|P5|Overall Study|Withdrawal by Subject|0
150450|NCT00676403|534980|P4|Overall Study|Withdrawal by Subject|0
150451|NCT00676403|534981|P3|Overall Study|Withdrawal by Subject|0
150452|NCT00676403|534982|P2|Overall Study|Withdrawal by Subject|0
150453|NCT00676403|534983|P1|Overall Study|Withdrawal by Subject|0
150454|NCT00676403|534978|P6|Overall Study|Reason Unspecified|1
150455|NCT00676403|534979|P5|Overall Study|Reason Unspecified|0
150456|NCT00676403|534980|P4|Overall Study|Reason Unspecified|0
150457|NCT00676403|534981|P3|Overall Study|Reason Unspecified|1
150458|NCT00676403|534982|P2|Overall Study|Reason Unspecified|0
150459|NCT00676403|534983|P1|Overall Study|Reason Unspecified|1
150460|NCT00676403|534978|P6|Overall Study|Lost to Follow-up|1
150461|NCT00676403|534979|P5|Overall Study|Lost to Follow-up|0
150462|NCT00676403|534980|P4|Overall Study|Lost to Follow-up|0
150463|NCT00676403|534981|P3|Overall Study|Lost to Follow-up|0
150464|NCT00676403|534982|P2|Overall Study|Lost to Follow-up|0
150465|NCT00676403|534983|P1|Overall Study|Lost to Follow-up|0
150466|NCT00676403|534978|P6|Overall Study|Adverse Event|2
150467|NCT00676403|534979|P5|Overall Study|Adverse Event|1
150468|NCT00676403|534980|P4|Overall Study|Adverse Event|5
150469|NCT00676403|534981|P3|Overall Study|Adverse Event|0
150470|NCT00676403|534982|P2|Overall Study|Adverse Event|2
150471|NCT00676403|534983|P1|Overall Study|Adverse Event|1
150472|NCT00676338|535126|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
150473|NCT00676338|535127|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
150474|NCT00676338|535128|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
150475|NCT00676338|535129|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
150476|NCT00676338|535126|P4|Overall Study|Entry Criteria Not Met|1
150477|NCT00676338|535127|P3|Overall Study|Entry Criteria Not Met|1
150478|NCT00676338|535128|P2|Overall Study|Entry Criteria Not Met|2
150479|NCT00676338|535129|P1|Overall Study|Entry Criteria Not Met|0
150480|NCT00676338|535126|P4|Overall Study|Withdrawal by Subject|6
150481|NCT00676338|535127|P3|Overall Study|Withdrawal by Subject|12
150482|NCT00676338|535128|P2|Overall Study|Withdrawal by Subject|9
150483|NCT00676338|535129|P1|Overall Study|Withdrawal by Subject|17
150484|NCT00676338|535126|P4|Overall Study|Protocol Violation|5
150485|NCT00676338|535127|P3|Overall Study|Protocol Violation|2
150486|NCT00676338|535128|P2|Overall Study|Protocol Violation|9
150487|NCT00676338|535129|P1|Overall Study|Protocol Violation|5
150488|NCT00676338|535126|P4|Overall Study|Physician Decision|3
150489|NCT00676338|535127|P3|Overall Study|Physician Decision|2
150490|NCT00676338|535128|P2|Overall Study|Physician Decision|3
150491|NCT00676338|535129|P1|Overall Study|Physician Decision|3
150492|NCT00676338|535126|P4|Overall Study|Lost to Follow-up|4
150493|NCT00676338|535127|P3|Overall Study|Lost to Follow-up|3
150494|NCT00676338|535128|P2|Overall Study|Lost to Follow-up|1
150495|NCT00676338|535129|P1|Overall Study|Lost to Follow-up|4
150496|NCT00676338|535126|P4|Overall Study|Adverse Event|1
150497|NCT00676338|535127|P3|Overall Study|Adverse Event|5
150498|NCT00676338|535128|P2|Overall Study|Adverse Event|6
150499|NCT00676338|535129|P1|Overall Study|Adverse Event|6
150500|NCT00676208|535181|P2|Overall Study|Incomplete data|4
150501|NCT00676208|535182|P1|Overall Study|Incomplete data|2
150502|NCT00676208|535181|P2|Overall Study|Lost to Follow-up|2
150503|NCT00676208|535182|P1|Overall Study|Lost to Follow-up|0
150504|NCT00676195|535190|P1|Overall Study|Physician Decision|1
150505|NCT00676195|535190|P1|Overall Study|Adverse Event|1
150506|NCT00676195|535190|P1|Overall Study|Lost to Follow-up|1
150507|NCT00676143|535215|P2|Overall Study|Vasogenic edema recurrence|3
150508|NCT00676143|535216|P1|Overall Study|Vasogenic edema recurrence|1
150509|NCT00676143|535215|P2|Overall Study|Participant participation unknown|4
150510|NCT00676143|535216|P1|Overall Study|Participant participation unknown|1
150511|NCT00676143|535215|P2|Overall Study|Not specified|20
150512|NCT00676143|535216|P1|Overall Study|Not specified|11
150513|NCT00676143|535215|P2|Overall Study|Loss of caregiver|3
150514|NCT00676143|535216|P1|Overall Study|Loss of caregiver|5
150515|NCT00676143|535215|P2|Overall Study|Failed to return|1
150516|NCT00676143|535216|P1|Overall Study|Failed to return|2
150517|NCT00676143|535215|P2|Overall Study|Discontinuation of study by sponsor|88
150518|NCT00676143|535216|P1|Overall Study|Discontinuation of study by sponsor|65
150519|NCT00676143|535215|P2|Overall Study|Withdrawal by Subject|42
150520|NCT00676143|535216|P1|Overall Study|Withdrawal by Subject|24
150521|NCT00676143|535215|P2|Overall Study|Protocol Violation|8
150522|NCT00676143|535216|P1|Overall Study|Protocol Violation|4
150523|NCT00676143|535215|P2|Overall Study|Physician Decision|8
150524|NCT00676143|535216|P1|Overall Study|Physician Decision|5
150525|NCT00676143|535215|P2|Overall Study|Lost to Follow-up|13
150526|NCT00676143|535216|P1|Overall Study|Lost to Follow-up|0
150527|NCT00676143|535215|P2|Overall Study|Lack of Efficacy|6
150528|NCT00676143|535216|P1|Overall Study|Lack of Efficacy|0
150529|NCT00676143|535215|P2|Overall Study|Death|4
150530|NCT00676143|535216|P1|Overall Study|Death|4
150531|NCT00676143|535215|P2|Overall Study|Adverse Event|60
150532|NCT00676143|535216|P1|Overall Study|Adverse Event|34
150533|NCT00676130|535256|P2|Overall Study|Withdrawal by Subject|1
150534|NCT00676130|535257|P1|Overall Study|Withdrawal by Subject|0
150535|NCT00676130|535256|P2|Overall Study|Found ineligible|2
150536|NCT00676130|535257|P1|Overall Study|Found ineligible|3
150537|NCT00676130|535256|P2|Overall Study|Lost to Follow-up|1
150538|NCT00676130|535257|P1|Overall Study|Lost to Follow-up|0
150539|NCT00676091|535267|P2|Toddler Dose|Parent or legal guardian request|0
150540|NCT00676091|535268|P1|Toddler Dose|Parent or legal guardian request|1
150541|NCT00676091|535267|P2|Toddler Dose|Failed to return|0
150542|NCT00676091|535268|P1|Toddler Dose|Failed to return|2
150543|NCT00676091|535267|P2|After Infant Series|Failed to return|1
150544|NCT00676091|535268|P1|After Infant Series|Failed to return|1
150545|NCT00676091|535267|P2|After Infant Series|Protocol Violation|1
150546|NCT00676091|535268|P1|After Infant Series|Protocol Violation|0
150547|NCT00676091|535267|P2|After Infant Series|Adverse Event|1
150548|NCT00676091|535268|P1|After Infant Series|Adverse Event|0
150549|NCT00676091|535267|P2|Infant Series|Died prior to receiving 7vPnC|1
150550|NCT00676091|535268|P1|Infant Series|Died prior to receiving 7vPnC|0
150551|NCT00676091|535267|P2|Infant Series|Lost to Follow-up|0
150552|NCT00676091|535268|P1|Infant Series|Lost to Follow-up|1
150553|NCT00676091|535267|P2|Infant Series|Failed to return|3
150554|NCT00676091|535268|P1|Infant Series|Failed to return|1
150555|NCT00676091|535267|P2|Infant Series|Adverse Event|3
150556|NCT00676091|535268|P1|Infant Series|Adverse Event|2
150557|NCT00676091|535267|P2|Infant Series|Protocol Violation|3
150558|NCT00676091|535268|P1|Infant Series|Protocol Violation|6
150559|NCT00676091|535267|P2|Infant Series|Parent or legal guardian request|8
150560|NCT00676091|535268|P1|Infant Series|Parent or legal guardian request|10
150561|NCT00676052|535325|P6|Overall Study|Withdrawal by Subject|0
150562|NCT00676052|535326|P5|Overall Study|Withdrawal by Subject|0
150563|NCT00676052|535327|P4|Overall Study|Withdrawal by Subject|0
150564|NCT00676052|535328|P3|Overall Study|Withdrawal by Subject|1
150565|NCT00676052|535329|P2|Overall Study|Withdrawal by Subject|0
150566|NCT00676052|535330|P1|Overall Study|Withdrawal by Subject|1
150567|NCT00676052|535325|P6|Overall Study|Physician Decision|1
150568|NCT00676052|535326|P5|Overall Study|Physician Decision|0
150569|NCT00676052|535327|P4|Overall Study|Physician Decision|0
150570|NCT00676052|535328|P3|Overall Study|Physician Decision|1
150571|NCT00676052|535329|P2|Overall Study|Physician Decision|1
150572|NCT00676052|535330|P1|Overall Study|Physician Decision|1
150573|NCT00676052|535325|P6|Overall Study|Lost to Follow-up|0
150574|NCT00676052|535326|P5|Overall Study|Lost to Follow-up|1
150575|NCT00676052|535327|P4|Overall Study|Lost to Follow-up|0
150576|NCT00676052|535328|P3|Overall Study|Lost to Follow-up|0
150577|NCT00676052|535329|P2|Overall Study|Lost to Follow-up|0
150578|NCT00676052|535330|P1|Overall Study|Lost to Follow-up|0
150579|NCT00676052|535325|P6|Overall Study|Protocol Violation|2
150580|NCT00676052|535326|P5|Overall Study|Protocol Violation|1
150581|NCT00676052|535327|P4|Overall Study|Protocol Violation|2
150582|NCT00676052|535328|P3|Overall Study|Protocol Violation|2
150583|NCT00676052|535329|P2|Overall Study|Protocol Violation|3
150584|NCT00676052|535330|P1|Overall Study|Protocol Violation|5
150585|NCT00676052|535325|P6|Overall Study|Lack of Efficacy|1
150586|NCT00676052|535326|P5|Overall Study|Lack of Efficacy|2
150587|NCT00676052|535327|P4|Overall Study|Lack of Efficacy|1
150588|NCT00676052|535328|P3|Overall Study|Lack of Efficacy|1
150589|NCT00676052|535329|P2|Overall Study|Lack of Efficacy|2
150590|NCT00676052|535330|P1|Overall Study|Lack of Efficacy|2
150591|NCT00676052|535325|P6|Overall Study|Adverse Event|2
150592|NCT00676052|535326|P5|Overall Study|Adverse Event|2
150593|NCT00676052|535327|P4|Overall Study|Adverse Event|2
150594|NCT00676052|535328|P3|Overall Study|Adverse Event|1
150595|NCT00676052|535329|P2|Overall Study|Adverse Event|1
150596|NCT00676052|535330|P1|Overall Study|Adverse Event|0
150597|NCT00675948|535379|P2|Overall Study|Patient feels unable to take medication|1
150598|NCT00675948|535380|P1|Overall Study|Patient feels unable to take medication|0
150599|NCT00675948|535379|P2|Overall Study|Patient unable to comply with diaries|0
150600|NCT00675948|535380|P1|Overall Study|Patient unable to comply with diaries|1
150601|NCT00675948|535379|P2|Overall Study|Patient died|0
150602|NCT00675948|535380|P1|Overall Study|Patient died|1
150603|NCT00675948|535379|P2|Overall Study|Sponsor decision|1
150604|NCT00675948|535380|P1|Overall Study|Sponsor decision|0
150605|NCT00675948|535379|P2|Overall Study|Pain under control|0
150606|NCT00675948|535380|P1|Overall Study|Pain under control|1
150607|NCT00675948|535379|P2|Overall Study|Protocol Violation|0
150608|NCT00675948|535380|P1|Overall Study|Protocol Violation|1
150609|NCT00675948|535379|P2|Overall Study|Lost to Follow-up|0
150610|NCT00675948|535380|P1|Overall Study|Lost to Follow-up|2
150611|NCT00675948|535379|P2|Overall Study|Withdrawal by Subject|0
150612|NCT00675948|535380|P1|Overall Study|Withdrawal by Subject|7
150613|NCT00675948|535379|P2|Overall Study|Lack of Efficacy|0
150614|NCT00675948|535380|P1|Overall Study|Lack of Efficacy|3
150615|NCT00675948|535379|P2|Overall Study|Adverse Event|1
150616|NCT00675948|535380|P1|Overall Study|Adverse Event|23
150617|NCT00675766|535431|P4|Overall Study|Lost to Follow-up|26
150618|NCT00675766|535432|P3|Overall Study|Lost to Follow-up|21
150619|NCT00675766|535433|P2|Overall Study|Lost to Follow-up|5
150620|NCT00675766|535434|P1|Overall Study|Lost to Follow-up|6
150621|NCT00675597|535444|P1|Overall Study|Withdrawal by Subject|3
150622|NCT00675506|535478|P2|Overall Study|Schedule conflict|1
150623|NCT00675506|535479|P1|Overall Study|Schedule conflict|0
150624|NCT00675506|535478|P2|Overall Study|Declined participation|0
150625|NCT00675506|535479|P1|Overall Study|Declined participation|1
150626|NCT00675506|535478|P2|Overall Study|Disclosed history of cancer|0
150627|NCT00675506|535479|P1|Overall Study|Disclosed history of cancer|1
150628|NCT00675506|535478|P2|Overall Study|Hypersensitivity Reaction|0
150629|NCT00675506|535479|P1|Overall Study|Hypersensitivity Reaction|1
150630|NCT00675506|535478|P2|Overall Study|Elevated IGF-1|0
150631|NCT00675506|535479|P1|Overall Study|Elevated IGF-1|2
150632|NCT00675506|535478|P2|Overall Study|Elevated IGF-1 prior to treatment|0
150633|NCT00675506|535479|P1|Overall Study|Elevated IGF-1 prior to treatment|1
150634|NCT00675506|535478|P2|Overall Study|Elevated fasting glucose|1
150635|NCT00675506|535479|P1|Overall Study|Elevated fasting glucose|2
150636|NCT00675506|535478|P2|Overall Study|Lost interest|5
150637|NCT00675506|535479|P1|Overall Study|Lost interest|3
150638|NCT00675506|535478|P2|Overall Study|Lost to Follow-up|5
150639|NCT00675506|535479|P1|Overall Study|Lost to Follow-up|1
150640|NCT00675441|535495|P1|Overall Study|Death|1
150641|NCT00675441|535495|P1|Overall Study|Withdrawal by Subject|2
150642|NCT00675428|535501|P2|Overall Study|Physician Decision|0
150643|NCT00675428|535502|P1|Overall Study|Physician Decision|1
150644|NCT00675428|535501|P2|Overall Study|No Disease Response After Cycle 6|1
150645|NCT00675428|535502|P1|Overall Study|No Disease Response After Cycle 6|0
150646|NCT00675428|535501|P2|Overall Study|Disease Progression|2
150647|NCT00675428|535502|P1|Overall Study|Disease Progression|2
150648|NCT00675103|535544|P1|Overall Study|Adverse Event|1
150649|NCT00675103|535544|P1|Overall Study|Lack of Efficacy|2
150650|NCT00674986|535551|P2|Overall Study|Other reasons|8
150651|NCT00674986|535552|P1|Overall Study|Other reasons|4
150652|NCT00674986|535551|P2|Overall Study|Lost to Follow-up|53
150653|NCT00674986|535552|P1|Overall Study|Lost to Follow-up|25
150654|NCT00674986|535551|P2|Overall Study|Subject withdrew consent|19
150655|NCT00674986|535552|P1|Overall Study|Subject withdrew consent|12
150656|NCT00674986|535551|P2|Overall Study|Adverse Event|1
150657|NCT00674986|535552|P1|Overall Study|Adverse Event|2
150658|NCT00674973|535573|P2|Overall Study|Protocol Violation|1
150659|NCT00674973|535574|P1|Overall Study|Protocol Violation|0
150660|NCT00674973|535573|P2|Overall Study|Death|15
150661|NCT00674973|535574|P1|Overall Study|Death|19
150662|NCT00674973|535573|P2|Overall Study|Adverse Event|9
150663|NCT00674973|535574|P1|Overall Study|Adverse Event|2
150664|NCT00674973|535573|P2|Overall Study|Failure to Return|0
150665|NCT00674973|535574|P1|Overall Study|Failure to Return|1
150666|NCT00674973|535573|P2|Overall Study|Refused Treatment|5
150667|NCT00674973|535574|P1|Overall Study|Refused Treatment|1
150668|NCT00674973|535573|P2|Overall Study|Insufficient Therapeutic Response|72
150669|NCT00674973|535574|P1|Overall Study|Insufficient Therapeutic Response|77
150670|NCT00674817|535588|P1|Period 4|Adverse Event|1
150671|NCT00674817|535588|P1|Period 3|Protocol Violation|1
150672|NCT00674817|535588|P1|Period 3|Adverse Event|1
150673|NCT00674817|535588|P1|Period 1|Protocol Violation|1
150674|NCT00674817|535588|P1|Period 1|Withdrawal by Subject|2
150675|NCT00674700|535765|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
150676|NCT00674700|535766|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
150677|NCT00674700|535767|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
150678|NCT00674700|535765|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
150679|NCT00674700|535766|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
150680|NCT00674700|535767|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
150681|NCT00674700|535765|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
150682|NCT00674700|535766|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
150683|NCT00674700|535767|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
150684|NCT00674700|535765|P3|Year 1|Any other reason not above-mentioned|6
150685|NCT00674700|535766|P2|Year 1|Any other reason not above-mentioned|7
150686|NCT00674700|535767|P1|Year 1|Any other reason not above-mentioned|7
150687|NCT00674700|535765|P3|Year 1|Withdrawal by Subject|6
150688|NCT00674700|535766|P2|Year 1|Withdrawal by Subject|7
150689|NCT00674700|535767|P1|Year 1|Withdrawal by Subject|7
150690|NCT00674700|535765|P3|Year 1|Adverse Event|5
150691|NCT00674700|535766|P2|Year 1|Adverse Event|20
150692|NCT00674700|535767|P1|Year 1|Adverse Event|17
150693|NCT00674661|535780|P2|Overall Study|Withdrawal by Subject|5
150694|NCT00674661|535781|P1|Overall Study|Withdrawal by Subject|0
150695|NCT00674661|535780|P2|Overall Study|Lost to Follow-up|3
150696|NCT00674661|535781|P1|Overall Study|Lost to Follow-up|6
150697|NCT00674661|535780|P2|Overall Study|not specified|7
150698|NCT00674661|535781|P1|Overall Study|not specified|5
150699|NCT00674362|535901|P2|Open Label|Other: Subject moved to extension study|0
150700|NCT00674362|535902|P1|Open Label|Other: Subject moved to extension study|1
150701|NCT00674362|535901|P2|Open Label|Adverse Event|0
150702|NCT00674362|535902|P1|Open Label|Adverse Event|1
150703|NCT00674362|535901|P2|Double Blind|Other: Surgery|1
150704|NCT00674362|535902|P1|Double Blind|Other: Surgery|0
150705|NCT00674362|535901|P2|Double Blind|Other: Loss of Patient Compliance|1
150706|NCT00674362|535902|P1|Double Blind|Other: Loss of Patient Compliance|0
150707|NCT00674362|535901|P2|Double Blind|Withdrawal by Subject|3
150708|NCT00674362|535902|P1|Double Blind|Withdrawal by Subject|4
150709|NCT00674362|535901|P2|Double Blind|Loss of efficacy|1
150710|NCT00674362|535902|P1|Double Blind|Loss of efficacy|0
150711|NCT00674362|535901|P2|Double Blind|Lack of Efficacy|6
150712|NCT00674362|535902|P1|Double Blind|Lack of Efficacy|2
150713|NCT00674362|535901|P2|Double Blind|Adverse Event|6
150714|NCT00674362|535902|P1|Double Blind|Adverse Event|6
150715|NCT00674323|535970|P3|Overall Study|Protocol Violation|0
150716|NCT00674323|535971|P2|Overall Study|Protocol Violation|0
150717|NCT00674323|535972|P1|Overall Study|Protocol Violation|1
150718|NCT00674323|535970|P3|Overall Study|Adverse Event|0
150719|NCT00674323|535971|P2|Overall Study|Adverse Event|1
150720|NCT00674323|535972|P1|Overall Study|Adverse Event|0
150721|NCT00674154|536014|P2|Overall Study|Did not want parathyroidectomy|2
150722|NCT00674154|536015|P1|Overall Study|Did not want parathyroidectomy|0
150723|NCT00674154|536014|P2|Overall Study|Withdrawal by Subject|1
150724|NCT00674154|536015|P1|Overall Study|Withdrawal by Subject|3
150725|NCT00674128|536023|P2|Overall Study|Withdrawal by Subject|23
150726|NCT00674128|536024|P1|Overall Study|Withdrawal by Subject|25
150727|NCT00673933|536049|P1|Overall Study|Lost to Follow-up|1
150728|NCT00673933|536049|P1|Overall Study|Withdrawal by Subject|2
150729|NCT00673881|536065|P1|Overall Study|Withdrawal by Subject|1
150730|NCT00673816|536079|P1|Overall Study|Withdrawal by Subject|1
150731|NCT00673816|536079|P1|Overall Study|Adverse Event|1
150732|NCT00673673|536114|P1|Overall Study|Investigators' discretion|2
150733|NCT00673673|536114|P1|Overall Study|Withdrawal by Subject|3
150734|NCT00673673|536114|P1|Overall Study|Adverse Event|4
150735|NCT00673673|536114|P1|Overall Study|Progressive disease|27
150736|NCT00673660|536120|P1|Overall Study|Lost to Follow-up|107
150737|NCT00673465|536142|P12|Part 1/Period 2 (United States)|Protocol Violation|0
150738|NCT00673465|536143|P11|Part 1/Period 2 (United States)|Protocol Violation|0
150739|NCT00673465|536144|P10|Part 1/Period 2 (United States)|Protocol Violation|0
150740|NCT00673465|536145|P9|Part 1/Period 2 (United States)|Protocol Violation|0
150741|NCT00673465|536146|P8|Part 1/Period 2 (United States)|Protocol Violation|0
150742|NCT00673465|536147|P7|Part 1/Period 2 (United States)|Protocol Violation|0
150743|NCT00673465|536148|P6|Part 1/Period 2 (United States)|Protocol Violation|0
150744|NCT00673465|536149|P5|Part 1/Period 2 (United States)|Protocol Violation|1
150745|NCT00673465|536150|P4|Part 1/Period 2 (United States)|Protocol Violation|0
150746|NCT00673465|536151|P3|Part 1/Period 2 (United States)|Protocol Violation|0
150747|NCT00673465|536152|P2|Part 1/Period 2 (United States)|Protocol Violation|0
150748|NCT00673465|536153|P1|Part 1/Period 2 (United States)|Protocol Violation|0
150749|NCT00673465|536142|P12|Part 1/Period 1 (United States)|Protocol Violation|0
150750|NCT00673465|536143|P11|Part 1/Period 1 (United States)|Protocol Violation|0
150751|NCT00673465|536144|P10|Part 1/Period 1 (United States)|Protocol Violation|0
150752|NCT00673465|536145|P9|Part 1/Period 1 (United States)|Protocol Violation|0
150753|NCT00673465|536146|P8|Part 1/Period 1 (United States)|Protocol Violation|0
150754|NCT00673465|536147|P7|Part 1/Period 1 (United States)|Protocol Violation|0
150755|NCT00673465|536148|P6|Part 1/Period 1 (United States)|Protocol Violation|1
150756|NCT00673465|536149|P5|Part 1/Period 1 (United States)|Protocol Violation|1
150757|NCT00673465|536150|P4|Part 1/Period 1 (United States)|Protocol Violation|0
150758|NCT00673465|536151|P3|Part 1/Period 1 (United States)|Protocol Violation|0
150759|NCT00673465|536152|P2|Part 1/Period 1 (United States)|Protocol Violation|0
150760|NCT00673465|536153|P1|Part 1/Period 1 (United States)|Protocol Violation|0
150761|NCT00673452|536202|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
150762|NCT00673452|536203|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
150763|NCT00673452|536202|P2|Continuation Double-Blind Phase|Physician Decision|0
150764|NCT00673452|536203|P1|Continuation Double-Blind Phase|Physician Decision|2
150765|NCT00673452|536202|P2|Continuation Double-Blind Phase|Sponsor Decision|3
150766|NCT00673452|536203|P1|Continuation Double-Blind Phase|Sponsor Decision|0
150767|NCT00673452|536202|P2|Continuation Double-Blind Phase|Protocol Violation|3
150768|NCT00673452|536203|P1|Continuation Double-Blind Phase|Protocol Violation|2
150769|NCT00673452|536202|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
150770|NCT00673452|536203|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
150771|NCT00673452|536202|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
150772|NCT00673452|536203|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
150773|NCT00673452|536202|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
150774|NCT00673452|536203|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
150775|NCT00673452|536202|P2|Continuation Double-Blind Phase|Adverse Event|13
150776|NCT00673452|536203|P1|Continuation Double-Blind Phase|Adverse Event|5
150777|NCT00673452|536202|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
150778|NCT00673452|536203|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
150779|NCT00673452|536202|P2|Acute Double-Blind Phase|Sponsor Decision|1
150780|NCT00673452|536203|P1|Acute Double-Blind Phase|Sponsor Decision|0
150781|NCT00673452|536202|P2|Acute Double-Blind Phase|Protocol Violation|3
150782|NCT00673452|536203|P1|Acute Double-Blind Phase|Protocol Violation|5
150783|NCT00673452|536202|P2|Acute Double-Blind Phase|Physician Decision|6
150784|NCT00673452|536203|P1|Acute Double-Blind Phase|Physician Decision|0
150785|NCT00673452|536202|P2|Acute Double-Blind Phase|Lost to Follow-up|19
150786|NCT00673452|536203|P1|Acute Double-Blind Phase|Lost to Follow-up|16
150787|NCT00673452|536202|P2|Acute Double-Blind Phase|Lack of Efficacy|14
150788|NCT00673452|536203|P1|Acute Double-Blind Phase|Lack of Efficacy|9
150789|NCT00673452|536202|P2|Acute Double-Blind Phase|Adverse Event|24
150790|NCT00673452|536203|P1|Acute Double-Blind Phase|Adverse Event|41
150791|NCT00673387|536266|P8|Overall Study|Lost to Follow-up|5
150792|NCT00673387|536267|P7|Overall Study|Lost to Follow-up|8
150793|NCT00673387|536268|P6|Overall Study|Lost to Follow-up|5
150794|NCT00673387|536269|P5|Overall Study|Lost to Follow-up|6
150795|NCT00673387|536270|P4|Overall Study|Lost to Follow-up|6
150796|NCT00673387|536271|P3|Overall Study|Lost to Follow-up|5
150797|NCT00673387|536272|P2|Overall Study|Lost to Follow-up|6
150798|NCT00673387|536273|P1|Overall Study|Lost to Follow-up|8
150799|NCT00673387|536266|P8|Overall Study|Protocol Violation|3
150800|NCT00673387|536267|P7|Overall Study|Protocol Violation|1
150801|NCT00673387|536268|P6|Overall Study|Protocol Violation|1
150802|NCT00673387|536269|P5|Overall Study|Protocol Violation|0
150803|NCT00673387|536270|P4|Overall Study|Protocol Violation|2
150804|NCT00673387|536271|P3|Overall Study|Protocol Violation|1
150805|NCT00673387|536272|P2|Overall Study|Protocol Violation|0
150806|NCT00673387|536273|P1|Overall Study|Protocol Violation|3
150807|NCT00673387|536266|P8|Overall Study|Physician Decision|1
150808|NCT00673387|536267|P7|Overall Study|Physician Decision|1
150809|NCT00673387|536268|P6|Overall Study|Physician Decision|5
150810|NCT00673387|536269|P5|Overall Study|Physician Decision|0
150811|NCT00673387|536270|P4|Overall Study|Physician Decision|0
150812|NCT00673387|536271|P3|Overall Study|Physician Decision|0
150813|NCT00673387|536272|P2|Overall Study|Physician Decision|0
150814|NCT00673387|536273|P1|Overall Study|Physician Decision|0
150815|NCT00673387|536266|P8|Overall Study|Adverse Event|5
150816|NCT00673387|536267|P7|Overall Study|Adverse Event|5
150817|NCT00673387|536268|P6|Overall Study|Adverse Event|2
150818|NCT00673387|536269|P5|Overall Study|Adverse Event|6
150819|NCT00673387|536270|P4|Overall Study|Adverse Event|2
150820|NCT00673387|536271|P3|Overall Study|Adverse Event|5
150821|NCT00673387|536272|P2|Overall Study|Adverse Event|1
150822|NCT00673387|536273|P1|Overall Study|Adverse Event|3
150823|NCT00673387|536266|P8|Overall Study|Withdrawal by Subject|21
150824|NCT00673387|536267|P7|Overall Study|Withdrawal by Subject|15
150825|NCT00673387|536268|P6|Overall Study|Withdrawal by Subject|21
150826|NCT00673387|536269|P5|Overall Study|Withdrawal by Subject|18
150827|NCT00673387|536270|P4|Overall Study|Withdrawal by Subject|16
150828|NCT00673387|536271|P3|Overall Study|Withdrawal by Subject|20
150829|NCT00673387|536272|P2|Overall Study|Withdrawal by Subject|16
150830|NCT00673387|536273|P1|Overall Study|Withdrawal by Subject|15
150831|NCT00673361|536489|P1|Overall Study|Screen Failure|2
150832|NCT00673257|536493|P1|Overall Study|Unable to obtain specimen|1
150833|NCT00673257|536493|P1|Overall Study|Withdrawal by Subject|4
150834|NCT00673231|536502|P4|Overall Study|Study criteria,compliance,safety, other|4
150835|NCT00673231|536503|P3|Overall Study|Study criteria,compliance,safety, other|7
150836|NCT00673231|536504|P2|Overall Study|Study criteria,compliance,safety, other|5
150837|NCT00673231|536505|P1|Overall Study|Study criteria,compliance,safety, other|8
150838|NCT00673231|536502|P4|Overall Study|Death|0
150839|NCT00673231|536503|P3|Overall Study|Death|1
150840|NCT00673231|536504|P2|Overall Study|Death|0
150841|NCT00673231|536505|P1|Overall Study|Death|0
150842|NCT00673231|536502|P4|Overall Study|Lost to Follow-up|2
150843|NCT00673231|536503|P3|Overall Study|Lost to Follow-up|1
150844|NCT00673231|536504|P2|Overall Study|Lost to Follow-up|2
150845|NCT00673231|536505|P1|Overall Study|Lost to Follow-up|1
150846|NCT00673231|536502|P4|Overall Study|Adverse Event|6
150847|NCT00673231|536503|P3|Overall Study|Adverse Event|9
150848|NCT00673231|536504|P2|Overall Study|Adverse Event|5
150849|NCT00673231|536505|P1|Overall Study|Adverse Event|6
150850|NCT00673231|536502|P4|Overall Study|Withdrawal by Subject|6
150851|NCT00673231|536503|P3|Overall Study|Withdrawal by Subject|8
150852|NCT00673231|536504|P2|Overall Study|Withdrawal by Subject|10
150853|NCT00673231|536505|P1|Overall Study|Withdrawal by Subject|14
150854|NCT00673179|536537|P2|Overall Study|Toxicity/Complications|0
150855|NCT00673179|536538|P1|Overall Study|Toxicity/Complications|3
150856|NCT00673049|536587|P4|After Progression on Erlotinib|study terminated by sponsor|4
150857|NCT00673049|536588|P3|After Progression on Erlotinib|study terminated by sponsor|0
150858|NCT00673049|536589|P2|After Progression on Erlotinib|study terminated by sponsor|0
150859|NCT00673049|536590|P1|After Progression on Erlotinib|study terminated by sponsor|0
150860|NCT00673049|536587|P4|After Progression on Erlotinib|Withdrawal by Subject|5
150861|NCT00673049|536588|P3|After Progression on Erlotinib|Withdrawal by Subject|0
150862|NCT00673049|536589|P2|After Progression on Erlotinib|Withdrawal by Subject|0
150863|NCT00673049|536590|P1|After Progression on Erlotinib|Withdrawal by Subject|0
150864|NCT00673049|536587|P4|After Progression on Erlotinib|Lost to Follow-up|3
150865|NCT00673049|536588|P3|After Progression on Erlotinib|Lost to Follow-up|0
150866|NCT00673049|536589|P2|After Progression on Erlotinib|Lost to Follow-up|0
150867|NCT00673049|536590|P1|After Progression on Erlotinib|Lost to Follow-up|0
150868|NCT00673049|536587|P4|After Progression on Erlotinib|Death|71
150869|NCT00673049|536588|P3|After Progression on Erlotinib|Death|0
150870|NCT00673049|536589|P2|After Progression on Erlotinib|Death|0
150871|NCT00673049|536590|P1|After Progression on Erlotinib|Death|0
150872|NCT00673049|536587|P4|Before Progression on Erlotinib|Switched to figitumumab|0
150873|NCT00673049|536588|P3|Before Progression on Erlotinib|Switched to figitumumab|0
150874|NCT00673049|536589|P2|Before Progression on Erlotinib|Switched to figitumumab|83
150875|NCT00673049|536590|P1|Before Progression on Erlotinib|Switched to figitumumab|0
150876|NCT00673049|536587|P4|Before Progression on Erlotinib|study terminated by sponsor|0
150877|NCT00673049|536588|P3|Before Progression on Erlotinib|study terminated by sponsor|0
150878|NCT00673049|536589|P2|Before Progression on Erlotinib|study terminated by sponsor|14
150879|NCT00673049|536590|P1|Before Progression on Erlotinib|study terminated by sponsor|18
150880|NCT00673049|536587|P4|Before Progression on Erlotinib|Other|0
150881|NCT00673049|536588|P3|Before Progression on Erlotinib|Other|0
150882|NCT00673049|536589|P2|Before Progression on Erlotinib|Other|2
150883|NCT00673049|536590|P1|Before Progression on Erlotinib|Other|1
150884|NCT00673049|536587|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
150885|NCT00673049|536588|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
150886|NCT00673049|536589|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
150887|NCT00673049|536590|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
150888|NCT00673049|536587|P4|Before Progression on Erlotinib|Lost to Follow-up|0
150889|NCT00673049|536588|P3|Before Progression on Erlotinib|Lost to Follow-up|0
150890|NCT00673049|536589|P2|Before Progression on Erlotinib|Lost to Follow-up|5
150891|NCT00673049|536590|P1|Before Progression on Erlotinib|Lost to Follow-up|9
150892|NCT00673049|536587|P4|Before Progression on Erlotinib|Death|0
150893|NCT00673049|536588|P3|Before Progression on Erlotinib|Death|1
150894|NCT00673049|536589|P2|Before Progression on Erlotinib|Death|167
150895|NCT00673049|536590|P1|Before Progression on Erlotinib|Death|235
150896|NCT00673049|536587|P4|Before Progression on Erlotinib|Randomized but not treated|0
150897|NCT00673049|536588|P3|Before Progression on Erlotinib|Randomized but not treated|0
150898|NCT00673049|536589|P2|Before Progression on Erlotinib|Randomized but not treated|1
150899|NCT00673049|536590|P1|Before Progression on Erlotinib|Randomized but not treated|3
150900|NCT00672984|536614|P3|Third Intervention|Adverse Event|1
150901|NCT00672984|536615|P2|Third Intervention|Adverse Event|0
150902|NCT00672984|536616|P1|Third Intervention|Adverse Event|1
150903|NCT00672984|536614|P3|Second Intervention|Protocol Violation|1
150904|NCT00672984|536615|P2|Second Intervention|Protocol Violation|1
150905|NCT00672984|536616|P1|Second Intervention|Protocol Violation|0
150906|NCT00672984|536614|P3|Second Intervention|Withdrawal by Subject|0
150907|NCT00672984|536615|P2|Second Intervention|Withdrawal by Subject|3
150908|NCT00672984|536616|P1|Second Intervention|Withdrawal by Subject|0
150909|NCT00672984|536614|P3|Second Intervention|Non-compliance with facility policies|0
150910|NCT00672984|536615|P2|Second Intervention|Non-compliance with facility policies|2
150911|NCT00672984|536616|P1|Second Intervention|Non-compliance with facility policies|0
150912|NCT00672984|536614|P3|First Intervention|Sponsor decision|0
150913|NCT00672984|536615|P2|First Intervention|Sponsor decision|0
150914|NCT00672984|536616|P1|First Intervention|Sponsor decision|3
150915|NCT00672984|536614|P3|First Intervention|Withdrawal by Subject|2
150916|NCT00672984|536615|P2|First Intervention|Withdrawal by Subject|2
150917|NCT00672984|536616|P1|First Intervention|Withdrawal by Subject|1
150918|NCT00672984|536614|P3|First Intervention|Adverse Event|0
150919|NCT00672984|536615|P2|First Intervention|Adverse Event|0
150920|NCT00672984|536616|P1|First Intervention|Adverse Event|5
150921|NCT00672958|536667|P2|Overall Study|Reason not specified|3
150922|NCT00672958|536668|P1|Overall Study|Reason not specified|0
150923|NCT00672958|536667|P2|Overall Study|Lost to Follow-up|17
150924|NCT00672958|536668|P1|Overall Study|Lost to Follow-up|22
150925|NCT00672958|536667|P2|Overall Study|Voluntary withdrawal|8
150926|NCT00672958|536668|P1|Overall Study|Voluntary withdrawal|12
150927|NCT00672958|536667|P2|Overall Study|Protocol deviations|5
150928|NCT00672958|536668|P1|Overall Study|Protocol deviations|11
150929|NCT00672958|536667|P2|Overall Study|Non-compliance with study drug|3
150930|NCT00672958|536668|P1|Overall Study|Non-compliance with study drug|2
150931|NCT00672958|536667|P2|Overall Study|Lack of Efficacy|11
150932|NCT00672958|536668|P1|Overall Study|Lack of Efficacy|6
150933|NCT00672958|536667|P2|Overall Study|Adverse Event|9
150934|NCT00672958|536668|P1|Overall Study|Adverse Event|11
150935|NCT00672841|536720|P2|Overall Study|Pregnancy|1
150936|NCT00672841|536721|P1|Overall Study|Pregnancy|0
150937|NCT00672841|536720|P2|Overall Study|Adverse Event|3
150938|NCT00672841|536721|P1|Overall Study|Adverse Event|0
150939|NCT00672841|536720|P2|Overall Study|Antifungal therapy, negative glucan|4
150940|NCT00672841|536721|P1|Overall Study|Antifungal therapy, negative glucan|0
150941|NCT00672841|536720|P2|Overall Study|icteric specimens|3
150942|NCT00672841|536721|P1|Overall Study|icteric specimens|0
150943|NCT00672841|536720|P2|Overall Study|Comfort care|4
150944|NCT00672841|536721|P1|Overall Study|Comfort care|1
150945|NCT00672646|536743|P3|Overall Study|Withdrawal by Subject|1
150946|NCT00672646|536744|P2|Overall Study|Withdrawal by Subject|0
150947|NCT00672646|536745|P1|Overall Study|Withdrawal by Subject|0
150948|NCT00672646|536743|P3|Overall Study|Lost to Follow-up|2
150949|NCT00672646|536744|P2|Overall Study|Lost to Follow-up|1
150950|NCT00672646|536745|P1|Overall Study|Lost to Follow-up|0
150951|NCT00672633|536770|P2|Overall Study|Withdrawal by Subject|1
150952|NCT00672633|536771|P1|Overall Study|Withdrawal by Subject|0
150953|NCT00672620|536785|P4|Overall Study|Reason not Specified|1
150954|NCT00672620|536786|P3|Overall Study|Reason not Specified|2
150955|NCT00672620|536787|P2|Overall Study|Reason not Specified|3
150956|NCT00672620|536788|P1|Overall Study|Reason not Specified|3
150957|NCT00672620|536785|P4|Overall Study|Lost to Follow-up|11
150958|NCT00672620|536786|P3|Overall Study|Lost to Follow-up|8
150959|NCT00672620|536787|P2|Overall Study|Lost to Follow-up|19
150960|NCT00672620|536788|P1|Overall Study|Lost to Follow-up|8
150961|NCT00672620|536785|P4|Overall Study|Withdrawal of Consent|6
150962|NCT00672620|536786|P3|Overall Study|Withdrawal of Consent|5
150963|NCT00672620|536787|P2|Overall Study|Withdrawal of Consent|12
150964|NCT00672620|536788|P1|Overall Study|Withdrawal of Consent|6
150965|NCT00672620|536785|P4|Overall Study|Protocol Deviations|5
150966|NCT00672620|536786|P3|Overall Study|Protocol Deviations|2
150967|NCT00672620|536787|P2|Overall Study|Protocol Deviations|7
150968|NCT00672620|536788|P1|Overall Study|Protocol Deviations|5
150969|NCT00672620|536785|P4|Overall Study|Noncompliance with Study Drug|2
150970|NCT00672620|536786|P3|Overall Study|Noncompliance with Study Drug|0
150971|NCT00672620|536787|P2|Overall Study|Noncompliance with Study Drug|4
150972|NCT00672620|536788|P1|Overall Study|Noncompliance with Study Drug|3
150973|NCT00672620|536785|P4|Overall Study|Lack of Efficacy|0
150974|NCT00672620|536786|P3|Overall Study|Lack of Efficacy|2
150975|NCT00672620|536787|P2|Overall Study|Lack of Efficacy|2
150976|NCT00672620|536788|P1|Overall Study|Lack of Efficacy|1
150977|NCT00672620|536785|P4|Overall Study|Adverse Event|17
150978|NCT00672620|536786|P3|Overall Study|Adverse Event|12
150979|NCT00672620|536787|P2|Overall Study|Adverse Event|7
150980|NCT00672620|536788|P1|Overall Study|Adverse Event|7
150981|NCT00672555|536853|P1|Overall Study|Did not want to answer questionnaire|2
150982|NCT00672555|536853|P1|Overall Study|Lost to Follow-up|4
150983|NCT00672490|536864|P2|Overall Study|No reason was provided|2
150984|NCT00672490|536865|P1|Overall Study|No reason was provided|6
150985|NCT00672490|536864|P2|Overall Study|Lost to Follow-up|5
150986|NCT00672490|536865|P1|Overall Study|Lost to Follow-up|1
150987|NCT00672490|536864|P2|Overall Study|Intolerance|2
150988|NCT00672490|536865|P1|Overall Study|Intolerance|0
150989|NCT00672490|536864|P2|Overall Study|Violation of Concomitant Medicine|0
150990|NCT00672490|536865|P1|Overall Study|Violation of Concomitant Medicine|1
150991|NCT00672490|536864|P2|Overall Study|Adverse Event|8
150992|NCT00672490|536865|P1|Overall Study|Adverse Event|5
150993|NCT00672490|536864|P2|Overall Study|Mismatch Include/Exclude Criteria|0
150994|NCT00672490|536865|P1|Overall Study|Mismatch Include/Exclude Criteria|1
150995|NCT00672490|536864|P2|Overall Study|Lack of Compliance|7
150996|NCT00672490|536865|P1|Overall Study|Lack of Compliance|2
150997|NCT00672490|536864|P2|Overall Study|Withdrawal by Subject|8
150998|NCT00672490|536865|P1|Overall Study|Withdrawal by Subject|8
150999|NCT00672477|536889|P2|Overall Study|no study drug for low GFR, health cond.|3
151000|NCT00672477|536890|P1|Overall Study|no study drug for low GFR, health cond.|1
151001|NCT00672477|536889|P2|Overall Study|Lack of Efficacy|1
151002|NCT00672477|536890|P1|Overall Study|Lack of Efficacy|1
151003|NCT00672477|536889|P2|Overall Study|Withdrawal by Subject|3
151004|NCT00672477|536890|P1|Overall Study|Withdrawal by Subject|5
151005|NCT00672477|536889|P2|Overall Study|Protocol Violation|1
151006|NCT00672477|536890|P1|Overall Study|Protocol Violation|1
151007|NCT00672477|536889|P2|Overall Study|Physician Decision|0
151008|NCT00672477|536890|P1|Overall Study|Physician Decision|2
151009|NCT00672477|536889|P2|Overall Study|Death|11
151010|NCT00672477|536890|P1|Overall Study|Death|7
151011|NCT00672477|536889|P2|Overall Study|Adverse Event|7
151012|NCT00672477|536890|P1|Overall Study|Adverse Event|10
151013|NCT00672256|536932|P1|Overall Study|PI dropped, bad data|44
151014|NCT00672139|536957|P2|Overall Study|hospice discharge, caregiver requests|2
151015|NCT00672139|536958|P1|Overall Study|hospice discharge, caregiver requests|3
151016|NCT00672139|536957|P2|Overall Study|Protocol Violation|1
151017|NCT00672139|536958|P1|Overall Study|Protocol Violation|1
151018|NCT00672139|536957|P2|Overall Study|Lack of Efficacy|1
151019|NCT00672139|536958|P1|Overall Study|Lack of Efficacy|4
151020|NCT00672139|536957|P2|Overall Study|Physician Decision|0
151021|NCT00672139|536958|P1|Overall Study|Physician Decision|2
151022|NCT00672139|536957|P2|Overall Study|Adverse Event|7
151023|NCT00672139|536958|P1|Overall Study|Adverse Event|4
151024|NCT00672139|536957|P2|Overall Study|Withdrawal by Subject|11
151025|NCT00672139|536958|P1|Overall Study|Withdrawal by Subject|2
151026|NCT00672139|536957|P2|Overall Study|Death|23
151027|NCT00672139|536958|P1|Overall Study|Death|14
151028|NCT00671931|537015|P5|Overall Study|Physician Decision|1
151029|NCT00671931|537016|P4|Overall Study|Physician Decision|2
151030|NCT00671931|537017|P3|Overall Study|Physician Decision|0
151031|NCT00671931|537018|P2|Overall Study|Physician Decision|0
151032|NCT00671931|537019|P1|Overall Study|Physician Decision|1
151033|NCT00671879|537039|P3|Overall Study|Withdrawal by Subject|6
151034|NCT00671879|537040|P2|Overall Study|Withdrawal by Subject|4
151035|NCT00671879|537041|P1|Overall Study|Withdrawal by Subject|0
151036|NCT00671853|537054|P2|Overall Study|Non-adherence with study procedures|4
151037|NCT00671853|537055|P1|Overall Study|Non-adherence with study procedures|1
151038|NCT00671853|537054|P2|Overall Study|Physician Decision|2
151039|NCT00671853|537055|P1|Overall Study|Physician Decision|0
151040|NCT00671853|537054|P2|Overall Study|Lost to Follow-up|8
151041|NCT00671853|537055|P1|Overall Study|Lost to Follow-up|8
151042|NCT00671853|537054|P2|Overall Study|Withdrawal by Subject|5
151043|NCT00671853|537055|P1|Overall Study|Withdrawal by Subject|1
151044|NCT00671853|537054|P2|Overall Study|Adverse Event|1
151045|NCT00671853|537055|P1|Overall Study|Adverse Event|7
151046|NCT00671853|537054|P2|Overall Study|Lack of Efficacy|7
151047|NCT00671853|537055|P1|Overall Study|Lack of Efficacy|3
151048|NCT00671788|537071|P1|Overall Study|Other|1
151049|NCT00671788|537071|P1|Overall Study|MD Decision|1
151050|NCT00671788|537071|P1|Overall Study|Ineligible|1
151051|NCT00671788|537071|P1|Overall Study|Refused further treatment|3
151052|NCT00671788|537071|P1|Overall Study|Adverse Event|8
151053|NCT00671749|537078|P1|Overall Study|Lost to Follow-up|1
151054|NCT00671749|537078|P1|Overall Study|Protocol Violation|1
151055|NCT00671749|537078|P1|Overall Study|Withdrawal by Subject|4
151056|NCT00671749|537078|P1|Overall Study|Adverse Event|2
151057|NCT00671554|537137|P1|Overall Study|Disease progression|3
151058|NCT00671437|537176|P1|Overall Study|Ineligible post-hoc|1
151059|NCT00671437|537176|P1|Overall Study|Adverse Event|3
151060|NCT00671437|537176|P1|Overall Study|Cutaneous SCC of head and neck|3
151061|NCT00671437|537176|P1|Overall Study|Progressive disease before C1 week 8|8
151062|NCT00671060|537210|P2|Overall Study|Physician Decision|1
151063|NCT00671060|537211|P1|Overall Study|Physician Decision|0
151064|NCT00671060|537210|P2|Overall Study|Protocol Violation|0
151065|NCT00671060|537211|P1|Overall Study|Protocol Violation|1
151066|NCT00670930|537237|P2|Overall Study|Lost to Follow-up|0
151067|NCT00670930|537238|P1|Overall Study|Lost to Follow-up|1
151068|NCT00670930|537237|P2|Overall Study|Adminstrative Problem|1
151069|NCT00670930|537238|P1|Overall Study|Adminstrative Problem|0
151070|NCT00670800|537254|P2|Overall Study|2 controls were insulin resistant|2
151071|NCT00670800|537255|P1|Overall Study|2 controls were insulin resistant|0
151072|NCT00670748|537275|P4|Overall Study|Not off study|1
151073|NCT00670748|537276|P3|Overall Study|Not off study|1
151074|NCT00670748|537277|P2|Overall Study|Not off study|1
151075|NCT00670748|537278|P1|Overall Study|Not off study|2
151076|NCT00670748|537275|P4|Overall Study|Death during treatment|0
151077|NCT00670748|537276|P3|Overall Study|Death during treatment|1
151078|NCT00670748|537277|P2|Overall Study|Death during treatment|1
151079|NCT00670748|537278|P1|Overall Study|Death during treatment|1
151080|NCT00670540|537313|P1|Overall Study|missing information inclusion criteria|1
151081|NCT00670540|537313|P1|Overall Study|controls randomised for no follow up|2770
151082|NCT00670540|537313|P1|Overall Study|refused to participate|189
151083|NCT00670540|537313|P1|Overall Study|not living in France|348
151084|NCT00670540|537313|P1|Overall Study|ineligible|17
151085|NCT00670449|537358|P4|Overall Study|Abnormal Laboratory Value(s)|0
151086|NCT00670449|537359|P3|Overall Study|Abnormal Laboratory Value(s)|0
151087|NCT00670449|537360|P2|Overall Study|Abnormal Laboratory Value(s)|2
151088|NCT00670449|537361|P1|Overall Study|Abnormal Laboratory Value(s)|0
151089|NCT00670449|537358|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
151090|NCT00670449|537359|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
151091|NCT00670449|537360|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
151092|NCT00670449|537361|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
151093|NCT00670449|537358|P4|Overall Study|Subject Withdrew Consent|1
151094|NCT00670449|537359|P3|Overall Study|Subject Withdrew Consent|0
151095|NCT00670449|537360|P2|Overall Study|Subject Withdrew Consent|2
151096|NCT00670449|537361|P1|Overall Study|Subject Withdrew Consent|0
151097|NCT00670449|537358|P4|Overall Study|Administrative Problems|1
151098|NCT00670449|537359|P3|Overall Study|Administrative Problems|0
151099|NCT00670449|537360|P2|Overall Study|Administrative Problems|2
151100|NCT00670449|537361|P1|Overall Study|Administrative Problems|0
151101|NCT00670449|537358|P4|Overall Study|Protocol Deviation|1
151102|NCT00670449|537359|P3|Overall Study|Protocol Deviation|0
151103|NCT00670449|537360|P2|Overall Study|Protocol Deviation|2
151104|NCT00670449|537361|P1|Overall Study|Protocol Deviation|1
151105|NCT00670449|537358|P4|Overall Study|Adverse Event|5
151106|NCT00670449|537359|P3|Overall Study|Adverse Event|8
151107|NCT00670449|537360|P2|Overall Study|Adverse Event|2
151108|NCT00670449|537361|P1|Overall Study|Adverse Event|6
151109|NCT00670306|537385|P1|Overall Study|incl/excl criterias did not meet|19
151110|NCT00670306|537385|P1|Overall Study|Lost to Follow-up|8
151111|NCT00670306|537385|P1|Overall Study|Physician Decision|1
151112|NCT00670306|537385|P1|Overall Study|Withdrawal by Subject|9
151113|NCT00670306|537385|P1|Overall Study|Lack of Efficacy|10
151114|NCT00670306|537385|P1|Overall Study|Adverse Event|8
151115|NCT00670228|537424|P2|Overall Study|Not meeting the selection criteria|0
151116|NCT00670228|537425|P1|Overall Study|Not meeting the selection criteria|2
151117|NCT00670228|537424|P2|Overall Study|Not treated|2
151118|NCT00670228|537425|P1|Overall Study|Not treated|2
151119|NCT00670228|537424|P2|Overall Study|Death or MACE|1
151120|NCT00670228|537425|P1|Overall Study|Death or MACE|0
151121|NCT00670228|537424|P2|Overall Study|Adverse Event|0
151122|NCT00670228|537425|P1|Overall Study|Adverse Event|1
151123|NCT00670111|537449|P3|Enrollment to One Month|Physician Decision|0
151124|NCT00670111|537450|P2|Enrollment to One Month|Physician Decision|0
151125|NCT00670111|537451|P1|Enrollment to One Month|Physician Decision|1
151126|NCT00670111|537449|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
151127|NCT00670111|537450|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
151128|NCT00670111|537451|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
151129|NCT00670111|537449|P3|Enrollment to One Month|Testing Failure|13
151130|NCT00670111|537450|P2|Enrollment to One Month|Testing Failure|0
151131|NCT00670111|537451|P1|Enrollment to One Month|Testing Failure|0
151132|NCT00670007|537459|P1|Overall Study|Withdrawal by Subject|4
151133|NCT00670007|537459|P1|Overall Study|Adverse Event|1
151134|NCT00670007|537459|P1|Overall Study|Adverse event, serious fatal|1
151135|NCT00670007|537459|P1|Overall Study|Travel/Vacation|1
151136|NCT00670007|537459|P1|Overall Study|Lung transplant|1
151137|NCT00670007|537459|P1|Overall Study|Drug abuse|1
151138|NCT00669955|537486|P2|Overall Study|not compliant with study drug/visit|3
151139|NCT00669955|537487|P1|Overall Study|not compliant with study drug/visit|2
151140|NCT00669955|537486|P2|Overall Study|Investigator Sponsor Judgement|1
151141|NCT00669955|537487|P1|Overall Study|Investigator Sponsor Judgement|0
151142|NCT00669955|537486|P2|Overall Study|Protocol Violation|7
151143|NCT00669955|537487|P1|Overall Study|Protocol Violation|2
151144|NCT00669955|537486|P2|Overall Study|Lost to Follow-up|7
151145|NCT00669955|537487|P1|Overall Study|Lost to Follow-up|5
151146|NCT00669955|537486|P2|Overall Study|Withdrawal by Subject|3
151147|NCT00669955|537487|P1|Overall Study|Withdrawal by Subject|2
151148|NCT00669955|537486|P2|Overall Study|Death|1
151149|NCT00669955|537487|P1|Overall Study|Death|0
151150|NCT00669955|537486|P2|Overall Study|Adverse Event|5
151151|NCT00669955|537487|P1|Overall Study|Adverse Event|3
151152|NCT00669942|537517|P12|Parts 2 and 3|Protocol Violation|0
151153|NCT00669942|537518|P11|Parts 2 and 3|Protocol Violation|0
151154|NCT00669942|537519|P10|Parts 2 and 3|Protocol Violation|0
151155|NCT00669942|537520|P9|Parts 2 and 3|Protocol Violation|0
151156|NCT00669942|537521|P8|Parts 2 and 3|Protocol Violation|0
151157|NCT00669942|537522|P7|Parts 2 and 3|Protocol Violation|0
151158|NCT00669942|537523|P6|Parts 2 and 3|Protocol Violation|1
151159|NCT00669942|537524|P5|Parts 2 and 3|Protocol Violation|0
151160|NCT00669942|537525|P4|Parts 2 and 3|Protocol Violation|0
151161|NCT00669942|537526|P3|Parts 2 and 3|Protocol Violation|0
151162|NCT00669942|537527|P2|Parts 2 and 3|Protocol Violation|0
151163|NCT00669942|537528|P1|Parts 2 and 3|Protocol Violation|0
151164|NCT00669942|537517|P12|Parts 2 and 3|Withdrawal by Subject|0
151165|NCT00669942|537518|P11|Parts 2 and 3|Withdrawal by Subject|0
151166|NCT00669942|537519|P10|Parts 2 and 3|Withdrawal by Subject|0
151167|NCT00669942|537520|P9|Parts 2 and 3|Withdrawal by Subject|2
151168|NCT00669942|537521|P8|Parts 2 and 3|Withdrawal by Subject|0
151169|NCT00669942|537522|P7|Parts 2 and 3|Withdrawal by Subject|0
151170|NCT00669942|537523|P6|Parts 2 and 3|Withdrawal by Subject|1
151171|NCT00669942|537524|P5|Parts 2 and 3|Withdrawal by Subject|0
151172|NCT00669942|537525|P4|Parts 2 and 3|Withdrawal by Subject|0
151173|NCT00669942|537526|P3|Parts 2 and 3|Withdrawal by Subject|0
151174|NCT00669942|537527|P2|Parts 2 and 3|Withdrawal by Subject|0
151175|NCT00669942|537528|P1|Parts 2 and 3|Withdrawal by Subject|0
151176|NCT00669942|537517|P12|Parts 2 and 3|Adverse Event|0
151177|NCT00669942|537518|P11|Parts 2 and 3|Adverse Event|0
151178|NCT00669942|537519|P10|Parts 2 and 3|Adverse Event|0
151179|NCT00669942|537520|P9|Parts 2 and 3|Adverse Event|1
151180|NCT00669942|537521|P8|Parts 2 and 3|Adverse Event|2
151181|NCT00669942|537522|P7|Parts 2 and 3|Adverse Event|0
151182|NCT00669942|537523|P6|Parts 2 and 3|Adverse Event|0
151183|NCT00669942|537524|P5|Parts 2 and 3|Adverse Event|0
151184|NCT00669942|537525|P4|Parts 2 and 3|Adverse Event|0
151185|NCT00669942|537526|P3|Parts 2 and 3|Adverse Event|0
151186|NCT00669942|537527|P2|Parts 2 and 3|Adverse Event|0
151187|NCT00669942|537528|P1|Parts 2 and 3|Adverse Event|0
151188|NCT00669903|537611|P4|Overall Study|Protocol Violation|0
151189|NCT00669903|537612|P3|Overall Study|Protocol Violation|0
151190|NCT00669903|537613|P2|Overall Study|Protocol Violation|1
151191|NCT00669903|537614|P1|Overall Study|Protocol Violation|0
151192|NCT00669903|537611|P4|Overall Study|Lost to Follow-up|1
151193|NCT00669903|537612|P3|Overall Study|Lost to Follow-up|0
151194|NCT00669903|537613|P2|Overall Study|Lost to Follow-up|1
151195|NCT00669903|537614|P1|Overall Study|Lost to Follow-up|1
151196|NCT00669903|537611|P4|Overall Study|Withdrawal by Subject|2
151197|NCT00669903|537612|P3|Overall Study|Withdrawal by Subject|2
151198|NCT00669903|537613|P2|Overall Study|Withdrawal by Subject|2
151199|NCT00669903|537614|P1|Overall Study|Withdrawal by Subject|0
151200|NCT00669903|537611|P4|Overall Study|Adverse Event|1
151201|NCT00669903|537612|P3|Overall Study|Adverse Event|3
151202|NCT00669903|537613|P2|Overall Study|Adverse Event|1
151203|NCT00669903|537614|P1|Overall Study|Adverse Event|0
151204|NCT00669877|537644|P1|Overall Study|Disease Progression/Death|4
151205|NCT00669864|537649|P1|Overall Study|Other|2
151206|NCT00669864|537649|P1|Overall Study|Withdrawal by Subject|3
151207|NCT00669864|537649|P1|Overall Study|Protocol Violation|2
151208|NCT00669864|537649|P1|Overall Study|Lost to Follow-up|2
151209|NCT00669617|537663|P5|Period 3|Lost to Follow-up|0
151210|NCT00669617|537664|P4|Period 3|Lost to Follow-up|0
151211|NCT00669617|537665|P3|Period 3|Lost to Follow-up|0
151212|NCT00669617|537666|P2|Period 3|Lost to Follow-up|0
151213|NCT00669617|537667|P1|Period 3|Lost to Follow-up|1
151214|NCT00669617|537663|P5|Period 1|Protocol Deviation|1
151215|NCT00669617|537664|P4|Period 1|Protocol Deviation|0
151216|NCT00669617|537665|P3|Period 1|Protocol Deviation|0
151217|NCT00669617|537666|P2|Period 1|Protocol Deviation|0
151218|NCT00669617|537667|P1|Period 1|Protocol Deviation|0
151219|NCT00669617|537663|P5|Period 1|Withdrawal by Subject|0
151220|NCT00669617|537664|P4|Period 1|Withdrawal by Subject|0
151221|NCT00669617|537665|P3|Period 1|Withdrawal by Subject|1
151222|NCT00669617|537666|P2|Period 1|Withdrawal by Subject|0
151223|NCT00669617|537667|P1|Period 1|Withdrawal by Subject|0
151224|NCT00669396|537715|P2|Overall Study|Lost to Follow-up|12
151225|NCT00669396|537716|P1|Overall Study|Lost to Follow-up|10
151226|NCT00669331|537730|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
151227|NCT00669331|537731|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
151228|NCT00669331|537730|P2|Blinded Treatment Period|Physician Decision|3
151229|NCT00669331|537731|P1|Blinded Treatment Period|Physician Decision|3
151230|NCT00669331|537730|P2|Blinded Treatment Period|Death|2
151231|NCT00669331|537731|P1|Blinded Treatment Period|Death|0
151232|NCT00669331|537730|P2|Blinded Treatment Period|Lost to Follow-up|2
151233|NCT00669331|537731|P1|Blinded Treatment Period|Lost to Follow-up|3
151234|NCT00669331|537730|P2|Blinded Treatment Period|Withdrawal by Subject|19
151235|NCT00669331|537731|P1|Blinded Treatment Period|Withdrawal by Subject|17
151236|NCT00669331|537730|P2|Blinded Treatment Period|Protocol Violation|1
151237|NCT00669331|537731|P1|Blinded Treatment Period|Protocol Violation|1
151238|NCT00669331|537730|P2|Blinded Treatment Period|Adverse Event|10
151239|NCT00669331|537731|P1|Blinded Treatment Period|Adverse Event|16
151240|NCT00669331|537730|P2|Randomisation to First Dose|Randomised in error|10
151241|NCT00669331|537731|P1|Randomisation to First Dose|Randomised in error|3
151242|NCT00669331|537730|P2|Randomisation to First Dose|Sponsor decision|1
151243|NCT00669331|537731|P1|Randomisation to First Dose|Sponsor decision|0
151244|NCT00669331|537730|P2|Randomisation to First Dose|Death|0
151245|NCT00669331|537731|P1|Randomisation to First Dose|Death|1
151246|NCT00669331|537730|P2|Randomisation to First Dose|Lost to Follow-up|0
151247|NCT00669331|537731|P1|Randomisation to First Dose|Lost to Follow-up|2
151248|NCT00669331|537730|P2|Randomisation to First Dose|Withdrawal by Subject|2
151249|NCT00669331|537731|P1|Randomisation to First Dose|Withdrawal by Subject|3
151250|NCT00669331|537730|P2|Randomisation to First Dose|Protocol Violation|0
151251|NCT00669331|537731|P1|Randomisation to First Dose|Protocol Violation|1
151252|NCT00669331|537730|P2|Randomisation to First Dose|Adverse Event|0
151253|NCT00669331|537731|P1|Randomisation to First Dose|Adverse Event|1
151254|NCT00669318|537773|P1|Overall Study|Withdrawal by Subject|2
151255|NCT00669240|537790|P1|Overall Study|Enrolled but no dosing record|1
151256|NCT00669240|537790|P1|Overall Study|Enrolled but not treated|15
151257|NCT00669240|537790|P1|Overall Study|Other|19
151258|NCT00669240|537790|P1|Overall Study|Adverse Event|21
151259|NCT00669240|537790|P1|Overall Study|Lost to Follow-up|34
151260|NCT00669240|537790|P1|Overall Study|Withdrawal by Subject|42
151261|NCT00669240|537790|P1|Overall Study|Lack of Efficacy|33
151262|NCT00669110|537841|P2|Overall Study|Withdrawal by Subject|2
151263|NCT00669110|537842|P1|Overall Study|Withdrawal by Subject|0
151264|NCT00669110|537841|P2|Overall Study|Protocol Violation|5
151265|NCT00669110|537842|P1|Overall Study|Protocol Violation|0
151266|NCT00669110|537841|P2|Overall Study|Lost to Follow-up|0
151267|NCT00669110|537842|P1|Overall Study|Lost to Follow-up|1
151268|NCT00669110|537841|P2|Overall Study|Physician Decision|1
151269|NCT00669110|537842|P1|Overall Study|Physician Decision|0
151270|NCT00669110|537841|P2|Overall Study|Caregiver request|2
151271|NCT00669110|537842|P1|Overall Study|Caregiver request|3
151272|NCT00669110|537841|P2|Overall Study|Adverse Event|3
151273|NCT00669110|537842|P1|Overall Study|Adverse Event|4
151274|NCT00669071|537878|P1|Overall Study|Final visit 40 days out of window|1
151275|NCT00669071|537878|P1|Overall Study|Lost to Follow-up|3
151276|NCT00669032|537899|P2|Overall Study|No fulfilment of the selection criteria|5
151277|NCT00669032|537900|P1|Overall Study|No fulfilment of the selection criteria|5
151278|NCT00669032|537899|P2|Overall Study|Physician Decision|1
151279|NCT00669032|537900|P1|Overall Study|Physician Decision|1
151280|NCT00669032|537899|P2|Overall Study|Adverse Event|16
151281|NCT00669032|537900|P1|Overall Study|Adverse Event|12
151282|NCT00669032|537899|P2|Overall Study|Withdrawal by Subject|13
151283|NCT00669032|537900|P1|Overall Study|Withdrawal by Subject|12
151284|NCT00669032|537899|P2|Overall Study|Lack of Efficacy|19
151285|NCT00669032|537900|P1|Overall Study|Lack of Efficacy|8
151286|NCT00669032|537899|P2|Overall Study|Lost to Follow-up|5
151287|NCT00669032|537900|P1|Overall Study|Lost to Follow-up|6
151288|NCT00668863|537946|P1|Overall Study|Physician Decision|1
151289|NCT00668863|537946|P1|Overall Study|Subject’s work scheduling problem|1
151290|NCT00668863|537946|P1|Overall Study|Surgery|1
151291|NCT00668863|537946|P1|Overall Study|Withdrawal by Subject|1
151292|NCT00668863|537946|P1|Overall Study|Global Deterioration of Health Status|4
151293|NCT00668863|537946|P1|Overall Study|Study Terminated by Sponsor|8
151294|NCT00668863|537946|P1|Overall Study|Adverse Event|13
151295|NCT00668863|537946|P1|Overall Study|Objective Progression or Relapse|42
151296|NCT00668746|537976|P2|Overall Study|Lost to Follow-up|1
151297|NCT00668746|537977|P1|Overall Study|Lost to Follow-up|2
151298|NCT00668733|537997|P2|Overall Study|Withdrawal by Subject|4
151299|NCT00668733|537998|P1|Overall Study|Withdrawal by Subject|0
151300|NCT00668733|537997|P2|Overall Study|Lost to Follow-up|3
151301|NCT00668733|537998|P1|Overall Study|Lost to Follow-up|2
151302|NCT00668395|538043|P3|Overall Study|Physician Decision|0
151303|NCT00668395|538044|P2|Overall Study|Physician Decision|1
151304|NCT00668395|538045|P1|Overall Study|Physician Decision|1
151305|NCT00668395|538043|P3|Overall Study|Adverse Event|0
151306|NCT00668395|538044|P2|Overall Study|Adverse Event|1
151307|NCT00668395|538045|P1|Overall Study|Adverse Event|1
151308|NCT00668395|538043|P3|Overall Study|Withdrawal by Subject|1
151309|NCT00668395|538044|P2|Overall Study|Withdrawal by Subject|4
151310|NCT00668395|538045|P1|Overall Study|Withdrawal by Subject|4
151311|NCT00668317|538057|P1|Overall Study|Adverse Event|2
151312|NCT00668200|538072|P1|Overall Study|Lost to Follow-up|1
151313|NCT00668200|538072|P1|Overall Study|Withdrawal by Subject|2
151314|NCT00667992|538080|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
151315|NCT00667992|538081|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
151316|NCT00667992|538080|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
151317|NCT00667992|538081|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
151318|NCT00667992|538080|P2|Wash-out|Withdrawal by Subject|0
151319|NCT00667992|538081|P1|Wash-out|Withdrawal by Subject|1
151320|NCT00667992|538080|P2|Wash-out|Failure to wash-out|2
151321|NCT00667992|538081|P1|Wash-out|Failure to wash-out|2
151322|NCT00667992|538080|P2|Wash-out|Not within one doubling dilution|3
151323|NCT00667992|538081|P1|Wash-out|Not within one doubling dilution|4
151324|NCT00667992|538080|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
151325|NCT00667992|538081|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
151326|NCT00667992|538080|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
151327|NCT00667992|538081|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
151328|NCT00667992|538080|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
151329|NCT00667992|538081|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
151330|NCT00667992|538080|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
151331|NCT00667992|538081|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
151332|NCT00667992|538080|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
151333|NCT00667992|538081|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
151334|NCT00667992|538080|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
151335|NCT00667992|538081|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
151336|NCT00667992|538080|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
151337|NCT00667992|538081|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
151338|NCT00667992|538080|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
151339|NCT00667992|538081|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
151340|NCT00667875|538138|P3|Overall Study|Withdrawal by Subject|7
151341|NCT00667875|538139|P2|Overall Study|Withdrawal by Subject|9
151342|NCT00667875|538140|P1|Overall Study|Withdrawal by Subject|10
151343|NCT00667875|538138|P3|Overall Study|Adverse Event|6
151344|NCT00667875|538139|P2|Overall Study|Adverse Event|2
151345|NCT00667875|538140|P1|Overall Study|Adverse Event|0
151346|NCT00667810|538174|P4|Overall Study|Not specified|0
151347|NCT00667810|538175|P3|Overall Study|Not specified|5
151348|NCT00667810|538176|P2|Overall Study|Not specified|6
151349|NCT00667810|538177|P1|Overall Study|Not specified|6
151350|NCT00667810|538174|P4|Overall Study|Vasogenic Edema Recurrence|0
151351|NCT00667810|538175|P3|Overall Study|Vasogenic Edema Recurrence|0
151352|NCT00667810|538176|P2|Overall Study|Vasogenic Edema Recurrence|3
151353|NCT00667810|538177|P1|Overall Study|Vasogenic Edema Recurrence|0
151354|NCT00667810|538174|P4|Overall Study|Loss of Caregiver|0
151355|NCT00667810|538175|P3|Overall Study|Loss of Caregiver|3
151356|NCT00667810|538176|P2|Overall Study|Loss of Caregiver|1
151357|NCT00667810|538177|P1|Overall Study|Loss of Caregiver|0
151358|NCT00667810|538174|P4|Overall Study|Failed to Return|0
151359|NCT00667810|538175|P3|Overall Study|Failed to Return|2
151360|NCT00667810|538176|P2|Overall Study|Failed to Return|0
151361|NCT00667810|538177|P1|Overall Study|Failed to Return|0
151362|NCT00667810|538174|P4|Overall Study|Discontinuation of Study by Sponsor|0
151363|NCT00667810|538175|P3|Overall Study|Discontinuation of Study by Sponsor|155
151364|NCT00667810|538176|P2|Overall Study|Discontinuation of Study by Sponsor|118
151365|NCT00667810|538177|P1|Overall Study|Discontinuation of Study by Sponsor|130
151366|NCT00667810|538174|P4|Overall Study|Withdrawal by Subject|1
151367|NCT00667810|538175|P3|Overall Study|Withdrawal by Subject|29
151368|NCT00667810|538176|P2|Overall Study|Withdrawal by Subject|20
151369|NCT00667810|538177|P1|Overall Study|Withdrawal by Subject|14
151370|NCT00667810|538174|P4|Overall Study|Protocol Violation|0
151371|NCT00667810|538175|P3|Overall Study|Protocol Violation|0
151372|NCT00667810|538176|P2|Overall Study|Protocol Violation|2
151373|NCT00667810|538177|P1|Overall Study|Protocol Violation|0
151374|NCT00667810|538174|P4|Overall Study|Physician Decision|0
151375|NCT00667810|538175|P3|Overall Study|Physician Decision|2
151376|NCT00667810|538176|P2|Overall Study|Physician Decision|1
151377|NCT00667810|538177|P1|Overall Study|Physician Decision|1
151378|NCT00667810|538174|P4|Overall Study|Lost to Follow-up|0
151379|NCT00667810|538175|P3|Overall Study|Lost to Follow-up|2
151380|NCT00667810|538176|P2|Overall Study|Lost to Follow-up|4
151381|NCT00667810|538177|P1|Overall Study|Lost to Follow-up|1
151382|NCT00667810|538174|P4|Overall Study|Lack of Efficacy|0
151383|NCT00667810|538175|P3|Overall Study|Lack of Efficacy|2
151384|NCT00667810|538176|P2|Overall Study|Lack of Efficacy|0
151385|NCT00667810|538177|P1|Overall Study|Lack of Efficacy|1
151386|NCT00667810|538174|P4|Overall Study|Death|0
151387|NCT00667810|538175|P3|Overall Study|Death|3
151388|NCT00667810|538176|P2|Overall Study|Death|1
151389|NCT00667810|538177|P1|Overall Study|Death|1
151390|NCT00667810|538174|P4|Overall Study|Adverse Event|1
151391|NCT00667810|538175|P3|Overall Study|Adverse Event|19
151392|NCT00667810|538176|P2|Overall Study|Adverse Event|14
151393|NCT00667810|538177|P1|Overall Study|Adverse Event|13
151394|NCT00667732|538253|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
151395|NCT00667732|538254|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
151396|NCT00667732|538255|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
151397|NCT00667732|538253|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
151398|NCT00667732|538254|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
151399|NCT00667732|538255|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
151400|NCT00667732|538253|P3|Run -In (8 Weeks)|Adverse Event|0
151401|NCT00667732|538254|P2|Run -In (8 Weeks)|Adverse Event|0
151402|NCT00667732|538255|P1|Run -In (8 Weeks)|Adverse Event|4
151403|NCT00667602|538283|P3|Overall Study|Protocol Violation|0
151404|NCT00667602|538284|P2|Overall Study|Protocol Violation|1
151405|NCT00667602|538285|P1|Overall Study|Protocol Violation|0
151406|NCT00667602|538283|P3|Overall Study|Administrative reason|2
151407|NCT00667602|538284|P2|Overall Study|Administrative reason|0
151408|NCT00667602|538285|P1|Overall Study|Administrative reason|0
151409|NCT00667602|538283|P3|Overall Study|Lost to Follow-up|6
151410|NCT00667602|538284|P2|Overall Study|Lost to Follow-up|5
151411|NCT00667602|538285|P1|Overall Study|Lost to Follow-up|4
151412|NCT00667602|538283|P3|Overall Study|Withdrawal by Subject|10
151413|NCT00667602|538284|P2|Overall Study|Withdrawal by Subject|9
151414|NCT00667602|538285|P1|Overall Study|Withdrawal by Subject|4
151415|NCT00667576|538353|P5|Overall Study|Missed Visit|0
151416|NCT00667576|538354|P4|Overall Study|Missed Visit|1
151417|NCT00667576|538355|P3|Overall Study|Missed Visit|0
151418|NCT00667576|538356|P2|Overall Study|Missed Visit|0
151419|NCT00667576|538357|P1|Overall Study|Missed Visit|0
151420|NCT00667576|538353|P5|Overall Study|Physician Decision|0
151421|NCT00667576|538354|P4|Overall Study|Physician Decision|1
151422|NCT00667576|538355|P3|Overall Study|Physician Decision|0
151423|NCT00667576|538356|P2|Overall Study|Physician Decision|0
151424|NCT00667576|538357|P1|Overall Study|Physician Decision|0
151425|NCT00667576|538353|P5|Overall Study|Protocol Violation|0
151426|NCT00667576|538354|P4|Overall Study|Protocol Violation|1
151427|NCT00667576|538355|P3|Overall Study|Protocol Violation|0
151428|NCT00667576|538356|P2|Overall Study|Protocol Violation|0
151429|NCT00667576|538357|P1|Overall Study|Protocol Violation|0
151430|NCT00667576|538353|P5|Overall Study|Lost to Follow-up|0
151431|NCT00667576|538354|P4|Overall Study|Lost to Follow-up|0
151432|NCT00667576|538355|P3|Overall Study|Lost to Follow-up|1
151433|NCT00667576|538356|P2|Overall Study|Lost to Follow-up|0
151434|NCT00667576|538357|P1|Overall Study|Lost to Follow-up|0
151435|NCT00667576|538353|P5|Overall Study|Adverse Event|0
151436|NCT00667576|538354|P4|Overall Study|Adverse Event|0
151437|NCT00667576|538355|P3|Overall Study|Adverse Event|0
151438|NCT00667576|538356|P2|Overall Study|Adverse Event|1
151439|NCT00667576|538357|P1|Overall Study|Adverse Event|1
151440|NCT00667576|538353|P5|Overall Study|Withdrawal by Subject|1
151441|NCT00667576|538354|P4|Overall Study|Withdrawal by Subject|1
151442|NCT00667576|538355|P3|Overall Study|Withdrawal by Subject|1
151443|NCT00667576|538356|P2|Overall Study|Withdrawal by Subject|0
151444|NCT00667576|538357|P1|Overall Study|Withdrawal by Subject|1
151445|NCT00667563|538404|P1|Overall Study|Protocol Violation|24
151446|NCT00667459|538424|P2|Overall Study|Lost to Follow-up|43
151447|NCT00667459|538425|P1|Overall Study|Lost to Follow-up|8
151448|NCT00667459|538424|P2|Overall Study|Death|2
151449|NCT00667459|538425|P1|Overall Study|Death|0
151450|NCT00667446|538467|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
151451|NCT00667446|538468|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
151452|NCT00667446|538467|P2|Treatment Period (36 Months)|Therapeutic Failure|1
151453|NCT00667446|538468|P1|Treatment Period (36 Months)|Therapeutic Failure|1
151454|NCT00667446|538467|P2|Treatment Period (36 Months)|Protocol Violation|1
151455|NCT00667446|538468|P1|Treatment Period (36 Months)|Protocol Violation|1
151456|NCT00667446|538467|P2|Treatment Period (36 Months)|Lost to Follow-up|0
151457|NCT00667446|538468|P1|Treatment Period (36 Months)|Lost to Follow-up|1
151458|NCT00667446|538467|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
151459|NCT00667446|538468|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
151460|NCT00667446|538467|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
151461|NCT00667446|538468|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
151462|NCT00667446|538467|P2|Treatment Period (36 Months)|Personal reasons|2
151463|NCT00667446|538468|P1|Treatment Period (36 Months)|Personal reasons|2
151464|NCT00667446|538467|P2|Treatment Period (36 Months)|Other|2
151465|NCT00667446|538468|P1|Treatment Period (36 Months)|Other|2
151557|NCT00666926|538727|P13|Overall Study|Withdrawal by Subject|0
151466|NCT00667446|538467|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
151467|NCT00667446|538468|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
151468|NCT00667420|538490|P1|Overall Study|Withdrawal by Subject|2
151469|NCT00667420|538490|P1|Overall Study|Physician Decision|1
151470|NCT00667420|538490|P1|Overall Study|Lack of Efficacy|5
151471|NCT00667420|538490|P1|Overall Study|Adverse Event|2
151472|NCT00667394|538500|P2|Overall Study|Progressive disease|0
151473|NCT00667394|538501|P1|Overall Study|Progressive disease|1
151474|NCT00667394|538500|P2|Overall Study|Adverse Event|0
151475|NCT00667394|538501|P1|Overall Study|Adverse Event|3
151476|NCT00667368|538528|P2|Overall Study|Discontinued early|17
151477|NCT00667368|538529|P1|Overall Study|Discontinued early|24
151478|NCT00667368|538528|P2|Overall Study|Lost to Follow-up|155
151479|NCT00667368|538529|P1|Overall Study|Lost to Follow-up|176
151480|NCT00667355|538537|P1|Overall Study|Other reason was not specified|5
151481|NCT00667355|538537|P1|Overall Study|Lost to Follow-up|1
151482|NCT00667355|538537|P1|Overall Study|Adverse Event|5
151483|NCT00667342|538562|P3|Overall Study|Ineligible|1
151484|NCT00667342|538563|P2|Overall Study|Ineligible|0
151485|NCT00667342|538564|P1|Overall Study|Ineligible|0
151486|NCT00667342|538562|P3|Overall Study|Adverse Event|1
151487|NCT00667342|538563|P2|Overall Study|Adverse Event|0
151488|NCT00667342|538564|P1|Overall Study|Adverse Event|0
151489|NCT00667342|538562|P3|Overall Study|Relapse or tumor progression|7
151490|NCT00667342|538563|P2|Overall Study|Relapse or tumor progression|0
151491|NCT00667342|538564|P1|Overall Study|Relapse or tumor progression|9
151492|NCT00667342|538562|P3|Overall Study|Physician Decision|0
151493|NCT00667342|538563|P2|Overall Study|Physician Decision|0
151494|NCT00667342|538564|P1|Overall Study|Physician Decision|3
151495|NCT00667342|538562|P3|Overall Study|Withdrawal by Subject|0
151496|NCT00667342|538563|P2|Overall Study|Withdrawal by Subject|0
151497|NCT00667342|538564|P1|Overall Study|Withdrawal by Subject|1
151498|NCT00667342|538562|P3|Overall Study|Protocol Violation|0
151499|NCT00667342|538563|P2|Overall Study|Protocol Violation|0
151500|NCT00667342|538564|P1|Overall Study|Protocol Violation|1
151501|NCT00667277|538602|P1|Overall Study|Withdrawal by Subject|2
151502|NCT00667251|538609|P2|Overall Study|Symptomatic progression|2
151503|NCT00667251|538610|P1|Overall Study|Symptomatic progression|1
151504|NCT00667251|538609|P2|Overall Study|Intercurrent Illness|3
151505|NCT00667251|538610|P1|Overall Study|Intercurrent Illness|4
151506|NCT00667251|538609|P2|Overall Study|Other/missing|84
151507|NCT00667251|538610|P1|Overall Study|Other/missing|46
151508|NCT00667251|538609|P2|Overall Study|Withdrawal by Subject|2
151509|NCT00667251|538610|P1|Overall Study|Withdrawal by Subject|6
151510|NCT00667251|538609|P2|Overall Study|Adverse Event|4
151511|NCT00667251|538610|P1|Overall Study|Adverse Event|13
151512|NCT00667225|538636|P2|Overall Study|Lost to Follow-up|1
151513|NCT00667225|538637|P1|Overall Study|Lost to Follow-up|0
151514|NCT00667225|538636|P2|Overall Study|Subject had no more lesions to treat.|0
151515|NCT00667225|538637|P1|Overall Study|Subject had no more lesions to treat.|1
151516|NCT00667095|538658|P2|Overall Study|Withdrawal by Subject|1
151517|NCT00667095|538659|P1|Overall Study|Withdrawal by Subject|0
151518|NCT00666965|538691|P4|Overall Study|Withdrawal by Subject|2
151519|NCT00666965|538692|P3|Overall Study|Withdrawal by Subject|0
151520|NCT00666965|538693|P2|Overall Study|Withdrawal by Subject|0
151521|NCT00666965|538694|P1|Overall Study|Withdrawal by Subject|0
151522|NCT00666965|538691|P4|Overall Study|Discontinuation criteria|2
151523|NCT00666965|538692|P3|Overall Study|Discontinuation criteria|1
151524|NCT00666965|538693|P2|Overall Study|Discontinuation criteria|1
151525|NCT00666965|538694|P1|Overall Study|Discontinuation criteria|2
151526|NCT00666965|538691|P4|Overall Study|Protocol Violation|2
151527|NCT00666965|538692|P3|Overall Study|Protocol Violation|0
151528|NCT00666965|538693|P2|Overall Study|Protocol Violation|0
151529|NCT00666965|538694|P1|Overall Study|Protocol Violation|0
151530|NCT00666965|538691|P4|Overall Study|Lack of Efficacy|0
151531|NCT00666965|538692|P3|Overall Study|Lack of Efficacy|0
151532|NCT00666965|538693|P2|Overall Study|Lack of Efficacy|1
151533|NCT00666965|538694|P1|Overall Study|Lack of Efficacy|1
151534|NCT00666965|538691|P4|Overall Study|Adverse Event|9
151535|NCT00666965|538692|P3|Overall Study|Adverse Event|1
151536|NCT00666965|538693|P2|Overall Study|Adverse Event|2
151537|NCT00666965|538694|P1|Overall Study|Adverse Event|0
151538|NCT00666926|538724|P16|Overall Study|Death|0
151539|NCT00666926|538725|P15|Overall Study|Death|0
151540|NCT00666926|538726|P14|Overall Study|Death|0
151541|NCT00666926|538727|P13|Overall Study|Death|0
151542|NCT00666926|538728|P12|Overall Study|Death|1
151543|NCT00666926|538729|P11|Overall Study|Death|0
151544|NCT00666926|538730|P10|Overall Study|Death|0
151545|NCT00666926|538731|P9|Overall Study|Death|0
151546|NCT00666926|538732|P8|Overall Study|Death|0
151547|NCT00666926|538733|P7|Overall Study|Death|0
151548|NCT00666926|538734|P6|Overall Study|Death|0
151549|NCT00666926|538735|P5|Overall Study|Death|0
151550|NCT00666926|538736|P4|Overall Study|Death|0
151551|NCT00666926|538737|P3|Overall Study|Death|0
151552|NCT00666926|538738|P2|Overall Study|Death|0
151553|NCT00666926|538739|P1|Overall Study|Death|0
151554|NCT00666926|538724|P16|Overall Study|Withdrawal by Subject|3
151555|NCT00666926|538725|P15|Overall Study|Withdrawal by Subject|3
151556|NCT00666926|538726|P14|Overall Study|Withdrawal by Subject|1
151558|NCT00666926|538728|P12|Overall Study|Withdrawal by Subject|3
151559|NCT00666926|538729|P11|Overall Study|Withdrawal by Subject|0
151560|NCT00666926|538730|P10|Overall Study|Withdrawal by Subject|3
151561|NCT00666926|538731|P9|Overall Study|Withdrawal by Subject|0
151562|NCT00666926|538732|P8|Overall Study|Withdrawal by Subject|1
151563|NCT00666926|538733|P7|Overall Study|Withdrawal by Subject|0
151564|NCT00666926|538734|P6|Overall Study|Withdrawal by Subject|0
151565|NCT00666926|538735|P5|Overall Study|Withdrawal by Subject|0
151566|NCT00666926|538736|P4|Overall Study|Withdrawal by Subject|0
151567|NCT00666926|538737|P3|Overall Study|Withdrawal by Subject|0
151568|NCT00666926|538738|P2|Overall Study|Withdrawal by Subject|0
151569|NCT00666926|538739|P1|Overall Study|Withdrawal by Subject|0
151570|NCT00666926|538724|P16|Overall Study|Other|4
151571|NCT00666926|538725|P15|Overall Study|Other|4
151572|NCT00666926|538726|P14|Overall Study|Other|2
151573|NCT00666926|538727|P13|Overall Study|Other|3
151574|NCT00666926|538728|P12|Overall Study|Other|26
151575|NCT00666926|538729|P11|Overall Study|Other|3
151576|NCT00666926|538730|P10|Overall Study|Other|5
151577|NCT00666926|538731|P9|Overall Study|Other|3
151578|NCT00666926|538732|P8|Overall Study|Other|0
151579|NCT00666926|538733|P7|Overall Study|Other|4
151580|NCT00666926|538734|P6|Overall Study|Other|3
151581|NCT00666926|538735|P5|Overall Study|Other|3
151582|NCT00666926|538736|P4|Overall Study|Other|3
151583|NCT00666926|538737|P3|Overall Study|Other|3
151584|NCT00666926|538738|P2|Overall Study|Other|4
151585|NCT00666926|538739|P1|Overall Study|Other|2
151586|NCT00666926|538724|P16|Overall Study|Lost to Follow-up|0
151587|NCT00666926|538725|P15|Overall Study|Lost to Follow-up|0
151588|NCT00666926|538726|P14|Overall Study|Lost to Follow-up|0
151589|NCT00666926|538727|P13|Overall Study|Lost to Follow-up|0
151590|NCT00666926|538728|P12|Overall Study|Lost to Follow-up|0
151591|NCT00666926|538729|P11|Overall Study|Lost to Follow-up|0
151592|NCT00666926|538730|P10|Overall Study|Lost to Follow-up|0
151593|NCT00666926|538731|P9|Overall Study|Lost to Follow-up|0
151594|NCT00666926|538732|P8|Overall Study|Lost to Follow-up|0
151595|NCT00666926|538733|P7|Overall Study|Lost to Follow-up|0
151596|NCT00666926|538734|P6|Overall Study|Lost to Follow-up|0
151597|NCT00666926|538735|P5|Overall Study|Lost to Follow-up|0
151598|NCT00666926|538736|P4|Overall Study|Lost to Follow-up|1
151599|NCT00666926|538737|P3|Overall Study|Lost to Follow-up|0
151600|NCT00666926|538738|P2|Overall Study|Lost to Follow-up|0
151601|NCT00666926|538739|P1|Overall Study|Lost to Follow-up|0
151602|NCT00666926|538724|P16|Overall Study|Lack of Efficacy|0
151603|NCT00666926|538725|P15|Overall Study|Lack of Efficacy|0
151604|NCT00666926|538726|P14|Overall Study|Lack of Efficacy|0
151605|NCT00666926|538727|P13|Overall Study|Lack of Efficacy|0
151606|NCT00666926|538728|P12|Overall Study|Lack of Efficacy|1
151607|NCT00666926|538729|P11|Overall Study|Lack of Efficacy|0
151608|NCT00666926|538730|P10|Overall Study|Lack of Efficacy|0
151609|NCT00666926|538731|P9|Overall Study|Lack of Efficacy|0
151610|NCT00666926|538732|P8|Overall Study|Lack of Efficacy|0
151611|NCT00666926|538733|P7|Overall Study|Lack of Efficacy|0
151612|NCT00666926|538734|P6|Overall Study|Lack of Efficacy|1
151613|NCT00666926|538735|P5|Overall Study|Lack of Efficacy|0
151614|NCT00666926|538736|P4|Overall Study|Lack of Efficacy|0
151615|NCT00666926|538737|P3|Overall Study|Lack of Efficacy|0
151616|NCT00666926|538738|P2|Overall Study|Lack of Efficacy|0
151617|NCT00666926|538739|P1|Overall Study|Lack of Efficacy|0
151618|NCT00666926|538724|P16|Overall Study|Laboratory abnormality|1
151619|NCT00666926|538725|P15|Overall Study|Laboratory abnormality|0
151620|NCT00666926|538726|P14|Overall Study|Laboratory abnormality|0
151621|NCT00666926|538727|P13|Overall Study|Laboratory abnormality|0
151622|NCT00666926|538728|P12|Overall Study|Laboratory abnormality|0
151623|NCT00666926|538729|P11|Overall Study|Laboratory abnormality|1
151624|NCT00666926|538730|P10|Overall Study|Laboratory abnormality|0
151625|NCT00666926|538731|P9|Overall Study|Laboratory abnormality|0
151626|NCT00666926|538732|P8|Overall Study|Laboratory abnormality|0
151627|NCT00666926|538733|P7|Overall Study|Laboratory abnormality|0
151628|NCT00666926|538734|P6|Overall Study|Laboratory abnormality|0
151629|NCT00666926|538735|P5|Overall Study|Laboratory abnormality|0
151630|NCT00666926|538736|P4|Overall Study|Laboratory abnormality|0
151631|NCT00666926|538737|P3|Overall Study|Laboratory abnormality|0
151632|NCT00666926|538738|P2|Overall Study|Laboratory abnormality|0
151633|NCT00666926|538739|P1|Overall Study|Laboratory abnormality|0
151634|NCT00666926|538724|P16|Overall Study|Adverse Event|0
151635|NCT00666926|538725|P15|Overall Study|Adverse Event|0
151636|NCT00666926|538726|P14|Overall Study|Adverse Event|1
151637|NCT00666926|538727|P13|Overall Study|Adverse Event|0
151638|NCT00666926|538728|P12|Overall Study|Adverse Event|2
151639|NCT00666926|538729|P11|Overall Study|Adverse Event|2
151640|NCT00666926|538730|P10|Overall Study|Adverse Event|2
151641|NCT00666926|538731|P9|Overall Study|Adverse Event|0
151642|NCT00666926|538732|P8|Overall Study|Adverse Event|0
151643|NCT00666926|538733|P7|Overall Study|Adverse Event|0
151644|NCT00666926|538734|P6|Overall Study|Adverse Event|0
151645|NCT00666926|538735|P5|Overall Study|Adverse Event|0
151646|NCT00666926|538736|P4|Overall Study|Adverse Event|0
151647|NCT00666926|538737|P3|Overall Study|Adverse Event|0
151648|NCT00666926|538738|P2|Overall Study|Adverse Event|0
151649|NCT00666926|538739|P1|Overall Study|Adverse Event|0
151650|NCT00666835|539048|P2|Overall Study|Physician Decision|2
151651|NCT00666835|539049|P1|Overall Study|Physician Decision|1
151652|NCT00666835|539048|P2|Overall Study|Planned operation|0
151653|NCT00666835|539049|P1|Overall Study|Planned operation|2
151654|NCT00666835|539048|P2|Overall Study|Hemoglobulin concentration|3
151655|NCT00666835|539049|P1|Overall Study|Hemoglobulin concentration|4
151656|NCT00666835|539048|P2|Overall Study|Kidney Transplantation (NTX)|2
151657|NCT00666835|539049|P1|Overall Study|Kidney Transplantation (NTX)|10
151658|NCT00666835|539048|P2|Overall Study|Death|4
151659|NCT00666835|539049|P1|Overall Study|Death|15
151660|NCT00666835|539048|P2|Overall Study|Protocol Violation|0
151661|NCT00666835|539049|P1|Overall Study|Protocol Violation|2
151662|NCT00666835|539048|P2|Overall Study|Adverse Event|6
151663|NCT00666835|539049|P1|Overall Study|Adverse Event|7
151664|NCT00666835|539048|P2|Overall Study|Incl./excl. not fulfilled|2
151665|NCT00666835|539049|P1|Overall Study|Incl./excl. not fulfilled|7
151666|NCT00666835|539048|P2|Overall Study|Lack of Efficacy|1
151667|NCT00666835|539049|P1|Overall Study|Lack of Efficacy|0
151668|NCT00666835|539048|P2|Overall Study|Withdrawal by Subject|2
151669|NCT00666835|539049|P1|Overall Study|Withdrawal by Subject|5
151670|NCT00666757|539059|P2|Overall Study|Sponsor decision|1
151671|NCT00666757|539060|P1|Overall Study|Sponsor decision|0
151672|NCT00666757|539059|P2|Overall Study|Physician Decision|2
151673|NCT00666757|539060|P1|Overall Study|Physician Decision|0
151674|NCT00666757|539059|P2|Overall Study|Lack of Efficacy|6
151675|NCT00666757|539060|P1|Overall Study|Lack of Efficacy|3
151676|NCT00666757|539059|P2|Overall Study|Withdrawal by Subject|17
151677|NCT00666757|539060|P1|Overall Study|Withdrawal by Subject|13
151678|NCT00666757|539059|P2|Overall Study|Adverse Event|12
151679|NCT00666757|539060|P1|Overall Study|Adverse Event|22
151680|NCT00666757|539059|P2|Overall Study|Protocol Violation|24
151681|NCT00666757|539060|P1|Overall Study|Protocol Violation|23
151682|NCT00666757|539059|P2|Overall Study|Lost to Follow-up|35
151683|NCT00666757|539060|P1|Overall Study|Lost to Follow-up|39
151684|NCT00666718|539119|P2|Overall Study|Physician Decision|2
151685|NCT00666718|539120|P1|Overall Study|Physician Decision|0
151686|NCT00666718|539119|P2|Overall Study|Withdrawal by Subject|12
151687|NCT00666718|539120|P1|Overall Study|Withdrawal by Subject|7
151688|NCT00666718|539119|P2|Overall Study|Protocol Violation|3
151689|NCT00666718|539120|P1|Overall Study|Protocol Violation|1
151690|NCT00666718|539119|P2|Overall Study|Entry Criteria Not Met|0
151691|NCT00666718|539120|P1|Overall Study|Entry Criteria Not Met|2
151692|NCT00666718|539119|P2|Overall Study|Lost to Follow-up|0
151693|NCT00666718|539120|P1|Overall Study|Lost to Follow-up|1
151694|NCT00666718|539119|P2|Overall Study|Death|0
151695|NCT00666718|539120|P1|Overall Study|Death|1
151696|NCT00666718|539119|P2|Overall Study|Adverse Event|1
151697|NCT00666718|539120|P1|Overall Study|Adverse Event|0
151698|NCT00666705|539146|P1|Overall Study|Withdrawal by Subject|1
151699|NCT00666679|539165|P2|Second Intervention|Death|1
151700|NCT00666679|539166|P1|Second Intervention|Death|0
151701|NCT00666679|539165|P2|Second Intervention|Adverse Event|0
151702|NCT00666679|539166|P1|Second Intervention|Adverse Event|1
151703|NCT00666679|539165|P2|Washout Period of 1 Week|Protocol Violation|1
151704|NCT00666679|539166|P1|Washout Period of 1 Week|Protocol Violation|0
151705|NCT00666679|539165|P2|Washout Period of 1 Week|Lost to Follow-up|1
151706|NCT00666679|539166|P1|Washout Period of 1 Week|Lost to Follow-up|0
151707|NCT00666679|539165|P2|First Intervention|Randomized did not start treatment|1
151708|NCT00666679|539166|P1|First Intervention|Randomized did not start treatment|1
151709|NCT00666679|539165|P2|First Intervention|Withdrawal by Subject|0
151710|NCT00666679|539166|P1|First Intervention|Withdrawal by Subject|1
151711|NCT00666679|539165|P2|First Intervention|Protocol Violation|0
151712|NCT00666679|539166|P1|First Intervention|Protocol Violation|1
151713|NCT00666679|539165|P2|First Intervention|Lost to Follow-up|0
151714|NCT00666679|539166|P1|First Intervention|Lost to Follow-up|1
151715|NCT00666588|539196|P4|Overall Study|inevaluable|0
151716|NCT00666588|539197|P3|Overall Study|inevaluable|0
151717|NCT00666588|539198|P2|Overall Study|inevaluable|0
151718|NCT00666588|539199|P1|Overall Study|inevaluable|2
151719|NCT00666588|539196|P4|Overall Study|ineligible|2
151720|NCT00666588|539197|P3|Overall Study|ineligible|0
151721|NCT00666588|539198|P2|Overall Study|ineligible|0
151722|NCT00666588|539199|P1|Overall Study|ineligible|2
151723|NCT00666562|539232|P3|Overall Study|Concomitant Medication|0
151724|NCT00666562|539233|P2|Overall Study|Concomitant Medication|1
151725|NCT00666562|539234|P1|Overall Study|Concomitant Medication|0
151726|NCT00666562|539232|P3|Overall Study|Withdrawal by Subject|0
151727|NCT00666562|539233|P2|Overall Study|Withdrawal by Subject|1
151728|NCT00666562|539234|P1|Overall Study|Withdrawal by Subject|0
151729|NCT00666536|539281|P2|Overall Study|Lost to Follow-up|3
151730|NCT00666536|539282|P1|Overall Study|Lost to Follow-up|4
151731|NCT00666536|539281|P2|Overall Study|Withdrawal by Subject|9
151732|NCT00666536|539282|P1|Overall Study|Withdrawal by Subject|10
151733|NCT00666536|539281|P2|Overall Study|Protocol deviation(s)|6
151734|NCT00666536|539282|P1|Overall Study|Protocol deviation(s)|8
151735|NCT00666536|539281|P2|Overall Study|Unsatisfactory therapeutic effect|0
151736|NCT00666536|539282|P1|Overall Study|Unsatisfactory therapeutic effect|2
151737|NCT00666536|539281|P2|Overall Study|Adverse Event|19
151738|NCT00666536|539282|P1|Overall Study|Adverse Event|9
151739|NCT00666458|539300|P2|Overall Study|Medical history of anemia|0
151740|NCT00666458|539301|P1|Overall Study|Medical history of anemia|1
151741|NCT00666458|539300|P2|Overall Study|Safety reasons|0
151742|NCT00666458|539301|P1|Overall Study|Safety reasons|1
151743|NCT00666458|539300|P2|Overall Study|Severe non-compliance to the protocol|1
151744|NCT00666458|539301|P1|Overall Study|Severe non-compliance to the protocol|1
151745|NCT00666458|539300|P2|Overall Study|Study specific discontinuation criteria|7
151746|NCT00666458|539301|P1|Overall Study|Study specific discontinuation criteria|14
151747|NCT00666458|539300|P2|Overall Study|Incorrect enrollment|1
151748|NCT00666458|539301|P1|Overall Study|Incorrect enrollment|7
151749|NCT00666458|539300|P2|Overall Study|Administrative reason by sponsor|1
151750|NCT00666458|539301|P1|Overall Study|Administrative reason by sponsor|1
151751|NCT00666458|539300|P2|Overall Study|Lost to Follow-up|3
151752|NCT00666458|539301|P1|Overall Study|Lost to Follow-up|0
151753|NCT00666458|539300|P2|Overall Study|Withdrawal by Subject|4
151754|NCT00666458|539301|P1|Overall Study|Withdrawal by Subject|5
151755|NCT00666458|539300|P2|Overall Study|Adverse Event|7
151756|NCT00666458|539301|P1|Overall Study|Adverse Event|8
151757|NCT00666328|539389|P1|Overall Study|No longer met eligibility criteria|1
151758|NCT00666328|539389|P1|Overall Study|Lost to Follow-up|2
151759|NCT00666328|539389|P1|Overall Study|Death|2
151760|NCT00666276|539402|P1|Overall Study|Protocol Violation|34
151761|NCT00666263|539426|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
151762|NCT00666263|539427|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
151763|NCT00666263|539426|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
151764|NCT00666263|539427|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
151765|NCT00666263|539426|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
151766|NCT00666263|539427|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
151767|NCT00666224|539571|P2|Open-Label|Undefined/Unknown|1
151768|NCT00666224|539572|P1|Open-Label|Undefined/Unknown|1
151769|NCT00666224|539571|P2|Open-Label|Noncompliance|1
151770|NCT00666224|539572|P1|Open-Label|Noncompliance|2
151771|NCT00666224|539571|P2|Open-Label|Pregnancy|5
151772|NCT00666224|539572|P1|Open-Label|Pregnancy|1
151773|NCT00666224|539571|P2|Open-Label|Physician Decision|5
151774|NCT00666224|539572|P1|Open-Label|Physician Decision|7
151775|NCT00666224|539571|P2|Open-Label|Withdrawal by Subject|25
151776|NCT00666224|539572|P1|Open-Label|Withdrawal by Subject|12
151777|NCT00666224|539571|P2|Open-Label|Lost to Follow-up|5
151778|NCT00666224|539572|P1|Open-Label|Lost to Follow-up|4
151779|NCT00666224|539571|P2|Open-Label|Adverse Event|43
151780|NCT00666224|539572|P1|Open-Label|Adverse Event|8
151781|NCT00666224|539571|P2|Double-Blind|Undefined/Unknown|1
151782|NCT00666224|539572|P1|Double-Blind|Undefined/Unknown|4
151783|NCT00666224|539571|P2|Double-Blind|Death|0
151784|NCT00666224|539572|P1|Double-Blind|Death|1
151785|NCT00666224|539571|P2|Double-Blind|Noncompliance|0
151786|NCT00666224|539572|P1|Double-Blind|Noncompliance|1
151787|NCT00666224|539571|P2|Double-Blind|Pregnancy|2
151788|NCT00666224|539572|P1|Double-Blind|Pregnancy|3
151789|NCT00666224|539571|P2|Double-Blind|Sponsor decision|0
151790|NCT00666224|539572|P1|Double-Blind|Sponsor decision|1
151791|NCT00666224|539571|P2|Double-Blind|Physician Decision|3
151792|NCT00666224|539572|P1|Double-Blind|Physician Decision|0
151793|NCT00666224|539571|P2|Double-Blind|Withdrawal by Subject|14
151794|NCT00666224|539572|P1|Double-Blind|Withdrawal by Subject|18
151795|NCT00666224|539571|P2|Double-Blind|Lost to Follow-up|2
151796|NCT00666224|539572|P1|Double-Blind|Lost to Follow-up|2
151797|NCT00666224|539571|P2|Double-Blind|Adverse Event|5
151798|NCT00666224|539572|P1|Double-Blind|Adverse Event|15
151799|NCT00666211|539591|P2|Overall Study|Physician Decision|1
151800|NCT00666211|539592|P1|Overall Study|Physician Decision|0
151801|NCT00666211|539591|P2|Overall Study|off tx for other complicating disease|1
151802|NCT00666211|539592|P1|Overall Study|off tx for other complicating disease|0
151803|NCT00666211|539591|P2|Overall Study|Death|2
151804|NCT00666211|539592|P1|Overall Study|Death|0
151805|NCT00666211|539591|P2|Overall Study|hospital admission|5
151806|NCT00666211|539592|P1|Overall Study|hospital admission|0
151807|NCT00666211|539591|P2|Overall Study|toxicity|2
151808|NCT00666211|539592|P1|Overall Study|toxicity|0
151809|NCT00666211|539591|P2|Overall Study|Lost to Follow-up|0
151810|NCT00666211|539592|P1|Overall Study|Lost to Follow-up|2
151811|NCT00666211|539591|P2|Overall Study|disease progression|8
151812|NCT00666211|539592|P1|Overall Study|disease progression|1
151813|NCT00666211|539591|P2|Overall Study|patient non-compliant|6
151814|NCT00666211|539592|P1|Overall Study|patient non-compliant|6
151815|NCT00666211|539591|P2|Overall Study|went off medication, no more pain|0
151816|NCT00666211|539592|P1|Overall Study|went off medication, no more pain|1
151817|NCT00666211|539591|P2|Overall Study|Withdrawal by Subject|13
151818|NCT00666211|539592|P1|Overall Study|Withdrawal by Subject|10
151819|NCT00666198|539610|P1|Overall Study|No Drug Administration|4
151820|NCT00666198|539610|P1|Overall Study|Safety Not Assessable|6
151821|NCT00666198|539610|P1|Overall Study|No Visit After First Day of Treatment|13
151822|NCT00666198|539610|P1|Overall Study|Protocol Violation|10
151823|NCT00665925|539638|P4|Overall Study|Due to exclusion criteria|0
151824|NCT00665925|539639|P3|Overall Study|Due to exclusion criteria|0
151825|NCT00665925|539640|P2|Overall Study|Due to exclusion criteria|0
151826|NCT00665925|539641|P1|Overall Study|Due to exclusion criteria|1
151827|NCT00665925|539638|P4|Overall Study|Enrolled by mistake|1
151828|NCT00665925|539639|P3|Overall Study|Enrolled by mistake|0
151829|NCT00665925|539640|P2|Overall Study|Enrolled by mistake|0
151830|NCT00665925|539641|P1|Overall Study|Enrolled by mistake|0
151831|NCT00665925|539638|P4|Overall Study|Adverse Event|5
151832|NCT00665925|539639|P3|Overall Study|Adverse Event|10
151833|NCT00665925|539640|P2|Overall Study|Adverse Event|5
151834|NCT00665925|539641|P1|Overall Study|Adverse Event|1
151835|NCT00665925|539638|P4|Overall Study|Severe Non-Compliance to Protocol|1
151836|NCT00665925|539639|P3|Overall Study|Severe Non-Compliance to Protocol|1
151837|NCT00665925|539640|P2|Overall Study|Severe Non-Compliance to Protocol|0
151838|NCT00665925|539641|P1|Overall Study|Severe Non-Compliance to Protocol|0
151839|NCT00665925|539638|P4|Overall Study|Physician Decision|2
151840|NCT00665925|539639|P3|Overall Study|Physician Decision|1
151841|NCT00665925|539640|P2|Overall Study|Physician Decision|0
151842|NCT00665925|539641|P1|Overall Study|Physician Decision|0
151843|NCT00665925|539638|P4|Overall Study|Withdrawal by Subject|2
151844|NCT00665925|539639|P3|Overall Study|Withdrawal by Subject|3
151845|NCT00665925|539640|P2|Overall Study|Withdrawal by Subject|2
151846|NCT00665925|539641|P1|Overall Study|Withdrawal by Subject|2
151847|NCT00665925|539638|P4|Overall Study|Lost to Follow-up|2
151848|NCT00665925|539639|P3|Overall Study|Lost to Follow-up|2
151849|NCT00665925|539640|P2|Overall Study|Lost to Follow-up|2
151850|NCT00665925|539641|P1|Overall Study|Lost to Follow-up|1
151851|NCT00665925|539638|P4|Overall Study|Lack of Efficacy|8
151852|NCT00665925|539639|P3|Overall Study|Lack of Efficacy|9
151853|NCT00665925|539640|P2|Overall Study|Lack of Efficacy|8
151854|NCT00665925|539641|P1|Overall Study|Lack of Efficacy|10
151855|NCT00665847|540052|P1|Overall Study|Switch to Commercial Medication|1
151856|NCT00665847|540052|P1|Overall Study|Subject ineligible to continue the trial|1
151857|NCT00665847|540052|P1|Overall Study|Resistance to TMC125|1
151858|NCT00665847|540052|P1|Overall Study|Subject reached a virologic endpoint|4
151859|NCT00665847|540052|P1|Overall Study|Subject non-compliant|8
151860|NCT00665847|540052|P1|Overall Study|Withdrawal by Subject|2
151861|NCT00665847|540052|P1|Overall Study|Adverse Event|8
151862|NCT00665626|540071|P2|Overall Study|Death|0
151863|NCT00665626|540072|P1|Overall Study|Death|1
151864|NCT00665626|540071|P2|Overall Study|Unably to comply with dosing regimen|1
151865|NCT00665626|540072|P1|Overall Study|Unably to comply with dosing regimen|0
151866|NCT00665626|540071|P2|Overall Study|Did not fulfil inclusion criteria|1
151867|NCT00665626|540072|P1|Overall Study|Did not fulfil inclusion criteria|0
151868|NCT00665626|540071|P2|Overall Study|Due to exclusion criteria|1
151869|NCT00665626|540072|P1|Overall Study|Due to exclusion criteria|0
151870|NCT00665626|540071|P2|Overall Study|Adverse Event|9
151871|NCT00665626|540072|P1|Overall Study|Adverse Event|1
151872|NCT00665626|540071|P2|Overall Study|Protocol Violation|2
151873|NCT00665626|540072|P1|Overall Study|Protocol Violation|0
151874|NCT00665626|540071|P2|Overall Study|Withdrawal by Subject|1
151875|NCT00665626|540072|P1|Overall Study|Withdrawal by Subject|0
151876|NCT00665626|540071|P2|Overall Study|Lost to Follow-up|2
151877|NCT00665626|540072|P1|Overall Study|Lost to Follow-up|0
151878|NCT00665626|540071|P2|Overall Study|Lack of Efficacy|5
151879|NCT00665626|540072|P1|Overall Study|Lack of Efficacy|8
151880|NCT00665444|540149|P1|Overall Study|Study Terminated by Study Sponsor|1
151881|NCT00665444|540149|P1|Overall Study|Physician Decision|1
151882|NCT00665431|540161|P3|Overall Study|Other|2
151883|NCT00665431|540162|P2|Overall Study|Other|7
151884|NCT00665431|540163|P1|Overall Study|Other|4
151885|NCT00665431|540161|P3|Overall Study|Lost to Follow-up|1
151886|NCT00665431|540162|P2|Overall Study|Lost to Follow-up|3
151887|NCT00665431|540163|P1|Overall Study|Lost to Follow-up|3
151888|NCT00665431|540161|P3|Overall Study|Withdrawal by Subject|15
151889|NCT00665431|540162|P2|Overall Study|Withdrawal by Subject|25
151890|NCT00665431|540163|P1|Overall Study|Withdrawal by Subject|17
151891|NCT00665431|540161|P3|Overall Study|Adverse Event|6
151892|NCT00665431|540162|P2|Overall Study|Adverse Event|22
151893|NCT00665431|540163|P1|Overall Study|Adverse Event|16
151894|NCT00665366|540206|P2|Overall Study|Other reasons|1
151895|NCT00665366|540207|P1|Overall Study|Other reasons|4
151896|NCT00665366|540206|P2|Overall Study|No longer meets study criteria|1
151897|NCT00665366|540207|P1|Overall Study|No longer meets study criteria|0
151898|NCT00665366|540206|P2|Overall Study|Pregnancy|0
151899|NCT00665366|540207|P1|Overall Study|Pregnancy|1
151900|NCT00665366|540206|P2|Overall Study|Poor compliance/noncompliance|5
151901|NCT00665366|540207|P1|Overall Study|Poor compliance/noncompliance|3
151902|NCT00665366|540206|P2|Overall Study|Lost to Follow-up|5
151903|NCT00665366|540207|P1|Overall Study|Lost to Follow-up|3
151904|NCT00665366|540206|P2|Overall Study|Withdrawal by Subject|14
151905|NCT00665366|540207|P1|Overall Study|Withdrawal by Subject|11
151906|NCT00665366|540206|P2|Overall Study|Adverse Event|23
151907|NCT00665366|540207|P1|Overall Study|Adverse Event|25
151908|NCT00665366|540206|P2|Overall Study|Lack of Efficacy|10
151909|NCT00665366|540207|P1|Overall Study|Lack of Efficacy|11
151910|NCT00665353|540235|P1|Study Step 2|Lack of Efficacy|12
151911|NCT00665353|540235|P1|Study Step 2|Lost to Follow-up|2
151912|NCT00665353|540235|P1|Study Step 1|Withdrawal by Subject|2
151913|NCT00665353|540235|P1|Study Step 1|Adverse Event|1
151914|NCT00665002|540252|P1|Overall Study|Cytogenetic resistance|1
151915|NCT00665002|540252|P1|Overall Study|Progression/relapse during treatment|11
151916|NCT00664742|540266|P1|Overall Study|Lost to Follow-up|92
151917|NCT00664742|540266|P1|Overall Study|Withdrawal by Subject|31
151918|NCT00664742|540266|P1|Overall Study|Withdrawn due to adverse events|3
151919|NCT00664560|540274|P3|Overall Study|Other|5
151920|NCT00664560|540275|P2|Overall Study|Other|4
151921|NCT00664560|540276|P1|Overall Study|Other|11
151922|NCT00664560|540274|P3|Overall Study|Lost to Follow-up|0
151923|NCT00664560|540275|P2|Overall Study|Lost to Follow-up|2
151924|NCT00664560|540276|P1|Overall Study|Lost to Follow-up|0
151925|NCT00664560|540274|P3|Overall Study|Withdrawal by Subject|7
151926|NCT00664560|540275|P2|Overall Study|Withdrawal by Subject|13
151927|NCT00664560|540276|P1|Overall Study|Withdrawal by Subject|9
151928|NCT00664560|540274|P3|Overall Study|Adverse Event|7
151929|NCT00664560|540275|P2|Overall Study|Adverse Event|16
151930|NCT00664560|540276|P1|Overall Study|Adverse Event|19
151931|NCT00664534|540319|P2|Overall Study|Sponsor decision|6
151932|NCT00664534|540320|P1|Overall Study|Sponsor decision|8
151933|NCT00664534|540319|P2|Overall Study|Physician Decision|0
151934|NCT00664534|540320|P1|Overall Study|Physician Decision|8
151935|NCT00664534|540319|P2|Overall Study|Withdrawal by Subject|6
151936|NCT00664534|540320|P1|Overall Study|Withdrawal by Subject|7
151937|NCT00664534|540319|P2|Overall Study|Protocol Violation|8
151938|NCT00664534|540320|P1|Overall Study|Protocol Violation|10
151939|NCT00664534|540319|P2|Overall Study|Lost to Follow-up|10
151940|NCT00664534|540320|P1|Overall Study|Lost to Follow-up|6
151941|NCT00664534|540319|P2|Overall Study|Adverse Event|3
151942|NCT00664534|540320|P1|Overall Study|Adverse Event|2
151943|NCT00664521|540348|P2|Overall Study|Other|0
151944|NCT00664521|540349|P1|Overall Study|Other|1
151945|NCT00664521|540348|P2|Overall Study|Lost to Follow-up|0
151946|NCT00664521|540349|P1|Overall Study|Lost to Follow-up|1
151947|NCT00664521|540348|P2|Overall Study|Adverse Event|1
151948|NCT00664521|540349|P1|Overall Study|Adverse Event|4
151949|NCT00664326|540375|P1|Overall Study|ongoing with treatment|6
151950|NCT00664326|540375|P1|Overall Study|Physician Decision|1
151951|NCT00664326|540375|P1|Overall Study|Withdrawal by Subject|1
151952|NCT00664326|540375|P1|Overall Study|Noncompliance with study medication|3
151953|NCT00664326|540375|P1|Overall Study|Adverse Event|13
151954|NCT00664209|540394|P1|Study Treatment Period|Withdrawal by Subject|2
151955|NCT00664209|540394|P1|Study Treatment Period|Physician Decision|4
151956|NCT00664209|540394|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
151957|NCT00664105|540402|P1|Overall Study|Disease progression|7
151958|NCT00664105|540402|P1|Overall Study|Adverse Event|9
151959|NCT00664105|540402|P1|Overall Study|Withdrawal by Subject|5
151960|NCT00664105|540402|P1|Overall Study|Death|3
151961|NCT00664066|540409|P1|Overall Study|Study terminated|3
151962|NCT00663962|540415|P2|Overall Study|somnolence|0
151963|NCT00663962|540416|P1|Overall Study|somnolence|1
151964|NCT00663923|540422|P1|Overall Study|Lost to Follow-up|2
151965|NCT00663858|540439|P3|Overall Study|Other|4
151966|NCT00663858|540440|P2|Overall Study|Other|2
151967|NCT00663858|540441|P1|Overall Study|Other|8
151968|NCT00663858|540439|P3|Overall Study|Protocol Violation|4
151969|NCT00663858|540440|P2|Overall Study|Protocol Violation|3
151970|NCT00663858|540441|P1|Overall Study|Protocol Violation|5
151971|NCT00663858|540439|P3|Overall Study|Withdrawal by Subject|3
151972|NCT00663858|540440|P2|Overall Study|Withdrawal by Subject|3
151973|NCT00663858|540441|P1|Overall Study|Withdrawal by Subject|7
151974|NCT00663858|540439|P3|Overall Study|Lack of Efficacy|3
151975|NCT00663858|540440|P2|Overall Study|Lack of Efficacy|1
151976|NCT00663858|540441|P1|Overall Study|Lack of Efficacy|5
151977|NCT00663858|540439|P3|Overall Study|Adverse Event|6
151978|NCT00663858|540440|P2|Overall Study|Adverse Event|1
151979|NCT00663858|540441|P1|Overall Study|Adverse Event|9
151980|NCT00663702|540479|P2|Overall Study|Lack of Efficacy|3
151981|NCT00663702|540480|P1|Overall Study|Lack of Efficacy|3
151982|NCT00663702|540479|P2|Overall Study|Death|1
151983|NCT00663702|540480|P1|Overall Study|Death|1
151984|NCT00663702|540479|P2|Overall Study|Lost to Follow-up|0
151985|NCT00663702|540480|P1|Overall Study|Lost to Follow-up|3
151986|NCT00663702|540479|P2|Overall Study|Pregnancy|1
151987|NCT00663702|540480|P1|Overall Study|Pregnancy|0
151988|NCT00663702|540479|P2|Overall Study|Withdrawal by Subject|1
151989|NCT00663702|540480|P1|Overall Study|Withdrawal by Subject|3
151990|NCT00663702|540479|P2|Overall Study|Adverse Event|4
151991|NCT00663702|540480|P1|Overall Study|Adverse Event|8
151992|NCT00663260|540516|P3|Overall Study|non-compliance, not met criteria, etc.|3
151993|NCT00663260|540517|P2|Overall Study|non-compliance, not met criteria, etc.|2
151994|NCT00663260|540518|P1|Overall Study|non-compliance, not met criteria, etc.|3
151995|NCT00663260|540516|P3|Overall Study|Lost to Follow-up|0
151996|NCT00663260|540517|P2|Overall Study|Lost to Follow-up|1
151997|NCT00663260|540518|P1|Overall Study|Lost to Follow-up|0
151998|NCT00663260|540516|P3|Overall Study|Death|1
151999|NCT00663260|540517|P2|Overall Study|Death|0
152000|NCT00663260|540518|P1|Overall Study|Death|1
152001|NCT00663260|540516|P3|Overall Study|Withdrawal by Subject|6
152002|NCT00663260|540517|P2|Overall Study|Withdrawal by Subject|1
152003|NCT00663260|540518|P1|Overall Study|Withdrawal by Subject|3
152004|NCT00663260|540516|P3|Overall Study|Adverse Event|6
152005|NCT00663260|540517|P2|Overall Study|Adverse Event|7
152006|NCT00663260|540518|P1|Overall Study|Adverse Event|12
152007|NCT00663260|540516|P3|Overall Study|Lack of Efficacy|0
152008|NCT00663260|540517|P2|Overall Study|Lack of Efficacy|0
152009|NCT00663260|540518|P1|Overall Study|Lack of Efficacy|2
152010|NCT00663234|540532|P1|Overall Study|Not willing to adhere to requirements|1
152011|NCT00663208|540565|P7|Follow-up Period|Other reason|1
152012|NCT00663208|540566|P6|Follow-up Period|Other reason|0
152013|NCT00663208|540567|P5|Follow-up Period|Other reason|0
152014|NCT00663208|540568|P4|Follow-up Period|Other reason|0
152015|NCT00663208|540569|P3|Follow-up Period|Other reason|0
152016|NCT00663208|540570|P2|Follow-up Period|Other reason|0
152017|NCT00663208|540571|P1|Follow-up Period|Other reason|1
152018|NCT00663208|540565|P7|Follow-up Period|Lost to Follow-up|0
152019|NCT00663208|540566|P6|Follow-up Period|Lost to Follow-up|0
152020|NCT00663208|540567|P5|Follow-up Period|Lost to Follow-up|0
152021|NCT00663208|540568|P4|Follow-up Period|Lost to Follow-up|2
152022|NCT00663208|540569|P3|Follow-up Period|Lost to Follow-up|3
152023|NCT00663208|540570|P2|Follow-up Period|Lost to Follow-up|0
152024|NCT00663208|540571|P1|Follow-up Period|Lost to Follow-up|2
152025|NCT00663208|540565|P7|Treatment Period|Lost to Follow-up|0
152026|NCT00663208|540566|P6|Treatment Period|Lost to Follow-up|0
152027|NCT00663208|540567|P5|Treatment Period|Lost to Follow-up|0
152028|NCT00663208|540568|P4|Treatment Period|Lost to Follow-up|0
152029|NCT00663208|540569|P3|Treatment Period|Lost to Follow-up|0
152030|NCT00663208|540570|P2|Treatment Period|Lost to Follow-up|1
152031|NCT00663208|540571|P1|Treatment Period|Lost to Follow-up|0
152032|NCT00663117|540749|P2|Overall Study|Lack of Efficacy|0
152033|NCT00663117|540750|P1|Overall Study|Lack of Efficacy|1
152034|NCT00663052|540764|P2|Overall Study|Other|1
152035|NCT00663052|540765|P1|Overall Study|Other|0
152036|NCT00663052|540764|P2|Overall Study|Unsatisfactory Response - Efficacy|1
152037|NCT00663052|540765|P1|Overall Study|Unsatisfactory Response - Efficacy|1
152038|NCT00663052|540764|P2|Overall Study|Withdrawal by Subject|5
152039|NCT00663052|540765|P1|Overall Study|Withdrawal by Subject|2
152040|NCT00663052|540764|P2|Overall Study|Protocol Violation|0
152041|NCT00663052|540765|P1|Overall Study|Protocol Violation|1
152042|NCT00663052|540764|P2|Overall Study|Discontinuation of Study by Sponsor|0
152043|NCT00663052|540765|P1|Overall Study|Discontinuation of Study by Sponsor|2
152044|NCT00663052|540764|P2|Overall Study|Adverse Event|3
152045|NCT00663052|540765|P1|Overall Study|Adverse Event|6
152046|NCT00663026|540848|P3|Overall Study|Withdrawal by Subject|1
152047|NCT00663026|540849|P2|Overall Study|Withdrawal by Subject|0
152048|NCT00663026|540850|P1|Overall Study|Withdrawal by Subject|0
152049|NCT00663026|540848|P3|Overall Study|Caregiver Request|0
152050|NCT00663026|540849|P2|Overall Study|Caregiver Request|2
152051|NCT00663026|540850|P1|Overall Study|Caregiver Request|0
152052|NCT00663026|540848|P3|Overall Study|Adverse Event|3
152053|NCT00663026|540849|P2|Overall Study|Adverse Event|2
152054|NCT00663026|540850|P1|Overall Study|Adverse Event|0
152055|NCT00663026|540848|P3|Overall Study|Other|0
152056|NCT00663026|540849|P2|Overall Study|Other|2
152057|NCT00663026|540850|P1|Overall Study|Other|1
152058|NCT00663026|540848|P3|Overall Study|Lost to Follow-up|0
152059|NCT00663026|540849|P2|Overall Study|Lost to Follow-up|0
152060|NCT00663026|540850|P1|Overall Study|Lost to Follow-up|1
152061|NCT00662909|540873|P3|Overall Study|Eligibility criterion not met|1
152062|NCT00662909|540874|P2|Overall Study|Eligibility criterion not met|1
152063|NCT00662909|540875|P1|Overall Study|Eligibility criterion not met|0
152064|NCT00662909|540873|P3|Overall Study|Physician Decision|2
152065|NCT00662909|540874|P2|Overall Study|Physician Decision|1
152066|NCT00662909|540875|P1|Overall Study|Physician Decision|1
152067|NCT00662909|540873|P3|Overall Study|Non-compliance with study procedures|2
152068|NCT00662909|540874|P2|Overall Study|Non-compliance with study procedures|3
152069|NCT00662909|540875|P1|Overall Study|Non-compliance with study procedures|3
152070|NCT00662909|540873|P3|Overall Study|Randomized- never received study drug|0
152071|NCT00662909|540874|P2|Overall Study|Randomized- never received study drug|0
152072|NCT00662909|540875|P1|Overall Study|Randomized- never received study drug|1
152073|NCT00662909|540873|P3|Overall Study|Protocol Violation|5
152074|NCT00662909|540874|P2|Overall Study|Protocol Violation|4
152075|NCT00662909|540875|P1|Overall Study|Protocol Violation|7
152076|NCT00662909|540873|P3|Overall Study|Lost to Follow-up|3
152077|NCT00662909|540874|P2|Overall Study|Lost to Follow-up|9
152078|NCT00662909|540875|P1|Overall Study|Lost to Follow-up|2
152079|NCT00662909|540873|P3|Overall Study|Withdrawal by Subject|16
152080|NCT00662909|540874|P2|Overall Study|Withdrawal by Subject|22
152081|NCT00662909|540875|P1|Overall Study|Withdrawal by Subject|29
152082|NCT00662909|540873|P3|Overall Study|Lack of Efficacy|5
152083|NCT00662909|540874|P2|Overall Study|Lack of Efficacy|1
152084|NCT00662909|540875|P1|Overall Study|Lack of Efficacy|9
152085|NCT00662909|540873|P3|Overall Study|Adverse Event|19
152086|NCT00662909|540874|P2|Overall Study|Adverse Event|18
152087|NCT00662909|540875|P1|Overall Study|Adverse Event|17
152088|NCT00662857|540973|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
152089|NCT00662857|540974|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
152090|NCT00662857|540973|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
152091|NCT00662857|540974|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
152092|NCT00662857|540973|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
152093|NCT00662857|540974|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
152094|NCT00662831|540989|P2|Overall Study|Adverse Event|16
152095|NCT00662831|540990|P1|Overall Study|Adverse Event|23
152096|NCT00662831|540989|P2|Overall Study|Protocol Violation|4
152097|NCT00662831|540990|P1|Overall Study|Protocol Violation|8
152098|NCT00662831|540989|P2|Overall Study|Other|31
152099|NCT00662831|540990|P1|Overall Study|Other|62
152100|NCT00662831|540989|P2|Overall Study|Withdrawal by Subject|1
152101|NCT00662831|540990|P1|Overall Study|Withdrawal by Subject|2
152102|NCT00662831|540989|P2|Overall Study|Lost to Follow-up|0
152103|NCT00662831|540990|P1|Overall Study|Lost to Follow-up|1
152104|NCT00662831|540989|P2|Overall Study|Lack of Efficacy|6
152105|NCT00662831|540990|P1|Overall Study|Lack of Efficacy|6
152106|NCT00662831|540989|P2|Overall Study|Death|1
152107|NCT00662831|540990|P1|Overall Study|Death|4
152108|NCT00662649|541070|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
152109|NCT00662649|541071|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
152110|NCT00662649|541072|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
152111|NCT00662649|541073|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
152112|NCT00662649|541074|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
152113|NCT00662649|541070|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
152114|NCT00662649|541071|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
152115|NCT00662649|541072|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
152116|NCT00662649|541073|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
152117|NCT00662649|541074|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
152118|NCT00662649|541070|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
152119|NCT00662649|541071|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
152120|NCT00662649|541072|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
152121|NCT00662649|541073|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
152122|NCT00662649|541074|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
152123|NCT00662649|541070|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
152124|NCT00662649|541071|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
152125|NCT00662649|541072|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
152126|NCT00662649|541073|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
152127|NCT00662649|541074|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
152128|NCT00662649|541070|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
152129|NCT00662649|541071|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
152130|NCT00662649|541072|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
152131|NCT00662649|541073|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
152132|NCT00662649|541074|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
152133|NCT00662649|541070|P5|Extension Study (Month 24 to 60)|Adverse Event|10
152134|NCT00662649|541071|P4|Extension Study (Month 24 to 60)|Adverse Event|6
152135|NCT00662649|541072|P3|Extension Study (Month 24 to 60)|Adverse Event|0
152136|NCT00662649|541073|P2|Extension Study (Month 24 to 60)|Adverse Event|9
152137|NCT00662649|541074|P1|Extension Study (Month 24 to 60)|Adverse Event|6
152138|NCT00662649|541070|P5|Extension Study (Month 24 to 60)|Administrative problems|0
152139|NCT00662649|541071|P4|Extension Study (Month 24 to 60)|Administrative problems|1
152140|NCT00662649|541072|P3|Extension Study (Month 24 to 60)|Administrative problems|0
152141|NCT00662649|541073|P2|Extension Study (Month 24 to 60)|Administrative problems|0
152142|NCT00662649|541074|P1|Extension Study (Month 24 to 60)|Administrative problems|0
152143|NCT00662649|541070|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
152144|NCT00662649|541071|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
152145|NCT00662649|541072|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
152146|NCT00662649|541073|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
152147|NCT00662649|541074|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
152148|NCT00662649|541070|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
152149|NCT00662649|541071|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
152150|NCT00662649|541072|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
152151|NCT00662649|541073|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
152152|NCT00662649|541074|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
152153|NCT00662649|541070|P5|Core Study (24 Months)|Death|0
152154|NCT00662649|541071|P4|Core Study (24 Months)|Death|0
152155|NCT00662649|541072|P3|Core Study (24 Months)|Death|2
152156|NCT00662649|541073|P2|Core Study (24 Months)|Death|0
152157|NCT00662649|541074|P1|Core Study (24 Months)|Death|1
152158|NCT00662649|541070|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
152159|NCT00662649|541071|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
152160|NCT00662649|541072|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
152161|NCT00662649|541073|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
152162|NCT00662649|541074|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
152163|NCT00662649|541070|P5|Core Study (24 Months)|Protocol Violation|0
152164|NCT00662649|541071|P4|Core Study (24 Months)|Protocol Violation|0
152165|NCT00662649|541072|P3|Core Study (24 Months)|Protocol Violation|4
152166|NCT00662649|541073|P2|Core Study (24 Months)|Protocol Violation|5
152167|NCT00662649|541074|P1|Core Study (24 Months)|Protocol Violation|5
152168|NCT00662649|541070|P5|Core Study (24 Months)|Lost to Follow-up|0
152169|NCT00662649|541071|P4|Core Study (24 Months)|Lost to Follow-up|0
152170|NCT00662649|541072|P3|Core Study (24 Months)|Lost to Follow-up|7
152171|NCT00662649|541073|P2|Core Study (24 Months)|Lost to Follow-up|5
152172|NCT00662649|541074|P1|Core Study (24 Months)|Lost to Follow-up|3
152173|NCT00662649|541070|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
152174|NCT00662649|541071|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
152175|NCT00662649|541072|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
152176|NCT00662649|541073|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
152177|NCT00662649|541074|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
152178|NCT00662649|541070|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
152179|NCT00662649|541071|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
152180|NCT00662649|541072|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
152181|NCT00662649|541073|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
152182|NCT00662649|541074|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
152183|NCT00662649|541070|P5|Core Study (24 Months)|Adverse Event|0
152184|NCT00662649|541071|P4|Core Study (24 Months)|Adverse Event|0
152185|NCT00662649|541072|P3|Core Study (24 Months)|Adverse Event|18
152186|NCT00662649|541073|P2|Core Study (24 Months)|Adverse Event|13
152187|NCT00662649|541074|P1|Core Study (24 Months)|Adverse Event|22
152188|NCT00662649|541070|P5|Core Study (24 Months)|Withdrawal by Subject|0
152189|NCT00662649|541071|P4|Core Study (24 Months)|Withdrawal by Subject|0
152190|NCT00662649|541072|P3|Core Study (24 Months)|Withdrawal by Subject|28
152191|NCT00662649|541073|P2|Core Study (24 Months)|Withdrawal by Subject|17
152192|NCT00662649|541074|P1|Core Study (24 Months)|Withdrawal by Subject|31
152193|NCT00662558|541114|P2|Overall Study|Randomized But Did Not Receive Treatment|8
152194|NCT00662558|541115|P1|Overall Study|Randomized But Did Not Receive Treatment|2
152195|NCT00662558|541114|P2|Overall Study|Withdrawal by Subject|12
152196|NCT00662558|541115|P1|Overall Study|Withdrawal by Subject|7
152197|NCT00662558|541114|P2|Overall Study|Other|14
152198|NCT00662558|541115|P1|Overall Study|Other|9
152199|NCT00662558|541114|P2|Overall Study|Lost to Follow-up|10
152200|NCT00662558|541115|P1|Overall Study|Lost to Follow-up|13
152201|NCT00662558|541114|P2|Overall Study|Lack of Efficacy|7
152202|NCT00662558|541115|P1|Overall Study|Lack of Efficacy|4
152203|NCT00662558|541114|P2|Overall Study|Adverse Event|59
152204|NCT00662558|541115|P1|Overall Study|Adverse Event|21
152205|NCT00662532|541166|P2|Overall Study|Lost to Follow-up|1
152206|NCT00662532|541167|P1|Overall Study|Lost to Follow-up|0
152207|NCT00662532|541166|P2|Overall Study|Adverse Event|1
152208|NCT00662532|541167|P1|Overall Study|Adverse Event|0
152209|NCT00662363|541182|P2|Overall Study|Protocol Violation|1
152210|NCT00662363|541183|P1|Overall Study|Protocol Violation|1
152211|NCT00662363|541182|P2|Overall Study|Discharged early from rehab|1
152212|NCT00662363|541183|P1|Overall Study|Discharged early from rehab|4
152213|NCT00662363|541182|P2|Overall Study|Adverse Event|3
152214|NCT00662363|541183|P1|Overall Study|Adverse Event|0
152215|NCT00662363|541182|P2|Overall Study|Withdrawal by Subject|5
152216|NCT00662363|541183|P1|Overall Study|Withdrawal by Subject|6
152217|NCT00662311|541194|P3|Overall Study|Respiratory Infection|0
152218|NCT00662311|541195|P2|Overall Study|Respiratory Infection|0
152219|NCT00662311|541196|P1|Overall Study|Respiratory Infection|1
152220|NCT00662129|541247|P1|Overall Study|Ineligible|1
152221|NCT00662129|541247|P1|Overall Study|Cancel prior to beginning treatment|1
152222|NCT00662129|541247|P1|Overall Study|Protocol Violation|1
152223|NCT00662038|541257|P1|Overall Study|Continued treatment|5
152224|NCT00662038|541257|P1|Overall Study|Adverse Event|358
152225|NCT00662038|541257|P1|Overall Study|Death|95
152226|NCT00662038|541257|P1|Overall Study|Lost to Follow-up|1
152227|NCT00662038|541257|P1|Overall Study|Lung transplantation|44
152228|NCT00662038|541257|P1|Overall Study|Physician Decision|19
152229|NCT00662038|541257|P1|Overall Study|Sponsor decision|1
152230|NCT00662038|541257|P1|Overall Study|Withdrawal by Subject|83
152231|NCT00662038|541257|P1|Overall Study|Withdrawn consent|22
152232|NCT00662038|541257|P1|Overall Study|Reason not specified|3
152233|NCT00662025|541261|P1|Overall Study|Domestic circumstances|1
152234|NCT00662025|541261|P1|Overall Study|Target lesion cannot be evaluated|1
152235|NCT00662025|541261|P1|Overall Study|Results of other clinical study|2
152236|NCT00662025|541261|P1|Overall Study|Withdrawal by Subject|1
152237|NCT00662025|541261|P1|Overall Study|Adverse Event|7
152238|NCT00662025|541261|P1|Overall Study|Objective progression or relapse|51
152239|NCT00662012|541281|P1|Overall Study|Withdrawal by Subject|1
152240|NCT00662012|541281|P1|Overall Study|Death|1
152241|NCT00662012|541281|P1|Overall Study|Lost to Follow-up|85
152242|NCT00661999|541289|P3|Overall Study|Other Medical Problems|9
152243|NCT00661999|541290|P2|Overall Study|Other Medical Problems|4
152244|NCT00661999|541291|P1|Overall Study|Other Medical Problems|4
152245|NCT00661999|541289|P3|Overall Study|Alternative Treatment|0
152246|NCT00661999|541290|P2|Overall Study|Alternative Treatment|0
152247|NCT00661999|541291|P1|Overall Study|Alternative Treatment|1
152248|NCT00661999|541289|P3|Overall Study|Withdrawal by Subject|14
152249|NCT00661999|541290|P2|Overall Study|Withdrawal by Subject|23
152250|NCT00661999|541291|P1|Overall Study|Withdrawal by Subject|30
152251|NCT00661999|541289|P3|Overall Study|Other Reasons|23
152252|NCT00661999|541290|P2|Overall Study|Other Reasons|12
152253|NCT00661999|541291|P1|Overall Study|Other Reasons|5
152254|NCT00661999|541289|P3|Overall Study|Death|3
152255|NCT00661999|541290|P2|Overall Study|Death|6
152256|NCT00661999|541291|P1|Overall Study|Death|8
152257|NCT00661999|541289|P3|Overall Study|Adverse Event|8
152258|NCT00661999|541290|P2|Overall Study|Adverse Event|5
152259|NCT00661999|541291|P1|Overall Study|Adverse Event|11
152260|NCT00661830|541368|P2|Overall Study|Other reason|5
152261|NCT00661830|541369|P1|Overall Study|Other reason|1
152262|NCT00661830|541368|P2|Overall Study|Withdrawal by Subject|1
152263|NCT00661830|541369|P1|Overall Study|Withdrawal by Subject|1
152264|NCT00661830|541368|P2|Overall Study|Lost to Follow-up|3
152265|NCT00661830|541369|P1|Overall Study|Lost to Follow-up|1
152266|NCT00661830|541368|P2|Overall Study|Death|33
152267|NCT00661830|541369|P1|Overall Study|Death|37
152268|NCT00661778|541381|P1|Overall Study|Withdrawal of Consent|1
152269|NCT00661778|541381|P1|Overall Study|Protocol Violation|2
152270|NCT00661778|541381|P1|Overall Study|Reason not Specified|6
152271|NCT00661778|541381|P1|Overall Study|Adverse Event|18
152272|NCT00661778|541381|P1|Overall Study|Disease Progression|23
152273|NCT00661726|541388|P1|Overall Study|Adverse Event|1
152274|NCT00661713|541411|P8|Overall Study|Inappropriate Enrollment|0
152275|NCT00661713|541412|P7|Overall Study|Inappropriate Enrollment|1
152276|NCT00661713|541413|P6|Overall Study|Inappropriate Enrollment|0
152277|NCT00661713|541414|P5|Overall Study|Inappropriate Enrollment|0
152278|NCT00661713|541415|P4|Overall Study|Inappropriate Enrollment|0
152279|NCT00661713|541416|P3|Overall Study|Inappropriate Enrollment|0
152280|NCT00661713|541417|P2|Overall Study|Inappropriate Enrollment|0
152281|NCT00661713|541418|P1|Overall Study|Inappropriate Enrollment|0
152282|NCT00661713|541411|P8|Overall Study|Adverse Event|0
152283|NCT00661713|541412|P7|Overall Study|Adverse Event|1
152284|NCT00661713|541413|P6|Overall Study|Adverse Event|0
152285|NCT00661713|541414|P5|Overall Study|Adverse Event|0
152286|NCT00661713|541415|P4|Overall Study|Adverse Event|0
152287|NCT00661713|541416|P3|Overall Study|Adverse Event|0
152288|NCT00661713|541417|P2|Overall Study|Adverse Event|0
152289|NCT00661713|541418|P1|Overall Study|Adverse Event|0
152290|NCT00661713|541411|P8|Overall Study|Administrative Reason|0
152291|NCT00661713|541412|P7|Overall Study|Administrative Reason|1
152292|NCT00661713|541413|P6|Overall Study|Administrative Reason|2
152293|NCT00661713|541414|P5|Overall Study|Administrative Reason|2
152294|NCT00661713|541415|P4|Overall Study|Administrative Reason|2
152295|NCT00661713|541416|P3|Overall Study|Administrative Reason|0
152296|NCT00661713|541417|P2|Overall Study|Administrative Reason|1
152297|NCT00661713|541418|P1|Overall Study|Administrative Reason|0
152298|NCT00661713|541411|P8|Overall Study|Lost to Follow-up|1
152299|NCT00661713|541412|P7|Overall Study|Lost to Follow-up|14
152300|NCT00661713|541413|P6|Overall Study|Lost to Follow-up|7
152301|NCT00661713|541414|P5|Overall Study|Lost to Follow-up|5
152302|NCT00661713|541415|P4|Overall Study|Lost to Follow-up|2
152303|NCT00661713|541416|P3|Overall Study|Lost to Follow-up|2
152304|NCT00661713|541417|P2|Overall Study|Lost to Follow-up|7
152305|NCT00661713|541418|P1|Overall Study|Lost to Follow-up|2
152306|NCT00661713|541411|P8|Overall Study|Withdrawal by Subject|9
152307|NCT00661713|541412|P7|Overall Study|Withdrawal by Subject|45
152308|NCT00661713|541413|P6|Overall Study|Withdrawal by Subject|26
152309|NCT00661713|541414|P5|Overall Study|Withdrawal by Subject|12
152310|NCT00661713|541415|P4|Overall Study|Withdrawal by Subject|21
152311|NCT00661713|541416|P3|Overall Study|Withdrawal by Subject|12
152312|NCT00661713|541417|P2|Overall Study|Withdrawal by Subject|25
152313|NCT00661713|541418|P1|Overall Study|Withdrawal by Subject|11
152314|NCT00661713|541411|P8|Overall Study|Protocol Violation|1
152315|NCT00661713|541412|P7|Overall Study|Protocol Violation|2
152316|NCT00661713|541413|P6|Overall Study|Protocol Violation|2
152317|NCT00661713|541414|P5|Overall Study|Protocol Violation|0
152318|NCT00661713|541415|P4|Overall Study|Protocol Violation|3
152319|NCT00661713|541416|P3|Overall Study|Protocol Violation|3
152320|NCT00661713|541417|P2|Overall Study|Protocol Violation|6
152321|NCT00661713|541418|P1|Overall Study|Protocol Violation|1
152322|NCT00661713|541411|P8|Overall Study|Unable to Classify|0
152323|NCT00661713|541412|P7|Overall Study|Unable to Classify|0
152324|NCT00661713|541413|P6|Overall Study|Unable to Classify|0
152325|NCT00661713|541414|P5|Overall Study|Unable to Classify|0
152326|NCT00661713|541415|P4|Overall Study|Unable to Classify|0
152327|NCT00661713|541416|P3|Overall Study|Unable to Classify|0
152328|NCT00661713|541417|P2|Overall Study|Unable to Classify|0
152329|NCT00661713|541418|P1|Overall Study|Unable to Classify|1
152330|NCT00661713|541411|P8|Overall Study|Death|0
152331|NCT00661713|541412|P7|Overall Study|Death|0
152332|NCT00661713|541413|P6|Overall Study|Death|0
152333|NCT00661713|541414|P5|Overall Study|Death|1
152334|NCT00661713|541415|P4|Overall Study|Death|0
152335|NCT00661713|541416|P3|Overall Study|Death|0
152336|NCT00661713|541417|P2|Overall Study|Death|0
152337|NCT00661713|541418|P1|Overall Study|Death|1
152338|NCT00661687|541508|P1|Overall Study|Adverse Event|2
152339|NCT00661687|541508|P1|Overall Study|Physician Decision|1
152340|NCT00661687|541508|P1|Overall Study|Inability to maintain wearing schedule|3
152341|NCT00661687|541508|P1|Overall Study|Positive slit lamp findings|4
152342|NCT00661687|541508|P1|Overall Study|Study related symptoms and complaints|5
152343|NCT00661661|541536|P2|Overall Study|Not assigned treatment|0
152344|NCT00661661|541537|P1|Overall Study|Not assigned treatment|1
152345|NCT00661661|541536|P2|Overall Study|Other|7
152346|NCT00661661|541537|P1|Overall Study|Other|22
152347|NCT00661661|541536|P2|Overall Study|Withdrawal by Subject|5
152348|NCT00661661|541537|P1|Overall Study|Withdrawal by Subject|15
152349|NCT00661661|541536|P2|Overall Study|Lost to Follow-up|1
152350|NCT00661661|541537|P1|Overall Study|Lost to Follow-up|0
152351|NCT00661661|541536|P2|Overall Study|Lack of Efficacy|2
152352|NCT00661661|541537|P1|Overall Study|Lack of Efficacy|3
152353|NCT00661661|541536|P2|Overall Study|Adverse Event|24
152354|NCT00661661|541537|P1|Overall Study|Adverse Event|99
152355|NCT00661622|541613|P2|Overall Study|Protocol Violation|0
152356|NCT00661622|541614|P1|Overall Study|Protocol Violation|1
152357|NCT00661609|541628|P1|Overall Study|Disease progression|3
152358|NCT00661609|541628|P1|Overall Study|Survival follow up stage discontinued|11
152359|NCT00661609|541628|P1|Overall Study|PI Decision|1
152360|NCT00661609|541628|P1|Overall Study|Withdrawal by Subject|2
152361|NCT00661609|541628|P1|Overall Study|Death|20
152362|NCT00661609|541628|P1|Overall Study|Adverse Event|4
152363|NCT00661531|541668|P1|Overall Study|Withdrawal by Subject|3
152364|NCT00661505|541673|P1|Overall Study|Not Specified|2
152365|NCT00661505|541673|P1|Overall Study|Lost to Follow-up|3
152366|NCT00661505|541673|P1|Overall Study|Withdrawal by Subject|8
152367|NCT00661505|541673|P1|Overall Study|Protocol Violation|14
152368|NCT00661505|541673|P1|Overall Study|Adverse Event|3
152369|NCT00661492|541701|P2|Overall Study|Other|0
152370|NCT00661492|541702|P1|Overall Study|Other|1
152371|NCT00661492|541701|P2|Overall Study|Lost to Follow-up|1
152372|NCT00661492|541702|P1|Overall Study|Lost to Follow-up|0
152373|NCT00661492|541701|P2|Overall Study|Investigator Request|0
152374|NCT00661492|541702|P1|Overall Study|Investigator Request|1
152375|NCT00661492|541701|P2|Overall Study|Patient Request|1
152376|NCT00661492|541702|P1|Overall Study|Patient Request|6
152377|NCT00661492|541701|P2|Overall Study|Disease Progression|14
152378|NCT00661492|541702|P1|Overall Study|Disease Progression|44
152379|NCT00661492|541701|P2|Overall Study|Adverse Event|13
152380|NCT00661492|541702|P1|Overall Study|Adverse Event|16
152381|NCT00661427|541748|P2|Overall Study|Patient not treated|2
152382|NCT00661427|541749|P1|Overall Study|Patient not treated|0
152383|NCT00661427|541748|P2|Overall Study|Adverse Event|5
152384|NCT00661427|541749|P1|Overall Study|Adverse Event|5
152385|NCT00661388|541757|P1|Overall Study|Administrative reasons|1
152386|NCT00661388|541757|P1|Overall Study|Dialysis initiation|1
152387|NCT00661388|541757|P1|Overall Study|Renal transplantation|1
152388|NCT00661388|541757|P1|Overall Study|Protocol Violation|7
152389|NCT00661388|541757|P1|Overall Study|Adverse Event|14
152390|NCT00661362|541780|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
152391|NCT00661362|541781|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
152392|NCT00661362|541780|P2|Overall Study|Safety reasons|0
152393|NCT00661362|541781|P1|Overall Study|Safety reasons|1
152394|NCT00661362|541780|P2|Overall Study|Severe non-compliance to protocol|1
152395|NCT00661362|541781|P1|Overall Study|Severe non-compliance to protocol|0
152396|NCT00661362|541780|P2|Overall Study|Lost to Follow-up|1
152397|NCT00661362|541781|P1|Overall Study|Lost to Follow-up|3
152398|NCT00661362|541780|P2|Overall Study|Withdrawal by Subject|23
152399|NCT00661362|541781|P1|Overall Study|Withdrawal by Subject|13
152400|NCT00661362|541780|P2|Overall Study|Study specific discontinuation criteria|11
152401|NCT00661362|541781|P1|Overall Study|Study specific discontinuation criteria|4
152402|NCT00661362|541780|P2|Overall Study|Incorrect enrollment|0
152403|NCT00661362|541781|P1|Overall Study|Incorrect enrollment|2
152404|NCT00661362|541780|P2|Overall Study|Adverse Event|4
152405|NCT00661362|541781|P1|Overall Study|Adverse Event|5
152406|NCT00661258|541799|P2|Overall Study|caught by police and in detox center|1
152407|NCT00661258|541800|P1|Overall Study|caught by police and in detox center|2
152408|NCT00661258|541799|P2|Overall Study|Death|0
152409|NCT00661258|541800|P1|Overall Study|Death|1
152410|NCT00661193|541810|P2|Overall Study|Not protocol specified|0
152411|NCT00661193|541811|P1|Overall Study|Not protocol specified|1
152412|NCT00661193|541810|P2|Overall Study|Progression|24
152413|NCT00661193|541811|P1|Overall Study|Progression|27
152414|NCT00661193|541810|P2|Overall Study|Withdrawal by Subject|1
152415|NCT00661193|541811|P1|Overall Study|Withdrawal by Subject|3
152416|NCT00661193|541810|P2|Overall Study|Adverse Event|1
152417|NCT00661193|541811|P1|Overall Study|Adverse Event|2
152418|NCT00661089|542036|P2|Overall Study|death at 8 weeks due to new stroke|1
152419|NCT00661089|542037|P1|Overall Study|death at 8 weeks due to new stroke|0
152420|NCT00661089|542036|P2|Overall Study|1 subject withdrawal|1
152421|NCT00661089|542037|P1|Overall Study|1 subject withdrawal|0
152422|NCT00660907|542085|P2|Overall Study|Various|8
152423|NCT00660907|542086|P1|Overall Study|Various|11
152424|NCT00660907|542085|P2|Overall Study|Death|3
152425|NCT00660907|542086|P1|Overall Study|Death|1
152426|NCT00660907|542085|P2|Overall Study|Safety|0
152427|NCT00660907|542086|P1|Overall Study|Safety|1
152428|NCT00660907|542085|P2|Overall Study|Poor/Non-Compliance|1
152429|NCT00660907|542086|P1|Overall Study|Poor/Non-Compliance|5
152430|NCT00660907|542085|P2|Overall Study|Lost to Follow-up|3
152431|NCT00660907|542086|P1|Overall Study|Lost to Follow-up|3
152432|NCT00660907|542085|P2|Overall Study|Withdrawal by Subject|32
152433|NCT00660907|542086|P1|Overall Study|Withdrawal by Subject|23
152434|NCT00660907|542085|P2|Overall Study|Subject No Longer Meets Study Criteria|27
152435|NCT00660907|542086|P1|Overall Study|Subject No Longer Meets Study Criteria|6
152436|NCT00660907|542085|P2|Overall Study|Adverse Event|19
152437|NCT00660907|542086|P1|Overall Study|Adverse Event|33
152438|NCT00660907|542085|P2|Overall Study|Incorrect Enrollment|1
152439|NCT00660907|542086|P1|Overall Study|Incorrect Enrollment|1
152440|NCT00660829|542100|P2|Overall Study|Other|4
152441|NCT00660829|542101|P1|Overall Study|Other|9
152442|NCT00660829|542100|P2|Overall Study|Lost to Follow-up|2
152443|NCT00660829|542101|P1|Overall Study|Lost to Follow-up|3
152444|NCT00660829|542100|P2|Overall Study|Withdrawal by Subject|2
152445|NCT00660829|542101|P1|Overall Study|Withdrawal by Subject|1
152446|NCT00660829|542100|P2|Overall Study|Non-Compliance|4
152447|NCT00660829|542101|P1|Overall Study|Non-Compliance|0
152448|NCT00660829|542100|P2|Overall Study|Lack of Efficacy|3
152449|NCT00660829|542101|P1|Overall Study|Lack of Efficacy|2
152450|NCT00660829|542100|P2|Overall Study|Adverse Event|4
152451|NCT00660829|542101|P1|Overall Study|Adverse Event|3
152452|NCT00660816|542119|P2|Overall Study|Complicating Disease|1
152453|NCT00660816|542120|P1|Overall Study|Complicating Disease|0
152454|NCT00660816|542119|P2|Overall Study|Disease Progression|12
152455|NCT00660816|542120|P1|Overall Study|Disease Progression|16
152456|NCT00660816|542119|P2|Overall Study|Protocol Violation|0
152457|NCT00660816|542120|P1|Overall Study|Protocol Violation|1
152458|NCT00660816|542119|P2|Overall Study|Physician Decision|2
152459|NCT00660816|542120|P1|Overall Study|Physician Decision|0
152460|NCT00660816|542119|P2|Overall Study|Lack of Efficacy|0
152461|NCT00660816|542120|P1|Overall Study|Lack of Efficacy|1
152462|NCT00660816|542119|P2|Overall Study|Death|2
152463|NCT00660816|542120|P1|Overall Study|Death|0
152464|NCT00660816|542119|P2|Overall Study|Withdrawal by Subject|0
152465|NCT00660816|542120|P1|Overall Study|Withdrawal by Subject|1
152466|NCT00660816|542119|P2|Overall Study|Adverse Event|2
152467|NCT00660816|542120|P1|Overall Study|Adverse Event|1
152468|NCT00660699|542132|P1|Overall Study|Withdrawal by Subject|2
152469|NCT00660660|542148|P2|Overall Study|New medication after randomization|0
152470|NCT00660660|542149|P1|Overall Study|New medication after randomization|1
152471|NCT00660660|542148|P2|Overall Study|Incorrect enrollment and other|1
152472|NCT00660660|542149|P1|Overall Study|Incorrect enrollment and other|0
152473|NCT00660660|542148|P2|Overall Study|Withdrawal by Subject|0
152474|NCT00660660|542149|P1|Overall Study|Withdrawal by Subject|3
152475|NCT00660660|542148|P2|Overall Study|Lack of Efficacy|2
152476|NCT00660660|542149|P1|Overall Study|Lack of Efficacy|0
152477|NCT00660660|542148|P2|Overall Study|Lost to Follow-up|6
152478|NCT00660660|542149|P1|Overall Study|Lost to Follow-up|0
152479|NCT00660660|542148|P2|Overall Study|Adverse Event|0
152480|NCT00660660|542149|P1|Overall Study|Adverse Event|1
152481|NCT00660595|542249|P2|Overall Study|Non Specified reasons|0
152482|NCT00660595|542250|P1|Overall Study|Non Specified reasons|5
152483|NCT00660595|542249|P2|Overall Study|Participant left hospital|0
152484|NCT00660595|542250|P1|Overall Study|Participant left hospital|1
152485|NCT00660595|542249|P2|Overall Study|Did not consent to participate in study|8
152486|NCT00660595|542250|P1|Overall Study|Did not consent to participate in study|12
152487|NCT00660595|542249|P2|Overall Study|Lost to Follow-up|1
152488|NCT00660595|542250|P1|Overall Study|Lost to Follow-up|0
152489|NCT00660400|542311|P1|Overall Study|Withdrawal by Subject|1
152490|NCT00660400|542311|P1|Overall Study|Intracranial hemorrhage|1
152491|NCT00660400|542311|P1|Overall Study|Suboptimal organ function|1
152492|NCT00660400|542311|P1|Overall Study|Lack of insurance approval|1
152493|NCT00660387|542320|P2|Overall Study|Protocol Violation|0
152494|NCT00660387|542321|P1|Overall Study|Protocol Violation|1
152495|NCT00660387|542320|P2|Overall Study|Lack of Efficacy|1
152496|NCT00660387|542321|P1|Overall Study|Lack of Efficacy|0
152497|NCT00660387|542320|P2|Overall Study|Adverse Event|2
152498|NCT00660387|542321|P1|Overall Study|Adverse Event|1
152499|NCT00660348|542375|P2|Overall Study|Withdrawal by Subject|0
152500|NCT00660348|542376|P1|Overall Study|Withdrawal by Subject|1
152501|NCT00660309|542384|P2|Overall Study|Withdrawal by Subject|3
152502|NCT00660309|542385|P1|Overall Study|Withdrawal by Subject|0
152503|NCT00660309|542384|P2|Overall Study|Adverse Event|0
152504|NCT00660309|542385|P1|Overall Study|Adverse Event|2
152505|NCT00660192|542426|P2|Overall Study|Lost to Follow-up|3
152506|NCT00660192|542427|P1|Overall Study|Lost to Follow-up|2
152507|NCT00660179|542438|P3|Overall Study|Incorrect randomization|0
152508|NCT00660179|542439|P2|Overall Study|Incorrect randomization|0
152509|NCT00660179|542440|P1|Overall Study|Incorrect randomization|1
152510|NCT00660179|542438|P3|Overall Study|Administrative reason|1
152511|NCT00660179|542439|P2|Overall Study|Administrative reason|0
152512|NCT00660179|542440|P1|Overall Study|Administrative reason|0
152513|NCT00660179|542438|P3|Overall Study|Lost to Follow-up|2
152514|NCT00660179|542439|P2|Overall Study|Lost to Follow-up|5
152515|NCT00660179|542440|P1|Overall Study|Lost to Follow-up|7
152516|NCT00660179|542438|P3|Overall Study|Withdrawal of consent|4
152517|NCT00660179|542439|P2|Overall Study|Withdrawal of consent|6
152518|NCT00660179|542440|P1|Overall Study|Withdrawal of consent|4
152519|NCT00660179|542438|P3|Overall Study|Death|34
152520|NCT00660179|542439|P2|Overall Study|Death|47
152521|NCT00660179|542440|P1|Overall Study|Death|44
152522|NCT00660023|542485|P1|Overall Study|Other Screening Failure|9
152523|NCT00660023|542485|P1|Overall Study|Missed Pregnancy Test|1
152524|NCT00660023|542485|P1|Overall Study|Withdrawal by Subject|1
152525|NCT00660023|542485|P1|Overall Study|Renal Transplantation|3
152526|NCT00660023|542485|P1|Overall Study|Blood Transfusion|5
152527|NCT00660023|542485|P1|Overall Study|Death|8
152528|NCT00660023|542485|P1|Overall Study|Adverse Event|2
152529|NCT00660010|542496|P1|Overall Study|Noncompliance with visit schedule|3
152530|NCT00660010|542496|P1|Overall Study|Adverse Event|1
152531|NCT00660010|542496|P1|Overall Study|Lost to Follow-up|3
152532|NCT00660010|542496|P1|Overall Study|Withdrawal by Subject|2
152533|NCT00659984|542510|P1|Overall Study|Adverse Event|1
152534|NCT00659880|542530|P1|Overall Study|Lost to Follow-up|5
152535|NCT00659815|542537|P2|Overall Study|Withdrawal by Subject|1
152536|NCT00659815|542538|P1|Overall Study|Withdrawal by Subject|1
152537|NCT00659815|542537|P2|Overall Study|Inability to maintain wearing schedule|2
152538|NCT00659815|542538|P1|Overall Study|Inability to maintain wearing schedule|1
152539|NCT00659815|542537|P2|Overall Study|Study related symptoms and complaints|1
152540|NCT00659815|542538|P1|Overall Study|Study related symptoms and complaints|2
152541|NCT00659607|542598|P1|Overall Study|Inconsistent BP measuring date|2
152542|NCT00659607|542598|P1|Overall Study|No recorded efficacy data|15
152543|NCT00659607|542598|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
152544|NCT00659607|542598|P1|Overall Study|Unknown measuring date of blood pressure|85
152545|NCT00659607|542598|P1|Overall Study|No blood pressure recorded|147
152546|NCT00659581|542616|P1|Overall Study|Other|6393
152547|NCT00659581|542616|P1|Overall Study|Lack of Efficacy|1183
152548|NCT00659581|542616|P1|Overall Study|Adverse Event|1006
152549|NCT00659529|542628|P1|Overall Study|Screen failure|9
152550|NCT00659529|542628|P1|Overall Study|Protocol Violation|3
152551|NCT00659529|542628|P1|Overall Study|Withdrawal by Subject|4
152552|NCT00659490|542635|P3|Overall Study|Lost to Follow-up|1
152553|NCT00659490|542636|P2|Overall Study|Lost to Follow-up|0
152554|NCT00659490|542637|P1|Overall Study|Lost to Follow-up|2
152555|NCT00659438|542710|P2|Overall Study|Lost to Follow-up|0
152556|NCT00659438|542711|P1|Overall Study|Lost to Follow-up|1
152557|NCT00659438|542710|P2|Overall Study|Death|6
152558|NCT00659438|542711|P1|Overall Study|Death|11
152559|NCT00659438|542710|P2|Overall Study|Withdrawal by Subject|2
152560|NCT00659438|542711|P1|Overall Study|Withdrawal by Subject|2
152561|NCT00659425|542743|P10|Overall Study|Other|6
152562|NCT00659425|542744|P9|Overall Study|Other|0
152563|NCT00659425|542745|P8|Overall Study|Other|2
152564|NCT00659425|542746|P7|Overall Study|Other|3
152565|NCT00659425|542747|P6|Overall Study|Other|0
152566|NCT00659425|542748|P5|Overall Study|Other|4
152567|NCT00659425|542749|P4|Overall Study|Other|2
152568|NCT00659425|542750|P3|Overall Study|Other|1
152569|NCT00659425|542751|P2|Overall Study|Other|1
152570|NCT00659425|542752|P1|Overall Study|Other|0
152571|NCT00659425|542743|P10|Overall Study|Investigator Discretion|0
152572|NCT00659425|542744|P9|Overall Study|Investigator Discretion|0
152573|NCT00659425|542745|P8|Overall Study|Investigator Discretion|3
152574|NCT00659425|542746|P7|Overall Study|Investigator Discretion|0
152575|NCT00659425|542747|P6|Overall Study|Investigator Discretion|1
152576|NCT00659425|542748|P5|Overall Study|Investigator Discretion|0
152577|NCT00659425|542749|P4|Overall Study|Investigator Discretion|0
152578|NCT00659425|542750|P3|Overall Study|Investigator Discretion|0
152579|NCT00659425|542751|P2|Overall Study|Investigator Discretion|0
152580|NCT00659425|542752|P1|Overall Study|Investigator Discretion|0
152581|NCT00659425|542743|P10|Overall Study|Adverse Event|4
152582|NCT00659425|542744|P9|Overall Study|Adverse Event|1
152583|NCT00659425|542745|P8|Overall Study|Adverse Event|3
152584|NCT00659425|542746|P7|Overall Study|Adverse Event|0
152585|NCT00659425|542747|P6|Overall Study|Adverse Event|1
152586|NCT00659425|542748|P5|Overall Study|Adverse Event|0
152587|NCT00659425|542749|P4|Overall Study|Adverse Event|0
152588|NCT00659425|542750|P3|Overall Study|Adverse Event|0
152589|NCT00659425|542751|P2|Overall Study|Adverse Event|0
152590|NCT00659425|542752|P1|Overall Study|Adverse Event|0
152591|NCT00659425|542743|P10|Overall Study|Death|0
152592|NCT00659425|542744|P9|Overall Study|Death|0
152593|NCT00659425|542745|P8|Overall Study|Death|0
152594|NCT00659425|542746|P7|Overall Study|Death|1
152595|NCT00659425|542747|P6|Overall Study|Death|0
152596|NCT00659425|542748|P5|Overall Study|Death|0
152597|NCT00659425|542749|P4|Overall Study|Death|1
152598|NCT00659425|542750|P3|Overall Study|Death|0
152599|NCT00659425|542751|P2|Overall Study|Death|0
152600|NCT00659425|542752|P1|Overall Study|Death|0
152601|NCT00659425|542743|P10|Overall Study|Disease progression|3
152602|NCT00659425|542744|P9|Overall Study|Disease progression|5
152603|NCT00659425|542745|P8|Overall Study|Disease progression|3
152604|NCT00659425|542746|P7|Overall Study|Disease progression|4
152605|NCT00659425|542747|P6|Overall Study|Disease progression|2
152606|NCT00659425|542748|P5|Overall Study|Disease progression|0
152607|NCT00659425|542749|P4|Overall Study|Disease progression|1
152608|NCT00659425|542750|P3|Overall Study|Disease progression|0
152609|NCT00659425|542751|P2|Overall Study|Disease progression|0
152610|NCT00659425|542752|P1|Overall Study|Disease progression|1
152611|NCT00659373|542983|P2|Overall Study|Assessment Missed|2
152612|NCT00659373|542984|P1|Overall Study|Assessment Missed|2
152613|NCT00659373|542983|P2|Overall Study|Withdrawal by Subject|5
152614|NCT00659373|542984|P1|Overall Study|Withdrawal by Subject|3
152615|NCT00659334|543005|P7|Overall Study|Screen Failure|1
152616|NCT00659334|543006|P6|Overall Study|Screen Failure|0
152617|NCT00659334|543007|P5|Overall Study|Screen Failure|0
152618|NCT00659334|543008|P4|Overall Study|Screen Failure|0
152619|NCT00659334|543009|P3|Overall Study|Screen Failure|0
152620|NCT00659334|543010|P2|Overall Study|Screen Failure|5
152621|NCT00659334|543011|P1|Overall Study|Screen Failure|8
152622|NCT00659269|543038|P2|Overall Study|Physician Decision|1
152623|NCT00659269|543039|P1|Overall Study|Physician Decision|1
152624|NCT00659230|543069|P2|Overall Study|Did not return post-randomization|3
152625|NCT00659230|543070|P1|Overall Study|Did not return post-randomization|2
152626|NCT00659230|543069|P2|Overall Study|Lost source documentation|4
152627|NCT00659230|543070|P1|Overall Study|Lost source documentation|5
152628|NCT00659230|543069|P2|Overall Study|Lost to Follow-up|5
152629|NCT00659230|543070|P1|Overall Study|Lost to Follow-up|2
152630|NCT00659061|543093|P2|Overall Study|Migration due to political unrest|15
152631|NCT00659061|543094|P1|Overall Study|Migration due to political unrest|21
152632|NCT00658996|543112|P2|Second Intervention|Positive slit lamp finding|1
152633|NCT00658996|543113|P1|Second Intervention|Positive slit lamp finding|0
152634|NCT00658996|543112|P2|Second Intervention|Developed a stye on upper lid|0
152635|NCT00658996|543113|P1|Second Intervention|Developed a stye on upper lid|1
152636|NCT00658996|543112|P2|Crossover Period|Ineligible|1
152637|NCT00658996|543113|P1|Crossover Period|Ineligible|1
152638|NCT00658996|543112|P2|Crossover Period|Physician Decision|0
152639|NCT00658996|543113|P1|Crossover Period|Physician Decision|1
152640|NCT00658996|543112|P2|First Intervention|Lack of lenses|1
152641|NCT00658996|543113|P1|First Intervention|Lack of lenses|0
152642|NCT00658996|543112|P2|First Intervention|Positive slit lamp finding|0
152643|NCT00658996|543113|P1|First Intervention|Positive slit lamp finding|1
152644|NCT00658814|543125|P2|Maintenance Therapy|Not eligible|0
152645|NCT00658814|543126|P1|Maintenance Therapy|Not eligible|1
152646|NCT00658814|543125|P2|Maintenance Therapy|Not protocol specified|0
152647|NCT00658814|543126|P1|Maintenance Therapy|Not protocol specified|1
152648|NCT00658814|543125|P2|Maintenance Therapy|Adverse Event|1
152649|NCT00658814|543126|P1|Maintenance Therapy|Adverse Event|1
152650|NCT00658814|543125|P2|Consolidation Therapy|Not eligible|2
152651|NCT00658814|543126|P1|Consolidation Therapy|Not eligible|2
152652|NCT00658814|543125|P2|Consolidation Therapy|Not protocol specified|1
152653|NCT00658814|543126|P1|Consolidation Therapy|Not protocol specified|0
152654|NCT00658814|543125|P2|Remission Induction Chemotherapy|Not eligible|2
152655|NCT00658814|543126|P1|Remission Induction Chemotherapy|Not eligible|1
152656|NCT00658814|543125|P2|Remission Induction Chemotherapy|Not protocol specified|4
152657|NCT00658814|543126|P1|Remission Induction Chemotherapy|Not protocol specified|2
152658|NCT00658814|543125|P2|Remission Induction Chemotherapy|Death|4
152659|NCT00658814|543126|P1|Remission Induction Chemotherapy|Death|1
152660|NCT00658814|543125|P2|Remission Induction Chemotherapy|Progression/Relapse|1
152661|NCT00658814|543126|P1|Remission Induction Chemotherapy|Progression/Relapse|0
152662|NCT00658814|543125|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
152663|NCT00658814|543126|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
152664|NCT00658814|543125|P2|Remission Induction Chemotherapy|Adverse Event|3
152665|NCT00658814|543126|P1|Remission Induction Chemotherapy|Adverse Event|1
152666|NCT00658788|543140|P1|Overall Study|Treatment Discontinuation|32
152667|NCT00658788|543140|P1|Overall Study|Lost to Follow-up|18
152668|NCT00658788|543140|P1|Overall Study|Withdrawal by Subject|13
152669|NCT00658788|543140|P1|Overall Study|Adverse Event|11
152670|NCT00658775|543195|P2|Overall Study|Not specified|8
152671|NCT00658775|543196|P1|Overall Study|Not specified|7
152672|NCT00658775|543195|P2|Overall Study|Withdrawal of consent|7
152673|NCT00658775|543196|P1|Overall Study|Withdrawal of consent|8
152674|NCT00658775|543195|P2|Overall Study|Withdrawal by Subject|4
152675|NCT00658775|543196|P1|Overall Study|Withdrawal by Subject|6
152676|NCT00658775|543195|P2|Overall Study|Lost to Follow-up|18
152677|NCT00658775|543196|P1|Overall Study|Lost to Follow-up|17
152678|NCT00658775|543195|P2|Overall Study|Adverse Event|6
152679|NCT00658775|543196|P1|Overall Study|Adverse Event|4
152680|NCT00658723|543219|P3|Overall Study|Withdrawal by Subject|1
152681|NCT00658723|543220|P2|Overall Study|Withdrawal by Subject|0
152682|NCT00658723|543221|P1|Overall Study|Withdrawal by Subject|1
152683|NCT00658723|543219|P3|Overall Study|Scheduling Issue|0
152684|NCT00658723|543220|P2|Overall Study|Scheduling Issue|1
152685|NCT00658723|543221|P1|Overall Study|Scheduling Issue|1
152686|NCT00658723|543219|P3|Overall Study|Death|4
152687|NCT00658723|543220|P2|Overall Study|Death|1
152688|NCT00658723|543221|P1|Overall Study|Death|2
152689|NCT00658723|543219|P3|Overall Study|Lost to Follow-up|2
152690|NCT00658723|543220|P2|Overall Study|Lost to Follow-up|2
152691|NCT00658723|543221|P1|Overall Study|Lost to Follow-up|0
152692|NCT00658684|543259|P4|Overall Study|Pregnancy|0
152693|NCT00658684|543260|P3|Overall Study|Pregnancy|0
152694|NCT00658684|543261|P2|Overall Study|Pregnancy|1
152695|NCT00658684|543262|P1|Overall Study|Pregnancy|1
152696|NCT00658684|543259|P4|Overall Study|Protocol Violation|0
152697|NCT00658684|543260|P3|Overall Study|Protocol Violation|0
152698|NCT00658684|543261|P2|Overall Study|Protocol Violation|1
152699|NCT00658684|543262|P1|Overall Study|Protocol Violation|1
152700|NCT00658684|543259|P4|Overall Study|Lack of Efficacy|0
152701|NCT00658684|543260|P3|Overall Study|Lack of Efficacy|0
152702|NCT00658684|543261|P2|Overall Study|Lack of Efficacy|1
152703|NCT00658684|543262|P1|Overall Study|Lack of Efficacy|1
152704|NCT00658684|543259|P4|Overall Study|Withdrawal by Subject|1
152705|NCT00658684|543260|P3|Overall Study|Withdrawal by Subject|1
152706|NCT00658684|543261|P2|Overall Study|Withdrawal by Subject|4
152707|NCT00658684|543262|P1|Overall Study|Withdrawal by Subject|6
152708|NCT00658684|543259|P4|Overall Study|Adverse Event|0
152709|NCT00658684|543260|P3|Overall Study|Adverse Event|2
152710|NCT00658684|543261|P2|Overall Study|Adverse Event|8
152711|NCT00658684|543262|P1|Overall Study|Adverse Event|10
152712|NCT00658658|543317|P5|Overall Study|Other|1
152713|NCT00658658|543318|P4|Overall Study|Other|0
152714|NCT00658658|543319|P3|Overall Study|Other|0
152715|NCT00658658|543320|P2|Overall Study|Other|0
152716|NCT00658658|543321|P1|Overall Study|Other|0
152717|NCT00658658|543317|P5|Overall Study|Protocol-specified Criteria|0
152718|NCT00658658|543318|P4|Overall Study|Protocol-specified Criteria|0
152719|NCT00658658|543319|P3|Overall Study|Protocol-specified Criteria|0
152720|NCT00658658|543320|P2|Overall Study|Protocol-specified Criteria|0
152721|NCT00658658|543321|P1|Overall Study|Protocol-specified Criteria|1
152722|NCT00658658|543317|P5|Overall Study|Disease Progression|3
152723|NCT00658658|543318|P4|Overall Study|Disease Progression|1
152724|NCT00658658|543319|P3|Overall Study|Disease Progression|0
152725|NCT00658658|543320|P2|Overall Study|Disease Progression|1
152726|NCT00658658|543321|P1|Overall Study|Disease Progression|0
152727|NCT00658658|543317|P5|Overall Study|Death|1
152728|NCT00658658|543318|P4|Overall Study|Death|1
152729|NCT00658658|543319|P3|Overall Study|Death|0
152730|NCT00658658|543320|P2|Overall Study|Death|0
152731|NCT00658658|543321|P1|Overall Study|Death|4
152732|NCT00658658|543317|P5|Overall Study|Withdrawal by Subject|0
152733|NCT00658658|543318|P4|Overall Study|Withdrawal by Subject|0
152734|NCT00658658|543319|P3|Overall Study|Withdrawal by Subject|0
152735|NCT00658658|543320|P2|Overall Study|Withdrawal by Subject|1
152736|NCT00658658|543321|P1|Overall Study|Withdrawal by Subject|0
152737|NCT00658632|543380|P2|Overall Study|Not specified|8
152738|NCT00658632|543381|P1|Overall Study|Not specified|7
152739|NCT00658632|543380|P2|Overall Study|Pregnancy|1
152740|NCT00658632|543381|P1|Overall Study|Pregnancy|1
152741|NCT00658632|543380|P2|Overall Study|Withdrawal of consent|14
152742|NCT00658632|543381|P1|Overall Study|Withdrawal of consent|8
152743|NCT00658632|543380|P2|Overall Study|Lack of Efficacy|1
152744|NCT00658632|543381|P1|Overall Study|Lack of Efficacy|0
152745|NCT00658632|543380|P2|Overall Study|Withdrawal by Subject|7
152746|NCT00658632|543381|P1|Overall Study|Withdrawal by Subject|10
152747|NCT00658632|543380|P2|Overall Study|Lost to Follow-up|23
152748|NCT00658632|543381|P1|Overall Study|Lost to Follow-up|25
152749|NCT00658632|543380|P2|Overall Study|Adverse Event|11
152750|NCT00658632|543381|P1|Overall Study|Adverse Event|13
152751|NCT00658606|543422|P2|Overall Study|Lack of Compliance|3
152752|NCT00658606|543423|P1|Overall Study|Lack of Compliance|0
152753|NCT00658606|543422|P2|Overall Study|Withdrawal by Subject|16
152754|NCT00658606|543423|P1|Overall Study|Withdrawal by Subject|7
152755|NCT00658606|543422|P2|Overall Study|Lost to Follow-up|0
152756|NCT00658606|543423|P1|Overall Study|Lost to Follow-up|1
152757|NCT00658606|543422|P2|Overall Study|Lack of Efficacy|3
152758|NCT00658606|543423|P1|Overall Study|Lack of Efficacy|6
152759|NCT00658606|543422|P2|Overall Study|Adverse Event|1
152760|NCT00658606|543423|P1|Overall Study|Adverse Event|2
152761|NCT00658567|543452|P3|Overall Study|At Discretion of Sponsor|1
152762|NCT00658567|543453|P2|Overall Study|At Discretion of Sponsor|1
152763|NCT00658567|543454|P1|Overall Study|At Discretion of Sponsor|1
152764|NCT00658567|543452|P3|Overall Study|Physician Decision|0
152765|NCT00658567|543453|P2|Overall Study|Physician Decision|1
152766|NCT00658567|543454|P1|Overall Study|Physician Decision|0
152767|NCT00658567|543452|P3|Overall Study|Voluntary Withdrawal of Consent|2
152768|NCT00658567|543453|P2|Overall Study|Voluntary Withdrawal of Consent|0
152769|NCT00658567|543454|P1|Overall Study|Voluntary Withdrawal of Consent|2
152770|NCT00658567|543452|P3|Overall Study|Adverse Event|3
152771|NCT00658567|543453|P2|Overall Study|Adverse Event|2
152772|NCT00658567|543454|P1|Overall Study|Adverse Event|5
152773|NCT00658541|543465|P2|Washout Period of 7 Days|Withdrawal by Subject|1
152774|NCT00658541|543466|P1|Washout Period of 7 Days|Withdrawal by Subject|0
152775|NCT00658541|543465|P2|Washout Period of 7 Days|Withdrawal by Subject|1
152776|NCT00658541|543466|P1|Washout Period of 7 Days|Withdrawal by Subject|1
152777|NCT00658528|543478|P2|Overall Study|Not specified|4
152778|NCT00658528|543479|P1|Overall Study|Not specified|8
152779|NCT00658528|543478|P2|Overall Study|Withdrawal of consent|6
152780|NCT00658528|543479|P1|Overall Study|Withdrawal of consent|5
152781|NCT00658528|543478|P2|Overall Study|Withdrawal by Subject|6
152782|NCT00658528|543479|P1|Overall Study|Withdrawal by Subject|8
152783|NCT00658528|543478|P2|Overall Study|Lost to Follow-up|22
152784|NCT00658528|543479|P1|Overall Study|Lost to Follow-up|14
152785|NCT00658528|543478|P2|Overall Study|Adverse Event|7
152786|NCT00658528|543479|P1|Overall Study|Adverse Event|5
152787|NCT00658359|543504|P3|Overall Study|Lack of Efficacy|0
152788|NCT00658359|543505|P2|Overall Study|Lack of Efficacy|1
152789|NCT00658359|543506|P1|Overall Study|Lack of Efficacy|0
152790|NCT00658359|543504|P3|Overall Study|Lost to Follow-up|4
152791|NCT00658359|543505|P2|Overall Study|Lost to Follow-up|2
152792|NCT00658359|543506|P1|Overall Study|Lost to Follow-up|2
152793|NCT00658359|543504|P3|Overall Study|Withdrawal by Subject|2
152794|NCT00658359|543505|P2|Overall Study|Withdrawal by Subject|4
152795|NCT00658359|543506|P1|Overall Study|Withdrawal by Subject|7
152796|NCT00658359|543504|P3|Overall Study|Includes protocol Amendments 3 and 4|29
152797|NCT00658359|543505|P2|Overall Study|Includes protocol Amendments 3 and 4|31
152798|NCT00658359|543506|P1|Overall Study|Includes protocol Amendments 3 and 4|2
152799|NCT00658359|543504|P3|Overall Study|Protocol Violation|0
152800|NCT00658359|543505|P2|Overall Study|Protocol Violation|0
152801|NCT00658359|543506|P1|Overall Study|Protocol Violation|1
152802|NCT00658359|543504|P3|Overall Study|Adverse Event|9
152803|NCT00658359|543505|P2|Overall Study|Adverse Event|6
152804|NCT00658359|543506|P1|Overall Study|Adverse Event|13
152805|NCT00658359|543504|P3|Overall Study|Death|2
152806|NCT00658359|543505|P2|Overall Study|Death|1
152807|NCT00658359|543506|P1|Overall Study|Death|3
152808|NCT00658333|543594|P2|Overall Study|Adverse Event|1
152809|NCT00658333|543595|P1|Overall Study|Adverse Event|2
152810|NCT00658320|543605|P2|Extension Study: After Month 24|Subject withdrew consent|0
152811|NCT00658320|543606|P1|Extension Study: After Month 24|Subject withdrew consent|2
152812|NCT00658320|543605|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
152813|NCT00658320|543606|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
152814|NCT00658320|543605|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
152815|NCT00658320|543606|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
152816|NCT00658320|543605|P2|Core Study: 12 Months|Subject withdrew consent|3
152817|NCT00658320|543606|P1|Core Study: 12 Months|Subject withdrew consent|5
152818|NCT00657709|543643|P5|Overall Study|Protocol Violation|2
152819|NCT00657709|543644|P4|Overall Study|Protocol Violation|1
152820|NCT00657709|543645|P3|Overall Study|Protocol Violation|0
152821|NCT00657709|543646|P2|Overall Study|Protocol Violation|2
152822|NCT00657709|543647|P1|Overall Study|Protocol Violation|0
152823|NCT00657709|543643|P5|Overall Study|Lost to Follow-up|21
152824|NCT00657709|543644|P4|Overall Study|Lost to Follow-up|1
152825|NCT00657709|543645|P3|Overall Study|Lost to Follow-up|7
152826|NCT00657709|543646|P2|Overall Study|Lost to Follow-up|9
152827|NCT00657709|543647|P1|Overall Study|Lost to Follow-up|9
152828|NCT00657709|543643|P5|Overall Study|Withdrawal by Subject|9
152829|NCT00657709|543644|P4|Overall Study|Withdrawal by Subject|5
152830|NCT00657709|543645|P3|Overall Study|Withdrawal by Subject|15
152831|NCT00657709|543646|P2|Overall Study|Withdrawal by Subject|15
152832|NCT00657709|543647|P1|Overall Study|Withdrawal by Subject|7
152833|NCT00657709|543643|P5|Overall Study|AE or Death|1
152834|NCT00657709|543644|P4|Overall Study|AE or Death|7
152835|NCT00657709|543645|P3|Overall Study|AE or Death|6
152836|NCT00657709|543646|P2|Overall Study|AE or Death|7
152837|NCT00657709|543647|P1|Overall Study|AE or Death|7
152838|NCT00657618|543696|P1|Overall Study|didn't start due to schedule conflicts|1
152839|NCT00657618|543696|P1|Overall Study|negative for leishmaniasis|2
152840|NCT00657618|543696|P1|Overall Study|Withdrawal by Subject|8
152841|NCT00657618|543696|P1|Overall Study|Adverse Event|32
152842|NCT00657553|543703|P2|Overall Study|low accrual, no analysis run|5
152843|NCT00657553|543704|P1|Overall Study|low accrual, no analysis run|5
152844|NCT00657540|543712|P2|Overall Study|Lost to Follow-up|4
152845|NCT00657540|543713|P1|Overall Study|Lost to Follow-up|1
152846|NCT00657371|543727|P1|Overall Study|Pre-existing medical condition|4
152847|NCT00657371|543727|P1|Overall Study|Device- related reasons|13
152848|NCT00657371|543727|P1|Overall Study|Protocol Violation|2
152849|NCT00657371|543727|P1|Overall Study|Unable to intubate the cecum|5
152850|NCT00657371|543727|P1|Overall Study|Poor bowel preparation|15
152851|NCT00657358|543732|P1|Overall Study|Lack of Efficacy|6
152852|NCT00657267|543744|P1|Overall Study|Adverse Event|9
152853|NCT00657267|543744|P1|Overall Study|Progressive disease|45
152854|NCT00657150|543754|P2|Treatment|Not Specified|15
152855|NCT00657150|543755|P1|Treatment|Not Specified|13
152856|NCT00657150|543754|P2|Treatment|Withdrawal by Subject|20
152857|NCT00657150|543755|P1|Treatment|Withdrawal by Subject|23
152858|NCT00657150|543754|P2|Treatment|Lost to Follow-up|0
152859|NCT00657150|543755|P1|Treatment|Lost to Follow-up|1
152860|NCT00657150|543754|P2|Treatment|Non-compliant with protocol|9
152861|NCT00657150|543755|P1|Treatment|Non-compliant with protocol|10
152862|NCT00657150|543754|P2|Treatment|Adverse Event|53
152863|NCT00657150|543755|P1|Treatment|Adverse Event|60
152864|NCT00657150|543754|P2|Overall Study|Not Specified|38
152865|NCT00657150|543755|P1|Overall Study|Not Specified|38
152866|NCT00657150|543754|P2|Overall Study|Withdrawal by Subject|36
152867|NCT00657150|543755|P1|Overall Study|Withdrawal by Subject|51
152868|NCT00657150|543754|P2|Overall Study|Lost to Follow-up|0
152869|NCT00657150|543755|P1|Overall Study|Lost to Follow-up|2
152870|NCT00657150|543754|P2|Overall Study|Non-compliant with protocol|9
152871|NCT00657150|543755|P1|Overall Study|Non-compliant with protocol|5
152872|NCT00657150|543754|P2|Overall Study|Adverse Event|10
152873|NCT00657150|543755|P1|Overall Study|Adverse Event|19
152874|NCT00657046|543786|P3|Overall Study|Surgery|1
152875|NCT00657046|543787|P2|Overall Study|Surgery|0
152876|NCT00657046|543788|P1|Overall Study|Surgery|0
152877|NCT00657046|543786|P3|Overall Study|Death|1
152878|NCT00657046|543787|P2|Overall Study|Death|0
152879|NCT00657046|543788|P1|Overall Study|Death|0
152880|NCT00657046|543786|P3|Overall Study|Withdrawal by Subject|0
152881|NCT00657046|543787|P2|Overall Study|Withdrawal by Subject|0
152882|NCT00657046|543788|P1|Overall Study|Withdrawal by Subject|1
152883|NCT00657046|543786|P3|Overall Study|Protocol Violation|0
152884|NCT00657046|543787|P2|Overall Study|Protocol Violation|2
152885|NCT00657046|543788|P1|Overall Study|Protocol Violation|2
152886|NCT00657046|543786|P3|Overall Study|Adverse Event|0
152887|NCT00657046|543787|P2|Overall Study|Adverse Event|1
152888|NCT00657046|543788|P1|Overall Study|Adverse Event|1
152889|NCT00657020|543820|P2|PERIOD 1|Adverse Event|1
152890|NCT00657020|543821|P1|PERIOD 1|Adverse Event|0
152891|NCT00656851|543871|P2|Overall Study|Withdrawal by Subject|4
152892|NCT00656851|543872|P1|Overall Study|Withdrawal by Subject|0
152893|NCT00656799|543894|P1|Overall Study|Death|2
152894|NCT00656669|543916|P1|AC (Cycles 6-9)|Did not start segment 3|1
152895|NCT00656669|543916|P1|AC (Cycles 6-9)|Adverse Event|1
152896|NCT00656669|543916|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
152897|NCT00656669|543916|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
152898|NCT00656617|543955|P1|Overall Study|Move to different clinical trial|2
152899|NCT00656617|543955|P1|Overall Study|Insurance Issues|2
152900|NCT00656617|543955|P1|Overall Study|Death|2
152901|NCT00656617|543955|P1|Overall Study|Adverse Event|1
152902|NCT00656513|543964|P3|Overall Study|Missing baseline form|5
152903|NCT00656513|543965|P2|Overall Study|Missing baseline form|5
152904|NCT00656513|543966|P1|Overall Study|Missing baseline form|0
152905|NCT00656513|543964|P3|Overall Study|Treatment completed outside of timeframe|1
152906|NCT00656513|543965|P2|Overall Study|Treatment completed outside of timeframe|3
152907|NCT00656513|543966|P1|Overall Study|Treatment completed outside of timeframe|0
152908|NCT00656513|543964|P3|Overall Study|Incomplete treatment|0
152909|NCT00656513|543965|P2|Overall Study|Incomplete treatment|0
152910|NCT00656513|543966|P1|Overall Study|Incomplete treatment|3
152911|NCT00656513|543964|P3|Overall Study|Missing data|9
152912|NCT00656513|543965|P2|Overall Study|Missing data|11
152913|NCT00656513|543966|P1|Overall Study|Missing data|0
152914|NCT00656513|543964|P3|Overall Study|Death|1
152915|NCT00656513|543965|P2|Overall Study|Death|0
152916|NCT00656513|543966|P1|Overall Study|Death|0
152917|NCT00656513|543964|P3|Overall Study|Withdrawal by Subject|4
152918|NCT00656513|543965|P2|Overall Study|Withdrawal by Subject|11
152919|NCT00656513|543966|P1|Overall Study|Withdrawal by Subject|0
152920|NCT00656513|543964|P3|Overall Study|Protocol Violation|2
152921|NCT00656513|543965|P2|Overall Study|Protocol Violation|0
152922|NCT00656513|543966|P1|Overall Study|Protocol Violation|1
152923|NCT00656474|544013|P1|Overall Study|Other Reason|1
152924|NCT00656370|544031|P1|Overall Study|Alternates|3
152925|NCT00656370|544031|P1|Overall Study|Screen Failures|7
152926|NCT00656292|544039|P2|Overall Study|Screen failure|2
152927|NCT00656292|544040|P1|Overall Study|Screen failure|1
152928|NCT00656292|544039|P2|Overall Study|Withdrawal by Subject|3
152929|NCT00656292|544040|P1|Overall Study|Withdrawal by Subject|2
152930|NCT00656175|544067|P2|Overall Study|Transportation issues|1
152931|NCT00656175|544068|P1|Overall Study|Transportation issues|0
152932|NCT00656175|544067|P2|Overall Study|Adverse Event|0
152933|NCT00656175|544068|P1|Overall Study|Adverse Event|1
152934|NCT00656136|544076|P2|Overall Study|Unknown and others|4
152935|NCT00656136|544077|P1|Overall Study|Unknown and others|4
152936|NCT00656136|544076|P2|Overall Study|Patient refused to take study medication|10
152937|NCT00656136|544077|P1|Overall Study|Patient refused to take study medication|7
152938|NCT00656136|544076|P2|Overall Study|Protocol Violation|3
152939|NCT00656136|544077|P1|Overall Study|Protocol Violation|2
152940|NCT00656136|544076|P2|Overall Study|Other Adverse Event|51
152941|NCT00656136|544077|P1|Overall Study|Other Adverse Event|5
152942|NCT00656136|544076|P2|Overall Study|Progressive disease|322
152943|NCT00656136|544077|P1|Overall Study|Progressive disease|177
152944|NCT00656084|544087|P1|Overall Study|Investigator Request|1
152945|NCT00656084|544087|P1|Overall Study|Patient Request|1
152946|NCT00656084|544087|P1|Overall Study|Withdrawal by Subject|1
152947|NCT00656084|544087|P1|Overall Study|Adverse Event|4
152948|NCT00656058|544094|P1|Overall Study|Withdrawal by Subject|4
152949|NCT00656058|544094|P1|Overall Study|Withdrawal by Subject|2
152950|NCT00656019|544107|P4|Overall Study|Lost to Follow-up|0
152951|NCT00656019|544108|P3|Overall Study|Lost to Follow-up|0
152952|NCT00656019|544109|P2|Overall Study|Lost to Follow-up|1
152953|NCT00656019|544110|P1|Overall Study|Lost to Follow-up|2
152954|NCT00656019|544107|P4|Overall Study|Withdrawal by Subject|0
152955|NCT00656019|544108|P3|Overall Study|Withdrawal by Subject|0
152956|NCT00656019|544109|P2|Overall Study|Withdrawal by Subject|0
152957|NCT00656019|544110|P1|Overall Study|Withdrawal by Subject|2
152958|NCT00656019|544107|P4|Overall Study|Not Eligible|0
152959|NCT00656019|544108|P3|Overall Study|Not Eligible|0
152960|NCT00656019|544109|P2|Overall Study|Not Eligible|0
152961|NCT00656019|544110|P1|Overall Study|Not Eligible|10
152962|NCT00655889|544120|P1|Overall Study|Protocol Violation|1
152963|NCT00655889|544120|P1|Overall Study|Inadequate cell growth|1
152964|NCT00655876|544127|P2|Overall Study|Protocol Violation|7
152965|NCT00655876|544128|P1|Overall Study|Protocol Violation|9
152966|NCT00655863|544147|P3|Overall Study|Lost to Follow-up|1
152967|NCT00655863|544148|P2|Overall Study|Lost to Follow-up|0
152968|NCT00655863|544149|P1|Overall Study|Lost to Follow-up|0
152969|NCT00655850|544208|P1|Overall Study|Withdrawal by Subject|1
152970|NCT00655850|544208|P1|Overall Study|Death|2
152971|NCT00655824|544215|P1|Overall Study|Deterioration of Trial Disease|2
152972|NCT00655824|544215|P1|Overall Study|Withdrawal by Subject|4
152973|NCT00655824|544215|P1|Overall Study|Protocol Violation|1
152974|NCT00655824|544215|P1|Overall Study|Early Termination of Study by Sponsor|74
152975|NCT00655824|544215|P1|Overall Study|Adverse Event|3
152976|NCT00655746|544263|P1|Overall Study|Withdrawal by Subject|1
152977|NCT00655733|544282|P2|Overall Study|Physician Decision|1
152978|NCT00655733|544283|P1|Overall Study|Physician Decision|0
152979|NCT00655733|544282|P2|Overall Study|Withdrawal by Subject|3
152980|NCT00655733|544283|P1|Overall Study|Withdrawal by Subject|3
152981|NCT00655733|544282|P2|Overall Study|Adverse Event|2
152982|NCT00655733|544283|P1|Overall Study|Adverse Event|2
152983|NCT00655733|544282|P2|Overall Study|Lost to Follow-up|2
152984|NCT00655733|544283|P1|Overall Study|Lost to Follow-up|2
152985|NCT00655668|544289|P1|Overall Study|Withdrawal by Subject|2
152986|NCT00655668|544289|P1|Overall Study|New Lymphoma Treatment Started|4
152987|NCT00655668|544289|P1|Overall Study|Other|1
152988|NCT00655668|544289|P1|Overall Study|Study Terminated|9
152989|NCT00655668|544289|P1|Overall Study|Disease Progression|27
152990|NCT00655668|544289|P1|Overall Study|Death|5
152991|NCT00655668|544289|P1|Overall Study|Adverse Event|6
152992|NCT00655629|544316|P2|Overall Study|consent withdrawn|4
152993|NCT00655629|544317|P1|Overall Study|consent withdrawn|6
152994|NCT00655629|544316|P2|Overall Study|Protocol Violation|3
152995|NCT00655629|544317|P1|Overall Study|Protocol Violation|5
152996|NCT00655629|544316|P2|Overall Study|Lost to Follow-up|3
152997|NCT00655629|544317|P1|Overall Study|Lost to Follow-up|4
152998|NCT00655629|544316|P2|Overall Study|Lack of Efficacy|12
152999|NCT00655629|544317|P1|Overall Study|Lack of Efficacy|2
153000|NCT00655629|544316|P2|Overall Study|Adverse Event|1
153001|NCT00655629|544317|P1|Overall Study|Adverse Event|4
153002|NCT00655564|544353|P1|Overall Study|Desired Alternate Therapy|1
153003|NCT00655564|544353|P1|Overall Study|Lost to Follow-up|1
153004|NCT00655564|544353|P1|Overall Study|Adverse Event|1
153005|NCT00655551|544361|P3|Period 4 (up to 7 Days)|Adverse Event|0
153006|NCT00655551|544362|P2|Period 4 (up to 7 Days)|Adverse Event|2
153007|NCT00655551|544363|P1|Period 4 (up to 7 Days)|Adverse Event|0
153008|NCT00655551|544361|P3|Period 3 (up to 7 Days)|Adverse Event|4
153009|NCT00655551|544362|P2|Period 3 (up to 7 Days)|Adverse Event|0
153010|NCT00655551|544363|P1|Period 3 (up to 7 Days)|Adverse Event|0
153011|NCT00655551|544361|P3|Period 2 (up to 7 Days)|Adverse Event|0
153012|NCT00655551|544362|P2|Period 2 (up to 7 Days)|Adverse Event|1
153013|NCT00655551|544363|P1|Period 2 (up to 7 Days)|Adverse Event|0
153014|NCT00655551|544361|P3|All Periods Combined|Adverse Event|4
153015|NCT00655551|544362|P2|All Periods Combined|Adverse Event|3
153016|NCT00655551|544363|P1|All Periods Combined|Adverse Event|0
153017|NCT00655486|544377|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
153018|NCT00655486|544377|P1|Overall Study|Other: Could not tolerate BID dosing|1
153019|NCT00655486|544377|P1|Overall Study|Other: Pregnancy|1
153020|NCT00655486|544377|P1|Overall Study|Unsatisfactory compliance|2
153021|NCT00655486|544377|P1|Overall Study|Protocol Violation|1
153022|NCT00655486|544377|P1|Overall Study|Withdrawal by Subject|4
153023|NCT00655486|544377|P1|Overall Study|Lack of Efficacy|8
153024|NCT00655486|544377|P1|Overall Study|Adverse Event|10
153025|NCT00655356|544384|P2|Overall Study|Other Reason|0
153026|NCT00655356|544385|P1|Overall Study|Other Reason|1
153027|NCT00655356|544384|P2|Overall Study|Protocol Violation|1
153028|NCT00655356|544385|P1|Overall Study|Protocol Violation|2
153029|NCT00655356|544384|P2|Overall Study|Adverse Event|1
153030|NCT00655356|544385|P1|Overall Study|Adverse Event|1
153031|NCT00655356|544384|P2|Overall Study|Sponsor Request|4
153032|NCT00655356|544385|P1|Overall Study|Sponsor Request|10
153033|NCT00655356|544384|P2|Overall Study|Withdrawal by Subject|4
153034|NCT00655356|544385|P1|Overall Study|Withdrawal by Subject|3
153035|NCT00654940|544436|P2|Period 1|Intolerable Pain Level|0
153036|NCT00654940|544437|P1|Period 1|Intolerable Pain Level|1
153037|NCT00654940|544436|P2|Period 1|Adverse Event|1
153038|NCT00654940|544437|P1|Period 1|Adverse Event|0
153039|NCT00654901|544461|P4|Overall Study|Withdrawal by Subject|0
153040|NCT00654901|544462|P3|Overall Study|Withdrawal by Subject|1
153041|NCT00654901|544463|P2|Overall Study|Withdrawal by Subject|0
153042|NCT00654901|544464|P1|Overall Study|Withdrawal by Subject|3
153043|NCT00654901|544461|P4|Overall Study|Lost to Follow-up|0
153044|NCT00654901|544462|P3|Overall Study|Lost to Follow-up|1
153045|NCT00654901|544463|P2|Overall Study|Lost to Follow-up|0
153046|NCT00654901|544464|P1|Overall Study|Lost to Follow-up|1
153047|NCT00654875|544484|P2|Overall Study|Administrative Problems|0
153048|NCT00654875|544485|P1|Overall Study|Administrative Problems|1
153049|NCT00654875|544484|P2|Overall Study|Abnormal Test Procedure Result(s)|0
153050|NCT00654875|544485|P1|Overall Study|Abnormal Test Procedure Result(s)|1
153051|NCT00654875|544484|P2|Overall Study|Lost to Follow-up|3
153052|NCT00654875|544485|P1|Overall Study|Lost to Follow-up|1
153053|NCT00654875|544484|P2|Overall Study|Lack of Efficacy|2
153054|NCT00654875|544485|P1|Overall Study|Lack of Efficacy|2
153055|NCT00654875|544484|P2|Overall Study|Protocol Violation|3
153056|NCT00654875|544485|P1|Overall Study|Protocol Violation|3
153057|NCT00654875|544484|P2|Overall Study|Withdrawal by Subject|4
153058|NCT00654875|544485|P1|Overall Study|Withdrawal by Subject|4
153059|NCT00654875|544484|P2|Overall Study|Adverse Event|5
153060|NCT00654875|544485|P1|Overall Study|Adverse Event|5
153061|NCT00654745|544518|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
153062|NCT00654745|544518|P1|Overall Study|Withdrawal by Subject|10
153063|NCT00654745|544518|P1|Overall Study|Protocol Violation|11
153064|NCT00654745|544518|P1|Overall Study|Lost to Follow-up|7
153065|NCT00654745|544518|P1|Overall Study|Adverse Event|12
153066|NCT00654641|544563|P2|Overall Study|Lost to Follow-up|3
153067|NCT00654641|544564|P1|Overall Study|Lost to Follow-up|2
153068|NCT00654628|544570|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
153069|NCT00654628|544570|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
153070|NCT00654628|544570|P1|6-week Active Treatment Period|Out of window period|1
153071|NCT00654628|544570|P1|6-week Active Treatment Period|Transferred to branch hospital|1
153072|NCT00654628|544570|P1|6-week Active Treatment Period|Lost to Follow-up|10
153073|NCT00654628|544570|P1|6-week Active Treatment Period|Adverse Event|9
153074|NCT00654498|544619|P2|Overall Study|Other reason not defined above|5
153075|NCT00654498|544620|P1|Overall Study|Other reason not defined above|4
153076|NCT00654498|544619|P2|Overall Study|Withdrawal by Subject|0
153077|NCT00654498|544620|P1|Overall Study|Withdrawal by Subject|1
153078|NCT00654498|544619|P2|Overall Study|Lost to Follow-up|5
153079|NCT00654498|544620|P1|Overall Study|Lost to Follow-up|1
153080|NCT00654498|544619|P2|Overall Study|Protocol Violation|1
153081|NCT00654498|544620|P1|Overall Study|Protocol Violation|1
153082|NCT00654498|544619|P2|Overall Study|Adverse Event|1
153083|NCT00654498|544620|P1|Overall Study|Adverse Event|6
153084|NCT00654498|544619|P2|Overall Study|Not Treated|0
153085|NCT00654498|544620|P1|Overall Study|Not Treated|1
153086|NCT00654420|544652|P4|Phase II|Missing Disposition Record|0
153087|NCT00654420|544653|P3|Phase II|Missing Disposition Record|1
153088|NCT00654420|544654|P2|Phase II|Missing Disposition Record|0
153089|NCT00654420|544655|P1|Phase II|Missing Disposition Record|0
153090|NCT00654420|544652|P4|Phase II|Withdrawal by Subject|1
153091|NCT00654420|544653|P3|Phase II|Withdrawal by Subject|4
153092|NCT00654420|544654|P2|Phase II|Withdrawal by Subject|0
153093|NCT00654420|544655|P1|Phase II|Withdrawal by Subject|0
153094|NCT00654420|544652|P4|Phase II|Progressive Disease|29
153095|NCT00654420|544653|P3|Phase II|Progressive Disease|29
153096|NCT00654420|544654|P2|Phase II|Progressive Disease|0
153097|NCT00654420|544655|P1|Phase II|Progressive Disease|0
153098|NCT00654420|544652|P4|Phase II|Physician Decision|4
153099|NCT00654420|544653|P3|Phase II|Physician Decision|0
153100|NCT00654420|544654|P2|Phase II|Physician Decision|0
153101|NCT00654420|544655|P1|Phase II|Physician Decision|0
153102|NCT00654420|544652|P4|Phase II|Lost to Follow-up|1
153103|NCT00654420|544653|P3|Phase II|Lost to Follow-up|0
153104|NCT00654420|544654|P2|Phase II|Lost to Follow-up|0
153105|NCT00654420|544655|P1|Phase II|Lost to Follow-up|0
153106|NCT00654420|544652|P4|Phase II|Adverse Event|3
153107|NCT00654420|544653|P3|Phase II|Adverse Event|3
153108|NCT00654420|544654|P2|Phase II|Adverse Event|0
153109|NCT00654420|544655|P1|Phase II|Adverse Event|0
153110|NCT00654420|544652|P4|Phase I (Dose Escalation)|Progressive Disease|0
153111|NCT00654420|544653|P3|Phase I (Dose Escalation)|Progressive Disease|0
153112|NCT00654420|544654|P2|Phase I (Dose Escalation)|Progressive Disease|15
153113|NCT00654420|544655|P1|Phase I (Dose Escalation)|Progressive Disease|4
153114|NCT00654420|544652|P4|Phase I (Dose Escalation)|Adverse Event|0
153115|NCT00654420|544653|P3|Phase I (Dose Escalation)|Adverse Event|0
153116|NCT00654420|544654|P2|Phase I (Dose Escalation)|Adverse Event|1
153117|NCT00654420|544655|P1|Phase I (Dose Escalation)|Adverse Event|0
153118|NCT00654381|544681|P6|Extension Stage|Closure of the trial site|1
153119|NCT00654381|544682|P5|Extension Stage|Closure of the trial site|1
153120|NCT00654381|544683|P4|Extension Stage|Closure of the trial site|0
153121|NCT00654381|544684|P3|Extension Stage|Closure of the trial site|0
153122|NCT00654381|544685|P2|Extension Stage|Closure of the trial site|0
153123|NCT00654381|544686|P1|Extension Stage|Closure of the trial site|0
153124|NCT00654381|544681|P6|Extension Stage|Withdrawal by Subject|1
153125|NCT00654381|544682|P5|Extension Stage|Withdrawal by Subject|1
153126|NCT00654381|544683|P4|Extension Stage|Withdrawal by Subject|1
153127|NCT00654381|544684|P3|Extension Stage|Withdrawal by Subject|1
153128|NCT00654381|544685|P2|Extension Stage|Withdrawal by Subject|0
153129|NCT00654381|544686|P1|Extension Stage|Withdrawal by Subject|0
153130|NCT00654381|544681|P6|Extension Stage|Lack of Efficacy|0
153131|NCT00654381|544682|P5|Extension Stage|Lack of Efficacy|0
153132|NCT00654381|544683|P4|Extension Stage|Lack of Efficacy|0
153133|NCT00654381|544684|P3|Extension Stage|Lack of Efficacy|1
153134|NCT00654381|544685|P2|Extension Stage|Lack of Efficacy|0
153135|NCT00654381|544686|P1|Extension Stage|Lack of Efficacy|0
153136|NCT00654381|544681|P6|Extension Stage|Protocol Violation|0
153137|NCT00654381|544682|P5|Extension Stage|Protocol Violation|0
153138|NCT00654381|544683|P4|Extension Stage|Protocol Violation|1
153139|NCT00654381|544684|P3|Extension Stage|Protocol Violation|0
153140|NCT00654381|544685|P2|Extension Stage|Protocol Violation|0
153141|NCT00654381|544686|P1|Extension Stage|Protocol Violation|0
153142|NCT00654381|544681|P6|Extension Stage|Adverse Event|1
153143|NCT00654381|544682|P5|Extension Stage|Adverse Event|1
153144|NCT00654381|544683|P4|Extension Stage|Adverse Event|7
153145|NCT00654381|544684|P3|Extension Stage|Adverse Event|9
153146|NCT00654381|544685|P2|Extension Stage|Adverse Event|2
153147|NCT00654381|544686|P1|Extension Stage|Adverse Event|1
153148|NCT00654381|544681|P6|2nd Stage|Investigator's decision|0
153149|NCT00654381|544682|P5|2nd Stage|Investigator's decision|0
153150|NCT00654381|544683|P4|2nd Stage|Investigator's decision|1
153151|NCT00654381|544684|P3|2nd Stage|Investigator's decision|1
153152|NCT00654381|544685|P2|2nd Stage|Investigator's decision|0
153153|NCT00654381|544686|P1|2nd Stage|Investigator's decision|0
153154|NCT00654381|544681|P6|2nd Stage|Withdrawal by Subject|1
153155|NCT00654381|544682|P5|2nd Stage|Withdrawal by Subject|1
153156|NCT00654381|544683|P4|2nd Stage|Withdrawal by Subject|0
153157|NCT00654381|544684|P3|2nd Stage|Withdrawal by Subject|0
153158|NCT00654381|544685|P2|2nd Stage|Withdrawal by Subject|0
153159|NCT00654381|544686|P1|2nd Stage|Withdrawal by Subject|0
153160|NCT00654381|544681|P6|2nd Stage|Adverse Event|2
153161|NCT00654381|544682|P5|2nd Stage|Adverse Event|7
153162|NCT00654381|544683|P4|2nd Stage|Adverse Event|3
153163|NCT00654381|544684|P3|2nd Stage|Adverse Event|2
153164|NCT00654381|544685|P2|2nd Stage|Adverse Event|0
153165|NCT00654381|544686|P1|2nd Stage|Adverse Event|2
153166|NCT00654381|544681|P6|1st Stage|Investigator's decision|0
153167|NCT00654381|544682|P5|1st Stage|Investigator's decision|0
153168|NCT00654381|544683|P4|1st Stage|Investigator's decision|1
153169|NCT00654381|544684|P3|1st Stage|Investigator's decision|0
153170|NCT00654381|544685|P2|1st Stage|Investigator's decision|0
153171|NCT00654381|544686|P1|1st Stage|Investigator's decision|0
153172|NCT00654381|544681|P6|1st Stage|Withdrawal by Subject|1
153173|NCT00654381|544682|P5|1st Stage|Withdrawal by Subject|0
153174|NCT00654381|544683|P4|1st Stage|Withdrawal by Subject|1
153175|NCT00654381|544684|P3|1st Stage|Withdrawal by Subject|0
153176|NCT00654381|544685|P2|1st Stage|Withdrawal by Subject|0
153177|NCT00654381|544686|P1|1st Stage|Withdrawal by Subject|0
153178|NCT00654381|544681|P6|1st Stage|Adverse Event|1
153179|NCT00654381|544682|P5|1st Stage|Adverse Event|2
153180|NCT00654381|544683|P4|1st Stage|Adverse Event|3
153181|NCT00654381|544684|P3|1st Stage|Adverse Event|3
153182|NCT00654381|544685|P2|1st Stage|Adverse Event|3
153183|NCT00654381|544686|P1|1st Stage|Adverse Event|3
153184|NCT00654368|544723|P3|Overall Study|Adverse Event|6
153185|NCT00654368|544724|P2|Overall Study|Adverse Event|9
153186|NCT00654368|544725|P1|Overall Study|Adverse Event|14
153187|NCT00654368|544723|P3|Overall Study|Other|3
153188|NCT00654368|544724|P2|Overall Study|Other|2
153189|NCT00654368|544725|P1|Overall Study|Other|0
153190|NCT00654368|544723|P3|Overall Study|Pregnancy|2
153191|NCT00654368|544724|P2|Overall Study|Pregnancy|0
153192|NCT00654368|544725|P1|Overall Study|Pregnancy|0
153193|NCT00654368|544723|P3|Overall Study|Death|0
153194|NCT00654368|544724|P2|Overall Study|Death|0
153195|NCT00654368|544725|P1|Overall Study|Death|1
153196|NCT00654368|544723|P3|Overall Study|Physician Decision|2
153197|NCT00654368|544724|P2|Overall Study|Physician Decision|0
153198|NCT00654368|544725|P1|Overall Study|Physician Decision|0
153199|NCT00654368|544723|P3|Overall Study|Requirement for alternative therapy|1
153200|NCT00654368|544724|P2|Overall Study|Requirement for alternative therapy|1
153201|NCT00654368|544725|P1|Overall Study|Requirement for alternative therapy|1
153202|NCT00654368|544723|P3|Overall Study|Disease progression|13
153203|NCT00654368|544724|P2|Overall Study|Disease progression|31
153204|NCT00654368|544725|P1|Overall Study|Disease progression|21
153205|NCT00654368|544723|P3|Overall Study|Withdrawal by Subject|2
153206|NCT00654368|544724|P2|Overall Study|Withdrawal by Subject|2
153207|NCT00654368|544725|P1|Overall Study|Withdrawal by Subject|5
153208|NCT00654368|544723|P3|Overall Study|Non-compliance|2
153209|NCT00654368|544724|P2|Overall Study|Non-compliance|1
153210|NCT00654368|544725|P1|Overall Study|Non-compliance|2
153211|NCT00654368|544723|P3|Overall Study|Protocol deviation|1
153212|NCT00654368|544724|P2|Overall Study|Protocol deviation|2
153213|NCT00654368|544725|P1|Overall Study|Protocol deviation|3
153214|NCT00654368|544723|P3|Overall Study|Ineligibility determined|0
153215|NCT00654368|544724|P2|Overall Study|Ineligibility determined|0
153216|NCT00654368|544725|P1|Overall Study|Ineligibility determined|6
153217|NCT00654355|544758|P2|Overall Study|Lost to Follow-up|2
153218|NCT00654355|544759|P1|Overall Study|Lost to Follow-up|2
153219|NCT00654186|544790|P1|Overall Study|Withdrawal by Subject|5
153220|NCT00654095|544815|P1|Overall Study|Did not meet inclusion criteria|1
153221|NCT00654095|544815|P1|Overall Study|Adverse reaction did not improve (5)|4
153222|NCT00654095|544815|P1|Overall Study|Elevated alanine aminotransferase (4)|7
153223|NCT00654095|544815|P1|Overall Study|Withdrawal by Subject|5
153224|NCT00654095|544815|P1|Overall Study|Adverse Event|11
153225|NCT00654095|544815|P1|Overall Study|Elevated alanine aminotransferase (3)|1
153226|NCT00654095|544815|P1|Overall Study|Elevated triglyceride level (2)|1
153227|NCT00654095|544815|P1|Overall Study|Drop in low density lipoprotein (1)|2
153228|NCT00654004|544825|P2|Overall Study|Lost to Follow-up|0
153229|NCT00654004|544826|P1|Overall Study|Lost to Follow-up|1
153230|NCT00653939|544842|P2|Overall Study|Not Specified|6
153231|NCT00653939|544843|P1|Overall Study|Not Specified|2
153232|NCT00653939|544842|P2|Overall Study|Disease Progression|3
153233|NCT00653939|544843|P1|Overall Study|Disease Progression|2
153234|NCT00653939|544842|P2|Overall Study|Physician Decision|0
153235|NCT00653939|544843|P1|Overall Study|Physician Decision|4
153236|NCT00653939|544842|P2|Overall Study|Withdrawal by Subject|3
153237|NCT00653939|544843|P1|Overall Study|Withdrawal by Subject|3
153238|NCT00653939|544842|P2|Overall Study|Adverse Event|3
153239|NCT00653939|544843|P1|Overall Study|Adverse Event|1
153240|NCT00653523|544868|P1|Overall Study|Adverse reaction did not improve (4)|1
153241|NCT00653523|544868|P1|Overall Study|Elevated alanine aminotransferase (3)|2
153242|NCT00653523|544868|P1|Overall Study|Withdrawal by Subject|6
153243|NCT00653523|544868|P1|Overall Study|Adverse Event|7
153244|NCT00653523|544868|P1|Overall Study|Elevated creatine phosphokinase (2)|1
153245|NCT00653523|544868|P1|Overall Study|Drop in low density lipoprotein (1)|2
153246|NCT00653328|544872|P1|Overall Study|Drug manufacturer no longing making drug|2
153247|NCT00653328|544872|P1|Overall Study|Disease progression|10
153248|NCT00653328|544872|P1|Overall Study|Adverse Event|2
153249|NCT00653328|544872|P1|Overall Study|Withdrawal by Subject|1
153250|NCT00653263|544879|P1|Overall Study|Physician Decision|1
153251|NCT00653263|544879|P1|Overall Study|Withdrawal by Subject|1
153252|NCT00653224|544887|P2|Overall Study|Other|4
153253|NCT00653224|544888|P1|Overall Study|Other|2
153254|NCT00653224|544887|P2|Overall Study|Lost to Follow-up|0
153255|NCT00653224|544888|P1|Overall Study|Lost to Follow-up|1
153256|NCT00653224|544887|P2|Overall Study|Loss of efficacy|0
153257|NCT00653224|544888|P1|Overall Study|Loss of efficacy|1
153258|NCT00653224|544887|P2|Overall Study|Lack of Efficacy|2
153259|NCT00653224|544888|P1|Overall Study|Lack of Efficacy|1
153260|NCT00653224|544887|P2|Overall Study|Adverse Event|1
153261|NCT00653224|544888|P1|Overall Study|Adverse Event|2
153262|NCT00653159|545074|P2|Overall Study|Lost to Follow-up|2
153263|NCT00653159|545075|P1|Overall Study|Lost to Follow-up|1
153264|NCT00653159|545074|P2|Overall Study|Adverse Event|1
153265|NCT00653159|545075|P1|Overall Study|Adverse Event|4
153266|NCT00653068|545102|P1|Overall Study|Ineligible|2
153267|NCT00653068|545102|P1|Overall Study|Withdrawal by Subject|1
153268|NCT00653068|545102|P1|Overall Study|Physician Decision|4
153269|NCT00653068|545102|P1|Overall Study|Lack of Efficacy|34
153270|NCT00653068|545102|P1|Overall Study|Death|9
153271|NCT00652938|545116|P3|Overall Study|fear of blood sampling|0
153272|NCT00652938|545117|P2|Overall Study|fear of blood sampling|1
153273|NCT00652938|545118|P1|Overall Study|fear of blood sampling|0
153274|NCT00652938|545116|P3|Overall Study|Lost to Follow-up|2
153275|NCT00652938|545117|P2|Overall Study|Lost to Follow-up|0
153276|NCT00652938|545118|P1|Overall Study|Lost to Follow-up|0
153277|NCT00652938|545116|P3|Overall Study|Withdrawal by Subject|1
153278|NCT00652938|545117|P2|Overall Study|Withdrawal by Subject|6
153279|NCT00652938|545118|P1|Overall Study|Withdrawal by Subject|0
153280|NCT00652938|545116|P3|Overall Study|Adverse Event|2
153281|NCT00652938|545117|P2|Overall Study|Adverse Event|0
153282|NCT00652938|545118|P1|Overall Study|Adverse Event|1
153283|NCT00652899|545183|P1|Overall Study|Treating physician decision|1
153284|NCT00652899|545183|P1|Overall Study|Death|1
153285|NCT00652834|545193|P1|Overall Study|Lost to Follow-up|2
153286|NCT00652834|545193|P1|Overall Study|Withdrawal by Subject|3
153287|NCT00652626|545204|P7|Extension Phase|Death|1
153288|NCT00652626|545205|P6|Extension Phase|Death|1
153289|NCT00652626|545206|P5|Extension Phase|Death|0
153290|NCT00652626|545207|P4|Extension Phase|Death|0
153291|NCT00652626|545208|P3|Extension Phase|Death|0
153292|NCT00652626|545209|P2|Extension Phase|Death|0
153293|NCT00652626|545210|P1|Extension Phase|Death|0
153294|NCT00652626|545204|P7|Extension Phase|Physician Decision|1
153295|NCT00652626|545205|P6|Extension Phase|Physician Decision|1
153296|NCT00652626|545206|P5|Extension Phase|Physician Decision|0
153297|NCT00652626|545207|P4|Extension Phase|Physician Decision|0
153298|NCT00652626|545208|P3|Extension Phase|Physician Decision|0
153299|NCT00652626|545209|P2|Extension Phase|Physician Decision|0
153300|NCT00652626|545210|P1|Extension Phase|Physician Decision|0
153301|NCT00652626|545204|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
153302|NCT00652626|545205|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
153303|NCT00652626|545206|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
153304|NCT00652626|545207|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
153305|NCT00652626|545208|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
153306|NCT00652626|545209|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
153307|NCT00652626|545210|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
153308|NCT00652626|545204|P7|Extension Phase|Adverse Event|1
153309|NCT00652626|545205|P6|Extension Phase|Adverse Event|2
153310|NCT00652626|545206|P5|Extension Phase|Adverse Event|0
153311|NCT00652626|545207|P4|Extension Phase|Adverse Event|0
153312|NCT00652626|545208|P3|Extension Phase|Adverse Event|0
153313|NCT00652626|545209|P2|Extension Phase|Adverse Event|0
153314|NCT00652626|545210|P1|Extension Phase|Adverse Event|0
153315|NCT00652626|545204|P7|Extension Phase|Withdrawal by Subject|0
153316|NCT00652626|545205|P6|Extension Phase|Withdrawal by Subject|2
153317|NCT00652626|545206|P5|Extension Phase|Withdrawal by Subject|0
153318|NCT00652626|545207|P4|Extension Phase|Withdrawal by Subject|0
153319|NCT00652626|545208|P3|Extension Phase|Withdrawal by Subject|0
153320|NCT00652626|545209|P2|Extension Phase|Withdrawal by Subject|0
153321|NCT00652626|545210|P1|Extension Phase|Withdrawal by Subject|0
153322|NCT00652626|545204|P7|Initial Treatment Phase|Lost to Follow-up|0
153323|NCT00652626|545205|P6|Initial Treatment Phase|Lost to Follow-up|0
153324|NCT00652626|545206|P5|Initial Treatment Phase|Lost to Follow-up|1
153325|NCT00652626|545207|P4|Initial Treatment Phase|Lost to Follow-up|0
153326|NCT00652626|545208|P3|Initial Treatment Phase|Lost to Follow-up|0
153327|NCT00652626|545209|P2|Initial Treatment Phase|Lost to Follow-up|0
153328|NCT00652626|545210|P1|Initial Treatment Phase|Lost to Follow-up|0
153329|NCT00652626|545204|P7|Initial Treatment Phase|Sponsor Request|0
153330|NCT00652626|545205|P6|Initial Treatment Phase|Sponsor Request|0
153331|NCT00652626|545206|P5|Initial Treatment Phase|Sponsor Request|0
153332|NCT00652626|545207|P4|Initial Treatment Phase|Sponsor Request|0
153333|NCT00652626|545208|P3|Initial Treatment Phase|Sponsor Request|1
153334|NCT00652626|545209|P2|Initial Treatment Phase|Sponsor Request|0
153335|NCT00652626|545210|P1|Initial Treatment Phase|Sponsor Request|0
153336|NCT00652626|545204|P7|Initial Treatment Phase|Physician Decision|0
153337|NCT00652626|545205|P6|Initial Treatment Phase|Physician Decision|0
153338|NCT00652626|545206|P5|Initial Treatment Phase|Physician Decision|1
153339|NCT00652626|545207|P4|Initial Treatment Phase|Physician Decision|0
153340|NCT00652626|545208|P3|Initial Treatment Phase|Physician Decision|0
153341|NCT00652626|545209|P2|Initial Treatment Phase|Physician Decision|0
153342|NCT00652626|545210|P1|Initial Treatment Phase|Physician Decision|0
153343|NCT00652626|545204|P7|Initial Treatment Phase|Protocol Violation|0
153344|NCT00652626|545205|P6|Initial Treatment Phase|Protocol Violation|0
153345|NCT00652626|545206|P5|Initial Treatment Phase|Protocol Violation|0
153346|NCT00652626|545207|P4|Initial Treatment Phase|Protocol Violation|1
153347|NCT00652626|545208|P3|Initial Treatment Phase|Protocol Violation|0
153348|NCT00652626|545209|P2|Initial Treatment Phase|Protocol Violation|0
153349|NCT00652626|545210|P1|Initial Treatment Phase|Protocol Violation|0
153350|NCT00652626|545204|P7|Initial Treatment Phase|Adverse Event|0
153351|NCT00652626|545205|P6|Initial Treatment Phase|Adverse Event|0
153352|NCT00652626|545206|P5|Initial Treatment Phase|Adverse Event|1
153353|NCT00652626|545207|P4|Initial Treatment Phase|Adverse Event|0
153354|NCT00652626|545208|P3|Initial Treatment Phase|Adverse Event|0
153355|NCT00652626|545209|P2|Initial Treatment Phase|Adverse Event|0
153356|NCT00652626|545210|P1|Initial Treatment Phase|Adverse Event|0
153357|NCT00652366|545279|P5|Overall Study|Not specified|0
153358|NCT00652366|545280|P4|Overall Study|Not specified|4
153359|NCT00652366|545281|P3|Overall Study|Not specified|3
153360|NCT00652366|545282|P2|Overall Study|Not specified|2
153361|NCT00652366|545283|P1|Overall Study|Not specified|5
153362|NCT00652366|545279|P5|Overall Study|Refused treatment|5
153363|NCT00652366|545280|P4|Overall Study|Refused treatment|17
153364|NCT00652366|545281|P3|Overall Study|Refused treatment|6
153365|NCT00652366|545282|P2|Overall Study|Refused treatment|7
153366|NCT00652366|545283|P1|Overall Study|Refused treatment|3
153367|NCT00652366|545279|P5|Overall Study|Protocol Violation|0
153368|NCT00652366|545280|P4|Overall Study|Protocol Violation|0
153369|NCT00652366|545281|P3|Overall Study|Protocol Violation|0
153370|NCT00652366|545282|P2|Overall Study|Protocol Violation|0
153371|NCT00652366|545283|P1|Overall Study|Protocol Violation|1
153372|NCT00652366|545279|P5|Overall Study|Violation of Selection Criteria|0
153373|NCT00652366|545280|P4|Overall Study|Violation of Selection Criteria|0
153374|NCT00652366|545281|P3|Overall Study|Violation of Selection Criteria|1
153375|NCT00652366|545282|P2|Overall Study|Violation of Selection Criteria|0
153376|NCT00652366|545283|P1|Overall Study|Violation of Selection Criteria|0
153377|NCT00652366|545279|P5|Overall Study|Lack of Efficacy|13
153378|NCT00652366|545280|P4|Overall Study|Lack of Efficacy|133
153379|NCT00652366|545281|P3|Overall Study|Lack of Efficacy|53
153380|NCT00652366|545282|P2|Overall Study|Lack of Efficacy|58
153381|NCT00652366|545283|P1|Overall Study|Lack of Efficacy|84
153382|NCT00652366|545279|P5|Overall Study|Death|5
153383|NCT00652366|545280|P4|Overall Study|Death|8
153384|NCT00652366|545281|P3|Overall Study|Death|1
153385|NCT00652366|545282|P2|Overall Study|Death|4
153386|NCT00652366|545283|P1|Overall Study|Death|5
153387|NCT00652366|545279|P5|Overall Study|Adverse Event|13
153388|NCT00652366|545280|P4|Overall Study|Adverse Event|17
153389|NCT00652366|545281|P3|Overall Study|Adverse Event|7
153390|NCT00652366|545282|P2|Overall Study|Adverse Event|4
153391|NCT00652366|545283|P1|Overall Study|Adverse Event|8
153392|NCT00652340|545318|P2|Overall Study|Had not progressed.|3
153393|NCT00652340|545319|P1|Overall Study|Had not progressed.|4
153394|NCT00652327|545329|P2|Overall Study|Lost to Follow-up|3
153395|NCT00652327|545330|P1|Overall Study|Lost to Follow-up|0
153396|NCT00652327|545329|P2|Overall Study|Adverse Event|2
153397|NCT00652327|545330|P1|Overall Study|Adverse Event|0
153398|NCT00652093|545372|P6|Overall Study|Physician Decision|0
153399|NCT00652093|545373|P5|Overall Study|Physician Decision|1
153400|NCT00652093|545374|P4|Overall Study|Physician Decision|0
153401|NCT00652093|545375|P3|Overall Study|Physician Decision|0
153402|NCT00652093|545376|P2|Overall Study|Physician Decision|0
153403|NCT00652093|545377|P1|Overall Study|Physician Decision|0
153404|NCT00652093|545372|P6|Overall Study|Withdrawal by Subject|0
153405|NCT00652093|545373|P5|Overall Study|Withdrawal by Subject|1
153406|NCT00652093|545374|P4|Overall Study|Withdrawal by Subject|0
153407|NCT00652093|545375|P3|Overall Study|Withdrawal by Subject|1
153408|NCT00652093|545376|P2|Overall Study|Withdrawal by Subject|0
153409|NCT00652093|545377|P1|Overall Study|Withdrawal by Subject|0
153410|NCT00652028|545461|P4|Overall Study|Physician Decision|0
153411|NCT00652028|545462|P3|Overall Study|Physician Decision|1
153412|NCT00652028|545463|P2|Overall Study|Physician Decision|0
153413|NCT00652028|545464|P1|Overall Study|Physician Decision|0
153414|NCT00652028|545461|P4|Overall Study|No Longer Meets Entry Criteria|0
153415|NCT00652028|545462|P3|Overall Study|No Longer Meets Entry Criteria|0
153416|NCT00652028|545463|P2|Overall Study|No Longer Meets Entry Criteria|1
153417|NCT00652028|545464|P1|Overall Study|No Longer Meets Entry Criteria|0
153418|NCT00652028|545461|P4|Overall Study|Adverse Event|0
153419|NCT00652028|545462|P3|Overall Study|Adverse Event|0
153420|NCT00652028|545463|P2|Overall Study|Adverse Event|0
153421|NCT00652028|545464|P1|Overall Study|Adverse Event|1
153422|NCT00651924|545508|P2|Overall Study|Withdrawal by Subject|5
153423|NCT00651924|545509|P1|Overall Study|Withdrawal by Subject|0
153424|NCT00651924|545508|P2|Overall Study|Withdrawal by PI|2
153425|NCT00651924|545509|P1|Overall Study|Withdrawal by PI|0
153426|NCT00651820|545515|P1|Overall Study|Lost to Follow-up|2
153427|NCT00651755|545547|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
153428|NCT00651755|545548|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
153429|NCT00651755|545547|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
153430|NCT00651755|545548|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
153431|NCT00651313|545593|P2|Overall Study|Adminstrative Discontinuation|3
153432|NCT00651313|545594|P1|Overall Study|Adminstrative Discontinuation|2
153433|NCT00651313|545593|P2|Overall Study|Lost to Follow-up|1
153434|NCT00651313|545594|P1|Overall Study|Lost to Follow-up|1
153435|NCT00651313|545593|P2|Overall Study|Withdrawal by Subject|1
153436|NCT00651313|545594|P1|Overall Study|Withdrawal by Subject|3
153437|NCT00651313|545593|P2|Overall Study|Adverse Event|1
153438|NCT00651313|545594|P1|Overall Study|Adverse Event|0
153439|NCT00651261|545602|P2|Overall Study|Never treated|3
153440|NCT00651261|545603|P1|Overall Study|Never treated|5
153441|NCT00651261|545602|P2|Overall Study|Other disease or participant decisions|23
153442|NCT00651261|545603|P1|Overall Study|Other disease or participant decisions|23
153443|NCT00651261|545602|P2|Overall Study|Alternative therapy|107
153444|NCT00651261|545603|P1|Overall Study|Alternative therapy|109
153445|NCT00651261|545602|P2|Overall Study|Disease progression|58
153446|NCT00651261|545603|P1|Overall Study|Disease progression|58
153447|NCT00651261|545602|P2|Overall Study|Induction failure|35
153448|NCT00651261|545603|P1|Overall Study|Induction failure|24
153449|NCT00651261|545602|P2|Overall Study|Withdrawal by Subject|40
153450|NCT00651261|545603|P1|Overall Study|Withdrawal by Subject|22
153451|NCT00651261|545602|P2|Overall Study|Death|18
153452|NCT00651261|545603|P1|Overall Study|Death|18
153453|NCT00651261|545602|P2|Overall Study|Adverse Event|22
153454|NCT00651261|545603|P1|Overall Study|Adverse Event|32
153455|NCT00651183|545619|P2|Overall Study|missing|0
153456|NCT00651183|545620|P1|Overall Study|missing|1
153457|NCT00651183|545619|P2|Overall Study|Other reasons|2
153458|NCT00651183|545620|P1|Overall Study|Other reasons|4
153459|NCT00651183|545619|P2|Overall Study|Lost to Follow-up|1
153460|NCT00651183|545620|P1|Overall Study|Lost to Follow-up|3
153461|NCT00651183|545619|P2|Overall Study|Withdrawal by Subject|3
153462|NCT00651183|545620|P1|Overall Study|Withdrawal by Subject|6
153463|NCT00651183|545619|P2|Overall Study|Tolerability insufficient +Patients wish|1
153464|NCT00651183|545620|P1|Overall Study|Tolerability insufficient +Patients wish|0
153465|NCT00651183|545619|P2|Overall Study|Tolerability insufficient|2
153466|NCT00651183|545620|P1|Overall Study|Tolerability insufficient|5
153467|NCT00651183|545619|P2|Overall Study|Efficacy insufficient + patients wish|1
153468|NCT00651183|545620|P1|Overall Study|Efficacy insufficient + patients wish|0
153469|NCT00651183|545619|P2|Overall Study|Lack of Efficacy|0
153470|NCT00651183|545620|P1|Overall Study|Lack of Efficacy|1
153471|NCT00651157|545632|P1|Overall Study|Protocol Violation|1
153472|NCT00651157|545632|P1|Overall Study|Death|1
153473|NCT00651118|545642|P4|Overall Study|Withdrawal by Subject|1
153474|NCT00651118|545643|P3|Overall Study|Withdrawal by Subject|1
153475|NCT00651118|545644|P2|Overall Study|Withdrawal by Subject|1
153476|NCT00651118|545645|P1|Overall Study|Withdrawal by Subject|0
153477|NCT00651118|545642|P4|Overall Study|administrative|1
153478|NCT00651118|545643|P3|Overall Study|administrative|2
153479|NCT00651118|545644|P2|Overall Study|administrative|4
153480|NCT00651118|545645|P1|Overall Study|administrative|1
153481|NCT00651118|545642|P4|Overall Study|Lost to Follow-up|2
153482|NCT00651118|545643|P3|Overall Study|Lost to Follow-up|1
153483|NCT00651118|545644|P2|Overall Study|Lost to Follow-up|0
153484|NCT00651118|545645|P1|Overall Study|Lost to Follow-up|2
153485|NCT00651118|545642|P4|Overall Study|Protocol Violation|2
153486|NCT00651118|545643|P3|Overall Study|Protocol Violation|6
153487|NCT00651118|545644|P2|Overall Study|Protocol Violation|2
153488|NCT00651118|545645|P1|Overall Study|Protocol Violation|2
153489|NCT00651118|545642|P4|Overall Study|Adverse Event|1
153490|NCT00651118|545643|P3|Overall Study|Adverse Event|1
153491|NCT00651118|545644|P2|Overall Study|Adverse Event|0
153492|NCT00651118|545645|P1|Overall Study|Adverse Event|4
153493|NCT00650845|545708|P2|Overall Study|Protocol Violation|13
153494|NCT00650845|545709|P1|Overall Study|Protocol Violation|0
153495|NCT00650845|545708|P2|Overall Study|Withdrawal by Subject|0
153496|NCT00650845|545709|P1|Overall Study|Withdrawal by Subject|5
153497|NCT00650806|545729|P4|Overall Study|Not specified|0
153498|NCT00650806|545730|P3|Overall Study|Not specified|2
153499|NCT00650806|545731|P2|Overall Study|Not specified|1
153500|NCT00650806|545732|P1|Overall Study|Not specified|1
153501|NCT00650806|545729|P4|Overall Study|Study terminated by sponsor|4
153502|NCT00650806|545730|P3|Overall Study|Study terminated by sponsor|5
153503|NCT00650806|545731|P2|Overall Study|Study terminated by sponsor|3
153504|NCT00650806|545732|P1|Overall Study|Study terminated by sponsor|2
153505|NCT00650806|545729|P4|Overall Study|Noncompliance with study drug regimen|0
153506|NCT00650806|545730|P3|Overall Study|Noncompliance with study drug regimen|0
153507|NCT00650806|545731|P2|Overall Study|Noncompliance with study drug regimen|1
153508|NCT00650806|545732|P1|Overall Study|Noncompliance with study drug regimen|1
153509|NCT00650806|545729|P4|Overall Study|Withdrawal by Subject|6
153510|NCT00650806|545730|P3|Overall Study|Withdrawal by Subject|8
153511|NCT00650806|545731|P2|Overall Study|Withdrawal by Subject|5
153512|NCT00650806|545732|P1|Overall Study|Withdrawal by Subject|7
153513|NCT00650806|545729|P4|Overall Study|Pregnancy|1
153514|NCT00650806|545730|P3|Overall Study|Pregnancy|0
153515|NCT00650806|545731|P2|Overall Study|Pregnancy|0
153516|NCT00650806|545732|P1|Overall Study|Pregnancy|0
153517|NCT00650806|545729|P4|Overall Study|Protocol Violation|1
153518|NCT00650806|545730|P3|Overall Study|Protocol Violation|0
153519|NCT00650806|545731|P2|Overall Study|Protocol Violation|0
153520|NCT00650806|545732|P1|Overall Study|Protocol Violation|0
153521|NCT00650806|545729|P4|Overall Study|Lost to Follow-up|10
153522|NCT00650806|545730|P3|Overall Study|Lost to Follow-up|11
153523|NCT00650806|545731|P2|Overall Study|Lost to Follow-up|6
153524|NCT00650806|545732|P1|Overall Study|Lost to Follow-up|7
153525|NCT00650806|545729|P4|Overall Study|Adverse Event|4
153526|NCT00650806|545730|P3|Overall Study|Adverse Event|3
153527|NCT00650806|545731|P2|Overall Study|Adverse Event|5
153528|NCT00650806|545732|P1|Overall Study|Adverse Event|0
153529|NCT00650767|545774|P4|Overall Study|Other|0
153530|NCT00650767|545775|P3|Overall Study|Other|0
153531|NCT00650767|545776|P2|Overall Study|Other|1
153532|NCT00650767|545777|P1|Overall Study|Other|1
153533|NCT00650767|545774|P4|Overall Study|Lost to Follow-up|0
153534|NCT00650767|545775|P3|Overall Study|Lost to Follow-up|1
153535|NCT00650767|545776|P2|Overall Study|Lost to Follow-up|1
153536|NCT00650767|545777|P1|Overall Study|Lost to Follow-up|1
153537|NCT00650767|545774|P4|Overall Study|Withdrawal by Subject|3
153538|NCT00650767|545775|P3|Overall Study|Withdrawal by Subject|3
153539|NCT00650767|545776|P2|Overall Study|Withdrawal by Subject|4
153540|NCT00650767|545777|P1|Overall Study|Withdrawal by Subject|2
153541|NCT00650767|545774|P4|Overall Study|Death|0
153542|NCT00650767|545775|P3|Overall Study|Death|0
153543|NCT00650767|545776|P2|Overall Study|Death|0
153544|NCT00650767|545777|P1|Overall Study|Death|1
153545|NCT00650767|545774|P4|Overall Study|Adverse Event|8
153546|NCT00650767|545775|P3|Overall Study|Adverse Event|10
153547|NCT00650767|545776|P2|Overall Study|Adverse Event|3
153548|NCT00650767|545777|P1|Overall Study|Adverse Event|0
153549|NCT00650585|546281|P2|Overall Study|Excluded/ruled ineligible|129
153550|NCT00650585|546282|P1|Overall Study|Excluded/ruled ineligible|357
153551|NCT00650585|546281|P2|Overall Study|No parental consent|866
153552|NCT00650585|546282|P1|Overall Study|No parental consent|935
153553|NCT00650585|546281|P2|Overall Study|Lost to Follow-up|482
153554|NCT00650585|546282|P1|Overall Study|Lost to Follow-up|505
153555|NCT00650104|546326|P1|Overall Study|Sponsor Terminated Dosing|1
153556|NCT00650104|546326|P1|Overall Study|Non-compliance|2
153557|NCT00650104|546326|P1|Overall Study|Lost to Follow-up|1
153558|NCT00650104|546326|P1|Overall Study|Physician Decision|7
153559|NCT00650104|546326|P1|Overall Study|Withdrawal by Subject|11
153560|NCT00650104|546326|P1|Overall Study|Death|2
153561|NCT00650104|546326|P1|Overall Study|Adverse Event|17
153562|NCT00650091|546341|P3|Amended Study Design|Not specified|0
153563|NCT00650091|546342|P2|Amended Study Design|Not specified|3
153564|NCT00650091|546343|P1|Amended Study Design|Not specified|1
153565|NCT00650091|546341|P3|Amended Study Design|Lung transplantation|0
153566|NCT00650091|546342|P2|Amended Study Design|Lung transplantation|2
153567|NCT00650091|546343|P1|Amended Study Design|Lung transplantation|4
153568|NCT00650091|546341|P3|Amended Study Design|Adverse Event|0
153569|NCT00650091|546342|P2|Amended Study Design|Adverse Event|4
153570|NCT00650091|546343|P1|Amended Study Design|Adverse Event|1
153571|NCT00650091|546341|P3|Amended Study Design|Physician Decision|0
153572|NCT00650091|546342|P2|Amended Study Design|Physician Decision|0
153573|NCT00650091|546343|P1|Amended Study Design|Physician Decision|5
153574|NCT00650091|546341|P3|Amended Study Design|Withdrawal by Subject|0
153575|NCT00650091|546342|P2|Amended Study Design|Withdrawal by Subject|11
153576|NCT00650091|546343|P1|Amended Study Design|Withdrawal by Subject|12
153577|NCT00649428|546386|P2|Overall Study|Physician Decision|1
153578|NCT00649428|546387|P1|Overall Study|Physician Decision|0
153579|NCT00649428|546386|P2|Overall Study|Protocol Violation|2
153580|NCT00649428|546387|P1|Overall Study|Protocol Violation|6
153581|NCT00649428|546386|P2|Overall Study|Insufficient manufacturing yield|1
153582|NCT00649428|546387|P1|Overall Study|Insufficient manufacturing yield|5
153583|NCT00649428|546386|P2|Overall Study|Lost to Follow-up|3
153584|NCT00649428|546387|P1|Overall Study|Lost to Follow-up|1
153585|NCT00649428|546386|P2|Overall Study|Withdrawal by Subject|6
153586|NCT00649428|546387|P1|Overall Study|Withdrawal by Subject|6
153587|NCT00649428|546386|P2|Overall Study|Adverse Event|2
153588|NCT00649428|546387|P1|Overall Study|Adverse Event|2
153589|NCT00649389|546403|P4|Overall Study|Other|6
153590|NCT00649389|546404|P3|Overall Study|Other|1
153591|NCT00649389|546405|P2|Overall Study|Other|9
153592|NCT00649389|546406|P1|Overall Study|Other|3
153593|NCT00649389|546403|P4|Overall Study|Withdrawal by Subject|23
153594|NCT00649389|546404|P3|Overall Study|Withdrawal by Subject|19
153595|NCT00649389|546405|P2|Overall Study|Withdrawal by Subject|21
153596|NCT00649389|546406|P1|Overall Study|Withdrawal by Subject|20
153597|NCT00649389|546403|P4|Overall Study|Protocol Violation|8
153598|NCT00649389|546404|P3|Overall Study|Protocol Violation|9
153599|NCT00649389|546405|P2|Overall Study|Protocol Violation|13
153600|NCT00649389|546406|P1|Overall Study|Protocol Violation|11
153601|NCT00649389|546403|P4|Overall Study|Lost to Follow-up|26
153602|NCT00649389|546404|P3|Overall Study|Lost to Follow-up|21
153603|NCT00649389|546405|P2|Overall Study|Lost to Follow-up|17
153604|NCT00649389|546406|P1|Overall Study|Lost to Follow-up|15
153605|NCT00649389|546403|P4|Overall Study|Adverse Event|48
153606|NCT00649389|546404|P3|Overall Study|Adverse Event|38
153607|NCT00649389|546405|P2|Overall Study|Adverse Event|46
153608|NCT00649389|546406|P1|Overall Study|Adverse Event|22
153609|NCT00649220|546428|P1|Overall Study|Withdrawal by Subject|1
153610|NCT00649220|546428|P1|Overall Study|Adverse Event|2
153611|NCT00648895|546449|P2|Overall Study|Lack of Efficacy|1
153612|NCT00648895|546450|P1|Overall Study|Lack of Efficacy|0
153613|NCT00648167|546456|P1|Overall Study|unable to swallow tablets|1
153614|NCT00648167|546456|P1|Overall Study|Adverse Event|6
153615|NCT00648037|546476|P1|Overall Study|Other|1
153616|NCT00648037|546476|P1|Overall Study|Relapse|2
153617|NCT00648037|546476|P1|Overall Study|Adverse Event|11
153618|NCT00648037|546476|P1|Overall Study|Withdrawal by Subject|1
153619|NCT00648037|546476|P1|Overall Study|Not Treated|1
153620|NCT00647699|546495|P2|Overall Study|Withdrawal by Subject|8
153621|NCT00647699|546496|P1|Overall Study|Withdrawal by Subject|3
153622|NCT00647699|546495|P2|Overall Study|Lost to Follow-up|4
153623|NCT00647699|546496|P1|Overall Study|Lost to Follow-up|5
153624|NCT00647556|546504|P2|Overall Study|Surgery for pre-existing neck pain|0
153625|NCT00647556|546505|P1|Overall Study|Surgery for pre-existing neck pain|1
153626|NCT00647556|546504|P2|Overall Study|Withdrawal by Subject|0
153627|NCT00647556|546505|P1|Overall Study|Withdrawal by Subject|1
153628|NCT00647556|546504|P2|Overall Study|Protocol Violation|1
153629|NCT00647556|546505|P1|Overall Study|Protocol Violation|0
153630|NCT00647556|546504|P2|Overall Study|Lost to Follow-up|0
153631|NCT00647556|546505|P1|Overall Study|Lost to Follow-up|1
153632|NCT00647556|546504|P2|Overall Study|Adverse Event|1
153633|NCT00647556|546505|P1|Overall Study|Adverse Event|0
153634|NCT00647270|546535|P3|Period 2, Placebo Switched to Adalimumab|Other|0
153635|NCT00647270|546536|P2|Period 2, Placebo Switched to Adalimumab|Other|6
153636|NCT00647270|546537|P1|Period 2, Placebo Switched to Adalimumab|Other|2
153637|NCT00647270|546535|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
153638|NCT00647270|546536|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
153639|NCT00647270|546537|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
153640|NCT00647270|546535|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
153641|NCT00647270|546536|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
153642|NCT00647270|546537|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
153643|NCT00647270|546535|P3|Period 1, Placebo-control (12 Weeks)|Other|8
153644|NCT00647270|546536|P2|Period 1, Placebo-control (12 Weeks)|Other|4
153645|NCT00647270|546537|P1|Period 1, Placebo-control (12 Weeks)|Other|4
153646|NCT00647270|546535|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
153647|NCT00647270|546536|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
153648|NCT00647270|546537|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
153649|NCT00647270|546535|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
153650|NCT00647270|546536|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
153651|NCT00647270|546537|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
153652|NCT00647270|546535|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
153653|NCT00647270|546536|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
153654|NCT00647270|546537|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
153655|NCT00646958|546563|P3|Overall Study|Did not receive study drug|2
153656|NCT00646958|546564|P2|Overall Study|Did not receive study drug|0
153657|NCT00646958|546565|P1|Overall Study|Did not receive study drug|2
153658|NCT00646958|546563|P3|Overall Study|Withdrawal by Subject|0
153659|NCT00646958|546564|P2|Overall Study|Withdrawal by Subject|2
153660|NCT00646958|546565|P1|Overall Study|Withdrawal by Subject|1
153661|NCT00646958|546563|P3|Overall Study|Abnormal screening lab tests|0
153662|NCT00646958|546564|P2|Overall Study|Abnormal screening lab tests|1
153663|NCT00646958|546565|P1|Overall Study|Abnormal screening lab tests|1
153664|NCT00646958|546563|P3|Overall Study|Protocol Violation|0
153665|NCT00646958|546564|P2|Overall Study|Protocol Violation|1
153666|NCT00646958|546565|P1|Overall Study|Protocol Violation|1
153667|NCT00646958|546563|P3|Overall Study|Lost to Follow-up|7
153668|NCT00646958|546564|P2|Overall Study|Lost to Follow-up|5
153669|NCT00646958|546565|P1|Overall Study|Lost to Follow-up|1
153670|NCT00646958|546563|P3|Overall Study|Adverse Event|0
153671|NCT00646958|546564|P2|Overall Study|Adverse Event|0
153672|NCT00646958|546565|P1|Overall Study|Adverse Event|4
153673|NCT00646958|546563|P3|Overall Study|Lack of Efficacy|0
153674|NCT00646958|546564|P2|Overall Study|Lack of Efficacy|0
153675|NCT00646958|546565|P1|Overall Study|Lack of Efficacy|1
153676|NCT00646776|546578|P2|Overall Study|Investigator discretion|4
153677|NCT00646776|546579|P1|Overall Study|Investigator discretion|0
153678|NCT00646776|546578|P2|Overall Study|Adverse Event|9
153679|NCT00646776|546579|P1|Overall Study|Adverse Event|1
153680|NCT00646399|546677|P2|Overall Study|Other Reason|11
153681|NCT00646399|546678|P1|Overall Study|Other Reason|11
153682|NCT00646399|546677|P2|Overall Study|Withdrawal by Subject|10
153683|NCT00646399|546678|P1|Overall Study|Withdrawal by Subject|9
153684|NCT00646399|546677|P2|Overall Study|Death|53
153685|NCT00646399|546678|P1|Overall Study|Death|63
153686|NCT00646282|546686|P2|Overall Study|Protocol terminated|4
153687|NCT00646282|546687|P1|Overall Study|Protocol terminated|4
153688|NCT00645944|546710|P2|Received Medication|Protocol Violation|1
153689|NCT00645944|546711|P1|Received Medication|Protocol Violation|2
153690|NCT00645944|546710|P2|Received Medication|Lost to Follow-up|0
153691|NCT00645944|546711|P1|Received Medication|Lost to Follow-up|1
153692|NCT00645944|546710|P2|Received Medication|Withdrawal by Subject|1
153693|NCT00645944|546711|P1|Received Medication|Withdrawal by Subject|1
153694|NCT00645944|546710|P2|Received Medication|Adverse Event|1
153695|NCT00645944|546711|P1|Received Medication|Adverse Event|2
153696|NCT00645944|546710|P2|Randomized|Withdrawal by Subject|2
153697|NCT00645944|546711|P1|Randomized|Withdrawal by Subject|1
153698|NCT00645853|546719|P2|Overall Study|recall of ICF, planned operation, death|4
153699|NCT00645853|546720|P1|Overall Study|recall of ICF, planned operation, death|7
153700|NCT00645853|546719|P2|Overall Study|Discontinuation criteria|2
153701|NCT00645853|546720|P1|Overall Study|Discontinuation criteria|2
153702|NCT00645853|546719|P2|Overall Study|Protocol Violation|2
153703|NCT00645853|546720|P1|Overall Study|Protocol Violation|0
153704|NCT00645853|546719|P2|Overall Study|Withdrawal by Subject|2
153705|NCT00645853|546720|P1|Overall Study|Withdrawal by Subject|5
153706|NCT00645853|546719|P2|Overall Study|AZ study closure in Hungary|40
153707|NCT00645853|546720|P1|Overall Study|AZ study closure in Hungary|60
153708|NCT00645853|546719|P2|Overall Study|Adverse Event|7
153709|NCT00645853|546720|P1|Overall Study|Adverse Event|18
153710|NCT00645788|546751|P4|Overall Study|Pulmonary exacerbation|9
153711|NCT00645788|546752|P3|Overall Study|Pulmonary exacerbation|11
153712|NCT00645788|546753|P2|Overall Study|Pulmonary exacerbation|16
153713|NCT00645788|546754|P1|Overall Study|Pulmonary exacerbation|13
153714|NCT00645788|546751|P4|Overall Study|Withdrawal by Subject|2
153715|NCT00645788|546752|P3|Overall Study|Withdrawal by Subject|0
153716|NCT00645788|546753|P2|Overall Study|Withdrawal by Subject|1
153717|NCT00645788|546754|P1|Overall Study|Withdrawal by Subject|0
153718|NCT00645788|546751|P4|Overall Study|Protocol Violation|0
153719|NCT00645788|546752|P3|Overall Study|Protocol Violation|2
153720|NCT00645788|546753|P2|Overall Study|Protocol Violation|0
153721|NCT00645788|546754|P1|Overall Study|Protocol Violation|1
153722|NCT00645788|546751|P4|Overall Study|Lost to Follow-up|0
153723|NCT00645788|546752|P3|Overall Study|Lost to Follow-up|0
153724|NCT00645788|546753|P2|Overall Study|Lost to Follow-up|0
153725|NCT00645788|546754|P1|Overall Study|Lost to Follow-up|1
153726|NCT00645788|546751|P4|Overall Study|Adverse Event|3
153727|NCT00645788|546752|P3|Overall Study|Adverse Event|5
153728|NCT00645788|546753|P2|Overall Study|Adverse Event|9
153729|NCT00645788|546754|P1|Overall Study|Adverse Event|4
153730|NCT00645788|546751|P4|Overall Study|Did not receive study drug|0
153731|NCT00645788|546752|P3|Overall Study|Did not receive study drug|0
153732|NCT00645788|546753|P2|Overall Study|Did not receive study drug|1
153733|NCT00645788|546754|P1|Overall Study|Did not receive study drug|1
153734|NCT00645671|546812|P2|Overall Study|Physician Decision|1
153735|NCT00645671|546813|P1|Overall Study|Physician Decision|0
153736|NCT00645671|546812|P2|Overall Study|Adverse Event|1
153737|NCT00645671|546813|P1|Overall Study|Adverse Event|0
153738|NCT00645671|546812|P2|Overall Study|Withdrawal by Subject|4
153739|NCT00645671|546813|P1|Overall Study|Withdrawal by Subject|0
153740|NCT00645671|546812|P2|Overall Study|Protocol Violation|0
153741|NCT00645671|546813|P1|Overall Study|Protocol Violation|1
153742|NCT00645593|546827|P2|Overall Study|Later found to be ineligible|0
153743|NCT00645593|546828|P1|Overall Study|Later found to be ineligible|1
153744|NCT00645567|546840|P1|Overall Study|Adverse Event|1
153745|NCT00645528|546848|P1|Overall Study|Did not show up for Visit 2|7
153746|NCT00645411|546861|P4|Overall Study|Unable to classify|4
153747|NCT00645411|546862|P3|Overall Study|Unable to classify|3
153748|NCT00645411|546863|P2|Overall Study|Unable to classify|0
153749|NCT00645411|546864|P1|Overall Study|Unable to classify|0
153750|NCT00645411|546861|P4|Overall Study|Inappropriate enrollment|1
153751|NCT00645411|546862|P3|Overall Study|Inappropriate enrollment|4
153752|NCT00645411|546863|P2|Overall Study|Inappropriate enrollment|0
153753|NCT00645411|546864|P1|Overall Study|Inappropriate enrollment|0
153754|NCT00645411|546861|P4|Overall Study|Protocol Violation|0
153755|NCT00645411|546862|P3|Overall Study|Protocol Violation|1
153756|NCT00645411|546863|P2|Overall Study|Protocol Violation|0
153757|NCT00645411|546864|P1|Overall Study|Protocol Violation|1
153758|NCT00645411|546861|P4|Overall Study|Lost to Follow-up|75
153759|NCT00645411|546862|P3|Overall Study|Lost to Follow-up|124
153760|NCT00645411|546863|P2|Overall Study|Lost to Follow-up|5
153761|NCT00645411|546864|P1|Overall Study|Lost to Follow-up|10
153762|NCT00645411|546861|P4|Overall Study|Withdrawal by Subject|21
153763|NCT00645411|546862|P3|Overall Study|Withdrawal by Subject|19
153764|NCT00645411|546863|P2|Overall Study|Withdrawal by Subject|1
153765|NCT00645411|546864|P1|Overall Study|Withdrawal by Subject|2
153766|NCT00645411|546861|P4|Overall Study|Adverse Event|2
153767|NCT00645411|546862|P3|Overall Study|Adverse Event|0
153768|NCT00645411|546863|P2|Overall Study|Adverse Event|0
153769|NCT00645411|546864|P1|Overall Study|Adverse Event|0
153770|NCT00645164|546906|P1|Overall Study|Protocol Violation|1
153771|NCT00645164|546906|P1|Overall Study|Withdrawal by Subject|4
153772|NCT00645164|546906|P1|Overall Study|Lost to Follow-up|2
153773|NCT00645099|546912|P2|Overall Study|Other|5
153774|NCT00645099|546913|P1|Overall Study|Other|9
153775|NCT00645099|546912|P2|Overall Study|Adverse Event|5
153776|NCT00645099|546913|P1|Overall Study|Adverse Event|11
153777|NCT00645099|546912|P2|Overall Study|Lost to Follow-up|4
153778|NCT00645099|546913|P1|Overall Study|Lost to Follow-up|6
153779|NCT00645099|546912|P2|Overall Study|Withdrawal by Subject|22
153780|NCT00645099|546913|P1|Overall Study|Withdrawal by Subject|30
153781|NCT00645099|546912|P2|Overall Study|Lack of Efficacy|6
153782|NCT00645099|546913|P1|Overall Study|Lack of Efficacy|15
153783|NCT00644995|546982|P2|Overall Study|Refused|0
153784|NCT00644995|546983|P1|Overall Study|Refused|1
153785|NCT00644995|546982|P2|Overall Study|Lost to Follow-up|4
153786|NCT00644995|546983|P1|Overall Study|Lost to Follow-up|1
153787|NCT00644969|547003|P2|Post Treatment Phase|Other|0
153788|NCT00644969|547004|P1|Post Treatment Phase|Other|1
153789|NCT00644969|547003|P2|Post Treatment Phase|Lost to Follow-up|1
153790|NCT00644969|547004|P1|Post Treatment Phase|Lost to Follow-up|4
153791|NCT00644969|547003|P2|Post Treatment Phase|Withdrawal by Subject|2
153792|NCT00644969|547004|P1|Post Treatment Phase|Withdrawal by Subject|4
153793|NCT00644969|547003|P2|Post Treatment Phase|Death|0
153794|NCT00644969|547004|P1|Post Treatment Phase|Death|1
153795|NCT00644969|547003|P2|Treatment Phase|Other|1
153796|NCT00644969|547004|P1|Treatment Phase|Other|4
153797|NCT00644969|547003|P2|Treatment Phase|Lost to Follow-up|2
153798|NCT00644969|547004|P1|Treatment Phase|Lost to Follow-up|2
153799|NCT00644969|547003|P2|Treatment Phase|Withdrawal by Subject|0
153800|NCT00644969|547004|P1|Treatment Phase|Withdrawal by Subject|4
153801|NCT00644969|547003|P2|Treatment Phase|Adverse Event|0
153802|NCT00644969|547004|P1|Treatment Phase|Adverse Event|3
153803|NCT00644969|547003|P2|Treatment Phase|Randomized, not treated|0
153804|NCT00644969|547004|P1|Treatment Phase|Randomized, not treated|1
153805|NCT00644917|547050|P1|Overall Study|Withdrawal by Subject|2
153806|NCT00644787|547058|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
153807|NCT00644787|547059|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
153808|NCT00644787|547060|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
153809|NCT00644787|547058|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
153810|NCT00644787|547059|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
153811|NCT00644787|547060|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
153812|NCT00644787|547058|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
153813|NCT00644787|547059|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
153814|NCT00644787|547060|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
153815|NCT00644787|547058|P3|Period 2: Double Blind Phase|Adverse Event|4
153816|NCT00644787|547059|P2|Period 2: Double Blind Phase|Adverse Event|2
153817|NCT00644787|547060|P1|Period 2: Double Blind Phase|Adverse Event|0
153818|NCT00644787|547058|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
153819|NCT00644787|547059|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
153820|NCT00644787|547060|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
153821|NCT00644787|547058|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
153822|NCT00644787|547059|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
153823|NCT00644787|547060|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
153824|NCT00644787|547058|P3|Period 1: Titration Phase|Worsening of symptoms|0
153825|NCT00644787|547059|P2|Period 1: Titration Phase|Worsening of symptoms|0
153826|NCT00644787|547060|P1|Period 1: Titration Phase|Worsening of symptoms|1
153827|NCT00644787|547058|P3|Period 1: Titration Phase|Worsening of complications|0
153828|NCT00644787|547059|P2|Period 1: Titration Phase|Worsening of complications|0
153829|NCT00644787|547060|P1|Period 1: Titration Phase|Worsening of complications|1
153830|NCT00644787|547058|P3|Period 1: Titration Phase|Worsening of underlying disease|0
153831|NCT00644787|547059|P2|Period 1: Titration Phase|Worsening of underlying disease|0
153832|NCT00644787|547060|P1|Period 1: Titration Phase|Worsening of underlying disease|5
153833|NCT00644787|547058|P3|Period 1: Titration Phase|Physician Decision|0
153834|NCT00644787|547059|P2|Period 1: Titration Phase|Physician Decision|0
153835|NCT00644787|547060|P1|Period 1: Titration Phase|Physician Decision|1
153836|NCT00644787|547058|P3|Period 1: Titration Phase|Withdrawal by Subject|0
153837|NCT00644787|547059|P2|Period 1: Titration Phase|Withdrawal by Subject|0
153838|NCT00644787|547060|P1|Period 1: Titration Phase|Withdrawal by Subject|2
153839|NCT00644787|547058|P3|Period 1: Titration Phase|Adverse Event|0
153840|NCT00644787|547059|P2|Period 1: Titration Phase|Adverse Event|0
153841|NCT00644787|547060|P1|Period 1: Titration Phase|Adverse Event|11
153842|NCT00644358|547102|P1|Overall Study|Other Unspecified|11
153843|NCT00644358|547102|P1|Overall Study|Noncompliance|14
153844|NCT00644358|547102|P1|Overall Study|Protocol Violation|5
153845|NCT00644358|547102|P1|Overall Study|Lack of Effectiveness|39
153846|NCT00644358|547102|P1|Overall Study|Consent Withdrawal|64
153847|NCT00644358|547102|P1|Overall Study|Lost to Follow-up|105
153848|NCT00644358|547102|P1|Overall Study|Adverse Event|124
153849|NCT00644332|547109|P1|Overall Study|Could Not Attend Scheduled Visits|1
153850|NCT00644332|547109|P1|Overall Study|Did Not Meet Eligibility Requirements|1
153851|NCT00644332|547109|P1|Overall Study|Completion Status Unknown|2
153852|NCT00644332|547109|P1|Overall Study|Withdrawal by Subject|6
153853|NCT00644332|547109|P1|Overall Study|Adverse Event|11
153854|NCT00644228|547135|P2|Maintenance|On Treatment|40
153855|NCT00644228|547136|P1|Maintenance|On Treatment|26
153856|NCT00644228|547135|P2|Maintenance|Not Protocol-Specified|15
153857|NCT00644228|547136|P1|Maintenance|Not Protocol-Specified|14
153858|NCT00644228|547135|P2|Maintenance|Death|3
153859|NCT00644228|547136|P1|Maintenance|Death|3
153860|NCT00644228|547135|P2|Maintenance|Progression/Relapse|42
153861|NCT00644228|547136|P1|Maintenance|Progression/Relapse|67
153862|NCT00644228|547135|P2|Maintenance|Withdrawal by Subject|4
153863|NCT00644228|547136|P1|Maintenance|Withdrawal by Subject|6
153864|NCT00644228|547135|P2|Maintenance|Adverse Event|31
153865|NCT00644228|547136|P1|Maintenance|Adverse Event|27
153866|NCT00644228|547135|P2|Induction Therapy|Not Protocol-Specified|28
153867|NCT00644228|547136|P1|Induction Therapy|Not Protocol-Specified|24
153868|NCT00644228|547135|P2|Induction Therapy|Death|7
153869|NCT00644228|547136|P1|Induction Therapy|Death|3
153870|NCT00644228|547135|P2|Induction Therapy|Progression/Relapse|12
153871|NCT00644228|547136|P1|Induction Therapy|Progression/Relapse|24
153872|NCT00644228|547135|P2|Induction Therapy|Withdrawal by Subject|3
153873|NCT00644228|547136|P1|Induction Therapy|Withdrawal by Subject|10
153874|NCT00644228|547135|P2|Induction Therapy|Adverse Event|55
153875|NCT00644228|547136|P1|Induction Therapy|Adverse Event|22
153876|NCT00644228|547135|P2|Randomization & Eligibility|Invalid Consent|1
153877|NCT00644228|547136|P1|Randomization & Eligibility|Invalid Consent|0
153878|NCT00644228|547135|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
153879|NCT00644228|547136|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
153880|NCT00644228|547135|P2|Randomization & Eligibility|Ineligible|21
153881|NCT00644228|547136|P1|Randomization & Eligibility|Ineligible|31
153882|NCT00644059|547165|P3|Overall Study|Unable to classify|3
153883|NCT00644059|547166|P2|Overall Study|Unable to classify|2
153884|NCT00644059|547167|P1|Overall Study|Unable to classify|6
153885|NCT00644059|547165|P3|Overall Study|Protocol Deviation/violation|15
153886|NCT00644059|547166|P2|Overall Study|Protocol Deviation/violation|19
153887|NCT00644059|547167|P1|Overall Study|Protocol Deviation/violation|20
153888|NCT00644059|547165|P3|Overall Study|Inappropriate Enrollment|0
153889|NCT00644059|547166|P2|Overall Study|Inappropriate Enrollment|3
153890|NCT00644059|547167|P1|Overall Study|Inappropriate Enrollment|1
153891|NCT00644059|547165|P3|Overall Study|Adverse Event|1
153892|NCT00644059|547166|P2|Overall Study|Adverse Event|5
153893|NCT00644059|547167|P1|Overall Study|Adverse Event|8
153894|NCT00644059|547165|P3|Overall Study|Withdrawal by Subject|30
153895|NCT00644059|547166|P2|Overall Study|Withdrawal by Subject|60
153896|NCT00644059|547167|P1|Overall Study|Withdrawal by Subject|52
153897|NCT00644059|547165|P3|Overall Study|Lost to Follow-up|16
153898|NCT00644059|547166|P2|Overall Study|Lost to Follow-up|34
153899|NCT00644059|547167|P1|Overall Study|Lost to Follow-up|37
153900|NCT00643916|547257|P6|Overall Study|Not Vaccinated|0
153901|NCT00643916|547258|P5|Overall Study|Not Vaccinated|2
153902|NCT00643916|547259|P4|Overall Study|Not Vaccinated|0
153903|NCT00643916|547260|P3|Overall Study|Not Vaccinated|3
153904|NCT00643916|547261|P2|Overall Study|Not Vaccinated|2
153905|NCT00643916|547262|P1|Overall Study|Not Vaccinated|2
153906|NCT00643916|547257|P6|Overall Study|Withdrawal by Subject|1
153907|NCT00643916|547258|P5|Overall Study|Withdrawal by Subject|0
153908|NCT00643916|547259|P4|Overall Study|Withdrawal by Subject|1
153909|NCT00643916|547260|P3|Overall Study|Withdrawal by Subject|2
153910|NCT00643916|547261|P2|Overall Study|Withdrawal by Subject|2
153911|NCT00643916|547262|P1|Overall Study|Withdrawal by Subject|2
153912|NCT00643916|547257|P6|Overall Study|Lost to Follow-up|0
153913|NCT00643916|547258|P5|Overall Study|Lost to Follow-up|0
153914|NCT00643916|547259|P4|Overall Study|Lost to Follow-up|0
153915|NCT00643916|547260|P3|Overall Study|Lost to Follow-up|0
153916|NCT00643916|547261|P2|Overall Study|Lost to Follow-up|1
153917|NCT00643916|547262|P1|Overall Study|Lost to Follow-up|0
153918|NCT00643916|547257|P6|Overall Study|Protocol Violation|0
153919|NCT00643916|547258|P5|Overall Study|Protocol Violation|0
153920|NCT00643916|547259|P4|Overall Study|Protocol Violation|1
153921|NCT00643916|547260|P3|Overall Study|Protocol Violation|1
153922|NCT00643916|547261|P2|Overall Study|Protocol Violation|1
153923|NCT00643916|547262|P1|Overall Study|Protocol Violation|0
153924|NCT00643851|547285|P3|Overall Study|Non-compl., not met criteria, etc.|6
153925|NCT00643851|547286|P2|Overall Study|Non-compl., not met criteria, etc.|4
153926|NCT00643851|547287|P1|Overall Study|Non-compl., not met criteria, etc.|3
153927|NCT00643851|547285|P3|Overall Study|Withdrawal by Subject|9
153928|NCT00643851|547286|P2|Overall Study|Withdrawal by Subject|15
153929|NCT00643851|547287|P1|Overall Study|Withdrawal by Subject|8
153930|NCT00643851|547285|P3|Overall Study|Lost to Follow-up|9
153931|NCT00643851|547286|P2|Overall Study|Lost to Follow-up|6
153932|NCT00643851|547287|P1|Overall Study|Lost to Follow-up|4
153933|NCT00643851|547285|P3|Overall Study|Adverse Event|6
153934|NCT00643851|547286|P2|Overall Study|Adverse Event|6
153935|NCT00643851|547287|P1|Overall Study|Adverse Event|2
153936|NCT00643851|547285|P3|Overall Study|Lack of Efficacy|0
153937|NCT00643851|547286|P2|Overall Study|Lack of Efficacy|1
153938|NCT00643851|547287|P1|Overall Study|Lack of Efficacy|0
153939|NCT00643851|547285|P3|Overall Study|Death|0
153940|NCT00643851|547286|P2|Overall Study|Death|1
153941|NCT00643851|547287|P1|Overall Study|Death|0
153942|NCT00643760|547315|P5|Overall Study|Withdrawal by Subject|1
153943|NCT00643760|547316|P4|Overall Study|Withdrawal by Subject|4
153944|NCT00643760|547317|P3|Overall Study|Withdrawal by Subject|2
153945|NCT00643760|547318|P2|Overall Study|Withdrawal by Subject|1
153946|NCT00643760|547319|P1|Overall Study|Withdrawal by Subject|3
153947|NCT00643760|547315|P5|Overall Study|Investigator Discretion|0
153948|NCT00643760|547316|P4|Overall Study|Investigator Discretion|2
153949|NCT00643760|547317|P3|Overall Study|Investigator Discretion|0
153950|NCT00643760|547318|P2|Overall Study|Investigator Discretion|0
153951|NCT00643760|547319|P1|Overall Study|Investigator Discretion|0
153952|NCT00643760|547315|P5|Overall Study|Lost to Follow-up|3
153953|NCT00643760|547316|P4|Overall Study|Lost to Follow-up|3
153954|NCT00643760|547317|P3|Overall Study|Lost to Follow-up|1
153955|NCT00643760|547318|P2|Overall Study|Lost to Follow-up|2
153956|NCT00643760|547319|P1|Overall Study|Lost to Follow-up|6
153957|NCT00643760|547315|P5|Overall Study|Protocol Violation|6
153958|NCT00643760|547316|P4|Overall Study|Protocol Violation|4
153959|NCT00643760|547317|P3|Overall Study|Protocol Violation|4
153960|NCT00643760|547318|P2|Overall Study|Protocol Violation|6
153961|NCT00643760|547319|P1|Overall Study|Protocol Violation|7
153962|NCT00643760|547315|P5|Overall Study|Lack of Efficacy|3
153963|NCT00643760|547316|P4|Overall Study|Lack of Efficacy|4
153964|NCT00643760|547317|P3|Overall Study|Lack of Efficacy|0
153965|NCT00643760|547318|P2|Overall Study|Lack of Efficacy|1
153966|NCT00643760|547319|P1|Overall Study|Lack of Efficacy|3
153967|NCT00643760|547315|P5|Overall Study|Adverse Event|6
153968|NCT00643760|547316|P4|Overall Study|Adverse Event|21
153969|NCT00643760|547317|P3|Overall Study|Adverse Event|12
153970|NCT00643760|547318|P2|Overall Study|Adverse Event|5
153971|NCT00643760|547319|P1|Overall Study|Adverse Event|11
153972|NCT00643682|547423|P2|Overall Study|did not keep appointment|509
153973|NCT00643682|547424|P1|Overall Study|did not keep appointment|522
153974|NCT00643604|547436|P1|Overall Study|Death|1
153975|NCT00643565|547464|P2|Overall Study|Lost to Follow-up|0
153976|NCT00643565|547465|P1|Overall Study|Lost to Follow-up|2
153977|NCT00643565|547464|P2|Overall Study|Withdrawal by Subject|1
153978|NCT00643565|547465|P1|Overall Study|Withdrawal by Subject|2
153979|NCT00643565|547464|P2|Overall Study|Ongoing in Follow-up|39
153980|NCT00643565|547465|P1|Overall Study|Ongoing in Follow-up|39
153981|NCT00643565|547464|P2|Overall Study|Death|34
153982|NCT00643565|547465|P1|Overall Study|Death|37
153983|NCT00643487|547487|P1|Overall Study|Technical difficulty|3
153984|NCT00643448|547494|P3|Overall Study|QTcF>550 ms|0
153985|NCT00643448|547495|P2|Overall Study|QTcF>550 ms|3
153986|NCT00643448|547496|P1|Overall Study|QTcF>550 ms|0
153987|NCT00643448|547494|P3|Overall Study|Adverse Event|2
153988|NCT00643448|547495|P2|Overall Study|Adverse Event|2
153989|NCT00643448|547496|P1|Overall Study|Adverse Event|2
153990|NCT00643448|547494|P3|Overall Study|Lack of Efficacy|4
153991|NCT00643448|547495|P2|Overall Study|Lack of Efficacy|0
153992|NCT00643448|547496|P1|Overall Study|Lack of Efficacy|2
153993|NCT00643201|547513|P2|Completed Study Follow Up|non-specified|0
153994|NCT00643201|547514|P1|Completed Study Follow Up|non-specified|1
153995|NCT00643201|547513|P2|Completed Study Follow Up|Lost to Follow-up|16
153996|NCT00643201|547514|P1|Completed Study Follow Up|Lost to Follow-up|18
153997|NCT00643201|547513|P2|Completed Study Follow Up|Withdrawal by Subject|29
153998|NCT00643201|547514|P1|Completed Study Follow Up|Withdrawal by Subject|23
153999|NCT00643201|547513|P2|Completed Study Follow Up|Death|34
154000|NCT00643201|547514|P1|Completed Study Follow Up|Death|28
154001|NCT00643201|547513|P2|Randomized, Completed 6 Months of Study|not specified|107
154002|NCT00643201|547514|P1|Randomized, Completed 6 Months of Study|not specified|107
154003|NCT00643201|547513|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
154004|NCT00643201|547514|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
154005|NCT00643201|547513|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
154006|NCT00643201|547514|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
154007|NCT00643201|547513|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
154008|NCT00643201|547514|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
154009|NCT00643201|547513|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
154010|NCT00643201|547514|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
154011|NCT00643201|547513|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
154012|NCT00643201|547514|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
154013|NCT00643201|547513|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
154014|NCT00643201|547514|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
154015|NCT00643201|547513|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
154016|NCT00643201|547514|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
154017|NCT00643201|547513|P2|Randomized, Completed 6 Months of Study|Death|26
154018|NCT00643201|547514|P1|Randomized, Completed 6 Months of Study|Death|20
154019|NCT00643123|547562|P2|Overall Study|Withdrawal by Subject|1
154020|NCT00643123|547563|P1|Overall Study|Withdrawal by Subject|1
154021|NCT00643123|547562|P2|Overall Study|Lost to Follow-up|0
154022|NCT00643123|547563|P1|Overall Study|Lost to Follow-up|4
154023|NCT00643006|547593|P2|Overall Study|Lost to Follow-up|4
154024|NCT00643006|547594|P1|Overall Study|Lost to Follow-up|5
154025|NCT00642993|547604|P2|Overall Study|Administrative|0
154026|NCT00642993|547605|P1|Overall Study|Administrative|1
154027|NCT00642993|547604|P2|Overall Study|Did not meet protocol eligibility|1
154028|NCT00642993|547605|P1|Overall Study|Did not meet protocol eligibility|0
154029|NCT00642993|547604|P2|Overall Study|Protocol Violation|4
154030|NCT00642993|547605|P1|Overall Study|Protocol Violation|1
154031|NCT00642993|547604|P2|Overall Study|Withdrew - reason unrelated to treatment|3
154032|NCT00642993|547605|P1|Overall Study|Withdrew - reason unrelated to treatment|11
154033|NCT00642993|547604|P2|Overall Study|Lost to Follow-up|4
154034|NCT00642993|547605|P1|Overall Study|Lost to Follow-up|8
154035|NCT00642993|547604|P2|Overall Study|Adverse Event|4
154036|NCT00642993|547605|P1|Overall Study|Adverse Event|85
154037|NCT00642902|547623|P4|Overall Study|Other|4
154038|NCT00642902|547624|P3|Overall Study|Other|1
154039|NCT00642902|547625|P2|Overall Study|Other|5
154040|NCT00642902|547626|P1|Overall Study|Other|1
154041|NCT00642902|547623|P4|Overall Study|Randomized, but not treated|0
154042|NCT00642902|547624|P3|Overall Study|Randomized, but not treated|1
154043|NCT00642902|547625|P2|Overall Study|Randomized, but not treated|0
154044|NCT00642902|547626|P1|Overall Study|Randomized, but not treated|0
154045|NCT00642902|547623|P4|Overall Study|Premature termination of clinical trial|35
154046|NCT00642902|547624|P3|Overall Study|Premature termination of clinical trial|35
154047|NCT00642902|547625|P2|Overall Study|Premature termination of clinical trial|32
154048|NCT00642902|547626|P1|Overall Study|Premature termination of clinical trial|37
154049|NCT00642902|547623|P4|Overall Study|Death|0
154050|NCT00642902|547624|P3|Overall Study|Death|0
154051|NCT00642902|547625|P2|Overall Study|Death|0
154052|NCT00642902|547626|P1|Overall Study|Death|1
154053|NCT00642902|547623|P4|Overall Study|Lack of Efficacy|0
154054|NCT00642902|547624|P3|Overall Study|Lack of Efficacy|3
154055|NCT00642902|547625|P2|Overall Study|Lack of Efficacy|3
154056|NCT00642902|547626|P1|Overall Study|Lack of Efficacy|0
154057|NCT00642902|547623|P4|Overall Study|Lost to Follow-up|0
154058|NCT00642902|547624|P3|Overall Study|Lost to Follow-up|0
154059|NCT00642902|547625|P2|Overall Study|Lost to Follow-up|1
154060|NCT00642902|547626|P1|Overall Study|Lost to Follow-up|1
154061|NCT00642902|547623|P4|Overall Study|Adverse Event|1
154062|NCT00642902|547624|P3|Overall Study|Adverse Event|3
154063|NCT00642902|547625|P2|Overall Study|Adverse Event|1
154064|NCT00642902|547626|P1|Overall Study|Adverse Event|0
154065|NCT00642850|547648|P1|Overall Study|Other reasons|7
154066|NCT00642850|547648|P1|Overall Study|Blood transfusion|6
154067|NCT00642850|547648|P1|Overall Study|Kidney transplantation|8
154068|NCT00642850|547648|P1|Overall Study|Protocol Violation|2
154069|NCT00642850|547648|P1|Overall Study|Lack of Efficacy|1
154070|NCT00642850|547648|P1|Overall Study|Adverse Event|2
154071|NCT00642850|547648|P1|Overall Study|Death|7
154072|NCT00642811|547664|P6|Overall Study|Other|0
154073|NCT00642811|547665|P5|Overall Study|Other|0
154074|NCT00642811|547666|P4|Overall Study|Other|1
154075|NCT00642811|547667|P3|Overall Study|Other|0
154076|NCT00642811|547668|P2|Overall Study|Other|1
154077|NCT00642811|547669|P1|Overall Study|Other|0
154078|NCT00642811|547664|P6|Overall Study|Severe Non-compliance to protocol|0
154079|NCT00642811|547665|P5|Overall Study|Severe Non-compliance to protocol|0
154080|NCT00642811|547666|P4|Overall Study|Severe Non-compliance to protocol|0
154081|NCT00642811|547667|P3|Overall Study|Severe Non-compliance to protocol|0
154082|NCT00642811|547668|P2|Overall Study|Severe Non-compliance to protocol|0
154083|NCT00642811|547669|P1|Overall Study|Severe Non-compliance to protocol|1
154084|NCT00642811|547664|P6|Overall Study|Developement of discontinuation criteria|0
154085|NCT00642811|547665|P5|Overall Study|Developement of discontinuation criteria|1
154086|NCT00642811|547666|P4|Overall Study|Developement of discontinuation criteria|0
154087|NCT00642811|547667|P3|Overall Study|Developement of discontinuation criteria|0
154088|NCT00642811|547668|P2|Overall Study|Developement of discontinuation criteria|0
154089|NCT00642811|547669|P1|Overall Study|Developement of discontinuation criteria|0
154090|NCT00642811|547664|P6|Overall Study|Adverse Event|1
154091|NCT00642811|547665|P5|Overall Study|Adverse Event|0
154092|NCT00642811|547666|P4|Overall Study|Adverse Event|0
154093|NCT00642811|547667|P3|Overall Study|Adverse Event|0
154094|NCT00642811|547668|P2|Overall Study|Adverse Event|3
154095|NCT00642811|547669|P1|Overall Study|Adverse Event|2
154096|NCT00642772|547691|P1|Overall Study|Withdrawal by Subject|7
154097|NCT00642772|547691|P1|Overall Study|Lost to Follow-up|3
154098|NCT00642759|547695|P1|Overall Study|Protocol Violation|1
154099|NCT00642746|547704|P2|Overall Study|Patient unevaluable|0
154100|NCT00642746|547705|P1|Overall Study|Patient unevaluable|1
154101|NCT00642707|547719|P4|Overall Study|Withdrawal by Subject|0
154102|NCT00642707|547720|P3|Overall Study|Withdrawal by Subject|0
154103|NCT00642707|547721|P2|Overall Study|Withdrawal by Subject|0
154104|NCT00642707|547722|P1|Overall Study|Withdrawal by Subject|1
154105|NCT00642707|547719|P4|Overall Study|Adverse Event|2
154106|NCT00642707|547720|P3|Overall Study|Adverse Event|0
154107|NCT00642707|547721|P2|Overall Study|Adverse Event|0
154108|NCT00642707|547722|P1|Overall Study|Adverse Event|0
154109|NCT00642668|547743|P1|Overall Study|Blood Transfusion|2
154110|NCT00642668|547743|P1|Overall Study|Dialysis Initiation|5
154111|NCT00642668|547743|P1|Overall Study|Failure to Return|1
154112|NCT00642668|547743|P1|Overall Study|Insufficient Therapeutic Response|1
154113|NCT00642668|547743|P1|Overall Study|Death|2
154114|NCT00642668|547743|P1|Overall Study|Adverse Event|2
154115|NCT00642668|547743|P1|Overall Study|Lost to Follow-up|1
154116|NCT00642642|547751|P1|Treatment & Follow Up|Lost to Follow-up|10
154117|NCT00642642|547751|P1|Treatment & Follow Up|Withdrawal by Subject|5
154118|NCT00642642|547751|P1|Treatment & Follow Up|Adverse Event|2
154119|NCT00642616|547768|P4|Overall Study|Physician Decision|1
154120|NCT00642616|547769|P3|Overall Study|Physician Decision|1
154121|NCT00642616|547770|P2|Overall Study|Physician Decision|0
154122|NCT00642616|547771|P1|Overall Study|Physician Decision|0
154123|NCT00642616|547768|P4|Overall Study|Protocol Violation|0
154124|NCT00642616|547769|P3|Overall Study|Protocol Violation|2
154125|NCT00642616|547770|P2|Overall Study|Protocol Violation|0
154126|NCT00642616|547771|P1|Overall Study|Protocol Violation|0
154127|NCT00642616|547768|P4|Overall Study|Withdrawal by Subject|1
154128|NCT00642616|547769|P3|Overall Study|Withdrawal by Subject|1
154129|NCT00642616|547770|P2|Overall Study|Withdrawal by Subject|1
154130|NCT00642616|547771|P1|Overall Study|Withdrawal by Subject|0
154131|NCT00642616|547768|P4|Overall Study|Study Terminated by Sponsor|5
154132|NCT00642616|547769|P3|Overall Study|Study Terminated by Sponsor|4
154133|NCT00642616|547770|P2|Overall Study|Study Terminated by Sponsor|6
154134|NCT00642616|547771|P1|Overall Study|Study Terminated by Sponsor|7
154135|NCT00642616|547768|P4|Overall Study|Adverse Event|0
154136|NCT00642616|547769|P3|Overall Study|Adverse Event|1
154137|NCT00642616|547770|P2|Overall Study|Adverse Event|0
154138|NCT00642616|547771|P1|Overall Study|Adverse Event|2
154139|NCT00642473|547804|P2|Overall Study|Other|2
154140|NCT00642473|547805|P1|Overall Study|Other|2
154141|NCT00642473|547804|P2|Overall Study|Progression or death|4
154142|NCT00642473|547805|P1|Overall Study|Progression or death|2
154143|NCT00642473|547804|P2|Overall Study|Withdrawal by Subject|5
154144|NCT00642473|547805|P1|Overall Study|Withdrawal by Subject|0
154145|NCT00642460|547819|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
154146|NCT00642460|547820|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
154147|NCT00642460|547821|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
154148|NCT00642460|547822|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
154149|NCT00642460|547823|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
154150|NCT00642460|547824|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
154151|NCT00642460|547819|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
154152|NCT00642460|547820|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
154153|NCT00642460|547821|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
154154|NCT00642460|547822|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
154155|NCT00642460|547823|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
154156|NCT00642460|547824|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
154157|NCT00642460|547819|P6|Part III: Open-Label Up to Week 260|Death|3
154158|NCT00642460|547820|P5|Part III: Open-Label Up to Week 260|Death|0
154159|NCT00642460|547821|P4|Part III: Open-Label Up to Week 260|Death|0
154160|NCT00642460|547822|P3|Part III: Open-Label Up to Week 260|Death|0
154161|NCT00642460|547823|P2|Part III: Open-Label Up to Week 260|Death|0
154162|NCT00642460|547824|P1|Part III: Open-Label Up to Week 260|Death|0
154163|NCT00642460|547819|P6|Part III: Open-Label Up to Week 260|Other|2
154164|NCT00642460|547820|P5|Part III: Open-Label Up to Week 260|Other|2
154165|NCT00642460|547821|P4|Part III: Open-Label Up to Week 260|Other|0
154166|NCT00642460|547822|P3|Part III: Open-Label Up to Week 260|Other|0
154167|NCT00642460|547823|P2|Part III: Open-Label Up to Week 260|Other|0
154168|NCT00642460|547824|P1|Part III: Open-Label Up to Week 260|Other|0
154169|NCT00642460|547819|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
154170|NCT00642460|547820|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
154171|NCT00642460|547821|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
154172|NCT00642460|547822|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
154173|NCT00642460|547823|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
154174|NCT00642460|547824|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
154175|NCT00642460|547819|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
154176|NCT00642460|547820|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
154177|NCT00642460|547821|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
154178|NCT00642460|547822|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
154179|NCT00642460|547823|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
154180|NCT00642460|547824|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
154181|NCT00642460|547819|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
154182|NCT00642460|547820|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
154183|NCT00642460|547821|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
154184|NCT00642460|547822|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
154185|NCT00642460|547823|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
154186|NCT00642460|547824|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
154187|NCT00642460|547819|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
154188|NCT00642460|547820|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
154189|NCT00642460|547821|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
154190|NCT00642460|547822|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
154191|NCT00642460|547823|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
154192|NCT00642460|547824|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
154193|NCT00642460|547819|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
154194|NCT00642460|547820|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
154195|NCT00642460|547821|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
154196|NCT00642460|547822|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
154197|NCT00642460|547823|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
154198|NCT00642460|547824|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
154199|NCT00642460|547819|P6|Part II: Open-Label Up to Week 92|Failure to return|0
154200|NCT00642460|547820|P5|Part II: Open-Label Up to Week 92|Failure to return|0
154201|NCT00642460|547821|P4|Part II: Open-Label Up to Week 92|Failure to return|0
154202|NCT00642460|547822|P3|Part II: Open-Label Up to Week 92|Failure to return|0
154203|NCT00642460|547823|P2|Part II: Open-Label Up to Week 92|Failure to return|1
154204|NCT00642460|547824|P1|Part II: Open-Label Up to Week 92|Failure to return|0
154205|NCT00642460|547819|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
154206|NCT00642460|547820|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
154207|NCT00642460|547821|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
154208|NCT00642460|547822|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
154209|NCT00642460|547823|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
154210|NCT00642460|547824|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
154211|NCT00642460|547819|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
154212|NCT00642460|547820|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
154213|NCT00642460|547821|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
154214|NCT00642460|547822|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
154215|NCT00642460|547823|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
154216|NCT00642460|547824|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
154217|NCT00642460|547819|P6|Part II: Open-Label Up to Week 92|Death|0
154218|NCT00642460|547820|P5|Part II: Open-Label Up to Week 92|Death|0
154219|NCT00642460|547821|P4|Part II: Open-Label Up to Week 92|Death|2
154220|NCT00642460|547822|P3|Part II: Open-Label Up to Week 92|Death|0
154221|NCT00642460|547823|P2|Part II: Open-Label Up to Week 92|Death|1
154222|NCT00642460|547824|P1|Part II: Open-Label Up to Week 92|Death|0
154223|NCT00642460|547819|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
154224|NCT00642460|547820|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
154225|NCT00642460|547821|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
154226|NCT00642460|547822|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
154227|NCT00642460|547823|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
154228|NCT00642460|547824|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
154229|NCT00642460|547819|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
154230|NCT00642460|547820|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
154231|NCT00642460|547821|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
154232|NCT00642460|547822|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
154233|NCT00642460|547823|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
154234|NCT00642460|547824|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
154235|NCT00642460|547819|P6|Part I: 12 Week Double-Blind|Adverse Event|0
154236|NCT00642460|547820|P5|Part I: 12 Week Double-Blind|Adverse Event|0
154237|NCT00642460|547821|P4|Part I: 12 Week Double-Blind|Adverse Event|0
154238|NCT00642460|547822|P3|Part I: 12 Week Double-Blind|Adverse Event|1
154239|NCT00642460|547823|P2|Part I: 12 Week Double-Blind|Adverse Event|1
154240|NCT00642460|547824|P1|Part I: 12 Week Double-Blind|Adverse Event|0
154241|NCT00642369|547899|P2|Overall Study|Lack of Efficacy|2
154242|NCT00642369|547900|P1|Overall Study|Lack of Efficacy|2
154243|NCT00642369|547899|P2|Overall Study|misdiagnosis|1
154244|NCT00642369|547900|P1|Overall Study|misdiagnosis|0
154245|NCT00642369|547899|P2|Overall Study|Withdrawal by Subject|0
154246|NCT00642369|547900|P1|Overall Study|Withdrawal by Subject|1
154247|NCT00642369|547899|P2|Overall Study|Adverse Event|3
154248|NCT00642369|547900|P1|Overall Study|Adverse Event|2
154249|NCT00642356|547910|P2|Overall Study|Lack of Efficacy|0
154250|NCT00642356|547911|P1|Overall Study|Lack of Efficacy|1
154251|NCT00642356|547910|P2|Overall Study|Protocol Violation|3
154252|NCT00642356|547911|P1|Overall Study|Protocol Violation|0
154253|NCT00642356|547910|P2|Overall Study|Adverse Event|0
154254|NCT00642356|547911|P1|Overall Study|Adverse Event|1
154255|NCT00642304|547919|P1|Overall Study|Transplantation|1
154256|NCT00642304|547919|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
154257|NCT00642304|547919|P1|Overall Study|Blood transfusion|2
154258|NCT00642304|547919|P1|Overall Study|Death|1
154259|NCT00642304|547919|P1|Overall Study|Adverse Event|1
154260|NCT00642278|547935|P7|Overall Study|Not specified|0
154261|NCT00642278|547936|P6|Overall Study|Not specified|1
154262|NCT00642278|547937|P5|Overall Study|Not specified|0
154263|NCT00642278|547938|P4|Overall Study|Not specified|1
154264|NCT00642278|547939|P3|Overall Study|Not specified|0
154265|NCT00642278|547940|P2|Overall Study|Not specified|1
154266|NCT00642278|547941|P1|Overall Study|Not specified|2
154267|NCT00642278|547935|P7|Overall Study|Noncompliance with study drug regimen|0
154268|NCT00642278|547936|P6|Overall Study|Noncompliance with study drug regimen|0
154269|NCT00642278|547937|P5|Overall Study|Noncompliance with study drug regimen|0
154270|NCT00642278|547938|P4|Overall Study|Noncompliance with study drug regimen|1
154271|NCT00642278|547939|P3|Overall Study|Noncompliance with study drug regimen|0
154272|NCT00642278|547940|P2|Overall Study|Noncompliance with study drug regimen|0
154273|NCT00642278|547941|P1|Overall Study|Noncompliance with study drug regimen|0
154274|NCT00642278|547935|P7|Overall Study|Withdrawal by Subject|2
154275|NCT00642278|547936|P6|Overall Study|Withdrawal by Subject|2
154276|NCT00642278|547937|P5|Overall Study|Withdrawal by Subject|6
154277|NCT00642278|547938|P4|Overall Study|Withdrawal by Subject|3
154278|NCT00642278|547939|P3|Overall Study|Withdrawal by Subject|1
154279|NCT00642278|547940|P2|Overall Study|Withdrawal by Subject|1
154280|NCT00642278|547941|P1|Overall Study|Withdrawal by Subject|1
154281|NCT00642278|547935|P7|Overall Study|Protocol Violation|2
154282|NCT00642278|547936|P6|Overall Study|Protocol Violation|1
154283|NCT00642278|547937|P5|Overall Study|Protocol Violation|0
154284|NCT00642278|547938|P4|Overall Study|Protocol Violation|1
154285|NCT00642278|547939|P3|Overall Study|Protocol Violation|1
154286|NCT00642278|547940|P2|Overall Study|Protocol Violation|0
154287|NCT00642278|547941|P1|Overall Study|Protocol Violation|0
154288|NCT00642278|547935|P7|Overall Study|Physician Decision|0
154289|NCT00642278|547936|P6|Overall Study|Physician Decision|0
154290|NCT00642278|547937|P5|Overall Study|Physician Decision|0
154291|NCT00642278|547938|P4|Overall Study|Physician Decision|1
154292|NCT00642278|547939|P3|Overall Study|Physician Decision|0
154293|NCT00642278|547940|P2|Overall Study|Physician Decision|0
154294|NCT00642278|547941|P1|Overall Study|Physician Decision|0
154295|NCT00642278|547935|P7|Overall Study|Lost to Follow-up|1
154296|NCT00642278|547936|P6|Overall Study|Lost to Follow-up|1
154297|NCT00642278|547937|P5|Overall Study|Lost to Follow-up|0
154298|NCT00642278|547938|P4|Overall Study|Lost to Follow-up|1
154299|NCT00642278|547939|P3|Overall Study|Lost to Follow-up|0
154300|NCT00642278|547940|P2|Overall Study|Lost to Follow-up|1
154301|NCT00642278|547941|P1|Overall Study|Lost to Follow-up|5
154302|NCT00642278|547935|P7|Overall Study|Lack of Efficacy|0
154303|NCT00642278|547936|P6|Overall Study|Lack of Efficacy|0
154304|NCT00642278|547937|P5|Overall Study|Lack of Efficacy|0
154305|NCT00642278|547938|P4|Overall Study|Lack of Efficacy|0
154306|NCT00642278|547939|P3|Overall Study|Lack of Efficacy|0
154307|NCT00642278|547940|P2|Overall Study|Lack of Efficacy|1
154308|NCT00642278|547941|P1|Overall Study|Lack of Efficacy|0
154309|NCT00642278|547935|P7|Overall Study|Adverse Event|0
154310|NCT00642278|547936|P6|Overall Study|Adverse Event|2
154311|NCT00642278|547937|P5|Overall Study|Adverse Event|2
154312|NCT00642278|547938|P4|Overall Study|Adverse Event|1
154313|NCT00642278|547939|P3|Overall Study|Adverse Event|3
154314|NCT00642278|547940|P2|Overall Study|Adverse Event|1
154315|NCT00642278|547941|P1|Overall Study|Adverse Event|2
154316|NCT00642174|547994|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
154317|NCT00642174|547995|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
154318|NCT00641719|548038|P2|Overall Study|Reason Not Specified|2
154319|NCT00641719|548039|P1|Overall Study|Reason Not Specified|1
154320|NCT00641719|548038|P2|Overall Study|Withdrawal by Subject|4
154321|NCT00641719|548039|P1|Overall Study|Withdrawal by Subject|4
154322|NCT00641719|548038|P2|Overall Study|Adverse Event|29
154323|NCT00641719|548039|P1|Overall Study|Adverse Event|24
154324|NCT00641719|548038|P2|Overall Study|Lack of Efficacy|2
154325|NCT00641719|548039|P1|Overall Study|Lack of Efficacy|1
154326|NCT00641706|548063|P2|Overall Study|Lead Investigator Decision|1
154327|NCT00641706|548064|P1|Overall Study|Lead Investigator Decision|0
154328|NCT00641706|548063|P2|Overall Study|Clinical Decline|0
154329|NCT00641706|548064|P1|Overall Study|Clinical Decline|1
154330|NCT00641706|548063|P2|Overall Study|Withdrawal by Subject|1
154331|NCT00641706|548064|P1|Overall Study|Withdrawal by Subject|6
154332|NCT00641706|548063|P2|Overall Study|Adverse Event|1
154333|NCT00641706|548064|P1|Overall Study|Adverse Event|2
154334|NCT00641667|548076|P1|Overall Study|Worsening of underlying disease|3
154335|NCT00641667|548076|P1|Overall Study|Physician Decision|1
154336|NCT00641667|548076|P1|Overall Study|Adverse Event|1
154337|NCT00641667|548076|P1|Overall Study|Withdrawal by Subject|1
154338|NCT00641537|548104|P8|24-Week Supplemental Follow-up Period|Other|1
154339|NCT00641537|548105|P7|24-Week Supplemental Follow-up Period|Other|1
154340|NCT00641537|548106|P6|24-Week Supplemental Follow-up Period|Other|0
154341|NCT00641537|548107|P5|24-Week Supplemental Follow-up Period|Other|3
154342|NCT00641537|548108|P4|24-Week Supplemental Follow-up Period|Other|1
154343|NCT00641537|548109|P3|24-Week Supplemental Follow-up Period|Other|2
154344|NCT00641537|548110|P2|24-Week Supplemental Follow-up Period|Other|2
154345|NCT00641537|548111|P1|24-Week Supplemental Follow-up Period|Other|0
154346|NCT00641537|548104|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
154347|NCT00641537|548105|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
154348|NCT00641537|548106|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
154349|NCT00641537|548107|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
154350|NCT00641537|548108|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
154351|NCT00641537|548109|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
154352|NCT00641537|548110|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
154353|NCT00641537|548111|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
154354|NCT00641537|548104|P8|96-week Period|Other|6
154355|NCT00641537|548105|P7|96-week Period|Other|4
154356|NCT00641537|548106|P6|96-week Period|Other|6
154357|NCT00641537|548107|P5|96-week Period|Other|12
154358|NCT00641537|548108|P4|96-week Period|Other|9
154359|NCT00641537|548109|P3|96-week Period|Other|14
154360|NCT00641537|548110|P2|96-week Period|Other|7
154361|NCT00641537|548111|P1|96-week Period|Other|4
154362|NCT00641537|548104|P8|96-week Period|Death|0
154363|NCT00641537|548105|P7|96-week Period|Death|0
154364|NCT00641537|548106|P6|96-week Period|Death|0
154365|NCT00641537|548107|P5|96-week Period|Death|0
154366|NCT00641537|548108|P4|96-week Period|Death|0
154367|NCT00641537|548109|P3|96-week Period|Death|1
154368|NCT00641537|548110|P2|96-week Period|Death|0
154369|NCT00641537|548111|P1|96-week Period|Death|2
154370|NCT00641537|548104|P8|96-week Period|Protocol Violation|0
154371|NCT00641537|548105|P7|96-week Period|Protocol Violation|0
154372|NCT00641537|548106|P6|96-week Period|Protocol Violation|1
154373|NCT00641537|548107|P5|96-week Period|Protocol Violation|0
154374|NCT00641537|548108|P4|96-week Period|Protocol Violation|1
154375|NCT00641537|548109|P3|96-week Period|Protocol Violation|0
154376|NCT00641537|548110|P2|96-week Period|Protocol Violation|1
154377|NCT00641537|548111|P1|96-week Period|Protocol Violation|0
154378|NCT00641537|548104|P8|96-week Period|Lost to Follow-up|0
154379|NCT00641537|548105|P7|96-week Period|Lost to Follow-up|1
154380|NCT00641537|548106|P6|96-week Period|Lost to Follow-up|0
154381|NCT00641537|548107|P5|96-week Period|Lost to Follow-up|4
154382|NCT00641537|548108|P4|96-week Period|Lost to Follow-up|2
154383|NCT00641537|548109|P3|96-week Period|Lost to Follow-up|2
154384|NCT00641537|548110|P2|96-week Period|Lost to Follow-up|1
154385|NCT00641537|548111|P1|96-week Period|Lost to Follow-up|3
154386|NCT00641537|548104|P8|96-week Period|Adverse Event|0
154387|NCT00641537|548105|P7|96-week Period|Adverse Event|0
154388|NCT00641537|548106|P6|96-week Period|Adverse Event|0
154389|NCT00641537|548107|P5|96-week Period|Adverse Event|2
154390|NCT00641537|548108|P4|96-week Period|Adverse Event|0
154391|NCT00641537|548109|P3|96-week Period|Adverse Event|3
154392|NCT00641537|548110|P2|96-week Period|Adverse Event|1
154393|NCT00641537|548111|P1|96-week Period|Adverse Event|0
154394|NCT00641147|548166|P2|Completed 16 Months.|Lost to Follow-up|0
154395|NCT00641147|548167|P1|Completed 16 Months.|Lost to Follow-up|1
154396|NCT00641147|548166|P2|Completed 16 Months.|Physician Decision|0
154397|NCT00641147|548167|P1|Completed 16 Months.|Physician Decision|1
154398|NCT00641147|548166|P2|Completed 12 Months.|Withdrawal by Subject|1
154399|NCT00641147|548167|P1|Completed 12 Months.|Withdrawal by Subject|0
154400|NCT00641147|548166|P2|Completed 12 Months.|Physician Decision|1
154401|NCT00641147|548167|P1|Completed 12 Months.|Physician Decision|1
154402|NCT00641147|548166|P2|Completed 8 Months.|Withdrawal by Subject|1
154403|NCT00641147|548167|P1|Completed 8 Months.|Withdrawal by Subject|0
154404|NCT00641147|548166|P2|Completed 8 Months.|non compliance|0
154405|NCT00641147|548167|P1|Completed 8 Months.|non compliance|1
154406|NCT00641147|548166|P2|Completed 8 Months.|Physician Decision|1
154407|NCT00641147|548167|P1|Completed 8 Months.|Physician Decision|2
154408|NCT00641147|548166|P2|Completed 4 Months.|Adverse Event|0
154409|NCT00641147|548167|P1|Completed 4 Months.|Adverse Event|1
154410|NCT00641147|548166|P2|Completed 4 Months.|Physician Decision|0
154411|NCT00641147|548167|P1|Completed 4 Months.|Physician Decision|1
154412|NCT00641056|548211|P2|Overall Study|Sponsor Decision|2
154413|NCT00641056|548212|P1|Overall Study|Sponsor Decision|1
154414|NCT00641056|548211|P2|Overall Study|Subject Decision|19
154415|NCT00641056|548212|P1|Overall Study|Subject Decision|6
154416|NCT00641056|548211|P2|Overall Study|Entry Criteria Not Met|0
154417|NCT00641056|548212|P1|Overall Study|Entry Criteria Not Met|3
154418|NCT00641056|548211|P2|Overall Study|Protocol Violation|0
154419|NCT00641056|548212|P1|Overall Study|Protocol Violation|2
154420|NCT00641056|548211|P2|Overall Study|Physician Decision|1
154421|NCT00641056|548212|P1|Overall Study|Physician Decision|3
154422|NCT00641056|548211|P2|Overall Study|Lost to Follow-up|1
154423|NCT00641056|548212|P1|Overall Study|Lost to Follow-up|2
154424|NCT00641056|548211|P2|Overall Study|Adverse Event|2
154425|NCT00641056|548212|P1|Overall Study|Adverse Event|12
154426|NCT00641043|548240|P2|Overall Study|Other incl. lack of efficacy|2
154427|NCT00641043|548241|P1|Overall Study|Other incl. lack of efficacy|4
154428|NCT00641043|548240|P2|Overall Study|Withdrawal by Subject|4
154429|NCT00641043|548241|P1|Overall Study|Withdrawal by Subject|4
154430|NCT00641043|548240|P2|Overall Study|Lost to Follow-up|2
154431|NCT00641043|548241|P1|Overall Study|Lost to Follow-up|3
154432|NCT00641043|548240|P2|Overall Study|Protocol Violation|3
154433|NCT00641043|548241|P1|Overall Study|Protocol Violation|2
154434|NCT00641043|548240|P2|Overall Study|Adverse Event|4
154435|NCT00641043|548241|P1|Overall Study|Adverse Event|6
154436|NCT00640926|548278|P3|Overall Study|Withdrawal by Subject|1
154437|NCT00640926|548279|P2|Overall Study|Withdrawal by Subject|0
154438|NCT00640926|548280|P1|Overall Study|Withdrawal by Subject|1
154439|NCT00640926|548278|P3|Overall Study|Lost to Follow-up|2
154440|NCT00640926|548279|P2|Overall Study|Lost to Follow-up|1
154441|NCT00640926|548280|P1|Overall Study|Lost to Follow-up|3
154442|NCT00640926|548278|P3|Overall Study|Protocol Violation|2
154443|NCT00640926|548279|P2|Overall Study|Protocol Violation|0
154444|NCT00640926|548280|P1|Overall Study|Protocol Violation|2
154445|NCT00640926|548278|P3|Overall Study|Lack of Efficacy|1
154446|NCT00640926|548279|P2|Overall Study|Lack of Efficacy|2
154447|NCT00640926|548280|P1|Overall Study|Lack of Efficacy|0
154448|NCT00640926|548278|P3|Overall Study|Adverse Event|2
154449|NCT00640926|548279|P2|Overall Study|Adverse Event|3
154450|NCT00640926|548280|P1|Overall Study|Adverse Event|2
154451|NCT00640835|548293|P2|Overall Study|Other Reason|4
154452|NCT00640835|548294|P1|Overall Study|Other Reason|19
154453|NCT00640835|548293|P2|Overall Study|Lost to Follow-up|13
154454|NCT00640835|548294|P1|Overall Study|Lost to Follow-up|17
154455|NCT00640835|548293|P2|Overall Study|Protocol Violation|2
154456|NCT00640835|548294|P1|Overall Study|Protocol Violation|2
154457|NCT00640835|548293|P2|Overall Study|Sponsor's Decision|7
154458|NCT00640835|548294|P1|Overall Study|Sponsor's Decision|11
154459|NCT00640835|548293|P2|Overall Study|Physician Decision|14
154460|NCT00640835|548294|P1|Overall Study|Physician Decision|10
154461|NCT00640835|548293|P2|Overall Study|Withdrawal by Subject|14
154462|NCT00640835|548294|P1|Overall Study|Withdrawal by Subject|12
154463|NCT00640835|548293|P2|Overall Study|Adverse Event|3
154464|NCT00640835|548294|P1|Overall Study|Adverse Event|5
154465|NCT00640614|548358|P2|Overall Study|Lost to Follow-up|0
154466|NCT00640614|548359|P1|Overall Study|Lost to Follow-up|1
154467|NCT00640601|548401|P1|Overall Study|treatment naive, combination therapy|10
154468|NCT00640601|548401|P1|Overall Study|Physician Decision|8
154469|NCT00640601|548401|P1|Overall Study|Lost to Follow-up|9
154470|NCT00640601|548401|P1|Overall Study|Lack of Efficacy|16
154471|NCT00640601|548401|P1|Overall Study|Protocol Violation|6
154472|NCT00640601|548401|P1|Overall Study|Withdrawal by Subject|20
154473|NCT00640601|548401|P1|Overall Study|Adverse Event|43
154474|NCT00640562|548417|P2|Overall Study|Glycosylated Hemoglobin >8|0
154475|NCT00640562|548418|P1|Overall Study|Glycosylated Hemoglobin >8|1
154476|NCT00640562|548417|P2|Overall Study|Low study drug dose|1
154477|NCT00640562|548418|P1|Overall Study|Low study drug dose|0
154478|NCT00640562|548417|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
154479|NCT00640562|548418|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
154480|NCT00640562|548417|P2|Overall Study|Known risperidone intolerance|1
154481|NCT00640562|548418|P1|Overall Study|Known risperidone intolerance|0
154482|NCT00640562|548417|P2|Overall Study|Withdrawal by Subject|10
154483|NCT00640562|548418|P1|Overall Study|Withdrawal by Subject|6
154484|NCT00640562|548417|P2|Overall Study|Protocol Violation|4
154485|NCT00640562|548418|P1|Overall Study|Protocol Violation|2
154486|NCT00640562|548417|P2|Overall Study|Lack of Efficacy|4
154487|NCT00640562|548418|P1|Overall Study|Lack of Efficacy|1
154488|NCT00640562|548417|P2|Overall Study|Adverse Event|5
154489|NCT00640562|548418|P1|Overall Study|Adverse Event|8
154490|NCT00640510|548446|P2|Overall Study|Physician Decision|1
154491|NCT00640510|548447|P1|Overall Study|Physician Decision|0
154492|NCT00640510|548446|P2|Overall Study|Protocol Violation|0
154493|NCT00640510|548447|P1|Overall Study|Protocol Violation|1
154494|NCT00640510|548446|P2|Overall Study|Lack of Efficacy|1
154495|NCT00640510|548447|P1|Overall Study|Lack of Efficacy|0
154496|NCT00640393|548459|P3|Part 2|Adverse Event|0
154497|NCT00640393|548460|P2|Part 2|Adverse Event|1
154498|NCT00640393|548461|P1|Part 2|Adverse Event|0
154499|NCT00640393|548459|P3|Part 2|Non-adherence|0
154500|NCT00640393|548460|P2|Part 2|Non-adherence|1
154501|NCT00640393|548461|P1|Part 2|Non-adherence|0
154502|NCT00640393|548459|P3|Part 2|Withdrawal by Subject|1
154503|NCT00640393|548460|P2|Part 2|Withdrawal by Subject|6
154504|NCT00640393|548461|P1|Part 2|Withdrawal by Subject|0
154505|NCT00640393|548459|P3|Part 2|Lost to Follow-up|2
154506|NCT00640393|548460|P2|Part 2|Lost to Follow-up|2
154507|NCT00640393|548461|P1|Part 2|Lost to Follow-up|0
154508|NCT00640393|548459|P3|Randomization|Never randomized by site|0
154509|NCT00640393|548460|P2|Randomization|Never randomized by site|0
154510|NCT00640393|548461|P1|Randomization|Never randomized by site|2
154511|NCT00640393|548459|P3|Randomization|Withdrawn per protocol|0
154512|NCT00640393|548460|P2|Randomization|Withdrawn per protocol|0
154513|NCT00640393|548461|P1|Randomization|Withdrawn per protocol|17
154514|NCT00640393|548459|P3|Part 1|Withdrawal by Subject|0
154515|NCT00640393|548460|P2|Part 1|Withdrawal by Subject|0
154516|NCT00640393|548461|P1|Part 1|Withdrawal by Subject|3
154517|NCT00640393|548459|P3|Part 1|Lost to Follow-up|0
154518|NCT00640393|548460|P2|Part 1|Lost to Follow-up|0
154519|NCT00640393|548461|P1|Part 1|Lost to Follow-up|2
154520|NCT00640341|548526|P3|Overall Study|Adverse event and positive slit lamp|0
154521|NCT00640341|548527|P2|Overall Study|Adverse event and positive slit lamp|0
154522|NCT00640341|548528|P1|Overall Study|Adverse event and positive slit lamp|1
154523|NCT00640341|548526|P3|Overall Study|Ineligable at Baseline|2
154524|NCT00640341|548527|P2|Overall Study|Ineligable at Baseline|3
154525|NCT00640341|548528|P1|Overall Study|Ineligable at Baseline|5
154526|NCT00640341|548526|P3|Overall Study|Poor fit/Uncomfortable|0
154527|NCT00640341|548527|P2|Overall Study|Poor fit/Uncomfortable|0
154528|NCT00640341|548528|P1|Overall Study|Poor fit/Uncomfortable|4
154529|NCT00640341|548526|P3|Overall Study|Unacceptable Lens Movement|0
154530|NCT00640341|548527|P2|Overall Study|Unacceptable Lens Movement|0
154531|NCT00640341|548528|P1|Overall Study|Unacceptable Lens Movement|1
154532|NCT00640341|548526|P3|Overall Study|Withdrawal by Subject|1
154533|NCT00640341|548527|P2|Overall Study|Withdrawal by Subject|0
154534|NCT00640341|548528|P1|Overall Study|Withdrawal by Subject|4
154535|NCT00640341|548526|P3|Overall Study|Lost to Follow-up|0
154536|NCT00640341|548527|P2|Overall Study|Lost to Follow-up|0
154537|NCT00640341|548528|P1|Overall Study|Lost to Follow-up|2
154538|NCT00640341|548526|P3|Overall Study|Failure to Follow Subject Instructions|0
154539|NCT00640341|548527|P2|Overall Study|Failure to Follow Subject Instructions|0
154540|NCT00640341|548528|P1|Overall Study|Failure to Follow Subject Instructions|1
154541|NCT00640341|548526|P3|Overall Study|Inability to Maintain Wearing Schedule|0
154542|NCT00640341|548527|P2|Overall Study|Inability to Maintain Wearing Schedule|1
154543|NCT00640341|548528|P1|Overall Study|Inability to Maintain Wearing Schedule|1
154544|NCT00640341|548526|P3|Overall Study|Study Related Symptoms/Complaints|2
154545|NCT00640341|548527|P2|Overall Study|Study Related Symptoms/Complaints|1
154546|NCT00640341|548528|P1|Overall Study|Study Related Symptoms/Complaints|2
154547|NCT00640341|548526|P3|Overall Study|Positive Slit Lamp Findings|1
154548|NCT00640341|548527|P2|Overall Study|Positive Slit Lamp Findings|0
154549|NCT00640341|548528|P1|Overall Study|Positive Slit Lamp Findings|0
154550|NCT00640341|548526|P3|Overall Study|Adverse Event|1
154551|NCT00640341|548527|P2|Overall Study|Adverse Event|0
154552|NCT00640341|548528|P1|Overall Study|Adverse Event|0
154553|NCT00640328|548548|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
154554|NCT00640328|548549|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
154555|NCT00640328|548550|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
154556|NCT00640328|548551|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
154557|NCT00640328|548552|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
154558|NCT00640328|548553|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
154559|NCT00640328|548548|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
154560|NCT00640328|548549|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
154561|NCT00640328|548550|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
154562|NCT00640328|548551|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
154563|NCT00640328|548552|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
154564|NCT00640328|548553|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
154565|NCT00640328|548548|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
154566|NCT00640328|548549|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
154567|NCT00640328|548550|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
154568|NCT00640328|548551|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
154569|NCT00640328|548552|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
154570|NCT00640328|548553|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
154571|NCT00640328|548548|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
154572|NCT00640328|548549|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
154573|NCT00640328|548550|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
154574|NCT00640328|548551|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
154575|NCT00640328|548552|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
154576|NCT00640328|548553|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
154577|NCT00640315|548719|P2|Overall Study|Withdrawal by Subject|1
154578|NCT00640315|548720|P1|Overall Study|Withdrawal by Subject|0
154579|NCT00640224|548953|P4|Overall Study|Headaches|0
154580|NCT00640224|548954|P3|Overall Study|Headaches|0
154581|NCT00640224|548955|P2|Overall Study|Headaches|1
154582|NCT00640224|548956|P1|Overall Study|Headaches|0
154583|NCT00640224|548953|P4|Overall Study|Withdrawal by Subject|0
154584|NCT00640224|548954|P3|Overall Study|Withdrawal by Subject|0
154585|NCT00640224|548955|P2|Overall Study|Withdrawal by Subject|0
154586|NCT00640224|548956|P1|Overall Study|Withdrawal by Subject|1
154587|NCT00640224|548953|P4|Overall Study|Lost to Follow-up|0
154588|NCT00640224|548954|P3|Overall Study|Lost to Follow-up|0
154589|NCT00640224|548955|P2|Overall Study|Lost to Follow-up|2
154590|NCT00640224|548956|P1|Overall Study|Lost to Follow-up|5
154591|NCT00640042|549054|P1|Enrollment|Did not receive study drug|83
154592|NCT00640016|549070|P4|Overall Study|Adverse Event|1
154593|NCT00640016|549071|P3|Overall Study|Adverse Event|0
154594|NCT00640016|549072|P2|Overall Study|Adverse Event|0
154595|NCT00640016|549073|P1|Overall Study|Adverse Event|0
154596|NCT00640016|549070|P4|Overall Study|Study termination|2
154597|NCT00640016|549071|P3|Overall Study|Study termination|3
154598|NCT00640016|549072|P2|Overall Study|Study termination|1
154599|NCT00640016|549073|P1|Overall Study|Study termination|2
154600|NCT00640016|549070|P4|Overall Study|Withdrawal by Subject|0
154601|NCT00640016|549071|P3|Overall Study|Withdrawal by Subject|0
154602|NCT00640016|549072|P2|Overall Study|Withdrawal by Subject|1
154603|NCT00640016|549073|P1|Overall Study|Withdrawal by Subject|0
154604|NCT00639769|549125|P1|Overall Study|Withdrawal by Subject|4
154605|NCT00639769|549125|P1|Overall Study|Disease progression|26
154606|NCT00639769|549125|P1|Overall Study|Lack of Efficacy|1
154607|NCT00639769|549125|P1|Overall Study|Adverse Event|7
154608|NCT00639769|549125|P1|Overall Study|Death|2
154609|NCT00639678|549142|P4|Overall Study|Lack of Compliance|0
154610|NCT00639678|549143|P3|Overall Study|Lack of Compliance|1
154611|NCT00639678|549144|P2|Overall Study|Lack of Compliance|0
154612|NCT00639678|549145|P1|Overall Study|Lack of Compliance|0
154613|NCT00639678|549142|P4|Overall Study|Adverse Event|0
154614|NCT00639678|549143|P3|Overall Study|Adverse Event|0
154615|NCT00639678|549144|P2|Overall Study|Adverse Event|1
154616|NCT00639678|549145|P1|Overall Study|Adverse Event|0
154617|NCT00639678|549142|P4|Overall Study|Lost to Follow-up|0
154618|NCT00639678|549143|P3|Overall Study|Lost to Follow-up|6
154619|NCT00639678|549144|P2|Overall Study|Lost to Follow-up|0
154620|NCT00639678|549145|P1|Overall Study|Lost to Follow-up|1
154621|NCT00639678|549142|P4|Overall Study|Withdrawal by Subject|0
154622|NCT00639678|549143|P3|Overall Study|Withdrawal by Subject|4
154623|NCT00639678|549144|P2|Overall Study|Withdrawal by Subject|0
154624|NCT00639678|549145|P1|Overall Study|Withdrawal by Subject|3
154625|NCT00639509|549210|P1|Overall Study|Death|1
154626|NCT00639457|549218|P2|Overall Study|Withdrawal by Subject|3
154627|NCT00639457|549219|P1|Overall Study|Withdrawal by Subject|2
154628|NCT00639379|549278|P2|Period 1 - 2 Weeks|lens issue|0
154629|NCT00639379|549279|P1|Period 1 - 2 Weeks|lens issue|3
154630|NCT00639379|549278|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
154631|NCT00639379|549279|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
154632|NCT00639223|549295|P2|Overall Study|Lost to Follow-up|2
154633|NCT00639223|549296|P1|Overall Study|Lost to Follow-up|0
154634|NCT00639002|549336|P1|Overall Study|Lack of Efficacy|1
154635|NCT00639002|549336|P1|Overall Study|Physician Decision|6
154636|NCT00639002|549336|P1|Overall Study|Disease progression|3
154637|NCT00639002|549336|P1|Overall Study|Protocol Violation|1
154638|NCT00639002|549336|P1|Overall Study|Adverse Event|1
154639|NCT00639002|549336|P1|Overall Study|Death|1
154640|NCT00638989|549345|P3|Overall Study|Lost to Follow-up|1
154641|NCT00638989|549346|P2|Overall Study|Lost to Follow-up|0
154642|NCT00638989|549347|P1|Overall Study|Lost to Follow-up|0
154643|NCT00638963|549387|P2|Overall Study|Withdrawal by Subject|0
154644|NCT00638963|549388|P1|Overall Study|Withdrawal by Subject|1
154645|NCT00638846|549428|P2|Overall Study|lens issue|3
154646|NCT00638846|549429|P1|Overall Study|lens issue|1
154647|NCT00638846|549428|P2|Overall Study|Lost to Follow-up|2
154648|NCT00638846|549429|P1|Overall Study|Lost to Follow-up|3
154649|NCT00638846|549428|P2|Overall Study|Adverse Event|1
154650|NCT00638846|549429|P1|Overall Study|Adverse Event|0
154651|NCT00638690|549473|P2|Overall Study|Lost to Follow-up|2
154652|NCT00638690|549474|P1|Overall Study|Lost to Follow-up|4
154653|NCT00638690|549473|P2|Overall Study|Withdrawal by Subject|5
154654|NCT00638690|549474|P1|Overall Study|Withdrawal by Subject|22
154655|NCT00638690|549473|P2|Overall Study|Death|335
154656|NCT00638690|549474|P1|Overall Study|Death|655
154657|NCT00638443|549492|P2|First Intervention|Adverse Event|1
154658|NCT00638443|549493|P1|First Intervention|Adverse Event|2
154659|NCT00638378|549521|P1|Overall Study|Physician Decision|4
154660|NCT00638378|549521|P1|Overall Study|Disease progression|15
154661|NCT00638378|549521|P1|Overall Study|Adverse Event|1
154662|NCT00638378|549521|P1|Overall Study|Death|2
154663|NCT00638235|549550|P9|Overall Study|Lost to Follow-up|18
154664|NCT00638235|549551|P8|Overall Study|Lost to Follow-up|1
154665|NCT00638235|549552|P7|Overall Study|Lost to Follow-up|0
154666|NCT00638235|549553|P6|Overall Study|Lost to Follow-up|26
154667|NCT00638235|549554|P5|Overall Study|Lost to Follow-up|13
154668|NCT00638235|549555|P4|Overall Study|Lost to Follow-up|10
154669|NCT00638235|549556|P3|Overall Study|Lost to Follow-up|18
154670|NCT00638235|549557|P2|Overall Study|Lost to Follow-up|3
154671|NCT00638235|549558|P1|Overall Study|Lost to Follow-up|31
154672|NCT00638183|549968|P1|Overall Study|Other reason not defined above|27
154673|NCT00638183|549968|P1|Overall Study|Lost to Follow-up|46
154674|NCT00638183|549968|P1|Overall Study|Physician Decision|9
154675|NCT00638183|549968|P1|Overall Study|Lack of Efficacy|14
154676|NCT00638183|549968|P1|Overall Study|Adverse Event|23
154677|NCT00638157|549977|P2|Overall Study|Randomized, not treated|0
154678|NCT00638157|549978|P1|Overall Study|Randomized, not treated|2
154679|NCT00638157|549977|P2|Overall Study|Not Specified|2
154680|NCT00638157|549978|P1|Overall Study|Not Specified|1
154681|NCT00638157|549977|P2|Overall Study|Physician Decision|0
154682|NCT00638157|549978|P1|Overall Study|Physician Decision|1
154683|NCT00638157|549977|P2|Overall Study|Lost to Follow-up|0
154684|NCT00638157|549978|P1|Overall Study|Lost to Follow-up|1
154685|NCT00638157|549977|P2|Overall Study|Microbiological failure|0
154686|NCT00638157|549978|P1|Overall Study|Microbiological failure|1
154687|NCT00638157|549977|P2|Overall Study|Clinical (symptomatic) failure|1
154688|NCT00638157|549978|P1|Overall Study|Clinical (symptomatic) failure|1
154689|NCT00638157|549977|P2|Overall Study|Adverse Event|1
154690|NCT00638157|549978|P1|Overall Study|Adverse Event|0
154691|NCT00638027|549988|P2|Overall Study|Adverse Event|2
154692|NCT00638027|549989|P1|Overall Study|Adverse Event|0
154693|NCT00637806|550036|P4|Extension Phase|Study Discontinued|1
154694|NCT00637806|550037|P3|Extension Phase|Study Discontinued|0
154695|NCT00637806|550038|P2|Extension Phase|Study Discontinued|0
154696|NCT00637806|550039|P1|Extension Phase|Study Discontinued|0
154697|NCT00637806|550036|P4|Double-blind Phase|Study Discontinued|0
154698|NCT00637806|550037|P3|Double-blind Phase|Study Discontinued|1
154699|NCT00637806|550038|P2|Double-blind Phase|Study Discontinued|0
154700|NCT00637806|550039|P1|Double-blind Phase|Study Discontinued|2
154701|NCT00637728|550074|P3|Double-blind Phase|Study Discontinued|0
154702|NCT00637728|550075|P2|Double-blind Phase|Study Discontinued|1
154703|NCT00637728|550076|P1|Double-blind Phase|Study Discontinued|1
154704|NCT00637728|550074|P3|Double-blind Phase|Non-compliance|0
154705|NCT00637728|550075|P2|Double-blind Phase|Non-compliance|0
154706|NCT00637728|550076|P1|Double-blind Phase|Non-compliance|2
154707|NCT00637728|550074|P3|Double-blind Phase|Adverse Event|0
154708|NCT00637728|550075|P2|Double-blind Phase|Adverse Event|0
154709|NCT00637728|550076|P1|Double-blind Phase|Adverse Event|1
154710|NCT00637572|550091|P2|Overall Study|Illicit Drug Use|0
154711|NCT00637572|550092|P1|Overall Study|Illicit Drug Use|1
154712|NCT00637572|550091|P2|Overall Study|Withdrawal by Subject|2
154713|NCT00637572|550092|P1|Overall Study|Withdrawal by Subject|0
154714|NCT00637572|550091|P2|Overall Study|Physician Decision|1
154715|NCT00637572|550092|P1|Overall Study|Physician Decision|1
154716|NCT00637572|550091|P2|Overall Study|Lost to Follow-up|1
154717|NCT00637572|550092|P1|Overall Study|Lost to Follow-up|0
154718|NCT00637572|550091|P2|Overall Study|Death|1
154719|NCT00637572|550092|P1|Overall Study|Death|0
154720|NCT00637572|550091|P2|Overall Study|Adverse Event|2
154721|NCT00637572|550092|P1|Overall Study|Adverse Event|1
154722|NCT00637416|550131|P2|Overall Study|Unable to take study drug|1
154723|NCT00637416|550132|P1|Overall Study|Unable to take study drug|0
154724|NCT00637416|550131|P2|Overall Study|Lost to Follow-up|1
154725|NCT00637416|550132|P1|Overall Study|Lost to Follow-up|1
154726|NCT00637377|550142|P4|Overall Study|Other (no further information available)|5
154727|NCT00637377|550143|P3|Overall Study|Other (no further information available)|10
154728|NCT00637377|550144|P2|Overall Study|Other (no further information available)|6
154729|NCT00637377|550145|P1|Overall Study|Other (no further information available)|7
154730|NCT00637377|550142|P4|Overall Study|Withdrawal by Subject|11
154731|NCT00637377|550143|P3|Overall Study|Withdrawal by Subject|13
154732|NCT00637377|550144|P2|Overall Study|Withdrawal by Subject|15
154733|NCT00637377|550145|P1|Overall Study|Withdrawal by Subject|11
154734|NCT00637377|550142|P4|Overall Study|Protocol Violation|0
154735|NCT00637377|550143|P3|Overall Study|Protocol Violation|1
154736|NCT00637377|550144|P2|Overall Study|Protocol Violation|1
154737|NCT00637377|550145|P1|Overall Study|Protocol Violation|2
154738|NCT00637377|550142|P4|Overall Study|Lost to Follow-up|2
154739|NCT00637377|550143|P3|Overall Study|Lost to Follow-up|2
154740|NCT00637377|550144|P2|Overall Study|Lost to Follow-up|1
154741|NCT00637377|550145|P1|Overall Study|Lost to Follow-up|4
154742|NCT00637377|550142|P4|Overall Study|Lack of Efficacy|1
154743|NCT00637377|550143|P3|Overall Study|Lack of Efficacy|1
154744|NCT00637377|550144|P2|Overall Study|Lack of Efficacy|0
154745|NCT00637377|550145|P1|Overall Study|Lack of Efficacy|0
154746|NCT00637377|550142|P4|Overall Study|Death|1
154747|NCT00637377|550143|P3|Overall Study|Death|2
154748|NCT00637377|550144|P2|Overall Study|Death|3
154749|NCT00637377|550145|P1|Overall Study|Death|1
154750|NCT00637377|550142|P4|Overall Study|Adverse Event|9
154751|NCT00637377|550143|P3|Overall Study|Adverse Event|8
154752|NCT00637377|550144|P2|Overall Study|Adverse Event|6
154753|NCT00637377|550145|P1|Overall Study|Adverse Event|2
154754|NCT00637273|550194|P3|Overall Study|Loss of Glucose Control|1
154755|NCT00637273|550195|P2|Overall Study|Loss of Glucose Control|1
154756|NCT00637273|550196|P1|Overall Study|Loss of Glucose Control|1
154757|NCT00637273|550194|P3|Overall Study|Administrative|0
154758|NCT00637273|550195|P2|Overall Study|Administrative|0
154759|NCT00637273|550196|P1|Overall Study|Administrative|2
154760|NCT00637273|550194|P3|Overall Study|Investigator Decision|1
154761|NCT00637273|550195|P2|Overall Study|Investigator Decision|3
154762|NCT00637273|550196|P1|Overall Study|Investigator Decision|1
154763|NCT00637273|550194|P3|Overall Study|Withdrawal of Consent|18
154764|NCT00637273|550195|P2|Overall Study|Withdrawal of Consent|6
154765|NCT00637273|550196|P1|Overall Study|Withdrawal of Consent|18
154766|NCT00637273|550194|P3|Overall Study|Protocol Violation|1
154767|NCT00637273|550195|P2|Overall Study|Protocol Violation|4
154768|NCT00637273|550196|P1|Overall Study|Protocol Violation|2
154769|NCT00637273|550194|P3|Overall Study|Lost to Follow-up|13
154770|NCT00637273|550195|P2|Overall Study|Lost to Follow-up|9
154771|NCT00637273|550196|P1|Overall Study|Lost to Follow-up|8
154772|NCT00637273|550194|P3|Overall Study|Adverse Event|7
154773|NCT00637273|550195|P2|Overall Study|Adverse Event|5
154774|NCT00637273|550196|P1|Overall Study|Adverse Event|11
154775|NCT00637195|550252|P2|Overall Study|Withdrawal by Subject|1
154776|NCT00637195|550253|P1|Overall Study|Withdrawal by Subject|0
154777|NCT00637195|550252|P2|Overall Study|Other|0
154778|NCT00637195|550253|P1|Overall Study|Other|2
154779|NCT00637195|550252|P2|Overall Study|Lost to Follow-up|0
154780|NCT00637195|550253|P1|Overall Study|Lost to Follow-up|1
154781|NCT00637156|550289|P2|Overall Study|Lost to Follow-up|16
154782|NCT00637156|550290|P1|Overall Study|Lost to Follow-up|10
154783|NCT00637156|550289|P2|Overall Study|Death|1
154784|NCT00637156|550290|P1|Overall Study|Death|0
154785|NCT00637156|550289|P2|Overall Study|Withdrawal by Subject|7
154786|NCT00637156|550290|P1|Overall Study|Withdrawal by Subject|0
154787|NCT00637000|550332|P2|Overall Study|Withdrawal by Subject|3
154788|NCT00637000|550333|P1|Overall Study|Withdrawal by Subject|4
154789|NCT00636987|550373|P1|Overall Study|5 year visit window not complete|69
154790|NCT00636987|550373|P1|Overall Study|Lost to Follow-up|63
154791|NCT00636987|550373|P1|Overall Study|Explanted|13
154792|NCT00636987|550373|P1|Overall Study|Death|44
154793|NCT00636961|550383|P2|Period 2|Adverse Event|0
154794|NCT00636961|550384|P1|Period 2|Adverse Event|1
154795|NCT00636961|550383|P2|Period 1|Administrative problems|1
154796|NCT00636961|550384|P1|Period 1|Administrative problems|1
154797|NCT00636818|550398|P1|Overall Study|Withdrawal by Subject|4
154798|NCT00636818|550398|P1|Overall Study|Protocol Violation|1
154799|NCT00636818|550398|P1|Overall Study|Entry Criteria Exclusion|3
154800|NCT00636818|550398|P1|Overall Study|Lost to Follow-up|2
154801|NCT00636818|550398|P1|Overall Study|Adverse Event|1
154802|NCT00636792|550423|P1|Overall Study|Other|3
154803|NCT00636792|550423|P1|Overall Study|Withdrawal by Subject|3
154804|NCT00636792|550423|P1|Overall Study|Progressive Disease|4
154805|NCT00636792|550423|P1|Overall Study|Physician Decision|7
154806|NCT00636792|550423|P1|Overall Study|Adverse Event|16
154807|NCT00636636|550470|P2|Overall Study|Withdrawal by Subject|9
154808|NCT00636636|550471|P1|Overall Study|Withdrawal by Subject|4
154809|NCT00636636|550470|P2|Overall Study|Death|1
154810|NCT00636636|550471|P1|Overall Study|Death|0
154811|NCT00636636|550470|P2|Overall Study|Lost to Follow-up|1
154812|NCT00636636|550471|P1|Overall Study|Lost to Follow-up|0
154813|NCT00636636|550470|P2|Overall Study|Protocol Violation|2
154814|NCT00636636|550471|P1|Overall Study|Protocol Violation|2
154815|NCT00636636|550470|P2|Overall Study|Lack of Efficacy|12
154816|NCT00636636|550471|P1|Overall Study|Lack of Efficacy|7
154817|NCT00636636|550470|P2|Overall Study|Adverse Event|8
154818|NCT00636636|550471|P1|Overall Study|Adverse Event|19
154819|NCT00636636|550470|P2|Overall Study|Other reason|6
154820|NCT00636636|550471|P1|Overall Study|Other reason|4
154821|NCT00636610|550487|P2|Overall Study|Reason for discontinuation not available|2
154822|NCT00636610|550488|P1|Overall Study|Reason for discontinuation not available|3
154823|NCT00636610|550487|P2|Overall Study|Disease progression - clinical|3
154824|NCT00636610|550488|P1|Overall Study|Disease progression - clinical|8
154825|NCT00636610|550487|P2|Overall Study|Disease progression - radiographic|51
154826|NCT00636610|550488|P1|Overall Study|Disease progression - radiographic|41
154827|NCT00636610|550487|P2|Overall Study|Subject decision to withdraw|11
154828|NCT00636610|550488|P1|Overall Study|Subject decision to withdraw|15
154829|NCT00636610|550487|P2|Overall Study|Physician decision to withdraw patient|9
154830|NCT00636610|550488|P1|Overall Study|Physician decision to withdraw patient|15
154831|NCT00636610|550487|P2|Overall Study|Death|3
154832|NCT00636610|550488|P1|Overall Study|Death|6
154833|NCT00636610|550487|P2|Overall Study|Adverse Event|4
154834|NCT00636610|550488|P1|Overall Study|Adverse Event|4
154835|NCT00636441|550505|P7|Overall Study|Screen Failure|17
154836|NCT00636441|550506|P6|Overall Study|Screen Failure|0
154837|NCT00636441|550507|P5|Overall Study|Screen Failure|0
154838|NCT00636441|550508|P4|Overall Study|Screen Failure|0
154839|NCT00636441|550509|P3|Overall Study|Screen Failure|0
154840|NCT00636441|550510|P2|Overall Study|Screen Failure|0
154841|NCT00636441|550511|P1|Overall Study|Screen Failure|0
154842|NCT00636441|550505|P7|Overall Study|Late, ineligible|1
154843|NCT00636441|550506|P6|Overall Study|Late, ineligible|0
154844|NCT00636441|550507|P5|Overall Study|Late, ineligible|0
154845|NCT00636441|550508|P4|Overall Study|Late, ineligible|0
154846|NCT00636441|550509|P3|Overall Study|Late, ineligible|0
154847|NCT00636441|550510|P2|Overall Study|Late, ineligible|0
154848|NCT00636441|550511|P1|Overall Study|Late, ineligible|0
154849|NCT00636441|550505|P7|Overall Study|Adverse Event|0
154850|NCT00636441|550506|P6|Overall Study|Adverse Event|1
154851|NCT00636441|550507|P5|Overall Study|Adverse Event|0
154852|NCT00636441|550508|P4|Overall Study|Adverse Event|0
154853|NCT00636441|550509|P3|Overall Study|Adverse Event|1
154854|NCT00636441|550510|P2|Overall Study|Adverse Event|1
154855|NCT00636441|550511|P1|Overall Study|Adverse Event|0
154856|NCT00636363|550554|P3|Overall Study|Withdrawal by Subject|2
154857|NCT00636363|550555|P2|Overall Study|Withdrawal by Subject|3
154858|NCT00636363|550556|P1|Overall Study|Withdrawal by Subject|1
154859|NCT00636363|550554|P3|Overall Study|Lost to Follow-up|2
154860|NCT00636363|550555|P2|Overall Study|Lost to Follow-up|4
154861|NCT00636363|550556|P1|Overall Study|Lost to Follow-up|3
154862|NCT00636363|550554|P3|Overall Study|Protocol Violation|0
154863|NCT00636363|550555|P2|Overall Study|Protocol Violation|3
154864|NCT00636363|550556|P1|Overall Study|Protocol Violation|0
154865|NCT00636363|550554|P3|Overall Study|Lack of motivation|1
154866|NCT00636363|550555|P2|Overall Study|Lack of motivation|0
154867|NCT00636363|550556|P1|Overall Study|Lack of motivation|1
154868|NCT00636363|550554|P3|Overall Study|Missed > 1 visit|3
154869|NCT00636363|550555|P2|Overall Study|Missed > 1 visit|1
154870|NCT00636363|550556|P1|Overall Study|Missed > 1 visit|0
154871|NCT00636363|550554|P3|Overall Study|Met ineligibility criteria|3
154872|NCT00636363|550555|P2|Overall Study|Met ineligibility criteria|0
154873|NCT00636363|550556|P1|Overall Study|Met ineligibility criteria|0
154874|NCT00636363|550554|P3|Overall Study|Study related symptoms/complaints|4
154875|NCT00636363|550555|P2|Overall Study|Study related symptoms/complaints|7
154876|NCT00636363|550556|P1|Overall Study|Study related symptoms/complaints|8
154877|NCT00636363|550554|P3|Overall Study|Positive slit lamp finding|1
154878|NCT00636363|550555|P2|Overall Study|Positive slit lamp finding|2
154879|NCT00636363|550556|P1|Overall Study|Positive slit lamp finding|0
154880|NCT00636363|550554|P3|Overall Study|Adverse Event|1
154881|NCT00636363|550555|P2|Overall Study|Adverse Event|0
154882|NCT00636363|550556|P1|Overall Study|Adverse Event|0
154883|NCT00636363|550554|P3|Overall Study|Conjunctivitis|1
154884|NCT00636363|550555|P2|Overall Study|Conjunctivitis|0
154885|NCT00636363|550556|P1|Overall Study|Conjunctivitis|0
154886|NCT00636207|550577|P7|Overall Study|Withdrawal by Subject|0
154887|NCT00636207|550578|P6|Overall Study|Withdrawal by Subject|0
154888|NCT00636207|550579|P5|Overall Study|Withdrawal by Subject|1
154889|NCT00636207|550580|P4|Overall Study|Withdrawal by Subject|0
154890|NCT00636207|550581|P3|Overall Study|Withdrawal by Subject|0
154891|NCT00636207|550582|P2|Overall Study|Withdrawal by Subject|1
154892|NCT00636207|550583|P1|Overall Study|Withdrawal by Subject|0
154893|NCT00636207|550577|P7|Overall Study|Adverse Event|0
154894|NCT00636207|550578|P6|Overall Study|Adverse Event|0
154895|NCT00636207|550579|P5|Overall Study|Adverse Event|0
154896|NCT00636207|550580|P4|Overall Study|Adverse Event|0
154897|NCT00636207|550581|P3|Overall Study|Adverse Event|0
154898|NCT00636207|550582|P2|Overall Study|Adverse Event|0
154899|NCT00636207|550583|P1|Overall Study|Adverse Event|1
154900|NCT00636194|550647|P2|Overall Study|Protocol Violation|0
154901|NCT00636194|550648|P1|Overall Study|Protocol Violation|2
154902|NCT00636194|550647|P2|Overall Study|Study related symptoms and complaints|0
154903|NCT00636194|550648|P1|Overall Study|Study related symptoms and complaints|1
154904|NCT00636168|550660|P2|Treated With Study Drug|Still remains on treatment|94
154905|NCT00636168|550661|P1|Treated With Study Drug|Still remains on treatment|48
154906|NCT00636168|550660|P2|Treated With Study Drug|non-specified|1
154907|NCT00636168|550661|P1|Treated With Study Drug|non-specified|1
154908|NCT00636168|550660|P2|Treated With Study Drug|No longer meets criteria|0
154909|NCT00636168|550661|P1|Treated With Study Drug|No longer meets criteria|1
154910|NCT00636168|550660|P2|Treated With Study Drug|Pregnancy|0
154911|NCT00636168|550661|P1|Treated With Study Drug|Pregnancy|1
154912|NCT00636168|550660|P2|Treated With Study Drug|Death|0
154913|NCT00636168|550661|P1|Treated With Study Drug|Death|3
154914|NCT00636168|550660|P2|Treated With Study Drug|Poor or non-compliance|3
154915|NCT00636168|550661|P1|Treated With Study Drug|Poor or non-compliance|1
154916|NCT00636168|550660|P2|Treated With Study Drug|Withdrawal by Subject|20
154917|NCT00636168|550661|P1|Treated With Study Drug|Withdrawal by Subject|16
154918|NCT00636168|550660|P2|Treated With Study Drug|Adverse Event|20
154919|NCT00636168|550661|P1|Treated With Study Drug|Adverse Event|244
154920|NCT00636168|550660|P2|Treated With Study Drug|Recurrence of disease|273
154921|NCT00636168|550661|P1|Treated With Study Drug|Recurrence of disease|132
154922|NCT00636168|550660|P2|Randomized to Study Drug|No longer met study criteria|0
154923|NCT00636168|550661|P1|Randomized to Study Drug|No longer met study criteria|1
154924|NCT00636168|550660|P2|Randomized to Study Drug|Adverse Event|0
154925|NCT00636168|550661|P1|Randomized to Study Drug|Adverse Event|1
154926|NCT00636168|550660|P2|Randomized to Study Drug|Withdrawal by Subject|2
154927|NCT00636168|550661|P1|Randomized to Study Drug|Withdrawal by Subject|2
154928|NCT00636155|550681|P1|Overall Study|Physician Decision|5
154929|NCT00636155|550681|P1|Overall Study|Stem cell transplant|1
154930|NCT00636155|550681|P1|Overall Study|Withdrawal by Subject|3
154931|NCT00636155|550681|P1|Overall Study|Lack of Efficacy|1
154932|NCT00636155|550681|P1|Overall Study|Adverse Event|8
154933|NCT00635999|550723|P3|Overall Study|Withdrawal by Subject|1
154934|NCT00635999|550724|P2|Overall Study|Withdrawal by Subject|2
154935|NCT00635999|550725|P1|Overall Study|Withdrawal by Subject|4
154936|NCT00635882|550742|P6|Overall Study|Protocol Violation|0
154937|NCT00635882|550743|P5|Overall Study|Protocol Violation|0
154938|NCT00635882|550744|P4|Overall Study|Protocol Violation|0
154939|NCT00635882|550745|P3|Overall Study|Protocol Violation|0
154940|NCT00635882|550746|P2|Overall Study|Protocol Violation|0
154941|NCT00635882|550747|P1|Overall Study|Protocol Violation|1
154942|NCT00635804|550877|P8|Overall Study|Withdrawal by Subject|0
154943|NCT00635804|550878|P7|Overall Study|Withdrawal by Subject|0
154944|NCT00635804|550879|P6|Overall Study|Withdrawal by Subject|0
154945|NCT00635804|550880|P5|Overall Study|Withdrawal by Subject|0
154946|NCT00635804|550881|P4|Overall Study|Withdrawal by Subject|0
154947|NCT00635804|550882|P3|Overall Study|Withdrawal by Subject|0
154948|NCT00635804|550883|P2|Overall Study|Withdrawal by Subject|0
154949|NCT00635804|550884|P1|Overall Study|Withdrawal by Subject|1
154950|NCT00635804|550877|P8|Overall Study|Adverse Event|0
154951|NCT00635804|550878|P7|Overall Study|Adverse Event|0
154952|NCT00635804|550879|P6|Overall Study|Adverse Event|1
154953|NCT00635804|550880|P5|Overall Study|Adverse Event|0
154954|NCT00635804|550881|P4|Overall Study|Adverse Event|0
154955|NCT00635804|550882|P3|Overall Study|Adverse Event|0
154956|NCT00635804|550883|P2|Overall Study|Adverse Event|0
154957|NCT00635804|550884|P1|Overall Study|Adverse Event|0
154958|NCT00635661|550990|P1|Overall Study|Withdrawal by Subject|4
154959|NCT00635648|550994|P1|Overall Study|Other reason|2
154960|NCT00635648|550994|P1|Overall Study|Noncompliance with protocol|1
154961|NCT00635648|550994|P1|Overall Study|No improvement after 7-10 days treatment|4
154962|NCT00635648|550994|P1|Overall Study|Use of other antifungal agent needed|1
154963|NCT00635648|550994|P1|Overall Study|Rapid progression of baseline disease|4
154964|NCT00635648|550994|P1|Overall Study|Physician Decision|4
154965|NCT00635648|550994|P1|Overall Study|Withdrawal by Subject|9
154966|NCT00635648|550994|P1|Overall Study|Adverse Event|12
154967|NCT00635570|551016|P2|Overall Study|Early termination(No sexual activity)|1
154968|NCT00635570|551017|P1|Overall Study|Early termination(No sexual activity)|1
154969|NCT00635570|551016|P2|Overall Study|Did not complete survey|1
154970|NCT00635570|551017|P1|Overall Study|Did not complete survey|2
154971|NCT00635570|551016|P2|Overall Study|Physician Decision|0
154972|NCT00635570|551017|P1|Overall Study|Physician Decision|1
154973|NCT00635570|551016|P2|Overall Study|Adverse Event|0
154974|NCT00635570|551017|P1|Overall Study|Adverse Event|2
154975|NCT00635570|551016|P2|Overall Study|Withdrawal by Subject|1
154976|NCT00635570|551017|P1|Overall Study|Withdrawal by Subject|1
154977|NCT00635570|551016|P2|Overall Study|Lost to Follow-up|8
154978|NCT00635570|551017|P1|Overall Study|Lost to Follow-up|8
154979|NCT00635492|551031|P2|Overall Study|Withdrawal by Subject|45
154980|NCT00635492|551032|P1|Overall Study|Withdrawal by Subject|82
154981|NCT00635492|551031|P2|Overall Study|Sponsor decision|3
154982|NCT00635492|551032|P1|Overall Study|Sponsor decision|2
154983|NCT00635492|551031|P2|Overall Study|Physician Decision|22
154984|NCT00635492|551032|P1|Overall Study|Physician Decision|32
154985|NCT00635492|551031|P2|Overall Study|Lost to Follow-up|172
154986|NCT00635492|551032|P1|Overall Study|Lost to Follow-up|151
154987|NCT00635492|551031|P2|Overall Study|Death|40
154988|NCT00635492|551032|P1|Overall Study|Death|12
154989|NCT00635427|551090|P5|Overall Study|Withdrawal Of Consent|2
154990|NCT00635427|551091|P4|Overall Study|Withdrawal Of Consent|2
154991|NCT00635427|551092|P3|Overall Study|Withdrawal Of Consent|0
154992|NCT00635427|551093|P2|Overall Study|Withdrawal Of Consent|0
154993|NCT00635427|551094|P1|Overall Study|Withdrawal Of Consent|0
154994|NCT00635427|551090|P5|Overall Study|Termination Of Study By Sponsor|6
154995|NCT00635427|551091|P4|Overall Study|Termination Of Study By Sponsor|6
154996|NCT00635427|551092|P3|Overall Study|Termination Of Study By Sponsor|10
154997|NCT00635427|551093|P2|Overall Study|Termination Of Study By Sponsor|6
154998|NCT00635427|551094|P1|Overall Study|Termination Of Study By Sponsor|12
154999|NCT00635427|551090|P5|Overall Study|Death|0
155000|NCT00635427|551091|P4|Overall Study|Death|1
155001|NCT00635427|551092|P3|Overall Study|Death|0
155002|NCT00635427|551093|P2|Overall Study|Death|0
155003|NCT00635427|551094|P1|Overall Study|Death|0
155004|NCT00635427|551090|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
155005|NCT00635427|551091|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
155006|NCT00635427|551092|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
155007|NCT00635427|551093|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
155008|NCT00635427|551094|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
155009|NCT00635349|551133|P2|Overall Study|Adverse Event|9
155010|NCT00635349|551134|P1|Overall Study|Adverse Event|11
155011|NCT00635349|551133|P2|Overall Study|Lost to Follow-up|3
155012|NCT00635349|551134|P1|Overall Study|Lost to Follow-up|4
155013|NCT00635349|551133|P2|Overall Study|Withdrawal by Subject|8
155014|NCT00635349|551134|P1|Overall Study|Withdrawal by Subject|3
155015|NCT00635349|551133|P2|Overall Study|Protocol Violation|22
155016|NCT00635349|551134|P1|Overall Study|Protocol Violation|18
155017|NCT00635349|551133|P2|Overall Study|Other|6
155018|NCT00635349|551134|P1|Overall Study|Other|8
155019|NCT00635219|551188|P5|Overall Study|Administrative or Other Reasons|1
155020|NCT00635219|551189|P4|Overall Study|Administrative or Other Reasons|0
155021|NCT00635219|551190|P3|Overall Study|Administrative or Other Reasons|1
155022|NCT00635219|551191|P2|Overall Study|Administrative or Other Reasons|1
155023|NCT00635219|551192|P1|Overall Study|Administrative or Other Reasons|0
155024|NCT00635219|551188|P5|Overall Study|Lost to Follow-up|3
155025|NCT00635219|551189|P4|Overall Study|Lost to Follow-up|0
155026|NCT00635219|551190|P3|Overall Study|Lost to Follow-up|2
155027|NCT00635219|551191|P2|Overall Study|Lost to Follow-up|0
155028|NCT00635219|551192|P1|Overall Study|Lost to Follow-up|0
155029|NCT00635219|551188|P5|Overall Study|Withdrawal of Consent|8
155030|NCT00635219|551189|P4|Overall Study|Withdrawal of Consent|11
155031|NCT00635219|551190|P3|Overall Study|Withdrawal of Consent|8
155032|NCT00635219|551191|P2|Overall Study|Withdrawal of Consent|6
155033|NCT00635219|551192|P1|Overall Study|Withdrawal of Consent|8
155034|NCT00635219|551188|P5|Overall Study|Protocol Violation|4
155035|NCT00635219|551189|P4|Overall Study|Protocol Violation|2
155036|NCT00635219|551190|P3|Overall Study|Protocol Violation|3
155037|NCT00635219|551191|P2|Overall Study|Protocol Violation|2
155038|NCT00635219|551192|P1|Overall Study|Protocol Violation|0
155039|NCT00635219|551188|P5|Overall Study|Non-compliance With Study Product|1
155040|NCT00635219|551189|P4|Overall Study|Non-compliance With Study Product|2
155041|NCT00635219|551190|P3|Overall Study|Non-compliance With Study Product|0
155042|NCT00635219|551191|P2|Overall Study|Non-compliance With Study Product|0
155043|NCT00635219|551192|P1|Overall Study|Non-compliance With Study Product|0
155044|NCT00635219|551188|P5|Overall Study|Lack of Efficacy|6
155045|NCT00635219|551189|P4|Overall Study|Lack of Efficacy|4
155046|NCT00635219|551190|P3|Overall Study|Lack of Efficacy|3
155047|NCT00635219|551191|P2|Overall Study|Lack of Efficacy|6
155048|NCT00635219|551192|P1|Overall Study|Lack of Efficacy|5
155049|NCT00635219|551188|P5|Overall Study|Adverse Event|19
155050|NCT00635219|551189|P4|Overall Study|Adverse Event|15
155051|NCT00635219|551190|P3|Overall Study|Adverse Event|18
155052|NCT00635219|551191|P2|Overall Study|Adverse Event|10
155053|NCT00635219|551192|P1|Overall Study|Adverse Event|12
155054|NCT00635154|551249|P1|Overall Study|Still on treatment|21
155055|NCT00635154|551249|P1|Overall Study|Other|4
155056|NCT00635154|551249|P1|Overall Study|Alternative Treatment|8
155057|NCT00635102|551292|P2|Overall Study|Withdrawal by Subject|8
155058|NCT00635102|551293|P1|Overall Study|Withdrawal by Subject|7
155059|NCT00635089|551387|P1|Overall Study|Not Specified|31
155060|NCT00635089|551387|P1|Overall Study|Lost to Follow-up|8
155061|NCT00635089|551387|P1|Overall Study|Protocol Deviation|4
155062|NCT00635089|551387|P1|Overall Study|Lack of Efficacy|28
155063|NCT00635089|551387|P1|Overall Study|Adverse Event|7
155064|NCT00635050|551414|P1|Overall Study|Withdrawal by Subject|1
155065|NCT00635024|551421|P1|Overall Study|Adverse Event|1
155066|NCT00634933|551432|P5|Part B: Week 24 to Week 52|Other|1
155067|NCT00634933|551433|P4|Part B: Week 24 to Week 52|Other|0
155068|NCT00634933|551434|P3|Part B: Week 24 to Week 52|Other|5
155069|NCT00634933|551435|P2|Part B: Week 24 to Week 52|Other|0
155070|NCT00634933|551436|P1|Part B: Week 24 to Week 52|Other|0
155071|NCT00634933|551432|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
155072|NCT00634933|551433|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
155073|NCT00634933|551434|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
155074|NCT00634933|551435|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
155075|NCT00634933|551436|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
155076|NCT00634933|551432|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
155077|NCT00634933|551433|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
155078|NCT00634933|551434|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
155079|NCT00634933|551435|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
155080|NCT00634933|551436|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
155081|NCT00634933|551432|P5|Part B: Week 24 to Week 52|Protocol Violation|1
155082|NCT00634933|551433|P4|Part B: Week 24 to Week 52|Protocol Violation|0
155083|NCT00634933|551434|P3|Part B: Week 24 to Week 52|Protocol Violation|0
155084|NCT00634933|551435|P2|Part B: Week 24 to Week 52|Protocol Violation|0
155085|NCT00634933|551436|P1|Part B: Week 24 to Week 52|Protocol Violation|0
155086|NCT00634933|551432|P5|Part B: Week 24 to Week 52|Physician Decision|0
155087|NCT00634933|551433|P4|Part B: Week 24 to Week 52|Physician Decision|0
155088|NCT00634933|551434|P3|Part B: Week 24 to Week 52|Physician Decision|1
155089|NCT00634933|551435|P2|Part B: Week 24 to Week 52|Physician Decision|1
155090|NCT00634933|551436|P1|Part B: Week 24 to Week 52|Physician Decision|0
155091|NCT00634933|551432|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
155092|NCT00634933|551433|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
155093|NCT00634933|551434|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
155094|NCT00634933|551435|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
155095|NCT00634933|551436|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
155096|NCT00634933|551432|P5|Part B: Week 24 to Week 52|Adverse Event|0
155097|NCT00634933|551433|P4|Part B: Week 24 to Week 52|Adverse Event|1
155098|NCT00634933|551434|P3|Part B: Week 24 to Week 52|Adverse Event|1
155099|NCT00634933|551435|P2|Part B: Week 24 to Week 52|Adverse Event|1
155100|NCT00634933|551436|P1|Part B: Week 24 to Week 52|Adverse Event|0
155101|NCT00634933|551432|P5|Between Part A and Part B|Physician Decision|0
155102|NCT00634933|551433|P4|Between Part A and Part B|Physician Decision|0
155103|NCT00634933|551434|P3|Between Part A and Part B|Physician Decision|0
155104|NCT00634933|551435|P2|Between Part A and Part B|Physician Decision|1
155105|NCT00634933|551436|P1|Between Part A and Part B|Physician Decision|0
155106|NCT00634933|551432|P5|Part A: Baseline to Week 24|Other|0
155107|NCT00634933|551433|P4|Part A: Baseline to Week 24|Other|0
155108|NCT00634933|551434|P3|Part A: Baseline to Week 24|Other|5
155109|NCT00634933|551435|P2|Part A: Baseline to Week 24|Other|8
155110|NCT00634933|551436|P1|Part A: Baseline to Week 24|Other|1
155111|NCT00634933|551432|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
155112|NCT00634933|551433|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
155113|NCT00634933|551434|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
155114|NCT00634933|551435|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
155115|NCT00634933|551436|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
155116|NCT00634933|551432|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
155117|NCT00634933|551433|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
155118|NCT00634933|551434|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
155119|NCT00634933|551435|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
155120|NCT00634933|551436|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
155121|NCT00634933|551432|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
155122|NCT00634933|551433|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
155123|NCT00634933|551434|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
155124|NCT00634933|551435|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
155125|NCT00634933|551436|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
155126|NCT00634933|551432|P5|Part A: Baseline to Week 24|Investigator Request|0
155127|NCT00634933|551433|P4|Part A: Baseline to Week 24|Investigator Request|0
155128|NCT00634933|551434|P3|Part A: Baseline to Week 24|Investigator Request|1
155129|NCT00634933|551435|P2|Part A: Baseline to Week 24|Investigator Request|1
155130|NCT00634933|551436|P1|Part A: Baseline to Week 24|Investigator Request|1
155131|NCT00634933|551432|P5|Part A: Baseline to Week 24|Failed to Return|0
155132|NCT00634933|551433|P4|Part A: Baseline to Week 24|Failed to Return|0
155133|NCT00634933|551434|P3|Part A: Baseline to Week 24|Failed to Return|0
155134|NCT00634933|551435|P2|Part A: Baseline to Week 24|Failed to Return|0
155135|NCT00634933|551436|P1|Part A: Baseline to Week 24|Failed to Return|1
155136|NCT00634933|551432|P5|Part A: Baseline to Week 24|Death|0
155137|NCT00634933|551433|P4|Part A: Baseline to Week 24|Death|0
155138|NCT00634933|551434|P3|Part A: Baseline to Week 24|Death|0
155139|NCT00634933|551435|P2|Part A: Baseline to Week 24|Death|0
155140|NCT00634933|551436|P1|Part A: Baseline to Week 24|Death|1
155141|NCT00634933|551432|P5|Part A: Baseline to Week 24|Adverse Event|0
155142|NCT00634933|551433|P4|Part A: Baseline to Week 24|Adverse Event|0
155143|NCT00634933|551434|P3|Part A: Baseline to Week 24|Adverse Event|8
155144|NCT00634933|551435|P2|Part A: Baseline to Week 24|Adverse Event|4
155145|NCT00634933|551436|P1|Part A: Baseline to Week 24|Adverse Event|4
155146|NCT00634920|551505|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
155147|NCT00634920|551506|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
155148|NCT00634920|551507|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
155149|NCT00634920|551505|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
155150|NCT00634920|551506|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
155151|NCT00634920|551507|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
155152|NCT00634920|551505|P3|Period 2 - Post-Randomization|Death|0
155153|NCT00634920|551506|P2|Period 2 - Post-Randomization|Death|5
155154|NCT00634920|551507|P1|Period 2 - Post-Randomization|Death|2
155155|NCT00634920|551505|P3|Period 2 - Post-Randomization|Rejection|0
155156|NCT00634920|551506|P2|Period 2 - Post-Randomization|Rejection|5
155157|NCT00634920|551507|P1|Period 2 - Post-Randomization|Rejection|11
155158|NCT00634920|551505|P3|Period 2 - Post-Randomization|Adverse Event|0
155159|NCT00634920|551506|P2|Period 2 - Post-Randomization|Adverse Event|9
155160|NCT00634920|551507|P1|Period 2 - Post-Randomization|Adverse Event|37
155161|NCT00634920|551505|P3|Period 1 - Pre-Randomization|Other issues|6
155162|NCT00634920|551506|P2|Period 1 - Pre-Randomization|Other issues|0
155163|NCT00634920|551507|P1|Period 1 - Pre-Randomization|Other issues|0
155164|NCT00634920|551505|P3|Period 1 - Pre-Randomization|Non-Compliance|3
155165|NCT00634920|551506|P2|Period 1 - Pre-Randomization|Non-Compliance|0
155166|NCT00634920|551507|P1|Period 1 - Pre-Randomization|Non-Compliance|0
155167|NCT00634920|551505|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
155168|NCT00634920|551506|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
155169|NCT00634920|551507|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
155170|NCT00634920|551505|P3|Period 1 - Pre-Randomization|Rejections|55
155171|NCT00634920|551506|P2|Period 1 - Pre-Randomization|Rejections|0
155172|NCT00634920|551507|P1|Period 1 - Pre-Randomization|Rejections|0
155173|NCT00634920|551505|P3|Period 1 - Pre-Randomization|Wound healing problems|16
155174|NCT00634920|551506|P2|Period 1 - Pre-Randomization|Wound healing problems|0
155175|NCT00634920|551507|P1|Period 1 - Pre-Randomization|Wound healing problems|0
155176|NCT00634920|551505|P3|Period 1 - Pre-Randomization|Adverse Event|36
155177|NCT00634920|551506|P2|Period 1 - Pre-Randomization|Adverse Event|0
155178|NCT00634920|551507|P1|Period 1 - Pre-Randomization|Adverse Event|0
155179|NCT00634907|551551|P2|Overall Study|Withdrawal by Subject|8
155180|NCT00634907|551552|P1|Overall Study|Withdrawal by Subject|11
155181|NCT00634907|551551|P2|Overall Study|Physician Decision|9
155182|NCT00634907|551552|P1|Overall Study|Physician Decision|3
155183|NCT00634907|551551|P2|Overall Study|Withdrawal by Subject|0
155184|NCT00634907|551552|P1|Overall Study|Withdrawal by Subject|3
155185|NCT00634842|551576|P2|Overall Study|Subject off study drug for too long|1
155186|NCT00634842|551577|P1|Overall Study|Subject off study drug for too long|0
155187|NCT00634842|551576|P2|Overall Study|No wish to keep taking Avandia|1
155188|NCT00634842|551577|P1|Overall Study|No wish to keep taking Avandia|0
155189|NCT00634842|551576|P2|Overall Study|No need of study drug to treat diabetes|1
155190|NCT00634842|551577|P1|Overall Study|No need of study drug to treat diabetes|0
155191|NCT00634842|551576|P2|Overall Study|Discontinued due to injection|2
155192|NCT00634842|551577|P1|Overall Study|Discontinued due to injection|0
155193|NCT00634842|551576|P2|Overall Study|Lack of time and intolerance to drug|1
155194|NCT00634842|551577|P1|Overall Study|Lack of time and intolerance to drug|0
155195|NCT00634842|551576|P2|Overall Study|Withdrawal by Subject|3
155196|NCT00634842|551577|P1|Overall Study|Withdrawal by Subject|1
155197|NCT00634842|551576|P2|Overall Study|Physician Decision|0
155198|NCT00634842|551577|P1|Overall Study|Physician Decision|1
155199|NCT00634842|551576|P2|Overall Study|Lost to Follow-up|2
155200|NCT00634842|551577|P1|Overall Study|Lost to Follow-up|1
155201|NCT00634842|551576|P2|Overall Study|Inclusion criteria were not met|0
155202|NCT00634842|551577|P1|Overall Study|Inclusion criteria were not met|1
155203|NCT00634842|551576|P2|Overall Study|Move to another state|0
155204|NCT00634842|551577|P1|Overall Study|Move to another state|1
155205|NCT00634842|551576|P2|Overall Study|Protocol Violation|4
155206|NCT00634842|551577|P1|Overall Study|Protocol Violation|8
155207|NCT00634842|551576|P2|Overall Study|Adverse Event|3
155208|NCT00634842|551577|P1|Overall Study|Adverse Event|2
155209|NCT00634751|551593|P4|Pancreatic and Bilial Tract Cancer|Death|1
155210|NCT00634751|551594|P3|Pancreatic and Bilial Tract Cancer|Death|1
155211|NCT00634751|551595|P2|Pancreatic and Bilial Tract Cancer|Death|0
155212|NCT00634751|551596|P1|Pancreatic and Bilial Tract Cancer|Death|0
155213|NCT00634751|551593|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
155214|NCT00634751|551594|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
155215|NCT00634751|551595|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
155216|NCT00634751|551596|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
155217|NCT00634751|551593|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
155218|NCT00634751|551594|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
155219|NCT00634751|551595|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
155220|NCT00634751|551596|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
155221|NCT00634647|551614|P1|Overall Study|declined to participate before treatment|1
155222|NCT00634647|551614|P1|Overall Study|refused further treatment|3
155223|NCT00634647|551614|P1|Overall Study|death on study|5
155224|NCT00634569|551633|P2|Overall Study|Physician Decision|1
155225|NCT00634569|551634|P1|Overall Study|Physician Decision|0
155226|NCT00634569|551633|P2|Overall Study|Withdrawal by Subject|4
155227|NCT00634569|551634|P1|Overall Study|Withdrawal by Subject|0
155228|NCT00634543|551648|P2|Overall Study|Lost to Follow-up|1
155229|NCT00634543|551649|P1|Overall Study|Lost to Follow-up|0
155230|NCT00634543|551648|P2|Overall Study|Withdrawal by Subject|4
155231|NCT00634543|551649|P1|Overall Study|Withdrawal by Subject|4
155232|NCT00634543|551648|P2|Overall Study|Adverse Event|11
155233|NCT00634543|551649|P1|Overall Study|Adverse Event|11
155234|NCT00634543|551648|P2|Overall Study|Protocol Violation|3
155235|NCT00634543|551649|P1|Overall Study|Protocol Violation|3
155236|NCT00634543|551648|P2|Overall Study|Other|2
155237|NCT00634543|551649|P1|Overall Study|Other|1
155238|NCT00634504|551667|P2|Overall Study|Protocol Violation|0
155239|NCT00634504|551668|P1|Overall Study|Protocol Violation|1
155240|NCT00634244|551719|P3|Overall Study|Other complicating disease|0
155241|NCT00634244|551720|P2|Overall Study|Other complicating disease|1
155242|NCT00634244|551721|P1|Overall Study|Other complicating disease|0
155243|NCT00634244|551719|P3|Overall Study|Disease progression/relapse|0
155244|NCT00634244|551720|P2|Overall Study|Disease progression/relapse|1
155245|NCT00634244|551721|P1|Overall Study|Disease progression/relapse|0
155246|NCT00634244|551719|P3|Overall Study|Physician Decision|0
155247|NCT00634244|551720|P2|Overall Study|Physician Decision|1
155248|NCT00634244|551721|P1|Overall Study|Physician Decision|0
155249|NCT00634244|551719|P3|Overall Study|Withdrawal by Subject|0
155250|NCT00634244|551720|P2|Overall Study|Withdrawal by Subject|1
155251|NCT00634244|551721|P1|Overall Study|Withdrawal by Subject|0
155252|NCT00634244|551719|P3|Overall Study|Adverse Event|0
155253|NCT00634244|551720|P2|Overall Study|Adverse Event|2
155254|NCT00634244|551721|P1|Overall Study|Adverse Event|0
155255|NCT00634244|551719|P3|Overall Study|Death|0
155256|NCT00634244|551720|P2|Overall Study|Death|6
155257|NCT00634244|551721|P1|Overall Study|Death|1
155258|NCT00634244|551719|P3|Overall Study|Never started treatment|0
155259|NCT00634244|551720|P2|Overall Study|Never started treatment|1
155260|NCT00634244|551721|P1|Overall Study|Never started treatment|0
155261|NCT00634179|551732|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
155262|NCT00634114|551751|P3|Overall Study|Other reason|1
155263|NCT00634114|551752|P2|Overall Study|Other reason|1
155264|NCT00634114|551753|P1|Overall Study|Other reason|1
155265|NCT00634114|551751|P3|Overall Study|Difficult to continue|1
155266|NCT00634114|551752|P2|Overall Study|Difficult to continue|1
155267|NCT00634114|551753|P1|Overall Study|Difficult to continue|3
155268|NCT00634114|551751|P3|Overall Study|Recurrence of reflux esophagitis|21
155269|NCT00634114|551752|P2|Overall Study|Recurrence of reflux esophagitis|15
155270|NCT00634114|551753|P1|Overall Study|Recurrence of reflux esophagitis|5
155271|NCT00634114|551751|P3|Overall Study|Incorrect enrolment|0
155272|NCT00634114|551752|P2|Overall Study|Incorrect enrolment|1
155273|NCT00634114|551753|P1|Overall Study|Incorrect enrolment|0
155274|NCT00634114|551751|P3|Overall Study|Pregnancy|0
155275|NCT00634114|551752|P2|Overall Study|Pregnancy|0
155276|NCT00634114|551753|P1|Overall Study|Pregnancy|1
155277|NCT00634114|551751|P3|Overall Study|Protocol Violation|1
155278|NCT00634114|551752|P2|Overall Study|Protocol Violation|3
155279|NCT00634114|551753|P1|Overall Study|Protocol Violation|3
155280|NCT00634114|551751|P3|Overall Study|Lost to Follow-up|1
155281|NCT00634114|551752|P2|Overall Study|Lost to Follow-up|0
155282|NCT00634114|551753|P1|Overall Study|Lost to Follow-up|0
155283|NCT00634114|551751|P3|Overall Study|Withdrawal by Subject|11
155284|NCT00634114|551752|P2|Overall Study|Withdrawal by Subject|6
155285|NCT00634114|551753|P1|Overall Study|Withdrawal by Subject|9
155286|NCT00634114|551751|P3|Overall Study|Adverse Event|3
155287|NCT00634114|551752|P2|Overall Study|Adverse Event|8
155288|NCT00634114|551753|P1|Overall Study|Adverse Event|6
155289|NCT00634088|551771|P4|Time Period 3: Dose Level 3|Progressive disease|0
155290|NCT00634088|551772|P3|Time Period 3: Dose Level 3|Progressive disease|1
155291|NCT00634088|551773|P2|Time Period 3: Dose Level 3|Progressive disease|0
155292|NCT00634088|551774|P1|Time Period 3: Dose Level 3|Progressive disease|0
155293|NCT00634088|551771|P4|Time Period 2: Dose Level 2|Progressive disease|0
155294|NCT00634088|551772|P3|Time Period 2: Dose Level 2|Progressive disease|0
155295|NCT00634088|551773|P2|Time Period 2: Dose Level 2|Progressive disease|1
155296|NCT00634088|551774|P1|Time Period 2: Dose Level 2|Progressive disease|0
155297|NCT00634088|551771|P4|Time Period 2: Dose Level 2|Adverse Event|0
155298|NCT00634088|551772|P3|Time Period 2: Dose Level 2|Adverse Event|0
155299|NCT00634088|551773|P2|Time Period 2: Dose Level 2|Adverse Event|2
155300|NCT00634088|551774|P1|Time Period 2: Dose Level 2|Adverse Event|0
155301|NCT00634088|551771|P4|Time Period 1: Dose Level 1|Adverse Event|0
155302|NCT00634088|551772|P3|Time Period 1: Dose Level 1|Adverse Event|0
155303|NCT00634088|551773|P2|Time Period 1: Dose Level 1|Adverse Event|0
155304|NCT00634088|551774|P1|Time Period 1: Dose Level 1|Adverse Event|3
155305|NCT00634088|551771|P4|Time Period 1: Dose Level 1|Physician Decision|0
155306|NCT00634088|551772|P3|Time Period 1: Dose Level 1|Physician Decision|0
155307|NCT00634088|551773|P2|Time Period 1: Dose Level 1|Physician Decision|0
155308|NCT00634088|551774|P1|Time Period 1: Dose Level 1|Physician Decision|1
155309|NCT00634088|551771|P4|Time Period 1: Dose Level 1|Disease progression|0
155310|NCT00634088|551772|P3|Time Period 1: Dose Level 1|Disease progression|0
155311|NCT00634088|551773|P2|Time Period 1: Dose Level 1|Disease progression|0
155312|NCT00634088|551774|P1|Time Period 1: Dose Level 1|Disease progression|2
155313|NCT00634049|551825|P1|Overall Study|Screening failure|1
155314|NCT00634049|551825|P1|Overall Study|Died prior to receiving study drug|1
155315|NCT00634049|551825|P1|Overall Study|Never received study drug|1
155316|NCT00634036|551904|P2|Overall Study|Withdrawal by Subject|1
155317|NCT00634036|551905|P1|Overall Study|Withdrawal by Subject|1
155318|NCT00634036|551904|P2|Overall Study|Lost to Follow-up|1
155319|NCT00634036|551905|P1|Overall Study|Lost to Follow-up|1
155320|NCT00634010|551919|P2|Overall Study|Non-Compliant|1
155321|NCT00634010|551920|P1|Overall Study|Non-Compliant|1
155322|NCT00634010|551919|P2|Overall Study|Disease Progression|1
155323|NCT00634010|551920|P1|Overall Study|Disease Progression|1
155324|NCT00634010|551919|P2|Overall Study|Physician Decision|1
155325|NCT00634010|551920|P1|Overall Study|Physician Decision|1
155326|NCT00634010|551919|P2|Overall Study|Withdrawal by Subject|6
155327|NCT00634010|551920|P1|Overall Study|Withdrawal by Subject|5
155328|NCT00634010|551919|P2|Overall Study|Adverse Event|5
155329|NCT00634010|551920|P1|Overall Study|Adverse Event|2
155330|NCT00633984|551928|P2|Overall Study|Hospitalized|0
155331|NCT00633984|551929|P1|Overall Study|Hospitalized|1
155332|NCT00633984|551928|P2|Overall Study|Withdrawal by Subject|7
155333|NCT00633984|551929|P1|Overall Study|Withdrawal by Subject|8
155334|NCT00633984|551928|P2|Overall Study|Lost to Follow-up|6
155335|NCT00633984|551929|P1|Overall Study|Lost to Follow-up|0
155336|NCT00633932|551940|P3|Overall Study|Moved Away|0
155337|NCT00633932|551941|P2|Overall Study|Moved Away|0
155338|NCT00633932|551942|P1|Overall Study|Moved Away|1
155339|NCT00633932|551940|P3|Overall Study|Doctor's judgement|0
155340|NCT00633932|551941|P2|Overall Study|Doctor's judgement|0
155341|NCT00633932|551942|P1|Overall Study|Doctor's judgement|1
155342|NCT00633932|551940|P3|Overall Study|Physician Decision|1
155343|NCT00633932|551941|P2|Overall Study|Physician Decision|0
155344|NCT00633932|551942|P1|Overall Study|Physician Decision|0
155345|NCT00633932|551940|P3|Overall Study|Protocol Violation|3
155346|NCT00633932|551941|P2|Overall Study|Protocol Violation|2
155347|NCT00633932|551942|P1|Overall Study|Protocol Violation|5
155348|NCT00633932|551940|P3|Overall Study|Lost to Follow-up|2
155349|NCT00633932|551941|P2|Overall Study|Lost to Follow-up|0
155350|NCT00633932|551942|P1|Overall Study|Lost to Follow-up|1
155351|NCT00633932|551940|P3|Overall Study|Withdrawal by Subject|1
155352|NCT00633932|551941|P2|Overall Study|Withdrawal by Subject|9
155353|NCT00633932|551942|P1|Overall Study|Withdrawal by Subject|3
155354|NCT00633932|551940|P3|Overall Study|Adverse Event|4
155355|NCT00633932|551941|P2|Overall Study|Adverse Event|3
155356|NCT00633932|551942|P1|Overall Study|Adverse Event|1
155357|NCT00633893|551973|P3|Overall Study|not specified|31
155358|NCT00633893|551974|P2|Overall Study|not specified|33
155359|NCT00633893|551975|P1|Overall Study|not specified|28
155360|NCT00633893|551973|P3|Overall Study|Not meet/no longer meets criteria|4
155361|NCT00633893|551974|P2|Overall Study|Not meet/no longer meets criteria|6
155362|NCT00633893|551975|P1|Overall Study|Not meet/no longer meets criteria|4
155363|NCT00633893|551973|P3|Overall Study|Pregnancy|1
155364|NCT00633893|551974|P2|Overall Study|Pregnancy|1
155365|NCT00633893|551975|P1|Overall Study|Pregnancy|2
155366|NCT00633893|551973|P3|Overall Study|Poor/non-compliance|3
155367|NCT00633893|551974|P2|Overall Study|Poor/non-compliance|12
155368|NCT00633893|551975|P1|Overall Study|Poor/non-compliance|5
155369|NCT00633893|551973|P3|Overall Study|Lost to Follow-up|8
155370|NCT00633893|551974|P2|Overall Study|Lost to Follow-up|4
155371|NCT00633893|551975|P1|Overall Study|Lost to Follow-up|2
155372|NCT00633893|551973|P3|Overall Study|Withdrawal by Subject|6
155373|NCT00633893|551974|P2|Overall Study|Withdrawal by Subject|12
155374|NCT00633893|551975|P1|Overall Study|Withdrawal by Subject|7
155375|NCT00633893|551973|P3|Overall Study|Adverse Event|126
155376|NCT00633893|551974|P2|Overall Study|Adverse Event|58
155377|NCT00633893|551975|P1|Overall Study|Adverse Event|65
155378|NCT00633893|551973|P3|Overall Study|Death|9
155379|NCT00633893|551974|P2|Overall Study|Death|3
155380|NCT00633893|551975|P1|Overall Study|Death|1
155381|NCT00633880|552049|P3|Open Label Titration|Withdrawal by Subject|0
155382|NCT00633880|552050|P2|Open Label Titration|Withdrawal by Subject|0
155383|NCT00633880|552051|P1|Open Label Titration|Withdrawal by Subject|4
155384|NCT00633880|552049|P3|Open Label Titration|Physician Decision|0
155385|NCT00633880|552050|P2|Open Label Titration|Physician Decision|0
155386|NCT00633880|552051|P1|Open Label Titration|Physician Decision|1
155387|NCT00633880|552049|P3|Open Label Titration|Protocol Violation|0
155388|NCT00633880|552050|P2|Open Label Titration|Protocol Violation|0
155389|NCT00633880|552051|P1|Open Label Titration|Protocol Violation|6
155390|NCT00633880|552049|P3|Open Label Titration|Treatment Failure|0
155391|NCT00633880|552050|P2|Open Label Titration|Treatment Failure|0
155392|NCT00633880|552051|P1|Open Label Titration|Treatment Failure|55
155393|NCT00633880|552049|P3|Open Label Titration|Adverse Event|0
155394|NCT00633880|552050|P2|Open Label Titration|Adverse Event|0
155395|NCT00633880|552051|P1|Open Label Titration|Adverse Event|13
155396|NCT00633880|552049|P3|Open Label Titration|Lack of Efficacy|0
155397|NCT00633880|552050|P2|Open Label Titration|Lack of Efficacy|0
155398|NCT00633880|552051|P1|Open Label Titration|Lack of Efficacy|1
155399|NCT00633750|552087|P1|Overall Study|Withdrawal by Subject|3
155400|NCT00633750|552087|P1|Overall Study|Adverse Event|2
155401|NCT00633594|552096|P3|Overall Study|Disease Progression|1
155402|NCT00633594|552097|P2|Overall Study|Disease Progression|0
155403|NCT00633594|552098|P1|Overall Study|Disease Progression|0
155404|NCT00633594|552096|P3|Overall Study|Death|2
155405|NCT00633594|552097|P2|Overall Study|Death|1
155406|NCT00633594|552098|P1|Overall Study|Death|0
155407|NCT00633594|552096|P3|Overall Study|Adverse Event|7
155408|NCT00633594|552097|P2|Overall Study|Adverse Event|4
155409|NCT00633594|552098|P1|Overall Study|Adverse Event|0
155410|NCT00633477|552127|P2|Overall Study|Randomized but not treated|0
155411|NCT00633477|552128|P1|Overall Study|Randomized but not treated|1
155412|NCT00633477|552127|P2|Overall Study|Death|0
155413|NCT00633477|552128|P1|Overall Study|Death|1
155414|NCT00633464|552144|P2|Overall Study|Never Treated (Randomized in error)|1
155415|NCT00633464|552145|P1|Overall Study|Never Treated (Randomized in error)|0
155416|NCT00633464|552144|P2|Overall Study|Never Treated (Not met study criteria)|1
155417|NCT00633464|552145|P1|Overall Study|Never Treated (Not met study criteria)|0
155418|NCT00633360|552180|P2|Overall Study|Protocol Violation|1
155419|NCT00633360|552181|P1|Overall Study|Protocol Violation|0
155420|NCT00633360|552180|P2|Overall Study|Adverse Event|1
155421|NCT00633360|552181|P1|Overall Study|Adverse Event|3
155422|NCT00633360|552180|P2|Overall Study|Lost to Follow-up|1
155423|NCT00633360|552181|P1|Overall Study|Lost to Follow-up|1
155424|NCT00633243|552204|P2|Overall Study|Couldn't tolerate side-effects|1
155425|NCT00633243|552205|P1|Overall Study|Couldn't tolerate side-effects|1
155426|NCT00633243|552204|P2|Overall Study|Mental Health--Depression|1
155427|NCT00633243|552205|P1|Overall Study|Mental Health--Depression|0
155428|NCT00633243|552204|P2|Overall Study|Not comfortable with self-injecting|1
155429|NCT00633243|552205|P1|Overall Study|Not comfortable with self-injecting|0
155430|NCT00633243|552204|P2|Overall Study|Homeless--no refrigeration for meds|1
155431|NCT00633243|552205|P1|Overall Study|Homeless--no refrigeration for meds|0
155432|NCT00633243|552204|P2|Overall Study|incarceration|2
155433|NCT00633243|552205|P1|Overall Study|incarceration|0
155434|NCT00633243|552204|P2|Overall Study|Withdrawal by Subject|1
155435|NCT00633243|552205|P1|Overall Study|Withdrawal by Subject|0
155436|NCT00633217|552213|P2|Overall Study|Withdrew Consent|3
155437|NCT00633217|552214|P1|Overall Study|Withdrew Consent|3
155438|NCT00633217|552213|P2|Overall Study|Investigator Discretion|0
155439|NCT00633217|552214|P1|Overall Study|Investigator Discretion|2
155440|NCT00633217|552213|P2|Overall Study|Lost to Follow-up|2
155441|NCT00633217|552214|P1|Overall Study|Lost to Follow-up|2
155442|NCT00633217|552213|P2|Overall Study|Protocol Violation|7
155443|NCT00633217|552214|P1|Overall Study|Protocol Violation|3
155444|NCT00633217|552213|P2|Overall Study|Lack of Efficacy|2
155445|NCT00633217|552214|P1|Overall Study|Lack of Efficacy|0
155446|NCT00633217|552213|P2|Overall Study|Adverse Event|9
155447|NCT00633217|552214|P1|Overall Study|Adverse Event|5
155448|NCT00633152|552226|P2|Overall Study|Miscellaneous Other|2
155449|NCT00633152|552227|P1|Overall Study|Miscellaneous Other|3
155450|NCT00633152|552226|P2|Overall Study|Lost to Follow-up|1
155451|NCT00633152|552227|P1|Overall Study|Lost to Follow-up|4
155452|NCT00633152|552226|P2|Overall Study|Withdrawal by Subject|1
155453|NCT00633152|552227|P1|Overall Study|Withdrawal by Subject|1
155454|NCT00633152|552226|P2|Overall Study|Randomized, did not receive study drug|2
155455|NCT00633152|552227|P1|Overall Study|Randomized, did not receive study drug|5
155456|NCT00633152|552226|P2|Overall Study|Adverse Event|0
155457|NCT00633152|552227|P1|Overall Study|Adverse Event|1
155458|NCT00633139|552238|P3|Overall Study|Withdrawal by Subject|0
155459|NCT00633139|552239|P2|Overall Study|Withdrawal by Subject|1
155460|NCT00633139|552240|P1|Overall Study|Withdrawal by Subject|0
155461|NCT00633139|552238|P3|Overall Study|Non compliance|1
155462|NCT00633139|552239|P2|Overall Study|Non compliance|0
155463|NCT00633139|552240|P1|Overall Study|Non compliance|0
155464|NCT00633126|552254|P1|Overall Study|Did not receive full dose|1
155465|NCT00633074|552268|P2|Overall Study|Adverse Event|0
155466|NCT00633074|552269|P1|Overall Study|Adverse Event|1
155467|NCT00632931|552322|P3|Part 2|Withdrawal by Subject|3
155468|NCT00632931|552323|P2|Part 2|Withdrawal by Subject|0
155469|NCT00632931|552324|P1|Part 2|Withdrawal by Subject|0
155470|NCT00632931|552322|P3|Part 2|Lack of Efficacy|17
155471|NCT00632931|552323|P2|Part 2|Lack of Efficacy|0
155472|NCT00632931|552324|P1|Part 2|Lack of Efficacy|0
155473|NCT00632931|552322|P3|Part 2|Death|1
155474|NCT00632931|552323|P2|Part 2|Death|0
155475|NCT00632931|552324|P1|Part 2|Death|0
155476|NCT00632931|552322|P3|Part 2|Adverse Event|3
155477|NCT00632931|552323|P2|Part 2|Adverse Event|0
155478|NCT00632931|552324|P1|Part 2|Adverse Event|0
155479|NCT00632931|552322|P3|Part 1, Period 1|Withdrawal by Subject|0
155480|NCT00632931|552323|P2|Part 1, Period 1|Withdrawal by Subject|0
155481|NCT00632931|552324|P1|Part 1, Period 1|Withdrawal by Subject|1
155482|NCT00632931|552322|P3|Part 1, Period 1|Protocol Violation|0
155483|NCT00632931|552323|P2|Part 1, Period 1|Protocol Violation|0
155484|NCT00632931|552324|P1|Part 1, Period 1|Protocol Violation|1
155485|NCT00632749|552394|P14|Overall Study|Reason other than those specified above|2
155486|NCT00632749|552395|P13|Overall Study|Reason other than those specified above|0
155487|NCT00632749|552396|P12|Overall Study|Reason other than those specified above|1
155488|NCT00632749|552397|P11|Overall Study|Reason other than those specified above|2
155489|NCT00632749|552398|P10|Overall Study|Reason other than those specified above|0
155490|NCT00632749|552399|P9|Overall Study|Reason other than those specified above|0
155491|NCT00632749|552400|P8|Overall Study|Reason other than those specified above|0
155492|NCT00632749|552401|P7|Overall Study|Reason other than those specified above|1
155493|NCT00632749|552402|P6|Overall Study|Reason other than those specified above|0
155494|NCT00632749|552403|P5|Overall Study|Reason other than those specified above|1
155495|NCT00632749|552404|P4|Overall Study|Reason other than those specified above|0
155496|NCT00632749|552405|P3|Overall Study|Reason other than those specified above|0
155497|NCT00632749|552406|P2|Overall Study|Reason other than those specified above|2
155498|NCT00632749|552407|P1|Overall Study|Reason other than those specified above|0
155499|NCT00632749|552394|P14|Overall Study|Refuse to continue medication|0
155500|NCT00632749|552395|P13|Overall Study|Refuse to continue medication|0
155501|NCT00632749|552396|P12|Overall Study|Refuse to continue medication|0
155502|NCT00632749|552397|P11|Overall Study|Refuse to continue medication|0
155503|NCT00632749|552398|P10|Overall Study|Refuse to continue medication|1
155504|NCT00632749|552399|P9|Overall Study|Refuse to continue medication|0
155505|NCT00632749|552400|P8|Overall Study|Refuse to continue medication|0
155506|NCT00632749|552401|P7|Overall Study|Refuse to continue medication|0
155507|NCT00632749|552402|P6|Overall Study|Refuse to continue medication|0
155508|NCT00632749|552403|P5|Overall Study|Refuse to continue medication|0
155509|NCT00632749|552404|P4|Overall Study|Refuse to continue medication|1
155510|NCT00632749|552405|P3|Overall Study|Refuse to continue medication|0
155511|NCT00632749|552406|P2|Overall Study|Refuse to continue medication|0
155512|NCT00632749|552407|P1|Overall Study|Refuse to continue medication|0
155513|NCT00632749|552394|P14|Overall Study|Other Adverse event|0
155514|NCT00632749|552395|P13|Overall Study|Other Adverse event|1
155515|NCT00632749|552396|P12|Overall Study|Other Adverse event|0
155516|NCT00632749|552397|P11|Overall Study|Other Adverse event|1
155517|NCT00632749|552398|P10|Overall Study|Other Adverse event|0
155518|NCT00632749|552399|P9|Overall Study|Other Adverse event|2
155519|NCT00632749|552400|P8|Overall Study|Other Adverse event|2
155520|NCT00632749|552401|P7|Overall Study|Other Adverse event|1
155521|NCT00632749|552402|P6|Overall Study|Other Adverse event|4
155522|NCT00632749|552403|P5|Overall Study|Other Adverse event|2
155523|NCT00632749|552404|P4|Overall Study|Other Adverse event|1
155524|NCT00632749|552405|P3|Overall Study|Other Adverse event|1
155525|NCT00632749|552406|P2|Overall Study|Other Adverse event|1
155526|NCT00632749|552407|P1|Overall Study|Other Adverse event|1
155527|NCT00632749|552394|P14|Overall Study|Progressive disease|4
155528|NCT00632749|552395|P13|Overall Study|Progressive disease|2
155529|NCT00632749|552396|P12|Overall Study|Progressive disease|3
155530|NCT00632749|552397|P11|Overall Study|Progressive disease|4
155531|NCT00632749|552398|P10|Overall Study|Progressive disease|2
155532|NCT00632749|552399|P9|Overall Study|Progressive disease|3
155533|NCT00632749|552400|P8|Overall Study|Progressive disease|2
155534|NCT00632749|552401|P7|Overall Study|Progressive disease|3
155535|NCT00632749|552402|P6|Overall Study|Progressive disease|4
155536|NCT00632749|552403|P5|Overall Study|Progressive disease|4
155537|NCT00632749|552404|P4|Overall Study|Progressive disease|2
155538|NCT00632749|552405|P3|Overall Study|Progressive disease|2
155539|NCT00632749|552406|P2|Overall Study|Progressive disease|2
155540|NCT00632749|552407|P1|Overall Study|Progressive disease|3
155541|NCT00632736|552701|P1|Overall Study|Other|16
155542|NCT00632736|552701|P1|Overall Study|Non-compliance|10
155543|NCT00632736|552701|P1|Overall Study|Sponsor terminated study|5
155544|NCT00632736|552701|P1|Overall Study|Lack of Efficacy|5
155545|NCT00632736|552701|P1|Overall Study|Withdrawal by Subject|99
155546|NCT00632736|552701|P1|Overall Study|Protocol Violation|14
155547|NCT00632736|552701|P1|Overall Study|Lost to Follow-up|15
155548|NCT00632736|552701|P1|Overall Study|Adverse Event|104
155549|NCT00632541|552736|P1|Overall Study|Adverse Event|7
155550|NCT00632502|552745|P2|Overall Study|Randomized not treated|0
155551|NCT00632502|552746|P1|Overall Study|Randomized not treated|3
155552|NCT00632502|552745|P2|Overall Study|Adverse Event|1
155553|NCT00632502|552746|P1|Overall Study|Adverse Event|0
155554|NCT00632463|552790|P3|Overall Study|Adverse Event|0
155555|NCT00632463|552791|P2|Overall Study|Adverse Event|1
155556|NCT00632463|552792|P1|Overall Study|Adverse Event|0
155557|NCT00632424|552809|P1|Overall Study|Study Drug Toxicity|1
155558|NCT00632424|552809|P1|Overall Study|Disease Progression|17
155559|NCT00632229|552847|P2|Overall Study|Undisclosed reasons within the first wee|1
155560|NCT00632229|552848|P1|Overall Study|Undisclosed reasons within the first wee|0
155561|NCT00632229|552847|P2|Overall Study|Lack of Efficacy|2
155562|NCT00632229|552848|P1|Overall Study|Lack of Efficacy|0
155563|NCT00632229|552847|P2|Overall Study|Lost to Follow-up|3
155564|NCT00632229|552848|P1|Overall Study|Lost to Follow-up|0
155565|NCT00632229|552847|P2|Overall Study|Adverse Event|0
155566|NCT00632229|552848|P1|Overall Study|Adverse Event|6
155567|NCT00632203|552858|P2|Overall Study|Did not start study treatment|0
155568|NCT00632203|552859|P1|Overall Study|Did not start study treatment|1
155569|NCT00632125|552877|P1|Overall Study|Moved to other dialysis unit, etc.|102
155570|NCT00632125|552877|P1|Overall Study|Development of uncontrolled hypertension|5
155571|NCT00632125|552877|P1|Overall Study|Non-compliance|8
155572|NCT00632125|552877|P1|Overall Study|Need for systemic immunosuppressive medi|8
155573|NCT00632125|552877|P1|Overall Study|Renal transplantation|17
155574|NCT00632125|552877|P1|Overall Study|Adverse Event|36
155575|NCT00632125|552877|P1|Overall Study|Withdrawal by Subject|44
155576|NCT00632125|552877|P1|Overall Study|Death|82
155577|NCT00632099|552883|P2|Overall Study|Lost to Follow-up|3
155578|NCT00632099|552884|P1|Overall Study|Lost to Follow-up|3
155579|NCT00632021|552892|P2|Overall Study|Withdrawal/death|7
155580|NCT00632021|552893|P1|Overall Study|Withdrawal/death|4
155581|NCT00631969|552903|P2|Overall Study|No Drug Exposure|2
155582|NCT00631969|552904|P1|Overall Study|No Drug Exposure|2
155583|NCT00631969|552903|P2|Overall Study|Noncompliant With Study Medication|1
155584|NCT00631969|552904|P1|Overall Study|Noncompliant With Study Medication|0
155585|NCT00631969|552903|P2|Overall Study|Consent Withdrawn|7
155586|NCT00631969|552904|P1|Overall Study|Consent Withdrawn|5
155587|NCT00631969|552903|P2|Overall Study|Protocol Violation|1
155588|NCT00631969|552904|P1|Overall Study|Protocol Violation|1
155589|NCT00631969|552903|P2|Overall Study|Lost to Follow-up|1
155590|NCT00631969|552904|P1|Overall Study|Lost to Follow-up|2
155591|NCT00631969|552903|P2|Overall Study|Lack of Efficacy|8
155592|NCT00631969|552904|P1|Overall Study|Lack of Efficacy|2
155593|NCT00631969|552903|P2|Overall Study|Adverse Event|1
155594|NCT00631969|552904|P1|Overall Study|Adverse Event|3
155595|NCT00631917|552950|P2|Overall Study|Death|0
155596|NCT00631917|552951|P1|Overall Study|Death|1
155597|NCT00631917|552950|P2|Overall Study|Administrative problems|0
155598|NCT00631917|552951|P1|Overall Study|Administrative problems|2
155599|NCT00631917|552950|P2|Overall Study|Lost to Follow-up|7
155600|NCT00631917|552951|P1|Overall Study|Lost to Follow-up|7
155601|NCT00631917|552950|P2|Overall Study|Subject withdrew consent|33
155602|NCT00631917|552951|P1|Overall Study|Subject withdrew consent|25
155603|NCT00631917|552950|P2|Overall Study|Protocol deviation|5
155604|NCT00631917|552951|P1|Overall Study|Protocol deviation|6
155605|NCT00631917|552950|P2|Overall Study|No longer required study drug|1
155606|NCT00631917|552951|P1|Overall Study|No longer required study drug|0
155607|NCT00631917|552950|P2|Overall Study|Unsatisfactory therapeutic effect|14
155608|NCT00631917|552951|P1|Overall Study|Unsatisfactory therapeutic effect|8
155609|NCT00631917|552950|P2|Overall Study|Abnormal test procedure result(s)|2
155610|NCT00631917|552951|P1|Overall Study|Abnormal test procedure result(s)|3
155611|NCT00631917|552950|P2|Overall Study|Abnormal laboratory value(s)|1
155612|NCT00631917|552951|P1|Overall Study|Abnormal laboratory value(s)|2
155613|NCT00631917|552950|P2|Overall Study|Adverse Event|45
155614|NCT00631917|552951|P1|Overall Study|Adverse Event|34
155615|NCT00631696|552978|P2|Overall Study|Adverse Event|0
155616|NCT00631696|552979|P1|Overall Study|Adverse Event|5
155617|NCT00631696|552978|P2|Overall Study|Study terminated by sponsor|3
155618|NCT00631696|552979|P1|Overall Study|Study terminated by sponsor|3
155619|NCT00631696|552978|P2|Overall Study|Protocol Violation|9
155620|NCT00631696|552979|P1|Overall Study|Protocol Violation|9
155621|NCT00631696|552978|P2|Overall Study|Other|8
155622|NCT00631696|552979|P1|Overall Study|Other|8
155623|NCT00631696|552978|P2|Overall Study|Withdrawal by Subject|9
155624|NCT00631696|552979|P1|Overall Study|Withdrawal by Subject|2
155625|NCT00631696|552978|P2|Overall Study|Lost to Follow-up|10
155626|NCT00631696|552979|P1|Overall Study|Lost to Follow-up|7
155627|NCT00631696|552978|P2|Overall Study|Follow up after database release date|0
155628|NCT00631696|552979|P1|Overall Study|Follow up after database release date|1
155629|NCT00631696|552978|P2|Overall Study|Discontinued after database release date|0
155715|NCT00631189|553161|P1|Treatment Phase|Protocol Violation|0
155630|NCT00631696|552979|P1|Overall Study|Discontinued after database release date|1
155631|NCT00631696|552978|P2|Overall Study|Entered, not randomized to treatment|1
155632|NCT00631696|552979|P1|Overall Study|Entered, not randomized to treatment|1
155633|NCT00631657|553022|P3|7-Day Discontinuation Period|Other|0
155634|NCT00631657|553023|P2|7-Day Discontinuation Period|Other|0
155635|NCT00631657|553024|P1|7-Day Discontinuation Period|Other|1
155636|NCT00631657|553022|P3|7-Day Discontinuation Period|Not Treated|1
155637|NCT00631657|553023|P2|7-Day Discontinuation Period|Not Treated|1
155638|NCT00631657|553024|P1|7-Day Discontinuation Period|Not Treated|1
155639|NCT00631657|553022|P3|6-Month Treatment Period|Not Treated|1
155640|NCT00631657|553023|P2|6-Month Treatment Period|Not Treated|0
155641|NCT00631657|553024|P1|6-Month Treatment Period|Not Treated|2
155642|NCT00631657|553022|P3|6-Month Treatment Period|Other|4
155643|NCT00631657|553023|P2|6-Month Treatment Period|Other|0
155644|NCT00631657|553024|P1|6-Month Treatment Period|Other|16
155645|NCT00631657|553022|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
155646|NCT00631657|553023|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
155647|NCT00631657|553024|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
155648|NCT00631657|553022|P3|6-Month Treatment Period|Lost to Follow-up|2
155649|NCT00631657|553023|P2|6-Month Treatment Period|Lost to Follow-up|0
155650|NCT00631657|553024|P1|6-Month Treatment Period|Lost to Follow-up|7
155651|NCT00631657|553022|P3|6-Month Treatment Period|Lack of Efficacy|25
155652|NCT00631657|553023|P2|6-Month Treatment Period|Lack of Efficacy|0
155653|NCT00631657|553024|P1|6-Month Treatment Period|Lack of Efficacy|34
155654|NCT00631657|553022|P3|6-Month Treatment Period|Withdrawal by Subject|5
155655|NCT00631657|553023|P2|6-Month Treatment Period|Withdrawal by Subject|0
155656|NCT00631657|553024|P1|6-Month Treatment Period|Withdrawal by Subject|14
155657|NCT00631657|553022|P3|6-Month Treatment Period|Adverse Event|7
155658|NCT00631657|553023|P2|6-Month Treatment Period|Adverse Event|0
155659|NCT00631657|553024|P1|6-Month Treatment Period|Adverse Event|47
155660|NCT00631540|553051|P1|Overall Study|Core Lab Data Unavailable|3
155661|NCT00631540|553051|P1|Overall Study|Lost to Follow-up|2
155662|NCT00631540|553051|P1|Overall Study|Death|4
155663|NCT00631540|553051|P1|Overall Study|Withdrawal by Subject|5
155664|NCT00631488|553063|P3|Overall Study|Protocol Violation|1
155665|NCT00631488|553064|P2|Overall Study|Protocol Violation|0
155666|NCT00631488|553065|P1|Overall Study|Protocol Violation|0
155667|NCT00631488|553063|P3|Overall Study|Physician Decision|1
155668|NCT00631488|553064|P2|Overall Study|Physician Decision|0
155669|NCT00631488|553065|P1|Overall Study|Physician Decision|1
155670|NCT00631488|553063|P3|Overall Study|Lost to Follow-up|0
155671|NCT00631488|553064|P2|Overall Study|Lost to Follow-up|2
155672|NCT00631488|553065|P1|Overall Study|Lost to Follow-up|2
155673|NCT00631488|553063|P3|Overall Study|Adverse Event|0
155674|NCT00631488|553064|P2|Overall Study|Adverse Event|0
155675|NCT00631488|553065|P1|Overall Study|Adverse Event|1
155676|NCT00631475|553085|P1|Overall Study|Preparation for lung transplant|8
155677|NCT00631475|553085|P1|Overall Study|Withdrew consent|5
155678|NCT00631475|553085|P1|Overall Study|Adverse Event|14
155679|NCT00631475|553085|P1|Overall Study|Death|18
155680|NCT00631410|553104|P2|Overall Study|Surgery|0
155681|NCT00631410|553105|P1|Overall Study|Surgery|1
155682|NCT00631410|553104|P2|Overall Study|Objective Progression or Relapse|3
155683|NCT00631410|553105|P1|Overall Study|Objective Progression or Relapse|4
155684|NCT00631410|553104|P2|Overall Study|Adverse Event|3
155685|NCT00631410|553105|P1|Overall Study|Adverse Event|1
155686|NCT00631371|553124|P2|Overall Study|Death|239
155687|NCT00631371|553125|P1|Overall Study|Death|263
155688|NCT00631371|553124|P2|Overall Study|Discontinuation of study by Sponsor|76
155689|NCT00631371|553125|P1|Overall Study|Discontinuation of study by Sponsor|70
155690|NCT00631371|553124|P2|Overall Study|subject request|45
155691|NCT00631371|553125|P1|Overall Study|subject request|38
155692|NCT00631371|553124|P2|Overall Study|Other reason|12
155693|NCT00631371|553125|P1|Overall Study|Other reason|5
155694|NCT00631371|553124|P2|Overall Study|Lost to Follow-up|19
155695|NCT00631371|553125|P1|Overall Study|Lost to Follow-up|24
155696|NCT00631189|553158|P4|Treatment Phase|patient did not take pravastatin|0
155697|NCT00631189|553159|P3|Treatment Phase|patient did not take pravastatin|1
155698|NCT00631189|553160|P2|Treatment Phase|patient did not take pravastatin|0
155699|NCT00631189|553161|P1|Treatment Phase|patient did not take pravastatin|0
155700|NCT00631189|553158|P4|Treatment Phase|Pregnancy|0
155701|NCT00631189|553159|P3|Treatment Phase|Pregnancy|1
155702|NCT00631189|553160|P2|Treatment Phase|Pregnancy|0
155703|NCT00631189|553161|P1|Treatment Phase|Pregnancy|0
155704|NCT00631189|553158|P4|Treatment Phase|Lost to Follow-up|0
155705|NCT00631189|553159|P3|Treatment Phase|Lost to Follow-up|0
155706|NCT00631189|553160|P2|Treatment Phase|Lost to Follow-up|1
155707|NCT00631189|553161|P1|Treatment Phase|Lost to Follow-up|0
155708|NCT00631189|553158|P4|Treatment Phase|Adverse Event|4
155709|NCT00631189|553159|P3|Treatment Phase|Adverse Event|2
155710|NCT00631189|553160|P2|Treatment Phase|Adverse Event|3
155711|NCT00631189|553161|P1|Treatment Phase|Adverse Event|0
155712|NCT00631189|553158|P4|Treatment Phase|Protocol Violation|2
155713|NCT00631189|553159|P3|Treatment Phase|Protocol Violation|6
155714|NCT00631189|553160|P2|Treatment Phase|Protocol Violation|1
155716|NCT00631189|553158|P4|Treatment Phase|Withdrawal by Subject|1
155717|NCT00631189|553159|P3|Treatment Phase|Withdrawal by Subject|1
155718|NCT00631189|553160|P2|Treatment Phase|Withdrawal by Subject|2
155719|NCT00631189|553161|P1|Treatment Phase|Withdrawal by Subject|0
155720|NCT00631189|553158|P4|Initial Phase|Withdrawal by Subject|0
155721|NCT00631189|553159|P3|Initial Phase|Withdrawal by Subject|0
155722|NCT00631189|553160|P2|Initial Phase|Withdrawal by Subject|0
155723|NCT00631189|553161|P1|Initial Phase|Withdrawal by Subject|4
155724|NCT00631189|553158|P4|Initial Phase|Protocol Violation|0
155725|NCT00631189|553159|P3|Initial Phase|Protocol Violation|0
155726|NCT00631189|553160|P2|Initial Phase|Protocol Violation|0
155727|NCT00631189|553161|P1|Initial Phase|Protocol Violation|347
155728|NCT00631020|553203|P1|Overall Study|Incarcerated|1
155729|NCT00631020|553203|P1|Overall Study|Lost to Follow-up|7
155730|NCT00631007|553218|P6|Overall Study|Other|0
155731|NCT00631007|553219|P5|Overall Study|Other|1
155732|NCT00631007|553220|P4|Overall Study|Other|0
155733|NCT00631007|553221|P3|Overall Study|Other|0
155734|NCT00631007|553222|P2|Overall Study|Other|1
155735|NCT00631007|553223|P1|Overall Study|Other|2
155736|NCT00631007|553218|P6|Overall Study|Withdrawal by Subject|3
155737|NCT00631007|553219|P5|Overall Study|Withdrawal by Subject|1
155738|NCT00631007|553220|P4|Overall Study|Withdrawal by Subject|2
155739|NCT00631007|553221|P3|Overall Study|Withdrawal by Subject|2
155740|NCT00631007|553222|P2|Overall Study|Withdrawal by Subject|5
155741|NCT00631007|553223|P1|Overall Study|Withdrawal by Subject|4
155742|NCT00631007|553218|P6|Overall Study|Persistent Hyperglycemia|5
155743|NCT00631007|553219|P5|Overall Study|Persistent Hyperglycemia|2
155744|NCT00631007|553220|P4|Overall Study|Persistent Hyperglycemia|1
155745|NCT00631007|553221|P3|Overall Study|Persistent Hyperglycemia|5
155746|NCT00631007|553222|P2|Overall Study|Persistent Hyperglycemia|2
155747|NCT00631007|553223|P1|Overall Study|Persistent Hyperglycemia|2
155748|NCT00631007|553218|P6|Overall Study|Physician Decision|2
155749|NCT00631007|553219|P5|Overall Study|Physician Decision|0
155750|NCT00631007|553220|P4|Overall Study|Physician Decision|0
155751|NCT00631007|553221|P3|Overall Study|Physician Decision|1
155752|NCT00631007|553222|P2|Overall Study|Physician Decision|0
155753|NCT00631007|553223|P1|Overall Study|Physician Decision|1
155754|NCT00631007|553218|P6|Overall Study|Lost to Follow-up|3
155755|NCT00631007|553219|P5|Overall Study|Lost to Follow-up|5
155756|NCT00631007|553220|P4|Overall Study|Lost to Follow-up|4
155757|NCT00631007|553221|P3|Overall Study|Lost to Follow-up|2
155758|NCT00631007|553222|P2|Overall Study|Lost to Follow-up|1
155759|NCT00631007|553223|P1|Overall Study|Lost to Follow-up|2
155760|NCT00631007|553218|P6|Overall Study|Adverse Event|2
155761|NCT00631007|553219|P5|Overall Study|Adverse Event|3
155762|NCT00631007|553220|P4|Overall Study|Adverse Event|2
155763|NCT00631007|553221|P3|Overall Study|Adverse Event|0
155764|NCT00631007|553222|P2|Overall Study|Adverse Event|2
155765|NCT00631007|553223|P1|Overall Study|Adverse Event|0
155766|NCT00630994|553243|P1|Overall Study|Other|1
155767|NCT00630994|553243|P1|Overall Study|Lack of Efficacy|1
155768|NCT00630994|553243|P1|Overall Study|Disease Progression|1
155769|NCT00630994|553243|P1|Overall Study|Adverse Event|1
155770|NCT00630916|553273|P1|Overall Study|Lack of Efficacy|3
155771|NCT00630916|553273|P1|Overall Study|Physician Decision|47
155772|NCT00630916|553273|P1|Overall Study|Protocol Violation|7
155773|NCT00630916|553273|P1|Overall Study|Withdrawal by Subject|30
155774|NCT00630916|553273|P1|Overall Study|Lost to Follow-up|5
155775|NCT00630916|553273|P1|Overall Study|Explant|8
155776|NCT00630916|553273|P1|Overall Study|Death|110
155777|NCT00630877|553283|P3|Overall Study|Personal reasons|1
155778|NCT00630877|553284|P2|Overall Study|Personal reasons|0
155779|NCT00630877|553285|P1|Overall Study|Personal reasons|0
155780|NCT00630877|553283|P3|Overall Study|Protocol violation|1
155781|NCT00630877|553284|P2|Overall Study|Protocol violation|0
155782|NCT00630877|553285|P1|Overall Study|Protocol violation|1
155783|NCT00630877|553283|P3|Overall Study|Noncompliance|1
155784|NCT00630877|553284|P2|Overall Study|Noncompliance|3
155785|NCT00630877|553285|P1|Overall Study|Noncompliance|2
155786|NCT00630877|553283|P3|Overall Study|Lost to Follow-up|0
155787|NCT00630877|553284|P2|Overall Study|Lost to Follow-up|0
155788|NCT00630877|553285|P1|Overall Study|Lost to Follow-up|2
155789|NCT00630877|553283|P3|Overall Study|Withdrawal by Subject|0
155790|NCT00630877|553284|P2|Overall Study|Withdrawal by Subject|4
155791|NCT00630877|553285|P1|Overall Study|Withdrawal by Subject|3
155792|NCT00630877|553283|P3|Overall Study|Adverse Event|7
155793|NCT00630877|553284|P2|Overall Study|Adverse Event|8
155794|NCT00630877|553285|P1|Overall Study|Adverse Event|11
155795|NCT00630864|553303|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
155796|NCT00630864|553303|P1|Part 1 (up to Week 6)|Adverse Event|1
155797|NCT00630838|553342|P2|Overall Study|Lost to Follow-up|1
155798|NCT00630838|553343|P1|Overall Study|Lost to Follow-up|0
155799|NCT00630838|553342|P2|Overall Study|Death|1
155800|NCT00630838|553343|P1|Overall Study|Death|0
155801|NCT00630825|553355|P4|Overall Study|Withdrawal by Subject|3
155802|NCT00630825|553356|P3|Overall Study|Withdrawal by Subject|2
155803|NCT00630825|553357|P2|Overall Study|Withdrawal by Subject|2
155804|NCT00630825|553358|P1|Overall Study|Withdrawal by Subject|2
155805|NCT00630825|553355|P4|Overall Study|Physician Decision|0
155806|NCT00630825|553356|P3|Overall Study|Physician Decision|0
155807|NCT00630825|553357|P2|Overall Study|Physician Decision|0
155808|NCT00630825|553358|P1|Overall Study|Physician Decision|1
155809|NCT00630825|553355|P4|Overall Study|Lost to Follow-up|1
155810|NCT00630825|553356|P3|Overall Study|Lost to Follow-up|1
155811|NCT00630825|553357|P2|Overall Study|Lost to Follow-up|1
155812|NCT00630825|553358|P1|Overall Study|Lost to Follow-up|1
155813|NCT00630825|553355|P4|Overall Study|Entry Criteria Not Met|1
155814|NCT00630825|553356|P3|Overall Study|Entry Criteria Not Met|2
155815|NCT00630825|553357|P2|Overall Study|Entry Criteria Not Met|0
155816|NCT00630825|553358|P1|Overall Study|Entry Criteria Not Met|1
155817|NCT00630825|553355|P4|Overall Study|Adverse Event|1
155818|NCT00630825|553356|P3|Overall Study|Adverse Event|3
155819|NCT00630825|553357|P2|Overall Study|Adverse Event|4
155820|NCT00630825|553358|P1|Overall Study|Adverse Event|4
155821|NCT00630786|553430|P3|Overall Study|Not specified|0
155822|NCT00630786|553431|P2|Overall Study|Not specified|0
155823|NCT00630786|553432|P1|Overall Study|Not specified|1
155824|NCT00630786|553430|P3|Overall Study|Lost to Follow-up|0
155825|NCT00630786|553431|P2|Overall Study|Lost to Follow-up|1
155826|NCT00630786|553432|P1|Overall Study|Lost to Follow-up|0
155827|NCT00630786|553430|P3|Overall Study|Withdrawal by Subject|1
155828|NCT00630786|553431|P2|Overall Study|Withdrawal by Subject|1
155829|NCT00630786|553432|P1|Overall Study|Withdrawal by Subject|0
155830|NCT00630786|553430|P3|Overall Study|Physician Decision|1
155831|NCT00630786|553431|P2|Overall Study|Physician Decision|0
155832|NCT00630786|553432|P1|Overall Study|Physician Decision|0
155833|NCT00630747|553451|P1|Overall Study|Returned to country of origin|1
155834|NCT00630747|553451|P1|Overall Study|Transferred to Study TKT031NPU|7
155835|NCT00630747|553451|P1|Overall Study|Death|1
155836|NCT00630539|553504|P4|Overall Study|Withdrawal by Subject|1
155837|NCT00630539|553505|P3|Overall Study|Withdrawal by Subject|0
155838|NCT00630539|553506|P2|Overall Study|Withdrawal by Subject|1
155839|NCT00630539|553507|P1|Overall Study|Withdrawal by Subject|0
155840|NCT00630539|553504|P4|Overall Study|Adverse Event|2
155841|NCT00630539|553505|P3|Overall Study|Adverse Event|1
155842|NCT00630539|553506|P2|Overall Study|Adverse Event|3
155843|NCT00630539|553507|P1|Overall Study|Adverse Event|1
155844|NCT00630396|553603|P1|Overall Study|Lost to Follow-up|3
155845|NCT00630396|553603|P1|Overall Study|Death|4
155846|NCT00630344|553609|P1|Overall Study|Other|1
155847|NCT00630344|553609|P1|Overall Study|Intercurrent Illness|1
155848|NCT00630344|553609|P1|Overall Study|Withdrawal by Subject|1
155849|NCT00630344|553609|P1|Overall Study|Physician Decision|9
155850|NCT00630344|553609|P1|Overall Study|Progressive Disease|19
155851|NCT00630344|553609|P1|Overall Study|Adverse Event|5
155852|NCT00630331|553621|P3|Overall Study|Protocol Violation|6
155853|NCT00630331|553622|P2|Overall Study|Protocol Violation|5
155854|NCT00630331|553623|P1|Overall Study|Protocol Violation|4
155855|NCT00630331|553621|P3|Overall Study|Unable to classify|3
155856|NCT00630331|553622|P2|Overall Study|Unable to classify|4
155857|NCT00630331|553623|P1|Overall Study|Unable to classify|9
155858|NCT00630331|553621|P3|Overall Study|Inappropriate enrollment|3
155859|NCT00630331|553622|P2|Overall Study|Inappropriate enrollment|6
155860|NCT00630331|553623|P1|Overall Study|Inappropriate enrollment|3
155861|NCT00630331|553621|P3|Overall Study|Lost to Follow-up|170
155862|NCT00630331|553622|P2|Overall Study|Lost to Follow-up|143
155863|NCT00630331|553623|P1|Overall Study|Lost to Follow-up|175
155864|NCT00630331|553621|P3|Overall Study|Withdrawal by Subject|5
155865|NCT00630331|553622|P2|Overall Study|Withdrawal by Subject|7
155866|NCT00630331|553623|P1|Overall Study|Withdrawal by Subject|12
155867|NCT00630331|553621|P3|Overall Study|Adverse Event|0
155868|NCT00630331|553622|P2|Overall Study|Adverse Event|0
155869|NCT00630331|553623|P1|Overall Study|Adverse Event|1
155870|NCT00630331|553621|P3|Overall Study|Death|1
155871|NCT00630331|553622|P2|Overall Study|Death|1
155872|NCT00630331|553623|P1|Overall Study|Death|2
155873|NCT00630305|553664|P1|Overall Study|Inability to insert contact lens|1
155874|NCT00630305|553664|P1|Overall Study|Withdrawal by Subject|1
155875|NCT00630292|553686|P1|Overall Study|Withdrawal by Subject|1
155876|NCT00630058|553692|P2|Overall Study|stopping criteria|2
155877|NCT00630058|553693|P1|Overall Study|stopping criteria|3
155878|NCT00630058|553692|P2|Overall Study|Withdrawal by Subject|1
155879|NCT00630058|553693|P1|Overall Study|Withdrawal by Subject|0
155880|NCT00630058|553692|P2|Overall Study|Adverse Event|1
155881|NCT00630058|553693|P1|Overall Study|Adverse Event|1
155882|NCT00629772|553724|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
155883|NCT00629772|553725|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
155884|NCT00629772|553724|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
155885|NCT00629772|553725|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
155886|NCT00629707|553745|P2|Overall Study|Physician Decision|1
155887|NCT00629707|553746|P1|Overall Study|Physician Decision|0
155888|NCT00629707|553745|P2|Overall Study|Withdrawal by Subject|1
155889|NCT00629707|553746|P1|Overall Study|Withdrawal by Subject|0
155890|NCT00629265|553766|P2|Overall Study|Unknown Reason|2
155891|NCT00629265|553767|P1|Overall Study|Unknown Reason|2
155892|NCT00629265|553766|P2|Overall Study|Unrelated Medical Complications|1
155893|NCT00629265|553767|P1|Overall Study|Unrelated Medical Complications|3
155894|NCT00629265|553766|P2|Overall Study|Needed Esophageal Dilation|1
155895|NCT00629265|553767|P1|Overall Study|Needed Esophageal Dilation|4
155896|NCT00629265|553766|P2|Overall Study|Other CA Requiring Treatment|3
155897|NCT00629265|553767|P1|Overall Study|Other CA Requiring Treatment|1
155898|NCT00629265|553766|P2|Overall Study|HNC Recurrence|0
155899|NCT00629265|553767|P1|Overall Study|HNC Recurrence|4
155900|NCT00629265|553766|P2|Overall Study|Adverse Event|0
155901|NCT00629265|553767|P1|Overall Study|Adverse Event|2
155902|NCT00629265|553766|P2|Overall Study|Death|0
155903|NCT00629265|553767|P1|Overall Study|Death|1
155904|NCT00629265|553766|P2|Overall Study|Withdrawal by Subject|8
155905|NCT00629265|553767|P1|Overall Study|Withdrawal by Subject|11
155906|NCT00629265|553766|P2|Overall Study|Lost to Follow-up|5
155907|NCT00629265|553767|P1|Overall Study|Lost to Follow-up|4
155908|NCT00629239|553777|P2|Overall Study|Physician Decision|0
155909|NCT00629239|553778|P1|Overall Study|Physician Decision|1
155910|NCT00629239|553777|P2|Overall Study|Adverse Event|4
155911|NCT00629239|553778|P1|Overall Study|Adverse Event|7
155912|NCT00628927|553842|P2|Overall Study|Equipment failure|0
155913|NCT00628927|553843|P1|Overall Study|Equipment failure|1
155914|NCT00628927|553842|P2|Overall Study|Lost to Follow-up|0
155915|NCT00628927|553843|P1|Overall Study|Lost to Follow-up|1
155916|NCT00628927|553842|P2|Overall Study|Problems performing blood draw|0
155917|NCT00628927|553843|P1|Overall Study|Problems performing blood draw|6
155918|NCT00628862|553888|P3|Overall Study|COPD Exacerbation|0
155919|NCT00628862|553889|P2|Overall Study|COPD Exacerbation|1
155920|NCT00628862|553890|P1|Overall Study|COPD Exacerbation|0
155921|NCT00628862|553888|P3|Overall Study|Protocol Violation|0
155922|NCT00628862|553889|P2|Overall Study|Protocol Violation|0
155923|NCT00628862|553890|P1|Overall Study|Protocol Violation|1
155924|NCT00628862|553888|P3|Overall Study|Lost to Follow-up|1
155925|NCT00628862|553889|P2|Overall Study|Lost to Follow-up|2
155926|NCT00628862|553890|P1|Overall Study|Lost to Follow-up|0
155927|NCT00628862|553888|P3|Overall Study|Withdrawal by Subject|11
155928|NCT00628862|553889|P2|Overall Study|Withdrawal by Subject|6
155929|NCT00628862|553890|P1|Overall Study|Withdrawal by Subject|4
155930|NCT00628862|553888|P3|Overall Study|Adverse Event|10
155931|NCT00628862|553889|P2|Overall Study|Adverse Event|8
155932|NCT00628862|553890|P1|Overall Study|Adverse Event|6
155933|NCT00628758|553936|P2|Overall Study|Treatment Failure|2
155934|NCT00628758|553937|P1|Overall Study|Treatment Failure|0
155935|NCT00628758|553936|P2|Overall Study|Investigator Moved|0
155936|NCT00628758|553937|P1|Overall Study|Investigator Moved|3
155937|NCT00628758|553936|P2|Overall Study|Pregnancy|2
155938|NCT00628758|553937|P1|Overall Study|Pregnancy|2
155939|NCT00628758|553936|P2|Overall Study|Lost to Follow-up|31
155940|NCT00628758|553937|P1|Overall Study|Lost to Follow-up|25
155941|NCT00628758|553936|P2|Overall Study|Protocol Violation|1
155942|NCT00628758|553937|P1|Overall Study|Protocol Violation|5
155943|NCT00628758|553936|P2|Overall Study|Death|0
155944|NCT00628758|553937|P1|Overall Study|Death|1
155945|NCT00628758|553936|P2|Overall Study|Withdrawal by Subject|3
155946|NCT00628758|553937|P1|Overall Study|Withdrawal by Subject|6
155947|NCT00628758|553936|P2|Overall Study|Adverse Event|3
155948|NCT00628758|553937|P1|Overall Study|Adverse Event|2
155949|NCT00628446|553981|P1|Overall Study|Protocol Violation|3
155950|NCT00628446|553981|P1|Overall Study|Withdrawal by Subject|1
155951|NCT00628446|553981|P1|Overall Study|Lost to Follow-up|3
155952|NCT00628355|553992|P2|Overall Study|Withdrawal by Subject|1
155953|NCT00628355|553993|P1|Overall Study|Withdrawal by Subject|1
155954|NCT00628251|554004|P3|Cross-over/ Continuation of Olaparib|Other|0
155955|NCT00628251|554005|P2|Cross-over/ Continuation of Olaparib|Other|1
155956|NCT00628251|554006|P1|Cross-over/ Continuation of Olaparib|Other|1
155957|NCT00628251|554004|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
155958|NCT00628251|554005|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
155959|NCT00628251|554006|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
155960|NCT00628251|554004|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
155961|NCT00628251|554005|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
155962|NCT00628251|554006|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
155963|NCT00628251|554004|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
155964|NCT00628251|554005|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
155965|NCT00628251|554006|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
155966|NCT00628251|554004|P3|Randomised Part|Did not receive cross over treatment|8
155967|NCT00628251|554005|P2|Randomised Part|Did not receive cross over treatment|0
155968|NCT00628251|554006|P1|Randomised Part|Did not receive cross over treatment|0
155969|NCT00628212|554049|P4|Overall Study|Physician Decision|3
155970|NCT00628212|554050|P3|Overall Study|Physician Decision|2
155971|NCT00628212|554051|P2|Overall Study|Physician Decision|1
155972|NCT00628212|554052|P1|Overall Study|Physician Decision|1
155973|NCT00628212|554049|P4|Overall Study|Adverse Event|2
155974|NCT00628212|554050|P3|Overall Study|Adverse Event|1
155975|NCT00628212|554051|P2|Overall Study|Adverse Event|0
155976|NCT00628212|554052|P1|Overall Study|Adverse Event|2
155977|NCT00628108|554100|P2|Overall Study|Withdrawal by Subject|0
155978|NCT00628108|554101|P1|Overall Study|Withdrawal by Subject|1
155979|NCT00628108|554100|P2|Overall Study|Adverse Event|3
155980|NCT00628108|554101|P1|Overall Study|Adverse Event|0
155981|NCT00628030|554133|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
155982|NCT00628030|554134|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
155983|NCT00628030|554133|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
155984|NCT00628030|554134|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
155985|NCT00628030|554133|P2|Baseline to Post-Assessment|Lost to Follow-up|29
155986|NCT00628030|554134|P1|Baseline to Post-Assessment|Lost to Follow-up|28
155987|NCT00627926|554160|P3|Overall Study|Noncompliance/unspecified|17
155988|NCT00627926|554161|P2|Overall Study|Noncompliance/unspecified|23
155989|NCT00627926|554162|P1|Overall Study|Noncompliance/unspecified|8
155990|NCT00627926|554160|P3|Overall Study|Lack of Efficacy|38
155991|NCT00627926|554161|P2|Overall Study|Lack of Efficacy|40
155992|NCT00627926|554162|P1|Overall Study|Lack of Efficacy|118
155993|NCT00627926|554160|P3|Overall Study|Withdrawal by Subject|0
155994|NCT00627926|554161|P2|Overall Study|Withdrawal by Subject|1
155995|NCT00627926|554162|P1|Overall Study|Withdrawal by Subject|2
155996|NCT00627926|554160|P3|Overall Study|Lost to Follow-up|4
155997|NCT00627926|554161|P2|Overall Study|Lost to Follow-up|3
155998|NCT00627926|554162|P1|Overall Study|Lost to Follow-up|4
155999|NCT00627926|554160|P3|Overall Study|Death|0
156000|NCT00627926|554161|P2|Overall Study|Death|0
156001|NCT00627926|554162|P1|Overall Study|Death|1
156002|NCT00627926|554160|P3|Overall Study|Adverse Event|36
156003|NCT00627926|554161|P2|Overall Study|Adverse Event|37
156004|NCT00627926|554162|P1|Overall Study|Adverse Event|26
156005|NCT00627705|554214|P2|Overall Study|Lost to Follow-up|1
156006|NCT00627705|554215|P1|Overall Study|Lost to Follow-up|0
156007|NCT00627705|554214|P2|Overall Study|Withdrawal by Subject|2
156008|NCT00627705|554215|P1|Overall Study|Withdrawal by Subject|0
156009|NCT00627705|554214|P2|Overall Study|Adverse Event|0
156010|NCT00627705|554215|P1|Overall Study|Adverse Event|1
156011|NCT00627705|554214|P2|Overall Study|Unwilling to take the compound (taste)|3
156012|NCT00627705|554215|P1|Overall Study|Unwilling to take the compound (taste)|1
156013|NCT00627523|554266|P2|Overall Study|Not specified|0
156014|NCT00627523|554267|P1|Overall Study|Not specified|1
156015|NCT00627523|554266|P2|Overall Study|Withdrawal by Subject|2
156016|NCT00627523|554267|P1|Overall Study|Withdrawal by Subject|0
156017|NCT00627523|554266|P2|Overall Study|Lack of Efficacy|0
156018|NCT00627523|554267|P1|Overall Study|Lack of Efficacy|1
156019|NCT00627497|554295|P4|Overall Study|Lost to Follow-up|0
156020|NCT00627497|554296|P3|Overall Study|Lost to Follow-up|0
156021|NCT00627497|554297|P2|Overall Study|Lost to Follow-up|1
156022|NCT00627497|554298|P1|Overall Study|Lost to Follow-up|1
156023|NCT00627458|554359|P3|Overall Study|Lost to Follow-up|0
156024|NCT00627458|554360|P2|Overall Study|Lost to Follow-up|1
156025|NCT00627458|554361|P1|Overall Study|Lost to Follow-up|1
156026|NCT00627458|554359|P3|Overall Study|Withdrawal by Subject|5
156027|NCT00627458|554360|P2|Overall Study|Withdrawal by Subject|6
156028|NCT00627458|554361|P1|Overall Study|Withdrawal by Subject|2
156029|NCT00627458|554359|P3|Overall Study|Migrated from study area|1
156030|NCT00627458|554360|P2|Overall Study|Migrated from study area|0
156031|NCT00627458|554361|P1|Overall Study|Migrated from study area|1
156032|NCT00627445|554436|P2|Overall Study|Other|8
156033|NCT00627445|554437|P1|Overall Study|Other|6
156034|NCT00627445|554436|P2|Overall Study|Lack of Efficacy|1
156035|NCT00627445|554437|P1|Overall Study|Lack of Efficacy|0
156036|NCT00627445|554436|P2|Overall Study|Adverse Event|3
156037|NCT00627445|554437|P1|Overall Study|Adverse Event|3
156038|NCT00627393|554480|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
156039|NCT00627393|554481|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
156040|NCT00627393|554480|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
156041|NCT00627393|554481|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
156042|NCT00627393|554480|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
156043|NCT00627393|554481|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
156044|NCT00627393|554480|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
156045|NCT00627393|554481|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
156046|NCT00627094|554517|P2|Overall Study|Other reason|0
156047|NCT00627094|554518|P1|Overall Study|Other reason|1
156048|NCT00627094|554517|P2|Overall Study|ulcer healed|7
156049|NCT00627094|554518|P1|Overall Study|ulcer healed|1
156050|NCT00627094|554517|P2|Overall Study|Withdrawal by Subject|1
156051|NCT00627094|554518|P1|Overall Study|Withdrawal by Subject|1
156052|NCT00627094|554517|P2|Overall Study|Lost to Follow-up|0
156053|NCT00627094|554518|P1|Overall Study|Lost to Follow-up|1
156054|NCT00627094|554517|P2|Overall Study|Adverse Event|7
156055|NCT00627094|554518|P1|Overall Study|Adverse Event|8
156056|NCT00627042|554530|P1|Overall Study|Withdrawal by Subject|2
156057|NCT00627016|554542|P2|Overall Study|Pregnancy|0
156058|NCT00627016|554543|P1|Overall Study|Pregnancy|1
156059|NCT00627016|554542|P2|Overall Study|Placed on Excluded Drugs|0
156060|NCT00627016|554543|P1|Overall Study|Placed on Excluded Drugs|1
156061|NCT00627016|554542|P2|Overall Study|Lack of Efficacy|0
156062|NCT00627016|554543|P1|Overall Study|Lack of Efficacy|1
156063|NCT00627016|554542|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
156064|NCT00627016|554543|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
156065|NCT00627016|554542|P2|Overall Study|Withdrawal by Subject|1
156066|NCT00627016|554543|P1|Overall Study|Withdrawal by Subject|2
156067|NCT00627016|554542|P2|Overall Study|Lost to Follow-up|1
156068|NCT00627016|554543|P1|Overall Study|Lost to Follow-up|0
156069|NCT00627016|554542|P2|Overall Study|Protocol Violation|2
156070|NCT00627016|554543|P1|Overall Study|Protocol Violation|0
156071|NCT00627016|554542|P2|Overall Study|Adverse Event|1
156072|NCT00627016|554543|P1|Overall Study|Adverse Event|1
156073|NCT00626925|554555|P2|Overall Study|Time constraints|1
156074|NCT00626925|554556|P1|Overall Study|Time constraints|3
156075|NCT00626925|554555|P2|Overall Study|Lack of Efficacy|4
156076|NCT00626925|554556|P1|Overall Study|Lack of Efficacy|1
156077|NCT00626925|554555|P2|Overall Study|Adverse effect|2
156078|NCT00626925|554556|P1|Overall Study|Adverse effect|6
156079|NCT00626925|554555|P2|Overall Study|relapse|0
156080|NCT00626925|554556|P1|Overall Study|relapse|1
156081|NCT00626925|554555|P2|Overall Study|Lost to Follow-up|2
156082|NCT00626925|554556|P1|Overall Study|Lost to Follow-up|1
156083|NCT00626821|554588|P1|Overall Study|other/unknown reason|104
156084|NCT00626821|554588|P1|Overall Study|Product dysfunction|21
156085|NCT00626821|554588|P1|Overall Study|Physician Decision|9
156086|NCT00626821|554588|P1|Overall Study|Withdrawal by Subject|10
156087|NCT00626821|554588|P1|Overall Study|Protocol Violation|33
156088|NCT00626821|554588|P1|Overall Study|Adverse Event|44
156089|NCT00626639|554689|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
156090|NCT00626639|554690|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
156091|NCT00626561|554730|P1|Overall Study|Disease Progression|2
156092|NCT00626561|554730|P1|Overall Study|Withdrawal by Subject|2
156093|NCT00626548|554736|P2|Overall Study|Other termination reason|613
156094|NCT00626548|554737|P1|Overall Study|Other termination reason|493
156095|NCT00626548|554736|P2|Overall Study|Lost to Follow-up|2
156096|NCT00626548|554737|P1|Overall Study|Lost to Follow-up|2
156097|NCT00626548|554736|P2|Overall Study|Protocol Violation|11
156098|NCT00626548|554737|P1|Overall Study|Protocol Violation|4
156099|NCT00626548|554736|P2|Overall Study|Withdrawal by Subject|46
156100|NCT00626548|554737|P1|Overall Study|Withdrawal by Subject|42
156101|NCT00626548|554736|P2|Overall Study|Adverse Event|44
156102|NCT00626548|554737|P1|Overall Study|Adverse Event|164
156103|NCT00626522|554751|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
156104|NCT00626522|554752|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
156105|NCT00626522|554753|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
156106|NCT00626522|554754|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
156107|NCT00626522|554755|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
156108|NCT00626522|554756|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
156109|NCT00626522|554751|P6|Overall Study|Inconsistent reason reported|0
156110|NCT00626522|554752|P5|Overall Study|Inconsistent reason reported|0
156111|NCT00626522|554753|P4|Overall Study|Inconsistent reason reported|0
156112|NCT00626522|554754|P3|Overall Study|Inconsistent reason reported|0
156113|NCT00626522|554755|P2|Overall Study|Inconsistent reason reported|0
156114|NCT00626522|554756|P1|Overall Study|Inconsistent reason reported|1
156115|NCT00626522|554751|P6|Overall Study|Lost to Follow-up|0
156116|NCT00626522|554752|P5|Overall Study|Lost to Follow-up|0
156117|NCT00626522|554753|P4|Overall Study|Lost to Follow-up|0
156118|NCT00626522|554754|P3|Overall Study|Lost to Follow-up|0
156119|NCT00626522|554755|P2|Overall Study|Lost to Follow-up|1
156120|NCT00626522|554756|P1|Overall Study|Lost to Follow-up|0
156121|NCT00626522|554751|P6|Overall Study|COPD exacerbation|0
156122|NCT00626522|554752|P5|Overall Study|COPD exacerbation|1
156123|NCT00626522|554753|P4|Overall Study|COPD exacerbation|1
156124|NCT00626522|554754|P3|Overall Study|COPD exacerbation|0
156125|NCT00626522|554755|P2|Overall Study|COPD exacerbation|0
156126|NCT00626522|554756|P1|Overall Study|COPD exacerbation|0
156127|NCT00626522|554751|P6|Overall Study|Withdrawal by Subject|1
156128|NCT00626522|554752|P5|Overall Study|Withdrawal by Subject|4
156129|NCT00626522|554753|P4|Overall Study|Withdrawal by Subject|0
156130|NCT00626522|554754|P3|Overall Study|Withdrawal by Subject|5
156131|NCT00626522|554755|P2|Overall Study|Withdrawal by Subject|5
156132|NCT00626522|554756|P1|Overall Study|Withdrawal by Subject|2
156133|NCT00626522|554751|P6|Overall Study|Adverse Event|1
156134|NCT00626522|554752|P5|Overall Study|Adverse Event|1
156135|NCT00626522|554753|P4|Overall Study|Adverse Event|0
156136|NCT00626522|554754|P3|Overall Study|Adverse Event|2
156137|NCT00626522|554755|P2|Overall Study|Adverse Event|1
156138|NCT00626522|554756|P1|Overall Study|Adverse Event|2
156139|NCT00626522|554751|P6|Overall Study|Protocol Violation|0
156140|NCT00626522|554752|P5|Overall Study|Protocol Violation|1
156141|NCT00626522|554753|P4|Overall Study|Protocol Violation|0
156142|NCT00626522|554754|P3|Overall Study|Protocol Violation|0
156143|NCT00626522|554755|P2|Overall Study|Protocol Violation|0
156144|NCT00626522|554756|P1|Overall Study|Protocol Violation|0
156145|NCT00626405|554819|P2|Overall Study|Withdrawal by Subject|1
156146|NCT00626405|554820|P1|Overall Study|Withdrawal by Subject|0
156147|NCT00626405|554819|P2|Overall Study|Deemed Ineligible|0
156148|NCT00626405|554820|P1|Overall Study|Deemed Ineligible|1
156149|NCT00626392|554836|P6|Coadministration Period|Other|1
156150|NCT00626392|554837|P5|Coadministration Period|Other|1
156151|NCT00626392|554838|P4|Coadministration Period|Other|1
156152|NCT00626392|554839|P3|Coadministration Period|Other|3
156153|NCT00626392|554840|P2|Coadministration Period|Other|2
156154|NCT00626392|554841|P1|Coadministration Period|Other|0
156155|NCT00626392|554836|P6|Coadministration Period|Protocol Violation|0
156156|NCT00626392|554837|P5|Coadministration Period|Protocol Violation|1
156157|NCT00626392|554838|P4|Coadministration Period|Protocol Violation|1
156158|NCT00626392|554839|P3|Coadministration Period|Protocol Violation|0
156159|NCT00626392|554840|P2|Coadministration Period|Protocol Violation|1
156160|NCT00626392|554841|P1|Coadministration Period|Protocol Violation|0
156161|NCT00626392|554836|P6|Coadministration Period|Withdrawal by Subject|1
156162|NCT00626392|554837|P5|Coadministration Period|Withdrawal by Subject|0
156163|NCT00626392|554838|P4|Coadministration Period|Withdrawal by Subject|1
156164|NCT00626392|554839|P3|Coadministration Period|Withdrawal by Subject|0
156165|NCT00626392|554840|P2|Coadministration Period|Withdrawal by Subject|1
156166|NCT00626392|554841|P1|Coadministration Period|Withdrawal by Subject|1
156167|NCT00626392|554836|P6|Coadministration Period|Adverse Event|4
156168|NCT00626392|554837|P5|Coadministration Period|Adverse Event|3
156169|NCT00626392|554838|P4|Coadministration Period|Adverse Event|4
156170|NCT00626392|554839|P3|Coadministration Period|Adverse Event|7
156171|NCT00626392|554840|P2|Coadministration Period|Adverse Event|1
156172|NCT00626392|554841|P1|Coadministration Period|Adverse Event|3
156173|NCT00626392|554836|P6|Run-in Period|Noncompliance|0
156174|NCT00626392|554837|P5|Run-in Period|Noncompliance|0
156175|NCT00626392|554838|P4|Run-in Period|Noncompliance|0
156176|NCT00626392|554839|P3|Run-in Period|Noncompliance|1
156177|NCT00626392|554840|P2|Run-in Period|Noncompliance|0
156178|NCT00626392|554841|P1|Run-in Period|Noncompliance|1
156179|NCT00626392|554836|P6|Run-in Period|Withdrawal by Subject|1
156180|NCT00626392|554837|P5|Run-in Period|Withdrawal by Subject|3
156181|NCT00626392|554838|P4|Run-in Period|Withdrawal by Subject|1
156182|NCT00626392|554839|P3|Run-in Period|Withdrawal by Subject|1
156183|NCT00626392|554840|P2|Run-in Period|Withdrawal by Subject|1
156184|NCT00626392|554841|P1|Run-in Period|Withdrawal by Subject|0
156185|NCT00626392|554836|P6|Run-in Period|Adverse Event|0
156186|NCT00626392|554837|P5|Run-in Period|Adverse Event|1
156187|NCT00626392|554838|P4|Run-in Period|Adverse Event|0
156188|NCT00626392|554839|P3|Run-in Period|Adverse Event|1
156189|NCT00626392|554840|P2|Run-in Period|Adverse Event|0
156190|NCT00626392|554841|P1|Run-in Period|Adverse Event|0
156191|NCT00626327|554860|P3|Overall Study|Protocol Violation|26
156192|NCT00626327|554861|P2|Overall Study|Protocol Violation|4
156193|NCT00626327|554862|P1|Overall Study|Protocol Violation|26
156194|NCT00626327|554860|P3|Overall Study|Administrative Reason|6
156195|NCT00626327|554861|P2|Overall Study|Administrative Reason|0
156196|NCT00626327|554862|P1|Overall Study|Administrative Reason|2
156197|NCT00626327|554860|P3|Overall Study|Inappropriate enrollment|3
156198|NCT00626327|554861|P2|Overall Study|Inappropriate enrollment|5
156199|NCT00626327|554862|P1|Overall Study|Inappropriate enrollment|4
156200|NCT00626327|554860|P3|Overall Study|Lost to Follow-up|23
156201|NCT00626327|554861|P2|Overall Study|Lost to Follow-up|21
156202|NCT00626327|554862|P1|Overall Study|Lost to Follow-up|24
156203|NCT00626327|554860|P3|Overall Study|Adverse Event|0
156204|NCT00626327|554861|P2|Overall Study|Adverse Event|0
156205|NCT00626327|554862|P1|Overall Study|Adverse Event|1
156206|NCT00626327|554860|P3|Overall Study|Withdrawal by Subject|30
156207|NCT00626327|554861|P2|Overall Study|Withdrawal by Subject|29
156208|NCT00626327|554862|P1|Overall Study|Withdrawal by Subject|21
156209|NCT00626275|554888|P8|Part B|Withdrawal by Subject|1
156210|NCT00626275|554889|P7|Part B|Withdrawal by Subject|0
156211|NCT00626275|554890|P6|Part B|Withdrawal by Subject|0
156212|NCT00626275|554891|P5|Part B|Withdrawal by Subject|0
156213|NCT00626275|554892|P4|Part B|Withdrawal by Subject|0
156214|NCT00626275|554893|P3|Part B|Withdrawal by Subject|0
156215|NCT00626275|554894|P2|Part B|Withdrawal by Subject|0
156216|NCT00626275|554895|P1|Part B|Withdrawal by Subject|0
156217|NCT00626275|554888|P8|Part B|Lost to Follow-up|0
156218|NCT00626275|554889|P7|Part B|Lost to Follow-up|1
156219|NCT00626275|554890|P6|Part B|Lost to Follow-up|0
156220|NCT00626275|554891|P5|Part B|Lost to Follow-up|0
156221|NCT00626275|554892|P4|Part B|Lost to Follow-up|0
156222|NCT00626275|554893|P3|Part B|Lost to Follow-up|0
156223|NCT00626275|554894|P2|Part B|Lost to Follow-up|0
156224|NCT00626275|554895|P1|Part B|Lost to Follow-up|0
156225|NCT00626275|554888|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
156226|NCT00626275|554889|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
156227|NCT00626275|554890|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
156228|NCT00626275|554891|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
156229|NCT00626275|554892|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
156230|NCT00626275|554893|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
156231|NCT00626275|554894|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
156232|NCT00626275|554895|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
156233|NCT00626275|554888|P8|Part A - Treatment Period 1|Adverse Event|0
156234|NCT00626275|554889|P7|Part A - Treatment Period 1|Adverse Event|0
156235|NCT00626275|554890|P6|Part A - Treatment Period 1|Adverse Event|0
156236|NCT00626275|554891|P5|Part A - Treatment Period 1|Adverse Event|0
156237|NCT00626275|554892|P4|Part A - Treatment Period 1|Adverse Event|0
156238|NCT00626275|554893|P3|Part A - Treatment Period 1|Adverse Event|0
156239|NCT00626275|554894|P2|Part A - Treatment Period 1|Adverse Event|0
156240|NCT00626275|554895|P1|Part A - Treatment Period 1|Adverse Event|1
156241|NCT00626093|554939|P1|Overall Study|One of the required devices not implante|6
156242|NCT00626093|554939|P1|Overall Study|Protocol Violation|1
156243|NCT00626093|554939|P1|Overall Study|Withdrawal by Subject|6
156244|NCT00626093|554939|P1|Overall Study|Physician Decision|4
156245|NCT00626093|554939|P1|Overall Study|Death|1
156246|NCT00626093|554939|P1|Overall Study|Lost to Follow-up|5
156247|NCT00626028|554946|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
156248|NCT00626028|554947|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
156249|NCT00626028|554946|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
156250|NCT00626028|554947|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
156251|NCT00626028|554946|P2|Treatment 1 NO First, O2 Last|Device Failure|1
156252|NCT00626028|554947|P1|Treatment 1 NO First, O2 Last|Device Failure|0
156253|NCT00626028|554946|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
156254|NCT00626028|554947|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
156255|NCT00625872|554967|P2|Overall Study|Randomized but not treated|1
156256|NCT00625872|554968|P1|Overall Study|Randomized but not treated|0
156257|NCT00625872|554967|P2|Overall Study|Terminated by sponsor|5
156258|NCT00625872|554968|P1|Overall Study|Terminated by sponsor|2
156259|NCT00625872|554967|P2|Overall Study|Does not meet inclusion criteria|0
156260|NCT00625872|554968|P1|Overall Study|Does not meet inclusion criteria|1
156261|NCT00625872|554967|P2|Overall Study|Withdrawal by Subject|0
156262|NCT00625872|554968|P1|Overall Study|Withdrawal by Subject|1
156263|NCT00625820|555078|P1|Overall Study|Withdrawal by Subject|1
156264|NCT00625742|555084|P1|Overall Study|Ineligible|1
156265|NCT00625742|555084|P1|Overall Study|Lost to Follow-up|4
156266|NCT00625742|555084|P1|Overall Study|Adverse Event|4
156267|NCT00625742|555084|P1|Overall Study|Withdrawal by Subject|1
156268|NCT00625742|555084|P1|Overall Study|Disease Progression|2
156269|NCT00625586|555098|P1|Overall Study|Adverse Event|1
156270|NCT00625443|555111|P3|Overall Study|Not specified|1
156271|NCT00625443|555112|P2|Overall Study|Not specified|1
156272|NCT00625443|555113|P1|Overall Study|Not specified|0
156273|NCT00625443|555111|P3|Overall Study|Physician Decision|2
156274|NCT00625443|555112|P2|Overall Study|Physician Decision|4
156275|NCT00625443|555113|P1|Overall Study|Physician Decision|0
156276|NCT00625443|555111|P3|Overall Study|Withdrawal by Subject|2
156277|NCT00625443|555112|P2|Overall Study|Withdrawal by Subject|1
156278|NCT00625443|555113|P1|Overall Study|Withdrawal by Subject|0
156279|NCT00625443|555111|P3|Overall Study|Platelet count increase >=500,000/mm3|0
156280|NCT00625443|555112|P2|Overall Study|Platelet count increase >=500,000/mm3|0
156281|NCT00625443|555113|P1|Overall Study|Platelet count increase >=500,000/mm3|1
156282|NCT00625443|555111|P3|Overall Study|Non-compliance with protocol|0
156283|NCT00625443|555112|P2|Overall Study|Non-compliance with protocol|1
156284|NCT00625443|555113|P1|Overall Study|Non-compliance with protocol|0
156285|NCT00625443|555111|P3|Overall Study|Adverse Event|0
156286|NCT00625443|555112|P2|Overall Study|Adverse Event|4
156287|NCT00625443|555113|P1|Overall Study|Adverse Event|1
156288|NCT00625365|555193|P1|Overall Study|VSD|1
156289|NCT00625365|555193|P1|Overall Study|No IV access|5
156290|NCT00625365|555193|P1|Overall Study|Withdrawal by Subject|1
156291|NCT00625183|555199|P1|Overall Study|Disease Progression|1
156292|NCT00625131|555210|P3|Overall Study|Withdrawal by Subject|5
156293|NCT00625131|555211|P2|Overall Study|Withdrawal by Subject|0
156294|NCT00625131|555212|P1|Overall Study|Withdrawal by Subject|1
156295|NCT00625131|555210|P3|Overall Study|Lost to Follow-up|0
156296|NCT00625131|555211|P2|Overall Study|Lost to Follow-up|2
156297|NCT00625131|555212|P1|Overall Study|Lost to Follow-up|3
156298|NCT00624832|555235|P4|Overall Study|Abnormal Laboratory Value|0
156299|NCT00624832|555236|P3|Overall Study|Abnormal Laboratory Value|0
156300|NCT00624832|555237|P2|Overall Study|Abnormal Laboratory Value|0
156301|NCT00624832|555238|P1|Overall Study|Abnormal Laboratory Value|2
156302|NCT00624832|555235|P4|Overall Study|Adverse Event|1
156303|NCT00624832|555236|P3|Overall Study|Adverse Event|0
156304|NCT00624832|555237|P2|Overall Study|Adverse Event|1
156305|NCT00624832|555238|P1|Overall Study|Adverse Event|0
156306|NCT00624780|555269|P6|Follow-up (Week 26)|Other|0
156307|NCT00624780|555270|P5|Follow-up (Week 26)|Other|0
156308|NCT00624780|555271|P4|Follow-up (Week 26)|Other|0
156309|NCT00624780|555272|P3|Follow-up (Week 26)|Other|0
156310|NCT00624780|555273|P2|Follow-up (Week 26)|Other|1
156311|NCT00624780|555274|P1|Follow-up (Week 26)|Other|1
156312|NCT00624780|555269|P6|Follow-up (Week 26)|Withdrawal by Subject|0
156313|NCT00624780|555270|P5|Follow-up (Week 26)|Withdrawal by Subject|0
156314|NCT00624780|555271|P4|Follow-up (Week 26)|Withdrawal by Subject|0
156315|NCT00624780|555272|P3|Follow-up (Week 26)|Withdrawal by Subject|0
156316|NCT00624780|555273|P2|Follow-up (Week 26)|Withdrawal by Subject|0
156317|NCT00624780|555274|P1|Follow-up (Week 26)|Withdrawal by Subject|1
156318|NCT00624780|555269|P6|Follow-up (Week 26)|Lost to Follow-up|0
156319|NCT00624780|555270|P5|Follow-up (Week 26)|Lost to Follow-up|1
156320|NCT00624780|555271|P4|Follow-up (Week 26)|Lost to Follow-up|0
156321|NCT00624780|555272|P3|Follow-up (Week 26)|Lost to Follow-up|1
156322|NCT00624780|555273|P2|Follow-up (Week 26)|Lost to Follow-up|0
156323|NCT00624780|555274|P1|Follow-up (Week 26)|Lost to Follow-up|0
156324|NCT00624780|555269|P6|Follow-up (Week 26)|Adverse Event|0
156325|NCT00624780|555270|P5|Follow-up (Week 26)|Adverse Event|1
156326|NCT00624780|555271|P4|Follow-up (Week 26)|Adverse Event|0
156327|NCT00624780|555272|P3|Follow-up (Week 26)|Adverse Event|0
156328|NCT00624780|555273|P2|Follow-up (Week 26)|Adverse Event|0
156329|NCT00624780|555274|P1|Follow-up (Week 26)|Adverse Event|0
156330|NCT00624780|555269|P6|Follow-up (Week 26)|Death|0
156331|NCT00624780|555270|P5|Follow-up (Week 26)|Death|0
156332|NCT00624780|555271|P4|Follow-up (Week 26)|Death|0
156333|NCT00624780|555272|P3|Follow-up (Week 26)|Death|1
156334|NCT00624780|555273|P2|Follow-up (Week 26)|Death|0
156335|NCT00624780|555274|P1|Follow-up (Week 26)|Death|0
156336|NCT00624780|555269|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
156337|NCT00624780|555270|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
156338|NCT00624780|555271|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
156339|NCT00624780|555272|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
156340|NCT00624780|555273|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
156341|NCT00624780|555274|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
156342|NCT00624780|555269|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
156343|NCT00624780|555270|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
156344|NCT00624780|555271|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
156345|NCT00624780|555272|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
156346|NCT00624780|555273|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
156347|NCT00624780|555274|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
156348|NCT00624780|555269|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
156349|NCT00624780|555270|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
156350|NCT00624780|555271|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
156351|NCT00624780|555272|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
156352|NCT00624780|555273|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
156353|NCT00624780|555274|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
156354|NCT00624780|555269|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
156355|NCT00624780|555270|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
156356|NCT00624780|555271|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
156357|NCT00624780|555272|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
156358|NCT00624780|555273|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
156359|NCT00624780|555274|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
156360|NCT00624780|555269|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
156361|NCT00624780|555270|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
156362|NCT00624780|555271|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
156363|NCT00624780|555272|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
156364|NCT00624780|555273|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
156365|NCT00624780|555274|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
156366|NCT00624780|555269|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
156367|NCT00624780|555270|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
156368|NCT00624780|555271|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
156369|NCT00624780|555272|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
156370|NCT00624780|555273|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
156371|NCT00624780|555274|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
156372|NCT00624780|555269|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
156373|NCT00624780|555270|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
156374|NCT00624780|555271|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
156375|NCT00624780|555272|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
156376|NCT00624780|555273|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
156377|NCT00624780|555274|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
156378|NCT00624780|555269|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
156379|NCT00624780|555270|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
156380|NCT00624780|555271|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
156381|NCT00624780|555272|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
156382|NCT00624780|555273|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
156383|NCT00624780|555274|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
156384|NCT00624780|555269|P6|Treatment Optimization (Up to Week 12)|Other|0
156385|NCT00624780|555270|P5|Treatment Optimization (Up to Week 12)|Other|9
156386|NCT00624780|555271|P4|Treatment Optimization (Up to Week 12)|Other|2
156387|NCT00624780|555272|P3|Treatment Optimization (Up to Week 12)|Other|8
156388|NCT00624780|555273|P2|Treatment Optimization (Up to Week 12)|Other|4
156389|NCT00624780|555274|P1|Treatment Optimization (Up to Week 12)|Other|10
156390|NCT00624780|555269|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
156391|NCT00624780|555270|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
156392|NCT00624780|555271|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
156393|NCT00624780|555272|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
156394|NCT00624780|555273|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
156395|NCT00624780|555274|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
156396|NCT00624780|555269|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
156397|NCT00624780|555270|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
156398|NCT00624780|555271|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
156399|NCT00624780|555272|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
156400|NCT00624780|555273|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
156401|NCT00624780|555274|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
156402|NCT00624780|555269|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
156403|NCT00624780|555270|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
156404|NCT00624780|555271|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
156405|NCT00624780|555272|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
156406|NCT00624780|555273|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
156407|NCT00624780|555274|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
156408|NCT00624780|555269|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
156409|NCT00624780|555270|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
156410|NCT00624780|555271|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
156411|NCT00624780|555272|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
156412|NCT00624780|555273|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
156413|NCT00624780|555274|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
156414|NCT00624585|555456|P1|Overall Study|Adverse Event|3
156415|NCT00624585|555456|P1|Overall Study|Disease Progression|6
156416|NCT00624585|555456|P1|Overall Study|Death|3
156417|NCT00624520|555486|P2|Overall Study|Death|1
156418|NCT00624520|555487|P1|Overall Study|Death|0
156419|NCT00624520|555486|P2|Overall Study|Withdrawal by Subject|7
156420|NCT00624520|555487|P1|Overall Study|Withdrawal by Subject|12
156421|NCT00624468|555514|P4|Safety Follow-up (SFU) Period|Other|1
156422|NCT00624468|555515|P3|Safety Follow-up (SFU) Period|Other|1
156423|NCT00624468|555516|P2|Safety Follow-up (SFU) Period|Other|0
156424|NCT00624468|555517|P1|Safety Follow-up (SFU) Period|Other|0
156425|NCT00624468|555514|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
156426|NCT00624468|555515|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
156427|NCT00624468|555516|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
156428|NCT00624468|555517|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
156429|NCT00624468|555514|P4|Double-blind Period|Withdrew Prematurely|0
156430|NCT00624468|555515|P3|Double-blind Period|Withdrew Prematurely|0
156431|NCT00624468|555516|P2|Double-blind Period|Withdrew Prematurely|1
156432|NCT00624468|555517|P1|Double-blind Period|Withdrew Prematurely|1
156433|NCT00624468|555514|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
156434|NCT00624468|555515|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
156435|NCT00624468|555516|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
156436|NCT00624468|555517|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
156437|NCT00624377|555584|P1|Overall Study|Non-evaluable population|84
156438|NCT00624377|555584|P1|Overall Study|Other|91
156439|NCT00624377|555584|P1|Overall Study|Adverse Event|14
156440|NCT00624377|555584|P1|Overall Study|Withdrawal by Subject|100
156441|NCT00624377|555584|P1|Overall Study|Lost to Follow-up|355
156442|NCT00624338|555598|P3|Overall Study|Randomized but not treated|3
156443|NCT00624338|555599|P2|Overall Study|Randomized but not treated|1
156444|NCT00624338|555600|P1|Overall Study|Randomized but not treated|2
156445|NCT00624338|555598|P3|Overall Study|Other|9
156446|NCT00624338|555599|P2|Overall Study|Other|5
156447|NCT00624338|555600|P1|Overall Study|Other|15
156448|NCT00624338|555598|P3|Overall Study|Termination of 150 mg group by Sponsor|0
156449|NCT00624338|555599|P2|Overall Study|Termination of 150 mg group by Sponsor|55
156450|NCT00624338|555600|P1|Overall Study|Termination of 150 mg group by Sponsor|0
156451|NCT00624338|555598|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
156452|NCT00624338|555599|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
156453|NCT00624338|555600|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
156454|NCT00624338|555598|P3|Overall Study|Death|0
156455|NCT00624338|555599|P2|Overall Study|Death|2
156456|NCT00624338|555600|P1|Overall Study|Death|0
156457|NCT00624338|555598|P3|Overall Study|Protocol Violation|2
156458|NCT00624338|555599|P2|Overall Study|Protocol Violation|3
156459|NCT00624338|555600|P1|Overall Study|Protocol Violation|3
156460|NCT00624338|555598|P3|Overall Study|Lack of Efficacy|14
156461|NCT00624338|555599|P2|Overall Study|Lack of Efficacy|3
156462|NCT00624338|555600|P1|Overall Study|Lack of Efficacy|11
156463|NCT00624338|555598|P3|Overall Study|Lost to Follow-up|0
156464|NCT00624338|555599|P2|Overall Study|Lost to Follow-up|0
156465|NCT00624338|555600|P1|Overall Study|Lost to Follow-up|1
156466|NCT00624338|555598|P3|Overall Study|Adverse Event|18
156467|NCT00624338|555599|P2|Overall Study|Adverse Event|14
156468|NCT00624338|555600|P1|Overall Study|Adverse Event|14
156469|NCT00624286|555622|P2|Overall Study|Death|1
156470|NCT00624286|555623|P1|Overall Study|Death|0
156471|NCT00624286|555622|P2|Overall Study|Abnormal test procedure result(s)|1
156472|NCT00624286|555623|P1|Overall Study|Abnormal test procedure result(s)|0
156473|NCT00624286|555622|P2|Overall Study|Not stated|1
156474|NCT00624286|555623|P1|Overall Study|Not stated|0
156475|NCT00624286|555622|P2|Overall Study|Lack of Efficacy|6
156476|NCT00624286|555623|P1|Overall Study|Lack of Efficacy|1
156477|NCT00624286|555622|P2|Overall Study|Administrative problems|0
156478|NCT00624286|555623|P1|Overall Study|Administrative problems|3
156479|NCT00624286|555622|P2|Overall Study|Lost to Follow-up|2
156480|NCT00624286|555623|P1|Overall Study|Lost to Follow-up|3
156481|NCT00624286|555622|P2|Overall Study|Withdrawal by Subject|4
156482|NCT00624286|555623|P1|Overall Study|Withdrawal by Subject|5
156483|NCT00624286|555622|P2|Overall Study|Adverse Event|3
156484|NCT00624286|555623|P1|Overall Study|Adverse Event|6
156485|NCT00624286|555622|P2|Overall Study|Protocol Deviation|9
156486|NCT00624286|555623|P1|Overall Study|Protocol Deviation|7
156487|NCT00624065|555676|P2|Overall Study|Met protocol-defined stopping criteria|9
156488|NCT00624065|555677|P1|Overall Study|Met protocol-defined stopping criteria|4
156489|NCT00624065|555676|P2|Overall Study|Lack of Efficacy|3
156490|NCT00624065|555677|P1|Overall Study|Lack of Efficacy|0
156491|NCT00624065|555676|P2|Overall Study|Consent withdrawn|5
156492|NCT00624065|555677|P1|Overall Study|Consent withdrawn|6
156493|NCT00624065|555676|P2|Overall Study|Lost to Follow-up|1
156494|NCT00624065|555677|P1|Overall Study|Lost to Follow-up|4
156495|NCT00624065|555676|P2|Overall Study|Adverse Event|6
156496|NCT00624065|555677|P1|Overall Study|Adverse Event|5
156497|NCT00624052|555689|P4|Overall Study|Changed job/ran out if meds|0
156498|NCT00624052|555690|P3|Overall Study|Changed job/ran out if meds|0
156499|NCT00624052|555691|P2|Overall Study|Changed job/ran out if meds|2
156500|NCT00624052|555692|P1|Overall Study|Changed job/ran out if meds|0
156501|NCT00624052|555689|P4|Overall Study|Consent withdrawn|0
156502|NCT00624052|555690|P3|Overall Study|Consent withdrawn|1
156503|NCT00624052|555691|P2|Overall Study|Consent withdrawn|1
156504|NCT00624052|555692|P1|Overall Study|Consent withdrawn|3
156505|NCT00624052|555689|P4|Overall Study|Non compliant with the protocol|1
156506|NCT00624052|555690|P3|Overall Study|Non compliant with the protocol|1
156507|NCT00624052|555691|P2|Overall Study|Non compliant with the protocol|1
156508|NCT00624052|555692|P1|Overall Study|Non compliant with the protocol|2
156509|NCT00624052|555689|P4|Overall Study|Lost to Follow-up|0
156510|NCT00624052|555690|P3|Overall Study|Lost to Follow-up|1
156511|NCT00624052|555691|P2|Overall Study|Lost to Follow-up|3
156512|NCT00624052|555692|P1|Overall Study|Lost to Follow-up|2
156513|NCT00624052|555689|P4|Overall Study|Lack of Efficacy|0
156514|NCT00624052|555690|P3|Overall Study|Lack of Efficacy|0
156515|NCT00624052|555691|P2|Overall Study|Lack of Efficacy|1
156516|NCT00624052|555692|P1|Overall Study|Lack of Efficacy|1
156517|NCT00624052|555689|P4|Overall Study|Adverse Event|3
156518|NCT00624052|555690|P3|Overall Study|Adverse Event|0
156519|NCT00624052|555691|P2|Overall Study|Adverse Event|6
156520|NCT00624052|555692|P1|Overall Study|Adverse Event|7
156521|NCT00623935|555769|P1|Overall Study|Patient Declined Transplant|1
156522|NCT00623935|555769|P1|Overall Study|Death|1
156523|NCT00623831|555776|P2|Overall Study|Progressive Disease|1
156524|NCT00623831|555777|P1|Overall Study|Progressive Disease|0
156525|NCT00623831|555776|P2|Overall Study|Withdrawal by Subject|0
156526|NCT00623831|555777|P1|Overall Study|Withdrawal by Subject|1
156527|NCT00623805|555789|P2|Overall Study|Reason not Specified|6
156528|NCT00623805|555790|P1|Overall Study|Reason not Specified|3
156529|NCT00623805|555789|P2|Overall Study|Protocol Violation|1
156530|NCT00623805|555790|P1|Overall Study|Protocol Violation|1
156531|NCT00623805|555789|P2|Overall Study|Lost to Follow-up|2
156532|NCT00623805|555790|P1|Overall Study|Lost to Follow-up|2
156533|NCT00623805|555789|P2|Overall Study|Lack of Efficacy|7
156534|NCT00623805|555790|P1|Overall Study|Lack of Efficacy|3
156535|NCT00623805|555789|P2|Overall Study|Death|0
156536|NCT00623805|555790|P1|Overall Study|Death|2
156537|NCT00623805|555789|P2|Overall Study|Adverse Event|6
156538|NCT00623805|555790|P1|Overall Study|Adverse Event|9
156539|NCT00623779|555807|P3|Overall Study|Criteria from CSR|1
156540|NCT00623779|555808|P2|Overall Study|Criteria from CSR|0
156541|NCT00623779|555809|P1|Overall Study|Criteria from CSR|2
156542|NCT00623779|555807|P3|Overall Study|Adverse Event|0
156543|NCT00623779|555808|P2|Overall Study|Adverse Event|3
156544|NCT00623779|555809|P1|Overall Study|Adverse Event|1
156545|NCT00623766|555858|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
156546|NCT00623766|555859|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
156547|NCT00623766|555858|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
156548|NCT00623766|555859|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
156549|NCT00623766|555858|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
156550|NCT00623766|555859|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
156551|NCT00623766|555858|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
156552|NCT00623766|555859|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
156553|NCT00623766|555858|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
156554|NCT00623766|555859|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
156555|NCT00623727|555883|P2|Open Label Follow-up|Participant convenience|1
156556|NCT00623727|555884|P1|Open Label Follow-up|Participant convenience|0
156557|NCT00623727|555883|P2|Open Label Follow-up|Study termination|6
156558|NCT00623727|555884|P1|Open Label Follow-up|Study termination|0
156559|NCT00623727|555883|P2|Open Label Follow-up|Withdrawal by Subject|1
156560|NCT00623727|555884|P1|Open Label Follow-up|Withdrawal by Subject|0
156561|NCT00623727|555883|P2|Double Blind (DB)|Protocol Violation|2
156562|NCT00623727|555884|P1|Double Blind (DB)|Protocol Violation|2
156563|NCT00623727|555883|P2|Double Blind (DB)|Lost to Follow-up|1
156564|NCT00623727|555884|P1|Double Blind (DB)|Lost to Follow-up|1
156565|NCT00623727|555883|P2|Double Blind (DB)|Termination of the double-blind period|21
156566|NCT00623727|555884|P1|Double Blind (DB)|Termination of the double-blind period|22
156567|NCT00623727|555883|P2|Double Blind (DB)|Lack of Efficacy|2
156568|NCT00623727|555884|P1|Double Blind (DB)|Lack of Efficacy|2
156569|NCT00623727|555883|P2|Double Blind (DB)|Withdrawal by Subject|2
156570|NCT00623727|555884|P1|Double Blind (DB)|Withdrawal by Subject|8
156571|NCT00623727|555883|P2|Double Blind (DB)|Physician Decision|1
156572|NCT00623727|555884|P1|Double Blind (DB)|Physician Decision|0
156573|NCT00623727|555883|P2|Double Blind (DB)|Adverse Event|3
156574|NCT00623727|555884|P1|Double Blind (DB)|Adverse Event|1
156575|NCT00623597|555939|P2|Overall Study|Failed to return|0
156576|NCT00623597|555940|P1|Overall Study|Failed to return|1
156577|NCT00623545|556003|P1|Overall Study|Withdrawal by Subject|4
156578|NCT00623545|556003|P1|Overall Study|Adverse Event|6
156579|NCT00623480|556023|P2|Overall Study|Site closed by sponsor|1
156580|NCT00623480|556024|P1|Overall Study|Site closed by sponsor|0
156581|NCT00623480|556023|P2|Overall Study|Protocol Violation|1
156582|NCT00623480|556024|P1|Overall Study|Protocol Violation|0
156583|NCT00623480|556023|P2|Overall Study|Non-compliant with study medication|0
156584|NCT00623480|556024|P1|Overall Study|Non-compliant with study medication|4
156585|NCT00623480|556023|P2|Overall Study|Lack of Efficacy|0
156586|NCT00623480|556024|P1|Overall Study|Lack of Efficacy|1
156587|NCT00623480|556023|P2|Overall Study|Withdrawal by Subject|4
156588|NCT00623480|556024|P1|Overall Study|Withdrawal by Subject|2
156589|NCT00623480|556023|P2|Overall Study|Lost to Follow-up|1
156590|NCT00623480|556024|P1|Overall Study|Lost to Follow-up|0
156591|NCT00623467|556036|P1|Overall Study|Withdrawal by Subject|2
156592|NCT00623467|556036|P1|Overall Study|Protocol Violation|4
156593|NCT00623467|556036|P1|Overall Study|Lost to Follow-up|1
156594|NCT00623428|556106|P2|Follow-up Period|Death|1
156595|NCT00623428|556107|P1|Follow-up Period|Death|0
156596|NCT00623428|556106|P2|Follow-up Period|Reason not specified|1
156597|NCT00623428|556107|P1|Follow-up Period|Reason not specified|1
156598|NCT00623428|556106|P2|Follow-up Period|Did not cooperate|3
156599|NCT00623428|556107|P1|Follow-up Period|Did not cooperate|0
156600|NCT00623428|556106|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
156601|NCT00623428|556107|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
156602|NCT00623428|556106|P2|Follow-up Period|Patient withdrew consent|4
156603|NCT00623428|556107|P1|Follow-up Period|Patient withdrew consent|5
156604|NCT00623428|556106|P2|Follow-up Period|Failure to return|2
156605|NCT00623428|556107|P1|Follow-up Period|Failure to return|10
156606|NCT00623428|556106|P2|Follow-up Period|Relapse post-treatment|3
156607|NCT00623428|556107|P1|Follow-up Period|Relapse post-treatment|11
156608|NCT00623428|556106|P2|Treatment Period|Withdrawal by Subject|1
156609|NCT00623428|556107|P1|Treatment Period|Withdrawal by Subject|0
156610|NCT00623428|556106|P2|Treatment Period|Other|1
156611|NCT00623428|556107|P1|Treatment Period|Other|0
156612|NCT00623428|556106|P2|Treatment Period|Insufficient therapeutic response|2
156613|NCT00623428|556107|P1|Treatment Period|Insufficient therapeutic response|0
156614|NCT00623428|556106|P2|Treatment Period|Did not cooperate / refused treatment|13
156615|NCT00623428|556107|P1|Treatment Period|Did not cooperate / refused treatment|0
156616|NCT00623428|556106|P2|Treatment Period|Death|1
156617|NCT00623428|556107|P1|Treatment Period|Death|0
156618|NCT00623428|556106|P2|Treatment Period|Adverse event/intercurrent illness|9
156619|NCT00623428|556107|P1|Treatment Period|Adverse event/intercurrent illness|0
156620|NCT00623233|556125|P1|Overall Study|Withdrawal by Subject|3
156621|NCT00623233|556125|P1|Overall Study|Lost to Follow-up|1
156622|NCT00623233|556125|P1|Overall Study|Physician Decision|10
156623|NCT00623233|556125|P1|Overall Study|Adverse Event|10
156624|NCT00623194|556132|P1|Overall Study|Unclassified|1
156625|NCT00623194|556132|P1|Overall Study|Protocol Violation|3
156626|NCT00623194|556132|P1|Overall Study|Lack of Efficacy|1
156627|NCT00623103|556169|P2|Overall Study|Protocol deviation|1
156628|NCT00623103|556170|P1|Overall Study|Protocol deviation|2
156629|NCT00623103|556169|P2|Overall Study|Death|11
156630|NCT00623103|556170|P1|Overall Study|Death|11
156631|NCT00623103|556169|P2|Overall Study|Administrative problems|4
156632|NCT00623103|556170|P1|Overall Study|Administrative problems|2
156633|NCT00623103|556169|P2|Overall Study|Lost to Follow-up|1
156634|NCT00623103|556170|P1|Overall Study|Lost to Follow-up|4
156635|NCT00623103|556169|P2|Overall Study|Withdrawal by Subject|24
156636|NCT00623103|556170|P1|Overall Study|Withdrawal by Subject|18
156637|NCT00623103|556169|P2|Overall Study|Unsatisfactory therapeutic effect|12
156638|NCT00623103|556170|P1|Overall Study|Unsatisfactory therapeutic effect|4
156639|NCT00623103|556169|P2|Overall Study|Adverse Event|60
156640|NCT00623103|556170|P1|Overall Study|Adverse Event|70
156641|NCT00622908|556198|P2|Overall Study|Termination by study sponser|1
156642|NCT00622908|556199|P1|Overall Study|Termination by study sponser|0
156643|NCT00622908|556198|P2|Overall Study|Refusal|1
156644|NCT00622908|556199|P1|Overall Study|Refusal|0
156645|NCT00622908|556198|P2|Overall Study|Lost to Follow-up|0
156646|NCT00622908|556199|P1|Overall Study|Lost to Follow-up|1
156647|NCT00622908|556198|P2|Overall Study|Lack of Efficacy|7
156648|NCT00622908|556199|P1|Overall Study|Lack of Efficacy|1
156649|NCT00622908|556198|P2|Overall Study|Adverse Event|1
156650|NCT00622908|556199|P1|Overall Study|Adverse Event|0
156651|NCT00622908|556198|P2|Overall Study|Protocol Violation|0
156652|NCT00622908|556199|P1|Overall Study|Protocol Violation|1
156653|NCT00622869|556214|P3|Overall Study|Missing|1
156654|NCT00622869|556215|P2|Overall Study|Missing|1
156655|NCT00622869|556216|P1|Overall Study|Missing|0
156656|NCT00622869|556214|P3|Overall Study|Graft Loss|2
156657|NCT00622869|556215|P2|Overall Study|Graft Loss|3
156658|NCT00622869|556216|P1|Overall Study|Graft Loss|5
156659|NCT00622869|556214|P3|Overall Study|Lost to Follow-up|2
156660|NCT00622869|556215|P2|Overall Study|Lost to Follow-up|4
156661|NCT00622869|556216|P1|Overall Study|Lost to Follow-up|2
156662|NCT00622869|556214|P3|Overall Study|Death|10
156663|NCT00622869|556215|P2|Overall Study|Death|15
156664|NCT00622869|556216|P1|Overall Study|Death|12
156665|NCT00622869|556214|P3|Overall Study|Administrative Problems|13
156666|NCT00622869|556215|P2|Overall Study|Administrative Problems|17
156667|NCT00622869|556216|P1|Overall Study|Administrative Problems|11
156668|NCT00622869|556214|P3|Overall Study|Subject Withdrew Consent|11
156669|NCT00622869|556215|P2|Overall Study|Subject Withdrew Consent|17
156670|NCT00622869|556216|P1|Overall Study|Subject Withdrew Consent|13
156671|NCT00622739|556235|P2|Overall Study|Lost to Follow-up|1
156672|NCT00622739|556236|P1|Overall Study|Lost to Follow-up|0
156673|NCT00622739|556235|P2|Overall Study|Withdrawal by Subject|1
156674|NCT00622739|556236|P1|Overall Study|Withdrawal by Subject|0
156675|NCT00622739|556235|P2|Overall Study|Lack of Efficacy|2
156676|NCT00622739|556236|P1|Overall Study|Lack of Efficacy|0
156677|NCT00622739|556235|P2|Overall Study|Adverse Event|2
156678|NCT00622739|556236|P1|Overall Study|Adverse Event|1
156679|NCT00622739|556235|P2|Overall Study|Physician Decision|0
156680|NCT00622739|556236|P1|Overall Study|Physician Decision|1
156681|NCT00622726|556244|P2|August, 2010 to April, 2013|Death|5
156682|NCT00622726|556245|P1|August, 2010 to April, 2013|Death|1
156683|NCT00622726|556244|P2|March, 2008 to August, 2010|Death|2
156684|NCT00622726|556245|P1|March, 2008 to August, 2010|Death|5
156685|NCT00622713|556255|P1|Overall Study|Did not meet eligibility criteria|1
156686|NCT00622713|556255|P1|Overall Study|Subject no longer required study drug|1
156687|NCT00622713|556255|P1|Overall Study|Death|2
156688|NCT00622713|556255|P1|Overall Study|Lost to Follow-up|5
156689|NCT00622713|556255|P1|Overall Study|Withdrawal by Subject|11
156690|NCT00622713|556255|P1|Overall Study|Administrative problems|4
156691|NCT00622713|556255|P1|Overall Study|Adverse Event|35
156692|NCT00622700|556266|P7|Extension Treatment Period|Other than specified above|1
156693|NCT00622700|556267|P6|Extension Treatment Period|Other than specified above|1
156694|NCT00622700|556268|P5|Extension Treatment Period|Other than specified above|0
156695|NCT00622700|556269|P4|Extension Treatment Period|Other than specified above|0
156696|NCT00622700|556270|P3|Extension Treatment Period|Other than specified above|0
156697|NCT00622700|556271|P2|Extension Treatment Period|Other than specified above|0
156698|NCT00622700|556272|P1|Extension Treatment Period|Other than specified above|0
156699|NCT00622700|556266|P7|Extension Treatment Period|Missing|0
156700|NCT00622700|556267|P6|Extension Treatment Period|Missing|1
156701|NCT00622700|556268|P5|Extension Treatment Period|Missing|3
156702|NCT00622700|556269|P4|Extension Treatment Period|Missing|2
156703|NCT00622700|556270|P3|Extension Treatment Period|Missing|0
156704|NCT00622700|556271|P2|Extension Treatment Period|Missing|0
156705|NCT00622700|556272|P1|Extension Treatment Period|Missing|0
156706|NCT00622700|556266|P7|Extension Treatment Period|Withdrawal by Subject|10
156707|NCT00622700|556267|P6|Extension Treatment Period|Withdrawal by Subject|6
156708|NCT00622700|556268|P5|Extension Treatment Period|Withdrawal by Subject|16
156709|NCT00622700|556269|P4|Extension Treatment Period|Withdrawal by Subject|11
156710|NCT00622700|556270|P3|Extension Treatment Period|Withdrawal by Subject|0
156711|NCT00622700|556271|P2|Extension Treatment Period|Withdrawal by Subject|0
156712|NCT00622700|556272|P1|Extension Treatment Period|Withdrawal by Subject|0
156713|NCT00622700|556266|P7|Extension Treatment Period|Progressive Disease|2
156714|NCT00622700|556267|P6|Extension Treatment Period|Progressive Disease|0
156715|NCT00622700|556268|P5|Extension Treatment Period|Progressive Disease|2
156716|NCT00622700|556269|P4|Extension Treatment Period|Progressive Disease|1
156717|NCT00622700|556270|P3|Extension Treatment Period|Progressive Disease|0
156718|NCT00622700|556271|P2|Extension Treatment Period|Progressive Disease|0
156719|NCT00622700|556272|P1|Extension Treatment Period|Progressive Disease|0
156720|NCT00622700|556266|P7|Extension Treatment Period|Lost to Follow-up|0
156721|NCT00622700|556267|P6|Extension Treatment Period|Lost to Follow-up|0
156722|NCT00622700|556268|P5|Extension Treatment Period|Lost to Follow-up|1
156723|NCT00622700|556269|P4|Extension Treatment Period|Lost to Follow-up|0
156724|NCT00622700|556270|P3|Extension Treatment Period|Lost to Follow-up|0
156725|NCT00622700|556271|P2|Extension Treatment Period|Lost to Follow-up|0
156726|NCT00622700|556272|P1|Extension Treatment Period|Lost to Follow-up|0
156727|NCT00622700|556266|P7|Extension Treatment Period|Protocol Violation|0
156728|NCT00622700|556267|P6|Extension Treatment Period|Protocol Violation|2
156729|NCT00622700|556268|P5|Extension Treatment Period|Protocol Violation|0
156730|NCT00622700|556269|P4|Extension Treatment Period|Protocol Violation|0
156731|NCT00622700|556270|P3|Extension Treatment Period|Protocol Violation|0
156732|NCT00622700|556271|P2|Extension Treatment Period|Protocol Violation|0
156733|NCT00622700|556272|P1|Extension Treatment Period|Protocol Violation|0
156734|NCT00622700|556266|P7|Extension Treatment Period|Lack of Efficacy|9
156735|NCT00622700|556267|P6|Extension Treatment Period|Lack of Efficacy|1
156736|NCT00622700|556268|P5|Extension Treatment Period|Lack of Efficacy|8
156737|NCT00622700|556269|P4|Extension Treatment Period|Lack of Efficacy|2
156738|NCT00622700|556270|P3|Extension Treatment Period|Lack of Efficacy|0
156739|NCT00622700|556271|P2|Extension Treatment Period|Lack of Efficacy|0
156740|NCT00622700|556272|P1|Extension Treatment Period|Lack of Efficacy|0
156741|NCT00622700|556266|P7|Extension Treatment Period|Adverse Event|8
156742|NCT00622700|556267|P6|Extension Treatment Period|Adverse Event|6
156743|NCT00622700|556268|P5|Extension Treatment Period|Adverse Event|9
156744|NCT00622700|556269|P4|Extension Treatment Period|Adverse Event|5
156745|NCT00622700|556270|P3|Extension Treatment Period|Adverse Event|0
156746|NCT00622700|556271|P2|Extension Treatment Period|Adverse Event|0
156747|NCT00622700|556272|P1|Extension Treatment Period|Adverse Event|0
156748|NCT00622700|556266|P7|Core Treatment Period|Other than specified above|0
156749|NCT00622700|556267|P6|Core Treatment Period|Other than specified above|0
156750|NCT00622700|556268|P5|Core Treatment Period|Other than specified above|0
156751|NCT00622700|556269|P4|Core Treatment Period|Other than specified above|0
156752|NCT00622700|556270|P3|Core Treatment Period|Other than specified above|5
156753|NCT00622700|556271|P2|Core Treatment Period|Other than specified above|2
156754|NCT00622700|556272|P1|Core Treatment Period|Other than specified above|2
156755|NCT00622700|556266|P7|Core Treatment Period|Withdrawal by Subject|0
156756|NCT00622700|556267|P6|Core Treatment Period|Withdrawal by Subject|0
156757|NCT00622700|556268|P5|Core Treatment Period|Withdrawal by Subject|0
156758|NCT00622700|556269|P4|Core Treatment Period|Withdrawal by Subject|0
156759|NCT00622700|556270|P3|Core Treatment Period|Withdrawal by Subject|15
156760|NCT00622700|556271|P2|Core Treatment Period|Withdrawal by Subject|18
156761|NCT00622700|556272|P1|Core Treatment Period|Withdrawal by Subject|12
156762|NCT00622700|556266|P7|Core Treatment Period|Progressive Disease|0
156763|NCT00622700|556267|P6|Core Treatment Period|Progressive Disease|0
156764|NCT00622700|556268|P5|Core Treatment Period|Progressive Disease|0
156765|NCT00622700|556269|P4|Core Treatment Period|Progressive Disease|0
156766|NCT00622700|556270|P3|Core Treatment Period|Progressive Disease|0
156767|NCT00622700|556271|P2|Core Treatment Period|Progressive Disease|1
156768|NCT00622700|556272|P1|Core Treatment Period|Progressive Disease|3
156769|NCT00622700|556266|P7|Core Treatment Period|Death|0
156770|NCT00622700|556267|P6|Core Treatment Period|Death|0
156771|NCT00622700|556268|P5|Core Treatment Period|Death|0
156772|NCT00622700|556269|P4|Core Treatment Period|Death|0
156773|NCT00622700|556270|P3|Core Treatment Period|Death|0
156774|NCT00622700|556271|P2|Core Treatment Period|Death|0
156775|NCT00622700|556272|P1|Core Treatment Period|Death|1
156776|NCT00622700|556266|P7|Core Treatment Period|Lost to Follow-up|0
156777|NCT00622700|556267|P6|Core Treatment Period|Lost to Follow-up|0
156778|NCT00622700|556268|P5|Core Treatment Period|Lost to Follow-up|0
156779|NCT00622700|556269|P4|Core Treatment Period|Lost to Follow-up|0
156780|NCT00622700|556270|P3|Core Treatment Period|Lost to Follow-up|1
156781|NCT00622700|556271|P2|Core Treatment Period|Lost to Follow-up|1
156782|NCT00622700|556272|P1|Core Treatment Period|Lost to Follow-up|1
156783|NCT00622700|556266|P7|Core Treatment Period|Lack of Efficacy|0
156784|NCT00622700|556267|P6|Core Treatment Period|Lack of Efficacy|0
156785|NCT00622700|556268|P5|Core Treatment Period|Lack of Efficacy|0
156786|NCT00622700|556269|P4|Core Treatment Period|Lack of Efficacy|0
156787|NCT00622700|556270|P3|Core Treatment Period|Lack of Efficacy|12
156788|NCT00622700|556271|P2|Core Treatment Period|Lack of Efficacy|6
156789|NCT00622700|556272|P1|Core Treatment Period|Lack of Efficacy|19
156790|NCT00622700|556266|P7|Core Treatment Period|Adverse Event|0
156791|NCT00622700|556267|P6|Core Treatment Period|Adverse Event|0
156792|NCT00622700|556268|P5|Core Treatment Period|Adverse Event|0
156793|NCT00622700|556269|P4|Core Treatment Period|Adverse Event|0
156794|NCT00622700|556270|P3|Core Treatment Period|Adverse Event|18
156795|NCT00622700|556271|P2|Core Treatment Period|Adverse Event|25
156796|NCT00622700|556272|P1|Core Treatment Period|Adverse Event|18
156797|NCT00622700|556266|P7|Core Treatment Period|Randomized but Not Treated|0
156798|NCT00622700|556267|P6|Core Treatment Period|Randomized but Not Treated|0
156799|NCT00622700|556268|P5|Core Treatment Period|Randomized but Not Treated|0
156800|NCT00622700|556269|P4|Core Treatment Period|Randomized but Not Treated|0
156801|NCT00622700|556270|P3|Core Treatment Period|Randomized but Not Treated|2
156802|NCT00622700|556271|P2|Core Treatment Period|Randomized but Not Treated|2
156803|NCT00622700|556272|P1|Core Treatment Period|Randomized but Not Treated|0
156804|NCT00622635|556331|P6|Treatment Period 3|Withdrawal by Subject|0
156805|NCT00622635|556332|P5|Treatment Period 3|Withdrawal by Subject|0
156806|NCT00622635|556333|P4|Treatment Period 3|Withdrawal by Subject|1
156807|NCT00622635|556334|P3|Treatment Period 3|Withdrawal by Subject|0
156808|NCT00622635|556335|P2|Treatment Period 3|Withdrawal by Subject|0
156809|NCT00622635|556336|P1|Treatment Period 3|Withdrawal by Subject|0
156810|NCT00622635|556331|P6|Treatment Period 3|Adverse Event|0
156811|NCT00622635|556332|P5|Treatment Period 3|Adverse Event|0
156812|NCT00622635|556333|P4|Treatment Period 3|Adverse Event|2
156813|NCT00622635|556334|P3|Treatment Period 3|Adverse Event|0
156814|NCT00622635|556335|P2|Treatment Period 3|Adverse Event|0
156815|NCT00622635|556336|P1|Treatment Period 3|Adverse Event|0
156816|NCT00622635|556331|P6|Treatment Period 2|Adverse Event|0
156817|NCT00622635|556332|P5|Treatment Period 2|Adverse Event|0
156818|NCT00622635|556333|P4|Treatment Period 2|Adverse Event|0
156819|NCT00622635|556334|P3|Treatment Period 2|Adverse Event|0
156820|NCT00622635|556335|P2|Treatment Period 2|Adverse Event|0
156821|NCT00622635|556336|P1|Treatment Period 2|Adverse Event|1
156822|NCT00622635|556331|P6|Treatment Period 1|Abnormal test procedure result(s)|0
156823|NCT00622635|556332|P5|Treatment Period 1|Abnormal test procedure result(s)|1
156824|NCT00622635|556333|P4|Treatment Period 1|Abnormal test procedure result(s)|0
156825|NCT00622635|556334|P3|Treatment Period 1|Abnormal test procedure result(s)|0
156826|NCT00622635|556335|P2|Treatment Period 1|Abnormal test procedure result(s)|0
156827|NCT00622635|556336|P1|Treatment Period 1|Abnormal test procedure result(s)|0
156828|NCT00622635|556331|P6|Treatment Period 1|Withdrawal by Subject|0
156829|NCT00622635|556332|P5|Treatment Period 1|Withdrawal by Subject|0
156830|NCT00622635|556333|P4|Treatment Period 1|Withdrawal by Subject|0
156831|NCT00622635|556334|P3|Treatment Period 1|Withdrawal by Subject|0
156832|NCT00622635|556335|P2|Treatment Period 1|Withdrawal by Subject|1
156833|NCT00622635|556336|P1|Treatment Period 1|Withdrawal by Subject|0
156834|NCT00622635|556331|P6|Treatment Period 1|Adverse Event|0
156835|NCT00622635|556332|P5|Treatment Period 1|Adverse Event|0
156836|NCT00622635|556333|P4|Treatment Period 1|Adverse Event|0
156837|NCT00622635|556334|P3|Treatment Period 1|Adverse Event|1
156838|NCT00622635|556335|P2|Treatment Period 1|Adverse Event|0
156839|NCT00622635|556336|P1|Treatment Period 1|Adverse Event|0
156840|NCT00622440|556414|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
156841|NCT00622440|556415|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
156842|NCT00622440|556414|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
156843|NCT00622440|556415|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
156844|NCT00622440|556414|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
156845|NCT00622440|556415|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
156846|NCT00622440|556414|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
156847|NCT00622440|556415|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
156848|NCT00622401|556441|P3|Overall Study|Disease progression prior to treatment|0
156849|NCT00622401|556442|P2|Overall Study|Disease progression prior to treatment|2
156850|NCT00622401|556443|P1|Overall Study|Disease progression prior to treatment|3
156851|NCT00622388|556450|P1|Overall Study|Insurance Expired|1
156852|NCT00622388|556450|P1|Overall Study|Withdrew Consent|1
156853|NCT00622388|556450|P1|Overall Study|Took Prohibited Medication|2
156854|NCT00622388|556450|P1|Overall Study|Received Alternate Anticancer Therapy|8
156855|NCT00622388|556450|P1|Overall Study|Death|3
156856|NCT00622388|556450|P1|Overall Study|Participant Refusal|1
156857|NCT00622388|556450|P1|Overall Study|Protocol Violation|3
156858|NCT00622388|556450|P1|Overall Study|Adverse Event|6
156859|NCT00622388|556450|P1|Overall Study|Disease Progression|47
156860|NCT00622336|556468|P1|Extension Phase|Other|9
156861|NCT00622336|556468|P1|Extension Phase|Lost to Follow-up|1
156862|NCT00622336|556468|P1|Extension Phase|Withdrawal by Subject|1
156863|NCT00622336|556468|P1|Extension Phase|Lack of therapeutic effect|2
156864|NCT00622336|556468|P1|Extension Phase|Progressive Disease|6
156865|NCT00622336|556468|P1|Extension Phase|Adverse Event|2
156866|NCT00622336|556468|P1|Treatment Phase|Lost to Follow-up|2
156867|NCT00622336|556468|P1|Treatment Phase|Withdrawal by Subject|13
156868|NCT00622336|556468|P1|Treatment Phase|Lack of therapeutic effect|13
156869|NCT00622336|556468|P1|Treatment Phase|Death|14
156870|NCT00622336|556468|P1|Treatment Phase|Other|40
156871|NCT00622336|556468|P1|Treatment Phase|Adverse Event|46
156872|NCT00622336|556468|P1|Treatment Phase|Progression of Disease|181
156873|NCT00622284|556479|P2|Overall Study|Other reason (not specified)|24
156874|NCT00622284|556480|P1|Overall Study|Other reason (not specified)|33
156875|NCT00622284|556479|P2|Overall Study|Withdrawal by Subject|24
156876|NCT00622284|556480|P1|Overall Study|Withdrawal by Subject|27
156877|NCT00622284|556479|P2|Overall Study|Lost to Follow-up|13
156878|NCT00622284|556480|P1|Overall Study|Lost to Follow-up|11
156879|NCT00622284|556479|P2|Overall Study|Protocol Violation|5
156880|NCT00622284|556480|P1|Overall Study|Protocol Violation|12
156881|NCT00622284|556479|P2|Overall Study|Adverse Event|90
156882|NCT00622284|556480|P1|Overall Study|Adverse Event|61
156883|NCT00622284|556479|P2|Overall Study|Lack of Efficacy|15
156884|NCT00622284|556480|P1|Overall Study|Lack of Efficacy|45
156885|NCT00622167|556542|P1|Overall Study|Did not meet angiographic criteria|20
156886|NCT00621985|556546|P1|Dexamethasone Admission|Adverse Event|1
156887|NCT00621959|556554|P2|Overall Study|Other|3
156888|NCT00621959|556555|P1|Overall Study|Other|1
156889|NCT00621959|556554|P2|Overall Study|Withdrawal by Subject|1
156890|NCT00621959|556555|P1|Overall Study|Withdrawal by Subject|1
156891|NCT00621959|556554|P2|Overall Study|Lost to Follow-up|2
156892|NCT00621959|556555|P1|Overall Study|Lost to Follow-up|0
156893|NCT00621959|556554|P2|Overall Study|Lack of Efficacy|1
156894|NCT00621959|556555|P1|Overall Study|Lack of Efficacy|1
156895|NCT00621959|556554|P2|Overall Study|Adverse Event|2
156896|NCT00621959|556555|P1|Overall Study|Adverse Event|4
156897|NCT00621855|556594|P5|Overall Study|Patients did not receive study drug|2
156898|NCT00621855|556595|P4|Overall Study|Patients did not receive study drug|4
156899|NCT00621855|556596|P3|Overall Study|Patients did not receive study drug|5
156900|NCT00621855|556597|P2|Overall Study|Patients did not receive study drug|3
156901|NCT00621855|556598|P1|Overall Study|Patients did not receive study drug|3
156902|NCT00621855|556594|P5|Overall Study|Other|4
156903|NCT00621855|556595|P4|Overall Study|Other|5
156904|NCT00621855|556596|P3|Overall Study|Other|6
156905|NCT00621855|556597|P2|Overall Study|Other|7
156906|NCT00621855|556598|P1|Overall Study|Other|9
156907|NCT00621855|556594|P5|Overall Study|Withdrawal by Subject|9
156908|NCT00621855|556595|P4|Overall Study|Withdrawal by Subject|13
156909|NCT00621855|556596|P3|Overall Study|Withdrawal by Subject|13
156910|NCT00621855|556597|P2|Overall Study|Withdrawal by Subject|11
156911|NCT00621855|556598|P1|Overall Study|Withdrawal by Subject|16
156912|NCT00621855|556594|P5|Overall Study|Protocol Violation|8
156913|NCT00621855|556595|P4|Overall Study|Protocol Violation|7
156914|NCT00621855|556596|P3|Overall Study|Protocol Violation|6
156915|NCT00621855|556597|P2|Overall Study|Protocol Violation|8
156916|NCT00621855|556598|P1|Overall Study|Protocol Violation|16
156917|NCT00621855|556594|P5|Overall Study|Lost to Follow-up|1
156918|NCT00621855|556595|P4|Overall Study|Lost to Follow-up|4
156919|NCT00621855|556596|P3|Overall Study|Lost to Follow-up|3
156920|NCT00621855|556597|P2|Overall Study|Lost to Follow-up|1
156921|NCT00621855|556598|P1|Overall Study|Lost to Follow-up|0
156922|NCT00621855|556594|P5|Overall Study|Adverse Event|31
156923|NCT00621855|556595|P4|Overall Study|Adverse Event|34
156924|NCT00621855|556596|P3|Overall Study|Adverse Event|48
156925|NCT00621855|556597|P2|Overall Study|Adverse Event|31
156926|NCT00621855|556598|P1|Overall Study|Adverse Event|32
156927|NCT00621842|556640|P1|Overall Study|Lack of Efficacy|2
156928|NCT00621842|556640|P1|Overall Study|Protocol Violation|4
156929|NCT00621842|556640|P1|Overall Study|Withdrawal by Subject|7
156930|NCT00621842|556640|P1|Overall Study|Adverse Event|6
156931|NCT00621777|556657|P2|Randomized Phase|Death|1
156932|NCT00621777|556658|P1|Randomized Phase|Death|0
156933|NCT00621777|556657|P2|Randomized Phase|administrative|3
156934|NCT00621777|556658|P1|Randomized Phase|administrative|0
156935|NCT00621777|556657|P2|Randomized Phase|Withdrawal by Subject|9
156936|NCT00621777|556658|P1|Randomized Phase|Withdrawal by Subject|1
156937|NCT00621777|556657|P2|Randomized Phase|Lost to Follow-up|3
156938|NCT00621777|556658|P1|Randomized Phase|Lost to Follow-up|3
156939|NCT00621777|556657|P2|Randomized Phase|Adverse Event|3
156940|NCT00621777|556658|P1|Randomized Phase|Adverse Event|3
156941|NCT00621777|556657|P2|Open Phase|Lost to Follow-up|0
156942|NCT00621777|556658|P1|Open Phase|Lost to Follow-up|10
156943|NCT00621777|556657|P2|Open Phase|administrative|0
156944|NCT00621777|556658|P1|Open Phase|administrative|13
156945|NCT00621777|556657|P2|Open Phase|Withdrawal by Subject|0
156946|NCT00621777|556658|P1|Open Phase|Withdrawal by Subject|17
156947|NCT00621777|556657|P2|Open Phase|Did not abstain during open phase|0
156948|NCT00621777|556658|P1|Open Phase|Did not abstain during open phase|56
156949|NCT00621777|556657|P2|Open Phase|Adverse Event|0
156950|NCT00621777|556658|P1|Open Phase|Adverse Event|20
156951|NCT00621764|556673|P4|Overall Study|Protocol Violation|1
156952|NCT00621764|556674|P3|Overall Study|Protocol Violation|0
156953|NCT00621764|556675|P2|Overall Study|Protocol Violation|0
156954|NCT00621764|556676|P1|Overall Study|Protocol Violation|0
156955|NCT00621621|556722|P2|Overall Study|Subjects were exited at EP study|0
156956|NCT00621621|556723|P1|Overall Study|Subjects were exited at EP study|30
156957|NCT00621582|556731|P1|Overall Study|issues not identified by investigators|18
156958|NCT00621582|556731|P1|Overall Study|Lost to Follow-up|24
156959|NCT00621582|556731|P1|Overall Study|Protocol Violation|57
156960|NCT00621582|556731|P1|Overall Study|Adverse Event|7
156961|NCT00621543|556738|P1|Overall Study|Lost to Follow-up|23
156962|NCT00621517|556762|P2|Overall Study|Adverse Event|0
156963|NCT00621517|556763|P1|Overall Study|Adverse Event|1
156964|NCT00621517|556762|P2|Overall Study|Withdrawal by Subject|4
156965|NCT00621517|556763|P1|Overall Study|Withdrawal by Subject|3
156966|NCT00621517|556762|P2|Overall Study|Lost to Follow-up|3
156967|NCT00621517|556763|P1|Overall Study|Lost to Follow-up|3
156968|NCT00621504|556771|P2|Overall Study|Death|6
156969|NCT00621504|556772|P1|Overall Study|Death|6
156970|NCT00621504|556771|P2|Overall Study|Other|0
156971|NCT00621504|556772|P1|Overall Study|Other|1
156972|NCT00621504|556771|P2|Overall Study|Lost to Follow-up|10
156973|NCT00621504|556772|P1|Overall Study|Lost to Follow-up|8
156974|NCT00621504|556771|P2|Overall Study|Withdrew consent|6
156975|NCT00621504|556772|P1|Overall Study|Withdrew consent|9
156976|NCT00621504|556771|P2|Overall Study|At the request of sponsor/investigator|0
156977|NCT00621504|556772|P1|Overall Study|At the request of sponsor/investigator|1
156978|NCT00621504|556771|P2|Overall Study|Adverse Event|3
156979|NCT00621504|556772|P1|Overall Study|Adverse Event|1
156980|NCT00621322|556806|P6|Overall Study|Migrated/moved from study area|2
156981|NCT00621322|556807|P5|Overall Study|Migrated/moved from study area|0
156982|NCT00621322|556808|P4|Overall Study|Migrated/moved from study area|1
156983|NCT00621322|556809|P3|Overall Study|Migrated/moved from study area|1
156984|NCT00621322|556810|P2|Overall Study|Migrated/moved from study area|0
156985|NCT00621322|556811|P1|Overall Study|Migrated/moved from study area|1
156986|NCT00621322|556806|P6|Overall Study|Withdrawal by Subject|2
156987|NCT00621322|556807|P5|Overall Study|Withdrawal by Subject|0
156988|NCT00621322|556808|P4|Overall Study|Withdrawal by Subject|1
156989|NCT00621322|556809|P3|Overall Study|Withdrawal by Subject|0
156990|NCT00621322|556810|P2|Overall Study|Withdrawal by Subject|0
156991|NCT00621322|556811|P1|Overall Study|Withdrawal by Subject|0
156992|NCT00621322|556806|P6|Overall Study|Physician Decision|0
156993|NCT00621322|556807|P5|Overall Study|Physician Decision|0
156994|NCT00621322|556808|P4|Overall Study|Physician Decision|1
156995|NCT00621322|556809|P3|Overall Study|Physician Decision|1
156996|NCT00621322|556810|P2|Overall Study|Physician Decision|0
156997|NCT00621322|556811|P1|Overall Study|Physician Decision|0
156998|NCT00621322|556806|P6|Overall Study|Lost to Follow-up|0
156999|NCT00621322|556807|P5|Overall Study|Lost to Follow-up|1
157000|NCT00621322|556808|P4|Overall Study|Lost to Follow-up|0
157001|NCT00621322|556809|P3|Overall Study|Lost to Follow-up|0
157002|NCT00621322|556810|P2|Overall Study|Lost to Follow-up|0
157003|NCT00621322|556811|P1|Overall Study|Lost to Follow-up|0
157004|NCT00621296|556891|P1|Overall Study|Stopping Criteria|3
157005|NCT00621296|556891|P1|Overall Study|Unmatch Criteria|1
157006|NCT00621296|556891|P1|Overall Study|Physician Decision|7
157007|NCT00621296|556891|P1|Overall Study|Lack of Efficacy|1
157008|NCT00621296|556891|P1|Overall Study|Adverse Event|2
157009|NCT00621257|556900|P5|Overall Study|Withdrawal by Subject|1
157010|NCT00621257|556901|P4|Overall Study|Withdrawal by Subject|1
157011|NCT00621257|556902|P3|Overall Study|Withdrawal by Subject|0
157012|NCT00621257|556903|P2|Overall Study|Withdrawal by Subject|0
157013|NCT00621257|556904|P1|Overall Study|Withdrawal by Subject|0
157014|NCT00621257|556900|P5|Overall Study|Physician Decision|1
157015|NCT00621257|556901|P4|Overall Study|Physician Decision|1
157016|NCT00621257|556902|P3|Overall Study|Physician Decision|0
157017|NCT00621257|556903|P2|Overall Study|Physician Decision|2
157018|NCT00621257|556904|P1|Overall Study|Physician Decision|0
157019|NCT00621257|556900|P5|Overall Study|Adverse Event|0
157020|NCT00621257|556901|P4|Overall Study|Adverse Event|0
157021|NCT00621257|556902|P3|Overall Study|Adverse Event|1
157022|NCT00621257|556903|P2|Overall Study|Adverse Event|1
157023|NCT00621257|556904|P1|Overall Study|Adverse Event|0
157024|NCT00621257|556900|P5|Overall Study|Lost to Follow-up|7
157025|NCT00621257|556901|P4|Overall Study|Lost to Follow-up|4
157026|NCT00621257|556902|P3|Overall Study|Lost to Follow-up|2
157027|NCT00621257|556903|P2|Overall Study|Lost to Follow-up|0
157028|NCT00621257|556904|P1|Overall Study|Lost to Follow-up|4
157029|NCT00621244|556920|P4|Overall Study|Administrative problems|2
157030|NCT00621244|556921|P3|Overall Study|Administrative problems|0
157031|NCT00621244|556922|P2|Overall Study|Administrative problems|1
157032|NCT00621244|556923|P1|Overall Study|Administrative problems|5
157033|NCT00621244|556920|P4|Overall Study|Adverse Event|2
157034|NCT00621244|556921|P3|Overall Study|Adverse Event|9
157035|NCT00621244|556922|P2|Overall Study|Adverse Event|7
157036|NCT00621244|556923|P1|Overall Study|Adverse Event|27
157037|NCT00621244|556920|P4|Overall Study|Death|1
157038|NCT00621244|556921|P3|Overall Study|Death|1
157039|NCT00621244|556922|P2|Overall Study|Death|3
157040|NCT00621244|556923|P1|Overall Study|Death|3
157041|NCT00621244|556920|P4|Overall Study|Disease progression|15
157042|NCT00621244|556921|P3|Overall Study|Disease progression|20
157043|NCT00621244|556922|P2|Overall Study|Disease progression|20
157044|NCT00621244|556923|P1|Overall Study|Disease progression|44
157045|NCT00621244|556920|P4|Overall Study|Withdrawal by Subject|3
157046|NCT00621244|556921|P3|Overall Study|Withdrawal by Subject|3
157047|NCT00621244|556922|P2|Overall Study|Withdrawal by Subject|3
157048|NCT00621244|556923|P1|Overall Study|Withdrawal by Subject|7
157049|NCT00621192|557027|P4|Overall Study|Final Assessments not Completed|1
157050|NCT00621192|557028|P3|Overall Study|Final Assessments not Completed|3
157051|NCT00621192|557029|P2|Overall Study|Final Assessments not Completed|0
157052|NCT00621192|557030|P1|Overall Study|Final Assessments not Completed|0
157053|NCT00621192|557027|P4|Overall Study|Death|0
157054|NCT00621192|557028|P3|Overall Study|Death|0
157055|NCT00621192|557029|P2|Overall Study|Death|5
157056|NCT00621192|557030|P1|Overall Study|Death|2
157057|NCT00621192|557027|P4|Overall Study|Adverse Event|1
157058|NCT00621192|557028|P3|Overall Study|Adverse Event|0
157059|NCT00621192|557029|P2|Overall Study|Adverse Event|1
157060|NCT00621192|557030|P1|Overall Study|Adverse Event|0
157061|NCT00621192|557027|P4|Overall Study|Protocol Violation|1
157062|NCT00621192|557028|P3|Overall Study|Protocol Violation|0
157063|NCT00621192|557029|P2|Overall Study|Protocol Violation|0
157064|NCT00621192|557030|P1|Overall Study|Protocol Violation|1
157065|NCT00621192|557027|P4|Overall Study|Physician Decision|0
157066|NCT00621192|557028|P3|Overall Study|Physician Decision|0
157067|NCT00621192|557029|P2|Overall Study|Physician Decision|3
157068|NCT00621192|557030|P1|Overall Study|Physician Decision|1
157069|NCT00621192|557027|P4|Overall Study|Withdrawal by Subject|0
157070|NCT00621192|557028|P3|Overall Study|Withdrawal by Subject|2
157071|NCT00621192|557029|P2|Overall Study|Withdrawal by Subject|0
157072|NCT00621192|557030|P1|Overall Study|Withdrawal by Subject|0
157073|NCT00621153|557054|P2|Overall Study|Withdrawal by Subject|5
157074|NCT00621153|557055|P1|Overall Study|Withdrawal by Subject|4
157075|NCT00621153|557054|P2|Overall Study|Lost to Follow-up|1
157076|NCT00621153|557055|P1|Overall Study|Lost to Follow-up|5
157077|NCT00621153|557054|P2|Overall Study|Adverse Event|2
157078|NCT00621153|557055|P1|Overall Study|Adverse Event|3
157079|NCT00621153|557054|P2|Overall Study|Safety Reason|7
157080|NCT00621153|557055|P1|Overall Study|Safety Reason|8
157081|NCT00621140|557063|P2|Overall Study|Other incl. lack of efficacy|5
157082|NCT00621140|557064|P1|Overall Study|Other incl. lack of efficacy|6
157083|NCT00621140|557063|P2|Overall Study|Withdrawal by Subject|6
157084|NCT00621140|557064|P1|Overall Study|Withdrawal by Subject|4
157085|NCT00621140|557063|P2|Overall Study|Lost to Follow-up|2
157086|NCT00621140|557064|P1|Overall Study|Lost to Follow-up|1
157087|NCT00621140|557063|P2|Overall Study|Adverse Event|5
157088|NCT00621140|557064|P1|Overall Study|Adverse Event|4
157089|NCT00621023|557111|P1|Overall Study|Follow up discontinued|1
157090|NCT00621023|557111|P1|Overall Study|Death|5
157091|NCT00620854|557128|P6|Washout 1|Withdrawal by Subject|0
157092|NCT00620854|557129|P5|Washout 1|Withdrawal by Subject|0
157093|NCT00620854|557130|P4|Washout 1|Withdrawal by Subject|1
157094|NCT00620854|557131|P3|Washout 1|Withdrawal by Subject|1
157095|NCT00620854|557132|P2|Washout 1|Withdrawal by Subject|0
157096|NCT00620854|557133|P1|Washout 1|Withdrawal by Subject|0
157097|NCT00620815|557164|P3|Overall Study|Protocol Violation|1
157098|NCT00620815|557165|P2|Overall Study|Protocol Violation|2
157099|NCT00620815|557166|P1|Overall Study|Protocol Violation|1
157100|NCT00620815|557164|P3|Overall Study|Inappropriate enrolment|1
157101|NCT00620815|557165|P2|Overall Study|Inappropriate enrolment|0
157102|NCT00620815|557166|P1|Overall Study|Inappropriate enrolment|0
157103|NCT00620815|557164|P3|Overall Study|Lost to Follow-up|3
157104|NCT00620815|557165|P2|Overall Study|Lost to Follow-up|6
157105|NCT00620815|557166|P1|Overall Study|Lost to Follow-up|1
157106|NCT00620815|557164|P3|Overall Study|Withdrawal by Subject|0
157107|NCT00620815|557165|P2|Overall Study|Withdrawal by Subject|2
157108|NCT00620815|557166|P1|Overall Study|Withdrawal by Subject|1
157109|NCT00620815|557164|P3|Overall Study|Adverse Event|2
157110|NCT00620815|557165|P2|Overall Study|Adverse Event|1
157111|NCT00620815|557166|P1|Overall Study|Adverse Event|1
157112|NCT00620776|557206|P2|Overall Study|Withdrawal by Subject|2
157113|NCT00620776|557207|P1|Overall Study|Withdrawal by Subject|3
157114|NCT00620776|557206|P2|Overall Study|Lost to Follow-up|5
157115|NCT00620776|557207|P1|Overall Study|Lost to Follow-up|2
157116|NCT00620776|557206|P2|Overall Study|Lack of Efficacy|1
157117|NCT00620776|557207|P1|Overall Study|Lack of Efficacy|2
157118|NCT00620776|557206|P2|Overall Study|Adverse Event|3
157119|NCT00620776|557207|P1|Overall Study|Adverse Event|2
157120|NCT00620776|557206|P2|Overall Study|Did not receive treatment|5
157121|NCT00620776|557207|P1|Overall Study|Did not receive treatment|3
157122|NCT00620763|557235|P2|Period: Second Intervention|Withdrawal by Subject|0
157123|NCT00620763|557236|P1|Period: Second Intervention|Withdrawal by Subject|1
157124|NCT00620763|557235|P2|Period: First Intervention|Protocol Violation|3
157125|NCT00620763|557236|P1|Period: First Intervention|Protocol Violation|0
157126|NCT00620763|557235|P2|Period: First Intervention|Withdrawal by Subject|2
157127|NCT00620763|557236|P1|Period: First Intervention|Withdrawal by Subject|0
157128|NCT00620750|557242|P1|Overall Study|Lost to Follow-up|25
157129|NCT00620659|557257|P6|Treatment Period 3|Withdrawal by Subject|0
157130|NCT00620659|557258|P5|Treatment Period 3|Withdrawal by Subject|0
157131|NCT00620659|557259|P4|Treatment Period 3|Withdrawal by Subject|1
157132|NCT00620659|557260|P3|Treatment Period 3|Withdrawal by Subject|0
157133|NCT00620659|557261|P2|Treatment Period 3|Withdrawal by Subject|0
157134|NCT00620659|557262|P1|Treatment Period 3|Withdrawal by Subject|0
157135|NCT00620659|557257|P6|Treatment Period 3|Adverse Event|0
157136|NCT00620659|557258|P5|Treatment Period 3|Adverse Event|0
157137|NCT00620659|557259|P4|Treatment Period 3|Adverse Event|0
157138|NCT00620659|557260|P3|Treatment Period 3|Adverse Event|0
157139|NCT00620659|557261|P2|Treatment Period 3|Adverse Event|2
157140|NCT00620659|557262|P1|Treatment Period 3|Adverse Event|0
157141|NCT00620659|557257|P6|Placebo Washout Period 2|Adverse Event|0
157142|NCT00620659|557258|P5|Placebo Washout Period 2|Adverse Event|0
157143|NCT00620659|557259|P4|Placebo Washout Period 2|Adverse Event|0
157144|NCT00620659|557260|P3|Placebo Washout Period 2|Adverse Event|0
157145|NCT00620659|557261|P2|Placebo Washout Period 2|Adverse Event|0
157146|NCT00620659|557262|P1|Placebo Washout Period 2|Adverse Event|2
157147|NCT00620659|557257|P6|Treatment Period 2|Withdrawal by Subject|0
157148|NCT00620659|557258|P5|Treatment Period 2|Withdrawal by Subject|3
157149|NCT00620659|557259|P4|Treatment Period 2|Withdrawal by Subject|0
157150|NCT00620659|557260|P3|Treatment Period 2|Withdrawal by Subject|1
157151|NCT00620659|557261|P2|Treatment Period 2|Withdrawal by Subject|0
157152|NCT00620659|557262|P1|Treatment Period 2|Withdrawal by Subject|0
157153|NCT00620659|557257|P6|Treatment Period 2|Adverse Event|0
157154|NCT00620659|557258|P5|Treatment Period 2|Adverse Event|2
157155|NCT00620659|557259|P4|Treatment Period 2|Adverse Event|0
157156|NCT00620659|557260|P3|Treatment Period 2|Adverse Event|0
157157|NCT00620659|557261|P2|Treatment Period 2|Adverse Event|3
157158|NCT00620659|557262|P1|Treatment Period 2|Adverse Event|0
157159|NCT00620659|557257|P6|Placebo Washout Period 1|Withdrawal by Subject|0
157160|NCT00620659|557258|P5|Placebo Washout Period 1|Withdrawal by Subject|0
157161|NCT00620659|557259|P4|Placebo Washout Period 1|Withdrawal by Subject|1
157162|NCT00620659|557260|P3|Placebo Washout Period 1|Withdrawal by Subject|0
157163|NCT00620659|557261|P2|Placebo Washout Period 1|Withdrawal by Subject|0
157164|NCT00620659|557262|P1|Placebo Washout Period 1|Withdrawal by Subject|0
157165|NCT00620659|557257|P6|Treatment Period 1|Withdrawal by Subject|0
157166|NCT00620659|557258|P5|Treatment Period 1|Withdrawal by Subject|1
157167|NCT00620659|557259|P4|Treatment Period 1|Withdrawal by Subject|0
157168|NCT00620659|557260|P3|Treatment Period 1|Withdrawal by Subject|1
157169|NCT00620659|557261|P2|Treatment Period 1|Withdrawal by Subject|0
157170|NCT00620659|557262|P1|Treatment Period 1|Withdrawal by Subject|1
157171|NCT00620659|557257|P6|Treatment Period 1|Protocol Violation|0
157172|NCT00620659|557258|P5|Treatment Period 1|Protocol Violation|0
157173|NCT00620659|557259|P4|Treatment Period 1|Protocol Violation|0
157174|NCT00620659|557260|P3|Treatment Period 1|Protocol Violation|0
157175|NCT00620659|557261|P2|Treatment Period 1|Protocol Violation|0
157176|NCT00620659|557262|P1|Treatment Period 1|Protocol Violation|1
157177|NCT00620659|557257|P6|Treatment Period 1|Adverse Event|0
157178|NCT00620659|557258|P5|Treatment Period 1|Adverse Event|0
157179|NCT00620659|557259|P4|Treatment Period 1|Adverse Event|3
157180|NCT00620659|557260|P3|Treatment Period 1|Adverse Event|0
157181|NCT00620659|557261|P2|Treatment Period 1|Adverse Event|0
157182|NCT00620659|557262|P1|Treatment Period 1|Adverse Event|1
157183|NCT00620555|557280|P1|Overall Study|Visit failure against planned|1
157184|NCT00620555|557280|P1|Overall Study|Choice of other treatment|1
157185|NCT00620555|557280|P1|Overall Study|Withdrawal by Subject|1
157186|NCT00620555|557280|P1|Overall Study|Lack of Efficacy|12
157187|NCT00620555|557280|P1|Overall Study|Protocol Violation|2
157188|NCT00620555|557280|P1|Overall Study|Adverse Event|4
157189|NCT00620542|557289|P4|Part B (2 Year Core Study)|IVUS not available|2
157190|NCT00620542|557290|P3|Part B (2 Year Core Study)|IVUS not available|3
157191|NCT00620542|557291|P2|Part B (2 Year Core Study)|IVUS not available|0
157192|NCT00620542|557292|P1|Part B (2 Year Core Study)|IVUS not available|0
157193|NCT00620542|557289|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
157194|NCT00620542|557290|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
157195|NCT00620542|557291|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
157196|NCT00620542|557292|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
157197|NCT00620542|557289|P4|Part B (2 Year Core Study)|Safety reasons|3
157198|NCT00620542|557290|P3|Part B (2 Year Core Study)|Safety reasons|2
157199|NCT00620542|557291|P2|Part B (2 Year Core Study)|Safety reasons|0
157200|NCT00620542|557292|P1|Part B (2 Year Core Study)|Safety reasons|0
157201|NCT00620542|557289|P4|Part B (2 Year Core Study)|Protocol Violation|16
157202|NCT00620542|557290|P3|Part B (2 Year Core Study)|Protocol Violation|13
157203|NCT00620542|557291|P2|Part B (2 Year Core Study)|Protocol Violation|0
157204|NCT00620542|557292|P1|Part B (2 Year Core Study)|Protocol Violation|0
157205|NCT00620542|557289|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
157206|NCT00620542|557290|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
157207|NCT00620542|557291|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
157208|NCT00620542|557292|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
157209|NCT00620542|557289|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
157210|NCT00620542|557290|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
157211|NCT00620542|557291|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
157212|NCT00620542|557292|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
157213|NCT00620542|557289|P4|Part B (2 Year Core Study)|Protocol Violation|5
157214|NCT00620542|557290|P3|Part B (2 Year Core Study)|Protocol Violation|3
157215|NCT00620542|557291|P2|Part B (2 Year Core Study)|Protocol Violation|0
157216|NCT00620542|557292|P1|Part B (2 Year Core Study)|Protocol Violation|0
157217|NCT00620542|557289|P4|Part B (2 Year Core Study)|Adverse Event|49
157218|NCT00620542|557290|P3|Part B (2 Year Core Study)|Adverse Event|46
157219|NCT00620542|557291|P2|Part B (2 Year Core Study)|Adverse Event|0
157220|NCT00620542|557292|P1|Part B (2 Year Core Study)|Adverse Event|0
157221|NCT00620542|557289|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
157222|NCT00620542|557290|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
157223|NCT00620542|557291|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
157224|NCT00620542|557292|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
157225|NCT00620542|557289|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
157226|NCT00620542|557290|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
157227|NCT00620542|557291|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
157228|NCT00620542|557292|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
157229|NCT00620542|557289|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
157230|NCT00620542|557290|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
157231|NCT00620542|557291|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
157232|NCT00620542|557292|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
157233|NCT00620542|557289|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
157234|NCT00620542|557290|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
157235|NCT00620542|557291|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
157236|NCT00620542|557292|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
157237|NCT00620542|557289|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
157238|NCT00620542|557290|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
157239|NCT00620542|557291|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
157240|NCT00620542|557292|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
157241|NCT00620542|557289|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
157242|NCT00620542|557290|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
157243|NCT00620542|557291|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
157244|NCT00620542|557292|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
157245|NCT00620542|557289|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
157246|NCT00620542|557290|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
157247|NCT00620542|557291|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
157248|NCT00620542|557292|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
157249|NCT00620464|557332|P2|Overall Study|Used prohibited medication|0
157250|NCT00620464|557333|P1|Overall Study|Used prohibited medication|1
157251|NCT00620464|557332|P2|Overall Study|Personal|2
157252|NCT00620464|557333|P1|Overall Study|Personal|2
157253|NCT00620464|557332|P2|Overall Study|Planning Pregnancy|4
157254|NCT00620464|557333|P1|Overall Study|Planning Pregnancy|1
157255|NCT00620464|557332|P2|Overall Study|Lost to Follow-up|1
157256|NCT00620464|557333|P1|Overall Study|Lost to Follow-up|1
157257|NCT00620464|557332|P2|Overall Study|Adverse Event|17
157258|NCT00620464|557333|P1|Overall Study|Adverse Event|15
157259|NCT00620373|557352|P1|Overall Study|Unverified cancer status|33
157260|NCT00620282|557371|P3|Overall Study|Withdrawal by Subject|0
157261|NCT00620282|557372|P2|Overall Study|Withdrawal by Subject|1
157262|NCT00620282|557373|P1|Overall Study|Withdrawal by Subject|0
157263|NCT00620282|557371|P3|Overall Study|Arterial line unable to be placed|1
157264|NCT00620282|557372|P2|Overall Study|Arterial line unable to be placed|0
157265|NCT00620282|557373|P1|Overall Study|Arterial line unable to be placed|0
157266|NCT00620282|557371|P3|Overall Study|Adverse Event|0
157267|NCT00620282|557372|P2|Overall Study|Adverse Event|1
157268|NCT00620282|557373|P1|Overall Study|Adverse Event|0
157269|NCT00620113|557437|P4|Overall Study|Withdrawal by Subject|5
157270|NCT00620113|557438|P3|Overall Study|Withdrawal by Subject|3
157271|NCT00620113|557439|P2|Overall Study|Withdrawal by Subject|1
157272|NCT00620113|557440|P1|Overall Study|Withdrawal by Subject|5
157273|NCT00620113|557437|P4|Overall Study|Protocol Violation|0
157274|NCT00620113|557438|P3|Overall Study|Protocol Violation|0
157275|NCT00620113|557439|P2|Overall Study|Protocol Violation|1
157276|NCT00620113|557440|P1|Overall Study|Protocol Violation|2
157277|NCT00620113|557437|P4|Overall Study|Physician Decision|2
157278|NCT00620113|557438|P3|Overall Study|Physician Decision|0
157279|NCT00620113|557439|P2|Overall Study|Physician Decision|0
157280|NCT00620113|557440|P1|Overall Study|Physician Decision|1
157281|NCT00620113|557437|P4|Overall Study|Lack of Efficacy|2
157282|NCT00620113|557438|P3|Overall Study|Lack of Efficacy|0
157283|NCT00620113|557439|P2|Overall Study|Lack of Efficacy|3
157284|NCT00620113|557440|P1|Overall Study|Lack of Efficacy|2
157285|NCT00620113|557437|P4|Overall Study|Adverse Event|1
157286|NCT00620113|557438|P3|Overall Study|Adverse Event|2
157287|NCT00620113|557439|P2|Overall Study|Adverse Event|2
157288|NCT00620113|557440|P1|Overall Study|Adverse Event|3
157289|NCT00620074|557490|P1|Overall Study|Adverse Event|1
157290|NCT00620035|557498|P1|Overall Study|Other Reason|38
157291|NCT00620035|557498|P1|Overall Study|Withdrawal of Informed Consent|1
157292|NCT00620035|557498|P1|Overall Study|Adverse Event|106
157293|NCT00620022|557508|P2|Treatment Period 2|Adverse Event|2
157294|NCT00620022|557509|P1|Treatment Period 2|Adverse Event|2
157295|NCT00620022|557508|P2|Treatment Period 1|Subject withdrew consent|0
157296|NCT00620022|557509|P1|Treatment Period 1|Subject withdrew consent|1
157297|NCT00620022|557508|P2|Treatment Period 1|Adverse Event|6
157298|NCT00620022|557509|P1|Treatment Period 1|Adverse Event|4
157299|NCT00619983|557521|P4|Test Drug Alone|Failure of daily diary device|2
157300|NCT00619983|557522|P3|Test Drug Alone|Failure of daily diary device|2
157301|NCT00619983|557523|P2|Test Drug Alone|Failure of daily diary device|1
157302|NCT00619983|557524|P1|Test Drug Alone|Failure of daily diary device|1
157303|NCT00619983|557521|P4|Test Drug Alone|Withdrawal by Subject|1
157304|NCT00619983|557522|P3|Test Drug Alone|Withdrawal by Subject|0
157305|NCT00619983|557523|P2|Test Drug Alone|Withdrawal by Subject|0
157306|NCT00619983|557524|P1|Test Drug Alone|Withdrawal by Subject|1
157307|NCT00619957|557551|P2|Month 48 Open-Label|Withdrawal by Subject|9
157308|NCT00619957|557552|P1|Month 48 Open-Label|Withdrawal by Subject|6
157309|NCT00619957|557551|P2|Month 48 Open-Label|Lost to Follow-up|4
157310|NCT00619957|557552|P1|Month 48 Open-Label|Lost to Follow-up|2
157311|NCT00619957|557551|P2|Month 48 Open-Label|Adverse Event|4
157312|NCT00619957|557552|P1|Month 48 Open-Label|Adverse Event|4
157313|NCT00619957|557551|P2|Month 24 Double-Blind|Did not take any study medication|1
157314|NCT00619957|557552|P1|Month 24 Double-Blind|Did not take any study medication|0
157315|NCT00619957|557551|P2|Month 24 Double-Blind|Lost to Follow-up|0
157316|NCT00619957|557552|P1|Month 24 Double-Blind|Lost to Follow-up|1
157317|NCT00619957|557551|P2|Month 24 Double-Blind|Withdrawal by Subject|9
157318|NCT00619957|557552|P1|Month 24 Double-Blind|Withdrawal by Subject|7
157319|NCT00619957|557551|P2|Month 24 Double-Blind|Protocol Violation|0
157320|NCT00619957|557552|P1|Month 24 Double-Blind|Protocol Violation|1
157321|NCT00619957|557551|P2|Month 24 Double-Blind|Adverse Event|7
157322|NCT00619957|557552|P1|Month 24 Double-Blind|Adverse Event|9
157323|NCT00619918|557634|P2|Overall Study|Left before receiving first dose|8
157324|NCT00619918|557635|P1|Overall Study|Left before receiving first dose|5
157325|NCT00619918|557634|P2|Overall Study|Transfer to outside facility|3
157326|NCT00619918|557635|P1|Overall Study|Transfer to outside facility|3
157327|NCT00619918|557634|P2|Overall Study|Physician Decision|8
157328|NCT00619918|557635|P1|Overall Study|Physician Decision|8
157329|NCT00619918|557634|P2|Overall Study|Withdrawal by Subject|3
157330|NCT00619918|557635|P1|Overall Study|Withdrawal by Subject|4
157331|NCT00619892|557645|P2|Overall Study|Intercurrent illness|1
157332|NCT00619892|557646|P1|Overall Study|Intercurrent illness|0
157333|NCT00619892|557645|P2|Overall Study|Lost to Follow-up|1
157334|NCT00619892|557646|P1|Overall Study|Lost to Follow-up|0
157335|NCT00619892|557645|P2|Overall Study|Adverse Event|0
157336|NCT00619892|557646|P1|Overall Study|Adverse Event|3
157337|NCT00619827|557656|P2|Overall Study|Withdrawal by Subject|2
157338|NCT00619827|557657|P1|Overall Study|Withdrawal by Subject|2
157339|NCT00619827|557656|P2|Overall Study|Adverse Event|2
157340|NCT00619827|557657|P1|Overall Study|Adverse Event|1
157341|NCT00619801|557665|P2|Overall Study|Loss of efficacy|1
157342|NCT00619801|557666|P1|Overall Study|Loss of efficacy|0
157343|NCT00619801|557665|P2|Overall Study|Withdrawal by Subject|1
157344|NCT00619801|557666|P1|Overall Study|Withdrawal by Subject|1
157345|NCT00619801|557665|P2|Overall Study|Lack of Efficacy|1
157346|NCT00619801|557666|P1|Overall Study|Lack of Efficacy|0
157347|NCT00619645|557723|P1|Overall Study|Adverse Event|1
157348|NCT00619619|557737|P8|Overall Study|Adverse Event|2
157349|NCT00619619|557738|P7|Overall Study|Adverse Event|0
157350|NCT00619619|557739|P6|Overall Study|Adverse Event|0
157351|NCT00619619|557740|P5|Overall Study|Adverse Event|2
157352|NCT00619619|557741|P4|Overall Study|Adverse Event|0
157353|NCT00619619|557742|P3|Overall Study|Adverse Event|0
157354|NCT00619619|557743|P2|Overall Study|Adverse Event|0
157355|NCT00619619|557744|P1|Overall Study|Adverse Event|0
157356|NCT00619619|557737|P8|Overall Study|Protocol Violation|1
157357|NCT00619619|557738|P7|Overall Study|Protocol Violation|1
157358|NCT00619619|557739|P6|Overall Study|Protocol Violation|0
157359|NCT00619619|557740|P5|Overall Study|Protocol Violation|0
157360|NCT00619619|557741|P4|Overall Study|Protocol Violation|1
157361|NCT00619619|557742|P3|Overall Study|Protocol Violation|0
157362|NCT00619619|557743|P2|Overall Study|Protocol Violation|0
157363|NCT00619619|557744|P1|Overall Study|Protocol Violation|0
157364|NCT00619619|557737|P8|Overall Study|Physician Decision|0
157365|NCT00619619|557738|P7|Overall Study|Physician Decision|0
157366|NCT00619619|557739|P6|Overall Study|Physician Decision|0
157367|NCT00619619|557740|P5|Overall Study|Physician Decision|0
157368|NCT00619619|557741|P4|Overall Study|Physician Decision|0
157369|NCT00619619|557742|P3|Overall Study|Physician Decision|1
157370|NCT00619619|557743|P2|Overall Study|Physician Decision|0
157371|NCT00619619|557744|P1|Overall Study|Physician Decision|0
157372|NCT00619502|557831|P2|Overall Study|Lost to Follow-up|10
157373|NCT00619502|557832|P1|Overall Study|Lost to Follow-up|8
157374|NCT00619489|557844|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
157375|NCT00619489|557845|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
157376|NCT00619489|557844|P2|Overall Study|Lack of Efficacy|11
157377|NCT00619489|557845|P1|Overall Study|Lack of Efficacy|0
157378|NCT00619489|557844|P2|Overall Study|Withdrawal by Subject|1
157379|NCT00619489|557845|P1|Overall Study|Withdrawal by Subject|1
157380|NCT00619489|557844|P2|Overall Study|Adverse Event|7
157381|NCT00619489|557845|P1|Overall Study|Adverse Event|0
157382|NCT00619476|557867|P4|Overall Study|Withdrawal by Subject|4
157383|NCT00619476|557868|P3|Overall Study|Withdrawal by Subject|5
157384|NCT00619476|557869|P2|Overall Study|Withdrawal by Subject|7
157385|NCT00619476|557870|P1|Overall Study|Withdrawal by Subject|5
157386|NCT00619476|557867|P4|Overall Study|Investigator Discretion|0
157387|NCT00619476|557868|P3|Overall Study|Investigator Discretion|2
157388|NCT00619476|557869|P2|Overall Study|Investigator Discretion|2
157389|NCT00619476|557870|P1|Overall Study|Investigator Discretion|2
157390|NCT00619476|557867|P4|Overall Study|Lost to Follow-up|1
157391|NCT00619476|557868|P3|Overall Study|Lost to Follow-up|0
157392|NCT00619476|557869|P2|Overall Study|Lost to Follow-up|2
157393|NCT00619476|557870|P1|Overall Study|Lost to Follow-up|1
157394|NCT00619476|557867|P4|Overall Study|Protocol Violation|9
157395|NCT00619476|557868|P3|Overall Study|Protocol Violation|4
157396|NCT00619476|557869|P2|Overall Study|Protocol Violation|4
157397|NCT00619476|557870|P1|Overall Study|Protocol Violation|5
157398|NCT00619476|557867|P4|Overall Study|Lack of Efficacy|4
157399|NCT00619476|557868|P3|Overall Study|Lack of Efficacy|1
157400|NCT00619476|557869|P2|Overall Study|Lack of Efficacy|1
157401|NCT00619476|557870|P1|Overall Study|Lack of Efficacy|6
157402|NCT00619476|557867|P4|Overall Study|Adverse Event|16
157403|NCT00619476|557868|P3|Overall Study|Adverse Event|12
157404|NCT00619476|557869|P2|Overall Study|Adverse Event|6
157405|NCT00619476|557870|P1|Overall Study|Adverse Event|12
157406|NCT00619385|557955|P3|Overall Study|Other|1
157407|NCT00619385|557956|P2|Overall Study|Other|2
157408|NCT00619385|557957|P1|Overall Study|Other|1
157409|NCT00619385|557955|P3|Overall Study|Adverse Event|3
157410|NCT00619385|557956|P2|Overall Study|Adverse Event|0
157411|NCT00619385|557957|P1|Overall Study|Adverse Event|0
157412|NCT00619359|557972|P2|Overall Study|Progressive Disease|1
157413|NCT00619359|557973|P1|Overall Study|Progressive Disease|3
157414|NCT00619359|557972|P2|Overall Study|Withdrawal by Subject|20
157415|NCT00619359|557973|P1|Overall Study|Withdrawal by Subject|19
157416|NCT00619359|557972|P2|Overall Study|Protocol Violation|1
157417|NCT00619359|557973|P1|Overall Study|Protocol Violation|1
157418|NCT00619359|557972|P2|Overall Study|Physician Decision|7
157419|NCT00619359|557973|P1|Overall Study|Physician Decision|0
157420|NCT00619359|557972|P2|Overall Study|Lost to Follow-up|16
157421|NCT00619359|557973|P1|Overall Study|Lost to Follow-up|12
157422|NCT00619359|557972|P2|Overall Study|Adverse Event|36
157423|NCT00619359|557973|P1|Overall Study|Adverse Event|32
157424|NCT00619307|557985|P2|Overall Study|MS attack plus steroids|1
157425|NCT00619307|557986|P1|Overall Study|MS attack plus steroids|0
157426|NCT00619307|557985|P2|Overall Study|Severe migraine|1
157427|NCT00619307|557986|P1|Overall Study|Severe migraine|0
157428|NCT00619307|557985|P2|Overall Study|Withdrew consent|0
157429|NCT00619307|557986|P1|Overall Study|Withdrew consent|1
157430|NCT00619307|557985|P2|Overall Study|Protocol Violation|0
157431|NCT00619307|557986|P1|Overall Study|Protocol Violation|3
157432|NCT00619307|557985|P2|Overall Study|Lost to Follow-up|1
157433|NCT00619307|557986|P1|Overall Study|Lost to Follow-up|0
157434|NCT00619307|557985|P2|Overall Study|Adverse Event|1
157435|NCT00619307|557986|P1|Overall Study|Adverse Event|0
157436|NCT00619229|558023|P2|Overall Study|Investigator planned Cataract Operation|0
157437|NCT00619229|558024|P1|Overall Study|Investigator planned Cataract Operation|1
157438|NCT00619229|558023|P2|Overall Study|Termination of the Study by the Sponsor|1
157439|NCT00619229|558024|P1|Overall Study|Termination of the Study by the Sponsor|1
157440|NCT00619229|558023|P2|Overall Study|Lost to Follow-up|0
157441|NCT00619229|558024|P1|Overall Study|Lost to Follow-up|1
157442|NCT00619229|558023|P2|Overall Study|Withdrawal by Subject|1
157443|NCT00619229|558024|P1|Overall Study|Withdrawal by Subject|1
157444|NCT00619177|558063|P1|Overall Study|Not specified reasons|6
157445|NCT00619177|558063|P1|Overall Study|Missing termination information|481
157446|NCT00619177|558063|P1|Overall Study|Lack of Efficacy|1
157447|NCT00619177|558063|P1|Overall Study|Lost to Follow-up|2
157448|NCT00619177|558063|P1|Overall Study|Adverse Event|18
157449|NCT00619151|558073|P2|Overall Study|Study terminated prior to followup|0
157450|NCT00619151|558074|P1|Overall Study|Study terminated prior to followup|1
157451|NCT00619112|558084|P2|Overall Study|Adverse Event|2
157452|NCT00619112|558085|P1|Overall Study|Adverse Event|1
157453|NCT00619099|558106|P2|Overall Study|Physician Decision|6
157454|NCT00619099|558107|P1|Overall Study|Physician Decision|9
157455|NCT00619099|558106|P2|Overall Study|Withdrawal by Subject|2
157456|NCT00619099|558107|P1|Overall Study|Withdrawal by Subject|10
157457|NCT00619099|558106|P2|Overall Study|Emergence of Clinically Significant Lab|2
157458|NCT00619099|558107|P1|Overall Study|Emergence of Clinically Significant Lab|1
157459|NCT00619099|558106|P2|Overall Study|Adverse Event|3
157460|NCT00619099|558107|P1|Overall Study|Adverse Event|4
157461|NCT00619099|558106|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
157462|NCT00619099|558107|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
157463|NCT00619099|558106|P2|Overall Study|Progressive Disease|5
157464|NCT00619099|558107|P1|Overall Study|Progressive Disease|7
157465|NCT00618995|558129|P4|Period 4|Adverse Event|0
157466|NCT00618995|558130|P3|Period 4|Adverse Event|0
157467|NCT00618995|558131|P2|Period 4|Adverse Event|0
157468|NCT00618995|558132|P1|Period 4|Adverse Event|1
157469|NCT00618995|558129|P4|Period 2|Protocol Violation|0
157470|NCT00618995|558130|P3|Period 2|Protocol Violation|1
157471|NCT00618995|558131|P2|Period 2|Protocol Violation|0
157472|NCT00618995|558132|P1|Period 2|Protocol Violation|0
157473|NCT00618995|558129|P4|Period 1|Protocol Violation|0
157474|NCT00618995|558130|P3|Period 1|Protocol Violation|1
157475|NCT00618995|558131|P2|Period 1|Protocol Violation|1
157476|NCT00618995|558132|P1|Period 1|Protocol Violation|0
157477|NCT00618995|558129|P4|Period 1|Adverse Event|0
157478|NCT00618995|558130|P3|Period 1|Adverse Event|1
157479|NCT00618995|558131|P2|Period 1|Adverse Event|0
157480|NCT00618995|558132|P1|Period 1|Adverse Event|0
157481|NCT00618982|558146|P1|Overall Study|ongoing, still treated with study med.|25
157482|NCT00618982|558146|P1|Overall Study|Protocol Violation|1
157483|NCT00618982|558146|P1|Overall Study|Withdrawal by Subject|1
157484|NCT00618982|558146|P1|Overall Study|Adverse Event|23
157485|NCT00618956|558169|P2|Overall Study|did not meet criteria, non-compliance|1
157486|NCT00618956|558170|P1|Overall Study|did not meet criteria, non-compliance|2
157487|NCT00618956|558169|P2|Overall Study|Protocol Violation|2
157488|NCT00618956|558170|P1|Overall Study|Protocol Violation|2
157489|NCT00618956|558169|P2|Overall Study|Lost to Follow-up|5
157490|NCT00618956|558170|P1|Overall Study|Lost to Follow-up|4
157491|NCT00618956|558169|P2|Overall Study|Withdrawal by Subject|7
157492|NCT00618956|558170|P1|Overall Study|Withdrawal by Subject|5
157493|NCT00618956|558169|P2|Overall Study|Lack of Efficacy|1
157494|NCT00618956|558170|P1|Overall Study|Lack of Efficacy|2
157495|NCT00618956|558169|P2|Overall Study|Adverse Event|34
157496|NCT00618956|558170|P1|Overall Study|Adverse Event|10
157497|NCT00618826|558195|P1|Overall Study|Adverse Event|1
157498|NCT00618813|558200|P1|Overall Study|Withdrawal by Subject|1
157499|NCT00618813|558200|P1|Overall Study|Physician Decision|2
157500|NCT00618813|558200|P1|Overall Study|Lack of Efficacy|1
157501|NCT00618787|558210|P2|Overall Study|Lost to Follow-up|0
157502|NCT00618787|558211|P1|Overall Study|Lost to Follow-up|1
157503|NCT00618787|558210|P2|Overall Study|Withdrawal by Subject|1
157504|NCT00618787|558211|P1|Overall Study|Withdrawal by Subject|2
157505|NCT00618787|558210|P2|Overall Study|Adverse Event|1
157506|NCT00618787|558211|P1|Overall Study|Adverse Event|0
157507|NCT00618774|558219|P2|Overall Study|Withdrawal by Subject|0
157508|NCT00618774|558220|P1|Overall Study|Withdrawal by Subject|1
157509|NCT00618774|558219|P2|Overall Study|Adverse Event|3
157510|NCT00618774|558220|P1|Overall Study|Adverse Event|5
157511|NCT00618748|558253|P3|Overall Study|Withdrawal by Subject|5
157512|NCT00618748|558254|P2|Overall Study|Withdrawal by Subject|1
157513|NCT00618748|558255|P1|Overall Study|Withdrawal by Subject|4
157514|NCT00618748|558253|P3|Overall Study|Physician Decision|1
157515|NCT00618748|558254|P2|Overall Study|Physician Decision|1
157516|NCT00618748|558255|P1|Overall Study|Physician Decision|3
157517|NCT00618748|558253|P3|Overall Study|Adverse Event|8
157518|NCT00618748|558254|P2|Overall Study|Adverse Event|3
157519|NCT00618748|558255|P1|Overall Study|Adverse Event|4
157520|NCT00618722|558300|P4|Overall Study|Miscellaneous Reasons|1
157521|NCT00618722|558301|P3|Overall Study|Miscellaneous Reasons|1
157522|NCT00618722|558302|P2|Overall Study|Miscellaneous Reasons|0
157523|NCT00618722|558303|P1|Overall Study|Miscellaneous Reasons|0
157524|NCT00618722|558300|P4|Overall Study|Lost to Follow-up|2
157525|NCT00618722|558301|P3|Overall Study|Lost to Follow-up|0
157526|NCT00618722|558302|P2|Overall Study|Lost to Follow-up|0
157527|NCT00618722|558303|P1|Overall Study|Lost to Follow-up|2
157528|NCT00618722|558300|P4|Overall Study|Inability to Complete Study Procedure|0
157529|NCT00618722|558301|P3|Overall Study|Inability to Complete Study Procedure|0
157530|NCT00618722|558302|P2|Overall Study|Inability to Complete Study Procedure|1
157531|NCT00618722|558303|P1|Overall Study|Inability to Complete Study Procedure|0
157532|NCT00618722|558300|P4|Overall Study|Patient Request|1
157533|NCT00618722|558301|P3|Overall Study|Patient Request|1
157534|NCT00618722|558302|P2|Overall Study|Patient Request|1
157535|NCT00618722|558303|P1|Overall Study|Patient Request|1
157536|NCT00618722|558300|P4|Overall Study|Refusal of Treatment|0
157537|NCT00618722|558301|P3|Overall Study|Refusal of Treatment|1
157538|NCT00618722|558302|P2|Overall Study|Refusal of Treatment|0
157539|NCT00618722|558303|P1|Overall Study|Refusal of Treatment|0
157540|NCT00618618|558341|P4|Overall Study|Death|0
157541|NCT00618618|558342|P3|Overall Study|Death|0
157542|NCT00618618|558343|P2|Overall Study|Death|1
157543|NCT00618618|558344|P1|Overall Study|Death|0
157544|NCT00618618|558341|P4|Overall Study|Did Not Meet Entry Criteria|0
157545|NCT00618618|558342|P3|Overall Study|Did Not Meet Entry Criteria|1
157546|NCT00618618|558343|P2|Overall Study|Did Not Meet Entry Criteria|0
157547|NCT00618618|558344|P1|Overall Study|Did Not Meet Entry Criteria|0
157548|NCT00618618|558341|P4|Overall Study|Non-compliance|0
157549|NCT00618618|558342|P3|Overall Study|Non-compliance|0
157550|NCT00618618|558343|P2|Overall Study|Non-compliance|1
157551|NCT00618618|558344|P1|Overall Study|Non-compliance|1
157552|NCT00618618|558341|P4|Overall Study|Lost to Follow-up|1
157553|NCT00618618|558342|P3|Overall Study|Lost to Follow-up|0
157554|NCT00618618|558343|P2|Overall Study|Lost to Follow-up|0
157555|NCT00618618|558344|P1|Overall Study|Lost to Follow-up|3
157556|NCT00618618|558341|P4|Overall Study|Inability to Complete Study Procedures|0
157557|NCT00618618|558342|P3|Overall Study|Inability to Complete Study Procedures|0
157558|NCT00618618|558343|P2|Overall Study|Inability to Complete Study Procedures|1
157559|NCT00618618|558344|P1|Overall Study|Inability to Complete Study Procedures|0
157560|NCT00618618|558341|P4|Overall Study|Patient Request|0
157561|NCT00618618|558342|P3|Overall Study|Patient Request|2
157562|NCT00618618|558343|P2|Overall Study|Patient Request|0
157563|NCT00618618|558344|P1|Overall Study|Patient Request|0
157564|NCT00618514|558403|P3|Overall Study|Lost to Follow-up|4
157565|NCT00618514|558404|P2|Overall Study|Lost to Follow-up|12
157566|NCT00618514|558405|P1|Overall Study|Lost to Follow-up|11
157567|NCT00618449|558425|P2|Overall Study|Lost to Follow-up|110
157568|NCT00618449|558426|P1|Overall Study|Lost to Follow-up|98
157569|NCT00618410|558445|P2|Washout Period (2 Weeks)|Physician Decision|1
157570|NCT00618410|558446|P1|Washout Period (2 Weeks)|Physician Decision|0
157571|NCT00618371|558462|P1|Overall Study|Withdrawal by Subject|2
157572|NCT00618072|558495|P3|Overall Study|Physician Decision|1
157573|NCT00618072|558496|P2|Overall Study|Physician Decision|1
157574|NCT00618072|558497|P1|Overall Study|Physician Decision|0
157575|NCT00618072|558495|P3|Overall Study|Lost to Follow-up|3
157576|NCT00618072|558496|P2|Overall Study|Lost to Follow-up|0
157577|NCT00618072|558497|P1|Overall Study|Lost to Follow-up|2
157578|NCT00617929|558553|P1|Overall Study|Physician Decision|1
157579|NCT00617903|558565|P2|Overall Study|noncompliance|1
157580|NCT00617903|558566|P1|Overall Study|noncompliance|0
157581|NCT00617903|558565|P2|Overall Study|Adverse Event|1
157582|NCT00617903|558566|P1|Overall Study|Adverse Event|0
157583|NCT00617903|558565|P2|Overall Study|Lack of Efficacy|1
157584|NCT00617903|558566|P1|Overall Study|Lack of Efficacy|0
157585|NCT00617903|558565|P2|Overall Study|Lost to Follow-up|1
157586|NCT00617903|558566|P1|Overall Study|Lost to Follow-up|1
157587|NCT00617903|558565|P2|Overall Study|Withdrawal by Subject|3
157588|NCT00617903|558566|P1|Overall Study|Withdrawal by Subject|2
157589|NCT00617890|558612|P4|Overall Study|Not treated|1
157590|NCT00617890|558613|P3|Overall Study|Not treated|1
157591|NCT00617890|558614|P2|Overall Study|Not treated|0
157592|NCT00617890|558615|P1|Overall Study|Not treated|1
157593|NCT00617890|558612|P4|Overall Study|Adverse Event|8
157594|NCT00617890|558613|P3|Overall Study|Adverse Event|3
157595|NCT00617890|558614|P2|Overall Study|Adverse Event|0
157596|NCT00617890|558615|P1|Overall Study|Adverse Event|1
157597|NCT00617890|558612|P4|Overall Study|Protocol Violation|0
157598|NCT00617890|558613|P3|Overall Study|Protocol Violation|0
157599|NCT00617890|558614|P2|Overall Study|Protocol Violation|1
157600|NCT00617890|558615|P1|Overall Study|Protocol Violation|2
157601|NCT00617890|558612|P4|Overall Study|Withdrawal by Subject|2
157602|NCT00617890|558613|P3|Overall Study|Withdrawal by Subject|0
157603|NCT00617890|558614|P2|Overall Study|Withdrawal by Subject|1
157604|NCT00617890|558615|P1|Overall Study|Withdrawal by Subject|4
157605|NCT00617890|558612|P4|Overall Study|Lost to Follow-up|2
157606|NCT00617890|558613|P3|Overall Study|Lost to Follow-up|1
157607|NCT00617890|558614|P2|Overall Study|Lost to Follow-up|0
157608|NCT00617890|558615|P1|Overall Study|Lost to Follow-up|0
157609|NCT00617890|558612|P4|Overall Study|Lack of Efficacy|97
157610|NCT00617890|558613|P3|Overall Study|Lack of Efficacy|30
157611|NCT00617890|558614|P2|Overall Study|Lack of Efficacy|26
157612|NCT00617890|558615|P1|Overall Study|Lack of Efficacy|23
157613|NCT00617890|558612|P4|Overall Study|Treatment ongoing at data cut-off|5
157614|NCT00617890|558613|P3|Overall Study|Treatment ongoing at data cut-off|0
157615|NCT00617890|558614|P2|Overall Study|Treatment ongoing at data cut-off|0
157616|NCT00617890|558615|P1|Overall Study|Treatment ongoing at data cut-off|0
157617|NCT00617851|558651|P4|Overall Study|Unable to classify|0
157618|NCT00617851|558652|P3|Overall Study|Unable to classify|1
157619|NCT00617851|558653|P2|Overall Study|Unable to classify|0
157620|NCT00617851|558654|P1|Overall Study|Unable to classify|1
157621|NCT00617851|558651|P4|Overall Study|Inappropriate Enrollment|1
157622|NCT00617851|558652|P3|Overall Study|Inappropriate Enrollment|1
157623|NCT00617851|558653|P2|Overall Study|Inappropriate Enrollment|4
157624|NCT00617851|558654|P1|Overall Study|Inappropriate Enrollment|5
157625|NCT00617851|558651|P4|Overall Study|Lost to Follow-up|19
157626|NCT00617851|558652|P3|Overall Study|Lost to Follow-up|31
157627|NCT00617851|558653|P2|Overall Study|Lost to Follow-up|29
157628|NCT00617851|558654|P1|Overall Study|Lost to Follow-up|27
157629|NCT00617851|558651|P4|Overall Study|Withdrawal by Subject|4
157630|NCT00617851|558652|P3|Overall Study|Withdrawal by Subject|12
157631|NCT00617851|558653|P2|Overall Study|Withdrawal by Subject|7
157632|NCT00617851|558654|P1|Overall Study|Withdrawal by Subject|14
157633|NCT00617851|558651|P4|Overall Study|Death|1
157634|NCT00617851|558652|P3|Overall Study|Death|0
157635|NCT00617851|558653|P2|Overall Study|Death|0
157636|NCT00617851|558654|P1|Overall Study|Death|0
157637|NCT00617773|558692|P1|Overall Study|Protocol Violation|1
157638|NCT00617773|558692|P1|Overall Study|Progressive disease|19
157639|NCT00617773|558692|P1|Overall Study|Death|1
157640|NCT00617773|558692|P1|Overall Study|Withdrawal by Subject|1
157641|NCT00617773|558692|P1|Overall Study|Lack of compliance with the protocol|1
157642|NCT00617773|558692|P1|Overall Study|Physician Decision|1
157643|NCT00617734|558709|P2|Overall Study|Lost to Follow-up|1
157644|NCT00617734|558710|P1|Overall Study|Lost to Follow-up|0
157645|NCT00617734|558709|P2|Overall Study|Found Ineligible After Randomization|4
157646|NCT00617734|558710|P1|Overall Study|Found Ineligible After Randomization|1
157647|NCT00617734|558709|P2|Overall Study|Protocol Violation|0
157648|NCT00617734|558710|P1|Overall Study|Protocol Violation|1
157649|NCT00617734|558709|P2|Overall Study|Adverse Event|1
157650|NCT00617734|558710|P1|Overall Study|Adverse Event|4
157651|NCT00617734|558709|P2|Overall Study|Withdrew Consent|0
157652|NCT00617734|558710|P1|Overall Study|Withdrew Consent|2
157653|NCT00617708|558731|P3|Overall Study|Not eligible|5
157654|NCT00617708|558732|P2|Overall Study|Not eligible|3
157655|NCT00617708|558733|P1|Overall Study|Not eligible|1
157656|NCT00617708|558731|P3|Overall Study|Not protocol specified|2
157657|NCT00617708|558732|P2|Overall Study|Not protocol specified|4
157658|NCT00617708|558733|P1|Overall Study|Not protocol specified|1
157659|NCT00617708|558731|P3|Overall Study|Progression/Relapse|36
157660|NCT00617708|558732|P2|Overall Study|Progression/Relapse|40
157661|NCT00617708|558733|P1|Overall Study|Progression/Relapse|7
157662|NCT00617708|558731|P3|Overall Study|Death|5
157663|NCT00617708|558732|P2|Overall Study|Death|6
157664|NCT00617708|558733|P1|Overall Study|Death|0
157665|NCT00617708|558731|P3|Overall Study|Withdrawal by Subject|7
157666|NCT00617708|558732|P2|Overall Study|Withdrawal by Subject|1
157667|NCT00617708|558733|P1|Overall Study|Withdrawal by Subject|1
157668|NCT00617708|558731|P3|Overall Study|Adverse Event|9
157669|NCT00617708|558732|P2|Overall Study|Adverse Event|6
157670|NCT00617708|558733|P1|Overall Study|Adverse Event|0
157671|NCT00617669|558750|P2|Overall Study|Patients randomized but not treated|3
157672|NCT00617669|558751|P1|Overall Study|Patients randomized but not treated|2
157673|NCT00617669|558750|P2|Overall Study|Reason not otherwise captured, eg; death|290
157674|NCT00617669|558751|P1|Overall Study|Reason not otherwise captured, eg; death|265
157675|NCT00617669|558750|P2|Overall Study|Protocol Violation|3
157676|NCT00617669|558751|P1|Overall Study|Protocol Violation|2
157677|NCT00617669|558750|P2|Overall Study|Adverse Event|76
157678|NCT00617669|558751|P1|Overall Study|Adverse Event|87
157679|NCT00617669|558750|P2|Overall Study|Lost to Follow-up|2
157680|NCT00617669|558751|P1|Overall Study|Lost to Follow-up|3
157681|NCT00617669|558750|P2|Overall Study|Withdrawal by Subject|77
157682|NCT00617669|558751|P1|Overall Study|Withdrawal by Subject|71
157683|NCT00617604|558773|P2|Overall Study|Randomized but Never Received Study Drug|3
157684|NCT00617604|558774|P1|Overall Study|Randomized but Never Received Study Drug|3
157685|NCT00617604|558773|P2|Overall Study|Withdrawal by Subject|6
157686|NCT00617604|558774|P1|Overall Study|Withdrawal by Subject|4
157687|NCT00617604|558773|P2|Overall Study|Miscellaneous Reasons|10
157688|NCT00617604|558774|P1|Overall Study|Miscellaneous Reasons|8
157689|NCT00617604|558773|P2|Overall Study|Lost to Follow-up|0
157690|NCT00617604|558774|P1|Overall Study|Lost to Follow-up|1
157691|NCT00617604|558773|P2|Overall Study|Death|1
157692|NCT00617604|558774|P1|Overall Study|Death|2
157693|NCT00617591|558818|P1|Overall Study|Withdrew consent during Maintenance|6
157694|NCT00617591|558818|P1|Overall Study|Withdrew consent during Induction|4
157695|NCT00617461|558834|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
157696|NCT00617461|558835|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
157697|NCT00617461|558834|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
157698|NCT00617461|558835|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
157699|NCT00617461|558834|P2|Second Treatment Intervention Period|Lack of Efficacy|3
157700|NCT00617461|558835|P1|Second Treatment Intervention Period|Lack of Efficacy|0
157701|NCT00617461|558834|P2|Second Treatment Intervention Period|Adverse Event|1
157702|NCT00617461|558835|P1|Second Treatment Intervention Period|Adverse Event|0
157703|NCT00617461|558834|P2|4-Day Crossover Period|Withdrawal by Subject|0
157704|NCT00617461|558835|P1|4-Day Crossover Period|Withdrawal by Subject|1
157705|NCT00617461|558834|P2|First Treatment Intervention Period|Withdrawal by Subject|0
157706|NCT00617461|558835|P1|First Treatment Intervention Period|Withdrawal by Subject|4
157707|NCT00617461|558834|P2|First Treatment Intervention Period|Investigator Discretion|1
157708|NCT00617461|558835|P1|First Treatment Intervention Period|Investigator Discretion|1
157709|NCT00617461|558834|P2|First Treatment Intervention Period|Lost to Follow-up|1
157710|NCT00617461|558835|P1|First Treatment Intervention Period|Lost to Follow-up|0
157711|NCT00617461|558834|P2|First Treatment Intervention Period|Protocol Violation|1
157712|NCT00617461|558835|P1|First Treatment Intervention Period|Protocol Violation|2
157713|NCT00617461|558834|P2|First Treatment Intervention Period|Lack of Efficacy|0
157714|NCT00617461|558835|P1|First Treatment Intervention Period|Lack of Efficacy|1
157715|NCT00617461|558834|P2|First Treatment Intervention Period|Adverse Event|0
157716|NCT00617461|558835|P1|First Treatment Intervention Period|Adverse Event|2
157717|NCT00617409|558891|P3|Overall Study|Alternative Therapy|0
157718|NCT00617409|558892|P2|Overall Study|Alternative Therapy|2
157719|NCT00617409|558893|P1|Overall Study|Alternative Therapy|1
157720|NCT00617409|558891|P3|Overall Study|Death|4
157721|NCT00617409|558892|P2|Overall Study|Death|5
157722|NCT00617409|558893|P1|Overall Study|Death|3
157723|NCT00617409|558891|P3|Overall Study|Disease Progression|18
157724|NCT00617409|558892|P2|Overall Study|Disease Progression|8
157725|NCT00617409|558893|P1|Overall Study|Disease Progression|8
157726|NCT00617409|558891|P3|Overall Study|Adverse Event|3
157727|NCT00617409|558892|P2|Overall Study|Adverse Event|2
157728|NCT00617409|558893|P1|Overall Study|Adverse Event|0
157729|NCT00617409|558891|P3|Overall Study|Withdrawal by Subject|2
157730|NCT00617409|558892|P2|Overall Study|Withdrawal by Subject|1
157731|NCT00617409|558893|P1|Overall Study|Withdrawal by Subject|4
157732|NCT00617357|558908|P1|Overall Study|Physician Decision|1
157733|NCT00617357|558908|P1|Overall Study|Withdrawal by Subject|1
157734|NCT00617357|558908|P1|Overall Study|insurance concerns|2
157735|NCT00617357|558908|P1|Overall Study|Death|5
157736|NCT00617357|558908|P1|Overall Study|Lost to Follow-up|7
157737|NCT00617305|558921|P3|Overall Study|Withdrawal by Subject|0
157738|NCT00617305|558922|P2|Overall Study|Withdrawal by Subject|0
157739|NCT00617305|558923|P1|Overall Study|Withdrawal by Subject|1
157740|NCT00617305|558921|P3|Overall Study|Protocol Violation|1
157741|NCT00617305|558922|P2|Overall Study|Protocol Violation|0
157742|NCT00617305|558923|P1|Overall Study|Protocol Violation|1
157743|NCT00617305|558921|P3|Overall Study|Physician Decision|0
157744|NCT00617305|558922|P2|Overall Study|Physician Decision|0
157745|NCT00617305|558923|P1|Overall Study|Physician Decision|1
157746|NCT00617305|558921|P3|Overall Study|Death|0
157747|NCT00617305|558922|P2|Overall Study|Death|0
157748|NCT00617305|558923|P1|Overall Study|Death|1
157749|NCT00617305|558921|P3|Overall Study|Adverse Event|0
157750|NCT00617305|558922|P2|Overall Study|Adverse Event|0
157751|NCT00617305|558923|P1|Overall Study|Adverse Event|4
157752|NCT00617279|558979|P2|Overall Study|Death|2
157753|NCT00617279|558980|P1|Overall Study|Death|1
157754|NCT00617279|558979|P2|Overall Study|Lost to Follow-up|0
157755|NCT00617279|558980|P1|Overall Study|Lost to Follow-up|1
157756|NCT00617279|558979|P2|Overall Study|Graft abandonment|0
157757|NCT00617279|558980|P1|Overall Study|Graft abandonment|2
157758|NCT00617279|558979|P2|Overall Study|Study terminated by Sponsor|15
157759|NCT00617279|558980|P1|Overall Study|Study terminated by Sponsor|10
157760|NCT00617240|559036|P2|Overall Study|Lack of Efficacy|0
157761|NCT00617240|559037|P1|Overall Study|Lack of Efficacy|1
157762|NCT00617201|559057|P2|Overall Study|Lost to Follow-up|13
157763|NCT00617201|559058|P1|Overall Study|Lost to Follow-up|9
157764|NCT00617123|559086|P2|Study Treatment Period|Noncompliance with Protocol|1
157765|NCT00617123|559087|P1|Study Treatment Period|Noncompliance with Protocol|0
157766|NCT00617123|559086|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
157767|NCT00617123|559087|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
157768|NCT00617123|559086|P2|Study Treatment Period|Adverse Event|3
157769|NCT00617123|559087|P1|Study Treatment Period|Adverse Event|7
157770|NCT00617123|559086|P2|Study Treatment Period|Withdrawal by Subject|12
157771|NCT00617123|559087|P1|Study Treatment Period|Withdrawal by Subject|8
157772|NCT00617123|559086|P2|Referral Screening Period|Adverse Event|1
157773|NCT00617123|559087|P1|Referral Screening Period|Adverse Event|0
157774|NCT00617123|559086|P2|Referral Screening Period|Did Not Wish To Continue|1
157775|NCT00617123|559087|P1|Referral Screening Period|Did Not Wish To Continue|3
157776|NCT00617123|559086|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
157777|NCT00617123|559087|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
157778|NCT00617084|559118|P2|Overall Study|Missed 12 Months visit|19
157779|NCT00617084|559119|P1|Overall Study|Missed 12 Months visit|16
157780|NCT00617084|559118|P2|Overall Study|Withdrawal by Subject|7
157781|NCT00617084|559119|P1|Overall Study|Withdrawal by Subject|5
157782|NCT00616967|559172|P3|Overall Study|Withdrawal by Subject|1
157783|NCT00616967|559173|P2|Overall Study|Withdrawal by Subject|0
157784|NCT00616967|559174|P1|Overall Study|Withdrawal by Subject|0
157785|NCT00616928|559187|P4|Overall Study|Lost to Follow-up|0
157786|NCT00616928|559188|P3|Overall Study|Lost to Follow-up|0
157787|NCT00616928|559189|P2|Overall Study|Lost to Follow-up|7
157788|NCT00616928|559190|P1|Overall Study|Lost to Follow-up|5
157789|NCT00616928|559187|P4|Overall Study|Other|5
157790|NCT00616928|559188|P3|Overall Study|Other|15
157791|NCT00616928|559189|P2|Overall Study|Other|8
157792|NCT00616928|559190|P1|Overall Study|Other|51
157793|NCT00616928|559187|P4|Overall Study|Adverse Event|2
157794|NCT00616928|559188|P3|Overall Study|Adverse Event|2
157795|NCT00616928|559189|P2|Overall Study|Adverse Event|3
157796|NCT00616928|559190|P1|Overall Study|Adverse Event|6
157797|NCT00616902|559254|P2|Overall Study|Termination of study|6
157798|NCT00616902|559255|P1|Overall Study|Termination of study|6
157799|NCT00616759|559298|P2|Overall Study|Withdrawal by Subject|2
157800|NCT00616759|559299|P1|Overall Study|Withdrawal by Subject|1
157801|NCT00616759|559298|P2|Overall Study|Physician Decision|0
157802|NCT00616759|559299|P1|Overall Study|Physician Decision|2
157803|NCT00616655|559308|P3|Overall Study|Other|5
157804|NCT00616655|559309|P2|Overall Study|Other|6
157805|NCT00616655|559310|P1|Overall Study|Other|6
157806|NCT00616655|559308|P3|Overall Study|Does not meet in/ex criteria|2
157807|NCT00616655|559309|P2|Overall Study|Does not meet in/ex criteria|0
157808|NCT00616655|559310|P1|Overall Study|Does not meet in/ex criteria|0
157809|NCT00616655|559308|P3|Overall Study|Withdrawal by Subject|11
157810|NCT00616655|559309|P2|Overall Study|Withdrawal by Subject|7
157811|NCT00616655|559310|P1|Overall Study|Withdrawal by Subject|9
157812|NCT00616655|559308|P3|Overall Study|Protocol Violation|3
157813|NCT00616655|559309|P2|Overall Study|Protocol Violation|4
157814|NCT00616655|559310|P1|Overall Study|Protocol Violation|2
157815|NCT00616655|559308|P3|Overall Study|Lost to Follow-up|10
157816|NCT00616655|559309|P2|Overall Study|Lost to Follow-up|12
157817|NCT00616655|559310|P1|Overall Study|Lost to Follow-up|3
157818|NCT00616655|559308|P3|Overall Study|Lack of Efficacy|5
157819|NCT00616655|559309|P2|Overall Study|Lack of Efficacy|5
157820|NCT00616655|559310|P1|Overall Study|Lack of Efficacy|5
157821|NCT00616655|559308|P3|Overall Study|Adverse Event|12
157822|NCT00616655|559309|P2|Overall Study|Adverse Event|7
157823|NCT00616655|559310|P1|Overall Study|Adverse Event|10
157824|NCT00616642|559350|P2|Overall Study|Withdrawal by Subject|1
157825|NCT00616642|559351|P1|Overall Study|Withdrawal by Subject|0
157826|NCT00616629|559362|P5|Overall Study|AV-block|0
157827|NCT00616629|559363|P4|Overall Study|AV-block|0
157828|NCT00616629|559364|P3|Overall Study|AV-block|0
157829|NCT00616629|559365|P2|Overall Study|AV-block|0
157830|NCT00616629|559366|P1|Overall Study|AV-block|1
157831|NCT00616629|559362|P5|Overall Study|Protocol Violation|0
157832|NCT00616629|559363|P4|Overall Study|Protocol Violation|0
157833|NCT00616629|559364|P3|Overall Study|Protocol Violation|1
157834|NCT00616629|559365|P2|Overall Study|Protocol Violation|2
157835|NCT00616629|559366|P1|Overall Study|Protocol Violation|1
157836|NCT00616603|559411|P3|Overall Study|Physician Decision|2
157837|NCT00616603|559412|P2|Overall Study|Physician Decision|0
157838|NCT00616603|559413|P1|Overall Study|Physician Decision|2
157839|NCT00616434|559436|P2|Overall Study|Protocol deviation|1
157840|NCT00616434|559437|P1|Overall Study|Protocol deviation|0
157841|NCT00616434|559436|P2|Overall Study|Withdrawal by Subject|1
157842|NCT00616434|559437|P1|Overall Study|Withdrawal by Subject|1
157843|NCT00616434|559436|P2|Overall Study|Physician Decision|4
157844|NCT00616434|559437|P1|Overall Study|Physician Decision|0
157845|NCT00616434|559436|P2|Overall Study|Adverse Event|2
157846|NCT00616434|559437|P1|Overall Study|Adverse Event|5
157847|NCT00616421|559450|P3|Overall Study|Unable to classify|0
157848|NCT00616421|559451|P2|Overall Study|Unable to classify|0
157849|NCT00616421|559452|P1|Overall Study|Unable to classify|1
157850|NCT00616421|559450|P3|Overall Study|Protocol Violation|2
157851|NCT00616421|559451|P2|Overall Study|Protocol Violation|1
157852|NCT00616421|559452|P1|Overall Study|Protocol Violation|0
157853|NCT00616421|559450|P3|Overall Study|Administrative reason|0
157854|NCT00616421|559451|P2|Overall Study|Administrative reason|0
157855|NCT00616421|559452|P1|Overall Study|Administrative reason|1
157856|NCT00616421|559450|P3|Overall Study|Inappropriate enrollment|1
157857|NCT00616421|559451|P2|Overall Study|Inappropriate enrollment|0
157858|NCT00616421|559452|P1|Overall Study|Inappropriate enrollment|3
157859|NCT00616421|559450|P3|Overall Study|Lost to Follow-up|30
157860|NCT00616421|559451|P2|Overall Study|Lost to Follow-up|26
157861|NCT00616421|559452|P1|Overall Study|Lost to Follow-up|12
157862|NCT00616421|559450|P3|Overall Study|Withdrawal by Subject|8
157863|NCT00616421|559451|P2|Overall Study|Withdrawal by Subject|11
157864|NCT00616421|559452|P1|Overall Study|Withdrawal by Subject|9
157865|NCT00616239|559493|P1|Overall Study|Withdrawal by Subject|2
157866|NCT00616018|559517|P1|Overall Study|Protocol Violation|3
157867|NCT00615992|559522|P1|Overall Study|Protocol Violation|67
157868|NCT00615914|559548|P1|Overall Study|Irregularly enrolled patients|10
157869|NCT00615914|559548|P1|Overall Study|No treatment|2
157870|NCT00615914|559548|P1|Overall Study|No data was collected.|65
157871|NCT00615914|559548|P1|Overall Study|Physician Decision|4
157872|NCT00615914|559548|P1|Overall Study|Withdrawal by Subject|16
157873|NCT00615914|559548|P1|Overall Study|Lost to Follow-up|187
157874|NCT00615914|559548|P1|Overall Study|Lack of Efficacy|59
157875|NCT00615914|559548|P1|Overall Study|Death|20
157876|NCT00615914|559548|P1|Overall Study|Adverse Event|274
157877|NCT00615901|559555|P1|Overall Study|Adverse Event|7
157878|NCT00615901|559555|P1|Overall Study|Withdrawal by Subject|2
157879|NCT00615836|559563|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
157880|NCT00615836|559564|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
157881|NCT00615836|559565|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
157882|NCT00615836|559566|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
157883|NCT00615836|559567|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
157884|NCT00615836|559563|P5|Extension Study (FE992026 CS31)|Not reported|0
157885|NCT00615836|559564|P4|Extension Study (FE992026 CS31)|Not reported|4
157886|NCT00615836|559565|P3|Extension Study (FE992026 CS31)|Not reported|1
157887|NCT00615836|559566|P2|Extension Study (FE992026 CS31)|Not reported|4
157888|NCT00615836|559567|P1|Extension Study (FE992026 CS31)|Not reported|6
157889|NCT00615836|559563|P5|Extension Study (FE992026 CS31)|Not specified|0
157890|NCT00615836|559564|P4|Extension Study (FE992026 CS31)|Not specified|8
157891|NCT00615836|559565|P3|Extension Study (FE992026 CS31)|Not specified|8
157892|NCT00615836|559566|P2|Extension Study (FE992026 CS31)|Not specified|7
157893|NCT00615836|559567|P1|Extension Study (FE992026 CS31)|Not specified|10
157894|NCT00615836|559563|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
157895|NCT00615836|559564|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
157896|NCT00615836|559565|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
157897|NCT00615836|559566|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
157898|NCT00615836|559567|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
157899|NCT00615836|559563|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
157900|NCT00615836|559564|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
157901|NCT00615836|559565|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
157902|NCT00615836|559566|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
157903|NCT00615836|559567|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
157904|NCT00615836|559563|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
157905|NCT00615836|559564|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
157906|NCT00615836|559565|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
157907|NCT00615836|559566|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
157908|NCT00615836|559567|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
157909|NCT00615836|559563|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
157910|NCT00615836|559564|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
157911|NCT00615836|559565|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
157912|NCT00615836|559566|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
157913|NCT00615836|559567|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
157914|NCT00615836|559563|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
157915|NCT00615836|559564|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
157916|NCT00615836|559565|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
157917|NCT00615836|559566|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
157918|NCT00615836|559567|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
157919|NCT00615836|559563|P5|Extension Study (FE992026 CS31)|Adverse Event|0
157920|NCT00615836|559564|P4|Extension Study (FE992026 CS31)|Adverse Event|13
157921|NCT00615836|559565|P3|Extension Study (FE992026 CS31)|Adverse Event|15
157922|NCT00615836|559566|P2|Extension Study (FE992026 CS31)|Adverse Event|12
157923|NCT00615836|559567|P1|Extension Study (FE992026 CS31)|Adverse Event|7
157924|NCT00615719|559627|P1|Overall Study|Physician Decision|5
157925|NCT00615550|559641|P2|Overall Study|Lost to Follow-up|1
157926|NCT00615550|559642|P1|Overall Study|Lost to Follow-up|6
157927|NCT00615459|559665|P4|Period III|Unsatisfactory therapeutic effect|0
157928|NCT00615459|559666|P3|Period III|Unsatisfactory therapeutic effect|0
157929|NCT00615459|559667|P2|Period III|Unsatisfactory therapeutic effect|1
157930|NCT00615459|559668|P1|Period III|Unsatisfactory therapeutic effect|0
157931|NCT00615459|559665|P4|Period III|Administrative problems|0
157932|NCT00615459|559666|P3|Period III|Administrative problems|1
157933|NCT00615459|559667|P2|Period III|Administrative problems|1
157934|NCT00615459|559668|P1|Period III|Administrative problems|0
157935|NCT00615459|559665|P4|Period III|Adverse Event|0
157936|NCT00615459|559666|P3|Period III|Adverse Event|0
157937|NCT00615459|559667|P2|Period III|Adverse Event|1
157938|NCT00615459|559668|P1|Period III|Adverse Event|0
157939|NCT00615459|559665|P4|Period II|Lost to Follow-up|1
157940|NCT00615459|559666|P3|Period II|Lost to Follow-up|0
157941|NCT00615459|559667|P2|Period II|Lost to Follow-up|0
157942|NCT00615459|559668|P1|Period II|Lost to Follow-up|0
157943|NCT00615459|559665|P4|Period II|Adverse Event|0
157944|NCT00615459|559666|P3|Period II|Adverse Event|0
157945|NCT00615459|559667|P2|Period II|Adverse Event|0
157946|NCT00615459|559668|P1|Period II|Adverse Event|1
157947|NCT00615459|559665|P4|Period I|Abnormal test procedure results|0
157948|NCT00615459|559666|P3|Period I|Abnormal test procedure results|1
157949|NCT00615459|559667|P2|Period I|Abnormal test procedure results|1
157950|NCT00615459|559668|P1|Period I|Abnormal test procedure results|1
157951|NCT00615459|559665|P4|Period I|Subject withdrew consent|1
157952|NCT00615459|559666|P3|Period I|Subject withdrew consent|0
157953|NCT00615459|559667|P2|Period I|Subject withdrew consent|0
157954|NCT00615459|559668|P1|Period I|Subject withdrew consent|1
157955|NCT00615459|559665|P4|Period I|Adverse Event|0
157956|NCT00615459|559666|P3|Period I|Adverse Event|1
157957|NCT00615459|559667|P2|Period I|Adverse Event|0
157958|NCT00615459|559668|P1|Period I|Adverse Event|2
157959|NCT00615290|559703|P1|Overall Study|Other|2
157960|NCT00615290|559703|P1|Overall Study|Withdrawal by Subject|1
157961|NCT00615290|559703|P1|Overall Study|Lost to Follow-up|3
157962|NCT00615290|559703|P1|Overall Study|Adverse Event|2
157963|NCT00615264|559717|P2|Overall Study|Dermal Hypersensitivity|3
157964|NCT00615264|559718|P1|Overall Study|Dermal Hypersensitivity|0
157965|NCT00615264|559717|P2|Overall Study|Not defined|4
157966|NCT00615264|559718|P1|Overall Study|Not defined|7
157967|NCT00615264|559717|P2|Overall Study|Protocol Violation|7
157968|NCT00615264|559718|P1|Overall Study|Protocol Violation|11
157969|NCT00615264|559717|P2|Overall Study|Death|1
157970|NCT00615264|559718|P1|Overall Study|Death|1
157971|NCT00615264|559717|P2|Overall Study|Adverse Event|5
157972|NCT00615264|559718|P1|Overall Study|Adverse Event|8
157973|NCT00615264|559717|P2|Overall Study|Lost to Follow-up|13
157974|NCT00615264|559718|P1|Overall Study|Lost to Follow-up|6
157975|NCT00615264|559717|P2|Overall Study|Withdrawal by Subject|19
157976|NCT00615264|559718|P1|Overall Study|Withdrawal by Subject|17
157977|NCT00615199|559730|P4|Overall Study|Withdrawal by Subject|0
157978|NCT00615199|559731|P3|Overall Study|Withdrawal by Subject|0
157979|NCT00615199|559732|P2|Overall Study|Withdrawal by Subject|1
157980|NCT00615199|559733|P1|Overall Study|Withdrawal by Subject|2
157981|NCT00615199|559730|P4|Overall Study|Other|1
157982|NCT00615199|559731|P3|Overall Study|Other|0
157983|NCT00615199|559732|P2|Overall Study|Other|0
157984|NCT00615199|559733|P1|Overall Study|Other|0
157985|NCT00615199|559730|P4|Overall Study|Lost to Follow-up|0
157986|NCT00615199|559731|P3|Overall Study|Lost to Follow-up|0
157987|NCT00615199|559732|P2|Overall Study|Lost to Follow-up|0
157988|NCT00615199|559733|P1|Overall Study|Lost to Follow-up|1
157989|NCT00615199|559730|P4|Overall Study|Lack of Efficacy|1
157990|NCT00615199|559731|P3|Overall Study|Lack of Efficacy|0
157991|NCT00615199|559732|P2|Overall Study|Lack of Efficacy|0
157992|NCT00615199|559733|P1|Overall Study|Lack of Efficacy|2
157993|NCT00615199|559730|P4|Overall Study|Adverse Event|0
157994|NCT00615199|559731|P3|Overall Study|Adverse Event|1
157995|NCT00615199|559732|P2|Overall Study|Adverse Event|1
157996|NCT00615199|559733|P1|Overall Study|Adverse Event|3
157997|NCT00615108|559767|P1|Overall Study|Lost to Follow-up|15
157998|NCT00615108|559767|P1|Overall Study|Other|370
157999|NCT00615108|559767|P1|Overall Study|Adverse Event|122
158000|NCT00615069|559782|P1|Overall Study|Withdrawal by Subject|4
158001|NCT00615069|559782|P1|Overall Study|Physician Decision|2
158002|NCT00615069|559782|P1|Overall Study|Death|10
158003|NCT00615056|559791|P4|Overall Study|Randomized but not treated|0
158004|NCT00615056|559792|P3|Overall Study|Randomized but not treated|0
158005|NCT00615056|559793|P2|Overall Study|Randomized but not treated|0
158006|NCT00615056|559794|P1|Overall Study|Randomized but not treated|3
158007|NCT00615056|559791|P4|Overall Study|Discontinued by Sponsor|0
158008|NCT00615056|559792|P3|Overall Study|Discontinued by Sponsor|0
158009|NCT00615056|559793|P2|Overall Study|Discontinued by Sponsor|0
158010|NCT00615056|559794|P1|Overall Study|Discontinued by Sponsor|1
158011|NCT00615056|559791|P4|Overall Study|Withdrawal by Subject|0
158012|NCT00615056|559792|P3|Overall Study|Withdrawal by Subject|1
158013|NCT00615056|559793|P2|Overall Study|Withdrawal by Subject|1
158014|NCT00615056|559794|P1|Overall Study|Withdrawal by Subject|0
158015|NCT00615056|559791|P4|Overall Study|Objective progression or relapse|0
158016|NCT00615056|559792|P3|Overall Study|Objective progression or relapse|0
158017|NCT00615056|559793|P2|Overall Study|Objective progression or relapse|2
158018|NCT00615056|559794|P1|Overall Study|Objective progression or relapse|0
158019|NCT00615056|559791|P4|Overall Study|Other|7
158020|NCT00615056|559792|P3|Overall Study|Other|10
158021|NCT00615056|559793|P2|Overall Study|Other|15
158022|NCT00615056|559794|P1|Overall Study|Other|13
158023|NCT00615056|559791|P4|Overall Study|Lost to Follow-up|5
158024|NCT00615056|559792|P3|Overall Study|Lost to Follow-up|4
158025|NCT00615056|559793|P2|Overall Study|Lost to Follow-up|2
158026|NCT00615056|559794|P1|Overall Study|Lost to Follow-up|1
158027|NCT00615056|559791|P4|Overall Study|Death|23
158028|NCT00615056|559792|P3|Overall Study|Death|21
158029|NCT00615056|559793|P2|Overall Study|Death|31
158030|NCT00615056|559794|P1|Overall Study|Death|31
158031|NCT00615030|559824|P12|Period III|Administrative problems|0
158032|NCT00615030|559825|P11|Period III|Administrative problems|0
158033|NCT00615030|559826|P10|Period III|Administrative problems|0
158034|NCT00615030|559827|P9|Period III|Administrative problems|0
158035|NCT00615030|559828|P8|Period III|Administrative problems|0
158036|NCT00615030|559829|P7|Period III|Administrative problems|0
158037|NCT00615030|559830|P6|Period III|Administrative problems|0
158038|NCT00615030|559831|P5|Period III|Administrative problems|0
158039|NCT00615030|559832|P4|Period III|Administrative problems|1
158040|NCT00615030|559833|P3|Period III|Administrative problems|0
158041|NCT00615030|559834|P2|Period III|Administrative problems|0
158042|NCT00615030|559835|P1|Period III|Administrative problems|1
158043|NCT00615030|559824|P12|Period II|Subject withdrew consent|0
158044|NCT00615030|559825|P11|Period II|Subject withdrew consent|0
158045|NCT00615030|559826|P10|Period II|Subject withdrew consent|0
158046|NCT00615030|559827|P9|Period II|Subject withdrew consent|0
158047|NCT00615030|559828|P8|Period II|Subject withdrew consent|0
158048|NCT00615030|559829|P7|Period II|Subject withdrew consent|1
158049|NCT00615030|559830|P6|Period II|Subject withdrew consent|0
158050|NCT00615030|559831|P5|Period II|Subject withdrew consent|0
158051|NCT00615030|559832|P4|Period II|Subject withdrew consent|1
158052|NCT00615030|559833|P3|Period II|Subject withdrew consent|0
158053|NCT00615030|559834|P2|Period II|Subject withdrew consent|0
158054|NCT00615030|559835|P1|Period II|Subject withdrew consent|0
158055|NCT00615030|559824|P12|Period II|Adverse Event|0
158056|NCT00615030|559825|P11|Period II|Adverse Event|0
158057|NCT00615030|559826|P10|Period II|Adverse Event|0
158058|NCT00615030|559827|P9|Period II|Adverse Event|1
158059|NCT00615030|559828|P8|Period II|Adverse Event|0
158060|NCT00615030|559829|P7|Period II|Adverse Event|0
158061|NCT00615030|559830|P6|Period II|Adverse Event|0
158062|NCT00615030|559831|P5|Period II|Adverse Event|0
158063|NCT00615030|559832|P4|Period II|Adverse Event|0
158064|NCT00615030|559833|P3|Period II|Adverse Event|1
158065|NCT00615030|559834|P2|Period II|Adverse Event|0
158066|NCT00615030|559835|P1|Period II|Adverse Event|0
158067|NCT00615030|559824|P12|Period I|Abnormal laboratory value(s)|0
158068|NCT00615030|559825|P11|Period I|Abnormal laboratory value(s)|0
158069|NCT00615030|559826|P10|Period I|Abnormal laboratory value(s)|0
158070|NCT00615030|559827|P9|Period I|Abnormal laboratory value(s)|0
158071|NCT00615030|559828|P8|Period I|Abnormal laboratory value(s)|0
158072|NCT00615030|559829|P7|Period I|Abnormal laboratory value(s)|0
158073|NCT00615030|559830|P6|Period I|Abnormal laboratory value(s)|1
158074|NCT00615030|559831|P5|Period I|Abnormal laboratory value(s)|0
158075|NCT00615030|559832|P4|Period I|Abnormal laboratory value(s)|0
158076|NCT00615030|559833|P3|Period I|Abnormal laboratory value(s)|0
158077|NCT00615030|559834|P2|Period I|Abnormal laboratory value(s)|0
158078|NCT00615030|559835|P1|Period I|Abnormal laboratory value(s)|0
158079|NCT00615030|559824|P12|Period I|Subject withdrew consent|1
158080|NCT00615030|559825|P11|Period I|Subject withdrew consent|1
158081|NCT00615030|559826|P10|Period I|Subject withdrew consent|0
158082|NCT00615030|559827|P9|Period I|Subject withdrew consent|1
158083|NCT00615030|559828|P8|Period I|Subject withdrew consent|0
158084|NCT00615030|559829|P7|Period I|Subject withdrew consent|0
158085|NCT00615030|559830|P6|Period I|Subject withdrew consent|0
158086|NCT00615030|559831|P5|Period I|Subject withdrew consent|0
158087|NCT00615030|559832|P4|Period I|Subject withdrew consent|0
158088|NCT00615030|559833|P3|Period I|Subject withdrew consent|0
158089|NCT00615030|559834|P2|Period I|Subject withdrew consent|0
158090|NCT00615030|559835|P1|Period I|Subject withdrew consent|0
158091|NCT00615030|559824|P12|Period I|Protocol deviation|0
158092|NCT00615030|559825|P11|Period I|Protocol deviation|0
158093|NCT00615030|559826|P10|Period I|Protocol deviation|0
158094|NCT00615030|559827|P9|Period I|Protocol deviation|0
158095|NCT00615030|559828|P8|Period I|Protocol deviation|0
158096|NCT00615030|559829|P7|Period I|Protocol deviation|0
158097|NCT00615030|559830|P6|Period I|Protocol deviation|0
158098|NCT00615030|559831|P5|Period I|Protocol deviation|0
158099|NCT00615030|559832|P4|Period I|Protocol deviation|0
158100|NCT00615030|559833|P3|Period I|Protocol deviation|0
158101|NCT00615030|559834|P2|Period I|Protocol deviation|0
158102|NCT00615030|559835|P1|Period I|Protocol deviation|1
158103|NCT00615030|559824|P12|Period I|Administrative problem|0
158104|NCT00615030|559825|P11|Period I|Administrative problem|0
158105|NCT00615030|559826|P10|Period I|Administrative problem|0
158106|NCT00615030|559827|P9|Period I|Administrative problem|0
158107|NCT00615030|559828|P8|Period I|Administrative problem|0
158108|NCT00615030|559829|P7|Period I|Administrative problem|0
158109|NCT00615030|559830|P6|Period I|Administrative problem|0
158110|NCT00615030|559831|P5|Period I|Administrative problem|1
158111|NCT00615030|559832|P4|Period I|Administrative problem|0
158112|NCT00615030|559833|P3|Period I|Administrative problem|0
158113|NCT00615030|559834|P2|Period I|Administrative problem|0
158114|NCT00615030|559835|P1|Period I|Administrative problem|0
158115|NCT00615017|559855|P6|Overall Study|Physician discontinued drug|1
158116|NCT00615017|559856|P5|Overall Study|Physician discontinued drug|0
158117|NCT00615017|559857|P4|Overall Study|Physician discontinued drug|0
158118|NCT00615017|559858|P3|Overall Study|Physician discontinued drug|0
158119|NCT00615017|559859|P2|Overall Study|Physician discontinued drug|0
158120|NCT00615017|559860|P1|Overall Study|Physician discontinued drug|0
158121|NCT00615017|559855|P6|Overall Study|Transferred out of Intensive Care Unit|0
158122|NCT00615017|559856|P5|Overall Study|Transferred out of Intensive Care Unit|0
158123|NCT00615017|559857|P4|Overall Study|Transferred out of Intensive Care Unit|1
158124|NCT00615017|559858|P3|Overall Study|Transferred out of Intensive Care Unit|0
158125|NCT00615017|559859|P2|Overall Study|Transferred out of Intensive Care Unit|0
158126|NCT00615017|559860|P1|Overall Study|Transferred out of Intensive Care Unit|0
158127|NCT00615017|559855|P6|Overall Study|Sepsis resolved|0
158128|NCT00615017|559856|P5|Overall Study|Sepsis resolved|0
158129|NCT00615017|559857|P4|Overall Study|Sepsis resolved|0
158130|NCT00615017|559858|P3|Overall Study|Sepsis resolved|1
158131|NCT00615017|559859|P2|Overall Study|Sepsis resolved|0
158132|NCT00615017|559860|P1|Overall Study|Sepsis resolved|0
158133|NCT00615017|559855|P6|Overall Study|Death|1
158134|NCT00615017|559856|P5|Overall Study|Death|1
158135|NCT00615017|559857|P4|Overall Study|Death|0
158136|NCT00615017|559858|P3|Overall Study|Death|2
158137|NCT00615017|559859|P2|Overall Study|Death|0
158138|NCT00615017|559860|P1|Overall Study|Death|0
158139|NCT00615017|559855|P6|Overall Study|Adverse Event|1
158140|NCT00615017|559856|P5|Overall Study|Adverse Event|0
158141|NCT00615017|559857|P4|Overall Study|Adverse Event|0
158142|NCT00615017|559858|P3|Overall Study|Adverse Event|2
158143|NCT00615017|559859|P2|Overall Study|Adverse Event|1
158144|NCT00615017|559860|P1|Overall Study|Adverse Event|0
158145|NCT00614991|560018|P6|Overall Study|Adverse Event|0
158146|NCT00614991|560019|P5|Overall Study|Adverse Event|1
158147|NCT00614991|560020|P4|Overall Study|Adverse Event|0
158148|NCT00614991|560021|P3|Overall Study|Adverse Event|0
158149|NCT00614991|560022|P2|Overall Study|Adverse Event|3
158150|NCT00614991|560023|P1|Overall Study|Adverse Event|3
158151|NCT00614939|560057|P2|Overall Study|Hospitalized due to kidney transplant|0
158152|NCT00614939|560058|P1|Overall Study|Hospitalized due to kidney transplant|1
158153|NCT00614939|560057|P2|Overall Study|Poor/non-compliance|0
158154|NCT00614939|560058|P1|Overall Study|Poor/non-compliance|4
158155|NCT00614939|560057|P2|Overall Study|Death|3
158156|NCT00614939|560058|P1|Overall Study|Death|4
158157|NCT00614939|560057|P2|Overall Study|Incorrect enrollment|2
158158|NCT00614939|560058|P1|Overall Study|Incorrect enrollment|1
158159|NCT00614939|560057|P2|Overall Study|Adverse Event|5
158160|NCT00614939|560058|P1|Overall Study|Adverse Event|2
158161|NCT00614939|560057|P2|Overall Study|Study specific discontinuation criteris|16
158162|NCT00614939|560058|P1|Overall Study|Study specific discontinuation criteris|13
158163|NCT00614939|560057|P2|Overall Study|Withdrawal by Subject|17
158164|NCT00614939|560058|P1|Overall Study|Withdrawal by Subject|10
158165|NCT00614926|560092|P2|Overall Study|Adverse Event|0
158166|NCT00614926|560093|P1|Overall Study|Adverse Event|3
158167|NCT00614926|560092|P2|Overall Study|Burden of travel|0
158168|NCT00614926|560093|P1|Overall Study|Burden of travel|1
158169|NCT00614874|560106|P1|Overall Study|Withdrawal by Subject|1
158170|NCT00614874|560106|P1|Overall Study|Protocol Violation|1
158171|NCT00614744|560115|P2|Overall Study|Incomplete for Behavior Issues|2
158172|NCT00614744|560116|P1|Overall Study|Incomplete for Behavior Issues|0
158173|NCT00614744|560115|P2|Overall Study|Lost to Follow-up|4
158174|NCT00614744|560116|P1|Overall Study|Lost to Follow-up|5
158175|NCT00614614|560142|P5|Booster Vaccination Phase|Other|1
158176|NCT00614614|560143|P4|Booster Vaccination Phase|Other|2
158177|NCT00614614|560144|P3|Booster Vaccination Phase|Other|3
158178|NCT00614614|560145|P2|Booster Vaccination Phase|Other|1
158179|NCT00614614|560146|P1|Booster Vaccination Phase|Other|0
158180|NCT00614614|560142|P5|Booster Vaccination Phase|Protocol Violation|0
158181|NCT00614614|560143|P4|Booster Vaccination Phase|Protocol Violation|3
158182|NCT00614614|560144|P3|Booster Vaccination Phase|Protocol Violation|2
158183|NCT00614614|560145|P2|Booster Vaccination Phase|Protocol Violation|0
158184|NCT00614614|560146|P1|Booster Vaccination Phase|Protocol Violation|0
158185|NCT00614614|560142|P5|Booster Vaccination Phase|Lost to Follow-up|8
158186|NCT00614614|560143|P4|Booster Vaccination Phase|Lost to Follow-up|10
158187|NCT00614614|560144|P3|Booster Vaccination Phase|Lost to Follow-up|17
158188|NCT00614614|560145|P2|Booster Vaccination Phase|Lost to Follow-up|5
158189|NCT00614614|560146|P1|Booster Vaccination Phase|Lost to Follow-up|0
158190|NCT00614614|560142|P5|Booster Vaccination Phase|Withdrawal by Subject|4
158191|NCT00614614|560143|P4|Booster Vaccination Phase|Withdrawal by Subject|3
158192|NCT00614614|560144|P3|Booster Vaccination Phase|Withdrawal by Subject|4
158193|NCT00614614|560145|P2|Booster Vaccination Phase|Withdrawal by Subject|0
158194|NCT00614614|560146|P1|Booster Vaccination Phase|Withdrawal by Subject|0
158195|NCT00614614|560142|P5|Booster Vaccination Phase|Adverse Event|0
158196|NCT00614614|560143|P4|Booster Vaccination Phase|Adverse Event|1
158197|NCT00614614|560144|P3|Booster Vaccination Phase|Adverse Event|1
158198|NCT00614614|560145|P2|Booster Vaccination Phase|Adverse Event|0
158199|NCT00614614|560146|P1|Booster Vaccination Phase|Adverse Event|0
158200|NCT00614614|560142|P5|Primary Vaccination Phase|Other|0
158201|NCT00614614|560143|P4|Primary Vaccination Phase|Other|0
158202|NCT00614614|560144|P3|Primary Vaccination Phase|Other|0
158203|NCT00614614|560145|P2|Primary Vaccination Phase|Other|0
158204|NCT00614614|560146|P1|Primary Vaccination Phase|Other|4
158205|NCT00614614|560142|P5|Primary Vaccination Phase|Protocol Violation|0
158206|NCT00614614|560143|P4|Primary Vaccination Phase|Protocol Violation|0
158207|NCT00614614|560144|P3|Primary Vaccination Phase|Protocol Violation|0
158208|NCT00614614|560145|P2|Primary Vaccination Phase|Protocol Violation|3
158209|NCT00614614|560146|P1|Primary Vaccination Phase|Protocol Violation|9
158210|NCT00614614|560142|P5|Primary Vaccination Phase|Lost to Follow-up|0
158211|NCT00614614|560143|P4|Primary Vaccination Phase|Lost to Follow-up|0
158212|NCT00614614|560144|P3|Primary Vaccination Phase|Lost to Follow-up|0
158213|NCT00614614|560145|P2|Primary Vaccination Phase|Lost to Follow-up|8
158214|NCT00614614|560146|P1|Primary Vaccination Phase|Lost to Follow-up|26
158215|NCT00614614|560142|P5|Primary Vaccination Phase|Withdrawal by Subject|0
158216|NCT00614614|560143|P4|Primary Vaccination Phase|Withdrawal by Subject|0
158217|NCT00614614|560144|P3|Primary Vaccination Phase|Withdrawal by Subject|0
158218|NCT00614614|560145|P2|Primary Vaccination Phase|Withdrawal by Subject|6
158219|NCT00614614|560146|P1|Primary Vaccination Phase|Withdrawal by Subject|45
158220|NCT00614614|560142|P5|Primary Vaccination Phase|Adverse Event|0
158221|NCT00614614|560143|P4|Primary Vaccination Phase|Adverse Event|0
158222|NCT00614614|560144|P3|Primary Vaccination Phase|Adverse Event|0
158223|NCT00614614|560145|P2|Primary Vaccination Phase|Adverse Event|0
158224|NCT00614614|560146|P1|Primary Vaccination Phase|Adverse Event|6
158225|NCT00614575|560269|P1|Overall Study|No treatment|1
158226|NCT00614575|560269|P1|Overall Study|Irregularly enrolled patients|23
158227|NCT00614575|560269|P1|Overall Study|No data were collected.|18
158228|NCT00614575|560269|P1|Overall Study|Physician Decision|2
158229|NCT00614575|560269|P1|Overall Study|Death|3
158230|NCT00614575|560269|P1|Overall Study|Withdrawal by Subject|6
158231|NCT00614575|560269|P1|Overall Study|Lack of Efficacy|14
158232|NCT00614575|560269|P1|Overall Study|Lost to Follow-up|55
158233|NCT00614575|560269|P1|Overall Study|Adverse Event|106
158234|NCT00614523|560280|P2|Overall Study|Administrative Decision|46
158235|NCT00614523|560281|P1|Overall Study|Administrative Decision|23
158236|NCT00614523|560280|P2|Overall Study|Disease Progression|8
158237|NCT00614523|560281|P1|Overall Study|Disease Progression|0
158238|NCT00614523|560280|P2|Overall Study|Ineligibility Determined|2
158239|NCT00614523|560281|P1|Overall Study|Ineligibility Determined|1
158240|NCT00614523|560280|P2|Overall Study|Other|11
158241|NCT00614523|560281|P1|Overall Study|Other|6
158242|NCT00614523|560280|P2|Overall Study|Withdrawal by Subject|22
158243|NCT00614523|560281|P1|Overall Study|Withdrawal by Subject|12
158244|NCT00614523|560280|P2|Overall Study|Protocol Violation|2
158245|NCT00614523|560281|P1|Overall Study|Protocol Violation|3
158246|NCT00614523|560280|P2|Overall Study|Lost to Follow-up|1
158247|NCT00614523|560281|P1|Overall Study|Lost to Follow-up|0
158248|NCT00614523|560280|P2|Overall Study|Lack of Efficacy|11
158249|NCT00614523|560281|P1|Overall Study|Lack of Efficacy|9
158250|NCT00614523|560280|P2|Overall Study|Death|8
158251|NCT00614523|560281|P1|Overall Study|Death|5
158252|NCT00614523|560280|P2|Overall Study|Adverse Event|20
158253|NCT00614523|560281|P1|Overall Study|Adverse Event|4
158254|NCT00614393|560337|P5|Overall Study|Not Treated|2
158255|NCT00614393|560338|P4|Overall Study|Not Treated|0
158256|NCT00614393|560339|P3|Overall Study|Not Treated|0
158257|NCT00614393|560340|P2|Overall Study|Not Treated|0
158258|NCT00614393|560341|P1|Overall Study|Not Treated|0
158259|NCT00614393|560337|P5|Overall Study|Other|2
158260|NCT00614393|560338|P4|Overall Study|Other|4
158261|NCT00614393|560339|P3|Overall Study|Other|0
158262|NCT00614393|560340|P2|Overall Study|Other|0
158263|NCT00614393|560341|P1|Overall Study|Other|4
158264|NCT00614393|560337|P5|Overall Study|Withdrawal by Subject|13
158265|NCT00614393|560338|P4|Overall Study|Withdrawal by Subject|16
158266|NCT00614393|560339|P3|Overall Study|Withdrawal by Subject|1
158267|NCT00614393|560340|P2|Overall Study|Withdrawal by Subject|1
158268|NCT00614393|560341|P1|Overall Study|Withdrawal by Subject|20
158269|NCT00614393|560337|P5|Overall Study|Terminated by Sponsor|1
158270|NCT00614393|560338|P4|Overall Study|Terminated by Sponsor|0
158271|NCT00614393|560339|P3|Overall Study|Terminated by Sponsor|0
158272|NCT00614393|560340|P2|Overall Study|Terminated by Sponsor|0
158273|NCT00614393|560341|P1|Overall Study|Terminated by Sponsor|0
158274|NCT00614393|560337|P5|Overall Study|Protocol Violation|0
158275|NCT00614393|560338|P4|Overall Study|Protocol Violation|0
158276|NCT00614393|560339|P3|Overall Study|Protocol Violation|0
158277|NCT00614393|560340|P2|Overall Study|Protocol Violation|0
158278|NCT00614393|560341|P1|Overall Study|Protocol Violation|1
158279|NCT00614393|560337|P5|Overall Study|Progressive Disease|130
158280|NCT00614393|560338|P4|Overall Study|Progressive Disease|138
158281|NCT00614393|560339|P3|Overall Study|Progressive Disease|5
158282|NCT00614393|560340|P2|Overall Study|Progressive Disease|5
158283|NCT00614393|560341|P1|Overall Study|Progressive Disease|118
158284|NCT00614393|560337|P5|Overall Study|Physician Decision|9
158285|NCT00614393|560338|P4|Overall Study|Physician Decision|8
158286|NCT00614393|560339|P3|Overall Study|Physician Decision|1
158287|NCT00614393|560340|P2|Overall Study|Physician Decision|0
158288|NCT00614393|560341|P1|Overall Study|Physician Decision|17
158289|NCT00614393|560337|P5|Overall Study|Lost to Follow-up|2
158290|NCT00614393|560338|P4|Overall Study|Lost to Follow-up|1
158291|NCT00614393|560339|P3|Overall Study|Lost to Follow-up|0
158292|NCT00614393|560340|P2|Overall Study|Lost to Follow-up|0
158293|NCT00614393|560341|P1|Overall Study|Lost to Follow-up|0
158294|NCT00614393|560337|P5|Overall Study|Adverse Event|21
158295|NCT00614393|560338|P4|Overall Study|Adverse Event|13
158296|NCT00614393|560339|P3|Overall Study|Adverse Event|3
158297|NCT00614393|560340|P2|Overall Study|Adverse Event|2
158298|NCT00614393|560341|P1|Overall Study|Adverse Event|20
158299|NCT00614380|560387|P4|Overall Study|Consent withdrawn|0
158300|NCT00614380|560388|P3|Overall Study|Consent withdrawn|0
158301|NCT00614380|560389|P2|Overall Study|Consent withdrawn|1
158302|NCT00614380|560390|P1|Overall Study|Consent withdrawn|3
158303|NCT00614380|560387|P4|Overall Study|Non compliant with the protocol|2
158304|NCT00614380|560388|P3|Overall Study|Non compliant with the protocol|1
158305|NCT00614380|560389|P2|Overall Study|Non compliant with the protocol|2
158306|NCT00614380|560390|P1|Overall Study|Non compliant with the protocol|12
158307|NCT00614380|560387|P4|Overall Study|Lost to Follow-up|0
158308|NCT00614380|560388|P3|Overall Study|Lost to Follow-up|0
158309|NCT00614380|560389|P2|Overall Study|Lost to Follow-up|1
158310|NCT00614380|560390|P1|Overall Study|Lost to Follow-up|6
158311|NCT00614380|560387|P4|Overall Study|Adverse Event|0
158312|NCT00614380|560388|P3|Overall Study|Adverse Event|0
158313|NCT00614380|560389|P2|Overall Study|Adverse Event|4
158314|NCT00614380|560390|P1|Overall Study|Adverse Event|14
158315|NCT00614120|560457|P4|Overall Study|Lost to Follow-up|4
158316|NCT00614120|560458|P3|Overall Study|Lost to Follow-up|3
158317|NCT00614120|560459|P2|Overall Study|Lost to Follow-up|2
158318|NCT00614120|560460|P1|Overall Study|Lost to Follow-up|1
158319|NCT00614120|560457|P4|Overall Study|Taken inhibition medication eg Prandin|1
158320|NCT00614120|560458|P3|Overall Study|Taken inhibition medication eg Prandin|1
158321|NCT00614120|560459|P2|Overall Study|Taken inhibition medication eg Prandin|0
158322|NCT00614120|560460|P1|Overall Study|Taken inhibition medication eg Prandin|0
158323|NCT00614120|560457|P4|Overall Study|Late syphilis, latent|0
158324|NCT00614120|560458|P3|Overall Study|Late syphilis, latent|0
158325|NCT00614120|560459|P2|Overall Study|Late syphilis, latent|0
158326|NCT00614120|560460|P1|Overall Study|Late syphilis, latent|1
158327|NCT00614120|560457|P4|Overall Study|Lack of trial product|0
158328|NCT00614120|560458|P3|Overall Study|Lack of trial product|2
158329|NCT00614120|560459|P2|Overall Study|Lack of trial product|3
158330|NCT00614120|560460|P1|Overall Study|Lack of trial product|3
158331|NCT00614120|560457|P4|Overall Study|Hypoglycaemia|1
158332|NCT00614120|560458|P3|Overall Study|Hypoglycaemia|0
158333|NCT00614120|560459|P2|Overall Study|Hypoglycaemia|0
158334|NCT00614120|560460|P1|Overall Study|Hypoglycaemia|0
158335|NCT00614120|560457|P4|Overall Study|hCG positive (not pregnant)|0
158336|NCT00614120|560458|P3|Overall Study|hCG positive (not pregnant)|1
158337|NCT00614120|560459|P2|Overall Study|hCG positive (not pregnant)|0
158338|NCT00614120|560460|P1|Overall Study|hCG positive (not pregnant)|0
158339|NCT00614120|560457|P4|Overall Study|Did not meet trial criteria|1
158340|NCT00614120|560458|P3|Overall Study|Did not meet trial criteria|1
158341|NCT00614120|560459|P2|Overall Study|Did not meet trial criteria|1
158342|NCT00614120|560460|P1|Overall Study|Did not meet trial criteria|0
158343|NCT00614120|560457|P4|Overall Study|Withdrawal by Subject|3
158344|NCT00614120|560458|P3|Overall Study|Withdrawal by Subject|16
158345|NCT00614120|560459|P2|Overall Study|Withdrawal by Subject|10
158346|NCT00614120|560460|P1|Overall Study|Withdrawal by Subject|9
158347|NCT00614120|560457|P4|Overall Study|Withdrawal criteria|0
158348|NCT00614120|560458|P3|Overall Study|Withdrawal criteria|0
158349|NCT00614120|560459|P2|Overall Study|Withdrawal criteria|0
158350|NCT00614120|560460|P1|Overall Study|Withdrawal criteria|1
158351|NCT00614120|560457|P4|Overall Study|Protocol Violation|1
158352|NCT00614120|560458|P3|Overall Study|Protocol Violation|3
158353|NCT00614120|560459|P2|Overall Study|Protocol Violation|5
158354|NCT00614120|560460|P1|Overall Study|Protocol Violation|2
158355|NCT00614120|560457|P4|Overall Study|Lack of Efficacy|2
158356|NCT00614120|560458|P3|Overall Study|Lack of Efficacy|2
158357|NCT00614120|560459|P2|Overall Study|Lack of Efficacy|3
158358|NCT00614120|560460|P1|Overall Study|Lack of Efficacy|3
158359|NCT00614120|560457|P4|Overall Study|Adverse Event|3
158360|NCT00614120|560458|P3|Overall Study|Adverse Event|30
158361|NCT00614120|560459|P2|Overall Study|Adverse Event|22
158362|NCT00614120|560460|P1|Overall Study|Adverse Event|9
158363|NCT00614055|560501|P3|Overall Study|Unclassified|2
158364|NCT00614055|560502|P2|Overall Study|Unclassified|4
158365|NCT00614055|560503|P1|Overall Study|Unclassified|1
158366|NCT00614055|560501|P3|Overall Study|Lack of Efficacy|2
158367|NCT00614055|560502|P2|Overall Study|Lack of Efficacy|0
158368|NCT00614055|560503|P1|Overall Study|Lack of Efficacy|0
158369|NCT00614055|560501|P3|Overall Study|Protocol Violation|1
158370|NCT00614055|560502|P2|Overall Study|Protocol Violation|2
158371|NCT00614055|560503|P1|Overall Study|Protocol Violation|2
158372|NCT00614055|560501|P3|Overall Study|Adverse Event|0
158373|NCT00614055|560502|P2|Overall Study|Adverse Event|0
158374|NCT00614055|560503|P1|Overall Study|Adverse Event|1
158375|NCT00613951|560550|P3|Overall Study|Unclassified|2
158376|NCT00613951|560551|P2|Overall Study|Unclassified|3
158377|NCT00613951|560552|P1|Overall Study|Unclassified|5
158378|NCT00613951|560550|P3|Overall Study|Protocol Violation|1
158379|NCT00613951|560551|P2|Overall Study|Protocol Violation|1
158380|NCT00613951|560552|P1|Overall Study|Protocol Violation|1
158381|NCT00613951|560550|P3|Overall Study|Lack of Efficacy|1
158382|NCT00613951|560551|P2|Overall Study|Lack of Efficacy|1
158383|NCT00613951|560552|P1|Overall Study|Lack of Efficacy|0
158384|NCT00613951|560550|P3|Overall Study|Adverse Event|1
158385|NCT00613951|560551|P2|Overall Study|Adverse Event|0
158386|NCT00613951|560552|P1|Overall Study|Adverse Event|1
158387|NCT00613938|560597|P4|Overall Study|Other|3
158388|NCT00613938|560598|P3|Overall Study|Other|1
158389|NCT00613938|560599|P2|Overall Study|Other|2
158390|NCT00613938|560600|P1|Overall Study|Other|1
158391|NCT00613938|560597|P4|Overall Study|Lack of Efficacy|9
158392|NCT00613938|560598|P3|Overall Study|Lack of Efficacy|5
158393|NCT00613938|560599|P2|Overall Study|Lack of Efficacy|18
158394|NCT00613938|560600|P1|Overall Study|Lack of Efficacy|16
158395|NCT00613938|560597|P4|Overall Study|Adverse Event|5
158396|NCT00613938|560598|P3|Overall Study|Adverse Event|8
158397|NCT00613938|560599|P2|Overall Study|Adverse Event|4
158398|NCT00613938|560600|P1|Overall Study|Adverse Event|1
158399|NCT00613938|560597|P4|Overall Study|Withdrawal by Subject|9
158400|NCT00613938|560598|P3|Overall Study|Withdrawal by Subject|9
158401|NCT00613938|560599|P2|Overall Study|Withdrawal by Subject|4
158402|NCT00613938|560600|P1|Overall Study|Withdrawal by Subject|2
158403|NCT00613925|560632|P2|Overall Study|1 did not tolerate outpatient biopsy|1
158404|NCT00613925|560633|P1|Overall Study|1 did not tolerate outpatient biopsy|0
158405|NCT00613821|560643|P2|Overall Study|Physician Decision|1
158406|NCT00613821|560644|P1|Overall Study|Physician Decision|1
158407|NCT00613821|560643|P2|Overall Study|Withdrawal by Subject|0
158408|NCT00613821|560644|P1|Overall Study|Withdrawal by Subject|1
158409|NCT00613730|560650|P1|Overall Study|Administrative decision|1
158410|NCT00613730|560650|P1|Overall Study|Disease progression|2
158411|NCT00613626|560659|P3|Overall Study|Ineligible|0
158412|NCT00613626|560660|P2|Overall Study|Ineligible|1
158413|NCT00613626|560661|P1|Overall Study|Ineligible|0
158414|NCT00613574|560677|P1|Overall Study|Other|1
158415|NCT00613574|560677|P1|Overall Study|Lost to Follow-up|2
158416|NCT00613574|560677|P1|Overall Study|Adverse Event|3
158417|NCT00613509|560689|P2|Cycle 1|Other administrative reason|1
158418|NCT00613509|560690|P1|Cycle 1|Other administrative reason|0
158419|NCT00613509|560689|P2|Cycle 1|Unacceptable Toxicity|0
158420|NCT00613509|560690|P1|Cycle 1|Unacceptable Toxicity|1
158421|NCT00613509|560689|P2|Cycle 1|Disease Progression|6
158422|NCT00613509|560690|P1|Cycle 1|Disease Progression|2
158423|NCT00613509|560689|P2|Cycle 1|Adverse Event|1
158424|NCT00613509|560690|P1|Cycle 1|Adverse Event|2
158425|NCT00613366|560736|P2|Overall Study|Withdrawal by Subject|2
158426|NCT00613366|560737|P1|Overall Study|Withdrawal by Subject|3
158427|NCT00613327|560745|P1|Overall Study|Other|47
158428|NCT00613327|560745|P1|Overall Study|Protocol Violation|2
158429|NCT00613327|560745|P1|Overall Study|Withdrawal by Subject|6
158430|NCT00613327|560745|P1|Overall Study|Lost to Follow-up|8
158431|NCT00613327|560745|P1|Overall Study|Adverse Event|38
158432|NCT00613314|560764|P1|Overall Study|Other reason not defined above|90
158433|NCT00613314|560764|P1|Overall Study|Lost to Follow-up|46
158434|NCT00613314|560764|P1|Overall Study|Protocol Violation|14
158435|NCT00613314|560764|P1|Overall Study|Adverse Event|5
158436|NCT00613301|560772|P1|Overall Study|Irregularly enrolled patients|12
158437|NCT00613301|560772|P1|Overall Study|No data was collected|53
158438|NCT00613301|560772|P1|Overall Study|Physician Decision|2
158439|NCT00613301|560772|P1|Overall Study|Lack of Efficacy|13
158440|NCT00613301|560772|P1|Overall Study|Death|6
158441|NCT00613301|560772|P1|Overall Study|Withdrawal by Subject|5
158442|NCT00613301|560772|P1|Overall Study|Lost to Follow-up|88
158443|NCT00613301|560772|P1|Overall Study|Adverse Event|49
158444|NCT00613106|560781|P2|Overall Study|misc|3
158445|NCT00613106|560782|P1|Overall Study|misc|4
158446|NCT00613106|560781|P2|Overall Study|Lost to Follow-up|2
158447|NCT00613106|560782|P1|Overall Study|Lost to Follow-up|7
158448|NCT00613106|560781|P2|Overall Study|Withdrawal by Subject|3
158449|NCT00613106|560782|P1|Overall Study|Withdrawal by Subject|6
158450|NCT00613106|560781|P2|Overall Study|Adverse Event|1
158451|NCT00613106|560782|P1|Overall Study|Adverse Event|3
158452|NCT00613080|560788|P1|Overall Study|Ineligible / no protocol treatment|11
158453|NCT00613015|560815|P6|Overall Study|Lost to Follow-up|3
158454|NCT00613015|560816|P5|Overall Study|Lost to Follow-up|2
158455|NCT00613015|560817|P4|Overall Study|Lost to Follow-up|3
158456|NCT00613015|560818|P3|Overall Study|Lost to Follow-up|3
158457|NCT00613015|560819|P2|Overall Study|Lost to Follow-up|1
158458|NCT00613015|560820|P1|Overall Study|Lost to Follow-up|0
158459|NCT00612807|560856|P2|Overall Study|Withdrawal by Subject|0
158460|NCT00612807|560857|P1|Overall Study|Withdrawal by Subject|2
158461|NCT00612690|560892|P2|Overall Study|Withdrawal by Site|0
158462|NCT00612690|560893|P1|Overall Study|Withdrawal by Site|11
158463|NCT00612690|560892|P2|Overall Study|Withdrawal by Subject|20
158464|NCT00612690|560893|P1|Overall Study|Withdrawal by Subject|32
158465|NCT00612690|560892|P2|Overall Study|Lost to Follow-up|98
158466|NCT00612690|560893|P1|Overall Study|Lost to Follow-up|72
158467|NCT00612677|560901|P1|Overall Study|study closed before treatment started|1
158468|NCT00612534|560969|P4|Overall Study|Other Reason|0
158469|NCT00612534|560970|P3|Overall Study|Other Reason|0
158470|NCT00612534|560971|P2|Overall Study|Other Reason|1
158471|NCT00612534|560972|P1|Overall Study|Other Reason|0
158472|NCT00612534|560969|P4|Overall Study|Lack of Efficacy|16
158473|NCT00612534|560970|P3|Overall Study|Lack of Efficacy|5
158474|NCT00612534|560971|P2|Overall Study|Lack of Efficacy|12
158475|NCT00612534|560972|P1|Overall Study|Lack of Efficacy|13
158476|NCT00612534|560969|P4|Overall Study|Adverse Event|1
158477|NCT00612534|560970|P3|Overall Study|Adverse Event|2
158478|NCT00612534|560971|P2|Overall Study|Adverse Event|4
158479|NCT00612534|560972|P1|Overall Study|Adverse Event|0
158480|NCT00612508|560984|P2|Overall Study|Withdrawal by Subject|4
158481|NCT00612508|560985|P1|Overall Study|Withdrawal by Subject|3
158482|NCT00612456|560996|P3|Overall Study|Withdrawal by Subject|0
158483|NCT00612456|560997|P2|Overall Study|Withdrawal by Subject|1
158484|NCT00612456|560998|P1|Overall Study|Withdrawal by Subject|0
158485|NCT00612456|560996|P3|Overall Study|Lack of Efficacy|0
158486|NCT00612456|560997|P2|Overall Study|Lack of Efficacy|1
158487|NCT00612456|560998|P1|Overall Study|Lack of Efficacy|1
158488|NCT00612456|560996|P3|Overall Study|Adverse Event|0
158489|NCT00612456|560997|P2|Overall Study|Adverse Event|0
158490|NCT00612456|560998|P1|Overall Study|Adverse Event|1
158491|NCT00612352|561061|P2|Overall Study|didn't return calls/show up on test date|1
158492|NCT00612352|561062|P1|Overall Study|didn't return calls/show up on test date|4
158493|NCT00612352|561061|P2|Overall Study|moved out of state|0
158494|NCT00612352|561062|P1|Overall Study|moved out of state|1
158495|NCT00612352|561061|P2|Overall Study|Withdrawal by Subject|5
158496|NCT00612352|561062|P1|Overall Study|Withdrawal by Subject|3
158497|NCT00612352|561061|P2|Overall Study|Adverse Event|0
158498|NCT00612352|561062|P1|Overall Study|Adverse Event|1
158499|NCT00612313|561182|P2|Overall Study|Lost to Follow-up|4
158500|NCT00612313|561183|P1|Overall Study|Lost to Follow-up|11
158501|NCT00612313|561182|P2|Overall Study|Withdrawal by Subject|9
158502|NCT00612313|561183|P1|Overall Study|Withdrawal by Subject|6
158503|NCT00612105|561207|P2|Period Title 3: 3-Week Taper Phase|Other|0
158504|NCT00612105|561208|P1|Period Title 3: 3-Week Taper Phase|Other|1
158505|NCT00612105|561207|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
158506|NCT00612105|561208|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
158507|NCT00612105|561207|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
158508|NCT00612105|561208|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
158509|NCT00612105|561207|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
158510|NCT00612105|561208|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
158511|NCT00612105|561207|P2|Period Title 1: 6-Week Titration Phase|Other|1
158512|NCT00612105|561208|P1|Period Title 1: 6-Week Titration Phase|Other|0
158513|NCT00612105|561207|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
158514|NCT00612105|561208|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
158515|NCT00612105|561207|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
158516|NCT00612105|561208|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
158517|NCT00612105|561207|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
158518|NCT00612105|561208|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
158519|NCT00612105|561207|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
158520|NCT00612105|561208|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
158521|NCT00612105|561207|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
158522|NCT00612105|561208|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
158523|NCT00612105|561207|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
158524|NCT00612105|561208|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
158525|NCT00612105|561207|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
158526|NCT00612105|561208|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
158527|NCT00612066|561258|P1|Overall Study|Adverse Event|1
158528|NCT00612040|561265|P3|Overall Study|Unclassified|5
158529|NCT00612040|561266|P2|Overall Study|Unclassified|2
158530|NCT00612040|561267|P1|Overall Study|Unclassified|2
158531|NCT00612040|561265|P3|Overall Study|Lack of Efficacy|0
158532|NCT00612040|561266|P2|Overall Study|Lack of Efficacy|1
158533|NCT00612040|561267|P1|Overall Study|Lack of Efficacy|2
158534|NCT00612040|561265|P3|Overall Study|Protocol Violation|1
158535|NCT00612040|561266|P2|Overall Study|Protocol Violation|2
158536|NCT00612040|561267|P1|Overall Study|Protocol Violation|1
158537|NCT00612040|561265|P3|Overall Study|Adverse Event|1
158538|NCT00612040|561266|P2|Overall Study|Adverse Event|2
158539|NCT00612040|561267|P1|Overall Study|Adverse Event|0
158540|NCT00611884|561340|P4|Overall Study|Unclassified|3
158541|NCT00611884|561341|P3|Overall Study|Unclassified|2
158542|NCT00611884|561342|P2|Overall Study|Unclassified|4
158543|NCT00611884|561343|P1|Overall Study|Unclassified|7
158544|NCT00611884|561340|P4|Overall Study|Lack of Efficacy|0
158545|NCT00611884|561341|P3|Overall Study|Lack of Efficacy|0
158546|NCT00611884|561342|P2|Overall Study|Lack of Efficacy|1
158547|NCT00611884|561343|P1|Overall Study|Lack of Efficacy|0
158548|NCT00611884|561340|P4|Overall Study|Non-Compliance|2
158549|NCT00611884|561341|P3|Overall Study|Non-Compliance|2
158550|NCT00611884|561342|P2|Overall Study|Non-Compliance|4
158551|NCT00611884|561343|P1|Overall Study|Non-Compliance|1
158552|NCT00611884|561340|P4|Overall Study|Adverse Event|1
158553|NCT00611884|561341|P3|Overall Study|Adverse Event|0
158554|NCT00611884|561342|P2|Overall Study|Adverse Event|0
158555|NCT00611884|561343|P1|Overall Study|Adverse Event|1
158556|NCT00611806|561399|P2|Overall Study|Lost to Follow-up|0
158557|NCT00611806|561400|P1|Overall Study|Lost to Follow-up|6
158558|NCT00611806|561399|P2|Overall Study|Adverse Event|1
158559|NCT00611806|561400|P1|Overall Study|Adverse Event|2
158560|NCT00611806|561399|P2|Overall Study|Withdrawal by Subject|2
158561|NCT00611806|561400|P1|Overall Study|Withdrawal by Subject|8
158562|NCT00611767|561414|P2|Overall Study|Physician Decision|0
158563|NCT00611767|561415|P1|Overall Study|Physician Decision|1
158564|NCT00611767|561414|P2|Overall Study|didn't like the medication|1
158565|NCT00611767|561415|P1|Overall Study|didn't like the medication|1
158566|NCT00611767|561414|P2|Overall Study|Thiopental not available|0
158567|NCT00611767|561415|P1|Overall Study|Thiopental not available|3
158568|NCT00611767|561414|P2|Overall Study|Withdrawal by Subject|1
158569|NCT00611767|561415|P1|Overall Study|Withdrawal by Subject|4
158570|NCT00611715|561577|P2|Overall Study|two patients are still on treatment|0
158571|NCT00611715|561578|P1|Overall Study|two patients are still on treatment|2
158572|NCT00611715|561577|P2|Overall Study|Death|0
158573|NCT00611715|561578|P1|Overall Study|Death|1
158574|NCT00611715|561577|P2|Overall Study|Adverse Event|1
158575|NCT00611715|561578|P1|Overall Study|Adverse Event|9
158576|NCT00611715|561577|P2|Overall Study|Withdrawal by Subject|1
158577|NCT00611715|561578|P1|Overall Study|Withdrawal by Subject|5
158578|NCT00611715|561577|P2|Overall Study|Disease Progression|4
158579|NCT00611715|561578|P1|Overall Study|Disease Progression|24
158580|NCT00611559|561598|P3|Overall Study|Protocol Violation|1
158581|NCT00611559|561599|P2|Overall Study|Protocol Violation|0
158582|NCT00611559|561600|P1|Overall Study|Protocol Violation|1
158583|NCT00611559|561598|P3|Overall Study|Lost to Follow-up|0
158584|NCT00611559|561599|P2|Overall Study|Lost to Follow-up|1
158585|NCT00611559|561600|P1|Overall Study|Lost to Follow-up|0
158586|NCT00611533|561659|P2|Second Intervention (6 Weeks)|Adverse Event|2
158587|NCT00611533|561660|P1|Second Intervention (6 Weeks)|Adverse Event|0
158588|NCT00611533|561659|P2|First Intervention (6 Weeks)|Adverse Event|1
158589|NCT00611533|561660|P1|First Intervention (6 Weeks)|Adverse Event|0
158590|NCT00611533|561659|P2|First Intervention (6 Weeks)|Never started study|1
158591|NCT00611533|561660|P1|First Intervention (6 Weeks)|Never started study|0
158592|NCT00611455|561694|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
158593|NCT00611455|561695|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
158594|NCT00611455|561696|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
158595|NCT00611455|561694|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
158596|NCT00611455|561695|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
158597|NCT00611455|561696|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
158598|NCT00611455|561694|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
158599|NCT00611455|561695|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
158600|NCT00611455|561696|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
158601|NCT00611455|561694|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
158602|NCT00611455|561695|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
158603|NCT00611455|561696|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
158604|NCT00611455|561694|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
158605|NCT00611455|561695|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
158606|NCT00611455|561696|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
158607|NCT00611455|561694|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
158608|NCT00611455|561695|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
158609|NCT00611455|561696|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
158610|NCT00611455|561694|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
158611|NCT00611455|561695|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
158612|NCT00611455|561696|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
158613|NCT00611455|561694|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
158614|NCT00611455|561695|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
158615|NCT00611455|561696|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
158616|NCT00611455|561694|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
158617|NCT00611455|561695|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
158618|NCT00611455|561696|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
158619|NCT00611455|561694|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
158620|NCT00611455|561695|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
158621|NCT00611455|561696|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
158622|NCT00611455|561694|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
158623|NCT00611455|561695|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
158624|NCT00611455|561696|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
158625|NCT00611455|561694|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
158626|NCT00611455|561695|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
158627|NCT00611455|561696|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
158628|NCT00611455|561694|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
158629|NCT00611455|561695|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
158630|NCT00611455|561696|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
158631|NCT00611455|561694|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
158632|NCT00611455|561695|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
158633|NCT00611455|561696|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
158634|NCT00611455|561694|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
158635|NCT00611455|561695|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
158636|NCT00611455|561696|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
158637|NCT00611455|561694|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
158638|NCT00611455|561695|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
158639|NCT00611455|561696|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
158640|NCT00611455|561694|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
158641|NCT00611455|561695|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
158642|NCT00611455|561696|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
158643|NCT00611455|561694|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
158644|NCT00611455|561695|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
158645|NCT00611455|561696|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
158646|NCT00611455|561694|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
158647|NCT00611455|561695|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
158648|NCT00611455|561696|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
158649|NCT00611455|561694|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
158650|NCT00611455|561695|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
158651|NCT00611455|561696|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
158652|NCT00611455|561694|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
158653|NCT00611455|561695|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
158654|NCT00611455|561696|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
158655|NCT00611247|561876|P2|Overall Study|Lack of Efficacy|16
158656|NCT00611247|561877|P1|Overall Study|Lack of Efficacy|1
158657|NCT00611247|561876|P2|Overall Study|Death|5
158658|NCT00611247|561877|P1|Overall Study|Death|1
158659|NCT00611130|561889|P2|Overall Study|Death|0
158660|NCT00611130|561890|P1|Overall Study|Death|1
158661|NCT00611130|561889|P2|Overall Study|Adverse Event|0
158662|NCT00611130|561890|P1|Overall Study|Adverse Event|1
158663|NCT00611130|561889|P2|Overall Study|Administrative|1
158664|NCT00611130|561890|P1|Overall Study|Administrative|1
158665|NCT00611130|561889|P2|Overall Study|Incarceration|2
158666|NCT00611130|561890|P1|Overall Study|Incarceration|3
158667|NCT00611130|561889|P2|Overall Study|Other|4
158668|NCT00611130|561890|P1|Overall Study|Other|5
158669|NCT00611130|561889|P2|Overall Study|Withdrawal by Subject|5
158670|NCT00611130|561890|P1|Overall Study|Withdrawal by Subject|6
158671|NCT00611130|561889|P2|Overall Study|Protocol noncompliance|6
158672|NCT00611130|561890|P1|Overall Study|Protocol noncompliance|7
158673|NCT00611130|561889|P2|Overall Study|Lost to Follow-up|29
158674|NCT00611130|561890|P1|Overall Study|Lost to Follow-up|25
158675|NCT00611026|561900|P3|Double-blind Treatment Period|Other|18
158676|NCT00611026|561901|P2|Double-blind Treatment Period|Other|20
158677|NCT00611026|561902|P1|Double-blind Treatment Period|Other|13
158678|NCT00611026|561900|P3|Double-blind Treatment Period|Withdrawal by Subject|16
158679|NCT00611026|561901|P2|Double-blind Treatment Period|Withdrawal by Subject|19
158680|NCT00611026|561902|P1|Double-blind Treatment Period|Withdrawal by Subject|7
158681|NCT00611026|561900|P3|Double-blind Treatment Period|Lost to Follow-up|14
158682|NCT00611026|561901|P2|Double-blind Treatment Period|Lost to Follow-up|11
158683|NCT00611026|561902|P1|Double-blind Treatment Period|Lost to Follow-up|6
158684|NCT00611026|561900|P3|Double-blind Treatment Period|Lack of Efficacy|4
158685|NCT00611026|561901|P2|Double-blind Treatment Period|Lack of Efficacy|10
158686|NCT00611026|561902|P1|Double-blind Treatment Period|Lack of Efficacy|11
158687|NCT00611026|561900|P3|Double-blind Treatment Period|Adverse Event|46
158688|NCT00611026|561901|P2|Double-blind Treatment Period|Adverse Event|28
158689|NCT00611026|561902|P1|Double-blind Treatment Period|Adverse Event|9
158690|NCT00611026|561900|P3|Double-blind Treatment Period|Death|0
158691|NCT00611026|561901|P2|Double-blind Treatment Period|Death|0
158692|NCT00611026|561902|P1|Double-blind Treatment Period|Death|1
158693|NCT00611026|561900|P3|Randomized to Double-blind Treatment|Not treated|3
158694|NCT00611026|561901|P2|Randomized to Double-blind Treatment|Not treated|1
158695|NCT00611026|561902|P1|Randomized to Double-blind Treatment|Not treated|2
158696|NCT00610857|561979|P1|Overall Study|Not evaluable for response|2
158697|NCT00610714|561994|P2|Overall Study|Study completion at 120 PFS events|2
158698|NCT00610714|561995|P1|Overall Study|Study completion at 120 PFS events|2
158699|NCT00610714|561994|P2|Overall Study|Withdrawal by Subject|3
158700|NCT00610714|561995|P1|Overall Study|Withdrawal by Subject|9
158701|NCT00610714|561994|P2|Overall Study|Death|18
158702|NCT00610714|561995|P1|Overall Study|Death|12
158703|NCT00610714|561994|P2|Overall Study|Adverse Event|1
158704|NCT00610714|561995|P1|Overall Study|Adverse Event|3
158705|NCT00610675|562033|P1|Overall Study|Other reason (not specified)|25
158706|NCT00610675|562033|P1|Overall Study|Lost to Follow-up|31
158707|NCT00610675|562033|P1|Overall Study|Lack of Compliance|7
158708|NCT00610675|562033|P1|Overall Study|Reasons unrelated to trial|27
158709|NCT00610675|562033|P1|Overall Study|Withdrawal by Subject|28
158710|NCT00610675|562033|P1|Overall Study|Insufficient Effect|31
158711|NCT00610675|562033|P1|Overall Study|Adverse Event|67
158712|NCT00610675|562033|P1|Overall Study|Untreated|4
158713|NCT00610649|562055|P11|Overall Study|Withdrawal by Subject|0
158714|NCT00610649|562056|P10|Overall Study|Withdrawal by Subject|1
158715|NCT00610649|562057|P9|Overall Study|Withdrawal by Subject|0
158716|NCT00610649|562058|P8|Overall Study|Withdrawal by Subject|0
158717|NCT00610649|562059|P7|Overall Study|Withdrawal by Subject|0
158718|NCT00610649|562060|P6|Overall Study|Withdrawal by Subject|0
158719|NCT00610649|562061|P5|Overall Study|Withdrawal by Subject|0
158720|NCT00610649|562062|P4|Overall Study|Withdrawal by Subject|0
158721|NCT00610649|562063|P3|Overall Study|Withdrawal by Subject|0
158722|NCT00610649|562064|P2|Overall Study|Withdrawal by Subject|0
158723|NCT00610649|562065|P1|Overall Study|Withdrawal by Subject|0
158724|NCT00610649|562055|P11|Overall Study|Family Emergency|0
158725|NCT00610649|562056|P10|Overall Study|Family Emergency|0
158726|NCT00610649|562057|P9|Overall Study|Family Emergency|0
158727|NCT00610649|562058|P8|Overall Study|Family Emergency|0
158728|NCT00610649|562059|P7|Overall Study|Family Emergency|0
158729|NCT00610649|562060|P6|Overall Study|Family Emergency|0
158730|NCT00610649|562061|P5|Overall Study|Family Emergency|0
158731|NCT00610649|562062|P4|Overall Study|Family Emergency|0
158732|NCT00610649|562063|P3|Overall Study|Family Emergency|0
158733|NCT00610649|562064|P2|Overall Study|Family Emergency|1
158734|NCT00610649|562065|P1|Overall Study|Family Emergency|0
158735|NCT00610649|562055|P11|Overall Study|Adverse Event|1
158736|NCT00610649|562056|P10|Overall Study|Adverse Event|0
158737|NCT00610649|562057|P9|Overall Study|Adverse Event|0
158738|NCT00610649|562058|P8|Overall Study|Adverse Event|0
158739|NCT00610649|562059|P7|Overall Study|Adverse Event|0
158740|NCT00610649|562060|P6|Overall Study|Adverse Event|0
158741|NCT00610649|562061|P5|Overall Study|Adverse Event|0
158742|NCT00610649|562062|P4|Overall Study|Adverse Event|0
158743|NCT00610649|562063|P3|Overall Study|Adverse Event|0
158744|NCT00610649|562064|P2|Overall Study|Adverse Event|0
158745|NCT00610649|562065|P1|Overall Study|Adverse Event|1
158746|NCT00610441|562129|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
158747|NCT00610441|562130|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
158748|NCT00610441|562131|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
158749|NCT00610441|562132|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
158750|NCT00610441|562129|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
158751|NCT00610441|562130|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
158752|NCT00610441|562131|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
158753|NCT00610441|562132|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
158754|NCT00610441|562129|P4|Treatment Period 2 - 3 Weeks|Other|1
158755|NCT00610441|562130|P3|Treatment Period 2 - 3 Weeks|Other|0
158756|NCT00610441|562131|P2|Treatment Period 2 - 3 Weeks|Other|1
158757|NCT00610441|562132|P1|Treatment Period 2 - 3 Weeks|Other|1
158758|NCT00610441|562129|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
158759|NCT00610441|562130|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
158760|NCT00610441|562131|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
158761|NCT00610441|562132|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
158762|NCT00610441|562129|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
158763|NCT00610441|562130|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
158764|NCT00610441|562131|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
158765|NCT00610441|562132|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
158766|NCT00610441|562129|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
158767|NCT00610441|562130|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
158768|NCT00610441|562131|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
158769|NCT00610441|562132|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
158770|NCT00610441|562129|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
158771|NCT00610441|562130|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
158772|NCT00610441|562131|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
158773|NCT00610441|562132|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
158774|NCT00610441|562129|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
158775|NCT00610441|562130|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
158776|NCT00610441|562131|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
158777|NCT00610441|562132|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
158778|NCT00610441|562129|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
158779|NCT00610441|562130|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
158780|NCT00610441|562131|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
158781|NCT00610441|562132|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
158782|NCT00610363|562241|P2|Overall Study|Other than specified above|1
158783|NCT00610363|562242|P1|Overall Study|Other than specified above|1
158784|NCT00610363|562241|P2|Overall Study|Withdrawal by Subject|0
158785|NCT00610363|562242|P1|Overall Study|Withdrawal by Subject|1
158786|NCT00610363|562241|P2|Overall Study|Lost to Follow-up|0
158787|NCT00610363|562242|P1|Overall Study|Lost to Follow-up|4
158788|NCT00610363|562241|P2|Overall Study|Lack of Efficacy|0
158789|NCT00610363|562242|P1|Overall Study|Lack of Efficacy|2
158790|NCT00610363|562241|P2|Overall Study|Adverse Event|1
158791|NCT00610363|562242|P1|Overall Study|Adverse Event|3
158792|NCT00610363|562241|P2|Overall Study|Non-compliance with protocol|1
158793|NCT00610363|562242|P1|Overall Study|Non-compliance with protocol|0
158794|NCT00610207|562267|P1|Overall Study|Lost to Follow-up|3
158795|NCT00610168|562274|P2|Overall Study|Withdrawal by Subject|0
158796|NCT00610168|562275|P1|Overall Study|Withdrawal by Subject|2
158797|NCT00610155|562294|P6|Period 3|Adverse Event|0
158798|NCT00610155|562295|P5|Period 3|Adverse Event|0
158799|NCT00610155|562296|P4|Period 3|Adverse Event|0
158800|NCT00610155|562297|P3|Period 3|Adverse Event|0
158801|NCT00610155|562298|P2|Period 3|Adverse Event|0
158802|NCT00610155|562299|P1|Period 3|Adverse Event|1
158803|NCT00610155|562294|P6|Period 1|Withdrawal by Subject|0
158804|NCT00610155|562295|P5|Period 1|Withdrawal by Subject|0
158805|NCT00610155|562296|P4|Period 1|Withdrawal by Subject|0
158806|NCT00610155|562297|P3|Period 1|Withdrawal by Subject|1
158807|NCT00610155|562298|P2|Period 1|Withdrawal by Subject|0
158808|NCT00610155|562299|P1|Period 1|Withdrawal by Subject|0
158809|NCT00610129|562346|P1|Overall Study|Not treated since patients ineligible|3
158810|NCT00609986|562352|P2|Overall Study|Did not receive transplant or treatment|3
158811|NCT00609986|562353|P1|Overall Study|Did not receive transplant or treatment|8
158812|NCT00609973|562367|P2|Overall Study|Withdrawal by Subject|1
158813|NCT00609973|562368|P1|Overall Study|Withdrawal by Subject|0
158814|NCT00609973|562367|P2|Overall Study|Lost to Follow-up|1
158815|NCT00609973|562368|P1|Overall Study|Lost to Follow-up|2
158816|NCT00609973|562367|P2|Overall Study|Protocol Violation|3
158817|NCT00609973|562368|P1|Overall Study|Protocol Violation|4
158818|NCT00609973|562367|P2|Overall Study|Adverse Event|1
158819|NCT00609973|562368|P1|Overall Study|Adverse Event|2
158820|NCT00609947|562376|P1|Overall Study|Death|1
158821|NCT00609869|562381|P1|Overall Study|Mantle cell: not evaluable|4
158822|NCT00609869|562381|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
158823|NCT00609869|562381|P1|Overall Study|Hepatitis B infection|1
158824|NCT00609869|562381|P1|Overall Study|Severe tumor flare reaction|1
158825|NCT00609869|562381|P1|Overall Study|Seizures|1
158826|NCT00609869|562381|P1|Overall Study|Withdrawal by Subject|1
158827|NCT00609869|562381|P1|Overall Study|Severe hematologic toxicity|1
158828|NCT00609869|562381|P1|Overall Study|Withdrawn, ischemic stroke|1
158829|NCT00609765|562400|P1|Overall Study|Study ended prior to 12 months|1
158830|NCT00609674|562414|P2|Overall Study|Withdrew consent|1
158831|NCT00609674|562415|P1|Overall Study|Withdrew consent|2
158832|NCT00609674|562414|P2|Overall Study|Lost to Follow-up|0
158833|NCT00609674|562415|P1|Overall Study|Lost to Follow-up|1
158834|NCT00609674|562414|P2|Overall Study|Protocol Violation|5
158835|NCT00609674|562415|P1|Overall Study|Protocol Violation|3
158836|NCT00609674|562414|P2|Overall Study|Adverse Event|1
158837|NCT00609674|562415|P1|Overall Study|Adverse Event|1
158838|NCT00609622|562451|P2|Overall Study|Global deterioration of health status|2
158839|NCT00609622|562452|P1|Overall Study|Global deterioration of health status|6
158840|NCT00609622|562451|P2|Overall Study|Other|14
158841|NCT00609622|562452|P1|Overall Study|Other|7
158842|NCT00609622|562451|P2|Overall Study|Study terminated by sponsor|3
158843|NCT00609622|562452|P1|Overall Study|Study terminated by sponsor|16
158844|NCT00609622|562451|P2|Overall Study|Objective progression or relapse|41
158845|NCT00609622|562452|P1|Overall Study|Objective progression or relapse|47
158846|NCT00609622|562451|P2|Overall Study|Protocol Violation|1
158847|NCT00609622|562452|P1|Overall Study|Protocol Violation|1
158848|NCT00609622|562451|P2|Overall Study|Death|4
158849|NCT00609622|562452|P1|Overall Study|Death|1
158850|NCT00609622|562451|P2|Overall Study|Withdrawal by Subject|20
158851|NCT00609622|562452|P1|Overall Study|Withdrawal by Subject|4
158852|NCT00609622|562451|P2|Overall Study|Adverse Event|10
158853|NCT00609622|562452|P1|Overall Study|Adverse Event|14
158854|NCT00609518|562474|P2|Overall Study|Death from Adverse Event|2
158855|NCT00609518|562475|P1|Overall Study|Death from Adverse Event|2
158856|NCT00609518|562474|P2|Overall Study|Physician Decision|3
158857|NCT00609518|562475|P1|Overall Study|Physician Decision|1
158858|NCT00609518|562474|P2|Overall Study|Lost to Follow-up|0
158859|NCT00609518|562475|P1|Overall Study|Lost to Follow-up|3
158860|NCT00609518|562474|P2|Overall Study|Withdrawal by Subject|3
158861|NCT00609518|562475|P1|Overall Study|Withdrawal by Subject|5
158862|NCT00609518|562474|P2|Overall Study|Death from Study Disease|32
158863|NCT00609518|562475|P1|Overall Study|Death from Study Disease|32
158864|NCT00609492|562490|P3|Overall Study|Lost to Follow-up|4
158865|NCT00609492|562491|P2|Overall Study|Lost to Follow-up|1
158866|NCT00609492|562492|P1|Overall Study|Lost to Follow-up|1
158867|NCT00609492|562490|P3|Overall Study|Withdrawal by Subject|3
158868|NCT00609492|562491|P2|Overall Study|Withdrawal by Subject|2
158869|NCT00609492|562492|P1|Overall Study|Withdrawal by Subject|0
158870|NCT00609466|562577|P3|Overall Study|Lack of Efficacy|2
158871|NCT00609466|562578|P2|Overall Study|Lack of Efficacy|2
158872|NCT00609466|562579|P1|Overall Study|Lack of Efficacy|0
158873|NCT00609466|562577|P3|Overall Study|Adverse Event|1
158874|NCT00609466|562578|P2|Overall Study|Adverse Event|3
158875|NCT00609466|562579|P1|Overall Study|Adverse Event|2
158876|NCT00609466|562577|P3|Overall Study|Withdrawal by Subject|1
158877|NCT00609466|562578|P2|Overall Study|Withdrawal by Subject|1
158878|NCT00609466|562579|P1|Overall Study|Withdrawal by Subject|0
158879|NCT00609362|562607|P2|Overall Study|Adverse Event|0
158880|NCT00609362|562608|P1|Overall Study|Adverse Event|1
158881|NCT00609362|562607|P2|Overall Study|Withdrawal by Subject|1
158882|NCT00609362|562608|P1|Overall Study|Withdrawal by Subject|2
158883|NCT00609336|562618|P1|Overall Study|LA or Met at Surgery|9
158884|NCT00609336|562618|P1|Overall Study|Death|1
158885|NCT00609336|562618|P1|Overall Study|Protocol Violation|3
158886|NCT00609245|562630|P1|Overall Study|Adverse Event|1
158887|NCT00609167|562638|P2|Overall Study|Stem Cell Transplant|6
158888|NCT00609167|562639|P1|Overall Study|Stem Cell Transplant|0
158889|NCT00609167|562638|P2|Overall Study|Disease Progression|0
158890|NCT00609167|562639|P1|Overall Study|Disease Progression|1
158891|NCT00609167|562638|P2|Overall Study|Adverse Event|1
158892|NCT00609167|562639|P1|Overall Study|Adverse Event|5
158893|NCT00609167|562638|P2|Overall Study|Lack of Efficacy|0
158894|NCT00609167|562639|P1|Overall Study|Lack of Efficacy|1
158895|NCT00609167|562638|P2|Overall Study|Withdrawal by Subject|0
158896|NCT00609167|562639|P1|Overall Study|Withdrawal by Subject|1
158897|NCT00608985|562665|P4|Overall Study|Lost to Follow-up|0
158898|NCT00608985|562666|P3|Overall Study|Lost to Follow-up|0
158899|NCT00608985|562667|P2|Overall Study|Lost to Follow-up|1
158900|NCT00608985|562668|P1|Overall Study|Lost to Follow-up|2
158901|NCT00608985|562665|P4|Overall Study|Withdrawal of Consent|1
158902|NCT00608985|562666|P3|Overall Study|Withdrawal of Consent|1
158903|NCT00608985|562667|P2|Overall Study|Withdrawal of Consent|1
158904|NCT00608985|562668|P1|Overall Study|Withdrawal of Consent|5
158905|NCT00608985|562665|P4|Overall Study|Administrative/Other|2
158906|NCT00608985|562666|P3|Overall Study|Administrative/Other|1
158907|NCT00608985|562667|P2|Overall Study|Administrative/Other|4
158908|NCT00608985|562668|P1|Overall Study|Administrative/Other|7
158909|NCT00608985|562665|P4|Overall Study|Adverse Event|6
158910|NCT00608985|562666|P3|Overall Study|Adverse Event|4
158911|NCT00608985|562667|P2|Overall Study|Adverse Event|7
158912|NCT00608985|562668|P1|Overall Study|Adverse Event|2
158913|NCT00608959|562700|P1|Part 1|Did not meet eligibility criteria|1
158914|NCT00608907|562713|P3|Overall Study|Progressive Disease|0
158915|NCT00608907|562714|P2|Overall Study|Progressive Disease|0
158916|NCT00608907|562715|P1|Overall Study|Progressive Disease|1
158917|NCT00608907|562713|P3|Overall Study|Withdrawal by Subject|0
158918|NCT00608907|562714|P2|Overall Study|Withdrawal by Subject|0
158919|NCT00608907|562715|P1|Overall Study|Withdrawal by Subject|4
158920|NCT00608907|562713|P3|Overall Study|Death|0
158921|NCT00608907|562714|P2|Overall Study|Death|0
158922|NCT00608907|562715|P1|Overall Study|Death|1
158923|NCT00608907|562713|P3|Overall Study|Adverse Event|1
158924|NCT00608907|562714|P2|Overall Study|Adverse Event|0
158925|NCT00608907|562715|P1|Overall Study|Adverse Event|6
158926|NCT00608881|562725|P2|Overall Study|Institutionalized|2
158927|NCT00608881|562726|P1|Overall Study|Institutionalized|1
158928|NCT00608881|562725|P2|Overall Study|Physician Decision|5
158929|NCT00608881|562726|P1|Overall Study|Physician Decision|5
158930|NCT00608881|562725|P2|Overall Study|Withdrawal by Subject|29
158931|NCT00608881|562726|P1|Overall Study|Withdrawal by Subject|18
158932|NCT00608881|562725|P2|Overall Study|Lost to Follow-up|14
158933|NCT00608881|562726|P1|Overall Study|Lost to Follow-up|28
158934|NCT00608881|562725|P2|Overall Study|Adverse Event|3
158935|NCT00608881|562726|P1|Overall Study|Adverse Event|5
158936|NCT00608881|562725|P2|Overall Study|Death|13
158937|NCT00608881|562726|P1|Overall Study|Death|22
158938|NCT00608868|562760|P1|Overall Study|Physician Decision|2
158939|NCT00608868|562760|P1|Overall Study|Adverse Event|1
158940|NCT00608868|562760|P1|Overall Study|Lost to Follow-up|2
158941|NCT00608868|562760|P1|Overall Study|Protocol Violation|3
158942|NCT00608868|562760|P1|Overall Study|Withdrawal by Subject|7
158943|NCT00608842|562771|P4|Overall Study|Lost to Follow-up|0
158944|NCT00608842|562772|P3|Overall Study|Lost to Follow-up|0
158945|NCT00608842|562773|P2|Overall Study|Lost to Follow-up|0
158946|NCT00608842|562774|P1|Overall Study|Lost to Follow-up|1
158947|NCT00608842|562771|P4|Overall Study|Participant's Request|1
158948|NCT00608842|562772|P3|Overall Study|Participant's Request|2
158949|NCT00608842|562773|P2|Overall Study|Participant's Request|1
158950|NCT00608842|562774|P1|Overall Study|Participant's Request|0
158951|NCT00608829|562808|P1|Overall Study|Subject refuses to follow up or return.|5
158952|NCT00608829|562808|P1|Overall Study|Withdrawal by Subject|4
158953|NCT00608829|562808|P1|Overall Study|Death|6
158954|NCT00608582|562834|P2|Overall Study|Early stage Design Change|3
158955|NCT00608582|562835|P1|Overall Study|Early stage Design Change|0
158956|NCT00608582|562834|P2|Overall Study|Illicit Drug Use|0
158957|NCT00608582|562835|P1|Overall Study|Illicit Drug Use|1
158958|NCT00608582|562834|P2|Overall Study|No Best Response in Phase 1 located|1
158959|NCT00608582|562835|P1|Overall Study|No Best Response in Phase 1 located|1
158960|NCT00608582|562834|P2|Overall Study|Lost to Follow-up|0
158961|NCT00608582|562835|P1|Overall Study|Lost to Follow-up|2
158962|NCT00608569|562845|P2|Overall Study|Unable to adhere with study requirements|1
158963|NCT00608569|562846|P1|Overall Study|Unable to adhere with study requirements|0
158964|NCT00608569|562845|P2|Overall Study|Adverse Event|0
158965|NCT00608569|562846|P1|Overall Study|Adverse Event|1
158966|NCT00608569|562845|P2|Overall Study|Withdrawal by Subject|0
158967|NCT00608569|562846|P1|Overall Study|Withdrawal by Subject|1
158968|NCT00608569|562845|P2|Overall Study|Lost to Follow-up|5
158969|NCT00608569|562846|P1|Overall Study|Lost to Follow-up|4
158970|NCT00608569|562845|P2|Overall Study|Death|3
158971|NCT00608569|562846|P1|Overall Study|Death|4
158972|NCT00608543|562866|P1|Overall Study|Adverse Event|4
158973|NCT00608530|562879|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
158974|NCT00608530|562880|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
158975|NCT00608530|562881|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
158976|NCT00608530|562882|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
158977|NCT00608530|562879|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
158978|NCT00608530|562880|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
158979|NCT00608530|562881|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
158980|NCT00608530|562882|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
158981|NCT00608530|562879|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
158982|NCT00608530|562880|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
158983|NCT00608530|562881|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
158984|NCT00608530|562882|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
158985|NCT00608530|562879|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
158986|NCT00608530|562880|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
158987|NCT00608530|562881|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
158988|NCT00608530|562882|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
158989|NCT00608530|562879|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
158990|NCT00608530|562880|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
158991|NCT00608530|562881|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
158992|NCT00608530|562882|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
158993|NCT00608530|562879|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
158994|NCT00608530|562880|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
158995|NCT00608530|562881|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
158996|NCT00608530|562882|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
158997|NCT00608517|562903|P3|Overall Study|Death|0
158998|NCT00608517|562904|P2|Overall Study|Death|0
158999|NCT00608517|562905|P1|Overall Study|Death|1
159000|NCT00608426|563085|P2|Overall Study|refused, health issues, wrong address|348
159001|NCT00608426|563086|P1|Overall Study|refused, health issues, wrong address|319
159002|NCT00608426|563085|P2|Overall Study|Lost to Follow-up|521
159003|NCT00608426|563086|P1|Overall Study|Lost to Follow-up|485
159004|NCT00608426|563085|P2|Overall Study|Death|36
159005|NCT00608426|563086|P1|Overall Study|Death|32
159006|NCT00608322|563098|P2|Overall Study|Death|1
159007|NCT00608322|563099|P1|Overall Study|Death|2
159008|NCT00608244|563105|P1|Overall Study|Low trough levels|1
159009|NCT00608244|563105|P1|Overall Study|Adverse Event|1
159010|NCT00608205|563116|P2|Overall Study|Patient non-compliant|1
159011|NCT00608205|563117|P1|Overall Study|Patient non-compliant|0
159012|NCT00608205|563116|P2|Overall Study|Adverse Event|2
159013|NCT00608205|563117|P1|Overall Study|Adverse Event|3
159014|NCT00608023|563234|P3|Overall Study|Unknown reason|0
159015|NCT00608023|563235|P2|Overall Study|Unknown reason|3
159016|NCT00608023|563236|P1|Overall Study|Unknown reason|0
159017|NCT00608023|563234|P3|Overall Study|Protocol Violation|1
159018|NCT00608023|563235|P2|Overall Study|Protocol Violation|3
159019|NCT00608023|563236|P1|Overall Study|Protocol Violation|1
159020|NCT00608023|563234|P3|Overall Study|Lost to Follow-up|1
159021|NCT00608023|563235|P2|Overall Study|Lost to Follow-up|2
159022|NCT00608023|563236|P1|Overall Study|Lost to Follow-up|2
159023|NCT00608023|563234|P3|Overall Study|Adverse Event|5
159024|NCT00608023|563235|P2|Overall Study|Adverse Event|4
159025|NCT00608023|563236|P1|Overall Study|Adverse Event|1
159026|NCT00608023|563234|P3|Overall Study|Withdrawal by Subject|7
159027|NCT00608023|563235|P2|Overall Study|Withdrawal by Subject|10
159028|NCT00608023|563236|P1|Overall Study|Withdrawal by Subject|8
159029|NCT00607997|563260|P4|Overall Study|Other without explanation|1
159030|NCT00607997|563261|P3|Overall Study|Other without explanation|4
159031|NCT00607997|563262|P2|Overall Study|Other without explanation|0
159032|NCT00607997|563263|P1|Overall Study|Other without explanation|2
159033|NCT00607997|563260|P4|Overall Study|Relapse, recurrent illness|0
159034|NCT00607997|563261|P3|Overall Study|Relapse, recurrent illness|2
159035|NCT00607997|563262|P2|Overall Study|Relapse, recurrent illness|0
159036|NCT00607997|563263|P1|Overall Study|Relapse, recurrent illness|4
159037|NCT00607997|563260|P4|Overall Study|Physician Decision|0
159038|NCT00607997|563261|P3|Overall Study|Physician Decision|0
159039|NCT00607997|563262|P2|Overall Study|Physician Decision|1
159040|NCT00607997|563263|P1|Overall Study|Physician Decision|4
159041|NCT00607997|563260|P4|Overall Study|Adverse Event|0
159042|NCT00607997|563261|P3|Overall Study|Adverse Event|2
159043|NCT00607997|563262|P2|Overall Study|Adverse Event|1
159044|NCT00607997|563263|P1|Overall Study|Adverse Event|3
159045|NCT00607997|563260|P4|Overall Study|Death|5
159046|NCT00607997|563261|P3|Overall Study|Death|2
159047|NCT00607997|563262|P2|Overall Study|Death|5
159048|NCT00607997|563263|P1|Overall Study|Death|8
159049|NCT00607997|563260|P4|Overall Study|Lack of Efficacy|10
159050|NCT00607997|563261|P3|Overall Study|Lack of Efficacy|14
159051|NCT00607997|563262|P2|Overall Study|Lack of Efficacy|20
159052|NCT00607997|563263|P1|Overall Study|Lack of Efficacy|6
159053|NCT00607919|563321|P2|Open-Label Phase|Parent/Caregiver Decision|2
159054|NCT00607919|563322|P1|Open-Label Phase|Parent/Caregiver Decision|1
159055|NCT00607919|563321|P2|Open-Label Phase|Withdrawal by Subject|2
159056|NCT00607919|563322|P1|Open-Label Phase|Withdrawal by Subject|2
159057|NCT00607919|563321|P2|Open-Label Phase|Protocol Violation|2
159058|NCT00607919|563322|P1|Open-Label Phase|Protocol Violation|2
159059|NCT00607919|563321|P2|Open-Label Phase|Lost to Follow-up|1
159060|NCT00607919|563322|P1|Open-Label Phase|Lost to Follow-up|4
159061|NCT00607919|563321|P2|Open-Label Phase|Adverse Event|5
159062|NCT00607919|563322|P1|Open-Label Phase|Adverse Event|1
159063|NCT00607919|563321|P2|Acute Phase|Withdrawal by Subject|3
159064|NCT00607919|563322|P1|Acute Phase|Withdrawal by Subject|3
159065|NCT00607919|563321|P2|Acute Phase|Protocol Violation|1
159066|NCT00607919|563322|P1|Acute Phase|Protocol Violation|5
159067|NCT00607919|563321|P2|Acute Phase|Parent/Caregiver Decision|4
159068|NCT00607919|563322|P1|Acute Phase|Parent/Caregiver Decision|6
159069|NCT00607919|563321|P2|Acute Phase|Lost to Follow-up|3
159070|NCT00607919|563322|P1|Acute Phase|Lost to Follow-up|9
159071|NCT00607919|563321|P2|Acute Phase|Lack of Efficacy|2
159072|NCT00607919|563322|P1|Acute Phase|Lack of Efficacy|1
159073|NCT00607919|563321|P2|Acute Phase|Entry Criteria Not Met|1
159074|NCT00607919|563322|P1|Acute Phase|Entry Criteria Not Met|1
159075|NCT00607919|563321|P2|Acute Phase|Adverse Event|2
159076|NCT00607919|563322|P1|Acute Phase|Adverse Event|9
159077|NCT00607893|563380|P2|Overall Study|Withdrew due to hypertensive urgency|1
159078|NCT00607893|563381|P1|Overall Study|Withdrew due to hypertensive urgency|1
159079|NCT00607893|563380|P2|Overall Study|Declined to be treated|0
159080|NCT00607893|563381|P1|Overall Study|Declined to be treated|1
159081|NCT00607893|563380|P2|Overall Study|withdrew could not tolerate CPAP|1
159082|NCT00607893|563381|P1|Overall Study|withdrew could not tolerate CPAP|0
159083|NCT00607893|563380|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
159084|NCT00607893|563381|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
159085|NCT00607893|563380|P2|Overall Study|withdrew due to loss of interest|1
159086|NCT00607893|563381|P1|Overall Study|withdrew due to loss of interest|0
159087|NCT00607893|563380|P2|Overall Study|Lost to Follow-up|0
159088|NCT00607893|563381|P1|Overall Study|Lost to Follow-up|4
159089|NCT00607880|563409|P2|Overall Study|Unable to place port due to occlusion|0
159090|NCT00607880|563410|P1|Overall Study|Unable to place port due to occlusion|1
159091|NCT00607789|563460|P2|Overall Study|Withdrawal by Subject|0
159092|NCT00607789|563461|P1|Overall Study|Withdrawal by Subject|1
159093|NCT00607789|563460|P2|Overall Study|Lost to Follow-up|5
159094|NCT00607789|563461|P1|Overall Study|Lost to Follow-up|0
159095|NCT00607789|563460|P2|Overall Study|Inadequate adherence|0
159096|NCT00607789|563461|P1|Overall Study|Inadequate adherence|3
159097|NCT00607789|563460|P2|Overall Study|Lack of Efficacy|1
159098|NCT00607789|563461|P1|Overall Study|Lack of Efficacy|0
159099|NCT00607789|563460|P2|Overall Study|Adverse Event|0
159100|NCT00607789|563461|P1|Overall Study|Adverse Event|3
159101|NCT00607724|563476|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
159102|NCT00607724|563477|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
159103|NCT00607724|563478|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
159104|NCT00607724|563479|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
159105|NCT00607724|563480|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
159106|NCT00607724|563481|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
159107|NCT00607724|563482|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
159108|NCT00607724|563476|P7|Stage 2: Expanded Cohort|Physician Decision|0
159109|NCT00607724|563477|P6|Stage 2: Expanded Cohort|Physician Decision|1
159110|NCT00607724|563478|P5|Stage 2: Expanded Cohort|Physician Decision|1
159111|NCT00607724|563479|P4|Stage 2: Expanded Cohort|Physician Decision|0
159112|NCT00607724|563480|P3|Stage 2: Expanded Cohort|Physician Decision|0
159113|NCT00607724|563481|P2|Stage 2: Expanded Cohort|Physician Decision|0
159114|NCT00607724|563482|P1|Stage 2: Expanded Cohort|Physician Decision|0
159115|NCT00607724|563476|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
159116|NCT00607724|563477|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
159117|NCT00607724|563478|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
159118|NCT00607724|563479|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
159119|NCT00607724|563480|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
159120|NCT00607724|563481|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
159121|NCT00607724|563482|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
159122|NCT00607724|563476|P7|Stage 2: Expanded Cohort|Adverse Event|1
159123|NCT00607724|563477|P6|Stage 2: Expanded Cohort|Adverse Event|0
159124|NCT00607724|563478|P5|Stage 2: Expanded Cohort|Adverse Event|0
159125|NCT00607724|563479|P4|Stage 2: Expanded Cohort|Adverse Event|0
159126|NCT00607724|563480|P3|Stage 2: Expanded Cohort|Adverse Event|0
159127|NCT00607724|563481|P2|Stage 2: Expanded Cohort|Adverse Event|0
159128|NCT00607724|563482|P1|Stage 2: Expanded Cohort|Adverse Event|0
159129|NCT00607724|563476|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
159130|NCT00607724|563477|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
159131|NCT00607724|563478|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
159132|NCT00607724|563479|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
159133|NCT00607724|563480|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
159134|NCT00607724|563481|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
159135|NCT00607724|563482|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
159136|NCT00607386|563640|P1|Overall Study|Physician Decision|1
159137|NCT00607373|563655|P2|Follow-up Period|Withdrawal by Subject|3
159138|NCT00607373|563656|P1|Follow-up Period|Withdrawal by Subject|1
159139|NCT00607373|563655|P2|Follow-up Period|Protocol Violation|1
159140|NCT00607373|563656|P1|Follow-up Period|Protocol Violation|0
159141|NCT00607373|563655|P2|Follow-up Period|Not specified|1
159142|NCT00607373|563656|P1|Follow-up Period|Not specified|0
159143|NCT00607373|563655|P2|Treatment Period|Withdrawal by Subject|1
159144|NCT00607373|563656|P1|Treatment Period|Withdrawal by Subject|0
159145|NCT00607373|563655|P2|Treatment Period|Physician Decision|1
159146|NCT00607373|563656|P1|Treatment Period|Physician Decision|0
159147|NCT00607373|563655|P2|Treatment Period|Adverse Event|4
159148|NCT00607373|563656|P1|Treatment Period|Adverse Event|0
159149|NCT00607087|563758|P3|Period 3|Adverse Event|0
159150|NCT00607087|563759|P2|Period 3|Adverse Event|1
159151|NCT00607087|563760|P1|Period 3|Adverse Event|0
159152|NCT00607087|563758|P3|Period 3|Withdrawal by Subject|0
159153|NCT00607087|563759|P2|Period 3|Withdrawal by Subject|1
159154|NCT00607087|563760|P1|Period 3|Withdrawal by Subject|2
159155|NCT00607087|563758|P3|Period 2|Poor compliance to protocol|1
159156|NCT00607087|563759|P2|Period 2|Poor compliance to protocol|0
159157|NCT00607087|563760|P1|Period 2|Poor compliance to protocol|0
159158|NCT00607087|563758|P3|Period 2|Adverse Event|3
159159|NCT00607087|563759|P2|Period 2|Adverse Event|1
159160|NCT00607087|563760|P1|Period 2|Adverse Event|0
159161|NCT00607087|563758|P3|Period 2|Other reason|0
159162|NCT00607087|563759|P2|Period 2|Other reason|1
159163|NCT00607087|563760|P1|Period 2|Other reason|1
159164|NCT00607087|563758|P3|Period 2|Withdrawal by Subject|1
159165|NCT00607087|563759|P2|Period 2|Withdrawal by Subject|1
159166|NCT00607087|563760|P1|Period 2|Withdrawal by Subject|0
159167|NCT00607087|563758|P3|Period 1|Other reason|2
159168|NCT00607087|563759|P2|Period 1|Other reason|4
159169|NCT00607087|563760|P1|Period 1|Other reason|0
159170|NCT00607087|563758|P3|Period 1|Lost to Follow-up|0
159171|NCT00607087|563759|P2|Period 1|Lost to Follow-up|0
159172|NCT00607087|563760|P1|Period 1|Lost to Follow-up|1
159173|NCT00607087|563758|P3|Period 1|Poor compliance to protocol|0
159174|NCT00607087|563759|P2|Period 1|Poor compliance to protocol|0
159175|NCT00607087|563760|P1|Period 1|Poor compliance to protocol|1
159176|NCT00607087|563758|P3|Period 1|Adverse Event|0
159177|NCT00607087|563759|P2|Period 1|Adverse Event|0
159178|NCT00607087|563760|P1|Period 1|Adverse Event|3
159179|NCT00607087|563758|P3|Period 1|Withdrawal by Subject|3
159180|NCT00607087|563759|P2|Period 1|Withdrawal by Subject|2
159181|NCT00607087|563760|P1|Period 1|Withdrawal by Subject|7
159182|NCT00607087|563758|P3|Overall Study|Lost to Follow-up|0
159183|NCT00607087|563759|P2|Overall Study|Lost to Follow-up|0
159184|NCT00607087|563760|P1|Overall Study|Lost to Follow-up|1
159185|NCT00607087|563758|P3|Overall Study|Poor compliance to protocol|1
159186|NCT00607087|563759|P2|Overall Study|Poor compliance to protocol|0
159187|NCT00607087|563760|P1|Overall Study|Poor compliance to protocol|1
159188|NCT00607087|563758|P3|Overall Study|Other reason|2
159189|NCT00607087|563759|P2|Overall Study|Other reason|5
159190|NCT00607087|563760|P1|Overall Study|Other reason|1
159191|NCT00607087|563758|P3|Overall Study|Adverse Event|3
159192|NCT00607087|563759|P2|Overall Study|Adverse Event|2
159193|NCT00607087|563760|P1|Overall Study|Adverse Event|3
159194|NCT00607087|563758|P3|Overall Study|Withdrawal by Subject|4
159195|NCT00607087|563759|P2|Overall Study|Withdrawal by Subject|4
159196|NCT00607087|563760|P1|Overall Study|Withdrawal by Subject|9
159197|NCT00607048|563818|P6|Overall Study|Other|1
159198|NCT00607048|563819|P5|Overall Study|Other|0
159199|NCT00607048|563820|P4|Overall Study|Other|0
159200|NCT00607048|563821|P3|Overall Study|Other|0
159201|NCT00607048|563822|P2|Overall Study|Other|1
159202|NCT00607048|563823|P1|Overall Study|Other|1
159203|NCT00607048|563818|P6|Overall Study|Withdrawal by Subject|2
159204|NCT00607048|563819|P5|Overall Study|Withdrawal by Subject|0
159205|NCT00607048|563820|P4|Overall Study|Withdrawal by Subject|1
159206|NCT00607048|563821|P3|Overall Study|Withdrawal by Subject|0
159207|NCT00607048|563822|P2|Overall Study|Withdrawal by Subject|0
159208|NCT00607048|563823|P1|Overall Study|Withdrawal by Subject|0
159209|NCT00607048|563818|P6|Overall Study|Objective disease progression - relapse|2
159210|NCT00607048|563819|P5|Overall Study|Objective disease progression - relapse|2
159211|NCT00607048|563820|P4|Overall Study|Objective disease progression - relapse|2
159212|NCT00607048|563821|P3|Overall Study|Objective disease progression - relapse|4
159213|NCT00607048|563822|P2|Overall Study|Objective disease progression - relapse|2
159214|NCT00607048|563823|P1|Overall Study|Objective disease progression - relapse|1
159215|NCT00607048|563818|P6|Overall Study|Global deterioration of health|0
159216|NCT00607048|563819|P5|Overall Study|Global deterioration of health|0
159217|NCT00607048|563820|P4|Overall Study|Global deterioration of health|0
159218|NCT00607048|563821|P3|Overall Study|Global deterioration of health|0
159219|NCT00607048|563822|P2|Overall Study|Global deterioration of health|0
159220|NCT00607048|563823|P1|Overall Study|Global deterioration of health|1
159221|NCT00607048|563818|P6|Overall Study|Adverse Event|0
159222|NCT00607048|563819|P5|Overall Study|Adverse Event|4
159223|NCT00607048|563820|P4|Overall Study|Adverse Event|0
159224|NCT00607048|563821|P3|Overall Study|Adverse Event|0
159225|NCT00607048|563822|P2|Overall Study|Adverse Event|1
159226|NCT00607048|563823|P1|Overall Study|Adverse Event|0
159227|NCT00606931|563914|P1|Overall Study|Withdrawal by Subject|3
159228|NCT00606905|563922|P2|Overall Study|Withdrew|5
159229|NCT00606905|563923|P1|Overall Study|Withdrew|5
159230|NCT00606905|563922|P2|Overall Study|Non-Index Pregnancy|4
159231|NCT00606905|563923|P1|Overall Study|Non-Index Pregnancy|1
159232|NCT00606905|563922|P2|Overall Study|No Pregnancy|6
159233|NCT00606905|563923|P1|Overall Study|No Pregnancy|9
159234|NCT00606892|563929|P2|First Intervention|Protocol Violation|4
159235|NCT00606892|563930|P1|First Intervention|Protocol Violation|1
159236|NCT00606801|563964|P2|Intervention|Protocol Violation|3
159237|NCT00606801|563965|P1|Intervention|Protocol Violation|3
159238|NCT00606684|563993|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
159239|NCT00606684|563994|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
159240|NCT00606684|563995|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
159241|NCT00606684|563996|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
159242|NCT00606684|563997|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
159243|NCT00606684|563998|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
159244|NCT00606684|563999|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
159245|NCT00606684|563993|P7|Double-Blind Treatment Period|Physician Decision|2
159246|NCT00606684|563994|P6|Double-Blind Treatment Period|Physician Decision|1
159247|NCT00606684|563995|P5|Double-Blind Treatment Period|Physician Decision|3
159248|NCT00606684|563996|P4|Double-Blind Treatment Period|Physician Decision|0
159249|NCT00606684|563997|P3|Double-Blind Treatment Period|Physician Decision|1
159250|NCT00606684|563998|P2|Double-Blind Treatment Period|Physician Decision|5
159251|NCT00606684|563999|P1|Double-Blind Treatment Period|Physician Decision|0
159252|NCT00606684|563993|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
159253|NCT00606684|563994|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
159254|NCT00606684|563995|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
159255|NCT00606684|563996|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
159256|NCT00606684|563997|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
159257|NCT00606684|563998|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
159258|NCT00606684|563999|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
159259|NCT00606684|563993|P7|Double-Blind Treatment Period|Protocol Violation|4
159260|NCT00606684|563994|P6|Double-Blind Treatment Period|Protocol Violation|3
159261|NCT00606684|563995|P5|Double-Blind Treatment Period|Protocol Violation|0
159262|NCT00606684|563996|P4|Double-Blind Treatment Period|Protocol Violation|3
159263|NCT00606684|563997|P3|Double-Blind Treatment Period|Protocol Violation|5
159264|NCT00606684|563998|P2|Double-Blind Treatment Period|Protocol Violation|5
159265|NCT00606684|563999|P1|Double-Blind Treatment Period|Protocol Violation|0
159266|NCT00606684|563993|P7|Double-Blind Treatment Period|Lack of Efficacy|0
159267|NCT00606684|563994|P6|Double-Blind Treatment Period|Lack of Efficacy|0
159268|NCT00606684|563995|P5|Double-Blind Treatment Period|Lack of Efficacy|1
159269|NCT00606684|563996|P4|Double-Blind Treatment Period|Lack of Efficacy|0
159270|NCT00606684|563997|P3|Double-Blind Treatment Period|Lack of Efficacy|0
159271|NCT00606684|563998|P2|Double-Blind Treatment Period|Lack of Efficacy|1
159272|NCT00606684|563999|P1|Double-Blind Treatment Period|Lack of Efficacy|0
159273|NCT00606684|563993|P7|Double-Blind Treatment Period|Adverse Event|1
159274|NCT00606684|563994|P6|Double-Blind Treatment Period|Adverse Event|0
159275|NCT00606684|563995|P5|Double-Blind Treatment Period|Adverse Event|2
159276|NCT00606684|563996|P4|Double-Blind Treatment Period|Adverse Event|4
159277|NCT00606684|563997|P3|Double-Blind Treatment Period|Adverse Event|2
159278|NCT00606684|563998|P2|Double-Blind Treatment Period|Adverse Event|3
159279|NCT00606684|563999|P1|Double-Blind Treatment Period|Adverse Event|0
159280|NCT00606684|563993|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
159281|NCT00606684|563994|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
159282|NCT00606684|563995|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
159283|NCT00606684|563996|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
159284|NCT00606684|563997|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
159285|NCT00606684|563998|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
159286|NCT00606684|563999|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
159287|NCT00606684|563993|P7|2-week Single-Blind Run-in Period|Adverse Event|0
159288|NCT00606684|563994|P6|2-week Single-Blind Run-in Period|Adverse Event|0
159289|NCT00606684|563995|P5|2-week Single-Blind Run-in Period|Adverse Event|0
159290|NCT00606684|563996|P4|2-week Single-Blind Run-in Period|Adverse Event|0
159291|NCT00606684|563997|P3|2-week Single-Blind Run-in Period|Adverse Event|0
159292|NCT00606684|563998|P2|2-week Single-Blind Run-in Period|Adverse Event|0
159293|NCT00606684|563999|P1|2-week Single-Blind Run-in Period|Adverse Event|2
159294|NCT00606684|563993|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
159295|NCT00606684|563994|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
159296|NCT00606684|563995|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
159297|NCT00606684|563996|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
159298|NCT00606684|563997|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
159299|NCT00606684|563998|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
159300|NCT00606684|563999|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
159301|NCT00606684|563993|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
159302|NCT00606684|563994|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
159303|NCT00606684|563995|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
159304|NCT00606684|563996|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
159305|NCT00606684|563997|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
159306|NCT00606684|563998|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
159307|NCT00606684|563999|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
159308|NCT00606684|563993|P7|2-week Single-Blind Run-in Period|Physician Decision|0
159309|NCT00606684|563994|P6|2-week Single-Blind Run-in Period|Physician Decision|0
159310|NCT00606684|563995|P5|2-week Single-Blind Run-in Period|Physician Decision|0
159311|NCT00606684|563996|P4|2-week Single-Blind Run-in Period|Physician Decision|0
159312|NCT00606684|563997|P3|2-week Single-Blind Run-in Period|Physician Decision|0
159313|NCT00606684|563998|P2|2-week Single-Blind Run-in Period|Physician Decision|0
159314|NCT00606684|563999|P1|2-week Single-Blind Run-in Period|Physician Decision|18
159315|NCT00606684|563993|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
159316|NCT00606684|563994|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
159317|NCT00606684|563995|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
159318|NCT00606684|563996|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
159319|NCT00606684|563997|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
159320|NCT00606684|563998|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
159321|NCT00606684|563999|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
159322|NCT00606684|563993|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
159323|NCT00606684|563994|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
159324|NCT00606684|563995|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
159325|NCT00606684|563996|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
159326|NCT00606684|563997|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
159327|NCT00606684|563998|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
159328|NCT00606684|563999|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
159329|NCT00606632|564031|P1|Overall Study|Miscellaneous reasons|9
159330|NCT00606632|564031|P1|Overall Study|Withdrawal by Subject|13
159331|NCT00606593|564038|P10|Overall Study|Administrative/Other|0
159332|NCT00606593|564039|P9|Overall Study|Administrative/Other|0
159333|NCT00606593|564040|P8|Overall Study|Administrative/Other|0
159334|NCT00606593|564041|P7|Overall Study|Administrative/Other|0
159335|NCT00606593|564042|P6|Overall Study|Administrative/Other|0
159336|NCT00606593|564043|P5|Overall Study|Administrative/Other|0
159337|NCT00606593|564044|P4|Overall Study|Administrative/Other|0
159338|NCT00606593|564045|P3|Overall Study|Administrative/Other|1
159339|NCT00606593|564046|P2|Overall Study|Administrative/Other|0
159340|NCT00606593|564047|P1|Overall Study|Administrative/Other|0
159341|NCT00606593|564038|P10|Overall Study|Withdrawal of consent|0
159342|NCT00606593|564039|P9|Overall Study|Withdrawal of consent|0
159343|NCT00606593|564040|P8|Overall Study|Withdrawal of consent|0
159344|NCT00606593|564041|P7|Overall Study|Withdrawal of consent|0
159345|NCT00606593|564042|P6|Overall Study|Withdrawal of consent|0
159346|NCT00606593|564043|P5|Overall Study|Withdrawal of consent|0
159347|NCT00606593|564044|P4|Overall Study|Withdrawal of consent|0
159348|NCT00606593|564045|P3|Overall Study|Withdrawal of consent|1
159349|NCT00606593|564046|P2|Overall Study|Withdrawal of consent|0
159350|NCT00606593|564047|P1|Overall Study|Withdrawal of consent|1
159351|NCT00606593|564038|P10|Overall Study|Adverse Event|0
159352|NCT00606593|564039|P9|Overall Study|Adverse Event|1
159353|NCT00606593|564040|P8|Overall Study|Adverse Event|2
159354|NCT00606593|564041|P7|Overall Study|Adverse Event|1
159355|NCT00606593|564042|P6|Overall Study|Adverse Event|0
159356|NCT00606593|564043|P5|Overall Study|Adverse Event|1
159357|NCT00606593|564044|P4|Overall Study|Adverse Event|1
159358|NCT00606593|564045|P3|Overall Study|Adverse Event|0
159359|NCT00606593|564046|P2|Overall Study|Adverse Event|0
159360|NCT00606593|564047|P1|Overall Study|Adverse Event|0
159361|NCT00606580|564068|P3|Overall Study|Withdrawal by Subject|0
159362|NCT00606580|564069|P2|Overall Study|Withdrawal by Subject|1
159363|NCT00606580|564070|P1|Overall Study|Withdrawal by Subject|0
159364|NCT00606580|564068|P3|Overall Study|Withdrawal by investigator|6
159365|NCT00606580|564069|P2|Overall Study|Withdrawal by investigator|1
159366|NCT00606580|564070|P1|Overall Study|Withdrawal by investigator|0
159367|NCT00606580|564068|P3|Overall Study|Clinical failures|12
159368|NCT00606580|564069|P2|Overall Study|Clinical failures|0
159369|NCT00606580|564070|P1|Overall Study|Clinical failures|1
159370|NCT00606580|564068|P3|Overall Study|Lost to Follow-up|4
159371|NCT00606580|564069|P2|Overall Study|Lost to Follow-up|1
159372|NCT00606580|564070|P1|Overall Study|Lost to Follow-up|1
159373|NCT00606502|564136|P2|Treatment|Treatment ongoing at time of data cutoff|3
159374|NCT00606502|564137|P1|Treatment|Treatment ongoing at time of data cutoff|0
159375|NCT00606502|564136|P2|Randomization|Randomized but not treated|0
159376|NCT00606502|564137|P1|Randomization|Randomized but not treated|3
159377|NCT00606320|564158|P1|Overall Study|Progression to depressive phase|4
159378|NCT00606320|564158|P1|Overall Study|Withdrawal by Subject|10
159379|NCT00606320|564158|P1|Overall Study|Protocol Violation|8
159380|NCT00606320|564158|P1|Overall Study|Physician Decision|7
159381|NCT00606320|564158|P1|Overall Study|Lack of Efficacy|5
159382|NCT00606320|564158|P1|Overall Study|Adverse Event|3
159383|NCT00606281|564165|P2|Overall Study|Change of residence or other commitments|1
159384|NCT00606281|564166|P1|Overall Study|Change of residence or other commitments|1
159385|NCT00606281|564165|P2|Overall Study|Progression to depressive phase|1
159386|NCT00606281|564166|P1|Overall Study|Progression to depressive phase|1
159387|NCT00606281|564165|P2|Overall Study|Withdrawal by Subject|13
159388|NCT00606281|564166|P1|Overall Study|Withdrawal by Subject|11
159389|NCT00606281|564165|P2|Overall Study|Protocol Violation|3
159390|NCT00606281|564166|P1|Overall Study|Protocol Violation|3
159391|NCT00606281|564165|P2|Overall Study|Physician Decision|1
159392|NCT00606281|564166|P1|Overall Study|Physician Decision|0
159393|NCT00606281|564165|P2|Overall Study|Lack of Efficacy|35
159394|NCT00606281|564166|P1|Overall Study|Lack of Efficacy|28
159395|NCT00606281|564165|P2|Overall Study|Death|0
159396|NCT00606281|564166|P1|Overall Study|Death|1
159397|NCT00606281|564165|P2|Overall Study|Adverse Event|12
159398|NCT00606281|564166|P1|Overall Study|Adverse Event|11
159399|NCT00606229|564174|P1|Overall Study|change of residence or other commitments|2
159400|NCT00606229|564174|P1|Overall Study|does not meet inclusion criterion 1-3|4
159401|NCT00606229|564174|P1|Overall Study|Withdrawal by Subject|4
159402|NCT00606229|564174|P1|Overall Study|Lack of Efficacy|1
159403|NCT00606229|564174|P1|Overall Study|Adverse Event|11
159404|NCT00606177|564181|P2|Overall Study|Change of residence or other commitments|1
159405|NCT00606177|564182|P1|Overall Study|Change of residence or other commitments|1
159406|NCT00606177|564181|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
159407|NCT00606177|564182|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
159408|NCT00606177|564181|P2|Overall Study|Progression to depressive phase|1
159409|NCT00606177|564182|P1|Overall Study|Progression to depressive phase|6
159410|NCT00606177|564181|P2|Overall Study|Withdrawal by Subject|6
159411|NCT00606177|564182|P1|Overall Study|Withdrawal by Subject|5
159412|NCT00606177|564181|P2|Overall Study|Protocol Violation|4
159413|NCT00606177|564182|P1|Overall Study|Protocol Violation|1
159414|NCT00606177|564181|P2|Overall Study|Physician Decision|0
159415|NCT00606177|564182|P1|Overall Study|Physician Decision|1
159416|NCT00606177|564181|P2|Overall Study|Lack of Efficacy|7
159417|NCT00606177|564182|P1|Overall Study|Lack of Efficacy|3
159418|NCT00606177|564181|P2|Overall Study|Adverse Event|5
159419|NCT00606177|564182|P1|Overall Study|Adverse Event|9
159420|NCT00606086|564209|P2|Overall Study|Randomized, not treated|2
159421|NCT00606086|564210|P1|Overall Study|Randomized, not treated|1
159422|NCT00606086|564209|P2|Overall Study|Non-compliance|1
159423|NCT00606086|564210|P1|Overall Study|Non-compliance|0
159424|NCT00606086|564209|P2|Overall Study|Withdrawal by Subject|3
159425|NCT00606086|564210|P1|Overall Study|Withdrawal by Subject|5
159426|NCT00606086|564209|P2|Overall Study|Protocol Violation|0
159427|NCT00606086|564210|P1|Overall Study|Protocol Violation|1
159428|NCT00606086|564209|P2|Overall Study|Lost to Follow-up|8
159429|NCT00606086|564210|P1|Overall Study|Lost to Follow-up|4
159430|NCT00606086|564209|P2|Overall Study|Adverse Event|1
159431|NCT00606086|564210|P1|Overall Study|Adverse Event|1
159432|NCT00606034|564216|P1|Overall Study|incarceration|1
159433|NCT00606021|564224|P3|Maintenance Phase|Lost to Follow-up|2
159434|NCT00606021|564225|P2|Maintenance Phase|Lost to Follow-up|5
159435|NCT00606021|564226|P1|Maintenance Phase|Lost to Follow-up|0
159436|NCT00606021|564224|P3|Maintenance Phase|Physician Decision|0
159437|NCT00606021|564225|P2|Maintenance Phase|Physician Decision|1
159438|NCT00606021|564226|P1|Maintenance Phase|Physician Decision|0
159439|NCT00606021|564224|P3|Maintenance Phase|Death|15
159440|NCT00606021|564225|P2|Maintenance Phase|Death|17
159441|NCT00606021|564226|P1|Maintenance Phase|Death|0
159442|NCT00606021|564224|P3|Induction Phase|Lost to Follow-up|0
159443|NCT00606021|564225|P2|Induction Phase|Lost to Follow-up|0
159444|NCT00606021|564226|P1|Induction Phase|Lost to Follow-up|10
159445|NCT00606021|564224|P3|Induction Phase|Withdrawal by Subject|0
159446|NCT00606021|564225|P2|Induction Phase|Withdrawal by Subject|0
159447|NCT00606021|564226|P1|Induction Phase|Withdrawal by Subject|2
159448|NCT00606021|564224|P3|Induction Phase|Physician Decision|0
159449|NCT00606021|564225|P2|Induction Phase|Physician Decision|0
159450|NCT00606021|564226|P1|Induction Phase|Physician Decision|2
159451|NCT00606021|564224|P3|Induction Phase|Death|0
159452|NCT00606021|564225|P2|Induction Phase|Death|0
159453|NCT00606021|564226|P1|Induction Phase|Death|73
159454|NCT00606008|564244|P1|Overall Study|Withdrawal by Subject|4
159455|NCT00606008|564244|P1|Overall Study|Adverse Event|1
159456|NCT00605917|564258|P1|Overall Study|Protocol Violation|79
159457|NCT00605865|564310|P1|Overall Study|Protocol Violation|115
159458|NCT00605839|564352|P3|Overall Study|Protocol Violation|0
159459|NCT00605839|564353|P2|Overall Study|Protocol Violation|0
159460|NCT00605839|564354|P1|Overall Study|Protocol Violation|1
159461|NCT00605813|564362|P1|Overall Study|Protocol Violation|25
159462|NCT00605722|564375|P1|Overall Study|Failure to return|1
159463|NCT00605722|564375|P1|Overall Study|Insufficient therapeutic response|44
159464|NCT00605722|564375|P1|Overall Study|Adverse Event|6
159465|NCT00605657|564396|P1|Overall Study|Protocol Violation|1
159466|NCT00605657|564396|P1|Overall Study|Adverse Event|1
159467|NCT00605540|564401|P1|Overall Study|Lost to Follow-up|23
159468|NCT00605540|564401|P1|Overall Study|Death|15
159469|NCT00605475|564419|P10|Overall Study|Withdrawal by Subject|1
159470|NCT00605475|564420|P9|Overall Study|Withdrawal by Subject|0
159471|NCT00605475|564421|P8|Overall Study|Withdrawal by Subject|0
159472|NCT00605475|564422|P7|Overall Study|Withdrawal by Subject|0
159473|NCT00605475|564423|P6|Overall Study|Withdrawal by Subject|2
159474|NCT00605475|564424|P5|Overall Study|Withdrawal by Subject|0
159475|NCT00605475|564425|P4|Overall Study|Withdrawal by Subject|0
159476|NCT00605475|564426|P3|Overall Study|Withdrawal by Subject|0
159477|NCT00605475|564427|P2|Overall Study|Withdrawal by Subject|0
159478|NCT00605475|564428|P1|Overall Study|Withdrawal by Subject|0
159479|NCT00605475|564419|P10|Overall Study|Protocol Violation|0
159480|NCT00605475|564420|P9|Overall Study|Protocol Violation|0
159481|NCT00605475|564421|P8|Overall Study|Protocol Violation|0
159482|NCT00605475|564422|P7|Overall Study|Protocol Violation|0
159483|NCT00605475|564423|P6|Overall Study|Protocol Violation|0
159484|NCT00605475|564424|P5|Overall Study|Protocol Violation|1
159485|NCT00605475|564425|P4|Overall Study|Protocol Violation|0
159486|NCT00605475|564426|P3|Overall Study|Protocol Violation|0
159487|NCT00605475|564427|P2|Overall Study|Protocol Violation|0
159488|NCT00605475|564428|P1|Overall Study|Protocol Violation|0
159489|NCT00605475|564419|P10|Overall Study|Lost to Follow-up|1
159490|NCT00605475|564420|P9|Overall Study|Lost to Follow-up|1
159491|NCT00605475|564421|P8|Overall Study|Lost to Follow-up|0
159492|NCT00605475|564422|P7|Overall Study|Lost to Follow-up|0
159493|NCT00605475|564423|P6|Overall Study|Lost to Follow-up|0
159494|NCT00605475|564424|P5|Overall Study|Lost to Follow-up|0
159495|NCT00605475|564425|P4|Overall Study|Lost to Follow-up|0
159496|NCT00605475|564426|P3|Overall Study|Lost to Follow-up|0
159497|NCT00605475|564427|P2|Overall Study|Lost to Follow-up|0
159498|NCT00605475|564428|P1|Overall Study|Lost to Follow-up|0
159499|NCT00605475|564419|P10|Overall Study|Administrative problems|0
159500|NCT00605475|564420|P9|Overall Study|Administrative problems|0
159501|NCT00605475|564421|P8|Overall Study|Administrative problems|0
159502|NCT00605475|564422|P7|Overall Study|Administrative problems|1
159503|NCT00605475|564423|P6|Overall Study|Administrative problems|0
159504|NCT00605475|564424|P5|Overall Study|Administrative problems|0
159505|NCT00605475|564425|P4|Overall Study|Administrative problems|0
159506|NCT00605475|564426|P3|Overall Study|Administrative problems|0
159507|NCT00605475|564427|P2|Overall Study|Administrative problems|0
159508|NCT00605475|564428|P1|Overall Study|Administrative problems|0
159509|NCT00605475|564419|P10|Overall Study|Abnormal Laboratory Values|0
159510|NCT00605475|564420|P9|Overall Study|Abnormal Laboratory Values|1
159511|NCT00605475|564421|P8|Overall Study|Abnormal Laboratory Values|0
159512|NCT00605475|564422|P7|Overall Study|Abnormal Laboratory Values|0
159513|NCT00605475|564423|P6|Overall Study|Abnormal Laboratory Values|0
159514|NCT00605475|564424|P5|Overall Study|Abnormal Laboratory Values|0
159515|NCT00605475|564425|P4|Overall Study|Abnormal Laboratory Values|0
159516|NCT00605475|564426|P3|Overall Study|Abnormal Laboratory Values|0
159517|NCT00605475|564427|P2|Overall Study|Abnormal Laboratory Values|0
159518|NCT00605475|564428|P1|Overall Study|Abnormal Laboratory Values|0
159519|NCT00605345|564605|P2|Overall Study|Protocol Violation|2
159520|NCT00605345|564606|P1|Overall Study|Protocol Violation|0
159521|NCT00605345|564605|P2|Overall Study|Adverse Event|1
159522|NCT00605345|564606|P1|Overall Study|Adverse Event|0
159523|NCT00605345|564605|P2|Overall Study|Withdrawal by Subject|0
159524|NCT00605345|564606|P1|Overall Study|Withdrawal by Subject|1
159525|NCT00605319|564622|P1|Overall Study|Adverse Event|6
159526|NCT00605306|564634|P2|Overall Study|Adverse Event|1
159527|NCT00605306|564635|P1|Overall Study|Adverse Event|0
159528|NCT00605293|564649|P2|Overall Study|Principal Investigator Decision|1
159529|NCT00605293|564650|P1|Overall Study|Principal Investigator Decision|0
159530|NCT00605293|564649|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
159531|NCT00605293|564650|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
159532|NCT00605293|564649|P2|Overall Study|Incorrect Epoetin Beta Administration|0
159533|NCT00605293|564650|P1|Overall Study|Incorrect Epoetin Beta Administration|1
159534|NCT00605293|564649|P2|Overall Study|Renal Transplantation|1
159535|NCT00605293|564650|P1|Overall Study|Renal Transplantation|3
159536|NCT00605293|564649|P2|Overall Study|Blood Transfusion|1
159537|NCT00605293|564650|P1|Overall Study|Blood Transfusion|7
159538|NCT00605293|564649|P2|Overall Study|Holidays Dialysis Out|0
159539|NCT00605293|564650|P1|Overall Study|Holidays Dialysis Out|1
159540|NCT00605293|564649|P2|Overall Study|Adverse Event|0
159541|NCT00605293|564650|P1|Overall Study|Adverse Event|1
159542|NCT00605293|564649|P2|Overall Study|Insufficient Therapeutic Response|0
159543|NCT00605293|564650|P1|Overall Study|Insufficient Therapeutic Response|2
159544|NCT00605293|564649|P2|Overall Study|Death|1
159545|NCT00605293|564650|P1|Overall Study|Death|2
159546|NCT00605280|564670|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
159547|NCT00605280|564671|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
159548|NCT00605280|564672|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
159549|NCT00605280|564673|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
159550|NCT00605280|564670|P4|Year 3 Extension|Other|0
159551|NCT00605280|564671|P3|Year 3 Extension|Other|0
159552|NCT00605280|564672|P2|Year 3 Extension|Other|0
159553|NCT00605280|564673|P1|Year 3 Extension|Other|2
159554|NCT00605280|564670|P4|Year 3 Extension|Withdrawal by Subject|5
159555|NCT00605280|564671|P3|Year 3 Extension|Withdrawal by Subject|0
159556|NCT00605280|564672|P2|Year 3 Extension|Withdrawal by Subject|0
159557|NCT00605280|564673|P1|Year 3 Extension|Withdrawal by Subject|2
159558|NCT00605280|564670|P4|Year 3 Extension|Physician Decision|2
159559|NCT00605280|564671|P3|Year 3 Extension|Physician Decision|0
159560|NCT00605280|564672|P2|Year 3 Extension|Physician Decision|0
159561|NCT00605280|564673|P1|Year 3 Extension|Physician Decision|0
159562|NCT00605280|564670|P4|Year 3 Extension|Adverse Event|2
159563|NCT00605280|564671|P3|Year 3 Extension|Adverse Event|0
159564|NCT00605280|564672|P2|Year 3 Extension|Adverse Event|0
159565|NCT00605280|564673|P1|Year 3 Extension|Adverse Event|2
159566|NCT00605280|564670|P4|Year 2|Lost to Follow-up or Patient non-comply|2
159567|NCT00605280|564671|P3|Year 2|Lost to Follow-up or Patient non-comply|0
159568|NCT00605280|564672|P2|Year 2|Lost to Follow-up or Patient non-comply|0
159569|NCT00605280|564673|P1|Year 2|Lost to Follow-up or Patient non-comply|4
159570|NCT00605280|564670|P4|Year 2|Other|1
159571|NCT00605280|564671|P3|Year 2|Other|0
159572|NCT00605280|564672|P2|Year 2|Other|0
159573|NCT00605280|564673|P1|Year 2|Other|1
159574|NCT00605280|564670|P4|Year 2|Withdrawal by Subject|4
159575|NCT00605280|564671|P3|Year 2|Withdrawal by Subject|0
159576|NCT00605280|564672|P2|Year 2|Withdrawal by Subject|0
159577|NCT00605280|564673|P1|Year 2|Withdrawal by Subject|4
159578|NCT00605280|564670|P4|Year 2|Physician Decision|11
159579|NCT00605280|564671|P3|Year 2|Physician Decision|4
159580|NCT00605280|564672|P2|Year 2|Physician Decision|6
159581|NCT00605280|564673|P1|Year 2|Physician Decision|11
159582|NCT00605280|564670|P4|Year 2|Adverse Event|4
159583|NCT00605280|564671|P3|Year 2|Adverse Event|2
159584|NCT00605280|564672|P2|Year 2|Adverse Event|0
159585|NCT00605280|564673|P1|Year 2|Adverse Event|4
159586|NCT00605280|564670|P4|Year 1|Lost to Follow-up or Patient non-comply|2
159587|NCT00605280|564671|P3|Year 1|Lost to Follow-up or Patient non-comply|0
159588|NCT00605280|564672|P2|Year 1|Lost to Follow-up or Patient non-comply|1
159589|NCT00605280|564673|P1|Year 1|Lost to Follow-up or Patient non-comply|5
159590|NCT00605280|564670|P4|Year 1|Other|1
159591|NCT00605280|564671|P3|Year 1|Other|0
159592|NCT00605280|564672|P2|Year 1|Other|1
159593|NCT00605280|564673|P1|Year 1|Other|2
159594|NCT00605280|564670|P4|Year 1|Withdrawal by Subject|4
159595|NCT00605280|564671|P3|Year 1|Withdrawal by Subject|0
159596|NCT00605280|564672|P2|Year 1|Withdrawal by Subject|4
159597|NCT00605280|564673|P1|Year 1|Withdrawal by Subject|2
159598|NCT00605280|564670|P4|Year 1|Physician Decision|6
159599|NCT00605280|564671|P3|Year 1|Physician Decision|0
159600|NCT00605280|564672|P2|Year 1|Physician Decision|4
159601|NCT00605280|564673|P1|Year 1|Physician Decision|7
159602|NCT00605280|564670|P4|Year 1|Adverse Event|5
159603|NCT00605280|564671|P3|Year 1|Adverse Event|1
159604|NCT00605280|564672|P2|Year 1|Adverse Event|1
159605|NCT00605280|564673|P1|Year 1|Adverse Event|3
159606|NCT00605280|564670|P4|Year 1|Protocol Violation|1
159607|NCT00605280|564671|P3|Year 1|Protocol Violation|0
159608|NCT00605280|564672|P2|Year 1|Protocol Violation|0
159609|NCT00605280|564673|P1|Year 1|Protocol Violation|0
159610|NCT00605267|564707|P2|Overall Study|Withdrawal by Subject|3
159611|NCT00605267|564708|P1|Overall Study|Withdrawal by Subject|2
159612|NCT00605267|564707|P2|Overall Study|Lack of Efficacy|5
159613|NCT00605267|564708|P1|Overall Study|Lack of Efficacy|1
159614|NCT00605267|564707|P2|Overall Study|Adverse Event|1
159615|NCT00605267|564708|P1|Overall Study|Adverse Event|0
159616|NCT00605176|564756|P3|Overall Study|Other (not due to AE)|0
159617|NCT00605176|564757|P2|Overall Study|Other (not due to AE)|1
159618|NCT00605176|564758|P1|Overall Study|Other (not due to AE)|1
159619|NCT00605176|564756|P3|Overall Study|Use of concomitant therapy|1
159620|NCT00605176|564757|P2|Overall Study|Use of concomitant therapy|0
159621|NCT00605176|564758|P1|Overall Study|Use of concomitant therapy|1
159622|NCT00605176|564756|P3|Overall Study|Non-complicance with study procedures|0
159623|NCT00605176|564757|P2|Overall Study|Non-complicance with study procedures|0
159624|NCT00605176|564758|P1|Overall Study|Non-complicance with study procedures|1
159625|NCT00605176|564756|P3|Overall Study|Lost to Follow-up|1
159626|NCT00605176|564757|P2|Overall Study|Lost to Follow-up|2
159627|NCT00605176|564758|P1|Overall Study|Lost to Follow-up|2
159628|NCT00605176|564756|P3|Overall Study|Withdrawal by Subject|4
159629|NCT00605176|564757|P2|Overall Study|Withdrawal by Subject|2
159630|NCT00605176|564758|P1|Overall Study|Withdrawal by Subject|4
159631|NCT00605176|564756|P3|Overall Study|Adverse Event|3
159632|NCT00605176|564757|P2|Overall Study|Adverse Event|1
159633|NCT00605176|564758|P1|Overall Study|Adverse Event|2
159634|NCT00605085|564781|P2|Overall Study|administrative reasons|8
159635|NCT00605085|564782|P1|Overall Study|administrative reasons|18
159636|NCT00605085|564781|P2|Overall Study|Lost to Follow-up|5
159637|NCT00605085|564782|P1|Overall Study|Lost to Follow-up|10
159638|NCT00605085|564781|P2|Overall Study|Protocol Violation|2
159639|NCT00605085|564782|P1|Overall Study|Protocol Violation|3
159640|NCT00605085|564781|P2|Overall Study|Pregnancy|0
159641|NCT00605085|564782|P1|Overall Study|Pregnancy|2
159642|NCT00605085|564781|P2|Overall Study|Adverse Event|5
159643|NCT00605085|564782|P1|Overall Study|Adverse Event|9
159644|NCT00605085|564781|P2|Overall Study|Withdrawal by Subject|5
159645|NCT00605085|564782|P1|Overall Study|Withdrawal by Subject|8
159646|NCT00605033|564815|P2|Overall Study|Protocol Violation|1
159647|NCT00605033|564816|P1|Overall Study|Protocol Violation|1
159648|NCT00605033|564815|P2|Overall Study|Withdrawal by Subject|4
159649|NCT00605033|564816|P1|Overall Study|Withdrawal by Subject|3
159650|NCT00605033|564815|P2|Overall Study|Lost to Follow-up|1
159651|NCT00605033|564816|P1|Overall Study|Lost to Follow-up|1
159652|NCT00605033|564815|P2|Overall Study|Adverse Event|2
159653|NCT00605033|564816|P1|Overall Study|Adverse Event|2
159654|NCT00604825|564839|P4|Overall Study|Exclusion criterion met|1
159655|NCT00604825|564840|P3|Overall Study|Exclusion criterion met|0
159656|NCT00604825|564841|P2|Overall Study|Exclusion criterion met|0
159657|NCT00604825|564842|P1|Overall Study|Exclusion criterion met|0
159658|NCT00604825|564839|P4|Overall Study|Physician Decision|1
159659|NCT00604825|564840|P3|Overall Study|Physician Decision|0
159660|NCT00604825|564841|P2|Overall Study|Physician Decision|0
159661|NCT00604825|564842|P1|Overall Study|Physician Decision|0
159662|NCT00604825|564839|P4|Overall Study|Did not meet eligibility criteria|0
159663|NCT00604825|564840|P3|Overall Study|Did not meet eligibility criteria|2
159664|NCT00604825|564841|P2|Overall Study|Did not meet eligibility criteria|0
159665|NCT00604825|564842|P1|Overall Study|Did not meet eligibility criteria|0
159666|NCT00604825|564839|P4|Overall Study|Lack of Efficacy|0
159667|NCT00604825|564840|P3|Overall Study|Lack of Efficacy|1
159668|NCT00604825|564841|P2|Overall Study|Lack of Efficacy|2
159669|NCT00604825|564842|P1|Overall Study|Lack of Efficacy|3
159670|NCT00604825|564839|P4|Overall Study|Withdrawal by Subject|5
159671|NCT00604825|564840|P3|Overall Study|Withdrawal by Subject|5
159672|NCT00604825|564841|P2|Overall Study|Withdrawal by Subject|3
159673|NCT00604825|564842|P1|Overall Study|Withdrawal by Subject|4
159674|NCT00604825|564839|P4|Overall Study|Protocol Violation|0
159675|NCT00604825|564840|P3|Overall Study|Protocol Violation|0
159676|NCT00604825|564841|P2|Overall Study|Protocol Violation|1
159677|NCT00604825|564842|P1|Overall Study|Protocol Violation|0
159678|NCT00604825|564839|P4|Overall Study|Lost to Follow-up|0
159679|NCT00604825|564840|P3|Overall Study|Lost to Follow-up|1
159680|NCT00604825|564841|P2|Overall Study|Lost to Follow-up|3
159681|NCT00604825|564842|P1|Overall Study|Lost to Follow-up|0
159682|NCT00604825|564839|P4|Overall Study|Adverse Event|4
159683|NCT00604825|564840|P3|Overall Study|Adverse Event|7
159684|NCT00604825|564841|P2|Overall Study|Adverse Event|6
159685|NCT00604825|564842|P1|Overall Study|Adverse Event|2
159686|NCT00604786|565070|P2|Overall Study|Lost to Follow-up|0
159687|NCT00604786|565071|P1|Overall Study|Lost to Follow-up|2
159688|NCT00604721|565077|P1|Overall Study|Withdrawal by Subject|1
159689|NCT00604721|565077|P1|Overall Study|Physician Decision|1
159690|NCT00604708|565085|P2|Overall Study|Adverse Event|6
159691|NCT00604708|565086|P1|Overall Study|Adverse Event|6
159692|NCT00604708|565085|P2|Overall Study|administrative reasons|11
159693|NCT00604708|565086|P1|Overall Study|administrative reasons|9
159694|NCT00604708|565085|P2|Overall Study|Lost to Follow-up|5
159695|NCT00604708|565086|P1|Overall Study|Lost to Follow-up|5
159696|NCT00604708|565085|P2|Overall Study|Protocol Violation|8
159697|NCT00604708|565086|P1|Overall Study|Protocol Violation|2
159698|NCT00604708|565085|P2|Overall Study|Withdrawal by Subject|10
159699|NCT00604708|565086|P1|Overall Study|Withdrawal by Subject|9
159700|NCT00604695|565096|P2|Overall Study|Did not receive first bolus.|4
159701|NCT00604695|565097|P1|Overall Study|Did not receive first bolus.|0
159702|NCT00604669|565119|P1|Overall Study|lack of information in chart|7
159703|NCT00604565|565125|P2|Overall Study|Study terminated|3
159704|NCT00604565|565126|P1|Overall Study|Study terminated|0
159705|NCT00604500|565145|P1|Overall Study|Did not meet protocol eligibility|1
159706|NCT00604500|565145|P1|Overall Study|Administrative|1
159707|NCT00604500|565145|P1|Overall Study|Withdrawal by Subject|4
159708|NCT00604500|565145|P1|Overall Study|Treatment Failure|1
159709|NCT00604500|565145|P1|Overall Study|Protocol Violation|2
159710|NCT00604500|565145|P1|Overall Study|Adverse Event|2
159711|NCT00604383|565159|P2|Overall Study|Physician Decision|3
159712|NCT00604383|565160|P1|Overall Study|Physician Decision|0
159713|NCT00604383|565159|P2|Overall Study|Adverse Event|9
159714|NCT00604383|565160|P1|Overall Study|Adverse Event|16
159715|NCT00604383|565159|P2|Overall Study|Death|22
159716|NCT00604383|565160|P1|Overall Study|Death|14
159717|NCT00604383|565159|P2|Overall Study|Lost to Follow-up|19
159718|NCT00604383|565160|P1|Overall Study|Lost to Follow-up|24
159719|NCT00604383|565159|P2|Overall Study|Withdrawal by Subject|31
159720|NCT00604383|565160|P1|Overall Study|Withdrawal by Subject|33
159721|NCT00604279|565176|P2|Overall Study|Other|4
159722|NCT00604279|565177|P1|Overall Study|Other|8
159723|NCT00604279|565176|P2|Overall Study|Adverse Event|5
159724|NCT00604279|565177|P1|Overall Study|Adverse Event|4
159725|NCT00604279|565176|P2|Overall Study|Withdrawal by Subject|5
159726|NCT00604279|565177|P1|Overall Study|Withdrawal by Subject|16
159727|NCT00604279|565176|P2|Overall Study|Protocol Violation|1
159728|NCT00604279|565177|P1|Overall Study|Protocol Violation|3
159729|NCT00604279|565176|P2|Overall Study|Pregnancy|0
159730|NCT00604279|565177|P1|Overall Study|Pregnancy|2
159731|NCT00604279|565176|P2|Overall Study|Lost to Follow-up|14
159732|NCT00604279|565177|P1|Overall Study|Lost to Follow-up|9
159733|NCT00604279|565176|P2|Overall Study|Lack of Efficacy|9
159734|NCT00604279|565177|P1|Overall Study|Lack of Efficacy|22
159735|NCT00604214|565193|P2|Day 91 to Day 180|Withdrawal by Subject|1
159736|NCT00604214|565194|P1|Day 91 to Day 180|Withdrawal by Subject|1
159737|NCT00604214|565193|P2|Day 91 to Day 180|Lost to Follow-up|8
159738|NCT00604214|565194|P1|Day 91 to Day 180|Lost to Follow-up|6
159739|NCT00604214|565193|P2|Day 91 to Day 180|Death|23
159740|NCT00604214|565194|P1|Day 91 to Day 180|Death|19
159741|NCT00604214|565193|P2|Day 29 to Day 90|Withdrawal by Subject|6
159742|NCT00604214|565194|P1|Day 29 to Day 90|Withdrawal by Subject|0
159743|NCT00604214|565193|P2|Day 29 to Day 90|Lost to Follow-up|6
159744|NCT00604214|565194|P1|Day 29 to Day 90|Lost to Follow-up|4
159745|NCT00604214|565193|P2|Day 29 to Day 90|Death|67
159746|NCT00604214|565194|P1|Day 29 to Day 90|Death|64
159747|NCT00604214|565193|P2|Baseline to Day 28|Withdrawal by Subject|7
159748|NCT00604214|565194|P1|Baseline to Day 28|Withdrawal by Subject|3
159749|NCT00604214|565193|P2|Baseline to Day 28|Lost to Follow-up|4
159750|NCT00604214|565194|P1|Baseline to Day 28|Lost to Follow-up|2
159751|NCT00604214|565193|P2|Baseline to Day 28|Death|202
159752|NCT00604214|565194|P1|Baseline to Day 28|Death|223
159753|NCT00604188|565226|P2|Overall Study|Did not receive study drug|1
159754|NCT00604188|565227|P1|Overall Study|Did not receive study drug|0
159755|NCT00604188|565226|P2|Overall Study|Non-compliance with protocol|4
159756|NCT00604188|565227|P1|Overall Study|Non-compliance with protocol|4
159757|NCT00604188|565226|P2|Overall Study|Withdrawal by Subject|1
159758|NCT00604188|565227|P1|Overall Study|Withdrawal by Subject|5
159759|NCT00604188|565226|P2|Overall Study|Lost to Follow-up|15
159760|NCT00604188|565227|P1|Overall Study|Lost to Follow-up|17
159761|NCT00604188|565226|P2|Overall Study|Adverse Event|4
159762|NCT00604188|565227|P1|Overall Study|Adverse Event|1
159763|NCT00604175|565250|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
159764|NCT00604175|565251|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
159765|NCT00604175|565252|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
159766|NCT00604175|565250|P3|Week 29 Through Week 72|Site closure|0
159767|NCT00604175|565251|P2|Week 29 Through Week 72|Site closure|1
159768|NCT00604175|565252|P1|Week 29 Through Week 72|Site closure|0
159769|NCT00604175|565250|P3|Week 29 Through Week 72|Lost to Follow-up|2
159770|NCT00604175|565251|P2|Week 29 Through Week 72|Lost to Follow-up|6
159771|NCT00604175|565252|P1|Week 29 Through Week 72|Lost to Follow-up|12
159772|NCT00604175|565250|P3|Week 29 Through Week 72|Death|1
159773|NCT00604175|565251|P2|Week 29 Through Week 72|Death|0
159774|NCT00604175|565252|P1|Week 29 Through Week 72|Death|0
159775|NCT00604175|565250|P3|Entry Through Week 28|Did not start intervention|1
159776|NCT00604175|565251|P2|Entry Through Week 28|Did not start intervention|0
159777|NCT00604175|565252|P1|Entry Through Week 28|Did not start intervention|2
159778|NCT00604175|565250|P3|Entry Through Week 28|Ineligible|0
159779|NCT00604175|565251|P2|Entry Through Week 28|Ineligible|0
159780|NCT00604175|565252|P1|Entry Through Week 28|Ineligible|1
159781|NCT00604175|565250|P3|Entry Through Week 28|Lost to Follow-up|0
159782|NCT00604175|565251|P2|Entry Through Week 28|Lost to Follow-up|3
159783|NCT00604175|565252|P1|Entry Through Week 28|Lost to Follow-up|4
159784|NCT00604175|565250|P3|Entry Through Week 28|Withdrawal by Subject|0
159785|NCT00604175|565251|P2|Entry Through Week 28|Withdrawal by Subject|0
159786|NCT00604175|565252|P1|Entry Through Week 28|Withdrawal by Subject|1
159787|NCT00604175|565250|P3|Entry Through Week 28|Death|0
159788|NCT00604175|565251|P2|Entry Through Week 28|Death|0
159789|NCT00604175|565252|P1|Entry Through Week 28|Death|2
159790|NCT00604162|565305|P1|Overall Study|Withdrawal by Subject|1
159791|NCT00604162|565305|P1|Overall Study|Physician Decision|3
159792|NCT00603915|565347|P1|Overall Study|Physician Decision|1
159793|NCT00603837|565377|P2|Overall Study|Physician Decision|0
159794|NCT00603837|565378|P1|Overall Study|Physician Decision|3
159795|NCT00603798|565387|P3|Overall Study|Not due to AE|4
159796|NCT00603798|565388|P2|Overall Study|Not due to AE|1
159797|NCT00603798|565389|P1|Overall Study|Not due to AE|1
159798|NCT00603798|565387|P3|Overall Study|Non-compliance with study procedures|0
159799|NCT00603798|565388|P2|Overall Study|Non-compliance with study procedures|1
159800|NCT00603798|565389|P1|Overall Study|Non-compliance with study procedures|0
159801|NCT00603798|565387|P3|Overall Study|Lost to Follow-up|1
159802|NCT00603798|565388|P2|Overall Study|Lost to Follow-up|0
159803|NCT00603798|565389|P1|Overall Study|Lost to Follow-up|1
159804|NCT00603798|565387|P3|Overall Study|Withdrawal by Subject|4
159805|NCT00603798|565388|P2|Overall Study|Withdrawal by Subject|3
159806|NCT00603798|565389|P1|Overall Study|Withdrawal by Subject|4
159807|NCT00603798|565387|P3|Overall Study|Adverse Event|1
159808|NCT00603798|565388|P2|Overall Study|Adverse Event|2
159809|NCT00603798|565389|P1|Overall Study|Adverse Event|4
159810|NCT00603746|565412|P6|Overall Study|Withdrawal by Subject|1
159811|NCT00603746|565413|P5|Overall Study|Withdrawal by Subject|3
159812|NCT00603746|565414|P4|Overall Study|Withdrawal by Subject|1
159813|NCT00603746|565415|P3|Overall Study|Withdrawal by Subject|0
159814|NCT00603746|565416|P2|Overall Study|Withdrawal by Subject|0
159815|NCT00603746|565417|P1|Overall Study|Withdrawal by Subject|1
159816|NCT00603746|565412|P6|Overall Study|Physician Decision|0
159817|NCT00603746|565413|P5|Overall Study|Physician Decision|1
159818|NCT00603746|565414|P4|Overall Study|Physician Decision|0
159819|NCT00603746|565415|P3|Overall Study|Physician Decision|0
159820|NCT00603746|565416|P2|Overall Study|Physician Decision|0
159821|NCT00603746|565417|P1|Overall Study|Physician Decision|1
159822|NCT00603746|565412|P6|Overall Study|Lost to Follow-up|0
159823|NCT00603746|565413|P5|Overall Study|Lost to Follow-up|0
159824|NCT00603746|565414|P4|Overall Study|Lost to Follow-up|0
159825|NCT00603746|565415|P3|Overall Study|Lost to Follow-up|1
159826|NCT00603746|565416|P2|Overall Study|Lost to Follow-up|1
159827|NCT00603746|565417|P1|Overall Study|Lost to Follow-up|0
159828|NCT00603746|565412|P6|Overall Study|Protocol Violation|0
159829|NCT00603746|565413|P5|Overall Study|Protocol Violation|1
159830|NCT00603746|565414|P4|Overall Study|Protocol Violation|0
159831|NCT00603746|565415|P3|Overall Study|Protocol Violation|1
159832|NCT00603746|565416|P2|Overall Study|Protocol Violation|3
159833|NCT00603746|565417|P1|Overall Study|Protocol Violation|0
159834|NCT00603746|565412|P6|Overall Study|Lack of Efficacy|8
159835|NCT00603746|565413|P5|Overall Study|Lack of Efficacy|12
159836|NCT00603746|565414|P4|Overall Study|Lack of Efficacy|11
159837|NCT00603746|565415|P3|Overall Study|Lack of Efficacy|6
159838|NCT00603746|565416|P2|Overall Study|Lack of Efficacy|11
159839|NCT00603746|565417|P1|Overall Study|Lack of Efficacy|34
159840|NCT00603746|565412|P6|Overall Study|Adverse Event|4
159841|NCT00603746|565413|P5|Overall Study|Adverse Event|0
159842|NCT00603746|565414|P4|Overall Study|Adverse Event|1
159843|NCT00603746|565415|P3|Overall Study|Adverse Event|0
159844|NCT00603746|565416|P2|Overall Study|Adverse Event|3
159845|NCT00603746|565417|P1|Overall Study|Adverse Event|2
159846|NCT00603733|565565|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
159847|NCT00603733|565566|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
159848|NCT00603733|565565|P2|Maintenance Phase ITT|Physician Decision|1
159849|NCT00603733|565566|P1|Maintenance Phase ITT|Physician Decision|0
159850|NCT00603733|565565|P2|Maintenance Phase ITT|Lack of Efficacy|2
159851|NCT00603733|565566|P1|Maintenance Phase ITT|Lack of Efficacy|2
159852|NCT00603733|565565|P2|Maintenance Phase ITT|Lost to Follow-up|1
159853|NCT00603733|565566|P1|Maintenance Phase ITT|Lost to Follow-up|0
159854|NCT00603733|565565|P2|Maintenance Phase ITT|Protocol Violation|1
159855|NCT00603733|565566|P1|Maintenance Phase ITT|Protocol Violation|1
159856|NCT00603733|565565|P2|Maintenance Phase ITT|Withdrawal by Subject|0
159857|NCT00603733|565566|P1|Maintenance Phase ITT|Withdrawal by Subject|1
159858|NCT00603733|565565|P2|Maintenance Phase ITT|Adverse Event|6
159859|NCT00603733|565566|P1|Maintenance Phase ITT|Adverse Event|3
159860|NCT00603733|565565|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
159861|NCT00603733|565566|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
159862|NCT00603733|565565|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
159863|NCT00603733|565566|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
159864|NCT00603733|565565|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
159865|NCT00603733|565566|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
159866|NCT00603733|565565|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
159867|NCT00603733|565566|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
159868|NCT00603733|565565|P2|Run-In Phase - 4 Weeks|Adverse Event|1
159869|NCT00603733|565566|P1|Run-In Phase - 4 Weeks|Adverse Event|2
159870|NCT00603733|565565|P2|Active Phase ITT|Subject moved, site closed|1
159871|NCT00603733|565566|P1|Active Phase ITT|Subject moved, site closed|1
159872|NCT00603733|565565|P2|Active Phase ITT|Lack of Efficacy|2
159873|NCT00603733|565566|P1|Active Phase ITT|Lack of Efficacy|1
159874|NCT00603733|565565|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
159875|NCT00603733|565566|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
159876|NCT00603733|565565|P2|Active Phase ITT|Lost to Follow-up|1
159877|NCT00603733|565566|P1|Active Phase ITT|Lost to Follow-up|0
159878|NCT00603733|565565|P2|Active Phase ITT|Withdrawal by Subject|3
159879|NCT00603733|565566|P1|Active Phase ITT|Withdrawal by Subject|0
159880|NCT00603733|565565|P2|Active Phase ITT|Adverse Event|7
159881|NCT00603733|565566|P1|Active Phase ITT|Adverse Event|8
159882|NCT00603590|565595|P2|Overall Study|Cardiovascular event|1
159883|NCT00603590|565596|P1|Overall Study|Cardiovascular event|0
159884|NCT00603590|565595|P2|Overall Study|Lost to Follow-up|4
159885|NCT00603590|565596|P1|Overall Study|Lost to Follow-up|8
159886|NCT00603590|565595|P2|Overall Study|Adverse Event|0
159887|NCT00603590|565596|P1|Overall Study|Adverse Event|2
159888|NCT00603590|565595|P2|Overall Study|Patient discontinued study drug|15
159889|NCT00603590|565596|P1|Overall Study|Patient discontinued study drug|22
159890|NCT00603590|565595|P2|Overall Study|Refused blood test|1
159891|NCT00603590|565596|P1|Overall Study|Refused blood test|5
159892|NCT00603590|565595|P2|Overall Study|Did not attend study clinic|30
159893|NCT00603590|565596|P1|Overall Study|Did not attend study clinic|39
159894|NCT00603538|565620|P3|Overall Study|Objective progression or relapse|0
159895|NCT00603538|565621|P2|Overall Study|Objective progression or relapse|0
159896|NCT00603538|565622|P1|Overall Study|Objective progression or relapse|3
159897|NCT00603538|565620|P3|Overall Study|Adverse Event|2
159898|NCT00603538|565621|P2|Overall Study|Adverse Event|4
159899|NCT00603538|565622|P1|Overall Study|Adverse Event|0
159900|NCT00603525|565662|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
159901|NCT00603525|565663|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
159902|NCT00603525|565664|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
159903|NCT00603525|565662|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
159904|NCT00603525|565663|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
159905|NCT00603525|565664|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
159906|NCT00603525|565662|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
159907|NCT00603525|565663|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
159908|NCT00603525|565664|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
159909|NCT00603525|565662|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
159910|NCT00603525|565663|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
159911|NCT00603525|565664|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
159996|NCT00603382|566002|P4|Overall Study|Withdrawal by Subject|1
159912|NCT00603525|565662|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
159913|NCT00603525|565663|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
159914|NCT00603525|565664|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
159915|NCT00603525|565662|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
159916|NCT00603525|565663|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
159917|NCT00603525|565664|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
159918|NCT00603525|565662|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
159919|NCT00603525|565663|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
159920|NCT00603525|565664|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
159921|NCT00603525|565662|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
159922|NCT00603525|565663|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
159923|NCT00603525|565664|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
159924|NCT00603525|565662|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
159925|NCT00603525|565663|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
159926|NCT00603525|565664|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
159927|NCT00603525|565662|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
159928|NCT00603525|565663|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
159929|NCT00603525|565664|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
159930|NCT00603525|565662|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
159931|NCT00603525|565663|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
159932|NCT00603525|565664|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
159933|NCT00603525|565662|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
159934|NCT00603525|565663|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
159935|NCT00603525|565664|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
159936|NCT00603525|565662|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
159937|NCT00603525|565663|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
159938|NCT00603525|565664|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
159939|NCT00603525|565662|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
159940|NCT00603525|565663|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
159941|NCT00603525|565664|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
159942|NCT00603525|565662|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
159943|NCT00603525|565663|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
159944|NCT00603525|565664|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
159945|NCT00603512|565796|P5|Overall Study|Randomized but not treated|0
159946|NCT00603512|565797|P4|Overall Study|Randomized but not treated|2
159947|NCT00603512|565798|P3|Overall Study|Randomized but not treated|1
159948|NCT00603512|565799|P2|Overall Study|Randomized but not treated|1
159949|NCT00603512|565800|P1|Overall Study|Randomized but not treated|0
159950|NCT00603512|565796|P5|Overall Study|Withdrawal by Subject|1
159951|NCT00603512|565797|P4|Overall Study|Withdrawal by Subject|0
159952|NCT00603512|565798|P3|Overall Study|Withdrawal by Subject|0
159953|NCT00603512|565799|P2|Overall Study|Withdrawal by Subject|0
159954|NCT00603512|565800|P1|Overall Study|Withdrawal by Subject|0
159955|NCT00603512|565796|P5|Overall Study|Other|1
159956|NCT00603512|565797|P4|Overall Study|Other|1
159957|NCT00603512|565798|P3|Overall Study|Other|0
159958|NCT00603512|565799|P2|Overall Study|Other|1
159959|NCT00603512|565800|P1|Overall Study|Other|2
159960|NCT00603512|565796|P5|Overall Study|Lack of Efficacy|1
159961|NCT00603512|565797|P4|Overall Study|Lack of Efficacy|0
159962|NCT00603512|565798|P3|Overall Study|Lack of Efficacy|0
159963|NCT00603512|565799|P2|Overall Study|Lack of Efficacy|1
159964|NCT00603512|565800|P1|Overall Study|Lack of Efficacy|0
159965|NCT00603512|565796|P5|Overall Study|Adverse Event|2
159966|NCT00603512|565797|P4|Overall Study|Adverse Event|4
159967|NCT00603512|565798|P3|Overall Study|Adverse Event|4
159968|NCT00603512|565799|P2|Overall Study|Adverse Event|2
159969|NCT00603512|565800|P1|Overall Study|Adverse Event|0
159970|NCT00603473|565942|P1|Overall Study|Protocol Violation|1
159971|NCT00603473|565942|P1|Overall Study|Lack of Efficacy|4
159972|NCT00603473|565942|P1|Overall Study|Adverse Event|4
159973|NCT00603447|565955|P7|Overall Study|Withdrew Consent|1
159974|NCT00603447|565956|P6|Overall Study|Withdrew Consent|0
159975|NCT00603447|565957|P5|Overall Study|Withdrew Consent|1
159976|NCT00603447|565958|P4|Overall Study|Withdrew Consent|0
159977|NCT00603447|565959|P3|Overall Study|Withdrew Consent|0
159978|NCT00603447|565960|P2|Overall Study|Withdrew Consent|2
159979|NCT00603447|565961|P1|Overall Study|Withdrew Consent|0
159980|NCT00603447|565955|P7|Overall Study|Other|13
159981|NCT00603447|565956|P6|Overall Study|Other|0
159982|NCT00603447|565957|P5|Overall Study|Other|3
159983|NCT00603447|565958|P4|Overall Study|Other|0
159984|NCT00603447|565959|P3|Overall Study|Other|1
159985|NCT00603447|565960|P2|Overall Study|Other|0
159986|NCT00603447|565961|P1|Overall Study|Other|0
159987|NCT00603447|565955|P7|Overall Study|Adverse Event|10
159988|NCT00603447|565956|P6|Overall Study|Adverse Event|2
159989|NCT00603447|565957|P5|Overall Study|Adverse Event|1
159990|NCT00603447|565958|P4|Overall Study|Adverse Event|2
159991|NCT00603447|565959|P3|Overall Study|Adverse Event|1
159992|NCT00603447|565960|P2|Overall Study|Adverse Event|1
159993|NCT00603447|565961|P1|Overall Study|Adverse Event|0
159994|NCT00603382|566000|P6|Overall Study|Withdrawal by Subject|1
159995|NCT00603382|566001|P5|Overall Study|Withdrawal by Subject|0
159997|NCT00603382|566003|P3|Overall Study|Withdrawal by Subject|1
159998|NCT00603382|566004|P2|Overall Study|Withdrawal by Subject|3
159999|NCT00603382|566005|P1|Overall Study|Withdrawal by Subject|3
160000|NCT00603382|566000|P6|Overall Study|Physician Decision|3
160001|NCT00603382|566001|P5|Overall Study|Physician Decision|1
160002|NCT00603382|566002|P4|Overall Study|Physician Decision|0
160003|NCT00603382|566003|P3|Overall Study|Physician Decision|2
160004|NCT00603382|566004|P2|Overall Study|Physician Decision|0
160005|NCT00603382|566005|P1|Overall Study|Physician Decision|0
160006|NCT00603382|566000|P6|Overall Study|Lost to Follow-up|1
160007|NCT00603382|566001|P5|Overall Study|Lost to Follow-up|0
160008|NCT00603382|566002|P4|Overall Study|Lost to Follow-up|1
160009|NCT00603382|566003|P3|Overall Study|Lost to Follow-up|1
160010|NCT00603382|566004|P2|Overall Study|Lost to Follow-up|1
160011|NCT00603382|566005|P1|Overall Study|Lost to Follow-up|0
160012|NCT00603382|566000|P6|Overall Study|Protocol Violation|0
160013|NCT00603382|566001|P5|Overall Study|Protocol Violation|1
160014|NCT00603382|566002|P4|Overall Study|Protocol Violation|2
160015|NCT00603382|566003|P3|Overall Study|Protocol Violation|1
160016|NCT00603382|566004|P2|Overall Study|Protocol Violation|0
160017|NCT00603382|566005|P1|Overall Study|Protocol Violation|1
160018|NCT00603382|566000|P6|Overall Study|Lack of Efficacy|11
160019|NCT00603382|566001|P5|Overall Study|Lack of Efficacy|6
160020|NCT00603382|566002|P4|Overall Study|Lack of Efficacy|6
160021|NCT00603382|566003|P3|Overall Study|Lack of Efficacy|3
160022|NCT00603382|566004|P2|Overall Study|Lack of Efficacy|9
160023|NCT00603382|566005|P1|Overall Study|Lack of Efficacy|14
160024|NCT00603382|566000|P6|Overall Study|Adverse Event|2
160025|NCT00603382|566001|P5|Overall Study|Adverse Event|1
160026|NCT00603382|566002|P4|Overall Study|Adverse Event|2
160027|NCT00603382|566003|P3|Overall Study|Adverse Event|1
160028|NCT00603382|566004|P2|Overall Study|Adverse Event|1
160029|NCT00603382|566005|P1|Overall Study|Adverse Event|0
160030|NCT00603304|566153|P2|Overall Study|Patient Decision|0
160031|NCT00603304|566154|P1|Overall Study|Patient Decision|2
160032|NCT00603304|566153|P2|Overall Study|Not Specified|0
160033|NCT00603304|566154|P1|Overall Study|Not Specified|2
160034|NCT00603304|566153|P2|Overall Study|Moved Away|2
160035|NCT00603304|566154|P1|Overall Study|Moved Away|0
160036|NCT00603304|566153|P2|Overall Study|Non-Compliant|1
160037|NCT00603304|566154|P1|Overall Study|Non-Compliant|0
160038|NCT00603304|566153|P2|Overall Study|Exclusionary Medication|3
160039|NCT00603304|566154|P1|Overall Study|Exclusionary Medication|2
160040|NCT00603304|566153|P2|Overall Study|Crossed Over to Open Label Therapy|3
160041|NCT00603304|566154|P1|Overall Study|Crossed Over to Open Label Therapy|3
160042|NCT00603304|566153|P2|Overall Study|Unacceptable Treatment Toxicity|8
160043|NCT00603304|566154|P1|Overall Study|Unacceptable Treatment Toxicity|5
160044|NCT00603304|566153|P2|Overall Study|Adverse Event|2
160045|NCT00603304|566154|P1|Overall Study|Adverse Event|4
160046|NCT00603304|566153|P2|Overall Study|Protocol Violation|0
160047|NCT00603304|566154|P1|Overall Study|Protocol Violation|1
160048|NCT00603304|566153|P2|Overall Study|Withdrawal by Subject|5
160049|NCT00603304|566154|P1|Overall Study|Withdrawal by Subject|8
160050|NCT00603304|566153|P2|Overall Study|Lost to Follow-up|7
160051|NCT00603304|566154|P1|Overall Study|Lost to Follow-up|5
160052|NCT00603278|566210|P6|Overall Study|Lost to Follow-up|0
160053|NCT00603278|566211|P5|Overall Study|Lost to Follow-up|1
160054|NCT00603278|566212|P4|Overall Study|Lost to Follow-up|0
160055|NCT00603278|566213|P3|Overall Study|Lost to Follow-up|0
160056|NCT00603278|566214|P2|Overall Study|Lost to Follow-up|0
160057|NCT00603278|566215|P1|Overall Study|Lost to Follow-up|1
160058|NCT00603278|566210|P6|Overall Study|Physician Decision|1
160059|NCT00603278|566211|P5|Overall Study|Physician Decision|2
160060|NCT00603278|566212|P4|Overall Study|Physician Decision|0
160061|NCT00603278|566213|P3|Overall Study|Physician Decision|0
160062|NCT00603278|566214|P2|Overall Study|Physician Decision|1
160063|NCT00603278|566215|P1|Overall Study|Physician Decision|0
160064|NCT00603278|566210|P6|Overall Study|Protocol Violation|1
160065|NCT00603278|566211|P5|Overall Study|Protocol Violation|0
160066|NCT00603278|566212|P4|Overall Study|Protocol Violation|1
160067|NCT00603278|566213|P3|Overall Study|Protocol Violation|1
160068|NCT00603278|566214|P2|Overall Study|Protocol Violation|0
160069|NCT00603278|566215|P1|Overall Study|Protocol Violation|3
160070|NCT00603278|566210|P6|Overall Study|Withdrawal by Subject|2
160071|NCT00603278|566211|P5|Overall Study|Withdrawal by Subject|1
160072|NCT00603278|566212|P4|Overall Study|Withdrawal by Subject|2
160073|NCT00603278|566213|P3|Overall Study|Withdrawal by Subject|1
160074|NCT00603278|566214|P2|Overall Study|Withdrawal by Subject|3
160075|NCT00603278|566215|P1|Overall Study|Withdrawal by Subject|2
160076|NCT00603278|566210|P6|Overall Study|Adverse Event|1
160077|NCT00603278|566211|P5|Overall Study|Adverse Event|2
160078|NCT00603278|566212|P4|Overall Study|Adverse Event|0
160079|NCT00603278|566213|P3|Overall Study|Adverse Event|1
160080|NCT00603278|566214|P2|Overall Study|Adverse Event|3
160081|NCT00603278|566215|P1|Overall Study|Adverse Event|0
160082|NCT00603278|566210|P6|Overall Study|Lack of Efficacy|14
160083|NCT00603278|566211|P5|Overall Study|Lack of Efficacy|7
160084|NCT00603278|566212|P4|Overall Study|Lack of Efficacy|8
160085|NCT00603278|566213|P3|Overall Study|Lack of Efficacy|11
160086|NCT00603278|566214|P2|Overall Study|Lack of Efficacy|10
160087|NCT00603278|566215|P1|Overall Study|Lack of Efficacy|35
160088|NCT00603265|566364|P3|Overall Study|Protocol Violation|0
160089|NCT00603265|566365|P2|Overall Study|Protocol Violation|0
160090|NCT00603265|566366|P1|Overall Study|Protocol Violation|1
160091|NCT00603265|566364|P3|Overall Study|Participant Left Country, No Responses|0
160092|NCT00603265|566365|P2|Overall Study|Participant Left Country, No Responses|1
160093|NCT00603265|566366|P1|Overall Study|Participant Left Country, No Responses|0
160094|NCT00603265|566364|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
160095|NCT00603265|566365|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
160096|NCT00603265|566366|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
160097|NCT00603265|566364|P3|Overall Study|Lost to Follow-up|0
160098|NCT00603265|566365|P2|Overall Study|Lost to Follow-up|1
160099|NCT00603265|566366|P1|Overall Study|Lost to Follow-up|0
160100|NCT00603265|566364|P3|Overall Study|Lack of Efficacy|3
160101|NCT00603265|566365|P2|Overall Study|Lack of Efficacy|0
160102|NCT00603265|566366|P1|Overall Study|Lack of Efficacy|3
160103|NCT00603265|566364|P3|Overall Study|Withdrawal by Subject|1
160104|NCT00603265|566365|P2|Overall Study|Withdrawal by Subject|2
160105|NCT00603265|566366|P1|Overall Study|Withdrawal by Subject|1
160106|NCT00603265|566364|P3|Overall Study|Adverse Event|1
160107|NCT00603265|566365|P2|Overall Study|Adverse Event|11
160108|NCT00603265|566366|P1|Overall Study|Adverse Event|2
160109|NCT00603239|566394|P2|Overall Study|Subject decision|1
160110|NCT00603239|566395|P1|Overall Study|Subject decision|2
160111|NCT00603239|566394|P2|Overall Study|Protocol Violation|0
160112|NCT00603239|566395|P1|Overall Study|Protocol Violation|2
160113|NCT00603239|566394|P2|Overall Study|Physician Decision|0
160114|NCT00603239|566395|P1|Overall Study|Physician Decision|2
160115|NCT00603239|566394|P2|Overall Study|Lost to Follow-up|1
160116|NCT00603239|566395|P1|Overall Study|Lost to Follow-up|2
160117|NCT00603239|566394|P2|Overall Study|Loss of glucose control|0
160118|NCT00603239|566395|P1|Overall Study|Loss of glucose control|3
160119|NCT00603239|566394|P2|Overall Study|Entry criteria not met|1
160120|NCT00603239|566395|P1|Overall Study|Entry criteria not met|0
160121|NCT00603239|566394|P2|Overall Study|Adverse Event|1
160122|NCT00603239|566395|P1|Overall Study|Adverse Event|4
160123|NCT00602979|566456|P5|Overall Study|Failed Intubation|0
160124|NCT00602979|566457|P4|Overall Study|Failed Intubation|1
160125|NCT00602979|566458|P3|Overall Study|Failed Intubation|0
160126|NCT00602979|566459|P2|Overall Study|Failed Intubation|1
160127|NCT00602979|566460|P1|Overall Study|Failed Intubation|0
160128|NCT00602979|566456|P5|Overall Study|Lost to Follow-up|3
160129|NCT00602979|566457|P4|Overall Study|Lost to Follow-up|2
160130|NCT00602979|566458|P3|Overall Study|Lost to Follow-up|3
160131|NCT00602979|566459|P2|Overall Study|Lost to Follow-up|2
160132|NCT00602979|566460|P1|Overall Study|Lost to Follow-up|3
160133|NCT00602927|566510|P2|Period 3: 13 Days|MRI data quality|2
160134|NCT00602927|566511|P1|Period 3: 13 Days|MRI data quality|2
160135|NCT00602927|566510|P2|Period 3: 13 Days|Protocol Violation|1
160136|NCT00602927|566511|P1|Period 3: 13 Days|Protocol Violation|0
160137|NCT00602927|566510|P2|Period 2: 14 Days|Protocol Violation|2
160138|NCT00602927|566511|P1|Period 2: 14 Days|Protocol Violation|0
160139|NCT00602927|566510|P2|Period 1: 13 Days|Claustrophobia|1
160140|NCT00602927|566511|P1|Period 1: 13 Days|Claustrophobia|0
160141|NCT00602927|566510|P2|Period 1: 13 Days|Time|0
160142|NCT00602927|566511|P1|Period 1: 13 Days|Time|1
160143|NCT00602927|566510|P2|Period 1: 13 Days|MRI scanner technical issue|0
160144|NCT00602927|566511|P1|Period 1: 13 Days|MRI scanner technical issue|1
160145|NCT00602927|566510|P2|Period 1: 13 Days|Protocol Violation|4
160146|NCT00602927|566511|P1|Period 1: 13 Days|Protocol Violation|2
160147|NCT00602797|566523|P1|Overall Study|Adverse Event|1
160148|NCT00602641|566540|P2|Overall Study|Other|1
160149|NCT00602641|566541|P1|Overall Study|Other|3
160150|NCT00602641|566540|P2|Overall Study|Administrative Closure|1
160151|NCT00602641|566541|P1|Overall Study|Administrative Closure|1
160152|NCT00602641|566540|P2|Overall Study|Physician Decision|4
160153|NCT00602641|566541|P1|Overall Study|Physician Decision|5
160154|NCT00602641|566540|P2|Overall Study|Other Complicating Disease|2
160155|NCT00602641|566541|P1|Overall Study|Other Complicating Disease|5
160156|NCT00602641|566540|P2|Overall Study|Alternative therapy|2
160157|NCT00602641|566541|P1|Overall Study|Alternative therapy|5
160158|NCT00602641|566540|P2|Overall Study|Withdrawal by Subject|12
160159|NCT00602641|566541|P1|Overall Study|Withdrawal by Subject|15
160160|NCT00602641|566540|P2|Overall Study|Death|5
160161|NCT00602641|566541|P1|Overall Study|Death|6
160162|NCT00602641|566540|P2|Overall Study|Disease progression|55
160163|NCT00602641|566541|P1|Overall Study|Disease progression|38
160164|NCT00602641|566540|P2|Overall Study|Adverse Event|53
160165|NCT00602641|566541|P1|Overall Study|Adverse Event|62
160166|NCT00602641|566540|P2|Overall Study|Still on treatment at time of analysis|15
160167|NCT00602641|566541|P1|Overall Study|Still on treatment at time of analysis|8
160168|NCT00602641|566540|P2|Overall Study|Never started protocol therapy|2
160169|NCT00602641|566541|P1|Overall Study|Never started protocol therapy|6
160170|NCT00602537|566555|P2|Follow Up Study Comparison|Withdrawal by Subject|2
160171|NCT00602537|566556|P1|Follow Up Study Comparison|Withdrawal by Subject|2
160172|NCT00602537|566555|P2|Follow Up Study Comparison|Lost to Follow-up|1
160173|NCT00602537|566556|P1|Follow Up Study Comparison|Lost to Follow-up|8
160174|NCT00602537|566555|P2|Follow Up Study Comparison|Adverse Event|0
160175|NCT00602537|566556|P1|Follow Up Study Comparison|Adverse Event|1
160176|NCT00602537|566555|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
160177|NCT00602537|566556|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
160178|NCT00602537|566555|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
160179|NCT00602537|566556|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
160180|NCT00602537|566555|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
160181|NCT00602537|566556|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
160182|NCT00602537|566555|P2|12 Week Double Blind Comparison|Adverse Event|5
160183|NCT00602537|566556|P1|12 Week Double Blind Comparison|Adverse Event|2
160184|NCT00602472|566566|P2|Overall Study|Other incl. lack of efficacy|2
160185|NCT00602472|566567|P1|Overall Study|Other incl. lack of efficacy|4
160186|NCT00602472|566566|P2|Overall Study|Withdrawal by Subject|14
160187|NCT00602472|566567|P1|Overall Study|Withdrawal by Subject|8
160188|NCT00602472|566566|P2|Overall Study|Protocol Violation|19
160189|NCT00602472|566567|P1|Overall Study|Protocol Violation|4
160190|NCT00602472|566566|P2|Overall Study|Adverse Event|23
160191|NCT00602472|566567|P1|Overall Study|Adverse Event|5
160192|NCT00602420|566627|P2|Overall Study|Adverse Event|0
160193|NCT00602420|566628|P1|Overall Study|Adverse Event|1
160194|NCT00602420|566627|P2|Overall Study|Withdrawal by Subject|17
160195|NCT00602420|566628|P1|Overall Study|Withdrawal by Subject|18
160196|NCT00602420|566627|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
160197|NCT00602420|566628|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
160198|NCT00602420|566627|P2|Overall Study|Death|4
160199|NCT00602420|566628|P1|Overall Study|Death|1
160200|NCT00601900|566736|P2|Overall Study|Withdrawal by Subject|3
160201|NCT00601900|566737|P1|Overall Study|Withdrawal by Subject|0
160202|NCT00601835|566753|P2|Overall Study|Relocate|2
160203|NCT00601835|566754|P1|Overall Study|Relocate|12
160204|NCT00601835|566753|P2|Overall Study|Adverse Event|1
160205|NCT00601835|566754|P1|Overall Study|Adverse Event|1
160206|NCT00601835|566753|P2|Overall Study|Lost to Follow-up|5
160207|NCT00601835|566754|P1|Overall Study|Lost to Follow-up|37
160208|NCT00601835|566753|P2|Overall Study|Physician Decision|0
160209|NCT00601835|566754|P1|Overall Study|Physician Decision|1
160210|NCT00601835|566753|P2|Overall Study|Withdrawal by Subject|6
160211|NCT00601835|566754|P1|Overall Study|Withdrawal by Subject|9
160212|NCT00601640|566846|P3|Overall Study|change in eligibility status|1
160213|NCT00601640|566847|P2|Overall Study|change in eligibility status|1
160214|NCT00601640|566848|P1|Overall Study|change in eligibility status|0
160215|NCT00601640|566846|P3|Overall Study|intercurrent illness|0
160216|NCT00601640|566847|P2|Overall Study|intercurrent illness|0
160217|NCT00601640|566848|P1|Overall Study|intercurrent illness|1
160218|NCT00601640|566846|P3|Overall Study|Adverse Event|2
160219|NCT00601640|566847|P2|Overall Study|Adverse Event|4
160220|NCT00601640|566848|P1|Overall Study|Adverse Event|0
160221|NCT00601640|566846|P3|Overall Study|Death|0
160222|NCT00601640|566847|P2|Overall Study|Death|0
160223|NCT00601640|566848|P1|Overall Study|Death|1
160224|NCT00601640|566846|P3|Overall Study|Withdrawal by Subject|7
160225|NCT00601640|566847|P2|Overall Study|Withdrawal by Subject|0
160226|NCT00601640|566848|P1|Overall Study|Withdrawal by Subject|3
160227|NCT00601523|566873|P2|Overall Study|not specified|1
160228|NCT00601523|566874|P1|Overall Study|not specified|9
160229|NCT00601523|566873|P2|Overall Study|Withdrawal by Subject|9
160230|NCT00601523|566874|P1|Overall Study|Withdrawal by Subject|18
160231|NCT00601523|566873|P2|Overall Study|Lost to Follow-up|1
160232|NCT00601523|566874|P1|Overall Study|Lost to Follow-up|0
160233|NCT00601523|566873|P2|Overall Study|Protocol Violation|1
160234|NCT00601523|566874|P1|Overall Study|Protocol Violation|5
160235|NCT00601523|566873|P2|Overall Study|Lack of Efficacy|0
160236|NCT00601523|566874|P1|Overall Study|Lack of Efficacy|3
160237|NCT00601523|566873|P2|Overall Study|Adverse Event|14
160238|NCT00601523|566874|P1|Overall Study|Adverse Event|42
160239|NCT00601458|566909|P3|Overall Study|Early Termination|1
160240|NCT00601458|566910|P2|Overall Study|Early Termination|1
160241|NCT00601458|566911|P1|Overall Study|Early Termination|0
160242|NCT00601458|566909|P3|Overall Study|Protocol Violation|1
160243|NCT00601458|566910|P2|Overall Study|Protocol Violation|2
160244|NCT00601458|566911|P1|Overall Study|Protocol Violation|3
160245|NCT00601458|566909|P3|Overall Study|Incomplete Data|0
160246|NCT00601458|566910|P2|Overall Study|Incomplete Data|2
160247|NCT00601458|566911|P1|Overall Study|Incomplete Data|0
160248|NCT00601458|566909|P3|Overall Study|Dosing Error|0
160249|NCT00601458|566910|P2|Overall Study|Dosing Error|0
160250|NCT00601458|566911|P1|Overall Study|Dosing Error|1
160251|NCT00601419|566922|P1|Overall Study|Missed Visits|1
160252|NCT00601419|566922|P1|Overall Study|Lost to Follow-up|3
160253|NCT00601354|566952|P2|Overall Study|Lost to Follow-up|5
160254|NCT00601354|566953|P1|Overall Study|Lost to Follow-up|4
160255|NCT00601250|566965|P2|Overall Study|Other incl. lack of efficacy|9
160256|NCT00601250|566966|P1|Overall Study|Other incl. lack of efficacy|2
160257|NCT00601250|566965|P2|Overall Study|Withdrawal by Subject|13
160258|NCT00601250|566966|P1|Overall Study|Withdrawal by Subject|4
160259|NCT00601250|566965|P2|Overall Study|Lost to Follow-up|6
160260|NCT00601250|566966|P1|Overall Study|Lost to Follow-up|2
160261|NCT00601250|566965|P2|Overall Study|Protocol Violation|2
160262|NCT00601250|566966|P1|Overall Study|Protocol Violation|3
160263|NCT00601250|566965|P2|Overall Study|Adverse Event|9
160264|NCT00601250|566966|P1|Overall Study|Adverse Event|3
160265|NCT00601172|567002|P2|Overall Study|Did not meet continuation criteria|20
160266|NCT00601172|567003|P1|Overall Study|Did not meet continuation criteria|19
160267|NCT00601172|567002|P2|Overall Study|Withdrawal by Subject|27
160268|NCT00601172|567003|P1|Overall Study|Withdrawal by Subject|35
160269|NCT00601172|567002|P2|Overall Study|Physician Decision|28
160270|NCT00601172|567003|P1|Overall Study|Physician Decision|27
160271|NCT00601172|567002|P2|Overall Study|Lost to Follow-up|3
160272|NCT00601172|567003|P1|Overall Study|Lost to Follow-up|4
160273|NCT00601172|567002|P2|Overall Study|Protocol Violation|5
160274|NCT00601172|567003|P1|Overall Study|Protocol Violation|2
160275|NCT00601172|567002|P2|Overall Study|Lack of Efficacy|12
160276|NCT00601172|567003|P1|Overall Study|Lack of Efficacy|11
160277|NCT00601172|567002|P2|Overall Study|Adverse Event|32
160278|NCT00601172|567003|P1|Overall Study|Adverse Event|43
160279|NCT00601107|567060|P4|Overall Study|Undefined|0
160280|NCT00601107|567061|P3|Overall Study|Undefined|1
160281|NCT00601107|567062|P2|Overall Study|Undefined|0
160282|NCT00601107|567063|P1|Overall Study|Undefined|1
160283|NCT00601107|567060|P4|Overall Study|Worsening of Psoriasis|4
160284|NCT00601107|567061|P3|Overall Study|Worsening of Psoriasis|1
160285|NCT00601107|567062|P2|Overall Study|Worsening of Psoriasis|1
160286|NCT00601107|567063|P1|Overall Study|Worsening of Psoriasis|4
160287|NCT00601107|567060|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
160288|NCT00601107|567061|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
160289|NCT00601107|567062|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
160290|NCT00601107|567063|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
160291|NCT00601107|567060|P4|Overall Study|Lost to Follow-up|3
160292|NCT00601107|567061|P3|Overall Study|Lost to Follow-up|0
160293|NCT00601107|567062|P2|Overall Study|Lost to Follow-up|3
160294|NCT00601107|567063|P1|Overall Study|Lost to Follow-up|3
160295|NCT00601107|567060|P4|Overall Study|Withdrawal by Subject|4
160296|NCT00601107|567061|P3|Overall Study|Withdrawal by Subject|7
160297|NCT00601107|567062|P2|Overall Study|Withdrawal by Subject|4
160298|NCT00601107|567063|P1|Overall Study|Withdrawal by Subject|5
160299|NCT00601107|567060|P4|Overall Study|Adverse Event|0
160300|NCT00601107|567061|P3|Overall Study|Adverse Event|3
160301|NCT00601107|567062|P2|Overall Study|Adverse Event|1
160302|NCT00601107|567063|P1|Overall Study|Adverse Event|0
160303|NCT00600938|567083|P4|Extension Study|Death|0
160304|NCT00600938|567084|P3|Extension Study|Death|0
160305|NCT00600938|567085|P2|Extension Study|Death|0
160306|NCT00600938|567086|P1|Extension Study|Death|1
160307|NCT00600938|567083|P4|Extension Study|Lost to Follow-up|0
160308|NCT00600938|567084|P3|Extension Study|Lost to Follow-up|2
160309|NCT00600938|567085|P2|Extension Study|Lost to Follow-up|1
160310|NCT00600938|567086|P1|Extension Study|Lost to Follow-up|1
160311|NCT00600938|567083|P4|Extension Study|Withdrawal by Subject|0
160312|NCT00600938|567084|P3|Extension Study|Withdrawal by Subject|3
160313|NCT00600938|567085|P2|Extension Study|Withdrawal by Subject|2
160314|NCT00600938|567086|P1|Extension Study|Withdrawal by Subject|2
160315|NCT00600938|567083|P4|Extension Study|Unsatisfactory therapeutic effect|0
160316|NCT00600938|567084|P3|Extension Study|Unsatisfactory therapeutic effect|1
160317|NCT00600938|567085|P2|Extension Study|Unsatisfactory therapeutic effect|1
160318|NCT00600938|567086|P1|Extension Study|Unsatisfactory therapeutic effect|4
160319|NCT00600938|567083|P4|Extension Study|Abnormal test procedure results|1
160320|NCT00600938|567084|P3|Extension Study|Abnormal test procedure results|1
160321|NCT00600938|567085|P2|Extension Study|Abnormal test procedure results|1
160322|NCT00600938|567086|P1|Extension Study|Abnormal test procedure results|0
160323|NCT00600938|567083|P4|Extension Study|Adverse Event|0
160324|NCT00600938|567084|P3|Extension Study|Adverse Event|2
160325|NCT00600938|567085|P2|Extension Study|Adverse Event|0
160326|NCT00600938|567086|P1|Extension Study|Adverse Event|1
160327|NCT00600938|567083|P4|Core Study|Protocol Violation|0
160328|NCT00600938|567084|P3|Core Study|Protocol Violation|0
160329|NCT00600938|567085|P2|Core Study|Protocol Violation|2
160330|NCT00600938|567086|P1|Core Study|Protocol Violation|1
160331|NCT00600938|567083|P4|Core Study|Death|0
160332|NCT00600938|567084|P3|Core Study|Death|0
160333|NCT00600938|567085|P2|Core Study|Death|1
160334|NCT00600938|567086|P1|Core Study|Death|1
160335|NCT00600938|567083|P4|Core Study|Lost to Follow-up|0
160336|NCT00600938|567084|P3|Core Study|Lost to Follow-up|0
160337|NCT00600938|567085|P2|Core Study|Lost to Follow-up|2
160338|NCT00600938|567086|P1|Core Study|Lost to Follow-up|3
160339|NCT00600938|567083|P4|Core Study|Patient withdrew consent|0
160340|NCT00600938|567084|P3|Core Study|Patient withdrew consent|0
160341|NCT00600938|567085|P2|Core Study|Patient withdrew consent|12
160342|NCT00600938|567086|P1|Core Study|Patient withdrew consent|7
160343|NCT00600938|567083|P4|Core Study|Unsatisfactory therapeutic effect|0
160344|NCT00600938|567084|P3|Core Study|Unsatisfactory therapeutic effect|0
160345|NCT00600938|567085|P2|Core Study|Unsatisfactory therapeutic effect|2
160346|NCT00600938|567086|P1|Core Study|Unsatisfactory therapeutic effect|1
160347|NCT00600938|567083|P4|Core Study|Abnormal test procedure result(s)|0
160348|NCT00600938|567084|P3|Core Study|Abnormal test procedure result(s)|0
160349|NCT00600938|567085|P2|Core Study|Abnormal test procedure result(s)|2
160350|NCT00600938|567086|P1|Core Study|Abnormal test procedure result(s)|3
160351|NCT00600886|567150|P2|Extension - After Crossover (CAS)|Death|0
160352|NCT00600886|567151|P1|Extension - After Crossover (CAS)|Death|1
160353|NCT00600886|567150|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
160354|NCT00600886|567151|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
160355|NCT00600886|567150|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
160356|NCT00600886|567151|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
160357|NCT00600886|567150|P2|Extension - After Crossover (CAS)|Administrative Problems|4
160358|NCT00600886|567151|P1|Extension - After Crossover (CAS)|Administrative Problems|4
160359|NCT00600886|567150|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
160360|NCT00600886|567151|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
160361|NCT00600886|567150|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
160362|NCT00600886|567151|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
160363|NCT00600886|567150|P2|Extension - After Crossover (CAS)|Adverse Event|1
160364|NCT00600886|567151|P1|Extension - After Crossover (CAS)|Adverse Event|19
160365|NCT00600886|567150|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
160366|NCT00600886|567151|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
160367|NCT00600886|567150|P2|Extension - Same Treatment (FAS)|Death|1
160368|NCT00600886|567151|P1|Extension - Same Treatment (FAS)|Death|1
160369|NCT00600886|567150|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
160370|NCT00600886|567151|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
160371|NCT00600886|567150|P2|Extension - Same Treatment (FAS)|Adverse Event|1
160372|NCT00600886|567151|P1|Extension - Same Treatment (FAS)|Adverse Event|4
160373|NCT00600886|567150|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
160374|NCT00600886|567151|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
160375|NCT00600886|567150|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
160376|NCT00600886|567151|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
160377|NCT00600886|567150|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
160378|NCT00600886|567151|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
160379|NCT00600886|567150|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
160380|NCT00600886|567151|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
160381|NCT00600886|567150|P2|Core Phase - Full Analysis Set (FAS)|Death|1
160382|NCT00600886|567151|P1|Core Phase - Full Analysis Set (FAS)|Death|0
160383|NCT00600886|567150|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
160384|NCT00600886|567151|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
160385|NCT00600886|567150|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
160386|NCT00600886|567151|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
160387|NCT00600886|567150|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
160388|NCT00600886|567151|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
160389|NCT00600886|567150|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
160390|NCT00600886|567151|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
160391|NCT00600886|567150|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
160392|NCT00600886|567151|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
160393|NCT00600886|567150|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
160394|NCT00600886|567151|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
160395|NCT00600886|567150|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
160396|NCT00600886|567151|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
160397|NCT00600821|567215|P2|Overall Study|Other|3
160398|NCT00600821|567216|P1|Overall Study|Other|2
160399|NCT00600821|567215|P2|Overall Study|Randomized but not treated|1
160400|NCT00600821|567216|P1|Overall Study|Randomized but not treated|0
160401|NCT00600821|567215|P2|Overall Study|Objective progression or relapse|1
160402|NCT00600821|567216|P1|Overall Study|Objective progression or relapse|0
160403|NCT00600821|567215|P2|Overall Study|Terminated by sponsor|6
160404|NCT00600821|567216|P1|Overall Study|Terminated by sponsor|8
160405|NCT00600821|567215|P2|Overall Study|Withdrawal by Subject|1
160406|NCT00600821|567216|P1|Overall Study|Withdrawal by Subject|1
160407|NCT00600821|567215|P2|Overall Study|Lost to Follow-up|2
160408|NCT00600821|567216|P1|Overall Study|Lost to Follow-up|2
160409|NCT00600821|567215|P2|Overall Study|Death|46
160410|NCT00600821|567216|P1|Overall Study|Death|45
160411|NCT00600756|567244|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
160412|NCT00600756|567245|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
160413|NCT00600756|567244|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
160414|NCT00600756|567245|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
160415|NCT00600756|567244|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
160416|NCT00600756|567245|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
160417|NCT00600756|567244|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
160418|NCT00600756|567245|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
160419|NCT00600756|567244|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
160420|NCT00600756|567245|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
160667|NCT00599313|567830|P1|Overall Study|Disease Progression|12
160421|NCT00600756|567244|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
160422|NCT00600756|567245|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
160423|NCT00600756|567244|P2|Overall Study Analysis After 12 Months|Adverse Event|44
160424|NCT00600756|567245|P1|Overall Study Analysis After 12 Months|Adverse Event|53
160425|NCT00600756|567244|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
160426|NCT00600756|567245|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
160427|NCT00600756|567244|P2|Analysis After 6 Months|Lost to Follow-up|8
160428|NCT00600756|567245|P1|Analysis After 6 Months|Lost to Follow-up|10
160429|NCT00600756|567244|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
160430|NCT00600756|567245|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
160431|NCT00600756|567244|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
160432|NCT00600756|567245|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
160433|NCT00600756|567244|P2|Analysis After 6 Months|Incorrect Enrollment|21
160434|NCT00600756|567245|P1|Analysis After 6 Months|Incorrect Enrollment|12
160435|NCT00600756|567244|P2|Analysis After 6 Months|Withdrawal by Subject|30
160436|NCT00600756|567245|P1|Analysis After 6 Months|Withdrawal by Subject|38
160437|NCT00600756|567244|P2|Analysis After 6 Months|Adverse Event|33
160438|NCT00600756|567245|P1|Analysis After 6 Months|Adverse Event|43
160439|NCT00600613|567354|P1|Overall Study|Protocol Deviation|1
160440|NCT00600353|567360|P2|Overall Study|History of prepartive regimen|1
160441|NCT00600353|567361|P1|Overall Study|History of prepartive regimen|0
160442|NCT00600353|567360|P2|Overall Study|history of malignancy within 5 years|0
160443|NCT00600353|567361|P1|Overall Study|history of malignancy within 5 years|1
160444|NCT00600171|567379|P6|Overall Study|Lost to Follow-up|0
160445|NCT00600171|567380|P5|Overall Study|Lost to Follow-up|0
160446|NCT00600171|567381|P4|Overall Study|Lost to Follow-up|1
160447|NCT00600171|567382|P3|Overall Study|Lost to Follow-up|0
160448|NCT00600171|567383|P2|Overall Study|Lost to Follow-up|0
160449|NCT00600171|567384|P1|Overall Study|Lost to Follow-up|0
160450|NCT00600171|567379|P6|Overall Study|Physician Decision|2
160451|NCT00600171|567380|P5|Overall Study|Physician Decision|0
160452|NCT00600171|567381|P4|Overall Study|Physician Decision|1
160453|NCT00600171|567382|P3|Overall Study|Physician Decision|0
160454|NCT00600171|567383|P2|Overall Study|Physician Decision|1
160455|NCT00600171|567384|P1|Overall Study|Physician Decision|0
160456|NCT00600171|567379|P6|Overall Study|Withdrawal by Subject|1
160457|NCT00600171|567380|P5|Overall Study|Withdrawal by Subject|1
160458|NCT00600171|567381|P4|Overall Study|Withdrawal by Subject|1
160459|NCT00600171|567382|P3|Overall Study|Withdrawal by Subject|0
160460|NCT00600171|567383|P2|Overall Study|Withdrawal by Subject|0
160461|NCT00600171|567384|P1|Overall Study|Withdrawal by Subject|3
160462|NCT00600171|567379|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
160463|NCT00600171|567380|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
160464|NCT00600171|567381|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
160465|NCT00600171|567382|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
160466|NCT00600171|567383|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
160467|NCT00600171|567384|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
160468|NCT00600171|567379|P6|Overall Study|Protocol Violation|0
160469|NCT00600171|567380|P5|Overall Study|Protocol Violation|0
160470|NCT00600171|567381|P4|Overall Study|Protocol Violation|1
160471|NCT00600171|567382|P3|Overall Study|Protocol Violation|0
160472|NCT00600171|567383|P2|Overall Study|Protocol Violation|2
160473|NCT00600171|567384|P1|Overall Study|Protocol Violation|1
160474|NCT00600171|567379|P6|Overall Study|Lack of Efficacy|0
160475|NCT00600171|567380|P5|Overall Study|Lack of Efficacy|4
160476|NCT00600171|567381|P4|Overall Study|Lack of Efficacy|5
160477|NCT00600171|567382|P3|Overall Study|Lack of Efficacy|3
160478|NCT00600171|567383|P2|Overall Study|Lack of Efficacy|12
160479|NCT00600171|567384|P1|Overall Study|Lack of Efficacy|9
160480|NCT00600171|567379|P6|Overall Study|Adverse Event|0
160481|NCT00600171|567380|P5|Overall Study|Adverse Event|1
160482|NCT00600171|567381|P4|Overall Study|Adverse Event|0
160483|NCT00600171|567382|P3|Overall Study|Adverse Event|0
160484|NCT00600171|567383|P2|Overall Study|Adverse Event|1
160485|NCT00600171|567384|P1|Overall Study|Adverse Event|0
160486|NCT00600119|567458|P6|Follow-up Period|Other|0
160487|NCT00600119|567459|P5|Follow-up Period|Other|0
160488|NCT00600119|567460|P4|Follow-up Period|Other|0
160489|NCT00600119|567461|P3|Follow-up Period|Other|0
160490|NCT00600119|567462|P2|Follow-up Period|Other|0
160491|NCT00600119|567463|P1|Follow-up Period|Other|1
160492|NCT00600119|567458|P6|Follow-up Period|Adverse Event|1
160493|NCT00600119|567459|P5|Follow-up Period|Adverse Event|0
160494|NCT00600119|567460|P4|Follow-up Period|Adverse Event|0
160495|NCT00600119|567461|P3|Follow-up Period|Adverse Event|0
160496|NCT00600119|567462|P2|Follow-up Period|Adverse Event|0
160497|NCT00600119|567463|P1|Follow-up Period|Adverse Event|0
160498|NCT00600119|567458|P6|Double-blind Treatment Period|Adverse Event|10
160499|NCT00600119|567459|P5|Double-blind Treatment Period|Adverse Event|2
160500|NCT00600119|567460|P4|Double-blind Treatment Period|Adverse Event|1
160501|NCT00600119|567461|P3|Double-blind Treatment Period|Adverse Event|0
160502|NCT00600119|567462|P2|Double-blind Treatment Period|Adverse Event|1
160503|NCT00600119|567463|P1|Double-blind Treatment Period|Adverse Event|1
160504|NCT00600119|567458|P6|Double-blind Treatment Period|Lost to Follow-up|0
160505|NCT00600119|567459|P5|Double-blind Treatment Period|Lost to Follow-up|0
160506|NCT00600119|567460|P4|Double-blind Treatment Period|Lost to Follow-up|0
160507|NCT00600119|567461|P3|Double-blind Treatment Period|Lost to Follow-up|0
160508|NCT00600119|567462|P2|Double-blind Treatment Period|Lost to Follow-up|1
160509|NCT00600119|567463|P1|Double-blind Treatment Period|Lost to Follow-up|0
160510|NCT00600119|567458|P6|Double-blind Treatment Period|Physician Decision|0
160511|NCT00600119|567459|P5|Double-blind Treatment Period|Physician Decision|0
160512|NCT00600119|567460|P4|Double-blind Treatment Period|Physician Decision|0
160513|NCT00600119|567461|P3|Double-blind Treatment Period|Physician Decision|0
160514|NCT00600119|567462|P2|Double-blind Treatment Period|Physician Decision|0
160515|NCT00600119|567463|P1|Double-blind Treatment Period|Physician Decision|2
160516|NCT00600119|567458|P6|Double-blind Treatment Period|Sponsor Decision|0
160517|NCT00600119|567459|P5|Double-blind Treatment Period|Sponsor Decision|1
160518|NCT00600119|567460|P4|Double-blind Treatment Period|Sponsor Decision|0
160519|NCT00600119|567461|P3|Double-blind Treatment Period|Sponsor Decision|0
160520|NCT00600119|567462|P2|Double-blind Treatment Period|Sponsor Decision|1
160521|NCT00600119|567463|P1|Double-blind Treatment Period|Sponsor Decision|0
160522|NCT00600119|567458|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
160523|NCT00600119|567459|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
160524|NCT00600119|567460|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
160525|NCT00600119|567461|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
160526|NCT00600119|567462|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
160527|NCT00600119|567463|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
160528|NCT00600119|567458|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
160529|NCT00600119|567459|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
160530|NCT00600119|567460|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
160531|NCT00600119|567461|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
160532|NCT00600119|567462|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
160533|NCT00600119|567463|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
160534|NCT00600119|567458|P6|Double-blind Treatment Period|Other|1
160535|NCT00600119|567459|P5|Double-blind Treatment Period|Other|2
160536|NCT00600119|567460|P4|Double-blind Treatment Period|Other|0
160537|NCT00600119|567461|P3|Double-blind Treatment Period|Other|0
160538|NCT00600119|567462|P2|Double-blind Treatment Period|Other|0
160539|NCT00600119|567463|P1|Double-blind Treatment Period|Other|0
160540|NCT00600119|567458|P6|Double-blind Treatment Period|Withdrawal by Subject|3
160541|NCT00600119|567459|P5|Double-blind Treatment Period|Withdrawal by Subject|0
160542|NCT00600119|567460|P4|Double-blind Treatment Period|Withdrawal by Subject|1
160543|NCT00600119|567461|P3|Double-blind Treatment Period|Withdrawal by Subject|0
160544|NCT00600119|567462|P2|Double-blind Treatment Period|Withdrawal by Subject|0
160545|NCT00600119|567463|P1|Double-blind Treatment Period|Withdrawal by Subject|2
160546|NCT00600119|567458|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
160547|NCT00600119|567459|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
160548|NCT00600119|567460|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
160549|NCT00600119|567461|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
160550|NCT00600119|567462|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
160551|NCT00600119|567463|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
160552|NCT00600119|567458|P6|Single-blind Placebo run-in Period|Adverse Event|1
160553|NCT00600119|567459|P5|Single-blind Placebo run-in Period|Adverse Event|0
160554|NCT00600119|567460|P4|Single-blind Placebo run-in Period|Adverse Event|1
160555|NCT00600119|567461|P3|Single-blind Placebo run-in Period|Adverse Event|0
160556|NCT00600119|567462|P2|Single-blind Placebo run-in Period|Adverse Event|0
160557|NCT00600119|567463|P1|Single-blind Placebo run-in Period|Adverse Event|0
160558|NCT00600119|567458|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
160559|NCT00600119|567459|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
160560|NCT00600119|567460|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
160561|NCT00600119|567461|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
160562|NCT00600119|567462|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
160563|NCT00600119|567463|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
160564|NCT00600119|567458|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
160565|NCT00600119|567459|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
160566|NCT00600119|567460|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
160567|NCT00600119|567461|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
160568|NCT00600119|567462|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
160569|NCT00600119|567463|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
160570|NCT00600119|567458|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
160571|NCT00600119|567459|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
160572|NCT00600119|567460|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
160573|NCT00600119|567461|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
160574|NCT00600119|567462|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
160575|NCT00600119|567463|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
160576|NCT00600119|567458|P6|Single-blind Placebo run-in Period|Other - Not specified|1
160577|NCT00600119|567459|P5|Single-blind Placebo run-in Period|Other - Not specified|1
160578|NCT00600119|567460|P4|Single-blind Placebo run-in Period|Other - Not specified|0
160579|NCT00600119|567461|P3|Single-blind Placebo run-in Period|Other - Not specified|0
160580|NCT00600119|567462|P2|Single-blind Placebo run-in Period|Other - Not specified|0
160581|NCT00600119|567463|P1|Single-blind Placebo run-in Period|Other - Not specified|1
160582|NCT00600106|567497|P2|Overall Study|Withdrawal by Subject|1
160583|NCT00600106|567498|P1|Overall Study|Withdrawal by Subject|1
160584|NCT00600067|567545|P2|Overall Study|Lack of Efficacy|0
160585|NCT00600067|567546|P1|Overall Study|Lack of Efficacy|1
160586|NCT00600067|567545|P2|Overall Study|protocol non-compliance|3
160587|NCT00600067|567546|P1|Overall Study|protocol non-compliance|0
160588|NCT00600067|567545|P2|Overall Study|Lost to Follow-up|3
160589|NCT00600067|567546|P1|Overall Study|Lost to Follow-up|2
160590|NCT00600067|567545|P2|Overall Study|Adverse Event|1
160591|NCT00600067|567546|P1|Overall Study|Adverse Event|0
160592|NCT00600028|567556|P2|Second Intervention (12 Weeks)|Adverse Event|2
160593|NCT00600028|567557|P1|Second Intervention (12 Weeks)|Adverse Event|0
160594|NCT00600028|567556|P2|First Intervention (12 Weeks)|Adverse Event|1
160595|NCT00600028|567557|P1|First Intervention (12 Weeks)|Adverse Event|0
160596|NCT00600028|567556|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
160597|NCT00600028|567557|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
160598|NCT00599924|567587|P7|Overall Study|Other|2
160599|NCT00599924|567588|P6|Overall Study|Other|0
160600|NCT00599924|567589|P5|Overall Study|Other|2
160601|NCT00599924|567590|P4|Overall Study|Other|1
160602|NCT00599924|567591|P3|Overall Study|Other|0
160603|NCT00599924|567592|P2|Overall Study|Other|0
160604|NCT00599924|567593|P1|Overall Study|Other|0
160605|NCT00599924|567587|P7|Overall Study|Withdrawal by Subject|0
160606|NCT00599924|567588|P6|Overall Study|Withdrawal by Subject|0
160607|NCT00599924|567589|P5|Overall Study|Withdrawal by Subject|1
160608|NCT00599924|567590|P4|Overall Study|Withdrawal by Subject|0
160609|NCT00599924|567591|P3|Overall Study|Withdrawal by Subject|1
160610|NCT00599924|567592|P2|Overall Study|Withdrawal by Subject|0
160611|NCT00599924|567593|P1|Overall Study|Withdrawal by Subject|0
160612|NCT00599924|567587|P7|Overall Study|Protocol Violation|0
160613|NCT00599924|567588|P6|Overall Study|Protocol Violation|0
160614|NCT00599924|567589|P5|Overall Study|Protocol Violation|0
160615|NCT00599924|567590|P4|Overall Study|Protocol Violation|1
160616|NCT00599924|567591|P3|Overall Study|Protocol Violation|0
160617|NCT00599924|567592|P2|Overall Study|Protocol Violation|0
160618|NCT00599924|567593|P1|Overall Study|Protocol Violation|0
160619|NCT00599924|567587|P7|Overall Study|Death|1
160620|NCT00599924|567588|P6|Overall Study|Death|2
160621|NCT00599924|567589|P5|Overall Study|Death|0
160622|NCT00599924|567590|P4|Overall Study|Death|2
160623|NCT00599924|567591|P3|Overall Study|Death|0
160624|NCT00599924|567592|P2|Overall Study|Death|0
160625|NCT00599924|567593|P1|Overall Study|Death|0
160626|NCT00599924|567587|P7|Overall Study|Adverse Event|2
160627|NCT00599924|567588|P6|Overall Study|Adverse Event|0
160628|NCT00599924|567589|P5|Overall Study|Adverse Event|0
160629|NCT00599924|567590|P4|Overall Study|Adverse Event|2
160630|NCT00599924|567591|P3|Overall Study|Adverse Event|0
160631|NCT00599924|567592|P2|Overall Study|Adverse Event|0
160632|NCT00599924|567593|P1|Overall Study|Adverse Event|0
160633|NCT00599924|567587|P7|Overall Study|Lack of Efficacy|0
160634|NCT00599924|567588|P6|Overall Study|Lack of Efficacy|2
160635|NCT00599924|567589|P5|Overall Study|Lack of Efficacy|3
160636|NCT00599924|567590|P4|Overall Study|Lack of Efficacy|2
160637|NCT00599924|567591|P3|Overall Study|Lack of Efficacy|1
160638|NCT00599924|567592|P2|Overall Study|Lack of Efficacy|5
160639|NCT00599924|567593|P1|Overall Study|Lack of Efficacy|3
160640|NCT00599755|567697|P1|Overall Study|No data available|1
160641|NCT00599755|567697|P1|Overall Study|Other Reason|2
160642|NCT00599755|567697|P1|Overall Study|Progression of Disease|3
160643|NCT00599755|567697|P1|Overall Study|Withdrawal by Subject|2
160644|NCT00599755|567697|P1|Overall Study|Adverse Event|11
160645|NCT00599521|567708|P2|Overall Study|Pregnancy|2
160646|NCT00599521|567709|P1|Overall Study|Pregnancy|0
160647|NCT00599521|567708|P2|Overall Study|Lost to Follow-up|23
160648|NCT00599521|567709|P1|Overall Study|Lost to Follow-up|23
160649|NCT00599521|567708|P2|Overall Study|Protocol Violation|1
160650|NCT00599521|567709|P1|Overall Study|Protocol Violation|1
160651|NCT00599521|567708|P2|Overall Study|Withdrawal by Subject|34
160652|NCT00599521|567709|P1|Overall Study|Withdrawal by Subject|28
160653|NCT00599521|567708|P2|Overall Study|Adverse Event|1
160654|NCT00599521|567709|P1|Overall Study|Adverse Event|4
160655|NCT00599521|567708|P2|Overall Study|Lack of Efficacy|8
160656|NCT00599521|567709|P1|Overall Study|Lack of Efficacy|4
160657|NCT00599339|567723|P1|Overall Study|Study Termination Status Unknown|12
160658|NCT00599339|567723|P1|Overall Study|No valid data consent|36
160659|NCT00599339|567723|P1|Overall Study|Lost to Follow-up|221
160660|NCT00599339|567723|P1|Overall Study|Other Reason|179
160661|NCT00599339|567723|P1|Overall Study|Withdrawal by Subject|137
160662|NCT00599339|567723|P1|Overall Study|Adverse Event|79
160663|NCT00599326|567825|P1|Overall Study|Noncompliant|1
160664|NCT00599326|567825|P1|Overall Study|Lost to Follow-up|1
160665|NCT00599313|567830|P1|Overall Study|Ineligible|1
160666|NCT00599313|567830|P1|Overall Study|Patient Request|4
160668|NCT00599313|567830|P1|Overall Study|Adverse Event|19
160669|NCT00599196|567872|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
160670|NCT00599196|567872|P1|Overall Study|Other: Patient Stopped Due To Moving|1
160671|NCT00599196|567872|P1|Overall Study|Other: Pt Moved To Australia|1
160672|NCT00599196|567872|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
160673|NCT00599196|567872|P1|Overall Study|Other: Spouse Withdrew Consent|1
160674|NCT00599196|567872|P1|Overall Study|Other: Patient Leaving For Israel|1
160675|NCT00599196|567872|P1|Overall Study|Lost to Follow-up|17
160676|NCT00599196|567872|P1|Overall Study|Study ended per sponsor|197
160677|NCT00599196|567872|P1|Overall Study|Subject withdrew consent|43
160678|NCT00599196|567872|P1|Overall Study|Unsatisfactory compliance of subject|3
160679|NCT00599196|567872|P1|Overall Study|Adverse Event|93
160680|NCT00599196|567872|P1|Overall Study|Lack of Efficacy|22
160681|NCT00599027|567903|P2|Overall Study|Treatment Failure|1
160682|NCT00599027|567904|P1|Overall Study|Treatment Failure|0
160683|NCT00599027|567903|P2|Overall Study|Adverse Event|1
160684|NCT00599027|567904|P1|Overall Study|Adverse Event|0
160685|NCT00599027|567903|P2|Overall Study|Withdrawal by Subject|1
160686|NCT00599027|567904|P1|Overall Study|Withdrawal by Subject|1
160687|NCT00598871|567917|P2|Overall Study|Adverse Event|1
160688|NCT00598871|567918|P1|Overall Study|Adverse Event|0
160689|NCT00598832|567928|P2|Overall Study|Non compliance|0
160690|NCT00598832|567929|P1|Overall Study|Non compliance|1
160691|NCT00598832|567928|P2|Overall Study|Physician Decision|4
160692|NCT00598832|567929|P1|Overall Study|Physician Decision|1
160693|NCT00598832|567928|P2|Overall Study|Pregnancy|2
160694|NCT00598832|567929|P1|Overall Study|Pregnancy|2
160695|NCT00598832|567928|P2|Overall Study|Lost to Follow-up|29
160696|NCT00598832|567929|P1|Overall Study|Lost to Follow-up|24
160697|NCT00598832|567928|P2|Overall Study|Protocol Violation|2
160698|NCT00598832|567929|P1|Overall Study|Protocol Violation|0
160699|NCT00598832|567928|P2|Overall Study|Withdrawal by Subject|36
160700|NCT00598832|567929|P1|Overall Study|Withdrawal by Subject|25
160701|NCT00598832|567928|P2|Overall Study|Adverse Event|2
160702|NCT00598832|567929|P1|Overall Study|Adverse Event|6
160703|NCT00598832|567928|P2|Overall Study|Lack of Efficacy|7
160704|NCT00598832|567929|P1|Overall Study|Lack of Efficacy|3
160705|NCT00598702|567982|P8|Overall Study|Dose limiting toxicity|0
160706|NCT00598702|567983|P7|Overall Study|Dose limiting toxicity|0
160707|NCT00598702|567984|P6|Overall Study|Dose limiting toxicity|1
160708|NCT00598702|567985|P5|Overall Study|Dose limiting toxicity|1
160709|NCT00598702|567986|P4|Overall Study|Dose limiting toxicity|1
160710|NCT00598702|567987|P3|Overall Study|Dose limiting toxicity|0
160711|NCT00598702|567988|P2|Overall Study|Dose limiting toxicity|0
160712|NCT00598702|567989|P1|Overall Study|Dose limiting toxicity|0
160713|NCT00598702|567982|P8|Overall Study|Physician Decision|0
160714|NCT00598702|567983|P7|Overall Study|Physician Decision|0
160715|NCT00598702|567984|P6|Overall Study|Physician Decision|0
160716|NCT00598702|567985|P5|Overall Study|Physician Decision|1
160717|NCT00598702|567986|P4|Overall Study|Physician Decision|0
160718|NCT00598702|567987|P3|Overall Study|Physician Decision|0
160719|NCT00598702|567988|P2|Overall Study|Physician Decision|0
160720|NCT00598702|567989|P1|Overall Study|Physician Decision|0
160721|NCT00598702|567982|P8|Overall Study|Withdrawal by Subject|0
160722|NCT00598702|567983|P7|Overall Study|Withdrawal by Subject|0
160723|NCT00598702|567984|P6|Overall Study|Withdrawal by Subject|0
160724|NCT00598702|567985|P5|Overall Study|Withdrawal by Subject|1
160725|NCT00598702|567986|P4|Overall Study|Withdrawal by Subject|1
160726|NCT00598702|567987|P3|Overall Study|Withdrawal by Subject|0
160727|NCT00598702|567988|P2|Overall Study|Withdrawal by Subject|0
160728|NCT00598702|567989|P1|Overall Study|Withdrawal by Subject|0
160729|NCT00598702|567982|P8|Overall Study|Adverse Event|0
160730|NCT00598702|567983|P7|Overall Study|Adverse Event|0
160731|NCT00598702|567984|P6|Overall Study|Adverse Event|0
160732|NCT00598702|567985|P5|Overall Study|Adverse Event|0
160733|NCT00598702|567986|P4|Overall Study|Adverse Event|1
160734|NCT00598702|567987|P3|Overall Study|Adverse Event|0
160735|NCT00598702|567988|P2|Overall Study|Adverse Event|0
160736|NCT00598702|567989|P1|Overall Study|Adverse Event|0
160737|NCT00598702|567982|P8|Overall Study|Early discharge from hospital|0
160738|NCT00598702|567983|P7|Overall Study|Early discharge from hospital|1
160739|NCT00598702|567984|P6|Overall Study|Early discharge from hospital|10
160740|NCT00598702|567985|P5|Overall Study|Early discharge from hospital|0
160741|NCT00598702|567986|P4|Overall Study|Early discharge from hospital|5
160742|NCT00598702|567987|P3|Overall Study|Early discharge from hospital|2
160743|NCT00598702|567988|P2|Overall Study|Early discharge from hospital|0
160744|NCT00598702|567989|P1|Overall Study|Early discharge from hospital|0
160745|NCT00598702|567982|P8|Overall Study|Not specified|0
160746|NCT00598702|567983|P7|Overall Study|Not specified|0
160747|NCT00598702|567984|P6|Overall Study|Not specified|1
160748|NCT00598702|567985|P5|Overall Study|Not specified|0
160749|NCT00598702|567986|P4|Overall Study|Not specified|0
160750|NCT00598702|567987|P3|Overall Study|Not specified|0
160751|NCT00598702|567988|P2|Overall Study|Not specified|2
160752|NCT00598702|567989|P1|Overall Study|Not specified|0
160753|NCT00598650|568044|P1|Overall Study|Physician Decision|2
160754|NCT00598650|568044|P1|Overall Study|Prohibited Concomitant Medication|2
160755|NCT00598650|568044|P1|Overall Study|Not eligible|1
160756|NCT00598650|568044|P1|Overall Study|No treatment for 3 weeks|1
160757|NCT00598650|568044|P1|Overall Study|Adverse Event|18
160758|NCT00598650|568044|P1|Overall Study|Withdrawal by Subject|3
160759|NCT00598585|568053|P2|Overall Study|Lost to Follow-up|0
160760|NCT00598585|568054|P1|Overall Study|Lost to Follow-up|1
160761|NCT00598559|568063|P3|Overall Study|Subject unable/unwilling to attend visit|0
160762|NCT00598559|568064|P2|Overall Study|Subject unable/unwilling to attend visit|7
160763|NCT00598559|568065|P1|Overall Study|Subject unable/unwilling to attend visit|4
160764|NCT00598559|568063|P3|Overall Study|Early discharge from hospital|3
160765|NCT00598559|568064|P2|Overall Study|Early discharge from hospital|12
160766|NCT00598559|568065|P1|Overall Study|Early discharge from hospital|9
160767|NCT00598559|568063|P3|Overall Study|Protocol Non-compliance|0
160768|NCT00598559|568064|P2|Overall Study|Protocol Non-compliance|0
160769|NCT00598559|568065|P1|Overall Study|Protocol Non-compliance|1
160770|NCT00598559|568063|P3|Overall Study|Withdrawal by Subject|0
160771|NCT00598559|568064|P2|Overall Study|Withdrawal by Subject|2
160772|NCT00598559|568065|P1|Overall Study|Withdrawal by Subject|2
160773|NCT00598559|568063|P3|Overall Study|Adverse Event|0
160774|NCT00598559|568064|P2|Overall Study|Adverse Event|7
160775|NCT00598559|568065|P1|Overall Study|Adverse Event|11
160776|NCT00598442|568092|P3|Overall Study|Started dialysis|0
160777|NCT00598442|568093|P2|Overall Study|Started dialysis|0
160778|NCT00598442|568094|P1|Overall Study|Started dialysis|1
160779|NCT00598442|568092|P3|Overall Study|Site closed by sponsor|1
160780|NCT00598442|568093|P2|Overall Study|Site closed by sponsor|2
160781|NCT00598442|568094|P1|Overall Study|Site closed by sponsor|5
160782|NCT00598442|568092|P3|Overall Study|Renal transplant|1
160783|NCT00598442|568093|P2|Overall Study|Renal transplant|0
160784|NCT00598442|568094|P1|Overall Study|Renal transplant|0
160785|NCT00598442|568092|P3|Overall Study|Relocation|0
160786|NCT00598442|568093|P2|Overall Study|Relocation|4
160787|NCT00598442|568094|P1|Overall Study|Relocation|1
160788|NCT00598442|568092|P3|Overall Study|Noncompliance|1
160789|NCT00598442|568093|P2|Overall Study|Noncompliance|2
160790|NCT00598442|568094|P1|Overall Study|Noncompliance|0
160791|NCT00598442|568092|P3|Overall Study|Withdrawal by Subject|6
160792|NCT00598442|568093|P2|Overall Study|Withdrawal by Subject|16
160793|NCT00598442|568094|P1|Overall Study|Withdrawal by Subject|8
160794|NCT00598442|568092|P3|Overall Study|Physician Decision|1
160795|NCT00598442|568093|P2|Overall Study|Physician Decision|1
160796|NCT00598442|568094|P1|Overall Study|Physician Decision|2
160797|NCT00598442|568092|P3|Overall Study|Lost to Follow-up|3
160798|NCT00598442|568093|P2|Overall Study|Lost to Follow-up|3
160799|NCT00598442|568094|P1|Overall Study|Lost to Follow-up|4
160800|NCT00598442|568092|P3|Overall Study|Death|11
160801|NCT00598442|568093|P2|Overall Study|Death|11
160802|NCT00598442|568094|P1|Overall Study|Death|19
160803|NCT00598442|568092|P3|Overall Study|Adverse Event|0
160804|NCT00598442|568093|P2|Overall Study|Adverse Event|0
160805|NCT00598442|568094|P1|Overall Study|Adverse Event|3
160806|NCT00598273|568111|P3|Overall Study|Started dialysis|5
160807|NCT00598273|568112|P2|Overall Study|Started dialysis|4
160808|NCT00598273|568113|P1|Overall Study|Started dialysis|6
160809|NCT00598273|568111|P3|Overall Study|Site elected to close|0
160810|NCT00598273|568112|P2|Overall Study|Site elected to close|0
160811|NCT00598273|568113|P1|Overall Study|Site elected to close|1
160812|NCT00598273|568111|P3|Overall Study|Renal transplant|1
160813|NCT00598273|568112|P2|Overall Study|Renal transplant|0
160814|NCT00598273|568113|P1|Overall Study|Renal transplant|1
160815|NCT00598273|568111|P3|Overall Study|Relocation|4
160816|NCT00598273|568112|P2|Overall Study|Relocation|2
160817|NCT00598273|568113|P1|Overall Study|Relocation|0
160818|NCT00598273|568111|P3|Overall Study|Noncompliance|3
160819|NCT00598273|568112|P2|Overall Study|Noncompliance|2
160820|NCT00598273|568113|P1|Overall Study|Noncompliance|3
160821|NCT00598273|568111|P3|Overall Study|Withdrawal by Subject|10
160822|NCT00598273|568112|P2|Overall Study|Withdrawal by Subject|10
160823|NCT00598273|568113|P1|Overall Study|Withdrawal by Subject|12
160824|NCT00598273|568111|P3|Overall Study|Physician Decision|1
160825|NCT00598273|568112|P2|Overall Study|Physician Decision|0
160826|NCT00598273|568113|P1|Overall Study|Physician Decision|0
160827|NCT00598273|568111|P3|Overall Study|Lost to Follow-up|5
160828|NCT00598273|568112|P2|Overall Study|Lost to Follow-up|3
160829|NCT00598273|568113|P1|Overall Study|Lost to Follow-up|8
160830|NCT00598273|568111|P3|Overall Study|Death|8
160831|NCT00598273|568112|P2|Overall Study|Death|12
160832|NCT00598273|568113|P1|Overall Study|Death|6
160833|NCT00598273|568111|P3|Overall Study|Adverse Event|2
160834|NCT00598273|568112|P2|Overall Study|Adverse Event|5
160835|NCT00598273|568113|P1|Overall Study|Adverse Event|4
160836|NCT00598078|568127|P2|Period 2 (Day 2)|Adverse Event|0
160837|NCT00598078|568128|P1|Period 2 (Day 2)|Adverse Event|1
160838|NCT00597766|568181|P3|Follow-up 2, Week 8|Lost to Follow-up|1
160839|NCT00597766|568182|P2|Follow-up 2, Week 8|Lost to Follow-up|0
160840|NCT00597766|568183|P1|Follow-up 2, Week 8|Lost to Follow-up|0
160841|NCT00597766|568181|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
160842|NCT00597766|568182|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
160843|NCT00597766|568183|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
160844|NCT00597753|568202|P2|Overall Study|Site elected to close|4
160845|NCT00597753|568203|P1|Overall Study|Site elected to close|2
160846|NCT00597753|568202|P2|Overall Study|Site closed by sponsor|7
160847|NCT00597753|568203|P1|Overall Study|Site closed by sponsor|19
160848|NCT00597753|568202|P2|Overall Study|Renal transplant|3
160849|NCT00597753|568203|P1|Overall Study|Renal transplant|10
160850|NCT00597753|568202|P2|Overall Study|Relocation|6
160851|NCT00597753|568203|P1|Overall Study|Relocation|17
160852|NCT00597753|568202|P2|Overall Study|Noncompliance|1
160853|NCT00597753|568203|P1|Overall Study|Noncompliance|2
160854|NCT00597753|568202|P2|Overall Study|Never dosed|0
160855|NCT00597753|568203|P1|Overall Study|Never dosed|2
160856|NCT00597753|568202|P2|Overall Study|Discontinued Dialysis|1
160857|NCT00597753|568203|P1|Overall Study|Discontinued Dialysis|0
160858|NCT00597753|568202|P2|Overall Study|Withdrawal by Subject|12
160859|NCT00597753|568203|P1|Overall Study|Withdrawal by Subject|35
160860|NCT00597753|568202|P2|Overall Study|Pregnancy|0
160861|NCT00597753|568203|P1|Overall Study|Pregnancy|1
160862|NCT00597753|568202|P2|Overall Study|Physician Decision|1
160863|NCT00597753|568203|P1|Overall Study|Physician Decision|5
160864|NCT00597753|568202|P2|Overall Study|Lost to Follow-up|3
160865|NCT00597753|568203|P1|Overall Study|Lost to Follow-up|10
160866|NCT00597753|568202|P2|Overall Study|Lack of Efficacy|0
160867|NCT00597753|568203|P1|Overall Study|Lack of Efficacy|2
160868|NCT00597753|568202|P2|Overall Study|Death|29
160869|NCT00597753|568203|P1|Overall Study|Death|55
160870|NCT00597753|568202|P2|Overall Study|Adverse Event|2
160871|NCT00597753|568203|P1|Overall Study|Adverse Event|6
160872|NCT00597714|568237|P3|Overall Study|Recipient death|10
160873|NCT00597714|568238|P2|Overall Study|Recipient death|0
160874|NCT00597714|568239|P1|Overall Study|Recipient death|0
160875|NCT00597714|568237|P3|Overall Study|Death|0
160876|NCT00597714|568238|P2|Overall Study|Death|46
160877|NCT00597714|568239|P1|Overall Study|Death|56
160878|NCT00597701|568251|P2|Overall Study|Did not start intervention (pharmacy er)|2
160879|NCT00597701|568252|P1|Overall Study|Did not start intervention (pharmacy er)|0
160880|NCT00597701|568251|P2|Overall Study|Physician Decision|0
160881|NCT00597701|568252|P1|Overall Study|Physician Decision|2
160882|NCT00597701|568251|P2|Overall Study|Death|1
160883|NCT00597701|568252|P1|Overall Study|Death|0
160884|NCT00597701|568251|P2|Overall Study|Withdrawal by Subject|5
160885|NCT00597701|568252|P1|Overall Study|Withdrawal by Subject|5
160886|NCT00597584|568274|P2|Overall Study|Renal transplant|7
160887|NCT00597584|568275|P1|Overall Study|Renal transplant|9
160888|NCT00597584|568274|P2|Overall Study|Relocation|6
160889|NCT00597584|568275|P1|Overall Study|Relocation|8
160890|NCT00597584|568274|P2|Overall Study|Never dosed|0
160891|NCT00597584|568275|P1|Overall Study|Never dosed|1
160892|NCT00597584|568274|P2|Overall Study|Lost ability to consent|1
160893|NCT00597584|568275|P1|Overall Study|Lost ability to consent|1
160894|NCT00597584|568274|P2|Overall Study|Discontinued Dialysis|1
160895|NCT00597584|568275|P1|Overall Study|Discontinued Dialysis|0
160896|NCT00597584|568274|P2|Overall Study|Withdrawal by Subject|12
160897|NCT00597584|568275|P1|Overall Study|Withdrawal by Subject|44
160898|NCT00597584|568274|P2|Overall Study|Pregnancy|0
160899|NCT00597584|568275|P1|Overall Study|Pregnancy|2
160900|NCT00597584|568274|P2|Overall Study|Physician Decision|0
160901|NCT00597584|568275|P1|Overall Study|Physician Decision|3
160902|NCT00597584|568274|P2|Overall Study|Lost to Follow-up|4
160903|NCT00597584|568275|P1|Overall Study|Lost to Follow-up|2
160904|NCT00597584|568274|P2|Overall Study|Lack of Efficacy|0
160905|NCT00597584|568275|P1|Overall Study|Lack of Efficacy|1
160906|NCT00597584|568274|P2|Overall Study|Death|30
160907|NCT00597584|568275|P1|Overall Study|Death|53
160908|NCT00597584|568274|P2|Overall Study|Adverse Event|2
160909|NCT00597584|568275|P1|Overall Study|Adverse Event|4
160910|NCT00597519|568300|P1|Overall Study|Death|1
160911|NCT00597506|568304|P1|Overall Study|Subject is being followed for survival|1
160912|NCT00597376|568354|P2|Overall Study|Adverse Event|1
160913|NCT00597376|568355|P1|Overall Study|Adverse Event|4
160914|NCT00597376|568354|P2|Overall Study|Withdrawal by Subject|3
160915|NCT00597376|568355|P1|Overall Study|Withdrawal by Subject|4
160916|NCT00597207|568396|P2|Overall Study|Lost to Follow-up|7
160917|NCT00597207|568397|P1|Overall Study|Lost to Follow-up|5
160918|NCT00597116|568405|P2|Overall Study|Progressive disease|6
160919|NCT00597116|568406|P1|Overall Study|Progressive disease|11
160920|NCT00597116|568405|P2|Overall Study|Lost to Follow-up|0
160921|NCT00597116|568406|P1|Overall Study|Lost to Follow-up|1
160922|NCT00597116|568405|P2|Overall Study|Death|1
160923|NCT00597116|568406|P1|Overall Study|Death|0
160924|NCT00597116|568405|P2|Overall Study|Physician Decision|1
160925|NCT00597116|568406|P1|Overall Study|Physician Decision|0
160926|NCT00597116|568405|P2|Overall Study|Withdrawal by Subject|2
160927|NCT00597116|568406|P1|Overall Study|Withdrawal by Subject|0
160928|NCT00597116|568405|P2|Overall Study|Adverse Event|1
160929|NCT00597116|568406|P1|Overall Study|Adverse Event|2
160930|NCT00597012|568432|P2|Overall Study|Lost to Follow-up|2
160931|NCT00597012|568433|P1|Overall Study|Lost to Follow-up|0
160932|NCT00597012|568432|P2|Overall Study|Ineligible|0
160933|NCT00597012|568433|P1|Overall Study|Ineligible|2
160934|NCT00597012|568432|P2|Overall Study|Withdrawal by Subject|4
160935|NCT00597012|568433|P1|Overall Study|Withdrawal by Subject|7
160936|NCT00597012|568432|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
160937|NCT00597012|568433|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
160938|NCT00597012|568432|P2|Overall Study|Death|1
160939|NCT00597012|568433|P1|Overall Study|Death|1
160940|NCT00596960|568445|P2|Overall Study|No alcohol use data|1
160941|NCT00596960|568446|P1|Overall Study|No alcohol use data|0
160942|NCT00596960|568445|P2|Overall Study|Protocol Violation|1
160943|NCT00596960|568446|P1|Overall Study|Protocol Violation|0
160944|NCT00596960|568445|P2|Overall Study|Physician Decision|0
160945|NCT00596960|568446|P1|Overall Study|Physician Decision|1
160946|NCT00596960|568445|P2|Overall Study|Incarcerated|0
160947|NCT00596960|568446|P1|Overall Study|Incarcerated|2
160948|NCT00596960|568445|P2|Overall Study|Withdrawal by Subject|0
160949|NCT00596960|568446|P1|Overall Study|Withdrawal by Subject|1
160950|NCT00596960|568445|P2|Overall Study|Lost to Follow-up|5
160951|NCT00596960|568446|P1|Overall Study|Lost to Follow-up|6
160952|NCT00596960|568445|P2|Overall Study|Death|2
160953|NCT00596960|568446|P1|Overall Study|Death|1
160954|NCT00596947|568458|P2|Overall Study|Lost to Follow-up|0
160955|NCT00596947|568459|P1|Overall Study|Lost to Follow-up|1
160956|NCT00596947|568458|P2|Overall Study|study halted due to low enrollment|3
160957|NCT00596947|568459|P1|Overall Study|study halted due to low enrollment|5
160958|NCT00596934|568499|P1|Overall Study|Withdrawal by Subject|1
160959|NCT00596934|568499|P1|Overall Study|Protocol Violation|1
160960|NCT00596830|568512|P2|Overall Study|Randomized but not treated|7
160961|NCT00596830|568513|P1|Overall Study|Randomized but not treated|3
160962|NCT00596830|568512|P2|Overall Study|Follow-up was discontinued|0
160963|NCT00596830|568513|P1|Overall Study|Follow-up was discontinued|1
160964|NCT00596830|568512|P2|Overall Study|Study terminated by sponsor|62
160965|NCT00596830|568513|P1|Overall Study|Study terminated by sponsor|51
160966|NCT00596830|568512|P2|Overall Study|Withdrawal by Subject|12
160967|NCT00596830|568513|P1|Overall Study|Withdrawal by Subject|22
160968|NCT00596830|568512|P2|Overall Study|Lost to Follow-up|11
160969|NCT00596830|568513|P1|Overall Study|Lost to Follow-up|7
160970|NCT00596830|568512|P2|Overall Study|Death|247
160971|NCT00596830|568513|P1|Overall Study|Death|258
160972|NCT00596817|568539|P2|Double-blind Period|Other Reasons|18
160973|NCT00596817|568540|P1|Double-blind Period|Other Reasons|10
160974|NCT00596817|568539|P2|Double-blind Period|Lost to Follow-up|2
160975|NCT00596817|568540|P1|Double-blind Period|Lost to Follow-up|0
160976|NCT00596817|568539|P2|Double-blind Period|Withdrawal of Consent|3
160977|NCT00596817|568540|P1|Double-blind Period|Withdrawal of Consent|7
160978|NCT00596817|568539|P2|Double-blind Period|Protocol Violation|8
160979|NCT00596817|568540|P1|Double-blind Period|Protocol Violation|11
160980|NCT00596817|568539|P2|Double-blind Period|Non-compliance With Study Product|4
160981|NCT00596817|568540|P1|Double-blind Period|Non-compliance With Study Product|3
160982|NCT00596817|568539|P2|Double-blind Period|Lack of Efficacy|28
160983|NCT00596817|568540|P1|Double-blind Period|Lack of Efficacy|52
160984|NCT00596817|568539|P2|Double-blind Period|Adverse Event|16
160985|NCT00596817|568540|P1|Double-blind Period|Adverse Event|5
160986|NCT00596817|568539|P2|Open-label Period to Double-blind Period|Other Reasons|14
160987|NCT00596817|568540|P1|Open-label Period to Double-blind Period|Other Reasons|0
160988|NCT00596817|568539|P2|Open-label Period to Double-blind Period|Not Eligible|49
160989|NCT00596817|568540|P1|Open-label Period to Double-blind Period|Not Eligible|0
160990|NCT00596817|568539|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
160991|NCT00596817|568540|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
160992|NCT00596817|568539|P2|Open-label Period to Double-blind Period|Adverse Event|5
160993|NCT00596817|568540|P1|Open-label Period to Double-blind Period|Adverse Event|0
160994|NCT00596817|568539|P2|Open-label Period|Other Reasons|65
160995|NCT00596817|568540|P1|Open-label Period|Other Reasons|0
160996|NCT00596817|568539|P2|Open-label Period|Lack of Efficacy|33
160997|NCT00596817|568540|P1|Open-label Period|Lack of Efficacy|0
160998|NCT00596817|568539|P2|Open-label Period|Adverse Event|49
160999|NCT00596817|568540|P1|Open-label Period|Adverse Event|0
161000|NCT00596752|568565|P2|Overall Study|Protocol Violation|0
161001|NCT00596752|568566|P1|Overall Study|Protocol Violation|1
161002|NCT00596752|568565|P2|Overall Study|Lack of Efficacy|7
161003|NCT00596752|568566|P1|Overall Study|Lack of Efficacy|4
161004|NCT00596752|568565|P2|Overall Study|Unsatisfactory Compliance|6
161005|NCT00596752|568566|P1|Overall Study|Unsatisfactory Compliance|9
161006|NCT00596752|568565|P2|Overall Study|Withdrawal by Subject|9
161007|NCT00596752|568566|P1|Overall Study|Withdrawal by Subject|12
161008|NCT00596752|568565|P2|Overall Study|Lost to Follow-up|38
161009|NCT00596752|568566|P1|Overall Study|Lost to Follow-up|22
161010|NCT00596752|568565|P2|Overall Study|Adverse Event|34
161011|NCT00596752|568566|P1|Overall Study|Adverse Event|34
161012|NCT00596752|568565|P2|Overall Study|Other Reason|49
161013|NCT00596752|568566|P1|Overall Study|Other Reason|44
161014|NCT00596687|568596|P2|Overall Study|cancelled surgery|1
161015|NCT00596687|568597|P1|Overall Study|cancelled surgery|1
161016|NCT00596687|568596|P2|Overall Study|Withdrawal by Subject|1
161017|NCT00596687|568597|P1|Overall Study|Withdrawal by Subject|3
161018|NCT00596687|568596|P2|Overall Study|continuous insulin infusion during TPN|1
161019|NCT00596687|568597|P1|Overall Study|continuous insulin infusion during TPN|2
161020|NCT00596687|568596|P2|Overall Study|< 24 hours of insulin treatment|6
161021|NCT00596687|568597|P1|Overall Study|< 24 hours of insulin treatment|8
161022|NCT00596635|568608|P3|Overall Study|Could not provide urine specimen|2
161023|NCT00596635|568609|P2|Overall Study|Could not provide urine specimen|2
161024|NCT00596635|568610|P1|Overall Study|Could not provide urine specimen|1
161025|NCT00596635|568608|P3|Overall Study|Hip fracture|3
161026|NCT00596635|568609|P2|Overall Study|Hip fracture|3
161027|NCT00596635|568610|P1|Overall Study|Hip fracture|2
161028|NCT00596635|568608|P3|Overall Study|Treatment for symptomatic UTI|3
161029|NCT00596635|568609|P2|Overall Study|Treatment for symptomatic UTI|6
161030|NCT00596635|568610|P1|Overall Study|Treatment for symptomatic UTI|4
161031|NCT00596635|568608|P3|Overall Study|Lost to Follow-up|0
161032|NCT00596635|568609|P2|Overall Study|Lost to Follow-up|2
161033|NCT00596635|568610|P1|Overall Study|Lost to Follow-up|0
161034|NCT00596466|568636|P1|Overall Study|Enrolled, not treated|2
161035|NCT00596466|568636|P1|Overall Study|Unpecified|2
161036|NCT00596466|568636|P1|Overall Study|Protocol Violation|2
161037|NCT00596466|568636|P1|Overall Study|Withdrawal by Subject|2
161038|NCT00596466|568636|P1|Overall Study|Adverse Event|4
161039|NCT00596466|568636|P1|Overall Study|Lack of Efficacy|5
161040|NCT00596427|568666|P2|Overall Study|Protocol Violation|0
161041|NCT00596427|568667|P1|Overall Study|Protocol Violation|1
161042|NCT00596427|568666|P2|Overall Study|Increased Fasting Triacylglycerol level|0
161043|NCT00596427|568667|P1|Overall Study|Increased Fasting Triacylglycerol level|1
161044|NCT00596427|568666|P2|Overall Study|Withdrawal by Subject|2
161045|NCT00596427|568667|P1|Overall Study|Withdrawal by Subject|2
161046|NCT00596362|568695|P1|Overall Study|Progressive Disease|1
161047|NCT00596011|568731|P2|Overall Study|Adverse Event|7
161048|NCT00596011|568732|P1|Overall Study|Adverse Event|11
161049|NCT00596011|568731|P2|Overall Study|Withdrawal by Subject|3
161050|NCT00596011|568732|P1|Overall Study|Withdrawal by Subject|2
161051|NCT00595959|568748|P1|Overall Study|Lost to Follow-up|1
161052|NCT00595959|568748|P1|Overall Study|Withdrawal by Subject|1
161053|NCT00595920|568782|P1|Overall Study|The OLTERMS study was discontinued by th|116
161054|NCT00595868|568793|P2|Overall Study|Lost to Follow-up|50
161055|NCT00595868|568794|P1|Overall Study|Lost to Follow-up|45
161056|NCT00595764|568817|P2|Overall Study|Withdrawal by Subject|0
161057|NCT00595764|568818|P1|Overall Study|Withdrawal by Subject|4
161058|NCT00595764|568817|P2|Overall Study|Missed 3 PM visits|7
161059|NCT00595764|568818|P1|Overall Study|Missed 3 PM visits|1
161060|NCT00595764|568817|P2|Overall Study|Missed Medication >1 week|17
161061|NCT00595764|568818|P1|Overall Study|Missed Medication >1 week|10
161062|NCT00595764|568817|P2|Overall Study|Protocol Violation|19
161063|NCT00595764|568818|P1|Overall Study|Protocol Violation|24
161064|NCT00595582|568832|P1|Overall Study|Physician Decision|5
161065|NCT00595582|568832|P1|Overall Study|Adverse Event|2
161066|NCT00595582|568832|P1|Overall Study|Lost to Follow-up|1
161067|NCT00595582|568832|P1|Overall Study|Pilot study that PI terminated|2
161068|NCT00595517|568857|P1|Overall Study|No intention to attend regularly|1
161069|NCT00595517|568857|P1|Overall Study|usage of prohibited treatment|1
161070|NCT00595517|568857|P1|Overall Study|Recurrence of ulcer|5
161071|NCT00595517|568857|P1|Overall Study|Protocol Violation|2
161072|NCT00595517|568857|P1|Overall Study|Withdrawal by Subject|4
161073|NCT00595517|568857|P1|Overall Study|Adverse Event|6
161074|NCT00595504|568866|P2|Overall Study|Physician Decision|0
161075|NCT00595504|568867|P1|Overall Study|Physician Decision|1
161076|NCT00595504|568866|P2|Overall Study|Withdrawal by Subject|3
161077|NCT00595504|568867|P1|Overall Study|Withdrawal by Subject|1
161078|NCT00595478|568879|P2|36-week Follow-up Period|Withdrawal by Subject|4
161079|NCT00595478|568880|P1|36-week Follow-up Period|Withdrawal by Subject|4
161080|NCT00595478|568879|P2|36-week Follow-up Period|Lost to Follow-up|4
161081|NCT00595478|568880|P1|36-week Follow-up Period|Lost to Follow-up|5
161082|NCT00595465|568891|P3|Overall Study|administrative reason|1
161083|NCT00595465|568892|P2|Overall Study|administrative reason|0
161084|NCT00595465|568893|P1|Overall Study|administrative reason|0
161085|NCT00595465|568891|P3|Overall Study|Lost to Follow-up|2
161086|NCT00595465|568892|P2|Overall Study|Lost to Follow-up|0
161087|NCT00595465|568893|P1|Overall Study|Lost to Follow-up|0
161088|NCT00595465|568891|P3|Overall Study|Protocol Violation|0
161089|NCT00595465|568892|P2|Overall Study|Protocol Violation|1
161090|NCT00595465|568893|P1|Overall Study|Protocol Violation|2
161091|NCT00595465|568891|P3|Overall Study|Pregnancy|1
161092|NCT00595465|568892|P2|Overall Study|Pregnancy|0
161093|NCT00595465|568893|P1|Overall Study|Pregnancy|0
161094|NCT00595465|568891|P3|Overall Study|Adverse Event|3
161095|NCT00595465|568892|P2|Overall Study|Adverse Event|3
161096|NCT00595465|568893|P1|Overall Study|Adverse Event|4
161097|NCT00595413|568905|P4|Overall Study|Other|0
161098|NCT00595413|568906|P3|Overall Study|Other|5
161099|NCT00595413|568907|P2|Overall Study|Other|1
161100|NCT00595413|568908|P1|Overall Study|Other|5
161101|NCT00595413|568905|P4|Overall Study|Death|0
161102|NCT00595413|568906|P3|Overall Study|Death|1
161103|NCT00595413|568907|P2|Overall Study|Death|0
161104|NCT00595413|568908|P1|Overall Study|Death|0
161105|NCT00595413|568905|P4|Overall Study|Lost to Follow-up|3
161106|NCT00595413|568906|P3|Overall Study|Lost to Follow-up|1
161107|NCT00595413|568907|P2|Overall Study|Lost to Follow-up|2
161108|NCT00595413|568908|P1|Overall Study|Lost to Follow-up|2
161109|NCT00595413|568905|P4|Overall Study|Adverse Event|1
161110|NCT00595413|568906|P3|Overall Study|Adverse Event|1
161111|NCT00595413|568907|P2|Overall Study|Adverse Event|2
161112|NCT00595413|568908|P1|Overall Study|Adverse Event|0
161113|NCT00595335|568949|P2|Six Months to Twelve Months|Disease Progression|0
161114|NCT00595335|568950|P1|Six Months to Twelve Months|Disease Progression|1
161115|NCT00595335|568949|P2|Six Months to Twelve Months|Withdrawal by Subject|1
161116|NCT00595335|568950|P1|Six Months to Twelve Months|Withdrawal by Subject|0
161117|NCT00595335|568949|P2|Baseline to Six Months|Adverse Event|0
161118|NCT00595335|568950|P1|Baseline to Six Months|Adverse Event|1
161119|NCT00595335|568949|P2|Baseline to Six Months|Disease Progression|1
161120|NCT00595335|568950|P1|Baseline to Six Months|Disease Progression|1
161121|NCT00595335|568949|P2|Baseline to Six Months|Withdrawal by Subject|1
161122|NCT00595335|568950|P1|Baseline to Six Months|Withdrawal by Subject|0
161123|NCT00595309|568970|P1|Overall Study|personal reason|1
161124|NCT00595309|568970|P1|Overall Study|acute infection after V0|1
161125|NCT00595309|568970|P1|Overall Study|planned vaccination against yellow fever|1
161126|NCT00595309|568970|P1|Overall Study|Lost to Follow-up|1
161127|NCT00595127|569000|P1|Overall Study|joined another trial|1
161128|NCT00595127|569000|P1|Overall Study|Relapsed|3
161129|NCT00595127|569000|P1|Overall Study|Death|6
161130|NCT00595075|569022|P2|Overall Study|Withdrawal by Subject|0
161131|NCT00595075|569023|P1|Overall Study|Withdrawal by Subject|1
161132|NCT00594958|569044|P3|Overall Study|administrative|2
161133|NCT00594958|569045|P2|Overall Study|administrative|0
161134|NCT00594958|569046|P1|Overall Study|administrative|3
161135|NCT00594958|569044|P3|Overall Study|Lost to Follow-up|3
161136|NCT00594958|569045|P2|Overall Study|Lost to Follow-up|0
161137|NCT00594958|569046|P1|Overall Study|Lost to Follow-up|5
161138|NCT00594958|569044|P3|Overall Study|Protocol Violation|2
161139|NCT00594958|569045|P2|Overall Study|Protocol Violation|0
161140|NCT00594958|569046|P1|Overall Study|Protocol Violation|1
161141|NCT00594958|569044|P3|Overall Study|Pregnancy|0
161142|NCT00594958|569045|P2|Overall Study|Pregnancy|2
161143|NCT00594958|569046|P1|Overall Study|Pregnancy|0
161144|NCT00594958|569044|P3|Overall Study|Adverse Event|2
161145|NCT00594958|569045|P2|Overall Study|Adverse Event|1
161146|NCT00594958|569046|P1|Overall Study|Adverse Event|4
161147|NCT00594958|569044|P3|Overall Study|Withdrawal by Subject|1
161148|NCT00594958|569045|P2|Overall Study|Withdrawal by Subject|0
161149|NCT00594958|569046|P1|Overall Study|Withdrawal by Subject|1
161150|NCT00594906|569067|P2|Overall Study|Death|1
161151|NCT00594906|569068|P1|Overall Study|Death|0
161152|NCT00594906|569067|P2|Overall Study|Physician Decision|1
161153|NCT00594906|569068|P1|Overall Study|Physician Decision|0
161154|NCT00594906|569067|P2|Overall Study|Physician Decision|0
161155|NCT00594906|569068|P1|Overall Study|Physician Decision|1
161156|NCT00594880|569076|P2|Overall Study|Lost to Follow-up|0
161157|NCT00594880|569077|P1|Overall Study|Lost to Follow-up|1
161158|NCT00594880|569076|P2|Overall Study|Withdrawal by Subject|1
161159|NCT00594880|569077|P1|Overall Study|Withdrawal by Subject|1
161160|NCT00594854|569089|P2|Overall Study|Study terminated|10
161161|NCT00594854|569090|P1|Overall Study|Study terminated|7
161162|NCT00594815|569100|P1|Overall Study|Toxicity|4
161163|NCT00594815|569100|P1|Overall Study|Withdrawal by Subject|2
161164|NCT00594815|569100|P1|Overall Study|Never Treated|3
161165|NCT00594659|569125|P3|Overall Study|Lost to Follow-up|7
161166|NCT00594659|569126|P2|Overall Study|Lost to Follow-up|9
161167|NCT00594659|569127|P1|Overall Study|Lost to Follow-up|13
161168|NCT00594646|569138|P1|Overall Study|Lost to Follow-up|15
161169|NCT00594646|569138|P1|Overall Study|Withdrawal by Subject|1
161170|NCT00594568|569146|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
161171|NCT00594568|569147|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
161172|NCT00594568|569148|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
161173|NCT00594568|569146|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
161174|NCT00594568|569147|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
161175|NCT00594568|569148|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
161176|NCT00594568|569146|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
161177|NCT00594568|569147|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
161178|NCT00594568|569148|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
161179|NCT00594568|569146|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
161180|NCT00594568|569147|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
161181|NCT00594568|569148|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
161182|NCT00594568|569146|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
161183|NCT00594568|569147|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
161184|NCT00594568|569148|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
161185|NCT00594568|569146|P3|Safety Follow Up (SFU)-Optional|Death|0
161186|NCT00594568|569147|P2|Safety Follow Up (SFU)-Optional|Death|1
161187|NCT00594568|569148|P1|Safety Follow Up (SFU)-Optional|Death|0
161188|NCT00594568|569146|P3|Delayed Start|Sponsor Decision|59
161189|NCT00594568|569147|P2|Delayed Start|Sponsor Decision|66
161190|NCT00594568|569148|P1|Delayed Start|Sponsor Decision|77
161191|NCT00594568|569146|P3|Delayed Start|Caregiver Decision|2
161192|NCT00594568|569147|P2|Delayed Start|Caregiver Decision|6
161193|NCT00594568|569148|P1|Delayed Start|Caregiver Decision|5
161194|NCT00594568|569146|P3|Delayed Start|Lost to Follow-up|1
161195|NCT00594568|569147|P2|Delayed Start|Lost to Follow-up|0
161196|NCT00594568|569148|P1|Delayed Start|Lost to Follow-up|0
161197|NCT00594568|569146|P3|Delayed Start|Physician Decision|1
161198|NCT00594568|569147|P2|Delayed Start|Physician Decision|0
161199|NCT00594568|569148|P1|Delayed Start|Physician Decision|0
161200|NCT00594568|569146|P3|Delayed Start|Withdrawal by Subject|0
161201|NCT00594568|569147|P2|Delayed Start|Withdrawal by Subject|3
161202|NCT00594568|569148|P1|Delayed Start|Withdrawal by Subject|4
161203|NCT00594568|569146|P3|Delayed Start|Adverse Event|2
161204|NCT00594568|569147|P2|Delayed Start|Adverse Event|2
161205|NCT00594568|569148|P1|Delayed Start|Adverse Event|12
161206|NCT00594568|569146|P3|Delayed Start|Death|1
161207|NCT00594568|569147|P2|Delayed Start|Death|0
161208|NCT00594568|569148|P1|Delayed Start|Death|0
161209|NCT00594568|569146|P3|Initial Treatment|Entry criteria exclusion|1
161210|NCT00594568|569147|P2|Initial Treatment|Entry criteria exclusion|1
161211|NCT00594568|569148|P1|Initial Treatment|Entry criteria exclusion|0
161212|NCT00594568|569146|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
161213|NCT00594568|569147|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
161214|NCT00594568|569148|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
161215|NCT00594568|569146|P3|Initial Treatment|Caregiver decision|36
161216|NCT00594568|569147|P2|Initial Treatment|Caregiver decision|36
161217|NCT00594568|569148|P1|Initial Treatment|Caregiver decision|21
161218|NCT00594568|569146|P3|Initial Treatment|Sponsor decision|147
161219|NCT00594568|569147|P2|Initial Treatment|Sponsor decision|142
161220|NCT00594568|569148|P1|Initial Treatment|Sponsor decision|193
161221|NCT00594568|569146|P3|Initial Treatment|Withdrawal by Subject|46
161222|NCT00594568|569147|P2|Initial Treatment|Withdrawal by Subject|31
161223|NCT00594568|569148|P1|Initial Treatment|Withdrawal by Subject|25
161224|NCT00594568|569146|P3|Initial Treatment|Protocol Violation|5
161225|NCT00594568|569147|P2|Initial Treatment|Protocol Violation|2
161226|NCT00594568|569148|P1|Initial Treatment|Protocol Violation|2
161227|NCT00594568|569146|P3|Initial Treatment|Physician Decision|4
161228|NCT00594568|569147|P2|Initial Treatment|Physician Decision|2
161229|NCT00594568|569148|P1|Initial Treatment|Physician Decision|3
161230|NCT00594568|569146|P3|Initial Treatment|Lost to Follow-up|4
161231|NCT00594568|569147|P2|Initial Treatment|Lost to Follow-up|1
161232|NCT00594568|569148|P1|Initial Treatment|Lost to Follow-up|4
161233|NCT00594568|569146|P3|Initial Treatment|Death|15
161234|NCT00594568|569147|P2|Initial Treatment|Death|11
161235|NCT00594568|569148|P1|Initial Treatment|Death|6
161236|NCT00594568|569146|P3|Initial Treatment|Adverse Event|144
161237|NCT00594568|569147|P2|Initial Treatment|Adverse Event|121
161238|NCT00594568|569148|P1|Initial Treatment|Adverse Event|51
161239|NCT00594516|569236|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
161240|NCT00594516|569237|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
161241|NCT00594516|569238|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
161242|NCT00594516|569236|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
161243|NCT00594516|569237|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
161244|NCT00594516|569238|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
161245|NCT00594516|569236|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
161246|NCT00594516|569237|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
161247|NCT00594516|569238|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
161248|NCT00594516|569236|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
161249|NCT00594516|569237|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
161250|NCT00594516|569238|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
161251|NCT00594516|569236|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
161252|NCT00594516|569237|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
161253|NCT00594516|569238|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
161254|NCT00594516|569236|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
161255|NCT00594516|569237|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
161256|NCT00594516|569238|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
161257|NCT00594516|569236|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
161258|NCT00594516|569237|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
161259|NCT00594516|569238|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
161260|NCT00594516|569236|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
161261|NCT00594516|569237|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
161262|NCT00594516|569238|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
161263|NCT00594516|569236|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
161264|NCT00594516|569237|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
161265|NCT00594516|569238|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
161266|NCT00594464|569246|P1|Overall Study|Delay in operation|2
161267|NCT00594464|569246|P1|Overall Study|Withdrawal by Subject|1
161268|NCT00594399|569375|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
161269|NCT00594399|569376|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
161270|NCT00594399|569377|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
161271|NCT00594399|569375|P3|Rerandomization Arm 1 Only|Death|0
161272|NCT00594399|569376|P2|Rerandomization Arm 1 Only|Death|1
161273|NCT00594399|569377|P1|Rerandomization Arm 1 Only|Death|2
161274|NCT00594399|569375|P3|Initial 3 Month Counseling|Family illness|0
161275|NCT00594399|569376|P2|Initial 3 Month Counseling|Family illness|0
161276|NCT00594399|569377|P1|Initial 3 Month Counseling|Family illness|1
161277|NCT00594399|569375|P3|Initial 3 Month Counseling|Moved|0
161278|NCT00594399|569376|P2|Initial 3 Month Counseling|Moved|0
161279|NCT00594399|569377|P1|Initial 3 Month Counseling|Moved|1
161280|NCT00594399|569375|P3|Initial 3 Month Counseling|Pain|0
161281|NCT00594399|569376|P2|Initial 3 Month Counseling|Pain|0
161282|NCT00594399|569377|P1|Initial 3 Month Counseling|Pain|2
161283|NCT00594399|569375|P3|Initial 3 Month Counseling|Too busy|0
161284|NCT00594399|569376|P2|Initial 3 Month Counseling|Too busy|1
161285|NCT00594399|569377|P1|Initial 3 Month Counseling|Too busy|7
161286|NCT00594399|569375|P3|Initial 3 Month Counseling|Personal issues|0
161287|NCT00594399|569376|P2|Initial 3 Month Counseling|Personal issues|0
161288|NCT00594399|569377|P1|Initial 3 Month Counseling|Personal issues|2
161289|NCT00594399|569375|P3|Initial 3 Month Counseling|Lack of Interest|0
161290|NCT00594399|569376|P2|Initial 3 Month Counseling|Lack of Interest|3
161291|NCT00594399|569377|P1|Initial 3 Month Counseling|Lack of Interest|3
161292|NCT00594399|569375|P3|Initial 3 Month Counseling|Not ready to exercise|0
161293|NCT00594399|569376|P2|Initial 3 Month Counseling|Not ready to exercise|0
161294|NCT00594399|569377|P1|Initial 3 Month Counseling|Not ready to exercise|1
161295|NCT00594386|569399|P1|Overall Study|Other: Loss of drivers license|1
161296|NCT00594386|569399|P1|Overall Study|Other: Patient wants prescription Neupro|1
161297|NCT00594386|569399|P1|Overall Study|Other: Site terminated participation|1
161298|NCT00594386|569399|P1|Overall Study|Other: Sponsor closure of study|1
161299|NCT00594386|569399|P1|Overall Study|Other: Study terminated per investigator|2
161300|NCT00594386|569399|P1|Overall Study|Other: Subject admitted to nursing home|1
161301|NCT00594386|569399|P1|Overall Study|Other: Subject moved to Seattle|1
161302|NCT00594386|569399|P1|Overall Study|Other: Patient went off patch (hospital)|1
161303|NCT00594386|569399|P1|Overall Study|Lost to Follow-up|6
161304|NCT00594386|569399|P1|Overall Study|Study ended per sponsor|115
161305|NCT00594386|569399|P1|Overall Study|Subject withdrew consent|35
161306|NCT00594386|569399|P1|Overall Study|Unsatisfactory compliance of subject|11
161307|NCT00594386|569399|P1|Overall Study|Adverse Event|68
161308|NCT00594386|569399|P1|Overall Study|Lack of Efficacy|12
161309|NCT00594386|569399|P1|Overall Study|Major protocol violation|2
161310|NCT00594204|569432|P2|Overall Study|Randomized but not treated|1
161311|NCT00594204|569433|P1|Overall Study|Randomized but not treated|4
161312|NCT00594204|569432|P2|Overall Study|Lack of Efficacy|4
161313|NCT00594204|569433|P1|Overall Study|Lack of Efficacy|3
161314|NCT00594204|569432|P2|Overall Study|Other|3
161315|NCT00594204|569433|P1|Overall Study|Other|4
161316|NCT00594204|569432|P2|Overall Study|Withdrawal by Subject|29
161317|NCT00594204|569433|P1|Overall Study|Withdrawal by Subject|23
161318|NCT00594204|569432|P2|Overall Study|Lost to Follow-up|5
161319|NCT00594204|569433|P1|Overall Study|Lost to Follow-up|9
161320|NCT00594204|569432|P2|Overall Study|Adverse Event|3
161321|NCT00594204|569433|P1|Overall Study|Adverse Event|15
161322|NCT00594178|569443|P1|Overall Study|Physician Decision|5
161323|NCT00594165|569448|P1|Overall Study|Other: Site terminated participation|2
161324|NCT00594165|569448|P1|Overall Study|Other: Subject enrolled in other trial|1
161325|NCT00594165|569448|P1|Overall Study|Other: House bound; can't get to clinic|1
161326|NCT00594165|569448|P1|Overall Study|Other: Brain surgery controlled symptoms|1
161327|NCT00594165|569448|P1|Overall Study|Other: Subject moving|3
161328|NCT00594165|569448|P1|Overall Study|Other: PI discretion|5
161329|NCT00594165|569448|P1|Overall Study|Lost to Follow-up|4
161330|NCT00594165|569448|P1|Overall Study|Study ended per sponsor|102
161331|NCT00594165|569448|P1|Overall Study|Subject withdrew consent|27
161332|NCT00594165|569448|P1|Overall Study|Unsatisfactory compliance of subject|6
161333|NCT00594165|569448|P1|Overall Study|Adverse Event|52
161334|NCT00594165|569448|P1|Overall Study|Lack of Efficacy|12
161335|NCT00594165|569448|P1|Overall Study|Major protocol violation|1
161336|NCT00594100|569454|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
161337|NCT00594100|569454|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
161338|NCT00594100|569454|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
161339|NCT00594100|569454|P1|Procedure|Technical Failure|9
161340|NCT00594035|569470|P2|Overall Study|Subject couldn't return due to job|1
161341|NCT00594035|569471|P1|Overall Study|Subject couldn't return due to job|0
161342|NCT00594035|569470|P2|Overall Study|Subject transferred to nursing home|1
161343|NCT00594035|569471|P1|Overall Study|Subject transferred to nursing home|0
161344|NCT00594035|569470|P2|Overall Study|Withdrawal by Subject|0
161345|NCT00594035|569471|P1|Overall Study|Withdrawal by Subject|1
161346|NCT00594035|569470|P2|Overall Study|Lost to Follow-up|1
161347|NCT00594035|569471|P1|Overall Study|Lost to Follow-up|1
161348|NCT00593957|569497|P3|Overall Study|Physician Decision|2
161349|NCT00593957|569498|P2|Overall Study|Physician Decision|1
161350|NCT00593957|569499|P1|Overall Study|Physician Decision|0
161351|NCT00593918|569523|P2|Overall Study|Withdrawal by Subject|24
161352|NCT00593918|569524|P1|Overall Study|Withdrawal by Subject|5
161353|NCT00593840|569537|P1|Overall Study|Withdrawal by Subject|1
161354|NCT00593827|569549|P2|Overall Study|On Active Treatment/Pending|2
161355|NCT00593827|569550|P1|Overall Study|On Active Treatment/Pending|0
161356|NCT00593814|569574|P2|Overall Study|Physician Decision|0
161357|NCT00593814|569575|P1|Overall Study|Physician Decision|3
161358|NCT00593814|569574|P2|Overall Study|Lost to Follow-up|0
161359|NCT00593814|569575|P1|Overall Study|Lost to Follow-up|7
161360|NCT00593814|569574|P2|Overall Study|Withdrawal by Subject|0
161361|NCT00593814|569575|P1|Overall Study|Withdrawal by Subject|7
161362|NCT00593814|569574|P2|Overall Study|Death|0
161363|NCT00593814|569575|P1|Overall Study|Death|7
161364|NCT00593736|569587|P4|Treatment Period and Placebo Run-out|Various|0
161365|NCT00593736|569588|P3|Treatment Period and Placebo Run-out|Various|1
161366|NCT00593736|569589|P2|Treatment Period and Placebo Run-out|Various|1
161367|NCT00593736|569590|P1|Treatment Period and Placebo Run-out|Various|1
161368|NCT00593736|569587|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
161369|NCT00593736|569588|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
161370|NCT00593736|569589|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
161371|NCT00593736|569590|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
161372|NCT00593736|569587|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
161373|NCT00593736|569588|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
161374|NCT00593736|569589|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
161375|NCT00593736|569590|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
161376|NCT00593736|569587|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
161377|NCT00593736|569588|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
161378|NCT00593736|569589|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
161379|NCT00593736|569590|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
161380|NCT00593736|569587|P4|Screening Period and Placebo Run-in|Various|25
161381|NCT00593736|569588|P3|Screening Period and Placebo Run-in|Various|0
161382|NCT00593736|569589|P2|Screening Period and Placebo Run-in|Various|0
161383|NCT00593736|569590|P1|Screening Period and Placebo Run-in|Various|0
161384|NCT00593736|569587|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
161385|NCT00593736|569588|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
161386|NCT00593736|569589|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
161387|NCT00593736|569590|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
161388|NCT00593736|569587|P4|Screening Period and Placebo Run-in|Study Termination|15
161389|NCT00593736|569588|P3|Screening Period and Placebo Run-in|Study Termination|0
161390|NCT00593736|569589|P2|Screening Period and Placebo Run-in|Study Termination|0
161391|NCT00593736|569590|P1|Screening Period and Placebo Run-in|Study Termination|0
161392|NCT00593736|569587|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
161393|NCT00593736|569588|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
161394|NCT00593736|569589|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
161395|NCT00593736|569590|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
161396|NCT00593736|569587|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
161397|NCT00593736|569588|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
161398|NCT00593736|569589|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
161399|NCT00593736|569590|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
161400|NCT00593736|569587|P4|Screening Period and Placebo Run-in|Adverse Event|3
161401|NCT00593736|569588|P3|Screening Period and Placebo Run-in|Adverse Event|0
161402|NCT00593736|569589|P2|Screening Period and Placebo Run-in|Adverse Event|0
161403|NCT00593736|569590|P1|Screening Period and Placebo Run-in|Adverse Event|0
161404|NCT00593684|569838|P2|Overall Study|Death|1
161405|NCT00593684|569839|P1|Overall Study|Death|2
161406|NCT00593606|569865|P1|Overall Study|Screen Failure|3
161407|NCT00593606|569865|P1|Overall Study|Run-In Failure|5
161408|NCT00593606|569865|P1|Overall Study|Lost to Follow-up|2
161409|NCT00593606|569865|P1|Overall Study|Protocol Violation|3
161410|NCT00593606|569865|P1|Overall Study|Withdrawal by Subject|1
161411|NCT00593606|569865|P1|Overall Study|Adverse Event|13
161412|NCT00593554|569963|P2|Overall Study|Disease Progression|2
161413|NCT00593554|569964|P1|Overall Study|Disease Progression|1
161414|NCT00593554|569963|P2|Overall Study|Withdrawal by Subject|0
161415|NCT00593554|569964|P1|Overall Study|Withdrawal by Subject|1
161416|NCT00593554|569963|P2|Overall Study|Physician Decision|1
161417|NCT00593554|569964|P1|Overall Study|Physician Decision|0
161418|NCT00593554|569963|P2|Overall Study|Death|2
161419|NCT00593554|569964|P1|Overall Study|Death|1
161420|NCT00593385|570059|P1|Overall Study|Withdrawal by Subject|9
161421|NCT00593385|570059|P1|Overall Study|Lost to Follow-up|17
161422|NCT00593385|570059|P1|Overall Study|Death|14
161423|NCT00593333|570120|P2|Overall Study|Lost to Follow-up|11
161424|NCT00593333|570121|P1|Overall Study|Lost to Follow-up|10
161425|NCT00593112|570144|P2|Overall Study|Withdrawal by Subject|0
161426|NCT00593112|570145|P1|Overall Study|Withdrawal by Subject|5
161427|NCT00593112|570144|P2|Overall Study|Unreadable Scan|0
161428|NCT00593112|570145|P1|Overall Study|Unreadable Scan|1
161429|NCT00593112|570144|P2|Overall Study|Abnormal Scan|0
161430|NCT00593112|570145|P1|Overall Study|Abnormal Scan|1
161431|NCT00593112|570144|P2|Overall Study|Scan Anxiety|0
161432|NCT00593112|570145|P1|Overall Study|Scan Anxiety|3
161433|NCT00592904|570172|P4|Overall Study|Not specified|0
161434|NCT00592904|570173|P3|Overall Study|Not specified|0
161435|NCT00592904|570174|P2|Overall Study|Not specified|3
161436|NCT00592904|570175|P1|Overall Study|Not specified|3
161437|NCT00592904|570172|P4|Overall Study|Physician Decision|0
161438|NCT00592904|570173|P3|Overall Study|Physician Decision|1
161439|NCT00592904|570174|P2|Overall Study|Physician Decision|3
161440|NCT00592904|570175|P1|Overall Study|Physician Decision|0
161441|NCT00592904|570172|P4|Overall Study|Lack of Efficacy|3
161442|NCT00592904|570173|P3|Overall Study|Lack of Efficacy|2
161443|NCT00592904|570174|P2|Overall Study|Lack of Efficacy|7
161444|NCT00592904|570175|P1|Overall Study|Lack of Efficacy|2
161445|NCT00592904|570172|P4|Overall Study|Withdrawal by Subject|2
161446|NCT00592904|570173|P3|Overall Study|Withdrawal by Subject|1
161447|NCT00592904|570174|P2|Overall Study|Withdrawal by Subject|16
161448|NCT00592904|570175|P1|Overall Study|Withdrawal by Subject|4
161449|NCT00592904|570172|P4|Overall Study|Protocol Violation|1
161450|NCT00592904|570173|P3|Overall Study|Protocol Violation|0
161451|NCT00592904|570174|P2|Overall Study|Protocol Violation|1
161452|NCT00592904|570175|P1|Overall Study|Protocol Violation|1
161453|NCT00592904|570172|P4|Overall Study|Adverse Event|5
161454|NCT00592904|570173|P3|Overall Study|Adverse Event|13
161455|NCT00592904|570174|P2|Overall Study|Adverse Event|25
161456|NCT00592904|570175|P1|Overall Study|Adverse Event|15
161457|NCT00592852|570201|P1|Overall Study|Withdrawal by Subject|1
161458|NCT00592852|570201|P1|Overall Study|Found ineligible|1
161459|NCT00592852|570201|P1|Overall Study|Adverse Event|3
161460|NCT00592852|570201|P1|Overall Study|Non-compliance|1
161461|NCT00592839|570209|P3|Overall Study|Lost to Follow-up|1
161462|NCT00592839|570210|P2|Overall Study|Lost to Follow-up|1
161463|NCT00592839|570211|P1|Overall Study|Lost to Follow-up|0
161464|NCT00592839|570209|P3|Overall Study|Adverse Event|0
161465|NCT00592839|570210|P2|Overall Study|Adverse Event|1
161466|NCT00592839|570211|P1|Overall Study|Adverse Event|0
161467|NCT00592839|570209|P3|Overall Study|Protocol Violation|2
161468|NCT00592839|570210|P2|Overall Study|Protocol Violation|1
161469|NCT00592839|570211|P1|Overall Study|Protocol Violation|1
161470|NCT00592839|570209|P3|Overall Study|Withdrawal by Subject|3
161471|NCT00592839|570210|P2|Overall Study|Withdrawal by Subject|1
161472|NCT00592839|570211|P1|Overall Study|Withdrawal by Subject|1
161473|NCT00592774|570239|P5|Overall Study|Not specified|2
161474|NCT00592774|570240|P4|Overall Study|Not specified|0
161475|NCT00592774|570241|P3|Overall Study|Not specified|1
161476|NCT00592774|570242|P2|Overall Study|Not specified|1
161477|NCT00592774|570243|P1|Overall Study|Not specified|0
161478|NCT00592774|570239|P5|Overall Study|Physician Decision|1
161479|NCT00592774|570240|P4|Overall Study|Physician Decision|0
161480|NCT00592774|570241|P3|Overall Study|Physician Decision|1
161481|NCT00592774|570242|P2|Overall Study|Physician Decision|1
161482|NCT00592774|570243|P1|Overall Study|Physician Decision|0
161483|NCT00592774|570239|P5|Overall Study|Lack of Efficacy|2
161484|NCT00592774|570240|P4|Overall Study|Lack of Efficacy|0
161485|NCT00592774|570241|P3|Overall Study|Lack of Efficacy|0
161486|NCT00592774|570242|P2|Overall Study|Lack of Efficacy|3
161487|NCT00592774|570243|P1|Overall Study|Lack of Efficacy|3
161488|NCT00592774|570239|P5|Overall Study|Withdrawal by Subject|0
161489|NCT00592774|570240|P4|Overall Study|Withdrawal by Subject|0
161490|NCT00592774|570241|P3|Overall Study|Withdrawal by Subject|0
161491|NCT00592774|570242|P2|Overall Study|Withdrawal by Subject|7
161492|NCT00592774|570243|P1|Overall Study|Withdrawal by Subject|3
161493|NCT00592774|570239|P5|Overall Study|Protocol Violation|1
161494|NCT00592774|570240|P4|Overall Study|Protocol Violation|0
161495|NCT00592774|570241|P3|Overall Study|Protocol Violation|0
161496|NCT00592774|570242|P2|Overall Study|Protocol Violation|1
161497|NCT00592774|570243|P1|Overall Study|Protocol Violation|0
161498|NCT00592774|570239|P5|Overall Study|Adverse Event|8
161499|NCT00592774|570240|P4|Overall Study|Adverse Event|14
161500|NCT00592774|570241|P3|Overall Study|Adverse Event|2
161501|NCT00592774|570242|P2|Overall Study|Adverse Event|19
161502|NCT00592774|570243|P1|Overall Study|Adverse Event|5
161503|NCT00592683|570315|P2|Overall Study|Lost to Follow-up|1
161504|NCT00592683|570316|P1|Overall Study|Lost to Follow-up|0
161505|NCT00592683|570315|P2|Overall Study|Other|0
161506|NCT00592683|570316|P1|Overall Study|Other|1
161507|NCT00592683|570315|P2|Overall Study|Study drug expired|0
161508|NCT00592683|570316|P1|Overall Study|Study drug expired|1
161509|NCT00592683|570315|P2|Overall Study|Protocol Violation|0
161510|NCT00592683|570316|P1|Overall Study|Protocol Violation|1
161511|NCT00592683|570315|P2|Overall Study|Adverse Event|2
161512|NCT00592683|570316|P1|Overall Study|Adverse Event|0
161513|NCT00592683|570315|P2|Overall Study|Withdrawal by Subject|0
161514|NCT00592683|570316|P1|Overall Study|Withdrawal by Subject|1
161515|NCT00592683|570315|P2|Overall Study|Found ineligible|1
161516|NCT00592683|570316|P1|Overall Study|Found ineligible|0
161517|NCT00592631|570326|P2|Overall Study|Lost to Follow-up|2
161518|NCT00592631|570327|P1|Overall Study|Lost to Follow-up|0
161519|NCT00592384|570376|P2|Overall Study|Withdrawal by Subject|6
161520|NCT00592384|570377|P1|Overall Study|Withdrawal by Subject|5
161521|NCT00592358|570385|P1|Overall Study|Inability to swallow pills|1
161522|NCT00592358|570385|P1|Overall Study|Lack of Efficacy|2
161523|NCT00592358|570385|P1|Overall Study|Adverse Event|1
161524|NCT00592358|570385|P1|Overall Study|Withdrawal by Subject|2
161525|NCT00592319|570392|P2|Overall Study|Lost to Follow-up|3
161526|NCT00592319|570393|P1|Overall Study|Lost to Follow-up|0
161527|NCT00592072|570468|P2|Wash Out Period|Lost to Follow-up|1
161528|NCT00592072|570469|P1|Wash Out Period|Lost to Follow-up|1
161529|NCT00592007|570491|P1|Overall Study|patient ineligible (out of lab range)|1
161530|NCT00592007|570491|P1|Overall Study|Withdrawal by Subject|1
161531|NCT00591864|570503|P1|Overall Study|Incomplete Imaging|5
161532|NCT00591851|570509|P1|Overall Study|Progressive Disease|1
161533|NCT00591851|570509|P1|Overall Study|Adverse Event|2
161534|NCT00591851|570509|P1|Overall Study|Withdrawal by Subject|3
161535|NCT00591773|570549|P3|Overall Study|Other|4
161536|NCT00591773|570550|P2|Overall Study|Other|1
161537|NCT00591773|570551|P1|Overall Study|Other|1
161538|NCT00591773|570549|P3|Overall Study|Lack of Efficacy|2
161539|NCT00591773|570550|P2|Overall Study|Lack of Efficacy|2
161540|NCT00591773|570551|P1|Overall Study|Lack of Efficacy|1
161541|NCT00591773|570549|P3|Overall Study|Withdrawal by Subject|3
161542|NCT00591773|570550|P2|Overall Study|Withdrawal by Subject|5
161543|NCT00591773|570551|P1|Overall Study|Withdrawal by Subject|2
161544|NCT00591773|570549|P3|Overall Study|Lost to Follow-up|1
161545|NCT00591773|570550|P2|Overall Study|Lost to Follow-up|4
161546|NCT00591773|570551|P1|Overall Study|Lost to Follow-up|1
161547|NCT00591773|570549|P3|Overall Study|Protocol Violation|0
161548|NCT00591773|570550|P2|Overall Study|Protocol Violation|3
161549|NCT00591773|570551|P1|Overall Study|Protocol Violation|2
161550|NCT00591773|570549|P3|Overall Study|Adverse Event|6
161551|NCT00591773|570550|P2|Overall Study|Adverse Event|9
161552|NCT00591773|570551|P1|Overall Study|Adverse Event|9
161553|NCT00591734|570610|P1|Overall Study|Intercurrent Illness|8
161554|NCT00591734|570610|P1|Overall Study|Physician Decision|5
161555|NCT00591734|570610|P1|Overall Study|Adverse Event|5
161556|NCT00591734|570610|P1|Overall Study|Lack of Efficacy|35
161557|NCT00591721|570616|P2|Overall Study|Intervention not received|8
161558|NCT00591721|570617|P1|Overall Study|Intervention not received|10
161559|NCT00591721|570616|P2|Overall Study|Lost to Follow-up|4
161560|NCT00591721|570617|P1|Overall Study|Lost to Follow-up|1
161561|NCT00591721|570616|P2|Overall Study|Withdrawal by Subject|10
161562|NCT00591721|570617|P1|Overall Study|Withdrawal by Subject|10
161563|NCT00591591|570625|P2|Overall Study|Lack of Efficacy|2
161564|NCT00591591|570626|P1|Overall Study|Lack of Efficacy|10
161565|NCT00591591|570625|P2|Overall Study|Withdrawal by Subject|37
161566|NCT00591591|570626|P1|Overall Study|Withdrawal by Subject|1
161567|NCT00591578|570643|P3|Open-Label Extension Phase|Other|0
161568|NCT00591578|570644|P2|Open-Label Extension Phase|Other|0
161569|NCT00591578|570645|P1|Open-Label Extension Phase|Other|1
161570|NCT00591578|570643|P3|Open-Label Extension Phase|Withdrawal by Subject|0
161571|NCT00591578|570644|P2|Open-Label Extension Phase|Withdrawal by Subject|1
161572|NCT00591578|570645|P1|Open-Label Extension Phase|Withdrawal by Subject|1
161573|NCT00591578|570643|P3|Open-Label Extension Phase|Lost to Follow-up|0
161574|NCT00591578|570644|P2|Open-Label Extension Phase|Lost to Follow-up|4
161575|NCT00591578|570645|P1|Open-Label Extension Phase|Lost to Follow-up|1
161576|NCT00591578|570643|P3|Open-Label Extension Phase|Adverse Event|0
161577|NCT00591578|570644|P2|Open-Label Extension Phase|Adverse Event|5
161578|NCT00591578|570645|P1|Open-Label Extension Phase|Adverse Event|3
161579|NCT00591578|570643|P3|Double-Blind Treatment Phase|Other|4
161580|NCT00591578|570644|P2|Double-Blind Treatment Phase|Other|9
161581|NCT00591578|570645|P1|Double-Blind Treatment Phase|Other|4
161582|NCT00591578|570643|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
161583|NCT00591578|570644|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
161584|NCT00591578|570645|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
161585|NCT00591578|570643|P3|Double-Blind Treatment Phase|Pregnancy|0
161586|NCT00591578|570644|P2|Double-Blind Treatment Phase|Pregnancy|0
161587|NCT00591578|570645|P1|Double-Blind Treatment Phase|Pregnancy|1
161588|NCT00591578|570643|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
161589|NCT00591578|570644|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
161590|NCT00591578|570645|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
161591|NCT00591578|570643|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
161592|NCT00591578|570644|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
161593|NCT00591578|570645|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
161594|NCT00591578|570643|P3|Double-Blind Treatment Phase|Protocol Violation|3
161595|NCT00591578|570644|P2|Double-Blind Treatment Phase|Protocol Violation|2
161596|NCT00591578|570645|P1|Double-Blind Treatment Phase|Protocol Violation|3
161597|NCT00591578|570643|P3|Double-Blind Treatment Phase|Adverse Event|19
161598|NCT00591578|570644|P2|Double-Blind Treatment Phase|Adverse Event|26
161599|NCT00591578|570645|P1|Double-Blind Treatment Phase|Adverse Event|20
161600|NCT00591565|570696|P1|Overall Study|lost follow up, withdrawn|5
161601|NCT00591370|570700|P1|Overall Study|Not Treated|2
161602|NCT00591344|570708|P2|Overall Study|Did not want to come off medication|1
161603|NCT00591344|570709|P1|Overall Study|Did not want to come off medication|0
161604|NCT00591344|570708|P2|Overall Study|Lost to Follow-up|1
161605|NCT00591344|570709|P1|Overall Study|Lost to Follow-up|0
161606|NCT00591344|570708|P2|Overall Study|Death|1
161607|NCT00591344|570709|P1|Overall Study|Death|0
161608|NCT00591344|570708|P2|Overall Study|Underwent DBS|2
161609|NCT00591344|570709|P1|Overall Study|Underwent DBS|2
161610|NCT00591344|570708|P2|Overall Study|Medical complications|3
161611|NCT00591344|570709|P1|Overall Study|Medical complications|1
161612|NCT00591344|570708|P2|Overall Study|Moved out of state|0
161613|NCT00591344|570709|P1|Overall Study|Moved out of state|1
161614|NCT00591344|570708|P2|Overall Study|Transportation issues|0
161615|NCT00591344|570709|P1|Overall Study|Transportation issues|1
161616|NCT00591266|570735|P3|Overall Study|Other|5
161617|NCT00591266|570736|P2|Overall Study|Other|4
161618|NCT00591266|570737|P1|Overall Study|Other|1
161619|NCT00591266|570735|P3|Overall Study|Lack of Efficacy|0
161620|NCT00591266|570736|P2|Overall Study|Lack of Efficacy|2
161621|NCT00591266|570737|P1|Overall Study|Lack of Efficacy|0
161622|NCT00591266|570735|P3|Overall Study|Withdrawal by Subject|5
161623|NCT00591266|570736|P2|Overall Study|Withdrawal by Subject|2
161624|NCT00591266|570737|P1|Overall Study|Withdrawal by Subject|6
161625|NCT00591266|570735|P3|Overall Study|Protocol Violation|1
161626|NCT00591266|570736|P2|Overall Study|Protocol Violation|0
161627|NCT00591266|570737|P1|Overall Study|Protocol Violation|0
161628|NCT00591266|570735|P3|Overall Study|Lost to Follow-up|0
161629|NCT00591266|570736|P2|Overall Study|Lost to Follow-up|1
161630|NCT00591266|570737|P1|Overall Study|Lost to Follow-up|0
161631|NCT00591266|570735|P3|Overall Study|Adverse Event|3
161632|NCT00591266|570736|P2|Overall Study|Adverse Event|2
161633|NCT00591266|570737|P1|Overall Study|Adverse Event|2
161634|NCT00591253|570790|P3|Overall Study|Other|3
161635|NCT00591253|570791|P2|Overall Study|Other|5
161636|NCT00591253|570792|P1|Overall Study|Other|5
161637|NCT00591253|570790|P3|Overall Study|Lack of Efficacy|3
161638|NCT00591253|570791|P2|Overall Study|Lack of Efficacy|0
161639|NCT00591253|570792|P1|Overall Study|Lack of Efficacy|1
161640|NCT00591253|570790|P3|Overall Study|Withdrawal by Subject|6
161641|NCT00591253|570791|P2|Overall Study|Withdrawal by Subject|7
161642|NCT00591253|570792|P1|Overall Study|Withdrawal by Subject|1
161643|NCT00591253|570790|P3|Overall Study|Lost to Follow-up|0
161644|NCT00591253|570791|P2|Overall Study|Lost to Follow-up|4
161645|NCT00591253|570792|P1|Overall Study|Lost to Follow-up|2
161646|NCT00591253|570790|P3|Overall Study|Protocol Violation|2
161647|NCT00591253|570791|P2|Overall Study|Protocol Violation|2
161648|NCT00591253|570792|P1|Overall Study|Protocol Violation|2
161649|NCT00591253|570790|P3|Overall Study|Adverse Event|1
161650|NCT00591253|570791|P2|Overall Study|Adverse Event|3
161651|NCT00591253|570792|P1|Overall Study|Adverse Event|3
161652|NCT00591214|570860|P1|Overall Study|Withdrawal by Subject|1
161653|NCT00591214|570860|P1|Overall Study|Physician Decision|7
161654|NCT00591149|570869|P1|Overall Study|Withdrawal by Subject|1
161655|NCT00591149|570869|P1|Overall Study|Adverse Event|4
161656|NCT00591006|570885|P24|Overall Study|Adverse Event|0
161657|NCT00591006|570886|P23|Overall Study|Adverse Event|1
161658|NCT00591006|570887|P22|Overall Study|Adverse Event|0
161659|NCT00591006|570888|P21|Overall Study|Adverse Event|0
161660|NCT00591006|570889|P20|Overall Study|Adverse Event|0
161661|NCT00591006|570890|P19|Overall Study|Adverse Event|0
161662|NCT00591006|570891|P18|Overall Study|Adverse Event|0
161663|NCT00591006|570892|P17|Overall Study|Adverse Event|0
161664|NCT00591006|570893|P16|Overall Study|Adverse Event|0
161665|NCT00591006|570894|P15|Overall Study|Adverse Event|0
161666|NCT00591006|570895|P14|Overall Study|Adverse Event|0
161667|NCT00591006|570896|P13|Overall Study|Adverse Event|0
161668|NCT00591006|570897|P12|Overall Study|Adverse Event|0
161669|NCT00591006|570898|P11|Overall Study|Adverse Event|0
161670|NCT00591006|570899|P10|Overall Study|Adverse Event|0
161671|NCT00591006|570900|P9|Overall Study|Adverse Event|0
161672|NCT00591006|570901|P8|Overall Study|Adverse Event|0
161673|NCT00591006|570902|P7|Overall Study|Adverse Event|0
161674|NCT00591006|570903|P6|Overall Study|Adverse Event|0
161675|NCT00591006|570904|P5|Overall Study|Adverse Event|0
161676|NCT00591006|570905|P4|Overall Study|Adverse Event|0
161677|NCT00591006|570906|P3|Overall Study|Adverse Event|0
161678|NCT00591006|570907|P2|Overall Study|Adverse Event|0
161679|NCT00591006|570908|P1|Overall Study|Adverse Event|0
161680|NCT00591006|570885|P24|Overall Study|Withdrawal by Subject|1
161681|NCT00591006|570886|P23|Overall Study|Withdrawal by Subject|0
161682|NCT00591006|570887|P22|Overall Study|Withdrawal by Subject|0
161683|NCT00591006|570888|P21|Overall Study|Withdrawal by Subject|0
161684|NCT00591006|570889|P20|Overall Study|Withdrawal by Subject|0
161685|NCT00591006|570890|P19|Overall Study|Withdrawal by Subject|0
161686|NCT00591006|570891|P18|Overall Study|Withdrawal by Subject|0
161687|NCT00591006|570892|P17|Overall Study|Withdrawal by Subject|0
161688|NCT00591006|570893|P16|Overall Study|Withdrawal by Subject|1
161689|NCT00591006|570894|P15|Overall Study|Withdrawal by Subject|0
161690|NCT00591006|570895|P14|Overall Study|Withdrawal by Subject|0
161691|NCT00591006|570896|P13|Overall Study|Withdrawal by Subject|0
161692|NCT00591006|570897|P12|Overall Study|Withdrawal by Subject|0
161693|NCT00591006|570898|P11|Overall Study|Withdrawal by Subject|0
161694|NCT00591006|570899|P10|Overall Study|Withdrawal by Subject|0
161695|NCT00591006|570900|P9|Overall Study|Withdrawal by Subject|0
161696|NCT00591006|570901|P8|Overall Study|Withdrawal by Subject|0
161697|NCT00591006|570902|P7|Overall Study|Withdrawal by Subject|0
161698|NCT00591006|570903|P6|Overall Study|Withdrawal by Subject|0
161699|NCT00591006|570904|P5|Overall Study|Withdrawal by Subject|0
161700|NCT00591006|570905|P4|Overall Study|Withdrawal by Subject|0
161701|NCT00591006|570906|P3|Overall Study|Withdrawal by Subject|0
161702|NCT00591006|570907|P2|Overall Study|Withdrawal by Subject|0
161703|NCT00591006|570908|P1|Overall Study|Withdrawal by Subject|0
161704|NCT00590980|570926|P1|Overall Study|Did not meet all inclusion criteria|10
161705|NCT00590967|570932|P2|Overall Study|Did not receive chemo per protocol|0
161706|NCT00590967|570933|P1|Overall Study|Did not receive chemo per protocol|1
161707|NCT00590967|570932|P2|Overall Study|Did not sign consent form|1
161708|NCT00590967|570933|P1|Overall Study|Did not sign consent form|0
161709|NCT00590967|570932|P2|Overall Study|Non-compliant|2
161710|NCT00590967|570933|P1|Overall Study|Non-compliant|0
161711|NCT00590967|570932|P2|Overall Study|Poor performance status|1
161712|NCT00590967|570933|P1|Overall Study|Poor performance status|0
161713|NCT00590967|570932|P2|Overall Study|Ineligible|0
161714|NCT00590967|570933|P1|Overall Study|Ineligible|1
161715|NCT00590967|570932|P2|Overall Study|Withdrawal by Subject|1
161716|NCT00590967|570933|P1|Overall Study|Withdrawal by Subject|1
161717|NCT00590902|570945|P1|Overall Study|Death|1
161718|NCT00590759|570980|P1|Overall Study|Lost to Follow-up|28
161719|NCT00590759|570980|P1|Overall Study|Death|52
161720|NCT00590720|570987|P2|Overall Study|Withdrawal by Subject|1
161721|NCT00590720|570988|P1|Overall Study|Withdrawal by Subject|0
161722|NCT00590720|570987|P2|Overall Study|Lost to Follow-up|0
161723|NCT00590720|570988|P1|Overall Study|Lost to Follow-up|1
161724|NCT00590590|571033|P3|Overall Study|Did not complete study|0
161725|NCT00590590|571034|P2|Overall Study|Did not complete study|1
161726|NCT00590590|571035|P1|Overall Study|Did not complete study|0
161727|NCT00590590|571033|P3|Overall Study|Did not complete due to study closure|1
161728|NCT00590590|571034|P2|Overall Study|Did not complete due to study closure|1
161729|NCT00590590|571035|P1|Overall Study|Did not complete due to study closure|1
161730|NCT00590590|571033|P3|Overall Study|Withdrawal by Subject|1
161731|NCT00590590|571034|P2|Overall Study|Withdrawal by Subject|1
161732|NCT00590590|571035|P1|Overall Study|Withdrawal by Subject|0
161733|NCT00590590|571033|P3|Overall Study|Lost to Follow-up|2
161734|NCT00590590|571034|P2|Overall Study|Lost to Follow-up|1
161735|NCT00590590|571035|P1|Overall Study|Lost to Follow-up|4
161736|NCT00590590|571033|P3|Overall Study|Protocol Violation|2
161737|NCT00590590|571034|P2|Overall Study|Protocol Violation|0
161738|NCT00590590|571035|P1|Overall Study|Protocol Violation|0
161739|NCT00590590|571033|P3|Overall Study|Adverse Event|0
161740|NCT00590590|571034|P2|Overall Study|Adverse Event|0
161741|NCT00590590|571035|P1|Overall Study|Adverse Event|1
161742|NCT00590590|571033|P3|Overall Study|Lack of Efficacy|0
161743|NCT00590590|571034|P2|Overall Study|Lack of Efficacy|2
161744|NCT00590590|571035|P1|Overall Study|Lack of Efficacy|1
161745|NCT00590577|571062|P4|Overall Study|Various reasons|2
161746|NCT00590577|571063|P3|Overall Study|Various reasons|1
161747|NCT00590577|571064|P2|Overall Study|Various reasons|3
161748|NCT00590577|571065|P1|Overall Study|Various reasons|1
161749|NCT00590577|571062|P4|Overall Study|Pregnancy|0
161750|NCT00590577|571063|P3|Overall Study|Pregnancy|0
161751|NCT00590577|571064|P2|Overall Study|Pregnancy|1
161752|NCT00590577|571065|P1|Overall Study|Pregnancy|0
161753|NCT00590577|571062|P4|Overall Study|Lost to Follow-up|9
161754|NCT00590577|571063|P3|Overall Study|Lost to Follow-up|6
161755|NCT00590577|571064|P2|Overall Study|Lost to Follow-up|6
161756|NCT00590577|571065|P1|Overall Study|Lost to Follow-up|12
161757|NCT00590577|571062|P4|Overall Study|Adverse Event|11
161758|NCT00590577|571063|P3|Overall Study|Adverse Event|13
161759|NCT00590577|571064|P2|Overall Study|Adverse Event|10
161760|NCT00590577|571065|P1|Overall Study|Adverse Event|10
161761|NCT00590577|571062|P4|Overall Study|Withdrawal by Subject|26
161762|NCT00590577|571063|P3|Overall Study|Withdrawal by Subject|30
161763|NCT00590577|571064|P2|Overall Study|Withdrawal by Subject|28
161764|NCT00590577|571065|P1|Overall Study|Withdrawal by Subject|23
161765|NCT00590577|571062|P4|Overall Study|Lack of Efficacy|45
161766|NCT00590577|571063|P3|Overall Study|Lack of Efficacy|23
161767|NCT00590577|571064|P2|Overall Study|Lack of Efficacy|28
161768|NCT00590577|571065|P1|Overall Study|Lack of Efficacy|31
161769|NCT00590564|571083|P1|Overall Study|Patient Non-compliance|6
161770|NCT00590564|571083|P1|Overall Study|Patient Found to be Ineligible|1
161771|NCT00590564|571083|P1|Overall Study|Protocol Violation|1
161772|NCT00590564|571083|P1|Overall Study|Lost to Follow-up|6
161773|NCT00590564|571083|P1|Overall Study|Withdrawal by Subject|4
161774|NCT00590538|571087|P1|Overall Study|Study terminated before completed|2
161775|NCT00590317|571129|P2|Overall Study|Lack of Efficacy|5
161776|NCT00590317|571130|P1|Overall Study|Lack of Efficacy|1
161777|NCT00590135|571160|P1|Overall Study|Primary endpoint measure not obtainable|59
161778|NCT00590044|571170|P2|Overall Study|Protocol Violation|0
161779|NCT00590044|571171|P1|Overall Study|Protocol Violation|1
161780|NCT00590044|571170|P2|Overall Study|wrong insulin arm assigned|0
161781|NCT00590044|571171|P1|Overall Study|wrong insulin arm assigned|1
161782|NCT00590044|571170|P2|Overall Study|Withdrawal by Subject|2
161783|NCT00590044|571171|P1|Overall Study|Withdrawal by Subject|2
161784|NCT00590031|571177|P1|Overall Study|Admin Hold|1
161785|NCT00590031|571177|P1|Overall Study|Metastatic Disease|1
161786|NCT00590031|571177|P1|Overall Study|Withdrawal by Subject|1
161787|NCT00590031|571177|P1|Overall Study|Adverse Event|3
161788|NCT00589979|571204|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
161789|NCT00589979|571205|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
161790|NCT00589979|571206|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
161791|NCT00589979|571204|P3|Double-Blind Treatment Period 3|Protocol Violation|0
161792|NCT00589979|571205|P2|Double-Blind Treatment Period 3|Protocol Violation|1
161793|NCT00589979|571206|P1|Double-Blind Treatment Period 3|Protocol Violation|0
161794|NCT00589979|571204|P3|Double-Blind Treatment Period 2|Other|1
161795|NCT00589979|571205|P2|Double-Blind Treatment Period 2|Other|0
161796|NCT00589979|571206|P1|Double-Blind Treatment Period 2|Other|0
161797|NCT00589979|571204|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
161798|NCT00589979|571205|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
161799|NCT00589979|571206|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
161800|NCT00589979|571204|P3|Double-Blind Treatment Period 2|Adverse Event|0
161801|NCT00589979|571205|P2|Double-Blind Treatment Period 2|Adverse Event|1
161802|NCT00589979|571206|P1|Double-Blind Treatment Period 2|Adverse Event|0
161803|NCT00589979|571204|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
161804|NCT00589979|571205|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
161805|NCT00589979|571206|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
161806|NCT00589979|571204|P3|Double-Blind Treatment Period 1|Protocol Violation|1
161807|NCT00589979|571205|P2|Double-Blind Treatment Period 1|Protocol Violation|1
161808|NCT00589979|571206|P1|Double-Blind Treatment Period 1|Protocol Violation|0
161809|NCT00589979|571204|P3|Double-Blind Treatment Period 1|Adverse Event|0
161810|NCT00589979|571205|P2|Double-Blind Treatment Period 1|Adverse Event|1
161811|NCT00589979|571206|P1|Double-Blind Treatment Period 1|Adverse Event|0
161812|NCT00589979|571204|P3|Run-In Period|Informed Consent Withdrawn|0
161813|NCT00589979|571205|P2|Run-In Period|Informed Consent Withdrawn|0
161814|NCT00589979|571206|P1|Run-In Period|Informed Consent Withdrawn|4
161815|NCT00589979|571204|P3|Run-In Period|Withdrawal by Subject|0
161816|NCT00589979|571205|P2|Run-In Period|Withdrawal by Subject|0
161817|NCT00589979|571206|P1|Run-In Period|Withdrawal by Subject|10
161818|NCT00589979|571204|P3|Run-In Period|Did not qualify for randomization|0
161819|NCT00589979|571205|P2|Run-In Period|Did not qualify for randomization|0
161820|NCT00589979|571206|P1|Run-In Period|Did not qualify for randomization|54
161821|NCT00589979|571204|P3|Run-In Period|Protocol Violation|0
161822|NCT00589979|571205|P2|Run-In Period|Protocol Violation|0
161823|NCT00589979|571206|P1|Run-In Period|Protocol Violation|3
161824|NCT00589979|571204|P3|Run-In Period|Adverse Event|0
161825|NCT00589979|571205|P2|Run-In Period|Adverse Event|0
161826|NCT00589979|571206|P1|Run-In Period|Adverse Event|5
161827|NCT00589914|571245|P2|Overall Study|Other|17
161828|NCT00589914|571246|P1|Overall Study|Other|22
161829|NCT00589914|571245|P2|Overall Study|Withdrawal by Subject|49
161830|NCT00589914|571246|P1|Overall Study|Withdrawal by Subject|55
161831|NCT00589914|571245|P2|Overall Study|Pregnancy|0
161832|NCT00589914|571246|P1|Overall Study|Pregnancy|1
161833|NCT00589914|571245|P2|Overall Study|Lost to Follow-up|18
161834|NCT00589914|571246|P1|Overall Study|Lost to Follow-up|11
161835|NCT00589914|571245|P2|Overall Study|Lack of Efficacy|43
161836|NCT00589914|571246|P1|Overall Study|Lack of Efficacy|40
161837|NCT00589914|571245|P2|Overall Study|Death|0
161838|NCT00589914|571246|P1|Overall Study|Death|2
161839|NCT00589914|571245|P2|Overall Study|Adverse Event|10
161840|NCT00589914|571246|P1|Overall Study|Adverse Event|19
161841|NCT00589784|571282|P2|Overall Study|Adverse Event|4
161842|NCT00589784|571283|P1|Overall Study|Adverse Event|0
161843|NCT00589784|571282|P2|Overall Study|Patient inevaluable|0
161844|NCT00589784|571283|P1|Overall Study|Patient inevaluable|1
161845|NCT00589784|571282|P2|Overall Study|Withdrawal by Subject|6
161846|NCT00589784|571283|P1|Overall Study|Withdrawal by Subject|0
161847|NCT00589693|571290|P2|Overall Study|Protocol Violation|1
161848|NCT00589693|571291|P1|Overall Study|Protocol Violation|1
161849|NCT00589693|571290|P2|Overall Study|Physician Decision|1
161850|NCT00589693|571291|P1|Overall Study|Physician Decision|0
161851|NCT00589693|571290|P2|Overall Study|Lost to Follow-up|0
161852|NCT00589693|571291|P1|Overall Study|Lost to Follow-up|1
161853|NCT00589693|571290|P2|Overall Study|Lack of Efficacy|1
161854|NCT00589693|571291|P1|Overall Study|Lack of Efficacy|0
161855|NCT00589693|571290|P2|Overall Study|Death|16
161856|NCT00589693|571291|P1|Overall Study|Death|26
161857|NCT00589693|571290|P2|Overall Study|Adverse Event|4
161858|NCT00589693|571291|P1|Overall Study|Adverse Event|4
161859|NCT00589693|571290|P2|Overall Study|randomized in error|6
161860|NCT00589693|571291|P1|Overall Study|randomized in error|12
161861|NCT00589667|571305|P1|Overall Study|Withdrawal by Subject|1
161862|NCT00589667|571305|P1|Overall Study|Adverse Event|2
161863|NCT00589628|571312|P2|Overall Study|Lost to Follow-up|1
161864|NCT00589628|571313|P1|Overall Study|Lost to Follow-up|0
161865|NCT00589602|571319|P1|Overall Study|Did not collect enough CD34+ cells|1
161866|NCT00589472|571354|P1|Overall Study|Adverse Event|1
161867|NCT00589303|571366|P2|Overall Study|Withdrawal by Subject|1
161868|NCT00589303|571367|P1|Overall Study|Withdrawal by Subject|2
161869|NCT00589290|571373|P1|Overall Study|Withdrawal by Subject|1
161870|NCT00589121|571396|P2|Overall Study|No protocol treatment received|1
161871|NCT00589121|571397|P1|Overall Study|No protocol treatment received|0
161872|NCT00589121|571396|P2|Overall Study|Protocol Violation|6
161873|NCT00589121|571397|P1|Overall Study|Protocol Violation|2
161874|NCT00589108|571417|P3|Overall Study|Death|4
161875|NCT00589108|571418|P2|Overall Study|Death|3
161876|NCT00589108|571419|P1|Overall Study|Death|3
161877|NCT00589108|571417|P3|Overall Study|Lost to Follow-up|1
161878|NCT00589108|571418|P2|Overall Study|Lost to Follow-up|1
161879|NCT00589108|571419|P1|Overall Study|Lost to Follow-up|1
161880|NCT00588952|571449|P2|Overall Study|Withdrawal by Subject|5
161881|NCT00588952|571450|P1|Overall Study|Withdrawal by Subject|3
161882|NCT00588952|571449|P2|Overall Study|Adverse Event|2
161883|NCT00588952|571450|P1|Overall Study|Adverse Event|0
161884|NCT00588861|571478|P2|10 Years|Incomplete due to study termination|114
161885|NCT00588861|571479|P1|10 Years|Incomplete due to study termination|107
161886|NCT00588861|571478|P2|8 Years|Patients did not return for follow-up|114
161887|NCT00588861|571479|P1|8 Years|Patients did not return for follow-up|105
161888|NCT00588861|571478|P2|6 Years|Patients did not return for follow-up|109
161889|NCT00588861|571479|P1|6 Years|Patients did not return for follow-up|104
161890|NCT00588861|571478|P2|4 Years|Patients did not return for follow-up|103
161891|NCT00588861|571479|P1|4 Years|Patients did not return for follow-up|91
161892|NCT00588861|571478|P2|2 Years|Patients did not return for follow-up|87
161893|NCT00588861|571479|P1|2 Years|Patients did not return for follow-up|92
161894|NCT00588861|571478|P2|1 Year|Patients did not return for follow-up|82
161895|NCT00588861|571479|P1|1 Year|Patients did not return for follow-up|89
161896|NCT00588861|571478|P2|6 Months|Patients did not return for follow-up|73
161897|NCT00588861|571479|P1|6 Months|Patients did not return for follow-up|98
161898|NCT00588861|571478|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
161899|NCT00588861|571479|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
161900|NCT00588822|571500|P1|Overall Study|progression of disease|8
161901|NCT00588731|571520|P2|Overall Study|Withdrawal by Subject|2
161902|NCT00588731|571521|P1|Overall Study|Withdrawal by Subject|3
161903|NCT00588692|571531|P2|Overall Study|Death|0
161904|NCT00588692|571532|P1|Overall Study|Death|1
161905|NCT00588692|571531|P2|Overall Study|Cancer|0
161906|NCT00588692|571532|P1|Overall Study|Cancer|1
161907|NCT00588692|571531|P2|Overall Study|Severe Peptic Ulcer Disease|0
161908|NCT00588692|571532|P1|Overall Study|Severe Peptic Ulcer Disease|1
161909|NCT00588692|571531|P2|Overall Study|Hip Surgery|1
161910|NCT00588692|571532|P1|Overall Study|Hip Surgery|0
161911|NCT00588692|571531|P2|Overall Study|Withdrawal by Subject|2
161912|NCT00588692|571532|P1|Overall Study|Withdrawal by Subject|4
161913|NCT00588666|571568|P1|Overall Study|Adverse Event|4
161914|NCT00588640|571573|P1|Overall Study|Ineligible Patient|1
161915|NCT00588640|571573|P1|Overall Study|Physician Decision|1
161916|NCT00588445|571592|P1|Overall Study|Not Treated|10
161917|NCT00588445|571592|P1|Overall Study|Disease Progression|1
161918|NCT00588445|571592|P1|Overall Study|Withdrawal by Subject|3
161919|NCT00588445|571592|P1|Overall Study|Protocol Violation|1
161920|NCT00588354|571616|P2|Baseline to 4 Weeks|Lost to Follow-up|1
161921|NCT00588354|571617|P1|Baseline to 4 Weeks|Lost to Follow-up|0
161922|NCT00588354|571616|P2|Baseline to 2 Weeks|Lack of Efficacy|0
161923|NCT00588354|571617|P1|Baseline to 2 Weeks|Lack of Efficacy|1
161924|NCT00588354|571616|P2|Baseline to 2 Weeks|Adverse Event|0
161925|NCT00588354|571617|P1|Baseline to 2 Weeks|Adverse Event|1
161926|NCT00588341|571637|P1|Overall Study|Patient ineligible|1
161927|NCT00588341|571637|P1|Overall Study|Not treated due to metastatic disease|1
161928|NCT00588341|571637|P1|Overall Study|Withdrawal by Subject|3
161929|NCT00588237|571641|P1|Overall Study|Patien not treated|1
161930|NCT00588237|571641|P1|Overall Study|Evaluable for toxicity only|3
161931|NCT00588146|571664|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
161932|NCT00588146|571665|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
161933|NCT00588094|571671|P1|Overall Study|Progression of Disease|2
161934|NCT00588094|571671|P1|Overall Study|Adverse Event|3
161935|NCT00587964|571694|P1|Overall Study|Progression of Disease|4
161936|NCT00587964|571694|P1|Overall Study|Patient did not receive intervention|5
161937|NCT00587964|571694|P1|Overall Study|Patient found to be ineligible|1
161938|NCT00587964|571694|P1|Overall Study|Lost to Follow-up|1
161939|NCT00587964|571694|P1|Overall Study|Withdrawal by Subject|1
161940|NCT00587860|571700|P2|Overall Study|Withdrawal by Subject|3
161941|NCT00587860|571701|P1|Overall Study|Withdrawal by Subject|3
161942|NCT00587860|571700|P2|Overall Study|Lost to Follow-up|2
161943|NCT00587860|571701|P1|Overall Study|Lost to Follow-up|2
161944|NCT00587847|571721|P1|Overall Study|Adverse Event|2
161945|NCT00587847|571721|P1|Overall Study|Lack of Efficacy|5
161946|NCT00587795|571744|P2|Overall Study|Withdrawal by Subject|0
161947|NCT00587795|571745|P1|Overall Study|Withdrawal by Subject|1
161948|NCT00587639|571799|P1|Overall Study|Withdrawal by Subject|1
161949|NCT00587587|571806|P2|Overall Study|Lost to Follow-up|1
161950|NCT00587587|571807|P1|Overall Study|Lost to Follow-up|6
161951|NCT00587457|571861|P3|Overall Study|Development of neutralizing Abs|1
161952|NCT00587457|571862|P2|Overall Study|Development of neutralizing Abs|0
161953|NCT00587457|571863|P1|Overall Study|Development of neutralizing Abs|0
161954|NCT00587457|571861|P3|Overall Study|Undefined|1
161955|NCT00587457|571862|P2|Overall Study|Undefined|0
161956|NCT00587457|571863|P1|Overall Study|Undefined|0
161957|NCT00587457|571861|P3|Overall Study|Initiation of alternative therapy|0
161958|NCT00587457|571862|P2|Overall Study|Initiation of alternative therapy|1
161959|NCT00587457|571863|P1|Overall Study|Initiation of alternative therapy|0
161960|NCT00587457|571861|P3|Overall Study|Disease progression|2
161961|NCT00587457|571862|P2|Overall Study|Disease progression|0
161962|NCT00587457|571863|P1|Overall Study|Disease progression|2
161963|NCT00587457|571861|P3|Overall Study|Adverse Event|1
161964|NCT00587457|571862|P2|Overall Study|Adverse Event|2
161965|NCT00587457|571863|P1|Overall Study|Adverse Event|1
161966|NCT00587431|571900|P2|Overall Study|Withdrawal by Subject|1
161967|NCT00587431|571901|P1|Overall Study|Withdrawal by Subject|0
161968|NCT00587431|571900|P2|Overall Study|Adverse Event|0
161969|NCT00587431|571901|P1|Overall Study|Adverse Event|1
161970|NCT00587288|571912|P2|Overall Study|Protocol Violation|0
161971|NCT00587288|571913|P1|Overall Study|Protocol Violation|1
161972|NCT00587288|571912|P2|Overall Study|Lack of Efficacy|8
161973|NCT00587288|571913|P1|Overall Study|Lack of Efficacy|2
161974|NCT00587288|571912|P2|Overall Study|Adverse Event|1
161975|NCT00587288|571913|P1|Overall Study|Adverse Event|0
161976|NCT00587223|571931|P1|Overall Study|Adverse Event|1
161977|NCT00587171|571948|P2|Overall Study|Lost to Follow-up|1
161978|NCT00587171|571949|P1|Overall Study|Lost to Follow-up|1
161979|NCT00587158|571979|P2|Overall Study|Subject did not want to take study med|1
161980|NCT00587158|571980|P1|Overall Study|Subject did not want to take study med|0
161981|NCT00587158|571979|P2|Overall Study|Death|1
161982|NCT00587158|571980|P1|Overall Study|Death|0
161983|NCT00587158|571979|P2|Overall Study|Lost to Follow-up|2
161984|NCT00587158|571980|P1|Overall Study|Lost to Follow-up|1
161985|NCT00587158|571979|P2|Overall Study|Physician Decision|1
161986|NCT00587158|571980|P1|Overall Study|Physician Decision|0
161987|NCT00587158|571979|P2|Overall Study|Did not want to do 24 hr urine collect.|3
161988|NCT00587158|571980|P1|Overall Study|Did not want to do 24 hr urine collect.|4
161989|NCT00587054|572033|P1|Overall Study|Patient not treated|9
161990|NCT00586898|572053|P1|Overall Study|Evaluable for Toxicity Only|5
161991|NCT00586898|572053|P1|Overall Study|Patiemt Non-compliance|1
161992|NCT00586898|572053|P1|Overall Study|Adverse Event|1
161993|NCT00586846|572057|P1|Overall Study|Evaluable for Toxicity Only|4
161994|NCT00586846|572057|P1|Overall Study|Death|1
161995|NCT00586846|572057|P1|Overall Study|Physician Decision|1
161996|NCT00586820|572063|P2|Overall Study|Unsuccessful PCI|0
161997|NCT00586820|572064|P1|Overall Study|Unsuccessful PCI|1
161998|NCT00586703|572095|P1|Overall Study|Death|12
161999|NCT00586690|572102|P2|Overall Study|Lab can't accommodate|0
162000|NCT00586690|572103|P1|Overall Study|Lab can't accommodate|1
162001|NCT00586690|572102|P2|Overall Study|Lack of Efficacy|0
162002|NCT00586690|572103|P1|Overall Study|Lack of Efficacy|2
162003|NCT00586690|572102|P2|Overall Study|Adverse Event|0
162004|NCT00586690|572103|P1|Overall Study|Adverse Event|1
162005|NCT00586690|572102|P2|Overall Study|Disease Progression|0
162006|NCT00586690|572103|P1|Overall Study|Disease Progression|10
162007|NCT00586690|572102|P2|Overall Study|Death|0
162008|NCT00586690|572103|P1|Overall Study|Death|2
162009|NCT00586664|572113|P3|Overall Study|Exclusion criteria met|0
162010|NCT00586664|572114|P2|Overall Study|Exclusion criteria met|0
162011|NCT00586664|572115|P1|Overall Study|Exclusion criteria met|2
162012|NCT00586664|572113|P3|Overall Study|Withdrawal by Subject|1
162013|NCT00586664|572114|P2|Overall Study|Withdrawal by Subject|7
162014|NCT00586664|572115|P1|Overall Study|Withdrawal by Subject|3
162015|NCT00586625|572161|P2|Overall Study|Subject unable to return for visit|0
162016|NCT00586625|572162|P1|Overall Study|Subject unable to return for visit|2
162017|NCT00586625|572161|P2|Overall Study|Subject non-compliance|1
162018|NCT00586625|572162|P1|Overall Study|Subject non-compliance|0
162019|NCT00586625|572161|P2|Overall Study|Withdrawal by Subject|10
162020|NCT00586625|572162|P1|Overall Study|Withdrawal by Subject|32
162021|NCT00586625|572161|P2|Overall Study|Protocol Violation|0
162022|NCT00586625|572162|P1|Overall Study|Protocol Violation|3
162023|NCT00586625|572161|P2|Overall Study|Adverse Event|6
162024|NCT00586625|572162|P1|Overall Study|Adverse Event|6
162025|NCT00586612|572170|P2|Booster Phase|Lost to Follow-up|1
162026|NCT00586612|572171|P1|Booster Phase|Lost to Follow-up|3
162027|NCT00586612|572170|P2|Primary Phase|Withdrawal by Subject|2
162028|NCT00586612|572171|P1|Primary Phase|Withdrawal by Subject|0
162029|NCT00586612|572170|P2|Primary Phase|Lost to Follow-up|1
162030|NCT00586612|572171|P1|Primary Phase|Lost to Follow-up|0
162031|NCT00586612|572170|P2|Primary Phase|Protocol Violation|0
162032|NCT00586612|572171|P1|Primary Phase|Protocol Violation|1
162033|NCT00586521|572241|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
162034|NCT00586495|572248|P1|Follow-up|Switch to commercial drug|10
162035|NCT00586495|572248|P1|Follow-up|Protocol driven decision point|37
162036|NCT00586495|572248|P1|Follow-up|Withdrawal by Subject|4
162037|NCT00586495|572248|P1|Follow-up|Lost to Follow-up|1
162038|NCT00586495|572248|P1|Follow-up|Death|40
162039|NCT00586495|572248|P1|Treatment Period|Switch to commercial drug|10
162040|NCT00586495|572248|P1|Treatment Period|Disease progression, recurrence/relapse|71
162041|NCT00586495|572248|P1|Treatment Period|Withdrawal by Subject|1
162042|NCT00586495|572248|P1|Treatment Period|Protocol Violation|1
162043|NCT00586495|572248|P1|Treatment Period|Death|1
162044|NCT00586495|572248|P1|Treatment Period|Adverse Event|11
162045|NCT00586469|572277|P2|Overall Study|Adverse Event|1
162046|NCT00586469|572278|P1|Overall Study|Adverse Event|0
162047|NCT00586339|572305|P3|Overall Study|Withdrawal by Subject|1
162048|NCT00586339|572306|P2|Overall Study|Withdrawal by Subject|3
162049|NCT00586339|572307|P1|Overall Study|Withdrawal by Subject|1
162050|NCT00586339|572305|P3|Overall Study|Lost to Follow-up|5
162051|NCT00586339|572306|P2|Overall Study|Lost to Follow-up|4
162052|NCT00586339|572307|P1|Overall Study|Lost to Follow-up|6
162053|NCT00586326|572405|P1|Treated Through 5-yr Follow Up-Treated|Other|2
162054|NCT00586326|572405|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
162055|NCT00586326|572405|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
162056|NCT00586326|572405|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
162057|NCT00586326|572405|P1|Treated Through 5-yr Follow Up-Treated|Death|2
162058|NCT00586326|572405|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
162059|NCT00586326|572405|P1|Device Placed toTreatment-ITT|Physician Decision|1
162060|NCT00586326|572405|P1|Device Placed toTreatment-ITT|Positive Margins|3
162061|NCT00586326|572405|P1|Device Placed toTreatment-ITT|Microinvasion|1
162062|NCT00586326|572405|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
162063|NCT00586326|572405|P1|Device Placed toTreatment-ITT|Skin Distance|7
162064|NCT00586326|572405|P1|Enrollment to Device Placement-Enrolled|Other|1
162065|NCT00586326|572405|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
162066|NCT00586326|572405|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
162067|NCT00586326|572405|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
162068|NCT00586326|572405|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
162069|NCT00586326|572405|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
162070|NCT00586313|572416|P1|Overall Study|Lack of Efficacy|2
162071|NCT00586157|572452|P2|Second Intervention|Adverse Event|1
162072|NCT00586157|572453|P1|Second Intervention|Adverse Event|0
162073|NCT00586157|572452|P2|Second Intervention|Worsening behavior|0
162074|NCT00586157|572453|P1|Second Intervention|Worsening behavior|1
162075|NCT00586157|572452|P2|Second Intervention|Withdrawal by Subject|0
162076|NCT00586157|572453|P1|Second Intervention|Withdrawal by Subject|1
162077|NCT00586157|572452|P2|First Intervention|Worsening behavior|0
162078|NCT00586157|572453|P1|First Intervention|Worsening behavior|1
162079|NCT00586105|572463|P1|Overall Study|Reason not reported|1
162080|NCT00586105|572463|P1|Overall Study|Switched to commercial drug|9
162081|NCT00586105|572463|P1|Overall Study|Disease progression|19
162082|NCT00586105|572463|P1|Overall Study|Withdrawal by Subject|3
162083|NCT00586105|572463|P1|Overall Study|Protocol Violation|1
162084|NCT00586105|572463|P1|Overall Study|Death|2
162085|NCT00586105|572463|P1|Overall Study|Adverse Event|4
162086|NCT00586066|572478|P2|Overall Study|Withdrawal of consent|2
162087|NCT00586066|572479|P1|Overall Study|Withdrawal of consent|4
162088|NCT00586066|572478|P2|Overall Study|Physician Decision|0
162089|NCT00586066|572479|P1|Overall Study|Physician Decision|1
162090|NCT00586066|572478|P2|Overall Study|Adverse Event|2
162091|NCT00586066|572479|P1|Overall Study|Adverse Event|2
162092|NCT00586066|572478|P2|Overall Study|Lack of Efficacy|3
162093|NCT00586066|572479|P1|Overall Study|Lack of Efficacy|5
162094|NCT00586066|572478|P2|Overall Study|Lost to Follow-up|3
162095|NCT00586066|572479|P1|Overall Study|Lost to Follow-up|6
162096|NCT00585975|572491|P2|Overall Study|Enrollment met/over-enrolled|9
162097|NCT00585975|572492|P1|Overall Study|Enrollment met/over-enrolled|10
162098|NCT00585975|572491|P2|Overall Study|Lost to Follow-up|1
162099|NCT00585975|572492|P1|Overall Study|Lost to Follow-up|2
162100|NCT00585975|572491|P2|Overall Study|Withdrawal by Subject|3
162101|NCT00585975|572492|P1|Overall Study|Withdrawal by Subject|3
162102|NCT00585923|572502|P2|Overall Study|Physician decided not to continue|33
162103|NCT00585923|572503|P1|Overall Study|Physician decided not to continue|31
162104|NCT00585689|572534|P1|Overall Study|Death|1
162105|NCT00585689|572534|P1|Overall Study|Patient had unresectable disease|1
162106|NCT00585689|572534|P1|Overall Study|Patient Declined Surgery|1
162107|NCT00585689|572534|P1|Overall Study|Adverse Event|1
162108|NCT00585689|572534|P1|Overall Study|Received different ABI-007 schedule|3
162109|NCT00585585|572580|P1|Overall Study|Adverse Event|1
162110|NCT00585546|572584|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
162111|NCT00585546|572584|P1|Clenbuterol Treatment - up to 12 Months|Death|1
162112|NCT00585533|572598|P1|Overall Study|objective or symptomatic progression|9
162113|NCT00585468|572607|P2|First Intervention|Withdrawal by Subject|1
162114|NCT00585468|572608|P1|First Intervention|Withdrawal by Subject|1
162115|NCT00585351|572640|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
162116|NCT00585351|572641|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
162117|NCT00585351|572642|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
162118|NCT00585351|572643|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
162119|NCT00585351|572644|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
162120|NCT00585351|572645|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
162121|NCT00585351|572646|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
162122|NCT00585351|572647|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
162123|NCT00585351|572640|P8|Enrollment Period (Intervention)|Death|0
162124|NCT00585351|572641|P7|Enrollment Period (Intervention)|Death|1
162125|NCT00585351|572642|P6|Enrollment Period (Intervention)|Death|0
162126|NCT00585351|572643|P5|Enrollment Period (Intervention)|Death|1
162127|NCT00585351|572644|P4|Enrollment Period (Intervention)|Death|0
162128|NCT00585351|572645|P3|Enrollment Period (Intervention)|Death|0
162129|NCT00585351|572646|P2|Enrollment Period (Intervention)|Death|0
162130|NCT00585351|572647|P1|Enrollment Period (Intervention)|Death|0
162131|NCT00585351|572640|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
162132|NCT00585351|572641|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
162133|NCT00585351|572642|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
162134|NCT00585351|572643|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
162135|NCT00585351|572644|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
162136|NCT00585351|572645|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
162137|NCT00585351|572646|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
162138|NCT00585351|572647|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
162139|NCT00585351|572640|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
162140|NCT00585351|572641|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
162141|NCT00585351|572642|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
162142|NCT00585351|572643|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
162143|NCT00585351|572644|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
162144|NCT00585351|572645|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
162145|NCT00585351|572646|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
162146|NCT00585351|572647|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
162147|NCT00585351|572640|P8|Notification Period (Informed Consent)|No study medication on flight|0
162148|NCT00585351|572641|P7|Notification Period (Informed Consent)|No study medication on flight|0
162149|NCT00585351|572642|P6|Notification Period (Informed Consent)|No study medication on flight|0
162150|NCT00585351|572643|P5|Notification Period (Informed Consent)|No study medication on flight|0
162151|NCT00585351|572644|P4|Notification Period (Informed Consent)|No study medication on flight|0
162152|NCT00585351|572645|P3|Notification Period (Informed Consent)|No study medication on flight|0
162153|NCT00585351|572646|P2|Notification Period (Informed Consent)|No study medication on flight|1
162154|NCT00585351|572647|P1|Notification Period (Informed Consent)|No study medication on flight|0
162155|NCT00585351|572640|P8|Notification Period (Informed Consent)|Flight aborted|0
162156|NCT00585351|572641|P7|Notification Period (Informed Consent)|Flight aborted|0
162157|NCT00585351|572642|P6|Notification Period (Informed Consent)|Flight aborted|0
162158|NCT00585351|572643|P5|Notification Period (Informed Consent)|Flight aborted|0
162159|NCT00585351|572644|P4|Notification Period (Informed Consent)|Flight aborted|0
162160|NCT00585351|572645|P3|Notification Period (Informed Consent)|Flight aborted|0
162161|NCT00585351|572646|P2|Notification Period (Informed Consent)|Flight aborted|1
162162|NCT00585351|572647|P1|Notification Period (Informed Consent)|Flight aborted|2
162163|NCT00585351|572640|P8|Notification Period (Informed Consent)|Physician Decision|0
162164|NCT00585351|572641|P7|Notification Period (Informed Consent)|Physician Decision|0
162165|NCT00585351|572642|P6|Notification Period (Informed Consent)|Physician Decision|0
162166|NCT00585351|572643|P5|Notification Period (Informed Consent)|Physician Decision|0
162167|NCT00585351|572644|P4|Notification Period (Informed Consent)|Physician Decision|0
162168|NCT00585351|572645|P3|Notification Period (Informed Consent)|Physician Decision|0
162169|NCT00585351|572646|P2|Notification Period (Informed Consent)|Physician Decision|2
162170|NCT00585351|572647|P1|Notification Period (Informed Consent)|Physician Decision|0
162171|NCT00585325|572663|P2|Overall Study|Withdrawal by Subject|1
162172|NCT00585325|572664|P1|Overall Study|Withdrawal by Subject|1
162173|NCT00585312|572672|P2|Overall Study|Study terminated by the sponsor|31
162174|NCT00585312|572673|P1|Overall Study|Study terminated by the sponsor|34
162175|NCT00585312|572672|P2|Overall Study|Withdrawal by Subject|1
162176|NCT00585312|572673|P1|Overall Study|Withdrawal by Subject|5
162177|NCT00585312|572672|P2|Overall Study|Reason not specified|0
162178|NCT00585312|572673|P1|Overall Study|Reason not specified|2
162179|NCT00585312|572672|P2|Overall Study|Lost to Follow-up|1
162180|NCT00585312|572673|P1|Overall Study|Lost to Follow-up|1
162181|NCT00585312|572672|P2|Overall Study|Lack of Efficacy|11
162182|NCT00585312|572673|P1|Overall Study|Lack of Efficacy|6
162183|NCT00585312|572672|P2|Overall Study|Adverse Event|0
162184|NCT00585312|572673|P1|Overall Study|Adverse Event|3
162185|NCT00585286|572685|P1|Overall Study|Lost to Follow-up|1
162186|NCT00585221|572701|P1|Overall Study|Protocol Violation|8
162187|NCT00585169|572711|P1|Overall Study|Withdrawal by Subject|1
162188|NCT00585078|572721|P1|Overall Study|Death|1
162189|NCT00585078|572721|P1|Overall Study|Adverse Event|10
162190|NCT00585078|572721|P1|Overall Study|Disease Progression|24
162191|NCT00585078|572721|P1|Overall Study|Poor performance status|1
162192|NCT00585078|572721|P1|Overall Study|Withdrawal by Subject|4
162193|NCT00585052|572728|P1|Overall Study|Withdrawal by Subject|1
162194|NCT00585039|572735|P2|Overall Study|medication spilled|0
162195|NCT00585039|572736|P1|Overall Study|medication spilled|2
162196|NCT00584987|572765|P4|Overall Study|Adverse Event|1
162197|NCT00584987|572766|P3|Overall Study|Adverse Event|0
162198|NCT00584987|572767|P2|Overall Study|Adverse Event|0
162199|NCT00584987|572768|P1|Overall Study|Adverse Event|0
162200|NCT00584987|572765|P4|Overall Study|Protocol Violation|0
162201|NCT00584987|572766|P3|Overall Study|Protocol Violation|1
162202|NCT00584987|572767|P2|Overall Study|Protocol Violation|1
162203|NCT00584987|572768|P1|Overall Study|Protocol Violation|1
162204|NCT00584909|572816|P1|Overall Study|Adverse Event|4
162205|NCT00584844|572826|P1|Overall Study|Screen Failure|20
162206|NCT00584844|572826|P1|Overall Study|Withdrawal by Subject|59
162207|NCT00584740|572878|P2|Overall Study|Lost to Follow-up|1
162208|NCT00584740|572879|P1|Overall Study|Lost to Follow-up|0
162209|NCT00584740|572878|P2|Overall Study|Withdrawal by Subject|2
162210|NCT00584740|572879|P1|Overall Study|Withdrawal by Subject|3
162211|NCT00584740|572878|P2|Overall Study|Lack of Efficacy|2
162212|NCT00584740|572879|P1|Overall Study|Lack of Efficacy|8
162213|NCT00584740|572878|P2|Overall Study|Adverse Event|1
162214|NCT00584740|572879|P1|Overall Study|Adverse Event|1
162215|NCT00584727|572897|P6|Third Intervention|Protocol Violation|2
162216|NCT00584727|572898|P5|Third Intervention|Protocol Violation|4
162217|NCT00584727|572899|P4|Third Intervention|Protocol Violation|0
162218|NCT00584727|572900|P3|Third Intervention|Protocol Violation|1
162219|NCT00584727|572901|P2|Third Intervention|Protocol Violation|0
162220|NCT00584727|572902|P1|Third Intervention|Protocol Violation|0
162221|NCT00584727|572897|P6|First Intervention|Discontinuation|0
162222|NCT00584727|572898|P5|First Intervention|Discontinuation|0
162223|NCT00584727|572899|P4|First Intervention|Discontinuation|0
162224|NCT00584727|572900|P3|First Intervention|Discontinuation|1
162225|NCT00584727|572901|P2|First Intervention|Discontinuation|0
162226|NCT00584727|572902|P1|First Intervention|Discontinuation|0
162227|NCT00584454|572940|P1|Overall Study|Clinical Hold|2
162228|NCT00584454|572940|P1|Overall Study|Relocation|1
162229|NCT00584454|572940|P1|Overall Study|Adverse Event|1
162230|NCT00584415|572944|P1|Overall Study|Adverse Event|7
162231|NCT00584194|572963|P1|Overall Study|Not specified|135
162232|NCT00583947|572977|P2|Cross-over Period|not specified|1
162233|NCT00583947|572978|P1|Cross-over Period|not specified|1
162234|NCT00583947|572977|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
162235|NCT00583947|572978|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
162236|NCT00583947|572977|P2|Cross-over Period|Withdrawal by Subject|0
162237|NCT00583947|572978|P1|Cross-over Period|Withdrawal by Subject|2
162238|NCT00583947|572977|P2|Cross-over Period|Adverse Event|0
162239|NCT00583947|572978|P1|Cross-over Period|Adverse Event|2
162240|NCT00583596|573144|P1|Overall Study|Outside f-up window|26
162241|NCT00583596|573144|P1|Overall Study|Not consented|15
162242|NCT00583596|573144|P1|Overall Study|Data not complete|1
162243|NCT00583596|573144|P1|Overall Study|Lost to Follow-up|94
162244|NCT00583596|573144|P1|Overall Study|Withdrawal by Subject|6
162245|NCT00583596|573144|P1|Overall Study|Death|2
162246|NCT00583596|573144|P1|Overall Study|Excluded due to Hurricane Katrina|30
162247|NCT00583596|573144|P1|Overall Study|Lost to Follow-up|110
162248|NCT00583557|573149|P1|Overall Study|Did not receive belimumab in LBRA99|2
162249|NCT00583557|573149|P1|Overall Study|Other|5
162250|NCT00583557|573149|P1|Overall Study|Lack of Compliance|5
162251|NCT00583557|573149|P1|Overall Study|Lack of Efficacy|31
162252|NCT00583557|573149|P1|Overall Study|Adverse Event|9
162253|NCT00583557|573149|P1|Overall Study|Withdrawal by Subject|18
162254|NCT00583453|573180|P2|Overall Study|discontinued intervention|2
162255|NCT00583453|573181|P1|Overall Study|discontinued intervention|0
162256|NCT00583362|573214|P1|Overall Study|Withdrawal by Subject|57
162257|NCT00583362|573214|P1|Overall Study|Protocol Violation|2
162258|NCT00583362|573214|P1|Overall Study|Physician Decision|19
162259|NCT00583362|573214|P1|Overall Study|Sponsor request due to missed doses|1
162260|NCT00583362|573214|P1|Overall Study|Behavioral problems and non-compliance|1
162261|NCT00583362|573214|P1|Overall Study|Misunderstanding of protocol|1
162262|NCT00583362|573214|P1|Overall Study|Missed visits due to staff changes|1
162263|NCT00583362|573214|P1|Overall Study|Subject moved out of the country/state|2
162264|NCT00583362|573214|P1|Overall Study|Subject not dosed in LBSL99|1
162265|NCT00583362|573214|P1|Overall Study|Current site closed|7
162266|NCT00583362|573214|P1|Overall Study|Miscommunication of visit window|5
162267|NCT00583362|573214|P1|Overall Study|Pregnancy|7
162268|NCT00583362|573214|P1|Overall Study|Non-compliance with study drug|28
162269|NCT00583362|573214|P1|Overall Study|Lost to Follow-up|4
162270|NCT00583362|573214|P1|Overall Study|Lack of Efficacy|22
162271|NCT00583362|573214|P1|Overall Study|Adverse Event|44
162272|NCT00583219|573238|P1|Phase 2|Withdrawal by Subject|1
162273|NCT00583115|573255|P1|Overall Study|Death|1
162274|NCT00583102|573260|P1|Overall Study|Adverse Event|3
162275|NCT00582972|573264|P1|Overall Study|Protocol Violation|2
162276|NCT00582933|573273|P1|Overall Study|Physician Decision|3
162277|NCT00582907|573277|P4|2nd Course|Lack of Efficacy|0
162278|NCT00582907|573278|P3|2nd Course|Lack of Efficacy|0
162279|NCT00582907|573279|P2|2nd Course|Lack of Efficacy|0
162280|NCT00582907|573280|P1|2nd Course|Lack of Efficacy|1
162281|NCT00582907|573277|P4|1st Course|Lost to Follow-up|1
162282|NCT00582907|573278|P3|1st Course|Lost to Follow-up|0
162283|NCT00582907|573279|P2|1st Course|Lost to Follow-up|0
162284|NCT00582907|573280|P1|1st Course|Lost to Follow-up|0
162285|NCT00582907|573277|P4|1st Course|Withdrawal by Subject|0
162286|NCT00582907|573278|P3|1st Course|Withdrawal by Subject|0
162287|NCT00582907|573279|P2|1st Course|Withdrawal by Subject|0
162288|NCT00582907|573280|P1|1st Course|Withdrawal by Subject|1
162289|NCT00582816|573319|P1|Overall Study|Engraftment Failure|3
162290|NCT00582790|573329|P1|Overall Study|Rapid progression of disease|1
162291|NCT00582738|573338|P2|Overall Study|Withdrawal by Subject|3
162292|NCT00582738|573339|P1|Overall Study|Withdrawal by Subject|0
162293|NCT00582738|573338|P2|Overall Study|Protocol Violation|1
162294|NCT00582738|573339|P1|Overall Study|Protocol Violation|1
162295|NCT00582738|573338|P2|Overall Study|Other|0
162296|NCT00582738|573339|P1|Overall Study|Other|1
162297|NCT00582738|573338|P2|Overall Study|Graft Lost|1
162298|NCT00582738|573339|P1|Overall Study|Graft Lost|0
162299|NCT00582738|573338|P2|Overall Study|Adverse Event|5
162300|NCT00582738|573339|P1|Overall Study|Adverse Event|0
162301|NCT00582738|573338|P2|Overall Study|Administrative Problems|8
162302|NCT00582738|573339|P1|Overall Study|Administrative Problems|7
162303|NCT00582712|573363|P1|Overall Study|Complicating disease requiring treatment|1
162304|NCT00582712|573363|P1|Overall Study|Withdrawal by Subject|1
162305|NCT00582712|573363|P1|Overall Study|Lack of Efficacy|1
162306|NCT00582712|573363|P1|Overall Study|Adverse Event|1
162307|NCT00582608|573378|P1|Overall Study|Lack of accrual|4
162308|NCT00582608|573378|P1|Overall Study|Patient Ineligible|1
162309|NCT00582608|573378|P1|Overall Study|Not Treated|7
162310|NCT00582556|573385|P3|Overall Study|Physician Decision|1
162311|NCT00582556|573386|P2|Overall Study|Physician Decision|0
162312|NCT00582556|573387|P1|Overall Study|Physician Decision|0
162313|NCT00582556|573385|P3|Overall Study|Withdrawal by Subject|1
162314|NCT00582556|573386|P2|Overall Study|Withdrawal by Subject|1
162315|NCT00582556|573387|P1|Overall Study|Withdrawal by Subject|0
162316|NCT00582491|573415|P2|Overall Study|Withdrawal by Subject|0
162317|NCT00582491|573416|P1|Overall Study|Withdrawal by Subject|1
162318|NCT00582426|573440|P2|Overall Study|Use of illicit drugs|0
162319|NCT00582426|573441|P1|Overall Study|Use of illicit drugs|1
162320|NCT00582426|573440|P2|Overall Study|Disease Progression|2
162321|NCT00582426|573441|P1|Overall Study|Disease Progression|2
162322|NCT00582426|573440|P2|Overall Study|Withdrawal by Subject|2
162323|NCT00582426|573441|P1|Overall Study|Withdrawal by Subject|3
162324|NCT00582426|573440|P2|Overall Study|Death|3
162325|NCT00582426|573441|P1|Overall Study|Death|4
162326|NCT00582426|573440|P2|Overall Study|Protocol Violation|2
162327|NCT00582426|573441|P1|Overall Study|Protocol Violation|6
162328|NCT00582426|573440|P2|Overall Study|Adverse Event|2
162329|NCT00582426|573441|P1|Overall Study|Adverse Event|4
162330|NCT00582426|573440|P2|Overall Study|Lost to Follow-up|2
162331|NCT00582426|573441|P1|Overall Study|Lost to Follow-up|0
162332|NCT00582309|573488|P3|Overall Study|Protocol Violation|2
162333|NCT00582309|573489|P2|Overall Study|Protocol Violation|0
162334|NCT00582309|573490|P1|Overall Study|Protocol Violation|0
162335|NCT00582114|573505|P2|Overall Study|Stopped by data safety monitoring board|20
162336|NCT00582114|573506|P1|Overall Study|Stopped by data safety monitoring board|19
162337|NCT00582114|573505|P2|Overall Study|Physician Decision|6
162338|NCT00582114|573506|P1|Overall Study|Physician Decision|0
162339|NCT00582114|573505|P2|Overall Study|Adverse Event|1
162340|NCT00582114|573506|P1|Overall Study|Adverse Event|1
162341|NCT00582114|573505|P2|Overall Study|Withdrawal by Subject|16
162342|NCT00582114|573506|P1|Overall Study|Withdrawal by Subject|8
162343|NCT00582114|573505|P2|Overall Study|Lost to Follow-up|6
162344|NCT00582114|573506|P1|Overall Study|Lost to Follow-up|7
162345|NCT00582114|573505|P2|Overall Study|Kidney Transplant|1
162346|NCT00582114|573506|P1|Overall Study|Kidney Transplant|3
162347|NCT00582114|573505|P2|Overall Study|Death|4
162348|NCT00582114|573506|P1|Overall Study|Death|4
162349|NCT00582036|573521|P2|Overall Study|Withdrawal by Subject|1
162350|NCT00582036|573522|P1|Overall Study|Withdrawal by Subject|0
162351|NCT00582010|573530|P2|Overall Study|Death|1
162352|NCT00582010|573531|P1|Overall Study|Death|0
162353|NCT00581945|573560|P2|Overall Study|Death|0
162354|NCT00581945|573561|P1|Overall Study|Death|1
162355|NCT00581945|573560|P2|Overall Study|Withdrawal by Subject|6
162356|NCT00581945|573561|P1|Overall Study|Withdrawal by Subject|2
162357|NCT00581945|573560|P2|Overall Study|Unsatisfactory therapeutic effect|0
162358|NCT00581945|573561|P1|Overall Study|Unsatisfactory therapeutic effect|2
162359|NCT00581945|573560|P2|Overall Study|Adverse Event|4
162360|NCT00581945|573561|P1|Overall Study|Adverse Event|4
162361|NCT00581919|573577|P1|Overall Study|Withdrawal by Subject|1
162362|NCT00581919|573577|P1|Overall Study|Started Non-Protocol Therapy|2
162363|NCT00581919|573577|P1|Overall Study|Other Complicating Disease|1
162364|NCT00581919|573577|P1|Overall Study|Physician Decision|1
162365|NCT00581919|573577|P1|Overall Study|Disease Progression|10
162366|NCT00581919|573577|P1|Overall Study|Death|1
162367|NCT00581919|573577|P1|Overall Study|Adverse Event|8
162368|NCT00581828|573596|P1|Overall Study|Protocol Violation|1
162369|NCT00581776|573600|P1|Overall Study|Disease progression or no response|3
162370|NCT00581555|573618|P2|Overall Study|Other reasons|4
162371|NCT00581555|573619|P1|Overall Study|Other reasons|16
162372|NCT00581555|573618|P2|Overall Study|Lost to Follow-up|2
162373|NCT00581555|573619|P1|Overall Study|Lost to Follow-up|2
162374|NCT00581555|573618|P2|Overall Study|Withdrawal by Subject|9
162375|NCT00581555|573619|P1|Overall Study|Withdrawal by Subject|18
162376|NCT00581555|573618|P2|Overall Study|Physician Decision|2
162377|NCT00581555|573619|P1|Overall Study|Physician Decision|3
162378|NCT00581555|573618|P2|Overall Study|Adverse Event|3
162379|NCT00581555|573619|P1|Overall Study|Adverse Event|4
162380|NCT00581542|573643|P2|Overall Study|Lost to Follow-up|21
162381|NCT00581542|573644|P1|Overall Study|Lost to Follow-up|9
162382|NCT00581542|573643|P2|Overall Study|they met an exclusion criteria|2
162383|NCT00581542|573644|P1|Overall Study|they met an exclusion criteria|2
162384|NCT00581360|573698|P1|Overall Study|Withdrawal by Subject|1
162385|NCT00581308|573717|P1|Month 12|Other|1
162386|NCT00581308|573717|P1|Month 12|Device Removed|1
162387|NCT00581308|573717|P1|Month 12|Withdrawal by Subject|3
162388|NCT00581308|573717|P1|Month 12|Lost to Follow-up|14
162389|NCT00581308|573717|P1|Month 12|Death|1
162390|NCT00581308|573717|P1|Month 6|Withdrawal by Subject|2
162391|NCT00581308|573717|P1|Month 6|Lost to Follow-up|1
162392|NCT00581308|573717|P1|Month 1|Uknown|1
162393|NCT00581308|573717|P1|Month 1|Device Removed|2
162394|NCT00581308|573717|P1|Month 1|Withdrawal by Subject|2
162395|NCT00581308|573717|P1|Month 1|Lost to Follow-up|3
162396|NCT00581308|573717|P1|Pre Discharge|Device Removed|1
162397|NCT00581308|573717|P1|Pre Discharge|Lost to Follow-up|1
162398|NCT00581113|573748|P2|Overall Study|Withdrawal by Subject|1
162399|NCT00581113|573749|P1|Overall Study|Withdrawal by Subject|0
162400|NCT00581100|573759|P2|Overall Study|Other|0
162401|NCT00581100|573760|P1|Overall Study|Other|3
162402|NCT00581100|573759|P2|Overall Study|Withdrawal by Subject|4
162403|NCT00581100|573760|P1|Overall Study|Withdrawal by Subject|1
162404|NCT00581100|573759|P2|Overall Study|Adverse Event|1
162405|NCT00581100|573760|P1|Overall Study|Adverse Event|2
162406|NCT00581100|573759|P2|Overall Study|Death|0
162407|NCT00581100|573760|P1|Overall Study|Death|1
162408|NCT00580983|573813|P1|Overall Study|Did not complete 12 mon post RT studies|7
162409|NCT00580970|573820|P1|Treatment (Lovastatin)|Death|1
162410|NCT00580970|573820|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
162411|NCT00580970|573820|P1|Treatment (Lovastatin)|Physician Decision|4
162412|NCT00580970|573820|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
162413|NCT00580970|573820|P1|Treatment (Lovastatin)|Non-compliance|6
162414|NCT00580970|573820|P1|Pre-treatment|Non-compliance|1
162415|NCT00580866|573835|P2|Overall Study|Lost to Follow-up|2
162416|NCT00580866|573836|P1|Overall Study|Lost to Follow-up|2
162417|NCT00580840|573860|P4|Double-Blind|Other: Forbidden Medication|0
162418|NCT00580840|573861|P3|Double-Blind|Other: Forbidden Medication|1
162419|NCT00580840|573862|P2|Double-Blind|Other: Forbidden Medication|0
162420|NCT00580840|573863|P1|Double-Blind|Other: Forbidden Medication|0
162421|NCT00580840|573860|P4|Double-Blind|Other: Discontinued Methotrexate|0
162422|NCT00580840|573861|P3|Double-Blind|Other: Discontinued Methotrexate|0
162423|NCT00580840|573862|P2|Double-Blind|Other: Discontinued Methotrexate|1
162424|NCT00580840|573863|P1|Double-Blind|Other: Discontinued Methotrexate|0
162425|NCT00580840|573860|P4|Double-Blind|Withdrawal by Subject|2
162426|NCT00580840|573861|P3|Double-Blind|Withdrawal by Subject|2
162427|NCT00580840|573862|P2|Double-Blind|Withdrawal by Subject|1
162428|NCT00580840|573863|P1|Double-Blind|Withdrawal by Subject|0
162429|NCT00580840|573860|P4|Double-Blind|Lost to Follow-up|2
162430|NCT00580840|573861|P3|Double-Blind|Lost to Follow-up|0
162431|NCT00580840|573862|P2|Double-Blind|Lost to Follow-up|1
162432|NCT00580840|573863|P1|Double-Blind|Lost to Follow-up|0
162433|NCT00580840|573860|P4|Double-Blind|Loss of Efficacy|10
162434|NCT00580840|573861|P3|Double-Blind|Loss of Efficacy|2
162435|NCT00580840|573862|P2|Double-Blind|Loss of Efficacy|1
162436|NCT00580840|573863|P1|Double-Blind|Loss of Efficacy|0
162437|NCT00580840|573860|P4|Double-Blind|Adverse Event|1
162438|NCT00580840|573861|P3|Double-Blind|Adverse Event|4
162439|NCT00580840|573862|P2|Double-Blind|Adverse Event|3
162440|NCT00580840|573863|P1|Double-Blind|Adverse Event|0
162441|NCT00580840|573860|P4|Run-in|Other: Exclusionary Lab Value|0
162442|NCT00580840|573861|P3|Run-in|Other: Exclusionary Lab Value|0
162443|NCT00580840|573862|P2|Run-in|Other: Exclusionary Lab Value|0
162444|NCT00580840|573863|P1|Run-in|Other: Exclusionary Lab Value|1
162445|NCT00580840|573860|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
162446|NCT00580840|573861|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
162447|NCT00580840|573862|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
162448|NCT00580840|573863|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
162449|NCT00580840|573860|P4|Run-in|Other: Per Sponsor Request|0
162450|NCT00580840|573861|P3|Run-in|Other: Per Sponsor Request|0
162451|NCT00580840|573862|P2|Run-in|Other: Per Sponsor Request|0
162452|NCT00580840|573863|P1|Run-in|Other: Per Sponsor Request|2
162453|NCT00580840|573860|P4|Run-in|Withdrawal by Subject|0
162454|NCT00580840|573861|P3|Run-in|Withdrawal by Subject|0
162455|NCT00580840|573862|P2|Run-in|Withdrawal by Subject|0
162456|NCT00580840|573863|P1|Run-in|Withdrawal by Subject|5
162457|NCT00580840|573860|P4|Run-in|Lost to Follow-up|0
162458|NCT00580840|573861|P3|Run-in|Lost to Follow-up|0
162459|NCT00580840|573862|P2|Run-in|Lost to Follow-up|0
162460|NCT00580840|573863|P1|Run-in|Lost to Follow-up|4
162461|NCT00580840|573860|P4|Run-in|Loss of Efficacy|0
162462|NCT00580840|573861|P3|Run-in|Loss of Efficacy|0
162463|NCT00580840|573862|P2|Run-in|Loss of Efficacy|0
162464|NCT00580840|573863|P1|Run-in|Loss of Efficacy|1
162465|NCT00580840|573860|P4|Run-in|Lack of Efficacy|0
162466|NCT00580840|573861|P3|Run-in|Lack of Efficacy|0
162467|NCT00580840|573862|P2|Run-in|Lack of Efficacy|0
162468|NCT00580840|573863|P1|Run-in|Lack of Efficacy|93
162469|NCT00580840|573860|P4|Run-in|Adverse Event|0
162470|NCT00580840|573861|P3|Run-in|Adverse Event|0
162471|NCT00580840|573862|P2|Run-in|Adverse Event|0
162472|NCT00580840|573863|P1|Run-in|Adverse Event|17
162473|NCT00580801|573971|P3|Overall Study|Travel|0
162474|NCT00580801|573972|P2|Overall Study|Travel|0
162475|NCT00580801|573973|P1|Overall Study|Travel|1
162476|NCT00580801|573971|P3|Overall Study|Participant non-compliant|1
162477|NCT00580801|573972|P2|Overall Study|Participant non-compliant|0
162478|NCT00580801|573973|P1|Overall Study|Participant non-compliant|0
162479|NCT00580801|573971|P3|Overall Study|Reached a virologic endpoint|2
162480|NCT00580801|573972|P2|Overall Study|Reached a virologic endpoint|1
162481|NCT00580801|573973|P1|Overall Study|Reached a virologic endpoint|0
162482|NCT00580801|573971|P3|Overall Study|Lost to Follow-up|0
162483|NCT00580801|573972|P2|Overall Study|Lost to Follow-up|0
162484|NCT00580801|573973|P1|Overall Study|Lost to Follow-up|2
162485|NCT00580801|573971|P3|Overall Study|Adverse Event|0
162486|NCT00580801|573972|P2|Overall Study|Adverse Event|0
162487|NCT00580801|573973|P1|Overall Study|Adverse Event|2
162488|NCT00580801|573971|P3|Overall Study|Physician Decision|0
162489|NCT00580801|573972|P2|Overall Study|Physician Decision|0
162490|NCT00580801|573973|P1|Overall Study|Physician Decision|1
162491|NCT00580788|574012|P4|Overall Study|Adverse Event|1
162492|NCT00580788|574013|P3|Overall Study|Adverse Event|0
162493|NCT00580788|574014|P2|Overall Study|Adverse Event|0
162494|NCT00580788|574015|P1|Overall Study|Adverse Event|0
162495|NCT00580723|574073|P1|Overall Study|Lost to Follow-up|5
162496|NCT00580723|574073|P1|Overall Study|Did not want to participate in extension|3
162497|NCT00580606|574116|P2|Open Label (OL)|Needed Prohibited Medication|1
162498|NCT00580606|574117|P1|Open Label (OL)|Needed Prohibited Medication|0
162499|NCT00580606|574116|P2|Open Label (OL)|Physician Decision|1
162500|NCT00580606|574117|P1|Open Label (OL)|Physician Decision|1
162501|NCT00580606|574116|P2|Open Label (OL)|Non-compliance|0
162502|NCT00580606|574117|P1|Open Label (OL)|Non-compliance|2
162503|NCT00580606|574116|P2|Open Label (OL)|Pregnancy|1
162504|NCT00580606|574117|P1|Open Label (OL)|Pregnancy|0
162505|NCT00580606|574116|P2|Open Label (OL)|Lost to Follow-up|1
162506|NCT00580606|574117|P1|Open Label (OL)|Lost to Follow-up|0
162507|NCT00580606|574116|P2|Open Label (OL)|Dosing Symptoms|1
162508|NCT00580606|574117|P1|Open Label (OL)|Dosing Symptoms|0
162509|NCT00580606|574116|P2|Open Label (OL)|Withdrawal by Subject|6
162510|NCT00580606|574117|P1|Open Label (OL)|Withdrawal by Subject|4
162511|NCT00580606|574116|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
162512|NCT00580606|574117|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
162513|NCT00580047|574196|P3|Overall Study|Withdrawal by Subject|0
162514|NCT00580047|574197|P2|Overall Study|Withdrawal by Subject|0
162515|NCT00580047|574198|P1|Overall Study|Withdrawal by Subject|1
162516|NCT00580047|574196|P3|Overall Study|Withdrawal by Subject|2
162517|NCT00580047|574197|P2|Overall Study|Withdrawal by Subject|1
162518|NCT00580047|574198|P1|Overall Study|Withdrawal by Subject|1
162519|NCT00580047|574196|P3|Overall Study|Lost to Follow-up|0
162520|NCT00580047|574197|P2|Overall Study|Lost to Follow-up|1
162521|NCT00580047|574198|P1|Overall Study|Lost to Follow-up|1
162522|NCT00580034|574209|P2|Overall Study|Toxicity|0
162523|NCT00580034|574210|P1|Overall Study|Toxicity|10
162524|NCT00579982|574216|P1|Overall Study|Protocol Violation|4
162525|NCT00579982|574216|P1|Overall Study|Adverse Event|4
162526|NCT00579826|574237|P2|Overall Study|Withdrawal by Subject|3
162527|NCT00579826|574238|P1|Overall Study|Withdrawal by Subject|5
162528|NCT00579670|574272|P5|Overall Study|Withdrawal by Subject|0
162529|NCT00579670|574273|P4|Overall Study|Withdrawal by Subject|0
162530|NCT00579670|574274|P3|Overall Study|Withdrawal by Subject|1
162531|NCT00579670|574275|P2|Overall Study|Withdrawal by Subject|0
162532|NCT00579670|574276|P1|Overall Study|Withdrawal by Subject|0
162533|NCT00579670|574272|P5|Overall Study|Other|0
162534|NCT00579670|574273|P4|Overall Study|Other|2
162535|NCT00579670|574274|P3|Overall Study|Other|1
162536|NCT00579670|574275|P2|Overall Study|Other|0
162537|NCT00579670|574276|P1|Overall Study|Other|0
162538|NCT00579670|574272|P5|Overall Study|Lost to Follow-up|0
162539|NCT00579670|574273|P4|Overall Study|Lost to Follow-up|4
162540|NCT00579670|574274|P3|Overall Study|Lost to Follow-up|0
162541|NCT00579670|574275|P2|Overall Study|Lost to Follow-up|1
162542|NCT00579670|574276|P1|Overall Study|Lost to Follow-up|0
162543|NCT00579670|574272|P5|Overall Study|Lack of Efficacy|0
162544|NCT00579670|574273|P4|Overall Study|Lack of Efficacy|14
162545|NCT00579670|574274|P3|Overall Study|Lack of Efficacy|1
162546|NCT00579670|574275|P2|Overall Study|Lack of Efficacy|0
162547|NCT00579670|574276|P1|Overall Study|Lack of Efficacy|0
162548|NCT00579670|574272|P5|Overall Study|Adverse Event|0
162549|NCT00579670|574273|P4|Overall Study|Adverse Event|2
162550|NCT00579670|574274|P3|Overall Study|Adverse Event|1
162551|NCT00579670|574275|P2|Overall Study|Adverse Event|0
162552|NCT00579670|574276|P1|Overall Study|Adverse Event|1
162553|NCT00579670|574272|P5|Overall Study|Death|0
162554|NCT00579670|574273|P4|Overall Study|Death|0
162555|NCT00579670|574274|P3|Overall Study|Death|0
162556|NCT00579670|574275|P2|Overall Study|Death|0
162557|NCT00579670|574276|P1|Overall Study|Death|1
162558|NCT00579501|574488|P1|Overall Study|Radiation therapy before surgery|1
162559|NCT00579501|574488|P1|Overall Study|Secondary lesion|1
162560|NCT00579501|574488|P1|Overall Study|toxicity|1
162561|NCT00579501|574488|P1|Overall Study|End of neoadjuvant therapy|25
162562|NCT00579501|574488|P1|Overall Study|Death|1
162563|NCT00579345|574516|P8|Overall Study|Death|0
162564|NCT00579345|574517|P7|Overall Study|Death|0
162565|NCT00579345|574518|P6|Overall Study|Death|0
162566|NCT00579345|574519|P5|Overall Study|Death|0
162567|NCT00579345|574520|P4|Overall Study|Death|1
162568|NCT00579345|574521|P3|Overall Study|Death|1
162569|NCT00579345|574522|P2|Overall Study|Death|1
162570|NCT00579345|574523|P1|Overall Study|Death|1
162571|NCT00579345|574516|P8|Overall Study|Protocol Violation|1
162572|NCT00579345|574517|P7|Overall Study|Protocol Violation|0
162573|NCT00579345|574518|P6|Overall Study|Protocol Violation|0
162574|NCT00579345|574519|P5|Overall Study|Protocol Violation|0
162575|NCT00579345|574520|P4|Overall Study|Protocol Violation|0
162576|NCT00579345|574521|P3|Overall Study|Protocol Violation|0
162577|NCT00579345|574522|P2|Overall Study|Protocol Violation|0
162578|NCT00579345|574523|P1|Overall Study|Protocol Violation|1
162579|NCT00579345|574516|P8|Overall Study|Adverse Event|0
162580|NCT00579345|574517|P7|Overall Study|Adverse Event|0
162581|NCT00579345|574518|P6|Overall Study|Adverse Event|0
162582|NCT00579345|574519|P5|Overall Study|Adverse Event|0
162583|NCT00579345|574520|P4|Overall Study|Adverse Event|0
162584|NCT00579345|574521|P3|Overall Study|Adverse Event|1
162585|NCT00579345|574522|P2|Overall Study|Adverse Event|0
162586|NCT00579345|574523|P1|Overall Study|Adverse Event|0
162587|NCT00579345|574516|P8|Overall Study|Lost to Follow-up|0
162588|NCT00579345|574517|P7|Overall Study|Lost to Follow-up|0
162589|NCT00579345|574518|P6|Overall Study|Lost to Follow-up|0
162590|NCT00579345|574519|P5|Overall Study|Lost to Follow-up|0
162591|NCT00579345|574520|P4|Overall Study|Lost to Follow-up|0
162592|NCT00579345|574521|P3|Overall Study|Lost to Follow-up|0
162593|NCT00579345|574522|P2|Overall Study|Lost to Follow-up|0
162594|NCT00579345|574523|P1|Overall Study|Lost to Follow-up|1
162595|NCT00579345|574516|P8|Overall Study|Withdrawal by Subject|1
162596|NCT00579345|574517|P7|Overall Study|Withdrawal by Subject|0
162597|NCT00579345|574518|P6|Overall Study|Withdrawal by Subject|0
162598|NCT00579345|574519|P5|Overall Study|Withdrawal by Subject|0
162599|NCT00579345|574520|P4|Overall Study|Withdrawal by Subject|0
162600|NCT00579345|574521|P3|Overall Study|Withdrawal by Subject|0
162601|NCT00579345|574522|P2|Overall Study|Withdrawal by Subject|0
162602|NCT00579345|574523|P1|Overall Study|Withdrawal by Subject|2
162603|NCT00579254|574555|P1|Overall Study|Discontinued when study terminated|73
162604|NCT00579254|574555|P1|Overall Study|Lost to Follow-up|39
162605|NCT00579098|574579|P2|Overall Study|AF returned after ablation|2
162606|NCT00579098|574580|P1|Overall Study|AF returned after ablation|3
162607|NCT00579098|574579|P2|Overall Study|Withdrawal by Subject|3
162608|NCT00579098|574580|P1|Overall Study|Withdrawal by Subject|2
162609|NCT00579098|574579|P2|Overall Study|Adverse Event|3
162610|NCT00579098|574580|P1|Overall Study|Adverse Event|2
162611|NCT00579098|574579|P2|Overall Study|Lost to Follow-up|0
162612|NCT00579098|574580|P1|Overall Study|Lost to Follow-up|2
162613|NCT00579059|574596|P2|Overall Study|Study Canceled at 1 Year|10
162614|NCT00579059|574597|P1|Overall Study|Study Canceled at 1 Year|21
162615|NCT00578942|574671|P1|Overall Study|Lost to Follow-up|1
162616|NCT00578877|574710|P2|Overall Study|did not provide follow-up data|17
162617|NCT00578877|574711|P1|Overall Study|did not provide follow-up data|12
162618|NCT00578877|574710|P2|Overall Study|early discontinue|101
162619|NCT00578877|574711|P1|Overall Study|early discontinue|61
162620|NCT00578877|574710|P2|Overall Study|Lost to Follow-up|10
162621|NCT00578877|574711|P1|Overall Study|Lost to Follow-up|8
162622|NCT00578864|574719|P2|Overall Study|Death|0
162623|NCT00578864|574720|P1|Overall Study|Death|1
162624|NCT00578812|574736|P2|Overall Study|Not treated|7
162625|NCT00578812|574737|P1|Overall Study|Not treated|6
162626|NCT00578786|574776|P3|Overall Study|Qualified but Not Enrolled in Extension|0
162627|NCT00578786|574777|P2|Overall Study|Qualified but Not Enrolled in Extension|3
162628|NCT00578786|574778|P1|Overall Study|Qualified but Not Enrolled in Extension|0
162629|NCT00578786|574776|P3|Overall Study|Not Otherwise Specified|1
162630|NCT00578786|574777|P2|Overall Study|Not Otherwise Specified|4
162631|NCT00578786|574778|P1|Overall Study|Not Otherwise Specified|0
162632|NCT00578786|574776|P3|Overall Study|Pregnancy|0
162633|NCT00578786|574777|P2|Overall Study|Pregnancy|1
162634|NCT00578786|574778|P1|Overall Study|Pregnancy|0
162635|NCT00578786|574776|P3|Overall Study|Lost to Follow-up|0
162636|NCT00578786|574777|P2|Overall Study|Lost to Follow-up|4
162637|NCT00578786|574778|P1|Overall Study|Lost to Follow-up|0
162638|NCT00578786|574776|P3|Overall Study|Sponsor Decision|1
162639|NCT00578786|574777|P2|Overall Study|Sponsor Decision|0
162640|NCT00578786|574778|P1|Overall Study|Sponsor Decision|0
162641|NCT00578786|574776|P3|Overall Study|Physician Decision|1
162642|NCT00578786|574777|P2|Overall Study|Physician Decision|0
162643|NCT00578786|574778|P1|Overall Study|Physician Decision|1
162644|NCT00578786|574776|P3|Overall Study|Protocol Violation|1
162645|NCT00578786|574777|P2|Overall Study|Protocol Violation|3
162646|NCT00578786|574778|P1|Overall Study|Protocol Violation|0
162647|NCT00578786|574776|P3|Overall Study|Withdrawal by Subject|5
162648|NCT00578786|574777|P2|Overall Study|Withdrawal by Subject|8
162649|NCT00578786|574778|P1|Overall Study|Withdrawal by Subject|7
162650|NCT00578786|574776|P3|Overall Study|Early Escape from Prior Study|2
162651|NCT00578786|574777|P2|Overall Study|Early Escape from Prior Study|1
162652|NCT00578786|574778|P1|Overall Study|Early Escape from Prior Study|2
162653|NCT00578786|574776|P3|Overall Study|Lack of Efficacy|2
162654|NCT00578786|574777|P2|Overall Study|Lack of Efficacy|5
162655|NCT00578786|574778|P1|Overall Study|Lack of Efficacy|2
162656|NCT00578786|574776|P3|Overall Study|Adverse Event|17
162657|NCT00578786|574777|P2|Overall Study|Adverse Event|37
162658|NCT00578786|574778|P1|Overall Study|Adverse Event|27
162659|NCT00578565|574877|P1|Overall Study|Adverse Event|3
162660|NCT00578448|574907|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
162661|NCT00578448|574907|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
162662|NCT00578448|574907|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
162663|NCT00578448|574907|P1|Day 1 up to 3 Years of Planned Study|Death|1
162664|NCT00578318|574971|P2|Overall Study|Physician Decision|0
162665|NCT00578318|574972|P1|Overall Study|Physician Decision|1
162666|NCT00578318|574971|P2|Overall Study|Lost to Follow-up|0
162667|NCT00578318|574972|P1|Overall Study|Lost to Follow-up|2
162668|NCT00578227|575054|P3|Overall Study|Withdrawal by Subject|3
162669|NCT00578227|575055|P2|Overall Study|Withdrawal by Subject|1
162670|NCT00578227|575056|P1|Overall Study|Withdrawal by Subject|5
162671|NCT00578227|575054|P3|Overall Study|Lost to Follow-up|1
162672|NCT00578227|575055|P2|Overall Study|Lost to Follow-up|1
162673|NCT00578227|575056|P1|Overall Study|Lost to Follow-up|0
162674|NCT00578136|575262|P2|Overall Study|Not given intervention|1
162675|NCT00578136|575263|P1|Overall Study|Not given intervention|1
162676|NCT00577889|575281|P3|Overall Study|Withdrawal by Subject|0
162677|NCT00577889|575282|P2|Overall Study|Withdrawal by Subject|0
162678|NCT00577889|575283|P1|Overall Study|Withdrawal by Subject|1
162679|NCT00577863|575302|P2|Overall Study|Did Not Receive at Least One Injection|1
162680|NCT00577863|575303|P1|Overall Study|Did Not Receive at Least One Injection|0
162681|NCT00577863|575302|P2|Overall Study|Sponsor Decision|7
162682|NCT00577863|575303|P1|Overall Study|Sponsor Decision|2
162683|NCT00577863|575302|P2|Overall Study|Withdrawal by Subject|2
162684|NCT00577863|575303|P1|Overall Study|Withdrawal by Subject|0
162685|NCT00577863|575302|P2|Overall Study|Entry Criteria Exclusion|0
162686|NCT00577863|575303|P1|Overall Study|Entry Criteria Exclusion|1
162687|NCT00577863|575302|P2|Overall Study|Lost to Follow-up|2
162688|NCT00577863|575303|P1|Overall Study|Lost to Follow-up|2
162689|NCT00577863|575302|P2|Overall Study|Death|0
162690|NCT00577863|575303|P1|Overall Study|Death|1
162691|NCT00577863|575302|P2|Overall Study|Adverse Event|2
162692|NCT00577863|575303|P1|Overall Study|Adverse Event|4
162693|NCT00577824|575345|P3|Overall Study|Protocol Violation|0
162694|NCT00577824|575346|P2|Overall Study|Protocol Violation|1
162695|NCT00577824|575347|P1|Overall Study|Protocol Violation|1
162696|NCT00577824|575345|P3|Overall Study|Patient decision|1
162697|NCT00577824|575346|P2|Overall Study|Patient decision|1
162698|NCT00577824|575347|P1|Overall Study|Patient decision|0
162699|NCT00577824|575345|P3|Overall Study|Adverse Event|1
162700|NCT00577824|575346|P2|Overall Study|Adverse Event|18
162701|NCT00577824|575347|P1|Overall Study|Adverse Event|6
162702|NCT00577772|575405|P2|Overall Study|Lost to Follow-up|1
162703|NCT00577772|575406|P1|Overall Study|Lost to Follow-up|0
162704|NCT00577720|575416|P4|Overall Study|Withdrawal by Subject|2
162705|NCT00577720|575417|P3|Overall Study|Withdrawal by Subject|0
162706|NCT00577720|575418|P2|Overall Study|Withdrawal by Subject|0
162707|NCT00577720|575419|P1|Overall Study|Withdrawal by Subject|2
162708|NCT00577720|575416|P4|Overall Study|Protocol Violation|1
162709|NCT00577720|575417|P3|Overall Study|Protocol Violation|0
162710|NCT00577720|575418|P2|Overall Study|Protocol Violation|0
162711|NCT00577720|575419|P1|Overall Study|Protocol Violation|0
162712|NCT00577720|575416|P4|Overall Study|Lost to Follow-up|0
162713|NCT00577720|575417|P3|Overall Study|Lost to Follow-up|1
162714|NCT00577720|575418|P2|Overall Study|Lost to Follow-up|0
162715|NCT00577720|575419|P1|Overall Study|Lost to Follow-up|0
162716|NCT00577720|575416|P4|Overall Study|Adverse Event|4
162717|NCT00577720|575417|P3|Overall Study|Adverse Event|0
162718|NCT00577720|575418|P2|Overall Study|Adverse Event|1
162719|NCT00577720|575419|P1|Overall Study|Adverse Event|2
162720|NCT00577707|575437|P1|Overall Study|Withdrawal by Subject|3
162721|NCT00577655|575445|P2|Overall Study|Lost to Follow-up|1
162722|NCT00577655|575446|P1|Overall Study|Lost to Follow-up|1
162723|NCT00577655|575445|P2|Overall Study|Protocol Violation|1
162724|NCT00577655|575446|P1|Overall Study|Protocol Violation|0
162725|NCT00577655|575445|P2|Overall Study|Patient Request|2
162726|NCT00577655|575446|P1|Overall Study|Patient Request|0
162727|NCT00577642|575484|P1|Overall Study|Clinical Disease Progression|1
162728|NCT00577629|575488|P1|Long Term Follow-Up|Physician Decision|1
162729|NCT00577629|575488|P1|Long Term Follow-Up|Withdrawal by Subject|4
162730|NCT00577629|575488|P1|Long Term Follow-Up|Lost to Follow-up|5
162731|NCT00577629|575488|P1|Long Term Follow-Up|Death|15
162732|NCT00577629|575488|P1|Treatment Period|Death|1
162733|NCT00577473|575502|P2|Overall Study|Lack of Efficacy|7
162734|NCT00577473|575503|P1|Overall Study|Lack of Efficacy|8
162735|NCT00577473|575502|P2|Overall Study|Physician Decision|2
162736|NCT00577473|575503|P1|Overall Study|Physician Decision|2
162737|NCT00577473|575502|P2|Overall Study|Withdrawal by Subject|6
162738|NCT00577473|575503|P1|Overall Study|Withdrawal by Subject|2
162739|NCT00577473|575502|P2|Overall Study|Adverse Event|5
162740|NCT00577473|575503|P1|Overall Study|Adverse Event|8
162741|NCT00577473|575502|P2|Overall Study|Protocol Violation|4
162742|NCT00577473|575503|P1|Overall Study|Protocol Violation|1
162743|NCT00577460|575534|P3|Overall Study|not specified|2
162744|NCT00577460|575535|P2|Overall Study|not specified|3
162745|NCT00577460|575536|P1|Overall Study|not specified|0
162746|NCT00577460|575534|P3|Overall Study|Withdrawal by Subject|6
162747|NCT00577460|575535|P2|Overall Study|Withdrawal by Subject|5
162748|NCT00577460|575536|P1|Overall Study|Withdrawal by Subject|5
162749|NCT00577460|575534|P3|Overall Study|Lost to Follow-up|4
162750|NCT00577460|575535|P2|Overall Study|Lost to Follow-up|3
162751|NCT00577460|575536|P1|Overall Study|Lost to Follow-up|0
162752|NCT00577460|575534|P3|Overall Study|Protocol Violation|1
162753|NCT00577460|575535|P2|Overall Study|Protocol Violation|1
162754|NCT00577460|575536|P1|Overall Study|Protocol Violation|0
162755|NCT00577460|575534|P3|Overall Study|Adverse Event|14
162756|NCT00577460|575535|P2|Overall Study|Adverse Event|7
162757|NCT00577460|575536|P1|Overall Study|Adverse Event|11
162758|NCT00577408|575645|P2|Overall Study|Psychiatric hospitalization|1
162759|NCT00577408|575646|P1|Overall Study|Psychiatric hospitalization|0
162760|NCT00577408|575645|P2|Overall Study|Death|1
162761|NCT00577408|575646|P1|Overall Study|Death|0
162762|NCT00577408|575645|P2|Overall Study|Scheduling Issues|3
162763|NCT00577408|575646|P1|Overall Study|Scheduling Issues|0
162764|NCT00577408|575645|P2|Overall Study|Moved out of state|1
162765|NCT00577408|575646|P1|Overall Study|Moved out of state|0
162766|NCT00577408|575645|P2|Overall Study|Refused Oral Naltrexone|1
162767|NCT00577408|575646|P1|Overall Study|Refused Oral Naltrexone|0
162768|NCT00577408|575645|P2|Overall Study|Non-compliance with study meds|3
162769|NCT00577408|575646|P1|Overall Study|Non-compliance with study meds|0
162770|NCT00577408|575645|P2|Overall Study|Continued opioid use|2
162771|NCT00577408|575646|P1|Overall Study|Continued opioid use|3
162772|NCT00577408|575645|P2|Overall Study|Stopped attending study visits|11
162773|NCT00577408|575646|P1|Overall Study|Stopped attending study visits|9
162774|NCT00577395|575654|P2|Overall Study|Study was terminated early by Sponsor|6
162775|NCT00577395|575655|P1|Overall Study|Study was terminated early by Sponsor|7
162776|NCT00577382|575665|P2|Overall Study|Lost to Follow-up|2
162777|NCT00577382|575666|P1|Overall Study|Lost to Follow-up|2
162778|NCT00577382|575665|P2|Overall Study|Death|1
162779|NCT00577382|575666|P1|Overall Study|Death|1
162780|NCT00577382|575665|P2|Overall Study|Intercurrent Illness|2
162781|NCT00577382|575666|P1|Overall Study|Intercurrent Illness|1
162782|NCT00577382|575665|P2|Overall Study|Progressive Disease|19
162783|NCT00577382|575666|P1|Overall Study|Progressive Disease|17
162784|NCT00577382|575665|P2|Overall Study|Withdrawal by Subject|1
162785|NCT00577382|575666|P1|Overall Study|Withdrawal by Subject|0
162786|NCT00577382|575665|P2|Overall Study|Adverse Event|6
162787|NCT00577382|575666|P1|Overall Study|Adverse Event|0
162788|NCT00577122|575809|P2|Overall Study|Alternative Therapy|1
162789|NCT00577122|575810|P1|Overall Study|Alternative Therapy|0
162790|NCT00577122|575809|P2|Overall Study|Prog, refract disease during active trt|5
162791|NCT00577122|575810|P1|Overall Study|Prog, refract disease during active trt|8
162792|NCT00577122|575809|P2|Overall Study|Progression, relapse during active trt|8
162793|NCT00577122|575810|P1|Overall Study|Progression, relapse during active trt|6
162794|NCT00577122|575809|P2|Overall Study|Adverse Event|2
162795|NCT00577122|575810|P1|Overall Study|Adverse Event|0
162796|NCT00577096|575824|P2|Short Term Participation|Death|1
162797|NCT00577096|575825|P1|Short Term Participation|Death|1
162798|NCT00577096|575824|P2|Short Term Participation|Withdrawal by Subject|5
162799|NCT00577096|575825|P1|Short Term Participation|Withdrawal by Subject|3
162800|NCT00577096|575824|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
162801|NCT00577096|575825|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
162802|NCT00577031|575858|P1|Overall Study|Death|6
162803|NCT00577031|575858|P1|Overall Study|Medical decision|14
162804|NCT00577031|575858|P1|Overall Study|Need for surgery|17
162805|NCT00577031|575858|P1|Overall Study|Participant non-compliance|5
162806|NCT00577031|575858|P1|Overall Study|Participant withdrew consent|13
162807|NCT00577031|575858|P1|Overall Study|Protocol Violation|5
162808|NCT00577031|575858|P1|Overall Study|Progression of disease|93
162809|NCT00577031|575858|P1|Overall Study|Adverse Event|52
162810|NCT00577005|575879|P2|Overall Study|Withdrawal by Subject|1
162811|NCT00577005|575880|P1|Overall Study|Withdrawal by Subject|2
162812|NCT00577005|575879|P2|Overall Study|Lost to Follow-up|2
162813|NCT00577005|575880|P1|Overall Study|Lost to Follow-up|3
162814|NCT00576927|575894|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
162815|NCT00576927|575894|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
162816|NCT00576927|575894|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
162817|NCT00576927|575894|P1|Sleep Hygiene Behavioral Intervention|Death|1
162818|NCT00576927|575894|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
162819|NCT00576927|575894|P1|Baseline|Withdrawal by Subject|3
162820|NCT00576927|575894|P1|Baseline|Medication Change by PCP of subject|1
162821|NCT00576927|575894|P1|Baseline|Physician Decision|9
162822|NCT00576927|575894|P1|Clinical Assessment|Physician Decision|1
162823|NCT00576927|575894|P1|Clinical Assessment|Withdrawal by Subject|10
162824|NCT00576927|575894|P1|Clinical Assessment|Death|1
162825|NCT00576927|575894|P1|Clinical Assessment|Lack of Efficacy|24
162826|NCT00576901|575906|P1|Overall Study|Protocol Violation|1
162827|NCT00576901|575906|P1|Overall Study|Disease course|1
162828|NCT00576901|575906|P1|Overall Study|Withdrawal by Subject|1
162829|NCT00576823|575917|P3|40-week Safety Extension Phase|Lack of Efficacy|0
162830|NCT00576823|575918|P2|40-week Safety Extension Phase|Lack of Efficacy|0
162831|NCT00576823|575919|P1|40-week Safety Extension Phase|Lack of Efficacy|1
162832|NCT00576823|575917|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
162833|NCT00576823|575918|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
162834|NCT00576823|575919|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
162835|NCT00576758|575935|P2|Follow-up Period|Withdrew consent|1
162836|NCT00576758|575936|P1|Follow-up Period|Withdrew consent|2
162837|NCT00576758|575935|P2|Follow-up Period|Insufficient therapeutic response|5
162838|NCT00576758|575936|P1|Follow-up Period|Insufficient therapeutic response|16
162839|NCT00576758|575935|P2|Follow-up Period|Death|3
162840|NCT00576758|575936|P1|Follow-up Period|Death|3
162841|NCT00576758|575935|P2|Follow-up Period|Administrative/Other|8
162842|NCT00576758|575936|P1|Follow-up Period|Administrative/Other|6
162843|NCT00576758|575935|P2|Extension Treatment Period|Administrative/Other|1
162844|NCT00576758|575936|P1|Extension Treatment Period|Administrative/Other|3
162845|NCT00576758|575935|P2|Extension Treatment Period|Insufficient therapeutic response|33
162846|NCT00576758|575936|P1|Extension Treatment Period|Insufficient therapeutic response|30
162847|NCT00576758|575935|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
162848|NCT00576758|575936|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
162849|NCT00576758|575935|P2|Extension Treatment Period|Death|1
162850|NCT00576758|575936|P1|Extension Treatment Period|Death|1
162851|NCT00576758|575935|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
162852|NCT00576758|575936|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
162853|NCT00576758|575935|P2|Induction Treatment Period|Withdrew consent|0
162854|NCT00576758|575936|P1|Induction Treatment Period|Withdrew consent|1
162855|NCT00576758|575935|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
162856|NCT00576758|575936|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
162857|NCT00576758|575935|P2|Induction Treatment Period|Death|0
162858|NCT00576758|575936|P1|Induction Treatment Period|Death|1
162859|NCT00576758|575935|P2|Induction Treatment Period|Violation of selection criteria at entry|1
162860|NCT00576758|575936|P1|Induction Treatment Period|Violation of selection criteria at entry|1
162861|NCT00576758|575935|P2|Induction Treatment Period|Insufficient therapeutic response|0
162862|NCT00576758|575936|P1|Induction Treatment Period|Insufficient therapeutic response|2
162863|NCT00576758|575935|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
162864|NCT00576758|575936|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
162865|NCT00576732|575982|P6|OPEN LABEL|Protocol Violation|0
162866|NCT00576732|575983|P5|OPEN LABEL|Protocol Violation|1
162867|NCT00576732|575984|P4|OPEN LABEL|Protocol Violation|2
162868|NCT00576732|575985|P3|OPEN LABEL|Protocol Violation|0
162869|NCT00576732|575986|P2|OPEN LABEL|Protocol Violation|0
162870|NCT00576732|575987|P1|OPEN LABEL|Protocol Violation|0
162871|NCT00576732|575982|P6|OPEN LABEL|Lack of Efficacy|3
162872|NCT00576732|575983|P5|OPEN LABEL|Lack of Efficacy|2
162873|NCT00576732|575984|P4|OPEN LABEL|Lack of Efficacy|2
162874|NCT00576732|575985|P3|OPEN LABEL|Lack of Efficacy|0
162875|NCT00576732|575986|P2|OPEN LABEL|Lack of Efficacy|0
162876|NCT00576732|575987|P1|OPEN LABEL|Lack of Efficacy|0
162877|NCT00576732|575982|P6|OPEN LABEL|OTHER|2
162878|NCT00576732|575983|P5|OPEN LABEL|OTHER|0
162879|NCT00576732|575984|P4|OPEN LABEL|OTHER|0
162880|NCT00576732|575985|P3|OPEN LABEL|OTHER|0
162881|NCT00576732|575986|P2|OPEN LABEL|OTHER|0
162882|NCT00576732|575987|P1|OPEN LABEL|OTHER|0
162883|NCT00576732|575982|P6|OPEN LABEL|Withdrawal by Subject|1
162884|NCT00576732|575983|P5|OPEN LABEL|Withdrawal by Subject|0
162885|NCT00576732|575984|P4|OPEN LABEL|Withdrawal by Subject|1
162886|NCT00576732|575985|P3|OPEN LABEL|Withdrawal by Subject|0
162887|NCT00576732|575986|P2|OPEN LABEL|Withdrawal by Subject|0
162888|NCT00576732|575987|P1|OPEN LABEL|Withdrawal by Subject|0
162889|NCT00576732|575982|P6|OPEN LABEL|Lost to Follow-up|1
162890|NCT00576732|575983|P5|OPEN LABEL|Lost to Follow-up|1
162891|NCT00576732|575984|P4|OPEN LABEL|Lost to Follow-up|2
162892|NCT00576732|575985|P3|OPEN LABEL|Lost to Follow-up|0
162893|NCT00576732|575986|P2|OPEN LABEL|Lost to Follow-up|0
162894|NCT00576732|575987|P1|OPEN LABEL|Lost to Follow-up|0
162895|NCT00576732|575982|P6|OPEN LABEL|Adverse Event|1
162896|NCT00576732|575983|P5|OPEN LABEL|Adverse Event|0
162897|NCT00576732|575984|P4|OPEN LABEL|Adverse Event|4
162898|NCT00576732|575985|P3|OPEN LABEL|Adverse Event|0
162899|NCT00576732|575986|P2|OPEN LABEL|Adverse Event|0
162900|NCT00576732|575987|P1|OPEN LABEL|Adverse Event|0
162901|NCT00576732|575982|P6|DOUBLE BLIND|Protocol Violation|0
162902|NCT00576732|575983|P5|DOUBLE BLIND|Protocol Violation|0
162903|NCT00576732|575984|P4|DOUBLE BLIND|Protocol Violation|0
162904|NCT00576732|575985|P3|DOUBLE BLIND|Protocol Violation|0
162905|NCT00576732|575986|P2|DOUBLE BLIND|Protocol Violation|0
162906|NCT00576732|575987|P1|DOUBLE BLIND|Protocol Violation|1
162907|NCT00576732|575982|P6|DOUBLE BLIND|Lack of Efficacy|0
162908|NCT00576732|575983|P5|DOUBLE BLIND|Lack of Efficacy|0
162909|NCT00576732|575984|P4|DOUBLE BLIND|Lack of Efficacy|0
162910|NCT00576732|575985|P3|DOUBLE BLIND|Lack of Efficacy|0
162911|NCT00576732|575986|P2|DOUBLE BLIND|Lack of Efficacy|1
162912|NCT00576732|575987|P1|DOUBLE BLIND|Lack of Efficacy|6
162913|NCT00576732|575982|P6|DOUBLE BLIND|OTHER|0
162914|NCT00576732|575983|P5|DOUBLE BLIND|OTHER|0
162915|NCT00576732|575984|P4|DOUBLE BLIND|OTHER|0
162916|NCT00576732|575985|P3|DOUBLE BLIND|OTHER|1
162917|NCT00576732|575986|P2|DOUBLE BLIND|OTHER|2
162918|NCT00576732|575987|P1|DOUBLE BLIND|OTHER|0
162919|NCT00576732|575982|P6|DOUBLE BLIND|Withdrawal by Subject|0
162920|NCT00576732|575983|P5|DOUBLE BLIND|Withdrawal by Subject|0
162921|NCT00576732|575984|P4|DOUBLE BLIND|Withdrawal by Subject|0
162922|NCT00576732|575985|P3|DOUBLE BLIND|Withdrawal by Subject|3
162923|NCT00576732|575986|P2|DOUBLE BLIND|Withdrawal by Subject|1
162924|NCT00576732|575987|P1|DOUBLE BLIND|Withdrawal by Subject|1
162925|NCT00576732|575982|P6|DOUBLE BLIND|Lost to Follow-up|0
162926|NCT00576732|575983|P5|DOUBLE BLIND|Lost to Follow-up|0
162927|NCT00576732|575984|P4|DOUBLE BLIND|Lost to Follow-up|0
162928|NCT00576732|575985|P3|DOUBLE BLIND|Lost to Follow-up|1
162929|NCT00576732|575986|P2|DOUBLE BLIND|Lost to Follow-up|1
162930|NCT00576732|575987|P1|DOUBLE BLIND|Lost to Follow-up|0
162931|NCT00576732|575982|P6|DOUBLE BLIND|Adverse Event|0
162932|NCT00576732|575983|P5|DOUBLE BLIND|Adverse Event|0
162933|NCT00576732|575984|P4|DOUBLE BLIND|Adverse Event|0
162934|NCT00576732|575985|P3|DOUBLE BLIND|Adverse Event|1
162935|NCT00576732|575986|P2|DOUBLE BLIND|Adverse Event|0
162936|NCT00576732|575987|P1|DOUBLE BLIND|Adverse Event|0
162937|NCT00576693|576019|P2|Overall Study|Withdrawal by Subject|13
162938|NCT00576693|576020|P1|Overall Study|Withdrawal by Subject|3
162939|NCT00576693|576019|P2|Overall Study|Lost to Follow-up|11
162940|NCT00576693|576020|P1|Overall Study|Lost to Follow-up|7
162941|NCT00576628|576026|P1|Overall Study|Dialysis|15
162942|NCT00576628|576026|P1|Overall Study|Transplantation|1
162943|NCT00576628|576026|P1|Overall Study|The patient move into other town|1
162944|NCT00576628|576026|P1|Overall Study|Progression of Renal Failure|1
162945|NCT00576628|576026|P1|Overall Study|Progression of Kidney Disease|1
162946|NCT00576628|576026|P1|Overall Study|RBC transfusion|1
162947|NCT00576628|576026|P1|Overall Study|Pregnancy|1
162948|NCT00576628|576026|P1|Overall Study|Refused Treatment|8
162949|NCT00576628|576026|P1|Overall Study|Failure to return|1
162950|NCT00576628|576026|P1|Overall Study|Death|2
162951|NCT00576628|576026|P1|Overall Study|Adverse Event|11
162952|NCT00576576|576046|P1|Overall Study|Protocol Violation|1
162953|NCT00576576|576046|P1|Overall Study|Lost to Follow-up|6
162954|NCT00576472|576080|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
162955|NCT00576472|576081|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
162956|NCT00576472|576082|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
162957|NCT00576472|576083|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
162958|NCT00576472|576084|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
162959|NCT00576472|576085|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
162960|NCT00576472|576086|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
162961|NCT00576472|576087|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
162962|NCT00576472|576088|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
162963|NCT00576472|576089|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
162964|NCT00576472|576090|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
162965|NCT00576472|576091|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
162966|NCT00576472|576092|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
162967|NCT00576472|576093|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
162968|NCT00576472|576094|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
162969|NCT00576472|576080|P15|MPH Home Maintenance Phase|Medical reasons|6
162970|NCT00576472|576081|P14|MPH Home Maintenance Phase|Medical reasons|0
162971|NCT00576472|576082|P13|MPH Home Maintenance Phase|Medical reasons|0
162972|NCT00576472|576083|P12|MPH Home Maintenance Phase|Medical reasons|0
162973|NCT00576472|576084|P11|MPH Home Maintenance Phase|Medical reasons|0
162974|NCT00576472|576085|P10|MPH Home Maintenance Phase|Medical reasons|0
162975|NCT00576472|576086|P9|MPH Home Maintenance Phase|Medical reasons|0
162976|NCT00576472|576087|P8|MPH Home Maintenance Phase|Medical reasons|0
162977|NCT00576472|576088|P7|MPH Home Maintenance Phase|Medical reasons|0
162978|NCT00576472|576089|P6|MPH Home Maintenance Phase|Medical reasons|0
162979|NCT00576472|576090|P5|MPH Home Maintenance Phase|Medical reasons|0
162980|NCT00576472|576091|P4|MPH Home Maintenance Phase|Medical reasons|0
162981|NCT00576472|576092|P3|MPH Home Maintenance Phase|Medical reasons|0
162982|NCT00576472|576093|P2|MPH Home Maintenance Phase|Medical reasons|0
162983|NCT00576472|576094|P1|MPH Home Maintenance Phase|Medical reasons|0
162984|NCT00576472|576080|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
162985|NCT00576472|576081|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
162986|NCT00576472|576082|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
162987|NCT00576472|576083|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
162988|NCT00576472|576084|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
162989|NCT00576472|576085|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
162990|NCT00576472|576086|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
162991|NCT00576472|576087|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
162992|NCT00576472|576088|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
162993|NCT00576472|576089|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
162994|NCT00576472|576090|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
162995|NCT00576472|576091|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
162996|NCT00576472|576092|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
162997|NCT00576472|576093|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
162998|NCT00576472|576094|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
162999|NCT00576472|576080|P15|MPH Home Maintenance Phase|Side effects|8
163000|NCT00576472|576081|P14|MPH Home Maintenance Phase|Side effects|0
163001|NCT00576472|576082|P13|MPH Home Maintenance Phase|Side effects|0
163002|NCT00576472|576083|P12|MPH Home Maintenance Phase|Side effects|0
163003|NCT00576472|576084|P11|MPH Home Maintenance Phase|Side effects|0
163004|NCT00576472|576085|P10|MPH Home Maintenance Phase|Side effects|0
163005|NCT00576472|576086|P9|MPH Home Maintenance Phase|Side effects|0
163006|NCT00576472|576087|P8|MPH Home Maintenance Phase|Side effects|0
163007|NCT00576472|576088|P7|MPH Home Maintenance Phase|Side effects|0
163008|NCT00576472|576089|P6|MPH Home Maintenance Phase|Side effects|0
163009|NCT00576472|576090|P5|MPH Home Maintenance Phase|Side effects|0
163010|NCT00576472|576091|P4|MPH Home Maintenance Phase|Side effects|0
163011|NCT00576472|576092|P3|MPH Home Maintenance Phase|Side effects|0
163012|NCT00576472|576093|P2|MPH Home Maintenance Phase|Side effects|0
163013|NCT00576472|576094|P1|MPH Home Maintenance Phase|Side effects|0
163014|NCT00576472|576080|P15|MPH Home Maintenance Phase|Insufficient data|0
163015|NCT00576472|576081|P14|MPH Home Maintenance Phase|Insufficient data|4
163016|NCT00576472|576082|P13|MPH Home Maintenance Phase|Insufficient data|0
163017|NCT00576472|576083|P12|MPH Home Maintenance Phase|Insufficient data|0
163018|NCT00576472|576084|P11|MPH Home Maintenance Phase|Insufficient data|0
163019|NCT00576472|576085|P10|MPH Home Maintenance Phase|Insufficient data|0
163020|NCT00576472|576086|P9|MPH Home Maintenance Phase|Insufficient data|0
163021|NCT00576472|576087|P8|MPH Home Maintenance Phase|Insufficient data|0
163022|NCT00576472|576088|P7|MPH Home Maintenance Phase|Insufficient data|0
163023|NCT00576472|576089|P6|MPH Home Maintenance Phase|Insufficient data|0
163024|NCT00576472|576090|P5|MPH Home Maintenance Phase|Insufficient data|0
163025|NCT00576472|576091|P4|MPH Home Maintenance Phase|Insufficient data|0
163026|NCT00576472|576092|P3|MPH Home Maintenance Phase|Insufficient data|0
163027|NCT00576472|576093|P2|MPH Home Maintenance Phase|Insufficient data|0
163028|NCT00576472|576094|P1|MPH Home Maintenance Phase|Insufficient data|0
163029|NCT00576472|576080|P15|MPH Home Maintenance Phase|Declined to participate|0
163030|NCT00576472|576081|P14|MPH Home Maintenance Phase|Declined to participate|7
163031|NCT00576472|576082|P13|MPH Home Maintenance Phase|Declined to participate|0
163032|NCT00576472|576083|P12|MPH Home Maintenance Phase|Declined to participate|0
163033|NCT00576472|576084|P11|MPH Home Maintenance Phase|Declined to participate|0
163034|NCT00576472|576085|P10|MPH Home Maintenance Phase|Declined to participate|0
163035|NCT00576472|576086|P9|MPH Home Maintenance Phase|Declined to participate|0
163036|NCT00576472|576087|P8|MPH Home Maintenance Phase|Declined to participate|0
163037|NCT00576472|576088|P7|MPH Home Maintenance Phase|Declined to participate|0
163038|NCT00576472|576089|P6|MPH Home Maintenance Phase|Declined to participate|0
163039|NCT00576472|576090|P5|MPH Home Maintenance Phase|Declined to participate|0
163040|NCT00576472|576091|P4|MPH Home Maintenance Phase|Declined to participate|0
163041|NCT00576472|576092|P3|MPH Home Maintenance Phase|Declined to participate|0
163042|NCT00576472|576093|P2|MPH Home Maintenance Phase|Declined to participate|0
163043|NCT00576472|576094|P1|MPH Home Maintenance Phase|Declined to participate|0
163044|NCT00576472|576080|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
163045|NCT00576472|576081|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
163046|NCT00576472|576082|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
163047|NCT00576472|576083|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
163048|NCT00576472|576084|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
163049|NCT00576472|576085|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
163050|NCT00576472|576086|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
163051|NCT00576472|576087|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
163052|NCT00576472|576088|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
163053|NCT00576472|576089|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
163054|NCT00576472|576090|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
163055|NCT00576472|576091|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
163056|NCT00576472|576092|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
163057|NCT00576472|576093|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
163058|NCT00576472|576094|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
163059|NCT00576472|576080|P15|MPH Cross Over Phase|Did not complete cross over phase|0
163060|NCT00576472|576081|P14|MPH Cross Over Phase|Did not complete cross over phase|0
163061|NCT00576472|576082|P13|MPH Cross Over Phase|Did not complete cross over phase|0
163062|NCT00576472|576083|P12|MPH Cross Over Phase|Did not complete cross over phase|1
163063|NCT00576472|576084|P11|MPH Cross Over Phase|Did not complete cross over phase|1
163064|NCT00576472|576085|P10|MPH Cross Over Phase|Did not complete cross over phase|0
163065|NCT00576472|576086|P9|MPH Cross Over Phase|Did not complete cross over phase|2
163066|NCT00576472|576087|P8|MPH Cross Over Phase|Did not complete cross over phase|0
163067|NCT00576472|576088|P7|MPH Cross Over Phase|Did not complete cross over phase|0
163068|NCT00576472|576089|P6|MPH Cross Over Phase|Did not complete cross over phase|0
163069|NCT00576472|576090|P5|MPH Cross Over Phase|Did not complete cross over phase|0
163070|NCT00576472|576091|P4|MPH Cross Over Phase|Did not complete cross over phase|0
163071|NCT00576472|576092|P3|MPH Cross Over Phase|Did not complete cross over phase|0
163072|NCT00576472|576093|P2|MPH Cross Over Phase|Did not complete cross over phase|0
163073|NCT00576472|576094|P1|MPH Cross Over Phase|Did not complete cross over phase|0
163074|NCT00576472|576080|P15|MPH Cross Over Phase|Physician Decision|0
163075|NCT00576472|576081|P14|MPH Cross Over Phase|Physician Decision|0
163076|NCT00576472|576082|P13|MPH Cross Over Phase|Physician Decision|0
163077|NCT00576472|576083|P12|MPH Cross Over Phase|Physician Decision|0
163078|NCT00576472|576084|P11|MPH Cross Over Phase|Physician Decision|0
163079|NCT00576472|576085|P10|MPH Cross Over Phase|Physician Decision|0
163080|NCT00576472|576086|P9|MPH Cross Over Phase|Physician Decision|0
163081|NCT00576472|576087|P8|MPH Cross Over Phase|Physician Decision|0
163082|NCT00576472|576088|P7|MPH Cross Over Phase|Physician Decision|4
163083|NCT00576472|576089|P6|MPH Cross Over Phase|Physician Decision|0
163084|NCT00576472|576090|P5|MPH Cross Over Phase|Physician Decision|0
163085|NCT00576472|576091|P4|MPH Cross Over Phase|Physician Decision|0
163086|NCT00576472|576092|P3|MPH Cross Over Phase|Physician Decision|0
163087|NCT00576472|576093|P2|MPH Cross Over Phase|Physician Decision|0
163088|NCT00576472|576094|P1|MPH Cross Over Phase|Physician Decision|0
163089|NCT00576472|576080|P15|MPH Cross Over Phase|Ineligible due to disease|0
163090|NCT00576472|576081|P14|MPH Cross Over Phase|Ineligible due to disease|0
163091|NCT00576472|576082|P13|MPH Cross Over Phase|Ineligible due to disease|0
163092|NCT00576472|576083|P12|MPH Cross Over Phase|Ineligible due to disease|0
163093|NCT00576472|576084|P11|MPH Cross Over Phase|Ineligible due to disease|0
163094|NCT00576472|576085|P10|MPH Cross Over Phase|Ineligible due to disease|0
163095|NCT00576472|576086|P9|MPH Cross Over Phase|Ineligible due to disease|0
163096|NCT00576472|576087|P8|MPH Cross Over Phase|Ineligible due to disease|0
163097|NCT00576472|576088|P7|MPH Cross Over Phase|Ineligible due to disease|2
163098|NCT00576472|576089|P6|MPH Cross Over Phase|Ineligible due to disease|0
163099|NCT00576472|576090|P5|MPH Cross Over Phase|Ineligible due to disease|0
163100|NCT00576472|576091|P4|MPH Cross Over Phase|Ineligible due to disease|0
163101|NCT00576472|576092|P3|MPH Cross Over Phase|Ineligible due to disease|0
163102|NCT00576472|576093|P2|MPH Cross Over Phase|Ineligible due to disease|0
163103|NCT00576472|576094|P1|MPH Cross Over Phase|Ineligible due to disease|0
163104|NCT00576472|576080|P15|MPH Cross Over Phase|Withdrawal by Subject|0
163105|NCT00576472|576081|P14|MPH Cross Over Phase|Withdrawal by Subject|0
163106|NCT00576472|576082|P13|MPH Cross Over Phase|Withdrawal by Subject|0
163107|NCT00576472|576083|P12|MPH Cross Over Phase|Withdrawal by Subject|0
163108|NCT00576472|576084|P11|MPH Cross Over Phase|Withdrawal by Subject|0
163109|NCT00576472|576085|P10|MPH Cross Over Phase|Withdrawal by Subject|0
163110|NCT00576472|576086|P9|MPH Cross Over Phase|Withdrawal by Subject|0
163111|NCT00576472|576087|P8|MPH Cross Over Phase|Withdrawal by Subject|0
163112|NCT00576472|576088|P7|MPH Cross Over Phase|Withdrawal by Subject|6
163113|NCT00576472|576089|P6|MPH Cross Over Phase|Withdrawal by Subject|0
163114|NCT00576472|576090|P5|MPH Cross Over Phase|Withdrawal by Subject|0
163115|NCT00576472|576091|P4|MPH Cross Over Phase|Withdrawal by Subject|0
163116|NCT00576472|576092|P3|MPH Cross Over Phase|Withdrawal by Subject|0
163117|NCT00576472|576093|P2|MPH Cross Over Phase|Withdrawal by Subject|0
163118|NCT00576472|576094|P1|MPH Cross Over Phase|Withdrawal by Subject|0
163119|NCT00576472|576080|P15|MPH In-Lab Phase|Psychiatric exclusion|0
163120|NCT00576472|576081|P14|MPH In-Lab Phase|Psychiatric exclusion|0
163121|NCT00576472|576082|P13|MPH In-Lab Phase|Psychiatric exclusion|0
163122|NCT00576472|576083|P12|MPH In-Lab Phase|Psychiatric exclusion|0
163123|NCT00576472|576084|P11|MPH In-Lab Phase|Psychiatric exclusion|0
163124|NCT00576472|576085|P10|MPH In-Lab Phase|Psychiatric exclusion|0
163125|NCT00576472|576086|P9|MPH In-Lab Phase|Psychiatric exclusion|0
163126|NCT00576472|576087|P8|MPH In-Lab Phase|Psychiatric exclusion|0
163127|NCT00576472|576088|P7|MPH In-Lab Phase|Psychiatric exclusion|0
163128|NCT00576472|576089|P6|MPH In-Lab Phase|Psychiatric exclusion|0
163129|NCT00576472|576090|P5|MPH In-Lab Phase|Psychiatric exclusion|0
163130|NCT00576472|576091|P4|MPH In-Lab Phase|Psychiatric exclusion|10
163131|NCT00576472|576092|P3|MPH In-Lab Phase|Psychiatric exclusion|0
163132|NCT00576472|576093|P2|MPH In-Lab Phase|Psychiatric exclusion|0
163133|NCT00576472|576094|P1|MPH In-Lab Phase|Psychiatric exclusion|0
163134|NCT00576472|576080|P15|MPH In-Lab Phase|No attention/academic problems|0
163135|NCT00576472|576081|P14|MPH In-Lab Phase|No attention/academic problems|0
163136|NCT00576472|576082|P13|MPH In-Lab Phase|No attention/academic problems|0
163137|NCT00576472|576083|P12|MPH In-Lab Phase|No attention/academic problems|0
163138|NCT00576472|576084|P11|MPH In-Lab Phase|No attention/academic problems|0
163139|NCT00576472|576085|P10|MPH In-Lab Phase|No attention/academic problems|0
163140|NCT00576472|576086|P9|MPH In-Lab Phase|No attention/academic problems|0
163141|NCT00576472|576087|P8|MPH In-Lab Phase|No attention/academic problems|0
163142|NCT00576472|576088|P7|MPH In-Lab Phase|No attention/academic problems|0
163143|NCT00576472|576089|P6|MPH In-Lab Phase|No attention/academic problems|0
163144|NCT00576472|576090|P5|MPH In-Lab Phase|No attention/academic problems|0
163145|NCT00576472|576091|P4|MPH In-Lab Phase|No attention/academic problems|245
163146|NCT00576472|576092|P3|MPH In-Lab Phase|No attention/academic problems|0
163147|NCT00576472|576093|P2|MPH In-Lab Phase|No attention/academic problems|0
163148|NCT00576472|576094|P1|MPH In-Lab Phase|No attention/academic problems|0
163149|NCT00576472|576080|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163150|NCT00576472|576081|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163151|NCT00576472|576082|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163152|NCT00576472|576083|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163153|NCT00576472|576084|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163154|NCT00576472|576085|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163155|NCT00576472|576086|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163156|NCT00576472|576087|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163157|NCT00576472|576088|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163158|NCT00576472|576089|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163159|NCT00576472|576090|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163160|NCT00576472|576091|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
163161|NCT00576472|576092|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163162|NCT00576472|576093|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163163|NCT00576472|576094|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
163164|NCT00576472|576080|P15|MPH In-Lab Phase|Lost to Follow-up|0
163165|NCT00576472|576081|P14|MPH In-Lab Phase|Lost to Follow-up|0
163166|NCT00576472|576082|P13|MPH In-Lab Phase|Lost to Follow-up|0
163167|NCT00576472|576083|P12|MPH In-Lab Phase|Lost to Follow-up|0
163168|NCT00576472|576084|P11|MPH In-Lab Phase|Lost to Follow-up|0
163169|NCT00576472|576085|P10|MPH In-Lab Phase|Lost to Follow-up|0
163170|NCT00576472|576086|P9|MPH In-Lab Phase|Lost to Follow-up|0
163171|NCT00576472|576087|P8|MPH In-Lab Phase|Lost to Follow-up|0
163172|NCT00576472|576088|P7|MPH In-Lab Phase|Lost to Follow-up|0
163173|NCT00576472|576089|P6|MPH In-Lab Phase|Lost to Follow-up|0
163174|NCT00576472|576090|P5|MPH In-Lab Phase|Lost to Follow-up|0
163175|NCT00576472|576091|P4|MPH In-Lab Phase|Lost to Follow-up|1
163176|NCT00576472|576092|P3|MPH In-Lab Phase|Lost to Follow-up|0
163177|NCT00576472|576093|P2|MPH In-Lab Phase|Lost to Follow-up|0
163178|NCT00576472|576094|P1|MPH In-Lab Phase|Lost to Follow-up|0
163179|NCT00576472|576080|P15|MPH In-Lab Phase|Declined participation in medication pha|0
163180|NCT00576472|576081|P14|MPH In-Lab Phase|Declined participation in medication pha|0
163181|NCT00576472|576082|P13|MPH In-Lab Phase|Declined participation in medication pha|0
163182|NCT00576472|576083|P12|MPH In-Lab Phase|Declined participation in medication pha|0
163183|NCT00576472|576084|P11|MPH In-Lab Phase|Declined participation in medication pha|0
163184|NCT00576472|576085|P10|MPH In-Lab Phase|Declined participation in medication pha|0
163185|NCT00576472|576086|P9|MPH In-Lab Phase|Declined participation in medication pha|0
163186|NCT00576472|576087|P8|MPH In-Lab Phase|Declined participation in medication pha|0
163187|NCT00576472|576088|P7|MPH In-Lab Phase|Declined participation in medication pha|0
163188|NCT00576472|576089|P6|MPH In-Lab Phase|Declined participation in medication pha|0
163189|NCT00576472|576090|P5|MPH In-Lab Phase|Declined participation in medication pha|0
163190|NCT00576472|576091|P4|MPH In-Lab Phase|Declined participation in medication pha|75
163191|NCT00576472|576092|P3|MPH In-Lab Phase|Declined participation in medication pha|0
163192|NCT00576472|576093|P2|MPH In-Lab Phase|Declined participation in medication pha|0
163193|NCT00576472|576094|P1|MPH In-Lab Phase|Declined participation in medication pha|0
163194|NCT00576420|576187|P3|Overall Study|Death|1
163195|NCT00576420|576188|P2|Overall Study|Death|0
163196|NCT00576420|576189|P1|Overall Study|Death|0
163197|NCT00576381|576354|P1|Overall Study|Adverse Event|4
163198|NCT00576381|576354|P1|Overall Study|Reoperation|3
163199|NCT00576316|576358|P1|Overall Study|Protocol Violation|9
163200|NCT00576316|576358|P1|Overall Study|Withdrawal by Subject|2
163201|NCT00576316|576358|P1|Overall Study|Adverse Event|9
163202|NCT00576303|576363|P1|Long Term Safety Period|Early withdrawal|16
163203|NCT00576303|576363|P1|Efficacy Evaluation Period|Early withdrawal|5
163204|NCT00576303|576363|P1|Dose Titration Period|Early withdrawal|17
163205|NCT00576199|576381|P1|Overall Study|Reason Unspecified|2
163206|NCT00576199|576381|P1|Overall Study|Refused Treatment|2
163207|NCT00576199|576381|P1|Overall Study|Insufficient Therapeutic Response|14
163208|NCT00576199|576381|P1|Overall Study|Adverse Event|12
163209|NCT00576056|576394|P1|Overall Study|Physician Decision|1
163210|NCT00576056|576394|P1|Overall Study|did not meet eligibility criteria|8
163211|NCT00576056|576394|P1|Overall Study|Withdrawal by Subject|2
163212|NCT00576056|576394|P1|Overall Study|Lack of Efficacy|1
163213|NCT00576056|576394|P1|Overall Study|Death|1
163214|NCT00576056|576394|P1|Overall Study|Adverse Event|1
163215|NCT00575666|576410|P2|Overall Study|Physician Decision|1
163216|NCT00575666|576411|P1|Overall Study|Physician Decision|1
163217|NCT00575666|576410|P2|Overall Study|Withdrawal by Subject|2
163218|NCT00575666|576411|P1|Overall Study|Withdrawal by Subject|3
163219|NCT00575588|576451|P2|Overall Study|Impossible to determine HbA1c|1
163220|NCT00575588|576452|P1|Overall Study|Impossible to determine HbA1c|0
163221|NCT00575588|576451|P2|Overall Study|Patient moved|3
163222|NCT00575588|576452|P1|Overall Study|Patient moved|1
163223|NCT00575588|576451|P2|Overall Study|Elevated triglyceride|0
163224|NCT00575588|576452|P1|Overall Study|Elevated triglyceride|1
163225|NCT00575588|576451|P2|Overall Study|Safety reasons|1
163226|NCT00575588|576452|P1|Overall Study|Safety reasons|2
163227|NCT00575588|576451|P2|Overall Study|Severe non-compliance to protocol|7
163228|NCT00575588|576452|P1|Overall Study|Severe non-compliance to protocol|5
163229|NCT00575588|576451|P2|Overall Study|Study specific discontinuation criteria|218
163230|NCT00575588|576452|P1|Overall Study|Study specific discontinuation criteria|203
163231|NCT00575588|576451|P2|Overall Study|Incorrect enrollment|4
163232|NCT00575588|576452|P1|Overall Study|Incorrect enrollment|8
163233|NCT00575588|576451|P2|Overall Study|Death|2
163234|NCT00575588|576452|P1|Overall Study|Death|4
163235|NCT00575588|576451|P2|Overall Study|Lost to Follow-up|3
163236|NCT00575588|576452|P1|Overall Study|Lost to Follow-up|1
163237|NCT00575588|576451|P2|Overall Study|Withdrawal by Subject|31
163238|NCT00575588|576452|P1|Overall Study|Withdrawal by Subject|27
163239|NCT00575588|576451|P2|Overall Study|Adverse Event|13
163240|NCT00575588|576452|P1|Overall Study|Adverse Event|11
163241|NCT00575510|576475|P3|Overall Study|Pregnancy|1
163242|NCT00575510|576476|P2|Overall Study|Pregnancy|0
163243|NCT00575510|576477|P1|Overall Study|Pregnancy|0
163244|NCT00575510|576475|P3|Overall Study|Clinic Called Patient|7
163245|NCT00575510|576476|P2|Overall Study|Clinic Called Patient|7
163246|NCT00575510|576477|P1|Overall Study|Clinic Called Patient|7
163247|NCT00575510|576475|P3|Overall Study|Withdrawal by Subject|0
163248|NCT00575510|576476|P2|Overall Study|Withdrawal by Subject|0
163249|NCT00575510|576477|P1|Overall Study|Withdrawal by Subject|1
163250|NCT00575510|576475|P3|Overall Study|Lost to Follow-up|9
163251|NCT00575510|576476|P2|Overall Study|Lost to Follow-up|6
163252|NCT00575510|576477|P1|Overall Study|Lost to Follow-up|4
163253|NCT00575380|576490|P2|Overall Study|Various|2
163254|NCT00575380|576491|P1|Overall Study|Various|0
163255|NCT00575380|576490|P2|Overall Study|Adverse Event|1
163256|NCT00575380|576491|P1|Overall Study|Adverse Event|0
163257|NCT00575380|576490|P2|Overall Study|Withdrawal by Subject|0
163258|NCT00575380|576491|P1|Overall Study|Withdrawal by Subject|1
163259|NCT00575094|576633|P1|Overall Study|Withdrawal by Subject|1
163260|NCT00575094|576633|P1|Overall Study|Adverse Event|2
163261|NCT00575042|576637|P1|Overall Study|Lost to Follow-up|1
163262|NCT00575042|576637|P1|Overall Study|Adverse Event|2
163263|NCT00574951|576688|P1|Overall Study|Ineligible - improper prior treatment|1
163264|NCT00574912|576696|P1|Overall Study|Physician Decision|2
163265|NCT00574912|576696|P1|Overall Study|scheduling conflicts|3
163266|NCT00574912|576696|P1|Overall Study|Could not place IV lines.|3
163267|NCT00574873|576710|P2|Overall Study|Extension Study|0
163268|NCT00574873|576711|P1|Overall Study|Extension Study|126
163269|NCT00574873|576710|P2|Overall Study|Blank, site closed per local regulations|2
163270|NCT00574873|576711|P1|Overall Study|Blank, site closed per local regulations|2
163271|NCT00574873|576710|P2|Overall Study|Discontinuation of study by sponsor|199
163272|NCT00574873|576711|P1|Overall Study|Discontinuation of study by sponsor|5
163273|NCT00574873|576710|P2|Overall Study|Other|4
163274|NCT00574873|576711|P1|Overall Study|Other|40
163275|NCT00574873|576710|P2|Overall Study|Lost to Follow-up|5
163276|NCT00574873|576711|P1|Overall Study|Lost to Follow-up|14
163277|NCT00574873|576710|P2|Overall Study|Death|14
163278|NCT00574873|576711|P1|Overall Study|Death|15
163279|NCT00574873|576710|P2|Overall Study|Investigator request|8
163280|NCT00574873|576711|P1|Overall Study|Investigator request|18
163281|NCT00574873|576710|P2|Overall Study|Withdrawal by Subject|19
163282|NCT00574873|576711|P1|Overall Study|Withdrawal by Subject|18
163283|NCT00574847|576729|P2|Overall Study|Did not receive medication (declined)|5
163284|NCT00574847|576730|P1|Overall Study|Did not receive medication (declined)|2
163285|NCT00574847|576729|P2|Overall Study|Physician Decision|0
163286|NCT00574847|576730|P1|Overall Study|Physician Decision|1
163287|NCT00574847|576729|P2|Overall Study|Withdrawal by Subject|2
163288|NCT00574847|576730|P1|Overall Study|Withdrawal by Subject|2
163289|NCT00574847|576729|P2|Overall Study|Death|0
163290|NCT00574847|576730|P1|Overall Study|Death|1
163291|NCT00574847|576729|P2|Overall Study|Adverse Event|0
163292|NCT00574847|576730|P1|Overall Study|Adverse Event|2
163293|NCT00574795|576775|P1|Toddler Dose|Withdrawal by Subject|1
163294|NCT00574795|576775|P1|After Infant Series|Adverse Event|2
163295|NCT00574795|576775|P1|After Infant Series|Withdrawal by Subject|1
163296|NCT00574795|576775|P1|Infant Series|Adverse Event|1
163297|NCT00574795|576775|P1|Infant Series|Protocol Violation|2
163298|NCT00574795|576775|P1|Infant Series|Withdrawal by Subject|2
163299|NCT00574405|576858|P2|Overall Study|Withdrawal by Subject|2
163300|NCT00574405|576859|P1|Overall Study|Withdrawal by Subject|3
163301|NCT00574288|576879|P7|Overall Study|Other|0
163302|NCT00574288|576880|P6|Overall Study|Other|0
163303|NCT00574288|576881|P5|Overall Study|Other|0
163304|NCT00574288|576882|P4|Overall Study|Other|0
163305|NCT00574288|576883|P3|Overall Study|Other|0
163306|NCT00574288|576884|P2|Overall Study|Other|1
163307|NCT00574288|576885|P1|Overall Study|Other|1
163308|NCT00574288|576879|P7|Overall Study|Progressive Disease|0
163309|NCT00574288|576880|P6|Overall Study|Progressive Disease|0
163310|NCT00574288|576881|P5|Overall Study|Progressive Disease|1
163311|NCT00574288|576882|P4|Overall Study|Progressive Disease|2
163312|NCT00574288|576883|P3|Overall Study|Progressive Disease|3
163313|NCT00574288|576884|P2|Overall Study|Progressive Disease|2
163314|NCT00574288|576885|P1|Overall Study|Progressive Disease|17
163315|NCT00574288|576879|P7|Overall Study|Study Terminated By Sponsor|5
163316|NCT00574288|576880|P6|Overall Study|Study Terminated By Sponsor|0
163317|NCT00574288|576881|P5|Overall Study|Study Terminated By Sponsor|0
163318|NCT00574288|576882|P4|Overall Study|Study Terminated By Sponsor|0
163319|NCT00574288|576883|P3|Overall Study|Study Terminated By Sponsor|0
163320|NCT00574288|576884|P2|Overall Study|Study Terminated By Sponsor|0
163321|NCT00574288|576885|P1|Overall Study|Study Terminated By Sponsor|0
163322|NCT00574288|576879|P7|Overall Study|Lost to Follow-up|2
163323|NCT00574288|576880|P6|Overall Study|Lost to Follow-up|1
163324|NCT00574288|576881|P5|Overall Study|Lost to Follow-up|0
163325|NCT00574288|576882|P4|Overall Study|Lost to Follow-up|0
163326|NCT00574288|576883|P3|Overall Study|Lost to Follow-up|0
163327|NCT00574288|576884|P2|Overall Study|Lost to Follow-up|0
163328|NCT00574288|576885|P1|Overall Study|Lost to Follow-up|0
163329|NCT00574288|576879|P7|Overall Study|Death|21
163330|NCT00574288|576880|P6|Overall Study|Death|25
163331|NCT00574288|576881|P5|Overall Study|Death|0
163332|NCT00574288|576882|P4|Overall Study|Death|0
163333|NCT00574288|576883|P3|Overall Study|Death|0
163334|NCT00574288|576884|P2|Overall Study|Death|0
163335|NCT00574288|576885|P1|Overall Study|Death|0
163336|NCT00574288|576879|P7|Overall Study|Adverse Event|0
163337|NCT00574288|576880|P6|Overall Study|Adverse Event|0
163338|NCT00574288|576881|P5|Overall Study|Adverse Event|1
163339|NCT00574288|576882|P4|Overall Study|Adverse Event|0
163340|NCT00574288|576883|P3|Overall Study|Adverse Event|0
163341|NCT00574288|576884|P2|Overall Study|Adverse Event|0
163342|NCT00574288|576885|P1|Overall Study|Adverse Event|2
163343|NCT00574275|576923|P2|Overall Study|Operation for curative intent|1
163344|NCT00574275|576924|P1|Overall Study|Operation for curative intent|0
163345|NCT00574275|576923|P2|Overall Study|Insurance change|1
163346|NCT00574275|576924|P1|Overall Study|Insurance change|0
163347|NCT00574275|576923|P2|Overall Study|Patient and Investigator decision|1
163348|NCT00574275|576924|P1|Overall Study|Patient and Investigator decision|0
163349|NCT00574275|576923|P2|Overall Study|Protocol Violation|1
163350|NCT00574275|576924|P1|Overall Study|Protocol Violation|0
163351|NCT00574275|576923|P2|Overall Study|Physician Decision|1
163352|NCT00574275|576924|P1|Overall Study|Physician Decision|1
163353|NCT00574275|576923|P2|Overall Study|Error calculating tumor measurement|0
163354|NCT00574275|576924|P1|Overall Study|Error calculating tumor measurement|1
163355|NCT00574275|576923|P2|Overall Study|Withdrawal by Subject|17
163356|NCT00574275|576924|P1|Overall Study|Withdrawal by Subject|15
163357|NCT00574275|576923|P2|Overall Study|Study stopped based on DMC decision|23
163358|NCT00574275|576924|P1|Overall Study|Study stopped based on DMC decision|62
163359|NCT00574275|576923|P2|Overall Study|Lost to Follow-up|1
163360|NCT00574275|576924|P1|Overall Study|Lost to Follow-up|2
163361|NCT00574275|576923|P2|Overall Study|Disease progression|146
163362|NCT00574275|576924|P1|Overall Study|Disease progression|160
163363|NCT00574275|576923|P2|Overall Study|Adverse Event|76
163364|NCT00574275|576924|P1|Overall Study|Adverse Event|32
163365|NCT00574275|576923|P2|Overall Study|Randomized but not treated|3
163366|NCT00574275|576924|P1|Overall Study|Randomized but not treated|2
163367|NCT00574249|576942|P2|Overall Study|PPD test taken twice|1
163368|NCT00574249|576943|P1|Overall Study|PPD test taken twice|0
163369|NCT00574249|576942|P2|Overall Study|Excluded by company|1
163370|NCT00574249|576943|P1|Overall Study|Excluded by company|0
163371|NCT00574249|576942|P2|Overall Study|Pregnancy|0
163372|NCT00574249|576943|P1|Overall Study|Pregnancy|1
163373|NCT00574249|576942|P2|Overall Study|Physician Decision|0
163374|NCT00574249|576943|P1|Overall Study|Physician Decision|1
163375|NCT00574249|576942|P2|Overall Study|Withdrawal by Subject|0
163376|NCT00574249|576943|P1|Overall Study|Withdrawal by Subject|3
163377|NCT00574249|576942|P2|Overall Study|History of carcinoma|0
163378|NCT00574249|576943|P1|Overall Study|History of carcinoma|1
163379|NCT00574249|576942|P2|Overall Study|Protocol Violation|2
163380|NCT00574249|576943|P1|Overall Study|Protocol Violation|5
163381|NCT00574249|576942|P2|Overall Study|Lost to Follow-up|3
163382|NCT00574249|576943|P1|Overall Study|Lost to Follow-up|4
163383|NCT00574249|576942|P2|Overall Study|Lack of Efficacy|3
163384|NCT00574249|576943|P1|Overall Study|Lack of Efficacy|5
163385|NCT00574249|576942|P2|Overall Study|Adverse Event|18
163386|NCT00574249|576943|P1|Overall Study|Adverse Event|6
163387|NCT00574145|576994|P2|Overall Study|Withdrawal by Subject|1
163388|NCT00574145|576995|P1|Overall Study|Withdrawal by Subject|2
163389|NCT00574080|577007|P2|Overall Study|Death|10
163390|NCT00574080|577008|P1|Overall Study|Death|10
163391|NCT00573937|577057|P2|Overall Study|Study Terminated|1
163392|NCT00573937|577058|P1|Overall Study|Study Terminated|0
163393|NCT00573859|577072|P1|Smoking Versus Abstinence|Scheduling conflicts|12
163394|NCT00573859|577072|P1|Medication Versus Placebo|Scheduling conflicts|12
163395|NCT00573833|577078|P1|Overall Study|Not Treated|2
163396|NCT00573794|577085|P1|Overall Study|Not Specified|46
163397|NCT00573794|577085|P1|Overall Study|Lack of Efficacy|94
163398|NCT00573794|577085|P1|Overall Study|Protocol Violation|6
163399|NCT00573794|577085|P1|Overall Study|Lost to Follow-up|13
163400|NCT00573794|577085|P1|Overall Study|Withdrew Consent|90
163401|NCT00573794|577085|P1|Overall Study|Adverse Event|81
163402|NCT00573768|577116|P3|Overall Study|Lost to Follow-up|1
163403|NCT00573768|577117|P2|Overall Study|Lost to Follow-up|0
163404|NCT00573768|577118|P1|Overall Study|Lost to Follow-up|0
163405|NCT00573768|577116|P3|Overall Study|Withdrawal by Subject|0
163406|NCT00573768|577117|P2|Overall Study|Withdrawal by Subject|1
163407|NCT00573768|577118|P1|Overall Study|Withdrawal by Subject|0
163408|NCT00573768|577116|P3|Overall Study|Protocol Violation|1
163409|NCT00573768|577117|P2|Overall Study|Protocol Violation|0
163410|NCT00573768|577118|P1|Overall Study|Protocol Violation|1
163411|NCT00573768|577116|P3|Overall Study|Adverse Event|2
163412|NCT00573768|577117|P2|Overall Study|Adverse Event|1
163413|NCT00573768|577118|P1|Overall Study|Adverse Event|1
163414|NCT00573755|577128|P2|Overall Study|Still receiving treatment|0
163415|NCT00573755|577129|P1|Overall Study|Still receiving treatment|1
163416|NCT00573534|577145|P1|Overall Study|oppositional behavior|3
163417|NCT00573469|577186|P3|Overall Study|Not Specified|3
163418|NCT00573469|577187|P2|Overall Study|Not Specified|1
163419|NCT00573469|577188|P1|Overall Study|Not Specified|5
163420|NCT00573469|577186|P3|Overall Study|Withdrawal by Subject|0
163421|NCT00573469|577187|P2|Overall Study|Withdrawal by Subject|2
163422|NCT00573469|577188|P1|Overall Study|Withdrawal by Subject|0
163423|NCT00573469|577186|P3|Overall Study|Adverse Event|1
163424|NCT00573469|577187|P2|Overall Study|Adverse Event|1
163425|NCT00573469|577188|P1|Overall Study|Adverse Event|1
163426|NCT00573443|577211|P3|Open-Label Extension Phase|Not Specified|0
163427|NCT00573443|577212|P2|Open-Label Extension Phase|Not Specified|0
163428|NCT00573443|577213|P1|Open-Label Extension Phase|Not Specified|2
163429|NCT00573443|577211|P3|Open-Label Extension Phase|Protocol Violation|0
163430|NCT00573443|577212|P2|Open-Label Extension Phase|Protocol Violation|0
163431|NCT00573443|577213|P1|Open-Label Extension Phase|Protocol Violation|2
163432|NCT00573443|577211|P3|Open-Label Extension Phase|Withdrawal by Subject|0
163433|NCT00573443|577212|P2|Open-Label Extension Phase|Withdrawal by Subject|0
163434|NCT00573443|577213|P1|Open-Label Extension Phase|Withdrawal by Subject|3
163435|NCT00573443|577211|P3|Open-Label Extension Phase|Serious Adverse Event|0
163436|NCT00573443|577212|P2|Open-Label Extension Phase|Serious Adverse Event|0
163437|NCT00573443|577213|P1|Open-Label Extension Phase|Serious Adverse Event|5
163438|NCT00573443|577211|P3|Open-Label Extension Phase|Adverse Event|0
163439|NCT00573443|577212|P2|Open-Label Extension Phase|Adverse Event|0
163440|NCT00573443|577213|P1|Open-Label Extension Phase|Adverse Event|3
163441|NCT00573443|577211|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
163442|NCT00573443|577212|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
163443|NCT00573443|577213|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
163444|NCT00573443|577211|P3|Open-Label Extension Phase|Lost to Follow-up|0
163445|NCT00573443|577212|P2|Open-Label Extension Phase|Lost to Follow-up|0
163446|NCT00573443|577213|P1|Open-Label Extension Phase|Lost to Follow-up|1
163447|NCT00573443|577211|P3|Double-Blind Phase|Not specified|3
163448|NCT00573443|577212|P2|Double-Blind Phase|Not specified|2
163449|NCT00573443|577213|P1|Double-Blind Phase|Not specified|0
163450|NCT00573443|577211|P3|Double-Blind Phase|Protocol Violation|1
163451|NCT00573443|577212|P2|Double-Blind Phase|Protocol Violation|2
163452|NCT00573443|577213|P1|Double-Blind Phase|Protocol Violation|0
163453|NCT00573443|577211|P3|Double-Blind Phase|Withdrawal by Subject|7
163454|NCT00573443|577212|P2|Double-Blind Phase|Withdrawal by Subject|2
163455|NCT00573443|577213|P1|Double-Blind Phase|Withdrawal by Subject|2
163456|NCT00573443|577211|P3|Double-Blind Phase|Medication refusal due to AE|0
163457|NCT00573443|577212|P2|Double-Blind Phase|Medication refusal due to AE|2
163458|NCT00573443|577213|P1|Double-Blind Phase|Medication refusal due to AE|2
163459|NCT00573443|577211|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
163460|NCT00573443|577212|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
163461|NCT00573443|577213|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
163462|NCT00573443|577211|P3|Double-Blind Phase|Adverse Event|0
163463|NCT00573443|577212|P2|Double-Blind Phase|Adverse Event|5
163464|NCT00573443|577213|P1|Double-Blind Phase|Adverse Event|1
163465|NCT00573443|577211|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
163466|NCT00573443|577212|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
163467|NCT00573443|577213|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
163468|NCT00573443|577211|P3|Double-Blind Phase|Lost to Follow-up|2
163469|NCT00573443|577212|P2|Double-Blind Phase|Lost to Follow-up|3
163470|NCT00573443|577213|P1|Double-Blind Phase|Lost to Follow-up|1
163471|NCT00573430|577243|P3|Overall Study|Eligibility criteria not fulfilled|3
163472|NCT00573430|577244|P2|Overall Study|Eligibility criteria not fulfilled|0
163473|NCT00573430|577245|P1|Overall Study|Eligibility criteria not fulfilled|0
163474|NCT00573430|577243|P3|Overall Study|Protocol Violation|1
163475|NCT00573430|577244|P2|Overall Study|Protocol Violation|1
163476|NCT00573430|577245|P1|Overall Study|Protocol Violation|0
163477|NCT00573430|577243|P3|Overall Study|Withdrawal by Subject|1
163478|NCT00573430|577244|P2|Overall Study|Withdrawal by Subject|0
163479|NCT00573430|577245|P1|Overall Study|Withdrawal by Subject|1
163480|NCT00573430|577243|P3|Overall Study|Adverse Event|2
163481|NCT00573430|577244|P2|Overall Study|Adverse Event|0
163482|NCT00573430|577245|P1|Overall Study|Adverse Event|0
163483|NCT00573430|577243|P3|Overall Study|Incorrect enrollment of randomization|3
163484|NCT00573430|577244|P2|Overall Study|Incorrect enrollment of randomization|4
163485|NCT00573430|577245|P1|Overall Study|Incorrect enrollment of randomization|0
163486|NCT00573391|577267|P2|Overall Study|Death|0
163487|NCT00573391|577268|P1|Overall Study|Death|1
163488|NCT00573391|577267|P2|Overall Study|study stopped|2
163489|NCT00573391|577268|P1|Overall Study|study stopped|2
163490|NCT00573313|577278|P4|Overall Study|Protocol Violation|0
163491|NCT00573313|577279|P3|Overall Study|Protocol Violation|6
163492|NCT00573313|577280|P2|Overall Study|Protocol Violation|0
163493|NCT00573313|577281|P1|Overall Study|Protocol Violation|5
163494|NCT00573248|577329|P2|Overall Study|scheduling conflicts|11
163495|NCT00573248|577330|P1|Overall Study|scheduling conflicts|15
163496|NCT00573183|577344|P2|Overall Study|Other|2
163497|NCT00573183|577345|P1|Overall Study|Other|5
163498|NCT00573183|577344|P2|Overall Study|Incarceration|8
163499|NCT00573183|577345|P1|Overall Study|Incarceration|5
163500|NCT00573183|577344|P2|Overall Study|Adverse Event|0
163501|NCT00573183|577345|P1|Overall Study|Adverse Event|2
163502|NCT00573183|577344|P2|Overall Study|Death|1
163503|NCT00573183|577345|P1|Overall Study|Death|0
163504|NCT00573183|577344|P2|Overall Study|Withdrawal by Subject|2
163505|NCT00573183|577345|P1|Overall Study|Withdrawal by Subject|8
163506|NCT00573183|577344|P2|Overall Study|Lost to Follow-up|50
163507|NCT00573183|577345|P1|Overall Study|Lost to Follow-up|52
163508|NCT00573170|577353|P6|Third Treatment Period|Lost to Follow-up|2
163509|NCT00573170|577354|P5|Third Treatment Period|Lost to Follow-up|0
163510|NCT00573170|577355|P4|Third Treatment Period|Lost to Follow-up|0
163511|NCT00573170|577356|P3|Third Treatment Period|Lost to Follow-up|0
163512|NCT00573170|577357|P2|Third Treatment Period|Lost to Follow-up|0
163513|NCT00573170|577358|P1|Third Treatment Period|Lost to Follow-up|0
163514|NCT00573170|577353|P6|Third Treatment Period|Withdrawal by Subject|0
163515|NCT00573170|577354|P5|Third Treatment Period|Withdrawal by Subject|0
163516|NCT00573170|577355|P4|Third Treatment Period|Withdrawal by Subject|0
163517|NCT00573170|577356|P3|Third Treatment Period|Withdrawal by Subject|0
163518|NCT00573170|577357|P2|Third Treatment Period|Withdrawal by Subject|0
163519|NCT00573170|577358|P1|Third Treatment Period|Withdrawal by Subject|1
163520|NCT00573170|577353|P6|Second Washout Period|Other|2
163521|NCT00573170|577354|P5|Second Washout Period|Other|6
163522|NCT00573170|577355|P4|Second Washout Period|Other|4
163523|NCT00573170|577356|P3|Second Washout Period|Other|1
163524|NCT00573170|577357|P2|Second Washout Period|Other|2
163525|NCT00573170|577358|P1|Second Washout Period|Other|1
163526|NCT00573170|577353|P6|Second Washout Period|Lost to Follow-up|0
163527|NCT00573170|577354|P5|Second Washout Period|Lost to Follow-up|0
163528|NCT00573170|577355|P4|Second Washout Period|Lost to Follow-up|1
163529|NCT00573170|577356|P3|Second Washout Period|Lost to Follow-up|0
163530|NCT00573170|577357|P2|Second Washout Period|Lost to Follow-up|0
163531|NCT00573170|577358|P1|Second Washout Period|Lost to Follow-up|0
163532|NCT00573170|577353|P6|Second Washout Period|Withdrawal by Subject|0
163533|NCT00573170|577354|P5|Second Washout Period|Withdrawal by Subject|1
163534|NCT00573170|577355|P4|Second Washout Period|Withdrawal by Subject|0
163535|NCT00573170|577356|P3|Second Washout Period|Withdrawal by Subject|2
163536|NCT00573170|577357|P2|Second Washout Period|Withdrawal by Subject|1
163537|NCT00573170|577358|P1|Second Washout Period|Withdrawal by Subject|1
163538|NCT00573170|577353|P6|Second Washout Period|Protocol Violation|0
163539|NCT00573170|577354|P5|Second Washout Period|Protocol Violation|0
163540|NCT00573170|577355|P4|Second Washout Period|Protocol Violation|0
163541|NCT00573170|577356|P3|Second Washout Period|Protocol Violation|1
163542|NCT00573170|577357|P2|Second Washout Period|Protocol Violation|1
163543|NCT00573170|577358|P1|Second Washout Period|Protocol Violation|2
163544|NCT00573170|577353|P6|Second Washout Period|Adverse Event|0
163545|NCT00573170|577354|P5|Second Washout Period|Adverse Event|1
163546|NCT00573170|577355|P4|Second Washout Period|Adverse Event|0
163547|NCT00573170|577356|P3|Second Washout Period|Adverse Event|0
163548|NCT00573170|577357|P2|Second Washout Period|Adverse Event|0
163549|NCT00573170|577358|P1|Second Washout Period|Adverse Event|1
163550|NCT00573170|577353|P6|First Washout Period|Other|0
163551|NCT00573170|577354|P5|First Washout Period|Other|0
163552|NCT00573170|577355|P4|First Washout Period|Other|1
163553|NCT00573170|577356|P3|First Washout Period|Other|1
163554|NCT00573170|577357|P2|First Washout Period|Other|0
163555|NCT00573170|577358|P1|First Washout Period|Other|4
163556|NCT00573170|577353|P6|First Washout Period|Withdrawal by Subject|3
163557|NCT00573170|577354|P5|First Washout Period|Withdrawal by Subject|3
163558|NCT00573170|577355|P4|First Washout Period|Withdrawal by Subject|2
163559|NCT00573170|577356|P3|First Washout Period|Withdrawal by Subject|0
163560|NCT00573170|577357|P2|First Washout Period|Withdrawal by Subject|0
163561|NCT00573170|577358|P1|First Washout Period|Withdrawal by Subject|2
163562|NCT00573170|577353|P6|First Washout Period|Lost to Follow-up|2
163563|NCT00573170|577354|P5|First Washout Period|Lost to Follow-up|0
163564|NCT00573170|577355|P4|First Washout Period|Lost to Follow-up|2
163565|NCT00573170|577356|P3|First Washout Period|Lost to Follow-up|0
163566|NCT00573170|577357|P2|First Washout Period|Lost to Follow-up|1
163567|NCT00573170|577358|P1|First Washout Period|Lost to Follow-up|1
163568|NCT00573170|577353|P6|First Washout Period|Lack of Efficacy|1
163569|NCT00573170|577354|P5|First Washout Period|Lack of Efficacy|0
163570|NCT00573170|577355|P4|First Washout Period|Lack of Efficacy|0
163571|NCT00573170|577356|P3|First Washout Period|Lack of Efficacy|0
163572|NCT00573170|577357|P2|First Washout Period|Lack of Efficacy|0
163573|NCT00573170|577358|P1|First Washout Period|Lack of Efficacy|0
163574|NCT00573170|577353|P6|First Washout Period|Adverse Event|1
163575|NCT00573170|577354|P5|First Washout Period|Adverse Event|0
163576|NCT00573170|577355|P4|First Washout Period|Adverse Event|0
163577|NCT00573170|577356|P3|First Washout Period|Adverse Event|0
163578|NCT00573170|577357|P2|First Washout Period|Adverse Event|1
163579|NCT00573170|577358|P1|First Washout Period|Adverse Event|1
163580|NCT00573170|577353|P6|First Treatment Period|Did Not Treat Attack 1|0
163581|NCT00573170|577354|P5|First Treatment Period|Did Not Treat Attack 1|1
163582|NCT00573170|577355|P4|First Treatment Period|Did Not Treat Attack 1|0
163583|NCT00573170|577356|P3|First Treatment Period|Did Not Treat Attack 1|0
163584|NCT00573170|577357|P2|First Treatment Period|Did Not Treat Attack 1|0
163585|NCT00573170|577358|P1|First Treatment Period|Did Not Treat Attack 1|0
163586|NCT00573157|577434|P2|Overall Study|Other|1
163587|NCT00573157|577435|P1|Overall Study|Other|1
163588|NCT00573157|577434|P2|Overall Study|Adverse Event|1
163589|NCT00573157|577435|P1|Overall Study|Adverse Event|3
163590|NCT00573144|577447|P2|Overall Study|Withdrawal by Subject|3
163591|NCT00573144|577448|P1|Overall Study|Withdrawal by Subject|2
163592|NCT00573131|577460|P2|Overall Study|Withdrawal by Subject|8
163593|NCT00573131|577461|P1|Overall Study|Withdrawal by Subject|10
163594|NCT00573066|577467|P1|Overall Study|Postoperative bleeding|1
163595|NCT00573066|577467|P1|Overall Study|IV malfunction|1
163596|NCT00573066|577467|P1|Overall Study|Exclusion criteria|18
163597|NCT00572910|577511|P11|Overall Study|Withdrawal by Subject|1
163598|NCT00572910|577512|P10|Overall Study|Withdrawal by Subject|2
163599|NCT00572910|577513|P9|Overall Study|Withdrawal by Subject|2
163600|NCT00572910|577514|P8|Overall Study|Withdrawal by Subject|2
163601|NCT00572910|577515|P7|Overall Study|Withdrawal by Subject|0
163602|NCT00572910|577516|P6|Overall Study|Withdrawal by Subject|3
163603|NCT00572910|577517|P5|Overall Study|Withdrawal by Subject|1
163604|NCT00572910|577518|P4|Overall Study|Withdrawal by Subject|0
163605|NCT00572910|577519|P3|Overall Study|Withdrawal by Subject|1
163606|NCT00572910|577520|P2|Overall Study|Withdrawal by Subject|0
163607|NCT00572910|577521|P1|Overall Study|Withdrawal by Subject|3
163608|NCT00572910|577511|P11|Overall Study|Lost to Follow-up|0
163609|NCT00572910|577512|P10|Overall Study|Lost to Follow-up|1
163610|NCT00572910|577513|P9|Overall Study|Lost to Follow-up|0
163611|NCT00572910|577514|P8|Overall Study|Lost to Follow-up|0
163612|NCT00572910|577515|P7|Overall Study|Lost to Follow-up|0
163613|NCT00572910|577516|P6|Overall Study|Lost to Follow-up|0
163614|NCT00572910|577517|P5|Overall Study|Lost to Follow-up|1
163615|NCT00572910|577518|P4|Overall Study|Lost to Follow-up|2
163616|NCT00572910|577519|P3|Overall Study|Lost to Follow-up|1
163617|NCT00572910|577520|P2|Overall Study|Lost to Follow-up|1
163618|NCT00572910|577521|P1|Overall Study|Lost to Follow-up|0
163619|NCT00572910|577511|P11|Overall Study|Adverse Event|2
163620|NCT00572910|577512|P10|Overall Study|Adverse Event|3
163621|NCT00572910|577513|P9|Overall Study|Adverse Event|1
163622|NCT00572910|577514|P8|Overall Study|Adverse Event|2
163623|NCT00572910|577515|P7|Overall Study|Adverse Event|4
163624|NCT00572910|577516|P6|Overall Study|Adverse Event|0
163625|NCT00572910|577517|P5|Overall Study|Adverse Event|0
163626|NCT00572910|577518|P4|Overall Study|Adverse Event|2
163627|NCT00572910|577519|P3|Overall Study|Adverse Event|0
163628|NCT00572910|577520|P2|Overall Study|Adverse Event|2
163629|NCT00572910|577521|P1|Overall Study|Adverse Event|1
163630|NCT00572832|577588|P2|Overall Study|Pregnancy|1
163631|NCT00572832|577589|P1|Overall Study|Pregnancy|0
163632|NCT00572832|577588|P2|Overall Study|Lost to Follow-up|11
163633|NCT00572832|577589|P1|Overall Study|Lost to Follow-up|0
163634|NCT00572728|577595|P1|Overall Study|Pathology missing|1
163635|NCT00572728|577595|P1|Overall Study|FLT2 after second chemotherapy initiated|7
163636|NCT00572728|577595|P1|Overall Study|Second chemotherapy not initiated|1
163637|NCT00572728|577595|P1|Overall Study|FLT2 not completed|5
163638|NCT00572728|577595|P1|Overall Study|First Chemotherapy not initiated|2
163639|NCT00572728|577595|P1|Overall Study|FLT1 not completed|4
163640|NCT00572728|577595|P1|Overall Study|Offstudy due to complicating disease|1
163641|NCT00572728|577595|P1|Overall Study|Enrolled under Amendment 4|5
163642|NCT00572728|577595|P1|Overall Study|Ineligible|3
163643|NCT00572728|577595|P1|Overall Study|Withdrawal by Subject|10
163644|NCT00572624|577609|P2|Overall Study|Health issues unrelated to the study|0
163645|NCT00572624|577610|P1|Overall Study|Health issues unrelated to the study|1
163646|NCT00572624|577609|P2|Overall Study|Problem with vascular access|0
163647|NCT00572624|577610|P1|Overall Study|Problem with vascular access|1
163648|NCT00572624|577609|P2|Overall Study|Refused to do the stress test|0
163649|NCT00572624|577610|P1|Overall Study|Refused to do the stress test|1
163650|NCT00572624|577609|P2|Overall Study|Admitted to being a smoker|0
163651|NCT00572624|577610|P1|Overall Study|Admitted to being a smoker|1
163652|NCT00572624|577609|P2|Overall Study|Started a new job-- no time for study|0
163653|NCT00572624|577610|P1|Overall Study|Started a new job-- no time for study|1
163654|NCT00572624|577609|P2|Overall Study|Medication change|0
163655|NCT00572624|577610|P1|Overall Study|Medication change|1
163656|NCT00572624|577609|P2|Overall Study|Wanted to do a different diet program|0
163657|NCT00572624|577610|P1|Overall Study|Wanted to do a different diet program|1
163658|NCT00572624|577609|P2|Overall Study|Lost to Follow-up|4
163659|NCT00572624|577610|P1|Overall Study|Lost to Follow-up|10
163660|NCT00572572|577638|P2|Overall Study|Withdrawal by Subject|6
163661|NCT00572572|577639|P1|Overall Study|Withdrawal by Subject|3
163662|NCT00572533|577657|P2|Overall Study|Transfer out of Facility|1
163663|NCT00572533|577658|P1|Overall Study|Transfer out of Facility|0
163664|NCT00572533|577657|P2|Overall Study|Social Issues|0
163665|NCT00572533|577658|P1|Overall Study|Social Issues|1
163666|NCT00572533|577657|P2|Overall Study|Received Kidney Transplant|1
163667|NCT00572533|577658|P1|Overall Study|Received Kidney Transplant|2
163668|NCT00572533|577657|P2|Overall Study|Death|1
163669|NCT00572533|577658|P1|Overall Study|Death|4
163670|NCT00572156|577697|P4|Overall Study|Sponsor Decision|19
163671|NCT00572156|577698|P3|Overall Study|Sponsor Decision|17
163672|NCT00572156|577699|P2|Overall Study|Sponsor Decision|16
163673|NCT00572156|577700|P1|Overall Study|Sponsor Decision|20
163674|NCT00572156|577697|P4|Overall Study|Patient/Parent Decision|3
163675|NCT00572156|577698|P3|Overall Study|Patient/Parent Decision|4
163676|NCT00572156|577699|P2|Overall Study|Patient/Parent Decision|6
163677|NCT00572156|577700|P1|Overall Study|Patient/Parent Decision|1
163678|NCT00572156|577697|P4|Overall Study|Protocol Violation|2
163679|NCT00572156|577698|P3|Overall Study|Protocol Violation|0
163680|NCT00572156|577699|P2|Overall Study|Protocol Violation|2
163681|NCT00572156|577700|P1|Overall Study|Protocol Violation|1
163682|NCT00572156|577697|P4|Overall Study|Lost to Follow-up|0
163683|NCT00572156|577698|P3|Overall Study|Lost to Follow-up|1
163684|NCT00572156|577699|P2|Overall Study|Lost to Follow-up|1
163685|NCT00572156|577700|P1|Overall Study|Lost to Follow-up|1
163686|NCT00572156|577697|P4|Overall Study|Adverse Event|1
163687|NCT00572156|577698|P3|Overall Study|Adverse Event|5
163688|NCT00572156|577699|P2|Overall Study|Adverse Event|1
163689|NCT00572156|577700|P1|Overall Study|Adverse Event|3
163690|NCT00572039|577771|P2|Overall Study|Ill|1
163691|NCT00572039|577772|P1|Overall Study|Ill|5
163692|NCT00572039|577771|P2|Overall Study|Death|3
163693|NCT00572039|577772|P1|Overall Study|Death|2
163694|NCT00572039|577771|P2|Overall Study|Withdrawal by Subject|6
163695|NCT00572039|577772|P1|Overall Study|Withdrawal by Subject|9
163696|NCT00571948|577804|P2|Overall Study|Parent were afraid of blood colection|5
163697|NCT00571948|577805|P1|Overall Study|Parent were afraid of blood colection|2
163698|NCT00571948|577804|P2|Overall Study|infant refused study meal|4
163699|NCT00571948|577805|P1|Overall Study|infant refused study meal|3
163700|NCT00571948|577804|P2|Overall Study|Protocol Violation|3
163701|NCT00571948|577805|P1|Overall Study|Protocol Violation|3
163702|NCT00571948|577804|P2|Overall Study|Withdrawal by Subject|2
163703|NCT00571948|577805|P1|Overall Study|Withdrawal by Subject|1
163704|NCT00571948|577804|P2|Overall Study|Lost to Follow-up|0
163705|NCT00571948|577805|P1|Overall Study|Lost to Follow-up|2
163706|NCT00571922|577813|P2|Overall Study|Completion unknown|36
163707|NCT00571922|577814|P1|Overall Study|Completion unknown|36
163708|NCT00571701|577824|P2|Second Intervention 12 Months|Withdrawal by Subject|0
163709|NCT00571701|577825|P1|Second Intervention 12 Months|Withdrawal by Subject|3
163710|NCT00571701|577824|P2|Second Intervention 12 Months|Adverse Event|1
163711|NCT00571701|577825|P1|Second Intervention 12 Months|Adverse Event|0
163712|NCT00571701|577824|P2|First Intervention 12 Months|Death|0
163713|NCT00571701|577825|P1|First Intervention 12 Months|Death|1
163714|NCT00571701|577824|P2|First Intervention 12 Months|Withdrawal by Subject|1
163715|NCT00571701|577825|P1|First Intervention 12 Months|Withdrawal by Subject|2
163716|NCT00571688|577851|P2|Overall Study|subject moved out of the area|0
163717|NCT00571688|577852|P1|Overall Study|subject moved out of the area|1
163718|NCT00571688|577851|P2|Overall Study|subject did not tolerate Consta|0
163719|NCT00571688|577852|P1|Overall Study|subject did not tolerate Consta|1
163720|NCT00571688|577851|P2|Overall Study|Lost to Follow-up|6
163721|NCT00571688|577852|P1|Overall Study|Lost to Follow-up|3
163722|NCT00571662|577858|P1|Overall Study|Adverse Event|5
163723|NCT00571662|577858|P1|Overall Study|psychiatric instability|1
163724|NCT00571662|577858|P1|Overall Study|Withdrawal by Subject|2
163725|NCT00571649|577866|P2|Follow-up Period|Protocol Violation|12
163726|NCT00571649|577867|P1|Follow-up Period|Protocol Violation|5
163727|NCT00571649|577866|P2|Follow-up Period|Patient convenience|121
163728|NCT00571649|577867|P1|Follow-up Period|Patient convenience|136
163729|NCT00571649|577866|P2|Follow-up Period|Lost to Follow-up|92
163730|NCT00571649|577867|P1|Follow-up Period|Lost to Follow-up|95
163731|NCT00571649|577866|P2|Follow-up Period|Physician Decision|13
163732|NCT00571649|577867|P1|Follow-up Period|Physician Decision|7
163733|NCT00571649|577866|P2|Follow-up Period|Death|133
163734|NCT00571649|577867|P1|Follow-up Period|Death|132
163735|NCT00571649|577866|P2|Follow-up Period|Withdrawal by Subject|115
163736|NCT00571649|577867|P1|Follow-up Period|Withdrawal by Subject|119
163737|NCT00571649|577866|P2|Follow-up Period|Clinical endpoint reached|2
163738|NCT00571649|577867|P1|Follow-up Period|Clinical endpoint reached|5
163739|NCT00571649|577866|P2|Follow-up Period|Adverse Event|40
163740|NCT00571649|577867|P1|Follow-up Period|Adverse Event|46
163741|NCT00571649|577866|P2|Treatment Period|Technical problems|5
163742|NCT00571649|577867|P1|Treatment Period|Technical problems|3
163743|NCT00571649|577866|P2|Treatment Period|Protocol Violation|92
163744|NCT00571649|577867|P1|Treatment Period|Protocol Violation|90
163745|NCT00571649|577866|P2|Treatment Period|Patient convenience|13
163746|NCT00571649|577867|P1|Treatment Period|Patient convenience|11
163747|NCT00571649|577866|P2|Treatment Period|Non-compliant with study medication|89
163748|NCT00571649|577867|P1|Treatment Period|Non-compliant with study medication|88
163749|NCT00571649|577866|P2|Treatment Period|Lost to Follow-up|41
163750|NCT00571649|577867|P1|Treatment Period|Lost to Follow-up|43
163751|NCT00571649|577866|P2|Treatment Period|Physician Decision|9
163752|NCT00571649|577867|P1|Treatment Period|Physician Decision|8
163753|NCT00571649|577866|P2|Treatment Period|Death|59
163754|NCT00571649|577867|P1|Treatment Period|Death|76
163755|NCT00571649|577866|P2|Treatment Period|Withdrawal by Subject|255
163756|NCT00571649|577867|P1|Treatment Period|Withdrawal by Subject|285
163757|NCT00571649|577866|P2|Treatment Period|Clinical endpoint reached|56
163758|NCT00571649|577867|P1|Treatment Period|Clinical endpoint reached|50
163759|NCT00571649|577866|P2|Treatment Period|Adverse Event|385
163760|NCT00571649|577867|P1|Treatment Period|Adverse Event|438
163761|NCT00571103|577951|P1|Overall Study|Lost to Follow-up|1
163762|NCT00571103|577951|P1|Overall Study|Withdrawal by Subject|1
163763|NCT00571064|577956|P1|Overall Study|Not specified|2
163764|NCT00571064|577956|P1|Overall Study|Withdrawal by Subject|2
163765|NCT00571064|577956|P1|Overall Study|Protocol Violation|4
163766|NCT00571064|577956|P1|Overall Study|Adverse Event|13
163767|NCT00571038|577971|P2|Overall Study|Moved out of state|2
163768|NCT00571038|577972|P1|Overall Study|Moved out of state|2
163769|NCT00571038|577971|P2|Overall Study|Withdrawal by Subject|3
163770|NCT00571038|577972|P1|Overall Study|Withdrawal by Subject|1
163771|NCT00571038|577971|P2|Overall Study|Death|5
163772|NCT00571038|577972|P1|Overall Study|Death|7
163773|NCT00571038|577971|P2|Overall Study|Lost to Follow-up|4
163774|NCT00571038|577972|P1|Overall Study|Lost to Follow-up|1
163775|NCT00570921|578027|P1|Overall Study|Physician Decision|1
163776|NCT00570921|578027|P1|Overall Study|Protocol Violation|1
163777|NCT00570908|578033|P1|Overall Study|Withdrawal by Subject|2
163778|NCT00570908|578033|P1|Overall Study|Adverse Event|5
163779|NCT00570778|578037|P4|Overall Study|Subject no longer requires study drug|0
163780|NCT00570778|578038|P3|Overall Study|Subject no longer requires study drug|0
163781|NCT00570778|578039|P2|Overall Study|Subject no longer requires study drug|1
163782|NCT00570778|578040|P1|Overall Study|Subject no longer requires study drug|0
163783|NCT00570778|578037|P4|Overall Study|Lost to Follow-up|0
163784|NCT00570778|578038|P3|Overall Study|Lost to Follow-up|1
163785|NCT00570778|578039|P2|Overall Study|Lost to Follow-up|0
163786|NCT00570778|578040|P1|Overall Study|Lost to Follow-up|0
163787|NCT00570778|578037|P4|Overall Study|Unsatisfactory therapeutic effect|0
163788|NCT00570778|578038|P3|Overall Study|Unsatisfactory therapeutic effect|0
163789|NCT00570778|578039|P2|Overall Study|Unsatisfactory therapeutic effect|0
163790|NCT00570778|578040|P1|Overall Study|Unsatisfactory therapeutic effect|1
163791|NCT00570778|578037|P4|Overall Study|Abnormal test procedure|0
163792|NCT00570778|578038|P3|Overall Study|Abnormal test procedure|0
163793|NCT00570778|578039|P2|Overall Study|Abnormal test procedure|0
163794|NCT00570778|578040|P1|Overall Study|Abnormal test procedure|1
163795|NCT00570778|578037|P4|Overall Study|Subject withdrew consent|1
163796|NCT00570778|578038|P3|Overall Study|Subject withdrew consent|0
163797|NCT00570778|578039|P2|Overall Study|Subject withdrew consent|1
163798|NCT00570778|578040|P1|Overall Study|Subject withdrew consent|0
163799|NCT00570778|578037|P4|Overall Study|Adverse Event|1
163800|NCT00570778|578038|P3|Overall Study|Adverse Event|4
163801|NCT00570778|578039|P2|Overall Study|Adverse Event|1
163802|NCT00570778|578040|P1|Overall Study|Adverse Event|0
163803|NCT00570778|578037|P4|Overall Study|Protocol deviation|2
163804|NCT00570778|578038|P3|Overall Study|Protocol deviation|2
163805|NCT00570778|578039|P2|Overall Study|Protocol deviation|1
163806|NCT00570778|578040|P1|Overall Study|Protocol deviation|2
163807|NCT00570739|578081|P4|Overall Study|Not specified|3
163808|NCT00570739|578082|P3|Overall Study|Not specified|5
163809|NCT00570739|578083|P2|Overall Study|Not specified|2
163810|NCT00570739|578084|P1|Overall Study|Not specified|0
163811|NCT00570739|578081|P4|Overall Study|Met discontinuation criteria|1
163812|NCT00570739|578082|P3|Overall Study|Met discontinuation criteria|1
163813|NCT00570739|578083|P2|Overall Study|Met discontinuation criteria|0
163814|NCT00570739|578084|P1|Overall Study|Met discontinuation criteria|1
163815|NCT00570739|578081|P4|Overall Study|Required restricted medication|0
163816|NCT00570739|578082|P3|Overall Study|Required restricted medication|1
163817|NCT00570739|578083|P2|Overall Study|Required restricted medication|0
163818|NCT00570739|578084|P1|Overall Study|Required restricted medication|0
163819|NCT00570739|578081|P4|Overall Study|Withdrawal by Subject|5
163820|NCT00570739|578082|P3|Overall Study|Withdrawal by Subject|3
163821|NCT00570739|578083|P2|Overall Study|Withdrawal by Subject|7
163822|NCT00570739|578084|P1|Overall Study|Withdrawal by Subject|7
163823|NCT00570739|578081|P4|Overall Study|Physician Decision|0
163824|NCT00570739|578082|P3|Overall Study|Physician Decision|0
163825|NCT00570739|578083|P2|Overall Study|Physician Decision|1
163826|NCT00570739|578084|P1|Overall Study|Physician Decision|1
163827|NCT00570739|578081|P4|Overall Study|Lost to Follow-up|1
163828|NCT00570739|578082|P3|Overall Study|Lost to Follow-up|4
163829|NCT00570739|578083|P2|Overall Study|Lost to Follow-up|5
163830|NCT00570739|578084|P1|Overall Study|Lost to Follow-up|4
163831|NCT00570739|578081|P4|Overall Study|Adverse Event|2
163832|NCT00570739|578082|P3|Overall Study|Adverse Event|2
163833|NCT00570739|578083|P2|Overall Study|Adverse Event|6
163834|NCT00570739|578084|P1|Overall Study|Adverse Event|8
163835|NCT00570713|578236|P2|Overall Study|Discontinuation of Study by the Sponsor|7
163836|NCT00570713|578237|P1|Overall Study|Discontinuation of Study by the Sponsor|10
163837|NCT00570713|578236|P2|Overall Study|Withdrawal by Subject|3
163838|NCT00570713|578237|P1|Overall Study|Withdrawal by Subject|3
163839|NCT00570713|578236|P2|Overall Study|Physician Decision|2
163840|NCT00570713|578237|P1|Overall Study|Physician Decision|2
163841|NCT00570713|578236|P2|Overall Study|Lack of Efficacy|49
163842|NCT00570713|578237|P1|Overall Study|Lack of Efficacy|40
163843|NCT00570713|578236|P2|Overall Study|Death|7
163844|NCT00570713|578237|P1|Overall Study|Death|7
163845|NCT00570713|578236|P2|Overall Study|Adverse Event|9
163846|NCT00570713|578237|P1|Overall Study|Adverse Event|16
163847|NCT00570687|578255|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163848|NCT00570687|578256|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163849|NCT00570687|578257|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163850|NCT00570687|578258|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
163851|NCT00570687|578259|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163852|NCT00570687|578260|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163853|NCT00570687|578261|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163854|NCT00570687|578262|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163855|NCT00570687|578263|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163856|NCT00570687|578264|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163857|NCT00570687|578255|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163858|NCT00570687|578256|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
163859|NCT00570687|578257|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163860|NCT00570687|578258|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163861|NCT00570687|578259|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163862|NCT00570687|578260|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163863|NCT00570687|578261|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163864|NCT00570687|578262|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163865|NCT00570687|578263|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163866|NCT00570687|578264|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163867|NCT00570687|578255|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
163868|NCT00570687|578256|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
163869|NCT00570687|578257|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
163870|NCT00570687|578258|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
163871|NCT00570687|578259|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
163872|NCT00570687|578260|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
163873|NCT00570687|578261|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163874|NCT00570687|578262|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163875|NCT00570687|578263|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163876|NCT00570687|578264|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
163877|NCT00570674|578290|P7|Overall Study|Withdrawal by Subject|0
163878|NCT00570674|578291|P6|Overall Study|Withdrawal by Subject|0
163879|NCT00570674|578292|P5|Overall Study|Withdrawal by Subject|0
163880|NCT00570674|578293|P4|Overall Study|Withdrawal by Subject|0
163881|NCT00570674|578294|P3|Overall Study|Withdrawal by Subject|1
163882|NCT00570674|578295|P2|Overall Study|Withdrawal by Subject|0
163883|NCT00570674|578296|P1|Overall Study|Withdrawal by Subject|0
163884|NCT00570505|578319|P1|Overall Study|Other loss to follow-up|4
163885|NCT00570505|578319|P1|Overall Study|Lost to Follow-up|23
163886|NCT00570505|578319|P1|Overall Study|Withdrawal by Subject|7
163887|NCT00570505|578319|P1|Overall Study|Adverse Event|7
163888|NCT00570492|578332|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
163889|NCT00570492|578333|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
163890|NCT00570492|578334|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
163891|NCT00570492|578332|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
163892|NCT00570492|578333|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
163893|NCT00570492|578334|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
163894|NCT00570492|578332|P3|52-week Double-blind Treatment Period|Physician Decision|4
163895|NCT00570492|578333|P2|52-week Double-blind Treatment Period|Physician Decision|2
163896|NCT00570492|578334|P1|52-week Double-blind Treatment Period|Physician Decision|0
163897|NCT00570492|578332|P3|52-week Double-blind Treatment Period|Adverse Event|5
163898|NCT00570492|578333|P2|52-week Double-blind Treatment Period|Adverse Event|5
163899|NCT00570492|578334|P1|52-week Double-blind Treatment Period|Adverse Event|0
163900|NCT00570492|578332|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
163901|NCT00570492|578333|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
163902|NCT00570492|578334|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
163903|NCT00570492|578332|P3|52-week Double-blind Treatment Period|Protocol Violation|15
163904|NCT00570492|578333|P2|52-week Double-blind Treatment Period|Protocol Violation|12
163905|NCT00570492|578334|P1|52-week Double-blind Treatment Period|Protocol Violation|0
163906|NCT00570492|578332|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
163907|NCT00570492|578333|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
163908|NCT00570492|578334|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
163909|NCT00570492|578332|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
163910|NCT00570492|578333|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
163911|NCT00570492|578334|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
163912|NCT00570492|578332|P3|16-week Single-blind Baseline Period|Adverse Event|0
163913|NCT00570492|578333|P2|16-week Single-blind Baseline Period|Adverse Event|0
163914|NCT00570492|578334|P1|16-week Single-blind Baseline Period|Adverse Event|1
163915|NCT00570492|578332|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
163916|NCT00570492|578333|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
163917|NCT00570492|578334|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
163918|NCT00570492|578332|P3|16-week Single-blind Baseline Period|Protocol Violation|0
163919|NCT00570492|578333|P2|16-week Single-blind Baseline Period|Protocol Violation|0
163920|NCT00570492|578334|P1|16-week Single-blind Baseline Period|Protocol Violation|15
163921|NCT00570492|578332|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
163922|NCT00570492|578333|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
163923|NCT00570492|578334|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
163924|NCT00570492|578332|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
163925|NCT00570492|578333|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
163926|NCT00570492|578334|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
163927|NCT00570492|578332|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
163928|NCT00570492|578333|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
163929|NCT00570492|578334|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
163930|NCT00570401|578372|P1|Overall Study|Adverse Event|2
163931|NCT00570310|578406|P2|Overall Study|Lack of Efficacy|4
163932|NCT00570310|578407|P1|Overall Study|Lack of Efficacy|1
163933|NCT00570310|578406|P2|Overall Study|Adverse Event|2
163934|NCT00570310|578407|P1|Overall Study|Adverse Event|1
163935|NCT00570232|578415|P1|Overall Study|discontinued due to noncompliance|2
163936|NCT00570232|578415|P1|Overall Study|discontinued due to recurrence|8
163937|NCT00570232|578415|P1|Overall Study|discontinued due to medical condition|3
163938|NCT00570232|578415|P1|Overall Study|Adverse Event|10
163939|NCT00570141|578421|P1|Overall Study|Lost to Follow-up|1
163940|NCT00570141|578421|P1|Overall Study|Missed visits|1
163941|NCT00570141|578421|P1|Overall Study|Adverse Event|1
163942|NCT00570063|578437|P2|Overall Study|Sponsor's Decision|3
163943|NCT00570063|578438|P1|Overall Study|Sponsor's Decision|7
163944|NCT00570063|578437|P2|Overall Study|Withdrawal by Subject|3
163945|NCT00570063|578438|P1|Overall Study|Withdrawal by Subject|4
163946|NCT00570063|578437|P2|Overall Study|Lack of Efficacy|1
163947|NCT00570063|578438|P1|Overall Study|Lack of Efficacy|0
163948|NCT00570063|578437|P2|Overall Study|Adverse Event|1
163949|NCT00570063|578438|P1|Overall Study|Adverse Event|4
163950|NCT00570037|578504|P2|Overall Study|Could not reach for 6-8 week contact|69
163951|NCT00570037|578505|P1|Overall Study|Could not reach for 6-8 week contact|44
163952|NCT00569946|578515|P1|Overall Study|Global Deterioration of Health Status|1
163953|NCT00569946|578515|P1|Overall Study|Objective Progression or Relapse|42
163954|NCT00569946|578515|P1|Overall Study|Adverse Event|16
163955|NCT00569803|578547|P8|Overall Study|Withdrawal by Subject|1
163956|NCT00569803|578548|P7|Overall Study|Withdrawal by Subject|0
163957|NCT00569803|578549|P6|Overall Study|Withdrawal by Subject|0
163958|NCT00569803|578550|P5|Overall Study|Withdrawal by Subject|0
163959|NCT00569803|578551|P4|Overall Study|Withdrawal by Subject|0
163960|NCT00569803|578552|P3|Overall Study|Withdrawal by Subject|0
163961|NCT00569803|578553|P2|Overall Study|Withdrawal by Subject|0
163962|NCT00569803|578554|P1|Overall Study|Withdrawal by Subject|0
163963|NCT00569803|578547|P8|Overall Study|injection syringe leaked during dosing|0
163964|NCT00569803|578548|P7|Overall Study|injection syringe leaked during dosing|0
163965|NCT00569803|578549|P6|Overall Study|injection syringe leaked during dosing|0
163966|NCT00569803|578550|P5|Overall Study|injection syringe leaked during dosing|0
163967|NCT00569803|578551|P4|Overall Study|injection syringe leaked during dosing|1
163968|NCT00569803|578552|P3|Overall Study|injection syringe leaked during dosing|0
163969|NCT00569803|578553|P2|Overall Study|injection syringe leaked during dosing|0
163970|NCT00569803|578554|P1|Overall Study|injection syringe leaked during dosing|0
163971|NCT00569803|578547|P8|Overall Study|Lost to Follow-up|0
163972|NCT00569803|578548|P7|Overall Study|Lost to Follow-up|0
163973|NCT00569803|578549|P6|Overall Study|Lost to Follow-up|0
163974|NCT00569803|578550|P5|Overall Study|Lost to Follow-up|0
163975|NCT00569803|578551|P4|Overall Study|Lost to Follow-up|0
163976|NCT00569803|578552|P3|Overall Study|Lost to Follow-up|0
163977|NCT00569803|578553|P2|Overall Study|Lost to Follow-up|0
163978|NCT00569803|578554|P1|Overall Study|Lost to Follow-up|1
163979|NCT00569777|578681|P2|Overall Study|pregnant|0
163980|NCT00569777|578682|P1|Overall Study|pregnant|1
163981|NCT00569777|578681|P2|Overall Study|did not meet exclusion criteria|2
163982|NCT00569777|578682|P1|Overall Study|did not meet exclusion criteria|1
163983|NCT00569777|578681|P2|Overall Study|scheduled eye surgery|1
163984|NCT00569777|578682|P1|Overall Study|scheduled eye surgery|0
163985|NCT00569777|578681|P2|Overall Study|Lost to Follow-up|0
163986|NCT00569777|578682|P1|Overall Study|Lost to Follow-up|1
163987|NCT00569777|578681|P2|Overall Study|Adverse Event|0
163988|NCT00569777|578682|P1|Overall Study|Adverse Event|3
163989|NCT00569777|578681|P2|Overall Study|Withdrawal by Subject|0
163990|NCT00569777|578682|P1|Overall Study|Withdrawal by Subject|4
163991|NCT00569582|578732|P1|Overall Study|Subject was non-compliant.|1
163992|NCT00569582|578732|P1|Overall Study|Subject was too ill to travel.|1
163993|NCT00569582|578732|P1|Overall Study|Adverse Event|7
163994|NCT00569582|578732|P1|Overall Study|Death|2
163995|NCT00569582|578732|P1|Overall Study|Withdrawal by Subject|5
163996|NCT00569374|578748|P1|Overall Study|Withdrawal by Subject|4
163997|NCT00569270|578767|P2|Period: First Intervention|Protocol Violation|1
163998|NCT00569270|578768|P1|Period: First Intervention|Protocol Violation|0
163999|NCT00569231|578803|P1|Overall Study|Non-compliance|2
164000|NCT00569231|578803|P1|Overall Study|Car accident injury|1
164001|NCT00569231|578803|P1|Overall Study|Withdrawal by Subject|1
164002|NCT00569231|578803|P1|Overall Study|Airfare expense|2
164003|NCT00569231|578803|P1|Overall Study|Study unrelated surgery|1
164004|NCT00569166|578841|P3|Overall Study|Lost to Follow-up|1
164005|NCT00569166|578842|P2|Overall Study|Lost to Follow-up|1
164006|NCT00569166|578843|P1|Overall Study|Lost to Follow-up|2
164007|NCT00569166|578841|P3|Overall Study|Withdrawal by Subject|3
164008|NCT00569166|578842|P2|Overall Study|Withdrawal by Subject|5
164009|NCT00569166|578843|P1|Overall Study|Withdrawal by Subject|7
164010|NCT00569127|578877|P2|Overall Study|Still on Treatment|3
164011|NCT00569127|578878|P1|Overall Study|Still on Treatment|7
164012|NCT00569127|578877|P2|Overall Study|Not Eligible|11
164013|NCT00569127|578878|P1|Overall Study|Not Eligible|14
164014|NCT00569127|578877|P2|Overall Study|Lost to Follow-up|3
164015|NCT00569127|578878|P1|Overall Study|Lost to Follow-up|0
164016|NCT00569127|578877|P2|Overall Study|Not Specified|19
164017|NCT00569127|578878|P1|Overall Study|Not Specified|20
164018|NCT00569127|578877|P2|Overall Study|Death|3
164019|NCT00569127|578878|P1|Overall Study|Death|4
164020|NCT00569127|578877|P2|Overall Study|Progression|100
164021|NCT00569127|578878|P1|Overall Study|Progression|99
164022|NCT00569127|578877|P2|Overall Study|Withdrawal by Subject|27
164023|NCT00569127|578878|P1|Overall Study|Withdrawal by Subject|13
164024|NCT00569127|578877|P2|Overall Study|Adverse Event|47
164025|NCT00569127|578878|P1|Overall Study|Adverse Event|57
164026|NCT00568958|578913|P2|Follow-Up|Family Emergency|0
164027|NCT00568958|578914|P1|Follow-Up|Family Emergency|1
164028|NCT00568958|578913|P2|Follow-Up|Physician Decision|1
164029|NCT00568958|578914|P1|Follow-Up|Physician Decision|1
164030|NCT00568958|578913|P2|Follow-Up|Withdrawal by Subject|3
164031|NCT00568958|578914|P1|Follow-Up|Withdrawal by Subject|6
164032|NCT00568958|578913|P2|Allocation|Physician Decision|0
164033|NCT00568958|578914|P1|Allocation|Physician Decision|2
164034|NCT00568958|578913|P2|Allocation|Withdrawal by Subject|3
164035|NCT00568958|578914|P1|Allocation|Withdrawal by Subject|7
164036|NCT00568776|578947|P4|Overall Study|Miscellaeneous|4
164037|NCT00568776|578948|P3|Overall Study|Miscellaeneous|1
164038|NCT00568776|578949|P2|Overall Study|Miscellaeneous|3
164039|NCT00568776|578950|P1|Overall Study|Miscellaeneous|3
164040|NCT00568776|578947|P4|Overall Study|Sponsor Decision|42
164041|NCT00568776|578948|P3|Overall Study|Sponsor Decision|41
164042|NCT00568776|578949|P2|Overall Study|Sponsor Decision|2
164043|NCT00568776|578950|P1|Overall Study|Sponsor Decision|2
164044|NCT00568776|578947|P4|Overall Study|Loss of Caregiver|2
164045|NCT00568776|578948|P3|Overall Study|Loss of Caregiver|1
164046|NCT00568776|578949|P2|Overall Study|Loss of Caregiver|2
164047|NCT00568776|578950|P1|Overall Study|Loss of Caregiver|0
164048|NCT00568776|578947|P4|Overall Study|Withdrawal by Subject|7
164049|NCT00568776|578948|P3|Overall Study|Withdrawal by Subject|13
164050|NCT00568776|578949|P2|Overall Study|Withdrawal by Subject|15
164051|NCT00568776|578950|P1|Overall Study|Withdrawal by Subject|13
164052|NCT00568776|578947|P4|Overall Study|Protocol Violation|1
164053|NCT00568776|578948|P3|Overall Study|Protocol Violation|1
164054|NCT00568776|578949|P2|Overall Study|Protocol Violation|0
164055|NCT00568776|578950|P1|Overall Study|Protocol Violation|1
164056|NCT00568776|578947|P4|Overall Study|Lost to Follow-up|1
164057|NCT00568776|578948|P3|Overall Study|Lost to Follow-up|1
164058|NCT00568776|578949|P2|Overall Study|Lost to Follow-up|1
164059|NCT00568776|578950|P1|Overall Study|Lost to Follow-up|1
164060|NCT00568776|578947|P4|Overall Study|Lack of Efficacy|4
164061|NCT00568776|578948|P3|Overall Study|Lack of Efficacy|2
164062|NCT00568776|578949|P2|Overall Study|Lack of Efficacy|2
164063|NCT00568776|578950|P1|Overall Study|Lack of Efficacy|2
164064|NCT00568776|578947|P4|Overall Study|Physician Decision|0
164065|NCT00568776|578948|P3|Overall Study|Physician Decision|0
164066|NCT00568776|578949|P2|Overall Study|Physician Decision|2
164067|NCT00568776|578950|P1|Overall Study|Physician Decision|0
164068|NCT00568776|578947|P4|Overall Study|Death|3
164069|NCT00568776|578948|P3|Overall Study|Death|4
164070|NCT00568776|578949|P2|Overall Study|Death|1
164071|NCT00568776|578950|P1|Overall Study|Death|0
164072|NCT00568776|578947|P4|Overall Study|Adverse Event|8
164073|NCT00568776|578948|P3|Overall Study|Adverse Event|10
164074|NCT00568776|578949|P2|Overall Study|Adverse Event|8
164075|NCT00568776|578950|P1|Overall Study|Adverse Event|8
164076|NCT00568685|578987|P3|Overall Study|Protocol Violation|0
164077|NCT00568685|578988|P2|Overall Study|Protocol Violation|0
164078|NCT00568685|578989|P1|Overall Study|Protocol Violation|1
164079|NCT00568685|578987|P3|Overall Study|Withdrawal by Subject|2
164080|NCT00568685|578988|P2|Overall Study|Withdrawal by Subject|2
164081|NCT00568685|578989|P1|Overall Study|Withdrawal by Subject|7
164082|NCT00568685|578987|P3|Overall Study|Adverse Event|3
164083|NCT00568685|578988|P2|Overall Study|Adverse Event|3
164084|NCT00568685|578989|P1|Overall Study|Adverse Event|2
164085|NCT00568555|579023|P2|Overall Study|Withdrawal by Subject|1
164086|NCT00568555|579024|P1|Overall Study|Withdrawal by Subject|1
164087|NCT00568451|579042|P4|Overall Study|Disease Progression|7
164088|NCT00568451|579043|P3|Overall Study|Disease Progression|2
164089|NCT00568451|579044|P2|Overall Study|Disease Progression|0
164090|NCT00568451|579045|P1|Overall Study|Disease Progression|0
164091|NCT00568399|579061|P1|Overall Study|Withdrawal by Subject|8
164092|NCT00568399|579061|P1|Overall Study|Adverse Event|5
164093|NCT00568399|579061|P1|Overall Study|Death|2
164094|NCT00568334|579076|P2|Overall Study|Lost to Follow-up|0
164095|NCT00568334|579077|P1|Overall Study|Lost to Follow-up|1
164096|NCT00568334|579076|P2|Overall Study|Withdrawal by Subject|1
164097|NCT00568334|579077|P1|Overall Study|Withdrawal by Subject|0
164098|NCT00568178|579103|P6|Open Label Extension|Withdrawal by Subject|4
164099|NCT00568178|579104|P5|Open Label Extension|Withdrawal by Subject|4
164100|NCT00568178|579105|P4|Open Label Extension|Withdrawal by Subject|0
164101|NCT00568178|579106|P3|Open Label Extension|Withdrawal by Subject|0
164102|NCT00568178|579107|P2|Open Label Extension|Withdrawal by Subject|0
164103|NCT00568178|579108|P1|Open Label Extension|Withdrawal by Subject|0
164104|NCT00568178|579103|P6|Open Label Extension|Termination of Trial|47
164105|NCT00568178|579104|P5|Open Label Extension|Termination of Trial|45
164106|NCT00568178|579105|P4|Open Label Extension|Termination of Trial|0
164107|NCT00568178|579106|P3|Open Label Extension|Termination of Trial|0
164108|NCT00568178|579107|P2|Open Label Extension|Termination of Trial|0
164109|NCT00568178|579108|P1|Open Label Extension|Termination of Trial|0
164110|NCT00568178|579103|P6|Open Label Extension|Progressive Disease|1
164111|NCT00568178|579104|P5|Open Label Extension|Progressive Disease|3
164112|NCT00568178|579105|P4|Open Label Extension|Progressive Disease|0
164113|NCT00568178|579106|P3|Open Label Extension|Progressive Disease|0
164114|NCT00568178|579107|P2|Open Label Extension|Progressive Disease|0
164115|NCT00568178|579108|P1|Open Label Extension|Progressive Disease|0
164116|NCT00568178|579103|P6|Open Label Extension|Pregnancy|1
164117|NCT00568178|579104|P5|Open Label Extension|Pregnancy|0
164118|NCT00568178|579105|P4|Open Label Extension|Pregnancy|0
164119|NCT00568178|579106|P3|Open Label Extension|Pregnancy|0
164120|NCT00568178|579107|P2|Open Label Extension|Pregnancy|0
164121|NCT00568178|579108|P1|Open Label Extension|Pregnancy|0
164122|NCT00568178|579103|P6|Open Label Extension|Physician Decision|8
164123|NCT00568178|579104|P5|Open Label Extension|Physician Decision|9
164124|NCT00568178|579105|P4|Open Label Extension|Physician Decision|0
164125|NCT00568178|579106|P3|Open Label Extension|Physician Decision|0
164126|NCT00568178|579107|P2|Open Label Extension|Physician Decision|0
164127|NCT00568178|579108|P1|Open Label Extension|Physician Decision|0
164128|NCT00568178|579103|P6|Open Label Extension|Lost to Follow-up|11
164129|NCT00568178|579104|P5|Open Label Extension|Lost to Follow-up|6
164130|NCT00568178|579105|P4|Open Label Extension|Lost to Follow-up|0
164131|NCT00568178|579106|P3|Open Label Extension|Lost to Follow-up|0
164132|NCT00568178|579107|P2|Open Label Extension|Lost to Follow-up|0
164133|NCT00568178|579108|P1|Open Label Extension|Lost to Follow-up|0
164134|NCT00568178|579103|P6|Open Label Extension|Protocol Violation|0
164135|NCT00568178|579104|P5|Open Label Extension|Protocol Violation|1
164136|NCT00568178|579105|P4|Open Label Extension|Protocol Violation|0
164137|NCT00568178|579106|P3|Open Label Extension|Protocol Violation|0
164138|NCT00568178|579107|P2|Open Label Extension|Protocol Violation|0
164139|NCT00568178|579108|P1|Open Label Extension|Protocol Violation|0
164140|NCT00568178|579103|P6|Open Label Extension|Adverse Event|8
164141|NCT00568178|579104|P5|Open Label Extension|Adverse Event|11
164142|NCT00568178|579105|P4|Open Label Extension|Adverse Event|0
164143|NCT00568178|579106|P3|Open Label Extension|Adverse Event|0
164144|NCT00568178|579107|P2|Open Label Extension|Adverse Event|0
164145|NCT00568178|579108|P1|Open Label Extension|Adverse Event|0
164146|NCT00568178|579103|P6|Double Blind Base Study|Progressive Disease|0
164147|NCT00568178|579104|P5|Double Blind Base Study|Progressive Disease|0
164148|NCT00568178|579105|P4|Double Blind Base Study|Progressive Disease|1
164149|NCT00568178|579106|P3|Double Blind Base Study|Progressive Disease|0
164150|NCT00568178|579107|P2|Double Blind Base Study|Progressive Disease|0
164151|NCT00568178|579108|P1|Double Blind Base Study|Progressive Disease|0
164152|NCT00568178|579103|P6|Double Blind Base Study|Withdrawal by Subject|0
164153|NCT00568178|579104|P5|Double Blind Base Study|Withdrawal by Subject|0
164154|NCT00568178|579105|P4|Double Blind Base Study|Withdrawal by Subject|0
164155|NCT00568178|579106|P3|Double Blind Base Study|Withdrawal by Subject|0
164156|NCT00568178|579107|P2|Double Blind Base Study|Withdrawal by Subject|1
164157|NCT00568178|579108|P1|Double Blind Base Study|Withdrawal by Subject|1
164158|NCT00568178|579103|P6|Double Blind Base Study|Protocol Violation|0
164159|NCT00568178|579104|P5|Double Blind Base Study|Protocol Violation|0
164160|NCT00568178|579105|P4|Double Blind Base Study|Protocol Violation|0
164161|NCT00568178|579106|P3|Double Blind Base Study|Protocol Violation|0
164162|NCT00568178|579107|P2|Double Blind Base Study|Protocol Violation|2
164163|NCT00568178|579108|P1|Double Blind Base Study|Protocol Violation|3
164164|NCT00568178|579103|P6|Double Blind Base Study|Physician Decision|0
164165|NCT00568178|579104|P5|Double Blind Base Study|Physician Decision|0
164166|NCT00568178|579105|P4|Double Blind Base Study|Physician Decision|1
164167|NCT00568178|579106|P3|Double Blind Base Study|Physician Decision|0
164168|NCT00568178|579107|P2|Double Blind Base Study|Physician Decision|1
164169|NCT00568178|579108|P1|Double Blind Base Study|Physician Decision|1
164170|NCT00568178|579103|P6|Double Blind Base Study|Lost to Follow-up|0
164171|NCT00568178|579104|P5|Double Blind Base Study|Lost to Follow-up|0
164172|NCT00568178|579105|P4|Double Blind Base Study|Lost to Follow-up|1
164173|NCT00568178|579106|P3|Double Blind Base Study|Lost to Follow-up|0
164174|NCT00568178|579107|P2|Double Blind Base Study|Lost to Follow-up|0
164175|NCT00568178|579108|P1|Double Blind Base Study|Lost to Follow-up|1
164176|NCT00568178|579103|P6|Double Blind Base Study|Adverse Event|0
164177|NCT00568178|579104|P5|Double Blind Base Study|Adverse Event|0
164178|NCT00568178|579105|P4|Double Blind Base Study|Adverse Event|2
164179|NCT00568178|579106|P3|Double Blind Base Study|Adverse Event|1
164180|NCT00568178|579107|P2|Double Blind Base Study|Adverse Event|2
164181|NCT00568178|579108|P1|Double Blind Base Study|Adverse Event|0
164182|NCT00568061|579139|P2|Overall Study|Adverse Event|1
164183|NCT00568061|579140|P1|Overall Study|Adverse Event|0
164184|NCT00568061|579139|P2|Overall Study|Inclusion / exclusion criteria|1
164185|NCT00568061|579140|P1|Overall Study|Inclusion / exclusion criteria|5
164186|NCT00567996|579184|P3|Overall Study|Patient's inability to use the device|0
164187|NCT00567996|579185|P2|Overall Study|Patient's inability to use the device|1
164188|NCT00567996|579186|P1|Overall Study|Patient's inability to use the device|0
164189|NCT00567996|579184|P3|Overall Study|Death|2
164190|NCT00567996|579185|P2|Overall Study|Death|0
164191|NCT00567996|579186|P1|Overall Study|Death|1
164192|NCT00567996|579184|P3|Overall Study|Administrative problems|0
164193|NCT00567996|579185|P2|Overall Study|Administrative problems|1
164194|NCT00567996|579186|P1|Overall Study|Administrative problems|1
164195|NCT00567996|579184|P3|Overall Study|Unsatisfactory therapeutic effect|15
164196|NCT00567996|579185|P2|Overall Study|Unsatisfactory therapeutic effect|2
164197|NCT00567996|579186|P1|Overall Study|Unsatisfactory therapeutic effect|1
164198|NCT00567996|579184|P3|Overall Study|Lost to Follow-up|2
164199|NCT00567996|579185|P2|Overall Study|Lost to Follow-up|5
164200|NCT00567996|579186|P1|Overall Study|Lost to Follow-up|2
164201|NCT00567996|579184|P3|Overall Study|Abnormal test procedure result(s)|1
164202|NCT00567996|579185|P2|Overall Study|Abnormal test procedure result(s)|1
164203|NCT00567996|579186|P1|Overall Study|Abnormal test procedure result(s)|2
164204|NCT00567996|579184|P3|Overall Study|Abnormal Lab value(s)|2
164205|NCT00567996|579185|P2|Overall Study|Abnormal Lab value(s)|1
164206|NCT00567996|579186|P1|Overall Study|Abnormal Lab value(s)|2
164207|NCT00567996|579184|P3|Overall Study|Withdrawal by Subject|22
164208|NCT00567996|579185|P2|Overall Study|Withdrawal by Subject|12
164209|NCT00567996|579186|P1|Overall Study|Withdrawal by Subject|8
164210|NCT00567996|579184|P3|Overall Study|Protocol Deviation|13
164211|NCT00567996|579185|P2|Overall Study|Protocol Deviation|11
164212|NCT00567996|579186|P1|Overall Study|Protocol Deviation|9
164213|NCT00567996|579184|P3|Overall Study|Adverse Event|13
164214|NCT00567996|579185|P2|Overall Study|Adverse Event|16
164215|NCT00567996|579186|P1|Overall Study|Adverse Event|18
164216|NCT00567892|579202|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
164217|NCT00567892|579203|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
164218|NCT00567892|579204|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
164219|NCT00567892|579205|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
164220|NCT00567892|579202|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
164221|NCT00567892|579203|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
164222|NCT00567892|579204|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
164223|NCT00567892|579205|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
164224|NCT00567879|579223|P6|Overall Study|Disease progression|3
164225|NCT00567879|579224|P5|Overall Study|Disease progression|11
164226|NCT00567879|579225|P4|Overall Study|Disease progression|5
164227|NCT00567879|579226|P3|Overall Study|Disease progression|15
164228|NCT00567879|579227|P2|Overall Study|Disease progression|7
164229|NCT00567879|579228|P1|Overall Study|Disease progression|5
164230|NCT00567879|579223|P6|Overall Study|New cancer therapy|0
164231|NCT00567879|579224|P5|Overall Study|New cancer therapy|0
164232|NCT00567879|579225|P4|Overall Study|New cancer therapy|0
164233|NCT00567879|579226|P3|Overall Study|New cancer therapy|1
164234|NCT00567879|579227|P2|Overall Study|New cancer therapy|0
164235|NCT00567879|579228|P1|Overall Study|New cancer therapy|0
164236|NCT00567879|579223|P6|Overall Study|Withdrawal by Subject|0
164237|NCT00567879|579224|P5|Overall Study|Withdrawal by Subject|0
164238|NCT00567879|579225|P4|Overall Study|Withdrawal by Subject|1
164239|NCT00567879|579226|P3|Overall Study|Withdrawal by Subject|3
164240|NCT00567879|579227|P2|Overall Study|Withdrawal by Subject|0
164241|NCT00567879|579228|P1|Overall Study|Withdrawal by Subject|0
164242|NCT00567879|579223|P6|Overall Study|Abnormal test procedure(s)|0
164243|NCT00567879|579224|P5|Overall Study|Abnormal test procedure(s)|0
164244|NCT00567879|579225|P4|Overall Study|Abnormal test procedure(s)|0
164245|NCT00567879|579226|P3|Overall Study|Abnormal test procedure(s)|1
164246|NCT00567879|579227|P2|Overall Study|Abnormal test procedure(s)|0
164247|NCT00567879|579228|P1|Overall Study|Abnormal test procedure(s)|0
164248|NCT00567879|579223|P6|Overall Study|Adverse Event|0
164249|NCT00567879|579224|P5|Overall Study|Adverse Event|1
164250|NCT00567879|579225|P4|Overall Study|Adverse Event|0
164251|NCT00567879|579226|P3|Overall Study|Adverse Event|1
164252|NCT00567879|579227|P2|Overall Study|Adverse Event|0
164253|NCT00567879|579228|P1|Overall Study|Adverse Event|2
164254|NCT00567593|579295|P1|Overall Study|Physician Decision|1
164255|NCT00567593|579295|P1|Overall Study|Adverse Event|1
164256|NCT00567567|579302|P3|Overall Study|Unable adequate stem cell for transplant|2
164257|NCT00567567|579303|P2|Overall Study|Unable adequate stem cell for transplant|0
164258|NCT00567567|579304|P1|Overall Study|Unable adequate stem cell for transplant|0
164259|NCT00567567|579302|P3|Overall Study|Enrolled another COG therapeutic study|0
164260|NCT00567567|579303|P2|Overall Study|Enrolled another COG therapeutic study|80
164261|NCT00567567|579304|P1|Overall Study|Enrolled another COG therapeutic study|99
164262|NCT00567567|579302|P3|Overall Study|Refusal by patient/parent/guardian|122
164263|NCT00567567|579303|P2|Overall Study|Refusal by patient/parent/guardian|16
164264|NCT00567567|579304|P1|Overall Study|Refusal by patient/parent/guardian|9
164265|NCT00567567|579302|P3|Overall Study|Ineligible|9
164266|NCT00567567|579303|P2|Overall Study|Ineligible|0
164267|NCT00567567|579304|P1|Overall Study|Ineligible|4
164268|NCT00567567|579302|P3|Overall Study|Withdrawal by Subject|2
164269|NCT00567567|579303|P2|Overall Study|Withdrawal by Subject|0
164270|NCT00567567|579304|P1|Overall Study|Withdrawal by Subject|0
164271|NCT00567567|579302|P3|Overall Study|Physician Decision|84
164272|NCT00567567|579303|P2|Overall Study|Physician Decision|18
164273|NCT00567567|579304|P1|Overall Study|Physician Decision|16
164274|NCT00567567|579302|P3|Overall Study|Lost to Follow-up|1
164275|NCT00567567|579303|P2|Overall Study|Lost to Follow-up|0
164276|NCT00567567|579304|P1|Overall Study|Lost to Follow-up|0
164277|NCT00567567|579302|P3|Overall Study|Lack of Efficacy|48
164278|NCT00567567|579303|P2|Overall Study|Lack of Efficacy|17
164279|NCT00567567|579304|P1|Overall Study|Lack of Efficacy|16
164280|NCT00567567|579302|P3|Overall Study|Death|5
164281|NCT00567567|579303|P2|Overall Study|Death|1
164282|NCT00567567|579304|P1|Overall Study|Death|8
164283|NCT00567567|579302|P3|Overall Study|Adverse Event|5
164284|NCT00567567|579303|P2|Overall Study|Adverse Event|2
164285|NCT00567567|579304|P1|Overall Study|Adverse Event|0
164286|NCT00567541|579330|P2|Overall Study|Adverse Event|1
164287|NCT00567541|579331|P1|Overall Study|Adverse Event|0
164288|NCT00567502|579341|P4|Overall Study|Never Initiated Treatment|72
164289|NCT00567502|579342|P3|Overall Study|Never Initiated Treatment|0
164290|NCT00567502|579343|P2|Overall Study|Never Initiated Treatment|0
164291|NCT00567502|579344|P1|Overall Study|Never Initiated Treatment|0
164292|NCT00567502|579341|P4|Overall Study|Sponsor request|1
164293|NCT00567502|579342|P3|Overall Study|Sponsor request|30
164294|NCT00567502|579343|P2|Overall Study|Sponsor request|0
164295|NCT00567502|579344|P1|Overall Study|Sponsor request|9
164296|NCT00567502|579341|P4|Overall Study|Participant request|1
164297|NCT00567502|579342|P3|Overall Study|Participant request|33
164298|NCT00567502|579343|P2|Overall Study|Participant request|1
164299|NCT00567502|579344|P1|Overall Study|Participant request|12
164300|NCT00567502|579341|P4|Overall Study|Other|6
164301|NCT00567502|579342|P3|Overall Study|Other|134
164302|NCT00567502|579343|P2|Overall Study|Other|2
164303|NCT00567502|579344|P1|Overall Study|Other|64
164304|NCT00567502|579341|P4|Overall Study|Death|5
164305|NCT00567502|579342|P3|Overall Study|Death|360
164306|NCT00567502|579343|P2|Overall Study|Death|16
164307|NCT00567502|579344|P1|Overall Study|Death|65
164308|NCT00567502|579341|P4|Overall Study|Lost to Follow-up|2
164309|NCT00567502|579342|P3|Overall Study|Lost to Follow-up|351
164310|NCT00567502|579343|P2|Overall Study|Lost to Follow-up|14
164311|NCT00567502|579344|P1|Overall Study|Lost to Follow-up|91
164312|NCT00567476|579381|P2|Overall Study|Non-adherence to protocol|1
164313|NCT00567476|579382|P1|Overall Study|Non-adherence to protocol|0
164314|NCT00567476|579381|P2|Overall Study|Medical Decision|1
164315|NCT00567476|579382|P1|Overall Study|Medical Decision|0
164316|NCT00567476|579381|P2|Overall Study|Administrative issues|0
164317|NCT00567476|579382|P1|Overall Study|Administrative issues|1
164318|NCT00567476|579381|P2|Overall Study|Lost to Follow-up|1
164319|NCT00567476|579382|P1|Overall Study|Lost to Follow-up|0
164320|NCT00567476|579381|P2|Overall Study|Protocol Violation|1
164321|NCT00567476|579382|P1|Overall Study|Protocol Violation|4
164322|NCT00567476|579381|P2|Overall Study|Pregnancy|0
164323|NCT00567476|579382|P1|Overall Study|Pregnancy|1
164324|NCT00567476|579381|P2|Overall Study|Adverse Event|0
164325|NCT00567476|579382|P1|Overall Study|Adverse Event|2
164326|NCT00567268|579424|P1|Overall Study|"Safety Evaluation Not Assessable"|1
164327|NCT00567268|579424|P1|Overall Study|No Drug Administration|4
164328|NCT00567268|579424|P1|Overall Study|No Visit After First Day of Treatment|2
164329|NCT00567268|579424|P1|Overall Study|Lost to Follow-up|36
164330|NCT00567268|579424|P1|Overall Study|Protocol Violation|7
164331|NCT00567255|579475|P2|Overall Study|Drug noncompliance,moved,other|15
164332|NCT00567255|579476|P1|Overall Study|Drug noncompliance,moved,other|25
164333|NCT00567255|579475|P2|Overall Study|Pregnancy|0
164334|NCT00567255|579476|P1|Overall Study|Pregnancy|6
164335|NCT00567255|579475|P2|Overall Study|Protocol Violation|8
164336|NCT00567255|579476|P1|Overall Study|Protocol Violation|20
164337|NCT00567255|579475|P2|Overall Study|Lack of Efficacy|33
164338|NCT00567255|579476|P1|Overall Study|Lack of Efficacy|19
164339|NCT00567255|579475|P2|Overall Study|Withdrawal by Subject|56
164340|NCT00567255|579476|P1|Overall Study|Withdrawal by Subject|75
164341|NCT00567255|579475|P2|Overall Study|Lost to Follow-up|48
164342|NCT00567255|579476|P1|Overall Study|Lost to Follow-up|77
164343|NCT00567255|579475|P2|Overall Study|Adverse Event|68
164344|NCT00567255|579476|P1|Overall Study|Adverse Event|241
164345|NCT00567190|579539|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
164346|NCT00567190|579540|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
164347|NCT00567190|579539|P2|Overall Study|Death|221
164348|NCT00567190|579540|P1|Overall Study|Death|168
164349|NCT00567164|579560|P3|Overall Study|Missing|0
164350|NCT00567164|579561|P2|Overall Study|Missing|0
164351|NCT00567164|579562|P1|Overall Study|Missing|1
164352|NCT00567164|579560|P3|Overall Study|Primary Reason coded as 'Other'|16
164353|NCT00567164|579561|P2|Overall Study|Primary Reason coded as 'Other'|8
164354|NCT00567164|579562|P1|Overall Study|Primary Reason coded as 'Other'|37
164355|NCT00567164|579560|P3|Overall Study|Pregnancy|6
164356|NCT00567164|579561|P2|Overall Study|Pregnancy|4
164357|NCT00567164|579562|P1|Overall Study|Pregnancy|20
164358|NCT00567164|579560|P3|Overall Study|Lost to Follow-up|21
164359|NCT00567164|579561|P2|Overall Study|Lost to Follow-up|23
164360|NCT00567164|579562|P1|Overall Study|Lost to Follow-up|202
164361|NCT00567164|579560|P3|Overall Study|Death|1
164362|NCT00567164|579561|P2|Overall Study|Death|0
164363|NCT00567164|579562|P1|Overall Study|Death|0
164364|NCT00567164|579560|P3|Overall Study|Adverse Event|9
164365|NCT00567164|579561|P2|Overall Study|Adverse Event|13
164366|NCT00567164|579562|P1|Overall Study|Adverse Event|92
164367|NCT00567164|579560|P3|Overall Study|Protocol Violation|2
164368|NCT00567164|579561|P2|Overall Study|Protocol Violation|4
164369|NCT00567164|579562|P1|Overall Study|Protocol Violation|23
164370|NCT00567164|579560|P3|Overall Study|Withdrawal by Subject|17
164371|NCT00567164|579561|P2|Overall Study|Withdrawal by Subject|21
164372|NCT00567164|579562|P1|Overall Study|Withdrawal by Subject|171
164373|NCT00567112|579634|P3|Washout Period 3 (3 Days)|Protocol Violation|0
164374|NCT00567112|579635|P2|Washout Period 3 (3 Days)|Protocol Violation|0
164375|NCT00567112|579636|P1|Washout Period 3 (3 Days)|Protocol Violation|1
164376|NCT00567112|579634|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
164377|NCT00567112|579635|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
164378|NCT00567112|579636|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
164379|NCT00567112|579634|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
164380|NCT00567112|579635|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
164381|NCT00567112|579636|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
164382|NCT00566995|579667|P1|Overall Study|Withdrew consent|4
164383|NCT00566995|579667|P1|Overall Study|Physician Decision|1
164384|NCT00566995|579667|P1|Overall Study|Toxicity|3
164385|NCT00566982|579674|P2|Overall Study|Other-family problems & doctor's request|2
164386|NCT00566982|579675|P1|Overall Study|Other-family problems & doctor's request|0
164387|NCT00566982|579674|P2|Overall Study|Lost to Follow-up|1
164388|NCT00566982|579675|P1|Overall Study|Lost to Follow-up|0
164389|NCT00566982|579674|P2|Overall Study|Protocol Violation|4
164390|NCT00566982|579675|P1|Overall Study|Protocol Violation|1
164391|NCT00566982|579674|P2|Overall Study|Withdrawal by Subject|14
164392|NCT00566982|579675|P1|Overall Study|Withdrawal by Subject|1
164393|NCT00566982|579674|P2|Overall Study|Adverse Event|48
164394|NCT00566982|579675|P1|Overall Study|Adverse Event|6
164395|NCT00566852|579740|P2|Overall Study|Missing reason not reported|20
164396|NCT00566852|579741|P1|Overall Study|Missing reason not reported|16
164397|NCT00566852|579740|P2|Overall Study|Missing reason not specified|2
164398|NCT00566852|579741|P1|Overall Study|Missing reason not specified|1
164399|NCT00566852|579740|P2|Overall Study|Not tested due to disability|12
164400|NCT00566852|579741|P1|Overall Study|Not tested due to disability|6
164401|NCT00566852|579740|P2|Overall Study|Patient refusal|37
164402|NCT00566852|579741|P1|Overall Study|Patient refusal|37
164403|NCT00566852|579740|P2|Overall Study|Withdrawal by Subject|25
164404|NCT00566852|579741|P1|Overall Study|Withdrawal by Subject|30
164405|NCT00566852|579740|P2|Overall Study|Death|78
164406|NCT00566852|579741|P1|Overall Study|Death|95
164407|NCT00566852|579740|P2|Overall Study|Protocol Violation|24
164408|NCT00566852|579741|P1|Overall Study|Protocol Violation|22
164409|NCT00566735|579759|P2|Overall Study|Switched into a manic episode|1
164410|NCT00566735|579760|P1|Overall Study|Switched into a manic episode|0
164411|NCT00566735|579759|P2|Overall Study|Refused neuropsychological testing|5
164412|NCT00566735|579760|P1|Overall Study|Refused neuropsychological testing|2
164413|NCT00566735|579759|P2|Overall Study|Withdrawal by Subject|1
164414|NCT00566735|579760|P1|Overall Study|Withdrawal by Subject|0
164415|NCT00566722|579773|P3|Overall Study|Noncompliant with drug administration|1
164416|NCT00566722|579774|P2|Overall Study|Noncompliant with drug administration|0
164417|NCT00566722|579775|P1|Overall Study|Noncompliant with drug administration|0
164418|NCT00566722|579773|P3|Overall Study|Serious adverse event|0
164419|NCT00566722|579774|P2|Overall Study|Serious adverse event|1
164420|NCT00566722|579775|P1|Overall Study|Serious adverse event|0
164421|NCT00566722|579773|P3|Overall Study|Did not meet exclusion criteria|2
164422|NCT00566722|579774|P2|Overall Study|Did not meet exclusion criteria|0
164423|NCT00566722|579775|P1|Overall Study|Did not meet exclusion criteria|0
164424|NCT00566722|579773|P3|Overall Study|Lack of Efficacy|4
164425|NCT00566722|579774|P2|Overall Study|Lack of Efficacy|2
164426|NCT00566722|579775|P1|Overall Study|Lack of Efficacy|1
164427|NCT00566722|579773|P3|Overall Study|Lost to Follow-up|1
164428|NCT00566722|579774|P2|Overall Study|Lost to Follow-up|1
164429|NCT00566722|579775|P1|Overall Study|Lost to Follow-up|1
164430|NCT00566722|579773|P3|Overall Study|Withdrawal by Subject|1
164431|NCT00566722|579774|P2|Overall Study|Withdrawal by Subject|0
164432|NCT00566722|579775|P1|Overall Study|Withdrawal by Subject|0
164433|NCT00566722|579773|P3|Overall Study|Adverse Event|0
164434|NCT00566722|579774|P2|Overall Study|Adverse Event|1
164435|NCT00566722|579775|P1|Overall Study|Adverse Event|0
164436|NCT00566709|579821|P2|Overall Study|Protocol Violation|0
164437|NCT00566709|579822|P1|Overall Study|Protocol Violation|5
164438|NCT00566696|579838|P1|Overall Study|Non-Patient Donors|37
164439|NCT00566696|579838|P1|Overall Study|Physician Decision|1
164440|NCT00566696|579838|P1|Overall Study|Health Status Change|1
164441|NCT00566696|579838|P1|Overall Study|Muromonab not available|1
164442|NCT00566696|579838|P1|Overall Study|Met Exclusion Criteria|2
164443|NCT00566631|579846|P1|Part 2: Extension Phase|Other|5
164444|NCT00566631|579846|P1|Part 2: Extension Phase|Death|1
164445|NCT00566631|579846|P1|Part 2: Extension Phase|Lost to Follow-up|6
164446|NCT00566631|579846|P1|Part 2: Extension Phase|Adverse Event|11
164447|NCT00566631|579846|P1|Part 2: Extension Phase|Withdrawal by Subject|34
164448|NCT00566631|579846|P1|Part 2: Extension Phase|Lack of Efficacy|25
164449|NCT00566631|579846|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
164450|NCT00566631|579846|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
164451|NCT00566631|579846|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
164452|NCT00566631|579846|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
164453|NCT00566631|579846|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
164454|NCT00566631|579846|P1|Part 1: Core Treatment Phase|Adverse Event|9
164455|NCT00566631|579846|P1|Part 1: Core Treatment Phase|Physician Decision|1
164456|NCT00566631|579846|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
164457|NCT00566527|579873|P3|Overall Study|Withdrawal by Subject|43
164458|NCT00566527|579874|P2|Overall Study|Withdrawal by Subject|43
164459|NCT00566527|579875|P1|Overall Study|Withdrawal by Subject|6
164460|NCT00566527|579873|P3|Overall Study|Lost to Follow-up|4
164461|NCT00566527|579874|P2|Overall Study|Lost to Follow-up|4
164462|NCT00566527|579875|P1|Overall Study|Lost to Follow-up|3
164463|NCT00566527|579873|P3|Overall Study|Physician Decision|20
164464|NCT00566527|579874|P2|Overall Study|Physician Decision|8
164465|NCT00566527|579875|P1|Overall Study|Physician Decision|3
164466|NCT00566527|579873|P3|Overall Study|Adverse Event|1
164467|NCT00566527|579874|P2|Overall Study|Adverse Event|0
164468|NCT00566527|579875|P1|Overall Study|Adverse Event|2
164469|NCT00566527|579873|P3|Overall Study|Reason not provided|10
164470|NCT00566527|579874|P2|Overall Study|Reason not provided|11
164471|NCT00566527|579875|P1|Overall Study|Reason not provided|3
164472|NCT00566254|579936|P2|Overall Study|Not Specified|2
164473|NCT00566254|579937|P1|Overall Study|Not Specified|0
164474|NCT00566254|579936|P2|Overall Study|Lack of Efficacy|6
164475|NCT00566254|579937|P1|Overall Study|Lack of Efficacy|5
164476|NCT00566254|579936|P2|Overall Study|Withdrawal by Subject|2
164477|NCT00566254|579937|P1|Overall Study|Withdrawal by Subject|1
164478|NCT00566254|579936|P2|Overall Study|Protocol Violation|3
164479|NCT00566254|579937|P1|Overall Study|Protocol Violation|1
164480|NCT00566254|579936|P2|Overall Study|Adverse Event|1
164481|NCT00566254|579937|P1|Overall Study|Adverse Event|3
164482|NCT00566111|579966|P2|Overall Study|Adverse Event|2
164483|NCT00566111|579967|P1|Overall Study|Adverse Event|0
164484|NCT00566020|579981|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
164485|NCT00566020|579982|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
164486|NCT00566020|579981|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
164487|NCT00566020|579982|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
164488|NCT00566020|579981|P2|46-week Long-term Administration Phase|Physician Decision|7
164489|NCT00566020|579982|P1|46-week Long-term Administration Phase|Physician Decision|0
164490|NCT00566020|579981|P2|46-week Long-term Administration Phase|Adverse Event|7
164491|NCT00566020|579982|P1|46-week Long-term Administration Phase|Adverse Event|0
164492|NCT00566020|579981|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
164493|NCT00566020|579982|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
164494|NCT00566020|579981|P2|6-week Dosage Adjustment Phase|Adverse Event|0
164495|NCT00566020|579982|P1|6-week Dosage Adjustment Phase|Adverse Event|5
164496|NCT00565812|580010|P3|Overall Study|Physician Decision|0
164497|NCT00565812|580011|P2|Overall Study|Physician Decision|0
164498|NCT00565812|580012|P1|Overall Study|Physician Decision|2
164499|NCT00565812|580010|P3|Overall Study|Follow-up Visit Not Completed|1
164500|NCT00565812|580011|P2|Overall Study|Follow-up Visit Not Completed|0
164501|NCT00565812|580012|P1|Overall Study|Follow-up Visit Not Completed|2
164502|NCT00565812|580010|P3|Overall Study|Low Compliance|1
164503|NCT00565812|580011|P2|Overall Study|Low Compliance|0
164504|NCT00565812|580012|P1|Overall Study|Low Compliance|1
164505|NCT00565812|580010|P3|Overall Study|Surgical Intervention|2
164506|NCT00565812|580011|P2|Overall Study|Surgical Intervention|1
164507|NCT00565812|580012|P1|Overall Study|Surgical Intervention|0
164508|NCT00565812|580010|P3|Overall Study|Research Site Closure|8
164509|NCT00565812|580011|P2|Overall Study|Research Site Closure|1
164510|NCT00565812|580012|P1|Overall Study|Research Site Closure|6
164511|NCT00565812|580010|P3|Overall Study|Domestic Reasons|3
164512|NCT00565812|580011|P2|Overall Study|Domestic Reasons|1
164513|NCT00565812|580012|P1|Overall Study|Domestic Reasons|7
164514|NCT00565812|580010|P3|Overall Study|Sponsor Decision|1
164515|NCT00565812|580011|P2|Overall Study|Sponsor Decision|5
164516|NCT00565812|580012|P1|Overall Study|Sponsor Decision|1
164517|NCT00565812|580010|P3|Overall Study|Relocated Out of Area|9
164518|NCT00565812|580011|P2|Overall Study|Relocated Out of Area|8
164519|NCT00565812|580012|P1|Overall Study|Relocated Out of Area|5
164520|NCT00565812|580010|P3|Overall Study|Jury Duty|0
164521|NCT00565812|580011|P2|Overall Study|Jury Duty|0
164522|NCT00565812|580012|P1|Overall Study|Jury Duty|1
164523|NCT00565812|580010|P3|Overall Study|Adverse Event|40
164524|NCT00565812|580011|P2|Overall Study|Adverse Event|54
164525|NCT00565812|580012|P1|Overall Study|Adverse Event|41
164526|NCT00565812|580010|P3|Overall Study|Protocol Violation|4
164527|NCT00565812|580011|P2|Overall Study|Protocol Violation|6
164528|NCT00565812|580012|P1|Overall Study|Protocol Violation|2
164529|NCT00565812|580010|P3|Overall Study|Work Schedule|1
164530|NCT00565812|580011|P2|Overall Study|Work Schedule|3
164531|NCT00565812|580012|P1|Overall Study|Work Schedule|5
164532|NCT00565812|580010|P3|Overall Study|Withdrawal by Subject|48
164533|NCT00565812|580011|P2|Overall Study|Withdrawal by Subject|47
164534|NCT00565812|580012|P1|Overall Study|Withdrawal by Subject|58
164535|NCT00565812|580010|P3|Overall Study|Lost to Follow-up|8
164536|NCT00565812|580011|P2|Overall Study|Lost to Follow-up|8
164537|NCT00565812|580012|P1|Overall Study|Lost to Follow-up|10
164538|NCT00565812|580010|P3|Overall Study|Did not Meet Entrance Criteria|1
164539|NCT00565812|580011|P2|Overall Study|Did not Meet Entrance Criteria|0
164540|NCT00565812|580012|P1|Overall Study|Did not Meet Entrance Criteria|1
164541|NCT00565812|580010|P3|Overall Study|Death|3
164542|NCT00565812|580011|P2|Overall Study|Death|1
164543|NCT00565812|580012|P1|Overall Study|Death|2
164544|NCT00565747|580151|P2|Overall Study|No embryo transfer|73
164545|NCT00565747|580152|P1|Overall Study|No embryo transfer|67
164546|NCT00565721|580162|P1|Overall Study|Other reasons|6
164547|NCT00565721|580162|P1|Overall Study|Physician Decision|2
164548|NCT00565721|580162|P1|Overall Study|Technical Problems|1
164549|NCT00565721|580162|P1|Overall Study|Lost to Follow-up|6
164550|NCT00565721|580162|P1|Overall Study|Screen Failure|2
164551|NCT00565617|580202|P1|Overall Study|Withdrawal by Subject|1
164552|NCT00565604|580206|P1|Overall Study|Lost to Follow-up|2
164553|NCT00565604|580206|P1|Overall Study|Failure to treat|2
164554|NCT00565448|580234|P2|Overall Study|Withdrawal by Subject|0
164555|NCT00565448|580235|P1|Overall Study|Withdrawal by Subject|1
164556|NCT00565448|580234|P2|Overall Study|Disease progression|0
164557|NCT00565448|580235|P1|Overall Study|Disease progression|1
164558|NCT00565448|580234|P2|Overall Study|Adverse Event|2
164559|NCT00565448|580235|P1|Overall Study|Adverse Event|1
164560|NCT00565409|580246|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
164561|NCT00565409|580247|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
164562|NCT00565409|580248|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
164563|NCT00565409|580249|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
164564|NCT00565409|580246|P4|Period 2 Double-Blind|Other|9
164565|NCT00565409|580247|P3|Period 2 Double-Blind|Other|5
164566|NCT00565409|580248|P2|Period 2 Double-Blind|Other|4
164567|NCT00565409|580249|P1|Period 2 Double-Blind|Other|0
164568|NCT00565409|580246|P4|Period 2 Double-Blind|Lost to Follow-up|0
164569|NCT00565409|580247|P3|Period 2 Double-Blind|Lost to Follow-up|1
164570|NCT00565409|580248|P2|Period 2 Double-Blind|Lost to Follow-up|0
164571|NCT00565409|580249|P1|Period 2 Double-Blind|Lost to Follow-up|0
164572|NCT00565409|580246|P4|Period 2 Double-Blind|Protocol Violation|2
164573|NCT00565409|580247|P3|Period 2 Double-Blind|Protocol Violation|6
164574|NCT00565409|580248|P2|Period 2 Double-Blind|Protocol Violation|4
164575|NCT00565409|580249|P1|Period 2 Double-Blind|Protocol Violation|0
164576|NCT00565409|580246|P4|Period 2 Double-Blind|Death|0
164577|NCT00565409|580247|P3|Period 2 Double-Blind|Death|0
164578|NCT00565409|580248|P2|Period 2 Double-Blind|Death|2
164579|NCT00565409|580249|P1|Period 2 Double-Blind|Death|0
164580|NCT00565409|580246|P4|Period 2 Double-Blind|Adverse Event|5
164581|NCT00565409|580247|P3|Period 2 Double-Blind|Adverse Event|4
164582|NCT00565409|580248|P2|Period 2 Double-Blind|Adverse Event|7
164583|NCT00565409|580249|P1|Period 2 Double-Blind|Adverse Event|0
164584|NCT00565409|580246|P4|After Period 1, Prior to Period 2|did not meet criteria|0
164585|NCT00565409|580247|P3|After Period 1, Prior to Period 2|did not meet criteria|0
164586|NCT00565409|580248|P2|After Period 1, Prior to Period 2|did not meet criteria|0
164587|NCT00565409|580249|P1|After Period 1, Prior to Period 2|did not meet criteria|152
164588|NCT00565409|580246|P4|Period 1 Open Label|no conclusion of participation record|0
164589|NCT00565409|580247|P3|Period 1 Open Label|no conclusion of participation record|0
164590|NCT00565409|580248|P2|Period 1 Open Label|no conclusion of participation record|0
164591|NCT00565409|580249|P1|Period 1 Open Label|no conclusion of participation record|1
164592|NCT00565409|580246|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
164593|NCT00565409|580247|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
164594|NCT00565409|580248|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
164595|NCT00565409|580249|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
164596|NCT00565409|580246|P4|Period 1 Open Label|Protocol Violation|0
164597|NCT00565409|580247|P3|Period 1 Open Label|Protocol Violation|0
164598|NCT00565409|580248|P2|Period 1 Open Label|Protocol Violation|0
164599|NCT00565409|580249|P1|Period 1 Open Label|Protocol Violation|14
164600|NCT00565409|580246|P4|Period 1 Open Label|Other|0
164601|NCT00565409|580247|P3|Period 1 Open Label|Other|0
164602|NCT00565409|580248|P2|Period 1 Open Label|Other|0
164603|NCT00565409|580249|P1|Period 1 Open Label|Other|21
164604|NCT00565409|580246|P4|Period 1 Open Label|Lost to Follow-up|0
164605|NCT00565409|580247|P3|Period 1 Open Label|Lost to Follow-up|0
164606|NCT00565409|580248|P2|Period 1 Open Label|Lost to Follow-up|0
164607|NCT00565409|580249|P1|Period 1 Open Label|Lost to Follow-up|1
164608|NCT00565409|580246|P4|Period 1 Open Label|Death|0
164609|NCT00565409|580247|P3|Period 1 Open Label|Death|0
164610|NCT00565409|580248|P2|Period 1 Open Label|Death|0
164611|NCT00565409|580249|P1|Period 1 Open Label|Death|2
164612|NCT00565409|580246|P4|Period 1 Open Label|Adverse Event|0
164613|NCT00565409|580247|P3|Period 1 Open Label|Adverse Event|0
164614|NCT00565409|580248|P2|Period 1 Open Label|Adverse Event|0
164615|NCT00565409|580249|P1|Period 1 Open Label|Adverse Event|17
164616|NCT00565136|580385|P1|Overall Study|Protocol Violation|1
164617|NCT00565136|580385|P1|Overall Study|Withdrawal by Subject|1
164618|NCT00565136|580385|P1|Overall Study|Lost to Follow-up|1
164619|NCT00565058|580426|P2|Overall Study|Adverse Event|0
164620|NCT00565058|580427|P1|Overall Study|Adverse Event|1
164621|NCT00564902|580474|P3|Overall Study|Death|0
164622|NCT00564902|580475|P2|Overall Study|Death|1
164623|NCT00564902|580476|P1|Overall Study|Death|1
164624|NCT00564902|580474|P3|Overall Study|Withdrawal by Subject|4
164625|NCT00564902|580475|P2|Overall Study|Withdrawal by Subject|3
164626|NCT00564902|580476|P1|Overall Study|Withdrawal by Subject|0
164627|NCT00564889|580508|P1|Overall Study|Other, not specified|4
164628|NCT00564889|580508|P1|Overall Study|Disease progression|3
164629|NCT00564889|580508|P1|Overall Study|Alternative treatment|3
164630|NCT00564889|580508|P1|Overall Study|Adverse Event|12
164631|NCT00564889|580508|P1|Overall Study|Death|7
164632|NCT00564850|580523|P1|Overall Study|Protocol Violation|2
164633|NCT00564733|580541|P1|Overall Study|Ineligible|5
164634|NCT00564733|580541|P1|Overall Study|Withdrawal by Subject|4
164635|NCT00564629|580575|P2|Overall Study|Vomited within 2 hours of receiving drug|9
164636|NCT00564629|580576|P1|Overall Study|Vomited within 2 hours of receiving drug|15
164637|NCT00564486|580601|P4|Overall Study|Lost to Follow-up|2
164638|NCT00564486|580602|P3|Overall Study|Lost to Follow-up|2
164639|NCT00564486|580603|P2|Overall Study|Lost to Follow-up|0
164640|NCT00564486|580604|P1|Overall Study|Lost to Follow-up|3
164641|NCT00564486|580601|P4|Overall Study|Subject refused to have blood drawn|0
164642|NCT00564486|580602|P3|Overall Study|Subject refused to have blood drawn|1
164643|NCT00564486|580603|P2|Overall Study|Subject refused to have blood drawn|0
164644|NCT00564486|580604|P1|Overall Study|Subject refused to have blood drawn|0
164645|NCT00564486|580601|P4|Overall Study|Withdrawal by Subject|5
164646|NCT00564486|580602|P3|Overall Study|Withdrawal by Subject|0
164647|NCT00564486|580603|P2|Overall Study|Withdrawal by Subject|0
164648|NCT00564486|580604|P1|Overall Study|Withdrawal by Subject|4
164649|NCT00564486|580601|P4|Overall Study|Adverse Event|0
164650|NCT00564486|580602|P3|Overall Study|Adverse Event|0
164651|NCT00564486|580603|P2|Overall Study|Adverse Event|1
164652|NCT00564486|580604|P1|Overall Study|Adverse Event|0
164653|NCT00564278|580655|P2|Overall Study|Withdrawal by Subject|7
164654|NCT00564278|580656|P1|Overall Study|Withdrawal by Subject|11
164655|NCT00564278|580655|P2|Overall Study|Physician Decision|2
164656|NCT00564278|580656|P1|Overall Study|Physician Decision|1
164657|NCT00564278|580655|P2|Overall Study|Lost to Follow-up|33
164658|NCT00564278|580656|P1|Overall Study|Lost to Follow-up|35
164659|NCT00564070|580678|P2|Overall Study|Worsening depression, referred to care|0
164660|NCT00564070|580679|P1|Overall Study|Worsening depression, referred to care|3
164661|NCT00564070|580678|P2|Overall Study|Lost to Follow-up|7
164662|NCT00564070|580679|P1|Overall Study|Lost to Follow-up|9
164663|NCT00563797|580705|P2|Overall Study|Lost to Follow-up|2
164664|NCT00563797|580706|P1|Overall Study|Lost to Follow-up|7
164665|NCT00563706|580727|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
164666|NCT00563706|580728|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
164667|NCT00563706|580729|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
164668|NCT00563706|580730|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
164669|NCT00563706|580731|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
164670|NCT00563706|580732|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
164671|NCT00563706|580733|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
164672|NCT00563706|580734|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
164673|NCT00563706|580735|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
164674|NCT00563706|580727|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
164675|NCT00563706|580728|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
164676|NCT00563706|580729|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
164677|NCT00563706|580730|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
164678|NCT00563706|580731|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
164679|NCT00563706|580732|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
164680|NCT00563706|580733|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
164681|NCT00563706|580734|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
164682|NCT00563706|580735|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
164683|NCT00563706|580727|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
164684|NCT00563706|580728|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
164685|NCT00563706|580729|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
164686|NCT00563706|580730|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
164687|NCT00563706|580731|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
164688|NCT00563706|580732|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
164689|NCT00563706|580733|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
164690|NCT00563706|580734|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
164691|NCT00563706|580735|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
164692|NCT00563706|580727|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
164693|NCT00563706|580728|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
164694|NCT00563706|580729|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
164695|NCT00563706|580730|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
164696|NCT00563706|580731|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
164697|NCT00563706|580732|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
164698|NCT00563706|580733|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
164699|NCT00563706|580734|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
164700|NCT00563706|580735|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
164701|NCT00563706|580727|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
164702|NCT00563706|580728|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
164703|NCT00563706|580729|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
164704|NCT00563706|580730|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
164705|NCT00563706|580731|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
164706|NCT00563706|580732|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
164707|NCT00563706|580733|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
164708|NCT00563706|580734|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
164709|NCT00563706|580735|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
164710|NCT00563381|580851|P2|Overall Study|Individual different reasons|34
164711|NCT00563381|580852|P1|Overall Study|Individual different reasons|24
164712|NCT00563381|580851|P2|Overall Study|Lack of Efficacy|24
164713|NCT00563381|580852|P1|Overall Study|Lack of Efficacy|32
164714|NCT00563381|580851|P2|Overall Study|Withdrawal by Subject|209
164715|NCT00563381|580852|P1|Overall Study|Withdrawal by Subject|192
164716|NCT00563381|580851|P2|Overall Study|Lost to Follow-up|15
164717|NCT00563381|580852|P1|Overall Study|Lost to Follow-up|7
164718|NCT00563381|580851|P2|Overall Study|Protocol Violation|74
164719|NCT00563381|580852|P1|Overall Study|Protocol Violation|66
164720|NCT00563381|580851|P2|Overall Study|Adverse Event|292
164721|NCT00563381|580852|P1|Overall Study|Adverse Event|264
164722|NCT00563368|580925|P7|Overall Study|not specified|0
164723|NCT00563368|580926|P6|Overall Study|not specified|4
164724|NCT00563368|580927|P5|Overall Study|not specified|4
164725|NCT00563368|580928|P4|Overall Study|not specified|4
164726|NCT00563368|580929|P3|Overall Study|not specified|3
164727|NCT00563368|580930|P2|Overall Study|not specified|5
164728|NCT00563368|580931|P1|Overall Study|not specified|5
164729|NCT00563368|580925|P7|Overall Study|requirement for restricted medication|0
164730|NCT00563368|580926|P6|Overall Study|requirement for restricted medication|0
164731|NCT00563368|580927|P5|Overall Study|requirement for restricted medication|0
164732|NCT00563368|580928|P4|Overall Study|requirement for restricted medication|0
164733|NCT00563368|580929|P3|Overall Study|requirement for restricted medication|2
164734|NCT00563368|580930|P2|Overall Study|requirement for restricted medication|0
164735|NCT00563368|580931|P1|Overall Study|requirement for restricted medication|0
164736|NCT00563368|580925|P7|Overall Study|Pregnancy|0
164737|NCT00563368|580926|P6|Overall Study|Pregnancy|2
164738|NCT00563368|580927|P5|Overall Study|Pregnancy|1
164739|NCT00563368|580928|P4|Overall Study|Pregnancy|2
164740|NCT00563368|580929|P3|Overall Study|Pregnancy|1
164741|NCT00563368|580930|P2|Overall Study|Pregnancy|0
164742|NCT00563368|580931|P1|Overall Study|Pregnancy|1
164743|NCT00563368|580925|P7|Overall Study|protocol non-compliance|3
164744|NCT00563368|580926|P6|Overall Study|protocol non-compliance|1
164745|NCT00563368|580927|P5|Overall Study|protocol non-compliance|0
164746|NCT00563368|580928|P4|Overall Study|protocol non-compliance|1
164747|NCT00563368|580929|P3|Overall Study|protocol non-compliance|2
164748|NCT00563368|580930|P2|Overall Study|protocol non-compliance|1
164749|NCT00563368|580931|P1|Overall Study|protocol non-compliance|1
164750|NCT00563368|580925|P7|Overall Study|Withdrawal by Subject|4
164751|NCT00563368|580926|P6|Overall Study|Withdrawal by Subject|5
164752|NCT00563368|580927|P5|Overall Study|Withdrawal by Subject|8
164753|NCT00563368|580928|P4|Overall Study|Withdrawal by Subject|7
164754|NCT00563368|580929|P3|Overall Study|Withdrawal by Subject|5
164755|NCT00563368|580930|P2|Overall Study|Withdrawal by Subject|6
164756|NCT00563368|580931|P1|Overall Study|Withdrawal by Subject|11
164757|NCT00563368|580925|P7|Overall Study|Adverse Event|17
164758|NCT00563368|580926|P6|Overall Study|Adverse Event|10
164759|NCT00563368|580927|P5|Overall Study|Adverse Event|6
164760|NCT00563368|580928|P4|Overall Study|Adverse Event|9
164761|NCT00563368|580929|P3|Overall Study|Adverse Event|5
164762|NCT00563368|580930|P2|Overall Study|Adverse Event|4
164763|NCT00563368|580931|P1|Overall Study|Adverse Event|3
164764|NCT00563368|580925|P7|Overall Study|Lost to Follow-up|9
164765|NCT00563368|580926|P6|Overall Study|Lost to Follow-up|8
164766|NCT00563368|580927|P5|Overall Study|Lost to Follow-up|9
164767|NCT00563368|580928|P4|Overall Study|Lost to Follow-up|6
164768|NCT00563368|580929|P3|Overall Study|Lost to Follow-up|12
164769|NCT00563368|580930|P2|Overall Study|Lost to Follow-up|14
164770|NCT00563368|580931|P1|Overall Study|Lost to Follow-up|14
164771|NCT00563316|580954|P1|Overall Study|Other|1
164772|NCT00563316|580954|P1|Overall Study|On-going in study as of 16 July 2009.|5
164773|NCT00563316|580954|P1|Overall Study|Death|1
164774|NCT00563316|580954|P1|Overall Study|Lost to Follow-up|2
164775|NCT00563316|580954|P1|Overall Study|Physician Decision|1
164776|NCT00563316|580954|P1|Overall Study|Adverse Event|2
164777|NCT00562965|580979|P2|Overall Study|Other|1
164778|NCT00562965|580980|P1|Overall Study|Other|0
164779|NCT00562965|580979|P2|Overall Study|Lost to Follow-up|0
164780|NCT00562965|580980|P1|Overall Study|Lost to Follow-up|1
164781|NCT00562965|580979|P2|Overall Study|Death|4
164782|NCT00562965|580980|P1|Overall Study|Death|2
164783|NCT00562965|580979|P2|Overall Study|Withdrawal by Subject|1
164784|NCT00562965|580980|P1|Overall Study|Withdrawal by Subject|0
164785|NCT00562861|581001|P2|Overall Study|Lost to Follow-up|3
164786|NCT00562861|581002|P1|Overall Study|Lost to Follow-up|7
164787|NCT00562861|581001|P2|Overall Study|noncompliance, moved|2
164788|NCT00562861|581002|P1|Overall Study|noncompliance, moved|7
164789|NCT00562861|581001|P2|Overall Study|Lack of Efficacy|5
164790|NCT00562861|581002|P1|Overall Study|Lack of Efficacy|5
164791|NCT00562861|581001|P2|Overall Study|Adverse Event|1
164792|NCT00562861|581002|P1|Overall Study|Adverse Event|1
164793|NCT00562627|581011|P3|Overall Study|Protocol Violation|1
164794|NCT00562627|581012|P2|Overall Study|Protocol Violation|1
164795|NCT00562627|581013|P1|Overall Study|Protocol Violation|1
164796|NCT00562588|581029|P2|Overall Study|Other|2
164797|NCT00562588|581030|P1|Overall Study|Other|0
164798|NCT00562588|581029|P2|Overall Study|Withdrawal by Subject|9
164799|NCT00562588|581030|P1|Overall Study|Withdrawal by Subject|10
164800|NCT00562588|581029|P2|Overall Study|Lost to Follow-up|4
164801|NCT00562588|581030|P1|Overall Study|Lost to Follow-up|12
164802|NCT00562588|581029|P2|Overall Study|Protocol Violation|26
164803|NCT00562588|581030|P1|Overall Study|Protocol Violation|30
164804|NCT00562588|581029|P2|Overall Study|Adverse Event|58
164805|NCT00562588|581030|P1|Overall Study|Adverse Event|40
164806|NCT00562484|581060|P2|Overall Study|Reason not provided or not specified|12
164807|NCT00562484|581061|P1|Overall Study|Reason not provided or not specified|25
164808|NCT00562484|581060|P2|Overall Study|Lost to Follow-up|71
164809|NCT00562484|581061|P1|Overall Study|Lost to Follow-up|132
164810|NCT00562484|581060|P2|Overall Study|Moved away from the study area|9
164811|NCT00562484|581061|P1|Overall Study|Moved away from the study area|20
164812|NCT00562484|581060|P2|Overall Study|Withdrawal by Subject|9
164813|NCT00562484|581061|P1|Overall Study|Withdrawal by Subject|12
164814|NCT00562484|581060|P2|Overall Study|Protocol Violation|2
164815|NCT00562484|581061|P1|Overall Study|Protocol Violation|11
164816|NCT00562484|581060|P2|Overall Study|Adverse Event|1
164817|NCT00562484|581061|P1|Overall Study|Adverse Event|6
164818|NCT00562354|581093|P2|Overall Study|Lost to Follow-up|1
164819|NCT00562354|581094|P1|Overall Study|Lost to Follow-up|0
164820|NCT00562354|581093|P2|Overall Study|Physician Decision|1
164821|NCT00562354|581094|P1|Overall Study|Physician Decision|0
164822|NCT00562302|581156|P2|Overall Study|Not stated|4
164823|NCT00562302|581157|P1|Overall Study|Not stated|1
164824|NCT00562302|581156|P2|Overall Study|Lung resection prior to study completion|7
164825|NCT00562302|581157|P1|Overall Study|Lung resection prior to study completion|7
164826|NCT00562302|581156|P2|Overall Study|Death|2
164827|NCT00562302|581157|P1|Overall Study|Death|1
164828|NCT00562302|581156|P2|Overall Study|Withdrawal by Subject|8
164829|NCT00562302|581157|P1|Overall Study|Withdrawal by Subject|7
164830|NCT00562302|581156|P2|Overall Study|Non-compliance|2
164831|NCT00562302|581157|P1|Overall Study|Non-compliance|1
164832|NCT00562302|581156|P2|Overall Study|Adverse Event|6
164833|NCT00562302|581157|P1|Overall Study|Adverse Event|0
164834|NCT00562302|581156|P2|Overall Study|Lost to Follow-up|3
164835|NCT00562302|581157|P1|Overall Study|Lost to Follow-up|3
164836|NCT00562159|581179|P2|Overall Study|Did not meet protocol eligibility|1
164837|NCT00562159|581180|P1|Overall Study|Did not meet protocol eligibility|1
164838|NCT00562159|581179|P2|Overall Study|Protocol Violation|12
164839|NCT00562159|581180|P1|Overall Study|Protocol Violation|12
164840|NCT00562159|581179|P2|Overall Study|Withdrawal by Subject|8
164841|NCT00562159|581180|P1|Overall Study|Withdrawal by Subject|9
164842|NCT00562159|581179|P2|Overall Study|Lost to Follow-up|4
164843|NCT00562159|581180|P1|Overall Study|Lost to Follow-up|5
164844|NCT00562159|581179|P2|Overall Study|Adverse Event|8
164845|NCT00562159|581180|P1|Overall Study|Adverse Event|11
164846|NCT00562120|581192|P4|First Intervention Period|Randomized but not Treated|0
164847|NCT00562120|581193|P3|First Intervention Period|Randomized but not Treated|0
164848|NCT00562120|581194|P2|First Intervention Period|Randomized but not Treated|0
164849|NCT00562120|581195|P1|First Intervention Period|Randomized but not Treated|1
164850|NCT00562120|581192|P4|First Intervention Period|Adverse Event|0
164851|NCT00562120|581193|P3|First Intervention Period|Adverse Event|0
164852|NCT00562120|581194|P2|First Intervention Period|Adverse Event|0
164853|NCT00562120|581195|P1|First Intervention Period|Adverse Event|1
164854|NCT00562094|581227|P1|Overall Study|Lost to Follow-up|62
164855|NCT00561977|581242|P3|Overall Study|Pregnancy|1
164856|NCT00561977|581243|P2|Overall Study|Pregnancy|1
164857|NCT00561977|581244|P1|Overall Study|Pregnancy|0
164858|NCT00561977|581242|P3|Overall Study|Withdrawal by Subject|1
164859|NCT00561977|581243|P2|Overall Study|Withdrawal by Subject|2
164860|NCT00561977|581244|P1|Overall Study|Withdrawal by Subject|0
164861|NCT00561951|581270|P3|Overall Study|Adverse Event Occured Before Treatment|1
164862|NCT00561951|581271|P2|Overall Study|Adverse Event Occured Before Treatment|2
164863|NCT00561951|581272|P1|Overall Study|Adverse Event Occured Before Treatment|1
164864|NCT00561951|581270|P3|Overall Study|Meet Withdrawal Criterion|1
164865|NCT00561951|581271|P2|Overall Study|Meet Withdrawal Criterion|1
164866|NCT00561951|581272|P1|Overall Study|Meet Withdrawal Criterion|0
164867|NCT00561951|581270|P3|Overall Study|Pregnancy|0
164868|NCT00561951|581271|P2|Overall Study|Pregnancy|1
164869|NCT00561951|581272|P1|Overall Study|Pregnancy|0
164870|NCT00561951|581270|P3|Overall Study|Physician Decision|0
164871|NCT00561951|581271|P2|Overall Study|Physician Decision|0
164872|NCT00561951|581272|P1|Overall Study|Physician Decision|1
164873|NCT00561951|581270|P3|Overall Study|Protocol Violation|4
164874|NCT00561951|581271|P2|Overall Study|Protocol Violation|3
164875|NCT00561951|581272|P1|Overall Study|Protocol Violation|4
164876|NCT00561951|581270|P3|Overall Study|Withdrawal by Subject|10
164877|NCT00561951|581271|P2|Overall Study|Withdrawal by Subject|9
164878|NCT00561951|581272|P1|Overall Study|Withdrawal by Subject|10
164879|NCT00561951|581270|P3|Overall Study|Lost to Follow-up|0
164880|NCT00561951|581271|P2|Overall Study|Lost to Follow-up|1
164881|NCT00561951|581272|P1|Overall Study|Lost to Follow-up|1
164882|NCT00561951|581270|P3|Overall Study|Lack of Efficacy|2
164883|NCT00561951|581271|P2|Overall Study|Lack of Efficacy|3
164884|NCT00561951|581272|P1|Overall Study|Lack of Efficacy|5
164885|NCT00561951|581270|P3|Overall Study|Adverse Event|14
164886|NCT00561951|581271|P2|Overall Study|Adverse Event|14
164887|NCT00561951|581272|P1|Overall Study|Adverse Event|11
164888|NCT00561925|581328|P5|Open-Label Extension Period|Declined entry into extension period|50
164889|NCT00561925|581329|P4|Open-Label Extension Period|Declined entry into extension period|43
164890|NCT00561925|581330|P3|Open-Label Extension Period|Declined entry into extension period|0
164891|NCT00561925|581331|P2|Open-Label Extension Period|Declined entry into extension period|0
164892|NCT00561925|581332|P1|Open-Label Extension Period|Declined entry into extension period|0
164893|NCT00561925|581328|P5|144-week Double-blind, Double-dummy|Other|0
164894|NCT00561925|581329|P4|144-week Double-blind, Double-dummy|Other|0
164895|NCT00561925|581330|P3|144-week Double-blind, Double-dummy|Other|11
164896|NCT00561925|581331|P2|144-week Double-blind, Double-dummy|Other|8
164897|NCT00561925|581332|P1|144-week Double-blind, Double-dummy|Other|0
164898|NCT00561925|581328|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
164899|NCT00561925|581329|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
164900|NCT00561925|581330|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
164901|NCT00561925|581331|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
164902|NCT00561925|581332|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
164903|NCT00561925|581328|P5|144-week Double-blind, Double-dummy|Death|0
164904|NCT00561925|581329|P4|144-week Double-blind, Double-dummy|Death|0
164905|NCT00561925|581330|P3|144-week Double-blind, Double-dummy|Death|3
164906|NCT00561925|581331|P2|144-week Double-blind, Double-dummy|Death|6
164907|NCT00561925|581332|P1|144-week Double-blind, Double-dummy|Death|0
164908|NCT00561925|581328|P5|144-week Double-blind, Double-dummy|Pregnancy|0
164909|NCT00561925|581329|P4|144-week Double-blind, Double-dummy|Pregnancy|0
164910|NCT00561925|581330|P3|144-week Double-blind, Double-dummy|Pregnancy|9
164911|NCT00561925|581331|P2|144-week Double-blind, Double-dummy|Pregnancy|1
164912|NCT00561925|581332|P1|144-week Double-blind, Double-dummy|Pregnancy|0
164913|NCT00561925|581328|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
164914|NCT00561925|581329|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
164915|NCT00561925|581330|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
164916|NCT00561925|581331|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
164917|NCT00561925|581332|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
164918|NCT00561925|581328|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
164919|NCT00561925|581329|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
164920|NCT00561925|581330|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
164921|NCT00561925|581331|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
164922|NCT00561925|581332|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
164923|NCT00561925|581328|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
164924|NCT00561925|581329|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
164925|NCT00561925|581330|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
164926|NCT00561925|581331|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
164927|NCT00561925|581332|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
164928|NCT00561925|581328|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
164929|NCT00561925|581329|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
164930|NCT00561925|581330|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
164931|NCT00561925|581331|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
164932|NCT00561925|581332|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
164933|NCT00561925|581328|P5|144-week Double-blind, Double-dummy|Adverse Event|0
164934|NCT00561925|581329|P4|144-week Double-blind, Double-dummy|Adverse Event|0
164935|NCT00561925|581330|P3|144-week Double-blind, Double-dummy|Adverse Event|43
164936|NCT00561925|581331|P2|144-week Double-blind, Double-dummy|Adverse Event|48
164937|NCT00561925|581332|P1|144-week Double-blind, Double-dummy|Adverse Event|0
164938|NCT00561925|581328|P5|14 Day Lead-In Period|Other|0
164939|NCT00561925|581329|P4|14 Day Lead-In Period|Other|0
164940|NCT00561925|581330|P3|14 Day Lead-In Period|Other|0
164941|NCT00561925|581331|P2|14 Day Lead-In Period|Other|0
164942|NCT00561925|581332|P1|14 Day Lead-In Period|Other|5
164943|NCT00561925|581328|P5|14 Day Lead-In Period|Withdrawal by Subject|0
164944|NCT00561925|581329|P4|14 Day Lead-In Period|Withdrawal by Subject|0
164945|NCT00561925|581330|P3|14 Day Lead-In Period|Withdrawal by Subject|0
164946|NCT00561925|581331|P2|14 Day Lead-In Period|Withdrawal by Subject|0
164947|NCT00561925|581332|P1|14 Day Lead-In Period|Withdrawal by Subject|4
164948|NCT00561925|581328|P5|14 Day Lead-In Period|Lost to Follow-up|0
164949|NCT00561925|581329|P4|14 Day Lead-In Period|Lost to Follow-up|0
164950|NCT00561925|581330|P3|14 Day Lead-In Period|Lost to Follow-up|0
164951|NCT00561925|581331|P2|14 Day Lead-In Period|Lost to Follow-up|0
164952|NCT00561925|581332|P1|14 Day Lead-In Period|Lost to Follow-up|4
164953|NCT00561925|581328|P5|14 Day Lead-In Period|In/Exclusion criteria|0
164954|NCT00561925|581329|P4|14 Day Lead-In Period|In/Exclusion criteria|0
164955|NCT00561925|581330|P3|14 Day Lead-In Period|In/Exclusion criteria|0
164956|NCT00561925|581331|P2|14 Day Lead-In Period|In/Exclusion criteria|0
164957|NCT00561925|581332|P1|14 Day Lead-In Period|In/Exclusion criteria|4
164958|NCT00561925|581328|P5|14 Day Lead-In Period|Adverse Event|0
164959|NCT00561925|581329|P4|14 Day Lead-In Period|Adverse Event|0
164960|NCT00561925|581330|P3|14 Day Lead-In Period|Adverse Event|0
164961|NCT00561925|581331|P2|14 Day Lead-In Period|Adverse Event|0
164962|NCT00561925|581332|P1|14 Day Lead-In Period|Adverse Event|38
164963|NCT00561912|581381|P1|Overall Study|ineligible|1
164964|NCT00561821|581393|P4|Overall Study|Adverse Event|1
164965|NCT00561821|581394|P3|Overall Study|Adverse Event|1
164966|NCT00561821|581395|P2|Overall Study|Adverse Event|3
164967|NCT00561821|581396|P1|Overall Study|Adverse Event|2
164968|NCT00561821|581393|P4|Overall Study|Other (reason not specified)|0
164969|NCT00561821|581394|P3|Overall Study|Other (reason not specified)|0
164970|NCT00561821|581395|P2|Overall Study|Other (reason not specified)|1
164971|NCT00561821|581396|P1|Overall Study|Other (reason not specified)|1
164972|NCT00561821|581393|P4|Overall Study|Reasons not related to trial|0
164973|NCT00561821|581394|P3|Overall Study|Reasons not related to trial|0
164974|NCT00561821|581395|P2|Overall Study|Reasons not related to trial|1
164975|NCT00561821|581396|P1|Overall Study|Reasons not related to trial|2
164976|NCT00561821|581393|P4|Overall Study|Withdrawal by Subject|2
164977|NCT00561821|581394|P3|Overall Study|Withdrawal by Subject|0
164978|NCT00561821|581395|P2|Overall Study|Withdrawal by Subject|1
164979|NCT00561821|581396|P1|Overall Study|Withdrawal by Subject|0
164980|NCT00561821|581393|P4|Overall Study|Not treated|0
164981|NCT00561821|581394|P3|Overall Study|Not treated|1
164982|NCT00561821|581395|P2|Overall Study|Not treated|0
164983|NCT00561821|581396|P1|Overall Study|Not treated|0
164984|NCT00561795|581472|P4|Overall Study|Physician Decision|0
164985|NCT00561795|581473|P3|Overall Study|Physician Decision|0
164986|NCT00561795|581474|P2|Overall Study|Physician Decision|0
164987|NCT00561795|581475|P1|Overall Study|Physician Decision|1
164988|NCT00561795|581472|P4|Overall Study|Study Closed/Terminated|0
164989|NCT00561795|581473|P3|Overall Study|Study Closed/Terminated|0
164990|NCT00561795|581474|P2|Overall Study|Study Closed/Terminated|3
164991|NCT00561795|581475|P1|Overall Study|Study Closed/Terminated|0
164992|NCT00561795|581472|P4|Overall Study|Adverse Event|0
164993|NCT00561795|581473|P3|Overall Study|Adverse Event|0
164994|NCT00561795|581474|P2|Overall Study|Adverse Event|3
164995|NCT00561795|581475|P1|Overall Study|Adverse Event|3
164996|NCT00561730|581495|P1|Overall Study|Not specified reasons|1
164997|NCT00561730|581495|P1|Overall Study|Lost to Follow-up|5
164998|NCT00561730|581495|P1|Overall Study|Handling of the drug|1
164999|NCT00561730|581495|P1|Overall Study|Adverse Event|2
165000|NCT00561678|581511|P2|Overall Study|anesthesia provider refusal|0
165001|NCT00561678|581512|P1|Overall Study|anesthesia provider refusal|1
165002|NCT00561678|581511|P2|Overall Study|surgery rescheduled to different site|2
165003|NCT00561678|581512|P1|Overall Study|surgery rescheduled to different site|2
165004|NCT00561678|581511|P2|Overall Study|surgery cancelled|1
165005|NCT00561678|581512|P1|Overall Study|surgery cancelled|1
165006|NCT00561678|581511|P2|Overall Study|Withdrawal by Subject|3
165007|NCT00561678|581512|P1|Overall Study|Withdrawal by Subject|4
165008|NCT00561652|581530|P2|Overall Study|Withdrawal by Subject|1
165009|NCT00561652|581531|P1|Overall Study|Withdrawal by Subject|0
165010|NCT00561574|581614|P2|Overall Study|Other|7
165011|NCT00561574|581615|P1|Overall Study|Other|5
165012|NCT00561574|581614|P2|Overall Study|Lost to Follow-up|0
165013|NCT00561574|581615|P1|Overall Study|Lost to Follow-up|1
165014|NCT00561574|581614|P2|Overall Study|Reason Unrelated to Trial|2
165015|NCT00561574|581615|P1|Overall Study|Reason Unrelated to Trial|6
165016|NCT00561574|581614|P2|Overall Study|Withdrawal by Subject|4
165017|NCT00561574|581615|P1|Overall Study|Withdrawal by Subject|4
165018|NCT00561574|581614|P2|Overall Study|Lack of Efficacy|21
165019|NCT00561574|581615|P1|Overall Study|Lack of Efficacy|11
165020|NCT00561574|581614|P2|Overall Study|Adverse Event|24
165021|NCT00561574|581615|P1|Overall Study|Adverse Event|21
165022|NCT00561470|581641|P2|Overall Study|Ongoing Treatment|14
165023|NCT00561470|581642|P1|Overall Study|Ongoing Treatment|11
165024|NCT00561470|581641|P2|Overall Study|Planning surgery|1
165025|NCT00561470|581642|P1|Overall Study|Planning surgery|1
165026|NCT00561470|581641|P2|Overall Study|Missed visit window|4
165027|NCT00561470|581642|P1|Overall Study|Missed visit window|1
165028|NCT00561470|581641|P2|Overall Study|Randomized but not treated|5
165029|NCT00561470|581642|P1|Overall Study|Randomized but not treated|5
165030|NCT00561470|581641|P2|Overall Study|Unauthorized procedure|1
165031|NCT00561470|581642|P1|Overall Study|Unauthorized procedure|3
165032|NCT00561470|581641|P2|Overall Study|Metastatic surgery|12
165033|NCT00561470|581642|P1|Overall Study|Metastatic surgery|10
165034|NCT00561470|581641|P2|Overall Study|Subject request|77
165035|NCT00561470|581642|P1|Overall Study|Subject request|43
165036|NCT00561470|581641|P2|Overall Study|Consent Withdrawn|6
165037|NCT00561470|581642|P1|Overall Study|Consent Withdrawn|2
165038|NCT00561470|581641|P2|Overall Study|Physician Decision|20
165039|NCT00561470|581642|P1|Overall Study|Physician Decision|21
165040|NCT00561470|581641|P2|Overall Study|Lost to Follow-up|0
165041|NCT00561470|581642|P1|Overall Study|Lost to Follow-up|2
165042|NCT00561470|581641|P2|Overall Study|poor compliance to protocol|4
165043|NCT00561470|581642|P1|Overall Study|poor compliance to protocol|4
165044|NCT00561470|581641|P2|Overall Study|Disease progression|305
165045|NCT00561470|581642|P1|Overall Study|Disease progression|437
165046|NCT00561470|581641|P2|Overall Study|Adverse Event|163
165047|NCT00561470|581642|P1|Overall Study|Adverse Event|74
165048|NCT00561392|581678|P1|Overall Study|Administrative problems|4
165049|NCT00561392|581678|P1|Overall Study|Withdrawal by Subject|8
165050|NCT00561392|581678|P1|Overall Study|Protocol Violation|1
165051|NCT00561392|581678|P1|Overall Study|Lack of Efficacy|2
165052|NCT00561392|581678|P1|Overall Study|Adverse Event|38
165053|NCT00561353|581700|P10|Overall Study|Withdrawal by Subject|0
165054|NCT00561353|581701|P9|Overall Study|Withdrawal by Subject|0
165055|NCT00561353|581702|P8|Overall Study|Withdrawal by Subject|0
165056|NCT00561353|581703|P7|Overall Study|Withdrawal by Subject|0
165057|NCT00561353|581704|P6|Overall Study|Withdrawal by Subject|0
165058|NCT00561353|581705|P5|Overall Study|Withdrawal by Subject|0
165059|NCT00561353|581706|P4|Overall Study|Withdrawal by Subject|0
165060|NCT00561353|581707|P3|Overall Study|Withdrawal by Subject|0
165061|NCT00561353|581708|P2|Overall Study|Withdrawal by Subject|2
165062|NCT00561353|581709|P1|Overall Study|Withdrawal by Subject|0
165063|NCT00561353|581700|P10|Overall Study|Lost to Follow-up|0
165064|NCT00561353|581701|P9|Overall Study|Lost to Follow-up|0
165065|NCT00561353|581702|P8|Overall Study|Lost to Follow-up|0
165066|NCT00561353|581703|P7|Overall Study|Lost to Follow-up|0
165067|NCT00561353|581704|P6|Overall Study|Lost to Follow-up|0
165068|NCT00561353|581705|P5|Overall Study|Lost to Follow-up|0
165069|NCT00561353|581706|P4|Overall Study|Lost to Follow-up|0
165070|NCT00561353|581707|P3|Overall Study|Lost to Follow-up|1
165071|NCT00561353|581708|P2|Overall Study|Lost to Follow-up|0
165072|NCT00561353|581709|P1|Overall Study|Lost to Follow-up|2
165073|NCT00561353|581700|P10|Overall Study|Adverse Event|1
165074|NCT00561353|581701|P9|Overall Study|Adverse Event|0
165075|NCT00561353|581702|P8|Overall Study|Adverse Event|0
165076|NCT00561353|581703|P7|Overall Study|Adverse Event|1
165077|NCT00561353|581704|P6|Overall Study|Adverse Event|0
165078|NCT00561353|581705|P5|Overall Study|Adverse Event|0
165079|NCT00561353|581706|P4|Overall Study|Adverse Event|2
165080|NCT00561353|581707|P3|Overall Study|Adverse Event|0
165081|NCT00561353|581708|P2|Overall Study|Adverse Event|0
165082|NCT00561353|581709|P1|Overall Study|Adverse Event|0
165083|NCT00561353|581700|P10|Overall Study|Not specified|0
165084|NCT00561353|581701|P9|Overall Study|Not specified|0
165085|NCT00561353|581702|P8|Overall Study|Not specified|0
165086|NCT00561353|581703|P7|Overall Study|Not specified|0
165087|NCT00561353|581704|P6|Overall Study|Not specified|2
165088|NCT00561353|581705|P5|Overall Study|Not specified|0
165089|NCT00561353|581706|P4|Overall Study|Not specified|0
165090|NCT00561353|581707|P3|Overall Study|Not specified|1
165091|NCT00561353|581708|P2|Overall Study|Not specified|0
165092|NCT00561353|581709|P1|Overall Study|Not specified|1
165093|NCT00561353|581700|P10|Overall Study|Subject ineligible to continue the trial|1
165094|NCT00561353|581701|P9|Overall Study|Subject ineligible to continue the trial|2
165095|NCT00561353|581702|P8|Overall Study|Subject ineligible to continue the trial|0
165096|NCT00561353|581703|P7|Overall Study|Subject ineligible to continue the trial|1
165097|NCT00561353|581704|P6|Overall Study|Subject ineligible to continue the trial|1
165098|NCT00561353|581705|P5|Overall Study|Subject ineligible to continue the trial|0
165099|NCT00561353|581706|P4|Overall Study|Subject ineligible to continue the trial|0
165100|NCT00561353|581707|P3|Overall Study|Subject ineligible to continue the trial|0
165101|NCT00561353|581708|P2|Overall Study|Subject ineligible to continue the trial|0
165102|NCT00561353|581709|P1|Overall Study|Subject ineligible to continue the trial|0
165103|NCT00561353|581700|P10|Overall Study|Subject reached a virologic endpoint|0
165104|NCT00561353|581701|P9|Overall Study|Subject reached a virologic endpoint|5
165105|NCT00561353|581702|P8|Overall Study|Subject reached a virologic endpoint|4
165106|NCT00561353|581703|P7|Overall Study|Subject reached a virologic endpoint|4
165107|NCT00561353|581704|P6|Overall Study|Subject reached a virologic endpoint|3
165108|NCT00561353|581705|P5|Overall Study|Subject reached a virologic endpoint|1
165109|NCT00561353|581706|P4|Overall Study|Subject reached a virologic endpoint|4
165110|NCT00561353|581707|P3|Overall Study|Subject reached a virologic endpoint|1
165111|NCT00561353|581708|P2|Overall Study|Subject reached a virologic endpoint|1
165112|NCT00561353|581709|P1|Overall Study|Subject reached a virologic endpoint|2
165113|NCT00561340|581864|P2|Overall Study|refused to drink pediasure|0
165114|NCT00561340|581865|P1|Overall Study|refused to drink pediasure|6
165115|NCT00561080|581885|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
165116|NCT00561080|581886|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
165117|NCT00561080|581887|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
165118|NCT00561080|581885|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
165119|NCT00561080|581886|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
165120|NCT00561080|581887|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
165121|NCT00561080|581885|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
165122|NCT00561080|581886|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
165123|NCT00561080|581887|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
165124|NCT00561080|581885|P3|12-month Post Last Dose Follow-up|Adverse Event|1
165125|NCT00561080|581886|P2|12-month Post Last Dose Follow-up|Adverse Event|3
165126|NCT00561080|581887|P1|12-month Post Last Dose Follow-up|Adverse Event|3
165127|NCT00561080|581885|P3|Vaccination Period (up to Month 4)|Other|1
165128|NCT00561080|581886|P2|Vaccination Period (up to Month 4)|Other|2
165129|NCT00561080|581887|P1|Vaccination Period (up to Month 4)|Other|0
165130|NCT00561080|581885|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
165131|NCT00561080|581886|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
165132|NCT00561080|581887|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
165133|NCT00561080|581885|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
165134|NCT00561080|581886|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
165135|NCT00561080|581887|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
165136|NCT00561080|581885|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
165137|NCT00561080|581886|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
165138|NCT00561080|581887|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
165139|NCT00561080|581885|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
165140|NCT00561080|581886|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
165141|NCT00561080|581887|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
165142|NCT00561080|581885|P3|Vaccination Period (up to Month 4)|Adverse Event|6
165143|NCT00561080|581886|P2|Vaccination Period (up to Month 4)|Adverse Event|4
165144|NCT00561080|581887|P1|Vaccination Period (up to Month 4)|Adverse Event|0
165145|NCT00561015|581964|P6|Overall Study|Participant non-compliance|0
165146|NCT00561015|581965|P5|Overall Study|Participant non-compliance|0
165147|NCT00561015|581966|P4|Overall Study|Participant non-compliance|0
165148|NCT00561015|581967|P3|Overall Study|Participant non-compliance|0
165149|NCT00561015|581968|P2|Overall Study|Participant non-compliance|0
165150|NCT00561015|581969|P1|Overall Study|Participant non-compliance|2
165151|NCT00561015|581964|P6|Overall Study|Lost to Follow-up|3
165152|NCT00561015|581965|P5|Overall Study|Lost to Follow-up|0
165153|NCT00561015|581966|P4|Overall Study|Lost to Follow-up|1
165154|NCT00561015|581967|P3|Overall Study|Lost to Follow-up|0
165155|NCT00561015|581968|P2|Overall Study|Lost to Follow-up|0
165156|NCT00561015|581969|P1|Overall Study|Lost to Follow-up|2
165157|NCT00561015|581964|P6|Overall Study|Adverse Event|0
165158|NCT00561015|581965|P5|Overall Study|Adverse Event|1
165159|NCT00561015|581966|P4|Overall Study|Adverse Event|0
165160|NCT00561015|581967|P3|Overall Study|Adverse Event|0
165161|NCT00561015|581968|P2|Overall Study|Adverse Event|0
165162|NCT00561015|581969|P1|Overall Study|Adverse Event|0
165163|NCT00560950|582060|P2|Overall Study|Lost to Follow-up|0
165164|NCT00560950|582061|P1|Overall Study|Lost to Follow-up|1
165165|NCT00560937|582099|P2|Overall Study|Physician Decision|1
165166|NCT00560937|582100|P1|Overall Study|Physician Decision|1
165167|NCT00560937|582099|P2|Overall Study|Withdrawal by Subject|1
165168|NCT00560937|582100|P1|Overall Study|Withdrawal by Subject|0
165169|NCT00560885|582116|P1|Overall Study|Withdrawal by Subject|1
165170|NCT00560885|582116|P1|Overall Study|Death|7
165171|NCT00560833|582141|P5|Overall Study|Never received drug|1
165172|NCT00560833|582142|P4|Overall Study|Never received drug|0
165173|NCT00560833|582143|P3|Overall Study|Never received drug|0
165174|NCT00560833|582144|P2|Overall Study|Never received drug|1
165175|NCT00560833|582145|P1|Overall Study|Never received drug|0
165176|NCT00560833|582141|P5|Overall Study|Other|0
165177|NCT00560833|582142|P4|Overall Study|Other|0
165178|NCT00560833|582143|P3|Overall Study|Other|3
165179|NCT00560833|582144|P2|Overall Study|Other|1
165180|NCT00560833|582145|P1|Overall Study|Other|1
165181|NCT00560833|582141|P5|Overall Study|Participant uncooperative|2
165182|NCT00560833|582142|P4|Overall Study|Participant uncooperative|4
165183|NCT00560833|582143|P3|Overall Study|Participant uncooperative|4
165184|NCT00560833|582144|P2|Overall Study|Participant uncooperative|5
165185|NCT00560833|582145|P1|Overall Study|Participant uncooperative|5
165186|NCT00560833|582141|P5|Overall Study|Lack of Efficacy|4
165187|NCT00560833|582142|P4|Overall Study|Lack of Efficacy|4
165188|NCT00560833|582143|P3|Overall Study|Lack of Efficacy|6
165189|NCT00560833|582144|P2|Overall Study|Lack of Efficacy|9
165190|NCT00560833|582145|P1|Overall Study|Lack of Efficacy|22
165191|NCT00560833|582141|P5|Overall Study|Lost to Follow-up|0
165192|NCT00560833|582142|P4|Overall Study|Lost to Follow-up|0
165193|NCT00560833|582143|P3|Overall Study|Lost to Follow-up|1
165194|NCT00560833|582144|P2|Overall Study|Lost to Follow-up|0
165195|NCT00560833|582145|P1|Overall Study|Lost to Follow-up|0
165196|NCT00560833|582141|P5|Overall Study|Adverse Event|35
165197|NCT00560833|582142|P4|Overall Study|Adverse Event|23
165198|NCT00560833|582143|P3|Overall Study|Adverse Event|25
165199|NCT00560833|582144|P2|Overall Study|Adverse Event|10
165200|NCT00560833|582145|P1|Overall Study|Adverse Event|16
165201|NCT00560794|582177|P1|Overall Study|Received Bone Marrow Transplant|6
165202|NCT00560794|582177|P1|Overall Study|Hematological Relapse|1
165203|NCT00560794|582177|P1|Overall Study|Minimal Residual Disease Relapse|1
165204|NCT00560794|582177|P1|Overall Study|Patient was not Compliant|1
165205|NCT00560794|582177|P1|Overall Study|Adverse Event|2
165206|NCT00560755|582194|P1|Overall Study|Physician Decision|2
165207|NCT00560755|582194|P1|Overall Study|Adverse Event|8
165208|NCT00560755|582194|P1|Overall Study|Lost to Follow-up|9
165209|NCT00560755|582194|P1|Overall Study|Withdrawal by Subject|26
165210|NCT00560755|582194|P1|Overall Study|Protocol Violation|15
165211|NCT00560703|582215|P2|Overall Study|non-compliance|1
165212|NCT00560703|582216|P1|Overall Study|non-compliance|0
165213|NCT00560703|582215|P2|Overall Study|Withdrawal by Subject|1
165214|NCT00560703|582216|P1|Overall Study|Withdrawal by Subject|0
165215|NCT00560703|582215|P2|Overall Study|Protocol Violation|2
165216|NCT00560703|582216|P1|Overall Study|Protocol Violation|0
165217|NCT00560703|582215|P2|Overall Study|Adverse Event|2
165218|NCT00560703|582216|P1|Overall Study|Adverse Event|0
165219|NCT00560573|582233|P6|Overall Study|Enrolled, not treated|0
165220|NCT00560573|582234|P5|Overall Study|Enrolled, not treated|1
165221|NCT00560573|582235|P4|Overall Study|Enrolled, not treated|0
165222|NCT00560573|582236|P3|Overall Study|Enrolled, not treated|0
165223|NCT00560573|582237|P2|Overall Study|Enrolled, not treated|0
165224|NCT00560573|582238|P1|Overall Study|Enrolled, not treated|0
165225|NCT00560573|582233|P6|Overall Study|Other|3
165226|NCT00560573|582234|P5|Overall Study|Other|3
165227|NCT00560573|582235|P4|Overall Study|Other|3
165228|NCT00560573|582236|P3|Overall Study|Other|2
165229|NCT00560573|582237|P2|Overall Study|Other|2
165230|NCT00560573|582238|P1|Overall Study|Other|2
165231|NCT00560573|582233|P6|Overall Study|Withdrawal by Subject|0
165232|NCT00560573|582234|P5|Overall Study|Withdrawal by Subject|1
165233|NCT00560573|582235|P4|Overall Study|Withdrawal by Subject|1
165234|NCT00560573|582236|P3|Overall Study|Withdrawal by Subject|0
165235|NCT00560573|582237|P2|Overall Study|Withdrawal by Subject|0
165236|NCT00560573|582238|P1|Overall Study|Withdrawal by Subject|0
165237|NCT00560573|582233|P6|Overall Study|Lost to Follow-up|0
165238|NCT00560573|582234|P5|Overall Study|Lost to Follow-up|1
165239|NCT00560573|582235|P4|Overall Study|Lost to Follow-up|1
165240|NCT00560573|582236|P3|Overall Study|Lost to Follow-up|0
165241|NCT00560573|582237|P2|Overall Study|Lost to Follow-up|0
165242|NCT00560573|582238|P1|Overall Study|Lost to Follow-up|0
165243|NCT00560573|582233|P6|Overall Study|Death|10
165244|NCT00560573|582234|P5|Overall Study|Death|1
165245|NCT00560573|582235|P4|Overall Study|Death|5
165246|NCT00560573|582236|P3|Overall Study|Death|4
165247|NCT00560573|582237|P2|Overall Study|Death|1
165248|NCT00560573|582238|P1|Overall Study|Death|4
165249|NCT00560508|582315|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
165250|NCT00560508|582316|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
165251|NCT00560508|582315|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
165252|NCT00560508|582316|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
165253|NCT00560508|582315|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
165254|NCT00560508|582316|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
165255|NCT00560508|582315|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
165256|NCT00560508|582316|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
165257|NCT00560508|582315|P2|12 Week Double-blind Period|Withdrawal by Subject|1
165258|NCT00560508|582316|P1|12 Week Double-blind Period|Withdrawal by Subject|1
165259|NCT00560508|582315|P2|12 Week Double-blind Period|Protocol Violation|0
165260|NCT00560508|582316|P1|12 Week Double-blind Period|Protocol Violation|1
165261|NCT00560508|582315|P2|12 Week Double-blind Period|Adverse Event|2
165262|NCT00560508|582316|P1|12 Week Double-blind Period|Adverse Event|3
165263|NCT00560417|582375|P2|Overall Study|Withdrawal by Subject|3
165264|NCT00560417|582376|P1|Overall Study|Withdrawal by Subject|3
165265|NCT00560417|582375|P2|Overall Study|Sponsor Decision|0
165266|NCT00560417|582376|P1|Overall Study|Sponsor Decision|2
165267|NCT00560417|582375|P2|Overall Study|Protocol Violation|5
165268|NCT00560417|582376|P1|Overall Study|Protocol Violation|6
165269|NCT00560417|582375|P2|Overall Study|Physician Decision|6
165270|NCT00560417|582376|P1|Overall Study|Physician Decision|2
165271|NCT00560417|582375|P2|Overall Study|Lost to Follow-up|1
165272|NCT00560417|582376|P1|Overall Study|Lost to Follow-up|0
165273|NCT00560417|582375|P2|Overall Study|Entry Criteria Not Met|0
165274|NCT00560417|582376|P1|Overall Study|Entry Criteria Not Met|1
165275|NCT00560417|582375|P2|Overall Study|Adverse Event|2
165276|NCT00560417|582376|P1|Overall Study|Adverse Event|3
165277|NCT00560404|582404|P2|Overall Study|Other withdrawal reason|5
165278|NCT00560404|582405|P1|Overall Study|Other withdrawal reason|13
165279|NCT00560404|582404|P2|Overall Study|Failure to return|2
165280|NCT00560404|582405|P1|Overall Study|Failure to return|1
165281|NCT00560404|582404|P2|Overall Study|Withdrew Consent|0
165282|NCT00560404|582405|P1|Overall Study|Withdrew Consent|4
165283|NCT00560404|582404|P2|Overall Study|Administrative Reasons|1
165284|NCT00560404|582405|P1|Overall Study|Administrative Reasons|1
165285|NCT00560404|582404|P2|Overall Study|Protocol Violation|7
165286|NCT00560404|582405|P1|Overall Study|Protocol Violation|12
165287|NCT00560404|582404|P2|Overall Study|Death|3
165288|NCT00560404|582405|P1|Overall Study|Death|3
165289|NCT00560404|582404|P2|Overall Study|Adverse Event|3
165290|NCT00560404|582405|P1|Overall Study|Adverse Event|2
165291|NCT00560391|582452|P5|Overall Study|Still on treatment|2
165292|NCT00560391|582453|P4|Overall Study|Still on treatment|1
165293|NCT00560391|582454|P3|Overall Study|Still on treatment|0
165294|NCT00560391|582455|P2|Overall Study|Still on treatment|0
165295|NCT00560391|582456|P1|Overall Study|Still on treatment|0
165296|NCT00560352|582512|P3|Overall Study|Maximum clinical benefit|0
165297|NCT00560352|582513|P2|Overall Study|Maximum clinical benefit|0
165298|NCT00560352|582514|P1|Overall Study|Maximum clinical benefit|1
165299|NCT00560352|582512|P3|Overall Study|Withdrawal by Subject|1
165300|NCT00560352|582513|P2|Overall Study|Withdrawal by Subject|1
165301|NCT00560352|582514|P1|Overall Study|Withdrawal by Subject|1
165302|NCT00560352|582512|P3|Overall Study|Disease progression|1
165303|NCT00560352|582513|P2|Overall Study|Disease progression|1
165304|NCT00560352|582514|P1|Overall Study|Disease progression|0
165305|NCT00560352|582512|P3|Overall Study|Study drug toxicity|1
165306|NCT00560352|582513|P2|Overall Study|Study drug toxicity|0
165307|NCT00560352|582514|P1|Overall Study|Study drug toxicity|3
165308|NCT00560352|582512|P3|Overall Study|Adverse event unrelated to study drug|1
165309|NCT00560352|582513|P2|Overall Study|Adverse event unrelated to study drug|1
165310|NCT00560352|582514|P1|Overall Study|Adverse event unrelated to study drug|2
165311|NCT00560313|582531|P1|Overall Study|Protocol Violation|1
165312|NCT00560313|582531|P1|Overall Study|Lost to Follow-up|1
165313|NCT00560313|582531|P1|Overall Study|Withdrawal by Subject|2
165314|NCT00560313|582531|P1|Overall Study|Adverse Events or Death|2
165315|NCT00560235|582558|P3|Phase 2|Ongoing at Date of Cut-Off|1
165316|NCT00560235|582559|P2|Phase 2|Ongoing at Date of Cut-Off|0
165317|NCT00560235|582560|P1|Phase 2|Ongoing at Date of Cut-Off|0
165318|NCT00560235|582558|P3|Phase 2|Discontinued|96
165319|NCT00560235|582559|P2|Phase 2|Discontinued|0
165320|NCT00560235|582560|P1|Phase 2|Discontinued|0
165321|NCT00560235|582558|P3|Phase 1B|Discontinued|0
165322|NCT00560235|582559|P2|Phase 1B|Discontinued|19
165323|NCT00560235|582560|P1|Phase 1B|Discontinued|0
165324|NCT00560235|582558|P3|Phase 1|Discontinued|0
165325|NCT00560235|582559|P2|Phase 1|Discontinued|0
165326|NCT00560235|582560|P1|Phase 1|Discontinued|8
165327|NCT00560105|582591|P2|Overall Study|musculoskeletal chest discomfort with us|2
165328|NCT00560105|582592|P1|Overall Study|musculoskeletal chest discomfort with us|1
165329|NCT00560066|582606|P2|Overall Study|Missing primary reason|2
165330|NCT00560066|582607|P1|Overall Study|Missing primary reason|0
165331|NCT00560066|582606|P2|Overall Study|Administrative reason|5
165332|NCT00560066|582607|P1|Overall Study|Administrative reason|0
165333|NCT00560066|582606|P2|Overall Study|Protocol Violation|1
165334|NCT00560066|582607|P1|Overall Study|Protocol Violation|0
165335|NCT00560066|582606|P2|Overall Study|Lost to Follow-up|10
165336|NCT00560066|582607|P1|Overall Study|Lost to Follow-up|4
165337|NCT00560066|582606|P2|Overall Study|Withdrawal by Subject|3
165338|NCT00560066|582607|P1|Overall Study|Withdrawal by Subject|0
165339|NCT00560066|582606|P2|Overall Study|Death|1
165340|NCT00560066|582607|P1|Overall Study|Death|2
165341|NCT00559988|582639|P2|Overall Study|ICD device explanted|17
165342|NCT00559988|582640|P1|Overall Study|ICD device explanted|10
165343|NCT00559988|582639|P2|Overall Study|Lost to Follow-up|56
165344|NCT00559988|582640|P1|Overall Study|Lost to Follow-up|42
165345|NCT00559988|582639|P2|Overall Study|Withdrawal by Subject|139
165346|NCT00559988|582640|P1|Overall Study|Withdrawal by Subject|152
165347|NCT00559988|582639|P2|Overall Study|Death|140
165348|NCT00559988|582640|P1|Overall Study|Death|147
165349|NCT00559962|582670|P8|Overall Study|Inclusion/exclusion criteria not met|0
165350|NCT00559962|582671|P7|Overall Study|Inclusion/exclusion criteria not met|1
165351|NCT00559962|582672|P6|Overall Study|Inclusion/exclusion criteria not met|0
165352|NCT00559962|582673|P5|Overall Study|Inclusion/exclusion criteria not met|0
165353|NCT00559962|582674|P4|Overall Study|Inclusion/exclusion criteria not met|0
165354|NCT00559962|582675|P3|Overall Study|Inclusion/exclusion criteria not met|0
165355|NCT00559962|582676|P2|Overall Study|Inclusion/exclusion criteria not met|0
165356|NCT00559962|582677|P1|Overall Study|Inclusion/exclusion criteria not met|0
165357|NCT00559962|582670|P8|Overall Study|Withdrawal by Subject|2
165358|NCT00559962|582671|P7|Overall Study|Withdrawal by Subject|0
165359|NCT00559962|582672|P6|Overall Study|Withdrawal by Subject|1
165360|NCT00559962|582673|P5|Overall Study|Withdrawal by Subject|3
165361|NCT00559962|582674|P4|Overall Study|Withdrawal by Subject|0
165362|NCT00559962|582675|P3|Overall Study|Withdrawal by Subject|2
165363|NCT00559962|582676|P2|Overall Study|Withdrawal by Subject|1
165364|NCT00559962|582677|P1|Overall Study|Withdrawal by Subject|1
165365|NCT00559962|582670|P8|Overall Study|Lost to Follow-up|0
165366|NCT00559962|582671|P7|Overall Study|Lost to Follow-up|0
165367|NCT00559962|582672|P6|Overall Study|Lost to Follow-up|0
165368|NCT00559962|582673|P5|Overall Study|Lost to Follow-up|0
165369|NCT00559962|582674|P4|Overall Study|Lost to Follow-up|0
165370|NCT00559962|582675|P3|Overall Study|Lost to Follow-up|0
165371|NCT00559962|582676|P2|Overall Study|Lost to Follow-up|1
165372|NCT00559962|582677|P1|Overall Study|Lost to Follow-up|0
165373|NCT00559962|582670|P8|Overall Study|Adverse Event|2
165374|NCT00559962|582671|P7|Overall Study|Adverse Event|4
165375|NCT00559962|582672|P6|Overall Study|Adverse Event|4
165376|NCT00559962|582673|P5|Overall Study|Adverse Event|11
165377|NCT00559962|582674|P4|Overall Study|Adverse Event|5
165378|NCT00559962|582675|P3|Overall Study|Adverse Event|8
165379|NCT00559962|582676|P2|Overall Study|Adverse Event|7
165380|NCT00559962|582677|P1|Overall Study|Adverse Event|1
165381|NCT00559949|582697|P1|Overall Study|No disease evaluation per protocol|1
165382|NCT00559949|582697|P1|Overall Study|Withdrawal by Subject|4
165383|NCT00559949|582697|P1|Overall Study|Adverse Event|1
165384|NCT00559949|582697|P1|Overall Study|Progressive Disease during cycle 1|1
165385|NCT00559845|582713|P1|Overall Study|Premature Surgery-Investigator Decision|1
165386|NCT00559845|582713|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
165387|NCT00559845|582713|P1|Overall Study|Adverse Event|3
165388|NCT00559845|582713|P1|Overall Study|Disease Progression|1
165389|NCT00559845|582713|P1|Overall Study|Withdrew Consent|1
165390|NCT00559754|582722|P1|Overall Study|Withdrawal by Subject|2
165391|NCT00559754|582722|P1|Overall Study|Investigator criteria|2
165392|NCT00559754|582722|P1|Overall Study|Protocol Violation|1
165393|NCT00559754|582722|P1|Overall Study|Adverse Event|5
165394|NCT00559754|582722|P1|Overall Study|Disease progression|1
165395|NCT00559637|582746|P1|Overall Study|Inclusion or exclusion criteria violated|2
165396|NCT00559637|582746|P1|Overall Study|Change of home|1
165397|NCT00559637|582746|P1|Overall Study|Change of center|1
165398|NCT00559637|582746|P1|Overall Study|Delayed administration of C.E.R.A|1
165399|NCT00559637|582746|P1|Overall Study|Participation in another study|1
165400|NCT00559637|582746|P1|Overall Study|Suspected lung cancer|1
165401|NCT00559637|582746|P1|Overall Study|Started requiring dialysis after month 7|2
165402|NCT00559637|582746|P1|Overall Study|Insufficient response|3
165403|NCT00559637|582746|P1|Overall Study|Failure to return|6
165404|NCT00559637|582746|P1|Overall Study|Withdrawal criteria fulfilled|4
165405|NCT00559637|582746|P1|Overall Study|Protocol Violation|6
165406|NCT00559637|582746|P1|Overall Study|Withdrawal by Subject|4
165407|NCT00559637|582746|P1|Overall Study|Adverse Event|22
165408|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
165409|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
165410|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|non-specified|0
165411|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|non-specified|71
165412|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
165413|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
165414|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
165415|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
165416|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
165417|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
165418|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|Death|0
165419|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|Death|20
165420|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
165421|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
165422|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
165423|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
165424|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
165425|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
165426|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
165427|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
165428|NCT00559585|582759|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
165429|NCT00559585|582760|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
165430|NCT00559585|582759|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
165431|NCT00559585|582760|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
165432|NCT00559585|582759|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
165433|NCT00559585|582760|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
165434|NCT00559585|582759|P2|Double Blind ST Period Main Study|Investigator Decision|1
165435|NCT00559585|582760|P1|Double Blind ST Period Main Study|Investigator Decision|0
165436|NCT00559585|582759|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
165437|NCT00559585|582760|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
165438|NCT00559585|582759|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
165439|NCT00559585|582760|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
165440|NCT00559585|582759|P2|Double Blind ST Period Main Study|Early Discontinuation|1
165441|NCT00559585|582760|P1|Double Blind ST Period Main Study|Early Discontinuation|0
165442|NCT00559585|582759|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
165443|NCT00559585|582760|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
165444|NCT00559585|582759|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
165445|NCT00559585|582760|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
165446|NCT00559585|582759|P2|Double Blind ST Period Main Study|Missed Doses|1
165447|NCT00559585|582760|P1|Double Blind ST Period Main Study|Missed Doses|0
165448|NCT00559585|582759|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
165449|NCT00559585|582760|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
165450|NCT00559585|582759|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
165451|NCT00559585|582760|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
165452|NCT00559585|582759|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
165453|NCT00559585|582760|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
165454|NCT00559585|582759|P2|Double Blind ST Period Main Study|Death|1
165455|NCT00559585|582760|P1|Double Blind ST Period Main Study|Death|1
165456|NCT00559585|582759|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
165457|NCT00559585|582760|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
165458|NCT00559585|582759|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
165459|NCT00559585|582760|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
165460|NCT00559585|582759|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
165461|NCT00559585|582760|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
165462|NCT00559585|582759|P2|Double Blind ST Period Main Study|Adverse Event|25
165463|NCT00559585|582760|P1|Double Blind ST Period Main Study|Adverse Event|17
165464|NCT00559507|582820|P1|Overall Study|Not treated, patient ineligible|3
165465|NCT00559377|582826|P1|Overall Study|Withdrawal by Subject|9
165466|NCT00559364|582836|P2|Overall Study|Inclusion/exclusion criteria failure|0
165467|NCT00559364|582837|P1|Overall Study|Inclusion/exclusion criteria failure|1
165468|NCT00559273|582849|P2|Evaluation Period (8 Weeks)|Physician Decision|1
165469|NCT00559273|582850|P1|Evaluation Period (8 Weeks)|Physician Decision|0
165470|NCT00559273|582849|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
165471|NCT00559273|582850|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
165472|NCT00559273|582849|P2|Evaluation Period (8 Weeks)|Adverse Event|1
165473|NCT00559273|582850|P1|Evaluation Period (8 Weeks)|Adverse Event|0
165474|NCT00559273|582849|P2|Evaluation Period (8 Weeks)|Death|3
165475|NCT00559273|582850|P1|Evaluation Period (8 Weeks)|Death|1
165476|NCT00559273|582849|P2|Correction Period (20 Weeks)|Did not received study treatment|0
165477|NCT00559273|582850|P1|Correction Period (20 Weeks)|Did not received study treatment|2
165478|NCT00559273|582849|P2|Correction Period (20 Weeks)|Participant treated by another center|1
165479|NCT00559273|582850|P1|Correction Period (20 Weeks)|Participant treated by another center|0
165480|NCT00559273|582849|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
165481|NCT00559273|582850|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
165482|NCT00559273|582849|P2|Correction Period (20 Weeks)|Adverse Event|1
165483|NCT00559273|582850|P1|Correction Period (20 Weeks)|Adverse Event|2
165484|NCT00559273|582849|P2|Correction Period (20 Weeks)|Death|4
165485|NCT00559273|582850|P1|Correction Period (20 Weeks)|Death|3
165486|NCT00559104|582872|P2|Overall Study|Lack of Efficacy|0
165487|NCT00559104|582873|P1|Overall Study|Lack of Efficacy|9
165488|NCT00558896|582894|P7|Overall Study|Continues on treatment|6
165489|NCT00558896|582895|P6|Overall Study|Continues on treatment|25
165490|NCT00558896|582896|P5|Overall Study|Continues on treatment|9
165491|NCT00558896|582897|P4|Overall Study|Continues on treatment|1
165492|NCT00558896|582898|P3|Overall Study|Continues on treatment|0
165493|NCT00558896|582899|P2|Overall Study|Continues on treatment|1
165494|NCT00558896|582900|P1|Overall Study|Continues on treatment|10
165495|NCT00558896|582894|P7|Overall Study|Physician discretion|3
165496|NCT00558896|582895|P6|Overall Study|Physician discretion|3
165497|NCT00558896|582896|P5|Overall Study|Physician discretion|1
165498|NCT00558896|582897|P4|Overall Study|Physician discretion|2
165499|NCT00558896|582898|P3|Overall Study|Physician discretion|1
165500|NCT00558896|582899|P2|Overall Study|Physician discretion|2
165501|NCT00558896|582900|P1|Overall Study|Physician discretion|3
165502|NCT00558896|582894|P7|Overall Study|Alternative Treatment|1
165503|NCT00558896|582895|P6|Overall Study|Alternative Treatment|7
165504|NCT00558896|582896|P5|Overall Study|Alternative Treatment|6
165505|NCT00558896|582897|P4|Overall Study|Alternative Treatment|2
165506|NCT00558896|582898|P3|Overall Study|Alternative Treatment|0
165507|NCT00558896|582899|P2|Overall Study|Alternative Treatment|2
165508|NCT00558896|582900|P1|Overall Study|Alternative Treatment|2
165509|NCT00558896|582894|P7|Overall Study|Withdrawal by Subject|5
165510|NCT00558896|582895|P6|Overall Study|Withdrawal by Subject|5
165511|NCT00558896|582896|P5|Overall Study|Withdrawal by Subject|1
165512|NCT00558896|582897|P4|Overall Study|Withdrawal by Subject|1
165513|NCT00558896|582898|P3|Overall Study|Withdrawal by Subject|1
165514|NCT00558896|582899|P2|Overall Study|Withdrawal by Subject|1
165515|NCT00558896|582900|P1|Overall Study|Withdrawal by Subject|2
165516|NCT00558896|582894|P7|Overall Study|Death|6
165517|NCT00558896|582895|P6|Overall Study|Death|2
165518|NCT00558896|582896|P5|Overall Study|Death|2
165519|NCT00558896|582897|P4|Overall Study|Death|3
165520|NCT00558896|582898|P3|Overall Study|Death|2
165521|NCT00558896|582899|P2|Overall Study|Death|0
165522|NCT00558896|582900|P1|Overall Study|Death|3
165523|NCT00558896|582894|P7|Overall Study|Adverse Event|3
165524|NCT00558896|582895|P6|Overall Study|Adverse Event|10
165525|NCT00558896|582896|P5|Overall Study|Adverse Event|4
165526|NCT00558896|582897|P4|Overall Study|Adverse Event|3
165527|NCT00558896|582898|P3|Overall Study|Adverse Event|1
165528|NCT00558896|582899|P2|Overall Study|Adverse Event|1
165529|NCT00558896|582900|P1|Overall Study|Adverse Event|1
165530|NCT00558831|582941|P1|Overall Study|Lost to Follow-up|1
165531|NCT00558753|582998|P2|Overall Study|Lost to Follow-up|7
165532|NCT00558753|582999|P1|Overall Study|Lost to Follow-up|5
165533|NCT00558701|583011|P2|Overall Study|Protocol Deviations|4
165534|NCT00558701|583012|P1|Overall Study|Protocol Deviations|1
165535|NCT00558636|583020|P2|Follow-up|Premature termination of the study|7
165536|NCT00558636|583021|P1|Follow-up|Premature termination of the study|12
165537|NCT00558636|583020|P2|Treatment|Disease progression|5
165538|NCT00558636|583021|P1|Treatment|Disease progression|1
165539|NCT00558636|583020|P2|Treatment|Premature termination of the study|37
165540|NCT00558636|583021|P1|Treatment|Premature termination of the study|35
165541|NCT00558636|583020|P2|Treatment|Withdrawal by Subject|0
165542|NCT00558636|583021|P1|Treatment|Withdrawal by Subject|2
165543|NCT00558636|583020|P2|Treatment|Adverse Event|2
165544|NCT00558636|583021|P1|Treatment|Adverse Event|9
165545|NCT00558558|583121|P1|Overall Study|Lack of Efficacy|4
165546|NCT00558558|583121|P1|Overall Study|Withdrawal by Subject|1
165547|NCT00558558|583121|P1|Overall Study|Unable to swallow|1
165548|NCT00558467|583127|P2|Overall Study|Patient moving out of state|1
165549|NCT00558467|583128|P1|Overall Study|Patient moving out of state|0
165550|NCT00558467|583127|P2|Overall Study|Lack of Efficacy|1
165551|NCT00558467|583128|P1|Overall Study|Lack of Efficacy|0
165552|NCT00558467|583127|P2|Overall Study|Adverse Event|2
165553|NCT00558467|583128|P1|Overall Study|Adverse Event|1
165554|NCT00558428|583188|P4|Overall Study|Other|1
165555|NCT00558428|583189|P3|Overall Study|Other|0
165556|NCT00558428|583190|P2|Overall Study|Other|0
165557|NCT00558428|583191|P1|Overall Study|Other|3
165558|NCT00558428|583188|P4|Overall Study|Consent withdrawn|1
165559|NCT00558428|583189|P3|Overall Study|Consent withdrawn|0
165560|NCT00558428|583190|P2|Overall Study|Consent withdrawn|1
165561|NCT00558428|583191|P1|Overall Study|Consent withdrawn|2
165562|NCT00558428|583188|P4|Overall Study|Non compliant with protocol|3
165563|NCT00558428|583189|P3|Overall Study|Non compliant with protocol|0
165564|NCT00558428|583190|P2|Overall Study|Non compliant with protocol|0
165565|NCT00558428|583191|P1|Overall Study|Non compliant with protocol|1
165566|NCT00558428|583188|P4|Overall Study|Lack of Efficacy|2
165567|NCT00558428|583189|P3|Overall Study|Lack of Efficacy|1
165568|NCT00558428|583190|P2|Overall Study|Lack of Efficacy|0
165569|NCT00558428|583191|P1|Overall Study|Lack of Efficacy|0
165570|NCT00558428|583188|P4|Overall Study|Lost to Follow-up|0
165571|NCT00558428|583189|P3|Overall Study|Lost to Follow-up|0
165572|NCT00558428|583190|P2|Overall Study|Lost to Follow-up|1
165573|NCT00558428|583191|P1|Overall Study|Lost to Follow-up|0
165574|NCT00558428|583188|P4|Overall Study|Adverse Event|4
165575|NCT00558428|583189|P3|Overall Study|Adverse Event|3
165576|NCT00558428|583190|P2|Overall Study|Adverse Event|22
165577|NCT00558428|583191|P1|Overall Study|Adverse Event|6
165578|NCT00558363|583231|P2|Overall Study|Hospitalized; Unable to Continue|1
165579|NCT00558363|583232|P1|Overall Study|Hospitalized; Unable to Continue|0
165580|NCT00558363|583231|P2|Overall Study|Randomized in Error|2
165581|NCT00558363|583232|P1|Overall Study|Randomized in Error|1
165582|NCT00558363|583231|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
165583|NCT00558363|583232|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
165584|NCT00558363|583231|P2|Overall Study|Lost to Follow-up|1
165585|NCT00558363|583232|P1|Overall Study|Lost to Follow-up|0
165586|NCT00558363|583231|P2|Overall Study|Protocol Violation|1
165587|NCT00558363|583232|P1|Overall Study|Protocol Violation|2
165588|NCT00558363|583231|P2|Overall Study|Lack of Efficacy|2
165589|NCT00558363|583232|P1|Overall Study|Lack of Efficacy|2
165590|NCT00558363|583231|P2|Overall Study|Adverse Event|5
165591|NCT00558363|583232|P1|Overall Study|Adverse Event|5
165592|NCT00558363|583231|P2|Overall Study|Withdrawal by Subject|4
165593|NCT00558363|583232|P1|Overall Study|Withdrawal by Subject|11
165594|NCT00558363|583231|P2|Overall Study|Physician Decision|4
165595|NCT00558363|583232|P1|Overall Study|Physician Decision|18
165596|NCT00558285|583287|P5|Overall Study|Protocol deviation|0
165597|NCT00558285|583288|P4|Overall Study|Protocol deviation|1
165598|NCT00558285|583289|P3|Overall Study|Protocol deviation|0
165599|NCT00558285|583290|P2|Overall Study|Protocol deviation|1
165600|NCT00558285|583291|P1|Overall Study|Protocol deviation|1
165601|NCT00558285|583287|P5|Overall Study|Administrative problems|1
165602|NCT00558285|583288|P4|Overall Study|Administrative problems|1
165603|NCT00558285|583289|P3|Overall Study|Administrative problems|0
165604|NCT00558285|583290|P2|Overall Study|Administrative problems|0
165605|NCT00558285|583291|P1|Overall Study|Administrative problems|0
165606|NCT00558285|583287|P5|Overall Study|Lost to Follow-up|0
165607|NCT00558285|583288|P4|Overall Study|Lost to Follow-up|0
165608|NCT00558285|583289|P3|Overall Study|Lost to Follow-up|0
165609|NCT00558285|583290|P2|Overall Study|Lost to Follow-up|1
165610|NCT00558285|583291|P1|Overall Study|Lost to Follow-up|1
165611|NCT00558285|583287|P5|Overall Study|Subject withdrew consent|1
165612|NCT00558285|583288|P4|Overall Study|Subject withdrew consent|1
165613|NCT00558285|583289|P3|Overall Study|Subject withdrew consent|1
165614|NCT00558285|583290|P2|Overall Study|Subject withdrew consent|0
165615|NCT00558285|583291|P1|Overall Study|Subject withdrew consent|2
165616|NCT00558285|583287|P5|Overall Study|Abnormal test procedure result(s)|0
165617|NCT00558285|583288|P4|Overall Study|Abnormal test procedure result(s)|0
165618|NCT00558285|583289|P3|Overall Study|Abnormal test procedure result(s)|0
165619|NCT00558285|583290|P2|Overall Study|Abnormal test procedure result(s)|0
165620|NCT00558285|583291|P1|Overall Study|Abnormal test procedure result(s)|1
165621|NCT00558285|583287|P5|Overall Study|Adverse Event|2
165622|NCT00558285|583288|P4|Overall Study|Adverse Event|1
165623|NCT00558285|583289|P3|Overall Study|Adverse Event|4
165624|NCT00558285|583290|P2|Overall Study|Adverse Event|1
165625|NCT00558285|583291|P1|Overall Study|Adverse Event|1
165626|NCT00558272|583335|P2|Overall Study|Withdrawal by Subject|1
165627|NCT00558272|583336|P1|Overall Study|Withdrawal by Subject|0
165628|NCT00558272|583335|P2|Overall Study|Incorrectly enrolled|0
165629|NCT00558272|583336|P1|Overall Study|Incorrectly enrolled|1
165630|NCT00558272|583335|P2|Overall Study|AZ study team decision|1
165631|NCT00558272|583336|P1|Overall Study|AZ study team decision|0
165632|NCT00558272|583335|P2|Overall Study|Dev. of study specific discon. criteria|0
165633|NCT00558272|583336|P1|Overall Study|Dev. of study specific discon. criteria|1
165634|NCT00558272|583335|P2|Overall Study|Death|0
165635|NCT00558272|583336|P1|Overall Study|Death|1
165636|NCT00558272|583335|P2|Overall Study|Adverse Event|0
165637|NCT00558272|583336|P1|Overall Study|Adverse Event|10
165638|NCT00558259|583376|P2|Overall Study|Withdrawal by Subject|13
165639|NCT00558259|583377|P1|Overall Study|Withdrawal by Subject|12
165640|NCT00558259|583376|P2|Overall Study|Protocol Violation|5
165641|NCT00558259|583377|P1|Overall Study|Protocol Violation|9
165642|NCT00558259|583376|P2|Overall Study|Adverse Event|81
165643|NCT00558259|583377|P1|Overall Study|Adverse Event|50
165644|NCT00558103|583417|P6|Monotherapy Extension Phase|Disease Progression|8
165645|NCT00558103|583418|P5|Monotherapy Extension Phase|Disease Progression|0
165646|NCT00558103|583419|P4|Monotherapy Extension Phase|Disease Progression|0
165647|NCT00558103|583420|P3|Monotherapy Extension Phase|Disease Progression|0
165648|NCT00558103|583421|P2|Monotherapy Extension Phase|Disease Progression|0
165649|NCT00558103|583422|P1|Monotherapy Extension Phase|Disease Progression|0
165650|NCT00558103|583417|P6|Monotherapy Extension Phase|Protocol Violation|1
165651|NCT00558103|583418|P5|Monotherapy Extension Phase|Protocol Violation|0
165652|NCT00558103|583419|P4|Monotherapy Extension Phase|Protocol Violation|0
165653|NCT00558103|583420|P3|Monotherapy Extension Phase|Protocol Violation|0
165654|NCT00558103|583421|P2|Monotherapy Extension Phase|Protocol Violation|0
165655|NCT00558103|583422|P1|Monotherapy Extension Phase|Protocol Violation|0
165656|NCT00558103|583417|P6|Randomized Treatment Phase|Adverse Event|0
165657|NCT00558103|583418|P5|Randomized Treatment Phase|Adverse Event|1
165658|NCT00558103|583419|P4|Randomized Treatment Phase|Adverse Event|1
165659|NCT00558103|583420|P3|Randomized Treatment Phase|Adverse Event|0
165660|NCT00558103|583421|P2|Randomized Treatment Phase|Adverse Event|0
165661|NCT00558103|583422|P1|Randomized Treatment Phase|Adverse Event|0
165662|NCT00558103|583417|P6|Randomized Treatment Phase|Disease Progression|0
165663|NCT00558103|583418|P5|Randomized Treatment Phase|Disease Progression|0
165664|NCT00558103|583419|P4|Randomized Treatment Phase|Disease Progression|0
165665|NCT00558103|583420|P3|Randomized Treatment Phase|Disease Progression|1
165666|NCT00558103|583421|P2|Randomized Treatment Phase|Disease Progression|0
165667|NCT00558103|583422|P1|Randomized Treatment Phase|Disease Progression|1
165668|NCT00558103|583417|P6|Randomized Treatment Phase|Withdrawal by Subject|0
165669|NCT00558103|583418|P5|Randomized Treatment Phase|Withdrawal by Subject|1
165670|NCT00558103|583419|P4|Randomized Treatment Phase|Withdrawal by Subject|0
165671|NCT00558103|583420|P3|Randomized Treatment Phase|Withdrawal by Subject|0
165672|NCT00558103|583421|P2|Randomized Treatment Phase|Withdrawal by Subject|2
165673|NCT00558103|583422|P1|Randomized Treatment Phase|Withdrawal by Subject|2
165674|NCT00558103|583417|P6|Randomized Treatment Phase|Lost to Follow-up|0
165675|NCT00558103|583418|P5|Randomized Treatment Phase|Lost to Follow-up|3
165676|NCT00558103|583419|P4|Randomized Treatment Phase|Lost to Follow-up|1
165677|NCT00558103|583420|P3|Randomized Treatment Phase|Lost to Follow-up|2
165678|NCT00558103|583421|P2|Randomized Treatment Phase|Lost to Follow-up|2
165679|NCT00558103|583422|P1|Randomized Treatment Phase|Lost to Follow-up|2
165680|NCT00558064|583452|P2|Overall Study|No visit within allowance period|0
165681|NCT00558064|583453|P1|Overall Study|No visit within allowance period|1
165682|NCT00558064|583452|P2|Overall Study|Withdrawal by Subject|1
165683|NCT00558064|583453|P1|Overall Study|Withdrawal by Subject|0
165684|NCT00558064|583452|P2|Overall Study|Lost to Follow-up|1
165685|NCT00558064|583453|P1|Overall Study|Lost to Follow-up|0
165686|NCT00558064|583452|P2|Overall Study|Protocol Violation|0
165687|NCT00558064|583453|P1|Overall Study|Protocol Violation|1
165688|NCT00558064|583452|P2|Overall Study|Lack of Efficacy|1
165689|NCT00558064|583453|P1|Overall Study|Lack of Efficacy|0
165690|NCT00558064|583452|P2|Overall Study|Adverse Event|2
165691|NCT00558064|583453|P1|Overall Study|Adverse Event|3
165692|NCT00558025|583475|P2|Overall Study|Protocol Violation|0
165693|NCT00558025|583476|P1|Overall Study|Protocol Violation|1
165694|NCT00558025|583475|P2|Overall Study|Withdrawal by Subject|2
165695|NCT00558025|583476|P1|Overall Study|Withdrawal by Subject|2
165696|NCT00558025|583475|P2|Overall Study|Adverse Event|1
165697|NCT00558025|583476|P1|Overall Study|Adverse Event|1
165773|NCT00557856|583526|P6|Part 1: Dose Escalation Phase|Death|1
165698|NCT00557856|583523|P9|Part 2: Exploratory Phase|global deterioration of health status|1
165699|NCT00557856|583524|P8|Part 2: Exploratory Phase|global deterioration of health status|0
165700|NCT00557856|583525|P7|Part 2: Exploratory Phase|global deterioration of health status|0
165701|NCT00557856|583526|P6|Part 2: Exploratory Phase|global deterioration of health status|0
165702|NCT00557856|583527|P5|Part 2: Exploratory Phase|global deterioration of health status|0
165703|NCT00557856|583528|P4|Part 2: Exploratory Phase|global deterioration of health status|0
165704|NCT00557856|583529|P3|Part 2: Exploratory Phase|global deterioration of health status|0
165705|NCT00557856|583530|P2|Part 2: Exploratory Phase|global deterioration of health status|0
165706|NCT00557856|583531|P1|Part 2: Exploratory Phase|global deterioration of health status|0
165707|NCT00557856|583523|P9|Part 2: Exploratory Phase|Death|2
165708|NCT00557856|583524|P8|Part 2: Exploratory Phase|Death|0
165709|NCT00557856|583525|P7|Part 2: Exploratory Phase|Death|0
165710|NCT00557856|583526|P6|Part 2: Exploratory Phase|Death|0
165711|NCT00557856|583527|P5|Part 2: Exploratory Phase|Death|0
165712|NCT00557856|583528|P4|Part 2: Exploratory Phase|Death|0
165713|NCT00557856|583529|P3|Part 2: Exploratory Phase|Death|0
165714|NCT00557856|583530|P2|Part 2: Exploratory Phase|Death|0
165715|NCT00557856|583531|P1|Part 2: Exploratory Phase|Death|0
165716|NCT00557856|583523|P9|Part 2: Exploratory Phase|Other|1
165717|NCT00557856|583524|P8|Part 2: Exploratory Phase|Other|0
165718|NCT00557856|583525|P7|Part 2: Exploratory Phase|Other|0
165719|NCT00557856|583526|P6|Part 2: Exploratory Phase|Other|0
165720|NCT00557856|583527|P5|Part 2: Exploratory Phase|Other|0
165721|NCT00557856|583528|P4|Part 2: Exploratory Phase|Other|0
165722|NCT00557856|583529|P3|Part 2: Exploratory Phase|Other|0
165723|NCT00557856|583530|P2|Part 2: Exploratory Phase|Other|0
165724|NCT00557856|583531|P1|Part 2: Exploratory Phase|Other|0
165725|NCT00557856|583523|P9|Part 2: Exploratory Phase|Adverse Event|4
165726|NCT00557856|583524|P8|Part 2: Exploratory Phase|Adverse Event|0
165727|NCT00557856|583525|P7|Part 2: Exploratory Phase|Adverse Event|0
165728|NCT00557856|583526|P6|Part 2: Exploratory Phase|Adverse Event|0
165729|NCT00557856|583527|P5|Part 2: Exploratory Phase|Adverse Event|0
165730|NCT00557856|583528|P4|Part 2: Exploratory Phase|Adverse Event|0
165731|NCT00557856|583529|P3|Part 2: Exploratory Phase|Adverse Event|0
165732|NCT00557856|583530|P2|Part 2: Exploratory Phase|Adverse Event|0
165733|NCT00557856|583531|P1|Part 2: Exploratory Phase|Adverse Event|0
165734|NCT00557856|583523|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
165735|NCT00557856|583524|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
165736|NCT00557856|583525|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
165737|NCT00557856|583526|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
165738|NCT00557856|583527|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
165739|NCT00557856|583528|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
165740|NCT00557856|583529|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
165741|NCT00557856|583530|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
165742|NCT00557856|583531|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
165743|NCT00557856|583523|P9|Part 2: Exploratory Phase|objective progression or relapse|15
165744|NCT00557856|583524|P8|Part 2: Exploratory Phase|objective progression or relapse|0
165745|NCT00557856|583525|P7|Part 2: Exploratory Phase|objective progression or relapse|0
165746|NCT00557856|583526|P6|Part 2: Exploratory Phase|objective progression or relapse|0
165747|NCT00557856|583527|P5|Part 2: Exploratory Phase|objective progression or relapse|0
165748|NCT00557856|583528|P4|Part 2: Exploratory Phase|objective progression or relapse|0
165749|NCT00557856|583529|P3|Part 2: Exploratory Phase|objective progression or relapse|0
165750|NCT00557856|583530|P2|Part 2: Exploratory Phase|objective progression or relapse|0
165751|NCT00557856|583531|P1|Part 2: Exploratory Phase|objective progression or relapse|0
165752|NCT00557856|583523|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
165753|NCT00557856|583524|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
165754|NCT00557856|583525|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
165755|NCT00557856|583526|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
165756|NCT00557856|583527|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
165757|NCT00557856|583528|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
165758|NCT00557856|583529|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
165759|NCT00557856|583530|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
165760|NCT00557856|583531|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
165761|NCT00557856|583523|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
165762|NCT00557856|583524|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
165763|NCT00557856|583525|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
165764|NCT00557856|583526|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
165765|NCT00557856|583527|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
165766|NCT00557856|583528|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
165767|NCT00557856|583529|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
165768|NCT00557856|583530|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
165769|NCT00557856|583531|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
165770|NCT00557856|583523|P9|Part 1: Dose Escalation Phase|Death|0
165771|NCT00557856|583524|P8|Part 1: Dose Escalation Phase|Death|0
165772|NCT00557856|583525|P7|Part 1: Dose Escalation Phase|Death|0
165774|NCT00557856|583527|P5|Part 1: Dose Escalation Phase|Death|0
165775|NCT00557856|583528|P4|Part 1: Dose Escalation Phase|Death|0
165776|NCT00557856|583529|P3|Part 1: Dose Escalation Phase|Death|0
165777|NCT00557856|583530|P2|Part 1: Dose Escalation Phase|Death|0
165778|NCT00557856|583531|P1|Part 1: Dose Escalation Phase|Death|0
165779|NCT00557856|583523|P9|Part 1: Dose Escalation Phase|Other|0
165780|NCT00557856|583524|P8|Part 1: Dose Escalation Phase|Other|1
165781|NCT00557856|583525|P7|Part 1: Dose Escalation Phase|Other|0
165782|NCT00557856|583526|P6|Part 1: Dose Escalation Phase|Other|0
165783|NCT00557856|583527|P5|Part 1: Dose Escalation Phase|Other|0
165784|NCT00557856|583528|P4|Part 1: Dose Escalation Phase|Other|1
165785|NCT00557856|583529|P3|Part 1: Dose Escalation Phase|Other|1
165786|NCT00557856|583530|P2|Part 1: Dose Escalation Phase|Other|0
165787|NCT00557856|583531|P1|Part 1: Dose Escalation Phase|Other|0
165788|NCT00557856|583523|P9|Part 1: Dose Escalation Phase|Adverse Event|0
165789|NCT00557856|583524|P8|Part 1: Dose Escalation Phase|Adverse Event|2
165790|NCT00557856|583525|P7|Part 1: Dose Escalation Phase|Adverse Event|1
165791|NCT00557856|583526|P6|Part 1: Dose Escalation Phase|Adverse Event|3
165792|NCT00557856|583527|P5|Part 1: Dose Escalation Phase|Adverse Event|1
165793|NCT00557856|583528|P4|Part 1: Dose Escalation Phase|Adverse Event|1
165794|NCT00557856|583529|P3|Part 1: Dose Escalation Phase|Adverse Event|1
165795|NCT00557856|583530|P2|Part 1: Dose Escalation Phase|Adverse Event|0
165796|NCT00557856|583531|P1|Part 1: Dose Escalation Phase|Adverse Event|1
165797|NCT00557856|583523|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
165798|NCT00557856|583524|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
165799|NCT00557856|583525|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
165800|NCT00557856|583526|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
165801|NCT00557856|583527|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
165802|NCT00557856|583528|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
165803|NCT00557856|583529|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
165804|NCT00557856|583530|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
165805|NCT00557856|583531|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
165806|NCT00557856|583523|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
165807|NCT00557856|583524|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
165808|NCT00557856|583525|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
165809|NCT00557856|583526|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
165810|NCT00557856|583527|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
165811|NCT00557856|583528|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
165812|NCT00557856|583529|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
165813|NCT00557856|583530|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
165814|NCT00557856|583531|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
165815|NCT00557830|583730|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
165816|NCT00557830|583731|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
165817|NCT00557830|583732|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
165818|NCT00557830|583730|P3|Screening Treatment Phase|Adverse Event|0
165819|NCT00557830|583731|P2|Screening Treatment Phase|Adverse Event|0
165820|NCT00557830|583732|P1|Screening Treatment Phase|Adverse Event|2
165821|NCT00557830|583730|P3|Screening Treatment Phase|Withdrawal by Subject|0
165822|NCT00557830|583731|P2|Screening Treatment Phase|Withdrawal by Subject|0
165823|NCT00557830|583732|P1|Screening Treatment Phase|Withdrawal by Subject|1
165824|NCT00557622|583754|P2|12-Week Treatment Phase|Lost to Follow-up|1
165825|NCT00557622|583755|P1|12-Week Treatment Phase|Lost to Follow-up|0
165826|NCT00557622|583754|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
165827|NCT00557622|583755|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
165828|NCT00557622|583754|P2|4-Week Run-in Phase|Withdrawal by Subject|0
165829|NCT00557622|583755|P1|4-Week Run-in Phase|Withdrawal by Subject|1
165830|NCT00557505|583784|P9|Overall Study|Withdrawal by Subject|1
165831|NCT00557505|583785|P8|Overall Study|Withdrawal by Subject|0
165832|NCT00557505|583786|P7|Overall Study|Withdrawal by Subject|0
165833|NCT00557505|583787|P6|Overall Study|Withdrawal by Subject|0
165834|NCT00557505|583788|P5|Overall Study|Withdrawal by Subject|0
165835|NCT00557505|583789|P4|Overall Study|Withdrawal by Subject|1
165836|NCT00557505|583790|P3|Overall Study|Withdrawal by Subject|0
165837|NCT00557505|583791|P2|Overall Study|Withdrawal by Subject|0
165838|NCT00557505|583792|P1|Overall Study|Withdrawal by Subject|0
165839|NCT00557505|583784|P9|Overall Study|Objective progression or relapse|15
165840|NCT00557505|583785|P8|Overall Study|Objective progression or relapse|5
165841|NCT00557505|583786|P7|Overall Study|Objective progression or relapse|2
165842|NCT00557505|583787|P6|Overall Study|Objective progression or relapse|3
165843|NCT00557505|583788|P5|Overall Study|Objective progression or relapse|2
165844|NCT00557505|583789|P4|Overall Study|Objective progression or relapse|2
165845|NCT00557505|583790|P3|Overall Study|Objective progression or relapse|3
165846|NCT00557505|583791|P2|Overall Study|Objective progression or relapse|3
165847|NCT00557505|583792|P1|Overall Study|Objective progression or relapse|2
165848|NCT00557505|583784|P9|Overall Study|Global deterioration of health|0
165849|NCT00557505|583785|P8|Overall Study|Global deterioration of health|0
165850|NCT00557505|583786|P7|Overall Study|Global deterioration of health|0
165851|NCT00557505|583787|P6|Overall Study|Global deterioration of health|0
165852|NCT00557505|583788|P5|Overall Study|Global deterioration of health|0
165853|NCT00557505|583789|P4|Overall Study|Global deterioration of health|0
165854|NCT00557505|583790|P3|Overall Study|Global deterioration of health|0
165855|NCT00557505|583791|P2|Overall Study|Global deterioration of health|0
165856|NCT00557505|583792|P1|Overall Study|Global deterioration of health|1
165857|NCT00557505|583784|P9|Overall Study|Adverse Event|0
165858|NCT00557505|583785|P8|Overall Study|Adverse Event|0
165859|NCT00557505|583786|P7|Overall Study|Adverse Event|1
165860|NCT00557505|583787|P6|Overall Study|Adverse Event|0
165861|NCT00557505|583788|P5|Overall Study|Adverse Event|0
165862|NCT00557505|583789|P4|Overall Study|Adverse Event|0
165863|NCT00557505|583790|P3|Overall Study|Adverse Event|1
165864|NCT00557505|583791|P2|Overall Study|Adverse Event|0
165865|NCT00557505|583792|P1|Overall Study|Adverse Event|0
165866|NCT00557505|583784|P9|Overall Study|Death|1
165867|NCT00557505|583785|P8|Overall Study|Death|0
165868|NCT00557505|583786|P7|Overall Study|Death|0
165869|NCT00557505|583787|P6|Overall Study|Death|0
165870|NCT00557505|583788|P5|Overall Study|Death|0
165871|NCT00557505|583789|P4|Overall Study|Death|0
165872|NCT00557505|583790|P3|Overall Study|Death|0
165873|NCT00557505|583791|P2|Overall Study|Death|0
165874|NCT00557505|583792|P1|Overall Study|Death|0
165875|NCT00557492|583956|P1|Overall Study|Change in health insurance|1
165876|NCT00557466|583974|P6|Overall Study|Lost to Follow-up|0
165877|NCT00557466|583975|P5|Overall Study|Lost to Follow-up|0
165878|NCT00557466|583976|P4|Overall Study|Lost to Follow-up|1
165879|NCT00557466|583977|P3|Overall Study|Lost to Follow-up|0
165880|NCT00557466|583978|P2|Overall Study|Lost to Follow-up|0
165881|NCT00557466|583979|P1|Overall Study|Lost to Follow-up|0
165882|NCT00557466|583974|P6|Overall Study|Abnormal test procedure results|0
165883|NCT00557466|583975|P5|Overall Study|Abnormal test procedure results|0
165884|NCT00557466|583976|P4|Overall Study|Abnormal test procedure results|0
165885|NCT00557466|583977|P3|Overall Study|Abnormal test procedure results|1
165886|NCT00557466|583978|P2|Overall Study|Abnormal test procedure results|0
165887|NCT00557466|583979|P1|Overall Study|Abnormal test procedure results|0
165888|NCT00557466|583974|P6|Overall Study|Administrative problems|0
165889|NCT00557466|583975|P5|Overall Study|Administrative problems|0
165890|NCT00557466|583976|P4|Overall Study|Administrative problems|0
165891|NCT00557466|583977|P3|Overall Study|Administrative problems|1
165892|NCT00557466|583978|P2|Overall Study|Administrative problems|1
165893|NCT00557466|583979|P1|Overall Study|Administrative problems|0
165894|NCT00557466|583974|P6|Overall Study|Subject withdrew consent|2
165895|NCT00557466|583975|P5|Overall Study|Subject withdrew consent|1
165896|NCT00557466|583976|P4|Overall Study|Subject withdrew consent|0
165897|NCT00557466|583977|P3|Overall Study|Subject withdrew consent|0
165898|NCT00557466|583978|P2|Overall Study|Subject withdrew consent|0
165899|NCT00557466|583979|P1|Overall Study|Subject withdrew consent|0
165900|NCT00557466|583974|P6|Overall Study|Protocol deviation|0
165901|NCT00557466|583975|P5|Overall Study|Protocol deviation|0
165902|NCT00557466|583976|P4|Overall Study|Protocol deviation|2
165903|NCT00557466|583977|P3|Overall Study|Protocol deviation|0
165904|NCT00557466|583978|P2|Overall Study|Protocol deviation|1
165905|NCT00557466|583979|P1|Overall Study|Protocol deviation|0
165906|NCT00557466|583974|P6|Overall Study|Abnormal laboratory value(s)|0
165907|NCT00557466|583975|P5|Overall Study|Abnormal laboratory value(s)|0
165908|NCT00557466|583976|P4|Overall Study|Abnormal laboratory value(s)|0
165909|NCT00557466|583977|P3|Overall Study|Abnormal laboratory value(s)|0
165910|NCT00557466|583978|P2|Overall Study|Abnormal laboratory value(s)|2
165911|NCT00557466|583979|P1|Overall Study|Abnormal laboratory value(s)|1
165912|NCT00557466|583974|P6|Overall Study|Adverse Event|4
165913|NCT00557466|583975|P5|Overall Study|Adverse Event|2
165914|NCT00557466|583976|P4|Overall Study|Adverse Event|1
165915|NCT00557466|583977|P3|Overall Study|Adverse Event|4
165916|NCT00557466|583978|P2|Overall Study|Adverse Event|1
165917|NCT00557466|583979|P1|Overall Study|Adverse Event|3
165918|NCT00557440|584032|P3|Treatment Period 1|Adverse Event|1
165919|NCT00557440|584033|P2|Treatment Period 1|Adverse Event|0
165920|NCT00557440|584034|P1|Treatment Period 1|Adverse Event|0
165921|NCT00557323|584088|P1|Overall Study|Administrative change|2
165922|NCT00557323|584088|P1|Overall Study|Withdrawal by Subject|2
165923|NCT00557323|584088|P1|Overall Study|Death|3
165924|NCT00557310|584093|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
165925|NCT00557310|584093|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
165926|NCT00557310|584093|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
165927|NCT00557310|584093|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
165928|NCT00557310|584093|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
165929|NCT00557310|584093|P1|Main Study (0 - 18 Months)|Adverse Event|4
165930|NCT00557245|584139|P3|Overall Study|Ineligible|2
165931|NCT00557245|584140|P2|Overall Study|Ineligible|4
165932|NCT00557245|584141|P1|Overall Study|Ineligible|5
165933|NCT00557245|584139|P3|Overall Study|Lost to Follow-up|10
165934|NCT00557245|584140|P2|Overall Study|Lost to Follow-up|8
165935|NCT00557245|584141|P1|Overall Study|Lost to Follow-up|7
165936|NCT00557076|584181|P2|Overall Study|Unblinding|1
165937|NCT00557076|584182|P1|Overall Study|Unblinding|0
165938|NCT00556998|584190|P1|Voriconazole Oral|Intolerant of oral treatment|1
165939|NCT00556998|584190|P1|Voriconazole Oral|Adverse Event|1
165940|NCT00556998|584190|P1|Voriconazole Intravenous (IV)|Other|4
165941|NCT00556998|584190|P1|Voriconazole Intravenous (IV)|Adverse Event|1
165942|NCT00556933|584225|P4|CNI Withdrawal vs. Minimization|Death|1
165943|NCT00556933|584226|P3|CNI Withdrawal vs. Minimization|Death|0
165944|NCT00556933|584227|P2|CNI Withdrawal vs. Minimization|Death|0
165945|NCT00556933|584228|P1|CNI Withdrawal vs. Minimization|Death|0
165946|NCT00556933|584225|P4|CNI Withdrawal vs. Minimization|Graft loss|0
165947|NCT00556933|584226|P3|CNI Withdrawal vs. Minimization|Graft loss|2
165948|NCT00556933|584227|P2|CNI Withdrawal vs. Minimization|Graft loss|1
165949|NCT00556933|584228|P1|CNI Withdrawal vs. Minimization|Graft loss|0
165950|NCT00556933|584225|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
165951|NCT00556933|584226|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
165952|NCT00556933|584227|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
165953|NCT00556933|584228|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
165954|NCT00556933|584225|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
165955|NCT00556933|584226|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
165956|NCT00556933|584227|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
165957|NCT00556933|584228|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
165958|NCT00556933|584225|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
165959|NCT00556933|584226|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
165960|NCT00556933|584227|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
165961|NCT00556933|584228|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
165962|NCT00556933|584225|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
165963|NCT00556933|584226|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
165964|NCT00556933|584227|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
165965|NCT00556933|584228|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
165966|NCT00556933|584225|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
165967|NCT00556933|584226|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
165968|NCT00556933|584227|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
165969|NCT00556933|584228|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
165970|NCT00556933|584225|P4|Single vs. Divided-dose rATG Induction|Death|0
165971|NCT00556933|584226|P3|Single vs. Divided-dose rATG Induction|Death|0
165972|NCT00556933|584227|P2|Single vs. Divided-dose rATG Induction|Death|1
165973|NCT00556933|584228|P1|Single vs. Divided-dose rATG Induction|Death|0
165974|NCT00556933|584225|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
165975|NCT00556933|584226|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
165976|NCT00556933|584227|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
165977|NCT00556933|584228|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
165978|NCT00556933|584225|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
165979|NCT00556933|584226|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
165980|NCT00556933|584227|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
165981|NCT00556933|584228|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
165982|NCT00556933|584225|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
165983|NCT00556933|584226|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
165984|NCT00556933|584227|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
165985|NCT00556933|584228|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
165986|NCT00556894|584285|P3|Overall Study|Withdrawal by Subject|1
165987|NCT00556894|584286|P2|Overall Study|Withdrawal by Subject|1
165988|NCT00556894|584287|P1|Overall Study|Withdrawal by Subject|1
165989|NCT00556894|584285|P3|Overall Study|Change in therapy|2
165990|NCT00556894|584286|P2|Overall Study|Change in therapy|1
165991|NCT00556894|584287|P1|Overall Study|Change in therapy|2
165992|NCT00556894|584285|P3|Overall Study|regulatory decision in Bulgaria|13
165993|NCT00556894|584286|P2|Overall Study|regulatory decision in Bulgaria|14
165994|NCT00556894|584287|P1|Overall Study|regulatory decision in Bulgaria|10
165995|NCT00556894|584285|P3|Overall Study|Death|0
165996|NCT00556894|584286|P2|Overall Study|Death|0
165997|NCT00556894|584287|P1|Overall Study|Death|1
165998|NCT00556894|584285|P3|Overall Study|Adverse Event|3
165999|NCT00556894|584286|P2|Overall Study|Adverse Event|3
166000|NCT00556894|584287|P1|Overall Study|Adverse Event|2
166001|NCT00556712|584297|P2|Overall Study|Ongoing at Data Cutoff|66
166002|NCT00556712|584298|P1|Overall Study|Ongoing at Data Cutoff|32
166003|NCT00556712|584297|P2|Overall Study|Not Specified|2
166004|NCT00556712|584298|P1|Overall Study|Not Specified|2
166005|NCT00556712|584297|P2|Overall Study|Failure to Return|3
166006|NCT00556712|584298|P1|Overall Study|Failure to Return|2
166007|NCT00556712|584297|P2|Overall Study|Refused Treatment|16
166008|NCT00556712|584298|P1|Overall Study|Refused Treatment|17
166009|NCT00556712|584297|P2|Overall Study|Protocol Violation|2
166010|NCT00556712|584298|P1|Overall Study|Protocol Violation|3
166011|NCT00556712|584297|P2|Overall Study|Progressive Disease|320
166012|NCT00556712|584298|P1|Overall Study|Progressive Disease|383
166013|NCT00556712|584297|P2|Overall Study|Death|10
166014|NCT00556712|584298|P1|Overall Study|Death|5
166015|NCT00556712|584297|P2|Overall Study|Adverse Event|19
166016|NCT00556712|584298|P1|Overall Study|Adverse Event|7
166017|NCT00556673|584376|P2|Overall Study|Protocol deviation|2
166018|NCT00556673|584377|P1|Overall Study|Protocol deviation|3
166019|NCT00556439|584513|P4|After Week 12 (Randomized Study Period)|Severe infection|0
166020|NCT00556439|584514|P3|After Week 12 (Randomized Study Period)|Severe infection|0
166021|NCT00556439|584515|P2|After Week 12 (Randomized Study Period)|Severe infection|0
166022|NCT00556439|584516|P1|After Week 12 (Randomized Study Period)|Severe infection|1
166023|NCT00556439|584513|P4|After Week 12 (Randomized Study Period)|Malignancy|1
166024|NCT00556439|584514|P3|After Week 12 (Randomized Study Period)|Malignancy|0
166025|NCT00556439|584515|P2|After Week 12 (Randomized Study Period)|Malignancy|1
166026|NCT00556439|584516|P1|After Week 12 (Randomized Study Period)|Malignancy|0
166027|NCT00556439|584513|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
166028|NCT00556439|584514|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
166029|NCT00556439|584515|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
166030|NCT00556439|584516|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
166031|NCT00556439|584513|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
166032|NCT00556439|584514|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
166033|NCT00556439|584515|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
166034|NCT00556439|584516|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
166035|NCT00556439|584513|P4|Study Entry to Week 12|Malignancy|0
166036|NCT00556439|584514|P3|Study Entry to Week 12|Malignancy|1
166037|NCT00556439|584515|P2|Study Entry to Week 12|Malignancy|0
166038|NCT00556439|584516|P1|Study Entry to Week 12|Malignancy|0
166039|NCT00556439|584513|P4|Study Entry to Week 12|Recurrent infection|0
166040|NCT00556439|584514|P3|Study Entry to Week 12|Recurrent infection|0
166041|NCT00556439|584515|P2|Study Entry to Week 12|Recurrent infection|0
166042|NCT00556439|584516|P1|Study Entry to Week 12|Recurrent infection|1
166043|NCT00556439|584513|P4|Study Entry to Week 12|Withdrawal by Subject|0
166044|NCT00556439|584514|P3|Study Entry to Week 12|Withdrawal by Subject|1
166045|NCT00556439|584515|P2|Study Entry to Week 12|Withdrawal by Subject|0
166046|NCT00556439|584516|P1|Study Entry to Week 12|Withdrawal by Subject|1
166047|NCT00556439|584513|P4|Study Entry to Week 12|Physician Decision|0
166048|NCT00556439|584514|P3|Study Entry to Week 12|Physician Decision|0
166049|NCT00556439|584515|P2|Study Entry to Week 12|Physician Decision|0
166050|NCT00556439|584516|P1|Study Entry to Week 12|Physician Decision|1
166051|NCT00556439|584513|P4|Study Entry to Week 12|Lack of Efficacy|0
166052|NCT00556439|584514|P3|Study Entry to Week 12|Lack of Efficacy|6
166053|NCT00556439|584515|P2|Study Entry to Week 12|Lack of Efficacy|0
166054|NCT00556439|584516|P1|Study Entry to Week 12|Lack of Efficacy|5
166055|NCT00556426|584526|P1|Overall Study|Death|6
166056|NCT00556426|584526|P1|Overall Study|Withdrawal by Subject|3
166057|NCT00556374|584548|P2|Overall Study|Lost to Follow-up|5
166058|NCT00556374|584549|P1|Overall Study|Lost to Follow-up|7
166059|NCT00556374|584548|P2|Overall Study|Death|43
166060|NCT00556374|584549|P1|Overall Study|Death|50
166061|NCT00556374|584548|P2|Overall Study|Withdrawal by Subject|172
166062|NCT00556374|584549|P1|Overall Study|Withdrawal by Subject|190
166063|NCT00556322|584567|P2|Overall Study|Death|14
166064|NCT00556322|584568|P1|Overall Study|Death|20
166065|NCT00556322|584567|P2|Overall Study|Ongoing at data cutoff|5
166066|NCT00556322|584568|P1|Overall Study|Ongoing at data cutoff|3
166067|NCT00556322|584567|P2|Overall Study|Protocol Violation|1
166068|NCT00556322|584568|P1|Overall Study|Protocol Violation|5
166069|NCT00556322|584567|P2|Overall Study|Withdrawal by Subject|7
166070|NCT00556322|584568|P1|Overall Study|Withdrawal by Subject|19
166071|NCT00556322|584567|P2|Overall Study|Lost to Follow-up|3
166072|NCT00556322|584568|P1|Overall Study|Lost to Follow-up|5
166073|NCT00556322|584567|P2|Overall Study|Other|1
166074|NCT00556322|584568|P1|Overall Study|Other|4
166075|NCT00556322|584567|P2|Overall Study|Adverse Event|4
166076|NCT00556322|584568|P1|Overall Study|Adverse Event|7
166077|NCT00556322|584567|P2|Overall Study|Insufficient therapeutic response|168
166078|NCT00556322|584568|P1|Overall Study|Insufficient therapeutic response|158
166079|NCT00556166|584616|P1|Overall Study|Withdrawal by Subject|1
166080|NCT00556075|584629|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
166081|NCT00556075|584630|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
166082|NCT00556075|584631|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
166083|NCT00556075|584629|P3|Overall Study|Personal issues|0
166084|NCT00556075|584630|P2|Overall Study|Personal issues|1
166085|NCT00556075|584631|P1|Overall Study|Personal issues|4
166086|NCT00556075|584629|P3|Overall Study|Adverse Event|0
166087|NCT00556075|584630|P2|Overall Study|Adverse Event|2
166088|NCT00556075|584631|P1|Overall Study|Adverse Event|1
166089|NCT00556075|584629|P3|Overall Study|Not eligible|2
166090|NCT00556075|584630|P2|Overall Study|Not eligible|1
166091|NCT00556075|584631|P1|Overall Study|Not eligible|1
166092|NCT00556075|584629|P3|Overall Study|Protocol Violation|3
166093|NCT00556075|584630|P2|Overall Study|Protocol Violation|1
166094|NCT00556075|584631|P1|Overall Study|Protocol Violation|1
166095|NCT00556075|584629|P3|Overall Study|Withdrawal by Subject|0
166096|NCT00556075|584630|P2|Overall Study|Withdrawal by Subject|3
166097|NCT00556075|584631|P1|Overall Study|Withdrawal by Subject|3
166098|NCT00556075|584629|P3|Overall Study|Lost to Follow-up|3
166099|NCT00556075|584630|P2|Overall Study|Lost to Follow-up|0
166100|NCT00556075|584631|P1|Overall Study|Lost to Follow-up|3
166101|NCT00555906|584683|P5|Phase 2|Randomized but not Treated|2
166102|NCT00555906|584684|P4|Phase 2|Randomized but not Treated|0
166103|NCT00555906|584685|P3|Phase 2|Randomized but not Treated|0
166104|NCT00555906|584686|P2|Phase 2|Randomized but not Treated|0
166105|NCT00555906|584687|P1|Phase 2|Randomized but not Treated|0
166106|NCT00555906|584683|P5|Phase 2|Other|6
166107|NCT00555906|584684|P4|Phase 2|Other|0
166108|NCT00555906|584685|P3|Phase 2|Other|0
166109|NCT00555906|584686|P2|Phase 2|Other|0
166110|NCT00555906|584687|P1|Phase 2|Other|0
166111|NCT00555906|584683|P5|Phase 2|Withdrawal by Subject|2
166112|NCT00555906|584684|P4|Phase 2|Withdrawal by Subject|0
166113|NCT00555906|584685|P3|Phase 2|Withdrawal by Subject|0
166114|NCT00555906|584686|P2|Phase 2|Withdrawal by Subject|0
166115|NCT00555906|584687|P1|Phase 2|Withdrawal by Subject|0
166116|NCT00555906|584683|P5|Phase 2|Objective Progression or Relapse|16
166117|NCT00555906|584684|P4|Phase 2|Objective Progression or Relapse|0
166118|NCT00555906|584685|P3|Phase 2|Objective Progression or Relapse|0
166119|NCT00555906|584686|P2|Phase 2|Objective Progression or Relapse|0
166120|NCT00555906|584687|P1|Phase 2|Objective Progression or Relapse|0
166121|NCT00555906|584683|P5|Phase 2|Global Deterioration of Health Status|2
166122|NCT00555906|584684|P4|Phase 2|Global Deterioration of Health Status|0
166123|NCT00555906|584685|P3|Phase 2|Global Deterioration of Health Status|0
166124|NCT00555906|584686|P2|Phase 2|Global Deterioration of Health Status|0
166125|NCT00555906|584687|P1|Phase 2|Global Deterioration of Health Status|0
166126|NCT00555906|584683|P5|Phase 2|Adverse Event|4
166127|NCT00555906|584684|P4|Phase 2|Adverse Event|0
166128|NCT00555906|584685|P3|Phase 2|Adverse Event|0
166129|NCT00555906|584686|P2|Phase 2|Adverse Event|0
166130|NCT00555906|584687|P1|Phase 2|Adverse Event|0
166131|NCT00555906|584683|P5|Phase 1|Withdrawal by Subject|0
166132|NCT00555906|584684|P4|Phase 1|Withdrawal by Subject|1
166133|NCT00555906|584685|P3|Phase 1|Withdrawal by Subject|0
166134|NCT00555906|584686|P2|Phase 1|Withdrawal by Subject|0
166135|NCT00555906|584687|P1|Phase 1|Withdrawal by Subject|0
166136|NCT00555906|584683|P5|Phase 1|Adverse Event|0
166137|NCT00555906|584684|P4|Phase 1|Adverse Event|2
166138|NCT00555906|584685|P3|Phase 1|Adverse Event|3
166139|NCT00555906|584686|P2|Phase 1|Adverse Event|0
166140|NCT00555906|584687|P1|Phase 1|Adverse Event|0
166141|NCT00555906|584683|P5|Phase 1|Global Deterioration of Health Status|0
166142|NCT00555906|584684|P4|Phase 1|Global Deterioration of Health Status|1
166143|NCT00555906|584685|P3|Phase 1|Global Deterioration of Health Status|1
166144|NCT00555906|584686|P2|Phase 1|Global Deterioration of Health Status|1
166145|NCT00555906|584687|P1|Phase 1|Global Deterioration of Health Status|0
166146|NCT00555906|584683|P5|Phase 1|Objective Progression or Relapse|0
166147|NCT00555906|584684|P4|Phase 1|Objective Progression or Relapse|1
166148|NCT00555906|584685|P3|Phase 1|Objective Progression or Relapse|3
166149|NCT00555906|584686|P2|Phase 1|Objective Progression or Relapse|5
166150|NCT00555906|584687|P1|Phase 1|Objective Progression or Relapse|3
166151|NCT00555672|584803|P2|Overall Study|Participant refused|0
166152|NCT00555672|584804|P1|Overall Study|Participant refused|2
166153|NCT00555672|584803|P2|Overall Study|Other|1
166154|NCT00555672|584804|P1|Overall Study|Other|3
166155|NCT00555672|584803|P2|Overall Study|Objective progression or relapse|5
166156|NCT00555672|584804|P1|Overall Study|Objective progression or relapse|11
166157|NCT00555672|584803|P2|Overall Study|Adverse Event|2
166158|NCT00555672|584804|P1|Overall Study|Adverse Event|8
166159|NCT00555672|584803|P2|Overall Study|Death|2
166160|NCT00555672|584804|P1|Overall Study|Death|0
166161|NCT00555620|584829|P6|Overall Study|Not specified|3
166162|NCT00555620|584830|P5|Overall Study|Not specified|0
166163|NCT00555620|584831|P4|Overall Study|Not specified|1
166164|NCT00555620|584832|P3|Overall Study|Not specified|0
166165|NCT00555620|584833|P2|Overall Study|Not specified|0
166166|NCT00555620|584834|P1|Overall Study|Not specified|0
166167|NCT00555620|584829|P6|Overall Study|Participant refused treatment|1
166168|NCT00555620|584830|P5|Overall Study|Participant refused treatment|0
166169|NCT00555620|584831|P4|Overall Study|Participant refused treatment|0
166170|NCT00555620|584832|P3|Overall Study|Participant refused treatment|1
166171|NCT00555620|584833|P2|Overall Study|Participant refused treatment|1
166172|NCT00555620|584834|P1|Overall Study|Participant refused treatment|0
166173|NCT00555620|584829|P6|Overall Study|Objective progression or relapse|16
166174|NCT00555620|584830|P5|Overall Study|Objective progression or relapse|3
166175|NCT00555620|584831|P4|Overall Study|Objective progression or relapse|17
166176|NCT00555620|584832|P3|Overall Study|Objective progression or relapse|12
166177|NCT00555620|584833|P2|Overall Study|Objective progression or relapse|5
166178|NCT00555620|584834|P1|Overall Study|Objective progression or relapse|6
166179|NCT00555620|584829|P6|Overall Study|Adverse Event|1
166180|NCT00555620|584830|P5|Overall Study|Adverse Event|0
166181|NCT00555620|584831|P4|Overall Study|Adverse Event|5
166182|NCT00555620|584832|P3|Overall Study|Adverse Event|1
166183|NCT00555620|584833|P2|Overall Study|Adverse Event|0
166184|NCT00555620|584834|P1|Overall Study|Adverse Event|0
166185|NCT00555620|584829|P6|Overall Study|Study terminated by sponsor|0
166186|NCT00555620|584830|P5|Overall Study|Study terminated by sponsor|0
166187|NCT00555620|584831|P4|Overall Study|Study terminated by sponsor|0
166188|NCT00555620|584832|P3|Overall Study|Study terminated by sponsor|1
166189|NCT00555620|584833|P2|Overall Study|Study terminated by sponsor|0
166190|NCT00555620|584834|P1|Overall Study|Study terminated by sponsor|0
166191|NCT00555620|584829|P6|Overall Study|Death|1
166192|NCT00555620|584830|P5|Overall Study|Death|0
166193|NCT00555620|584831|P4|Overall Study|Death|0
166194|NCT00555620|584832|P3|Overall Study|Death|0
166195|NCT00555620|584833|P2|Overall Study|Death|1
166196|NCT00555620|584834|P1|Overall Study|Death|0
166197|NCT00555568|584958|P3|Overall Study|Lost to Follow-up|16
166198|NCT00555568|584959|P2|Overall Study|Lost to Follow-up|16
166199|NCT00555568|584960|P1|Overall Study|Lost to Follow-up|26
166200|NCT00555477|584982|P2|Overall Study|Physician Decision|2
166201|NCT00555477|584983|P1|Overall Study|Physician Decision|1
166202|NCT00555477|584982|P2|Overall Study|Withdrawal by Subject|2
166203|NCT00555477|584983|P1|Overall Study|Withdrawal by Subject|1
166204|NCT00555477|584982|P2|Overall Study|Adverse Event|9
166205|NCT00555477|584983|P1|Overall Study|Adverse Event|0
166206|NCT00555438|584999|P1|Between 10 Days and 30 Days Postoperativ|Death|5
166207|NCT00555438|584999|P1|10 Days Post-operative|Death|4
166208|NCT00555425|585009|P2|Overall Study|Became pregnant and transferred care|1
166209|NCT00555425|585010|P1|Overall Study|Became pregnant and transferred care|0
166210|NCT00555425|585009|P2|Overall Study|Met criteria for protective transfer|3
166211|NCT00555425|585010|P1|Overall Study|Met criteria for protective transfer|16
166212|NCT00555425|585009|P2|Overall Study|Missed 3 physician management visits|0
166213|NCT00555425|585010|P1|Overall Study|Missed 3 physician management visits|1
166214|NCT00555425|585009|P2|Overall Study|Missed Medication > 1 wk|15
166215|NCT00555425|585010|P1|Overall Study|Missed Medication > 1 wk|34
166216|NCT00555321|585046|P5|Long-term Extension Phase|Other Reason|0
166217|NCT00555321|585047|P4|Long-term Extension Phase|Other Reason|0
166218|NCT00555321|585048|P3|Long-term Extension Phase|Other Reason|2
166219|NCT00555321|585049|P2|Long-term Extension Phase|Other Reason|0
166220|NCT00555321|585050|P1|Long-term Extension Phase|Other Reason|1
166221|NCT00555321|585046|P5|Long-term Extension Phase|Participant did not meet study criteria|1
166222|NCT00555321|585047|P4|Long-term Extension Phase|Participant did not meet study criteria|0
166223|NCT00555321|585048|P3|Long-term Extension Phase|Participant did not meet study criteria|0
166224|NCT00555321|585049|P2|Long-term Extension Phase|Participant did not meet study criteria|0
166225|NCT00555321|585050|P1|Long-term Extension Phase|Participant did not meet study criteria|0
166226|NCT00555321|585046|P5|Long-term Extension Phase|Death|0
166227|NCT00555321|585047|P4|Long-term Extension Phase|Death|3
166228|NCT00555321|585048|P3|Long-term Extension Phase|Death|0
166229|NCT00555321|585049|P2|Long-term Extension Phase|Death|0
166230|NCT00555321|585050|P1|Long-term Extension Phase|Death|2
166231|NCT00555321|585046|P5|Long-term Extension Phase|Administrative reason by sponsor|23
166232|NCT00555321|585047|P4|Long-term Extension Phase|Administrative reason by sponsor|31
166233|NCT00555321|585048|P3|Long-term Extension Phase|Administrative reason by sponsor|18
166234|NCT00555321|585049|P2|Long-term Extension Phase|Administrative reason by sponsor|21
166235|NCT00555321|585050|P1|Long-term Extension Phase|Administrative reason by sponsor|23
166236|NCT00555321|585046|P5|Long-term Extension Phase|Withdrawal by Subject|2
166237|NCT00555321|585047|P4|Long-term Extension Phase|Withdrawal by Subject|3
166238|NCT00555321|585048|P3|Long-term Extension Phase|Withdrawal by Subject|2
166239|NCT00555321|585049|P2|Long-term Extension Phase|Withdrawal by Subject|1
166240|NCT00555321|585050|P1|Long-term Extension Phase|Withdrawal by Subject|2
166241|NCT00555321|585046|P5|Long-term Extension Phase|Adverse Event|0
166242|NCT00555321|585047|P4|Long-term Extension Phase|Adverse Event|1
166243|NCT00555321|585048|P3|Long-term Extension Phase|Adverse Event|2
166244|NCT00555321|585049|P2|Long-term Extension Phase|Adverse Event|5
166245|NCT00555321|585050|P1|Long-term Extension Phase|Adverse Event|2
166246|NCT00555321|585046|P5|Treatment Phase up to 12-months|Never treated|4
166247|NCT00555321|585047|P4|Treatment Phase up to 12-months|Never treated|0
166248|NCT00555321|585048|P3|Treatment Phase up to 12-months|Never treated|1
166249|NCT00555321|585049|P2|Treatment Phase up to 12-months|Never treated|3
166250|NCT00555321|585050|P1|Treatment Phase up to 12-months|Never treated|2
166251|NCT00555321|585046|P5|Treatment Phase up to 12-months|Other Reason|0
166252|NCT00555321|585047|P4|Treatment Phase up to 12-months|Other Reason|0
166253|NCT00555321|585048|P3|Treatment Phase up to 12-months|Other Reason|2
166254|NCT00555321|585049|P2|Treatment Phase up to 12-months|Other Reason|3
166255|NCT00555321|585050|P1|Treatment Phase up to 12-months|Other Reason|1
166256|NCT00555321|585046|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
166257|NCT00555321|585047|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
166258|NCT00555321|585048|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
166259|NCT00555321|585049|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
166260|NCT00555321|585050|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
166261|NCT00555321|585046|P5|Treatment Phase up to 12-months|Death|0
166262|NCT00555321|585047|P4|Treatment Phase up to 12-months|Death|0
166263|NCT00555321|585048|P3|Treatment Phase up to 12-months|Death|4
166264|NCT00555321|585049|P2|Treatment Phase up to 12-months|Death|1
166265|NCT00555321|585050|P1|Treatment Phase up to 12-months|Death|2
166266|NCT00555321|585046|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
166267|NCT00555321|585047|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
166268|NCT00555321|585048|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
166269|NCT00555321|585049|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
166270|NCT00555321|585050|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
166271|NCT00555321|585046|P5|Treatment Phase up to 12-months|Adverse Event|18
166272|NCT00555321|585047|P4|Treatment Phase up to 12-months|Adverse Event|7
166273|NCT00555321|585048|P3|Treatment Phase up to 12-months|Adverse Event|11
166274|NCT00555321|585049|P2|Treatment Phase up to 12-months|Adverse Event|7
166275|NCT00555321|585050|P1|Treatment Phase up to 12-months|Adverse Event|6
166276|NCT00555217|585354|P2|Overall Study|close out sites|17
166277|NCT00555217|585355|P1|Overall Study|close out sites|21
166278|NCT00555217|585354|P2|Overall Study|Lost to Follow-up|20
166279|NCT00555217|585355|P1|Overall Study|Lost to Follow-up|19
166280|NCT00555217|585354|P2|Overall Study|Withdrawal by Subject|31
166281|NCT00555217|585355|P1|Overall Study|Withdrawal by Subject|35
166282|NCT00555061|585392|P1|Overall Study|Participant enrolled, but never treated|1
166283|NCT00555061|585392|P1|Overall Study|Withdrawal by Subject|2
166284|NCT00555061|585392|P1|Overall Study|Lost to Follow-up|2
166285|NCT00555061|585392|P1|Overall Study|Protocol Violation|1
166286|NCT00555061|585392|P1|Overall Study|Adverse Event|3
166287|NCT00555009|585411|P2|Overall Study|Terminated by Sponsor|5
166288|NCT00555009|585412|P1|Overall Study|Terminated by Sponsor|2
166289|NCT00555009|585411|P2|Overall Study|Withdrawal by Subject|1
166290|NCT00555009|585412|P1|Overall Study|Withdrawal by Subject|0
166291|NCT00554840|585492|P2|Overall Study|Physician Decision|1
166292|NCT00554840|585493|P1|Overall Study|Physician Decision|0
166293|NCT00554801|585511|P2|Overall Study|Withdrawal by Subject|0
166294|NCT00554801|585512|P1|Overall Study|Withdrawal by Subject|14
166295|NCT00554801|585511|P2|Overall Study|left area before completion|0
166296|NCT00554801|585512|P1|Overall Study|left area before completion|5
166297|NCT00554619|585534|P1|Overall Study|Liver Function Test Abnormality|1
166298|NCT00554619|585534|P1|Overall Study|Physician Decision|1
166299|NCT00554619|585534|P1|Overall Study|Adverse Event|1
166300|NCT00554515|585546|P1|Overall Study|Misc|15
166301|NCT00554515|585546|P1|Overall Study|Other|1
166302|NCT00554515|585546|P1|Overall Study|Achieved Stable Disease|7
166303|NCT00554515|585546|P1|Overall Study|Death|2
166304|NCT00554515|585546|P1|Overall Study|Adverse Event|9
166305|NCT00554515|585546|P1|Overall Study|Withdrawal by Subject|11
166306|NCT00554515|585546|P1|Overall Study|Physician Decision|18
166307|NCT00554515|585546|P1|Overall Study|Disease progression|52
166308|NCT00554515|585546|P1|Overall Study|Withdrawal by Subject|3
166309|NCT00554229|585603|P2|Overall Study|Randomised but no treatment received|0
166310|NCT00554229|585604|P1|Overall Study|Randomised but no treatment received|1
166311|NCT00554229|585603|P2|Overall Study|Reason not otherwise captured, eg; death|140
166312|NCT00554229|585604|P1|Overall Study|Reason not otherwise captured, eg; death|119
166313|NCT00554229|585603|P2|Overall Study|Protocol Violation|3
166314|NCT00554229|585604|P1|Overall Study|Protocol Violation|3
166315|NCT00554229|585603|P2|Overall Study|Adverse Event|39
166316|NCT00554229|585604|P1|Overall Study|Adverse Event|71
166317|NCT00554229|585603|P2|Overall Study|Withdrawal by Subject|37
166318|NCT00554229|585604|P1|Overall Study|Withdrawal by Subject|29
166319|NCT00554229|585603|P2|Overall Study|Lost to Follow-up|6
166320|NCT00554229|585604|P1|Overall Study|Lost to Follow-up|3
166321|NCT00554216|585629|P3|Overall Study|Lack of Efficacy|0
166322|NCT00554216|585630|P2|Overall Study|Lack of Efficacy|3
166323|NCT00554216|585631|P1|Overall Study|Lack of Efficacy|15
166324|NCT00554216|585629|P3|Overall Study|not specified|10
166325|NCT00554216|585630|P2|Overall Study|not specified|7
166326|NCT00554216|585631|P1|Overall Study|not specified|12
166327|NCT00554216|585629|P3|Overall Study|Restricted med|1
166328|NCT00554216|585630|P2|Overall Study|Restricted med|1
166329|NCT00554216|585631|P1|Overall Study|Restricted med|3
166330|NCT00554216|585629|P3|Overall Study|Pregnancy|14
166331|NCT00554216|585630|P2|Overall Study|Pregnancy|1
166332|NCT00554216|585631|P1|Overall Study|Pregnancy|2
166333|NCT00554216|585629|P3|Overall Study|Non compliance|5
166334|NCT00554216|585630|P2|Overall Study|Non compliance|4
166335|NCT00554216|585631|P1|Overall Study|Non compliance|10
166336|NCT00554216|585629|P3|Overall Study|Withdrawal by Subject|43
166337|NCT00554216|585630|P2|Overall Study|Withdrawal by Subject|31
166338|NCT00554216|585631|P1|Overall Study|Withdrawal by Subject|92
166339|NCT00554216|585629|P3|Overall Study|Adverse Event|36
166340|NCT00554216|585630|P2|Overall Study|Adverse Event|16
166341|NCT00554216|585631|P1|Overall Study|Adverse Event|16
166342|NCT00554216|585629|P3|Overall Study|Lost to Follow-up|63
166343|NCT00554216|585630|P2|Overall Study|Lost to Follow-up|31
166344|NCT00554216|585631|P1|Overall Study|Lost to Follow-up|92
166345|NCT00554190|585642|P1|Overall Study|Termination forms not completed|10
166346|NCT00554099|585651|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
166347|NCT00554099|585652|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
166348|NCT00554099|585653|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
166349|NCT00554099|585651|P3|Non-Treatment Phase (9 Months)|Relapse|1
166350|NCT00554099|585652|P2|Non-Treatment Phase (9 Months)|Relapse|1
166351|NCT00554099|585653|P1|Non-Treatment Phase (9 Months)|Relapse|2
166352|NCT00554099|585651|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
166353|NCT00554099|585652|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
166354|NCT00554099|585653|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
166355|NCT00554099|585651|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
166356|NCT00554099|585652|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
166357|NCT00554099|585653|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
166358|NCT00554099|585651|P3|Treatment Period (12 Weeks)|Protocol Violation|2
166359|NCT00554099|585652|P2|Treatment Period (12 Weeks)|Protocol Violation|0
166360|NCT00554099|585653|P1|Treatment Period (12 Weeks)|Protocol Violation|0
166361|NCT00554099|585651|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
166362|NCT00554099|585652|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
166363|NCT00554099|585653|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
166364|NCT00554099|585651|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
166365|NCT00554099|585652|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
166366|NCT00554099|585653|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
166367|NCT00554099|585651|P3|Treatment Period (12 Weeks)|Physician Decision|0
166368|NCT00554099|585652|P2|Treatment Period (12 Weeks)|Physician Decision|0
166369|NCT00554099|585653|P1|Treatment Period (12 Weeks)|Physician Decision|3
166370|NCT00554099|585651|P3|Treatment Period (12 Weeks)|Adverse Event|1
166371|NCT00554099|585652|P2|Treatment Period (12 Weeks)|Adverse Event|5
166372|NCT00554099|585653|P1|Treatment Period (12 Weeks)|Adverse Event|3
166373|NCT00553787|585708|P3|Overall Study|not specified|13
166374|NCT00553787|585709|P2|Overall Study|not specified|10
166375|NCT00553787|585710|P1|Overall Study|not specified|18
166376|NCT00553787|585708|P3|Overall Study|Requirement for restricted medication|5
166377|NCT00553787|585709|P2|Overall Study|Requirement for restricted medication|7
166378|NCT00553787|585710|P1|Overall Study|Requirement for restricted medication|8
166379|NCT00553787|585708|P3|Overall Study|non compliance|11
166380|NCT00553787|585709|P2|Overall Study|non compliance|0
166381|NCT00553787|585710|P1|Overall Study|non compliance|4
166382|NCT00553787|585708|P3|Overall Study|Pregnancy|2
166383|NCT00553787|585709|P2|Overall Study|Pregnancy|1
166384|NCT00553787|585710|P1|Overall Study|Pregnancy|0
166385|NCT00553787|585708|P3|Overall Study|Lack of Efficacy|3
166386|NCT00553787|585709|P2|Overall Study|Lack of Efficacy|1
166387|NCT00553787|585710|P1|Overall Study|Lack of Efficacy|31
166388|NCT00553787|585708|P3|Overall Study|Withdrawal by Subject|83
166389|NCT00553787|585709|P2|Overall Study|Withdrawal by Subject|40
166390|NCT00553787|585710|P1|Overall Study|Withdrawal by Subject|151
166391|NCT00553787|585708|P3|Overall Study|Lost to Follow-up|78
166392|NCT00553787|585709|P2|Overall Study|Lost to Follow-up|44
166393|NCT00553787|585710|P1|Overall Study|Lost to Follow-up|132
166394|NCT00553787|585708|P3|Overall Study|Adverse Event|67
166395|NCT00553787|585709|P2|Overall Study|Adverse Event|21
166396|NCT00553787|585710|P1|Overall Study|Adverse Event|34
166397|NCT00553696|585742|P4|Overall Study|Withdrawal by Subject|0
166398|NCT00553696|585743|P3|Overall Study|Withdrawal by Subject|0
166399|NCT00553696|585744|P2|Overall Study|Withdrawal by Subject|1
166400|NCT00553696|585745|P1|Overall Study|Withdrawal by Subject|0
166401|NCT00553696|585742|P4|Overall Study|Objective progression or relapse|0
166402|NCT00553696|585743|P3|Overall Study|Objective progression or relapse|6
166403|NCT00553696|585744|P2|Overall Study|Objective progression or relapse|9
166404|NCT00553696|585745|P1|Overall Study|Objective progression or relapse|2
166405|NCT00553696|585742|P4|Overall Study|Global deterioration of health status|0
166406|NCT00553696|585743|P3|Overall Study|Global deterioration of health status|0
166407|NCT00553696|585744|P2|Overall Study|Global deterioration of health status|2
166408|NCT00553696|585745|P1|Overall Study|Global deterioration of health status|0
166409|NCT00553696|585742|P4|Overall Study|Adverse Event|1
166410|NCT00553696|585743|P3|Overall Study|Adverse Event|0
166411|NCT00553696|585744|P2|Overall Study|Adverse Event|4
166412|NCT00553696|585745|P1|Overall Study|Adverse Event|2
166413|NCT00553644|585783|P1|Overall Study|Alternative therapy|6
166414|NCT00553644|585783|P1|Overall Study|Physician Decision|1
166415|NCT00553644|585783|P1|Overall Study|Withdrawal by Subject|4
166416|NCT00553644|585783|P1|Overall Study|Adverse Event|17
166417|NCT00553631|585792|P2|Overall Study|Lost to Follow-up|0
166418|NCT00553631|585793|P1|Overall Study|Lost to Follow-up|1
166419|NCT00553631|585792|P2|Overall Study|Withdrawal by Subject|1
166420|NCT00553631|585793|P1|Overall Study|Withdrawal by Subject|0
166421|NCT00553605|585815|P2|Overall Study|Randomized but not treated|0
166422|NCT00553605|585816|P1|Overall Study|Randomized but not treated|2
166423|NCT00553605|585815|P2|Overall Study|Did not receive full dose|0
166424|NCT00553605|585816|P1|Overall Study|Did not receive full dose|1
166425|NCT00553605|585815|P2|Overall Study|Did not meet entrance criteria|3
166426|NCT00553605|585816|P1|Overall Study|Did not meet entrance criteria|1
166427|NCT00553514|585845|P5|Overall Study|Other|1
166428|NCT00553514|585846|P4|Overall Study|Other|0
166429|NCT00553514|585847|P3|Overall Study|Other|0
166430|NCT00553514|585848|P2|Overall Study|Other|1
166431|NCT00553514|585849|P1|Overall Study|Other|1
166432|NCT00553514|585845|P5|Overall Study|Risk of multiple pregnancy|0
166433|NCT00553514|585846|P4|Overall Study|Risk of multiple pregnancy|1
166434|NCT00553514|585847|P3|Overall Study|Risk of multiple pregnancy|0
166435|NCT00553514|585848|P2|Overall Study|Risk of multiple pregnancy|2
166436|NCT00553514|585849|P1|Overall Study|Risk of multiple pregnancy|0
166437|NCT00553514|585845|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
166438|NCT00553514|585846|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
166439|NCT00553514|585847|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
166440|NCT00553514|585848|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
166441|NCT00553514|585849|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
166442|NCT00553514|585845|P5|Overall Study|Lack of ovarian response|6
166443|NCT00553514|585846|P4|Overall Study|Lack of ovarian response|5
166444|NCT00553514|585847|P3|Overall Study|Lack of ovarian response|5
166445|NCT00553514|585848|P2|Overall Study|Lack of ovarian response|5
166446|NCT00553514|585849|P1|Overall Study|Lack of ovarian response|4
166447|NCT00553514|585845|P5|Overall Study|Protocol deviation|0
166448|NCT00553514|585846|P4|Overall Study|Protocol deviation|1
166449|NCT00553514|585847|P3|Overall Study|Protocol deviation|0
166450|NCT00553514|585848|P2|Overall Study|Protocol deviation|0
166451|NCT00553514|585849|P1|Overall Study|Protocol deviation|0
166452|NCT00553501|585886|P1|Overall Study|Progression|1
166453|NCT00553501|585886|P1|Overall Study|Death|1
166454|NCT00553501|585886|P1|Overall Study|Adverse Event|2
166455|NCT00553475|585895|P3|Overall Study|Due to moving|0
166456|NCT00553475|585896|P2|Overall Study|Due to moving|1
166457|NCT00553475|585897|P1|Overall Study|Due to moving|0
166458|NCT00553475|585895|P3|Overall Study|Physician Decision|0
166459|NCT00553475|585896|P2|Overall Study|Physician Decision|0
166460|NCT00553475|585897|P1|Overall Study|Physician Decision|1
166461|NCT00553475|585895|P3|Overall Study|Withdrawal by Subject|0
166462|NCT00553475|585896|P2|Overall Study|Withdrawal by Subject|1
166463|NCT00553475|585897|P1|Overall Study|Withdrawal by Subject|1
166464|NCT00553475|585895|P3|Overall Study|Lack of Efficacy|0
166465|NCT00553475|585896|P2|Overall Study|Lack of Efficacy|1
166466|NCT00553475|585897|P1|Overall Study|Lack of Efficacy|7
166467|NCT00553475|585895|P3|Overall Study|Adverse Event|13
166468|NCT00553475|585896|P2|Overall Study|Adverse Event|17
166469|NCT00553475|585897|P1|Overall Study|Adverse Event|7
166470|NCT00553462|586019|P1|Overall Study|Physician Decision|1
166471|NCT00553462|586019|P1|Overall Study|Withdrawal by Subject|5
166472|NCT00553462|586019|P1|Overall Study|Progression|4
166473|NCT00553462|586019|P1|Overall Study|Adverse Event|4
166474|NCT00553436|586025|P1|Overall Study|Conversion to another procedure|1
166475|NCT00553358|586034|P3|Overall Study|Other: Reason Not Specified|20
166476|NCT00553358|586035|P2|Overall Study|Other: Reason Not Specified|4
166477|NCT00553358|586036|P1|Overall Study|Other: Reason Not Specified|15
166478|NCT00553358|586034|P3|Overall Study|Missing|1
166479|NCT00553358|586035|P2|Overall Study|Missing|1
166480|NCT00553358|586036|P1|Overall Study|Missing|1
166481|NCT00553358|586034|P3|Overall Study|Participant Withdrawal from Drug|3
166482|NCT00553358|586035|P2|Overall Study|Participant Withdrawal from Drug|0
166483|NCT00553358|586036|P1|Overall Study|Participant Withdrawal from Drug|0
166484|NCT00553358|586034|P3|Overall Study|Recurrence of Disease|1
166485|NCT00553358|586035|P2|Overall Study|Recurrence of Disease|4
166486|NCT00553358|586036|P1|Overall Study|Recurrence of Disease|3
166487|NCT00553358|586034|P3|Overall Study|Withdrawal by Subject|1
166488|NCT00553358|586035|P2|Overall Study|Withdrawal by Subject|0
166489|NCT00553358|586036|P1|Overall Study|Withdrawal by Subject|5
166490|NCT00553358|586034|P3|Overall Study|Protocol Violation|1
166491|NCT00553358|586035|P2|Overall Study|Protocol Violation|1
166492|NCT00553358|586036|P1|Overall Study|Protocol Violation|0
166493|NCT00553358|586034|P3|Overall Study|Lost to Follow-up|1
166494|NCT00553358|586035|P2|Overall Study|Lost to Follow-up|0
166495|NCT00553358|586036|P1|Overall Study|Lost to Follow-up|0
166496|NCT00553358|586034|P3|Overall Study|Adverse Event|32
166497|NCT00553358|586035|P2|Overall Study|Adverse Event|2
166498|NCT00553358|586036|P1|Overall Study|Adverse Event|29
166499|NCT00553332|586062|P1|Overall Study|ineligible, incorrect diagnosis|1
166500|NCT00553319|586074|P3|Overall Study|moved|1
166501|NCT00553319|586075|P2|Overall Study|moved|0
166502|NCT00553319|586076|P1|Overall Study|moved|1
166503|NCT00553319|586074|P3|Overall Study|incarceration|0
166504|NCT00553319|586075|P2|Overall Study|incarceration|0
166505|NCT00553319|586076|P1|Overall Study|incarceration|1
166506|NCT00553319|586074|P3|Overall Study|non-compliance|2
166507|NCT00553319|586075|P2|Overall Study|non-compliance|0
166508|NCT00553319|586076|P1|Overall Study|non-compliance|0
166509|NCT00553319|586074|P3|Overall Study|wanted treatment elsewhere|1
166510|NCT00553319|586075|P2|Overall Study|wanted treatment elsewhere|1
166511|NCT00553319|586076|P1|Overall Study|wanted treatment elsewhere|2
166512|NCT00553319|586074|P3|Overall Study|Lost to Follow-up|5
166513|NCT00553319|586075|P2|Overall Study|Lost to Follow-up|9
166514|NCT00553319|586076|P1|Overall Study|Lost to Follow-up|10
166515|NCT00553280|586087|P1|Overall Study|Physician Decision|1
166516|NCT00553280|586087|P1|Overall Study|Withdrawal by Subject|3
166517|NCT00553280|586087|P1|Overall Study|Lack of Efficacy|3
166518|NCT00553280|586087|P1|Overall Study|Adverse Event|19
166519|NCT00553267|586099|P3|Overall Study|Specified category|1
166520|NCT00553267|586100|P2|Overall Study|Specified category|2
166521|NCT00553267|586101|P1|Overall Study|Specified category|1
166522|NCT00553267|586099|P3|Overall Study|Consent withdrawn|1
166523|NCT00553267|586100|P2|Overall Study|Consent withdrawn|3
166524|NCT00553267|586101|P1|Overall Study|Consent withdrawn|2
166525|NCT00553267|586099|P3|Overall Study|Lost to Follow-up|1
166526|NCT00553267|586100|P2|Overall Study|Lost to Follow-up|0
166527|NCT00553267|586101|P1|Overall Study|Lost to Follow-up|0
166528|NCT00553267|586099|P3|Overall Study|Non compliant with protocol|2
166529|NCT00553267|586100|P2|Overall Study|Non compliant with protocol|3
166530|NCT00553267|586101|P1|Overall Study|Non compliant with protocol|3
166531|NCT00553267|586099|P3|Overall Study|Adverse Event|5
166532|NCT00553267|586100|P2|Overall Study|Adverse Event|10
166533|NCT00553267|586101|P1|Overall Study|Adverse Event|8
166534|NCT00553202|586136|P1|Overall Study|Fails to meet organ function|6
166535|NCT00553202|586136|P1|Overall Study|No donor identified|16
166536|NCT00553202|586136|P1|Overall Study|Withdrawal by Subject|1
166537|NCT00553202|586136|P1|Overall Study|Physician Decision|28
166538|NCT00553202|586136|P1|Overall Study|Lost to Follow-up|1
166539|NCT00553202|586136|P1|Overall Study|Death|16
166540|NCT00553150|586146|P4|Overall Study|Ineligible|1
166541|NCT00553150|586147|P3|Overall Study|Ineligible|0
166542|NCT00553150|586148|P2|Overall Study|Ineligible|0
166543|NCT00553150|586149|P1|Overall Study|Ineligible|0
166544|NCT00553150|586146|P4|Overall Study|Protocol Violation|1
166545|NCT00553150|586147|P3|Overall Study|Protocol Violation|0
166546|NCT00553150|586148|P2|Overall Study|Protocol Violation|0
166547|NCT00553150|586149|P1|Overall Study|Protocol Violation|0
166548|NCT00553150|586146|P4|Overall Study|Withdrawal by Subject|2
166549|NCT00553150|586147|P3|Overall Study|Withdrawal by Subject|0
166550|NCT00553150|586148|P2|Overall Study|Withdrawal by Subject|0
166551|NCT00553150|586149|P1|Overall Study|Withdrawal by Subject|0
166552|NCT00552760|586194|P2|Overall Study|Medication Change|0
166553|NCT00552760|586195|P1|Overall Study|Medication Change|1
166554|NCT00552760|586194|P2|Overall Study|Withdrawal by Subject|0
166555|NCT00552760|586195|P1|Overall Study|Withdrawal by Subject|3
166556|NCT00552760|586194|P2|Overall Study|Medical Condition|1
166557|NCT00552760|586195|P1|Overall Study|Medical Condition|1
166558|NCT00552760|586194|P2|Overall Study|Non-compliance|1
166559|NCT00552760|586195|P1|Overall Study|Non-compliance|1
166560|NCT00552760|586194|P2|Overall Study|Lost to Follow-up|1
166561|NCT00552760|586195|P1|Overall Study|Lost to Follow-up|1
166562|NCT00552760|586194|P2|Overall Study|Protocol Violation|1
166563|NCT00552760|586195|P1|Overall Study|Protocol Violation|0
166564|NCT00552760|586194|P2|Overall Study|Relapsed- Mixed Event|5
166565|NCT00552760|586195|P1|Overall Study|Relapsed- Mixed Event|3
166566|NCT00552760|586194|P2|Overall Study|Relapse- Manic Event|3
166567|NCT00552760|586195|P1|Overall Study|Relapse- Manic Event|3
166568|NCT00552760|586194|P2|Overall Study|Relapsed- Depressed Event|16
166569|NCT00552760|586195|P1|Overall Study|Relapsed- Depressed Event|10
166570|NCT00552760|586194|P2|Overall Study|Adverse Event|5
166571|NCT00552760|586195|P1|Overall Study|Adverse Event|3
166572|NCT00552669|586222|P2|Overall Study|Death|7
166573|NCT00552669|586223|P1|Overall Study|Death|3
166574|NCT00552578|586235|P2|Overall Study|Lost to Follow-up|1
166575|NCT00552578|586236|P1|Overall Study|Lost to Follow-up|1
166576|NCT00552513|586248|P2|Overall Study|Lost to Follow-up|1
166577|NCT00552513|586249|P1|Overall Study|Lost to Follow-up|5
166578|NCT00552396|586294|P7|Overall Study|protocol withdrawal criteria|9
166579|NCT00552396|586295|P6|Overall Study|protocol withdrawal criteria|3
166580|NCT00552396|586296|P5|Overall Study|protocol withdrawal criteria|3
166581|NCT00552396|586297|P4|Overall Study|protocol withdrawal criteria|6
166582|NCT00552396|586298|P3|Overall Study|protocol withdrawal criteria|3
166583|NCT00552396|586299|P2|Overall Study|protocol withdrawal criteria|3
166584|NCT00552396|586300|P1|Overall Study|protocol withdrawal criteria|3
166585|NCT00552344|586337|P1|Overall Study|Other Reason|22
166586|NCT00552344|586337|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
166587|NCT00552344|586337|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
166588|NCT00552344|586337|P1|Overall Study|AE, non-serious non-fatal|38
166589|NCT00552344|586337|P1|Overall Study|SAE, non-fatal|6
166590|NCT00552344|586337|P1|Overall Study|Withdrawal by Subject|48
166591|NCT00552344|586337|P1|Overall Study|Lost to Follow-up|8
166592|NCT00552344|586337|P1|Overall Study|Loss of efficacy|75
166593|NCT00552344|586337|P1|Overall Study|Lack of Efficacy|55
166594|NCT00552305|586346|P1|Overall Study|Other: Subject went to rehab|1
166595|NCT00552305|586346|P1|Overall Study|Other: Subject incarcerated|1
166596|NCT00552305|586346|P1|Overall Study|Other: Subject moved from area|2
166597|NCT00552305|586346|P1|Overall Study|Other: Health problems, not drug related|1
166598|NCT00552305|586346|P1|Overall Study|Other: Subject became pregnant|1
166599|NCT00552305|586346|P1|Overall Study|Other: Subject underwent surgery|4
166600|NCT00552305|586346|P1|Overall Study|Other: Unable to attend visits|1
166601|NCT00552305|586346|P1|Overall Study|Other: Personal problems|1
166602|NCT00552305|586346|P1|Overall Study|Other: Site closed|4
166603|NCT00552305|586346|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
166604|NCT00552305|586346|P1|Overall Study|AE/Other: prohibited drug required|1
166605|NCT00552305|586346|P1|Overall Study|Poor compliance/lost to follow-up|1
166606|NCT00552305|586346|P1|Overall Study|Unsatisfactory compliance|11
166607|NCT00552305|586346|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
166608|NCT00552305|586346|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
166609|NCT00552305|586346|P1|Overall Study|Lack of efficacy/withdrew consent|1
166610|NCT00552305|586346|P1|Overall Study|Withdrawal by Subject|44
166611|NCT00552305|586346|P1|Overall Study|Protocol Violation|3
166612|NCT00552305|586346|P1|Overall Study|Lost to Follow-up|4
166613|NCT00552305|586346|P1|Overall Study|Lack of Efficacy|120
166614|NCT00552305|586346|P1|Overall Study|Adverse Event|43
166615|NCT00552279|586356|P2|Overall Study|Other|1
166616|NCT00552279|586357|P1|Overall Study|Other|1
166617|NCT00552279|586356|P2|Overall Study|Lost to Follow-up|0
166618|NCT00552279|586357|P1|Overall Study|Lost to Follow-up|1
166619|NCT00552279|586356|P2|Overall Study|Withdrawal by Subject|1
166620|NCT00552279|586357|P1|Overall Study|Withdrawal by Subject|12
166621|NCT00552279|586356|P2|Overall Study|Adverse Event|1
166622|NCT00552279|586357|P1|Overall Study|Adverse Event|0
166623|NCT00552240|586383|P2|Overall Study|not specified|0
166624|NCT00552240|586384|P1|Overall Study|not specified|1
166625|NCT00552240|586383|P2|Overall Study|Lack of Efficacy|0
166626|NCT00552240|586384|P1|Overall Study|Lack of Efficacy|6
166627|NCT00552240|586383|P2|Overall Study|Withdrawal by Subject|2
166628|NCT00552240|586384|P1|Overall Study|Withdrawal by Subject|2
166629|NCT00552240|586383|P2|Overall Study|Lost to Follow-up|6
166630|NCT00552240|586384|P1|Overall Study|Lost to Follow-up|5
166631|NCT00552240|586383|P2|Overall Study|Protocol Violation|1
166632|NCT00552240|586384|P1|Overall Study|Protocol Violation|1
166633|NCT00552240|586383|P2|Overall Study|Adverse Event|9
166634|NCT00552240|586384|P1|Overall Study|Adverse Event|9
166635|NCT00552188|586486|P2|Overall Study|Subject returned to home country|1
166636|NCT00552188|586487|P1|Overall Study|Subject returned to home country|0
166637|NCT00552188|586486|P2|Overall Study|Withdrawal of consent|1
166638|NCT00552188|586487|P1|Overall Study|Withdrawal of consent|0
166639|NCT00552188|586486|P2|Overall Study|Lost to Follow-up|1
166640|NCT00552188|586487|P1|Overall Study|Lost to Follow-up|2
166641|NCT00552188|586486|P2|Overall Study|Adverse Event|2
166642|NCT00552188|586487|P1|Overall Study|Adverse Event|0
166643|NCT00552175|586498|P3|Overall Study|Reason Not Specified|1
166644|NCT00552175|586499|P2|Overall Study|Reason Not Specified|1
166645|NCT00552175|586500|P1|Overall Study|Reason Not Specified|3
166646|NCT00552175|586498|P3|Overall Study|Entry Criteria Not Met|0
166647|NCT00552175|586499|P2|Overall Study|Entry Criteria Not Met|1
166648|NCT00552175|586500|P1|Overall Study|Entry Criteria Not Met|1
166649|NCT00552175|586498|P3|Overall Study|Lost to Follow-up|1
166650|NCT00552175|586499|P2|Overall Study|Lost to Follow-up|0
166651|NCT00552175|586500|P1|Overall Study|Lost to Follow-up|0
166652|NCT00552175|586498|P3|Overall Study|Withdrawal by Subject|1
166653|NCT00552175|586499|P2|Overall Study|Withdrawal by Subject|2
166654|NCT00552175|586500|P1|Overall Study|Withdrawal by Subject|2
166655|NCT00552175|586498|P3|Overall Study|Adverse Event|10
166656|NCT00552175|586499|P2|Overall Study|Adverse Event|9
166657|NCT00552175|586500|P1|Overall Study|Adverse Event|9
166658|NCT00552175|586498|P3|Overall Study|Lack of Efficacy|1
166659|NCT00552175|586499|P2|Overall Study|Lack of Efficacy|0
166660|NCT00552175|586500|P1|Overall Study|Lack of Efficacy|2
166661|NCT00552110|586540|P5|Overall Study|Nonserious Adverse Event (AE)|0
166662|NCT00552110|586541|P4|Overall Study|Nonserious Adverse Event (AE)|1
166663|NCT00552110|586542|P3|Overall Study|Nonserious Adverse Event (AE)|0
166664|NCT00552110|586543|P2|Overall Study|Nonserious Adverse Event (AE)|0
166665|NCT00552110|586544|P1|Overall Study|Nonserious Adverse Event (AE)|1
166666|NCT00552110|586540|P5|Overall Study|Increased Blood Pressure at Visit 2|0
166667|NCT00552110|586541|P4|Overall Study|Increased Blood Pressure at Visit 2|1
166668|NCT00552110|586542|P3|Overall Study|Increased Blood Pressure at Visit 2|0
166669|NCT00552110|586543|P2|Overall Study|Increased Blood Pressure at Visit 2|0
166670|NCT00552110|586544|P1|Overall Study|Increased Blood Pressure at Visit 2|0
166671|NCT00552110|586540|P5|Overall Study|Delay of Study due to Relabeling|0
166672|NCT00552110|586541|P4|Overall Study|Delay of Study due to Relabeling|1
166673|NCT00552110|586542|P3|Overall Study|Delay of Study due to Relabeling|0
166674|NCT00552110|586543|P2|Overall Study|Delay of Study due to Relabeling|0
166675|NCT00552110|586544|P1|Overall Study|Delay of Study due to Relabeling|0
166676|NCT00552110|586540|P5|Overall Study|Use of Prohibited Medication|0
166677|NCT00552110|586541|P4|Overall Study|Use of Prohibited Medication|0
166678|NCT00552110|586542|P3|Overall Study|Use of Prohibited Medication|0
166679|NCT00552110|586543|P2|Overall Study|Use of Prohibited Medication|1
166680|NCT00552110|586544|P1|Overall Study|Use of Prohibited Medication|1
166681|NCT00552110|586540|P5|Overall Study|Withdrawn per Sponsor|1
166682|NCT00552110|586541|P4|Overall Study|Withdrawn per Sponsor|0
166683|NCT00552110|586542|P3|Overall Study|Withdrawn per Sponsor|0
166684|NCT00552110|586543|P2|Overall Study|Withdrawn per Sponsor|1
166685|NCT00552110|586544|P1|Overall Study|Withdrawn per Sponsor|0
166686|NCT00552110|586540|P5|Overall Study|Failed to Comply With Study Requirements|1
166687|NCT00552110|586541|P4|Overall Study|Failed to Comply With Study Requirements|0
166688|NCT00552110|586542|P3|Overall Study|Failed to Comply With Study Requirements|1
166689|NCT00552110|586543|P2|Overall Study|Failed to Comply With Study Requirements|1
166690|NCT00552110|586544|P1|Overall Study|Failed to Comply With Study Requirements|1
166691|NCT00552110|586540|P5|Overall Study|Lost to Follow-up|1
166692|NCT00552110|586541|P4|Overall Study|Lost to Follow-up|1
166693|NCT00552110|586542|P3|Overall Study|Lost to Follow-up|0
166694|NCT00552110|586543|P2|Overall Study|Lost to Follow-up|0
166695|NCT00552110|586544|P1|Overall Study|Lost to Follow-up|0
166696|NCT00552110|586540|P5|Overall Study|Withdrawal by Subject|2
166697|NCT00552110|586541|P4|Overall Study|Withdrawal by Subject|3
166698|NCT00552110|586542|P3|Overall Study|Withdrawal by Subject|0
166699|NCT00552110|586543|P2|Overall Study|Withdrawal by Subject|2
166700|NCT00552110|586544|P1|Overall Study|Withdrawal by Subject|0
166701|NCT00552110|586540|P5|Overall Study|Lack of Efficacy|4
166702|NCT00552110|586541|P4|Overall Study|Lack of Efficacy|1
166703|NCT00552110|586542|P3|Overall Study|Lack of Efficacy|0
166704|NCT00552110|586543|P2|Overall Study|Lack of Efficacy|0
166705|NCT00552110|586544|P1|Overall Study|Lack of Efficacy|1
166706|NCT00552110|586540|P5|Overall Study|Serious or Life-Threatening AE|0
166707|NCT00552110|586541|P4|Overall Study|Serious or Life-Threatening AE|0
166708|NCT00552110|586542|P3|Overall Study|Serious or Life-Threatening AE|1
166709|NCT00552110|586543|P2|Overall Study|Serious or Life-Threatening AE|0
166710|NCT00552110|586544|P1|Overall Study|Serious or Life-Threatening AE|0
166711|NCT00552084|586563|P2|Overall Study|change in anti-arrythmic drug|1
166712|NCT00552084|586564|P1|Overall Study|change in anti-arrythmic drug|1
166713|NCT00552084|586563|P2|Overall Study|Protocol Violation|0
166714|NCT00552084|586564|P1|Overall Study|Protocol Violation|1
166715|NCT00552084|586563|P2|Overall Study|Withdrawal by Subject|5
166716|NCT00552084|586564|P1|Overall Study|Withdrawal by Subject|4
166717|NCT00552084|586563|P2|Overall Study|Adverse Event|3
166718|NCT00552084|586564|P1|Overall Study|Adverse Event|2
166719|NCT00552058|586572|P2|Overall Study|Other: Early Roll Over|0
166720|NCT00552058|586573|P1|Overall Study|Other: Early Roll Over|1
166721|NCT00552058|586572|P2|Overall Study|Other: Sponsors Decision|1
166722|NCT00552058|586573|P1|Overall Study|Other: Sponsors Decision|0
166723|NCT00552058|586572|P2|Overall Study|Other: Randomized in error|1
166724|NCT00552058|586573|P1|Overall Study|Other: Randomized in error|0
166725|NCT00552058|586572|P2|Overall Study|Other: Positive Stool Result|1
166726|NCT00552058|586573|P1|Overall Study|Other: Positive Stool Result|0
166727|NCT00552058|586572|P2|Overall Study|Other: Low CDAI score, entry violation|1
166728|NCT00552058|586573|P1|Overall Study|Other: Low CDAI score, entry violation|0
166729|NCT00552058|586572|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
166730|NCT00552058|586573|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
166731|NCT00552058|586572|P2|Overall Study|Other: Non Compliance|2
166732|NCT00552058|586573|P1|Overall Study|Other: Non Compliance|1
166733|NCT00552058|586572|P2|Overall Study|Other: Protocol Violation|1
166734|NCT00552058|586573|P1|Overall Study|Other: Protocol Violation|0
166735|NCT00552058|586572|P2|Overall Study|Withdrawal by Subject|4
166736|NCT00552058|586573|P1|Overall Study|Withdrawal by Subject|4
166737|NCT00552058|586572|P2|Overall Study|Lost to Follow-up|0
166738|NCT00552058|586573|P1|Overall Study|Lost to Follow-up|1
166739|NCT00552058|586572|P2|Overall Study|Lack of Efficacy|5
166740|NCT00552058|586573|P1|Overall Study|Lack of Efficacy|1
166741|NCT00552058|586572|P2|Overall Study|Adverse Event|7
166742|NCT00552058|586573|P1|Overall Study|Adverse Event|8
166743|NCT00552032|586613|P2|Overall Study|Lost to Follow-up|5
166744|NCT00552032|586614|P1|Overall Study|Lost to Follow-up|8
166745|NCT00552032|586613|P2|Overall Study|Protocol Violation|12
166746|NCT00552032|586614|P1|Overall Study|Protocol Violation|7
166747|NCT00552032|586613|P2|Overall Study|Withdrawal by Subject|2
166748|NCT00552032|586614|P1|Overall Study|Withdrawal by Subject|2
166749|NCT00551759|586658|P1|Overall Study|Ineligible|1
166750|NCT00551759|586658|P1|Overall Study|Death|5
166751|NCT00551759|586658|P1|Overall Study|Adverse Event|7
166752|NCT00551642|586699|P2|Overall Study|Inclusion/Exclusion criteria|4
166753|NCT00551642|586700|P1|Overall Study|Inclusion/Exclusion criteria|4
166754|NCT00551642|586699|P2|Overall Study|Delivery device failure|3
166755|NCT00551642|586700|P1|Overall Study|Delivery device failure|1
166756|NCT00551642|586699|P2|Overall Study|Physician Decision|1
166757|NCT00551642|586700|P1|Overall Study|Physician Decision|0
166758|NCT00551642|586699|P2|Overall Study|Protocol Violation|11
166759|NCT00551642|586700|P1|Overall Study|Protocol Violation|6
166760|NCT00551642|586699|P2|Overall Study|Death|31
166761|NCT00551642|586700|P1|Overall Study|Death|33
166762|NCT00551642|586699|P2|Overall Study|Adverse Event|12
166763|NCT00551642|586700|P1|Overall Study|Adverse Event|15
166764|NCT00551642|586699|P2|Overall Study|Withdrawal by Subject|1
166765|NCT00551642|586700|P1|Overall Study|Withdrawal by Subject|2
166766|NCT00551525|586706|P1|Overall Study|Protocol Violation|5
166767|NCT00551460|586715|P1|Overall Study|Not analyzable (did not start treatment)|4
166768|NCT00551460|586715|P1|Overall Study|Ineligible|4
166769|NCT00551460|586715|P1|Overall Study|Death|7
166770|NCT00551460|586715|P1|Overall Study|Physician Decision|1
166771|NCT00551460|586715|P1|Overall Study|Withdrawal by Subject|1
166772|NCT00551460|586715|P1|Overall Study|Adverse Event|1
166773|NCT00551421|586721|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
166774|NCT00551369|586728|P1|Overall Study|Not treated per protocol and re|1
166775|NCT00551369|586728|P1|Overall Study|Withdrawal by Subject|1
166776|NCT00551369|586728|P1|Overall Study|Protocol Violation|5
166777|NCT00551291|586736|P1|Overall Study|Physician Decision|1
166778|NCT00551213|586744|P2|Overall Study|Not Treated|2
166779|NCT00551213|586745|P1|Overall Study|Not Treated|1
166780|NCT00551213|586744|P2|Overall Study|Withdrawal by Subject|0
166781|NCT00551213|586745|P1|Overall Study|Withdrawal by Subject|2
166782|NCT00551213|586744|P2|Overall Study|Progressive Disease|12
166783|NCT00551213|586745|P1|Overall Study|Progressive Disease|41
166784|NCT00551213|586744|P2|Overall Study|Adverse Event|3
166785|NCT00551213|586745|P1|Overall Study|Adverse Event|6
166786|NCT00551161|586789|P1|Overall Study|Withdrawal by Subject|1
166787|NCT00551135|586797|P4|Overall Study|Withdrawal by Subject|1
166788|NCT00551135|586798|P3|Overall Study|Withdrawal by Subject|3
166789|NCT00551135|586799|P2|Overall Study|Withdrawal by Subject|0
166790|NCT00551135|586800|P1|Overall Study|Withdrawal by Subject|1
166791|NCT00551135|586797|P4|Overall Study|Other|2
166792|NCT00551135|586798|P3|Overall Study|Other|1
166793|NCT00551135|586799|P2|Overall Study|Other|2
166794|NCT00551135|586800|P1|Overall Study|Other|3
166795|NCT00551135|586797|P4|Overall Study|Lost to Follow-up|1
166796|NCT00551135|586798|P3|Overall Study|Lost to Follow-up|0
166797|NCT00551135|586799|P2|Overall Study|Lost to Follow-up|0
166798|NCT00551135|586800|P1|Overall Study|Lost to Follow-up|0
166799|NCT00551135|586797|P4|Overall Study|Adverse Event|1
166800|NCT00551135|586798|P3|Overall Study|Adverse Event|1
166801|NCT00551135|586799|P2|Overall Study|Adverse Event|0
166802|NCT00551135|586800|P1|Overall Study|Adverse Event|1
166803|NCT00551031|586929|P5|Overall Study|Did not receive vaccine|0
166804|NCT00551031|586930|P4|Overall Study|Did not receive vaccine|0
166805|NCT00551031|586931|P3|Overall Study|Did not receive vaccine|0
166806|NCT00551031|586932|P2|Overall Study|Did not receive vaccine|2
166807|NCT00551031|586933|P1|Overall Study|Did not receive vaccine|1
166808|NCT00551031|586929|P5|Overall Study|Serious Adverse Event|0
166809|NCT00551031|586930|P4|Overall Study|Serious Adverse Event|0
166810|NCT00551031|586931|P3|Overall Study|Serious Adverse Event|1
166811|NCT00551031|586932|P2|Overall Study|Serious Adverse Event|2
166812|NCT00551031|586933|P1|Overall Study|Serious Adverse Event|0
166813|NCT00551031|586929|P5|Overall Study|Withdrawal by Subject|0
166814|NCT00551031|586930|P4|Overall Study|Withdrawal by Subject|2
166815|NCT00551031|586931|P3|Overall Study|Withdrawal by Subject|1
166816|NCT00551031|586932|P2|Overall Study|Withdrawal by Subject|4
166817|NCT00551031|586933|P1|Overall Study|Withdrawal by Subject|0
166818|NCT00551031|586929|P5|Overall Study|Lost to Follow-up|1
166819|NCT00551031|586930|P4|Overall Study|Lost to Follow-up|1
166820|NCT00551031|586931|P3|Overall Study|Lost to Follow-up|0
166821|NCT00551031|586932|P2|Overall Study|Lost to Follow-up|1
166822|NCT00551031|586933|P1|Overall Study|Lost to Follow-up|0
166823|NCT00551031|586929|P5|Overall Study|Protocol Violation|0
166824|NCT00551031|586930|P4|Overall Study|Protocol Violation|0
166825|NCT00551031|586931|P3|Overall Study|Protocol Violation|0
166826|NCT00551031|586932|P2|Overall Study|Protocol Violation|1
166827|NCT00551031|586933|P1|Overall Study|Protocol Violation|1
166828|NCT00551031|586929|P5|Overall Study|Adverse Event|0
166829|NCT00551031|586930|P4|Overall Study|Adverse Event|0
166830|NCT00551031|586931|P3|Overall Study|Adverse Event|0
166831|NCT00551031|586932|P2|Overall Study|Adverse Event|1
166832|NCT00551031|586933|P1|Overall Study|Adverse Event|0
166833|NCT00550953|586962|P2|Overall Study|Not able to visit the site|3
166834|NCT00550953|586963|P1|Overall Study|Not able to visit the site|2
166835|NCT00550953|586962|P2|Overall Study|Adverse Event|3
166836|NCT00550953|586963|P1|Overall Study|Adverse Event|4
166837|NCT00550836|587010|P2|Overall Study|Withdrawal by Subject|9
166838|NCT00550836|587011|P1|Overall Study|Withdrawal by Subject|3
166839|NCT00550771|587027|P2|Overall Study|Protocol Violation|5
166840|NCT00550771|587028|P1|Overall Study|Protocol Violation|4
166841|NCT00550771|587027|P2|Overall Study|Withdrawal by Subject|1
166842|NCT00550771|587028|P1|Overall Study|Withdrawal by Subject|0
166843|NCT00550771|587027|P2|Overall Study|Physician Decision|0
166844|NCT00550771|587028|P1|Overall Study|Physician Decision|2
166845|NCT00550771|587027|P2|Overall Study|Discontinued for study-related reasons|1
166846|NCT00550771|587028|P1|Overall Study|Discontinued for study-related reasons|0
166847|NCT00550771|587027|P2|Overall Study|Adverse Event|3
166848|NCT00550771|587028|P1|Overall Study|Adverse Event|11
166849|NCT00550745|587042|P2|Overall Study|Screen failure|0
166850|NCT00550745|587043|P1|Overall Study|Screen failure|1
166851|NCT00550745|587042|P2|Overall Study|Withdrawal by Subject|10
166852|NCT00550745|587043|P1|Overall Study|Withdrawal by Subject|17
166853|NCT00550745|587042|P2|Overall Study|Protocol Violation|2
166854|NCT00550745|587043|P1|Overall Study|Protocol Violation|4
166855|NCT00550745|587042|P2|Overall Study|Physician Decision|2
166856|NCT00550745|587043|P1|Overall Study|Physician Decision|0
166857|NCT00550745|587042|P2|Overall Study|Lost to Follow-up|30
166858|NCT00550745|587043|P1|Overall Study|Lost to Follow-up|45
166859|NCT00550745|587042|P2|Overall Study|Death|16
166860|NCT00550745|587043|P1|Overall Study|Death|20
166861|NCT00550732|587051|P1|Overall Study|Adverse Event|1
166862|NCT00550732|587051|P1|Overall Study|Palliative care|1
166863|NCT00550732|587051|P1|Overall Study|Lost to Follow-up|1
166864|NCT00550732|587051|P1|Overall Study|Physician Decision|2
166865|NCT00550732|587051|P1|Overall Study|Withdrawal by Subject|2
166866|NCT00550732|587051|P1|Overall Study|Death|4
166867|NCT00550680|587062|P1|Overall Study|Screen Failure|6
166868|NCT00550680|587062|P1|Overall Study|Refused Treatment|19
166869|NCT00550680|587062|P1|Overall Study|Protocol Violation|7
166870|NCT00550680|587062|P1|Overall Study|Not Specified|10
166871|NCT00550680|587062|P1|Overall Study|Lack of Efficacy|1
166872|NCT00550680|587062|P1|Overall Study|Lost to Follow-up|3
166873|NCT00550680|587062|P1|Overall Study|Early Improvement|1
166874|NCT00550680|587062|P1|Overall Study|Death|3
166875|NCT00550680|587062|P1|Overall Study|Adverse Event|5
166876|NCT00550680|587062|P1|Overall Study|Administrative Reasons|1
166877|NCT00550550|587094|P2|Overall Study|Randomized But Not Treated|0
166878|NCT00550550|587095|P1|Overall Study|Randomized But Not Treated|1
166879|NCT00550550|587094|P2|Overall Study|Did Not Meet Protocol Eligibility|1
166880|NCT00550550|587095|P1|Overall Study|Did Not Meet Protocol Eligibility|1
166881|NCT00550550|587094|P2|Overall Study|Protocol Violation|14
166882|NCT00550550|587095|P1|Overall Study|Protocol Violation|5
166883|NCT00550550|587094|P2|Overall Study|Withdrawal by Subject|8
166884|NCT00550550|587095|P1|Overall Study|Withdrawal by Subject|10
166885|NCT00550550|587094|P2|Overall Study|Lost to Follow-up|0
166886|NCT00550550|587095|P1|Overall Study|Lost to Follow-up|4
166887|NCT00550550|587094|P2|Overall Study|Treatment Failure|1
166888|NCT00550550|587095|P1|Overall Study|Treatment Failure|0
166889|NCT00550550|587094|P2|Overall Study|Adverse Event|5
166890|NCT00550550|587095|P1|Overall Study|Adverse Event|13
166891|NCT00550537|587107|P1|Overall Study|Treated closer to home|4
166892|NCT00550537|587107|P1|Overall Study|Declining performance status|2
166893|NCT00550537|587107|P1|Overall Study|Other complicating ilness|3
166894|NCT00550537|587107|P1|Overall Study|Change in treatment plan|4
166895|NCT00550537|587107|P1|Overall Study|Withdrawal by Subject|7
166896|NCT00550537|587107|P1|Overall Study|Disease progression before|46
166897|NCT00550537|587107|P1|Overall Study|Adverse Event|20
166898|NCT00550537|587107|P1|Overall Study|Death|18
166899|NCT00550459|587124|P2|Overall Study|Withdrawal by Subject|1
166900|NCT00550459|587125|P1|Overall Study|Withdrawal by Subject|1
166901|NCT00550459|587124|P2|Overall Study|Adverse Event|2
166902|NCT00550459|587125|P1|Overall Study|Adverse Event|0
166903|NCT00550446|587194|P11|Post Week 12|Other|0
166904|NCT00550446|587195|P10|Post Week 12|Other|1
166905|NCT00550446|587196|P9|Post Week 12|Other|1
166906|NCT00550446|587197|P8|Post Week 12|Other|0
166907|NCT00550446|587198|P7|Post Week 12|Other|1
166908|NCT00550446|587199|P6|Post Week 12|Other|0
166909|NCT00550446|587200|P5|Post Week 12|Other|0
166910|NCT00550446|587201|P4|Post Week 12|Other|1
166911|NCT00550446|587202|P3|Post Week 12|Other|0
166912|NCT00550446|587203|P2|Post Week 12|Other|1
166913|NCT00550446|587204|P1|Post Week 12|Other|1
166914|NCT00550446|587194|P11|Post Week 12|Withdrawal by Subject|0
166915|NCT00550446|587195|P10|Post Week 12|Withdrawal by Subject|0
166916|NCT00550446|587196|P9|Post Week 12|Withdrawal by Subject|0
166917|NCT00550446|587197|P8|Post Week 12|Withdrawal by Subject|0
166918|NCT00550446|587198|P7|Post Week 12|Withdrawal by Subject|0
166919|NCT00550446|587199|P6|Post Week 12|Withdrawal by Subject|0
166920|NCT00550446|587200|P5|Post Week 12|Withdrawal by Subject|1
166921|NCT00550446|587201|P4|Post Week 12|Withdrawal by Subject|0
166922|NCT00550446|587202|P3|Post Week 12|Withdrawal by Subject|0
166923|NCT00550446|587203|P2|Post Week 12|Withdrawal by Subject|0
166924|NCT00550446|587204|P1|Post Week 12|Withdrawal by Subject|0
166925|NCT00550446|587194|P11|Post Week 12|Lost to Follow-up|0
166926|NCT00550446|587195|P10|Post Week 12|Lost to Follow-up|0
166927|NCT00550446|587196|P9|Post Week 12|Lost to Follow-up|0
166928|NCT00550446|587197|P8|Post Week 12|Lost to Follow-up|0
166929|NCT00550446|587198|P7|Post Week 12|Lost to Follow-up|1
166930|NCT00550446|587199|P6|Post Week 12|Lost to Follow-up|0
166931|NCT00550446|587200|P5|Post Week 12|Lost to Follow-up|0
166932|NCT00550446|587201|P4|Post Week 12|Lost to Follow-up|1
166933|NCT00550446|587202|P3|Post Week 12|Lost to Follow-up|1
166934|NCT00550446|587203|P2|Post Week 12|Lost to Follow-up|0
166935|NCT00550446|587204|P1|Post Week 12|Lost to Follow-up|0
166936|NCT00550446|587194|P11|Post Week 12|Lack of Efficacy|1
166937|NCT00550446|587195|P10|Post Week 12|Lack of Efficacy|2
166938|NCT00550446|587196|P9|Post Week 12|Lack of Efficacy|1
166939|NCT00550446|587197|P8|Post Week 12|Lack of Efficacy|1
166940|NCT00550446|587198|P7|Post Week 12|Lack of Efficacy|0
166941|NCT00550446|587199|P6|Post Week 12|Lack of Efficacy|0
166942|NCT00550446|587200|P5|Post Week 12|Lack of Efficacy|0
166943|NCT00550446|587201|P4|Post Week 12|Lack of Efficacy|0
166944|NCT00550446|587202|P3|Post Week 12|Lack of Efficacy|1
166945|NCT00550446|587203|P2|Post Week 12|Lack of Efficacy|0
166946|NCT00550446|587204|P1|Post Week 12|Lack of Efficacy|0
166947|NCT00550446|587194|P11|Post Week 12|Adverse Event|0
166948|NCT00550446|587195|P10|Post Week 12|Adverse Event|4
166949|NCT00550446|587196|P9|Post Week 12|Adverse Event|0
166950|NCT00550446|587197|P8|Post Week 12|Adverse Event|0
166951|NCT00550446|587198|P7|Post Week 12|Adverse Event|0
166952|NCT00550446|587199|P6|Post Week 12|Adverse Event|1
166953|NCT00550446|587200|P5|Post Week 12|Adverse Event|1
166954|NCT00550446|587201|P4|Post Week 12|Adverse Event|1
166955|NCT00550446|587202|P3|Post Week 12|Adverse Event|1
166956|NCT00550446|587203|P2|Post Week 12|Adverse Event|1
166957|NCT00550446|587204|P1|Post Week 12|Adverse Event|2
166958|NCT00550446|587194|P11|Up To Week 12|Randomized not treated|0
166959|NCT00550446|587195|P10|Up To Week 12|Randomized not treated|0
166960|NCT00550446|587196|P9|Up To Week 12|Randomized not treated|0
166961|NCT00550446|587197|P8|Up To Week 12|Randomized not treated|0
166962|NCT00550446|587198|P7|Up To Week 12|Randomized not treated|0
166963|NCT00550446|587199|P6|Up To Week 12|Randomized not treated|0
166964|NCT00550446|587200|P5|Up To Week 12|Randomized not treated|0
166965|NCT00550446|587201|P4|Up To Week 12|Randomized not treated|0
166966|NCT00550446|587202|P3|Up To Week 12|Randomized not treated|1
166967|NCT00550446|587203|P2|Up To Week 12|Randomized not treated|1
166968|NCT00550446|587204|P1|Up To Week 12|Randomized not treated|0
166969|NCT00550446|587194|P11|Up To Week 12|Other|0
166970|NCT00550446|587195|P10|Up To Week 12|Other|0
166971|NCT00550446|587196|P9|Up To Week 12|Other|0
166972|NCT00550446|587197|P8|Up To Week 12|Other|0
166973|NCT00550446|587198|P7|Up To Week 12|Other|4
166974|NCT00550446|587199|P6|Up To Week 12|Other|1
166975|NCT00550446|587200|P5|Up To Week 12|Other|0
166976|NCT00550446|587201|P4|Up To Week 12|Other|0
166977|NCT00550446|587202|P3|Up To Week 12|Other|0
166978|NCT00550446|587203|P2|Up To Week 12|Other|0
166979|NCT00550446|587204|P1|Up To Week 12|Other|3
166980|NCT00550446|587194|P11|Up To Week 12|Withdrawal by Subject|0
166981|NCT00550446|587195|P10|Up To Week 12|Withdrawal by Subject|0
166982|NCT00550446|587196|P9|Up To Week 12|Withdrawal by Subject|0
166983|NCT00550446|587197|P8|Up To Week 12|Withdrawal by Subject|0
166984|NCT00550446|587198|P7|Up To Week 12|Withdrawal by Subject|3
166985|NCT00550446|587199|P6|Up To Week 12|Withdrawal by Subject|1
166986|NCT00550446|587200|P5|Up To Week 12|Withdrawal by Subject|0
166987|NCT00550446|587201|P4|Up To Week 12|Withdrawal by Subject|2
166988|NCT00550446|587202|P3|Up To Week 12|Withdrawal by Subject|3
166989|NCT00550446|587203|P2|Up To Week 12|Withdrawal by Subject|0
166990|NCT00550446|587204|P1|Up To Week 12|Withdrawal by Subject|2
166991|NCT00550446|587194|P11|Up To Week 12|Lost to Follow-up|0
166992|NCT00550446|587195|P10|Up To Week 12|Lost to Follow-up|0
166993|NCT00550446|587196|P9|Up To Week 12|Lost to Follow-up|0
166994|NCT00550446|587197|P8|Up To Week 12|Lost to Follow-up|0
166995|NCT00550446|587198|P7|Up To Week 12|Lost to Follow-up|2
166996|NCT00550446|587199|P6|Up To Week 12|Lost to Follow-up|1
166997|NCT00550446|587200|P5|Up To Week 12|Lost to Follow-up|1
166998|NCT00550446|587201|P4|Up To Week 12|Lost to Follow-up|0
166999|NCT00550446|587202|P3|Up To Week 12|Lost to Follow-up|0
167000|NCT00550446|587203|P2|Up To Week 12|Lost to Follow-up|1
167001|NCT00550446|587204|P1|Up To Week 12|Lost to Follow-up|0
167002|NCT00550446|587194|P11|Up To Week 12|Lack of Efficacy|0
167003|NCT00550446|587195|P10|Up To Week 12|Lack of Efficacy|0
167004|NCT00550446|587196|P9|Up To Week 12|Lack of Efficacy|0
167005|NCT00550446|587197|P8|Up To Week 12|Lack of Efficacy|0
167006|NCT00550446|587198|P7|Up To Week 12|Lack of Efficacy|3
167007|NCT00550446|587199|P6|Up To Week 12|Lack of Efficacy|3
167008|NCT00550446|587200|P5|Up To Week 12|Lack of Efficacy|0
167009|NCT00550446|587201|P4|Up To Week 12|Lack of Efficacy|1
167010|NCT00550446|587202|P3|Up To Week 12|Lack of Efficacy|0
167011|NCT00550446|587203|P2|Up To Week 12|Lack of Efficacy|1
167012|NCT00550446|587204|P1|Up To Week 12|Lack of Efficacy|3
167013|NCT00550446|587194|P11|Up To Week 12|Adverse Event|0
167014|NCT00550446|587195|P10|Up To Week 12|Adverse Event|0
167015|NCT00550446|587196|P9|Up To Week 12|Adverse Event|0
167016|NCT00550446|587197|P8|Up To Week 12|Adverse Event|0
167017|NCT00550446|587198|P7|Up To Week 12|Adverse Event|1
167018|NCT00550446|587199|P6|Up To Week 12|Adverse Event|2
167019|NCT00550446|587200|P5|Up To Week 12|Adverse Event|2
167020|NCT00550446|587201|P4|Up To Week 12|Adverse Event|0
167021|NCT00550446|587202|P3|Up To Week 12|Adverse Event|0
167022|NCT00550446|587203|P2|Up To Week 12|Adverse Event|2
167023|NCT00550446|587204|P1|Up To Week 12|Adverse Event|2
167024|NCT00550420|587636|P1|Overall Study|Prohibited medicine|1
167025|NCT00550420|587636|P1|Overall Study|Exclusion criteria|1
167026|NCT00550420|587636|P1|Overall Study|Out of Electrocardiogram criteria|1
167027|NCT00550420|587636|P1|Overall Study|Caregiver's decision to withdraw|1
167028|NCT00550420|587636|P1|Overall Study|Unethical stop of enrollment|2
167029|NCT00550420|587636|P1|Overall Study|Lack of curative effect|1
167030|NCT00550420|587636|P1|Overall Study|Investigators opinion|1
167031|NCT00550420|587636|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
167032|NCT00550420|587636|P1|Overall Study|Missing|2
167033|NCT00550420|587636|P1|Overall Study|Still in study at termination|206
167034|NCT00550420|587636|P1|Overall Study|Withdrawal by Subject|30
167035|NCT00550420|587636|P1|Overall Study|Protocol Violation|11
167036|NCT00550420|587636|P1|Overall Study|Lost to Follow-up|8
167037|NCT00550420|587636|P1|Overall Study|Adverse Event|28
167038|NCT00550407|587659|P3|26-Week Randomized Phase|Withdrawal by Subject|3
167039|NCT00550407|587660|P2|26-Week Randomized Phase|Withdrawal by Subject|1
167040|NCT00550407|587661|P1|26-Week Randomized Phase|Withdrawal by Subject|0
167041|NCT00550407|587659|P3|26-Week Randomized Phase|Investigator Discretion|0
167042|NCT00550407|587660|P2|26-Week Randomized Phase|Investigator Discretion|1
167043|NCT00550407|587661|P1|26-Week Randomized Phase|Investigator Discretion|0
167044|NCT00550407|587659|P3|26-Week Randomized Phase|Lack of Efficacy|19
167045|NCT00550407|587660|P2|26-Week Randomized Phase|Lack of Efficacy|36
167046|NCT00550407|587661|P1|26-Week Randomized Phase|Lack of Efficacy|0
167047|NCT00550407|587659|P3|26-Week Randomized Phase|Adverse Event|2
167048|NCT00550407|587660|P2|26-Week Randomized Phase|Adverse Event|5
167049|NCT00550407|587661|P1|26-Week Randomized Phase|Adverse Event|0
167050|NCT00550407|587659|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
167051|NCT00550407|587660|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
167052|NCT00550407|587661|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
167053|NCT00550407|587659|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
167054|NCT00550407|587660|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
167055|NCT00550407|587661|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
167056|NCT00550407|587659|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
167057|NCT00550407|587660|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
167058|NCT00550407|587661|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
167059|NCT00550407|587659|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
167060|NCT00550407|587660|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
167061|NCT00550407|587661|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
167062|NCT00550407|587659|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
167063|NCT00550407|587660|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
167064|NCT00550407|587661|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
167065|NCT00550407|587659|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
167066|NCT00550407|587660|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
167067|NCT00550407|587661|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
167068|NCT00550407|587659|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
167069|NCT00550407|587660|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
167070|NCT00550407|587661|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
167071|NCT00550407|587659|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
167072|NCT00550407|587660|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
167073|NCT00550407|587661|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
167074|NCT00550173|587727|P3|Overall Study|Lost to Follow-up|3
167075|NCT00550173|587728|P2|Overall Study|Lost to Follow-up|4
167076|NCT00550173|587729|P1|Overall Study|Lost to Follow-up|4
167077|NCT00550173|587727|P3|Overall Study|Sponsor Decision|1
167078|NCT00550173|587728|P2|Overall Study|Sponsor Decision|7
167079|NCT00550173|587729|P1|Overall Study|Sponsor Decision|13
167080|NCT00550173|587727|P3|Overall Study|Withdrawal by Subject|17
167081|NCT00550173|587728|P2|Overall Study|Withdrawal by Subject|12
167082|NCT00550173|587729|P1|Overall Study|Withdrawal by Subject|9
167083|NCT00550173|587727|P3|Overall Study|Physician Decision|2
167084|NCT00550173|587728|P2|Overall Study|Physician Decision|2
167085|NCT00550173|587729|P1|Overall Study|Physician Decision|1
167086|NCT00550173|587727|P3|Overall Study|Death|50
167087|NCT00550173|587728|P2|Overall Study|Death|38
167088|NCT00550173|587729|P1|Overall Study|Death|45
167089|NCT00550147|587758|P1|Quetiapine Addition Treatment Period|Moved out of state|1
167090|NCT00550147|587758|P1|Quetiapine Addition Treatment Period|Noncompliance|2
167091|NCT00550147|587758|P1|Quetiapine Addition Treatment Period|Adverse Event|3
167092|NCT00550147|587758|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
167093|NCT00550147|587758|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
167094|NCT00550043|587781|P5|Overall Study|Other Reasons- Unspecified|0
167095|NCT00550043|587782|P4|Overall Study|Other Reasons- Unspecified|1
167096|NCT00550043|587783|P3|Overall Study|Other Reasons- Unspecified|0
167097|NCT00550043|587784|P2|Overall Study|Other Reasons- Unspecified|1
167098|NCT00550043|587785|P1|Overall Study|Other Reasons- Unspecified|0
167099|NCT00550043|587781|P5|Overall Study|Subject Withdrew Consent|0
167100|NCT00550043|587782|P4|Overall Study|Subject Withdrew Consent|0
167101|NCT00550043|587783|P3|Overall Study|Subject Withdrew Consent|1
167102|NCT00550043|587784|P2|Overall Study|Subject Withdrew Consent|2
167103|NCT00550043|587785|P1|Overall Study|Subject Withdrew Consent|0
167104|NCT00550043|587781|P5|Overall Study|Adverse Event|1
167105|NCT00550043|587782|P4|Overall Study|Adverse Event|1
167106|NCT00550043|587783|P3|Overall Study|Adverse Event|0
167107|NCT00550043|587784|P2|Overall Study|Adverse Event|0
167108|NCT00550043|587785|P1|Overall Study|Adverse Event|0
167109|NCT00549939|587840|P3|40-week Open Label Treatment Period|Other|4
167110|NCT00549939|587841|P2|40-week Open Label Treatment Period|Other|1
167111|NCT00549939|587842|P1|40-week Open Label Treatment Period|Other|0
167112|NCT00549939|587840|P3|40-week Open Label Treatment Period|Protocol Violation|0
167113|NCT00549939|587841|P2|40-week Open Label Treatment Period|Protocol Violation|1
167114|NCT00549939|587842|P1|40-week Open Label Treatment Period|Protocol Violation|0
167115|NCT00549939|587840|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
167116|NCT00549939|587841|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
167117|NCT00549939|587842|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
167118|NCT00549939|587840|P3|40-week Open Label Treatment Period|Adverse Event|1
167119|NCT00549939|587841|P2|40-week Open Label Treatment Period|Adverse Event|2
167120|NCT00549939|587842|P1|40-week Open Label Treatment Period|Adverse Event|0
167121|NCT00549939|587840|P3|12-week Double Blind Treatment Period|Too many blood draws|0
167122|NCT00549939|587841|P2|12-week Double Blind Treatment Period|Too many blood draws|1
167123|NCT00549939|587842|P1|12-week Double Blind Treatment Period|Too many blood draws|0
167124|NCT00549939|587840|P3|12-week Double Blind Treatment Period|Adverse Event|2
167125|NCT00549939|587841|P2|12-week Double Blind Treatment Period|Adverse Event|1
167126|NCT00549939|587842|P1|12-week Double Blind Treatment Period|Adverse Event|1
167127|NCT00549900|587869|P1|Overall Study|Adverse Event|1
167128|NCT00549770|587925|P8|Overall Study|Adverse Event|4
167129|NCT00549770|587926|P7|Overall Study|Adverse Event|5
167130|NCT00549770|587927|P6|Overall Study|Adverse Event|0
167131|NCT00549770|587928|P5|Overall Study|Adverse Event|1
167132|NCT00549770|587929|P4|Overall Study|Adverse Event|2
167133|NCT00549770|587930|P3|Overall Study|Adverse Event|1
167134|NCT00549770|587931|P2|Overall Study|Adverse Event|3
167135|NCT00549770|587932|P1|Overall Study|Adverse Event|1
167136|NCT00549770|587925|P8|Overall Study|Abnormal laboratory values|0
167137|NCT00549770|587926|P7|Overall Study|Abnormal laboratory values|0
167138|NCT00549770|587927|P6|Overall Study|Abnormal laboratory values|1
167139|NCT00549770|587928|P5|Overall Study|Abnormal laboratory values|0
167140|NCT00549770|587929|P4|Overall Study|Abnormal laboratory values|0
167141|NCT00549770|587930|P3|Overall Study|Abnormal laboratory values|0
167142|NCT00549770|587931|P2|Overall Study|Abnormal laboratory values|0
167143|NCT00549770|587932|P1|Overall Study|Abnormal laboratory values|0
167144|NCT00549770|587925|P8|Overall Study|Abnormal test procedure results|1
167145|NCT00549770|587926|P7|Overall Study|Abnormal test procedure results|1
167146|NCT00549770|587927|P6|Overall Study|Abnormal test procedure results|1
167147|NCT00549770|587928|P5|Overall Study|Abnormal test procedure results|0
167148|NCT00549770|587929|P4|Overall Study|Abnormal test procedure results|2
167149|NCT00549770|587930|P3|Overall Study|Abnormal test procedure results|0
167150|NCT00549770|587931|P2|Overall Study|Abnormal test procedure results|0
167151|NCT00549770|587932|P1|Overall Study|Abnormal test procedure results|0
167152|NCT00549770|587925|P8|Overall Study|Lack of Efficacy|8
167153|NCT00549770|587926|P7|Overall Study|Lack of Efficacy|3
167154|NCT00549770|587927|P6|Overall Study|Lack of Efficacy|1
167155|NCT00549770|587928|P5|Overall Study|Lack of Efficacy|5
167156|NCT00549770|587929|P4|Overall Study|Lack of Efficacy|3
167157|NCT00549770|587930|P3|Overall Study|Lack of Efficacy|2
167158|NCT00549770|587931|P2|Overall Study|Lack of Efficacy|0
167159|NCT00549770|587932|P1|Overall Study|Lack of Efficacy|1
167160|NCT00549770|587925|P8|Overall Study|Withdrawal by Subject|9
167161|NCT00549770|587926|P7|Overall Study|Withdrawal by Subject|4
167162|NCT00549770|587927|P6|Overall Study|Withdrawal by Subject|6
167163|NCT00549770|587928|P5|Overall Study|Withdrawal by Subject|6
167164|NCT00549770|587929|P4|Overall Study|Withdrawal by Subject|5
167165|NCT00549770|587930|P3|Overall Study|Withdrawal by Subject|4
167166|NCT00549770|587931|P2|Overall Study|Withdrawal by Subject|6
167167|NCT00549770|587932|P1|Overall Study|Withdrawal by Subject|4
167168|NCT00549770|587925|P8|Overall Study|Lost to Follow-up|0
167169|NCT00549770|587926|P7|Overall Study|Lost to Follow-up|0
167170|NCT00549770|587927|P6|Overall Study|Lost to Follow-up|2
167171|NCT00549770|587928|P5|Overall Study|Lost to Follow-up|3
167172|NCT00549770|587929|P4|Overall Study|Lost to Follow-up|2
167173|NCT00549770|587930|P3|Overall Study|Lost to Follow-up|2
167174|NCT00549770|587931|P2|Overall Study|Lost to Follow-up|0
167175|NCT00549770|587932|P1|Overall Study|Lost to Follow-up|0
167176|NCT00549770|587925|P8|Overall Study|Administrative problems|1
167177|NCT00549770|587926|P7|Overall Study|Administrative problems|0
167178|NCT00549770|587927|P6|Overall Study|Administrative problems|0
167179|NCT00549770|587928|P5|Overall Study|Administrative problems|0
167180|NCT00549770|587929|P4|Overall Study|Administrative problems|0
167181|NCT00549770|587930|P3|Overall Study|Administrative problems|0
167182|NCT00549770|587931|P2|Overall Study|Administrative problems|1
167183|NCT00549770|587932|P1|Overall Study|Administrative problems|0
167184|NCT00549770|587925|P8|Overall Study|Protocol deviation|2
167185|NCT00549770|587926|P7|Overall Study|Protocol deviation|1
167186|NCT00549770|587927|P6|Overall Study|Protocol deviation|2
167187|NCT00549770|587928|P5|Overall Study|Protocol deviation|2
167188|NCT00549770|587929|P4|Overall Study|Protocol deviation|2
167189|NCT00549770|587930|P3|Overall Study|Protocol deviation|1
167190|NCT00549770|587931|P2|Overall Study|Protocol deviation|1
167191|NCT00549770|587932|P1|Overall Study|Protocol deviation|1
167192|NCT00549757|588016|P2|Extension Period (in Average 9 Months)|Patient's request|436
167193|NCT00549757|588017|P1|Extension Period (in Average 9 Months)|Patient's request|421
167194|NCT00549757|588016|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
167195|NCT00549757|588017|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
167196|NCT00549757|588016|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
167197|NCT00549757|588017|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
167198|NCT00549757|588016|P2|Extension Period (in Average 9 Months)|Death|136
167199|NCT00549757|588017|P1|Extension Period (in Average 9 Months)|Death|143
167200|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
167201|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
167202|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
167203|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
167204|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
167205|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
167206|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Death|200
167207|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Death|188
167208|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
167209|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
167210|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
167211|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
167212|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
167213|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
167214|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
167215|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
167216|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
167217|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
167218|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
167219|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
167220|NCT00549757|588016|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
167221|NCT00549757|588017|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
167222|NCT00549718|588079|P4|Overall Study|Administrative|1
167223|NCT00549718|588080|P3|Overall Study|Administrative|2
167224|NCT00549718|588081|P2|Overall Study|Administrative|2
167225|NCT00549718|588082|P1|Overall Study|Administrative|2
167226|NCT00549718|588079|P4|Overall Study|Withdrawal by Subject|13
167227|NCT00549718|588080|P3|Overall Study|Withdrawal by Subject|12
167228|NCT00549718|588081|P2|Overall Study|Withdrawal by Subject|18
167229|NCT00549718|588082|P1|Overall Study|Withdrawal by Subject|9
167230|NCT00549718|588079|P4|Overall Study|Lost to Follow-up|6
167231|NCT00549718|588080|P3|Overall Study|Lost to Follow-up|0
167232|NCT00549718|588081|P2|Overall Study|Lost to Follow-up|2
167233|NCT00549718|588082|P1|Overall Study|Lost to Follow-up|4
167234|NCT00549718|588079|P4|Overall Study|Adverse Event|3
167235|NCT00549718|588080|P3|Overall Study|Adverse Event|7
167236|NCT00549718|588081|P2|Overall Study|Adverse Event|8
167237|NCT00549718|588082|P1|Overall Study|Adverse Event|6
167238|NCT00549718|588079|P4|Overall Study|Insufficient clinical response|32
167239|NCT00549718|588080|P3|Overall Study|Insufficient clinical response|18
167240|NCT00549718|588081|P2|Overall Study|Insufficient clinical response|7
167241|NCT00549718|588082|P1|Overall Study|Insufficient clinical response|20
167242|NCT00549640|588098|P2|Overall Study|Lost to Follow-up|4
167243|NCT00549640|588099|P1|Overall Study|Lost to Follow-up|7
167244|NCT00549640|588098|P2|Overall Study|Adverse Event|0
167245|NCT00549640|588099|P1|Overall Study|Adverse Event|5
167246|NCT00549640|588098|P2|Overall Study|Withdrawal by Subject|12
167247|NCT00549640|588099|P1|Overall Study|Withdrawal by Subject|6
167248|NCT00549601|588112|P3|Received Study Drug|Withdrawal by Subject|1
167249|NCT00549601|588113|P2|Received Study Drug|Withdrawal by Subject|0
167250|NCT00549601|588114|P1|Received Study Drug|Withdrawal by Subject|2
167251|NCT00549601|588112|P3|Received Study Drug|Protocol Violation|1
167252|NCT00549601|588113|P2|Received Study Drug|Protocol Violation|4
167253|NCT00549601|588114|P1|Received Study Drug|Protocol Violation|3
167254|NCT00549601|588112|P3|Received Study Drug|Lost to Follow-up|1
167255|NCT00549601|588113|P2|Received Study Drug|Lost to Follow-up|1
167256|NCT00549601|588114|P1|Received Study Drug|Lost to Follow-up|0
167257|NCT00549601|588112|P3|Received Study Drug|Death|0
167258|NCT00549601|588113|P2|Received Study Drug|Death|1
167259|NCT00549601|588114|P1|Received Study Drug|Death|0
167260|NCT00549601|588112|P3|Received Study Drug|Adverse Event|1
167261|NCT00549601|588113|P2|Received Study Drug|Adverse Event|5
167262|NCT00549601|588114|P1|Received Study Drug|Adverse Event|2
167263|NCT00549601|588112|P3|Randomized|Withdrawal by Subject|1
167264|NCT00549601|588113|P2|Randomized|Withdrawal by Subject|1
167265|NCT00549601|588114|P1|Randomized|Withdrawal by Subject|0
167266|NCT00549601|588112|P3|Randomized|Protocol Violation|1
167267|NCT00549601|588113|P2|Randomized|Protocol Violation|0
167268|NCT00549601|588114|P1|Randomized|Protocol Violation|0
167269|NCT00549562|588136|P1|Overall Study|Lack of Efficacy|1
167270|NCT00549562|588136|P1|Overall Study|Adverse Event|1
167271|NCT00549549|588148|P4|Overall Study|Randomized but not treated|1
167272|NCT00549549|588149|P3|Overall Study|Randomized but not treated|1
167273|NCT00549549|588150|P2|Overall Study|Randomized but not treated|0
167274|NCT00549549|588151|P1|Overall Study|Randomized but not treated|0
167275|NCT00549549|588148|P4|Overall Study|Other|11
167276|NCT00549549|588149|P3|Overall Study|Other|9
167277|NCT00549549|588150|P2|Overall Study|Other|9
167278|NCT00549549|588151|P1|Overall Study|Other|9
167279|NCT00549549|588148|P4|Overall Study|Withdrawal by Subject|0
167280|NCT00549549|588149|P3|Overall Study|Withdrawal by Subject|1
167281|NCT00549549|588150|P2|Overall Study|Withdrawal by Subject|4
167282|NCT00549549|588151|P1|Overall Study|Withdrawal by Subject|0
167283|NCT00549549|588148|P4|Overall Study|Lost to Follow-up|2
167284|NCT00549549|588149|P3|Overall Study|Lost to Follow-up|1
167285|NCT00549549|588150|P2|Overall Study|Lost to Follow-up|0
167286|NCT00549549|588151|P1|Overall Study|Lost to Follow-up|1
167287|NCT00549549|588148|P4|Overall Study|Lack of Efficacy|2
167288|NCT00549549|588149|P3|Overall Study|Lack of Efficacy|4
167289|NCT00549549|588150|P2|Overall Study|Lack of Efficacy|6
167290|NCT00549549|588151|P1|Overall Study|Lack of Efficacy|9
167291|NCT00549549|588148|P4|Overall Study|Adverse Event|9
167292|NCT00549549|588149|P3|Overall Study|Adverse Event|1
167293|NCT00549549|588150|P2|Overall Study|Adverse Event|3
167294|NCT00549549|588151|P1|Overall Study|Adverse Event|5
167295|NCT00549445|588219|P2|Overall Study|Sputum & Blood Samples Not Available|17
167296|NCT00549445|588220|P1|Overall Study|Sputum & Blood Samples Not Available|15
167297|NCT00549328|588239|P1|Overall Study|Use of Prohibited Medication|1
167298|NCT00549328|588239|P1|Overall Study|Death|1
167299|NCT00549328|588239|P1|Overall Study|Disease Progression|10
167300|NCT00549328|588239|P1|Overall Study|Adverse Event|2
167301|NCT00549302|588250|P3|Open-Label|Withdrawal by Subject|6
167302|NCT00549302|588251|P2|Open-Label|Withdrawal by Subject|0
167303|NCT00549302|588252|P1|Open-Label|Withdrawal by Subject|0
167304|NCT00549302|588250|P3|Open-Label|New drug pulmonary atrial hypertension|2
167305|NCT00549302|588251|P2|Open-Label|New drug pulmonary atrial hypertension|0
167306|NCT00549302|588252|P1|Open-Label|New drug pulmonary atrial hypertension|0
167307|NCT00549302|588250|P3|Open-Label|Other|3
167308|NCT00549302|588251|P2|Open-Label|Other|0
167309|NCT00549302|588252|P1|Open-Label|Other|0
167310|NCT00549302|588250|P3|Open-Label|Lost to Follow-up|2
167311|NCT00549302|588251|P2|Open-Label|Lost to Follow-up|0
167312|NCT00549302|588252|P1|Open-Label|Lost to Follow-up|0
167313|NCT00549302|588250|P3|Open-Label|Investigator Decision|5
167314|NCT00549302|588251|P2|Open-Label|Investigator Decision|0
167315|NCT00549302|588252|P1|Open-Label|Investigator Decision|0
167316|NCT00549302|588250|P3|Open-Label|Death|40
167317|NCT00549302|588251|P2|Open-Label|Death|0
167318|NCT00549302|588252|P1|Open-Label|Death|0
167319|NCT00549302|588250|P3|Open-Label|Adverse Event|11
167320|NCT00549302|588251|P2|Open-Label|Adverse Event|0
167321|NCT00549302|588252|P1|Open-Label|Adverse Event|0
167322|NCT00549302|588250|P3|Double-Blind|New condition or starts new therapy|0
167323|NCT00549302|588251|P2|Double-Blind|New condition or starts new therapy|2
167324|NCT00549302|588252|P1|Double-Blind|New condition or starts new therapy|0
167325|NCT00549302|588250|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
167326|NCT00549302|588251|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
167327|NCT00549302|588252|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
167328|NCT00549302|588250|P3|Double-Blind|Lost to Follow-up|0
167329|NCT00549302|588251|P2|Double-Blind|Lost to Follow-up|2
167330|NCT00549302|588252|P1|Double-Blind|Lost to Follow-up|1
167331|NCT00549302|588250|P3|Double-Blind|Sponsor Decision|0
167332|NCT00549302|588251|P2|Double-Blind|Sponsor Decision|1
167333|NCT00549302|588252|P1|Double-Blind|Sponsor Decision|0
167334|NCT00549302|588250|P3|Double-Blind|Investigator Decision|0
167335|NCT00549302|588251|P2|Double-Blind|Investigator Decision|5
167336|NCT00549302|588252|P1|Double-Blind|Investigator Decision|1
167337|NCT00549302|588250|P3|Double-Blind|Withdrawal by Subject|0
167338|NCT00549302|588251|P2|Double-Blind|Withdrawal by Subject|8
167339|NCT00549302|588252|P1|Double-Blind|Withdrawal by Subject|3
167340|NCT00549302|588250|P3|Double-Blind|Adverse Event|0
167341|NCT00549302|588251|P2|Double-Blind|Adverse Event|16
167342|NCT00549302|588252|P1|Double-Blind|Adverse Event|3
167343|NCT00549302|588250|P3|Double-Blind|Death|0
167344|NCT00549302|588251|P2|Double-Blind|Death|9
167345|NCT00549302|588252|P1|Double-Blind|Death|2
167346|NCT00549198|588264|P2|Overall Study|Not Exposed to Study Drug|4
167347|NCT00549198|588265|P1|Overall Study|Not Exposed to Study Drug|3
167348|NCT00549198|588264|P2|Overall Study|Pregnancy|3
167349|NCT00549198|588265|P1|Overall Study|Pregnancy|0
167350|NCT00549198|588264|P2|Overall Study|No scan facilities|2
167351|NCT00549198|588265|P1|Overall Study|No scan facilities|0
167352|NCT00549198|588264|P2|Overall Study|Participant overweight, no scan possible|0
167353|NCT00549198|588265|P1|Overall Study|Participant overweight, no scan possible|1
167354|NCT00549198|588264|P2|Overall Study|Participant planning pregnancy|0
167355|NCT00549198|588265|P1|Overall Study|Participant planning pregnancy|1
167356|NCT00549198|588264|P2|Overall Study|Prohibited Medication|2
167357|NCT00549198|588265|P1|Overall Study|Prohibited Medication|1
167358|NCT00549198|588264|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
167359|NCT00549198|588265|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
167360|NCT00549198|588264|P2|Overall Study|Participant not able to perform Week 96|0
167361|NCT00549198|588265|P1|Overall Study|Participant not able to perform Week 96|1
167362|NCT00549198|588264|P2|Overall Study|Participant Moved|0
167363|NCT00549198|588265|P1|Overall Study|Participant Moved|2
167364|NCT00549198|588264|P2|Overall Study|Disease Progression|0
167365|NCT00549198|588265|P1|Overall Study|Disease Progression|1
167366|NCT00549198|588264|P2|Overall Study|Withdrawal by Subject|7
167367|NCT00549198|588265|P1|Overall Study|Withdrawal by Subject|7
167368|NCT00549198|588264|P2|Overall Study|Investigator Decision|3
167369|NCT00549198|588265|P1|Overall Study|Investigator Decision|4
167370|NCT00549198|588264|P2|Overall Study|Protocol Violation|2
167371|NCT00549198|588265|P1|Overall Study|Protocol Violation|7
167372|NCT00549198|588264|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
167373|NCT00549198|588265|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
167374|NCT00549198|588264|P2|Overall Study|Lost to Follow-up|8
167375|NCT00549198|588265|P1|Overall Study|Lost to Follow-up|7
167376|NCT00549198|588264|P2|Overall Study|Non-compliance|4
167377|NCT00549198|588265|P1|Overall Study|Non-compliance|2
167378|NCT00549198|588264|P2|Overall Study|Protocol-defined Virological Failure|0
167379|NCT00549198|588265|P1|Overall Study|Protocol-defined Virological Failure|7
167380|NCT00549198|588264|P2|Overall Study|Insufficient Viral Load Response|2
167381|NCT00549198|588265|P1|Overall Study|Insufficient Viral Load Response|4
167382|NCT00549198|588264|P2|Overall Study|Adverse Event|26
167383|NCT00549198|588265|P1|Overall Study|Adverse Event|28
167384|NCT00549055|588402|P1|Overall Study|Very low visual acuity (VA)|1
167385|NCT00549055|588402|P1|Overall Study|Choroidal neovascularization|1
167386|NCT00549055|588402|P1|Overall Study|Growth choroidal neovascularisation|1
167387|NCT00549055|588402|P1|Overall Study|Vitreous hemorrhage|1
167388|NCT00549055|588402|P1|Overall Study|Active choroidal neovascula increased|1
167389|NCT00549055|588402|P1|Overall Study|Decrease of size|1
167390|NCT00549055|588402|P1|Overall Study|Progression to fibrosis|2
167391|NCT00549055|588402|P1|Overall Study|Stabilization|5
167392|NCT00549055|588402|P1|Overall Study|Lack of efficacy|18
167393|NCT00549055|588402|P1|Overall Study|Adverse Event|4
167394|NCT00548847|588426|P1|Overall Study|Disease progression|7
167395|NCT00548808|588433|P2|Overall Study|Sponsor Decision|1
167396|NCT00548808|588434|P1|Overall Study|Sponsor Decision|1
167397|NCT00548808|588433|P2|Overall Study|Lack of Efficacy|0
167398|NCT00548808|588434|P1|Overall Study|Lack of Efficacy|2
167399|NCT00548808|588433|P2|Overall Study|Entry Criteria Not Met|2
167400|NCT00548808|588434|P1|Overall Study|Entry Criteria Not Met|2
167401|NCT00548808|588433|P2|Overall Study|Death|0
167402|NCT00548808|588434|P1|Overall Study|Death|2
167403|NCT00548808|588433|P2|Overall Study|Adverse Event|5
167404|NCT00548808|588434|P1|Overall Study|Adverse Event|4
167405|NCT00548808|588433|P2|Overall Study|Physician Decision|3
167406|NCT00548808|588434|P1|Overall Study|Physician Decision|6
167407|NCT00548808|588433|P2|Overall Study|Withdrawal by Subject|4
167408|NCT00548808|588434|P1|Overall Study|Withdrawal by Subject|8
167409|NCT00548808|588433|P2|Overall Study|Protocol Violation|8
167410|NCT00548808|588434|P1|Overall Study|Protocol Violation|8
167411|NCT00548808|588433|P2|Overall Study|Lost to Follow-up|3
167412|NCT00548808|588434|P1|Overall Study|Lost to Follow-up|9
167413|NCT00548717|588458|P2|Overall Study|Alternative treatment for GVHD|0
167414|NCT00548717|588459|P1|Overall Study|Alternative treatment for GVHD|1
167415|NCT00548717|588458|P2|Overall Study|Relapse|0
167416|NCT00548717|588459|P1|Overall Study|Relapse|3
167417|NCT00548717|588458|P2|Overall Study|Death|2
167418|NCT00548717|588459|P1|Overall Study|Death|5
167419|NCT00548548|588487|P2|Overall Study|Lost to Follow-up|18
167420|NCT00548548|588488|P1|Overall Study|Lost to Follow-up|17
167421|NCT00548548|588487|P2|Overall Study|Death|348
167422|NCT00548548|588488|P1|Overall Study|Death|345
167423|NCT00548405|588531|P3|Overall Study|Randomized but not treated|0
167424|NCT00548405|588532|P2|Overall Study|Randomized but not treated|0
167425|NCT00548405|588533|P1|Overall Study|Randomized but not treated|1
167426|NCT00548405|588531|P3|Overall Study|Sponsor decision|0
167427|NCT00548405|588532|P2|Overall Study|Sponsor decision|0
167428|NCT00548405|588533|P1|Overall Study|Sponsor decision|1
167429|NCT00548405|588531|P3|Overall Study|Death|1
167430|NCT00548405|588532|P2|Overall Study|Death|1
167431|NCT00548405|588533|P1|Overall Study|Death|0
167432|NCT00548405|588531|P3|Overall Study|Lost to Follow-up|2
167433|NCT00548405|588532|P2|Overall Study|Lost to Follow-up|1
167434|NCT00548405|588533|P1|Overall Study|Lost to Follow-up|1
167435|NCT00548405|588531|P3|Overall Study|Withdrawal by Subject|5
167436|NCT00548405|588532|P2|Overall Study|Withdrawal by Subject|12
167437|NCT00548405|588533|P1|Overall Study|Withdrawal by Subject|36
167438|NCT00548405|588531|P3|Overall Study|Protocol Violation|0
167439|NCT00548405|588532|P2|Overall Study|Protocol Violation|0
167440|NCT00548405|588533|P1|Overall Study|Protocol Violation|1
167441|NCT00548405|588531|P3|Overall Study|Pregnancy|0
167442|NCT00548405|588532|P2|Overall Study|Pregnancy|0
167443|NCT00548405|588533|P1|Overall Study|Pregnancy|1
167444|NCT00548405|588531|P3|Overall Study|Physician Decision|1
167445|NCT00548405|588532|P2|Overall Study|Physician Decision|4
167446|NCT00548405|588533|P1|Overall Study|Physician Decision|3
167447|NCT00548405|588531|P3|Overall Study|Lack of Efficacy|0
167448|NCT00548405|588532|P2|Overall Study|Lack of Efficacy|0
167449|NCT00548405|588533|P1|Overall Study|Lack of Efficacy|6
167450|NCT00548405|588531|P3|Overall Study|Adverse Event|0
167451|NCT00548405|588532|P2|Overall Study|Adverse Event|2
167452|NCT00548405|588533|P1|Overall Study|Adverse Event|6
167453|NCT00548340|588554|P3|Overall Study|Other|1
167454|NCT00548340|588555|P2|Overall Study|Other|1
167455|NCT00548340|588556|P1|Overall Study|Other|1
167456|NCT00548340|588554|P3|Overall Study|Withdrawal by Subject|3
167457|NCT00548340|588555|P2|Overall Study|Withdrawal by Subject|4
167458|NCT00548340|588556|P1|Overall Study|Withdrawal by Subject|2
167459|NCT00548340|588554|P3|Overall Study|Lost to Follow-up|0
167460|NCT00548340|588555|P2|Overall Study|Lost to Follow-up|1
167461|NCT00548340|588556|P1|Overall Study|Lost to Follow-up|1
167462|NCT00548340|588554|P3|Overall Study|Adverse Event|2
167463|NCT00548340|588555|P2|Overall Study|Adverse Event|2
167464|NCT00548340|588556|P1|Overall Study|Adverse Event|2
167465|NCT00548340|588554|P3|Overall Study|Protocol Violation|3
167466|NCT00548340|588555|P2|Overall Study|Protocol Violation|3
167467|NCT00548340|588556|P1|Overall Study|Protocol Violation|2
167468|NCT00548327|588575|P2|Overall Study|Adverse Event|1
167469|NCT00548327|588576|P1|Overall Study|Adverse Event|0
167470|NCT00548262|588594|P1|Overall Study|Withdrawal by Subject|1
167471|NCT00548262|588594|P1|Overall Study|Other|3
167472|NCT00548262|588594|P1|Overall Study|Lost to Follow-up|1
167473|NCT00548262|588594|P1|Overall Study|Lack of Efficacy|4
167474|NCT00548262|588594|P1|Overall Study|Adverse Event|2
167475|NCT00548262|588594|P1|Overall Study|Death|21
167476|NCT00548249|588624|P5|Overall Study|Sponsor's request|0
167477|NCT00548249|588625|P4|Overall Study|Sponsor's request|1
167478|NCT00548249|588626|P3|Overall Study|Sponsor's request|0
167479|NCT00548249|588627|P2|Overall Study|Sponsor's request|0
167480|NCT00548249|588628|P1|Overall Study|Sponsor's request|0
167481|NCT00548249|588624|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
167482|NCT00548249|588625|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
167483|NCT00548249|588626|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
167484|NCT00548249|588627|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
167485|NCT00548249|588628|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
167486|NCT00548249|588624|P5|Overall Study|Withdrawal by Subject|0
167487|NCT00548249|588625|P4|Overall Study|Withdrawal by Subject|0
167488|NCT00548249|588626|P3|Overall Study|Withdrawal by Subject|0
167489|NCT00548249|588627|P2|Overall Study|Withdrawal by Subject|0
167490|NCT00548249|588628|P1|Overall Study|Withdrawal by Subject|2
167491|NCT00548249|588624|P5|Overall Study|Prolonged hospitalization|0
167492|NCT00548249|588625|P4|Overall Study|Prolonged hospitalization|1
167493|NCT00548249|588626|P3|Overall Study|Prolonged hospitalization|2
167494|NCT00548249|588627|P2|Overall Study|Prolonged hospitalization|0
167495|NCT00548249|588628|P1|Overall Study|Prolonged hospitalization|0
167496|NCT00548249|588624|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
167497|NCT00548249|588625|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
167498|NCT00548249|588626|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
167499|NCT00548249|588627|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
167500|NCT00548249|588628|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
167501|NCT00548249|588624|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
167502|NCT00548249|588625|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
167503|NCT00548249|588626|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
167504|NCT00548249|588627|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
167505|NCT00548249|588628|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
167506|NCT00548249|588624|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
167507|NCT00548249|588625|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
167508|NCT00548249|588626|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
167509|NCT00548249|588627|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
167510|NCT00548249|588628|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
167511|NCT00548249|588624|P5|Overall Study|Adverse Event|1
167512|NCT00548249|588625|P4|Overall Study|Adverse Event|1
167513|NCT00548249|588626|P3|Overall Study|Adverse Event|0
167514|NCT00548249|588627|P2|Overall Study|Adverse Event|2
167515|NCT00548249|588628|P1|Overall Study|Adverse Event|2
167516|NCT00548249|588624|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
167517|NCT00548249|588625|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
167518|NCT00548249|588626|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
167519|NCT00548249|588627|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
167520|NCT00548249|588628|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
167521|NCT00548249|588624|P5|Overall Study|Miscellaneous|2
167522|NCT00548249|588625|P4|Overall Study|Miscellaneous|0
167523|NCT00548249|588626|P3|Overall Study|Miscellaneous|2
167524|NCT00548249|588627|P2|Overall Study|Miscellaneous|3
167525|NCT00548249|588628|P1|Overall Study|Miscellaneous|2
167526|NCT00548249|588624|P5|Overall Study|Protocol Violation|3
167527|NCT00548249|588625|P4|Overall Study|Protocol Violation|0
167528|NCT00548249|588626|P3|Overall Study|Protocol Violation|4
167529|NCT00548249|588627|P2|Overall Study|Protocol Violation|1
167530|NCT00548249|588628|P1|Overall Study|Protocol Violation|1
167531|NCT00548249|588624|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
167532|NCT00548249|588625|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
167533|NCT00548249|588626|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
167534|NCT00548249|588627|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
167535|NCT00548249|588628|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
167536|NCT00548249|588624|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
167537|NCT00548249|588625|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
167538|NCT00548249|588626|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
167539|NCT00548249|588627|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
167540|NCT00548249|588628|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
167541|NCT00548184|588665|P1|Overall Study|Found Her2 negative|1
167542|NCT00548184|588665|P1|Overall Study|took other drug|1
167543|NCT00548184|588665|P1|Overall Study|Adverse Event|3
167544|NCT00548145|588671|P2|Overall Study|Physician Decision|1
167545|NCT00548145|588672|P1|Overall Study|Physician Decision|1
167546|NCT00548145|588671|P2|Overall Study|Withdrawal by Subject|2
167547|NCT00548145|588672|P1|Overall Study|Withdrawal by Subject|0
167548|NCT00548145|588671|P2|Overall Study|Death|1
167549|NCT00548145|588672|P1|Overall Study|Death|0
167550|NCT00547911|588697|P6|Overall Study|Adverse Event|0
167551|NCT00547911|588698|P5|Overall Study|Adverse Event|0
167552|NCT00547911|588699|P4|Overall Study|Adverse Event|1
167553|NCT00547911|588700|P3|Overall Study|Adverse Event|0
167554|NCT00547911|588701|P2|Overall Study|Adverse Event|0
167555|NCT00547911|588702|P1|Overall Study|Adverse Event|0
167556|NCT00547703|588733|P2|Overall Study|Lost to Follow-up|0
167557|NCT00547703|588734|P1|Overall Study|Lost to Follow-up|1
167558|NCT00547534|588759|P1|Overall Study|Disease Progression|4
167559|NCT00547534|588759|P1|Overall Study|Adverse Event|7
167560|NCT00547521|588767|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
167561|NCT00547521|588768|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
167562|NCT00547521|588767|P2|Long Term Extension (LTE) Study|Not Specified|2
167563|NCT00547521|588768|P1|Long Term Extension (LTE) Study|Not Specified|0
167564|NCT00547521|588767|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
167565|NCT00547521|588768|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
167566|NCT00547521|588767|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
167567|NCT00547521|588768|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
167568|NCT00547521|588767|P2|Long Term Extension (LTE) Study|Adverse Event|9
167569|NCT00547521|588768|P1|Long Term Extension (LTE) Study|Adverse Event|0
167570|NCT00547521|588767|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
167571|NCT00547521|588768|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
167572|NCT00547521|588767|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
167573|NCT00547521|588768|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
167574|NCT00547521|588767|P2|Short Term Study (4 Months)|Withdrawal of consent|1
167575|NCT00547521|588768|P1|Short Term Study (4 Months)|Withdrawal of consent|0
167576|NCT00547521|588767|P2|Short Term Study (4 Months)|Lack of Efficacy|2
167577|NCT00547521|588768|P1|Short Term Study (4 Months)|Lack of Efficacy|0
167578|NCT00547521|588767|P2|Short Term Study (4 Months)|Adverse Event|0
167579|NCT00547521|588768|P1|Short Term Study (4 Months)|Adverse Event|1
167580|NCT00547378|588845|P3|All Implanted Cohort|Other reasons|1
167581|NCT00547378|588846|P2|All Implanted Cohort|Other reasons|0
167582|NCT00547378|588847|P1|All Implanted Cohort|Other reasons|1
167583|NCT00547378|588845|P3|All Implanted Cohort|Site closure|1
167584|NCT00547378|588846|P2|All Implanted Cohort|Site closure|0
167585|NCT00547378|588847|P1|All Implanted Cohort|Site closure|2
167586|NCT00547378|588845|P3|All Implanted Cohort|Physician Decision|6
167587|NCT00547378|588846|P2|All Implanted Cohort|Physician Decision|2
167588|NCT00547378|588847|P1|All Implanted Cohort|Physician Decision|0
167589|NCT00547378|588845|P3|All Implanted Cohort|Death|4
167590|NCT00547378|588846|P2|All Implanted Cohort|Death|1
167591|NCT00547378|588847|P1|All Implanted Cohort|Death|3
167592|NCT00547378|588845|P3|All Implanted Cohort|Lost to Follow-up|14
167593|NCT00547378|588846|P2|All Implanted Cohort|Lost to Follow-up|1
167594|NCT00547378|588847|P1|All Implanted Cohort|Lost to Follow-up|0
167595|NCT00547378|588845|P3|All Implanted Cohort|Adverse Event|17
167596|NCT00547378|588846|P2|All Implanted Cohort|Adverse Event|10
167597|NCT00547378|588847|P1|All Implanted Cohort|Adverse Event|4
167598|NCT00547378|588845|P3|All Implanted Cohort|Withdrawal by Subject|27
167599|NCT00547378|588846|P2|All Implanted Cohort|Withdrawal by Subject|4
167600|NCT00547378|588847|P1|All Implanted Cohort|Withdrawal by Subject|5
167601|NCT00547378|588845|P3|Randomized Cohort|Other reasons|0
167602|NCT00547378|588846|P2|Randomized Cohort|Other reasons|0
167603|NCT00547378|588847|P1|Randomized Cohort|Other reasons|2
167604|NCT00547378|588845|P3|Randomized Cohort|Adverse Event|0
167605|NCT00547378|588846|P2|Randomized Cohort|Adverse Event|0
167606|NCT00547378|588847|P1|Randomized Cohort|Adverse Event|1
167607|NCT00547378|588845|P3|Randomized Cohort|Lost to Follow-up|0
167608|NCT00547378|588846|P2|Randomized Cohort|Lost to Follow-up|0
167609|NCT00547378|588847|P1|Randomized Cohort|Lost to Follow-up|1
167610|NCT00547378|588845|P3|Randomized Cohort|Death|0
167611|NCT00547378|588846|P2|Randomized Cohort|Death|1
167612|NCT00547378|588847|P1|Randomized Cohort|Death|0
167613|NCT00547378|588845|P3|Randomized Cohort|Withdrawal by Subject|0
167614|NCT00547378|588846|P2|Randomized Cohort|Withdrawal by Subject|5
167615|NCT00547378|588847|P1|Randomized Cohort|Withdrawal by Subject|7
167616|NCT00547365|588857|P1|Overall Study|death (not related to study)|4
167617|NCT00547365|588857|P1|Overall Study|Protocol Violation|2
167618|NCT00547365|588857|P1|Overall Study|Lost to Follow-up|1
167619|NCT00547365|588857|P1|Overall Study|Physician Decision|1
167620|NCT00547157|588864|P2|Overall Study|Lost to Follow-up|2
167621|NCT00547157|588865|P1|Overall Study|Lost to Follow-up|4
167622|NCT00547157|588864|P2|Overall Study|Administrative decision|2
167623|NCT00547157|588865|P1|Overall Study|Administrative decision|3
167624|NCT00547157|588864|P2|Overall Study|Withdrawal by Subject|1
167625|NCT00547157|588865|P1|Overall Study|Withdrawal by Subject|3
167626|NCT00547157|588864|P2|Overall Study|Death|18
167627|NCT00547157|588865|P1|Overall Study|Death|38
167628|NCT00547157|588864|P2|Overall Study|Other|0
167629|NCT00547157|588865|P1|Overall Study|Other|1
167630|NCT00547118|588883|P2|Overall Study|Study suspended|8
167631|NCT00547118|588884|P1|Overall Study|Study suspended|7
167632|NCT00547118|588883|P2|Overall Study|Did not qualify prior to starting drug|1
167633|NCT00547118|588884|P1|Overall Study|Did not qualify prior to starting drug|1
167634|NCT00546910|588928|P2|Overall Study|Withdrawal by Subject|0
167635|NCT00546910|588929|P1|Overall Study|Withdrawal by Subject|2
167636|NCT00546910|588928|P2|Overall Study|Physician Decision|1
167637|NCT00546910|588929|P1|Overall Study|Physician Decision|0
167638|NCT00546910|588928|P2|Overall Study|Lack of Efficacy|7
167639|NCT00546910|588929|P1|Overall Study|Lack of Efficacy|5
167640|NCT00546910|588928|P2|Overall Study|Adverse Event|3
167641|NCT00546910|588929|P1|Overall Study|Adverse Event|2
167642|NCT00546871|588995|P2|Study Extension Period|Withdrawal by Subject|1
167643|NCT00546871|588996|P1|Study Extension Period|Withdrawal by Subject|0
167644|NCT00546871|588995|P2|Study Extension Period|Protocol Violation|0
167645|NCT00546871|588996|P1|Study Extension Period|Protocol Violation|1
167646|NCT00546871|588995|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
167647|NCT00546871|588996|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
167648|NCT00546871|588995|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
167649|NCT00546871|588996|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
167650|NCT00546871|588995|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
167651|NCT00546871|588996|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
167652|NCT00546819|589101|P2|Overall Study|Withdrawal by Subject|2
167653|NCT00546819|589102|P1|Overall Study|Withdrawal by Subject|4
167654|NCT00546819|589101|P2|Overall Study|Lost to Follow-up|1
167655|NCT00546819|589102|P1|Overall Study|Lost to Follow-up|2
167656|NCT00546819|589101|P2|Overall Study|Adverse Event|3
167657|NCT00546819|589102|P1|Overall Study|Adverse Event|2
167658|NCT00546754|589114|P2|Overall Study|Missing|7
167659|NCT00546754|589115|P1|Overall Study|Missing|14
167660|NCT00546754|589114|P2|Overall Study|Patient's Decision|1
167661|NCT00546754|589115|P1|Overall Study|Patient's Decision|0
167662|NCT00546754|589114|P2|Overall Study|Elevated Creatinine and Potassium levels|1
167663|NCT00546754|589115|P1|Overall Study|Elevated Creatinine and Potassium levels|0
167664|NCT00546754|589114|P2|Overall Study|Missing Cooperation|0
167665|NCT00546754|589115|P1|Overall Study|Missing Cooperation|1
167666|NCT00546754|589114|P2|Overall Study|Suicide|0
167667|NCT00546754|589115|P1|Overall Study|Suicide|1
167668|NCT00546754|589114|P2|Overall Study|Hip Replacement|0
167669|NCT00546754|589115|P1|Overall Study|Hip Replacement|1
167670|NCT00546754|589114|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
167671|NCT00546754|589115|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
167672|NCT00546754|589114|P2|Overall Study|Dyspnea|0
167673|NCT00546754|589115|P1|Overall Study|Dyspnea|1
167674|NCT00546754|589114|P2|Overall Study|Withdrawal by Subject|7
167675|NCT00546754|589115|P1|Overall Study|Withdrawal by Subject|6
167676|NCT00546754|589114|P2|Overall Study|Protocol Violation|0
167677|NCT00546754|589115|P1|Overall Study|Protocol Violation|3
167678|NCT00546754|589114|P2|Overall Study|Lost to Follow-up|15
167679|NCT00546754|589115|P1|Overall Study|Lost to Follow-up|9
167680|NCT00546754|589114|P2|Overall Study|Lack of Efficacy|1
167681|NCT00546754|589115|P1|Overall Study|Lack of Efficacy|1
167682|NCT00546754|589114|P2|Overall Study|Adverse Event|16
167683|NCT00546754|589115|P1|Overall Study|Adverse Event|11
167684|NCT00546754|589114|P2|Overall Study|Serious Adverse Event|1
167685|NCT00546754|589115|P1|Overall Study|Serious Adverse Event|1
167686|NCT00546715|589158|P4|Overall Study|Withdrawal by Subject|0
167687|NCT00546715|589159|P3|Overall Study|Withdrawal by Subject|0
167688|NCT00546715|589160|P2|Overall Study|Withdrawal by Subject|1
167689|NCT00546715|589161|P1|Overall Study|Withdrawal by Subject|0
167690|NCT00546637|589216|P2|Overall Study|Randomized, but not treated|1
167691|NCT00546637|589217|P1|Overall Study|Randomized, but not treated|3
167692|NCT00546637|589216|P2|Overall Study|Withdrawal by Subject|9
167693|NCT00546637|589217|P1|Overall Study|Withdrawal by Subject|7
167694|NCT00546637|589216|P2|Overall Study|Other|12
167695|NCT00546637|589217|P1|Overall Study|Other|10
167696|NCT00546637|589216|P2|Overall Study|Lost to Follow-up|2
167697|NCT00546637|589217|P1|Overall Study|Lost to Follow-up|2
167698|NCT00546637|589216|P2|Overall Study|Lack of Efficacy|5
167699|NCT00546637|589217|P1|Overall Study|Lack of Efficacy|5
167700|NCT00546637|589216|P2|Overall Study|Adverse Event|20
167701|NCT00546637|589217|P1|Overall Study|Adverse Event|46
167702|NCT00546572|589291|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
167703|NCT00546572|589292|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
167704|NCT00546572|589291|P2|Vax 2 / Year 1|Adverse Event|0
167705|NCT00546572|589292|P1|Vax 2 / Year 1|Adverse Event|1
167706|NCT00546572|589291|P2|Vax 2 / Year 1|Other|1
167707|NCT00546572|589292|P1|Vax 2 / Year 1|Other|1
167708|NCT00546572|589291|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
167709|NCT00546572|589292|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
167710|NCT00546572|589291|P2|Vax 1 / Year 0|Lost to Follow-up|1
167711|NCT00546572|589292|P1|Vax 1 / Year 0|Lost to Follow-up|0
167712|NCT00546572|589291|P2|Vax 1 / Year 0|Adverse Event|1
167713|NCT00546572|589292|P1|Vax 1 / Year 0|Adverse Event|0
167714|NCT00546572|589291|P2|Vax 1 / Year 0|Death|2
167715|NCT00546572|589292|P1|Vax 1 / Year 0|Death|2
167716|NCT00546572|589291|P2|Vax 1 / Year 0|Protocol Violation|4
167717|NCT00546572|589292|P1|Vax 1 / Year 0|Protocol Violation|3
167718|NCT00546572|589291|P2|Vax 1 / Year 0|Withdrawal by Subject|2
167719|NCT00546572|589292|P1|Vax 1 / Year 0|Withdrawal by Subject|3
167720|NCT00546572|589291|P2|Vax 1 / Year 0|Randomized, not treated|1
167721|NCT00546572|589292|P1|Vax 1 / Year 0|Randomized, not treated|1
167722|NCT00546481|589336|P3|Maintenance Phase (CERA)|Other Reason|1
167723|NCT00546481|589337|P2|Maintenance Phase (CERA)|Other Reason|0
167724|NCT00546481|589338|P1|Maintenance Phase (CERA)|Other Reason|0
167725|NCT00546481|589336|P3|Maintenance Phase (CERA)|Kidney transplantation|1
167726|NCT00546481|589337|P2|Maintenance Phase (CERA)|Kidney transplantation|0
167727|NCT00546481|589338|P1|Maintenance Phase (CERA)|Kidney transplantation|0
167728|NCT00546481|589336|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
167729|NCT00546481|589337|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
167730|NCT00546481|589338|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
167731|NCT00546481|589336|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
167732|NCT00546481|589337|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
167733|NCT00546481|589338|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
167734|NCT00546481|589336|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
167735|NCT00546481|589337|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
167736|NCT00546481|589338|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
167737|NCT00546481|589336|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
167738|NCT00546481|589337|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
167739|NCT00546481|589338|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
167740|NCT00546481|589336|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
167741|NCT00546481|589337|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
167742|NCT00546481|589338|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
167743|NCT00546481|589336|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
167744|NCT00546481|589337|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
167745|NCT00546481|589338|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
167746|NCT00546481|589336|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
167747|NCT00546481|589337|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
167748|NCT00546481|589338|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
167749|NCT00546377|589365|P1|Overall Study|Adverse Event|6
167750|NCT00546377|589365|P1|Overall Study|Deemed ineligible|1
167751|NCT00546364|589373|P3|Overall Study|Sponsor decision|1
167752|NCT00546364|589374|P2|Overall Study|Sponsor decision|0
167753|NCT00546364|589375|P1|Overall Study|Sponsor decision|0
167754|NCT00546364|589373|P3|Overall Study|Physician Decision|1
167755|NCT00546364|589374|P2|Overall Study|Physician Decision|0
167756|NCT00546364|589375|P1|Overall Study|Physician Decision|0
167757|NCT00546364|589373|P3|Overall Study|Target lesions resected|0
167758|NCT00546364|589374|P2|Overall Study|Target lesions resected|0
167759|NCT00546364|589375|P1|Overall Study|Target lesions resected|1
167760|NCT00546364|589373|P3|Overall Study|Palliative treatment|1
167761|NCT00546364|589374|P2|Overall Study|Palliative treatment|0
167762|NCT00546364|589375|P1|Overall Study|Palliative treatment|1
167763|NCT00546364|589373|P3|Overall Study|Mixed response|0
167764|NCT00546364|589374|P2|Overall Study|Mixed response|0
167765|NCT00546364|589375|P1|Overall Study|Mixed response|1
167766|NCT00546364|589373|P3|Overall Study|Prior taxotere|0
167767|NCT00546364|589374|P2|Overall Study|Prior taxotere|0
167768|NCT00546364|589375|P1|Overall Study|Prior taxotere|1
167769|NCT00546364|589373|P3|Overall Study|Withdrawal by Subject|3
167770|NCT00546364|589374|P2|Overall Study|Withdrawal by Subject|6
167771|NCT00546364|589375|P1|Overall Study|Withdrawal by Subject|5
167772|NCT00546364|589373|P3|Overall Study|No longer meets study criteria|0
167773|NCT00546364|589374|P2|Overall Study|No longer meets study criteria|1
167774|NCT00546364|589375|P1|Overall Study|No longer meets study criteria|1
167775|NCT00546364|589373|P3|Overall Study|Poor compliance/noncompliance|1
167776|NCT00546364|589374|P2|Overall Study|Poor compliance/noncompliance|0
167777|NCT00546364|589375|P1|Overall Study|Poor compliance/noncompliance|0
167778|NCT00546364|589373|P3|Overall Study|Administrative reason by sponsor|0
167779|NCT00546364|589374|P2|Overall Study|Administrative reason by sponsor|0
167780|NCT00546364|589375|P1|Overall Study|Administrative reason by sponsor|1
167781|NCT00546364|589373|P3|Overall Study|Completed and off treatment|2
167782|NCT00546364|589374|P2|Overall Study|Completed and off treatment|0
167783|NCT00546364|589375|P1|Overall Study|Completed and off treatment|1
167784|NCT00546364|589373|P3|Overall Study|Disease progression|8
167785|NCT00546364|589374|P2|Overall Study|Disease progression|11
167786|NCT00546364|589375|P1|Overall Study|Disease progression|5
167787|NCT00546351|589410|P1|Overall Study|Other reasons for premature termination|17
167788|NCT00546351|589410|P1|Overall Study|Unsatisfactory compliance|9
167789|NCT00546351|589410|P1|Overall Study|Protocol Deviation|1
167790|NCT00546351|589410|P1|Overall Study|Lost to Follow-up|9
167791|NCT00546351|589410|P1|Overall Study|Withdrawal by Subject|109
167792|NCT00546351|589410|P1|Overall Study|Lack of Efficacy|15
167793|NCT00546351|589410|P1|Overall Study|Adverse Event|76
167794|NCT00546260|589456|P2|Overall Study|Drug not given pre diagnostic angiogr|2
167795|NCT00546260|589457|P1|Overall Study|Drug not given pre diagnostic angiogr|8
167796|NCT00546117|589479|P2|Overall Study|Inability to schedule follow-up visit|0
167797|NCT00546117|589480|P1|Overall Study|Inability to schedule follow-up visit|1
167798|NCT00546117|589479|P2|Overall Study|Withdrawal by Subject|0
167799|NCT00546117|589480|P1|Overall Study|Withdrawal by Subject|3
167800|NCT00546078|589499|P2|Overall Study|Other reason|1
167801|NCT00546078|589500|P1|Overall Study|Other reason|1
167802|NCT00546078|589499|P2|Overall Study|Withdrawal by Subject|3
167803|NCT00546078|589500|P1|Overall Study|Withdrawal by Subject|2
167804|NCT00546078|589499|P2|Overall Study|Lost to Follow-up|3
167805|NCT00546078|589500|P1|Overall Study|Lost to Follow-up|1
167806|NCT00546052|589538|P1|Overall Study|Non Compliance|7
167807|NCT00546052|589538|P1|Overall Study|Withdrawal by Subject|20
167808|NCT00546052|589538|P1|Overall Study|Protocol Violation|9
167809|NCT00546052|589538|P1|Overall Study|Lost to Follow-up|144
167810|NCT00546052|589538|P1|Overall Study|Adverse Event|47
167811|NCT00546000|589556|P1|Overall Study|Baseline HPA Axis Supression|2
167812|NCT00546000|589556|P1|Overall Study|Lost to Follow-up|1
167813|NCT00546000|589556|P1|Overall Study|Adverse Event|1
167814|NCT00545948|589575|P3|Overall Study|Not Treated|7
167815|NCT00545948|589576|P2|Overall Study|Not Treated|1
167816|NCT00545948|589577|P1|Overall Study|Not Treated|1
167817|NCT00545844|589587|P1|Overall Study|Withdrawal by Subject|2
167818|NCT00545844|589587|P1|Overall Study|Protocol Violation|1
167819|NCT00545844|589587|P1|Overall Study|Lost to Follow-up|9
167820|NCT00545792|589601|P1|Overall Study|Withdrawal by Subject|1
167821|NCT00545779|589606|P1|Overall Study|Failure to return|3
167822|NCT00545779|589606|P1|Overall Study|Adverse Event/intercurrent illness|5
167823|NCT00545779|589606|P1|Overall Study|Withdrawal by Subject|20
167824|NCT00545779|589606|P1|Overall Study|Did not cooperate|7
167825|NCT00545779|589606|P1|Overall Study|Other protocol violation|1
167826|NCT00545779|589606|P1|Overall Study|Violation of selection criteria at entry|8
167827|NCT00545753|589626|P3|Overall Study|Protocol Violation|4
167828|NCT00545753|589627|P2|Overall Study|Protocol Violation|1
167829|NCT00545753|589628|P1|Overall Study|Protocol Violation|3
167830|NCT00545753|589626|P3|Overall Study|Lost to Follow-up|12
167831|NCT00545753|589627|P2|Overall Study|Lost to Follow-up|3
167832|NCT00545753|589628|P1|Overall Study|Lost to Follow-up|13
167833|NCT00545753|589626|P3|Overall Study|Withdrawal by Subject|10
167834|NCT00545753|589627|P2|Overall Study|Withdrawal by Subject|1
167835|NCT00545753|589628|P1|Overall Study|Withdrawal by Subject|0
167836|NCT00545740|589641|P4|Overall Study|Husband against study|0
167837|NCT00545740|589642|P3|Overall Study|Husband against study|1
167838|NCT00545740|589643|P2|Overall Study|Husband against study|0
167839|NCT00545740|589644|P1|Overall Study|Husband against study|0
167840|NCT00545740|589641|P4|Overall Study|Patient difficulties|0
167841|NCT00545740|589642|P3|Overall Study|Patient difficulties|0
167842|NCT00545740|589643|P2|Overall Study|Patient difficulties|1
167843|NCT00545740|589644|P1|Overall Study|Patient difficulties|0
167844|NCT00545740|589641|P4|Overall Study|Non-adherence to visits|0
167845|NCT00545740|589642|P3|Overall Study|Non-adherence to visits|0
167846|NCT00545740|589643|P2|Overall Study|Non-adherence to visits|1
167847|NCT00545740|589644|P1|Overall Study|Non-adherence to visits|0
167848|NCT00545740|589641|P4|Overall Study|Lack of time|0
167849|NCT00545740|589642|P3|Overall Study|Lack of time|0
167850|NCT00545740|589643|P2|Overall Study|Lack of time|1
167851|NCT00545740|589644|P1|Overall Study|Lack of time|0
167852|NCT00545740|589641|P4|Overall Study|Sponsor decision|0
167853|NCT00545740|589642|P3|Overall Study|Sponsor decision|0
167854|NCT00545740|589643|P2|Overall Study|Sponsor decision|1
167855|NCT00545740|589644|P1|Overall Study|Sponsor decision|0
167856|NCT00545740|589641|P4|Overall Study|Accepted only monthly telephone calls|0
167857|NCT00545740|589642|P3|Overall Study|Accepted only monthly telephone calls|0
167858|NCT00545740|589643|P2|Overall Study|Accepted only monthly telephone calls|0
167859|NCT00545740|589644|P1|Overall Study|Accepted only monthly telephone calls|1
167860|NCT00545740|589641|P4|Overall Study|Physician Decision|0
167861|NCT00545740|589642|P3|Overall Study|Physician Decision|3
167862|NCT00545740|589643|P2|Overall Study|Physician Decision|0
167863|NCT00545740|589644|P1|Overall Study|Physician Decision|0
167864|NCT00545740|589641|P4|Overall Study|Missed visit|0
167865|NCT00545740|589642|P3|Overall Study|Missed visit|0
167866|NCT00545740|589643|P2|Overall Study|Missed visit|0
167867|NCT00545740|589644|P1|Overall Study|Missed visit|1
167868|NCT00545740|589641|P4|Overall Study|Site closure|0
167869|NCT00545740|589642|P3|Overall Study|Site closure|0
167870|NCT00545740|589643|P2|Overall Study|Site closure|0
167871|NCT00545740|589644|P1|Overall Study|Site closure|1
167872|NCT00545740|589641|P4|Overall Study|Suspected Diverticulitis Recurrence|1
167873|NCT00545740|589642|P3|Overall Study|Suspected Diverticulitis Recurrence|1
167874|NCT00545740|589643|P2|Overall Study|Suspected Diverticulitis Recurrence|1
167875|NCT00545740|589644|P1|Overall Study|Suspected Diverticulitis Recurrence|1
167876|NCT00545740|589641|P4|Overall Study|Diverticulitis attack|1
167877|NCT00545740|589642|P3|Overall Study|Diverticulitis attack|1
167878|NCT00545740|589643|P2|Overall Study|Diverticulitis attack|0
167879|NCT00545740|589644|P1|Overall Study|Diverticulitis attack|0
167880|NCT00545740|589641|P4|Overall Study|Moved|0
167881|NCT00545740|589642|P3|Overall Study|Moved|1
167882|NCT00545740|589643|P2|Overall Study|Moved|0
167883|NCT00545740|589644|P1|Overall Study|Moved|2
167884|NCT00545740|589641|P4|Overall Study|Non-compliance|0
167885|NCT00545740|589642|P3|Overall Study|Non-compliance|1
167886|NCT00545740|589643|P2|Overall Study|Non-compliance|2
167887|NCT00545740|589644|P1|Overall Study|Non-compliance|0
167888|NCT00545740|589641|P4|Overall Study|Protocol Violation|0
167889|NCT00545740|589642|P3|Overall Study|Protocol Violation|1
167890|NCT00545740|589643|P2|Overall Study|Protocol Violation|3
167891|NCT00545740|589644|P1|Overall Study|Protocol Violation|1
167892|NCT00545740|589641|P4|Overall Study|Lost to Follow-up|6
167893|NCT00545740|589642|P3|Overall Study|Lost to Follow-up|5
167894|NCT00545740|589643|P2|Overall Study|Lost to Follow-up|5
167895|NCT00545740|589644|P1|Overall Study|Lost to Follow-up|7
167896|NCT00545740|589641|P4|Overall Study|Adverse Event|9
167897|NCT00545740|589642|P3|Overall Study|Adverse Event|19
167898|NCT00545740|589643|P2|Overall Study|Adverse Event|18
167899|NCT00545740|589644|P1|Overall Study|Adverse Event|10
167900|NCT00545740|589641|P4|Overall Study|Withdrawal by Subject|18
167901|NCT00545740|589642|P3|Overall Study|Withdrawal by Subject|16
167902|NCT00545740|589643|P2|Overall Study|Withdrawal by Subject|15
167903|NCT00545740|589644|P1|Overall Study|Withdrawal by Subject|17
167904|NCT00545740|589641|P4|Overall Study|Lack of Efficacy|36
167905|NCT00545740|589642|P3|Overall Study|Lack of Efficacy|47
167906|NCT00545740|589643|P2|Overall Study|Lack of Efficacy|35
167907|NCT00545740|589644|P1|Overall Study|Lack of Efficacy|34
167908|NCT00545688|589682|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
167909|NCT00545688|589683|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
167910|NCT00545688|589684|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
167911|NCT00545688|589685|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
167912|NCT00545688|589682|P4|Follow-Up Period|Unspecified Reason|8
167913|NCT00545688|589683|P3|Follow-Up Period|Unspecified Reason|6
167914|NCT00545688|589684|P2|Follow-Up Period|Unspecified Reason|5
167915|NCT00545688|589685|P1|Follow-Up Period|Unspecified Reason|2
167916|NCT00545688|589682|P4|Follow-Up Period|Lost to Follow-up|1
167917|NCT00545688|589683|P3|Follow-Up Period|Lost to Follow-up|3
167918|NCT00545688|589684|P2|Follow-Up Period|Lost to Follow-up|3
167919|NCT00545688|589685|P1|Follow-Up Period|Lost to Follow-up|3
167920|NCT00545688|589682|P4|Follow-Up Period|Refused Treatment|2
167921|NCT00545688|589683|P3|Follow-Up Period|Refused Treatment|0
167922|NCT00545688|589684|P2|Follow-Up Period|Refused Treatment|2
167923|NCT00545688|589685|P1|Follow-Up Period|Refused Treatment|6
167924|NCT00545688|589682|P4|Follow-Up Period|Disease Progression|9
167925|NCT00545688|589683|P3|Follow-Up Period|Disease Progression|9
167926|NCT00545688|589684|P2|Follow-Up Period|Disease Progression|5
167927|NCT00545688|589685|P1|Follow-Up Period|Disease Progression|6
167928|NCT00545688|589682|P4|Follow-Up Period|Death|6
167929|NCT00545688|589683|P3|Follow-Up Period|Death|2
167930|NCT00545688|589684|P2|Follow-Up Period|Death|2
167931|NCT00545688|589685|P1|Follow-Up Period|Death|4
167932|NCT00545688|589682|P4|Adjuvant Treatment Period|Unknown Reason|0
167933|NCT00545688|589683|P3|Adjuvant Treatment Period|Unknown Reason|0
167934|NCT00545688|589684|P2|Adjuvant Treatment Period|Unknown Reason|1
167935|NCT00545688|589685|P1|Adjuvant Treatment Period|Unknown Reason|0
167936|NCT00545688|589682|P4|Adjuvant Treatment Period|Adverse Event|2
167937|NCT00545688|589683|P3|Adjuvant Treatment Period|Adverse Event|2
167938|NCT00545688|589684|P2|Adjuvant Treatment Period|Adverse Event|3
167939|NCT00545688|589685|P1|Adjuvant Treatment Period|Adverse Event|0
167940|NCT00545688|589682|P4|Adjuvant Treatment Period|Lost to Follow-up|0
167941|NCT00545688|589683|P3|Adjuvant Treatment Period|Lost to Follow-up|1
167942|NCT00545688|589684|P2|Adjuvant Treatment Period|Lost to Follow-up|0
167943|NCT00545688|589685|P1|Adjuvant Treatment Period|Lost to Follow-up|1
167944|NCT00545688|589682|P4|Adjuvant Treatment Period|Refused Treatment|5
167945|NCT00545688|589683|P3|Adjuvant Treatment Period|Refused Treatment|1
167946|NCT00545688|589684|P2|Adjuvant Treatment Period|Refused Treatment|1
167947|NCT00545688|589685|P1|Adjuvant Treatment Period|Refused Treatment|1
167948|NCT00545688|589682|P4|Adjuvant Treatment Period|Disease Progression|7
167949|NCT00545688|589683|P3|Adjuvant Treatment Period|Disease Progression|0
167950|NCT00545688|589684|P2|Adjuvant Treatment Period|Disease Progression|3
167951|NCT00545688|589685|P1|Adjuvant Treatment Period|Disease Progression|3
167952|NCT00545688|589682|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
167953|NCT00545688|589683|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
167954|NCT00545688|589684|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
167955|NCT00545688|589685|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
167956|NCT00545688|589682|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
167957|NCT00545688|589683|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
167958|NCT00545688|589684|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
167959|NCT00545688|589685|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
167960|NCT00545688|589682|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
167961|NCT00545688|589683|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
167962|NCT00545688|589684|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
167963|NCT00545688|589685|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
167964|NCT00545688|589682|P4|Neo-Adjuvant Treatment Period|Death|0
167965|NCT00545688|589683|P3|Neo-Adjuvant Treatment Period|Death|0
167966|NCT00545688|589684|P2|Neo-Adjuvant Treatment Period|Death|1
167967|NCT00545688|589685|P1|Neo-Adjuvant Treatment Period|Death|0
167968|NCT00545688|589682|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
167969|NCT00545688|589683|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
167970|NCT00545688|589684|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
167971|NCT00545688|589685|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
167972|NCT00545688|589682|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
167973|NCT00545688|589683|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
167974|NCT00545688|589684|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
167975|NCT00545688|589685|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
167976|NCT00545688|589682|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
167977|NCT00545688|589683|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
167978|NCT00545688|589684|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
167979|NCT00545688|589685|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
167980|NCT00545584|589784|P3|Overall Study|Two or more reasons for discontinuation|8
167981|NCT00545584|589785|P2|Overall Study|Two or more reasons for discontinuation|19
167982|NCT00545584|589786|P1|Overall Study|Two or more reasons for discontinuation|17
167983|NCT00545584|589784|P3|Overall Study|Only one reason for discontinuation|48
167984|NCT00545584|589785|P2|Overall Study|Only one reason for discontinuation|61
167985|NCT00545584|589786|P1|Overall Study|Only one reason for discontinuation|62
167986|NCT00545571|589797|P1|Overall Study|Kidney Transplantation|3
167987|NCT00545571|589797|P1|Overall Study|Early Termination of Study|24
167988|NCT00545571|589797|P1|Overall Study|Transfusion|12
167989|NCT00545571|589797|P1|Overall Study|Screen Failure|16
167990|NCT00545571|589797|P1|Overall Study|Refused Treatment|1
167991|NCT00545571|589797|P1|Overall Study|Protocol Violation|2
167992|NCT00545571|589797|P1|Overall Study|Lack of Efficacy|1
167993|NCT00545571|589797|P1|Overall Study|Death|5
167994|NCT00545571|589797|P1|Overall Study|Adverse Event|2
167995|NCT00545571|589797|P1|Overall Study|Administrative Reasons|1
167996|NCT00545441|589821|P2|Overall Study|Patients were not treated|3
167997|NCT00545441|589822|P1|Overall Study|Patients were not treated|1
167998|NCT00545441|589821|P2|Overall Study|Persistence or recurrence of fistula|2
167999|NCT00545441|589822|P1|Overall Study|Persistence or recurrence of fistula|5
168000|NCT00545441|589821|P2|Overall Study|Withdrawal by Subject|1
168001|NCT00545441|589822|P1|Overall Study|Withdrawal by Subject|1
168002|NCT00545441|589821|P2|Overall Study|Technical failure|1
168003|NCT00545441|589822|P1|Overall Study|Technical failure|0
168004|NCT00545441|589821|P2|Overall Study|Lost to Follow-up|5
168005|NCT00545441|589822|P1|Overall Study|Lost to Follow-up|9
168006|NCT00545441|589821|P2|Overall Study|Fistula draining at 6 months|4
168007|NCT00545441|589822|P1|Overall Study|Fistula draining at 6 months|2
168008|NCT00545402|589830|P2|Overall Study|Reason not specified|1
168009|NCT00545402|589831|P1|Overall Study|Reason not specified|1
168010|NCT00545402|589830|P2|Overall Study|Protocol Violation|0
168011|NCT00545402|589831|P1|Overall Study|Protocol Violation|1
168012|NCT00545402|589830|P2|Overall Study|Withdrawal by Subject|1
168013|NCT00545402|589831|P1|Overall Study|Withdrawal by Subject|0
168014|NCT00545402|589830|P2|Overall Study|Graft loss|4
168015|NCT00545402|589831|P1|Overall Study|Graft loss|2
168016|NCT00545402|589830|P2|Overall Study|Death|7
168017|NCT00545402|589831|P1|Overall Study|Death|5
168018|NCT00545402|589830|P2|Overall Study|Use of unauthorized immunosuppressant|7
168019|NCT00545402|589831|P1|Overall Study|Use of unauthorized immunosuppressant|8
168020|NCT00545402|589830|P2|Overall Study|Discontinuation of treatment|9
168021|NCT00545402|589831|P1|Overall Study|Discontinuation of treatment|17
168022|NCT00545363|589849|P2|Overall Study|Other|1
168023|NCT00545363|589850|P1|Overall Study|Other|1
168024|NCT00545363|589849|P2|Overall Study|Lost to Follow-up|0
168025|NCT00545363|589850|P1|Overall Study|Lost to Follow-up|2
168026|NCT00545363|589849|P2|Overall Study|Did not meet entry criteria|1
168027|NCT00545363|589850|P1|Overall Study|Did not meet entry criteria|1
168028|NCT00545363|589849|P2|Overall Study|Non-compliance|1
168029|NCT00545363|589850|P1|Overall Study|Non-compliance|3
168030|NCT00545363|589849|P2|Overall Study|Withdrawal by Subject|5
168031|NCT00545363|589850|P1|Overall Study|Withdrawal by Subject|6
168032|NCT00545363|589849|P2|Overall Study|Adverse Event|7
168033|NCT00545363|589850|P1|Overall Study|Adverse Event|6
168034|NCT00545298|589865|P3|Overall Study|Issues with Standard of Care|1
168035|NCT00545298|589866|P2|Overall Study|Issues with Standard of Care|0
168036|NCT00545298|589867|P1|Overall Study|Issues with Standard of Care|2
168037|NCT00545272|589884|P6|Overall Study|Lost to Follow-up|0
168038|NCT00545272|589885|P5|Overall Study|Lost to Follow-up|1
168039|NCT00545272|589886|P4|Overall Study|Lost to Follow-up|0
168040|NCT00545272|589887|P3|Overall Study|Lost to Follow-up|0
168041|NCT00545272|589888|P2|Overall Study|Lost to Follow-up|0
168042|NCT00545272|589889|P1|Overall Study|Lost to Follow-up|0
168043|NCT00545272|589884|P6|Overall Study|Abnormal test procedure result(s)|0
168044|NCT00545272|589885|P5|Overall Study|Abnormal test procedure result(s)|1
168045|NCT00545272|589886|P4|Overall Study|Abnormal test procedure result(s)|0
168046|NCT00545272|589887|P3|Overall Study|Abnormal test procedure result(s)|0
168047|NCT00545272|589888|P2|Overall Study|Abnormal test procedure result(s)|0
168048|NCT00545272|589889|P1|Overall Study|Abnormal test procedure result(s)|0
168049|NCT00545272|589884|P6|Overall Study|Abnormal laboratory value(s)|1
168050|NCT00545272|589885|P5|Overall Study|Abnormal laboratory value(s)|0
168051|NCT00545272|589886|P4|Overall Study|Abnormal laboratory value(s)|0
168052|NCT00545272|589887|P3|Overall Study|Abnormal laboratory value(s)|0
168053|NCT00545272|589888|P2|Overall Study|Abnormal laboratory value(s)|0
168054|NCT00545272|589889|P1|Overall Study|Abnormal laboratory value(s)|0
168055|NCT00545272|589884|P6|Overall Study|Adverse Event|1
168056|NCT00545272|589885|P5|Overall Study|Adverse Event|0
168057|NCT00545272|589886|P4|Overall Study|Adverse Event|0
168058|NCT00545272|589887|P3|Overall Study|Adverse Event|1
168059|NCT00545272|589888|P2|Overall Study|Adverse Event|0
168060|NCT00545272|589889|P1|Overall Study|Adverse Event|0
168061|NCT00545272|589884|P6|Overall Study|Protocol deviation|1
168062|NCT00545272|589885|P5|Overall Study|Protocol deviation|0
168063|NCT00545272|589886|P4|Overall Study|Protocol deviation|1
168064|NCT00545272|589887|P3|Overall Study|Protocol deviation|0
168065|NCT00545272|589888|P2|Overall Study|Protocol deviation|1
168066|NCT00545272|589889|P1|Overall Study|Protocol deviation|0
168067|NCT00545233|589941|P2|Overall Study|Physician Decision|1
168068|NCT00545233|589942|P1|Overall Study|Physician Decision|2
168069|NCT00545233|589941|P2|Overall Study|Insufficient response|15
168070|NCT00545233|589942|P1|Overall Study|Insufficient response|14
168071|NCT00545233|589941|P2|Overall Study|Failure to Return|6
168072|NCT00545233|589942|P1|Overall Study|Failure to Return|4
168073|NCT00545233|589941|P2|Overall Study|Refused Treatment|7
168074|NCT00545233|589942|P1|Overall Study|Refused Treatment|9
168075|NCT00545233|589941|P2|Overall Study|Protocol Violation|0
168076|NCT00545233|589942|P1|Overall Study|Protocol Violation|2
168077|NCT00545233|589941|P2|Overall Study|Violation of Selection Criteria at Entry|1
168078|NCT00545233|589942|P1|Overall Study|Violation of Selection Criteria at Entry|5
168079|NCT00545233|589941|P2|Overall Study|Adverse Event|5
168080|NCT00545233|589942|P1|Overall Study|Adverse Event|10
168081|NCT00545168|590001|P3|Overall Study|Visit for Day 21 was not done in error|2
168082|NCT00545168|590002|P2|Overall Study|Visit for Day 21 was not done in error|0
168083|NCT00545168|590003|P1|Overall Study|Visit for Day 21 was not done in error|1
168084|NCT00545168|590001|P3|Overall Study|Protocol Violation|1
168085|NCT00545168|590002|P2|Overall Study|Protocol Violation|0
168086|NCT00545168|590003|P1|Overall Study|Protocol Violation|1
168087|NCT00545168|590001|P3|Overall Study|Withdrawal by Subject|13
168088|NCT00545168|590002|P2|Overall Study|Withdrawal by Subject|0
168089|NCT00545168|590003|P1|Overall Study|Withdrawal by Subject|9
168090|NCT00545168|590001|P3|Overall Study|Lost to Follow-up|5
168091|NCT00545168|590002|P2|Overall Study|Lost to Follow-up|5
168092|NCT00545168|590003|P1|Overall Study|Lost to Follow-up|5
168093|NCT00545103|590029|P4|Overall Study|Death|0
168094|NCT00545103|590030|P3|Overall Study|Death|0
168095|NCT00545103|590031|P2|Overall Study|Death|1
168096|NCT00545103|590032|P1|Overall Study|Death|0
168097|NCT00545103|590029|P4|Overall Study|Subject met endpoint under protocol v. 1|0
168098|NCT00545103|590030|P3|Overall Study|Subject met endpoint under protocol v. 1|1
168099|NCT00545103|590031|P2|Overall Study|Subject met endpoint under protocol v. 1|0
168100|NCT00545103|590032|P1|Overall Study|Subject met endpoint under protocol v. 1|0
168101|NCT00545103|590029|P4|Overall Study|Does not want to take study drug anymore|0
168102|NCT00545103|590030|P3|Overall Study|Does not want to take study drug anymore|1
168103|NCT00545103|590031|P2|Overall Study|Does not want to take study drug anymore|0
168104|NCT00545103|590032|P1|Overall Study|Does not want to take study drug anymore|1
168105|NCT00545103|590029|P4|Overall Study|Use of prohibited medication|0
168106|NCT00545103|590030|P3|Overall Study|Use of prohibited medication|1
168107|NCT00545103|590031|P2|Overall Study|Use of prohibited medication|0
168108|NCT00545103|590032|P1|Overall Study|Use of prohibited medication|0
168109|NCT00545103|590029|P4|Overall Study|Subject moved|0
168110|NCT00545103|590030|P3|Overall Study|Subject moved|0
168111|NCT00545103|590031|P2|Overall Study|Subject moved|1
168112|NCT00545103|590032|P1|Overall Study|Subject moved|0
168113|NCT00545103|590029|P4|Overall Study|Investigator decision|0
168114|NCT00545103|590030|P3|Overall Study|Investigator decision|1
168115|NCT00545103|590031|P2|Overall Study|Investigator decision|0
168116|NCT00545103|590032|P1|Overall Study|Investigator decision|0
168117|NCT00545103|590029|P4|Overall Study|Noncompliance|0
168118|NCT00545103|590030|P3|Overall Study|Noncompliance|0
168119|NCT00545103|590031|P2|Overall Study|Noncompliance|1
168120|NCT00545103|590032|P1|Overall Study|Noncompliance|0
168121|NCT00545103|590029|P4|Overall Study|Subject's decision|0
168122|NCT00545103|590030|P3|Overall Study|Subject's decision|0
168123|NCT00545103|590031|P2|Overall Study|Subject's decision|0
168124|NCT00545103|590032|P1|Overall Study|Subject's decision|1
168125|NCT00545103|590029|P4|Overall Study|Personal reasons|0
168126|NCT00545103|590030|P3|Overall Study|Personal reasons|0
168127|NCT00545103|590031|P2|Overall Study|Personal reasons|0
168128|NCT00545103|590032|P1|Overall Study|Personal reasons|1
168129|NCT00545103|590029|P4|Overall Study|Diverticulitis crisis|1
168130|NCT00545103|590030|P3|Overall Study|Diverticulitis crisis|0
168131|NCT00545103|590031|P2|Overall Study|Diverticulitis crisis|0
168132|NCT00545103|590032|P1|Overall Study|Diverticulitis crisis|0
168133|NCT00545103|590029|P4|Overall Study|Wish to start a family|1
168134|NCT00545103|590030|P3|Overall Study|Wish to start a family|0
168135|NCT00545103|590031|P2|Overall Study|Wish to start a family|0
168136|NCT00545103|590032|P1|Overall Study|Wish to start a family|0
168137|NCT00545103|590029|P4|Overall Study|Investigational product not taken|1
168138|NCT00545103|590030|P3|Overall Study|Investigational product not taken|0
168139|NCT00545103|590031|P2|Overall Study|Investigational product not taken|0
168140|NCT00545103|590032|P1|Overall Study|Investigational product not taken|1
168141|NCT00545103|590029|P4|Overall Study|Difficult to open package|1
168142|NCT00545103|590030|P3|Overall Study|Difficult to open package|0
168143|NCT00545103|590031|P2|Overall Study|Difficult to open package|0
168144|NCT00545103|590032|P1|Overall Study|Difficult to open package|0
168145|NCT00545103|590029|P4|Overall Study|Suspected recurrence of diverticulitis|3
168146|NCT00545103|590030|P3|Overall Study|Suspected recurrence of diverticulitis|0
168147|NCT00545103|590031|P2|Overall Study|Suspected recurrence of diverticulitis|0
168148|NCT00545103|590032|P1|Overall Study|Suspected recurrence of diverticulitis|1
168149|NCT00545103|590029|P4|Overall Study|Protocol Violation|0
168150|NCT00545103|590030|P3|Overall Study|Protocol Violation|3
168151|NCT00545103|590031|P2|Overall Study|Protocol Violation|2
168152|NCT00545103|590032|P1|Overall Study|Protocol Violation|1
168153|NCT00545103|590029|P4|Overall Study|Lost to Follow-up|4
168154|NCT00545103|590030|P3|Overall Study|Lost to Follow-up|3
168155|NCT00545103|590031|P2|Overall Study|Lost to Follow-up|6
168156|NCT00545103|590032|P1|Overall Study|Lost to Follow-up|4
168157|NCT00545103|590029|P4|Overall Study|Adverse Event|10
168158|NCT00545103|590030|P3|Overall Study|Adverse Event|17
168159|NCT00545103|590031|P2|Overall Study|Adverse Event|12
168160|NCT00545103|590032|P1|Overall Study|Adverse Event|11
168161|NCT00545103|590029|P4|Overall Study|Withdrawal by Subject|22
168162|NCT00545103|590030|P3|Overall Study|Withdrawal by Subject|18
168163|NCT00545103|590031|P2|Overall Study|Withdrawal by Subject|10
168164|NCT00545103|590032|P1|Overall Study|Withdrawal by Subject|6
168165|NCT00545103|590029|P4|Overall Study|Lack of Efficacy|27
168166|NCT00545103|590030|P3|Overall Study|Lack of Efficacy|31
168167|NCT00545103|590031|P2|Overall Study|Lack of Efficacy|45
168168|NCT00545103|590032|P1|Overall Study|Lack of Efficacy|48
168169|NCT00545064|590066|P1|Overall Study|inclement weather|1
168170|NCT00545064|590066|P1|Overall Study|cancel all appointments, no rebooking|1
168171|NCT00545064|590066|P1|Overall Study|did not complete course of treatment|1
168172|NCT00545064|590066|P1|Overall Study|Withdrawal by Subject|2
168173|NCT00545064|590066|P1|Overall Study|Lost to Follow-up|3
168174|NCT00545051|590077|P2|Overall Study|Administrative reasons|1
168175|NCT00545051|590078|P1|Overall Study|Administrative reasons|0
168176|NCT00545051|590077|P2|Overall Study|Withdrawal by Subject|1
168177|NCT00545051|590078|P1|Overall Study|Withdrawal by Subject|0
168178|NCT00545051|590077|P2|Overall Study|Protocol Violation|0
168179|NCT00545051|590078|P1|Overall Study|Protocol Violation|1
168180|NCT00545051|590077|P2|Overall Study|Violation of inclusion/exclusion|2
168181|NCT00545051|590078|P1|Overall Study|Violation of inclusion/exclusion|0
168182|NCT00545051|590077|P2|Overall Study|Death|0
168183|NCT00545051|590078|P1|Overall Study|Death|1
168184|NCT00545051|590077|P2|Overall Study|Adverse Event|3
168185|NCT00545051|590078|P1|Overall Study|Adverse Event|7
168186|NCT00544882|590122|P3|Cycle 3: Follow-up|Pregnancy|0
168187|NCT00544882|590123|P2|Cycle 3: Follow-up|Pregnancy|1
168188|NCT00544882|590124|P1|Cycle 3: Follow-up|Pregnancy|0
168189|NCT00544882|590122|P3|Cycle 3: Follow-up|Noncompliance|0
168190|NCT00544882|590123|P2|Cycle 3: Follow-up|Noncompliance|1
168191|NCT00544882|590124|P1|Cycle 3: Follow-up|Noncompliance|0
168192|NCT00544882|590122|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
168193|NCT00544882|590123|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
168194|NCT00544882|590124|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
168195|NCT00544882|590122|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
168196|NCT00544882|590123|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
168197|NCT00544882|590124|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
168198|NCT00544882|590122|P3|Cycle 1: Run-in Cycle|Adverse Event|0
168199|NCT00544882|590123|P2|Cycle 1: Run-in Cycle|Adverse Event|0
168200|NCT00544882|590124|P1|Cycle 1: Run-in Cycle|Adverse Event|1
168201|NCT00544882|590122|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
168202|NCT00544882|590123|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
168203|NCT00544882|590124|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
168204|NCT00544869|590149|P3|Overall Study|Physician Decision|0
168205|NCT00544869|590150|P2|Overall Study|Physician Decision|0
168206|NCT00544869|590151|P1|Overall Study|Physician Decision|2
168207|NCT00544869|590149|P3|Overall Study|Lack of Efficacy|0
168208|NCT00544869|590150|P2|Overall Study|Lack of Efficacy|1
168209|NCT00544869|590151|P1|Overall Study|Lack of Efficacy|1
168210|NCT00544869|590149|P3|Overall Study|Adverse Event|0
168211|NCT00544869|590150|P2|Overall Study|Adverse Event|1
168212|NCT00544869|590151|P1|Overall Study|Adverse Event|6
168213|NCT00544869|590149|P3|Overall Study|Rsolution of congenitive symptoms|0
168214|NCT00544869|590150|P2|Overall Study|Rsolution of congenitive symptoms|0
168215|NCT00544869|590151|P1|Overall Study|Rsolution of congenitive symptoms|3
168216|NCT00544817|590159|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
168217|NCT00544817|590159|P1|Follow-up Systemic Therapy|Physician Decision|3
168218|NCT00544817|590159|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
168219|NCT00544817|590159|P1|No Treatment Interval|Adverse Event|1
168220|NCT00544817|590159|P1|No Treatment Interval|Physician Decision|3
168221|NCT00544817|590159|P1|No Treatment Interval|Lack of Efficacy|8
168222|NCT00544817|590159|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
168223|NCT00544817|590159|P1|Combined Modality|Adverse Event|2
168224|NCT00544817|590159|P1|Combined Modality|Worsening Neurologic Symptoms|2
168225|NCT00544817|590159|P1|Combined Modality|Lack of Efficacy|2
168226|NCT00544648|590208|P2|Overall Study|progression of disease|0
168227|NCT00544648|590209|P1|Overall Study|progression of disease|1
168228|NCT00544648|590208|P2|Overall Study|Adverse Event|1
168229|NCT00544648|590209|P1|Overall Study|Adverse Event|1
168230|NCT00544648|590208|P2|Overall Study|Withdrawal by Subject|0
168231|NCT00544648|590209|P1|Overall Study|Withdrawal by Subject|1
168232|NCT00544557|590223|P1|Overall Study|Other|98
168233|NCT00544557|590223|P1|Overall Study|Lack of Efficacy|196
168234|NCT00544557|590223|P1|Overall Study|Adverse Event|140
168235|NCT00544544|590254|P1|Overall Study|Lost to Follow-up|1
168236|NCT00544544|590254|P1|Overall Study|Adverse Event|1
168237|NCT00544544|590254|P1|Overall Study|Withdrawal by Subject|1
168238|NCT00544440|590258|P1|Overall Study|Other|5
168239|NCT00544440|590258|P1|Overall Study|Progressive Disease|47
168240|NCT00544440|590258|P1|Overall Study|Subject Non-compliance|1
168241|NCT00544440|590258|P1|Overall Study|Withdrawal by Subject|2
168242|NCT00544440|590258|P1|Overall Study|Adverse Event|1
168243|NCT00544440|590258|P1|Overall Study|Other|1
168244|NCT00544167|590265|P1|Overall Study|Physician Decision|8
168245|NCT00544167|590265|P1|Overall Study|Adverse Event|21
168246|NCT00543985|590269|P1|Overall Study|Withdrawal by Subject|4
168247|NCT00543855|590280|P4|Overall Study|Protocol Violation|0
168248|NCT00543855|590281|P3|Overall Study|Protocol Violation|0
168249|NCT00543855|590282|P2|Overall Study|Protocol Violation|0
168250|NCT00543855|590283|P1|Overall Study|Protocol Violation|1
168251|NCT00543855|590280|P4|Overall Study|Withdrawal by Subject|0
168252|NCT00543855|590281|P3|Overall Study|Withdrawal by Subject|2
168253|NCT00543855|590282|P2|Overall Study|Withdrawal by Subject|1
168254|NCT00543855|590283|P1|Overall Study|Withdrawal by Subject|0
168255|NCT00543855|590280|P4|Overall Study|Lost to Follow-up|0
168256|NCT00543855|590281|P3|Overall Study|Lost to Follow-up|1
168257|NCT00543855|590282|P2|Overall Study|Lost to Follow-up|0
168258|NCT00543855|590283|P1|Overall Study|Lost to Follow-up|0
168259|NCT00543855|590280|P4|Overall Study|Adverse Event|4
168260|NCT00543855|590281|P3|Overall Study|Adverse Event|3
168261|NCT00543855|590282|P2|Overall Study|Adverse Event|1
168262|NCT00543855|590283|P1|Overall Study|Adverse Event|3
168263|NCT00543803|590305|P1|Overall Study|not specified|86
168264|NCT00543803|590305|P1|Overall Study|Lost to Follow-up|20
168265|NCT00543803|590305|P1|Overall Study|Lack of Efficacy|22
168266|NCT00543803|590305|P1|Overall Study|Adverse Event|14
168267|NCT00543725|590333|P2|Overall Study|Not specified|3
168268|NCT00543725|590334|P1|Overall Study|Not specified|3
168269|NCT00543725|590333|P2|Overall Study|Lost to Follow-up|11
168270|NCT00543725|590334|P1|Overall Study|Lost to Follow-up|15
168271|NCT00543725|590333|P2|Overall Study|Withdrawal by Subject|13
168272|NCT00543725|590334|P1|Overall Study|Withdrawal by Subject|4
168273|NCT00543725|590333|P2|Overall Study|Protocol Violation|1
168274|NCT00543725|590334|P1|Overall Study|Protocol Violation|0
168275|NCT00543725|590333|P2|Overall Study|Subject Reached A Virologic Endpoint|14
168276|NCT00543725|590334|P1|Overall Study|Subject Reached A Virologic Endpoint|22
168277|NCT00543725|590333|P2|Overall Study|Subject Ineligible To Continue The Trial|0
168278|NCT00543725|590334|P1|Overall Study|Subject Ineligible To Continue The Trial|2
168279|NCT00543725|590333|P2|Overall Study|Subject Non-Compliant|4
168280|NCT00543725|590334|P1|Overall Study|Subject Non-Compliant|4
168281|NCT00543725|590333|P2|Overall Study|Sponsor's Decision|1
168282|NCT00543725|590334|P1|Overall Study|Sponsor's Decision|0
168283|NCT00543725|590333|P2|Overall Study|Adverse Event|27
168284|NCT00543725|590334|P1|Overall Study|Adverse Event|18
168285|NCT00543569|590360|P4|Overall Study|Randomized but never received study drug|3
168286|NCT00543569|590361|P3|Overall Study|Randomized but never received study drug|5
168287|NCT00543569|590362|P2|Overall Study|Randomized but never received study drug|3
168288|NCT00543569|590363|P1|Overall Study|Randomized but never received study drug|3
168289|NCT00543569|590360|P4|Overall Study|Miscellaneous Reasons|4
168290|NCT00543569|590361|P3|Overall Study|Miscellaneous Reasons|11
168291|NCT00543569|590362|P2|Overall Study|Miscellaneous Reasons|3
168292|NCT00543569|590363|P1|Overall Study|Miscellaneous Reasons|7
168293|NCT00543569|590360|P4|Overall Study|Lost to Follow-up|1
168294|NCT00543569|590361|P3|Overall Study|Lost to Follow-up|1
168295|NCT00543569|590362|P2|Overall Study|Lost to Follow-up|0
168296|NCT00543569|590363|P1|Overall Study|Lost to Follow-up|0
168297|NCT00543569|590360|P4|Overall Study|Death|1
168298|NCT00543569|590361|P3|Overall Study|Death|3
168299|NCT00543569|590362|P2|Overall Study|Death|2
168300|NCT00543569|590363|P1|Overall Study|Death|2
168301|NCT00543543|590469|P4|Extension Study|Withdrawal by Subject|120
168302|NCT00543543|590470|P3|Extension Study|Withdrawal by Subject|0
168303|NCT00543543|590471|P2|Extension Study|Withdrawal by Subject|0
168304|NCT00543543|590472|P1|Extension Study|Withdrawal by Subject|0
168305|NCT00543543|590469|P4|Extension Study|Protocol Violation|11
168306|NCT00543543|590470|P3|Extension Study|Protocol Violation|0
168307|NCT00543543|590471|P2|Extension Study|Protocol Violation|0
168308|NCT00543543|590472|P1|Extension Study|Protocol Violation|0
168309|NCT00543543|590469|P4|Extension Study|Pregnancy|6
168310|NCT00543543|590470|P3|Extension Study|Pregnancy|0
168311|NCT00543543|590471|P2|Extension Study|Pregnancy|0
168312|NCT00543543|590472|P1|Extension Study|Pregnancy|0
168313|NCT00543543|590469|P4|Extension Study|Physician Decision|7
168314|NCT00543543|590470|P3|Extension Study|Physician Decision|0
168315|NCT00543543|590471|P2|Extension Study|Physician Decision|0
168316|NCT00543543|590472|P1|Extension Study|Physician Decision|0
168317|NCT00543543|590469|P4|Extension Study|Lost to Follow-up|77
168318|NCT00543543|590470|P3|Extension Study|Lost to Follow-up|0
168319|NCT00543543|590471|P2|Extension Study|Lost to Follow-up|0
168320|NCT00543543|590472|P1|Extension Study|Lost to Follow-up|0
168321|NCT00543543|590469|P4|Extension Study|Adverse Event|5
168322|NCT00543543|590470|P3|Extension Study|Adverse Event|0
168323|NCT00543543|590471|P2|Extension Study|Adverse Event|0
168324|NCT00543543|590472|P1|Extension Study|Adverse Event|0
168325|NCT00543543|590469|P4|Base Study|Withdrawal by Subject|503
168326|NCT00543543|590470|P3|Base Study|Withdrawal by Subject|5
168327|NCT00543543|590471|P2|Base Study|Withdrawal by Subject|482
168328|NCT00543543|590472|P1|Base Study|Withdrawal by Subject|7
168329|NCT00543543|590469|P4|Base Study|Protocol Violation|6
168330|NCT00543543|590470|P3|Base Study|Protocol Violation|0
168331|NCT00543543|590471|P2|Base Study|Protocol Violation|6
168332|NCT00543543|590472|P1|Base Study|Protocol Violation|0
168333|NCT00543543|590469|P4|Base Study|Physician Decision|7
168334|NCT00543543|590470|P3|Base Study|Physician Decision|0
168335|NCT00543543|590471|P2|Base Study|Physician Decision|4
168336|NCT00543543|590472|P1|Base Study|Physician Decision|0
168337|NCT00543543|590469|P4|Base Study|Lost to Follow-up|701
168338|NCT00543543|590470|P3|Base Study|Lost to Follow-up|9
168339|NCT00543543|590471|P2|Base Study|Lost to Follow-up|749
168340|NCT00543543|590472|P1|Base Study|Lost to Follow-up|12
168341|NCT00543543|590469|P4|Base Study|Adverse Event|5
168342|NCT00543543|590470|P3|Base Study|Adverse Event|0
168343|NCT00543543|590471|P2|Base Study|Adverse Event|11
168344|NCT00543543|590472|P1|Base Study|Adverse Event|1
168345|NCT00543296|590530|P1|Overall Study|Physician Decision|7
168346|NCT00543140|590537|P1|Overall Study|Conversion to different procedure|1
168347|NCT00543140|590537|P1|Overall Study|Subject moved|1
168348|NCT00543140|590537|P1|Overall Study|Death|1
168349|NCT00543140|590537|P1|Overall Study|SAE leading to explant of SAGB|3
168350|NCT00543140|590537|P1|Overall Study|Insufficient weight loss|10
168351|NCT00543140|590537|P1|Overall Study|Protocol Violation|10
168352|NCT00543140|590537|P1|Overall Study|Withdrawal by Subject|13
168353|NCT00543140|590537|P1|Overall Study|Lost to Follow-up|33
168354|NCT00542997|590560|P1|Efficacy Period|Adverse Event|3
168355|NCT00542997|590560|P1|Wash in / Wash Out Period|Adverse Event|3
168356|NCT00542997|590560|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
168357|NCT00542880|590582|P2|Period 3|Adverse Event|2
168358|NCT00542880|590583|P1|Period 3|Adverse Event|0
168359|NCT00542880|590582|P2|Period 2|Not specified|1
168360|NCT00542880|590583|P1|Period 2|Not specified|0
168361|NCT00542880|590582|P2|Period 2|Severe non-compliance|1
168362|NCT00542880|590583|P1|Period 2|Severe non-compliance|0
168363|NCT00542880|590582|P2|Period 2|Discontinuation criteria|0
168364|NCT00542880|590583|P1|Period 2|Discontinuation criteria|2
168365|NCT00542880|590582|P2|Period 2|Eligibility not fulfilled|1
168366|NCT00542880|590583|P1|Period 2|Eligibility not fulfilled|0
168367|NCT00542880|590582|P2|Period 2|Adverse Event|7
168368|NCT00542880|590583|P1|Period 2|Adverse Event|5
168369|NCT00542880|590582|P2|Period 1|Protocol Violation|1
168370|NCT00542880|590583|P1|Period 1|Protocol Violation|0
168371|NCT00542880|590582|P2|Period 1|Withdrawal by Subject|1
168372|NCT00542880|590583|P1|Period 1|Withdrawal by Subject|1
168373|NCT00542880|590582|P2|Period 1|Development of study-specific criteria|2
168374|NCT00542880|590583|P1|Period 1|Development of study-specific criteria|1
168375|NCT00542880|590582|P2|Period 1|Adverse Event|2
168376|NCT00542880|590583|P1|Period 1|Adverse Event|2
168377|NCT00542880|590582|P2|Period 1|Eligibility criteria not fulfilled|6
168378|NCT00542880|590583|P1|Period 1|Eligibility criteria not fulfilled|2
168379|NCT00542828|590619|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
168380|NCT00542828|590619|P1|Overall Study|Study Prematurely Discontinued|7
168381|NCT00542828|590619|P1|Overall Study|Need for Prohibited Treatment|3
168382|NCT00542828|590619|P1|Overall Study|Physician Decision|1
168383|NCT00542815|590637|P3|Overall Study|Other reasons|10
168384|NCT00542815|590638|P2|Overall Study|Other reasons|10
168385|NCT00542815|590639|P1|Overall Study|Other reasons|24
168386|NCT00542815|590637|P3|Overall Study|Withdrawal by Subject|8
168387|NCT00542815|590638|P2|Overall Study|Withdrawal by Subject|5
168388|NCT00542815|590639|P1|Overall Study|Withdrawal by Subject|41
168389|NCT00542815|590637|P3|Overall Study|Protocol Violation|2
168390|NCT00542815|590638|P2|Overall Study|Protocol Violation|1
168391|NCT00542815|590639|P1|Overall Study|Protocol Violation|1
168392|NCT00542815|590637|P3|Overall Study|Physician Decision|0
168393|NCT00542815|590638|P2|Overall Study|Physician Decision|1
168394|NCT00542815|590639|P1|Overall Study|Physician Decision|2
168395|NCT00542815|590637|P3|Overall Study|Lack of Efficacy|0
168396|NCT00542815|590638|P2|Overall Study|Lack of Efficacy|2
168397|NCT00542815|590639|P1|Overall Study|Lack of Efficacy|9
168398|NCT00542815|590637|P3|Overall Study|Death|3
168399|NCT00542815|590638|P2|Overall Study|Death|7
168400|NCT00542815|590639|P1|Overall Study|Death|10
168401|NCT00542815|590637|P3|Overall Study|Adverse Event|9
168402|NCT00542815|590638|P2|Overall Study|Adverse Event|6
168403|NCT00542815|590639|P1|Overall Study|Adverse Event|19
168404|NCT00542789|590652|P2|Overall Study|Recurrence of Gastric Ulcer|57
168405|NCT00542789|590653|P1|Overall Study|Recurrence of Gastric Ulcer|8
168406|NCT00542789|590652|P2|Overall Study|Protocol Violation|1
168407|NCT00542789|590653|P1|Overall Study|Protocol Violation|8
168408|NCT00542789|590652|P2|Overall Study|Withdrawal by Subject|3
168409|NCT00542789|590653|P1|Overall Study|Withdrawal by Subject|7
168410|NCT00542789|590652|P2|Overall Study|Adverse Event|17
168411|NCT00542789|590653|P1|Overall Study|Adverse Event|18
168412|NCT00542425|590753|P5|Extended 24 Weeks of Treatment|Other|1
168413|NCT00542425|590754|P4|Extended 24 Weeks of Treatment|Other|0
168414|NCT00542425|590755|P3|Extended 24 Weeks of Treatment|Other|0
168415|NCT00542425|590756|P2|Extended 24 Weeks of Treatment|Other|1
168416|NCT00542425|590757|P1|Extended 24 Weeks of Treatment|Other|1
168503|NCT00542386|590796|P5|Overall Study|Death|1
168417|NCT00542425|590753|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
168418|NCT00542425|590754|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
168419|NCT00542425|590755|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
168420|NCT00542425|590756|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
168421|NCT00542425|590757|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
168422|NCT00542425|590753|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
168423|NCT00542425|590754|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
168424|NCT00542425|590755|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
168425|NCT00542425|590756|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
168426|NCT00542425|590757|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
168427|NCT00542425|590753|P5|Extended 24 Weeks of Treatment|Adverse Event|0
168428|NCT00542425|590754|P4|Extended 24 Weeks of Treatment|Adverse Event|1
168429|NCT00542425|590755|P3|Extended 24 Weeks of Treatment|Adverse Event|1
168430|NCT00542425|590756|P2|Extended 24 Weeks of Treatment|Adverse Event|0
168431|NCT00542425|590757|P1|Extended 24 Weeks of Treatment|Adverse Event|0
168432|NCT00542425|590753|P5|Initial 24 Weeks|Other|0
168433|NCT00542425|590754|P4|Initial 24 Weeks|Other|0
168434|NCT00542425|590755|P3|Initial 24 Weeks|Other|1
168435|NCT00542425|590756|P2|Initial 24 Weeks|Other|2
168436|NCT00542425|590757|P1|Initial 24 Weeks|Other|0
168437|NCT00542425|590753|P5|Initial 24 Weeks|Refusal of treatment|1
168438|NCT00542425|590754|P4|Initial 24 Weeks|Refusal of treatment|4
168439|NCT00542425|590755|P3|Initial 24 Weeks|Refusal of treatment|1
168440|NCT00542425|590756|P2|Initial 24 Weeks|Refusal of treatment|2
168441|NCT00542425|590757|P1|Initial 24 Weeks|Refusal of treatment|2
168442|NCT00542425|590753|P5|Initial 24 Weeks|Protocol Violation|0
168443|NCT00542425|590754|P4|Initial 24 Weeks|Protocol Violation|1
168444|NCT00542425|590755|P3|Initial 24 Weeks|Protocol Violation|0
168445|NCT00542425|590756|P2|Initial 24 Weeks|Protocol Violation|0
168446|NCT00542425|590757|P1|Initial 24 Weeks|Protocol Violation|0
168447|NCT00542425|590753|P5|Initial 24 Weeks|Non-compliance|1
168448|NCT00542425|590754|P4|Initial 24 Weeks|Non-compliance|1
168449|NCT00542425|590755|P3|Initial 24 Weeks|Non-compliance|0
168450|NCT00542425|590756|P2|Initial 24 Weeks|Non-compliance|0
168451|NCT00542425|590757|P1|Initial 24 Weeks|Non-compliance|0
168452|NCT00542425|590753|P5|Initial 24 Weeks|Lost to Follow-up|0
168453|NCT00542425|590754|P4|Initial 24 Weeks|Lost to Follow-up|0
168454|NCT00542425|590755|P3|Initial 24 Weeks|Lost to Follow-up|1
168455|NCT00542425|590756|P2|Initial 24 Weeks|Lost to Follow-up|2
168456|NCT00542425|590757|P1|Initial 24 Weeks|Lost to Follow-up|2
168457|NCT00542425|590753|P5|Initial 24 Weeks|Inability to complete procedures|2
168458|NCT00542425|590754|P4|Initial 24 Weeks|Inability to complete procedures|1
168459|NCT00542425|590755|P3|Initial 24 Weeks|Inability to complete procedures|2
168460|NCT00542425|590756|P2|Initial 24 Weeks|Inability to complete procedures|3
168461|NCT00542425|590757|P1|Initial 24 Weeks|Inability to complete procedures|0
168462|NCT00542425|590753|P5|Initial 24 Weeks|Adverse Event|2
168463|NCT00542425|590754|P4|Initial 24 Weeks|Adverse Event|3
168464|NCT00542425|590755|P3|Initial 24 Weeks|Adverse Event|1
168465|NCT00542425|590756|P2|Initial 24 Weeks|Adverse Event|1
168466|NCT00542425|590757|P1|Initial 24 Weeks|Adverse Event|0
168467|NCT00542425|590753|P5|Initial 24 Weeks|Administrative reasons|0
168468|NCT00542425|590754|P4|Initial 24 Weeks|Administrative reasons|1
168469|NCT00542425|590755|P3|Initial 24 Weeks|Administrative reasons|1
168470|NCT00542425|590756|P2|Initial 24 Weeks|Administrative reasons|0
168471|NCT00542425|590757|P1|Initial 24 Weeks|Administrative reasons|0
168472|NCT00542386|590795|P6|Overall Study|Other Reasons|2
168473|NCT00542386|590796|P5|Overall Study|Other Reasons|4
168474|NCT00542386|590797|P4|Overall Study|Other Reasons|3
168475|NCT00542386|590798|P3|Overall Study|Other Reasons|4
168476|NCT00542386|590799|P2|Overall Study|Other Reasons|1
168477|NCT00542386|590800|P1|Overall Study|Other Reasons|4
168478|NCT00542386|590795|P6|Overall Study|Withdrawal by Subject|7
168479|NCT00542386|590796|P5|Overall Study|Withdrawal by Subject|15
168480|NCT00542386|590797|P4|Overall Study|Withdrawal by Subject|11
168481|NCT00542386|590798|P3|Overall Study|Withdrawal by Subject|10
168482|NCT00542386|590799|P2|Overall Study|Withdrawal by Subject|8
168483|NCT00542386|590800|P1|Overall Study|Withdrawal by Subject|5
168484|NCT00542386|590795|P6|Overall Study|Protocol Violation|4
168485|NCT00542386|590796|P5|Overall Study|Protocol Violation|0
168486|NCT00542386|590797|P4|Overall Study|Protocol Violation|0
168487|NCT00542386|590798|P3|Overall Study|Protocol Violation|1
168488|NCT00542386|590799|P2|Overall Study|Protocol Violation|0
168489|NCT00542386|590800|P1|Overall Study|Protocol Violation|0
168490|NCT00542386|590795|P6|Overall Study|Physician Decision|0
168491|NCT00542386|590796|P5|Overall Study|Physician Decision|0
168492|NCT00542386|590797|P4|Overall Study|Physician Decision|1
168493|NCT00542386|590798|P3|Overall Study|Physician Decision|0
168494|NCT00542386|590799|P2|Overall Study|Physician Decision|0
168495|NCT00542386|590800|P1|Overall Study|Physician Decision|1
168496|NCT00542386|590795|P6|Overall Study|Lack of Efficacy|31
168497|NCT00542386|590796|P5|Overall Study|Lack of Efficacy|7
168498|NCT00542386|590797|P4|Overall Study|Lack of Efficacy|13
168499|NCT00542386|590798|P3|Overall Study|Lack of Efficacy|10
168500|NCT00542386|590799|P2|Overall Study|Lack of Efficacy|12
168501|NCT00542386|590800|P1|Overall Study|Lack of Efficacy|32
168502|NCT00542386|590795|P6|Overall Study|Death|2
168504|NCT00542386|590797|P4|Overall Study|Death|2
168505|NCT00542386|590798|P3|Overall Study|Death|1
168506|NCT00542386|590799|P2|Overall Study|Death|0
168507|NCT00542386|590800|P1|Overall Study|Death|0
168508|NCT00542386|590795|P6|Overall Study|Adverse Event|4
168509|NCT00542386|590796|P5|Overall Study|Adverse Event|13
168510|NCT00542386|590797|P4|Overall Study|Adverse Event|8
168511|NCT00542386|590798|P3|Overall Study|Adverse Event|7
168512|NCT00542386|590799|P2|Overall Study|Adverse Event|7
168513|NCT00542386|590800|P1|Overall Study|Adverse Event|1
168514|NCT00542321|590822|P2|Overall Study|Death|1
168515|NCT00542321|590823|P1|Overall Study|Death|0
168516|NCT00542269|590845|P3|Overall Study|Administrative problems|1
168517|NCT00542269|590846|P2|Overall Study|Administrative problems|1
168518|NCT00542269|590847|P1|Overall Study|Administrative problems|1
168519|NCT00542269|590845|P3|Overall Study|Withdrawal by Subject|0
168520|NCT00542269|590846|P2|Overall Study|Withdrawal by Subject|0
168521|NCT00542269|590847|P1|Overall Study|Withdrawal by Subject|1
168522|NCT00542269|590845|P3|Overall Study|Protocol Violation|0
168523|NCT00542269|590846|P2|Overall Study|Protocol Violation|1
168524|NCT00542269|590847|P1|Overall Study|Protocol Violation|1
168525|NCT00542269|590845|P3|Overall Study|Adverse Event|5
168526|NCT00542269|590846|P2|Overall Study|Adverse Event|4
168527|NCT00542269|590847|P1|Overall Study|Adverse Event|10
168528|NCT00542178|590882|P8|Overall Study|did not complete year 4 follow-up|85
168529|NCT00542178|590883|P7|Overall Study|did not complete year 4 follow-up|87
168530|NCT00542178|590884|P6|Overall Study|did not complete year 4 follow-up|89
168531|NCT00542178|590885|P5|Overall Study|did not complete year 4 follow-up|64
168532|NCT00542178|590886|P4|Overall Study|did not complete year 4 follow-up|62
168533|NCT00542178|590887|P3|Overall Study|did not complete year 4 follow-up|74
168534|NCT00542178|590888|P2|Overall Study|did not complete year 4 follow-up|80
168535|NCT00542178|590889|P1|Overall Study|did not complete year 4 follow-up|75
168536|NCT00541970|590907|P4|Month 60|Protocol Violation|72
168537|NCT00541970|590908|P3|Month 60|Protocol Violation|82
168538|NCT00541970|590909|P2|Month 60|Protocol Violation|77
168539|NCT00541970|590910|P1|Month 60|Protocol Violation|78
168540|NCT00541970|590907|P4|Month 48|Lost to Follow-up|73
168541|NCT00541970|590908|P3|Month 48|Lost to Follow-up|68
168542|NCT00541970|590909|P2|Month 48|Lost to Follow-up|68
168543|NCT00541970|590910|P1|Month 48|Lost to Follow-up|66
168544|NCT00541970|590907|P4|Month 48|Other|0
168545|NCT00541970|590908|P3|Month 48|Other|1
168546|NCT00541970|590909|P2|Month 48|Other|1
168547|NCT00541970|590910|P1|Month 48|Other|3
168548|NCT00541970|590907|P4|Month 48|Withdrawal by Subject|2
168549|NCT00541970|590908|P3|Month 48|Withdrawal by Subject|4
168550|NCT00541970|590909|P2|Month 48|Withdrawal by Subject|4
168551|NCT00541970|590910|P1|Month 48|Withdrawal by Subject|2
168552|NCT00541970|590907|P4|Month 36|Protocol Violation|60
168553|NCT00541970|590908|P3|Month 36|Protocol Violation|66
168554|NCT00541970|590909|P2|Month 36|Protocol Violation|66
168555|NCT00541970|590910|P1|Month 36|Protocol Violation|61
168556|NCT00541970|590907|P4|Month 24|Protocol Violation|21
168557|NCT00541970|590908|P3|Month 24|Protocol Violation|31
168558|NCT00541970|590909|P2|Month 24|Protocol Violation|31
168559|NCT00541970|590910|P1|Month 24|Protocol Violation|29
168560|NCT00541970|590907|P4|Month 24|Adverse Event|1
168561|NCT00541970|590908|P3|Month 24|Adverse Event|1
168562|NCT00541970|590909|P2|Month 24|Adverse Event|1
168563|NCT00541970|590910|P1|Month 24|Adverse Event|0
168564|NCT00541970|590907|P4|Month 18|Protocol Violation|16
168565|NCT00541970|590908|P3|Month 18|Protocol Violation|24
168566|NCT00541970|590909|P2|Month 18|Protocol Violation|23
168567|NCT00541970|590910|P1|Month 18|Protocol Violation|14
168568|NCT00541970|590907|P4|Month 18|Adverse Event|1
168569|NCT00541970|590908|P3|Month 18|Adverse Event|1
168570|NCT00541970|590909|P2|Month 18|Adverse Event|1
168571|NCT00541970|590910|P1|Month 18|Adverse Event|0
168572|NCT00541970|590907|P4|Month 12|Protocol Violation|15
168573|NCT00541970|590908|P3|Month 12|Protocol Violation|20
168574|NCT00541970|590909|P2|Month 12|Protocol Violation|21
168575|NCT00541970|590910|P1|Month 12|Protocol Violation|12
168576|NCT00541970|590907|P4|Month 12|Adverse Event|1
168577|NCT00541970|590908|P3|Month 12|Adverse Event|1
168578|NCT00541970|590909|P2|Month 12|Adverse Event|1
168579|NCT00541970|590910|P1|Month 12|Adverse Event|0
168580|NCT00541970|590907|P4|Month 7|Protocol Violation|5
168581|NCT00541970|590908|P3|Month 7|Protocol Violation|11
168582|NCT00541970|590909|P2|Month 7|Protocol Violation|13
168583|NCT00541970|590910|P1|Month 7|Protocol Violation|9
168584|NCT00541931|591061|P2|Overall Study|Transportation Issue|1
168585|NCT00541931|591062|P1|Overall Study|Transportation Issue|0
168586|NCT00541931|591061|P2|Overall Study|Withdrawal by Subject|0
168587|NCT00541931|591062|P1|Overall Study|Withdrawal by Subject|1
168588|NCT00541931|591061|P2|Overall Study|Lost to Follow-up|3
168589|NCT00541931|591062|P1|Overall Study|Lost to Follow-up|3
168590|NCT00541931|591061|P2|Overall Study|Adverse Event|0
168591|NCT00541931|591062|P1|Overall Study|Adverse Event|1
168592|NCT00541866|591075|P5|Overall Study|Physician Decision|0
168593|NCT00541866|591076|P4|Overall Study|Physician Decision|1
168594|NCT00541866|591077|P3|Overall Study|Physician Decision|2
168595|NCT00541866|591078|P2|Overall Study|Physician Decision|0
168596|NCT00541866|591079|P1|Overall Study|Physician Decision|0
168597|NCT00541866|591075|P5|Overall Study|Not Reported or Other|1
168598|NCT00541866|591076|P4|Overall Study|Not Reported or Other|3
168599|NCT00541866|591077|P3|Overall Study|Not Reported or Other|3
168600|NCT00541866|591078|P2|Overall Study|Not Reported or Other|3
168601|NCT00541866|591079|P1|Overall Study|Not Reported or Other|11
168602|NCT00541866|591075|P5|Overall Study|Lack of Efficacy|14
168603|NCT00541866|591076|P4|Overall Study|Lack of Efficacy|12
168604|NCT00541866|591077|P3|Overall Study|Lack of Efficacy|10
168605|NCT00541866|591078|P2|Overall Study|Lack of Efficacy|15
168606|NCT00541866|591079|P1|Overall Study|Lack of Efficacy|19
168607|NCT00541866|591075|P5|Overall Study|Death|0
168608|NCT00541866|591076|P4|Overall Study|Death|0
168609|NCT00541866|591077|P3|Overall Study|Death|0
168610|NCT00541866|591078|P2|Overall Study|Death|0
168611|NCT00541866|591079|P1|Overall Study|Death|1
168612|NCT00541866|591075|P5|Overall Study|Adverse Event|0
168613|NCT00541866|591076|P4|Overall Study|Adverse Event|0
168614|NCT00541866|591077|P3|Overall Study|Adverse Event|0
168615|NCT00541866|591078|P2|Overall Study|Adverse Event|0
168616|NCT00541866|591079|P1|Overall Study|Adverse Event|3
168617|NCT00541775|591120|P3|Overall Study|Withdrawal by Subject and Other|2
168618|NCT00541775|591121|P2|Overall Study|Withdrawal by Subject and Other|0
168619|NCT00541775|591122|P1|Overall Study|Withdrawal by Subject and Other|5
168620|NCT00541775|591120|P3|Overall Study|Protocol Violation|0
168621|NCT00541775|591121|P2|Overall Study|Protocol Violation|0
168622|NCT00541775|591122|P1|Overall Study|Protocol Violation|1
168623|NCT00541775|591120|P3|Overall Study|Lost to Follow-up|2
168624|NCT00541775|591121|P2|Overall Study|Lost to Follow-up|0
168625|NCT00541775|591122|P1|Overall Study|Lost to Follow-up|0
168626|NCT00541775|591120|P3|Overall Study|Lack of Efficacy|3
168627|NCT00541775|591121|P2|Overall Study|Lack of Efficacy|0
168628|NCT00541775|591122|P1|Overall Study|Lack of Efficacy|0
168629|NCT00541775|591120|P3|Overall Study|Adverse Event|1
168630|NCT00541775|591121|P2|Overall Study|Adverse Event|2
168631|NCT00541775|591122|P1|Overall Study|Adverse Event|3
168632|NCT00541658|591148|P3|Overall Study|Took No Study Drug|0
168633|NCT00541658|591149|P2|Overall Study|Took No Study Drug|0
168634|NCT00541658|591150|P1|Overall Study|Took No Study Drug|1
168635|NCT00541658|591148|P3|Overall Study|Withdrawal by Subject|32
168636|NCT00541658|591149|P2|Overall Study|Withdrawal by Subject|32
168637|NCT00541658|591150|P1|Overall Study|Withdrawal by Subject|28
168638|NCT00541658|591148|P3|Overall Study|Protocol Violation|1
168639|NCT00541658|591149|P2|Overall Study|Protocol Violation|1
168640|NCT00541658|591150|P1|Overall Study|Protocol Violation|0
168641|NCT00541658|591148|P3|Overall Study|Lost to Follow-up|6
168642|NCT00541658|591149|P2|Overall Study|Lost to Follow-up|3
168643|NCT00541658|591150|P1|Overall Study|Lost to Follow-up|3
168644|NCT00541658|591148|P3|Overall Study|Physician Decision|4
168645|NCT00541658|591149|P2|Overall Study|Physician Decision|0
168646|NCT00541658|591150|P1|Overall Study|Physician Decision|0
168647|NCT00541658|591148|P3|Overall Study|Adverse Event|25
168648|NCT00541658|591149|P2|Overall Study|Adverse Event|37
168649|NCT00541658|591150|P1|Overall Study|Adverse Event|28
168650|NCT00541450|591313|P2|Phase B|Withdrawal by Subject|6
168651|NCT00541450|591314|P1|Phase B|Withdrawal by Subject|8
168652|NCT00541450|591313|P2|Phase B|Protocol Violation|3
168653|NCT00541450|591314|P1|Phase B|Protocol Violation|3
168654|NCT00541450|591313|P2|Phase B|Pregnancy|1
168655|NCT00541450|591314|P1|Phase B|Pregnancy|0
168656|NCT00541450|591313|P2|Phase B|Physician Decision|2
168657|NCT00541450|591314|P1|Phase B|Physician Decision|4
168658|NCT00541450|591313|P2|Phase B|Lost to Follow-up|4
168659|NCT00541450|591314|P1|Phase B|Lost to Follow-up|6
168660|NCT00541450|591313|P2|Phase B|Hyperglycemia|9
168661|NCT00541450|591314|P1|Phase B|Hyperglycemia|10
168662|NCT00541450|591313|P2|Phase B|Adverse Event|6
168663|NCT00541450|591314|P1|Phase B|Adverse Event|6
168664|NCT00541450|591313|P2|Phase A|Withdrawal by Subject|7
168665|NCT00541450|591314|P1|Phase A|Withdrawal by Subject|7
168666|NCT00541450|591313|P2|Phase A|Protocol Violation|3
168667|NCT00541450|591314|P1|Phase A|Protocol Violation|2
168668|NCT00541450|591313|P2|Phase A|Physician Decision|0
168669|NCT00541450|591314|P1|Phase A|Physician Decision|2
168670|NCT00541450|591313|P2|Phase A|Lost to Follow-up|4
168671|NCT00541450|591314|P1|Phase A|Lost to Follow-up|6
168672|NCT00541450|591313|P2|Phase A|Hyperglycemia|1
168673|NCT00541450|591314|P1|Phase A|Hyperglycemia|0
168674|NCT00541450|591313|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
168675|NCT00541450|591314|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
168676|NCT00541450|591313|P2|Phase A|Adverse Event|0
168677|NCT00541450|591314|P1|Phase A|Adverse Event|3
168678|NCT00541346|591332|P1|Follow-up|Adverse Event|1
168679|NCT00541307|591346|P1|Overall Study|Surgical Bypass|5
168680|NCT00541307|591346|P1|Overall Study|Subject returned early (outside window)|1
168681|NCT00541307|591346|P1|Overall Study|Lost to Follow-up|4
168682|NCT00541307|591346|P1|Overall Study|Withdrawal by Subject|6
168683|NCT00541307|591346|P1|Overall Study|Physician Decision|3
168684|NCT00541307|591346|P1|Overall Study|Death|5
168685|NCT00541229|591371|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
168686|NCT00541229|591372|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
168687|NCT00541229|591373|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
168688|NCT00541229|591374|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
168689|NCT00541229|591375|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
168690|NCT00541229|591376|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
168691|NCT00541229|591371|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
168692|NCT00541229|591372|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
168693|NCT00541229|591373|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
168694|NCT00541229|591374|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
168695|NCT00541229|591375|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
168696|NCT00541229|591376|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
168697|NCT00541229|591371|P6|Treatment Period III (Week 11)|Adverse Event|0
168698|NCT00541229|591372|P5|Treatment Period III (Week 11)|Adverse Event|1
168699|NCT00541229|591373|P4|Treatment Period III (Week 11)|Adverse Event|0
168700|NCT00541229|591374|P3|Treatment Period III (Week 11)|Adverse Event|0
168701|NCT00541229|591375|P2|Treatment Period III (Week 11)|Adverse Event|0
168702|NCT00541229|591376|P1|Treatment Period III (Week 11)|Adverse Event|0
168703|NCT00541229|591371|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
168704|NCT00541229|591372|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
168705|NCT00541229|591373|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
168706|NCT00541229|591374|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
168707|NCT00541229|591375|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
168708|NCT00541229|591376|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
168709|NCT00541229|591371|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
168710|NCT00541229|591372|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
168711|NCT00541229|591373|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
168712|NCT00541229|591374|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
168713|NCT00541229|591375|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
168714|NCT00541229|591376|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
168715|NCT00541229|591371|P6|Washout Period II (Week 7-10)|Protocol Violation|0
168716|NCT00541229|591372|P5|Washout Period II (Week 7-10)|Protocol Violation|0
168717|NCT00541229|591373|P4|Washout Period II (Week 7-10)|Protocol Violation|0
168718|NCT00541229|591374|P3|Washout Period II (Week 7-10)|Protocol Violation|0
168719|NCT00541229|591375|P2|Washout Period II (Week 7-10)|Protocol Violation|0
168720|NCT00541229|591376|P1|Washout Period II (Week 7-10)|Protocol Violation|1
168721|NCT00541229|591371|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
168722|NCT00541229|591372|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
168723|NCT00541229|591373|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
168724|NCT00541229|591374|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
168725|NCT00541229|591375|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
168726|NCT00541229|591376|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
168727|NCT00541229|591371|P6|Treatment Period II (Week 6)|Protocol Violation|1
168728|NCT00541229|591372|P5|Treatment Period II (Week 6)|Protocol Violation|1
168729|NCT00541229|591373|P4|Treatment Period II (Week 6)|Protocol Violation|0
168730|NCT00541229|591374|P3|Treatment Period II (Week 6)|Protocol Violation|0
168731|NCT00541229|591375|P2|Treatment Period II (Week 6)|Protocol Violation|0
168732|NCT00541229|591376|P1|Treatment Period II (Week 6)|Protocol Violation|0
168733|NCT00541229|591371|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
168734|NCT00541229|591372|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
168735|NCT00541229|591373|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
168736|NCT00541229|591374|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
168737|NCT00541229|591375|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
168738|NCT00541229|591376|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
168739|NCT00541229|591371|P6|Washout Period I (Week 2-5)|Protocol Violation|1
168740|NCT00541229|591372|P5|Washout Period I (Week 2-5)|Protocol Violation|0
168741|NCT00541229|591373|P4|Washout Period I (Week 2-5)|Protocol Violation|0
168742|NCT00541229|591374|P3|Washout Period I (Week 2-5)|Protocol Violation|0
168743|NCT00541229|591375|P2|Washout Period I (Week 2-5)|Protocol Violation|0
168744|NCT00541229|591376|P1|Washout Period I (Week 2-5)|Protocol Violation|0
168745|NCT00541229|591371|P6|Washout Period I (Week 2-5)|Physician Decision|0
168746|NCT00541229|591372|P5|Washout Period I (Week 2-5)|Physician Decision|0
168747|NCT00541229|591373|P4|Washout Period I (Week 2-5)|Physician Decision|1
168748|NCT00541229|591374|P3|Washout Period I (Week 2-5)|Physician Decision|0
168749|NCT00541229|591375|P2|Washout Period I (Week 2-5)|Physician Decision|0
168750|NCT00541229|591376|P1|Washout Period I (Week 2-5)|Physician Decision|0
168751|NCT00541229|591371|P6|Washout Period I (Week 2-5)|Adverse Event|0
168752|NCT00541229|591372|P5|Washout Period I (Week 2-5)|Adverse Event|0
168753|NCT00541229|591373|P4|Washout Period I (Week 2-5)|Adverse Event|0
168754|NCT00541229|591374|P3|Washout Period I (Week 2-5)|Adverse Event|1
168755|NCT00541229|591375|P2|Washout Period I (Week 2-5)|Adverse Event|0
168756|NCT00541229|591376|P1|Washout Period I (Week 2-5)|Adverse Event|1
168757|NCT00541229|591371|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
168758|NCT00541229|591372|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
168759|NCT00541229|591373|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
168760|NCT00541229|591374|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
168761|NCT00541229|591375|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
168762|NCT00541229|591376|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
168763|NCT00541229|591371|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
168764|NCT00541229|591372|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
168765|NCT00541229|591373|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
168766|NCT00541229|591374|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
168767|NCT00541229|591375|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
168768|NCT00541229|591376|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
168769|NCT00541229|591371|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
168770|NCT00541229|591372|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
168771|NCT00541229|591373|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
168772|NCT00541229|591374|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
168773|NCT00541229|591375|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
168774|NCT00541229|591376|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
168775|NCT00541229|591371|P6|Treatment Period I (Week 1)|Physician Decision|0
168776|NCT00541229|591372|P5|Treatment Period I (Week 1)|Physician Decision|0
168777|NCT00541229|591373|P4|Treatment Period I (Week 1)|Physician Decision|0
168778|NCT00541229|591374|P3|Treatment Period I (Week 1)|Physician Decision|1
168779|NCT00541229|591375|P2|Treatment Period I (Week 1)|Physician Decision|0
168780|NCT00541229|591376|P1|Treatment Period I (Week 1)|Physician Decision|0
168781|NCT00541099|591395|P1|Overall Study|Ineligible|3
168782|NCT00541034|591401|P1|Overall Study|Non-Compliance|3
168783|NCT00540644|591428|P2|Overall Study|Noncomplilance|0
168784|NCT00540644|591429|P1|Overall Study|Noncomplilance|1
168785|NCT00540644|591428|P2|Overall Study|Withdrawal by Subject|2
168786|NCT00540644|591429|P1|Overall Study|Withdrawal by Subject|2
168787|NCT00540644|591428|P2|Overall Study|Physician Decision|5
168788|NCT00540644|591429|P1|Overall Study|Physician Decision|0
168789|NCT00540644|591428|P2|Overall Study|Disease Progression|1
168790|NCT00540644|591429|P1|Overall Study|Disease Progression|3
168791|NCT00540644|591428|P2|Overall Study|Adverse Event|1
168792|NCT00540644|591429|P1|Overall Study|Adverse Event|3
168793|NCT00540592|591449|P10|Overall Study|Withdrawal by Subject|0
168794|NCT00540592|591450|P9|Overall Study|Withdrawal by Subject|0
168795|NCT00540592|591451|P8|Overall Study|Withdrawal by Subject|0
168796|NCT00540592|591452|P7|Overall Study|Withdrawal by Subject|0
168797|NCT00540592|591453|P6|Overall Study|Withdrawal by Subject|0
168798|NCT00540592|591454|P5|Overall Study|Withdrawal by Subject|0
168799|NCT00540592|591455|P4|Overall Study|Withdrawal by Subject|1
168800|NCT00540592|591456|P3|Overall Study|Withdrawal by Subject|1
168801|NCT00540592|591457|P2|Overall Study|Withdrawal by Subject|0
168802|NCT00540592|591458|P1|Overall Study|Withdrawal by Subject|0
168803|NCT00540592|591449|P10|Overall Study|Lost to Follow-up|0
168804|NCT00540592|591450|P9|Overall Study|Lost to Follow-up|0
168805|NCT00540592|591451|P8|Overall Study|Lost to Follow-up|0
168806|NCT00540592|591452|P7|Overall Study|Lost to Follow-up|0
168807|NCT00540592|591453|P6|Overall Study|Lost to Follow-up|0
168808|NCT00540592|591454|P5|Overall Study|Lost to Follow-up|0
168809|NCT00540592|591455|P4|Overall Study|Lost to Follow-up|0
168810|NCT00540592|591456|P3|Overall Study|Lost to Follow-up|0
168811|NCT00540592|591457|P2|Overall Study|Lost to Follow-up|0
168812|NCT00540592|591458|P1|Overall Study|Lost to Follow-up|2
168813|NCT00540592|591449|P10|Overall Study|Adverse Event|2
168814|NCT00540592|591450|P9|Overall Study|Adverse Event|1
168815|NCT00540592|591451|P8|Overall Study|Adverse Event|1
168816|NCT00540592|591452|P7|Overall Study|Adverse Event|0
168817|NCT00540592|591453|P6|Overall Study|Adverse Event|0
168818|NCT00540592|591454|P5|Overall Study|Adverse Event|1
168819|NCT00540592|591455|P4|Overall Study|Adverse Event|0
168820|NCT00540592|591456|P3|Overall Study|Adverse Event|0
168821|NCT00540592|591457|P2|Overall Study|Adverse Event|1
168822|NCT00540592|591458|P1|Overall Study|Adverse Event|0
168823|NCT00540514|591697|P2|Overall Study|Paclitaxel not available|2
168824|NCT00540514|591698|P1|Overall Study|Paclitaxel not available|0
168825|NCT00540514|591697|P2|Overall Study|Excluded prior to treatment|7
168826|NCT00540514|591698|P1|Overall Study|Excluded prior to treatment|7
168827|NCT00540514|591697|P2|Overall Study|Withdrawal by Subject|67
168828|NCT00540514|591698|P1|Overall Study|Withdrawal by Subject|65
168829|NCT00540514|591697|P2|Overall Study|Lost to Follow-up|1
168830|NCT00540514|591698|P1|Overall Study|Lost to Follow-up|1
168831|NCT00540514|591697|P2|Overall Study|Protocol Deviation|4
168832|NCT00540514|591698|P1|Overall Study|Protocol Deviation|3
168833|NCT00540514|591697|P2|Overall Study|Physician Decision|99
168834|NCT00540514|591698|P1|Overall Study|Physician Decision|86
168835|NCT00540514|591697|P2|Overall Study|Adverse Event|24
168836|NCT00540514|591698|P1|Overall Study|Adverse Event|20
168837|NCT00540514|591697|P2|Overall Study|Unacceptable Toxicity|62
168838|NCT00540514|591698|P1|Overall Study|Unacceptable Toxicity|61
168839|NCT00540514|591697|P2|Overall Study|Still on treatment|0
168840|NCT00540514|591698|P1|Overall Study|Still on treatment|3
168841|NCT00540449|591730|P2|Overall Study|Not specified|4
168842|NCT00540449|591731|P1|Overall Study|Not specified|1
168843|NCT00540449|591730|P2|Overall Study|Withdrawal by Subject|10
168844|NCT00540449|591731|P1|Overall Study|Withdrawal by Subject|10
168845|NCT00540449|591730|P2|Overall Study|Subject Reached A Virologic Endpoint|8
168846|NCT00540449|591731|P1|Overall Study|Subject Reached A Virologic Endpoint|32
168847|NCT00540449|591730|P2|Overall Study|Subject Non-Compliant|5
168848|NCT00540449|591731|P1|Overall Study|Subject Non-Compliant|7
168849|NCT00540449|591730|P2|Overall Study|Lost to Follow-up|17
168850|NCT00540449|591731|P1|Overall Study|Lost to Follow-up|19
168851|NCT00540449|591730|P2|Overall Study|Subject Ineligible To Continue The Trial|1
168852|NCT00540449|591731|P1|Overall Study|Subject Ineligible To Continue The Trial|2
168853|NCT00540449|591730|P2|Overall Study|Sponsor's Decision|1
168854|NCT00540449|591731|P1|Overall Study|Sponsor's Decision|1
168855|NCT00540449|591730|P2|Overall Study|Adverse Event|32
168856|NCT00540449|591731|P1|Overall Study|Adverse Event|12
168857|NCT00540436|591753|P1|Second 12-Week Treatment Period|Adverse Event|1
168858|NCT00540436|591753|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
168859|NCT00540436|591753|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
168860|NCT00540436|591753|P1|First 12-Week Treatment Period|Adverse Event|1
168861|NCT00540423|591768|P3|Open-Label Treatment Period|Lack of Efficacy|2
168862|NCT00540423|591769|P2|Open-Label Treatment Period|Lack of Efficacy|0
168863|NCT00540423|591770|P1|Open-Label Treatment Period|Lack of Efficacy|0
168864|NCT00540423|591768|P3|Double-Blind Treatment Period|Adverse Event|0
168865|NCT00540423|591769|P2|Double-Blind Treatment Period|Adverse Event|1
168866|NCT00540423|591770|P1|Double-Blind Treatment Period|Adverse Event|0
168867|NCT00540293|591820|P1|Overall Study|Protocol violation, & subject schedule|12
168868|NCT00540293|591820|P1|Overall Study|Withdrawal by Subject|6
168869|NCT00540293|591820|P1|Overall Study|Adverse event not related to study drug|7
168870|NCT00540293|591820|P1|Overall Study|Adverse event related to study drug|10
168871|NCT00540228|591868|P5|Overall Study|Lost to Follow-up|0
168872|NCT00540228|591869|P4|Overall Study|Lost to Follow-up|0
168873|NCT00540228|591870|P3|Overall Study|Lost to Follow-up|0
168874|NCT00540228|591871|P2|Overall Study|Lost to Follow-up|1
168875|NCT00540228|591872|P1|Overall Study|Lost to Follow-up|1
168876|NCT00540228|591868|P5|Overall Study|Adverse Event|0
168877|NCT00540228|591869|P4|Overall Study|Adverse Event|0
168878|NCT00540228|591870|P3|Overall Study|Adverse Event|0
168879|NCT00540228|591871|P2|Overall Study|Adverse Event|0
168880|NCT00540228|591872|P1|Overall Study|Adverse Event|2
168881|NCT00540124|591942|P3|Overall Study|Withdrawal by Subject|0
168882|NCT00540124|591943|P2|Overall Study|Withdrawal by Subject|1
168883|NCT00540124|591944|P1|Overall Study|Withdrawal by Subject|1
168884|NCT00540124|591942|P3|Overall Study|Lack of Efficacy|0
168885|NCT00540124|591943|P2|Overall Study|Lack of Efficacy|0
168886|NCT00540124|591944|P1|Overall Study|Lack of Efficacy|1
168887|NCT00540124|591942|P3|Overall Study|Entry Criteria Not Met|0
168888|NCT00540124|591943|P2|Overall Study|Entry Criteria Not Met|0
168889|NCT00540124|591944|P1|Overall Study|Entry Criteria Not Met|2
168890|NCT00540124|591942|P3|Overall Study|Adverse Event|1
168891|NCT00540124|591943|P2|Overall Study|Adverse Event|2
168892|NCT00540124|591944|P1|Overall Study|Adverse Event|0
168893|NCT00540046|591990|P2|Overall Study|Lost to Follow-up|23
168894|NCT00540046|591991|P1|Overall Study|Lost to Follow-up|33
168895|NCT00539994|592027|P3|Overall Study|Physician Decision|1
168896|NCT00539994|592028|P2|Overall Study|Physician Decision|0
168897|NCT00539994|592029|P1|Overall Study|Physician Decision|0
168898|NCT00539994|592027|P3|Overall Study|Withdrawal by Subject|1
168899|NCT00539994|592028|P2|Overall Study|Withdrawal by Subject|0
168900|NCT00539994|592029|P1|Overall Study|Withdrawal by Subject|1
168901|NCT00539994|592027|P3|Overall Study|Lost to Follow-up|0
168902|NCT00539994|592028|P2|Overall Study|Lost to Follow-up|1
168903|NCT00539994|592029|P1|Overall Study|Lost to Follow-up|2
168904|NCT00539864|592079|P2|Overall Study|Withdrawal by Subject|1
168905|NCT00539864|592080|P1|Overall Study|Withdrawal by Subject|1
168906|NCT00539864|592079|P2|Overall Study|Lost to Follow-up|1
168907|NCT00539864|592080|P1|Overall Study|Lost to Follow-up|0
168908|NCT00539734|592092|P1|Overall Study|Protocol Violation|1
168909|NCT00539591|592111|P3|Overall Study|Disease progression|3
168910|NCT00539591|592112|P2|Overall Study|Disease progression|2
168911|NCT00539591|592113|P1|Overall Study|Disease progression|2
168912|NCT00539591|592111|P3|Overall Study|Toxicity|0
168913|NCT00539591|592112|P2|Overall Study|Toxicity|0
168914|NCT00539591|592113|P1|Overall Study|Toxicity|3
168915|NCT00539513|592265|P2|Overall Study|Lost to Follow-up|1
168916|NCT00539513|592266|P1|Overall Study|Lost to Follow-up|0
168917|NCT00539513|592265|P2|Overall Study|Withdrawal by Subject|1
168918|NCT00539513|592266|P1|Overall Study|Withdrawal by Subject|2
168919|NCT00539305|592280|P2|Overall Study|Withdrawal by Subject|1
168920|NCT00539305|592281|P1|Overall Study|Withdrawal by Subject|0
168921|NCT00539305|592280|P2|Overall Study|Substance Use|1
168922|NCT00539305|592281|P1|Overall Study|Substance Use|0
168923|NCT00539305|592280|P2|Overall Study|Adverse Event|0
168924|NCT00539305|592281|P1|Overall Study|Adverse Event|1
168925|NCT00539279|592295|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
168926|NCT00539279|592296|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
168927|NCT00539279|592295|P2|Post-Treatment Assessment|Lost to Follow-up|9
168928|NCT00539279|592296|P1|Post-Treatment Assessment|Lost to Follow-up|12
168929|NCT00539279|592295|P2|Treatment|Death|0
168930|NCT00539279|592296|P1|Treatment|Death|1
168931|NCT00539279|592295|P2|Treatment|Withdrawal by Subject|8
168932|NCT00539279|592296|P1|Treatment|Withdrawal by Subject|10
168933|NCT00539240|592322|P3|Overall Study|Adverse Event|10
168934|NCT00539240|592323|P2|Overall Study|Adverse Event|1
168935|NCT00539240|592324|P1|Overall Study|Adverse Event|3
168936|NCT00539240|592322|P3|Overall Study|Lost to Follow-up|1
168937|NCT00539240|592323|P2|Overall Study|Lost to Follow-up|3
168938|NCT00539240|592324|P1|Overall Study|Lost to Follow-up|2
168939|NCT00539240|592322|P3|Overall Study|Protocol Violation|4
168940|NCT00539240|592323|P2|Overall Study|Protocol Violation|1
168941|NCT00539240|592324|P1|Overall Study|Protocol Violation|1
168942|NCT00539240|592322|P3|Overall Study|Withdrawal by Subject|0
168943|NCT00539240|592323|P2|Overall Study|Withdrawal by Subject|2
168944|NCT00539240|592324|P1|Overall Study|Withdrawal by Subject|0
168945|NCT00539188|592343|P2|Overall Study|Lost to Follow-up|1
168946|NCT00539188|592344|P1|Overall Study|Lost to Follow-up|2
168947|NCT00539188|592343|P2|Overall Study|Withdrawal by Subject|0
168948|NCT00539188|592344|P1|Overall Study|Withdrawal by Subject|1
168949|NCT00539032|592367|P2|Overall Study|Withdrawal by Subject|1
168950|NCT00539032|592368|P1|Overall Study|Withdrawal by Subject|2
168951|NCT00539006|592382|P4|Treatment Period 2|Other|0
168952|NCT00539006|592383|P3|Treatment Period 2|Other|0
168953|NCT00539006|592384|P2|Treatment Period 2|Other|1
168954|NCT00539006|592385|P1|Treatment Period 2|Other|0
168955|NCT00539006|592382|P4|Treatment Period 2|Protocol Violation|0
168956|NCT00539006|592383|P3|Treatment Period 2|Protocol Violation|0
168957|NCT00539006|592384|P2|Treatment Period 2|Protocol Violation|0
168958|NCT00539006|592385|P1|Treatment Period 2|Protocol Violation|1
168959|NCT00539006|592382|P4|Washout|Other|3
168960|NCT00539006|592383|P3|Washout|Other|2
168961|NCT00539006|592384|P2|Washout|Other|1
168962|NCT00539006|592385|P1|Washout|Other|1
168963|NCT00539006|592382|P4|Washout|Failed to meet continuation criteria|6
168964|NCT00539006|592383|P3|Washout|Failed to meet continuation criteria|14
168965|NCT00539006|592384|P2|Washout|Failed to meet continuation criteria|5
168966|NCT00539006|592385|P1|Washout|Failed to meet continuation criteria|16
168967|NCT00539006|592382|P4|Washout|Withdrawal by Subject|0
168968|NCT00539006|592383|P3|Washout|Withdrawal by Subject|0
168969|NCT00539006|592384|P2|Washout|Withdrawal by Subject|2
168970|NCT00539006|592385|P1|Washout|Withdrawal by Subject|0
168971|NCT00539006|592382|P4|Washout|Protocol Violation|0
168972|NCT00539006|592383|P3|Washout|Protocol Violation|0
168973|NCT00539006|592384|P2|Washout|Protocol Violation|1
168974|NCT00539006|592385|P1|Washout|Protocol Violation|1
168975|NCT00539006|592382|P4|Washout|Adverse Event|0
168976|NCT00539006|592383|P3|Washout|Adverse Event|0
168977|NCT00539006|592384|P2|Washout|Adverse Event|1
168978|NCT00539006|592385|P1|Washout|Adverse Event|2
168979|NCT00539006|592382|P4|Treatment Period 1|Lack of Efficacy|1
168980|NCT00539006|592383|P3|Treatment Period 1|Lack of Efficacy|0
168981|NCT00539006|592384|P2|Treatment Period 1|Lack of Efficacy|0
168982|NCT00539006|592385|P1|Treatment Period 1|Lack of Efficacy|0
168983|NCT00539006|592382|P4|Treatment Period 1|Protocol Violation|0
168984|NCT00539006|592383|P3|Treatment Period 1|Protocol Violation|1
168985|NCT00539006|592384|P2|Treatment Period 1|Protocol Violation|0
168986|NCT00539006|592385|P1|Treatment Period 1|Protocol Violation|0
168987|NCT00539006|592382|P4|Treatment Period 1|Lost to Follow-up|0
168988|NCT00539006|592383|P3|Treatment Period 1|Lost to Follow-up|1
168989|NCT00539006|592384|P2|Treatment Period 1|Lost to Follow-up|0
168990|NCT00539006|592385|P1|Treatment Period 1|Lost to Follow-up|0
168991|NCT00539006|592382|P4|Pre-treatment|Other|0
168992|NCT00539006|592383|P3|Pre-treatment|Other|0
168993|NCT00539006|592384|P2|Pre-treatment|Other|1
168994|NCT00539006|592385|P1|Pre-treatment|Other|0
168995|NCT00538902|592430|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
168996|NCT00538902|592431|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
168997|NCT00538902|592432|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
168998|NCT00538902|592430|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
168999|NCT00538902|592431|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
169000|NCT00538902|592432|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
169001|NCT00538902|592430|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
169002|NCT00538902|592431|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
169003|NCT00538902|592432|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
169004|NCT00538902|592430|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
169005|NCT00538902|592431|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
169006|NCT00538902|592432|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
169007|NCT00538902|592430|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
169008|NCT00538902|592431|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
169009|NCT00538902|592432|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
169010|NCT00538902|592430|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
169011|NCT00538902|592431|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
169012|NCT00538902|592432|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
169013|NCT00538902|592430|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
169014|NCT00538902|592431|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
169015|NCT00538902|592432|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
169016|NCT00538902|592430|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
169017|NCT00538902|592431|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
169018|NCT00538902|592432|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
169019|NCT00538785|592493|P2|Overall Study|Lost to Follow-up|0
169020|NCT00538785|592494|P1|Overall Study|Lost to Follow-up|1
169021|NCT00538785|592493|P2|Overall Study|Withdrawal of consent|7
169022|NCT00538785|592494|P1|Overall Study|Withdrawal of consent|9
169023|NCT00538785|592493|P2|Overall Study|Death|10
169024|NCT00538785|592494|P1|Overall Study|Death|9
169025|NCT00538733|592515|P1|Overall Study|still on therapy|1
169026|NCT00538733|592515|P1|Overall Study|declined to participate|2
169027|NCT00538733|592515|P1|Overall Study|Death|1
169028|NCT00538733|592515|P1|Overall Study|Adverse Event|8
169029|NCT00538629|592565|P1|Overall Study|Subject's untimely distrust of medicine|1
169030|NCT00538629|592565|P1|Overall Study|Lost to Follow-up|6
169031|NCT00538629|592565|P1|Overall Study|Lack of Efficacy|12
169032|NCT00538629|592565|P1|Overall Study|Adverse Event|2
169033|NCT00538629|592565|P1|Overall Study|At subject's request|1
169034|NCT00538590|592621|P2|Overall Study|Death|0
169035|NCT00538590|592622|P1|Overall Study|Death|1
169036|NCT00538473|592660|P2|Overall Study|Adverse Event|0
169037|NCT00538473|592661|P1|Overall Study|Adverse Event|1
169038|NCT00538291|592741|P1|Overall Study|Withdrawal by Subject|1
169039|NCT00538291|592741|P1|Overall Study|Adverse Event|2
169040|NCT00537979|592799|P2|Overall Study|Heart failure|1
169041|NCT00537979|592800|P1|Overall Study|Heart failure|0
169042|NCT00537979|592799|P2|Overall Study|Kidney transplant|3
169043|NCT00537979|592800|P1|Overall Study|Kidney transplant|0
169044|NCT00537979|592799|P2|Overall Study|Death|3
169045|NCT00537979|592800|P1|Overall Study|Death|0
169046|NCT00537979|592799|P2|Overall Study|Non-compliance with treatment/procedure|2
169047|NCT00537979|592800|P1|Overall Study|Non-compliance with treatment/procedure|2
169048|NCT00537979|592799|P2|Overall Study|Lack of Efficacy|1
169049|NCT00537979|592800|P1|Overall Study|Lack of Efficacy|0
169050|NCT00537979|592799|P2|Overall Study|Lost to Follow-up|4
169051|NCT00537979|592800|P1|Overall Study|Lost to Follow-up|1
169052|NCT00537979|592799|P2|Overall Study|Withdrawal by Subject|4
169053|NCT00537979|592800|P1|Overall Study|Withdrawal by Subject|1
169054|NCT00537979|592799|P2|Overall Study|Adverse Event|2
169055|NCT00537979|592800|P1|Overall Study|Adverse Event|2
169056|NCT00537940|592816|P2|Overall Study|Other|12
169057|NCT00537940|592817|P1|Overall Study|Other|10
169058|NCT00537940|592816|P2|Overall Study|Study terminated by sponsor|3
169059|NCT00537940|592817|P1|Overall Study|Study terminated by sponsor|2
169060|NCT00537940|592816|P2|Overall Study|Pregnancy|1
169061|NCT00537940|592817|P1|Overall Study|Pregnancy|1
169062|NCT00537940|592816|P2|Overall Study|Protocol Violation|4
169063|NCT00537940|592817|P1|Overall Study|Protocol Violation|6
169064|NCT00537940|592816|P2|Overall Study|Withdrawal by Subject|95
169065|NCT00537940|592817|P1|Overall Study|Withdrawal by Subject|113
169066|NCT00537940|592816|P2|Overall Study|Lost to Follow-up|29
169067|NCT00537940|592817|P1|Overall Study|Lost to Follow-up|23
169068|NCT00537940|592816|P2|Overall Study|Lack of Efficacy|16
169069|NCT00537940|592817|P1|Overall Study|Lack of Efficacy|8
169070|NCT00537940|592816|P2|Overall Study|Adverse Event|19
169071|NCT00537940|592817|P1|Overall Study|Adverse Event|20
169072|NCT00537823|592841|P2|Overall Study|Adverse Event|0
169073|NCT00537823|592842|P1|Overall Study|Adverse Event|2
169074|NCT00537810|592868|P4|Overall Study|Medically withdrawn|1
169075|NCT00537810|592869|P3|Overall Study|Medically withdrawn|0
169076|NCT00537810|592870|P2|Overall Study|Medically withdrawn|2
169077|NCT00537810|592871|P1|Overall Study|Medically withdrawn|2
169078|NCT00537810|592868|P4|Overall Study|Withdrawal by Subject|3
169079|NCT00537810|592869|P3|Overall Study|Withdrawal by Subject|4
169080|NCT00537810|592870|P2|Overall Study|Withdrawal by Subject|11
169081|NCT00537810|592871|P1|Overall Study|Withdrawal by Subject|4
169082|NCT00537771|592887|P2|Overall Study|Severe Non-Compliance to Protocol|2
169083|NCT00537771|592888|P1|Overall Study|Severe Non-Compliance to Protocol|4
169084|NCT00537771|592887|P2|Overall Study|Protocol Violation|6
169085|NCT00537771|592888|P1|Overall Study|Protocol Violation|2
169086|NCT00537771|592887|P2|Overall Study|Lost to Follow-up|15
169087|NCT00537771|592888|P1|Overall Study|Lost to Follow-up|9
169088|NCT00537771|592887|P2|Overall Study|Adverse Event|15
169089|NCT00537771|592888|P1|Overall Study|Adverse Event|8
169090|NCT00537771|592887|P2|Overall Study|Withdrawal by Subject|23
169091|NCT00537771|592888|P1|Overall Study|Withdrawal by Subject|6
169092|NCT00537745|592898|P1|Overall Study|Subject unable to provide Interlock info|1
169093|NCT00537745|592898|P1|Overall Study|Withdrawal by Subject|2
169094|NCT00537745|592898|P1|Overall Study|Did not meet eligibility criteria|2
169095|NCT00537485|592943|P2|Overall Study|Physician Decision|0
169096|NCT00537485|592944|P1|Overall Study|Physician Decision|1
169097|NCT00537485|592943|P2|Overall Study|Withdrawal by Subject|3
169098|NCT00537485|592944|P1|Overall Study|Withdrawal by Subject|1
169099|NCT00537485|592943|P2|Overall Study|Withdrawal by Subject|2
169100|NCT00537485|592944|P1|Overall Study|Withdrawal by Subject|3
169101|NCT00537485|592943|P2|Overall Study|Adverse Event|5
169102|NCT00537485|592944|P1|Overall Study|Adverse Event|10
169103|NCT00537394|593017|P3|2nd Year of Follow-up|Clinic site closure|0
169104|NCT00537394|593018|P2|2nd Year of Follow-up|Clinic site closure|0
169105|NCT00537394|593019|P1|2nd Year of Follow-up|Clinic site closure|1
169106|NCT00537394|593017|P3|2nd Year of Follow-up|Lost to Follow-up|2
169107|NCT00537394|593018|P2|2nd Year of Follow-up|Lost to Follow-up|7
169108|NCT00537394|593019|P1|2nd Year of Follow-up|Lost to Follow-up|6
169109|NCT00537394|593017|P3|2nd Year of Follow-up|Withdrawal by Subject|2
169110|NCT00537394|593018|P2|2nd Year of Follow-up|Withdrawal by Subject|1
169111|NCT00537394|593019|P1|2nd Year of Follow-up|Withdrawal by Subject|0
169112|NCT00537394|593017|P3|2nd Year of Follow-up|Death|2
169113|NCT00537394|593018|P2|2nd Year of Follow-up|Death|1
169114|NCT00537394|593019|P1|2nd Year of Follow-up|Death|4
169115|NCT00537394|593017|P3|First Year of Follow-up|Lost to Follow-up|1
169116|NCT00537394|593018|P2|First Year of Follow-up|Lost to Follow-up|5
169117|NCT00537394|593019|P1|First Year of Follow-up|Lost to Follow-up|1
169118|NCT00537394|593017|P3|First Year of Follow-up|Withdrawal by Subject|1
169119|NCT00537394|593018|P2|First Year of Follow-up|Withdrawal by Subject|6
169120|NCT00537394|593019|P1|First Year of Follow-up|Withdrawal by Subject|3
169121|NCT00537394|593017|P3|First Year of Follow-up|Severe debilitation|1
169122|NCT00537394|593018|P2|First Year of Follow-up|Severe debilitation|0
169123|NCT00537394|593019|P1|First Year of Follow-up|Severe debilitation|1
169124|NCT00537394|593017|P3|First Year of Follow-up|Death|0
169125|NCT00537394|593018|P2|First Year of Follow-up|Death|0
169126|NCT00537394|593019|P1|First Year of Follow-up|Death|7
169127|NCT00537381|593055|P2|Overall Study|Other|3
169128|NCT00537381|593056|P1|Overall Study|Other|5
169129|NCT00537381|593055|P2|Overall Study|Sponsor decision|9
169130|NCT00537381|593056|P1|Overall Study|Sponsor decision|14
169131|NCT00537381|593055|P2|Overall Study|Disease Progression|18
169132|NCT00537381|593056|P1|Overall Study|Disease Progression|9
169133|NCT00537381|593055|P2|Overall Study|Physician Decision|6
169134|NCT00537381|593056|P1|Overall Study|Physician Decision|7
169135|NCT00537381|593055|P2|Overall Study|Withdrawal by Subject|14
169136|NCT00537381|593056|P1|Overall Study|Withdrawal by Subject|5
169137|NCT00537381|593055|P2|Overall Study|Death|3
169138|NCT00537381|593056|P1|Overall Study|Death|3
169139|NCT00537381|593055|P2|Overall Study|Adverse Event|9
169140|NCT00537381|593056|P1|Overall Study|Adverse Event|13
169141|NCT00537329|593076|P1|Overall Study|Other|1
169142|NCT00537329|593076|P1|Overall Study|Withdrawal by Subject|4
169143|NCT00537329|593076|P1|Overall Study|Lost to Follow-up|6
169144|NCT00537329|593076|P1|Overall Study|Lack of Efficacy|2
169145|NCT00537329|593076|P1|Overall Study|Adverse Event|3
169146|NCT00537329|593076|P1|Overall Study|Death|10
169147|NCT00537316|593096|P7|Part 2|Administrative|1
169148|NCT00537316|593097|P6|Part 2|Administrative|4
169149|NCT00537316|593098|P5|Part 2|Administrative|1
169150|NCT00537316|593099|P4|Part 2|Administrative|3
169151|NCT00537316|593100|P3|Part 2|Administrative|24
169152|NCT00537316|593101|P2|Part 2|Administrative|8
169153|NCT00537316|593102|P1|Part 2|Administrative|16
169154|NCT00537316|593096|P7|Part 2|Withdrawal by Subject|0
169155|NCT00537316|593097|P6|Part 2|Withdrawal by Subject|0
169156|NCT00537316|593098|P5|Part 2|Withdrawal by Subject|0
169157|NCT00537316|593099|P4|Part 2|Withdrawal by Subject|0
169158|NCT00537316|593100|P3|Part 2|Withdrawal by Subject|4
169159|NCT00537316|593101|P2|Part 2|Withdrawal by Subject|1
169160|NCT00537316|593102|P1|Part 2|Withdrawal by Subject|5
169161|NCT00537316|593096|P7|Part 2|Lost to Follow-up|0
169162|NCT00537316|593097|P6|Part 2|Lost to Follow-up|0
169163|NCT00537316|593098|P5|Part 2|Lost to Follow-up|0
169164|NCT00537316|593099|P4|Part 2|Lost to Follow-up|0
169165|NCT00537316|593100|P3|Part 2|Lost to Follow-up|2
169166|NCT00537316|593101|P2|Part 2|Lost to Follow-up|0
169167|NCT00537316|593102|P1|Part 2|Lost to Follow-up|1
169168|NCT00537316|593096|P7|Part 2|Adverse Event|0
169169|NCT00537316|593097|P6|Part 2|Adverse Event|0
169170|NCT00537316|593098|P5|Part 2|Adverse Event|0
169171|NCT00537316|593099|P4|Part 2|Adverse Event|0
169172|NCT00537316|593100|P3|Part 2|Adverse Event|2
169173|NCT00537316|593101|P2|Part 2|Adverse Event|0
169174|NCT00537316|593102|P1|Part 2|Adverse Event|4
169175|NCT00537316|593096|P7|Part 2|Never entered follow-up|1
169176|NCT00537316|593097|P6|Part 2|Never entered follow-up|0
169177|NCT00537316|593098|P5|Part 2|Never entered follow-up|0
169178|NCT00537316|593099|P4|Part 2|Never entered follow-up|0
169179|NCT00537316|593100|P3|Part 2|Never entered follow-up|0
169180|NCT00537316|593101|P2|Part 2|Never entered follow-up|0
169181|NCT00537316|593102|P1|Part 2|Never entered follow-up|0
169182|NCT00537316|593096|P7|Part 1|Administrative|0
169183|NCT00537316|593097|P6|Part 1|Administrative|0
169184|NCT00537316|593098|P5|Part 1|Administrative|0
169185|NCT00537316|593099|P4|Part 1|Administrative|0
169186|NCT00537316|593100|P3|Part 1|Administrative|2
169187|NCT00537316|593101|P2|Part 1|Administrative|0
169188|NCT00537316|593102|P1|Part 1|Administrative|0
169189|NCT00537316|593096|P7|Part 1|Did not meet protocol eligibility|0
169190|NCT00537316|593097|P6|Part 1|Did not meet protocol eligibility|0
169191|NCT00537316|593098|P5|Part 1|Did not meet protocol eligibility|0
169192|NCT00537316|593099|P4|Part 1|Did not meet protocol eligibility|0
169193|NCT00537316|593100|P3|Part 1|Did not meet protocol eligibility|2
169194|NCT00537316|593101|P2|Part 1|Did not meet protocol eligibility|3
169195|NCT00537316|593102|P1|Part 1|Did not meet protocol eligibility|1
169196|NCT00537316|593096|P7|Part 1|Protocol Violation|0
169197|NCT00537316|593097|P6|Part 1|Protocol Violation|0
169198|NCT00537316|593098|P5|Part 1|Protocol Violation|0
169199|NCT00537316|593099|P4|Part 1|Protocol Violation|0
169200|NCT00537316|593100|P3|Part 1|Protocol Violation|1
169201|NCT00537316|593101|P2|Part 1|Protocol Violation|5
169202|NCT00537316|593102|P1|Part 1|Protocol Violation|1
169203|NCT00537316|593096|P7|Part 1|Withdrawal by Subject|0
169204|NCT00537316|593097|P6|Part 1|Withdrawal by Subject|0
169205|NCT00537316|593098|P5|Part 1|Withdrawal by Subject|0
169206|NCT00537316|593099|P4|Part 1|Withdrawal by Subject|0
169207|NCT00537316|593100|P3|Part 1|Withdrawal by Subject|4
169208|NCT00537316|593101|P2|Part 1|Withdrawal by Subject|8
169209|NCT00537316|593102|P1|Part 1|Withdrawal by Subject|3
169210|NCT00537316|593096|P7|Part 1|Lost to Follow-up|0
169211|NCT00537316|593097|P6|Part 1|Lost to Follow-up|0
169212|NCT00537316|593098|P5|Part 1|Lost to Follow-up|0
169213|NCT00537316|593099|P4|Part 1|Lost to Follow-up|0
169214|NCT00537316|593100|P3|Part 1|Lost to Follow-up|0
169215|NCT00537316|593101|P2|Part 1|Lost to Follow-up|0
169216|NCT00537316|593102|P1|Part 1|Lost to Follow-up|1
169217|NCT00537316|593096|P7|Part 1|Protocol defined clinical event|0
169218|NCT00537316|593097|P6|Part 1|Protocol defined clinical event|0
169219|NCT00537316|593098|P5|Part 1|Protocol defined clinical event|0
169220|NCT00537316|593099|P4|Part 1|Protocol defined clinical event|0
169221|NCT00537316|593100|P3|Part 1|Protocol defined clinical event|0
169222|NCT00537316|593101|P2|Part 1|Protocol defined clinical event|0
169223|NCT00537316|593102|P1|Part 1|Protocol defined clinical event|1
169224|NCT00537316|593096|P7|Part 1|Adverse Event|0
169225|NCT00537316|593097|P6|Part 1|Adverse Event|0
169226|NCT00537316|593098|P5|Part 1|Adverse Event|0
169227|NCT00537316|593099|P4|Part 1|Adverse Event|0
169228|NCT00537316|593100|P3|Part 1|Adverse Event|8
169229|NCT00537316|593101|P2|Part 1|Adverse Event|11
169230|NCT00537316|593102|P1|Part 1|Adverse Event|7
169231|NCT00537303|593129|P2|Overall Study|Unclassified|7
169232|NCT00537303|593130|P1|Overall Study|Unclassified|8
169233|NCT00537303|593129|P2|Overall Study|Withdrawal criteria|3
169234|NCT00537303|593130|P1|Overall Study|Withdrawal criteria|3
169235|NCT00537303|593129|P2|Overall Study|Protocol Violation|4
169236|NCT00537303|593130|P1|Overall Study|Protocol Violation|8
169237|NCT00537303|593129|P2|Overall Study|Lack of Efficacy|7
169238|NCT00537303|593130|P1|Overall Study|Lack of Efficacy|6
169239|NCT00537303|593129|P2|Overall Study|Adverse Event|4
169240|NCT00537303|593130|P1|Overall Study|Adverse Event|1
169241|NCT00537277|593151|P1|Overall Study|Non-compliance with trial procedures|15
169242|NCT00537277|593151|P1|Overall Study|Inability to tolerate trial medication|4
169243|NCT00537277|593151|P1|Overall Study|Unclassified|4
169244|NCT00537277|593151|P1|Overall Study|Protocol Violation|11
169245|NCT00537277|593151|P1|Overall Study|Lost to Follow-up|12
169246|NCT00537277|593151|P1|Overall Study|Lack of Efficacy|2
169247|NCT00537277|593151|P1|Overall Study|Adverse Event|1
169248|NCT00537238|593162|P2|Overall Study|Other|52
169249|NCT00537238|593163|P1|Overall Study|Other|44
169250|NCT00537238|593162|P2|Overall Study|Does not meet entrance criteria|2
169251|NCT00537238|593163|P1|Overall Study|Does not meet entrance criteria|0
169252|NCT00537238|593162|P2|Overall Study|Protocol Violation|19
169253|NCT00537238|593163|P1|Overall Study|Protocol Violation|15
169254|NCT00537238|593162|P2|Overall Study|Withdrawal by Subject|47
169255|NCT00537238|593163|P1|Overall Study|Withdrawal by Subject|51
169256|NCT00537238|593162|P2|Overall Study|Lost to Follow-up|8
169257|NCT00537238|593163|P1|Overall Study|Lost to Follow-up|12
169258|NCT00537238|593162|P2|Overall Study|Lack of Efficacy|21
169259|NCT00537238|593163|P1|Overall Study|Lack of Efficacy|20
169260|NCT00537238|593162|P2|Overall Study|Adverse Event|22
169261|NCT00537238|593163|P1|Overall Study|Adverse Event|31
169262|NCT00537238|593162|P2|Overall Study|Death|2
169263|NCT00537238|593163|P1|Overall Study|Death|1
169264|NCT00537199|593183|P1|Overall Study|Study Terminated|1
169265|NCT00537095|593189|P2|Overall Study|Incorrect enrolment|1
169266|NCT00537095|593190|P1|Overall Study|Incorrect enrolment|0
169267|NCT00537095|593189|P2|Overall Study|subjective disease progression|1
169268|NCT00537095|593190|P1|Overall Study|subjective disease progression|0
169269|NCT00537095|593189|P2|Overall Study|Withdrawal by Subject|2
169270|NCT00537095|593190|P1|Overall Study|Withdrawal by Subject|2
169271|NCT00537095|593189|P2|Overall Study|Death|1
169272|NCT00537095|593190|P1|Overall Study|Death|3
169273|NCT00537095|593189|P2|Overall Study|disease progression|48
169274|NCT00537095|593190|P1|Overall Study|disease progression|21
169275|NCT00537095|593189|P2|Overall Study|Adverse Event|4
169276|NCT00537095|593190|P1|Overall Study|Adverse Event|24
169277|NCT00537095|593189|P2|Overall Study|surgery|0
169278|NCT00537095|593190|P1|Overall Study|surgery|1
169279|NCT00537082|593205|P3|Overall Study|Discontinued before initiating treatment|0
169280|NCT00537082|593206|P2|Overall Study|Discontinued before initiating treatment|0
169281|NCT00537082|593207|P1|Overall Study|Discontinued before initiating treatment|3
169282|NCT00537082|593205|P3|Overall Study|Withdrawal by Subject|0
169283|NCT00537082|593206|P2|Overall Study|Withdrawal by Subject|1
169284|NCT00537082|593207|P1|Overall Study|Withdrawal by Subject|0
169285|NCT00537082|593205|P3|Overall Study|Lack of Efficacy|2
169286|NCT00537082|593206|P2|Overall Study|Lack of Efficacy|0
169287|NCT00537082|593207|P1|Overall Study|Lack of Efficacy|0
169288|NCT00537082|593205|P3|Overall Study|Protocol Violation|1
169289|NCT00537082|593206|P2|Overall Study|Protocol Violation|2
169290|NCT00537082|593207|P1|Overall Study|Protocol Violation|0
169291|NCT00537082|593205|P3|Overall Study|Adverse Event|3
169292|NCT00537082|593206|P2|Overall Study|Adverse Event|6
169293|NCT00537082|593207|P1|Overall Study|Adverse Event|6
169294|NCT00537056|593224|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
169295|NCT00537030|593236|P1|Overall Study|Inevaluable|3
169296|NCT00537030|593236|P1|Overall Study|Confirm patient ineligibility|1
169297|NCT00537030|593236|P1|Overall Study|Disease progression or relapse during ac|1
169298|NCT00537030|593236|P1|Overall Study|Greater then or equal to a Grade 2 aller|7
169299|NCT00537030|593236|P1|Overall Study|Withdrawal by Subject|2
169300|NCT00537030|593236|P1|Overall Study|Physician Decision|2
169301|NCT00537017|593240|P1|Follow-up Phase|Withdrawal by Subject|9
169302|NCT00537017|593240|P1|Treatment Phase|Protocol Violation|2
169303|NCT00537017|593240|P1|Treatment Phase|Withdrawal by Subject|13
169304|NCT00537017|593240|P1|Treatment Phase|Adverse Event|19
169305|NCT00536991|593251|P1|Overall Study|patient ineligible|2
169306|NCT00536991|593251|P1|Overall Study|Physician Decision|1
169307|NCT00536991|593251|P1|Overall Study|Withdrawal by Subject|10
169308|NCT00536978|593258|P1|Overall Study|Not eligible for Adback Infusion|22
169309|NCT00536874|593287|P1|Overall Study|Withdrawal by Subject|1
169310|NCT00536874|593287|P1|Overall Study|Death|2
169311|NCT00536874|593287|P1|Overall Study|Adverse Event|1
169312|NCT00536809|593297|P1|Phase II|Referred for surgical resection|1
169313|NCT00536809|593297|P1|Phase II|Adverse Event|1
169314|NCT00536744|593320|P2|Overall Study|PI tried alternative treatment|3
169315|NCT00536744|593321|P1|Overall Study|PI tried alternative treatment|1
169316|NCT00536744|593320|P2|Overall Study|Withdrawal by Subject|8
169317|NCT00536744|593321|P1|Overall Study|Withdrawal by Subject|7
169318|NCT00536744|593320|P2|Overall Study|Lost to Follow-up|5
169319|NCT00536744|593321|P1|Overall Study|Lost to Follow-up|3
169320|NCT00536744|593320|P2|Overall Study|Physician Decision|1
169321|NCT00536744|593321|P1|Overall Study|Physician Decision|3
169322|NCT00536744|593320|P2|Overall Study|Death|1
169323|NCT00536744|593321|P1|Overall Study|Death|2
169324|NCT00536744|593320|P2|Overall Study|Adverse Event|10
169325|NCT00536744|593321|P1|Overall Study|Adverse Event|13
169326|NCT00536731|593330|P3|Overall Study|Other|0
169327|NCT00536731|593331|P2|Overall Study|Other|1
169328|NCT00536731|593332|P1|Overall Study|Other|1
169329|NCT00536731|593330|P3|Overall Study|Safety reasons|1
169330|NCT00536731|593331|P2|Overall Study|Safety reasons|0
169331|NCT00536731|593332|P1|Overall Study|Safety reasons|0
169332|NCT00536731|593330|P3|Overall Study|Intake of prohibited conc. medication|1
169333|NCT00536731|593331|P2|Overall Study|Intake of prohibited conc. medication|0
169334|NCT00536731|593332|P1|Overall Study|Intake of prohibited conc. medication|0
169335|NCT00536731|593330|P3|Overall Study|Withdrawal by Subject|0
169336|NCT00536731|593331|P2|Overall Study|Withdrawal by Subject|2
169337|NCT00536731|593332|P1|Overall Study|Withdrawal by Subject|0
169338|NCT00536731|593330|P3|Overall Study|Adverse Event|3
169339|NCT00536731|593331|P2|Overall Study|Adverse Event|2
169340|NCT00536731|593332|P1|Overall Study|Adverse Event|3
169341|NCT00536575|593376|P1|Overall Study|Death|1
169342|NCT00536575|593376|P1|Overall Study|Withdrawal by Subject|1
169343|NCT00536510|593382|P2|Overall Study|Patient Discontinued for Other Reasons|2
169344|NCT00536510|593383|P1|Overall Study|Patient Discontinued for Other Reasons|2
169345|NCT00536510|593382|P2|Overall Study|Laboratory Adverse Event|1
169346|NCT00536510|593383|P1|Overall Study|Laboratory Adverse Event|2
169347|NCT00536510|593382|P2|Overall Study|Flushing with Product|0
169348|NCT00536510|593383|P1|Overall Study|Flushing with Product|20
169349|NCT00536510|593382|P2|Overall Study|Withdrawal by Subject|9
169350|NCT00536510|593383|P1|Overall Study|Withdrawal by Subject|16
169351|NCT00536510|593382|P2|Overall Study|Protocol Violation|5
169352|NCT00536510|593383|P1|Overall Study|Protocol Violation|4
169353|NCT00536510|593382|P2|Overall Study|Lost to Follow-up|8
169354|NCT00536510|593383|P1|Overall Study|Lost to Follow-up|11
169355|NCT00536510|593382|P2|Overall Study|Adverse Event|4
169356|NCT00536510|593383|P1|Overall Study|Adverse Event|27
169357|NCT00536484|593393|P2|Overall Study|Other|0
169358|NCT00536484|593394|P1|Overall Study|Other|4
169359|NCT00536484|593393|P2|Overall Study|Lack of Efficacy|5
169360|NCT00536484|593394|P1|Overall Study|Lack of Efficacy|16
169361|NCT00536484|593393|P2|Overall Study|Lost to Follow-up|6
169362|NCT00536484|593394|P1|Overall Study|Lost to Follow-up|8
169363|NCT00536484|593393|P2|Overall Study|Withdrawal by Subject|11
169364|NCT00536484|593394|P1|Overall Study|Withdrawal by Subject|11
169365|NCT00536484|593393|P2|Overall Study|Adverse Event|34
169366|NCT00536484|593394|P1|Overall Study|Adverse Event|21
169367|NCT00536471|593428|P4|Overall Study|Sponsor Decision|2
169368|NCT00536471|593429|P3|Overall Study|Sponsor Decision|3
169369|NCT00536471|593430|P2|Overall Study|Sponsor Decision|1
169370|NCT00536471|593431|P1|Overall Study|Sponsor Decision|0
169371|NCT00536471|593428|P4|Overall Study|Death|2
169372|NCT00536471|593429|P3|Overall Study|Death|1
169373|NCT00536471|593430|P2|Overall Study|Death|0
169374|NCT00536471|593431|P1|Overall Study|Death|0
169375|NCT00536471|593428|P4|Overall Study|Physician Decision|2
169376|NCT00536471|593429|P3|Overall Study|Physician Decision|3
169377|NCT00536471|593430|P2|Overall Study|Physician Decision|1
169378|NCT00536471|593431|P1|Overall Study|Physician Decision|11
169379|NCT00536471|593428|P4|Overall Study|Protocol Violation|3
169380|NCT00536471|593429|P3|Overall Study|Protocol Violation|2
169381|NCT00536471|593430|P2|Overall Study|Protocol Violation|1
169382|NCT00536471|593431|P1|Overall Study|Protocol Violation|8
169383|NCT00536471|593428|P4|Overall Study|Lack of Efficacy|9
169384|NCT00536471|593429|P3|Overall Study|Lack of Efficacy|11
169385|NCT00536471|593430|P2|Overall Study|Lack of Efficacy|18
169386|NCT00536471|593431|P1|Overall Study|Lack of Efficacy|17
169387|NCT00536471|593428|P4|Overall Study|Withdrawal by Subject|21
169388|NCT00536471|593429|P3|Overall Study|Withdrawal by Subject|43
169389|NCT00536471|593430|P2|Overall Study|Withdrawal by Subject|24
169390|NCT00536471|593431|P1|Overall Study|Withdrawal by Subject|40
169391|NCT00536471|593428|P4|Overall Study|Adverse Event|13
169392|NCT00536471|593429|P3|Overall Study|Adverse Event|28
169393|NCT00536471|593430|P2|Overall Study|Adverse Event|16
169394|NCT00536471|593431|P1|Overall Study|Adverse Event|32
169395|NCT00536471|593428|P4|Overall Study|Lost to Follow-up|22
169396|NCT00536471|593429|P3|Overall Study|Lost to Follow-up|48
169397|NCT00536471|593430|P2|Overall Study|Lost to Follow-up|23
169398|NCT00536471|593431|P1|Overall Study|Lost to Follow-up|48
169399|NCT00536380|593676|P3|Overall Study|Administrative|1
169400|NCT00536380|593677|P2|Overall Study|Administrative|0
169401|NCT00536380|593678|P1|Overall Study|Administrative|0
169402|NCT00536380|593676|P3|Overall Study|Did not meet protocol eligibility|1
169403|NCT00536380|593677|P2|Overall Study|Did not meet protocol eligibility|0
169404|NCT00536380|593678|P1|Overall Study|Did not meet protocol eligibility|0
169405|NCT00536380|593676|P3|Overall Study|Noncompliance with protocol|2
169406|NCT00536380|593677|P2|Overall Study|Noncompliance with protocol|2
169407|NCT00536380|593678|P1|Overall Study|Noncompliance with protocol|3
169408|NCT00536380|593676|P3|Overall Study|Withdrawal related to study drug|2
169409|NCT00536380|593677|P2|Overall Study|Withdrawal related to study drug|5
169410|NCT00536380|593678|P1|Overall Study|Withdrawal related to study drug|7
169411|NCT00536380|593676|P3|Overall Study|Withdrawal unrelated to study drug|1
169412|NCT00536380|593677|P2|Overall Study|Withdrawal unrelated to study drug|0
169413|NCT00536380|593678|P1|Overall Study|Withdrawal unrelated to study drug|2
169414|NCT00536380|593676|P3|Overall Study|Lost to Follow-up|1
169415|NCT00536380|593677|P2|Overall Study|Lost to Follow-up|0
169416|NCT00536380|593678|P1|Overall Study|Lost to Follow-up|0
169417|NCT00536380|593676|P3|Overall Study|Adverse Event|2
169418|NCT00536380|593677|P2|Overall Study|Adverse Event|2
169419|NCT00536380|593678|P1|Overall Study|Adverse Event|0
169420|NCT00536263|593702|P3|Overall Study|Did not meet protocol eligibility|2
169421|NCT00536263|593703|P2|Overall Study|Did not meet protocol eligibility|2
169422|NCT00536263|593704|P1|Overall Study|Did not meet protocol eligibility|1
169423|NCT00536263|593702|P3|Overall Study|Noncompliance with protocol|1
169424|NCT00536263|593703|P2|Overall Study|Noncompliance with protocol|0
169425|NCT00536263|593704|P1|Overall Study|Noncompliance with protocol|0
169426|NCT00536263|593702|P3|Overall Study|Subject withdrew - treatment related|2
169427|NCT00536263|593703|P2|Overall Study|Subject withdrew - treatment related|3
169428|NCT00536263|593704|P1|Overall Study|Subject withdrew - treatment related|0
169429|NCT00536263|593702|P3|Overall Study|Subject withdrew - not treatment related|5
169430|NCT00536263|593703|P2|Overall Study|Subject withdrew - not treatment related|0
169431|NCT00536263|593704|P1|Overall Study|Subject withdrew - not treatment related|2
169432|NCT00536263|593702|P3|Overall Study|Lost to Follow-up|4
169433|NCT00536263|593703|P2|Overall Study|Lost to Follow-up|4
169434|NCT00536263|593704|P1|Overall Study|Lost to Follow-up|3
169435|NCT00536263|593702|P3|Overall Study|Adverse Event|7
169436|NCT00536263|593703|P2|Overall Study|Adverse Event|5
169437|NCT00536263|593704|P1|Overall Study|Adverse Event|5
169438|NCT00536198|593744|P2|Overall Study|Protocol Violation|1
169439|NCT00536198|593745|P1|Overall Study|Protocol Violation|0
169440|NCT00536198|593744|P2|Overall Study|Pregnancy|1
169441|NCT00536198|593745|P1|Overall Study|Pregnancy|1
169442|NCT00536198|593744|P2|Overall Study|Rescue|9
169443|NCT00536198|593745|P1|Overall Study|Rescue|3
169444|NCT00536198|593744|P2|Overall Study|Adverse Event|2
169445|NCT00536198|593745|P1|Overall Study|Adverse Event|2
169446|NCT00536198|593744|P2|Overall Study|Withdrawal by Subject|12
169447|NCT00536198|593745|P1|Overall Study|Withdrawal by Subject|16
169448|NCT00536198|593744|P2|Overall Study|Lost to Follow-up|14
169449|NCT00536198|593745|P1|Overall Study|Lost to Follow-up|15
169450|NCT00536120|593784|P2|Overall Study|Missed Study Visit|1
169451|NCT00536120|593785|P1|Overall Study|Missed Study Visit|0
169452|NCT00536120|593784|P2|Overall Study|Steroid Use|2
169453|NCT00536120|593785|P1|Overall Study|Steroid Use|0
169454|NCT00536120|593784|P2|Overall Study|Sponsor Decision Due to Lab Values|0
169455|NCT00536120|593785|P1|Overall Study|Sponsor Decision Due to Lab Values|1
169456|NCT00536120|593784|P2|Overall Study|Non-compliance|0
169457|NCT00536120|593785|P1|Overall Study|Non-compliance|1
169458|NCT00536120|593784|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
169459|NCT00536120|593785|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
169460|NCT00536120|593784|P2|Overall Study|Lost to Follow-up|0
169461|NCT00536120|593785|P1|Overall Study|Lost to Follow-up|1
169462|NCT00536107|593799|P2|Overall Study|Study Termination|4
169463|NCT00536107|593800|P1|Overall Study|Study Termination|2
169464|NCT00536107|593799|P2|Overall Study|Withdrawal by Subject|1
169465|NCT00536107|593800|P1|Overall Study|Withdrawal by Subject|0
169466|NCT00536107|593799|P2|Overall Study|Incorrect enrolment|0
169467|NCT00536107|593800|P1|Overall Study|Incorrect enrolment|1
169468|NCT00536107|593799|P2|Overall Study|Death|1
169469|NCT00536107|593800|P1|Overall Study|Death|5
169470|NCT00535847|593854|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
169471|NCT00535847|593855|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
169472|NCT00535847|593856|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
169473|NCT00535847|593854|P3|Overall Study|Non compliance|0
169474|NCT00535847|593855|P2|Overall Study|Non compliance|1
169475|NCT00535847|593856|P1|Overall Study|Non compliance|1
169476|NCT00535847|593854|P3|Overall Study|Adverse Event|2
169477|NCT00535847|593855|P2|Overall Study|Adverse Event|3
169478|NCT00535847|593856|P1|Overall Study|Adverse Event|5
169479|NCT00535730|593922|P2|Overall Study|Withdrawal by Subject|4
169480|NCT00535730|593923|P1|Overall Study|Withdrawal by Subject|0
169481|NCT00535730|593922|P2|Overall Study|Protocol Violation|0
169482|NCT00535730|593923|P1|Overall Study|Protocol Violation|1
169483|NCT00535730|593922|P2|Overall Study|Physician Decision|1
169484|NCT00535730|593923|P1|Overall Study|Physician Decision|0
169485|NCT00535730|593922|P2|Overall Study|Lost to Follow-up|1
169486|NCT00535730|593923|P1|Overall Study|Lost to Follow-up|0
169487|NCT00535730|593922|P2|Overall Study|Adverse Event|1
169488|NCT00535730|593923|P1|Overall Study|Adverse Event|1
169489|NCT00535626|593944|P1|Overall Study|Unable to return|2
169490|NCT00535626|593944|P1|Overall Study|Subject terminated|31
169491|NCT00535626|593944|P1|Overall Study|Removal/revision of study component|8
169492|NCT00535626|593944|P1|Overall Study|Withdrawal by Subject|20
169493|NCT00535626|593944|P1|Overall Study|Lost to Follow-up|29
169494|NCT00535626|593944|P1|Overall Study|Death|15
169495|NCT00535496|593971|P4|Overall Study|Not treated with sugammadex|0
169496|NCT00535496|593972|P3|Overall Study|Not treated with sugammadex|0
169497|NCT00535496|593973|P2|Overall Study|Not treated with sugammadex|1
169498|NCT00535496|593974|P1|Overall Study|Not treated with sugammadex|0
169499|NCT00535496|593971|P4|Overall Study|Lost to Follow-up|0
169500|NCT00535496|593972|P3|Overall Study|Lost to Follow-up|0
169501|NCT00535496|593973|P2|Overall Study|Lost to Follow-up|1
169502|NCT00535496|593974|P1|Overall Study|Lost to Follow-up|0
169503|NCT00535405|593994|P5|Overall Study|Withdrawal by Subject|8
169504|NCT00535405|593995|P4|Overall Study|Withdrawal by Subject|10
169505|NCT00535405|593996|P3|Overall Study|Withdrawal by Subject|10
169506|NCT00535405|593997|P2|Overall Study|Withdrawal by Subject|11
169507|NCT00535405|593998|P1|Overall Study|Withdrawal by Subject|5
169508|NCT00535405|593994|P5|Overall Study|Protocol Violation|0
169509|NCT00535405|593995|P4|Overall Study|Protocol Violation|1
169510|NCT00535405|593996|P3|Overall Study|Protocol Violation|2
169511|NCT00535405|593997|P2|Overall Study|Protocol Violation|2
169512|NCT00535405|593998|P1|Overall Study|Protocol Violation|2
169513|NCT00535405|593994|P5|Overall Study|Physician Decision|1
169514|NCT00535405|593995|P4|Overall Study|Physician Decision|1
169515|NCT00535405|593996|P3|Overall Study|Physician Decision|0
169516|NCT00535405|593997|P2|Overall Study|Physician Decision|2
169517|NCT00535405|593998|P1|Overall Study|Physician Decision|3
169518|NCT00535405|593994|P5|Overall Study|Lost to Follow-up|1
169519|NCT00535405|593995|P4|Overall Study|Lost to Follow-up|2
169520|NCT00535405|593996|P3|Overall Study|Lost to Follow-up|3
169521|NCT00535405|593997|P2|Overall Study|Lost to Follow-up|3
169522|NCT00535405|593998|P1|Overall Study|Lost to Follow-up|1
169523|NCT00535405|593994|P5|Overall Study|Adverse Event|6
169524|NCT00535405|593995|P4|Overall Study|Adverse Event|8
169525|NCT00535405|593996|P3|Overall Study|Adverse Event|3
169526|NCT00535405|593997|P2|Overall Study|Adverse Event|8
169527|NCT00535405|593998|P1|Overall Study|Adverse Event|6
169528|NCT00535288|594059|P5|Overall Study|Not specified|1
169529|NCT00535288|594060|P4|Overall Study|Not specified|2
169530|NCT00535288|594061|P3|Overall Study|Not specified|1
169531|NCT00535288|594062|P2|Overall Study|Not specified|1
169532|NCT00535288|594063|P1|Overall Study|Not specified|2
169533|NCT00535288|594059|P5|Overall Study|Unwilling to cooperate|4
169534|NCT00535288|594060|P4|Overall Study|Unwilling to cooperate|3
169535|NCT00535288|594061|P3|Overall Study|Unwilling to cooperate|3
169536|NCT00535288|594062|P2|Overall Study|Unwilling to cooperate|6
169537|NCT00535288|594063|P1|Overall Study|Unwilling to cooperate|6
169538|NCT00535288|594059|P5|Overall Study|Lack of Efficacy|7
169539|NCT00535288|594060|P4|Overall Study|Lack of Efficacy|4
169540|NCT00535288|594061|P3|Overall Study|Lack of Efficacy|4
169541|NCT00535288|594062|P2|Overall Study|Lack of Efficacy|3
169542|NCT00535288|594063|P1|Overall Study|Lack of Efficacy|26
169543|NCT00535288|594059|P5|Overall Study|Lost to Follow-up|0
169544|NCT00535288|594060|P4|Overall Study|Lost to Follow-up|0
169545|NCT00535288|594061|P3|Overall Study|Lost to Follow-up|0
169546|NCT00535288|594062|P2|Overall Study|Lost to Follow-up|3
169547|NCT00535288|594063|P1|Overall Study|Lost to Follow-up|0
169548|NCT00535288|594059|P5|Overall Study|Adverse Event|30
169549|NCT00535288|594060|P4|Overall Study|Adverse Event|20
169550|NCT00535288|594061|P3|Overall Study|Adverse Event|25
169551|NCT00535288|594062|P2|Overall Study|Adverse Event|19
169552|NCT00535288|594063|P1|Overall Study|Adverse Event|20
169553|NCT00535262|594140|P1|Overall Study|No funding|3
169554|NCT00535223|594146|P2|Overall Study|Withdrawal by Subject|1
169555|NCT00535223|594147|P1|Overall Study|Withdrawal by Subject|4
169556|NCT00535145|594155|P1|Phase II|Subject non-compliance|2
169557|NCT00535145|594155|P1|Phase II|Withdrawal by Subject|5
169558|NCT00535145|594155|P1|Phase II|Lost to Follow-up|5
169559|NCT00535145|594155|P1|Phase II|Lack of Efficacy|1
169560|NCT00535145|594155|P1|Phase II|Adverse Event|2
169561|NCT00535145|594155|P1|Phase I|(diagnosis)|3
169562|NCT00535145|594155|P1|Phase I|(PI decision)|1
169563|NCT00535145|594155|P1|Phase I|(protocol violation)|1
169564|NCT00535145|594155|P1|Phase I|(eligibility)|8
169565|NCT00535145|594155|P1|Phase I|Withdrawal by Subject|6
169566|NCT00535145|594155|P1|Phase I|Lost to Follow-up|7
169567|NCT00535145|594155|P1|Phase I|Adverse Event|3
169568|NCT00535132|594167|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
169569|NCT00535132|594168|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
169570|NCT00535132|594167|P2|Safety Analysis Set|Did Not Receive Study Medication|2
169571|NCT00535132|594168|P1|Safety Analysis Set|Did Not Receive Study Medication|2
169572|NCT00534976|594249|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
169573|NCT00534976|594250|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
169574|NCT00534976|594249|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
169575|NCT00534976|594250|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
169576|NCT00534976|594249|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
169577|NCT00534976|594250|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
169578|NCT00534638|594311|P2|Overall Study|Refused participation to study|883
169579|NCT00534638|594312|P1|Overall Study|Refused participation to study|1665
169580|NCT00534638|594311|P2|Overall Study|Rejected origin of signature|2
169581|NCT00534638|594312|P1|Overall Study|Rejected origin of signature|0
169582|NCT00534638|594311|P2|Overall Study|Received without ICF|1
169583|NCT00534638|594312|P1|Overall Study|Received without ICF|0
169584|NCT00534638|594311|P2|Overall Study|Subject unable to read|1
169585|NCT00534638|594312|P1|Overall Study|Subject unable to read|0
169586|NCT00534638|594311|P2|Overall Study|ICF not returned|1
169587|NCT00534638|594312|P1|Overall Study|ICF not returned|0
169588|NCT00534638|594311|P2|Overall Study|Mentally disabled|0
169589|NCT00534638|594312|P1|Overall Study|Mentally disabled|1
169590|NCT00534638|594311|P2|Overall Study|Death|5
169591|NCT00534638|594312|P1|Overall Study|Death|5
169592|NCT00534638|594311|P2|Overall Study|Pregnancy|4
169593|NCT00534638|594312|P1|Overall Study|Pregnancy|6
169594|NCT00534638|594311|P2|Overall Study|Blinded treatment broken|0
169595|NCT00534638|594312|P1|Overall Study|Blinded treatment broken|2
169596|NCT00534638|594311|P2|Overall Study|Urticaria|0
169597|NCT00534638|594312|P1|Overall Study|Urticaria|1
169598|NCT00534638|594311|P2|Overall Study|Already received HPV vaccine|1
169599|NCT00534638|594312|P1|Overall Study|Already received HPV vaccine|0
169600|NCT00534638|594311|P2|Overall Study|Lost to Follow-up|10875
169601|NCT00534638|594312|P1|Overall Study|Lost to Follow-up|4793
169602|NCT00534638|594311|P2|Overall Study|Migrated/moved from study area|13
169603|NCT00534638|594312|P1|Overall Study|Migrated/moved from study area|14
169604|NCT00534638|594311|P2|Overall Study|Withdrawal by Subject|5
169605|NCT00534638|594312|P1|Overall Study|Withdrawal by Subject|4
169606|NCT00534599|594347|P2|Overall Study|Other|0
169607|NCT00534599|594348|P1|Overall Study|Other|7
169608|NCT00534599|594347|P2|Overall Study|Withdrawal by Subject|6
169609|NCT00534599|594348|P1|Overall Study|Withdrawal by Subject|4
169610|NCT00534599|594347|P2|Overall Study|Lost to Follow-up|14
169611|NCT00534599|594348|P1|Overall Study|Lost to Follow-up|11
169612|NCT00534599|594347|P2|Overall Study|Protocol Violation|3
169613|NCT00534599|594348|P1|Overall Study|Protocol Violation|1
169614|NCT00534599|594347|P2|Overall Study|Generalized anxiety disorder worsened|1
169615|NCT00534599|594348|P1|Overall Study|Generalized anxiety disorder worsened|0
169616|NCT00534599|594347|P2|Overall Study|Lack of Efficacy|1
169617|NCT00534599|594348|P1|Overall Study|Lack of Efficacy|0
169618|NCT00534599|594347|P2|Overall Study|Developed study-specific d/c criteria|0
169619|NCT00534599|594348|P1|Overall Study|Developed study-specific d/c criteria|5
169620|NCT00534599|594347|P2|Overall Study|Mis-randomization|2
169621|NCT00534599|594348|P1|Overall Study|Mis-randomization|2
169622|NCT00534599|594347|P2|Overall Study|Incorrect enrollment|1
169623|NCT00534599|594348|P1|Overall Study|Incorrect enrollment|2
169624|NCT00534599|594347|P2|Overall Study|Adverse Event|4
169625|NCT00534599|594348|P1|Overall Study|Adverse Event|25
169626|NCT00534495|594384|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
169627|NCT00534495|594385|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
169628|NCT00534495|594386|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
169629|NCT00534495|594384|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
169630|NCT00534495|594385|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
169631|NCT00534495|594386|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
169632|NCT00534495|594384|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
169633|NCT00534495|594385|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
169634|NCT00534495|594386|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
169635|NCT00534495|594384|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
169636|NCT00534495|594385|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
169637|NCT00534495|594386|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
169638|NCT00534495|594384|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
169639|NCT00534495|594385|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
169640|NCT00534495|594386|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
169641|NCT00534495|594384|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
169642|NCT00534495|594385|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
169643|NCT00534495|594386|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
169644|NCT00534495|594384|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
169645|NCT00534495|594385|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
169646|NCT00534495|594386|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
169647|NCT00534495|594384|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
169648|NCT00534495|594385|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
169649|NCT00534495|594386|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
169650|NCT00534495|594384|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
169651|NCT00534495|594385|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
169652|NCT00534495|594386|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
169653|NCT00534404|594424|P3|Overall Study|Lost to Follow-up|201
169654|NCT00534404|594425|P2|Overall Study|Lost to Follow-up|138
169655|NCT00534404|594426|P1|Overall Study|Lost to Follow-up|170
169656|NCT00534404|594424|P3|Overall Study|Removed by study staff|1
169657|NCT00534404|594425|P2|Overall Study|Removed by study staff|3
169658|NCT00534404|594426|P1|Overall Study|Removed by study staff|2
169659|NCT00534404|594424|P3|Overall Study|Withdrawal by Subject|38
169660|NCT00534404|594425|P2|Overall Study|Withdrawal by Subject|2
169661|NCT00534404|594426|P1|Overall Study|Withdrawal by Subject|8
169662|NCT00534404|594424|P3|Overall Study|Death|2
169663|NCT00534404|594425|P2|Overall Study|Death|0
169664|NCT00534404|594426|P1|Overall Study|Death|0
169665|NCT00534352|594457|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
169666|NCT00534352|594457|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
169667|NCT00534352|594457|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
169668|NCT00534352|594457|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
169669|NCT00534352|594457|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
169670|NCT00534352|594457|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
169671|NCT00534313|594501|P4|Long-term Period|Not specified|2
169672|NCT00534313|594502|P3|Long-term Period|Not specified|2
169673|NCT00534313|594503|P2|Long-term Period|Not specified|2
169674|NCT00534313|594504|P1|Long-term Period|Not specified|1
169675|NCT00534313|594501|P4|Long-term Period|Administrative reason by sponsor|18
169676|NCT00534313|594502|P3|Long-term Period|Administrative reason by sponsor|26
169677|NCT00534313|594503|P2|Long-term Period|Administrative reason by sponsor|15
169678|NCT00534313|594504|P1|Long-term Period|Administrative reason by sponsor|17
169679|NCT00534313|594501|P4|Long-term Period|Poor compliance/noncompliance|0
169680|NCT00534313|594502|P3|Long-term Period|Poor compliance/noncompliance|1
169681|NCT00534313|594503|P2|Long-term Period|Poor compliance/noncompliance|1
169682|NCT00534313|594504|P1|Long-term Period|Poor compliance/noncompliance|0
169683|NCT00534313|594501|P4|Long-term Period|No longer meets study criteria|0
169684|NCT00534313|594502|P3|Long-term Period|No longer meets study criteria|0
169685|NCT00534313|594503|P2|Long-term Period|No longer meets study criteria|1
169686|NCT00534313|594504|P1|Long-term Period|No longer meets study criteria|0
169687|NCT00534313|594501|P4|Long-term Period|Withdrawal by Subject|0
169688|NCT00534313|594502|P3|Long-term Period|Withdrawal by Subject|0
169689|NCT00534313|594503|P2|Long-term Period|Withdrawal by Subject|2
169690|NCT00534313|594504|P1|Long-term Period|Withdrawal by Subject|2
169691|NCT00534313|594501|P4|Long-term Period|Lost to Follow-up|0
169692|NCT00534313|594502|P3|Long-term Period|Lost to Follow-up|0
169693|NCT00534313|594503|P2|Long-term Period|Lost to Follow-up|2
169694|NCT00534313|594504|P1|Long-term Period|Lost to Follow-up|1
169695|NCT00534313|594501|P4|Long-term Period|Lack of Efficacy|12
169696|NCT00534313|594502|P3|Long-term Period|Lack of Efficacy|14
169697|NCT00534313|594503|P2|Long-term Period|Lack of Efficacy|10
169698|NCT00534313|594504|P1|Long-term Period|Lack of Efficacy|14
169699|NCT00534313|594501|P4|Long-term Period|Adverse Event|1
169700|NCT00534313|594502|P3|Long-term Period|Adverse Event|0
169701|NCT00534313|594503|P2|Long-term Period|Adverse Event|1
169702|NCT00534313|594504|P1|Long-term Period|Adverse Event|2
169703|NCT00534313|594501|P4|Short-term Period|Pregnancy|0
169704|NCT00534313|594502|P3|Short-term Period|Pregnancy|1
169705|NCT00534313|594503|P2|Short-term Period|Pregnancy|0
169706|NCT00534313|594504|P1|Short-term Period|Pregnancy|0
169707|NCT00534313|594501|P4|Short-term Period|Participant withdrew consent|2
169708|NCT00534313|594502|P3|Short-term Period|Participant withdrew consent|0
169709|NCT00534313|594503|P2|Short-term Period|Participant withdrew consent|0
169710|NCT00534313|594504|P1|Short-term Period|Participant withdrew consent|2
169711|NCT00534313|594501|P4|Short-term Period|Participant not meeting study criteria|1
169712|NCT00534313|594502|P3|Short-term Period|Participant not meeting study criteria|0
169713|NCT00534313|594503|P2|Short-term Period|Participant not meeting study criteria|0
169714|NCT00534313|594504|P1|Short-term Period|Participant not meeting study criteria|0
169715|NCT00534313|594501|P4|Short-term Period|Lack of Efficacy|3
169716|NCT00534313|594502|P3|Short-term Period|Lack of Efficacy|0
169717|NCT00534313|594503|P2|Short-term Period|Lack of Efficacy|4
169718|NCT00534313|594504|P1|Short-term Period|Lack of Efficacy|3
169719|NCT00534313|594501|P4|Short-term Period|Adverse Event|3
169720|NCT00534313|594502|P3|Short-term Period|Adverse Event|1
169721|NCT00534313|594503|P2|Short-term Period|Adverse Event|2
169722|NCT00534313|594504|P1|Short-term Period|Adverse Event|1
169723|NCT00534248|594599|P2|Overall Study|Withdrawal by Subject|255
169724|NCT00534248|594600|P1|Overall Study|Withdrawal by Subject|263
169725|NCT00534248|594599|P2|Overall Study|Protocol Violation|4
169726|NCT00534248|594600|P1|Overall Study|Protocol Violation|3
169727|NCT00534248|594599|P2|Overall Study|Physician Decision|7
169728|NCT00534248|594600|P1|Overall Study|Physician Decision|10
169729|NCT00534248|594599|P2|Overall Study|Other protocol specified criteria|3
169730|NCT00534248|594600|P1|Overall Study|Other protocol specified criteria|13
169731|NCT00534248|594599|P2|Overall Study|Lost to Follow-up|375
169732|NCT00534248|594600|P1|Overall Study|Lost to Follow-up|353
169733|NCT00534248|594599|P2|Overall Study|Adverse Event|29
169734|NCT00534248|594600|P1|Overall Study|Adverse Event|19
169735|NCT00534105|594630|P2|Overall Study|Lost to Follow-up|39
169736|NCT00534105|594631|P1|Overall Study|Lost to Follow-up|23
169737|NCT00534092|594645|P2|Overall Study|personal reasons/family concerns|0
169738|NCT00534092|594646|P1|Overall Study|personal reasons/family concerns|1
169739|NCT00534092|594645|P2|Overall Study|Lost to Follow-up|0
169740|NCT00534092|594646|P1|Overall Study|Lost to Follow-up|1
169741|NCT00533949|594684|P4|Overall Study|Withdrawal by Subject|1
169742|NCT00533949|594685|P3|Overall Study|Withdrawal by Subject|1
169743|NCT00533949|594686|P2|Overall Study|Withdrawal by Subject|2
169744|NCT00533949|594687|P1|Overall Study|Withdrawal by Subject|3
169745|NCT00533949|594684|P4|Overall Study|Protocol Violation|9
169746|NCT00533949|594685|P3|Overall Study|Protocol Violation|9
169747|NCT00533949|594686|P2|Overall Study|Protocol Violation|12
169748|NCT00533949|594687|P1|Overall Study|Protocol Violation|12
169749|NCT00533897|594718|P8|Long Term Extension (LTE)|not specified|6
169750|NCT00533897|594719|P7|Long Term Extension (LTE)|not specified|1
169751|NCT00533897|594720|P6|Long Term Extension (LTE)|not specified|0
169752|NCT00533897|594721|P5|Long Term Extension (LTE)|not specified|0
169753|NCT00533897|594722|P4|Long Term Extension (LTE)|not specified|0
169754|NCT00533897|594723|P3|Long Term Extension (LTE)|not specified|0
169755|NCT00533897|594724|P2|Long Term Extension (LTE)|not specified|0
169756|NCT00533897|594725|P1|Long Term Extension (LTE)|not specified|0
169757|NCT00533897|594718|P8|Long Term Extension (LTE)|Lost to Follow-up|1
169758|NCT00533897|594719|P7|Long Term Extension (LTE)|Lost to Follow-up|1
169759|NCT00533897|594720|P6|Long Term Extension (LTE)|Lost to Follow-up|0
169760|NCT00533897|594721|P5|Long Term Extension (LTE)|Lost to Follow-up|0
169761|NCT00533897|594722|P4|Long Term Extension (LTE)|Lost to Follow-up|0
169762|NCT00533897|594723|P3|Long Term Extension (LTE)|Lost to Follow-up|0
169763|NCT00533897|594724|P2|Long Term Extension (LTE)|Lost to Follow-up|0
169764|NCT00533897|594725|P1|Long Term Extension (LTE)|Lost to Follow-up|0
169765|NCT00533897|594718|P8|Long Term Extension (LTE)|Pregnancy|2
169766|NCT00533897|594719|P7|Long Term Extension (LTE)|Pregnancy|0
169767|NCT00533897|594720|P6|Long Term Extension (LTE)|Pregnancy|0
169768|NCT00533897|594721|P5|Long Term Extension (LTE)|Pregnancy|0
169769|NCT00533897|594722|P4|Long Term Extension (LTE)|Pregnancy|0
169770|NCT00533897|594723|P3|Long Term Extension (LTE)|Pregnancy|0
169771|NCT00533897|594724|P2|Long Term Extension (LTE)|Pregnancy|0
169772|NCT00533897|594725|P1|Long Term Extension (LTE)|Pregnancy|0
169773|NCT00533897|594718|P8|Long Term Extension (LTE)|Adverse Event|5
169774|NCT00533897|594719|P7|Long Term Extension (LTE)|Adverse Event|2
169775|NCT00533897|594720|P6|Long Term Extension (LTE)|Adverse Event|0
169776|NCT00533897|594721|P5|Long Term Extension (LTE)|Adverse Event|0
169777|NCT00533897|594722|P4|Long Term Extension (LTE)|Adverse Event|0
169778|NCT00533897|594723|P3|Long Term Extension (LTE)|Adverse Event|0
169779|NCT00533897|594724|P2|Long Term Extension (LTE)|Adverse Event|0
169780|NCT00533897|594725|P1|Long Term Extension (LTE)|Adverse Event|0
169781|NCT00533897|594718|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
169782|NCT00533897|594719|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
169783|NCT00533897|594720|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
169784|NCT00533897|594721|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
169785|NCT00533897|594722|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
169786|NCT00533897|594723|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
169787|NCT00533897|594724|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
169788|NCT00533897|594725|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
169789|NCT00533897|594718|P8|Long Term Extension (LTE)|Lack of Efficacy|3
169790|NCT00533897|594719|P7|Long Term Extension (LTE)|Lack of Efficacy|5
169791|NCT00533897|594720|P6|Long Term Extension (LTE)|Lack of Efficacy|0
169792|NCT00533897|594721|P5|Long Term Extension (LTE)|Lack of Efficacy|0
169793|NCT00533897|594722|P4|Long Term Extension (LTE)|Lack of Efficacy|0
169794|NCT00533897|594723|P3|Long Term Extension (LTE)|Lack of Efficacy|0
169795|NCT00533897|594724|P2|Long Term Extension (LTE)|Lack of Efficacy|0
169796|NCT00533897|594725|P1|Long Term Extension (LTE)|Lack of Efficacy|0
169797|NCT00533897|594718|P8|Long Term Extension (LTE)|Death|3
169798|NCT00533897|594719|P7|Long Term Extension (LTE)|Death|1
169799|NCT00533897|594720|P6|Long Term Extension (LTE)|Death|0
169800|NCT00533897|594721|P5|Long Term Extension (LTE)|Death|0
169801|NCT00533897|594722|P4|Long Term Extension (LTE)|Death|0
169802|NCT00533897|594723|P3|Long Term Extension (LTE)|Death|0
169803|NCT00533897|594724|P2|Long Term Extension (LTE)|Death|0
169804|NCT00533897|594725|P1|Long Term Extension (LTE)|Death|0
169805|NCT00533897|594718|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
169806|NCT00533897|594719|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
169807|NCT00533897|594720|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
169808|NCT00533897|594721|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
169809|NCT00533897|594722|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
169810|NCT00533897|594723|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
169811|NCT00533897|594724|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
169812|NCT00533897|594725|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
169813|NCT00533897|594718|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
169814|NCT00533897|594719|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
169815|NCT00533897|594720|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
169816|NCT00533897|594721|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
169817|NCT00533897|594722|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
169818|NCT00533897|594723|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
169819|NCT00533897|594724|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
169820|NCT00533897|594725|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
169821|NCT00533897|594718|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
169822|NCT00533897|594719|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
169823|NCT00533897|594720|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
169824|NCT00533897|594721|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
169825|NCT00533897|594722|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
169826|NCT00533897|594723|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
169827|NCT00533897|594724|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
169828|NCT00533897|594725|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
169829|NCT00533897|594718|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
169830|NCT00533897|594719|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
169831|NCT00533897|594720|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
169832|NCT00533897|594721|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
169833|NCT00533897|594722|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
169834|NCT00533897|594723|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
169835|NCT00533897|594724|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
169836|NCT00533897|594725|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
169837|NCT00533897|594718|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
169838|NCT00533897|594719|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
169839|NCT00533897|594720|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
169840|NCT00533897|594721|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
169841|NCT00533897|594722|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
169842|NCT00533897|594723|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
169843|NCT00533897|594724|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
169844|NCT00533897|594725|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
169845|NCT00533897|594718|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
169846|NCT00533897|594719|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
169847|NCT00533897|594720|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
169848|NCT00533897|594721|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
169849|NCT00533897|594722|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
169850|NCT00533897|594723|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
169851|NCT00533897|594724|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
169852|NCT00533897|594725|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
169853|NCT00533897|594718|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
169854|NCT00533897|594719|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
169855|NCT00533897|594720|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
169856|NCT00533897|594721|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
169857|NCT00533897|594722|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
169858|NCT00533897|594723|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
169859|NCT00533897|594724|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
169860|NCT00533897|594725|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
169861|NCT00533897|594718|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
169862|NCT00533897|594719|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
169863|NCT00533897|594720|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
169864|NCT00533897|594721|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
169865|NCT00533897|594722|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
169866|NCT00533897|594723|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
169867|NCT00533897|594724|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
169868|NCT00533897|594725|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
169869|NCT00533897|594718|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
169870|NCT00533897|594719|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
169871|NCT00533897|594720|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
169872|NCT00533897|594721|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
169873|NCT00533897|594722|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
169874|NCT00533897|594723|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
169875|NCT00533897|594724|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
169876|NCT00533897|594725|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
169877|NCT00533897|594718|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
169878|NCT00533897|594719|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
169879|NCT00533897|594720|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
169880|NCT00533897|594721|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
169881|NCT00533897|594722|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
169882|NCT00533897|594723|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
169883|NCT00533897|594724|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
169884|NCT00533897|594725|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
169885|NCT00533897|594718|P8|Lead-in (LI) Period 1|Adverse Event|0
169886|NCT00533897|594719|P7|Lead-in (LI) Period 1|Adverse Event|0
169887|NCT00533897|594720|P6|Lead-in (LI) Period 1|Adverse Event|0
169888|NCT00533897|594721|P5|Lead-in (LI) Period 1|Adverse Event|0
169889|NCT00533897|594722|P4|Lead-in (LI) Period 1|Adverse Event|0
169890|NCT00533897|594723|P3|Lead-in (LI) Period 1|Adverse Event|0
169891|NCT00533897|594724|P2|Lead-in (LI) Period 1|Adverse Event|0
169892|NCT00533897|594725|P1|Lead-in (LI) Period 1|Adverse Event|1
169893|NCT00533702|594865|P2|Overall Study|Found ineligible after randomization|1
169894|NCT00533702|594866|P1|Overall Study|Found ineligible after randomization|2
169895|NCT00533702|594865|P2|Overall Study|Withdrawal by Subject|1
169896|NCT00533702|594866|P1|Overall Study|Withdrawal by Subject|3
169897|NCT00533507|594897|P1|Overall Study|Withdrawal by Subject|1
169898|NCT00533273|594942|P2|Open-label|Withdrawal by Subject|0
169899|NCT00533273|594943|P1|Open-label|Withdrawal by Subject|6
169900|NCT00533273|594942|P2|Double-blind|Withdrew consent|2
169901|NCT00533273|594943|P1|Double-blind|Withdrew consent|0
169902|NCT00532948|594992|P3|Overall Study|Failure to return|0
169903|NCT00532948|594993|P2|Overall Study|Failure to return|1
169904|NCT00532948|594994|P1|Overall Study|Failure to return|0
169905|NCT00532948|594992|P3|Overall Study|Violation of selection criteria at entry|0
169906|NCT00532948|594993|P2|Overall Study|Violation of selection criteria at entry|1
169907|NCT00532948|594994|P1|Overall Study|Violation of selection criteria at entry|0
169908|NCT00532948|594992|P3|Overall Study|Death|4
169909|NCT00532948|594993|P2|Overall Study|Death|3
169910|NCT00532948|594994|P1|Overall Study|Death|3
169911|NCT00532948|594992|P3|Overall Study|Protocol Violation|0
169912|NCT00532948|594993|P2|Overall Study|Protocol Violation|0
169913|NCT00532948|594994|P1|Overall Study|Protocol Violation|1
169914|NCT00532935|595026|P2|Overall Study|Protocol Specific Criteria|15
169915|NCT00532935|595027|P1|Overall Study|Protocol Specific Criteria|11
169916|NCT00532935|595026|P2|Overall Study|Withdrawal by Subject|9
169917|NCT00532935|595027|P1|Overall Study|Withdrawal by Subject|10
169918|NCT00532935|595026|P2|Overall Study|Protocol Violation|2
169919|NCT00532935|595027|P1|Overall Study|Protocol Violation|4
169920|NCT00532935|595026|P2|Overall Study|Pregnancy|0
169921|NCT00532935|595027|P1|Overall Study|Pregnancy|1
169922|NCT00532935|595026|P2|Overall Study|Physician Decision|5
169923|NCT00532935|595027|P1|Overall Study|Physician Decision|4
169924|NCT00532935|595026|P2|Overall Study|Lost to Follow-up|6
169925|NCT00532935|595027|P1|Overall Study|Lost to Follow-up|10
169926|NCT00532935|595026|P2|Overall Study|Lack of Efficacy|3
169927|NCT00532935|595027|P1|Overall Study|Lack of Efficacy|0
169928|NCT00532935|595026|P2|Overall Study|Adverse Event|12
169929|NCT00532935|595027|P1|Overall Study|Adverse Event|11
169930|NCT00532883|595045|P4|Overall Study|Early Study Termination|4
169931|NCT00532883|595046|P3|Overall Study|Early Study Termination|1
169932|NCT00532883|595047|P2|Overall Study|Early Study Termination|4
169933|NCT00532883|595048|P1|Overall Study|Early Study Termination|4
169934|NCT00532883|595045|P4|Overall Study|Subject was Nonadherent|0
169935|NCT00532883|595046|P3|Overall Study|Subject was Nonadherent|1
169936|NCT00532883|595047|P2|Overall Study|Subject was Nonadherent|1
169937|NCT00532883|595048|P1|Overall Study|Subject was Nonadherent|0
169938|NCT00532883|595045|P4|Overall Study|Withdrawal by Subject|0
169939|NCT00532883|595046|P3|Overall Study|Withdrawal by Subject|1
169940|NCT00532883|595047|P2|Overall Study|Withdrawal by Subject|1
169941|NCT00532883|595048|P1|Overall Study|Withdrawal by Subject|0
169942|NCT00532883|595045|P4|Overall Study|Lost to Follow-up|0
169943|NCT00532883|595046|P3|Overall Study|Lost to Follow-up|1
169944|NCT00532883|595047|P2|Overall Study|Lost to Follow-up|1
169945|NCT00532883|595048|P1|Overall Study|Lost to Follow-up|1
169946|NCT00532883|595045|P4|Overall Study|Adverse Event|1
169947|NCT00532883|595046|P3|Overall Study|Adverse Event|0
169948|NCT00532883|595047|P2|Overall Study|Adverse Event|0
169949|NCT00532883|595048|P1|Overall Study|Adverse Event|1
169950|NCT00532779|595061|P3|Overall Study|Drug noncompliance, moved, other|29
169951|NCT00532779|595062|P2|Overall Study|Drug noncompliance, moved, other|23
169952|NCT00532779|595063|P1|Overall Study|Drug noncompliance, moved, other|14
169953|NCT00532779|595061|P3|Overall Study|Death|0
169954|NCT00532779|595062|P2|Overall Study|Death|1
169955|NCT00532779|595063|P1|Overall Study|Death|0
169956|NCT00532779|595061|P3|Overall Study|Pregnancy|3
169957|NCT00532779|595062|P2|Overall Study|Pregnancy|5
169958|NCT00532779|595063|P1|Overall Study|Pregnancy|2
169959|NCT00532779|595061|P3|Overall Study|Protocol Violation|7
169960|NCT00532779|595062|P2|Overall Study|Protocol Violation|9
169961|NCT00532779|595063|P1|Overall Study|Protocol Violation|5
169962|NCT00532779|595061|P3|Overall Study|Lack of Efficacy|40
169963|NCT00532779|595062|P2|Overall Study|Lack of Efficacy|12
169964|NCT00532779|595063|P1|Overall Study|Lack of Efficacy|12
169965|NCT00532779|595061|P3|Overall Study|Withdrawal by Subject|90
169966|NCT00532779|595062|P2|Overall Study|Withdrawal by Subject|60
169967|NCT00532779|595063|P1|Overall Study|Withdrawal by Subject|63
169968|NCT00532779|595061|P3|Overall Study|Lost to Follow-up|66
169969|NCT00532779|595062|P2|Overall Study|Lost to Follow-up|65
169970|NCT00532779|595063|P1|Overall Study|Lost to Follow-up|76
169971|NCT00532779|595061|P3|Overall Study|Adverse Event|56
169972|NCT00532779|595062|P2|Overall Study|Adverse Event|112
169973|NCT00532779|595063|P1|Overall Study|Adverse Event|122
169974|NCT00532493|595124|P2|Overall Study|Contraindicative Medication|0
169975|NCT00532493|595125|P1|Overall Study|Contraindicative Medication|1
169976|NCT00532493|595124|P2|Overall Study|Subject Moved Away|1
169977|NCT00532493|595125|P1|Overall Study|Subject Moved Away|3
169978|NCT00532493|595124|P2|Overall Study|Protocol Deviation|0
169979|NCT00532493|595125|P1|Overall Study|Protocol Deviation|1
169980|NCT00532493|595124|P2|Overall Study|Adverse Event|5
169981|NCT00532493|595125|P1|Overall Study|Adverse Event|6
169982|NCT00532493|595124|P2|Overall Study|Physician Decision|6
169983|NCT00532493|595125|P1|Overall Study|Physician Decision|1
169984|NCT00532493|595124|P2|Overall Study|Withdrawal by Subject|9
169985|NCT00532493|595125|P1|Overall Study|Withdrawal by Subject|7
169986|NCT00532493|595124|P2|Overall Study|Lost to Follow-up|7
169987|NCT00532493|595125|P1|Overall Study|Lost to Follow-up|10
169988|NCT00532493|595124|P2|Overall Study|Death|1
169989|NCT00532493|595125|P1|Overall Study|Death|1
169990|NCT00532441|595159|P2|Overall Study|Death|0
169991|NCT00532441|595160|P1|Overall Study|Death|1
169992|NCT00532298|595175|P6|Overall Study|Lost to Follow-up|1
169993|NCT00532298|595176|P5|Overall Study|Lost to Follow-up|0
169994|NCT00532298|595177|P4|Overall Study|Lost to Follow-up|0
169995|NCT00532298|595178|P3|Overall Study|Lost to Follow-up|1
169996|NCT00532298|595179|P2|Overall Study|Lost to Follow-up|1
169997|NCT00532298|595180|P1|Overall Study|Lost to Follow-up|1
169998|NCT00532298|595175|P6|Overall Study|Adverse Event|1
169999|NCT00532298|595176|P5|Overall Study|Adverse Event|1
170000|NCT00532298|595177|P4|Overall Study|Adverse Event|0
170001|NCT00532298|595178|P3|Overall Study|Adverse Event|0
170002|NCT00532298|595179|P2|Overall Study|Adverse Event|0
170003|NCT00532298|595180|P1|Overall Study|Adverse Event|1
170004|NCT00532259|595260|P1|Overall Study|Protocol Violation|1
170005|NCT00532259|595260|P1|Overall Study|Physician Decision|3
170006|NCT00532259|595260|P1|Overall Study|Lost to Follow-up|3
170007|NCT00532259|595260|P1|Overall Study|Lack of Efficacy|21
170008|NCT00532259|595260|P1|Overall Study|Death|1
170009|NCT00532259|595260|P1|Overall Study|Adverse Event|1
170010|NCT00532259|595260|P1|Overall Study|Withdrawal by Subject|2
170011|NCT00532155|595267|P2|Overall Study|Did not receive study medication|6
170012|NCT00532155|595268|P1|Overall Study|Did not receive study medication|2
170013|NCT00532155|595267|P2|Overall Study|Study termination stop further treatment|0
170014|NCT00532155|595268|P1|Overall Study|Study termination stop further treatment|4
170015|NCT00532155|595267|P2|Overall Study|Study terminated by sponsor|0
170016|NCT00532155|595268|P1|Overall Study|Study terminated by sponsor|1
170017|NCT00532155|595267|P2|Overall Study|Study stopped|0
170018|NCT00532155|595268|P1|Overall Study|Study stopped|1
170019|NCT00532155|595267|P2|Overall Study|Had brain metastasis, was mis-randomized|0
170020|NCT00532155|595268|P1|Overall Study|Had brain metastasis, was mis-randomized|1
170021|NCT00532155|595267|P2|Overall Study|Progressive disease (by incorrect scan)|1
170022|NCT00532155|595268|P1|Overall Study|Progressive disease (by incorrect scan)|0
170023|NCT00532155|595267|P2|Overall Study|Promotor ended study|0
170024|NCT00532155|595268|P1|Overall Study|Promotor ended study|1
170025|NCT00532155|595267|P2|Overall Study|Occurence of a secondary cancer|1
170026|NCT00532155|595268|P1|Overall Study|Occurence of a secondary cancer|0
170027|NCT00532155|595267|P2|Overall Study|Occurence of a second cancer|1
170028|NCT00532155|595268|P1|Overall Study|Occurence of a second cancer|0
170029|NCT00532155|595267|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
170030|NCT00532155|595268|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
170031|NCT00532155|595267|P2|Overall Study|Moved|0
170032|NCT00532155|595268|P1|Overall Study|Moved|1
170033|NCT00532155|595267|P2|Overall Study|Consent withdrawn|7
170034|NCT00532155|595268|P1|Overall Study|Consent withdrawn|5
170035|NCT00532155|595267|P2|Overall Study|Withdrawal by Subject|44
170036|NCT00532155|595268|P1|Overall Study|Withdrawal by Subject|23
170037|NCT00532155|595267|P2|Overall Study|Physician Decision|15
170038|NCT00532155|595268|P1|Overall Study|Physician Decision|16
170039|NCT00532155|595267|P2|Overall Study|Lost to Follow-up|0
170040|NCT00532155|595268|P1|Overall Study|Lost to Follow-up|2
170041|NCT00532155|595267|P2|Overall Study|Protocol Violation|3
170042|NCT00532155|595268|P1|Overall Study|Protocol Violation|1
170043|NCT00532155|595267|P2|Overall Study|Lack of Efficacy|255
170044|NCT00532155|595268|P1|Overall Study|Lack of Efficacy|332
170045|NCT00532155|595267|P2|Overall Study|Adverse Event|123
170046|NCT00532155|595268|P1|Overall Study|Adverse Event|66
170047|NCT00532129|595282|P1|Follow-up Period|Other|6
170048|NCT00532129|595282|P1|Follow-up Period|Lost to Follow-up|1
170049|NCT00532129|595282|P1|Follow-up Period|Disease progression|57
170050|NCT00532129|595282|P1|Follow-up Period|Adverse event/Serious adverse event|1
170051|NCT00532129|595282|P1|Treatment Period|Other|5
170052|NCT00532129|595282|P1|Treatment Period|Protocol Violation|1
170053|NCT00532129|595282|P1|Treatment Period|Disease progression|3
170054|NCT00532129|595282|P1|Treatment Period|Physician Decision|15
170055|NCT00532129|595282|P1|Treatment Period|Adverse event/Serious adverse event|25
170056|NCT00531960|595302|P2|Overall Study|Not Specified|10
170057|NCT00531960|595303|P1|Overall Study|Not Specified|4
170058|NCT00531960|595302|P2|Overall Study|Refused Treatment|6
170059|NCT00531960|595303|P1|Overall Study|Refused Treatment|5
170060|NCT00531960|595302|P2|Overall Study|Violation of Selection Criteria|0
170061|NCT00531960|595303|P1|Overall Study|Violation of Selection Criteria|2
170062|NCT00531960|595302|P2|Overall Study|Lack of Efficacy|41
170063|NCT00531960|595303|P1|Overall Study|Lack of Efficacy|42
170064|NCT00531960|595302|P2|Overall Study|Death|2
170065|NCT00531960|595303|P1|Overall Study|Death|3
170066|NCT00531960|595302|P2|Overall Study|Adverse Event|4
170067|NCT00531960|595303|P1|Overall Study|Adverse Event|5
170068|NCT00531947|595321|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
170069|NCT00531947|595322|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
170070|NCT00531947|595321|P2|Overall Study|Non-Compliance|7
170071|NCT00531947|595322|P1|Overall Study|Non-Compliance|4
170072|NCT00531947|595321|P2|Overall Study|Protocol Violation|1
170073|NCT00531947|595322|P1|Overall Study|Protocol Violation|2
170074|NCT00531947|595321|P2|Overall Study|Withdrawal by Subject|19
170075|NCT00531947|595322|P1|Overall Study|Withdrawal by Subject|14
170076|NCT00531947|595321|P2|Overall Study|Lost to Follow-up|9
170077|NCT00531947|595322|P1|Overall Study|Lost to Follow-up|12
170078|NCT00531947|595321|P2|Overall Study|Adverse Event|10
170079|NCT00531947|595322|P1|Overall Study|Adverse Event|5
170080|NCT00531934|595366|P2|Overall Study|Not specified|2
170081|NCT00531934|595367|P1|Overall Study|Not specified|2
170082|NCT00531934|595366|P2|Overall Study|Withdrawal by Subject|1
170083|NCT00531934|595367|P1|Overall Study|Withdrawal by Subject|1
170084|NCT00531934|595366|P2|Overall Study|Death|10
170085|NCT00531934|595367|P1|Overall Study|Death|7
170086|NCT00531934|595366|P2|Overall Study|Progression|42
170087|NCT00531934|595367|P1|Overall Study|Progression|52
170088|NCT00531934|595366|P2|Overall Study|Adverse Event|8
170089|NCT00531934|595367|P1|Overall Study|Adverse Event|4
170090|NCT00531752|595495|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
170091|NCT00531752|595496|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
170092|NCT00531752|595497|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
170093|NCT00531752|595498|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
170094|NCT00531752|595495|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
170095|NCT00531752|595496|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
170096|NCT00531752|595497|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
170097|NCT00531752|595498|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
170098|NCT00531752|595495|P4|Second Double-blind Intervention Period|Other|0
170099|NCT00531752|595496|P3|Second Double-blind Intervention Period|Other|0
170100|NCT00531752|595497|P2|Second Double-blind Intervention Period|Other|1
170101|NCT00531752|595498|P1|Second Double-blind Intervention Period|Other|1
170102|NCT00531752|595495|P4|Second Double-blind Intervention Period|Adverse Event|0
170103|NCT00531752|595496|P3|Second Double-blind Intervention Period|Adverse Event|0
170104|NCT00531752|595497|P2|Second Double-blind Intervention Period|Adverse Event|1
170105|NCT00531752|595498|P1|Second Double-blind Intervention Period|Adverse Event|1
170106|NCT00531752|595495|P4|First Double-blind Intervention Period|Randomized but not treated|0
170107|NCT00531752|595496|P3|First Double-blind Intervention Period|Randomized but not treated|0
170108|NCT00531752|595497|P2|First Double-blind Intervention Period|Randomized but not treated|0
170109|NCT00531752|595498|P1|First Double-blind Intervention Period|Randomized but not treated|1
170110|NCT00531752|595495|P4|First Double-blind Intervention Period|Lost to Follow-up|1
170111|NCT00531752|595496|P3|First Double-blind Intervention Period|Lost to Follow-up|1
170112|NCT00531752|595497|P2|First Double-blind Intervention Period|Lost to Follow-up|0
170113|NCT00531752|595498|P1|First Double-blind Intervention Period|Lost to Follow-up|0
170114|NCT00531752|595495|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
170115|NCT00531752|595496|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
170116|NCT00531752|595497|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
170117|NCT00531752|595498|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
170118|NCT00531752|595495|P4|First Double-blind Intervention Period|Other|0
170119|NCT00531752|595496|P3|First Double-blind Intervention Period|Other|4
170120|NCT00531752|595497|P2|First Double-blind Intervention Period|Other|4
170121|NCT00531752|595498|P1|First Double-blind Intervention Period|Other|1
170122|NCT00531752|595495|P4|First Double-blind Intervention Period|Adverse Event|1
170123|NCT00531752|595496|P3|First Double-blind Intervention Period|Adverse Event|1
170124|NCT00531752|595497|P2|First Double-blind Intervention Period|Adverse Event|0
170125|NCT00531752|595498|P1|First Double-blind Intervention Period|Adverse Event|2
170126|NCT00531479|595609|P2|Overall Study|Did not receive treatment|3
170127|NCT00531479|595610|P1|Overall Study|Did not receive treatment|2
170128|NCT00531479|595609|P2|Overall Study|Withdrawal by Subject|6
170129|NCT00531479|595610|P1|Overall Study|Withdrawal by Subject|6
170130|NCT00531479|595609|P2|Overall Study|Other|1
170131|NCT00531479|595610|P1|Overall Study|Other|0
170132|NCT00531479|595609|P2|Overall Study|Lost to Follow-up|2
170133|NCT00531479|595610|P1|Overall Study|Lost to Follow-up|0
170134|NCT00531479|595609|P2|Overall Study|Death|71
170135|NCT00531479|595610|P1|Overall Study|Death|68
170136|NCT00531427|595641|P2|Overall Study|Administrative|9
170137|NCT00531427|595642|P1|Overall Study|Administrative|4
170138|NCT00531427|595641|P2|Overall Study|Lack of Efficacy|39
170139|NCT00531427|595642|P1|Overall Study|Lack of Efficacy|14
170140|NCT00531427|595641|P2|Overall Study|Lost to Follow-up|3
170141|NCT00531427|595642|P1|Overall Study|Lost to Follow-up|4
170142|NCT00531427|595641|P2|Overall Study|Adverse Event|30
170143|NCT00531427|595642|P1|Overall Study|Adverse Event|44
170144|NCT00531427|595641|P2|Overall Study|Withdrawal by Subject|13
170145|NCT00531427|595642|P1|Overall Study|Withdrawal by Subject|7
170146|NCT00531284|595670|P17|Overall Study|Other|0
170147|NCT00531284|595671|P16|Overall Study|Other|0
170148|NCT00531284|595672|P15|Overall Study|Other|1
170149|NCT00531284|595673|P14|Overall Study|Other|0
170150|NCT00531284|595674|P13|Overall Study|Other|0
170151|NCT00531284|595675|P12|Overall Study|Other|2
170152|NCT00531284|595676|P11|Overall Study|Other|0
170153|NCT00531284|595677|P10|Overall Study|Other|1
170154|NCT00531284|595678|P9|Overall Study|Other|2
170155|NCT00531284|595679|P8|Overall Study|Other|0
170156|NCT00531284|595680|P7|Overall Study|Other|0
170157|NCT00531284|595681|P6|Overall Study|Other|1
170158|NCT00531284|595682|P5|Overall Study|Other|2
170159|NCT00531284|595683|P4|Overall Study|Other|10
170160|NCT00531284|595684|P3|Overall Study|Other|0
170161|NCT00531284|595685|P2|Overall Study|Other|0
170162|NCT00531284|595686|P1|Overall Study|Other|1
170163|NCT00531284|595670|P17|Overall Study|Withdrawal by Subject|1
170164|NCT00531284|595671|P16|Overall Study|Withdrawal by Subject|1
170165|NCT00531284|595672|P15|Overall Study|Withdrawal by Subject|0
170166|NCT00531284|595673|P14|Overall Study|Withdrawal by Subject|1
170167|NCT00531284|595674|P13|Overall Study|Withdrawal by Subject|0
170168|NCT00531284|595675|P12|Overall Study|Withdrawal by Subject|3
170169|NCT00531284|595676|P11|Overall Study|Withdrawal by Subject|0
170170|NCT00531284|595677|P10|Overall Study|Withdrawal by Subject|0
170171|NCT00531284|595678|P9|Overall Study|Withdrawal by Subject|0
170172|NCT00531284|595679|P8|Overall Study|Withdrawal by Subject|0
170173|NCT00531284|595680|P7|Overall Study|Withdrawal by Subject|0
170174|NCT00531284|595681|P6|Overall Study|Withdrawal by Subject|0
170175|NCT00531284|595682|P5|Overall Study|Withdrawal by Subject|0
170176|NCT00531284|595683|P4|Overall Study|Withdrawal by Subject|4
170177|NCT00531284|595684|P3|Overall Study|Withdrawal by Subject|0
170178|NCT00531284|595685|P2|Overall Study|Withdrawal by Subject|0
170179|NCT00531284|595686|P1|Overall Study|Withdrawal by Subject|1
170180|NCT00531284|595670|P17|Overall Study|Adverse Event|2
170181|NCT00531284|595671|P16|Overall Study|Adverse Event|0
170182|NCT00531284|595672|P15|Overall Study|Adverse Event|1
170183|NCT00531284|595673|P14|Overall Study|Adverse Event|1
170184|NCT00531284|595674|P13|Overall Study|Adverse Event|0
170185|NCT00531284|595675|P12|Overall Study|Adverse Event|5
170186|NCT00531284|595676|P11|Overall Study|Adverse Event|0
170187|NCT00531284|595677|P10|Overall Study|Adverse Event|0
170188|NCT00531284|595678|P9|Overall Study|Adverse Event|3
170189|NCT00531284|595679|P8|Overall Study|Adverse Event|2
170190|NCT00531284|595680|P7|Overall Study|Adverse Event|3
170191|NCT00531284|595681|P6|Overall Study|Adverse Event|2
170192|NCT00531284|595682|P5|Overall Study|Adverse Event|0
170193|NCT00531284|595683|P4|Overall Study|Adverse Event|7
170194|NCT00531284|595684|P3|Overall Study|Adverse Event|1
170195|NCT00531284|595685|P2|Overall Study|Adverse Event|1
170196|NCT00531284|595686|P1|Overall Study|Adverse Event|0
170197|NCT00531284|595670|P17|Overall Study|Progressive Disease|5
170198|NCT00531284|595671|P16|Overall Study|Progressive Disease|11
170199|NCT00531284|595672|P15|Overall Study|Progressive Disease|2
170200|NCT00531284|595673|P14|Overall Study|Progressive Disease|1
170201|NCT00531284|595674|P13|Overall Study|Progressive Disease|2
170202|NCT00531284|595675|P12|Overall Study|Progressive Disease|14
170203|NCT00531284|595676|P11|Overall Study|Progressive Disease|3
170204|NCT00531284|595677|P10|Overall Study|Progressive Disease|3
170205|NCT00531284|595678|P9|Overall Study|Progressive Disease|6
170206|NCT00531284|595679|P8|Overall Study|Progressive Disease|8
170207|NCT00531284|595680|P7|Overall Study|Progressive Disease|3
170208|NCT00531284|595681|P6|Overall Study|Progressive Disease|4
170209|NCT00531284|595682|P5|Overall Study|Progressive Disease|4
170210|NCT00531284|595683|P4|Overall Study|Progressive Disease|42
170211|NCT00531284|595684|P3|Overall Study|Progressive Disease|5
170212|NCT00531284|595685|P2|Overall Study|Progressive Disease|3
170213|NCT00531284|595686|P1|Overall Study|Progressive Disease|1
170214|NCT00531206|595836|P1|Overall Study|including non-related adverse events|8
170215|NCT00531206|595836|P1|Overall Study|Lost to Follow-up|5
170216|NCT00531206|595836|P1|Overall Study|Lack of Efficacy|2
170217|NCT00531206|595836|P1|Overall Study|Adverse Event related|5
170218|NCT00531050|595866|P6|Part 2: Period 3|Abnormal test procedure|1
170219|NCT00531050|595867|P5|Part 2: Period 3|Abnormal test procedure|0
170220|NCT00531050|595868|P4|Part 2: Period 3|Abnormal test procedure|0
170221|NCT00531050|595869|P3|Part 2: Period 3|Abnormal test procedure|0
170222|NCT00531050|595870|P2|Part 2: Period 3|Abnormal test procedure|0
170223|NCT00531050|595871|P1|Part 2: Period 3|Abnormal test procedure|1
170224|NCT00531050|595866|P6|Part 2: Period 1|Adverse Event|1
170225|NCT00531050|595867|P5|Part 2: Period 1|Adverse Event|0
170226|NCT00531050|595868|P4|Part 2: Period 1|Adverse Event|0
170227|NCT00531050|595869|P3|Part 2: Period 1|Adverse Event|0
170228|NCT00531050|595870|P2|Part 2: Period 1|Adverse Event|0
170229|NCT00531050|595871|P1|Part 2: Period 1|Adverse Event|0
170230|NCT00531050|595866|P6|Part 1: Period 3|Adverse Event|0
170231|NCT00531050|595867|P5|Part 1: Period 3|Adverse Event|0
170232|NCT00531050|595868|P4|Part 1: Period 3|Adverse Event|0
170233|NCT00531050|595869|P3|Part 1: Period 3|Adverse Event|0
170234|NCT00531050|595870|P2|Part 1: Period 3|Adverse Event|0
170235|NCT00531050|595871|P1|Part 1: Period 3|Adverse Event|1
170236|NCT00531050|595866|P6|Part 1: Period 1|Protocol Deviation|0
170237|NCT00531050|595867|P5|Part 1: Period 1|Protocol Deviation|0
170238|NCT00531050|595868|P4|Part 1: Period 1|Protocol Deviation|1
170239|NCT00531050|595869|P3|Part 1: Period 1|Protocol Deviation|0
170240|NCT00531050|595870|P2|Part 1: Period 1|Protocol Deviation|0
170241|NCT00531050|595871|P1|Part 1: Period 1|Protocol Deviation|0
170242|NCT00531050|595866|P6|Part 1: Period 1|Adverse Event|0
170243|NCT00531050|595867|P5|Part 1: Period 1|Adverse Event|0
170244|NCT00531050|595868|P4|Part 1: Period 1|Adverse Event|0
170245|NCT00531050|595869|P3|Part 1: Period 1|Adverse Event|0
170246|NCT00531050|595870|P2|Part 1: Period 1|Adverse Event|1
170247|NCT00531050|595871|P1|Part 1: Period 1|Adverse Event|0
170248|NCT00531011|595900|P2|Overall Study|Physician Decision|3
170249|NCT00531011|595901|P1|Overall Study|Physician Decision|0
170250|NCT00531011|595900|P2|Overall Study|Lost to Follow-up|0
170251|NCT00531011|595901|P1|Overall Study|Lost to Follow-up|1
170252|NCT00531011|595900|P2|Overall Study|Death|0
170253|NCT00531011|595901|P1|Overall Study|Death|1
170254|NCT00531011|595900|P2|Overall Study|Withdrawal by Subject|4
170255|NCT00531011|595901|P1|Overall Study|Withdrawal by Subject|2
170256|NCT00530946|595947|P4|Overall Study|Noncompliance|0
170257|NCT00530946|595948|P3|Overall Study|Noncompliance|0
170258|NCT00530946|595949|P2|Overall Study|Noncompliance|0
170259|NCT00530946|595950|P1|Overall Study|Noncompliance|1
170260|NCT00530946|595947|P4|Overall Study|Protocol Violation|1
170261|NCT00530946|595948|P3|Overall Study|Protocol Violation|0
170262|NCT00530946|595949|P2|Overall Study|Protocol Violation|0
170263|NCT00530946|595950|P1|Overall Study|Protocol Violation|0
170264|NCT00530946|595947|P4|Overall Study|Adverse Event|1
170265|NCT00530946|595948|P3|Overall Study|Adverse Event|1
170266|NCT00530946|595949|P2|Overall Study|Adverse Event|2
170267|NCT00530946|595950|P1|Overall Study|Adverse Event|1
170268|NCT00530920|596003|P3|Overall Study|Withdrawal by Subject|1
170269|NCT00530920|596004|P2|Overall Study|Withdrawal by Subject|0
170270|NCT00530920|596005|P1|Overall Study|Withdrawal by Subject|0
170271|NCT00530920|596003|P3|Overall Study|Adverse Event|3
170272|NCT00530920|596004|P2|Overall Study|Adverse Event|0
170273|NCT00530920|596005|P1|Overall Study|Adverse Event|0
170274|NCT00530920|596003|P3|Overall Study|Randomized but not treated|0
170275|NCT00530920|596004|P2|Overall Study|Randomized but not treated|2
170276|NCT00530920|596005|P1|Overall Study|Randomized but not treated|0
170277|NCT00530894|596065|P4|Overall Study|Alive and censored prior to 1 year|0
170278|NCT00530894|596066|P3|Overall Study|Alive and censored prior to 1 year|0
170279|NCT00530894|596067|P2|Overall Study|Alive and censored prior to 1 year|0
170280|NCT00530894|596068|P1|Overall Study|Alive and censored prior to 1 year|2
170281|NCT00530894|596065|P4|Overall Study|Withdrawal by Subject|5
170282|NCT00530894|596066|P3|Overall Study|Withdrawal by Subject|0
170283|NCT00530894|596067|P2|Overall Study|Withdrawal by Subject|23
170284|NCT00530894|596068|P1|Overall Study|Withdrawal by Subject|1
170285|NCT00530894|596065|P4|Overall Study|Lost to Follow-up|0
170286|NCT00530894|596066|P3|Overall Study|Lost to Follow-up|0
170287|NCT00530894|596067|P2|Overall Study|Lost to Follow-up|3
170288|NCT00530894|596068|P1|Overall Study|Lost to Follow-up|1
170289|NCT00530894|596065|P4|Overall Study|Death|89
170290|NCT00530894|596066|P3|Overall Study|Death|55
170291|NCT00530894|596067|P2|Overall Study|Death|89
170292|NCT00530894|596068|P1|Overall Study|Death|84
170293|NCT00530855|596096|P1|Overall Study|Other reason for premature termination|17
170294|NCT00530855|596096|P1|Overall Study|Lost to Follow-up|9
170295|NCT00530855|596096|P1|Overall Study|Unsatisfactory compliance of subject|11
170296|NCT00530855|596096|P1|Overall Study|Protocol Violation|3
170297|NCT00530855|596096|P1|Overall Study|Non Fatal Non Serious AE|12
170298|NCT00530855|596096|P1|Overall Study|Non Fatal Serious AE|7
170299|NCT00530855|596096|P1|Overall Study|Fatal Serious AE|3
170300|NCT00530855|596096|P1|Overall Study|Withdrawal by Subject|30
170301|NCT00530855|596096|P1|Overall Study|Lack of Efficacy|20
170302|NCT00530842|596105|P2|Period 2|Individual different reasons|0
170303|NCT00530842|596106|P1|Period 2|Individual different reasons|2
170304|NCT00530842|596105|P2|Period 2|Withdrawal by Subject|2
170305|NCT00530842|596106|P1|Period 2|Withdrawal by Subject|1
170306|NCT00530842|596105|P2|Period 2|Protocol Violation|0
170307|NCT00530842|596106|P1|Period 2|Protocol Violation|1
170308|NCT00530842|596105|P2|Period 2|Lost to Follow-up|4
170309|NCT00530842|596106|P1|Period 2|Lost to Follow-up|0
170310|NCT00530842|596105|P2|Period 2|Lack of Efficacy|0
170311|NCT00530842|596106|P1|Period 2|Lack of Efficacy|1
170312|NCT00530842|596105|P2|Period 2|Adverse Event|3
170313|NCT00530842|596106|P1|Period 2|Adverse Event|3
170314|NCT00530842|596105|P2|Period 1|Individual different reasons|3
170315|NCT00530842|596106|P1|Period 1|Individual different reasons|2
170316|NCT00530842|596105|P2|Period 1|Withdrawal by Subject|3
170317|NCT00530842|596106|P1|Period 1|Withdrawal by Subject|2
170318|NCT00530842|596105|P2|Period 1|Protocol Violation|1
170319|NCT00530842|596106|P1|Period 1|Protocol Violation|2
170320|NCT00530842|596105|P2|Period 1|Lack of Efficacy|1
170321|NCT00530842|596106|P1|Period 1|Lack of Efficacy|1
170322|NCT00530842|596105|P2|Period 1|Adverse Event|3
170323|NCT00530842|596106|P1|Period 1|Adverse Event|7
170324|NCT00530842|596105|P2|Overall Study|Individual different reasons|3
170325|NCT00530842|596106|P1|Overall Study|Individual different reasons|4
170326|NCT00530842|596105|P2|Overall Study|Withdrawal by Subject|5
170327|NCT00530842|596106|P1|Overall Study|Withdrawal by Subject|4
170328|NCT00530842|596105|P2|Overall Study|Protocol Violation|2
170329|NCT00530842|596106|P1|Overall Study|Protocol Violation|3
170330|NCT00530842|596105|P2|Overall Study|Lost to Follow-up|4
170331|NCT00530842|596106|P1|Overall Study|Lost to Follow-up|0
170332|NCT00530842|596105|P2|Overall Study|Lack of Efficacy|1
170333|NCT00530842|596106|P1|Overall Study|Lack of Efficacy|2
170334|NCT00530842|596105|P2|Overall Study|Adverse Event|6
170335|NCT00530842|596106|P1|Overall Study|Adverse Event|10
170336|NCT00530816|596233|P3|Overall Study|Withdrawal by Subject|6
170337|NCT00530816|596234|P2|Overall Study|Withdrawal by Subject|2
170338|NCT00530816|596235|P1|Overall Study|Withdrawal by Subject|1
170339|NCT00530816|596233|P3|Overall Study|Other|4
170340|NCT00530816|596234|P2|Overall Study|Other|3
170341|NCT00530816|596235|P1|Overall Study|Other|3
170342|NCT00530816|596233|P3|Overall Study|Adverse Event|7
170343|NCT00530816|596234|P2|Overall Study|Adverse Event|13
170344|NCT00530816|596235|P1|Overall Study|Adverse Event|6
170345|NCT00530816|596233|P3|Overall Study|Progressive Disease|24
170346|NCT00530816|596234|P2|Overall Study|Progressive Disease|24
170347|NCT00530816|596235|P1|Overall Study|Progressive Disease|16
170348|NCT00530790|596261|P1|Overall Study|Physician Decision|1
170349|NCT00530790|596261|P1|Overall Study|Withdrawal by Subject|2
170350|NCT00530790|596261|P1|Overall Study|Adverse Event|2
170351|NCT00530777|596283|P2|Overall Study|Unable to adhere to visit schedule|1
170352|NCT00530777|596284|P1|Overall Study|Unable to adhere to visit schedule|5
170353|NCT00530777|596283|P2|Overall Study|Withdrawal by Subject|1
170354|NCT00530777|596284|P1|Overall Study|Withdrawal by Subject|0
170355|NCT00530777|596283|P2|Overall Study|Physician Decision|0
170356|NCT00530777|596284|P1|Overall Study|Physician Decision|1
170357|NCT00530777|596283|P2|Overall Study|Death|2
170358|NCT00530777|596284|P1|Overall Study|Death|1
170359|NCT00530777|596283|P2|Overall Study|Lost to Follow-up|1
170360|NCT00530777|596284|P1|Overall Study|Lost to Follow-up|0
170361|NCT00530712|596341|P1|12 Month Follow-up Visit|Death|9
170362|NCT00530712|596341|P1|12 Month Follow-up Visit|Lost to Follow-up|7
170363|NCT00530712|596341|P1|12 Month Follow-up Visit|Missed Visit|3
170364|NCT00530712|596341|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
170365|NCT00530712|596341|P1|6 Month Follow-up Visit|Death|2
170366|NCT00530712|596341|P1|6 Month Follow-up Visit|Lost to Follow-up|3
170367|NCT00530712|596341|P1|6 Month Follow-up Visit|Missed Visit|3
170368|NCT00530712|596341|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
170369|NCT00530712|596341|P1|30 Day Follow-up Visit|Missed Visit|5
170370|NCT00530712|596341|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
170371|NCT00530504|596360|P1|Overall Study|Exited study due to other reasons|33
170372|NCT00530504|596360|P1|Overall Study|Withdrawal by Subject|39
170373|NCT00530504|596360|P1|Overall Study|Lost to Follow-up|26
170374|NCT00530504|596360|P1|Overall Study|Death|54
170375|NCT00530439|596366|P2|Overall Study|Severe malformation/abortion|3
170376|NCT00530439|596367|P1|Overall Study|Severe malformation/abortion|0
170377|NCT00530439|596366|P2|Overall Study|Twin pregnancy|2
170378|NCT00530439|596367|P1|Overall Study|Twin pregnancy|0
170379|NCT00530439|596366|P2|Overall Study|Misclassification|0
170380|NCT00530439|596367|P1|Overall Study|Misclassification|2
170381|NCT00530439|596366|P2|Overall Study|Missed abortion|4
170382|NCT00530439|596367|P1|Overall Study|Missed abortion|1
170383|NCT00530439|596366|P2|Overall Study|Withdraw|14
170384|NCT00530439|596367|P1|Overall Study|Withdraw|18
170385|NCT00530439|596366|P2|Overall Study|GDM|3
170386|NCT00530439|596367|P1|Overall Study|GDM|9
170387|NCT00530348|596375|P2|Overall Study|Noncompliance with inclusion criterion 3|1
170388|NCT00530348|596376|P1|Overall Study|Noncompliance with inclusion criterion 3|0
170389|NCT00530348|596375|P2|Overall Study|Randomised in error|0
170390|NCT00530348|596376|P1|Overall Study|Randomised in error|1
170391|NCT00530348|596375|P2|Overall Study|Withdrawal by Subject|12
170392|NCT00530348|596376|P1|Overall Study|Withdrawal by Subject|12
170393|NCT00530348|596375|P2|Overall Study|Pregnancy|0
170394|NCT00530348|596376|P1|Overall Study|Pregnancy|1
170395|NCT00530348|596375|P2|Overall Study|Physician Decision|2
170396|NCT00530348|596376|P1|Overall Study|Physician Decision|1
170397|NCT00530348|596375|P2|Overall Study|Lost to Follow-up|2
170398|NCT00530348|596376|P1|Overall Study|Lost to Follow-up|0
170399|NCT00530348|596375|P2|Overall Study|Lack of Efficacy|0
170400|NCT00530348|596376|P1|Overall Study|Lack of Efficacy|2
170401|NCT00530348|596375|P2|Overall Study|Death|1
170402|NCT00530348|596376|P1|Overall Study|Death|0
170403|NCT00530348|596375|P2|Overall Study|Adverse Event|1
170404|NCT00530348|596376|P1|Overall Study|Adverse Event|5
170405|NCT00530335|596392|P1|Overall Study|Physician Decision|1
170406|NCT00530335|596392|P1|Overall Study|Withdrawal by Subject|1
170407|NCT00530335|596392|P1|Overall Study|Protocol Violation|1
170408|NCT00530335|596392|P1|Overall Study|Adverse Event|3
170409|NCT00530270|596409|P2|Overall Study|Protocol Violation|0
170410|NCT00530270|596410|P1|Overall Study|Protocol Violation|1
170411|NCT00530257|596424|P1|Overall Study|Lost to Follow-up|1
170412|NCT00530218|596452|P1|Overall Study|Death|12
170413|NCT00530218|596452|P1|Overall Study|CMV Not Detected|13
170414|NCT00530088|596459|P1|Overall Study|Other Not Specified|2
170415|NCT00530088|596459|P1|Overall Study|Physician Decision|4
170416|NCT00530088|596459|P1|Overall Study|Disease Progression|4
170417|NCT00530075|596464|P1|Overall Study|Withdrawal by Subject|1
170418|NCT00530075|596464|P1|Overall Study|Protocol Violation|1
170419|NCT00530075|596464|P1|Overall Study|Lack of Efficacy|3
170420|NCT00530075|596464|P1|Overall Study|Death|1
170421|NCT00530075|596464|P1|Overall Study|Adverse Event|1
170422|NCT00530023|596477|P2|Overall Study|Withdrawal by Subject|1
170423|NCT00530023|596478|P1|Overall Study|Withdrawal by Subject|0
170424|NCT00529802|596492|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
170425|NCT00529802|596492|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
170426|NCT00529802|596492|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
170427|NCT00529802|596492|P1|Evaluable for Primary Endpoint|Death|1
170428|NCT00529802|596492|P1|Evaluable for Primary Endpoint|Adverse Event|2
170429|NCT00529802|596492|P1|Evaluable for Primary Endpoint|Worsening performance status|2
170430|NCT00529802|596492|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
170431|NCT00529789|596498|P1|Study Period IV|Lost to Follow-up|3
170432|NCT00529789|596498|P1|Study Period IV|Lack of Efficacy|1
170433|NCT00529789|596498|P1|Study Period IV|Adverse Event|1
170434|NCT00529789|596498|P1|Study Period IV|Parent/Caregiver Decision|1
170435|NCT00529789|596498|P1|Study Period II/III|Lost to Follow-up|3
170436|NCT00529789|596498|P1|Study Period II/III|Physician Decision|3
170437|NCT00529789|596498|P1|Study Period II/III|Protocol Violation|3
170438|NCT00529789|596498|P1|Study Period II/III|Withdrawal by Subject|1
170439|NCT00529789|596498|P1|Study Period II/III|Lack of Efficacy|2
170440|NCT00529789|596498|P1|Study Period II/III|Adverse Event|3
170441|NCT00529789|596498|P1|Study Period II/III|Parent/Caregiver Decision|9
170442|NCT00529763|596523|P3|Overall Study|Patient Withdrew Consent|2
170443|NCT00529763|596524|P2|Overall Study|Patient Withdrew Consent|3
170444|NCT00529763|596525|P1|Overall Study|Patient Withdrew Consent|2
170445|NCT00529763|596523|P3|Overall Study|Study Drug Toxicity|1
170446|NCT00529763|596524|P2|Overall Study|Study Drug Toxicity|6
170447|NCT00529763|596525|P1|Overall Study|Study Drug Toxicity|1
170448|NCT00529763|596523|P3|Overall Study|Stem Cell Transplant|0
170449|NCT00529763|596524|P2|Overall Study|Stem Cell Transplant|3
170450|NCT00529763|596525|P1|Overall Study|Stem Cell Transplant|0
170451|NCT00529763|596523|P3|Overall Study|Lost to Follow-up|1
170452|NCT00529763|596524|P2|Overall Study|Lost to Follow-up|1
170453|NCT00529763|596525|P1|Overall Study|Lost to Follow-up|0
170454|NCT00529763|596523|P3|Overall Study|Disease Progression|1
170455|NCT00529763|596524|P2|Overall Study|Disease Progression|16
170456|NCT00529763|596525|P1|Overall Study|Disease Progression|6
170457|NCT00529763|596523|P3|Overall Study|Death|1
170458|NCT00529763|596524|P2|Overall Study|Death|1
170459|NCT00529763|596525|P1|Overall Study|Death|0
170460|NCT00529763|596523|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
170461|NCT00529763|596524|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
170462|NCT00529763|596525|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
170463|NCT00529659|596563|P2|Overall Study|Withdrawal by Subject|6
170464|NCT00529659|596564|P1|Overall Study|Withdrawal by Subject|1
170465|NCT00529659|596563|P2|Overall Study|Protocol Violation|6
170466|NCT00529659|596564|P1|Overall Study|Protocol Violation|2
170467|NCT00529659|596563|P2|Overall Study|Physician Decision|2
170468|NCT00529659|596564|P1|Overall Study|Physician Decision|0
170469|NCT00529659|596563|P2|Overall Study|Lost to Follow-up|2
170470|NCT00529659|596564|P1|Overall Study|Lost to Follow-up|0
170471|NCT00529659|596563|P2|Overall Study|Adverse Event|7
170472|NCT00529659|596564|P1|Overall Study|Adverse Event|8
170473|NCT00529633|596582|P2|Overall Study|Withdrawal by Subject|1
170474|NCT00529633|596583|P1|Overall Study|Withdrawal by Subject|1
170475|NCT00529568|596595|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
170476|NCT00529568|596596|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
170477|NCT00529568|596597|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
170478|NCT00529568|596595|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
170479|NCT00529568|596596|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
170480|NCT00529568|596597|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
170481|NCT00529568|596595|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
170482|NCT00529568|596596|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
170483|NCT00529568|596597|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
170484|NCT00529568|596595|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
170565|NCT00529451|596852|P4|Overall Study|Subject withdrew consent|12
170485|NCT00529568|596596|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
170486|NCT00529568|596597|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
170487|NCT00529568|596595|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
170488|NCT00529568|596596|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
170489|NCT00529568|596597|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
170490|NCT00529568|596595|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
170491|NCT00529568|596596|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
170492|NCT00529568|596597|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
170493|NCT00529568|596595|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
170494|NCT00529568|596596|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
170495|NCT00529568|596597|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
170496|NCT00529568|596595|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
170497|NCT00529568|596596|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
170498|NCT00529568|596597|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
170499|NCT00529568|596595|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
170500|NCT00529568|596596|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
170501|NCT00529568|596597|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
170502|NCT00529568|596595|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
170503|NCT00529568|596596|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
170504|NCT00529568|596597|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
170505|NCT00529568|596595|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
170506|NCT00529568|596596|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
170507|NCT00529568|596597|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
170508|NCT00529542|596660|P2|Overall Study|Lost to Follow-up|1
170509|NCT00529542|596661|P1|Overall Study|Lost to Follow-up|0
170510|NCT00529542|596660|P2|Overall Study|Withdrawal by Subject|0
170511|NCT00529542|596661|P1|Overall Study|Withdrawal by Subject|1
170512|NCT00529529|596704|P3|Overall Study|Administrative problems|3
170513|NCT00529529|596705|P2|Overall Study|Administrative problems|0
170514|NCT00529529|596706|P1|Overall Study|Administrative problems|1
170515|NCT00529529|596704|P3|Overall Study|Abnormal test procedure result(s)|0
170516|NCT00529529|596705|P2|Overall Study|Abnormal test procedure result(s)|0
170517|NCT00529529|596706|P1|Overall Study|Abnormal test procedure result(s)|1
170518|NCT00529529|596704|P3|Overall Study|Death|0
170519|NCT00529529|596705|P2|Overall Study|Death|0
170520|NCT00529529|596706|P1|Overall Study|Death|2
170521|NCT00529529|596704|P3|Overall Study|Unsatisfactory therapeutic effect|2
170522|NCT00529529|596705|P2|Overall Study|Unsatisfactory therapeutic effect|2
170523|NCT00529529|596706|P1|Overall Study|Unsatisfactory therapeutic effect|2
170524|NCT00529529|596704|P3|Overall Study|Lost to Follow-up|1
170525|NCT00529529|596705|P2|Overall Study|Lost to Follow-up|3
170526|NCT00529529|596706|P1|Overall Study|Lost to Follow-up|5
170527|NCT00529529|596704|P3|Overall Study|Protocol deviation|5
170528|NCT00529529|596705|P2|Overall Study|Protocol deviation|12
170529|NCT00529529|596706|P1|Overall Study|Protocol deviation|8
170530|NCT00529529|596704|P3|Overall Study|Subject withdrew consent|12
170531|NCT00529529|596705|P2|Overall Study|Subject withdrew consent|9
170532|NCT00529529|596706|P1|Overall Study|Subject withdrew consent|12
170533|NCT00529529|596704|P3|Overall Study|Adverse Event|8
170534|NCT00529529|596705|P2|Overall Study|Adverse Event|17
170535|NCT00529529|596706|P1|Overall Study|Adverse Event|12
170536|NCT00529516|596765|P3|Overall Study|Lost to Follow-up|1
170537|NCT00529516|596766|P2|Overall Study|Lost to Follow-up|0
170538|NCT00529516|596767|P1|Overall Study|Lost to Follow-up|0
170539|NCT00529516|596765|P3|Overall Study|Withdrawal by Subject|0
170540|NCT00529516|596766|P2|Overall Study|Withdrawal by Subject|1
170541|NCT00529516|596767|P1|Overall Study|Withdrawal by Subject|1
170542|NCT00529516|596765|P3|Overall Study|Adverse Event|0
170543|NCT00529516|596766|P2|Overall Study|Adverse Event|1
170544|NCT00529516|596767|P1|Overall Study|Adverse Event|2
170545|NCT00529451|596852|P4|Overall Study|Administrative problems|2
170546|NCT00529451|596853|P3|Overall Study|Administrative problems|0
170547|NCT00529451|596854|P2|Overall Study|Administrative problems|1
170548|NCT00529451|596855|P1|Overall Study|Administrative problems|1
170549|NCT00529451|596852|P4|Overall Study|Protocol deviation|1
170550|NCT00529451|596853|P3|Overall Study|Protocol deviation|4
170551|NCT00529451|596854|P2|Overall Study|Protocol deviation|1
170552|NCT00529451|596855|P1|Overall Study|Protocol deviation|1
170553|NCT00529451|596852|P4|Overall Study|Lost to Follow-up|4
170554|NCT00529451|596853|P3|Overall Study|Lost to Follow-up|4
170555|NCT00529451|596854|P2|Overall Study|Lost to Follow-up|7
170556|NCT00529451|596855|P1|Overall Study|Lost to Follow-up|4
170557|NCT00529451|596852|P4|Overall Study|Unsatisfactory therapeutic response|4
170558|NCT00529451|596853|P3|Overall Study|Unsatisfactory therapeutic response|5
170559|NCT00529451|596854|P2|Overall Study|Unsatisfactory therapeutic response|2
170560|NCT00529451|596855|P1|Overall Study|Unsatisfactory therapeutic response|6
170561|NCT00529451|596852|P4|Overall Study|Adverse Event|8
170562|NCT00529451|596853|P3|Overall Study|Adverse Event|14
170563|NCT00529451|596854|P2|Overall Study|Adverse Event|16
170564|NCT00529451|596855|P1|Overall Study|Adverse Event|9
170566|NCT00529451|596853|P3|Overall Study|Subject withdrew consent|13
170567|NCT00529451|596854|P2|Overall Study|Subject withdrew consent|21
170568|NCT00529451|596855|P1|Overall Study|Subject withdrew consent|16
170569|NCT00529399|596882|P3|Overall Study|Non-compliant|0
170570|NCT00529399|596883|P2|Overall Study|Non-compliant|1
170571|NCT00529399|596884|P1|Overall Study|Non-compliant|0
170572|NCT00529399|596882|P3|Overall Study|Withdrawal by Subject|1
170573|NCT00529399|596883|P2|Overall Study|Withdrawal by Subject|0
170574|NCT00529399|596884|P1|Overall Study|Withdrawal by Subject|1
170575|NCT00529399|596882|P3|Overall Study|Lost to Follow-up|1
170576|NCT00529399|596883|P2|Overall Study|Lost to Follow-up|0
170577|NCT00529399|596884|P1|Overall Study|Lost to Follow-up|1
170578|NCT00529308|596894|P2|Overall Study|Withdrawal by Subject|1
170579|NCT00529308|596895|P1|Overall Study|Withdrawal by Subject|1
170580|NCT00529243|596924|P1|Overall Study|Relocated|1
170581|NCT00529243|596924|P1|Overall Study|Death|1
170582|NCT00529243|596924|P1|Overall Study|Adverse Event|1
170583|NCT00529217|596929|P1|Overall Study|Unable to adhere to study schedule|2
170584|NCT00529217|596929|P1|Overall Study|Lack of Efficacy|2
170585|NCT00529152|596965|P1|Overall Study|Lost to Follow-up|1
170586|NCT00529152|596965|P1|Overall Study|Withdrawal by Subject|2
170587|NCT00529152|596965|P1|Overall Study|Adverse Event|2
170588|NCT00529100|596989|P2|Overall Study|Participant Ineligibility|1
170589|NCT00529100|596990|P1|Overall Study|Participant Ineligibility|0
170590|NCT00529100|596989|P2|Overall Study|Withdrawal by Subject|1
170591|NCT00529100|596990|P1|Overall Study|Withdrawal by Subject|0
170592|NCT00529100|596989|P2|Overall Study|Progressive Disease|1
170593|NCT00529100|596990|P1|Overall Study|Progressive Disease|0
170594|NCT00529100|596989|P2|Overall Study|Protocol Violation|1
170595|NCT00529100|596990|P1|Overall Study|Protocol Violation|0
170596|NCT00529100|596989|P2|Overall Study|Adverse Event|5
170597|NCT00529100|596990|P1|Overall Study|Adverse Event|0
170598|NCT00529087|597007|P3|Overall Study|Protocol deviation|2
170599|NCT00529087|597008|P2|Overall Study|Protocol deviation|1
170600|NCT00529087|597009|P1|Overall Study|Protocol deviation|1
170601|NCT00529087|597007|P3|Overall Study|Withdrawal by Subject|3
170602|NCT00529087|597008|P2|Overall Study|Withdrawal by Subject|3
170603|NCT00529087|597009|P1|Overall Study|Withdrawal by Subject|3
170604|NCT00529087|597007|P3|Overall Study|Protocol Violation|6
170605|NCT00529087|597008|P2|Overall Study|Protocol Violation|7
170606|NCT00529087|597009|P1|Overall Study|Protocol Violation|8
170607|NCT00529087|597007|P3|Overall Study|Lost to Follow-up|1
170608|NCT00529087|597008|P2|Overall Study|Lost to Follow-up|4
170609|NCT00529087|597009|P1|Overall Study|Lost to Follow-up|6
170610|NCT00529087|597007|P3|Overall Study|Adverse Event|4
170611|NCT00529087|597008|P2|Overall Study|Adverse Event|13
170612|NCT00529087|597009|P1|Overall Study|Adverse Event|10
170613|NCT00529035|597073|P1|Overall Study|Withdrawal by Subject|1
170614|NCT00528957|597086|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
170615|NCT00528957|597087|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
170616|NCT00528957|597086|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
170617|NCT00528957|597087|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
170618|NCT00528957|597086|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
170619|NCT00528957|597087|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
170620|NCT00528957|597086|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
170621|NCT00528957|597087|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
170622|NCT00528957|597086|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
170623|NCT00528957|597087|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
170624|NCT00528957|597086|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
170625|NCT00528957|597087|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
170626|NCT00528957|597086|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
170627|NCT00528957|597087|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
170628|NCT00528957|597086|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
170629|NCT00528957|597087|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
170630|NCT00528957|597086|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
170631|NCT00528957|597087|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
170632|NCT00528957|597086|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
170633|NCT00528957|597087|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
170634|NCT00528957|597086|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
170635|NCT00528957|597087|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
170636|NCT00528957|597086|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
170637|NCT00528957|597087|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
170638|NCT00528957|597086|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
170639|NCT00528957|597087|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
170640|NCT00528957|597086|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
170641|NCT00528957|597087|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
170642|NCT00528957|597086|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
170643|NCT00528957|597087|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
170644|NCT00528957|597086|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
170645|NCT00528957|597087|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
170646|NCT00528931|597228|P1|Overall Study|Lost to Follow-up|1
170647|NCT00528879|597240|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
170648|NCT00528879|597241|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
170649|NCT00528879|597242|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
170650|NCT00528879|597243|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
170651|NCT00528879|597240|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
170652|NCT00528879|597241|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
170653|NCT00528879|597242|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
170654|NCT00528879|597243|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
170655|NCT00528879|597240|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
170656|NCT00528879|597241|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
170657|NCT00528879|597242|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
170658|NCT00528879|597243|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
170659|NCT00528879|597240|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
170660|NCT00528879|597241|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
170661|NCT00528879|597242|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
170662|NCT00528879|597243|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
170663|NCT00528879|597240|P4|Long-term Period (Weeks 24 to 102)|Death|0
170664|NCT00528879|597241|P3|Long-term Period (Weeks 24 to 102)|Death|0
170665|NCT00528879|597242|P2|Long-term Period (Weeks 24 to 102)|Death|1
170666|NCT00528879|597243|P1|Long-term Period (Weeks 24 to 102)|Death|0
170667|NCT00528879|597240|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
170668|NCT00528879|597241|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
170669|NCT00528879|597242|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
170670|NCT00528879|597243|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
170671|NCT00528879|597240|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
170672|NCT00528879|597241|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
170673|NCT00528879|597242|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
170674|NCT00528879|597243|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
170675|NCT00528879|597240|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
170676|NCT00528879|597241|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
170677|NCT00528879|597242|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
170678|NCT00528879|597243|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
170679|NCT00528879|597240|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
170680|NCT00528879|597241|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
170681|NCT00528879|597242|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
170682|NCT00528879|597243|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
170683|NCT00528879|597240|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
170684|NCT00528879|597241|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
170685|NCT00528879|597242|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
170686|NCT00528879|597243|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
170687|NCT00528879|597240|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
170688|NCT00528879|597241|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
170689|NCT00528879|597242|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
170690|NCT00528879|597243|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
170691|NCT00528879|597240|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
170692|NCT00528879|597241|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
170693|NCT00528879|597242|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
170694|NCT00528879|597243|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
170695|NCT00528879|597240|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
170696|NCT00528879|597241|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
170697|NCT00528879|597242|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
170698|NCT00528879|597243|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
170699|NCT00528879|597240|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
170700|NCT00528879|597241|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
170701|NCT00528879|597242|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
170702|NCT00528879|597243|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
170703|NCT00528879|597240|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
170704|NCT00528879|597241|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
170705|NCT00528879|597242|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
170706|NCT00528879|597243|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
170707|NCT00528879|597240|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
170708|NCT00528879|597241|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
170709|NCT00528879|597242|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
170710|NCT00528879|597243|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
170711|NCT00528866|597309|P1|Overall Study|Protocol Violation|6
170712|NCT00528840|597321|P1|Overall Study|Not Specified|2
170713|NCT00528840|597321|P1|Overall Study|Administrative Reasons|1
170714|NCT00528840|597321|P1|Overall Study|Death|2
170715|NCT00528840|597321|P1|Overall Study|Withdrawal by Subject|17
170716|NCT00528840|597321|P1|Overall Study|Adverse Event|1
170717|NCT00528840|597321|P1|Overall Study|Lost to Follow-up|10
170718|NCT00528801|597335|P2|Overall Study|Administrative Reasons|1
170719|NCT00528801|597336|P1|Overall Study|Administrative Reasons|0
170720|NCT00528801|597335|P2|Overall Study|Lost to Follow-up|4
170721|NCT00528801|597336|P1|Overall Study|Lost to Follow-up|15
170722|NCT00528801|597335|P2|Overall Study|Protocol Violation|5
170723|NCT00528801|597336|P1|Overall Study|Protocol Violation|11
170724|NCT00528801|597335|P2|Overall Study|Withdrawal by Subject|1
170725|NCT00528801|597336|P1|Overall Study|Withdrawal by Subject|1
170726|NCT00528775|597350|P1|Overall Study|Other not specified|1
170727|NCT00528645|597358|P1|Overall Study|Adverse Event|3
170728|NCT00528606|597367|P2|Overall Study|Not specified|0
170729|NCT00528606|597368|P1|Overall Study|Not specified|2
170730|NCT00528606|597367|P2|Overall Study|Adverse Event|0
170731|NCT00528606|597368|P1|Overall Study|Adverse Event|3
170732|NCT00528606|597367|P2|Overall Study|Lost to Follow-up|1
170733|NCT00528606|597368|P1|Overall Study|Lost to Follow-up|4
170734|NCT00528606|597367|P2|Overall Study|Withdrew consent|3
170735|NCT00528606|597368|P1|Overall Study|Withdrew consent|4
170736|NCT00528567|597392|P2|Overall Study|Administrative/Other|75
170737|NCT00528567|597393|P1|Overall Study|Administrative/Other|22
170738|NCT00528567|597392|P2|Overall Study|Other Protocol Violation|21
170739|NCT00528567|597393|P1|Overall Study|Other Protocol Violation|5
170740|NCT00528567|597392|P2|Overall Study|Failure to Return|4
170741|NCT00528567|597393|P1|Overall Study|Failure to Return|1
170742|NCT00528567|597392|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
170743|NCT00528567|597393|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
170744|NCT00528567|597392|P2|Overall Study|Withdrew Consent|55
170745|NCT00528567|597393|P1|Overall Study|Withdrew Consent|59
170746|NCT00528567|597392|P2|Overall Study|Violation Criteria at Entry|17
170747|NCT00528567|597393|P1|Overall Study|Violation Criteria at Entry|3
170748|NCT00528567|597392|P2|Overall Study|Adverse Event/Intermittent Illness|29
170749|NCT00528567|597393|P1|Overall Study|Adverse Event/Intermittent Illness|255
170750|NCT00528567|597392|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
170751|NCT00528567|597393|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
170752|NCT00528567|597392|P2|Overall Study|Death|5
170753|NCT00528567|597393|P1|Overall Study|Death|4
170754|NCT00528528|597460|P4|Overall Study|Ongoing participant|0
170755|NCT00528528|597461|P3|Overall Study|Ongoing participant|1
170756|NCT00528528|597462|P2|Overall Study|Ongoing participant|0
170757|NCT00528528|597463|P1|Overall Study|Ongoing participant|0
170758|NCT00528528|597460|P4|Overall Study|Withdrawal by Subject|1
170759|NCT00528528|597461|P3|Overall Study|Withdrawal by Subject|1
170760|NCT00528528|597462|P2|Overall Study|Withdrawal by Subject|2
170761|NCT00528528|597463|P1|Overall Study|Withdrawal by Subject|3
170762|NCT00528528|597460|P4|Overall Study|Other|0
170763|NCT00528528|597461|P3|Overall Study|Other|0
170764|NCT00528528|597462|P2|Overall Study|Other|1
170765|NCT00528528|597463|P1|Overall Study|Other|0
170766|NCT00528528|597460|P4|Overall Study|Ineligible to continue the trial|1
170767|NCT00528528|597461|P3|Overall Study|Ineligible to continue the trial|0
170768|NCT00528528|597462|P2|Overall Study|Ineligible to continue the trial|0
170769|NCT00528528|597463|P1|Overall Study|Ineligible to continue the trial|0
170770|NCT00528528|597460|P4|Overall Study|Lost to Follow-up|1
170771|NCT00528528|597461|P3|Overall Study|Lost to Follow-up|1
170772|NCT00528528|597462|P2|Overall Study|Lost to Follow-up|0
170773|NCT00528528|597463|P1|Overall Study|Lost to Follow-up|0
170774|NCT00528424|597501|P1|Overall Study|Not specified|12
170775|NCT00528424|597501|P1|Overall Study|Administrative reason|2
170776|NCT00528424|597501|P1|Overall Study|Withdrew consent|2
170777|NCT00528424|597501|P1|Overall Study|Lost to Follow-up|13
170778|NCT00528411|597516|P3|Overall Study|Prior commitment medication|0
170779|NCT00528411|597517|P2|Overall Study|Prior commitment medication|1
170780|NCT00528411|597518|P1|Overall Study|Prior commitment medication|0
170781|NCT00528411|597516|P3|Overall Study|Severe non-compliance to protocol|0
170782|NCT00528411|597517|P2|Overall Study|Severe non-compliance to protocol|1
170783|NCT00528411|597518|P1|Overall Study|Severe non-compliance to protocol|0
170784|NCT00528411|597516|P3|Overall Study|Incorrect Enrolment|0
170785|NCT00528411|597517|P2|Overall Study|Incorrect Enrolment|1
170786|NCT00528411|597518|P1|Overall Study|Incorrect Enrolment|1
170787|NCT00528411|597516|P3|Overall Study|Adverse Event|1
170788|NCT00528411|597517|P2|Overall Study|Adverse Event|0
170789|NCT00528411|597518|P1|Overall Study|Adverse Event|4
170790|NCT00528372|597655|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
170791|NCT00528372|597656|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
170792|NCT00528372|597657|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
170793|NCT00528372|597658|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
170794|NCT00528372|597659|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
170795|NCT00528372|597660|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
170796|NCT00528372|597661|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
170797|NCT00528372|597662|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
170798|NCT00528372|597663|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
170799|NCT00528372|597655|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
170800|NCT00528372|597656|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
170801|NCT00528372|597657|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
170802|NCT00528372|597658|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
170803|NCT00528372|597659|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
170804|NCT00528372|597660|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
170805|NCT00528372|597661|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
170806|NCT00528372|597662|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
170807|NCT00528372|597663|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
170808|NCT00528372|597655|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
170809|NCT00528372|597656|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
170810|NCT00528372|597657|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
170811|NCT00528372|597658|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
170812|NCT00528372|597659|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
170813|NCT00528372|597660|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
170814|NCT00528372|597661|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
170815|NCT00528372|597662|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
170816|NCT00528372|597663|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
170817|NCT00528372|597655|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
170818|NCT00528372|597656|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
170819|NCT00528372|597657|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
170820|NCT00528372|597658|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
170821|NCT00528372|597659|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
170822|NCT00528372|597660|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
170823|NCT00528372|597661|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
170824|NCT00528372|597662|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
170825|NCT00528372|597663|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
170826|NCT00528372|597655|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
170827|NCT00528372|597656|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
170828|NCT00528372|597657|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
170829|NCT00528372|597658|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
170830|NCT00528372|597659|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
170831|NCT00528372|597660|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
170832|NCT00528372|597661|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
170833|NCT00528372|597662|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
170834|NCT00528372|597663|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
170835|NCT00528372|597655|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
170836|NCT00528372|597656|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
170837|NCT00528372|597657|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
170838|NCT00528372|597658|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
170839|NCT00528372|597659|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
170840|NCT00528372|597660|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
170841|NCT00528372|597661|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
170842|NCT00528372|597662|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
170843|NCT00528372|597663|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
170844|NCT00528372|597655|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
170845|NCT00528372|597656|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
170846|NCT00528372|597657|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
170847|NCT00528372|597658|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
170848|NCT00528372|597659|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
170849|NCT00528372|597660|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
170850|NCT00528372|597661|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
170851|NCT00528372|597662|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
170852|NCT00528372|597663|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
170853|NCT00528372|597655|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
170854|NCT00528372|597656|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
170855|NCT00528372|597657|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
170856|NCT00528372|597658|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
170857|NCT00528372|597659|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
170858|NCT00528372|597660|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
170859|NCT00528372|597661|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
170860|NCT00528372|597662|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
170861|NCT00528372|597663|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
170862|NCT00528372|597655|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
170863|NCT00528372|597656|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
170864|NCT00528372|597657|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
170865|NCT00528372|597658|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
170866|NCT00528372|597659|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
170867|NCT00528372|597660|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
170868|NCT00528372|597661|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
170869|NCT00528372|597662|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
170870|NCT00528372|597663|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
170871|NCT00528372|597655|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
170872|NCT00528372|597656|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
170873|NCT00528372|597657|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
170874|NCT00528372|597658|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
170875|NCT00528372|597659|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
170876|NCT00528372|597660|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
170877|NCT00528372|597661|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
170878|NCT00528372|597662|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
170879|NCT00528372|597663|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
170880|NCT00528372|597655|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
170881|NCT00528372|597656|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
170882|NCT00528372|597657|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
170883|NCT00528372|597658|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
170884|NCT00528372|597659|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
170885|NCT00528372|597660|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
170886|NCT00528372|597661|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
170887|NCT00528372|597662|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
170888|NCT00528372|597663|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
170889|NCT00528372|597655|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
170890|NCT00528372|597656|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
170891|NCT00528372|597657|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
170892|NCT00528372|597658|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
170893|NCT00528372|597659|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
170894|NCT00528372|597660|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
170895|NCT00528372|597661|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
170896|NCT00528372|597662|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
170897|NCT00528372|597663|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
170898|NCT00528372|597655|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
170899|NCT00528372|597656|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
170900|NCT00528372|597657|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
170901|NCT00528372|597658|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
170902|NCT00528372|597659|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
170903|NCT00528372|597660|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
170904|NCT00528372|597661|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
170905|NCT00528372|597662|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
170906|NCT00528372|597663|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
170907|NCT00528372|597655|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
170908|NCT00528372|597656|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
170909|NCT00528372|597657|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
170910|NCT00528372|597658|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
170911|NCT00528372|597659|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
170912|NCT00528372|597660|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
170913|NCT00528372|597661|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
170914|NCT00528372|597662|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
170915|NCT00528372|597663|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
170916|NCT00528372|597655|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
170917|NCT00528372|597656|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
170918|NCT00528372|597657|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
170919|NCT00528372|597658|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
170920|NCT00528372|597659|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
170921|NCT00528372|597660|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
170922|NCT00528372|597661|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
170923|NCT00528372|597662|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
170924|NCT00528372|597663|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
170925|NCT00528112|597795|P2|Extension Phase|Protocol Violation|2
170926|NCT00528112|597796|P1|Extension Phase|Protocol Violation|0
170927|NCT00528112|597795|P2|Extension Phase|Adverse Event|36
170928|NCT00528112|597796|P1|Extension Phase|Adverse Event|0
170929|NCT00528112|597795|P2|Extension Phase|Death|1
170930|NCT00528112|597796|P1|Extension Phase|Death|0
170931|NCT00528112|597795|P2|Extension Phase|Lost to Follow-up|12
170932|NCT00528112|597796|P1|Extension Phase|Lost to Follow-up|0
170933|NCT00528112|597795|P2|Extension Phase|Pregnancy|3
170934|NCT00528112|597796|P1|Extension Phase|Pregnancy|0
170935|NCT00528112|597795|P2|Extension Phase|Other reasons|100
170936|NCT00528112|597796|P1|Extension Phase|Other reasons|0
170937|NCT00528112|597795|P2|Extension Phase|Withdrawal by Subject|3
170938|NCT00528112|597796|P1|Extension Phase|Withdrawal by Subject|0
170939|NCT00528112|597795|P2|Treatment up to 3 Years|Other reasons|186
170940|NCT00528112|597796|P1|Treatment up to 3 Years|Other reasons|186
170941|NCT00528112|597795|P2|Treatment up to 3 Years|Pregnancy|10
170942|NCT00528112|597796|P1|Treatment up to 3 Years|Pregnancy|9
170943|NCT00528112|597795|P2|Treatment up to 3 Years|Lost to Follow-up|61
170944|NCT00528112|597796|P1|Treatment up to 3 Years|Lost to Follow-up|63
170945|NCT00528112|597795|P2|Treatment up to 3 Years|Death|1
170946|NCT00528112|597796|P1|Treatment up to 3 Years|Death|0
170947|NCT00528112|597795|P2|Treatment up to 3 Years|Protocol Violation|16
170948|NCT00528112|597796|P1|Treatment up to 3 Years|Protocol Violation|16
170949|NCT00528112|597795|P2|Treatment up to 3 Years|Withdrawal by Subject|31
170950|NCT00528112|597796|P1|Treatment up to 3 Years|Withdrawal by Subject|26
170951|NCT00528112|597795|P2|Treatment up to 3 Years|Adverse Event|278
170952|NCT00528112|597796|P1|Treatment up to 3 Years|Adverse Event|313
170953|NCT00528021|597854|P4|Overall Study|Lack of Efficacy|9
170954|NCT00528021|597855|P3|Overall Study|Lack of Efficacy|7
170955|NCT00528021|597856|P2|Overall Study|Lack of Efficacy|13
170956|NCT00528021|597857|P1|Overall Study|Lack of Efficacy|17
170957|NCT00527982|597869|P2|Overall Study|Physician Decision|0
170958|NCT00527982|597870|P1|Overall Study|Physician Decision|1
170959|NCT00527904|597911|P1|Overall Study|misc|22
170960|NCT00527904|597911|P1|Overall Study|Lost to Follow-up|8
170961|NCT00527904|597911|P1|Overall Study|Withdrawal by Subject|21
170962|NCT00527904|597911|P1|Overall Study|Adverse Event|45
170963|NCT00527826|597930|P2|Overall Study|Participant moved away|1
170964|NCT00527826|597931|P1|Overall Study|Participant moved away|0
170965|NCT00527826|597930|P2|Overall Study|Additional Intake of Viani forte|1
170966|NCT00527826|597931|P1|Overall Study|Additional Intake of Viani forte|0
170967|NCT00527826|597930|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
170968|NCT00527826|597931|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
170969|NCT00527826|597930|P2|Overall Study|Inclusion Criteria Not Met|3
170970|NCT00527826|597931|P1|Overall Study|Inclusion Criteria Not Met|3
170971|NCT00527826|597930|P2|Overall Study|Withdrawal by Subject|8
170972|NCT00527826|597931|P1|Overall Study|Withdrawal by Subject|5
170973|NCT00527826|597930|P2|Overall Study|Lost to Follow-up|2
170974|NCT00527826|597931|P1|Overall Study|Lost to Follow-up|3
170975|NCT00527826|597930|P2|Overall Study|Adverse Event|10
170976|NCT00527826|597931|P1|Overall Study|Adverse Event|10
170977|NCT00527787|597980|P2|Overall Study|misc|2
170978|NCT00527787|597981|P1|Overall Study|misc|5
170979|NCT00527787|597980|P2|Overall Study|Duodenal Ulcer|10
170980|NCT00527787|597981|P1|Overall Study|Duodenal Ulcer|1
170981|NCT00527787|597980|P2|Overall Study|Lost to Follow-up|2
170982|NCT00527787|597981|P1|Overall Study|Lost to Follow-up|5
170983|NCT00527787|597980|P2|Overall Study|Withdrawal by Subject|25
170984|NCT00527787|597981|P1|Overall Study|Withdrawal by Subject|13
170985|NCT00527787|597980|P2|Overall Study|Adverse Event|24
170986|NCT00527787|597981|P1|Overall Study|Adverse Event|14
170987|NCT00527748|598003|P1|Overall Study|Other|3
170988|NCT00527735|598010|P3|Overall Study|Completed treatment during maintenance|1
170989|NCT00527735|598011|P2|Overall Study|Completed treatment during maintenance|2
170990|NCT00527735|598012|P1|Overall Study|Completed treatment during maintenance|2
170991|NCT00527735|598010|P3|Overall Study|Poor compliance or noncompliance|1
170992|NCT00527735|598011|P2|Overall Study|Poor compliance or noncompliance|1
170993|NCT00527735|598012|P1|Overall Study|Poor compliance or noncompliance|0
170994|NCT00527735|598010|P3|Overall Study|Lost to Follow-up|3
170995|NCT00527735|598011|P2|Overall Study|Lost to Follow-up|0
170996|NCT00527735|598012|P1|Overall Study|Lost to Follow-up|0
170997|NCT00527735|598010|P3|Overall Study|No longer met study criteria|1
170998|NCT00527735|598011|P2|Overall Study|No longer met study criteria|2
170999|NCT00527735|598012|P1|Overall Study|No longer met study criteria|2
171000|NCT00527735|598010|P3|Overall Study|Withdrawal by Subject|3
171001|NCT00527735|598011|P2|Overall Study|Withdrawal by Subject|4
171002|NCT00527735|598012|P1|Overall Study|Withdrawal by Subject|5
171003|NCT00527735|598010|P3|Overall Study|Not identified|5
171004|NCT00527735|598011|P2|Overall Study|Not identified|5
171005|NCT00527735|598012|P1|Overall Study|Not identified|5
171006|NCT00527735|598010|P3|Overall Study|Adverse Event|7
171007|NCT00527735|598011|P2|Overall Study|Adverse Event|6
171008|NCT00527735|598012|P1|Overall Study|Adverse Event|10
171009|NCT00527735|598010|P3|Overall Study|Completed treatment in treatment phase|18
171010|NCT00527735|598011|P2|Overall Study|Completed treatment in treatment phase|13
171011|NCT00527735|598012|P1|Overall Study|Completed treatment in treatment phase|14
171012|NCT00527735|598010|P3|Overall Study|Death|15
171013|NCT00527735|598011|P2|Overall Study|Death|13
171014|NCT00527735|598012|P1|Overall Study|Death|23
171015|NCT00527735|598010|P3|Overall Study|Disease progression|53
171016|NCT00527735|598011|P2|Overall Study|Disease progression|61
171017|NCT00527735|598012|P1|Overall Study|Disease progression|47
171018|NCT00527618|598098|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
171019|NCT00527618|598099|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
171020|NCT00527618|598098|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
171021|NCT00527618|598099|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
171022|NCT00527618|598098|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
171023|NCT00527618|598099|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
171024|NCT00527618|598098|P2|Week 13-14 (Washout)|Lost to Follow-up|0
171025|NCT00527618|598099|P1|Week 13-14 (Washout)|Lost to Follow-up|1
171026|NCT00527618|598098|P2|Week 1-12 (First Intervention)|Adverse Event|1
171027|NCT00527618|598099|P1|Week 1-12 (First Intervention)|Adverse Event|0
171028|NCT00527618|598098|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
171029|NCT00527618|598099|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
171030|NCT00527605|598114|P2|Overall Study|Protocol Violation|2
171031|NCT00527605|598115|P1|Overall Study|Protocol Violation|1
171032|NCT00527605|598114|P2|Overall Study|Lost to Follow-up|2
171033|NCT00527605|598115|P1|Overall Study|Lost to Follow-up|6
171034|NCT00527605|598114|P2|Overall Study|Withdrawal by Subject|7
171035|NCT00527605|598115|P1|Overall Study|Withdrawal by Subject|3
171036|NCT00527605|598114|P2|Overall Study|Adverse Event|0
171037|NCT00527605|598115|P1|Overall Study|Adverse Event|3
171038|NCT00527514|598166|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
171039|NCT00527514|598166|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
171040|NCT00527514|598166|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
171041|NCT00527514|598166|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
171042|NCT00527514|598166|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
171043|NCT00527514|598166|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
171044|NCT00527514|598166|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
171045|NCT00527488|598182|P4|Overall Study|Withdrawn prior to dosing|0
171046|NCT00527488|598183|P3|Overall Study|Withdrawn prior to dosing|1
171047|NCT00527488|598184|P2|Overall Study|Withdrawn prior to dosing|1
171048|NCT00527488|598185|P1|Overall Study|Withdrawn prior to dosing|0
171049|NCT00527423|598268|P1|Overall Study|Death|9
171050|NCT00527423|598268|P1|Overall Study|OTHER|4
171051|NCT00527423|598268|P1|Overall Study|Lost to Follow-up|4
171052|NCT00527423|598268|P1|Overall Study|Withdrawal by Subject|10
171053|NCT00527423|598268|P1|Overall Study|Physician Decision|4
171054|NCT00527423|598268|P1|Overall Study|Adverse Event|5
171055|NCT00527423|598268|P1|Overall Study|Protocol Violation|1
171056|NCT00527397|598274|P1|Overall Study|Study terminated by sponsor|13
171057|NCT00527397|598274|P1|Overall Study|Withdrawal by Subject|6
171058|NCT00527397|598274|P1|Overall Study|Protocol Violation|1
171059|NCT00527397|598274|P1|Overall Study|Lack of Efficacy|1
171060|NCT00527397|598274|P1|Overall Study|Adverse Event|3
171061|NCT00527332|598300|P2|Overall Study|Withdrew consent|1
171062|NCT00527332|598301|P1|Overall Study|Withdrew consent|5
171063|NCT00527332|598300|P2|Overall Study|Protocol Violation|8
171064|NCT00527332|598301|P1|Overall Study|Protocol Violation|4
171065|NCT00527319|598310|P3|Overall Study|Adverse Event|1
171066|NCT00527319|598311|P2|Overall Study|Adverse Event|0
171067|NCT00527319|598312|P1|Overall Study|Adverse Event|0
171068|NCT00527319|598310|P3|Overall Study|Intercurrent Medical Illness|3
171069|NCT00527319|598311|P2|Overall Study|Intercurrent Medical Illness|1
171070|NCT00527319|598312|P1|Overall Study|Intercurrent Medical Illness|0
171071|NCT00527319|598310|P3|Overall Study|Death|1
171072|NCT00527319|598311|P2|Overall Study|Death|3
171073|NCT00527319|598312|P1|Overall Study|Death|0
171074|NCT00527319|598310|P3|Overall Study|Lost to Follow-up|0
171075|NCT00527319|598311|P2|Overall Study|Lost to Follow-up|0
171076|NCT00527319|598312|P1|Overall Study|Lost to Follow-up|1
171077|NCT00527319|598310|P3|Overall Study|Withdrawal by Subject|1
171078|NCT00527319|598311|P2|Overall Study|Withdrawal by Subject|0
171079|NCT00527319|598312|P1|Overall Study|Withdrawal by Subject|5
171080|NCT00527111|598342|P2|Overall Study|Other|2
171081|NCT00527111|598343|P1|Overall Study|Other|2
171082|NCT00527111|598342|P2|Overall Study|Patient Request|5
171083|NCT00527111|598343|P1|Overall Study|Patient Request|2
171084|NCT00527111|598342|P2|Overall Study|Investigator Request|1
171085|NCT00527111|598343|P1|Overall Study|Investigator Request|2
171086|NCT00527111|598342|P2|Overall Study|Death|1
171087|NCT00527111|598343|P1|Overall Study|Death|0
171088|NCT00527111|598342|P2|Overall Study|Adverse Event|13
171089|NCT00527111|598343|P1|Overall Study|Adverse Event|14
171090|NCT00527072|598365|P1|Overall Study|Withdrawal by Subject|7
171091|NCT00527072|598365|P1|Overall Study|Protocol Violation|2
171092|NCT00527072|598365|P1|Overall Study|Lost to Follow-up|3
171093|NCT00527072|598365|P1|Overall Study|Lack of Efficacy|11
171094|NCT00527072|598365|P1|Overall Study|Adverse Event|13
171095|NCT00526994|598374|P3|Overall Study|incarcerated, impaired, incomplete|3
171096|NCT00526994|598375|P2|Overall Study|incarcerated, impaired, incomplete|3
171097|NCT00526994|598376|P1|Overall Study|incarcerated, impaired, incomplete|4
171098|NCT00526994|598374|P3|Overall Study|Withdrawal by Subject|5
171099|NCT00526994|598375|P2|Overall Study|Withdrawal by Subject|7
171100|NCT00526994|598376|P1|Overall Study|Withdrawal by Subject|2
171101|NCT00526994|598374|P3|Overall Study|Death|3
171102|NCT00526994|598375|P2|Overall Study|Death|3
171103|NCT00526994|598376|P1|Overall Study|Death|4
171104|NCT00526994|598374|P3|Overall Study|Lost to Follow-up|96
171105|NCT00526994|598375|P2|Overall Study|Lost to Follow-up|108
171106|NCT00526994|598376|P1|Overall Study|Lost to Follow-up|98
171107|NCT00526890|598393|P1|Overall Study|Adverse Event|2
171108|NCT00526799|598405|P2|Overall Study|Intercurrent Complicating Disease|1
171109|NCT00526799|598406|P1|Overall Study|Intercurrent Complicating Disease|0
171110|NCT00526799|598405|P2|Overall Study|Withdrawal by Subject|0
171111|NCT00526799|598406|P1|Overall Study|Withdrawal by Subject|1
171112|NCT00526669|598414|P2|Combined Treatment Phase|Death|2
171113|NCT00526669|598415|P1|Combined Treatment Phase|Death|0
171114|NCT00526669|598414|P2|Combined Treatment Phase|Sponsor Terminated Study|2
171115|NCT00526669|598415|P1|Combined Treatment Phase|Sponsor Terminated Study|0
171116|NCT00526669|598414|P2|Combined Treatment Phase|Withdrawal by Subject|2
171117|NCT00526669|598415|P1|Combined Treatment Phase|Withdrawal by Subject|0
171118|NCT00526669|598414|P2|Combined Treatment Phase|Lost to Follow-up|2
171119|NCT00526669|598415|P1|Combined Treatment Phase|Lost to Follow-up|0
171120|NCT00526630|598444|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
171121|NCT00526630|598445|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
171122|NCT00526630|598444|P2|First Intervention Period - 12 Weeks|Withdrawn|3
171123|NCT00526630|598445|P1|First Intervention Period - 12 Weeks|Withdrawn|0
171124|NCT00526331|598544|P1|Overall Study|Sponsor Termination|55
171125|NCT00526227|598552|P1|Overall Study|Death|1
171126|NCT00526227|598552|P1|Overall Study|Device not implanted|1
171127|NCT00526162|598563|P1|Overall Study|Device not implanted|3
171128|NCT00526110|598593|P2|Overall Study|Poor Tolerance|5
171129|NCT00526110|598594|P1|Overall Study|Poor Tolerance|0
171130|NCT00526110|598593|P2|Overall Study|Withdrawal by Subject|2
171131|NCT00526110|598594|P1|Overall Study|Withdrawal by Subject|0
171132|NCT00526110|598593|P2|Overall Study|Maximal Response|6
171133|NCT00526110|598594|P1|Overall Study|Maximal Response|0
171134|NCT00526110|598593|P2|Overall Study|Disease Progression|19
171135|NCT00526110|598594|P1|Overall Study|Disease Progression|0
171136|NCT00526110|598593|P2|Overall Study|Adverse Event|9
171137|NCT00526110|598594|P1|Overall Study|Adverse Event|2
171138|NCT00526097|598603|P2|Overall Study|Other|1
171139|NCT00526097|598604|P1|Overall Study|Other|2
171140|NCT00526097|598603|P2|Overall Study|Withdrawal by Subject|1
171141|NCT00526097|598604|P1|Overall Study|Withdrawal by Subject|3
171142|NCT00526097|598603|P2|Overall Study|Protocol Violation|10
171143|NCT00526097|598604|P1|Overall Study|Protocol Violation|4
171144|NCT00526097|598603|P2|Overall Study|Adverse Event|44
171145|NCT00526097|598604|P1|Overall Study|Adverse Event|6
171146|NCT00525915|598791|P2|Overall Study|Unrelated illness|0
171147|NCT00525915|598792|P1|Overall Study|Unrelated illness|1
171148|NCT00525915|598791|P2|Overall Study|Refused Surgery|2
171149|NCT00525915|598792|P1|Overall Study|Refused Surgery|1
171150|NCT00525915|598791|P2|Overall Study|Withdrawal by Subject|0
171151|NCT00525915|598792|P1|Overall Study|Withdrawal by Subject|1
171152|NCT00525915|598791|P2|Overall Study|Disease Progression|6
171153|NCT00525915|598792|P1|Overall Study|Disease Progression|5
171154|NCT00525915|598791|P2|Overall Study|Non-Compliance|1
171155|NCT00525915|598792|P1|Overall Study|Non-Compliance|0
171156|NCT00525902|598798|P1|Overall Study|Lack of Efficacy|1
171157|NCT00525824|598820|P4|Overall Study|Other|1
171158|NCT00525824|598821|P3|Overall Study|Other|3
171159|NCT00525824|598822|P2|Overall Study|Other|3
171160|NCT00525824|598823|P1|Overall Study|Other|1
171161|NCT00525824|598820|P4|Overall Study|Safety reasons|0
171162|NCT00525824|598821|P3|Overall Study|Safety reasons|1
171163|NCT00525824|598822|P2|Overall Study|Safety reasons|0
171164|NCT00525824|598823|P1|Overall Study|Safety reasons|1
171165|NCT00525824|598820|P4|Overall Study|Severe non-compliance|1
171166|NCT00525824|598821|P3|Overall Study|Severe non-compliance|1
171167|NCT00525824|598822|P2|Overall Study|Severe non-compliance|1
171168|NCT00525824|598823|P1|Overall Study|Severe non-compliance|0
171169|NCT00525824|598820|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
171170|NCT00525824|598821|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
171171|NCT00525824|598822|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
171172|NCT00525824|598823|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
171173|NCT00525824|598820|P4|Overall Study|Lost to Follow-up|0
171174|NCT00525824|598821|P3|Overall Study|Lost to Follow-up|4
171175|NCT00525824|598822|P2|Overall Study|Lost to Follow-up|2
171176|NCT00525824|598823|P1|Overall Study|Lost to Follow-up|4
171177|NCT00525824|598820|P4|Overall Study|Withdrawal by Subject|4
171178|NCT00525824|598821|P3|Overall Study|Withdrawal by Subject|3
171179|NCT00525824|598822|P2|Overall Study|Withdrawal by Subject|9
171180|NCT00525824|598823|P1|Overall Study|Withdrawal by Subject|5
171181|NCT00525824|598820|P4|Overall Study|Adverse Event|7
171182|NCT00525824|598821|P3|Overall Study|Adverse Event|6
171183|NCT00525824|598822|P2|Overall Study|Adverse Event|11
171184|NCT00525824|598823|P1|Overall Study|Adverse Event|7
171185|NCT00525512|598928|P4|Open-Label Phase|Other reason (not specified)|5
171186|NCT00525512|598929|P3|Open-Label Phase|Other reason (not specified)|4
171187|NCT00525512|598930|P2|Open-Label Phase|Other reason (not specified)|0
171188|NCT00525512|598931|P1|Open-Label Phase|Other reason (not specified)|0
171189|NCT00525512|598928|P4|Open-Label Phase|Lost to Follow-up|0
171190|NCT00525512|598929|P3|Open-Label Phase|Lost to Follow-up|1
171191|NCT00525512|598930|P2|Open-Label Phase|Lost to Follow-up|0
171192|NCT00525512|598931|P1|Open-Label Phase|Lost to Follow-up|0
171193|NCT00525512|598928|P4|Open-Label Phase|Adverse Event|0
171194|NCT00525512|598929|P3|Open-Label Phase|Adverse Event|1
171195|NCT00525512|598930|P2|Open-Label Phase|Adverse Event|0
171196|NCT00525512|598931|P1|Open-Label Phase|Adverse Event|0
171197|NCT00525512|598928|P4|Double-Blind Phase|Other reason (not specified)|0
171198|NCT00525512|598929|P3|Double-Blind Phase|Other reason (not specified)|0
171199|NCT00525512|598930|P2|Double-Blind Phase|Other reason (not specified)|13
171200|NCT00525512|598931|P1|Double-Blind Phase|Other reason (not specified)|12
171201|NCT00525512|598928|P4|Double-Blind Phase|Lack of Efficacy|0
171202|NCT00525512|598929|P3|Double-Blind Phase|Lack of Efficacy|0
171203|NCT00525512|598930|P2|Double-Blind Phase|Lack of Efficacy|5
171204|NCT00525512|598931|P1|Double-Blind Phase|Lack of Efficacy|13
171205|NCT00525512|598928|P4|Double-Blind Phase|Withdrawal by Subject|0
171206|NCT00525512|598929|P3|Double-Blind Phase|Withdrawal by Subject|0
171207|NCT00525512|598930|P2|Double-Blind Phase|Withdrawal by Subject|12
171208|NCT00525512|598931|P1|Double-Blind Phase|Withdrawal by Subject|17
171209|NCT00525512|598928|P4|Double-Blind Phase|Lost to Follow-up|0
171210|NCT00525512|598929|P3|Double-Blind Phase|Lost to Follow-up|0
171211|NCT00525512|598930|P2|Double-Blind Phase|Lost to Follow-up|7
171212|NCT00525512|598931|P1|Double-Blind Phase|Lost to Follow-up|3
171213|NCT00525512|598928|P4|Double-Blind Phase|Protocol Violation|0
171214|NCT00525512|598929|P3|Double-Blind Phase|Protocol Violation|0
171215|NCT00525512|598930|P2|Double-Blind Phase|Protocol Violation|1
171216|NCT00525512|598931|P1|Double-Blind Phase|Protocol Violation|3
171217|NCT00525512|598928|P4|Double-Blind Phase|Adverse Event|0
171218|NCT00525512|598929|P3|Double-Blind Phase|Adverse Event|0
171219|NCT00525512|598930|P2|Double-Blind Phase|Adverse Event|28
171220|NCT00525512|598931|P1|Double-Blind Phase|Adverse Event|48
171221|NCT00525499|599073|P4|Overall Study|Protocol Violation|0
171222|NCT00525499|599074|P3|Overall Study|Protocol Violation|1
171223|NCT00525499|599075|P2|Overall Study|Protocol Violation|1
171224|NCT00525499|599076|P1|Overall Study|Protocol Violation|0
171225|NCT00525499|599073|P4|Overall Study|Withdrawal by Subject|2
171226|NCT00525499|599074|P3|Overall Study|Withdrawal by Subject|5
171227|NCT00525499|599075|P2|Overall Study|Withdrawal by Subject|1
171228|NCT00525499|599076|P1|Overall Study|Withdrawal by Subject|5
171229|NCT00525499|599073|P4|Overall Study|Adverse Event|1
171230|NCT00525499|599074|P3|Overall Study|Adverse Event|0
171231|NCT00525499|599075|P2|Overall Study|Adverse Event|1
171232|NCT00525499|599076|P1|Overall Study|Adverse Event|0
171233|NCT00525499|599073|P4|Overall Study|Lost to Follow-up|4
171234|NCT00525499|599074|P3|Overall Study|Lost to Follow-up|1
171235|NCT00525499|599075|P2|Overall Study|Lost to Follow-up|4
171236|NCT00525499|599076|P1|Overall Study|Lost to Follow-up|2
171237|NCT00525265|599103|P2|Overall Study|Protocol Violation|0
171238|NCT00525265|599104|P1|Overall Study|Protocol Violation|1
171239|NCT00525161|599161|P1|Overall Study|Adverse Event|1
171240|NCT00525148|599171|P4|Overall Study|Other than stated|3
171241|NCT00525148|599172|P3|Overall Study|Other than stated|0
171242|NCT00525148|599173|P2|Overall Study|Other than stated|1
171243|NCT00525148|599174|P1|Overall Study|Other than stated|2
171244|NCT00525148|599171|P4|Overall Study|Refused continuation of study medication|1
171245|NCT00525148|599172|P3|Overall Study|Refused continuation of study medication|0
171246|NCT00525148|599173|P2|Overall Study|Refused continuation of study medication|2
171247|NCT00525148|599174|P1|Overall Study|Refused continuation of study medication|0
171248|NCT00525148|599171|P4|Overall Study|Progressive disease|49
171249|NCT00525148|599172|P3|Overall Study|Progressive disease|6
171250|NCT00525148|599173|P2|Overall Study|Progressive disease|30
171251|NCT00525148|599174|P1|Overall Study|Progressive disease|18
171252|NCT00525148|599171|P4|Overall Study|Other Adverse Event|8
171253|NCT00525148|599172|P3|Overall Study|Other Adverse Event|1
171254|NCT00525148|599173|P2|Overall Study|Other Adverse Event|5
171255|NCT00525148|599174|P1|Overall Study|Other Adverse Event|3
171256|NCT00525031|599202|P2|Overall Study|Disease Progression|1
171257|NCT00525031|599203|P1|Overall Study|Disease Progression|1
171258|NCT00524771|599217|P2|Overall Study|Protocol Violation|585
171259|NCT00524771|599218|P1|Overall Study|Protocol Violation|220
171260|NCT00524745|599232|P4|Overall Study|subject withdrawal or lost to follow up|22
171261|NCT00524745|599233|P3|Overall Study|subject withdrawal or lost to follow up|29
171262|NCT00524745|599234|P2|Overall Study|subject withdrawal or lost to follow up|13
171263|NCT00524745|599235|P1|Overall Study|subject withdrawal or lost to follow up|34
171264|NCT00524680|599261|P4|Overall Study|Withdrawal by Subject|1
171265|NCT00524680|599262|P3|Overall Study|Withdrawal by Subject|1
171266|NCT00524680|599263|P2|Overall Study|Withdrawal by Subject|0
171267|NCT00524680|599264|P1|Overall Study|Withdrawal by Subject|1
171268|NCT00524680|599261|P4|Overall Study|not specified|3
171269|NCT00524680|599262|P3|Overall Study|not specified|2
171270|NCT00524680|599263|P2|Overall Study|not specified|1
171271|NCT00524680|599264|P1|Overall Study|not specified|0
171272|NCT00524680|599261|P4|Overall Study|Adverse Event|1
171273|NCT00524680|599262|P3|Overall Study|Adverse Event|0
171274|NCT00524680|599263|P2|Overall Study|Adverse Event|0
171275|NCT00524680|599264|P1|Overall Study|Adverse Event|2
171276|NCT00524680|599261|P4|Overall Study|progression|1
171277|NCT00524680|599262|P3|Overall Study|progression|0
171278|NCT00524680|599263|P2|Overall Study|progression|0
171279|NCT00524680|599264|P1|Overall Study|progression|0
171280|NCT00524589|599286|P1|Overall Study|Disease Progression|16
171281|NCT00524589|599286|P1|Overall Study|Withdrawal by Subject|2
171282|NCT00524485|599337|P1|Overall Study|Withdrawal by Subject|5
171283|NCT00524459|599347|P1|Overall Study|Other|1
171284|NCT00524459|599347|P1|Overall Study|Withdrawal by Subject|1
171285|NCT00524420|599357|P2|Overall Study|Lack of Efficacy|0
171286|NCT00524420|599358|P1|Overall Study|Lack of Efficacy|1
171287|NCT00524368|599376|P2|Overall Study|Other|2
171288|NCT00524368|599377|P1|Overall Study|Other|3
171289|NCT00524368|599376|P2|Overall Study|Ineligible to Continue the study|5
171290|NCT00524368|599377|P1|Overall Study|Ineligible to Continue the study|2
171291|NCT00524368|599376|P2|Overall Study|Sponsor's Decision|0
171292|NCT00524368|599377|P1|Overall Study|Sponsor's Decision|2
171293|NCT00524368|599376|P2|Overall Study|Reached a Virologic Endpoint|2
171294|NCT00524368|599377|P1|Overall Study|Reached a Virologic Endpoint|3
171295|NCT00524368|599376|P2|Overall Study|Non-compliant|9
171296|NCT00524368|599377|P1|Overall Study|Non-compliant|8
171297|NCT00524368|599376|P2|Overall Study|Withdrawal by Subject|5
171298|NCT00524368|599377|P1|Overall Study|Withdrawal by Subject|4
171299|NCT00524368|599376|P2|Overall Study|Lost to Follow-up|13
171300|NCT00524368|599377|P1|Overall Study|Lost to Follow-up|9
171301|NCT00524368|599376|P2|Overall Study|Adverse Event|12
171302|NCT00524368|599377|P1|Overall Study|Adverse Event|10
171303|NCT00524316|599411|P1|Overall Study|Disease Progression|7
171304|NCT00524316|599411|P1|Overall Study|Adverse Event|7
171305|NCT00524316|599411|P1|Overall Study|Withdrawal by Subject|2
171306|NCT00524303|599423|P3|Overall Study|Completed 5 years|1
171307|NCT00524303|599424|P2|Overall Study|Completed 5 years|0
171308|NCT00524303|599425|P1|Overall Study|Completed 5 years|0
171309|NCT00524303|599423|P3|Overall Study|Physician Decision|1
171310|NCT00524303|599424|P2|Overall Study|Physician Decision|0
171311|NCT00524303|599425|P1|Overall Study|Physician Decision|0
171312|NCT00524303|599423|P3|Overall Study|Sponsor Request|1
171313|NCT00524303|599424|P2|Overall Study|Sponsor Request|0
171314|NCT00524303|599425|P1|Overall Study|Sponsor Request|0
171315|NCT00524303|599423|P3|Overall Study|Disease Recurrence|0
171316|NCT00524303|599424|P2|Overall Study|Disease Recurrence|1
171317|NCT00524303|599425|P1|Overall Study|Disease Recurrence|0
171318|NCT00524303|599423|P3|Overall Study|Disease Progression|1
171319|NCT00524303|599424|P2|Overall Study|Disease Progression|4
171320|NCT00524303|599425|P1|Overall Study|Disease Progression|0
171321|NCT00524303|599423|P3|Overall Study|Worsening Peripheral Neuropathy|0
171322|NCT00524303|599424|P2|Overall Study|Worsening Peripheral Neuropathy|0
171323|NCT00524303|599425|P1|Overall Study|Worsening Peripheral Neuropathy|1
171324|NCT00524303|599423|P3|Overall Study|Did not Complete Study Dosing|0
171325|NCT00524303|599424|P2|Overall Study|Did not Complete Study Dosing|0
171326|NCT00524303|599425|P1|Overall Study|Did not Complete Study Dosing|1
171327|NCT00524303|599423|P3|Overall Study|Adverse Event|3
171328|NCT00524303|599424|P2|Overall Study|Adverse Event|2
171329|NCT00524303|599425|P1|Overall Study|Adverse Event|1
171330|NCT00524303|599423|P3|Overall Study|Death|3
171331|NCT00524303|599424|P2|Overall Study|Death|2
171332|NCT00524303|599425|P1|Overall Study|Death|0
171333|NCT00524303|599423|P3|Overall Study|Withdrawal by Subject|4
171334|NCT00524303|599424|P2|Overall Study|Withdrawal by Subject|0
171335|NCT00524303|599425|P1|Overall Study|Withdrawal by Subject|3
171336|NCT00524303|599423|P3|Overall Study|Protocol Violation|1
171337|NCT00524303|599424|P2|Overall Study|Protocol Violation|1
171338|NCT00524303|599425|P1|Overall Study|Protocol Violation|0
171339|NCT00524303|599423|P3|Overall Study|Lost to Follow-up|3
171340|NCT00524303|599424|P2|Overall Study|Lost to Follow-up|0
171341|NCT00524303|599425|P1|Overall Study|Lost to Follow-up|6
171342|NCT00524173|599477|P2|Overall Study|Had not reached endpoint at study close|1
171343|NCT00524173|599478|P1|Overall Study|Had not reached endpoint at study close|4
171344|NCT00524173|599477|P2|Overall Study|Death|0
171345|NCT00524173|599478|P1|Overall Study|Death|1
171346|NCT00524173|599477|P2|Overall Study|Lost to Follow-up|1
171347|NCT00524173|599478|P1|Overall Study|Lost to Follow-up|0
171348|NCT00524134|599490|P1|Overall Study|Physician Decision|1
171349|NCT00524134|599490|P1|Overall Study|Withdrawal by Subject|1
171350|NCT00524121|599497|P1|Overall Study|Not treated (changed mind)|1
171351|NCT00524121|599497|P1|Overall Study|Not treated (became ineligible)|4
171352|NCT00524121|599497|P1|Overall Study|Death|1
171353|NCT00524121|599497|P1|Overall Study|Other|1
171354|NCT00524121|599497|P1|Overall Study|Patient refused|2
171355|NCT00524121|599497|P1|Overall Study|Adverse Event|4
171356|NCT00524121|599497|P1|Overall Study|Disease progression|6
171357|NCT00524043|599517|P3|Overall Study|Various (eg, incarceration)|0
171358|NCT00524043|599518|P2|Overall Study|Various (eg, incarceration)|1
171359|NCT00524043|599519|P1|Overall Study|Various (eg, incarceration)|2
171360|NCT00524043|599517|P3|Overall Study|Lost to Follow-up|3
171361|NCT00524043|599518|P2|Overall Study|Lost to Follow-up|5
171362|NCT00524043|599519|P1|Overall Study|Lost to Follow-up|3
171363|NCT00524043|599517|P3|Overall Study|Adverse Event|7
171364|NCT00524043|599518|P2|Overall Study|Adverse Event|2
171365|NCT00524043|599519|P1|Overall Study|Adverse Event|5
171366|NCT00524043|599517|P3|Overall Study|Withdrawal by Subject|7
171367|NCT00524043|599518|P2|Overall Study|Withdrawal by Subject|7
171368|NCT00524043|599519|P1|Overall Study|Withdrawal by Subject|5
171369|NCT00524043|599517|P3|Overall Study|Lack of Efficacy|14
171370|NCT00524043|599518|P2|Overall Study|Lack of Efficacy|13
171371|NCT00524043|599519|P1|Overall Study|Lack of Efficacy|15
171372|NCT00524030|599541|P2|Overall Study|Death|1
171373|NCT00524030|599542|P1|Overall Study|Death|0
171374|NCT00524030|599541|P2|Overall Study|Adverse Event|21
171375|NCT00524030|599542|P1|Overall Study|Adverse Event|3
171376|NCT00524030|599541|P2|Overall Study|Pregnancy|0
171377|NCT00524030|599542|P1|Overall Study|Pregnancy|1
171378|NCT00524030|599541|P2|Overall Study|Protocol Violation|1
171379|NCT00524030|599542|P1|Overall Study|Protocol Violation|0
171380|NCT00524030|599541|P2|Overall Study|Noncompliance/Investigator discretion|2
171381|NCT00524030|599542|P1|Overall Study|Noncompliance/Investigator discretion|0
171382|NCT00524030|599541|P2|Overall Study|Withdrawal by Subject|8
171383|NCT00524030|599542|P1|Overall Study|Withdrawal by Subject|3
171384|NCT00524030|599541|P2|Overall Study|Lost to Follow-up|2
171385|NCT00524030|599542|P1|Overall Study|Lost to Follow-up|0
171386|NCT00524030|599541|P2|Overall Study|Lack of Efficacy|24
171387|NCT00524030|599542|P1|Overall Study|Lack of Efficacy|10
171388|NCT00523991|599560|P2|Overall Study|Other reason (not specified)|0
171389|NCT00523991|599561|P1|Overall Study|Other reason (not specified)|3
171390|NCT00523991|599560|P2|Overall Study|Withdrawal by Subject|17
171391|NCT00523991|599561|P1|Overall Study|Withdrawal by Subject|7
171392|NCT00523991|599560|P2|Overall Study|Lost to Follow-up|1
171393|NCT00523991|599561|P1|Overall Study|Lost to Follow-up|4
171394|NCT00523991|599560|P2|Overall Study|Protocol Violation|4
171395|NCT00523991|599561|P1|Overall Study|Protocol Violation|1
171396|NCT00523991|599560|P2|Overall Study|Adverse Event|5
171397|NCT00523991|599561|P1|Overall Study|Adverse Event|6
171398|NCT00523978|599841|P2|Overall Study|Death|0
171399|NCT00523978|599842|P1|Overall Study|Death|1
171400|NCT00523978|599841|P2|Overall Study|Screen Failures|1
171401|NCT00523978|599842|P1|Overall Study|Screen Failures|5
171402|NCT00523978|599841|P2|Overall Study|Withdrawal by Subject|7
171403|NCT00523978|599842|P1|Overall Study|Withdrawal by Subject|3
171404|NCT00523848|599864|P1|Overall Study|Other, unspecified|4
171405|NCT00523848|599864|P1|Overall Study|Disease Progression|5
171406|NCT00523848|599864|P1|Overall Study|NOT TREATED (Became ineligible)|2
171407|NCT00523848|599864|P1|Overall Study|Withdrawal by Subject|2
171408|NCT00523848|599864|P1|Overall Study|Adverse Event|11
171409|NCT00523744|599874|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
171410|NCT00523744|599874|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
171411|NCT00523744|599874|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
171412|NCT00523744|599874|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
171413|NCT00523744|599874|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
171414|NCT00523744|599874|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
171415|NCT00523718|599893|P2|Overall Study|Protocol Violation|0
171416|NCT00523718|599894|P1|Overall Study|Protocol Violation|2
171417|NCT00523718|599893|P2|Overall Study|Withdrawal by Subject|0
171418|NCT00523718|599894|P1|Overall Study|Withdrawal by Subject|1
171419|NCT00523705|599908|P2|Overall Study|No time for study.|1
171420|NCT00523705|599909|P1|Overall Study|No time for study.|0
171421|NCT00523640|599921|P1|Overall Study|Death|1
171422|NCT00523549|599938|P2|Overall Study|Lost to Follow-up|5
171423|NCT00523549|599939|P1|Overall Study|Lost to Follow-up|3
171424|NCT00523549|599938|P2|Overall Study|Patient withdrew consent|6
171425|NCT00523549|599939|P1|Overall Study|Patient withdrew consent|7
171426|NCT00523549|599938|P2|Overall Study|Protocol Deviation|1
171427|NCT00523549|599939|P1|Overall Study|Protocol Deviation|3
171428|NCT00523549|599938|P2|Overall Study|Unsatisfactory therapeutic effect|1
171429|NCT00523549|599939|P1|Overall Study|Unsatisfactory therapeutic effect|0
171430|NCT00523549|599938|P2|Overall Study|Adverse Event|3
171431|NCT00523549|599939|P1|Overall Study|Adverse Event|6
171432|NCT00523419|599957|P1|Overall Study|Death due to Adverse Event|2
171433|NCT00523419|599957|P1|Overall Study|Death due to Study Disease|4
171434|NCT00523419|599957|P1|Overall Study|Progressive Disease|22
171435|NCT00523419|599957|P1|Overall Study|Physician Decision|2
171436|NCT00523419|599957|P1|Overall Study|Withdrawal by Subject|1
171437|NCT00523419|599957|P1|Overall Study|Adverse Event|1
171438|NCT00523367|599967|P1|Overall Study|4 Withdrawn by PI|4
171439|NCT00523367|599967|P1|Overall Study|19 screen failures|19
171440|NCT00523341|599973|P2|Overall Study|Disease Progression|0
171441|NCT00523341|599974|P1|Overall Study|Disease Progression|1
171442|NCT00523341|599973|P2|Overall Study|Ineligibility Determined|4
171443|NCT00523341|599974|P1|Overall Study|Ineligibility Determined|3
171444|NCT00523341|599973|P2|Overall Study|Protocol Deviation|5
171445|NCT00523341|599974|P1|Overall Study|Protocol Deviation|6
171446|NCT00523341|599973|P2|Overall Study|Requirement for Alternative Therapy|14
171447|NCT00523341|599974|P1|Overall Study|Requirement for Alternative Therapy|4
171448|NCT00523341|599973|P2|Overall Study|Physician Decision|13
171449|NCT00523341|599974|P1|Overall Study|Physician Decision|14
171450|NCT00523341|599973|P2|Overall Study|Non-compliance|13
171451|NCT00523341|599974|P1|Overall Study|Non-compliance|20
171452|NCT00523341|599973|P2|Overall Study|Lost to Follow-up|61
171453|NCT00523341|599974|P1|Overall Study|Lost to Follow-up|73
171454|NCT00523341|599973|P2|Overall Study|Death|110
171455|NCT00523341|599974|P1|Overall Study|Death|101
171456|NCT00523341|599973|P2|Overall Study|Adverse Event|155
171457|NCT00523341|599974|P1|Overall Study|Adverse Event|122
171458|NCT00523341|599973|P2|Overall Study|Other|198
171459|NCT00523341|599974|P1|Overall Study|Other|181
171460|NCT00523341|599973|P2|Overall Study|Withdrawal by Subject|427
171461|NCT00523341|599974|P1|Overall Study|Withdrawal by Subject|399
171462|NCT00522951|600078|P2|Period 2|residual contrast medium|1
171463|NCT00522951|600079|P1|Period 2|residual contrast medium|1
171464|NCT00522951|600078|P2|Period 2|Withdrawal by Subject|0
171465|NCT00522951|600079|P1|Period 2|Withdrawal by Subject|1
171466|NCT00522951|600078|P2|Washout Period|Death|1
171467|NCT00522951|600079|P1|Washout Period|Death|0
171468|NCT00522951|600078|P2|Washout Period|Adverse Event|1
171469|NCT00522951|600079|P1|Washout Period|Adverse Event|0
171470|NCT00522951|600078|P2|Period 1|body motion|1
171471|NCT00522951|600079|P1|Period 1|body motion|0
171472|NCT00522873|600134|P2|Overall Study|Never Received Medication|0
171473|NCT00522873|600135|P1|Overall Study|Never Received Medication|1
171474|NCT00522873|600134|P2|Overall Study|Medication Errors|1
171475|NCT00522873|600135|P1|Overall Study|Medication Errors|1
171476|NCT00522873|600134|P2|Overall Study|Personal Reasons|1
171477|NCT00522873|600135|P1|Overall Study|Personal Reasons|8
171478|NCT00522873|600134|P2|Overall Study|Lost to Follow-up|3
171479|NCT00522873|600135|P1|Overall Study|Lost to Follow-up|11
171480|NCT00522873|600134|P2|Overall Study|Protocol Violation|4
171481|NCT00522873|600135|P1|Overall Study|Protocol Violation|14
171482|NCT00522873|600134|P2|Overall Study|Withdrawal by Subject|9
171483|NCT00522873|600135|P1|Overall Study|Withdrawal by Subject|20
171484|NCT00522873|600134|P2|Overall Study|Adverse Event|26
171485|NCT00522873|600135|P1|Overall Study|Adverse Event|41
171486|NCT00522626|600148|P1|Overall Study|Lost to Follow-up|7
171487|NCT00522548|600154|P2|Overall Study|Withdrawal by Subject|2
171488|NCT00522548|600155|P1|Overall Study|Withdrawal by Subject|0
171489|NCT00522548|600154|P2|Overall Study|Adverse Event|2
171490|NCT00522548|600155|P1|Overall Study|Adverse Event|2
171491|NCT00522457|600183|P1|Overall Study|Adverse Event|2
171492|NCT00522457|600183|P1|Overall Study|Due to disease progression|16
171493|NCT00522431|600189|P1|Overall Study|Other/unknown|1
171494|NCT00522431|600189|P1|Overall Study|Subject non-compliance|1
171495|NCT00522431|600189|P1|Overall Study|Withdrawal by Subject|2
171496|NCT00522431|600189|P1|Overall Study|Protocol Violation|2
171497|NCT00522431|600189|P1|Overall Study|Adverse Event|5
171498|NCT00522418|600196|P2|Overall Study|Lack of Efficacy|1
171499|NCT00522418|600197|P1|Overall Study|Lack of Efficacy|0
171500|NCT00522418|600196|P2|Overall Study|Consent Withdraw|2
171501|NCT00522418|600197|P1|Overall Study|Consent Withdraw|1
171502|NCT00522418|600196|P2|Overall Study|Reason Not Specified|1
171503|NCT00522418|600197|P1|Overall Study|Reason Not Specified|3
171504|NCT00522418|600196|P2|Overall Study|Noncompliance|2
171505|NCT00522418|600197|P1|Overall Study|Noncompliance|2
171506|NCT00522418|600196|P2|Overall Study|Early Study Termination|47
171507|NCT00522418|600197|P1|Overall Study|Early Study Termination|46
171508|NCT00522418|600196|P2|Overall Study|Local IRB Consent Violation|5
171509|NCT00522418|600197|P1|Overall Study|Local IRB Consent Violation|5
171510|NCT00522392|600245|P2|Overall Study|Non-compliance|1
171511|NCT00522392|600246|P1|Overall Study|Non-compliance|0
171512|NCT00522392|600245|P2|Overall Study|Physician Decision|1
171513|NCT00522392|600246|P1|Overall Study|Physician Decision|0
171514|NCT00522392|600245|P2|Overall Study|Withdrawal by Subject|1
171515|NCT00522392|600246|P1|Overall Study|Withdrawal by Subject|1
171516|NCT00522392|600245|P2|Overall Study|Adverse Event|7
171517|NCT00522392|600246|P1|Overall Study|Adverse Event|7
171518|NCT00522392|600245|P2|Overall Study|Disease progression|3
171519|NCT00522392|600246|P1|Overall Study|Disease progression|0
171520|NCT00522379|600263|P5|Overall Study|Subject Withdrawal|0
171521|NCT00522379|600264|P4|Overall Study|Subject Withdrawal|1
171522|NCT00522379|600265|P3|Overall Study|Subject Withdrawal|0
171523|NCT00522379|600266|P2|Overall Study|Subject Withdrawal|0
171524|NCT00522379|600267|P1|Overall Study|Subject Withdrawal|0
171525|NCT00522379|600263|P5|Overall Study|Site Closed|0
171526|NCT00522379|600264|P4|Overall Study|Site Closed|1
171527|NCT00522379|600265|P3|Overall Study|Site Closed|0
171528|NCT00522379|600266|P2|Overall Study|Site Closed|0
171529|NCT00522379|600267|P1|Overall Study|Site Closed|0
171530|NCT00522379|600263|P5|Overall Study|Family Problem|0
171531|NCT00522379|600264|P4|Overall Study|Family Problem|0
171532|NCT00522379|600265|P3|Overall Study|Family Problem|1
171533|NCT00522379|600266|P2|Overall Study|Family Problem|0
171534|NCT00522379|600267|P1|Overall Study|Family Problem|0
171535|NCT00522379|600263|P5|Overall Study|Sponsor Request|0
171536|NCT00522379|600264|P4|Overall Study|Sponsor Request|0
171537|NCT00522379|600265|P3|Overall Study|Sponsor Request|0
171538|NCT00522379|600266|P2|Overall Study|Sponsor Request|1
171539|NCT00522379|600267|P1|Overall Study|Sponsor Request|0
171540|NCT00522379|600263|P5|Overall Study|Subject Moved|0
171541|NCT00522379|600264|P4|Overall Study|Subject Moved|0
171542|NCT00522379|600265|P3|Overall Study|Subject Moved|0
171543|NCT00522379|600266|P2|Overall Study|Subject Moved|1
171544|NCT00522379|600267|P1|Overall Study|Subject Moved|1
171545|NCT00522379|600263|P5|Overall Study|Dispensing error|0
171546|NCT00522379|600264|P4|Overall Study|Dispensing error|1
171547|NCT00522379|600265|P3|Overall Study|Dispensing error|0
171548|NCT00522379|600266|P2|Overall Study|Dispensing error|0
171549|NCT00522379|600267|P1|Overall Study|Dispensing error|1
171550|NCT00522379|600263|P5|Overall Study|Randomization error|1
171551|NCT00522379|600264|P4|Overall Study|Randomization error|0
171552|NCT00522379|600265|P3|Overall Study|Randomization error|0
171553|NCT00522379|600266|P2|Overall Study|Randomization error|0
171554|NCT00522379|600267|P1|Overall Study|Randomization error|0
171555|NCT00522379|600263|P5|Overall Study|Lost to Follow-up|2
171556|NCT00522379|600264|P4|Overall Study|Lost to Follow-up|2
171557|NCT00522379|600265|P3|Overall Study|Lost to Follow-up|4
171558|NCT00522379|600266|P2|Overall Study|Lost to Follow-up|0
171559|NCT00522379|600267|P1|Overall Study|Lost to Follow-up|1
171560|NCT00522379|600263|P5|Overall Study|Unsatisfactory Subject Compliance|0
171561|NCT00522379|600264|P4|Overall Study|Unsatisfactory Subject Compliance|0
171562|NCT00522379|600265|P3|Overall Study|Unsatisfactory Subject Compliance|0
171563|NCT00522379|600266|P2|Overall Study|Unsatisfactory Subject Compliance|2
171564|NCT00522379|600267|P1|Overall Study|Unsatisfactory Subject Compliance|1
171565|NCT00522379|600263|P5|Overall Study|Protocol Violation|0
171566|NCT00522379|600264|P4|Overall Study|Protocol Violation|0
171567|NCT00522379|600265|P3|Overall Study|Protocol Violation|2
171568|NCT00522379|600266|P2|Overall Study|Protocol Violation|1
171569|NCT00522379|600267|P1|Overall Study|Protocol Violation|1
171570|NCT00522379|600263|P5|Overall Study|Withdrawal by Subject|0
171571|NCT00522379|600264|P4|Overall Study|Withdrawal by Subject|2
171572|NCT00522379|600265|P3|Overall Study|Withdrawal by Subject|1
171573|NCT00522379|600266|P2|Overall Study|Withdrawal by Subject|3
171574|NCT00522379|600267|P1|Overall Study|Withdrawal by Subject|2
171575|NCT00522379|600263|P5|Overall Study|Lack of Efficacy|7
171576|NCT00522379|600264|P4|Overall Study|Lack of Efficacy|2
171577|NCT00522379|600265|P3|Overall Study|Lack of Efficacy|2
171578|NCT00522379|600266|P2|Overall Study|Lack of Efficacy|0
171579|NCT00522379|600267|P1|Overall Study|Lack of Efficacy|3
171580|NCT00522379|600263|P5|Overall Study|Adverse Event|17
171581|NCT00522379|600264|P4|Overall Study|Adverse Event|5
171582|NCT00522379|600265|P3|Overall Study|Adverse Event|12
171583|NCT00522379|600266|P2|Overall Study|Adverse Event|15
171584|NCT00522379|600267|P1|Overall Study|Adverse Event|12
171585|NCT00522301|600369|P1|Overall Study|Adverse Event|5
171586|NCT00522301|600369|P1|Overall Study|Withdrawal by Subject|1
171587|NCT00522275|600373|P1|Overall Study|Other: Subject had surgery for epilepsy|2
171588|NCT00522275|600373|P1|Overall Study|Other: Subject ran out of medication|1
171589|NCT00522275|600373|P1|Overall Study|Other: Sponsor request|2
171590|NCT00522275|600373|P1|Overall Study|Other: Travel to / from site difficulty|3
171591|NCT00522275|600373|P1|Overall Study|Other: Site / clinic closed|4
171592|NCT00522275|600373|P1|Overall Study|Other: Subject arrested|1
171593|NCT00522275|600373|P1|Overall Study|Other: Subject relocated|2
171594|NCT00522275|600373|P1|Overall Study|Other: Subject is pregnant|2
171595|NCT00522275|600373|P1|Overall Study|Other: Subject wants to become pregnant|2
171596|NCT00522275|600373|P1|Overall Study|Lost to Follow-up|8
171597|NCT00522275|600373|P1|Overall Study|Unsatisfactory compliance|11
171598|NCT00522275|600373|P1|Overall Study|Protocol deviation|1
171599|NCT00522275|600373|P1|Overall Study|Subject withdrew consent|16
171600|NCT00522275|600373|P1|Overall Study|Lack of Efficacy|80
171601|NCT00522275|600373|P1|Overall Study|Adverse Event|35
171602|NCT00522041|600394|P2|Overall Study|Did not receive treatment|1
171603|NCT00522041|600395|P1|Overall Study|Did not receive treatment|0
171604|NCT00522041|600394|P2|Overall Study|Voluntary withdrawal|4
171605|NCT00522041|600395|P1|Overall Study|Voluntary withdrawal|5
171606|NCT00522041|600394|P2|Overall Study|Lost to Follow-up|4
171607|NCT00522041|600395|P1|Overall Study|Lost to Follow-up|1
171608|NCT00522041|600394|P2|Overall Study|Protocol Violation|0
171609|NCT00522041|600395|P1|Overall Study|Protocol Violation|2
171610|NCT00522041|600394|P2|Overall Study|Adverse Event|3
171611|NCT00522041|600395|P1|Overall Study|Adverse Event|9
171612|NCT00521599|600454|P3|Overall Study|Did not meet protocol eligibility|1
171613|NCT00521599|600455|P2|Overall Study|Did not meet protocol eligibility|2
171614|NCT00521599|600456|P1|Overall Study|Did not meet protocol eligibility|2
171615|NCT00521599|600454|P3|Overall Study|Protocol Violation|2
171616|NCT00521599|600455|P2|Overall Study|Protocol Violation|4
171617|NCT00521599|600456|P1|Overall Study|Protocol Violation|2
171618|NCT00521599|600454|P3|Overall Study|Withdrawal by subject treatment related|2
171619|NCT00521599|600455|P2|Overall Study|Withdrawal by subject treatment related|1
171620|NCT00521599|600456|P1|Overall Study|Withdrawal by subject treatment related|3
171621|NCT00521599|600454|P3|Overall Study|Withdrawal by Subject|1
171622|NCT00521599|600455|P2|Overall Study|Withdrawal by Subject|5
171623|NCT00521599|600456|P1|Overall Study|Withdrawal by Subject|3
171624|NCT00521599|600454|P3|Overall Study|Lost to Follow-up|2
171625|NCT00521599|600455|P2|Overall Study|Lost to Follow-up|1
171626|NCT00521599|600456|P1|Overall Study|Lost to Follow-up|2
171627|NCT00521599|600454|P3|Overall Study|Treatment Failure|22
171628|NCT00521599|600455|P2|Overall Study|Treatment Failure|9
171629|NCT00521599|600456|P1|Overall Study|Treatment Failure|8
171630|NCT00521599|600454|P3|Overall Study|Adverse Event|6
171631|NCT00521599|600455|P2|Overall Study|Adverse Event|7
171632|NCT00521599|600456|P1|Overall Study|Adverse Event|5
171633|NCT00521586|600467|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
171634|NCT00521586|600468|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
171635|NCT00521586|600467|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
171636|NCT00521586|600468|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
171637|NCT00521586|600467|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
171638|NCT00521586|600468|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
171639|NCT00521586|600467|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
171640|NCT00521586|600468|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
171641|NCT00521586|600467|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
171642|NCT00521586|600468|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
171643|NCT00521586|600467|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
171644|NCT00521586|600468|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
171645|NCT00521586|600467|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
171646|NCT00521586|600468|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
171647|NCT00521586|600467|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
171648|NCT00521586|600468|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
171649|NCT00521586|600467|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
171650|NCT00521586|600468|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
171651|NCT00521586|600467|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
171652|NCT00521586|600468|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
171653|NCT00521586|600467|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
171654|NCT00521586|600468|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
171655|NCT00521586|600467|P2|Initial Vaccination (Year 0)|Failed to return|1
171656|NCT00521586|600468|P1|Initial Vaccination (Year 0)|Failed to return|0
171657|NCT00521586|600467|P2|Initial Vaccination (Year 0)|Death|0
171658|NCT00521586|600468|P1|Initial Vaccination (Year 0)|Death|1
171659|NCT00521586|600467|P2|Initial Vaccination (Year 0)|Adverse Event|1
171660|NCT00521586|600468|P1|Initial Vaccination (Year 0)|Adverse Event|0
171661|NCT00521586|600467|P2|Initial Vaccination (Year 0)|Investigator request|0
171662|NCT00521586|600468|P1|Initial Vaccination (Year 0)|Investigator request|2
171663|NCT00521586|600467|P2|Initial Vaccination (Year 0)|Other, unspecified|1
171664|NCT00521586|600468|P1|Initial Vaccination (Year 0)|Other, unspecified|3
171665|NCT00521586|600467|P2|Initial Vaccination (Year 0)|Protocol Violation|5
171666|NCT00521586|600468|P1|Initial Vaccination (Year 0)|Protocol Violation|2
171667|NCT00521586|600467|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
171668|NCT00521586|600468|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
171669|NCT00521586|600467|P2|Initial Vaccination (Year 0)|Subject request|11
171670|NCT00521586|600468|P1|Initial Vaccination (Year 0)|Subject request|8
171671|NCT00521365|600541|P1|Overall Study|Usage of not allowed drugs|6
171672|NCT00521365|600541|P1|Overall Study|Drug compliance|3
171673|NCT00521365|600541|P1|Overall Study|Protocol deviation|2
171674|NCT00521365|600541|P1|Overall Study|Lost to Follow-up|6
171675|NCT00521365|600541|P1|Overall Study|Adverse Event|3
171676|NCT00521339|600571|P3|Treatment Extension Phase|Death|1
171677|NCT00521339|600572|P2|Treatment Extension Phase|Death|0
171678|NCT00521339|600573|P1|Treatment Extension Phase|Death|0
171679|NCT00521339|600571|P3|Treatment Extension Phase|Withdrawal by Subject|2
171680|NCT00521339|600572|P2|Treatment Extension Phase|Withdrawal by Subject|0
171681|NCT00521339|600573|P1|Treatment Extension Phase|Withdrawal by Subject|0
171682|NCT00521339|600571|P3|Treatment Phase|Protocol Violation|0
171683|NCT00521339|600572|P2|Treatment Phase|Protocol Violation|0
171684|NCT00521339|600573|P1|Treatment Phase|Protocol Violation|1
171685|NCT00521339|600571|P3|Treatment Phase|Lost to Follow-up|0
171686|NCT00521339|600572|P2|Treatment Phase|Lost to Follow-up|0
171687|NCT00521339|600573|P1|Treatment Phase|Lost to Follow-up|1
171688|NCT00521339|600571|P3|Treatment Phase|Withdrawal by Subject|0
171689|NCT00521339|600572|P2|Treatment Phase|Withdrawal by Subject|0
171690|NCT00521339|600573|P1|Treatment Phase|Withdrawal by Subject|3
171691|NCT00521339|600571|P3|Treatment Phase|Lack of Efficacy|0
171692|NCT00521339|600572|P2|Treatment Phase|Lack of Efficacy|0
171693|NCT00521339|600573|P1|Treatment Phase|Lack of Efficacy|3
171694|NCT00521339|600571|P3|Treatment Phase|Intolerability to study drug|0
171695|NCT00521339|600572|P2|Treatment Phase|Intolerability to study drug|0
171696|NCT00521339|600573|P1|Treatment Phase|Intolerability to study drug|2
171697|NCT00521339|600571|P3|Treatment Phase|Adverse Event|0
171698|NCT00521339|600572|P2|Treatment Phase|Adverse Event|0
171699|NCT00521339|600573|P1|Treatment Phase|Adverse Event|2
171700|NCT00521144|600641|P5|Overall Study|Progressive Disease|6
171701|NCT00521144|600642|P4|Overall Study|Progressive Disease|0
171702|NCT00521144|600643|P3|Overall Study|Progressive Disease|2
171703|NCT00521144|600644|P2|Overall Study|Progressive Disease|2
171704|NCT00521144|600645|P1|Overall Study|Progressive Disease|4
171705|NCT00521144|600641|P5|Overall Study|Adverse Event|1
171706|NCT00521144|600642|P4|Overall Study|Adverse Event|0
171707|NCT00521144|600643|P3|Overall Study|Adverse Event|0
171708|NCT00521144|600644|P2|Overall Study|Adverse Event|1
171709|NCT00521144|600645|P1|Overall Study|Adverse Event|0
171710|NCT00521144|600641|P5|Overall Study|Not Treated|0
171711|NCT00521144|600642|P4|Overall Study|Not Treated|1
171712|NCT00521144|600643|P3|Overall Study|Not Treated|0
171713|NCT00521144|600644|P2|Overall Study|Not Treated|0
171714|NCT00521144|600645|P1|Overall Study|Not Treated|0
171715|NCT00521079|600659|P2|Overall Study|Withdrawal by Subject|3
171716|NCT00521079|600660|P1|Overall Study|Withdrawal by Subject|5
171717|NCT00521079|600659|P2|Overall Study|Lost to Follow-up|1
171718|NCT00521079|600660|P1|Overall Study|Lost to Follow-up|2
171719|NCT00521079|600659|P2|Overall Study|Adverse Event|1
171720|NCT00521079|600660|P1|Overall Study|Adverse Event|7
171721|NCT00521053|600670|P1|Observation Phase|Physician Decision|1
171811|NCT00520572|600820|P6|Overall Study|Did not receive Treatment|0
171722|NCT00521053|600670|P1|Observation Phase|Other non-study melanoma treatment|1
171723|NCT00521053|600670|P1|Observation Phase|Adverse Event|1
171724|NCT00521053|600670|P1|Observation Phase|Death|2
171725|NCT00521053|600670|P1|Observation Phase|Additional PV-10 via alternate protocol|8
171726|NCT00521053|600670|P1|Observation Phase|Disease Progression|55
171727|NCT00521014|600680|P1|Overall Study|Inevaluable, not treated|1
171728|NCT00521001|600684|P1|Overall Study|Ineligible|1
171729|NCT00520975|600693|P2|Overall Study|Not start protocol therapy|2
171730|NCT00520975|600694|P1|Overall Study|Not start protocol therapy|1
171731|NCT00520975|600693|P2|Overall Study|Other reasons|2
171732|NCT00520975|600694|P1|Overall Study|Other reasons|4
171733|NCT00520975|600693|P2|Overall Study|Other therapy|4
171734|NCT00520975|600694|P1|Overall Study|Other therapy|2
171735|NCT00520975|600693|P2|Overall Study|Withdrawal by Subject|5
171736|NCT00520975|600694|P1|Overall Study|Withdrawal by Subject|3
171737|NCT00520975|600693|P2|Overall Study|Death|2
171738|NCT00520975|600694|P1|Overall Study|Death|0
171739|NCT00520975|600693|P2|Overall Study|Adverse Event|10
171740|NCT00520975|600694|P1|Overall Study|Adverse Event|7
171741|NCT00520975|600693|P2|Overall Study|Disease progression|23
171742|NCT00520975|600694|P1|Overall Study|Disease progression|31
171743|NCT00520936|600726|P8|Overall Study|Protocol Violation|0
171744|NCT00520936|600727|P7|Overall Study|Protocol Violation|1
171745|NCT00520936|600728|P6|Overall Study|Protocol Violation|0
171746|NCT00520936|600729|P5|Overall Study|Protocol Violation|1
171747|NCT00520936|600730|P4|Overall Study|Protocol Violation|0
171748|NCT00520936|600731|P3|Overall Study|Protocol Violation|1
171749|NCT00520936|600732|P2|Overall Study|Protocol Violation|1
171750|NCT00520936|600733|P1|Overall Study|Protocol Violation|0
171751|NCT00520936|600726|P8|Overall Study|Death|0
171752|NCT00520936|600727|P7|Overall Study|Death|1
171753|NCT00520936|600728|P6|Overall Study|Death|0
171754|NCT00520936|600729|P5|Overall Study|Death|0
171755|NCT00520936|600730|P4|Overall Study|Death|0
171756|NCT00520936|600731|P3|Overall Study|Death|0
171757|NCT00520936|600732|P2|Overall Study|Death|0
171758|NCT00520936|600733|P1|Overall Study|Death|0
171759|NCT00520936|600726|P8|Overall Study|Toxicity Requiring Removal from Study|0
171760|NCT00520936|600727|P7|Overall Study|Toxicity Requiring Removal from Study|2
171761|NCT00520936|600728|P6|Overall Study|Toxicity Requiring Removal from Study|0
171762|NCT00520936|600729|P5|Overall Study|Toxicity Requiring Removal from Study|0
171763|NCT00520936|600730|P4|Overall Study|Toxicity Requiring Removal from Study|0
171764|NCT00520936|600731|P3|Overall Study|Toxicity Requiring Removal from Study|0
171765|NCT00520936|600732|P2|Overall Study|Toxicity Requiring Removal from Study|1
171766|NCT00520936|600733|P1|Overall Study|Toxicity Requiring Removal from Study|0
171767|NCT00520936|600726|P8|Overall Study|Withdrawal by Subject|1
171768|NCT00520936|600727|P7|Overall Study|Withdrawal by Subject|0
171769|NCT00520936|600728|P6|Overall Study|Withdrawal by Subject|0
171770|NCT00520936|600729|P5|Overall Study|Withdrawal by Subject|0
171771|NCT00520936|600730|P4|Overall Study|Withdrawal by Subject|0
171772|NCT00520936|600731|P3|Overall Study|Withdrawal by Subject|0
171773|NCT00520936|600732|P2|Overall Study|Withdrawal by Subject|0
171774|NCT00520936|600733|P1|Overall Study|Withdrawal by Subject|0
171775|NCT00520936|600726|P8|Overall Study|Physician Decision|0
171776|NCT00520936|600727|P7|Overall Study|Physician Decision|0
171777|NCT00520936|600728|P6|Overall Study|Physician Decision|0
171778|NCT00520936|600729|P5|Overall Study|Physician Decision|0
171779|NCT00520936|600730|P4|Overall Study|Physician Decision|0
171780|NCT00520936|600731|P3|Overall Study|Physician Decision|1
171781|NCT00520936|600732|P2|Overall Study|Physician Decision|2
171782|NCT00520936|600733|P1|Overall Study|Physician Decision|0
171783|NCT00520845|600760|P1|Overall Study|Alternative Therapy|1
171784|NCT00520845|600760|P1|Overall Study|Withdrawal by Subject|1
171785|NCT00520845|600760|P1|Overall Study|Disease Progression, relapse|13
171786|NCT00520845|600760|P1|Overall Study|Adverse Event|4
171787|NCT00520845|600760|P1|Overall Study|Death|3
171788|NCT00520767|600768|P1|Overall Study|Death|2
171789|NCT00520741|600774|P2|Overall Study|Other reasons for premature termination|6
171790|NCT00520741|600775|P1|Overall Study|Other reasons for premature termination|0
171791|NCT00520741|600774|P2|Overall Study|Lost to Follow-up|4
171792|NCT00520741|600775|P1|Overall Study|Lost to Follow-up|4
171793|NCT00520741|600774|P2|Overall Study|Unsatisfactory compliance of subject|3
171794|NCT00520741|600775|P1|Overall Study|Unsatisfactory compliance of subject|4
171795|NCT00520741|600774|P2|Overall Study|Protocol Violation|15
171796|NCT00520741|600775|P1|Overall Study|Protocol Violation|2
171797|NCT00520741|600774|P2|Overall Study|Withdrawal by Subject|11
171798|NCT00520741|600775|P1|Overall Study|Withdrawal by Subject|0
171799|NCT00520741|600774|P2|Overall Study|Lack of Efficacy|30
171800|NCT00520741|600775|P1|Overall Study|Lack of Efficacy|11
171801|NCT00520741|600774|P2|Overall Study|Adverse Event|56
171802|NCT00520741|600775|P1|Overall Study|Adverse Event|16
171803|NCT00520676|600793|P2|Overall Study|Withdrawal by Subject|11
171804|NCT00520676|600794|P1|Overall Study|Withdrawal by Subject|7
171805|NCT00520676|600793|P2|Overall Study|Physician Decision|1
171806|NCT00520676|600794|P1|Overall Study|Physician Decision|4
171807|NCT00520676|600793|P2|Overall Study|Lost to Follow-up|10
171808|NCT00520676|600794|P1|Overall Study|Lost to Follow-up|6
171809|NCT00520676|600793|P2|Overall Study|Death|81
171810|NCT00520676|600794|P1|Overall Study|Death|84
171812|NCT00520572|600821|P5|Overall Study|Did not receive Treatment|0
171813|NCT00520572|600822|P4|Overall Study|Did not receive Treatment|0
171814|NCT00520572|600823|P3|Overall Study|Did not receive Treatment|1
171815|NCT00520572|600824|P2|Overall Study|Did not receive Treatment|0
171816|NCT00520572|600825|P1|Overall Study|Did not receive Treatment|1
171817|NCT00520572|600820|P6|Overall Study|Long break in taking Medication|0
171818|NCT00520572|600821|P5|Overall Study|Long break in taking Medication|0
171819|NCT00520572|600822|P4|Overall Study|Long break in taking Medication|1
171820|NCT00520572|600823|P3|Overall Study|Long break in taking Medication|0
171821|NCT00520572|600824|P2|Overall Study|Long break in taking Medication|0
171822|NCT00520572|600825|P1|Overall Study|Long break in taking Medication|0
171823|NCT00520572|600820|P6|Overall Study|Oral corticotherapy for acute urticaria|0
171824|NCT00520572|600821|P5|Overall Study|Oral corticotherapy for acute urticaria|0
171825|NCT00520572|600822|P4|Overall Study|Oral corticotherapy for acute urticaria|0
171826|NCT00520572|600823|P3|Overall Study|Oral corticotherapy for acute urticaria|0
171827|NCT00520572|600824|P2|Overall Study|Oral corticotherapy for acute urticaria|1
171828|NCT00520572|600825|P1|Overall Study|Oral corticotherapy for acute urticaria|0
171829|NCT00520572|600820|P6|Overall Study|Incorrect enrollment|0
171830|NCT00520572|600821|P5|Overall Study|Incorrect enrollment|1
171831|NCT00520572|600822|P4|Overall Study|Incorrect enrollment|0
171832|NCT00520572|600823|P3|Overall Study|Incorrect enrollment|1
171833|NCT00520572|600824|P2|Overall Study|Incorrect enrollment|0
171834|NCT00520572|600825|P1|Overall Study|Incorrect enrollment|1
171835|NCT00520572|600820|P6|Overall Study|Lost to Follow-up|0
171836|NCT00520572|600821|P5|Overall Study|Lost to Follow-up|1
171837|NCT00520572|600822|P4|Overall Study|Lost to Follow-up|0
171838|NCT00520572|600823|P3|Overall Study|Lost to Follow-up|0
171839|NCT00520572|600824|P2|Overall Study|Lost to Follow-up|0
171840|NCT00520572|600825|P1|Overall Study|Lost to Follow-up|0
171841|NCT00520572|600820|P6|Overall Study|Lack of Efficacy|0
171842|NCT00520572|600821|P5|Overall Study|Lack of Efficacy|1
171843|NCT00520572|600822|P4|Overall Study|Lack of Efficacy|2
171844|NCT00520572|600823|P3|Overall Study|Lack of Efficacy|1
171845|NCT00520572|600824|P2|Overall Study|Lack of Efficacy|1
171846|NCT00520572|600825|P1|Overall Study|Lack of Efficacy|1
171847|NCT00520572|600820|P6|Overall Study|Protocol Violation|0
171848|NCT00520572|600821|P5|Overall Study|Protocol Violation|0
171849|NCT00520572|600822|P4|Overall Study|Protocol Violation|0
171850|NCT00520572|600823|P3|Overall Study|Protocol Violation|1
171851|NCT00520572|600824|P2|Overall Study|Protocol Violation|0
171852|NCT00520572|600825|P1|Overall Study|Protocol Violation|0
171853|NCT00520572|600820|P6|Overall Study|Withdrawal by Subject|0
171854|NCT00520572|600821|P5|Overall Study|Withdrawal by Subject|2
171855|NCT00520572|600822|P4|Overall Study|Withdrawal by Subject|2
171856|NCT00520572|600823|P3|Overall Study|Withdrawal by Subject|5
171857|NCT00520572|600824|P2|Overall Study|Withdrawal by Subject|9
171858|NCT00520572|600825|P1|Overall Study|Withdrawal by Subject|0
171859|NCT00520572|600820|P6|Overall Study|Adverse Event|2
171860|NCT00520572|600821|P5|Overall Study|Adverse Event|7
171861|NCT00520572|600822|P4|Overall Study|Adverse Event|9
171862|NCT00520572|600823|P3|Overall Study|Adverse Event|6
171863|NCT00520572|600824|P2|Overall Study|Adverse Event|3
171864|NCT00520572|600825|P1|Overall Study|Adverse Event|9
171865|NCT00520546|600863|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
171866|NCT00520546|600863|P1|Overall Study|Withdrawal by Subject|1
171867|NCT00520494|600878|P1|Overall Study|Withdrawal by Subject|1
171868|NCT00520403|600905|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
171869|NCT00520403|600905|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
171870|NCT00520403|600905|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
171871|NCT00520403|600905|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
171872|NCT00520403|600905|P1|Bevacizumab + IFN/Vinblastine|Death|2
171873|NCT00520403|600905|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
171874|NCT00520403|600905|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
171875|NCT00520403|600905|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
171876|NCT00520351|600914|P2|First Intervention|Withdrawal by Subject|1
171877|NCT00520351|600915|P1|First Intervention|Withdrawal by Subject|1
171878|NCT00520299|600930|P3|Overall Study|Progressive disease|4
171879|NCT00520299|600931|P2|Overall Study|Progressive disease|3
171880|NCT00520299|600932|P1|Overall Study|Progressive disease|0
171881|NCT00520299|600930|P3|Overall Study|Withdrawal by Subject|2
171882|NCT00520299|600931|P2|Overall Study|Withdrawal by Subject|0
171883|NCT00520299|600932|P1|Overall Study|Withdrawal by Subject|0
171884|NCT00520130|600987|P2|Overall Study|Physician Decision|1
171885|NCT00520130|600988|P1|Overall Study|Physician Decision|1
171886|NCT00520130|600987|P2|Overall Study|Disease progression on study|0
171887|NCT00520130|600988|P1|Overall Study|Disease progression on study|4
171888|NCT00520039|601030|P2|Overall Study|Exclusion criteria met at first visit|5
171889|NCT00520039|601031|P1|Overall Study|Exclusion criteria met at first visit|7
171890|NCT00520013|601044|P3|Overall Study|Physician Decision|3
171891|NCT00520013|601045|P2|Overall Study|Physician Decision|0
171892|NCT00520013|601046|P1|Overall Study|Physician Decision|0
171893|NCT00520013|601044|P3|Overall Study|Death|0
171894|NCT00520013|601045|P2|Overall Study|Death|1
171895|NCT00520013|601046|P1|Overall Study|Death|0
171896|NCT00520013|601044|P3|Overall Study|Clinical Progression|0
171897|NCT00520013|601045|P2|Overall Study|Clinical Progression|1
171898|NCT00520013|601046|P1|Overall Study|Clinical Progression|3
171899|NCT00520013|601044|P3|Overall Study|Progressive Disease|0
171900|NCT00520013|601045|P2|Overall Study|Progressive Disease|3
171901|NCT00520013|601046|P1|Overall Study|Progressive Disease|7
171902|NCT00520013|601044|P3|Overall Study|Adverse Event|7
171903|NCT00520013|601045|P2|Overall Study|Adverse Event|10
171904|NCT00520013|601046|P1|Overall Study|Adverse Event|2
171905|NCT00520013|601044|P3|Overall Study|Withdrawal by Subject|1
171906|NCT00520013|601045|P2|Overall Study|Withdrawal by Subject|0
171907|NCT00520013|601046|P1|Overall Study|Withdrawal by Subject|0
171908|NCT00519896|601056|P1|Overall Study|Adverse Event|1
171909|NCT00519896|601056|P1|Overall Study|Protocol Violation|1
171910|NCT00519831|601062|P1|Overall Study|Adverse Event|3
171911|NCT00519779|601079|P2|Overall Study|Withdrawal by Subject|1
171912|NCT00519779|601080|P1|Overall Study|Withdrawal by Subject|0
171913|NCT00519649|601096|P1|Overall Study|Withdrawal by Subject|1
171914|NCT00519636|601109|P4|Post Study Period|Subject randomized in error|1
171915|NCT00519636|601110|P3|Post Study Period|Subject randomized in error|0
171916|NCT00519636|601111|P2|Post Study Period|Subject randomized in error|0
171917|NCT00519636|601112|P1|Post Study Period|Subject randomized in error|0
171918|NCT00519636|601109|P4|Treatment Period 2|Subject misrandomized|1
171919|NCT00519636|601110|P3|Treatment Period 2|Subject misrandomized|0
171920|NCT00519636|601111|P2|Treatment Period 2|Subject misrandomized|0
171921|NCT00519636|601112|P1|Treatment Period 2|Subject misrandomized|0
171922|NCT00519636|601109|P4|Treatment Period 2|Per doctors request|0
171923|NCT00519636|601110|P3|Treatment Period 2|Per doctors request|1
171924|NCT00519636|601111|P2|Treatment Period 2|Per doctors request|0
171925|NCT00519636|601112|P1|Treatment Period 2|Per doctors request|0
171926|NCT00519636|601109|P4|Treatment Period 2|Subject randomized in error|0
171927|NCT00519636|601110|P3|Treatment Period 2|Subject randomized in error|0
171928|NCT00519636|601111|P2|Treatment Period 2|Subject randomized in error|1
171929|NCT00519636|601112|P1|Treatment Period 2|Subject randomized in error|0
171930|NCT00519636|601109|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
171931|NCT00519636|601110|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
171932|NCT00519636|601111|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
171933|NCT00519636|601112|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
171934|NCT00519636|601109|P4|Washout Period|Prohibited medications|0
171935|NCT00519636|601110|P3|Washout Period|Prohibited medications|1
171936|NCT00519636|601111|P2|Washout Period|Prohibited medications|0
171937|NCT00519636|601112|P1|Washout Period|Prohibited medications|0
171938|NCT00519636|601109|P4|Washout Period|Subject randomized in error|0
171939|NCT00519636|601110|P3|Washout Period|Subject randomized in error|1
171940|NCT00519636|601111|P2|Washout Period|Subject randomized in error|0
171941|NCT00519636|601112|P1|Washout Period|Subject randomized in error|0
171942|NCT00519636|601109|P4|Washout Period|Per doctors request|0
171943|NCT00519636|601110|P3|Washout Period|Per doctors request|0
171944|NCT00519636|601111|P2|Washout Period|Per doctors request|1
171945|NCT00519636|601112|P1|Washout Period|Per doctors request|0
171946|NCT00519636|601109|P4|Washout Period|Non-compliant|0
171947|NCT00519636|601110|P3|Washout Period|Non-compliant|0
171948|NCT00519636|601111|P2|Washout Period|Non-compliant|1
171949|NCT00519636|601112|P1|Washout Period|Non-compliant|0
171950|NCT00519636|601109|P4|Washout Period|Participating in study at another site|0
171951|NCT00519636|601110|P3|Washout Period|Participating in study at another site|0
171952|NCT00519636|601111|P2|Washout Period|Participating in study at another site|0
171953|NCT00519636|601112|P1|Washout Period|Participating in study at another site|1
171954|NCT00519636|601109|P4|Washout Period|Out of pollen area > 48 hours|0
171955|NCT00519636|601110|P3|Washout Period|Out of pollen area > 48 hours|0
171956|NCT00519636|601111|P2|Washout Period|Out of pollen area > 48 hours|0
171957|NCT00519636|601112|P1|Washout Period|Out of pollen area > 48 hours|1
171958|NCT00519636|601109|P4|Washout Period|Failed to meet continuation criteria|3
171959|NCT00519636|601110|P3|Washout Period|Failed to meet continuation criteria|9
171960|NCT00519636|601111|P2|Washout Period|Failed to meet continuation criteria|11
171961|NCT00519636|601112|P1|Washout Period|Failed to meet continuation criteria|14
171962|NCT00519636|601109|P4|Washout Period|Withdrawal by Subject|0
171963|NCT00519636|601110|P3|Washout Period|Withdrawal by Subject|1
171964|NCT00519636|601111|P2|Washout Period|Withdrawal by Subject|0
171965|NCT00519636|601112|P1|Washout Period|Withdrawal by Subject|1
171966|NCT00519636|601109|P4|Washout Period|Protocol Violation|2
171967|NCT00519636|601110|P3|Washout Period|Protocol Violation|1
171968|NCT00519636|601111|P2|Washout Period|Protocol Violation|0
171969|NCT00519636|601112|P1|Washout Period|Protocol Violation|0
171970|NCT00519636|601109|P4|Washout Period|Lost to Follow-up|0
171971|NCT00519636|601110|P3|Washout Period|Lost to Follow-up|0
171972|NCT00519636|601111|P2|Washout Period|Lost to Follow-up|0
171973|NCT00519636|601112|P1|Washout Period|Lost to Follow-up|1
171974|NCT00519636|601109|P4|Washout Period|Adverse Event|0
171975|NCT00519636|601110|P3|Washout Period|Adverse Event|1
171976|NCT00519636|601111|P2|Washout Period|Adverse Event|1
171977|NCT00519636|601112|P1|Washout Period|Adverse Event|2
172062|NCT00518986|601397|P1|Overall Study|Protocol Violation|5
171978|NCT00519636|601109|P4|Treatment Period 1|Sponsor request due to missed visit|0
171979|NCT00519636|601110|P3|Treatment Period 1|Sponsor request due to missed visit|0
171980|NCT00519636|601111|P2|Treatment Period 1|Sponsor request due to missed visit|0
171981|NCT00519636|601112|P1|Treatment Period 1|Sponsor request due to missed visit|1
171982|NCT00519636|601109|P4|Treatment Period 1|Adverse Event|0
171983|NCT00519636|601110|P3|Treatment Period 1|Adverse Event|1
171984|NCT00519636|601111|P2|Treatment Period 1|Adverse Event|0
171985|NCT00519636|601112|P1|Treatment Period 1|Adverse Event|1
171986|NCT00519623|601142|P1|Overall Study|Adverse Event|1
171987|NCT00519532|601176|P1|Overall Study|Lost to Follow-up|2
171988|NCT00519532|601176|P1|Overall Study|Withdrawal by Subject|5
171989|NCT00519532|601176|P1|Overall Study|Adverse Event|11
171990|NCT00519428|601186|P3|Overall Study|unstated|2
171991|NCT00519428|601187|P2|Overall Study|unstated|3
171992|NCT00519428|601188|P1|Overall Study|unstated|1
171993|NCT00519428|601186|P3|Overall Study|Withdrawal by Subject|7
171994|NCT00519428|601187|P2|Overall Study|Withdrawal by Subject|3
171995|NCT00519428|601188|P1|Overall Study|Withdrawal by Subject|8
171996|NCT00519428|601186|P3|Overall Study|Lost to Follow-up|6
171997|NCT00519428|601187|P2|Overall Study|Lost to Follow-up|7
171998|NCT00519428|601188|P1|Overall Study|Lost to Follow-up|7
171999|NCT00519428|601186|P3|Overall Study|Adverse Event|10
172000|NCT00519428|601187|P2|Overall Study|Adverse Event|2
172001|NCT00519428|601188|P1|Overall Study|Adverse Event|5
172002|NCT00519376|601208|P16|Treatment Period 4|Lost to Follow-up|0
172003|NCT00519376|601209|P15|Treatment Period 4|Lost to Follow-up|0
172004|NCT00519376|601210|P14|Treatment Period 4|Lost to Follow-up|0
172005|NCT00519376|601211|P13|Treatment Period 4|Lost to Follow-up|0
172006|NCT00519376|601212|P12|Treatment Period 4|Lost to Follow-up|0
172007|NCT00519376|601213|P11|Treatment Period 4|Lost to Follow-up|0
172008|NCT00519376|601214|P10|Treatment Period 4|Lost to Follow-up|0
172009|NCT00519376|601215|P9|Treatment Period 4|Lost to Follow-up|0
172010|NCT00519376|601216|P8|Treatment Period 4|Lost to Follow-up|0
172011|NCT00519376|601217|P7|Treatment Period 4|Lost to Follow-up|0
172012|NCT00519376|601218|P6|Treatment Period 4|Lost to Follow-up|0
172013|NCT00519376|601219|P5|Treatment Period 4|Lost to Follow-up|0
172014|NCT00519376|601220|P4|Treatment Period 4|Lost to Follow-up|0
172015|NCT00519376|601221|P3|Treatment Period 4|Lost to Follow-up|1
172016|NCT00519376|601222|P2|Treatment Period 4|Lost to Follow-up|0
172017|NCT00519376|601223|P1|Treatment Period 4|Lost to Follow-up|0
172018|NCT00519376|601208|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172019|NCT00519376|601209|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172020|NCT00519376|601210|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172021|NCT00519376|601211|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
172022|NCT00519376|601212|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172023|NCT00519376|601213|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172024|NCT00519376|601214|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172025|NCT00519376|601215|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172026|NCT00519376|601216|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172027|NCT00519376|601217|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172028|NCT00519376|601218|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172029|NCT00519376|601219|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172030|NCT00519376|601220|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172031|NCT00519376|601221|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172032|NCT00519376|601222|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172033|NCT00519376|601223|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
172034|NCT00519285|601347|P2|Overall Study|Treatment ongoing|2
172035|NCT00519285|601348|P1|Overall Study|Treatment ongoing|1
172036|NCT00519285|601347|P2|Overall Study|Not treated|7
172037|NCT00519285|601348|P1|Overall Study|Not treated|8
172038|NCT00519285|601347|P2|Overall Study|Reason unspecified|8
172039|NCT00519285|601348|P1|Overall Study|Reason unspecified|5
172040|NCT00519285|601347|P2|Overall Study|Poor compliance to protocol|7
172041|NCT00519285|601348|P1|Overall Study|Poor compliance to protocol|5
172042|NCT00519285|601347|P2|Overall Study|Consent withdrawn|5
172043|NCT00519285|601348|P1|Overall Study|Consent withdrawn|4
172044|NCT00519285|601347|P2|Overall Study|Participant's request|84
172045|NCT00519285|601348|P1|Overall Study|Participant's request|53
172046|NCT00519285|601347|P2|Overall Study|Physician Decision|47
172047|NCT00519285|601348|P1|Overall Study|Physician Decision|75
172048|NCT00519285|601347|P2|Overall Study|Disease progression|186
172049|NCT00519285|601348|P1|Overall Study|Disease progression|334
172050|NCT00519285|601347|P2|Overall Study|Adverse Event|266
172051|NCT00519285|601348|P1|Overall Study|Adverse Event|127
172052|NCT00519194|601374|P1|Overall Study|Lost to Follow-up|3
172053|NCT00519194|601374|P1|Overall Study|Death|9
172054|NCT00519194|601374|P1|Overall Study|Withdrawal by Subject|9
172055|NCT00519077|601389|P1|Overall Study|Other|2
172056|NCT00519077|601389|P1|Overall Study|Death|6
172057|NCT00518986|601396|P2|Overall Study|Non-Specific|1
172058|NCT00518986|601397|P1|Overall Study|Non-Specific|2
172059|NCT00518986|601396|P2|Overall Study|Withdrawal by Subject|4
172060|NCT00518986|601397|P1|Overall Study|Withdrawal by Subject|4
172061|NCT00518986|601396|P2|Overall Study|Protocol Violation|7
172063|NCT00518986|601396|P2|Overall Study|Physician Decision|3
172064|NCT00518986|601397|P1|Overall Study|Physician Decision|0
172065|NCT00518986|601396|P2|Overall Study|Lost to Follow-up|2
172066|NCT00518986|601397|P1|Overall Study|Lost to Follow-up|3
172067|NCT00518986|601396|P2|Overall Study|Lack of Efficacy|2
172068|NCT00518986|601397|P1|Overall Study|Lack of Efficacy|0
172069|NCT00518986|601396|P2|Overall Study|Adverse Event|7
172070|NCT00518986|601397|P1|Overall Study|Adverse Event|12
172071|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
172072|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
172073|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Subject decision|0
172074|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Subject decision|2
172075|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
172076|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
172077|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
172078|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
172079|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Creatine increased|0
172080|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Creatine increased|1
172081|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Change in treatment|1
172082|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Change in treatment|1
172083|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
172084|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
172085|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
172086|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
172087|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
172088|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
172089|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
172090|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
172091|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
172092|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
172093|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
172094|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
172095|NCT00518882|601523|P2|Open-Label Extension, Week 26-78|Adverse Event|9
172096|NCT00518882|601524|P1|Open-Label Extension, Week 26-78|Adverse Event|3
172097|NCT00518882|601523|P2|Double-Blind, Week 0-26|Mutual consent|1
172098|NCT00518882|601524|P1|Double-Blind, Week 0-26|Mutual consent|0
172099|NCT00518882|601523|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
172100|NCT00518882|601524|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
172101|NCT00518882|601523|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
172102|NCT00518882|601524|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
172103|NCT00518882|601523|P2|Double-Blind, Week 0-26|Loss of trust|1
172104|NCT00518882|601524|P1|Double-Blind, Week 0-26|Loss of trust|0
172105|NCT00518882|601523|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
172106|NCT00518882|601524|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
172107|NCT00518882|601523|P2|Double-Blind, Week 0-26|Subject decision|1
172108|NCT00518882|601524|P1|Double-Blind, Week 0-26|Subject decision|1
172109|NCT00518882|601523|P2|Double-Blind, Week 0-26|Lost to follow up|1
172110|NCT00518882|601524|P1|Double-Blind, Week 0-26|Lost to follow up|2
172111|NCT00518882|601523|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
172112|NCT00518882|601524|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
172113|NCT00518882|601523|P2|Double-Blind, Week 0-26|Protocol Violation|3
172114|NCT00518882|601524|P1|Double-Blind, Week 0-26|Protocol Violation|4
172115|NCT00518882|601523|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
172116|NCT00518882|601524|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
172117|NCT00518882|601523|P2|Double-Blind, Week 0-26|Adverse Event|31
172118|NCT00518882|601524|P1|Double-Blind, Week 0-26|Adverse Event|23
172119|NCT00518687|601705|P2|Overall Study|Withdrawal by Subject|110
172120|NCT00518687|601706|P1|Overall Study|Withdrawal by Subject|110
172121|NCT00518687|601705|P2|Overall Study|Study terminated by sponsor|918
172122|NCT00518687|601706|P1|Overall Study|Study terminated by sponsor|930
172123|NCT00518687|601705|P2|Overall Study|Protocol Violation|10
172124|NCT00518687|601706|P1|Overall Study|Protocol Violation|8
172125|NCT00518687|601705|P2|Overall Study|Progressive disease|2
172126|NCT00518687|601706|P1|Overall Study|Progressive disease|2
172127|NCT00518687|601705|P2|Overall Study|Physician Decision|48
172128|NCT00518687|601706|P1|Overall Study|Physician Decision|42
172129|NCT00518687|601705|P2|Overall Study|Lost to Follow-up|155
172130|NCT00518687|601706|P1|Overall Study|Lost to Follow-up|144
172131|NCT00518687|601705|P2|Overall Study|Adverse Event|177
172132|NCT00518687|601706|P1|Overall Study|Adverse Event|201
172133|NCT00518622|601726|P8|Overall Study|Study medication taken incorrectly|0
172134|NCT00518622|601727|P7|Overall Study|Study medication taken incorrectly|0
172135|NCT00518622|601728|P6|Overall Study|Study medication taken incorrectly|0
172136|NCT00518622|601729|P5|Overall Study|Study medication taken incorrectly|0
172137|NCT00518622|601730|P4|Overall Study|Study medication taken incorrectly|0
172138|NCT00518622|601731|P3|Overall Study|Study medication taken incorrectly|0
172139|NCT00518622|601732|P2|Overall Study|Study medication taken incorrectly|1
172140|NCT00518622|601733|P1|Overall Study|Study medication taken incorrectly|0
172141|NCT00518622|601726|P8|Overall Study|Lost to Follow-up|0
172142|NCT00518622|601727|P7|Overall Study|Lost to Follow-up|0
172143|NCT00518622|601728|P6|Overall Study|Lost to Follow-up|0
172144|NCT00518622|601729|P5|Overall Study|Lost to Follow-up|0
172145|NCT00518622|601730|P4|Overall Study|Lost to Follow-up|0
172146|NCT00518622|601731|P3|Overall Study|Lost to Follow-up|1
172147|NCT00518622|601732|P2|Overall Study|Lost to Follow-up|0
172148|NCT00518622|601733|P1|Overall Study|Lost to Follow-up|0
172149|NCT00518531|601761|P2|Treatment Period 2|Non-compliance|2
172150|NCT00518531|601762|P1|Treatment Period 2|Non-compliance|1
172151|NCT00518531|601761|P2|Treatment Period 2|Protocol-specified criteria|1
172152|NCT00518531|601762|P1|Treatment Period 2|Protocol-specified criteria|0
172153|NCT00518531|601761|P2|Treatment Period 2|Adverse Event|7
172154|NCT00518531|601762|P1|Treatment Period 2|Adverse Event|1
172155|NCT00518531|601761|P2|Treatment Period 2|Complete out of scheduled visit window|2
172156|NCT00518531|601762|P1|Treatment Period 2|Complete out of scheduled visit window|1
172157|NCT00518531|601761|P2|Treatment Period 2|Withdrawal by Subject|8
172158|NCT00518531|601762|P1|Treatment Period 2|Withdrawal by Subject|0
172159|NCT00518531|601761|P2|Treatment Period 1|Early crossover|3
172160|NCT00518531|601762|P1|Treatment Period 1|Early crossover|1
172161|NCT00518531|601761|P2|Treatment Period 1|Withdrawal by Subject|6
172162|NCT00518531|601762|P1|Treatment Period 1|Withdrawal by Subject|4
172163|NCT00518531|601761|P2|Treatment Period 1|Protocol Violation|0
172164|NCT00518531|601762|P1|Treatment Period 1|Protocol Violation|2
172165|NCT00518531|601761|P2|Treatment Period 1|Physician Decision|0
172166|NCT00518531|601762|P1|Treatment Period 1|Physician Decision|1
172167|NCT00518531|601761|P2|Treatment Period 1|Lost to Follow-up|3
172168|NCT00518531|601762|P1|Treatment Period 1|Lost to Follow-up|5
172169|NCT00518531|601761|P2|Treatment Period 1|Adverse Event|0
172170|NCT00518531|601762|P1|Treatment Period 1|Adverse Event|5
172171|NCT00518336|601807|P2|Year 9|Personal reasons|0
172172|NCT00518336|601808|P1|Year 9|Personal reasons|1
172173|NCT00518336|601807|P2|Year 9|Lost to Follow-up|0
172174|NCT00518336|601808|P1|Year 9|Lost to Follow-up|3
172175|NCT00518336|601807|P2|Year 9|Migrated/moved from study area|1
172176|NCT00518336|601808|P1|Year 9|Migrated/moved from study area|1
172177|NCT00518336|601807|P2|Year 8|Could not attend in time|1
172178|NCT00518336|601808|P1|Year 8|Could not attend in time|0
172179|NCT00518336|601807|P2|Year 8|Lost to Follow-up|1
172180|NCT00518336|601808|P1|Year 8|Lost to Follow-up|1
172181|NCT00518336|601807|P2|Year 7|Could not attend in time|3
172182|NCT00518336|601808|P1|Year 7|Could not attend in time|0
172183|NCT00518336|601807|P2|Year 7|Lost to Follow-up|0
172184|NCT00518336|601808|P1|Year 7|Lost to Follow-up|2
172185|NCT00518323|601974|P4|Overall Study|Prohibited medication and others|0
172186|NCT00518323|601975|P3|Overall Study|Prohibited medication and others|1
172187|NCT00518323|601976|P2|Overall Study|Prohibited medication and others|1
172188|NCT00518323|601977|P1|Overall Study|Prohibited medication and others|3
172189|NCT00518323|601974|P4|Overall Study|Adverse Event|0
172190|NCT00518323|601975|P3|Overall Study|Adverse Event|1
172191|NCT00518323|601976|P2|Overall Study|Adverse Event|1
172192|NCT00518323|601977|P1|Overall Study|Adverse Event|1
172193|NCT00518323|601974|P4|Overall Study|Lost to Follow-up|3
172194|NCT00518323|601975|P3|Overall Study|Lost to Follow-up|1
172195|NCT00518323|601976|P2|Overall Study|Lost to Follow-up|2
172196|NCT00518323|601977|P1|Overall Study|Lost to Follow-up|0
172197|NCT00518323|601974|P4|Overall Study|Withdrawal by Subject|2
172198|NCT00518323|601975|P3|Overall Study|Withdrawal by Subject|4
172199|NCT00518323|601976|P2|Overall Study|Withdrawal by Subject|2
172200|NCT00518323|601977|P1|Overall Study|Withdrawal by Subject|1
172201|NCT00518323|601974|P4|Overall Study|Lack of Efficacy|20
172202|NCT00518323|601975|P3|Overall Study|Lack of Efficacy|4
172203|NCT00518323|601976|P2|Overall Study|Lack of Efficacy|2
172204|NCT00518323|601977|P1|Overall Study|Lack of Efficacy|14
172205|NCT00518284|602007|P4|Overall Study|Study Termination|2
172206|NCT00518284|602008|P3|Overall Study|Study Termination|1
172207|NCT00518284|602009|P2|Overall Study|Study Termination|2
172208|NCT00518284|602010|P1|Overall Study|Study Termination|0
172209|NCT00518284|602007|P4|Overall Study|Adverse Event|0
172210|NCT00518284|602008|P3|Overall Study|Adverse Event|0
172211|NCT00518284|602009|P2|Overall Study|Adverse Event|1
172212|NCT00518284|602010|P1|Overall Study|Adverse Event|0
172213|NCT00518206|602066|P2|Overall Study|Completion Status Unknown|0
172214|NCT00518206|602067|P1|Overall Study|Completion Status Unknown|1
172215|NCT00518206|602066|P2|Overall Study|Reason Unknown|0
172216|NCT00518206|602067|P1|Overall Study|Reason Unknown|1
172217|NCT00518206|602066|P2|Overall Study|Drug Supply Issue|0
172218|NCT00518206|602067|P1|Overall Study|Drug Supply Issue|1
172219|NCT00518206|602066|P2|Overall Study|Withdrawal by Subject|0
172220|NCT00518206|602067|P1|Overall Study|Withdrawal by Subject|2
172221|NCT00518206|602066|P2|Overall Study|Disease Progression Requiring Therapy|6
172222|NCT00518206|602067|P1|Overall Study|Disease Progression Requiring Therapy|6
172223|NCT00518180|602084|P3|Overall Study|Adverse Event|0
172224|NCT00518180|602085|P2|Overall Study|Adverse Event|0
172225|NCT00518180|602086|P1|Overall Study|Adverse Event|1
172226|NCT00518180|602084|P3|Overall Study|Unable to classify|0
172227|NCT00518180|602085|P2|Overall Study|Unable to classify|2
172228|NCT00518180|602086|P1|Overall Study|Unable to classify|0
172229|NCT00518180|602084|P3|Overall Study|Protocol Violation|4
172230|NCT00518180|602085|P2|Overall Study|Protocol Violation|7
172231|NCT00518180|602086|P1|Overall Study|Protocol Violation|5
172232|NCT00518180|602084|P3|Overall Study|Administrative reason|2
172233|NCT00518180|602085|P2|Overall Study|Administrative reason|2
172234|NCT00518180|602086|P1|Overall Study|Administrative reason|0
172235|NCT00518180|602084|P3|Overall Study|Lost to Follow-up|34
172236|NCT00518180|602085|P2|Overall Study|Lost to Follow-up|28
172237|NCT00518180|602086|P1|Overall Study|Lost to Follow-up|30
172238|NCT00518180|602084|P3|Overall Study|Withdrawal by Subject|42
172239|NCT00518180|602085|P2|Overall Study|Withdrawal by Subject|30
172240|NCT00518180|602086|P1|Overall Study|Withdrawal by Subject|29
172241|NCT00518115|602138|P10|Overall Study|Moved Out of State|1
172242|NCT00518115|602139|P9|Overall Study|Moved Out of State|0
172243|NCT00518115|602140|P8|Overall Study|Moved Out of State|0
172244|NCT00518115|602141|P7|Overall Study|Moved Out of State|0
172245|NCT00518115|602142|P6|Overall Study|Moved Out of State|0
172246|NCT00518115|602143|P5|Overall Study|Moved Out of State|0
172247|NCT00518115|602144|P4|Overall Study|Moved Out of State|0
172248|NCT00518115|602145|P3|Overall Study|Moved Out of State|0
172249|NCT00518115|602146|P2|Overall Study|Moved Out of State|0
172250|NCT00518115|602147|P1|Overall Study|Moved Out of State|0
172251|NCT00518115|602138|P10|Overall Study|Withdrew Consent|0
172252|NCT00518115|602139|P9|Overall Study|Withdrew Consent|0
172253|NCT00518115|602140|P8|Overall Study|Withdrew Consent|0
172254|NCT00518115|602141|P7|Overall Study|Withdrew Consent|0
172255|NCT00518115|602142|P6|Overall Study|Withdrew Consent|1
172256|NCT00518115|602143|P5|Overall Study|Withdrew Consent|0
172257|NCT00518115|602144|P4|Overall Study|Withdrew Consent|0
172258|NCT00518115|602145|P3|Overall Study|Withdrew Consent|0
172259|NCT00518115|602146|P2|Overall Study|Withdrew Consent|0
172260|NCT00518115|602147|P1|Overall Study|Withdrew Consent|0
172261|NCT00518115|602138|P10|Overall Study|Family Emergency; Had to Go to England|0
172262|NCT00518115|602139|P9|Overall Study|Family Emergency; Had to Go to England|0
172263|NCT00518115|602140|P8|Overall Study|Family Emergency; Had to Go to England|0
172264|NCT00518115|602141|P7|Overall Study|Family Emergency; Had to Go to England|0
172265|NCT00518115|602142|P6|Overall Study|Family Emergency; Had to Go to England|0
172266|NCT00518115|602143|P5|Overall Study|Family Emergency; Had to Go to England|1
172267|NCT00518115|602144|P4|Overall Study|Family Emergency; Had to Go to England|0
172268|NCT00518115|602145|P3|Overall Study|Family Emergency; Had to Go to England|0
172269|NCT00518115|602146|P2|Overall Study|Family Emergency; Had to Go to England|0
172270|NCT00518115|602147|P1|Overall Study|Family Emergency; Had to Go to England|0
172271|NCT00518115|602138|P10|Overall Study|Violation of Exclusion Criteria|0
172272|NCT00518115|602139|P9|Overall Study|Violation of Exclusion Criteria|0
172273|NCT00518115|602140|P8|Overall Study|Violation of Exclusion Criteria|0
172274|NCT00518115|602141|P7|Overall Study|Violation of Exclusion Criteria|1
172275|NCT00518115|602142|P6|Overall Study|Violation of Exclusion Criteria|0
172276|NCT00518115|602143|P5|Overall Study|Violation of Exclusion Criteria|0
172277|NCT00518115|602144|P4|Overall Study|Violation of Exclusion Criteria|1
172278|NCT00518115|602145|P3|Overall Study|Violation of Exclusion Criteria|0
172279|NCT00518115|602146|P2|Overall Study|Violation of Exclusion Criteria|0
172280|NCT00518115|602147|P1|Overall Study|Violation of Exclusion Criteria|0
172281|NCT00518115|602138|P10|Overall Study|Wrong Monotherapy Administered|0
172282|NCT00518115|602139|P9|Overall Study|Wrong Monotherapy Administered|0
172283|NCT00518115|602140|P8|Overall Study|Wrong Monotherapy Administered|0
172284|NCT00518115|602141|P7|Overall Study|Wrong Monotherapy Administered|1
172285|NCT00518115|602142|P6|Overall Study|Wrong Monotherapy Administered|0
172286|NCT00518115|602143|P5|Overall Study|Wrong Monotherapy Administered|0
172287|NCT00518115|602144|P4|Overall Study|Wrong Monotherapy Administered|0
172288|NCT00518115|602145|P3|Overall Study|Wrong Monotherapy Administered|1
172289|NCT00518115|602146|P2|Overall Study|Wrong Monotherapy Administered|0
172290|NCT00518115|602147|P1|Overall Study|Wrong Monotherapy Administered|0
172291|NCT00518115|602138|P10|Overall Study|Different Monotherapy Diabetic Drug|0
172292|NCT00518115|602139|P9|Overall Study|Different Monotherapy Diabetic Drug|1
172293|NCT00518115|602140|P8|Overall Study|Different Monotherapy Diabetic Drug|0
172294|NCT00518115|602141|P7|Overall Study|Different Monotherapy Diabetic Drug|0
172295|NCT00518115|602142|P6|Overall Study|Different Monotherapy Diabetic Drug|0
172296|NCT00518115|602143|P5|Overall Study|Different Monotherapy Diabetic Drug|0
172297|NCT00518115|602144|P4|Overall Study|Different Monotherapy Diabetic Drug|0
172298|NCT00518115|602145|P3|Overall Study|Different Monotherapy Diabetic Drug|1
172299|NCT00518115|602146|P2|Overall Study|Different Monotherapy Diabetic Drug|0
172300|NCT00518115|602147|P1|Overall Study|Different Monotherapy Diabetic Drug|0
172301|NCT00518115|602138|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
172302|NCT00518115|602139|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
172303|NCT00518115|602140|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
172304|NCT00518115|602141|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
172305|NCT00518115|602142|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
172306|NCT00518115|602143|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
172307|NCT00518115|602144|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
172308|NCT00518115|602145|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
172309|NCT00518115|602146|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
172310|NCT00518115|602147|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
172311|NCT00518115|602138|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
172312|NCT00518115|602139|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
172313|NCT00518115|602140|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
172314|NCT00518115|602141|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
172315|NCT00518115|602142|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
172316|NCT00518115|602143|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
172317|NCT00518115|602144|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
172318|NCT00518115|602145|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
172319|NCT00518115|602146|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
172320|NCT00518115|602147|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
172321|NCT00518115|602138|P10|Overall Study|Non-Compliance|1
172322|NCT00518115|602139|P9|Overall Study|Non-Compliance|0
172323|NCT00518115|602140|P8|Overall Study|Non-Compliance|1
172324|NCT00518115|602141|P7|Overall Study|Non-Compliance|1
172325|NCT00518115|602142|P6|Overall Study|Non-Compliance|1
172326|NCT00518115|602143|P5|Overall Study|Non-Compliance|1
172327|NCT00518115|602144|P4|Overall Study|Non-Compliance|0
172328|NCT00518115|602145|P3|Overall Study|Non-Compliance|1
172329|NCT00518115|602146|P2|Overall Study|Non-Compliance|0
172330|NCT00518115|602147|P1|Overall Study|Non-Compliance|1
172331|NCT00518115|602138|P10|Overall Study|Lack of Efficacy|0
172332|NCT00518115|602139|P9|Overall Study|Lack of Efficacy|0
172333|NCT00518115|602140|P8|Overall Study|Lack of Efficacy|1
172334|NCT00518115|602141|P7|Overall Study|Lack of Efficacy|0
172335|NCT00518115|602142|P6|Overall Study|Lack of Efficacy|0
172336|NCT00518115|602143|P5|Overall Study|Lack of Efficacy|0
172337|NCT00518115|602144|P4|Overall Study|Lack of Efficacy|1
172338|NCT00518115|602145|P3|Overall Study|Lack of Efficacy|1
172339|NCT00518115|602146|P2|Overall Study|Lack of Efficacy|0
172340|NCT00518115|602147|P1|Overall Study|Lack of Efficacy|1
172341|NCT00518115|602138|P10|Overall Study|Withdrawal by Subject|3
172342|NCT00518115|602139|P9|Overall Study|Withdrawal by Subject|1
172343|NCT00518115|602140|P8|Overall Study|Withdrawal by Subject|2
172344|NCT00518115|602141|P7|Overall Study|Withdrawal by Subject|0
172345|NCT00518115|602142|P6|Overall Study|Withdrawal by Subject|1
172346|NCT00518115|602143|P5|Overall Study|Withdrawal by Subject|2
172347|NCT00518115|602144|P4|Overall Study|Withdrawal by Subject|0
172348|NCT00518115|602145|P3|Overall Study|Withdrawal by Subject|5
172349|NCT00518115|602146|P2|Overall Study|Withdrawal by Subject|1
172350|NCT00518115|602147|P1|Overall Study|Withdrawal by Subject|1
172351|NCT00518115|602138|P10|Overall Study|Protocol Violation|0
172352|NCT00518115|602139|P9|Overall Study|Protocol Violation|0
172353|NCT00518115|602140|P8|Overall Study|Protocol Violation|0
172354|NCT00518115|602141|P7|Overall Study|Protocol Violation|0
172355|NCT00518115|602142|P6|Overall Study|Protocol Violation|0
172356|NCT00518115|602143|P5|Overall Study|Protocol Violation|0
172357|NCT00518115|602144|P4|Overall Study|Protocol Violation|0
172358|NCT00518115|602145|P3|Overall Study|Protocol Violation|1
172359|NCT00518115|602146|P2|Overall Study|Protocol Violation|3
172360|NCT00518115|602147|P1|Overall Study|Protocol Violation|1
172361|NCT00518115|602138|P10|Overall Study|Lost to Follow-up|1
172362|NCT00518115|602139|P9|Overall Study|Lost to Follow-up|1
172363|NCT00518115|602140|P8|Overall Study|Lost to Follow-up|1
172364|NCT00518115|602141|P7|Overall Study|Lost to Follow-up|0
172365|NCT00518115|602142|P6|Overall Study|Lost to Follow-up|3
172366|NCT00518115|602143|P5|Overall Study|Lost to Follow-up|1
172367|NCT00518115|602144|P4|Overall Study|Lost to Follow-up|3
172368|NCT00518115|602145|P3|Overall Study|Lost to Follow-up|2
172369|NCT00518115|602146|P2|Overall Study|Lost to Follow-up|0
172370|NCT00518115|602147|P1|Overall Study|Lost to Follow-up|0
172371|NCT00518115|602138|P10|Overall Study|Adverse Event|9
172372|NCT00518115|602139|P9|Overall Study|Adverse Event|2
172373|NCT00518115|602140|P8|Overall Study|Adverse Event|10
172374|NCT00518115|602141|P7|Overall Study|Adverse Event|5
172375|NCT00518115|602142|P6|Overall Study|Adverse Event|5
172376|NCT00518115|602143|P5|Overall Study|Adverse Event|5
172377|NCT00518115|602144|P4|Overall Study|Adverse Event|6
172378|NCT00518115|602145|P3|Overall Study|Adverse Event|5
172379|NCT00518115|602146|P2|Overall Study|Adverse Event|1
172380|NCT00518115|602147|P1|Overall Study|Adverse Event|6
172381|NCT00518011|602322|P2|Overall Study|Withdrawal by Subject|0
172382|NCT00518011|602323|P1|Overall Study|Withdrawal by Subject|1
172383|NCT00518011|602322|P2|Overall Study|Other Reasons|2
172384|NCT00518011|602323|P1|Overall Study|Other Reasons|3
172385|NCT00518011|602322|P2|Overall Study|Disease Progression|2
172386|NCT00518011|602323|P1|Overall Study|Disease Progression|2
172387|NCT00518011|602322|P2|Overall Study|Adverse Event|3
172388|NCT00518011|602323|P1|Overall Study|Adverse Event|2
172389|NCT00518011|602322|P2|Overall Study|Death|1
172390|NCT00518011|602323|P1|Overall Study|Death|1
172391|NCT00517933|602345|P2|Period 2|Underwent lung transplant|2
172392|NCT00517933|602346|P1|Period 2|Underwent lung transplant|0
172393|NCT00517933|602345|P2|Period 2|Withdrawal by Subject|3
172394|NCT00517933|602346|P1|Period 2|Withdrawal by Subject|1
172395|NCT00517933|602345|P2|Period 2|Physician Decision|0
172396|NCT00517933|602346|P1|Period 2|Physician Decision|1
172397|NCT00517933|602345|P2|Period 2|Adverse Event|4
172398|NCT00517933|602346|P1|Period 2|Adverse Event|2
172399|NCT00517933|602345|P2|Period 2|Death|4
172400|NCT00517933|602346|P1|Period 2|Death|2
172401|NCT00517933|602345|P2|Period 1|Underwent lung transplant|1
172402|NCT00517933|602346|P1|Period 1|Underwent lung transplant|0
172403|NCT00517933|602345|P2|Period 1|Lost to Follow-up|0
172404|NCT00517933|602346|P1|Period 1|Lost to Follow-up|2
172405|NCT00517933|602345|P2|Period 1|Adverse Event|4
172406|NCT00517933|602346|P1|Period 1|Adverse Event|4
172407|NCT00517933|602345|P2|Period 1|Death|1
172408|NCT00517933|602346|P1|Period 1|Death|2
172409|NCT00517881|602410|P1|Overall Study|Renal transplantation|2
172410|NCT00517881|602410|P1|Overall Study|Adverse Event|1
172411|NCT00517881|602410|P1|Overall Study|Protocol Violation|2
172412|NCT00517829|602422|P2|Overall Study|Other|1
172413|NCT00517829|602423|P1|Overall Study|Other|3
172414|NCT00517829|602422|P2|Overall Study|Investigator Request|3
172415|NCT00517829|602423|P1|Overall Study|Investigator Request|5
172416|NCT00517829|602422|P2|Overall Study|Patient Request|5
172417|NCT00517829|602423|P1|Overall Study|Patient Request|6
172418|NCT00517829|602422|P2|Overall Study|Disease Progression|32
172419|NCT00517829|602423|P1|Overall Study|Disease Progression|39
172420|NCT00517829|602422|P2|Overall Study|Adverse Event|34
172421|NCT00517829|602423|P1|Overall Study|Adverse Event|22
172422|NCT00517751|602437|P1|Overall Study|Missing|3
172423|NCT00517751|602437|P1|Overall Study|Patient not due for visit|76
172424|NCT00517751|602437|P1|Overall Study|patient not over due|6
172425|NCT00517751|602437|P1|Overall Study|Lost to Follow-up|4
172426|NCT00517751|602437|P1|Overall Study|Withdrawal by Subject|37
172427|NCT00517751|602437|P1|Overall Study|Death|3
172428|NCT00517699|602460|P1|Overall Study|Study terminated by Sponsor|2
172429|NCT00517699|602460|P1|Overall Study|Administrative error|1
172430|NCT00517699|602460|P1|Overall Study|Lack of Efficacy|1
172431|NCT00517699|602460|P1|Overall Study|Withdrawal by Subject|1
172432|NCT00517634|602468|P6|Second Treatment Period|Withdrawal by Subject|0
172433|NCT00517634|602469|P5|Second Treatment Period|Withdrawal by Subject|1
172434|NCT00517634|602470|P4|Second Treatment Period|Withdrawal by Subject|0
172435|NCT00517634|602471|P3|Second Treatment Period|Withdrawal by Subject|0
172436|NCT00517634|602472|P2|Second Treatment Period|Withdrawal by Subject|0
172437|NCT00517634|602473|P1|Second Treatment Period|Withdrawal by Subject|0
172438|NCT00517413|602575|P1|Overall Study|Other-Reasons|23
172439|NCT00517413|602575|P1|Overall Study|Failure to return|1
172440|NCT00517413|602575|P1|Overall Study|Withdrawal by Subject|2
172441|NCT00517413|602575|P1|Overall Study|Protocol Violation|15
172442|NCT00517413|602575|P1|Overall Study|Death|13
172443|NCT00517413|602575|P1|Overall Study|Adverse Event|7
172444|NCT00517361|602596|P1|Overall Study|The study was terminated|5
172445|NCT00517361|602596|P1|Overall Study|Death|6
172446|NCT00517296|602605|P2|Overall Study|Withdrawal by Subject|0
172447|NCT00517296|602606|P1|Overall Study|Withdrawal by Subject|1
172448|NCT00517192|602618|P2|Overall Study|Early termination of the trial|18
172449|NCT00517192|602619|P1|Overall Study|Early termination of the trial|16
172450|NCT00517192|602618|P2|Overall Study|Withdrawal by Subject|0
172451|NCT00517192|602619|P1|Overall Study|Withdrawal by Subject|1
172452|NCT00517192|602618|P2|Overall Study|Lost to Follow-up|1
172453|NCT00517192|602619|P1|Overall Study|Lost to Follow-up|1
172454|NCT00517192|602618|P2|Overall Study|Adverse Event|1
172455|NCT00517192|602619|P1|Overall Study|Adverse Event|1
172456|NCT00516906|602726|P2|Overall Study|Final Dressing Removal Data not captured|2
172457|NCT00516906|602727|P1|Overall Study|Final Dressing Removal Data not captured|6
172458|NCT00516893|602737|P1|Overall Study|Received Medication From Another Study|1
172459|NCT00516893|602737|P1|Overall Study|Pregnancy|1
172460|NCT00516893|602737|P1|Overall Study|Relocated|1
172461|NCT00516893|602737|P1|Overall Study|Persistent Antibodies per Protocol|6
172462|NCT00516893|602737|P1|Overall Study|Death|1
172463|NCT00516893|602737|P1|Overall Study|Noncompliance|2
172464|NCT00516893|602737|P1|Overall Study|Withdrawal by Subject|2
172465|NCT00516893|602737|P1|Overall Study|Adverse Event|3
172466|NCT00516893|602737|P1|Overall Study|Lost to Follow-up|4
172467|NCT00516737|602746|P2|Overall Study|Lack of Qualifying Event|6
172468|NCT00516737|602747|P1|Overall Study|Lack of Qualifying Event|9
172469|NCT00516737|602746|P2|Overall Study|Withdrawal by Subject|1
172470|NCT00516737|602747|P1|Overall Study|Withdrawal by Subject|0
172471|NCT00516737|602746|P2|Overall Study|Physician Decision|1
172472|NCT00516737|602747|P1|Overall Study|Physician Decision|0
172473|NCT00516737|602746|P2|Overall Study|Lost to Follow-up|0
172474|NCT00516737|602747|P1|Overall Study|Lost to Follow-up|2
172475|NCT00516386|602786|P1|Overall Study|Lost to Follow-up|2
172476|NCT00516386|602786|P1|Overall Study|not interested in the study|4
172477|NCT00516321|602793|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
172478|NCT00516321|602794|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
172479|NCT00516321|602795|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
172480|NCT00516321|602793|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
172481|NCT00516321|602794|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
172482|NCT00516321|602795|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
172483|NCT00516321|602793|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
172484|NCT00516321|602794|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
172485|NCT00516321|602795|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
172486|NCT00516321|602793|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
172487|NCT00516321|602794|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
172488|NCT00516321|602795|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
172489|NCT00516321|602793|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
172490|NCT00516321|602794|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
172491|NCT00516321|602795|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
172492|NCT00516321|602793|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
172493|NCT00516321|602794|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
172494|NCT00516321|602795|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
172495|NCT00516321|602793|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
172496|NCT00516321|602794|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
172497|NCT00516321|602795|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
172498|NCT00516321|602793|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
172499|NCT00516321|602794|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
172500|NCT00516321|602795|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
172501|NCT00516321|602793|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
172502|NCT00516321|602794|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
172503|NCT00516321|602795|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
172504|NCT00516321|602793|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
172505|NCT00516321|602794|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
172506|NCT00516321|602795|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
172507|NCT00516321|602793|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
172508|NCT00516321|602794|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
172509|NCT00516321|602795|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
172510|NCT00516295|602846|P3|Overall Study|Ineligible|0
172511|NCT00516295|602847|P2|Overall Study|Ineligible|0
172512|NCT00516295|602848|P1|Overall Study|Ineligible|1
172513|NCT00516295|602846|P3|Overall Study|Lack of Efficacy|0
172514|NCT00516295|602847|P2|Overall Study|Lack of Efficacy|0
172515|NCT00516295|602848|P1|Overall Study|Lack of Efficacy|2
172516|NCT00516269|602861|P2|Overall Study|Protocol Violation|1
172517|NCT00516269|602862|P1|Overall Study|Protocol Violation|0
172518|NCT00516269|602861|P2|Overall Study|Lost to Follow-up|1
172519|NCT00516269|602862|P1|Overall Study|Lost to Follow-up|0
172520|NCT00516269|602861|P2|Overall Study|Adverse Event|1
172521|NCT00516269|602862|P1|Overall Study|Adverse Event|2
172522|NCT00516139|602883|P1|Overall Study|Lack of Efficacy|1
172523|NCT00516139|602883|P1|Overall Study|Withdrawal by Subject|8
172524|NCT00516139|602883|P1|Overall Study|Protocol Violation|1
172525|NCT00516139|602883|P1|Overall Study|Lost to Follow-up|1
172526|NCT00516139|602883|P1|Overall Study|Adverse Event|27
172527|NCT00516074|602914|P2|Overall Study|Loss of Glucose Control|0
172528|NCT00516074|602915|P1|Overall Study|Loss of Glucose Control|2
172529|NCT00516074|602914|P2|Overall Study|Subject Decision|2
172530|NCT00516074|602915|P1|Overall Study|Subject Decision|4
172531|NCT00516074|602914|P2|Overall Study|Adverse Event|1
172532|NCT00516074|602915|P1|Overall Study|Adverse Event|0
172533|NCT00516048|602933|P3|Overall Study|Subject Decision|0
172534|NCT00516048|602934|P2|Overall Study|Subject Decision|2
172535|NCT00516048|602935|P1|Overall Study|Subject Decision|0
172536|NCT00516048|602933|P3|Overall Study|Death|1
172537|NCT00516048|602934|P2|Overall Study|Death|0
172538|NCT00516048|602935|P1|Overall Study|Death|0
172539|NCT00515827|602962|P2|Second Intervention (12 Weeks)|Consent withdraw|0
172540|NCT00515827|602963|P1|Second Intervention (12 Weeks)|Consent withdraw|1
172541|NCT00515827|602962|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
172542|NCT00515827|602963|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
172543|NCT00515671|602998|P2|Overall Study|incarcerated|2
172544|NCT00515671|602999|P1|Overall Study|incarcerated|1
172545|NCT00515671|602998|P2|Overall Study|Withdrawal by Subject|5
172546|NCT00515671|602999|P1|Overall Study|Withdrawal by Subject|3
172547|NCT00515671|602998|P2|Overall Study|Lost to Follow-up|10
172548|NCT00515671|602999|P1|Overall Study|Lost to Follow-up|13
172549|NCT00515619|603007|P1|Overall Study|Other: Subject interested in other AED|1
172550|NCT00515619|603007|P1|Overall Study|Other: Drug available on license|1
172551|NCT00515619|603007|P1|Overall Study|Other: Request from sponsor|1
172552|NCT00515619|603007|P1|Overall Study|Other: Subject became pregnant|1
172553|NCT00515619|603007|P1|Overall Study|Other: Investigator decision|1
172554|NCT00515619|603007|P1|Overall Study|Other: Subject moved to another country|1
172555|NCT00515619|603007|P1|Overall Study|Other: Subject required surgery|1
172556|NCT00515619|603007|P1|Overall Study|Other: Subject cannot attend visits|2
172557|NCT00515619|603007|P1|Overall Study|Other: Site discontinuing trials|2
172558|NCT00515619|603007|P1|Overall Study|Unsatisfactory compliance|6
172559|NCT00515619|603007|P1|Overall Study|Lost to Follow-up|4
172560|NCT00515619|603007|P1|Overall Study|Protocol Violation|3
172561|NCT00515619|603007|P1|Overall Study|Withdrawal by Subject|66
172562|NCT00515619|603007|P1|Overall Study|Lack of Efficacy|92
172563|NCT00515619|603007|P1|Overall Study|Adverse Event|34
172564|NCT00515541|603019|P4|Overall Study|Withdrawal by Subject|2
172565|NCT00515541|603020|P3|Overall Study|Withdrawal by Subject|0
172566|NCT00515541|603021|P2|Overall Study|Withdrawal by Subject|2
172567|NCT00515541|603022|P1|Overall Study|Withdrawal by Subject|0
172568|NCT00515541|603019|P4|Overall Study|No show for appointments|2
172569|NCT00515541|603020|P3|Overall Study|No show for appointments|0
172570|NCT00515541|603021|P2|Overall Study|No show for appointments|1
172571|NCT00515541|603022|P1|Overall Study|No show for appointments|0
172572|NCT00515541|603019|P4|Overall Study|Physician Decision|1
172573|NCT00515541|603020|P3|Overall Study|Physician Decision|0
172574|NCT00515541|603021|P2|Overall Study|Physician Decision|2
172575|NCT00515541|603022|P1|Overall Study|Physician Decision|0
172576|NCT00515502|603044|P12|Treatment Period 2|Adverse Event|0
172577|NCT00515502|603045|P11|Treatment Period 2|Adverse Event|0
172578|NCT00515502|603046|P10|Treatment Period 2|Adverse Event|0
172579|NCT00515502|603047|P9|Treatment Period 2|Adverse Event|0
172580|NCT00515502|603048|P8|Treatment Period 2|Adverse Event|0
172581|NCT00515502|603049|P7|Treatment Period 2|Adverse Event|0
172582|NCT00515502|603050|P6|Treatment Period 2|Adverse Event|0
172583|NCT00515502|603051|P5|Treatment Period 2|Adverse Event|0
172584|NCT00515502|603052|P4|Treatment Period 2|Adverse Event|0
172585|NCT00515502|603053|P3|Treatment Period 2|Adverse Event|0
172586|NCT00515502|603054|P2|Treatment Period 2|Adverse Event|1
172587|NCT00515502|603055|P1|Treatment Period 2|Adverse Event|0
172588|NCT00515502|603044|P12|Treatment Period 1|Adverse Event|1
172589|NCT00515502|603045|P11|Treatment Period 1|Adverse Event|0
172590|NCT00515502|603046|P10|Treatment Period 1|Adverse Event|0
172591|NCT00515502|603047|P9|Treatment Period 1|Adverse Event|1
172592|NCT00515502|603048|P8|Treatment Period 1|Adverse Event|0
172593|NCT00515502|603049|P7|Treatment Period 1|Adverse Event|1
172594|NCT00515502|603050|P6|Treatment Period 1|Adverse Event|0
172595|NCT00515502|603051|P5|Treatment Period 1|Adverse Event|0
172596|NCT00515502|603052|P4|Treatment Period 1|Adverse Event|0
172597|NCT00515502|603053|P3|Treatment Period 1|Adverse Event|0
172598|NCT00515502|603054|P2|Treatment Period 1|Adverse Event|0
172599|NCT00515502|603055|P1|Treatment Period 1|Adverse Event|0
172600|NCT00515463|603215|P2|Overall Study|Other|1
172601|NCT00515463|603216|P1|Overall Study|Other|0
172602|NCT00515463|603215|P2|Overall Study|Lost to Follow-up|5
172603|NCT00515463|603216|P1|Overall Study|Lost to Follow-up|6
172604|NCT00515463|603215|P2|Overall Study|Withdrawal by Subject|4
172605|NCT00515463|603216|P1|Overall Study|Withdrawal by Subject|3
172606|NCT00515463|603215|P2|Overall Study|Adverse Event|2
172607|NCT00515463|603216|P1|Overall Study|Adverse Event|1
172608|NCT00515463|603215|P2|Overall Study|Physician Decision|2
172609|NCT00515463|603216|P1|Overall Study|Physician Decision|4
172610|NCT00515294|603399|P4|Overall Study|Caffeine amount inaccurate|0
172611|NCT00515294|603400|P3|Overall Study|Caffeine amount inaccurate|7
172612|NCT00515294|603401|P2|Overall Study|Caffeine amount inaccurate|0
172613|NCT00515294|603402|P1|Overall Study|Caffeine amount inaccurate|5
172614|NCT00515294|603399|P4|Overall Study|Driver simulator problems|3
172615|NCT00515294|603400|P3|Overall Study|Driver simulator problems|1
172616|NCT00515294|603401|P2|Overall Study|Driver simulator problems|1
172617|NCT00515294|603402|P1|Overall Study|Driver simulator problems|1
172618|NCT00515294|603399|P4|Overall Study|Lost to Follow-up|1
172619|NCT00515294|603400|P3|Overall Study|Lost to Follow-up|3
172620|NCT00515294|603401|P2|Overall Study|Lost to Follow-up|2
172621|NCT00515294|603402|P1|Overall Study|Lost to Follow-up|3
172622|NCT00515216|603416|P1|Overall Study|Withdrawal by Subject|1
172623|NCT00515112|603478|P2|Overall Study|The study was terminated|2
172624|NCT00515112|603479|P1|Overall Study|The study was terminated|3
172625|NCT00515112|603478|P2|Overall Study|Death|1
172626|NCT00515112|603479|P1|Overall Study|Death|0
172627|NCT00515099|603489|P2|Overall Study|IRB Recommendation|0
172628|NCT00515099|603490|P1|Overall Study|IRB Recommendation|1
172629|NCT00515099|603489|P2|Overall Study|Withdrawal by Subject|0
172630|NCT00515099|603490|P1|Overall Study|Withdrawal by Subject|2
172631|NCT00515099|603489|P2|Overall Study|Lost to Follow-up|4
172632|NCT00515099|603490|P1|Overall Study|Lost to Follow-up|0
172633|NCT00515086|603512|P4|Overall Study|Death|0
172634|NCT00515086|603513|P3|Overall Study|Death|0
172635|NCT00515086|603514|P2|Overall Study|Death|0
172636|NCT00515086|603515|P1|Overall Study|Death|2
172637|NCT00515086|603512|P4|Overall Study|Study drug no longer required|0
172638|NCT00515086|603513|P3|Overall Study|Study drug no longer required|0
172639|NCT00515086|603514|P2|Overall Study|Study drug no longer required|1
172640|NCT00515086|603515|P1|Overall Study|Study drug no longer required|0
172641|NCT00515086|603512|P4|Overall Study|Lost to Follow-up|0
172642|NCT00515086|603513|P3|Overall Study|Lost to Follow-up|0
172643|NCT00515086|603514|P2|Overall Study|Lost to Follow-up|0
172644|NCT00515086|603515|P1|Overall Study|Lost to Follow-up|1
172645|NCT00515086|603512|P4|Overall Study|Unsatisfactory therapeutic effect|2
172646|NCT00515086|603513|P3|Overall Study|Unsatisfactory therapeutic effect|3
172647|NCT00515086|603514|P2|Overall Study|Unsatisfactory therapeutic effect|3
172648|NCT00515086|603515|P1|Overall Study|Unsatisfactory therapeutic effect|18
172649|NCT00515086|603512|P4|Overall Study|Withdrawal by Subject|1
172650|NCT00515086|603513|P3|Overall Study|Withdrawal by Subject|0
172651|NCT00515086|603514|P2|Overall Study|Withdrawal by Subject|0
172652|NCT00515086|603515|P1|Overall Study|Withdrawal by Subject|1
172653|NCT00515086|603512|P4|Overall Study|Administrative|0
172654|NCT00515086|603513|P3|Overall Study|Administrative|0
172655|NCT00515086|603514|P2|Overall Study|Administrative|1
172656|NCT00515086|603515|P1|Overall Study|Administrative|1
172657|NCT00515086|603512|P4|Overall Study|Adverse Event|3
172658|NCT00515086|603513|P3|Overall Study|Adverse Event|2
172659|NCT00515086|603514|P2|Overall Study|Adverse Event|1
172660|NCT00515086|603515|P1|Overall Study|Adverse Event|1
172661|NCT00515073|603542|P1|Overall Study|Physician Decision|1
172662|NCT00515073|603542|P1|Overall Study|Withdrawal by Subject|1
172663|NCT00515034|603550|P4|Overall Study|Other|1
172664|NCT00515034|603551|P3|Overall Study|Other|2
172665|NCT00515034|603552|P2|Overall Study|Other|0
172666|NCT00515034|603553|P1|Overall Study|Other|1
172667|NCT00515034|603550|P4|Overall Study|Physician Decision|1
172668|NCT00515034|603551|P3|Overall Study|Physician Decision|1
172669|NCT00515034|603552|P2|Overall Study|Physician Decision|0
172670|NCT00515034|603553|P1|Overall Study|Physician Decision|0
172671|NCT00515034|603550|P4|Overall Study|Withdrawal by Subject|0
172672|NCT00515034|603551|P3|Overall Study|Withdrawal by Subject|3
172673|NCT00515034|603552|P2|Overall Study|Withdrawal by Subject|0
172674|NCT00515034|603553|P1|Overall Study|Withdrawal by Subject|1
172675|NCT00515034|603550|P4|Overall Study|Death|3
172676|NCT00515034|603551|P3|Overall Study|Death|1
172677|NCT00515034|603552|P2|Overall Study|Death|2
172678|NCT00515034|603553|P1|Overall Study|Death|4
172679|NCT00515034|603550|P4|Overall Study|Adverse Event|0
172680|NCT00515034|603551|P3|Overall Study|Adverse Event|1
172681|NCT00515034|603552|P2|Overall Study|Adverse Event|0
172682|NCT00515034|603553|P1|Overall Study|Adverse Event|2
172683|NCT00515008|603573|P2|Overall Study|Scheduling conflict|0
172684|NCT00515008|603574|P1|Overall Study|Scheduling conflict|1
172685|NCT00515008|603573|P2|Overall Study|Left the Boston Area|1
172686|NCT00515008|603574|P1|Overall Study|Left the Boston Area|1
172687|NCT00515008|603573|P2|Overall Study|Declined|3
172688|NCT00515008|603574|P1|Overall Study|Declined|0
172689|NCT00515008|603573|P2|Overall Study|Lost to Follow-up|0
172690|NCT00515008|603574|P1|Overall Study|Lost to Follow-up|1
172691|NCT00514943|603598|P2|Stage 2|Other than stated above|2
172692|NCT00514943|603599|P1|Stage 2|Other than stated above|0
172693|NCT00514943|603598|P2|Stage 2|Patient refused to continue study meds|0
172694|NCT00514943|603599|P1|Stage 2|Patient refused to continue study meds|2
172695|NCT00514943|603598|P2|Stage 2|Other Adverse Event|10
172696|NCT00514943|603599|P1|Stage 2|Other Adverse Event|3
172697|NCT00514943|603598|P2|Stage 2|Progressive disease|24
172698|NCT00514943|603599|P1|Stage 2|Progressive disease|27
172699|NCT00514943|603598|P2|Stage 1|Other than stated above|7
172700|NCT00514943|603599|P1|Stage 1|Other than stated above|1
172701|NCT00514943|603598|P2|Stage 1|Patient refused to continue study meds|3
172702|NCT00514943|603599|P1|Stage 1|Patient refused to continue study meds|8
172703|NCT00514943|603598|P2|Stage 1|Not treated|2
172704|NCT00514943|603599|P1|Stage 1|Not treated|1
172705|NCT00514943|603598|P2|Stage 1|Other Adverse Event|6
172706|NCT00514943|603599|P1|Stage 1|Other Adverse Event|16
172707|NCT00514943|603598|P2|Stage 1|Progressive disease|8
172708|NCT00514943|603599|P1|Stage 1|Progressive disease|4
172709|NCT00514917|603657|P2|Overall Study|Undefined|5
172710|NCT00514917|603658|P1|Overall Study|Undefined|11
172711|NCT00514917|603657|P2|Overall Study|Discontinued due to study closure|81
172712|NCT00514917|603658|P1|Overall Study|Discontinued due to study closure|88
172713|NCT00514917|603657|P2|Overall Study|Withdrawal by Subject|16
172714|NCT00514917|603658|P1|Overall Study|Withdrawal by Subject|18
172715|NCT00514917|603657|P2|Overall Study|Lost to Follow-up|3
172716|NCT00514917|603658|P1|Overall Study|Lost to Follow-up|4
172717|NCT00514917|603657|P2|Overall Study|Protocol Violation|0
172718|NCT00514917|603658|P1|Overall Study|Protocol Violation|1
172719|NCT00514917|603657|P2|Overall Study|Death|10
172720|NCT00514917|603658|P1|Overall Study|Death|4
172721|NCT00514904|603686|P2|Overall Study|Lost to Follow-up|3
172722|NCT00514904|603687|P1|Overall Study|Lost to Follow-up|21
172723|NCT00514904|603686|P2|Overall Study|Withdrawal by Subject|2
172724|NCT00514904|603687|P1|Overall Study|Withdrawal by Subject|3
172725|NCT00514813|603752|P4|Overall Study|Death|2
172726|NCT00514813|603753|P3|Overall Study|Death|3
172727|NCT00514813|603754|P2|Overall Study|Death|2
172728|NCT00514813|603755|P1|Overall Study|Death|0
172729|NCT00514813|603752|P4|Overall Study|Kidney transplant|0
172730|NCT00514813|603753|P3|Overall Study|Kidney transplant|2
172731|NCT00514813|603754|P2|Overall Study|Kidney transplant|6
172732|NCT00514813|603755|P1|Overall Study|Kidney transplant|0
172733|NCT00514813|603752|P4|Overall Study|Lack of Efficacy|0
172734|NCT00514813|603753|P3|Overall Study|Lack of Efficacy|0
172735|NCT00514813|603754|P2|Overall Study|Lack of Efficacy|1
172736|NCT00514813|603755|P1|Overall Study|Lack of Efficacy|0
172737|NCT00514813|603752|P4|Overall Study|Withdrawal by Subject|0
172738|NCT00514813|603753|P3|Overall Study|Withdrawal by Subject|0
172739|NCT00514813|603754|P2|Overall Study|Withdrawal by Subject|1
172740|NCT00514813|603755|P1|Overall Study|Withdrawal by Subject|0
172741|NCT00514813|603752|P4|Overall Study|Protocol Violation|0
172742|NCT00514813|603753|P3|Overall Study|Protocol Violation|0
172743|NCT00514813|603754|P2|Overall Study|Protocol Violation|0
172744|NCT00514813|603755|P1|Overall Study|Protocol Violation|1
172745|NCT00514813|603752|P4|Overall Study|Adverse Event|0
172746|NCT00514813|603753|P3|Overall Study|Adverse Event|2
172747|NCT00514813|603754|P2|Overall Study|Adverse Event|2
172748|NCT00514813|603755|P1|Overall Study|Adverse Event|0
172749|NCT00514813|603752|P4|Overall Study|Study terminated|2
172750|NCT00514813|603753|P3|Overall Study|Study terminated|40
172751|NCT00514813|603754|P2|Overall Study|Study terminated|74
172752|NCT00514813|603755|P1|Overall Study|Study terminated|14
172753|NCT00514735|603775|P2|Overall Study|Lost to Follow-up|1
172754|NCT00514735|603776|P1|Overall Study|Lost to Follow-up|0
172755|NCT00514735|603775|P2|Overall Study|Death|0
172756|NCT00514735|603776|P1|Overall Study|Death|1
172757|NCT00514735|603775|P2|Overall Study|Withdrawal by Subject|5
172758|NCT00514735|603776|P1|Overall Study|Withdrawal by Subject|13
172759|NCT00514683|603812|P5|Overall Study|Reason other than listed above|1
172760|NCT00514683|603813|P4|Overall Study|Reason other than listed above|0
172761|NCT00514683|603814|P3|Overall Study|Reason other than listed above|2
172762|NCT00514683|603815|P2|Overall Study|Reason other than listed above|1
172763|NCT00514683|603816|P1|Overall Study|Reason other than listed above|0
172764|NCT00514683|603812|P5|Overall Study|Withdrawal by Subject|4
172765|NCT00514683|603813|P4|Overall Study|Withdrawal by Subject|0
172766|NCT00514683|603814|P3|Overall Study|Withdrawal by Subject|1
172767|NCT00514683|603815|P2|Overall Study|Withdrawal by Subject|2
172768|NCT00514683|603816|P1|Overall Study|Withdrawal by Subject|2
172769|NCT00514683|603812|P5|Overall Study|Protocol Violation|0
172770|NCT00514683|603813|P4|Overall Study|Protocol Violation|1
172771|NCT00514683|603814|P3|Overall Study|Protocol Violation|0
172772|NCT00514683|603815|P2|Overall Study|Protocol Violation|1
172773|NCT00514683|603816|P1|Overall Study|Protocol Violation|1
172774|NCT00514683|603812|P5|Overall Study|Adverse Event|27
172775|NCT00514683|603813|P4|Overall Study|Adverse Event|13
172776|NCT00514683|603814|P3|Overall Study|Adverse Event|15
172777|NCT00514683|603815|P2|Overall Study|Adverse Event|20
172778|NCT00514683|603816|P1|Overall Study|Adverse Event|21
172779|NCT00514683|603812|P5|Overall Study|Not treated|1
172780|NCT00514683|603813|P4|Overall Study|Not treated|0
172781|NCT00514683|603814|P3|Overall Study|Not treated|0
172782|NCT00514683|603815|P2|Overall Study|Not treated|1
172783|NCT00514683|603816|P1|Overall Study|Not treated|2
172784|NCT00514514|604015|P3|Extension - 4 Years|Adverse Event|3
172785|NCT00514514|604016|P2|Extension - 4 Years|Adverse Event|6
172786|NCT00514514|604017|P1|Extension - 4 Years|Adverse Event|9
172787|NCT00514514|604015|P3|Extension - 4 Years|Death|6
172788|NCT00514514|604016|P2|Extension - 4 Years|Death|3
172789|NCT00514514|604017|P1|Extension - 4 Years|Death|8
172790|NCT00514514|604015|P3|Extension - 4 Years|Administrative problems|1
172791|NCT00514514|604016|P2|Extension - 4 Years|Administrative problems|1
172792|NCT00514514|604017|P1|Extension - 4 Years|Administrative problems|3
172793|NCT00514514|604015|P3|Extension - 4 Years|Lost to Follow-up|9
172794|NCT00514514|604016|P2|Extension - 4 Years|Lost to Follow-up|10
172795|NCT00514514|604017|P1|Extension - 4 Years|Lost to Follow-up|12
172796|NCT00514514|604015|P3|Extension - 4 Years|Withdrawal by Subject|2
172797|NCT00514514|604016|P2|Extension - 4 Years|Withdrawal by Subject|2
172798|NCT00514514|604017|P1|Extension - 4 Years|Withdrawal by Subject|5
172799|NCT00514514|604015|P3|Randomized - 9 Month|Adverse Event|27
172800|NCT00514514|604016|P2|Randomized - 9 Month|Adverse Event|44
172801|NCT00514514|604017|P1|Randomized - 9 Month|Adverse Event|25
172802|NCT00514514|604015|P3|Randomized - 9 Month|Abnormal laboratory values|1
172803|NCT00514514|604016|P2|Randomized - 9 Month|Abnormal laboratory values|3
172804|NCT00514514|604017|P1|Randomized - 9 Month|Abnormal laboratory values|0
172805|NCT00514514|604015|P3|Randomized - 9 Month|Lack of Efficacy|1
172806|NCT00514514|604016|P2|Randomized - 9 Month|Lack of Efficacy|3
172807|NCT00514514|604017|P1|Randomized - 9 Month|Lack of Efficacy|2
172808|NCT00514514|604015|P3|Randomized - 9 Month|Protocol Violation|0
172809|NCT00514514|604016|P2|Randomized - 9 Month|Protocol Violation|1
172810|NCT00514514|604017|P1|Randomized - 9 Month|Protocol Violation|1
172811|NCT00514514|604015|P3|Randomized - 9 Month|Withdrawal by Subject|5
172812|NCT00514514|604016|P2|Randomized - 9 Month|Withdrawal by Subject|7
172813|NCT00514514|604017|P1|Randomized - 9 Month|Withdrawal by Subject|7
172814|NCT00514514|604015|P3|Randomized - 9 Month|Administrative problems|2
172815|NCT00514514|604016|P2|Randomized - 9 Month|Administrative problems|1
172816|NCT00514514|604017|P1|Randomized - 9 Month|Administrative problems|1
172817|NCT00514514|604015|P3|Randomized - 9 Month|Death|2
172818|NCT00514514|604016|P2|Randomized - 9 Month|Death|2
172819|NCT00514514|604017|P1|Randomized - 9 Month|Death|3
172820|NCT00514514|604015|P3|Pre-phase|Withdrawal by Subject|0
172821|NCT00514514|604016|P2|Pre-phase|Withdrawal by Subject|0
172822|NCT00514514|604017|P1|Pre-phase|Withdrawal by Subject|66
172823|NCT00514514|604015|P3|Pre-phase|Adverse Event|0
172824|NCT00514514|604016|P2|Pre-phase|Adverse Event|0
172825|NCT00514514|604017|P1|Pre-phase|Adverse Event|137
172826|NCT00514514|604015|P3|Pre-phase|Lack of Efficacy|0
172827|NCT00514514|604016|P2|Pre-phase|Lack of Efficacy|0
172828|NCT00514514|604017|P1|Pre-phase|Lack of Efficacy|35
172829|NCT00514514|604015|P3|Pre-phase|abnormal lab values|0
172830|NCT00514514|604016|P2|Pre-phase|abnormal lab values|0
172831|NCT00514514|604017|P1|Pre-phase|abnormal lab values|23
172832|NCT00514514|604015|P3|Pre-phase|Lost to Follow-up|0
172833|NCT00514514|604016|P2|Pre-phase|Lost to Follow-up|0
172834|NCT00514514|604017|P1|Pre-phase|Lost to Follow-up|2
172835|NCT00514514|604015|P3|Pre-phase|abnormal test procedure results|0
172836|NCT00514514|604016|P2|Pre-phase|abnormal test procedure results|0
172837|NCT00514514|604017|P1|Pre-phase|abnormal test procedure results|15
172838|NCT00514514|604015|P3|Pre-phase|condition no longer requires study drug|0
172839|NCT00514514|604016|P2|Pre-phase|condition no longer requires study drug|0
172840|NCT00514514|604017|P1|Pre-phase|condition no longer requires study drug|7
172841|NCT00514514|604015|P3|Pre-phase|Protocol Violation|0
172842|NCT00514514|604016|P2|Pre-phase|Protocol Violation|0
172843|NCT00514514|604017|P1|Pre-phase|Protocol Violation|6
172844|NCT00514514|604015|P3|Pre-phase|administrative problems|0
172845|NCT00514514|604016|P2|Pre-phase|administrative problems|0
172846|NCT00514514|604017|P1|Pre-phase|administrative problems|2
172847|NCT00514514|604015|P3|Pre-phase|Death|0
172848|NCT00514514|604016|P2|Pre-phase|Death|0
172849|NCT00514514|604017|P1|Pre-phase|Death|10
172850|NCT00514449|604069|P2|Overall Study|Lost to Follow-up|0
172851|NCT00514449|604070|P1|Overall Study|Lost to Follow-up|1
172852|NCT00514449|604069|P2|Overall Study|Protocol Violation|2
172853|NCT00514449|604070|P1|Overall Study|Protocol Violation|1
172854|NCT00514449|604069|P2|Overall Study|Withdrawal by Subject|2
172855|NCT00514449|604070|P1|Overall Study|Withdrawal by Subject|1
172856|NCT00514020|604091|P1|Overall Study|"patients moved to the no tx group"|6
172857|NCT00514020|604091|P1|Overall Study|patient went to radiation treatment|1
172858|NCT00514020|604091|P1|Overall Study|other complicating disease|2
172859|NCT00514020|604091|P1|Overall Study|disease progression|9
172860|NCT00514020|604091|P1|Overall Study|Physician Decision|1
172861|NCT00514020|604091|P1|Overall Study|Withdrawal by Subject|3
172862|NCT00514020|604091|P1|Overall Study|Adverse Event|6
172863|NCT00513708|604123|P3|Overall Study|Lost to Follow-up|4
172864|NCT00513708|604124|P2|Overall Study|Lost to Follow-up|4
172865|NCT00513708|604125|P1|Overall Study|Lost to Follow-up|4
172866|NCT00513695|604139|P1|Overall Study|Progression prior to surgery|3
172867|NCT00513695|604139|P1|Overall Study|Discontinued therapy|2
172868|NCT00513682|604148|P1|Washout Phase|Adverse Event|2
172869|NCT00513604|604178|P5|Overall Study|Death during treatment|0
172870|NCT00513604|604179|P4|Overall Study|Death during treatment|0
172871|NCT00513604|604180|P3|Overall Study|Death during treatment|2
172872|NCT00513604|604181|P2|Overall Study|Death during treatment|3
172873|NCT00513604|604182|P1|Overall Study|Death during treatment|0
172874|NCT00513604|604178|P5|Overall Study|Not treated|0
172875|NCT00513604|604179|P4|Overall Study|Not treated|0
172876|NCT00513604|604180|P3|Overall Study|Not treated|1
172877|NCT00513604|604181|P2|Overall Study|Not treated|0
172878|NCT00513604|604182|P1|Overall Study|Not treated|2
172879|NCT00513500|604216|P2|Overall Study|Hospitalized|14
172880|NCT00513500|604217|P1|Overall Study|Hospitalized|4
172881|NCT00513500|604216|P2|Overall Study|Death|1
172882|NCT00513500|604217|P1|Overall Study|Death|2
172883|NCT00513500|604216|P2|Overall Study|Lost to Follow-up|39
172884|NCT00513500|604217|P1|Overall Study|Lost to Follow-up|35
172885|NCT00513474|604229|P2|Overall Study|Participant Withdrew Consent|0
172886|NCT00513474|604230|P1|Overall Study|Participant Withdrew Consent|1
172887|NCT00513474|604229|P2|Overall Study|Death|9
172888|NCT00513474|604230|P1|Overall Study|Death|6
172889|NCT00513409|604249|P2|Overall Study|Visit 3 not done|2
172890|NCT00513409|604250|P1|Overall Study|Visit 3 not done|1
172891|NCT00513409|604249|P2|Overall Study|Physician Decision|0
172892|NCT00513409|604250|P1|Overall Study|Physician Decision|1
172893|NCT00513409|604249|P2|Overall Study|Lost to Follow-up|1
172894|NCT00513409|604250|P1|Overall Study|Lost to Follow-up|0
172895|NCT00513409|604249|P2|Overall Study|Withdrawal by Subject|2
172896|NCT00513409|604250|P1|Overall Study|Withdrawal by Subject|0
172897|NCT00513409|604249|P2|Overall Study|Adverse Event|1
172898|NCT00513409|604250|P1|Overall Study|Adverse Event|0
172899|NCT00513357|604306|P2|Overall Study|Disease Progression|1
172900|NCT00513357|604307|P1|Overall Study|Disease Progression|2
172901|NCT00513357|604306|P2|Overall Study|Withdrawal by Subject|4
172902|NCT00513357|604307|P1|Overall Study|Withdrawal by Subject|5
172903|NCT00513357|604306|P2|Overall Study|Death|0
172904|NCT00513357|604307|P1|Overall Study|Death|2
172905|NCT00513357|604306|P2|Overall Study|Adverse Event|2
172906|NCT00513357|604307|P1|Overall Study|Adverse Event|4
172907|NCT00513357|604306|P2|Overall Study|did not receive allocated placebo|3
172908|NCT00513357|604307|P1|Overall Study|did not receive allocated placebo|2
172909|NCT00513305|604326|P2|Overall Study|Sponsor Decision|2
172910|NCT00513305|604327|P1|Overall Study|Sponsor Decision|0
172911|NCT00513305|604326|P2|Overall Study|Persistent hypocellularity|1
172912|NCT00513305|604327|P1|Overall Study|Persistent hypocellularity|0
172913|NCT00513305|604326|P2|Overall Study|Physician Decision|0
172914|NCT00513305|604327|P1|Overall Study|Physician Decision|1
172915|NCT00513305|604326|P2|Overall Study|Hematologic counts did not recover|0
172916|NCT00513305|604327|P1|Overall Study|Hematologic counts did not recover|1
172917|NCT00513305|604326|P2|Overall Study|Eligible for stem cell transplant|0
172918|NCT00513305|604327|P1|Overall Study|Eligible for stem cell transplant|1
172919|NCT00513305|604326|P2|Overall Study|Disease progression|5
172920|NCT00513305|604327|P1|Overall Study|Disease progression|8
172921|NCT00513305|604326|P2|Overall Study|Withdrawal by Subject|2
172922|NCT00513305|604327|P1|Overall Study|Withdrawal by Subject|1
172923|NCT00513305|604326|P2|Overall Study|Lack of Efficacy|13
172924|NCT00513305|604327|P1|Overall Study|Lack of Efficacy|8
172925|NCT00513305|604326|P2|Overall Study|Death (through Consolidation Treatment)|2
172926|NCT00513305|604327|P1|Overall Study|Death (through Consolidation Treatment)|2
172927|NCT00513305|604326|P2|Overall Study|Adverse Event|2
172928|NCT00513305|604327|P1|Overall Study|Adverse Event|6
172929|NCT00513240|604364|P2|Overall Study|Withdrawal by Subject|4
172930|NCT00513240|604365|P1|Overall Study|Withdrawal by Subject|7
172931|NCT00513240|604364|P2|Overall Study|Death|3
172932|NCT00513240|604365|P1|Overall Study|Death|3
172933|NCT00513240|604364|P2|Overall Study|Did not have intended surgery|0
172934|NCT00513240|604365|P1|Overall Study|Did not have intended surgery|3
172935|NCT00513071|604372|P1|Overall Study|Physician Decision|3
172936|NCT00513071|604372|P1|Overall Study|Withdrawal by Subject|1
172937|NCT00513071|604372|P1|Overall Study|Adverse Event|1
172938|NCT00513019|604384|P2|Overall Study|Withdrawal by Subject|5
172939|NCT00513019|604385|P1|Overall Study|Withdrawal by Subject|4
172940|NCT00513019|604384|P2|Overall Study|Adverse Event|0
172941|NCT00513019|604385|P1|Overall Study|Adverse Event|1
172942|NCT00512902|604391|P1|Overall Study|Lost to Follow-up|1
172943|NCT00512902|604391|P1|Overall Study|Adverse Event|7
172944|NCT00512798|604406|P2|Overall Study|Withdrawal by Subject|0
172945|NCT00512798|604407|P1|Overall Study|Withdrawal by Subject|3
172946|NCT00512798|604406|P2|Overall Study|Progression of disease|20
172947|NCT00512798|604407|P1|Overall Study|Progression of disease|14
172948|NCT00512798|604406|P2|Overall Study|Adverse Event|4
172949|NCT00512798|604407|P1|Overall Study|Adverse Event|2
172950|NCT00512798|604406|P2|Overall Study|Death|3
172951|NCT00512798|604407|P1|Overall Study|Death|0
172952|NCT00512707|604418|P2|Overall Study|Unable to tolerate the smell of the gel|0
172953|NCT00512707|604419|P1|Overall Study|Unable to tolerate the smell of the gel|1
172954|NCT00512707|604418|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
172955|NCT00512707|604419|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
172956|NCT00512707|604418|P2|Overall Study|Developed skin irritation|1
172957|NCT00512707|604419|P1|Overall Study|Developed skin irritation|2
172958|NCT00512707|604418|P2|Overall Study|Lost to Follow-up|11
172959|NCT00512707|604419|P1|Overall Study|Lost to Follow-up|5
172960|NCT00512252|604469|P3|Overall Study|Death|1
172961|NCT00512252|604470|P2|Overall Study|Death|0
172962|NCT00512252|604471|P1|Overall Study|Death|0
172963|NCT00512252|604469|P3|Overall Study|Protocol Violation|1
172964|NCT00512252|604470|P2|Overall Study|Protocol Violation|0
172965|NCT00512252|604471|P1|Overall Study|Protocol Violation|0
172966|NCT00512252|604469|P3|Overall Study|Lost to Follow-up|1
172967|NCT00512252|604470|P2|Overall Study|Lost to Follow-up|0
172968|NCT00512252|604471|P1|Overall Study|Lost to Follow-up|0
172969|NCT00512148|604499|P1|Primay Study Period|Withdrawal by Subject|1
172970|NCT00512096|604504|P1|Overall Study|Lack of Efficacy|3
172971|NCT00512096|604504|P1|Overall Study|Withdrawal by Subject|2
172972|NCT00512096|604504|P1|Overall Study|Adverse Event|2
172973|NCT00511901|604532|P2|Overall Study|Withdrawal by Subject|3
172974|NCT00511901|604533|P1|Overall Study|Withdrawal by Subject|1
172975|NCT00511836|604571|P2|Double-blind Period|Lost to Follow-up|0
172976|NCT00511836|604572|P1|Double-blind Period|Lost to Follow-up|1
172977|NCT00511810|604589|P2|Overall Study|Refused second scn|1
172978|NCT00511810|604590|P1|Overall Study|Refused second scn|0
172979|NCT00511810|604589|P2|Overall Study|Lack of Efficacy|2
172980|NCT00511810|604590|P1|Overall Study|Lack of Efficacy|0
172981|NCT00511810|604589|P2|Overall Study|Lost to Follow-up|2
172982|NCT00511810|604590|P1|Overall Study|Lost to Follow-up|1
172983|NCT00511797|604600|P4|Overall Study|Other (moving etc)|2
172984|NCT00511797|604601|P3|Overall Study|Other (moving etc)|1
172985|NCT00511797|604602|P2|Overall Study|Other (moving etc)|0
172986|NCT00511797|604603|P1|Overall Study|Other (moving etc)|1
172987|NCT00511797|604600|P4|Overall Study|Partially missing diary|0
172988|NCT00511797|604601|P3|Overall Study|Partially missing diary|1
172989|NCT00511797|604602|P2|Overall Study|Partially missing diary|0
172990|NCT00511797|604603|P1|Overall Study|Partially missing diary|0
172991|NCT00511797|604600|P4|Overall Study|Study drug not taken|1
172992|NCT00511797|604601|P3|Overall Study|Study drug not taken|0
172993|NCT00511797|604602|P2|Overall Study|Study drug not taken|1
172994|NCT00511797|604603|P1|Overall Study|Study drug not taken|0
172995|NCT00511797|604600|P4|Overall Study|Never dispensed|3
172996|NCT00511797|604601|P3|Overall Study|Never dispensed|1
172997|NCT00511797|604602|P2|Overall Study|Never dispensed|0
172998|NCT00511797|604603|P1|Overall Study|Never dispensed|1
172999|NCT00511797|604600|P4|Overall Study|Withdrawal by Subject|2
173000|NCT00511797|604601|P3|Overall Study|Withdrawal by Subject|4
173001|NCT00511797|604602|P2|Overall Study|Withdrawal by Subject|3
173002|NCT00511797|604603|P1|Overall Study|Withdrawal by Subject|3
173003|NCT00511797|604600|P4|Overall Study|Protocol Violation|3
173004|NCT00511797|604601|P3|Overall Study|Protocol Violation|2
173005|NCT00511797|604602|P2|Overall Study|Protocol Violation|2
173006|NCT00511797|604603|P1|Overall Study|Protocol Violation|0
173007|NCT00511797|604600|P4|Overall Study|Pregnancy|1
173008|NCT00511797|604601|P3|Overall Study|Pregnancy|0
173009|NCT00511797|604602|P2|Overall Study|Pregnancy|0
173010|NCT00511797|604603|P1|Overall Study|Pregnancy|0
173011|NCT00511797|604600|P4|Overall Study|Lost to Follow-up|1
173012|NCT00511797|604601|P3|Overall Study|Lost to Follow-up|0
173013|NCT00511797|604602|P2|Overall Study|Lost to Follow-up|0
173014|NCT00511797|604603|P1|Overall Study|Lost to Follow-up|1
173015|NCT00511797|604600|P4|Overall Study|Adverse Event|2
173016|NCT00511797|604601|P3|Overall Study|Adverse Event|2
173017|NCT00511797|604602|P2|Overall Study|Adverse Event|2
173018|NCT00511797|604603|P1|Overall Study|Adverse Event|1
173019|NCT00511667|604722|P2|Overall Study|Other|1
173020|NCT00511667|604723|P1|Overall Study|Other|2
173021|NCT00511667|604722|P2|Overall Study|Site terminated|1
173022|NCT00511667|604723|P1|Overall Study|Site terminated|6
173023|NCT00511667|604722|P2|Overall Study|Withdrawal by Subject|0
173024|NCT00511667|604723|P1|Overall Study|Withdrawal by Subject|2
173025|NCT00511667|604722|P2|Overall Study|Protocol Violation|1
173026|NCT00511667|604723|P1|Overall Study|Protocol Violation|1
173027|NCT00511667|604722|P2|Overall Study|Adverse Event|0
173028|NCT00511667|604723|P1|Overall Study|Adverse Event|1
173029|NCT00511472|604758|P2|Overall Study|Not reported|2
173030|NCT00511472|604759|P1|Overall Study|Not reported|2
173031|NCT00511472|604758|P2|Overall Study|Laboratory Adverse Event|2
173032|NCT00511472|604759|P1|Overall Study|Laboratory Adverse Event|0
173033|NCT00511472|604758|P2|Overall Study|Clinical Adverse Event|2
173034|NCT00511472|604759|P1|Overall Study|Clinical Adverse Event|1
173035|NCT00511433|604778|P2|Overall Study|Other Reason|1
173036|NCT00511433|604779|P1|Overall Study|Other Reason|1
173037|NCT00511433|604778|P2|Overall Study|Adverse Event|0
173038|NCT00511433|604779|P1|Overall Study|Adverse Event|5
173039|NCT00511355|604819|P2|Overall Study|Other reason pre-treatment|1
173040|NCT00511355|604820|P1|Overall Study|Other reason pre-treatment|0
173041|NCT00511355|604819|P2|Overall Study|Withdrawal of informed consent|1
173042|NCT00511355|604820|P1|Overall Study|Withdrawal of informed consent|0
173043|NCT00511355|604819|P2|Overall Study|Pre-treatment (serious) adverse event|1
173044|NCT00511355|604820|P1|Overall Study|Pre-treatment (serious) adverse event|0
173045|NCT00511355|604819|P2|Overall Study|Other Reason|1
173046|NCT00511355|604820|P1|Overall Study|Other Reason|0
173047|NCT00511355|604819|P2|Overall Study|Lost to Follow-up|1
173048|NCT00511355|604820|P1|Overall Study|Lost to Follow-up|2
173049|NCT00511355|604819|P2|Overall Study|Pregnancy Wish|0
173050|NCT00511355|604820|P1|Overall Study|Pregnancy Wish|1
173051|NCT00511355|604819|P2|Overall Study|Adverse Event|4
173052|NCT00511355|604820|P1|Overall Study|Adverse Event|4
173053|NCT00511342|604920|P2|Overall Study|Other Reason|2
173054|NCT00511342|604921|P1|Overall Study|Other Reason|2
173055|NCT00511342|604920|P2|Overall Study|Lost to Follow-up|5
173056|NCT00511342|604921|P1|Overall Study|Lost to Follow-up|1
173057|NCT00511342|604920|P2|Overall Study|Pregnancy wish|1
173058|NCT00511342|604921|P1|Overall Study|Pregnancy wish|0
173059|NCT00511342|604920|P2|Overall Study|Pregnancy|1
173060|NCT00511342|604921|P1|Overall Study|Pregnancy|0
173061|NCT00511342|604920|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
173062|NCT00511342|604921|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
173063|NCT00511342|604920|P2|Overall Study|Unacceptable vaginal bleeding|1
173064|NCT00511342|604921|P1|Overall Study|Unacceptable vaginal bleeding|2
173065|NCT00511238|604952|P2|Overall Study|various reasons|14
173066|NCT00511238|604953|P1|Overall Study|various reasons|4
173067|NCT00511238|604952|P2|Overall Study|Progressive Disease|157
173068|NCT00511238|604953|P1|Overall Study|Progressive Disease|23
173069|NCT00511238|604952|P2|Overall Study|Withdrawal by Subject|22
173070|NCT00511238|604953|P1|Overall Study|Withdrawal by Subject|2
173071|NCT00511238|604952|P2|Overall Study|Adverse Event|33
173072|NCT00511238|604953|P1|Overall Study|Adverse Event|13
173073|NCT00511199|604972|P2|Overall Study|Other Reason|37
173074|NCT00511199|604973|P1|Overall Study|Other Reason|78
173075|NCT00511199|604972|P2|Overall Study|Lost to Follow-up|17
173076|NCT00511199|604973|P1|Overall Study|Lost to Follow-up|40
173077|NCT00511199|604972|P2|Overall Study|Pregnancy Wish|8
173078|NCT00511199|604973|P1|Overall Study|Pregnancy Wish|16
173079|NCT00511199|604972|P2|Overall Study|Pregnancy|3
173080|NCT00511199|604973|P1|Overall Study|Pregnancy|6
173081|NCT00511199|604972|P2|Overall Study|Withdrawal of Informed Consent|4
173082|NCT00511199|604973|P1|Overall Study|Withdrawal of Informed Consent|19
173083|NCT00511199|604972|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
173084|NCT00511199|604973|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
173085|NCT00511199|604972|P2|Overall Study|Unacceptable Vaginal Bleeding|4
173086|NCT00511199|604973|P1|Overall Study|Unacceptable Vaginal Bleeding|63
173087|NCT00511147|605002|P1|Overall Study|Required platelet transfusion|1
173088|NCT00511147|605002|P1|Overall Study|Disease progression|5
173089|NCT00511147|605002|P1|Overall Study|Withdrawal by Subject|1
173090|NCT00511134|605011|P2|Overall Study|Withdrawal by Subject|2
173091|NCT00511134|605012|P1|Overall Study|Withdrawal by Subject|0
173092|NCT00511108|605024|P4|Overall Study|Withdrawal by Subject|2
173093|NCT00511108|605025|P3|Overall Study|Withdrawal by Subject|3
173094|NCT00511108|605026|P2|Overall Study|Withdrawal by Subject|0
173095|NCT00511108|605027|P1|Overall Study|Withdrawal by Subject|4
173096|NCT00511108|605024|P4|Overall Study|Physician Decision|1
173097|NCT00511108|605025|P3|Overall Study|Physician Decision|0
173098|NCT00511108|605026|P2|Overall Study|Physician Decision|0
173099|NCT00511108|605027|P1|Overall Study|Physician Decision|0
173100|NCT00511108|605024|P4|Overall Study|Lost to Follow-up|0
173101|NCT00511108|605025|P3|Overall Study|Lost to Follow-up|1
173102|NCT00511108|605026|P2|Overall Study|Lost to Follow-up|2
173103|NCT00511108|605027|P1|Overall Study|Lost to Follow-up|0
173104|NCT00511108|605024|P4|Overall Study|Adverse Event|2
173105|NCT00511108|605025|P3|Overall Study|Adverse Event|1
173106|NCT00511108|605026|P2|Overall Study|Adverse Event|0
173107|NCT00511108|605027|P1|Overall Study|Adverse Event|2
173108|NCT00511004|605054|P3|Overall Study|Lost to Follow-up|4
173109|NCT00511004|605055|P2|Overall Study|Lost to Follow-up|0
173110|NCT00511004|605056|P1|Overall Study|Lost to Follow-up|0
173111|NCT00510952|605075|P2|Overall Study|Did Not Receive Study Drug|0
173112|NCT00510952|605076|P1|Overall Study|Did Not Receive Study Drug|2
173113|NCT00510952|605075|P2|Overall Study|Withdrawal by Subject|7
173114|NCT00510952|605076|P1|Overall Study|Withdrawal by Subject|6
173115|NCT00510952|605075|P2|Overall Study|Sponsor Decision|0
173116|NCT00510952|605076|P1|Overall Study|Sponsor Decision|1
173117|NCT00510952|605075|P2|Overall Study|Protocol Violation|4
173118|NCT00510952|605076|P1|Overall Study|Protocol Violation|7
173119|NCT00510952|605075|P2|Overall Study|Physician Decision|1
173120|NCT00510952|605076|P1|Overall Study|Physician Decision|1
173121|NCT00510952|605075|P2|Overall Study|Lost to Follow-up|3
173122|NCT00510952|605076|P1|Overall Study|Lost to Follow-up|5
173123|NCT00510952|605075|P2|Overall Study|Entry Criteria Not Met|1
173124|NCT00510952|605076|P1|Overall Study|Entry Criteria Not Met|3
173125|NCT00510952|605075|P2|Overall Study|Adverse Event|0
173126|NCT00510952|605076|P1|Overall Study|Adverse Event|1
173127|NCT00510887|605102|P1|Overall Study|Lost to Follow-up|1
173128|NCT00510874|605118|P7|Overall Study|Lost to Follow-up|1
173129|NCT00510874|605119|P6|Overall Study|Lost to Follow-up|0
173130|NCT00510874|605120|P5|Overall Study|Lost to Follow-up|4
173131|NCT00510874|605121|P4|Overall Study|Lost to Follow-up|3
173132|NCT00510874|605122|P3|Overall Study|Lost to Follow-up|1
173133|NCT00510874|605123|P2|Overall Study|Lost to Follow-up|3
173134|NCT00510874|605124|P1|Overall Study|Lost to Follow-up|2
173135|NCT00510874|605118|P7|Overall Study|Withdrawal by Subject|0
173136|NCT00510874|605119|P6|Overall Study|Withdrawal by Subject|0
173137|NCT00510874|605120|P5|Overall Study|Withdrawal by Subject|3
173138|NCT00510874|605121|P4|Overall Study|Withdrawal by Subject|0
173139|NCT00510874|605122|P3|Overall Study|Withdrawal by Subject|0
173140|NCT00510874|605123|P2|Overall Study|Withdrawal by Subject|1
173141|NCT00510874|605124|P1|Overall Study|Withdrawal by Subject|1
173142|NCT00510835|605227|P3|Overall Study|Withdrawal by Subject|2
173143|NCT00510835|605228|P2|Overall Study|Withdrawal by Subject|2
173144|NCT00510835|605229|P1|Overall Study|Withdrawal by Subject|6
173145|NCT00510783|605255|P2|Overall Study|Protocol Violation|1
173146|NCT00510783|605256|P1|Overall Study|Protocol Violation|0
173147|NCT00510783|605255|P2|Overall Study|Withdrawal by Subject|3
173148|NCT00510783|605256|P1|Overall Study|Withdrawal by Subject|2
173149|NCT00510783|605255|P2|Overall Study|Lost to Follow-up|25
173150|NCT00510783|605256|P1|Overall Study|Lost to Follow-up|29
173151|NCT00510692|605268|P2|Overall Study|Withdrawal by Subject|0
173152|NCT00510692|605269|P1|Overall Study|Withdrawal by Subject|1
173153|NCT00510692|605268|P2|Overall Study|Adverse Event|3
173154|NCT00510692|605269|P1|Overall Study|Adverse Event|1
173155|NCT00510653|605283|P1|Overall Study|Monetary|3
173156|NCT00510653|605283|P1|Overall Study|Withdrawal by Subject|8
173157|NCT00510510|605290|P3|Overall Study|Protocol Violation|4
173158|NCT00510510|605291|P2|Overall Study|Protocol Violation|3
173159|NCT00510510|605292|P1|Overall Study|Protocol Violation|0
173160|NCT00510510|605290|P3|Overall Study|Lost to Follow-up|1
173161|NCT00510510|605291|P2|Overall Study|Lost to Follow-up|0
173162|NCT00510510|605292|P1|Overall Study|Lost to Follow-up|0
173163|NCT00510510|605290|P3|Overall Study|Withdrawal by Subject|3
173164|NCT00510510|605291|P2|Overall Study|Withdrawal by Subject|2
173165|NCT00510510|605292|P1|Overall Study|Withdrawal by Subject|1
173166|NCT00510510|605290|P3|Overall Study|Subjects no longer requires study drug|2
173167|NCT00510510|605291|P2|Overall Study|Subjects no longer requires study drug|0
173168|NCT00510510|605292|P1|Overall Study|Subjects no longer requires study drug|0
173169|NCT00510510|605290|P3|Overall Study|Lack of Efficacy|1
173170|NCT00510510|605291|P2|Overall Study|Lack of Efficacy|1
173171|NCT00510510|605292|P1|Overall Study|Lack of Efficacy|0
173172|NCT00510510|605290|P3|Overall Study|Adverse Event|6
173173|NCT00510510|605291|P2|Overall Study|Adverse Event|3
173174|NCT00510510|605292|P1|Overall Study|Adverse Event|4
173175|NCT00510484|605310|P2|Wash-out Period|Adverse Event|1
173176|NCT00510484|605311|P1|Wash-out Period|Adverse Event|0
173177|NCT00510458|605331|P1|Overall Study|Revision|2
173178|NCT00510458|605331|P1|Overall Study|Withdrawal by Subject|3
173179|NCT00510458|605331|P1|Overall Study|Lost to Follow-up|6
173180|NCT00510458|605331|P1|Overall Study|Terminated|14
173181|NCT00510458|605331|P1|Overall Study|Death|1
173182|NCT00510458|605331|P1|Overall Study|5 year not evaluable/missed|21
173183|NCT00510289|605344|P1|Overall Study|Progressed prior to starting drug|2
173184|NCT00510289|605344|P1|Overall Study|Lost to Follow-up|1
173185|NCT00510289|605344|P1|Overall Study|Refused bone marrow biopsy|2
173186|NCT00510289|605344|P1|Overall Study|Withdrawal by Subject|7
173187|NCT00510276|605354|P2|Extension Open-Label Phase|Subject Decision|9
173188|NCT00510276|605355|P1|Extension Open-Label Phase|Subject Decision|7
173189|NCT00510276|605354|P2|Extension Open-Label Phase|Sponsor Decision|0
173190|NCT00510276|605355|P1|Extension Open-Label Phase|Sponsor Decision|1
173191|NCT00510276|605354|P2|Extension Open-Label Phase|Protocol Violation|1
173192|NCT00510276|605355|P1|Extension Open-Label Phase|Protocol Violation|0
173193|NCT00510276|605354|P2|Extension Open-Label Phase|Physician Decision|3
173194|NCT00510276|605355|P1|Extension Open-Label Phase|Physician Decision|2
173195|NCT00510276|605354|P2|Extension Open-Label Phase|Lost to Follow-up|10
173196|NCT00510276|605355|P1|Extension Open-Label Phase|Lost to Follow-up|12
173197|NCT00510276|605354|P2|Extension Open-Label Phase|Lack of Efficacy|7
173198|NCT00510276|605355|P1|Extension Open-Label Phase|Lack of Efficacy|2
173199|NCT00510276|605354|P2|Extension Open-Label Phase|Adverse Event|18
173200|NCT00510276|605355|P1|Extension Open-Label Phase|Adverse Event|9
173201|NCT00510276|605354|P2|Acute Double-Blind Phase|Subject Decision|28
173202|NCT00510276|605355|P1|Acute Double-Blind Phase|Subject Decision|26
173203|NCT00510276|605354|P2|Acute Double-Blind Phase|Sponsor Decision|1
173204|NCT00510276|605355|P1|Acute Double-Blind Phase|Sponsor Decision|2
173205|NCT00510276|605354|P2|Acute Double-Blind Phase|Protocol Violation|3
173206|NCT00510276|605355|P1|Acute Double-Blind Phase|Protocol Violation|4
173207|NCT00510276|605354|P2|Acute Double-Blind Phase|Physician Decision|3
173208|NCT00510276|605355|P1|Acute Double-Blind Phase|Physician Decision|0
173209|NCT00510276|605354|P2|Acute Double-Blind Phase|Lost to Follow-up|49
173210|NCT00510276|605355|P1|Acute Double-Blind Phase|Lost to Follow-up|48
173211|NCT00510276|605354|P2|Acute Double-Blind Phase|Lack of Efficacy|4
173212|NCT00510276|605355|P1|Acute Double-Blind Phase|Lack of Efficacy|3
173213|NCT00510276|605354|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
173214|NCT00510276|605355|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
173215|NCT00510276|605354|P2|Acute Double-Blind Phase|Adverse Event|6
173216|NCT00510276|605355|P1|Acute Double-Blind Phase|Adverse Event|21
173217|NCT00510146|605449|P2|Open-Label Treatment|Sponsor Decision|0
173218|NCT00510146|605450|P1|Open-Label Treatment|Sponsor Decision|2
173219|NCT00510146|605449|P2|Open-Label Treatment|Clinical Relapse|1
173220|NCT00510146|605450|P1|Open-Label Treatment|Clinical Relapse|1
173221|NCT00510146|605449|P2|Open-Label Treatment|Withdrawal by Subject|12
173222|NCT00510146|605450|P1|Open-Label Treatment|Withdrawal by Subject|24
173223|NCT00510146|605449|P2|Open-Label Treatment|Protocol Violation|2
173224|NCT00510146|605450|P1|Open-Label Treatment|Protocol Violation|4
173225|NCT00510146|605449|P2|Open-Label Treatment|Physician Decision|1
173226|NCT00510146|605450|P1|Open-Label Treatment|Physician Decision|3
173227|NCT00510146|605449|P2|Open-Label Treatment|Lost to Follow-up|1
173228|NCT00510146|605450|P1|Open-Label Treatment|Lost to Follow-up|10
173229|NCT00510146|605449|P2|Open-Label Treatment|Lack of Efficacy|0
173230|NCT00510146|605450|P1|Open-Label Treatment|Lack of Efficacy|4
173231|NCT00510146|605449|P2|Open-Label Treatment|Death|1
173232|NCT00510146|605450|P1|Open-Label Treatment|Death|1
173233|NCT00510146|605449|P2|Open-Label Treatment|Adverse Event|8
173234|NCT00510146|605450|P1|Open-Label Treatment|Adverse Event|22
173235|NCT00510146|605449|P2|Double-Blind Treatment|Entry Criteria Not Met|0
173236|NCT00510146|605450|P1|Double-Blind Treatment|Entry Criteria Not Met|3
173237|NCT00510146|605449|P2|Double-Blind Treatment|Clinical Relapse|1
173238|NCT00510146|605450|P1|Double-Blind Treatment|Clinical Relapse|0
173239|NCT00510146|605449|P2|Double-Blind Treatment|Withdrawal by Subject|13
173240|NCT00510146|605450|P1|Double-Blind Treatment|Withdrawal by Subject|27
173241|NCT00510146|605449|P2|Double-Blind Treatment|Protocol Violation|2
173242|NCT00510146|605450|P1|Double-Blind Treatment|Protocol Violation|1
173243|NCT00510146|605449|P2|Double-Blind Treatment|Physician Decision|0
173244|NCT00510146|605450|P1|Double-Blind Treatment|Physician Decision|6
173245|NCT00510146|605449|P2|Double-Blind Treatment|Lost to Follow-up|7
173246|NCT00510146|605450|P1|Double-Blind Treatment|Lost to Follow-up|3
173247|NCT00510146|605449|P2|Double-Blind Treatment|Lack of Efficacy|13
173248|NCT00510146|605450|P1|Double-Blind Treatment|Lack of Efficacy|6
173249|NCT00510146|605449|P2|Double-Blind Treatment|Adverse Event|13
173250|NCT00510146|605450|P1|Double-Blind Treatment|Adverse Event|30
173251|NCT00510068|605539|P2|Open-label Period|Abnormal laboratory value (s)|0
173252|NCT00510068|605540|P1|Open-label Period|Abnormal laboratory value (s)|1
173253|NCT00510068|605539|P2|Open-label Period|Protocol Violation|0
173254|NCT00510068|605540|P1|Open-label Period|Protocol Violation|2
173255|NCT00510068|605539|P2|Open-label Period|New cancer therapy|0
173256|NCT00510068|605540|P1|Open-label Period|New cancer therapy|7
173257|NCT00510068|605539|P2|Open-label Period|Death|0
173258|NCT00510068|605540|P1|Open-label Period|Death|7
173259|NCT00510068|605539|P2|Open-label Period|Administrative problems|0
173260|NCT00510068|605540|P1|Open-label Period|Administrative problems|17
173261|NCT00510068|605539|P2|Open-label Period|Withdrawal by Subject|0
173262|NCT00510068|605540|P1|Open-label Period|Withdrawal by Subject|21
173263|NCT00510068|605539|P2|Open-label Period|Adverse Event|0
173264|NCT00510068|605540|P1|Open-label Period|Adverse Event|46
173265|NCT00510068|605539|P2|Open-label Period|Disease Progression|0
173266|NCT00510068|605540|P1|Open-label Period|Disease Progression|124
173267|NCT00510068|605539|P2|Double-blind Period|Protocol Violation|0
173268|NCT00510068|605540|P1|Double-blind Period|Protocol Violation|6
173269|NCT00510068|605539|P2|Double-blind Period|Lost to Follow-up|0
173270|NCT00510068|605540|P1|Double-blind Period|Lost to Follow-up|1
173271|NCT00510068|605539|P2|Double-blind Period|Abnormal test result (s)|0
173272|NCT00510068|605540|P1|Double-blind Period|Abnormal test result (s)|1
173273|NCT00510068|605539|P2|Double-blind Period|Death|3
173274|NCT00510068|605540|P1|Double-blind Period|Death|4
173275|NCT00510068|605539|P2|Double-blind Period|Withdrawal by Subject|6
173276|NCT00510068|605540|P1|Double-blind Period|Withdrawal by Subject|8
173277|NCT00510068|605539|P2|Double-blind Period|Adverse Event|7
173278|NCT00510068|605540|P1|Double-blind Period|Adverse Event|37
173279|NCT00510068|605539|P2|Double-blind Period|Final primary analysis|18
173280|NCT00510068|605540|P1|Double-blind Period|Final primary analysis|52
173281|NCT00510068|605539|P2|Double-blind Period|Disease progression|169
173282|NCT00510068|605540|P1|Double-blind Period|Disease progression|98
173283|NCT00509925|605581|P2|Overall Study|Personal reasons|1
173284|NCT00509925|605582|P1|Overall Study|Personal reasons|0
173285|NCT00509899|605630|P8|Overall Study|Lack of Efficacy|0
173286|NCT00509899|605631|P7|Overall Study|Lack of Efficacy|0
173287|NCT00509899|605632|P6|Overall Study|Lack of Efficacy|1
173288|NCT00509899|605633|P5|Overall Study|Lack of Efficacy|0
173289|NCT00509899|605634|P4|Overall Study|Lack of Efficacy|0
173290|NCT00509899|605635|P3|Overall Study|Lack of Efficacy|2
173291|NCT00509899|605636|P2|Overall Study|Lack of Efficacy|0
173292|NCT00509899|605637|P1|Overall Study|Lack of Efficacy|1
173293|NCT00509899|605630|P8|Overall Study|Death|1
173294|NCT00509899|605631|P7|Overall Study|Death|1
173295|NCT00509899|605632|P6|Overall Study|Death|1
173296|NCT00509899|605633|P5|Overall Study|Death|1
173297|NCT00509899|605634|P4|Overall Study|Death|0
173298|NCT00509899|605635|P3|Overall Study|Death|3
173299|NCT00509899|605636|P2|Overall Study|Death|2
173300|NCT00509899|605637|P1|Overall Study|Death|2
173301|NCT00509899|605630|P8|Overall Study|Intercurrent Illness|0
173302|NCT00509899|605631|P7|Overall Study|Intercurrent Illness|0
173303|NCT00509899|605632|P6|Overall Study|Intercurrent Illness|1
173304|NCT00509899|605633|P5|Overall Study|Intercurrent Illness|0
173305|NCT00509899|605634|P4|Overall Study|Intercurrent Illness|1
173306|NCT00509899|605635|P3|Overall Study|Intercurrent Illness|0
173307|NCT00509899|605636|P2|Overall Study|Intercurrent Illness|0
173308|NCT00509899|605637|P1|Overall Study|Intercurrent Illness|1
173309|NCT00509899|605630|P8|Overall Study|Physician Decision|0
173310|NCT00509899|605631|P7|Overall Study|Physician Decision|0
173311|NCT00509899|605632|P6|Overall Study|Physician Decision|4
173312|NCT00509899|605633|P5|Overall Study|Physician Decision|1
173313|NCT00509899|605634|P4|Overall Study|Physician Decision|0
173314|NCT00509899|605635|P3|Overall Study|Physician Decision|7
173315|NCT00509899|605636|P2|Overall Study|Physician Decision|2
173316|NCT00509899|605637|P1|Overall Study|Physician Decision|4
173317|NCT00509899|605630|P8|Overall Study|Withdrawal by Subject|0
173318|NCT00509899|605631|P7|Overall Study|Withdrawal by Subject|0
173319|NCT00509899|605632|P6|Overall Study|Withdrawal by Subject|2
173320|NCT00509899|605633|P5|Overall Study|Withdrawal by Subject|3
173321|NCT00509899|605634|P4|Overall Study|Withdrawal by Subject|0
173322|NCT00509899|605635|P3|Overall Study|Withdrawal by Subject|3
173323|NCT00509899|605636|P2|Overall Study|Withdrawal by Subject|2
173324|NCT00509899|605637|P1|Overall Study|Withdrawal by Subject|6
173325|NCT00509899|605630|P8|Overall Study|Unacceptable Toxicity|0
173326|NCT00509899|605631|P7|Overall Study|Unacceptable Toxicity|0
173327|NCT00509899|605632|P6|Overall Study|Unacceptable Toxicity|0
173328|NCT00509899|605633|P5|Overall Study|Unacceptable Toxicity|0
173329|NCT00509899|605634|P4|Overall Study|Unacceptable Toxicity|2
173330|NCT00509899|605635|P3|Overall Study|Unacceptable Toxicity|0
173331|NCT00509899|605636|P2|Overall Study|Unacceptable Toxicity|0
173332|NCT00509899|605637|P1|Overall Study|Unacceptable Toxicity|1
173333|NCT00509899|605630|P8|Overall Study|Progressive disease|0
173334|NCT00509899|605631|P7|Overall Study|Progressive disease|0
173335|NCT00509899|605632|P6|Overall Study|Progressive disease|1
173336|NCT00509899|605633|P5|Overall Study|Progressive disease|0
173337|NCT00509899|605634|P4|Overall Study|Progressive disease|1
173338|NCT00509899|605635|P3|Overall Study|Progressive disease|5
173339|NCT00509899|605636|P2|Overall Study|Progressive disease|3
173340|NCT00509899|605637|P1|Overall Study|Progressive disease|1
173341|NCT00509795|605696|P4|Overall Study|Withdrawal by Subject|8
173342|NCT00509795|605697|P3|Overall Study|Withdrawal by Subject|7
173343|NCT00509795|605698|P2|Overall Study|Withdrawal by Subject|5
173344|NCT00509795|605699|P1|Overall Study|Withdrawal by Subject|10
173345|NCT00509795|605696|P4|Overall Study|Protocol Violation|1
173346|NCT00509795|605697|P3|Overall Study|Protocol Violation|3
173347|NCT00509795|605698|P2|Overall Study|Protocol Violation|0
173348|NCT00509795|605699|P1|Overall Study|Protocol Violation|3
173349|NCT00509795|605696|P4|Overall Study|OTHER|1
173350|NCT00509795|605697|P3|Overall Study|OTHER|4
173351|NCT00509795|605698|P2|Overall Study|OTHER|0
173352|NCT00509795|605699|P1|Overall Study|OTHER|1
173353|NCT00509795|605696|P4|Overall Study|Lost to Follow-up|4
173354|NCT00509795|605697|P3|Overall Study|Lost to Follow-up|4
173355|NCT00509795|605698|P2|Overall Study|Lost to Follow-up|2
173356|NCT00509795|605699|P1|Overall Study|Lost to Follow-up|1
173357|NCT00509795|605696|P4|Overall Study|Lack of Efficacy|2
173358|NCT00509795|605697|P3|Overall Study|Lack of Efficacy|2
173359|NCT00509795|605698|P2|Overall Study|Lack of Efficacy|0
173360|NCT00509795|605699|P1|Overall Study|Lack of Efficacy|0
173361|NCT00509795|605696|P4|Overall Study|Death|7
173362|NCT00509795|605697|P3|Overall Study|Death|2
173363|NCT00509795|605698|P2|Overall Study|Death|1
173364|NCT00509795|605699|P1|Overall Study|Death|3
173365|NCT00509795|605696|P4|Overall Study|Adverse Event|4
173366|NCT00509795|605697|P3|Overall Study|Adverse Event|5
173367|NCT00509795|605698|P2|Overall Study|Adverse Event|3
173368|NCT00509795|605699|P1|Overall Study|Adverse Event|4
173369|NCT00509769|605730|P1|Overall Study|Use of prohibited therapies during study|1
173370|NCT00509769|605730|P1|Overall Study|Physician Decision|8
173371|NCT00509769|605730|P1|Overall Study|Patient’s decision|1
173372|NCT00509769|605730|P1|Overall Study|Adverse Event|4
173373|NCT00509769|605730|P1|Overall Study|Progressive disease|77
173374|NCT00509600|605739|P1|Overall Study|Adverse Event|1
173375|NCT00509366|605817|P5|Overall Study|Not Treated (Screen Failure)|0
173376|NCT00509366|605818|P4|Overall Study|Not Treated (Screen Failure)|0
173377|NCT00509366|605819|P3|Overall Study|Not Treated (Screen Failure)|1
173378|NCT00509366|605820|P2|Overall Study|Not Treated (Screen Failure)|1
173379|NCT00509366|605821|P1|Overall Study|Not Treated (Screen Failure)|1
173380|NCT00509262|605845|P2|Overall Study|Withdrawal by Subject|11
173381|NCT00509262|605846|P1|Overall Study|Withdrawal by Subject|24
173382|NCT00509262|605845|P2|Overall Study|Protocol Violation|2
173383|NCT00509262|605846|P1|Overall Study|Protocol Violation|2
173384|NCT00509262|605845|P2|Overall Study|Physician Decision|3
173385|NCT00509262|605846|P1|Overall Study|Physician Decision|1
173386|NCT00509262|605845|P2|Overall Study|Lost to Follow-up|6
173387|NCT00509262|605846|P1|Overall Study|Lost to Follow-up|1
173388|NCT00509262|605845|P2|Overall Study|Lack of Efficacy|0
173389|NCT00509262|605846|P1|Overall Study|Lack of Efficacy|1
173390|NCT00509262|605845|P2|Overall Study|Not specified|2
173391|NCT00509262|605846|P1|Overall Study|Not specified|2
173392|NCT00509262|605845|P2|Overall Study|Adverse Event|18
173393|NCT00509262|605846|P1|Overall Study|Adverse Event|16
173394|NCT00509236|605864|P2|Overall Study|Scheduled Kidney Transplant|0
173395|NCT00509236|605865|P1|Overall Study|Scheduled Kidney Transplant|1
173396|NCT00509236|605864|P2|Overall Study|Excluded Medication|1
173397|NCT00509236|605865|P1|Overall Study|Excluded Medication|1
173398|NCT00509236|605864|P2|Overall Study|Protocol Violation|0
173399|NCT00509236|605865|P1|Overall Study|Protocol Violation|3
173400|NCT00509236|605864|P2|Overall Study|Withdrawal by Subject|10
173401|NCT00509236|605865|P1|Overall Study|Withdrawal by Subject|5
173402|NCT00509236|605864|P2|Overall Study|Adverse Event|9
173403|NCT00509236|605865|P1|Overall Study|Adverse Event|7
173404|NCT00509223|605880|P2|Overall Study|Did not meet revised inclusion criteria|62
173405|NCT00509223|605881|P1|Overall Study|Did not meet revised inclusion criteria|56
173406|NCT00509223|605880|P2|Overall Study|Including: subject change of address|2
173407|NCT00509223|605881|P1|Overall Study|Including: subject change of address|5
173408|NCT00509223|605880|P2|Overall Study|Withdrawal by Subject|6
173409|NCT00509223|605881|P1|Overall Study|Withdrawal by Subject|25
173410|NCT00509223|605880|P2|Overall Study|Adverse Event|1
173411|NCT00509223|605881|P1|Overall Study|Adverse Event|1
173412|NCT00509223|605880|P2|Overall Study|Lost to Follow-up|1
173413|NCT00509223|605881|P1|Overall Study|Lost to Follow-up|1
173414|NCT00509106|605904|P2|Overall Study|Death|6
173415|NCT00509106|605905|P1|Overall Study|Death|6
173416|NCT00509106|605904|P2|Overall Study|Other|0
173417|NCT00509106|605905|P1|Overall Study|Other|1
173418|NCT00509106|605904|P2|Overall Study|Lost to Follow-up|10
173419|NCT00509106|605905|P1|Overall Study|Lost to Follow-up|16
173420|NCT00509106|605904|P2|Overall Study|Withdrew consent|8
173421|NCT00509106|605905|P1|Overall Study|Withdrew consent|4
173422|NCT00509106|605904|P2|Overall Study|At the request of sponsor/investigator|2
173423|NCT00509106|605905|P1|Overall Study|At the request of sponsor/investigator|1
173424|NCT00509106|605904|P2|Overall Study|Noncompliance|1
173425|NCT00509106|605905|P1|Overall Study|Noncompliance|0
173426|NCT00509106|605904|P2|Overall Study|Adverse Event|2
173427|NCT00509106|605905|P1|Overall Study|Adverse Event|3
173428|NCT00509067|605913|P2|Overall Study|Protocol Violation|3
173429|NCT00509067|605914|P1|Overall Study|Protocol Violation|0
173430|NCT00509067|605913|P2|Overall Study|Adverse Event|1
173431|NCT00509067|605914|P1|Overall Study|Adverse Event|3
173432|NCT00509067|605913|P2|Overall Study|Lost to Follow-up|1
173433|NCT00509067|605914|P1|Overall Study|Lost to Follow-up|1
173434|NCT00509028|605933|P2|Overall Study|Non-compliance|1
173435|NCT00509028|605934|P1|Overall Study|Non-compliance|2
173436|NCT00509028|605933|P2|Overall Study|Protocol Violation|2
173437|NCT00509028|605934|P1|Overall Study|Protocol Violation|4
173438|NCT00509028|605933|P2|Overall Study|Lost to Follow-up|1
173439|NCT00509028|605934|P1|Overall Study|Lost to Follow-up|0
173440|NCT00509028|605933|P2|Overall Study|Withdrawal by Subject|3
173441|NCT00509028|605934|P1|Overall Study|Withdrawal by Subject|4
173442|NCT00509028|605933|P2|Overall Study|Adverse Event|0
173443|NCT00509028|605934|P1|Overall Study|Adverse Event|2
173444|NCT00508924|605974|P4|Overall Study|Protocol Violation|1
173445|NCT00508924|605975|P3|Overall Study|Protocol Violation|1
173446|NCT00508924|605976|P2|Overall Study|Protocol Violation|0
173447|NCT00508924|605977|P1|Overall Study|Protocol Violation|0
173448|NCT00508872|605991|P1|Overall Study|Physician Decision|1
173449|NCT00508872|605991|P1|Overall Study|Lost to Follow-up|1
173450|NCT00508820|605997|P2|Overall Study|Protocol-specified Criteria|12
173451|NCT00508820|605998|P1|Overall Study|Protocol-specified Criteria|3
173452|NCT00508820|605997|P2|Overall Study|Requirement for alternative therapy|15
173453|NCT00508820|605998|P1|Overall Study|Requirement for alternative therapy|7
173454|NCT00508820|605997|P2|Overall Study|Noncompliance|0
173455|NCT00508820|605998|P1|Overall Study|Noncompliance|1
173456|NCT00508820|605997|P2|Overall Study|Other|2
173457|NCT00508820|605998|P1|Overall Study|Other|11
173458|NCT00508820|605997|P2|Overall Study|Withdrawal by Subject|12
173459|NCT00508820|605998|P1|Overall Study|Withdrawal by Subject|10
173460|NCT00508820|605997|P2|Overall Study|Protocol Violation|0
173461|NCT00508820|605998|P1|Overall Study|Protocol Violation|2
173462|NCT00508820|605997|P2|Overall Study|Pregnancy|2
173463|NCT00508820|605998|P1|Overall Study|Pregnancy|0
173464|NCT00508820|605997|P2|Overall Study|Physician Decision|2
173465|NCT00508820|605998|P1|Overall Study|Physician Decision|8
173466|NCT00508820|605997|P2|Overall Study|Lost to Follow-up|1
173467|NCT00508820|605998|P1|Overall Study|Lost to Follow-up|1
173468|NCT00508820|605997|P2|Overall Study|Death|8
173469|NCT00508820|605998|P1|Overall Study|Death|6
173470|NCT00508820|605997|P2|Overall Study|Adverse Event|10
173471|NCT00508820|605998|P1|Overall Study|Adverse Event|6
173472|NCT00508755|606008|P1|Overall Study|Withdrawal by Subject|1
173473|NCT00508742|606016|P2|Period 3: Toddler Dose|Other|4
173474|NCT00508742|606017|P1|Period 3: Toddler Dose|Other|5
173475|NCT00508742|606016|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
173476|NCT00508742|606017|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
173477|NCT00508742|606016|P2|Period 3: Toddler Dose|Lost to Follow-up|3
173478|NCT00508742|606017|P1|Period 3: Toddler Dose|Lost to Follow-up|2
173479|NCT00508742|606016|P2|Period 3: Toddler Dose|Adverse Event|0
173480|NCT00508742|606017|P1|Period 3: Toddler Dose|Adverse Event|1
173481|NCT00508742|606016|P2|Period 2: After Infant Series|Other|1
173482|NCT00508742|606017|P1|Period 2: After Infant Series|Other|2
173483|NCT00508742|606016|P2|Period 2: After Infant Series|Failed to Return|0
173484|NCT00508742|606017|P1|Period 2: After Infant Series|Failed to Return|1
173485|NCT00508742|606016|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
173486|NCT00508742|606017|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
173487|NCT00508742|606016|P2|Period 2: After Infant Series|Protocol Violation|0
173488|NCT00508742|606017|P1|Period 2: After Infant Series|Protocol Violation|1
173489|NCT00508742|606016|P2|Period 2: After Infant Series|Lost to Follow-up|1
173490|NCT00508742|606017|P1|Period 2: After Infant Series|Lost to Follow-up|1
173491|NCT00508742|606016|P2|Period 2: After Infant Series|Adverse Event|6
173492|NCT00508742|606017|P1|Period 2: After Infant Series|Adverse Event|2
173493|NCT00508742|606016|P2|Period 1: Infant Series|Other|1
173494|NCT00508742|606017|P1|Period 1: Infant Series|Other|4
173495|NCT00508742|606016|P2|Period 1: Infant Series|Physician Decision|0
173496|NCT00508742|606017|P1|Period 1: Infant Series|Physician Decision|1
173497|NCT00508742|606016|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
173498|NCT00508742|606017|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
173499|NCT00508742|606016|P2|Period 1: Infant Series|Protocol Violation|0
173500|NCT00508742|606017|P1|Period 1: Infant Series|Protocol Violation|1
173501|NCT00508742|606016|P2|Period 1: Infant Series|Adverse Event|4
173502|NCT00508742|606017|P1|Period 1: Infant Series|Adverse Event|5
173503|NCT00508651|606042|P2|Overall Study|Withdrawal by Subject|1
173504|NCT00508651|606043|P1|Overall Study|Withdrawal by Subject|1
173505|NCT00508651|606042|P2|Overall Study|Lost to Follow-up|1
173506|NCT00508651|606043|P1|Overall Study|Lost to Follow-up|3
173507|NCT00508482|606124|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
173508|NCT00508482|606125|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
173509|NCT00508482|606126|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
173510|NCT00508482|606124|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
173511|NCT00508482|606125|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
173512|NCT00508482|606126|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
173513|NCT00508482|606124|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
173514|NCT00508482|606125|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
173515|NCT00508482|606126|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
173516|NCT00508404|606170|P1|Overall Study|Other - Not Specified|3
173517|NCT00508404|606170|P1|Overall Study|Lost to Follow-up|2
173518|NCT00508404|606170|P1|Overall Study|Protocol-specified Criteria|2
173519|NCT00508404|606170|P1|Overall Study|Withdrawal by Subject|3
173520|NCT00508404|606170|P1|Overall Study|Physician Decision|2
173521|NCT00508404|606170|P1|Overall Study|Death|16
173522|NCT00508404|606170|P1|Overall Study|Adverse Event|2
173523|NCT00508404|606170|P1|Overall Study|Ongoing at Data Cut-off|12
173524|NCT00508391|606197|P2|Second Treatment|Withdrawal by Subject|0
173525|NCT00508391|606198|P1|Second Treatment|Withdrawal by Subject|2
173526|NCT00508391|606197|P2|First Treatment|Withdrawal by Subject|3
173527|NCT00508391|606198|P1|First Treatment|Withdrawal by Subject|6
173528|NCT00508274|606209|P1|Overall Study|Withdrawal by Subject|1
173529|NCT00508274|606209|P1|Overall Study|Adverse Event|1
173530|NCT00508157|606237|P2|Overall Study|Other known cause|1
173531|NCT00508157|606238|P1|Overall Study|Other known cause|0
173532|NCT00508157|606237|P2|Overall Study|Subject no longer met study criteria|1
173533|NCT00508157|606238|P1|Overall Study|Subject no longer met study criteria|0
173534|NCT00508157|606237|P2|Overall Study|Lost to Follow-up|0
173535|NCT00508157|606238|P1|Overall Study|Lost to Follow-up|1
173536|NCT00508157|606237|P2|Overall Study|Subject Withdrew Consent|0
173537|NCT00508157|606238|P1|Overall Study|Subject Withdrew Consent|1
173538|NCT00508157|606237|P2|Overall Study|Adverse Event|1
173539|NCT00508157|606238|P1|Overall Study|Adverse Event|0
173540|NCT00508144|606260|P1|Overall Study|Death|5
173541|NCT00508144|606260|P1|Overall Study|Not eligible|6
173542|NCT00508027|606286|P1|Dose Level 2|Withdrawal by Subject|2
173543|NCT00508027|606286|P1|Dose Level 2|Lost to Follow-up|2
173544|NCT00508027|606286|P1|Dose Level 1|Physician Decision|2
173545|NCT00508027|606286|P1|Dose Level 1|Withdrawal by Subject|2
173546|NCT00508027|606286|P1|Dose Level 1|Lost to Follow-up|4
173547|NCT00508001|606327|P3|Overall Study|Withdrawal by Subject|1
173548|NCT00508001|606328|P2|Overall Study|Withdrawal by Subject|4
173549|NCT00508001|606329|P1|Overall Study|Withdrawal by Subject|4
173550|NCT00508001|606327|P3|Overall Study|Death|1
173551|NCT00508001|606328|P2|Overall Study|Death|1
173552|NCT00508001|606329|P1|Overall Study|Death|0
173553|NCT00508001|606327|P3|Overall Study|condition under investigation worsened|1
173554|NCT00508001|606328|P2|Overall Study|condition under investigation worsened|7
173555|NCT00508001|606329|P1|Overall Study|condition under investigation worsened|13
173556|NCT00508001|606327|P3|Overall Study|Adverse Event|4
173557|NCT00508001|606328|P2|Overall Study|Adverse Event|0
173558|NCT00508001|606329|P1|Overall Study|Adverse Event|2
173559|NCT00507819|606346|P2|Washout (6 Weeks)|Withdrawal by Subject|0
173560|NCT00507819|606347|P1|Washout (6 Weeks)|Withdrawal by Subject|1
173561|NCT00507689|606366|P2|Randomized Period|Withdrawal by Subject|1
173562|NCT00507689|606367|P1|Randomized Period|Withdrawal by Subject|0
173563|NCT00507689|606366|P2|Randomized Period|Adverse Event|1
173564|NCT00507689|606367|P1|Randomized Period|Adverse Event|1
173565|NCT00507689|606366|P2|Pre-Randomization Period|Withdrawal by Subject|0
173566|NCT00507689|606367|P1|Pre-Randomization Period|Withdrawal by Subject|1
173567|NCT00507689|606366|P2|Pre-Randomization Period|Physician Decision|0
173568|NCT00507689|606367|P1|Pre-Randomization Period|Physician Decision|1
173569|NCT00507689|606366|P2|Pre-Randomization Period|Adverse Event|0
173570|NCT00507689|606367|P1|Pre-Randomization Period|Adverse Event|1
173571|NCT00507546|606399|P2|Overall Study|Physician Decision|1
173572|NCT00507546|606400|P1|Overall Study|Physician Decision|0
173573|NCT00507546|606399|P2|Overall Study|Protocol Violation|0
173574|NCT00507546|606400|P1|Overall Study|Protocol Violation|1
173575|NCT00507546|606399|P2|Overall Study|Withdrawal by Subject|0
173576|NCT00507546|606400|P1|Overall Study|Withdrawal by Subject|1
173577|NCT00507507|606410|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
173578|NCT00507507|606411|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
173579|NCT00507507|606410|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
173580|NCT00507507|606411|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
173581|NCT00507507|606410|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
173582|NCT00507507|606411|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
173583|NCT00507507|606410|P2|Treatment Period|Withdrawal by Subject|47
173584|NCT00507507|606411|P1|Treatment Period|Withdrawal by Subject|46
173585|NCT00507507|606410|P2|Treatment Period|Adverse Event|1
173586|NCT00507507|606411|P1|Treatment Period|Adverse Event|1
173587|NCT00507507|606410|P2|Treatment Period|Protocol Violation|2
173588|NCT00507507|606411|P1|Treatment Period|Protocol Violation|1
173589|NCT00507507|606410|P2|Treatment Period|Physician Decision|1
173590|NCT00507507|606411|P1|Treatment Period|Physician Decision|4
173591|NCT00507507|606410|P2|Treatment Period|Lost to Follow-up|2
173592|NCT00507507|606411|P1|Treatment Period|Lost to Follow-up|0
173593|NCT00507455|606446|P3|Overall Study|Other - miscellaneous reason|1
173594|NCT00507455|606447|P2|Overall Study|Other - miscellaneous reason|0
173595|NCT00507455|606448|P1|Overall Study|Other - miscellaneous reason|1
173596|NCT00507455|606446|P3|Overall Study|Lack of Efficacy|0
173597|NCT00507455|606447|P2|Overall Study|Lack of Efficacy|1
173598|NCT00507455|606448|P1|Overall Study|Lack of Efficacy|0
173599|NCT00507455|606446|P3|Overall Study|Lost to Follow-up|2
173600|NCT00507455|606447|P2|Overall Study|Lost to Follow-up|0
173601|NCT00507455|606448|P1|Overall Study|Lost to Follow-up|2
173602|NCT00507455|606446|P3|Overall Study|Protocol Violation|1
173603|NCT00507455|606447|P2|Overall Study|Protocol Violation|1
173604|NCT00507455|606448|P1|Overall Study|Protocol Violation|4
173605|NCT00507455|606446|P3|Overall Study|Withdrawal by Subject|2
173606|NCT00507455|606447|P2|Overall Study|Withdrawal by Subject|1
173607|NCT00507455|606448|P1|Overall Study|Withdrawal by Subject|2
173608|NCT00507455|606446|P3|Overall Study|Adverse Event|6
173609|NCT00507455|606447|P2|Overall Study|Adverse Event|3
173610|NCT00507455|606448|P1|Overall Study|Adverse Event|3
173611|NCT00507442|606511|P4|Overall Study|Not Specified|2
173612|NCT00507442|606512|P3|Overall Study|Not Specified|2
173613|NCT00507442|606513|P2|Overall Study|Not Specified|5
173614|NCT00507442|606514|P1|Overall Study|Not Specified|2
173615|NCT00507442|606511|P4|Overall Study|Withdrawal by Subject|1
173616|NCT00507442|606512|P3|Overall Study|Withdrawal by Subject|2
173617|NCT00507442|606513|P2|Overall Study|Withdrawal by Subject|4
173618|NCT00507442|606514|P1|Overall Study|Withdrawal by Subject|4
173619|NCT00507442|606511|P4|Overall Study|Progressive Disease|0
173620|NCT00507442|606512|P3|Overall Study|Progressive Disease|2
173621|NCT00507442|606513|P2|Overall Study|Progressive Disease|4
173622|NCT00507442|606514|P1|Overall Study|Progressive Disease|2
173623|NCT00507442|606511|P4|Overall Study|Physician Decision|1
173624|NCT00507442|606512|P3|Overall Study|Physician Decision|4
173625|NCT00507442|606513|P2|Overall Study|Physician Decision|2
173626|NCT00507442|606514|P1|Overall Study|Physician Decision|0
173627|NCT00507442|606511|P4|Overall Study|Lost to Follow-up|0
173628|NCT00507442|606512|P3|Overall Study|Lost to Follow-up|1
173629|NCT00507442|606513|P2|Overall Study|Lost to Follow-up|0
173630|NCT00507442|606514|P1|Overall Study|Lost to Follow-up|0
173631|NCT00507442|606511|P4|Overall Study|Protocol Violation|0
173632|NCT00507442|606512|P3|Overall Study|Protocol Violation|0
173633|NCT00507442|606513|P2|Overall Study|Protocol Violation|1
173634|NCT00507442|606514|P1|Overall Study|Protocol Violation|0
173635|NCT00507442|606511|P4|Overall Study|Adverse Event|1
173636|NCT00507442|606512|P3|Overall Study|Adverse Event|4
173637|NCT00507442|606513|P2|Overall Study|Adverse Event|11
173638|NCT00507442|606514|P1|Overall Study|Adverse Event|8
173639|NCT00507429|606566|P2|Maintenance Phase|Progressive Disease|0
173640|NCT00507429|606567|P1|Maintenance Phase|Progressive Disease|14
173641|NCT00507429|606566|P2|Treatment Phase|Other|3
173642|NCT00507429|606567|P1|Treatment Phase|Other|6
173643|NCT00507429|606566|P2|Treatment Phase|Physician Decision|2
173644|NCT00507429|606567|P1|Treatment Phase|Physician Decision|4
173645|NCT00507429|606566|P2|Treatment Phase|Withdrawal by Subject|3
173646|NCT00507429|606567|P1|Treatment Phase|Withdrawal by Subject|3
173647|NCT00507429|606566|P2|Treatment Phase|Adverse Event|5
173648|NCT00507429|606567|P1|Treatment Phase|Adverse Event|12
173649|NCT00507429|606566|P2|Treatment Phase|Disease Progression|5
173650|NCT00507429|606567|P1|Treatment Phase|Disease Progression|12
173651|NCT00507416|606578|P3|Overall Study|Did not Receive Study Treatment|4
173652|NCT00507416|606579|P2|Overall Study|Did not Receive Study Treatment|9
173653|NCT00507416|606580|P1|Overall Study|Did not Receive Study Treatment|3
173654|NCT00507416|606578|P3|Overall Study|Other|13
173655|NCT00507416|606579|P2|Overall Study|Other|16
173656|NCT00507416|606580|P1|Overall Study|Other|11
173657|NCT00507416|606578|P3|Overall Study|Patient declined further treatment|11
173658|NCT00507416|606579|P2|Overall Study|Patient declined further treatment|14
173659|NCT00507416|606580|P1|Overall Study|Patient declined further treatment|18
173660|NCT00507416|606578|P3|Overall Study|Progressive Disease|13
173661|NCT00507416|606579|P2|Overall Study|Progressive Disease|10
173662|NCT00507416|606580|P1|Overall Study|Progressive Disease|20
173663|NCT00507416|606578|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
173664|NCT00507416|606579|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
173665|NCT00507416|606580|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
173666|NCT00507416|606578|P3|Overall Study|Protocol Violation|0
173667|NCT00507416|606579|P2|Overall Study|Protocol Violation|2
173668|NCT00507416|606580|P1|Overall Study|Protocol Violation|1
173669|NCT00507416|606578|P3|Overall Study|Adverse Event|65
173670|NCT00507416|606579|P2|Overall Study|Adverse Event|67
173671|NCT00507416|606580|P1|Overall Study|Adverse Event|58
173672|NCT00507130|606622|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
173673|NCT00507130|606623|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
173674|NCT00507130|606624|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
173675|NCT00507130|606625|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
173676|NCT00507130|606622|P4|Overall Study|Lost to Follow-up|1
173677|NCT00507130|606623|P3|Overall Study|Lost to Follow-up|1
173678|NCT00507130|606624|P2|Overall Study|Lost to Follow-up|0
173679|NCT00507130|606625|P1|Overall Study|Lost to Follow-up|0
173680|NCT00506948|606667|P1|Overall Study|Physician Decision|1
173681|NCT00506948|606667|P1|Overall Study|Adverse Event|5
173682|NCT00506948|606667|P1|Overall Study|Death|4
173683|NCT00506922|606676|P5|Overall Study|Withdrawal by Subject|1
173684|NCT00506922|606677|P4|Overall Study|Withdrawal by Subject|0
173685|NCT00506922|606678|P3|Overall Study|Withdrawal by Subject|0
173686|NCT00506922|606679|P2|Overall Study|Withdrawal by Subject|0
173687|NCT00506922|606680|P1|Overall Study|Withdrawal by Subject|0
173688|NCT00506922|606676|P5|Overall Study|Physician Decision|0
173689|NCT00506922|606677|P4|Overall Study|Physician Decision|2
173690|NCT00506922|606678|P3|Overall Study|Physician Decision|0
173691|NCT00506922|606679|P2|Overall Study|Physician Decision|0
173692|NCT00506922|606680|P1|Overall Study|Physician Decision|0
173693|NCT00506883|606691|P3|Overall Study|Other|1
173694|NCT00506883|606692|P2|Overall Study|Other|1
173695|NCT00506883|606693|P1|Overall Study|Other|5
173696|NCT00506883|606691|P3|Overall Study|Lack of Efficacy|1
173697|NCT00506883|606692|P2|Overall Study|Lack of Efficacy|1
173698|NCT00506883|606693|P1|Overall Study|Lack of Efficacy|0
173699|NCT00506883|606691|P3|Overall Study|Withdrawal by Subject|1
173700|NCT00506883|606692|P2|Overall Study|Withdrawal by Subject|0
173701|NCT00506883|606693|P1|Overall Study|Withdrawal by Subject|1
173702|NCT00506883|606691|P3|Overall Study|Lost to Follow-up|1
173703|NCT00506883|606692|P2|Overall Study|Lost to Follow-up|1
173704|NCT00506883|606693|P1|Overall Study|Lost to Follow-up|1
173705|NCT00506831|606706|P1|Overall Study|Withdrawal by Subject|1
173706|NCT00506831|606706|P1|Overall Study|Death|1
173707|NCT00506662|606738|P2|Overall Study|Not recorded|6
173708|NCT00506662|606739|P1|Overall Study|Not recorded|4
173709|NCT00506662|606738|P2|Overall Study|Trial terminated|16
173710|NCT00506662|606739|P1|Overall Study|Trial terminated|10
173711|NCT00506662|606738|P2|Overall Study|Protocol Violation|4
173712|NCT00506662|606739|P1|Overall Study|Protocol Violation|2
173713|NCT00506662|606738|P2|Overall Study|Lack of Efficacy|0
173714|NCT00506662|606739|P1|Overall Study|Lack of Efficacy|1
173715|NCT00506662|606738|P2|Overall Study|Adverse Event|2
173716|NCT00506662|606739|P1|Overall Study|Adverse Event|0
173717|NCT00506493|606773|P1|Overall Study|Withdrawal by Subject|5
173718|NCT00506493|606773|P1|Overall Study|Death|6
173719|NCT00506454|606782|P2|Overall Study|Withdrawal by Subject|1
173720|NCT00506454|606783|P1|Overall Study|Withdrawal by Subject|1
173721|NCT00506441|606789|P2|Period 2; Double-blind Period|Other Reason|1
173722|NCT00506441|606790|P1|Period 2; Double-blind Period|Other Reason|1
173723|NCT00506441|606789|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
173724|NCT00506441|606790|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
173725|NCT00506441|606789|P2|Period 2; Double-blind Period|Physician Decision|1
173726|NCT00506441|606790|P1|Period 2; Double-blind Period|Physician Decision|1
173727|NCT00506441|606789|P2|Period 2; Double-blind Period|Lack of Efficacy|2
173728|NCT00506441|606790|P1|Period 2; Double-blind Period|Lack of Efficacy|0
173729|NCT00506441|606789|P2|Period 2; Double-blind Period|Adverse Event|1
173730|NCT00506441|606790|P1|Period 2; Double-blind Period|Adverse Event|0
173731|NCT00506441|606789|P2|Period 1; Open-label Period|Other Reasons|0
173732|NCT00506441|606790|P1|Period 1; Open-label Period|Other Reasons|13
173733|NCT00506441|606789|P2|Period 1; Open-label Period|Withdrawal by Subject|0
173734|NCT00506441|606790|P1|Period 1; Open-label Period|Withdrawal by Subject|13
173735|NCT00506441|606789|P2|Period 1; Open-label Period|Protocol Violation|0
173736|NCT00506441|606790|P1|Period 1; Open-label Period|Protocol Violation|9
173737|NCT00506441|606789|P2|Period 1; Open-label Period|Physician Decision|0
173738|NCT00506441|606790|P1|Period 1; Open-label Period|Physician Decision|5
173739|NCT00506441|606789|P2|Period 1; Open-label Period|Lost to Follow-up|0
173740|NCT00506441|606790|P1|Period 1; Open-label Period|Lost to Follow-up|2
173741|NCT00506441|606789|P2|Period 1; Open-label Period|Lack of Efficacy|0
173742|NCT00506441|606790|P1|Period 1; Open-label Period|Lack of Efficacy|13
173743|NCT00506441|606789|P2|Period 1; Open-label Period|Adverse Event|0
173744|NCT00506441|606790|P1|Period 1; Open-label Period|Adverse Event|21
173745|NCT00506415|606798|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
173746|NCT00506415|606799|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
173747|NCT00506415|606800|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
173748|NCT00506415|606801|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
173749|NCT00506415|606798|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
173750|NCT00506415|606799|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
173751|NCT00506415|606800|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
173752|NCT00506415|606801|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
173753|NCT00506415|606798|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
173754|NCT00506415|606799|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
173755|NCT00506415|606800|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
173756|NCT00506415|606801|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
173757|NCT00506415|606798|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
173758|NCT00506415|606799|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
173759|NCT00506415|606800|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
173760|NCT00506415|606801|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
173761|NCT00506415|606798|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
173762|NCT00506415|606799|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
173763|NCT00506415|606800|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
173764|NCT00506415|606801|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
173765|NCT00506415|606798|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
173766|NCT00506415|606799|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
173767|NCT00506415|606800|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
173768|NCT00506415|606801|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
173769|NCT00506415|606798|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
173770|NCT00506415|606799|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
173771|NCT00506415|606800|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
173772|NCT00506415|606801|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
173773|NCT00506415|606798|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
173774|NCT00506415|606799|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
173775|NCT00506415|606800|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
173776|NCT00506415|606801|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
173777|NCT00506415|606798|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
173778|NCT00506415|606799|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
173779|NCT00506415|606800|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
173780|NCT00506415|606801|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
173781|NCT00506415|606798|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
173782|NCT00506415|606799|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
173783|NCT00506415|606800|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
173784|NCT00506415|606801|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
173785|NCT00506415|606798|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
173786|NCT00506415|606799|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
173787|NCT00506415|606800|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
173788|NCT00506415|606801|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
173789|NCT00506415|606798|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
173790|NCT00506415|606799|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
173791|NCT00506415|606800|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
173792|NCT00506415|606801|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
173793|NCT00506415|606798|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
173794|NCT00506415|606799|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
173795|NCT00506415|606800|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
173796|NCT00506415|606801|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
173797|NCT00506415|606798|P4|Double Blind (Maximum 48 Weeks )|Death|0
173798|NCT00506415|606799|P3|Double Blind (Maximum 48 Weeks )|Death|3
173799|NCT00506415|606800|P2|Double Blind (Maximum 48 Weeks )|Death|5
173800|NCT00506415|606801|P1|Double Blind (Maximum 48 Weeks )|Death|0
173801|NCT00506415|606798|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
173802|NCT00506415|606799|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
173803|NCT00506415|606800|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
173804|NCT00506415|606801|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
173805|NCT00506415|606798|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
173806|NCT00506415|606799|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
173807|NCT00506415|606800|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
173808|NCT00506415|606801|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
173809|NCT00506415|606798|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
173810|NCT00506415|606799|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
173811|NCT00506415|606800|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
173812|NCT00506415|606801|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
173813|NCT00506415|606798|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
173814|NCT00506415|606799|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
173815|NCT00506415|606800|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
173816|NCT00506415|606801|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
173817|NCT00506415|606798|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
173818|NCT00506415|606799|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
173819|NCT00506415|606800|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
173820|NCT00506415|606801|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
173821|NCT00506415|606798|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
173822|NCT00506415|606799|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
173823|NCT00506415|606800|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
173824|NCT00506415|606801|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
173825|NCT00506415|606798|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
173826|NCT00506415|606799|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
173827|NCT00506415|606800|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
173828|NCT00506415|606801|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
173829|NCT00506415|606798|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
173830|NCT00506415|606799|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
173831|NCT00506415|606800|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
173832|NCT00506415|606801|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
173833|NCT00506415|606798|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
173834|NCT00506415|606799|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
173835|NCT00506415|606800|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
173836|NCT00506415|606801|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
173837|NCT00506415|606798|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
173838|NCT00506415|606799|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
173839|NCT00506415|606800|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
173840|NCT00506415|606801|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
173841|NCT00506389|606826|P3|In-treatment Period|Randomized but not treated|1
173842|NCT00506389|606827|P2|In-treatment Period|Randomized but not treated|1
173843|NCT00506389|606828|P1|In-treatment Period|Randomized but not treated|4
173844|NCT00506389|606826|P3|In-treatment Period|Adverse Event|2
173845|NCT00506389|606827|P2|In-treatment Period|Adverse Event|5
173846|NCT00506389|606828|P1|In-treatment Period|Adverse Event|11
173847|NCT00506389|606826|P3|In-treatment Period|Lack of Efficacy|0
173848|NCT00506389|606827|P2|In-treatment Period|Lack of Efficacy|2
173849|NCT00506389|606828|P1|In-treatment Period|Lack of Efficacy|0
173850|NCT00506389|606826|P3|In-treatment Period|Withdrawal by Subject|4
173851|NCT00506389|606827|P2|In-treatment Period|Withdrawal by Subject|3
173852|NCT00506389|606828|P1|In-treatment Period|Withdrawal by Subject|3
173853|NCT00506389|606826|P3|In-treatment Period|Reasons not related to trial|0
173854|NCT00506389|606827|P2|In-treatment Period|Reasons not related to trial|1
173855|NCT00506389|606828|P1|In-treatment Period|Reasons not related to trial|4
173856|NCT00506389|606826|P3|In-treatment Period|Lack of compliance|0
173857|NCT00506389|606827|P2|In-treatment Period|Lack of compliance|0
173858|NCT00506389|606828|P1|In-treatment Period|Lack of compliance|1
173859|NCT00506389|606826|P3|In-treatment Period|Lost to Follow-up|1
173860|NCT00506389|606827|P2|In-treatment Period|Lost to Follow-up|0
173861|NCT00506389|606828|P1|In-treatment Period|Lost to Follow-up|0
173862|NCT00506389|606826|P3|In-treatment Period|Not specified|4
173863|NCT00506389|606827|P2|In-treatment Period|Not specified|3
173864|NCT00506389|606828|P1|In-treatment Period|Not specified|3
173865|NCT00506350|606854|P9|Overall Study|Not specified|2
173866|NCT00506350|606855|P8|Overall Study|Not specified|2
173867|NCT00506350|606856|P7|Overall Study|Not specified|0
173868|NCT00506350|606857|P6|Overall Study|Not specified|0
173869|NCT00506350|606858|P5|Overall Study|Not specified|3
173870|NCT00506350|606859|P4|Overall Study|Not specified|0
173871|NCT00506350|606860|P3|Overall Study|Not specified|3
173872|NCT00506350|606861|P2|Overall Study|Not specified|1
173873|NCT00506350|606862|P1|Overall Study|Not specified|1
173874|NCT00506350|606854|P9|Overall Study|Medical Reason|0
173875|NCT00506350|606855|P8|Overall Study|Medical Reason|0
173876|NCT00506350|606856|P7|Overall Study|Medical Reason|0
173877|NCT00506350|606857|P6|Overall Study|Medical Reason|0
173878|NCT00506350|606858|P5|Overall Study|Medical Reason|1
173879|NCT00506350|606859|P4|Overall Study|Medical Reason|0
173880|NCT00506350|606860|P3|Overall Study|Medical Reason|0
173881|NCT00506350|606861|P2|Overall Study|Medical Reason|0
173882|NCT00506350|606862|P1|Overall Study|Medical Reason|0
173883|NCT00506350|606854|P9|Overall Study|Lost to Follow-up|2
173884|NCT00506350|606855|P8|Overall Study|Lost to Follow-up|0
173885|NCT00506350|606856|P7|Overall Study|Lost to Follow-up|0
173886|NCT00506350|606857|P6|Overall Study|Lost to Follow-up|1
173887|NCT00506350|606858|P5|Overall Study|Lost to Follow-up|2
173888|NCT00506350|606859|P4|Overall Study|Lost to Follow-up|1
173889|NCT00506350|606860|P3|Overall Study|Lost to Follow-up|1
173890|NCT00506350|606861|P2|Overall Study|Lost to Follow-up|1
173891|NCT00506350|606862|P1|Overall Study|Lost to Follow-up|1
173892|NCT00506350|606854|P9|Overall Study|Withdrawal by Subject|0
173893|NCT00506350|606855|P8|Overall Study|Withdrawal by Subject|2
173894|NCT00506350|606856|P7|Overall Study|Withdrawal by Subject|1
173895|NCT00506350|606857|P6|Overall Study|Withdrawal by Subject|1
173896|NCT00506350|606858|P5|Overall Study|Withdrawal by Subject|4
173897|NCT00506350|606859|P4|Overall Study|Withdrawal by Subject|1
173898|NCT00506350|606860|P3|Overall Study|Withdrawal by Subject|1
173899|NCT00506350|606861|P2|Overall Study|Withdrawal by Subject|1
173900|NCT00506350|606862|P1|Overall Study|Withdrawal by Subject|0
173901|NCT00506350|606854|P9|Overall Study|Protocol Violation|0
173902|NCT00506350|606855|P8|Overall Study|Protocol Violation|0
173903|NCT00506350|606856|P7|Overall Study|Protocol Violation|1
173904|NCT00506350|606857|P6|Overall Study|Protocol Violation|0
173905|NCT00506350|606858|P5|Overall Study|Protocol Violation|0
173906|NCT00506350|606859|P4|Overall Study|Protocol Violation|0
173907|NCT00506350|606860|P3|Overall Study|Protocol Violation|1
173908|NCT00506350|606861|P2|Overall Study|Protocol Violation|0
173909|NCT00506350|606862|P1|Overall Study|Protocol Violation|0
173910|NCT00506350|606854|P9|Overall Study|Adverse Event|1
173911|NCT00506350|606855|P8|Overall Study|Adverse Event|1
173912|NCT00506350|606856|P7|Overall Study|Adverse Event|0
173913|NCT00506350|606857|P6|Overall Study|Adverse Event|0
173914|NCT00506350|606858|P5|Overall Study|Adverse Event|0
173915|NCT00506350|606859|P4|Overall Study|Adverse Event|0
173916|NCT00506350|606860|P3|Overall Study|Adverse Event|0
173917|NCT00506350|606861|P2|Overall Study|Adverse Event|0
173918|NCT00506350|606862|P1|Overall Study|Adverse Event|0
173919|NCT00506350|606854|P9|Overall Study|Serious Adverse Event|0
173920|NCT00506350|606855|P8|Overall Study|Serious Adverse Event|0
173921|NCT00506350|606856|P7|Overall Study|Serious Adverse Event|0
173922|NCT00506350|606857|P6|Overall Study|Serious Adverse Event|0
173923|NCT00506350|606858|P5|Overall Study|Serious Adverse Event|0
173924|NCT00506350|606859|P4|Overall Study|Serious Adverse Event|0
173925|NCT00506350|606860|P3|Overall Study|Serious Adverse Event|0
173926|NCT00506350|606861|P2|Overall Study|Serious Adverse Event|0
173927|NCT00506350|606862|P1|Overall Study|Serious Adverse Event|1
173928|NCT00506285|607009|P2|6-month Open Label Phase|Withdrawal by Subject|5
173929|NCT00506285|607010|P1|6-month Open Label Phase|Withdrawal by Subject|9
173930|NCT00506285|607009|P2|6-month Open Label Phase|Lost to Follow-up|7
173931|NCT00506285|607010|P1|6-month Open Label Phase|Lost to Follow-up|1
173932|NCT00506285|607009|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
173933|NCT00506285|607010|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
173934|NCT00506285|607009|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
173935|NCT00506285|607010|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
173936|NCT00506285|607009|P2|3 Week Screening Phase|Withdrawal by Subject|10
173937|NCT00506285|607010|P1|3 Week Screening Phase|Withdrawal by Subject|17
173938|NCT00506077|607025|P2|Treatment Period 2|Withdrawal by Subject|0
173939|NCT00506077|607026|P1|Treatment Period 2|Withdrawal by Subject|1
173940|NCT00506077|607025|P2|Treatment Period 2|Adverse Event|1
173941|NCT00506077|607026|P1|Treatment Period 2|Adverse Event|0
173942|NCT00506077|607025|P2|Treatment Period 1|Withdrawal by Subject|0
173943|NCT00506077|607026|P1|Treatment Period 1|Withdrawal by Subject|2
173944|NCT00506077|607025|P2|Treatment Period 1|Lost to Follow-up|2
173945|NCT00506077|607026|P1|Treatment Period 1|Lost to Follow-up|0
173946|NCT00506077|607025|P2|Treatment Period 1|Adverse Event|1
173947|NCT00506077|607026|P1|Treatment Period 1|Adverse Event|2
173948|NCT00505934|607068|P1|Overall Study|Other: IV dose needed to be changed|1
173949|NCT00505934|607068|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
173950|NCT00505934|607068|P1|Overall Study|Adverse Event|1
173951|NCT00505921|607074|P1|Overall Study|Failed to Mobilize|8
173952|NCT00505921|607074|P1|Overall Study|Ineligible|1
173953|NCT00505778|607091|P2|Overall Study|Took No Study Drug|2
173954|NCT00505778|607092|P1|Overall Study|Took No Study Drug|2
173955|NCT00505778|607091|P2|Overall Study|Relapse|65
173956|NCT00505778|607092|P1|Overall Study|Relapse|65
173957|NCT00505778|607091|P2|Overall Study|Withdrawal by Subject|14
173958|NCT00505778|607092|P1|Overall Study|Withdrawal by Subject|29
173959|NCT00505778|607091|P2|Overall Study|Protocol Violation|9
173960|NCT00505778|607092|P1|Overall Study|Protocol Violation|7
173961|NCT00505778|607091|P2|Overall Study|Unable to Meet Protocol Criteria|1
173962|NCT00505778|607092|P1|Overall Study|Unable to Meet Protocol Criteria|4
173963|NCT00505778|607091|P2|Overall Study|Lost to Follow-up|23
173964|NCT00505778|607092|P1|Overall Study|Lost to Follow-up|17
173965|NCT00505778|607091|P2|Overall Study|Physician Decision|14
173966|NCT00505778|607092|P1|Overall Study|Physician Decision|8
173967|NCT00505778|607091|P2|Overall Study|Adverse Event|7
173968|NCT00505778|607092|P1|Overall Study|Adverse Event|2
173969|NCT00505765|607111|P3|Overall Study|Noncompliance|3
173970|NCT00505765|607112|P2|Overall Study|Noncompliance|1
173971|NCT00505765|607113|P1|Overall Study|Noncompliance|0
173972|NCT00505765|607111|P3|Overall Study|Adverse Event|0
173973|NCT00505765|607112|P2|Overall Study|Adverse Event|2
173974|NCT00505765|607113|P1|Overall Study|Adverse Event|1
173975|NCT00505765|607111|P3|Overall Study|Withdrawal by Subject|0
173976|NCT00505765|607112|P2|Overall Study|Withdrawal by Subject|0
173977|NCT00505765|607113|P1|Overall Study|Withdrawal by Subject|1
173978|NCT00505752|607140|P4|Overall Study|Other|2
173979|NCT00505752|607141|P3|Overall Study|Other|1
173980|NCT00505752|607142|P2|Overall Study|Other|2
173981|NCT00505752|607143|P1|Overall Study|Other|1
173982|NCT00505752|607140|P4|Overall Study|All embryos/blastocysts discarded|1
173983|NCT00505752|607141|P3|Overall Study|All embryos/blastocysts discarded|1
173984|NCT00505752|607142|P2|Overall Study|All embryos/blastocysts discarded|0
173985|NCT00505752|607143|P1|Overall Study|All embryos/blastocysts discarded|0
173986|NCT00505752|607140|P4|Overall Study|No Fertilization|1
173987|NCT00505752|607141|P3|Overall Study|No Fertilization|2
173988|NCT00505752|607142|P2|Overall Study|No Fertilization|1
173989|NCT00505752|607143|P1|Overall Study|No Fertilization|1
173990|NCT00505752|607140|P4|Overall Study|No oocytes retrieved|1
173991|NCT00505752|607141|P3|Overall Study|No oocytes retrieved|0
173992|NCT00505752|607142|P2|Overall Study|No oocytes retrieved|2
173993|NCT00505752|607143|P1|Overall Study|No oocytes retrieved|0
173994|NCT00505752|607140|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
173995|NCT00505752|607141|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
173996|NCT00505752|607142|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
173997|NCT00505752|607143|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
173998|NCT00505752|607140|P4|Overall Study|Lack of ovarian response|0
173999|NCT00505752|607141|P3|Overall Study|Lack of ovarian response|0
174000|NCT00505752|607142|P2|Overall Study|Lack of ovarian response|3
174001|NCT00505752|607143|P1|Overall Study|Lack of ovarian response|1
174002|NCT00505752|607140|P4|Overall Study|Lost to Follow-up|0
174003|NCT00505752|607141|P3|Overall Study|Lost to Follow-up|0
174004|NCT00505752|607142|P2|Overall Study|Lost to Follow-up|0
174005|NCT00505752|607143|P1|Overall Study|Lost to Follow-up|1
174006|NCT00505752|607140|P4|Overall Study|Adverse Event|0
174007|NCT00505752|607141|P3|Overall Study|Adverse Event|1
174008|NCT00505752|607142|P2|Overall Study|Adverse Event|0
174009|NCT00505752|607143|P1|Overall Study|Adverse Event|1
174010|NCT00505687|607157|P1|Overall Study|Other: As Per Sponsor|8
174011|NCT00505687|607157|P1|Overall Study|Other: Disease Progression|1
174012|NCT00505687|607157|P1|Overall Study|Other: Neupro Given In Hospital|1
174013|NCT00505687|607157|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
174014|NCT00505687|607157|P1|Overall Study|Other: Prolonged Hospitalization|1
174015|NCT00505687|607157|P1|Overall Study|Other: Scheduled DBS Surgery|1
174016|NCT00505687|607157|P1|Overall Study|Other: Underwent Implantation Of DBS|1
174017|NCT00505687|607157|P1|Overall Study|Lost to Follow-up|1
174018|NCT00505687|607157|P1|Overall Study|Subject withdrew consent|15
174019|NCT00505687|607157|P1|Overall Study|Adverse Event|48
174020|NCT00505687|607157|P1|Overall Study|Lack of Efficacy|15
174021|NCT00505687|607157|P1|Overall Study|Important protocol violation|2
174022|NCT00505661|607163|P1|Overall Study|Not Eligible|4
174023|NCT00505622|607174|P3|Overall Study|Study termination by sponsor|90
174024|NCT00505622|607175|P2|Overall Study|Study termination by sponsor|98
174025|NCT00505622|607176|P1|Overall Study|Study termination by sponsor|115
174026|NCT00505622|607174|P3|Overall Study|Withdrawal by Subject|2
174027|NCT00505622|607175|P2|Overall Study|Withdrawal by Subject|3
174028|NCT00505622|607176|P1|Overall Study|Withdrawal by Subject|0
174029|NCT00505622|607174|P3|Overall Study|Protocol Violation|0
174030|NCT00505622|607175|P2|Overall Study|Protocol Violation|1
174031|NCT00505622|607176|P1|Overall Study|Protocol Violation|1
174032|NCT00505622|607174|P3|Overall Study|Adverse Event|4
174033|NCT00505622|607175|P2|Overall Study|Adverse Event|6
174034|NCT00505622|607176|P1|Overall Study|Adverse Event|5
174035|NCT00505414|607201|P5|Maintenance Phase|underlying disease and therapy required|0
174036|NCT00505414|607202|P4|Maintenance Phase|underlying disease and therapy required|0
174037|NCT00505414|607203|P3|Maintenance Phase|underlying disease and therapy required|2
174038|NCT00505414|607204|P2|Maintenance Phase|underlying disease and therapy required|2
174039|NCT00505414|607205|P1|Maintenance Phase|underlying disease and therapy required|0
174040|NCT00505414|607201|P5|Maintenance Phase|Withdrawal by Subject|0
174041|NCT00505414|607202|P4|Maintenance Phase|Withdrawal by Subject|0
174042|NCT00505414|607203|P3|Maintenance Phase|Withdrawal by Subject|1
174043|NCT00505414|607204|P2|Maintenance Phase|Withdrawal by Subject|0
174044|NCT00505414|607205|P1|Maintenance Phase|Withdrawal by Subject|0
174045|NCT00505414|607201|P5|Maintenance Phase|Lack of Efficacy|0
174046|NCT00505414|607202|P4|Maintenance Phase|Lack of Efficacy|0
174047|NCT00505414|607203|P3|Maintenance Phase|Lack of Efficacy|1
174048|NCT00505414|607204|P2|Maintenance Phase|Lack of Efficacy|1
174049|NCT00505414|607205|P1|Maintenance Phase|Lack of Efficacy|2
174050|NCT00505414|607201|P5|Maintenance Phase|Death|0
174051|NCT00505414|607202|P4|Maintenance Phase|Death|0
174052|NCT00505414|607203|P3|Maintenance Phase|Death|1
174053|NCT00505414|607204|P2|Maintenance Phase|Death|0
174054|NCT00505414|607205|P1|Maintenance Phase|Death|2
174055|NCT00505414|607201|P5|Maintenance Phase|Adverse Event|0
174056|NCT00505414|607202|P4|Maintenance Phase|Adverse Event|0
174057|NCT00505414|607203|P3|Maintenance Phase|Adverse Event|3
174058|NCT00505414|607204|P2|Maintenance Phase|Adverse Event|2
174059|NCT00505414|607205|P1|Maintenance Phase|Adverse Event|2
174060|NCT00505414|607201|P5|Titration Phase|Underlying disease and therapy required|3
174061|NCT00505414|607202|P4|Titration Phase|Underlying disease and therapy required|7
174062|NCT00505414|607203|P3|Titration Phase|Underlying disease and therapy required|0
174063|NCT00505414|607204|P2|Titration Phase|Underlying disease and therapy required|0
174064|NCT00505414|607205|P1|Titration Phase|Underlying disease and therapy required|0
174065|NCT00505414|607201|P5|Titration Phase|Withdrawal by Subject|4
174066|NCT00505414|607202|P4|Titration Phase|Withdrawal by Subject|3
174067|NCT00505414|607203|P3|Titration Phase|Withdrawal by Subject|0
174068|NCT00505414|607204|P2|Titration Phase|Withdrawal by Subject|0
174069|NCT00505414|607205|P1|Titration Phase|Withdrawal by Subject|0
174070|NCT00505414|607201|P5|Titration Phase|Protocol Violation|1
174071|NCT00505414|607202|P4|Titration Phase|Protocol Violation|0
174072|NCT00505414|607203|P3|Titration Phase|Protocol Violation|0
174073|NCT00505414|607204|P2|Titration Phase|Protocol Violation|0
174074|NCT00505414|607205|P1|Titration Phase|Protocol Violation|0
174075|NCT00505414|607201|P5|Titration Phase|Lack of Efficacy|1
174076|NCT00505414|607202|P4|Titration Phase|Lack of Efficacy|10
174077|NCT00505414|607203|P3|Titration Phase|Lack of Efficacy|0
174078|NCT00505414|607204|P2|Titration Phase|Lack of Efficacy|0
174079|NCT00505414|607205|P1|Titration Phase|Lack of Efficacy|0
174080|NCT00505414|607201|P5|Titration Phase|Death|0
174081|NCT00505414|607202|P4|Titration Phase|Death|2
174082|NCT00505414|607203|P3|Titration Phase|Death|0
174083|NCT00505414|607204|P2|Titration Phase|Death|0
174084|NCT00505414|607205|P1|Titration Phase|Death|0
174085|NCT00505414|607201|P5|Titration Phase|Adverse Event|3
174086|NCT00505414|607202|P4|Titration Phase|Adverse Event|8
174087|NCT00505414|607203|P3|Titration Phase|Adverse Event|0
174088|NCT00505414|607204|P2|Titration Phase|Adverse Event|0
174089|NCT00505414|607205|P1|Titration Phase|Adverse Event|0
174090|NCT00505375|607222|P2|Overall Study|Travel issues|1
174091|NCT00505375|607223|P1|Overall Study|Travel issues|0
174092|NCT00505375|607222|P2|Overall Study|Pregnancy|0
174093|NCT00505375|607223|P1|Overall Study|Pregnancy|1
174094|NCT00505375|607222|P2|Overall Study|Lost to Follow-up|2
174095|NCT00505375|607223|P1|Overall Study|Lost to Follow-up|0
174096|NCT00505375|607222|P2|Overall Study|Withdrawal by Subject|2
174097|NCT00505375|607223|P1|Overall Study|Withdrawal by Subject|2
174098|NCT00505375|607222|P2|Overall Study|Death|0
174099|NCT00505375|607223|P1|Overall Study|Death|1
174100|NCT00505284|607245|P5|Overall Study|Not specified|4
174101|NCT00505284|607246|P4|Overall Study|Not specified|4
174102|NCT00505284|607247|P3|Overall Study|Not specified|0
174103|NCT00505284|607248|P2|Overall Study|Not specified|0
174104|NCT00505284|607249|P1|Overall Study|Not specified|5
174105|NCT00505284|607245|P5|Overall Study|Physician Decision|0
174106|NCT00505284|607246|P4|Overall Study|Physician Decision|0
174107|NCT00505284|607247|P3|Overall Study|Physician Decision|0
174108|NCT00505284|607248|P2|Overall Study|Physician Decision|1
174109|NCT00505284|607249|P1|Overall Study|Physician Decision|0
174110|NCT00505284|607245|P5|Overall Study|Lack of Efficacy|1
174111|NCT00505284|607246|P4|Overall Study|Lack of Efficacy|1
174112|NCT00505284|607247|P3|Overall Study|Lack of Efficacy|1
174113|NCT00505284|607248|P2|Overall Study|Lack of Efficacy|1
174114|NCT00505284|607249|P1|Overall Study|Lack of Efficacy|0
174115|NCT00505284|607245|P5|Overall Study|Withdrawal by Subject|6
174116|NCT00505284|607246|P4|Overall Study|Withdrawal by Subject|0
174117|NCT00505284|607247|P3|Overall Study|Withdrawal by Subject|1
174118|NCT00505284|607248|P2|Overall Study|Withdrawal by Subject|6
174119|NCT00505284|607249|P1|Overall Study|Withdrawal by Subject|2
174120|NCT00505284|607245|P5|Overall Study|Protocol Violation|0
174121|NCT00505284|607246|P4|Overall Study|Protocol Violation|0
174122|NCT00505284|607247|P3|Overall Study|Protocol Violation|1
174123|NCT00505284|607248|P2|Overall Study|Protocol Violation|1
174124|NCT00505284|607249|P1|Overall Study|Protocol Violation|0
174125|NCT00505284|607245|P5|Overall Study|Adverse Event|22
174126|NCT00505284|607246|P4|Overall Study|Adverse Event|14
174127|NCT00505284|607247|P3|Overall Study|Adverse Event|9
174128|NCT00505284|607248|P2|Overall Study|Adverse Event|7
174129|NCT00505284|607249|P1|Overall Study|Adverse Event|3
174130|NCT00505076|607319|P3|Overall Study|Withdrawal by Subject|2
174131|NCT00505076|607320|P2|Overall Study|Withdrawal by Subject|1
174132|NCT00505076|607321|P1|Overall Study|Withdrawal by Subject|0
174133|NCT00505076|607319|P3|Overall Study|Protocol Violation|2
174134|NCT00505076|607320|P2|Overall Study|Protocol Violation|1
174135|NCT00505076|607321|P1|Overall Study|Protocol Violation|2
174136|NCT00505076|607319|P3|Overall Study|Adverse Event|1
174137|NCT00505076|607320|P2|Overall Study|Adverse Event|0
174138|NCT00505076|607321|P1|Overall Study|Adverse Event|1
174139|NCT00504881|607350|P2|Overall Study|AE of unknown type|0
174140|NCT00504881|607351|P1|Overall Study|AE of unknown type|1
174141|NCT00504881|607350|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
174142|NCT00504881|607351|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
174143|NCT00504881|607350|P2|Overall Study|AE, non-serious non-fatal|14
174144|NCT00504881|607351|P1|Overall Study|AE, non-serious non-fatal|4
174145|NCT00504881|607350|P2|Overall Study|SAE, non-fatal|6
174146|NCT00504881|607351|P1|Overall Study|SAE, non-fatal|2
174147|NCT00504881|607350|P2|Overall Study|AE, serious fatal|1
174148|NCT00504881|607351|P1|Overall Study|AE, serious fatal|0
174149|NCT00504881|607350|P2|Overall Study|Safety Visit not performed|1
174150|NCT00504881|607351|P1|Overall Study|Safety Visit not performed|0
174151|NCT00504881|607350|P2|Overall Study|No Birth Control|1
174152|NCT00504881|607351|P1|Overall Study|No Birth Control|0
174153|NCT00504881|607350|P2|Overall Study|Non-Compliance|0
174154|NCT00504881|607351|P1|Overall Study|Non-Compliance|1
174155|NCT00504881|607350|P2|Overall Study|Withdrawal by Subject|4
174156|NCT00504881|607351|P1|Overall Study|Withdrawal by Subject|1
174157|NCT00504881|607350|P2|Overall Study|Lost to Follow-up|2
174158|NCT00504881|607351|P1|Overall Study|Lost to Follow-up|0
174159|NCT00504881|607350|P2|Overall Study|Lack of Efficacy|5
174160|NCT00504881|607351|P1|Overall Study|Lack of Efficacy|1
174161|NCT00504777|607401|P1|Overall Study|Adverse Event|1
174162|NCT00504725|607414|P2|Overall Study|Protocol Violation|0
174163|NCT00504725|607415|P1|Overall Study|Protocol Violation|1
174164|NCT00504595|607438|P4|Overall Study|Not specified|0
174165|NCT00504595|607439|P3|Overall Study|Not specified|2
174166|NCT00504595|607440|P2|Overall Study|Not specified|0
174167|NCT00504595|607441|P1|Overall Study|Not specified|0
174168|NCT00504595|607438|P4|Overall Study|Lack of Efficacy|0
174169|NCT00504595|607439|P3|Overall Study|Lack of Efficacy|0
174170|NCT00504595|607440|P2|Overall Study|Lack of Efficacy|0
174171|NCT00504595|607441|P1|Overall Study|Lack of Efficacy|1
174172|NCT00504556|607458|P5|Overall Study|not in safety analysis set|1
174173|NCT00504556|607459|P4|Overall Study|not in safety analysis set|0
174174|NCT00504556|607460|P3|Overall Study|not in safety analysis set|1
174175|NCT00504556|607461|P2|Overall Study|not in safety analysis set|1
174176|NCT00504556|607462|P1|Overall Study|not in safety analysis set|0
174177|NCT00504556|607458|P5|Overall Study|not specified|0
174178|NCT00504556|607459|P4|Overall Study|not specified|3
174179|NCT00504556|607460|P3|Overall Study|not specified|2
174180|NCT00504556|607461|P2|Overall Study|not specified|2
174181|NCT00504556|607462|P1|Overall Study|not specified|2
174182|NCT00504556|607458|P5|Overall Study|data monitor committee decision|0
174183|NCT00504556|607459|P4|Overall Study|data monitor committee decision|100
174184|NCT00504556|607460|P3|Overall Study|data monitor committee decision|0
174185|NCT00504556|607461|P2|Overall Study|data monitor committee decision|0
174186|NCT00504556|607462|P1|Overall Study|data monitor committee decision|0
174187|NCT00504556|607458|P5|Overall Study|did not meet entry criteria|0
174188|NCT00504556|607459|P4|Overall Study|did not meet entry criteria|1
174189|NCT00504556|607460|P3|Overall Study|did not meet entry criteria|1
174190|NCT00504556|607461|P2|Overall Study|did not meet entry criteria|0
174191|NCT00504556|607462|P1|Overall Study|did not meet entry criteria|2
174192|NCT00504556|607458|P5|Overall Study|administrative reasons|2
174193|NCT00504556|607459|P4|Overall Study|administrative reasons|1
174194|NCT00504556|607460|P3|Overall Study|administrative reasons|2
174195|NCT00504556|607461|P2|Overall Study|administrative reasons|2
174196|NCT00504556|607462|P1|Overall Study|administrative reasons|0
174197|NCT00504556|607458|P5|Overall Study|Withdrawal by Subject|12
174198|NCT00504556|607459|P4|Overall Study|Withdrawal by Subject|8
174199|NCT00504556|607460|P3|Overall Study|Withdrawal by Subject|7
174200|NCT00504556|607461|P2|Overall Study|Withdrawal by Subject|16
174201|NCT00504556|607462|P1|Overall Study|Withdrawal by Subject|16
174202|NCT00504556|607458|P5|Overall Study|Lost to Follow-up|1
174203|NCT00504556|607459|P4|Overall Study|Lost to Follow-up|1
174204|NCT00504556|607460|P3|Overall Study|Lost to Follow-up|1
174205|NCT00504556|607461|P2|Overall Study|Lost to Follow-up|0
174206|NCT00504556|607462|P1|Overall Study|Lost to Follow-up|0
174207|NCT00504556|607458|P5|Overall Study|Protocol Violation|2
174208|NCT00504556|607459|P4|Overall Study|Protocol Violation|1
174209|NCT00504556|607460|P3|Overall Study|Protocol Violation|2
174210|NCT00504556|607461|P2|Overall Study|Protocol Violation|3
174211|NCT00504556|607462|P1|Overall Study|Protocol Violation|1
174212|NCT00504556|607458|P5|Overall Study|Death|2
174213|NCT00504556|607459|P4|Overall Study|Death|0
174214|NCT00504556|607460|P3|Overall Study|Death|1
174215|NCT00504556|607461|P2|Overall Study|Death|3
174216|NCT00504556|607462|P1|Overall Study|Death|3
174217|NCT00504556|607458|P5|Overall Study|Adverse Event|5
174218|NCT00504556|607459|P4|Overall Study|Adverse Event|13
174219|NCT00504556|607460|P3|Overall Study|Adverse Event|14
174220|NCT00504556|607461|P2|Overall Study|Adverse Event|11
174221|NCT00504556|607462|P1|Overall Study|Adverse Event|11
174222|NCT00504426|607530|P4|Overall Study|Withdrawal by Subject|0
174223|NCT00504426|607531|P3|Overall Study|Withdrawal by Subject|0
174224|NCT00504426|607532|P2|Overall Study|Withdrawal by Subject|0
174225|NCT00504426|607533|P1|Overall Study|Withdrawal by Subject|2
174226|NCT00504426|607530|P4|Overall Study|Protocol Violation|0
174227|NCT00504426|607531|P3|Overall Study|Protocol Violation|2
174228|NCT00504426|607532|P2|Overall Study|Protocol Violation|1
174229|NCT00504426|607533|P1|Overall Study|Protocol Violation|1
174230|NCT00504426|607530|P4|Overall Study|Adverse Event|0
174231|NCT00504426|607531|P3|Overall Study|Adverse Event|2
174232|NCT00504426|607532|P2|Overall Study|Adverse Event|0
174233|NCT00504426|607533|P1|Overall Study|Adverse Event|0
174234|NCT00504309|607553|P6|Overall Study|Withdrawal by Subject|0
174235|NCT00504309|607554|P5|Overall Study|Withdrawal by Subject|0
174236|NCT00504309|607555|P4|Overall Study|Withdrawal by Subject|0
174237|NCT00504309|607556|P3|Overall Study|Withdrawal by Subject|1
174238|NCT00504309|607557|P2|Overall Study|Withdrawal by Subject|0
174239|NCT00504309|607558|P1|Overall Study|Withdrawal by Subject|0
174240|NCT00504309|607553|P6|Overall Study|Death|0
174241|NCT00504309|607554|P5|Overall Study|Death|1
174242|NCT00504309|607555|P4|Overall Study|Death|0
174243|NCT00504309|607556|P3|Overall Study|Death|0
174244|NCT00504309|607557|P2|Overall Study|Death|0
174245|NCT00504309|607558|P1|Overall Study|Death|0
174246|NCT00504257|607596|P1|Overall Study|ineligible histology|2
174247|NCT00504257|607596|P1|Overall Study|Withdrawal by Subject|2
174248|NCT00504231|607608|P4|Overall Study|Discrepant chart documentation re route|0
174249|NCT00504231|607609|P3|Overall Study|Discrepant chart documentation re route|1
174250|NCT00504231|607610|P2|Overall Study|Discrepant chart documentation re route|0
174251|NCT00504231|607611|P1|Overall Study|Discrepant chart documentation re route|0
174252|NCT00504166|607631|P2|Overall Study|Lost to Follow-up|3
174253|NCT00504166|607632|P1|Overall Study|Lost to Follow-up|1
174254|NCT00504166|607631|P2|Overall Study|Physician Decision|1
174255|NCT00504166|607632|P1|Overall Study|Physician Decision|1
174256|NCT00504166|607631|P2|Overall Study|Withdrawal by Subject|6
174257|NCT00504166|607632|P1|Overall Study|Withdrawal by Subject|3
174258|NCT00504166|607631|P2|Overall Study|Adverse Event|4
174259|NCT00504166|607632|P1|Overall Study|Adverse Event|1
174260|NCT00504153|607638|P1|Overall Study|Death|1
174261|NCT00504153|607638|P1|Overall Study|Adverse Event|4
174262|NCT00504153|607638|P1|Overall Study|Withdrawal by Subject|1
174263|NCT00504075|607646|P1|Overall Study|Required other therapeutic intervention|1
174264|NCT00504075|607646|P1|Overall Study|Withdrawal by Subject|1
174265|NCT00504075|607646|P1|Overall Study|Lost to Follow-up|5
174266|NCT00504075|607646|P1|Overall Study|Adverse Event|1
174267|NCT00503997|607656|P1|Overall Study|Withdrawal by Subject|1
174268|NCT00503997|607656|P1|Overall Study|Death|1
174269|NCT00503997|607656|P1|Overall Study|Adverse Event|5
174270|NCT00503997|607656|P1|Overall Study|disease progression|1
174271|NCT00503984|607662|P6|Overall Study|Death|0
174272|NCT00503984|607663|P5|Overall Study|Death|1
174273|NCT00503984|607664|P4|Overall Study|Death|0
174274|NCT00503984|607665|P3|Overall Study|Death|0
174275|NCT00503984|607666|P2|Overall Study|Death|0
174276|NCT00503984|607667|P1|Overall Study|Death|0
174277|NCT00503984|607662|P6|Overall Study|Adverse Event|0
174278|NCT00503984|607663|P5|Overall Study|Adverse Event|0
174279|NCT00503984|607664|P4|Overall Study|Adverse Event|0
174280|NCT00503984|607665|P3|Overall Study|Adverse Event|0
174281|NCT00503984|607666|P2|Overall Study|Adverse Event|1
174282|NCT00503984|607667|P1|Overall Study|Adverse Event|0
174283|NCT00503984|607662|P6|Overall Study|Protocol Violation|0
174284|NCT00503984|607663|P5|Overall Study|Protocol Violation|0
174285|NCT00503984|607664|P4|Overall Study|Protocol Violation|0
174286|NCT00503984|607665|P3|Overall Study|Protocol Violation|0
174287|NCT00503984|607666|P2|Overall Study|Protocol Violation|1
174288|NCT00503984|607667|P1|Overall Study|Protocol Violation|0
174289|NCT00503906|607693|P1|Overall Study|Withdrawal by Subject|1
174290|NCT00503841|607715|P1|Overall Study|All screen failures|44
174291|NCT00503776|607723|P4|Overall Study|Physician Decision|1
174292|NCT00503776|607724|P3|Overall Study|Physician Decision|1
174293|NCT00503776|607725|P2|Overall Study|Physician Decision|0
174294|NCT00503776|607726|P1|Overall Study|Physician Decision|0
174295|NCT00503776|607723|P4|Overall Study|Withdrawal by Subject|1
174296|NCT00503776|607724|P3|Overall Study|Withdrawal by Subject|1
174297|NCT00503776|607725|P2|Overall Study|Withdrawal by Subject|0
174298|NCT00503776|607726|P1|Overall Study|Withdrawal by Subject|1
174299|NCT00503698|607759|P2|Overall Study|Not exposed to trial drug|6
174300|NCT00503698|607760|P1|Overall Study|Not exposed to trial drug|11
174301|NCT00503698|607759|P2|Overall Study|Unclassified|32
174302|NCT00503698|607760|P1|Overall Study|Unclassified|48
174303|NCT00503698|607759|P2|Overall Study|Critically ill|0
174304|NCT00503698|607760|P1|Overall Study|Critically ill|2
174305|NCT00503698|607759|P2|Overall Study|Move to nonparticipating dialysis center|1
174306|NCT00503698|607760|P1|Overall Study|Move to nonparticipating dialysis center|2
174307|NCT00503698|607759|P2|Overall Study|Switch to peritoneal or home dialysis|2
174308|NCT00503698|607760|P1|Overall Study|Switch to peritoneal or home dialysis|2
174309|NCT00503698|607759|P2|Overall Study|Any condition in exclusion criteria|6
174310|NCT00503698|607760|P1|Overall Study|Any condition in exclusion criteria|4
174311|NCT00503698|607759|P2|Overall Study|Pregnancy/intention to become pregnant|0
174312|NCT00503698|607760|P1|Overall Study|Pregnancy/intention to become pregnant|1
174313|NCT00503698|607759|P2|Overall Study|End hemodialysis due to renal transplant|4
174314|NCT00503698|607760|P1|Overall Study|End hemodialysis due to renal transplant|10
174315|NCT00503698|607759|P2|Overall Study|Trial terminated|253
174316|NCT00503698|607760|P1|Overall Study|Trial terminated|216
174317|NCT00503698|607759|P2|Overall Study|Lack of Efficacy|4
174318|NCT00503698|607760|P1|Overall Study|Lack of Efficacy|3
174319|NCT00503698|607759|P2|Overall Study|Death|0
174320|NCT00503698|607760|P1|Overall Study|Death|1
174321|NCT00503698|607759|P2|Overall Study|Adverse Event|41
174322|NCT00503698|607760|P1|Overall Study|Adverse Event|52
174323|NCT00503698|607759|P2|Overall Study|Protocol Violation|6
174324|NCT00503698|607760|P1|Overall Study|Protocol Violation|5
174325|NCT00503425|607774|P1|Overall Study|Missing Data/Unknown|4
174326|NCT00503425|607774|P1|Overall Study|Death|3
174327|NCT00503425|607774|P1|Overall Study|Lost to Follow-up|3
174328|NCT00503425|607774|P1|Overall Study|Withdrawal by Subject|8
174329|NCT00503425|607774|P1|Overall Study|Lack of Efficacy|25
174330|NCT00503425|607774|P1|Overall Study|Adverse Event|5
174331|NCT00503425|607774|P1|Overall Study|Participant files lost|6
174332|NCT00503399|607784|P2|Overall Study|Lost to Follow-up|2
174333|NCT00503399|607785|P1|Overall Study|Lost to Follow-up|0
174334|NCT00503399|607784|P2|Overall Study|Adverse Event|3
174335|NCT00503399|607785|P1|Overall Study|Adverse Event|0
174336|NCT00503399|607784|P2|Overall Study|Withdrawal by Subject|2
174337|NCT00503399|607785|P1|Overall Study|Withdrawal by Subject|4
174338|NCT00503399|607784|P2|Overall Study|Protocol Violation|0
174339|NCT00503399|607785|P1|Overall Study|Protocol Violation|1
174340|NCT00503399|607784|P2|Overall Study|Death|1
174341|NCT00503399|607785|P1|Overall Study|Death|2
174342|NCT00503308|607809|P2|Overall Study|Protocol Violation|1
174343|NCT00503308|607810|P1|Overall Study|Protocol Violation|2
174344|NCT00503139|607816|P1|Overall Study|Protocol Violation|4
174345|NCT00503139|607816|P1|Overall Study|Case Report Forms were not collected|4
174346|NCT00503009|607864|P3|Overall Study|Physician Decision|1
174347|NCT00503009|607865|P2|Overall Study|Physician Decision|1
174348|NCT00503009|607866|P1|Overall Study|Physician Decision|0
174349|NCT00503009|607864|P3|Overall Study|Withdrawal by Subject|1
174350|NCT00503009|607865|P2|Overall Study|Withdrawal by Subject|1
174351|NCT00503009|607866|P1|Overall Study|Withdrawal by Subject|0
174352|NCT00503009|607864|P3|Overall Study|Protocol Violation|1
174353|NCT00503009|607865|P2|Overall Study|Protocol Violation|0
174354|NCT00503009|607866|P1|Overall Study|Protocol Violation|1
174355|NCT00502996|607883|P1|Overall Study|Adverse Event|2
174356|NCT00502996|607883|P1|Overall Study|Withdrawal Informed Consent|6
174357|NCT00502996|607883|P1|Overall Study|Treatment failure|25
174358|NCT00502996|607883|P1|Overall Study|Protocol Violation|2
174359|NCT00502996|607883|P1|Overall Study|Lost to Follow-up|9
174360|NCT00502840|607951|P1|Overall Study|Not specified|20
174361|NCT00502840|607951|P1|Overall Study|Administrative problems|1
174362|NCT00502840|607951|P1|Overall Study|Lost to Follow-up|6
174363|NCT00502840|607951|P1|Overall Study|Withdrawal by Subject|5
174364|NCT00502840|607951|P1|Overall Study|Protocol Violation|4
174365|NCT00502840|607951|P1|Overall Study|Lack of Efficacy|11
174366|NCT00502840|607951|P1|Overall Study|Additional or changed therapy|48
174367|NCT00502840|607951|P1|Overall Study|Adverse Event|5
174368|NCT00502801|607979|P1|End of Therapy to Test of Cure|OTHER|2
174369|NCT00502801|607979|P1|End of Therapy to Test of Cure|Death|3
174370|NCT00502801|607979|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
174371|NCT00502801|607979|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
174372|NCT00502801|607979|P1|Treatment Period|OTHER|30
174373|NCT00502801|607979|P1|Treatment Period|Death|14
174374|NCT00502801|607979|P1|Treatment Period|Adverse Event|7
174375|NCT00502801|607979|P1|Treatment Period|Withdrawal by Subject|3
174376|NCT00502775|607987|P3|Overall Study|Subject took disallowed drug|1
174377|NCT00502775|607988|P2|Overall Study|Subject took disallowed drug|0
174378|NCT00502775|607989|P1|Overall Study|Subject took disallowed drug|0
174379|NCT00502775|607987|P3|Overall Study|Subject in jail|0
174380|NCT00502775|607988|P2|Overall Study|Subject in jail|1
174381|NCT00502775|607989|P1|Overall Study|Subject in jail|0
174382|NCT00502775|607987|P3|Overall Study|Declining pollen counts|1
174383|NCT00502775|607988|P2|Overall Study|Declining pollen counts|1
174384|NCT00502775|607989|P1|Overall Study|Declining pollen counts|0
174385|NCT00502775|607987|P3|Overall Study|Outside pollen area more than 48 hours|0
174386|NCT00502775|607988|P2|Overall Study|Outside pollen area more than 48 hours|1
174387|NCT00502775|607989|P1|Overall Study|Outside pollen area more than 48 hours|0
174388|NCT00502775|607987|P3|Overall Study|Non-compliance|2
174389|NCT00502775|607988|P2|Overall Study|Non-compliance|2
174390|NCT00502775|607989|P1|Overall Study|Non-compliance|0
174391|NCT00502775|607987|P3|Overall Study|Randomized in error|1
174392|NCT00502775|607988|P2|Overall Study|Randomized in error|1
174393|NCT00502775|607989|P1|Overall Study|Randomized in error|0
174394|NCT00502775|607987|P3|Overall Study|Logpad compliance <80%|0
174395|NCT00502775|607988|P2|Overall Study|Logpad compliance <80%|0
174396|NCT00502775|607989|P1|Overall Study|Logpad compliance <80%|1
174397|NCT00502775|607987|P3|Overall Study|Subject unable to swallow capsule|1
174398|NCT00502775|607988|P2|Overall Study|Subject unable to swallow capsule|0
174399|NCT00502775|607989|P1|Overall Study|Subject unable to swallow capsule|1
174400|NCT00502775|607987|P3|Overall Study|Non-compliance with eDiary|1
174401|NCT00502775|607988|P2|Overall Study|Non-compliance with eDiary|1
174402|NCT00502775|607989|P1|Overall Study|Non-compliance with eDiary|4
174403|NCT00502775|607987|P3|Overall Study|Sponsor Terminated Study|1
174404|NCT00502775|607988|P2|Overall Study|Sponsor Terminated Study|0
174405|NCT00502775|607989|P1|Overall Study|Sponsor Terminated Study|1
174406|NCT00502775|607987|P3|Overall Study|Withdrawal by Subject|2
174407|NCT00502775|607988|P2|Overall Study|Withdrawal by Subject|1
174408|NCT00502775|607989|P1|Overall Study|Withdrawal by Subject|1
174409|NCT00502775|607987|P3|Overall Study|Protocol Violation|2
174410|NCT00502775|607988|P2|Overall Study|Protocol Violation|5
174411|NCT00502775|607989|P1|Overall Study|Protocol Violation|1
174412|NCT00502775|607987|P3|Overall Study|Adverse Event|1
174413|NCT00502775|607988|P2|Overall Study|Adverse Event|2
174414|NCT00502775|607989|P1|Overall Study|Adverse Event|1
174415|NCT00502697|608032|P2|Overall Study|did not meet assignment criteria|2
174416|NCT00502697|608033|P1|Overall Study|did not meet assignment criteria|4
174417|NCT00502697|608032|P2|Overall Study|found not to meet eligibility criteria|4
174418|NCT00502697|608033|P1|Overall Study|found not to meet eligibility criteria|3
174419|NCT00502697|608032|P2|Overall Study|disenrolled due to pregnancy loss|5
174420|NCT00502697|608033|P1|Overall Study|disenrolled due to pregnancy loss|3
174421|NCT00502697|608032|P2|Overall Study|Withdrawal by Subject|1
174422|NCT00502697|608033|P1|Overall Study|Withdrawal by Subject|3
174423|NCT00502671|608041|P1|Overall Study|Adverse Event|19
174424|NCT00502671|608041|P1|Overall Study|Protocol Violation|16
174425|NCT00502671|608041|P1|Overall Study|Lost to Follow-up|7
174426|NCT00502671|608041|P1|Overall Study|Personal Reasons|22
174427|NCT00502671|608041|P1|Overall Study|Disease Progression|13
174428|NCT00502593|608058|P12|Overall Study|Lost to Follow-up|0
174429|NCT00502593|608059|P11|Overall Study|Lost to Follow-up|1
174430|NCT00502593|608060|P10|Overall Study|Lost to Follow-up|0
174431|NCT00502593|608061|P9|Overall Study|Lost to Follow-up|3
174432|NCT00502593|608062|P8|Overall Study|Lost to Follow-up|0
174433|NCT00502593|608063|P7|Overall Study|Lost to Follow-up|0
174434|NCT00502593|608064|P6|Overall Study|Lost to Follow-up|0
174435|NCT00502593|608065|P5|Overall Study|Lost to Follow-up|0
174436|NCT00502593|608066|P4|Overall Study|Lost to Follow-up|1
174437|NCT00502593|608067|P3|Overall Study|Lost to Follow-up|1
174438|NCT00502593|608068|P2|Overall Study|Lost to Follow-up|1
174439|NCT00502593|608069|P1|Overall Study|Lost to Follow-up|2
174440|NCT00502593|608058|P12|Overall Study|Withdrawal by Subject|0
174441|NCT00502593|608059|P11|Overall Study|Withdrawal by Subject|1
174442|NCT00502593|608060|P10|Overall Study|Withdrawal by Subject|0
174443|NCT00502593|608061|P9|Overall Study|Withdrawal by Subject|3
174444|NCT00502593|608062|P8|Overall Study|Withdrawal by Subject|0
174445|NCT00502593|608063|P7|Overall Study|Withdrawal by Subject|3
174446|NCT00502593|608064|P6|Overall Study|Withdrawal by Subject|0
174447|NCT00502593|608065|P5|Overall Study|Withdrawal by Subject|2
174448|NCT00502593|608066|P4|Overall Study|Withdrawal by Subject|2
174449|NCT00502593|608067|P3|Overall Study|Withdrawal by Subject|6
174450|NCT00502593|608068|P2|Overall Study|Withdrawal by Subject|0
174451|NCT00502593|608069|P1|Overall Study|Withdrawal by Subject|0
174452|NCT00502593|608058|P12|Overall Study|Withdrawn unspecified reason|0
174453|NCT00502593|608059|P11|Overall Study|Withdrawn unspecified reason|0
174454|NCT00502593|608060|P10|Overall Study|Withdrawn unspecified reason|0
174455|NCT00502593|608061|P9|Overall Study|Withdrawn unspecified reason|0
174456|NCT00502593|608062|P8|Overall Study|Withdrawn unspecified reason|0
174457|NCT00502593|608063|P7|Overall Study|Withdrawn unspecified reason|2
174458|NCT00502593|608064|P6|Overall Study|Withdrawn unspecified reason|0
174459|NCT00502593|608065|P5|Overall Study|Withdrawn unspecified reason|2
174460|NCT00502593|608066|P4|Overall Study|Withdrawn unspecified reason|1
174461|NCT00502593|608067|P3|Overall Study|Withdrawn unspecified reason|3
174462|NCT00502593|608068|P2|Overall Study|Withdrawn unspecified reason|1
174463|NCT00502593|608069|P1|Overall Study|Withdrawn unspecified reason|1
174464|NCT00502320|608585|P2|Overall Study|Adverse Event|5
174465|NCT00502320|608586|P1|Overall Study|Adverse Event|3
174466|NCT00502320|608585|P2|Overall Study|Screen Failure|1
174467|NCT00502320|608586|P1|Overall Study|Screen Failure|0
174468|NCT00502320|608585|P2|Overall Study|No longer met criteria|0
174469|NCT00502320|608586|P1|Overall Study|No longer met criteria|1
174470|NCT00502320|608585|P2|Overall Study|Withdrew Consent|0
174471|NCT00502320|608586|P1|Overall Study|Withdrew Consent|1
174472|NCT00502320|608585|P2|Overall Study|Lost to Follow-up|1
174473|NCT00502320|608586|P1|Overall Study|Lost to Follow-up|1
174474|NCT00502242|608598|P2|Overall Study|Withdrawal by Subject|7
174475|NCT00502242|608599|P1|Overall Study|Withdrawal by Subject|6
174476|NCT00502242|608598|P2|Overall Study|Protocol Violation|1
174477|NCT00502242|608599|P1|Overall Study|Protocol Violation|3
174478|NCT00502242|608598|P2|Overall Study|Other - Unspecified|14
174479|NCT00502242|608599|P1|Overall Study|Other - Unspecified|8
174480|NCT00502242|608598|P2|Overall Study|Physician Decision|3
174481|NCT00502242|608599|P1|Overall Study|Physician Decision|2
174482|NCT00502242|608598|P2|Overall Study|Adverse Event|20
174483|NCT00502242|608599|P1|Overall Study|Adverse Event|31
174484|NCT00502242|608598|P2|Overall Study|Lack of Efficacy|11
174485|NCT00502242|608599|P1|Overall Study|Lack of Efficacy|1
174486|NCT00502203|608663|P1|Overall Study|Inevaluable|1
174487|NCT00501969|608672|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
174488|NCT00501969|608672|P1|Overall Study|Other: Admin Request from the Sponsor|3
174489|NCT00501969|608672|P1|Overall Study|Other: As Required by Local EC|2
174490|NCT00501969|608672|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
174491|NCT00501969|608672|P1|Overall Study|Other: Pat Pending Surgery for PD|1
174492|NCT00501969|608672|P1|Overall Study|Other: Patient is Going to Have DBS|1
174493|NCT00501969|608672|P1|Overall Study|Other: Patients + Investigator Agreement|1
174494|NCT00501969|608672|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
174495|NCT00501969|608672|P1|Overall Study|Other: Sponsor Stopped Study|12
174496|NCT00501969|608672|P1|Overall Study|Other: Sponsor Termination at Site|1
174497|NCT00501969|608672|P1|Overall Study|Other: Sponsors Request|10
174498|NCT00501969|608672|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
174499|NCT00501969|608672|P1|Overall Study|Lost to Follow-up|4
174500|NCT00501969|608672|P1|Overall Study|Subject withdrew consent|51
174501|NCT00501969|608672|P1|Overall Study|Unsatisfactory compliance of subject|7
174502|NCT00501969|608672|P1|Overall Study|Adverse Event|76
174503|NCT00501969|608672|P1|Overall Study|Lack of Efficacy|29
174504|NCT00501969|608672|P1|Overall Study|Major Protocol Violation|4
174505|NCT00501852|608704|P1|Overall Study|Withdrawal by Subject|2
174506|NCT00501852|608704|P1|Overall Study|Adverse Event|3
174507|NCT00501644|608724|P1|Overall Study|Withdrawal by Subject|1
174508|NCT00501644|608724|P1|Overall Study|Adverse Event|4
174509|NCT00501540|608753|P1|Overall Study|Death|5
174510|NCT00501293|608765|P2|Maintenance Period|Application site reaction|0
174511|NCT00501293|608766|P1|Maintenance Period|Application site reaction|1
174512|NCT00501293|608765|P2|Maintenance Period|Would not wear patch|0
174513|NCT00501293|608766|P1|Maintenance Period|Would not wear patch|1
174514|NCT00501293|608765|P2|Maintenance Period|Went into rehabilitation|0
174515|NCT00501293|608766|P1|Maintenance Period|Went into rehabilitation|1
174516|NCT00501293|608765|P2|Maintenance Period|Noncompliant with study medication|0
174517|NCT00501293|608766|P1|Maintenance Period|Noncompliant with study medication|5
174518|NCT00501293|608765|P2|Maintenance Period|Lack of Efficacy|1
174519|NCT00501293|608766|P1|Maintenance Period|Lack of Efficacy|4
174520|NCT00501293|608765|P2|Maintenance Period|Protocol Violation|1
174521|NCT00501293|608766|P1|Maintenance Period|Protocol Violation|2
174522|NCT00501293|608765|P2|Maintenance Period|Adverse Event|6
174523|NCT00501293|608766|P1|Maintenance Period|Adverse Event|6
174524|NCT00501293|608765|P2|Maintenance Period|Lost to Follow-up|7
174525|NCT00501293|608766|P1|Maintenance Period|Lost to Follow-up|12
174526|NCT00501293|608765|P2|Maintenance Period|Withdrawal by Subject|13
174527|NCT00501293|608766|P1|Maintenance Period|Withdrawal by Subject|14
174528|NCT00501293|608765|P2|Optimization Period|Enrolled in error|0
174529|NCT00501293|608766|P1|Optimization Period|Enrolled in error|1
174530|NCT00501228|608793|P1|Overall Study|Withdrawal by Subject|1
174531|NCT00501085|608797|P1|Overall Study|Other loss to follow-up|32
174532|NCT00501085|608797|P1|Overall Study|Study closed by sponsor|109
174533|NCT00501085|608797|P1|Overall Study|Non-Compliance|24
174534|NCT00501085|608797|P1|Overall Study|Adverse Event|4
174535|NCT00501085|608797|P1|Overall Study|Explantation Surgery|26
174536|NCT00501085|608797|P1|Overall Study|Revision Surgery|7
174537|NCT00501085|608797|P1|Overall Study|Subject Decision|1
174538|NCT00501085|608797|P1|Overall Study|Withdrawal by Subject|34
174539|NCT00501085|608797|P1|Overall Study|Lost to Follow-up|195
174540|NCT00501059|608807|P2|Overall Study|Not treated|17
174541|NCT00501059|608808|P1|Overall Study|Not treated|25
174542|NCT00501059|608807|P2|Overall Study|Lost to Follow-up|198
174543|NCT00501059|608808|P1|Overall Study|Lost to Follow-up|210
174544|NCT00501059|608807|P2|Overall Study|Adverse Event|122
174545|NCT00501059|608808|P1|Overall Study|Adverse Event|129
174546|NCT00501059|608807|P2|Overall Study|Reason not given|1
174547|NCT00501059|608808|P1|Overall Study|Reason not given|3
174548|NCT00501059|608807|P2|Overall Study|Non-compliant with study treatment|16
174549|NCT00501059|608808|P1|Overall Study|Non-compliant with study treatment|23
174550|NCT00501059|608807|P2|Overall Study|Consent withdrawn by subject|873
174551|NCT00501059|608808|P1|Overall Study|Consent withdrawn by subject|817
174552|NCT00501059|608807|P2|Overall Study|Insufficient therapeutic effect|5
174553|NCT00501059|608808|P1|Overall Study|Insufficient therapeutic effect|4
174554|NCT00501059|608807|P2|Overall Study|Clinical endpoint reached|123
174555|NCT00501059|608808|P1|Overall Study|Clinical endpoint reached|110
174556|NCT00501059|608807|P2|Overall Study|Missing end-of-study page|92
174557|NCT00501059|608808|P1|Overall Study|Missing end-of-study page|91
174558|NCT00501059|608807|P2|Overall Study|Other|239
174559|NCT00501059|608808|P1|Overall Study|Other|236
174560|NCT00501059|608807|P2|Overall Study|Death|137
174561|NCT00501059|608808|P1|Overall Study|Death|140
174562|NCT00501059|608807|P2|Overall Study|Protocol Violation|69
174563|NCT00501059|608808|P1|Overall Study|Protocol Violation|80
174564|NCT00501046|608828|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
174565|NCT00501046|608829|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
174566|NCT00501046|608828|P2|Overall Study|Withdrawal by Subject|83
174567|NCT00501046|608829|P1|Overall Study|Withdrawal by Subject|84
174568|NCT00501046|608828|P2|Overall Study|Protocol Violation|1
174569|NCT00501046|608829|P1|Overall Study|Protocol Violation|2
174570|NCT00501046|608828|P2|Overall Study|Pregnancy|3
174571|NCT00501046|608829|P1|Overall Study|Pregnancy|0
174572|NCT00501046|608828|P2|Overall Study|Physician Decision|2
174573|NCT00501046|608829|P1|Overall Study|Physician Decision|7
174574|NCT00501046|608828|P2|Overall Study|Lost to Follow-up|13
174575|NCT00501046|608829|P1|Overall Study|Lost to Follow-up|14
174576|NCT00501046|608828|P2|Overall Study|Death|30
174577|NCT00501046|608829|P1|Overall Study|Death|23
174578|NCT00501046|608828|P2|Overall Study|Adverse Event|25
174579|NCT00501046|608829|P1|Overall Study|Adverse Event|21
174580|NCT00501007|608835|P2|Overall Study|Inclusion criteria not met.|25
174581|NCT00501007|608836|P1|Overall Study|Inclusion criteria not met.|29
174582|NCT00500760|608844|P2|Overall Study|Other|2
174583|NCT00500760|608845|P1|Overall Study|Other|1
174584|NCT00500760|608844|P2|Overall Study|Lost to Follow-up|0
174585|NCT00500760|608845|P1|Overall Study|Lost to Follow-up|3
174586|NCT00500760|608844|P2|Overall Study|Administrative decision|0
174587|NCT00500760|608845|P1|Overall Study|Administrative decision|2
174588|NCT00500760|608844|P2|Overall Study|Withdrawal by Subject|7
174589|NCT00500760|608845|P1|Overall Study|Withdrawal by Subject|5
174590|NCT00500760|608844|P2|Overall Study|Death|15
174591|NCT00500760|608845|P1|Overall Study|Death|32
174592|NCT00500682|608865|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
174593|NCT00500682|608866|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
174594|NCT00500682|608865|P2|Overall Study|Withdrawal by Subject|74
174595|NCT00500682|608866|P1|Overall Study|Withdrawal by Subject|80
174596|NCT00500682|608865|P2|Overall Study|Protocol Violation|3
174597|NCT00500682|608866|P1|Overall Study|Protocol Violation|1
174598|NCT00500682|608865|P2|Overall Study|Pregnancy|0
174599|NCT00500682|608866|P1|Overall Study|Pregnancy|2
174600|NCT00500682|608865|P2|Overall Study|Physician Decision|10
174601|NCT00500682|608866|P1|Overall Study|Physician Decision|6
174602|NCT00500682|608865|P2|Overall Study|Lost to Follow-up|11
174603|NCT00500682|608866|P1|Overall Study|Lost to Follow-up|11
174604|NCT00500682|608865|P2|Overall Study|Death|16
174605|NCT00500682|608866|P1|Overall Study|Death|25
174606|NCT00500682|608865|P2|Overall Study|Adverse Event|29
174607|NCT00500682|608866|P1|Overall Study|Adverse Event|37
174608|NCT00500539|608900|P1|Follow-up Period (16 Weeks)|Missing|3
174609|NCT00500539|608900|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
174610|NCT00500539|608900|P1|Follow-up Period (16 Weeks)|Death|1
174611|NCT00500539|608900|P1|Follow-up Period (16 Weeks)|Administrative problems|1
174612|NCT00500539|608900|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
174613|NCT00500539|608900|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
174614|NCT00500539|608900|P1|Follow-up Period (16 Weeks)|Adverse Event|1
174615|NCT00500539|608900|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
174616|NCT00500539|608900|P1|Treatment Period (24 Weeks)|Administrative problems|2
174617|NCT00500539|608900|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
174618|NCT00500539|608900|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
174619|NCT00500539|608900|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
174620|NCT00500539|608900|P1|Treatment Period (24 Weeks)|Adverse Event|4
174621|NCT00500370|608926|P2|Overall Study|Subject Decision|17
174622|NCT00500370|608927|P1|Overall Study|Subject Decision|10
174623|NCT00500370|608926|P2|Overall Study|Sponsor Decision|0
174624|NCT00500370|608927|P1|Overall Study|Sponsor Decision|2
174625|NCT00500370|608926|P2|Overall Study|Protocol Violation|4
174626|NCT00500370|608927|P1|Overall Study|Protocol Violation|2
174627|NCT00500370|608926|P2|Overall Study|Lost to Follow-up|10
174628|NCT00500370|608927|P1|Overall Study|Lost to Follow-up|10
174629|NCT00500370|608926|P2|Overall Study|Adverse Event|3
174630|NCT00500370|608927|P1|Overall Study|Adverse Event|9
174631|NCT00500357|608963|P1|Overall Study|Death|1
174632|NCT00500331|608989|P7|Overall Study|Protocol violated|0
174633|NCT00500331|608990|P6|Overall Study|Protocol violated|0
174634|NCT00500331|608991|P5|Overall Study|Protocol violated|0
174635|NCT00500331|608992|P4|Overall Study|Protocol violated|1
174636|NCT00500331|608993|P3|Overall Study|Protocol violated|0
174637|NCT00500331|608994|P2|Overall Study|Protocol violated|0
174638|NCT00500331|608995|P1|Overall Study|Protocol violated|0
174639|NCT00500331|608989|P7|Overall Study|State ban of biological samples export|0
174640|NCT00500331|608990|P6|Overall Study|State ban of biological samples export|0
174641|NCT00500331|608991|P5|Overall Study|State ban of biological samples export|0
174642|NCT00500331|608992|P4|Overall Study|State ban of biological samples export|1
174643|NCT00500331|608993|P3|Overall Study|State ban of biological samples export|0
174644|NCT00500331|608994|P2|Overall Study|State ban of biological samples export|0
174645|NCT00500331|608995|P1|Overall Study|State ban of biological samples export|0
174646|NCT00500331|608989|P7|Overall Study|Diabetologist nurse in the study|0
174647|NCT00500331|608990|P6|Overall Study|Diabetologist nurse in the study|0
174648|NCT00500331|608991|P5|Overall Study|Diabetologist nurse in the study|0
174649|NCT00500331|608992|P4|Overall Study|Diabetologist nurse in the study|0
174650|NCT00500331|608993|P3|Overall Study|Diabetologist nurse in the study|1
174651|NCT00500331|608994|P2|Overall Study|Diabetologist nurse in the study|0
174652|NCT00500331|608995|P1|Overall Study|Diabetologist nurse in the study|0
174653|NCT00500331|608989|P7|Overall Study|Participant was randomized by mistake|0
174654|NCT00500331|608990|P6|Overall Study|Participant was randomized by mistake|0
174655|NCT00500331|608991|P5|Overall Study|Participant was randomized by mistake|0
174656|NCT00500331|608992|P4|Overall Study|Participant was randomized by mistake|0
174657|NCT00500331|608993|P3|Overall Study|Participant was randomized by mistake|0
174658|NCT00500331|608994|P2|Overall Study|Participant was randomized by mistake|0
174659|NCT00500331|608995|P1|Overall Study|Participant was randomized by mistake|1
174660|NCT00500331|608989|P7|Overall Study|Sponsor decided to withdraw participant|0
174661|NCT00500331|608990|P6|Overall Study|Sponsor decided to withdraw participant|0
174662|NCT00500331|608991|P5|Overall Study|Sponsor decided to withdraw participant|0
174663|NCT00500331|608992|P4|Overall Study|Sponsor decided to withdraw participant|0
174664|NCT00500331|608993|P3|Overall Study|Sponsor decided to withdraw participant|0
174665|NCT00500331|608994|P2|Overall Study|Sponsor decided to withdraw participant|0
174666|NCT00500331|608995|P1|Overall Study|Sponsor decided to withdraw participant|1
174667|NCT00500331|608989|P7|Overall Study|Exclusion citeria not met on Visit 4|0
174668|NCT00500331|608990|P6|Overall Study|Exclusion citeria not met on Visit 4|0
174669|NCT00500331|608991|P5|Overall Study|Exclusion citeria not met on Visit 4|0
174670|NCT00500331|608992|P4|Overall Study|Exclusion citeria not met on Visit 4|0
174671|NCT00500331|608993|P3|Overall Study|Exclusion citeria not met on Visit 4|0
174672|NCT00500331|608994|P2|Overall Study|Exclusion citeria not met on Visit 4|0
174673|NCT00500331|608995|P1|Overall Study|Exclusion citeria not met on Visit 4|1
174674|NCT00500331|608989|P7|Overall Study|Didn't return for continuation of study|0
174675|NCT00500331|608990|P6|Overall Study|Didn't return for continuation of study|0
174676|NCT00500331|608991|P5|Overall Study|Didn't return for continuation of study|0
174677|NCT00500331|608992|P4|Overall Study|Didn't return for continuation of study|0
174678|NCT00500331|608993|P3|Overall Study|Didn't return for continuation of study|0
174679|NCT00500331|608994|P2|Overall Study|Didn't return for continuation of study|0
174680|NCT00500331|608995|P1|Overall Study|Didn't return for continuation of study|1
174681|NCT00500331|608989|P7|Overall Study|Increased serum creatinine from Baseline|0
174682|NCT00500331|608990|P6|Overall Study|Increased serum creatinine from Baseline|1
174683|NCT00500331|608991|P5|Overall Study|Increased serum creatinine from Baseline|0
174684|NCT00500331|608992|P4|Overall Study|Increased serum creatinine from Baseline|0
174685|NCT00500331|608993|P3|Overall Study|Increased serum creatinine from Baseline|0
174686|NCT00500331|608994|P2|Overall Study|Increased serum creatinine from Baseline|0
174687|NCT00500331|608995|P1|Overall Study|Increased serum creatinine from Baseline|0
174688|NCT00500331|608989|P7|Overall Study|Liver function test abnormality|0
174689|NCT00500331|608990|P6|Overall Study|Liver function test abnormality|0
174690|NCT00500331|608991|P5|Overall Study|Liver function test abnormality|0
174691|NCT00500331|608992|P4|Overall Study|Liver function test abnormality|0
174692|NCT00500331|608993|P3|Overall Study|Liver function test abnormality|1
174693|NCT00500331|608994|P2|Overall Study|Liver function test abnormality|0
174694|NCT00500331|608995|P1|Overall Study|Liver function test abnormality|0
174695|NCT00500331|608989|P7|Overall Study|Lack of Efficacy|0
174696|NCT00500331|608990|P6|Overall Study|Lack of Efficacy|0
174697|NCT00500331|608991|P5|Overall Study|Lack of Efficacy|0
174698|NCT00500331|608992|P4|Overall Study|Lack of Efficacy|0
174699|NCT00500331|608993|P3|Overall Study|Lack of Efficacy|0
174700|NCT00500331|608994|P2|Overall Study|Lack of Efficacy|1
174701|NCT00500331|608995|P1|Overall Study|Lack of Efficacy|3
174702|NCT00500331|608989|P7|Overall Study|Withdrawal by Subject|1
174703|NCT00500331|608990|P6|Overall Study|Withdrawal by Subject|1
174704|NCT00500331|608991|P5|Overall Study|Withdrawal by Subject|0
174705|NCT00500331|608992|P4|Overall Study|Withdrawal by Subject|5
174706|NCT00500331|608993|P3|Overall Study|Withdrawal by Subject|1
174707|NCT00500331|608994|P2|Overall Study|Withdrawal by Subject|0
174708|NCT00500331|608995|P1|Overall Study|Withdrawal by Subject|4
174709|NCT00500331|608989|P7|Overall Study|Protocol Violation|1
174710|NCT00500331|608990|P6|Overall Study|Protocol Violation|1
174711|NCT00500331|608991|P5|Overall Study|Protocol Violation|1
174712|NCT00500331|608992|P4|Overall Study|Protocol Violation|0
174713|NCT00500331|608993|P3|Overall Study|Protocol Violation|1
174714|NCT00500331|608994|P2|Overall Study|Protocol Violation|1
174715|NCT00500331|608995|P1|Overall Study|Protocol Violation|3
174716|NCT00500331|608989|P7|Overall Study|Lost to Follow-up|0
174717|NCT00500331|608990|P6|Overall Study|Lost to Follow-up|0
174718|NCT00500331|608991|P5|Overall Study|Lost to Follow-up|1
174719|NCT00500331|608992|P4|Overall Study|Lost to Follow-up|2
174720|NCT00500331|608993|P3|Overall Study|Lost to Follow-up|1
174721|NCT00500331|608994|P2|Overall Study|Lost to Follow-up|1
174722|NCT00500331|608995|P1|Overall Study|Lost to Follow-up|1
174723|NCT00500331|608989|P7|Overall Study|Adverse Event|0
174724|NCT00500331|608990|P6|Overall Study|Adverse Event|2
174725|NCT00500331|608991|P5|Overall Study|Adverse Event|2
174726|NCT00500331|608992|P4|Overall Study|Adverse Event|1
174727|NCT00500331|608993|P3|Overall Study|Adverse Event|0
174728|NCT00500331|608994|P2|Overall Study|Adverse Event|2
174729|NCT00500331|608995|P1|Overall Study|Adverse Event|0
174730|NCT00500318|609132|P2|Overall Study|Other Reason|1
174731|NCT00500318|609133|P1|Overall Study|Other Reason|0
174732|NCT00500318|609132|P2|Overall Study|Lack of Efficacy|3
174733|NCT00500318|609133|P1|Overall Study|Lack of Efficacy|0
174734|NCT00500318|609132|P2|Overall Study|Withdrawal by Subject|2
174735|NCT00500318|609133|P1|Overall Study|Withdrawal by Subject|1
174736|NCT00500318|609132|P2|Overall Study|Protocol Violation|3
174737|NCT00500318|609133|P1|Overall Study|Protocol Violation|1
174738|NCT00500318|609132|P2|Overall Study|Adverse Event|8
174739|NCT00500318|609133|P1|Overall Study|Adverse Event|3
174740|NCT00500292|609150|P3|Overall Study|Other|4
174741|NCT00500292|609151|P2|Overall Study|Other|1
174742|NCT00500292|609152|P1|Overall Study|Other|1
174743|NCT00500292|609150|P3|Overall Study|Withdrawal by Subject|0
174744|NCT00500292|609151|P2|Overall Study|Withdrawal by Subject|1
174745|NCT00500292|609152|P1|Overall Study|Withdrawal by Subject|0
174746|NCT00500292|609150|P3|Overall Study|Condition under investigation worsened|19
174747|NCT00500292|609151|P2|Overall Study|Condition under investigation worsened|23
174748|NCT00500292|609152|P1|Overall Study|Condition under investigation worsened|21
174749|NCT00500292|609150|P3|Overall Study|Adverse Event|4
174750|NCT00500292|609151|P2|Overall Study|Adverse Event|6
174751|NCT00500292|609152|P1|Overall Study|Adverse Event|3
174752|NCT00500149|609173|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
174753|NCT00500149|609174|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
174754|NCT00500149|609173|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
174755|NCT00500149|609174|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
174756|NCT00500149|609173|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
174757|NCT00500149|609174|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
174758|NCT00500149|609173|P2|First Intervention (Cross-over Phase)|Adverse Event|1
174759|NCT00500149|609174|P1|First Intervention (Cross-over Phase)|Adverse Event|0
174760|NCT00500149|609173|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
174761|NCT00500149|609174|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
174762|NCT00500149|609173|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
174763|NCT00500149|609174|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
174764|NCT00500149|609173|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
174765|NCT00500149|609174|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
174766|NCT00500110|609182|P1|Overall Study|Withdrawal by Subject|3
174767|NCT00500071|609186|P1|30-day Safety Follow-up|Lost to Follow-up|17
174768|NCT00500071|609186|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
174769|NCT00500071|609186|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
174770|NCT00500071|609186|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
174771|NCT00500071|609186|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
174772|NCT00500071|609186|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
174773|NCT00500071|609186|P1|Screening and Washout Phase|Protocol Violation|1
174774|NCT00499889|609204|P1|Overall Study|Infection prior to treatment|1
174775|NCT00499863|609212|P2|Overall Study|Lost to Follow-up|1
174776|NCT00499863|609213|P1|Overall Study|Lost to Follow-up|1
174777|NCT00499863|609212|P2|Overall Study|Sponsor decision|2
174778|NCT00499863|609213|P1|Overall Study|Sponsor decision|2
174779|NCT00499863|609212|P2|Overall Study|Adverse Event|2
174780|NCT00499863|609213|P1|Overall Study|Adverse Event|8
174781|NCT00499863|609212|P2|Overall Study|Withdrawal by Subject|4
174782|NCT00499863|609213|P1|Overall Study|Withdrawal by Subject|6
174783|NCT00499863|609212|P2|Overall Study|Protocol Violation|7
174784|NCT00499863|609213|P1|Overall Study|Protocol Violation|12
174785|NCT00499863|609212|P2|Overall Study|Lack of Efficacy|27
174786|NCT00499863|609213|P1|Overall Study|Lack of Efficacy|21
174787|NCT00500266|609241|P1|Overall Study|Assigned, not treated|4
174788|NCT00500266|609241|P1|Overall Study|Withdrawal by Subject|3
174789|NCT00500266|609241|P1|Overall Study|Lost to Follow-up|3
174790|NCT00500266|609241|P1|Overall Study|Death|3
174791|NCT00499746|609248|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
174792|NCT00499746|609248|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
174793|NCT00499746|609248|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
174794|NCT00499746|609248|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
174795|NCT00499694|609317|P1|Overall Study|Patient never received treatment.|1
174796|NCT00499681|609326|P2|Overall Study|disease progression|1
174797|NCT00499681|609327|P1|Overall Study|disease progression|0
174798|NCT00499681|609326|P2|Overall Study|toxicity|1
174799|NCT00499681|609327|P1|Overall Study|toxicity|0
174800|NCT00499616|609354|P4|Overall Study|Patient/Parent Refusal|0
174801|NCT00499616|609355|P3|Overall Study|Patient/Parent Refusal|3
174802|NCT00499616|609356|P2|Overall Study|Patient/Parent Refusal|5
174803|NCT00499616|609357|P1|Overall Study|Patient/Parent Refusal|1
174804|NCT00499616|609354|P4|Overall Study|Not evaluable|41
174805|NCT00499616|609355|P3|Overall Study|Not evaluable|0
174806|NCT00499616|609356|P2|Overall Study|Not evaluable|0
174807|NCT00499616|609357|P1|Overall Study|Not evaluable|0
174808|NCT00499616|609354|P4|Overall Study|Ineligible|15
174809|NCT00499616|609355|P3|Overall Study|Ineligible|0
174810|NCT00499616|609356|P2|Overall Study|Ineligible|2
174811|NCT00499616|609357|P1|Overall Study|Ineligible|1
174812|NCT00499616|609354|P4|Overall Study|Withdrawal by Subject|0
174813|NCT00499616|609355|P3|Overall Study|Withdrawal by Subject|1
174814|NCT00499616|609356|P2|Overall Study|Withdrawal by Subject|0
174815|NCT00499616|609357|P1|Overall Study|Withdrawal by Subject|1
174816|NCT00499616|609354|P4|Overall Study|Physician Decision|0
174817|NCT00499616|609355|P3|Overall Study|Physician Decision|9
174818|NCT00499616|609356|P2|Overall Study|Physician Decision|16
174819|NCT00499616|609357|P1|Overall Study|Physician Decision|6
174820|NCT00499616|609354|P4|Overall Study|Lost to Follow-up|0
174821|NCT00499616|609355|P3|Overall Study|Lost to Follow-up|1
174822|NCT00499616|609356|P2|Overall Study|Lost to Follow-up|0
174823|NCT00499616|609357|P1|Overall Study|Lost to Follow-up|0
174824|NCT00499616|609354|P4|Overall Study|Lack of Efficacy|0
174825|NCT00499616|609355|P3|Overall Study|Lack of Efficacy|19
174826|NCT00499616|609356|P2|Overall Study|Lack of Efficacy|0
174827|NCT00499616|609357|P1|Overall Study|Lack of Efficacy|5
174828|NCT00499616|609354|P4|Overall Study|Death|1
174829|NCT00499616|609355|P3|Overall Study|Death|3
174830|NCT00499616|609356|P2|Overall Study|Death|5
174831|NCT00499616|609357|P1|Overall Study|Death|1
174832|NCT00499603|609394|P2|Overall Study|Adverse Event|1
174833|NCT00499603|609395|P1|Overall Study|Adverse Event|0
174834|NCT00499590|609408|P3|Overall Study|Not treated|1
174835|NCT00499590|609409|P2|Overall Study|Not treated|0
174836|NCT00499590|609410|P1|Overall Study|Not treated|1
174837|NCT00499590|609408|P3|Overall Study|Study Terminated|112
174838|NCT00499590|609409|P2|Overall Study|Study Terminated|112
174839|NCT00499590|609410|P1|Overall Study|Study Terminated|112
174840|NCT00499486|609421|P1|Overall Study|Withdrawal by Subject|16
174841|NCT00499460|609448|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
174842|NCT00499460|609449|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
174843|NCT00499460|609448|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
174844|NCT00499460|609449|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
174845|NCT00499460|609448|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
174846|NCT00499460|609449|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
174847|NCT00499369|609478|P5|Overall Study|Ineligible|0
174848|NCT00499369|609479|P4|Overall Study|Ineligible|1
174849|NCT00499369|609480|P3|Overall Study|Ineligible|1
174850|NCT00499369|609481|P2|Overall Study|Ineligible|2
174851|NCT00499369|609482|P1|Overall Study|Ineligible|2
174852|NCT00499369|609478|P5|Overall Study|Not protocol specified|0
174853|NCT00499369|609479|P4|Overall Study|Not protocol specified|1
174854|NCT00499369|609480|P3|Overall Study|Not protocol specified|3
174855|NCT00499369|609481|P2|Overall Study|Not protocol specified|0
174856|NCT00499369|609482|P1|Overall Study|Not protocol specified|2
174857|NCT00499369|609478|P5|Overall Study|Death|0
174858|NCT00499369|609479|P4|Overall Study|Death|0
174859|NCT00499369|609480|P3|Overall Study|Death|0
174860|NCT00499369|609481|P2|Overall Study|Death|1
174861|NCT00499369|609482|P1|Overall Study|Death|0
174862|NCT00499369|609478|P5|Overall Study|Progression|10
174863|NCT00499369|609479|P4|Overall Study|Progression|6
174864|NCT00499369|609480|P3|Overall Study|Progression|9
174865|NCT00499369|609481|P2|Overall Study|Progression|12
174866|NCT00499369|609482|P1|Overall Study|Progression|10
174867|NCT00499369|609478|P5|Overall Study|Withdrawal by Subject|0
174868|NCT00499369|609479|P4|Overall Study|Withdrawal by Subject|0
174869|NCT00499369|609480|P3|Overall Study|Withdrawal by Subject|1
174870|NCT00499369|609481|P2|Overall Study|Withdrawal by Subject|1
174871|NCT00499369|609482|P1|Overall Study|Withdrawal by Subject|0
174872|NCT00499369|609478|P5|Overall Study|Adverse Event|2
174873|NCT00499369|609479|P4|Overall Study|Adverse Event|1
174874|NCT00499369|609480|P3|Overall Study|Adverse Event|3
174875|NCT00499369|609481|P2|Overall Study|Adverse Event|2
174876|NCT00499369|609482|P1|Overall Study|Adverse Event|2
174877|NCT00499252|609518|P1|Overall Study|<no further label>|3
174878|NCT00499252|609518|P1|Overall Study|Ineligible|4
174879|NCT00499252|609518|P1|Overall Study|Refused further treatment|2
174880|NCT00499252|609518|P1|Overall Study|Adverse Event|3
174881|NCT00499122|609528|P1|Overall Study|Withdrawal by Subject|2
174882|NCT00499031|609571|P1|Overall Study|Never treated|1
174883|NCT00499031|609571|P1|Overall Study|Required test not done|1
174884|NCT00499031|609571|P1|Overall Study|Improper pre-protocol treatment|1
174885|NCT00498797|609594|P2|Overall Study|Other|1
174886|NCT00498797|609595|P1|Overall Study|Other|3
174887|NCT00498797|609594|P2|Overall Study|Condition under investigation worsened|21
174888|NCT00498797|609595|P1|Overall Study|Condition under investigation worsened|19
174889|NCT00498797|609594|P2|Overall Study|Adverse Event|5
174890|NCT00498797|609595|P1|Overall Study|Adverse Event|12
174891|NCT00498797|609594|P2|Overall Study|Withdrawal by Subject|2
174892|NCT00498797|609595|P1|Overall Study|Withdrawal by Subject|4
174893|NCT00498602|609653|P7|Overall Study|Not specified|0
174894|NCT00498602|609654|P6|Overall Study|Not specified|3
174895|NCT00498602|609655|P5|Overall Study|Not specified|0
174896|NCT00498602|609656|P4|Overall Study|Not specified|0
174897|NCT00498602|609657|P3|Overall Study|Not specified|1
174898|NCT00498602|609658|P2|Overall Study|Not specified|3
174899|NCT00498602|609659|P1|Overall Study|Not specified|2
174900|NCT00498602|609653|P7|Overall Study|Subject Request|1
174901|NCT00498602|609654|P6|Overall Study|Subject Request|4
174902|NCT00498602|609655|P5|Overall Study|Subject Request|1
174903|NCT00498602|609656|P4|Overall Study|Subject Request|1
174904|NCT00498602|609657|P3|Overall Study|Subject Request|1
174905|NCT00498602|609658|P2|Overall Study|Subject Request|0
174906|NCT00498602|609659|P1|Overall Study|Subject Request|3
174907|NCT00498602|609653|P7|Overall Study|Investigator Request|0
174908|NCT00498602|609654|P6|Overall Study|Investigator Request|0
174909|NCT00498602|609655|P5|Overall Study|Investigator Request|0
174910|NCT00498602|609656|P4|Overall Study|Investigator Request|0
174911|NCT00498602|609657|P3|Overall Study|Investigator Request|1
174912|NCT00498602|609658|P2|Overall Study|Investigator Request|0
174913|NCT00498602|609659|P1|Overall Study|Investigator Request|0
174914|NCT00498602|609653|P7|Overall Study|Caregiver Request|0
174915|NCT00498602|609654|P6|Overall Study|Caregiver Request|2
174916|NCT00498602|609655|P5|Overall Study|Caregiver Request|1
174917|NCT00498602|609656|P4|Overall Study|Caregiver Request|0
174918|NCT00498602|609657|P3|Overall Study|Caregiver Request|2
174919|NCT00498602|609658|P2|Overall Study|Caregiver Request|2
174920|NCT00498602|609659|P1|Overall Study|Caregiver Request|2
174921|NCT00498602|609653|P7|Overall Study|AE not related to Study Drug|1
174922|NCT00498602|609654|P6|Overall Study|AE not related to Study Drug|2
174923|NCT00498602|609655|P5|Overall Study|AE not related to Study Drug|2
174924|NCT00498602|609656|P4|Overall Study|AE not related to Study Drug|0
174925|NCT00498602|609657|P3|Overall Study|AE not related to Study Drug|0
174926|NCT00498602|609658|P2|Overall Study|AE not related to Study Drug|3
174927|NCT00498602|609659|P1|Overall Study|AE not related to Study Drug|1
174928|NCT00498602|609653|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
174929|NCT00498602|609654|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
174930|NCT00498602|609655|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
174931|NCT00498602|609656|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
174932|NCT00498602|609657|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
174933|NCT00498602|609658|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
174934|NCT00498602|609659|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
174935|NCT00498602|609653|P7|Overall Study|Lost to Follow-up|0
174936|NCT00498602|609654|P6|Overall Study|Lost to Follow-up|0
174937|NCT00498602|609655|P5|Overall Study|Lost to Follow-up|0
174938|NCT00498602|609656|P4|Overall Study|Lost to Follow-up|2
174939|NCT00498602|609657|P3|Overall Study|Lost to Follow-up|0
174940|NCT00498602|609658|P2|Overall Study|Lost to Follow-up|2
174941|NCT00498602|609659|P1|Overall Study|Lost to Follow-up|0
174942|NCT00498602|609653|P7|Overall Study|Lack of Efficacy|0
174943|NCT00498602|609654|P6|Overall Study|Lack of Efficacy|0
174944|NCT00498602|609655|P5|Overall Study|Lack of Efficacy|0
174945|NCT00498602|609656|P4|Overall Study|Lack of Efficacy|0
174946|NCT00498602|609657|P3|Overall Study|Lack of Efficacy|0
174947|NCT00498602|609658|P2|Overall Study|Lack of Efficacy|0
174948|NCT00498602|609659|P1|Overall Study|Lack of Efficacy|1
174949|NCT00498602|609653|P7|Overall Study|Death|0
174950|NCT00498602|609654|P6|Overall Study|Death|1
174951|NCT00498602|609655|P5|Overall Study|Death|0
174952|NCT00498602|609656|P4|Overall Study|Death|0
174953|NCT00498602|609657|P3|Overall Study|Death|0
174954|NCT00498602|609658|P2|Overall Study|Death|0
174955|NCT00498602|609659|P1|Overall Study|Death|0
174956|NCT00498485|609707|P2|Overall Study|Adverse Event|5
174957|NCT00498485|609708|P1|Overall Study|Adverse Event|1
174958|NCT00498433|609719|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
174959|NCT00498433|609720|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
174960|NCT00498433|609721|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
174961|NCT00498433|609719|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
174962|NCT00498433|609720|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
174963|NCT00498433|609721|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
174964|NCT00498433|609719|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
174965|NCT00498433|609720|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
174966|NCT00498433|609721|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
174967|NCT00498433|609719|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
174968|NCT00498433|609720|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
174969|NCT00498433|609721|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
174970|NCT00498368|609766|P2|Overall Study|Withdrawal by Subject|2
174971|NCT00498368|609767|P1|Overall Study|Withdrawal by Subject|3
174972|NCT00498355|609779|P1|Overall Study|Lost to Follow-up|1
174973|NCT00498186|609787|P1|Overall Study|Other|10
174974|NCT00498186|609787|P1|Overall Study|Lost to Follow-up|3
174975|NCT00498186|609787|P1|Overall Study|Withdrawal by Subject|18
174976|NCT00498186|609787|P1|Overall Study|Unsatisfactory compliance of subject|12
174977|NCT00498186|609787|P1|Overall Study|Adverse Event|89
174978|NCT00498186|609787|P1|Overall Study|Lack of Efficacy|31
174979|NCT00498186|609787|P1|Overall Study|Protocol Violation|10
175064|NCT00496626|610164|P2|Overall Study|Withdrawal by Subject|4
174980|NCT00498173|609794|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
174981|NCT00498173|609795|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
174982|NCT00498173|609796|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
174983|NCT00497874|609826|P2|Overall Study|Unable to schedule|24
174984|NCT00497874|609827|P1|Overall Study|Unable to schedule|37
174985|NCT00497874|609826|P2|Overall Study|Unable to contact|67
174986|NCT00497874|609827|P1|Overall Study|Unable to contact|52
174987|NCT00497874|609826|P2|Overall Study|Death|4
174988|NCT00497874|609827|P1|Overall Study|Death|2
174989|NCT00497874|609826|P2|Overall Study|Illness|4
174990|NCT00497874|609827|P1|Overall Study|Illness|8
174991|NCT00497874|609826|P2|Overall Study|Withdrawal by Subject|17
174992|NCT00497874|609827|P1|Overall Study|Withdrawal by Subject|48
174993|NCT00497796|609845|P2|Overall Study|Not applicable (randomized not treated)|4
174994|NCT00497796|609846|P1|Overall Study|Not applicable (randomized not treated)|0
174995|NCT00497796|609845|P2|Overall Study|Lost to Follow-up|1
174996|NCT00497796|609846|P1|Overall Study|Lost to Follow-up|0
174997|NCT00497796|609845|P2|Overall Study|Investigator/sponsor discretion|34
174998|NCT00497796|609846|P1|Overall Study|Investigator/sponsor discretion|31
174999|NCT00497796|609845|P2|Overall Study|Consent withdrawn|3
175000|NCT00497796|609846|P1|Overall Study|Consent withdrawn|10
175001|NCT00497796|609845|P2|Overall Study|CMV infection or disease treatment|4
175002|NCT00497796|609846|P1|Overall Study|CMV infection or disease treatment|30
175003|NCT00497796|609845|P2|Overall Study|Adverse event (related)|4
175004|NCT00497796|609846|P1|Overall Study|Adverse event (related)|5
175005|NCT00497796|609845|P2|Overall Study|Adverse event (not related)|9
175006|NCT00497796|609846|P1|Overall Study|Adverse event (not related)|9
175007|NCT00497198|609933|P2|Overall Study|Withdrawal by Subject|1
175008|NCT00497198|609934|P1|Overall Study|Withdrawal by Subject|0
175009|NCT00497198|609933|P2|Overall Study|Physician Decision|2
175010|NCT00497198|609934|P1|Overall Study|Physician Decision|1
175011|NCT00497198|609933|P2|Overall Study|Adverse Event|2
175012|NCT00497198|609934|P1|Overall Study|Adverse Event|4
175013|NCT00497146|609950|P2|Long-term Follow-up Period|Other|1
175014|NCT00497146|609951|P1|Long-term Follow-up Period|Other|0
175015|NCT00497146|609950|P2|Long-term Follow-up Period|Lost to Follow-up|1
175016|NCT00497146|609951|P1|Long-term Follow-up Period|Lost to Follow-up|5
175017|NCT00497146|609950|P2|Long-term Follow-up Period|Withdrawal by Subject|2
175018|NCT00497146|609951|P1|Long-term Follow-up Period|Withdrawal by Subject|8
175019|NCT00497146|609950|P2|Long-term Follow-up Period|Adverse Event|2
175020|NCT00497146|609951|P1|Long-term Follow-up Period|Adverse Event|2
175021|NCT00497146|609950|P2|Treatment Period|Other Reason|3
175022|NCT00497146|609951|P1|Treatment Period|Other Reason|2
175023|NCT00497146|609950|P2|Treatment Period|Unable to dose reduce per protocol|1
175024|NCT00497146|609951|P1|Treatment Period|Unable to dose reduce per protocol|4
175025|NCT00497146|609950|P2|Treatment Period|Change in RAAS inhibitor therapy|2
175026|NCT00497146|609951|P1|Treatment Period|Change in RAAS inhibitor therapy|5
175027|NCT00497146|609950|P2|Treatment Period|Required dialysis|1
175028|NCT00497146|609951|P1|Treatment Period|Required dialysis|4
175029|NCT00497146|609950|P2|Treatment Period|Lost to Follow-up|3
175030|NCT00497146|609951|P1|Treatment Period|Lost to Follow-up|1
175031|NCT00497146|609950|P2|Treatment Period|Withdrawal by Subject|9
175032|NCT00497146|609951|P1|Treatment Period|Withdrawal by Subject|5
175033|NCT00497146|609950|P2|Treatment Period|Adverse Event|2
175034|NCT00497146|609951|P1|Treatment Period|Adverse Event|6
175035|NCT00496964|610019|P2|Overall Study|Withdrawal by Subject|1
175036|NCT00496964|610020|P1|Overall Study|Withdrawal by Subject|0
175037|NCT00496873|610038|P1|Overall Study|Withdrawal by Subject|3
175038|NCT00496873|610038|P1|Overall Study|Death|2
175039|NCT00496873|610038|P1|Overall Study|Ineligible|2
175040|NCT00496834|610071|P2|Overall Study|Blood Pressure control failure|1
175041|NCT00496834|610072|P1|Overall Study|Blood Pressure control failure|2
175042|NCT00496834|610071|P2|Overall Study|Lost to Follow-up|0
175043|NCT00496834|610072|P1|Overall Study|Lost to Follow-up|2
175044|NCT00496834|610071|P2|Overall Study|IP administration violation|0
175045|NCT00496834|610072|P1|Overall Study|IP administration violation|2
175046|NCT00496834|610071|P2|Overall Study|Adverse Event|3
175047|NCT00496834|610072|P1|Overall Study|Adverse Event|5
175048|NCT00496834|610071|P2|Overall Study|Inclusion/exclusion criteria not met|2
175049|NCT00496834|610072|P1|Overall Study|Inclusion/exclusion criteria not met|3
175050|NCT00496834|610071|P2|Overall Study|Contraindicated medication administered|1
175051|NCT00496834|610072|P1|Overall Study|Contraindicated medication administered|0
175052|NCT00496834|610071|P2|Overall Study|Withdrawal by Subject|6
175053|NCT00496834|610072|P1|Overall Study|Withdrawal by Subject|4
175054|NCT00496782|610091|P2|Overall Study|Protocol Violation|2
175055|NCT00496782|610092|P1|Overall Study|Protocol Violation|1
175056|NCT00496769|610126|P2|Overall Study|>=1 reason assigned per patient|649
175057|NCT00496769|610127|P1|Overall Study|>=1 reason assigned per patient|558
175058|NCT00496730|610151|P2|Overall Study|Withdrawal by Subject|2
175059|NCT00496730|610152|P1|Overall Study|Withdrawal by Subject|2
175060|NCT00496730|610151|P2|Overall Study|Lost to Follow-up|3
175061|NCT00496730|610152|P1|Overall Study|Lost to Follow-up|4
175062|NCT00496626|610164|P2|Overall Study|Relocated|1
175063|NCT00496626|610165|P1|Overall Study|Relocated|0
175065|NCT00496626|610165|P1|Overall Study|Withdrawal by Subject|5
175066|NCT00496626|610164|P2|Overall Study|Protocol Violation|0
175067|NCT00496626|610165|P1|Overall Study|Protocol Violation|1
175068|NCT00496626|610164|P2|Overall Study|Lost to Follow-up|1
175069|NCT00496626|610165|P1|Overall Study|Lost to Follow-up|0
175070|NCT00496587|610177|P1|Overall Study|Complications unrelated|2
175071|NCT00496587|610177|P1|Overall Study|Death|1
175072|NCT00496587|610177|P1|Overall Study|Withdrawal by Subject|2
175073|NCT00496587|610177|P1|Overall Study|Progressive Disease|24
175074|NCT00496587|610177|P1|Overall Study|Adverse Event|2
175075|NCT00496483|610183|P1|Overall Study|Lack of Efficacy|1
175076|NCT00496483|610183|P1|Overall Study|Adverse Event|2
175077|NCT00496483|610183|P1|Overall Study|Not dosed|9
175078|NCT00496470|610200|P2|Overall Study|Other reason|2
175079|NCT00496470|610201|P1|Overall Study|Other reason|0
175080|NCT00496470|610200|P2|Overall Study|Incorrectly enrolled|5
175081|NCT00496470|610201|P1|Overall Study|Incorrectly enrolled|13
175082|NCT00496470|610200|P2|Overall Study|Withdrawal by Subject|12
175083|NCT00496470|610201|P1|Overall Study|Withdrawal by Subject|5
175084|NCT00496470|610200|P2|Overall Study|Adverse Event|10
175085|NCT00496470|610201|P1|Overall Study|Adverse Event|8
175086|NCT00496366|610287|P1|Overall Study|Death|1
175087|NCT00496197|610318|P1|Overall Study|Protocol Violation|8
175088|NCT00496197|610318|P1|Overall Study|Other|14
175089|NCT00496197|610318|P1|Overall Study|Pathogen not isolated baseline specimen|4
175090|NCT00496197|610318|P1|Overall Study|Withdrawal by Subject|11
175091|NCT00496197|610318|P1|Overall Study|Lost to Follow-up|11
175092|NCT00496197|610318|P1|Overall Study|Insufficient bacteriological response|10
175093|NCT00496197|610318|P1|Overall Study|Insufficient clinical response|3
175094|NCT00496197|610318|P1|Overall Study|Does not meet entrance criteria|5
175095|NCT00496197|610318|P1|Overall Study|Adverse Event|13
175096|NCT00496197|610318|P1|Overall Study|Discontinued study due to death|43
175097|NCT00496080|610345|P1|Overall Study|Physician Decision|6
175098|NCT00496080|610345|P1|Overall Study|Withdrawal by Subject|5
175099|NCT00496080|610345|P1|Overall Study|Surgical re-intervention|7
175100|NCT00496080|610345|P1|Overall Study|Lost to Follow-up|9
175101|NCT00496054|610355|P1|Overall Study|Lost to Follow-up|7
175102|NCT00496054|610355|P1|Overall Study|Adverse Event|1
175103|NCT00495820|610384|P2|Overall Study|Adverse Event|1
175104|NCT00495820|610385|P1|Overall Study|Adverse Event|1
175105|NCT00495794|610397|P2|Overall Study|Pharmacist did not activate patient|0
175106|NCT00495794|610398|P1|Overall Study|Pharmacist did not activate patient|522
175107|NCT00495755|610408|P1|Overall Study|Adverse Event|3
175108|NCT00495677|610420|P7|Stage 1 (25 Days)|Adverse Event|0
175109|NCT00495677|610421|P6|Stage 1 (25 Days)|Adverse Event|0
175110|NCT00495677|610422|P5|Stage 1 (25 Days)|Adverse Event|0
175111|NCT00495677|610423|P4|Stage 1 (25 Days)|Adverse Event|0
175112|NCT00495677|610424|P3|Stage 1 (25 Days)|Adverse Event|1
175113|NCT00495677|610425|P2|Stage 1 (25 Days)|Adverse Event|0
175114|NCT00495677|610426|P1|Stage 1 (25 Days)|Adverse Event|0
175115|NCT00495625|610481|P1|Overall Study|Did not complete at least 1 42 day cycle|10
175116|NCT00495612|610492|P2|Overall Study|Subject's Decision to Withdraw|0
175117|NCT00495612|610493|P1|Overall Study|Subject's Decision to Withdraw|3
175118|NCT00495612|610492|P2|Overall Study|Lost to Follow-up|0
175119|NCT00495612|610493|P1|Overall Study|Lost to Follow-up|1
175120|NCT00495586|610511|P2|Overall Study|Withdrawal by Subject|4
175121|NCT00495586|610512|P1|Overall Study|Withdrawal by Subject|4
175122|NCT00495521|610522|P2|Overall Study|Physician Decision|1
175123|NCT00495521|610523|P1|Overall Study|Physician Decision|0
175124|NCT00495495|610553|P1|Overall Study|Protocol Violation|99
175125|NCT00495469|610573|P7|Overall Study|ST depression at randomisation in ECG|0
175126|NCT00495469|610574|P6|Overall Study|ST depression at randomisation in ECG|0
175127|NCT00495469|610575|P5|Overall Study|ST depression at randomisation in ECG|0
175128|NCT00495469|610576|P4|Overall Study|ST depression at randomisation in ECG|0
175129|NCT00495469|610577|P3|Overall Study|ST depression at randomisation in ECG|0
175130|NCT00495469|610578|P2|Overall Study|ST depression at randomisation in ECG|1
175131|NCT00495469|610579|P1|Overall Study|ST depression at randomisation in ECG|0
175132|NCT00495469|610573|P7|Overall Study|Liver function test abnormality|0
175133|NCT00495469|610574|P6|Overall Study|Liver function test abnormality|0
175134|NCT00495469|610575|P5|Overall Study|Liver function test abnormality|0
175135|NCT00495469|610576|P4|Overall Study|Liver function test abnormality|0
175136|NCT00495469|610577|P3|Overall Study|Liver function test abnormality|0
175137|NCT00495469|610578|P2|Overall Study|Liver function test abnormality|1
175138|NCT00495469|610579|P1|Overall Study|Liver function test abnormality|0
175139|NCT00495469|610573|P7|Overall Study|Lack of Efficacy|1
175140|NCT00495469|610574|P6|Overall Study|Lack of Efficacy|0
175141|NCT00495469|610575|P5|Overall Study|Lack of Efficacy|0
175142|NCT00495469|610576|P4|Overall Study|Lack of Efficacy|0
175143|NCT00495469|610577|P3|Overall Study|Lack of Efficacy|0
175144|NCT00495469|610578|P2|Overall Study|Lack of Efficacy|0
175145|NCT00495469|610579|P1|Overall Study|Lack of Efficacy|0
175146|NCT00495469|610573|P7|Overall Study|Withdrawal by Subject|3
175147|NCT00495469|610574|P6|Overall Study|Withdrawal by Subject|2
175148|NCT00495469|610575|P5|Overall Study|Withdrawal by Subject|3
175149|NCT00495469|610576|P4|Overall Study|Withdrawal by Subject|3
175150|NCT00495469|610577|P3|Overall Study|Withdrawal by Subject|1
175151|NCT00495469|610578|P2|Overall Study|Withdrawal by Subject|3
175152|NCT00495469|610579|P1|Overall Study|Withdrawal by Subject|5
175153|NCT00495469|610573|P7|Overall Study|Protocol Violation|0
175154|NCT00495469|610574|P6|Overall Study|Protocol Violation|2
175155|NCT00495469|610575|P5|Overall Study|Protocol Violation|1
175156|NCT00495469|610576|P4|Overall Study|Protocol Violation|0
175157|NCT00495469|610577|P3|Overall Study|Protocol Violation|0
175158|NCT00495469|610578|P2|Overall Study|Protocol Violation|0
175159|NCT00495469|610579|P1|Overall Study|Protocol Violation|0
175160|NCT00495469|610573|P7|Overall Study|Lost to Follow-up|0
175161|NCT00495469|610574|P6|Overall Study|Lost to Follow-up|0
175162|NCT00495469|610575|P5|Overall Study|Lost to Follow-up|0
175163|NCT00495469|610576|P4|Overall Study|Lost to Follow-up|1
175164|NCT00495469|610577|P3|Overall Study|Lost to Follow-up|3
175165|NCT00495469|610578|P2|Overall Study|Lost to Follow-up|1
175166|NCT00495469|610579|P1|Overall Study|Lost to Follow-up|1
175167|NCT00495469|610573|P7|Overall Study|Adverse Event|1
175168|NCT00495469|610574|P6|Overall Study|Adverse Event|1
175169|NCT00495469|610575|P5|Overall Study|Adverse Event|1
175170|NCT00495469|610576|P4|Overall Study|Adverse Event|0
175171|NCT00495469|610577|P3|Overall Study|Adverse Event|3
175172|NCT00495469|610578|P2|Overall Study|Adverse Event|1
175173|NCT00495469|610579|P1|Overall Study|Adverse Event|0
175174|NCT00495391|610723|P2|Overall Study|Withdrawal by Subject|3
175175|NCT00495391|610724|P1|Overall Study|Withdrawal by Subject|2
175176|NCT00495391|610723|P2|Overall Study|Lack of Efficacy|18
175177|NCT00495391|610724|P1|Overall Study|Lack of Efficacy|34
175178|NCT00495131|610762|P2|Overall Study|Withdrawal by Subject|0
175179|NCT00495131|610763|P1|Overall Study|Withdrawal by Subject|1
175180|NCT00495131|610762|P2|Overall Study|Lost to Follow-up|2
175181|NCT00495131|610763|P1|Overall Study|Lost to Follow-up|0
175182|NCT00495131|610762|P2|Overall Study|Lack of Efficacy|2
175183|NCT00495131|610763|P1|Overall Study|Lack of Efficacy|0
175184|NCT00495131|610762|P2|Overall Study|Adverse Event|2
175185|NCT00495131|610763|P1|Overall Study|Adverse Event|6
175186|NCT00494871|610791|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
175187|NCT00494871|610792|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
175188|NCT00494871|610791|P2|Follow-up (FU) Period|Withdrawal by Subject|5
175189|NCT00494871|610792|P1|Follow-up (FU) Period|Withdrawal by Subject|5
175190|NCT00494871|610791|P2|Follow-up (FU) Period|Protocol Violation|0
175191|NCT00494871|610792|P1|Follow-up (FU) Period|Protocol Violation|1
175192|NCT00494871|610791|P2|Follow-up (FU) Period|Physician Decision|1
175193|NCT00494871|610792|P1|Follow-up (FU) Period|Physician Decision|0
175194|NCT00494871|610791|P2|Follow-up (FU) Period|Lost to Follow-up|2
175195|NCT00494871|610792|P1|Follow-up (FU) Period|Lost to Follow-up|6
175196|NCT00494871|610791|P2|Follow-up (FU) Period|Death|12
175197|NCT00494871|610792|P1|Follow-up (FU) Period|Death|13
175198|NCT00494871|610791|P2|Follow-up (FU) Period|Adverse Event|1
175199|NCT00494871|610792|P1|Follow-up (FU) Period|Adverse Event|1
175200|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
175201|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
175202|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
175203|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
175204|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
175205|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
175206|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
175207|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
175208|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
175209|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
175210|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
175211|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
175212|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
175213|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
175214|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
175215|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
175216|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Physician Decision|13
175217|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Physician Decision|4
175218|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Death|3
175219|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Death|8
175220|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
175221|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
175222|NCT00494871|610791|P2|Double-blind (DB) Treatment Period|Adverse Event|70
175223|NCT00494871|610792|P1|Double-blind (DB) Treatment Period|Adverse Event|73
175224|NCT00494780|610833|P2|Overall Study|Insurance Issues|1
175225|NCT00494780|610834|P1|Overall Study|Insurance Issues|0
175226|NCT00494780|610833|P2|Overall Study|Residual Tumour Mass|1
175227|NCT00494780|610834|P1|Overall Study|Residual Tumour Mass|0
175228|NCT00494780|610833|P2|Overall Study|Non-compliance|0
175229|NCT00494780|610834|P1|Overall Study|Non-compliance|1
175230|NCT00494780|610833|P2|Overall Study|New Treatment|2
175231|NCT00494780|610834|P1|Overall Study|New Treatment|2
175232|NCT00494780|610833|P2|Overall Study|Progression of Study Disease|8
175233|NCT00494780|610834|P1|Overall Study|Progression of Study Disease|7
175234|NCT00494780|610833|P2|Overall Study|Withdrew before Dosed|1
175235|NCT00494780|610834|P1|Overall Study|Withdrew before Dosed|0
175236|NCT00494780|610833|P2|Overall Study|Adverse Event|0
175237|NCT00494780|610834|P1|Overall Study|Adverse Event|1
175238|NCT00494676|610872|P2|Second Intervention|Withdrawal by Subject|1
175239|NCT00494676|610873|P1|Second Intervention|Withdrawal by Subject|1
175240|NCT00494676|610872|P2|First Intervention|Withdrawal by Subject|3
175241|NCT00494676|610873|P1|First Intervention|Withdrawal by Subject|1
175242|NCT00494676|610872|P2|Allocation|Withdrawal by Subject|4
175243|NCT00494676|610873|P1|Allocation|Withdrawal by Subject|2
175244|NCT00494507|610888|P4|Open-Label Phase|Worsening Disease|2
175245|NCT00494507|610889|P3|Open-Label Phase|Worsening Disease|0
175246|NCT00494507|610890|P2|Open-Label Phase|Worsening Disease|0
175247|NCT00494507|610891|P1|Open-Label Phase|Worsening Disease|0
175248|NCT00494507|610888|P4|Open-Label Phase|Adverse Event|3
175249|NCT00494507|610889|P3|Open-Label Phase|Adverse Event|5
175250|NCT00494507|610890|P2|Open-Label Phase|Adverse Event|1
175251|NCT00494507|610891|P1|Open-Label Phase|Adverse Event|0
175252|NCT00494507|610888|P4|Double-Blind Phase|Negative DNA test|1
175253|NCT00494507|610889|P3|Double-Blind Phase|Negative DNA test|0
175254|NCT00494507|610890|P2|Double-Blind Phase|Negative DNA test|0
175255|NCT00494507|610891|P1|Double-Blind Phase|Negative DNA test|0
175256|NCT00494507|610888|P4|Double-Blind Phase|Subject Non-compliance|0
175257|NCT00494507|610889|P3|Double-Blind Phase|Subject Non-compliance|1
175258|NCT00494507|610890|P2|Double-Blind Phase|Subject Non-compliance|0
175259|NCT00494507|610891|P1|Double-Blind Phase|Subject Non-compliance|0
175260|NCT00494507|610888|P4|Double-Blind Phase|Withdrawal by Subject|0
175261|NCT00494507|610889|P3|Double-Blind Phase|Withdrawal by Subject|0
175262|NCT00494507|610890|P2|Double-Blind Phase|Withdrawal by Subject|0
175263|NCT00494507|610891|P1|Double-Blind Phase|Withdrawal by Subject|1
175264|NCT00494507|610888|P4|Double-Blind Phase|Adverse Event|0
175265|NCT00494507|610889|P3|Double-Blind Phase|Adverse Event|1
175266|NCT00494507|610890|P2|Double-Blind Phase|Adverse Event|0
175267|NCT00494507|610891|P1|Double-Blind Phase|Adverse Event|2
175268|NCT00494481|610958|P2|Overall Study|Never received IP|0
175269|NCT00494481|610959|P1|Overall Study|Never received IP|2
175270|NCT00494481|610958|P2|Overall Study|Other|0
175271|NCT00494481|610959|P1|Overall Study|Other|1
175272|NCT00494481|610958|P2|Overall Study|Adverse Event|11
175273|NCT00494481|610959|P1|Overall Study|Adverse Event|15
175274|NCT00494481|610958|P2|Overall Study|Condition under investigation worsened|13
175275|NCT00494481|610959|P1|Overall Study|Condition under investigation worsened|11
175276|NCT00494442|610967|P2|Overall Study|Intercurrent illness|1
175277|NCT00494442|610968|P1|Overall Study|Intercurrent illness|0
175278|NCT00494442|610967|P2|Overall Study|Non-compliance|1
175279|NCT00494442|610968|P1|Overall Study|Non-compliance|0
175280|NCT00494442|610967|P2|Overall Study|Physician Decision|1
175281|NCT00494442|610968|P1|Overall Study|Physician Decision|0
175282|NCT00494442|610967|P2|Overall Study|Adverse Event|2
175283|NCT00494442|610968|P1|Overall Study|Adverse Event|0
175284|NCT00494442|610967|P2|Overall Study|Lack of Efficacy|10
175285|NCT00494442|610968|P1|Overall Study|Lack of Efficacy|16
175286|NCT00494442|610967|P2|Overall Study|Death|1
175287|NCT00494442|610968|P1|Overall Study|Death|1
175288|NCT00494299|610984|P2|Overall Study|Protocol Driven Decision Point|22
175289|NCT00494299|610985|P1|Overall Study|Protocol Driven Decision Point|11
175290|NCT00494299|610984|P2|Overall Study|Site Closed by Sponsor|0
175291|NCT00494299|610985|P1|Overall Study|Site Closed by Sponsor|6
175292|NCT00494299|610984|P2|Overall Study|Participant Did Not Take Study Drug|2
175293|NCT00494299|610985|P1|Overall Study|Participant Did Not Take Study Drug|0
175294|NCT00494299|610984|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
175295|NCT00494299|610985|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
175296|NCT00494299|610984|P2|Overall Study|Withdrawal by Subject|3
175297|NCT00494299|610985|P1|Overall Study|Withdrawal by Subject|8
175298|NCT00494299|610984|P2|Overall Study|Protocol Violation|2
175299|NCT00494299|610985|P1|Overall Study|Protocol Violation|1
175300|NCT00494299|610984|P2|Overall Study|Physician Decision|2
175301|NCT00494299|610985|P1|Overall Study|Physician Decision|0
175302|NCT00494299|610984|P2|Overall Study|Lost to Follow-up|0
175303|NCT00494299|610985|P1|Overall Study|Lost to Follow-up|1
175304|NCT00494299|610984|P2|Overall Study|Adverse Event|13
175305|NCT00494299|610985|P1|Overall Study|Adverse Event|93
175306|NCT00494234|610997|P2|Overall Study|Death|1
175307|NCT00494234|610998|P1|Overall Study|Death|2
175308|NCT00494234|610997|P2|Overall Study|Withdrawal by Subject|0
175309|NCT00494234|610998|P1|Overall Study|Withdrawal by Subject|1
175310|NCT00494234|610997|P2|Overall Study|Lack of Efficacy|9
175311|NCT00494234|610998|P1|Overall Study|Lack of Efficacy|12
175312|NCT00494221|611017|P3|Overall Study|Withdrawal by Subject|0
175313|NCT00494221|611018|P2|Overall Study|Withdrawal by Subject|2
175314|NCT00494221|611019|P1|Overall Study|Withdrawal by Subject|1
175315|NCT00494221|611017|P3|Overall Study|Death|14
175316|NCT00494221|611018|P2|Overall Study|Death|9
175317|NCT00494221|611019|P1|Overall Study|Death|15
175318|NCT00494091|611060|P2|Overall Study|Withdrawal by Subject|7
175319|NCT00494091|611061|P1|Overall Study|Withdrawal by Subject|0
175320|NCT00494091|611060|P2|Overall Study|Not Specified|11
175321|NCT00494091|611061|P1|Overall Study|Not Specified|1
175322|NCT00494091|611060|P2|Overall Study|Lost to Follow-up|4
175323|NCT00494091|611061|P1|Overall Study|Lost to Follow-up|0
175324|NCT00494091|611060|P2|Overall Study|Death|54
175325|NCT00494091|611061|P1|Overall Study|Death|5
175326|NCT00494026|611083|P1|Overall Study|Sponsor Decision|4
175327|NCT00494013|611093|P2|Overall Study|Sponsor Decision|1
175328|NCT00494013|611094|P1|Overall Study|Sponsor Decision|0
175329|NCT00494013|611093|P2|Overall Study|Withdrawal by Subject|14
175330|NCT00494013|611094|P1|Overall Study|Withdrawal by Subject|13
175331|NCT00494013|611093|P2|Overall Study|Protocol Violation|5
175332|NCT00494013|611094|P1|Overall Study|Protocol Violation|8
175333|NCT00494013|611093|P2|Overall Study|Physician Decision|5
175334|NCT00494013|611094|P1|Overall Study|Physician Decision|3
175335|NCT00494013|611093|P2|Overall Study|Lost to Follow-up|6
175336|NCT00494013|611094|P1|Overall Study|Lost to Follow-up|5
175337|NCT00494013|611093|P2|Overall Study|Entry Criteria Not Met|4
175338|NCT00494013|611094|P1|Overall Study|Entry Criteria Not Met|1
175339|NCT00494013|611093|P2|Overall Study|Adverse Event|1
175340|NCT00494013|611094|P1|Overall Study|Adverse Event|0
175341|NCT00493974|611124|P2|Overall Study|Lost to Follow-up|6
175342|NCT00493974|611125|P1|Overall Study|Lost to Follow-up|4
175343|NCT00493974|611124|P2|Overall Study|Withdrawal by Subject|6
175344|NCT00493974|611125|P1|Overall Study|Withdrawal by Subject|8
175345|NCT00493974|611124|P2|Overall Study|Death|2
175346|NCT00493974|611125|P1|Overall Study|Death|1
175347|NCT00493779|611152|P1|Overall Study|Logistical issue at site|1
175348|NCT00493649|611159|P1|Overall Study|Other|13
175349|NCT00493649|611159|P1|Overall Study|Lost to Follow-up|1
175350|NCT00493649|611159|P1|Overall Study|Disease Progression|1
175351|NCT00493649|611159|P1|Overall Study|Investigator Request|2
175352|NCT00493649|611159|P1|Overall Study|Patient Request|21
175353|NCT00493649|611159|P1|Overall Study|Adverse Event|44
175354|NCT00493636|611172|P2|Overall Study|Mis-randomization|1
175355|NCT00493636|611173|P1|Overall Study|Mis-randomization|1
175356|NCT00493636|611172|P2|Overall Study|Disease progression/recurrence/relapse|1
175357|NCT00493636|611173|P1|Overall Study|Disease progression/recurrence/relapse|0
175358|NCT00493636|611172|P2|Overall Study|Withdrawal by Subject|0
175359|NCT00493636|611173|P1|Overall Study|Withdrawal by Subject|1
175360|NCT00493454|611187|P1|Overall Study|Withdrawal by Subject|1
175361|NCT00493311|611193|P2|Overall Study|Need for rescue medication|2
175362|NCT00493311|611194|P1|Overall Study|Need for rescue medication|2
175363|NCT00493285|611214|P6|Overall Study|Lost to Follow-up|0
175364|NCT00493285|611215|P5|Overall Study|Lost to Follow-up|1
175365|NCT00493285|611216|P4|Overall Study|Lost to Follow-up|0
175366|NCT00493285|611217|P3|Overall Study|Lost to Follow-up|0
175367|NCT00493285|611218|P2|Overall Study|Lost to Follow-up|0
175368|NCT00493285|611219|P1|Overall Study|Lost to Follow-up|0
175369|NCT00493246|611451|P8|Overall Study|Lost to Follow-up|0
175370|NCT00493246|611452|P7|Overall Study|Lost to Follow-up|1
175371|NCT00493246|611453|P6|Overall Study|Lost to Follow-up|0
175372|NCT00493246|611454|P5|Overall Study|Lost to Follow-up|0
175373|NCT00493246|611455|P4|Overall Study|Lost to Follow-up|0
175374|NCT00493246|611456|P3|Overall Study|Lost to Follow-up|0
175375|NCT00493246|611457|P2|Overall Study|Lost to Follow-up|0
175376|NCT00493246|611458|P1|Overall Study|Lost to Follow-up|0
175377|NCT00493246|611451|P8|Overall Study|No access to draw blood|0
175378|NCT00493246|611452|P7|Overall Study|No access to draw blood|0
175379|NCT00493246|611453|P6|Overall Study|No access to draw blood|1
175380|NCT00493246|611454|P5|Overall Study|No access to draw blood|0
175381|NCT00493246|611455|P4|Overall Study|No access to draw blood|0
175382|NCT00493246|611456|P3|Overall Study|No access to draw blood|0
175383|NCT00493246|611457|P2|Overall Study|No access to draw blood|0
175384|NCT00493246|611458|P1|Overall Study|No access to draw blood|0
175385|NCT00493246|611451|P8|Overall Study|Withdrawal by Subject|0
175386|NCT00493246|611452|P7|Overall Study|Withdrawal by Subject|0
175387|NCT00493246|611453|P6|Overall Study|Withdrawal by Subject|0
175388|NCT00493246|611454|P5|Overall Study|Withdrawal by Subject|1
175389|NCT00493246|611455|P4|Overall Study|Withdrawal by Subject|0
175390|NCT00493246|611456|P3|Overall Study|Withdrawal by Subject|0
175391|NCT00493246|611457|P2|Overall Study|Withdrawal by Subject|0
175392|NCT00493246|611458|P1|Overall Study|Withdrawal by Subject|0
175393|NCT00493220|611522|P6|Third Intervention|Withdrawal by Subject|0
175394|NCT00493220|611523|P5|Third Intervention|Withdrawal by Subject|0
175395|NCT00493220|611524|P4|Third Intervention|Withdrawal by Subject|0
175396|NCT00493220|611525|P3|Third Intervention|Withdrawal by Subject|0
175397|NCT00493220|611526|P2|Third Intervention|Withdrawal by Subject|0
175398|NCT00493220|611527|P1|Third Intervention|Withdrawal by Subject|1
175399|NCT00493038|611550|P2|Follow-up|Lost to Follow-up|0
175400|NCT00493038|611551|P1|Follow-up|Lost to Follow-up|1
175401|NCT00493038|611550|P2|Treatment|Other|1
175402|NCT00493038|611551|P1|Treatment|Other|0
175403|NCT00493038|611550|P2|Treatment|Withdrawal by Subject|12
175404|NCT00493038|611551|P1|Treatment|Withdrawal by Subject|11
175405|NCT00493038|611550|P2|Treatment|Lost to Follow-up|3
175406|NCT00493038|611551|P1|Treatment|Lost to Follow-up|5
175407|NCT00493038|611550|P2|Treatment|Adverse Event|4
175408|NCT00493038|611551|P1|Treatment|Adverse Event|8
175409|NCT00493012|611567|P2|Overall Study|Lost to Follow-up|17
175410|NCT00493012|611568|P1|Overall Study|Lost to Follow-up|18
175411|NCT00492856|611611|P4|Post-consolidation|Observation Arm|0
175412|NCT00492856|611612|P3|Post-consolidation|Observation Arm|27
175413|NCT00492856|611613|P2|Post-consolidation|Observation Arm|0
175414|NCT00492856|611614|P1|Post-consolidation|Observation Arm|0
175415|NCT00492856|611611|P4|Post-consolidation|Lost to Follow-up|0
175416|NCT00492856|611612|P3|Post-consolidation|Lost to Follow-up|0
175417|NCT00492856|611613|P2|Post-consolidation|Lost to Follow-up|2
175418|NCT00492856|611614|P1|Post-consolidation|Lost to Follow-up|0
175419|NCT00492856|611611|P4|Post-consolidation|Not protocol specified|0
175420|NCT00492856|611612|P3|Post-consolidation|Not protocol specified|0
175421|NCT00492856|611613|P2|Post-consolidation|Not protocol specified|1
175422|NCT00492856|611614|P1|Post-consolidation|Not protocol specified|0
175423|NCT00492856|611611|P4|Post-consolidation|Death|0
175424|NCT00492856|611612|P3|Post-consolidation|Death|0
175425|NCT00492856|611613|P2|Post-consolidation|Death|1
175426|NCT00492856|611614|P1|Post-consolidation|Death|0
175427|NCT00492856|611611|P4|Post-consolidation|Withdrawal by Subject|0
175428|NCT00492856|611612|P3|Post-consolidation|Withdrawal by Subject|0
175429|NCT00492856|611613|P2|Post-consolidation|Withdrawal by Subject|4
175430|NCT00492856|611614|P1|Post-consolidation|Withdrawal by Subject|0
175431|NCT00492856|611611|P4|Post-consolidation|Adverse Event|1
175432|NCT00492856|611612|P3|Post-consolidation|Adverse Event|0
175433|NCT00492856|611613|P2|Post-consolidation|Adverse Event|4
175434|NCT00492856|611614|P1|Post-consolidation|Adverse Event|0
175435|NCT00492856|611611|P4|Consolidation|Lost to Follow-up|0
175436|NCT00492856|611612|P3|Consolidation|Lost to Follow-up|0
175437|NCT00492856|611613|P2|Consolidation|Lost to Follow-up|0
175438|NCT00492856|611614|P1|Consolidation|Lost to Follow-up|1
175439|NCT00492856|611611|P4|Consolidation|Not protocol specified|0
175440|NCT00492856|611612|P3|Consolidation|Not protocol specified|0
175441|NCT00492856|611613|P2|Consolidation|Not protocol specified|0
175442|NCT00492856|611614|P1|Consolidation|Not protocol specified|2
175443|NCT00492856|611611|P4|Consolidation|Adverse Event|0
175444|NCT00492856|611612|P3|Consolidation|Adverse Event|0
175445|NCT00492856|611613|P2|Consolidation|Adverse Event|0
175446|NCT00492856|611614|P1|Consolidation|Adverse Event|6
175447|NCT00492856|611611|P4|Induction|Death|0
175448|NCT00492856|611612|P3|Induction|Death|0
175449|NCT00492856|611613|P2|Induction|Death|0
175450|NCT00492856|611614|P1|Induction|Death|3
175451|NCT00492856|611611|P4|Induction|Withdrawal by Subject|0
175452|NCT00492856|611612|P3|Induction|Withdrawal by Subject|0
175453|NCT00492856|611613|P2|Induction|Withdrawal by Subject|0
175454|NCT00492856|611614|P1|Induction|Withdrawal by Subject|1
175455|NCT00492856|611611|P4|Induction|Adverse Event|0
175456|NCT00492856|611612|P3|Induction|Adverse Event|0
175457|NCT00492856|611613|P2|Induction|Adverse Event|0
175458|NCT00492856|611614|P1|Induction|Adverse Event|2
175459|NCT00492752|611628|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
175460|NCT00492752|611629|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
175461|NCT00492752|611630|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
175462|NCT00492752|611631|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
175463|NCT00492752|611628|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
175464|NCT00492752|611629|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
175465|NCT00492752|611630|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
175466|NCT00492752|611631|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
175467|NCT00492752|611628|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
175468|NCT00492752|611629|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
175469|NCT00492752|611630|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
175470|NCT00492752|611631|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
175471|NCT00492752|611628|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
175472|NCT00492752|611629|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
175473|NCT00492752|611630|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
175474|NCT00492752|611631|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
175475|NCT00492752|611628|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
175476|NCT00492752|611629|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
175477|NCT00492752|611630|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
175478|NCT00492752|611631|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
175479|NCT00492752|611628|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
175480|NCT00492752|611629|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
175481|NCT00492752|611630|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
175482|NCT00492752|611631|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
175483|NCT00492752|611628|P4|Follow-up and/or Open Label Sorafenib|Death|1
175484|NCT00492752|611629|P3|Follow-up and/or Open Label Sorafenib|Death|45
175485|NCT00492752|611630|P2|Follow-up and/or Open Label Sorafenib|Death|5
175486|NCT00492752|611631|P1|Follow-up and/or Open Label Sorafenib|Death|75
175487|NCT00492752|611628|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
175488|NCT00492752|611629|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
175489|NCT00492752|611630|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
175490|NCT00492752|611631|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
175491|NCT00492752|611628|P4|Double Blind Treatment|Protocol Violation|0
175492|NCT00492752|611629|P3|Double Blind Treatment|Protocol Violation|1
175493|NCT00492752|611630|P2|Double Blind Treatment|Protocol Violation|0
175494|NCT00492752|611631|P1|Double Blind Treatment|Protocol Violation|0
175495|NCT00492752|611628|P4|Double Blind Treatment|Adverse Event|0
175496|NCT00492752|611629|P3|Double Blind Treatment|Adverse Event|0
175497|NCT00492752|611630|P2|Double Blind Treatment|Adverse Event|0
175498|NCT00492752|611631|P1|Double Blind Treatment|Adverse Event|1
175499|NCT00492752|611628|P4|Double Blind Treatment|Death|0
175500|NCT00492752|611629|P3|Double Blind Treatment|Death|2
175501|NCT00492752|611630|P2|Double Blind Treatment|Death|0
175502|NCT00492752|611631|P1|Double Blind Treatment|Death|13
175503|NCT00492726|611666|P2|Overall Study|Non compliant with study medication|3
175504|NCT00492726|611667|P1|Overall Study|Non compliant with study medication|0
175505|NCT00492726|611666|P2|Overall Study|Withdrawal by Subject|3
175506|NCT00492726|611667|P1|Overall Study|Withdrawal by Subject|6
175507|NCT00492726|611666|P2|Overall Study|Physician Decision|1
175508|NCT00492726|611667|P1|Overall Study|Physician Decision|0
175509|NCT00492726|611666|P2|Overall Study|Lost to Follow-up|19
175510|NCT00492726|611667|P1|Overall Study|Lost to Follow-up|27
175511|NCT00492726|611666|P2|Overall Study|Lack of Efficacy|2
175512|NCT00492726|611667|P1|Overall Study|Lack of Efficacy|0
175513|NCT00492726|611666|P2|Overall Study|Death|2
175514|NCT00492726|611667|P1|Overall Study|Death|7
175515|NCT00492726|611666|P2|Overall Study|Adverse Event|6
175516|NCT00492726|611667|P1|Overall Study|Adverse Event|10
175517|NCT00492557|611712|P2|Overall Study|Lost to Follow-up|1
175518|NCT00492557|611713|P1|Overall Study|Lost to Follow-up|0
175519|NCT00492557|611712|P2|Overall Study|Failed to return|0
175520|NCT00492557|611713|P1|Overall Study|Failed to return|1
175521|NCT00492557|611712|P2|Overall Study|Adverse Event|0
175522|NCT00492557|611713|P1|Overall Study|Adverse Event|1
175523|NCT00492557|611712|P2|Overall Study|Death|1
175524|NCT00492557|611713|P1|Overall Study|Death|1
175525|NCT00492557|611712|P2|Overall Study|Other|2
175526|NCT00492557|611713|P1|Overall Study|Other|2
175527|NCT00492557|611712|P2|Overall Study|Protocol Violation|8
175528|NCT00492557|611713|P1|Overall Study|Protocol Violation|7
175529|NCT00492557|611712|P2|Overall Study|Subject request|11
175530|NCT00492557|611713|P1|Overall Study|Subject request|12
175531|NCT00492531|611743|P2|Overall Study|Withdrawn(More than one reason selected)|23
175532|NCT00492531|611744|P1|Overall Study|Withdrawn(More than one reason selected)|22
175533|NCT00492297|611817|P1|Survival Only Follow-up|Study terminated by sponsor|12
175534|NCT00492297|611817|P1|Survival Only Follow-up|Lack of Efficacy|1
175535|NCT00492297|611817|P1|Survival Only Follow-up|Death|46
175536|NCT00492297|611817|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
175537|NCT00492297|611817|P1|Active Follow-up 30(+4) Days Duration|Death|17
175538|NCT00492297|611817|P1|Treatment|Study terminated by sponsor|3
175539|NCT00492297|611817|P1|Treatment|Death|2
175540|NCT00492284|611835|P4|Overall Study|Withdrawal by Subject|2
175541|NCT00492284|611836|P3|Overall Study|Withdrawal by Subject|0
175542|NCT00492284|611837|P2|Overall Study|Withdrawal by Subject|0
175543|NCT00492284|611838|P1|Overall Study|Withdrawal by Subject|1
175544|NCT00492284|611835|P4|Overall Study|Death|5
175545|NCT00492284|611836|P3|Overall Study|Death|2
175546|NCT00492284|611837|P2|Overall Study|Death|3
175547|NCT00492284|611838|P1|Overall Study|Death|0
175548|NCT00492284|611835|P4|Overall Study|Lost to Follow-up|1
175549|NCT00492284|611836|P3|Overall Study|Lost to Follow-up|3
175550|NCT00492284|611837|P2|Overall Study|Lost to Follow-up|0
175551|NCT00492284|611838|P1|Overall Study|Lost to Follow-up|0
175552|NCT00492284|611835|P4|Overall Study|Adverse Event|2
175553|NCT00492284|611836|P3|Overall Study|Adverse Event|1
175554|NCT00492284|611837|P2|Overall Study|Adverse Event|1
175555|NCT00492284|611838|P1|Overall Study|Adverse Event|0
175556|NCT00492232|611882|P2|Open-Label Treatment|Withdrawal by Subject|0
175557|NCT00492232|611883|P1|Open-Label Treatment|Withdrawal by Subject|1
175558|NCT00492232|611882|P2|Double-Blind Treatment|Randomized not treated|0
175559|NCT00492232|611883|P1|Double-Blind Treatment|Randomized not treated|1
175560|NCT00492232|611882|P2|Double-Blind Treatment|Other|5
175561|NCT00492232|611883|P1|Double-Blind Treatment|Other|6
175562|NCT00492232|611882|P2|Double-Blind Treatment|Lack of Efficacy|0
175563|NCT00492232|611883|P1|Double-Blind Treatment|Lack of Efficacy|1
175564|NCT00492232|611882|P2|Double-Blind Treatment|Withdrawal by Subject|8
175565|NCT00492232|611883|P1|Double-Blind Treatment|Withdrawal by Subject|4
175566|NCT00492232|611882|P2|Double-Blind Treatment|Lost to Follow-up|3
175567|NCT00492232|611883|P1|Double-Blind Treatment|Lost to Follow-up|2
175568|NCT00492232|611882|P2|Double-Blind Treatment|Protocol Violation|7
175569|NCT00492232|611883|P1|Double-Blind Treatment|Protocol Violation|3
175570|NCT00492232|611882|P2|Double-Blind Treatment|Adverse Event|2
175571|NCT00492232|611883|P1|Double-Blind Treatment|Adverse Event|1
175572|NCT00492232|611882|P2|Placebo Run-in|Missing|2
175573|NCT00492232|611883|P1|Placebo Run-in|Missing|0
175574|NCT00492232|611882|P2|Placebo Run-in|Other|6
175575|NCT00492232|611883|P1|Placebo Run-in|Other|0
175576|NCT00492232|611882|P2|Placebo Run-in|Entrance criteria not met|45
175577|NCT00492232|611883|P1|Placebo Run-in|Entrance criteria not met|0
175578|NCT00492232|611882|P2|Placebo Run-in|Pregnancy|1
175579|NCT00492232|611883|P1|Placebo Run-in|Pregnancy|0
175580|NCT00492232|611882|P2|Placebo Run-in|Withdrawal by Subject|8
175581|NCT00492232|611883|P1|Placebo Run-in|Withdrawal by Subject|0
175582|NCT00492232|611882|P2|Placebo Run-in|Lost to Follow-up|3
175583|NCT00492232|611883|P1|Placebo Run-in|Lost to Follow-up|0
175584|NCT00492232|611882|P2|Placebo Run-in|Protocol Violation|3
175585|NCT00492232|611883|P1|Placebo Run-in|Protocol Violation|0
175586|NCT00492232|611882|P2|Placebo Run-in|Adverse Event|2
175587|NCT00492232|611883|P1|Placebo Run-in|Adverse Event|0
175588|NCT00492063|611935|P4|Overall Study|Protocol Violation|1
175589|NCT00492063|611936|P3|Overall Study|Protocol Violation|0
175590|NCT00492063|611937|P2|Overall Study|Protocol Violation|0
175591|NCT00492063|611938|P1|Overall Study|Protocol Violation|0
175592|NCT00492063|611935|P4|Overall Study|Lost to Follow-up|3
175593|NCT00492063|611936|P3|Overall Study|Lost to Follow-up|5
175594|NCT00492063|611937|P2|Overall Study|Lost to Follow-up|11
175595|NCT00492063|611938|P1|Overall Study|Lost to Follow-up|6
175596|NCT00492063|611935|P4|Overall Study|Withdrawal by Subject|4
175597|NCT00492063|611936|P3|Overall Study|Withdrawal by Subject|5
175598|NCT00492063|611937|P2|Overall Study|Withdrawal by Subject|3
175599|NCT00492063|611938|P1|Overall Study|Withdrawal by Subject|4
175600|NCT00492063|611935|P4|Overall Study|Death|2
175601|NCT00492063|611936|P3|Overall Study|Death|1
175602|NCT00492063|611937|P2|Overall Study|Death|0
175603|NCT00492063|611938|P1|Overall Study|Death|0
175604|NCT00492024|611962|P2|Follow up|Lost to Follow-up|1
175605|NCT00492024|611963|P1|Follow up|Lost to Follow-up|1
175606|NCT00492024|611962|P2|Follow up|Lack of Efficacy|1
175607|NCT00492024|611963|P1|Follow up|Lack of Efficacy|0
175608|NCT00492024|611962|P2|Treatment|Withdrawal by Subject|0
175609|NCT00492024|611963|P1|Treatment|Withdrawal by Subject|2
175610|NCT00492024|611962|P2|Treatment|Lost to Follow-up|1
175611|NCT00492024|611963|P1|Treatment|Lost to Follow-up|3
175612|NCT00492024|611962|P2|Treatment|Lack of Efficacy|20
175613|NCT00492024|611963|P1|Treatment|Lack of Efficacy|21
175614|NCT00492024|611962|P2|Treatment|Adverse Event|1
175615|NCT00492024|611963|P1|Treatment|Adverse Event|3
175616|NCT00491894|611979|P1|Overall Study|Other-Intake of prohibited medication|1
175617|NCT00491894|611979|P1|Overall Study|Protocol Violation|2
175618|NCT00491894|611979|P1|Overall Study|Physician Decision|2
175619|NCT00491894|611979|P1|Overall Study|Other-Failed to meet any criteria|2
175620|NCT00491894|611979|P1|Overall Study|Lack of Efficacy|2
175621|NCT00491894|611979|P1|Overall Study|Lost to Follow-up|3
175622|NCT00491894|611979|P1|Overall Study|Death|3
175623|NCT00491894|611979|P1|Overall Study|Withdrawal by Subject|5
175624|NCT00491894|611979|P1|Overall Study|Adverse Event|14
175625|NCT00491764|612006|P6|Overall Study|Administrative|0
175626|NCT00491764|612007|P5|Overall Study|Administrative|0
175627|NCT00491764|612008|P4|Overall Study|Administrative|1
175628|NCT00491764|612009|P3|Overall Study|Administrative|2
175629|NCT00491764|612010|P2|Overall Study|Administrative|0
175630|NCT00491764|612011|P1|Overall Study|Administrative|1
175631|NCT00491764|612006|P6|Overall Study|Did not Meet Protocol Eligibility|1
175632|NCT00491764|612007|P5|Overall Study|Did not Meet Protocol Eligibility|1
175633|NCT00491764|612008|P4|Overall Study|Did not Meet Protocol Eligibility|0
175634|NCT00491764|612009|P3|Overall Study|Did not Meet Protocol Eligibility|1
175635|NCT00491764|612010|P2|Overall Study|Did not Meet Protocol Eligibility|1
175636|NCT00491764|612011|P1|Overall Study|Did not Meet Protocol Eligibility|0
175637|NCT00491764|612006|P6|Overall Study|Non Compliance with the Protocol|0
175638|NCT00491764|612007|P5|Overall Study|Non Compliance with the Protocol|0
175639|NCT00491764|612008|P4|Overall Study|Non Compliance with the Protocol|0
175640|NCT00491764|612009|P3|Overall Study|Non Compliance with the Protocol|0
175641|NCT00491764|612010|P2|Overall Study|Non Compliance with the Protocol|0
175642|NCT00491764|612011|P1|Overall Study|Non Compliance with the Protocol|1
175643|NCT00491764|612006|P6|Overall Study|Withdrawal by Subject|4
175644|NCT00491764|612007|P5|Overall Study|Withdrawal by Subject|2
175645|NCT00491764|612008|P4|Overall Study|Withdrawal by Subject|2
175646|NCT00491764|612009|P3|Overall Study|Withdrawal by Subject|1
175647|NCT00491764|612010|P2|Overall Study|Withdrawal by Subject|3
175648|NCT00491764|612011|P1|Overall Study|Withdrawal by Subject|2
175649|NCT00491764|612006|P6|Overall Study|Lost to Follow-up|3
175650|NCT00491764|612007|P5|Overall Study|Lost to Follow-up|0
175651|NCT00491764|612008|P4|Overall Study|Lost to Follow-up|1
175652|NCT00491764|612009|P3|Overall Study|Lost to Follow-up|0
175653|NCT00491764|612010|P2|Overall Study|Lost to Follow-up|1
175654|NCT00491764|612011|P1|Overall Study|Lost to Follow-up|0
175655|NCT00491764|612006|P6|Overall Study|Adverse Event|1
175656|NCT00491764|612007|P5|Overall Study|Adverse Event|0
175657|NCT00491764|612008|P4|Overall Study|Adverse Event|4
175658|NCT00491764|612009|P3|Overall Study|Adverse Event|4
175659|NCT00491764|612010|P2|Overall Study|Adverse Event|2
175660|NCT00491764|612011|P1|Overall Study|Adverse Event|1
175661|NCT00491608|612044|P1|Overall Study|Withdrawal by Subject|1
175662|NCT00491608|612044|P1|Overall Study|Death|2
175663|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
175664|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
175665|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
175666|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
175667|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
175668|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
175669|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
175670|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
175671|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
175672|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
175673|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
175674|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
175675|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
175676|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
175677|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
175678|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
175679|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
175680|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
175681|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
175682|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
175683|NCT00491556|612055|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
175684|NCT00491556|612056|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
175685|NCT00491556|612055|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
175686|NCT00491556|612056|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
175687|NCT00491556|612055|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
175688|NCT00491556|612056|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
175689|NCT00491556|612055|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
175690|NCT00491556|612056|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
175691|NCT00491556|612055|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
175692|NCT00491556|612056|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
175693|NCT00491556|612055|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
175694|NCT00491556|612056|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
175695|NCT00491556|612055|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
175696|NCT00491556|612056|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
175697|NCT00491556|612055|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
175698|NCT00491556|612056|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
175699|NCT00491556|612055|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
175700|NCT00491556|612056|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
175701|NCT00491556|612055|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
175702|NCT00491556|612056|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
175703|NCT00491530|612115|P3|Overall Study|Use of Prohibited Medication|1
175704|NCT00491530|612116|P2|Overall Study|Use of Prohibited Medication|0
175705|NCT00491530|612117|P1|Overall Study|Use of Prohibited Medication|0
175706|NCT00491530|612115|P3|Overall Study|Patient Request|0
175707|NCT00491530|612116|P2|Overall Study|Patient Request|1
175708|NCT00491530|612117|P1|Overall Study|Patient Request|0
175709|NCT00491530|612115|P3|Overall Study|Investigator Discretion|0
175710|NCT00491530|612116|P2|Overall Study|Investigator Discretion|1
175711|NCT00491530|612117|P1|Overall Study|Investigator Discretion|0
175712|NCT00491530|612115|P3|Overall Study|Lack of Efficacy|0
175713|NCT00491530|612116|P2|Overall Study|Lack of Efficacy|1
175714|NCT00491530|612117|P1|Overall Study|Lack of Efficacy|0
175715|NCT00491530|612115|P3|Overall Study|Lost to Follow-up|2
175716|NCT00491530|612116|P2|Overall Study|Lost to Follow-up|2
175717|NCT00491530|612117|P1|Overall Study|Lost to Follow-up|3
175718|NCT00491530|612115|P3|Overall Study|Withdrawal by Subject|0
175719|NCT00491530|612116|P2|Overall Study|Withdrawal by Subject|0
175720|NCT00491530|612117|P1|Overall Study|Withdrawal by Subject|3
175721|NCT00491530|612115|P3|Overall Study|Adverse Event|2
175722|NCT00491530|612116|P2|Overall Study|Adverse Event|1
175723|NCT00491530|612117|P1|Overall Study|Adverse Event|6
175724|NCT00491504|612147|P4|Overall Study|Protocol Violation|2
175725|NCT00491504|612148|P3|Overall Study|Protocol Violation|3
175726|NCT00491504|612149|P2|Overall Study|Protocol Violation|0
175727|NCT00491504|612150|P1|Overall Study|Protocol Violation|0
175728|NCT00491504|612147|P4|Overall Study|Withdrawal by Subject|2
175729|NCT00491504|612148|P3|Overall Study|Withdrawal by Subject|1
175730|NCT00491504|612149|P2|Overall Study|Withdrawal by Subject|0
175731|NCT00491504|612150|P1|Overall Study|Withdrawal by Subject|0
175732|NCT00491504|612147|P4|Overall Study|Adverse Event|0
175733|NCT00491504|612148|P3|Overall Study|Adverse Event|0
175734|NCT00491504|612149|P2|Overall Study|Adverse Event|1
175735|NCT00491504|612150|P1|Overall Study|Adverse Event|0
175736|NCT00491400|612160|P2|Overall Study|Withdrawal by Subject|4
175737|NCT00491400|612161|P1|Overall Study|Withdrawal by Subject|5
175738|NCT00491387|612169|P1|Overall Study|study terminated|20
175739|NCT00491322|612184|P2|Overall Study|Pregnancy|1
175740|NCT00491322|612185|P1|Overall Study|Pregnancy|0
175741|NCT00491322|612184|P2|Overall Study|Protocol Violation|0
175742|NCT00491322|612185|P1|Overall Study|Protocol Violation|1
175743|NCT00491179|612204|P2|Overall Study|Withdrawal by Subject|1
175744|NCT00491179|612205|P1|Overall Study|Withdrawal by Subject|2
175745|NCT00491179|612204|P2|Overall Study|Adverse Event|1
175746|NCT00491179|612205|P1|Overall Study|Adverse Event|5
175747|NCT00491075|612213|P1|Overall Study|Physician Decision|1
175748|NCT00491075|612213|P1|Overall Study|Withdrawal by Subject|1
175749|NCT00490971|612219|P5|Maintenance|Not specified|3
175750|NCT00490971|612220|P4|Maintenance|Not specified|9
175751|NCT00490971|612221|P3|Maintenance|Not specified|11
175752|NCT00490971|612222|P2|Maintenance|Not specified|0
175753|NCT00490971|612223|P1|Maintenance|Not specified|0
175754|NCT00490971|612219|P5|Maintenance|Withdrawal by Subject|18
175755|NCT00490971|612220|P4|Maintenance|Withdrawal by Subject|28
175756|NCT00490971|612221|P3|Maintenance|Withdrawal by Subject|26
175757|NCT00490971|612222|P2|Maintenance|Withdrawal by Subject|0
175758|NCT00490971|612223|P1|Maintenance|Withdrawal by Subject|0
175759|NCT00490971|612219|P5|Maintenance|Protocol Violation|1
175760|NCT00490971|612220|P4|Maintenance|Protocol Violation|1
175761|NCT00490971|612221|P3|Maintenance|Protocol Violation|4
175762|NCT00490971|612222|P2|Maintenance|Protocol Violation|0
175763|NCT00490971|612223|P1|Maintenance|Protocol Violation|0
175764|NCT00490971|612219|P5|Maintenance|Pregnancy|0
175765|NCT00490971|612220|P4|Maintenance|Pregnancy|0
175766|NCT00490971|612221|P3|Maintenance|Pregnancy|1
175767|NCT00490971|612222|P2|Maintenance|Pregnancy|0
175768|NCT00490971|612223|P1|Maintenance|Pregnancy|0
175769|NCT00490971|612219|P5|Maintenance|Lost to Follow-up|10
175770|NCT00490971|612220|P4|Maintenance|Lost to Follow-up|8
175771|NCT00490971|612221|P3|Maintenance|Lost to Follow-up|5
175772|NCT00490971|612222|P2|Maintenance|Lost to Follow-up|0
175773|NCT00490971|612223|P1|Maintenance|Lost to Follow-up|0
175774|NCT00490971|612219|P5|Maintenance|Death|0
175775|NCT00490971|612220|P4|Maintenance|Death|2
175776|NCT00490971|612221|P3|Maintenance|Death|0
175777|NCT00490971|612222|P2|Maintenance|Death|0
175778|NCT00490971|612223|P1|Maintenance|Death|0
175779|NCT00490971|612219|P5|Maintenance|Adverse Event|7
175780|NCT00490971|612220|P4|Maintenance|Adverse Event|5
175781|NCT00490971|612221|P3|Maintenance|Adverse Event|4
175782|NCT00490971|612222|P2|Maintenance|Adverse Event|0
175783|NCT00490971|612223|P1|Maintenance|Adverse Event|0
175784|NCT00490971|612219|P5|Acute/Continuation|Not specified|0
175785|NCT00490971|612220|P4|Acute/Continuation|Not specified|0
175786|NCT00490971|612221|P3|Acute/Continuation|Not specified|0
175787|NCT00490971|612222|P2|Acute/Continuation|Not specified|4
175788|NCT00490971|612223|P1|Acute/Continuation|Not specified|11
175789|NCT00490971|612219|P5|Acute/Continuation|Withdrawal by Subject|0
175790|NCT00490971|612220|P4|Acute/Continuation|Withdrawal by Subject|0
175791|NCT00490971|612221|P3|Acute/Continuation|Withdrawal by Subject|0
175792|NCT00490971|612222|P2|Acute/Continuation|Withdrawal by Subject|24
175793|NCT00490971|612223|P1|Acute/Continuation|Withdrawal by Subject|92
175794|NCT00490971|612219|P5|Acute/Continuation|Protocol Violation|0
175795|NCT00490971|612220|P4|Acute/Continuation|Protocol Violation|0
175796|NCT00490971|612221|P3|Acute/Continuation|Protocol Violation|0
175797|NCT00490971|612222|P2|Acute/Continuation|Protocol Violation|2
175798|NCT00490971|612223|P1|Acute/Continuation|Protocol Violation|10
175799|NCT00490971|612219|P5|Acute/Continuation|Lost to Follow-up|0
175800|NCT00490971|612220|P4|Acute/Continuation|Lost to Follow-up|0
175801|NCT00490971|612221|P3|Acute/Continuation|Lost to Follow-up|0
175802|NCT00490971|612222|P2|Acute/Continuation|Lost to Follow-up|7
175803|NCT00490971|612223|P1|Acute/Continuation|Lost to Follow-up|23
175804|NCT00490971|612219|P5|Acute/Continuation|Lack of Efficacy|0
175805|NCT00490971|612220|P4|Acute/Continuation|Lack of Efficacy|0
175806|NCT00490971|612221|P3|Acute/Continuation|Lack of Efficacy|0
175807|NCT00490971|612222|P2|Acute/Continuation|Lack of Efficacy|12
175808|NCT00490971|612223|P1|Acute/Continuation|Lack of Efficacy|106
175809|NCT00490971|612219|P5|Acute/Continuation|Death|0
175810|NCT00490971|612220|P4|Acute/Continuation|Death|0
175811|NCT00490971|612221|P3|Acute/Continuation|Death|0
175812|NCT00490971|612222|P2|Acute/Continuation|Death|0
175813|NCT00490971|612223|P1|Acute/Continuation|Death|2
175814|NCT00490971|612219|P5|Acute/Continuation|Adverse Event|0
175815|NCT00490971|612220|P4|Acute/Continuation|Adverse Event|0
175816|NCT00490971|612221|P3|Acute/Continuation|Adverse Event|0
175817|NCT00490971|612222|P2|Acute/Continuation|Adverse Event|13
175818|NCT00490971|612223|P1|Acute/Continuation|Adverse Event|62
175819|NCT00490945|612270|P5|Overall Study|Adverse Event|0
175820|NCT00490945|612271|P4|Overall Study|Adverse Event|0
175821|NCT00490945|612272|P3|Overall Study|Adverse Event|0
175822|NCT00490945|612273|P2|Overall Study|Adverse Event|1
175823|NCT00490945|612274|P1|Overall Study|Adverse Event|0
175824|NCT00490919|612310|P3|Double-blind Phase|Administrative|6
175825|NCT00490919|612311|P2|Double-blind Phase|Administrative|6
175826|NCT00490919|612312|P1|Double-blind Phase|Administrative|0
175827|NCT00490919|612310|P3|Double-blind Phase|Lack of Efficacy|36
175828|NCT00490919|612311|P2|Double-blind Phase|Lack of Efficacy|22
175829|NCT00490919|612312|P1|Double-blind Phase|Lack of Efficacy|0
175830|NCT00490919|612310|P3|Double-blind Phase|Lost to Follow-up|11
175831|NCT00490919|612311|P2|Double-blind Phase|Lost to Follow-up|8
175832|NCT00490919|612312|P1|Double-blind Phase|Lost to Follow-up|0
175833|NCT00490919|612310|P3|Double-blind Phase|Withdrawal by Subject|11
175834|NCT00490919|612311|P2|Double-blind Phase|Withdrawal by Subject|10
175835|NCT00490919|612312|P1|Double-blind Phase|Withdrawal by Subject|0
175836|NCT00490919|612310|P3|Double-blind Phase|Adverse Event|20
175837|NCT00490919|612311|P2|Double-blind Phase|Adverse Event|40
175838|NCT00490919|612312|P1|Double-blind Phase|Adverse Event|0
175839|NCT00490919|612310|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
175840|NCT00490919|612311|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
175841|NCT00490919|612312|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
175842|NCT00490919|612310|P3|Open-label Run-in Period|Administrative|0
175843|NCT00490919|612311|P2|Open-label Run-in Period|Administrative|0
175844|NCT00490919|612312|P1|Open-label Run-in Period|Administrative|40
175845|NCT00490919|612310|P3|Open-label Run-in Period|Lack of Efficacy|0
175846|NCT00490919|612311|P2|Open-label Run-in Period|Lack of Efficacy|0
175847|NCT00490919|612312|P1|Open-label Run-in Period|Lack of Efficacy|143
175848|NCT00490919|612310|P3|Open-label Run-in Period|Lost to Follow-up|0
175849|NCT00490919|612311|P2|Open-label Run-in Period|Lost to Follow-up|0
175850|NCT00490919|612312|P1|Open-label Run-in Period|Lost to Follow-up|21
175851|NCT00490919|612310|P3|Open-label Run-in Period|Withdrawal by Subject|0
175852|NCT00490919|612311|P2|Open-label Run-in Period|Withdrawal by Subject|0
175853|NCT00490919|612312|P1|Open-label Run-in Period|Withdrawal by Subject|37
175854|NCT00490919|612310|P3|Open-label Run-in Period|Adverse Event|0
175855|NCT00490919|612311|P2|Open-label Run-in Period|Adverse Event|0
175856|NCT00490919|612312|P1|Open-label Run-in Period|Adverse Event|239
175857|NCT00490841|612323|P1|Overall Study|30 day f/u, only non-study stent used|3
175858|NCT00490841|612323|P1|Overall Study|Lost to Follow-up|1
175859|NCT00490841|612323|P1|Overall Study|Withdrawal by Subject|4
175860|NCT00490841|612323|P1|Overall Study|Death|5
175861|NCT00490815|612345|P2|Overall Study|Death|3
175862|NCT00490815|612346|P1|Overall Study|Death|1
175863|NCT00490815|612345|P2|Overall Study|Lost to Follow-up|3
175864|NCT00490815|612346|P1|Overall Study|Lost to Follow-up|1
175865|NCT00490815|612345|P2|Overall Study|Withdrawal by Subject|0
175866|NCT00490815|612346|P1|Overall Study|Withdrawal by Subject|4
175867|NCT00490815|612345|P2|Overall Study|Adverse Event|3
175868|NCT00490815|612346|P1|Overall Study|Adverse Event|2
175869|NCT00490724|612374|P3|Period II|Treatment Discontinuation|3
175870|NCT00490724|612375|P2|Period II|Treatment Discontinuation|1
175871|NCT00490724|612376|P1|Period II|Treatment Discontinuation|3
175872|NCT00490724|612374|P3|Period I|Physician Decision|1
175873|NCT00490724|612375|P2|Period I|Physician Decision|0
175874|NCT00490724|612376|P1|Period I|Physician Decision|0
175875|NCT00490698|612441|P1|Overall Study|Physician Decision|2
175876|NCT00490698|612441|P1|Overall Study|Disease Progression|7
175877|NCT00490698|612441|P1|Overall Study|Withdrawal by Subject|1
175878|NCT00490646|612447|P2|Overall Study|Never Treated (withdrew consent)|1
175879|NCT00490646|612448|P1|Overall Study|Never Treated (withdrew consent)|0
175880|NCT00490646|612447|P2|Overall Study|Never Treated (had an adverse event)|0
175881|NCT00490646|612448|P1|Overall Study|Never Treated (had an adverse event)|1
175882|NCT00490646|612447|P2|Overall Study|Still on trastuzumab monotherapy|1
175883|NCT00490646|612448|P1|Overall Study|Still on trastuzumab monotherapy|1
175884|NCT00490568|612468|P1|Overall Study|Participant withdrawal due to surgery|1
175885|NCT00490568|612468|P1|Overall Study|Participant died|1
175886|NCT00490568|612468|P1|Overall Study|Efficacy related|3
175887|NCT00490568|612468|P1|Overall Study|Non-Compliance|7
175888|NCT00490568|612468|P1|Overall Study|Investigator decision|3
175889|NCT00490568|612468|P1|Overall Study|Unmet inclusion-exclusion criteria|5
175890|NCT00490568|612468|P1|Overall Study|Disease progression|4
175891|NCT00490568|612468|P1|Overall Study|Legal representative withdrew consent|1
175892|NCT00490568|612468|P1|Overall Study|Participant refused follow-up|9
175893|NCT00490568|612468|P1|Overall Study|Abnormal ECG|25
175894|NCT00490568|612468|P1|Overall Study|Caregiver related|20
175895|NCT00490568|612468|P1|Overall Study|Exclusion criteria met|1
175896|NCT00490568|612468|P1|Overall Study|Other|1
175897|NCT00490568|612468|P1|Overall Study|Still in the study at termination|974
175898|NCT00490568|612468|P1|Overall Study|Withdrawal by Subject|135
175899|NCT00490568|612468|P1|Overall Study|Protocol Violation|45
175900|NCT00490568|612468|P1|Overall Study|Lost to Follow-up|13
175901|NCT00490568|612468|P1|Overall Study|Adverse Event|116
175902|NCT00490555|612492|P4|Overall Study|noncompliant with drug administration|0
175903|NCT00490555|612493|P3|Overall Study|noncompliant with drug administration|2
175904|NCT00490555|612494|P2|Overall Study|noncompliant with drug administration|0
175905|NCT00490555|612495|P1|Overall Study|noncompliant with drug administration|0
175906|NCT00490542|612523|P2|Overall Study|Lack of Efficacy|1
175907|NCT00490542|612524|P1|Overall Study|Lack of Efficacy|1
175908|NCT00490542|612523|P2|Overall Study|Adverse Event|3
175909|NCT00490542|612524|P1|Overall Study|Adverse Event|3
175910|NCT00490542|612523|P2|Overall Study|Lost to Follow-up|0
175911|NCT00490542|612524|P1|Overall Study|Lost to Follow-up|3
175912|NCT00490490|612530|P1|Completed Assessment for TTP|Lost to Follow-up|2
175913|NCT00490490|612530|P1|Completed Assessment for TTP|Withdrawal by Subject|1
175914|NCT00490451|612547|P2|Overall Study|Progressive Disease|34
175915|NCT00490451|612548|P1|Overall Study|Progressive Disease|53
175916|NCT00490451|612547|P2|Overall Study|Protocol Violation|0
175917|NCT00490451|612548|P1|Overall Study|Protocol Violation|1
175918|NCT00490451|612547|P2|Overall Study|Investigator Decision|0
175919|NCT00490451|612548|P1|Overall Study|Investigator Decision|1
175920|NCT00490451|612547|P2|Overall Study|Withdrawal by Subject|0
175921|NCT00490451|612548|P1|Overall Study|Withdrawal by Subject|2
175922|NCT00490451|612547|P2|Overall Study|Death|1
175923|NCT00490451|612548|P1|Overall Study|Death|3
175924|NCT00490451|612547|P2|Overall Study|Adverse Event|3
175925|NCT00490451|612548|P1|Overall Study|Adverse Event|3
175926|NCT00490139|612590|P4|Overall Study|Participant Withdrew Consent|116
175927|NCT00490139|612591|P3|Overall Study|Participant Withdrew Consent|208
175928|NCT00490139|612592|P2|Overall Study|Participant Withdrew Consent|110
175929|NCT00490139|612593|P1|Overall Study|Participant Withdrew Consent|146
175930|NCT00490139|612590|P4|Overall Study|Lost to Follow-up|56
175931|NCT00490139|612591|P3|Overall Study|Lost to Follow-up|58
175932|NCT00490139|612592|P2|Overall Study|Lost to Follow-up|46
175933|NCT00490139|612593|P1|Overall Study|Lost to Follow-up|56
175934|NCT00490139|612590|P4|Overall Study|Death|135
175935|NCT00490139|612591|P3|Overall Study|Death|168
175936|NCT00490139|612592|P2|Overall Study|Death|119
175937|NCT00490139|612593|P1|Overall Study|Death|106
175938|NCT00490061|612628|P1|Overall Study|Physician Decision|1
175939|NCT00490035|612637|P4|Overall Study|AE of unknown type|0
175940|NCT00490035|612638|P3|Overall Study|AE of unknown type|2
175941|NCT00490035|612639|P2|Overall Study|AE of unknown type|0
175942|NCT00490035|612640|P1|Overall Study|AE of unknown type|0
175943|NCT00490035|612637|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
175944|NCT00490035|612638|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
175945|NCT00490035|612639|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
175946|NCT00490035|612640|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
175947|NCT00490035|612637|P4|Overall Study|AE, serious fatal|0
175948|NCT00490035|612638|P3|Overall Study|AE, serious fatal|0
175949|NCT00490035|612639|P2|Overall Study|AE, serious fatal|0
175950|NCT00490035|612640|P1|Overall Study|AE, serious fatal|1
175951|NCT00490035|612637|P4|Overall Study|Other reason|1
175952|NCT00490035|612638|P3|Overall Study|Other reason|3
175953|NCT00490035|612639|P2|Overall Study|Other reason|1
175954|NCT00490035|612640|P1|Overall Study|Other reason|0
175955|NCT00490035|612637|P4|Overall Study|Withdrawal by Subject|0
175956|NCT00490035|612638|P3|Overall Study|Withdrawal by Subject|1
175957|NCT00490035|612639|P2|Overall Study|Withdrawal by Subject|1
175958|NCT00490035|612640|P1|Overall Study|Withdrawal by Subject|2
175959|NCT00490035|612637|P4|Overall Study|Lost to Follow-up|0
175960|NCT00490035|612638|P3|Overall Study|Lost to Follow-up|1
175961|NCT00490035|612639|P2|Overall Study|Lost to Follow-up|0
175962|NCT00490035|612640|P1|Overall Study|Lost to Follow-up|2
175963|NCT00490035|612637|P4|Overall Study|AE, non-serious non-fatal|5
175964|NCT00490035|612638|P3|Overall Study|AE, non-serious non-fatal|4
175965|NCT00490035|612639|P2|Overall Study|AE, non-serious non-fatal|4
175966|NCT00490035|612640|P1|Overall Study|AE, non-serious non-fatal|3
175967|NCT00490022|612740|P2|Overall Study|Subject failed to disclose concommitant|1
175968|NCT00490022|612741|P1|Overall Study|Subject failed to disclose concommitant|0
175969|NCT00490022|612740|P2|Overall Study|Withdrawal by Subject|0
175970|NCT00490022|612741|P1|Overall Study|Withdrawal by Subject|1
175971|NCT00490022|612740|P2|Overall Study|Adverse Event|2
175972|NCT00490022|612741|P1|Overall Study|Adverse Event|0
175973|NCT00489853|612799|P3|Treatment Period 3|Study specific discontinuation criteria|0
175974|NCT00489853|612800|P2|Treatment Period 3|Study specific discontinuation criteria|1
175975|NCT00489853|612801|P1|Treatment Period 3|Study specific discontinuation criteria|0
175976|NCT00489853|612799|P3|Wash-out Period 2|Study specific discontinuation criteria|2
175977|NCT00489853|612800|P2|Wash-out Period 2|Study specific discontinuation criteria|2
175978|NCT00489853|612801|P1|Wash-out Period 2|Study specific discontinuation criteria|3
175979|NCT00489853|612799|P3|Wash-out Period 2|Adverse Event|0
175980|NCT00489853|612800|P2|Wash-out Period 2|Adverse Event|1
175981|NCT00489853|612801|P1|Wash-out Period 2|Adverse Event|1
175982|NCT00489853|612799|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
175983|NCT00489853|612800|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
175984|NCT00489853|612801|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
175985|NCT00489853|612799|P3|Wash-out Period 1|Protocol Violation|1
175986|NCT00489853|612800|P2|Wash-out Period 1|Protocol Violation|1
175987|NCT00489853|612801|P1|Wash-out Period 1|Protocol Violation|0
175988|NCT00489853|612799|P3|Wash-out Period 1|Adverse Event|1
175989|NCT00489853|612800|P2|Wash-out Period 1|Adverse Event|1
175990|NCT00489853|612801|P1|Wash-out Period 1|Adverse Event|0
175991|NCT00489853|612799|P3|Wash-out Period 1|Withdrawal by Subject|0
175992|NCT00489853|612800|P2|Wash-out Period 1|Withdrawal by Subject|0
175993|NCT00489853|612801|P1|Wash-out Period 1|Withdrawal by Subject|1
175994|NCT00489736|612898|P2|Overall Study|Not coded/ Not pre-specified|8
175995|NCT00489736|612899|P1|Overall Study|Not coded/ Not pre-specified|5
175996|NCT00489736|612898|P2|Overall Study|Poor compliance|2
175997|NCT00489736|612899|P1|Overall Study|Poor compliance|6
175998|NCT00489736|612898|P2|Overall Study|Adverse Event|45
175999|NCT00489736|612899|P1|Overall Study|Adverse Event|32
176000|NCT00489736|612898|P2|Overall Study|Lack of Efficacy|14
176001|NCT00489736|612899|P1|Overall Study|Lack of Efficacy|53
176002|NCT00489554|612909|P1|Overall Study|Lost to Follow-up|1
176003|NCT00489554|612909|P1|Overall Study|Withdrawal by Subject|1
176004|NCT00489554|612909|P1|Overall Study|Adverse Event|2
176005|NCT00489541|612929|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
176006|NCT00489541|612930|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
176007|NCT00489541|612929|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
176008|NCT00489541|612930|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
176009|NCT00489541|612929|P2|12-Month Clinical Follow-up|Death|2
176010|NCT00489541|612930|P1|12-Month Clinical Follow-up|Death|3
176011|NCT00489541|612929|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
176012|NCT00489541|612930|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
176013|NCT00489541|612929|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
176014|NCT00489541|612930|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
176015|NCT00489541|612929|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
176016|NCT00489541|612930|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
176017|NCT00489489|612941|P3|Overall Study|Other than above|0
176018|NCT00489489|612942|P2|Overall Study|Other than above|1
176019|NCT00489489|612943|P1|Overall Study|Other than above|0
176020|NCT00489489|612941|P3|Overall Study|Participant did not wish to continue|0
176021|NCT00489489|612942|P2|Overall Study|Participant did not wish to continue|1
176022|NCT00489489|612943|P1|Overall Study|Participant did not wish to continue|1
176023|NCT00489489|612941|P3|Overall Study|Progressive disease|0
176024|NCT00489489|612942|P2|Overall Study|Progressive disease|1
176025|NCT00489489|612943|P1|Overall Study|Progressive disease|0
176026|NCT00489489|612941|P3|Overall Study|Protocol Violation|1
176027|NCT00489489|612942|P2|Overall Study|Protocol Violation|0
176028|NCT00489489|612943|P1|Overall Study|Protocol Violation|1
176029|NCT00489489|612941|P3|Overall Study|Adverse Event|1
176030|NCT00489489|612942|P2|Overall Study|Adverse Event|1
176031|NCT00489489|612943|P1|Overall Study|Adverse Event|1
176032|NCT00489489|612941|P3|Overall Study|Not treated due to protocol violation|1
176033|NCT00489489|612942|P2|Overall Study|Not treated due to protocol violation|1
176034|NCT00489489|612943|P1|Overall Study|Not treated due to protocol violation|0
176035|NCT00489476|612975|P4|Overall Study|Lost to Follow-up|0
176036|NCT00489476|612976|P3|Overall Study|Lost to Follow-up|0
176037|NCT00489476|612977|P2|Overall Study|Lost to Follow-up|1
176038|NCT00489476|612978|P1|Overall Study|Lost to Follow-up|0
176039|NCT00489424|612999|P3|Overall Study|Administrative problems|1
176040|NCT00489424|613000|P2|Overall Study|Administrative problems|2
176041|NCT00489424|613001|P1|Overall Study|Administrative problems|0
176042|NCT00489424|612999|P3|Overall Study|Lack of Efficacy|0
176043|NCT00489424|613000|P2|Overall Study|Lack of Efficacy|0
176044|NCT00489424|613001|P1|Overall Study|Lack of Efficacy|1
176045|NCT00489424|612999|P3|Overall Study|Adverse Event|4
176046|NCT00489424|613000|P2|Overall Study|Adverse Event|3
176047|NCT00489424|613001|P1|Overall Study|Adverse Event|3
176048|NCT00489411|613032|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
176049|NCT00489411|613033|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
176050|NCT00489411|613032|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
176051|NCT00489411|613033|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
176052|NCT00489411|613032|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
176053|NCT00489411|613033|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
176054|NCT00489411|613032|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
176055|NCT00489411|613033|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
176056|NCT00489411|613032|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
176057|NCT00489411|613033|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
176058|NCT00489359|613047|P2|Overall Study|Adverse Event|16
176059|NCT00489359|613048|P1|Overall Study|Adverse Event|0
176060|NCT00489359|613047|P2|Overall Study|Withdrawal by Subject|5
176061|NCT00489359|613048|P1|Overall Study|Withdrawal by Subject|1
176062|NCT00489359|613047|P2|Overall Study|Lost to Follow-up|0
176063|NCT00489359|613048|P1|Overall Study|Lost to Follow-up|1
176064|NCT00489359|613047|P2|Overall Study|Progressive Disease|6
176065|NCT00489359|613048|P1|Overall Study|Progressive Disease|5
176066|NCT00489359|613047|P2|Overall Study|Death|2
176067|NCT00489359|613048|P1|Overall Study|Death|0
176068|NCT00489255|613109|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
176069|NCT00489255|613110|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
176070|NCT00489255|613109|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
176071|NCT00489255|613110|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
176072|NCT00489255|613109|P2|Period 3: Days 57 to 84|Adverse Event|3
176073|NCT00489255|613110|P1|Period 3: Days 57 to 84|Adverse Event|3
176074|NCT00489255|613109|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
176075|NCT00489255|613110|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
176076|NCT00489255|613109|P2|Period 2: Days 29 to 56|Adverse Event|1
176077|NCT00489255|613110|P1|Period 2: Days 29 to 56|Adverse Event|3
176078|NCT00489255|613109|P2|Period 1: Days 1 to 28|Noncompliance|0
176079|NCT00489255|613110|P1|Period 1: Days 1 to 28|Noncompliance|2
176080|NCT00489255|613109|P2|Period 1: Days 1 to 28|Physician Decision|4
176081|NCT00489255|613110|P1|Period 1: Days 1 to 28|Physician Decision|1
176082|NCT00489255|613109|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
176083|NCT00489255|613110|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
176084|NCT00489255|613109|P2|Period 1: Days 1 to 28|Adverse Event|8
176085|NCT00489255|613110|P1|Period 1: Days 1 to 28|Adverse Event|21
176086|NCT00489255|613109|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
176087|NCT00489255|613110|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
176088|NCT00489216|613158|P1|Overall Study|Adverse Event|1
176089|NCT00488826|613180|P3|Overall Study|Protocol Deviations|1
176090|NCT00488826|613181|P2|Overall Study|Protocol Deviations|1
176091|NCT00488826|613182|P1|Overall Study|Protocol Deviations|2
176092|NCT00488826|613180|P3|Overall Study|Lost to Follow-up|0
176093|NCT00488826|613181|P2|Overall Study|Lost to Follow-up|1
176094|NCT00488826|613182|P1|Overall Study|Lost to Follow-up|5
176095|NCT00488826|613180|P3|Overall Study|Adverse Event|4
176096|NCT00488826|613181|P2|Overall Study|Adverse Event|15
176097|NCT00488826|613182|P1|Overall Study|Adverse Event|9
176098|NCT00488826|613180|P3|Overall Study|Protocol Violation|2
176099|NCT00488826|613181|P2|Overall Study|Protocol Violation|0
176100|NCT00488826|613182|P1|Overall Study|Protocol Violation|0
176101|NCT00488826|613180|P3|Overall Study|Withdrawal by Subject|19
176102|NCT00488826|613181|P2|Overall Study|Withdrawal by Subject|35
176103|NCT00488826|613182|P1|Overall Study|Withdrawal by Subject|40
176104|NCT00488774|613197|P4|Overall Study|Lost to Follow-up|1
176105|NCT00488774|613198|P3|Overall Study|Lost to Follow-up|1
176106|NCT00488774|613199|P2|Overall Study|Lost to Follow-up|0
176107|NCT00488774|613200|P1|Overall Study|Lost to Follow-up|0
176108|NCT00488774|613197|P4|Overall Study|Other|2
176109|NCT00488774|613198|P3|Overall Study|Other|2
176110|NCT00488774|613199|P2|Overall Study|Other|3
176111|NCT00488774|613200|P1|Overall Study|Other|6
176112|NCT00488774|613197|P4|Overall Study|Withdrawal of consent|0
176113|NCT00488774|613198|P3|Overall Study|Withdrawal of consent|2
176114|NCT00488774|613199|P2|Overall Study|Withdrawal of consent|2
176115|NCT00488774|613200|P1|Overall Study|Withdrawal of consent|2
176116|NCT00488683|613217|P3|Overall Study|Unable to Classify|0
176117|NCT00488683|613218|P2|Overall Study|Unable to Classify|0
176118|NCT00488683|613219|P1|Overall Study|Unable to Classify|1
176119|NCT00488683|613217|P3|Overall Study|Protocol Violation|0
176120|NCT00488683|613218|P2|Overall Study|Protocol Violation|1
176121|NCT00488683|613219|P1|Overall Study|Protocol Violation|5
176122|NCT00488683|613217|P3|Overall Study|Lost to Follow-up|0
176123|NCT00488683|613218|P2|Overall Study|Lost to Follow-up|3
176124|NCT00488683|613219|P1|Overall Study|Lost to Follow-up|5
176125|NCT00488683|613217|P3|Overall Study|Withdrawal by Subject|2
176126|NCT00488683|613218|P2|Overall Study|Withdrawal by Subject|2
176127|NCT00488683|613219|P1|Overall Study|Withdrawal by Subject|1
176128|NCT00488644|613278|P1|Overall Study|Not Evaluable|1
176129|NCT00488644|613278|P1|Overall Study|Not Eligible|1
176130|NCT00488631|613288|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
176131|NCT00488631|613289|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
176132|NCT00488631|613290|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
176133|NCT00488631|613291|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
176134|NCT00488631|613292|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
176135|NCT00488631|613293|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
176136|NCT00488631|613294|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
176137|NCT00488631|613295|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
176138|NCT00488631|613296|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
176139|NCT00488631|613297|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
176140|NCT00488631|613288|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
176141|NCT00488631|613289|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
176142|NCT00488631|613290|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
176143|NCT00488631|613291|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
176144|NCT00488631|613292|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
176145|NCT00488631|613293|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
176146|NCT00488631|613294|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
176147|NCT00488631|613295|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
176148|NCT00488631|613296|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
176149|NCT00488631|613297|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
176150|NCT00488631|613288|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
176151|NCT00488631|613289|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
176152|NCT00488631|613290|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
176153|NCT00488631|613291|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
176154|NCT00488631|613292|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
176155|NCT00488631|613293|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
176156|NCT00488631|613294|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
176157|NCT00488631|613295|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
176158|NCT00488631|613296|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
176159|NCT00488631|613297|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
176160|NCT00488631|613288|P10|Open Label Study Extension (Week 54-228)|Death|0
176161|NCT00488631|613289|P9|Open Label Study Extension (Week 54-228)|Death|1
176162|NCT00488631|613290|P8|Open Label Study Extension (Week 54-228)|Death|0
176163|NCT00488631|613291|P7|Open Label Study Extension (Week 54-228)|Death|0
176164|NCT00488631|613292|P6|Open Label Study Extension (Week 54-228)|Death|0
176165|NCT00488631|613293|P5|Open Label Study Extension (Week 54-228)|Death|0
176166|NCT00488631|613294|P4|Open Label Study Extension (Week 54-228)|Death|0
176167|NCT00488631|613295|P3|Open Label Study Extension (Week 54-228)|Death|0
176168|NCT00488631|613296|P2|Open Label Study Extension (Week 54-228)|Death|0
176169|NCT00488631|613297|P1|Open Label Study Extension (Week 54-228)|Death|0
176170|NCT00488631|613288|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
176171|NCT00488631|613289|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
176172|NCT00488631|613290|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
176173|NCT00488631|613291|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
176174|NCT00488631|613292|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
176175|NCT00488631|613293|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
176176|NCT00488631|613294|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
176177|NCT00488631|613295|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
176178|NCT00488631|613296|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
176179|NCT00488631|613297|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
176180|NCT00488631|613288|P10|Double Blind Period (Week 0-54)|Other|0
176181|NCT00488631|613289|P9|Double Blind Period (Week 0-54)|Other|0
176182|NCT00488631|613290|P8|Double Blind Period (Week 0-54)|Other|0
176183|NCT00488631|613291|P7|Double Blind Period (Week 0-54)|Other|0
176184|NCT00488631|613292|P6|Double Blind Period (Week 0-54)|Other|34
176185|NCT00488631|613293|P5|Double Blind Period (Week 0-54)|Other|14
176186|NCT00488631|613294|P4|Double Blind Period (Week 0-54)|Other|11
176187|NCT00488631|613295|P3|Double Blind Period (Week 0-54)|Other|10
176188|NCT00488631|613296|P2|Double Blind Period (Week 0-54)|Other|12
176189|NCT00488631|613297|P1|Double Blind Period (Week 0-54)|Other|6
176190|NCT00488631|613288|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
176191|NCT00488631|613289|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
176192|NCT00488631|613290|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
176193|NCT00488631|613291|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
176194|NCT00488631|613292|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
176195|NCT00488631|613293|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
176196|NCT00488631|613294|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
176197|NCT00488631|613295|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
176198|NCT00488631|613296|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
176199|NCT00488631|613297|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
176200|NCT00488631|613288|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
176201|NCT00488631|613289|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
176202|NCT00488631|613290|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
176203|NCT00488631|613291|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
176204|NCT00488631|613292|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
176205|NCT00488631|613293|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
176206|NCT00488631|613294|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
176207|NCT00488631|613295|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
176208|NCT00488631|613296|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
176209|NCT00488631|613297|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
176210|NCT00488631|613288|P10|Double Blind Period (Week 0-54)|Death|0
176211|NCT00488631|613289|P9|Double Blind Period (Week 0-54)|Death|0
176212|NCT00488631|613290|P8|Double Blind Period (Week 0-54)|Death|0
176213|NCT00488631|613291|P7|Double Blind Period (Week 0-54)|Death|0
176214|NCT00488631|613292|P6|Double Blind Period (Week 0-54)|Death|1
176215|NCT00488631|613293|P5|Double Blind Period (Week 0-54)|Death|0
176216|NCT00488631|613294|P4|Double Blind Period (Week 0-54)|Death|0
176217|NCT00488631|613295|P3|Double Blind Period (Week 0-54)|Death|0
176218|NCT00488631|613296|P2|Double Blind Period (Week 0-54)|Death|0
176219|NCT00488631|613297|P1|Double Blind Period (Week 0-54)|Death|0
176220|NCT00488631|613288|P10|Double Blind Period (Week 0-54)|Adverse Event|0
176221|NCT00488631|613289|P9|Double Blind Period (Week 0-54)|Adverse Event|0
176222|NCT00488631|613290|P8|Double Blind Period (Week 0-54)|Adverse Event|0
176223|NCT00488631|613291|P7|Double Blind Period (Week 0-54)|Adverse Event|0
176224|NCT00488631|613292|P6|Double Blind Period (Week 0-54)|Adverse Event|50
176225|NCT00488631|613293|P5|Double Blind Period (Week 0-54)|Adverse Event|30
176226|NCT00488631|613294|P4|Double Blind Period (Week 0-54)|Adverse Event|12
176227|NCT00488631|613295|P3|Double Blind Period (Week 0-54)|Adverse Event|12
176228|NCT00488631|613296|P2|Double Blind Period (Week 0-54)|Adverse Event|12
176229|NCT00488631|613297|P1|Double Blind Period (Week 0-54)|Adverse Event|17
176230|NCT00488618|613334|P2|Overall Study|Lost to Follow-up|0
176231|NCT00488618|613335|P1|Overall Study|Lost to Follow-up|1
176232|NCT00488618|613334|P2|Overall Study|Withdrawal of Consent|13
176233|NCT00488618|613335|P1|Overall Study|Withdrawal of Consent|15
176234|NCT00488618|613334|P2|Overall Study|Protocol Violation|2
176235|NCT00488618|613335|P1|Overall Study|Protocol Violation|0
176236|NCT00488618|613334|P2|Overall Study|Insufficient Therapeutic Response|11
176237|NCT00488618|613335|P1|Overall Study|Insufficient Therapeutic Response|18
176238|NCT00488618|613334|P2|Overall Study|Adverse Event|17
176239|NCT00488618|613335|P1|Overall Study|Adverse Event|13
176240|NCT00488592|613343|P1|Overall Study|Enrolled but not treated|1
176241|NCT00488592|613343|P1|Overall Study|Disease progression|1
176242|NCT00488592|613343|P1|Overall Study|Withdrawal by Subject|1
176243|NCT00488514|613347|P1|Overall Study|Increased use of concomitant medication|1
176244|NCT00488514|613347|P1|Overall Study|Increase in number of migraines|2
176245|NCT00488514|613347|P1|Overall Study|Participant had too few migraines|5
176246|NCT00488514|613347|P1|Overall Study|Investigator decision|1
176247|NCT00488514|613347|P1|Overall Study|Withdrawn per medical monitor decision|2
176248|NCT00488514|613347|P1|Overall Study|Postive drug screen|1
176249|NCT00488514|613347|P1|Overall Study|Did not meet criteria for treatment|30
176250|NCT00488514|613347|P1|Overall Study|Lack of Efficacy|28
176251|NCT00488514|613347|P1|Overall Study|Withdrawal by Subject|106
176252|NCT00488514|613347|P1|Overall Study|Protocol Violation|32
176253|NCT00488514|613347|P1|Overall Study|Lost to Follow-up|44
176254|NCT00488514|613347|P1|Overall Study|Adverse Event|41
176255|NCT00488475|613435|P1|Overall Study|Other|1754
176256|NCT00488345|613464|P3|Overall Study|Parent/legal guardian request|1
176257|NCT00488345|613465|P2|Overall Study|Parent/legal guardian request|1
176258|NCT00488345|613466|P1|Overall Study|Parent/legal guardian request|0
176259|NCT00488345|613464|P3|Overall Study|Surgical team recommendation|0
176260|NCT00488345|613465|P2|Overall Study|Surgical team recommendation|1
176261|NCT00488345|613466|P1|Overall Study|Surgical team recommendation|0
176262|NCT00488345|613464|P3|Overall Study|Institutional Review Board review|1
176263|NCT00488345|613465|P2|Overall Study|Institutional Review Board review|0
176264|NCT00488345|613466|P1|Overall Study|Institutional Review Board review|0
176265|NCT00488345|613464|P3|Overall Study|Unable to administer antibiotics at home|0
176266|NCT00488345|613465|P2|Overall Study|Unable to administer antibiotics at home|1
176267|NCT00488345|613466|P1|Overall Study|Unable to administer antibiotics at home|0
176268|NCT00488345|613464|P3|Overall Study|Adverse Event|1
176269|NCT00488345|613465|P2|Overall Study|Adverse Event|1
176270|NCT00488345|613466|P1|Overall Study|Adverse Event|0
176271|NCT00488319|613492|P3|Overall Study|Other reasons for withdrawal|12
176272|NCT00488319|613493|P2|Overall Study|Other reasons for withdrawal|4
176273|NCT00488319|613494|P1|Overall Study|Other reasons for withdrawal|0
176274|NCT00488319|613492|P3|Overall Study|Withdrawal by Subject|44
176275|NCT00488319|613493|P2|Overall Study|Withdrawal by Subject|20
176276|NCT00488319|613494|P1|Overall Study|Withdrawal by Subject|5
176277|NCT00488319|613492|P3|Overall Study|Lost to Follow-up|16
176278|NCT00488319|613493|P2|Overall Study|Lost to Follow-up|5
176279|NCT00488319|613494|P1|Overall Study|Lost to Follow-up|3
176280|NCT00488319|613492|P3|Overall Study|Lack of Efficacy|27
176281|NCT00488319|613493|P2|Overall Study|Lack of Efficacy|12
176282|NCT00488319|613494|P1|Overall Study|Lack of Efficacy|6
176283|NCT00488319|613492|P3|Overall Study|Adverse Event|23
176284|NCT00488319|613493|P2|Overall Study|Adverse Event|2
176285|NCT00488319|613494|P1|Overall Study|Adverse Event|1
176286|NCT00488293|613581|P2|Overall Study|Misrandomization/Other Unspecified|1
176287|NCT00488293|613582|P1|Overall Study|Misrandomization/Other Unspecified|1
176288|NCT00488293|613581|P2|Overall Study|Death|1
176289|NCT00488293|613582|P1|Overall Study|Death|2
176290|NCT00488293|613581|P2|Overall Study|Withdrawal by Subject|3
176291|NCT00488293|613582|P1|Overall Study|Withdrawal by Subject|5
176292|NCT00488293|613581|P2|Overall Study|Lost to Follow-up|25
176293|NCT00488293|613582|P1|Overall Study|Lost to Follow-up|28
176294|NCT00488033|613627|P2|Overall Study|Withdrawal by Subject|0
176295|NCT00488033|613628|P1|Overall Study|Withdrawal by Subject|1
176296|NCT00487981|613644|P1|Overall Study|Hypothyroidism diagnosis|1
176297|NCT00487942|613652|P4|Overall Study|Withdrawal by Subject|0
176298|NCT00487942|613653|P3|Overall Study|Withdrawal by Subject|2
176299|NCT00487942|613654|P2|Overall Study|Withdrawal by Subject|1
176300|NCT00487942|613655|P1|Overall Study|Withdrawal by Subject|0
176301|NCT00487942|613652|P4|Overall Study|Protocol Violation|0
176302|NCT00487942|613653|P3|Overall Study|Protocol Violation|0
176303|NCT00487942|613654|P2|Overall Study|Protocol Violation|1
176304|NCT00487942|613655|P1|Overall Study|Protocol Violation|1
176305|NCT00487942|613652|P4|Overall Study|Lost to Follow-up|1
176306|NCT00487942|613653|P3|Overall Study|Lost to Follow-up|0
176307|NCT00487942|613654|P2|Overall Study|Lost to Follow-up|0
176308|NCT00487942|613655|P1|Overall Study|Lost to Follow-up|1
176309|NCT00487942|613652|P4|Overall Study|Adverse Event|1
176310|NCT00487942|613653|P3|Overall Study|Adverse Event|1
176311|NCT00487942|613654|P2|Overall Study|Adverse Event|1
176312|NCT00487942|613655|P1|Overall Study|Adverse Event|1
176313|NCT00487825|614039|P2|Overall Study|not specified|2
176314|NCT00487825|614040|P1|Overall Study|not specified|3
176315|NCT00487825|614039|P2|Overall Study|Lack of Efficacy|1
176316|NCT00487825|614040|P1|Overall Study|Lack of Efficacy|1
176317|NCT00487825|614039|P2|Overall Study|Adverse Event|2
176318|NCT00487825|614040|P1|Overall Study|Adverse Event|2
176319|NCT00487747|614052|P1|Overall Study|Lack of Efficacy|1
176320|NCT00487747|614052|P1|Overall Study|Lost to Follow-up|9
176321|NCT00487747|614052|P1|Overall Study|Adverse Event|1
176322|NCT00487695|614069|P2|Second Procedure|Withdrawal by Subject|2
176323|NCT00487695|614070|P1|Second Procedure|Withdrawal by Subject|1
176324|NCT00487695|614069|P2|Second Procedure|active wheezing|1
176325|NCT00487695|614070|P1|Second Procedure|active wheezing|0
176326|NCT00487695|614069|P2|First Procedure|esophageal stricture found (excl crit)|0
176327|NCT00487695|614070|P1|First Procedure|esophageal stricture found (excl crit)|1
176328|NCT00487695|614069|P2|First Procedure|active wheezing (did not have procedure)|0
176329|NCT00487695|614070|P1|First Procedure|active wheezing (did not have procedure)|1
176330|NCT00487695|614069|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
176331|NCT00487695|614070|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
176332|NCT00487578|614098|P2|Overall Study|Lost to Follow-up|1
176333|NCT00487578|614099|P1|Overall Study|Lost to Follow-up|0
176334|NCT00487578|614098|P2|Overall Study|Lack of Efficacy|1
176335|NCT00487578|614099|P1|Overall Study|Lack of Efficacy|0
176336|NCT00487578|614098|P2|Overall Study|Adverse Event|2
176337|NCT00487578|614099|P1|Overall Study|Adverse Event|1
176338|NCT00487552|614119|P1|Overall Study|Stent not placed|1
176339|NCT00487552|614119|P1|Overall Study|Death due to progressive malignancy|2
176340|NCT00487552|614119|P1|Overall Study|Unsuccessful magnet placements|3
176341|NCT00487539|614128|P4|Overall Study|Other|2
176342|NCT00487539|614129|P3|Overall Study|Other|2
176343|NCT00487539|614130|P2|Overall Study|Other|1
176344|NCT00487539|614131|P1|Overall Study|Other|3
176345|NCT00487539|614128|P4|Overall Study|Unsatisfactory therapeutic effect|1
176346|NCT00487539|614129|P3|Overall Study|Unsatisfactory therapeutic effect|0
176347|NCT00487539|614130|P2|Overall Study|Unsatisfactory therapeutic effect|0
176348|NCT00487539|614131|P1|Overall Study|Unsatisfactory therapeutic effect|1
176349|NCT00487539|614128|P4|Overall Study|Adverse Event|1
176350|NCT00487539|614129|P3|Overall Study|Adverse Event|1
176351|NCT00487539|614130|P2|Overall Study|Adverse Event|2
176352|NCT00487539|614131|P1|Overall Study|Adverse Event|3
176353|NCT00487435|614165|P1|Overall Study|Other|83
176354|NCT00487435|614165|P1|Overall Study|Study Medication Non-Compliant|32
176355|NCT00487435|614165|P1|Overall Study|Resolution Of Pain|1
176356|NCT00487435|614165|P1|Overall Study|Withdrawal by Subject|132
176357|NCT00487435|614165|P1|Overall Study|Pregnancy|2
176358|NCT00487435|614165|P1|Overall Study|Lost to Follow-up|54
176359|NCT00487435|614165|P1|Overall Study|Lack of Efficacy|33
176360|NCT00487435|614165|P1|Overall Study|Death|2
176361|NCT00487435|614165|P1|Overall Study|Adverse Event|146
176362|NCT00487279|614178|P2|Overall Study|Withdrawal by Subject|2
176363|NCT00487279|614179|P1|Overall Study|Withdrawal by Subject|0
176364|NCT00487279|614178|P2|Overall Study|Death|0
176365|NCT00487279|614179|P1|Overall Study|Death|1
176366|NCT00487240|614189|P2|Overall Study|Physician Decision|0
176367|NCT00487240|614190|P1|Overall Study|Physician Decision|2
176368|NCT00487240|614189|P2|Overall Study|Sponsor Decision|1
176369|NCT00487240|614190|P1|Overall Study|Sponsor Decision|2
176370|NCT00487240|614189|P2|Overall Study|Entry Criteria Not Met|4
176371|NCT00487240|614190|P1|Overall Study|Entry Criteria Not Met|3
176372|NCT00487240|614189|P2|Overall Study|Protocol Violation|5
176373|NCT00487240|614190|P1|Overall Study|Protocol Violation|5
176374|NCT00487240|614189|P2|Overall Study|Adverse Event|4
176375|NCT00487240|614190|P1|Overall Study|Adverse Event|0
176376|NCT00487240|614189|P2|Overall Study|Lost to Follow-up|6
176377|NCT00487240|614190|P1|Overall Study|Lost to Follow-up|7
176378|NCT00487240|614189|P2|Overall Study|Withdrawal by Subject|6
176379|NCT00487240|614190|P1|Overall Study|Withdrawal by Subject|12
176380|NCT00487188|614218|P3|Maintenance Phase|Administrative|1
176381|NCT00487188|614219|P2|Maintenance Phase|Administrative|0
176382|NCT00487188|614220|P1|Maintenance Phase|Administrative|0
176383|NCT00487188|614218|P3|Maintenance Phase|Lost to Follow-up|0
176384|NCT00487188|614219|P2|Maintenance Phase|Lost to Follow-up|0
176385|NCT00487188|614220|P1|Maintenance Phase|Lost to Follow-up|1
176386|NCT00487188|614218|P3|Maintenance Phase|Death|0
176387|NCT00487188|614219|P2|Maintenance Phase|Death|0
176388|NCT00487188|614220|P1|Maintenance Phase|Death|1
176389|NCT00487188|614218|P3|Maintenance Phase|Adverse Event|0
176390|NCT00487188|614219|P2|Maintenance Phase|Adverse Event|0
176391|NCT00487188|614220|P1|Maintenance Phase|Adverse Event|1
176392|NCT00487188|614218|P3|Induction Phase|Administrative|0
176393|NCT00487188|614219|P2|Induction Phase|Administrative|1
176394|NCT00487188|614220|P1|Induction Phase|Administrative|0
176395|NCT00487188|614218|P3|Induction Phase|Lost to Follow-up|0
176396|NCT00487188|614219|P2|Induction Phase|Lost to Follow-up|2
176397|NCT00487188|614220|P1|Induction Phase|Lost to Follow-up|2
176398|NCT00487188|614218|P3|Induction Phase|Refused Treatment|0
176399|NCT00487188|614219|P2|Induction Phase|Refused Treatment|2
176400|NCT00487188|614220|P1|Induction Phase|Refused Treatment|1
176401|NCT00487188|614218|P3|Induction Phase|Protocol Violation|0
176402|NCT00487188|614219|P2|Induction Phase|Protocol Violation|0
176403|NCT00487188|614220|P1|Induction Phase|Protocol Violation|1
176404|NCT00487188|614218|P3|Induction Phase|Lack of Efficacy|0
176405|NCT00487188|614219|P2|Induction Phase|Lack of Efficacy|1
176406|NCT00487188|614220|P1|Induction Phase|Lack of Efficacy|0
176407|NCT00487188|614218|P3|Induction Phase|Adverse Event|0
176408|NCT00487188|614219|P2|Induction Phase|Adverse Event|0
176409|NCT00487188|614220|P1|Induction Phase|Adverse Event|5
176410|NCT00487188|614218|P3|Induction Phase|Abnormality of Laboratory Test|0
176411|NCT00487188|614219|P2|Induction Phase|Abnormality of Laboratory Test|1
176412|NCT00487188|614220|P1|Induction Phase|Abnormality of Laboratory Test|0
176413|NCT00487162|614259|P2|Overall Study|Withdrawal by Subject|3
176414|NCT00487162|614260|P1|Overall Study|Withdrawal by Subject|2
176415|NCT00487162|614259|P2|Overall Study|Physician Decision|1
176416|NCT00487162|614260|P1|Overall Study|Physician Decision|0
176417|NCT00487162|614259|P2|Overall Study|Adverse Event|1
176418|NCT00487162|614260|P1|Overall Study|Adverse Event|0
176419|NCT00487084|614271|P3|Overall Study|Did not receive intervention|5
176420|NCT00487084|614272|P2|Overall Study|Did not receive intervention|3
176421|NCT00487084|614273|P1|Overall Study|Did not receive intervention|4
176422|NCT00486954|614294|P5|Randomized Part|Sponsor Terminated Study|13
176423|NCT00486954|614295|P4|Randomized Part|Sponsor Terminated Study|19
176424|NCT00486954|614296|P3|Randomized Part|Sponsor Terminated Study|0
176425|NCT00486954|614297|P2|Randomized Part|Sponsor Terminated Study|0
176426|NCT00486954|614298|P1|Randomized Part|Sponsor Terminated Study|0
176427|NCT00486954|614294|P5|Randomized Part|Withdrawal by Subject|0
176428|NCT00486954|614295|P4|Randomized Part|Withdrawal by Subject|1
176429|NCT00486954|614296|P3|Randomized Part|Withdrawal by Subject|0
176430|NCT00486954|614297|P2|Randomized Part|Withdrawal by Subject|0
176431|NCT00486954|614298|P1|Randomized Part|Withdrawal by Subject|0
176432|NCT00486954|614294|P5|Randomized Part|Lost to Follow-up|1
176433|NCT00486954|614295|P4|Randomized Part|Lost to Follow-up|0
176434|NCT00486954|614296|P3|Randomized Part|Lost to Follow-up|0
176435|NCT00486954|614297|P2|Randomized Part|Lost to Follow-up|0
176436|NCT00486954|614298|P1|Randomized Part|Lost to Follow-up|0
176437|NCT00486954|614294|P5|Pilot Part|Disease Progression|0
176438|NCT00486954|614295|P4|Pilot Part|Disease Progression|0
176439|NCT00486954|614296|P3|Pilot Part|Disease Progression|1
176440|NCT00486954|614297|P2|Pilot Part|Disease Progression|0
176441|NCT00486954|614298|P1|Pilot Part|Disease Progression|2
176442|NCT00486954|614294|P5|Pilot Part|Adverse Event|0
176443|NCT00486954|614295|P4|Pilot Part|Adverse Event|0
176444|NCT00486954|614296|P3|Pilot Part|Adverse Event|5
176445|NCT00486954|614297|P2|Pilot Part|Adverse Event|0
176446|NCT00486954|614298|P1|Pilot Part|Adverse Event|4
176447|NCT00486902|614396|P2|Overall Study|No toradol due to hemmorhage or allergy|1
176448|NCT00486902|614397|P1|Overall Study|No toradol due to hemmorhage or allergy|3
176449|NCT00486902|614396|P2|Overall Study|Did not meet inclusion criteria|0
176450|NCT00486902|614397|P1|Overall Study|Did not meet inclusion criteria|1
176451|NCT00486902|614396|P2|Overall Study|spinal anesthetic protocal violation|1
176452|NCT00486902|614397|P1|Overall Study|spinal anesthetic protocal violation|1
176453|NCT00486902|614396|P2|Overall Study|decision for postpartum tubal ligation|1
176454|NCT00486902|614397|P1|Overall Study|decision for postpartum tubal ligation|3
176455|NCT00486902|614396|P2|Overall Study|Withdrawal by Subject|2
176456|NCT00486902|614397|P1|Overall Study|Withdrawal by Subject|1
176457|NCT00486837|614464|P2|Overall Study|No sputum, devise issues, exacerbation|4
176458|NCT00486837|614465|P1|Overall Study|No sputum, devise issues, exacerbation|3
176459|NCT00486837|614464|P2|Overall Study|Protocol Violation|2
176460|NCT00486837|614465|P1|Overall Study|Protocol Violation|4
176461|NCT00486837|614464|P2|Overall Study|Adverse Event|1
176462|NCT00486837|614465|P1|Overall Study|Adverse Event|1
176463|NCT00486837|614464|P2|Overall Study|Withdrawal by Subject|0
176464|NCT00486837|614465|P1|Overall Study|Withdrawal by Subject|1
176465|NCT00486811|614484|P3|Overall Study|All other|7
176466|NCT00486811|614485|P2|Overall Study|All other|11
176467|NCT00486811|614486|P1|Overall Study|All other|18
176468|NCT00486811|614484|P3|Overall Study|Study drug non-compliant|3
176469|NCT00486811|614485|P2|Overall Study|Study drug non-compliant|6
176470|NCT00486811|614486|P1|Overall Study|Study drug non-compliant|5
176471|NCT00486811|614484|P3|Overall Study|Withdrawal by Subject|58
176472|NCT00486811|614485|P2|Overall Study|Withdrawal by Subject|44
176473|NCT00486811|614486|P1|Overall Study|Withdrawal by Subject|33
176474|NCT00486811|614484|P3|Overall Study|Lost to Follow-up|4
176475|NCT00486811|614485|P2|Overall Study|Lost to Follow-up|6
176476|NCT00486811|614486|P1|Overall Study|Lost to Follow-up|4
176477|NCT00486811|614484|P3|Overall Study|Lack of Efficacy|7
176478|NCT00486811|614485|P2|Overall Study|Lack of Efficacy|14
176479|NCT00486811|614486|P1|Overall Study|Lack of Efficacy|34
176480|NCT00486811|614484|P3|Overall Study|Adverse Event|135
176481|NCT00486811|614485|P2|Overall Study|Adverse Event|60
176482|NCT00486811|614486|P1|Overall Study|Adverse Event|28
176483|NCT00486759|614529|P2|Safety Follow-up|Adverse event/intercurrent illness|0
176484|NCT00486759|614530|P1|Safety Follow-up|Adverse event/intercurrent illness|4
176485|NCT00486759|614529|P2|Safety Follow-up|Refused treatment/did not cooperate|4
176486|NCT00486759|614530|P1|Safety Follow-up|Refused treatment/did not cooperate|6
176487|NCT00486759|614529|P2|Safety Follow-up|Administrative/not specified|6
176488|NCT00486759|614530|P1|Safety Follow-up|Administrative/not specified|8
176489|NCT00486759|614529|P2|Safety Follow-up|Failure to return|6
176490|NCT00486759|614530|P1|Safety Follow-up|Failure to return|9
176491|NCT00486759|614529|P2|Safety Follow-up|Withdrew consent|23
176492|NCT00486759|614530|P1|Safety Follow-up|Withdrew consent|32
176493|NCT00486759|614529|P2|Safety Follow-up|Death|29
176494|NCT00486759|614530|P1|Safety Follow-up|Death|40
176495|NCT00486759|614529|P2|Safety Follow-up|Insufficient therapeutic response|50
176496|NCT00486759|614530|P1|Safety Follow-up|Insufficient therapeutic response|40
176497|NCT00486759|614529|P2|Treatment|Failure to return|1
176498|NCT00486759|614530|P1|Treatment|Failure to return|1
176499|NCT00486759|614529|P2|Treatment|Other protocol violation|5
176500|NCT00486759|614530|P1|Treatment|Other protocol violation|1
176501|NCT00486759|614529|P2|Treatment|Violation of selection criteria at entry|3
176502|NCT00486759|614530|P1|Treatment|Violation of selection criteria at entry|3
176503|NCT00486759|614529|P2|Treatment|Refused treatment|7
176504|NCT00486759|614530|P1|Treatment|Refused treatment|10
176505|NCT00486759|614529|P2|Treatment|Administrative/reason not specified|21
176506|NCT00486759|614530|P1|Treatment|Administrative/reason not specified|17
176507|NCT00486759|614529|P2|Treatment|Withdrew consent|12
176508|NCT00486759|614530|P1|Treatment|Withdrew consent|15
176509|NCT00486759|614529|P2|Treatment|Death|10
176510|NCT00486759|614530|P1|Treatment|Death|17
176511|NCT00486759|614529|P2|Treatment|Insufficient therapeutic response|39
176512|NCT00486759|614530|P1|Treatment|Insufficient therapeutic response|37
176513|NCT00486759|614529|P2|Treatment|Adverse event/intercurrent illness|39
176514|NCT00486759|614530|P1|Treatment|Adverse event/intercurrent illness|86
176515|NCT00486720|614542|P2|Overall Study|Progressive Disease|1
176516|NCT00486720|614543|P1|Overall Study|Progressive Disease|0
176517|NCT00486720|614542|P2|Overall Study|Withdrawal by Subject|1
176518|NCT00486720|614543|P1|Overall Study|Withdrawal by Subject|3
176519|NCT00486720|614542|P2|Overall Study|Protocol Violation|0
176520|NCT00486720|614543|P1|Overall Study|Protocol Violation|1
176521|NCT00486720|614542|P2|Overall Study|Physician Decision|2
176522|NCT00486720|614543|P1|Overall Study|Physician Decision|1
176523|NCT00486720|614542|P2|Overall Study|Lack of Efficacy|6
176524|NCT00486720|614543|P1|Overall Study|Lack of Efficacy|4
176525|NCT00486720|614542|P2|Overall Study|Adverse Event|2
176526|NCT00486720|614543|P1|Overall Study|Adverse Event|1
176527|NCT00486434|614602|P2|Overall Study|Personal reasons|6
176528|NCT00486434|614603|P1|Overall Study|Personal reasons|5
176529|NCT00486434|614602|P2|Overall Study|Death|2
176530|NCT00486434|614603|P1|Overall Study|Death|1
176531|NCT00486434|614602|P2|Overall Study|Lost to Follow-up|3
176532|NCT00486434|614603|P1|Overall Study|Lost to Follow-up|2
176533|NCT00486434|614602|P2|Overall Study|Lack of Efficacy|19
176534|NCT00486434|614603|P1|Overall Study|Lack of Efficacy|12
176535|NCT00486434|614602|P2|Overall Study|Protocol Violation|21
176536|NCT00486434|614603|P1|Overall Study|Protocol Violation|22
176537|NCT00486434|614602|P2|Overall Study|Adverse Event|44
176538|NCT00486434|614603|P1|Overall Study|Adverse Event|118
176539|NCT00486434|614602|P2|Overall Study|Withdrawal by Subject|39
176540|NCT00486434|614603|P1|Overall Study|Withdrawal by Subject|34
176541|NCT00486330|614613|P1|Overall Study|Adverse Event|2
176542|NCT00486291|614619|P2|Overall Study|requirement for restricted medication|3
176543|NCT00486291|614620|P1|Overall Study|requirement for restricted medication|0
176544|NCT00486291|614619|P2|Overall Study|protocol non-compliance|15
176545|NCT00486291|614620|P1|Overall Study|protocol non-compliance|10
176546|NCT00486291|614619|P2|Overall Study|Lost to Follow-up|7
176547|NCT00486291|614620|P1|Overall Study|Lost to Follow-up|3
176548|NCT00486291|614619|P2|Overall Study|Adverse Event|4
176549|NCT00486291|614620|P1|Overall Study|Adverse Event|3
176550|NCT00486278|614628|P1|Overall Study|Physician Decision|2
176551|NCT00486278|614628|P1|Overall Study|Withdrawal by Subject|2
176552|NCT00486278|614628|P1|Overall Study|Adverse Event|5
176553|NCT00486265|614762|P1|Overall Study|Lack of Efficacy|8
176554|NCT00486265|614762|P1|Overall Study|Adverse Event|1
176555|NCT00486252|614766|P1|Overall Study|Other|18
176556|NCT00486252|614766|P1|Overall Study|Lost to Follow-up|24
176557|NCT00486252|614766|P1|Overall Study|Lack of Efficacy|9
176558|NCT00486252|614766|P1|Overall Study|Adverse Event|7
176559|NCT00486226|614781|P1|Overall Study|Lost to Follow-up|8
176560|NCT00486226|614781|P1|Overall Study|Withdrawal by Subject|1
176561|NCT00486226|614781|P1|Overall Study|Adverse Event|1
176562|NCT00486226|614781|P1|Overall Study|Death|3
176563|NCT00486044|614791|P2|Overall Study|Lost to Follow-up|1
176564|NCT00486044|614792|P1|Overall Study|Lost to Follow-up|0
176565|NCT00486044|614791|P2|Overall Study|Adverse Event|1
176566|NCT00486044|614792|P1|Overall Study|Adverse Event|0
176567|NCT00486044|614791|P2|Overall Study|Withdrawal by Subject|1
176568|NCT00486044|614792|P1|Overall Study|Withdrawal by Subject|2
176569|NCT00485758|614885|P2|Overall Study|Study Terminated by Sponsor|0
176570|NCT00485758|614886|P1|Overall Study|Study Terminated by Sponsor|3
176571|NCT00485758|614885|P2|Overall Study|Withdrawal by Subject|27
176572|NCT00485758|614886|P1|Overall Study|Withdrawal by Subject|32
176573|NCT00485758|614885|P2|Overall Study|Protocol Violation|2
176574|NCT00485758|614886|P1|Overall Study|Protocol Violation|11
176575|NCT00485758|614885|P2|Overall Study|Physician Decision|3
176576|NCT00485758|614886|P1|Overall Study|Physician Decision|3
176577|NCT00485758|614885|P2|Overall Study|Lost to Follow-up|1
176578|NCT00485758|614886|P1|Overall Study|Lost to Follow-up|5
176579|NCT00485758|614885|P2|Overall Study|Death|1
176580|NCT00485758|614886|P1|Overall Study|Death|0
176581|NCT00485758|614885|P2|Overall Study|Adverse Event|31
176582|NCT00485758|614886|P1|Overall Study|Adverse Event|102
176583|NCT00485732|614898|P2|Overall Study|Lost to Follow-up|2
176584|NCT00485732|614899|P1|Overall Study|Lost to Follow-up|2
176585|NCT00485732|614898|P2|Overall Study|Withdrawal by Subject|4
176586|NCT00485732|614899|P1|Overall Study|Withdrawal by Subject|5
176587|NCT00485732|614898|P2|Overall Study|Protocol Violation|3
176588|NCT00485732|614899|P1|Overall Study|Protocol Violation|1
176589|NCT00485472|614937|P2|Overall Study|Lost to Follow-up|1
176590|NCT00485472|614938|P1|Overall Study|Lost to Follow-up|0
176591|NCT00485472|614937|P2|Overall Study|Other|1
176592|NCT00485472|614938|P1|Overall Study|Other|2
176593|NCT00485472|614937|P2|Overall Study|Protocol Violation|1
176594|NCT00485472|614938|P1|Overall Study|Protocol Violation|0
176595|NCT00485472|614937|P2|Overall Study|Withdrawal by Subject|0
176596|NCT00485472|614938|P1|Overall Study|Withdrawal by Subject|1
176597|NCT00485472|614937|P2|Overall Study|Lack of Efficacy|4
176598|NCT00485472|614938|P1|Overall Study|Lack of Efficacy|5
176599|NCT00485472|614937|P2|Overall Study|Adverse Event|5
176600|NCT00485472|614938|P1|Overall Study|Adverse Event|8
176601|NCT00485303|614975|P1|Overall Study|Treatment ongoing at cutoff date|2
176602|NCT00485303|614975|P1|Overall Study|Initiation of new anti-cancer treatment|2
176603|NCT00485303|614975|P1|Overall Study|Other|3
176604|NCT00485303|614975|P1|Overall Study|Progressive Disease|44
176605|NCT00485303|614975|P1|Overall Study|Adverse Event|5
176606|NCT00485264|614993|P6|Overall Study|Other Reason|0
176607|NCT00485264|614994|P5|Overall Study|Other Reason|0
176608|NCT00485264|614995|P4|Overall Study|Other Reason|0
176609|NCT00485264|614996|P3|Overall Study|Other Reason|0
176610|NCT00485264|614997|P2|Overall Study|Other Reason|0
176611|NCT00485264|614998|P1|Overall Study|Other Reason|3
176612|NCT00485264|614993|P6|Overall Study|Lost to Follow-up|1
176613|NCT00485264|614994|P5|Overall Study|Lost to Follow-up|0
176614|NCT00485264|614995|P4|Overall Study|Lost to Follow-up|0
176615|NCT00485264|614996|P3|Overall Study|Lost to Follow-up|1
176616|NCT00485264|614997|P2|Overall Study|Lost to Follow-up|1
176617|NCT00485264|614998|P1|Overall Study|Lost to Follow-up|2
176618|NCT00485264|614993|P6|Overall Study|Non-Compliant|0
176619|NCT00485264|614994|P5|Overall Study|Non-Compliant|1
176620|NCT00485264|614995|P4|Overall Study|Non-Compliant|0
176621|NCT00485264|614996|P3|Overall Study|Non-Compliant|1
176622|NCT00485264|614997|P2|Overall Study|Non-Compliant|2
176623|NCT00485264|614998|P1|Overall Study|Non-Compliant|17
176624|NCT00485264|614993|P6|Overall Study|Not Able to Attend Clinic|2
176625|NCT00485264|614994|P5|Overall Study|Not Able to Attend Clinic|1
176626|NCT00485264|614995|P4|Overall Study|Not Able to Attend Clinic|1
176627|NCT00485264|614996|P3|Overall Study|Not Able to Attend Clinic|0
176628|NCT00485264|614997|P2|Overall Study|Not Able to Attend Clinic|0
176629|NCT00485264|614998|P1|Overall Study|Not Able to Attend Clinic|5
176630|NCT00485264|614993|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
176631|NCT00485264|614994|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
176632|NCT00485264|614995|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
176633|NCT00485264|614996|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
176634|NCT00485264|614997|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
176635|NCT00485264|614998|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
176636|NCT00485264|614993|P6|Overall Study|Physician Decision|0
176637|NCT00485264|614994|P5|Overall Study|Physician Decision|0
176638|NCT00485264|614995|P4|Overall Study|Physician Decision|0
176639|NCT00485264|614996|P3|Overall Study|Physician Decision|0
176640|NCT00485264|614997|P2|Overall Study|Physician Decision|2
176641|NCT00485264|614998|P1|Overall Study|Physician Decision|0
176642|NCT00485264|614993|P6|Overall Study|Guardian Consent Withdrawn|0
176643|NCT00485264|614994|P5|Overall Study|Guardian Consent Withdrawn|1
176644|NCT00485264|614995|P4|Overall Study|Guardian Consent Withdrawn|0
176645|NCT00485264|614996|P3|Overall Study|Guardian Consent Withdrawn|0
176646|NCT00485264|614997|P2|Overall Study|Guardian Consent Withdrawn|0
176647|NCT00485264|614998|P1|Overall Study|Guardian Consent Withdrawn|1
176648|NCT00485264|614993|P6|Overall Study|Lack of Efficacy|0
176649|NCT00485264|614994|P5|Overall Study|Lack of Efficacy|0
176650|NCT00485264|614995|P4|Overall Study|Lack of Efficacy|0
176651|NCT00485264|614996|P3|Overall Study|Lack of Efficacy|0
176652|NCT00485264|614997|P2|Overall Study|Lack of Efficacy|1
176653|NCT00485264|614998|P1|Overall Study|Lack of Efficacy|0
176654|NCT00485264|614993|P6|Overall Study|Number/Volume/Timing of Study Meds|0
176655|NCT00485264|614994|P5|Overall Study|Number/Volume/Timing of Study Meds|0
176656|NCT00485264|614995|P4|Overall Study|Number/Volume/Timing of Study Meds|0
176657|NCT00485264|614996|P3|Overall Study|Number/Volume/Timing of Study Meds|1
176658|NCT00485264|614997|P2|Overall Study|Number/Volume/Timing of Study Meds|1
176659|NCT00485264|614998|P1|Overall Study|Number/Volume/Timing of Study Meds|2
176660|NCT00485264|614993|P6|Overall Study|Disallowed Medication|1
176661|NCT00485264|614994|P5|Overall Study|Disallowed Medication|0
176662|NCT00485264|614995|P4|Overall Study|Disallowed Medication|0
176663|NCT00485264|614996|P3|Overall Study|Disallowed Medication|0
176664|NCT00485264|614997|P2|Overall Study|Disallowed Medication|0
176665|NCT00485264|614998|P1|Overall Study|Disallowed Medication|0
176666|NCT00485264|614993|P6|Overall Study|Pregnancy|0
176667|NCT00485264|614994|P5|Overall Study|Pregnancy|0
176668|NCT00485264|614995|P4|Overall Study|Pregnancy|0
176669|NCT00485264|614996|P3|Overall Study|Pregnancy|0
176670|NCT00485264|614997|P2|Overall Study|Pregnancy|0
176671|NCT00485264|614998|P1|Overall Study|Pregnancy|4
176672|NCT00485264|614993|P6|Overall Study|Adverse Event|3
176673|NCT00485264|614994|P5|Overall Study|Adverse Event|1
176674|NCT00485264|614995|P4|Overall Study|Adverse Event|3
176675|NCT00485264|614996|P3|Overall Study|Adverse Event|2
176676|NCT00485264|614997|P2|Overall Study|Adverse Event|0
176677|NCT00485264|614998|P1|Overall Study|Adverse Event|1
176678|NCT00485264|614993|P6|Overall Study|Death|0
176679|NCT00485264|614994|P5|Overall Study|Death|1
176680|NCT00485264|614995|P4|Overall Study|Death|0
176681|NCT00485264|614996|P3|Overall Study|Death|0
176682|NCT00485264|614997|P2|Overall Study|Death|0
176683|NCT00485264|614998|P1|Overall Study|Death|1
176684|NCT00485264|614993|P6|Overall Study|Enrolled But Not Given Treatment|0
176685|NCT00485264|614994|P5|Overall Study|Enrolled But Not Given Treatment|1
176686|NCT00485264|614995|P4|Overall Study|Enrolled But Not Given Treatment|0
176687|NCT00485264|614996|P3|Overall Study|Enrolled But Not Given Treatment|0
176688|NCT00485264|614997|P2|Overall Study|Enrolled But Not Given Treatment|0
176689|NCT00485264|614998|P1|Overall Study|Enrolled But Not Given Treatment|0
176690|NCT00485173|615086|P2|Overall Study|Lost to Follow-up|61
176691|NCT00485173|615087|P1|Overall Study|Lost to Follow-up|32
176692|NCT00485173|615086|P2|Overall Study|Death|3
176693|NCT00485173|615087|P1|Overall Study|Death|4
176694|NCT00485134|615135|P8|Overall Study|Pregnancy|0
176695|NCT00485134|615136|P7|Overall Study|Pregnancy|1
176696|NCT00485134|615137|P6|Overall Study|Pregnancy|0
176697|NCT00485134|615138|P5|Overall Study|Pregnancy|0
176698|NCT00485134|615139|P4|Overall Study|Pregnancy|0
176699|NCT00485134|615140|P3|Overall Study|Pregnancy|0
176700|NCT00485134|615141|P2|Overall Study|Pregnancy|0
176701|NCT00485134|615142|P1|Overall Study|Pregnancy|0
176702|NCT00485134|615135|P8|Overall Study|Unable to comply with study schedule|1
176703|NCT00485134|615136|P7|Overall Study|Unable to comply with study schedule|0
176704|NCT00485134|615137|P6|Overall Study|Unable to comply with study schedule|0
176705|NCT00485134|615138|P5|Overall Study|Unable to comply with study schedule|0
176706|NCT00485134|615139|P4|Overall Study|Unable to comply with study schedule|0
176707|NCT00485134|615140|P3|Overall Study|Unable to comply with study schedule|0
176708|NCT00485134|615141|P2|Overall Study|Unable to comply with study schedule|0
176709|NCT00485134|615142|P1|Overall Study|Unable to comply with study schedule|0
176710|NCT00485134|615135|P8|Overall Study|Non-compliance|0
176711|NCT00485134|615136|P7|Overall Study|Non-compliance|2
176712|NCT00485134|615137|P6|Overall Study|Non-compliance|2
176713|NCT00485134|615138|P5|Overall Study|Non-compliance|1
176714|NCT00485134|615139|P4|Overall Study|Non-compliance|0
176715|NCT00485134|615140|P3|Overall Study|Non-compliance|0
176716|NCT00485134|615141|P2|Overall Study|Non-compliance|0
176717|NCT00485134|615142|P1|Overall Study|Non-compliance|0
176718|NCT00485134|615135|P8|Overall Study|Positive drug test|0
176719|NCT00485134|615136|P7|Overall Study|Positive drug test|0
176720|NCT00485134|615137|P6|Overall Study|Positive drug test|1
176721|NCT00485134|615138|P5|Overall Study|Positive drug test|2
176722|NCT00485134|615139|P4|Overall Study|Positive drug test|0
176723|NCT00485134|615140|P3|Overall Study|Positive drug test|0
176724|NCT00485134|615141|P2|Overall Study|Positive drug test|0
176725|NCT00485134|615142|P1|Overall Study|Positive drug test|0
176726|NCT00485134|615135|P8|Overall Study|Withdrew for adverse event|0
176727|NCT00485134|615136|P7|Overall Study|Withdrew for adverse event|0
176728|NCT00485134|615137|P6|Overall Study|Withdrew for adverse event|0
176729|NCT00485134|615138|P5|Overall Study|Withdrew for adverse event|0
176730|NCT00485134|615139|P4|Overall Study|Withdrew for adverse event|0
176731|NCT00485134|615140|P3|Overall Study|Withdrew for adverse event|1
176732|NCT00485134|615141|P2|Overall Study|Withdrew for adverse event|0
176733|NCT00485134|615142|P1|Overall Study|Withdrew for adverse event|0
176734|NCT00485134|615135|P8|Overall Study|Change in health status|0
176735|NCT00485134|615136|P7|Overall Study|Change in health status|0
176736|NCT00485134|615137|P6|Overall Study|Change in health status|1
176737|NCT00485134|615138|P5|Overall Study|Change in health status|0
176738|NCT00485134|615139|P4|Overall Study|Change in health status|1
176739|NCT00485134|615140|P3|Overall Study|Change in health status|2
176740|NCT00485134|615141|P2|Overall Study|Change in health status|1
176741|NCT00485134|615142|P1|Overall Study|Change in health status|0
176742|NCT00485134|615135|P8|Overall Study|Withdrawal by Subject|0
176743|NCT00485134|615136|P7|Overall Study|Withdrawal by Subject|0
176744|NCT00485134|615137|P6|Overall Study|Withdrawal by Subject|0
176745|NCT00485134|615138|P5|Overall Study|Withdrawal by Subject|0
176746|NCT00485134|615139|P4|Overall Study|Withdrawal by Subject|0
176747|NCT00485134|615140|P3|Overall Study|Withdrawal by Subject|0
176748|NCT00485134|615141|P2|Overall Study|Withdrawal by Subject|1
176749|NCT00485134|615142|P1|Overall Study|Withdrawal by Subject|0
176750|NCT00485134|615135|P8|Overall Study|Lost to Follow-up|0
176751|NCT00485134|615136|P7|Overall Study|Lost to Follow-up|0
176752|NCT00485134|615137|P6|Overall Study|Lost to Follow-up|0
176753|NCT00485134|615138|P5|Overall Study|Lost to Follow-up|0
176754|NCT00485134|615139|P4|Overall Study|Lost to Follow-up|0
176755|NCT00485134|615140|P3|Overall Study|Lost to Follow-up|0
176756|NCT00485134|615141|P2|Overall Study|Lost to Follow-up|0
176757|NCT00485134|615142|P1|Overall Study|Lost to Follow-up|1
176758|NCT00485069|615164|P2|Overall Study|Withdrawal by Subject|6
176759|NCT00485069|615165|P1|Overall Study|Withdrawal by Subject|6
176760|NCT00485069|615164|P2|Overall Study|Protocol Violation|1
176761|NCT00485069|615165|P1|Overall Study|Protocol Violation|0
176762|NCT00485069|615164|P2|Overall Study|Lack of Efficacy|1
176763|NCT00485069|615165|P1|Overall Study|Lack of Efficacy|2
176764|NCT00485069|615164|P2|Overall Study|Adverse Event|4
176765|NCT00485069|615165|P1|Overall Study|Adverse Event|10
176766|NCT00484939|615210|P2|Overall Study|Reason Not Specified|6
176767|NCT00484939|615211|P1|Overall Study|Reason Not Specified|11
176768|NCT00484939|615210|P2|Overall Study|Screen Failure|2
176769|NCT00484939|615211|P1|Overall Study|Screen Failure|2
176770|NCT00484939|615210|P2|Overall Study|Disease progression|88
176771|NCT00484939|615211|P1|Overall Study|Disease progression|67
176772|NCT00484939|615210|P2|Overall Study|Discretion of Investigator or Sponsor|3
176773|NCT00484939|615211|P1|Overall Study|Discretion of Investigator or Sponsor|7
176774|NCT00484939|615210|P2|Overall Study|Lost to Follow-up|3
176775|NCT00484939|615211|P1|Overall Study|Lost to Follow-up|0
176776|NCT00484939|615210|P2|Overall Study|Protocol Violation|3
176777|NCT00484939|615211|P1|Overall Study|Protocol Violation|3
176778|NCT00484939|615210|P2|Overall Study|Patient Withdrew Consent|10
176779|NCT00484939|615211|P1|Overall Study|Patient Withdrew Consent|19
176780|NCT00484939|615210|P2|Overall Study|Adverse Event|12
176781|NCT00484939|615211|P1|Overall Study|Adverse Event|22
176782|NCT00484939|615210|P2|Overall Study|Death|13
176783|NCT00484939|615211|P1|Overall Study|Death|9
176784|NCT00484679|615231|P1|Overall Study|Withdrawal by Subject|3
176785|NCT00484419|615238|P3|Overall Study|sponsor decision, randomized in error|2
176786|NCT00484419|615239|P2|Overall Study|sponsor decision, randomized in error|0
176787|NCT00484419|615240|P1|Overall Study|sponsor decision, randomized in error|0
176788|NCT00484419|615238|P3|Overall Study|subject relocated|0
176789|NCT00484419|615239|P2|Overall Study|subject relocated|1
176790|NCT00484419|615240|P1|Overall Study|subject relocated|0
176791|NCT00484419|615238|P3|Overall Study|subject unable to receive medication|0
176792|NCT00484419|615239|P2|Overall Study|subject unable to receive medication|0
176793|NCT00484419|615240|P1|Overall Study|subject unable to receive medication|1
176794|NCT00484419|615238|P3|Overall Study|Physician Decision|1
176795|NCT00484419|615239|P2|Overall Study|Physician Decision|1
176796|NCT00484419|615240|P1|Overall Study|Physician Decision|1
176797|NCT00484419|615238|P3|Overall Study|required restricted medication|1
176798|NCT00484419|615239|P2|Overall Study|required restricted medication|0
176799|NCT00484419|615240|P1|Overall Study|required restricted medication|1
176800|NCT00484419|615238|P3|Overall Study|subject met discontinuation criteria|4
176801|NCT00484419|615239|P2|Overall Study|subject met discontinuation criteria|2
176802|NCT00484419|615240|P1|Overall Study|subject met discontinuation criteria|2
176803|NCT00484419|615238|P3|Overall Study|Withdrawal by Subject|1
176804|NCT00484419|615239|P2|Overall Study|Withdrawal by Subject|1
176805|NCT00484419|615240|P1|Overall Study|Withdrawal by Subject|3
176806|NCT00484419|615238|P3|Overall Study|Lost to Follow-up|2
176807|NCT00484419|615239|P2|Overall Study|Lost to Follow-up|0
176808|NCT00484419|615240|P1|Overall Study|Lost to Follow-up|1
176809|NCT00484419|615238|P3|Overall Study|Adverse Event|0
176810|NCT00484419|615239|P2|Overall Study|Adverse Event|0
176811|NCT00484419|615240|P1|Overall Study|Adverse Event|3
176812|NCT00484315|615307|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
176813|NCT00484315|615308|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
176814|NCT00484315|615307|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
176815|NCT00484315|615308|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
176816|NCT00484315|615307|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
176817|NCT00484315|615308|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
176818|NCT00484315|615307|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
176819|NCT00484315|615308|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
176820|NCT00484315|615307|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
176821|NCT00484315|615308|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
176822|NCT00484315|615307|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
176823|NCT00484315|615308|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
176824|NCT00484315|615307|P2|12-Month Clinical Follow-up|Death|2
176825|NCT00484315|615308|P1|12-Month Clinical Follow-up|Death|6
176826|NCT00484289|615319|P3|Post Marketing Phase|Adverse Event|0
176827|NCT00484289|615320|P2|Post Marketing Phase|Adverse Event|1
176828|NCT00484289|615321|P1|Post Marketing Phase|Adverse Event|0
176829|NCT00484289|615319|P3|Long Term Phase|Other Reason|1
176830|NCT00484289|615320|P2|Long Term Phase|Other Reason|5
176831|NCT00484289|615321|P1|Long Term Phase|Other Reason|0
176832|NCT00484289|615319|P3|Long Term Phase|Inadequate response|4
176833|NCT00484289|615320|P2|Long Term Phase|Inadequate response|7
176834|NCT00484289|615321|P1|Long Term Phase|Inadequate response|2
176835|NCT00484289|615319|P3|Long Term Phase|Withdrawal by Subject|6
176836|NCT00484289|615320|P2|Long Term Phase|Withdrawal by Subject|7
176837|NCT00484289|615321|P1|Long Term Phase|Withdrawal by Subject|0
176838|NCT00484289|615319|P3|Long Term Phase|Adverse Event|5
176839|NCT00484289|615320|P2|Long Term Phase|Adverse Event|17
176840|NCT00484289|615321|P1|Long Term Phase|Adverse Event|1
176841|NCT00484185|615393|P1|Overall Study|Death|2
176842|NCT00484185|615393|P1|Overall Study|Randomized but not treated|5
176843|NCT00484185|615393|P1|Overall Study|Other|20
176844|NCT00484185|615393|P1|Overall Study|Lost to Follow-up|44
176845|NCT00484159|615415|P3|Overall Study|Lost to Follow-up|0
176846|NCT00484159|615416|P2|Overall Study|Lost to Follow-up|1
176847|NCT00484159|615417|P1|Overall Study|Lost to Follow-up|1
176848|NCT00484094|615428|P1|Overall Study|Other|3
176849|NCT00484094|615428|P1|Overall Study|Discontinued|39
176850|NCT00483938|615444|P7|Overall Study|Other|32
176851|NCT00483938|615445|P6|Overall Study|Other|4
176852|NCT00483938|615446|P5|Overall Study|Other|0
176853|NCT00483938|615447|P4|Overall Study|Other|4
176854|NCT00483938|615448|P3|Overall Study|Other|0
176855|NCT00483938|615449|P2|Overall Study|Other|9
176856|NCT00483938|615450|P1|Overall Study|Other|3
176857|NCT00483938|615444|P7|Overall Study|Death|0
176858|NCT00483938|615445|P6|Overall Study|Death|0
176859|NCT00483938|615446|P5|Overall Study|Death|0
176860|NCT00483938|615447|P4|Overall Study|Death|0
176861|NCT00483938|615448|P3|Overall Study|Death|0
176862|NCT00483938|615449|P2|Overall Study|Death|2
176863|NCT00483938|615450|P1|Overall Study|Death|0
176864|NCT00483938|615444|P7|Overall Study|Lost to Follow-up|3
176865|NCT00483938|615445|P6|Overall Study|Lost to Follow-up|1
176866|NCT00483938|615446|P5|Overall Study|Lost to Follow-up|1
176867|NCT00483938|615447|P4|Overall Study|Lost to Follow-up|2
176868|NCT00483938|615448|P3|Overall Study|Lost to Follow-up|0
176869|NCT00483938|615449|P2|Overall Study|Lost to Follow-up|2
176870|NCT00483938|615450|P1|Overall Study|Lost to Follow-up|1
176871|NCT00483938|615444|P7|Overall Study|Withdrawal by Subject|2
176872|NCT00483938|615445|P6|Overall Study|Withdrawal by Subject|3
176873|NCT00483938|615446|P5|Overall Study|Withdrawal by Subject|1
176874|NCT00483938|615447|P4|Overall Study|Withdrawal by Subject|0
176875|NCT00483938|615448|P3|Overall Study|Withdrawal by Subject|0
176876|NCT00483938|615449|P2|Overall Study|Withdrawal by Subject|6
176877|NCT00483938|615450|P1|Overall Study|Withdrawal by Subject|1
176878|NCT00483938|615444|P7|Overall Study|Protocol Violation|3
176879|NCT00483938|615445|P6|Overall Study|Protocol Violation|0
176880|NCT00483938|615446|P5|Overall Study|Protocol Violation|0
176881|NCT00483938|615447|P4|Overall Study|Protocol Violation|0
176882|NCT00483938|615448|P3|Overall Study|Protocol Violation|0
176883|NCT00483938|615449|P2|Overall Study|Protocol Violation|0
176884|NCT00483938|615450|P1|Overall Study|Protocol Violation|0
176885|NCT00483756|615474|P3|Overall Study|Randomized, Not Treated|4
176886|NCT00483756|615475|P2|Overall Study|Randomized, Not Treated|4
176887|NCT00483756|615476|P1|Overall Study|Randomized, Not Treated|1
176888|NCT00483756|615474|P3|Overall Study|Other|3
176889|NCT00483756|615475|P2|Overall Study|Other|4
176890|NCT00483756|615476|P1|Overall Study|Other|2
176891|NCT00483756|615474|P3|Overall Study|Withdrawal by Subject|4
176892|NCT00483756|615475|P2|Overall Study|Withdrawal by Subject|3
176893|NCT00483756|615476|P1|Overall Study|Withdrawal by Subject|5
176894|NCT00483756|615474|P3|Overall Study|Lost to Follow-up|0
176895|NCT00483756|615475|P2|Overall Study|Lost to Follow-up|1
176896|NCT00483756|615476|P1|Overall Study|Lost to Follow-up|3
176897|NCT00483756|615474|P3|Overall Study|Lack of Efficacy|0
176898|NCT00483756|615475|P2|Overall Study|Lack of Efficacy|0
176899|NCT00483756|615476|P1|Overall Study|Lack of Efficacy|1
176900|NCT00483756|615474|P3|Overall Study|Adverse Event|40
176901|NCT00483756|615475|P2|Overall Study|Adverse Event|38
176902|NCT00483756|615476|P1|Overall Study|Adverse Event|19
176903|NCT00483756|615474|P3|Overall Study|Death|1
176904|NCT00483756|615475|P2|Overall Study|Death|0
176905|NCT00483756|615476|P1|Overall Study|Death|2
176906|NCT00483717|615540|P2|Overall Study|Withdrawal by Subject|0
176907|NCT00483717|615541|P1|Overall Study|Withdrawal by Subject|1
176908|NCT00483717|615540|P2|Overall Study|Lost to Follow-up|0
176909|NCT00483717|615541|P1|Overall Study|Lost to Follow-up|1
176910|NCT00483717|615540|P2|Overall Study|No treatment for migraine|13
176911|NCT00483717|615541|P1|Overall Study|No treatment for migraine|16
176912|NCT00483717|615540|P2|Overall Study|Time of dosing missing|1
176913|NCT00483717|615541|P1|Overall Study|Time of dosing missing|1
176914|NCT00483717|615540|P2|Overall Study|Protocol Violation|7
176915|NCT00483717|615541|P1|Overall Study|Protocol Violation|5
176916|NCT00483704|615564|P3|Treatment|Physician Decision|4
176917|NCT00483704|615565|P2|Treatment|Physician Decision|1
176918|NCT00483704|615566|P1|Treatment|Physician Decision|0
176919|NCT00483704|615564|P3|Treatment|Pregnancy|0
176920|NCT00483704|615565|P2|Treatment|Pregnancy|1
176921|NCT00483704|615566|P1|Treatment|Pregnancy|0
176922|NCT00483704|615564|P3|Treatment|Lack of Efficacy|1
176923|NCT00483704|615565|P2|Treatment|Lack of Efficacy|1
176924|NCT00483704|615566|P1|Treatment|Lack of Efficacy|1
176925|NCT00483704|615564|P3|Treatment|Lost to Follow-up|5
176926|NCT00483704|615565|P2|Treatment|Lost to Follow-up|7
176927|NCT00483704|615566|P1|Treatment|Lost to Follow-up|2
176928|NCT00483704|615564|P3|Treatment|Protocol Violation|5
176929|NCT00483704|615565|P2|Treatment|Protocol Violation|3
176930|NCT00483704|615566|P1|Treatment|Protocol Violation|6
176931|NCT00483704|615564|P3|Treatment|Withdrawal by Subject|21
176932|NCT00483704|615565|P2|Treatment|Withdrawal by Subject|12
176933|NCT00483704|615566|P1|Treatment|Withdrawal by Subject|16
176934|NCT00483704|615564|P3|Treatment|Adverse Event|4
176935|NCT00483704|615565|P2|Treatment|Adverse Event|5
176936|NCT00483704|615566|P1|Treatment|Adverse Event|3
176937|NCT00483704|615564|P3|Treatment|Lack of qualifying migraines|116
176938|NCT00483704|615565|P2|Treatment|Lack of qualifying migraines|99
176939|NCT00483704|615566|P1|Treatment|Lack of qualifying migraines|101
176940|NCT00483704|615564|P3|Randomization|Lack of qualifying migraines|31
176941|NCT00483704|615565|P2|Randomization|Lack of qualifying migraines|25
176942|NCT00483704|615566|P1|Randomization|Lack of qualifying migraines|21
176943|NCT00483704|615564|P3|Randomization|Progressive disease|1
176944|NCT00483704|615565|P2|Randomization|Progressive disease|0
176945|NCT00483704|615566|P1|Randomization|Progressive disease|0
176946|NCT00483704|615564|P3|Randomization|Physician Decision|0
176947|NCT00483704|615565|P2|Randomization|Physician Decision|4
176948|NCT00483704|615566|P1|Randomization|Physician Decision|2
176949|NCT00483704|615564|P3|Randomization|Pregnancy|0
176950|NCT00483704|615565|P2|Randomization|Pregnancy|0
176951|NCT00483704|615566|P1|Randomization|Pregnancy|1
176952|NCT00483704|615564|P3|Randomization|Lost to Follow-up|19
176953|NCT00483704|615565|P2|Randomization|Lost to Follow-up|14
176954|NCT00483704|615566|P1|Randomization|Lost to Follow-up|14
176955|NCT00483704|615564|P3|Randomization|Protocol Violation|22
176956|NCT00483704|615565|P2|Randomization|Protocol Violation|25
176957|NCT00483704|615566|P1|Randomization|Protocol Violation|14
176958|NCT00483704|615564|P3|Randomization|Withdrawal by Subject|18
176959|NCT00483704|615565|P2|Randomization|Withdrawal by Subject|28
176960|NCT00483704|615566|P1|Randomization|Withdrawal by Subject|19
176961|NCT00483652|615612|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
176962|NCT00483652|615613|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
176963|NCT00483652|615612|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
176964|NCT00483652|615613|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
176965|NCT00483652|615612|P2|Double-blind Treatment Period|Adverse Event|4
176966|NCT00483652|615613|P1|Double-blind Treatment Period|Adverse Event|3
176967|NCT00483652|615612|P2|Double-blind Treatment Period|Protocol Violation|1
176968|NCT00483652|615613|P1|Double-blind Treatment Period|Protocol Violation|2
176969|NCT00483574|615623|P2|Overall Study|Withdrawal by Subject|0
176970|NCT00483574|615624|P1|Overall Study|Withdrawal by Subject|52
176971|NCT00483574|615623|P2|Overall Study|Lost to Follow-up|4
176972|NCT00483574|615624|P1|Overall Study|Lost to Follow-up|16
176973|NCT00483574|615623|P2|Overall Study|Protocol Violation|9
176974|NCT00483574|615624|P1|Overall Study|Protocol Violation|28
176975|NCT00483574|615623|P2|Overall Study|Adverse Event|0
176976|NCT00483574|615624|P1|Overall Study|Adverse Event|6
176977|NCT00483548|615634|P2|Overall Study|Withdrawal by Subject|2
176978|NCT00483548|615635|P1|Overall Study|Withdrawal by Subject|5
176979|NCT00483548|615634|P2|Overall Study|Lost to Follow-up|4
176980|NCT00483548|615635|P1|Overall Study|Lost to Follow-up|3
176981|NCT00483548|615634|P2|Overall Study|Non-compliance with medication|0
176982|NCT00483548|615635|P1|Overall Study|Non-compliance with medication|2
176983|NCT00483548|615634|P2|Overall Study|Unable to comply with protocol schedule|0
176984|NCT00483548|615635|P1|Overall Study|Unable to comply with protocol schedule|1
176985|NCT00483548|615634|P2|Overall Study|Protocol required discontinuation|6
176986|NCT00483548|615635|P1|Overall Study|Protocol required discontinuation|6
176987|NCT00483548|615634|P2|Overall Study|Pregnancy|0
176988|NCT00483548|615635|P1|Overall Study|Pregnancy|1
176989|NCT00483548|615634|P2|Overall Study|Protocol Violation|7
176990|NCT00483548|615635|P1|Overall Study|Protocol Violation|11
176991|NCT00483548|615634|P2|Overall Study|Lack of Efficacy|8
176992|NCT00483548|615635|P1|Overall Study|Lack of Efficacy|4
176993|NCT00483548|615634|P2|Overall Study|Laboratory abnormality|2
176994|NCT00483548|615635|P1|Overall Study|Laboratory abnormality|1
176995|NCT00483548|615634|P2|Overall Study|Adverse Event|14
176996|NCT00483548|615635|P1|Overall Study|Adverse Event|25
176997|NCT00483548|615634|P2|Overall Study|Randomized; not treated with study drug|3
176998|NCT00483548|615635|P1|Overall Study|Randomized; not treated with study drug|1
176999|NCT00483405|615685|P1|Overall Study|Other complicating disease|1
177000|NCT00483405|615685|P1|Overall Study|Withdrawal by Subject|2
177001|NCT00483405|615685|P1|Overall Study|Death|3
177002|NCT00483405|615685|P1|Overall Study|Lack of Efficacy|14
177003|NCT00483405|615685|P1|Overall Study|Adverse Event|8
177004|NCT00483379|615694|P2|Treatment Period|Withdrawal by Subject|0
177005|NCT00483379|615695|P1|Treatment Period|Withdrawal by Subject|1
177006|NCT00483379|615694|P2|Treatment Period|Adverse Event|0
177007|NCT00483379|615695|P1|Treatment Period|Adverse Event|1
177008|NCT00483327|615731|P1|Overall Study|Patient Non Compliance|2
177009|NCT00483327|615731|P1|Overall Study|Lost to Follow-up|4
177010|NCT00483327|615731|P1|Overall Study|Withdrawal by Subject|3
177011|NCT00483327|615731|P1|Overall Study|Adverse Event|1
177012|NCT00483184|615763|P3|Overall Study|Protocol Violation|1
177013|NCT00483184|615764|P2|Overall Study|Protocol Violation|0
177014|NCT00483184|615765|P1|Overall Study|Protocol Violation|1
177015|NCT00483184|615763|P3|Overall Study|Adverse Event|2
177016|NCT00483184|615764|P2|Overall Study|Adverse Event|2
177017|NCT00483184|615765|P1|Overall Study|Adverse Event|1
177018|NCT00483184|615763|P3|Overall Study|Lost to Follow-up|0
177019|NCT00483184|615764|P2|Overall Study|Lost to Follow-up|0
177020|NCT00483184|615765|P1|Overall Study|Lost to Follow-up|1
177021|NCT00483184|615763|P3|Overall Study|Withdrawal by Subject|0
177022|NCT00483184|615764|P2|Overall Study|Withdrawal by Subject|2
177023|NCT00483184|615765|P1|Overall Study|Withdrawal by Subject|2
177024|NCT00483119|615775|P2|Overall Study|Physician Decision|0
177025|NCT00483119|615776|P1|Overall Study|Physician Decision|1
177026|NCT00483119|615775|P2|Overall Study|Adverse Event|1
177027|NCT00483119|615776|P1|Overall Study|Adverse Event|0
177028|NCT00483041|615790|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
177029|NCT00483041|615791|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
177030|NCT00483002|615821|P1|Overall Study|Other|967
177031|NCT00483002|615821|P1|Overall Study|Other|2
177032|NCT00483002|615821|P1|Overall Study|Lost to Follow-up|962
177033|NCT00483002|615821|P1|Overall Study|Lack of Efficacy|555
177034|NCT00483002|615821|P1|Overall Study|Adverse Event|68
177035|NCT00482729|615846|P2|Overall Study|Withdrawal by Subject|69
177036|NCT00482729|615847|P1|Overall Study|Withdrawal by Subject|67
177037|NCT00482729|615846|P2|Overall Study|Protocol Violation|18
177038|NCT00482729|615847|P1|Overall Study|Protocol Violation|10
177039|NCT00482729|615846|P2|Overall Study|Pregnancy|2
177040|NCT00482729|615847|P1|Overall Study|Pregnancy|4
177041|NCT00482729|615846|P2|Overall Study|Physician Decision|7
177042|NCT00482729|615847|P1|Overall Study|Physician Decision|10
177043|NCT00482729|615846|P2|Overall Study|Lost to Follow-up|66
177044|NCT00482729|615847|P1|Overall Study|Lost to Follow-up|86
177045|NCT00482729|615846|P2|Overall Study|Lack of Efficacy|16
177046|NCT00482729|615847|P1|Overall Study|Lack of Efficacy|4
177047|NCT00482729|615846|P2|Overall Study|Hyperglycemia Criteria|5
177048|NCT00482729|615847|P1|Overall Study|Hyperglycemia Criteria|7
177049|NCT00482729|615846|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
177050|NCT00482729|615847|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
177051|NCT00482729|615846|P2|Overall Study|Adverse Event|33
177052|NCT00482729|615847|P1|Overall Study|Adverse Event|29
177053|NCT00482703|615863|P2|Overall Study|Poor compliance|0
177054|NCT00482703|615864|P1|Overall Study|Poor compliance|1
177055|NCT00482612|615935|P4|Follow-up Period|Reasons not related to trial|3
177056|NCT00482612|615936|P3|Follow-up Period|Reasons not related to trial|1
177057|NCT00482612|615937|P2|Follow-up Period|Reasons not related to trial|0
177058|NCT00482612|615938|P1|Follow-up Period|Reasons not related to trial|1
177059|NCT00482612|615935|P4|Follow-up Period|Withdrawal by Subject|2
177060|NCT00482612|615936|P3|Follow-up Period|Withdrawal by Subject|7
177061|NCT00482612|615937|P2|Follow-up Period|Withdrawal by Subject|5
177062|NCT00482612|615938|P1|Follow-up Period|Withdrawal by Subject|3
177063|NCT00482612|615935|P4|Follow-up Period|Lack of Efficacy|0
177064|NCT00482612|615936|P3|Follow-up Period|Lack of Efficacy|1
177065|NCT00482612|615937|P2|Follow-up Period|Lack of Efficacy|0
177066|NCT00482612|615938|P1|Follow-up Period|Lack of Efficacy|2
177067|NCT00482612|615935|P4|Follow-up Period|Adverse Event|0
177068|NCT00482612|615936|P3|Follow-up Period|Adverse Event|9
177069|NCT00482612|615937|P2|Follow-up Period|Adverse Event|7
177070|NCT00482612|615938|P1|Follow-up Period|Adverse Event|4
177071|NCT00482612|615935|P4|Follow-up Period|Lost to Follow-up|1
177072|NCT00482612|615936|P3|Follow-up Period|Lost to Follow-up|2
177073|NCT00482612|615937|P2|Follow-up Period|Lost to Follow-up|4
177074|NCT00482612|615938|P1|Follow-up Period|Lost to Follow-up|0
177075|NCT00482612|615935|P4|Follow-up Period|Lack of compliance|0
177076|NCT00482612|615936|P3|Follow-up Period|Lack of compliance|1
177077|NCT00482612|615937|P2|Follow-up Period|Lack of compliance|0
177078|NCT00482612|615938|P1|Follow-up Period|Lack of compliance|0
177079|NCT00482612|615935|P4|Follow-up Period|Other|2
177080|NCT00482612|615936|P3|Follow-up Period|Other|1
177081|NCT00482612|615937|P2|Follow-up Period|Other|2
177082|NCT00482612|615938|P1|Follow-up Period|Other|4
177083|NCT00482612|615935|P4|In-treatment Period|No study medication administered|0
177084|NCT00482612|615936|P3|In-treatment Period|No study medication administered|1
177085|NCT00482612|615937|P2|In-treatment Period|No study medication administered|0
177086|NCT00482612|615938|P1|In-treatment Period|No study medication administered|0
177087|NCT00482391|615987|P1|Overall Study|Death|1
177088|NCT00482391|615987|P1|Overall Study|Adverse Event|1
177089|NCT00482391|615987|P1|Overall Study|Withdrawal by Subject|1
177090|NCT00482274|615992|P1|Overall Study|Adverse Event|1
177091|NCT00482170|616002|P2|Overall Study|Unspecified reason|2
177092|NCT00482170|616003|P1|Overall Study|Unspecified reason|0
177093|NCT00482170|616002|P2|Overall Study|Lost to Follow-up|0
177094|NCT00482170|616003|P1|Overall Study|Lost to Follow-up|2
177095|NCT00482170|616002|P2|Overall Study|Protocol Violation|3
177096|NCT00482170|616003|P1|Overall Study|Protocol Violation|2
177097|NCT00482170|616002|P2|Overall Study|Withdrawal by Subject|1
177098|NCT00482170|616003|P1|Overall Study|Withdrawal by Subject|6
177099|NCT00482170|616002|P2|Overall Study|Adverse Event|14
177100|NCT00482170|616003|P1|Overall Study|Adverse Event|5
177101|NCT00482053|616121|P1|Inter-treatment Period|Disease progression|1
177102|NCT00482014|616135|P4|Overall Study|Sponsor Decision|1
177103|NCT00482014|616136|P3|Overall Study|Sponsor Decision|1
177104|NCT00482014|616137|P2|Overall Study|Sponsor Decision|2
177105|NCT00482014|616138|P1|Overall Study|Sponsor Decision|1
177106|NCT00482014|616135|P4|Overall Study|Lack of Efficacy|6
177107|NCT00482014|616136|P3|Overall Study|Lack of Efficacy|4
177108|NCT00482014|616137|P2|Overall Study|Lack of Efficacy|0
177109|NCT00482014|616138|P1|Overall Study|Lack of Efficacy|1
177110|NCT00482014|616135|P4|Overall Study|Death|4
177111|NCT00482014|616136|P3|Overall Study|Death|1
177112|NCT00482014|616137|P2|Overall Study|Death|2
177113|NCT00482014|616138|P1|Overall Study|Death|1
177114|NCT00482014|616135|P4|Overall Study|Adverse Event|8
177115|NCT00482014|616136|P3|Overall Study|Adverse Event|2
177116|NCT00482014|616137|P2|Overall Study|Adverse Event|0
177117|NCT00482014|616138|P1|Overall Study|Adverse Event|3
177118|NCT00482014|616135|P4|Overall Study|Withdrawal by Subject|4
177119|NCT00482014|616136|P3|Overall Study|Withdrawal by Subject|3
177120|NCT00482014|616137|P2|Overall Study|Withdrawal by Subject|2
177121|NCT00482014|616138|P1|Overall Study|Withdrawal by Subject|1
177122|NCT00481988|616162|P2|Overall Study|Withdrawal by Subject|1
177123|NCT00481988|616163|P1|Overall Study|Withdrawal by Subject|1
177124|NCT00481871|616176|P5|Overall Study|Progressive Disease - pt withdrew|0
177125|NCT00481871|616177|P4|Overall Study|Progressive Disease - pt withdrew|0
177126|NCT00481871|616178|P3|Overall Study|Progressive Disease - pt withdrew|1
177127|NCT00481871|616179|P2|Overall Study|Progressive Disease - pt withdrew|0
177128|NCT00481871|616180|P1|Overall Study|Progressive Disease - pt withdrew|0
177129|NCT00481832|616205|P1|Inter-transplant Period|Lack of allogeneic donor|5
177130|NCT00481832|616205|P1|Inter-transplant Period|Disease relapse|11
177131|NCT00481832|616205|P1|Inter-transplant Period|Physician Decision|4
177132|NCT00481832|616205|P1|Inter-transplant Period|Death|3
177133|NCT00481832|616205|P1|Inter-transplant Period|Adverse Event|4
177134|NCT00481832|616205|P1|Enrollment|Unable to collect enough stem cells|2
177135|NCT00481832|616205|P1|Enrollment|Physician Decision|8
177136|NCT00481767|616220|P2|Overall Study|Lost to Follow-up|10
177137|NCT00481767|616221|P1|Overall Study|Lost to Follow-up|16
177138|NCT00481767|616220|P2|Overall Study|Withdrawal by Subject|11
177139|NCT00481767|616221|P1|Overall Study|Withdrawal by Subject|16
177140|NCT00481676|616255|P2|Overall Study|Administrative problem|0
177141|NCT00481676|616256|P1|Overall Study|Administrative problem|1
177142|NCT00481676|616255|P2|Overall Study|Unsatisfactory therapeutic effect|4
177143|NCT00481676|616256|P1|Overall Study|Unsatisfactory therapeutic effect|1
177144|NCT00481676|616255|P2|Overall Study|Adverse Event|1
177145|NCT00481676|616256|P1|Overall Study|Adverse Event|0
177146|NCT00481247|616306|P2|Overall Study|Did not receive treatment|2
177147|NCT00481247|616307|P1|Overall Study|Did not receive treatment|1
177148|NCT00481247|616306|P2|Overall Study|Varied|15
177149|NCT00481247|616307|P1|Overall Study|Varied|6
177150|NCT00481247|616306|P2|Overall Study|Administrative reason by sponsor|162
177151|NCT00481247|616307|P1|Overall Study|Administrative reason by sponsor|157
177152|NCT00481247|616306|P2|Overall Study|Poor compliance/noncompliance|7
177153|NCT00481247|616307|P1|Overall Study|Poor compliance/noncompliance|1
177154|NCT00481247|616306|P2|Overall Study|Lost to Follow-up|2
177155|NCT00481247|616307|P1|Overall Study|Lost to Follow-up|1
177156|NCT00481247|616306|P2|Overall Study|Pregnancy|1
177157|NCT00481247|616307|P1|Overall Study|Pregnancy|2
177158|NCT00481247|616306|P2|Overall Study|Withdrawal by Subject|13
177159|NCT00481247|616307|P1|Overall Study|Withdrawal by Subject|8
177160|NCT00481247|616306|P2|Overall Study|AE unrelated to study drug|4
177161|NCT00481247|616307|P1|Overall Study|AE unrelated to study drug|13
177162|NCT00481247|616306|P2|Overall Study|Treatment failure|14
177163|NCT00481247|616307|P1|Overall Study|Treatment failure|10
177164|NCT00481247|616306|P2|Overall Study|Intolerance|17
177165|NCT00481247|616307|P1|Overall Study|Intolerance|42
177166|NCT00481247|616306|P2|Overall Study|Disease progression|22
177167|NCT00481247|616307|P1|Overall Study|Disease progression|18
177168|NCT00481247|616306|P2|Overall Study|Death|1
177169|NCT00481247|616307|P1|Overall Study|Death|0
177170|NCT00481195|616331|P2|Overall Study|Miscellaneous|2
177171|NCT00481195|616332|P1|Overall Study|Miscellaneous|2
177172|NCT00481195|616331|P2|Overall Study|Withdrawal by Subject|9
177173|NCT00481195|616332|P1|Overall Study|Withdrawal by Subject|3
177174|NCT00481195|616331|P2|Overall Study|Protocol Violation|7
177175|NCT00481195|616332|P1|Overall Study|Protocol Violation|10
177176|NCT00481195|616331|P2|Overall Study|Physician Decision|1
177177|NCT00481195|616332|P1|Overall Study|Physician Decision|3
177178|NCT00481195|616331|P2|Overall Study|Lost to Follow-up|6
177179|NCT00481195|616332|P1|Overall Study|Lost to Follow-up|4
177180|NCT00481195|616331|P2|Overall Study|Lack of Efficacy|3
177181|NCT00481195|616332|P1|Overall Study|Lack of Efficacy|1
177182|NCT00481195|616331|P2|Overall Study|Adverse Event|11
177183|NCT00481195|616332|P1|Overall Study|Adverse Event|16
177184|NCT00481078|616418|P2|Overall Study|Brain metastasis|1
177185|NCT00481078|616419|P1|Overall Study|Brain metastasis|0
177186|NCT00481078|616418|P2|Overall Study|Received other treatment|1
177187|NCT00481078|616419|P1|Overall Study|Received other treatment|2
177188|NCT00481078|616418|P2|Overall Study|Information not available|0
177189|NCT00481078|616419|P1|Overall Study|Information not available|1
177190|NCT00481078|616418|P2|Overall Study|Withdrawal by Subject|1
177191|NCT00481078|616419|P1|Overall Study|Withdrawal by Subject|7
177192|NCT00481078|616418|P2|Overall Study|Intercurrent illness|0
177193|NCT00481078|616419|P1|Overall Study|Intercurrent illness|1
177194|NCT00481078|616418|P2|Overall Study|Death|3
177195|NCT00481078|616419|P1|Overall Study|Death|5
177196|NCT00481078|616418|P2|Overall Study|Adverse Event|3
177197|NCT00481078|616419|P1|Overall Study|Adverse Event|15
177198|NCT00481078|616418|P2|Overall Study|Progression of disease|11
177199|NCT00481078|616419|P1|Overall Study|Progression of disease|11
177200|NCT00481065|616437|P8|Overall Study|Unable to classify|0
177201|NCT00481065|616438|P7|Overall Study|Unable to classify|0
177202|NCT00481065|616439|P6|Overall Study|Unable to classify|0
177203|NCT00481065|616440|P5|Overall Study|Unable to classify|1
177204|NCT00481065|616441|P4|Overall Study|Unable to classify|0
177205|NCT00481065|616442|P3|Overall Study|Unable to classify|2
177206|NCT00481065|616443|P2|Overall Study|Unable to classify|1
177207|NCT00481065|616444|P1|Overall Study|Unable to classify|0
177208|NCT00481065|616437|P8|Overall Study|Protocol Violation|2
177209|NCT00481065|616438|P7|Overall Study|Protocol Violation|3
177210|NCT00481065|616439|P6|Overall Study|Protocol Violation|6
177211|NCT00481065|616440|P5|Overall Study|Protocol Violation|2
177212|NCT00481065|616441|P4|Overall Study|Protocol Violation|1
177213|NCT00481065|616442|P3|Overall Study|Protocol Violation|1
177214|NCT00481065|616443|P2|Overall Study|Protocol Violation|1
177215|NCT00481065|616444|P1|Overall Study|Protocol Violation|2
177216|NCT00481065|616437|P8|Overall Study|Administrative reason|0
177217|NCT00481065|616438|P7|Overall Study|Administrative reason|1
177218|NCT00481065|616439|P6|Overall Study|Administrative reason|2
177219|NCT00481065|616440|P5|Overall Study|Administrative reason|0
177220|NCT00481065|616441|P4|Overall Study|Administrative reason|0
177221|NCT00481065|616442|P3|Overall Study|Administrative reason|0
177222|NCT00481065|616443|P2|Overall Study|Administrative reason|0
177223|NCT00481065|616444|P1|Overall Study|Administrative reason|0
177224|NCT00481065|616437|P8|Overall Study|Inappropriate enrollment|1
177225|NCT00481065|616438|P7|Overall Study|Inappropriate enrollment|0
177226|NCT00481065|616439|P6|Overall Study|Inappropriate enrollment|1
177227|NCT00481065|616440|P5|Overall Study|Inappropriate enrollment|2
177228|NCT00481065|616441|P4|Overall Study|Inappropriate enrollment|0
177229|NCT00481065|616442|P3|Overall Study|Inappropriate enrollment|2
177230|NCT00481065|616443|P2|Overall Study|Inappropriate enrollment|0
177231|NCT00481065|616444|P1|Overall Study|Inappropriate enrollment|4
177232|NCT00481065|616437|P8|Overall Study|Lost to Follow-up|5
177233|NCT00481065|616438|P7|Overall Study|Lost to Follow-up|2
177234|NCT00481065|616439|P6|Overall Study|Lost to Follow-up|3
177235|NCT00481065|616440|P5|Overall Study|Lost to Follow-up|3
177236|NCT00481065|616441|P4|Overall Study|Lost to Follow-up|3
177237|NCT00481065|616442|P3|Overall Study|Lost to Follow-up|4
177238|NCT00481065|616443|P2|Overall Study|Lost to Follow-up|2
177239|NCT00481065|616444|P1|Overall Study|Lost to Follow-up|4
177240|NCT00481065|616437|P8|Overall Study|Withdrawal by Subject|10
177241|NCT00481065|616438|P7|Overall Study|Withdrawal by Subject|9
177242|NCT00481065|616439|P6|Overall Study|Withdrawal by Subject|12
177243|NCT00481065|616440|P5|Overall Study|Withdrawal by Subject|13
177244|NCT00481065|616441|P4|Overall Study|Withdrawal by Subject|11
177245|NCT00481065|616442|P3|Overall Study|Withdrawal by Subject|7
177246|NCT00481065|616443|P2|Overall Study|Withdrawal by Subject|12
177247|NCT00481065|616444|P1|Overall Study|Withdrawal by Subject|11
177248|NCT00481065|616437|P8|Overall Study|Adverse event or death|1
177249|NCT00481065|616438|P7|Overall Study|Adverse event or death|1
177250|NCT00481065|616439|P6|Overall Study|Adverse event or death|0
177251|NCT00481065|616440|P5|Overall Study|Adverse event or death|2
177252|NCT00481065|616441|P4|Overall Study|Adverse event or death|0
177253|NCT00481065|616442|P3|Overall Study|Adverse event or death|3
177254|NCT00481065|616443|P2|Overall Study|Adverse event or death|1
177255|NCT00481065|616444|P1|Overall Study|Adverse event or death|1
177256|NCT00480857|616534|P1|Overall Study|Lack of Efficacy|2
177257|NCT00480779|616544|P2|Overall Study|Job and Health-related|3
177258|NCT00480779|616545|P1|Overall Study|Job and Health-related|0
177259|NCT00480779|616544|P2|Overall Study|Other|0
177260|NCT00480779|616545|P1|Overall Study|Other|2
177261|NCT00480636|616582|P1|Overall Study|Lost to follow-up; subsequently died|1
177262|NCT00480636|616582|P1|Overall Study|Other|2
177263|NCT00480636|616582|P1|Overall Study|Lost to Follow-up|4
177264|NCT00480636|616582|P1|Overall Study|Death|12
177265|NCT00480532|616594|P4|Overall Study|Protocol Violation|0
177266|NCT00480532|616595|P3|Overall Study|Protocol Violation|1
177267|NCT00480532|616596|P2|Overall Study|Protocol Violation|0
177268|NCT00480532|616597|P1|Overall Study|Protocol Violation|0
177269|NCT00480532|616594|P4|Overall Study|Withdrawal by Subject|1
177270|NCT00480532|616595|P3|Overall Study|Withdrawal by Subject|3
177271|NCT00480532|616596|P2|Overall Study|Withdrawal by Subject|4
177272|NCT00480532|616597|P1|Overall Study|Withdrawal by Subject|2
177273|NCT00480493|616617|P2|Overall Study|moved|7
177274|NCT00480493|616618|P1|Overall Study|moved|2
177275|NCT00480324|616630|P2|Overall Study|Subject’s mother pregnant|1
177276|NCT00480324|616631|P1|Overall Study|Subject’s mother pregnant|0
177277|NCT00480324|616630|P2|Overall Study|Lost to Follow-up|8
177278|NCT00480324|616631|P1|Overall Study|Lost to Follow-up|17
177279|NCT00480324|616630|P2|Overall Study|Withdrawal by Subject|5
177280|NCT00480324|616631|P1|Overall Study|Withdrawal by Subject|14
177281|NCT00480324|616630|P2|Overall Study|Protocol Violation|1
177282|NCT00480324|616631|P1|Overall Study|Protocol Violation|0
177283|NCT00480324|616630|P2|Overall Study|Adverse Event|1
177284|NCT00480324|616631|P1|Overall Study|Adverse Event|1
177285|NCT00479882|616661|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
177286|NCT00479882|616662|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
177287|NCT00479882|616663|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
177288|NCT00479882|616664|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
177289|NCT00479882|616661|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
177290|NCT00479882|616662|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
177291|NCT00479882|616663|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
177292|NCT00479882|616664|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
177293|NCT00479882|616661|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
177294|NCT00479882|616662|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
177295|NCT00479882|616663|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
177296|NCT00479882|616664|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
177297|NCT00479882|616661|P4|Crossover: Period III (Weeks 13-20)|Other|2
177298|NCT00479882|616662|P3|Crossover: Period III (Weeks 13-20)|Other|2
177299|NCT00479882|616663|P2|Crossover: Period III (Weeks 13-20)|Other|0
177300|NCT00479882|616664|P1|Crossover: Period III (Weeks 13-20)|Other|5
177301|NCT00479882|616661|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
177302|NCT00479882|616662|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
177303|NCT00479882|616663|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
177304|NCT00479882|616664|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
177305|NCT00479882|616661|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
177306|NCT00479882|616662|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
177307|NCT00479882|616663|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
177308|NCT00479882|616664|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
177309|NCT00479882|616661|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
177310|NCT00479882|616662|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
177311|NCT00479882|616663|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
177312|NCT00479882|616664|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
177313|NCT00479882|616661|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
177314|NCT00479882|616662|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
177315|NCT00479882|616663|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
177316|NCT00479882|616664|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
177317|NCT00479882|616661|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
177318|NCT00479882|616662|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
177319|NCT00479882|616663|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
177320|NCT00479882|616664|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
177321|NCT00479882|616661|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
177322|NCT00479882|616662|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
177323|NCT00479882|616663|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
177324|NCT00479882|616664|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
177325|NCT00479882|616661|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
177326|NCT00479882|616662|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
177327|NCT00479882|616663|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
177328|NCT00479882|616664|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
177329|NCT00479882|616661|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
177330|NCT00479882|616662|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
177331|NCT00479882|616663|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
177332|NCT00479882|616664|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
177333|NCT00479882|616661|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
177334|NCT00479882|616662|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
177335|NCT00479882|616663|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
177336|NCT00479882|616664|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
177337|NCT00479882|616661|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
177338|NCT00479882|616662|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
177339|NCT00479882|616663|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
177340|NCT00479882|616664|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
177341|NCT00479856|616794|P1|Overall Study|Physician Decision|1
177342|NCT00479856|616794|P1|Overall Study|Withdrawal by Subject|1
177343|NCT00479856|616794|P1|Overall Study|Adverse Event|1
177344|NCT00479765|616803|P1|Overall Study|study terminated|4
177345|NCT00479713|616809|P2|Overall Study|Withdrawal by Subject|1
177346|NCT00479713|616810|P1|Overall Study|Withdrawal by Subject|4
177347|NCT00479713|616809|P2|Overall Study|Protocol Violation|1
177348|NCT00479713|616810|P1|Overall Study|Protocol Violation|0
177349|NCT00479713|616809|P2|Overall Study|Lost to Follow-up|1
177350|NCT00479713|616810|P1|Overall Study|Lost to Follow-up|0
177351|NCT00479713|616809|P2|Overall Study|Death|0
177352|NCT00479713|616810|P1|Overall Study|Death|1
177353|NCT00479713|616809|P2|Overall Study|Adverse Event|6
177354|NCT00479713|616810|P1|Overall Study|Adverse Event|8
177355|NCT00479674|616834|P1|Overall Study|none provided|3
177356|NCT00479674|616834|P1|Overall Study|Physician Decision|14
177357|NCT00479674|616834|P1|Overall Study|Withdrawal by Subject|6
177358|NCT00479674|616834|P1|Overall Study|Adverse Event|18
177359|NCT00479557|616849|P7|Overall Study|Not specified|0
177360|NCT00479557|616850|P6|Overall Study|Not specified|3
177361|NCT00479557|616851|P5|Overall Study|Not specified|0
177362|NCT00479557|616852|P4|Overall Study|Not specified|0
177363|NCT00479557|616853|P3|Overall Study|Not specified|1
177364|NCT00479557|616854|P2|Overall Study|Not specified|3
177365|NCT00479557|616855|P1|Overall Study|Not specified|2
177366|NCT00479557|616849|P7|Overall Study|Subject Request|1
177367|NCT00479557|616850|P6|Overall Study|Subject Request|4
177368|NCT00479557|616851|P5|Overall Study|Subject Request|1
177369|NCT00479557|616852|P4|Overall Study|Subject Request|1
177370|NCT00479557|616853|P3|Overall Study|Subject Request|1
177371|NCT00479557|616854|P2|Overall Study|Subject Request|0
177372|NCT00479557|616855|P1|Overall Study|Subject Request|3
177373|NCT00479557|616849|P7|Overall Study|Investigator Request|0
177374|NCT00479557|616850|P6|Overall Study|Investigator Request|0
177375|NCT00479557|616851|P5|Overall Study|Investigator Request|0
177376|NCT00479557|616852|P4|Overall Study|Investigator Request|0
177377|NCT00479557|616853|P3|Overall Study|Investigator Request|1
177378|NCT00479557|616854|P2|Overall Study|Investigator Request|0
177379|NCT00479557|616855|P1|Overall Study|Investigator Request|0
177380|NCT00479557|616849|P7|Overall Study|Caregiver Request|0
177381|NCT00479557|616850|P6|Overall Study|Caregiver Request|2
177382|NCT00479557|616851|P5|Overall Study|Caregiver Request|1
177383|NCT00479557|616852|P4|Overall Study|Caregiver Request|0
177384|NCT00479557|616853|P3|Overall Study|Caregiver Request|2
177385|NCT00479557|616854|P2|Overall Study|Caregiver Request|2
177386|NCT00479557|616855|P1|Overall Study|Caregiver Request|2
177387|NCT00479557|616849|P7|Overall Study|AE not related to Study Drug|1
177388|NCT00479557|616850|P6|Overall Study|AE not related to Study Drug|2
177389|NCT00479557|616851|P5|Overall Study|AE not related to Study Drug|2
177390|NCT00479557|616852|P4|Overall Study|AE not related to Study Drug|0
177391|NCT00479557|616853|P3|Overall Study|AE not related to Study Drug|0
177392|NCT00479557|616854|P2|Overall Study|AE not related to Study Drug|3
177393|NCT00479557|616855|P1|Overall Study|AE not related to Study Drug|1
177394|NCT00479557|616849|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
177395|NCT00479557|616850|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
177396|NCT00479557|616851|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
177397|NCT00479557|616852|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
177398|NCT00479557|616853|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
177399|NCT00479557|616854|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
177400|NCT00479557|616855|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
177401|NCT00479557|616849|P7|Overall Study|Lost to Follow-up|0
177402|NCT00479557|616850|P6|Overall Study|Lost to Follow-up|0
177403|NCT00479557|616851|P5|Overall Study|Lost to Follow-up|0
177404|NCT00479557|616852|P4|Overall Study|Lost to Follow-up|2
177405|NCT00479557|616853|P3|Overall Study|Lost to Follow-up|0
177406|NCT00479557|616854|P2|Overall Study|Lost to Follow-up|2
177407|NCT00479557|616855|P1|Overall Study|Lost to Follow-up|0
177408|NCT00479557|616849|P7|Overall Study|Lack of Efficacy|0
177409|NCT00479557|616850|P6|Overall Study|Lack of Efficacy|0
177410|NCT00479557|616851|P5|Overall Study|Lack of Efficacy|0
177411|NCT00479557|616852|P4|Overall Study|Lack of Efficacy|0
177412|NCT00479557|616853|P3|Overall Study|Lack of Efficacy|0
177413|NCT00479557|616854|P2|Overall Study|Lack of Efficacy|0
177414|NCT00479557|616855|P1|Overall Study|Lack of Efficacy|1
177415|NCT00479557|616849|P7|Overall Study|Death|0
177416|NCT00479557|616850|P6|Overall Study|Death|1
177417|NCT00479557|616851|P5|Overall Study|Death|0
177418|NCT00479557|616852|P4|Overall Study|Death|0
177419|NCT00479557|616853|P3|Overall Study|Death|0
177420|NCT00479557|616854|P2|Overall Study|Death|0
177421|NCT00479557|616855|P1|Overall Study|Death|0
177422|NCT00479466|616898|P6|Overall Study|Withdrawal by Subject|1
177423|NCT00479466|616899|P5|Overall Study|Withdrawal by Subject|3
177424|NCT00479466|616900|P4|Overall Study|Withdrawal by Subject|2
177425|NCT00479466|616901|P3|Overall Study|Withdrawal by Subject|0
177426|NCT00479466|616902|P2|Overall Study|Withdrawal by Subject|5
177427|NCT00479466|616903|P1|Overall Study|Withdrawal by Subject|3
177428|NCT00479466|616898|P6|Overall Study|Protocol Violation|0
177429|NCT00479466|616899|P5|Overall Study|Protocol Violation|0
177430|NCT00479466|616900|P4|Overall Study|Protocol Violation|0
177431|NCT00479466|616901|P3|Overall Study|Protocol Violation|0
177432|NCT00479466|616902|P2|Overall Study|Protocol Violation|0
177433|NCT00479466|616903|P1|Overall Study|Protocol Violation|1
177434|NCT00479466|616898|P6|Overall Study|Pregnancy|0
177435|NCT00479466|616899|P5|Overall Study|Pregnancy|1
177436|NCT00479466|616900|P4|Overall Study|Pregnancy|0
177437|NCT00479466|616901|P3|Overall Study|Pregnancy|0
177438|NCT00479466|616902|P2|Overall Study|Pregnancy|0
177439|NCT00479466|616903|P1|Overall Study|Pregnancy|0
177440|NCT00479466|616898|P6|Overall Study|Physician Decision|0
177441|NCT00479466|616899|P5|Overall Study|Physician Decision|0
177442|NCT00479466|616900|P4|Overall Study|Physician Decision|0
177443|NCT00479466|616901|P3|Overall Study|Physician Decision|1
177444|NCT00479466|616902|P2|Overall Study|Physician Decision|1
177445|NCT00479466|616903|P1|Overall Study|Physician Decision|2
177446|NCT00479466|616898|P6|Overall Study|Lost to Follow-up|2
177447|NCT00479466|616899|P5|Overall Study|Lost to Follow-up|2
177448|NCT00479466|616900|P4|Overall Study|Lost to Follow-up|0
177449|NCT00479466|616901|P3|Overall Study|Lost to Follow-up|1
177450|NCT00479466|616902|P2|Overall Study|Lost to Follow-up|1
177451|NCT00479466|616903|P1|Overall Study|Lost to Follow-up|0
177452|NCT00479466|616898|P6|Overall Study|Lack of Efficacy|0
177453|NCT00479466|616899|P5|Overall Study|Lack of Efficacy|0
177454|NCT00479466|616900|P4|Overall Study|Lack of Efficacy|0
177455|NCT00479466|616901|P3|Overall Study|Lack of Efficacy|1
177456|NCT00479466|616902|P2|Overall Study|Lack of Efficacy|0
177457|NCT00479466|616903|P1|Overall Study|Lack of Efficacy|2
177458|NCT00479466|616898|P6|Overall Study|Hyperglycemia|1
177459|NCT00479466|616899|P5|Overall Study|Hyperglycemia|0
177460|NCT00479466|616900|P4|Overall Study|Hyperglycemia|0
177461|NCT00479466|616901|P3|Overall Study|Hyperglycemia|0
177462|NCT00479466|616902|P2|Overall Study|Hyperglycemia|0
177463|NCT00479466|616903|P1|Overall Study|Hyperglycemia|0
177464|NCT00479466|616898|P6|Overall Study|Adverse Event|0
177465|NCT00479466|616899|P5|Overall Study|Adverse Event|2
177466|NCT00479466|616900|P4|Overall Study|Adverse Event|1
177467|NCT00479466|616901|P3|Overall Study|Adverse Event|0
177468|NCT00479466|616902|P2|Overall Study|Adverse Event|1
177469|NCT00479466|616903|P1|Overall Study|Adverse Event|5
177470|NCT00479401|616932|P3|Overall Study|Exclusion criteria, relocation|0
177471|NCT00479401|616933|P2|Overall Study|Exclusion criteria, relocation|3
177472|NCT00479401|616934|P1|Overall Study|Exclusion criteria, relocation|4
177473|NCT00479401|616932|P3|Overall Study|Withdrawal by Subject|2
177474|NCT00479401|616933|P2|Overall Study|Withdrawal by Subject|10
177475|NCT00479401|616934|P1|Overall Study|Withdrawal by Subject|16
177476|NCT00479401|616932|P3|Overall Study|Lost to Follow-up|1
177477|NCT00479401|616933|P2|Overall Study|Lost to Follow-up|1
177478|NCT00479401|616934|P1|Overall Study|Lost to Follow-up|1
177479|NCT00479401|616932|P3|Overall Study|Protocol Violation|1
177480|NCT00479401|616933|P2|Overall Study|Protocol Violation|1
177481|NCT00479401|616934|P1|Overall Study|Protocol Violation|2
177482|NCT00479401|616932|P3|Overall Study|Lack of Efficacy|4
177483|NCT00479401|616933|P2|Overall Study|Lack of Efficacy|2
177484|NCT00479401|616934|P1|Overall Study|Lack of Efficacy|2
177485|NCT00479401|616932|P3|Overall Study|Adverse Event|4
177486|NCT00479401|616933|P2|Overall Study|Adverse Event|20
177487|NCT00479401|616934|P1|Overall Study|Adverse Event|24
177488|NCT00479388|616989|P2|Overall Study|Withdrawal by Subject|17
177489|NCT00479388|616990|P1|Overall Study|Withdrawal by Subject|32
177490|NCT00479388|616989|P2|Overall Study|Protocol Violation|9
177491|NCT00479388|616990|P1|Overall Study|Protocol Violation|10
177492|NCT00479388|616989|P2|Overall Study|Lost to Follow-up|2
177493|NCT00479388|616990|P1|Overall Study|Lost to Follow-up|0
177494|NCT00479388|616989|P2|Overall Study|Adverse Event|45
177495|NCT00479388|616990|P1|Overall Study|Adverse Event|90
177496|NCT00479336|617004|P4|Overall Study|Resolution of all hepatic edema findings|0
177497|NCT00479336|617005|P3|Overall Study|Resolution of all hepatic edema findings|0
177498|NCT00479336|617006|P2|Overall Study|Resolution of all hepatic edema findings|1
177499|NCT00479336|617007|P1|Overall Study|Resolution of all hepatic edema findings|1
177500|NCT00479336|617004|P4|Overall Study|Physician Decision|2
177501|NCT00479336|617005|P3|Overall Study|Physician Decision|0
177502|NCT00479336|617006|P2|Overall Study|Physician Decision|1
177503|NCT00479336|617007|P1|Overall Study|Physician Decision|0
177504|NCT00479336|617004|P4|Overall Study|Withdrawal by Subject|0
177505|NCT00479336|617005|P3|Overall Study|Withdrawal by Subject|0
177506|NCT00479336|617006|P2|Overall Study|Withdrawal by Subject|2
177507|NCT00479336|617007|P1|Overall Study|Withdrawal by Subject|1
177508|NCT00479336|617004|P4|Overall Study|Protocol Violation|0
177509|NCT00479336|617005|P3|Overall Study|Protocol Violation|0
177510|NCT00479336|617006|P2|Overall Study|Protocol Violation|1
177511|NCT00479336|617007|P1|Overall Study|Protocol Violation|0
177512|NCT00479336|617004|P4|Overall Study|Lack of Efficacy|0
177513|NCT00479336|617005|P3|Overall Study|Lack of Efficacy|0
177514|NCT00479336|617006|P2|Overall Study|Lack of Efficacy|0
177515|NCT00479336|617007|P1|Overall Study|Lack of Efficacy|1
177516|NCT00479336|617004|P4|Overall Study|Adverse Event|3
177517|NCT00479336|617005|P3|Overall Study|Adverse Event|1
177518|NCT00479336|617006|P2|Overall Study|Adverse Event|1
177519|NCT00479336|617007|P1|Overall Study|Adverse Event|1
177520|NCT00479232|617030|P6|Overall Study|Withdrew Consent|3
177521|NCT00479232|617031|P5|Overall Study|Withdrew Consent|1
177522|NCT00479232|617032|P4|Overall Study|Withdrew Consent|0
177523|NCT00479232|617033|P3|Overall Study|Withdrew Consent|6
177524|NCT00479232|617034|P2|Overall Study|Withdrew Consent|2
177525|NCT00479232|617035|P1|Overall Study|Withdrew Consent|0
177526|NCT00479232|617030|P6|Overall Study|Progressive Disease|12
177527|NCT00479232|617031|P5|Overall Study|Progressive Disease|3
177528|NCT00479232|617032|P4|Overall Study|Progressive Disease|3
177529|NCT00479232|617033|P3|Overall Study|Progressive Disease|12
177530|NCT00479232|617034|P2|Overall Study|Progressive Disease|1
177531|NCT00479232|617035|P1|Overall Study|Progressive Disease|3
177532|NCT00479232|617030|P6|Overall Study|Physician Decision|1
177533|NCT00479232|617031|P5|Overall Study|Physician Decision|0
177534|NCT00479232|617032|P4|Overall Study|Physician Decision|0
177535|NCT00479232|617033|P3|Overall Study|Physician Decision|2
177536|NCT00479232|617034|P2|Overall Study|Physician Decision|0
177537|NCT00479232|617035|P1|Overall Study|Physician Decision|0
177538|NCT00479232|617030|P6|Overall Study|Lack of Efficacy|4
177539|NCT00479232|617031|P5|Overall Study|Lack of Efficacy|0
177540|NCT00479232|617032|P4|Overall Study|Lack of Efficacy|0
177541|NCT00479232|617033|P3|Overall Study|Lack of Efficacy|2
177542|NCT00479232|617034|P2|Overall Study|Lack of Efficacy|0
177543|NCT00479232|617035|P1|Overall Study|Lack of Efficacy|0
177544|NCT00479232|617030|P6|Overall Study|Deviation from Protocol|0
177545|NCT00479232|617031|P5|Overall Study|Deviation from Protocol|0
177546|NCT00479232|617032|P4|Overall Study|Deviation from Protocol|0
177547|NCT00479232|617033|P3|Overall Study|Deviation from Protocol|1
177548|NCT00479232|617034|P2|Overall Study|Deviation from Protocol|0
177549|NCT00479232|617035|P1|Overall Study|Deviation from Protocol|0
177550|NCT00479232|617030|P6|Overall Study|Adverse Event|10
177551|NCT00479232|617031|P5|Overall Study|Adverse Event|0
177552|NCT00479232|617032|P4|Overall Study|Adverse Event|0
177553|NCT00479232|617033|P3|Overall Study|Adverse Event|5
177554|NCT00479232|617034|P2|Overall Study|Adverse Event|0
177555|NCT00479232|617035|P1|Overall Study|Adverse Event|0
177556|NCT00478933|617088|P1|Overall Study|Inadequate data available|53
177557|NCT00478933|617088|P1|Overall Study|Informed consent not verified|3
177558|NCT00478933|617088|P1|Overall Study|Protocol Violation|22
177559|NCT00478881|617114|P2|Overall Study|Non-Compliance with Study Medication|2
177560|NCT00478881|617115|P1|Overall Study|Non-Compliance with Study Medication|0
177561|NCT00478881|617114|P2|Overall Study|Withdrawal by Subject|2
177562|NCT00478881|617115|P1|Overall Study|Withdrawal by Subject|6
177563|NCT00478881|617114|P2|Overall Study|Protocol Violation|2
177564|NCT00478881|617115|P1|Overall Study|Protocol Violation|2
177565|NCT00478881|617114|P2|Overall Study|Lost to Follow-up|1
177566|NCT00478881|617115|P1|Overall Study|Lost to Follow-up|0
177567|NCT00478881|617114|P2|Overall Study|Lack of Efficacy|3
177568|NCT00478881|617115|P1|Overall Study|Lack of Efficacy|0
177569|NCT00478881|617114|P2|Overall Study|Adverse Event|12
177570|NCT00478881|617115|P1|Overall Study|Adverse Event|31
177571|NCT00478777|617139|P1|Overall Study|Not treated with lenalidomide|6
177572|NCT00478777|617139|P1|Overall Study|End of therapy|2
177573|NCT00478777|617139|P1|Overall Study|Lymphocytes infusion|1
177574|NCT00478777|617139|P1|Overall Study|Lack of compliance|1
177575|NCT00478777|617139|P1|Overall Study|Intolerance of therapy|1
177576|NCT00478777|617139|P1|Overall Study|Physician Decision|1
177577|NCT00478777|617139|P1|Overall Study|Lost to Follow-up|3
177578|NCT00478777|617139|P1|Overall Study|Protocol Violation|3
177579|NCT00478777|617139|P1|Overall Study|Death|3
177580|NCT00478777|617139|P1|Overall Study|Withdrawal by Subject|4
177581|NCT00478777|617139|P1|Overall Study|Lack of Efficacy|23
177582|NCT00478777|617139|P1|Overall Study|Adverse Event|29
177583|NCT00478673|617146|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
177584|NCT00478673|617146|P1|12-Months Post-Procedure|Missed Visit|25
177585|NCT00478673|617146|P1|12-Months Post-Procedure|Withdrawal by Subject|6
177586|NCT00478673|617146|P1|12-Months Post-Procedure|Lost to Follow-up|4
177587|NCT00478673|617146|P1|12-Months Post-Procedure|Death|23
177588|NCT00478673|617146|P1|30-Days Post-Procedure|Missed Visit|7
177589|NCT00478673|617146|P1|30-Days Post-Procedure|Withdrawal by Subject|1
177590|NCT00478673|617146|P1|30-Days Post-Procedure|Death|2
177591|NCT00478647|617151|P1|Overall Study|Withdrawal by Subject|1
177592|NCT00478647|617151|P1|Overall Study|Adverse Event|1
177593|NCT00478608|617159|P1|Overall Study|Protocol Violation|3
177594|NCT00478608|617159|P1|Overall Study|Withdrawal by Subject|2
177595|NCT00478608|617159|P1|Overall Study|Serious Adverse Event|14
177596|NCT00478608|617159|P1|Overall Study|Adverse Event|1
177597|NCT00478257|617203|P2|Overall Study|Withdrawal by Subject|3
177598|NCT00478257|617204|P1|Overall Study|Withdrawal by Subject|8
177599|NCT00478244|617210|P1|Overall Study|Did not receive transplant|1
177600|NCT00478231|617223|P1|Overall Study|Randomized, not treated|3
177601|NCT00478231|617223|P1|Overall Study|Adverse Event|5
177602|NCT00478231|617223|P1|Overall Study|Other|9
177603|NCT00478231|617223|P1|Overall Study|Withdrawal by Subject|6
177604|NCT00478231|617223|P1|Overall Study|Lost to Follow-up|7
177605|NCT00478231|617223|P1|Overall Study|Lack of Efficacy|47
177606|NCT00478231|617223|P1|Overall Study|Death|7
177607|NCT00478205|617259|P2|Overall Study|Not specified|12
177608|NCT00478205|617260|P1|Overall Study|Not specified|24
177609|NCT00478205|617259|P2|Overall Study|Lack of Efficacy|0
177610|NCT00478205|617260|P1|Overall Study|Lack of Efficacy|1
177611|NCT00478205|617259|P2|Overall Study|Withdrawal by Subject|22
177612|NCT00478205|617260|P1|Overall Study|Withdrawal by Subject|61
177613|NCT00478205|617259|P2|Overall Study|Request of Investigator or Sponsor|5
177614|NCT00478205|617260|P1|Overall Study|Request of Investigator or Sponsor|4
177615|NCT00478205|617259|P2|Overall Study|Protocol Violation|5
177616|NCT00478205|617260|P1|Overall Study|Protocol Violation|15
177617|NCT00478205|617259|P2|Overall Study|Medication Non-compliance|4
177618|NCT00478205|617260|P1|Overall Study|Medication Non-compliance|9
177619|NCT00478205|617259|P2|Overall Study|Adverse Event|39
177620|NCT00478205|617260|P1|Overall Study|Adverse Event|182
177621|NCT00478140|617304|P1|Overall Study|Disease Progression|3
177622|NCT00478023|617333|P5|Overall Study|Lack of pain, Technical difficulties|3
177623|NCT00478023|617334|P4|Overall Study|Lack of pain, Technical difficulties|6
177624|NCT00478023|617335|P3|Overall Study|Lack of pain, Technical difficulties|5
177625|NCT00478023|617336|P2|Overall Study|Lack of pain, Technical difficulties|3
177626|NCT00478023|617337|P1|Overall Study|Lack of pain, Technical difficulties|7
177627|NCT00478023|617333|P5|Overall Study|Withdrawal by Subject|5
177628|NCT00478023|617334|P4|Overall Study|Withdrawal by Subject|4
177629|NCT00478023|617335|P3|Overall Study|Withdrawal by Subject|2
177630|NCT00478023|617336|P2|Overall Study|Withdrawal by Subject|3
177631|NCT00478023|617337|P1|Overall Study|Withdrawal by Subject|2
177632|NCT00478023|617333|P5|Overall Study|Lost to Follow-up|0
177633|NCT00478023|617334|P4|Overall Study|Lost to Follow-up|1
177634|NCT00478023|617335|P3|Overall Study|Lost to Follow-up|1
177635|NCT00478023|617336|P2|Overall Study|Lost to Follow-up|1
177636|NCT00478023|617337|P1|Overall Study|Lost to Follow-up|3
177637|NCT00478023|617333|P5|Overall Study|Lack of Efficacy|41
177638|NCT00478023|617334|P4|Overall Study|Lack of Efficacy|5
177639|NCT00478023|617335|P3|Overall Study|Lack of Efficacy|4
177640|NCT00478023|617336|P2|Overall Study|Lack of Efficacy|10
177641|NCT00478023|617337|P1|Overall Study|Lack of Efficacy|11
177642|NCT00478023|617333|P5|Overall Study|Death|0
177643|NCT00478023|617334|P4|Overall Study|Death|0
177644|NCT00478023|617335|P3|Overall Study|Death|0
177645|NCT00478023|617336|P2|Overall Study|Death|0
177646|NCT00478023|617337|P1|Overall Study|Death|1
177647|NCT00478023|617333|P5|Overall Study|Adverse Event|6
177648|NCT00478023|617334|P4|Overall Study|Adverse Event|14
177649|NCT00478023|617335|P3|Overall Study|Adverse Event|8
177650|NCT00478023|617336|P2|Overall Study|Adverse Event|7
177651|NCT00478023|617337|P1|Overall Study|Adverse Event|11
177652|NCT00477971|617356|P2|Overall Study|Alternative treatment|1
177653|NCT00477971|617357|P1|Overall Study|Alternative treatment|3
177654|NCT00477971|617356|P2|Overall Study|Death|4
177655|NCT00477971|617357|P1|Overall Study|Death|2
177656|NCT00477971|617356|P2|Overall Study|Adverse Event|0
177657|NCT00477971|617357|P1|Overall Study|Adverse Event|3
177658|NCT00477971|617356|P2|Overall Study|Withdrawal by Subject|1
177659|NCT00477971|617357|P1|Overall Study|Withdrawal by Subject|3
177660|NCT00477971|617356|P2|Overall Study|Disease progression|0
177661|NCT00477971|617357|P1|Overall Study|Disease progression|6
177662|NCT00477750|617369|P1|Overall Study|Currently Receiving Treatment|11
177663|NCT00477672|617381|P3|Overall Study|Discretion of Sponsor|0
177664|NCT00477672|617382|P2|Overall Study|Discretion of Sponsor|2
177665|NCT00477672|617383|P1|Overall Study|Discretion of Sponsor|1
177666|NCT00477672|617381|P3|Overall Study|Consent withdrawn|10
177667|NCT00477672|617382|P2|Overall Study|Consent withdrawn|5
177668|NCT00477672|617383|P1|Overall Study|Consent withdrawn|2
177669|NCT00477672|617381|P3|Overall Study|Protocol noncompliance|0
177670|NCT00477672|617382|P2|Overall Study|Protocol noncompliance|2
177671|NCT00477672|617383|P1|Overall Study|Protocol noncompliance|0
177672|NCT00477672|617381|P3|Overall Study|Physician Decision|0
177673|NCT00477672|617382|P2|Overall Study|Physician Decision|0
177674|NCT00477672|617383|P1|Overall Study|Physician Decision|1
177675|NCT00477672|617381|P3|Overall Study|Disease progression|0
177676|NCT00477672|617382|P2|Overall Study|Disease progression|1
177677|NCT00477672|617383|P1|Overall Study|Disease progression|0
177678|NCT00477672|617381|P3|Overall Study|Death|0
177679|NCT00477672|617382|P2|Overall Study|Death|1
177680|NCT00477672|617383|P1|Overall Study|Death|0
177681|NCT00477672|617381|P3|Overall Study|Adverse Event|6
177682|NCT00477672|617382|P2|Overall Study|Adverse Event|5
177683|NCT00477672|617383|P1|Overall Study|Adverse Event|3
177684|NCT00477633|617394|P1|Overall Study|Various (Moving, Enrollment closed)|75
177685|NCT00477633|617394|P1|Overall Study|Protocol Violation|25
177686|NCT00477633|617394|P1|Overall Study|Withdrawal by Subject|149
177687|NCT00477633|617394|P1|Overall Study|Lost to Follow-up|271
177688|NCT00477633|617394|P1|Overall Study|Pregnancy|23
177689|NCT00477633|617394|P1|Overall Study|Adverse Event|143
177690|NCT00477633|617394|P1|Overall Study|Did not receive treatment|23
177691|NCT00477607|617402|P2|Overall Study|Lost to Follow-up|7
177692|NCT00477607|617403|P1|Overall Study|Lost to Follow-up|7
177693|NCT00477594|617415|P2|Follow-up Period|Other|0
177694|NCT00477594|617416|P1|Follow-up Period|Other|1
177695|NCT00477594|617415|P2|Follow-up Period|Withdrawal by Subject|1
177696|NCT00477594|617416|P1|Follow-up Period|Withdrawal by Subject|2
177697|NCT00477594|617415|P2|Year 3|Withdrawal by Subject|0
177698|NCT00477594|617416|P1|Year 3|Withdrawal by Subject|1
177699|NCT00477594|617415|P2|Year 3|Adverse Event|0
177700|NCT00477594|617416|P1|Year 3|Adverse Event|1
177701|NCT00477594|617415|P2|Year 1 and Year 2|Other|0
177702|NCT00477594|617416|P1|Year 1 and Year 2|Other|1
177703|NCT00477594|617415|P2|Year 1 and Year 2|Withdrawal by Subject|1
177704|NCT00477594|617416|P1|Year 1 and Year 2|Withdrawal by Subject|2
177705|NCT00477594|617415|P2|Year 1 and Year 2|Physician Decision|1
177706|NCT00477594|617416|P1|Year 1 and Year 2|Physician Decision|2
177707|NCT00477594|617415|P2|Year 1 and Year 2|Adverse Event|2
177708|NCT00477594|617416|P1|Year 1 and Year 2|Adverse Event|4
177709|NCT00477490|617477|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
177710|NCT00477490|617478|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
177711|NCT00477490|617479|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
177712|NCT00477490|617480|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
177713|NCT00477490|617481|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
177714|NCT00477490|617482|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
177715|NCT00477490|617483|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
177716|NCT00477490|617484|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
177717|NCT00477490|617485|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
177718|NCT00477490|617477|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
177719|NCT00477490|617478|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
177720|NCT00477490|617479|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
177721|NCT00477490|617480|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
177722|NCT00477490|617481|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
177723|NCT00477490|617482|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
177724|NCT00477490|617483|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
177725|NCT00477490|617484|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
177726|NCT00477490|617485|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
177727|NCT00477490|617477|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
177728|NCT00477490|617478|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
177729|NCT00477490|617479|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
177730|NCT00477490|617480|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
177731|NCT00477490|617481|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
177732|NCT00477490|617482|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
177733|NCT00477490|617483|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
177734|NCT00477490|617484|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
177735|NCT00477490|617485|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
177736|NCT00477490|617477|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
177737|NCT00477490|617478|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
177738|NCT00477490|617479|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
177739|NCT00477490|617480|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
177740|NCT00477490|617481|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
177741|NCT00477490|617482|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
177742|NCT00477490|617483|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
177743|NCT00477490|617484|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
177744|NCT00477490|617485|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
177745|NCT00477490|617477|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
177746|NCT00477490|617478|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
177747|NCT00477490|617479|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
177748|NCT00477490|617480|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
177749|NCT00477490|617481|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
177750|NCT00477490|617482|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
177751|NCT00477490|617483|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
177752|NCT00477490|617484|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
177753|NCT00477490|617485|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
177754|NCT00477490|617477|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
177755|NCT00477490|617478|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
177756|NCT00477490|617479|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
177757|NCT00477490|617480|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
177758|NCT00477490|617481|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
177759|NCT00477490|617482|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
177760|NCT00477490|617483|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
177761|NCT00477490|617484|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
177762|NCT00477490|617485|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
177763|NCT00477490|617477|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
177764|NCT00477490|617478|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
177765|NCT00477490|617479|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
177766|NCT00477490|617480|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
177767|NCT00477490|617481|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
177768|NCT00477490|617482|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
177769|NCT00477490|617483|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
177770|NCT00477490|617484|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
177771|NCT00477490|617485|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
177772|NCT00477490|617477|P9|Part I: 4 Week Efficacy|Not Reported|0
177773|NCT00477490|617478|P8|Part I: 4 Week Efficacy|Not Reported|0
177774|NCT00477490|617479|P7|Part I: 4 Week Efficacy|Not Reported|0
177775|NCT00477490|617480|P6|Part I: 4 Week Efficacy|Not Reported|0
177776|NCT00477490|617481|P5|Part I: 4 Week Efficacy|Not Reported|1
177777|NCT00477490|617482|P4|Part I: 4 Week Efficacy|Not Reported|0
177778|NCT00477490|617483|P3|Part I: 4 Week Efficacy|Not Reported|3
177779|NCT00477490|617484|P2|Part I: 4 Week Efficacy|Not Reported|2
177780|NCT00477490|617485|P1|Part I: 4 Week Efficacy|Not Reported|1
177781|NCT00477490|617477|P9|Part I: 4 Week Efficacy|Other, not specified|0
177782|NCT00477490|617478|P8|Part I: 4 Week Efficacy|Other, not specified|0
177783|NCT00477490|617479|P7|Part I: 4 Week Efficacy|Other, not specified|0
177784|NCT00477490|617480|P6|Part I: 4 Week Efficacy|Other, not specified|0
177785|NCT00477490|617481|P5|Part I: 4 Week Efficacy|Other, not specified|1
177786|NCT00477490|617482|P4|Part I: 4 Week Efficacy|Other, not specified|1
177787|NCT00477490|617483|P3|Part I: 4 Week Efficacy|Other, not specified|0
177788|NCT00477490|617484|P2|Part I: 4 Week Efficacy|Other, not specified|4
177789|NCT00477490|617485|P1|Part I: 4 Week Efficacy|Other, not specified|2
177790|NCT00477490|617477|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
177791|NCT00477490|617478|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
177792|NCT00477490|617479|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
177793|NCT00477490|617480|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
177794|NCT00477490|617481|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
177795|NCT00477490|617482|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
177796|NCT00477490|617483|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
177797|NCT00477490|617484|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
177798|NCT00477490|617485|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
177799|NCT00477490|617477|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
177800|NCT00477490|617478|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
177801|NCT00477490|617479|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
177802|NCT00477490|617480|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
177803|NCT00477490|617481|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
177804|NCT00477490|617482|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
177805|NCT00477490|617483|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
177806|NCT00477490|617484|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
177807|NCT00477490|617485|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
177808|NCT00477490|617477|P9|Part I: 4 Week Efficacy|Protocol Violation|0
177809|NCT00477490|617478|P8|Part I: 4 Week Efficacy|Protocol Violation|0
177810|NCT00477490|617479|P7|Part I: 4 Week Efficacy|Protocol Violation|0
177811|NCT00477490|617480|P6|Part I: 4 Week Efficacy|Protocol Violation|0
177812|NCT00477490|617481|P5|Part I: 4 Week Efficacy|Protocol Violation|1
177813|NCT00477490|617482|P4|Part I: 4 Week Efficacy|Protocol Violation|0
177814|NCT00477490|617483|P3|Part I: 4 Week Efficacy|Protocol Violation|0
177815|NCT00477490|617484|P2|Part I: 4 Week Efficacy|Protocol Violation|0
177816|NCT00477490|617485|P1|Part I: 4 Week Efficacy|Protocol Violation|2
177817|NCT00477490|617477|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
177818|NCT00477490|617478|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
177819|NCT00477490|617479|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
177820|NCT00477490|617480|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
177821|NCT00477490|617481|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
177822|NCT00477490|617482|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
177823|NCT00477490|617483|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
177824|NCT00477490|617484|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
177825|NCT00477490|617485|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
177826|NCT00477490|617477|P9|Part I: 4 Week Efficacy|Adverse Event|0
177827|NCT00477490|617478|P8|Part I: 4 Week Efficacy|Adverse Event|0
177828|NCT00477490|617479|P7|Part I: 4 Week Efficacy|Adverse Event|0
177829|NCT00477490|617480|P6|Part I: 4 Week Efficacy|Adverse Event|0
177830|NCT00477490|617481|P5|Part I: 4 Week Efficacy|Adverse Event|6
177831|NCT00477490|617482|P4|Part I: 4 Week Efficacy|Adverse Event|5
177832|NCT00477490|617483|P3|Part I: 4 Week Efficacy|Adverse Event|0
177833|NCT00477490|617484|P2|Part I: 4 Week Efficacy|Adverse Event|4
177834|NCT00477490|617485|P1|Part I: 4 Week Efficacy|Adverse Event|1
177835|NCT00477464|617569|P1|Overall Study|Completion of protocol-defined follow-up|14
177836|NCT00477464|617569|P1|Overall Study|Death|36
177837|NCT00477464|617569|P1|Overall Study|Lost to Follow-up|1
177838|NCT00477386|617613|P2|Overall Study|Withdrawal by Subject|0
177839|NCT00477386|617614|P1|Overall Study|Withdrawal by Subject|1
177840|NCT00477386|617613|P2|Overall Study|Physician Decision|0
177841|NCT00477386|617614|P1|Overall Study|Physician Decision|1
177842|NCT00477386|617613|P2|Overall Study|Other|2
177843|NCT00477386|617614|P1|Overall Study|Other|1
177844|NCT00477386|617613|P2|Overall Study|Disease progression, refractory|3
177845|NCT00477386|617614|P1|Overall Study|Disease progression, refractory|1
177846|NCT00477386|617613|P2|Overall Study|Disease progression, relapse|4
177847|NCT00477386|617614|P1|Overall Study|Disease progression, relapse|3
177848|NCT00477386|617613|P2|Overall Study|Adverse Event|8
177849|NCT00477386|617614|P1|Overall Study|Adverse Event|4
177850|NCT00477334|617624|P2|Overall Study|Protocol Violation|1
177851|NCT00477334|617625|P1|Overall Study|Protocol Violation|7
177852|NCT00477334|617624|P2|Overall Study|Administrative Problems|15
177853|NCT00477334|617625|P1|Overall Study|Administrative Problems|39
177854|NCT00477334|617624|P2|Overall Study|Lost to Follow-up|4
177855|NCT00477334|617625|P1|Overall Study|Lost to Follow-up|15
177856|NCT00477334|617624|P2|Overall Study|Withdrawal by Subject|1
177857|NCT00477334|617625|P1|Overall Study|Withdrawal by Subject|2
177858|NCT00477334|617624|P2|Overall Study|Adverse Event|2
177859|NCT00477334|617625|P1|Overall Study|Adverse Event|1
177860|NCT00477334|617624|P2|Overall Study|Discontinued prior to taking study drug|53
177861|NCT00477334|617625|P1|Overall Study|Discontinued prior to taking study drug|106
177862|NCT00477295|617651|P2|Overall Study|Not specified|3
177863|NCT00477295|617652|P1|Overall Study|Not specified|4
177864|NCT00477295|617651|P2|Overall Study|Lost to Follow-up|11
177865|NCT00477295|617652|P1|Overall Study|Lost to Follow-up|21
177866|NCT00477295|617651|P2|Overall Study|Physician Decision|5
177867|NCT00477295|617652|P1|Overall Study|Physician Decision|4
177868|NCT00477295|617651|P2|Overall Study|Protocol Violation|8
177869|NCT00477295|617652|P1|Overall Study|Protocol Violation|3
177870|NCT00477295|617651|P2|Overall Study|Lack of Efficacy|23
177871|NCT00477295|617652|P1|Overall Study|Lack of Efficacy|23
177872|NCT00477295|617651|P2|Overall Study|Withdrawal by Subject|24
177873|NCT00477295|617652|P1|Overall Study|Withdrawal by Subject|35
177874|NCT00477295|617651|P2|Overall Study|Adverse Event|35
177875|NCT00477295|617652|P1|Overall Study|Adverse Event|31
177876|NCT00477269|617680|P3|Open Label Extension|Death|4
177877|NCT00477269|617681|P2|Open Label Extension|Death|0
177878|NCT00477269|617682|P1|Open Label Extension|Death|0
177879|NCT00477269|617680|P3|Open Label Extension|Adminiatrative problems|2
177880|NCT00477269|617681|P2|Open Label Extension|Adminiatrative problems|0
177881|NCT00477269|617682|P1|Open Label Extension|Adminiatrative problems|0
177882|NCT00477269|617680|P3|Open Label Extension|unsatisfactory therapeutic effects|2
177883|NCT00477269|617681|P2|Open Label Extension|unsatisfactory therapeutic effects|0
177884|NCT00477269|617682|P1|Open Label Extension|unsatisfactory therapeutic effects|0
177885|NCT00477269|617680|P3|Open Label Extension|Abnormal laboratory values|1
177886|NCT00477269|617681|P2|Open Label Extension|Abnormal laboratory values|0
177887|NCT00477269|617682|P1|Open Label Extension|Abnormal laboratory values|0
177888|NCT00477269|617680|P3|Open Label Extension|Adverse Event|4
177889|NCT00477269|617681|P2|Open Label Extension|Adverse Event|0
177890|NCT00477269|617682|P1|Open Label Extension|Adverse Event|0
177891|NCT00477269|617680|P3|Core Study|Withdrawn Consent|0
177892|NCT00477269|617681|P2|Core Study|Withdrawn Consent|1
177893|NCT00477269|617682|P1|Core Study|Withdrawn Consent|0
177894|NCT00477269|617680|P3|Core Study|Death|0
177895|NCT00477269|617681|P2|Core Study|Death|3
177896|NCT00477269|617682|P1|Core Study|Death|3
177897|NCT00477269|617680|P3|Core Study|Adverse Event|0
177898|NCT00477269|617681|P2|Core Study|Adverse Event|4
177899|NCT00477269|617682|P1|Core Study|Adverse Event|6
177900|NCT00477165|617761|P2|Overall Study|Adverse Event|2
177901|NCT00477165|617762|P1|Overall Study|Adverse Event|7
177902|NCT00477152|617774|P1|Overall Study|Adverse Event|1
177903|NCT00477152|617774|P1|Overall Study|Parent withdrew consent|2
177904|NCT00476957|617789|P2|Overall Study|Lost to Follow-up|193
177905|NCT00476957|617790|P1|Overall Study|Lost to Follow-up|176
177906|NCT00476593|617854|P4|Overall Study|Lost to Follow-up|22
177907|NCT00476593|617855|P3|Overall Study|Lost to Follow-up|8
177908|NCT00476593|617856|P2|Overall Study|Lost to Follow-up|2
177909|NCT00476593|617857|P1|Overall Study|Lost to Follow-up|10
177910|NCT00476476|617869|P2|Overall Study|Progressive Disease|17
177911|NCT00476476|617870|P1|Overall Study|Progressive Disease|0
177912|NCT00476476|617869|P2|Overall Study|Adverse Event|7
177913|NCT00476476|617870|P1|Overall Study|Adverse Event|2
177914|NCT00476229|617886|P1|Overall Study|Progressive shortness of breath|1
177915|NCT00476151|617892|P2|Overall Study|Physician Decision|2
177916|NCT00476151|617893|P1|Overall Study|Physician Decision|0
177917|NCT00476151|617892|P2|Overall Study|Withdrawal by Subject|0
177918|NCT00476151|617893|P1|Overall Study|Withdrawal by Subject|2
177919|NCT00476151|617892|P2|Overall Study|Protocol Violation|3
177920|NCT00476151|617893|P1|Overall Study|Protocol Violation|1
177921|NCT00476151|617892|P2|Overall Study|Adverse Event|2
177922|NCT00476151|617893|P1|Overall Study|Adverse Event|0
177923|NCT00476086|617899|P1|Overall Study|Progressive Disease|4
177924|NCT00476086|617899|P1|Overall Study|Alternative therapy|1
177925|NCT00476047|617905|P1|Overall Study|Lost to Follow-up|1
177926|NCT00476008|617931|P2|Overall Study|Death|0
177927|NCT00476008|617932|P1|Overall Study|Death|1
177928|NCT00476008|617931|P2|Overall Study|Withdrawal by Subject|1
177929|NCT00476008|617932|P1|Overall Study|Withdrawal by Subject|0
177930|NCT00476008|617931|P2|Overall Study|Physician Decision: Medication Noncompli|1
177931|NCT00476008|617932|P1|Overall Study|Physician Decision: Medication Noncompli|2
177932|NCT00476008|617931|P2|Overall Study|Placebo concerns|2
177933|NCT00476008|617932|P1|Overall Study|Placebo concerns|2
177934|NCT00476008|617931|P2|Overall Study|Adverse Event|4
177935|NCT00476008|617932|P1|Overall Study|Adverse Event|4
177936|NCT00475865|617986|P3|Overall Study|Other than above|0
177937|NCT00475865|617987|P2|Overall Study|Other than above|1
177938|NCT00475865|617988|P1|Overall Study|Other than above|0
177939|NCT00475865|617986|P3|Overall Study|Participant did not wish to continue|0
177940|NCT00475865|617987|P2|Overall Study|Participant did not wish to continue|0
177941|NCT00475865|617988|P1|Overall Study|Participant did not wish to continue|1
177942|NCT00475865|617986|P3|Overall Study|Progressive disease|2
177943|NCT00475865|617987|P2|Overall Study|Progressive disease|1
177944|NCT00475865|617988|P1|Overall Study|Progressive disease|0
177945|NCT00475865|617986|P3|Overall Study|Lack of Efficacy|0
177946|NCT00475865|617987|P2|Overall Study|Lack of Efficacy|0
177947|NCT00475865|617988|P1|Overall Study|Lack of Efficacy|1
177948|NCT00475865|617986|P3|Overall Study|Adverse Event|4
177949|NCT00475865|617987|P2|Overall Study|Adverse Event|3
177950|NCT00475865|617988|P1|Overall Study|Adverse Event|0
177951|NCT00475852|618018|P2|Overall Study|Lost to Follow-up|68
177952|NCT00475852|618019|P1|Overall Study|Lost to Follow-up|54
177953|NCT00475852|618018|P2|Overall Study|Withdrawal by Subject|24
177954|NCT00475852|618019|P1|Overall Study|Withdrawal by Subject|19
177955|NCT00475852|618018|P2|Overall Study|Death|456
177956|NCT00475852|618019|P1|Overall Study|Death|444
177957|NCT00475735|618070|P6|Treatment Period 2|Withdrawal by Subject|0
177958|NCT00475735|618071|P5|Treatment Period 2|Withdrawal by Subject|1
177959|NCT00475735|618072|P4|Treatment Period 2|Withdrawal by Subject|0
177960|NCT00475735|618073|P3|Treatment Period 2|Withdrawal by Subject|0
177961|NCT00475735|618074|P2|Treatment Period 2|Withdrawal by Subject|0
177962|NCT00475735|618075|P1|Treatment Period 2|Withdrawal by Subject|0
177963|NCT00475735|618070|P6|Treatment Period 2|Lack of Efficacy|1
177964|NCT00475735|618071|P5|Treatment Period 2|Lack of Efficacy|0
177965|NCT00475735|618072|P4|Treatment Period 2|Lack of Efficacy|0
177966|NCT00475735|618073|P3|Treatment Period 2|Lack of Efficacy|0
177967|NCT00475735|618074|P2|Treatment Period 2|Lack of Efficacy|0
177968|NCT00475735|618075|P1|Treatment Period 2|Lack of Efficacy|0
177969|NCT00475735|618070|P6|Treatment Period 2|Adverse Event|0
177970|NCT00475735|618071|P5|Treatment Period 2|Adverse Event|0
177971|NCT00475735|618072|P4|Treatment Period 2|Adverse Event|2
177972|NCT00475735|618073|P3|Treatment Period 2|Adverse Event|0
177973|NCT00475735|618074|P2|Treatment Period 2|Adverse Event|1
177974|NCT00475735|618075|P1|Treatment Period 2|Adverse Event|0
177975|NCT00475735|618070|P6|Treatment Washout|Protocol Violation|0
177976|NCT00475735|618071|P5|Treatment Washout|Protocol Violation|0
177977|NCT00475735|618072|P4|Treatment Washout|Protocol Violation|0
177978|NCT00475735|618073|P3|Treatment Washout|Protocol Violation|0
177979|NCT00475735|618074|P2|Treatment Washout|Protocol Violation|1
177980|NCT00475735|618075|P1|Treatment Washout|Protocol Violation|0
177981|NCT00475735|618070|P6|Treatment Washout|Lost to Follow-up|0
177982|NCT00475735|618071|P5|Treatment Washout|Lost to Follow-up|0
177983|NCT00475735|618072|P4|Treatment Washout|Lost to Follow-up|0
177984|NCT00475735|618073|P3|Treatment Washout|Lost to Follow-up|0
177985|NCT00475735|618074|P2|Treatment Washout|Lost to Follow-up|1
177986|NCT00475735|618075|P1|Treatment Washout|Lost to Follow-up|0
177987|NCT00475735|618070|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
177988|NCT00475735|618071|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
177989|NCT00475735|618072|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
177990|NCT00475735|618073|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
177991|NCT00475735|618074|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
177992|NCT00475735|618075|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
177993|NCT00475735|618070|P6|Treatment Period 1|DC due to AE but continuing|2
177994|NCT00475735|618071|P5|Treatment Period 1|DC due to AE but continuing|2
177995|NCT00475735|618072|P4|Treatment Period 1|DC due to AE but continuing|1
177996|NCT00475735|618073|P3|Treatment Period 1|DC due to AE but continuing|0
177997|NCT00475735|618074|P2|Treatment Period 1|DC due to AE but continuing|0
177998|NCT00475735|618075|P1|Treatment Period 1|DC due to AE but continuing|0
177999|NCT00475735|618070|P6|Treatment Period 1|Withdrawal by Subject|0
178000|NCT00475735|618071|P5|Treatment Period 1|Withdrawal by Subject|0
178001|NCT00475735|618072|P4|Treatment Period 1|Withdrawal by Subject|0
178002|NCT00475735|618073|P3|Treatment Period 1|Withdrawal by Subject|0
178003|NCT00475735|618074|P2|Treatment Period 1|Withdrawal by Subject|1
178004|NCT00475735|618075|P1|Treatment Period 1|Withdrawal by Subject|1
178005|NCT00475735|618070|P6|Treatment Period 1|Protocol Violation|0
178006|NCT00475735|618071|P5|Treatment Period 1|Protocol Violation|0
178007|NCT00475735|618072|P4|Treatment Period 1|Protocol Violation|1
178008|NCT00475735|618073|P3|Treatment Period 1|Protocol Violation|0
178009|NCT00475735|618074|P2|Treatment Period 1|Protocol Violation|0
178010|NCT00475735|618075|P1|Treatment Period 1|Protocol Violation|0
178011|NCT00475735|618070|P6|Treatment Period 1|Lost to Follow-up|1
178012|NCT00475735|618071|P5|Treatment Period 1|Lost to Follow-up|0
178013|NCT00475735|618072|P4|Treatment Period 1|Lost to Follow-up|0
178014|NCT00475735|618073|P3|Treatment Period 1|Lost to Follow-up|0
178015|NCT00475735|618074|P2|Treatment Period 1|Lost to Follow-up|0
178016|NCT00475735|618075|P1|Treatment Period 1|Lost to Follow-up|0
178017|NCT00475735|618070|P6|Treatment Period 1|Lack of Efficacy|0
178018|NCT00475735|618071|P5|Treatment Period 1|Lack of Efficacy|0
178019|NCT00475735|618072|P4|Treatment Period 1|Lack of Efficacy|0
178020|NCT00475735|618073|P3|Treatment Period 1|Lack of Efficacy|0
178021|NCT00475735|618074|P2|Treatment Period 1|Lack of Efficacy|0
178022|NCT00475735|618075|P1|Treatment Period 1|Lack of Efficacy|1
178023|NCT00475735|618070|P6|Treatment Period 1|Adverse Event|0
178024|NCT00475735|618071|P5|Treatment Period 1|Adverse Event|0
178025|NCT00475735|618072|P4|Treatment Period 1|Adverse Event|0
178026|NCT00475735|618073|P3|Treatment Period 1|Adverse Event|0
178027|NCT00475735|618074|P2|Treatment Period 1|Adverse Event|0
178028|NCT00475735|618075|P1|Treatment Period 1|Adverse Event|2
178029|NCT00475722|618088|P2|Overall Study|Protocol Violation|0
178030|NCT00475722|618089|P1|Overall Study|Protocol Violation|3
178031|NCT00475722|618088|P2|Overall Study|Withdrawal by Subject|12
178032|NCT00475722|618089|P1|Overall Study|Withdrawal by Subject|12
178033|NCT00475709|618095|P1|Overall Study|Lost to Follow-up|21
178034|NCT00475709|618095|P1|Overall Study|Device Explant|6
178035|NCT00475709|618095|P1|Overall Study|Death|41
178036|NCT00475709|618095|P1|Overall Study|Did not meet eligibility criteria|8
178037|NCT00475670|618103|P2|Overall Study|Not Specified|3
178038|NCT00475670|618104|P1|Overall Study|Not Specified|0
178039|NCT00475670|618103|P2|Overall Study|Failure to Return|1
178040|NCT00475670|618104|P1|Overall Study|Failure to Return|0
178041|NCT00475670|618103|P2|Overall Study|Refused treatment|2
178042|NCT00475670|618104|P1|Overall Study|Refused treatment|0
178043|NCT00475670|618103|P2|Overall Study|Lack of Efficacy|34
178044|NCT00475670|618104|P1|Overall Study|Lack of Efficacy|3
178045|NCT00475670|618103|P2|Overall Study|Death|1
178046|NCT00475670|618104|P1|Overall Study|Death|0
178047|NCT00475657|618128|P1|Overall Study|Sponsor's Decision|3
178048|NCT00475657|618128|P1|Overall Study|Death|1
178049|NCT00475423|618193|P1|Overall Study|Lost to Follow-up|7
178050|NCT00475423|618193|P1|Overall Study|Reason not specified|1
178051|NCT00475423|618193|P1|Overall Study|Death|1
178052|NCT00475423|618193|P1|Overall Study|Lack of Efficacy|8
178053|NCT00475423|618193|P1|Overall Study|Withdrawal by Subject|6
178054|NCT00475423|618193|P1|Overall Study|Adverse Event|4
178055|NCT00475423|618193|P1|Overall Study|Protocol Violation|5
178056|NCT00475306|618239|P4|Overall Study|Protocol Violation|1
178057|NCT00475306|618240|P3|Overall Study|Protocol Violation|0
178058|NCT00475306|618241|P2|Overall Study|Protocol Violation|1
178059|NCT00475306|618242|P1|Overall Study|Protocol Violation|1
178060|NCT00475228|618267|P2|Overall Study|Lost to Follow-up|17
178061|NCT00475228|618268|P1|Overall Study|Lost to Follow-up|17
178062|NCT00475176|618278|P1|Overall Study|Protocol Violation|1
178063|NCT00475176|618278|P1|Overall Study|Withdrawal by Subject|1
178064|NCT00475176|618278|P1|Overall Study|Adverse Event|2
178065|NCT00475033|618318|P2|Toddler Dose|Lost to Follow-up|0
178066|NCT00475033|618319|P1|Toddler Dose|Lost to Follow-up|1
178067|NCT00475033|618318|P2|Toddler Dose|Failed to return|0
178068|NCT00475033|618319|P1|Toddler Dose|Failed to return|1
178069|NCT00475033|618318|P2|Toddler Dose|Parent or legal guardian request|0
178070|NCT00475033|618319|P1|Toddler Dose|Parent or legal guardian request|2
178071|NCT00475033|618318|P2|After the Infant Series|Other|1
178072|NCT00475033|618319|P1|After the Infant Series|Other|0
178073|NCT00475033|618318|P2|After the Infant Series|Lost to Follow-up|0
178074|NCT00475033|618319|P1|After the Infant Series|Lost to Follow-up|1
178075|NCT00475033|618318|P2|After the Infant Series|Protocol Violation|0
178076|NCT00475033|618319|P1|After the Infant Series|Protocol Violation|1
178077|NCT00475033|618318|P2|After the Infant Series|Failed to return|1
178078|NCT00475033|618319|P1|After the Infant Series|Failed to return|2
178079|NCT00475033|618318|P2|After the Infant Series|Parent or legal guardian request|2
178080|NCT00475033|618319|P1|After the Infant Series|Parent or legal guardian request|2
178081|NCT00475033|618318|P2|After the Infant Series|Adverse Event|4
178082|NCT00475033|618319|P1|After the Infant Series|Adverse Event|0
178083|NCT00475033|618318|P2|Infant Series|Adverse Event|2
178084|NCT00475033|618319|P1|Infant Series|Adverse Event|0
178085|NCT00475033|618318|P2|Infant Series|Lost to Follow-up|0
178086|NCT00475033|618319|P1|Infant Series|Lost to Follow-up|2
178087|NCT00475033|618318|P2|Infant Series|Protocol Violation|2
178088|NCT00475033|618319|P1|Infant Series|Protocol Violation|1
178089|NCT00475033|618318|P2|Infant Series|Parent or legal guardian request|5
178090|NCT00475033|618319|P1|Infant Series|Parent or legal guardian request|1
178091|NCT00475033|618318|P2|Infant Series|Failed to return|4
178092|NCT00475033|618319|P1|Infant Series|Failed to return|3
178093|NCT00474994|618367|P1|Overall Study|Patient found to be ineligible|1
178094|NCT00474994|618367|P1|Overall Study|Patient evaluable for toxicity only|3
178095|NCT00474994|618367|P1|Overall Study|Patient Not treated|1
178096|NCT00474968|618373|P2|Overall Study|Sample not collected|1
178097|NCT00474968|618374|P1|Overall Study|Sample not collected|1
178098|NCT00474968|618373|P2|Overall Study|Protocol Violation|8
178099|NCT00474968|618374|P1|Overall Study|Protocol Violation|9
178100|NCT00474968|618373|P2|Overall Study|Withdrawal by Subject|7
178101|NCT00474968|618374|P1|Overall Study|Withdrawal by Subject|8
178102|NCT00474955|618384|P1|Overall Study|Personal reasons|5
178103|NCT00474955|618384|P1|Overall Study|Drug unavailability|1
178104|NCT00474955|618384|P1|Overall Study|Adverse Event|2
178105|NCT00474929|618400|P5|Overall Study|Physician Decision|0
178106|NCT00474929|618401|P4|Overall Study|Physician Decision|2
178107|NCT00474929|618402|P3|Overall Study|Physician Decision|1
178108|NCT00474929|618403|P2|Overall Study|Physician Decision|0
178109|NCT00474929|618404|P1|Overall Study|Physician Decision|0
178110|NCT00474929|618400|P5|Overall Study|Unrelated medical condition|0
178111|NCT00474929|618401|P4|Overall Study|Unrelated medical condition|0
178112|NCT00474929|618402|P3|Overall Study|Unrelated medical condition|1
178113|NCT00474929|618403|P2|Overall Study|Unrelated medical condition|0
178114|NCT00474929|618404|P1|Overall Study|Unrelated medical condition|0
178115|NCT00474929|618400|P5|Overall Study|Withdrawal by Subject|0
178116|NCT00474929|618401|P4|Overall Study|Withdrawal by Subject|0
178117|NCT00474929|618402|P3|Overall Study|Withdrawal by Subject|0
178118|NCT00474929|618403|P2|Overall Study|Withdrawal by Subject|1
178119|NCT00474929|618404|P1|Overall Study|Withdrawal by Subject|0
178120|NCT00474903|618421|P3|Overall Study|Protocol Violation|2
178121|NCT00474903|618422|P2|Overall Study|Protocol Violation|5
178122|NCT00474903|618423|P1|Overall Study|Protocol Violation|1
178123|NCT00474812|618445|P1|Overall Study|No Initiation of treatment|2
178124|NCT00474812|618445|P1|Overall Study|Withdrawal by Subject|5
178125|NCT00474786|618455|P2|Overall Study|Not specified|0
178126|NCT00474786|618456|P1|Overall Study|Not specified|5
178127|NCT00474786|618455|P2|Overall Study|Withdrawal by Subject|15
178128|NCT00474786|618456|P1|Overall Study|Withdrawal by Subject|15
178129|NCT00474786|618455|P2|Overall Study|Protocol Violation|0
178130|NCT00474786|618456|P1|Overall Study|Protocol Violation|2
178131|NCT00474786|618455|P2|Overall Study|Lost to Follow-up|7
178132|NCT00474786|618456|P1|Overall Study|Lost to Follow-up|4
178133|NCT00474786|618455|P2|Overall Study|Discontinuation of Study by Sponsor|59
178134|NCT00474786|618456|P1|Overall Study|Discontinuation of Study by Sponsor|42
178135|NCT00474786|618455|P2|Overall Study|Death|170
178136|NCT00474786|618456|P1|Overall Study|Death|189
178137|NCT00474786|618455|P2|Overall Study|Investigator Request|1
178138|NCT00474786|618456|P1|Overall Study|Investigator Request|2
178139|NCT00474786|618455|P2|Overall Study|Not Meeting Study Criteria|1
178140|NCT00474786|618456|P1|Overall Study|Not Meeting Study Criteria|0
178141|NCT00474760|618481|P7|Overall Study|Terminated by sponsor|2
178142|NCT00474760|618482|P6|Overall Study|Terminated by sponsor|0
178143|NCT00474760|618483|P5|Overall Study|Terminated by sponsor|0
178144|NCT00474760|618484|P4|Overall Study|Terminated by sponsor|0
178145|NCT00474760|618485|P3|Overall Study|Terminated by sponsor|0
178146|NCT00474760|618486|P2|Overall Study|Terminated by sponsor|0
178147|NCT00474760|618487|P1|Overall Study|Terminated by sponsor|0
178148|NCT00474760|618481|P7|Overall Study|Progressive disease|7
178149|NCT00474760|618482|P6|Overall Study|Progressive disease|20
178150|NCT00474760|618483|P5|Overall Study|Progressive disease|8
178151|NCT00474760|618484|P4|Overall Study|Progressive disease|2
178152|NCT00474760|618485|P3|Overall Study|Progressive disease|3
178153|NCT00474760|618486|P2|Overall Study|Progressive disease|2
178154|NCT00474760|618487|P1|Overall Study|Progressive disease|3
178155|NCT00474760|618481|P7|Overall Study|Other|0
178156|NCT00474760|618482|P6|Overall Study|Other|0
178157|NCT00474760|618483|P5|Overall Study|Other|1
178158|NCT00474760|618484|P4|Overall Study|Other|0
178159|NCT00474760|618485|P3|Overall Study|Other|0
178160|NCT00474760|618486|P2|Overall Study|Other|1
178161|NCT00474760|618487|P1|Overall Study|Other|0
178162|NCT00474760|618481|P7|Overall Study|Withdrawal by Subject|1
178163|NCT00474760|618482|P6|Overall Study|Withdrawal by Subject|1
178164|NCT00474760|618483|P5|Overall Study|Withdrawal by Subject|0
178165|NCT00474760|618484|P4|Overall Study|Withdrawal by Subject|1
178166|NCT00474760|618485|P3|Overall Study|Withdrawal by Subject|0
178167|NCT00474760|618486|P2|Overall Study|Withdrawal by Subject|0
178168|NCT00474760|618487|P1|Overall Study|Withdrawal by Subject|0
178169|NCT00474760|618481|P7|Overall Study|Laboratory abnormality|0
178170|NCT00474760|618482|P6|Overall Study|Laboratory abnormality|1
178171|NCT00474760|618483|P5|Overall Study|Laboratory abnormality|0
178172|NCT00474760|618484|P4|Overall Study|Laboratory abnormality|0
178173|NCT00474760|618485|P3|Overall Study|Laboratory abnormality|0
178174|NCT00474760|618486|P2|Overall Study|Laboratory abnormality|0
178175|NCT00474760|618487|P1|Overall Study|Laboratory abnormality|0
178176|NCT00474760|618481|P7|Overall Study|Adverse Event|0
178177|NCT00474760|618482|P6|Overall Study|Adverse Event|7
178178|NCT00474760|618483|P5|Overall Study|Adverse Event|1
178179|NCT00474760|618484|P4|Overall Study|Adverse Event|0
178180|NCT00474760|618485|P3|Overall Study|Adverse Event|0
178181|NCT00474760|618486|P2|Overall Study|Adverse Event|0
178182|NCT00474760|618487|P1|Overall Study|Adverse Event|0
178183|NCT00474760|618481|P7|Overall Study|Death|0
178184|NCT00474760|618482|P6|Overall Study|Death|0
178185|NCT00474760|618483|P5|Overall Study|Death|2
178186|NCT00474760|618484|P4|Overall Study|Death|0
178187|NCT00474760|618485|P3|Overall Study|Death|0
178188|NCT00474760|618486|P2|Overall Study|Death|0
178189|NCT00474760|618487|P1|Overall Study|Death|0
178190|NCT00474708|618594|P2|Overall Study|Physician Decision|6
178191|NCT00474708|618595|P1|Overall Study|Physician Decision|9
178192|NCT00474708|618594|P2|Overall Study|Lost to Follow-up|9
178193|NCT00474708|618595|P1|Overall Study|Lost to Follow-up|18
178194|NCT00474708|618594|P2|Overall Study|Lack of compliance|4
178195|NCT00474708|618595|P1|Overall Study|Lack of compliance|12
178196|NCT00474708|618594|P2|Overall Study|Withdrawal by Subject|0
178197|NCT00474708|618595|P1|Overall Study|Withdrawal by Subject|7
178198|NCT00474708|618594|P2|Overall Study|Suicide ideation/behavior|1
178199|NCT00474708|618595|P1|Overall Study|Suicide ideation/behavior|0
178200|NCT00474708|618594|P2|Overall Study|Lack of Efficacy|5
178201|NCT00474708|618595|P1|Overall Study|Lack of Efficacy|11
178202|NCT00474630|618605|P2|Overall Study|Drug noncompliance, other|4
178203|NCT00474630|618606|P1|Overall Study|Drug noncompliance, other|11
178204|NCT00474630|618605|P2|Overall Study|Lack of Efficacy|6
178205|NCT00474630|618606|P1|Overall Study|Lack of Efficacy|5
178206|NCT00474630|618605|P2|Overall Study|Protocol Violation|4
178207|NCT00474630|618606|P1|Overall Study|Protocol Violation|3
178208|NCT00474630|618605|P2|Overall Study|Withdrawal by Subject|15
178209|NCT00474630|618606|P1|Overall Study|Withdrawal by Subject|21
178210|NCT00474630|618605|P2|Overall Study|Lost to Follow-up|15
178211|NCT00474630|618606|P1|Overall Study|Lost to Follow-up|22
178212|NCT00474630|618605|P2|Overall Study|Adverse Event|26
178213|NCT00474630|618606|P1|Overall Study|Adverse Event|98
178214|NCT00474539|618662|P2|Toddler Dose|Protocol Violation|0
178215|NCT00474539|618663|P1|Toddler Dose|Protocol Violation|1
178216|NCT00474539|618662|P2|After Infant Series|Withdrawal by Subject|0
178217|NCT00474539|618663|P1|After Infant Series|Withdrawal by Subject|1
178218|NCT00474539|618662|P2|After Infant Series|Lost to Follow-up|0
178219|NCT00474539|618663|P1|After Infant Series|Lost to Follow-up|3
178220|NCT00474539|618662|P2|Infant Series|Protocol Violation|1
178221|NCT00474539|618663|P1|Infant Series|Protocol Violation|0
178222|NCT00474539|618662|P2|Infant Series|Lost to Follow-up|1
178223|NCT00474539|618663|P1|Infant Series|Lost to Follow-up|2
178224|NCT00474539|618662|P2|Infant Series|Randomization error|0
178225|NCT00474539|618663|P1|Infant Series|Randomization error|5
178226|NCT00474539|618662|P2|Infant Series|Withdrawal by Subject|4
178227|NCT00474539|618663|P1|Infant Series|Withdrawal by Subject|3
178228|NCT00474526|618728|P17|Overall Study|Withdrawal by Subject|1
178229|NCT00474526|618729|P16|Overall Study|Withdrawal by Subject|1
178230|NCT00474526|618730|P15|Overall Study|Withdrawal by Subject|22
178231|NCT00474526|618731|P14|Overall Study|Withdrawal by Subject|37
178232|NCT00474526|618732|P13|Overall Study|Withdrawal by Subject|4
178233|NCT00474526|618733|P12|Overall Study|Withdrawal by Subject|4
178234|NCT00474526|618734|P11|Overall Study|Withdrawal by Subject|5
178235|NCT00474526|618735|P10|Overall Study|Withdrawal by Subject|13
178236|NCT00474526|618736|P9|Overall Study|Withdrawal by Subject|4
178237|NCT00474526|618737|P8|Overall Study|Withdrawal by Subject|4
178238|NCT00474526|618738|P7|Overall Study|Withdrawal by Subject|12
178239|NCT00474526|618739|P6|Overall Study|Withdrawal by Subject|6
178240|NCT00474526|618740|P5|Overall Study|Withdrawal by Subject|38
178241|NCT00474526|618741|P4|Overall Study|Withdrawal by Subject|52
178242|NCT00474526|618742|P3|Overall Study|Withdrawal by Subject|21
178243|NCT00474526|618743|P2|Overall Study|Withdrawal by Subject|24
178244|NCT00474526|618744|P1|Overall Study|Withdrawal by Subject|9
178245|NCT00474526|618728|P17|Overall Study|UNABLE TO CLASSIFY|1
178246|NCT00474526|618729|P16|Overall Study|UNABLE TO CLASSIFY|6
178247|NCT00474526|618730|P15|Overall Study|UNABLE TO CLASSIFY|12
178248|NCT00474526|618731|P14|Overall Study|UNABLE TO CLASSIFY|20
178249|NCT00474526|618732|P13|Overall Study|UNABLE TO CLASSIFY|0
178250|NCT00474526|618733|P12|Overall Study|UNABLE TO CLASSIFY|0
178251|NCT00474526|618734|P11|Overall Study|UNABLE TO CLASSIFY|0
178252|NCT00474526|618735|P10|Overall Study|UNABLE TO CLASSIFY|3
178253|NCT00474526|618736|P9|Overall Study|UNABLE TO CLASSIFY|0
178254|NCT00474526|618737|P8|Overall Study|UNABLE TO CLASSIFY|1
178255|NCT00474526|618738|P7|Overall Study|UNABLE TO CLASSIFY|0
178256|NCT00474526|618739|P6|Overall Study|UNABLE TO CLASSIFY|2
178257|NCT00474526|618740|P5|Overall Study|UNABLE TO CLASSIFY|3
178258|NCT00474526|618741|P4|Overall Study|UNABLE TO CLASSIFY|1
178259|NCT00474526|618742|P3|Overall Study|UNABLE TO CLASSIFY|0
178260|NCT00474526|618743|P2|Overall Study|UNABLE TO CLASSIFY|0
178261|NCT00474526|618744|P1|Overall Study|UNABLE TO CLASSIFY|1
178262|NCT00474526|618728|P17|Overall Study|Protocol Violation|2
178263|NCT00474526|618729|P16|Overall Study|Protocol Violation|6
178264|NCT00474526|618730|P15|Overall Study|Protocol Violation|9
178265|NCT00474526|618731|P14|Overall Study|Protocol Violation|19
178266|NCT00474526|618732|P13|Overall Study|Protocol Violation|4
178267|NCT00474526|618733|P12|Overall Study|Protocol Violation|2
178268|NCT00474526|618734|P11|Overall Study|Protocol Violation|2
178269|NCT00474526|618735|P10|Overall Study|Protocol Violation|4
178270|NCT00474526|618736|P9|Overall Study|Protocol Violation|0
178271|NCT00474526|618737|P8|Overall Study|Protocol Violation|0
178272|NCT00474526|618738|P7|Overall Study|Protocol Violation|3
178273|NCT00474526|618739|P6|Overall Study|Protocol Violation|1
178274|NCT00474526|618740|P5|Overall Study|Protocol Violation|3
178275|NCT00474526|618741|P4|Overall Study|Protocol Violation|12
178276|NCT00474526|618742|P3|Overall Study|Protocol Violation|4
178277|NCT00474526|618743|P2|Overall Study|Protocol Violation|6
178278|NCT00474526|618744|P1|Overall Study|Protocol Violation|2
178279|NCT00474526|618728|P17|Overall Study|Lost to Follow-up|5
178280|NCT00474526|618729|P16|Overall Study|Lost to Follow-up|4
178281|NCT00474526|618730|P15|Overall Study|Lost to Follow-up|29
178282|NCT00474526|618731|P14|Overall Study|Lost to Follow-up|74
178283|NCT00474526|618732|P13|Overall Study|Lost to Follow-up|6
178284|NCT00474526|618733|P12|Overall Study|Lost to Follow-up|4
178285|NCT00474526|618734|P11|Overall Study|Lost to Follow-up|2
178286|NCT00474526|618735|P10|Overall Study|Lost to Follow-up|6
178287|NCT00474526|618736|P9|Overall Study|Lost to Follow-up|0
178288|NCT00474526|618737|P8|Overall Study|Lost to Follow-up|1
178289|NCT00474526|618738|P7|Overall Study|Lost to Follow-up|8
178290|NCT00474526|618739|P6|Overall Study|Lost to Follow-up|5
178291|NCT00474526|618740|P5|Overall Study|Lost to Follow-up|11
178292|NCT00474526|618741|P4|Overall Study|Lost to Follow-up|29
178293|NCT00474526|618742|P3|Overall Study|Lost to Follow-up|13
178294|NCT00474526|618743|P2|Overall Study|Lost to Follow-up|6
178295|NCT00474526|618744|P1|Overall Study|Lost to Follow-up|8
178296|NCT00474526|618728|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
178297|NCT00474526|618729|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
178298|NCT00474526|618730|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
178299|NCT00474526|618731|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
178300|NCT00474526|618732|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
178301|NCT00474526|618733|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
178302|NCT00474526|618734|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
178303|NCT00474526|618735|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
178304|NCT00474526|618736|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
178305|NCT00474526|618737|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
178306|NCT00474526|618738|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
178307|NCT00474526|618739|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
178308|NCT00474526|618740|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
178309|NCT00474526|618741|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
178310|NCT00474526|618742|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
178311|NCT00474526|618743|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
178312|NCT00474526|618744|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
178313|NCT00474526|618728|P17|Overall Study|Death|0
178314|NCT00474526|618729|P16|Overall Study|Death|0
178315|NCT00474526|618730|P15|Overall Study|Death|0
178316|NCT00474526|618731|P14|Overall Study|Death|3
178317|NCT00474526|618732|P13|Overall Study|Death|0
178318|NCT00474526|618733|P12|Overall Study|Death|0
178319|NCT00474526|618734|P11|Overall Study|Death|0
178320|NCT00474526|618735|P10|Overall Study|Death|0
178321|NCT00474526|618736|P9|Overall Study|Death|0
178322|NCT00474526|618737|P8|Overall Study|Death|0
178323|NCT00474526|618738|P7|Overall Study|Death|0
178324|NCT00474526|618739|P6|Overall Study|Death|0
178325|NCT00474526|618740|P5|Overall Study|Death|0
178326|NCT00474526|618741|P4|Overall Study|Death|0
178327|NCT00474526|618742|P3|Overall Study|Death|0
178328|NCT00474526|618743|P2|Overall Study|Death|0
178329|NCT00474526|618744|P1|Overall Study|Death|0
178330|NCT00474526|618728|P17|Overall Study|Adverse Event|0
178331|NCT00474526|618729|P16|Overall Study|Adverse Event|1
178332|NCT00474526|618730|P15|Overall Study|Adverse Event|1
178333|NCT00474526|618731|P14|Overall Study|Adverse Event|0
178334|NCT00474526|618732|P13|Overall Study|Adverse Event|0
178335|NCT00474526|618733|P12|Overall Study|Adverse Event|0
178336|NCT00474526|618734|P11|Overall Study|Adverse Event|0
178337|NCT00474526|618735|P10|Overall Study|Adverse Event|0
178338|NCT00474526|618736|P9|Overall Study|Adverse Event|0
178339|NCT00474526|618737|P8|Overall Study|Adverse Event|0
178340|NCT00474526|618738|P7|Overall Study|Adverse Event|1
178341|NCT00474526|618739|P6|Overall Study|Adverse Event|1
178342|NCT00474526|618740|P5|Overall Study|Adverse Event|2
178343|NCT00474526|618741|P4|Overall Study|Adverse Event|4
178344|NCT00474526|618742|P3|Overall Study|Adverse Event|2
178345|NCT00474526|618743|P2|Overall Study|Adverse Event|0
178346|NCT00474526|618744|P1|Overall Study|Adverse Event|2
178347|NCT00474526|618728|P17|Overall Study|ADMINISTRATIVE REASON|0
178348|NCT00474526|618729|P16|Overall Study|ADMINISTRATIVE REASON|0
178349|NCT00474526|618730|P15|Overall Study|ADMINISTRATIVE REASON|2
178350|NCT00474526|618731|P14|Overall Study|ADMINISTRATIVE REASON|1
178351|NCT00474526|618732|P13|Overall Study|ADMINISTRATIVE REASON|1
178352|NCT00474526|618733|P12|Overall Study|ADMINISTRATIVE REASON|1
178353|NCT00474526|618734|P11|Overall Study|ADMINISTRATIVE REASON|1
178354|NCT00474526|618735|P10|Overall Study|ADMINISTRATIVE REASON|1
178355|NCT00474526|618736|P9|Overall Study|ADMINISTRATIVE REASON|2
178356|NCT00474526|618737|P8|Overall Study|ADMINISTRATIVE REASON|0
178357|NCT00474526|618738|P7|Overall Study|ADMINISTRATIVE REASON|1
178358|NCT00474526|618739|P6|Overall Study|ADMINISTRATIVE REASON|1
178359|NCT00474526|618740|P5|Overall Study|ADMINISTRATIVE REASON|9
178360|NCT00474526|618741|P4|Overall Study|ADMINISTRATIVE REASON|20
178361|NCT00474526|618742|P3|Overall Study|ADMINISTRATIVE REASON|9
178362|NCT00474526|618743|P2|Overall Study|ADMINISTRATIVE REASON|9
178363|NCT00474526|618744|P1|Overall Study|ADMINISTRATIVE REASON|11
178364|NCT00474487|618909|P4|Overall Study|Death|0
178365|NCT00474487|618910|P3|Overall Study|Death|0
178366|NCT00474487|618911|P2|Overall Study|Death|1
178367|NCT00474487|618912|P1|Overall Study|Death|0
178368|NCT00474487|618909|P4|Overall Study|Inappropriate enrollment|0
178369|NCT00474487|618910|P3|Overall Study|Inappropriate enrollment|7
178370|NCT00474487|618911|P2|Overall Study|Inappropriate enrollment|0
178371|NCT00474487|618912|P1|Overall Study|Inappropriate enrollment|4
178372|NCT00474487|618909|P4|Overall Study|Lost to Follow-up|0
178373|NCT00474487|618910|P3|Overall Study|Lost to Follow-up|7
178374|NCT00474487|618911|P2|Overall Study|Lost to Follow-up|1
178375|NCT00474487|618912|P1|Overall Study|Lost to Follow-up|20
178376|NCT00474487|618909|P4|Overall Study|Withdrawal by Subject|0
178377|NCT00474487|618910|P3|Overall Study|Withdrawal by Subject|0
178378|NCT00474487|618911|P2|Overall Study|Withdrawal by Subject|0
178379|NCT00474487|618912|P1|Overall Study|Withdrawal by Subject|6
178380|NCT00474383|618932|P2|Extension|Progressive Disease|5
178381|NCT00474383|618933|P1|Extension|Progressive Disease|0
178382|NCT00474383|618932|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
178383|NCT00474383|618933|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
178384|NCT00474383|618932|P2|Main Study|Other|0
178385|NCT00474383|618933|P1|Main Study|Other|1
178386|NCT00474383|618932|P2|Main Study|Progressive Disease|0
178387|NCT00474383|618933|P1|Main Study|Progressive Disease|23
178388|NCT00474383|618932|P2|Main Study|Symptomatic Deterioration|0
178389|NCT00474383|618933|P1|Main Study|Symptomatic Deterioration|1
178390|NCT00474383|618932|P2|Main Study|Adverse Event|0
178391|NCT00474383|618933|P1|Main Study|Adverse Event|11
178392|NCT00474266|618948|P4|Overall Study|Withdrawal by Subject|7
178393|NCT00474266|618949|P3|Overall Study|Withdrawal by Subject|4
178394|NCT00474266|618950|P2|Overall Study|Withdrawal by Subject|20
178395|NCT00474266|618951|P1|Overall Study|Withdrawal by Subject|7
178396|NCT00474240|619059|P6|Overall Study|Removed due to lab value|1
178397|NCT00474240|619060|P5|Overall Study|Removed due to lab value|0
178398|NCT00474240|619061|P4|Overall Study|Removed due to lab value|0
178399|NCT00474240|619062|P3|Overall Study|Removed due to lab value|0
178400|NCT00474240|619063|P2|Overall Study|Removed due to lab value|0
178401|NCT00474240|619064|P1|Overall Study|Removed due to lab value|0
178402|NCT00474240|619059|P6|Overall Study|Adverse Event|16
178403|NCT00474240|619060|P5|Overall Study|Adverse Event|5
178404|NCT00474240|619061|P4|Overall Study|Adverse Event|14
178405|NCT00474240|619062|P3|Overall Study|Adverse Event|9
178406|NCT00474240|619063|P2|Overall Study|Adverse Event|0
178407|NCT00474240|619064|P1|Overall Study|Adverse Event|0
178408|NCT00474240|619059|P6|Overall Study|Withdrawal by Subject|1
178409|NCT00474240|619060|P5|Overall Study|Withdrawal by Subject|3
178410|NCT00474240|619061|P4|Overall Study|Withdrawal by Subject|2
178411|NCT00474240|619062|P3|Overall Study|Withdrawal by Subject|0
178412|NCT00474240|619063|P2|Overall Study|Withdrawal by Subject|1
178413|NCT00474240|619064|P1|Overall Study|Withdrawal by Subject|1
178414|NCT00474188|619089|P1|Overall Study|Study discontinued by sponsor|5
178415|NCT00474188|619089|P1|Overall Study|Withdrawal by Subject|1
178416|NCT00474175|619099|P3|Overall Study|Administrative|0
178417|NCT00474175|619100|P2|Overall Study|Administrative|1
178418|NCT00474175|619101|P1|Overall Study|Administrative|0
178419|NCT00474175|619099|P3|Overall Study|Protocol Violation|1
178420|NCT00474175|619100|P2|Overall Study|Protocol Violation|2
178421|NCT00474175|619101|P1|Overall Study|Protocol Violation|0
178422|NCT00474175|619099|P3|Overall Study|Ineligible|1
178423|NCT00474175|619100|P2|Overall Study|Ineligible|3
178424|NCT00474175|619101|P1|Overall Study|Ineligible|1
178425|NCT00474175|619099|P3|Overall Study|Withdrawal by Subject|1
178426|NCT00474175|619100|P2|Overall Study|Withdrawal by Subject|1
178427|NCT00474175|619101|P1|Overall Study|Withdrawal by Subject|0
178428|NCT00474175|619099|P3|Overall Study|Lack of Efficacy|1
178429|NCT00474175|619100|P2|Overall Study|Lack of Efficacy|0
178430|NCT00474175|619101|P1|Overall Study|Lack of Efficacy|0
178431|NCT00474058|619165|P2|Overall Study|Other|0
178432|NCT00474058|619166|P1|Overall Study|Other|2
178433|NCT00474058|619165|P2|Overall Study|Withdrawal by Subject|7
178434|NCT00474058|619166|P1|Overall Study|Withdrawal by Subject|11
178435|NCT00474058|619165|P2|Overall Study|Lack of Efficacy|4
178436|NCT00474058|619166|P1|Overall Study|Lack of Efficacy|0
178437|NCT00474058|619165|P2|Overall Study|Adverse Event|6
178438|NCT00474058|619166|P1|Overall Study|Adverse Event|11
178439|NCT00474045|619180|P2|Overall Study|Withdrawal criteria|50
178440|NCT00474045|619181|P1|Overall Study|Withdrawal criteria|60
178441|NCT00474045|619180|P2|Overall Study|Withdrawal by Subject|18
178442|NCT00474045|619181|P1|Overall Study|Withdrawal by Subject|16
178443|NCT00474045|619180|P2|Overall Study|Protocol Violation|12
178444|NCT00474045|619181|P1|Overall Study|Protocol Violation|10
178445|NCT00474045|619180|P2|Overall Study|Lost to Follow-up|1
178446|NCT00474045|619181|P1|Overall Study|Lost to Follow-up|1
178447|NCT00474045|619180|P2|Overall Study|Lack of Efficacy|9
178448|NCT00474045|619181|P1|Overall Study|Lack of Efficacy|0
178449|NCT00474045|619180|P2|Overall Study|Unclassified|3
178450|NCT00474045|619181|P1|Overall Study|Unclassified|1
178451|NCT00474045|619180|P2|Overall Study|Adverse Event|8
178452|NCT00474045|619181|P1|Overall Study|Adverse Event|18
178453|NCT00473889|619281|P2|Overall Study|Withdrawal by Subject|0
178454|NCT00473889|619282|P1|Overall Study|Withdrawal by Subject|5
178455|NCT00473889|619281|P2|Overall Study|Trial Terminated|6
178456|NCT00473889|619282|P1|Overall Study|Trial Terminated|3
178457|NCT00473889|619281|P2|Overall Study|Physician Decision|5
178458|NCT00473889|619282|P1|Overall Study|Physician Decision|10
178459|NCT00473889|619281|P2|Overall Study|Lost to Follow-up|1
178460|NCT00473889|619282|P1|Overall Study|Lost to Follow-up|2
178461|NCT00473889|619281|P2|Overall Study|Lack of Efficacy|29
178462|NCT00473889|619282|P1|Overall Study|Lack of Efficacy|28
178463|NCT00473889|619281|P2|Overall Study|Protocol Violation|2
178464|NCT00473889|619282|P1|Overall Study|Protocol Violation|4
178465|NCT00473889|619281|P2|Overall Study|Adverse Event|17
178466|NCT00473889|619282|P1|Overall Study|Adverse Event|30
178467|NCT00473889|619281|P2|Overall Study|Did not receive study medication|4
178468|NCT00473889|619282|P1|Overall Study|Did not receive study medication|1
178469|NCT00473876|619294|P2|Overall Study|Lost to Follow-up|1
178470|NCT00473876|619295|P1|Overall Study|Lost to Follow-up|3
178471|NCT00473824|619314|P2|Overall Study|Withdrawal by physician|0
178472|NCT00473824|619315|P1|Overall Study|Withdrawal by physician|1
178473|NCT00473824|619314|P2|Overall Study|Lost to Follow-up|0
178474|NCT00473824|619315|P1|Overall Study|Lost to Follow-up|1
178475|NCT00473824|619314|P2|Overall Study|Death|0
178476|NCT00473824|619315|P1|Overall Study|Death|1
178477|NCT00473824|619314|P2|Overall Study|Adverse Event|0
178478|NCT00473824|619315|P1|Overall Study|Adverse Event|1
178479|NCT00473824|619314|P2|Overall Study|Virologic Breakthrough|0
178480|NCT00473824|619315|P1|Overall Study|Virologic Breakthrough|1
178481|NCT00473746|619326|P5|Period 2 (Phase 2)|Reason not specified|3
178482|NCT00473746|619327|P4|Period 2 (Phase 2)|Reason not specified|0
178483|NCT00473746|619328|P3|Period 2 (Phase 2)|Reason not specified|0
178484|NCT00473746|619329|P2|Period 2 (Phase 2)|Reason not specified|0
178485|NCT00473746|619330|P1|Period 2 (Phase 2)|Reason not specified|0
178486|NCT00473746|619326|P5|Period 2 (Phase 2)|Progressive Disease|20
178487|NCT00473746|619327|P4|Period 2 (Phase 2)|Progressive Disease|0
178488|NCT00473746|619328|P3|Period 2 (Phase 2)|Progressive Disease|0
178489|NCT00473746|619329|P2|Period 2 (Phase 2)|Progressive Disease|0
178490|NCT00473746|619330|P1|Period 2 (Phase 2)|Progressive Disease|0
178491|NCT00473746|619326|P5|Period 2 (Phase 2)|Death|1
178492|NCT00473746|619327|P4|Period 2 (Phase 2)|Death|0
178493|NCT00473746|619328|P3|Period 2 (Phase 2)|Death|0
178494|NCT00473746|619329|P2|Period 2 (Phase 2)|Death|0
178495|NCT00473746|619330|P1|Period 2 (Phase 2)|Death|0
178496|NCT00473746|619326|P5|Period 2 (Phase 2)|Adverse Event|3
178497|NCT00473746|619327|P4|Period 2 (Phase 2)|Adverse Event|0
178498|NCT00473746|619328|P3|Period 2 (Phase 2)|Adverse Event|0
178499|NCT00473746|619329|P2|Period 2 (Phase 2)|Adverse Event|0
178500|NCT00473746|619330|P1|Period 2 (Phase 2)|Adverse Event|0
178501|NCT00473746|619326|P5|Period 1 (Phase 1)|Reason not specified|0
178502|NCT00473746|619327|P4|Period 1 (Phase 1)|Reason not specified|0
178503|NCT00473746|619328|P3|Period 1 (Phase 1)|Reason not specified|0
178504|NCT00473746|619329|P2|Period 1 (Phase 1)|Reason not specified|1
178505|NCT00473746|619330|P1|Period 1 (Phase 1)|Reason not specified|0
178506|NCT00473746|619326|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
178507|NCT00473746|619327|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
178508|NCT00473746|619328|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
178509|NCT00473746|619329|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
178510|NCT00473746|619330|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
178511|NCT00473746|619326|P5|Period 1 (Phase 1)|Progressive Disease|0
178512|NCT00473746|619327|P4|Period 1 (Phase 1)|Progressive Disease|10
178513|NCT00473746|619328|P3|Period 1 (Phase 1)|Progressive Disease|6
178514|NCT00473746|619329|P2|Period 1 (Phase 1)|Progressive Disease|6
178515|NCT00473746|619330|P1|Period 1 (Phase 1)|Progressive Disease|5
178516|NCT00473746|619326|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
178517|NCT00473746|619327|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
178518|NCT00473746|619328|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
178519|NCT00473746|619329|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
178520|NCT00473746|619330|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
178521|NCT00473746|619326|P5|Period 1 (Phase 1)|Adverse Event|0
178522|NCT00473746|619327|P4|Period 1 (Phase 1)|Adverse Event|0
178523|NCT00473746|619328|P3|Period 1 (Phase 1)|Adverse Event|0
178524|NCT00473746|619329|P2|Period 1 (Phase 1)|Adverse Event|0
178525|NCT00473746|619330|P1|Period 1 (Phase 1)|Adverse Event|1
178526|NCT00473668|619378|P3|Overall Study|Other|4
178527|NCT00473668|619379|P2|Overall Study|Other|3
178528|NCT00473668|619380|P1|Overall Study|Other|2
178529|NCT00473668|619378|P3|Overall Study|Lost to Follow-up|6
178530|NCT00473668|619379|P2|Overall Study|Lost to Follow-up|4
178531|NCT00473668|619380|P1|Overall Study|Lost to Follow-up|0
178532|NCT00473668|619378|P3|Overall Study|Migrated/moved from study area|0
178533|NCT00473668|619379|P2|Overall Study|Migrated/moved from study area|2
178534|NCT00473668|619380|P1|Overall Study|Migrated/moved from study area|3
178535|NCT00473668|619378|P3|Overall Study|Withdrawal by Subject|0
178536|NCT00473668|619379|P2|Overall Study|Withdrawal by Subject|2
178537|NCT00473668|619380|P1|Overall Study|Withdrawal by Subject|0
178538|NCT00473655|619433|P3|Overall Study|Lost to Follow-up|8
178539|NCT00473655|619434|P2|Overall Study|Lost to Follow-up|5
178540|NCT00473655|619435|P1|Overall Study|Lost to Follow-up|9
178541|NCT00473590|619482|P2|Overall Study|Other|1
178542|NCT00473590|619483|P1|Overall Study|Other|0
178543|NCT00473590|619482|P2|Overall Study|Withdrawal by Subject|3
178544|NCT00473590|619483|P1|Overall Study|Withdrawal by Subject|5
178545|NCT00473590|619482|P2|Overall Study|Physician Decision|4
178546|NCT00473590|619483|P1|Overall Study|Physician Decision|2
178547|NCT00473590|619482|P2|Overall Study|Non–protocol-specified therapy|5
178548|NCT00473590|619483|P1|Overall Study|Non–protocol-specified therapy|7
178549|NCT00473590|619482|P2|Overall Study|Progression not resulting in death|20
178550|NCT00473590|619483|P1|Overall Study|Progression not resulting in death|24
178551|NCT00473590|619482|P2|Overall Study|Death|2
178552|NCT00473590|619483|P1|Overall Study|Death|4
178553|NCT00473590|619482|P2|Overall Study|Adverse Event|3
178554|NCT00473590|619483|P1|Overall Study|Adverse Event|3
178555|NCT00473564|619499|P1|Overall Study|robot surgery aborted in OR|23
178556|NCT00473512|619509|P5|Period 2 (Phase 2)|Other|0
178557|NCT00473512|619510|P4|Period 2 (Phase 2)|Other|3
178558|NCT00473512|619511|P3|Period 2 (Phase 2)|Other|0
178559|NCT00473512|619512|P2|Period 2 (Phase 2)|Other|0
178560|NCT00473512|619513|P1|Period 2 (Phase 2)|Other|1
178561|NCT00473512|619509|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
178562|NCT00473512|619510|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
178563|NCT00473512|619511|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
178564|NCT00473512|619512|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
178565|NCT00473512|619513|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
178566|NCT00473512|619509|P5|Period 2 (Phase 2)|Disease Progression|1
178567|NCT00473512|619510|P4|Period 2 (Phase 2)|Disease Progression|17
178568|NCT00473512|619511|P3|Period 2 (Phase 2)|Disease Progression|2
178569|NCT00473512|619512|P2|Period 2 (Phase 2)|Disease Progression|2
178570|NCT00473512|619513|P1|Period 2 (Phase 2)|Disease Progression|0
178571|NCT00473512|619509|P5|Period 2 (Phase 2)|Death|1
178572|NCT00473512|619510|P4|Period 2 (Phase 2)|Death|1
178573|NCT00473512|619511|P3|Period 2 (Phase 2)|Death|0
178574|NCT00473512|619512|P2|Period 2 (Phase 2)|Death|0
178575|NCT00473512|619513|P1|Period 2 (Phase 2)|Death|0
178576|NCT00473512|619509|P5|Period 2 (Phase 2)|Adverse Event|0
178577|NCT00473512|619510|P4|Period 2 (Phase 2)|Adverse Event|1
178578|NCT00473512|619511|P3|Period 2 (Phase 2)|Adverse Event|0
178579|NCT00473512|619512|P2|Period 2 (Phase 2)|Adverse Event|0
178580|NCT00473512|619513|P1|Period 2 (Phase 2)|Adverse Event|0
178581|NCT00473512|619509|P5|Period 1 (Phase 1)|Other|0
178582|NCT00473512|619510|P4|Period 1 (Phase 1)|Other|1
178583|NCT00473512|619511|P3|Period 1 (Phase 1)|Other|0
178584|NCT00473512|619512|P2|Period 1 (Phase 1)|Other|0
178585|NCT00473512|619513|P1|Period 1 (Phase 1)|Other|0
178586|NCT00473512|619509|P5|Period 1 (Phase 1)|Disease Progression|1
178587|NCT00473512|619510|P4|Period 1 (Phase 1)|Disease Progression|10
178588|NCT00473512|619511|P3|Period 1 (Phase 1)|Disease Progression|0
178589|NCT00473512|619512|P2|Period 1 (Phase 1)|Disease Progression|1
178590|NCT00473512|619513|P1|Period 1 (Phase 1)|Disease Progression|1
178591|NCT00473512|619509|P5|Period 1 (Phase 1)|Death|0
178592|NCT00473512|619510|P4|Period 1 (Phase 1)|Death|1
178593|NCT00473512|619511|P3|Period 1 (Phase 1)|Death|0
178594|NCT00473512|619512|P2|Period 1 (Phase 1)|Death|0
178595|NCT00473512|619513|P1|Period 1 (Phase 1)|Death|0
178596|NCT00473512|619509|P5|Period 1 (Phase 1)|Adverse Event|0
178597|NCT00473512|619510|P4|Period 1 (Phase 1)|Adverse Event|5
178598|NCT00473512|619511|P3|Period 1 (Phase 1)|Adverse Event|0
178599|NCT00473512|619512|P2|Period 1 (Phase 1)|Adverse Event|0
178600|NCT00473512|619513|P1|Period 1 (Phase 1)|Adverse Event|0
178601|NCT00473434|619571|P1|Overall Study|No longer required|1
178602|NCT00473434|619571|P1|Overall Study|Switching to trial medication|1
178603|NCT00473434|619571|P1|Overall Study|Ceased in favor of Paliperidone|1
178604|NCT00473434|619571|P1|Overall Study|Reason not specified|6
178605|NCT00473434|619571|P1|Overall Study|Safety evaluation|1
178606|NCT00473434|619571|P1|Overall Study|Patient was selling medication to others|1
178607|NCT00473434|619571|P1|Overall Study|Adverse Event|3
178608|NCT00473434|619571|P1|Overall Study|Lack of Efficacy|3
178609|NCT00473434|619571|P1|Overall Study|Compliance|3
178610|NCT00473434|619571|P1|Overall Study|Withdrawal by Subject|9
178611|NCT00473434|619571|P1|Overall Study|Physician Decision|3
178612|NCT00473382|619636|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
178613|NCT00473382|619637|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
178614|NCT00473382|619638|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
178615|NCT00473382|619636|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
178616|NCT00473382|619637|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
178617|NCT00473382|619638|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
178618|NCT00473382|619636|P3|Open-label Extension Through Month 60|Subject's Decision|6
178619|NCT00473382|619637|P2|Open-label Extension Through Month 60|Subject's Decision|1
178620|NCT00473382|619638|P1|Open-label Extension Through Month 60|Subject's Decision|7
178621|NCT00473382|619636|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
178622|NCT00473382|619637|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
178623|NCT00473382|619638|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
178624|NCT00473382|619636|P3|Open-label Extension Through Month 60|Death|4
178625|NCT00473382|619637|P2|Open-label Extension Through Month 60|Death|7
178626|NCT00473382|619638|P1|Open-label Extension Through Month 60|Death|1
178627|NCT00473382|619636|P3|Open-label Extension Through Month 60|Adverse Event|2
178628|NCT00473382|619637|P2|Open-label Extension Through Month 60|Adverse Event|0
178629|NCT00473382|619638|P1|Open-label Extension Through Month 60|Adverse Event|0
178630|NCT00473382|619636|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
178631|NCT00473382|619637|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
178632|NCT00473382|619638|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
178633|NCT00473382|619636|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
178634|NCT00473382|619637|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
178635|NCT00473382|619638|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
178636|NCT00473382|619636|P3|Open-label Extension Through Month 48|Subject's Decision|6
178637|NCT00473382|619637|P2|Open-label Extension Through Month 48|Subject's Decision|1
178638|NCT00473382|619638|P1|Open-label Extension Through Month 48|Subject's Decision|5
178639|NCT00473382|619636|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
178640|NCT00473382|619637|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
178641|NCT00473382|619638|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
178642|NCT00473382|619636|P3|Open-label Extension Through Month 48|Death|3
178643|NCT00473382|619637|P2|Open-label Extension Through Month 48|Death|3
178644|NCT00473382|619638|P1|Open-label Extension Through Month 48|Death|1
178645|NCT00473382|619636|P3|Open-label Extension Through Month 48|Adverse Event|1
178646|NCT00473382|619637|P2|Open-label Extension Through Month 48|Adverse Event|0
178647|NCT00473382|619638|P1|Open-label Extension Through Month 48|Adverse Event|0
178648|NCT00473382|619636|P3|Core Study|Subject's decision|10
178649|NCT00473382|619637|P2|Core Study|Subject's decision|11
178650|NCT00473382|619638|P1|Core Study|Subject's decision|12
178651|NCT00473382|619636|P3|Core Study|Subject needed other treatment|2
178652|NCT00473382|619637|P2|Core Study|Subject needed other treatment|3
178653|NCT00473382|619638|P1|Core Study|Subject needed other treatment|1
178654|NCT00473382|619636|P3|Core Study|Subject non-compliance|1
178655|NCT00473382|619637|P2|Core Study|Subject non-compliance|2
178656|NCT00473382|619638|P1|Core Study|Subject non-compliance|5
178657|NCT00473382|619636|P3|Core Study|Physician Decision|2
178658|NCT00473382|619637|P2|Core Study|Physician Decision|2
178659|NCT00473382|619638|P1|Core Study|Physician Decision|1
178660|NCT00473382|619636|P3|Core Study|Lost to Follow-up|3
178661|NCT00473382|619637|P2|Core Study|Lost to Follow-up|3
178662|NCT00473382|619638|P1|Core Study|Lost to Follow-up|3
178663|NCT00473382|619636|P3|Core Study|Death|10
178664|NCT00473382|619637|P2|Core Study|Death|5
178665|NCT00473382|619638|P1|Core Study|Death|3
178666|NCT00473382|619636|P3|Core Study|Adverse Event|1
178667|NCT00473382|619637|P2|Core Study|Adverse Event|1
178668|NCT00473382|619638|P1|Core Study|Adverse Event|3
178669|NCT00473330|619696|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
178670|NCT00473330|619697|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
178671|NCT00473330|619698|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
178672|NCT00473330|619696|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
178673|NCT00473330|619697|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
178674|NCT00473330|619698|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
178675|NCT00473330|619696|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
178676|NCT00473330|619697|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
178677|NCT00473330|619698|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
178678|NCT00473330|619696|P3|Open-label Extension Through Month 60|Subject's Decision|4
178679|NCT00473330|619697|P2|Open-label Extension Through Month 60|Subject's Decision|3
178680|NCT00473330|619698|P1|Open-label Extension Through Month 60|Subject's Decision|1
178681|NCT00473330|619696|P3|Open-label Extension Through Month 60|Physician's Decision|3
178682|NCT00473330|619697|P2|Open-label Extension Through Month 60|Physician's Decision|1
178683|NCT00473330|619698|P1|Open-label Extension Through Month 60|Physician's Decision|2
178684|NCT00473330|619696|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
178685|NCT00473330|619697|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
178686|NCT00473330|619698|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
178687|NCT00473330|619696|P3|Open-label Extension Through Month 60|Death|1
178688|NCT00473330|619697|P2|Open-label Extension Through Month 60|Death|2
178689|NCT00473330|619698|P1|Open-label Extension Through Month 60|Death|2
178690|NCT00473330|619696|P3|Open-label Extension Through Month 60|Adverse Event|2
178691|NCT00473330|619697|P2|Open-label Extension Through Month 60|Adverse Event|0
178692|NCT00473330|619698|P1|Open-label Extension Through Month 60|Adverse Event|0
178693|NCT00473330|619696|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
178694|NCT00473330|619697|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
178695|NCT00473330|619698|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
178696|NCT00473330|619696|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
178697|NCT00473330|619697|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
178698|NCT00473330|619698|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
178699|NCT00473330|619696|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
178700|NCT00473330|619697|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
178701|NCT00473330|619698|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
178702|NCT00473330|619696|P3|Open-label Extension Through Month 48|Subject's Decision|3
178703|NCT00473330|619697|P2|Open-label Extension Through Month 48|Subject's Decision|3
178704|NCT00473330|619698|P1|Open-label Extension Through Month 48|Subject's Decision|1
178705|NCT00473330|619696|P3|Open-label Extension Through Month 48|Physician's Decision|3
178706|NCT00473330|619697|P2|Open-label Extension Through Month 48|Physician's Decision|1
178707|NCT00473330|619698|P1|Open-label Extension Through Month 48|Physician's Decision|2
178708|NCT00473330|619696|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
178709|NCT00473330|619697|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
178710|NCT00473330|619698|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
178711|NCT00473330|619696|P3|Open-label Extension Through Month 48|Death|0
178712|NCT00473330|619697|P2|Open-label Extension Through Month 48|Death|0
178713|NCT00473330|619698|P1|Open-label Extension Through Month 48|Death|2
178714|NCT00473330|619696|P3|Open-label Extension Through Month 48|Adverse Event|2
178715|NCT00473330|619697|P2|Open-label Extension Through Month 48|Adverse Event|0
178716|NCT00473330|619698|P1|Open-label Extension Through Month 48|Adverse Event|0
178717|NCT00473330|619696|P3|Core Study|Subject's Decision|19
178718|NCT00473330|619697|P2|Core Study|Subject's Decision|8
178719|NCT00473330|619698|P1|Core Study|Subject's Decision|9
178720|NCT00473330|619696|P3|Core Study|Subject Required Other Therapy|3
178721|NCT00473330|619697|P2|Core Study|Subject Required Other Therapy|1
178722|NCT00473330|619698|P1|Core Study|Subject Required Other Therapy|0
178723|NCT00473330|619696|P3|Core Study|Subject Non-compliance|1
178724|NCT00473330|619697|P2|Core Study|Subject Non-compliance|2
178725|NCT00473330|619698|P1|Core Study|Subject Non-compliance|1
178726|NCT00473330|619696|P3|Core Study|Physician Decision|3
178727|NCT00473330|619697|P2|Core Study|Physician Decision|1
178728|NCT00473330|619698|P1|Core Study|Physician Decision|2
178729|NCT00473330|619696|P3|Core Study|Lost to Follow-up|10
178730|NCT00473330|619697|P2|Core Study|Lost to Follow-up|5
178731|NCT00473330|619698|P1|Core Study|Lost to Follow-up|5
178732|NCT00473330|619696|P3|Core Study|Death|4
178733|NCT00473330|619697|P2|Core Study|Death|4
178734|NCT00473330|619698|P1|Core Study|Death|6
178735|NCT00473330|619696|P3|Core Study|Adverse Event|1
178736|NCT00473330|619697|P2|Core Study|Adverse Event|4
178737|NCT00473330|619698|P1|Core Study|Adverse Event|4
178738|NCT00473265|619753|P1|Overall Study|Off treatment early|15
178739|NCT00473265|619753|P1|Overall Study|Unrelated adverse event|5
178740|NCT00473083|619765|P3|Overall Study|Adverse Event|0
178741|NCT00473083|619766|P2|Overall Study|Adverse Event|0
178742|NCT00473083|619767|P1|Overall Study|Adverse Event|1
178743|NCT00472641|619842|P1|Overall Study|Lost to Follow-up|1
178744|NCT00472641|619842|P1|Overall Study|Adverse Event|3
178745|NCT00472641|619842|P1|Overall Study|Lack of Efficacy|3
178746|NCT00472446|619862|P4|Overall Study|Questionnaires not returned|4
178747|NCT00472446|619863|P3|Overall Study|Questionnaires not returned|6
178748|NCT00472446|619864|P2|Overall Study|Questionnaires not returned|6
178749|NCT00472446|619865|P1|Overall Study|Questionnaires not returned|5
178750|NCT00472446|619862|P4|Overall Study|Reintervention|1
178751|NCT00472446|619863|P3|Overall Study|Reintervention|1
178752|NCT00472446|619864|P2|Overall Study|Reintervention|0
178753|NCT00472446|619865|P1|Overall Study|Reintervention|0
178754|NCT00472446|619862|P4|Overall Study|Protocol Violation|1
178755|NCT00472446|619863|P3|Overall Study|Protocol Violation|0
178756|NCT00472446|619864|P2|Overall Study|Protocol Violation|0
178757|NCT00472446|619865|P1|Overall Study|Protocol Violation|0
178758|NCT00472420|619895|P1|Follow-up Period|Protocol Violation|1
178759|NCT00472420|619895|P1|Follow-up Period|Lost to Follow-up|2
178760|NCT00472420|619895|P1|Follow-up Period|Physician Decision|9
178761|NCT00472420|619895|P1|Follow-up Period|Death|5
178762|NCT00472420|619895|P1|Induction Treatment Period|Death|3
178763|NCT00472420|619895|P1|Induction Treatment Period|Non-compliance|1
178764|NCT00472420|619895|P1|Induction Treatment Period|Adverse Event|3
178765|NCT00472420|619895|P1|Induction Treatment Period|Physician Decision|9
178766|NCT00472303|619903|P3|Maintenance Phase|not specified|0
178767|NCT00472303|619904|P2|Maintenance Phase|not specified|1
178768|NCT00472303|619905|P1|Maintenance Phase|not specified|1
178769|NCT00472303|619903|P3|Maintenance Phase|Resolution of pain|1
178770|NCT00472303|619904|P2|Maintenance Phase|Resolution of pain|0
178771|NCT00472303|619905|P1|Maintenance Phase|Resolution of pain|0
178772|NCT00472303|619903|P3|Maintenance Phase|Trial medication non-compliant|1
178773|NCT00472303|619904|P2|Maintenance Phase|Trial medication non-compliant|0
178774|NCT00472303|619905|P1|Maintenance Phase|Trial medication non-compliant|0
178775|NCT00472303|619903|P3|Maintenance Phase|Withdrawal by Subject|3
178776|NCT00472303|619904|P2|Maintenance Phase|Withdrawal by Subject|7
178777|NCT00472303|619905|P1|Maintenance Phase|Withdrawal by Subject|6
178778|NCT00472303|619903|P3|Maintenance Phase|Lack of Efficacy|4
178779|NCT00472303|619904|P2|Maintenance Phase|Lack of Efficacy|2
178780|NCT00472303|619905|P1|Maintenance Phase|Lack of Efficacy|2
178781|NCT00472303|619903|P3|Maintenance Phase|Death|2
178782|NCT00472303|619904|P2|Maintenance Phase|Death|0
178783|NCT00472303|619905|P1|Maintenance Phase|Death|3
178784|NCT00472303|619903|P3|Maintenance Phase|Adverse Event|6
178785|NCT00472303|619904|P2|Maintenance Phase|Adverse Event|6
178786|NCT00472303|619905|P1|Maintenance Phase|Adverse Event|5
178787|NCT00472303|619903|P3|Discontinuations After Titration Phase|not specified|0
178788|NCT00472303|619904|P2|Discontinuations After Titration Phase|not specified|0
178789|NCT00472303|619905|P1|Discontinuations After Titration Phase|not specified|5
178790|NCT00472303|619903|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
178791|NCT00472303|619904|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
178792|NCT00472303|619905|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
178793|NCT00472303|619903|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
178794|NCT00472303|619904|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
178795|NCT00472303|619905|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
178796|NCT00472303|619903|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
178797|NCT00472303|619904|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
178798|NCT00472303|619905|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
178799|NCT00472303|619903|P3|Discontinuations After Titration Phase|Adverse Event|0
178800|NCT00472303|619904|P2|Discontinuations After Titration Phase|Adverse Event|0
178801|NCT00472303|619905|P1|Discontinuations After Titration Phase|Adverse Event|6
178802|NCT00472303|619903|P3|Titration Phase|not specified|0
178803|NCT00472303|619904|P2|Titration Phase|not specified|1
178804|NCT00472303|619905|P1|Titration Phase|not specified|3
178805|NCT00472303|619903|P3|Titration Phase|Trial Medication non-compliant|0
178806|NCT00472303|619904|P2|Titration Phase|Trial Medication non-compliant|1
178807|NCT00472303|619905|P1|Titration Phase|Trial Medication non-compliant|4
178808|NCT00472303|619903|P3|Titration Phase|Withdrawal by Subject|0
178809|NCT00472303|619904|P2|Titration Phase|Withdrawal by Subject|13
178810|NCT00472303|619905|P1|Titration Phase|Withdrawal by Subject|16
178811|NCT00472303|619903|P3|Titration Phase|Lack of Efficacy|0
178812|NCT00472303|619904|P2|Titration Phase|Lack of Efficacy|0
178813|NCT00472303|619905|P1|Titration Phase|Lack of Efficacy|10
178814|NCT00472303|619903|P3|Titration Phase|Death|0
178815|NCT00472303|619904|P2|Titration Phase|Death|2
178816|NCT00472303|619905|P1|Titration Phase|Death|4
178817|NCT00472303|619903|P3|Titration Phase|Adverse Event|0
178818|NCT00472303|619904|P2|Titration Phase|Adverse Event|12
178819|NCT00472303|619905|P1|Titration Phase|Adverse Event|22
178820|NCT00472290|619968|P1|Overall Study|Requirement for alternative therapy|7
178821|NCT00472290|619968|P1|Overall Study|Adverse Event|6
178822|NCT00472290|619968|P1|Overall Study|Withdrawal by Subject|5
178823|NCT00472290|619968|P1|Overall Study|Disease Progression|4
178824|NCT00472290|619968|P1|Overall Study|Lack of Efficacy|1
178825|NCT00472290|619968|P1|Overall Study|Lost to Follow-up|1
178826|NCT00472290|619968|P1|Overall Study|Death|3
178827|NCT00472290|619968|P1|Overall Study|Administrative Decision|37
178828|NCT00472290|619968|P1|Overall Study|Protocol Specified Criteria|7
178829|NCT00472290|619968|P1|Overall Study|Progression of Therapy-Related MDS|1
178830|NCT00472199|619980|P2|Overall Study|patient was asymptomatic|0
178831|NCT00472199|619981|P1|Overall Study|patient was asymptomatic|1
178832|NCT00472199|619980|P2|Overall Study|personal reason|1
178833|NCT00472199|619981|P1|Overall Study|personal reason|0
178834|NCT00472199|619980|P2|Overall Study|Withdrawal by Subject|5
178835|NCT00472199|619981|P1|Overall Study|Withdrawal by Subject|6
178836|NCT00472199|619980|P2|Overall Study|Protocol Violation|2
178837|NCT00472199|619981|P1|Overall Study|Protocol Violation|3
178838|NCT00472199|619980|P2|Overall Study|Lost to Follow-up|4
178839|NCT00472199|619981|P1|Overall Study|Lost to Follow-up|2
178840|NCT00472199|619980|P2|Overall Study|Lack of Efficacy|25
178841|NCT00472199|619981|P1|Overall Study|Lack of Efficacy|4
178842|NCT00472199|619980|P2|Overall Study|Adverse Event|23
178843|NCT00472199|619981|P1|Overall Study|Adverse Event|19
178844|NCT00472082|620047|P1|Overall Study|Study prematurely terminated|5
178845|NCT00472030|620069|P2|Overall Study|Physician Decision|0
178846|NCT00472030|620070|P1|Overall Study|Physician Decision|1
178847|NCT00471822|620086|P1|Overall Study|Protocol Violation|2
178848|NCT00471718|620094|P1|Overall Study|Withdrawal by Subject|1
178849|NCT00471718|620094|P1|Overall Study|disease progression|22
178850|NCT00471718|620094|P1|Overall Study|other complicating disease|1
178851|NCT00471718|620094|P1|Overall Study|Adverse Event|3
178852|NCT00471536|620122|P1|Overall Study|Withdrawal by Subject|1
178853|NCT00471497|620134|P3|Overall Study|Sub optimal response or treat. failure|0
178854|NCT00471497|620135|P2|Overall Study|Sub optimal response or treat. failure|3
178855|NCT00471497|620136|P1|Overall Study|Sub optimal response or treat. failure|8
178856|NCT00471497|620134|P3|Overall Study|Protocol Violation|5
178857|NCT00471497|620135|P2|Overall Study|Protocol Violation|3
178858|NCT00471497|620136|P1|Overall Study|Protocol Violation|3
178859|NCT00471497|620134|P3|Overall Study|Disease Progression|2
178860|NCT00471497|620135|P2|Overall Study|Disease Progression|2
178861|NCT00471497|620136|P1|Overall Study|Disease Progression|8
178862|NCT00471497|620134|P3|Overall Study|Death|0
178863|NCT00471497|620135|P2|Overall Study|Death|2
178864|NCT00471497|620136|P1|Overall Study|Death|0
178865|NCT00471497|620134|P3|Overall Study|Lost to Follow-up|1
178866|NCT00471497|620135|P2|Overall Study|Lost to Follow-up|2
178867|NCT00471497|620136|P1|Overall Study|Lost to Follow-up|1
178868|NCT00471497|620134|P3|Overall Study|Withdrawal by Subject|5
178869|NCT00471497|620135|P2|Overall Study|Withdrawal by Subject|5
178870|NCT00471497|620136|P1|Overall Study|Withdrawal by Subject|3
178871|NCT00471497|620134|P3|Overall Study|Condition no longer requires study drug|0
178872|NCT00471497|620135|P2|Overall Study|Condition no longer requires study drug|1
178873|NCT00471497|620136|P1|Overall Study|Condition no longer requires study drug|0
178874|NCT00471497|620134|P3|Overall Study|Abnormal Test Procedure|1
178875|NCT00471497|620135|P2|Overall Study|Abnormal Test Procedure|0
178876|NCT00471497|620136|P1|Overall Study|Abnormal Test Procedure|1
178877|NCT00471497|620134|P3|Overall Study|Abnormal Laboratory Value|4
178878|NCT00471497|620135|P2|Overall Study|Abnormal Laboratory Value|6
178879|NCT00471497|620136|P1|Overall Study|Abnormal Laboratory Value|3
178880|NCT00471497|620134|P3|Overall Study|Adverse Event|22
178881|NCT00471497|620135|P2|Overall Study|Adverse Event|11
178882|NCT00471497|620136|P1|Overall Study|Adverse Event|19
178883|NCT00471445|620146|P2|Overall Study|Protocol Violation|1
178884|NCT00471445|620147|P1|Overall Study|Protocol Violation|0
178885|NCT00471445|620146|P2|Overall Study|Ineligible|0
178886|NCT00471445|620147|P1|Overall Study|Ineligible|1
178887|NCT00471445|620146|P2|Overall Study|Withdrawal by Subject|1
178888|NCT00471445|620147|P1|Overall Study|Withdrawal by Subject|1
178889|NCT00471354|620160|P1|Overall Study|Patient/Caregiver Decision|12
178890|NCT00471354|620160|P1|Overall Study|Lack of Efficacy|5
178891|NCT00471354|620160|P1|Overall Study|Lost to Follow-up|3
178892|NCT00471354|620160|P1|Overall Study|Sponsor Decision|1
178893|NCT00471354|620160|P1|Overall Study|Physician Decision|4
178894|NCT00471354|620160|P1|Overall Study|Withdrawal by Subject|1
178895|NCT00471354|620160|P1|Overall Study|Protocol Violation|12
178896|NCT00471354|620160|P1|Overall Study|Adverse Event|13
178897|NCT00471354|620160|P1|Overall Study|Protocol Entry Criteria Not Met|1
178898|NCT00471328|620172|P2|Extension Phase|Administrative Problem|0
178899|NCT00471328|620173|P1|Extension Phase|Administrative Problem|1
178900|NCT00471328|620172|P2|Extension Phase|New cancer Therapy|0
178901|NCT00471328|620173|P1|Extension Phase|New cancer Therapy|1
178902|NCT00471328|620172|P2|Extension Phase|Disease Progression|44
178903|NCT00471328|620173|P1|Extension Phase|Disease Progression|32
178904|NCT00471328|620172|P2|Extension Phase|Treatment duration as per protocol|1
178905|NCT00471328|620173|P1|Extension Phase|Treatment duration as per protocol|0
178906|NCT00471328|620172|P2|Extension Phase|Protocol Deviation|1
178907|NCT00471328|620173|P1|Extension Phase|Protocol Deviation|3
178908|NCT00471328|620172|P2|Extension Phase|Death|7
178909|NCT00471328|620173|P1|Extension Phase|Death|1
178910|NCT00471328|620172|P2|Extension Phase|Withdrawal by Subject|2
178911|NCT00471328|620173|P1|Extension Phase|Withdrawal by Subject|0
178912|NCT00471328|620172|P2|Extension Phase|Adverse Event|12
178913|NCT00471328|620173|P1|Extension Phase|Adverse Event|3
178914|NCT00471328|620172|P2|Core Phase|Protocol Deviation|1
178915|NCT00471328|620173|P1|Core Phase|Protocol Deviation|0
178916|NCT00471328|620172|P2|Core Phase|Administrative Problem|1
178917|NCT00471328|620173|P1|Core Phase|Administrative Problem|0
178918|NCT00471328|620172|P2|Core Phase|Disease Progression|53
178919|NCT00471328|620173|P1|Core Phase|Disease Progression|78
178920|NCT00471328|620172|P2|Core Phase|Abnormal laboratory value|0
178921|NCT00471328|620173|P1|Core Phase|Abnormal laboratory value|1
178922|NCT00471328|620172|P2|Core Phase|Withdrawal by Subject|2
178923|NCT00471328|620173|P1|Core Phase|Withdrawal by Subject|2
178924|NCT00471328|620172|P2|Core Phase|Death|4
178925|NCT00471328|620173|P1|Core Phase|Death|8
178926|NCT00471328|620172|P2|Core Phase|Adverse Event|6
178927|NCT00471328|620173|P1|Core Phase|Adverse Event|18
178928|NCT00471315|620192|P1|Overall Study|Withdrawal by Subject|1
178929|NCT00471315|620192|P1|Overall Study|Adverse Event|7
178930|NCT00471276|620197|P1|Overall Study|Refused treatment|6
178931|NCT00471276|620197|P1|Overall Study|Other|3
178932|NCT00471276|620197|P1|Overall Study|Global deterioration of health status|1
178933|NCT00471276|620197|P1|Overall Study|Objective progression or relapse|54
178934|NCT00471276|620197|P1|Overall Study|Protocol Violation|1
178935|NCT00471276|620197|P1|Overall Study|Adverse Event|16
178936|NCT00471276|620197|P1|Overall Study|Death|2
178937|NCT00471237|620227|P7|Overall Study|Participant's decision|0
178938|NCT00471237|620228|P6|Overall Study|Participant's decision|1
178939|NCT00471237|620229|P5|Overall Study|Participant's decision|0
178940|NCT00471237|620230|P4|Overall Study|Participant's decision|0
178941|NCT00471237|620231|P3|Overall Study|Participant's decision|0
178942|NCT00471237|620232|P2|Overall Study|Participant's decision|0
178943|NCT00471237|620233|P1|Overall Study|Participant's decision|0
178944|NCT00471237|620227|P7|Overall Study|Participant shifted residence|0
178945|NCT00471237|620228|P6|Overall Study|Participant shifted residence|0
178946|NCT00471237|620229|P5|Overall Study|Participant shifted residence|1
178947|NCT00471237|620230|P4|Overall Study|Participant shifted residence|0
178948|NCT00471237|620231|P3|Overall Study|Participant shifted residence|0
178949|NCT00471237|620232|P2|Overall Study|Participant shifted residence|0
178950|NCT00471237|620233|P1|Overall Study|Participant shifted residence|0
178951|NCT00471237|620227|P7|Overall Study|Administration of prohibited medicine|0
178952|NCT00471237|620228|P6|Overall Study|Administration of prohibited medicine|0
178953|NCT00471237|620229|P5|Overall Study|Administration of prohibited medicine|1
178954|NCT00471237|620230|P4|Overall Study|Administration of prohibited medicine|0
178955|NCT00471237|620231|P3|Overall Study|Administration of prohibited medicine|0
178956|NCT00471237|620232|P2|Overall Study|Administration of prohibited medicine|0
178957|NCT00471237|620233|P1|Overall Study|Administration of prohibited medicine|0
178958|NCT00471237|620227|P7|Overall Study|Participant lost medication|0
178959|NCT00471237|620228|P6|Overall Study|Participant lost medication|0
178960|NCT00471237|620229|P5|Overall Study|Participant lost medication|1
178961|NCT00471237|620230|P4|Overall Study|Participant lost medication|0
178962|NCT00471237|620231|P3|Overall Study|Participant lost medication|0
178963|NCT00471237|620232|P2|Overall Study|Participant lost medication|0
178964|NCT00471237|620233|P1|Overall Study|Participant lost medication|0
178965|NCT00471237|620227|P7|Overall Study|High parathyroid hormone|0
178966|NCT00471237|620228|P6|Overall Study|High parathyroid hormone|0
178967|NCT00471237|620229|P5|Overall Study|High parathyroid hormone|0
178968|NCT00471237|620230|P4|Overall Study|High parathyroid hormone|0
178969|NCT00471237|620231|P3|Overall Study|High parathyroid hormone|1
178970|NCT00471237|620232|P2|Overall Study|High parathyroid hormone|0
178971|NCT00471237|620233|P1|Overall Study|High parathyroid hormone|0
178972|NCT00471237|620227|P7|Overall Study|Participant planned to travel to abraod|0
178973|NCT00471237|620228|P6|Overall Study|Participant planned to travel to abraod|1
178974|NCT00471237|620229|P5|Overall Study|Participant planned to travel to abraod|0
178975|NCT00471237|620230|P4|Overall Study|Participant planned to travel to abraod|0
178976|NCT00471237|620231|P3|Overall Study|Participant planned to travel to abraod|0
178977|NCT00471237|620232|P2|Overall Study|Participant planned to travel to abraod|0
178978|NCT00471237|620233|P1|Overall Study|Participant planned to travel to abraod|1
178979|NCT00471237|620227|P7|Overall Study|Early stopping due to non-efficacy|0
178980|NCT00471237|620228|P6|Overall Study|Early stopping due to non-efficacy|0
178981|NCT00471237|620229|P5|Overall Study|Early stopping due to non-efficacy|1
178982|NCT00471237|620230|P4|Overall Study|Early stopping due to non-efficacy|0
178983|NCT00471237|620231|P3|Overall Study|Early stopping due to non-efficacy|0
178984|NCT00471237|620232|P2|Overall Study|Early stopping due to non-efficacy|0
178985|NCT00471237|620233|P1|Overall Study|Early stopping due to non-efficacy|1
178986|NCT00471237|620227|P7|Overall Study|Met serum creatinine withdrawal criteria|0
178987|NCT00471237|620228|P6|Overall Study|Met serum creatinine withdrawal criteria|0
178988|NCT00471237|620229|P5|Overall Study|Met serum creatinine withdrawal criteria|0
178989|NCT00471237|620230|P4|Overall Study|Met serum creatinine withdrawal criteria|2
178990|NCT00471237|620231|P3|Overall Study|Met serum creatinine withdrawal criteria|2
178991|NCT00471237|620232|P2|Overall Study|Met serum creatinine withdrawal criteria|0
178992|NCT00471237|620233|P1|Overall Study|Met serum creatinine withdrawal criteria|1
178993|NCT00471237|620227|P7|Overall Study|Non-compliance|0
178994|NCT00471237|620228|P6|Overall Study|Non-compliance|0
178995|NCT00471237|620229|P5|Overall Study|Non-compliance|0
178996|NCT00471237|620230|P4|Overall Study|Non-compliance|1
178997|NCT00471237|620231|P3|Overall Study|Non-compliance|0
178998|NCT00471237|620232|P2|Overall Study|Non-compliance|1
178999|NCT00471237|620233|P1|Overall Study|Non-compliance|0
179000|NCT00471237|620227|P7|Overall Study|Sponsor terminated study|0
179001|NCT00471237|620228|P6|Overall Study|Sponsor terminated study|24
179002|NCT00471237|620229|P5|Overall Study|Sponsor terminated study|18
179003|NCT00471237|620230|P4|Overall Study|Sponsor terminated study|22
179004|NCT00471237|620231|P3|Overall Study|Sponsor terminated study|19
179005|NCT00471237|620232|P2|Overall Study|Sponsor terminated study|23
179006|NCT00471237|620233|P1|Overall Study|Sponsor terminated study|20
179007|NCT00471237|620227|P7|Overall Study|Withdrawal by Subject|2
179008|NCT00471237|620228|P6|Overall Study|Withdrawal by Subject|4
179009|NCT00471237|620229|P5|Overall Study|Withdrawal by Subject|7
179010|NCT00471237|620230|P4|Overall Study|Withdrawal by Subject|8
179011|NCT00471237|620231|P3|Overall Study|Withdrawal by Subject|5
179012|NCT00471237|620232|P2|Overall Study|Withdrawal by Subject|6
179013|NCT00471237|620233|P1|Overall Study|Withdrawal by Subject|8
179014|NCT00471237|620227|P7|Overall Study|Protocol Violation|1
179015|NCT00471237|620228|P6|Overall Study|Protocol Violation|4
179016|NCT00471237|620229|P5|Overall Study|Protocol Violation|2
179017|NCT00471237|620230|P4|Overall Study|Protocol Violation|2
179018|NCT00471237|620231|P3|Overall Study|Protocol Violation|3
179019|NCT00471237|620232|P2|Overall Study|Protocol Violation|6
179020|NCT00471237|620233|P1|Overall Study|Protocol Violation|3
179021|NCT00471237|620227|P7|Overall Study|Lost to Follow-up|0
179022|NCT00471237|620228|P6|Overall Study|Lost to Follow-up|0
179023|NCT00471237|620229|P5|Overall Study|Lost to Follow-up|3
179024|NCT00471237|620230|P4|Overall Study|Lost to Follow-up|2
179025|NCT00471237|620231|P3|Overall Study|Lost to Follow-up|0
179026|NCT00471237|620232|P2|Overall Study|Lost to Follow-up|1
179027|NCT00471237|620233|P1|Overall Study|Lost to Follow-up|1
179028|NCT00471237|620227|P7|Overall Study|Adverse Event|0
179029|NCT00471237|620228|P6|Overall Study|Adverse Event|5
179030|NCT00471237|620229|P5|Overall Study|Adverse Event|7
179031|NCT00471237|620230|P4|Overall Study|Adverse Event|8
179032|NCT00471237|620231|P3|Overall Study|Adverse Event|4
179033|NCT00471237|620232|P2|Overall Study|Adverse Event|5
179034|NCT00471237|620233|P1|Overall Study|Adverse Event|6
179035|NCT00471146|620383|P2|Overall Study|Other|5
179036|NCT00471146|620384|P1|Overall Study|Other|4
179037|NCT00471146|620383|P2|Overall Study|Randomized but not treated|8
179038|NCT00471146|620384|P1|Overall Study|Randomized but not treated|9
179039|NCT00471146|620383|P2|Overall Study|Global deterioration of health status|14
179040|NCT00471146|620384|P1|Overall Study|Global deterioration of health status|12
179041|NCT00471146|620383|P2|Overall Study|Objective progression or relapse|87
179042|NCT00471146|620384|P1|Overall Study|Objective progression or relapse|84
179043|NCT00471146|620383|P2|Overall Study|Protocol Violation|2
179044|NCT00471146|620384|P1|Overall Study|Protocol Violation|2
179045|NCT00471146|620383|P2|Overall Study|Lost to Follow-up|2
179046|NCT00471146|620384|P1|Overall Study|Lost to Follow-up|4
179047|NCT00471146|620383|P2|Overall Study|Death|12
179048|NCT00471146|620384|P1|Overall Study|Death|11
179049|NCT00471146|620383|P2|Overall Study|Withdrawal by Subject|11
179050|NCT00471146|620384|P1|Overall Study|Withdrawal by Subject|14
179051|NCT00471146|620383|P2|Overall Study|Adverse Event|33
179052|NCT00471146|620384|P1|Overall Study|Adverse Event|32
179053|NCT00471107|620409|P3|Overall Study|Technical problems/data loss|3
179054|NCT00471107|620410|P2|Overall Study|Technical problems/data loss|1
179055|NCT00471107|620411|P1|Overall Study|Technical problems/data loss|3
179056|NCT00470847|620428|P1|Overall Study|Pt still receiving treatment|1
179057|NCT00470834|620441|P2|Extension Period (24 Months)|Disease Progression|1
179058|NCT00470834|620442|P1|Extension Period (24 Months)|Disease Progression|0
179059|NCT00470834|620441|P2|Extension Period (24 Months)|Non-compliance|1
179060|NCT00470834|620442|P1|Extension Period (24 Months)|Non-compliance|0
179061|NCT00470834|620441|P2|Extension Period (24 Months)|Lost to Follow-up|1
179062|NCT00470834|620442|P1|Extension Period (24 Months)|Lost to Follow-up|0
179063|NCT00470834|620441|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
179064|NCT00470834|620442|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
179065|NCT00470834|620441|P2|Extension Period (24 Months)|Physician Decision|3
179066|NCT00470834|620442|P1|Extension Period (24 Months)|Physician Decision|4
179067|NCT00470834|620441|P2|Extension Period (24 Months)|Withdrawal by Subject|5
179068|NCT00470834|620442|P1|Extension Period (24 Months)|Withdrawal by Subject|2
179069|NCT00470834|620441|P2|Extension Period (24 Months)|Adverse Event|4
179070|NCT00470834|620442|P1|Extension Period (24 Months)|Adverse Event|3
179071|NCT00470834|620441|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
179249|NCT00468585|621196|P2|Overall Study|Withdrawal by Subject|0
179072|NCT00470834|620442|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
179073|NCT00470834|620441|P2|Treatment Period (18 Months)|Lack of Efficacy|0
179074|NCT00470834|620442|P1|Treatment Period (18 Months)|Lack of Efficacy|1
179075|NCT00470834|620441|P2|Treatment Period (18 Months)|Non-compliance|0
179076|NCT00470834|620442|P1|Treatment Period (18 Months)|Non-compliance|1
179077|NCT00470834|620441|P2|Treatment Period (18 Months)|Lost to Follow-up|0
179078|NCT00470834|620442|P1|Treatment Period (18 Months)|Lost to Follow-up|1
179079|NCT00470834|620441|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
179080|NCT00470834|620442|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
179081|NCT00470834|620441|P2|Treatment Period (18 Months)|Protocol Violation|1
179082|NCT00470834|620442|P1|Treatment Period (18 Months)|Protocol Violation|3
179083|NCT00470834|620441|P2|Treatment Period (18 Months)|Physician Decision|4
179084|NCT00470834|620442|P1|Treatment Period (18 Months)|Physician Decision|4
179085|NCT00470834|620441|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
179086|NCT00470834|620442|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
179087|NCT00470834|620441|P2|Treatment Period (18 Months)|Adverse Event|6
179088|NCT00470834|620442|P1|Treatment Period (18 Months)|Adverse Event|7
179089|NCT00470834|620441|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
179090|NCT00470834|620442|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
179091|NCT00470626|620456|P1|Overall Study|Withdrawal by Subject|7
179092|NCT00470626|620456|P1|Overall Study|Lost to Follow-up|10
179093|NCT00470535|620498|P1|Overall Study|Other|2
179094|NCT00470535|620498|P1|Overall Study|Death|1
179095|NCT00470535|620498|P1|Overall Study|Adverse Event|1
179096|NCT00470535|620498|P1|Overall Study|Withdrawal by Subject|1
179097|NCT00470535|620498|P1|Overall Study|Disease Progression|13
179098|NCT00470470|620507|P1|Overall Study|Not treated|1
179099|NCT00470470|620507|P1|Overall Study|Death|2
179100|NCT00470470|620507|P1|Overall Study|Adverse Event|2
179101|NCT00470418|620514|P2|Overall Study|Withdrawal by Subject|0
179102|NCT00470418|620515|P1|Overall Study|Withdrawal by Subject|1
179103|NCT00470366|620536|P1|Overall Study|Poor compliance|1
179104|NCT00470366|620536|P1|Overall Study|Adverse Event|3
179105|NCT00470275|620547|P1|Overall Study|Withdrawal by Subject|2
179106|NCT00470275|620547|P1|Overall Study|Lack of Efficacy|7
179107|NCT00470275|620547|P1|Overall Study|Death|1
179108|NCT00470262|620553|P2|Overall Study|Withdrawal by Subject|0
179109|NCT00470262|620554|P1|Overall Study|Withdrawal by Subject|2
179110|NCT00470184|620562|P1|Overall Study|recurrence|1
179111|NCT00470184|620562|P1|Overall Study|other|5
179112|NCT00470184|620562|P1|Overall Study|Withdrawal by Subject|4
179113|NCT00470184|620562|P1|Overall Study|Adverse Event|3
179114|NCT00470184|620562|P1|Overall Study|disease Progression|4
179115|NCT00470184|620562|P1|Overall Study|Not treated (other)|1
179116|NCT00470184|620562|P1|Overall Study|Not Treated(became ineligible)|4
179117|NCT00470158|620574|P5|Overall Study|Protocol Violation|0
179118|NCT00470158|620575|P4|Overall Study|Protocol Violation|0
179119|NCT00470158|620576|P3|Overall Study|Protocol Violation|0
179120|NCT00470158|620577|P2|Overall Study|Protocol Violation|0
179121|NCT00470158|620578|P1|Overall Study|Protocol Violation|1
179122|NCT00470158|620574|P5|Overall Study|Lost to Follow-up|4
179123|NCT00470158|620575|P4|Overall Study|Lost to Follow-up|5
179124|NCT00470158|620576|P3|Overall Study|Lost to Follow-up|8
179125|NCT00470158|620577|P2|Overall Study|Lost to Follow-up|8
179126|NCT00470158|620578|P1|Overall Study|Lost to Follow-up|7
179127|NCT00470158|620574|P5|Overall Study|Death|2
179128|NCT00470158|620575|P4|Overall Study|Death|0
179129|NCT00470158|620576|P3|Overall Study|Death|0
179130|NCT00470158|620577|P2|Overall Study|Death|0
179131|NCT00470158|620578|P1|Overall Study|Death|0
179132|NCT00470067|620611|P1|Overall Study|Disease Progression|6
179133|NCT00470067|620611|P1|Overall Study|Death|1
179134|NCT00470054|620615|P1|Overall Study|Ineligible|1
179135|NCT00469898|620623|P1|Overall Study|Decreased performance status|1
179136|NCT00469898|620623|P1|Overall Study|Disease progression|9
179137|NCT00469898|620623|P1|Overall Study|Death|4
179138|NCT00469898|620623|P1|Overall Study|Withdrawal by Subject|4
179139|NCT00469898|620623|P1|Overall Study|Adverse Event|7
179140|NCT00469859|620632|P2|Overall Study|Inevaluable|2
179141|NCT00469859|620633|P1|Overall Study|Inevaluable|0
179142|NCT00469833|620641|P1|Overall Study|No IV access|2
179143|NCT00469456|620668|P2|Overall Study|Withdrawal by Subject|1
179144|NCT00469456|620669|P1|Overall Study|Withdrawal by Subject|4
179145|NCT00469456|620668|P2|Overall Study|Protocol Violation|0
179146|NCT00469456|620669|P1|Overall Study|Protocol Violation|1
179147|NCT00469456|620668|P2|Overall Study|Adverse Event|3
179148|NCT00469456|620669|P1|Overall Study|Adverse Event|4
179149|NCT00469209|620698|P3|Overall Study|Adverse Event|1
179150|NCT00469209|620699|P2|Overall Study|Adverse Event|0
179151|NCT00469209|620700|P1|Overall Study|Adverse Event|1
179152|NCT00469092|620710|P2|Overall Study|Use of Corticosteroid|0
179153|NCT00469092|620711|P1|Overall Study|Use of Corticosteroid|1
179154|NCT00469092|620710|P2|Overall Study|Abnormal lab value|0
179155|NCT00469092|620711|P1|Overall Study|Abnormal lab value|1
179156|NCT00469092|620710|P2|Overall Study|Hypoglycaemic Episodes|1
179157|NCT00469092|620711|P1|Overall Study|Hypoglycaemic Episodes|1
179158|NCT00469092|620710|P2|Overall Study|Use of lipid lowering drug|0
179159|NCT00469092|620711|P1|Overall Study|Use of lipid lowering drug|1
179160|NCT00469092|620710|P2|Overall Study|Contraindication metformin/glimepiride|0
179161|NCT00469092|620711|P1|Overall Study|Contraindication metformin/glimepiride|1
179162|NCT00469092|620710|P2|Overall Study|Incorrectly Randomised|3
179163|NCT00469092|620711|P1|Overall Study|Incorrectly Randomised|4
179164|NCT00469092|620710|P2|Overall Study|Withdrawal Criteria|4
179165|NCT00469092|620711|P1|Overall Study|Withdrawal Criteria|3
179166|NCT00469092|620710|P2|Overall Study|Withdrawal by Subject|4
179167|NCT00469092|620711|P1|Overall Study|Withdrawal by Subject|4
179168|NCT00469092|620710|P2|Overall Study|Protocol Violation|3
179169|NCT00469092|620711|P1|Overall Study|Protocol Violation|3
179170|NCT00469092|620710|P2|Overall Study|Lost to Follow-up|2
179171|NCT00469092|620711|P1|Overall Study|Lost to Follow-up|1
179172|NCT00469092|620710|P2|Overall Study|Lack of Efficacy|0
179173|NCT00469092|620711|P1|Overall Study|Lack of Efficacy|1
179174|NCT00469092|620710|P2|Overall Study|Adverse Event|4
179175|NCT00469092|620711|P1|Overall Study|Adverse Event|5
179176|NCT00469079|620730|P3|Overall Study|Ineligible|0
179177|NCT00469079|620731|P2|Overall Study|Ineligible|1
179178|NCT00469079|620732|P1|Overall Study|Ineligible|0
179179|NCT00469079|620730|P3|Overall Study|Withdrawal by Subject|2
179180|NCT00469079|620731|P2|Overall Study|Withdrawal by Subject|2
179181|NCT00469079|620732|P1|Overall Study|Withdrawal by Subject|1
179182|NCT00469079|620730|P3|Overall Study|Lost to Follow-up|10
179183|NCT00469079|620731|P2|Overall Study|Lost to Follow-up|8
179184|NCT00469079|620732|P1|Overall Study|Lost to Follow-up|4
179185|NCT00469079|620730|P3|Overall Study|Adverse Event|2
179186|NCT00469079|620731|P2|Overall Study|Adverse Event|3
179187|NCT00469079|620732|P1|Overall Study|Adverse Event|1
179188|NCT00469079|620730|P3|Overall Study|Lack of Efficacy|5
179189|NCT00469079|620731|P2|Overall Study|Lack of Efficacy|8
179190|NCT00469079|620732|P1|Overall Study|Lack of Efficacy|3
179191|NCT00468910|620751|P2|Overall Study|Medical Contraindication|1
179192|NCT00468910|620752|P1|Overall Study|Medical Contraindication|0
179193|NCT00468910|620751|P2|Overall Study|Withdrawal by Subject|1
179194|NCT00468910|620752|P1|Overall Study|Withdrawal by Subject|2
179195|NCT00468910|620751|P2|Overall Study|Lost to Follow-up|1
179196|NCT00468910|620752|P1|Overall Study|Lost to Follow-up|2
179197|NCT00468858|620771|P3|Overall Study|Other|1
179198|NCT00468858|620772|P2|Overall Study|Other|0
179199|NCT00468858|620773|P1|Overall Study|Other|0
179200|NCT00468858|620771|P3|Overall Study|Lost to Follow-up|5
179201|NCT00468858|620772|P2|Overall Study|Lost to Follow-up|2
179202|NCT00468858|620773|P1|Overall Study|Lost to Follow-up|1
179203|NCT00468858|620771|P3|Overall Study|Relocation|3
179204|NCT00468858|620772|P2|Overall Study|Relocation|3
179205|NCT00468858|620773|P1|Overall Study|Relocation|1
179206|NCT00468858|620771|P3|Overall Study|Withdrawal by Subject|5
179207|NCT00468858|620772|P2|Overall Study|Withdrawal by Subject|4
179208|NCT00468858|620773|P1|Overall Study|Withdrawal by Subject|7
179209|NCT00468858|620771|P3|Overall Study|Adverse Event|0
179210|NCT00468858|620772|P2|Overall Study|Adverse Event|1
179211|NCT00468858|620773|P1|Overall Study|Adverse Event|0
179212|NCT00468845|620894|P3|Overall Study|Randomized, not treated|2
179213|NCT00468845|620895|P2|Overall Study|Randomized, not treated|4
179214|NCT00468845|620896|P1|Overall Study|Randomized, not treated|1
179215|NCT00468845|620894|P3|Overall Study|No longer willing to participate|10
179216|NCT00468845|620895|P2|Overall Study|No longer willing to participate|6
179217|NCT00468845|620896|P1|Overall Study|No longer willing to participate|5
179218|NCT00468845|620894|P3|Overall Study|Other|5
179219|NCT00468845|620895|P2|Overall Study|Other|9
179220|NCT00468845|620896|P1|Overall Study|Other|4
179221|NCT00468845|620894|P3|Overall Study|Lost to Follow-up|2
179222|NCT00468845|620895|P2|Overall Study|Lost to Follow-up|1
179223|NCT00468845|620896|P1|Overall Study|Lost to Follow-up|2
179224|NCT00468845|620894|P3|Overall Study|Adverse Event|11
179225|NCT00468845|620895|P2|Overall Study|Adverse Event|14
179226|NCT00468845|620896|P1|Overall Study|Adverse Event|9
179227|NCT00468819|621033|P3|Overall Study|Drop-outs (Treatment never received)|0
179228|NCT00468819|621034|P2|Overall Study|Drop-outs (Treatment never received)|0
179229|NCT00468819|621035|P1|Overall Study|Drop-outs (Treatment never received)|2
179230|NCT00468819|621033|P3|Overall Study|Lost to Follow-up|1
179231|NCT00468819|621034|P2|Overall Study|Lost to Follow-up|0
179232|NCT00468819|621035|P1|Overall Study|Lost to Follow-up|0
179233|NCT00468819|621033|P3|Overall Study|Withdrawal by Subject|1
179234|NCT00468819|621034|P2|Overall Study|Withdrawal by Subject|0
179235|NCT00468819|621035|P1|Overall Study|Withdrawal by Subject|4
179236|NCT00468728|621115|P2|Follow-up|mITT failure|31
179237|NCT00468728|621116|P1|Follow-up|mITT failure|34
179238|NCT00468728|621115|P2|Treatment|criteria for mITT population|11
179239|NCT00468728|621116|P1|Treatment|criteria for mITT population|4
179240|NCT00468676|621128|P2|Overall Study|Death|1
179241|NCT00468676|621129|P1|Overall Study|Death|2
179242|NCT00468676|621128|P2|Overall Study|Lost to Follow-up|11
179243|NCT00468676|621129|P1|Overall Study|Lost to Follow-up|14
179244|NCT00468650|621146|P1|Overall Study|Protocol Violation|1
179245|NCT00468650|621146|P1|Overall Study|Withdrawal by Subject|2
179246|NCT00468650|621146|P1|Overall Study|Lost to Follow-up|4
179247|NCT00468585|621194|P4|Overall Study|Withdrawal by Subject|1
179248|NCT00468585|621195|P3|Overall Study|Withdrawal by Subject|2
179250|NCT00468585|621197|P1|Overall Study|Withdrawal by Subject|0
179251|NCT00468585|621194|P4|Overall Study|Adverse Event|0
179252|NCT00468585|621195|P3|Overall Study|Adverse Event|1
179253|NCT00468585|621196|P2|Overall Study|Adverse Event|0
179254|NCT00468585|621197|P1|Overall Study|Adverse Event|0
179255|NCT00468585|621194|P4|Overall Study|Patient found to be ineligible|0
179256|NCT00468585|621195|P3|Overall Study|Patient found to be ineligible|1
179257|NCT00468585|621196|P2|Overall Study|Patient found to be ineligible|0
179258|NCT00468585|621197|P1|Overall Study|Patient found to be ineligible|0
179259|NCT00468585|621194|P4|Overall Study|Patient not treated|0
179260|NCT00468585|621195|P3|Overall Study|Patient not treated|1
179261|NCT00468585|621196|P2|Overall Study|Patient not treated|0
179262|NCT00468585|621197|P1|Overall Study|Patient not treated|1
179263|NCT00468559|621209|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
179264|NCT00468559|621210|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
179265|NCT00468559|621211|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
179266|NCT00468559|621209|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
179267|NCT00468559|621210|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
179268|NCT00468559|621211|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
179269|NCT00468559|621209|P3|Open-label Treatment Phase|Withdrawal by Subject|0
179270|NCT00468559|621210|P2|Open-label Treatment Phase|Withdrawal by Subject|0
179271|NCT00468559|621211|P1|Open-label Treatment Phase|Withdrawal by Subject|4
179272|NCT00468559|621209|P3|Open-label Treatment Phase|Lack of Efficacy|0
179273|NCT00468559|621210|P2|Open-label Treatment Phase|Lack of Efficacy|0
179274|NCT00468559|621211|P1|Open-label Treatment Phase|Lack of Efficacy|9
179275|NCT00468559|621209|P3|Open-label Treatment Phase|Adverse Event|0
179276|NCT00468559|621210|P2|Open-label Treatment Phase|Adverse Event|0
179277|NCT00468559|621211|P1|Open-label Treatment Phase|Adverse Event|5
179278|NCT00468546|621239|P2|Week 24 to Week 104 Analysis|Other|14
179279|NCT00468546|621240|P1|Week 24 to Week 104 Analysis|Other|17
179280|NCT00468546|621239|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
179281|NCT00468546|621240|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
179282|NCT00468546|621239|P2|Week 24 to Week 104 Analysis|Failure to return|2
179283|NCT00468546|621240|P1|Week 24 to Week 104 Analysis|Failure to return|1
179284|NCT00468546|621239|P2|Week 24 to Week 104 Analysis|Refused treatment|7
179285|NCT00468546|621240|P1|Week 24 to Week 104 Analysis|Refused treatment|4
179286|NCT00468546|621239|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
179287|NCT00468546|621240|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
179288|NCT00468546|621239|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
179289|NCT00468546|621240|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
179290|NCT00468546|621239|P2|Week 24 to Week 104 Analysis|Death|0
179291|NCT00468546|621240|P1|Week 24 to Week 104 Analysis|Death|1
179292|NCT00468546|621239|P2|Week 24 to Week 104 Analysis|Adverse Event|5
179293|NCT00468546|621240|P1|Week 24 to Week 104 Analysis|Adverse Event|2
179294|NCT00468546|621239|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
179295|NCT00468546|621240|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
179296|NCT00468546|621239|P2|Week 24 Analysis|Went onto rescue therapy|0
179297|NCT00468546|621240|P1|Week 24 Analysis|Went onto rescue therapy|1
179298|NCT00468546|621239|P2|Week 24 Analysis|Due to clinical hold|0
179299|NCT00468546|621240|P1|Week 24 Analysis|Due to clinical hold|1
179300|NCT00468546|621239|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
179301|NCT00468546|621240|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
179302|NCT00468546|621239|P2|Week 24 Analysis|Rescue therapy|0
179303|NCT00468546|621240|P1|Week 24 Analysis|Rescue therapy|2
179304|NCT00468546|621239|P2|Week 24 Analysis|Failure to return|4
179305|NCT00468546|621240|P1|Week 24 Analysis|Failure to return|3
179306|NCT00468546|621239|P2|Week 24 Analysis|Adverse Event|8
179307|NCT00468546|621240|P1|Week 24 Analysis|Adverse Event|1
179308|NCT00468546|621239|P2|Week 24 Analysis|Refused treatment|5
179309|NCT00468546|621240|P1|Week 24 Analysis|Refused treatment|5
179310|NCT00468546|621239|P2|Week 24 Analysis|Lack of Efficacy|37
179311|NCT00468546|621240|P1|Week 24 Analysis|Lack of Efficacy|83
179312|NCT00468481|621270|P2|Overall Study|Other|0
179313|NCT00468481|621271|P1|Overall Study|Other|6
179314|NCT00468481|621270|P2|Overall Study|Non-Compliance|0
179315|NCT00468481|621271|P1|Overall Study|Non-Compliance|5
179316|NCT00468481|621270|P2|Overall Study|Moved out of area|1
179317|NCT00468481|621271|P1|Overall Study|Moved out of area|4
179318|NCT00468481|621270|P2|Overall Study|Egg Donor|0
179319|NCT00468481|621271|P1|Overall Study|Egg Donor|1
179320|NCT00468481|621270|P2|Overall Study|Prohibited Medication|1
179321|NCT00468481|621271|P1|Overall Study|Prohibited Medication|1
179322|NCT00468481|621270|P2|Overall Study|susp/diag malignant/premalignant disease|0
179323|NCT00468481|621271|P1|Overall Study|susp/diag malignant/premalignant disease|1
179324|NCT00468481|621270|P2|Overall Study|Withdrawal by Subject|3
179325|NCT00468481|621271|P1|Overall Study|Withdrawal by Subject|12
179326|NCT00468481|621270|P2|Overall Study|Protocol Violation|8
179327|NCT00468481|621271|P1|Overall Study|Protocol Violation|18
179328|NCT00468481|621270|P2|Overall Study|Pregnancy|0
179329|NCT00468481|621271|P1|Overall Study|Pregnancy|2
179330|NCT00468481|621270|P2|Overall Study|Lost to Follow-up|8
179331|NCT00468481|621271|P1|Overall Study|Lost to Follow-up|25
179332|NCT00468481|621270|P2|Overall Study|Adverse Event|3
179333|NCT00468481|621271|P1|Overall Study|Adverse Event|13
179334|NCT00468312|621371|P2|Overall Study|Did not meet protocol eligibility|1
179335|NCT00468312|621372|P1|Overall Study|Did not meet protocol eligibility|0
179336|NCT00468312|621371|P2|Overall Study|Protocol Violation|1
179337|NCT00468312|621372|P1|Overall Study|Protocol Violation|2
179338|NCT00468312|621371|P2|Overall Study|Withdrawal by Subject|1
179339|NCT00468312|621372|P1|Overall Study|Withdrawal by Subject|0
179340|NCT00468312|621371|P2|Overall Study|Lack of Efficacy|1
179341|NCT00468312|621372|P1|Overall Study|Lack of Efficacy|0
179342|NCT00468312|621371|P2|Overall Study|Adverse Event|1
179343|NCT00468312|621372|P1|Overall Study|Adverse Event|2
179344|NCT00468299|621388|P2|Overall Study|Withdrawal by Subject|1
179345|NCT00468299|621389|P1|Overall Study|Withdrawal by Subject|0
179346|NCT00468286|621399|P2|Overall Study|Physician Decision|1
179347|NCT00468286|621400|P1|Overall Study|Physician Decision|0
179348|NCT00468286|621399|P2|Overall Study|Withdrawal by Subject|3
179349|NCT00468286|621400|P1|Overall Study|Withdrawal by Subject|4
179350|NCT00468286|621399|P2|Overall Study|Protocol Violation|2
179351|NCT00468286|621400|P1|Overall Study|Protocol Violation|2
179352|NCT00468286|621399|P2|Overall Study|Adverse Event|6
179353|NCT00468286|621400|P1|Overall Study|Adverse Event|1
179354|NCT00468143|621430|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
179355|NCT00468143|621431|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
179356|NCT00468143|621430|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
179357|NCT00468143|621431|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
179358|NCT00468104|621445|P2|Second Intervention|discarded for malposition of chest tube|2
179359|NCT00468104|621446|P1|Second Intervention|discarded for malposition of chest tube|0
179360|NCT00468104|621445|P2|Second Intervention|Withdrawal by Subject|2
179361|NCT00468104|621446|P1|Second Intervention|Withdrawal by Subject|5
179362|NCT00468104|621445|P2|First Intervention|trapped lung|0
179363|NCT00468104|621446|P1|First Intervention|trapped lung|1
179364|NCT00468104|621445|P2|First Intervention|associated prolonged pneumothorax|0
179365|NCT00468104|621446|P1|First Intervention|associated prolonged pneumothorax|1
179366|NCT00468104|621445|P2|First Intervention|large lung mass with minimal effusion|0
179367|NCT00468104|621446|P1|First Intervention|large lung mass with minimal effusion|1
179368|NCT00468104|621445|P2|First Intervention|malposition/blocked chest tube tube|0
179369|NCT00468104|621446|P1|First Intervention|malposition/blocked chest tube tube|2
179370|NCT00468104|621445|P2|First Intervention|died within 3 weeks|0
179371|NCT00468104|621446|P1|First Intervention|died within 3 weeks|1
179372|NCT00468104|621445|P2|First Intervention|bleeding at chest tube site--first dose|0
179373|NCT00468104|621446|P1|First Intervention|bleeding at chest tube site--first dose|1
179374|NCT00468104|621445|P2|First Intervention|Protocol Violation|1
179375|NCT00468104|621446|P1|First Intervention|Protocol Violation|2
179376|NCT00468052|621463|P2|Overall Study|Protocol Violation|8
179377|NCT00468052|621464|P1|Overall Study|Protocol Violation|7
179378|NCT00467961|621482|P1|Overall Study|Disease Progression|2
179379|NCT00467961|621482|P1|Overall Study|Technical Failures|5
179380|NCT00467896|621486|P1|Overall Study|Patient had no improvement|1
179381|NCT00467896|621486|P1|Overall Study|Started inhaled Remodulin|1
179382|NCT00467896|621486|P1|Overall Study|Started intravenous prostacyclin|1
179383|NCT00467896|621486|P1|Overall Study|Mainly used Prodose not I-neb® device|1
179384|NCT00467896|621486|P1|Overall Study|Patient weaned off iloprost|1
179385|NCT00467896|621486|P1|Overall Study|Patient had atrial septostomy|1
179386|NCT00467896|621486|P1|Overall Study|Patient received transplant|2
179387|NCT00467896|621486|P1|Overall Study|Changed therapy|2
179388|NCT00467896|621486|P1|Overall Study|Non-compliance|3
179389|NCT00467896|621486|P1|Overall Study|Serious Adverse Event|13
179390|NCT00467896|621486|P1|Overall Study|Adverse Event|7
179391|NCT00467896|621486|P1|Overall Study|Consent Withdrawal|18
179392|NCT00467870|621512|P6|Overall Study|Other/Unknown|0
179393|NCT00467870|621513|P5|Overall Study|Other/Unknown|4
179394|NCT00467870|621514|P4|Overall Study|Other/Unknown|5
179395|NCT00467870|621515|P3|Overall Study|Other/Unknown|1
179396|NCT00467870|621516|P2|Overall Study|Other/Unknown|5
179397|NCT00467870|621517|P1|Overall Study|Other/Unknown|8
179398|NCT00467870|621512|P6|Overall Study|Subject Non-compliance|0
179399|NCT00467870|621513|P5|Overall Study|Subject Non-compliance|5
179400|NCT00467870|621514|P4|Overall Study|Subject Non-compliance|1
179401|NCT00467870|621515|P3|Overall Study|Subject Non-compliance|0
179402|NCT00467870|621516|P2|Overall Study|Subject Non-compliance|4
179403|NCT00467870|621517|P1|Overall Study|Subject Non-compliance|3
179404|NCT00467870|621512|P6|Overall Study|Lost to Follow-up|0
179405|NCT00467870|621513|P5|Overall Study|Lost to Follow-up|3
179406|NCT00467870|621514|P4|Overall Study|Lost to Follow-up|1
179407|NCT00467870|621515|P3|Overall Study|Lost to Follow-up|1
179408|NCT00467870|621516|P2|Overall Study|Lost to Follow-up|3
179409|NCT00467870|621517|P1|Overall Study|Lost to Follow-up|5
179410|NCT00467870|621512|P6|Overall Study|Withdrawal by Subject|1
179411|NCT00467870|621513|P5|Overall Study|Withdrawal by Subject|10
179412|NCT00467870|621514|P4|Overall Study|Withdrawal by Subject|9
179413|NCT00467870|621515|P3|Overall Study|Withdrawal by Subject|0
179414|NCT00467870|621516|P2|Overall Study|Withdrawal by Subject|21
179415|NCT00467870|621517|P1|Overall Study|Withdrawal by Subject|14
179416|NCT00467870|621512|P6|Overall Study|Protocol Violation|0
179417|NCT00467870|621513|P5|Overall Study|Protocol Violation|0
179418|NCT00467870|621514|P4|Overall Study|Protocol Violation|2
179419|NCT00467870|621515|P3|Overall Study|Protocol Violation|1
179420|NCT00467870|621516|P2|Overall Study|Protocol Violation|1
179421|NCT00467870|621517|P1|Overall Study|Protocol Violation|2
179422|NCT00467870|621512|P6|Overall Study|Adverse Event|1
179423|NCT00467870|621513|P5|Overall Study|Adverse Event|15
179424|NCT00467870|621514|P4|Overall Study|Adverse Event|15
179425|NCT00467870|621515|P3|Overall Study|Adverse Event|1
179426|NCT00467870|621516|P2|Overall Study|Adverse Event|9
179427|NCT00467870|621517|P1|Overall Study|Adverse Event|13
179428|NCT00467857|621560|P2|Overall Study|Discontinuation reason missing|3
179429|NCT00467857|621561|P1|Overall Study|Discontinuation reason missing|0
179430|NCT00467857|621560|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
179431|NCT00467857|621561|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
179432|NCT00467857|621560|P2|Overall Study|Emergency care required|1
179433|NCT00467857|621561|P1|Overall Study|Emergency care required|0
179434|NCT00467857|621560|P2|Overall Study|Discharged from court service|1
179435|NCT00467857|621561|P1|Overall Study|Discharged from court service|0
179436|NCT00467857|621560|P2|Overall Study|Death|1
179437|NCT00467857|621561|P1|Overall Study|Death|0
179438|NCT00467857|621560|P2|Overall Study|Withdrew consent|0
179439|NCT00467857|621561|P1|Overall Study|Withdrew consent|2
179440|NCT00467857|621560|P2|Overall Study|Adverse Event|0
179441|NCT00467857|621561|P1|Overall Study|Adverse Event|1
179442|NCT00467831|621609|P1|Overall Study|Withdrawal by Subject|1
179443|NCT00467831|621609|P1|Overall Study|Death|2
179444|NCT00467779|621628|P15|Stage 3|Unspecified Reason|5
179445|NCT00467779|621629|P14|Stage 3|Unspecified Reason|0
179446|NCT00467779|621630|P13|Stage 3|Unspecified Reason|0
179447|NCT00467779|621631|P12|Stage 3|Unspecified Reason|0
179448|NCT00467779|621632|P11|Stage 3|Unspecified Reason|0
179449|NCT00467779|621633|P10|Stage 3|Unspecified Reason|0
179450|NCT00467779|621634|P9|Stage 3|Unspecified Reason|0
179451|NCT00467779|621635|P8|Stage 3|Unspecified Reason|0
179452|NCT00467779|621636|P7|Stage 3|Unspecified Reason|0
179453|NCT00467779|621637|P6|Stage 3|Unspecified Reason|0
179454|NCT00467779|621638|P5|Stage 3|Unspecified Reason|0
179455|NCT00467779|621639|P4|Stage 3|Unspecified Reason|0
179456|NCT00467779|621640|P3|Stage 3|Unspecified Reason|0
179457|NCT00467779|621641|P2|Stage 3|Unspecified Reason|0
179458|NCT00467779|621642|P1|Stage 3|Unspecified Reason|0
179459|NCT00467779|621628|P15|Stage 3|Disease Progression|9
179460|NCT00467779|621629|P14|Stage 3|Disease Progression|0
179461|NCT00467779|621630|P13|Stage 3|Disease Progression|0
179462|NCT00467779|621631|P12|Stage 3|Disease Progression|0
179463|NCT00467779|621632|P11|Stage 3|Disease Progression|0
179464|NCT00467779|621633|P10|Stage 3|Disease Progression|0
179465|NCT00467779|621634|P9|Stage 3|Disease Progression|0
179466|NCT00467779|621635|P8|Stage 3|Disease Progression|0
179467|NCT00467779|621636|P7|Stage 3|Disease Progression|0
179468|NCT00467779|621637|P6|Stage 3|Disease Progression|0
179469|NCT00467779|621638|P5|Stage 3|Disease Progression|0
179470|NCT00467779|621639|P4|Stage 3|Disease Progression|0
179471|NCT00467779|621640|P3|Stage 3|Disease Progression|0
179472|NCT00467779|621641|P2|Stage 3|Disease Progression|0
179473|NCT00467779|621642|P1|Stage 3|Disease Progression|0
179474|NCT00467779|621628|P15|Stage 3|Death|1
179475|NCT00467779|621629|P14|Stage 3|Death|0
179476|NCT00467779|621630|P13|Stage 3|Death|0
179477|NCT00467779|621631|P12|Stage 3|Death|0
179478|NCT00467779|621632|P11|Stage 3|Death|0
179479|NCT00467779|621633|P10|Stage 3|Death|0
179480|NCT00467779|621634|P9|Stage 3|Death|0
179481|NCT00467779|621635|P8|Stage 3|Death|0
179482|NCT00467779|621636|P7|Stage 3|Death|0
179483|NCT00467779|621637|P6|Stage 3|Death|0
179484|NCT00467779|621638|P5|Stage 3|Death|0
179485|NCT00467779|621639|P4|Stage 3|Death|0
179486|NCT00467779|621640|P3|Stage 3|Death|0
179487|NCT00467779|621641|P2|Stage 3|Death|0
179488|NCT00467779|621642|P1|Stage 3|Death|0
179489|NCT00467779|621628|P15|Stage 3|Adverse Event|2
179490|NCT00467779|621629|P14|Stage 3|Adverse Event|0
179491|NCT00467779|621630|P13|Stage 3|Adverse Event|0
179492|NCT00467779|621631|P12|Stage 3|Adverse Event|0
179493|NCT00467779|621632|P11|Stage 3|Adverse Event|0
179494|NCT00467779|621633|P10|Stage 3|Adverse Event|0
179495|NCT00467779|621634|P9|Stage 3|Adverse Event|0
179496|NCT00467779|621635|P8|Stage 3|Adverse Event|0
179497|NCT00467779|621636|P7|Stage 3|Adverse Event|0
179498|NCT00467779|621637|P6|Stage 3|Adverse Event|0
179499|NCT00467779|621638|P5|Stage 3|Adverse Event|0
179500|NCT00467779|621639|P4|Stage 3|Adverse Event|0
179501|NCT00467779|621640|P3|Stage 3|Adverse Event|0
179502|NCT00467779|621641|P2|Stage 3|Adverse Event|0
179503|NCT00467779|621642|P1|Stage 3|Adverse Event|0
179504|NCT00467779|621628|P15|Stage 2A|Withdrawal by Subject|0
179505|NCT00467779|621629|P14|Stage 2A|Withdrawal by Subject|1
179506|NCT00467779|621630|P13|Stage 2A|Withdrawal by Subject|0
179507|NCT00467779|621631|P12|Stage 2A|Withdrawal by Subject|0
179508|NCT00467779|621632|P11|Stage 2A|Withdrawal by Subject|0
179509|NCT00467779|621633|P10|Stage 2A|Withdrawal by Subject|0
179510|NCT00467779|621634|P9|Stage 2A|Withdrawal by Subject|0
179511|NCT00467779|621635|P8|Stage 2A|Withdrawal by Subject|0
179512|NCT00467779|621636|P7|Stage 2A|Withdrawal by Subject|0
179513|NCT00467779|621637|P6|Stage 2A|Withdrawal by Subject|0
179514|NCT00467779|621638|P5|Stage 2A|Withdrawal by Subject|0
179515|NCT00467779|621639|P4|Stage 2A|Withdrawal by Subject|0
179516|NCT00467779|621640|P3|Stage 2A|Withdrawal by Subject|0
179517|NCT00467779|621641|P2|Stage 2A|Withdrawal by Subject|0
179518|NCT00467779|621642|P1|Stage 2A|Withdrawal by Subject|0
179519|NCT00467779|621628|P15|Stage 2A|Unspecified Reason|0
179520|NCT00467779|621629|P14|Stage 2A|Unspecified Reason|7
179521|NCT00467779|621630|P13|Stage 2A|Unspecified Reason|0
179522|NCT00467779|621631|P12|Stage 2A|Unspecified Reason|0
179523|NCT00467779|621632|P11|Stage 2A|Unspecified Reason|0
179524|NCT00467779|621633|P10|Stage 2A|Unspecified Reason|0
179525|NCT00467779|621634|P9|Stage 2A|Unspecified Reason|0
179526|NCT00467779|621635|P8|Stage 2A|Unspecified Reason|0
179527|NCT00467779|621636|P7|Stage 2A|Unspecified Reason|0
179528|NCT00467779|621637|P6|Stage 2A|Unspecified Reason|0
179529|NCT00467779|621638|P5|Stage 2A|Unspecified Reason|0
179530|NCT00467779|621639|P4|Stage 2A|Unspecified Reason|0
179531|NCT00467779|621640|P3|Stage 2A|Unspecified Reason|0
179532|NCT00467779|621641|P2|Stage 2A|Unspecified Reason|0
179533|NCT00467779|621642|P1|Stage 2A|Unspecified Reason|0
179534|NCT00467779|621628|P15|Stage 2A|Disease Progression|0
179535|NCT00467779|621629|P14|Stage 2A|Disease Progression|10
179536|NCT00467779|621630|P13|Stage 2A|Disease Progression|0
179537|NCT00467779|621631|P12|Stage 2A|Disease Progression|0
179538|NCT00467779|621632|P11|Stage 2A|Disease Progression|0
179539|NCT00467779|621633|P10|Stage 2A|Disease Progression|0
179540|NCT00467779|621634|P9|Stage 2A|Disease Progression|0
179541|NCT00467779|621635|P8|Stage 2A|Disease Progression|0
179542|NCT00467779|621636|P7|Stage 2A|Disease Progression|0
179543|NCT00467779|621637|P6|Stage 2A|Disease Progression|0
179544|NCT00467779|621638|P5|Stage 2A|Disease Progression|0
179545|NCT00467779|621639|P4|Stage 2A|Disease Progression|0
179546|NCT00467779|621640|P3|Stage 2A|Disease Progression|0
179547|NCT00467779|621641|P2|Stage 2A|Disease Progression|0
179548|NCT00467779|621642|P1|Stage 2A|Disease Progression|0
179549|NCT00467779|621628|P15|Stage 2A|Death|0
179550|NCT00467779|621629|P14|Stage 2A|Death|1
179551|NCT00467779|621630|P13|Stage 2A|Death|0
179552|NCT00467779|621631|P12|Stage 2A|Death|0
179553|NCT00467779|621632|P11|Stage 2A|Death|0
179554|NCT00467779|621633|P10|Stage 2A|Death|0
179555|NCT00467779|621634|P9|Stage 2A|Death|0
179556|NCT00467779|621635|P8|Stage 2A|Death|0
179557|NCT00467779|621636|P7|Stage 2A|Death|0
179558|NCT00467779|621637|P6|Stage 2A|Death|0
179559|NCT00467779|621638|P5|Stage 2A|Death|0
179560|NCT00467779|621639|P4|Stage 2A|Death|0
179561|NCT00467779|621640|P3|Stage 2A|Death|0
179562|NCT00467779|621641|P2|Stage 2A|Death|0
179563|NCT00467779|621642|P1|Stage 2A|Death|0
179564|NCT00467779|621628|P15|Stage 2A|Adverse Event|0
179565|NCT00467779|621629|P14|Stage 2A|Adverse Event|2
179566|NCT00467779|621630|P13|Stage 2A|Adverse Event|0
179567|NCT00467779|621631|P12|Stage 2A|Adverse Event|0
179568|NCT00467779|621632|P11|Stage 2A|Adverse Event|0
179569|NCT00467779|621633|P10|Stage 2A|Adverse Event|0
179570|NCT00467779|621634|P9|Stage 2A|Adverse Event|0
179571|NCT00467779|621635|P8|Stage 2A|Adverse Event|0
179572|NCT00467779|621636|P7|Stage 2A|Adverse Event|0
179573|NCT00467779|621637|P6|Stage 2A|Adverse Event|0
179574|NCT00467779|621638|P5|Stage 2A|Adverse Event|0
179575|NCT00467779|621639|P4|Stage 2A|Adverse Event|0
179576|NCT00467779|621640|P3|Stage 2A|Adverse Event|0
179577|NCT00467779|621641|P2|Stage 2A|Adverse Event|0
179578|NCT00467779|621642|P1|Stage 2A|Adverse Event|0
179579|NCT00467779|621628|P15|Stage 2|Unspecified Reason|0
179580|NCT00467779|621629|P14|Stage 2|Unspecified Reason|0
179581|NCT00467779|621630|P13|Stage 2|Unspecified Reason|0
179582|NCT00467779|621631|P12|Stage 2|Unspecified Reason|0
179583|NCT00467779|621632|P11|Stage 2|Unspecified Reason|0
179584|NCT00467779|621633|P10|Stage 2|Unspecified Reason|0
179585|NCT00467779|621634|P9|Stage 2|Unspecified Reason|3
179586|NCT00467779|621635|P8|Stage 2|Unspecified Reason|0
179587|NCT00467779|621636|P7|Stage 2|Unspecified Reason|0
179588|NCT00467779|621637|P6|Stage 2|Unspecified Reason|0
179589|NCT00467779|621638|P5|Stage 2|Unspecified Reason|0
179590|NCT00467779|621639|P4|Stage 2|Unspecified Reason|0
179591|NCT00467779|621640|P3|Stage 2|Unspecified Reason|0
179592|NCT00467779|621641|P2|Stage 2|Unspecified Reason|0
179593|NCT00467779|621642|P1|Stage 2|Unspecified Reason|0
179594|NCT00467779|621628|P15|Stage 2|Disease Progression|0
179595|NCT00467779|621629|P14|Stage 2|Disease Progression|0
179596|NCT00467779|621630|P13|Stage 2|Disease Progression|0
179597|NCT00467779|621631|P12|Stage 2|Disease Progression|0
179598|NCT00467779|621632|P11|Stage 2|Disease Progression|0
179599|NCT00467779|621633|P10|Stage 2|Disease Progression|0
179600|NCT00467779|621634|P9|Stage 2|Disease Progression|16
179601|NCT00467779|621635|P8|Stage 2|Disease Progression|0
179602|NCT00467779|621636|P7|Stage 2|Disease Progression|0
179603|NCT00467779|621637|P6|Stage 2|Disease Progression|0
179604|NCT00467779|621638|P5|Stage 2|Disease Progression|0
179605|NCT00467779|621639|P4|Stage 2|Disease Progression|0
179606|NCT00467779|621640|P3|Stage 2|Disease Progression|0
179607|NCT00467779|621641|P2|Stage 2|Disease Progression|0
179608|NCT00467779|621642|P1|Stage 2|Disease Progression|0
179609|NCT00467779|621628|P15|Stage 2|Death|0
179610|NCT00467779|621629|P14|Stage 2|Death|0
179611|NCT00467779|621630|P13|Stage 2|Death|0
179612|NCT00467779|621631|P12|Stage 2|Death|0
179613|NCT00467779|621632|P11|Stage 2|Death|0
179614|NCT00467779|621633|P10|Stage 2|Death|0
179615|NCT00467779|621634|P9|Stage 2|Death|1
179616|NCT00467779|621635|P8|Stage 2|Death|0
179617|NCT00467779|621636|P7|Stage 2|Death|0
179618|NCT00467779|621637|P6|Stage 2|Death|0
179619|NCT00467779|621638|P5|Stage 2|Death|0
179620|NCT00467779|621639|P4|Stage 2|Death|0
179621|NCT00467779|621640|P3|Stage 2|Death|0
179622|NCT00467779|621641|P2|Stage 2|Death|0
179623|NCT00467779|621642|P1|Stage 2|Death|0
179624|NCT00467779|621628|P15|Stage 2|Adverse Event|0
179625|NCT00467779|621629|P14|Stage 2|Adverse Event|0
179626|NCT00467779|621630|P13|Stage 2|Adverse Event|0
179627|NCT00467779|621631|P12|Stage 2|Adverse Event|0
179628|NCT00467779|621632|P11|Stage 2|Adverse Event|0
179629|NCT00467779|621633|P10|Stage 2|Adverse Event|0
179630|NCT00467779|621634|P9|Stage 2|Adverse Event|1
179631|NCT00467779|621635|P8|Stage 2|Adverse Event|0
179632|NCT00467779|621636|P7|Stage 2|Adverse Event|0
179633|NCT00467779|621637|P6|Stage 2|Adverse Event|0
179634|NCT00467779|621638|P5|Stage 2|Adverse Event|0
179635|NCT00467779|621639|P4|Stage 2|Adverse Event|0
179636|NCT00467779|621640|P3|Stage 2|Adverse Event|0
179637|NCT00467779|621641|P2|Stage 2|Adverse Event|0
179638|NCT00467779|621642|P1|Stage 2|Adverse Event|0
179639|NCT00467779|621628|P15|Stage 1A|Unspecified Reason|0
179640|NCT00467779|621629|P14|Stage 1A|Unspecified Reason|0
179641|NCT00467779|621630|P13|Stage 1A|Unspecified Reason|1
179642|NCT00467779|621631|P12|Stage 1A|Unspecified Reason|1
179643|NCT00467779|621632|P11|Stage 1A|Unspecified Reason|0
179644|NCT00467779|621633|P10|Stage 1A|Unspecified Reason|0
179645|NCT00467779|621634|P9|Stage 1A|Unspecified Reason|0
179646|NCT00467779|621635|P8|Stage 1A|Unspecified Reason|0
179647|NCT00467779|621636|P7|Stage 1A|Unspecified Reason|0
179648|NCT00467779|621637|P6|Stage 1A|Unspecified Reason|0
179649|NCT00467779|621638|P5|Stage 1A|Unspecified Reason|0
179650|NCT00467779|621639|P4|Stage 1A|Unspecified Reason|0
179651|NCT00467779|621640|P3|Stage 1A|Unspecified Reason|0
179652|NCT00467779|621641|P2|Stage 1A|Unspecified Reason|0
179653|NCT00467779|621642|P1|Stage 1A|Unspecified Reason|0
179654|NCT00467779|621628|P15|Stage 1A|Withdrawal by Subject|0
179655|NCT00467779|621629|P14|Stage 1A|Withdrawal by Subject|0
179656|NCT00467779|621630|P13|Stage 1A|Withdrawal by Subject|1
179657|NCT00467779|621631|P12|Stage 1A|Withdrawal by Subject|1
179658|NCT00467779|621632|P11|Stage 1A|Withdrawal by Subject|1
179659|NCT00467779|621633|P10|Stage 1A|Withdrawal by Subject|0
179660|NCT00467779|621634|P9|Stage 1A|Withdrawal by Subject|0
179661|NCT00467779|621635|P8|Stage 1A|Withdrawal by Subject|0
179662|NCT00467779|621636|P7|Stage 1A|Withdrawal by Subject|0
179663|NCT00467779|621637|P6|Stage 1A|Withdrawal by Subject|0
179664|NCT00467779|621638|P5|Stage 1A|Withdrawal by Subject|0
179665|NCT00467779|621639|P4|Stage 1A|Withdrawal by Subject|0
179666|NCT00467779|621640|P3|Stage 1A|Withdrawal by Subject|0
179667|NCT00467779|621641|P2|Stage 1A|Withdrawal by Subject|0
179668|NCT00467779|621642|P1|Stage 1A|Withdrawal by Subject|0
179669|NCT00467779|621628|P15|Stage 1A|Physician Decision|0
179670|NCT00467779|621629|P14|Stage 1A|Physician Decision|0
179671|NCT00467779|621630|P13|Stage 1A|Physician Decision|0
179672|NCT00467779|621631|P12|Stage 1A|Physician Decision|0
179673|NCT00467779|621632|P11|Stage 1A|Physician Decision|0
179674|NCT00467779|621633|P10|Stage 1A|Physician Decision|1
179675|NCT00467779|621634|P9|Stage 1A|Physician Decision|0
179676|NCT00467779|621635|P8|Stage 1A|Physician Decision|0
179677|NCT00467779|621636|P7|Stage 1A|Physician Decision|0
179678|NCT00467779|621637|P6|Stage 1A|Physician Decision|0
179679|NCT00467779|621638|P5|Stage 1A|Physician Decision|0
179680|NCT00467779|621639|P4|Stage 1A|Physician Decision|0
179681|NCT00467779|621640|P3|Stage 1A|Physician Decision|0
179682|NCT00467779|621641|P2|Stage 1A|Physician Decision|0
179683|NCT00467779|621642|P1|Stage 1A|Physician Decision|0
179684|NCT00467779|621628|P15|Stage 1A|Disease Progression|0
179685|NCT00467779|621629|P14|Stage 1A|Disease Progression|0
179686|NCT00467779|621630|P13|Stage 1A|Disease Progression|2
179687|NCT00467779|621631|P12|Stage 1A|Disease Progression|5
179688|NCT00467779|621632|P11|Stage 1A|Disease Progression|2
179689|NCT00467779|621633|P10|Stage 1A|Disease Progression|2
179690|NCT00467779|621634|P9|Stage 1A|Disease Progression|0
179691|NCT00467779|621635|P8|Stage 1A|Disease Progression|0
179692|NCT00467779|621636|P7|Stage 1A|Disease Progression|0
179693|NCT00467779|621637|P6|Stage 1A|Disease Progression|0
179694|NCT00467779|621638|P5|Stage 1A|Disease Progression|0
179695|NCT00467779|621639|P4|Stage 1A|Disease Progression|0
179696|NCT00467779|621640|P3|Stage 1A|Disease Progression|0
179697|NCT00467779|621641|P2|Stage 1A|Disease Progression|0
179698|NCT00467779|621642|P1|Stage 1A|Disease Progression|0
179699|NCT00467779|621628|P15|Stage 1A|Death|0
179700|NCT00467779|621629|P14|Stage 1A|Death|0
179701|NCT00467779|621630|P13|Stage 1A|Death|1
179702|NCT00467779|621631|P12|Stage 1A|Death|1
179703|NCT00467779|621632|P11|Stage 1A|Death|0
179704|NCT00467779|621633|P10|Stage 1A|Death|0
179705|NCT00467779|621634|P9|Stage 1A|Death|0
179706|NCT00467779|621635|P8|Stage 1A|Death|0
179707|NCT00467779|621636|P7|Stage 1A|Death|0
179708|NCT00467779|621637|P6|Stage 1A|Death|0
179709|NCT00467779|621638|P5|Stage 1A|Death|0
179710|NCT00467779|621639|P4|Stage 1A|Death|0
179711|NCT00467779|621640|P3|Stage 1A|Death|0
179712|NCT00467779|621641|P2|Stage 1A|Death|0
179713|NCT00467779|621642|P1|Stage 1A|Death|0
179714|NCT00467779|621628|P15|Stage 1A|Adverse Event|0
179715|NCT00467779|621629|P14|Stage 1A|Adverse Event|0
179716|NCT00467779|621630|P13|Stage 1A|Adverse Event|1
179717|NCT00467779|621631|P12|Stage 1A|Adverse Event|0
179718|NCT00467779|621632|P11|Stage 1A|Adverse Event|0
179719|NCT00467779|621633|P10|Stage 1A|Adverse Event|0
179720|NCT00467779|621634|P9|Stage 1A|Adverse Event|0
179721|NCT00467779|621635|P8|Stage 1A|Adverse Event|0
179722|NCT00467779|621636|P7|Stage 1A|Adverse Event|0
179723|NCT00467779|621637|P6|Stage 1A|Adverse Event|0
179724|NCT00467779|621638|P5|Stage 1A|Adverse Event|0
179725|NCT00467779|621639|P4|Stage 1A|Adverse Event|0
179726|NCT00467779|621640|P3|Stage 1A|Adverse Event|0
179727|NCT00467779|621641|P2|Stage 1A|Adverse Event|0
179728|NCT00467779|621642|P1|Stage 1A|Adverse Event|0
179729|NCT00467779|621628|P15|Stage 1|Withdrawal by Subject|0
179730|NCT00467779|621629|P14|Stage 1|Withdrawal by Subject|0
179731|NCT00467779|621630|P13|Stage 1|Withdrawal by Subject|0
179732|NCT00467779|621631|P12|Stage 1|Withdrawal by Subject|0
179733|NCT00467779|621632|P11|Stage 1|Withdrawal by Subject|0
179734|NCT00467779|621633|P10|Stage 1|Withdrawal by Subject|0
179735|NCT00467779|621634|P9|Stage 1|Withdrawal by Subject|0
179736|NCT00467779|621635|P8|Stage 1|Withdrawal by Subject|1
179737|NCT00467779|621636|P7|Stage 1|Withdrawal by Subject|1
179738|NCT00467779|621637|P6|Stage 1|Withdrawal by Subject|0
179739|NCT00467779|621638|P5|Stage 1|Withdrawal by Subject|0
179740|NCT00467779|621639|P4|Stage 1|Withdrawal by Subject|0
179741|NCT00467779|621640|P3|Stage 1|Withdrawal by Subject|0
179742|NCT00467779|621641|P2|Stage 1|Withdrawal by Subject|0
179743|NCT00467779|621642|P1|Stage 1|Withdrawal by Subject|0
179744|NCT00467779|621628|P15|Stage 1|Physician Decision|0
179745|NCT00467779|621629|P14|Stage 1|Physician Decision|0
179746|NCT00467779|621630|P13|Stage 1|Physician Decision|0
179747|NCT00467779|621631|P12|Stage 1|Physician Decision|0
179748|NCT00467779|621632|P11|Stage 1|Physician Decision|0
179749|NCT00467779|621633|P10|Stage 1|Physician Decision|0
179750|NCT00467779|621634|P9|Stage 1|Physician Decision|0
179751|NCT00467779|621635|P8|Stage 1|Physician Decision|0
179752|NCT00467779|621636|P7|Stage 1|Physician Decision|0
179753|NCT00467779|621637|P6|Stage 1|Physician Decision|0
179754|NCT00467779|621638|P5|Stage 1|Physician Decision|0
179755|NCT00467779|621639|P4|Stage 1|Physician Decision|0
179756|NCT00467779|621640|P3|Stage 1|Physician Decision|0
179757|NCT00467779|621641|P2|Stage 1|Physician Decision|1
179758|NCT00467779|621642|P1|Stage 1|Physician Decision|0
179759|NCT00467779|621628|P15|Stage 1|Unspecified Reason|0
179760|NCT00467779|621629|P14|Stage 1|Unspecified Reason|0
179761|NCT00467779|621630|P13|Stage 1|Unspecified Reason|0
179762|NCT00467779|621631|P12|Stage 1|Unspecified Reason|0
179763|NCT00467779|621632|P11|Stage 1|Unspecified Reason|0
179764|NCT00467779|621633|P10|Stage 1|Unspecified Reason|0
179765|NCT00467779|621634|P9|Stage 1|Unspecified Reason|0
179766|NCT00467779|621635|P8|Stage 1|Unspecified Reason|0
179767|NCT00467779|621636|P7|Stage 1|Unspecified Reason|0
179768|NCT00467779|621637|P6|Stage 1|Unspecified Reason|2
179769|NCT00467779|621638|P5|Stage 1|Unspecified Reason|1
179770|NCT00467779|621639|P4|Stage 1|Unspecified Reason|0
179771|NCT00467779|621640|P3|Stage 1|Unspecified Reason|1
179772|NCT00467779|621641|P2|Stage 1|Unspecified Reason|0
179773|NCT00467779|621642|P1|Stage 1|Unspecified Reason|1
179774|NCT00467779|621628|P15|Stage 1|Disease Progression|0
179775|NCT00467779|621629|P14|Stage 1|Disease Progression|0
179776|NCT00467779|621630|P13|Stage 1|Disease Progression|0
179777|NCT00467779|621631|P12|Stage 1|Disease Progression|0
179778|NCT00467779|621632|P11|Stage 1|Disease Progression|0
179779|NCT00467779|621633|P10|Stage 1|Disease Progression|0
179780|NCT00467779|621634|P9|Stage 1|Disease Progression|0
179781|NCT00467779|621635|P8|Stage 1|Disease Progression|5
179782|NCT00467779|621636|P7|Stage 1|Disease Progression|4
179783|NCT00467779|621637|P6|Stage 1|Disease Progression|2
179784|NCT00467779|621638|P5|Stage 1|Disease Progression|2
179785|NCT00467779|621639|P4|Stage 1|Disease Progression|3
179786|NCT00467779|621640|P3|Stage 1|Disease Progression|2
179787|NCT00467779|621641|P2|Stage 1|Disease Progression|2
179788|NCT00467779|621642|P1|Stage 1|Disease Progression|2
179789|NCT00467779|621628|P15|Stage 1|Adverse Event|0
179790|NCT00467779|621629|P14|Stage 1|Adverse Event|0
179791|NCT00467779|621630|P13|Stage 1|Adverse Event|0
179792|NCT00467779|621631|P12|Stage 1|Adverse Event|0
179793|NCT00467779|621632|P11|Stage 1|Adverse Event|0
179794|NCT00467779|621633|P10|Stage 1|Adverse Event|0
179795|NCT00467779|621634|P9|Stage 1|Adverse Event|0
179796|NCT00467779|621635|P8|Stage 1|Adverse Event|1
179797|NCT00467779|621636|P7|Stage 1|Adverse Event|2
179798|NCT00467779|621637|P6|Stage 1|Adverse Event|1
179799|NCT00467779|621638|P5|Stage 1|Adverse Event|0
179800|NCT00467779|621639|P4|Stage 1|Adverse Event|0
179801|NCT00467779|621640|P3|Stage 1|Adverse Event|0
179802|NCT00467779|621641|P2|Stage 1|Adverse Event|0
179803|NCT00467779|621642|P1|Stage 1|Adverse Event|1
179804|NCT00467753|621816|P2|Overall Study|Adverse Event|0
179805|NCT00467753|621817|P1|Overall Study|Adverse Event|2
179806|NCT00467753|621816|P2|Overall Study|Lost to Follow-up|2
179807|NCT00467753|621817|P1|Overall Study|Lost to Follow-up|1
179808|NCT00467740|621828|P5|Overall Study|Lack of Efficacy|0
179809|NCT00467740|621829|P4|Overall Study|Lack of Efficacy|0
179810|NCT00467740|621830|P3|Overall Study|Lack of Efficacy|0
179811|NCT00467740|621831|P2|Overall Study|Lack of Efficacy|1
179812|NCT00467740|621832|P1|Overall Study|Lack of Efficacy|0
179813|NCT00467740|621828|P5|Overall Study|Withdrawal by Subject|0
179814|NCT00467740|621829|P4|Overall Study|Withdrawal by Subject|1
179815|NCT00467740|621830|P3|Overall Study|Withdrawal by Subject|0
179816|NCT00467740|621831|P2|Overall Study|Withdrawal by Subject|1
179817|NCT00467740|621832|P1|Overall Study|Withdrawal by Subject|1
179818|NCT00467740|621828|P5|Overall Study|Lost to Follow-up|0
179819|NCT00467740|621829|P4|Overall Study|Lost to Follow-up|0
179820|NCT00467740|621830|P3|Overall Study|Lost to Follow-up|0
179821|NCT00467740|621831|P2|Overall Study|Lost to Follow-up|1
179822|NCT00467740|621832|P1|Overall Study|Lost to Follow-up|0
179823|NCT00467740|621828|P5|Overall Study|Protocol Violation|0
179824|NCT00467740|621829|P4|Overall Study|Protocol Violation|0
179825|NCT00467740|621830|P3|Overall Study|Protocol Violation|1
179826|NCT00467740|621831|P2|Overall Study|Protocol Violation|0
179827|NCT00467740|621832|P1|Overall Study|Protocol Violation|0
179828|NCT00467740|621828|P5|Overall Study|Adverse Event|0
179829|NCT00467740|621829|P4|Overall Study|Adverse Event|0
179830|NCT00467740|621830|P3|Overall Study|Adverse Event|1
179831|NCT00467740|621831|P2|Overall Study|Adverse Event|0
179832|NCT00467740|621832|P1|Overall Study|Adverse Event|0
179833|NCT00467649|622021|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
179834|NCT00467649|622022|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
179835|NCT00467649|622023|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
179836|NCT00467649|622024|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
179837|NCT00467649|622025|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
179838|NCT00467649|622026|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
179839|NCT00467649|622021|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
179840|NCT00467649|622022|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
179841|NCT00467649|622023|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
179842|NCT00467649|622024|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
179843|NCT00467649|622025|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
179844|NCT00467649|622026|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
179845|NCT00467649|622021|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
179846|NCT00467649|622022|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
179847|NCT00467649|622023|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
179848|NCT00467649|622024|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
179849|NCT00467649|622025|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
179850|NCT00467649|622026|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
179851|NCT00467649|622021|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
179852|NCT00467649|622022|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
179853|NCT00467649|622023|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
179854|NCT00467649|622024|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
179855|NCT00467649|622025|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
179856|NCT00467649|622026|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
179857|NCT00467649|622021|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
179858|NCT00467649|622022|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
179859|NCT00467649|622023|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
179860|NCT00467649|622024|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
179861|NCT00467649|622025|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
179862|NCT00467649|622026|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
179863|NCT00467649|622021|P6|Phase 1 (Randomized Population)|Investigator Decision|0
179864|NCT00467649|622022|P5|Phase 1 (Randomized Population)|Investigator Decision|0
179865|NCT00467649|622023|P4|Phase 1 (Randomized Population)|Investigator Decision|0
179866|NCT00467649|622024|P3|Phase 1 (Randomized Population)|Investigator Decision|0
179867|NCT00467649|622025|P2|Phase 1 (Randomized Population)|Investigator Decision|0
179868|NCT00467649|622026|P1|Phase 1 (Randomized Population)|Investigator Decision|1
179869|NCT00467649|622021|P6|Phase 1 (Randomized Population)|Adverse Event|0
179870|NCT00467649|622022|P5|Phase 1 (Randomized Population)|Adverse Event|0
179871|NCT00467649|622023|P4|Phase 1 (Randomized Population)|Adverse Event|0
179872|NCT00467649|622024|P3|Phase 1 (Randomized Population)|Adverse Event|0
179873|NCT00467649|622025|P2|Phase 1 (Randomized Population)|Adverse Event|0
179874|NCT00467649|622026|P1|Phase 1 (Randomized Population)|Adverse Event|2
179875|NCT00467610|622066|P1|Overall Study|Withdrawal by Subject|1
179876|NCT00467597|622077|P2|Overall Study|Withdrawal by Subject|0
179877|NCT00467597|622078|P1|Overall Study|Withdrawal by Subject|2
179878|NCT00467584|622091|P3|Overall Study|Withdrawal by Subject|1
179879|NCT00467584|622092|P2|Overall Study|Withdrawal by Subject|5
179880|NCT00467584|622093|P1|Overall Study|Withdrawal by Subject|4
179881|NCT00467558|622103|P2|Overall Study|Lost to Follow-up|0
179882|NCT00467558|622104|P1|Overall Study|Lost to Follow-up|2
179883|NCT00467519|622114|P2|Overall Study|Withdrawal by Subject|10
179884|NCT00467519|622115|P1|Overall Study|Withdrawal by Subject|4
179885|NCT00467519|622114|P2|Overall Study|Lost to Follow-up|9
179886|NCT00467519|622115|P1|Overall Study|Lost to Follow-up|2
179887|NCT00467519|622114|P2|Overall Study|Protocol Violation|4
179888|NCT00467519|622115|P1|Overall Study|Protocol Violation|8
179889|NCT00467363|622144|P2|Overall Study|Lost to Follow-up|70
179890|NCT00467363|622145|P1|Overall Study|Lost to Follow-up|80
179891|NCT00467285|622192|P2|Overall Study|Lost to Follow-up|4
179892|NCT00467285|622193|P1|Overall Study|Lost to Follow-up|4
179893|NCT00467259|622213|P2|Overall Study|Site Closed|1
179894|NCT00467259|622214|P1|Overall Study|Site Closed|2
179895|NCT00467259|622213|P2|Overall Study|Lost to Follow-up|34
179896|NCT00467259|622214|P1|Overall Study|Lost to Follow-up|14
179897|NCT00467259|622213|P2|Overall Study|Physician Decision|2
179898|NCT00467259|622214|P1|Overall Study|Physician Decision|0
179899|NCT00467259|622213|P2|Overall Study|Withdrawal by Subject|108
179900|NCT00467259|622214|P1|Overall Study|Withdrawal by Subject|34
179901|NCT00467259|622213|P2|Overall Study|Protocol Violation|7
179902|NCT00467259|622214|P1|Overall Study|Protocol Violation|1
179903|NCT00467259|622213|P2|Overall Study|Adverse Event|90
179904|NCT00467259|622214|P1|Overall Study|Adverse Event|24
179905|NCT00467051|622231|P1|Overall Study|Adverse Event|2
179906|NCT00466947|622258|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
179907|NCT00466947|622259|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
179908|NCT00466947|622258|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
179909|NCT00466947|622259|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
179910|NCT00466947|622258|P2|Study End Analysis Period|Other – Forbidden vaccination|10
179911|NCT00466947|622259|P1|Study End Analysis Period|Other – Forbidden vaccination|21
179912|NCT00466947|622258|P2|Study End Analysis Period|Withdrawal by Subject|1267
179913|NCT00466947|622259|P1|Study End Analysis Period|Withdrawal by Subject|1264
179914|NCT00466947|622258|P2|Study End Analysis Period|Protocol Violation|17
179915|NCT00466947|622259|P1|Study End Analysis Period|Protocol Violation|9
179916|NCT00466947|622258|P2|Study End Analysis Period|Physician Decision|29
179917|NCT00466947|622259|P1|Study End Analysis Period|Physician Decision|29
179918|NCT00466947|622258|P2|Study End Analysis Period|Lost to Follow-up|1167
179919|NCT00466947|622259|P1|Study End Analysis Period|Lost to Follow-up|1137
179920|NCT00466947|622258|P2|Study End Analysis Period|Adverse Event|43
179921|NCT00466947|622259|P1|Study End Analysis Period|Adverse Event|35
179922|NCT00466947|622258|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
179923|NCT00466947|622259|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
179924|NCT00466687|622454|P1|Overall Study|Disease progression|29
179925|NCT00466687|622454|P1|Overall Study|Withdrawal by Subject|1
179926|NCT00466687|622454|P1|Overall Study|Other complicating illness|3
179927|NCT00466687|622454|P1|Overall Study|Adverse Event|1
179928|NCT00466505|622461|P1|Overall Study|Adverse Event|4
179929|NCT00466505|622461|P1|Overall Study|disease progression|13
179930|NCT00466193|622511|P2|Overall Study|Patient refused Visit 4 procedures|0
179931|NCT00466193|622512|P1|Overall Study|Patient refused Visit 4 procedures|1
179932|NCT00466193|622511|P2|Overall Study|Withdrawal by Subject|2
179933|NCT00466193|622512|P1|Overall Study|Withdrawal by Subject|7
179934|NCT00466193|622511|P2|Overall Study|Protocol Violation|1
179935|NCT00466193|622512|P1|Overall Study|Protocol Violation|1
179936|NCT00466193|622511|P2|Overall Study|Physician Decision|0
179937|NCT00466193|622512|P1|Overall Study|Physician Decision|1
179938|NCT00466193|622511|P2|Overall Study|Lost to Follow-up|4
179939|NCT00466193|622512|P1|Overall Study|Lost to Follow-up|2
179940|NCT00466193|622511|P2|Overall Study|Adverse Event|1
179941|NCT00466193|622512|P1|Overall Study|Adverse Event|0
179942|NCT00466167|622539|P3|Overall Study|Not treated|0
179943|NCT00466167|622540|P2|Overall Study|Not treated|0
179944|NCT00466167|622541|P1|Overall Study|Not treated|1
179945|NCT00466167|622539|P3|Overall Study|patient did not meet inclusion criteria|1
179946|NCT00466167|622540|P2|Overall Study|patient did not meet inclusion criteria|0
179947|NCT00466167|622541|P1|Overall Study|patient did not meet inclusion criteria|1
179948|NCT00466167|622539|P3|Overall Study|Withdrawal by Subject|6
179949|NCT00466167|622540|P2|Overall Study|Withdrawal by Subject|1
179950|NCT00466167|622541|P1|Overall Study|Withdrawal by Subject|4
179951|NCT00466167|622539|P3|Overall Study|Lost to Follow-up|2
179952|NCT00466167|622540|P2|Overall Study|Lost to Follow-up|2
179953|NCT00466167|622541|P1|Overall Study|Lost to Follow-up|3
179954|NCT00466167|622539|P3|Overall Study|Protocol Violation|2
179955|NCT00466167|622540|P2|Overall Study|Protocol Violation|1
179956|NCT00466167|622541|P1|Overall Study|Protocol Violation|1
179957|NCT00466167|622539|P3|Overall Study|Lack of Efficacy|3
179958|NCT00466167|622540|P2|Overall Study|Lack of Efficacy|0
179959|NCT00466167|622541|P1|Overall Study|Lack of Efficacy|2
179960|NCT00466167|622539|P3|Overall Study|Adverse Event|7
179961|NCT00466167|622540|P2|Overall Study|Adverse Event|8
179962|NCT00466167|622541|P1|Overall Study|Adverse Event|8
179963|NCT00465985|622602|P2|Part III - Open-label Treatment Period|Adverse Event|0
179964|NCT00465985|622603|P1|Part III - Open-label Treatment Period|Adverse Event|1
179965|NCT00465985|622602|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
179966|NCT00465985|622603|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
179967|NCT00465985|622602|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
179968|NCT00465985|622603|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
179969|NCT00465985|622602|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
179970|NCT00465985|622603|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
179971|NCT00465972|622626|P2|Overall Study|Withdrawal by Subject|1
179972|NCT00465972|622627|P1|Overall Study|Withdrawal by Subject|2
179973|NCT00465816|622647|P3|Overall Study|Lost to Follow-up|2
179974|NCT00465816|622648|P2|Overall Study|Lost to Follow-up|0
179975|NCT00465816|622649|P1|Overall Study|Lost to Follow-up|0
179976|NCT00465738|622731|P2|Overall Study|Other|5
179977|NCT00465738|622732|P1|Overall Study|Other|2
179978|NCT00465738|622731|P2|Overall Study|Withdrawal by Subject|0
179979|NCT00465738|622732|P1|Overall Study|Withdrawal by Subject|2
179980|NCT00465738|622731|P2|Overall Study|Adverse Event|1
179981|NCT00465738|622732|P1|Overall Study|Adverse Event|0
179982|NCT00465738|622731|P2|Overall Study|Lost to Follow-up|0
179983|NCT00465738|622732|P1|Overall Study|Lost to Follow-up|2
179984|NCT00465647|622826|P4|Overall Study|"The other reasons included loss of IV"|2
179985|NCT00465647|622827|P3|Overall Study|"The other reasons included loss of IV"|3
179986|NCT00465647|622828|P2|Overall Study|"The other reasons included loss of IV"|4
179987|NCT00465647|622829|P1|Overall Study|"The other reasons included loss of IV"|8
179988|NCT00465647|622826|P4|Overall Study|Withdrawal by Subject|7
179989|NCT00465647|622827|P3|Overall Study|Withdrawal by Subject|2
179990|NCT00465647|622828|P2|Overall Study|Withdrawal by Subject|2
179991|NCT00465647|622829|P1|Overall Study|Withdrawal by Subject|1
179992|NCT00465647|622826|P4|Overall Study|Adverse Event|2
179993|NCT00465647|622827|P3|Overall Study|Adverse Event|3
179994|NCT00465647|622828|P2|Overall Study|Adverse Event|0
179995|NCT00465647|622829|P1|Overall Study|Adverse Event|2
179996|NCT00465647|622826|P4|Overall Study|Administrative|2
179997|NCT00465647|622827|P3|Overall Study|Administrative|3
179998|NCT00465647|622828|P2|Overall Study|Administrative|2
179999|NCT00465647|622829|P1|Overall Study|Administrative|2
180000|NCT00465569|622854|P2|Overall Study|persistent eczema during dose escalation|0
180001|NCT00465569|622855|P1|Overall Study|persistent eczema during dose escalation|1
180002|NCT00465361|622878|P1|Baseline Assessment|Personal Issues/Scheduling|4
180003|NCT00465179|622882|P1|Overall Study|Progression of Disease|47
180004|NCT00465179|622882|P1|Overall Study|Withdrawal by Subject|2
180005|NCT00465179|622882|P1|Overall Study|Adverse Event|4
180006|NCT00465101|622888|P1|Overall Study|Withdrew consent prior to procedure|3
180007|NCT00465101|622888|P1|Overall Study|Physician Decision|1
180008|NCT00465101|622888|P1|Overall Study|Withdrawal by Subject|25
180009|NCT00465101|622888|P1|Overall Study|Death|3
180010|NCT00465101|622888|P1|Overall Study|Unable to obtain IRB approval|1
180011|NCT00465101|622888|P1|Overall Study|Site closed due to IRB expiration|1
180012|NCT00465101|622888|P1|Overall Study|Patient postponed procedure|1
180013|NCT00465101|622888|P1|Overall Study|Pt. Insurance not accepted at center|2
180014|NCT00465101|622888|P1|Overall Study|Other|6
180015|NCT00465101|622888|P1|Overall Study|Lost to Follow-up|5
180016|NCT00465101|622888|P1|Overall Study|Did not meet study criteria|4
180017|NCT00465101|622888|P1|Overall Study|Change in health precluded follow up|4
180018|NCT00465101|622888|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
180019|NCT00464945|622958|P2|Toddler Dose|Lost to Follow-up|1
180020|NCT00464945|622959|P1|Toddler Dose|Lost to Follow-up|0
180021|NCT00464945|622958|P2|After Infant Series|Withdrawal by Subject|2
180022|NCT00464945|622959|P1|After Infant Series|Withdrawal by Subject|0
180023|NCT00464945|622958|P2|Infant Series|Lost to Follow-up|0
180024|NCT00464945|622959|P1|Infant Series|Lost to Follow-up|1
180025|NCT00464945|622958|P2|Infant Series|Protocol Violation|0
180026|NCT00464945|622959|P1|Infant Series|Protocol Violation|1
180027|NCT00464945|622958|P2|Infant Series|Withdrawal by parent/guardian request|1
180028|NCT00464945|622959|P1|Infant Series|Withdrawal by parent/guardian request|2
180029|NCT00464815|622989|P2|Overall Study|Withdrawal by Subject|3
180030|NCT00464815|622990|P1|Overall Study|Withdrawal by Subject|6
180031|NCT00464737|623023|P3|Overall Study|Other: Subject's disability per sponsor|1
180032|NCT00464737|623024|P2|Overall Study|Other: Subject's disability per sponsor|0
180033|NCT00464737|623025|P1|Overall Study|Other: Subject's disability per sponsor|0
180034|NCT00464737|623023|P3|Overall Study|Other: Personal family reasons|1
180035|NCT00464737|623024|P2|Overall Study|Other: Personal family reasons|0
180036|NCT00464737|623025|P1|Overall Study|Other: Personal family reasons|0
180037|NCT00464737|623023|P3|Overall Study|Other: Study demands too great|0
180038|NCT00464737|623024|P2|Overall Study|Other: Study demands too great|1
180039|NCT00464737|623025|P1|Overall Study|Other: Study demands too great|0
180040|NCT00464737|623023|P3|Overall Study|Other: Subject left town; family illness|0
180041|NCT00464737|623024|P2|Overall Study|Other: Subject left town; family illness|0
180042|NCT00464737|623025|P1|Overall Study|Other: Subject left town; family illness|1
180043|NCT00464737|623023|P3|Overall Study|Other: Subject's schedule doesn't permit|0
180044|NCT00464737|623024|P2|Overall Study|Other: Subject's schedule doesn't permit|0
180045|NCT00464737|623025|P1|Overall Study|Other: Subject's schedule doesn't permit|1
180046|NCT00464737|623023|P3|Overall Study|Lost to Follow-up|5
180047|NCT00464737|623024|P2|Overall Study|Lost to Follow-up|2
180048|NCT00464737|623025|P1|Overall Study|Lost to Follow-up|5
180049|NCT00464737|623023|P3|Overall Study|Non-compliance|1
180050|NCT00464737|623024|P2|Overall Study|Non-compliance|1
180051|NCT00464737|623025|P1|Overall Study|Non-compliance|0
180052|NCT00464737|623023|P3|Overall Study|Protocol Violation|5
180053|NCT00464737|623024|P2|Overall Study|Protocol Violation|1
180054|NCT00464737|623025|P1|Overall Study|Protocol Violation|1
180055|NCT00464737|623023|P3|Overall Study|Withdrawal by Subject|5
180056|NCT00464737|623024|P2|Overall Study|Withdrawal by Subject|3
180057|NCT00464737|623025|P1|Overall Study|Withdrawal by Subject|5
180058|NCT00464737|623023|P3|Overall Study|Lack of Efficacy|4
180059|NCT00464737|623024|P2|Overall Study|Lack of Efficacy|7
180060|NCT00464737|623025|P1|Overall Study|Lack of Efficacy|7
180061|NCT00464737|623023|P3|Overall Study|Adverse Event|33
180062|NCT00464737|623024|P2|Overall Study|Adverse Event|17
180063|NCT00464737|623025|P1|Overall Study|Adverse Event|12
180064|NCT00464672|623105|P6|Overall Study|Lost to Follow-up|0
180065|NCT00464672|623106|P5|Overall Study|Lost to Follow-up|1
180066|NCT00464672|623107|P4|Overall Study|Lost to Follow-up|0
180067|NCT00464672|623108|P3|Overall Study|Lost to Follow-up|0
180068|NCT00464672|623109|P2|Overall Study|Lost to Follow-up|10
180069|NCT00464672|623110|P1|Overall Study|Lost to Follow-up|25
180070|NCT00464672|623105|P6|Overall Study|withdrawal of consent|4
180071|NCT00464672|623106|P5|Overall Study|withdrawal of consent|9
180072|NCT00464672|623107|P4|Overall Study|withdrawal of consent|1
180073|NCT00464672|623108|P3|Overall Study|withdrawal of consent|0
180074|NCT00464672|623109|P2|Overall Study|withdrawal of consent|0
180075|NCT00464672|623110|P1|Overall Study|withdrawal of consent|0
180076|NCT00464568|623189|P1|Overall Study|Adverse Event|2
180077|NCT00464542|623262|P1|Pre-treatment|Withdrawal by Subject|2
180078|NCT00464490|623269|P2|Overall Study|Physician Decision|11
180079|NCT00464490|623270|P1|Overall Study|Physician Decision|11
180080|NCT00464334|623317|P11|Overall Study|Withdrawal by Subject|0
180081|NCT00464334|623318|P10|Overall Study|Withdrawal by Subject|0
180082|NCT00464334|623319|P9|Overall Study|Withdrawal by Subject|3
180083|NCT00464334|623320|P8|Overall Study|Withdrawal by Subject|1
180084|NCT00464334|623321|P7|Overall Study|Withdrawal by Subject|2
180085|NCT00464334|623322|P6|Overall Study|Withdrawal by Subject|2
180086|NCT00464334|623323|P5|Overall Study|Withdrawal by Subject|2
180087|NCT00464334|623324|P4|Overall Study|Withdrawal by Subject|2
180088|NCT00464334|623325|P3|Overall Study|Withdrawal by Subject|4
180089|NCT00464334|623326|P2|Overall Study|Withdrawal by Subject|7
180090|NCT00464334|623327|P1|Overall Study|Withdrawal by Subject|1
180091|NCT00464334|623317|P11|Overall Study|Study Terminated by Sponsor|0
180092|NCT00464334|623318|P10|Overall Study|Study Terminated by Sponsor|0
180093|NCT00464334|623319|P9|Overall Study|Study Terminated by Sponsor|0
180094|NCT00464334|623320|P8|Overall Study|Study Terminated by Sponsor|0
180095|NCT00464334|623321|P7|Overall Study|Study Terminated by Sponsor|0
180096|NCT00464334|623322|P6|Overall Study|Study Terminated by Sponsor|0
180097|NCT00464334|623323|P5|Overall Study|Study Terminated by Sponsor|0
180098|NCT00464334|623324|P4|Overall Study|Study Terminated by Sponsor|1
180099|NCT00464334|623325|P3|Overall Study|Study Terminated by Sponsor|0
180100|NCT00464334|623326|P2|Overall Study|Study Terminated by Sponsor|0
180101|NCT00464334|623327|P1|Overall Study|Study Terminated by Sponsor|0
180102|NCT00464334|623317|P11|Overall Study|Progressive Disease|0
180103|NCT00464334|623318|P10|Overall Study|Progressive Disease|0
180104|NCT00464334|623319|P9|Overall Study|Progressive Disease|1
180105|NCT00464334|623320|P8|Overall Study|Progressive Disease|0
180106|NCT00464334|623321|P7|Overall Study|Progressive Disease|0
180107|NCT00464334|623322|P6|Overall Study|Progressive Disease|1
180108|NCT00464334|623323|P5|Overall Study|Progressive Disease|0
180109|NCT00464334|623324|P4|Overall Study|Progressive Disease|0
180110|NCT00464334|623325|P3|Overall Study|Progressive Disease|0
180111|NCT00464334|623326|P2|Overall Study|Progressive Disease|0
180112|NCT00464334|623327|P1|Overall Study|Progressive Disease|0
180113|NCT00464334|623317|P11|Overall Study|Lost to Follow-up|2
180114|NCT00464334|623318|P10|Overall Study|Lost to Follow-up|0
180115|NCT00464334|623319|P9|Overall Study|Lost to Follow-up|0
180116|NCT00464334|623320|P8|Overall Study|Lost to Follow-up|0
180117|NCT00464334|623321|P7|Overall Study|Lost to Follow-up|1
180118|NCT00464334|623322|P6|Overall Study|Lost to Follow-up|0
180119|NCT00464334|623323|P5|Overall Study|Lost to Follow-up|1
180120|NCT00464334|623324|P4|Overall Study|Lost to Follow-up|0
180121|NCT00464334|623325|P3|Overall Study|Lost to Follow-up|1
180122|NCT00464334|623326|P2|Overall Study|Lost to Follow-up|0
180123|NCT00464334|623327|P1|Overall Study|Lost to Follow-up|0
180124|NCT00464334|623317|P11|Overall Study|Lack of Efficacy|0
180125|NCT00464334|623318|P10|Overall Study|Lack of Efficacy|0
180126|NCT00464334|623319|P9|Overall Study|Lack of Efficacy|0
180127|NCT00464334|623320|P8|Overall Study|Lack of Efficacy|0
180128|NCT00464334|623321|P7|Overall Study|Lack of Efficacy|0
180129|NCT00464334|623322|P6|Overall Study|Lack of Efficacy|0
180130|NCT00464334|623323|P5|Overall Study|Lack of Efficacy|0
180131|NCT00464334|623324|P4|Overall Study|Lack of Efficacy|0
180132|NCT00464334|623325|P3|Overall Study|Lack of Efficacy|0
180133|NCT00464334|623326|P2|Overall Study|Lack of Efficacy|1
180134|NCT00464334|623327|P1|Overall Study|Lack of Efficacy|0
180135|NCT00464334|623317|P11|Overall Study|Adverse Event|2
180136|NCT00464334|623318|P10|Overall Study|Adverse Event|1
180137|NCT00464334|623319|P9|Overall Study|Adverse Event|2
180138|NCT00464334|623320|P8|Overall Study|Adverse Event|0
180139|NCT00464334|623321|P7|Overall Study|Adverse Event|0
180140|NCT00464334|623322|P6|Overall Study|Adverse Event|1
180141|NCT00464334|623323|P5|Overall Study|Adverse Event|1
180142|NCT00464334|623324|P4|Overall Study|Adverse Event|1
180143|NCT00464334|623325|P3|Overall Study|Adverse Event|0
180144|NCT00464334|623326|P2|Overall Study|Adverse Event|0
180145|NCT00464334|623327|P1|Overall Study|Adverse Event|0
180146|NCT00464308|623387|P3|Overall Study|Physician Decision|0
180147|NCT00464308|623388|P2|Overall Study|Physician Decision|0
180148|NCT00464308|623389|P1|Overall Study|Physician Decision|1
180149|NCT00464308|623387|P3|Overall Study|Patient discontinued and other reasons|23
180150|NCT00464308|623388|P2|Overall Study|Patient discontinued and other reasons|17
180151|NCT00464308|623389|P1|Overall Study|Patient discontinued and other reasons|17
180152|NCT00464308|623387|P3|Overall Study|Lost to Follow-up|20
180153|NCT00464308|623388|P2|Overall Study|Lost to Follow-up|19
180154|NCT00464308|623389|P1|Overall Study|Lost to Follow-up|29
180155|NCT00464308|623387|P3|Overall Study|Adverse Event|16
180156|NCT00464308|623388|P2|Overall Study|Adverse Event|27
180157|NCT00464308|623389|P1|Overall Study|Adverse Event|22
180158|NCT00464269|623419|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
180159|NCT00464269|623420|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
180160|NCT00464269|623421|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
180161|NCT00464269|623422|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
180162|NCT00464269|623419|P4|Overall Study|AE, non-serious non-fatal|4
180163|NCT00464269|623420|P3|Overall Study|AE, non-serious non-fatal|3
180164|NCT00464269|623421|P2|Overall Study|AE, non-serious non-fatal|8
180165|NCT00464269|623422|P1|Overall Study|AE, non-serious non-fatal|2
180166|NCT00464269|623419|P4|Overall Study|SAE, non-fatal|1
180167|NCT00464269|623420|P3|Overall Study|SAE, non-fatal|0
180168|NCT00464269|623421|P2|Overall Study|SAE, non-fatal|0
180169|NCT00464269|623422|P1|Overall Study|SAE, non-fatal|0
180170|NCT00464269|623419|P4|Overall Study|AE, serious fatal|1
180171|NCT00464269|623420|P3|Overall Study|AE, serious fatal|1
180172|NCT00464269|623421|P2|Overall Study|AE, serious fatal|0
180173|NCT00464269|623422|P1|Overall Study|AE, serious fatal|0
180174|NCT00464269|623419|P4|Overall Study|Other reason|1
180175|NCT00464269|623420|P3|Overall Study|Other reason|1
180176|NCT00464269|623421|P2|Overall Study|Other reason|3
180177|NCT00464269|623422|P1|Overall Study|Other reason|3
180178|NCT00464269|623419|P4|Overall Study|Withdrawal by Subject|1
180179|NCT00464269|623420|P3|Overall Study|Withdrawal by Subject|1
180180|NCT00464269|623421|P2|Overall Study|Withdrawal by Subject|2
180181|NCT00464269|623422|P1|Overall Study|Withdrawal by Subject|0
180182|NCT00464269|623419|P4|Overall Study|Lost to Follow-up|1
180183|NCT00464269|623420|P3|Overall Study|Lost to Follow-up|0
180184|NCT00464269|623421|P2|Overall Study|Lost to Follow-up|4
180185|NCT00464269|623422|P1|Overall Study|Lost to Follow-up|0
180186|NCT00464269|623419|P4|Overall Study|Lack of Efficacy|0
180187|NCT00464269|623420|P3|Overall Study|Lack of Efficacy|0
180188|NCT00464269|623421|P2|Overall Study|Lack of Efficacy|0
180189|NCT00464269|623422|P1|Overall Study|Lack of Efficacy|1
180190|NCT00464087|623560|P3|Overall Study|No PCI per inclusion criteria|29
180191|NCT00464087|623561|P2|Overall Study|No PCI per inclusion criteria|0
180192|NCT00464087|623562|P1|Overall Study|No PCI per inclusion criteria|0
180193|NCT00463866|623580|P2|Overall Study|Other|22
180194|NCT00463866|623581|P1|Overall Study|Other|22
180195|NCT00463866|623580|P2|Overall Study|Mis-Randomization of subject|1
180196|NCT00463866|623581|P1|Overall Study|Mis-Randomization of subject|0
180197|NCT00463866|623580|P2|Overall Study|Safety Reason|3
180198|NCT00463866|623581|P1|Overall Study|Safety Reason|1
180199|NCT00463866|623580|P2|Overall Study|Severe Non-Compliance to Protocol|21
180200|NCT00463866|623581|P1|Overall Study|Severe Non-Compliance to Protocol|25
180201|NCT00463866|623580|P2|Overall Study|Incorrect Enrolment|66
180202|NCT00463866|623581|P1|Overall Study|Incorrect Enrolment|64
180203|NCT00463866|623580|P2|Overall Study|Lost to Follow-up|55
180204|NCT00463866|623581|P1|Overall Study|Lost to Follow-up|46
180205|NCT00463866|623580|P2|Overall Study|Withdrawal by Subject|79
180206|NCT00463866|623581|P1|Overall Study|Withdrawal by Subject|81
180207|NCT00463866|623580|P2|Overall Study|Adverse Event|93
180208|NCT00463866|623581|P1|Overall Study|Adverse Event|70
180209|NCT00463840|623601|P1|Overall Study|Adverse Event|3
180210|NCT00463840|623601|P1|Overall Study|Withdrawal by Subject|2
180211|NCT00463840|623601|P1|Overall Study|Disease progression|7
180212|NCT00463801|623606|P1|Overall Study|No longer require therapy|1
180213|NCT00463801|623606|P1|Overall Study|Lost to Follow-up|5
180214|NCT00463801|623606|P1|Overall Study|Adverse Event|4
180215|NCT00463801|623606|P1|Overall Study|Lack of Efficacy|2
180216|NCT00463801|623606|P1|Overall Study|Protocol Violation|1
180217|NCT00463788|623612|P2|Overall Study|Randomized but not treated|1
180218|NCT00463788|623613|P1|Overall Study|Randomized but not treated|1
180219|NCT00463788|623612|P2|Overall Study|Other|0
180220|NCT00463788|623613|P1|Overall Study|Other|3
180221|NCT00463788|623612|P2|Overall Study|Protocol Violation|1
180222|NCT00463788|623613|P1|Overall Study|Protocol Violation|0
180223|NCT00463788|623612|P2|Overall Study|Lost to Follow-up|0
180224|NCT00463788|623613|P1|Overall Study|Lost to Follow-up|1
180225|NCT00463788|623612|P2|Overall Study|Symptomatic Deterioration|3
180226|NCT00463788|623613|P1|Overall Study|Symptomatic Deterioration|2
180227|NCT00463788|623612|P2|Overall Study|Death|3
180228|NCT00463788|623613|P1|Overall Study|Death|4
180229|NCT00463788|623612|P2|Overall Study|Withdrawal by Subject|2
180230|NCT00463788|623613|P1|Overall Study|Withdrawal by Subject|6
180231|NCT00463788|623612|P2|Overall Study|Adverse Event|2
180232|NCT00463788|623613|P1|Overall Study|Adverse Event|6
180233|NCT00463788|623612|P2|Overall Study|Progressive Disease|42
180234|NCT00463788|623613|P1|Overall Study|Progressive Disease|86
180235|NCT00463606|623631|P3|Overall Study|Protocol Violation|1
180236|NCT00463606|623632|P2|Overall Study|Protocol Violation|0
180237|NCT00463606|623633|P1|Overall Study|Protocol Violation|0
180238|NCT00463606|623631|P3|Overall Study|Participation in another ABT-335 trial|0
180239|NCT00463606|623632|P2|Overall Study|Participation in another ABT-335 trial|0
180240|NCT00463606|623633|P1|Overall Study|Participation in another ABT-335 trial|1
180241|NCT00463606|623631|P3|Overall Study|Patient randomized in error|0
180242|NCT00463606|623632|P2|Overall Study|Patient randomized in error|0
180243|NCT00463606|623633|P1|Overall Study|Patient randomized in error|1
180244|NCT00463606|623631|P3|Overall Study|Coordinator error|0
180245|NCT00463606|623632|P2|Overall Study|Coordinator error|0
180246|NCT00463606|623633|P1|Overall Study|Coordinator error|1
180247|NCT00463606|623631|P3|Overall Study|Exclusion criteria violation|0
180248|NCT00463606|623632|P2|Overall Study|Exclusion criteria violation|0
180249|NCT00463606|623633|P1|Overall Study|Exclusion criteria violation|2
180250|NCT00463606|623631|P3|Overall Study|Sponsor request|0
180251|NCT00463606|623632|P2|Overall Study|Sponsor request|1
180252|NCT00463606|623633|P1|Overall Study|Sponsor request|0
180253|NCT00463606|623631|P3|Overall Study|Physician Decision|0
180254|NCT00463606|623632|P2|Overall Study|Physician Decision|1
180255|NCT00463606|623633|P1|Overall Study|Physician Decision|0
180256|NCT00463606|623631|P3|Overall Study|Subject moved out of town|0
180257|NCT00463606|623632|P2|Overall Study|Subject moved out of town|0
180258|NCT00463606|623633|P1|Overall Study|Subject moved out of town|1
180259|NCT00463606|623631|P3|Overall Study|Subject noncompliance|0
180260|NCT00463606|623632|P2|Overall Study|Subject noncompliance|1
180261|NCT00463606|623633|P1|Overall Study|Subject noncompliance|1
180262|NCT00463606|623631|P3|Overall Study|Lost to Follow-up|3
180263|NCT00463606|623632|P2|Overall Study|Lost to Follow-up|2
180264|NCT00463606|623633|P1|Overall Study|Lost to Follow-up|2
180265|NCT00463606|623631|P3|Overall Study|Withdrawal by Subject|5
180266|NCT00463606|623632|P2|Overall Study|Withdrawal by Subject|11
180267|NCT00463606|623633|P1|Overall Study|Withdrawal by Subject|11
180268|NCT00463606|623631|P3|Overall Study|Adverse Event|11
180269|NCT00463606|623632|P2|Overall Study|Adverse Event|18
180270|NCT00463606|623633|P1|Overall Study|Adverse Event|21
180271|NCT00463580|623658|P2|Overall Study|Medical/psychiatric complications|2
180272|NCT00463580|623659|P1|Overall Study|Medical/psychiatric complications|0
180273|NCT00463580|623658|P2|Overall Study|schedule conflict|0
180274|NCT00463580|623659|P1|Overall Study|schedule conflict|2
180275|NCT00463580|623658|P2|Overall Study|Lost to Follow-up|0
180276|NCT00463580|623659|P1|Overall Study|Lost to Follow-up|1
180277|NCT00463567|623674|P7|Overall Study|Death|0
180278|NCT00463567|623675|P6|Overall Study|Death|0
180279|NCT00463567|623676|P5|Overall Study|Death|0
180280|NCT00463567|623677|P4|Overall Study|Death|0
180281|NCT00463567|623678|P3|Overall Study|Death|2
180282|NCT00463567|623679|P2|Overall Study|Death|0
180283|NCT00463567|623680|P1|Overall Study|Death|1
180284|NCT00463567|623674|P7|Overall Study|Abnormal test procedure result(s)|0
180285|NCT00463567|623675|P6|Overall Study|Abnormal test procedure result(s)|2
180286|NCT00463567|623676|P5|Overall Study|Abnormal test procedure result(s)|0
180287|NCT00463567|623677|P4|Overall Study|Abnormal test procedure result(s)|2
180288|NCT00463567|623678|P3|Overall Study|Abnormal test procedure result(s)|6
180289|NCT00463567|623679|P2|Overall Study|Abnormal test procedure result(s)|1
180290|NCT00463567|623680|P1|Overall Study|Abnormal test procedure result(s)|1
180291|NCT00463567|623674|P7|Overall Study|Abnormal lab value(s)|0
180292|NCT00463567|623675|P6|Overall Study|Abnormal lab value(s)|0
180293|NCT00463567|623676|P5|Overall Study|Abnormal lab value(s)|1
180294|NCT00463567|623677|P4|Overall Study|Abnormal lab value(s)|1
180295|NCT00463567|623678|P3|Overall Study|Abnormal lab value(s)|2
180296|NCT00463567|623679|P2|Overall Study|Abnormal lab value(s)|1
180297|NCT00463567|623680|P1|Overall Study|Abnormal lab value(s)|1
180298|NCT00463567|623674|P7|Overall Study|Lack of Efficacy|1
180299|NCT00463567|623675|P6|Overall Study|Lack of Efficacy|0
180300|NCT00463567|623676|P5|Overall Study|Lack of Efficacy|1
180301|NCT00463567|623677|P4|Overall Study|Lack of Efficacy|17
180302|NCT00463567|623678|P3|Overall Study|Lack of Efficacy|9
180303|NCT00463567|623679|P2|Overall Study|Lack of Efficacy|9
180304|NCT00463567|623680|P1|Overall Study|Lack of Efficacy|4
180305|NCT00463567|623674|P7|Overall Study|Administrative problems|2
180306|NCT00463567|623675|P6|Overall Study|Administrative problems|2
180307|NCT00463567|623676|P5|Overall Study|Administrative problems|3
180308|NCT00463567|623677|P4|Overall Study|Administrative problems|9
180309|NCT00463567|623678|P3|Overall Study|Administrative problems|6
180310|NCT00463567|623679|P2|Overall Study|Administrative problems|3
180311|NCT00463567|623680|P1|Overall Study|Administrative problems|5
180312|NCT00463567|623674|P7|Overall Study|Lost to Follow-up|1
180313|NCT00463567|623675|P6|Overall Study|Lost to Follow-up|1
180314|NCT00463567|623676|P5|Overall Study|Lost to Follow-up|1
180315|NCT00463567|623677|P4|Overall Study|Lost to Follow-up|8
180316|NCT00463567|623678|P3|Overall Study|Lost to Follow-up|13
180317|NCT00463567|623679|P2|Overall Study|Lost to Follow-up|6
180318|NCT00463567|623680|P1|Overall Study|Lost to Follow-up|12
180319|NCT00463567|623674|P7|Overall Study|Protocol Deviation|2
180320|NCT00463567|623675|P6|Overall Study|Protocol Deviation|1
180321|NCT00463567|623676|P5|Overall Study|Protocol Deviation|1
180322|NCT00463567|623677|P4|Overall Study|Protocol Deviation|11
180323|NCT00463567|623678|P3|Overall Study|Protocol Deviation|14
180324|NCT00463567|623679|P2|Overall Study|Protocol Deviation|9
180325|NCT00463567|623680|P1|Overall Study|Protocol Deviation|13
180326|NCT00463567|623674|P7|Overall Study|Withdrawal by Subject|1
180327|NCT00463567|623675|P6|Overall Study|Withdrawal by Subject|5
180328|NCT00463567|623676|P5|Overall Study|Withdrawal by Subject|6
180329|NCT00463567|623677|P4|Overall Study|Withdrawal by Subject|37
180330|NCT00463567|623678|P3|Overall Study|Withdrawal by Subject|20
180331|NCT00463567|623679|P2|Overall Study|Withdrawal by Subject|22
180332|NCT00463567|623680|P1|Overall Study|Withdrawal by Subject|29
180333|NCT00463567|623674|P7|Overall Study|Adverse Event|4
180334|NCT00463567|623675|P6|Overall Study|Adverse Event|10
180335|NCT00463567|623676|P5|Overall Study|Adverse Event|10
180336|NCT00463567|623677|P4|Overall Study|Adverse Event|46
180337|NCT00463567|623678|P3|Overall Study|Adverse Event|17
180338|NCT00463567|623679|P2|Overall Study|Adverse Event|26
180339|NCT00463567|623680|P1|Overall Study|Adverse Event|29
180340|NCT00463437|623715|P4|Overall Study|Other|7
180341|NCT00463437|623716|P3|Overall Study|Other|6
180342|NCT00463437|623717|P2|Overall Study|Other|11
180343|NCT00463437|623718|P1|Overall Study|Other|4
180344|NCT00463385|623784|P4|Overall Study|1 participant received commercial drug|0
180345|NCT00463385|623785|P3|Overall Study|1 participant received commercial drug|0
180346|NCT00463385|623786|P2|Overall Study|1 participant received commercial drug|1
180347|NCT00463385|623787|P1|Overall Study|1 participant received commercial drug|0
180348|NCT00463385|623784|P4|Overall Study|Missing|2
180349|NCT00463385|623785|P3|Overall Study|Missing|0
180350|NCT00463385|623786|P2|Overall Study|Missing|0
180351|NCT00463385|623787|P1|Overall Study|Missing|2
180352|NCT00463385|623784|P4|Overall Study|Death|0
180353|NCT00463385|623785|P3|Overall Study|Death|2
180354|NCT00463385|623786|P2|Overall Study|Death|1
180355|NCT00463385|623787|P1|Overall Study|Death|2
180356|NCT00463385|623784|P4|Overall Study|Lost to Follow-up|1
180357|NCT00463385|623785|P3|Overall Study|Lost to Follow-up|0
180358|NCT00463385|623786|P2|Overall Study|Lost to Follow-up|0
180359|NCT00463385|623787|P1|Overall Study|Lost to Follow-up|0
180360|NCT00463385|623784|P4|Overall Study|Withdrawal by Subject|4
180361|NCT00463385|623785|P3|Overall Study|Withdrawal by Subject|3
180362|NCT00463385|623786|P2|Overall Study|Withdrawal by Subject|3
180363|NCT00463385|623787|P1|Overall Study|Withdrawal by Subject|3
180364|NCT00463385|623784|P4|Overall Study|Lack of Efficacy|9
180365|NCT00463385|623785|P3|Overall Study|Lack of Efficacy|7
180366|NCT00463385|623786|P2|Overall Study|Lack of Efficacy|6
180367|NCT00463385|623787|P1|Overall Study|Lack of Efficacy|6
180368|NCT00463385|623784|P4|Overall Study|Adverse Event|2
180369|NCT00463385|623785|P3|Overall Study|Adverse Event|4
180370|NCT00463385|623786|P2|Overall Study|Adverse Event|8
180371|NCT00463385|623787|P1|Overall Study|Adverse Event|5
180372|NCT00463385|623784|P4|Overall Study|Other|4
180373|NCT00463385|623785|P3|Overall Study|Other|6
180374|NCT00463385|623786|P2|Overall Study|Other|3
180375|NCT00463385|623787|P1|Overall Study|Other|4
180376|NCT00463346|623839|P2|Overall Study|Withdrawal by Subject|3
180377|NCT00463346|623840|P1|Overall Study|Withdrawal by Subject|3
180378|NCT00463229|623850|P2|Overall Study|Death|3
180379|NCT00463229|623851|P1|Overall Study|Death|4
180380|NCT00463229|623850|P2|Overall Study|Lost to Follow-up|7
180381|NCT00463229|623851|P1|Overall Study|Lost to Follow-up|5
180382|NCT00463047|623857|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
180383|NCT00463047|623858|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
180384|NCT00463047|623857|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
180385|NCT00463047|623858|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
180386|NCT00463047|623857|P2|Double-Blind Treatment Period 2|Adverse Event|1
180387|NCT00463047|623858|P1|Double-Blind Treatment Period 2|Adverse Event|0
180388|NCT00463047|623857|P2|Double-Blind Treatment Period 1|Not specified|0
180389|NCT00463047|623858|P1|Double-Blind Treatment Period 1|Not specified|1
180390|NCT00463047|623857|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
180391|NCT00463047|623858|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
180392|NCT00463047|623857|P2|Double-Blind Treatment Period 1|Protocol Violation|2
180393|NCT00463047|623858|P1|Double-Blind Treatment Period 1|Protocol Violation|1
180394|NCT00463047|623857|P2|Double-Blind Treatment Period 1|Adverse Event|2
180395|NCT00463047|623858|P1|Double-Blind Treatment Period 1|Adverse Event|0
180396|NCT00463047|623857|P2|Titration Period 2|Not specified|2
180397|NCT00463047|623858|P1|Titration Period 2|Not specified|3
180398|NCT00463047|623857|P2|Titration Period 2|Non-compliance procedures|1
180399|NCT00463047|623858|P1|Titration Period 2|Non-compliance procedures|4
180400|NCT00463047|623857|P2|Titration Period 2|Non-compliance study medication|2
180401|NCT00463047|623858|P1|Titration Period 2|Non-compliance study medication|4
180402|NCT00463047|623857|P2|Titration Period 2|Lost to Follow-up|2
180403|NCT00463047|623858|P1|Titration Period 2|Lost to Follow-up|1
180404|NCT00463047|623857|P2|Titration Period 2|Protocol Violation|3
180405|NCT00463047|623858|P1|Titration Period 2|Protocol Violation|2
180406|NCT00463047|623857|P2|Titration Period 2|Withdrawal by Subject|0
180407|NCT00463047|623858|P1|Titration Period 2|Withdrawal by Subject|1
180408|NCT00463047|623857|P2|Titration Period 2|Lack of Efficacy|4
180409|NCT00463047|623858|P1|Titration Period 2|Lack of Efficacy|6
180410|NCT00463047|623857|P2|Titration Period 2|Adverse Event|9
180411|NCT00463047|623858|P1|Titration Period 2|Adverse Event|9
180412|NCT00463047|623857|P2|Titration Period 1|Not specified|2
180413|NCT00463047|623858|P1|Titration Period 1|Not specified|0
180414|NCT00463047|623857|P2|Titration Period 1|Non-compliance procedures|10
180415|NCT00463047|623858|P1|Titration Period 1|Non-compliance procedures|4
180416|NCT00463047|623857|P2|Titration Period 1|Withdrawal by Subject|5
180417|NCT00463047|623858|P1|Titration Period 1|Withdrawal by Subject|3
180418|NCT00463047|623857|P2|Titration Period 1|Protocol Violation|5
180419|NCT00463047|623858|P1|Titration Period 1|Protocol Violation|5
180420|NCT00463047|623857|P2|Titration Period 1|Non-compliance with study medication|5
180421|NCT00463047|623858|P1|Titration Period 1|Non-compliance with study medication|3
180422|NCT00463047|623857|P2|Titration Period 1|Lost to Follow-up|0
180423|NCT00463047|623858|P1|Titration Period 1|Lost to Follow-up|2
180424|NCT00463047|623857|P2|Titration Period 1|Lack of Efficacy|4
180425|NCT00463047|623858|P1|Titration Period 1|Lack of Efficacy|10
180426|NCT00463047|623857|P2|Titration Period 1|Adverse Event|8
180427|NCT00463047|623858|P1|Titration Period 1|Adverse Event|10
180428|NCT00462982|623943|P1|Overall Study|Patient Not Treated|2
180429|NCT00462982|623943|P1|Overall Study|Adverse Event|1
180430|NCT00462943|623950|P3|Overall Study|Withdrawal by Subject|0
180431|NCT00462943|623951|P2|Overall Study|Withdrawal by Subject|1
180432|NCT00462943|623952|P1|Overall Study|Withdrawal by Subject|0
180433|NCT00462943|623950|P3|Overall Study|Physician Decision|0
180434|NCT00462943|623951|P2|Overall Study|Physician Decision|0
180435|NCT00462943|623952|P1|Overall Study|Physician Decision|1
180436|NCT00462943|623950|P3|Overall Study|Transplant - not specified|1
180437|NCT00462943|623951|P2|Overall Study|Transplant - not specified|0
180438|NCT00462943|623952|P1|Overall Study|Transplant - not specified|1
180439|NCT00462943|623950|P3|Overall Study|Required Lymphocyte Infusion|0
180440|NCT00462943|623951|P2|Overall Study|Required Lymphocyte Infusion|0
180441|NCT00462943|623952|P1|Overall Study|Required Lymphocyte Infusion|1
180442|NCT00462943|623950|P3|Overall Study|Bone Marrow Transplant|0
180443|NCT00462943|623951|P2|Overall Study|Bone Marrow Transplant|0
180444|NCT00462943|623952|P1|Overall Study|Bone Marrow Transplant|1
180445|NCT00462943|623950|P3|Overall Study|Stem Cell Transplant|0
180446|NCT00462943|623951|P2|Overall Study|Stem Cell Transplant|1
180447|NCT00462943|623952|P1|Overall Study|Stem Cell Transplant|1
180448|NCT00462943|623950|P3|Overall Study|Death|7
180449|NCT00462943|623951|P2|Overall Study|Death|2
180450|NCT00462943|623952|P1|Overall Study|Death|5
180451|NCT00462943|623950|P3|Overall Study|Disease Progression|9
180452|NCT00462943|623951|P2|Overall Study|Disease Progression|15
180453|NCT00462943|623952|P1|Overall Study|Disease Progression|15
180454|NCT00462943|623950|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
180455|NCT00462943|623951|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
180456|NCT00462943|623952|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
180457|NCT00462943|623950|P3|Overall Study|Protocol Violation|0
180458|NCT00462943|623951|P2|Overall Study|Protocol Violation|0
180459|NCT00462943|623952|P1|Overall Study|Protocol Violation|1
180460|NCT00462943|623950|P3|Overall Study|Adverse Event|1
180461|NCT00462943|623951|P2|Overall Study|Adverse Event|4
180462|NCT00462943|623952|P1|Overall Study|Adverse Event|6
180463|NCT00462943|623950|P3|Overall Study|Failure to achieve a response|1
180464|NCT00462943|623951|P2|Overall Study|Failure to achieve a response|5
180465|NCT00462943|623952|P1|Overall Study|Failure to achieve a response|5
180466|NCT00462865|624044|P1|Overall Study|Adverse Event|1
180467|NCT00462826|624063|P1|Overall Study|Never treated|1
180468|NCT00462826|624063|P1|Overall Study|Ineligible - wrong primary|2
180469|NCT00462826|624063|P1|Overall Study|Ineligible - wrong cell type|1
180470|NCT00462826|624063|P1|Overall Study|Ineligible - second primary|1
180471|NCT00462748|624079|P3|Overall Study|Discontinued after 41 days Rx|0
180472|NCT00462748|624080|P2|Overall Study|Discontinued after 41 days Rx|0
180473|NCT00462748|624081|P1|Overall Study|Discontinued after 41 days Rx|1
180474|NCT00462748|624079|P3|Overall Study|Lost to Follow-up|1
180475|NCT00462748|624080|P2|Overall Study|Lost to Follow-up|1
180476|NCT00462748|624081|P1|Overall Study|Lost to Follow-up|1
180477|NCT00462748|624079|P3|Overall Study|Withdrew consent|0
180478|NCT00462748|624080|P2|Overall Study|Withdrew consent|3
180479|NCT00462748|624081|P1|Overall Study|Withdrew consent|3
180480|NCT00462748|624079|P3|Overall Study|Protocol Violation|1
180481|NCT00462748|624080|P2|Overall Study|Protocol Violation|2
180482|NCT00462748|624081|P1|Overall Study|Protocol Violation|0
180483|NCT00462748|624079|P3|Overall Study|Adverse Event|9
180484|NCT00462748|624080|P2|Overall Study|Adverse Event|5
180485|NCT00462748|624081|P1|Overall Study|Adverse Event|7
180486|NCT00462709|624134|P1|Overall Study|Withdrew to start treatment with Cetor|1
180487|NCT00462709|624134|P1|Overall Study|Physician Decision|1
180488|NCT00462709|624134|P1|Overall Study|Logistical reasons|2
180489|NCT00462709|624134|P1|Overall Study|Death|2
180490|NCT00462709|624134|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
180491|NCT00462709|624134|P1|Overall Study|Withdrawal by Subject|8
180492|NCT00462709|624134|P1|Overall Study|Lost to Follow-up|10
180493|NCT00462709|624134|P1|Overall Study|Transitioned to commercial C1INH-nf|40
180494|NCT00462670|624143|P2|Overall Study|Resolution of signs and symptoms|2
180495|NCT00462670|624144|P1|Overall Study|Resolution of signs and symptoms|0
180496|NCT00462670|624143|P2|Overall Study|Protocol Violation|0
180497|NCT00462670|624144|P1|Overall Study|Protocol Violation|1
180498|NCT00462670|624143|P2|Overall Study|Lack of Efficacy|0
180499|NCT00462670|624144|P1|Overall Study|Lack of Efficacy|1
180500|NCT00462670|624143|P2|Overall Study|Adverse Event|5
180501|NCT00462670|624144|P1|Overall Study|Adverse Event|3
180502|NCT00462501|624181|P1|Overall Study|Adverse Event|2
180503|NCT00462501|624181|P1|Overall Study|Not treated|3
180504|NCT00462462|624187|P2|Overall Study|Physician Decision|1
180505|NCT00462462|624188|P1|Overall Study|Physician Decision|0
180506|NCT00462384|624216|P1|Overall Study|Other|4
180507|NCT00462384|624216|P1|Overall Study|Withdrawal by Subject|1
180508|NCT00462384|624216|P1|Overall Study|Death|2
180509|NCT00462384|624216|P1|Overall Study|Adverse Event|2
180510|NCT00462345|624224|P1|Overall Study|Did not complete second course|1
180511|NCT00462345|624224|P1|Overall Study|Withdrawal by Subject|2
180512|NCT00462306|624259|P2|Overall Study|insufficient data|13
180513|NCT00462306|624260|P1|Overall Study|insufficient data|0
180514|NCT00461981|624386|P2|Overall Study|Withdrawal by Subject|3
180515|NCT00461981|624387|P1|Overall Study|Withdrawal by Subject|2
180516|NCT00461981|624386|P2|Overall Study|Lost to Follow-up|6
180517|NCT00461981|624387|P1|Overall Study|Lost to Follow-up|9
180518|NCT00461812|624503|P1|Overall Study|study terminated|10
180519|NCT00461786|624508|P1|Overall Study|Inevaluable (Never Treated)|1
180520|NCT00461786|624508|P1|Overall Study|Entry Criteria Not Met|2
180521|NCT00461708|624553|P2|Overall Study|Death|1
180522|NCT00461708|624554|P1|Overall Study|Death|8
180523|NCT00461708|624553|P2|Overall Study|Not specified|4
180524|NCT00461708|624554|P1|Overall Study|Not specified|4
180525|NCT00461708|624553|P2|Overall Study|Withdrawal by Subject|2
180526|NCT00461708|624554|P1|Overall Study|Withdrawal by Subject|8
180527|NCT00461708|624553|P2|Overall Study|Physician Decision|4
180528|NCT00461708|624554|P1|Overall Study|Physician Decision|10
180529|NCT00461708|624553|P2|Overall Study|Lack of Efficacy|20
180530|NCT00461708|624554|P1|Overall Study|Lack of Efficacy|68
180531|NCT00461708|624553|P2|Overall Study|Adverse Event|7
180532|NCT00461708|624554|P1|Overall Study|Adverse Event|17
180533|NCT00461682|624580|P1|Overall Study|Protocol Violation|1
180534|NCT00461630|624608|P2|Overall Study|Lost to Follow-up|95
180535|NCT00461630|624609|P1|Overall Study|Lost to Follow-up|108
180536|NCT00461630|624608|P2|Overall Study|Death|732
180537|NCT00461630|624609|P1|Overall Study|Death|798
180538|NCT00461500|624657|P2|Overall Study|Lost to Follow-up|2
180539|NCT00461500|624658|P1|Overall Study|Lost to Follow-up|2
180540|NCT00461500|624657|P2|Overall Study|No Longer Willing to Take Part in Study|0
180541|NCT00461500|624658|P1|Overall Study|No Longer Willing to Take Part in Study|1
180542|NCT00461500|624657|P2|Overall Study|Drug Treatment Misuse|0
180543|NCT00461500|624658|P1|Overall Study|Drug Treatment Misuse|1
180544|NCT00461500|624657|P2|Overall Study|Study Stopped|2
180545|NCT00461500|624658|P1|Overall Study|Study Stopped|1
180546|NCT00461500|624657|P2|Overall Study|Expired Drug Treatment|1
180547|NCT00461500|624658|P1|Overall Study|Expired Drug Treatment|1
180548|NCT00461500|624657|P2|Overall Study|Lack of Efficacy|1
180549|NCT00461500|624658|P1|Overall Study|Lack of Efficacy|0
180550|NCT00461500|624657|P2|Overall Study|Adverse Event|0
180551|NCT00461500|624658|P1|Overall Study|Adverse Event|1
180552|NCT00461305|624701|P2|Continued Treatment|Other (missing drug etc)|0
180553|NCT00461305|624702|P1|Continued Treatment|Other (missing drug etc)|2
180554|NCT00461305|624701|P2|Continued Treatment|Partially missing diary|0
180555|NCT00461305|624702|P1|Continued Treatment|Partially missing diary|2
180556|NCT00461305|624701|P2|Continued Treatment|Withdrawal by Subject|0
180557|NCT00461305|624702|P1|Continued Treatment|Withdrawal by Subject|48
180558|NCT00461305|624701|P2|Continued Treatment|Protocol Violation|0
180559|NCT00461305|624702|P1|Continued Treatment|Protocol Violation|13
180560|NCT00461305|624701|P2|Continued Treatment|Lost to Follow-up|0
180561|NCT00461305|624702|P1|Continued Treatment|Lost to Follow-up|4
180562|NCT00461305|624701|P2|Continued Treatment|Adverse Event|0
180563|NCT00461305|624702|P1|Continued Treatment|Adverse Event|26
180564|NCT00461305|624701|P2|Treatment|Other (missing drug etc)|0
180565|NCT00461305|624702|P1|Treatment|Other (missing drug etc)|2
180566|NCT00461305|624701|P2|Treatment|Partially missing diary|0
180567|NCT00461305|624702|P1|Treatment|Partially missing diary|2
180568|NCT00461305|624701|P2|Treatment|Study drug not taken|0
180569|NCT00461305|624702|P1|Treatment|Study drug not taken|1
180570|NCT00461305|624701|P2|Treatment|Never dispensed|0
180571|NCT00461305|624702|P1|Treatment|Never dispensed|5
180572|NCT00461305|624701|P2|Treatment|Withdrawal by Subject|2
180573|NCT00461305|624702|P1|Treatment|Withdrawal by Subject|48
180574|NCT00461305|624701|P2|Treatment|Protocol Violation|2
180575|NCT00461305|624702|P1|Treatment|Protocol Violation|13
180576|NCT00461305|624701|P2|Treatment|Lost to Follow-up|2
180577|NCT00461305|624702|P1|Treatment|Lost to Follow-up|4
180578|NCT00461305|624701|P2|Treatment|Adverse Event|3
180579|NCT00461305|624702|P1|Treatment|Adverse Event|26
180580|NCT00461253|624786|P2|Overall Study|administrative|7773
180581|NCT00461253|624787|P1|Overall Study|administrative|773
180582|NCT00461253|624786|P2|Overall Study|no response|11789
180583|NCT00461253|624787|P1|Overall Study|no response|2609
180584|NCT00461253|624786|P2|Overall Study|Protocol Violation|236
180585|NCT00461253|624787|P1|Overall Study|Protocol Violation|613
180586|NCT00461253|624786|P2|Overall Study|Death|0
180587|NCT00461253|624787|P1|Overall Study|Death|985
180588|NCT00461175|624795|P2|Overall Study|Protocol Violation|365
180589|NCT00461175|624796|P1|Overall Study|Protocol Violation|522
180590|NCT00461123|624806|P2|Overall Study|Withdrawal by Subject|3
180591|NCT00461123|624807|P1|Overall Study|Withdrawal by Subject|1
180592|NCT00461123|624806|P2|Overall Study|Protocol Violation|2
180593|NCT00461123|624807|P1|Overall Study|Protocol Violation|3
180594|NCT00461123|624806|P2|Overall Study|Lost to Follow-up|1
180595|NCT00461123|624807|P1|Overall Study|Lost to Follow-up|1
180596|NCT00461123|624806|P2|Overall Study|Adverse Event|0
180597|NCT00461123|624807|P1|Overall Study|Adverse Event|1
180598|NCT00461032|624852|P2|Overall Study|Not Specified|5
180599|NCT00461032|624853|P1|Overall Study|Not Specified|7
180600|NCT00461032|624852|P2|Overall Study|Patient Moved or Relocated|1
180601|NCT00461032|624853|P1|Overall Study|Patient Moved or Relocated|2
180602|NCT00461032|624852|P2|Overall Study|Withdrawal by Subject|15
180603|NCT00461032|624853|P1|Overall Study|Withdrawal by Subject|7
180604|NCT00461032|624852|P2|Overall Study|Protocol Violation|4
180605|NCT00461032|624853|P1|Overall Study|Protocol Violation|4
180606|NCT00461032|624852|P2|Overall Study|Lost to Follow-up|12
180607|NCT00461032|624853|P1|Overall Study|Lost to Follow-up|7
180608|NCT00461032|624852|P2|Overall Study|Lack of Efficacy|1
180609|NCT00461032|624853|P1|Overall Study|Lack of Efficacy|5
180610|NCT00461032|624852|P2|Overall Study|Adverse Event|6
180611|NCT00461032|624853|P1|Overall Study|Adverse Event|5
180612|NCT00460811|624879|P5|Overall Study|Lost to Follow-up|6
180613|NCT00460811|624880|P4|Overall Study|Lost to Follow-up|3
180614|NCT00460811|624881|P3|Overall Study|Lost to Follow-up|5
180615|NCT00460811|624882|P2|Overall Study|Lost to Follow-up|2
180616|NCT00460811|624883|P1|Overall Study|Lost to Follow-up|3
180617|NCT00460811|624879|P5|Overall Study|Physician Decision|0
180618|NCT00460811|624880|P4|Overall Study|Physician Decision|0
180619|NCT00460811|624881|P3|Overall Study|Physician Decision|0
180620|NCT00460811|624882|P2|Overall Study|Physician Decision|0
180621|NCT00460811|624883|P1|Overall Study|Physician Decision|1
180622|NCT00460811|624879|P5|Overall Study|Withdrawal by Subject|11
180623|NCT00460811|624880|P4|Overall Study|Withdrawal by Subject|3
180624|NCT00460811|624881|P3|Overall Study|Withdrawal by Subject|6
180625|NCT00460811|624882|P2|Overall Study|Withdrawal by Subject|7
180626|NCT00460811|624883|P1|Overall Study|Withdrawal by Subject|7
180627|NCT00460811|624879|P5|Overall Study|Noncompliance|1
180628|NCT00460811|624880|P4|Overall Study|Noncompliance|2
180629|NCT00460811|624881|P3|Overall Study|Noncompliance|0
180630|NCT00460811|624882|P2|Overall Study|Noncompliance|0
180631|NCT00460811|624883|P1|Overall Study|Noncompliance|1
180632|NCT00460811|624879|P5|Overall Study|Adverse Event|2
180633|NCT00460811|624880|P4|Overall Study|Adverse Event|10
180634|NCT00460811|624881|P3|Overall Study|Adverse Event|3
180635|NCT00460811|624882|P2|Overall Study|Adverse Event|6
180636|NCT00460811|624883|P1|Overall Study|Adverse Event|4
180637|NCT00460798|624925|P1|Overall Study|Missing/Incomplete Dosing Information|27
180638|NCT00460798|624925|P1|Overall Study|Ongoing at Date of Cut-Off|82
180639|NCT00460798|624925|P1|Overall Study|Other|27
180640|NCT00460798|624925|P1|Overall Study|Progressive Disease|99
180641|NCT00460798|624925|P1|Overall Study|Lost to Follow-up|19
180642|NCT00460798|624925|P1|Overall Study|Adverse Event|27
180643|NCT00460798|624925|P1|Overall Study|Death|59
180644|NCT00460746|624933|P1|Overall Study|Lost to Follow-up|1
180645|NCT00460746|624933|P1|Overall Study|Adverse Event|1
180646|NCT00460655|624948|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
180647|NCT00460655|624949|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
180648|NCT00460655|624950|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
180649|NCT00460655|624951|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
180650|NCT00460655|624948|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
180651|NCT00460655|624949|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
180652|NCT00460655|624950|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
180653|NCT00460655|624951|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
180654|NCT00460655|624948|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
180655|NCT00460655|624949|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
180656|NCT00460655|624950|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
180657|NCT00460655|624951|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
180658|NCT00460655|624948|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
180659|NCT00460655|624949|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
180660|NCT00460655|624950|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
180661|NCT00460655|624951|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
180662|NCT00460655|624948|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180663|NCT00460655|624949|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180664|NCT00460655|624950|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180665|NCT00460655|624951|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
180666|NCT00460655|624948|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
180667|NCT00460655|624949|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
180668|NCT00460655|624950|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
180669|NCT00460655|624951|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
180670|NCT00460603|624995|P12|Phase 2|Randomized, but not treated|0
180671|NCT00460603|624996|P11|Phase 2|Randomized, but not treated|0
180672|NCT00460603|624997|P10|Phase 2|Randomized, but not treated|3
180673|NCT00460603|624998|P9|Phase 2|Randomized, but not treated|0
180674|NCT00460603|624999|P8|Phase 2|Randomized, but not treated|0
180675|NCT00460603|625000|P7|Phase 2|Randomized, but not treated|0
180676|NCT00460603|625001|P6|Phase 2|Randomized, but not treated|0
180677|NCT00460603|625002|P5|Phase 2|Randomized, but not treated|0
180678|NCT00460603|625003|P4|Phase 2|Randomized, but not treated|0
180679|NCT00460603|625004|P3|Phase 2|Randomized, but not treated|0
180680|NCT00460603|625005|P2|Phase 2|Randomized, but not treated|0
180681|NCT00460603|625006|P1|Phase 2|Randomized, but not treated|0
180682|NCT00460603|624995|P12|Phase 2|Withdrawal by Subject|5
180683|NCT00460603|624996|P11|Phase 2|Withdrawal by Subject|4
180684|NCT00460603|624997|P10|Phase 2|Withdrawal by Subject|5
180685|NCT00460603|624998|P9|Phase 2|Withdrawal by Subject|0
180686|NCT00460603|624999|P8|Phase 2|Withdrawal by Subject|0
180687|NCT00460603|625000|P7|Phase 2|Withdrawal by Subject|0
180688|NCT00460603|625001|P6|Phase 2|Withdrawal by Subject|0
180689|NCT00460603|625002|P5|Phase 2|Withdrawal by Subject|0
180690|NCT00460603|625003|P4|Phase 2|Withdrawal by Subject|0
180691|NCT00460603|625004|P3|Phase 2|Withdrawal by Subject|0
180692|NCT00460603|625005|P2|Phase 2|Withdrawal by Subject|0
180693|NCT00460603|625006|P1|Phase 2|Withdrawal by Subject|0
180694|NCT00460603|624995|P12|Phase 2|Global Deterioration of Health Status|0
180695|NCT00460603|624996|P11|Phase 2|Global Deterioration of Health Status|1
180696|NCT00460603|624997|P10|Phase 2|Global Deterioration of Health Status|0
180697|NCT00460603|624998|P9|Phase 2|Global Deterioration of Health Status|0
180698|NCT00460603|624999|P8|Phase 2|Global Deterioration of Health Status|0
180699|NCT00460603|625000|P7|Phase 2|Global Deterioration of Health Status|0
180700|NCT00460603|625001|P6|Phase 2|Global Deterioration of Health Status|0
180701|NCT00460603|625002|P5|Phase 2|Global Deterioration of Health Status|0
180702|NCT00460603|625003|P4|Phase 2|Global Deterioration of Health Status|0
180703|NCT00460603|625004|P3|Phase 2|Global Deterioration of Health Status|0
180704|NCT00460603|625005|P2|Phase 2|Global Deterioration of Health Status|0
180705|NCT00460603|625006|P1|Phase 2|Global Deterioration of Health Status|0
180706|NCT00460603|624995|P12|Phase 2|Objective Progression or Relapse|17
180707|NCT00460603|624996|P11|Phase 2|Objective Progression or Relapse|10
180708|NCT00460603|624997|P10|Phase 2|Objective Progression or Relapse|9
180709|NCT00460603|624998|P9|Phase 2|Objective Progression or Relapse|0
180710|NCT00460603|624999|P8|Phase 2|Objective Progression or Relapse|0
180711|NCT00460603|625000|P7|Phase 2|Objective Progression or Relapse|0
180712|NCT00460603|625001|P6|Phase 2|Objective Progression or Relapse|0
180713|NCT00460603|625002|P5|Phase 2|Objective Progression or Relapse|0
180714|NCT00460603|625003|P4|Phase 2|Objective Progression or Relapse|0
180715|NCT00460603|625004|P3|Phase 2|Objective Progression or Relapse|0
180716|NCT00460603|625005|P2|Phase 2|Objective Progression or Relapse|0
180717|NCT00460603|625006|P1|Phase 2|Objective Progression or Relapse|0
180718|NCT00460603|624995|P12|Phase 2|Other|7
180719|NCT00460603|624996|P11|Phase 2|Other|16
180720|NCT00460603|624997|P10|Phase 2|Other|6
180721|NCT00460603|624998|P9|Phase 2|Other|0
180722|NCT00460603|624999|P8|Phase 2|Other|0
180723|NCT00460603|625000|P7|Phase 2|Other|0
180724|NCT00460603|625001|P6|Phase 2|Other|0
180725|NCT00460603|625002|P5|Phase 2|Other|0
180726|NCT00460603|625003|P4|Phase 2|Other|0
180727|NCT00460603|625004|P3|Phase 2|Other|0
180728|NCT00460603|625005|P2|Phase 2|Other|0
180729|NCT00460603|625006|P1|Phase 2|Other|0
180730|NCT00460603|624995|P12|Phase 2|Lost to Follow-up|0
180731|NCT00460603|624996|P11|Phase 2|Lost to Follow-up|0
180732|NCT00460603|624997|P10|Phase 2|Lost to Follow-up|1
180733|NCT00460603|624998|P9|Phase 2|Lost to Follow-up|0
180734|NCT00460603|624999|P8|Phase 2|Lost to Follow-up|0
180735|NCT00460603|625000|P7|Phase 2|Lost to Follow-up|0
180736|NCT00460603|625001|P6|Phase 2|Lost to Follow-up|0
180737|NCT00460603|625002|P5|Phase 2|Lost to Follow-up|0
180738|NCT00460603|625003|P4|Phase 2|Lost to Follow-up|0
180739|NCT00460603|625004|P3|Phase 2|Lost to Follow-up|0
180740|NCT00460603|625005|P2|Phase 2|Lost to Follow-up|0
180741|NCT00460603|625006|P1|Phase 2|Lost to Follow-up|0
180742|NCT00460603|624995|P12|Phase 2|Protocol Violation|0
180743|NCT00460603|624996|P11|Phase 2|Protocol Violation|1
180744|NCT00460603|624997|P10|Phase 2|Protocol Violation|1
180745|NCT00460603|624998|P9|Phase 2|Protocol Violation|0
180746|NCT00460603|624999|P8|Phase 2|Protocol Violation|0
180747|NCT00460603|625000|P7|Phase 2|Protocol Violation|0
180748|NCT00460603|625001|P6|Phase 2|Protocol Violation|0
180749|NCT00460603|625002|P5|Phase 2|Protocol Violation|0
180750|NCT00460603|625003|P4|Phase 2|Protocol Violation|0
180751|NCT00460603|625004|P3|Phase 2|Protocol Violation|0
180752|NCT00460603|625005|P2|Phase 2|Protocol Violation|0
180753|NCT00460603|625006|P1|Phase 2|Protocol Violation|0
180754|NCT00460603|624995|P12|Phase 2|Death|2
180755|NCT00460603|624996|P11|Phase 2|Death|2
180756|NCT00460603|624997|P10|Phase 2|Death|4
180757|NCT00460603|624998|P9|Phase 2|Death|0
180758|NCT00460603|624999|P8|Phase 2|Death|0
180759|NCT00460603|625000|P7|Phase 2|Death|0
180760|NCT00460603|625001|P6|Phase 2|Death|0
180761|NCT00460603|625002|P5|Phase 2|Death|0
180762|NCT00460603|625003|P4|Phase 2|Death|0
180763|NCT00460603|625004|P3|Phase 2|Death|0
180764|NCT00460603|625005|P2|Phase 2|Death|0
180765|NCT00460603|625006|P1|Phase 2|Death|0
180766|NCT00460603|624995|P12|Phase 2|Adverse Event|10
180767|NCT00460603|624996|P11|Phase 2|Adverse Event|9
180768|NCT00460603|624997|P10|Phase 2|Adverse Event|12
180769|NCT00460603|624998|P9|Phase 2|Adverse Event|0
180770|NCT00460603|624999|P8|Phase 2|Adverse Event|0
180771|NCT00460603|625000|P7|Phase 2|Adverse Event|0
180772|NCT00460603|625001|P6|Phase 2|Adverse Event|0
180773|NCT00460603|625002|P5|Phase 2|Adverse Event|0
180774|NCT00460603|625003|P4|Phase 2|Adverse Event|0
180775|NCT00460603|625004|P3|Phase 2|Adverse Event|0
180776|NCT00460603|625005|P2|Phase 2|Adverse Event|0
180777|NCT00460603|625006|P1|Phase 2|Adverse Event|0
180778|NCT00460603|624995|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180779|NCT00460603|624996|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180780|NCT00460603|624997|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
180781|NCT00460603|624998|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180782|NCT00460603|624999|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180783|NCT00460603|625000|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180784|NCT00460603|625001|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180785|NCT00460603|625002|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180786|NCT00460603|625003|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180787|NCT00460603|625004|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180788|NCT00460603|625005|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180789|NCT00460603|625006|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
180790|NCT00460603|624995|P12|Phase 1|Other|0
180791|NCT00460603|624996|P11|Phase 1|Other|0
180792|NCT00460603|624997|P10|Phase 1|Other|0
180793|NCT00460603|624998|P9|Phase 1|Other|0
180794|NCT00460603|624999|P8|Phase 1|Other|1
180795|NCT00460603|625000|P7|Phase 1|Other|0
180796|NCT00460603|625001|P6|Phase 1|Other|2
180797|NCT00460603|625002|P5|Phase 1|Other|1
180798|NCT00460603|625003|P4|Phase 1|Other|1
180799|NCT00460603|625004|P3|Phase 1|Other|1
180800|NCT00460603|625005|P2|Phase 1|Other|3
180801|NCT00460603|625006|P1|Phase 1|Other|0
180802|NCT00460603|624995|P12|Phase 1|Withdrawal by Subject|0
180803|NCT00460603|624996|P11|Phase 1|Withdrawal by Subject|0
180804|NCT00460603|624997|P10|Phase 1|Withdrawal by Subject|0
180805|NCT00460603|624998|P9|Phase 1|Withdrawal by Subject|2
180806|NCT00460603|624999|P8|Phase 1|Withdrawal by Subject|0
180807|NCT00460603|625000|P7|Phase 1|Withdrawal by Subject|1
180808|NCT00460603|625001|P6|Phase 1|Withdrawal by Subject|0
180809|NCT00460603|625002|P5|Phase 1|Withdrawal by Subject|3
180810|NCT00460603|625003|P4|Phase 1|Withdrawal by Subject|1
180811|NCT00460603|625004|P3|Phase 1|Withdrawal by Subject|1
180812|NCT00460603|625005|P2|Phase 1|Withdrawal by Subject|2
180813|NCT00460603|625006|P1|Phase 1|Withdrawal by Subject|1
180814|NCT00460603|624995|P12|Phase 1|Lack of Efficacy|0
180815|NCT00460603|624996|P11|Phase 1|Lack of Efficacy|0
180816|NCT00460603|624997|P10|Phase 1|Lack of Efficacy|0
180817|NCT00460603|624998|P9|Phase 1|Lack of Efficacy|11
180818|NCT00460603|624999|P8|Phase 1|Lack of Efficacy|2
180819|NCT00460603|625000|P7|Phase 1|Lack of Efficacy|2
180820|NCT00460603|625001|P6|Phase 1|Lack of Efficacy|2
180821|NCT00460603|625002|P5|Phase 1|Lack of Efficacy|2
180822|NCT00460603|625003|P4|Phase 1|Lack of Efficacy|2
180823|NCT00460603|625004|P3|Phase 1|Lack of Efficacy|1
180824|NCT00460603|625005|P2|Phase 1|Lack of Efficacy|0
180825|NCT00460603|625006|P1|Phase 1|Lack of Efficacy|1
180826|NCT00460603|624995|P12|Phase 1|Adverse Event|0
180827|NCT00460603|624996|P11|Phase 1|Adverse Event|0
180828|NCT00460603|624997|P10|Phase 1|Adverse Event|0
180829|NCT00460603|624998|P9|Phase 1|Adverse Event|4
180830|NCT00460603|624999|P8|Phase 1|Adverse Event|0
180831|NCT00460603|625000|P7|Phase 1|Adverse Event|3
180832|NCT00460603|625001|P6|Phase 1|Adverse Event|0
180833|NCT00460603|625002|P5|Phase 1|Adverse Event|0
180834|NCT00460603|625003|P4|Phase 1|Adverse Event|2
180835|NCT00460603|625004|P3|Phase 1|Adverse Event|1
180836|NCT00460603|625005|P2|Phase 1|Adverse Event|1
180837|NCT00460603|625006|P1|Phase 1|Adverse Event|3
180838|NCT00460603|624995|P12|Phase 1|Death|0
180839|NCT00460603|624996|P11|Phase 1|Death|0
180840|NCT00460603|624997|P10|Phase 1|Death|0
180841|NCT00460603|624998|P9|Phase 1|Death|1
180842|NCT00460603|624999|P8|Phase 1|Death|0
180843|NCT00460603|625000|P7|Phase 1|Death|0
180844|NCT00460603|625001|P6|Phase 1|Death|0
180845|NCT00460603|625002|P5|Phase 1|Death|0
180846|NCT00460603|625003|P4|Phase 1|Death|2
180847|NCT00460603|625004|P3|Phase 1|Death|0
180848|NCT00460603|625005|P2|Phase 1|Death|0
180849|NCT00460603|625006|P1|Phase 1|Death|1
180850|NCT00460577|625100|P2|Overall Study|Protocol Violation|6
180851|NCT00460577|625101|P1|Overall Study|Protocol Violation|2
180852|NCT00460564|625119|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
180853|NCT00460564|625120|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
180854|NCT00460564|625121|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
180855|NCT00460564|625122|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
180856|NCT00460564|625123|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
180857|NCT00460564|625124|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
180858|NCT00460564|625125|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
180859|NCT00460564|625126|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
180860|NCT00460564|625119|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
180861|NCT00460564|625120|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
180862|NCT00460564|625121|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
180863|NCT00460564|625122|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
180864|NCT00460564|625123|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
180865|NCT00460564|625124|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
180866|NCT00460564|625125|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
180867|NCT00460564|625126|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
180868|NCT00460564|625119|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
180869|NCT00460564|625120|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
180870|NCT00460564|625121|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
180871|NCT00460564|625122|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
180872|NCT00460564|625123|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
180873|NCT00460564|625124|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
180874|NCT00460564|625125|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
180875|NCT00460564|625126|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
180876|NCT00460564|625119|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180877|NCT00460564|625120|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180878|NCT00460564|625121|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180879|NCT00460564|625122|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180880|NCT00460564|625123|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180881|NCT00460564|625124|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180882|NCT00460564|625125|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
180883|NCT00460564|625126|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
180884|NCT00460564|625119|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
180885|NCT00460564|625120|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
180886|NCT00460564|625121|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
180887|NCT00460564|625122|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
180888|NCT00460564|625123|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
180889|NCT00460564|625124|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
180890|NCT00460564|625125|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
180891|NCT00460564|625126|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
180892|NCT00460434|625270|P2|Overall Study|Lost to Follow-up|7
180893|NCT00460434|625271|P1|Overall Study|Lost to Follow-up|3
180894|NCT00460408|625350|P4|Overall Study|Other|0
180895|NCT00460408|625351|P3|Overall Study|Other|0
180896|NCT00460408|625352|P2|Overall Study|Other|2
180897|NCT00460408|625353|P1|Overall Study|Other|12
180898|NCT00460408|625350|P4|Overall Study|Insufficient clinical response|0
180899|NCT00460408|625351|P3|Overall Study|Insufficient clinical response|5
180900|NCT00460408|625352|P2|Overall Study|Insufficient clinical response|1
180901|NCT00460408|625353|P1|Overall Study|Insufficient clinical response|5
180902|NCT00460408|625350|P4|Overall Study|Withdrawal by Subject|0
180903|NCT00460408|625351|P3|Overall Study|Withdrawal by Subject|0
180904|NCT00460408|625352|P2|Overall Study|Withdrawal by Subject|0
180905|NCT00460408|625353|P1|Overall Study|Withdrawal by Subject|31
180906|NCT00460408|625350|P4|Overall Study|Lost to Follow-up|0
180907|NCT00460408|625351|P3|Overall Study|Lost to Follow-up|1
180908|NCT00460408|625352|P2|Overall Study|Lost to Follow-up|0
180909|NCT00460408|625353|P1|Overall Study|Lost to Follow-up|11
180910|NCT00460408|625350|P4|Overall Study|Death|0
180911|NCT00460408|625351|P3|Overall Study|Death|0
180912|NCT00460408|625352|P2|Overall Study|Death|0
180913|NCT00460408|625353|P1|Overall Study|Death|7
180914|NCT00460408|625350|P4|Overall Study|Adverse Event|0
180915|NCT00460408|625351|P3|Overall Study|Adverse Event|0
180916|NCT00460408|625352|P2|Overall Study|Adverse Event|0
180917|NCT00460408|625353|P1|Overall Study|Adverse Event|1
180918|NCT00460265|625390|P2|Overall Study|Ongoing|47
180919|NCT00460265|625391|P1|Overall Study|Ongoing|60
180920|NCT00460265|625390|P2|Overall Study|Withdrawal by Subject|25
180921|NCT00460265|625391|P1|Overall Study|Withdrawal by Subject|10
180922|NCT00460265|625390|P2|Overall Study|Physician Decision|2
180923|NCT00460265|625391|P1|Overall Study|Physician Decision|1
180924|NCT00460265|625390|P2|Overall Study|Lost to Follow-up|15
180925|NCT00460265|625391|P1|Overall Study|Lost to Follow-up|14
180926|NCT00460239|625407|P9|Overall Study|Withdrawal by Subject|0
180927|NCT00460239|625408|P8|Overall Study|Withdrawal by Subject|0
180928|NCT00460239|625409|P7|Overall Study|Withdrawal by Subject|0
180929|NCT00460239|625410|P6|Overall Study|Withdrawal by Subject|1
180930|NCT00460239|625411|P5|Overall Study|Withdrawal by Subject|0
180931|NCT00460239|625412|P4|Overall Study|Withdrawal by Subject|0
180932|NCT00460239|625413|P3|Overall Study|Withdrawal by Subject|0
180933|NCT00460239|625414|P2|Overall Study|Withdrawal by Subject|0
180934|NCT00460239|625415|P1|Overall Study|Withdrawal by Subject|0
180935|NCT00460239|625407|P9|Overall Study|Physician Decision|0
180936|NCT00460239|625408|P8|Overall Study|Physician Decision|0
180937|NCT00460239|625409|P7|Overall Study|Physician Decision|0
180938|NCT00460239|625410|P6|Overall Study|Physician Decision|2
180939|NCT00460239|625411|P5|Overall Study|Physician Decision|0
180940|NCT00460239|625412|P4|Overall Study|Physician Decision|0
180941|NCT00460239|625413|P3|Overall Study|Physician Decision|0
180942|NCT00460239|625414|P2|Overall Study|Physician Decision|1
180943|NCT00460239|625415|P1|Overall Study|Physician Decision|0
180944|NCT00460109|625484|P1|Overall Study|Death|1
180945|NCT00460031|625492|P1|Overall Study|Death|1
180946|NCT00460031|625492|P1|Overall Study|Withdrawal by Subject|5
180947|NCT00460031|625492|P1|Overall Study|Adverse Event|5
180948|NCT00459979|625500|P1|Overall Study|Protocol Violation|1
180949|NCT00459979|625500|P1|Overall Study|Withdrawal by Subject|1
180950|NCT00459953|625512|P2|Overall Study|not analyzed-household member in study|1
180951|NCT00459953|625513|P1|Overall Study|not analyzed-household member in study|1
180952|NCT00459875|625519|P1|Overall Study|Adverse Event|2
180953|NCT00459875|625519|P1|Overall Study|Ineligible participant|1
180954|NCT00459706|625555|P2|Overall Study|Other|1
180955|NCT00459706|625556|P1|Overall Study|Other|0
180956|NCT00459706|625555|P2|Overall Study|Failed to Return|0
180957|NCT00459706|625556|P1|Overall Study|Failed to Return|1
180958|NCT00459706|625555|P2|Overall Study|Protocol Violation|1
180959|NCT00459706|625556|P1|Overall Study|Protocol Violation|2
180960|NCT00459706|625555|P2|Overall Study|Discontinuation of Study by Sponsor|0
180961|NCT00459706|625556|P1|Overall Study|Discontinuation of Study by Sponsor|1
180962|NCT00459706|625555|P2|Overall Study|Physician Decision|0
180963|NCT00459706|625556|P1|Overall Study|Physician Decision|2
180964|NCT00459706|625555|P2|Overall Study|Withdrawal by Subject|6
180965|NCT00459706|625556|P1|Overall Study|Withdrawal by Subject|1
180966|NCT00459706|625555|P2|Overall Study|Adverse Event|13
180967|NCT00459706|625556|P1|Overall Study|Adverse Event|19
180968|NCT00459667|625699|P3|Overall Study|No treatment administered|1
180969|NCT00459667|625700|P2|Overall Study|No treatment administered|3
180970|NCT00459667|625701|P1|Overall Study|No treatment administered|6
180971|NCT00459667|625699|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
180972|NCT00459667|625700|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
180973|NCT00459667|625701|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
180974|NCT00459667|625699|P3|Overall Study|Other disease modifying treatment|1
180975|NCT00459667|625700|P2|Overall Study|Other disease modifying treatment|2
180976|NCT00459667|625701|P1|Overall Study|Other disease modifying treatment|1
180977|NCT00459667|625699|P3|Overall Study|Withdrawal by Subject|5
180978|NCT00459667|625700|P2|Overall Study|Withdrawal by Subject|5
180979|NCT00459667|625701|P1|Overall Study|Withdrawal by Subject|3
180980|NCT00459667|625699|P3|Overall Study|Protocol Violation|0
180981|NCT00459667|625700|P2|Overall Study|Protocol Violation|0
180982|NCT00459667|625701|P1|Overall Study|Protocol Violation|1
180983|NCT00459667|625699|P3|Overall Study|Pregnancy|1
180984|NCT00459667|625700|P2|Overall Study|Pregnancy|1
180985|NCT00459667|625701|P1|Overall Study|Pregnancy|1
180986|NCT00459667|625699|P3|Overall Study|Lost to Follow-up|3
180987|NCT00459667|625700|P2|Overall Study|Lost to Follow-up|9
180988|NCT00459667|625701|P1|Overall Study|Lost to Follow-up|5
180989|NCT00459667|625699|P3|Overall Study|Adverse Event|8
180990|NCT00459667|625700|P2|Overall Study|Adverse Event|12
180991|NCT00459667|625701|P1|Overall Study|Adverse Event|9
180992|NCT00459537|625723|P2|Overall Study|Missing|0
180993|NCT00459537|625724|P1|Overall Study|Missing|1
180994|NCT00459537|625723|P2|Overall Study|Protocol Violation|3
180995|NCT00459537|625724|P1|Overall Study|Protocol Violation|4
180996|NCT00459537|625723|P2|Overall Study|Administrative problems|0
180997|NCT00459537|625724|P1|Overall Study|Administrative problems|3
180998|NCT00459537|625723|P2|Overall Study|Lost to Follow-up|30
180999|NCT00459537|625724|P1|Overall Study|Lost to Follow-up|27
181000|NCT00459537|625723|P2|Overall Study|Withdrawal by Subject|26
181001|NCT00459537|625724|P1|Overall Study|Withdrawal by Subject|20
181002|NCT00459537|625723|P2|Overall Study|Lack of Efficacy|11
181003|NCT00459537|625724|P1|Overall Study|Lack of Efficacy|10
181004|NCT00459537|625723|P2|Overall Study|Adverse Event|6
181005|NCT00459537|625724|P1|Overall Study|Adverse Event|1
181006|NCT00459355|625759|P2|Overall Study|Subject no longer met inc criteria|18
181007|NCT00459355|625760|P1|Overall Study|Subject no longer met inc criteria|20
181008|NCT00459342|625772|P1|Overall Study|Not eligible|1
181009|NCT00459316|625781|P3|Step 3|Withdrawal by Subject|1
181010|NCT00459316|625782|P2|Step 3|Withdrawal by Subject|0
181011|NCT00459316|625783|P1|Step 3|Withdrawal by Subject|3
181012|NCT00459316|625781|P3|Steps 1 & 2|Lost to Follow-up|2
181013|NCT00459316|625782|P2|Steps 1 & 2|Lost to Follow-up|0
181014|NCT00459316|625783|P1|Steps 1 & 2|Lost to Follow-up|5
181015|NCT00459316|625781|P3|Steps 1 & 2|Not willing to adhere to regulations|0
181104|NCT00457743|626138|P2|Overall Study|Lack of Efficacy|23
181016|NCT00459316|625782|P2|Steps 1 & 2|Not willing to adhere to regulations|0
181017|NCT00459316|625783|P1|Steps 1 & 2|Not willing to adhere to regulations|1
181018|NCT00459316|625781|P3|Steps 1 & 2|Withdrawal by Subject|0
181019|NCT00459316|625782|P2|Steps 1 & 2|Withdrawal by Subject|1
181020|NCT00459316|625783|P1|Steps 1 & 2|Withdrawal by Subject|6
181021|NCT00459316|625781|P3|Steps 1 & 2|Not able to get to clinic|0
181022|NCT00459316|625782|P2|Steps 1 & 2|Not able to get to clinic|4
181023|NCT00459316|625783|P1|Steps 1 & 2|Not able to get to clinic|7
181024|NCT00459316|625781|P3|Steps 1 & 2|Death|0
181025|NCT00459316|625782|P2|Steps 1 & 2|Death|1
181026|NCT00459316|625783|P1|Steps 1 & 2|Death|1
181027|NCT00459316|625781|P3|Steps 1 & 2|Other eligibility failure|0
181028|NCT00459316|625782|P2|Steps 1 & 2|Other eligibility failure|1
181029|NCT00459316|625783|P1|Steps 1 & 2|Other eligibility failure|1
181030|NCT00459290|625848|P1|Overall Study|Ineligible|2
181031|NCT00459290|625848|P1|Overall Study|Adverse Event|3
181032|NCT00459186|625862|P1|PET Imaging and Assessment|Adverse Event|3
181033|NCT00459186|625862|P1|Single Agent RAD001|Withdrawal by Subject|1
181034|NCT00459134|625869|P2|Overall Study|Multiple Reasons|3
181035|NCT00459134|625870|P1|Overall Study|Multiple Reasons|2
181036|NCT00459134|625869|P2|Overall Study|Progression|0
181037|NCT00459134|625870|P1|Overall Study|Progression|1
181038|NCT00459134|625869|P2|Overall Study|Toxicity|5
181039|NCT00459134|625870|P1|Overall Study|Toxicity|4
181040|NCT00459134|625869|P2|Overall Study|Surgery|2
181041|NCT00459134|625870|P1|Overall Study|Surgery|1
181042|NCT00459134|625869|P2|Overall Study|Lost to Follow-up|7
181043|NCT00459134|625870|P1|Overall Study|Lost to Follow-up|6
181044|NCT00459134|625869|P2|Overall Study|Withdrawal by Subject|7
181045|NCT00459134|625870|P1|Overall Study|Withdrawal by Subject|8
181046|NCT00459134|625869|P2|Overall Study|Physician Decision|1
181047|NCT00459134|625870|P1|Overall Study|Physician Decision|1
181048|NCT00459108|625882|P1|Overall Study|Progression|1
181049|NCT00459108|625882|P1|Overall Study|Death|2
181050|NCT00459108|625882|P1|Overall Study|Adverse Event|3
181051|NCT00459108|625882|P1|Overall Study|Withdrawal by Subject|5
181052|NCT00459056|625892|P2|First Intervention (First Three Months)|Lost to Follow-up|1
181053|NCT00459056|625893|P1|First Intervention (First Three Months)|Lost to Follow-up|1
181054|NCT00459043|625901|P2|Overall Study|Withdrawal by Subject|0
181055|NCT00459043|625902|P1|Overall Study|Withdrawal by Subject|1
181056|NCT00458705|625923|P1|Overall Study|Not Treated|1
181057|NCT00458705|625923|P1|Overall Study|Adverse Event|4
181058|NCT00458536|625927|P1|Overall Study|Progressive disease during treatment|2
181059|NCT00458536|625927|P1|Overall Study|Withdrawal by Subject|1
181060|NCT00458536|625927|P1|Overall Study|Ineligible due to toxicity|1
181061|NCT00458536|625927|P1|Overall Study|Patient did not have surgery|1
181062|NCT00458536|625927|P1|Overall Study|Did not have renal cell carcinoma|2
181063|NCT00458536|625927|P1|Overall Study|No measurable disease after surgery|2
181064|NCT00458536|625927|P1|Overall Study|Unable to make vaccine|3
181065|NCT00458536|625927|P1|Overall Study|Disease progression prior to treatment|7
181066|NCT00458393|625954|P2|Overall Study|Sites marked other on the form.|20
181067|NCT00458393|625955|P1|Overall Study|Sites marked other on the form.|19
181068|NCT00458393|625954|P2|Overall Study|Lost to Follow-up|92
181069|NCT00458393|625955|P1|Overall Study|Lost to Follow-up|115
181070|NCT00458393|625954|P2|Overall Study|Relocated|81
181071|NCT00458393|625955|P1|Overall Study|Relocated|77
181072|NCT00458393|625954|P2|Overall Study|Physician Decision|22
181073|NCT00458393|625955|P1|Overall Study|Physician Decision|31
181074|NCT00458393|625954|P2|Overall Study|Withdrawal by Subject|80
181075|NCT00458393|625955|P1|Overall Study|Withdrawal by Subject|67
181076|NCT00458302|626003|P2|Overall Study|Other|2
181077|NCT00458302|626004|P1|Overall Study|Other|4
181078|NCT00458302|626003|P2|Overall Study|Lost to Follow-up|0
181079|NCT00458302|626004|P1|Overall Study|Lost to Follow-up|2
181080|NCT00458302|626003|P2|Overall Study|Study Termination By Sponsor|0
181081|NCT00458302|626004|P1|Overall Study|Study Termination By Sponsor|1
181082|NCT00458302|626003|P2|Overall Study|Inc/Exc Criteria Not Met|1
181083|NCT00458302|626004|P1|Overall Study|Inc/Exc Criteria Not Met|1
181084|NCT00458302|626003|P2|Overall Study|Withdrawal by Subject|4
181085|NCT00458302|626004|P1|Overall Study|Withdrawal by Subject|6
181086|NCT00458302|626003|P2|Overall Study|Protocol Violation|2
181087|NCT00458302|626004|P1|Overall Study|Protocol Violation|0
181088|NCT00458302|626003|P2|Overall Study|Pregnancy|1
181089|NCT00458302|626004|P1|Overall Study|Pregnancy|2
181090|NCT00458302|626003|P2|Overall Study|Adverse Event|14
181091|NCT00458302|626004|P1|Overall Study|Adverse Event|4
181092|NCT00458211|626049|P1|Overall Study|Protocol Violation|2
181093|NCT00458211|626049|P1|Overall Study|Withdrawal by Subject|2
181094|NCT00458211|626049|P1|Overall Study|Lack of Efficacy|12
181095|NCT00457821|626091|P8|Part 2|Withdrawal by Subject|1
181096|NCT00457821|626092|P7|Part 2|Withdrawal by Subject|0
181097|NCT00457821|626093|P6|Part 2|Withdrawal by Subject|0
181098|NCT00457821|626094|P5|Part 2|Withdrawal by Subject|0
181099|NCT00457821|626095|P4|Part 2|Withdrawal by Subject|0
181100|NCT00457821|626096|P3|Part 2|Withdrawal by Subject|0
181101|NCT00457821|626097|P2|Part 2|Withdrawal by Subject|0
181102|NCT00457821|626098|P1|Part 2|Withdrawal by Subject|0
181103|NCT00457743|626137|P3|Overall Study|Lack of Efficacy|3
181105|NCT00457743|626139|P1|Overall Study|Lack of Efficacy|3
181106|NCT00457743|626137|P3|Overall Study|Adverse Event|0
181107|NCT00457743|626138|P2|Overall Study|Adverse Event|4
181108|NCT00457743|626139|P1|Overall Study|Adverse Event|0
181109|NCT00457691|626196|P2|Overall Study|Disease progression, study terminated|196
181110|NCT00457691|626197|P1|Overall Study|Disease progression, study terminated|180
181111|NCT00457691|626196|P2|Overall Study|Subject refused (reason other than AE)|19
181112|NCT00457691|626197|P1|Overall Study|Subject refused (reason other than AE)|14
181113|NCT00457691|626196|P2|Overall Study|Study terminated by Sponsor|1
181114|NCT00457691|626197|P1|Overall Study|Study terminated by Sponsor|1
181115|NCT00457691|626196|P2|Overall Study|Lost to Follow-up|14
181116|NCT00457691|626197|P1|Overall Study|Lost to Follow-up|23
181117|NCT00457691|626196|P2|Overall Study|Protocol Violation|3
181118|NCT00457691|626197|P1|Overall Study|Protocol Violation|1
181119|NCT00457691|626196|P2|Overall Study|Death|148
181120|NCT00457691|626197|P1|Overall Study|Death|163
181121|NCT00457691|626196|P2|Overall Study|Adverse Event|1
181122|NCT00457691|626197|P1|Overall Study|Adverse Event|4
181123|NCT00457418|626217|P1|Post PK Maintenance|Lost to Follow-up|1
181124|NCT00457418|626217|P1|Post PK Maintenance|Withdrawal by Subject|11
181125|NCT00457418|626217|P1|Post PK Maintenance|Progression of Disease|6
181126|NCT00457418|626217|P1|Post PK Maintenance|Adverse Event|10
181127|NCT00457418|626217|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
181128|NCT00457418|626217|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
181129|NCT00457418|626217|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
181130|NCT00457392|626229|P2|Overall Study|Randomized, Not Treated|3
181131|NCT00457392|626230|P1|Overall Study|Randomized, Not Treated|7
181132|NCT00457392|626229|P2|Overall Study|Study Terminated by Sponsor|4
181133|NCT00457392|626230|P1|Overall Study|Study Terminated by Sponsor|1
181134|NCT00457392|626229|P2|Overall Study|Other|4
181135|NCT00457392|626230|P1|Overall Study|Other|7
181136|NCT00457392|626229|P2|Overall Study|Protocol Violation|3
181137|NCT00457392|626230|P1|Overall Study|Protocol Violation|4
181138|NCT00457392|626229|P2|Overall Study|Lost to Follow-up|7
181139|NCT00457392|626230|P1|Overall Study|Lost to Follow-up|6
181140|NCT00457392|626229|P2|Overall Study|Withdrawal by Subject|8
181141|NCT00457392|626230|P1|Overall Study|Withdrawal by Subject|14
181142|NCT00457392|626229|P2|Overall Study|Global Deterioration of Health Status|8
181143|NCT00457392|626230|P1|Overall Study|Global Deterioration of Health Status|22
181144|NCT00457392|626229|P2|Overall Study|Adverse Event|41
181145|NCT00457392|626230|P1|Overall Study|Adverse Event|84
181146|NCT00457392|626229|P2|Overall Study|Death|106
181147|NCT00457392|626230|P1|Overall Study|Death|106
181148|NCT00457392|626229|P2|Overall Study|Objective Progression or Relapse|296
181149|NCT00457392|626230|P1|Overall Study|Objective Progression or Relapse|229
181150|NCT00457301|626248|P2|Overall Study|Death|7
181151|NCT00457301|626249|P1|Overall Study|Death|5
181152|NCT00457301|626248|P2|Overall Study|Censored out of the study|14
181153|NCT00457301|626249|P1|Overall Study|Censored out of the study|15
181154|NCT00457301|626248|P2|Overall Study|Withdrawal by Subject|3
181155|NCT00457301|626249|P1|Overall Study|Withdrawal by Subject|3
181156|NCT00457249|626263|P2|Overall Study|Serious Adverse Events|0
181157|NCT00457249|626264|P1|Overall Study|Serious Adverse Events|2
181158|NCT00457249|626263|P2|Overall Study|Withdrawal by Subject|1
181159|NCT00457249|626264|P1|Overall Study|Withdrawal by Subject|3
181160|NCT00457249|626263|P2|Overall Study|Protocol Violation|1
181161|NCT00457249|626264|P1|Overall Study|Protocol Violation|4
181162|NCT00457249|626263|P2|Overall Study|Lost to Follow-up|0
181163|NCT00457249|626264|P1|Overall Study|Lost to Follow-up|3
181164|NCT00457015|626303|P2|Overall Study|Left study site against medical advice|1
181165|NCT00457015|626304|P1|Overall Study|Left study site against medical advice|0
181166|NCT00457002|626320|P2|Overall Study|treated for 1 day; missing status/reason|0
181167|NCT00457002|626321|P1|Overall Study|treated for 1 day; missing status/reason|1
181168|NCT00457002|626320|P2|Overall Study|non-specified|38
181169|NCT00457002|626321|P1|Overall Study|non-specified|29
181170|NCT00457002|626320|P2|Overall Study|Administrative reason by Sponsor|0
181171|NCT00457002|626321|P1|Overall Study|Administrative reason by Sponsor|1
181172|NCT00457002|626320|P2|Overall Study|No longer met criteria|37
181173|NCT00457002|626321|P1|Overall Study|No longer met criteria|41
181174|NCT00457002|626320|P2|Overall Study|Poor/Non-compliance|33
181175|NCT00457002|626321|P1|Overall Study|Poor/Non-compliance|46
181176|NCT00457002|626320|P2|Overall Study|Lost to Follow-up|71
181177|NCT00457002|626321|P1|Overall Study|Lost to Follow-up|72
181178|NCT00457002|626320|P2|Overall Study|Withdrawal by Subject|271
181179|NCT00457002|626321|P1|Overall Study|Withdrawal by Subject|299
181180|NCT00457002|626320|P2|Overall Study|Adverse Event|260
181181|NCT00457002|626321|P1|Overall Study|Adverse Event|284
181182|NCT00457002|626320|P2|Overall Study|Death|47
181183|NCT00457002|626321|P1|Overall Study|Death|40
181184|NCT00456846|626425|P2|Overall Study|Other|2
181185|NCT00456846|626426|P1|Overall Study|Other|0
181186|NCT00456846|626425|P2|Overall Study|Participant Discretion|5
181187|NCT00456846|626426|P1|Overall Study|Participant Discretion|1
181188|NCT00456846|626425|P2|Overall Study|Protocol Deviation|0
181189|NCT00456846|626426|P1|Overall Study|Protocol Deviation|2
181190|NCT00456846|626425|P2|Overall Study|Physician Decision|6
181191|NCT00456846|626426|P1|Overall Study|Physician Decision|11
181192|NCT00456846|626425|P2|Overall Study|Adverse Event|15
181193|NCT00456846|626426|P1|Overall Study|Adverse Event|2
181194|NCT00456755|626467|P2|Overall Study|Lost to Follow-up|1
181195|NCT00456755|626468|P1|Overall Study|Lost to Follow-up|2
181196|NCT00456612|626482|P1|Overall Study|Withdrawal by Subject|3
181197|NCT00456599|626487|P1|Overall Study|Withdrawal by Subject|2
181198|NCT00456599|626487|P1|Overall Study|Non-compliance|1
181199|NCT00456521|626510|P2|Overall Study|Drug non-compliance, moved, other|11
181200|NCT00456521|626511|P1|Overall Study|Drug non-compliance, moved, other|26
181201|NCT00456521|626510|P2|Overall Study|Pregnancy|1
181202|NCT00456521|626511|P1|Overall Study|Pregnancy|1
181203|NCT00456521|626510|P2|Overall Study|Protocol Violation|0
181204|NCT00456521|626511|P1|Overall Study|Protocol Violation|4
181205|NCT00456521|626510|P2|Overall Study|Lack of Efficacy|6
181206|NCT00456521|626511|P1|Overall Study|Lack of Efficacy|3
181207|NCT00456521|626510|P2|Overall Study|Lost to Follow-up|17
181208|NCT00456521|626511|P1|Overall Study|Lost to Follow-up|22
181209|NCT00456521|626510|P2|Overall Study|Withdrawal by Subject|24
181210|NCT00456521|626511|P1|Overall Study|Withdrawal by Subject|43
181211|NCT00456521|626510|P2|Overall Study|Adverse Event|25
181212|NCT00456521|626511|P1|Overall Study|Adverse Event|150
181213|NCT00456495|626557|P1|Overall Study|Physician Decision|2
181214|NCT00456365|626564|P2|Overall Study|oncologic diagnosis|1
181215|NCT00456365|626565|P1|Overall Study|oncologic diagnosis|1
181216|NCT00456365|626564|P2|Overall Study|Pregnancy|1
181217|NCT00456365|626565|P1|Overall Study|Pregnancy|1
181218|NCT00456365|626564|P2|Overall Study|Withdrawal by Subject|7
181219|NCT00456365|626565|P1|Overall Study|Withdrawal by Subject|4
181220|NCT00456365|626564|P2|Overall Study|Lost to Follow-up|3
181221|NCT00456365|626565|P1|Overall Study|Lost to Follow-up|1
181222|NCT00455923|626622|P2|Overall Study|Other|1
181223|NCT00455923|626623|P1|Overall Study|Other|3
181224|NCT00455923|626622|P2|Overall Study|Pregnancy|2
181225|NCT00455923|626623|P1|Overall Study|Pregnancy|0
181226|NCT00455858|626639|P1|Overall Study|Withdrawal|1
181227|NCT00455858|626639|P1|Overall Study|Well controlled FPG without insulin|1
181228|NCT00455858|626639|P1|Overall Study|Lack of Efficacy|1
181229|NCT00455858|626639|P1|Overall Study|Protocol Violation|1
181230|NCT00455858|626639|P1|Overall Study|Lost to Follow-up|2
181231|NCT00455741|626649|P2|Overall Study|Physician Decision|1
181232|NCT00455741|626650|P1|Overall Study|Physician Decision|0
181233|NCT00455533|626736|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
181234|NCT00455533|626737|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
181235|NCT00455533|626738|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
181236|NCT00455533|626736|P3|Period Two: Randomized Period|Study Drug Toxicity|0
181237|NCT00455533|626737|P2|Period Two: Randomized Period|Study Drug Toxicity|2
181238|NCT00455533|626738|P1|Period Two: Randomized Period|Study Drug Toxicity|0
181239|NCT00455533|626736|P3|Period Two: Randomized Period|Other - need reasons|0
181240|NCT00455533|626737|P2|Period Two: Randomized Period|Other - need reasons|1
181241|NCT00455533|626738|P1|Period Two: Randomized Period|Other - need reasons|0
181242|NCT00455533|626736|P3|Period Two: Randomized Period|Lost to Follow-up|1
181243|NCT00455533|626737|P2|Period Two: Randomized Period|Lost to Follow-up|0
181244|NCT00455533|626738|P1|Period Two: Randomized Period|Lost to Follow-up|0
181245|NCT00455533|626736|P3|Period Two: Randomized Period|Disease Progression|1
181246|NCT00455533|626737|P2|Period Two: Randomized Period|Disease Progression|1
181247|NCT00455533|626738|P1|Period Two: Randomized Period|Disease Progression|0
181248|NCT00455533|626736|P3|Period Two: Randomized Period|Death|3
181249|NCT00455533|626737|P2|Period Two: Randomized Period|Death|0
181250|NCT00455533|626738|P1|Period Two: Randomized Period|Death|0
181251|NCT00455533|626736|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
181252|NCT00455533|626737|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
181253|NCT00455533|626738|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
181254|NCT00455533|626736|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
181255|NCT00455533|626737|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
181256|NCT00455533|626738|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
181257|NCT00455533|626736|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
181258|NCT00455533|626737|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
181259|NCT00455533|626738|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
181260|NCT00455533|626736|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
181261|NCT00455533|626737|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
181262|NCT00455533|626738|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
181263|NCT00455533|626736|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
181264|NCT00455533|626737|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
181265|NCT00455533|626738|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
181266|NCT00455533|626736|P3|Period One: Initial Chemotherapy|Not Reported|0
181267|NCT00455533|626737|P2|Period One: Initial Chemotherapy|Not Reported|0
181268|NCT00455533|626738|P1|Period One: Initial Chemotherapy|Not Reported|1
181269|NCT00455533|626736|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
181270|NCT00455533|626737|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
181271|NCT00455533|626738|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
181272|NCT00455533|626736|P3|Period One: Initial Chemotherapy|Disease Progression|0
181273|NCT00455533|626737|P2|Period One: Initial Chemotherapy|Disease Progression|0
181274|NCT00455533|626738|P1|Period One: Initial Chemotherapy|Disease Progression|5
181275|NCT00455533|626736|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
181276|NCT00455533|626737|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
181277|NCT00455533|626738|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
181278|NCT00455520|626787|P2|Double Blind Tapentadol ER vs Placebo|All other|6
181279|NCT00455520|626788|P1|Double Blind Tapentadol ER vs Placebo|All other|4
181280|NCT00455520|626787|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
181281|NCT00455520|626788|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
181282|NCT00455520|626787|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
181283|NCT00455520|626788|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
181284|NCT00455520|626787|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
181285|NCT00455520|626788|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
181286|NCT00455520|626787|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
181287|NCT00455520|626788|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
181288|NCT00455520|626787|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
181289|NCT00455520|626788|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
181290|NCT00455520|626787|P2|Open Label Tapentadol Extended Release|All other|0
181291|NCT00455520|626788|P1|Open Label Tapentadol Extended Release|All other|33
181292|NCT00455520|626787|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
181293|NCT00455520|626788|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
181294|NCT00455520|626787|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
181295|NCT00455520|626788|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
181296|NCT00455520|626787|P2|Open Label Tapentadol Extended Release|Adverse Event|0
181297|NCT00455520|626788|P1|Open Label Tapentadol Extended Release|Adverse Event|100
181298|NCT00455520|626787|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
181299|NCT00455520|626788|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
181300|NCT00455520|626787|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
181301|NCT00455520|626788|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
181302|NCT00455455|626804|P2|Washout|Withdrawal by Subject|0
181303|NCT00455455|626805|P1|Washout|Withdrawal by Subject|1
181304|NCT00455455|626804|P2|Washout|Withdrawal by Subject|1
181305|NCT00455455|626805|P1|Washout|Withdrawal by Subject|0
181306|NCT00455429|626825|P4|Overall Study|Other|1
181307|NCT00455429|626826|P3|Overall Study|Other|0
181308|NCT00455429|626827|P2|Overall Study|Other|2
181309|NCT00455429|626828|P1|Overall Study|Other|0
181310|NCT00455429|626825|P4|Overall Study|Non-compliance|1
181311|NCT00455429|626826|P3|Overall Study|Non-compliance|0
181312|NCT00455429|626827|P2|Overall Study|Non-compliance|0
181313|NCT00455429|626828|P1|Overall Study|Non-compliance|0
181314|NCT00455429|626825|P4|Overall Study|Personal Reason|0
181315|NCT00455429|626826|P3|Overall Study|Personal Reason|0
181316|NCT00455429|626827|P2|Overall Study|Personal Reason|0
181317|NCT00455429|626828|P1|Overall Study|Personal Reason|1
181318|NCT00455429|626825|P4|Overall Study|Randomly assigned but not treated|2
181319|NCT00455429|626826|P3|Overall Study|Randomly assigned but not treated|0
181320|NCT00455429|626827|P2|Overall Study|Randomly assigned but not treated|0
181321|NCT00455429|626828|P1|Overall Study|Randomly assigned but not treated|0
181322|NCT00455429|626825|P4|Overall Study|Adverse Event|3
181323|NCT00455429|626826|P3|Overall Study|Adverse Event|0
181324|NCT00455429|626827|P2|Overall Study|Adverse Event|1
181325|NCT00455429|626828|P1|Overall Study|Adverse Event|0
181326|NCT00455429|626825|P4|Overall Study|Lack of Efficacy|1
181327|NCT00455429|626826|P3|Overall Study|Lack of Efficacy|0
181328|NCT00455429|626827|P2|Overall Study|Lack of Efficacy|1
181329|NCT00455429|626828|P1|Overall Study|Lack of Efficacy|0
181330|NCT00455429|626825|P4|Overall Study|Withdrawal by Subject|0
181331|NCT00455429|626826|P3|Overall Study|Withdrawal by Subject|1
181332|NCT00455429|626827|P2|Overall Study|Withdrawal by Subject|1
181333|NCT00455429|626828|P1|Overall Study|Withdrawal by Subject|0
181334|NCT00455429|626825|P4|Overall Study|Lost to Follow-up|3
181335|NCT00455429|626826|P3|Overall Study|Lost to Follow-up|0
181336|NCT00455429|626827|P2|Overall Study|Lost to Follow-up|0
181337|NCT00455429|626828|P1|Overall Study|Lost to Follow-up|1
181338|NCT00455429|626825|P4|Overall Study|Study Terminated by Sponsor|3
181339|NCT00455429|626826|P3|Overall Study|Study Terminated by Sponsor|0
181340|NCT00455429|626827|P2|Overall Study|Study Terminated by Sponsor|0
181341|NCT00455429|626828|P1|Overall Study|Study Terminated by Sponsor|0
181342|NCT00455312|626887|P2|Overall Study|Death|1
181343|NCT00455312|626888|P1|Overall Study|Death|0
181344|NCT00455195|626914|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
181345|NCT00455195|626915|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
181346|NCT00455195|626914|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
181347|NCT00455195|626915|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
181348|NCT00455195|626914|P2|Double-blind Study AGLU02704|Death|0
181349|NCT00455195|626915|P1|Double-blind Study AGLU02704|Death|1
181350|NCT00455195|626914|P2|Double-blind Study AGLU02704|Adverse Event|1
181351|NCT00455195|626915|P1|Double-blind Study AGLU02704|Adverse Event|2
181352|NCT00455013|626932|P3|Long Term Extension (LTE)|non-specified|1
181353|NCT00455013|626933|P2|Long Term Extension (LTE)|non-specified|0
181354|NCT00455013|626934|P1|Long Term Extension (LTE)|non-specified|0
181355|NCT00455013|626932|P3|Long Term Extension (LTE)|Poor non-compliance|0
181356|NCT00455013|626933|P2|Long Term Extension (LTE)|Poor non-compliance|1
181357|NCT00455013|626934|P1|Long Term Extension (LTE)|Poor non-compliance|0
181358|NCT00455013|626932|P3|Long Term Extension (LTE)|Subject Request or refused|3
181359|NCT00455013|626933|P2|Long Term Extension (LTE)|Subject Request or refused|0
181360|NCT00455013|626934|P1|Long Term Extension (LTE)|Subject Request or refused|0
181361|NCT00455013|626932|P3|Long Term Extension (LTE)|No longer met criteria|1
181362|NCT00455013|626933|P2|Long Term Extension (LTE)|No longer met criteria|0
181363|NCT00455013|626934|P1|Long Term Extension (LTE)|No longer met criteria|0
181364|NCT00455013|626932|P3|Long Term Extension (LTE)|Death|0
181365|NCT00455013|626933|P2|Long Term Extension (LTE)|Death|1
181366|NCT00455013|626934|P1|Long Term Extension (LTE)|Death|1
181367|NCT00455013|626932|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
181368|NCT00455013|626933|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
181369|NCT00455013|626934|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
181370|NCT00455013|626932|P3|Long Term Extension (LTE)|Adverse Event|1
181371|NCT00455013|626933|P2|Long Term Extension (LTE)|Adverse Event|1
181372|NCT00455013|626934|P1|Long Term Extension (LTE)|Adverse Event|0
181373|NCT00455013|626932|P3|Short Term Period|Other|1
181374|NCT00455013|626933|P2|Short Term Period|Other|0
181375|NCT00455013|626934|P1|Short Term Period|Other|0
181376|NCT00455013|626932|P3|Short Term Period|Lack of Efficacy|0
181377|NCT00455013|626933|P2|Short Term Period|Lack of Efficacy|0
181378|NCT00455013|626934|P1|Short Term Period|Lack of Efficacy|4
181379|NCT00455013|626932|P3|Short Term Period|Withdrawal by Subject|1
181380|NCT00455013|626933|P2|Short Term Period|Withdrawal by Subject|0
181381|NCT00455013|626934|P1|Short Term Period|Withdrawal by Subject|0
181382|NCT00455013|626932|P3|Short Term Period|Adverse Event|0
181383|NCT00455013|626933|P2|Short Term Period|Adverse Event|5
181384|NCT00455013|626934|P1|Short Term Period|Adverse Event|2
181385|NCT00454987|627002|P3|Booster Period|Lost to Follow-up|0
181386|NCT00454987|627003|P2|Booster Period|Lost to Follow-up|0
181387|NCT00454987|627004|P1|Booster Period|Lost to Follow-up|1
181388|NCT00454987|627002|P3|Booster Period|Withdrawal by Subject|0
181389|NCT00454987|627003|P2|Booster Period|Withdrawal by Subject|1
181390|NCT00454987|627004|P1|Booster Period|Withdrawal by Subject|0
181391|NCT00454987|627002|P3|Booster Period|Adverse Event|0
181392|NCT00454987|627003|P2|Booster Period|Adverse Event|0
181393|NCT00454987|627004|P1|Booster Period|Adverse Event|1
181394|NCT00454909|627078|P3|Overall Study|Others|0
181395|NCT00454909|627079|P2|Overall Study|Others|0
181396|NCT00454909|627080|P1|Overall Study|Others|1
181397|NCT00454909|627078|P3|Overall Study|Lost to follow-up (complete vaccination)|1
181398|NCT00454909|627079|P2|Overall Study|Lost to follow-up (complete vaccination)|3
181399|NCT00454909|627080|P1|Overall Study|Lost to follow-up (complete vaccination)|5
181400|NCT00454909|627078|P3|Overall Study|Migrated/moved from study area|1
181401|NCT00454909|627079|P2|Overall Study|Migrated/moved from study area|0
181402|NCT00454909|627080|P1|Overall Study|Migrated/moved from study area|0
181403|NCT00454909|627078|P3|Overall Study|Withdrawal by Subject|0
181404|NCT00454909|627079|P2|Overall Study|Withdrawal by Subject|0
181405|NCT00454909|627080|P1|Overall Study|Withdrawal by Subject|1
181406|NCT00454857|627118|P1|Overall Study|Reason unknown|1
181407|NCT00454857|627118|P1|Overall Study|Other|11
181408|NCT00454857|627118|P1|Overall Study|Death|5
181409|NCT00454857|627118|P1|Overall Study|Noncompliance|6
181410|NCT00454857|627118|P1|Overall Study|Lost to Follow-up|16
181411|NCT00454857|627118|P1|Overall Study|Withdrawal by Subject|15
181412|NCT00454818|627143|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
181413|NCT00454818|627144|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
181414|NCT00454818|627145|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
181415|NCT00454818|627146|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
181416|NCT00454818|627147|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
181417|NCT00454818|627143|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
181418|NCT00454818|627144|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
181419|NCT00454818|627145|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
181420|NCT00454818|627146|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
181421|NCT00454818|627147|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
181422|NCT00454818|627143|P5|Phase 2: Randomized Double-blind|Death|1
181423|NCT00454818|627144|P4|Phase 2: Randomized Double-blind|Death|0
181424|NCT00454818|627145|P3|Phase 2: Randomized Double-blind|Death|0
181425|NCT00454818|627146|P2|Phase 2: Randomized Double-blind|Death|1
181426|NCT00454818|627147|P1|Phase 2: Randomized Double-blind|Death|0
181427|NCT00454818|627143|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
181428|NCT00454818|627144|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
181429|NCT00454818|627145|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
181430|NCT00454818|627146|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
181431|NCT00454818|627147|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
181432|NCT00454818|627143|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
181433|NCT00454818|627144|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
181434|NCT00454818|627145|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
181435|NCT00454818|627146|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
181436|NCT00454818|627147|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
181437|NCT00454818|627143|P5|Phase I: Open-label Dose-escalation|Death|0
181438|NCT00454818|627144|P4|Phase I: Open-label Dose-escalation|Death|0
181439|NCT00454818|627145|P3|Phase I: Open-label Dose-escalation|Death|0
181440|NCT00454818|627146|P2|Phase I: Open-label Dose-escalation|Death|1
181441|NCT00454818|627147|P1|Phase I: Open-label Dose-escalation|Death|0
181442|NCT00454818|627143|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
181443|NCT00454818|627144|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
181444|NCT00454818|627145|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
181445|NCT00454818|627146|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
181446|NCT00454818|627147|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
181447|NCT00454805|627226|P2|Overall Study|In order to begin radiotherapy|0
181448|NCT00454805|627227|P1|Overall Study|In order to begin radiotherapy|1
181449|NCT00454805|627226|P2|Overall Study|Disease progression|19
181450|NCT00454805|627227|P1|Overall Study|Disease progression|16
181451|NCT00454805|627226|P2|Overall Study|Death|2
181452|NCT00454805|627227|P1|Overall Study|Death|0
181453|NCT00454805|627226|P2|Overall Study|Withdrawal by Subject|2
181454|NCT00454805|627227|P1|Overall Study|Withdrawal by Subject|9
181455|NCT00454779|627243|P2|Second-line Treatment Phase|Ongoing|1
181456|NCT00454779|627244|P1|Second-line Treatment Phase|Ongoing|0
181457|NCT00454779|627243|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
181458|NCT00454779|627244|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
181459|NCT00454779|627243|P2|Second-line Treatment Phase|Withdrawal by Subject|1
181460|NCT00454779|627244|P1|Second-line Treatment Phase|Withdrawal by Subject|0
181461|NCT00454779|627243|P2|First-line Treatment Phase|Ongoing|0
181462|NCT00454779|627244|P1|First-line Treatment Phase|Ongoing|1
181463|NCT00454779|627243|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
181464|NCT00454779|627244|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
181465|NCT00454779|627243|P2|First-line Treatment Phase|Protocol Violation|1
181466|NCT00454779|627244|P1|First-line Treatment Phase|Protocol Violation|0
181467|NCT00454779|627243|P2|First-line Treatment Phase|Lost to Follow-up|0
181468|NCT00454779|627244|P1|First-line Treatment Phase|Lost to Follow-up|1
181469|NCT00454779|627243|P2|First-line Treatment Phase|Withdrawal by Subject|4
181470|NCT00454779|627244|P1|First-line Treatment Phase|Withdrawal by Subject|2
181471|NCT00454779|627243|P2|First-line Treatment Phase|Lack of Efficacy|2
181472|NCT00454779|627244|P1|First-line Treatment Phase|Lack of Efficacy|0
181473|NCT00454649|627282|P10|Overall Study|Withdrawal by Subject|0
181474|NCT00454649|627283|P9|Overall Study|Withdrawal by Subject|1
181475|NCT00454649|627284|P8|Overall Study|Withdrawal by Subject|2
181476|NCT00454649|627285|P7|Overall Study|Withdrawal by Subject|0
181477|NCT00454649|627286|P6|Overall Study|Withdrawal by Subject|1
181478|NCT00454649|627287|P5|Overall Study|Withdrawal by Subject|0
181479|NCT00454649|627288|P4|Overall Study|Withdrawal by Subject|0
181480|NCT00454649|627289|P3|Overall Study|Withdrawal by Subject|0
181481|NCT00454649|627290|P2|Overall Study|Withdrawal by Subject|0
181482|NCT00454649|627291|P1|Overall Study|Withdrawal by Subject|0
181483|NCT00454649|627282|P10|Overall Study|Other|1
181484|NCT00454649|627283|P9|Overall Study|Other|3
181485|NCT00454649|627284|P8|Overall Study|Other|0
181486|NCT00454649|627285|P7|Overall Study|Other|0
181487|NCT00454649|627286|P6|Overall Study|Other|0
181488|NCT00454649|627287|P5|Overall Study|Other|0
181489|NCT00454649|627288|P4|Overall Study|Other|3
181490|NCT00454649|627289|P3|Overall Study|Other|5
181491|NCT00454649|627290|P2|Overall Study|Other|1
181492|NCT00454649|627291|P1|Overall Study|Other|1
181493|NCT00454649|627282|P10|Overall Study|Lost to Follow-up|0
181494|NCT00454649|627283|P9|Overall Study|Lost to Follow-up|0
181495|NCT00454649|627284|P8|Overall Study|Lost to Follow-up|0
181496|NCT00454649|627285|P7|Overall Study|Lost to Follow-up|1
181497|NCT00454649|627286|P6|Overall Study|Lost to Follow-up|0
181498|NCT00454649|627287|P5|Overall Study|Lost to Follow-up|0
181499|NCT00454649|627288|P4|Overall Study|Lost to Follow-up|0
181500|NCT00454649|627289|P3|Overall Study|Lost to Follow-up|1
181501|NCT00454649|627290|P2|Overall Study|Lost to Follow-up|0
181502|NCT00454649|627291|P1|Overall Study|Lost to Follow-up|0
181503|NCT00454649|627282|P10|Overall Study|Adverse Event|2
181504|NCT00454649|627283|P9|Overall Study|Adverse Event|6
181505|NCT00454649|627284|P8|Overall Study|Adverse Event|4
181506|NCT00454649|627285|P7|Overall Study|Adverse Event|3
181507|NCT00454649|627286|P6|Overall Study|Adverse Event|2
181508|NCT00454649|627287|P5|Overall Study|Adverse Event|1
181509|NCT00454649|627288|P4|Overall Study|Adverse Event|0
181510|NCT00454649|627289|P3|Overall Study|Adverse Event|3
181511|NCT00454649|627290|P2|Overall Study|Adverse Event|1
181512|NCT00454649|627291|P1|Overall Study|Adverse Event|0
181513|NCT00454649|627282|P10|Overall Study|Lack of Efficacy|2
181514|NCT00454649|627283|P9|Overall Study|Lack of Efficacy|10
181515|NCT00454649|627284|P8|Overall Study|Lack of Efficacy|13
181516|NCT00454649|627285|P7|Overall Study|Lack of Efficacy|5
181517|NCT00454649|627286|P6|Overall Study|Lack of Efficacy|4
181518|NCT00454649|627287|P5|Overall Study|Lack of Efficacy|0
181519|NCT00454649|627288|P4|Overall Study|Lack of Efficacy|3
181520|NCT00454649|627289|P3|Overall Study|Lack of Efficacy|10
181521|NCT00454649|627290|P2|Overall Study|Lack of Efficacy|2
181522|NCT00454649|627291|P1|Overall Study|Lack of Efficacy|2
181523|NCT00454636|627420|P4|Overall Study|Lost to Follow-up|0
181524|NCT00454636|627421|P3|Overall Study|Lost to Follow-up|0
181525|NCT00454636|627422|P2|Overall Study|Lost to Follow-up|1
181526|NCT00454636|627423|P1|Overall Study|Lost to Follow-up|0
181527|NCT00454636|627420|P4|Overall Study|Patient refusal|2
181528|NCT00454636|627421|P3|Overall Study|Patient refusal|3
181529|NCT00454636|627422|P2|Overall Study|Patient refusal|1
181530|NCT00454636|627423|P1|Overall Study|Patient refusal|1
181531|NCT00454636|627420|P4|Overall Study|Death|1
181532|NCT00454636|627421|P3|Overall Study|Death|1
181533|NCT00454636|627422|P2|Overall Study|Death|1
181534|NCT00454636|627423|P1|Overall Study|Death|6
181535|NCT00454636|627420|P4|Overall Study|Protocol Violation|3
181536|NCT00454636|627421|P3|Overall Study|Protocol Violation|3
181537|NCT00454636|627422|P2|Overall Study|Protocol Violation|2
181538|NCT00454636|627423|P1|Overall Study|Protocol Violation|3
181539|NCT00454636|627420|P4|Overall Study|Disease Progression|11
181540|NCT00454636|627421|P3|Overall Study|Disease Progression|4
181541|NCT00454636|627422|P2|Overall Study|Disease Progression|12
181542|NCT00454636|627423|P1|Overall Study|Disease Progression|11
181543|NCT00454636|627420|P4|Overall Study|Adverse Event|15
181544|NCT00454636|627421|P3|Overall Study|Adverse Event|9
181545|NCT00454636|627422|P2|Overall Study|Adverse Event|6
181546|NCT00454636|627423|P1|Overall Study|Adverse Event|10
181547|NCT00454584|627456|P6|After Controlled Period|Other|17
181548|NCT00454584|627457|P5|After Controlled Period|Other|5
181549|NCT00454584|627458|P4|After Controlled Period|Other|13
181550|NCT00454584|627459|P3|After Controlled Period|Other|0
181551|NCT00454584|627460|P2|After Controlled Period|Other|0
181552|NCT00454584|627461|P1|After Controlled Period|Other|0
181553|NCT00454584|627456|P6|After Controlled Period|Other|0
181554|NCT00454584|627457|P5|After Controlled Period|Other|0
181555|NCT00454584|627458|P4|After Controlled Period|Other|1
181556|NCT00454584|627459|P3|After Controlled Period|Other|0
181557|NCT00454584|627460|P2|After Controlled Period|Other|0
181558|NCT00454584|627461|P1|After Controlled Period|Other|0
181559|NCT00454584|627456|P6|After Controlled Period|Lost to Follow-up|6
181560|NCT00454584|627457|P5|After Controlled Period|Lost to Follow-up|4
181561|NCT00454584|627458|P4|After Controlled Period|Lost to Follow-up|2
181562|NCT00454584|627459|P3|After Controlled Period|Lost to Follow-up|0
181563|NCT00454584|627460|P2|After Controlled Period|Lost to Follow-up|0
181564|NCT00454584|627461|P1|After Controlled Period|Lost to Follow-up|0
181565|NCT00454584|627456|P6|After Controlled Period|Lack of Efficacy|0
181566|NCT00454584|627457|P5|After Controlled Period|Lack of Efficacy|0
181567|NCT00454584|627458|P4|After Controlled Period|Lack of Efficacy|1
181568|NCT00454584|627459|P3|After Controlled Period|Lack of Efficacy|0
181569|NCT00454584|627460|P2|After Controlled Period|Lack of Efficacy|0
181570|NCT00454584|627461|P1|After Controlled Period|Lack of Efficacy|0
181571|NCT00454584|627456|P6|After Controlled Period|Adverse Event|9
181572|NCT00454584|627457|P5|After Controlled Period|Adverse Event|3
181573|NCT00454584|627458|P4|After Controlled Period|Adverse Event|9
181574|NCT00454584|627459|P3|After Controlled Period|Adverse Event|0
181575|NCT00454584|627460|P2|After Controlled Period|Adverse Event|0
181576|NCT00454584|627461|P1|After Controlled Period|Adverse Event|0
181577|NCT00454584|627456|P6|Controlled Period|Other|0
181578|NCT00454584|627457|P5|Controlled Period|Other|0
181579|NCT00454584|627458|P4|Controlled Period|Other|0
181580|NCT00454584|627459|P3|Controlled Period|Other|2
181581|NCT00454584|627460|P2|Controlled Period|Other|4
181582|NCT00454584|627461|P1|Controlled Period|Other|5
181583|NCT00454584|627456|P6|Controlled Period|Lost to Follow-up|0
181584|NCT00454584|627457|P5|Controlled Period|Lost to Follow-up|0
181585|NCT00454584|627458|P4|Controlled Period|Lost to Follow-up|0
181586|NCT00454584|627459|P3|Controlled Period|Lost to Follow-up|2
181587|NCT00454584|627460|P2|Controlled Period|Lost to Follow-up|2
181588|NCT00454584|627461|P1|Controlled Period|Lost to Follow-up|1
181589|NCT00454584|627456|P6|Controlled Period|Adverse Event|0
181590|NCT00454584|627457|P5|Controlled Period|Adverse Event|0
181591|NCT00454584|627458|P4|Controlled Period|Adverse Event|0
181592|NCT00454584|627459|P3|Controlled Period|Adverse Event|1
181593|NCT00454584|627460|P2|Controlled Period|Adverse Event|2
181594|NCT00454584|627461|P1|Controlled Period|Adverse Event|5
181595|NCT00454571|627483|P2|Overall Study|Withdrawal by Subject|5
181596|NCT00454571|627484|P1|Overall Study|Withdrawal by Subject|10
181597|NCT00454571|627483|P2|Overall Study|Protocol Violation|0
181598|NCT00454571|627484|P1|Overall Study|Protocol Violation|1
181599|NCT00454571|627483|P2|Overall Study|Physician Decision|1
181600|NCT00454571|627484|P1|Overall Study|Physician Decision|0
181601|NCT00454571|627483|P2|Overall Study|Adverse Event|0
181602|NCT00454571|627484|P1|Overall Study|Adverse Event|2
181603|NCT00454363|627519|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
181604|NCT00454363|627520|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
181605|NCT00454363|627519|P2|Overall Study|Adverse Event|2
181606|NCT00454363|627520|P1|Overall Study|Adverse Event|1
181607|NCT00454246|627545|P3|Overall Study|Early termination of study|9
181608|NCT00454246|627546|P2|Overall Study|Early termination of study|26
181609|NCT00454246|627547|P1|Overall Study|Early termination of study|62
181610|NCT00454246|627545|P3|Overall Study|Failure to return|0
181611|NCT00454246|627546|P2|Overall Study|Failure to return|0
181612|NCT00454246|627547|P1|Overall Study|Failure to return|1
181613|NCT00454246|627545|P3|Overall Study|Refused Treatment|0
181614|NCT00454246|627546|P2|Overall Study|Refused Treatment|1
181615|NCT00454246|627547|P1|Overall Study|Refused Treatment|1
181616|NCT00454246|627545|P3|Overall Study|Protocol Violation|0
181617|NCT00454246|627546|P2|Overall Study|Protocol Violation|0
181618|NCT00454246|627547|P1|Overall Study|Protocol Violation|1
181619|NCT00454246|627545|P3|Overall Study|Violation of selection criteria at entry|0
181620|NCT00454246|627546|P2|Overall Study|Violation of selection criteria at entry|0
181621|NCT00454246|627547|P1|Overall Study|Violation of selection criteria at entry|6
181622|NCT00454246|627545|P3|Overall Study|Adverse Event|0
181623|NCT00454246|627546|P2|Overall Study|Adverse Event|2
181624|NCT00454246|627547|P1|Overall Study|Adverse Event|2
181625|NCT00454207|627563|P2|Overall Study|Protocol Violation|1
181626|NCT00454207|627564|P1|Overall Study|Protocol Violation|0
181627|NCT00454207|627563|P2|Overall Study|Lack of Efficacy|0
181628|NCT00454207|627564|P1|Overall Study|Lack of Efficacy|1
181629|NCT00454207|627563|P2|Overall Study|Adverse Event|1
181630|NCT00454207|627564|P1|Overall Study|Adverse Event|3
181631|NCT00454194|627609|P2|Overall Study|Other Unspecified Reason|2
181632|NCT00454194|627610|P1|Overall Study|Other Unspecified Reason|2
181633|NCT00454194|627609|P2|Overall Study|Other Medical Problems|2
181634|NCT00454194|627610|P1|Overall Study|Other Medical Problems|1
181635|NCT00454194|627609|P2|Overall Study|Withdrawal by Subject|8
181636|NCT00454194|627610|P1|Overall Study|Withdrawal by Subject|12
181637|NCT00454194|627609|P2|Overall Study|Adverse Event|2
181638|NCT00454194|627610|P1|Overall Study|Adverse Event|7
181639|NCT00454181|627628|P2|Overall Study|Withdrawal by Subject|0
181640|NCT00454181|627629|P1|Overall Study|Withdrawal by Subject|2
181641|NCT00454181|627628|P2|Overall Study|Protocol Violation|1
181642|NCT00454181|627629|P1|Overall Study|Protocol Violation|1
181643|NCT00454181|627628|P2|Overall Study|Lost to Follow-up|1
181644|NCT00454181|627629|P1|Overall Study|Lost to Follow-up|11
181645|NCT00454181|627628|P2|Overall Study|Adverse Event|1
181646|NCT00454181|627629|P1|Overall Study|Adverse Event|1
181647|NCT00454142|627645|P1|Overall Study|Withdrawal by Subject|1
181648|NCT00454116|627663|P3|Overall Study|Other|0
181649|NCT00454116|627664|P2|Overall Study|Other|2
181650|NCT00454116|627665|P1|Overall Study|Other|2
181651|NCT00454116|627663|P3|Overall Study|Withdrawal by Subject|1
181652|NCT00454116|627664|P2|Overall Study|Withdrawal by Subject|3
181653|NCT00454116|627665|P1|Overall Study|Withdrawal by Subject|3
181654|NCT00454116|627663|P3|Overall Study|Condition under investigation worsened|18
181655|NCT00454116|627664|P2|Overall Study|Condition under investigation worsened|13
181656|NCT00454116|627665|P1|Overall Study|Condition under investigation worsened|17
181657|NCT00454116|627663|P3|Overall Study|Adverse Event|9
181658|NCT00454116|627664|P2|Overall Study|Adverse Event|11
181659|NCT00454116|627665|P1|Overall Study|Adverse Event|5
181660|NCT00454051|627675|P2|Overall Study|Protocol Violation|1
181661|NCT00454051|627676|P1|Overall Study|Protocol Violation|1
181662|NCT00454051|627675|P2|Overall Study|Withdrawal by Subject|0
181663|NCT00454051|627676|P1|Overall Study|Withdrawal by Subject|1
181664|NCT00454051|627675|P2|Overall Study|Adverse Event|2
181665|NCT00454051|627676|P1|Overall Study|Adverse Event|1
181666|NCT00453999|627709|P3|Overall Study|Subject Request|0
181667|NCT00453999|627710|P2|Overall Study|Subject Request|1
181668|NCT00453999|627711|P1|Overall Study|Subject Request|2
181669|NCT00453999|627709|P3|Overall Study|Withdrawal by Subject|1
181670|NCT00453999|627710|P2|Overall Study|Withdrawal by Subject|1
181671|NCT00453999|627711|P1|Overall Study|Withdrawal by Subject|2
181672|NCT00453999|627709|P3|Overall Study|Lost to Follow-up|1
181673|NCT00453999|627710|P2|Overall Study|Lost to Follow-up|1
181674|NCT00453999|627711|P1|Overall Study|Lost to Follow-up|0
181675|NCT00453999|627709|P3|Overall Study|Adverse Event|1
181676|NCT00453999|627710|P2|Overall Study|Adverse Event|2
181677|NCT00453999|627711|P1|Overall Study|Adverse Event|1
181678|NCT00453986|627739|P5|Overall Study|Lost to Follow-up|0
181679|NCT00453986|627740|P4|Overall Study|Lost to Follow-up|2
181680|NCT00453986|627741|P3|Overall Study|Lost to Follow-up|6
181681|NCT00453986|627742|P2|Overall Study|Lost to Follow-up|5
181682|NCT00453986|627743|P1|Overall Study|Lost to Follow-up|6
181683|NCT00453973|627838|P2|Overall Study|Sponsor Decision to Terminate Study|30
181684|NCT00453973|627839|P1|Overall Study|Sponsor Decision to Terminate Study|35
181685|NCT00453973|627838|P2|Overall Study|Site closed by sponsor|0
181686|NCT00453973|627839|P1|Overall Study|Site closed by sponsor|3
181687|NCT00453973|627838|P2|Overall Study|Renal transplant|1
181688|NCT00453973|627839|P1|Overall Study|Renal transplant|1
181689|NCT00453973|627838|P2|Overall Study|Relocation|0
181690|NCT00453973|627839|P1|Overall Study|Relocation|1
181691|NCT00453973|627838|P2|Overall Study|PI Decision|2
181692|NCT00453973|627839|P1|Overall Study|PI Decision|0
181693|NCT00453973|627838|P2|Overall Study|Withdrawal by Subject|6
181694|NCT00453973|627839|P1|Overall Study|Withdrawal by Subject|7
181695|NCT00453973|627838|P2|Overall Study|Adverse Event|9
181696|NCT00453973|627839|P1|Overall Study|Adverse Event|4
181697|NCT00453362|627950|P1|Overall Study|Screening Failure|14
181698|NCT00453362|627950|P1|Overall Study|Progression of disease|56
181699|NCT00453362|627950|P1|Overall Study|Withdrawal by Subject|3
181700|NCT00453362|627950|P1|Overall Study|Physician Decision|2
181701|NCT00453362|627950|P1|Overall Study|Death|7
181702|NCT00453362|627950|P1|Overall Study|Adverse Event|5
181703|NCT00453349|627976|P2|Completed Study|Lost to follow up after study treatment|11
181704|NCT00453349|627977|P1|Completed Study|Lost to follow up after study treatment|2
181705|NCT00453349|627976|P2|Completed Study|Withdrawal by Subject|5
181706|NCT00453349|627977|P1|Completed Study|Withdrawal by Subject|3
181707|NCT00453349|627976|P2|Completed Study|Protocol Violation|1
181708|NCT00453349|627977|P1|Completed Study|Protocol Violation|1
181709|NCT00453349|627976|P2|Completed Study|Lost to Follow-up|5
181710|NCT00453349|627977|P1|Completed Study|Lost to Follow-up|7
181711|NCT00453349|627976|P2|Completed Study|Lack of Efficacy|1
181712|NCT00453349|627977|P1|Completed Study|Lack of Efficacy|2
181713|NCT00453349|627976|P2|Completed Study|Adverse Event|11
181714|NCT00453349|627977|P1|Completed Study|Adverse Event|12
181715|NCT00453349|627976|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
181716|NCT00453349|627977|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
181717|NCT00453349|627976|P2|Randomized|Withdrawal by Subject|5
181718|NCT00453349|627977|P1|Randomized|Withdrawal by Subject|3
181719|NCT00453349|627976|P2|Randomized|Protocol Violation|1
181720|NCT00453349|627977|P1|Randomized|Protocol Violation|1
181721|NCT00453349|627976|P2|Randomized|Lost to Follow-up|5
181722|NCT00453349|627977|P1|Randomized|Lost to Follow-up|7
181723|NCT00453349|627976|P2|Randomized|Lack of Efficacy|1
181724|NCT00453349|627977|P1|Randomized|Lack of Efficacy|2
181725|NCT00453349|627976|P2|Randomized|Adverse Event|11
181726|NCT00453349|627977|P1|Randomized|Adverse Event|12
181727|NCT00453310|628008|P1|Overall Study|Progression of Disease|10
181728|NCT00453206|628012|P1|Overall Study|Death|1
181729|NCT00453180|628022|P2|Overall Study|Adverse Event|2
181730|NCT00453180|628023|P1|Overall Study|Adverse Event|1
181731|NCT00453180|628022|P2|Overall Study|Lost to Follow-up|1
181732|NCT00453180|628023|P1|Overall Study|Lost to Follow-up|2
181733|NCT00453154|628042|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
181734|NCT00453154|628043|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
181735|NCT00453154|628044|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
181736|NCT00453154|628045|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
181737|NCT00453154|628042|P4|Double BIind Maintenance|Medical Issues|1
181738|NCT00453154|628043|P3|Double BIind Maintenance|Medical Issues|3
181739|NCT00453154|628044|P2|Double BIind Maintenance|Medical Issues|0
181740|NCT00453154|628045|P1|Double BIind Maintenance|Medical Issues|0
181741|NCT00453154|628042|P4|Double BIind Maintenance|Progression|26
181742|NCT00453154|628043|P3|Double BIind Maintenance|Progression|29
181743|NCT00453154|628044|P2|Double BIind Maintenance|Progression|0
181744|NCT00453154|628045|P1|Double BIind Maintenance|Progression|0
181745|NCT00453154|628042|P4|Double BIind Maintenance|Withdrawal by Subject|4
181746|NCT00453154|628043|P3|Double BIind Maintenance|Withdrawal by Subject|4
181747|NCT00453154|628044|P2|Double BIind Maintenance|Withdrawal by Subject|0
181748|NCT00453154|628045|P1|Double BIind Maintenance|Withdrawal by Subject|0
181749|NCT00453154|628042|P4|Double BIind Maintenance|Death|1
181750|NCT00453154|628043|P3|Double BIind Maintenance|Death|2
181751|NCT00453154|628044|P2|Double BIind Maintenance|Death|0
181752|NCT00453154|628045|P1|Double BIind Maintenance|Death|0
181753|NCT00453154|628042|P4|Double BIind Maintenance|Adverse Event|12
181754|NCT00453154|628043|P3|Double BIind Maintenance|Adverse Event|3
181755|NCT00453154|628044|P2|Double BIind Maintenance|Adverse Event|0
181756|NCT00453154|628045|P1|Double BIind Maintenance|Adverse Event|0
181757|NCT00453102|628058|P1|Overall Study|Withdrawal by Subject|2
181758|NCT00453063|628069|P2|Overall Study|Protocol Violation|0
181759|NCT00453063|628070|P1|Overall Study|Protocol Violation|1
181760|NCT00453063|628069|P2|Overall Study|Withdrawal by Subject|1
181761|NCT00453063|628070|P1|Overall Study|Withdrawal by Subject|1
181762|NCT00453063|628069|P2|Overall Study|Adverse Event|2
181763|NCT00453063|628070|P1|Overall Study|Adverse Event|1
181764|NCT00452790|628090|P2|Toddler Dose|Parent/legal guardian request|1
181765|NCT00452790|628091|P1|Toddler Dose|Parent/legal guardian request|0
181766|NCT00452790|628090|P2|Toddler Dose|Failed to return|1
181767|NCT00452790|628091|P1|Toddler Dose|Failed to return|0
181768|NCT00452790|628090|P2|After Infant Series|Other reasons|0
181769|NCT00452790|628091|P1|After Infant Series|Other reasons|1
181770|NCT00452790|628090|P2|After Infant Series|Failed to return|0
181771|NCT00452790|628091|P1|After Infant Series|Failed to return|1
181772|NCT00452790|628090|P2|After Infant Series|Lost to Follow-up|0
181773|NCT00452790|628091|P1|After Infant Series|Lost to Follow-up|4
181774|NCT00452790|628090|P2|After Infant Series|Parent/legal guardian request|3
181775|NCT00452790|628091|P1|After Infant Series|Parent/legal guardian request|1
181776|NCT00452790|628090|P2|After Infant Series|Adverse Event|1
181777|NCT00452790|628091|P1|After Infant Series|Adverse Event|4
181778|NCT00452790|628090|P2|After Infant Series|Investigator request|10
181779|NCT00452790|628091|P1|After Infant Series|Investigator request|10
181780|NCT00452790|628090|P2|Infant Series|Death|1
181781|NCT00452790|628091|P1|Infant Series|Death|0
181782|NCT00452790|628090|P2|Infant Series|Investigator request|1
181783|NCT00452790|628091|P1|Infant Series|Investigator request|0
181784|NCT00452790|628090|P2|Infant Series|Other reasons|2
181785|NCT00452790|628091|P1|Infant Series|Other reasons|1
181786|NCT00452790|628090|P2|Infant Series|Adverse Event|2
181787|NCT00452790|628091|P1|Infant Series|Adverse Event|1
181788|NCT00452790|628090|P2|Infant Series|Lost to Follow-up|2
181789|NCT00452790|628091|P1|Infant Series|Lost to Follow-up|2
181790|NCT00452790|628090|P2|Infant Series|Protocol Violation|3
181791|NCT00452790|628091|P1|Infant Series|Protocol Violation|1
181792|NCT00452790|628090|P2|Infant Series|Failed to return|1
181793|NCT00452790|628091|P1|Infant Series|Failed to return|4
181794|NCT00452790|628090|P2|Infant Series|Parent/legal guardian request|6
181795|NCT00452790|628091|P1|Infant Series|Parent/legal guardian request|8
181796|NCT00452790|628090|P2|Infant Series|Clinical hold - consent withdrawn|123
181797|NCT00452790|628091|P1|Infant Series|Clinical hold - consent withdrawn|118
181798|NCT00452699|628127|P2|Overall Study|Other|7
181799|NCT00452699|628128|P1|Overall Study|Other|12
181800|NCT00452699|628127|P2|Overall Study|Withdrawal by Subject|25
181801|NCT00452699|628128|P1|Overall Study|Withdrawal by Subject|26
181802|NCT00452699|628127|P2|Overall Study|Protocol Violation|25
181803|NCT00452699|628128|P1|Overall Study|Protocol Violation|21
181804|NCT00452699|628127|P2|Overall Study|Lost to Follow-up|9
181805|NCT00452699|628128|P1|Overall Study|Lost to Follow-up|6
181806|NCT00452699|628127|P2|Overall Study|Lack of Efficacy|4
181807|NCT00452699|628128|P1|Overall Study|Lack of Efficacy|6
181808|NCT00452699|628127|P2|Overall Study|Adverse Event|3
181809|NCT00452699|628128|P1|Overall Study|Adverse Event|10
181810|NCT00452673|628144|P5|Dose Expansion Period|not specified|2
181811|NCT00452673|628145|P4|Dose Expansion Period|not specified|0
181812|NCT00452673|628146|P3|Dose Expansion Period|not specified|0
181813|NCT00452673|628147|P2|Dose Expansion Period|not specified|0
181814|NCT00452673|628148|P1|Dose Expansion Period|not specified|0
181815|NCT00452673|628144|P5|Dose Expansion Period|Disease Progression|19
181816|NCT00452673|628145|P4|Dose Expansion Period|Disease Progression|0
181817|NCT00452673|628146|P3|Dose Expansion Period|Disease Progression|0
181818|NCT00452673|628147|P2|Dose Expansion Period|Disease Progression|0
181819|NCT00452673|628148|P1|Dose Expansion Period|Disease Progression|0
181820|NCT00452673|628144|P5|Dose Escalation Period|Withdrawal by Subject|0
181821|NCT00452673|628145|P4|Dose Escalation Period|Withdrawal by Subject|1
181822|NCT00452673|628146|P3|Dose Escalation Period|Withdrawal by Subject|0
181823|NCT00452673|628147|P2|Dose Escalation Period|Withdrawal by Subject|0
181824|NCT00452673|628148|P1|Dose Escalation Period|Withdrawal by Subject|0
181825|NCT00452673|628144|P5|Dose Escalation Period|Adverse Event|0
181826|NCT00452673|628145|P4|Dose Escalation Period|Adverse Event|1
181827|NCT00452673|628146|P3|Dose Escalation Period|Adverse Event|0
181828|NCT00452673|628147|P2|Dose Escalation Period|Adverse Event|0
181829|NCT00452673|628148|P1|Dose Escalation Period|Adverse Event|0
181830|NCT00452673|628144|P5|Dose Escalation Period|not specified|0
181831|NCT00452673|628145|P4|Dose Escalation Period|not specified|0
181832|NCT00452673|628146|P3|Dose Escalation Period|not specified|1
181833|NCT00452673|628147|P2|Dose Escalation Period|not specified|0
181834|NCT00452673|628148|P1|Dose Escalation Period|not specified|0
181835|NCT00452673|628144|P5|Dose Escalation Period|study drug toxicity|0
181836|NCT00452673|628145|P4|Dose Escalation Period|study drug toxicity|1
181837|NCT00452673|628146|P3|Dose Escalation Period|study drug toxicity|3
181838|NCT00452673|628147|P2|Dose Escalation Period|study drug toxicity|3
181839|NCT00452673|628148|P1|Dose Escalation Period|study drug toxicity|1
181840|NCT00452673|628144|P5|Dose Escalation Period|Disease Progression|0
181841|NCT00452673|628145|P4|Dose Escalation Period|Disease Progression|6
181842|NCT00452673|628146|P3|Dose Escalation Period|Disease Progression|2
181843|NCT00452673|628147|P2|Dose Escalation Period|Disease Progression|6
181844|NCT00452673|628148|P1|Dose Escalation Period|Disease Progression|6
181845|NCT00452530|628195|P2|Overall Study|Not specified|11
181846|NCT00452530|628196|P1|Overall Study|Not specified|7
181847|NCT00452530|628195|P2|Overall Study|No longer met study criteria|22
181848|NCT00452530|628196|P1|Overall Study|No longer met study criteria|18
181849|NCT00452530|628195|P2|Overall Study|Poor compliance/noncompliance|2
181850|NCT00452530|628196|P1|Overall Study|Poor compliance/noncompliance|1
181851|NCT00452530|628195|P2|Overall Study|Lost to Follow-up|0
181852|NCT00452530|628196|P1|Overall Study|Lost to Follow-up|1
181853|NCT00452530|628195|P2|Overall Study|Withdrawal by Subject|57
181854|NCT00452530|628196|P1|Overall Study|Withdrawal by Subject|68
181855|NCT00452530|628195|P2|Overall Study|Adverse Event|44
181856|NCT00452530|628196|P1|Overall Study|Adverse Event|40
181857|NCT00452530|628195|P2|Overall Study|Death|0
181858|NCT00452530|628196|P1|Overall Study|Death|1
181859|NCT00452452|628217|P3|Overall Study|Lost to Follow-up|0
181860|NCT00452452|628218|P2|Overall Study|Lost to Follow-up|0
181861|NCT00452452|628219|P1|Overall Study|Lost to Follow-up|1
181862|NCT00452452|628217|P3|Overall Study|Withdrawal by Subject|0
181863|NCT00452452|628218|P2|Overall Study|Withdrawal by Subject|0
181864|NCT00452452|628219|P1|Overall Study|Withdrawal by Subject|1
181865|NCT00452452|628217|P3|Overall Study|Protocol Violation|1
181866|NCT00452452|628218|P2|Overall Study|Protocol Violation|0
181867|NCT00452452|628219|P1|Overall Study|Protocol Violation|0
181868|NCT00452400|628264|P5|Overall Study|Other reasons not listed above|1
181869|NCT00452400|628265|P4|Overall Study|Other reasons not listed above|1
181870|NCT00452400|628266|P3|Overall Study|Other reasons not listed above|0
181871|NCT00452400|628267|P2|Overall Study|Other reasons not listed above|0
181872|NCT00452400|628268|P1|Overall Study|Other reasons not listed above|0
181873|NCT00452400|628264|P5|Overall Study|Lack of Efficacy|0
181874|NCT00452400|628265|P4|Overall Study|Lack of Efficacy|0
181875|NCT00452400|628266|P3|Overall Study|Lack of Efficacy|0
181876|NCT00452400|628267|P2|Overall Study|Lack of Efficacy|0
181877|NCT00452400|628268|P1|Overall Study|Lack of Efficacy|2
181878|NCT00452400|628264|P5|Overall Study|Withdrawal by Subject|0
181879|NCT00452400|628265|P4|Overall Study|Withdrawal by Subject|0
181880|NCT00452400|628266|P3|Overall Study|Withdrawal by Subject|1
181881|NCT00452400|628267|P2|Overall Study|Withdrawal by Subject|0
181882|NCT00452400|628268|P1|Overall Study|Withdrawal by Subject|1
181883|NCT00452400|628264|P5|Overall Study|Lost to Follow-up|0
181884|NCT00452400|628265|P4|Overall Study|Lost to Follow-up|0
181885|NCT00452400|628266|P3|Overall Study|Lost to Follow-up|0
181886|NCT00452400|628267|P2|Overall Study|Lost to Follow-up|0
181887|NCT00452400|628268|P1|Overall Study|Lost to Follow-up|1
181888|NCT00452400|628264|P5|Overall Study|Protocol Violation|0
181889|NCT00452400|628265|P4|Overall Study|Protocol Violation|0
181890|NCT00452400|628266|P3|Overall Study|Protocol Violation|1
181891|NCT00452400|628267|P2|Overall Study|Protocol Violation|0
181892|NCT00452400|628268|P1|Overall Study|Protocol Violation|0
181893|NCT00452400|628264|P5|Overall Study|Adverse Event|2
181894|NCT00452400|628265|P4|Overall Study|Adverse Event|0
181895|NCT00452400|628266|P3|Overall Study|Adverse Event|5
181896|NCT00452400|628267|P2|Overall Study|Adverse Event|1
181897|NCT00452400|628268|P1|Overall Study|Adverse Event|1
181898|NCT00452361|628455|P2|Overall Study|Premature termination|9
181899|NCT00452361|628456|P1|Overall Study|Premature termination|13
181900|NCT00452361|628455|P2|Overall Study|Withdrawal by Subject|1
181901|NCT00452361|628456|P1|Overall Study|Withdrawal by Subject|0
181902|NCT00452361|628455|P2|Overall Study|Adverse Event|0
181903|NCT00452361|628456|P1|Overall Study|Adverse Event|8
181904|NCT00452348|628500|P2|Overall Study|Other|9
181905|NCT00452348|628501|P1|Overall Study|Other|9
181906|NCT00452348|628500|P2|Overall Study|Withdrawal by Subject|21
181907|NCT00452348|628501|P1|Overall Study|Withdrawal by Subject|18
181908|NCT00452348|628500|P2|Overall Study|Protocol Violation|28
181909|NCT00452348|628501|P1|Overall Study|Protocol Violation|22
181910|NCT00452348|628500|P2|Overall Study|Lost to Follow-up|8
181911|NCT00452348|628501|P1|Overall Study|Lost to Follow-up|14
181912|NCT00452348|628500|P2|Overall Study|Lack of Efficacy|9
181913|NCT00452348|628501|P1|Overall Study|Lack of Efficacy|10
181914|NCT00452348|628500|P2|Overall Study|Adverse Event|9
181915|NCT00452348|628501|P1|Overall Study|Adverse Event|6
181916|NCT00452114|628555|P2|Overall Study|Physician Decision|3
181917|NCT00452114|628556|P1|Overall Study|Physician Decision|3
181918|NCT00451958|628566|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
181919|NCT00451958|628567|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
181920|NCT00451958|628568|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
181921|NCT00451958|628569|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
181922|NCT00451958|628570|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
181923|NCT00451958|628566|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
181924|NCT00451958|628567|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
181925|NCT00451958|628568|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
181926|NCT00451958|628569|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
181927|NCT00451958|628570|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
181928|NCT00451958|628566|P5|CS21A (NCT00451958)|Physician Decision|0
181929|NCT00451958|628567|P4|CS21A (NCT00451958)|Physician Decision|4
181930|NCT00451958|628568|P3|CS21A (NCT00451958)|Physician Decision|4
181931|NCT00451958|628569|P2|CS21A (NCT00451958)|Physician Decision|4
181932|NCT00451958|628570|P1|CS21A (NCT00451958)|Physician Decision|2
181933|NCT00451958|628566|P5|CS21A (NCT00451958)|Protocol Violation|0
181934|NCT00451958|628567|P4|CS21A (NCT00451958)|Protocol Violation|0
181935|NCT00451958|628568|P3|CS21A (NCT00451958)|Protocol Violation|2
181936|NCT00451958|628569|P2|CS21A (NCT00451958)|Protocol Violation|3
181937|NCT00451958|628570|P1|CS21A (NCT00451958)|Protocol Violation|1
181938|NCT00451958|628566|P5|CS21A (NCT00451958)|Lost to Follow-up|0
181939|NCT00451958|628567|P4|CS21A (NCT00451958)|Lost to Follow-up|1
181940|NCT00451958|628568|P3|CS21A (NCT00451958)|Lost to Follow-up|1
181941|NCT00451958|628569|P2|CS21A (NCT00451958)|Lost to Follow-up|5
181942|NCT00451958|628570|P1|CS21A (NCT00451958)|Lost to Follow-up|6
181943|NCT00451958|628566|P5|CS21A (NCT00451958)|Adverse Event|0
181944|NCT00451958|628567|P4|CS21A (NCT00451958)|Adverse Event|17
181945|NCT00451958|628568|P3|CS21A (NCT00451958)|Adverse Event|14
181946|NCT00451958|628569|P2|CS21A (NCT00451958)|Adverse Event|34
181947|NCT00451958|628570|P1|CS21A (NCT00451958)|Adverse Event|21
181948|NCT00451906|628600|P1|Overall Study|Did not complete final visit|4
181949|NCT00451906|628600|P1|Overall Study|Other Reasons|121
181950|NCT00451906|628600|P1|Overall Study|Termination of the study|108
181951|NCT00451906|628600|P1|Overall Study|Progressive disease|1328
181952|NCT00451906|628600|P1|Overall Study|Protocol Violation|21
181953|NCT00451906|628600|P1|Overall Study|Withdrawal by Subject|111
181954|NCT00451906|628600|P1|Overall Study|Lost to Follow-up|31
181955|NCT00451906|628600|P1|Overall Study|Adverse Event|515
181956|NCT00451451|628623|P4|Overall Study|Other Reasons for Not Completing Study|14
181957|NCT00451451|628624|P3|Overall Study|Other Reasons for Not Completing Study|17
181958|NCT00451451|628625|P2|Overall Study|Other Reasons for Not Completing Study|30
181959|NCT00451451|628626|P1|Overall Study|Other Reasons for Not Completing Study|34
181960|NCT00451451|628623|P4|Overall Study|Death|1
181961|NCT00451451|628624|P3|Overall Study|Death|0
181962|NCT00451451|628625|P2|Overall Study|Death|0
181963|NCT00451451|628626|P1|Overall Study|Death|1
181964|NCT00451451|628623|P4|Overall Study|Subject Non-Compliance|3
181965|NCT00451451|628624|P3|Overall Study|Subject Non-Compliance|3
181966|NCT00451451|628625|P2|Overall Study|Subject Non-Compliance|4
181967|NCT00451451|628626|P1|Overall Study|Subject Non-Compliance|8
181968|NCT00451451|628623|P4|Overall Study|Investigator Decision|2
181969|NCT00451451|628624|P3|Overall Study|Investigator Decision|1
181970|NCT00451451|628625|P2|Overall Study|Investigator Decision|2
181971|NCT00451451|628626|P1|Overall Study|Investigator Decision|6
181972|NCT00451451|628623|P4|Overall Study|Consent Withdrawn|17
181973|NCT00451451|628624|P3|Overall Study|Consent Withdrawn|17
181974|NCT00451451|628625|P2|Overall Study|Consent Withdrawn|9
181975|NCT00451451|628626|P1|Overall Study|Consent Withdrawn|14
181976|NCT00451451|628623|P4|Overall Study|Lost to Follow-up|11
181977|NCT00451451|628624|P3|Overall Study|Lost to Follow-up|8
181978|NCT00451451|628625|P2|Overall Study|Lost to Follow-up|9
181979|NCT00451451|628626|P1|Overall Study|Lost to Follow-up|11
181980|NCT00451451|628623|P4|Overall Study|Adverse Event|10
181981|NCT00451451|628624|P3|Overall Study|Adverse Event|26
181982|NCT00451451|628625|P2|Overall Study|Adverse Event|21
181983|NCT00451451|628626|P1|Overall Study|Adverse Event|11
181984|NCT00451321|628661|P8|Overall Study|Sponsor decision to amend protocol|3
181985|NCT00451321|628662|P7|Overall Study|Sponsor decision to amend protocol|1
181986|NCT00451321|628663|P6|Overall Study|Sponsor decision to amend protocol|1
181987|NCT00451321|628664|P5|Overall Study|Sponsor decision to amend protocol|0
181988|NCT00451321|628665|P4|Overall Study|Sponsor decision to amend protocol|0
181989|NCT00451321|628666|P3|Overall Study|Sponsor decision to amend protocol|0
181990|NCT00451321|628667|P2|Overall Study|Sponsor decision to amend protocol|0
181991|NCT00451321|628668|P1|Overall Study|Sponsor decision to amend protocol|0
181992|NCT00451321|628661|P8|Overall Study|Study closed/terminated|3
181993|NCT00451321|628662|P7|Overall Study|Study closed/terminated|5
181994|NCT00451321|628663|P6|Overall Study|Study closed/terminated|7
181995|NCT00451321|628664|P5|Overall Study|Study closed/terminated|7
181996|NCT00451321|628665|P4|Overall Study|Study closed/terminated|5
181997|NCT00451321|628666|P3|Overall Study|Study closed/terminated|17
181998|NCT00451321|628667|P2|Overall Study|Study closed/terminated|1
181999|NCT00451321|628668|P1|Overall Study|Study closed/terminated|1
182000|NCT00451321|628661|P8|Overall Study|Withdrawal by Subject|0
182001|NCT00451321|628662|P7|Overall Study|Withdrawal by Subject|0
182002|NCT00451321|628663|P6|Overall Study|Withdrawal by Subject|0
182003|NCT00451321|628664|P5|Overall Study|Withdrawal by Subject|0
182004|NCT00451321|628665|P4|Overall Study|Withdrawal by Subject|4
182005|NCT00451321|628666|P3|Overall Study|Withdrawal by Subject|0
182006|NCT00451321|628667|P2|Overall Study|Withdrawal by Subject|1
182007|NCT00451321|628668|P1|Overall Study|Withdrawal by Subject|3
182008|NCT00451321|628661|P8|Overall Study|Lost to Follow-up|0
182009|NCT00451321|628662|P7|Overall Study|Lost to Follow-up|0
182010|NCT00451321|628663|P6|Overall Study|Lost to Follow-up|1
182011|NCT00451321|628664|P5|Overall Study|Lost to Follow-up|0
182012|NCT00451321|628665|P4|Overall Study|Lost to Follow-up|3
182013|NCT00451321|628666|P3|Overall Study|Lost to Follow-up|1
182014|NCT00451321|628667|P2|Overall Study|Lost to Follow-up|3
182015|NCT00451321|628668|P1|Overall Study|Lost to Follow-up|3
182016|NCT00451282|628840|P2|Overall Study|Lost to Follow-up|5
182017|NCT00451282|628841|P1|Overall Study|Lost to Follow-up|6
182018|NCT00451204|628855|P2|Overall Study|Other|2
182019|NCT00451204|628856|P1|Overall Study|Other|1
182020|NCT00451204|628855|P2|Overall Study|Patient refusal|4
182021|NCT00451204|628856|P1|Overall Study|Patient refusal|8
182022|NCT00451204|628855|P2|Overall Study|Protocol Violation|0
182023|NCT00451204|628856|P1|Overall Study|Protocol Violation|1
182024|NCT00451204|628855|P2|Overall Study|Lost to Follow-up|4
182025|NCT00451204|628856|P1|Overall Study|Lost to Follow-up|4
182026|NCT00451204|628855|P2|Overall Study|Lack of Efficacy|4
182027|NCT00451204|628856|P1|Overall Study|Lack of Efficacy|4
182028|NCT00451204|628855|P2|Overall Study|Adverse Event|6
182029|NCT00451204|628856|P1|Overall Study|Adverse Event|4
182030|NCT00451191|628874|P2|Overall Study|withdrawal or received alternate tx|11
182031|NCT00451191|628875|P1|Overall Study|withdrawal or received alternate tx|15
182032|NCT00450866|628897|P2|Overall Study|Physician Decision|0
182033|NCT00450866|628898|P1|Overall Study|Physician Decision|1
182034|NCT00450866|628897|P2|Overall Study|Death|0
182035|NCT00450866|628898|P1|Overall Study|Death|1
182036|NCT00450866|628897|P2|Overall Study|Withdrawal by Subject|2
182037|NCT00450866|628898|P1|Overall Study|Withdrawal by Subject|5
182038|NCT00450866|628897|P2|Overall Study|Adverse Event|1
182039|NCT00450866|628898|P1|Overall Study|Adverse Event|0
182040|NCT00450801|628908|P1|Overall Study|Death|1
182041|NCT00450749|628922|P3|Overall Study|Noncompliant|0
182042|NCT00450749|628923|P2|Overall Study|Noncompliant|1
182043|NCT00450749|628924|P1|Overall Study|Noncompliant|0
182044|NCT00450749|628922|P3|Overall Study|Withdrawal by Subject|2
182045|NCT00450749|628923|P2|Overall Study|Withdrawal by Subject|0
182046|NCT00450749|628924|P1|Overall Study|Withdrawal by Subject|0
182047|NCT00450723|628932|P1|Overall Study|Physician Decision|5
182048|NCT00450658|628940|P2|Overall Study|misc|10
182049|NCT00450658|628941|P1|Overall Study|misc|21
182050|NCT00450658|628940|P2|Overall Study|UGI ulcer|34
182051|NCT00450658|628941|P1|Overall Study|UGI ulcer|33
182052|NCT00450658|628940|P2|Overall Study|Lost to Follow-up|5
182053|NCT00450658|628941|P1|Overall Study|Lost to Follow-up|22
182054|NCT00450658|628940|P2|Overall Study|Withdrawal by Subject|26
182055|NCT00450658|628941|P1|Overall Study|Withdrawal by Subject|43
182056|NCT00450658|628940|P2|Overall Study|Adverse Event|15
182057|NCT00450658|628941|P1|Overall Study|Adverse Event|24
182058|NCT00450619|628955|P2|Overall Study|Adverse Event|0
182059|NCT00450619|628956|P1|Overall Study|Adverse Event|1
182060|NCT00450619|628955|P2|Overall Study|did not progress; refused further trmt|1
182061|NCT00450619|628956|P1|Overall Study|did not progress; refused further trmt|1
182062|NCT00450619|628955|P2|Overall Study|refused treatment after randomization|0
182063|NCT00450619|628956|P1|Overall Study|refused treatment after randomization|2
182064|NCT00450580|628982|P2|Overall Study|Withdrawal due to pregnancy|1
182065|NCT00450580|628983|P1|Overall Study|Withdrawal due to pregnancy|0
182066|NCT00450580|628982|P2|Overall Study|Patient could not swallow Norvir|0
182067|NCT00450580|628983|P1|Overall Study|Patient could not swallow Norvir|1
182068|NCT00450580|628982|P2|Overall Study|Patient went to Brazil|0
182069|NCT00450580|628983|P1|Overall Study|Patient went to Brazil|1
182070|NCT00450580|628982|P2|Overall Study|Could not comply with scheduled visits|0
182071|NCT00450580|628983|P1|Overall Study|Could not comply with scheduled visits|1
182072|NCT00450580|628982|P2|Overall Study|Protocol-defined virologic failure|0
182073|NCT00450580|628983|P1|Overall Study|Protocol-defined virologic failure|1
182074|NCT00450580|628982|P2|Overall Study|Protocol Violation|1
182075|NCT00450580|628983|P1|Overall Study|Protocol Violation|1
182076|NCT00450580|628982|P2|Overall Study|Withdrawal by Subject|2
182077|NCT00450580|628983|P1|Overall Study|Withdrawal by Subject|2
182078|NCT00450580|628982|P2|Overall Study|Lost to Follow-up|5
182079|NCT00450580|628983|P1|Overall Study|Lost to Follow-up|4
182080|NCT00450580|628982|P2|Overall Study|Adverse Event|7
182081|NCT00450580|628983|P1|Overall Study|Adverse Event|5
182082|NCT00450450|629003|P2|Overall Study|Missing Data|0
182083|NCT00450450|629004|P1|Overall Study|Missing Data|2
182084|NCT00450450|629003|P2|Overall Study|Relapse|0
182085|NCT00450450|629004|P1|Overall Study|Relapse|2
182086|NCT00450450|629003|P2|Overall Study|Death|3
182087|NCT00450450|629004|P1|Overall Study|Death|1
182088|NCT00450437|629028|P4|Overall Study|Unable to Classify|0
182089|NCT00450437|629029|P3|Overall Study|Unable to Classify|1
182090|NCT00450437|629030|P2|Overall Study|Unable to Classify|0
182091|NCT00450437|629031|P1|Overall Study|Unable to Classify|1
182092|NCT00450437|629028|P4|Overall Study|Administrative reason|0
182093|NCT00450437|629029|P3|Overall Study|Administrative reason|1
182094|NCT00450437|629030|P2|Overall Study|Administrative reason|0
182095|NCT00450437|629031|P1|Overall Study|Administrative reason|0
182096|NCT00450437|629028|P4|Overall Study|Inappropriate enrollment|0
182097|NCT00450437|629029|P3|Overall Study|Inappropriate enrollment|3
182098|NCT00450437|629030|P2|Overall Study|Inappropriate enrollment|1
182099|NCT00450437|629031|P1|Overall Study|Inappropriate enrollment|4
182100|NCT00450437|629028|P4|Overall Study|Protocol Violation|1
182101|NCT00450437|629029|P3|Overall Study|Protocol Violation|0
182102|NCT00450437|629030|P2|Overall Study|Protocol Violation|1
182103|NCT00450437|629031|P1|Overall Study|Protocol Violation|0
182104|NCT00450437|629028|P4|Overall Study|Lost to Follow-up|9
182105|NCT00450437|629029|P3|Overall Study|Lost to Follow-up|19
182106|NCT00450437|629030|P2|Overall Study|Lost to Follow-up|12
182107|NCT00450437|629031|P1|Overall Study|Lost to Follow-up|31
182108|NCT00450437|629028|P4|Overall Study|Withdrawal by Subject|1
182109|NCT00450437|629029|P3|Overall Study|Withdrawal by Subject|0
182110|NCT00450437|629030|P2|Overall Study|Withdrawal by Subject|2
182111|NCT00450437|629031|P1|Overall Study|Withdrawal by Subject|10
182112|NCT00450411|629062|P1|Overall Study|No protocol treatment|2
182113|NCT00450411|629062|P1|Overall Study|Protocol Violation|6
182114|NCT00450385|629067|P1|Overall Study|Other|3
182115|NCT00450385|629067|P1|Overall Study|Physician Decision|1
182116|NCT00450385|629067|P1|Overall Study|Adverse Event|1
182117|NCT00450385|629067|P1|Overall Study|Lack of Efficacy|2
182118|NCT00450385|629067|P1|Overall Study|Withdrawal by Subject|2
182119|NCT00450385|629067|P1|Overall Study|Protocol Violation|1
182120|NCT00450385|629067|P1|Overall Study|Death|3
182121|NCT00450372|629076|P1|Overall Study|Physician Decision|1
182122|NCT00450333|629089|P4|Overall Study|Death|2
182123|NCT00450333|629090|P3|Overall Study|Death|2
182124|NCT00450333|629091|P2|Overall Study|Death|2
182125|NCT00450333|629092|P1|Overall Study|Death|3
182126|NCT00450333|629089|P4|Overall Study|Kidney transplant|3
182127|NCT00450333|629090|P3|Overall Study|Kidney transplant|1
182128|NCT00450333|629091|P2|Overall Study|Kidney transplant|0
182129|NCT00450333|629092|P1|Overall Study|Kidney transplant|1
182130|NCT00450333|629089|P4|Overall Study|Withdrawal by Subject|0
182131|NCT00450333|629090|P3|Overall Study|Withdrawal by Subject|3
182132|NCT00450333|629091|P2|Overall Study|Withdrawal by Subject|0
182133|NCT00450333|629092|P1|Overall Study|Withdrawal by Subject|1
182134|NCT00450333|629089|P4|Overall Study|Protocol Violation|0
182135|NCT00450333|629090|P3|Overall Study|Protocol Violation|1
182136|NCT00450333|629091|P2|Overall Study|Protocol Violation|0
182137|NCT00450333|629092|P1|Overall Study|Protocol Violation|1
182138|NCT00450333|629089|P4|Overall Study|Adverse Event|2
182139|NCT00450333|629090|P3|Overall Study|Adverse Event|2
182140|NCT00450333|629091|P2|Overall Study|Adverse Event|7
182141|NCT00450333|629092|P1|Overall Study|Adverse Event|1
182142|NCT00450333|629089|P4|Overall Study|Study terminated|21
182143|NCT00450333|629090|P3|Overall Study|Study terminated|16
182144|NCT00450333|629091|P2|Overall Study|Study terminated|54
182145|NCT00450333|629092|P1|Overall Study|Study terminated|47
182146|NCT00450255|629115|P1|Overall Study|Prior RFA ablation of liver|1
182147|NCT00450216|629140|P2|Overall Study|misc|20
182148|NCT00450216|629141|P1|Overall Study|misc|21
182149|NCT00450216|629140|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
182150|NCT00450216|629141|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
182151|NCT00450216|629140|P2|Overall Study|Lost to Follow-up|9
182152|NCT00450216|629141|P1|Overall Study|Lost to Follow-up|16
182153|NCT00450216|629140|P2|Overall Study|Withdrawal by Subject|26
182154|NCT00450216|629141|P1|Overall Study|Withdrawal by Subject|48
182155|NCT00450216|629140|P2|Overall Study|Adverse Event|23
182156|NCT00450216|629141|P1|Overall Study|Adverse Event|38
182157|NCT00450112|629155|P2|Overall Study|Others|3
182158|NCT00450112|629156|P1|Overall Study|Others|2
182159|NCT00450112|629155|P2|Overall Study|Lost to Follow-up|1
182160|NCT00450112|629156|P1|Overall Study|Lost to Follow-up|2
182161|NCT00450112|629155|P2|Overall Study|Withdrawal by Subject|1
182162|NCT00450112|629156|P1|Overall Study|Withdrawal by Subject|4
182163|NCT00450112|629155|P2|Overall Study|Other Treatment Required|1
182164|NCT00450112|629156|P1|Overall Study|Other Treatment Required|5
182165|NCT00449956|629194|P3|Overall Study|Physician Decision|1
182166|NCT00449956|629195|P2|Overall Study|Physician Decision|1
182167|NCT00449956|629196|P1|Overall Study|Physician Decision|2
182168|NCT00449956|629194|P3|Overall Study|Withdrawal by Subject|0
182169|NCT00449956|629195|P2|Overall Study|Withdrawal by Subject|1
182170|NCT00449956|629196|P1|Overall Study|Withdrawal by Subject|0
182171|NCT00449956|629194|P3|Overall Study|Protocol Violation|1
182172|NCT00449956|629195|P2|Overall Study|Protocol Violation|1
182173|NCT00449956|629196|P1|Overall Study|Protocol Violation|1
182174|NCT00449956|629194|P3|Overall Study|Lack of Efficacy|1
182175|NCT00449956|629195|P2|Overall Study|Lack of Efficacy|0
182176|NCT00449956|629196|P1|Overall Study|Lack of Efficacy|0
182177|NCT00449956|629194|P3|Overall Study|Adverse Event|6
182178|NCT00449956|629195|P2|Overall Study|Adverse Event|1
182179|NCT00449956|629196|P1|Overall Study|Adverse Event|7
182180|NCT00449930|629212|P2|Overall Study|Glycemic discontinuation criteria|1
182181|NCT00449930|629213|P1|Overall Study|Glycemic discontinuation criteria|1
182182|NCT00449930|629212|P2|Overall Study|Withdrawal by Subject|23
182183|NCT00449930|629213|P1|Overall Study|Withdrawal by Subject|16
182184|NCT00449930|629212|P2|Overall Study|Protocol Violation|15
182185|NCT00449930|629213|P1|Overall Study|Protocol Violation|14
182186|NCT00449930|629212|P2|Overall Study|Physician Decision|2
182187|NCT00449930|629213|P1|Overall Study|Physician Decision|1
182188|NCT00449930|629212|P2|Overall Study|Lost to Follow-up|14
182189|NCT00449930|629213|P1|Overall Study|Lost to Follow-up|9
182190|NCT00449930|629212|P2|Overall Study|Lack of Efficacy|1
182191|NCT00449930|629213|P1|Overall Study|Lack of Efficacy|10
182192|NCT00449930|629212|P2|Overall Study|Trial Terminated ( Site Closed)|0
182193|NCT00449930|629213|P1|Overall Study|Trial Terminated ( Site Closed)|1
182194|NCT00449930|629212|P2|Overall Study|Adverse Event|19
182195|NCT00449930|629213|P1|Overall Study|Adverse Event|9
182196|NCT00449865|629229|P2|Overall Study|Study was stopped|328
182197|NCT00449865|629230|P1|Overall Study|Study was stopped|324
182198|NCT00449865|629229|P2|Overall Study|Protocol Violation|7
182199|NCT00449865|629230|P1|Overall Study|Protocol Violation|8
182200|NCT00449865|629229|P2|Overall Study|Death|40
182201|NCT00449865|629230|P1|Overall Study|Death|31
182202|NCT00449865|629229|P2|Overall Study|Physician Decision|12
182203|NCT00449865|629230|P1|Overall Study|Physician Decision|13
182204|NCT00449865|629229|P2|Overall Study|Lost to Follow-up|37
182205|NCT00449865|629230|P1|Overall Study|Lost to Follow-up|36
182206|NCT00449865|629229|P2|Overall Study|Withdrawal by Subject|110
182207|NCT00449865|629230|P1|Overall Study|Withdrawal by Subject|110
182208|NCT00449787|629238|P2|Overall Study|Did not require medication|92
182209|NCT00449787|629239|P1|Overall Study|Did not require medication|95
182210|NCT00449787|629238|P2|Overall Study|Lost to Follow-up|8
182211|NCT00449787|629239|P1|Overall Study|Lost to Follow-up|10
182212|NCT00449696|629255|P2|Overall Study|Others|0
182213|NCT00449696|629256|P1|Overall Study|Others|7
182214|NCT00449696|629255|P2|Overall Study|Lost to Follow-up|3
182215|NCT00449696|629256|P1|Overall Study|Lost to Follow-up|2
182216|NCT00449696|629255|P2|Overall Study|Withdrawal by Subject|5
182217|NCT00449696|629256|P1|Overall Study|Withdrawal by Subject|5
182218|NCT00449696|629255|P2|Overall Study|Other Treatment Required|1
182219|NCT00449696|629256|P1|Overall Study|Other Treatment Required|6
182220|NCT00449644|629282|P4|Overall Study|Rolled-over to treatment with TMC207|1
182221|NCT00449644|629283|P3|Overall Study|Rolled-over to treatment with TMC207|0
182222|NCT00449644|629284|P2|Overall Study|Rolled-over to treatment with TMC207|0
182223|NCT00449644|629285|P1|Overall Study|Rolled-over to treatment with TMC207|0
182224|NCT00449644|629282|P4|Overall Study|Not specified|0
182225|NCT00449644|629283|P3|Overall Study|Not specified|1
182226|NCT00449644|629284|P2|Overall Study|Not specified|4
182227|NCT00449644|629285|P1|Overall Study|Not specified|1
182228|NCT00449644|629282|P4|Overall Study|Inclusion/exclusion criteria not met|6
182229|NCT00449644|629283|P3|Overall Study|Inclusion/exclusion criteria not met|2
182230|NCT00449644|629284|P2|Overall Study|Inclusion/exclusion criteria not met|0
182231|NCT00449644|629285|P1|Overall Study|Inclusion/exclusion criteria not met|0
182232|NCT00449644|629282|P4|Overall Study|Withdrawal by Subject|7
182233|NCT00449644|629283|P3|Overall Study|Withdrawal by Subject|6
182234|NCT00449644|629284|P2|Overall Study|Withdrawal by Subject|4
182235|NCT00449644|629285|P1|Overall Study|Withdrawal by Subject|3
182236|NCT00449644|629282|P4|Overall Study|Protocol Violation|7
182237|NCT00449644|629283|P3|Overall Study|Protocol Violation|3
182238|NCT00449644|629284|P2|Overall Study|Protocol Violation|4
182239|NCT00449644|629285|P1|Overall Study|Protocol Violation|4
182240|NCT00449644|629282|P4|Overall Study|Pregnancy|2
182241|NCT00449644|629283|P3|Overall Study|Pregnancy|3
182242|NCT00449644|629284|P2|Overall Study|Pregnancy|0
182243|NCT00449644|629285|P1|Overall Study|Pregnancy|0
182244|NCT00449644|629282|P4|Overall Study|Lost to Follow-up|3
182245|NCT00449644|629283|P3|Overall Study|Lost to Follow-up|5
182246|NCT00449644|629284|P2|Overall Study|Lost to Follow-up|1
182247|NCT00449644|629285|P1|Overall Study|Lost to Follow-up|1
182248|NCT00449644|629282|P4|Overall Study|Death|1
182249|NCT00449644|629283|P3|Overall Study|Death|6
182250|NCT00449644|629284|P2|Overall Study|Death|0
182251|NCT00449644|629285|P1|Overall Study|Death|1
182252|NCT00449644|629282|P4|Overall Study|Adverse Event|5
182253|NCT00449644|629283|P3|Overall Study|Adverse Event|3
182254|NCT00449644|629284|P2|Overall Study|Adverse Event|0
182255|NCT00449644|629285|P1|Overall Study|Adverse Event|0
182256|NCT00449540|629305|P3|Treatment Phase|did not experience or treat migraine|17
182257|NCT00449540|629306|P2|Treatment Phase|did not experience or treat migraine|20
182258|NCT00449540|629307|P1|Treatment Phase|did not experience or treat migraine|0
182259|NCT00449540|629305|P3|Pretreatment Phase|No migraine experienced|0
182260|NCT00449540|629306|P2|Pretreatment Phase|No migraine experienced|0
182261|NCT00449540|629307|P1|Pretreatment Phase|No migraine experienced|66
182262|NCT00449176|629324|P3|Overall Study|all other|20
182263|NCT00449176|629325|P2|Overall Study|all other|19
182264|NCT00449176|629326|P1|Overall Study|all other|22
182265|NCT00449176|629324|P3|Overall Study|Study drug non-compliant|11
182266|NCT00449176|629325|P2|Overall Study|Study drug non-compliant|11
182267|NCT00449176|629326|P1|Overall Study|Study drug non-compliant|14
182268|NCT00449176|629324|P3|Overall Study|Lack of Efficacy|50
182269|NCT00449176|629325|P2|Overall Study|Lack of Efficacy|7
182270|NCT00449176|629326|P1|Overall Study|Lack of Efficacy|13
182271|NCT00449176|629324|P3|Overall Study|Adverse Event|15
182272|NCT00449176|629325|P2|Overall Study|Adverse Event|107
182273|NCT00449176|629326|P1|Overall Study|Adverse Event|51
182274|NCT00449176|629324|P3|Overall Study|Lost to Follow-up|12
182275|NCT00449176|629325|P2|Overall Study|Lost to Follow-up|8
182276|NCT00449176|629326|P1|Overall Study|Lost to Follow-up|13
182277|NCT00449176|629324|P3|Overall Study|Withdrawal by Subject|59
182278|NCT00449176|629325|P2|Overall Study|Withdrawal by Subject|43
182279|NCT00449176|629326|P1|Overall Study|Withdrawal by Subject|39
182280|NCT00449163|629352|P1|Overall Study|Physician Decision|3
182281|NCT00449150|629362|P3|Overall Study|Protocol Violation|1
182282|NCT00449150|629363|P2|Overall Study|Protocol Violation|2
182283|NCT00449150|629364|P1|Overall Study|Protocol Violation|1
182284|NCT00449150|629362|P3|Overall Study|Withdrawal by Subject|21
182285|NCT00449150|629363|P2|Overall Study|Withdrawal by Subject|18
182286|NCT00449150|629364|P1|Overall Study|Withdrawal by Subject|17
182287|NCT00449150|629362|P3|Overall Study|Not specified|14
182288|NCT00449150|629363|P2|Overall Study|Not specified|13
182289|NCT00449150|629364|P1|Overall Study|Not specified|16
182290|NCT00449150|629362|P3|Overall Study|Lack of Efficacy|2
182291|NCT00449150|629363|P2|Overall Study|Lack of Efficacy|2
182292|NCT00449150|629364|P1|Overall Study|Lack of Efficacy|1
182293|NCT00449150|629362|P3|Overall Study|Adverse Event|9
182294|NCT00449150|629363|P2|Overall Study|Adverse Event|18
182295|NCT00449150|629364|P1|Overall Study|Adverse Event|11
182296|NCT00449072|629374|P2|Overall Study|Relocation|2
182297|NCT00449072|629375|P1|Overall Study|Relocation|3
182298|NCT00449072|629374|P2|Overall Study|Sponsor decision|3
182299|NCT00449072|629375|P1|Overall Study|Sponsor decision|1
182300|NCT00449072|629374|P2|Overall Study|Non-compliance|5
182301|NCT00449072|629375|P1|Overall Study|Non-compliance|2
182302|NCT00449072|629374|P2|Overall Study|Excluded medication|2
182303|NCT00449072|629375|P1|Overall Study|Excluded medication|0
182304|NCT00449072|629374|P2|Overall Study|Not treated|1
182305|NCT00449072|629375|P1|Overall Study|Not treated|0
182306|NCT00449072|629374|P2|Overall Study|Physician Decision|0
182307|NCT00449072|629375|P1|Overall Study|Physician Decision|1
182308|NCT00449072|629374|P2|Overall Study|Lack of Efficacy|1
182309|NCT00449072|629375|P1|Overall Study|Lack of Efficacy|1
182310|NCT00449072|629374|P2|Overall Study|Withdrawal by Subject|8
182311|NCT00449072|629375|P1|Overall Study|Withdrawal by Subject|11
182312|NCT00449072|629374|P2|Overall Study|Lost to Follow-up|7
182313|NCT00449072|629375|P1|Overall Study|Lost to Follow-up|5
182314|NCT00449072|629374|P2|Overall Study|Protocol Violation|12
182315|NCT00449072|629375|P1|Overall Study|Protocol Violation|14
182316|NCT00449072|629374|P2|Overall Study|Adverse Event|1
182317|NCT00449072|629375|P1|Overall Study|Adverse Event|3
182318|NCT00449033|629412|P2|Follow-up Period|Reason Missing|113
182319|NCT00449033|629413|P1|Follow-up Period|Reason Missing|120
182320|NCT00449033|629412|P2|Follow-up Period|Lost to Follow-up|10
182321|NCT00449033|629413|P1|Follow-up Period|Lost to Follow-up|6
182322|NCT00449033|629412|P2|Follow-up Period|Death|311
182323|NCT00449033|629413|P1|Follow-up Period|Death|299
182324|NCT00449033|629412|P2|Treatment Period|Treatment Ongoing|4
182325|NCT00449033|629413|P1|Treatment Period|Treatment Ongoing|6
182326|NCT00449033|629412|P2|Treatment Period|Reason Missing|4
182327|NCT00449033|629413|P1|Treatment Period|Reason Missing|0
182328|NCT00449033|629412|P2|Treatment Period|Second Malignancy|1
182329|NCT00449033|629413|P1|Treatment Period|Second Malignancy|0
182330|NCT00449033|629412|P2|Treatment Period|Non-compliance|8
182331|NCT00449033|629413|P1|Treatment Period|Non-compliance|7
182332|NCT00449033|629412|P2|Treatment Period|Amended Protocol Criteria|18
182333|NCT00449033|629413|P1|Treatment Period|Amended Protocol Criteria|22
182334|NCT00449033|629412|P2|Treatment Period|Consent Withdrawn|20
182335|NCT00449033|629413|P1|Treatment Period|Consent Withdrawn|36
182336|NCT00449033|629412|P2|Treatment Period|Disease Progression|288
182337|NCT00449033|629413|P1|Treatment Period|Disease Progression|231
182338|NCT00449033|629412|P2|Treatment Period|Protocol Violation|7
182339|NCT00449033|629413|P1|Treatment Period|Protocol Violation|8
182340|NCT00449033|629412|P2|Treatment Period|Physician Decision|5
182341|NCT00449033|629413|P1|Treatment Period|Physician Decision|4
182342|NCT00449033|629412|P2|Treatment Period|Lost to Follow-up|2
182343|NCT00449033|629413|P1|Treatment Period|Lost to Follow-up|0
182344|NCT00449033|629412|P2|Treatment Period|Death|12
182345|NCT00449033|629413|P1|Treatment Period|Death|21
182346|NCT00449033|629412|P2|Treatment Period|Adverse Event|83
182347|NCT00449033|629413|P1|Treatment Period|Adverse Event|117
182348|NCT00448916|629451|P4|Overall Study|Protocol Violation|1
182349|NCT00448916|629452|P3|Overall Study|Protocol Violation|0
182350|NCT00448916|629453|P2|Overall Study|Protocol Violation|0
182351|NCT00448916|629454|P1|Overall Study|Protocol Violation|0
182352|NCT00448916|629451|P4|Overall Study|Lost to Follow-up|1
182353|NCT00448916|629452|P3|Overall Study|Lost to Follow-up|0
182354|NCT00448916|629453|P2|Overall Study|Lost to Follow-up|1
182355|NCT00448916|629454|P1|Overall Study|Lost to Follow-up|0
182356|NCT00448916|629451|P4|Overall Study|Not specified|0
182357|NCT00448916|629452|P3|Overall Study|Not specified|0
182358|NCT00448916|629453|P2|Overall Study|Not specified|0
182359|NCT00448916|629454|P1|Overall Study|Not specified|1
182360|NCT00448916|629451|P4|Overall Study|Withdrawal by Subject|1
182361|NCT00448916|629452|P3|Overall Study|Withdrawal by Subject|1
182362|NCT00448916|629453|P2|Overall Study|Withdrawal by Subject|3
182363|NCT00448916|629454|P1|Overall Study|Withdrawal by Subject|3
182364|NCT00448916|629451|P4|Overall Study|Lack of Efficacy|1
182365|NCT00448916|629452|P3|Overall Study|Lack of Efficacy|2
182366|NCT00448916|629453|P2|Overall Study|Lack of Efficacy|0
182367|NCT00448916|629454|P1|Overall Study|Lack of Efficacy|1
182368|NCT00448916|629451|P4|Overall Study|Adverse Event|2
182369|NCT00448916|629452|P3|Overall Study|Adverse Event|3
182370|NCT00448916|629453|P2|Overall Study|Adverse Event|2
182371|NCT00448916|629454|P1|Overall Study|Adverse Event|2
182372|NCT00448864|629528|P3|Overall Study|Protocol Violation|0
182373|NCT00448864|629529|P2|Overall Study|Protocol Violation|2
182374|NCT00448864|629530|P1|Overall Study|Protocol Violation|0
182375|NCT00448864|629528|P3|Overall Study|Withdrawal by Subject|0
182376|NCT00448864|629529|P2|Overall Study|Withdrawal by Subject|2
182377|NCT00448864|629530|P1|Overall Study|Withdrawal by Subject|0
182378|NCT00448864|629528|P3|Overall Study|Physician Decision|1
182379|NCT00448864|629529|P2|Overall Study|Physician Decision|0
182380|NCT00448864|629530|P1|Overall Study|Physician Decision|1
182381|NCT00448864|629528|P3|Overall Study|Lost to Follow-up|0
182382|NCT00448864|629529|P2|Overall Study|Lost to Follow-up|1
182383|NCT00448864|629530|P1|Overall Study|Lost to Follow-up|3
182384|NCT00448864|629528|P3|Overall Study|Death|0
182385|NCT00448864|629529|P2|Overall Study|Death|0
182386|NCT00448864|629530|P1|Overall Study|Death|1
182387|NCT00448760|629546|P1|Overall Study|Death|3
182388|NCT00448708|629555|P2|Overall Study|not listed|2
182389|NCT00448708|629556|P1|Overall Study|not listed|0
182390|NCT00448708|629555|P2|Overall Study|Lost to Follow-up|8
182391|NCT00448708|629556|P1|Overall Study|Lost to Follow-up|6
182392|NCT00448708|629555|P2|Overall Study|Withdrawal by Subject|4
182393|NCT00448708|629556|P1|Overall Study|Withdrawal by Subject|8
182394|NCT00448708|629555|P2|Overall Study|Death|17
182395|NCT00448708|629556|P1|Overall Study|Death|21
182396|NCT00448591|629615|P1|Overall Study|Termination of Study|70
182397|NCT00448591|629615|P1|Overall Study|Not specified|154
182398|NCT00448591|629615|P1|Overall Study|Treatment Regimen Completed|70
182399|NCT00448591|629615|P1|Overall Study|Lost to Follow-up|19
182400|NCT00448591|629615|P1|Overall Study|Protocol Violation|41
182401|NCT00448591|629615|P1|Overall Study|Adverse Event|382
182402|NCT00448591|629615|P1|Overall Study|Progressive Disease|1382
182403|NCT00448591|629615|P1|Overall Study|Withdrawal by Subject|178
182404|NCT00448539|629626|P2|Overall Study|Lost to Follow-up|3
182405|NCT00448539|629627|P1|Overall Study|Lost to Follow-up|1
182406|NCT00448539|629626|P2|Overall Study|Change of meds|3
182407|NCT00448539|629627|P1|Overall Study|Change of meds|2
182408|NCT00448539|629626|P2|Overall Study|Miscellaneous|1
182409|NCT00448539|629627|P1|Overall Study|Miscellaneous|2
182410|NCT00448539|629626|P2|Overall Study|Lack of Efficacy|40
182411|NCT00448539|629627|P1|Overall Study|Lack of Efficacy|27
182412|NCT00448539|629626|P2|Overall Study|Adverse Event|26
182413|NCT00448539|629627|P1|Overall Study|Adverse Event|9
182414|NCT00448539|629626|P2|Overall Study|Diary non-compliance|0
182415|NCT00448539|629627|P1|Overall Study|Diary non-compliance|1
182416|NCT00448539|629626|P2|Overall Study|Withdrawal by Subject|24
182417|NCT00448539|629627|P1|Overall Study|Withdrawal by Subject|20
182418|NCT00448539|629626|P2|Overall Study|Request of the investigator or sponsor|54
182419|NCT00448539|629627|P1|Overall Study|Request of the investigator or sponsor|67
182420|NCT00448539|629626|P2|Overall Study|Protocol Violation|0
182421|NCT00448539|629627|P1|Overall Study|Protocol Violation|1
182422|NCT00448539|629626|P2|Overall Study|Medication non-compliance|1
182423|NCT00448539|629627|P1|Overall Study|Medication non-compliance|4
182424|NCT00448448|629635|P2|Overall Study|Signed consent lost|1
182425|NCT00448448|629636|P1|Overall Study|Signed consent lost|0
182426|NCT00448448|629635|P2|Overall Study|Wrong diagnosis (n=3) or other|1
182427|NCT00448448|629636|P1|Overall Study|Wrong diagnosis (n=3) or other|2
182428|NCT00448448|629635|P2|Overall Study|Lost to Follow-up|1
182429|NCT00448448|629636|P1|Overall Study|Lost to Follow-up|2
182430|NCT00448448|629635|P2|Overall Study|On protocol when study ended|36
182431|NCT00448448|629636|P1|Overall Study|On protocol when study ended|83
182432|NCT00448448|629635|P2|Overall Study|Withdrawal by Subject|2
182433|NCT00448448|629636|P1|Overall Study|Withdrawal by Subject|13
182434|NCT00448435|629642|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
182435|NCT00448435|629643|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
182436|NCT00448344|629694|P2|Overall Study|Physician Decision|2
182437|NCT00448344|629695|P1|Overall Study|Physician Decision|1
182438|NCT00448344|629694|P2|Overall Study|Death|4
182439|NCT00448344|629695|P1|Overall Study|Death|3
182440|NCT00448344|629694|P2|Overall Study|Withdrawal by Subject|8
182441|NCT00448344|629695|P1|Overall Study|Withdrawal by Subject|6
182442|NCT00448344|629694|P2|Overall Study|Lost to Follow-up|22
182443|NCT00448344|629695|P1|Overall Study|Lost to Follow-up|20
182444|NCT00448279|629705|P2|Overall Study|Protocol Violation|1
182445|NCT00448279|629706|P1|Overall Study|Protocol Violation|0
182446|NCT00448279|629705|P2|Overall Study|Not specified|4
182447|NCT00448279|629706|P1|Overall Study|Not specified|6
182448|NCT00448279|629705|P2|Overall Study|Withdrawal by Subject|3
182449|NCT00448279|629706|P1|Overall Study|Withdrawal by Subject|4
182450|NCT00448279|629705|P2|Overall Study|Disease progression|18
182451|NCT00448279|629706|P1|Overall Study|Disease progression|16
182452|NCT00448279|629705|P2|Overall Study|Adverse Event|1
182453|NCT00448279|629706|P1|Overall Study|Adverse Event|1
182454|NCT00448279|629705|P2|Overall Study|Lost to Follow-up|2
182455|NCT00448279|629706|P1|Overall Study|Lost to Follow-up|2
182456|NCT00448136|629769|P2|Overall Study|Investigator's decision (progression)|0
182457|NCT00448136|629770|P1|Overall Study|Investigator's decision (progression)|1
182458|NCT00448136|629769|P2|Overall Study|Death|8
182459|NCT00448136|629770|P1|Overall Study|Death|3
182460|NCT00448123|629808|P2|Overall Study|Physician Decision|6
182461|NCT00448123|629809|P1|Overall Study|Physician Decision|6
182462|NCT00448123|629808|P2|Overall Study|Lost to Follow-up|6
182463|NCT00448123|629809|P1|Overall Study|Lost to Follow-up|9
182464|NCT00448019|629819|P1|Overall Study|Insurance Issues|1
182465|NCT00448019|629819|P1|Overall Study|Death|2
182466|NCT00448019|629819|P1|Overall Study|Disease progression|1
182467|NCT00448019|629819|P1|Overall Study|Withdrawal by Subject|3
182468|NCT00447902|629827|P2|Overall Study|Lack of Efficacy|1
182469|NCT00447902|629828|P1|Overall Study|Lack of Efficacy|2
182470|NCT00447902|629827|P2|Overall Study|included patients who discontinued|1
182471|NCT00447902|629828|P1|Overall Study|included patients who discontinued|1
182472|NCT00447902|629827|P2|Overall Study|Withdrawal by Subject|1
182473|NCT00447902|629828|P1|Overall Study|Withdrawal by Subject|0
182474|NCT00447902|629827|P2|Overall Study|Protocol Violation|0
182475|NCT00447902|629828|P1|Overall Study|Protocol Violation|1
182476|NCT00447902|629827|P2|Overall Study|Adverse Event|3
182477|NCT00447902|629828|P1|Overall Study|Adverse Event|0
182478|NCT00447876|629870|P2|Overall Study|Deterioration of symptomology|0
182479|NCT00447876|629871|P1|Overall Study|Deterioration of symptomology|1
182480|NCT00447876|629870|P2|Overall Study|Lost to Follow-up|0
182481|NCT00447876|629871|P1|Overall Study|Lost to Follow-up|1
182482|NCT00447876|629870|P2|Overall Study|Withdrawal by Subject|4
182483|NCT00447876|629871|P1|Overall Study|Withdrawal by Subject|1
182484|NCT00447603|629901|P3|Filter Period|Study terminated by Sponsor|10
182485|NCT00447603|629902|P2|Filter Period|Study terminated by Sponsor|1
182486|NCT00447603|629903|P1|Filter Period|Study terminated by Sponsor|0
182487|NCT00447603|629901|P3|Filter Period|Screen Failure|4
182488|NCT00447603|629902|P2|Filter Period|Screen Failure|3
182489|NCT00447603|629903|P1|Filter Period|Screen Failure|0
182490|NCT00447603|629901|P3|Filter Period|Adverse Event|1
182491|NCT00447603|629902|P2|Filter Period|Adverse Event|0
182492|NCT00447603|629903|P1|Filter Period|Adverse Event|0
182493|NCT00447603|629901|P3|Screening|Study Terminated by Sponsor|0
182494|NCT00447603|629902|P2|Screening|Study Terminated by Sponsor|0
182495|NCT00447603|629903|P1|Screening|Study Terminated by Sponsor|15
182496|NCT00447603|629901|P3|Screening|Screen Failure|0
182497|NCT00447603|629902|P2|Screening|Screen Failure|0
182498|NCT00447603|629903|P1|Screening|Screen Failure|4
182499|NCT00447603|629901|P3|Screening|Protocol Violation|0
182500|NCT00447603|629902|P2|Screening|Protocol Violation|0
182501|NCT00447603|629903|P1|Screening|Protocol Violation|1
182502|NCT00447603|629901|P3|Screening|Withdrawal by Subject|0
182503|NCT00447603|629902|P2|Screening|Withdrawal by Subject|0
182504|NCT00447603|629903|P1|Screening|Withdrawal by Subject|1
182505|NCT00447590|629923|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
182506|NCT00447590|629923|P1|Overall Study|Lost to Follow-up|24
182507|NCT00447590|629923|P1|Overall Study|Withdrawal by Subject|26
182508|NCT00447499|629932|P1|Overall Study|Physician Decision|1
182509|NCT00447499|629932|P1|Overall Study|Sponsor Decision|1
182510|NCT00447499|629932|P1|Overall Study|Patient Decision|4
182511|NCT00447499|629932|P1|Overall Study|Adverse Event|1
182512|NCT00447421|629942|P1|Overall Study|Sponsor Decision|2
182513|NCT00447421|629942|P1|Overall Study|Adverse Event|3
182514|NCT00447421|629942|P1|Overall Study|Lack of Efficacy|1
182515|NCT00447382|629954|P2|Overall Study|Unclassified|5
182516|NCT00447382|629955|P1|Overall Study|Unclassified|2
182517|NCT00447382|629954|P2|Overall Study|Protocol Violation|0
182518|NCT00447382|629955|P1|Overall Study|Protocol Violation|2
182519|NCT00447382|629954|P2|Overall Study|Lack of Efficacy|0
182520|NCT00447382|629955|P1|Overall Study|Lack of Efficacy|1
182521|NCT00447382|629954|P2|Overall Study|Adverse Event|1
182522|NCT00447382|629955|P1|Overall Study|Adverse Event|1
182523|NCT00447278|630016|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
182524|NCT00447278|630017|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
182525|NCT00447278|630016|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
182526|NCT00447278|630017|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
182527|NCT00447278|630016|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
182528|NCT00447278|630017|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
182529|NCT00447278|630016|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
182530|NCT00447278|630017|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
182531|NCT00447278|630016|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
182532|NCT00447278|630017|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
182533|NCT00447278|630016|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
182534|NCT00447278|630017|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
182535|NCT00447278|630016|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
182536|NCT00447278|630017|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
182537|NCT00447278|630016|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
182538|NCT00447278|630017|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
182539|NCT00447278|630016|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
182540|NCT00447278|630017|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
182541|NCT00447278|630016|P2|Period II (6 Month Open-Label)|Physician Decision|1
182542|NCT00447278|630017|P1|Period II (6 Month Open-Label)|Physician Decision|4
182543|NCT00447278|630016|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
182544|NCT00447278|630017|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
182545|NCT00447278|630016|P2|Period II (6 Month Open-Label)|Protocol Violation|7
182546|NCT00447278|630017|P1|Period II (6 Month Open-Label)|Protocol Violation|10
182547|NCT00447278|630016|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
182548|NCT00447278|630017|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
182549|NCT00447278|630016|P2|Period II (6 Month Open-Label)|Adverse Event|3
182550|NCT00447278|630017|P1|Period II (6 Month Open-Label)|Adverse Event|7
182551|NCT00447265|630038|P2|Overall Study|Physician Decision|0
182552|NCT00447265|630039|P1|Overall Study|Physician Decision|1
182553|NCT00447226|630052|P2|Double-blind Phase|Disease Progression|3
182554|NCT00447226|630053|P1|Double-blind Phase|Disease Progression|4
182555|NCT00447226|630052|P2|12-Week Open-label Phase|Physician Decision|1
182556|NCT00447226|630053|P1|12-Week Open-label Phase|Physician Decision|0
182557|NCT00447226|630052|P2|12-Week Open-label Phase|Disease Progression|20
182558|NCT00447226|630053|P1|12-Week Open-label Phase|Disease Progression|0
182559|NCT00447226|630052|P2|12-Week Open-label Phase|Protocol Violation|1
182560|NCT00447226|630053|P1|12-Week Open-label Phase|Protocol Violation|0
182561|NCT00447226|630052|P2|12-Week Open-label Phase|Adverse Event|3
182562|NCT00447226|630053|P1|12-Week Open-label Phase|Adverse Event|0
182563|NCT00447057|630079|P4|Overall Study|Death, study drug related|0
182564|NCT00447057|630080|P3|Overall Study|Death, study drug related|0
182565|NCT00447057|630081|P2|Overall Study|Death, study drug related|1
182566|NCT00447057|630082|P1|Overall Study|Death, study drug related|0
182567|NCT00447057|630079|P4|Overall Study|Death due to adverse event|2
182568|NCT00447057|630080|P3|Overall Study|Death due to adverse event|1
182569|NCT00447057|630081|P2|Overall Study|Death due to adverse event|0
182570|NCT00447057|630082|P1|Overall Study|Death due to adverse event|0
182571|NCT00447057|630079|P4|Overall Study|Progressive disease|18
182572|NCT00447057|630080|P3|Overall Study|Progressive disease|13
182573|NCT00447057|630081|P2|Overall Study|Progressive disease|43
182574|NCT00447057|630082|P1|Overall Study|Progressive disease|58
182575|NCT00447057|630079|P4|Overall Study|Sponsor decision|0
182576|NCT00447057|630080|P3|Overall Study|Sponsor decision|0
182577|NCT00447057|630081|P2|Overall Study|Sponsor decision|1
182578|NCT00447057|630082|P1|Overall Study|Sponsor decision|1
182579|NCT00447057|630079|P4|Overall Study|Physician Decision|1
182580|NCT00447057|630080|P3|Overall Study|Physician Decision|3
182581|NCT00447057|630081|P2|Overall Study|Physician Decision|6
182582|NCT00447057|630082|P1|Overall Study|Physician Decision|9
182583|NCT00447057|630079|P4|Overall Study|Withdrawal by Subject|1
182584|NCT00447057|630080|P3|Overall Study|Withdrawal by Subject|1
182585|NCT00447057|630081|P2|Overall Study|Withdrawal by Subject|5
182586|NCT00447057|630082|P1|Overall Study|Withdrawal by Subject|4
182587|NCT00447057|630079|P4|Overall Study|Protocol Violation|0
182588|NCT00447057|630080|P3|Overall Study|Protocol Violation|0
182589|NCT00447057|630081|P2|Overall Study|Protocol Violation|1
182590|NCT00447057|630082|P1|Overall Study|Protocol Violation|0
182591|NCT00447057|630079|P4|Overall Study|Entry criteria not met|0
182592|NCT00447057|630080|P3|Overall Study|Entry criteria not met|0
182593|NCT00447057|630081|P2|Overall Study|Entry criteria not met|1
182594|NCT00447057|630082|P1|Overall Study|Entry criteria not met|1
182595|NCT00447057|630079|P4|Overall Study|Lost to Follow-up|0
182596|NCT00447057|630080|P3|Overall Study|Lost to Follow-up|0
182597|NCT00447057|630081|P2|Overall Study|Lost to Follow-up|1
182598|NCT00447057|630082|P1|Overall Study|Lost to Follow-up|0
182599|NCT00447057|630079|P4|Overall Study|Death due to study disease|1
182600|NCT00447057|630080|P3|Overall Study|Death due to study disease|1
182601|NCT00447057|630081|P2|Overall Study|Death due to study disease|4
182602|NCT00447057|630082|P1|Overall Study|Death due to study disease|6
182603|NCT00447057|630079|P4|Overall Study|Adverse Event|3
182604|NCT00447057|630080|P3|Overall Study|Adverse Event|0
182605|NCT00447057|630081|P2|Overall Study|Adverse Event|10
182606|NCT00447057|630082|P1|Overall Study|Adverse Event|4
182607|NCT00447005|630100|P1|Overall Study|Lack of Efficacy|11
182608|NCT00447005|630100|P1|Overall Study|Adverse Event|1
182609|NCT00446992|630114|P1|Overall Study|Lost to Follow-up|5
182610|NCT00446992|630114|P1|Overall Study|Adverse Event|11
182611|NCT00446849|630126|P1|Maintenance Phase|concomitant medication use|1
182612|NCT00446849|630126|P1|Maintenance Phase|hydrocodone use|1
182613|NCT00446849|630126|P1|Maintenance Phase|study closure|1
182614|NCT00446849|630126|P1|Maintenance Phase|antibiotic use|1
182615|NCT00446849|630126|P1|Maintenance Phase|prohibited medication use|2
182616|NCT00446849|630126|P1|Maintenance Phase|noncompliance|2
182617|NCT00446849|630126|P1|Maintenance Phase|Pregnancy|1
182618|NCT00446849|630126|P1|Maintenance Phase|Lost to Follow-up|3
182619|NCT00446849|630126|P1|Maintenance Phase|Consent withdrawn|5
182620|NCT00446849|630126|P1|Maintenance Phase|Adverse Event|6
182621|NCT00446849|630126|P1|Maintenance Phase|Protocol Violation|7
182622|NCT00446849|630126|P1|Maintenance Phase|Lack of Efficacy|40
182623|NCT00446849|630126|P1|Acute Phase|noncompliance|1
182624|NCT00446849|630126|P1|Acute Phase|Physician Decision|1
182625|NCT00446849|630126|P1|Acute Phase|Lost to Follow-up|2
182626|NCT00446849|630126|P1|Acute Phase|Consent withdrawn|4
182627|NCT00446849|630126|P1|Acute Phase|Protocol Violation|10
182628|NCT00446849|630126|P1|Acute Phase|Lack of Efficacy|64
182629|NCT00446797|630138|P2|Overall Study|did not meet entrance criteria|1
182630|NCT00446797|630139|P1|Overall Study|did not meet entrance criteria|0
182631|NCT00446797|630138|P2|Overall Study|subject entered at another site|1
182632|NCT00446797|630139|P1|Overall Study|subject entered at another site|0
182633|NCT00446797|630138|P2|Overall Study|Protocol Violation|3
182634|NCT00446797|630139|P1|Overall Study|Protocol Violation|1
182635|NCT00446797|630138|P2|Overall Study|Withdrawal by Subject|2
182636|NCT00446797|630139|P1|Overall Study|Withdrawal by Subject|2
182637|NCT00446797|630138|P2|Overall Study|Lost to Follow-up|3
182638|NCT00446797|630139|P1|Overall Study|Lost to Follow-up|5
182639|NCT00446797|630138|P2|Overall Study|Lack of Efficacy|2
182640|NCT00446797|630139|P1|Overall Study|Lack of Efficacy|0
182641|NCT00446654|630185|P2|Overall Study|Adverse Event|0
182642|NCT00446654|630186|P1|Overall Study|Adverse Event|1
182643|NCT00446654|630185|P2|Overall Study|Withdrawal by Subject|0
182644|NCT00446654|630186|P1|Overall Study|Withdrawal by Subject|1
182645|NCT00446641|630194|P2|Overall Study|Lost to Follow-up|1
182646|NCT00446641|630195|P1|Overall Study|Lost to Follow-up|1
182647|NCT00446641|630194|P2|Overall Study|poor compliance|6
182648|NCT00446641|630195|P1|Overall Study|poor compliance|8
182649|NCT00446641|630194|P2|Overall Study|Withdrawal by Subject|3
182650|NCT00446641|630195|P1|Overall Study|Withdrawal by Subject|8
182651|NCT00446563|630215|P2|Overall Study|Administrative problems|1
182652|NCT00446563|630216|P1|Overall Study|Administrative problems|0
182653|NCT00446563|630215|P2|Overall Study|Withdrawal by Subject|1
182654|NCT00446563|630216|P1|Overall Study|Withdrawal by Subject|2
182655|NCT00446563|630215|P2|Overall Study|Unsatisfactory therapeutic effect|3
182656|NCT00446563|630216|P1|Overall Study|Unsatisfactory therapeutic effect|0
182744|NCT00446134|630420|P3|Overall Study|Reason Not Completed|1
182657|NCT00446563|630215|P2|Overall Study|Abnormal test procedure result(s)|0
182658|NCT00446563|630216|P1|Overall Study|Abnormal test procedure result(s)|1
182659|NCT00446563|630215|P2|Overall Study|Abnormal laboratory value(s)|1
182660|NCT00446563|630216|P1|Overall Study|Abnormal laboratory value(s)|0
182661|NCT00446563|630215|P2|Overall Study|Adverse Event|3
182662|NCT00446563|630216|P1|Overall Study|Adverse Event|4
182663|NCT00446511|630254|P4|Overall Study|Administrative Problems|1
182664|NCT00446511|630255|P3|Overall Study|Administrative Problems|4
182665|NCT00446511|630256|P2|Overall Study|Administrative Problems|0
182666|NCT00446511|630257|P1|Overall Study|Administrative Problems|3
182667|NCT00446511|630254|P4|Overall Study|Withdrawal by Subject|3
182668|NCT00446511|630255|P3|Overall Study|Withdrawal by Subject|0
182669|NCT00446511|630256|P2|Overall Study|Withdrawal by Subject|0
182670|NCT00446511|630257|P1|Overall Study|Withdrawal by Subject|0
182671|NCT00446511|630254|P4|Overall Study|Protocol Violation|1
182672|NCT00446511|630255|P3|Overall Study|Protocol Violation|0
182673|NCT00446511|630256|P2|Overall Study|Protocol Violation|0
182674|NCT00446511|630257|P1|Overall Study|Protocol Violation|0
182675|NCT00446511|630254|P4|Overall Study|Adverse Event|1
182676|NCT00446511|630255|P3|Overall Study|Adverse Event|3
182677|NCT00446511|630256|P2|Overall Study|Adverse Event|2
182678|NCT00446511|630257|P1|Overall Study|Adverse Event|7
182679|NCT00446459|630281|P1|12 Months|14 subjects to MMF + Rituximab Study|14
182680|NCT00446459|630281|P1|12 Months|Protocol Violation|4
182681|NCT00446459|630281|P1|8 Months|Protocol Violation|12
182682|NCT00446446|630289|P1|Overall Study|On Treatment at Time of Data Cut-off|1
182683|NCT00446446|630289|P1|Overall Study|Adverse Event|1
182684|NCT00446446|630289|P1|Overall Study|Disease Progession|2
182685|NCT00446446|630289|P1|Overall Study|Other|4
182686|NCT00446446|630289|P1|Overall Study|Withdrawal by Subject|6
182687|NCT00446446|630289|P1|Overall Study|Death|10
182688|NCT00446251|630313|P1|Overall Study|Lost to Follow-up|1
182689|NCT00446251|630313|P1|Overall Study|Rituximab Infusion Reaction|2
182690|NCT00446251|630313|P1|Overall Study|On-study Transplants|2
182691|NCT00446199|630323|P4|Overall Study|Move|0
182692|NCT00446199|630324|P3|Overall Study|Move|0
182693|NCT00446199|630325|P2|Overall Study|Move|1
182694|NCT00446199|630326|P1|Overall Study|Move|0
182695|NCT00446199|630323|P4|Overall Study|In-/Exclusion criterion violated|1
182696|NCT00446199|630324|P3|Overall Study|In-/Exclusion criterion violated|2
182697|NCT00446199|630325|P2|Overall Study|In-/Exclusion criterion violated|1
182698|NCT00446199|630326|P1|Overall Study|In-/Exclusion criterion violated|2
182699|NCT00446199|630323|P4|Overall Study|Lost interest in study participation|0
182700|NCT00446199|630324|P3|Overall Study|Lost interest in study participation|0
182701|NCT00446199|630325|P2|Overall Study|Lost interest in study participation|1
182702|NCT00446199|630326|P1|Overall Study|Lost interest in study participation|0
182703|NCT00446199|630323|P4|Overall Study|Hormone fear|1
182704|NCT00446199|630324|P3|Overall Study|Hormone fear|0
182705|NCT00446199|630325|P2|Overall Study|Hormone fear|0
182706|NCT00446199|630326|P1|Overall Study|Hormone fear|0
182707|NCT00446199|630323|P4|Overall Study|Non-compliant with visit schedule|2
182708|NCT00446199|630324|P3|Overall Study|Non-compliant with visit schedule|1
182709|NCT00446199|630325|P2|Overall Study|Non-compliant with visit schedule|1
182710|NCT00446199|630326|P1|Overall Study|Non-compliant with visit schedule|1
182711|NCT00446199|630323|P4|Overall Study|Non-compliant with study drug|0
182712|NCT00446199|630324|P3|Overall Study|Non-compliant with study drug|5
182713|NCT00446199|630325|P2|Overall Study|Non-compliant with study drug|0
182714|NCT00446199|630326|P1|Overall Study|Non-compliant with study drug|1
182715|NCT00446199|630323|P4|Overall Study|Lack of Efficacy|1
182716|NCT00446199|630324|P3|Overall Study|Lack of Efficacy|0
182717|NCT00446199|630325|P2|Overall Study|Lack of Efficacy|0
182718|NCT00446199|630326|P1|Overall Study|Lack of Efficacy|1
182719|NCT00446199|630323|P4|Overall Study|Randomization in Error|1
182720|NCT00446199|630324|P3|Overall Study|Randomization in Error|1
182721|NCT00446199|630325|P2|Overall Study|Randomization in Error|0
182722|NCT00446199|630326|P1|Overall Study|Randomization in Error|2
182723|NCT00446199|630323|P4|Overall Study|Site termination|1
182724|NCT00446199|630324|P3|Overall Study|Site termination|0
182725|NCT00446199|630325|P2|Overall Study|Site termination|0
182726|NCT00446199|630326|P1|Overall Study|Site termination|2
182727|NCT00446199|630323|P4|Overall Study|Withdrawal by Subject|10
182728|NCT00446199|630324|P3|Overall Study|Withdrawal by Subject|9
182729|NCT00446199|630325|P2|Overall Study|Withdrawal by Subject|5
182730|NCT00446199|630326|P1|Overall Study|Withdrawal by Subject|2
182731|NCT00446199|630323|P4|Overall Study|Protocol Violation|3
182732|NCT00446199|630324|P3|Overall Study|Protocol Violation|1
182733|NCT00446199|630325|P2|Overall Study|Protocol Violation|2
182734|NCT00446199|630326|P1|Overall Study|Protocol Violation|1
182735|NCT00446199|630323|P4|Overall Study|Lost to Follow-up|6
182736|NCT00446199|630324|P3|Overall Study|Lost to Follow-up|2
182737|NCT00446199|630325|P2|Overall Study|Lost to Follow-up|5
182738|NCT00446199|630326|P1|Overall Study|Lost to Follow-up|4
182739|NCT00446199|630323|P4|Overall Study|Adverse Event|4
182740|NCT00446199|630324|P3|Overall Study|Adverse Event|6
182741|NCT00446199|630325|P2|Overall Study|Adverse Event|4
182742|NCT00446199|630326|P1|Overall Study|Adverse Event|7
182743|NCT00446134|630419|P4|Overall Study|Reason Not Completed|2
182745|NCT00446134|630421|P2|Overall Study|Reason Not Completed|0
182746|NCT00446134|630422|P1|Overall Study|Reason Not Completed|3
182747|NCT00446134|630419|P4|Overall Study|Adverse Event-Diarrhea|0
182748|NCT00446134|630420|P3|Overall Study|Adverse Event-Diarrhea|2
182749|NCT00446134|630421|P2|Overall Study|Adverse Event-Diarrhea|1
182750|NCT00446134|630422|P1|Overall Study|Adverse Event-Diarrhea|1
182751|NCT00446134|630419|P4|Overall Study|Physician Decision|2
182752|NCT00446134|630420|P3|Overall Study|Physician Decision|0
182753|NCT00446134|630421|P2|Overall Study|Physician Decision|0
182754|NCT00446134|630422|P1|Overall Study|Physician Decision|0
182755|NCT00446134|630419|P4|Overall Study|Withdrawal by Subject|3
182756|NCT00446134|630420|P3|Overall Study|Withdrawal by Subject|1
182757|NCT00446134|630421|P2|Overall Study|Withdrawal by Subject|3
182758|NCT00446134|630422|P1|Overall Study|Withdrawal by Subject|3
182759|NCT00446134|630419|P4|Overall Study|Lost to Follow-up|1
182760|NCT00446134|630420|P3|Overall Study|Lost to Follow-up|1
182761|NCT00446134|630421|P2|Overall Study|Lost to Follow-up|3
182762|NCT00446134|630422|P1|Overall Study|Lost to Follow-up|1
182763|NCT00446134|630419|P4|Overall Study|Protocol Violation|0
182764|NCT00446134|630420|P3|Overall Study|Protocol Violation|1
182765|NCT00446134|630421|P2|Overall Study|Protocol Violation|2
182766|NCT00446134|630422|P1|Overall Study|Protocol Violation|0
182767|NCT00446134|630419|P4|Overall Study|Lack of Efficacy|19
182768|NCT00446134|630420|P3|Overall Study|Lack of Efficacy|24
182769|NCT00446134|630421|P2|Overall Study|Lack of Efficacy|19
182770|NCT00446134|630422|P1|Overall Study|Lack of Efficacy|19
182771|NCT00446134|630419|P4|Overall Study|Adverse Event|18
182772|NCT00446134|630420|P3|Overall Study|Adverse Event|13
182773|NCT00446134|630421|P2|Overall Study|Adverse Event|17
182774|NCT00446134|630422|P1|Overall Study|Adverse Event|7
182775|NCT00446095|630449|P5|Phase I (28 Days)|Lack of Efficacy|3
182776|NCT00446095|630450|P4|Phase I (28 Days)|Lack of Efficacy|0
182777|NCT00446095|630451|P3|Phase I (28 Days)|Lack of Efficacy|0
182778|NCT00446095|630452|P2|Phase I (28 Days)|Lack of Efficacy|0
182779|NCT00446095|630453|P1|Phase I (28 Days)|Lack of Efficacy|0
182780|NCT00446095|630449|P5|Phase I (28 Days)|Adverse Event|0
182781|NCT00446095|630450|P4|Phase I (28 Days)|Adverse Event|1
182782|NCT00446095|630451|P3|Phase I (28 Days)|Adverse Event|0
182783|NCT00446095|630452|P2|Phase I (28 Days)|Adverse Event|0
182784|NCT00446095|630453|P1|Phase I (28 Days)|Adverse Event|0
182785|NCT00446095|630449|P5|Phase II (8 Weeks)|Ongoing|0
182786|NCT00446095|630450|P4|Phase II (8 Weeks)|Ongoing|0
182787|NCT00446095|630451|P3|Phase II (8 Weeks)|Ongoing|1
182788|NCT00446095|630452|P2|Phase II (8 Weeks)|Ongoing|0
182789|NCT00446095|630453|P1|Phase II (8 Weeks)|Ongoing|0
182790|NCT00446095|630449|P5|Phase II (8 Weeks)|Lack of Efficacy|0
182791|NCT00446095|630450|P4|Phase II (8 Weeks)|Lack of Efficacy|0
182792|NCT00446095|630451|P3|Phase II (8 Weeks)|Lack of Efficacy|1
182793|NCT00446095|630452|P2|Phase II (8 Weeks)|Lack of Efficacy|2
182794|NCT00446095|630453|P1|Phase II (8 Weeks)|Lack of Efficacy|9
182795|NCT00446095|630449|P5|Phase II (8 Weeks)|Physician Decision|0
182796|NCT00446095|630450|P4|Phase II (8 Weeks)|Physician Decision|0
182797|NCT00446095|630451|P3|Phase II (8 Weeks)|Physician Decision|0
182798|NCT00446095|630452|P2|Phase II (8 Weeks)|Physician Decision|0
182799|NCT00446095|630453|P1|Phase II (8 Weeks)|Physician Decision|1
182800|NCT00446095|630449|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
182801|NCT00446095|630450|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
182802|NCT00446095|630451|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
182803|NCT00446095|630452|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
182804|NCT00446095|630453|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
182805|NCT00446095|630449|P5|Phase II (8 Weeks)|Adverse Event|0
182806|NCT00446095|630450|P4|Phase II (8 Weeks)|Adverse Event|0
182807|NCT00446095|630451|P3|Phase II (8 Weeks)|Adverse Event|1
182808|NCT00446095|630452|P2|Phase II (8 Weeks)|Adverse Event|1
182809|NCT00446095|630453|P1|Phase II (8 Weeks)|Adverse Event|0
182810|NCT00446095|630449|P5|Phase II (8 Weeks)|Lost to Follow-up|0
182811|NCT00446095|630450|P4|Phase II (8 Weeks)|Lost to Follow-up|0
182812|NCT00446095|630451|P3|Phase II (8 Weeks)|Lost to Follow-up|0
182813|NCT00446095|630452|P2|Phase II (8 Weeks)|Lost to Follow-up|0
182814|NCT00446095|630453|P1|Phase II (8 Weeks)|Lost to Follow-up|1
182815|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
182816|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
182817|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
182818|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
182819|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
182820|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
182821|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
182822|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
182823|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
182824|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
182825|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
182826|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
182827|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
182828|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
182829|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Death|2
182830|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Death|2
182831|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
182832|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
182833|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
182834|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
182835|NCT00446030|630476|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
182836|NCT00446030|630477|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
182837|NCT00446030|630476|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
182838|NCT00446030|630477|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
182839|NCT00446030|630476|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
182840|NCT00446030|630477|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
182841|NCT00446030|630476|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
182842|NCT00446030|630477|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
182843|NCT00446030|630476|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
182844|NCT00446030|630477|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
182845|NCT00446030|630476|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
182846|NCT00446030|630477|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
182847|NCT00446030|630476|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
182848|NCT00446030|630477|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
182849|NCT00446030|630476|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
182850|NCT00446030|630477|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
182851|NCT00446030|630476|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
182852|NCT00446030|630477|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
182853|NCT00445939|630488|P4|Period B - Week 4 - Week 8|Adverse Event|1
182854|NCT00445939|630489|P3|Period B - Week 4 - Week 8|Adverse Event|0
182855|NCT00445939|630490|P2|Period B - Week 4 - Week 8|Adverse Event|0
182856|NCT00445939|630491|P1|Period B - Week 4 - Week 8|Adverse Event|2
182857|NCT00445939|630488|P4|Period A - Week 0 - Week 4|Adverse Event|0
182858|NCT00445939|630489|P3|Period A - Week 0 - Week 4|Adverse Event|0
182859|NCT00445939|630490|P2|Period A - Week 0 - Week 4|Adverse Event|2
182860|NCT00445939|630491|P1|Period A - Week 0 - Week 4|Adverse Event|1
182861|NCT00445848|630539|P1|Overall Study|Other-Not protocol specified|5
182862|NCT00445848|630539|P1|Overall Study|Progression|62
182863|NCT00445848|630539|P1|Overall Study|Withdrawal by Subject|4
182864|NCT00445848|630539|P1|Overall Study|Adverse Event|14
182865|NCT00445770|630549|P3|Overall Study|Not specified|6
182866|NCT00445770|630550|P2|Overall Study|Not specified|5
182867|NCT00445770|630551|P1|Overall Study|Not specified|6
182868|NCT00445770|630549|P3|Overall Study|Lost to Follow-up|0
182869|NCT00445770|630550|P2|Overall Study|Lost to Follow-up|2
182870|NCT00445770|630551|P1|Overall Study|Lost to Follow-up|0
182871|NCT00445770|630549|P3|Overall Study|Lack of Efficacy|6
182872|NCT00445770|630550|P2|Overall Study|Lack of Efficacy|13
182873|NCT00445770|630551|P1|Overall Study|Lack of Efficacy|38
182874|NCT00445770|630549|P3|Overall Study|Adverse Event|19
182875|NCT00445770|630550|P2|Overall Study|Adverse Event|15
182876|NCT00445770|630551|P1|Overall Study|Adverse Event|9
182877|NCT00445692|630652|P1|Overall Study|Lack of Efficacy|5
182878|NCT00445692|630652|P1|Overall Study|Adverse Event|11
182879|NCT00445679|630662|P4|Overall Study|Lack of Efficacy|0
182880|NCT00445679|630663|P3|Overall Study|Lack of Efficacy|2
182881|NCT00445679|630664|P2|Overall Study|Lack of Efficacy|6
182882|NCT00445679|630665|P1|Overall Study|Lack of Efficacy|2
182883|NCT00445679|630662|P4|Overall Study|Withdrawal by Subject|18
182884|NCT00445679|630663|P3|Overall Study|Withdrawal by Subject|20
182885|NCT00445679|630664|P2|Overall Study|Withdrawal by Subject|14
182886|NCT00445679|630665|P1|Overall Study|Withdrawal by Subject|8
182887|NCT00445679|630662|P4|Overall Study|Protocol Violation|1
182888|NCT00445679|630663|P3|Overall Study|Protocol Violation|3
182889|NCT00445679|630664|P2|Overall Study|Protocol Violation|3
182890|NCT00445679|630665|P1|Overall Study|Protocol Violation|2
182891|NCT00445679|630662|P4|Overall Study|Withdrawal of Informed Consent|0
182892|NCT00445679|630663|P3|Overall Study|Withdrawal of Informed Consent|1
182893|NCT00445679|630664|P2|Overall Study|Withdrawal of Informed Consent|0
182894|NCT00445679|630665|P1|Overall Study|Withdrawal of Informed Consent|0
182895|NCT00445679|630662|P4|Overall Study|Compliance|2
182896|NCT00445679|630663|P3|Overall Study|Compliance|1
182897|NCT00445679|630664|P2|Overall Study|Compliance|2
182898|NCT00445679|630665|P1|Overall Study|Compliance|3
182899|NCT00445679|630662|P4|Overall Study|Lost to Follow-up|5
182900|NCT00445679|630663|P3|Overall Study|Lost to Follow-up|6
182901|NCT00445679|630664|P2|Overall Study|Lost to Follow-up|6
182902|NCT00445679|630665|P1|Overall Study|Lost to Follow-up|10
182903|NCT00445679|630662|P4|Overall Study|Physician Decision|0
182904|NCT00445679|630663|P3|Overall Study|Physician Decision|1
182905|NCT00445679|630664|P2|Overall Study|Physician Decision|0
182906|NCT00445679|630665|P1|Overall Study|Physician Decision|0
182907|NCT00445679|630662|P4|Overall Study|Failed to return|2
182908|NCT00445679|630663|P3|Overall Study|Failed to return|2
182909|NCT00445679|630664|P2|Overall Study|Failed to return|3
182910|NCT00445679|630665|P1|Overall Study|Failed to return|1
182911|NCT00445679|630662|P4|Overall Study|Adverse Event|19
182912|NCT00445679|630663|P3|Overall Study|Adverse Event|30
182913|NCT00445679|630664|P2|Overall Study|Adverse Event|12
182914|NCT00445679|630665|P1|Overall Study|Adverse Event|22
182915|NCT00445601|630701|P2|Overall Study|Death prior to TURBT|1
182916|NCT00445601|630702|P1|Overall Study|Death prior to TURBT|0
182917|NCT00445601|630701|P2|Overall Study|Adverse Event|0
182918|NCT00445601|630702|P1|Overall Study|Adverse Event|2
182919|NCT00445601|630701|P2|Overall Study|Drug Delivery Issue|2
182920|NCT00445601|630702|P1|Overall Study|Drug Delivery Issue|2
182921|NCT00445601|630701|P2|Overall Study|Incorrect Disease Status|6
182922|NCT00445601|630702|P1|Overall Study|Incorrect Disease Status|6
182923|NCT00445601|630701|P2|Overall Study|TURBT Complication|8
182924|NCT00445601|630702|P1|Overall Study|TURBT Complication|12
182925|NCT00445601|630701|P2|Overall Study|Withdrawal by Subject|11
182926|NCT00445601|630702|P1|Overall Study|Withdrawal by Subject|11
182927|NCT00445549|630719|P1|Overall Study|progressive disease|12
182928|NCT00445458|630743|P4|Overall Study|Surgery|0
182929|NCT00445458|630744|P3|Overall Study|Surgery|1
182930|NCT00445458|630745|P2|Overall Study|Surgery|0
182931|NCT00445458|630746|P1|Overall Study|Surgery|0
182932|NCT00445458|630743|P4|Overall Study|Physician Decision|1
182933|NCT00445458|630744|P3|Overall Study|Physician Decision|1
182934|NCT00445458|630745|P2|Overall Study|Physician Decision|0
182935|NCT00445458|630746|P1|Overall Study|Physician Decision|0
182936|NCT00445458|630743|P4|Overall Study|Death|0
182937|NCT00445458|630744|P3|Overall Study|Death|2
182938|NCT00445458|630745|P2|Overall Study|Death|1
182939|NCT00445458|630746|P1|Overall Study|Death|0
182940|NCT00445458|630743|P4|Overall Study|Adverse Event|0
182941|NCT00445458|630744|P3|Overall Study|Adverse Event|3
182942|NCT00445458|630745|P2|Overall Study|Adverse Event|0
182943|NCT00445458|630746|P1|Overall Study|Adverse Event|0
182944|NCT00445458|630743|P4|Overall Study|Withdrawal by Subject|0
182945|NCT00445458|630744|P3|Overall Study|Withdrawal by Subject|7
182946|NCT00445458|630745|P2|Overall Study|Withdrawal by Subject|0
182947|NCT00445458|630746|P1|Overall Study|Withdrawal by Subject|0
182948|NCT00445458|630743|P4|Overall Study|Disease Progression|27
182949|NCT00445458|630744|P3|Overall Study|Disease Progression|54
182950|NCT00445458|630745|P2|Overall Study|Disease Progression|4
182951|NCT00445458|630746|P1|Overall Study|Disease Progression|3
182952|NCT00445432|630764|P4|148 Weeks of Adalimumab Treatment|Not specified|9
182953|NCT00445432|630765|P3|148 Weeks of Adalimumab Treatment|Not specified|0
182954|NCT00445432|630766|P2|148 Weeks of Adalimumab Treatment|Not specified|0
182955|NCT00445432|630767|P1|148 Weeks of Adalimumab Treatment|Not specified|0
182956|NCT00445432|630764|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
182957|NCT00445432|630765|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
182958|NCT00445432|630766|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
182959|NCT00445432|630767|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
182960|NCT00445432|630764|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
182961|NCT00445432|630765|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
182962|NCT00445432|630766|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
182963|NCT00445432|630767|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
182964|NCT00445432|630764|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
182965|NCT00445432|630765|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
182966|NCT00445432|630766|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
182967|NCT00445432|630767|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
182968|NCT00445432|630764|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
182969|NCT00445432|630765|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
182970|NCT00445432|630766|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
182971|NCT00445432|630767|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
182972|NCT00445432|630764|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
182973|NCT00445432|630765|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
182974|NCT00445432|630766|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
182975|NCT00445432|630767|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
182976|NCT00445432|630764|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
182977|NCT00445432|630765|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
182978|NCT00445432|630766|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
182979|NCT00445432|630767|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
182980|NCT00445341|630800|P1|Overall Study|taken off treatment too early|1
182981|NCT00445341|630800|P1|Overall Study|refused further treatment|1
182982|NCT00445328|630807|P2|Overall Study|Protocol Violation|0
182983|NCT00445328|630808|P1|Overall Study|Protocol Violation|1
182984|NCT00445328|630807|P2|Overall Study|Withdrawal by Subject|0
182985|NCT00445328|630808|P1|Overall Study|Withdrawal by Subject|2
182986|NCT00445328|630807|P2|Overall Study|Other|2
182987|NCT00445328|630808|P1|Overall Study|Other|0
182988|NCT00445328|630807|P2|Overall Study|Adverse Event|3
182989|NCT00445328|630808|P1|Overall Study|Adverse Event|0
182990|NCT00445328|630807|P2|Overall Study|Death|1
182991|NCT00445328|630808|P1|Overall Study|Death|0
182992|NCT00445224|630969|P2|Specific Exercises|Withdrawal by Subject|0
182993|NCT00445224|630970|P1|Specific Exercises|Withdrawal by Subject|1
182994|NCT00445224|630969|P2|Specific Exercises|Withdrawal by Subject|3
182995|NCT00445224|630970|P1|Specific Exercises|Withdrawal by Subject|3
182996|NCT00445146|630997|P1|Overall Study|Pregnancy|1
182997|NCT00445146|630997|P1|Overall Study|Protocol Violation|4
182998|NCT00445146|630997|P1|Overall Study|Death|9
182999|NCT00445146|630997|P1|Overall Study|Lost to Follow-up|13
183000|NCT00445146|630997|P1|Overall Study|Adverse Event|13
183001|NCT00445146|630997|P1|Overall Study|Investigator’s Discretion|22
183002|NCT00445146|630997|P1|Overall Study|Lack of Efficacy|28
183003|NCT00445146|630997|P1|Overall Study|Withdrew Consent|29
183004|NCT00445003|631019|P3|Overall Study|Dropped|2
183005|NCT00445003|631020|P2|Overall Study|Dropped|3
183006|NCT00445003|631021|P1|Overall Study|Dropped|1
183007|NCT00445003|631019|P3|Overall Study|Missed Visit|1
183008|NCT00445003|631020|P2|Overall Study|Missed Visit|5
183009|NCT00445003|631021|P1|Overall Study|Missed Visit|3
183010|NCT00445003|631019|P3|Overall Study|Death|1
183011|NCT00445003|631020|P2|Overall Study|Death|2
183012|NCT00445003|631021|P1|Overall Study|Death|1
183013|NCT00444951|631053|P3|Overall Study|Withdrawal by Subject|3
183014|NCT00444951|631054|P2|Overall Study|Withdrawal by Subject|5
183015|NCT00444951|631055|P1|Overall Study|Withdrawal by Subject|4
183016|NCT00444951|631053|P3|Overall Study|Lost to Follow-up|0
183017|NCT00444951|631054|P2|Overall Study|Lost to Follow-up|1
183018|NCT00444951|631055|P1|Overall Study|Lost to Follow-up|1
183019|NCT00444925|631072|P3|Double-blind Treatment Period|Other|12
183020|NCT00444925|631073|P2|Double-blind Treatment Period|Other|7
183021|NCT00444925|631074|P1|Double-blind Treatment Period|Other|7
183022|NCT00444925|631072|P3|Double-blind Treatment Period|Withdrawal by Subject|7
183023|NCT00444925|631073|P2|Double-blind Treatment Period|Withdrawal by Subject|8
183024|NCT00444925|631074|P1|Double-blind Treatment Period|Withdrawal by Subject|6
183025|NCT00444925|631072|P3|Double-blind Treatment Period|Lost to Follow-up|5
183026|NCT00444925|631073|P2|Double-blind Treatment Period|Lost to Follow-up|8
183027|NCT00444925|631074|P1|Double-blind Treatment Period|Lost to Follow-up|4
183028|NCT00444925|631072|P3|Double-blind Treatment Period|Lack of Efficacy|13
183029|NCT00444925|631073|P2|Double-blind Treatment Period|Lack of Efficacy|5
183030|NCT00444925|631074|P1|Double-blind Treatment Period|Lack of Efficacy|5
183031|NCT00444925|631072|P3|Double-blind Treatment Period|Adverse Event|44
183032|NCT00444925|631073|P2|Double-blind Treatment Period|Adverse Event|28
183033|NCT00444925|631074|P1|Double-blind Treatment Period|Adverse Event|6
183034|NCT00444925|631072|P3|Double-blind Treatment Period|Death|0
183035|NCT00444925|631073|P2|Double-blind Treatment Period|Death|0
183036|NCT00444925|631074|P1|Double-blind Treatment Period|Death|2
183037|NCT00444925|631072|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
183038|NCT00444925|631073|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
183039|NCT00444925|631074|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
183040|NCT00444912|631138|P2|Overall Study|Participant Failed Mobilization|0
183041|NCT00444912|631139|P1|Overall Study|Participant Failed Mobilization|1
183042|NCT00444912|631138|P2|Overall Study|Lost to Follow-up|0
183043|NCT00444912|631139|P1|Overall Study|Lost to Follow-up|1
183044|NCT00444912|631138|P2|Overall Study|Death|2
183045|NCT00444912|631139|P1|Overall Study|Death|1
183046|NCT00444795|631180|P1|Overall Study|Treated Prior to the Contract Date|2
183047|NCT00444795|631180|P1|Overall Study|Not Treated|1
183048|NCT00444626|631185|P1|Initial Treatment Period|Lost to Follow-up|9
183049|NCT00444626|631185|P1|Initial Treatment Period|Adverse Event|1
183050|NCT00444626|631185|P1|Initial Treatment Period|Withdrawal by Subject|2
183051|NCT00444600|631215|P4|Overall Study|Missed visit|1
183052|NCT00444600|631216|P3|Overall Study|Missed visit|0
183053|NCT00444600|631217|P2|Overall Study|Missed visit|0
183054|NCT00444600|631218|P1|Overall Study|Missed visit|1
183055|NCT00444600|631215|P4|Overall Study|Dropped|7
183056|NCT00444600|631216|P3|Overall Study|Dropped|7
183057|NCT00444600|631217|P2|Overall Study|Dropped|11
183058|NCT00444600|631218|P1|Overall Study|Dropped|11
183059|NCT00444600|631215|P4|Overall Study|Death|2
183060|NCT00444600|631216|P3|Overall Study|Death|3
183061|NCT00444600|631217|P2|Overall Study|Death|5
183062|NCT00444600|631218|P1|Overall Study|Death|7
183063|NCT00444587|631310|P2|Overall Study|Missing|5
183064|NCT00444587|631311|P1|Overall Study|Missing|0
183065|NCT00444587|631310|P2|Overall Study|Protocol Violation|0
183066|NCT00444587|631311|P1|Overall Study|Protocol Violation|1
183067|NCT00444587|631310|P2|Overall Study|Investigator decision|0
183068|NCT00444587|631311|P1|Overall Study|Investigator decision|3
183069|NCT00444587|631310|P2|Overall Study|Refused treatment/did not cooperate|1
183070|NCT00444587|631311|P1|Overall Study|Refused treatment/did not cooperate|4
183071|NCT00444587|631310|P2|Overall Study|Progression of the disease|8
183072|NCT00444587|631311|P1|Overall Study|Progression of the disease|73
183073|NCT00444587|631310|P2|Overall Study|Death|1
183074|NCT00444587|631311|P1|Overall Study|Death|2
183075|NCT00444535|631332|P1|Overall Study|Adverse Event|3
183076|NCT00444535|631332|P1|Overall Study|Investigator decision|2
183077|NCT00444535|631332|P1|Overall Study|Withdrawal by Subject|3
183078|NCT00444535|631332|P1|Overall Study|Treatment is ongoing|16
183079|NCT00444457|631343|P4|Toddler Dose|Protocol Violation|1
183080|NCT00444457|631344|P3|Toddler Dose|Protocol Violation|0
183081|NCT00444457|631345|P2|Toddler Dose|Protocol Violation|0
183082|NCT00444457|631346|P1|Toddler Dose|Protocol Violation|1
183083|NCT00444457|631343|P4|Toddler Dose|Parent or legal guardian request|1
183084|NCT00444457|631344|P3|Toddler Dose|Parent or legal guardian request|2
183085|NCT00444457|631345|P2|Toddler Dose|Parent or legal guardian request|3
183086|NCT00444457|631346|P1|Toddler Dose|Parent or legal guardian request|0
183087|NCT00444457|631343|P4|Toddler Dose|Failed to return|3
183088|NCT00444457|631344|P3|Toddler Dose|Failed to return|1
183089|NCT00444457|631345|P2|Toddler Dose|Failed to return|2
183090|NCT00444457|631346|P1|Toddler Dose|Failed to return|2
183091|NCT00444457|631343|P4|Toddler Dose|Lost to Follow-up|3
183092|NCT00444457|631344|P3|Toddler Dose|Lost to Follow-up|1
183093|NCT00444457|631345|P2|Toddler Dose|Lost to Follow-up|1
183094|NCT00444457|631346|P1|Toddler Dose|Lost to Follow-up|4
183095|NCT00444457|631343|P4|After Infant Series|Other|0
183096|NCT00444457|631344|P3|After Infant Series|Other|0
183097|NCT00444457|631345|P2|After Infant Series|Other|1
183098|NCT00444457|631346|P1|After Infant Series|Other|0
183099|NCT00444457|631343|P4|After Infant Series|Investigator request|1
183100|NCT00444457|631344|P3|After Infant Series|Investigator request|0
183101|NCT00444457|631345|P2|After Infant Series|Investigator request|0
183102|NCT00444457|631346|P1|After Infant Series|Investigator request|0
183103|NCT00444457|631343|P4|After Infant Series|Adverse Event|0
183104|NCT00444457|631344|P3|After Infant Series|Adverse Event|0
183105|NCT00444457|631345|P2|After Infant Series|Adverse Event|2
183106|NCT00444457|631346|P1|After Infant Series|Adverse Event|2
183107|NCT00444457|631343|P4|After Infant Series|Protocol Violation|2
183108|NCT00444457|631344|P3|After Infant Series|Protocol Violation|2
183109|NCT00444457|631345|P2|After Infant Series|Protocol Violation|4
183110|NCT00444457|631346|P1|After Infant Series|Protocol Violation|2
183111|NCT00444457|631343|P4|After Infant Series|Lost to Follow-up|2
183112|NCT00444457|631344|P3|After Infant Series|Lost to Follow-up|5
183113|NCT00444457|631345|P2|After Infant Series|Lost to Follow-up|5
183114|NCT00444457|631346|P1|After Infant Series|Lost to Follow-up|5
183115|NCT00444457|631343|P4|After Infant Series|Failed to return|1
183116|NCT00444457|631344|P3|After Infant Series|Failed to return|5
183117|NCT00444457|631345|P2|After Infant Series|Failed to return|6
183118|NCT00444457|631346|P1|After Infant Series|Failed to return|7
183119|NCT00444457|631343|P4|After Infant Series|Parent or legal guardian request|3
183120|NCT00444457|631344|P3|After Infant Series|Parent or legal guardian request|6
183121|NCT00444457|631345|P2|After Infant Series|Parent or legal guardian request|11
183122|NCT00444457|631346|P1|After Infant Series|Parent or legal guardian request|4
183123|NCT00444457|631343|P4|After Infant Series|Other|1
183124|NCT00444457|631344|P3|After Infant Series|Other|1
183125|NCT00444457|631345|P2|After Infant Series|Other|1
183126|NCT00444457|631346|P1|After Infant Series|Other|0
183127|NCT00444457|631343|P4|Infant Series|Death|1
183128|NCT00444457|631344|P3|Infant Series|Death|1
183129|NCT00444457|631345|P2|Infant Series|Death|1
183130|NCT00444457|631346|P1|Infant Series|Death|0
183131|NCT00444457|631343|P4|Infant Series|Adverse Event|0
183132|NCT00444457|631344|P3|Infant Series|Adverse Event|2
183133|NCT00444457|631345|P2|Infant Series|Adverse Event|2
183134|NCT00444457|631346|P1|Infant Series|Adverse Event|1
183135|NCT00444457|631343|P4|Infant Series|Other|0
183136|NCT00444457|631344|P3|Infant Series|Other|4
183137|NCT00444457|631345|P2|Infant Series|Other|2
183138|NCT00444457|631346|P1|Infant Series|Other|0
183139|NCT00444457|631343|P4|Infant Series|Investigator request|2
183140|NCT00444457|631344|P3|Infant Series|Investigator request|3
183141|NCT00444457|631345|P2|Infant Series|Investigator request|3
183142|NCT00444457|631346|P1|Infant Series|Investigator request|4
183143|NCT00444457|631343|P4|Infant Series|Failed to return|2
183144|NCT00444457|631344|P3|Infant Series|Failed to return|4
183145|NCT00444457|631345|P2|Infant Series|Failed to return|4
183146|NCT00444457|631346|P1|Infant Series|Failed to return|5
183147|NCT00444457|631343|P4|Infant Series|Protocol Violation|3
183148|NCT00444457|631344|P3|Infant Series|Protocol Violation|6
183149|NCT00444457|631345|P2|Infant Series|Protocol Violation|8
183150|NCT00444457|631346|P1|Infant Series|Protocol Violation|16
183151|NCT00444457|631343|P4|Infant Series|Lost to Follow-up|6
183152|NCT00444457|631344|P3|Infant Series|Lost to Follow-up|7
183153|NCT00444457|631345|P2|Infant Series|Lost to Follow-up|11
183154|NCT00444457|631346|P1|Infant Series|Lost to Follow-up|10
183155|NCT00444457|631343|P4|Infant Series|Parent or legal guardian request|14
183156|NCT00444457|631344|P3|Infant Series|Parent or legal guardian request|34
183157|NCT00444457|631345|P2|Infant Series|Parent or legal guardian request|29
183158|NCT00444457|631346|P1|Infant Series|Parent or legal guardian request|18
183159|NCT00444457|631343|P4|Infant Series|Other|0
183160|NCT00444457|631344|P3|Infant Series|Other|0
183161|NCT00444457|631345|P2|Infant Series|Other|1
183162|NCT00444457|631346|P1|Infant Series|Other|0
183163|NCT00444275|631411|P5|Maintenance Treatment Phase|Ineffectiveness|14
183164|NCT00444275|631412|P4|Maintenance Treatment Phase|Ineffectiveness|3
183165|NCT00444275|631413|P3|Maintenance Treatment Phase|Ineffectiveness|5
183166|NCT00444275|631414|P2|Maintenance Treatment Phase|Ineffectiveness|0
183167|NCT00444275|631415|P1|Maintenance Treatment Phase|Ineffectiveness|0
183168|NCT00444275|631411|P5|Maintenance Treatment Phase|Protocol Violation|87
183169|NCT00444275|631412|P4|Maintenance Treatment Phase|Protocol Violation|88
183170|NCT00444275|631413|P3|Maintenance Treatment Phase|Protocol Violation|103
183171|NCT00444275|631414|P2|Maintenance Treatment Phase|Protocol Violation|0
183172|NCT00444275|631415|P1|Maintenance Treatment Phase|Protocol Violation|0
183173|NCT00444275|631411|P5|Maintenance Treatment Phase|Patient's wish|20
183174|NCT00444275|631412|P4|Maintenance Treatment Phase|Patient's wish|9
183175|NCT00444275|631413|P3|Maintenance Treatment Phase|Patient's wish|19
183176|NCT00444275|631414|P2|Maintenance Treatment Phase|Patient's wish|0
183177|NCT00444275|631415|P1|Maintenance Treatment Phase|Patient's wish|0
183178|NCT00444275|631411|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
183179|NCT00444275|631412|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
183180|NCT00444275|631413|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
183181|NCT00444275|631414|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
183182|NCT00444275|631415|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
183183|NCT00444275|631411|P5|Maintenance Treatment Phase|Adverse Event|13
183184|NCT00444275|631412|P4|Maintenance Treatment Phase|Adverse Event|2
183185|NCT00444275|631413|P3|Maintenance Treatment Phase|Adverse Event|3
183186|NCT00444275|631414|P2|Maintenance Treatment Phase|Adverse Event|0
183187|NCT00444275|631415|P1|Maintenance Treatment Phase|Adverse Event|0
183188|NCT00444275|631411|P5|Maintenance Treatment Phase|Lost to Follow-up|10
183189|NCT00444275|631412|P4|Maintenance Treatment Phase|Lost to Follow-up|14
183190|NCT00444275|631413|P3|Maintenance Treatment Phase|Lost to Follow-up|8
183191|NCT00444275|631414|P2|Maintenance Treatment Phase|Lost to Follow-up|0
183192|NCT00444275|631415|P1|Maintenance Treatment Phase|Lost to Follow-up|0
183193|NCT00444275|631411|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
183194|NCT00444275|631412|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
183195|NCT00444275|631413|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
183196|NCT00444275|631414|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
183197|NCT00444275|631415|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
183198|NCT00444145|631465|P1|Overall Study|Screen Failures|5
183199|NCT00444145|631465|P1|Overall Study|non-compliant|11
183200|NCT00444145|631465|P1|Overall Study|Lost to Follow-up|1
183201|NCT00444145|631465|P1|Overall Study|Withdrawal by Subject|2
183202|NCT00444106|631472|P3|Overall Study|Abnormal Test Procedure Results|1
183203|NCT00444106|631473|P2|Overall Study|Abnormal Test Procedure Results|0
183204|NCT00444106|631474|P1|Overall Study|Abnormal Test Procedure Results|0
183205|NCT00444106|631472|P3|Overall Study|Lost to Follow-up|0
183206|NCT00444106|631473|P2|Overall Study|Lost to Follow-up|1
183207|NCT00444106|631474|P1|Overall Study|Lost to Follow-up|2
183208|NCT00444067|631491|P2|Overall Study|Lost to Follow-up|1
183209|NCT00444067|631492|P1|Overall Study|Lost to Follow-up|0
183210|NCT00443898|631506|P4|Overall Study|Death|0
183211|NCT00443898|631507|P3|Overall Study|Death|0
183212|NCT00443898|631508|P2|Overall Study|Death|1
183213|NCT00443898|631509|P1|Overall Study|Death|0
183214|NCT00443898|631506|P4|Overall Study|Lost to Follow-up|10
183215|NCT00443898|631507|P3|Overall Study|Lost to Follow-up|14
183216|NCT00443898|631508|P2|Overall Study|Lost to Follow-up|10
183217|NCT00443898|631509|P1|Overall Study|Lost to Follow-up|10
183218|NCT00443898|631506|P4|Overall Study|Withdrawal by Subject|6
183219|NCT00443898|631507|P3|Overall Study|Withdrawal by Subject|10
183220|NCT00443898|631508|P2|Overall Study|Withdrawal by Subject|10
183221|NCT00443898|631509|P1|Overall Study|Withdrawal by Subject|11
183222|NCT00443898|631506|P4|Overall Study|Protocol Violation|0
183223|NCT00443898|631507|P3|Overall Study|Protocol Violation|1
183224|NCT00443898|631508|P2|Overall Study|Protocol Violation|1
183225|NCT00443898|631509|P1|Overall Study|Protocol Violation|1
183226|NCT00443898|631506|P4|Overall Study|Lack of Efficacy|1
183227|NCT00443898|631507|P3|Overall Study|Lack of Efficacy|3
183228|NCT00443898|631508|P2|Overall Study|Lack of Efficacy|3
183229|NCT00443898|631509|P1|Overall Study|Lack of Efficacy|2
183230|NCT00443898|631506|P4|Overall Study|Adverse Event|1
183231|NCT00443898|631507|P3|Overall Study|Adverse Event|1
183232|NCT00443898|631508|P2|Overall Study|Adverse Event|0
183233|NCT00443898|631509|P1|Overall Study|Adverse Event|0
183234|NCT00443872|631531|P1|Overall Study|Adverse Event|8
183235|NCT00443872|631531|P1|Overall Study|Lost to Follow-up|2
183236|NCT00443872|631531|P1|Overall Study|Protocol Violation|7
183237|NCT00443820|631548|P4|Overall Study|Death|0
183238|NCT00443820|631549|P3|Overall Study|Death|1
183239|NCT00443820|631550|P2|Overall Study|Death|0
183240|NCT00443820|631551|P1|Overall Study|Death|0
183241|NCT00443820|631548|P4|Overall Study|Administrative problems|1
183242|NCT00443820|631549|P3|Overall Study|Administrative problems|0
183243|NCT00443820|631550|P2|Overall Study|Administrative problems|0
183244|NCT00443820|631551|P1|Overall Study|Administrative problems|0
183245|NCT00443820|631548|P4|Overall Study|Lost to Follow-up|5
183246|NCT00443820|631549|P3|Overall Study|Lost to Follow-up|6
183247|NCT00443820|631550|P2|Overall Study|Lost to Follow-up|8
183248|NCT00443820|631551|P1|Overall Study|Lost to Follow-up|9
183249|NCT00443820|631548|P4|Overall Study|Withdrawal by Subject|9
183250|NCT00443820|631549|P3|Overall Study|Withdrawal by Subject|8
183251|NCT00443820|631550|P2|Overall Study|Withdrawal by Subject|7
183252|NCT00443820|631551|P1|Overall Study|Withdrawal by Subject|6
183253|NCT00443820|631548|P4|Overall Study|Protocol Violation|1
183254|NCT00443820|631549|P3|Overall Study|Protocol Violation|2
183255|NCT00443820|631550|P2|Overall Study|Protocol Violation|1
183256|NCT00443820|631551|P1|Overall Study|Protocol Violation|2
183257|NCT00443820|631548|P4|Overall Study|Lack of Efficacy|1
183258|NCT00443820|631549|P3|Overall Study|Lack of Efficacy|1
183259|NCT00443820|631550|P2|Overall Study|Lack of Efficacy|2
183260|NCT00443820|631551|P1|Overall Study|Lack of Efficacy|3
183261|NCT00443820|631548|P4|Overall Study|Adverse Event|0
183262|NCT00443820|631549|P3|Overall Study|Adverse Event|0
183263|NCT00443820|631550|P2|Overall Study|Adverse Event|1
183264|NCT00443820|631551|P1|Overall Study|Adverse Event|1
183265|NCT00443781|631573|P1|Overall Study|PD/FAD not done|1
183266|NCT00443781|631573|P1|Overall Study|Insurance not covered|2
183267|NCT00443781|631573|P1|Overall Study|Investigator terminated participation|1
183268|NCT00443781|631573|P1|Overall Study|Unable to comply with study follow up|2
183269|NCT00443781|631573|P1|Overall Study|Withdrawal by Subject|6
183270|NCT00443781|631573|P1|Overall Study|Protocol Violation|1
183271|NCT00443781|631573|P1|Overall Study|Physician Decision|2
183272|NCT00443781|631573|P1|Overall Study|Lost to Follow-up|10
183273|NCT00443755|631579|P2|Overall Study|Withdrawal by Subject|1
183274|NCT00443755|631580|P1|Overall Study|Withdrawal by Subject|2
183275|NCT00443729|631614|P2|Overall Study|Withdrawal by Subject|1
183276|NCT00443729|631615|P1|Overall Study|Withdrawal by Subject|3
183277|NCT00443729|631614|P2|Overall Study|Protocol Violation|1
183278|NCT00443729|631615|P1|Overall Study|Protocol Violation|1
183279|NCT00443729|631614|P2|Overall Study|Physician Decision|1
183280|NCT00443729|631615|P1|Overall Study|Physician Decision|2
183281|NCT00443729|631614|P2|Overall Study|Lost to Follow-up|1
183282|NCT00443729|631615|P1|Overall Study|Lost to Follow-up|0
183283|NCT00443729|631614|P2|Overall Study|Lack of Efficacy|2
183284|NCT00443729|631615|P1|Overall Study|Lack of Efficacy|4
183285|NCT00443729|631614|P2|Overall Study|Never Treated|1
183286|NCT00443729|631615|P1|Overall Study|Never Treated|0
183287|NCT00443703|631663|P2|Overall Study|Progressive Disease|0
183288|NCT00443703|631664|P1|Overall Study|Progressive Disease|1
183289|NCT00443703|631663|P2|Overall Study|Withdrawal by Subject|6
183290|NCT00443703|631664|P1|Overall Study|Withdrawal by Subject|9
183291|NCT00443703|631663|P2|Overall Study|Protocol Violation|1
183292|NCT00443703|631664|P1|Overall Study|Protocol Violation|1
183293|NCT00443703|631663|P2|Overall Study|Physician Decision|2
183294|NCT00443703|631664|P1|Overall Study|Physician Decision|4
183295|NCT00443703|631663|P2|Overall Study|Lost to Follow-up|4
183296|NCT00443703|631664|P1|Overall Study|Lost to Follow-up|0
183297|NCT00443703|631663|P2|Overall Study|Lack of Efficacy|1
183298|NCT00443703|631664|P1|Overall Study|Lack of Efficacy|3
183299|NCT00443703|631663|P2|Overall Study|Adverse Event|3
183300|NCT00443703|631664|P1|Overall Study|Adverse Event|7
183301|NCT00443703|631663|P2|Overall Study|Never Treated|1
183302|NCT00443703|631664|P1|Overall Study|Never Treated|3
183303|NCT00443651|631716|P2|Overall Study|Pregnancy|1
183304|NCT00443651|631717|P1|Overall Study|Pregnancy|0
183305|NCT00443651|631716|P2|Overall Study|Physician Decision|4
183306|NCT00443651|631717|P1|Overall Study|Physician Decision|13
183307|NCT00443651|631716|P2|Overall Study|Patient's/Guardian's Decision|30
183308|NCT00443651|631717|P1|Overall Study|Patient's/Guardian's Decision|58
183309|NCT00443651|631716|P2|Overall Study|Lost to Follow-up|12
183310|NCT00443651|631717|P1|Overall Study|Lost to Follow-up|18
183311|NCT00443651|631716|P2|Overall Study|Adverse Event|6
183312|NCT00443651|631717|P1|Overall Study|Adverse Event|5
183313|NCT00443651|631716|P2|Overall Study|Death|5
183314|NCT00443651|631717|P1|Overall Study|Death|1
183315|NCT00443599|631737|P2|Overall Study|Cardiopulmonary bypass canceled|1
183316|NCT00443599|631738|P1|Overall Study|Cardiopulmonary bypass canceled|3
183317|NCT00443599|631737|P2|Overall Study|Death|1
183318|NCT00443599|631738|P1|Overall Study|Death|1
183319|NCT00443599|631737|P2|Overall Study|Physician Decision|1
183320|NCT00443599|631738|P1|Overall Study|Physician Decision|2
183321|NCT00443560|631772|P2|Overall Study|Multiple pregnancies or fetal demise|4
183322|NCT00443560|631773|P1|Overall Study|Multiple pregnancies or fetal demise|2
183323|NCT00443560|631772|P2|Overall Study|No intrathecal dose|26
183324|NCT00443560|631773|P1|Overall Study|No intrathecal dose|58
183325|NCT00443534|631783|P1|Overall Study|Enrolled, Not Treated|1
183326|NCT00443534|631783|P1|Overall Study|Other|10
183327|NCT00443534|631783|P1|Overall Study|Study Terminated by Sponsor|12
183328|NCT00443534|631783|P1|Overall Study|Withdrawal by Subject|8
183329|NCT00443534|631783|P1|Overall Study|Death|9
183330|NCT00443534|631783|P1|Overall Study|Adverse Event|16
183331|NCT00443534|631783|P1|Overall Study|Lack of Efficacy|67
183332|NCT00443456|631790|P1|Overall Study|Withdrawal by Subject|1
183333|NCT00443456|631790|P1|Overall Study|Move|1
183334|NCT00443456|631790|P1|Overall Study|Adverse Event|16
183335|NCT00443430|631825|P2|Overall Study|Adverse Event|1
183336|NCT00443430|631826|P1|Overall Study|Adverse Event|1
183337|NCT00443430|631825|P2|Overall Study|Lack of Efficacy|3
183338|NCT00443430|631826|P1|Overall Study|Lack of Efficacy|3
183339|NCT00443261|631840|P1|Overall Study|Death|1
183340|NCT00443209|631846|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
183341|NCT00443209|631847|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
183342|NCT00443209|631846|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
183343|NCT00443209|631847|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
183344|NCT00443209|631846|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
183345|NCT00443209|631847|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
183346|NCT00443209|631846|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
183347|NCT00443209|631847|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
183348|NCT00443209|631846|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
183349|NCT00443209|631847|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
183350|NCT00443209|631846|P2|Months 13 to 18 Treatment Period|Adverse Event|0
183351|NCT00443209|631847|P1|Months 13 to 18 Treatment Period|Adverse Event|1
183352|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Not Treated|43
183353|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Not Treated|71
183354|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Missing|1
183355|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Missing|2
183356|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
183357|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
183358|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
183359|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
183360|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Pregnancy|4
183361|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Pregnancy|3
183362|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Physician Decision|4
183363|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Physician Decision|8
183364|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
183365|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
183366|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
183367|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
183368|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
183369|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
183370|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
183371|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
183372|NCT00443209|631846|P2|Months 1 to 12 Treatment Period|Adverse Event|11
183373|NCT00443209|631847|P1|Months 1 to 12 Treatment Period|Adverse Event|22
183374|NCT00443118|631864|P3|Overall Study|Withdrawal by Subject|0
183375|NCT00443118|631865|P2|Overall Study|Withdrawal by Subject|0
183376|NCT00443118|631866|P1|Overall Study|Withdrawal by Subject|1
183377|NCT00443118|631864|P3|Overall Study|unknown primary outcome|0
183378|NCT00443118|631865|P2|Overall Study|unknown primary outcome|1
183379|NCT00443118|631866|P1|Overall Study|unknown primary outcome|3
183380|NCT00443053|631912|P2|Overall Study|Physician Decision|4
183381|NCT00443053|631913|P1|Overall Study|Physician Decision|0
183382|NCT00443053|631912|P2|Overall Study|Other|4
183383|NCT00443053|631913|P1|Overall Study|Other|3
183384|NCT00443053|631912|P2|Overall Study|Noncompliance|1
183385|NCT00443053|631913|P1|Overall Study|Noncompliance|2
183386|NCT00443053|631912|P2|Overall Study|Did Not Meet Eligibility Criteria|0
183387|NCT00443053|631913|P1|Overall Study|Did Not Meet Eligibility Criteria|1
183388|NCT00443053|631912|P2|Overall Study|Lost to Follow-up|5
183389|NCT00443053|631913|P1|Overall Study|Lost to Follow-up|4
183390|NCT00443053|631912|P2|Overall Study|Withdrawal by Subject|18
183391|NCT00443053|631913|P1|Overall Study|Withdrawal by Subject|9
183392|NCT00443053|631912|P2|Overall Study|Adverse Event|1
183393|NCT00443053|631913|P1|Overall Study|Adverse Event|2
183394|NCT00443040|631934|P3|Overall Study|Converted to an open laparotomy|1
183395|NCT00443040|631935|P2|Overall Study|Converted to an open laparotomy|0
183396|NCT00443040|631936|P1|Overall Study|Converted to an open laparotomy|3
183397|NCT00443040|631934|P3|Overall Study|Withdrawal by Subject|0
183398|NCT00443040|631935|P2|Overall Study|Withdrawal by Subject|0
183399|NCT00443040|631936|P1|Overall Study|Withdrawal by Subject|1
183400|NCT00442962|631944|P1|Overall Study|Lost to Follow-up|7
183401|NCT00442962|631944|P1|Overall Study|Pregnancy|1
183402|NCT00442936|631962|P4|Overall Study|Protocol Violation|1
183403|NCT00442936|631963|P3|Overall Study|Protocol Violation|1
183404|NCT00442936|631964|P2|Overall Study|Protocol Violation|0
183405|NCT00442936|631965|P1|Overall Study|Protocol Violation|1
183406|NCT00442897|632013|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
183407|NCT00442897|632014|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
183408|NCT00442897|632013|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
183409|NCT00442897|632014|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
183410|NCT00442897|632013|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
183411|NCT00442897|632014|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
183412|NCT00442897|632013|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
183413|NCT00442897|632014|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
183414|NCT00442897|632013|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
183415|NCT00442897|632014|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
183416|NCT00442897|632013|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
183417|NCT00442897|632014|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
183418|NCT00442897|632013|P2|Base Study (12 Week Follow-up)|Death|1
183419|NCT00442897|632014|P1|Base Study (12 Week Follow-up)|Death|0
183420|NCT00442897|632013|P2|Base Study (12 Week Follow-up)|Adverse Event|0
183421|NCT00442897|632014|P1|Base Study (12 Week Follow-up)|Adverse Event|1
183422|NCT00442702|632024|P2|Evaluation Period|Site closure|1
183423|NCT00442702|632025|P1|Evaluation Period|Site closure|0
183424|NCT00442702|632024|P2|Evaluation Period|Failure to return|0
183425|NCT00442702|632025|P1|Evaluation Period|Failure to return|1
183426|NCT00442702|632024|P2|Evaluation Period|Renal transplant|1
183427|NCT00442702|632025|P1|Evaluation Period|Renal transplant|0
183428|NCT00442702|632024|P2|Evaluation Period|Refused treatment|1
183429|NCT00442702|632025|P1|Evaluation Period|Refused treatment|1
183430|NCT00442702|632024|P2|Evaluation Period|Insufficient Therapeutic Response|0
183431|NCT00442702|632025|P1|Evaluation Period|Insufficient Therapeutic Response|1
183432|NCT00442702|632024|P2|Evaluation Period|Death|1
183433|NCT00442702|632025|P1|Evaluation Period|Death|1
183434|NCT00442702|632024|P2|Evaluation Period|Adverse Event|0
183435|NCT00442702|632025|P1|Evaluation Period|Adverse Event|1
183436|NCT00442702|632024|P2|Titration Period|Hospitalized in another hospital|0
183437|NCT00442702|632025|P1|Titration Period|Hospitalized in another hospital|1
183438|NCT00442702|632024|P2|Titration Period|Failure to return|0
183439|NCT00442702|632025|P1|Titration Period|Failure to return|1
183440|NCT00442702|632024|P2|Titration Period|Refused Treatment|1
183441|NCT00442702|632025|P1|Titration Period|Refused Treatment|4
183442|NCT00442702|632024|P2|Titration Period|Insufficient Therapeutic Response|0
183443|NCT00442702|632025|P1|Titration Period|Insufficient Therapeutic Response|1
183444|NCT00442702|632024|P2|Titration Period|Death|2
183445|NCT00442702|632025|P1|Titration Period|Death|3
183446|NCT00442702|632024|P2|Titration Period|Adverse Event|0
183447|NCT00442702|632025|P1|Titration Period|Adverse Event|2
183448|NCT00442598|632090|P3|Overall Study|Death|0
183449|NCT00442598|632091|P2|Overall Study|Death|1
183450|NCT00442598|632092|P1|Overall Study|Death|0
183451|NCT00442598|632090|P3|Overall Study|Reduced creatinine clearance|0
183452|NCT00442598|632091|P2|Overall Study|Reduced creatinine clearance|0
183453|NCT00442598|632092|P1|Overall Study|Reduced creatinine clearance|1
183454|NCT00442598|632090|P3|Overall Study|CA125 progression|0
183455|NCT00442598|632091|P2|Overall Study|CA125 progression|1
183456|NCT00442598|632092|P1|Overall Study|CA125 progression|0
183457|NCT00442598|632090|P3|Overall Study|Clinical deterioration|0
183458|NCT00442598|632091|P2|Overall Study|Clinical deterioration|2
183459|NCT00442598|632092|P1|Overall Study|Clinical deterioration|1
183460|NCT00442598|632090|P3|Overall Study|Tumor progression|0
183461|NCT00442598|632091|P2|Overall Study|Tumor progression|4
183462|NCT00442598|632092|P1|Overall Study|Tumor progression|3
183463|NCT00442598|632090|P3|Overall Study|Adverse Event|0
183464|NCT00442598|632091|P2|Overall Study|Adverse Event|0
183465|NCT00442598|632092|P1|Overall Study|Adverse Event|1
183466|NCT00442572|632110|P2|Overall Study|Withdrawal by Subject|1
183467|NCT00442572|632111|P1|Overall Study|Withdrawal by Subject|0
183468|NCT00442572|632110|P2|Overall Study|Lost to Follow-up|1
183469|NCT00442572|632111|P1|Overall Study|Lost to Follow-up|0
183470|NCT00442572|632110|P2|Overall Study|Relapse|1
183471|NCT00442572|632111|P1|Overall Study|Relapse|8
183472|NCT00442559|632151|P2|Overall Study|Withdrawal by Subject|0
183473|NCT00442559|632152|P1|Overall Study|Withdrawal by Subject|1
183474|NCT00442559|632151|P2|Overall Study|Protocol Violation|1
183475|NCT00442559|632152|P1|Overall Study|Protocol Violation|1
183476|NCT00442559|632151|P2|Overall Study|Lost to Follow-up|34
183477|NCT00442559|632152|P1|Overall Study|Lost to Follow-up|32
183478|NCT00442546|632167|P3|Overall Study|Randomized But Not Treated|6
183479|NCT00442546|632168|P2|Overall Study|Randomized But Not Treated|4
183480|NCT00442546|632169|P1|Overall Study|Randomized But Not Treated|5
183481|NCT00442546|632167|P3|Overall Study|Withdrawal by Subject|7
183482|NCT00442546|632168|P2|Overall Study|Withdrawal by Subject|5
183483|NCT00442546|632169|P1|Overall Study|Withdrawal by Subject|5
183484|NCT00442546|632167|P3|Overall Study|Other|6
183485|NCT00442546|632168|P2|Overall Study|Other|9
183486|NCT00442546|632169|P1|Overall Study|Other|4
183487|NCT00442546|632167|P3|Overall Study|Lost to Follow-up|1
183488|NCT00442546|632168|P2|Overall Study|Lost to Follow-up|2
183489|NCT00442546|632169|P1|Overall Study|Lost to Follow-up|1
183490|NCT00442546|632167|P3|Overall Study|Adverse Event|13
183491|NCT00442546|632168|P2|Overall Study|Adverse Event|17
183492|NCT00442546|632169|P1|Overall Study|Adverse Event|11
183493|NCT00442468|632298|P1|Overall Study|Did not complete all study procedures|88
183494|NCT00442468|632298|P1|Overall Study|Withdrawal by Subject|91
183495|NCT00442468|632298|P1|Overall Study|Adverse Event|4
183496|NCT00442416|632328|P2|Overall Study|Administrative/Other|33
183497|NCT00442416|632329|P1|Overall Study|Administrative/Other|27
183498|NCT00442416|632328|P2|Overall Study|Withdrew consent|2
183499|NCT00442416|632329|P1|Overall Study|Withdrew consent|1
183500|NCT00442416|632328|P2|Overall Study|Protocol Violation|3
183501|NCT00442416|632329|P1|Overall Study|Protocol Violation|2
183502|NCT00442416|632328|P2|Overall Study|Lack of Efficacy|0
183503|NCT00442416|632329|P1|Overall Study|Lack of Efficacy|2
183504|NCT00442416|632328|P2|Overall Study|Death|0
183505|NCT00442416|632329|P1|Overall Study|Death|1
183506|NCT00442416|632328|P2|Overall Study|Adverse Event|1
183507|NCT00442416|632329|P1|Overall Study|Adverse Event|4
183508|NCT00442351|632368|P2|Overall Study|Not specified|1
183509|NCT00442351|632369|P1|Overall Study|Not specified|0
183510|NCT00442351|632368|P2|Overall Study|Did not meet protocol eligibility|0
183511|NCT00442351|632369|P1|Overall Study|Did not meet protocol eligibility|1
183512|NCT00442351|632368|P2|Overall Study|Administrative|5
183513|NCT00442351|632369|P1|Overall Study|Administrative|6
183514|NCT00442286|632391|P2|Overall Study|Patient Injury|0
183515|NCT00442286|632392|P1|Overall Study|Patient Injury|1
183516|NCT00442286|632391|P2|Overall Study|System explanted|0
183517|NCT00442286|632392|P1|Overall Study|System explanted|1
183518|NCT00442286|632391|P2|Overall Study|Withdrawal by Subject|0
183519|NCT00442286|632392|P1|Overall Study|Withdrawal by Subject|2
183520|NCT00442286|632391|P2|Overall Study|Lost to Follow-up|0
183521|NCT00442286|632392|P1|Overall Study|Lost to Follow-up|1
183522|NCT00442286|632391|P2|Overall Study|Death|2
183523|NCT00442286|632392|P1|Overall Study|Death|2
183524|NCT00442117|632454|P2|Overall Study|Met Withdrawal Criteria|1
183525|NCT00442117|632455|P1|Overall Study|Met Withdrawal Criteria|2
183526|NCT00442117|632454|P2|Overall Study|Non compliance with protocol|5
183527|NCT00442117|632455|P1|Overall Study|Non compliance with protocol|3
183528|NCT00442117|632454|P2|Overall Study|Major Deviation|20
183529|NCT00442117|632455|P1|Overall Study|Major Deviation|25
183530|NCT00442117|632454|P2|Overall Study|Withdrawal by Subject|2
183531|NCT00442117|632455|P1|Overall Study|Withdrawal by Subject|2
183532|NCT00442117|632454|P2|Overall Study|Lost to Follow-up|2
183533|NCT00442117|632455|P1|Overall Study|Lost to Follow-up|1
183534|NCT00442117|632454|P2|Overall Study|Lack of Efficacy|6
183535|NCT00442117|632455|P1|Overall Study|Lack of Efficacy|2
183536|NCT00442117|632454|P2|Overall Study|Adverse Event|2
183537|NCT00442117|632455|P1|Overall Study|Adverse Event|3
183538|NCT00441974|632486|P1|Overall Study|Protocol Violation|7
183539|NCT00441974|632486|P1|Overall Study|Lost to Follow-up|80
183540|NCT00441974|632486|P1|Overall Study|Consent Withdrawn|35
183541|NCT00441974|632486|P1|Overall Study|Adverse Event|6
183542|NCT00441792|632502|P2|Overall Study|Lost to Follow-up|2
183543|NCT00441792|632503|P1|Overall Study|Lost to Follow-up|0
183544|NCT00441727|632543|P3|Overall Study|Various reason specified|5
183545|NCT00441727|632544|P2|Overall Study|Various reason specified|8
183546|NCT00441727|632545|P1|Overall Study|Various reason specified|6
183547|NCT00441727|632543|P3|Overall Study|Safety Reasons|3
183548|NCT00441727|632544|P2|Overall Study|Safety Reasons|1
183549|NCT00441727|632545|P1|Overall Study|Safety Reasons|3
183550|NCT00441727|632543|P3|Overall Study|Lost to Follow-up|5
183551|NCT00441727|632544|P2|Overall Study|Lost to Follow-up|6
183552|NCT00441727|632545|P1|Overall Study|Lost to Follow-up|5
183553|NCT00441727|632543|P3|Overall Study|Withdrawal by Subject|47
183554|NCT00441727|632544|P2|Overall Study|Withdrawal by Subject|34
183555|NCT00441727|632545|P1|Overall Study|Withdrawal by Subject|40
183556|NCT00441727|632543|P3|Overall Study|Lack of Efficacy|48
183557|NCT00441727|632544|P2|Overall Study|Lack of Efficacy|8
183558|NCT00441727|632545|P1|Overall Study|Lack of Efficacy|7
183559|NCT00441727|632543|P3|Overall Study|Adverse Event|28
183560|NCT00441727|632544|P2|Overall Study|Adverse Event|33
183561|NCT00441727|632545|P1|Overall Study|Adverse Event|26
183562|NCT00441727|632543|P3|Overall Study|Protocol Violation|32
183563|NCT00441727|632544|P2|Overall Study|Protocol Violation|28
183564|NCT00441727|632545|P1|Overall Study|Protocol Violation|19
183565|NCT00441701|632578|P10|Overall Study|Withdrawal by Subject|0
183566|NCT00441701|632579|P9|Overall Study|Withdrawal by Subject|0
183567|NCT00441701|632580|P8|Overall Study|Withdrawal by Subject|0
183568|NCT00441701|632581|P7|Overall Study|Withdrawal by Subject|0
183569|NCT00441701|632582|P6|Overall Study|Withdrawal by Subject|0
183570|NCT00441701|632583|P5|Overall Study|Withdrawal by Subject|0
183571|NCT00441701|632584|P4|Overall Study|Withdrawal by Subject|1
183572|NCT00441701|632585|P3|Overall Study|Withdrawal by Subject|1
183573|NCT00441701|632586|P2|Overall Study|Withdrawal by Subject|2
183574|NCT00441701|632587|P1|Overall Study|Withdrawal by Subject|0
183575|NCT00441701|632578|P10|Overall Study|Lack of Efficacy|0
183576|NCT00441701|632579|P9|Overall Study|Lack of Efficacy|0
183577|NCT00441701|632580|P8|Overall Study|Lack of Efficacy|0
183578|NCT00441701|632581|P7|Overall Study|Lack of Efficacy|0
183579|NCT00441701|632582|P6|Overall Study|Lack of Efficacy|1
183580|NCT00441701|632583|P5|Overall Study|Lack of Efficacy|0
183581|NCT00441701|632584|P4|Overall Study|Lack of Efficacy|2
183582|NCT00441701|632585|P3|Overall Study|Lack of Efficacy|2
183583|NCT00441701|632586|P2|Overall Study|Lack of Efficacy|0
183584|NCT00441701|632587|P1|Overall Study|Lack of Efficacy|2
183585|NCT00441701|632578|P10|Overall Study|Adverse Event|0
183586|NCT00441701|632579|P9|Overall Study|Adverse Event|0
183587|NCT00441701|632580|P8|Overall Study|Adverse Event|0
183588|NCT00441701|632581|P7|Overall Study|Adverse Event|0
183589|NCT00441701|632582|P6|Overall Study|Adverse Event|2
183590|NCT00441701|632583|P5|Overall Study|Adverse Event|2
183591|NCT00441701|632584|P4|Overall Study|Adverse Event|0
183592|NCT00441701|632585|P3|Overall Study|Adverse Event|1
183593|NCT00441701|632586|P2|Overall Study|Adverse Event|2
183594|NCT00441701|632587|P1|Overall Study|Adverse Event|3
183595|NCT00441584|632669|P1|Overall Study|Failure to meet eligibility criteria|3
183596|NCT00441584|632669|P1|Overall Study|Lost to Follow-up|4
183597|NCT00441584|632669|P1|Overall Study|Protocol Violation|5
183598|NCT00441584|632669|P1|Overall Study|Adverse Event|6
183599|NCT00441584|632669|P1|Overall Study|Withdrawal by Subject|8
183600|NCT00441584|632669|P1|Overall Study|Lack of Efficacy|79
183601|NCT00441545|632677|P2|Second Intervention|Subject moved|1
183602|NCT00441545|632678|P1|Second Intervention|Subject moved|0
183603|NCT00441545|632677|P2|Second Intervention|Subject exceeded safety criteria|0
183604|NCT00441545|632678|P1|Second Intervention|Subject exceeded safety criteria|1
183605|NCT00441545|632677|P2|Second Intervention|Lack of Efficacy|1
183606|NCT00441545|632678|P1|Second Intervention|Lack of Efficacy|0
183607|NCT00441545|632677|P2|Second Intervention|Kidney Transplant|1
183608|NCT00441545|632678|P1|Second Intervention|Kidney Transplant|1
183609|NCT00441545|632677|P2|Second Intervention|Withdrawal by Subject|1
183610|NCT00441545|632678|P1|Second Intervention|Withdrawal by Subject|1
183611|NCT00441545|632677|P2|Second Intervention|Protocol Violation|1
183612|NCT00441545|632678|P1|Second Intervention|Protocol Violation|4
183613|NCT00441545|632677|P2|Second Intervention|Adverse Event|2
183614|NCT00441545|632678|P1|Second Intervention|Adverse Event|5
183615|NCT00441545|632677|P2|First Intervention|Sponsor's request|0
183616|NCT00441545|632678|P1|First Intervention|Sponsor's request|1
183617|NCT00441545|632677|P2|First Intervention|Site error|0
183618|NCT00441545|632678|P1|First Intervention|Site error|1
183619|NCT00441545|632677|P2|First Intervention|Extended hospitalization|0
183620|NCT00441545|632678|P1|First Intervention|Extended hospitalization|1
183621|NCT00441545|632677|P2|First Intervention|Subject met an exclusionary criteria|0
183622|NCT00441545|632678|P1|First Intervention|Subject met an exclusionary criteria|1
183623|NCT00441545|632677|P2|First Intervention|Subject exceeded safety criteria|1
183624|NCT00441545|632678|P1|First Intervention|Subject exceeded safety criteria|0
183625|NCT00441545|632677|P2|First Intervention|Lack of Efficacy|0
183626|NCT00441545|632678|P1|First Intervention|Lack of Efficacy|2
183627|NCT00441545|632677|P2|First Intervention|Kidney transplant|1
183628|NCT00441545|632678|P1|First Intervention|Kidney transplant|1
183629|NCT00441545|632677|P2|First Intervention|Withdrawal by Subject|3
183630|NCT00441545|632678|P1|First Intervention|Withdrawal by Subject|3
183631|NCT00441545|632677|P2|First Intervention|Protocol Violation|2
183632|NCT00441545|632678|P1|First Intervention|Protocol Violation|2
183633|NCT00441545|632677|P2|First Intervention|Adverse Event|5
183634|NCT00441545|632678|P1|First Intervention|Adverse Event|6
183635|NCT00441480|632692|P2|Overall Study|Withdrawal by Subject|3
183636|NCT00441480|632693|P1|Overall Study|Withdrawal by Subject|2
183637|NCT00441480|632692|P2|Overall Study|Protocol Violation|1
183638|NCT00441480|632693|P1|Overall Study|Protocol Violation|1
183639|NCT00441467|632725|P1|Overall Study|Progressive disease|9
183640|NCT00441467|632725|P1|Overall Study|Withdrawal by Subject|3
183641|NCT00441467|632725|P1|Overall Study|Adverse Event|6
183642|NCT00441441|632733|P2|Overall Study|Not specified|3
183643|NCT00441441|632734|P1|Overall Study|Not specified|3
183644|NCT00441441|632733|P2|Overall Study|Withdrawal by Subject|2
183645|NCT00441441|632734|P1|Overall Study|Withdrawal by Subject|1
183646|NCT00441441|632733|P2|Overall Study|Exacerbation of asthma|2
183647|NCT00441441|632734|P1|Overall Study|Exacerbation of asthma|1
183648|NCT00441441|632733|P2|Overall Study|Protocol Violation|6
183649|NCT00441441|632734|P1|Overall Study|Protocol Violation|4
183650|NCT00441441|632733|P2|Overall Study|Adverse Event|1
183651|NCT00441441|632734|P1|Overall Study|Adverse Event|2
183652|NCT00441363|632794|P2|Overall Study|not specified|0
183653|NCT00441363|632795|P1|Overall Study|not specified|2
183654|NCT00441363|632794|P2|Overall Study|Lost to Follow-up|2
183655|NCT00441363|632795|P1|Overall Study|Lost to Follow-up|2
183656|NCT00441363|632794|P2|Overall Study|Physician Decision|7
183657|NCT00441363|632795|P1|Overall Study|Physician Decision|6
183658|NCT00441363|632794|P2|Overall Study|Withdrawal by Subject|4
183659|NCT00441363|632795|P1|Overall Study|Withdrawal by Subject|3
183660|NCT00441363|632794|P2|Overall Study|Adverse Event|2
183661|NCT00441363|632795|P1|Overall Study|Adverse Event|4
183662|NCT00441337|632807|P4|Overall Study|Did not meet inclusion criteria|0
183663|NCT00441337|632808|P3|Overall Study|Did not meet inclusion criteria|1
183664|NCT00441337|632809|P2|Overall Study|Did not meet inclusion criteria|0
183665|NCT00441337|632810|P1|Overall Study|Did not meet inclusion criteria|0
183666|NCT00441337|632807|P4|Overall Study|Sponsor Decision|2
183667|NCT00441337|632808|P3|Overall Study|Sponsor Decision|1
183668|NCT00441337|632809|P2|Overall Study|Sponsor Decision|0
183669|NCT00441337|632810|P1|Overall Study|Sponsor Decision|0
183670|NCT00441337|632807|P4|Overall Study|Lost to Follow-up|1
183671|NCT00441337|632808|P3|Overall Study|Lost to Follow-up|0
183672|NCT00441337|632809|P2|Overall Study|Lost to Follow-up|0
183673|NCT00441337|632810|P1|Overall Study|Lost to Follow-up|0
183674|NCT00441337|632807|P4|Overall Study|Disease Progression|18
183675|NCT00441337|632808|P3|Overall Study|Disease Progression|4
183676|NCT00441337|632809|P2|Overall Study|Disease Progression|6
183677|NCT00441337|632810|P1|Overall Study|Disease Progression|6
183678|NCT00441272|632923|P2|Overall Study|Study terminated prior to enrollment|25
183679|NCT00441272|632924|P1|Overall Study|Study terminated prior to enrollment|25
183680|NCT00441168|632951|P2|Follow-up Period|Other|3
183681|NCT00441168|632952|P1|Follow-up Period|Other|1
183682|NCT00441168|632951|P2|Follow-up Period|Withdrawal by Subject|0
183683|NCT00441168|632952|P1|Follow-up Period|Withdrawal by Subject|3
183684|NCT00441168|632951|P2|Follow-up Period|Lost to Follow-up|6
183685|NCT00441168|632952|P1|Follow-up Period|Lost to Follow-up|5
183686|NCT00441168|632951|P2|Follow-up Period|Death|0
183687|NCT00441168|632952|P1|Follow-up Period|Death|3
183688|NCT00441168|632951|P2|Treatment Period|refractory disease|0
183689|NCT00441168|632952|P1|Treatment Period|refractory disease|1
183690|NCT00441168|632951|P2|Treatment Period|qualified for stem-cell transplantation|0
183691|NCT00441168|632952|P1|Treatment Period|qualified for stem-cell transplantation|3
183692|NCT00441168|632951|P2|Treatment Period|Withdrawal by Subject|0
183693|NCT00441168|632952|P1|Treatment Period|Withdrawal by Subject|3
183694|NCT00441168|632951|P2|Treatment Period|Lost to Follow-up|1
183695|NCT00441168|632952|P1|Treatment Period|Lost to Follow-up|0
183696|NCT00441168|632951|P2|Treatment Period|Protocol Violation|1
183697|NCT00441168|632952|P1|Treatment Period|Protocol Violation|0
183698|NCT00441168|632951|P2|Treatment Period|Progressive Disease|2
183699|NCT00441168|632952|P1|Treatment Period|Progressive Disease|0
183700|NCT00441168|632951|P2|Treatment Period|Adverse Event|2
183701|NCT00441168|632952|P1|Treatment Period|Adverse Event|1
183702|NCT00441168|632951|P2|Treatment Period|Death|0
183703|NCT00441168|632952|P1|Treatment Period|Death|3
183704|NCT00441142|632966|P4|Overall Study|Death|1
183705|NCT00441142|632967|P3|Overall Study|Death|0
183706|NCT00441142|632968|P2|Overall Study|Death|0
183707|NCT00441142|632969|P1|Overall Study|Death|0
183708|NCT00441142|632966|P4|Overall Study|Physician Decision|1
183709|NCT00441142|632967|P3|Overall Study|Physician Decision|0
183710|NCT00441142|632968|P2|Overall Study|Physician Decision|1
183711|NCT00441142|632969|P1|Overall Study|Physician Decision|0
183712|NCT00441142|632966|P4|Overall Study|Patient still receiving active study tx|2
183713|NCT00441142|632967|P3|Overall Study|Patient still receiving active study tx|0
183714|NCT00441142|632968|P2|Overall Study|Patient still receiving active study tx|0
183715|NCT00441142|632969|P1|Overall Study|Patient still receiving active study tx|1
183716|NCT00441142|632966|P4|Overall Study|Withdrawal by Subject|10
183717|NCT00441142|632967|P3|Overall Study|Withdrawal by Subject|2
183718|NCT00441142|632968|P2|Overall Study|Withdrawal by Subject|0
183719|NCT00441142|632969|P1|Overall Study|Withdrawal by Subject|0
183720|NCT00441142|632966|P4|Overall Study|Lack of Efficacy|32
183721|NCT00441142|632967|P3|Overall Study|Lack of Efficacy|17
183722|NCT00441142|632968|P2|Overall Study|Lack of Efficacy|3
183723|NCT00441142|632969|P1|Overall Study|Lack of Efficacy|3
183724|NCT00441142|632966|P4|Overall Study|Adverse Event|22
183725|NCT00441142|632967|P3|Overall Study|Adverse Event|3
183726|NCT00441142|632968|P2|Overall Study|Adverse Event|3
183727|NCT00441142|632969|P1|Overall Study|Adverse Event|2
183728|NCT00441116|632987|P2|Overall Study|Did not meet Eligibility Criteria|1
183729|NCT00441116|632988|P1|Overall Study|Did not meet Eligibility Criteria|1
183730|NCT00441116|632987|P2|Overall Study|Withdrawal by Subject|0
183731|NCT00441116|632988|P1|Overall Study|Withdrawal by Subject|1
183732|NCT00441116|632987|P2|Overall Study|Adverse Event|1
183733|NCT00441116|632988|P1|Overall Study|Adverse Event|1
183734|NCT00441103|633056|P2|Overall Study|Participant decided to stop|1
183735|NCT00441103|633057|P1|Overall Study|Participant decided to stop|0
183736|NCT00441103|633056|P2|Overall Study|Participant's reason|1
183737|NCT00441103|633057|P1|Overall Study|Participant's reason|0
183738|NCT00441103|633056|P2|Overall Study|Participant decided to withdraw|0
183739|NCT00441103|633057|P1|Overall Study|Participant decided to withdraw|1
183740|NCT00441103|633056|P2|Overall Study|Non-compliant|1
183741|NCT00441103|633057|P1|Overall Study|Non-compliant|0
183742|NCT00441103|633056|P2|Overall Study|Inclusion criteria absent|0
183743|NCT00441103|633057|P1|Overall Study|Inclusion criteria absent|1
183744|NCT00441103|633056|P2|Overall Study|Participant refused MRI|0
183745|NCT00441103|633057|P1|Overall Study|Participant refused MRI|1
183746|NCT00441103|633056|P2|Overall Study|Participant unable to use Rebiject II|0
183747|NCT00441103|633057|P1|Overall Study|Participant unable to use Rebiject II|1
183748|NCT00441103|633056|P2|Overall Study|Protocol Violation|0
183749|NCT00441103|633057|P1|Overall Study|Protocol Violation|1
183750|NCT00441103|633056|P2|Overall Study|Lost to Follow-up|0
183751|NCT00441103|633057|P1|Overall Study|Lost to Follow-up|1
183752|NCT00441103|633056|P2|Overall Study|Disease Progression|0
183753|NCT00441103|633057|P1|Overall Study|Disease Progression|2
183754|NCT00441103|633056|P2|Overall Study|Death|0
183755|NCT00441103|633057|P1|Overall Study|Death|1
183756|NCT00441103|633056|P2|Overall Study|Adverse Event|1
183757|NCT00441103|633057|P1|Overall Study|Adverse Event|2
183758|NCT00441090|633073|P5|Overall Study|Lack of Efficacy|0
183759|NCT00441090|633074|P4|Overall Study|Lack of Efficacy|0
183760|NCT00441090|633075|P3|Overall Study|Lack of Efficacy|0
183761|NCT00441090|633076|P2|Overall Study|Lack of Efficacy|0
183762|NCT00441090|633077|P1|Overall Study|Lack of Efficacy|1
183763|NCT00441090|633073|P5|Overall Study|Withdrawal by Subject|0
183764|NCT00441090|633074|P4|Overall Study|Withdrawal by Subject|0
183765|NCT00441090|633075|P3|Overall Study|Withdrawal by Subject|1
183766|NCT00441090|633076|P2|Overall Study|Withdrawal by Subject|0
183767|NCT00441090|633077|P1|Overall Study|Withdrawal by Subject|1
183768|NCT00441090|633073|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
183769|NCT00441090|633074|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
183770|NCT00441090|633075|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
183771|NCT00441090|633076|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
183772|NCT00441090|633077|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
183773|NCT00441090|633073|P5|Overall Study|Adverse Event|0
183774|NCT00441090|633074|P4|Overall Study|Adverse Event|0
183775|NCT00441090|633075|P3|Overall Study|Adverse Event|1
183776|NCT00441090|633076|P2|Overall Study|Adverse Event|1
183777|NCT00441090|633077|P1|Overall Study|Adverse Event|0
183778|NCT00441064|633121|P2|Overall Study|Patient withdrew consent|2
183779|NCT00441064|633122|P1|Overall Study|Patient withdrew consent|5
183780|NCT00441064|633121|P2|Overall Study|Protocol Deviation|2
183781|NCT00441064|633122|P1|Overall Study|Protocol Deviation|3
183782|NCT00441064|633121|P2|Overall Study|Unsatisfactory therapeutic effect|0
183783|NCT00441064|633122|P1|Overall Study|Unsatisfactory therapeutic effect|1
183784|NCT00441064|633121|P2|Overall Study|Abnormal test procedure results|1
183785|NCT00441064|633122|P1|Overall Study|Abnormal test procedure results|0
183786|NCT00441064|633121|P2|Overall Study|Abnormal laboratory values|2
183787|NCT00441064|633122|P1|Overall Study|Abnormal laboratory values|0
183788|NCT00441064|633121|P2|Overall Study|Adverse Event|0
183789|NCT00441064|633122|P1|Overall Study|Adverse Event|1
183790|NCT00441012|633134|P2|Overall Study|Subject Randomized but Not Vaccinated|0
183791|NCT00441012|633135|P1|Overall Study|Subject Randomized but Not Vaccinated|1
183792|NCT00441012|633134|P2|Overall Study|Withdrawal by Subject|0
183793|NCT00441012|633135|P1|Overall Study|Withdrawal by Subject|4
183794|NCT00441012|633134|P2|Overall Study|Protocol Violation|9
183795|NCT00441012|633135|P1|Overall Study|Protocol Violation|10
183796|NCT00441012|633134|P2|Overall Study|Lost to Follow-up|3
183797|NCT00441012|633135|P1|Overall Study|Lost to Follow-up|3
183798|NCT00441012|633134|P2|Overall Study|Adverse Event|1
183799|NCT00441012|633135|P1|Overall Study|Adverse Event|0
183800|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
183801|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
183802|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
183803|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
183804|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
183805|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Physician Decision|1
183806|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Physician Decision|0
183807|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Physician Decision|0
183808|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Physician Decision|0
183809|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Physician Decision|0
183810|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Other|0
183811|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Other|1
183812|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Other|0
183813|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Other|0
183814|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Other|0
183815|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
183816|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
183817|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
183818|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
183819|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
183820|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Sponsor Request|1
183821|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Sponsor Request|1
183822|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Sponsor Request|0
183823|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Sponsor Request|0
183824|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Sponsor Request|0
183825|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Participant Moved|1
183826|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Participant Moved|1
183827|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Participant Moved|0
183828|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Participant Moved|0
183829|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Participant Moved|0
183830|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Pregnancy|0
183831|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Pregnancy|3
183832|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Pregnancy|0
183833|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Pregnancy|0
183834|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Pregnancy|0
183835|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
183836|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
183837|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
183838|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
183839|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
183840|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Protocol Violation|0
183841|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Protocol Violation|1
183842|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Protocol Violation|0
183843|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Protocol Violation|0
183844|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Protocol Violation|0
183845|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
183846|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
183847|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
183848|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
183849|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
183850|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Non-compliance|1
183851|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Non-compliance|1
183852|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Non-compliance|0
183853|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Non-compliance|0
183854|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Non-compliance|0
183855|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
183856|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
183857|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
183858|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
183859|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
183860|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
183861|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
183862|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
183863|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
183864|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
183865|NCT00440947|633149|P5|Optional 60-Week Extension Phase|Adverse Event|3
183866|NCT00440947|633150|P4|Optional 60-Week Extension Phase|Adverse Event|1
183867|NCT00440947|633151|P3|Optional 60-Week Extension Phase|Adverse Event|0
183868|NCT00440947|633152|P2|Optional 60-Week Extension Phase|Adverse Event|0
183869|NCT00440947|633153|P1|Optional 60-Week Extension Phase|Adverse Event|0
183870|NCT00440947|633149|P5|48-Week Randomization Phase|Physician Decision|0
183871|NCT00440947|633150|P4|48-Week Randomization Phase|Physician Decision|0
183872|NCT00440947|633151|P3|48-Week Randomization Phase|Physician Decision|0
183873|NCT00440947|633152|P2|48-Week Randomization Phase|Physician Decision|2
183874|NCT00440947|633153|P1|48-Week Randomization Phase|Physician Decision|0
183875|NCT00440947|633149|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
183876|NCT00440947|633150|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
183877|NCT00440947|633151|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
183878|NCT00440947|633152|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
183879|NCT00440947|633153|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
183880|NCT00440947|633149|P5|48-Week Randomization Phase|Incarceration|0
183881|NCT00440947|633150|P4|48-Week Randomization Phase|Incarceration|0
183882|NCT00440947|633151|P3|48-Week Randomization Phase|Incarceration|0
183883|NCT00440947|633152|P2|48-Week Randomization Phase|Incarceration|3
183884|NCT00440947|633153|P1|48-Week Randomization Phase|Incarceration|0
183885|NCT00440947|633149|P5|48-Week Randomization Phase|Pregnancy|0
183886|NCT00440947|633150|P4|48-Week Randomization Phase|Pregnancy|0
183887|NCT00440947|633151|P3|48-Week Randomization Phase|Pregnancy|1
183888|NCT00440947|633152|P2|48-Week Randomization Phase|Pregnancy|0
183889|NCT00440947|633153|P1|48-Week Randomization Phase|Pregnancy|0
183890|NCT00440947|633149|P5|48-Week Randomization Phase|Withdrawal by Subject|0
183891|NCT00440947|633150|P4|48-Week Randomization Phase|Withdrawal by Subject|0
183892|NCT00440947|633151|P3|48-Week Randomization Phase|Withdrawal by Subject|4
183893|NCT00440947|633152|P2|48-Week Randomization Phase|Withdrawal by Subject|2
183894|NCT00440947|633153|P1|48-Week Randomization Phase|Withdrawal by Subject|0
183895|NCT00440947|633149|P5|48-Week Randomization Phase|Protocol Violation|0
183896|NCT00440947|633150|P4|48-Week Randomization Phase|Protocol Violation|0
183897|NCT00440947|633151|P3|48-Week Randomization Phase|Protocol Violation|1
183898|NCT00440947|633152|P2|48-Week Randomization Phase|Protocol Violation|0
183899|NCT00440947|633153|P1|48-Week Randomization Phase|Protocol Violation|0
183900|NCT00440947|633149|P5|48-Week Randomization Phase|Lost to Follow-up|0
183901|NCT00440947|633150|P4|48-Week Randomization Phase|Lost to Follow-up|0
183902|NCT00440947|633151|P3|48-Week Randomization Phase|Lost to Follow-up|8
183903|NCT00440947|633152|P2|48-Week Randomization Phase|Lost to Follow-up|2
183904|NCT00440947|633153|P1|48-Week Randomization Phase|Lost to Follow-up|0
183905|NCT00440947|633149|P5|48-Week Randomization Phase|Non-compliance|0
183906|NCT00440947|633150|P4|48-Week Randomization Phase|Non-compliance|0
183907|NCT00440947|633151|P3|48-Week Randomization Phase|Non-compliance|4
183908|NCT00440947|633152|P2|48-Week Randomization Phase|Non-compliance|3
183909|NCT00440947|633153|P1|48-Week Randomization Phase|Non-compliance|0
183910|NCT00440947|633149|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
183911|NCT00440947|633150|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
183912|NCT00440947|633151|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
183913|NCT00440947|633152|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
183914|NCT00440947|633153|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
183915|NCT00440947|633149|P5|48-Week Randomization Phase|Adverse Event|0
183916|NCT00440947|633150|P4|48-Week Randomization Phase|Adverse Event|0
183917|NCT00440947|633151|P3|48-Week Randomization Phase|Adverse Event|5
183918|NCT00440947|633152|P2|48-Week Randomization Phase|Adverse Event|2
183919|NCT00440947|633153|P1|48-Week Randomization Phase|Adverse Event|0
183920|NCT00440947|633149|P5|36-Week Induction Phase|Pregnancy|0
183921|NCT00440947|633150|P4|36-Week Induction Phase|Pregnancy|0
183922|NCT00440947|633151|P3|36-Week Induction Phase|Pregnancy|0
183923|NCT00440947|633152|P2|36-Week Induction Phase|Pregnancy|0
183924|NCT00440947|633153|P1|36-Week Induction Phase|Pregnancy|1
183925|NCT00440947|633149|P5|36-Week Induction Phase|Incarceration|0
183926|NCT00440947|633150|P4|36-Week Induction Phase|Incarceration|0
183927|NCT00440947|633151|P3|36-Week Induction Phase|Incarceration|0
183928|NCT00440947|633152|P2|36-Week Induction Phase|Incarceration|0
183929|NCT00440947|633153|P1|36-Week Induction Phase|Incarceration|3
183930|NCT00440947|633149|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
183931|NCT00440947|633150|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
183932|NCT00440947|633151|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
183933|NCT00440947|633152|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
183934|NCT00440947|633153|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
183935|NCT00440947|633149|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
183936|NCT00440947|633150|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
183937|NCT00440947|633151|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
183938|NCT00440947|633152|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
183939|NCT00440947|633153|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
183940|NCT00440947|633149|P5|36-Week Induction Phase|Took Exclusionary Medications|0
183941|NCT00440947|633150|P4|36-Week Induction Phase|Took Exclusionary Medications|0
183942|NCT00440947|633151|P3|36-Week Induction Phase|Took Exclusionary Medications|0
183943|NCT00440947|633152|P2|36-Week Induction Phase|Took Exclusionary Medications|0
183944|NCT00440947|633153|P1|36-Week Induction Phase|Took Exclusionary Medications|1
183945|NCT00440947|633149|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
183946|NCT00440947|633150|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
183947|NCT00440947|633151|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
183948|NCT00440947|633152|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
183949|NCT00440947|633153|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
183950|NCT00440947|633149|P5|36-Week Induction Phase|Withdrawal by Subject|0
183951|NCT00440947|633150|P4|36-Week Induction Phase|Withdrawal by Subject|0
183952|NCT00440947|633151|P3|36-Week Induction Phase|Withdrawal by Subject|0
183953|NCT00440947|633152|P2|36-Week Induction Phase|Withdrawal by Subject|0
183954|NCT00440947|633153|P1|36-Week Induction Phase|Withdrawal by Subject|7
183955|NCT00440947|633149|P5|36-Week Induction Phase|Lost to Follow-up|0
183956|NCT00440947|633150|P4|36-Week Induction Phase|Lost to Follow-up|0
183957|NCT00440947|633151|P3|36-Week Induction Phase|Lost to Follow-up|0
183958|NCT00440947|633152|P2|36-Week Induction Phase|Lost to Follow-up|0
183959|NCT00440947|633153|P1|36-Week Induction Phase|Lost to Follow-up|16
183960|NCT00440947|633149|P5|36-Week Induction Phase|Non-compliance|0
183961|NCT00440947|633150|P4|36-Week Induction Phase|Non-compliance|0
183962|NCT00440947|633151|P3|36-Week Induction Phase|Non-compliance|0
183963|NCT00440947|633152|P2|36-Week Induction Phase|Non-compliance|0
183964|NCT00440947|633153|P1|36-Week Induction Phase|Non-compliance|10
183965|NCT00440947|633149|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
183966|NCT00440947|633150|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
183967|NCT00440947|633151|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
183968|NCT00440947|633152|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
183969|NCT00440947|633153|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
183970|NCT00440947|633149|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
183971|NCT00440947|633150|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
183972|NCT00440947|633151|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
183973|NCT00440947|633152|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
183974|NCT00440947|633153|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
183975|NCT00440947|633149|P5|36-Week Induction Phase|Adverse Event|0
183976|NCT00440947|633150|P4|36-Week Induction Phase|Adverse Event|0
183977|NCT00440947|633151|P3|36-Week Induction Phase|Adverse Event|0
183978|NCT00440947|633152|P2|36-Week Induction Phase|Adverse Event|0
183979|NCT00440947|633153|P1|36-Week Induction Phase|Adverse Event|16
183980|NCT00440700|633228|P3|Overall Study|Withdrawal by Subject|4
183981|NCT00440700|633229|P2|Overall Study|Withdrawal by Subject|8
183982|NCT00440700|633230|P1|Overall Study|Withdrawal by Subject|8
183983|NCT00440557|633253|P3|Overall Study|Patient had surgery|0
183984|NCT00440557|633254|P2|Overall Study|Patient had surgery|0
183985|NCT00440557|633255|P1|Overall Study|Patient had surgery|1
183986|NCT00440557|633253|P3|Overall Study|Patient transferred to nursing home|0
183987|NCT00440557|633254|P2|Overall Study|Patient transferred to nursing home|1
183988|NCT00440557|633255|P1|Overall Study|Patient transferred to nursing home|0
183989|NCT00440557|633253|P3|Overall Study|Principal Investigator's office closed|4
183990|NCT00440557|633254|P2|Overall Study|Principal Investigator's office closed|6
183991|NCT00440557|633255|P1|Overall Study|Principal Investigator's office closed|3
183992|NCT00440557|633253|P3|Overall Study|Patient moved|1
183993|NCT00440557|633254|P2|Overall Study|Patient moved|2
183994|NCT00440557|633255|P1|Overall Study|Patient moved|1
183995|NCT00440557|633253|P3|Overall Study|Principal Investigator decision|1
183996|NCT00440557|633254|P2|Overall Study|Principal Investigator decision|3
183997|NCT00440557|633255|P1|Overall Study|Principal Investigator decision|0
183998|NCT00440557|633253|P3|Overall Study|Began Dialysis|4
183999|NCT00440557|633254|P2|Overall Study|Began Dialysis|1
184000|NCT00440557|633255|P1|Overall Study|Began Dialysis|4
184001|NCT00440557|633253|P3|Overall Study|Death|3
184002|NCT00440557|633254|P2|Overall Study|Death|6
184003|NCT00440557|633255|P1|Overall Study|Death|2
184004|NCT00440557|633253|P3|Overall Study|Adverse Event|5
184005|NCT00440557|633254|P2|Overall Study|Adverse Event|3
184006|NCT00440557|633255|P1|Overall Study|Adverse Event|3
184007|NCT00440557|633253|P3|Overall Study|Lost to Follow-up|6
184008|NCT00440557|633254|P2|Overall Study|Lost to Follow-up|2
184009|NCT00440557|633255|P1|Overall Study|Lost to Follow-up|1
184010|NCT00440557|633253|P3|Overall Study|Withdrawal by Subject|11
184011|NCT00440557|633254|P2|Overall Study|Withdrawal by Subject|5
184012|NCT00440557|633255|P1|Overall Study|Withdrawal by Subject|10
184013|NCT00440531|633287|P3|Overall Study|see pre-assignment details|0
184014|NCT00440531|633288|P2|Overall Study|see pre-assignment details|0
184015|NCT00440531|633289|P1|Overall Study|see pre-assignment details|2
184016|NCT00440531|633287|P3|Overall Study|Lost to Follow-up|5
184017|NCT00440531|633288|P2|Overall Study|Lost to Follow-up|3
184018|NCT00440531|633289|P1|Overall Study|Lost to Follow-up|4
184019|NCT00440531|633287|P3|Overall Study|Protocol Violation|0
184020|NCT00440531|633288|P2|Overall Study|Protocol Violation|2
184021|NCT00440531|633289|P1|Overall Study|Protocol Violation|1
184022|NCT00440531|633287|P3|Overall Study|Withdrawal by Subject|0
184023|NCT00440531|633288|P2|Overall Study|Withdrawal by Subject|0
184024|NCT00440531|633289|P1|Overall Study|Withdrawal by Subject|2
184025|NCT00440531|633287|P3|Overall Study|Adverse Event|2
184026|NCT00440531|633288|P2|Overall Study|Adverse Event|0
184027|NCT00440531|633289|P1|Overall Study|Adverse Event|1
184028|NCT00440518|633306|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
184029|NCT00440518|633307|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
184030|NCT00440518|633308|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
184031|NCT00440518|633306|P3|Maintenance and Safety Follow-up Periods|Other|2
184032|NCT00440518|633307|P2|Maintenance and Safety Follow-up Periods|Other|0
184033|NCT00440518|633308|P1|Maintenance and Safety Follow-up Periods|Other|0
184034|NCT00440518|633306|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
184035|NCT00440518|633307|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
184036|NCT00440518|633308|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
184037|NCT00440518|633306|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
184038|NCT00440518|633307|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
184039|NCT00440518|633308|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
184040|NCT00440518|633306|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
184041|NCT00440518|633307|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
184042|NCT00440518|633308|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
184043|NCT00440518|633306|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
184044|NCT00440518|633307|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
184045|NCT00440518|633308|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
184046|NCT00440518|633306|P3|Randomized /Titration Period|Adverse Event|0
184047|NCT00440518|633307|P2|Randomized /Titration Period|Adverse Event|3
184048|NCT00440518|633308|P1|Randomized /Titration Period|Adverse Event|2
184049|NCT00440518|633306|P3|Randomized /Titration Period|Lost to Follow-up|1
184050|NCT00440518|633307|P2|Randomized /Titration Period|Lost to Follow-up|2
184051|NCT00440518|633308|P1|Randomized /Titration Period|Lost to Follow-up|2
184052|NCT00440518|633306|P3|Randomized /Titration Period|Other|0
184053|NCT00440518|633307|P2|Randomized /Titration Period|Other|0
184054|NCT00440518|633308|P1|Randomized /Titration Period|Other|1
184055|NCT00440518|633306|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
184056|NCT00440518|633307|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
184057|NCT00440518|633308|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
184058|NCT00440518|633306|P3|Randomized /Titration Period|Protocol Deviation|0
184059|NCT00440518|633307|P2|Randomized /Titration Period|Protocol Deviation|0
184060|NCT00440518|633308|P1|Randomized /Titration Period|Protocol Deviation|1
184061|NCT00440518|633306|P3|Randomized /Titration Period|Subject Withdrew Consent|0
184062|NCT00440518|633307|P2|Randomized /Titration Period|Subject Withdrew Consent|1
184063|NCT00440518|633308|P1|Randomized /Titration Period|Subject Withdrew Consent|4
184064|NCT00440518|633306|P3|Randomized /Titration Period|Lack of Efficacy|1
184065|NCT00440518|633307|P2|Randomized /Titration Period|Lack of Efficacy|0
184066|NCT00440518|633308|P1|Randomized /Titration Period|Lack of Efficacy|1
184067|NCT00440466|633353|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
184068|NCT00440466|633354|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
184069|NCT00440466|633355|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
184070|NCT00440466|633353|P3|Overall Study|Began Dialysis|1
184071|NCT00440466|633354|P2|Overall Study|Began Dialysis|0
184072|NCT00440466|633355|P1|Overall Study|Began Dialysis|0
184073|NCT00440466|633353|P3|Overall Study|Withdrawal by Subject|9
184074|NCT00440466|633354|P2|Overall Study|Withdrawal by Subject|5
184075|NCT00440466|633355|P1|Overall Study|Withdrawal by Subject|2
184076|NCT00440466|633353|P3|Overall Study|Protocol Violation|4
184077|NCT00440466|633354|P2|Overall Study|Protocol Violation|0
184078|NCT00440466|633355|P1|Overall Study|Protocol Violation|2
184079|NCT00440466|633353|P3|Overall Study|Physician Decision|1
184080|NCT00440466|633354|P2|Overall Study|Physician Decision|0
184081|NCT00440466|633355|P1|Overall Study|Physician Decision|2
184082|NCT00440466|633353|P3|Overall Study|Lost to Follow-up|2
184083|NCT00440466|633354|P2|Overall Study|Lost to Follow-up|0
184084|NCT00440466|633355|P1|Overall Study|Lost to Follow-up|1
184085|NCT00440466|633353|P3|Overall Study|Adverse Event|11
184086|NCT00440466|633354|P2|Overall Study|Adverse Event|4
184087|NCT00440466|633355|P1|Overall Study|Adverse Event|3
184088|NCT00440466|633353|P3|Overall Study|Death|9
184089|NCT00440466|633354|P2|Overall Study|Death|2
184090|NCT00440466|633355|P1|Overall Study|Death|3
184091|NCT00440401|633389|P2|Overall Study|Not specified|5
184092|NCT00440401|633390|P1|Overall Study|Not specified|2
184093|NCT00440401|633389|P2|Overall Study|Adverse Event|1
184094|NCT00440401|633390|P1|Overall Study|Adverse Event|2
184095|NCT00440310|633400|P2|Overall Study|Status Unknown|3
184096|NCT00440310|633401|P1|Overall Study|Status Unknown|1
184097|NCT00440310|633400|P2|Overall Study|Other|0
184098|NCT00440310|633401|P1|Overall Study|Other|1
184099|NCT00440310|633400|P2|Overall Study|No Reply at EOS|7
184100|NCT00440310|633401|P1|Overall Study|No Reply at EOS|7
184101|NCT00440310|633400|P2|Overall Study|Withdrawal by Subject|14
184102|NCT00440310|633401|P1|Overall Study|Withdrawal by Subject|15
184103|NCT00440310|633400|P2|Overall Study|Protocol Violation|1
184104|NCT00440310|633401|P1|Overall Study|Protocol Violation|0
184105|NCT00440310|633400|P2|Overall Study|Lost to Follow-up|5
184106|NCT00440310|633401|P1|Overall Study|Lost to Follow-up|4
184107|NCT00440297|633409|P2|Overall Study|Randomized by mistake|0
184108|NCT00440297|633410|P1|Overall Study|Randomized by mistake|1
184109|NCT00440297|633409|P2|Overall Study|Withdrawal by Subject|6
184110|NCT00440297|633410|P1|Overall Study|Withdrawal by Subject|1
184111|NCT00440297|633409|P2|Overall Study|Protocol Violation|7
184112|NCT00440297|633410|P1|Overall Study|Protocol Violation|11
184113|NCT00440297|633409|P2|Overall Study|Physician Decision|0
184114|NCT00440297|633410|P1|Overall Study|Physician Decision|1
184115|NCT00440297|633409|P2|Overall Study|Lost to Follow-up|0
184116|NCT00440297|633410|P1|Overall Study|Lost to Follow-up|1
184117|NCT00440297|633409|P2|Overall Study|Adverse Event|5
184118|NCT00440297|633410|P1|Overall Study|Adverse Event|8
184119|NCT00440271|633426|P2|Overall Study|Other|0
184120|NCT00440271|633427|P1|Overall Study|Other|2
184121|NCT00440271|633426|P2|Overall Study|Due to closure of trial|10
184122|NCT00440271|633427|P1|Overall Study|Due to closure of trial|8
184123|NCT00440271|633426|P2|Overall Study|Lack of Efficacy|1
184124|NCT00440271|633427|P1|Overall Study|Lack of Efficacy|0
184125|NCT00440271|633426|P2|Overall Study|Withdrawal by Subject|2
184126|NCT00440271|633427|P1|Overall Study|Withdrawal by Subject|0
184127|NCT00440271|633426|P2|Overall Study|Lost to Follow-up|0
184128|NCT00440271|633427|P1|Overall Study|Lost to Follow-up|1
184129|NCT00440271|633426|P2|Overall Study|Adverse Event|1
184130|NCT00440271|633427|P1|Overall Study|Adverse Event|0
184131|NCT00440271|633426|P2|Overall Study|Protocol Violation|1
184132|NCT00440271|633427|P1|Overall Study|Protocol Violation|1
184133|NCT00440232|633461|P2|Overall Study|Onset of headache within 4 hours of fast|2
184134|NCT00440232|633462|P1|Overall Study|Onset of headache within 4 hours of fast|2
184135|NCT00440232|633461|P2|Overall Study|Unable to treat within allowed time|1
184136|NCT00440232|633462|P1|Overall Study|Unable to treat within allowed time|0
184137|NCT00440232|633461|P2|Overall Study|Lost to Follow-up|1
184138|NCT00440232|633462|P1|Overall Study|Lost to Follow-up|1
184139|NCT00440193|633472|P2|Observational Period|Participant convenience|0
184140|NCT00440193|633473|P1|Observational Period|Participant convenience|2
184141|NCT00440193|633472|P2|Observational Period|Clinical endpoint reached|0
184142|NCT00440193|633473|P1|Observational Period|Clinical endpoint reached|1
184143|NCT00440193|633472|P2|Observational Period|Physician Decision|0
184144|NCT00440193|633473|P1|Observational Period|Physician Decision|1
184145|NCT00440193|633472|P2|Observational Period|Withdrawal by Subject|8
184146|NCT00440193|633473|P1|Observational Period|Withdrawal by Subject|11
184147|NCT00440193|633472|P2|Observational Period|Protocol Violation|0
184148|NCT00440193|633473|P1|Observational Period|Protocol Violation|1
184149|NCT00440193|633472|P2|Observational Period|Lost to Follow-up|8
184150|NCT00440193|633473|P1|Observational Period|Lost to Follow-up|12
184151|NCT00440193|633472|P2|Observational Period|Death|20
184152|NCT00440193|633473|P1|Observational Period|Death|15
184153|NCT00440193|633472|P2|Observational Period|Adverse Event|2
184154|NCT00440193|633473|P1|Observational Period|Adverse Event|2
184155|NCT00440193|633472|P2|Treatment Period|Site closed by investigator|2
184156|NCT00440193|633473|P1|Treatment Period|Site closed by investigator|0
184157|NCT00440193|633472|P2|Treatment Period|Participant did not receive treatment|13
184158|NCT00440193|633473|P1|Treatment Period|Participant did not receive treatment|7
184159|NCT00440193|633472|P2|Treatment Period|Participant convenience|2
184160|NCT00440193|633473|P1|Treatment Period|Participant convenience|5
184161|NCT00440193|633472|P2|Treatment Period|Technical problems|1
184162|NCT00440193|633473|P1|Treatment Period|Technical problems|1
184163|NCT00440193|633472|P2|Treatment Period|Switch to commercial drug|2
184164|NCT00440193|633473|P1|Treatment Period|Switch to commercial drug|0
184165|NCT00440193|633472|P2|Treatment Period|Protocol driven decision point|2
184166|NCT00440193|633473|P1|Treatment Period|Protocol driven decision point|2
184167|NCT00440193|633472|P2|Treatment Period|Study terminated by sponsor|94
184168|NCT00440193|633473|P1|Treatment Period|Study terminated by sponsor|102
184169|NCT00440193|633472|P2|Treatment Period|Clinical endpoint reached|25
184170|NCT00440193|633473|P1|Treatment Period|Clinical endpoint reached|28
184171|NCT00440193|633472|P2|Treatment Period|Withdrawal by Subject|77
184172|NCT00440193|633473|P1|Treatment Period|Withdrawal by Subject|36
184173|NCT00440193|633472|P2|Treatment Period|Protocol Violation|19
184174|NCT00440193|633473|P1|Treatment Period|Protocol Violation|16
184175|NCT00440193|633472|P2|Treatment Period|Physician Decision|6
184176|NCT00440193|633473|P1|Treatment Period|Physician Decision|3
184177|NCT00440193|633472|P2|Treatment Period|Lost to Follow-up|18
184178|NCT00440193|633473|P1|Treatment Period|Lost to Follow-up|12
184179|NCT00440193|633472|P2|Treatment Period|Lack of Efficacy|1
184180|NCT00440193|633473|P1|Treatment Period|Lack of Efficacy|0
184181|NCT00440193|633472|P2|Treatment Period|Death|22
184182|NCT00440193|633473|P1|Treatment Period|Death|19
184183|NCT00440193|633472|P2|Treatment Period|Adverse Event|67
184184|NCT00440193|633473|P1|Treatment Period|Adverse Event|74
184185|NCT00440115|633519|P3|Overall Study|Incarceration|1
184186|NCT00440115|633520|P2|Overall Study|Incarceration|2
184187|NCT00440115|633521|P1|Overall Study|Incarceration|0
184188|NCT00440115|633519|P3|Overall Study|Death|5
184189|NCT00440115|633520|P2|Overall Study|Death|9
184190|NCT00440115|633521|P1|Overall Study|Death|7
184191|NCT00440011|633552|P2|Overall Study|Withdrawal by Subject|0
184192|NCT00440011|633553|P1|Overall Study|Withdrawal by Subject|1
184193|NCT00440011|633552|P2|Overall Study|Protocol Violation|1
184194|NCT00440011|633553|P1|Overall Study|Protocol Violation|1
184195|NCT00440011|633552|P2|Overall Study|Lost to Follow-up|2
184196|NCT00440011|633553|P1|Overall Study|Lost to Follow-up|0
184197|NCT00440011|633552|P2|Overall Study|Adverse Event|0
184198|NCT00440011|633553|P1|Overall Study|Adverse Event|2
184199|NCT00439777|633580|P2|Observational Period|Technical problems|1
184200|NCT00439777|633581|P1|Observational Period|Technical problems|0
184201|NCT00439777|633580|P2|Observational Period|Lack of Efficacy|0
184202|NCT00439777|633581|P1|Observational Period|Lack of Efficacy|1
184203|NCT00439777|633580|P2|Observational Period|Protocol driven decision point|1
184204|NCT00439777|633581|P1|Observational Period|Protocol driven decision point|0
184205|NCT00439777|633580|P2|Observational Period|Study terminated by sponsor|1
184206|NCT00439777|633581|P1|Observational Period|Study terminated by sponsor|3
184207|NCT00439777|633580|P2|Observational Period|Death|20
184208|NCT00439777|633581|P1|Observational Period|Death|27
184209|NCT00439777|633580|P2|Observational Period|Lost to Follow-up|11
184210|NCT00439777|633581|P1|Observational Period|Lost to Follow-up|1
184211|NCT00439777|633580|P2|Observational Period|Withdrawal by Subject|5
184212|NCT00439777|633581|P1|Observational Period|Withdrawal by Subject|9
184213|NCT00439777|633580|P2|Observational Period|Protocol Violation|2
184214|NCT00439777|633581|P1|Observational Period|Protocol Violation|0
184215|NCT00439777|633580|P2|Treatment Period|Participant convenience|8
184216|NCT00439777|633581|P1|Treatment Period|Participant convenience|12
184217|NCT00439777|633580|P2|Treatment Period|Technical problems|1
184218|NCT00439777|633581|P1|Treatment Period|Technical problems|3
184219|NCT00439777|633580|P2|Treatment Period|Clinical endpoint reached|13
184220|NCT00439777|633581|P1|Treatment Period|Clinical endpoint reached|26
184221|NCT00439777|633580|P2|Treatment Period|Physician Decision|18
184222|NCT00439777|633581|P1|Treatment Period|Physician Decision|7
184223|NCT00439777|633580|P2|Treatment Period|Protocol driven decision point|3
184224|NCT00439777|633581|P1|Treatment Period|Protocol driven decision point|1
184225|NCT00439777|633580|P2|Treatment Period|Lost to Follow-up|10
184226|NCT00439777|633581|P1|Treatment Period|Lost to Follow-up|8
184227|NCT00439777|633580|P2|Treatment Period|Lack of Efficacy|4
184228|NCT00439777|633581|P1|Treatment Period|Lack of Efficacy|1
184229|NCT00439777|633580|P2|Treatment Period|Withdrawal by Subject|118
184230|NCT00439777|633581|P1|Treatment Period|Withdrawal by Subject|66
184231|NCT00439777|633580|P2|Treatment Period|Protocol Violation|30
184232|NCT00439777|633581|P1|Treatment Period|Protocol Violation|23
184233|NCT00439777|633580|P2|Treatment Period|Adverse Event|92
184234|NCT00439777|633581|P1|Treatment Period|Adverse Event|111
184235|NCT00439777|633580|P2|Treatment Period|Did not take study treatment|8
184236|NCT00439777|633581|P1|Treatment Period|Did not take study treatment|7
184237|NCT00439777|633580|P2|Treatment Period|Site closed by investigator|1
184238|NCT00439777|633581|P1|Treatment Period|Site closed by investigator|0
184239|NCT00439777|633580|P2|Treatment Period|Study terminated by sponsor|132
184240|NCT00439777|633581|P1|Treatment Period|Study terminated by sponsor|125
184241|NCT00439777|633580|P2|Treatment Period|Death|21
184242|NCT00439777|633581|P1|Treatment Period|Death|29
184243|NCT00439738|633619|P2|Overall Study|Abnormal Lab Values|0
184244|NCT00439738|633620|P1|Overall Study|Abnormal Lab Values|1
184245|NCT00439738|633619|P2|Overall Study|Lack of Efficacy|2
184246|NCT00439738|633620|P1|Overall Study|Lack of Efficacy|2
184247|NCT00439738|633619|P2|Overall Study|Protocol Violation|3
184248|NCT00439738|633620|P1|Overall Study|Protocol Violation|6
184249|NCT00439738|633619|P2|Overall Study|Lost to Follow-up|6
184250|NCT00439738|633620|P1|Overall Study|Lost to Follow-up|5
184251|NCT00439738|633619|P2|Overall Study|Adverse Event|4
184252|NCT00439738|633620|P1|Overall Study|Adverse Event|6
184253|NCT00439738|633619|P2|Overall Study|Withdrawal by Subject|13
184254|NCT00439738|633620|P1|Overall Study|Withdrawal by Subject|16
184255|NCT00439725|633638|P2|Observational Period|Participant convenience|0
184256|NCT00439725|633639|P1|Observational Period|Participant convenience|1
184257|NCT00439725|633638|P2|Observational Period|Technical problems|0
184258|NCT00439725|633639|P1|Observational Period|Technical problems|1
184259|NCT00439725|633638|P2|Observational Period|Clinical endpoint reached|1
184260|NCT00439725|633639|P1|Observational Period|Clinical endpoint reached|3
184261|NCT00439725|633638|P2|Observational Period|Study termination by sponsor|1
184262|NCT00439725|633639|P1|Observational Period|Study termination by sponsor|1
184263|NCT00439725|633638|P2|Observational Period|Death|2
184264|NCT00439725|633639|P1|Observational Period|Death|0
184265|NCT00439725|633638|P2|Observational Period|Lost to Follow-up|1
184266|NCT00439725|633639|P1|Observational Period|Lost to Follow-up|0
184267|NCT00439725|633638|P2|Observational Period|Withdrawal by Subject|2
184268|NCT00439725|633639|P1|Observational Period|Withdrawal by Subject|2
184269|NCT00439725|633638|P2|Treatment Period|Participant did not receive treatment|4
184270|NCT00439725|633639|P1|Treatment Period|Participant did not receive treatment|4
184271|NCT00439725|633638|P2|Treatment Period|Death|1
184272|NCT00439725|633639|P1|Treatment Period|Death|1
184273|NCT00439725|633638|P2|Treatment Period|Protocol driven decision point|1
184274|NCT00439725|633639|P1|Treatment Period|Protocol driven decision point|1
184275|NCT00439725|633638|P2|Treatment Period|Participant convenience|0
184276|NCT00439725|633639|P1|Treatment Period|Participant convenience|1
184277|NCT00439725|633638|P2|Treatment Period|Lost to Follow-up|1
184278|NCT00439725|633639|P1|Treatment Period|Lost to Follow-up|1
184279|NCT00439725|633638|P2|Treatment Period|Technical problems|0
184280|NCT00439725|633639|P1|Treatment Period|Technical problems|1
184281|NCT00439725|633638|P2|Treatment Period|Clinical endpoint reached|50
184282|NCT00439725|633639|P1|Treatment Period|Clinical endpoint reached|6
184283|NCT00439725|633638|P2|Treatment Period|Protocol Violation|1
184284|NCT00439725|633639|P1|Treatment Period|Protocol Violation|2
184285|NCT00439725|633638|P2|Treatment Period|Physician Decision|1
184286|NCT00439725|633639|P1|Treatment Period|Physician Decision|1
184287|NCT00439725|633638|P2|Treatment Period|Adverse Event|18
184288|NCT00439725|633639|P1|Treatment Period|Adverse Event|39
184289|NCT00439725|633638|P2|Treatment Period|Site closed by investigator|2
184290|NCT00439725|633639|P1|Treatment Period|Site closed by investigator|1
184291|NCT00439725|633638|P2|Treatment Period|Study terminated by sponsor|148
184292|NCT00439725|633639|P1|Treatment Period|Study terminated by sponsor|156
184293|NCT00439725|633638|P2|Treatment Period|Withdrawal by Subject|19
184294|NCT00439725|633639|P1|Treatment Period|Withdrawal by Subject|22
184295|NCT00439647|633685|P2|Overall Study|Lack of Efficacy|4
184296|NCT00439647|633686|P1|Overall Study|Lack of Efficacy|0
184297|NCT00439647|633685|P2|Overall Study|Protocol Violation|4
184298|NCT00439647|633686|P1|Overall Study|Protocol Violation|3
184299|NCT00439647|633685|P2|Overall Study|Lost to Follow-up|12
184300|NCT00439647|633686|P1|Overall Study|Lost to Follow-up|4
184301|NCT00439647|633685|P2|Overall Study|Adverse Event|11
184302|NCT00439647|633686|P1|Overall Study|Adverse Event|11
184303|NCT00439647|633685|P2|Overall Study|Death|18
184304|NCT00439647|633686|P1|Overall Study|Death|15
184305|NCT00439647|633685|P2|Overall Study|Withdrawal by Subject|22
184306|NCT00439647|633686|P1|Overall Study|Withdrawal by Subject|25
184307|NCT00439569|633722|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
184308|NCT00439569|633722|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
184309|NCT00439569|633722|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
184310|NCT00439517|633735|P2|Overall Study|Subject in survival follow-up|0
184311|NCT00439517|633736|P1|Overall Study|Subject in survival follow-up|1
184312|NCT00439517|633735|P2|Overall Study|Subject on treatment|0
184313|NCT00439517|633736|P1|Overall Study|Subject on treatment|1
184314|NCT00439309|633804|P2|Follow-Up|Late response by subject|1
184315|NCT00439309|633805|P1|Follow-Up|Late response by subject|0
184316|NCT00439309|633804|P2|Follow-Up|Withdrawal by Subject|1
184317|NCT00439309|633805|P1|Follow-Up|Withdrawal by Subject|0
184318|NCT00439309|633804|P2|Follow-Up|Lost to Follow-up|0
184319|NCT00439309|633805|P1|Follow-Up|Lost to Follow-up|2
184320|NCT00439309|633804|P2|Follow-Up|Death|0
184321|NCT00439309|633805|P1|Follow-Up|Death|1
184322|NCT00439270|633824|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
184323|NCT00439270|633825|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
184324|NCT00439270|633826|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
184325|NCT00439270|633827|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
184326|NCT00439270|633828|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
184327|NCT00439270|633824|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
184328|NCT00439270|633825|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
184329|NCT00439270|633826|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
184330|NCT00439270|633827|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
184331|NCT00439270|633828|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
184332|NCT00439270|633824|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
184333|NCT00439270|633825|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
184334|NCT00439270|633826|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
184335|NCT00439270|633827|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
184336|NCT00439270|633828|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
184337|NCT00439270|633824|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
184338|NCT00439270|633825|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
184339|NCT00439270|633826|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
184340|NCT00439270|633827|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
184341|NCT00439270|633828|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
184342|NCT00439270|633824|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
184343|NCT00439270|633825|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
184344|NCT00439270|633826|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
184345|NCT00439270|633827|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
184346|NCT00439270|633828|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
184347|NCT00439270|633824|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
184348|NCT00439270|633825|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
184349|NCT00439270|633826|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
184350|NCT00439270|633827|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
184351|NCT00439270|633828|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
184352|NCT00439270|633824|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
184353|NCT00439270|633825|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
184354|NCT00439270|633826|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
184355|NCT00439270|633827|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
184356|NCT00439270|633828|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
184357|NCT00439270|633824|P5|Phase 2 (51.6 Months)|Disease progression|0
184358|NCT00439270|633825|P4|Phase 2 (51.6 Months)|Disease progression|18
184359|NCT00439270|633826|P3|Phase 2 (51.6 Months)|Disease progression|0
184360|NCT00439270|633827|P2|Phase 2 (51.6 Months)|Disease progression|0
184361|NCT00439270|633828|P1|Phase 2 (51.6 Months)|Disease progression|0
184362|NCT00439270|633824|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
184363|NCT00439270|633825|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
184364|NCT00439270|633826|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
184365|NCT00439270|633827|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
184366|NCT00439270|633828|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
184367|NCT00439270|633824|P5|Phase 1 (18.1 Months)|Disease progression|3
184368|NCT00439270|633825|P4|Phase 1 (18.1 Months)|Disease progression|0
184369|NCT00439270|633826|P3|Phase 1 (18.1 Months)|Disease progression|3
184370|NCT00439270|633827|P2|Phase 1 (18.1 Months)|Disease progression|2
184371|NCT00439270|633828|P1|Phase 1 (18.1 Months)|Disease progression|3
184372|NCT00439244|633870|P3|Overall Study|Administrative problems|0
184373|NCT00439244|633871|P2|Overall Study|Administrative problems|0
184374|NCT00439244|633872|P1|Overall Study|Administrative problems|1
184375|NCT00439244|633870|P3|Overall Study|Protocol Violation|0
184376|NCT00439244|633871|P2|Overall Study|Protocol Violation|1
184377|NCT00439244|633872|P1|Overall Study|Protocol Violation|0
184378|NCT00439244|633870|P3|Overall Study|Death|0
184379|NCT00439244|633871|P2|Overall Study|Death|1
184380|NCT00439244|633872|P1|Overall Study|Death|0
184381|NCT00439244|633870|P3|Overall Study|Lost to Follow-up|2
184382|NCT00439244|633871|P2|Overall Study|Lost to Follow-up|1
184383|NCT00439244|633872|P1|Overall Study|Lost to Follow-up|2
184384|NCT00439244|633870|P3|Overall Study|Withdrawal by Subject|2
184385|NCT00439244|633871|P2|Overall Study|Withdrawal by Subject|1
184386|NCT00439244|633872|P1|Overall Study|Withdrawal by Subject|3
184387|NCT00439244|633870|P3|Overall Study|Adverse Event|3
184388|NCT00439244|633871|P2|Overall Study|Adverse Event|2
184389|NCT00439244|633872|P1|Overall Study|Adverse Event|5
184390|NCT00439231|633892|P1|Overall Study|Lack of Efficacy|28
184391|NCT00439218|633896|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
184392|NCT00439179|633911|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
184393|NCT00439179|633912|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
184394|NCT00439179|633913|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
184395|NCT00439179|633914|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
184396|NCT00439140|633931|P3|Treatment Cycle 2|Lost to Follow-up|0
184397|NCT00439140|633932|P2|Treatment Cycle 2|Lost to Follow-up|1
184398|NCT00439140|633933|P1|Treatment Cycle 2|Lost to Follow-up|1
184399|NCT00439140|633931|P3|Treatment Cycle 2|Withdrawal by Subject|0
184400|NCT00439140|633932|P2|Treatment Cycle 2|Withdrawal by Subject|0
184401|NCT00439140|633933|P1|Treatment Cycle 2|Withdrawal by Subject|1
184402|NCT00439140|633931|P3|Treatment Cycle 1|Withdrawal by Subject|0
184403|NCT00439140|633932|P2|Treatment Cycle 1|Withdrawal by Subject|1
184404|NCT00439140|633933|P1|Treatment Cycle 1|Withdrawal by Subject|0
184405|NCT00439140|633931|P3|Treatment Cycle 1|Personal reasons|0
184406|NCT00439140|633932|P2|Treatment Cycle 1|Personal reasons|2
184407|NCT00439140|633933|P1|Treatment Cycle 1|Personal reasons|0
184408|NCT00439140|633931|P3|Treatment Cycle 1|Lost to Follow-up|1
184409|NCT00439140|633932|P2|Treatment Cycle 1|Lost to Follow-up|1
184410|NCT00439140|633933|P1|Treatment Cycle 1|Lost to Follow-up|1
184411|NCT00438815|634016|P1|Overall Study|Death|1
184412|NCT00438815|634016|P1|Overall Study|Withdrawal by Subject|6
184413|NCT00438815|634016|P1|Overall Study|Lost to Follow-up|6
184414|NCT00438815|634016|P1|Overall Study|Transitioned to commercial C1INH-nf|6
184415|NCT00438815|634016|P1|Overall Study|Noncompliance with protocol requirements|9
184416|NCT00438815|634016|P1|Overall Study|3-month follow-up no longer required|12
184417|NCT00438815|634016|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
184418|NCT00438672|634066|P2|Overall Study|Lost to Follow-up|9
184419|NCT00438672|634067|P1|Overall Study|Lost to Follow-up|7
184420|NCT00438659|634077|P2|Overall Study|Cancel|2
184421|NCT00438659|634078|P1|Overall Study|Cancel|5
184422|NCT00438659|634077|P2|Overall Study|Discontinued Mometasone/Placebo|2
184423|NCT00438659|634078|P1|Overall Study|Discontinued Mometasone/Placebo|1
184424|NCT00438464|634117|P2|Overall Study|Incomplete data submission|2
184425|NCT00438464|634118|P1|Overall Study|Incomplete data submission|0
184426|NCT00438464|634117|P2|Overall Study|Terminated Early|5
184427|NCT00438464|634118|P1|Overall Study|Terminated Early|14
184428|NCT00438399|634219|P6|Overall Study|Patien stopped study at visit 4 by error|0
184429|NCT00438399|634220|P5|Overall Study|Patien stopped study at visit 4 by error|0
184430|NCT00438399|634221|P4|Overall Study|Patien stopped study at visit 4 by error|0
184431|NCT00438399|634222|P3|Overall Study|Patien stopped study at visit 4 by error|0
184432|NCT00438399|634223|P2|Overall Study|Patien stopped study at visit 4 by error|0
184433|NCT00438399|634224|P1|Overall Study|Patien stopped study at visit 4 by error|1
184434|NCT00438399|634219|P6|Overall Study|Pregnancy|1
184435|NCT00438399|634220|P5|Overall Study|Pregnancy|0
184436|NCT00438399|634221|P4|Overall Study|Pregnancy|0
184437|NCT00438399|634222|P3|Overall Study|Pregnancy|0
184438|NCT00438399|634223|P2|Overall Study|Pregnancy|0
184439|NCT00438399|634224|P1|Overall Study|Pregnancy|0
184440|NCT00438399|634219|P6|Overall Study|Subje stopped study|0
184441|NCT00438399|634220|P5|Overall Study|Subje stopped study|0
184442|NCT00438399|634221|P4|Overall Study|Subje stopped study|0
184443|NCT00438399|634222|P3|Overall Study|Subje stopped study|1
184444|NCT00438399|634223|P2|Overall Study|Subje stopped study|0
184445|NCT00438399|634224|P1|Overall Study|Subje stopped study|0
184446|NCT00438399|634219|P6|Overall Study|Protocol Violation|1
184447|NCT00438399|634220|P5|Overall Study|Protocol Violation|0
184448|NCT00438399|634221|P4|Overall Study|Protocol Violation|0
184449|NCT00438399|634222|P3|Overall Study|Protocol Violation|1
184450|NCT00438399|634223|P2|Overall Study|Protocol Violation|0
184451|NCT00438399|634224|P1|Overall Study|Protocol Violation|0
184452|NCT00438399|634219|P6|Overall Study|Withdrawal by Subject|2
184453|NCT00438399|634220|P5|Overall Study|Withdrawal by Subject|2
184454|NCT00438399|634221|P4|Overall Study|Withdrawal by Subject|2
184455|NCT00438399|634222|P3|Overall Study|Withdrawal by Subject|3
184456|NCT00438399|634223|P2|Overall Study|Withdrawal by Subject|6
184457|NCT00438399|634224|P1|Overall Study|Withdrawal by Subject|5
184458|NCT00438399|634219|P6|Overall Study|Adverse Event|1
184459|NCT00438399|634220|P5|Overall Study|Adverse Event|0
184460|NCT00438399|634221|P4|Overall Study|Adverse Event|1
184461|NCT00438399|634222|P3|Overall Study|Adverse Event|1
184462|NCT00438399|634223|P2|Overall Study|Adverse Event|0
184463|NCT00438399|634224|P1|Overall Study|Adverse Event|0
184464|NCT00438399|634219|P6|Overall Study|Lost to Follow-up|1
184465|NCT00438399|634220|P5|Overall Study|Lost to Follow-up|1
184466|NCT00438399|634221|P4|Overall Study|Lost to Follow-up|1
184467|NCT00438399|634222|P3|Overall Study|Lost to Follow-up|1
184468|NCT00438399|634223|P2|Overall Study|Lost to Follow-up|2
184469|NCT00438399|634224|P1|Overall Study|Lost to Follow-up|2
184470|NCT00438360|634235|P2|Overall Study|not specified|15
184471|NCT00438360|634236|P1|Overall Study|not specified|24
184472|NCT00438360|634235|P2|Overall Study|Lack of Efficacy|27
184473|NCT00438360|634236|P1|Overall Study|Lack of Efficacy|42
184474|NCT00438360|634235|P2|Overall Study|Adverse Event|1
184475|NCT00438360|634236|P1|Overall Study|Adverse Event|6
184476|NCT00437983|634280|P2|Overall Study|Withdrawal by Subject|6
184477|NCT00437983|634281|P1|Overall Study|Withdrawal by Subject|5
184478|NCT00437983|634280|P2|Overall Study|Protocol Violation|1
184479|NCT00437983|634281|P1|Overall Study|Protocol Violation|2
184480|NCT00437983|634280|P2|Overall Study|Adverse Event|6
184481|NCT00437983|634281|P1|Overall Study|Adverse Event|6
184482|NCT00437645|634293|P2|Overall Study|Condition no longer requires study drug|1
184483|NCT00437645|634294|P1|Overall Study|Condition no longer requires study drug|1
184484|NCT00437645|634293|P2|Overall Study|Lack of Efficacy|1
184485|NCT00437645|634294|P1|Overall Study|Lack of Efficacy|2
184486|NCT00437645|634293|P2|Overall Study|Administrative problems|1
184487|NCT00437645|634294|P1|Overall Study|Administrative problems|2
184488|NCT00437645|634293|P2|Overall Study|Lost to Follow-up|3
184489|NCT00437645|634294|P1|Overall Study|Lost to Follow-up|2
184490|NCT00437645|634293|P2|Overall Study|Protocol Violation|3
184491|NCT00437645|634294|P1|Overall Study|Protocol Violation|3
184492|NCT00437645|634293|P2|Overall Study|Withdrawal by Subject|22
184493|NCT00437645|634294|P1|Overall Study|Withdrawal by Subject|10
184494|NCT00437645|634293|P2|Overall Study|Adverse Event|84
184495|NCT00437645|634294|P1|Overall Study|Adverse Event|15
184496|NCT00437489|634310|P2|Overall Study|Lost to Follow-up|1
184497|NCT00437489|634311|P1|Overall Study|Lost to Follow-up|0
184498|NCT00437489|634310|P2|Overall Study|Study terminated by sponsor|21
184499|NCT00437489|634311|P1|Overall Study|Study terminated by sponsor|23
184500|NCT00437281|634348|P20|Overall Study|Lost to Follow-up|1
184501|NCT00437281|634349|P19|Overall Study|Lost to Follow-up|0
184502|NCT00437281|634350|P18|Overall Study|Lost to Follow-up|0
184503|NCT00437281|634351|P17|Overall Study|Lost to Follow-up|0
184504|NCT00437281|634352|P16|Overall Study|Lost to Follow-up|0
184505|NCT00437281|634353|P15|Overall Study|Lost to Follow-up|0
184506|NCT00437281|634354|P14|Overall Study|Lost to Follow-up|0
184507|NCT00437281|634355|P13|Overall Study|Lost to Follow-up|0
184508|NCT00437281|634356|P12|Overall Study|Lost to Follow-up|0
184509|NCT00437281|634357|P11|Overall Study|Lost to Follow-up|0
184510|NCT00437281|634358|P10|Overall Study|Lost to Follow-up|0
184511|NCT00437281|634359|P9|Overall Study|Lost to Follow-up|0
184512|NCT00437281|634360|P8|Overall Study|Lost to Follow-up|0
184513|NCT00437281|634361|P7|Overall Study|Lost to Follow-up|0
184514|NCT00437281|634362|P6|Overall Study|Lost to Follow-up|0
184515|NCT00437281|634363|P5|Overall Study|Lost to Follow-up|0
184516|NCT00437281|634364|P4|Overall Study|Lost to Follow-up|0
184517|NCT00437281|634365|P3|Overall Study|Lost to Follow-up|0
184518|NCT00437281|634366|P2|Overall Study|Lost to Follow-up|0
184519|NCT00437281|634367|P1|Overall Study|Lost to Follow-up|0
184520|NCT00437281|634348|P20|Overall Study|Adverse Event|0
184521|NCT00437281|634349|P19|Overall Study|Adverse Event|1
184522|NCT00437281|634350|P18|Overall Study|Adverse Event|0
184523|NCT00437281|634351|P17|Overall Study|Adverse Event|0
184524|NCT00437281|634352|P16|Overall Study|Adverse Event|0
184525|NCT00437281|634353|P15|Overall Study|Adverse Event|1
184526|NCT00437281|634354|P14|Overall Study|Adverse Event|1
184527|NCT00437281|634355|P13|Overall Study|Adverse Event|0
184528|NCT00437281|634356|P12|Overall Study|Adverse Event|0
184529|NCT00437281|634357|P11|Overall Study|Adverse Event|0
184530|NCT00437281|634358|P10|Overall Study|Adverse Event|1
184531|NCT00437281|634359|P9|Overall Study|Adverse Event|0
184532|NCT00437281|634360|P8|Overall Study|Adverse Event|0
184533|NCT00437281|634361|P7|Overall Study|Adverse Event|0
184534|NCT00437281|634362|P6|Overall Study|Adverse Event|1
184535|NCT00437281|634363|P5|Overall Study|Adverse Event|0
184536|NCT00437281|634364|P4|Overall Study|Adverse Event|1
184537|NCT00437281|634365|P3|Overall Study|Adverse Event|0
184538|NCT00437281|634366|P2|Overall Study|Adverse Event|0
184539|NCT00437281|634367|P1|Overall Study|Adverse Event|0
184540|NCT00437203|634671|P10|Overall Study|Other|0
184541|NCT00437203|634672|P9|Overall Study|Other|0
184542|NCT00437203|634673|P8|Overall Study|Other|0
184543|NCT00437203|634674|P7|Overall Study|Other|1
184544|NCT00437203|634675|P6|Overall Study|Other|0
184545|NCT00437203|634676|P5|Overall Study|Other|0
184546|NCT00437203|634677|P4|Overall Study|Other|0
184547|NCT00437203|634678|P3|Overall Study|Other|0
184548|NCT00437203|634679|P2|Overall Study|Other|1
184549|NCT00437203|634680|P1|Overall Study|Other|0
184550|NCT00437203|634671|P10|Overall Study|Objective progression or relapse|2
184551|NCT00437203|634672|P9|Overall Study|Objective progression or relapse|2
184552|NCT00437203|634673|P8|Overall Study|Objective progression or relapse|1
184553|NCT00437203|634674|P7|Overall Study|Objective progression or relapse|6
184554|NCT00437203|634675|P6|Overall Study|Objective progression or relapse|3
184555|NCT00437203|634676|P5|Overall Study|Objective progression or relapse|3
184556|NCT00437203|634677|P4|Overall Study|Objective progression or relapse|3
184557|NCT00437203|634678|P3|Overall Study|Objective progression or relapse|2
184558|NCT00437203|634679|P2|Overall Study|Objective progression or relapse|6
184559|NCT00437203|634680|P1|Overall Study|Objective progression or relapse|5
184560|NCT00437203|634671|P10|Overall Study|Study terminated by sponsor|0
184561|NCT00437203|634672|P9|Overall Study|Study terminated by sponsor|1
184562|NCT00437203|634673|P8|Overall Study|Study terminated by sponsor|0
184563|NCT00437203|634674|P7|Overall Study|Study terminated by sponsor|0
184564|NCT00437203|634675|P6|Overall Study|Study terminated by sponsor|0
184565|NCT00437203|634676|P5|Overall Study|Study terminated by sponsor|0
184566|NCT00437203|634677|P4|Overall Study|Study terminated by sponsor|0
184567|NCT00437203|634678|P3|Overall Study|Study terminated by sponsor|0
184568|NCT00437203|634679|P2|Overall Study|Study terminated by sponsor|0
184569|NCT00437203|634680|P1|Overall Study|Study terminated by sponsor|0
184570|NCT00437203|634671|P10|Overall Study|Adverse Event|1
184571|NCT00437203|634672|P9|Overall Study|Adverse Event|0
184572|NCT00437203|634673|P8|Overall Study|Adverse Event|1
184573|NCT00437203|634674|P7|Overall Study|Adverse Event|0
184574|NCT00437203|634675|P6|Overall Study|Adverse Event|0
184575|NCT00437203|634676|P5|Overall Study|Adverse Event|0
184576|NCT00437203|634677|P4|Overall Study|Adverse Event|0
184577|NCT00437203|634678|P3|Overall Study|Adverse Event|0
184578|NCT00437203|634679|P2|Overall Study|Adverse Event|1
184579|NCT00437203|634680|P1|Overall Study|Adverse Event|1
184580|NCT00437203|634671|P10|Overall Study|Death|1
184581|NCT00437203|634672|P9|Overall Study|Death|0
184582|NCT00437203|634673|P8|Overall Study|Death|1
184583|NCT00437203|634674|P7|Overall Study|Death|0
184584|NCT00437203|634675|P6|Overall Study|Death|0
184585|NCT00437203|634676|P5|Overall Study|Death|0
184586|NCT00437203|634677|P4|Overall Study|Death|0
184587|NCT00437203|634678|P3|Overall Study|Death|1
184588|NCT00437203|634679|P2|Overall Study|Death|0
184589|NCT00437203|634680|P1|Overall Study|Death|0
184590|NCT00437125|634784|P1|Overall Study|Physician Decision|1
184591|NCT00437125|634784|P1|Overall Study|Withdrawal by Caregiver|2
184592|NCT00437125|634784|P1|Overall Study|Withdrawal by Subject|13
184593|NCT00437125|634784|P1|Overall Study|Lost to Follow-up|1
184594|NCT00437125|634784|P1|Overall Study|Lack of Efficacy|1
184595|NCT00437125|634784|P1|Overall Study|Clinical Relapse|1
184596|NCT00437125|634784|P1|Overall Study|Death|1
184597|NCT00437125|634784|P1|Overall Study|Adverse Event|12
184598|NCT00437073|634805|P2|Overall Study|Physician Decision|1
184599|NCT00437073|634806|P1|Overall Study|Physician Decision|0
184600|NCT00437073|634805|P2|Overall Study|Sponsor Terminated Study|0
184601|NCT00437073|634806|P1|Overall Study|Sponsor Terminated Study|1
184602|NCT00437034|634834|P1|Overall Study|Disease progression during treatment|5
184603|NCT00437034|634834|P1|Overall Study|Adverse Event|1
184604|NCT00436982|634840|P2|Overall Study|no RSA data|2
184605|NCT00436982|634841|P1|Overall Study|no RSA data|1
184606|NCT00436982|634840|P2|Overall Study|Did not receive allocated intervention|1
184607|NCT00436982|634841|P1|Overall Study|Did not receive allocated intervention|0
184608|NCT00436982|634840|P2|Overall Study|Withdrawal by Subject|1
184609|NCT00436982|634841|P1|Overall Study|Withdrawal by Subject|3
184610|NCT00436956|634912|P2|Overall Study|Not evaluable|0
184611|NCT00436956|634913|P1|Overall Study|Not evaluable|1
184612|NCT00436917|634922|P1|Overall Study|Still on treatment|47
184613|NCT00436917|634922|P1|Overall Study|Adverse Event|1
184614|NCT00436917|634922|P1|Overall Study|Withdrawal by Subject|6
184615|NCT00436852|634937|P2|Overall Study|Ineligible|0
184616|NCT00436852|634938|P1|Overall Study|Ineligible|1
184617|NCT00436852|634937|P2|Overall Study|Withdrawal by Subject|4
184618|NCT00436852|634938|P1|Overall Study|Withdrawal by Subject|2
184619|NCT00436852|634937|P2|Overall Study|Lack of Efficacy|7
184620|NCT00436852|634938|P1|Overall Study|Lack of Efficacy|9
184621|NCT00436852|634937|P2|Overall Study|Death|34
184622|NCT00436852|634938|P1|Overall Study|Death|23
184623|NCT00436826|634948|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
184624|NCT00436826|634949|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
184625|NCT00436826|634950|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
184626|NCT00436826|634951|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
184627|NCT00436826|634952|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
184628|NCT00436826|634953|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
184629|NCT00436826|634948|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
184630|NCT00436826|634949|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
184631|NCT00436826|634950|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
184632|NCT00436826|634951|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
184633|NCT00436826|634952|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
184634|NCT00436826|634953|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
184635|NCT00436826|634948|P6|Double Blind Period|Other|0
184636|NCT00436826|634949|P5|Double Blind Period|Other|0
184637|NCT00436826|634950|P4|Double Blind Period|Other|0
184638|NCT00436826|634951|P3|Double Blind Period|Other|0
184639|NCT00436826|634952|P2|Double Blind Period|Other|11
184640|NCT00436826|634953|P1|Double Blind Period|Other|10
184641|NCT00436826|634948|P6|Double Blind Period|Protocol Violation|0
184642|NCT00436826|634949|P5|Double Blind Period|Protocol Violation|0
184643|NCT00436826|634950|P4|Double Blind Period|Protocol Violation|0
184644|NCT00436826|634951|P3|Double Blind Period|Protocol Violation|0
184645|NCT00436826|634952|P2|Double Blind Period|Protocol Violation|0
184646|NCT00436826|634953|P1|Double Blind Period|Protocol Violation|1
184647|NCT00436826|634948|P6|Double Blind Period|Adverse Event|0
184648|NCT00436826|634949|P5|Double Blind Period|Adverse Event|0
184649|NCT00436826|634950|P4|Double Blind Period|Adverse Event|0
184650|NCT00436826|634951|P3|Double Blind Period|Adverse Event|0
184651|NCT00436826|634952|P2|Double Blind Period|Adverse Event|0
184652|NCT00436826|634953|P1|Double Blind Period|Adverse Event|2
184653|NCT00436748|634975|P2|Overall Study|Other|0
184654|NCT00436748|634976|P1|Overall Study|Other|3
184655|NCT00436748|634975|P2|Overall Study|Protocol-specified Criteria|4
184656|NCT00436748|634976|P1|Overall Study|Protocol-specified Criteria|5
184657|NCT00436748|634975|P2|Overall Study|Lost to Follow-up|1
184658|NCT00436748|634976|P1|Overall Study|Lost to Follow-up|0
184659|NCT00436748|634975|P2|Overall Study|Administrative Decision|0
184660|NCT00436748|634976|P1|Overall Study|Administrative Decision|1
184661|NCT00436748|634975|P2|Overall Study|Consent Withdrawn|4
184662|NCT00436748|634976|P1|Overall Study|Consent Withdrawn|1
184663|NCT00436748|634975|P2|Overall Study|Adverse Event|2
184664|NCT00436748|634976|P1|Overall Study|Adverse Event|0
184665|NCT00436748|634975|P2|Overall Study|Ineligibility Determined|1
184666|NCT00436748|634976|P1|Overall Study|Ineligibility Determined|1
184667|NCT00436644|635010|P1|Overall Study|Death|1
184668|NCT00436644|635010|P1|Overall Study|Adverse Event|2
184669|NCT00436618|635020|P3|Overall Study|Still on treatment|7
184670|NCT00436618|635021|P2|Overall Study|Still on treatment|2
184671|NCT00436618|635022|P1|Overall Study|Still on treatment|1
184672|NCT00436618|635020|P3|Overall Study|New Primary or Other Reasons|12
184673|NCT00436618|635021|P2|Overall Study|New Primary or Other Reasons|2
184674|NCT00436618|635022|P1|Overall Study|New Primary or Other Reasons|6
184675|NCT00436618|635020|P3|Overall Study|Death|3
184676|NCT00436618|635021|P2|Overall Study|Death|2
184677|NCT00436618|635022|P1|Overall Study|Death|4
184678|NCT00436618|635020|P3|Overall Study|Other Medical Problems|7
184679|NCT00436618|635021|P2|Overall Study|Other Medical Problems|1
184680|NCT00436618|635022|P1|Overall Study|Other Medical Problems|3
184681|NCT00436618|635020|P3|Overall Study|Alternate Treatment|12
184682|NCT00436618|635021|P2|Overall Study|Alternate Treatment|4
184683|NCT00436618|635022|P1|Overall Study|Alternate Treatment|3
184684|NCT00436618|635020|P3|Overall Study|Adverse Event|9
184685|NCT00436618|635021|P2|Overall Study|Adverse Event|8
184686|NCT00436618|635022|P1|Overall Study|Adverse Event|8
184687|NCT00436618|635020|P3|Overall Study|Withdrawal by Subject|11
184688|NCT00436618|635021|P2|Overall Study|Withdrawal by Subject|8
184689|NCT00436618|635022|P1|Overall Study|Withdrawal by Subject|5
184690|NCT00436605|635039|P1|Overall Study|Protocol Violation|3
184691|NCT00436566|635044|P1|Overall Study|Protocol Violation|1
184692|NCT00436566|635044|P1|Overall Study|Withdrawal by Subject|2
184693|NCT00436553|635051|P3|Overall Study|Withdrawal by Subject|3
184694|NCT00436553|635052|P2|Overall Study|Withdrawal by Subject|6
184695|NCT00436553|635053|P1|Overall Study|Withdrawal by Subject|5
184696|NCT00436553|635051|P3|Overall Study|Protocol Violation|0
184697|NCT00436553|635052|P2|Overall Study|Protocol Violation|0
184698|NCT00436553|635053|P1|Overall Study|Protocol Violation|1
184699|NCT00436553|635051|P3|Overall Study|Lost to Follow-up|0
184700|NCT00436553|635052|P2|Overall Study|Lost to Follow-up|2
184701|NCT00436553|635053|P1|Overall Study|Lost to Follow-up|0
184702|NCT00436553|635051|P3|Overall Study|Death|3
184703|NCT00436553|635052|P2|Overall Study|Death|1
184704|NCT00436553|635053|P1|Overall Study|Death|3
184705|NCT00436553|635051|P3|Overall Study|Adverse Event|4
184706|NCT00436553|635052|P2|Overall Study|Adverse Event|3
184707|NCT00436553|635053|P1|Overall Study|Adverse Event|4
184708|NCT00436501|635074|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
184709|NCT00436501|635075|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
184710|NCT00436501|635074|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
184711|NCT00436501|635075|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
184712|NCT00436436|635086|P1|Overall Study|Death|6
184713|NCT00436436|635086|P1|Overall Study|Adverse Event|2
184714|NCT00436436|635086|P1|Overall Study|Progression|4
184715|NCT00436345|635097|P2|Overall Study|ICU resident beyond follow-up period|0
184716|NCT00436345|635098|P1|Overall Study|ICU resident beyond follow-up period|3
184717|NCT00436332|635151|P1|Overall Study|Never Received Treatment|3
184718|NCT00436332|635151|P1|Overall Study|Ineligible|2
184719|NCT00436332|635151|P1|Overall Study|Not Protocol Specified|6
184720|NCT00436332|635151|P1|Overall Study|Death|2
184721|NCT00436332|635151|P1|Overall Study|Progression|59
184722|NCT00436332|635151|P1|Overall Study|Withdrawal by Subject|2
184723|NCT00436332|635151|P1|Overall Study|Adverse Event|9
184724|NCT00436215|635158|P1|Overall Study|Small bowel obstruction|1
184725|NCT00436215|635158|P1|Overall Study|Refused further treatment|3
184726|NCT00436163|635164|P1|Overall Study|Adverse Event|1
184727|NCT00436163|635164|P1|Overall Study|Lost to Follow-up|2
184728|NCT00436007|635212|P3|Overall Study|Other|1
184729|NCT00436007|635213|P2|Overall Study|Other|0
184730|NCT00436007|635214|P1|Overall Study|Other|0
184731|NCT00436007|635212|P3|Overall Study|Death|3
184732|NCT00436007|635213|P2|Overall Study|Death|1
184733|NCT00436007|635214|P1|Overall Study|Death|0
184734|NCT00436007|635212|P3|Overall Study|Physician Decision|2
184735|NCT00436007|635213|P2|Overall Study|Physician Decision|0
184736|NCT00436007|635214|P1|Overall Study|Physician Decision|0
184737|NCT00436007|635212|P3|Overall Study|Lost to Follow-up|13
184738|NCT00436007|635213|P2|Overall Study|Lost to Follow-up|10
184739|NCT00436007|635214|P1|Overall Study|Lost to Follow-up|14
184740|NCT00436007|635212|P3|Overall Study|Withdrawal by Subject|4
184741|NCT00436007|635213|P2|Overall Study|Withdrawal by Subject|3
184742|NCT00436007|635214|P1|Overall Study|Withdrawal by Subject|5
184743|NCT00435994|635262|P3|Overall Study|Lost to Follow-up|0
184744|NCT00435994|635263|P2|Overall Study|Lost to Follow-up|0
184745|NCT00435994|635264|P1|Overall Study|Lost to Follow-up|7
184746|NCT00435942|635275|P2|Overall Study|Other|1
184747|NCT00435942|635276|P1|Overall Study|Other|0
184748|NCT00435942|635275|P2|Overall Study|Technical Failure|0
184749|NCT00435942|635276|P1|Overall Study|Technical Failure|3
184750|NCT00435942|635275|P2|Overall Study|Conversion to Open Repair|0
184751|NCT00435942|635276|P1|Overall Study|Conversion to Open Repair|1
184752|NCT00435942|635275|P2|Overall Study|Lost to Follow-up|16
184753|NCT00435942|635276|P1|Overall Study|Lost to Follow-up|0
184754|NCT00435942|635275|P2|Overall Study|Withdrawal by Subject|0
184755|NCT00435942|635276|P1|Overall Study|Withdrawal by Subject|2
184756|NCT00435942|635275|P2|Overall Study|Death|10
184757|NCT00435942|635276|P1|Overall Study|Death|17
184758|NCT00435825|635316|P4|Overall Study|Did not complete full follow-up period|5
184759|NCT00435825|635317|P3|Overall Study|Did not complete full follow-up period|4
184760|NCT00435825|635318|P2|Overall Study|Did not complete full follow-up period|6
184761|NCT00435825|635319|P1|Overall Study|Did not complete full follow-up period|6
184762|NCT00435825|635316|P4|Overall Study|Did not enter follow-up|3
184763|NCT00435825|635317|P3|Overall Study|Did not enter follow-up|1
184764|NCT00435825|635318|P2|Overall Study|Did not enter follow-up|4
184765|NCT00435825|635319|P1|Overall Study|Did not enter follow-up|0
184766|NCT00435825|635316|P4|Overall Study|Did not receive study drug|0
184767|NCT00435825|635317|P3|Overall Study|Did not receive study drug|2
184768|NCT00435825|635318|P2|Overall Study|Did not receive study drug|0
184769|NCT00435825|635319|P1|Overall Study|Did not receive study drug|1
184770|NCT00435825|635316|P4|Overall Study|Failure to return|0
184771|NCT00435825|635317|P3|Overall Study|Failure to return|4
184772|NCT00435825|635318|P2|Overall Study|Failure to return|0
184773|NCT00435825|635319|P1|Overall Study|Failure to return|5
184774|NCT00435825|635316|P4|Overall Study|Refused treatment|5
184775|NCT00435825|635317|P3|Overall Study|Refused treatment|0
184776|NCT00435825|635318|P2|Overall Study|Refused treatment|0
184777|NCT00435825|635319|P1|Overall Study|Refused treatment|2
184778|NCT00435825|635316|P4|Overall Study|Other Protocol Violation|0
184779|NCT00435825|635317|P3|Overall Study|Other Protocol Violation|0
184780|NCT00435825|635318|P2|Overall Study|Other Protocol Violation|0
184781|NCT00435825|635319|P1|Overall Study|Other Protocol Violation|1
184782|NCT00435825|635316|P4|Overall Study|Insufficient Therapeutic Response|3
184783|NCT00435825|635317|P3|Overall Study|Insufficient Therapeutic Response|0
184784|NCT00435825|635318|P2|Overall Study|Insufficient Therapeutic Response|1
184785|NCT00435825|635319|P1|Overall Study|Insufficient Therapeutic Response|3
184786|NCT00435825|635316|P4|Overall Study|Abnormality of Laboratory Test|0
184787|NCT00435825|635317|P3|Overall Study|Abnormality of Laboratory Test|0
184788|NCT00435825|635318|P2|Overall Study|Abnormality of Laboratory Test|1
184789|NCT00435825|635319|P1|Overall Study|Abnormality of Laboratory Test|0
184790|NCT00435487|635442|P2|Overall Study|Received Drug in Other Treatment Group|1
184791|NCT00435487|635443|P1|Overall Study|Received Drug in Other Treatment Group|0
184792|NCT00435487|635442|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
184793|NCT00435487|635443|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
184794|NCT00435487|635442|P2|Overall Study|Withdrawal by Subject|1
184795|NCT00435487|635443|P1|Overall Study|Withdrawal by Subject|2
184796|NCT00435487|635442|P2|Overall Study|Other|2
184797|NCT00435487|635443|P1|Overall Study|Other|5
184798|NCT00435487|635442|P2|Overall Study|Lost to Follow-up|2
184799|NCT00435487|635443|P1|Overall Study|Lost to Follow-up|2
184800|NCT00435487|635442|P2|Overall Study|Adverse Event|3
184801|NCT00435487|635443|P1|Overall Study|Adverse Event|0
184802|NCT00435487|635442|P2|Overall Study|Death|4
184803|NCT00435487|635443|P1|Overall Study|Death|3
184804|NCT00435461|635462|P3|Overall Study|Lost to Follow-up|2
184805|NCT00435461|635463|P2|Overall Study|Lost to Follow-up|1
184806|NCT00435461|635464|P1|Overall Study|Lost to Follow-up|1
184807|NCT00435461|635462|P3|Overall Study|Non-Compliance of diary|1
184808|NCT00435461|635463|P2|Overall Study|Non-Compliance of diary|0
184809|NCT00435461|635464|P1|Overall Study|Non-Compliance of diary|2
184810|NCT00435461|635462|P3|Overall Study|Adverse Event|6
184811|NCT00435461|635463|P2|Overall Study|Adverse Event|2
184812|NCT00435461|635464|P1|Overall Study|Adverse Event|1
184813|NCT00435461|635462|P3|Overall Study|Noncompliance with study requirements|1
184814|NCT00435461|635463|P2|Overall Study|Noncompliance with study requirements|1
184815|NCT00435461|635464|P1|Overall Study|Noncompliance with study requirements|1
184816|NCT00435461|635462|P3|Overall Study|Participant ended study one day early|0
184817|NCT00435461|635463|P2|Overall Study|Participant ended study one day early|0
184818|NCT00435461|635464|P1|Overall Study|Participant ended study one day early|1
184819|NCT00435461|635462|P3|Overall Study|Participant moved eDiary,studymedication|0
184820|NCT00435461|635463|P2|Overall Study|Participant moved eDiary,studymedication|0
184821|NCT00435461|635464|P1|Overall Study|Participant moved eDiary,studymedication|1
184822|NCT00435461|635462|P3|Overall Study|Pregnancy|0
184823|NCT00435461|635463|P2|Overall Study|Pregnancy|0
184824|NCT00435461|635464|P1|Overall Study|Pregnancy|2
184825|NCT00435461|635462|P3|Overall Study|Participant could not swallow capsule|1
184826|NCT00435461|635463|P2|Overall Study|Participant could not swallow capsule|0
184827|NCT00435461|635464|P1|Overall Study|Participant could not swallow capsule|0
184828|NCT00435461|635462|P3|Overall Study|Participant could not tolerate symptoms|1
184829|NCT00435461|635463|P2|Overall Study|Participant could not tolerate symptoms|0
184830|NCT00435461|635464|P1|Overall Study|Participant could not tolerate symptoms|0
184831|NCT00435461|635462|P3|Overall Study|Randomized in error|0
184832|NCT00435461|635463|P2|Overall Study|Randomized in error|0
184833|NCT00435461|635464|P1|Overall Study|Randomized in error|1
184834|NCT00435461|635462|P3|Overall Study|Withdrawal by Subject|2
184835|NCT00435461|635463|P2|Overall Study|Withdrawal by Subject|0
184836|NCT00435461|635464|P1|Overall Study|Withdrawal by Subject|1
184837|NCT00435461|635462|P3|Overall Study|Lack of Efficacy|0
184838|NCT00435461|635463|P2|Overall Study|Lack of Efficacy|1
184839|NCT00435461|635464|P1|Overall Study|Lack of Efficacy|2
184840|NCT00435461|635462|P3|Overall Study|In error, two study medications switched|0
184841|NCT00435461|635463|P2|Overall Study|In error, two study medications switched|0
184842|NCT00435461|635464|P1|Overall Study|In error, two study medications switched|1
184843|NCT00435461|635462|P3|Overall Study|Compliance less than 80 percent|0
184844|NCT00435461|635463|P2|Overall Study|Compliance less than 80 percent|0
184845|NCT00435461|635464|P1|Overall Study|Compliance less than 80 percent|1
184846|NCT00435461|635462|P3|Overall Study|Participant randomized(inadequate score)|0
184847|NCT00435461|635463|P2|Overall Study|Participant randomized(inadequate score)|0
184848|NCT00435461|635464|P1|Overall Study|Participant randomized(inadequate score)|1
184849|NCT00435461|635462|P3|Overall Study|Protocol Violation|10
184850|NCT00435461|635463|P2|Overall Study|Protocol Violation|9
184851|NCT00435461|635464|P1|Overall Study|Protocol Violation|6
184852|NCT00435461|635462|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
184853|NCT00435461|635463|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
184854|NCT00435461|635464|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
184855|NCT00435409|635501|P3|Overall Study|Sponsor decision|0
184856|NCT00435409|635502|P2|Overall Study|Sponsor decision|3
184857|NCT00435409|635503|P1|Overall Study|Sponsor decision|0
184858|NCT00435409|635501|P3|Overall Study|Adverse Event|8
184859|NCT00435409|635502|P2|Overall Study|Adverse Event|0
184860|NCT00435409|635503|P1|Overall Study|Adverse Event|0
184861|NCT00435409|635501|P3|Overall Study|Not specified|1
184862|NCT00435409|635502|P2|Overall Study|Not specified|30
184863|NCT00435409|635503|P1|Overall Study|Not specified|45
184864|NCT00435409|635501|P3|Overall Study|Withdrawal by Subject|1
184865|NCT00435409|635502|P2|Overall Study|Withdrawal by Subject|7
184866|NCT00435409|635503|P1|Overall Study|Withdrawal by Subject|8
184867|NCT00435409|635501|P3|Overall Study|Global deterioration of health status|4
184868|NCT00435409|635502|P2|Overall Study|Global deterioration of health status|0
184869|NCT00435409|635503|P1|Overall Study|Global deterioration of health status|0
184870|NCT00435409|635501|P3|Overall Study|Objective progression or relapse|58
184871|NCT00435409|635502|P2|Overall Study|Objective progression or relapse|93
184872|NCT00435409|635503|P1|Overall Study|Objective progression or relapse|158
184873|NCT00435409|635501|P3|Overall Study|Death|6
184874|NCT00435409|635502|P2|Overall Study|Death|6
184875|NCT00435409|635503|P1|Overall Study|Death|8
184876|NCT00435409|635501|P3|Overall Study|Lost to Follow-up|0
184877|NCT00435409|635502|P2|Overall Study|Lost to Follow-up|2
184878|NCT00435409|635503|P1|Overall Study|Lost to Follow-up|1
184879|NCT00435409|635501|P3|Overall Study|Protocol Violation|0
184880|NCT00435409|635502|P2|Overall Study|Protocol Violation|2
184881|NCT00435409|635503|P1|Overall Study|Protocol Violation|1
184882|NCT00435370|635525|P2|Overall Study|Antipsychotic medication changed|2
184883|NCT00435370|635526|P1|Overall Study|Antipsychotic medication changed|4
184884|NCT00435370|635525|P2|Overall Study|Withdrawal by Subject|10
184885|NCT00435370|635526|P1|Overall Study|Withdrawal by Subject|10
184886|NCT00435370|635525|P2|Overall Study|Adverse Event|8
184887|NCT00435370|635526|P1|Overall Study|Adverse Event|8
184888|NCT00435188|635534|P2|Overall Study|Lost to Follow-up|6
184889|NCT00435188|635535|P1|Overall Study|Lost to Follow-up|5
184890|NCT00435188|635534|P2|Overall Study|Withdrawal by Subject|11
184891|NCT00435188|635535|P1|Overall Study|Withdrawal by Subject|16
184892|NCT00435188|635534|P2|Overall Study|Death|6
184893|NCT00435188|635535|P1|Overall Study|Death|1
184894|NCT00435162|635578|P6|Period 2 (2 Weeks)|Adverse Event|0
184895|NCT00435162|635579|P5|Period 2 (2 Weeks)|Adverse Event|0
184896|NCT00435162|635580|P4|Period 2 (2 Weeks)|Adverse Event|0
184897|NCT00435162|635581|P3|Period 2 (2 Weeks)|Adverse Event|0
184898|NCT00435162|635582|P2|Period 2 (2 Weeks)|Adverse Event|1
184899|NCT00435162|635583|P1|Period 2 (2 Weeks)|Adverse Event|0
184900|NCT00435045|635603|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
184901|NCT00435045|635604|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
184902|NCT00435045|635603|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
184903|NCT00435045|635604|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
184904|NCT00435045|635603|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
184905|NCT00435045|635604|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
184906|NCT00435045|635603|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
184907|NCT00435045|635604|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
184908|NCT00435045|635603|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
184909|NCT00435045|635604|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
184910|NCT00435045|635603|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
184911|NCT00435045|635604|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
184912|NCT00435045|635603|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
184913|NCT00435045|635604|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
184914|NCT00435045|635603|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
184915|NCT00435045|635604|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
184916|NCT00435045|635603|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
184917|NCT00435045|635604|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
184918|NCT00435045|635603|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
184919|NCT00435045|635604|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
184920|NCT00435045|635603|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
184921|NCT00435045|635604|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
184922|NCT00435019|635660|P2|Overall Study|Personal reasons for withdrawal|7
184923|NCT00435019|635661|P1|Overall Study|Personal reasons for withdrawal|8
184924|NCT00435019|635660|P2|Overall Study|Protocol Violation|1
184925|NCT00435019|635661|P1|Overall Study|Protocol Violation|3
184926|NCT00435019|635660|P2|Overall Study|Lack of Efficacy|2
184927|NCT00435019|635661|P1|Overall Study|Lack of Efficacy|1
184928|NCT00435019|635660|P2|Overall Study|Adverse Event|0
184929|NCT00435019|635661|P1|Overall Study|Adverse Event|1
184930|NCT00434967|635702|P4|Overall Study|Patient Disposition Challenges|3
184931|NCT00434967|635703|P3|Overall Study|Patient Disposition Challenges|0
184932|NCT00434967|635704|P2|Overall Study|Patient Disposition Challenges|0
184933|NCT00434967|635705|P1|Overall Study|Patient Disposition Challenges|2
184934|NCT00434967|635702|P4|Overall Study|Physician Decision|0
184935|NCT00434967|635703|P3|Overall Study|Physician Decision|1
184936|NCT00434967|635704|P2|Overall Study|Physician Decision|1
184937|NCT00434967|635705|P1|Overall Study|Physician Decision|1
184938|NCT00434967|635702|P4|Overall Study|Protocol Violation|1
184939|NCT00434967|635703|P3|Overall Study|Protocol Violation|0
184940|NCT00434967|635704|P2|Overall Study|Protocol Violation|1
184941|NCT00434967|635705|P1|Overall Study|Protocol Violation|0
184942|NCT00434967|635702|P4|Overall Study|Randomized in error|1
184943|NCT00434967|635703|P3|Overall Study|Randomized in error|0
184944|NCT00434967|635704|P2|Overall Study|Randomized in error|0
184945|NCT00434967|635705|P1|Overall Study|Randomized in error|0
184946|NCT00434967|635702|P4|Overall Study|Withdrawal by Subject|6
184947|NCT00434967|635703|P3|Overall Study|Withdrawal by Subject|4
184948|NCT00434967|635704|P2|Overall Study|Withdrawal by Subject|2
184949|NCT00434967|635705|P1|Overall Study|Withdrawal by Subject|2
184950|NCT00434967|635702|P4|Overall Study|Lost to Follow-up|0
184951|NCT00434967|635703|P3|Overall Study|Lost to Follow-up|1
184952|NCT00434967|635704|P2|Overall Study|Lost to Follow-up|0
184953|NCT00434967|635705|P1|Overall Study|Lost to Follow-up|0
184954|NCT00434967|635702|P4|Overall Study|Adverse Event|3
184955|NCT00434967|635703|P3|Overall Study|Adverse Event|3
184956|NCT00434967|635704|P2|Overall Study|Adverse Event|4
184957|NCT00434967|635705|P1|Overall Study|Adverse Event|2
184958|NCT00434954|635725|P2|Overall Study|Subject decision|22
184959|NCT00434954|635726|P1|Overall Study|Subject decision|8
184960|NCT00434954|635725|P2|Overall Study|Sponsor decision|0
184961|NCT00434954|635726|P1|Overall Study|Sponsor decision|1
184962|NCT00434954|635725|P2|Overall Study|Protocol Violation|27
184963|NCT00434954|635726|P1|Overall Study|Protocol Violation|36
184964|NCT00434954|635725|P2|Overall Study|Physician Decision|3
184965|NCT00434954|635726|P1|Overall Study|Physician Decision|6
184966|NCT00434954|635725|P2|Overall Study|Lost to Follow-up|1
184967|NCT00434954|635726|P1|Overall Study|Lost to Follow-up|0
184968|NCT00434954|635725|P2|Overall Study|Entry criteria not met|16
184969|NCT00434954|635726|P1|Overall Study|Entry criteria not met|14
184970|NCT00434954|635725|P2|Overall Study|Adverse Event|2
184971|NCT00434954|635726|P1|Overall Study|Adverse Event|17
184972|NCT00434876|635756|P2|Overall Study|Lost to Follow-up|1
184973|NCT00434876|635757|P1|Overall Study|Lost to Follow-up|1
184974|NCT00434759|635771|P2|Overall Study|family affairs|0
184975|NCT00434759|635772|P1|Overall Study|family affairs|2
184976|NCT00434759|635771|P2|Overall Study|Withdrawal by Subject|1
184977|NCT00434759|635772|P1|Overall Study|Withdrawal by Subject|17
184978|NCT00434759|635771|P2|Overall Study|Lack of Efficacy|4
184979|NCT00434759|635772|P1|Overall Study|Lack of Efficacy|5
184980|NCT00434642|635788|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
184981|NCT00434642|635789|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
184982|NCT00434642|635788|P2|Open-label Treatment Phase|Adverse Event|5
184983|NCT00434642|635789|P1|Open-label Treatment Phase|Adverse Event|0
184984|NCT00434642|635788|P2|Blinded Treatment Phase|Did not Receive Treatment|1
184985|NCT00434642|635789|P1|Blinded Treatment Phase|Did not Receive Treatment|4
184986|NCT00434642|635788|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
184987|NCT00434642|635789|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
184988|NCT00434642|635788|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
184989|NCT00434642|635789|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
184990|NCT00434642|635788|P2|Blinded Treatment Phase|Physician Decision|27
184991|NCT00434642|635789|P1|Blinded Treatment Phase|Physician Decision|19
184992|NCT00434642|635788|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
184993|NCT00434642|635789|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
184994|NCT00434642|635788|P2|Blinded Treatment Phase|Clinical Disease Progression|5
184995|NCT00434642|635789|P1|Blinded Treatment Phase|Clinical Disease Progression|4
184996|NCT00434642|635788|P2|Blinded Treatment Phase|Adverse Event|58
184997|NCT00434642|635789|P1|Blinded Treatment Phase|Adverse Event|12
184998|NCT00434590|635807|P2|Overall Study|Administrative problems|5
184999|NCT00434590|635808|P1|Overall Study|Administrative problems|5
185000|NCT00434421|635830|P1|Overall Study|Non-compliance with study treatment|1
185001|NCT00434421|635830|P1|Overall Study|Withdrawal by Subject|1
185002|NCT00434330|635858|P6|Overall Study|Subject Not Compliant With Study|0
185003|NCT00434330|635859|P5|Overall Study|Subject Not Compliant With Study|0
185004|NCT00434330|635860|P4|Overall Study|Subject Not Compliant With Study|0
185005|NCT00434330|635861|P3|Overall Study|Subject Not Compliant With Study|1
185006|NCT00434330|635862|P2|Overall Study|Subject Not Compliant With Study|0
185007|NCT00434330|635863|P1|Overall Study|Subject Not Compliant With Study|0
185008|NCT00434330|635858|P6|Overall Study|Renal transplant|0
185009|NCT00434330|635859|P5|Overall Study|Renal transplant|0
185010|NCT00434330|635860|P4|Overall Study|Renal transplant|1
185011|NCT00434330|635861|P3|Overall Study|Renal transplant|0
185012|NCT00434330|635862|P2|Overall Study|Renal transplant|0
185013|NCT00434330|635863|P1|Overall Study|Renal transplant|0
185014|NCT00434330|635858|P6|Overall Study|Withdrawal by Subject|0
185015|NCT00434330|635859|P5|Overall Study|Withdrawal by Subject|0
185016|NCT00434330|635860|P4|Overall Study|Withdrawal by Subject|1
185017|NCT00434330|635861|P3|Overall Study|Withdrawal by Subject|1
185018|NCT00434330|635862|P2|Overall Study|Withdrawal by Subject|0
185019|NCT00434330|635863|P1|Overall Study|Withdrawal by Subject|0
185020|NCT00434330|635858|P6|Overall Study|Death|1
185021|NCT00434330|635859|P5|Overall Study|Death|1
185022|NCT00434330|635860|P4|Overall Study|Death|0
185023|NCT00434330|635861|P3|Overall Study|Death|0
185024|NCT00434330|635862|P2|Overall Study|Death|0
185025|NCT00434330|635863|P1|Overall Study|Death|1
185026|NCT00434330|635858|P6|Overall Study|Adverse Event|0
185027|NCT00434330|635859|P5|Overall Study|Adverse Event|0
185028|NCT00434330|635860|P4|Overall Study|Adverse Event|0
185029|NCT00434330|635861|P3|Overall Study|Adverse Event|1
185030|NCT00434330|635862|P2|Overall Study|Adverse Event|0
185031|NCT00434330|635863|P1|Overall Study|Adverse Event|0
185032|NCT00434304|635895|P1|Overall Study|Withdrawal by Subject|4
185033|NCT00434304|635895|P1|Overall Study|Lack of Efficacy|2
185034|NCT00434304|635895|P1|Overall Study|Adverse Event|14
185035|NCT00434252|635944|P2|Overall Study|Withdrawal by Subject|7
185036|NCT00434252|635945|P1|Overall Study|Withdrawal by Subject|3
185037|NCT00434252|635944|P2|Overall Study|Physician Decision|8
185038|NCT00434252|635945|P1|Overall Study|Physician Decision|4
185039|NCT00434252|635944|P2|Overall Study|Lost to Follow-up|1
185040|NCT00434252|635945|P1|Overall Study|Lost to Follow-up|0
185041|NCT00434252|635944|P2|Overall Study|Death|2
185042|NCT00434252|635945|P1|Overall Study|Death|1
185043|NCT00434252|635944|P2|Overall Study|Adverse Event|13
185044|NCT00434252|635945|P1|Overall Study|Adverse Event|6
185045|NCT00434252|635944|P2|Overall Study|Lack of Efficacy|100
185046|NCT00434252|635945|P1|Overall Study|Lack of Efficacy|50
185047|NCT00434213|635979|P1|Overall Study|Non-compliant to study schedule|1
185048|NCT00434213|635979|P1|Overall Study|Application site reaction|1
185049|NCT00434213|635979|P1|Overall Study|Unable to comply with study visit window|2
185050|NCT00434213|635979|P1|Overall Study|Protocol Violation|3
185051|NCT00434213|635979|P1|Overall Study|Withdrawal by Subject|7
185052|NCT00434213|635979|P1|Overall Study|Lost to Follow-up|14
185053|NCT00434213|635979|P1|Overall Study|Lack of Efficacy|9
185054|NCT00434213|635979|P1|Overall Study|Adverse Event|12
185055|NCT00434161|635987|P3|Overall Study|Logistical error study assessments|3
185056|NCT00434161|635988|P2|Overall Study|Logistical error study assessments|0
185057|NCT00434161|635989|P1|Overall Study|Logistical error study assessments|1
185058|NCT00434161|635987|P3|Overall Study|Withdrawal by Subject|3
185059|NCT00434161|635988|P2|Overall Study|Withdrawal by Subject|0
185060|NCT00434161|635989|P1|Overall Study|Withdrawal by Subject|2
185061|NCT00434161|635987|P3|Overall Study|Non-Compliance|0
185062|NCT00434161|635988|P2|Overall Study|Non-Compliance|1
185063|NCT00434161|635989|P1|Overall Study|Non-Compliance|1
185064|NCT00434161|635987|P3|Overall Study|Death|1
185065|NCT00434161|635988|P2|Overall Study|Death|0
185066|NCT00434161|635989|P1|Overall Study|Death|1
185067|NCT00434161|635987|P3|Overall Study|Lost to Follow-up|0
185068|NCT00434161|635988|P2|Overall Study|Lost to Follow-up|1
185069|NCT00434161|635989|P1|Overall Study|Lost to Follow-up|0
185070|NCT00434161|635987|P3|Overall Study|Adverse Event|4
185071|NCT00434161|635988|P2|Overall Study|Adverse Event|1
185072|NCT00434161|635989|P1|Overall Study|Adverse Event|5
185073|NCT00434148|636033|P2|Overall Study|Abnormal test procedure result|1
185074|NCT00434148|636034|P1|Overall Study|Abnormal test procedure result|0
185075|NCT00434148|636033|P2|Overall Study|Condition no longer requires study drug|0
185076|NCT00434148|636034|P1|Overall Study|Condition no longer requires study drug|1
185077|NCT00434148|636033|P2|Overall Study|Lost to Follow-up|1
185078|NCT00434148|636034|P1|Overall Study|Lost to Follow-up|0
185079|NCT00434148|636033|P2|Overall Study|Administrative problems|10
185080|NCT00434148|636034|P1|Overall Study|Administrative problems|6
185081|NCT00434148|636033|P2|Overall Study|Protocol Violation|0
185082|NCT00434148|636034|P1|Overall Study|Protocol Violation|4
185083|NCT00434148|636033|P2|Overall Study|Withdrawal by Subject|15
185084|NCT00434148|636034|P1|Overall Study|Withdrawal by Subject|15
185085|NCT00434148|636033|P2|Overall Study|Lack of Efficacy|28
185086|NCT00434148|636034|P1|Overall Study|Lack of Efficacy|25
185087|NCT00434148|636033|P2|Overall Study|Adverse Event|18
185088|NCT00434148|636034|P1|Overall Study|Adverse Event|18
185089|NCT00434122|636070|P2|Overall Study|Travelling of subject.|0
185090|NCT00434122|636071|P1|Overall Study|Travelling of subject.|1
185091|NCT00434122|636070|P2|Overall Study|Low follicular response.|2
185092|NCT00434122|636071|P1|Overall Study|Low follicular response.|1
185093|NCT00434122|636070|P2|Overall Study|Large follicle size|2
185094|NCT00434122|636071|P1|Overall Study|Large follicle size|2
185095|NCT00434122|636070|P2|Overall Study|Personal reasons|1
185096|NCT00434122|636071|P1|Overall Study|Personal reasons|1
185097|NCT00434122|636070|P2|Overall Study|loss of subject contact|1
185098|NCT00434122|636071|P1|Overall Study|loss of subject contact|1
185099|NCT00434122|636070|P2|Overall Study|Non-compliance with protocol|1
185100|NCT00434122|636071|P1|Overall Study|Non-compliance with protocol|0
185101|NCT00434109|636080|P1|Overall Study|had embolism, did not receive sunitinib|3
185102|NCT00434109|636080|P1|Overall Study|Protocol Violation|1
185103|NCT00434109|636080|P1|Overall Study|Adverse Event|5
185104|NCT00434109|636080|P1|Overall Study|Physician Decision|9
185105|NCT00434057|636089|P1|Overall Study|Withdrawal by Subject|1
185106|NCT00433966|636127|P4|Stent Intervention/Randomization|Lost to Follow-up|47
185107|NCT00433966|636128|P3|Stent Intervention/Randomization|Lost to Follow-up|113
185108|NCT00433966|636129|P2|Stent Intervention/Randomization|Lost to Follow-up|0
185109|NCT00433966|636130|P1|Stent Intervention/Randomization|Lost to Follow-up|0
185110|NCT00433966|636127|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
185111|NCT00433966|636128|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
185112|NCT00433966|636129|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
185113|NCT00433966|636130|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
185114|NCT00433966|636127|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
185115|NCT00433966|636128|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
185116|NCT00433966|636129|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
185117|NCT00433966|636130|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
185118|NCT00433966|636127|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
185119|NCT00433966|636128|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
185120|NCT00433966|636129|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
185121|NCT00433966|636130|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
185122|NCT00433966|636127|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
185123|NCT00433966|636128|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
185124|NCT00433966|636129|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
185125|NCT00433966|636130|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
185126|NCT00433914|636152|P2|Overall Study|Lost to Follow-up|1
185127|NCT00433914|636153|P1|Overall Study|Lost to Follow-up|0
185128|NCT00433914|636152|P2|Overall Study|Withdrawal by Subject|2
185129|NCT00433914|636153|P1|Overall Study|Withdrawal by Subject|0
185130|NCT00433836|636173|P2|Overall Study|Abnormal laboratory values|1
185131|NCT00433836|636174|P1|Overall Study|Abnormal laboratory values|0
185132|NCT00433836|636173|P2|Overall Study|Condition no longer requires study drug|1
185133|NCT00433836|636174|P1|Overall Study|Condition no longer requires study drug|0
185134|NCT00433836|636173|P2|Overall Study|Protocol Violation|2
185135|NCT00433836|636174|P1|Overall Study|Protocol Violation|0
185136|NCT00433836|636173|P2|Overall Study|Unsatisfactory therapeutic effect|1
185137|NCT00433836|636174|P1|Overall Study|Unsatisfactory therapeutic effect|1
185138|NCT00433836|636173|P2|Overall Study|Withdrawal by Subject|1
185139|NCT00433836|636174|P1|Overall Study|Withdrawal by Subject|2
185140|NCT00433836|636173|P2|Overall Study|Lost to Follow-up|0
185141|NCT00433836|636174|P1|Overall Study|Lost to Follow-up|3
185142|NCT00433836|636173|P2|Overall Study|Adverse Event|0
185143|NCT00433836|636174|P1|Overall Study|Adverse Event|7
185144|NCT00433771|636186|P1|Overall Study|Failure to deploy stent|1
185145|NCT00433771|636186|P1|Overall Study|Death|2
185146|NCT00433771|636186|P1|Overall Study|Treated and later found to be ineligible|2
185147|NCT00433771|636186|P1|Overall Study|screen fail|14
185148|NCT00433654|636209|P2|Overall Study|Withdrawal by Subject|2
185149|NCT00433654|636210|P1|Overall Study|Withdrawal by Subject|1
185150|NCT00433654|636209|P2|Overall Study|Subject not yet due for visit|0
185151|NCT00433654|636210|P1|Overall Study|Subject not yet due for visit|4
185152|NCT00433654|636209|P2|Overall Study|Missed visit|3
185153|NCT00433654|636210|P1|Overall Study|Missed visit|6
185154|NCT00433654|636209|P2|Overall Study|Death|0
185155|NCT00433654|636210|P1|Overall Study|Death|4
185156|NCT00433537|636256|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
185157|NCT00433537|636257|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
185158|NCT00433537|636258|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
185159|NCT00433537|636256|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
185160|NCT00433537|636257|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
185161|NCT00433537|636258|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
185162|NCT00433537|636256|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
185163|NCT00433537|636257|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
185164|NCT00433537|636258|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
185165|NCT00433537|636256|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
185166|NCT00433537|636257|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
185167|NCT00433537|636258|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
185168|NCT00433537|636256|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
185169|NCT00433537|636257|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
185170|NCT00433537|636258|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
185171|NCT00433537|636256|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
185172|NCT00433537|636257|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
185173|NCT00433537|636258|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
185174|NCT00433537|636256|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
185175|NCT00433537|636257|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
185176|NCT00433537|636258|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
185177|NCT00433537|636256|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
185178|NCT00433537|636257|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
185179|NCT00433537|636258|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
185180|NCT00433537|636256|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
185181|NCT00433537|636257|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
185182|NCT00433537|636258|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
185183|NCT00433446|636267|P1|Overall Study|Ineligible|9
185184|NCT00433446|636267|P1|Overall Study|Other - Not Protocol specified|3
185185|NCT00433446|636267|P1|Overall Study|Progression|44
185186|NCT00433446|636267|P1|Overall Study|Refusal Unrelated to Adverse Event|1
185187|NCT00433446|636267|P1|Overall Study|Adverse Event|4
185188|NCT00433381|636277|P2|Overall Study|Lost to follow-up before 6 months|0
185189|NCT00433381|636278|P1|Overall Study|Lost to follow-up before 6 months|2
185190|NCT00433381|636277|P2|Overall Study|Ineligible / no protocol treatment|3
185191|NCT00433381|636278|P1|Overall Study|Ineligible / no protocol treatment|3
185192|NCT00433329|636284|P1|Overall Study|Physician Decision|1
185193|NCT00433329|636284|P1|Overall Study|Lost to Follow-up|1
185194|NCT00433329|636284|P1|Overall Study|Moved out of state|1
185195|NCT00433329|636284|P1|Overall Study|Discontinued sildenafil|2
185196|NCT00433329|636284|P1|Overall Study|Withdrew consent|3
185197|NCT00433329|636284|P1|Overall Study|Death|4
185198|NCT00433329|636284|P1|Overall Study|Adverse Event|9
185199|NCT00433290|636290|P2|Overall Study|Lost to Follow-up|0
185200|NCT00433290|636291|P1|Overall Study|Lost to Follow-up|1
185201|NCT00433290|636290|P2|Overall Study|Entry Criteria Not Met|1
185202|NCT00433290|636291|P1|Overall Study|Entry Criteria Not Met|0
185203|NCT00433290|636290|P2|Overall Study|Physician Decision|0
185204|NCT00433290|636291|P1|Overall Study|Physician Decision|2
185205|NCT00433290|636290|P2|Overall Study|Protocol Violation|2
185206|NCT00433290|636291|P1|Overall Study|Protocol Violation|3
185207|NCT00433290|636290|P2|Overall Study|Withdrawal by Subject|2
185208|NCT00433290|636291|P1|Overall Study|Withdrawal by Subject|4
185209|NCT00433290|636290|P2|Overall Study|Lack of Efficacy|5
185210|NCT00433290|636291|P1|Overall Study|Lack of Efficacy|1
185211|NCT00433290|636290|P2|Overall Study|Adverse Event|7
185212|NCT00433290|636291|P1|Overall Study|Adverse Event|24
185213|NCT00433199|636360|P2|Open-Label Period|Administrative|1
185214|NCT00433199|636361|P1|Open-Label Period|Administrative|0
185215|NCT00433199|636360|P2|Open-Label Period|Protocol Violation|2
185216|NCT00433199|636361|P1|Open-Label Period|Protocol Violation|0
185217|NCT00433199|636360|P2|Open-Label Period|Withdrawal by Subject|7
185218|NCT00433199|636361|P1|Open-Label Period|Withdrawal by Subject|0
185219|NCT00433199|636360|P2|Open-Label Period|Lost to Follow-up|3
185220|NCT00433199|636361|P1|Open-Label Period|Lost to Follow-up|0
185221|NCT00433199|636360|P2|Open-Label Period|Lack of Efficacy|2
185222|NCT00433199|636361|P1|Open-Label Period|Lack of Efficacy|0
185223|NCT00433199|636360|P2|Open-Label Period|Adverse Event|19
185224|NCT00433199|636361|P1|Open-Label Period|Adverse Event|0
185225|NCT00433199|636360|P2|Double-Blind Period|Administrative|5
185226|NCT00433199|636361|P1|Double-Blind Period|Administrative|1
185227|NCT00433199|636360|P2|Double-Blind Period|Protocol Violation|10
185228|NCT00433199|636361|P1|Double-Blind Period|Protocol Violation|1
185229|NCT00433199|636360|P2|Double-Blind Period|Withdrawal by Subject|19
185230|NCT00433199|636361|P1|Double-Blind Period|Withdrawal by Subject|8
185231|NCT00433199|636360|P2|Double-Blind Period|Lost to Follow-up|5
185232|NCT00433199|636361|P1|Double-Blind Period|Lost to Follow-up|2
185233|NCT00433199|636360|P2|Double-Blind Period|Lack of Efficacy|2
185234|NCT00433199|636361|P1|Double-Blind Period|Lack of Efficacy|0
185235|NCT00433199|636360|P2|Double-Blind Period|Adverse Event|25
185236|NCT00433199|636361|P1|Double-Blind Period|Adverse Event|0
185237|NCT00433160|636381|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
185238|NCT00433160|636382|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
185239|NCT00433160|636381|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
185240|NCT00433160|636382|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
185241|NCT00433160|636381|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
185242|NCT00433160|636382|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
185243|NCT00433160|636381|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
185244|NCT00433160|636382|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
185245|NCT00433160|636381|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
185246|NCT00433160|636382|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
185247|NCT00433160|636381|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
185248|NCT00433160|636382|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
185249|NCT00433160|636381|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
185250|NCT00433160|636382|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
185251|NCT00433160|636381|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
185252|NCT00433160|636382|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
185253|NCT00433160|636381|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
185254|NCT00433160|636382|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
185255|NCT00433160|636381|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
185256|NCT00433160|636382|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
185257|NCT00433160|636381|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
185258|NCT00433160|636382|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
185259|NCT00433160|636381|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
185260|NCT00433160|636382|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
185261|NCT00433160|636381|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
185262|NCT00433160|636382|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
185263|NCT00433160|636381|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
185264|NCT00433160|636382|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
185265|NCT00433160|636381|P2|52-Week Double-Blind (DB) Period|Death|0
185266|NCT00433160|636382|P1|52-Week Double-Blind (DB) Period|Death|0
185267|NCT00433160|636381|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
185268|NCT00433160|636382|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
185269|NCT00433017|636432|P2|Overall Study|Subject no longer requires study drug|1
185270|NCT00433017|636433|P1|Overall Study|Subject no longer requires study drug|1
185271|NCT00433017|636432|P2|Overall Study|Death|2
185272|NCT00433017|636433|P1|Overall Study|Death|2
185273|NCT00433017|636432|P2|Overall Study|Protocol Violation|0
185274|NCT00433017|636433|P1|Overall Study|Protocol Violation|1
185275|NCT00433017|636432|P2|Overall Study|Administrative problems|86
185276|NCT00433017|636433|P1|Overall Study|Administrative problems|80
185277|NCT00433017|636432|P2|Overall Study|Lost to Follow-up|4
185278|NCT00433017|636433|P1|Overall Study|Lost to Follow-up|3
185279|NCT00433017|636432|P2|Overall Study|Withdrawal by Subject|5
185280|NCT00433017|636433|P1|Overall Study|Withdrawal by Subject|4
185281|NCT00433017|636432|P2|Overall Study|Adverse Event|3
185282|NCT00433017|636433|P1|Overall Study|Adverse Event|5
185283|NCT00433004|636449|P2|Overall Study|Lost to Follow-up|7
185284|NCT00433004|636450|P1|Overall Study|Lost to Follow-up|5
185285|NCT00432991|636462|P2|Overall Study|Protocol Violation|12
185286|NCT00432991|636463|P1|Overall Study|Protocol Violation|7
185287|NCT00432965|636475|P2|Overall Study|Incomplete Data|3
185288|NCT00432965|636476|P1|Overall Study|Incomplete Data|4
185289|NCT00432965|636475|P2|Overall Study|Exclusionary Methods|2
185290|NCT00432965|636476|P1|Overall Study|Exclusionary Methods|1
185291|NCT00432965|636475|P2|Overall Study|Death|4
185292|NCT00432965|636476|P1|Overall Study|Death|3
185293|NCT00432965|636475|P2|Overall Study|Adverse Event|19
185294|NCT00432965|636476|P1|Overall Study|Adverse Event|22
185295|NCT00432965|636475|P2|Overall Study|Non-compliance|0
185296|NCT00432965|636476|P1|Overall Study|Non-compliance|7
185297|NCT00432965|636475|P2|Overall Study|Lack of Efficacy|13
185298|NCT00432965|636476|P1|Overall Study|Lack of Efficacy|8
185299|NCT00432965|636475|P2|Overall Study|Physician Decision|13
185300|NCT00432965|636476|P1|Overall Study|Physician Decision|14
185301|NCT00432965|636475|P2|Overall Study|Withdrawal by Subject|13
185302|NCT00432965|636476|P1|Overall Study|Withdrawal by Subject|13
185303|NCT00432965|636475|P2|Overall Study|Lost to Follow-up|19
185304|NCT00432965|636476|P1|Overall Study|Lost to Follow-up|22
185305|NCT00432835|636484|P2|Overall Study|Adverse event: lead dislodgement.|7
185306|NCT00432835|636485|P1|Overall Study|Adverse event: lead dislodgement.|6
185307|NCT00432809|636498|P3|1 Year Follow-up|Withdrawal by Subject|1
185308|NCT00432809|636499|P2|1 Year Follow-up|Withdrawal by Subject|0
185309|NCT00432809|636500|P1|1 Year Follow-up|Withdrawal by Subject|7
185310|NCT00432809|636498|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
185311|NCT00432809|636499|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
185312|NCT00432809|636500|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
185313|NCT00432744|636573|P2|Months 7 - 12|Too disabled to score|1
185314|NCT00432744|636574|P1|Months 7 - 12|Too disabled to score|0
185315|NCT00432744|636573|P2|Months 7 - 12|Withdrawal by Subject|0
185316|NCT00432744|636574|P1|Months 7 - 12|Withdrawal by Subject|1
185317|NCT00432744|636573|P2|Months 0-6|Too disabled to score|0
185318|NCT00432744|636574|P1|Months 0-6|Too disabled to score|1
185319|NCT00432744|636573|P2|Months 0-6|Withdrawal by Subject|4
185320|NCT00432744|636574|P1|Months 0-6|Withdrawal by Subject|4
185321|NCT00432666|636586|P2|Open-Label Extension Period|Physician Decision|0
185322|NCT00432666|636587|P1|Open-Label Extension Period|Physician Decision|3
185323|NCT00432666|636586|P2|Open-Label Extension Period|Consent withdrawn|0
185324|NCT00432666|636587|P1|Open-Label Extension Period|Consent withdrawn|10
185325|NCT00432666|636586|P2|Open-Label Extension Period|Adverse Event|0
185326|NCT00432666|636587|P1|Open-Label Extension Period|Adverse Event|5
185327|NCT00432666|636586|P2|Open-Label Extension Period|Lack of Efficacy|0
185328|NCT00432666|636587|P1|Open-Label Extension Period|Lack of Efficacy|6
185329|NCT00432666|636586|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
185330|NCT00432666|636587|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
185331|NCT00432666|636586|P2|Main Period|Consent Withdrawn|0
185332|NCT00432666|636587|P1|Main Period|Consent Withdrawn|1
185333|NCT00432666|636586|P2|Main Period|Adverse Event|1
185334|NCT00432666|636587|P1|Main Period|Adverse Event|1
185335|NCT00432562|636760|P2|Overall Study|Death|0
185336|NCT00432562|636761|P1|Overall Study|Death|3
185337|NCT00432380|636813|P3|Overall Study|Adverse Event|0
185338|NCT00432380|636814|P2|Overall Study|Adverse Event|0
185339|NCT00432380|636815|P1|Overall Study|Adverse Event|1
185340|NCT00432380|636813|P3|Overall Study|Migrated/moved from study area|1
185341|NCT00432380|636814|P2|Overall Study|Migrated/moved from study area|4
185342|NCT00432380|636815|P1|Overall Study|Migrated/moved from study area|3
185343|NCT00432276|636868|P2|Overall Study|Other|3
185344|NCT00432276|636869|P1|Overall Study|Other|2
185345|NCT00432276|636868|P2|Overall Study|Physician Decision|8
185346|NCT00432276|636869|P1|Overall Study|Physician Decision|6
185347|NCT00432276|636868|P2|Overall Study|Withdrawal by Subject|20
185348|NCT00432276|636869|P1|Overall Study|Withdrawal by Subject|25
185349|NCT00432276|636868|P2|Overall Study|Lost to Follow-up|2
185350|NCT00432276|636869|P1|Overall Study|Lost to Follow-up|6
185351|NCT00432276|636868|P2|Overall Study|Protocol Violation|20
185352|NCT00432276|636869|P1|Overall Study|Protocol Violation|25
185353|NCT00432276|636868|P2|Overall Study|Adverse Event|16
185354|NCT00432276|636869|P1|Overall Study|Adverse Event|13
185355|NCT00432276|636868|P2|Overall Study|Hyperglycemic Rescue|87
185356|NCT00432276|636869|P1|Overall Study|Hyperglycemic Rescue|44
185357|NCT00432237|636959|P4|Overall Study|Lack of Qualifying Event|84
185358|NCT00432237|636960|P3|Overall Study|Lack of Qualifying Event|69
185359|NCT00432237|636961|P2|Overall Study|Lack of Qualifying Event|71
185360|NCT00432237|636962|P1|Overall Study|Lack of Qualifying Event|38
185361|NCT00432237|636959|P4|Overall Study|Withdrawal by Subject|11
185362|NCT00432237|636960|P3|Overall Study|Withdrawal by Subject|9
185363|NCT00432237|636961|P2|Overall Study|Withdrawal by Subject|6
185364|NCT00432237|636962|P1|Overall Study|Withdrawal by Subject|5
185365|NCT00432237|636959|P4|Overall Study|Protocol Violation|8
185366|NCT00432237|636960|P3|Overall Study|Protocol Violation|11
185367|NCT00432237|636961|P2|Overall Study|Protocol Violation|10
185368|NCT00432237|636962|P1|Overall Study|Protocol Violation|13
185369|NCT00432237|636959|P4|Overall Study|Pregnancy|0
185370|NCT00432237|636960|P3|Overall Study|Pregnancy|0
185371|NCT00432237|636961|P2|Overall Study|Pregnancy|1
185372|NCT00432237|636962|P1|Overall Study|Pregnancy|0
185373|NCT00432237|636959|P4|Overall Study|Physician Decision|1
185374|NCT00432237|636960|P3|Overall Study|Physician Decision|2
185375|NCT00432237|636961|P2|Overall Study|Physician Decision|3
185376|NCT00432237|636962|P1|Overall Study|Physician Decision|1
185377|NCT00432237|636959|P4|Overall Study|Lost to Follow-up|18
185378|NCT00432237|636960|P3|Overall Study|Lost to Follow-up|18
185379|NCT00432237|636961|P2|Overall Study|Lost to Follow-up|10
185380|NCT00432237|636962|P1|Overall Study|Lost to Follow-up|10
185381|NCT00432237|636959|P4|Overall Study|Lack of Efficacy|1
185382|NCT00432237|636960|P3|Overall Study|Lack of Efficacy|0
185383|NCT00432237|636961|P2|Overall Study|Lack of Efficacy|0
185384|NCT00432237|636962|P1|Overall Study|Lack of Efficacy|0
185385|NCT00432237|636959|P4|Overall Study|Adverse Event|1
185386|NCT00432237|636960|P3|Overall Study|Adverse Event|0
185387|NCT00432237|636961|P2|Overall Study|Adverse Event|0
185388|NCT00432237|636962|P1|Overall Study|Adverse Event|0
185389|NCT00432159|637005|P5|Overall Study|Missing NDI and/or neuro. assessment|7
185390|NCT00432159|637006|P4|Overall Study|Missing NDI and/or neuro. assessment|3
185391|NCT00432159|637007|P3|Overall Study|Missing NDI and/or neuro. assessment|1
185392|NCT00432159|637008|P2|Overall Study|Missing NDI and/or neuro. assessment|24
185393|NCT00432159|637009|P1|Overall Study|Missing NDI and/or neuro. assessment|13
185394|NCT00432159|637005|P5|Overall Study|Failure|3
185395|NCT00432159|637006|P4|Overall Study|Failure|2
185396|NCT00432159|637007|P3|Overall Study|Failure|3
185397|NCT00432159|637008|P2|Overall Study|Failure|5
185398|NCT00432159|637009|P1|Overall Study|Failure|9
185399|NCT00432159|637005|P5|Overall Study|Death|0
185400|NCT00432159|637006|P4|Overall Study|Death|0
185401|NCT00432159|637007|P3|Overall Study|Death|0
185402|NCT00432159|637008|P2|Overall Study|Death|1
185403|NCT00432159|637009|P1|Overall Study|Death|0
185404|NCT00432042|637116|P3|Overall Study|Lost to Follow-up|0
185405|NCT00432042|637117|P2|Overall Study|Lost to Follow-up|1
185406|NCT00432042|637118|P1|Overall Study|Lost to Follow-up|5
185407|NCT00432042|637116|P3|Overall Study|Withdrawal by Subject|2
185408|NCT00432042|637117|P2|Overall Study|Withdrawal by Subject|0
185409|NCT00432042|637118|P1|Overall Study|Withdrawal by Subject|0
185410|NCT00432042|637116|P3|Overall Study|Protocol Violation|0
185411|NCT00432042|637117|P2|Overall Study|Protocol Violation|0
185412|NCT00432042|637118|P1|Overall Study|Protocol Violation|2
185413|NCT00431964|637131|P2|Overall Study|Due to Unstable Health|1
185414|NCT00431964|637132|P1|Overall Study|Due to Unstable Health|0
185415|NCT00431964|637131|P2|Overall Study|Parental Consent Withdrawn|2
185416|NCT00431964|637132|P1|Overall Study|Parental Consent Withdrawn|0
185417|NCT00431964|637131|P2|Overall Study|Withdrawal by Subject|1
185418|NCT00431964|637132|P1|Overall Study|Withdrawal by Subject|2
185419|NCT00431964|637131|P2|Overall Study|Physician Decision|2
185420|NCT00431964|637132|P1|Overall Study|Physician Decision|2
185421|NCT00431964|637131|P2|Overall Study|Lost to Follow-up|2
185422|NCT00431964|637132|P1|Overall Study|Lost to Follow-up|1
185423|NCT00431964|637131|P2|Overall Study|Adverse Event|0
185424|NCT00431964|637132|P1|Overall Study|Adverse Event|1
185425|NCT00431951|637142|P4|Overall Study|Adverse Event|0
185426|NCT00431951|637143|P3|Overall Study|Adverse Event|1
185427|NCT00431951|637144|P2|Overall Study|Adverse Event|0
185428|NCT00431951|637145|P1|Overall Study|Adverse Event|0
185429|NCT00431951|637142|P4|Overall Study|Withdrawal by Subject|0
185430|NCT00431951|637143|P3|Overall Study|Withdrawal by Subject|0
185431|NCT00431951|637144|P2|Overall Study|Withdrawal by Subject|1
185432|NCT00431951|637145|P1|Overall Study|Withdrawal by Subject|0
185433|NCT00431951|637142|P4|Overall Study|Lost to Follow-up|0
185434|NCT00431951|637143|P3|Overall Study|Lost to Follow-up|0
185435|NCT00431951|637144|P2|Overall Study|Lost to Follow-up|1
185436|NCT00431951|637145|P1|Overall Study|Lost to Follow-up|0
185437|NCT00431951|637142|P4|Overall Study|Inability to follow study procedures|2
185438|NCT00431951|637143|P3|Overall Study|Inability to follow study procedures|1
185439|NCT00431951|637144|P2|Overall Study|Inability to follow study procedures|0
185440|NCT00431951|637145|P1|Overall Study|Inability to follow study procedures|1
185441|NCT00431847|637207|P5|Overall Study|Protocol Violation|1
185442|NCT00431847|637208|P4|Overall Study|Protocol Violation|0
185443|NCT00431847|637209|P3|Overall Study|Protocol Violation|0
185444|NCT00431847|637210|P2|Overall Study|Protocol Violation|0
185445|NCT00431847|637211|P1|Overall Study|Protocol Violation|0
185446|NCT00431847|637207|P5|Overall Study|completion of less than two study visits|0
185447|NCT00431847|637208|P4|Overall Study|completion of less than two study visits|14
185448|NCT00431847|637209|P3|Overall Study|completion of less than two study visits|4
185449|NCT00431847|637210|P2|Overall Study|completion of less than two study visits|3
185450|NCT00431847|637211|P1|Overall Study|completion of less than two study visits|6
185451|NCT00431834|637285|P1|Overall Study|Lost to Follow-up|1
185452|NCT00431834|637285|P1|Overall Study|Missed Endpoint Visit|2
185453|NCT00431834|637285|P1|Overall Study|Death|3
185454|NCT00431834|637285|P1|Overall Study|Withdrawal by Subject|7
185455|NCT00431496|637301|P1|Overall Study|Protocol-specified criteria|5
185456|NCT00431496|637301|P1|Overall Study|Withdrawal by Subject|2
185457|NCT00431496|637301|P1|Overall Study|Lost to Follow-up|1
185458|NCT00431496|637301|P1|Overall Study|Adverse Event|3
185459|NCT00431444|637312|P2|Overall Study|Administrative Problems|1
185460|NCT00431444|637313|P1|Overall Study|Administrative Problems|0
185461|NCT00431444|637312|P2|Overall Study|Lost to Follow-up|0
185462|NCT00431444|637313|P1|Overall Study|Lost to Follow-up|1
185463|NCT00431444|637312|P2|Overall Study|Withdrawal by Subject|1
185464|NCT00431444|637313|P1|Overall Study|Withdrawal by Subject|1
185465|NCT00431444|637312|P2|Overall Study|Adverse Event|1
185466|NCT00431444|637313|P1|Overall Study|Adverse Event|2
185467|NCT00431444|637312|P2|Overall Study|Protocol Violation|4
185468|NCT00431444|637313|P1|Overall Study|Protocol Violation|1
185469|NCT00431067|637353|P1|Overall Study|Non-compliance,lost to follow-up|2
185470|NCT00431067|637353|P1|Overall Study|Progressive disease|30
185471|NCT00431067|637353|P1|Overall Study|Other Adverse Event|9
185472|NCT00430950|637378|P2|Overall Study|concomitant medication,etc.|7
185473|NCT00430950|637379|P1|Overall Study|concomitant medication,etc.|5
185474|NCT00430950|637378|P2|Overall Study|Withdrawal by Subject|0
185475|NCT00430950|637379|P1|Overall Study|Withdrawal by Subject|1
185476|NCT00430950|637378|P2|Overall Study|Adverse Event|6
185477|NCT00430950|637379|P1|Overall Study|Adverse Event|7
185478|NCT00430937|637393|P2|Overall Study|Unable to classify|1
185479|NCT00430937|637394|P1|Overall Study|Unable to classify|0
185480|NCT00430937|637393|P2|Overall Study|Protocol discontinuation criteria met|2
185481|NCT00430937|637394|P1|Overall Study|Protocol discontinuation criteria met|1
185482|NCT00430937|637393|P2|Overall Study|Administrative reasons|0
185483|NCT00430937|637394|P1|Overall Study|Administrative reasons|1
185484|NCT00430937|637393|P2|Overall Study|Inappropriate enrollment|1
185485|NCT00430937|637394|P1|Overall Study|Inappropriate enrollment|2
185486|NCT00430937|637393|P2|Overall Study|Lack of Efficacy|5
185487|NCT00430937|637394|P1|Overall Study|Lack of Efficacy|6
185488|NCT00430937|637393|P2|Overall Study|Protocol Violation|2
185489|NCT00430937|637394|P1|Overall Study|Protocol Violation|3
185490|NCT00430937|637393|P2|Overall Study|Withdrawal by Subject|2
185491|NCT00430937|637394|P1|Overall Study|Withdrawal by Subject|5
185492|NCT00430937|637393|P2|Overall Study|Lost to Follow-up|6
185493|NCT00430937|637394|P1|Overall Study|Lost to Follow-up|6
185494|NCT00430937|637393|P2|Overall Study|Death|1
185495|NCT00430937|637394|P1|Overall Study|Death|0
185496|NCT00430937|637393|P2|Overall Study|Adverse Event|8
185497|NCT00430937|637394|P1|Overall Study|Adverse Event|3
185498|NCT00430781|637405|P3|End-of-Study Analysis; 28 July 2011|Other|0
185499|NCT00430781|637406|P2|End-of-Study Analysis; 28 July 2011|Other|1
185500|NCT00430781|637407|P1|End-of-Study Analysis; 28 July 2011|Other|4
185501|NCT00430781|637405|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
185502|NCT00430781|637406|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
185503|NCT00430781|637407|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
185504|NCT00430781|637405|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
185505|NCT00430781|637406|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
185506|NCT00430781|637407|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
185507|NCT00430781|637405|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
185508|NCT00430781|637406|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
185509|NCT00430781|637407|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
185510|NCT00430781|637405|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
185511|NCT00430781|637406|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
185512|NCT00430781|637407|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
185513|NCT00430781|637405|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
185514|NCT00430781|637406|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
185515|NCT00430781|637407|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
185516|NCT00430781|637405|P3|Final Analysis; 31 July 2008|Ongoing|32
185517|NCT00430781|637406|P2|Final Analysis; 31 July 2008|Ongoing|29
185518|NCT00430781|637407|P1|Final Analysis; 31 July 2008|Ongoing|0
185519|NCT00430781|637405|P3|Final Analysis; 31 July 2008|Other|0
185520|NCT00430781|637406|P2|Final Analysis; 31 July 2008|Other|1
185521|NCT00430781|637407|P1|Final Analysis; 31 July 2008|Other|0
185522|NCT00430781|637405|P3|Final Analysis; 31 July 2008|Physician Decision|6
185523|NCT00430781|637406|P2|Final Analysis; 31 July 2008|Physician Decision|6
185524|NCT00430781|637407|P1|Final Analysis; 31 July 2008|Physician Decision|0
185525|NCT00430781|637405|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
185526|NCT00430781|637406|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
185527|NCT00430781|637407|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
185528|NCT00430781|637405|P3|Final Analysis; 31 July 2008|Protocol Violation|0
185529|NCT00430781|637406|P2|Final Analysis; 31 July 2008|Protocol Violation|1
185530|NCT00430781|637407|P1|Final Analysis; 31 July 2008|Protocol Violation|0
185531|NCT00430781|637405|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
185532|NCT00430781|637406|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
185533|NCT00430781|637407|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
185534|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Ongoing|25
185535|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Ongoing|20
185536|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Ongoing|23
185537|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Physician Decision|3
185538|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Physician Decision|3
185539|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Physician Decision|2
185540|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
185541|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
185542|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
185543|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Death|0
185544|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Death|1
185545|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Death|0
185546|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Disease Progression|22
185547|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Disease Progression|30
185548|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Disease Progression|16
185549|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
185550|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
185551|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
185552|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
185553|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
185554|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
185555|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
185556|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
185557|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
185558|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
185559|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
185560|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
185561|NCT00430781|637405|P3|Interim Analysis; 11 February 2008|Adverse Event|7
185562|NCT00430781|637406|P2|Interim Analysis; 11 February 2008|Adverse Event|3
185563|NCT00430781|637407|P1|Interim Analysis; 11 February 2008|Adverse Event|10
185564|NCT00430755|637449|P1|Overall Study|Withdrawal by Subject|53
185565|NCT00430716|637456|P3|Open Label Phase|Study terminated by sponsor|4
185566|NCT00430716|637457|P2|Open Label Phase|Study terminated by sponsor|5
185567|NCT00430716|637458|P1|Open Label Phase|Study terminated by sponsor|4
185568|NCT00430716|637456|P3|Open Label Phase|Protocol Violation|0
185569|NCT00430716|637457|P2|Open Label Phase|Protocol Violation|0
185570|NCT00430716|637458|P1|Open Label Phase|Protocol Violation|1
185571|NCT00430716|637456|P3|Open Label Phase|Other|1
185572|NCT00430716|637457|P2|Open Label Phase|Other|1
185573|NCT00430716|637458|P1|Open Label Phase|Other|3
185574|NCT00430716|637456|P3|Open Label Phase|No longer willing to participate|1
185575|NCT00430716|637457|P2|Open Label Phase|No longer willing to participate|1
185576|NCT00430716|637458|P1|Open Label Phase|No longer willing to participate|0
185577|NCT00430716|637456|P3|Open Label Phase|Lost to Follow-up|1
185578|NCT00430716|637457|P2|Open Label Phase|Lost to Follow-up|0
185579|NCT00430716|637458|P1|Open Label Phase|Lost to Follow-up|1
185580|NCT00430716|637456|P3|Double Blind Phase|Not met eligibility criteria|0
185581|NCT00430716|637457|P2|Double Blind Phase|Not met eligibility criteria|0
185582|NCT00430716|637458|P1|Double Blind Phase|Not met eligibility criteria|1
185583|NCT00430716|637456|P3|Double Blind Phase|Adverse Event|3
185584|NCT00430716|637457|P2|Double Blind Phase|Adverse Event|1
185585|NCT00430716|637458|P1|Double Blind Phase|Adverse Event|1
185586|NCT00430716|637456|P3|Double Blind Phase|Study terminated by sponsor|2
185587|NCT00430716|637457|P2|Double Blind Phase|Study terminated by sponsor|1
185588|NCT00430716|637458|P1|Double Blind Phase|Study terminated by sponsor|1
185589|NCT00430716|637456|P3|Double Blind Phase|Other|0
185590|NCT00430716|637457|P2|Double Blind Phase|Other|2
185591|NCT00430716|637458|P1|Double Blind Phase|Other|0
185592|NCT00430716|637456|P3|Double Blind Phase|No longer willing to participate|1
185593|NCT00430716|637457|P2|Double Blind Phase|No longer willing to participate|1
185594|NCT00430716|637458|P1|Double Blind Phase|No longer willing to participate|2
185595|NCT00430716|637456|P3|Double Blind Phase|Death|0
185596|NCT00430716|637457|P2|Double Blind Phase|Death|0
185597|NCT00430716|637458|P1|Double Blind Phase|Death|1
185598|NCT00430677|637490|P3|Long-term Extension Period|Poor compliance/noncompliance|0
185599|NCT00430677|637491|P2|Long-term Extension Period|Poor compliance/noncompliance|0
185600|NCT00430677|637492|P1|Long-term Extension Period|Poor compliance/noncompliance|1
185601|NCT00430677|637490|P3|Long-term Extension Period|Not specified|1
185602|NCT00430677|637491|P2|Long-term Extension Period|Not specified|1
185603|NCT00430677|637492|P1|Long-term Extension Period|Not specified|2
185604|NCT00430677|637490|P3|Long-term Extension Period|Administrative reason by sponsor|46
185605|NCT00430677|637491|P2|Long-term Extension Period|Administrative reason by sponsor|49
185606|NCT00430677|637492|P1|Long-term Extension Period|Administrative reason by sponsor|41
185607|NCT00430677|637490|P3|Long-term Extension Period|Pregnancy|0
185608|NCT00430677|637491|P2|Long-term Extension Period|Pregnancy|1
185609|NCT00430677|637492|P1|Long-term Extension Period|Pregnancy|1
185610|NCT00430677|637490|P3|Long-term Extension Period|Withdrawal by Subject|2
185611|NCT00430677|637491|P2|Long-term Extension Period|Withdrawal by Subject|1
185612|NCT00430677|637492|P1|Long-term Extension Period|Withdrawal by Subject|5
185613|NCT00430677|637490|P3|Long-term Extension Period|Lost to Follow-up|1
185614|NCT00430677|637491|P2|Long-term Extension Period|Lost to Follow-up|1
185615|NCT00430677|637492|P1|Long-term Extension Period|Lost to Follow-up|1
185616|NCT00430677|637490|P3|Long-term Extension Period|Lack of Efficacy|8
185617|NCT00430677|637491|P2|Long-term Extension Period|Lack of Efficacy|3
185618|NCT00430677|637492|P1|Long-term Extension Period|Lack of Efficacy|5
185619|NCT00430677|637490|P3|Long-term Extension Period|Adverse Event|5
185620|NCT00430677|637491|P2|Long-term Extension Period|Adverse Event|2
185621|NCT00430677|637492|P1|Long-term Extension Period|Adverse Event|3
185622|NCT00430677|637490|P3|Long-term Extension Period|Death|0
185623|NCT00430677|637491|P2|Long-term Extension Period|Death|0
185624|NCT00430677|637492|P1|Long-term Extension Period|Death|1
185625|NCT00430677|637490|P3|Short-term Period|Pregnancy|0
185626|NCT00430677|637491|P2|Short-term Period|Pregnancy|2
185627|NCT00430677|637492|P1|Short-term Period|Pregnancy|0
185628|NCT00430677|637490|P3|Short-term Period|Poor compliance/ noncompliance|0
185629|NCT00430677|637491|P2|Short-term Period|Poor compliance/ noncompliance|1
185630|NCT00430677|637492|P1|Short-term Period|Poor compliance/ noncompliance|0
185631|NCT00430677|637490|P3|Short-term Period|Participant no longer met study criteria|2
185632|NCT00430677|637491|P2|Short-term Period|Participant no longer met study criteria|1
185633|NCT00430677|637492|P1|Short-term Period|Participant no longer met study criteria|1
185634|NCT00430677|637490|P3|Short-term Period|Withdrawal by Subject|2
185635|NCT00430677|637491|P2|Short-term Period|Withdrawal by Subject|1
185636|NCT00430677|637492|P1|Short-term Period|Withdrawal by Subject|1
185637|NCT00430677|637490|P3|Short-term Period|Lack of Efficacy|4
185638|NCT00430677|637491|P2|Short-term Period|Lack of Efficacy|6
185639|NCT00430677|637492|P1|Short-term Period|Lack of Efficacy|5
185640|NCT00430677|637490|P3|Short-term Period|Adverse Event|9
185641|NCT00430677|637491|P2|Short-term Period|Adverse Event|13
185642|NCT00430677|637492|P1|Short-term Period|Adverse Event|15
185643|NCT00430677|637490|P3|Short-term Period|Death|5
185644|NCT00430677|637491|P2|Short-term Period|Death|1
185645|NCT00430677|637492|P1|Short-term Period|Death|1
185646|NCT00430638|637615|P2|Overall Study|Not specified|2
185647|NCT00430638|637616|P1|Overall Study|Not specified|2
185648|NCT00430638|637615|P2|Overall Study|Non-compliant|1
185649|NCT00430638|637616|P1|Overall Study|Non-compliant|2
185650|NCT00430638|637615|P2|Overall Study|Withdrawal by Subject|6
185651|NCT00430638|637616|P1|Overall Study|Withdrawal by Subject|4
185652|NCT00430638|637615|P2|Overall Study|Protocol Violation|4
185653|NCT00430638|637616|P1|Overall Study|Protocol Violation|6
185654|NCT00430638|637615|P2|Overall Study|Lost to Follow-up|7
185655|NCT00430638|637616|P1|Overall Study|Lost to Follow-up|1
185656|NCT00430638|637615|P2|Overall Study|Uncontrolled blood pressure|13
185657|NCT00430638|637616|P1|Overall Study|Uncontrolled blood pressure|48
185658|NCT00430638|637615|P2|Overall Study|Adverse Event|15
185659|NCT00430638|637616|P1|Overall Study|Adverse Event|15
185660|NCT00430573|637651|P1|Overall Study|Withdrawal by Subject|5
185661|NCT00430508|637660|P4|Overall Study|not specified|0
185662|NCT00430508|637661|P3|Overall Study|not specified|3
185663|NCT00430508|637662|P2|Overall Study|not specified|1
185664|NCT00430508|637663|P1|Overall Study|not specified|1
185665|NCT00430508|637660|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
185666|NCT00430508|637661|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
185667|NCT00430508|637662|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
185668|NCT00430508|637663|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
185669|NCT00430508|637660|P4|Overall Study|responder at visit 4|0
185670|NCT00430508|637661|P3|Overall Study|responder at visit 4|2
185671|NCT00430508|637662|P2|Overall Study|responder at visit 4|0
185672|NCT00430508|637663|P1|Overall Study|responder at visit 4|0
185673|NCT00430508|637660|P4|Overall Study|Withdrawal by Subject|1
185674|NCT00430508|637661|P3|Overall Study|Withdrawal by Subject|1
185675|NCT00430508|637662|P2|Overall Study|Withdrawal by Subject|1
185676|NCT00430508|637663|P1|Overall Study|Withdrawal by Subject|0
185677|NCT00430508|637660|P4|Overall Study|Adverse Event|3
185678|NCT00430508|637661|P3|Overall Study|Adverse Event|5
185679|NCT00430508|637662|P2|Overall Study|Adverse Event|3
185680|NCT00430508|637663|P1|Overall Study|Adverse Event|2
185681|NCT00430495|637701|P4|Overall Study|Randomized but not Treated|0
185682|NCT00430495|637702|P3|Overall Study|Randomized but not Treated|0
185683|NCT00430495|637703|P2|Overall Study|Randomized but not Treated|0
185684|NCT00430495|637704|P1|Overall Study|Randomized but not Treated|2
185685|NCT00430495|637701|P4|Overall Study|Other|4
185686|NCT00430495|637702|P3|Overall Study|Other|5
185687|NCT00430495|637703|P2|Overall Study|Other|2
185688|NCT00430495|637704|P1|Overall Study|Other|8
185689|NCT00430495|637701|P4|Overall Study|Disease Progression|0
185690|NCT00430495|637702|P3|Overall Study|Disease Progression|0
185691|NCT00430495|637703|P2|Overall Study|Disease Progression|1
185692|NCT00430495|637704|P1|Overall Study|Disease Progression|1
185693|NCT00430495|637701|P4|Overall Study|Protocol Violation|0
185694|NCT00430495|637702|P3|Overall Study|Protocol Violation|1
185695|NCT00430495|637703|P2|Overall Study|Protocol Violation|0
185696|NCT00430495|637704|P1|Overall Study|Protocol Violation|1
185697|NCT00430495|637701|P4|Overall Study|Lost to Follow-up|0
185698|NCT00430495|637702|P3|Overall Study|Lost to Follow-up|4
185699|NCT00430495|637703|P2|Overall Study|Lost to Follow-up|1
185700|NCT00430495|637704|P1|Overall Study|Lost to Follow-up|0
185701|NCT00430495|637701|P4|Overall Study|Death|0
185702|NCT00430495|637702|P3|Overall Study|Death|1
185703|NCT00430495|637703|P2|Overall Study|Death|0
185704|NCT00430495|637704|P1|Overall Study|Death|0
185705|NCT00430495|637701|P4|Overall Study|Adverse Event|0
185706|NCT00430495|637702|P3|Overall Study|Adverse Event|2
185707|NCT00430495|637703|P2|Overall Study|Adverse Event|3
185708|NCT00430495|637704|P1|Overall Study|Adverse Event|2
185709|NCT00430352|637742|P1|Overall Study|Not specified|48
185710|NCT00430352|637742|P1|Overall Study|Death|5
185711|NCT00430352|637742|P1|Overall Study|Adverse Event|16
185712|NCT00430352|637742|P1|Overall Study|Withdrawal by Subject|11
185713|NCT00430352|637742|P1|Overall Study|Disease progression|58
185714|NCT00430300|637760|P4|Overall Study|Other|1
185715|NCT00430300|637761|P3|Overall Study|Other|0
185716|NCT00430300|637762|P2|Overall Study|Other|0
185717|NCT00430300|637763|P1|Overall Study|Other|0
185718|NCT00430300|637760|P4|Overall Study|Laboratory abnormality|0
185719|NCT00430300|637761|P3|Overall Study|Laboratory abnormality|0
185720|NCT00430300|637762|P2|Overall Study|Laboratory abnormality|0
185721|NCT00430300|637763|P1|Overall Study|Laboratory abnormality|1
185722|NCT00430300|637760|P4|Overall Study|Withdrawal by Subject|0
185723|NCT00430300|637761|P3|Overall Study|Withdrawal by Subject|5
185724|NCT00430300|637762|P2|Overall Study|Withdrawal by Subject|0
185725|NCT00430300|637763|P1|Overall Study|Withdrawal by Subject|1
185726|NCT00430300|637760|P4|Overall Study|Adverse Event|1
185727|NCT00430300|637761|P3|Overall Study|Adverse Event|1
185728|NCT00430300|637762|P2|Overall Study|Adverse Event|2
185729|NCT00430300|637763|P1|Overall Study|Adverse Event|0
185730|NCT00430248|637868|P3|Overall Study|Reason Not Specified|11
185731|NCT00430248|637869|P2|Overall Study|Reason Not Specified|8
185732|NCT00430248|637870|P1|Overall Study|Reason Not Specified|8
185733|NCT00430248|637868|P3|Overall Study|Gout Flare|2
185734|NCT00430248|637869|P2|Overall Study|Gout Flare|7
185735|NCT00430248|637870|P1|Overall Study|Gout Flare|3
185736|NCT00430248|637868|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
185737|NCT00430248|637869|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
185738|NCT00430248|637870|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
185739|NCT00430248|637868|P3|Overall Study|Withdrawal by Subject|16
185740|NCT00430248|637869|P2|Overall Study|Withdrawal by Subject|20
185741|NCT00430248|637870|P1|Overall Study|Withdrawal by Subject|14
185742|NCT00430248|637868|P3|Overall Study|Therapeutic Failure|1
185743|NCT00430248|637869|P2|Overall Study|Therapeutic Failure|1
185744|NCT00430248|637870|P1|Overall Study|Therapeutic Failure|1
185745|NCT00430248|637868|P3|Overall Study|Lost to Follow-up|28
185746|NCT00430248|637869|P2|Overall Study|Lost to Follow-up|33
185747|NCT00430248|637870|P1|Overall Study|Lost to Follow-up|28
185748|NCT00430248|637868|P3|Overall Study|Personal Reasons|9
185749|NCT00430248|637869|P2|Overall Study|Personal Reasons|24
185750|NCT00430248|637870|P1|Overall Study|Personal Reasons|12
185751|NCT00430248|637868|P3|Overall Study|Protocol Violation|4
185752|NCT00430248|637869|P2|Overall Study|Protocol Violation|2
185753|NCT00430248|637870|P1|Overall Study|Protocol Violation|10
185754|NCT00430248|637868|P3|Overall Study|Adverse Event|64
185755|NCT00430248|637869|P2|Overall Study|Adverse Event|61
185756|NCT00430248|637870|P1|Overall Study|Adverse Event|49
185757|NCT00430092|637929|P3|Overall Study|Withdrawal by Subject|1
185758|NCT00430092|637930|P2|Overall Study|Withdrawal by Subject|1
185759|NCT00430092|637931|P1|Overall Study|Withdrawal by Subject|0
185760|NCT00430092|637929|P3|Overall Study|Protocol Violation|1
185761|NCT00430092|637930|P2|Overall Study|Protocol Violation|1
185762|NCT00430092|637931|P1|Overall Study|Protocol Violation|0
185763|NCT00430092|637929|P3|Overall Study|Lost to Follow-up|0
185764|NCT00430092|637930|P2|Overall Study|Lost to Follow-up|0
185765|NCT00430092|637931|P1|Overall Study|Lost to Follow-up|1
185766|NCT00430092|637929|P3|Overall Study|Lack of Efficacy|54
185767|NCT00430092|637930|P2|Overall Study|Lack of Efficacy|2
185768|NCT00430092|637931|P1|Overall Study|Lack of Efficacy|5
185769|NCT00430092|637929|P3|Overall Study|Adverse Event|1
185770|NCT00430092|637930|P2|Overall Study|Adverse Event|0
185771|NCT00430092|637931|P1|Overall Study|Adverse Event|0
185772|NCT00430027|637936|P1|Overall Study|Study terminated|8
185773|NCT00429923|637953|P3|Overall Study|Early Termination|0
185774|NCT00429923|637954|P2|Overall Study|Early Termination|1
185775|NCT00429923|637955|P1|Overall Study|Early Termination|0
185776|NCT00429923|637953|P3|Overall Study|Withdrew Consent|1
185777|NCT00429923|637954|P2|Overall Study|Withdrew Consent|0
185778|NCT00429923|637955|P1|Overall Study|Withdrew Consent|1
185779|NCT00429923|637953|P3|Overall Study|Lost to Follow-up|2
185780|NCT00429923|637954|P2|Overall Study|Lost to Follow-up|0
185781|NCT00429923|637955|P1|Overall Study|Lost to Follow-up|0
185782|NCT00429923|637953|P3|Overall Study|Lack of Efficacy|33
185783|NCT00429923|637954|P2|Overall Study|Lack of Efficacy|1
185784|NCT00429923|637955|P1|Overall Study|Lack of Efficacy|4
185785|NCT00429923|637953|P3|Overall Study|Adverse Event|3
185786|NCT00429923|637954|P2|Overall Study|Adverse Event|2
185787|NCT00429923|637955|P1|Overall Study|Adverse Event|0
185788|NCT00429793|637960|P1|Overall Study|Non-measurable|1
185789|NCT00429793|637960|P1|Overall Study|Never treated|1
185790|NCT00429793|637960|P1|Overall Study|Required test not done|1
185791|NCT00429793|637960|P1|Overall Study|Improper pre-protocol treatment|3
185792|NCT00429663|637987|P2|Overall Study|Death|0
185793|NCT00429663|637988|P1|Overall Study|Death|4
185794|NCT00429663|637987|P2|Overall Study|Withdrawal by Subject|5
185795|NCT00429663|637988|P1|Overall Study|Withdrawal by Subject|2
185796|NCT00429663|637987|P2|Overall Study|Physician Decision|3
185797|NCT00429663|637988|P1|Overall Study|Physician Decision|6
185798|NCT00429663|637987|P2|Overall Study|Lost to Follow-up|31
185799|NCT00429663|637988|P1|Overall Study|Lost to Follow-up|24
185800|NCT00429572|638002|P1|Overall Study|Disease progression|1
185801|NCT00429494|638014|P1|Overall Study|Death|6
185802|NCT00429494|638014|P1|Overall Study|Withdrawal by Subject|9
185803|NCT00429416|638018|P1|Overall Study|Death|1
185804|NCT00429364|638037|P2|Overall Study|Pregnancy|1
185805|NCT00429364|638038|P1|Overall Study|Pregnancy|0
185806|NCT00429364|638037|P2|Overall Study|Underwent aortic root surgery|18
185807|NCT00429364|638038|P1|Overall Study|Underwent aortic root surgery|10
185808|NCT00429364|638037|P2|Overall Study|Death|1
185809|NCT00429364|638038|P1|Overall Study|Death|0
185810|NCT00429364|638037|P2|Overall Study|Lost to Follow-up|6
185811|NCT00429364|638038|P1|Overall Study|Lost to Follow-up|7
185812|NCT00429364|638037|P2|Overall Study|Physician Decision|2
185813|NCT00429364|638038|P1|Overall Study|Physician Decision|4
185814|NCT00429364|638037|P2|Overall Study|Withdrawal by Subject|5
185815|NCT00429364|638038|P1|Overall Study|Withdrawal by Subject|11
185816|NCT00429299|638097|P3|Overall Study|Withdrawal by Subject|3
185817|NCT00429299|638098|P2|Overall Study|Withdrawal by Subject|1
185818|NCT00429299|638099|P1|Overall Study|Withdrawal by Subject|0
185819|NCT00429299|638097|P3|Overall Study|Protocol Violation|0
185820|NCT00429299|638098|P2|Overall Study|Protocol Violation|0
185821|NCT00429299|638099|P1|Overall Study|Protocol Violation|1
185822|NCT00429299|638097|P3|Overall Study|Adverse Event|1
185823|NCT00429299|638098|P2|Overall Study|Adverse Event|5
185824|NCT00429299|638099|P1|Overall Study|Adverse Event|2
185825|NCT00429299|638097|P3|Overall Study|Disease Progression|0
185826|NCT00429299|638098|P2|Overall Study|Disease Progression|1
185827|NCT00429299|638099|P1|Overall Study|Disease Progression|1
185828|NCT00429273|638131|P3|Overall Study|Adverse Event|2
185829|NCT00429273|638132|P2|Overall Study|Adverse Event|1
185830|NCT00429273|638133|P1|Overall Study|Adverse Event|1
185831|NCT00429273|638131|P3|Overall Study|Physician Decision|5
185832|NCT00429273|638132|P2|Overall Study|Physician Decision|5
185833|NCT00429273|638133|P1|Overall Study|Physician Decision|6
185834|NCT00429273|638131|P3|Overall Study|Lost to Follow-up|2
185835|NCT00429273|638132|P2|Overall Study|Lost to Follow-up|2
185836|NCT00429273|638133|P1|Overall Study|Lost to Follow-up|1
185837|NCT00429182|638141|P1|Overall Study|Not eligible|5
185838|NCT00429182|638141|P1|Overall Study|Not evaluable, Disease Progression|2
185839|NCT00429169|638148|P2|Overall Study|Ineligibility discovered after entry|1
185840|NCT00429169|638149|P1|Overall Study|Ineligibility discovered after entry|2
185841|NCT00429169|638148|P2|Overall Study|Lost to Follow-up|1
185842|NCT00429169|638149|P1|Overall Study|Lost to Follow-up|0
185843|NCT00429104|638167|P1|Overall Study|Protocol Violation|1
185844|NCT00429026|638172|P1|Overall Study|Inevaluable for response.|40
185845|NCT00428948|638199|P2|Overall Study|Protocol Deviation|1
185846|NCT00428948|638200|P1|Overall Study|Protocol Deviation|1
185847|NCT00428948|638199|P2|Overall Study|Subject Withdrew Consent|30
185848|NCT00428948|638200|P1|Overall Study|Subject Withdrew Consent|50
185849|NCT00428948|638199|P2|Overall Study|Investigator Withdrew Subject|4
185850|NCT00428948|638200|P1|Overall Study|Investigator Withdrew Subject|3
185851|NCT00428948|638199|P2|Overall Study|Subject Met Withdrawal Criteria|0
185852|NCT00428948|638200|P1|Overall Study|Subject Met Withdrawal Criteria|4
185853|NCT00428948|638199|P2|Overall Study|Adverse Event|24
185854|NCT00428948|638200|P1|Overall Study|Adverse Event|148
185855|NCT00428948|638199|P2|Overall Study|Lost to Follow-up|8
185856|NCT00428948|638200|P1|Overall Study|Lost to Follow-up|15
185857|NCT00428844|638228|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
185858|NCT00428844|638229|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
185859|NCT00428844|638230|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
185860|NCT00428844|638228|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
185861|NCT00428844|638229|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
185862|NCT00428844|638230|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
185863|NCT00428844|638228|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
185864|NCT00428844|638229|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
185865|NCT00428844|638230|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
185866|NCT00428844|638228|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
185867|NCT00428844|638229|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
185868|NCT00428844|638230|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
185869|NCT00428844|638228|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
185870|NCT00428844|638229|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
185871|NCT00428844|638230|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
185872|NCT00428844|638228|P3|Completed Study Drug Treatment|Randomized Not Treated|1
185873|NCT00428844|638229|P2|Completed Study Drug Treatment|Randomized Not Treated|0
185874|NCT00428844|638230|P1|Completed Study Drug Treatment|Randomized Not Treated|0
185875|NCT00428844|638228|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
185876|NCT00428844|638229|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
185877|NCT00428844|638230|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
185878|NCT00428844|638228|P3|Completed Study Drug Treatment|Protocol Violation|1
185879|NCT00428844|638229|P2|Completed Study Drug Treatment|Protocol Violation|1
185880|NCT00428844|638230|P1|Completed Study Drug Treatment|Protocol Violation|0
185881|NCT00428844|638228|P3|Completed Study Drug Treatment|Adverse Event|4
185882|NCT00428844|638229|P2|Completed Study Drug Treatment|Adverse Event|4
185883|NCT00428844|638230|P1|Completed Study Drug Treatment|Adverse Event|2
185884|NCT00428792|638253|P2|Overall Study|Lost to Follow-up|1
185885|NCT00428792|638254|P1|Overall Study|Lost to Follow-up|0
185886|NCT00428792|638253|P2|Overall Study|Lack of Efficacy|3
185887|NCT00428792|638254|P1|Overall Study|Lack of Efficacy|1
185888|NCT00428610|638281|P3|Overall Study|Withdrawal by Subject|0
185889|NCT00428610|638282|P2|Overall Study|Withdrawal by Subject|0
185890|NCT00428610|638283|P1|Overall Study|Withdrawal by Subject|4
185891|NCT00428610|638281|P3|Overall Study|Progressive Disease|22
185892|NCT00428610|638282|P2|Overall Study|Progressive Disease|14
185893|NCT00428610|638283|P1|Overall Study|Progressive Disease|42
185894|NCT00428610|638281|P3|Overall Study|Investigator Decision|1
185895|NCT00428610|638282|P2|Overall Study|Investigator Decision|1
185896|NCT00428610|638283|P1|Overall Study|Investigator Decision|2
185897|NCT00428610|638281|P3|Overall Study|Adverse Event|2
185898|NCT00428610|638282|P2|Overall Study|Adverse Event|3
185899|NCT00428610|638283|P1|Overall Study|Adverse Event|2
185900|NCT00428610|638281|P3|Overall Study|Death Due to Progressive Disease|2
185901|NCT00428610|638282|P2|Overall Study|Death Due to Progressive Disease|0
185902|NCT00428610|638283|P1|Overall Study|Death Due to Progressive Disease|0
185903|NCT00428610|638281|P3|Overall Study|Death Due to Adverse Event|5
185904|NCT00428610|638282|P2|Overall Study|Death Due to Adverse Event|0
185905|NCT00428610|638283|P1|Overall Study|Death Due to Adverse Event|3
185906|NCT00428597|638317|P2|Overall Study|Death|3
185907|NCT00428597|638318|P1|Overall Study|Death|1
185908|NCT00428597|638317|P2|Overall Study|Pregnancy|0
185909|NCT00428597|638318|P1|Overall Study|Pregnancy|1
185910|NCT00428597|638317|P2|Overall Study|Lost to Follow-up|1
185911|NCT00428597|638318|P1|Overall Study|Lost to Follow-up|0
185912|NCT00428597|638317|P2|Overall Study|Other|1
185913|NCT00428597|638318|P1|Overall Study|Other|1
185914|NCT00428597|638317|P2|Overall Study|Withdrawal by Subject|1
185915|NCT00428597|638318|P1|Overall Study|Withdrawal by Subject|2
185916|NCT00428597|638317|P2|Overall Study|Protocol Violation|1
185917|NCT00428597|638318|P1|Overall Study|Protocol Violation|2
185918|NCT00428597|638317|P2|Overall Study|Global Deterioration of Health Status|5
185919|NCT00428597|638318|P1|Overall Study|Global Deterioration of Health Status|1
185920|NCT00428597|638317|P2|Overall Study|Adverse Event|7
185921|NCT00428597|638318|P1|Overall Study|Adverse Event|15
185922|NCT00428597|638317|P2|Overall Study|Study Terminated by Sponsor|16
185923|NCT00428597|638318|P1|Overall Study|Study Terminated by Sponsor|41
185924|NCT00428597|638317|P2|Overall Study|Objective Progression or Relapse|47
185925|NCT00428597|638318|P1|Overall Study|Objective Progression or Relapse|19
185926|NCT00428597|638317|P2|Overall Study|Randomized but not treated|3
185927|NCT00428597|638318|P1|Overall Study|Randomized but not treated|3
185928|NCT00428441|638385|P1|Overall Study|Lost to Follow-up|1
185929|NCT00428389|638391|P2|Extension Phase|Administrative problems|1
185930|NCT00428389|638392|P1|Extension Phase|Administrative problems|1
185931|NCT00428389|638391|P2|Extension Phase|Protocol Violation|2
185932|NCT00428389|638392|P1|Extension Phase|Protocol Violation|3
185933|NCT00428389|638391|P2|Extension Phase|Death|0
185934|NCT00428389|638392|P1|Extension Phase|Death|1
185935|NCT00428389|638391|P2|Extension Phase|Lost to Follow-up|3
185936|NCT00428389|638392|P1|Extension Phase|Lost to Follow-up|0
185937|NCT00428389|638391|P2|Extension Phase|Withdrawal by Subject|6
185938|NCT00428389|638392|P1|Extension Phase|Withdrawal by Subject|6
185939|NCT00428389|638391|P2|Extension Phase|Lack of Efficacy|3
185940|NCT00428389|638392|P1|Extension Phase|Lack of Efficacy|4
185941|NCT00428389|638391|P2|Extension Phase|Adverse Event|11
185942|NCT00428389|638392|P1|Extension Phase|Adverse Event|17
185943|NCT00428389|638391|P2|Core Phase|Protocol deviation|2
185944|NCT00428389|638392|P1|Core Phase|Protocol deviation|0
185945|NCT00428389|638391|P2|Core Phase|Withdrawal by Subject|4
185946|NCT00428389|638392|P1|Core Phase|Withdrawal by Subject|3
185947|NCT00428389|638391|P2|Core Phase|Abnormal test procedure result(s)|1
185948|NCT00428389|638392|P1|Core Phase|Abnormal test procedure result(s)|0
185949|NCT00428389|638391|P2|Core Phase|Lack of Efficacy|0
185950|NCT00428389|638392|P1|Core Phase|Lack of Efficacy|2
185951|NCT00428389|638391|P2|Core Phase|Adverse Event|4
185952|NCT00428389|638392|P1|Core Phase|Adverse Event|6
185953|NCT00428246|638426|P3|Overall Study|Adverse Event|0
185954|NCT00428246|638427|P2|Overall Study|Adverse Event|0
185955|NCT00428246|638428|P1|Overall Study|Adverse Event|1
185956|NCT00428246|638426|P3|Overall Study|Withdrawal by Subject|1
185957|NCT00428246|638427|P2|Overall Study|Withdrawal by Subject|0
185958|NCT00428246|638428|P1|Overall Study|Withdrawal by Subject|0
185959|NCT00428220|638436|P1|Overall Study|Other|23
185960|NCT00428220|638436|P1|Overall Study|Adverse Event|51
185961|NCT00428220|638436|P1|Overall Study|Participant refused continued treatment|7
185962|NCT00428220|638436|P1|Overall Study|Objective progression or relapse|123
185963|NCT00428220|638436|P1|Overall Study|Lost to Follow-up|4
185964|NCT00428220|638436|P1|Overall Study|Global deterioration of health status|7
185965|NCT00428220|638436|P1|Overall Study|Participant died|8
185966|NCT00428116|638461|P2|Overall Study|Lost to Follow-up|0
185967|NCT00428116|638462|P1|Overall Study|Lost to Follow-up|1
185968|NCT00428116|638461|P2|Overall Study|Withdrawal by Subject|0
185969|NCT00428116|638462|P1|Overall Study|Withdrawal by Subject|1
185970|NCT00428116|638461|P2|Overall Study|Death|0
185971|NCT00428116|638462|P1|Overall Study|Death|1
185972|NCT00428090|638474|P4|Overall Study|Raised Creatinine Value|1
185973|NCT00428090|638475|P3|Overall Study|Raised Creatinine Value|0
185974|NCT00428090|638476|P2|Overall Study|Raised Creatinine Value|0
185975|NCT00428090|638477|P1|Overall Study|Raised Creatinine Value|0
185976|NCT00428090|638474|P4|Overall Study|Excluded for heart insufficiency|0
185977|NCT00428090|638475|P3|Overall Study|Excluded for heart insufficiency|1
185978|NCT00428090|638476|P2|Overall Study|Excluded for heart insufficiency|0
185979|NCT00428090|638477|P1|Overall Study|Excluded for heart insufficiency|0
185980|NCT00428090|638474|P4|Overall Study|Serious adverse event|0
185981|NCT00428090|638475|P3|Overall Study|Serious adverse event|1
185982|NCT00428090|638476|P2|Overall Study|Serious adverse event|0
185983|NCT00428090|638477|P1|Overall Study|Serious adverse event|0
185984|NCT00428090|638474|P4|Overall Study|Deterioration of cognitive status|0
185985|NCT00428090|638475|P3|Overall Study|Deterioration of cognitive status|1
185986|NCT00428090|638476|P2|Overall Study|Deterioration of cognitive status|0
185987|NCT00428090|638477|P1|Overall Study|Deterioration of cognitive status|0
185988|NCT00428090|638474|P4|Overall Study|High MMSE scores|0
185989|NCT00428090|638475|P3|Overall Study|High MMSE scores|1
185990|NCT00428090|638476|P2|Overall Study|High MMSE scores|0
185991|NCT00428090|638477|P1|Overall Study|High MMSE scores|0
185992|NCT00428090|638474|P4|Overall Study|Insufficient AD documentation|0
185993|NCT00428090|638475|P3|Overall Study|Insufficient AD documentation|1
185994|NCT00428090|638476|P2|Overall Study|Insufficient AD documentation|0
185995|NCT00428090|638477|P1|Overall Study|Insufficient AD documentation|0
185996|NCT00428090|638474|P4|Overall Study|Excluded for concerning QTc value|0
185997|NCT00428090|638475|P3|Overall Study|Excluded for concerning QTc value|1
185998|NCT00428090|638476|P2|Overall Study|Excluded for concerning QTc value|0
185999|NCT00428090|638477|P1|Overall Study|Excluded for concerning QTc value|0
186000|NCT00428090|638474|P4|Overall Study|Worsening of AD|0
186001|NCT00428090|638475|P3|Overall Study|Worsening of AD|1
186002|NCT00428090|638476|P2|Overall Study|Worsening of AD|0
186003|NCT00428090|638477|P1|Overall Study|Worsening of AD|0
186004|NCT00428090|638474|P4|Overall Study|Mental status of par. was|0
186005|NCT00428090|638475|P3|Overall Study|Mental status of par. was|0
186006|NCT00428090|638476|P2|Overall Study|Mental status of par. was|1
186007|NCT00428090|638477|P1|Overall Study|Mental status of par. was|0
186008|NCT00428090|638474|P4|Overall Study|Medical monitor terminated par.|0
186009|NCT00428090|638475|P3|Overall Study|Medical monitor terminated par.|0
186010|NCT00428090|638476|P2|Overall Study|Medical monitor terminated par.|1
186011|NCT00428090|638477|P1|Overall Study|Medical monitor terminated par.|0
186012|NCT00428090|638474|P4|Overall Study|Visit 7 exceed the visit window|0
186013|NCT00428090|638475|P3|Overall Study|Visit 7 exceed the visit window|0
186014|NCT00428090|638476|P2|Overall Study|Visit 7 exceed the visit window|1
186015|NCT00428090|638477|P1|Overall Study|Visit 7 exceed the visit window|0
186016|NCT00428090|638474|P4|Overall Study|Death of par.|0
186017|NCT00428090|638475|P3|Overall Study|Death of par.|1
186018|NCT00428090|638476|P2|Overall Study|Death of par.|0
186019|NCT00428090|638477|P1|Overall Study|Death of par.|1
186020|NCT00428090|638474|P4|Overall Study|Prohibited medication used for SAE|0
186021|NCT00428090|638475|P3|Overall Study|Prohibited medication used for SAE|0
186022|NCT00428090|638476|P2|Overall Study|Prohibited medication used for SAE|0
186023|NCT00428090|638477|P1|Overall Study|Prohibited medication used for SAE|1
186024|NCT00428090|638474|P4|Overall Study|Follow-Up visit not possible|0
186025|NCT00428090|638475|P3|Overall Study|Follow-Up visit not possible|0
186026|NCT00428090|638476|P2|Overall Study|Follow-Up visit not possible|0
186027|NCT00428090|638477|P1|Overall Study|Follow-Up visit not possible|1
186028|NCT00428090|638474|P4|Overall Study|Par. did not returned to visit|1
186029|NCT00428090|638475|P3|Overall Study|Par. did not returned to visit|0
186030|NCT00428090|638476|P2|Overall Study|Par. did not returned to visit|0
186031|NCT00428090|638477|P1|Overall Study|Par. did not returned to visit|1
186032|NCT00428090|638474|P4|Overall Study|Non-compliance|3
186033|NCT00428090|638475|P3|Overall Study|Non-compliance|1
186034|NCT00428090|638476|P2|Overall Study|Non-compliance|0
186035|NCT00428090|638477|P1|Overall Study|Non-compliance|4
186036|NCT00428090|638474|P4|Overall Study|Sponsor terminated study|0
186037|NCT00428090|638475|P3|Overall Study|Sponsor terminated study|0
186038|NCT00428090|638476|P2|Overall Study|Sponsor terminated study|1
186039|NCT00428090|638477|P1|Overall Study|Sponsor terminated study|0
186040|NCT00428090|638474|P4|Overall Study|Withdrawal by Subject|5
186041|NCT00428090|638475|P3|Overall Study|Withdrawal by Subject|15
186042|NCT00428090|638476|P2|Overall Study|Withdrawal by Subject|12
186043|NCT00428090|638477|P1|Overall Study|Withdrawal by Subject|10
186044|NCT00428090|638474|P4|Overall Study|Protocol Violation|3
186045|NCT00428090|638475|P3|Overall Study|Protocol Violation|3
186046|NCT00428090|638476|P2|Overall Study|Protocol Violation|1
186047|NCT00428090|638477|P1|Overall Study|Protocol Violation|3
186048|NCT00428090|638474|P4|Overall Study|Lost to Follow-up|4
186049|NCT00428090|638475|P3|Overall Study|Lost to Follow-up|1
186050|NCT00428090|638476|P2|Overall Study|Lost to Follow-up|6
186051|NCT00428090|638477|P1|Overall Study|Lost to Follow-up|3
186052|NCT00428090|638474|P4|Overall Study|Adverse Event|11
186053|NCT00428090|638475|P3|Overall Study|Adverse Event|10
186054|NCT00428090|638476|P2|Overall Study|Adverse Event|8
186055|NCT00428090|638477|P1|Overall Study|Adverse Event|10
186056|NCT00427999|638595|P1|Overall Study|Death|1
186057|NCT00427999|638595|P1|Overall Study|Withdrawal by Subject|9
186058|NCT00427999|638595|P1|Overall Study|Protocol Violation|2
186059|NCT00427999|638595|P1|Overall Study|Unsatisfactory therapeutic effect|13
186060|NCT00427999|638595|P1|Overall Study|Abnormal laboratory values|1
186061|NCT00427999|638595|P1|Overall Study|Adverse Event|6
186062|NCT00427960|638613|P2|Overall Study|Not Specified|1
186063|NCT00427960|638614|P1|Overall Study|Not Specified|0
186064|NCT00427960|638613|P2|Overall Study|Withdrawal by Subject|3
186065|NCT00427960|638614|P1|Overall Study|Withdrawal by Subject|0
186066|NCT00427960|638613|P2|Overall Study|Adverse Event|0
186067|NCT00427960|638614|P1|Overall Study|Adverse Event|2
186068|NCT00427934|638652|P4|Overall Study|Withdrawal by Subject|3
186069|NCT00427934|638653|P3|Overall Study|Withdrawal by Subject|1
186070|NCT00427934|638654|P2|Overall Study|Withdrawal by Subject|0
186071|NCT00427934|638655|P1|Overall Study|Withdrawal by Subject|0
186072|NCT00427934|638652|P4|Overall Study|Other|5
186073|NCT00427934|638653|P3|Overall Study|Other|11
186074|NCT00427934|638654|P2|Overall Study|Other|0
186075|NCT00427934|638655|P1|Overall Study|Other|0
186076|NCT00427934|638652|P4|Overall Study|Randomized But Did Not Receive Treatment|1
186077|NCT00427934|638653|P3|Overall Study|Randomized But Did Not Receive Treatment|1
186078|NCT00427934|638654|P2|Overall Study|Randomized But Did Not Receive Treatment|0
186079|NCT00427934|638655|P1|Overall Study|Randomized But Did Not Receive Treatment|0
186080|NCT00427934|638652|P4|Overall Study|Lack of Efficacy|2
186081|NCT00427934|638653|P3|Overall Study|Lack of Efficacy|5
186082|NCT00427934|638654|P2|Overall Study|Lack of Efficacy|0
186083|NCT00427934|638655|P1|Overall Study|Lack of Efficacy|0
186084|NCT00427934|638652|P4|Overall Study|Adverse Event|4
186085|NCT00427934|638653|P3|Overall Study|Adverse Event|5
186086|NCT00427934|638654|P2|Overall Study|Adverse Event|0
186087|NCT00427934|638655|P1|Overall Study|Adverse Event|1
186088|NCT00427921|638723|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
186089|NCT00427921|638723|P1|Overall Study|Adverse Event + Withdrawn from Study|1
186090|NCT00427921|638723|P1|Overall Study|Adverse Event + Lost Response|1
186091|NCT00427921|638723|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
186092|NCT00427921|638723|P1|Overall Study|Adverse Event + Worsening of CD|1
186093|NCT00427921|638723|P1|Overall Study|Adverse Event + No Response|1
186094|NCT00427921|638723|P1|Overall Study|Adverse Event + Withdrew Consent|1
186095|NCT00427921|638723|P1|Overall Study|Adverse Event + Hospitalization|1
186096|NCT00427921|638723|P1|Overall Study|Other reason not specified|10
186097|NCT00427921|638723|P1|Overall Study|Lost to Follow-up|2
186098|NCT00427921|638723|P1|Overall Study|Withdrawal by Subject|4
186099|NCT00427921|638723|P1|Overall Study|Adverse Event|26
186100|NCT00427895|638746|P8|Vax 2/Year 3 to 4|Failed to Return|0
186101|NCT00427895|638747|P7|Vax 2/Year 3 to 4|Failed to Return|0
186102|NCT00427895|638748|P6|Vax 2/Year 3 to 4|Failed to Return|0
186103|NCT00427895|638749|P5|Vax 2/Year 3 to 4|Failed to Return|1
186104|NCT00427895|638750|P4|Vax 2/Year 3 to 4|Failed to Return|0
186105|NCT00427895|638751|P3|Vax 2/Year 3 to 4|Failed to Return|0
186106|NCT00427895|638752|P2|Vax 2/Year 3 to 4|Failed to Return|0
186107|NCT00427895|638753|P1|Vax 2/Year 3 to 4|Failed to Return|0
186108|NCT00427895|638746|P8|Vax 2/Year 3 to 4|Protocol Violation|1
186109|NCT00427895|638747|P7|Vax 2/Year 3 to 4|Protocol Violation|0
186110|NCT00427895|638748|P6|Vax 2/Year 3 to 4|Protocol Violation|0
186111|NCT00427895|638749|P5|Vax 2/Year 3 to 4|Protocol Violation|0
186112|NCT00427895|638750|P4|Vax 2/Year 3 to 4|Protocol Violation|0
186113|NCT00427895|638751|P3|Vax 2/Year 3 to 4|Protocol Violation|0
186114|NCT00427895|638752|P2|Vax 2/Year 3 to 4|Protocol Violation|0
186115|NCT00427895|638753|P1|Vax 2/Year 3 to 4|Protocol Violation|0
186116|NCT00427895|638746|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
186117|NCT00427895|638747|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
186118|NCT00427895|638748|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
186119|NCT00427895|638749|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
186120|NCT00427895|638750|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
186121|NCT00427895|638751|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
186122|NCT00427895|638752|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
186123|NCT00427895|638753|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
186124|NCT00427895|638746|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
186125|NCT00427895|638747|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
186126|NCT00427895|638748|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
186127|NCT00427895|638749|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
186128|NCT00427895|638750|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
186129|NCT00427895|638751|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
186130|NCT00427895|638752|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
186131|NCT00427895|638753|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
186132|NCT00427895|638746|P8|Vax 1/Year 1 Follow-up|Other|0
186133|NCT00427895|638747|P7|Vax 1/Year 1 Follow-up|Other|0
186134|NCT00427895|638748|P6|Vax 1/Year 1 Follow-up|Other|0
186135|NCT00427895|638749|P5|Vax 1/Year 1 Follow-up|Other|0
186136|NCT00427895|638750|P4|Vax 1/Year 1 Follow-up|Other|2
186137|NCT00427895|638751|P3|Vax 1/Year 1 Follow-up|Other|0
186138|NCT00427895|638752|P2|Vax 1/Year 1 Follow-up|Other|0
186139|NCT00427895|638753|P1|Vax 1/Year 1 Follow-up|Other|0
186140|NCT00427895|638746|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
186141|NCT00427895|638747|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
186142|NCT00427895|638748|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
186143|NCT00427895|638749|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
186144|NCT00427895|638750|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
186145|NCT00427895|638751|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
186146|NCT00427895|638752|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
186147|NCT00427895|638753|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
186148|NCT00427895|638746|P8|Vax 1/Year 1 Follow-up|Death|0
186149|NCT00427895|638747|P7|Vax 1/Year 1 Follow-up|Death|0
186150|NCT00427895|638748|P6|Vax 1/Year 1 Follow-up|Death|0
186151|NCT00427895|638749|P5|Vax 1/Year 1 Follow-up|Death|0
186152|NCT00427895|638750|P4|Vax 1/Year 1 Follow-up|Death|0
186153|NCT00427895|638751|P3|Vax 1/Year 1 Follow-up|Death|0
186154|NCT00427895|638752|P2|Vax 1/Year 1 Follow-up|Death|0
186155|NCT00427895|638753|P1|Vax 1/Year 1 Follow-up|Death|1
186156|NCT00427895|638746|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
186157|NCT00427895|638747|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
186158|NCT00427895|638748|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
186159|NCT00427895|638749|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
186160|NCT00427895|638750|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
186161|NCT00427895|638751|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
186162|NCT00427895|638752|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
186163|NCT00427895|638753|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
186164|NCT00427895|638746|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
186165|NCT00427895|638747|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
186166|NCT00427895|638748|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
186167|NCT00427895|638749|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
186168|NCT00427895|638750|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
186169|NCT00427895|638751|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
186170|NCT00427895|638752|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
186171|NCT00427895|638753|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
186172|NCT00427895|638746|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
186173|NCT00427895|638747|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
186174|NCT00427895|638748|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
186175|NCT00427895|638749|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
186176|NCT00427895|638750|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
186177|NCT00427895|638751|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
186178|NCT00427895|638752|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
186179|NCT00427895|638753|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
186180|NCT00427895|638746|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
186181|NCT00427895|638747|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
186182|NCT00427895|638748|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
186183|NCT00427895|638749|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
186184|NCT00427895|638750|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
186185|NCT00427895|638751|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
186186|NCT00427895|638752|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
186187|NCT00427895|638753|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
186188|NCT00427895|638746|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
186189|NCT00427895|638747|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
186190|NCT00427895|638748|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
186191|NCT00427895|638749|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
186192|NCT00427895|638750|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
186193|NCT00427895|638751|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
186194|NCT00427895|638752|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
186195|NCT00427895|638753|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
186196|NCT00427895|638746|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
186197|NCT00427895|638747|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
186198|NCT00427895|638748|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
186199|NCT00427895|638749|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
186200|NCT00427895|638750|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
186201|NCT00427895|638751|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
186202|NCT00427895|638752|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
186203|NCT00427895|638753|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
186280|NCT00427011|638925|P1|Overall Study|Withdrawal by Subject|1
186204|NCT00427895|638746|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
186205|NCT00427895|638747|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
186206|NCT00427895|638748|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
186207|NCT00427895|638749|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
186208|NCT00427895|638750|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
186209|NCT00427895|638751|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
186210|NCT00427895|638752|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
186211|NCT00427895|638753|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
186212|NCT00427895|638746|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
186213|NCT00427895|638747|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
186214|NCT00427895|638748|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
186215|NCT00427895|638749|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
186216|NCT00427895|638750|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
186217|NCT00427895|638751|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
186218|NCT00427895|638752|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
186219|NCT00427895|638753|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
186220|NCT00427895|638746|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
186221|NCT00427895|638747|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
186222|NCT00427895|638748|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
186223|NCT00427895|638749|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
186224|NCT00427895|638750|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
186225|NCT00427895|638751|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
186226|NCT00427895|638752|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
186227|NCT00427895|638753|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
186228|NCT00427895|638746|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
186229|NCT00427895|638747|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
186230|NCT00427895|638748|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
186231|NCT00427895|638749|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
186232|NCT00427895|638750|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
186233|NCT00427895|638751|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
186234|NCT00427895|638752|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
186235|NCT00427895|638753|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
186236|NCT00427895|638746|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
186237|NCT00427895|638747|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
186238|NCT00427895|638748|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
186239|NCT00427895|638749|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
186240|NCT00427895|638750|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
186241|NCT00427895|638751|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
186242|NCT00427895|638752|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
186243|NCT00427895|638753|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
186244|NCT00427895|638746|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
186245|NCT00427895|638747|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
186246|NCT00427895|638748|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
186247|NCT00427895|638749|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
186248|NCT00427895|638750|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
186249|NCT00427895|638751|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
186250|NCT00427895|638752|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
186251|NCT00427895|638753|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
186252|NCT00427778|638828|P2|First Intervention (4 Weeks)|anxious about using ring|0
186253|NCT00427778|638829|P1|First Intervention (4 Weeks)|anxious about using ring|1
186254|NCT00427778|638828|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
186255|NCT00427778|638829|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
186256|NCT00427778|638828|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
186257|NCT00427778|638829|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
186258|NCT00427778|638828|P2|First Intervention (4 Weeks)|no longer interested|0
186259|NCT00427778|638829|P1|First Intervention (4 Weeks)|no longer interested|1
186260|NCT00427700|638854|P2|Overall Study|Pregnancy|2
186261|NCT00427700|638855|P1|Overall Study|Pregnancy|0
186262|NCT00427700|638854|P2|Overall Study|no induction of menses|4
186263|NCT00427700|638855|P1|Overall Study|no induction of menses|1
186264|NCT00427700|638854|P2|Overall Study|Lost to Follow-up|5
186265|NCT00427700|638855|P1|Overall Study|Lost to Follow-up|2
186266|NCT00427635|638871|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
186267|NCT00427635|638872|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
186268|NCT00427635|638871|P2|Treatment Phase|Withdrawal by Subject|0
186269|NCT00427635|638872|P1|Treatment Phase|Withdrawal by Subject|1
186270|NCT00427349|638904|P1|Overall Study|Never started therapy|1
186271|NCT00427349|638904|P1|Overall Study|Ineligible|1
186272|NCT00427349|638904|P1|Overall Study|Other|2
186273|NCT00427349|638904|P1|Overall Study|Alternative therapy|1
186274|NCT00427349|638904|P1|Overall Study|Withdrawal by Subject|3
186275|NCT00427349|638904|P1|Overall Study|Death|1
186276|NCT00427349|638904|P1|Overall Study|Adverse Event|14
186277|NCT00427349|638904|P1|Overall Study|Lack of Efficacy|23
186278|NCT00427011|638925|P1|Overall Study|Not specified|12
186279|NCT00427011|638925|P1|Overall Study|Lack of Efficacy|2
186281|NCT00427011|638925|P1|Overall Study|Adverse Event|10
186282|NCT00426842|638940|P1|Overall Study|Lost to Follow-up|1
186283|NCT00426764|638946|P1|Overall Study|Other|2
186284|NCT00426764|638946|P1|Overall Study|Protocol Violation|1
186285|NCT00426764|638946|P1|Overall Study|Physician Decision|1
186286|NCT00426764|638946|P1|Overall Study|Withdrawal by Subject|3
186287|NCT00426764|638946|P1|Overall Study|Adverse Event|19
186288|NCT00426764|638946|P1|Overall Study|Progressive disease|72
186289|NCT00426751|638962|P2|Overall Study|Other Reasons|12
186290|NCT00426751|638963|P1|Overall Study|Other Reasons|7
186291|NCT00426751|638962|P2|Overall Study|Consent Withdrawn|1
186292|NCT00426751|638963|P1|Overall Study|Consent Withdrawn|0
186293|NCT00426751|638962|P2|Overall Study|Lost to Follow-up|6
186294|NCT00426751|638963|P1|Overall Study|Lost to Follow-up|7
186295|NCT00426751|638962|P2|Overall Study|Adverse Event|1
186296|NCT00426751|638963|P1|Overall Study|Adverse Event|8
186297|NCT00426660|639007|P1|Overall Study|Enrolled Not Treated|15
186298|NCT00426660|639007|P1|Overall Study|Protocol Violation|1
186299|NCT00426660|639007|P1|Overall Study|Withdrawal by Subject|18
186300|NCT00426660|639007|P1|Overall Study|Other|23
186301|NCT00426660|639007|P1|Overall Study|Lost to Follow-up|15
186302|NCT00426660|639007|P1|Overall Study|Insufficient Clinical Response|22
186303|NCT00426660|639007|P1|Overall Study|Adverse Event|23
186304|NCT00426660|639007|P1|Overall Study|Death|14
186305|NCT00426556|639038|P4|Phase II - Extension Phase|Adverse Event|2
186306|NCT00426556|639039|P3|Phase II - Extension Phase|Adverse Event|0
186307|NCT00426556|639040|P2|Phase II - Extension Phase|Adverse Event|0
186308|NCT00426556|639041|P1|Phase II - Extension Phase|Adverse Event|0
186309|NCT00426556|639038|P4|Phase II - Extension Phase|Disease Progression|21
186310|NCT00426556|639039|P3|Phase II - Extension Phase|Disease Progression|0
186311|NCT00426556|639040|P2|Phase II - Extension Phase|Disease Progression|0
186312|NCT00426556|639041|P1|Phase II - Extension Phase|Disease Progression|0
186313|NCT00426556|639038|P4|Phase II - Core Phase|Adverse Event|8
186314|NCT00426556|639039|P3|Phase II - Core Phase|Adverse Event|0
186315|NCT00426556|639040|P2|Phase II - Core Phase|Adverse Event|0
186316|NCT00426556|639041|P1|Phase II - Core Phase|Adverse Event|0
186317|NCT00426556|639038|P4|Phase II - Core Phase|Disease Progression|16
186318|NCT00426556|639039|P3|Phase II - Core Phase|Disease Progression|0
186319|NCT00426556|639040|P2|Phase II - Core Phase|Disease Progression|0
186320|NCT00426556|639041|P1|Phase II - Core Phase|Disease Progression|0
186321|NCT00426556|639038|P4|Phase II - Core Phase|Withdrawal by Subject|3
186322|NCT00426556|639039|P3|Phase II - Core Phase|Withdrawal by Subject|0
186323|NCT00426556|639040|P2|Phase II - Core Phase|Withdrawal by Subject|0
186324|NCT00426556|639041|P1|Phase II - Core Phase|Withdrawal by Subject|0
186325|NCT00426556|639038|P4|Phase I - Extension Phase|Disease Progression|0
186326|NCT00426556|639039|P3|Phase I - Extension Phase|Disease Progression|6
186327|NCT00426556|639040|P2|Phase I - Extension Phase|Disease Progression|5
186328|NCT00426556|639041|P1|Phase I - Extension Phase|Disease Progression|5
186329|NCT00426556|639038|P4|Phase I - Extension Phase|Adverse Event|0
186330|NCT00426556|639039|P3|Phase I - Extension Phase|Adverse Event|1
186331|NCT00426556|639040|P2|Phase I - Extension Phase|Adverse Event|1
186332|NCT00426556|639041|P1|Phase I - Extension Phase|Adverse Event|0
186333|NCT00426556|639038|P4|Phase I - Core Phase|Death|0
186334|NCT00426556|639039|P3|Phase I - Core Phase|Death|0
186335|NCT00426556|639040|P2|Phase I - Core Phase|Death|1
186336|NCT00426556|639041|P1|Phase I - Core Phase|Death|0
186337|NCT00426556|639038|P4|Phase I - Core Phase|Adverse Event|0
186338|NCT00426556|639039|P3|Phase I - Core Phase|Adverse Event|1
186339|NCT00426556|639040|P2|Phase I - Core Phase|Adverse Event|3
186340|NCT00426556|639041|P1|Phase I - Core Phase|Adverse Event|1
186341|NCT00426556|639038|P4|Phase I - Core Phase|Disease Progression|0
186342|NCT00426556|639039|P3|Phase I - Core Phase|Disease Progression|2
186343|NCT00426556|639040|P2|Phase I - Core Phase|Disease Progression|6
186344|NCT00426556|639041|P1|Phase I - Core Phase|Disease Progression|0
186345|NCT00426361|639066|P3|Overall Study|Withdrawal by Subject|0
186346|NCT00426361|639067|P2|Overall Study|Withdrawal by Subject|3
186347|NCT00426361|639068|P1|Overall Study|Withdrawal by Subject|1
186348|NCT00426361|639066|P3|Overall Study|Lost to Follow-up|5
186349|NCT00426361|639067|P2|Overall Study|Lost to Follow-up|2
186350|NCT00426361|639068|P1|Overall Study|Lost to Follow-up|3
186351|NCT00426270|639127|P1|Overall Study|Adverse Event|5
186352|NCT00426270|639127|P1|Overall Study|Incorrectly Enrolled in the Study|1
186353|NCT00426231|639137|P2|Overall Study|Withdrawal by Subject|12
186354|NCT00426231|639138|P1|Overall Study|Withdrawal by Subject|9
186355|NCT00426127|639161|P1|Overall Study|Removed due to disease progression|1
186356|NCT00426127|639161|P1|Overall Study|Adverse Event|1
186357|NCT00425945|639169|P2|Overall Study|Moved from area|1
186358|NCT00425945|639170|P1|Overall Study|Moved from area|0
186359|NCT00425945|639169|P2|Overall Study|Began cancer treatments|0
186360|NCT00425945|639170|P1|Overall Study|Began cancer treatments|1
186361|NCT00425945|639169|P2|Overall Study|Began hypertension medication|0
186362|NCT00425945|639170|P1|Overall Study|Began hypertension medication|1
186363|NCT00425945|639169|P2|Overall Study|Lost to Follow-up|2
186364|NCT00425945|639170|P1|Overall Study|Lost to Follow-up|0
186365|NCT00425945|639169|P2|Overall Study|Inconvenience|2
186366|NCT00425945|639170|P1|Overall Study|Inconvenience|0
186367|NCT00425945|639169|P2|Overall Study|Concern about Supplement|0
186368|NCT00425945|639170|P1|Overall Study|Concern about Supplement|2
186369|NCT00425854|639208|P2|Overall Study|Other Adverse Event|2
186370|NCT00425854|639209|P1|Overall Study|Other Adverse Event|2
186371|NCT00425854|639208|P2|Overall Study|Dose reduction toxicity AE|7
186372|NCT00425854|639209|P1|Overall Study|Dose reduction toxicity AE|8
186373|NCT00425854|639208|P2|Overall Study|Progressive Disease|12
186374|NCT00425854|639209|P1|Overall Study|Progressive Disease|19
186375|NCT00425750|639242|P1|Overall Study|Progression of disease|18
186376|NCT00425750|639242|P1|Overall Study|Adverse Event|3
186377|NCT00425750|639242|P1|Overall Study|Withdrawal by Subject|3
186378|NCT00425750|639242|P1|Overall Study|Death|1
186379|NCT00425698|639250|P2|Overall Study|Withdrawal by Subject|1
186380|NCT00425698|639251|P1|Overall Study|Withdrawal by Subject|0
186381|NCT00425698|639250|P2|Overall Study|Adverse Event|1
186382|NCT00425698|639251|P1|Overall Study|Adverse Event|3
186383|NCT00425607|639266|P1|Overall Study|Withdrawal by Subject|1
186384|NCT00425607|639266|P1|Overall Study|Death|1
186385|NCT00425503|639270|P1|Overall Study|Protocol Violation|1
186386|NCT00425503|639270|P1|Overall Study|Adverse Event|2
186387|NCT00425438|639276|P2|Overall Study|Termination by Sponsor|27
186388|NCT00425438|639277|P1|Overall Study|Termination by Sponsor|25
186389|NCT00425373|639311|P9|Overall Study|Lack of Efficacy|5
186390|NCT00425373|639312|P8|Overall Study|Lack of Efficacy|0
186391|NCT00425373|639313|P7|Overall Study|Lack of Efficacy|3
186392|NCT00425373|639314|P6|Overall Study|Lack of Efficacy|3
186393|NCT00425373|639315|P5|Overall Study|Lack of Efficacy|1
186394|NCT00425373|639316|P4|Overall Study|Lack of Efficacy|0
186395|NCT00425373|639317|P3|Overall Study|Lack of Efficacy|0
186396|NCT00425373|639318|P2|Overall Study|Lack of Efficacy|0
186397|NCT00425373|639319|P1|Overall Study|Lack of Efficacy|0
186398|NCT00425373|639311|P9|Overall Study|Withdrawal by Subject|2
186399|NCT00425373|639312|P8|Overall Study|Withdrawal by Subject|2
186400|NCT00425373|639313|P7|Overall Study|Withdrawal by Subject|2
186401|NCT00425373|639314|P6|Overall Study|Withdrawal by Subject|0
186402|NCT00425373|639315|P5|Overall Study|Withdrawal by Subject|4
186403|NCT00425373|639316|P4|Overall Study|Withdrawal by Subject|1
186404|NCT00425373|639317|P3|Overall Study|Withdrawal by Subject|2
186405|NCT00425373|639318|P2|Overall Study|Withdrawal by Subject|0
186406|NCT00425373|639319|P1|Overall Study|Withdrawal by Subject|2
186407|NCT00425373|639311|P9|Overall Study|Protocol Violation|3
186408|NCT00425373|639312|P8|Overall Study|Protocol Violation|5
186409|NCT00425373|639313|P7|Overall Study|Protocol Violation|0
186410|NCT00425373|639314|P6|Overall Study|Protocol Violation|0
186411|NCT00425373|639315|P5|Overall Study|Protocol Violation|0
186412|NCT00425373|639316|P4|Overall Study|Protocol Violation|0
186413|NCT00425373|639317|P3|Overall Study|Protocol Violation|1
186414|NCT00425373|639318|P2|Overall Study|Protocol Violation|0
186415|NCT00425373|639319|P1|Overall Study|Protocol Violation|1
186416|NCT00425373|639311|P9|Overall Study|Lost to Follow-up|0
186417|NCT00425373|639312|P8|Overall Study|Lost to Follow-up|0
186418|NCT00425373|639313|P7|Overall Study|Lost to Follow-up|0
186419|NCT00425373|639314|P6|Overall Study|Lost to Follow-up|0
186420|NCT00425373|639315|P5|Overall Study|Lost to Follow-up|1
186421|NCT00425373|639316|P4|Overall Study|Lost to Follow-up|0
186422|NCT00425373|639317|P3|Overall Study|Lost to Follow-up|0
186423|NCT00425373|639318|P2|Overall Study|Lost to Follow-up|1
186424|NCT00425373|639319|P1|Overall Study|Lost to Follow-up|0
186425|NCT00425373|639311|P9|Overall Study|Adverse Event|8
186426|NCT00425373|639312|P8|Overall Study|Adverse Event|3
186427|NCT00425373|639313|P7|Overall Study|Adverse Event|2
186428|NCT00425373|639314|P6|Overall Study|Adverse Event|6
186429|NCT00425373|639315|P5|Overall Study|Adverse Event|4
186430|NCT00425373|639316|P4|Overall Study|Adverse Event|1
186431|NCT00425373|639317|P3|Overall Study|Adverse Event|0
186432|NCT00425373|639318|P2|Overall Study|Adverse Event|2
186433|NCT00425373|639319|P1|Overall Study|Adverse Event|2
186434|NCT00425308|639377|P2|Overall Study|Death|0
186435|NCT00425308|639378|P1|Overall Study|Death|1
186436|NCT00425308|639377|P2|Overall Study|Withdrawal by Subject|0
186437|NCT00425308|639378|P1|Overall Study|Withdrawal by Subject|1
186438|NCT00425308|639377|P2|Overall Study|Adverse Event|1
186439|NCT00425308|639378|P1|Overall Study|Adverse Event|2
186440|NCT00425269|639408|P2|Overall Study|moved or medical reason|4
186441|NCT00425269|639409|P1|Overall Study|moved or medical reason|5
186442|NCT00425269|639408|P2|Overall Study|Lost to Follow-up|9
186443|NCT00425269|639409|P1|Overall Study|Lost to Follow-up|9
186444|NCT00425269|639408|P2|Overall Study|Pregnancy|7
186445|NCT00425269|639409|P1|Overall Study|Pregnancy|5
186446|NCT00425113|639487|P2|Overall Study|Withdrawal by Subject|0
186447|NCT00425113|639488|P1|Overall Study|Withdrawal by Subject|1
186448|NCT00425113|639487|P2|Overall Study|missing study drug more than 14 days|1
186449|NCT00425113|639488|P1|Overall Study|missing study drug more than 14 days|0
186450|NCT00425113|639487|P2|Overall Study|diagnosis of abdominal TB|1
186451|NCT00425113|639488|P1|Overall Study|diagnosis of abdominal TB|0
186452|NCT00425113|639487|P2|Overall Study|uncontrolled diabetes mellitus|0
186453|NCT00425113|639488|P1|Overall Study|uncontrolled diabetes mellitus|1
186454|NCT00425100|639496|P1|Overall Study|Withdrawal by Subject|7
186455|NCT00425100|639496|P1|Overall Study|Protocol Violation|4
186456|NCT00425100|639496|P1|Overall Study|Lost to Follow-up|2
186457|NCT00425100|639496|P1|Overall Study|Lack of Efficacy|4
186458|NCT00425100|639496|P1|Overall Study|Adverse Event|36
186459|NCT00425061|639540|P7|Overall Study|Other|1
186460|NCT00425061|639541|P6|Overall Study|Other|0
186461|NCT00425061|639542|P5|Overall Study|Other|3
186462|NCT00425061|639543|P4|Overall Study|Other|0
186463|NCT00425061|639544|P3|Overall Study|Other|0
186464|NCT00425061|639545|P2|Overall Study|Other|0
186465|NCT00425061|639546|P1|Overall Study|Other|0
186466|NCT00425061|639540|P7|Overall Study|Physician Decision|0
186467|NCT00425061|639541|P6|Overall Study|Physician Decision|0
186468|NCT00425061|639542|P5|Overall Study|Physician Decision|1
186469|NCT00425061|639543|P4|Overall Study|Physician Decision|0
186470|NCT00425061|639544|P3|Overall Study|Physician Decision|0
186471|NCT00425061|639545|P2|Overall Study|Physician Decision|0
186472|NCT00425061|639546|P1|Overall Study|Physician Decision|0
186473|NCT00425061|639540|P7|Overall Study|Sponsor's request|15
186474|NCT00425061|639541|P6|Overall Study|Sponsor's request|4
186475|NCT00425061|639542|P5|Overall Study|Sponsor's request|19
186476|NCT00425061|639543|P4|Overall Study|Sponsor's request|0
186477|NCT00425061|639544|P3|Overall Study|Sponsor's request|0
186478|NCT00425061|639545|P2|Overall Study|Sponsor's request|0
186479|NCT00425061|639546|P1|Overall Study|Sponsor's request|0
186480|NCT00425061|639540|P7|Overall Study|Withdrawal by Subject|3
186481|NCT00425061|639541|P6|Overall Study|Withdrawal by Subject|0
186482|NCT00425061|639542|P5|Overall Study|Withdrawal by Subject|1
186483|NCT00425061|639543|P4|Overall Study|Withdrawal by Subject|0
186484|NCT00425061|639544|P3|Overall Study|Withdrawal by Subject|0
186485|NCT00425061|639545|P2|Overall Study|Withdrawal by Subject|1
186486|NCT00425061|639546|P1|Overall Study|Withdrawal by Subject|0
186487|NCT00425061|639540|P7|Overall Study|Protocol Violation|0
186488|NCT00425061|639541|P6|Overall Study|Protocol Violation|0
186489|NCT00425061|639542|P5|Overall Study|Protocol Violation|0
186490|NCT00425061|639543|P4|Overall Study|Protocol Violation|0
186491|NCT00425061|639544|P3|Overall Study|Protocol Violation|0
186492|NCT00425061|639545|P2|Overall Study|Protocol Violation|0
186493|NCT00425061|639546|P1|Overall Study|Protocol Violation|1
186494|NCT00425061|639540|P7|Overall Study|Lost to Follow-up|0
186495|NCT00425061|639541|P6|Overall Study|Lost to Follow-up|0
186496|NCT00425061|639542|P5|Overall Study|Lost to Follow-up|0
186497|NCT00425061|639543|P4|Overall Study|Lost to Follow-up|0
186498|NCT00425061|639544|P3|Overall Study|Lost to Follow-up|0
186499|NCT00425061|639545|P2|Overall Study|Lost to Follow-up|1
186500|NCT00425061|639546|P1|Overall Study|Lost to Follow-up|0
186501|NCT00425061|639540|P7|Overall Study|Adverse Event|0
186502|NCT00425061|639541|P6|Overall Study|Adverse Event|0
186503|NCT00425061|639542|P5|Overall Study|Adverse Event|2
186504|NCT00425061|639543|P4|Overall Study|Adverse Event|2
186505|NCT00425061|639544|P3|Overall Study|Adverse Event|0
186506|NCT00425061|639545|P2|Overall Study|Adverse Event|0
186507|NCT00425061|639546|P1|Overall Study|Adverse Event|1
186508|NCT00424827|639662|P1|Overall Study|Adverse Event|1
186509|NCT00424775|639670|P2|Overall Study|Lack of Efficacy|0
186510|NCT00424775|639671|P1|Overall Study|Lack of Efficacy|1
186511|NCT00424775|639670|P2|Overall Study|Adverse Event|0
186512|NCT00424775|639671|P1|Overall Study|Adverse Event|2
186513|NCT00424762|639681|P2|Overall Study|Lost to Follow-up|3
186514|NCT00424762|639682|P1|Overall Study|Lost to Follow-up|2
186515|NCT00424762|639681|P2|Overall Study|Withdrawal by Subject|19
186516|NCT00424762|639682|P1|Overall Study|Withdrawal by Subject|18
186517|NCT00424749|639692|P1|Overall Study|Withdrawal by Subject|1
186518|NCT00424645|639699|P2|Overall Study|Death|0
186519|NCT00424645|639700|P1|Overall Study|Death|1
186520|NCT00424632|639708|P10|Overall Study|Other|0
186521|NCT00424632|639709|P9|Overall Study|Other|1
186522|NCT00424632|639710|P8|Overall Study|Other|0
186523|NCT00424632|639711|P7|Overall Study|Other|0
186524|NCT00424632|639712|P6|Overall Study|Other|0
186525|NCT00424632|639713|P5|Overall Study|Other|0
186526|NCT00424632|639714|P4|Overall Study|Other|1
186527|NCT00424632|639715|P3|Overall Study|Other|0
186528|NCT00424632|639716|P2|Overall Study|Other|0
186529|NCT00424632|639717|P1|Overall Study|Other|0
186530|NCT00424632|639708|P10|Overall Study|Objective progression or relapse|4
186531|NCT00424632|639709|P9|Overall Study|Objective progression or relapse|12
186532|NCT00424632|639710|P8|Overall Study|Objective progression or relapse|3
186533|NCT00424632|639711|P7|Overall Study|Objective progression or relapse|7
186534|NCT00424632|639712|P6|Overall Study|Objective progression or relapse|13
186535|NCT00424632|639713|P5|Overall Study|Objective progression or relapse|2
186536|NCT00424632|639714|P4|Overall Study|Objective progression or relapse|2
186537|NCT00424632|639715|P3|Overall Study|Objective progression or relapse|1
186538|NCT00424632|639716|P2|Overall Study|Objective progression or relapse|1
186539|NCT00424632|639717|P1|Overall Study|Objective progression or relapse|1
186540|NCT00424632|639708|P10|Overall Study|Global deterioration of health status|0
186541|NCT00424632|639709|P9|Overall Study|Global deterioration of health status|0
186542|NCT00424632|639710|P8|Overall Study|Global deterioration of health status|0
186543|NCT00424632|639711|P7|Overall Study|Global deterioration of health status|0
186544|NCT00424632|639712|P6|Overall Study|Global deterioration of health status|0
186545|NCT00424632|639713|P5|Overall Study|Global deterioration of health status|1
186546|NCT00424632|639714|P4|Overall Study|Global deterioration of health status|1
186547|NCT00424632|639715|P3|Overall Study|Global deterioration of health status|0
186548|NCT00424632|639716|P2|Overall Study|Global deterioration of health status|0
186549|NCT00424632|639717|P1|Overall Study|Global deterioration of health status|0
186550|NCT00424632|639708|P10|Overall Study|Adverse Event|2
186551|NCT00424632|639709|P9|Overall Study|Adverse Event|3
186552|NCT00424632|639710|P8|Overall Study|Adverse Event|0
186553|NCT00424632|639711|P7|Overall Study|Adverse Event|0
186554|NCT00424632|639712|P6|Overall Study|Adverse Event|0
186555|NCT00424632|639713|P5|Overall Study|Adverse Event|0
186556|NCT00424632|639714|P4|Overall Study|Adverse Event|0
186557|NCT00424632|639715|P3|Overall Study|Adverse Event|0
186558|NCT00424632|639716|P2|Overall Study|Adverse Event|0
186559|NCT00424632|639717|P1|Overall Study|Adverse Event|0
186560|NCT00424632|639708|P10|Overall Study|Death|0
186561|NCT00424632|639709|P9|Overall Study|Death|0
186562|NCT00424632|639710|P8|Overall Study|Death|0
186563|NCT00424632|639711|P7|Overall Study|Death|0
186564|NCT00424632|639712|P6|Overall Study|Death|2
186565|NCT00424632|639713|P5|Overall Study|Death|0
186566|NCT00424632|639714|P4|Overall Study|Death|0
186567|NCT00424632|639715|P3|Overall Study|Death|0
186568|NCT00424632|639716|P2|Overall Study|Death|0
186569|NCT00424632|639717|P1|Overall Study|Death|0
186570|NCT00424593|639887|P2|Dose-Blind Extension Period|Physician Decision|0
186571|NCT00424593|639888|P1|Dose-Blind Extension Period|Physician Decision|3
186572|NCT00424593|639887|P2|Dose-Blind Extension Period|Lost to Follow-up|0
186573|NCT00424593|639888|P1|Dose-Blind Extension Period|Lost to Follow-up|6
186574|NCT00424593|639887|P2|Dose-Blind Extension Period|Protocol Violation|0
186575|NCT00424593|639888|P1|Dose-Blind Extension Period|Protocol Violation|9
186576|NCT00424593|639887|P2|Dose-Blind Extension Period|Lack of Efficacy|0
186577|NCT00424593|639888|P1|Dose-Blind Extension Period|Lack of Efficacy|9
186578|NCT00424593|639887|P2|Dose-Blind Extension Period|Adverse Event|0
186579|NCT00424593|639888|P1|Dose-Blind Extension Period|Adverse Event|18
186580|NCT00424593|639887|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
186581|NCT00424593|639888|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
186582|NCT00424593|639887|P2|Acute Double-Blind Period|Lack of Efficacy|1
186583|NCT00424593|639888|P1|Acute Double-Blind Period|Lack of Efficacy|0
186584|NCT00424593|639887|P2|Acute Double-Blind Period|Lost to Follow-up|1
186585|NCT00424593|639888|P1|Acute Double-Blind Period|Lost to Follow-up|1
186586|NCT00424593|639887|P2|Acute Double-Blind Period|Physician Decision|2
186587|NCT00424593|639888|P1|Acute Double-Blind Period|Physician Decision|1
186588|NCT00424593|639887|P2|Acute Double-Blind Period|Protocol Violation|2
186589|NCT00424593|639888|P1|Acute Double-Blind Period|Protocol Violation|2
186590|NCT00424593|639887|P2|Acute Double-Blind Period|Withdrawal by Subject|10
186591|NCT00424593|639888|P1|Acute Double-Blind Period|Withdrawal by Subject|11
186592|NCT00424593|639887|P2|Acute Double-Blind Period|Adverse Event|7
186593|NCT00424593|639888|P1|Acute Double-Blind Period|Adverse Event|16
186594|NCT00424528|639952|P3|Overall Study|noncompliance with study requirements|2
186595|NCT00424528|639953|P2|Overall Study|noncompliance with study requirements|1
186596|NCT00424528|639954|P1|Overall Study|noncompliance with study requirements|2
186597|NCT00424528|639952|P3|Overall Study|Lost to Follow-up|0
186598|NCT00424528|639953|P2|Overall Study|Lost to Follow-up|1
186599|NCT00424528|639954|P1|Overall Study|Lost to Follow-up|0
186600|NCT00424528|639952|P3|Overall Study|Protocol Violation|0
186601|NCT00424528|639953|P2|Overall Study|Protocol Violation|1
186602|NCT00424528|639954|P1|Overall Study|Protocol Violation|1
186603|NCT00424528|639952|P3|Overall Study|Adverse Event|2
186604|NCT00424528|639953|P2|Overall Study|Adverse Event|1
186605|NCT00424528|639954|P1|Overall Study|Adverse Event|2
186606|NCT00424515|640009|P2|Overall Study|Withdrawal by Subject|0
186607|NCT00424515|640010|P1|Overall Study|Withdrawal by Subject|1
186608|NCT00424515|640009|P2|Overall Study|Intercurrent Illness|1
186609|NCT00424515|640010|P1|Overall Study|Intercurrent Illness|0
186610|NCT00424515|640009|P2|Overall Study|Adverse Event|1
186611|NCT00424515|640010|P1|Overall Study|Adverse Event|0
186612|NCT00424515|640009|P2|Overall Study|Progressive Disease|11
186613|NCT00424515|640010|P1|Overall Study|Progressive Disease|10
186614|NCT00424476|640032|P3|Overall Study|Other|9
186615|NCT00424476|640033|P2|Overall Study|Other|3
186616|NCT00424476|640034|P1|Overall Study|Other|4
186617|NCT00424476|640032|P3|Overall Study|Physician Decision|3
186618|NCT00424476|640033|P2|Overall Study|Physician Decision|2
186619|NCT00424476|640034|P1|Overall Study|Physician Decision|3
186620|NCT00424476|640032|P3|Overall Study|Protocol Violation|3
186621|NCT00424476|640033|P2|Overall Study|Protocol Violation|2
186622|NCT00424476|640034|P1|Overall Study|Protocol Violation|7
186623|NCT00424476|640032|P3|Overall Study|Lost to Follow-up|3
186624|NCT00424476|640033|P2|Overall Study|Lost to Follow-up|6
186625|NCT00424476|640034|P1|Overall Study|Lost to Follow-up|4
186626|NCT00424476|640032|P3|Overall Study|Lack of Compliance|1
186627|NCT00424476|640033|P2|Overall Study|Lack of Compliance|1
186628|NCT00424476|640034|P1|Overall Study|Lack of Compliance|1
186629|NCT00424476|640032|P3|Overall Study|Lack of Efficacy|12
186630|NCT00424476|640033|P2|Overall Study|Lack of Efficacy|12
186631|NCT00424476|640034|P1|Overall Study|Lack of Efficacy|16
186632|NCT00424476|640032|P3|Overall Study|Adverse Event|15
186633|NCT00424476|640033|P2|Overall Study|Adverse Event|16
186634|NCT00424476|640034|P1|Overall Study|Adverse Event|19
186635|NCT00424476|640032|P3|Overall Study|Withdrawal by Subject|3
186636|NCT00424476|640033|P2|Overall Study|Withdrawal by Subject|6
186637|NCT00424476|640034|P1|Overall Study|Withdrawal by Subject|7
186638|NCT00424398|640060|P3|Overall Study|Subject met exclusion criteria|0
186639|NCT00424398|640061|P2|Overall Study|Subject met exclusion criteria|0
186640|NCT00424398|640062|P1|Overall Study|Subject met exclusion criteria|1
186641|NCT00424398|640060|P3|Overall Study|Withdrawal by Subject|0
186642|NCT00424398|640061|P2|Overall Study|Withdrawal by Subject|1
186643|NCT00424398|640062|P1|Overall Study|Withdrawal by Subject|2
186644|NCT00424385|640106|P1|Cohort 1|Withdrawal by Subject|1
186645|NCT00424385|640106|P1|Cohort 0|Physician Decision|1
186646|NCT00424385|640106|P1|Cohort 0|Withdrawal by Subject|5
186647|NCT00424372|640113|P1|Overall Study|Lack of Efficacy|6
186648|NCT00424372|640113|P1|Overall Study|Protocol Violation|1
186649|NCT00424372|640113|P1|Overall Study|Withdrawal by Subject|4
186650|NCT00424372|640113|P1|Overall Study|Health deterioration|1
186651|NCT00424372|640113|P1|Overall Study|Adverse Event|18
186652|NCT00424372|640113|P1|Overall Study|Death|1
186653|NCT00424346|640125|P4|Extension Phase|Protocol Violation|0
186654|NCT00424346|640126|P3|Extension Phase|Protocol Violation|1
186655|NCT00424346|640127|P2|Extension Phase|Protocol Violation|1
186656|NCT00424346|640128|P1|Extension Phase|Protocol Violation|0
186657|NCT00424346|640125|P4|Extension Phase|Death|1
186658|NCT00424346|640126|P3|Extension Phase|Death|0
186659|NCT00424346|640127|P2|Extension Phase|Death|0
186660|NCT00424346|640128|P1|Extension Phase|Death|0
186661|NCT00424346|640125|P4|Extension Phase|Administrative Problems|35
186662|NCT00424346|640126|P3|Extension Phase|Administrative Problems|32
186663|NCT00424346|640127|P2|Extension Phase|Administrative Problems|69
186664|NCT00424346|640128|P1|Extension Phase|Administrative Problems|0
186665|NCT00424346|640125|P4|Extension Phase|Lost to Follow-up|0
186666|NCT00424346|640126|P3|Extension Phase|Lost to Follow-up|0
186667|NCT00424346|640127|P2|Extension Phase|Lost to Follow-up|2
186668|NCT00424346|640128|P1|Extension Phase|Lost to Follow-up|0
186669|NCT00424346|640125|P4|Extension Phase|Withdrawal by Subject|4
186670|NCT00424346|640126|P3|Extension Phase|Withdrawal by Subject|3
186671|NCT00424346|640127|P2|Extension Phase|Withdrawal by Subject|5
186672|NCT00424346|640128|P1|Extension Phase|Withdrawal by Subject|0
186673|NCT00424346|640125|P4|Extension Phase|Lack of Efficacy|11
186674|NCT00424346|640126|P3|Extension Phase|Lack of Efficacy|14
186675|NCT00424346|640127|P2|Extension Phase|Lack of Efficacy|16
186676|NCT00424346|640128|P1|Extension Phase|Lack of Efficacy|0
186677|NCT00424346|640125|P4|Extension Phase|Adverse Event|4
186678|NCT00424346|640126|P3|Extension Phase|Adverse Event|5
186679|NCT00424346|640127|P2|Extension Phase|Adverse Event|9
186680|NCT00424346|640128|P1|Extension Phase|Adverse Event|0
186681|NCT00424346|640125|P4|Core Study|Protocol Violation|0
186682|NCT00424346|640126|P3|Core Study|Protocol Violation|2
186683|NCT00424346|640127|P2|Core Study|Protocol Violation|0
186684|NCT00424346|640128|P1|Core Study|Protocol Violation|0
186685|NCT00424346|640125|P4|Core Study|Administrative Problems|0
186686|NCT00424346|640126|P3|Core Study|Administrative Problems|1
186687|NCT00424346|640127|P2|Core Study|Administrative Problems|0
186688|NCT00424346|640128|P1|Core Study|Administrative Problems|1
186689|NCT00424346|640125|P4|Core Study|Lost to Follow-up|0
186690|NCT00424346|640126|P3|Core Study|Lost to Follow-up|0
186691|NCT00424346|640127|P2|Core Study|Lost to Follow-up|1
186692|NCT00424346|640128|P1|Core Study|Lost to Follow-up|1
186693|NCT00424346|640125|P4|Core Study|Withdrawal by Subject|2
186694|NCT00424346|640126|P3|Core Study|Withdrawal by Subject|0
186695|NCT00424346|640127|P2|Core Study|Withdrawal by Subject|0
186696|NCT00424346|640128|P1|Core Study|Withdrawal by Subject|1
186697|NCT00424346|640125|P4|Core Study|Lack of Efficacy|4
186698|NCT00424346|640126|P3|Core Study|Lack of Efficacy|0
186699|NCT00424346|640127|P2|Core Study|Lack of Efficacy|3
186700|NCT00424346|640128|P1|Core Study|Lack of Efficacy|1
186701|NCT00424346|640125|P4|Core Study|Abnormal Laboratory Values|0
186702|NCT00424346|640126|P3|Core Study|Abnormal Laboratory Values|0
186703|NCT00424346|640127|P2|Core Study|Abnormal Laboratory Values|1
186704|NCT00424346|640128|P1|Core Study|Abnormal Laboratory Values|0
186705|NCT00424346|640125|P4|Core Study|Adverse Event|1
186706|NCT00424346|640126|P3|Core Study|Adverse Event|1
186707|NCT00424346|640127|P2|Core Study|Adverse Event|3
186708|NCT00424346|640128|P1|Core Study|Adverse Event|5
186709|NCT00424294|640243|P2|Overall Study|Randomized but not Treated|0
186710|NCT00424294|640244|P1|Overall Study|Randomized but not Treated|1
186711|NCT00424294|640243|P2|Overall Study|Other|2
186712|NCT00424294|640244|P1|Overall Study|Other|0
186713|NCT00424294|640243|P2|Overall Study|Withdrawal by Subject|2
186714|NCT00424294|640244|P1|Overall Study|Withdrawal by Subject|1
186715|NCT00424294|640243|P2|Overall Study|Lack of Efficacy|1
186716|NCT00424294|640244|P1|Overall Study|Lack of Efficacy|2
186717|NCT00424294|640243|P2|Overall Study|Adverse Event|10
186718|NCT00424294|640244|P1|Overall Study|Adverse Event|4
186719|NCT00424255|640311|P2|Overall Study|Sponsor Terminated Study|167
186720|NCT00424255|640312|P1|Overall Study|Sponsor Terminated Study|161
186721|NCT00424255|640311|P2|Overall Study|Disease Progression|2
186722|NCT00424255|640312|P1|Overall Study|Disease Progression|0
186723|NCT00424255|640311|P2|Overall Study|Fatigue|0
186724|NCT00424255|640312|P1|Overall Study|Fatigue|1
186725|NCT00424255|640311|P2|Overall Study|Non-compliance by Participants|0
186726|NCT00424255|640312|P1|Overall Study|Non-compliance by Participants|1
186727|NCT00424255|640311|P2|Overall Study|Cognitive Disturbance|0
186728|NCT00424255|640312|P1|Overall Study|Cognitive Disturbance|1
186729|NCT00424255|640311|P2|Overall Study|Physician Decision|7
186730|NCT00424255|640312|P1|Overall Study|Physician Decision|3
186731|NCT00424255|640311|P2|Overall Study|Withdrawal by Subject|38
186732|NCT00424255|640312|P1|Overall Study|Withdrawal by Subject|34
186733|NCT00424255|640311|P2|Overall Study|Protocol Violation|1
186734|NCT00424255|640312|P1|Overall Study|Protocol Violation|0
186735|NCT00424255|640311|P2|Overall Study|Lost to Follow-up|20
186736|NCT00424255|640312|P1|Overall Study|Lost to Follow-up|26
186737|NCT00424255|640311|P2|Overall Study|Death|111
186738|NCT00424255|640312|P1|Overall Study|Death|115
186739|NCT00424190|640360|P2|Overall Study|Other|21
186740|NCT00424190|640361|P1|Overall Study|Other|15
186741|NCT00424190|640360|P2|Overall Study|Diagnosis of osteomyelitis|1
186742|NCT00424190|640361|P1|Overall Study|Diagnosis of osteomyelitis|0
186743|NCT00424190|640360|P2|Overall Study|Request of sponsor or investigator|2
186744|NCT00424190|640361|P1|Overall Study|Request of sponsor or investigator|0
186745|NCT00424190|640360|P2|Overall Study|Noncompliance|2
186746|NCT00424190|640361|P1|Overall Study|Noncompliance|1
186747|NCT00424190|640360|P2|Overall Study|Death|0
186748|NCT00424190|640361|P1|Overall Study|Death|3
186749|NCT00424190|640360|P2|Overall Study|Withdrew consent|4
186750|NCT00424190|640361|P1|Overall Study|Withdrew consent|3
186751|NCT00424177|640367|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
186752|NCT00424177|640367|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
186753|NCT00424177|640367|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
186754|NCT00424177|640367|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
186755|NCT00424177|640367|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
186756|NCT00424177|640367|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
186757|NCT00424177|640367|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
186758|NCT00424177|640367|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
186759|NCT00424177|640367|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
186760|NCT00424177|640367|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
186761|NCT00424047|640396|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
186762|NCT00424047|640397|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
186763|NCT00424047|640396|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
186764|NCT00424047|640397|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
186765|NCT00424047|640396|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
186766|NCT00424047|640397|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
186767|NCT00424047|640396|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
186768|NCT00424047|640397|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
186769|NCT00424047|640396|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
186770|NCT00424047|640397|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
186771|NCT00424047|640396|P2|On Study at Time of Unblinding|Other|4
186772|NCT00424047|640397|P1|On Study at Time of Unblinding|Other|5
186773|NCT00424047|640396|P2|On Study at Time of Unblinding|Death|11
186774|NCT00424047|640397|P1|On Study at Time of Unblinding|Death|11
186775|NCT00424047|640396|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
186776|NCT00424047|640397|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
186777|NCT00424047|640396|P2|On Study at Time of Unblinding|Lack of Efficacy|3
186778|NCT00424047|640397|P1|On Study at Time of Unblinding|Lack of Efficacy|1
186779|NCT00424047|640396|P2|On Study at Time of Unblinding|Progression of disease|128
186780|NCT00424047|640397|P1|On Study at Time of Unblinding|Progression of disease|92
186781|NCT00424047|640396|P2|On Study at Time of Unblinding|Adverse Event|12
186782|NCT00424047|640397|P1|On Study at Time of Unblinding|Adverse Event|22
186783|NCT00424047|640396|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
186784|NCT00424047|640397|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
186785|NCT00424047|640396|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
186786|NCT00424047|640397|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
186787|NCT00424047|640396|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
186788|NCT00424047|640397|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
186789|NCT00424047|640396|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
186790|NCT00424047|640397|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
186791|NCT00424047|640396|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
186792|NCT00424047|640397|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
186793|NCT00424047|640396|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
186794|NCT00424047|640397|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
186795|NCT00424021|640429|P4|AMB-220-E Study Period|Physician Decision|1
186796|NCT00424021|640430|P3|AMB-220-E Study Period|Physician Decision|0
186797|NCT00424021|640431|P2|AMB-220-E Study Period|Physician Decision|0
186798|NCT00424021|640432|P1|AMB-220-E Study Period|Physician Decision|0
186799|NCT00424021|640429|P4|AMB-220-E Study Period|Lost to Follow-up|1
186800|NCT00424021|640430|P3|AMB-220-E Study Period|Lost to Follow-up|1
186801|NCT00424021|640431|P2|AMB-220-E Study Period|Lost to Follow-up|1
186802|NCT00424021|640432|P1|AMB-220-E Study Period|Lost to Follow-up|0
186803|NCT00424021|640429|P4|AMB-220-E Study Period|Death|1
186804|NCT00424021|640430|P3|AMB-220-E Study Period|Death|1
186805|NCT00424021|640431|P2|AMB-220-E Study Period|Death|0
186806|NCT00424021|640432|P1|AMB-220-E Study Period|Death|0
186807|NCT00424021|640429|P4|AMB-220-E Study Period|Adverse Event|7
186808|NCT00424021|640430|P3|AMB-220-E Study Period|Adverse Event|3
186809|NCT00424021|640431|P2|AMB-220-E Study Period|Adverse Event|1
186810|NCT00424021|640432|P1|AMB-220-E Study Period|Adverse Event|1
186811|NCT00424021|640429|P4|NCT00046319 Study Period|Lost to Follow-up|0
186812|NCT00424021|640430|P3|NCT00046319 Study Period|Lost to Follow-up|0
186813|NCT00424021|640431|P2|NCT00046319 Study Period|Lost to Follow-up|1
186814|NCT00424021|640432|P1|NCT00046319 Study Period|Lost to Follow-up|0
186815|NCT00424021|640429|P4|NCT00046319 Study Period|Sponsor discretion|0
186816|NCT00424021|640430|P3|NCT00046319 Study Period|Sponsor discretion|0
186817|NCT00424021|640431|P2|NCT00046319 Study Period|Sponsor discretion|1
186818|NCT00424021|640432|P1|NCT00046319 Study Period|Sponsor discretion|0
186819|NCT00424021|640429|P4|NCT00046319 Study Period|Withdrawal by Subject|0
186820|NCT00424021|640430|P3|NCT00046319 Study Period|Withdrawal by Subject|0
186821|NCT00424021|640431|P2|NCT00046319 Study Period|Withdrawal by Subject|1
186822|NCT00424021|640432|P1|NCT00046319 Study Period|Withdrawal by Subject|0
186823|NCT00424021|640429|P4|NCT00046319 Study Period|Adverse Event|1
186824|NCT00424021|640430|P3|NCT00046319 Study Period|Adverse Event|1
186825|NCT00424021|640431|P2|NCT00046319 Study Period|Adverse Event|0
186826|NCT00424021|640432|P1|NCT00046319 Study Period|Adverse Event|1
186827|NCT00424008|640475|P2|Overall Study|Administrative|257
186828|NCT00424008|640476|P1|Overall Study|Administrative|266
186829|NCT00424008|640475|P2|Overall Study|Did not meet protocol eligibility|21
186830|NCT00424008|640476|P1|Overall Study|Did not meet protocol eligibility|16
186831|NCT00424008|640475|P2|Overall Study|Noncompliance with protocol|7
186832|NCT00424008|640476|P1|Overall Study|Noncompliance with protocol|13
186833|NCT00424008|640475|P2|Overall Study|Withdrawal by Subject|8
186834|NCT00424008|640476|P1|Overall Study|Withdrawal by Subject|5
186835|NCT00424008|640475|P2|Overall Study|Lost to Follow-up|2
186836|NCT00424008|640476|P1|Overall Study|Lost to Follow-up|1
186837|NCT00424008|640475|P2|Overall Study|Lack of Efficacy|34
186838|NCT00424008|640476|P1|Overall Study|Lack of Efficacy|40
186839|NCT00424008|640475|P2|Overall Study|Adverse Event|6
186840|NCT00424008|640476|P1|Overall Study|Adverse Event|8
186841|NCT00423943|640491|P2|Overall Study|Withdrawal by Subject|1
186842|NCT00423943|640492|P1|Overall Study|Withdrawal by Subject|3
186843|NCT00423930|640506|P1|Overall Study|Withdrawal by Subject|2
186844|NCT00423917|640511|P1|Overall Study|Ineligible|1
186845|NCT00423917|640511|P1|Overall Study|Cancel|2
186846|NCT00423891|640524|P3|Post-Dosing Follow Up|Lost to Follow-up|0
186847|NCT00423891|640525|P2|Post-Dosing Follow Up|Lost to Follow-up|0
186848|NCT00423891|640526|P1|Post-Dosing Follow Up|Lost to Follow-up|2
186849|NCT00423891|640524|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
186850|NCT00423891|640525|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
186851|NCT00423891|640526|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
186852|NCT00423891|640524|P3|Treatment|Lost to Follow-up|0
186853|NCT00423891|640525|P2|Treatment|Lost to Follow-up|0
186854|NCT00423891|640526|P1|Treatment|Lost to Follow-up|1
186855|NCT00423891|640524|P3|Treatment|Withdrawal by Subject|0
186856|NCT00423891|640525|P2|Treatment|Withdrawal by Subject|0
186857|NCT00423891|640526|P1|Treatment|Withdrawal by Subject|1
186858|NCT00423891|640524|P3|Enrolled|No longer met criteria|1
186859|NCT00423891|640525|P2|Enrolled|No longer met criteria|2
186860|NCT00423891|640526|P1|Enrolled|No longer met criteria|11
186861|NCT00423891|640524|P3|Enrolled|Lost to Follow-up|1
186862|NCT00423891|640525|P2|Enrolled|Lost to Follow-up|0
186863|NCT00423891|640526|P1|Enrolled|Lost to Follow-up|0
186864|NCT00423891|640524|P3|Enrolled|Withdrawal by Subject|1
186865|NCT00423891|640525|P2|Enrolled|Withdrawal by Subject|0
186866|NCT00423891|640526|P1|Enrolled|Withdrawal by Subject|0
186867|NCT00423852|640604|P1|Overall Study|Removed pior to the high-dose portion|3
186868|NCT00423813|640612|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
186869|NCT00423813|640613|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
186870|NCT00423813|640614|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
186871|NCT00423813|640612|P3|Overall Study|Will start exclusionary medications|0
186872|NCT00423813|640613|P2|Overall Study|Will start exclusionary medications|1
186873|NCT00423813|640614|P1|Overall Study|Will start exclusionary medications|0
186874|NCT00423813|640612|P3|Overall Study|Subject started night shift work|0
186875|NCT00423813|640613|P2|Overall Study|Subject started night shift work|0
186876|NCT00423813|640614|P1|Overall Study|Subject started night shift work|1
186877|NCT00423813|640612|P3|Overall Study|Pregnancy|1
186878|NCT00423813|640613|P2|Overall Study|Pregnancy|0
186879|NCT00423813|640614|P1|Overall Study|Pregnancy|0
186880|NCT00423813|640612|P3|Overall Study|Protocol Violation|4
186881|NCT00423813|640613|P2|Overall Study|Protocol Violation|4
186882|NCT00423813|640614|P1|Overall Study|Protocol Violation|9
186883|NCT00423813|640612|P3|Overall Study|Sponsor Decision|0
186884|NCT00423813|640613|P2|Overall Study|Sponsor Decision|1
186885|NCT00423813|640614|P1|Overall Study|Sponsor Decision|0
186886|NCT00423813|640612|P3|Overall Study|Physician Decision|0
186887|NCT00423813|640613|P2|Overall Study|Physician Decision|0
186888|NCT00423813|640614|P1|Overall Study|Physician Decision|2
186889|NCT00423813|640612|P3|Overall Study|Lack of Efficacy|19
186890|NCT00423813|640613|P2|Overall Study|Lack of Efficacy|18
186891|NCT00423813|640614|P1|Overall Study|Lack of Efficacy|23
186892|NCT00423813|640612|P3|Overall Study|Lost to Follow-up|4
186893|NCT00423813|640613|P2|Overall Study|Lost to Follow-up|4
186894|NCT00423813|640614|P1|Overall Study|Lost to Follow-up|5
186895|NCT00423813|640612|P3|Overall Study|Withdrawal by Subject|5
186896|NCT00423813|640613|P2|Overall Study|Withdrawal by Subject|8
186897|NCT00423813|640614|P1|Overall Study|Withdrawal by Subject|6
186898|NCT00423813|640612|P3|Overall Study|Adverse Event|40
186899|NCT00423813|640613|P2|Overall Study|Adverse Event|30
186900|NCT00423813|640614|P1|Overall Study|Adverse Event|11
186901|NCT00423800|640624|P2|Overall Study|Protocol Violation|1
186902|NCT00423800|640625|P1|Overall Study|Protocol Violation|0
186903|NCT00423735|640637|P3|Overall Study|Ineligible / No protocol treatment|0
186904|NCT00423735|640638|P2|Overall Study|Ineligible / No protocol treatment|6
186905|NCT00423735|640639|P1|Overall Study|Ineligible / No protocol treatment|8
186906|NCT00423722|640662|P2|Overall Study|Withdrawal by Subject|2
186907|NCT00423722|640663|P1|Overall Study|Withdrawal by Subject|4
186908|NCT00423722|640662|P2|Overall Study|Unable to complete questionnaires|4
186909|NCT00423722|640663|P1|Overall Study|Unable to complete questionnaires|4
186910|NCT00423722|640662|P2|Overall Study|Declined to participate|3
186911|NCT00423722|640663|P1|Overall Study|Declined to participate|2
186912|NCT00423722|640662|P2|Overall Study|Death|4
186913|NCT00423722|640663|P1|Overall Study|Death|4
186914|NCT00423670|640705|P8|Follow-up Period|Non-compliance with protocol|2
186915|NCT00423670|640706|P7|Follow-up Period|Non-compliance with protocol|3
186916|NCT00423670|640707|P6|Follow-up Period|Non-compliance with protocol|0
186917|NCT00423670|640708|P5|Follow-up Period|Non-compliance with protocol|0
186918|NCT00423670|640709|P4|Follow-up Period|Non-compliance with protocol|1
186919|NCT00423670|640710|P3|Follow-up Period|Non-compliance with protocol|1
186920|NCT00423670|640711|P2|Follow-up Period|Non-compliance with protocol|0
186921|NCT00423670|640712|P1|Follow-up Period|Non-compliance with protocol|2
186922|NCT00423670|640705|P8|Follow-up Period|Subject withdrew (not treatment related)|1
186923|NCT00423670|640706|P7|Follow-up Period|Subject withdrew (not treatment related)|1
186924|NCT00423670|640707|P6|Follow-up Period|Subject withdrew (not treatment related)|0
186925|NCT00423670|640708|P5|Follow-up Period|Subject withdrew (not treatment related)|1
186926|NCT00423670|640709|P4|Follow-up Period|Subject withdrew (not treatment related)|1
186927|NCT00423670|640710|P3|Follow-up Period|Subject withdrew (not treatment related)|2
186928|NCT00423670|640711|P2|Follow-up Period|Subject withdrew (not treatment related)|4
186929|NCT00423670|640712|P1|Follow-up Period|Subject withdrew (not treatment related)|1
186930|NCT00423670|640705|P8|Follow-up Period|Lost to Follow-up|0
186931|NCT00423670|640706|P7|Follow-up Period|Lost to Follow-up|5
186932|NCT00423670|640707|P6|Follow-up Period|Lost to Follow-up|0
186933|NCT00423670|640708|P5|Follow-up Period|Lost to Follow-up|1
186934|NCT00423670|640709|P4|Follow-up Period|Lost to Follow-up|3
186935|NCT00423670|640710|P3|Follow-up Period|Lost to Follow-up|8
186936|NCT00423670|640711|P2|Follow-up Period|Lost to Follow-up|12
186937|NCT00423670|640712|P1|Follow-up Period|Lost to Follow-up|0
186938|NCT00423670|640705|P8|Treatment Period|Non-compliance with protocol|2
186939|NCT00423670|640706|P7|Treatment Period|Non-compliance with protocol|2
186940|NCT00423670|640707|P6|Treatment Period|Non-compliance with protocol|0
186941|NCT00423670|640708|P5|Treatment Period|Non-compliance with protocol|2
186942|NCT00423670|640709|P4|Treatment Period|Non-compliance with protocol|3
186943|NCT00423670|640710|P3|Treatment Period|Non-compliance with protocol|1
186944|NCT00423670|640711|P2|Treatment Period|Non-compliance with protocol|1
186945|NCT00423670|640712|P1|Treatment Period|Non-compliance with protocol|3
186946|NCT00423670|640705|P8|Treatment Period|Investigator decision|1
186947|NCT00423670|640706|P7|Treatment Period|Investigator decision|0
186948|NCT00423670|640707|P6|Treatment Period|Investigator decision|0
186949|NCT00423670|640708|P5|Treatment Period|Investigator decision|0
186950|NCT00423670|640709|P4|Treatment Period|Investigator decision|0
186951|NCT00423670|640710|P3|Treatment Period|Investigator decision|0
186952|NCT00423670|640711|P2|Treatment Period|Investigator decision|0
186953|NCT00423670|640712|P1|Treatment Period|Investigator decision|0
186954|NCT00423670|640705|P8|Treatment Period|Subject withdrew (not treatment related)|0
186955|NCT00423670|640706|P7|Treatment Period|Subject withdrew (not treatment related)|3
186956|NCT00423670|640707|P6|Treatment Period|Subject withdrew (not treatment related)|0
186957|NCT00423670|640708|P5|Treatment Period|Subject withdrew (not treatment related)|5
186958|NCT00423670|640709|P4|Treatment Period|Subject withdrew (not treatment related)|4
186959|NCT00423670|640710|P3|Treatment Period|Subject withdrew (not treatment related)|4
186960|NCT00423670|640711|P2|Treatment Period|Subject withdrew (not treatment related)|9
186961|NCT00423670|640712|P1|Treatment Period|Subject withdrew (not treatment related)|3
186962|NCT00423670|640705|P8|Treatment Period|Lost to Follow-up|1
186963|NCT00423670|640706|P7|Treatment Period|Lost to Follow-up|3
186964|NCT00423670|640707|P6|Treatment Period|Lost to Follow-up|0
186965|NCT00423670|640708|P5|Treatment Period|Lost to Follow-up|6
186966|NCT00423670|640709|P4|Treatment Period|Lost to Follow-up|1
186967|NCT00423670|640710|P3|Treatment Period|Lost to Follow-up|3
186968|NCT00423670|640711|P2|Treatment Period|Lost to Follow-up|1
186969|NCT00423670|640712|P1|Treatment Period|Lost to Follow-up|2
186970|NCT00423670|640705|P8|Treatment Period|Protocol-defined clinical event|15
186971|NCT00423670|640706|P7|Treatment Period|Protocol-defined clinical event|16
186972|NCT00423670|640707|P6|Treatment Period|Protocol-defined clinical event|4
186973|NCT00423670|640708|P5|Treatment Period|Protocol-defined clinical event|5
186974|NCT00423670|640709|P4|Treatment Period|Protocol-defined clinical event|12
186975|NCT00423670|640710|P3|Treatment Period|Protocol-defined clinical event|4
186976|NCT00423670|640711|P2|Treatment Period|Protocol-defined clinical event|7
186977|NCT00423670|640712|P1|Treatment Period|Protocol-defined clinical event|0
186978|NCT00423670|640705|P8|Treatment Period|Adverse Event|2
186979|NCT00423670|640706|P7|Treatment Period|Adverse Event|7
186980|NCT00423670|640707|P6|Treatment Period|Adverse Event|4
186981|NCT00423670|640708|P5|Treatment Period|Adverse Event|9
186982|NCT00423670|640709|P4|Treatment Period|Adverse Event|20
186983|NCT00423670|640710|P3|Treatment Period|Adverse Event|15
186984|NCT00423670|640711|P2|Treatment Period|Adverse Event|12
186985|NCT00423670|640712|P1|Treatment Period|Adverse Event|8
186986|NCT00423670|640705|P8|Treatment Period|Switched to Arm 8 at TW 24|0
186987|NCT00423670|640706|P7|Treatment Period|Switched to Arm 8 at TW 24|0
186988|NCT00423670|640707|P6|Treatment Period|Switched to Arm 8 at TW 24|0
186989|NCT00423670|640708|P5|Treatment Period|Switched to Arm 8 at TW 24|0
186990|NCT00423670|640709|P4|Treatment Period|Switched to Arm 8 at TW 24|0
186991|NCT00423670|640710|P3|Treatment Period|Switched to Arm 8 at TW 24|0
186992|NCT00423670|640711|P2|Treatment Period|Switched to Arm 8 at TW 24|0
186993|NCT00423670|640712|P1|Treatment Period|Switched to Arm 8 at TW 24|36
186994|NCT00423657|640770|P2|Overall Study|Request of sponsor/investigator|0
186995|NCT00423657|640771|P1|Overall Study|Request of sponsor/investigator|1
186996|NCT00423657|640770|P2|Overall Study|Other|16
186997|NCT00423657|640771|P1|Overall Study|Other|15
186998|NCT00423657|640770|P2|Overall Study|Non-compliance|1
186999|NCT00423657|640771|P1|Overall Study|Non-compliance|0
187000|NCT00423657|640770|P2|Overall Study|Withdrew consent|8
187001|NCT00423657|640771|P1|Overall Study|Withdrew consent|10
187002|NCT00423605|640777|P1|Overall Study|Not one of the pre-specified options|5
187003|NCT00423605|640777|P1|Overall Study|Protocol Violation|7
187004|NCT00423605|640777|P1|Overall Study|Physician Decision|8
187005|NCT00423605|640777|P1|Overall Study|Sponsor Decision|3
187006|NCT00423605|640777|P1|Overall Study|Lack of Efficacy|38
187007|NCT00423605|640777|P1|Overall Study|Lost to Follow-up|15
187008|NCT00423605|640777|P1|Overall Study|Withdrawal by Subject|36
187009|NCT00423605|640777|P1|Overall Study|Adverse Event|129
187010|NCT00423592|640781|P1|Overall Study|Adverse Event (post Week 12)|5
187011|NCT00423592|640781|P1|Overall Study|Adverse Event (through Week 12)|2
187012|NCT00423579|640802|P2|Overall Study|Diagnosis of diabetes|1
187013|NCT00423579|640803|P1|Overall Study|Diagnosis of diabetes|0
187014|NCT00423579|640802|P2|Overall Study|Protocol Violation|3
187015|NCT00423579|640803|P1|Overall Study|Protocol Violation|1
187016|NCT00423579|640802|P2|Overall Study|Lost to Follow-up|0
187017|NCT00423579|640803|P1|Overall Study|Lost to Follow-up|3
187018|NCT00423488|640811|P2|Overall Study|No post baseline data|0
187019|NCT00423488|640812|P1|Overall Study|No post baseline data|3
187020|NCT00423488|640811|P2|Overall Study|No evidence of study drug intake|1
187021|NCT00423488|640812|P1|Overall Study|No evidence of study drug intake|2
187022|NCT00423449|640818|P5|Overall Study|Protocol Violation|0
187023|NCT00423449|640819|P4|Overall Study|Protocol Violation|1
187024|NCT00423449|640820|P3|Overall Study|Protocol Violation|2
187025|NCT00423449|640821|P2|Overall Study|Protocol Violation|0
187026|NCT00423449|640822|P1|Overall Study|Protocol Violation|0
187027|NCT00423449|640818|P5|Overall Study|Not Specified|0
187028|NCT00423449|640819|P4|Overall Study|Not Specified|1
187029|NCT00423449|640820|P3|Overall Study|Not Specified|0
187030|NCT00423449|640821|P2|Overall Study|Not Specified|0
187031|NCT00423449|640822|P1|Overall Study|Not Specified|0
187032|NCT00423449|640818|P5|Overall Study|Laboratory Adverse Event|0
187033|NCT00423449|640819|P4|Overall Study|Laboratory Adverse Event|0
187034|NCT00423449|640820|P3|Overall Study|Laboratory Adverse Event|2
187035|NCT00423449|640821|P2|Overall Study|Laboratory Adverse Event|1
187036|NCT00423449|640822|P1|Overall Study|Laboratory Adverse Event|0
187037|NCT00423449|640818|P5|Overall Study|Progressive Disease|4
187038|NCT00423449|640819|P4|Overall Study|Progressive Disease|11
187039|NCT00423449|640820|P3|Overall Study|Progressive Disease|8
187040|NCT00423449|640821|P2|Overall Study|Progressive Disease|3
187041|NCT00423449|640822|P1|Overall Study|Progressive Disease|1
187042|NCT00423449|640818|P5|Overall Study|Death|1
187043|NCT00423449|640819|P4|Overall Study|Death|1
187044|NCT00423449|640820|P3|Overall Study|Death|2
187045|NCT00423449|640821|P2|Overall Study|Death|0
187046|NCT00423449|640822|P1|Overall Study|Death|1
187047|NCT00423449|640818|P5|Overall Study|Clinical Adverse Event|2
187048|NCT00423449|640819|P4|Overall Study|Clinical Adverse Event|8
187049|NCT00423449|640820|P3|Overall Study|Clinical Adverse Event|1
187050|NCT00423449|640821|P2|Overall Study|Clinical Adverse Event|0
187051|NCT00423449|640822|P1|Overall Study|Clinical Adverse Event|1
187052|NCT00423332|640869|P2|Overall Study|Unblinded before 12 weeks|3
187053|NCT00423332|640870|P1|Overall Study|Unblinded before 12 weeks|1
187054|NCT00423332|640869|P2|Overall Study|Progressive at Week 6|1
187055|NCT00423332|640870|P1|Overall Study|Progressive at Week 6|0
187056|NCT00423332|640869|P2|Overall Study|Condition under investigation worsened|1
187057|NCT00423332|640870|P1|Overall Study|Condition under investigation worsened|1
187058|NCT00423332|640869|P2|Overall Study|Withdrawal by Subject|0
187059|NCT00423332|640870|P1|Overall Study|Withdrawal by Subject|1
187060|NCT00423332|640869|P2|Overall Study|Adverse Event|2
187061|NCT00423332|640870|P1|Overall Study|Adverse Event|6
187062|NCT00423319|640889|P2|Overall Study|Not specified|22
187063|NCT00423319|640890|P1|Overall Study|Not specified|23
187064|NCT00423319|640889|P2|Overall Study|No longer meets study criteria|15
187065|NCT00423319|640890|P1|Overall Study|No longer meets study criteria|15
187066|NCT00423319|640889|P2|Overall Study|Poor compliance or noncompliance|1
187067|NCT00423319|640890|P1|Overall Study|Poor compliance or noncompliance|1
187068|NCT00423319|640889|P2|Overall Study|Lost to Follow-up|3
187069|NCT00423319|640890|P1|Overall Study|Lost to Follow-up|4
187070|NCT00423319|640889|P2|Overall Study|Withdrawal by Subject|99
187071|NCT00423319|640890|P1|Overall Study|Withdrawal by Subject|86
187072|NCT00423319|640889|P2|Overall Study|Adverse Event|112
187073|NCT00423319|640890|P1|Overall Study|Adverse Event|93
187074|NCT00423319|640889|P2|Overall Study|Death|0
187075|NCT00423319|640890|P1|Overall Study|Death|2
187076|NCT00423293|640922|P1|Overall Study|Ineligible / No protocol treatment|11
187077|NCT00423267|640928|P2|Period A|Administrative|0
187078|NCT00423267|640929|P1|Period A|Administrative|1
187079|NCT00423267|640928|P2|Period A|Non-compliance with protocol|0
187080|NCT00423267|640929|P1|Period A|Non-compliance with protocol|1
187081|NCT00423267|640928|P2|Period A|Withdrawal by Subject|1
187082|NCT00423267|640929|P1|Period A|Withdrawal by Subject|0
187083|NCT00423189|640949|P3|Overall Study|Death|0
187084|NCT00423189|640950|P2|Overall Study|Death|1
187085|NCT00423189|640951|P1|Overall Study|Death|0
187086|NCT00423176|640973|P2|Overall Study|Did not meet protocol eligibility|4
187087|NCT00423176|640974|P1|Overall Study|Did not meet protocol eligibility|2
187088|NCT00423176|640973|P2|Overall Study|Protocol Violation|3
187089|NCT00423176|640974|P1|Overall Study|Protocol Violation|1
187090|NCT00423176|640973|P2|Overall Study|Withdrawal by Subject|3
187091|NCT00423176|640974|P1|Overall Study|Withdrawal by Subject|4
187092|NCT00423176|640973|P2|Overall Study|Lost to Follow-up|7
187093|NCT00423176|640974|P1|Overall Study|Lost to Follow-up|4
187094|NCT00423176|640973|P2|Overall Study|Treatment Failure|6
187095|NCT00423176|640974|P1|Overall Study|Treatment Failure|1
187096|NCT00423176|640973|P2|Overall Study|Adverse Event|6
187097|NCT00423176|640974|P1|Overall Study|Adverse Event|4
187098|NCT00423150|640982|P1|Overall Study|Administrative|4
187099|NCT00423150|640982|P1|Overall Study|Non-compliance with protocol|1
187100|NCT00423150|640982|P1|Overall Study|Withdrawal by Subject|1
187101|NCT00423150|640982|P1|Overall Study|Progression of disease being studied|69
187102|NCT00423150|640982|P1|Overall Study|Adverse Event|11
187103|NCT00423098|640988|P2|Overall Study|Death|0
187104|NCT00423098|640989|P1|Overall Study|Death|2
187105|NCT00423098|640988|P2|Overall Study|Administrative problems|1
187106|NCT00423098|640989|P1|Overall Study|Administrative problems|0
187107|NCT00423098|640988|P2|Overall Study|Unsatisfactory therapeutic effect|1
187108|NCT00423098|640989|P1|Overall Study|Unsatisfactory therapeutic effect|0
187109|NCT00423098|640988|P2|Overall Study|Adverse Event|2
187110|NCT00423098|640989|P1|Overall Study|Adverse Event|1
187111|NCT00423085|641016|P4|52-Week Open-Label Extension Phase|Death|2
187112|NCT00423085|641017|P3|52-Week Open-Label Extension Phase|Death|0
187113|NCT00423085|641018|P2|52-Week Open-Label Extension Phase|Death|0
187114|NCT00423085|641019|P1|52-Week Open-Label Extension Phase|Death|0
187115|NCT00423085|641016|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
187116|NCT00423085|641017|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
187117|NCT00423085|641018|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
187118|NCT00423085|641019|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
187119|NCT00423085|641016|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
187120|NCT00423085|641017|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
187121|NCT00423085|641018|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
187122|NCT00423085|641019|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
187123|NCT00423085|641016|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
187124|NCT00423085|641017|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
187125|NCT00423085|641018|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
187126|NCT00423085|641019|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
187127|NCT00423085|641016|P4|52-Week Open-Label Extension Phase|Adverse Event|97
187128|NCT00423085|641017|P3|52-Week Open-Label Extension Phase|Adverse Event|0
187129|NCT00423085|641018|P2|52-Week Open-Label Extension Phase|Adverse Event|0
187130|NCT00423085|641019|P1|52-Week Open-Label Extension Phase|Adverse Event|0
187131|NCT00423085|641016|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
187132|NCT00423085|641017|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
187133|NCT00423085|641018|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
187134|NCT00423085|641019|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
187135|NCT00423085|641016|P4|24-Week Double-Blind Treatment Phase|Death|0
187136|NCT00423085|641017|P3|24-Week Double-Blind Treatment Phase|Death|0
187137|NCT00423085|641018|P2|24-Week Double-Blind Treatment Phase|Death|1
187138|NCT00423085|641019|P1|24-Week Double-Blind Treatment Phase|Death|1
187139|NCT00423085|641016|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
187140|NCT00423085|641017|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
187141|NCT00423085|641018|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
187142|NCT00423085|641019|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
187143|NCT00423085|641016|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
187144|NCT00423085|641017|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
187145|NCT00423085|641018|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
187146|NCT00423085|641019|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
187147|NCT00423085|641016|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
187148|NCT00423085|641017|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
187149|NCT00423085|641018|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
187150|NCT00423085|641019|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
187151|NCT00423085|641016|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
187152|NCT00423085|641017|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
187153|NCT00423085|641018|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
187154|NCT00423085|641019|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
187155|NCT00423046|641048|P2|Overall Study|Other|345
187156|NCT00423046|641049|P1|Overall Study|Other|340
187157|NCT00422942|641115|P1|Overall Study|Study terminated by Sponsor|3
187158|NCT00422903|641134|P2|Overall Study|Informed Consent Withdrawn|2
187159|NCT00422903|641135|P1|Overall Study|Informed Consent Withdrawn|1
187160|NCT00422903|641134|P2|Overall Study|Adverse Event|2
187161|NCT00422903|641135|P1|Overall Study|Adverse Event|0
187162|NCT00422903|641134|P2|Overall Study|Disease Progression|1
187163|NCT00422903|641135|P1|Overall Study|Disease Progression|3
187164|NCT00422799|641184|P1|Overall Study|Adverse Event|7
187165|NCT00422799|641184|P1|Overall Study|Withdrawal by Subject|6
187166|NCT00422734|641193|P2|Overall Study|Partner Decision|3
187167|NCT00422734|641194|P1|Overall Study|Partner Decision|0
187168|NCT00422734|641193|P2|Overall Study|Adverse Event|3
187169|NCT00422734|641194|P1|Overall Study|Adverse Event|0
187170|NCT00422734|641193|P2|Overall Study|Withdrawal by Subject|8
187171|NCT00422734|641194|P1|Overall Study|Withdrawal by Subject|12
187172|NCT00422734|641193|P2|Overall Study|Protocol Violation|6
187173|NCT00422734|641194|P1|Overall Study|Protocol Violation|1
187174|NCT00422734|641193|P2|Overall Study|Physician Decision|1
187175|NCT00422734|641194|P1|Overall Study|Physician Decision|1
187176|NCT00422669|641240|P3|Overall Study|The study was terminated early.|7
187177|NCT00422669|641241|P2|Overall Study|The study was terminated early.|100
187178|NCT00422669|641242|P1|Overall Study|The study was terminated early.|98
187179|NCT00422513|641272|P2|Overall Study|Death|7
187180|NCT00422513|641273|P1|Overall Study|Death|3
187181|NCT00422513|641272|P2|Overall Study|Adverse Event|4
187182|NCT00422513|641273|P1|Overall Study|Adverse Event|4
187183|NCT00422513|641272|P2|Overall Study|early termination of the study|80
187184|NCT00422513|641273|P1|Overall Study|early termination of the study|67
187185|NCT00422513|641272|P2|Overall Study|Withdrawal by Subject|1
187186|NCT00422513|641273|P1|Overall Study|Withdrawal by Subject|2
187187|NCT00422513|641272|P2|Overall Study|Refused Treatment|2
187188|NCT00422513|641273|P1|Overall Study|Refused Treatment|4
187189|NCT00422513|641272|P2|Overall Study|Protocol Violation|7
187190|NCT00422513|641273|P1|Overall Study|Protocol Violation|23
187191|NCT00422513|641272|P2|Overall Study|Lack of Efficacy|5
187192|NCT00422513|641273|P1|Overall Study|Lack of Efficacy|4
187193|NCT00422422|641290|P1|Overall Study|AE, non-serious non-fatal|5
187194|NCT00422422|641290|P1|Overall Study|SAE, non-fatal|1
187195|NCT00422422|641290|P1|Overall Study|Withdrawal by Subject|2
187196|NCT00422422|641290|P1|Overall Study|Protocol Violation|1
187197|NCT00422422|641290|P1|Overall Study|Lack of Efficacy|1
187198|NCT00422383|641307|P5|Overall Study|Withdrawal by Subject|1
187199|NCT00422383|641308|P4|Overall Study|Withdrawal by Subject|0
187200|NCT00422383|641309|P3|Overall Study|Withdrawal by Subject|0
187201|NCT00422383|641310|P2|Overall Study|Withdrawal by Subject|5
187202|NCT00422383|641311|P1|Overall Study|Withdrawal by Subject|5
187203|NCT00422383|641307|P5|Overall Study|Protocol Violation|0
187204|NCT00422383|641308|P4|Overall Study|Protocol Violation|0
187205|NCT00422383|641309|P3|Overall Study|Protocol Violation|1
187206|NCT00422383|641310|P2|Overall Study|Protocol Violation|1
187207|NCT00422383|641311|P1|Overall Study|Protocol Violation|1
187208|NCT00422383|641307|P5|Overall Study|Lost to Follow-up|1
187209|NCT00422383|641308|P4|Overall Study|Lost to Follow-up|0
187210|NCT00422383|641309|P3|Overall Study|Lost to Follow-up|0
187211|NCT00422383|641310|P2|Overall Study|Lost to Follow-up|1
187212|NCT00422383|641311|P1|Overall Study|Lost to Follow-up|0
187213|NCT00422383|641307|P5|Overall Study|Lack of Efficacy|1
187214|NCT00422383|641308|P4|Overall Study|Lack of Efficacy|1
187215|NCT00422383|641309|P3|Overall Study|Lack of Efficacy|2
187216|NCT00422383|641310|P2|Overall Study|Lack of Efficacy|4
187217|NCT00422383|641311|P1|Overall Study|Lack of Efficacy|4
187218|NCT00422383|641307|P5|Overall Study|Adverse Event|0
187219|NCT00422383|641308|P4|Overall Study|Adverse Event|1
187220|NCT00422383|641309|P3|Overall Study|Adverse Event|1
187221|NCT00422383|641310|P2|Overall Study|Adverse Event|3
187222|NCT00422383|641311|P1|Overall Study|Adverse Event|5
187223|NCT00422292|641454|P4|Overall Study|Withdrawal by Subject|13
187224|NCT00422292|641455|P3|Overall Study|Withdrawal by Subject|7
187225|NCT00422292|641456|P2|Overall Study|Withdrawal by Subject|25
187226|NCT00422292|641457|P1|Overall Study|Withdrawal by Subject|6
187227|NCT00422292|641454|P4|Overall Study|Lost to Follow-up|6
187228|NCT00422292|641455|P3|Overall Study|Lost to Follow-up|6
187229|NCT00422292|641456|P2|Overall Study|Lost to Follow-up|12
187230|NCT00422292|641457|P1|Overall Study|Lost to Follow-up|6
187231|NCT00422292|641454|P4|Overall Study|Protocol Violation|5
187232|NCT00422292|641455|P3|Overall Study|Protocol Violation|8
187233|NCT00422292|641456|P2|Overall Study|Protocol Violation|25
187234|NCT00422292|641457|P1|Overall Study|Protocol Violation|4
187235|NCT00422292|641454|P4|Overall Study|Adverse Event|0
187236|NCT00422292|641455|P3|Overall Study|Adverse Event|1
187237|NCT00422292|641456|P2|Overall Study|Adverse Event|0
187238|NCT00422292|641457|P1|Overall Study|Adverse Event|1
187239|NCT00422292|641454|P4|Overall Study|Serious adverse events|0
187240|NCT00422292|641455|P3|Overall Study|Serious adverse events|0
187241|NCT00422292|641456|P2|Overall Study|Serious adverse events|4
187242|NCT00422292|641457|P1|Overall Study|Serious adverse events|1
187243|NCT00422227|641496|P2|Overall Study|Withdrawal by Subject|4
187244|NCT00422227|641497|P1|Overall Study|Withdrawal by Subject|0
187245|NCT00422227|641496|P2|Overall Study|Lost to Follow-up|3
187246|NCT00422227|641497|P1|Overall Study|Lost to Follow-up|1
187247|NCT00422227|641496|P2|Overall Study|Adverse Event|8
187248|NCT00422227|641497|P1|Overall Study|Adverse Event|3
187249|NCT00422162|641527|P2|Overall Study|Didn't Receive Treatment|1
187250|NCT00422162|641528|P1|Overall Study|Didn't Receive Treatment|0
187251|NCT00422162|641527|P2|Overall Study|Not Specified|1
187252|NCT00422162|641528|P1|Overall Study|Not Specified|0
187253|NCT00422162|641527|P2|Overall Study|Non-Compliant with Protocol|1
187254|NCT00422162|641528|P1|Overall Study|Non-Compliant with Protocol|1
187255|NCT00422162|641527|P2|Overall Study|Lost to Follow-up|2
187256|NCT00422162|641528|P1|Overall Study|Lost to Follow-up|1
187257|NCT00422162|641527|P2|Overall Study|Withdrawal by Subject|6
187258|NCT00422162|641528|P1|Overall Study|Withdrawal by Subject|7
187259|NCT00422162|641527|P2|Overall Study|Lack of Efficacy|10
187260|NCT00422162|641528|P1|Overall Study|Lack of Efficacy|4
187261|NCT00422162|641527|P2|Overall Study|Adverse Event|9
187262|NCT00422162|641528|P1|Overall Study|Adverse Event|11
187263|NCT00422097|641588|P8|Dose Level 2|Still on treatment|0
187264|NCT00422097|641589|P7|Dose Level 2|Still on treatment|0
187265|NCT00422097|641590|P6|Dose Level 2|Still on treatment|0
187266|NCT00422097|641591|P5|Dose Level 2|Still on treatment|0
187267|NCT00422097|641592|P4|Dose Level 2|Still on treatment|0
187268|NCT00422097|641593|P3|Dose Level 2|Still on treatment|0
187269|NCT00422097|641594|P2|Dose Level 2|Still on treatment|1
187270|NCT00422097|641595|P1|Dose Level 2|Still on treatment|0
187271|NCT00422058|641660|P6|Open-Label Extension, Week 20-104|Other|18
187272|NCT00422058|641661|P5|Open-Label Extension, Week 20-104|Other|16
187273|NCT00422058|641662|P4|Open-Label Extension, Week 20-104|Other|13
187274|NCT00422058|641663|P3|Open-Label Extension, Week 20-104|Other|6
187275|NCT00422058|641664|P2|Open-Label Extension, Week 20-104|Other|14
187276|NCT00422058|641665|P1|Open-Label Extension, Week 20-104|Other|13
187277|NCT00422058|641660|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
187278|NCT00422058|641661|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
187279|NCT00422058|641662|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
187280|NCT00422058|641663|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
187281|NCT00422058|641664|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
187282|NCT00422058|641665|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
187283|NCT00422058|641660|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
187284|NCT00422058|641661|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
187285|NCT00422058|641662|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
187286|NCT00422058|641663|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
187287|NCT00422058|641664|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
187288|NCT00422058|641665|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
187289|NCT00422058|641660|P6|Open-Label Extension, Week 20-104|Adverse Event|0
187290|NCT00422058|641661|P5|Open-Label Extension, Week 20-104|Adverse Event|4
187291|NCT00422058|641662|P4|Open-Label Extension, Week 20-104|Adverse Event|4
187292|NCT00422058|641663|P3|Open-Label Extension, Week 20-104|Adverse Event|7
187293|NCT00422058|641664|P2|Open-Label Extension, Week 20-104|Adverse Event|4
187294|NCT00422058|641665|P1|Open-Label Extension, Week 20-104|Adverse Event|3
187295|NCT00422058|641660|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
187296|NCT00422058|641661|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
187297|NCT00422058|641662|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
187298|NCT00422058|641663|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
187299|NCT00422058|641664|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
187300|NCT00422058|641665|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
187301|NCT00422058|641660|P6|Double-Blind, Week 0-20|Other|10
187302|NCT00422058|641661|P5|Double-Blind, Week 0-20|Other|4
187303|NCT00422058|641662|P4|Double-Blind, Week 0-20|Other|8
187304|NCT00422058|641663|P3|Double-Blind, Week 0-20|Other|8
187305|NCT00422058|641664|P2|Double-Blind, Week 0-20|Other|3
187306|NCT00422058|641665|P1|Double-Blind, Week 0-20|Other|11
187307|NCT00422058|641660|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
187308|NCT00422058|641661|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
187309|NCT00422058|641662|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
187310|NCT00422058|641663|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
187311|NCT00422058|641664|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
187312|NCT00422058|641665|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
187313|NCT00422058|641660|P6|Double-Blind, Week 0-20|Protocol Violation|2
187314|NCT00422058|641661|P5|Double-Blind, Week 0-20|Protocol Violation|2
187315|NCT00422058|641662|P4|Double-Blind, Week 0-20|Protocol Violation|3
187316|NCT00422058|641663|P3|Double-Blind, Week 0-20|Protocol Violation|2
187317|NCT00422058|641664|P2|Double-Blind, Week 0-20|Protocol Violation|2
187318|NCT00422058|641665|P1|Double-Blind, Week 0-20|Protocol Violation|3
187319|NCT00422058|641660|P6|Double-Blind, Week 0-20|Adverse Event|3
187320|NCT00422058|641661|P5|Double-Blind, Week 0-20|Adverse Event|5
187321|NCT00422058|641662|P4|Double-Blind, Week 0-20|Adverse Event|9
187322|NCT00422058|641663|P3|Double-Blind, Week 0-20|Adverse Event|5
187323|NCT00422058|641664|P2|Double-Blind, Week 0-20|Adverse Event|4
187324|NCT00422058|641665|P1|Double-Blind, Week 0-20|Adverse Event|3
187325|NCT00421993|641806|P4|Overall Study|Subject transportation issues|1
187326|NCT00421993|641807|P3|Overall Study|Subject transportation issues|0
187327|NCT00421993|641808|P2|Overall Study|Subject transportation issues|0
187328|NCT00421993|641809|P1|Overall Study|Subject transportation issues|0
187329|NCT00421993|641806|P4|Overall Study|Pregnancy|2
187330|NCT00421993|641807|P3|Overall Study|Pregnancy|1
187331|NCT00421993|641808|P2|Overall Study|Pregnancy|1
187332|NCT00421993|641809|P1|Overall Study|Pregnancy|0
187333|NCT00421993|641806|P4|Overall Study|Lack of Efficacy|5
187334|NCT00421993|641807|P3|Overall Study|Lack of Efficacy|0
187335|NCT00421993|641808|P2|Overall Study|Lack of Efficacy|3
187336|NCT00421993|641809|P1|Overall Study|Lack of Efficacy|0
187337|NCT00421993|641806|P4|Overall Study|Protocol Violation|1
187338|NCT00421993|641807|P3|Overall Study|Protocol Violation|0
187339|NCT00421993|641808|P2|Overall Study|Protocol Violation|2
187340|NCT00421993|641809|P1|Overall Study|Protocol Violation|2
187341|NCT00421993|641806|P4|Overall Study|Adverse Event|4
187342|NCT00421993|641807|P3|Overall Study|Adverse Event|6
187343|NCT00421993|641808|P2|Overall Study|Adverse Event|1
187344|NCT00421993|641809|P1|Overall Study|Adverse Event|11
187345|NCT00421993|641806|P4|Overall Study|Lost to Follow-up|20
187346|NCT00421993|641807|P3|Overall Study|Lost to Follow-up|22
187347|NCT00421993|641808|P2|Overall Study|Lost to Follow-up|19
187348|NCT00421993|641809|P1|Overall Study|Lost to Follow-up|18
187349|NCT00421993|641806|P4|Overall Study|Withdrawal by Subject|24
187350|NCT00421993|641807|P3|Overall Study|Withdrawal by Subject|23
187351|NCT00421993|641808|P2|Overall Study|Withdrawal by Subject|23
187352|NCT00421993|641809|P1|Overall Study|Withdrawal by Subject|22
187353|NCT00421928|641846|P3|Overall Study|Death|0
187354|NCT00421928|641847|P2|Overall Study|Death|1
187355|NCT00421928|641848|P1|Overall Study|Death|0
187356|NCT00421928|641846|P3|Overall Study|All other|27
187357|NCT00421928|641847|P2|Overall Study|All other|21
187358|NCT00421928|641848|P1|Overall Study|All other|26
187359|NCT00421928|641846|P3|Overall Study|Study drug non-compliant|4
187360|NCT00421928|641847|P2|Overall Study|Study drug non-compliant|7
187361|NCT00421928|641848|P1|Overall Study|Study drug non-compliant|6
187362|NCT00421928|641846|P3|Overall Study|Lack of Efficacy|35
187363|NCT00421928|641847|P2|Overall Study|Lack of Efficacy|7
187364|NCT00421928|641848|P1|Overall Study|Lack of Efficacy|15
187365|NCT00421928|641846|P3|Overall Study|Withdrawal by Subject|43
187366|NCT00421928|641847|P2|Overall Study|Withdrawal by Subject|48
187367|NCT00421928|641848|P1|Overall Study|Withdrawal by Subject|50
187368|NCT00421928|641846|P3|Overall Study|Lost to Follow-up|3
187369|NCT00421928|641847|P2|Overall Study|Lost to Follow-up|0
187370|NCT00421928|641848|P1|Overall Study|Lost to Follow-up|5
187371|NCT00421928|641846|P3|Overall Study|Adverse Event|22
187372|NCT00421928|641847|P2|Overall Study|Adverse Event|140
187373|NCT00421928|641848|P1|Overall Study|Adverse Event|61
187374|NCT00421889|641883|P9|Overall Study|Lost to Follow-up|1
187375|NCT00421889|641884|P8|Overall Study|Lost to Follow-up|0
187376|NCT00421889|641885|P7|Overall Study|Lost to Follow-up|0
187377|NCT00421889|641886|P6|Overall Study|Lost to Follow-up|0
187378|NCT00421889|641887|P5|Overall Study|Lost to Follow-up|0
187379|NCT00421889|641888|P4|Overall Study|Lost to Follow-up|0
187380|NCT00421889|641889|P3|Overall Study|Lost to Follow-up|0
187381|NCT00421889|641890|P2|Overall Study|Lost to Follow-up|0
187382|NCT00421889|641891|P1|Overall Study|Lost to Follow-up|0
187383|NCT00421889|641883|P9|Overall Study|Patient/Investigator request|3
187384|NCT00421889|641884|P8|Overall Study|Patient/Investigator request|1
187385|NCT00421889|641885|P7|Overall Study|Patient/Investigator request|0
187386|NCT00421889|641886|P6|Overall Study|Patient/Investigator request|9
187387|NCT00421889|641887|P5|Overall Study|Patient/Investigator request|0
187388|NCT00421889|641888|P4|Overall Study|Patient/Investigator request|0
187389|NCT00421889|641889|P3|Overall Study|Patient/Investigator request|0
187390|NCT00421889|641890|P2|Overall Study|Patient/Investigator request|0
187391|NCT00421889|641891|P1|Overall Study|Patient/Investigator request|0
187392|NCT00421889|641883|P9|Overall Study|Progressive disease|5
187393|NCT00421889|641884|P8|Overall Study|Progressive disease|1
187394|NCT00421889|641885|P7|Overall Study|Progressive disease|3
187395|NCT00421889|641886|P6|Overall Study|Progressive disease|21
187396|NCT00421889|641887|P5|Overall Study|Progressive disease|2
187397|NCT00421889|641888|P4|Overall Study|Progressive disease|3
187398|NCT00421889|641889|P3|Overall Study|Progressive disease|2
187399|NCT00421889|641890|P2|Overall Study|Progressive disease|2
187400|NCT00421889|641891|P1|Overall Study|Progressive disease|3
187401|NCT00421889|641883|P9|Overall Study|Death|0
187402|NCT00421889|641884|P8|Overall Study|Death|0
187403|NCT00421889|641885|P7|Overall Study|Death|0
187404|NCT00421889|641886|P6|Overall Study|Death|1
187405|NCT00421889|641887|P5|Overall Study|Death|1
187406|NCT00421889|641888|P4|Overall Study|Death|0
187407|NCT00421889|641889|P3|Overall Study|Death|0
187408|NCT00421889|641890|P2|Overall Study|Death|0
187409|NCT00421889|641891|P1|Overall Study|Death|0
187410|NCT00421889|641883|P9|Overall Study|Withdrawal by Subject|0
187411|NCT00421889|641884|P8|Overall Study|Withdrawal by Subject|0
187412|NCT00421889|641885|P7|Overall Study|Withdrawal by Subject|0
187413|NCT00421889|641886|P6|Overall Study|Withdrawal by Subject|0
187414|NCT00421889|641887|P5|Overall Study|Withdrawal by Subject|2
187415|NCT00421889|641888|P4|Overall Study|Withdrawal by Subject|0
187416|NCT00421889|641889|P3|Overall Study|Withdrawal by Subject|0
187417|NCT00421889|641890|P2|Overall Study|Withdrawal by Subject|3
187418|NCT00421889|641891|P1|Overall Study|Withdrawal by Subject|1
187419|NCT00421889|641883|P9|Overall Study|Adverse Event|2
187420|NCT00421889|641884|P8|Overall Study|Adverse Event|0
187421|NCT00421889|641885|P7|Overall Study|Adverse Event|1
187422|NCT00421889|641886|P6|Overall Study|Adverse Event|4
187423|NCT00421889|641887|P5|Overall Study|Adverse Event|1
187424|NCT00421889|641888|P4|Overall Study|Adverse Event|1
187425|NCT00421889|641889|P3|Overall Study|Adverse Event|1
187426|NCT00421889|641890|P2|Overall Study|Adverse Event|0
187427|NCT00421889|641891|P1|Overall Study|Adverse Event|1
187428|NCT00421733|641936|P3|Overall Study|Protocol deviation|2
187429|NCT00421733|641937|P2|Overall Study|Protocol deviation|7
187430|NCT00421733|641938|P1|Overall Study|Protocol deviation|4
187431|NCT00421733|641936|P3|Overall Study|Sponsor request|3
187432|NCT00421733|641937|P2|Overall Study|Sponsor request|0
187433|NCT00421733|641938|P1|Overall Study|Sponsor request|1
187434|NCT00421733|641936|P3|Overall Study|Did not satisfy entry criteria|2
187435|NCT00421733|641937|P2|Overall Study|Did not satisfy entry criteria|3
187436|NCT00421733|641938|P1|Overall Study|Did not satisfy entry criteria|1
187437|NCT00421733|641936|P3|Overall Study|Administrative|0
187438|NCT00421733|641937|P2|Overall Study|Administrative|0
187439|NCT00421733|641938|P1|Overall Study|Administrative|2
187440|NCT00421733|641936|P3|Overall Study|Required dialysis|0
187441|NCT00421733|641937|P2|Overall Study|Required dialysis|0
187442|NCT00421733|641938|P1|Overall Study|Required dialysis|1
187443|NCT00421733|641936|P3|Overall Study|Death|0
187444|NCT00421733|641937|P2|Overall Study|Death|3
187445|NCT00421733|641938|P1|Overall Study|Death|0
187446|NCT00421733|641936|P3|Overall Study|Withdrawal by Subject|7
187447|NCT00421733|641937|P2|Overall Study|Withdrawal by Subject|2
187448|NCT00421733|641938|P1|Overall Study|Withdrawal by Subject|1
187449|NCT00421733|641936|P3|Overall Study|Lost to Follow-up|4
187450|NCT00421733|641937|P2|Overall Study|Lost to Follow-up|2
187451|NCT00421733|641938|P1|Overall Study|Lost to Follow-up|1
187452|NCT00421733|641936|P3|Overall Study|Adverse Event|2
187453|NCT00421733|641937|P2|Overall Study|Adverse Event|9
187454|NCT00421733|641938|P1|Overall Study|Adverse Event|4
187455|NCT00421707|641958|P2|Period 3:Treatment Period 2|Adverse Event|2
187456|NCT00421707|641959|P1|Period 3:Treatment Period 2|Adverse Event|0
187457|NCT00421707|641958|P2|Period 3:Treatment Period 2|Protocol Violation|0
187458|NCT00421707|641959|P1|Period 3:Treatment Period 2|Protocol Violation|1
187459|NCT00421707|641958|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
187460|NCT00421707|641959|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
187461|NCT00421707|641958|P2|Period 2: Washout|Other: Pregnancy|1
187462|NCT00421707|641959|P1|Period 2: Washout|Other: Pregnancy|0
187463|NCT00421707|641958|P2|Period 2: Washout|Lost to Follow-up|1
187464|NCT00421707|641959|P1|Period 2: Washout|Lost to Follow-up|0
187465|NCT00421707|641958|P2|Period 2: Washout|Withdrawal by Subject|1
187466|NCT00421707|641959|P1|Period 2: Washout|Withdrawal by Subject|0
187467|NCT00421707|641958|P2|Period 2: Washout|Adverse Event|1
187468|NCT00421707|641959|P1|Period 2: Washout|Adverse Event|1
187469|NCT00421707|641958|P2|Period 1: Treatment Period 1|Protocol Violation|0
187470|NCT00421707|641959|P1|Period 1: Treatment Period 1|Protocol Violation|1
187471|NCT00421707|641958|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
187472|NCT00421707|641959|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
187473|NCT00421707|641958|P2|Period 1: Treatment Period 1|Adverse Event|2
187474|NCT00421707|641959|P1|Period 1: Treatment Period 1|Adverse Event|7
187475|NCT00421707|641958|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
187476|NCT00421707|641959|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
187477|NCT00421408|642010|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
187478|NCT00421408|642011|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
187479|NCT00421408|642010|P2|Overall Study|Lost to Follow-up|20
187480|NCT00421408|642011|P1|Overall Study|Lost to Follow-up|30
187481|NCT00421343|642029|P1|Overall Study|Lost to follow-up|3
187482|NCT00421343|642029|P1|Overall Study|Withdrawal by Subject|2
187483|NCT00421343|642029|P1|Overall Study|Death|1
187484|NCT00421174|642035|P2|Overall Study|Ineligible due to infection|0
187485|NCT00421174|642036|P1|Overall Study|Ineligible due to infection|2
187486|NCT00421174|642035|P2|Overall Study|Withdrawal by Subject|1
187487|NCT00421174|642036|P1|Overall Study|Withdrawal by Subject|0
187488|NCT00420927|642081|P7|Period 2|Took prohibited medication|0
187489|NCT00420927|642082|P6|Period 2|Took prohibited medication|0
187490|NCT00420927|642083|P5|Period 2|Took prohibited medication|1
187491|NCT00420927|642084|P4|Period 2|Took prohibited medication|0
187492|NCT00420927|642085|P3|Period 2|Took prohibited medication|0
187493|NCT00420927|642086|P2|Period 2|Took prohibited medication|0
187494|NCT00420927|642087|P1|Period 2|Took prohibited medication|0
187495|NCT00420927|642081|P7|Period 2|Methotrexate intolerance|1
187496|NCT00420927|642082|P6|Period 2|Methotrexate intolerance|0
187497|NCT00420927|642083|P5|Period 2|Methotrexate intolerance|0
187498|NCT00420927|642084|P4|Period 2|Methotrexate intolerance|0
187499|NCT00420927|642085|P3|Period 2|Methotrexate intolerance|0
187500|NCT00420927|642086|P2|Period 2|Methotrexate intolerance|0
187501|NCT00420927|642087|P1|Period 2|Methotrexate intolerance|0
187502|NCT00420927|642081|P7|Period 2|Noncompliant with study drug|2
187503|NCT00420927|642082|P6|Period 2|Noncompliant with study drug|0
187504|NCT00420927|642083|P5|Period 2|Noncompliant with study drug|0
187505|NCT00420927|642084|P4|Period 2|Noncompliant with study drug|1
187506|NCT00420927|642085|P3|Period 2|Noncompliant with study drug|0
187507|NCT00420927|642086|P2|Period 2|Noncompliant with study drug|0
187508|NCT00420927|642087|P1|Period 2|Noncompliant with study drug|0
187509|NCT00420927|642081|P7|Period 2|Randomization error|0
187510|NCT00420927|642082|P6|Period 2|Randomization error|1
187511|NCT00420927|642083|P5|Period 2|Randomization error|1
187512|NCT00420927|642084|P4|Period 2|Randomization error|0
187513|NCT00420927|642085|P3|Period 2|Randomization error|0
187514|NCT00420927|642086|P2|Period 2|Randomization error|0
187515|NCT00420927|642087|P1|Period 2|Randomization error|0
187516|NCT00420927|642081|P7|Period 2|Sponsor decision|1
187517|NCT00420927|642082|P6|Period 2|Sponsor decision|0
187518|NCT00420927|642083|P5|Period 2|Sponsor decision|0
187519|NCT00420927|642084|P4|Period 2|Sponsor decision|0
187520|NCT00420927|642085|P3|Period 2|Sponsor decision|1
187521|NCT00420927|642086|P2|Period 2|Sponsor decision|0
187522|NCT00420927|642087|P1|Period 2|Sponsor decision|0
187523|NCT00420927|642081|P7|Period 2|Physician Decision|0
187524|NCT00420927|642082|P6|Period 2|Physician Decision|1
187525|NCT00420927|642083|P5|Period 2|Physician Decision|1
187526|NCT00420927|642084|P4|Period 2|Physician Decision|0
187527|NCT00420927|642085|P3|Period 2|Physician Decision|0
187528|NCT00420927|642086|P2|Period 2|Physician Decision|0
187529|NCT00420927|642087|P1|Period 2|Physician Decision|0
187530|NCT00420927|642081|P7|Period 2|Subject unable to find transportation|1
187531|NCT00420927|642082|P6|Period 2|Subject unable to find transportation|0
187532|NCT00420927|642083|P5|Period 2|Subject unable to find transportation|0
187533|NCT00420927|642084|P4|Period 2|Subject unable to find transportation|0
187534|NCT00420927|642085|P3|Period 2|Subject unable to find transportation|0
187535|NCT00420927|642086|P2|Period 2|Subject unable to find transportation|0
187536|NCT00420927|642087|P1|Period 2|Subject unable to find transportation|0
187537|NCT00420927|642081|P7|Period 2|Received wrong treatment/incorrect dose|1
187538|NCT00420927|642082|P6|Period 2|Received wrong treatment/incorrect dose|0
187539|NCT00420927|642083|P5|Period 2|Received wrong treatment/incorrect dose|0
187540|NCT00420927|642084|P4|Period 2|Received wrong treatment/incorrect dose|0
187541|NCT00420927|642085|P3|Period 2|Received wrong treatment/incorrect dose|0
187542|NCT00420927|642086|P2|Period 2|Received wrong treatment/incorrect dose|0
187543|NCT00420927|642087|P1|Period 2|Received wrong treatment/incorrect dose|0
187544|NCT00420927|642081|P7|Period 2|Lack of efficacy/Loss of efficacy|6
187545|NCT00420927|642082|P6|Period 2|Lack of efficacy/Loss of efficacy|2
187546|NCT00420927|642083|P5|Period 2|Lack of efficacy/Loss of efficacy|6
187547|NCT00420927|642084|P4|Period 2|Lack of efficacy/Loss of efficacy|1
187548|NCT00420927|642085|P3|Period 2|Lack of efficacy/Loss of efficacy|2
187549|NCT00420927|642086|P2|Period 2|Lack of efficacy/Loss of efficacy|0
187550|NCT00420927|642087|P1|Period 2|Lack of efficacy/Loss of efficacy|0
187551|NCT00420927|642081|P7|Period 2|Lost to Follow-up|9
187552|NCT00420927|642082|P6|Period 2|Lost to Follow-up|3
187553|NCT00420927|642083|P5|Period 2|Lost to Follow-up|6
187554|NCT00420927|642084|P4|Period 2|Lost to Follow-up|2
187555|NCT00420927|642085|P3|Period 2|Lost to Follow-up|2
187556|NCT00420927|642086|P2|Period 2|Lost to Follow-up|0
187557|NCT00420927|642087|P1|Period 2|Lost to Follow-up|0
187558|NCT00420927|642081|P7|Period 2|Withdrawal by Subject|12
187559|NCT00420927|642082|P6|Period 2|Withdrawal by Subject|2
187560|NCT00420927|642083|P5|Period 2|Withdrawal by Subject|11
187561|NCT00420927|642084|P4|Period 2|Withdrawal by Subject|3
187562|NCT00420927|642085|P3|Period 2|Withdrawal by Subject|1
187563|NCT00420927|642086|P2|Period 2|Withdrawal by Subject|0
187564|NCT00420927|642087|P1|Period 2|Withdrawal by Subject|0
187565|NCT00420927|642081|P7|Period 2|Adverse Event|20
187566|NCT00420927|642082|P6|Period 2|Adverse Event|6
187567|NCT00420927|642083|P5|Period 2|Adverse Event|17
187568|NCT00420927|642084|P4|Period 2|Adverse Event|3
187569|NCT00420927|642085|P3|Period 2|Adverse Event|7
187570|NCT00420927|642086|P2|Period 2|Adverse Event|0
187571|NCT00420927|642087|P1|Period 2|Adverse Event|0
187572|NCT00420927|642081|P7|Period 1|Took prohibited medication|0
187573|NCT00420927|642082|P6|Period 1|Took prohibited medication|0
187574|NCT00420927|642083|P5|Period 1|Took prohibited medication|0
187575|NCT00420927|642084|P4|Period 1|Took prohibited medication|0
187576|NCT00420927|642085|P3|Period 1|Took prohibited medication|0
187577|NCT00420927|642086|P2|Period 1|Took prohibited medication|3
187578|NCT00420927|642087|P1|Period 1|Took prohibited medication|1
187579|NCT00420927|642081|P7|Period 1|Failed to meet entry criteria|0
187580|NCT00420927|642082|P6|Period 1|Failed to meet entry criteria|0
187581|NCT00420927|642083|P5|Period 1|Failed to meet entry criteria|0
187582|NCT00420927|642084|P4|Period 1|Failed to meet entry criteria|0
187583|NCT00420927|642085|P3|Period 1|Failed to meet entry criteria|0
187584|NCT00420927|642086|P2|Period 1|Failed to meet entry criteria|7
187585|NCT00420927|642087|P1|Period 1|Failed to meet entry criteria|8
187586|NCT00420927|642081|P7|Period 1|Received wrong treatment/incorrect dose|0
187587|NCT00420927|642082|P6|Period 1|Received wrong treatment/incorrect dose|0
187588|NCT00420927|642083|P5|Period 1|Received wrong treatment/incorrect dose|0
187589|NCT00420927|642084|P4|Period 1|Received wrong treatment/incorrect dose|0
187590|NCT00420927|642085|P3|Period 1|Received wrong treatment/incorrect dose|0
187591|NCT00420927|642086|P2|Period 1|Received wrong treatment/incorrect dose|1
187592|NCT00420927|642087|P1|Period 1|Received wrong treatment/incorrect dose|0
187593|NCT00420927|642081|P7|Period 1|Subject received new diagnosis|0
187594|NCT00420927|642082|P6|Period 1|Subject received new diagnosis|0
187595|NCT00420927|642083|P5|Period 1|Subject received new diagnosis|0
187596|NCT00420927|642084|P4|Period 1|Subject received new diagnosis|0
187597|NCT00420927|642085|P3|Period 1|Subject received new diagnosis|0
187598|NCT00420927|642086|P2|Period 1|Subject received new diagnosis|2
187599|NCT00420927|642087|P1|Period 1|Subject received new diagnosis|0
187600|NCT00420927|642081|P7|Period 1|Study site closure|0
187601|NCT00420927|642082|P6|Period 1|Study site closure|0
187602|NCT00420927|642083|P5|Period 1|Study site closure|0
187603|NCT00420927|642084|P4|Period 1|Study site closure|0
187604|NCT00420927|642085|P3|Period 1|Study site closure|0
187605|NCT00420927|642086|P2|Period 1|Study site closure|1
187606|NCT00420927|642087|P1|Period 1|Study site closure|0
187607|NCT00420927|642081|P7|Period 1|Suspected tuberculosis/positive test|0
187608|NCT00420927|642082|P6|Period 1|Suspected tuberculosis/positive test|0
187609|NCT00420927|642083|P5|Period 1|Suspected tuberculosis/positive test|0
187610|NCT00420927|642084|P4|Period 1|Suspected tuberculosis/positive test|0
187611|NCT00420927|642085|P3|Period 1|Suspected tuberculosis/positive test|0
187612|NCT00420927|642086|P2|Period 1|Suspected tuberculosis/positive test|1
187613|NCT00420927|642087|P1|Period 1|Suspected tuberculosis/positive test|1
187614|NCT00420927|642081|P7|Period 1|Randomization error|0
187615|NCT00420927|642082|P6|Period 1|Randomization error|0
187616|NCT00420927|642083|P5|Period 1|Randomization error|0
187617|NCT00420927|642084|P4|Period 1|Randomization error|0
187618|NCT00420927|642085|P3|Period 1|Randomization error|0
187619|NCT00420927|642086|P2|Period 1|Randomization error|0
187620|NCT00420927|642087|P1|Period 1|Randomization error|1
187621|NCT00420927|642081|P7|Period 1|Noncompliant with study drug|0
187622|NCT00420927|642082|P6|Period 1|Noncompliant with study drug|0
187623|NCT00420927|642083|P5|Period 1|Noncompliant with study drug|0
187624|NCT00420927|642084|P4|Period 1|Noncompliant with study drug|0
187625|NCT00420927|642085|P3|Period 1|Noncompliant with study drug|0
187626|NCT00420927|642086|P2|Period 1|Noncompliant with study drug|1
187627|NCT00420927|642087|P1|Period 1|Noncompliant with study drug|1
187628|NCT00420927|642081|P7|Period 1|Subject moved/relocated|0
187629|NCT00420927|642082|P6|Period 1|Subject moved/relocated|0
187630|NCT00420927|642083|P5|Period 1|Subject moved/relocated|0
187631|NCT00420927|642084|P4|Period 1|Subject moved/relocated|0
187632|NCT00420927|642085|P3|Period 1|Subject moved/relocated|0
187633|NCT00420927|642086|P2|Period 1|Subject moved/relocated|2
187634|NCT00420927|642087|P1|Period 1|Subject moved/relocated|0
187635|NCT00420927|642081|P7|Period 1|Death|0
187636|NCT00420927|642082|P6|Period 1|Death|0
187637|NCT00420927|642083|P5|Period 1|Death|0
187638|NCT00420927|642084|P4|Period 1|Death|0
187639|NCT00420927|642085|P3|Period 1|Death|0
187640|NCT00420927|642086|P2|Period 1|Death|0
187641|NCT00420927|642087|P1|Period 1|Death|2
187642|NCT00420927|642081|P7|Period 1|Lack of efficacy/Loss of efficacy|0
187643|NCT00420927|642082|P6|Period 1|Lack of efficacy/Loss of efficacy|0
187644|NCT00420927|642083|P5|Period 1|Lack of efficacy/Loss of efficacy|0
187645|NCT00420927|642084|P4|Period 1|Lack of efficacy/Loss of efficacy|0
187646|NCT00420927|642085|P3|Period 1|Lack of efficacy/Loss of efficacy|0
187647|NCT00420927|642086|P2|Period 1|Lack of efficacy/Loss of efficacy|6
187648|NCT00420927|642087|P1|Period 1|Lack of efficacy/Loss of efficacy|1
187649|NCT00420927|642081|P7|Period 1|Lost to Follow-up|0
187650|NCT00420927|642082|P6|Period 1|Lost to Follow-up|0
187651|NCT00420927|642083|P5|Period 1|Lost to Follow-up|0
187652|NCT00420927|642084|P4|Period 1|Lost to Follow-up|0
187653|NCT00420927|642085|P3|Period 1|Lost to Follow-up|0
187654|NCT00420927|642086|P2|Period 1|Lost to Follow-up|6
187655|NCT00420927|642087|P1|Period 1|Lost to Follow-up|8
187656|NCT00420927|642081|P7|Period 1|Withdrawal by Subject|0
187657|NCT00420927|642082|P6|Period 1|Withdrawal by Subject|0
187658|NCT00420927|642083|P5|Period 1|Withdrawal by Subject|0
187659|NCT00420927|642084|P4|Period 1|Withdrawal by Subject|0
187660|NCT00420927|642085|P3|Period 1|Withdrawal by Subject|0
187661|NCT00420927|642086|P2|Period 1|Withdrawal by Subject|12
187662|NCT00420927|642087|P1|Period 1|Withdrawal by Subject|7
187663|NCT00420927|642081|P7|Period 1|Adverse Event|0
187664|NCT00420927|642082|P6|Period 1|Adverse Event|0
187665|NCT00420927|642083|P5|Period 1|Adverse Event|0
187666|NCT00420927|642084|P4|Period 1|Adverse Event|0
187667|NCT00420927|642085|P3|Period 1|Adverse Event|0
187668|NCT00420927|642086|P2|Period 1|Adverse Event|15
187669|NCT00420927|642087|P1|Period 1|Adverse Event|19
187670|NCT00420849|642191|P1|Overall Study|Lost to Follow-up|1
187671|NCT00420849|642191|P1|Overall Study|Protocol Violation|1
187672|NCT00420849|642191|P1|Overall Study|Transplant|8
187673|NCT00420849|642191|P1|Overall Study|Not specified|14
187674|NCT00420849|642191|P1|Overall Study|Death|18
187675|NCT00420849|642191|P1|Overall Study|Withdrawal by Subject|28
187676|NCT00420849|642191|P1|Overall Study|Adverse Event|107
187677|NCT00420849|642191|P1|Overall Study|Lack of Efficacy|154
187678|NCT00420784|642260|P4|Overall Study|Other|5
187679|NCT00420784|642261|P3|Overall Study|Other|0
187680|NCT00420784|642262|P2|Overall Study|Other|2
187681|NCT00420784|642263|P1|Overall Study|Other|1
187682|NCT00420784|642260|P4|Overall Study|Virologic Stopping Rule|67
187683|NCT00420784|642261|P3|Overall Study|Virologic Stopping Rule|41
187684|NCT00420784|642262|P2|Overall Study|Virologic Stopping Rule|26
187685|NCT00420784|642263|P1|Overall Study|Virologic Stopping Rule|17
187686|NCT00420784|642260|P4|Overall Study|Lost to Follow-up|1
187687|NCT00420784|642261|P3|Overall Study|Lost to Follow-up|2
187688|NCT00420784|642262|P2|Overall Study|Lost to Follow-up|0
187689|NCT00420784|642263|P1|Overall Study|Lost to Follow-up|0
187690|NCT00420784|642260|P4|Overall Study|Withdrawal by Subject|0
187691|NCT00420784|642261|P3|Overall Study|Withdrawal by Subject|0
187692|NCT00420784|642262|P2|Overall Study|Withdrawal by Subject|1
187693|NCT00420784|642263|P1|Overall Study|Withdrawal by Subject|0
187694|NCT00420784|642260|P4|Overall Study|Adverse Event|5
187695|NCT00420784|642261|P3|Overall Study|Adverse Event|10
187696|NCT00420784|642262|P2|Overall Study|Adverse Event|29
187697|NCT00420784|642263|P1|Overall Study|Adverse Event|11
187698|NCT00420745|642292|P2|Overall Study|Age limit exceeded for Dose 2|0
187699|NCT00420745|642293|P1|Overall Study|Age limit exceeded for Dose 2|1
187700|NCT00420745|642292|P2|Overall Study|Recurrent pneumonia & bronchitis|1
187701|NCT00420745|642293|P1|Overall Study|Recurrent pneumonia & bronchitis|0
187702|NCT00420745|642292|P2|Overall Study|Physician Decision|1
187703|NCT00420745|642293|P1|Overall Study|Physician Decision|1
187704|NCT00420745|642292|P2|Overall Study|Protocol Violation|0
187705|NCT00420745|642293|P1|Overall Study|Protocol Violation|1
187706|NCT00420745|642292|P2|Overall Study|Lost to Follow-up|2
187707|NCT00420745|642293|P1|Overall Study|Lost to Follow-up|10
187708|NCT00420745|642292|P2|Overall Study|Adverse Event|2
187709|NCT00420745|642293|P1|Overall Study|Adverse Event|2
187710|NCT00420641|642312|P3|Overall Study|Other|3
187711|NCT00420641|642313|P2|Overall Study|Other|4
187712|NCT00420641|642314|P1|Overall Study|Other|4
187713|NCT00420641|642312|P3|Overall Study|Non-compliance|4
187714|NCT00420641|642313|P2|Overall Study|Non-compliance|5
187715|NCT00420641|642314|P1|Overall Study|Non-compliance|7
187716|NCT00420641|642312|P3|Overall Study|Lack of Efficacy|4
187717|NCT00420641|642313|P2|Overall Study|Lack of Efficacy|5
187718|NCT00420641|642314|P1|Overall Study|Lack of Efficacy|6
187719|NCT00420641|642312|P3|Overall Study|Withdrawal by Subject|14
187720|NCT00420641|642313|P2|Overall Study|Withdrawal by Subject|21
187721|NCT00420641|642314|P1|Overall Study|Withdrawal by Subject|15
187722|NCT00420641|642312|P3|Overall Study|Protocol Violation|7
187723|NCT00420641|642313|P2|Overall Study|Protocol Violation|8
187724|NCT00420641|642314|P1|Overall Study|Protocol Violation|8
187725|NCT00420641|642312|P3|Overall Study|Lost to Follow-up|2
187726|NCT00420641|642313|P2|Overall Study|Lost to Follow-up|4
187727|NCT00420641|642314|P1|Overall Study|Lost to Follow-up|2
187728|NCT00420641|642312|P3|Overall Study|Adverse Event|10
187729|NCT00420641|642313|P2|Overall Study|Adverse Event|25
187730|NCT00420641|642314|P1|Overall Study|Adverse Event|3
187731|NCT00420628|642390|P2|Overall Study|Adverse Event|0
187732|NCT00420628|642391|P1|Overall Study|Adverse Event|1
187733|NCT00420628|642390|P2|Overall Study|Lost to Follow-up|2
187734|NCT00420628|642391|P1|Overall Study|Lost to Follow-up|3
187735|NCT00420628|642390|P2|Overall Study|Withdrawn by parent or gaurdian|2
187736|NCT00420628|642391|P1|Overall Study|Withdrawn by parent or gaurdian|5
187737|NCT00420511|642407|P2|Overall Study|Lost to Follow-up|0
187738|NCT00420511|642408|P1|Overall Study|Lost to Follow-up|1
187739|NCT00420511|642407|P2|Overall Study|Adverse Event|1
187740|NCT00420511|642408|P1|Overall Study|Adverse Event|1
187741|NCT00420420|642429|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
187742|NCT00420420|642430|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
187743|NCT00420420|642429|P2|Overall Study|Withdrawal by Subject|0
187744|NCT00420420|642430|P1|Overall Study|Withdrawal by Subject|1
187745|NCT00420420|642429|P2|Overall Study|Protocol Violation|1
187746|NCT00420420|642430|P1|Overall Study|Protocol Violation|1
187747|NCT00420420|642429|P2|Overall Study|Adverse Event|3
187748|NCT00420420|642430|P1|Overall Study|Adverse Event|5
187749|NCT00420407|642448|P2|Overall Study|Withdrawal by Subject|2
187750|NCT00420407|642449|P1|Overall Study|Withdrawal by Subject|0
187751|NCT00420407|642448|P2|Overall Study|subject identified as Jehovah's witness|0
187752|NCT00420407|642449|P1|Overall Study|subject identified as Jehovah's witness|1
187753|NCT00420407|642448|P2|Overall Study|subject identified as detainee|0
187754|NCT00420407|642449|P1|Overall Study|subject identified as detainee|1
187755|NCT00420407|642448|P2|Overall Study|Physician Decision|1
187756|NCT00420407|642449|P1|Overall Study|Physician Decision|2
187757|NCT00420407|642448|P2|Overall Study|Lost to Follow-up|3
187758|NCT00420407|642449|P1|Overall Study|Lost to Follow-up|0
187759|NCT00420342|642458|P3|Overall Study|Withdrawal by Subject|0
187760|NCT00420342|642459|P2|Overall Study|Withdrawal by Subject|2
187761|NCT00420342|642460|P1|Overall Study|Withdrawal by Subject|0
187762|NCT00420342|642458|P3|Overall Study|Lost to Follow-up|1
187763|NCT00420342|642459|P2|Overall Study|Lost to Follow-up|0
187764|NCT00420342|642460|P1|Overall Study|Lost to Follow-up|1
187765|NCT00420316|642503|P2|Overall Study|Lost to Follow-up|8
187766|NCT00420316|642504|P1|Overall Study|Lost to Follow-up|12
187767|NCT00420316|642503|P2|Overall Study|Withdrawal by Subject|1
187768|NCT00420316|642504|P1|Overall Study|Withdrawal by Subject|0
187769|NCT00420303|642528|P2|Overall Study|Physician Decision|1
187770|NCT00420303|642529|P1|Overall Study|Physician Decision|0
187771|NCT00420303|642528|P2|Overall Study|Lack of Efficacy|3
187772|NCT00420303|642529|P1|Overall Study|Lack of Efficacy|0
187773|NCT00420303|642528|P2|Overall Study|Serious Adverse Event|0
187774|NCT00420303|642529|P1|Overall Study|Serious Adverse Event|1
187775|NCT00420290|642541|P2|Overall Study|did not meet inclusion/exclusion|1
187776|NCT00420290|642542|P1|Overall Study|did not meet inclusion/exclusion|1
187777|NCT00420290|642541|P2|Overall Study|Withdrawal by Subject|2
187778|NCT00420290|642542|P1|Overall Study|Withdrawal by Subject|0
187779|NCT00420290|642541|P2|Overall Study|Adverse Event|1
187780|NCT00420290|642542|P1|Overall Study|Adverse Event|3
187781|NCT00420238|642558|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
187782|NCT00420238|642559|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
187783|NCT00420238|642558|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
187784|NCT00420238|642559|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
187785|NCT00420238|642558|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
187786|NCT00420238|642559|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
187787|NCT00420238|642558|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
187788|NCT00420238|642559|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
187789|NCT00420238|642558|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
187790|NCT00420238|642559|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
187791|NCT00420238|642558|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
187792|NCT00420238|642559|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
187793|NCT00420212|642698|P3|Overall Study|Other-Unspecified|18
187794|NCT00420212|642699|P2|Overall Study|Other-Unspecified|14
187795|NCT00420212|642700|P1|Overall Study|Other-Unspecified|21
187796|NCT00420212|642698|P3|Overall Study|Death|1
187797|NCT00420212|642699|P2|Overall Study|Death|0
187798|NCT00420212|642700|P1|Overall Study|Death|0
187799|NCT00420212|642698|P3|Overall Study|Protocol Violation|8
187800|NCT00420212|642699|P2|Overall Study|Protocol Violation|4
187801|NCT00420212|642700|P1|Overall Study|Protocol Violation|4
187802|NCT00420212|642698|P3|Overall Study|Physician Decision|3
187803|NCT00420212|642699|P2|Overall Study|Physician Decision|4
187804|NCT00420212|642700|P1|Overall Study|Physician Decision|4
187805|NCT00420212|642698|P3|Overall Study|Withdrawal by Subject|19
187806|NCT00420212|642699|P2|Overall Study|Withdrawal by Subject|22
187807|NCT00420212|642700|P1|Overall Study|Withdrawal by Subject|31
187808|NCT00420212|642698|P3|Overall Study|Lost to Follow-up|11
187809|NCT00420212|642699|P2|Overall Study|Lost to Follow-up|11
187810|NCT00420212|642700|P1|Overall Study|Lost to Follow-up|9
187811|NCT00420212|642698|P3|Overall Study|Adverse Event|36
187812|NCT00420212|642699|P2|Overall Study|Adverse Event|40
187813|NCT00420212|642700|P1|Overall Study|Adverse Event|22
187814|NCT00420199|642726|P2|Overall Study|Participant no longer met study criteria|0
187815|NCT00420199|642727|P1|Overall Study|Participant no longer met study criteria|1
187816|NCT00420095|642793|P2|Overall Study|Lost to Follow-up|0
187817|NCT00420095|642794|P1|Overall Study|Lost to Follow-up|1
187818|NCT00420095|642793|P2|Overall Study|Protocol Violation|1
187819|NCT00420095|642794|P1|Overall Study|Protocol Violation|1
187820|NCT00420095|642793|P2|Overall Study|Adverse Event|0
187821|NCT00420095|642794|P1|Overall Study|Adverse Event|1
187822|NCT00420056|642812|P1|Overall Study|Objective progression or relapse|17
187823|NCT00420004|642852|P3|Overall Study|Sponsor Decision|1
187824|NCT00420004|642853|P2|Overall Study|Sponsor Decision|3
187825|NCT00420004|642854|P1|Overall Study|Sponsor Decision|3
187826|NCT00420004|642852|P3|Overall Study|Withdrawal by Subject|14
187827|NCT00420004|642853|P2|Overall Study|Withdrawal by Subject|42
187828|NCT00420004|642854|P1|Overall Study|Withdrawal by Subject|67
187829|NCT00420004|642852|P3|Overall Study|Protocol Violation|3
187830|NCT00420004|642853|P2|Overall Study|Protocol Violation|4
187831|NCT00420004|642854|P1|Overall Study|Protocol Violation|5
187832|NCT00420004|642852|P3|Overall Study|Physician Decision|2
187833|NCT00420004|642853|P2|Overall Study|Physician Decision|4
187834|NCT00420004|642854|P1|Overall Study|Physician Decision|14
187835|NCT00420004|642852|P3|Overall Study|Entry Criteria Not Met|0
187836|NCT00420004|642853|P2|Overall Study|Entry Criteria Not Met|1
187837|NCT00420004|642854|P1|Overall Study|Entry Criteria Not Met|0
187838|NCT00420004|642852|P3|Overall Study|Lost to Follow-up|10
187839|NCT00420004|642853|P2|Overall Study|Lost to Follow-up|12
187840|NCT00420004|642854|P1|Overall Study|Lost to Follow-up|31
187841|NCT00420004|642852|P3|Overall Study|Lack of Efficacy|1
187842|NCT00420004|642853|P2|Overall Study|Lack of Efficacy|4
187843|NCT00420004|642854|P1|Overall Study|Lack of Efficacy|5
187844|NCT00420004|642852|P3|Overall Study|Adverse Event|1
187845|NCT00420004|642853|P2|Overall Study|Adverse Event|1
187846|NCT00420004|642854|P1|Overall Study|Adverse Event|4
187847|NCT00419952|642919|P2|Overall Study|Abnormal ECG|0
187848|NCT00419952|642920|P1|Overall Study|Abnormal ECG|1
187849|NCT00419952|642919|P2|Overall Study|Diary or medication non-compliance|4
187850|NCT00419952|642920|P1|Overall Study|Diary or medication non-compliance|2
187851|NCT00419952|642919|P2|Overall Study|Occurence of 2 or more exacerbations|0
187852|NCT00419952|642920|P1|Overall Study|Occurence of 2 or more exacerbations|2
187853|NCT00419952|642919|P2|Overall Study|Intake of prohibited medication|2
187854|NCT00419952|642920|P1|Overall Study|Intake of prohibited medication|2
187855|NCT00419952|642919|P2|Overall Study|Incorrectly enrolled|3
187856|NCT00419952|642920|P1|Overall Study|Incorrectly enrolled|10
187857|NCT00419952|642919|P2|Overall Study|Physician Decision|3
187858|NCT00419952|642920|P1|Overall Study|Physician Decision|1
187859|NCT00419952|642919|P2|Overall Study|Pregnancy|2
187860|NCT00419952|642920|P1|Overall Study|Pregnancy|4
187861|NCT00419952|642919|P2|Overall Study|Protocol Violation|24
187862|NCT00419952|642920|P1|Overall Study|Protocol Violation|32
187863|NCT00419952|642919|P2|Overall Study|Lost to Follow-up|34
187864|NCT00419952|642920|P1|Overall Study|Lost to Follow-up|43
187865|NCT00419952|642919|P2|Overall Study|Withdrawal by Subject|43
187866|NCT00419952|642920|P1|Overall Study|Withdrawal by Subject|44
187867|NCT00419952|642919|P2|Overall Study|Adverse Event|10
187868|NCT00419952|642920|P1|Overall Study|Adverse Event|8
187869|NCT00419926|642954|P2|Overall Study|Death|1
187870|NCT00419926|642955|P1|Overall Study|Death|2
187871|NCT00419926|642954|P2|Overall Study|Lost to Follow-up|2
187872|NCT00419926|642955|P1|Overall Study|Lost to Follow-up|1
187873|NCT00419926|642954|P2|Overall Study|Administrative Problem|4
187874|NCT00419926|642955|P1|Overall Study|Administrative Problem|4
187875|NCT00419926|642954|P2|Overall Study|Withdrawal by Subject|3
187876|NCT00419926|642955|P1|Overall Study|Withdrawal by Subject|7
187877|NCT00419770|642971|P2|Overall Study|Withdrawal by Subject|1
187878|NCT00419770|642972|P1|Overall Study|Withdrawal by Subject|5
187879|NCT00419757|642980|P2|Overall Study|Multiple reasons|1
187880|NCT00419757|642981|P1|Overall Study|Multiple reasons|3
187881|NCT00419757|642980|P2|Overall Study|Study specific discontinuation criteria|8
187882|NCT00419757|642981|P1|Overall Study|Study specific discontinuation criteria|4
187883|NCT00419757|642980|P2|Overall Study|Protocol Violation|3
187884|NCT00419757|642981|P1|Overall Study|Protocol Violation|2
187885|NCT00419757|642980|P2|Overall Study|Withdrawal by Subject|1
187886|NCT00419757|642981|P1|Overall Study|Withdrawal by Subject|7
187887|NCT00419757|642980|P2|Overall Study|Lost to Follow-up|4
187888|NCT00419757|642981|P1|Overall Study|Lost to Follow-up|1
187889|NCT00419757|642980|P2|Overall Study|Adverse Event|4
187890|NCT00419757|642981|P1|Overall Study|Adverse Event|1
187891|NCT00419744|643020|P3|Overall Study|Incorrect medication kit dispensed|1
187892|NCT00419744|643021|P2|Overall Study|Incorrect medication kit dispensed|0
187893|NCT00419744|643022|P1|Overall Study|Incorrect medication kit dispensed|0
187894|NCT00419744|643020|P3|Overall Study|Spirometry mouthpiece issues|2
187895|NCT00419744|643021|P2|Overall Study|Spirometry mouthpiece issues|1
187896|NCT00419744|643022|P1|Overall Study|Spirometry mouthpiece issues|0
187897|NCT00419744|643020|P3|Overall Study|Physician Decision|6
187898|NCT00419744|643021|P2|Overall Study|Physician Decision|5
187899|NCT00419744|643022|P1|Overall Study|Physician Decision|10
187900|NCT00419744|643020|P3|Overall Study|Moving out of state|1
187901|NCT00419744|643021|P2|Overall Study|Moving out of state|0
187902|NCT00419744|643022|P1|Overall Study|Moving out of state|2
187903|NCT00419744|643020|P3|Overall Study|Randomized in error|7
187904|NCT00419744|643021|P2|Overall Study|Randomized in error|6
187905|NCT00419744|643022|P1|Overall Study|Randomized in error|9
187906|NCT00419744|643020|P3|Overall Study|Protocol Violation|8
187907|NCT00419744|643021|P2|Overall Study|Protocol Violation|7
187908|NCT00419744|643022|P1|Overall Study|Protocol Violation|4
187909|NCT00419744|643020|P3|Overall Study|Lost to Follow-up|6
187910|NCT00419744|643021|P2|Overall Study|Lost to Follow-up|10
187911|NCT00419744|643022|P1|Overall Study|Lost to Follow-up|8
187912|NCT00419744|643020|P3|Overall Study|Withdrawal by Subject|52
187913|NCT00419744|643021|P2|Overall Study|Withdrawal by Subject|49
187914|NCT00419744|643022|P1|Overall Study|Withdrawal by Subject|45
187915|NCT00419744|643020|P3|Overall Study|Adverse Event|50
187916|NCT00419744|643021|P2|Overall Study|Adverse Event|40
187917|NCT00419744|643022|P1|Overall Study|Adverse Event|39
187918|NCT00419393|643064|P1|Overall Study|Other: Investigator decision|1
187919|NCT00419393|643064|P1|Overall Study|Other: Other health problems|1
187920|NCT00419393|643064|P1|Overall Study|Other: Site closure|1
187921|NCT00419393|643064|P1|Overall Study|Other: Subject had temporal lobectomy|1
187922|NCT00419393|643064|P1|Overall Study|Other: Sponsor request|3
187923|NCT00419393|643064|P1|Overall Study|Withdrawal by Subject|7
187924|NCT00419393|643064|P1|Overall Study|Protocol Violation|5
187925|NCT00419393|643064|P1|Overall Study|Adverse Event|5
187926|NCT00419380|643074|P2|Overall Study|Withdrawal by Subject|1
187927|NCT00419380|643075|P1|Overall Study|Withdrawal by Subject|0
187928|NCT00419380|643074|P2|Overall Study|Lost to Follow-up|1
187929|NCT00419380|643075|P1|Overall Study|Lost to Follow-up|0
187930|NCT00419380|643074|P2|Overall Study|Physician Decision|1
187931|NCT00419380|643075|P1|Overall Study|Physician Decision|0
187932|NCT00419380|643074|P2|Overall Study|Lack of Efficacy|7
187933|NCT00419380|643075|P1|Overall Study|Lack of Efficacy|1
187934|NCT00419341|643083|P1|Efficacy Period|Termination of study site|1
187935|NCT00419341|643083|P1|Efficacy Period|Non-compliance|1
187936|NCT00419341|643083|P1|Efficacy Period|Lost to Follow-up|1
187937|NCT00419341|643083|P1|Efficacy Period|Protocol Violation|1
187938|NCT00419341|643083|P1|Efficacy Period|Withdrawal by Subject|6
187939|NCT00419341|643083|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
187940|NCT00419341|643083|P1|Wash in/Wash Out Period|Adverse Event|2
187941|NCT00419341|643083|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
187942|NCT00419263|643118|P3|Overall Study|Withdrawal by Subject|1
187943|NCT00419263|643119|P2|Overall Study|Withdrawal by Subject|0
187944|NCT00419263|643120|P1|Overall Study|Withdrawal by Subject|0
187945|NCT00419263|643118|P3|Overall Study|Adverse Event|1
187946|NCT00419263|643119|P2|Overall Study|Adverse Event|0
187947|NCT00419263|643120|P1|Overall Study|Adverse Event|0
187948|NCT00419263|643118|P3|Overall Study|Randomized in Error, Not Treated|0
187949|NCT00419263|643119|P2|Overall Study|Randomized in Error, Not Treated|1
187950|NCT00419263|643120|P1|Overall Study|Randomized in Error, Not Treated|1
187951|NCT00419263|643118|P3|Overall Study|Lost to Follow-up|1
187952|NCT00419263|643119|P2|Overall Study|Lost to Follow-up|1
187953|NCT00419263|643120|P1|Overall Study|Lost to Follow-up|2
187954|NCT00419159|643149|P2|Overall Study|Disease progression|76
187955|NCT00419159|643150|P1|Overall Study|Disease progression|79
187956|NCT00419159|643149|P2|Overall Study|Death|2
187957|NCT00419159|643150|P1|Overall Study|Death|2
187958|NCT00419159|643149|P2|Overall Study|Lost to Follow-up|1
187959|NCT00419159|643150|P1|Overall Study|Lost to Follow-up|0
187960|NCT00419159|643149|P2|Overall Study|Withdrawal by Subject|3
187961|NCT00419159|643150|P1|Overall Study|Withdrawal by Subject|10
187962|NCT00419159|643149|P2|Overall Study|Protocol Violation|0
187963|NCT00419159|643150|P1|Overall Study|Protocol Violation|1
187964|NCT00419159|643149|P2|Overall Study|Subject's no longer requires study drug|1
187965|NCT00419159|643150|P1|Overall Study|Subject's no longer requires study drug|0
187966|NCT00419159|643149|P2|Overall Study|Abnormal laboratory value(s)|2
187967|NCT00419159|643150|P1|Overall Study|Abnormal laboratory value(s)|0
187968|NCT00419159|643149|P2|Overall Study|Adverse Event|15
187969|NCT00419159|643150|P1|Overall Study|Adverse Event|7
187970|NCT00419120|643164|P1|Long Term Follow up Period|study ongoing|10
187971|NCT00419094|643171|P2|Overall Study|Other: No contact for extended period|1
187972|NCT00419094|643172|P1|Overall Study|Other: No contact for extended period|0
187973|NCT00419094|643171|P2|Overall Study|Other: Patient non-compliant|1
187974|NCT00419094|643172|P1|Overall Study|Other: Patient non-compliant|0
187975|NCT00419094|643171|P2|Overall Study|Other: Error determining exit criteria|0
187976|NCT00419094|643172|P1|Overall Study|Other: Error determining exit criteria|1
187977|NCT00419094|643171|P2|Overall Study|Withdrawal of consent|5
187978|NCT00419094|643172|P1|Overall Study|Withdrawal of consent|1
187979|NCT00419094|643171|P2|Overall Study|Protocol Violation|14
187980|NCT00419094|643172|P1|Overall Study|Protocol Violation|1
187981|NCT00419094|643171|P2|Overall Study|Lost to Follow-up|2
187982|NCT00419094|643172|P1|Overall Study|Lost to Follow-up|0
187983|NCT00419094|643171|P2|Overall Study|Lack of Efficacy|0
187984|NCT00419094|643172|P1|Overall Study|Lack of Efficacy|1
187985|NCT00419094|643171|P2|Overall Study|Adverse Event|7
187986|NCT00419094|643172|P1|Overall Study|Adverse Event|3
187987|NCT00419003|643186|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
187988|NCT00419003|643187|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
187989|NCT00419003|643186|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
187990|NCT00419003|643187|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
187991|NCT00418938|643241|P2|Overall Study|Ineligibility Determined|0
187992|NCT00418938|643242|P1|Overall Study|Ineligibility Determined|1
187993|NCT00418938|643241|P2|Overall Study|On-going|1
187994|NCT00418938|643242|P1|Overall Study|On-going|1
187995|NCT00418938|643241|P2|Overall Study|Adverse Event|1
187996|NCT00418938|643242|P1|Overall Study|Adverse Event|1
187997|NCT00418938|643241|P2|Overall Study|Lost to Follow-up|3
187998|NCT00418938|643242|P1|Overall Study|Lost to Follow-up|1
187999|NCT00418938|643241|P2|Overall Study|Withdrawal by Subject|15
188000|NCT00418938|643242|P1|Overall Study|Withdrawal by Subject|16
188001|NCT00418938|643241|P2|Overall Study|Administrative decision|3
188002|NCT00418938|643242|P1|Overall Study|Administrative decision|3
188003|NCT00418938|643241|P2|Overall Study|Reimbursement|0
188004|NCT00418938|643242|P1|Overall Study|Reimbursement|1
188005|NCT00418886|643262|P2|Overall Study|randomised but no treatment received|1
188006|NCT00418886|643263|P1|Overall Study|randomised but no treatment received|0
188007|NCT00418886|643262|P2|Overall Study|withdrawn due to other reason|0
188008|NCT00418886|643263|P1|Overall Study|withdrawn due to other reason|1
188009|NCT00418886|643262|P2|Overall Study|Lost to Follow-up|6
188010|NCT00418886|643263|P1|Overall Study|Lost to Follow-up|4
188011|NCT00418886|643262|P2|Overall Study|Withdrawal by Subject|10
188012|NCT00418886|643263|P1|Overall Study|Withdrawal by Subject|9
188013|NCT00418886|643262|P2|Overall Study|Death|147
188014|NCT00418886|643263|P1|Overall Study|Death|122
188015|NCT00418886|643262|P2|Overall Study|discontinue treatment survival follow up|91
188016|NCT00418886|643263|P1|Overall Study|discontinue treatment survival follow up|90
188017|NCT00418834|643289|P2|Overall Study|Withdrawal by Subject|7
188018|NCT00418834|643290|P1|Overall Study|Withdrawal by Subject|3
188019|NCT00418834|643289|P2|Overall Study|Protocol Violation|3
188020|NCT00418834|643290|P1|Overall Study|Protocol Violation|4
188021|NCT00418834|643289|P2|Overall Study|Lost to Follow-up|1
188022|NCT00418834|643290|P1|Overall Study|Lost to Follow-up|0
188023|NCT00418834|643289|P2|Overall Study|Adverse Event|9
188024|NCT00418834|643290|P1|Overall Study|Adverse Event|16
188025|NCT00418717|643350|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
188026|NCT00418717|643350|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
188027|NCT00418691|643358|P3|Overall Study|Progressive Disease|1
188028|NCT00418691|643359|P2|Overall Study|Progressive Disease|0
188029|NCT00418691|643360|P1|Overall Study|Progressive Disease|1
188030|NCT00418691|643358|P3|Overall Study|Started new medication voiding entry|1
188031|NCT00418691|643359|P2|Overall Study|Started new medication voiding entry|0
188032|NCT00418691|643360|P1|Overall Study|Started new medication voiding entry|0
188033|NCT00418691|643358|P3|Overall Study|Lost to Follow-up|3
188034|NCT00418691|643359|P2|Overall Study|Lost to Follow-up|2
188035|NCT00418691|643360|P1|Overall Study|Lost to Follow-up|1
188036|NCT00418665|643371|P3|Treatment Extension|Death|1
188037|NCT00418665|643372|P2|Treatment Extension|Death|0
188038|NCT00418665|643373|P1|Treatment Extension|Death|0
188039|NCT00418665|643371|P3|Treatment Extension|Physician Decision|1
188040|NCT00418665|643372|P2|Treatment Extension|Physician Decision|2
188041|NCT00418665|643373|P1|Treatment Extension|Physician Decision|2
188042|NCT00418665|643371|P3|Treatment Extension|Requirement for alternative therapy|0
188043|NCT00418665|643372|P2|Treatment Extension|Requirement for alternative therapy|2
188044|NCT00418665|643373|P1|Treatment Extension|Requirement for alternative therapy|2
188045|NCT00418665|643371|P3|Treatment Extension|Withdrawal by Subject|0
188046|NCT00418665|643372|P2|Treatment Extension|Withdrawal by Subject|0
188047|NCT00418665|643373|P1|Treatment Extension|Withdrawal by Subject|1
188048|NCT00418665|643371|P3|Treatment Extension|Adverse Event|0
188049|NCT00418665|643372|P2|Treatment Extension|Adverse Event|0
188050|NCT00418665|643373|P1|Treatment Extension|Adverse Event|1
188051|NCT00418665|643371|P3|Treatment Period|Physician Decision|3
188052|NCT00418665|643372|P2|Treatment Period|Physician Decision|0
188053|NCT00418665|643373|P1|Treatment Period|Physician Decision|1
188054|NCT00418665|643371|P3|Treatment Period|Requirement for alternative therapy|0
188055|NCT00418665|643372|P2|Treatment Period|Requirement for alternative therapy|0
188056|NCT00418665|643373|P1|Treatment Period|Requirement for alternative therapy|1
188057|NCT00418665|643371|P3|Treatment Period|Withdrawal by Subject|1
188058|NCT00418665|643372|P2|Treatment Period|Withdrawal by Subject|3
188059|NCT00418665|643373|P1|Treatment Period|Withdrawal by Subject|0
188060|NCT00418665|643371|P3|Treatment Period|Adverse Event|0
188061|NCT00418665|643372|P2|Treatment Period|Adverse Event|2
188062|NCT00418665|643373|P1|Treatment Period|Adverse Event|2
188063|NCT00418665|643371|P3|Treatment Period|Ineligibility determined|0
188064|NCT00418665|643372|P2|Treatment Period|Ineligibility determined|1
188065|NCT00418665|643373|P1|Treatment Period|Ineligibility determined|1
188066|NCT00418561|643407|P3|Overall Study|Participant's (guardian's) decision|0
188067|NCT00418561|643408|P2|Overall Study|Participant's (guardian's) decision|1
188068|NCT00418561|643409|P1|Overall Study|Participant's (guardian's) decision|0
188069|NCT00418522|643479|P2|Overall Study|Randomized but did not receive treatment|4
188070|NCT00418522|643480|P1|Overall Study|Randomized but did not receive treatment|7
188071|NCT00418522|643479|P2|Overall Study|Other|23
188072|NCT00418522|643480|P1|Overall Study|Other|27
188073|NCT00418522|643479|P2|Overall Study|Withdrawal by Subject|7
188074|NCT00418522|643480|P1|Overall Study|Withdrawal by Subject|31
188075|NCT00418522|643479|P2|Overall Study|Lost to Follow-up|4
188076|NCT00418522|643480|P1|Overall Study|Lost to Follow-up|10
188077|NCT00418522|643479|P2|Overall Study|Lack of Efficacy|3
188078|NCT00418522|643480|P1|Overall Study|Lack of Efficacy|1
188079|NCT00418522|643479|P2|Overall Study|Adverse Event|1
188080|NCT00418522|643480|P1|Overall Study|Adverse Event|7
188081|NCT00418379|643527|P3|Year 5|Any other reason not above-mentioned|3
188082|NCT00418379|643528|P2|Year 5|Any other reason not above-mentioned|4
188083|NCT00418379|643529|P1|Year 5|Any other reason not above-mentioned|2
188084|NCT00418379|643527|P3|Year 5|Adverse Event|0
188085|NCT00418379|643528|P2|Year 5|Adverse Event|1
188086|NCT00418379|643529|P1|Year 5|Adverse Event|0
188087|NCT00418379|643527|P3|Year 4|Any other reason not above-mentioned|0
188088|NCT00418379|643528|P2|Year 4|Any other reason not above-mentioned|1
188089|NCT00418379|643529|P1|Year 4|Any other reason not above-mentioned|1
188090|NCT00418379|643527|P3|Year 4|Withdrawal by Subject|2
188091|NCT00418379|643528|P2|Year 4|Withdrawal by Subject|3
188092|NCT00418379|643529|P1|Year 4|Withdrawal by Subject|2
188093|NCT00418379|643527|P3|Year 4|Adverse Event|0
188094|NCT00418379|643528|P2|Year 4|Adverse Event|1
188095|NCT00418379|643529|P1|Year 4|Adverse Event|0
188096|NCT00418379|643527|P3|Year 3|Any other reason not above-mentioned|1
188097|NCT00418379|643528|P2|Year 3|Any other reason not above-mentioned|1
188098|NCT00418379|643529|P1|Year 3|Any other reason not above-mentioned|2
188099|NCT00418379|643527|P3|Year 3|Withdrawal by Subject|2
188100|NCT00418379|643528|P2|Year 3|Withdrawal by Subject|1
188101|NCT00418379|643529|P1|Year 3|Withdrawal by Subject|1
188102|NCT00418379|643527|P3|Year 2|Any other reason not above-mentioned|6
188103|NCT00418379|643528|P2|Year 2|Any other reason not above-mentioned|1
188104|NCT00418379|643529|P1|Year 2|Any other reason not above-mentioned|2
188105|NCT00418379|643527|P3|Year 2|Withdrawal by Subject|3
188106|NCT00418379|643528|P2|Year 2|Withdrawal by Subject|1
188107|NCT00418379|643529|P1|Year 2|Withdrawal by Subject|1
188108|NCT00418379|643527|P3|Year 2|Adverse Event|1
188109|NCT00418379|643528|P2|Year 2|Adverse Event|2
188110|NCT00418379|643529|P1|Year 2|Adverse Event|5
188111|NCT00418379|643527|P3|Year 1|Any other reason not above-mentioned|7
188112|NCT00418379|643528|P2|Year 1|Any other reason not above-mentioned|5
188113|NCT00418379|643529|P1|Year 1|Any other reason not above-mentioned|2
188114|NCT00418379|643527|P3|Year 1|Withdrawal by Subject|5
188115|NCT00418379|643528|P2|Year 1|Withdrawal by Subject|8
188116|NCT00418379|643529|P1|Year 1|Withdrawal by Subject|7
188117|NCT00418379|643527|P3|Year 1|Adverse Event|3
188118|NCT00418379|643528|P2|Year 1|Adverse Event|15
188119|NCT00418379|643529|P1|Year 1|Adverse Event|9
188120|NCT00418314|643539|P2|Overall Study|Withdrawal by Subject|2
188121|NCT00418314|643540|P1|Overall Study|Withdrawal by Subject|1
188122|NCT00418184|643570|P2|Double-blind Phase|Poor compliance|1
188123|NCT00418184|643571|P1|Double-blind Phase|Poor compliance|3
188124|NCT00418184|643570|P2|Double-blind Phase|Adverse Event|1
188125|NCT00418184|643571|P1|Double-blind Phase|Adverse Event|2
188126|NCT00418184|643570|P2|Double-blind Phase|Withdrawal by Subject|9
188127|NCT00418184|643571|P1|Double-blind Phase|Withdrawal by Subject|22
188128|NCT00418145|643579|P1|Overall Study|study terminated|6
188129|NCT00417989|643654|P2|Overall Study|Physician Decision|2
188130|NCT00417989|643655|P1|Overall Study|Physician Decision|5
188131|NCT00417989|643654|P2|Overall Study|Death|1
188132|NCT00417989|643655|P1|Overall Study|Death|0
188133|NCT00417989|643654|P2|Overall Study|Protocol Violation|0
188134|NCT00417989|643655|P1|Overall Study|Protocol Violation|1
188135|NCT00417989|643654|P2|Overall Study|Lost to Follow-up|6
188136|NCT00417989|643655|P1|Overall Study|Lost to Follow-up|1
188137|NCT00417989|643654|P2|Overall Study|Withdrawal by Subject|13
188138|NCT00417989|643655|P1|Overall Study|Withdrawal by Subject|13
188139|NCT00417976|643677|P1|Overall Study|Treatment -related toxicity|2
188140|NCT00417976|643677|P1|Overall Study|Non compliance unrelated to toxicity|1
188141|NCT00417963|643682|P1|Overall Study|Study device could not be deployed|3
188142|NCT00417963|643682|P1|Overall Study|Death|17
188143|NCT00417963|643682|P1|Overall Study|Withdrawal by Subject|18
188144|NCT00417963|643682|P1|Overall Study|Lost to Follow-up|3
188145|NCT00417885|643699|P1|Overall Study|Transferred to Another Sunitinib Study|2
188146|NCT00417885|643699|P1|Overall Study|Objective Progression or Relapse|3
188147|NCT00417885|643699|P1|Overall Study|Adverse Event|1
188148|NCT00417612|643710|P2|Overall Study|Lost to Follow-up|0
188149|NCT00417612|643711|P1|Overall Study|Lost to Follow-up|1
188150|NCT00417612|643710|P2|Overall Study|Protocol Violation|2
188151|NCT00417612|643711|P1|Overall Study|Protocol Violation|0
188152|NCT00417612|643710|P2|Overall Study|Adverse Event|0
188153|NCT00417612|643711|P1|Overall Study|Adverse Event|2
188154|NCT00417612|643710|P2|Overall Study|Errant diagnosis|1
188155|NCT00417612|643711|P1|Overall Study|Errant diagnosis|0
188156|NCT00417482|643737|P3|Phase B 2nd 16 Weeks|Death|0
188157|NCT00417482|643738|P2|Phase B 2nd 16 Weeks|Death|1
188158|NCT00417482|643739|P1|Phase B 2nd 16 Weeks|Death|1
188159|NCT00417482|643737|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
188160|NCT00417482|643738|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
188161|NCT00417482|643739|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
188162|NCT00417482|643737|P3|Phase B 2nd 16 Weeks|Adverse Event|1
188163|NCT00417482|643738|P2|Phase B 2nd 16 Weeks|Adverse Event|0
188164|NCT00417482|643739|P1|Phase B 2nd 16 Weeks|Adverse Event|0
188165|NCT00417482|643737|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
188166|NCT00417482|643738|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
188167|NCT00417482|643739|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
188168|NCT00417482|643737|P3|Phase B 1st 16 Weeks|Death|0
188169|NCT00417482|643738|P2|Phase B 1st 16 Weeks|Death|0
188170|NCT00417482|643739|P1|Phase B 1st 16 Weeks|Death|1
188171|NCT00417482|643737|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
188172|NCT00417482|643738|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
188173|NCT00417482|643739|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
188174|NCT00417482|643737|P3|Phase B 1st 16 Weeks|Adverse Event|1
188175|NCT00417482|643738|P2|Phase B 1st 16 Weeks|Adverse Event|0
188176|NCT00417482|643739|P1|Phase B 1st 16 Weeks|Adverse Event|2
188177|NCT00417482|643737|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
188178|NCT00417482|643738|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
188179|NCT00417482|643739|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
188180|NCT00417248|643778|P1|Overall Study|Lack of Efficacy|1
188181|NCT00417248|643778|P1|Overall Study|Death|1
188182|NCT00417248|643778|P1|Overall Study|Study Terminated|6
188183|NCT00417170|643785|P2|Overall Study|Lost to Follow-up|1
188184|NCT00417170|643786|P1|Overall Study|Lost to Follow-up|0
188185|NCT00417170|643785|P2|Overall Study|Withdrawal by Subject|1
188186|NCT00417170|643786|P1|Overall Study|Withdrawal by Subject|1
188187|NCT00417170|643785|P2|Overall Study|Adverse Event|1
188188|NCT00417170|643786|P1|Overall Study|Adverse Event|1
188189|NCT00417079|643802|P2|Overall Study|abnormal liver function tests|1
188190|NCT00417079|643803|P1|Overall Study|abnormal liver function tests|0
188191|NCT00417079|643802|P2|Overall Study|Patient unable to come to the clinic|1
188192|NCT00417079|643803|P1|Overall Study|Patient unable to come to the clinic|0
188193|NCT00417079|643802|P2|Overall Study|Withdrawal by subject's family|1
188194|NCT00417079|643803|P1|Overall Study|Withdrawal by subject's family|0
188195|NCT00417079|643802|P2|Overall Study|Screening error|1
188196|NCT00417079|643803|P1|Overall Study|Screening error|2
188197|NCT00417079|643802|P2|Overall Study|Clinical deterioration|0
188198|NCT00417079|643803|P1|Overall Study|Clinical deterioration|1
188199|NCT00417079|643802|P2|Overall Study|Non-confirmed Disease progression|1
188200|NCT00417079|643803|P1|Overall Study|Non-confirmed Disease progression|1
188201|NCT00417079|643802|P2|Overall Study|Investigator's decision|4
188202|NCT00417079|643803|P1|Overall Study|Investigator's decision|1
188203|NCT00417079|643802|P2|Overall Study|Screened failure|1
188204|NCT00417079|643803|P1|Overall Study|Screened failure|2
188205|NCT00417079|643802|P2|Overall Study|Not treated|7
188206|NCT00417079|643803|P1|Overall Study|Not treated|6
188207|NCT00417079|643802|P2|Overall Study|Withdrawal by Subject|8
188208|NCT00417079|643803|P1|Overall Study|Withdrawal by Subject|17
188209|NCT00417079|643802|P2|Overall Study|Lost to Follow-up|0
188210|NCT00417079|643803|P1|Overall Study|Lost to Follow-up|2
188211|NCT00417079|643802|P2|Overall Study|Non-compliance to protocol|1
188212|NCT00417079|643803|P1|Overall Study|Non-compliance to protocol|0
188213|NCT00417079|643802|P2|Overall Study|Adverse Event|67
188214|NCT00417079|643803|P1|Overall Study|Adverse Event|32
188215|NCT00417079|643802|P2|Overall Study|Disease progression|180
188216|NCT00417079|643803|P1|Overall Study|Disease progression|267
188217|NCT00417027|643826|P3|Overall Study|Protocol Violation|5
188218|NCT00417027|643827|P2|Overall Study|Protocol Violation|5
188219|NCT00417027|643828|P1|Overall Study|Protocol Violation|0
188220|NCT00416884|643854|P1|Overall Study|Study terminated due to low accrual|1
188221|NCT00416715|643862|P1|Overall Study|Vitamin D levels not evaluable|8
188222|NCT00416715|643862|P1|Overall Study|Not evaluable for joint aches|7
188223|NCT00416624|643873|P4|Overall Study|Cancel|0
188224|NCT00416624|643874|P3|Overall Study|Cancel|0
188225|NCT00416624|643875|P2|Overall Study|Cancel|0
188226|NCT00416624|643876|P1|Overall Study|Cancel|1
188227|NCT00416624|643873|P4|Overall Study|Not Specified|5
188228|NCT00416624|643874|P3|Overall Study|Not Specified|5
188229|NCT00416624|643875|P2|Overall Study|Not Specified|11
188230|NCT00416624|643876|P1|Overall Study|Not Specified|8
188231|NCT00416624|643873|P4|Overall Study|Adverse Event|2
188232|NCT00416624|643874|P3|Overall Study|Adverse Event|2
188233|NCT00416624|643875|P2|Overall Study|Adverse Event|3
188234|NCT00416624|643876|P1|Overall Study|Adverse Event|8
188235|NCT00416624|643873|P4|Overall Study|Death|1
188236|NCT00416624|643874|P3|Overall Study|Death|7
188237|NCT00416624|643875|P2|Overall Study|Death|7
188238|NCT00416624|643876|P1|Overall Study|Death|4
188239|NCT00416624|643873|P4|Overall Study|Withdrawal by Subject|9
188240|NCT00416624|643874|P3|Overall Study|Withdrawal by Subject|4
188241|NCT00416624|643875|P2|Overall Study|Withdrawal by Subject|6
188242|NCT00416624|643876|P1|Overall Study|Withdrawal by Subject|1
188243|NCT00416598|643930|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
188244|NCT00416598|643930|P1|Decitabine Maintenance|Alternative treatment|2
188245|NCT00416598|643930|P1|Decitabine Maintenance|Progression/relapse|38
188246|NCT00416598|643930|P1|Decitabine Maintenance|Withdrawal by Subject|18
188247|NCT00416598|643930|P1|Decitabine Maintenance|Adverse Event|5
188248|NCT00416598|643930|P1|Induction & Intensification|Failed induction|87
188249|NCT00416598|643930|P1|Induction & Intensification|Relapse/progression|29
188250|NCT00416598|643930|P1|Induction & Intensification|Physician discretion/other medical issue|45
188251|NCT00416598|643930|P1|Induction & Intensification|Alternative Treatment|135
188252|NCT00416598|643930|P1|Induction & Intensification|Withdrawal by Subject|46
188253|NCT00416598|643930|P1|Induction & Intensification|Death|32
188254|NCT00416598|643930|P1|Induction & Intensification|Adverse Event|38
188255|NCT00416520|643956|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
188256|NCT00416520|643957|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
188257|NCT00416520|643958|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
188258|NCT00416520|643959|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
188259|NCT00416520|643956|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
188260|NCT00416520|643957|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
188261|NCT00416520|643958|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
188350|NCT00415532|644130|P2|Treatment Period|Noncompliance|1
188262|NCT00416520|643959|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
188263|NCT00416520|643956|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
188264|NCT00416520|643957|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
188265|NCT00416520|643958|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
188266|NCT00416520|643959|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
188267|NCT00416520|643956|P4|Open-label Period|Other Reasons|0
188268|NCT00416520|643957|P3|Open-label Period|Other Reasons|0
188269|NCT00416520|643958|P2|Open-label Period|Other Reasons|12
188270|NCT00416520|643959|P1|Open-label Period|Other Reasons|3
188271|NCT00416520|643956|P4|Open-label Period|Withdrawal by Subject|0
188272|NCT00416520|643957|P3|Open-label Period|Withdrawal by Subject|0
188273|NCT00416520|643958|P2|Open-label Period|Withdrawal by Subject|5
188274|NCT00416520|643959|P1|Open-label Period|Withdrawal by Subject|16
188275|NCT00416520|643956|P4|Open-label Period|Protocol Violation|0
188276|NCT00416520|643957|P3|Open-label Period|Protocol Violation|0
188277|NCT00416520|643958|P2|Open-label Period|Protocol Violation|3
188278|NCT00416520|643959|P1|Open-label Period|Protocol Violation|3
188279|NCT00416520|643956|P4|Open-label Period|Lack of Efficacy|0
188280|NCT00416520|643957|P3|Open-label Period|Lack of Efficacy|0
188281|NCT00416520|643958|P2|Open-label Period|Lack of Efficacy|1
188282|NCT00416520|643959|P1|Open-label Period|Lack of Efficacy|8
188283|NCT00416520|643956|P4|Open-label Period|Death|0
188284|NCT00416520|643957|P3|Open-label Period|Death|0
188285|NCT00416520|643958|P2|Open-label Period|Death|1
188286|NCT00416520|643959|P1|Open-label Period|Death|2
188287|NCT00416520|643956|P4|Open-label Period|Adverse Event|0
188288|NCT00416520|643957|P3|Open-label Period|Adverse Event|0
188289|NCT00416520|643958|P2|Open-label Period|Adverse Event|10
188290|NCT00416520|643959|P1|Open-label Period|Adverse Event|28
188291|NCT00416455|643988|P2|Overall Study|Inadequate pathology|2
188292|NCT00416455|643989|P1|Overall Study|Inadequate pathology|11
188293|NCT00416455|643988|P2|Overall Study|PET / CT poor quality|1
188294|NCT00416455|643989|P1|Overall Study|PET / CT poor quality|2
188295|NCT00416455|643988|P2|Overall Study|PET / CT not done|5
188296|NCT00416455|643989|P1|Overall Study|PET / CT not done|3
188297|NCT00416195|644003|P2|Overall Study|Not Specified|1
188298|NCT00416195|644004|P1|Overall Study|Not Specified|0
188299|NCT00416195|644003|P2|Overall Study|Protocol Violation|1
188300|NCT00416195|644004|P1|Overall Study|Protocol Violation|1
188301|NCT00416195|644003|P2|Overall Study|Adverse Event|2
188302|NCT00416195|644004|P1|Overall Study|Adverse Event|1
188303|NCT00416078|644029|P2|Overall Study|Lost to Follow-up|2
188304|NCT00416078|644030|P1|Overall Study|Lost to Follow-up|4
188305|NCT00416078|644029|P2|Overall Study|Physician Decision|0
188306|NCT00416078|644030|P1|Overall Study|Physician Decision|1
188307|NCT00416078|644029|P2|Overall Study|Withdrawal by Subject|2
188308|NCT00416078|644030|P1|Overall Study|Withdrawal by Subject|3
188309|NCT00416078|644029|P2|Overall Study|Death|4
188310|NCT00416078|644030|P1|Overall Study|Death|3
188311|NCT00415909|644046|P1|Overall Study|Death|1
188312|NCT00415909|644046|P1|Overall Study|Withdrawal by Subject|2
188313|NCT00415623|644072|P2|Overall Study|Withdrawal by Subject|1
188314|NCT00415623|644073|P1|Overall Study|Withdrawal by Subject|1
188315|NCT00415623|644072|P2|Overall Study|Death|0
188316|NCT00415623|644073|P1|Overall Study|Death|1
188317|NCT00415623|644072|P2|Overall Study|Adverse Event|4
188318|NCT00415623|644073|P1|Overall Study|Adverse Event|3
188319|NCT00415610|644100|P3|Overall Study|Death|5
188320|NCT00415610|644101|P2|Overall Study|Death|2
188321|NCT00415610|644102|P1|Overall Study|Death|3
188322|NCT00415597|644122|P1|Treatment|Multiple Reasons|1
188323|NCT00415597|644122|P1|Treatment|Sponsor Decision|1
188324|NCT00415597|644122|P1|Treatment|Administrative|3
188325|NCT00415597|644122|P1|Treatment|Drug Screen|2
188326|NCT00415597|644122|P1|Treatment|Lost to Follow-up|28
188327|NCT00415597|644122|P1|Treatment|Withdrawal by Subject|51
188328|NCT00415597|644122|P1|Treatment|Physician Decision|3
188329|NCT00415597|644122|P1|Treatment|Protocol Violation|67
188330|NCT00415597|644122|P1|Treatment|Lack of Efficacy|39
188331|NCT00415597|644122|P1|Treatment|Adverse Event|110
188332|NCT00415597|644122|P1|Enrollment|Protocol Violation|1
188333|NCT00415597|644122|P1|Enrollment|Withdrawal by Subject|1
188334|NCT00415532|644130|P2|Safety Follow Up Period|Requirement for alternative therapy|1
188335|NCT00415532|644131|P1|Safety Follow Up Period|Requirement for alternative therapy|0
188336|NCT00415532|644130|P2|Safety Follow Up Period|Noncompliance|0
188337|NCT00415532|644131|P1|Safety Follow Up Period|Noncompliance|1
188338|NCT00415532|644130|P2|Safety Follow Up Period|Ineligibility determined|1
188339|NCT00415532|644131|P1|Safety Follow Up Period|Ineligibility determined|1
188340|NCT00415532|644130|P2|Safety Follow Up Period|Other|4
188341|NCT00415532|644131|P1|Safety Follow Up Period|Other|1
188342|NCT00415532|644130|P2|Safety Follow Up Period|Withdrawal by Subject|3
188343|NCT00415532|644131|P1|Safety Follow Up Period|Withdrawal by Subject|2
188344|NCT00415532|644130|P2|Safety Follow Up Period|Death|0
188345|NCT00415532|644131|P1|Safety Follow Up Period|Death|3
188346|NCT00415532|644130|P2|Safety Follow Up Period|Adverse Event|3
188347|NCT00415532|644131|P1|Safety Follow Up Period|Adverse Event|1
188348|NCT00415532|644130|P2|Treatment Period|Requirement for alternative therapy|0
188349|NCT00415532|644131|P1|Treatment Period|Requirement for alternative therapy|1
188351|NCT00415532|644131|P1|Treatment Period|Noncompliance|1
188352|NCT00415532|644130|P2|Treatment Period|Ineligibility determined|1
188353|NCT00415532|644131|P1|Treatment Period|Ineligibility determined|1
188354|NCT00415532|644130|P2|Treatment Period|Other|2
188355|NCT00415532|644131|P1|Treatment Period|Other|2
188356|NCT00415532|644130|P2|Treatment Period|Withdrawal by Subject|6
188357|NCT00415532|644131|P1|Treatment Period|Withdrawal by Subject|6
188358|NCT00415532|644130|P2|Treatment Period|Protocol Violation|0
188359|NCT00415532|644131|P1|Treatment Period|Protocol Violation|1
188360|NCT00415532|644130|P2|Treatment Period|Lost to Follow-up|1
188361|NCT00415532|644131|P1|Treatment Period|Lost to Follow-up|1
188362|NCT00415532|644130|P2|Treatment Period|Death|1
188363|NCT00415532|644131|P1|Treatment Period|Death|2
188364|NCT00415532|644130|P2|Treatment Period|Adverse Event|3
188365|NCT00415532|644131|P1|Treatment Period|Adverse Event|2
188366|NCT00415519|644153|P2|Overall Study|Patient’s convenience|0
188367|NCT00415519|644154|P1|Overall Study|Patient’s convenience|1
188368|NCT00415519|644153|P2|Overall Study|Withdrawal by Subject|0
188369|NCT00415519|644154|P1|Overall Study|Withdrawal by Subject|2
188370|NCT00415519|644153|P2|Overall Study|Adverse Event|0
188371|NCT00415519|644154|P1|Overall Study|Adverse Event|1
188372|NCT00415194|644194|P2|Overall Study|Death Due to AE (Other Causes)|15
188373|NCT00415194|644195|P1|Overall Study|Death Due to AE (Other Causes)|27
188374|NCT00415194|644194|P2|Overall Study|Death Due to Procedural Related AE|1
188375|NCT00415194|644195|P1|Overall Study|Death Due to Procedural Related AE|0
188376|NCT00415194|644194|P2|Overall Study|Death Due to Study Drug Related AE|1
188377|NCT00415194|644195|P1|Overall Study|Death Due to Study Drug Related AE|11
188378|NCT00415194|644194|P2|Overall Study|Death Due to Study Disease|29
188379|NCT00415194|644195|P1|Overall Study|Death Due to Study Disease|26
188380|NCT00415194|644194|P2|Overall Study|Withdrawal by Subject|21
188381|NCT00415194|644195|P1|Overall Study|Withdrawal by Subject|28
188382|NCT00415194|644194|P2|Overall Study|Protocol Violation|2
188383|NCT00415194|644195|P1|Overall Study|Protocol Violation|4
188384|NCT00415194|644194|P2|Overall Study|Progressive Disease|217
188385|NCT00415194|644195|P1|Overall Study|Progressive Disease|180
188386|NCT00415194|644194|P2|Overall Study|Physician Decision|16
188387|NCT00415194|644195|P1|Overall Study|Physician Decision|10
188388|NCT00415194|644194|P2|Overall Study|Lost to Follow-up|0
188389|NCT00415194|644195|P1|Overall Study|Lost to Follow-up|1
188390|NCT00415194|644194|P2|Overall Study|Entry Criteria Not Met|8
188391|NCT00415194|644195|P1|Overall Study|Entry Criteria Not Met|4
188392|NCT00415194|644194|P2|Overall Study|Adverse Event|32
188393|NCT00415194|644195|P1|Overall Study|Adverse Event|37
188394|NCT00415168|644211|P1|Overall Study|Withdrawal by Subject|6
188395|NCT00415168|644211|P1|Overall Study|Sponsor Decision|4
188396|NCT00415168|644211|P1|Overall Study|Physician Decision|13
188397|NCT00415168|644211|P1|Overall Study|Lost to Follow-up|3
188398|NCT00415168|644211|P1|Overall Study|Death|26
188399|NCT00415051|644221|P1|Overall Study|Protocol Violation|1
188400|NCT00414973|644232|P4|Overall Study|Death|0
188401|NCT00414973|644233|P3|Overall Study|Death|1
188402|NCT00414973|644234|P2|Overall Study|Death|0
188403|NCT00414973|644235|P1|Overall Study|Death|0
188404|NCT00414973|644232|P4|Overall Study|Sponsor Decision|0
188405|NCT00414973|644233|P3|Overall Study|Sponsor Decision|0
188406|NCT00414973|644234|P2|Overall Study|Sponsor Decision|0
188407|NCT00414973|644235|P1|Overall Study|Sponsor Decision|1
188408|NCT00414973|644232|P4|Overall Study|Lost to Follow-up|0
188409|NCT00414973|644233|P3|Overall Study|Lost to Follow-up|0
188410|NCT00414973|644234|P2|Overall Study|Lost to Follow-up|2
188411|NCT00414973|644235|P1|Overall Study|Lost to Follow-up|0
188412|NCT00414973|644232|P4|Overall Study|Protocol Violation|0
188413|NCT00414973|644233|P3|Overall Study|Protocol Violation|0
188414|NCT00414973|644234|P2|Overall Study|Protocol Violation|4
188415|NCT00414973|644235|P1|Overall Study|Protocol Violation|3
188416|NCT00414973|644232|P4|Overall Study|Adverse Event|0
188417|NCT00414973|644233|P3|Overall Study|Adverse Event|1
188418|NCT00414973|644234|P2|Overall Study|Adverse Event|0
188419|NCT00414973|644235|P1|Overall Study|Adverse Event|10
188420|NCT00414973|644232|P4|Overall Study|Withdrawal by Subject|0
188421|NCT00414973|644233|P3|Overall Study|Withdrawal by Subject|1
188422|NCT00414973|644234|P2|Overall Study|Withdrawal by Subject|4
188423|NCT00414973|644235|P1|Overall Study|Withdrawal by Subject|14
188424|NCT00414908|644255|P2|Overall Study|Protocol Violation|1
188425|NCT00414908|644256|P1|Overall Study|Protocol Violation|1
188426|NCT00414726|644293|P2|Overall Study|Withdrawal by Subject|1
188427|NCT00414726|644294|P1|Overall Study|Withdrawal by Subject|0
188428|NCT00414661|644329|P4|Overall Study|Other|0
188429|NCT00414661|644330|P3|Overall Study|Other|0
188430|NCT00414661|644331|P2|Overall Study|Other|3
188431|NCT00414661|644332|P1|Overall Study|Other|6
188432|NCT00414661|644329|P4|Overall Study|Withdrawal by Subject|2
188433|NCT00414661|644330|P3|Overall Study|Withdrawal by Subject|2
188434|NCT00414661|644331|P2|Overall Study|Withdrawal by Subject|2
188435|NCT00414661|644332|P1|Overall Study|Withdrawal by Subject|5
188436|NCT00414661|644329|P4|Overall Study|Lost to Follow-up|1
188437|NCT00414661|644330|P3|Overall Study|Lost to Follow-up|0
188438|NCT00414661|644331|P2|Overall Study|Lost to Follow-up|4
188439|NCT00414661|644332|P1|Overall Study|Lost to Follow-up|1
188440|NCT00414661|644329|P4|Overall Study|Death|0
188441|NCT00414661|644330|P3|Overall Study|Death|0
188442|NCT00414661|644331|P2|Overall Study|Death|5
188443|NCT00414661|644332|P1|Overall Study|Death|2
188444|NCT00414609|644377|P3|Extension Study|Death|17
188445|NCT00414609|644378|P2|Extension Study|Death|0
188446|NCT00414609|644379|P1|Extension Study|Death|0
188447|NCT00414609|644377|P3|Extension Study|Administrative problems|1
188448|NCT00414609|644378|P2|Extension Study|Administrative problems|0
188449|NCT00414609|644379|P1|Extension Study|Administrative problems|0
188450|NCT00414609|644377|P3|Extension Study|Lost to Follow-up|10
188451|NCT00414609|644378|P2|Extension Study|Lost to Follow-up|0
188452|NCT00414609|644379|P1|Extension Study|Lost to Follow-up|0
188453|NCT00414609|644377|P3|Extension Study|Withdrawal by Subject|13
188454|NCT00414609|644378|P2|Extension Study|Withdrawal by Subject|0
188455|NCT00414609|644379|P1|Extension Study|Withdrawal by Subject|0
188456|NCT00414609|644377|P3|Extension Study|Unsatisfactory therapeutic effect|2
188457|NCT00414609|644378|P2|Extension Study|Unsatisfactory therapeutic effect|0
188458|NCT00414609|644379|P1|Extension Study|Unsatisfactory therapeutic effect|0
188459|NCT00414609|644377|P3|Extension Study|Adverse Event|14
188460|NCT00414609|644378|P2|Extension Study|Adverse Event|0
188461|NCT00414609|644379|P1|Extension Study|Adverse Event|0
188462|NCT00414609|644377|P3|Core Study|Death|0
188463|NCT00414609|644378|P2|Core Study|Death|14
188464|NCT00414609|644379|P1|Core Study|Death|7
188465|NCT00414609|644377|P3|Core Study|Administrative problems|0
188466|NCT00414609|644378|P2|Core Study|Administrative problems|2
188467|NCT00414609|644379|P1|Core Study|Administrative problems|0
188468|NCT00414609|644377|P3|Core Study|Lost to Follow-up|0
188469|NCT00414609|644378|P2|Core Study|Lost to Follow-up|4
188470|NCT00414609|644379|P1|Core Study|Lost to Follow-up|7
188471|NCT00414609|644377|P3|Core Study|Patient withdrew consent|0
188472|NCT00414609|644378|P2|Core Study|Patient withdrew consent|11
188473|NCT00414609|644379|P1|Core Study|Patient withdrew consent|10
188474|NCT00414609|644377|P3|Core Study|Protocol deviation|0
188475|NCT00414609|644378|P2|Core Study|Protocol deviation|1
188476|NCT00414609|644379|P1|Core Study|Protocol deviation|0
188477|NCT00414609|644377|P3|Core Study|Abnormal test procedure results|0
188478|NCT00414609|644378|P2|Core Study|Abnormal test procedure results|1
188479|NCT00414609|644379|P1|Core Study|Abnormal test procedure results|1
188480|NCT00414609|644377|P3|Core Study|Abnormal laboratory values|0
188481|NCT00414609|644378|P2|Core Study|Abnormal laboratory values|1
188482|NCT00414609|644379|P1|Core Study|Abnormal laboratory values|0
188483|NCT00414609|644377|P3|Core Study|Adverse Event|0
188484|NCT00414609|644378|P2|Core Study|Adverse Event|11
188485|NCT00414609|644379|P1|Core Study|Adverse Event|9
188486|NCT00414596|644402|P1|Overall Study|Protocol Violation|2
188487|NCT00414544|644411|P1|Overall Study|Lost to Follow-up|14
188488|NCT00414466|644434|P4|Overall Study|Withdrawn by Sponsor|0
188489|NCT00414466|644435|P3|Overall Study|Withdrawn by Sponsor|0
188490|NCT00414466|644436|P2|Overall Study|Withdrawn by Sponsor|0
188491|NCT00414466|644437|P1|Overall Study|Withdrawn by Sponsor|1
188492|NCT00414466|644434|P4|Overall Study|Lack of Efficacy|0
188493|NCT00414466|644435|P3|Overall Study|Lack of Efficacy|0
188494|NCT00414466|644436|P2|Overall Study|Lack of Efficacy|0
188495|NCT00414466|644437|P1|Overall Study|Lack of Efficacy|1
188496|NCT00414466|644434|P4|Overall Study|Adverse Event|1
188497|NCT00414466|644435|P3|Overall Study|Adverse Event|1
188498|NCT00414466|644436|P2|Overall Study|Adverse Event|0
188499|NCT00414466|644437|P1|Overall Study|Adverse Event|0
188500|NCT00414453|644455|P1|Overall Study|Abnormal lab work|16
188501|NCT00414440|644503|P2|Extension Period|Not included in follow up period|8
188502|NCT00414440|644504|P1|Extension Period|Not included in follow up period|18
188503|NCT00414440|644503|P2|Extension Period|Withdrawal by Subject|7
188504|NCT00414440|644504|P1|Extension Period|Withdrawal by Subject|9
188505|NCT00414440|644503|P2|Extension Period|Death|2
188506|NCT00414440|644504|P1|Extension Period|Death|1
188507|NCT00414440|644503|P2|Extension Period|Administrative|16
188508|NCT00414440|644504|P1|Extension Period|Administrative|16
188509|NCT00414440|644503|P2|Extension Period|Other|1
188510|NCT00414440|644504|P1|Extension Period|Other|1
188511|NCT00414440|644503|P2|Extension Period|Did not consent to continue follow up|54
188512|NCT00414440|644504|P1|Extension Period|Did not consent to continue follow up|61
188513|NCT00414440|644503|P2|Extension Period|Lost to Follow-up|52
188514|NCT00414440|644504|P1|Extension Period|Lost to Follow-up|44
188515|NCT00414440|644503|P2|Core Period|Withdrawal by Subject|32
188516|NCT00414440|644504|P1|Core Period|Withdrawal by Subject|70
188517|NCT00414388|644518|P1|Overall Study|Adverse Event|1
188518|NCT00414310|644526|P2|Overall Study|Not treated|0
188519|NCT00414310|644527|P1|Overall Study|Not treated|1
188520|NCT00414050|644561|P4|Overall Study|Subject Moved|1
188521|NCT00414050|644562|P3|Overall Study|Subject Moved|0
188522|NCT00414050|644563|P2|Overall Study|Subject Moved|0
188523|NCT00414050|644564|P1|Overall Study|Subject Moved|0
188524|NCT00414050|644561|P4|Overall Study|Subject discontinued for other reason|1
188525|NCT00414050|644562|P3|Overall Study|Subject discontinued for other reason|2
188526|NCT00414050|644563|P2|Overall Study|Subject discontinued for other reason|2
188527|NCT00414050|644564|P1|Overall Study|Subject discontinued for other reason|1
188528|NCT00414050|644561|P4|Overall Study|Withdrawal by Subject|4
188529|NCT00414050|644562|P3|Overall Study|Withdrawal by Subject|2
188530|NCT00414050|644563|P2|Overall Study|Withdrawal by Subject|3
188531|NCT00414050|644564|P1|Overall Study|Withdrawal by Subject|5
188532|NCT00414050|644561|P4|Overall Study|Lost to Follow-up|1
188533|NCT00414050|644562|P3|Overall Study|Lost to Follow-up|1
188534|NCT00414050|644563|P2|Overall Study|Lost to Follow-up|2
188535|NCT00414050|644564|P1|Overall Study|Lost to Follow-up|2
188536|NCT00414050|644561|P4|Overall Study|Adverse Event|1
188537|NCT00414050|644562|P3|Overall Study|Adverse Event|1
188538|NCT00414050|644563|P2|Overall Study|Adverse Event|1
188539|NCT00414050|644564|P1|Overall Study|Adverse Event|1
188540|NCT00414011|644578|P1|Overall Study|Withdrawal by Subject|2
188541|NCT00414011|644578|P1|Overall Study|Physician Decision|3
188542|NCT00413972|644587|P4|Overall Study|Not Specified|1
188543|NCT00413972|644588|P3|Overall Study|Not Specified|0
188544|NCT00413972|644589|P2|Overall Study|Not Specified|0
188545|NCT00413972|644590|P1|Overall Study|Not Specified|0
188546|NCT00413972|644587|P4|Overall Study|Protocol Violation|0
188547|NCT00413972|644588|P3|Overall Study|Protocol Violation|2
188548|NCT00413972|644589|P2|Overall Study|Protocol Violation|0
188549|NCT00413972|644590|P1|Overall Study|Protocol Violation|0
188550|NCT00413972|644587|P4|Overall Study|Withdrawal by Subject|2
188551|NCT00413972|644588|P3|Overall Study|Withdrawal by Subject|7
188552|NCT00413972|644589|P2|Overall Study|Withdrawal by Subject|5
188553|NCT00413972|644590|P1|Overall Study|Withdrawal by Subject|4
188554|NCT00413972|644587|P4|Overall Study|Lost to Follow-up|0
188555|NCT00413972|644588|P3|Overall Study|Lost to Follow-up|1
188556|NCT00413972|644589|P2|Overall Study|Lost to Follow-up|2
188557|NCT00413972|644590|P1|Overall Study|Lost to Follow-up|1
188558|NCT00413972|644587|P4|Overall Study|Adverse Event|0
188559|NCT00413972|644588|P3|Overall Study|Adverse Event|0
188560|NCT00413972|644589|P2|Overall Study|Adverse Event|1
188561|NCT00413972|644590|P1|Overall Study|Adverse Event|2
188562|NCT00413959|644600|P1|Overall Study|Pt had only one cycle.|1
188563|NCT00413920|644607|P2|Overall Study|Graft Loss|3
188564|NCT00413920|644608|P1|Overall Study|Graft Loss|5
188565|NCT00413920|644607|P2|Overall Study|Death|5
188566|NCT00413920|644608|P1|Overall Study|Death|3
188567|NCT00413920|644607|P2|Overall Study|Lack of Efficacy|9
188568|NCT00413920|644608|P1|Overall Study|Lack of Efficacy|11
188569|NCT00413920|644607|P2|Overall Study|Adverse Event|11
188570|NCT00413920|644608|P1|Overall Study|Adverse Event|9
188571|NCT00413894|644623|P1|Overall Study|Other|18
188572|NCT00413894|644623|P1|Overall Study|Protocol Violation|11
188573|NCT00413894|644623|P1|Overall Study|Adverse Event|28
188574|NCT00413894|644623|P1|Overall Study|Hb <10 grams/deciliter|12
188575|NCT00413894|644623|P1|Overall Study|Administrative Reasons|1
188576|NCT00413894|644623|P1|Overall Study|Withdrawal by Subject|10
188577|NCT00413777|644640|P2|Fixed-dose Period|Withdrew Consent|1
188578|NCT00413777|644641|P1|Fixed-dose Period|Withdrew Consent|0
188579|NCT00413777|644640|P2|Fixed-dose Period|Met Withdrawal Criteria|0
188580|NCT00413777|644641|P1|Fixed-dose Period|Met Withdrawal Criteria|1
188581|NCT00413777|644640|P2|Fixed-dose Period|Adverse Event|1
188582|NCT00413777|644641|P1|Fixed-dose Period|Adverse Event|2
188583|NCT00413777|644640|P2|Fixed-dose Period|Lost to Follow-up|1
188584|NCT00413777|644641|P1|Fixed-dose Period|Lost to Follow-up|1
188585|NCT00413699|644689|P2|Overall Study|No longer willing to participate|368
188586|NCT00413699|644690|P1|Overall Study|No longer willing to participate|116
188587|NCT00413699|644689|P2|Overall Study|Missing end of study page|4
188588|NCT00413699|644690|P1|Overall Study|Missing end of study page|0
188589|NCT00413699|644689|P2|Overall Study|Adverse event not related to study drug|248
188590|NCT00413699|644690|P1|Overall Study|Adverse event not related to study drug|113
188591|NCT00413699|644689|P2|Overall Study|Adverse event related to study drug|527
188592|NCT00413699|644690|P1|Overall Study|Adverse event related to study drug|178
188593|NCT00413699|644689|P2|Overall Study|Not specified|211
188594|NCT00413699|644690|P1|Overall Study|Not specified|67
188595|NCT00413699|644689|P2|Overall Study|Study terminated by Sponsor|1
188596|NCT00413699|644690|P1|Overall Study|Study terminated by Sponsor|0
188597|NCT00413699|644689|P2|Overall Study|Medication error without adverse event|1
188598|NCT00413699|644690|P1|Overall Study|Medication error without adverse event|0
188599|NCT00413699|644689|P2|Overall Study|Did not meet entrance criteria|2
188600|NCT00413699|644690|P1|Overall Study|Did not meet entrance criteria|2
188601|NCT00413699|644689|P2|Overall Study|Pregnancy|8
188602|NCT00413699|644690|P1|Overall Study|Pregnancy|10
188603|NCT00413699|644689|P2|Overall Study|Protocol Violation|89
188604|NCT00413699|644690|P1|Overall Study|Protocol Violation|38
188605|NCT00413699|644689|P2|Overall Study|Lost to Follow-up|101
188606|NCT00413699|644690|P1|Overall Study|Lost to Follow-up|31
188607|NCT00413699|644689|P2|Overall Study|Lack of Efficacy|115
188608|NCT00413699|644690|P1|Overall Study|Lack of Efficacy|59
188609|NCT00413699|644689|P2|Overall Study|Death|30
188610|NCT00413699|644690|P1|Overall Study|Death|25
188611|NCT00413660|644764|P11|Post Week 12|Other|0
188612|NCT00413660|644765|P10|Post Week 12|Other|0
188613|NCT00413660|644766|P9|Post Week 12|Other|0
188614|NCT00413660|644767|P8|Post Week 12|Other|0
188615|NCT00413660|644768|P7|Post Week 12|Other|1
188616|NCT00413660|644769|P6|Post Week 12|Other|1
188617|NCT00413660|644770|P5|Post Week 12|Other|1
188618|NCT00413660|644771|P4|Post Week 12|Other|0
188619|NCT00413660|644772|P3|Post Week 12|Other|3
188620|NCT00413660|644773|P2|Post Week 12|Other|2
188621|NCT00413660|644774|P1|Post Week 12|Other|1
188622|NCT00413660|644764|P11|Post Week 12|Withdrawal by Subject|1
188623|NCT00413660|644765|P10|Post Week 12|Withdrawal by Subject|0
188624|NCT00413660|644766|P9|Post Week 12|Withdrawal by Subject|0
188625|NCT00413660|644767|P8|Post Week 12|Withdrawal by Subject|0
188626|NCT00413660|644768|P7|Post Week 12|Withdrawal by Subject|0
188627|NCT00413660|644769|P6|Post Week 12|Withdrawal by Subject|0
188628|NCT00413660|644770|P5|Post Week 12|Withdrawal by Subject|1
188629|NCT00413660|644771|P4|Post Week 12|Withdrawal by Subject|0
188630|NCT00413660|644772|P3|Post Week 12|Withdrawal by Subject|1
188631|NCT00413660|644773|P2|Post Week 12|Withdrawal by Subject|1
188632|NCT00413660|644774|P1|Post Week 12|Withdrawal by Subject|0
188633|NCT00413660|644764|P11|Post Week 12|Lost to Follow-up|0
188634|NCT00413660|644765|P10|Post Week 12|Lost to Follow-up|0
188635|NCT00413660|644766|P9|Post Week 12|Lost to Follow-up|0
188636|NCT00413660|644767|P8|Post Week 12|Lost to Follow-up|0
188637|NCT00413660|644768|P7|Post Week 12|Lost to Follow-up|0
188638|NCT00413660|644769|P6|Post Week 12|Lost to Follow-up|0
188639|NCT00413660|644770|P5|Post Week 12|Lost to Follow-up|0
188640|NCT00413660|644771|P4|Post Week 12|Lost to Follow-up|0
188641|NCT00413660|644772|P3|Post Week 12|Lost to Follow-up|1
188642|NCT00413660|644773|P2|Post Week 12|Lost to Follow-up|1
188643|NCT00413660|644774|P1|Post Week 12|Lost to Follow-up|0
188644|NCT00413660|644764|P11|Post Week 12|Lack of Efficacy|0
188645|NCT00413660|644765|P10|Post Week 12|Lack of Efficacy|1
188646|NCT00413660|644766|P9|Post Week 12|Lack of Efficacy|0
188647|NCT00413660|644767|P8|Post Week 12|Lack of Efficacy|0
188648|NCT00413660|644768|P7|Post Week 12|Lack of Efficacy|0
188649|NCT00413660|644769|P6|Post Week 12|Lack of Efficacy|0
188650|NCT00413660|644770|P5|Post Week 12|Lack of Efficacy|0
188651|NCT00413660|644771|P4|Post Week 12|Lack of Efficacy|0
188652|NCT00413660|644772|P3|Post Week 12|Lack of Efficacy|1
188653|NCT00413660|644773|P2|Post Week 12|Lack of Efficacy|0
188654|NCT00413660|644774|P1|Post Week 12|Lack of Efficacy|0
188655|NCT00413660|644764|P11|Post Week 12|Adverse Event|0
188656|NCT00413660|644765|P10|Post Week 12|Adverse Event|0
188657|NCT00413660|644766|P9|Post Week 12|Adverse Event|0
188658|NCT00413660|644767|P8|Post Week 12|Adverse Event|0
188659|NCT00413660|644768|P7|Post Week 12|Adverse Event|2
188660|NCT00413660|644769|P6|Post Week 12|Adverse Event|2
188661|NCT00413660|644770|P5|Post Week 12|Adverse Event|4
188662|NCT00413660|644771|P4|Post Week 12|Adverse Event|1
188663|NCT00413660|644772|P3|Post Week 12|Adverse Event|2
188664|NCT00413660|644773|P2|Post Week 12|Adverse Event|0
188665|NCT00413660|644774|P1|Post Week 12|Adverse Event|2
188666|NCT00413660|644764|P11|Up To Week 12|Other|0
188667|NCT00413660|644765|P10|Up To Week 12|Other|0
188668|NCT00413660|644766|P9|Up To Week 12|Other|0
188669|NCT00413660|644767|P8|Up To Week 12|Other|0
188670|NCT00413660|644768|P7|Up To Week 12|Other|3
188671|NCT00413660|644769|P6|Up To Week 12|Other|4
188672|NCT00413660|644770|P5|Up To Week 12|Other|2
188673|NCT00413660|644771|P4|Up To Week 12|Other|1
188674|NCT00413660|644772|P3|Up To Week 12|Other|6
188675|NCT00413660|644773|P2|Up To Week 12|Other|1
188676|NCT00413660|644774|P1|Up To Week 12|Other|3
188677|NCT00413660|644764|P11|Up To Week 12|Randomized, Not Treated|0
188678|NCT00413660|644765|P10|Up To Week 12|Randomized, Not Treated|0
188679|NCT00413660|644766|P9|Up To Week 12|Randomized, Not Treated|0
188680|NCT00413660|644767|P8|Up To Week 12|Randomized, Not Treated|0
188681|NCT00413660|644768|P7|Up To Week 12|Randomized, Not Treated|0
188682|NCT00413660|644769|P6|Up To Week 12|Randomized, Not Treated|0
188683|NCT00413660|644770|P5|Up To Week 12|Randomized, Not Treated|0
188684|NCT00413660|644771|P4|Up To Week 12|Randomized, Not Treated|1
188685|NCT00413660|644772|P3|Up To Week 12|Randomized, Not Treated|0
188686|NCT00413660|644773|P2|Up To Week 12|Randomized, Not Treated|0
188687|NCT00413660|644774|P1|Up To Week 12|Randomized, Not Treated|1
188688|NCT00413660|644764|P11|Up To Week 12|Withdrawal by Subject|0
188689|NCT00413660|644765|P10|Up To Week 12|Withdrawal by Subject|0
188690|NCT00413660|644766|P9|Up To Week 12|Withdrawal by Subject|0
188691|NCT00413660|644767|P8|Up To Week 12|Withdrawal by Subject|0
188692|NCT00413660|644768|P7|Up To Week 12|Withdrawal by Subject|2
188693|NCT00413660|644769|P6|Up To Week 12|Withdrawal by Subject|2
188694|NCT00413660|644770|P5|Up To Week 12|Withdrawal by Subject|0
188695|NCT00413660|644771|P4|Up To Week 12|Withdrawal by Subject|2
188696|NCT00413660|644772|P3|Up To Week 12|Withdrawal by Subject|0
188697|NCT00413660|644773|P2|Up To Week 12|Withdrawal by Subject|2
188698|NCT00413660|644774|P1|Up To Week 12|Withdrawal by Subject|0
188699|NCT00413660|644764|P11|Up To Week 12|Lost to Follow-up|0
188700|NCT00413660|644765|P10|Up To Week 12|Lost to Follow-up|0
188701|NCT00413660|644766|P9|Up To Week 12|Lost to Follow-up|0
188702|NCT00413660|644767|P8|Up To Week 12|Lost to Follow-up|0
188703|NCT00413660|644768|P7|Up To Week 12|Lost to Follow-up|0
188704|NCT00413660|644769|P6|Up To Week 12|Lost to Follow-up|0
188705|NCT00413660|644770|P5|Up To Week 12|Lost to Follow-up|1
188706|NCT00413660|644771|P4|Up To Week 12|Lost to Follow-up|0
188707|NCT00413660|644772|P3|Up To Week 12|Lost to Follow-up|0
188708|NCT00413660|644773|P2|Up To Week 12|Lost to Follow-up|1
188709|NCT00413660|644774|P1|Up To Week 12|Lost to Follow-up|0
188710|NCT00413660|644764|P11|Up To Week 12|Lack of Efficacy|0
188711|NCT00413660|644765|P10|Up To Week 12|Lack of Efficacy|0
188712|NCT00413660|644766|P9|Up To Week 12|Lack of Efficacy|0
188713|NCT00413660|644767|P8|Up To Week 12|Lack of Efficacy|0
188714|NCT00413660|644768|P7|Up To Week 12|Lack of Efficacy|5
188715|NCT00413660|644769|P6|Up To Week 12|Lack of Efficacy|0
188716|NCT00413660|644770|P5|Up To Week 12|Lack of Efficacy|0
188717|NCT00413660|644771|P4|Up To Week 12|Lack of Efficacy|0
188718|NCT00413660|644772|P3|Up To Week 12|Lack of Efficacy|0
188719|NCT00413660|644773|P2|Up To Week 12|Lack of Efficacy|0
188720|NCT00413660|644774|P1|Up To Week 12|Lack of Efficacy|2
188721|NCT00413660|644764|P11|Up To Week 12|Adverse Event|0
188722|NCT00413660|644765|P10|Up To Week 12|Adverse Event|0
188723|NCT00413660|644766|P9|Up To Week 12|Adverse Event|0
188724|NCT00413660|644767|P8|Up To Week 12|Adverse Event|0
188725|NCT00413660|644768|P7|Up To Week 12|Adverse Event|1
188726|NCT00413660|644769|P6|Up To Week 12|Adverse Event|4
188727|NCT00413660|644770|P5|Up To Week 12|Adverse Event|6
188728|NCT00413660|644771|P4|Up To Week 12|Adverse Event|4
188729|NCT00413660|644772|P3|Up To Week 12|Adverse Event|1
188730|NCT00413660|644773|P2|Up To Week 12|Adverse Event|3
188731|NCT00413660|644774|P1|Up To Week 12|Adverse Event|1
188732|NCT00413413|645177|P3|Double-Blind|Lost to Follow-up|2
188733|NCT00413413|645178|P2|Double-Blind|Lost to Follow-up|4
188734|NCT00413413|645179|P1|Double-Blind|Lost to Follow-up|3
188735|NCT00413413|645177|P3|Double-Blind|Subject withdrew consent|9
188736|NCT00413413|645178|P2|Double-Blind|Subject withdrew consent|6
188737|NCT00413413|645179|P1|Double-Blind|Subject withdrew consent|4
188738|NCT00413413|645177|P3|Double-Blind|Protocol deviation|1
188739|NCT00413413|645178|P2|Double-Blind|Protocol deviation|2
188740|NCT00413413|645179|P1|Double-Blind|Protocol deviation|1
188741|NCT00413413|645177|P3|Double-Blind|Unsatisfactory therapeutic effect|1
188742|NCT00413413|645178|P2|Double-Blind|Unsatisfactory therapeutic effect|2
188743|NCT00413413|645179|P1|Double-Blind|Unsatisfactory therapeutic effect|1
188744|NCT00413413|645177|P3|Double-Blind|Adverse Event|5
188745|NCT00413413|645178|P2|Double-Blind|Adverse Event|0
188746|NCT00413413|645179|P1|Double-Blind|Adverse Event|6
188747|NCT00413413|645177|P3|Single-Blind|Lost to Follow-up|0
188748|NCT00413413|645178|P2|Single-Blind|Lost to Follow-up|8
188749|NCT00413413|645179|P1|Single-Blind|Lost to Follow-up|0
188750|NCT00413413|645177|P3|Single-Blind|Withdrawal by Subject|0
188751|NCT00413413|645178|P2|Single-Blind|Withdrawal by Subject|27
188752|NCT00413413|645179|P1|Single-Blind|Withdrawal by Subject|0
188753|NCT00413413|645177|P3|Single-Blind|Protocol Violation|0
188754|NCT00413413|645178|P2|Single-Blind|Protocol Violation|16
188755|NCT00413413|645179|P1|Single-Blind|Protocol Violation|0
188756|NCT00413413|645177|P3|Single-Blind|Subject no longer requires study drug|0
188757|NCT00413413|645178|P2|Single-Blind|Subject no longer requires study drug|151
188758|NCT00413413|645179|P1|Single-Blind|Subject no longer requires study drug|0
188759|NCT00413413|645177|P3|Single-Blind|Lack of Efficacy|0
188760|NCT00413413|645178|P2|Single-Blind|Lack of Efficacy|5
188761|NCT00413413|645179|P1|Single-Blind|Lack of Efficacy|0
188762|NCT00413413|645177|P3|Single-Blind|Adverse Event|0
188763|NCT00413413|645178|P2|Single-Blind|Adverse Event|9
188764|NCT00413413|645179|P1|Single-Blind|Adverse Event|0
188765|NCT00413374|645230|P1|Overall Study|Surgery|1
188766|NCT00413374|645230|P1|Overall Study|Lost to Follow-up|1
188767|NCT00413374|645230|P1|Overall Study|Adverse Event|1
188768|NCT00413374|645230|P1|Overall Study|Ineligible due to screening criteria.|3
188769|NCT00413283|645256|P4|Overall Study|Not specified|0
188770|NCT00413283|645257|P3|Overall Study|Not specified|1
188771|NCT00413283|645258|P2|Overall Study|Not specified|0
188772|NCT00413283|645259|P1|Overall Study|Not specified|0
188773|NCT00413283|645256|P4|Overall Study|Requirement for alternative therapy|0
188774|NCT00413283|645257|P3|Overall Study|Requirement for alternative therapy|0
188775|NCT00413283|645258|P2|Overall Study|Requirement for alternative therapy|2
188776|NCT00413283|645259|P1|Overall Study|Requirement for alternative therapy|0
188777|NCT00413283|645256|P4|Overall Study|Protocol deviation|0
188778|NCT00413283|645257|P3|Overall Study|Protocol deviation|0
188779|NCT00413283|645258|P2|Overall Study|Protocol deviation|1
188780|NCT00413283|645259|P1|Overall Study|Protocol deviation|0
188781|NCT00413283|645256|P4|Overall Study|Ineligibility determined|1
188782|NCT00413283|645257|P3|Overall Study|Ineligibility determined|0
188783|NCT00413283|645258|P2|Overall Study|Ineligibility determined|0
188784|NCT00413283|645259|P1|Overall Study|Ineligibility determined|0
188785|NCT00413283|645256|P4|Overall Study|Adverse Event|1
188786|NCT00413283|645257|P3|Overall Study|Adverse Event|0
188787|NCT00413283|645258|P2|Overall Study|Adverse Event|0
188788|NCT00413283|645259|P1|Overall Study|Adverse Event|0
188789|NCT00413283|645256|P4|Overall Study|Death|1
188790|NCT00413283|645257|P3|Overall Study|Death|1
188791|NCT00413283|645258|P2|Overall Study|Death|0
188792|NCT00413283|645259|P1|Overall Study|Death|0
188793|NCT00413283|645256|P4|Overall Study|Withdrawal by Subject|1
188794|NCT00413283|645257|P3|Overall Study|Withdrawal by Subject|0
188795|NCT00413283|645258|P2|Overall Study|Withdrawal by Subject|0
188796|NCT00413283|645259|P1|Overall Study|Withdrawal by Subject|1
188797|NCT00413244|645291|P2|Overall Study|Withdrawal by Subject|1
188798|NCT00413244|645292|P1|Overall Study|Withdrawal by Subject|10
188799|NCT00413231|645320|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
188800|NCT00413231|645320|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
188801|NCT00413231|645320|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
188802|NCT00413231|645320|P1|365-day to 60-month Post Treatment|Death|36
188803|NCT00413231|645320|P1|30-day to 365-day Post Treatment|Death|13
188804|NCT00413231|645320|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
188805|NCT00413231|645320|P1|0 to 30-day Post Treatment|Death|5
188806|NCT00413218|645352|P2|Overall Study|Withdrawal by Subject|1
188807|NCT00413218|645353|P1|Overall Study|Withdrawal by Subject|9
188808|NCT00413218|645352|P2|Overall Study|Missing|0
188809|NCT00413218|645353|P1|Overall Study|Missing|1
188810|NCT00413218|645352|P2|Overall Study|Admin|14
188811|NCT00413218|645353|P1|Overall Study|Admin|20
188812|NCT00413218|645352|P2|Overall Study|Lost to Follow-up|17
188813|NCT00413218|645353|P1|Overall Study|Lost to Follow-up|14
188814|NCT00413218|645352|P2|Overall Study|Death|56
188815|NCT00413218|645353|P1|Overall Study|Death|57
188816|NCT00413218|645352|P2|Overall Study|Randomized but didn't receive study drug|8
188817|NCT00413218|645353|P1|Overall Study|Randomized but didn't receive study drug|2
188818|NCT00413192|645379|P4|Overall Study|Not treated|1
188819|NCT00413192|645380|P3|Overall Study|Not treated|0
188820|NCT00413192|645381|P2|Overall Study|Not treated|0
188821|NCT00413192|645382|P1|Overall Study|Not treated|0
188822|NCT00413192|645379|P4|Overall Study|Not specified|2
188823|NCT00413192|645380|P3|Overall Study|Not specified|1
188824|NCT00413192|645381|P2|Overall Study|Not specified|1
188825|NCT00413192|645382|P1|Overall Study|Not specified|5
188826|NCT00413192|645379|P4|Overall Study|Intercurrent death|0
188827|NCT00413192|645380|P3|Overall Study|Intercurrent death|0
188828|NCT00413192|645381|P2|Overall Study|Intercurrent death|1
188829|NCT00413192|645382|P1|Overall Study|Intercurrent death|0
188830|NCT00413192|645379|P4|Overall Study|Intercurrent illness|1
188831|NCT00413192|645380|P3|Overall Study|Intercurrent illness|0
188832|NCT00413192|645381|P2|Overall Study|Intercurrent illness|0
188833|NCT00413192|645382|P1|Overall Study|Intercurrent illness|0
188834|NCT00413192|645379|P4|Overall Study|Withdrawal by Subject|1
188835|NCT00413192|645380|P3|Overall Study|Withdrawal by Subject|0
188836|NCT00413192|645381|P2|Overall Study|Withdrawal by Subject|5
188837|NCT00413192|645382|P1|Overall Study|Withdrawal by Subject|3
188838|NCT00413192|645379|P4|Overall Study|Toxicity|2
188839|NCT00413192|645380|P3|Overall Study|Toxicity|2
188840|NCT00413192|645381|P2|Overall Study|Toxicity|2
188841|NCT00413192|645382|P1|Overall Study|Toxicity|3
188842|NCT00413192|645379|P4|Overall Study|Disease progression|25
188843|NCT00413192|645380|P3|Overall Study|Disease progression|16
188844|NCT00413192|645381|P2|Overall Study|Disease progression|31
188845|NCT00413192|645382|P1|Overall Study|Disease progression|26
188846|NCT00413153|645422|P2|Overall Study|Adverse Event|0
188847|NCT00413153|645423|P1|Overall Study|Adverse Event|1
188848|NCT00413153|645422|P2|Overall Study|Withdrawal by Subject|1
188849|NCT00413153|645423|P1|Overall Study|Withdrawal by Subject|1
188850|NCT00413062|645447|P2|Overall Study|Other reason|34
188851|NCT00413062|645448|P1|Overall Study|Other reason|70
188852|NCT00413062|645447|P2|Overall Study|Lost to Follow-up|73
188853|NCT00413062|645448|P1|Overall Study|Lost to Follow-up|175
188854|NCT00413062|645447|P2|Overall Study|Pregnancy wish|6
188855|NCT00413062|645448|P1|Overall Study|Pregnancy wish|17
188856|NCT00413062|645447|P2|Overall Study|Pregnancy|5
188857|NCT00413062|645448|P1|Overall Study|Pregnancy|15
188858|NCT00413062|645447|P2|Overall Study|Withdrawal of informed consent|36
188859|NCT00413062|645448|P1|Overall Study|Withdrawal of informed consent|111
188860|NCT00413062|645447|P2|Overall Study|Pre-treatment (serious) adverse event|0
188861|NCT00413062|645448|P1|Overall Study|Pre-treatment (serious) adverse event|1
188862|NCT00413062|645447|P2|Overall Study|Adverse event/serious adverse event|56
188863|NCT00413062|645448|P1|Overall Study|Adverse event/serious adverse event|289
188864|NCT00413049|645474|P2|Overall Study|Lack of Efficacy|0
188865|NCT00413049|645475|P1|Overall Study|Lack of Efficacy|1
188866|NCT00413049|645474|P2|Overall Study|Abnormal laboratory value(s)|0
188867|NCT00413049|645475|P1|Overall Study|Abnormal laboratory value(s)|1
188868|NCT00413049|645474|P2|Overall Study|Subject no longer requires study drug|1
188869|NCT00413049|645475|P1|Overall Study|Subject no longer requires study drug|0
188870|NCT00413049|645474|P2|Overall Study|Protocol Violation|1
188871|NCT00413049|645475|P1|Overall Study|Protocol Violation|3
188872|NCT00413049|645474|P2|Overall Study|Lost to Follow-up|3
188873|NCT00413049|645475|P1|Overall Study|Lost to Follow-up|2
188874|NCT00413049|645474|P2|Overall Study|Withdrawal by Subject|5
188875|NCT00413049|645475|P1|Overall Study|Withdrawal by Subject|7
188876|NCT00413049|645474|P2|Overall Study|Adverse Event|8
188877|NCT00413049|645475|P1|Overall Study|Adverse Event|10
188878|NCT00413036|645491|P1|Overall Study|Missing|2
188879|NCT00413036|645491|P1|Overall Study|Other|26
188880|NCT00413036|645491|P1|Overall Study|Death|9
188881|NCT00413036|645491|P1|Overall Study|Withdrawal by Subject|7
188882|NCT00413036|645491|P1|Overall Study|Lack of Efficacy|129
188883|NCT00413036|645491|P1|Overall Study|Adverse Event|44
188884|NCT00413010|645501|P2|Overall Study|Due to termination of the study|52
188885|NCT00413010|645502|P1|Overall Study|Due to termination of the study|54
188886|NCT00413010|645501|P2|Overall Study|Withdrawal by Subject|2
188887|NCT00413010|645502|P1|Overall Study|Withdrawal by Subject|7
188888|NCT00413010|645501|P2|Overall Study|Lost to Follow-up|0
188889|NCT00413010|645502|P1|Overall Study|Lost to Follow-up|3
188890|NCT00413010|645501|P2|Overall Study|Lack of Efficacy|3
188891|NCT00413010|645502|P1|Overall Study|Lack of Efficacy|0
188892|NCT00413010|645501|P2|Overall Study|Laboratory abnormality|2
188893|NCT00413010|645502|P1|Overall Study|Laboratory abnormality|0
188894|NCT00413010|645501|P2|Overall Study|Adverse Event|4
188895|NCT00413010|645502|P1|Overall Study|Adverse Event|8
188896|NCT00412984|645524|P2|Overall Study|Not Reported|12
188897|NCT00412984|645525|P1|Overall Study|Not Reported|11
188898|NCT00412984|645524|P2|Overall Study|Other Reason|92
188899|NCT00412984|645525|P1|Overall Study|Other Reason|80
188900|NCT00412984|645524|P2|Overall Study|Physician Refused to Continue Treatment|89
188901|NCT00412984|645525|P1|Overall Study|Physician Refused to Continue Treatment|81
188902|NCT00412984|645524|P2|Overall Study|Administrative Reason by Sponsor|8
188903|NCT00412984|645525|P1|Overall Study|Administrative Reason by Sponsor|11
188904|NCT00412984|645524|P2|Overall Study|Subject No Longer Meets Study Criteria|100
188905|NCT00412984|645525|P1|Overall Study|Subject No Longer Meets Study Criteria|87
188906|NCT00412984|645524|P2|Overall Study|Pregnancy|0
188907|NCT00412984|645525|P1|Overall Study|Pregnancy|1
188908|NCT00412984|645524|P2|Overall Study|Poor/Noncompliance|77
188909|NCT00412984|645525|P1|Overall Study|Poor/Noncompliance|57
188910|NCT00412984|645524|P2|Overall Study|Lost to Follow-up|39
188911|NCT00412984|645525|P1|Overall Study|Lost to Follow-up|51
188912|NCT00412984|645524|P2|Overall Study|Withdrawal by Subject|989
188913|NCT00412984|645525|P1|Overall Study|Withdrawal by Subject|921
188914|NCT00412984|645524|P2|Overall Study|Adverse Event|738
188915|NCT00412984|645525|P1|Overall Study|Adverse Event|679
188916|NCT00412984|645524|P2|Overall Study|Death|349
188917|NCT00412984|645525|P1|Overall Study|Death|331
188918|NCT00412971|645569|P2|Overall Study|Protocol Violation|1
188919|NCT00412971|645570|P1|Overall Study|Protocol Violation|13
188920|NCT00412971|645569|P2|Overall Study|Lost to Follow-up|9
188921|NCT00412971|645570|P1|Overall Study|Lost to Follow-up|17
188922|NCT00412958|645583|P4|Overall Study|Transport issue|0
188923|NCT00412958|645584|P3|Overall Study|Transport issue|0
188924|NCT00412958|645585|P2|Overall Study|Transport issue|1
188925|NCT00412958|645586|P1|Overall Study|Transport issue|0
188926|NCT00412958|645583|P4|Overall Study|Death|0
188927|NCT00412958|645584|P3|Overall Study|Death|0
188928|NCT00412958|645585|P2|Overall Study|Death|1
188929|NCT00412958|645586|P1|Overall Study|Death|0
188930|NCT00412958|645583|P4|Overall Study|Lost to Follow-up|0
188931|NCT00412958|645584|P3|Overall Study|Lost to Follow-up|0
188932|NCT00412958|645585|P2|Overall Study|Lost to Follow-up|1
188933|NCT00412958|645586|P1|Overall Study|Lost to Follow-up|0
188934|NCT00412958|645583|P4|Overall Study|Adverse Event|0
188935|NCT00412958|645584|P3|Overall Study|Adverse Event|0
188936|NCT00412958|645585|P2|Overall Study|Adverse Event|1
188937|NCT00412958|645586|P1|Overall Study|Adverse Event|0
188938|NCT00412958|645583|P4|Overall Study|Withdrawal by Subject|1
188939|NCT00412958|645584|P3|Overall Study|Withdrawal by Subject|0
188940|NCT00412958|645585|P2|Overall Study|Withdrawal by Subject|0
188941|NCT00412958|645586|P1|Overall Study|Withdrawal by Subject|3
188942|NCT00412932|645596|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
188943|NCT00412932|645596|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
188944|NCT00412932|645596|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
188945|NCT00412932|645596|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
188946|NCT00412932|645596|P1|Olmesartan 40 mg|Withdrawal by Subject|1
188947|NCT00412932|645596|P1|Olmesartan 40 mg|Lack of Efficacy|3
188948|NCT00412932|645596|P1|Olmesartan 40 mg|Adverse Event|4
188949|NCT00412932|645596|P1|Olmesartan (Olm) 20 mg|Other|1
188950|NCT00412932|645596|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
188951|NCT00412932|645596|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
188952|NCT00412932|645596|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
188953|NCT00412932|645596|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
188954|NCT00412893|645607|P2|Overall Study|Randomized but Never Received Study Drug|6
188955|NCT00412893|645608|P1|Overall Study|Randomized but Never Received Study Drug|5
188956|NCT00412893|645607|P2|Overall Study|Administrative Reason|15
188957|NCT00412893|645608|P1|Overall Study|Administrative Reason|12
188958|NCT00412893|645607|P2|Overall Study|Did Not Cooperate|9
188959|NCT00412893|645608|P1|Overall Study|Did Not Cooperate|12
188960|NCT00412893|645607|P2|Overall Study|Other Protocol Violation|6
188961|NCT00412893|645608|P1|Overall Study|Other Protocol Violation|10
188962|NCT00412893|645607|P2|Overall Study|Violation of Selection at Entry|10
188963|NCT00412893|645608|P1|Overall Study|Violation of Selection at Entry|17
188964|NCT00412893|645607|P2|Overall Study|Lost to Follow-up|1
188965|NCT00412893|645608|P1|Overall Study|Lost to Follow-up|2
188966|NCT00412893|645607|P2|Overall Study|Insufficient Therapeutic Response|23
188967|NCT00412893|645608|P1|Overall Study|Insufficient Therapeutic Response|39
188968|NCT00412893|645607|P2|Overall Study|Death|21
188969|NCT00412893|645608|P1|Overall Study|Death|17
188970|NCT00412893|645607|P2|Overall Study|Adverse Event|53
188971|NCT00412893|645608|P1|Overall Study|Adverse Event|31
188972|NCT00412854|645646|P2|Overall Study|Withdrawn for other reasons|11
188973|NCT00412854|645647|P1|Overall Study|Withdrawn for other reasons|13
188974|NCT00412854|645646|P2|Overall Study|Withdrawn due to adverse events|5
188975|NCT00412854|645647|P1|Overall Study|Withdrawn due to adverse events|1
188976|NCT00412750|645687|P3|Overall Study|Lack of Efficacy|3
188977|NCT00412750|645688|P2|Overall Study|Lack of Efficacy|0
188978|NCT00412750|645689|P1|Overall Study|Lack of Efficacy|0
188979|NCT00412750|645687|P3|Overall Study|Withdrawal by Subject|2
188980|NCT00412750|645688|P2|Overall Study|Withdrawal by Subject|1
188981|NCT00412750|645689|P1|Overall Study|Withdrawal by Subject|0
188982|NCT00412750|645687|P3|Overall Study|Lost to Follow-up|1
188983|NCT00412750|645688|P2|Overall Study|Lost to Follow-up|0
188984|NCT00412750|645689|P1|Overall Study|Lost to Follow-up|1
188985|NCT00412750|645687|P3|Overall Study|Adverse Event|3
188986|NCT00412750|645688|P2|Overall Study|Adverse Event|3
188987|NCT00412750|645689|P1|Overall Study|Adverse Event|8
188988|NCT00412750|645687|P3|Overall Study|Administrative problems|14
188989|NCT00412750|645688|P2|Overall Study|Administrative problems|17
188990|NCT00412750|645689|P1|Overall Study|Administrative problems|21
188991|NCT00412750|645687|P3|Overall Study|Abnormal laboratory value(s)|0
188992|NCT00412750|645688|P2|Overall Study|Abnormal laboratory value(s)|0
188993|NCT00412750|645689|P1|Overall Study|Abnormal laboratory value(s)|1
188994|NCT00412737|645714|P2|Overall Study|Failure to Return|2
188995|NCT00412737|645715|P1|Overall Study|Failure to Return|6
188996|NCT00412737|645714|P2|Overall Study|Refused Treatment|2
188997|NCT00412737|645715|P1|Overall Study|Refused Treatment|6
188998|NCT00412737|645714|P2|Overall Study|Adverse Event|2
188999|NCT00412737|645715|P1|Overall Study|Adverse Event|3
189000|NCT00412737|645714|P2|Overall Study|Death|0
189001|NCT00412737|645715|P1|Overall Study|Death|1
189002|NCT00412607|645733|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
189003|NCT00412607|645733|P1|Overall Study|Death|61
189004|NCT00412607|645733|P1|Overall Study|Lost to Follow-up|19
189005|NCT00412607|645733|P1|Overall Study|Withdrawal by Subject|9
189006|NCT00412542|645746|P2|Overall Study|Not Eligible|1
189007|NCT00412542|645747|P1|Overall Study|Not Eligible|0
189008|NCT00412542|645746|P2|Overall Study|Withdrawal by Subject|2
189009|NCT00412542|645747|P1|Overall Study|Withdrawal by Subject|0
189010|NCT00412373|645832|P2|Overall Study|Not Specified|2
189011|NCT00412373|645833|P1|Overall Study|Not Specified|2
189012|NCT00412373|645832|P2|Overall Study|Withdrawal by Subject|27
189013|NCT00412373|645833|P1|Overall Study|Withdrawal by Subject|8
189014|NCT00412373|645832|P2|Overall Study|Lost to Follow-up|13
189015|NCT00412373|645833|P1|Overall Study|Lost to Follow-up|7
189016|NCT00412373|645832|P2|Overall Study|Lack of Efficacy|22
189017|NCT00412373|645833|P1|Overall Study|Lack of Efficacy|16
189018|NCT00412373|645832|P2|Overall Study|Adverse Event|13
189019|NCT00412373|645833|P1|Overall Study|Adverse Event|8
189020|NCT00412360|645875|P2|Overall Study|Not Transplanted|2
189021|NCT00412360|645876|P1|Overall Study|Not Transplanted|1
189022|NCT00412360|645875|P2|Overall Study|Lost to Follow-up|1
189023|NCT00412360|645876|P1|Overall Study|Lost to Follow-up|0
189024|NCT00412217|645906|P2|Overall Study|Not Specified|1
189025|NCT00412217|645907|P1|Overall Study|Not Specified|1
189026|NCT00412217|645906|P2|Overall Study|Study Terminated by Sponsor|33
189027|NCT00412217|645907|P1|Overall Study|Study Terminated by Sponsor|26
189028|NCT00412217|645906|P2|Overall Study|Lost to Follow-up|4
189029|NCT00412217|645907|P1|Overall Study|Lost to Follow-up|1
189030|NCT00412217|645906|P2|Overall Study|Withdrawal by Subject|0
189031|NCT00412217|645907|P1|Overall Study|Withdrawal by Subject|2
189032|NCT00412217|645906|P2|Overall Study|Investigator Decision|0
189033|NCT00412217|645907|P1|Overall Study|Investigator Decision|1
189034|NCT00412217|645906|P2|Overall Study|Disease Progression|3
189035|NCT00412217|645907|P1|Overall Study|Disease Progression|2
189036|NCT00412217|645906|P2|Overall Study|Death|4
189037|NCT00412217|645907|P1|Overall Study|Death|5
189038|NCT00412217|645906|P2|Overall Study|Insufficient Data Available|3
189039|NCT00412217|645907|P1|Overall Study|Insufficient Data Available|8
189040|NCT00412113|645921|P2|Overall Study|did not receive treatment|0
189041|NCT00412113|645922|P1|Overall Study|did not receive treatment|1
189042|NCT00412113|645921|P2|Overall Study|Adverse Event|15
189043|NCT00412113|645922|P1|Overall Study|Adverse Event|11
189044|NCT00412061|646006|P2|Open Label Phase|New Cancer Therapy|1
189045|NCT00412061|646007|P1|Open Label Phase|New Cancer Therapy|0
189046|NCT00412061|646006|P2|Open Label Phase|Lost to Follow-up|2
189047|NCT00412061|646007|P1|Open Label Phase|Lost to Follow-up|0
189048|NCT00412061|646006|P2|Open Label Phase|Death|7
189049|NCT00412061|646007|P1|Open Label Phase|Death|0
189050|NCT00412061|646006|P2|Open Label Phase|Administrative Problems|13
189051|NCT00412061|646007|P1|Open Label Phase|Administrative Problems|0
189052|NCT00412061|646006|P2|Open Label Phase|Withdrawal by Subject|15
189053|NCT00412061|646007|P1|Open Label Phase|Withdrawal by Subject|0
189054|NCT00412061|646006|P2|Open Label Phase|Adverse Event|46
189055|NCT00412061|646007|P1|Open Label Phase|Adverse Event|0
189056|NCT00412061|646006|P2|Open Label Phase|Disease Progression|86
189057|NCT00412061|646007|P1|Open Label Phase|Disease Progression|0
189058|NCT00412061|646006|P2|Double Blind Phase|Lost to Follow-up|1
189059|NCT00412061|646007|P1|Double Blind Phase|Lost to Follow-up|0
189060|NCT00412061|646006|P2|Double Blind Phase|New Cander Therapy|1
189061|NCT00412061|646007|P1|Double Blind Phase|New Cander Therapy|1
189062|NCT00412061|646006|P2|Double Blind Phase|Protocol Violation|4
189063|NCT00412061|646007|P1|Double Blind Phase|Protocol Violation|3
189064|NCT00412061|646006|P2|Double Blind Phase|Death|3
189065|NCT00412061|646007|P1|Double Blind Phase|Death|6
189066|NCT00412061|646006|P2|Double Blind Phase|Withdrawal by Subject|20
189067|NCT00412061|646007|P1|Double Blind Phase|Withdrawal by Subject|18
189068|NCT00412061|646006|P2|Double Blind Phase|Final Primary Analysis|14
189069|NCT00412061|646007|P1|Double Blind Phase|Final Primary Analysis|26
189070|NCT00412061|646006|P2|Double Blind Phase|Adverse Event|16
189071|NCT00412061|646007|P1|Double Blind Phase|Adverse Event|61
189072|NCT00412061|646006|P2|Double Blind Phase|Disease Progression|154
189073|NCT00412061|646007|P1|Double Blind Phase|Disease Progression|101
189074|NCT00411788|646025|P1|Overall Study|Adverse Event|1
189075|NCT00411788|646025|P1|Overall Study|Protocol Violation|1
189076|NCT00411762|646034|P1|Overall Study|Withdrawal by Subject|5
189077|NCT00411671|646058|P1|Overall Study|Lost to Follow-up|3
189078|NCT00411671|646058|P1|Overall Study|Death|2
189079|NCT00411671|646058|P1|Overall Study|Adverse Event|15
189080|NCT00411645|646066|P2|Overall Study|Lost to Follow-up|0
189081|NCT00411645|646067|P1|Overall Study|Lost to Follow-up|2
189082|NCT00411645|646066|P2|Overall Study|Investigator/Sponsor Decision|7
189083|NCT00411645|646067|P1|Overall Study|Investigator/Sponsor Decision|10
189084|NCT00411645|646066|P2|Overall Study|Death|135
189085|NCT00411645|646067|P1|Overall Study|Death|56
189086|NCT00411645|646066|P2|Overall Study|Consent Withdrawn|22
189087|NCT00411645|646067|P1|Overall Study|Consent Withdrawn|13
189088|NCT00411554|646098|P2|Overall Study|Patient Moved|0
189089|NCT00411554|646099|P1|Overall Study|Patient Moved|1
189090|NCT00411554|646098|P2|Overall Study|Withdrawal by Subject|0
189091|NCT00411554|646099|P1|Overall Study|Withdrawal by Subject|3
189092|NCT00411554|646098|P2|Overall Study|Lack of Efficacy|5
189093|NCT00411554|646099|P1|Overall Study|Lack of Efficacy|2
189094|NCT00411554|646098|P2|Overall Study|Adverse Event|4
189095|NCT00411554|646099|P1|Overall Study|Adverse Event|2
189096|NCT00411450|646125|P1|Overall Study|Ongoing at time of data cut-off.|3
189097|NCT00411216|646168|P2|Overall Study|Ten participants were entered into the c|2
189098|NCT00411216|646169|P1|Overall Study|Ten participants were entered into the c|0
189099|NCT00411151|646175|P1|Overall Study|Trial prematurely closed|4
189100|NCT00411151|646175|P1|Overall Study|Protocol Violation|1
189101|NCT00411151|646175|P1|Overall Study|Lost to Follow-up|2
189102|NCT00411151|646175|P1|Overall Study|Withdrawal by Subject|2
189103|NCT00411151|646175|P1|Overall Study|Death|38
189104|NCT00410813|646219|P2|Overall Study|Death|2
189105|NCT00410813|646220|P1|Overall Study|Death|0
189106|NCT00410813|646219|P2|Overall Study|Ineligible|4
189107|NCT00410813|646220|P1|Overall Study|Ineligible|2
189108|NCT00410813|646219|P2|Overall Study|Not protocol specified|4
189109|NCT00410813|646220|P1|Overall Study|Not protocol specified|3
189110|NCT00410813|646219|P2|Overall Study|Progression|21
189111|NCT00410813|646220|P1|Overall Study|Progression|32
189112|NCT00410813|646219|P2|Overall Study|Adverse Event|11
189113|NCT00410813|646220|P1|Overall Study|Adverse Event|6
189114|NCT00410761|646257|P2|Overall Study|Never received randomised treatment|1
189115|NCT00410761|646258|P1|Overall Study|Never received randomised treatment|0
189116|NCT00410761|646257|P2|Overall Study|Other|9
189117|NCT00410761|646258|P1|Overall Study|Other|12
189118|NCT00410761|646257|P2|Overall Study|Withdrawal by Subject|4
189119|NCT00410761|646258|P1|Overall Study|Withdrawal by Subject|8
189120|NCT00410761|646257|P2|Overall Study|objective disease progression|55
189121|NCT00410761|646258|P1|Overall Study|objective disease progression|71
189122|NCT00410761|646257|P2|Overall Study|Adverse Event|3
189123|NCT00410761|646258|P1|Overall Study|Adverse Event|29
189124|NCT00410605|646278|P1|Overall Study|Transferred to another Institution|1
189125|NCT00410605|646278|P1|Overall Study|Stopped treatmen to collect stem cells|1
189126|NCT00410605|646278|P1|Overall Study|Started Non-Protocol Therapy|3
189127|NCT00410605|646278|P1|Overall Study|Withdrawal by Subject|5
189128|NCT00410605|646278|P1|Overall Study|Physician Decision|3
189129|NCT00410605|646278|P1|Overall Study|Adverse Event|12
189130|NCT00410514|646290|P3|Overall Study|Non-compliant with study procedures|2
189131|NCT00410514|646291|P2|Overall Study|Non-compliant with study procedures|0
189132|NCT00410514|646292|P1|Overall Study|Non-compliant with study procedures|0
189133|NCT00410514|646290|P3|Overall Study|Lost to Follow-up|2
189134|NCT00410514|646291|P2|Overall Study|Lost to Follow-up|0
189135|NCT00410514|646292|P1|Overall Study|Lost to Follow-up|0
189136|NCT00410514|646290|P3|Overall Study|Protocol Violation|1
189137|NCT00410514|646291|P2|Overall Study|Protocol Violation|1
189138|NCT00410514|646292|P1|Overall Study|Protocol Violation|0
189139|NCT00410514|646290|P3|Overall Study|Adverse Event|2
189140|NCT00410514|646291|P2|Overall Study|Adverse Event|2
189141|NCT00410514|646292|P1|Overall Study|Adverse Event|2
189142|NCT00410410|646375|P9|Open-Label Period (OL)|not specified|7
189143|NCT00410410|646376|P8|Open-Label Period (OL)|not specified|0
189144|NCT00410410|646377|P7|Open-Label Period (OL)|not specified|0
189145|NCT00410410|646378|P6|Open-Label Period (OL)|not specified|0
189146|NCT00410410|646379|P5|Open-Label Period (OL)|not specified|0
189147|NCT00410410|646380|P4|Open-Label Period (OL)|not specified|0
189148|NCT00410410|646381|P3|Open-Label Period (OL)|not specified|0
189149|NCT00410410|646382|P2|Open-Label Period (OL)|not specified|0
189150|NCT00410410|646383|P1|Open-Label Period (OL)|not specified|0
189151|NCT00410410|646375|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
189152|NCT00410410|646376|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
189153|NCT00410410|646377|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
189154|NCT00410410|646378|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
189155|NCT00410410|646379|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
189156|NCT00410410|646380|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
189157|NCT00410410|646381|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
189158|NCT00410410|646382|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
189159|NCT00410410|646383|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
189160|NCT00410410|646375|P9|Open-Label Period (OL)|Pregnancy|1
189161|NCT00410410|646376|P8|Open-Label Period (OL)|Pregnancy|0
189162|NCT00410410|646377|P7|Open-Label Period (OL)|Pregnancy|0
189163|NCT00410410|646378|P6|Open-Label Period (OL)|Pregnancy|0
189164|NCT00410410|646379|P5|Open-Label Period (OL)|Pregnancy|0
189165|NCT00410410|646380|P4|Open-Label Period (OL)|Pregnancy|0
189166|NCT00410410|646381|P3|Open-Label Period (OL)|Pregnancy|0
189167|NCT00410410|646382|P2|Open-Label Period (OL)|Pregnancy|0
189168|NCT00410410|646383|P1|Open-Label Period (OL)|Pregnancy|0
189169|NCT00410410|646375|P9|Open-Label Period (OL)|Withdrawal by Subject|20
189170|NCT00410410|646376|P8|Open-Label Period (OL)|Withdrawal by Subject|0
189171|NCT00410410|646377|P7|Open-Label Period (OL)|Withdrawal by Subject|0
189172|NCT00410410|646378|P6|Open-Label Period (OL)|Withdrawal by Subject|0
189173|NCT00410410|646379|P5|Open-Label Period (OL)|Withdrawal by Subject|0
189174|NCT00410410|646380|P4|Open-Label Period (OL)|Withdrawal by Subject|0
189175|NCT00410410|646381|P3|Open-Label Period (OL)|Withdrawal by Subject|0
189176|NCT00410410|646382|P2|Open-Label Period (OL)|Withdrawal by Subject|0
189177|NCT00410410|646383|P1|Open-Label Period (OL)|Withdrawal by Subject|0
189178|NCT00410410|646375|P9|Open-Label Period (OL)|Lost to Follow-up|4
189179|NCT00410410|646376|P8|Open-Label Period (OL)|Lost to Follow-up|0
189180|NCT00410410|646377|P7|Open-Label Period (OL)|Lost to Follow-up|0
189181|NCT00410410|646378|P6|Open-Label Period (OL)|Lost to Follow-up|0
189182|NCT00410410|646379|P5|Open-Label Period (OL)|Lost to Follow-up|0
189183|NCT00410410|646380|P4|Open-Label Period (OL)|Lost to Follow-up|0
189184|NCT00410410|646381|P3|Open-Label Period (OL)|Lost to Follow-up|0
189185|NCT00410410|646382|P2|Open-Label Period (OL)|Lost to Follow-up|0
189186|NCT00410410|646383|P1|Open-Label Period (OL)|Lost to Follow-up|0
189187|NCT00410410|646375|P9|Open-Label Period (OL)|Lack of Efficacy|161
189188|NCT00410410|646376|P8|Open-Label Period (OL)|Lack of Efficacy|0
189189|NCT00410410|646377|P7|Open-Label Period (OL)|Lack of Efficacy|0
189190|NCT00410410|646378|P6|Open-Label Period (OL)|Lack of Efficacy|0
189191|NCT00410410|646379|P5|Open-Label Period (OL)|Lack of Efficacy|0
189192|NCT00410410|646380|P4|Open-Label Period (OL)|Lack of Efficacy|0
189193|NCT00410410|646381|P3|Open-Label Period (OL)|Lack of Efficacy|0
189194|NCT00410410|646382|P2|Open-Label Period (OL)|Lack of Efficacy|0
189195|NCT00410410|646383|P1|Open-Label Period (OL)|Lack of Efficacy|0
189196|NCT00410410|646375|P9|Open-Label Period (OL)|Adverse Event|10
189197|NCT00410410|646376|P8|Open-Label Period (OL)|Adverse Event|0
189198|NCT00410410|646377|P7|Open-Label Period (OL)|Adverse Event|0
189199|NCT00410410|646378|P6|Open-Label Period (OL)|Adverse Event|0
189200|NCT00410410|646379|P5|Open-Label Period (OL)|Adverse Event|0
189201|NCT00410410|646380|P4|Open-Label Period (OL)|Adverse Event|0
189202|NCT00410410|646381|P3|Open-Label Period (OL)|Adverse Event|0
189203|NCT00410410|646382|P2|Open-Label Period (OL)|Adverse Event|0
189204|NCT00410410|646383|P1|Open-Label Period (OL)|Adverse Event|0
189205|NCT00410410|646375|P9|Open-Label Period (OL)|Death|1
189206|NCT00410410|646376|P8|Open-Label Period (OL)|Death|0
189207|NCT00410410|646377|P7|Open-Label Period (OL)|Death|0
189208|NCT00410410|646378|P6|Open-Label Period (OL)|Death|0
189209|NCT00410410|646379|P5|Open-Label Period (OL)|Death|0
189210|NCT00410410|646380|P4|Open-Label Period (OL)|Death|0
189211|NCT00410410|646381|P3|Open-Label Period (OL)|Death|0
189212|NCT00410410|646382|P2|Open-Label Period (OL)|Death|0
189213|NCT00410410|646383|P1|Open-Label Period (OL)|Death|0
189214|NCT00410410|646375|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
189215|NCT00410410|646376|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
189216|NCT00410410|646377|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
189217|NCT00410410|646378|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
189218|NCT00410410|646379|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
189219|NCT00410410|646380|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
189220|NCT00410410|646381|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
189221|NCT00410410|646382|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
189222|NCT00410410|646383|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
189223|NCT00410410|646375|P9|Maintenance Period (MP)|Withdrawal by Subject|0
189224|NCT00410410|646376|P8|Maintenance Period (MP)|Withdrawal by Subject|1
189225|NCT00410410|646377|P7|Maintenance Period (MP)|Withdrawal by Subject|1
189226|NCT00410410|646378|P6|Maintenance Period (MP)|Withdrawal by Subject|0
189227|NCT00410410|646379|P5|Maintenance Period (MP)|Withdrawal by Subject|0
189228|NCT00410410|646380|P4|Maintenance Period (MP)|Withdrawal by Subject|0
189229|NCT00410410|646381|P3|Maintenance Period (MP)|Withdrawal by Subject|0
189230|NCT00410410|646382|P2|Maintenance Period (MP)|Withdrawal by Subject|0
189231|NCT00410410|646383|P1|Maintenance Period (MP)|Withdrawal by Subject|0
189232|NCT00410410|646375|P9|Maintenance Period (MP)|Lost to Follow-up|0
189233|NCT00410410|646376|P8|Maintenance Period (MP)|Lost to Follow-up|2
189234|NCT00410410|646377|P7|Maintenance Period (MP)|Lost to Follow-up|1
189235|NCT00410410|646378|P6|Maintenance Period (MP)|Lost to Follow-up|0
189236|NCT00410410|646379|P5|Maintenance Period (MP)|Lost to Follow-up|0
189237|NCT00410410|646380|P4|Maintenance Period (MP)|Lost to Follow-up|0
189238|NCT00410410|646381|P3|Maintenance Period (MP)|Lost to Follow-up|0
189239|NCT00410410|646382|P2|Maintenance Period (MP)|Lost to Follow-up|0
189240|NCT00410410|646383|P1|Maintenance Period (MP)|Lost to Follow-up|0
189241|NCT00410410|646375|P9|Maintenance Period (MP)|Lack of Efficacy|0
189242|NCT00410410|646376|P8|Maintenance Period (MP)|Lack of Efficacy|24
189243|NCT00410410|646377|P7|Maintenance Period (MP)|Lack of Efficacy|25
189244|NCT00410410|646378|P6|Maintenance Period (MP)|Lack of Efficacy|0
189245|NCT00410410|646379|P5|Maintenance Period (MP)|Lack of Efficacy|0
189246|NCT00410410|646380|P4|Maintenance Period (MP)|Lack of Efficacy|0
189247|NCT00410410|646381|P3|Maintenance Period (MP)|Lack of Efficacy|0
189248|NCT00410410|646382|P2|Maintenance Period (MP)|Lack of Efficacy|0
189249|NCT00410410|646383|P1|Maintenance Period (MP)|Lack of Efficacy|0
189250|NCT00410410|646375|P9|Maintenance Period (MP)|Adverse Event|0
189251|NCT00410410|646376|P8|Maintenance Period (MP)|Adverse Event|3
189252|NCT00410410|646377|P7|Maintenance Period (MP)|Adverse Event|1
189253|NCT00410410|646378|P6|Maintenance Period (MP)|Adverse Event|0
189254|NCT00410410|646379|P5|Maintenance Period (MP)|Adverse Event|0
189255|NCT00410410|646380|P4|Maintenance Period (MP)|Adverse Event|0
189256|NCT00410410|646381|P3|Maintenance Period (MP)|Adverse Event|0
189257|NCT00410410|646382|P2|Maintenance Period (MP)|Adverse Event|0
189258|NCT00410410|646383|P1|Maintenance Period (MP)|Adverse Event|0
189259|NCT00410410|646375|P9|Maintenance Period (MP)|Death|0
189260|NCT00410410|646376|P8|Maintenance Period (MP)|Death|0
189261|NCT00410410|646377|P7|Maintenance Period (MP)|Death|1
189262|NCT00410410|646378|P6|Maintenance Period (MP)|Death|0
189263|NCT00410410|646379|P5|Maintenance Period (MP)|Death|0
189264|NCT00410410|646380|P4|Maintenance Period (MP)|Death|0
189265|NCT00410410|646381|P3|Maintenance Period (MP)|Death|0
189266|NCT00410410|646382|P2|Maintenance Period (MP)|Death|0
189267|NCT00410410|646383|P1|Maintenance Period (MP)|Death|0
189268|NCT00410410|646375|P9|Induction Period (IP)|not specified|0
189269|NCT00410410|646376|P8|Induction Period (IP)|not specified|0
189270|NCT00410410|646377|P7|Induction Period (IP)|not specified|0
189271|NCT00410410|646378|P6|Induction Period (IP)|not specified|0
189272|NCT00410410|646379|P5|Induction Period (IP)|not specified|0
189273|NCT00410410|646380|P4|Induction Period (IP)|not specified|0
189274|NCT00410410|646381|P3|Induction Period (IP)|not specified|1
189275|NCT00410410|646382|P2|Induction Period (IP)|not specified|0
189276|NCT00410410|646383|P1|Induction Period (IP)|not specified|0
189277|NCT00410410|646375|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
189278|NCT00410410|646376|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
189279|NCT00410410|646377|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
189280|NCT00410410|646378|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
189281|NCT00410410|646379|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
189282|NCT00410410|646380|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
189283|NCT00410410|646381|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
189284|NCT00410410|646382|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
189285|NCT00410410|646383|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
189286|NCT00410410|646375|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
189287|NCT00410410|646376|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
189288|NCT00410410|646377|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
189289|NCT00410410|646378|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
189290|NCT00410410|646379|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
189291|NCT00410410|646380|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
189292|NCT00410410|646381|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
189293|NCT00410410|646382|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
189294|NCT00410410|646383|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
189295|NCT00410410|646375|P9|Induction Period (IP)|Withdrawal by Subject|0
189296|NCT00410410|646376|P8|Induction Period (IP)|Withdrawal by Subject|0
189297|NCT00410410|646377|P7|Induction Period (IP)|Withdrawal by Subject|0
189298|NCT00410410|646378|P6|Induction Period (IP)|Withdrawal by Subject|0
189299|NCT00410410|646379|P5|Induction Period (IP)|Withdrawal by Subject|2
189300|NCT00410410|646380|P4|Induction Period (IP)|Withdrawal by Subject|5
189301|NCT00410410|646381|P3|Induction Period (IP)|Withdrawal by Subject|3
189302|NCT00410410|646382|P2|Induction Period (IP)|Withdrawal by Subject|5
189303|NCT00410410|646383|P1|Induction Period (IP)|Withdrawal by Subject|3
189304|NCT00410410|646375|P9|Induction Period (IP)|Lost to Follow-up|0
189305|NCT00410410|646376|P8|Induction Period (IP)|Lost to Follow-up|0
189306|NCT00410410|646377|P7|Induction Period (IP)|Lost to Follow-up|0
189307|NCT00410410|646378|P6|Induction Period (IP)|Lost to Follow-up|1
189308|NCT00410410|646379|P5|Induction Period (IP)|Lost to Follow-up|0
189309|NCT00410410|646380|P4|Induction Period (IP)|Lost to Follow-up|3
189310|NCT00410410|646381|P3|Induction Period (IP)|Lost to Follow-up|2
189311|NCT00410410|646382|P2|Induction Period (IP)|Lost to Follow-up|2
189312|NCT00410410|646383|P1|Induction Period (IP)|Lost to Follow-up|2
189313|NCT00410410|646375|P9|Induction Period (IP)|Lack of Efficacy|0
189314|NCT00410410|646376|P8|Induction Period (IP)|Lack of Efficacy|0
189315|NCT00410410|646377|P7|Induction Period (IP)|Lack of Efficacy|0
189316|NCT00410410|646378|P6|Induction Period (IP)|Lack of Efficacy|7
189317|NCT00410410|646379|P5|Induction Period (IP)|Lack of Efficacy|7
189318|NCT00410410|646380|P4|Induction Period (IP)|Lack of Efficacy|8
189319|NCT00410410|646381|P3|Induction Period (IP)|Lack of Efficacy|8
189320|NCT00410410|646382|P2|Induction Period (IP)|Lack of Efficacy|24
189321|NCT00410410|646383|P1|Induction Period (IP)|Lack of Efficacy|26
189322|NCT00410410|646375|P9|Induction Period (IP)|Adverse Event|0
189323|NCT00410410|646376|P8|Induction Period (IP)|Adverse Event|0
189324|NCT00410410|646377|P7|Induction Period (IP)|Adverse Event|0
189325|NCT00410410|646378|P6|Induction Period (IP)|Adverse Event|0
189326|NCT00410410|646379|P5|Induction Period (IP)|Adverse Event|1
189327|NCT00410410|646380|P4|Induction Period (IP)|Adverse Event|4
189328|NCT00410410|646381|P3|Induction Period (IP)|Adverse Event|2
189329|NCT00410410|646382|P2|Induction Period (IP)|Adverse Event|4
189330|NCT00410410|646383|P1|Induction Period (IP)|Adverse Event|3
189331|NCT00410410|646375|P9|Induction Period (IP)|Death|0
189332|NCT00410410|646376|P8|Induction Period (IP)|Death|0
189333|NCT00410410|646377|P7|Induction Period (IP)|Death|0
189334|NCT00410410|646378|P6|Induction Period (IP)|Death|0
189335|NCT00410410|646379|P5|Induction Period (IP)|Death|0
189336|NCT00410410|646380|P4|Induction Period (IP)|Death|0
189337|NCT00410410|646381|P3|Induction Period (IP)|Death|0
189338|NCT00410410|646382|P2|Induction Period (IP)|Death|0
189339|NCT00410410|646383|P1|Induction Period (IP)|Death|1
189340|NCT00410384|646544|P3|Overall Study|Other|4
189341|NCT00410384|646545|P2|Overall Study|Other|8
189342|NCT00410384|646546|P1|Overall Study|Other|3
189343|NCT00410384|646544|P3|Overall Study|Physician Decision|4
189344|NCT00410384|646545|P2|Overall Study|Physician Decision|3
189345|NCT00410384|646546|P1|Overall Study|Physician Decision|3
189346|NCT00410384|646544|P3|Overall Study|Protocol Violation|6
189347|NCT00410384|646545|P2|Overall Study|Protocol Violation|6
189348|NCT00410384|646546|P1|Overall Study|Protocol Violation|6
189349|NCT00410384|646544|P3|Overall Study|Lost to Follow-up|6
189350|NCT00410384|646545|P2|Overall Study|Lost to Follow-up|6
189351|NCT00410384|646546|P1|Overall Study|Lost to Follow-up|4
189352|NCT00410384|646544|P3|Overall Study|Lack of Compliance|2
189353|NCT00410384|646545|P2|Overall Study|Lack of Compliance|2
189354|NCT00410384|646546|P1|Overall Study|Lack of Compliance|2
189355|NCT00410384|646544|P3|Overall Study|Lack of Efficacy|17
189356|NCT00410384|646545|P2|Overall Study|Lack of Efficacy|12
189357|NCT00410384|646546|P1|Overall Study|Lack of Efficacy|20
189358|NCT00410384|646544|P3|Overall Study|Adverse Event|23
189359|NCT00410384|646545|P2|Overall Study|Adverse Event|18
189360|NCT00410384|646546|P1|Overall Study|Adverse Event|23
189361|NCT00410384|646544|P3|Overall Study|Withdrawal by Subject|20
189362|NCT00410384|646545|P2|Overall Study|Withdrawal by Subject|17
189363|NCT00410384|646546|P1|Overall Study|Withdrawal by Subject|28
189364|NCT00410202|646619|P3|Off-treatment Follow up|Lost to Follow-up|0
189365|NCT00410202|646620|P2|Off-treatment Follow up|Lost to Follow-up|0
189366|NCT00410202|646621|P1|Off-treatment Follow up|Lost to Follow-up|1
189367|NCT00410202|646619|P3|Off-treatment Follow up|Follow up not required per protocol|1
189368|NCT00410202|646620|P2|Off-treatment Follow up|Follow up not required per protocol|0
189369|NCT00410202|646621|P1|Off-treatment Follow up|Follow up not required per protocol|3
189370|NCT00410202|646619|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
189371|NCT00410202|646620|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
189372|NCT00410202|646621|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
189373|NCT00410202|646619|P3|On-Treatment|Other Reason|1
189374|NCT00410202|646620|P2|On-Treatment|Other Reason|0
189375|NCT00410202|646621|P1|On-Treatment|Other Reason|0
189376|NCT00410202|646619|P3|On-Treatment|Withdrawal by Subject|1
189377|NCT00410202|646620|P2|On-Treatment|Withdrawal by Subject|1
189378|NCT00410202|646621|P1|On-Treatment|Withdrawal by Subject|2
189379|NCT00410202|646619|P3|On-Treatment|Lack of Efficacy|0
189380|NCT00410202|646620|P2|On-Treatment|Lack of Efficacy|4
189381|NCT00410202|646621|P1|On-Treatment|Lack of Efficacy|1
189382|NCT00410202|646619|P3|On-Treatment|Lost to Follow-up|1
189383|NCT00410202|646620|P2|On-Treatment|Lost to Follow-up|0
189384|NCT00410202|646621|P1|On-Treatment|Lost to Follow-up|1
189385|NCT00410202|646619|P3|On-Treatment|Death|0
189386|NCT00410202|646620|P2|On-Treatment|Death|0
189387|NCT00410202|646621|P1|On-Treatment|Death|1
189388|NCT00410202|646619|P3|On-Treatment|Adverse Event|2
189389|NCT00410202|646620|P2|On-Treatment|Adverse Event|3
189390|NCT00410202|646621|P1|On-Treatment|Adverse Event|1
189391|NCT00410202|646619|P3|On-Treatment|Continuing treatment|66
189392|NCT00410202|646620|P2|On-Treatment|Continuing treatment|71
189393|NCT00410202|646621|P1|On-Treatment|Continuing treatment|69
189394|NCT00410163|646708|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
189395|NCT00410163|646709|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
189396|NCT00410163|646708|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
189397|NCT00410163|646709|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
189398|NCT00410163|646708|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
189399|NCT00410163|646709|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
189400|NCT00410163|646708|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
189401|NCT00410163|646709|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
189402|NCT00410163|646708|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
189403|NCT00410163|646709|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
189404|NCT00410163|646708|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
189405|NCT00410163|646709|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
189406|NCT00410163|646708|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
189407|NCT00410163|646709|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
189408|NCT00410163|646708|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
189409|NCT00410163|646709|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
189410|NCT00410163|646708|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
189411|NCT00410163|646709|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
189412|NCT00410163|646708|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
189413|NCT00410163|646709|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
189414|NCT00410163|646708|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
189415|NCT00410163|646709|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
189416|NCT00410163|646708|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
189417|NCT00410163|646709|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
189418|NCT00410163|646708|P2|Treatment and Follow-up Phase (2 Years)|Death|1
189419|NCT00410163|646709|P1|Treatment and Follow-up Phase (2 Years)|Death|1
189420|NCT00410163|646708|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
189421|NCT00410163|646709|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
189422|NCT00410124|646762|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
189423|NCT00410124|646763|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
189424|NCT00410124|646762|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
189425|NCT00410124|646763|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
189426|NCT00410124|646762|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
189427|NCT00410124|646763|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
189428|NCT00410124|646762|P2|Extension Phase - Open Label (45 Months)|Death|10
189429|NCT00410124|646763|P1|Extension Phase - Open Label (45 Months)|Death|2
189430|NCT00410124|646762|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
189431|NCT00410124|646763|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
189432|NCT00410124|646762|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
189433|NCT00410124|646763|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
189434|NCT00410124|646762|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
189435|NCT00410124|646763|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
189436|NCT00410124|646762|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
189437|NCT00410124|646763|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
189438|NCT00410124|646762|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
189439|NCT00410124|646763|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
189440|NCT00410124|646762|P2|Core Phase Double Blind (15 Months)|Death|4
189441|NCT00410124|646763|P1|Core Phase Double Blind (15 Months)|Death|7
189442|NCT00410124|646762|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
189443|NCT00410124|646763|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
189444|NCT00410124|646762|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
189445|NCT00410124|646763|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
189446|NCT00410124|646762|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
189447|NCT00410124|646763|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
189448|NCT00410124|646762|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
189449|NCT00410124|646763|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
189450|NCT00410124|646762|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
189451|NCT00410124|646763|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
189452|NCT00410124|646762|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
189453|NCT00410124|646763|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
189454|NCT00410072|646794|P2|After Week 48 to Week 96|Withdrawal by Subject|1
189455|NCT00410072|646795|P1|After Week 48 to Week 96|Withdrawal by Subject|0
189456|NCT00410072|646794|P2|After Week 48 to Week 96|Pregnancy|2
189457|NCT00410072|646795|P1|After Week 48 to Week 96|Pregnancy|0
189458|NCT00410072|646794|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
189459|NCT00410072|646795|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
189460|NCT00410072|646794|P2|After Week 48 to Week 96|Not specified|0
189461|NCT00410072|646795|P1|After Week 48 to Week 96|Not specified|2
189462|NCT00410072|646794|P2|After Week 48 to Week 96|Lost to Follow-up|4
189463|NCT00410072|646795|P1|After Week 48 to Week 96|Lost to Follow-up|2
189464|NCT00410072|646794|P2|After Week 48 to Week 96|Lack of Efficacy|0
189465|NCT00410072|646795|P1|After Week 48 to Week 96|Lack of Efficacy|1
189466|NCT00410072|646794|P2|After Week 48 to Week 96|Death|1
189467|NCT00410072|646795|P1|After Week 48 to Week 96|Death|0
189468|NCT00410072|646794|P2|After Week 48 to Week 96|Adverse Event|2
189469|NCT00410072|646795|P1|After Week 48 to Week 96|Adverse Event|1
189470|NCT00410072|646794|P2|Day 1 to Week 48|Withdrawal by Subject|2
189471|NCT00410072|646795|P1|Day 1 to Week 48|Withdrawal by Subject|0
189472|NCT00410072|646794|P2|Day 1 to Week 48|Pregnancy|2
189473|NCT00410072|646795|P1|Day 1 to Week 48|Pregnancy|0
189474|NCT00410072|646794|P2|Day 1 to Week 48|poor compliance/noncompliance|3
189475|NCT00410072|646795|P1|Day 1 to Week 48|poor compliance/noncompliance|0
189476|NCT00410072|646794|P2|Day 1 to Week 48|Not specified|1
189477|NCT00410072|646795|P1|Day 1 to Week 48|Not specified|0
189478|NCT00410072|646794|P2|Day 1 to Week 48|Lost to Follow-up|2
189479|NCT00410072|646795|P1|Day 1 to Week 48|Lost to Follow-up|5
189480|NCT00410072|646794|P2|Day 1 to Week 48|Adverse Event|2
189481|NCT00410072|646795|P1|Day 1 to Week 48|Adverse Event|1
189482|NCT00410046|646835|P1|Overall Study|Lost to Follow-up|1
189483|NCT00410046|646835|P1|Overall Study|Withdrawal by Subject|1
189484|NCT00410046|646835|P1|Overall Study|Adverse Event|3
189485|NCT00409838|646866|P2|Long-term Extension Period|Pregnancy|0
189486|NCT00409838|646867|P1|Long-term Extension Period|Pregnancy|1
189487|NCT00409838|646866|P2|Long-term Extension Period|Poor compliance/noncompliance|0
189488|NCT00409838|646867|P1|Long-term Extension Period|Poor compliance/noncompliance|1
189489|NCT00409838|646866|P2|Long-term Extension Period|Withdrawal by Subject|0
189490|NCT00409838|646867|P1|Long-term Extension Period|Withdrawal by Subject|3
189491|NCT00409838|646866|P2|Long-term Extension Period|Lack of Efficacy|0
189492|NCT00409838|646867|P1|Long-term Extension Period|Lack of Efficacy|2
189493|NCT00409838|646866|P2|Long-term Extension Period|Death|0
189494|NCT00409838|646867|P1|Long-term Extension Period|Death|1
189495|NCT00409838|646866|P2|Long-term Extension Period|Adverse Event|0
189496|NCT00409838|646867|P1|Long-term Extension Period|Adverse Event|10
189497|NCT00409838|646866|P2|Short-term Period|Never Treated|0
189498|NCT00409838|646867|P1|Short-term Period|Never Treated|1
189499|NCT00409838|646866|P2|Short-term Period|Withdrawal by Subject|3
189500|NCT00409838|646867|P1|Short-term Period|Withdrawal by Subject|2
189501|NCT00409838|646866|P2|Short-term Period|Lost to Follow-up|1
189502|NCT00409838|646867|P1|Short-term Period|Lost to Follow-up|0
189503|NCT00409838|646866|P2|Short-term Period|Adverse Event|1
189504|NCT00409838|646867|P1|Short-term Period|Adverse Event|0
189505|NCT00409786|646932|P1|Overall Study|Withdrawal by Subject|3
189506|NCT00409773|646941|P5|Overall Study|Lack of Eligibility|1
189507|NCT00409773|646942|P4|Overall Study|Lack of Eligibility|0
189508|NCT00409773|646943|P3|Overall Study|Lack of Eligibility|0
189509|NCT00409773|646944|P2|Overall Study|Lack of Eligibility|0
189510|NCT00409773|646945|P1|Overall Study|Lack of Eligibility|0
189511|NCT00409773|646941|P5|Overall Study|Withdrawal by Subject|1
189512|NCT00409773|646942|P4|Overall Study|Withdrawal by Subject|2
189513|NCT00409773|646943|P3|Overall Study|Withdrawal by Subject|0
189514|NCT00409773|646944|P2|Overall Study|Withdrawal by Subject|0
189515|NCT00409773|646945|P1|Overall Study|Withdrawal by Subject|0
189516|NCT00409773|646941|P5|Overall Study|Protocol Violation|1
189517|NCT00409773|646942|P4|Overall Study|Protocol Violation|3
189518|NCT00409773|646943|P3|Overall Study|Protocol Violation|3
189519|NCT00409773|646944|P2|Overall Study|Protocol Violation|2
189520|NCT00409773|646945|P1|Overall Study|Protocol Violation|0
189521|NCT00409773|646941|P5|Overall Study|Physician Decision|0
189522|NCT00409773|646942|P4|Overall Study|Physician Decision|2
189523|NCT00409773|646943|P3|Overall Study|Physician Decision|0
189524|NCT00409773|646944|P2|Overall Study|Physician Decision|0
189525|NCT00409773|646945|P1|Overall Study|Physician Decision|0
189526|NCT00409773|646941|P5|Overall Study|Lost to Follow-up|1
189527|NCT00409773|646942|P4|Overall Study|Lost to Follow-up|3
189528|NCT00409773|646943|P3|Overall Study|Lost to Follow-up|2
189529|NCT00409773|646944|P2|Overall Study|Lost to Follow-up|1
189530|NCT00409773|646945|P1|Overall Study|Lost to Follow-up|6
189531|NCT00409773|646941|P5|Overall Study|Adverse Event|6
189532|NCT00409773|646942|P4|Overall Study|Adverse Event|2
189533|NCT00409773|646943|P3|Overall Study|Adverse Event|4
189534|NCT00409773|646944|P2|Overall Study|Adverse Event|4
189535|NCT00409773|646945|P1|Overall Study|Adverse Event|3
189536|NCT00409747|647027|P1|Overall Study|Withdrawal by Subject|1
189537|NCT00409708|647034|P2|Washout|Lost to Follow-up|3
189538|NCT00409708|647035|P1|Washout|Lost to Follow-up|1
189539|NCT00409708|647034|P2|Washout|Withdrawal by Subject|5
189540|NCT00409708|647035|P1|Washout|Withdrawal by Subject|11
189541|NCT00409708|647034|P2|Washout|Protocol Violation|1
189542|NCT00409708|647035|P1|Washout|Protocol Violation|0
189543|NCT00409708|647034|P2|Washout|Lack of Efficacy|1
189544|NCT00409708|647035|P1|Washout|Lack of Efficacy|9
189545|NCT00409708|647034|P2|Treatment|Administrative problems|0
189546|NCT00409708|647035|P1|Treatment|Administrative problems|5
189547|NCT00409708|647034|P2|Treatment|Lost to Follow-up|6
189548|NCT00409708|647035|P1|Treatment|Lost to Follow-up|0
189549|NCT00409708|647034|P2|Treatment|Withdrawal by Subject|8
189550|NCT00409708|647035|P1|Treatment|Withdrawal by Subject|3
189551|NCT00409708|647034|P2|Treatment|Protocol Violation|2
189552|NCT00409708|647035|P1|Treatment|Protocol Violation|6
189553|NCT00409708|647034|P2|Treatment|Lack of Efficacy|1
189554|NCT00409708|647035|P1|Treatment|Lack of Efficacy|0
189555|NCT00409708|647034|P2|Treatment|Abnormal test procedure result(s)|0
189556|NCT00409708|647035|P1|Treatment|Abnormal test procedure result(s)|1
189557|NCT00409682|647056|P3|EOW Double-blind Maintenance Period|Non-compliance|1
189558|NCT00409682|647057|P2|EOW Double-blind Maintenance Period|Non-compliance|0
189559|NCT00409682|647058|P1|EOW Double-blind Maintenance Period|Non-compliance|0
189560|NCT00409682|647056|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
189561|NCT00409682|647057|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
189562|NCT00409682|647058|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
189563|NCT00409682|647056|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
189564|NCT00409682|647057|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
189565|NCT00409682|647058|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
189566|NCT00409682|647056|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
189567|NCT00409682|647057|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
189568|NCT00409682|647058|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
189569|NCT00409682|647056|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
189570|NCT00409682|647057|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
189571|NCT00409682|647058|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
189572|NCT00409682|647056|P3|EOW Double-blind Maintenance Period|Adverse Event|12
189573|NCT00409682|647057|P2|EOW Double-blind Maintenance Period|Adverse Event|10
189574|NCT00409682|647058|P1|EOW Double-blind Maintenance Period|Adverse Event|0
189575|NCT00409682|647056|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
189576|NCT00409682|647057|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
189577|NCT00409682|647058|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
189578|NCT00409682|647056|P3|Open-label Induction Period|Protocol Violation|0
189579|NCT00409682|647057|P2|Open-label Induction Period|Protocol Violation|0
189580|NCT00409682|647058|P1|Open-label Induction Period|Protocol Violation|1
189581|NCT00409682|647056|P3|Open-label Induction Period|Lack of Efficacy|0
189582|NCT00409682|647057|P2|Open-label Induction Period|Lack of Efficacy|0
189583|NCT00409682|647058|P1|Open-label Induction Period|Lack of Efficacy|1
189584|NCT00409682|647056|P3|Open-label Induction Period|Adverse Event|0
189585|NCT00409682|647057|P2|Open-label Induction Period|Adverse Event|0
189586|NCT00409682|647058|P1|Open-label Induction Period|Adverse Event|1
189587|NCT00409617|647075|P1|Overall Study|Not described|14
189588|NCT00409617|647075|P1|Overall Study|Administrative reasons|1
189589|NCT00409617|647075|P1|Overall Study|Withdrawal by Subject|8
189590|NCT00409617|647075|P1|Overall Study|Protocol Violation|24
189591|NCT00409617|647075|P1|Overall Study|Lost to Follow-up|2
189592|NCT00409617|647075|P1|Overall Study|Lack of Efficacy|54
189593|NCT00409617|647075|P1|Overall Study|Adverse Event|57
189594|NCT00409578|647091|P4|Overall Study|Missing|1
189595|NCT00409578|647092|P3|Overall Study|Missing|0
189596|NCT00409578|647093|P2|Overall Study|Missing|1
189597|NCT00409578|647094|P1|Overall Study|Missing|0
189598|NCT00409578|647091|P4|Overall Study|Protocol Violation|1
189599|NCT00409578|647092|P3|Overall Study|Protocol Violation|3
189600|NCT00409578|647093|P2|Overall Study|Protocol Violation|2
189601|NCT00409578|647094|P1|Overall Study|Protocol Violation|3
189602|NCT00409578|647091|P4|Overall Study|Death|2
189603|NCT00409578|647092|P3|Overall Study|Death|4
189604|NCT00409578|647093|P2|Overall Study|Death|4
189605|NCT00409578|647094|P1|Overall Study|Death|2
189606|NCT00409578|647091|P4|Overall Study|Administrative problems|4
189607|NCT00409578|647092|P3|Overall Study|Administrative problems|2
189608|NCT00409578|647093|P2|Overall Study|Administrative problems|9
189609|NCT00409578|647094|P1|Overall Study|Administrative problems|8
189610|NCT00409578|647091|P4|Overall Study|Lost to Follow-up|2
189611|NCT00409578|647092|P3|Overall Study|Lost to Follow-up|2
189612|NCT00409578|647093|P2|Overall Study|Lost to Follow-up|0
189613|NCT00409578|647094|P1|Overall Study|Lost to Follow-up|2
189614|NCT00409578|647091|P4|Overall Study|Withdrawal by Subject|17
189615|NCT00409578|647092|P3|Overall Study|Withdrawal by Subject|16
189616|NCT00409578|647093|P2|Overall Study|Withdrawal by Subject|15
189617|NCT00409578|647094|P1|Overall Study|Withdrawal by Subject|8
189618|NCT00409578|647091|P4|Overall Study|Subject no longer requires study drug|1
189619|NCT00409578|647092|P3|Overall Study|Subject no longer requires study drug|0
189620|NCT00409578|647093|P2|Overall Study|Subject no longer requires study drug|0
189621|NCT00409578|647094|P1|Overall Study|Subject no longer requires study drug|0
189622|NCT00409578|647091|P4|Overall Study|Lack of Efficacy|2
189623|NCT00409578|647092|P3|Overall Study|Lack of Efficacy|0
189624|NCT00409578|647093|P2|Overall Study|Lack of Efficacy|0
189625|NCT00409578|647094|P1|Overall Study|Lack of Efficacy|0
189626|NCT00409578|647091|P4|Overall Study|Abnormal laboratory value(s)|4
189627|NCT00409578|647092|P3|Overall Study|Abnormal laboratory value(s)|2
189628|NCT00409578|647093|P2|Overall Study|Abnormal laboratory value(s)|2
189629|NCT00409578|647094|P1|Overall Study|Abnormal laboratory value(s)|2
189630|NCT00409578|647091|P4|Overall Study|Adverse Event|33
189631|NCT00409578|647092|P3|Overall Study|Adverse Event|25
189632|NCT00409578|647093|P2|Overall Study|Adverse Event|37
189633|NCT00409578|647094|P1|Overall Study|Adverse Event|27
189634|NCT00409409|647152|P2|Overall Study|Any other reason not above-mentioned|1
189635|NCT00409409|647153|P1|Overall Study|Any other reason not above-mentioned|0
189636|NCT00409409|647152|P2|Overall Study|Withdrawal by Subject|1
189637|NCT00409409|647153|P1|Overall Study|Withdrawal by Subject|1
189638|NCT00409409|647152|P2|Overall Study|Adverse Event|2
189639|NCT00409409|647153|P1|Overall Study|Adverse Event|7
189640|NCT00409344|647161|P2|Overall Study|no enrollment|0
189641|NCT00409344|647162|P1|Overall Study|no enrollment|0
189642|NCT00409331|647180|P1|Overall Study|Physician Decision|1
189643|NCT00409188|647202|P2|Overall Study|Ongoing at data cut-off|175
189644|NCT00409188|647203|P1|Overall Study|Ongoing at data cut-off|383
189645|NCT00409175|647219|P2|Overall Study|Liver transplantation|13
189646|NCT00409175|647220|P1|Overall Study|Liver transplantation|13
189647|NCT00409175|647219|P2|Overall Study|Negative genotype|1
189648|NCT00409175|647220|P1|Overall Study|Negative genotype|0
189649|NCT00409175|647219|P2|Overall Study|Withdrawal by Subject|2
189650|NCT00409175|647220|P1|Overall Study|Withdrawal by Subject|1
189651|NCT00409175|647219|P2|Overall Study|Adverse Event|3
189652|NCT00409175|647220|P1|Overall Study|Adverse Event|4
189653|NCT00409006|647246|P2|Overall Study|Physician Decision|2
189654|NCT00409006|647247|P1|Overall Study|Physician Decision|1
189655|NCT00409006|647246|P2|Overall Study|Withdrawal by Subject|2
189656|NCT00409006|647247|P1|Overall Study|Withdrawal by Subject|3
189657|NCT00409006|647246|P2|Overall Study|Lost to Follow-up|2
189658|NCT00409006|647247|P1|Overall Study|Lost to Follow-up|1
189659|NCT00409006|647246|P2|Overall Study|Death|6
189660|NCT00409006|647247|P1|Overall Study|Death|15
189661|NCT00408993|647263|P2|Overall Study|Withdrawal by Subject|3
189662|NCT00408993|647264|P1|Overall Study|Withdrawal by Subject|2
189663|NCT00408993|647263|P2|Overall Study|Lack of Efficacy|4
189664|NCT00408993|647264|P1|Overall Study|Lack of Efficacy|1
189665|NCT00408993|647263|P2|Overall Study|Protocol Violation|6
189666|NCT00408993|647264|P1|Overall Study|Protocol Violation|1
189667|NCT00408993|647263|P2|Overall Study|Adverse Event|4
189668|NCT00408993|647264|P1|Overall Study|Adverse Event|15
189669|NCT00408928|647296|P1|Overall Study|Infection indistinguishable from GVHD|1
189670|NCT00408928|647296|P1|Overall Study|Death|1
189671|NCT00408928|647296|P1|Overall Study|Withdrawal by Subject|1
189672|NCT00408902|647301|P1|Overall Study|Adverse Event|3
189673|NCT00408902|647301|P1|Overall Study|Lack of Efficacy|7
189674|NCT00408876|647311|P4|Overall Study|Physician Decision|0
189675|NCT00408876|647312|P3|Overall Study|Physician Decision|3
189676|NCT00408876|647313|P2|Overall Study|Physician Decision|0
189677|NCT00408876|647314|P1|Overall Study|Physician Decision|1
189678|NCT00408876|647311|P4|Overall Study|Protocol Violation|3
189679|NCT00408876|647312|P3|Overall Study|Protocol Violation|4
189680|NCT00408876|647313|P2|Overall Study|Protocol Violation|3
189681|NCT00408876|647314|P1|Overall Study|Protocol Violation|0
189682|NCT00408876|647311|P4|Overall Study|Lost to Follow-up|2
189683|NCT00408876|647312|P3|Overall Study|Lost to Follow-up|5
189684|NCT00408876|647313|P2|Overall Study|Lost to Follow-up|6
189685|NCT00408876|647314|P1|Overall Study|Lost to Follow-up|1
189686|NCT00408876|647311|P4|Overall Study|Lack of Efficacy|6
189687|NCT00408876|647312|P3|Overall Study|Lack of Efficacy|5
189688|NCT00408876|647313|P2|Overall Study|Lack of Efficacy|4
189689|NCT00408876|647314|P1|Overall Study|Lack of Efficacy|2
189690|NCT00408876|647311|P4|Overall Study|Withdrawal by Subject|14
189691|NCT00408876|647312|P3|Overall Study|Withdrawal by Subject|6
189692|NCT00408876|647313|P2|Overall Study|Withdrawal by Subject|6
189693|NCT00408876|647314|P1|Overall Study|Withdrawal by Subject|3
189694|NCT00408876|647311|P4|Overall Study|Adverse Event|10
189695|NCT00408876|647312|P3|Overall Study|Adverse Event|27
189696|NCT00408876|647313|P2|Overall Study|Adverse Event|17
189697|NCT00408876|647314|P1|Overall Study|Adverse Event|9
189698|NCT00408694|647564|P1|Overall Study|No protocol treatment|1
189699|NCT00408694|647564|P1|Overall Study|Ineligible|1
189700|NCT00408681|647576|P1|Overall Study|Adverse Event|7
189701|NCT00408681|647576|P1|Overall Study|Lack of Efficacy|2
189702|NCT00408629|647595|P2|Overall Study|Miscellaneous|15
189703|NCT00408629|647596|P1|Overall Study|Miscellaneous|11
189704|NCT00408629|647595|P2|Overall Study|Protocol Violation|5
189705|NCT00408629|647596|P1|Overall Study|Protocol Violation|1
189706|NCT00408629|647595|P2|Overall Study|Lack of Efficacy|73
189707|NCT00408629|647596|P1|Overall Study|Lack of Efficacy|63
189708|NCT00408629|647595|P2|Overall Study|Lost to Follow-up|1
189709|NCT00408629|647596|P1|Overall Study|Lost to Follow-up|1
189710|NCT00408629|647595|P2|Overall Study|Withdrawal by Subject|4
189711|NCT00408629|647596|P1|Overall Study|Withdrawal by Subject|8
189712|NCT00408629|647595|P2|Overall Study|Adverse Event|27
189713|NCT00408629|647596|P1|Overall Study|Adverse Event|13
189714|NCT00408499|647683|P5|Phase II- MTD Expansion|treatment delay|3
189715|NCT00408499|647684|P4|Phase II- MTD Expansion|treatment delay|0
189716|NCT00408499|647685|P3|Phase II- MTD Expansion|treatment delay|0
189717|NCT00408499|647686|P2|Phase II- MTD Expansion|treatment delay|0
189718|NCT00408499|647687|P1|Phase II- MTD Expansion|treatment delay|0
189719|NCT00408499|647683|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
189720|NCT00408499|647684|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
189721|NCT00408499|647685|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
189722|NCT00408499|647686|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
189723|NCT00408499|647687|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
189724|NCT00408499|647683|P5|Phase II- MTD Expansion|Physician Decision|1
189725|NCT00408499|647684|P4|Phase II- MTD Expansion|Physician Decision|0
189726|NCT00408499|647685|P3|Phase II- MTD Expansion|Physician Decision|0
189727|NCT00408499|647686|P2|Phase II- MTD Expansion|Physician Decision|0
189728|NCT00408499|647687|P1|Phase II- MTD Expansion|Physician Decision|0
189729|NCT00408499|647683|P5|Phase II- MTD Expansion|Death|2
189730|NCT00408499|647684|P4|Phase II- MTD Expansion|Death|0
189731|NCT00408499|647685|P3|Phase II- MTD Expansion|Death|0
189732|NCT00408499|647686|P2|Phase II- MTD Expansion|Death|0
189733|NCT00408499|647687|P1|Phase II- MTD Expansion|Death|0
189734|NCT00408499|647683|P5|Phase II- MTD Expansion|Adverse Event|9
189735|NCT00408499|647684|P4|Phase II- MTD Expansion|Adverse Event|0
189736|NCT00408499|647685|P3|Phase II- MTD Expansion|Adverse Event|0
189737|NCT00408499|647686|P2|Phase II- MTD Expansion|Adverse Event|0
189738|NCT00408499|647687|P1|Phase II- MTD Expansion|Adverse Event|0
189739|NCT00408499|647683|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
189740|NCT00408499|647684|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
189741|NCT00408499|647685|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
189742|NCT00408499|647686|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
189743|NCT00408499|647687|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
189744|NCT00408499|647683|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
189745|NCT00408499|647684|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
189746|NCT00408499|647685|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
189747|NCT00408499|647686|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
189748|NCT00408499|647687|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
189749|NCT00408499|647683|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
189750|NCT00408499|647684|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
189751|NCT00408499|647685|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
189752|NCT00408499|647686|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
189753|NCT00408499|647687|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
189754|NCT00408421|647704|P3|Treatment Re-Randomization|Withdrawal by Subject|0
189755|NCT00408421|647705|P2|Treatment Re-Randomization|Withdrawal by Subject|1
189756|NCT00408421|647706|P1|Treatment Re-Randomization|Withdrawal by Subject|2
189757|NCT00408421|647704|P3|Treatment Re-Randomization|Protocol Violation|0
189758|NCT00408421|647705|P2|Treatment Re-Randomization|Protocol Violation|1
189759|NCT00408421|647706|P1|Treatment Re-Randomization|Protocol Violation|1
189760|NCT00408421|647704|P3|Treatment Re-Randomization|Physician Decision|0
189761|NCT00408421|647705|P2|Treatment Re-Randomization|Physician Decision|3
189762|NCT00408421|647706|P1|Treatment Re-Randomization|Physician Decision|1
189763|NCT00408421|647704|P3|Treatment Re-Randomization|Lost to Follow-up|1
189764|NCT00408421|647705|P2|Treatment Re-Randomization|Lost to Follow-up|0
189765|NCT00408421|647706|P1|Treatment Re-Randomization|Lost to Follow-up|0
189766|NCT00408421|647704|P3|Treatment Re-Randomization|Lack of Efficacy|0
189767|NCT00408421|647705|P2|Treatment Re-Randomization|Lack of Efficacy|0
189768|NCT00408421|647706|P1|Treatment Re-Randomization|Lack of Efficacy|1
189769|NCT00408421|647704|P3|Treatment Re-Randomization|Adverse Event|4
189770|NCT00408421|647705|P2|Treatment Re-Randomization|Adverse Event|2
189771|NCT00408421|647706|P1|Treatment Re-Randomization|Adverse Event|2
189772|NCT00408421|647704|P3|Treatment Initial Randomization|Sponsor Decision|0
189773|NCT00408421|647705|P2|Treatment Initial Randomization|Sponsor Decision|0
189774|NCT00408421|647706|P1|Treatment Initial Randomization|Sponsor Decision|1
189775|NCT00408421|647704|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
189776|NCT00408421|647705|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
189777|NCT00408421|647706|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
189778|NCT00408421|647704|P3|Treatment Initial Randomization|Withdrawal by Subject|0
189779|NCT00408421|647705|P2|Treatment Initial Randomization|Withdrawal by Subject|7
189780|NCT00408421|647706|P1|Treatment Initial Randomization|Withdrawal by Subject|7
189781|NCT00408421|647704|P3|Treatment Initial Randomization|Protocol Violation|0
189782|NCT00408421|647705|P2|Treatment Initial Randomization|Protocol Violation|1
189783|NCT00408421|647706|P1|Treatment Initial Randomization|Protocol Violation|0
189784|NCT00408421|647704|P3|Treatment Initial Randomization|Physician Decision|0
189785|NCT00408421|647705|P2|Treatment Initial Randomization|Physician Decision|0
189786|NCT00408421|647706|P1|Treatment Initial Randomization|Physician Decision|1
189787|NCT00408421|647704|P3|Treatment Initial Randomization|Lost to Follow-up|0
189788|NCT00408421|647705|P2|Treatment Initial Randomization|Lost to Follow-up|3
189789|NCT00408421|647706|P1|Treatment Initial Randomization|Lost to Follow-up|0
189790|NCT00408421|647704|P3|Treatment Initial Randomization|Lack of Efficacy|0
189791|NCT00408421|647705|P2|Treatment Initial Randomization|Lack of Efficacy|2
189792|NCT00408421|647706|P1|Treatment Initial Randomization|Lack of Efficacy|2
189793|NCT00408421|647704|P3|Treatment Initial Randomization|Adverse Event|0
189794|NCT00408421|647705|P2|Treatment Initial Randomization|Adverse Event|9
189795|NCT00408421|647706|P1|Treatment Initial Randomization|Adverse Event|5
189796|NCT00408408|647786|P6|Overall Study|No follow up data|3
189797|NCT00408408|647787|P5|Overall Study|No follow up data|5
189798|NCT00408408|647788|P4|Overall Study|No follow up data|7
189799|NCT00408408|647789|P3|Overall Study|No follow up data|0
189800|NCT00408408|647790|P2|Overall Study|No follow up data|3
189801|NCT00408408|647791|P1|Overall Study|No follow up data|2
189802|NCT00408317|647853|P2|Second Intervention Period|Withdrawal of consent|1
189803|NCT00408317|647854|P1|Second Intervention Period|Withdrawal of consent|0
189804|NCT00408317|647853|P2|Second Intervention Period|Protocol Violation|1
189805|NCT00408317|647854|P1|Second Intervention Period|Protocol Violation|0
189806|NCT00408317|647853|P2|Second Intervention Period|Adverse Event|0
189807|NCT00408317|647854|P1|Second Intervention Period|Adverse Event|2
189808|NCT00408317|647853|P2|First Intervention Period|Adverse Event|1
189809|NCT00408317|647854|P1|First Intervention Period|Adverse Event|0
189810|NCT00407797|647897|P1|Overall Study|Withdrawal by Subject|3
189811|NCT00407797|647897|P1|Overall Study|Other|7
189812|NCT00407797|647897|P1|Overall Study|Adverse Event|6
189813|NCT00407797|647897|P1|Overall Study|Lost to Follow-up|2
189814|NCT00407758|647912|P1|Overall Study|ineligible –improper prior treatment|1
189815|NCT00407745|647925|P2|Overall Study|Randomized, unknown if treated|1
189816|NCT00407745|647926|P1|Overall Study|Randomized, unknown if treated|0
189817|NCT00407745|647925|P2|Overall Study|Other|0
189818|NCT00407745|647926|P1|Overall Study|Other|2
189819|NCT00407745|647925|P2|Overall Study|Adverse Event|8
189820|NCT00407745|647926|P1|Overall Study|Adverse Event|8
189821|NCT00407745|647925|P2|Overall Study|Protocol Violation|3
189822|NCT00407745|647926|P1|Overall Study|Protocol Violation|5
189823|NCT00407745|647925|P2|Overall Study|Withdrawal by Subject|3
189824|NCT00407745|647926|P1|Overall Study|Withdrawal by Subject|3
189825|NCT00407745|647925|P2|Overall Study|Lack of Efficacy|2
189826|NCT00407745|647926|P1|Overall Study|Lack of Efficacy|1
189827|NCT00407563|648010|P1|Overall Study|Patient continues on treatment|1
189828|NCT00407550|648020|P2|Overall Study|Insurance or Other medical condition|1
189829|NCT00407550|648021|P1|Overall Study|Insurance or Other medical condition|2
189830|NCT00407550|648020|P2|Overall Study|Death|0
189831|NCT00407550|648021|P1|Overall Study|Death|1
189832|NCT00407550|648020|P2|Overall Study|Withdrawal by Subject|2
189833|NCT00407550|648021|P1|Overall Study|Withdrawal by Subject|0
189834|NCT00407550|648020|P2|Overall Study|Adverse Event|1
189835|NCT00407550|648021|P1|Overall Study|Adverse Event|0
189836|NCT00407537|648029|P2|Overall Study|Withdrawal by Subject|16
189837|NCT00407537|648030|P1|Overall Study|Withdrawal by Subject|34
189838|NCT00407537|648029|P2|Overall Study|Other|7
189839|NCT00407537|648030|P1|Overall Study|Other|6
189840|NCT00407537|648029|P2|Overall Study|Lost to Follow-up|19
189841|NCT00407537|648030|P1|Overall Study|Lost to Follow-up|12
189842|NCT00407537|648029|P2|Overall Study|Adverse Event|0
189843|NCT00407537|648030|P1|Overall Study|Adverse Event|36
189844|NCT00407537|648029|P2|Overall Study|Death|2
189845|NCT00407537|648030|P1|Overall Study|Death|5
189846|NCT00407511|648078|P1|Overall Study|Withdrawal by Subject|4
189847|NCT00407511|648078|P1|Overall Study|Other|5
189848|NCT00407511|648078|P1|Overall Study|Lost to Follow-up|4
189849|NCT00407511|648078|P1|Overall Study|Adverse Event|9
189850|NCT00407030|648124|P3|Extension Period - up to 68 Weeks|Physician Decision|0
189851|NCT00407030|648125|P2|Extension Period - up to 68 Weeks|Physician Decision|2
189852|NCT00407030|648126|P1|Extension Period - up to 68 Weeks|Physician Decision|1
189853|NCT00407030|648124|P3|Extension Period - up to 68 Weeks|Patient Decision|0
189854|NCT00407030|648125|P2|Extension Period - up to 68 Weeks|Patient Decision|2
189855|NCT00407030|648126|P1|Extension Period - up to 68 Weeks|Patient Decision|1
189856|NCT00407030|648124|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
189857|NCT00407030|648125|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
189858|NCT00407030|648126|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
189859|NCT00407030|648124|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
189860|NCT00407030|648125|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
189861|NCT00407030|648126|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
189862|NCT00407030|648124|P3|Extension Period - up to 68 Weeks|Adverse Event|0
189863|NCT00407030|648125|P2|Extension Period - up to 68 Weeks|Adverse Event|0
189864|NCT00407030|648126|P1|Extension Period - up to 68 Weeks|Adverse Event|1
189865|NCT00407030|648124|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
189866|NCT00407030|648125|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
189867|NCT00407030|648126|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
189868|NCT00407030|648124|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
189869|NCT00407030|648125|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
189870|NCT00407030|648126|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
189871|NCT00407030|648124|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
189872|NCT00407030|648125|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
189873|NCT00407030|648126|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
189874|NCT00407030|648124|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
189875|NCT00407030|648125|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
189876|NCT00407030|648126|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
189877|NCT00407030|648124|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
189878|NCT00407030|648125|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
189879|NCT00407030|648126|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
189880|NCT00407030|648124|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
189881|NCT00407030|648125|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
189882|NCT00407030|648126|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
189883|NCT00407030|648124|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
189884|NCT00407030|648125|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
189885|NCT00407030|648126|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
189886|NCT00407030|648124|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
189887|NCT00407030|648125|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
189888|NCT00407030|648126|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
189889|NCT00406848|648154|P2|Overall Study|Sponsor Decision|1
189890|NCT00406848|648155|P1|Overall Study|Sponsor Decision|1
189891|NCT00406848|648154|P2|Overall Study|Physician Decision|2
189892|NCT00406848|648155|P1|Overall Study|Physician Decision|2
189893|NCT00406848|648154|P2|Overall Study|Lost to Follow-up|2
189894|NCT00406848|648155|P1|Overall Study|Lost to Follow-up|6
189895|NCT00406848|648154|P2|Overall Study|Protocol Violation|6
189896|NCT00406848|648155|P1|Overall Study|Protocol Violation|10
189897|NCT00406848|648154|P2|Overall Study|Lack of Efficacy|14
189898|NCT00406848|648155|P1|Overall Study|Lack of Efficacy|9
189899|NCT00406848|648154|P2|Overall Study|Adverse Event|7
189900|NCT00406848|648155|P1|Overall Study|Adverse Event|38
189901|NCT00406848|648154|P2|Overall Study|Withdrawal by Subject|22
189902|NCT00406848|648155|P1|Overall Study|Withdrawal by Subject|27
189903|NCT00406783|648219|P2|Overall Study|Protocol Violation|4
189904|NCT00406783|648220|P1|Overall Study|Protocol Violation|4
189905|NCT00406783|648219|P2|Overall Study|Withdrawal by Subject|4
189906|NCT00406783|648220|P1|Overall Study|Withdrawal by Subject|1
189907|NCT00406783|648219|P2|Overall Study|Lost to Follow-up|0
189908|NCT00406783|648220|P1|Overall Study|Lost to Follow-up|3
189909|NCT00406783|648219|P2|Overall Study|Treatment Failure|3
189910|NCT00406783|648220|P1|Overall Study|Treatment Failure|2
189911|NCT00406783|648219|P2|Overall Study|Adverse Event|4
189912|NCT00406783|648220|P1|Overall Study|Adverse Event|4
189913|NCT00406718|648235|P3|Overall Study|Lost to Follow-up|4
189914|NCT00406718|648236|P2|Overall Study|Lost to Follow-up|5
189915|NCT00406718|648237|P1|Overall Study|Lost to Follow-up|2
189916|NCT00406718|648235|P3|Overall Study|Withdrawal by Subject|4
189917|NCT00406718|648236|P2|Overall Study|Withdrawal by Subject|9
189918|NCT00406718|648237|P1|Overall Study|Withdrawal by Subject|2
189919|NCT00406692|648251|P1|Overall Study|Lack of Efficacy|1
189920|NCT00406692|648251|P1|Overall Study|Adverse Event|1
189921|NCT00406692|648251|P1|Overall Study|Physician Decision|1
189922|NCT00406692|648251|P1|Overall Study|Withdrawal by Subject|4
189923|NCT00406653|648261|P7|Open-Label Period|Refused followup|1
189924|NCT00406653|648262|P6|Open-Label Period|Refused followup|0
189925|NCT00406653|648263|P5|Open-Label Period|Refused followup|0
189926|NCT00406653|648264|P4|Open-Label Period|Refused followup|0
189927|NCT00406653|648265|P3|Open-Label Period|Refused followup|0
189928|NCT00406653|648266|P2|Open-Label Period|Refused followup|0
189929|NCT00406653|648267|P1|Open-Label Period|Refused followup|0
189930|NCT00406653|648261|P7|Open-Label Period|Discontinued by Sponsor|1
189931|NCT00406653|648262|P6|Open-Label Period|Discontinued by Sponsor|0
189932|NCT00406653|648263|P5|Open-Label Period|Discontinued by Sponsor|0
189933|NCT00406653|648264|P4|Open-Label Period|Discontinued by Sponsor|0
189934|NCT00406653|648265|P3|Open-Label Period|Discontinued by Sponsor|0
189935|NCT00406653|648266|P2|Open-Label Period|Discontinued by Sponsor|0
189936|NCT00406653|648267|P1|Open-Label Period|Discontinued by Sponsor|0
189937|NCT00406653|648261|P7|Open-Label Period|Declined participation but followup done|8
189938|NCT00406653|648262|P6|Open-Label Period|Declined participation but followup done|0
189939|NCT00406653|648263|P5|Open-Label Period|Declined participation but followup done|0
189940|NCT00406653|648264|P4|Open-Label Period|Declined participation but followup done|0
189941|NCT00406653|648265|P3|Open-Label Period|Declined participation but followup done|0
189942|NCT00406653|648266|P2|Open-Label Period|Declined participation but followup done|0
189943|NCT00406653|648267|P1|Open-Label Period|Declined participation but followup done|0
189944|NCT00406653|648261|P7|Open-Label Period|Administrative Reason By Sponsor|115
189945|NCT00406653|648262|P6|Open-Label Period|Administrative Reason By Sponsor|0
189946|NCT00406653|648263|P5|Open-Label Period|Administrative Reason By Sponsor|0
189947|NCT00406653|648264|P4|Open-Label Period|Administrative Reason By Sponsor|0
189948|NCT00406653|648265|P3|Open-Label Period|Administrative Reason By Sponsor|0
189949|NCT00406653|648266|P2|Open-Label Period|Administrative Reason By Sponsor|0
189950|NCT00406653|648267|P1|Open-Label Period|Administrative Reason By Sponsor|0
189951|NCT00406653|648261|P7|Open-Label Period|Pregnancy|2
189952|NCT00406653|648262|P6|Open-Label Period|Pregnancy|0
189953|NCT00406653|648263|P5|Open-Label Period|Pregnancy|0
189954|NCT00406653|648264|P4|Open-Label Period|Pregnancy|0
189955|NCT00406653|648265|P3|Open-Label Period|Pregnancy|0
189956|NCT00406653|648266|P2|Open-Label Period|Pregnancy|0
189957|NCT00406653|648267|P1|Open-Label Period|Pregnancy|0
189958|NCT00406653|648261|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
189959|NCT00406653|648262|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
189960|NCT00406653|648263|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
189961|NCT00406653|648264|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
189962|NCT00406653|648265|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
189963|NCT00406653|648266|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
189964|NCT00406653|648267|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
189965|NCT00406653|648261|P7|Open-Label Period|Withdrawal of Consent|11
189966|NCT00406653|648262|P6|Open-Label Period|Withdrawal of Consent|0
189967|NCT00406653|648263|P5|Open-Label Period|Withdrawal of Consent|0
189968|NCT00406653|648264|P4|Open-Label Period|Withdrawal of Consent|0
189969|NCT00406653|648265|P3|Open-Label Period|Withdrawal of Consent|0
189970|NCT00406653|648266|P2|Open-Label Period|Withdrawal of Consent|0
189971|NCT00406653|648267|P1|Open-Label Period|Withdrawal of Consent|0
189972|NCT00406653|648261|P7|Open-Label Period|Lost to Follow-up|6
189973|NCT00406653|648262|P6|Open-Label Period|Lost to Follow-up|0
189974|NCT00406653|648263|P5|Open-Label Period|Lost to Follow-up|0
189975|NCT00406653|648264|P4|Open-Label Period|Lost to Follow-up|0
189976|NCT00406653|648265|P3|Open-Label Period|Lost to Follow-up|0
189977|NCT00406653|648266|P2|Open-Label Period|Lost to Follow-up|0
189978|NCT00406653|648267|P1|Open-Label Period|Lost to Follow-up|0
189979|NCT00406653|648261|P7|Open-Label Period|Lack of Efficacy|160
189980|NCT00406653|648262|P6|Open-Label Period|Lack of Efficacy|0
189981|NCT00406653|648263|P5|Open-Label Period|Lack of Efficacy|0
189982|NCT00406653|648264|P4|Open-Label Period|Lack of Efficacy|0
189983|NCT00406653|648265|P3|Open-Label Period|Lack of Efficacy|0
189984|NCT00406653|648266|P2|Open-Label Period|Lack of Efficacy|0
189985|NCT00406653|648267|P1|Open-Label Period|Lack of Efficacy|0
189986|NCT00406653|648261|P7|Open-Label Period|Adverse Event|18
189987|NCT00406653|648262|P6|Open-Label Period|Adverse Event|0
189988|NCT00406653|648263|P5|Open-Label Period|Adverse Event|0
189989|NCT00406653|648264|P4|Open-Label Period|Adverse Event|0
189990|NCT00406653|648265|P3|Open-Label Period|Adverse Event|0
189991|NCT00406653|648266|P2|Open-Label Period|Adverse Event|0
189992|NCT00406653|648267|P1|Open-Label Period|Adverse Event|0
189993|NCT00406653|648261|P7|Open-Label Period|Death|1
189994|NCT00406653|648262|P6|Open-Label Period|Death|0
189995|NCT00406653|648263|P5|Open-Label Period|Death|0
189996|NCT00406653|648264|P4|Open-Label Period|Death|0
189997|NCT00406653|648265|P3|Open-Label Period|Death|0
189998|NCT00406653|648266|P2|Open-Label Period|Death|0
189999|NCT00406653|648267|P1|Open-Label Period|Death|0
190000|NCT00406653|648261|P7|Maintenance Period|Error in disease score evaluation|0
190001|NCT00406653|648262|P6|Maintenance Period|Error in disease score evaluation|0
190002|NCT00406653|648263|P5|Maintenance Period|Error in disease score evaluation|1
190003|NCT00406653|648264|P4|Maintenance Period|Error in disease score evaluation|0
190004|NCT00406653|648265|P3|Maintenance Period|Error in disease score evaluation|0
190005|NCT00406653|648266|P2|Maintenance Period|Error in disease score evaluation|0
190006|NCT00406653|648267|P1|Maintenance Period|Error in disease score evaluation|0
190007|NCT00406653|648261|P7|Maintenance Period|Administrative Reason By Sponsor|0
190008|NCT00406653|648262|P6|Maintenance Period|Administrative Reason By Sponsor|7
190009|NCT00406653|648263|P5|Maintenance Period|Administrative Reason By Sponsor|4
190010|NCT00406653|648264|P4|Maintenance Period|Administrative Reason By Sponsor|0
190011|NCT00406653|648265|P3|Maintenance Period|Administrative Reason By Sponsor|0
190012|NCT00406653|648266|P2|Maintenance Period|Administrative Reason By Sponsor|0
190013|NCT00406653|648267|P1|Maintenance Period|Administrative Reason By Sponsor|0
190014|NCT00406653|648261|P7|Maintenance Period|Pregnancy|0
190015|NCT00406653|648262|P6|Maintenance Period|Pregnancy|1
190016|NCT00406653|648263|P5|Maintenance Period|Pregnancy|0
190017|NCT00406653|648264|P4|Maintenance Period|Pregnancy|0
190018|NCT00406653|648265|P3|Maintenance Period|Pregnancy|0
190019|NCT00406653|648266|P2|Maintenance Period|Pregnancy|0
190020|NCT00406653|648267|P1|Maintenance Period|Pregnancy|0
190021|NCT00406653|648261|P7|Maintenance Period|Withdrawal of Consent|0
190022|NCT00406653|648262|P6|Maintenance Period|Withdrawal of Consent|0
190023|NCT00406653|648263|P5|Maintenance Period|Withdrawal of Consent|2
190024|NCT00406653|648264|P4|Maintenance Period|Withdrawal of Consent|0
190025|NCT00406653|648265|P3|Maintenance Period|Withdrawal of Consent|0
190026|NCT00406653|648266|P2|Maintenance Period|Withdrawal of Consent|0
190027|NCT00406653|648267|P1|Maintenance Period|Withdrawal of Consent|0
190028|NCT00406653|648261|P7|Maintenance Period|Lost to Follow-up|0
190029|NCT00406653|648262|P6|Maintenance Period|Lost to Follow-up|1
190030|NCT00406653|648263|P5|Maintenance Period|Lost to Follow-up|2
190031|NCT00406653|648264|P4|Maintenance Period|Lost to Follow-up|0
190032|NCT00406653|648265|P3|Maintenance Period|Lost to Follow-up|0
190033|NCT00406653|648266|P2|Maintenance Period|Lost to Follow-up|0
190034|NCT00406653|648267|P1|Maintenance Period|Lost to Follow-up|0
190035|NCT00406653|648261|P7|Maintenance Period|Lack of Efficacy|0
190036|NCT00406653|648262|P6|Maintenance Period|Lack of Efficacy|26
190037|NCT00406653|648263|P5|Maintenance Period|Lack of Efficacy|20
190038|NCT00406653|648264|P4|Maintenance Period|Lack of Efficacy|0
190039|NCT00406653|648265|P3|Maintenance Period|Lack of Efficacy|0
190040|NCT00406653|648266|P2|Maintenance Period|Lack of Efficacy|0
190041|NCT00406653|648267|P1|Maintenance Period|Lack of Efficacy|0
190042|NCT00406653|648261|P7|Maintenance Period|Adverse Event|0
190043|NCT00406653|648262|P6|Maintenance Period|Adverse Event|1
190044|NCT00406653|648263|P5|Maintenance Period|Adverse Event|1
190045|NCT00406653|648264|P4|Maintenance Period|Adverse Event|0
190046|NCT00406653|648265|P3|Maintenance Period|Adverse Event|0
190047|NCT00406653|648266|P2|Maintenance Period|Adverse Event|0
190048|NCT00406653|648267|P1|Maintenance Period|Adverse Event|0
190049|NCT00406653|648261|P7|Induction Period|Patient relocated|0
190050|NCT00406653|648262|P6|Induction Period|Patient relocated|0
190051|NCT00406653|648263|P5|Induction Period|Patient relocated|0
190052|NCT00406653|648264|P4|Induction Period|Patient relocated|0
190053|NCT00406653|648265|P3|Induction Period|Patient relocated|1
190054|NCT00406653|648266|P2|Induction Period|Patient relocated|0
190055|NCT00406653|648267|P1|Induction Period|Patient relocated|0
190056|NCT00406653|648261|P7|Induction Period|Incarcerated|0
190057|NCT00406653|648262|P6|Induction Period|Incarcerated|0
190058|NCT00406653|648263|P5|Induction Period|Incarcerated|0
190059|NCT00406653|648264|P4|Induction Period|Incarcerated|0
190060|NCT00406653|648265|P3|Induction Period|Incarcerated|1
190061|NCT00406653|648266|P2|Induction Period|Incarcerated|0
190062|NCT00406653|648267|P1|Induction Period|Incarcerated|0
190063|NCT00406653|648261|P7|Induction Period|Given prohibited drug|0
190064|NCT00406653|648262|P6|Induction Period|Given prohibited drug|0
190065|NCT00406653|648263|P5|Induction Period|Given prohibited drug|0
190066|NCT00406653|648264|P4|Induction Period|Given prohibited drug|0
190067|NCT00406653|648265|P3|Induction Period|Given prohibited drug|2
190068|NCT00406653|648266|P2|Induction Period|Given prohibited drug|1
190069|NCT00406653|648267|P1|Induction Period|Given prohibited drug|0
190070|NCT00406653|648261|P7|Induction Period|Declined participation but followup done|0
190071|NCT00406653|648262|P6|Induction Period|Declined participation but followup done|0
190072|NCT00406653|648263|P5|Induction Period|Declined participation but followup done|0
190073|NCT00406653|648264|P4|Induction Period|Declined participation but followup done|1
190074|NCT00406653|648265|P3|Induction Period|Declined participation but followup done|1
190075|NCT00406653|648266|P2|Induction Period|Declined participation but followup done|2
190076|NCT00406653|648267|P1|Induction Period|Declined participation but followup done|0
190077|NCT00406653|648261|P7|Induction Period|Pregnancy|0
190078|NCT00406653|648262|P6|Induction Period|Pregnancy|0
190079|NCT00406653|648263|P5|Induction Period|Pregnancy|0
190080|NCT00406653|648264|P4|Induction Period|Pregnancy|0
190081|NCT00406653|648265|P3|Induction Period|Pregnancy|0
190082|NCT00406653|648266|P2|Induction Period|Pregnancy|0
190083|NCT00406653|648267|P1|Induction Period|Pregnancy|1
190084|NCT00406653|648261|P7|Induction Period|Subject No Longer Meets Study Criteria|0
190085|NCT00406653|648262|P6|Induction Period|Subject No Longer Meets Study Criteria|0
190086|NCT00406653|648263|P5|Induction Period|Subject No Longer Meets Study Criteria|0
190087|NCT00406653|648264|P4|Induction Period|Subject No Longer Meets Study Criteria|2
190088|NCT00406653|648265|P3|Induction Period|Subject No Longer Meets Study Criteria|0
190089|NCT00406653|648266|P2|Induction Period|Subject No Longer Meets Study Criteria|0
190090|NCT00406653|648267|P1|Induction Period|Subject No Longer Meets Study Criteria|0
190091|NCT00406653|648261|P7|Induction Period|Withdrawal of Consent|0
190092|NCT00406653|648262|P6|Induction Period|Withdrawal of Consent|0
190093|NCT00406653|648263|P5|Induction Period|Withdrawal of Consent|0
190094|NCT00406653|648264|P4|Induction Period|Withdrawal of Consent|2
190095|NCT00406653|648265|P3|Induction Period|Withdrawal of Consent|1
190096|NCT00406653|648266|P2|Induction Period|Withdrawal of Consent|5
190097|NCT00406653|648267|P1|Induction Period|Withdrawal of Consent|2
190098|NCT00406653|648261|P7|Induction Period|Lost to Follow-up|0
190099|NCT00406653|648262|P6|Induction Period|Lost to Follow-up|0
190100|NCT00406653|648263|P5|Induction Period|Lost to Follow-up|0
190101|NCT00406653|648264|P4|Induction Period|Lost to Follow-up|0
190102|NCT00406653|648265|P3|Induction Period|Lost to Follow-up|0
190103|NCT00406653|648266|P2|Induction Period|Lost to Follow-up|2
190104|NCT00406653|648267|P1|Induction Period|Lost to Follow-up|0
190105|NCT00406653|648261|P7|Induction Period|Lack of Efficacy|0
190106|NCT00406653|648262|P6|Induction Period|Lack of Efficacy|0
190107|NCT00406653|648263|P5|Induction Period|Lack of Efficacy|0
190108|NCT00406653|648264|P4|Induction Period|Lack of Efficacy|10
190109|NCT00406653|648265|P3|Induction Period|Lack of Efficacy|8
190110|NCT00406653|648266|P2|Induction Period|Lack of Efficacy|14
190111|NCT00406653|648267|P1|Induction Period|Lack of Efficacy|11
190112|NCT00406653|648261|P7|Induction Period|Adverse Event|0
190113|NCT00406653|648262|P6|Induction Period|Adverse Event|0
190114|NCT00406653|648263|P5|Induction Period|Adverse Event|0
190115|NCT00406653|648264|P4|Induction Period|Adverse Event|11
190116|NCT00406653|648265|P3|Induction Period|Adverse Event|4
190117|NCT00406653|648266|P2|Induction Period|Adverse Event|10
190118|NCT00406653|648267|P1|Induction Period|Adverse Event|1
190119|NCT00406640|648348|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
190120|NCT00406640|648349|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
190121|NCT00406640|648348|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
190122|NCT00406640|648349|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
190123|NCT00406640|648348|P2|OL Extension Phase for Non-Responders|non-compliance|2
190124|NCT00406640|648349|P1|OL Extension Phase for Non-Responders|non-compliance|3
190125|NCT00406640|648348|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
190126|NCT00406640|648349|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
190127|NCT00406640|648348|P2|OL Extension Phase for Non-Responders|Physician Decision|0
190128|NCT00406640|648349|P1|OL Extension Phase for Non-Responders|Physician Decision|1
190129|NCT00406640|648348|P2|OL Extension Phase for Non-Responders|Failed to Return|0
190130|NCT00406640|648349|P1|OL Extension Phase for Non-Responders|Failed to Return|1
190131|NCT00406640|648348|P2|OL Extension Phase for Non-Responders|Adverse Event|6
190132|NCT00406640|648349|P1|OL Extension Phase for Non-Responders|Adverse Event|6
190133|NCT00406640|648348|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
190134|NCT00406640|648349|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
190135|NCT00406640|648348|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
190136|NCT00406640|648349|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
190137|NCT00406640|648348|P2|DB Continuation Phase for Responders|Protocol Violation|2
190138|NCT00406640|648349|P1|DB Continuation Phase for Responders|Protocol Violation|2
190139|NCT00406640|648348|P2|DB Continuation Phase for Responders|non-compliance|5
190140|NCT00406640|648349|P1|DB Continuation Phase for Responders|non-compliance|7
190141|NCT00406640|648348|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
190142|NCT00406640|648349|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
190143|NCT00406640|648348|P2|DB Continuation Phase for Responders|Physician Decision|3
190144|NCT00406640|648349|P1|DB Continuation Phase for Responders|Physician Decision|2
190145|NCT00406640|648348|P2|DB Continuation Phase for Responders|Failed to Return|2
190146|NCT00406640|648349|P1|DB Continuation Phase for Responders|Failed to Return|0
190147|NCT00406640|648348|P2|DB Continuation Phase for Responders|Death|0
190148|NCT00406640|648349|P1|DB Continuation Phase for Responders|Death|1
190149|NCT00406640|648348|P2|DB Continuation Phase for Responders|Adverse Event|11
190150|NCT00406640|648349|P1|DB Continuation Phase for Responders|Adverse Event|11
190151|NCT00406640|648348|P2|Acute Phase|Lack of Efficacy|3
190152|NCT00406640|648349|P1|Acute Phase|Lack of Efficacy|3
190153|NCT00406640|648348|P2|Acute Phase|Withdrawal by Subject|9
190154|NCT00406640|648349|P1|Acute Phase|Withdrawal by Subject|11
190155|NCT00406640|648348|P2|Acute Phase|Protocol Violation|2
190156|NCT00406640|648349|P1|Acute Phase|Protocol Violation|3
190157|NCT00406640|648348|P2|Acute Phase|Protocol deviation|10
190158|NCT00406640|648349|P1|Acute Phase|Protocol deviation|4
190159|NCT00406640|648348|P2|Acute Phase|Lost to Follow-up|4
190160|NCT00406640|648349|P1|Acute Phase|Lost to Follow-up|7
190161|NCT00406640|648348|P2|Acute Phase|Physician Decision|1
190162|NCT00406640|648349|P1|Acute Phase|Physician Decision|0
190163|NCT00406640|648348|P2|Acute Phase|Failed to Return|1
190164|NCT00406640|648349|P1|Acute Phase|Failed to Return|5
190165|NCT00406640|648348|P2|Acute Phase|Adverse Event|13
190166|NCT00406640|648349|P1|Acute Phase|Adverse Event|18
190167|NCT00406393|648381|P2|Overall Study|Did not undergo transplantation|1
190168|NCT00406393|648382|P1|Overall Study|Did not undergo transplantation|2
190169|NCT00406367|648412|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
190170|NCT00406367|648413|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
190171|NCT00406367|648412|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
190172|NCT00406367|648413|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
190173|NCT00406367|648412|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
190174|NCT00406367|648413|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
190175|NCT00406367|648412|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
190176|NCT00406367|648413|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
190177|NCT00406367|648412|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
190178|NCT00406367|648413|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
190179|NCT00406367|648412|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
190180|NCT00406367|648413|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
190181|NCT00406367|648412|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
190182|NCT00406367|648413|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
190183|NCT00406367|648412|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
190184|NCT00406367|648413|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
190185|NCT00406367|648412|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
190186|NCT00406367|648413|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
190187|NCT00406367|648412|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
190188|NCT00406367|648413|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
190189|NCT00406367|648412|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
190190|NCT00406367|648413|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
190191|NCT00406367|648412|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
190192|NCT00406367|648413|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
190193|NCT00406354|648428|P3|All Randomized and Treated Patients|Physician Decision|1
190194|NCT00406354|648429|P2|All Randomized and Treated Patients|Physician Decision|0
190195|NCT00406354|648430|P1|All Randomized and Treated Patients|Physician Decision|0
190196|NCT00406354|648428|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
190197|NCT00406354|648429|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
190198|NCT00406354|648430|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
190199|NCT00406354|648428|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
190200|NCT00406354|648429|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
190201|NCT00406354|648430|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
190202|NCT00406354|648428|P3|All Randomized and Treated Patients|Adverse Event|1
190203|NCT00406354|648429|P2|All Randomized and Treated Patients|Adverse Event|2
190204|NCT00406354|648430|P1|All Randomized and Treated Patients|Adverse Event|6
190205|NCT00406354|648428|P3|All Randomized and Treated Patients|Lack of Efficacy|17
190206|NCT00406354|648429|P2|All Randomized and Treated Patients|Lack of Efficacy|4
190207|NCT00406354|648430|P1|All Randomized and Treated Patients|Lack of Efficacy|7
190208|NCT00406354|648428|P3|All Randomized Patients|Protocol Violation|1
190209|NCT00406354|648429|P2|All Randomized Patients|Protocol Violation|0
190210|NCT00406354|648430|P1|All Randomized Patients|Protocol Violation|0
190211|NCT00406315|648501|P1|Overall Study|Withdrawal by Subject|30
190212|NCT00406315|648501|P1|Overall Study|Lost to Follow-up|21
190213|NCT00406315|648501|P1|Overall Study|Other|33
190214|NCT00406315|648501|P1|Overall Study|Lack of Efficacy|13
190215|NCT00406315|648501|P1|Overall Study|Laboratory Abnormality|4
190216|NCT00406315|648501|P1|Overall Study|Adverse Event|39
190217|NCT00406315|648501|P1|Overall Study|Death|1
190218|NCT00406029|648611|P5|Overall Study|Randomized in Error|1
190219|NCT00406029|648612|P4|Overall Study|Randomized in Error|3
190220|NCT00406029|648613|P3|Overall Study|Randomized in Error|2
190221|NCT00406029|648614|P2|Overall Study|Randomized in Error|0
190222|NCT00406029|648615|P1|Overall Study|Randomized in Error|0
190223|NCT00406029|648611|P5|Overall Study|Did Not Meet Eligibility Criteria|0
190224|NCT00406029|648612|P4|Overall Study|Did Not Meet Eligibility Criteria|0
190225|NCT00406029|648613|P3|Overall Study|Did Not Meet Eligibility Criteria|1
190226|NCT00406029|648614|P2|Overall Study|Did Not Meet Eligibility Criteria|0
190227|NCT00406029|648615|P1|Overall Study|Did Not Meet Eligibility Criteria|0
190228|NCT00406029|648611|P5|Overall Study|Protocol Violation|0
190229|NCT00406029|648612|P4|Overall Study|Protocol Violation|2
190230|NCT00406029|648613|P3|Overall Study|Protocol Violation|0
190231|NCT00406029|648614|P2|Overall Study|Protocol Violation|2
190232|NCT00406029|648615|P1|Overall Study|Protocol Violation|1
190233|NCT00406029|648611|P5|Overall Study|Withdrawal by Subject|0
190234|NCT00406029|648612|P4|Overall Study|Withdrawal by Subject|2
190235|NCT00406029|648613|P3|Overall Study|Withdrawal by Subject|2
190236|NCT00406029|648614|P2|Overall Study|Withdrawal by Subject|4
190237|NCT00406029|648615|P1|Overall Study|Withdrawal by Subject|3
190238|NCT00406029|648611|P5|Overall Study|Adverse Event|7
190239|NCT00406029|648612|P4|Overall Study|Adverse Event|10
190240|NCT00406029|648613|P3|Overall Study|Adverse Event|5
190241|NCT00406029|648614|P2|Overall Study|Adverse Event|2
190242|NCT00406029|648615|P1|Overall Study|Adverse Event|12
190243|NCT00405964|648719|P2|Overall Study|Protocol Violation|6
190244|NCT00405964|648720|P1|Overall Study|Protocol Violation|11
190245|NCT00405964|648719|P2|Overall Study|Withdrawal by Subject|23
190246|NCT00405964|648720|P1|Overall Study|Withdrawal by Subject|19
190247|NCT00405964|648719|P2|Overall Study|Lost to Follow-up|5
190248|NCT00405964|648720|P1|Overall Study|Lost to Follow-up|5
190249|NCT00405964|648719|P2|Overall Study|Adverse Event|16
190250|NCT00405964|648720|P1|Overall Study|Adverse Event|7
190251|NCT00405964|648719|P2|Overall Study|Treatment Failure|45
190252|NCT00405964|648720|P1|Overall Study|Treatment Failure|17
190253|NCT00405912|648742|P3|Overall Study|Lost to Follow-up|4
190254|NCT00405912|648743|P2|Overall Study|Lost to Follow-up|8
190255|NCT00405912|648744|P1|Overall Study|Lost to Follow-up|4
190256|NCT00405912|648742|P3|Overall Study|Withdrawal by Subject|12
190257|NCT00405912|648743|P2|Overall Study|Withdrawal by Subject|11
190258|NCT00405912|648744|P1|Overall Study|Withdrawal by Subject|12
190259|NCT00405821|648757|P2|Overall Study|initiated ART|8
190260|NCT00405821|648758|P1|Overall Study|initiated ART|9
190261|NCT00405821|648757|P2|Overall Study|Protocol Violation|0
190262|NCT00405821|648758|P1|Overall Study|Protocol Violation|1
190263|NCT00405821|648757|P2|Overall Study|Lost to Follow-up|7
190264|NCT00405821|648758|P1|Overall Study|Lost to Follow-up|7
190265|NCT00405821|648757|P2|Overall Study|Death|7
190266|NCT00405821|648758|P1|Overall Study|Death|5
190267|NCT00405756|648771|P3|Follow-up|Lost to Follow-up|4
190268|NCT00405756|648772|P2|Follow-up|Lost to Follow-up|8
190269|NCT00405756|648773|P1|Follow-up|Lost to Follow-up|2
190270|NCT00405756|648771|P3|Follow-up|Death|24
190271|NCT00405756|648772|P2|Follow-up|Death|31
190272|NCT00405756|648773|P1|Follow-up|Death|21
190273|NCT00405756|648771|P3|Follow-up|Ongoing in Follow-up Period|60
190274|NCT00405756|648772|P2|Follow-up|Ongoing in Follow-up Period|51
190275|NCT00405756|648773|P1|Follow-up|Ongoing in Follow-up Period|52
190276|NCT00405756|648771|P3|Open-label Extension|Other|7
190277|NCT00405756|648772|P2|Open-label Extension|Other|1
190278|NCT00405756|648773|P1|Open-label Extension|Other|0
190279|NCT00405756|648771|P3|Open-label Extension|Death|4
190280|NCT00405756|648772|P2|Open-label Extension|Death|2
190281|NCT00405756|648773|P1|Open-label Extension|Death|1
190282|NCT00405756|648771|P3|Open-label Extension|Withdrawal by Subject|3
190283|NCT00405756|648772|P2|Open-label Extension|Withdrawal by Subject|3
190284|NCT00405756|648773|P1|Open-label Extension|Withdrawal by Subject|2
190285|NCT00405756|648771|P3|Open-label Extension|Disease Progression|26
190286|NCT00405756|648772|P2|Open-label Extension|Disease Progression|23
190287|NCT00405756|648773|P1|Open-label Extension|Disease Progression|8
190288|NCT00405756|648771|P3|Open-label Extension|Adverse Event|7
190289|NCT00405756|648772|P2|Open-label Extension|Adverse Event|3
190290|NCT00405756|648773|P1|Open-label Extension|Adverse Event|1
190291|NCT00405756|648771|P3|Open-label Extension|Ongoing in Open Label Period|25
190292|NCT00405756|648772|P2|Open-label Extension|Ongoing in Open Label Period|15
190293|NCT00405756|648773|P1|Open-label Extension|Ongoing in Open Label Period|7
190294|NCT00405756|648771|P3|Double-blind Treatment|Not Specified|4
190295|NCT00405756|648772|P2|Double-blind Treatment|Not Specified|4
190296|NCT00405756|648773|P1|Double-blind Treatment|Not Specified|7
190297|NCT00405756|648771|P3|Double-blind Treatment|Protocol Violation|2
190298|NCT00405756|648772|P2|Double-blind Treatment|Protocol Violation|0
190299|NCT00405756|648773|P1|Double-blind Treatment|Protocol Violation|1
190300|NCT00405756|648771|P3|Double-blind Treatment|Death|4
190301|NCT00405756|648772|P2|Double-blind Treatment|Death|4
190302|NCT00405756|648773|P1|Double-blind Treatment|Death|4
190303|NCT00405756|648771|P3|Double-blind Treatment|Lost to Follow-up|0
190304|NCT00405756|648772|P2|Double-blind Treatment|Lost to Follow-up|0
190305|NCT00405756|648773|P1|Double-blind Treatment|Lost to Follow-up|1
190306|NCT00405756|648771|P3|Double-blind Treatment|Withdrawal by Subject|10
190307|NCT00405756|648772|P2|Double-blind Treatment|Withdrawal by Subject|9
190308|NCT00405756|648773|P1|Double-blind Treatment|Withdrawal by Subject|15
190309|NCT00405756|648771|P3|Double-blind Treatment|Lack of Efficacy|2
190310|NCT00405756|648772|P2|Double-blind Treatment|Lack of Efficacy|4
190311|NCT00405756|648773|P1|Double-blind Treatment|Lack of Efficacy|1
190312|NCT00405756|648771|P3|Double-blind Treatment|Disease Progression|102
190313|NCT00405756|648772|P2|Double-blind Treatment|Disease Progression|81
190314|NCT00405756|648773|P1|Double-blind Treatment|Disease Progression|47
190315|NCT00405756|648771|P3|Double-blind Treatment|Adverse Event|12
190316|NCT00405756|648772|P2|Double-blind Treatment|Adverse Event|27
190317|NCT00405756|648773|P1|Double-blind Treatment|Adverse Event|31
190318|NCT00405756|648771|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
190319|NCT00405756|648772|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
190320|NCT00405756|648773|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
190321|NCT00405652|648884|P1|Overall Study|Adverse Event|4
190322|NCT00405639|648891|P2|Overall Study|Seizure prior to receiving BNP|0
190323|NCT00405639|648892|P1|Overall Study|Seizure prior to receiving BNP|1
190324|NCT00405639|648891|P2|Overall Study|Adverse Event|0
190325|NCT00405639|648892|P1|Overall Study|Adverse Event|1
190326|NCT00405639|648891|P2|Overall Study|Withdrawal by Subject|0
190327|NCT00405639|648892|P1|Overall Study|Withdrawal by Subject|1
190328|NCT00405587|648908|P4|Overall Study|Participant not dosed|0
190329|NCT00405587|648909|P3|Overall Study|Participant not dosed|0
190330|NCT00405587|648910|P2|Overall Study|Participant not dosed|1
190331|NCT00405587|648911|P1|Overall Study|Participant not dosed|0
190332|NCT00405587|648908|P4|Overall Study|Withdrawal by Subject|2
190333|NCT00405587|648909|P3|Overall Study|Withdrawal by Subject|0
190334|NCT00405587|648910|P2|Overall Study|Withdrawal by Subject|0
190335|NCT00405587|648911|P1|Overall Study|Withdrawal by Subject|0
190336|NCT00405587|648908|P4|Overall Study|Radiation induced necrosis|0
190337|NCT00405587|648909|P3|Overall Study|Radiation induced necrosis|0
190338|NCT00405587|648910|P2|Overall Study|Radiation induced necrosis|1
190339|NCT00405587|648911|P1|Overall Study|Radiation induced necrosis|0
190340|NCT00405587|648908|P4|Overall Study|Lost to Follow-up|0
190341|NCT00405587|648909|P3|Overall Study|Lost to Follow-up|1
190342|NCT00405587|648910|P2|Overall Study|Lost to Follow-up|1
190343|NCT00405587|648911|P1|Overall Study|Lost to Follow-up|0
190344|NCT00405587|648908|P4|Overall Study|Adverse Event|0
190345|NCT00405587|648909|P3|Overall Study|Adverse Event|0
190346|NCT00405587|648910|P2|Overall Study|Adverse Event|0
190347|NCT00405587|648911|P1|Overall Study|Adverse Event|1
190348|NCT00405587|648908|P4|Overall Study|Physician Decision|0
190349|NCT00405587|648909|P3|Overall Study|Physician Decision|0
190350|NCT00405587|648910|P2|Overall Study|Physician Decision|2
190351|NCT00405587|648911|P1|Overall Study|Physician Decision|3
190352|NCT00405587|648908|P4|Overall Study|Disease Progression|17
190353|NCT00405587|648909|P3|Overall Study|Disease Progression|21
190354|NCT00405587|648910|P2|Overall Study|Disease Progression|23
190355|NCT00405587|648911|P1|Overall Study|Disease Progression|22
190356|NCT00405587|648908|P4|Overall Study|Death|1
190357|NCT00405587|648909|P3|Overall Study|Death|0
190358|NCT00405587|648910|P2|Overall Study|Death|0
190359|NCT00405587|648911|P1|Overall Study|Death|0
190360|NCT00405548|649029|P2|Overall Study|Withdrawal by Subject|0
190361|NCT00405548|649030|P1|Overall Study|Withdrawal by Subject|1
190362|NCT00405548|649029|P2|Overall Study|Venous access failed during study day|0
190363|NCT00405548|649030|P1|Overall Study|Venous access failed during study day|1
190364|NCT00405548|649029|P2|Overall Study|Unable to self-administer shots|0
190365|NCT00405548|649030|P1|Overall Study|Unable to self-administer shots|1
190366|NCT00405548|649029|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
190367|NCT00405548|649030|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
190368|NCT00405548|649029|P2|Overall Study|Cognitive Memory problems on study day|0
190369|NCT00405548|649030|P1|Overall Study|Cognitive Memory problems on study day|1
190370|NCT00405275|649092|P2|Overall Study|Unwilling to continue|9
190371|NCT00405275|649093|P1|Overall Study|Unwilling to continue|10
190372|NCT00405275|649092|P2|Overall Study|Withdrawal by Subject|9
190373|NCT00405275|649093|P1|Overall Study|Withdrawal by Subject|7
190374|NCT00405275|649092|P2|Overall Study|Lost to Follow-up|1
190375|NCT00405275|649093|P1|Overall Study|Lost to Follow-up|5
190376|NCT00405275|649092|P2|Overall Study|Death|0
190377|NCT00405275|649093|P1|Overall Study|Death|1
190378|NCT00405067|649102|P3|Overall Study|Lost to Follow-up|1
190379|NCT00405067|649103|P2|Overall Study|Lost to Follow-up|0
190380|NCT00405067|649104|P1|Overall Study|Lost to Follow-up|0
190381|NCT00405067|649102|P3|Overall Study|Adverse Event|4
190382|NCT00405067|649103|P2|Overall Study|Adverse Event|9
190383|NCT00405067|649104|P1|Overall Study|Adverse Event|4
190384|NCT00404924|649141|P2|Overall Study|Randomised but not received treatment|1
190385|NCT00404924|649142|P1|Overall Study|Randomised but not received treatment|1
190386|NCT00404924|649141|P2|Overall Study|Not Specified|11
190387|NCT00404924|649142|P1|Overall Study|Not Specified|25
190388|NCT00404924|649141|P2|Overall Study|Withdrawal by Subject|13
190389|NCT00404924|649142|P1|Overall Study|Withdrawal by Subject|26
190390|NCT00404924|649141|P2|Overall Study|Lost to Follow-up|1
190391|NCT00404924|649142|P1|Overall Study|Lost to Follow-up|1
190392|NCT00404924|649141|P2|Overall Study|Condition under investigation worsened|264
190393|NCT00404924|649142|P1|Overall Study|Condition under investigation worsened|475
190394|NCT00404924|649141|P2|Overall Study|Adverse Event|16
190395|NCT00404924|649142|P1|Overall Study|Adverse Event|75
190396|NCT00404820|649160|P2|Overall Study|Other|2
190397|NCT00404820|649161|P1|Overall Study|Other|0
190398|NCT00404820|649160|P2|Overall Study|Death|0
190399|NCT00404820|649161|P1|Overall Study|Death|1
190400|NCT00404820|649160|P2|Overall Study|Administrative problems|0
190401|NCT00404820|649161|P1|Overall Study|Administrative problems|2
190402|NCT00404820|649160|P2|Overall Study|Lost to Follow-up|3
190403|NCT00404820|649161|P1|Overall Study|Lost to Follow-up|7
190404|NCT00404820|649160|P2|Overall Study|Withdrawal by Subject|3
190405|NCT00404820|649161|P1|Overall Study|Withdrawal by Subject|5
190406|NCT00404820|649160|P2|Overall Study|Adverse Event|16
190407|NCT00404820|649161|P1|Overall Study|Adverse Event|4
190408|NCT00404768|649183|P4|Part C|Researcher suspended study medication|1
190409|NCT00404768|649184|P3|Part C|Researcher suspended study medication|0
190410|NCT00404768|649185|P2|Part C|Researcher suspended study medication|0
190411|NCT00404768|649186|P1|Part C|Researcher suspended study medication|0
190412|NCT00404768|649183|P4|Part C|Investigator discretion|1
190413|NCT00404768|649184|P3|Part C|Investigator discretion|0
190414|NCT00404768|649185|P2|Part C|Investigator discretion|0
190415|NCT00404768|649186|P1|Part C|Investigator discretion|0
190416|NCT00404768|649183|P4|Part C|Treatment failure|1
190417|NCT00404768|649184|P3|Part C|Treatment failure|0
190418|NCT00404768|649185|P2|Part C|Treatment failure|0
190419|NCT00404768|649186|P1|Part C|Treatment failure|0
190420|NCT00404768|649183|P4|Part C|Lack of Efficacy|2
190421|NCT00404768|649184|P3|Part C|Lack of Efficacy|0
190422|NCT00404768|649185|P2|Part C|Lack of Efficacy|0
190423|NCT00404768|649186|P1|Part C|Lack of Efficacy|0
190424|NCT00404768|649183|P4|Part C|Active labor|1
190425|NCT00404768|649184|P3|Part C|Active labor|0
190426|NCT00404768|649185|P2|Part C|Active labor|0
190427|NCT00404768|649186|P1|Part C|Active labor|0
190428|NCT00404768|649183|P4|Part C|Unsatisfactory uterine response to IP|1
190429|NCT00404768|649184|P3|Part C|Unsatisfactory uterine response to IP|0
190430|NCT00404768|649185|P2|Part C|Unsatisfactory uterine response to IP|0
190431|NCT00404768|649186|P1|Part C|Unsatisfactory uterine response to IP|0
190432|NCT00404768|649183|P4|Part C|Participant delivered baby|1
190433|NCT00404768|649184|P3|Part C|Participant delivered baby|0
190434|NCT00404768|649185|P2|Part C|Participant delivered baby|0
190435|NCT00404768|649186|P1|Part C|Participant delivered baby|0
190436|NCT00404768|649183|P4|Part C|Physician withdrew the study medication|0
190437|NCT00404768|649184|P3|Part C|Physician withdrew the study medication|1
190438|NCT00404768|649185|P2|Part C|Physician withdrew the study medication|0
190439|NCT00404768|649186|P1|Part C|Physician withdrew the study medication|0
190440|NCT00404768|649183|P4|Part C|Participant did not respond to therapy|1
190441|NCT00404768|649184|P3|Part C|Participant did not respond to therapy|1
190442|NCT00404768|649185|P2|Part C|Participant did not respond to therapy|0
190443|NCT00404768|649186|P1|Part C|Participant did not respond to therapy|0
190444|NCT00404768|649183|P4|Part C|Early withdrawal from study medication|0
190445|NCT00404768|649184|P3|Part C|Early withdrawal from study medication|1
190446|NCT00404768|649185|P2|Part C|Early withdrawal from study medication|0
190447|NCT00404768|649186|P1|Part C|Early withdrawal from study medication|0
190448|NCT00404768|649183|P4|Part C|Withdrawal by Subject|1
190449|NCT00404768|649184|P3|Part C|Withdrawal by Subject|2
190450|NCT00404768|649185|P2|Part C|Withdrawal by Subject|0
190451|NCT00404768|649186|P1|Part C|Withdrawal by Subject|0
190452|NCT00404768|649183|P4|Part C|Lost to Follow-up|1
190453|NCT00404768|649184|P3|Part C|Lost to Follow-up|3
190454|NCT00404768|649185|P2|Part C|Lost to Follow-up|0
190455|NCT00404768|649186|P1|Part C|Lost to Follow-up|0
190456|NCT00404768|649183|P4|Part C|Adverse Event|3
190457|NCT00404768|649184|P3|Part C|Adverse Event|0
190458|NCT00404768|649185|P2|Part C|Adverse Event|0
190459|NCT00404768|649186|P1|Part C|Adverse Event|0
190460|NCT00404768|649183|P4|Part A and B|Withdrawn as delivery imminemnt|0
190461|NCT00404768|649184|P3|Part A and B|Withdrawn as delivery imminemnt|0
190462|NCT00404768|649185|P2|Part A and B|Withdrawn as delivery imminemnt|1
190463|NCT00404768|649186|P1|Part A and B|Withdrawn as delivery imminemnt|0
190464|NCT00404768|649183|P4|Part A and B|Withdrawn due to labor progression|0
190465|NCT00404768|649184|P3|Part A and B|Withdrawn due to labor progression|0
190466|NCT00404768|649185|P2|Part A and B|Withdrawn due to labor progression|0
190467|NCT00404768|649186|P1|Part A and B|Withdrawn due to labor progression|1
190468|NCT00404755|649247|P1|Phase II (Escitalopram)|Lost to Follow-up|2
190469|NCT00404755|649247|P1|Phase I (Bupropion)|Other|1
190470|NCT00404755|649247|P1|Phase I (Bupropion)|Adverse Event|3
190471|NCT00404651|649262|P4|Overall Study|Withdrawal by Subject|6
190472|NCT00404651|649263|P3|Overall Study|Withdrawal by Subject|16
190473|NCT00404651|649264|P2|Overall Study|Withdrawal by Subject|12
190474|NCT00404651|649265|P1|Overall Study|Withdrawal by Subject|14
190475|NCT00404651|649262|P4|Overall Study|Lost to Follow-up|10
190476|NCT00404651|649263|P3|Overall Study|Lost to Follow-up|13
190477|NCT00404651|649264|P2|Overall Study|Lost to Follow-up|11
190478|NCT00404651|649265|P1|Overall Study|Lost to Follow-up|15
190479|NCT00404651|649262|P4|Overall Study|Protocol Violation|5
190480|NCT00404651|649263|P3|Overall Study|Protocol Violation|14
190481|NCT00404651|649264|P2|Overall Study|Protocol Violation|5
190482|NCT00404651|649265|P1|Overall Study|Protocol Violation|10
190483|NCT00404651|649262|P4|Overall Study|Serious Adverse Event|0
190484|NCT00404651|649263|P3|Overall Study|Serious Adverse Event|2
190485|NCT00404651|649264|P2|Overall Study|Serious Adverse Event|0
190486|NCT00404651|649265|P1|Overall Study|Serious Adverse Event|0
190487|NCT00404547|649293|P2|Overall Study|Reason not stated|6
190488|NCT00404547|649294|P1|Overall Study|Reason not stated|3
190489|NCT00404547|649293|P2|Overall Study|Other|0
190490|NCT00404547|649294|P1|Overall Study|Other|4
190491|NCT00404547|649293|P2|Overall Study|Lack of compliance|1
190492|NCT00404547|649294|P1|Overall Study|Lack of compliance|5
190493|NCT00404547|649293|P2|Overall Study|Lost to Follow-up|9
190494|NCT00404547|649294|P1|Overall Study|Lost to Follow-up|20
190495|NCT00404547|649293|P2|Overall Study|Protocol Violation|1
190496|NCT00404547|649294|P1|Overall Study|Protocol Violation|0
190497|NCT00404547|649293|P2|Overall Study|Withdrawal by Subject|2
190498|NCT00404547|649294|P1|Overall Study|Withdrawal by Subject|19
190499|NCT00404547|649293|P2|Overall Study|Adverse Event|6
190500|NCT00404547|649294|P1|Overall Study|Adverse Event|39
190501|NCT00404495|649304|P2|Overall Study|Withdrawal by Subject|0
190502|NCT00404495|649305|P1|Overall Study|Withdrawal by Subject|1
190503|NCT00404495|649304|P2|Overall Study|Not specified|0
190504|NCT00404495|649305|P1|Overall Study|Not specified|1
190505|NCT00404495|649304|P2|Overall Study|Lost to Follow-up|0
190506|NCT00404495|649305|P1|Overall Study|Lost to Follow-up|5
190507|NCT00404495|649304|P2|Overall Study|Death|11
190508|NCT00404495|649305|P1|Overall Study|Death|37
190509|NCT00404352|649324|P9|Open Label Extension (up to 36 Months)|Other|2
190510|NCT00404352|649325|P8|Open Label Extension (up to 36 Months)|Other|0
190511|NCT00404352|649326|P7|Open Label Extension (up to 36 Months)|Other|0
190512|NCT00404352|649327|P6|Open Label Extension (up to 36 Months)|Other|0
190513|NCT00404352|649328|P5|Open Label Extension (up to 36 Months)|Other|0
190514|NCT00404352|649329|P4|Open Label Extension (up to 36 Months)|Other|0
190515|NCT00404352|649330|P3|Open Label Extension (up to 36 Months)|Other|0
190516|NCT00404352|649331|P2|Open Label Extension (up to 36 Months)|Other|0
190517|NCT00404352|649332|P1|Open Label Extension (up to 36 Months)|Other|0
190518|NCT00404352|649324|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
190519|NCT00404352|649325|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
190520|NCT00404352|649326|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
190521|NCT00404352|649327|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
190522|NCT00404352|649328|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
190523|NCT00404352|649329|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
190524|NCT00404352|649330|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
190525|NCT00404352|649331|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
190526|NCT00404352|649332|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
190527|NCT00404352|649324|P9|Open Label (up to 24 Month)|Disease progression|0
190528|NCT00404352|649325|P8|Open Label (up to 24 Month)|Disease progression|0
190529|NCT00404352|649326|P7|Open Label (up to 24 Month)|Disease progression|0
190530|NCT00404352|649327|P6|Open Label (up to 24 Month)|Disease progression|0
190531|NCT00404352|649328|P5|Open Label (up to 24 Month)|Disease progression|0
190532|NCT00404352|649329|P4|Open Label (up to 24 Month)|Disease progression|1
190533|NCT00404352|649330|P3|Open Label (up to 24 Month)|Disease progression|0
190534|NCT00404352|649331|P2|Open Label (up to 24 Month)|Disease progression|0
190535|NCT00404352|649332|P1|Open Label (up to 24 Month)|Disease progression|0
190536|NCT00404352|649324|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
190537|NCT00404352|649325|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
190538|NCT00404352|649326|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
190539|NCT00404352|649327|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
190540|NCT00404352|649328|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
190541|NCT00404352|649329|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
190542|NCT00404352|649330|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
190543|NCT00404352|649331|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
190544|NCT00404352|649332|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
190545|NCT00404352|649324|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
190546|NCT00404352|649325|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
190547|NCT00404352|649326|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
190548|NCT00404352|649327|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
190549|NCT00404352|649328|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
190550|NCT00404352|649329|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
190551|NCT00404352|649330|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
190552|NCT00404352|649331|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
190553|NCT00404352|649332|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
190554|NCT00404352|649324|P9|Open Label (up to 24 Month)|Pregnancy|0
190555|NCT00404352|649325|P8|Open Label (up to 24 Month)|Pregnancy|0
190556|NCT00404352|649326|P7|Open Label (up to 24 Month)|Pregnancy|0
190557|NCT00404352|649327|P6|Open Label (up to 24 Month)|Pregnancy|1
190558|NCT00404352|649328|P5|Open Label (up to 24 Month)|Pregnancy|0
190559|NCT00404352|649329|P4|Open Label (up to 24 Month)|Pregnancy|0
190560|NCT00404352|649330|P3|Open Label (up to 24 Month)|Pregnancy|0
190561|NCT00404352|649331|P2|Open Label (up to 24 Month)|Pregnancy|0
190562|NCT00404352|649332|P1|Open Label (up to 24 Month)|Pregnancy|0
190563|NCT00404352|649324|P9|Open Label (up to 24 Month)|Adverse Event|0
190564|NCT00404352|649325|P8|Open Label (up to 24 Month)|Adverse Event|0
190565|NCT00404352|649326|P7|Open Label (up to 24 Month)|Adverse Event|0
190566|NCT00404352|649327|P6|Open Label (up to 24 Month)|Adverse Event|1
190567|NCT00404352|649328|P5|Open Label (up to 24 Month)|Adverse Event|1
190568|NCT00404352|649329|P4|Open Label (up to 24 Month)|Adverse Event|2
190569|NCT00404352|649330|P3|Open Label (up to 24 Month)|Adverse Event|0
190570|NCT00404352|649331|P2|Open Label (up to 24 Month)|Adverse Event|0
190571|NCT00404352|649332|P1|Open Label (up to 24 Month)|Adverse Event|0
190572|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Other|0
190573|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Other|0
190574|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Other|0
190575|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Other|0
190576|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Other|0
190577|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Other|0
190578|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Other|0
190579|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Other|1
190580|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Other|0
190581|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Physician Decision|0
190582|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Physician Decision|0
190583|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Physician Decision|0
190584|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Physician Decision|0
190585|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Physician Decision|0
190586|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Physician Decision|0
190587|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Physician Decision|1
190588|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Physician Decision|0
190589|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Physician Decision|0
190590|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
190591|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
190592|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
190593|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
190594|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
190595|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
190596|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
190597|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
190598|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
190599|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
190600|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
190601|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
190602|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
190603|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
190604|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
190605|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
190606|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
190607|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
190608|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Poor compliance|0
190609|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Poor compliance|0
190610|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Poor compliance|0
190611|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Poor compliance|0
190612|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Poor compliance|0
190613|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Poor compliance|0
190614|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Poor compliance|0
190615|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Poor compliance|0
190616|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Poor compliance|1
190617|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Disease progression|0
190618|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Disease progression|0
190619|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Disease progression|0
190620|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Disease progression|0
190621|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Disease progression|0
190622|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Disease progression|0
190623|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Disease progression|2
190624|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Disease progression|0
190625|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Disease progression|3
190626|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
190627|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
190628|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
190629|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
190630|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
190631|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
190632|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
190633|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
190634|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
190635|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
190636|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
190637|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
190638|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
190639|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
190640|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
190641|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
190642|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
190643|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
190644|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Death|0
190645|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Death|0
190646|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Death|0
190647|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Death|0
190648|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Death|0
190649|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Death|0
190650|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Death|1
190651|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Death|0
190652|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Death|0
190653|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Pregnancy|0
190654|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Pregnancy|0
190655|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Pregnancy|0
190656|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Pregnancy|0
190657|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Pregnancy|0
190658|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Pregnancy|0
190659|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Pregnancy|2
190660|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Pregnancy|0
190661|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Pregnancy|0
190662|NCT00404352|649324|P9|Double Blind (up to 24 Month)|Adverse Event|0
190663|NCT00404352|649325|P8|Double Blind (up to 24 Month)|Adverse Event|0
190664|NCT00404352|649326|P7|Double Blind (up to 24 Month)|Adverse Event|0
190665|NCT00404352|649327|P6|Double Blind (up to 24 Month)|Adverse Event|0
190666|NCT00404352|649328|P5|Double Blind (up to 24 Month)|Adverse Event|0
190667|NCT00404352|649329|P4|Double Blind (up to 24 Month)|Adverse Event|0
190668|NCT00404352|649330|P3|Double Blind (up to 24 Month)|Adverse Event|6
190669|NCT00404352|649331|P2|Double Blind (up to 24 Month)|Adverse Event|4
190670|NCT00404352|649332|P1|Double Blind (up to 24 Month)|Adverse Event|5
190671|NCT00404248|649367|P9|Overall Study|pts declining status|0
190672|NCT00404248|649368|P8|Overall Study|pts declining status|0
190673|NCT00404248|649369|P7|Overall Study|pts declining status|0
190674|NCT00404248|649370|P6|Overall Study|pts declining status|0
190675|NCT00404248|649371|P5|Overall Study|pts declining status|0
190676|NCT00404248|649372|P4|Overall Study|pts declining status|0
190677|NCT00404248|649373|P3|Overall Study|pts declining status|0
190678|NCT00404248|649374|P2|Overall Study|pts declining status|1
190679|NCT00404248|649375|P1|Overall Study|pts declining status|0
190680|NCT00404092|649410|P4|Overall Study|Adverse Event|0
190681|NCT00404092|649411|P3|Overall Study|Adverse Event|1
190682|NCT00404092|649412|P2|Overall Study|Adverse Event|0
190683|NCT00404092|649413|P1|Overall Study|Adverse Event|0
190684|NCT00404092|649410|P4|Overall Study|Death|0
190685|NCT00404092|649411|P3|Overall Study|Death|0
190686|NCT00404092|649412|P2|Overall Study|Death|0
190687|NCT00404092|649413|P1|Overall Study|Death|1
190688|NCT00404079|649429|P2|Overall Study|Lost to follow up, adverse event etc|20
190689|NCT00404079|649430|P1|Overall Study|Lost to follow up, adverse event etc|22
190690|NCT00404066|649436|P1|Overall Study|Withdrawal by Subject - Adverse event|2
190691|NCT00404066|649436|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
190692|NCT00403845|649441|P4|Treatment Period 3|Adverse Event|1
190693|NCT00403845|649442|P3|Treatment Period 3|Adverse Event|0
190694|NCT00403845|649443|P2|Treatment Period 3|Adverse Event|0
190695|NCT00403845|649444|P1|Treatment Period 3|Adverse Event|0
190696|NCT00403845|649441|P4|Treatment Period 3|Subject withdrew consent|1
190697|NCT00403845|649442|P3|Treatment Period 3|Subject withdrew consent|0
190698|NCT00403845|649443|P2|Treatment Period 3|Subject withdrew consent|0
190699|NCT00403845|649444|P1|Treatment Period 3|Subject withdrew consent|0
190700|NCT00403845|649441|P4|Treatment Period 2|Subject withdrew consent|0
190701|NCT00403845|649442|P3|Treatment Period 2|Subject withdrew consent|0
190702|NCT00403845|649443|P2|Treatment Period 2|Subject withdrew consent|0
190703|NCT00403845|649444|P1|Treatment Period 2|Subject withdrew consent|1
190704|NCT00403845|649441|P4|Treatment Period 1|Subject no longer needs study drug|1
190705|NCT00403845|649442|P3|Treatment Period 1|Subject no longer needs study drug|0
190706|NCT00403845|649443|P2|Treatment Period 1|Subject no longer needs study drug|0
190707|NCT00403845|649444|P1|Treatment Period 1|Subject no longer needs study drug|0
190708|NCT00403845|649441|P4|Treatment Period 1|Subject withdrew consent|0
190709|NCT00403845|649442|P3|Treatment Period 1|Subject withdrew consent|0
190710|NCT00403845|649443|P2|Treatment Period 1|Subject withdrew consent|0
190711|NCT00403845|649444|P1|Treatment Period 1|Subject withdrew consent|1
190712|NCT00403767|649468|P2|Overall Study|Missing/incomplete data|1
190713|NCT00403767|649469|P1|Overall Study|Missing/incomplete data|1
190714|NCT00403767|649468|P2|Overall Study|Study terminated by sponsor|69
190715|NCT00403767|649469|P1|Overall Study|Study terminated by sponsor|82
190716|NCT00403767|649468|P2|Overall Study|Clinical efficacy endpoint reached|332
190717|NCT00403767|649469|P1|Overall Study|Clinical efficacy endpoint reached|300
190718|NCT00403767|649468|P2|Overall Study|Protocol Violation|124
190719|NCT00403767|649469|P1|Overall Study|Protocol Violation|142
190720|NCT00403767|649468|P2|Overall Study|Lost to Follow-up|8
190721|NCT00403767|649469|P1|Overall Study|Lost to Follow-up|6
190722|NCT00403767|649468|P2|Overall Study|Investigator dec./not protocol-related|178
190723|NCT00403767|649469|P1|Overall Study|Investigator dec./not protocol-related|191
190724|NCT00403767|649468|P2|Overall Study|Consent withdrawn|673
190725|NCT00403767|649469|P1|Overall Study|Consent withdrawn|671
190726|NCT00403767|649468|P2|Overall Study|Non-compliant with study medication|164
190727|NCT00403767|649469|P1|Overall Study|Non-compliant with study medication|134
190728|NCT00403767|649468|P2|Overall Study|Adverse Event|919
190729|NCT00403767|649469|P1|Overall Study|Adverse Event|993
190730|NCT00403754|649493|P4|Core Treatment Period 2|Lack of Efficacy|0
190731|NCT00403754|649494|P3|Core Treatment Period 2|Lack of Efficacy|1
190732|NCT00403754|649495|P2|Core Treatment Period 2|Lack of Efficacy|0
190733|NCT00403754|649496|P1|Core Treatment Period 2|Lack of Efficacy|0
190734|NCT00403754|649493|P4|Core Treatment Period 1|Withdrawal by Subject|0
190735|NCT00403754|649494|P3|Core Treatment Period 1|Withdrawal by Subject|0
190736|NCT00403754|649495|P2|Core Treatment Period 1|Withdrawal by Subject|1
190737|NCT00403754|649496|P1|Core Treatment Period 1|Withdrawal by Subject|0
190738|NCT00403585|649523|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
190739|NCT00403585|649523|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
190740|NCT00403585|649523|P1|Initial Treatment Phase|Lost to Follow-up|2
190741|NCT00403546|649534|P3|Randomized Trial|Early Terminations|16
190742|NCT00403546|649535|P2|Randomized Trial|Early Terminations|17
190743|NCT00403546|649536|P1|Randomized Trial|Early Terminations|0
190744|NCT00403546|649534|P3|Screening Phase|Terminated Prior to Randomization|0
190745|NCT00403546|649535|P2|Screening Phase|Terminated Prior to Randomization|0
190746|NCT00403546|649536|P1|Screening Phase|Terminated Prior to Randomization|5
190747|NCT00403546|649534|P3|Screening Phase|Adverse Event|0
190748|NCT00403546|649535|P2|Screening Phase|Adverse Event|0
190749|NCT00403546|649536|P1|Screening Phase|Adverse Event|1
190750|NCT00403546|649534|P3|Screening Phase|Screening Failure|0
190751|NCT00403546|649535|P2|Screening Phase|Screening Failure|0
190752|NCT00403546|649536|P1|Screening Phase|Screening Failure|22
190753|NCT00403546|649534|P3|Signed Informed Consent/Open-Label|Adverse Event|0
190754|NCT00403546|649535|P2|Signed Informed Consent/Open-Label|Adverse Event|0
190755|NCT00403546|649536|P1|Signed Informed Consent/Open-Label|Adverse Event|5
190756|NCT00403546|649534|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
190757|NCT00403546|649535|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
190758|NCT00403546|649536|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
190759|NCT00403546|649534|P3|Signed Informed Consent/Open-Label|Early Termination|0
190760|NCT00403546|649535|P2|Signed Informed Consent/Open-Label|Early Termination|0
190761|NCT00403546|649536|P1|Signed Informed Consent/Open-Label|Early Termination|8
190762|NCT00403546|649534|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
190763|NCT00403546|649535|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
190764|NCT00403546|649536|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
190765|NCT00403481|649576|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
190766|NCT00403481|649576|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
190767|NCT00403481|649576|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
190768|NCT00403481|649576|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
190769|NCT00403481|649576|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
190770|NCT00403481|649576|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
190771|NCT00403481|649576|P1|Olm 40 mg|Other|1
190772|NCT00403481|649576|P1|Olm 40 mg|Withdrawal by Subject|1
190773|NCT00403481|649576|P1|Olm 40 mg|Protocol Violation|1
190774|NCT00403481|649576|P1|Olm 40 mg|Adverse Event|2
190775|NCT00403481|649576|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
190776|NCT00403481|649576|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
190777|NCT00403481|649576|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
190778|NCT00403481|649576|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
190779|NCT00403455|649591|P1|Overall Study|Withdrawal by Subject|1
190780|NCT00403390|649614|P2|Overall Study|non-compliant|0
190781|NCT00403390|649615|P1|Overall Study|non-compliant|1
190782|NCT00403390|649614|P2|Overall Study|samples lost|0
190783|NCT00403390|649615|P1|Overall Study|samples lost|1
190784|NCT00403390|649614|P2|Overall Study|Withdrawal by Subject|0
190785|NCT00403390|649615|P1|Overall Study|Withdrawal by Subject|1
190786|NCT00403273|649623|P2|Overall Study|pt. wanted to have a surgical procedure|1
190787|NCT00403273|649624|P1|Overall Study|pt. wanted to have a surgical procedure|0
190788|NCT00403273|649623|P2|Overall Study|Physician Decision|1
190789|NCT00403273|649624|P1|Overall Study|Physician Decision|0
190790|NCT00403273|649623|P2|Overall Study|Lost to Follow-up|2
190791|NCT00403273|649624|P1|Overall Study|Lost to Follow-up|3
190792|NCT00403234|649666|P4|Overall Study|Adverse Event|0
190793|NCT00403234|649667|P3|Overall Study|Adverse Event|1
190794|NCT00403234|649668|P2|Overall Study|Adverse Event|0
190795|NCT00403234|649669|P1|Overall Study|Adverse Event|1
190796|NCT00403234|649666|P4|Overall Study|Withdrawal by Subject|0
190797|NCT00403234|649667|P3|Overall Study|Withdrawal by Subject|0
190798|NCT00403234|649668|P2|Overall Study|Withdrawal by Subject|1
190799|NCT00403234|649669|P1|Overall Study|Withdrawal by Subject|0
190800|NCT00403130|649679|P1|Overall Study|Withdrawal by Subject|1
190801|NCT00403130|649679|P1|Overall Study|Lost to Follow up|1
190802|NCT00403130|649679|P1|Overall Study|Not Eligible|3
190803|NCT00402987|649732|P4|Overall Study|Lack of Efficacy|0
190804|NCT00402987|649733|P3|Overall Study|Lack of Efficacy|1
190805|NCT00402987|649734|P2|Overall Study|Lack of Efficacy|0
190806|NCT00402987|649735|P1|Overall Study|Lack of Efficacy|0
190807|NCT00402740|649905|P1|Overall Study|Subject disposition unknown.|1
190808|NCT00402740|649905|P1|Overall Study|No stent. Completed FU at 30 days.|5
190809|NCT00402740|649905|P1|Overall Study|Lost to Follow-up|6
190810|NCT00402740|649905|P1|Overall Study|Death|50
190811|NCT00402740|649905|P1|Overall Study|Withdrawal by Subject|18
190812|NCT00402727|649917|P2|Overall Study|non-compliance|1
190813|NCT00402727|649918|P1|Overall Study|non-compliance|0
190814|NCT00402727|649917|P2|Overall Study|supply problems|1
190815|NCT00402727|649918|P1|Overall Study|supply problems|2
190816|NCT00402727|649917|P2|Overall Study|Withdrawal by Subject|7
190817|NCT00402727|649918|P1|Overall Study|Withdrawal by Subject|3
190818|NCT00402727|649917|P2|Overall Study|Protocol Violation|4
190819|NCT00402727|649918|P1|Overall Study|Protocol Violation|0
190820|NCT00402727|649917|P2|Overall Study|Physician Decision|1
190821|NCT00402727|649918|P1|Overall Study|Physician Decision|1
190822|NCT00402727|649917|P2|Overall Study|Lost to Follow-up|11
190823|NCT00402727|649918|P1|Overall Study|Lost to Follow-up|24
190824|NCT00402727|649917|P2|Overall Study|Lack of Efficacy|3
190825|NCT00402727|649918|P1|Overall Study|Lack of Efficacy|1
190826|NCT00402727|649917|P2|Overall Study|Death|0
190827|NCT00402727|649918|P1|Overall Study|Death|1
190828|NCT00402727|649917|P2|Overall Study|Adverse Event|6
190829|NCT00402727|649918|P1|Overall Study|Adverse Event|10
190830|NCT00402688|649960|P3|Overall Study|Patient Left Town and Forgot Medication|1
190831|NCT00402688|649961|P2|Overall Study|Patient Left Town and Forgot Medication|0
190832|NCT00402688|649962|P1|Overall Study|Patient Left Town and Forgot Medication|0
190833|NCT00402688|649960|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
190834|NCT00402688|649961|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
190835|NCT00402688|649962|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
190836|NCT00402688|649960|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
190837|NCT00402688|649961|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
190838|NCT00402688|649962|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
190839|NCT00402688|649960|P3|Overall Study|Lost to Follow-up|2
190840|NCT00402688|649961|P2|Overall Study|Lost to Follow-up|0
190841|NCT00402688|649962|P1|Overall Study|Lost to Follow-up|1
190842|NCT00402688|649960|P3|Overall Study|Protocol Violation|1
190843|NCT00402688|649961|P2|Overall Study|Protocol Violation|1
190844|NCT00402688|649962|P1|Overall Study|Protocol Violation|1
190845|NCT00402688|649960|P3|Overall Study|Lack of Efficacy|5
190846|NCT00402688|649961|P2|Overall Study|Lack of Efficacy|4
190847|NCT00402688|649962|P1|Overall Study|Lack of Efficacy|4
190848|NCT00402688|649960|P3|Overall Study|Physician Decision|1
190849|NCT00402688|649961|P2|Overall Study|Physician Decision|0
190850|NCT00402688|649962|P1|Overall Study|Physician Decision|0
190851|NCT00402688|649960|P3|Overall Study|Withdrawal by Subject|1
190852|NCT00402688|649961|P2|Overall Study|Withdrawal by Subject|1
190853|NCT00402688|649962|P1|Overall Study|Withdrawal by Subject|3
190854|NCT00402688|649960|P3|Overall Study|Adverse Event|3
190855|NCT00402688|649961|P2|Overall Study|Adverse Event|9
190856|NCT00402688|649962|P1|Overall Study|Adverse Event|12
190857|NCT00402649|649985|P1|Overall Study|Withdrawal by Subject|1
190858|NCT00402649|649985|P1|Overall Study|Lost to Follow-up|1
190859|NCT00402597|650000|P5|Overall Study|reason not specified|20
190860|NCT00402597|650001|P4|Overall Study|reason not specified|14
190861|NCT00402597|650002|P3|Overall Study|reason not specified|27
190862|NCT00402597|650003|P2|Overall Study|reason not specified|4
190863|NCT00402597|650004|P1|Overall Study|reason not specified|30
190864|NCT00402597|650000|P5|Overall Study|Withdrawal by Subject|24
190865|NCT00402597|650001|P4|Overall Study|Withdrawal by Subject|15
190866|NCT00402597|650002|P3|Overall Study|Withdrawal by Subject|65
190867|NCT00402597|650003|P2|Overall Study|Withdrawal by Subject|16
190868|NCT00402597|650004|P1|Overall Study|Withdrawal by Subject|57
190869|NCT00402597|650000|P5|Overall Study|Lost to Follow-up|3
190870|NCT00402597|650001|P4|Overall Study|Lost to Follow-up|2
190871|NCT00402597|650002|P3|Overall Study|Lost to Follow-up|8
190872|NCT00402597|650003|P2|Overall Study|Lost to Follow-up|1
190873|NCT00402597|650004|P1|Overall Study|Lost to Follow-up|8
190874|NCT00402597|650000|P5|Overall Study|Adverse Event|71
190875|NCT00402597|650001|P4|Overall Study|Adverse Event|39
190876|NCT00402597|650002|P3|Overall Study|Adverse Event|106
190877|NCT00402597|650003|P2|Overall Study|Adverse Event|18
190878|NCT00402597|650004|P1|Overall Study|Adverse Event|81
190879|NCT00402597|650000|P5|Overall Study|Death|6
190880|NCT00402597|650001|P4|Overall Study|Death|4
190881|NCT00402597|650002|P3|Overall Study|Death|6
190882|NCT00402597|650003|P2|Overall Study|Death|7
190883|NCT00402597|650004|P1|Overall Study|Death|15
190884|NCT00402363|650045|P4|Overall Study|"Captured as Other"|2
190885|NCT00402363|650046|P3|Overall Study|"Captured as Other"|2
190886|NCT00402363|650047|P2|Overall Study|"Captured as Other"|2
190887|NCT00402363|650048|P1|Overall Study|"Captured as Other"|6
190888|NCT00402363|650045|P4|Overall Study|Lost to Follow-up|2
190889|NCT00402363|650046|P3|Overall Study|Lost to Follow-up|0
190890|NCT00402363|650047|P2|Overall Study|Lost to Follow-up|4
190891|NCT00402363|650048|P1|Overall Study|Lost to Follow-up|5
190892|NCT00402363|650045|P4|Overall Study|Protocol Violation|3
190893|NCT00402363|650046|P3|Overall Study|Protocol Violation|0
190894|NCT00402363|650047|P2|Overall Study|Protocol Violation|5
190895|NCT00402363|650048|P1|Overall Study|Protocol Violation|3
190896|NCT00402363|650045|P4|Overall Study|Withdrew Consent|1
190897|NCT00402363|650046|P3|Overall Study|Withdrew Consent|2
190898|NCT00402363|650047|P2|Overall Study|Withdrew Consent|5
190899|NCT00402363|650048|P1|Overall Study|Withdrew Consent|10
190900|NCT00402363|650045|P4|Overall Study|Adverse Event|2
190901|NCT00402363|650046|P3|Overall Study|Adverse Event|2
190902|NCT00402363|650047|P2|Overall Study|Adverse Event|14
190903|NCT00402363|650048|P1|Overall Study|Adverse Event|9
190904|NCT00402337|650111|P5|Overall Study|Other Reason|0
190905|NCT00402337|650112|P4|Overall Study|Other Reason|0
190906|NCT00402337|650113|P3|Overall Study|Other Reason|0
190907|NCT00402337|650114|P2|Overall Study|Other Reason|1
190908|NCT00402337|650115|P1|Overall Study|Other Reason|0
190909|NCT00402337|650111|P5|Overall Study|Physician Decision|0
190910|NCT00402337|650112|P4|Overall Study|Physician Decision|1
190911|NCT00402337|650113|P3|Overall Study|Physician Decision|0
190912|NCT00402337|650114|P2|Overall Study|Physician Decision|0
190913|NCT00402337|650115|P1|Overall Study|Physician Decision|0
190914|NCT00402337|650111|P5|Overall Study|Lost to Follow-up|0
190915|NCT00402337|650112|P4|Overall Study|Lost to Follow-up|2
190916|NCT00402337|650113|P3|Overall Study|Lost to Follow-up|1
190917|NCT00402337|650114|P2|Overall Study|Lost to Follow-up|0
190918|NCT00402337|650115|P1|Overall Study|Lost to Follow-up|0
190919|NCT00402337|650111|P5|Overall Study|Withdrawal by Subject|4
190920|NCT00402337|650112|P4|Overall Study|Withdrawal by Subject|6
190921|NCT00402337|650113|P3|Overall Study|Withdrawal by Subject|1
190922|NCT00402337|650114|P2|Overall Study|Withdrawal by Subject|3
190923|NCT00402337|650115|P1|Overall Study|Withdrawal by Subject|5
190924|NCT00402337|650111|P5|Overall Study|Noncompliance|2
190925|NCT00402337|650112|P4|Overall Study|Noncompliance|0
190926|NCT00402337|650113|P3|Overall Study|Noncompliance|0
190927|NCT00402337|650114|P2|Overall Study|Noncompliance|0
190928|NCT00402337|650115|P1|Overall Study|Noncompliance|0
190929|NCT00402337|650111|P5|Overall Study|Adverse Event|2
190930|NCT00402337|650112|P4|Overall Study|Adverse Event|3
190931|NCT00402337|650113|P3|Overall Study|Adverse Event|2
190932|NCT00402337|650114|P2|Overall Study|Adverse Event|2
190933|NCT00402337|650115|P1|Overall Study|Adverse Event|0
190934|NCT00402324|650154|P2|Overall Study|Death|0
190935|NCT00402324|650155|P1|Overall Study|Death|1
190936|NCT00402324|650154|P2|Overall Study|Adverse Event|4
190937|NCT00402324|650155|P1|Overall Study|Adverse Event|6
190938|NCT00402324|650154|P2|Overall Study|Lack of Efficacy|4
190939|NCT00402324|650155|P1|Overall Study|Lack of Efficacy|1
190940|NCT00402324|650154|P2|Overall Study|Sponsor Decision|5
190941|NCT00402324|650155|P1|Overall Study|Sponsor Decision|4
190942|NCT00402324|650154|P2|Overall Study|Physician Decision|4
190943|NCT00402324|650155|P1|Overall Study|Physician Decision|2
190944|NCT00402324|650154|P2|Overall Study|Withdrawal by Subject|2
190945|NCT00402324|650155|P1|Overall Study|Withdrawal by Subject|5
190946|NCT00402324|650154|P2|Overall Study|Protocol Violation|7
190947|NCT00402324|650155|P1|Overall Study|Protocol Violation|8
190948|NCT00402324|650154|P2|Overall Study|Protocol Entry Criteria Not Met|4
190949|NCT00402324|650155|P1|Overall Study|Protocol Entry Criteria Not Met|5
190950|NCT00402324|650154|P2|Overall Study|Lost to Follow-up|11
190951|NCT00402324|650155|P1|Overall Study|Lost to Follow-up|11
190952|NCT00402285|650188|P3|Overall Study|insufficient RNA quality|2
190953|NCT00402285|650189|P2|Overall Study|insufficient RNA quality|6
190954|NCT00402285|650190|P1|Overall Study|insufficient RNA quality|7
190955|NCT00402246|650198|P2|Overall Study|Deterioriating Condition|2
190956|NCT00402246|650199|P1|Overall Study|Deterioriating Condition|3
190957|NCT00402246|650198|P2|Overall Study|Center Closure|3
190958|NCT00402246|650199|P1|Overall Study|Center Closure|5
190959|NCT00402246|650198|P2|Overall Study|Patient's device explanted|2
190960|NCT00402246|650199|P1|Overall Study|Patient's device explanted|6
190961|NCT00402246|650198|P2|Overall Study|Heart Transplant|1
190962|NCT00402246|650199|P1|Overall Study|Heart Transplant|0
190963|NCT00402246|650198|P2|Overall Study|Insurance Issues|1
190964|NCT00402246|650199|P1|Overall Study|Insurance Issues|2
190965|NCT00402246|650198|P2|Overall Study|Missed Final Visit|2
190966|NCT00402246|650199|P1|Overall Study|Missed Final Visit|1
190967|NCT00402246|650198|P2|Overall Study|Protocol Violation|24
190968|NCT00402246|650199|P1|Overall Study|Protocol Violation|25
190969|NCT00402246|650198|P2|Overall Study|Physician Decision|26
190970|NCT00402246|650199|P1|Overall Study|Physician Decision|24
190971|NCT00402246|650198|P2|Overall Study|Withdrawal by Subject|87
190972|NCT00402246|650199|P1|Overall Study|Withdrawal by Subject|72
190973|NCT00402246|650198|P2|Overall Study|Lost to Follow-up|28
190974|NCT00402246|650199|P1|Overall Study|Lost to Follow-up|20
190975|NCT00402246|650198|P2|Overall Study|Death|58
190976|NCT00402246|650199|P1|Overall Study|Death|62
190977|NCT00402233|650233|P4|Overall Study|Worsening of other pre-existing disease|0
190978|NCT00402233|650234|P3|Overall Study|Worsening of other pre-existing disease|0
190979|NCT00402233|650235|P2|Overall Study|Worsening of other pre-existing disease|1
190980|NCT00402233|650236|P1|Overall Study|Worsening of other pre-existing disease|0
190981|NCT00402233|650233|P4|Overall Study|Worsening of disease under study|0
190982|NCT00402233|650234|P3|Overall Study|Worsening of disease under study|0
190983|NCT00402233|650235|P2|Overall Study|Worsening of disease under study|0
190984|NCT00402233|650236|P1|Overall Study|Worsening of disease under study|2
190985|NCT00402233|650233|P4|Overall Study|Withdrawal by Subject|2
190986|NCT00402233|650234|P3|Overall Study|Withdrawal by Subject|2
190987|NCT00402233|650235|P2|Overall Study|Withdrawal by Subject|1
190988|NCT00402233|650236|P1|Overall Study|Withdrawal by Subject|2
190989|NCT00402233|650233|P4|Overall Study|Protocol Violation|0
190990|NCT00402233|650234|P3|Overall Study|Protocol Violation|0
190991|NCT00402233|650235|P2|Overall Study|Protocol Violation|1
190992|NCT00402233|650236|P1|Overall Study|Protocol Violation|0
190993|NCT00402233|650233|P4|Overall Study|Adverse Event|9
190994|NCT00402233|650234|P3|Overall Study|Adverse Event|9
190995|NCT00402233|650235|P2|Overall Study|Adverse Event|7
190996|NCT00402233|650236|P1|Overall Study|Adverse Event|1
190997|NCT00402168|650271|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
190998|NCT00402168|650272|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
190999|NCT00402168|650271|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
191000|NCT00402168|650272|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
191001|NCT00402168|650271|P2|Long Term (LT)|non-specified|2
191002|NCT00402168|650272|P1|Long Term (LT)|non-specified|1
191003|NCT00402168|650271|P2|Long Term (LT)|Lack of Efficacy|2
191004|NCT00402168|650272|P1|Long Term (LT)|Lack of Efficacy|0
191005|NCT00402168|650271|P2|Long Term (LT)|Death|0
191006|NCT00402168|650272|P1|Long Term (LT)|Death|4
191007|NCT00402168|650271|P2|Long Term (LT)|Lost to Follow-up|0
191008|NCT00402168|650272|P1|Long Term (LT)|Lost to Follow-up|1
191009|NCT00402168|650271|P2|Long Term (LT)|Pregnancy|1
191010|NCT00402168|650272|P1|Long Term (LT)|Pregnancy|0
191011|NCT00402168|650271|P2|Long Term (LT)|Withdrawal by Subject|7
191012|NCT00402168|650272|P1|Long Term (LT)|Withdrawal by Subject|4
191013|NCT00402168|650271|P2|Long Term (LT)|Adverse Event|5
191014|NCT00402168|650272|P1|Long Term (LT)|Adverse Event|1
191015|NCT00402168|650271|P2|Treatment (up to 12 Months)|non-specified|1
191016|NCT00402168|650272|P1|Treatment (up to 12 Months)|non-specified|0
191017|NCT00402168|650271|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
191018|NCT00402168|650272|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
191019|NCT00402168|650271|P2|Treatment (up to 12 Months)|Death|1
191020|NCT00402168|650272|P1|Treatment (up to 12 Months)|Death|0
191021|NCT00402168|650271|P2|Randomized|Withdrawal by Subject|1
191022|NCT00402168|650272|P1|Randomized|Withdrawal by Subject|0
191023|NCT00402168|650271|P2|Randomized|Lost to Follow-up|0
191024|NCT00402168|650272|P1|Randomized|Lost to Follow-up|1
191025|NCT00402103|650329|P2|Overall Study|Administrative problems|0
191026|NCT00402103|650330|P1|Overall Study|Administrative problems|2
191027|NCT00402103|650329|P2|Overall Study|Lost to Follow-up|3
191028|NCT00402103|650330|P1|Overall Study|Lost to Follow-up|6
191029|NCT00402103|650329|P2|Overall Study|Patient withdrew consent|1
191030|NCT00402103|650330|P1|Overall Study|Patient withdrew consent|12
191031|NCT00402103|650329|P2|Overall Study|Protocol Deviation|0
191032|NCT00402103|650330|P1|Overall Study|Protocol Deviation|8
191033|NCT00402103|650329|P2|Overall Study|Condition no longer requires study drug|0
191034|NCT00402103|650330|P1|Overall Study|Condition no longer requires study drug|2
191035|NCT00402103|650329|P2|Overall Study|Unsatisfactory therapeutic effect|2
191036|NCT00402103|650330|P1|Overall Study|Unsatisfactory therapeutic effect|1
191037|NCT00402103|650329|P2|Overall Study|Adverse Event|7
191038|NCT00402103|650330|P1|Overall Study|Adverse Event|60
191039|NCT00402051|650346|P2|Overall Study|Lost to Follow-up|0
191040|NCT00402051|650347|P1|Overall Study|Lost to Follow-up|1
191041|NCT00402051|650346|P2|Overall Study|Death Due to Adverse Event|2
191042|NCT00402051|650347|P1|Overall Study|Death Due to Adverse Event|0
191043|NCT00402051|650346|P2|Overall Study|Death Due to Study Disease|1
191044|NCT00402051|650347|P1|Overall Study|Death Due to Study Disease|2
191045|NCT00402051|650346|P2|Overall Study|Death - Related to Study Drug|2
191046|NCT00402051|650347|P1|Overall Study|Death - Related to Study Drug|1
191047|NCT00402051|650346|P2|Overall Study|Withdrawal by Subject|3
191048|NCT00402051|650347|P1|Overall Study|Withdrawal by Subject|3
191049|NCT00402051|650346|P2|Overall Study|Physician Decision|3
191050|NCT00402051|650347|P1|Overall Study|Physician Decision|7
191051|NCT00402051|650346|P2|Overall Study|Adverse Event|4
191052|NCT00402051|650347|P1|Overall Study|Adverse Event|11
191053|NCT00402051|650346|P2|Overall Study|Progressive Disease|20
191054|NCT00402051|650347|P1|Overall Study|Progressive Disease|13
191055|NCT00402025|650364|P3|Overall Study|Participant Decision|1
191056|NCT00402025|650365|P2|Overall Study|Participant Decision|0
191057|NCT00402025|650366|P1|Overall Study|Participant Decision|0
191058|NCT00402025|650364|P3|Overall Study|Physician Decision|0
191059|NCT00402025|650365|P2|Overall Study|Physician Decision|1
191060|NCT00402025|650366|P1|Overall Study|Physician Decision|1
191061|NCT00402025|650364|P3|Overall Study|Disease Progression|2
191062|NCT00402025|650365|P2|Overall Study|Disease Progression|1
191063|NCT00402025|650366|P1|Overall Study|Disease Progression|1
191064|NCT00402025|650364|P3|Overall Study|Death|5
191065|NCT00402025|650365|P2|Overall Study|Death|1
191066|NCT00402025|650366|P1|Overall Study|Death|0
191067|NCT00402025|650364|P3|Overall Study|Adverse Event|2
191068|NCT00402025|650365|P2|Overall Study|Adverse Event|0
191069|NCT00402025|650366|P1|Overall Study|Adverse Event|0
191070|NCT00401973|650392|P3|Overall Study|Withdrawal by Subject|9
191071|NCT00401973|650393|P2|Overall Study|Withdrawal by Subject|12
191072|NCT00401973|650394|P1|Overall Study|Withdrawal by Subject|4
191073|NCT00401973|650392|P3|Overall Study|Sponsor Decision|0
191074|NCT00401973|650393|P2|Overall Study|Sponsor Decision|1
191075|NCT00401973|650394|P1|Overall Study|Sponsor Decision|0
191076|NCT00401973|650392|P3|Overall Study|Protocol Violation|3
191077|NCT00401973|650393|P2|Overall Study|Protocol Violation|2
191078|NCT00401973|650394|P1|Overall Study|Protocol Violation|1
191079|NCT00401973|650392|P3|Overall Study|Physician Decision|1
191080|NCT00401973|650393|P2|Overall Study|Physician Decision|0
191081|NCT00401973|650394|P1|Overall Study|Physician Decision|2
191082|NCT00401973|650392|P3|Overall Study|Lost to Follow-up|2
191083|NCT00401973|650393|P2|Overall Study|Lost to Follow-up|2
191084|NCT00401973|650394|P1|Overall Study|Lost to Follow-up|2
191085|NCT00401973|650392|P3|Overall Study|Lack of Efficacy|3
191086|NCT00401973|650393|P2|Overall Study|Lack of Efficacy|0
191087|NCT00401973|650394|P1|Overall Study|Lack of Efficacy|0
191088|NCT00401973|650392|P3|Overall Study|Clinical Relapse|1
191089|NCT00401973|650393|P2|Overall Study|Clinical Relapse|1
191090|NCT00401973|650394|P1|Overall Study|Clinical Relapse|0
191091|NCT00401973|650392|P3|Overall Study|Adverse Event|4
191092|NCT00401973|650393|P2|Overall Study|Adverse Event|8
191093|NCT00401973|650394|P1|Overall Study|Adverse Event|2
191094|NCT00401960|650433|P2|Overall Study|Death|0
191095|NCT00401960|650434|P1|Overall Study|Death|2
191096|NCT00401960|650433|P2|Overall Study|Lost to Follow-up|0
191097|NCT00401960|650434|P1|Overall Study|Lost to Follow-up|3
191098|NCT00401843|650464|P3|Overall Study|Received incorrect treatment|0
191099|NCT00401843|650465|P2|Overall Study|Received incorrect treatment|3
191100|NCT00401843|650466|P1|Overall Study|Received incorrect treatment|0
191101|NCT00401843|650464|P3|Overall Study|Randomized but not Treated|3
191102|NCT00401843|650465|P2|Overall Study|Randomized but not Treated|2
191103|NCT00401843|650466|P1|Overall Study|Randomized but not Treated|0
191104|NCT00401843|650464|P3|Overall Study|Withdrawal of consent to study agent|17
191105|NCT00401843|650465|P2|Overall Study|Withdrawal of consent to study agent|15
191106|NCT00401843|650466|P1|Overall Study|Withdrawal of consent to study agent|1
191107|NCT00401843|650464|P3|Overall Study|Withdrawal by Subject|5
191108|NCT00401843|650465|P2|Overall Study|Withdrawal by Subject|5
191109|NCT00401843|650466|P1|Overall Study|Withdrawal by Subject|1
191110|NCT00401843|650464|P3|Overall Study|Protocol Violation|1
191111|NCT00401843|650465|P2|Overall Study|Protocol Violation|0
191112|NCT00401843|650466|P1|Overall Study|Protocol Violation|0
191113|NCT00401843|650464|P3|Overall Study|Physician Decision|10
191114|NCT00401843|650465|P2|Overall Study|Physician Decision|16
191115|NCT00401843|650466|P1|Overall Study|Physician Decision|0
191116|NCT00401843|650464|P3|Overall Study|Other Unspecified|5
191117|NCT00401843|650465|P2|Overall Study|Other Unspecified|3
191118|NCT00401843|650466|P1|Overall Study|Other Unspecified|0
191119|NCT00401843|650464|P3|Overall Study|Lost to Follow-up|2
191120|NCT00401843|650465|P2|Overall Study|Lost to Follow-up|0
191121|NCT00401843|650466|P1|Overall Study|Lost to Follow-up|0
191122|NCT00401843|650464|P3|Overall Study|End of Study|2
191123|NCT00401843|650465|P2|Overall Study|End of Study|1
191124|NCT00401843|650466|P1|Overall Study|End of Study|1
191125|NCT00401843|650464|P3|Overall Study|Disease progression|49
191126|NCT00401843|650465|P2|Overall Study|Disease progression|60
191127|NCT00401843|650466|P1|Overall Study|Disease progression|10
191128|NCT00401843|650464|P3|Overall Study|Death|10
191129|NCT00401843|650465|P2|Overall Study|Death|8
191130|NCT00401843|650466|P1|Overall Study|Death|0
191131|NCT00401843|650464|P3|Overall Study|Adverse Event|27
191132|NCT00401843|650465|P2|Overall Study|Adverse Event|26
191133|NCT00401843|650466|P1|Overall Study|Adverse Event|7
191134|NCT00401843|650464|P3|Overall Study|Achieved Complete Response|11
191135|NCT00401843|650465|P2|Overall Study|Achieved Complete Response|5
191136|NCT00401843|650466|P1|Overall Study|Achieved Complete Response|1
191137|NCT00401830|650484|P2|Overall Study|Other: Personal / Family problems|0
191138|NCT00401830|650485|P1|Overall Study|Other: Personal / Family problems|1
191139|NCT00401830|650484|P2|Overall Study|Lost to Follow-up|3
191140|NCT00401830|650485|P1|Overall Study|Lost to Follow-up|1
191141|NCT00401830|650484|P2|Overall Study|Non-compliance with drug study|0
191142|NCT00401830|650485|P1|Overall Study|Non-compliance with drug study|1
191143|NCT00401830|650484|P2|Overall Study|Protocol Violation|3
191144|NCT00401830|650485|P1|Overall Study|Protocol Violation|3
191145|NCT00401830|650484|P2|Overall Study|Withdrawal by Subject|3
191146|NCT00401830|650485|P1|Overall Study|Withdrawal by Subject|4
191147|NCT00401830|650484|P2|Overall Study|Lack of Efficacy|5
191148|NCT00401830|650485|P1|Overall Study|Lack of Efficacy|11
191149|NCT00401830|650484|P2|Overall Study|Adverse Event|18
191150|NCT00401830|650485|P1|Overall Study|Adverse Event|10
191151|NCT00401752|650543|P2|Overall Study|Physician Decision|1
191152|NCT00401752|650544|P1|Overall Study|Physician Decision|1
191153|NCT00401752|650543|P2|Overall Study|Development of any exclusion criteria|2
191154|NCT00401752|650544|P1|Overall Study|Development of any exclusion criteria|4
191155|NCT00401752|650543|P2|Overall Study|Lost to Follow-up|4
191156|NCT00401752|650544|P1|Overall Study|Lost to Follow-up|1
191157|NCT00401752|650543|P2|Overall Study|Withdrawal by Subject|6
191158|NCT00401752|650544|P1|Overall Study|Withdrawal by Subject|2
191159|NCT00401752|650543|P2|Overall Study|Adverse Event|5
191160|NCT00401752|650544|P1|Overall Study|Adverse Event|2
191161|NCT00401726|650562|P2|Overall Study|Protocol Deviation|4
191162|NCT00401726|650563|P1|Overall Study|Protocol Deviation|9
191163|NCT00401726|650562|P2|Overall Study|Lack of Efficacy|6
191164|NCT00401726|650563|P1|Overall Study|Lack of Efficacy|4
191165|NCT00401726|650562|P2|Overall Study|Withdrawal by Subject|24
191166|NCT00401726|650563|P1|Overall Study|Withdrawal by Subject|18
191167|NCT00401726|650562|P2|Overall Study|Protocol Violation|3
191168|NCT00401726|650563|P1|Overall Study|Protocol Violation|6
191169|NCT00401726|650562|P2|Overall Study|Lost to Follow-up|20
191170|NCT00401726|650563|P1|Overall Study|Lost to Follow-up|23
191171|NCT00401726|650562|P2|Overall Study|Physician Decision|6
191172|NCT00401726|650563|P1|Overall Study|Physician Decision|3
191173|NCT00401726|650562|P2|Overall Study|Sponsor Request|1
191174|NCT00401726|650563|P1|Overall Study|Sponsor Request|0
191175|NCT00401726|650562|P2|Overall Study|Death|3
191176|NCT00401726|650563|P1|Overall Study|Death|0
191177|NCT00401726|650562|P2|Overall Study|Adverse Event|45
191178|NCT00401726|650563|P1|Overall Study|Adverse Event|34
191179|NCT00401544|650598|P4|Overall Study|Other|2
191180|NCT00401544|650599|P3|Overall Study|Other|2
191181|NCT00401544|650600|P2|Overall Study|Other|0
191182|NCT00401544|650601|P1|Overall Study|Other|0
191183|NCT00401544|650598|P4|Overall Study|Disease progression|0
191184|NCT00401544|650599|P3|Overall Study|Disease progression|0
191185|NCT00401544|650600|P2|Overall Study|Disease progression|1
191186|NCT00401544|650601|P1|Overall Study|Disease progression|0
191187|NCT00401544|650598|P4|Overall Study|Ineligibility determined|2
191188|NCT00401544|650599|P3|Overall Study|Ineligibility determined|0
191189|NCT00401544|650600|P2|Overall Study|Ineligibility determined|1
191190|NCT00401544|650601|P1|Overall Study|Ineligibility determined|0
191191|NCT00401544|650598|P4|Overall Study|Physician Decision|0
191192|NCT00401544|650599|P3|Overall Study|Physician Decision|0
191193|NCT00401544|650600|P2|Overall Study|Physician Decision|3
191194|NCT00401544|650601|P1|Overall Study|Physician Decision|1
191195|NCT00401544|650598|P4|Overall Study|Withdrawal by Subject|5
191196|NCT00401544|650599|P3|Overall Study|Withdrawal by Subject|6
191197|NCT00401544|650600|P2|Overall Study|Withdrawal by Subject|6
191198|NCT00401544|650601|P1|Overall Study|Withdrawal by Subject|7
191199|NCT00401544|650598|P4|Overall Study|Lost to Follow-up|1
191200|NCT00401544|650599|P3|Overall Study|Lost to Follow-up|1
191201|NCT00401544|650600|P2|Overall Study|Lost to Follow-up|0
191202|NCT00401544|650601|P1|Overall Study|Lost to Follow-up|2
191203|NCT00401544|650598|P4|Overall Study|Death|5
191204|NCT00401544|650599|P3|Overall Study|Death|2
191205|NCT00401544|650600|P2|Overall Study|Death|6
191206|NCT00401544|650601|P1|Overall Study|Death|3
191207|NCT00401544|650598|P4|Overall Study|Adverse Event|1
191208|NCT00401544|650599|P3|Overall Study|Adverse Event|1
191209|NCT00401544|650600|P2|Overall Study|Adverse Event|1
191210|NCT00401544|650601|P1|Overall Study|Adverse Event|5
191211|NCT00401531|650641|P2|Overall Study|Withdrawal by Subject|2
191212|NCT00401531|650642|P1|Overall Study|Withdrawal by Subject|3
191213|NCT00401531|650641|P2|Overall Study|Lost to Follow-up|1
191214|NCT00401531|650642|P1|Overall Study|Lost to Follow-up|1
191215|NCT00401531|650641|P2|Overall Study|Protocol Violation|7
191216|NCT00401531|650642|P1|Overall Study|Protocol Violation|3
191217|NCT00401531|650641|P2|Overall Study|Adverse Event|0
191218|NCT00401531|650642|P1|Overall Study|Adverse Event|2
191219|NCT00401258|650712|P1|Overall Study|Adverse Event|7
191220|NCT00401245|650727|P8|Double Blind Tapering Phase|Lack of Efficacy|0
191221|NCT00401245|650728|P7|Double Blind Tapering Phase|Lack of Efficacy|0
191222|NCT00401245|650729|P6|Double Blind Tapering Phase|Lack of Efficacy|1
191223|NCT00401245|650730|P5|Double Blind Tapering Phase|Lack of Efficacy|0
191224|NCT00401245|650731|P4|Double Blind Tapering Phase|Lack of Efficacy|0
191225|NCT00401245|650732|P3|Double Blind Tapering Phase|Lack of Efficacy|0
191226|NCT00401245|650733|P2|Double Blind Tapering Phase|Lack of Efficacy|0
191227|NCT00401245|650734|P1|Double Blind Tapering Phase|Lack of Efficacy|0
191228|NCT00401245|650727|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
191229|NCT00401245|650728|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
191230|NCT00401245|650729|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
191231|NCT00401245|650730|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
191232|NCT00401245|650731|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
191233|NCT00401245|650732|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
191234|NCT00401245|650733|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
191235|NCT00401245|650734|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
191236|NCT00401245|650727|P8|Double Blind Tapering Phase|Other|2
191237|NCT00401245|650728|P7|Double Blind Tapering Phase|Other|2
191238|NCT00401245|650729|P6|Double Blind Tapering Phase|Other|0
191239|NCT00401245|650730|P5|Double Blind Tapering Phase|Other|1
191240|NCT00401245|650731|P4|Double Blind Tapering Phase|Other|0
191241|NCT00401245|650732|P3|Double Blind Tapering Phase|Other|0
191242|NCT00401245|650733|P2|Double Blind Tapering Phase|Other|0
191243|NCT00401245|650734|P1|Double Blind Tapering Phase|Other|0
191244|NCT00401245|650727|P8|Double Blind Tapering Phase|Investigator request|1
191245|NCT00401245|650728|P7|Double Blind Tapering Phase|Investigator request|0
191246|NCT00401245|650729|P6|Double Blind Tapering Phase|Investigator request|0
191247|NCT00401245|650730|P5|Double Blind Tapering Phase|Investigator request|0
191248|NCT00401245|650731|P4|Double Blind Tapering Phase|Investigator request|0
191249|NCT00401245|650732|P3|Double Blind Tapering Phase|Investigator request|0
191250|NCT00401245|650733|P2|Double Blind Tapering Phase|Investigator request|0
191251|NCT00401245|650734|P1|Double Blind Tapering Phase|Investigator request|0
191252|NCT00401245|650727|P8|Double Blind Tapering Phase|Adverse Event|4
191253|NCT00401245|650728|P7|Double Blind Tapering Phase|Adverse Event|2
191254|NCT00401245|650729|P6|Double Blind Tapering Phase|Adverse Event|1
191255|NCT00401245|650730|P5|Double Blind Tapering Phase|Adverse Event|1
191256|NCT00401245|650731|P4|Double Blind Tapering Phase|Adverse Event|0
191257|NCT00401245|650732|P3|Double Blind Tapering Phase|Adverse Event|0
191258|NCT00401245|650733|P2|Double Blind Tapering Phase|Adverse Event|0
191259|NCT00401245|650734|P1|Double Blind Tapering Phase|Adverse Event|0
191260|NCT00401245|650727|P8|Open Label Phase|Lack of Efficacy|0
191261|NCT00401245|650728|P7|Open Label Phase|Lack of Efficacy|0
191262|NCT00401245|650729|P6|Open Label Phase|Lack of Efficacy|0
191263|NCT00401245|650730|P5|Open Label Phase|Lack of Efficacy|0
191264|NCT00401245|650731|P4|Open Label Phase|Lack of Efficacy|0
191265|NCT00401245|650732|P3|Open Label Phase|Lack of Efficacy|3
191266|NCT00401245|650733|P2|Open Label Phase|Lack of Efficacy|2
191267|NCT00401245|650734|P1|Open Label Phase|Lack of Efficacy|4
191268|NCT00401245|650727|P8|Open Label Phase|Withdrawal by Subject|0
191269|NCT00401245|650728|P7|Open Label Phase|Withdrawal by Subject|0
191270|NCT00401245|650729|P6|Open Label Phase|Withdrawal by Subject|0
191271|NCT00401245|650730|P5|Open Label Phase|Withdrawal by Subject|0
191272|NCT00401245|650731|P4|Open Label Phase|Withdrawal by Subject|1
191273|NCT00401245|650732|P3|Open Label Phase|Withdrawal by Subject|2
191274|NCT00401245|650733|P2|Open Label Phase|Withdrawal by Subject|3
191275|NCT00401245|650734|P1|Open Label Phase|Withdrawal by Subject|3
191276|NCT00401245|650727|P8|Open Label Phase|Protocol Violation|0
191277|NCT00401245|650728|P7|Open Label Phase|Protocol Violation|0
191278|NCT00401245|650729|P6|Open Label Phase|Protocol Violation|0
191279|NCT00401245|650730|P5|Open Label Phase|Protocol Violation|0
191280|NCT00401245|650731|P4|Open Label Phase|Protocol Violation|1
191281|NCT00401245|650732|P3|Open Label Phase|Protocol Violation|0
191282|NCT00401245|650733|P2|Open Label Phase|Protocol Violation|1
191283|NCT00401245|650734|P1|Open Label Phase|Protocol Violation|0
191284|NCT00401245|650727|P8|Open Label Phase|Other|0
191285|NCT00401245|650728|P7|Open Label Phase|Other|0
191286|NCT00401245|650729|P6|Open Label Phase|Other|0
191287|NCT00401245|650730|P5|Open Label Phase|Other|0
191288|NCT00401245|650731|P4|Open Label Phase|Other|8
191289|NCT00401245|650732|P3|Open Label Phase|Other|7
191290|NCT00401245|650733|P2|Open Label Phase|Other|8
191291|NCT00401245|650734|P1|Open Label Phase|Other|4
191292|NCT00401245|650727|P8|Open Label Phase|Lost to Follow-up|0
191293|NCT00401245|650728|P7|Open Label Phase|Lost to Follow-up|0
191294|NCT00401245|650729|P6|Open Label Phase|Lost to Follow-up|0
191295|NCT00401245|650730|P5|Open Label Phase|Lost to Follow-up|0
191296|NCT00401245|650731|P4|Open Label Phase|Lost to Follow-up|4
191297|NCT00401245|650732|P3|Open Label Phase|Lost to Follow-up|5
191298|NCT00401245|650733|P2|Open Label Phase|Lost to Follow-up|7
191299|NCT00401245|650734|P1|Open Label Phase|Lost to Follow-up|5
191300|NCT00401245|650727|P8|Open Label Phase|Adverse Event|0
191301|NCT00401245|650728|P7|Open Label Phase|Adverse Event|0
191302|NCT00401245|650729|P6|Open Label Phase|Adverse Event|0
191303|NCT00401245|650730|P5|Open Label Phase|Adverse Event|0
191304|NCT00401245|650731|P4|Open Label Phase|Adverse Event|7
191305|NCT00401245|650732|P3|Open Label Phase|Adverse Event|6
191306|NCT00401245|650733|P2|Open Label Phase|Adverse Event|14
191307|NCT00401245|650734|P1|Open Label Phase|Adverse Event|5
191308|NCT00401245|650727|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
191309|NCT00401245|650728|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
191310|NCT00401245|650729|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
191311|NCT00401245|650730|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
191312|NCT00401245|650731|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
191313|NCT00401245|650732|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
191314|NCT00401245|650733|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
191315|NCT00401245|650734|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
191316|NCT00401245|650727|P8|Double Blind Titration Phase|Withdrawal by Subject|0
191317|NCT00401245|650728|P7|Double Blind Titration Phase|Withdrawal by Subject|0
191318|NCT00401245|650729|P6|Double Blind Titration Phase|Withdrawal by Subject|0
191319|NCT00401245|650730|P5|Double Blind Titration Phase|Withdrawal by Subject|0
191320|NCT00401245|650731|P4|Double Blind Titration Phase|Withdrawal by Subject|2
191321|NCT00401245|650732|P3|Double Blind Titration Phase|Withdrawal by Subject|0
191322|NCT00401245|650733|P2|Double Blind Titration Phase|Withdrawal by Subject|1
191323|NCT00401245|650734|P1|Double Blind Titration Phase|Withdrawal by Subject|1
191324|NCT00401245|650727|P8|Double Blind Titration Phase|Protocol Violation|0
191325|NCT00401245|650728|P7|Double Blind Titration Phase|Protocol Violation|0
191326|NCT00401245|650729|P6|Double Blind Titration Phase|Protocol Violation|0
191327|NCT00401245|650730|P5|Double Blind Titration Phase|Protocol Violation|0
191328|NCT00401245|650731|P4|Double Blind Titration Phase|Protocol Violation|1
191329|NCT00401245|650732|P3|Double Blind Titration Phase|Protocol Violation|0
191330|NCT00401245|650733|P2|Double Blind Titration Phase|Protocol Violation|0
191331|NCT00401245|650734|P1|Double Blind Titration Phase|Protocol Violation|0
191332|NCT00401245|650727|P8|Double Blind Titration Phase|Other|0
191333|NCT00401245|650728|P7|Double Blind Titration Phase|Other|0
191334|NCT00401245|650729|P6|Double Blind Titration Phase|Other|0
191335|NCT00401245|650730|P5|Double Blind Titration Phase|Other|0
191336|NCT00401245|650731|P4|Double Blind Titration Phase|Other|0
191337|NCT00401245|650732|P3|Double Blind Titration Phase|Other|1
191338|NCT00401245|650733|P2|Double Blind Titration Phase|Other|0
191339|NCT00401245|650734|P1|Double Blind Titration Phase|Other|0
191340|NCT00401245|650727|P8|Double Blind Titration Phase|Adverse Event|0
191341|NCT00401245|650728|P7|Double Blind Titration Phase|Adverse Event|0
191342|NCT00401245|650729|P6|Double Blind Titration Phase|Adverse Event|0
191343|NCT00401245|650730|P5|Double Blind Titration Phase|Adverse Event|0
191344|NCT00401245|650731|P4|Double Blind Titration Phase|Adverse Event|12
191345|NCT00401245|650732|P3|Double Blind Titration Phase|Adverse Event|5
191346|NCT00401245|650733|P2|Double Blind Titration Phase|Adverse Event|2
191347|NCT00401245|650734|P1|Double Blind Titration Phase|Adverse Event|3
191348|NCT00401193|650802|P3|Overall Study|Other Event|2
191349|NCT00401193|650803|P2|Overall Study|Other Event|2
191350|NCT00401193|650804|P1|Overall Study|Other Event|3
191351|NCT00401193|650802|P3|Overall Study|Withdrawal by Subject|1
191352|NCT00401193|650803|P2|Overall Study|Withdrawal by Subject|0
191353|NCT00401193|650804|P1|Overall Study|Withdrawal by Subject|2
191354|NCT00401193|650802|P3|Overall Study|Lost to Follow-up|1
191355|NCT00401193|650803|P2|Overall Study|Lost to Follow-up|5
191356|NCT00401193|650804|P1|Overall Study|Lost to Follow-up|6
191357|NCT00401193|650802|P3|Overall Study|Protocol Violation|1
191358|NCT00401193|650803|P2|Overall Study|Protocol Violation|1
191359|NCT00401193|650804|P1|Overall Study|Protocol Violation|3
191360|NCT00401193|650802|P3|Overall Study|Adverse Event|1
191361|NCT00401193|650803|P2|Overall Study|Adverse Event|3
191362|NCT00401193|650804|P1|Overall Study|Adverse Event|1
191363|NCT00400946|650827|P5|Overall Study|Other|1
191364|NCT00400946|650828|P4|Overall Study|Other|0
191365|NCT00400946|650829|P3|Overall Study|Other|0
191366|NCT00400946|650830|P2|Overall Study|Other|0
191367|NCT00400946|650831|P1|Overall Study|Other|0
191368|NCT00400946|650827|P5|Overall Study|Clinical|9
191369|NCT00400946|650828|P4|Overall Study|Clinical|2
191370|NCT00400946|650829|P3|Overall Study|Clinical|0
191371|NCT00400946|650830|P2|Overall Study|Clinical|2
191372|NCT00400946|650831|P1|Overall Study|Clinical|1
191373|NCT00400946|650827|P5|Overall Study|Withdrawal by Subject|8
191374|NCT00400946|650828|P4|Overall Study|Withdrawal by Subject|5
191375|NCT00400946|650829|P3|Overall Study|Withdrawal by Subject|1
191376|NCT00400946|650830|P2|Overall Study|Withdrawal by Subject|5
191377|NCT00400946|650831|P1|Overall Study|Withdrawal by Subject|2
191378|NCT00400946|650827|P5|Overall Study|Transplant in CR1|1
191379|NCT00400946|650828|P4|Overall Study|Transplant in CR1|10
191380|NCT00400946|650829|P3|Overall Study|Transplant in CR1|0
191381|NCT00400946|650830|P2|Overall Study|Transplant in CR1|0
191382|NCT00400946|650831|P1|Overall Study|Transplant in CR1|0
191383|NCT00400946|650827|P5|Overall Study|Relapse|5
191384|NCT00400946|650828|P4|Overall Study|Relapse|1
191385|NCT00400946|650829|P3|Overall Study|Relapse|1
191386|NCT00400946|650830|P2|Overall Study|Relapse|2
191387|NCT00400946|650831|P1|Overall Study|Relapse|9
191388|NCT00400946|650827|P5|Overall Study|Remission Death|1
191389|NCT00400946|650828|P4|Overall Study|Remission Death|0
191390|NCT00400946|650829|P3|Overall Study|Remission Death|0
191391|NCT00400946|650830|P2|Overall Study|Remission Death|1
191392|NCT00400946|650831|P1|Overall Study|Remission Death|1
191393|NCT00400946|650827|P5|Overall Study|Lost to Follow-up|1
191394|NCT00400946|650828|P4|Overall Study|Lost to Follow-up|0
191395|NCT00400946|650829|P3|Overall Study|Lost to Follow-up|0
191396|NCT00400946|650830|P2|Overall Study|Lost to Follow-up|1
191397|NCT00400946|650831|P1|Overall Study|Lost to Follow-up|1
191398|NCT00400946|650827|P5|Overall Study|Induction Death|3
191399|NCT00400946|650828|P4|Overall Study|Induction Death|13
191400|NCT00400946|650829|P3|Overall Study|Induction Death|0
191401|NCT00400946|650830|P2|Overall Study|Induction Death|0
191402|NCT00400946|650831|P1|Overall Study|Induction Death|0
191403|NCT00400946|650827|P5|Overall Study|Induction Failure|8
191404|NCT00400946|650828|P4|Overall Study|Induction Failure|11
191405|NCT00400946|650829|P3|Overall Study|Induction Failure|0
191406|NCT00400946|650830|P2|Overall Study|Induction Failure|0
191407|NCT00400946|650831|P1|Overall Study|Induction Failure|0
191408|NCT00400946|650827|P5|Overall Study|Ineligible|1
191409|NCT00400946|650828|P4|Overall Study|Ineligible|5
191410|NCT00400946|650829|P3|Overall Study|Ineligible|0
191411|NCT00400946|650830|P2|Overall Study|Ineligible|0
191412|NCT00400946|650831|P1|Overall Study|Ineligible|0
191413|NCT00400764|650890|P5|Phase II|Withdrawal by Subject|0
191414|NCT00400764|650891|P4|Phase II|Withdrawal by Subject|1
191415|NCT00400764|650892|P3|Phase II|Withdrawal by Subject|1
191416|NCT00400764|650893|P2|Phase II|Withdrawal by Subject|0
191417|NCT00400764|650894|P1|Phase II|Withdrawal by Subject|0
191418|NCT00400764|650890|P5|Phase II|Patient began new, non-protocol, therapy|0
191419|NCT00400764|650891|P4|Phase II|Patient began new, non-protocol, therapy|0
191420|NCT00400764|650892|P3|Phase II|Patient began new, non-protocol, therapy|1
191421|NCT00400764|650893|P2|Phase II|Patient began new, non-protocol, therapy|0
191422|NCT00400764|650894|P1|Phase II|Patient began new, non-protocol, therapy|0
191423|NCT00400764|650890|P5|Phase II|Sponsor’s decision to terminate|11
191424|NCT00400764|650891|P4|Phase II|Sponsor’s decision to terminate|22
191425|NCT00400764|650892|P3|Phase II|Sponsor’s decision to terminate|18
191426|NCT00400764|650893|P2|Phase II|Sponsor’s decision to terminate|0
191427|NCT00400764|650894|P1|Phase II|Sponsor’s decision to terminate|0
191428|NCT00400764|650890|P5|Phase II|Physician Decision|0
191429|NCT00400764|650891|P4|Phase II|Physician Decision|1
191430|NCT00400764|650892|P3|Phase II|Physician Decision|1
191431|NCT00400764|650893|P2|Phase II|Physician Decision|0
191432|NCT00400764|650894|P1|Phase II|Physician Decision|0
191433|NCT00400764|650890|P5|Phase II|Lost to Follow-up|0
191434|NCT00400764|650891|P4|Phase II|Lost to Follow-up|0
191435|NCT00400764|650892|P3|Phase II|Lost to Follow-up|1
191436|NCT00400764|650893|P2|Phase II|Lost to Follow-up|0
191437|NCT00400764|650894|P1|Phase II|Lost to Follow-up|0
191438|NCT00400764|650890|P5|Phase II|Death|0
191439|NCT00400764|650891|P4|Phase II|Death|2
191440|NCT00400764|650892|P3|Phase II|Death|1
191441|NCT00400764|650893|P2|Phase II|Death|0
191442|NCT00400764|650894|P1|Phase II|Death|0
191443|NCT00400764|650890|P5|Phase Ib|Disease Progression|0
191444|NCT00400764|650891|P4|Phase Ib|Disease Progression|0
191445|NCT00400764|650892|P3|Phase Ib|Disease Progression|0
191446|NCT00400764|650893|P2|Phase Ib|Disease Progression|4
191447|NCT00400764|650894|P1|Phase Ib|Disease Progression|4
191448|NCT00400764|650890|P5|Phase Ib|Death|0
191449|NCT00400764|650891|P4|Phase Ib|Death|0
191450|NCT00400764|650892|P3|Phase Ib|Death|0
191451|NCT00400764|650893|P2|Phase Ib|Death|0
191452|NCT00400764|650894|P1|Phase Ib|Death|1
191453|NCT00400764|650890|P5|Phase Ib|Adverse Event|0
191454|NCT00400764|650891|P4|Phase Ib|Adverse Event|0
191455|NCT00400764|650892|P3|Phase Ib|Adverse Event|0
191456|NCT00400764|650893|P2|Phase Ib|Adverse Event|0
191457|NCT00400764|650894|P1|Phase Ib|Adverse Event|1
191458|NCT00400712|650947|P2|Overall Study|Physician Decision|4
191459|NCT00400712|650948|P1|Overall Study|Physician Decision|5
191460|NCT00400712|650947|P2|Overall Study|Withdrawal by Subject|12
191461|NCT00400712|650948|P1|Overall Study|Withdrawal by Subject|11
191462|NCT00400712|650947|P2|Overall Study|Death|0
191463|NCT00400712|650948|P1|Overall Study|Death|1
191464|NCT00400569|650983|P1|Overall Study|Death|1
191465|NCT00400400|650996|P2|Overall Study|Did not receive study drug|3
191466|NCT00400400|650997|P1|Overall Study|Did not receive study drug|1
191467|NCT00400400|650996|P2|Overall Study|Lost to Follow-up|1
191468|NCT00400400|650997|P1|Overall Study|Lost to Follow-up|0
191469|NCT00400400|650996|P2|Overall Study|Administrative Problem|0
191470|NCT00400400|650997|P1|Overall Study|Administrative Problem|1
191471|NCT00400400|650996|P2|Overall Study|Withdrawal by Subject|3
191472|NCT00400400|650997|P1|Overall Study|Withdrawal by Subject|1
191473|NCT00400400|650996|P2|Overall Study|Protocol Violation|0
191474|NCT00400400|650997|P1|Overall Study|Protocol Violation|2
191475|NCT00400400|650996|P2|Overall Study|Adverse Event|8
191476|NCT00400400|650997|P1|Overall Study|Adverse Event|9
191477|NCT00400179|651022|P2|Overall Study|Randomization error/patient ineligible|6
191478|NCT00400179|651023|P1|Overall Study|Randomization error/patient ineligible|1
191479|NCT00400179|651022|P2|Overall Study|Investigator judgment|1
191480|NCT00400179|651023|P1|Overall Study|Investigator judgment|0
191481|NCT00400179|651022|P2|Overall Study|Intercurrent illness|1
191482|NCT00400179|651023|P1|Overall Study|Intercurrent illness|0
191483|NCT00400179|651022|P2|Overall Study|Disease progression|1
191484|NCT00400179|651023|P1|Overall Study|Disease progression|1
191485|NCT00400179|651022|P2|Overall Study|Withdrew Consent|5
191486|NCT00400179|651023|P1|Overall Study|Withdrew Consent|1
191487|NCT00400179|651022|P2|Overall Study|Death|2
191488|NCT00400179|651023|P1|Overall Study|Death|1
191489|NCT00400179|651022|P2|Overall Study|Adverse Event|2
191490|NCT00400179|651023|P1|Overall Study|Adverse Event|2
191491|NCT00400153|651040|P3|Overall Study|Other reasons - not mentioned above|3
191492|NCT00400153|651041|P2|Overall Study|Other reasons - not mentioned above|5
191493|NCT00400153|651042|P1|Overall Study|Other reasons - not mentioned above|8
191494|NCT00400153|651040|P3|Overall Study|Withdrawal by Subject|10
191495|NCT00400153|651041|P2|Overall Study|Withdrawal by Subject|11
191496|NCT00400153|651042|P1|Overall Study|Withdrawal by Subject|12
191497|NCT00400153|651040|P3|Overall Study|Lost to Follow-up|4
191498|NCT00400153|651041|P2|Overall Study|Lost to Follow-up|1
191499|NCT00400153|651042|P1|Overall Study|Lost to Follow-up|2
191500|NCT00400153|651040|P3|Overall Study|Protocol Violation|9
191501|NCT00400153|651041|P2|Overall Study|Protocol Violation|4
191502|NCT00400153|651042|P1|Overall Study|Protocol Violation|7
191503|NCT00400153|651040|P3|Overall Study|AE due to other condition|15
191504|NCT00400153|651041|P2|Overall Study|AE due to other condition|14
191505|NCT00400153|651042|P1|Overall Study|AE due to other condition|3
191506|NCT00400153|651040|P3|Overall Study|AE due to other disease worsening|0
191507|NCT00400153|651041|P2|Overall Study|AE due to other disease worsening|1
191508|NCT00400153|651042|P1|Overall Study|AE due to other disease worsening|2
191509|NCT00400153|651040|P3|Overall Study|AE due to study disease worsening|20
191510|NCT00400153|651041|P2|Overall Study|AE due to study disease worsening|19
191511|NCT00400153|651042|P1|Overall Study|AE due to study disease worsening|14
191512|NCT00399893|651289|P2|Overall Study|Withdrawal by Subject|0
191513|NCT00399893|651290|P1|Overall Study|Withdrawal by Subject|1
191514|NCT00399802|651329|P2|Overall Study|Participant discontinued by mistake|1
191515|NCT00399802|651330|P1|Overall Study|Participant discontinued by mistake|0
191516|NCT00399802|651329|P2|Overall Study|Adverse Event|2
191517|NCT00399802|651330|P1|Overall Study|Adverse Event|0
191518|NCT00399763|651344|P2|Overall Study|Lost to Follow-up|3
191519|NCT00399763|651345|P1|Overall Study|Lost to Follow-up|2
191520|NCT00399568|651357|P2|Overall Study|Lost to Follow-up|2
191521|NCT00399568|651358|P1|Overall Study|Lost to Follow-up|2
191522|NCT00399568|651357|P2|Overall Study|Protocol non-compliance|2
191523|NCT00399568|651358|P1|Overall Study|Protocol non-compliance|2
191524|NCT00399568|651357|P2|Overall Study|Withdrawal by Subject|3
191525|NCT00399568|651358|P1|Overall Study|Withdrawal by Subject|7
191526|NCT00399568|651357|P2|Overall Study|Adverse Event|2
191527|NCT00399568|651358|P1|Overall Study|Adverse Event|1
191528|NCT00399542|651372|P2|Overall Study|Physician Decision|1
191529|NCT00399542|651373|P1|Overall Study|Physician Decision|0
191530|NCT00399542|651372|P2|Overall Study|Other|0
191531|NCT00399542|651373|P1|Overall Study|Other|1
191532|NCT00399542|651372|P2|Overall Study|Lost to Follow-up|6
191533|NCT00399542|651373|P1|Overall Study|Lost to Follow-up|6
191534|NCT00399542|651372|P2|Overall Study|Lack of Efficacy|8
191535|NCT00399542|651373|P1|Overall Study|Lack of Efficacy|18
191536|NCT00399542|651372|P2|Overall Study|Withdrawal by Subject|10
191537|NCT00399542|651373|P1|Overall Study|Withdrawal by Subject|28
191538|NCT00399542|651372|P2|Overall Study|Protocol Violation|3
191539|NCT00399542|651373|P1|Overall Study|Protocol Violation|13
191540|NCT00399542|651372|P2|Overall Study|Adverse Event|15
191541|NCT00399542|651373|P1|Overall Study|Adverse Event|18
191542|NCT00399516|651435|P1|Overall Study|Lost to Follow-up|2
191543|NCT00399360|651443|P4|Overall Study|Withdrawal by Subject|2
191544|NCT00399360|651444|P3|Overall Study|Withdrawal by Subject|0
191545|NCT00399360|651445|P2|Overall Study|Withdrawal by Subject|2
191546|NCT00399360|651446|P1|Overall Study|Withdrawal by Subject|0
191547|NCT00399360|651443|P4|Overall Study|Adverse Event|0
191548|NCT00399360|651444|P3|Overall Study|Adverse Event|1
191549|NCT00399360|651445|P2|Overall Study|Adverse Event|0
191550|NCT00399360|651446|P1|Overall Study|Adverse Event|0
191551|NCT00399360|651443|P4|Overall Study|Lost to Follow-up|4
191552|NCT00399360|651444|P3|Overall Study|Lost to Follow-up|2
191553|NCT00399360|651445|P2|Overall Study|Lost to Follow-up|1
191554|NCT00399360|651446|P1|Overall Study|Lost to Follow-up|2
191555|NCT00399035|651517|P3|Overall Study|Severe non-compliance with protocol|0
191556|NCT00399035|651518|P2|Overall Study|Severe non-compliance with protocol|1
191557|NCT00399035|651519|P1|Overall Study|Severe non-compliance with protocol|2
191558|NCT00399035|651517|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
191559|NCT00399035|651518|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
191560|NCT00399035|651519|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
191561|NCT00399035|651517|P3|Overall Study|Withdrawal by Subject|12
191562|NCT00399035|651518|P2|Overall Study|Withdrawal by Subject|15
191563|NCT00399035|651519|P1|Overall Study|Withdrawal by Subject|19
191564|NCT00399035|651517|P3|Overall Study|Lost to Follow-up|5
191565|NCT00399035|651518|P2|Overall Study|Lost to Follow-up|1
191566|NCT00399035|651519|P1|Overall Study|Lost to Follow-up|2
191567|NCT00399035|651517|P3|Overall Study|Death|234
191568|NCT00399035|651518|P2|Overall Study|Death|141
191569|NCT00399035|651519|P1|Overall Study|Death|289
191570|NCT00398866|651555|P3|Overall Study|Unable to complete requirements of study|1
191571|NCT00398866|651556|P2|Overall Study|Unable to complete requirements of study|1
191572|NCT00398866|651557|P1|Overall Study|Unable to complete requirements of study|1
191573|NCT00398866|651555|P3|Overall Study|Withdrawal by Subject|2
191574|NCT00398866|651556|P2|Overall Study|Withdrawal by Subject|1
191575|NCT00398866|651557|P1|Overall Study|Withdrawal by Subject|5
191576|NCT00398866|651555|P3|Overall Study|Lost to Follow-up|4
191577|NCT00398866|651556|P2|Overall Study|Lost to Follow-up|6
191578|NCT00398866|651557|P1|Overall Study|Lost to Follow-up|7
191579|NCT00398866|651555|P3|Overall Study|Lack of Efficacy|1
191580|NCT00398866|651556|P2|Overall Study|Lack of Efficacy|0
191581|NCT00398866|651557|P1|Overall Study|Lack of Efficacy|0
191582|NCT00398866|651555|P3|Overall Study|Adverse Event|0
191583|NCT00398866|651556|P2|Overall Study|Adverse Event|0
191584|NCT00398866|651557|P1|Overall Study|Adverse Event|1
191585|NCT00398632|651568|P1|Overall Study|Lack of Efficacy|1
191586|NCT00398632|651568|P1|Overall Study|Withdrawal by Subject|1
191587|NCT00398567|651576|P3|Overall Study|Protocol Violation|1
191588|NCT00398567|651577|P2|Overall Study|Protocol Violation|0
191589|NCT00398567|651578|P1|Overall Study|Protocol Violation|0
191590|NCT00398567|651576|P3|Overall Study|Adverse Event|2
191591|NCT00398567|651577|P2|Overall Study|Adverse Event|0
191592|NCT00398567|651578|P1|Overall Study|Adverse Event|0
191593|NCT00398567|651576|P3|Overall Study|Withdrawal by Subject|4
191594|NCT00398567|651577|P2|Overall Study|Withdrawal by Subject|0
191595|NCT00398567|651578|P1|Overall Study|Withdrawal by Subject|1
191596|NCT00398567|651576|P3|Overall Study|Disease Progression|27
191597|NCT00398567|651577|P2|Overall Study|Disease Progression|4
191598|NCT00398567|651578|P1|Overall Study|Disease Progression|3
191599|NCT00398411|651632|P2|Overall Study|Death|1
191600|NCT00398411|651633|P1|Overall Study|Death|0
191601|NCT00398320|651656|P1|Overall Study|Physician Decision|1
191602|NCT00398320|651656|P1|Overall Study|Adverse Event|4
191603|NCT00398320|651656|P1|Overall Study|Death|1
191604|NCT00398216|651669|P5|Overall Study|entrance criteria|2
191605|NCT00398216|651670|P4|Overall Study|entrance criteria|0
191606|NCT00398216|651671|P3|Overall Study|entrance criteria|0
191607|NCT00398216|651672|P2|Overall Study|entrance criteria|0
191608|NCT00398216|651673|P1|Overall Study|entrance criteria|0
191609|NCT00398216|651669|P5|Overall Study|administrative reasons|3
191610|NCT00398216|651670|P4|Overall Study|administrative reasons|3
191611|NCT00398216|651671|P3|Overall Study|administrative reasons|4
191612|NCT00398216|651672|P2|Overall Study|administrative reasons|4
191613|NCT00398216|651673|P1|Overall Study|administrative reasons|3
191614|NCT00398216|651669|P5|Overall Study|Withdrawal by Subject|2
191615|NCT00398216|651670|P4|Overall Study|Withdrawal by Subject|1
191616|NCT00398216|651671|P3|Overall Study|Withdrawal by Subject|3
191617|NCT00398216|651672|P2|Overall Study|Withdrawal by Subject|0
191618|NCT00398216|651673|P1|Overall Study|Withdrawal by Subject|1
191619|NCT00398216|651669|P5|Overall Study|Death|0
191620|NCT00398216|651670|P4|Overall Study|Death|0
191621|NCT00398216|651671|P3|Overall Study|Death|0
191622|NCT00398216|651672|P2|Overall Study|Death|3
191623|NCT00398216|651673|P1|Overall Study|Death|0
191624|NCT00398216|651669|P5|Overall Study|Lost to Follow-up|1
191625|NCT00398216|651670|P4|Overall Study|Lost to Follow-up|4
191626|NCT00398216|651671|P3|Overall Study|Lost to Follow-up|4
191627|NCT00398216|651672|P2|Overall Study|Lost to Follow-up|6
191628|NCT00398216|651673|P1|Overall Study|Lost to Follow-up|1
191629|NCT00398216|651669|P5|Overall Study|Protocol Violation|5
191630|NCT00398216|651670|P4|Overall Study|Protocol Violation|7
191631|NCT00398216|651671|P3|Overall Study|Protocol Violation|5
191632|NCT00398216|651672|P2|Overall Study|Protocol Violation|4
191633|NCT00398216|651673|P1|Overall Study|Protocol Violation|2
191634|NCT00398216|651669|P5|Overall Study|Adverse Event|2
191635|NCT00398216|651670|P4|Overall Study|Adverse Event|7
191636|NCT00398216|651671|P3|Overall Study|Adverse Event|5
191637|NCT00398216|651672|P2|Overall Study|Adverse Event|2
191638|NCT00398216|651673|P1|Overall Study|Adverse Event|4
191639|NCT00398138|651700|P1|Overall Study|Adverse Event|2
191640|NCT00398112|651705|P1|Overall Study|Death|1
191641|NCT00398112|651705|P1|Overall Study|Withdrawal by Subject|3
191642|NCT00398112|651705|P1|Overall Study|Alternative treatment|1
191643|NCT00398112|651705|P1|Overall Study|Disease progression|9
191644|NCT00398112|651705|P1|Overall Study|Adverse Event|4
191645|NCT00398086|651716|P3|Overall Study|Withdrawal by Subject|0
191646|NCT00398086|651717|P2|Overall Study|Withdrawal by Subject|7
191647|NCT00398086|651718|P1|Overall Study|Withdrawal by Subject|5
191648|NCT00398086|651716|P3|Overall Study|Physician Decision|0
191649|NCT00398086|651717|P2|Overall Study|Physician Decision|4
191650|NCT00398086|651718|P1|Overall Study|Physician Decision|1
191651|NCT00398086|651716|P3|Overall Study|Adverse Event|0
191652|NCT00398086|651717|P2|Overall Study|Adverse Event|4
191653|NCT00398086|651718|P1|Overall Study|Adverse Event|1
191654|NCT00398086|651716|P3|Overall Study|Unacceptable Toxicity|2
191655|NCT00398086|651717|P2|Overall Study|Unacceptable Toxicity|8
191656|NCT00398086|651718|P1|Overall Study|Unacceptable Toxicity|2
191657|NCT00398073|651752|P2|Overall Study|Withdrawal by Subject|0
191658|NCT00398073|651753|P1|Overall Study|Withdrawal by Subject|1
191659|NCT00398047|651763|P1|Overall Study|all patient progressed before completion|3
191660|NCT00397982|651773|P1|Overall Study|Unrelated health issues|1
191661|NCT00397982|651773|P1|Overall Study|noncompliance|1
191662|NCT00397982|651773|P1|Overall Study|Adverse Event|1
191663|NCT00397982|651773|P1|Overall Study|Withdrawal by Subject|1
191664|NCT00397930|651784|P2|Overall Study|Missing data|4
191665|NCT00397930|651785|P1|Overall Study|Missing data|0
191666|NCT00397930|651784|P2|Overall Study|Withdrawal by Subject|8
191667|NCT00397930|651785|P1|Overall Study|Withdrawal by Subject|0
191668|NCT00397930|651784|P2|Overall Study|Did not want to be in control group|1
191669|NCT00397930|651785|P1|Overall Study|Did not want to be in control group|0
191670|NCT00397930|651784|P2|Overall Study|Started own yoga program|1
191671|NCT00397930|651785|P1|Overall Study|Started own yoga program|1
191672|NCT00397930|651784|P2|Overall Study|Too time-consuming|9
191673|NCT00397930|651785|P1|Overall Study|Too time-consuming|2
191674|NCT00397930|651784|P2|Overall Study|Noncompliant|2
191675|NCT00397930|651785|P1|Overall Study|Noncompliant|3
191676|NCT00397930|651784|P2|Overall Study|Unknown reasons|14
191677|NCT00397930|651785|P1|Overall Study|Unknown reasons|9
191678|NCT00397930|651784|P2|Overall Study|Other medical|4
191679|NCT00397930|651785|P1|Overall Study|Other medical|9
191680|NCT00397930|651784|P2|Overall Study|Personal reasons|8
191681|NCT00397930|651785|P1|Overall Study|Personal reasons|14
191682|NCT00397891|651800|P5|Overall Study|Withdrawal by Subject|1
191683|NCT00397891|651801|P4|Overall Study|Withdrawal by Subject|0
191684|NCT00397891|651802|P3|Overall Study|Withdrawal by Subject|0
191685|NCT00397891|651803|P2|Overall Study|Withdrawal by Subject|0
191686|NCT00397891|651804|P1|Overall Study|Withdrawal by Subject|1
191687|NCT00397631|651925|P2|Overall Study|protocol discontinuation criteria|4
191688|NCT00397631|651926|P1|Overall Study|protocol discontinuation criteria|1
191689|NCT00397631|651925|P2|Overall Study|Withdrawal by Subject|14
191690|NCT00397631|651926|P1|Overall Study|Withdrawal by Subject|7
191691|NCT00397631|651925|P2|Overall Study|Protocol Violation|1
191692|NCT00397631|651926|P1|Overall Study|Protocol Violation|0
191693|NCT00397631|651925|P2|Overall Study|Physician Decision|0
191694|NCT00397631|651926|P1|Overall Study|Physician Decision|2
191695|NCT00397631|651925|P2|Overall Study|Lost to Follow-up|9
191696|NCT00397631|651926|P1|Overall Study|Lost to Follow-up|8
191697|NCT00397631|651925|P2|Overall Study|Lack of Efficacy|10
191698|NCT00397631|651926|P1|Overall Study|Lack of Efficacy|7
191699|NCT00397631|651925|P2|Overall Study|Adverse Event|6
191700|NCT00397631|651926|P1|Overall Study|Adverse Event|5
191701|NCT00397540|651938|P2|Overall Study|short follow-up duration < 12 months|0
191702|NCT00397540|651939|P1|Overall Study|short follow-up duration < 12 months|1
191703|NCT00397514|651945|P1|Overall Study|poor echocardiographic windows|1
191704|NCT00397514|651945|P1|Overall Study|early extubation|2
191705|NCT00397514|651945|P1|Overall Study|Not able to capture & pace LV intraoper.|4
191706|NCT00397514|651945|P1|Overall Study|Pacing wire malfunction|1
191707|NCT00397514|651945|P1|Overall Study|Withdrawal by Subject|1
191708|NCT00397488|651955|P1|Overall Study|Death|1
191709|NCT00397488|651955|P1|Overall Study|Adverse Event|3
191710|NCT00397488|651955|P1|Overall Study|Withdrawal by Subject|3
191711|NCT00397254|651975|P2|Overall Study|Lost to Follow-up|2
191712|NCT00397254|651976|P1|Overall Study|Lost to Follow-up|2
191713|NCT00397215|651998|P4|Month 6 (Day 180)|Other|0
191714|NCT00397215|651999|P3|Month 6 (Day 180)|Other|3
191715|NCT00397215|652000|P2|Month 6 (Day 180)|Other|0
191716|NCT00397215|652001|P1|Month 6 (Day 180)|Other|2
191717|NCT00397215|651998|P4|Month 6 (Day 180)|Adverse Event|0
191718|NCT00397215|651999|P3|Month 6 (Day 180)|Adverse Event|2
191719|NCT00397215|652000|P2|Month 6 (Day 180)|Adverse Event|3
191720|NCT00397215|652001|P1|Month 6 (Day 180)|Adverse Event|0
191721|NCT00397215|651998|P4|Month 0 (Day 0)|Other|3
191722|NCT00397215|651999|P3|Month 0 (Day 0)|Other|3
191723|NCT00397215|652000|P2|Month 0 (Day 0)|Other|1
191724|NCT00397215|652001|P1|Month 0 (Day 0)|Other|4
191725|NCT00397215|651998|P4|Month 0 (Day 0)|Withdrawal by Subject|1
191726|NCT00397215|651999|P3|Month 0 (Day 0)|Withdrawal by Subject|3
191727|NCT00397215|652000|P2|Month 0 (Day 0)|Withdrawal by Subject|3
191728|NCT00397215|652001|P1|Month 0 (Day 0)|Withdrawal by Subject|3
191729|NCT00397215|651998|P4|Month 0 (Day 0)|Adverse Event|0
191730|NCT00397215|651999|P3|Month 0 (Day 0)|Adverse Event|0
191731|NCT00397215|652000|P2|Month 0 (Day 0)|Adverse Event|1
191732|NCT00397215|652001|P1|Month 0 (Day 0)|Adverse Event|0
191733|NCT00397189|652137|P2|3 Weeks Period|Other|2
191734|NCT00397189|652138|P1|3 Weeks Period|Other|0
191735|NCT00397189|652137|P2|3 Weeks Period|Protocol Violation|3
191736|NCT00397189|652138|P1|3 Weeks Period|Protocol Violation|0
191737|NCT00397189|652137|P2|3 Weeks Period|Physician Decision|2
191738|NCT00397189|652138|P1|3 Weeks Period|Physician Decision|0
191739|NCT00397189|652137|P2|3 Weeks Period|Withdrawal by Subject|9
191740|NCT00397189|652138|P1|3 Weeks Period|Withdrawal by Subject|13
191741|NCT00397189|652137|P2|3 Weeks Period|Adverse Event|2
191742|NCT00397189|652138|P1|3 Weeks Period|Adverse Event|3
191743|NCT00397189|652137|P2|3 Weeks Period|Lost to Follow-up|4
191744|NCT00397189|652138|P1|3 Weeks Period|Lost to Follow-up|5
191745|NCT00397046|652165|P4|Overall Study|Disease Progression|5
191746|NCT00397046|652166|P3|Overall Study|Disease Progression|10
191747|NCT00397046|652167|P2|Overall Study|Disease Progression|3
191748|NCT00397046|652168|P1|Overall Study|Disease Progression|3
191749|NCT00397033|652189|P3|Overall Study|Other|2
191750|NCT00397033|652190|P2|Overall Study|Other|5
191751|NCT00397033|652191|P1|Overall Study|Other|0
191752|NCT00397033|652189|P3|Overall Study|Withdrawal by Subject|5
191753|NCT00397033|652190|P2|Overall Study|Withdrawal by Subject|7
191754|NCT00397033|652191|P1|Overall Study|Withdrawal by Subject|12
191755|NCT00397033|652189|P3|Overall Study|Lost to Follow-up|3
191756|NCT00397033|652190|P2|Overall Study|Lost to Follow-up|3
191757|NCT00397033|652191|P1|Overall Study|Lost to Follow-up|3
191758|NCT00397033|652189|P3|Overall Study|Lack of Efficacy|9
191759|NCT00397033|652190|P2|Overall Study|Lack of Efficacy|12
191760|NCT00397033|652191|P1|Overall Study|Lack of Efficacy|22
191761|NCT00397033|652189|P3|Overall Study|Adverse Event|4
191762|NCT00397033|652190|P2|Overall Study|Adverse Event|10
191763|NCT00397033|652191|P1|Overall Study|Adverse Event|7
191764|NCT00396877|652273|P2|Overall Study|Parent(s)/guardian(s)'s request|7
191765|NCT00396877|652274|P1|Overall Study|Parent(s)/guardian(s)'s request|4
191766|NCT00396877|652273|P2|Overall Study|Lost to Follow-up|1
191767|NCT00396877|652274|P1|Overall Study|Lost to Follow-up|2
191768|NCT00396812|652284|P1|Overall Study|Physician Decision|1
191769|NCT00396656|652296|P2|Second Treatment Period|Adverse Event|1
191770|NCT00396656|652297|P1|Second Treatment Period|Adverse Event|0
191771|NCT00396656|652296|P2|First Treatment Period|Withdrawal by Subject|2
191772|NCT00396656|652297|P1|First Treatment Period|Withdrawal by Subject|0
191773|NCT00396630|652315|P2|Overall Study|Not vaccinated at Visit 3|3
191774|NCT00396630|652316|P1|Overall Study|Not vaccinated at Visit 3|3
191775|NCT00396630|652315|P2|Overall Study|Withdrawal by Subject|1
191776|NCT00396630|652316|P1|Overall Study|Withdrawal by Subject|1
191777|NCT00396630|652315|P2|Overall Study|Lost to Follow-up|1
191778|NCT00396630|652316|P1|Overall Study|Lost to Follow-up|1
191779|NCT00396591|652336|P1|Overall Study|Participant request|1
191780|NCT00396591|652336|P1|Overall Study|Adverse Event|2
191781|NCT00396591|652336|P1|Overall Study|Disease Progression|13
191782|NCT00396565|652349|P3|Overall Study|Lack of Efficacy|11
191783|NCT00396565|652350|P2|Overall Study|Lack of Efficacy|64
191784|NCT00396565|652351|P1|Overall Study|Lack of Efficacy|32
191785|NCT00396565|652349|P3|Overall Study|Withdrawal by Subject|1
191786|NCT00396565|652350|P2|Overall Study|Withdrawal by Subject|13
191787|NCT00396565|652351|P1|Overall Study|Withdrawal by Subject|8
191788|NCT00396565|652349|P3|Overall Study|Adverse Event|3
191789|NCT00396565|652350|P2|Overall Study|Adverse Event|13
191790|NCT00396565|652351|P1|Overall Study|Adverse Event|5
191791|NCT00396565|652349|P3|Overall Study|Physician Decision|2
191792|NCT00396565|652350|P2|Overall Study|Physician Decision|1
191793|NCT00396565|652351|P1|Overall Study|Physician Decision|3
191794|NCT00396409|652376|P2|Period 2 - 2008|Lost to Follow-up|1
191795|NCT00396409|652377|P1|Period 2 - 2008|Lost to Follow-up|3
191796|NCT00396409|652376|P2|Period 2 - 2008|Withdrawal by Subject|1
191797|NCT00396409|652377|P1|Period 2 - 2008|Withdrawal by Subject|3
191798|NCT00396409|652376|P2|Period 2 - 2008|Protocol Violation|0
191799|NCT00396409|652377|P1|Period 2 - 2008|Protocol Violation|1
191800|NCT00396409|652376|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
191801|NCT00396409|652377|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
191802|NCT00396409|652376|P2|Period 1 - 2007|Lost to Follow-up|3
191803|NCT00396409|652377|P1|Period 1 - 2007|Lost to Follow-up|2
191804|NCT00396409|652376|P2|Period 1 - 2007|Withdrawal by Subject|1
191805|NCT00396409|652377|P1|Period 1 - 2007|Withdrawal by Subject|1
191806|NCT00396409|652376|P2|Period 1 - 2007|Lack of Efficacy|1
191807|NCT00396409|652377|P1|Period 1 - 2007|Lack of Efficacy|0
191808|NCT00396409|652376|P2|Period 1 - 2007|Adverse Event|1
191809|NCT00396409|652377|P1|Period 1 - 2007|Adverse Event|0
191810|NCT00396383|652407|P1|Overall Study|Lost to Follow-up|1
191811|NCT00396383|652407|P1|Overall Study|Death|2
191812|NCT00396331|652420|P1|Overall Study|Death|16
191813|NCT00396331|652420|P1|Overall Study|Lost to Follow-up|3
191814|NCT00396331|652420|P1|Overall Study|Did not go on to transplant|5
191815|NCT00396331|652420|P1|Overall Study|Failed to mobilize - no transplant|8
191816|NCT00396318|652473|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
191817|NCT00396279|652493|P1|Overall Study|Physician Decision|1
191818|NCT00396279|652493|P1|Overall Study|Withdrawal by Subject|1
191819|NCT00396279|652493|P1|Overall Study|Disease progression|2
191820|NCT00396279|652493|P1|Overall Study|Ongoing in study|26
191821|NCT00396253|652526|P1|Overall Study|Change in eligibility status|1
191822|NCT00396253|652526|P1|Overall Study|Physician Decision|1
191823|NCT00396253|652526|P1|Overall Study|Death|3
191824|NCT00396253|652526|P1|Overall Study|Withdrawal by Subject|7
191825|NCT00396253|652526|P1|Overall Study|Protocol Violation|1
191826|NCT00396162|652557|P2|Overall Study|Withdrawal by Subject|3
191827|NCT00396162|652558|P1|Overall Study|Withdrawal by Subject|2
191828|NCT00396136|652570|P1|Overall Study|Study device explanted|8
191829|NCT00396136|652570|P1|Overall Study|Lost to Follow-up|15
191830|NCT00396136|652570|P1|Overall Study|Withdrawal by Subject|59
191831|NCT00396136|652570|P1|Overall Study|Death|43
191832|NCT00396097|652577|P2|Overall Study|Insufficient Clinical Response|4
191833|NCT00396097|652578|P1|Overall Study|Insufficient Clinical Response|1
191834|NCT00396097|652577|P2|Overall Study|Adverse Event|5
191835|NCT00396097|652578|P1|Overall Study|Adverse Event|1
191836|NCT00396097|652577|P2|Overall Study|Protocol Violation|6
191837|NCT00396097|652578|P1|Overall Study|Protocol Violation|0
191838|NCT00396097|652577|P2|Overall Study|Not specified|5
191839|NCT00396097|652578|P1|Overall Study|Not specified|3
191840|NCT00396097|652577|P2|Overall Study|Lost to Follow-up|9
191841|NCT00396097|652578|P1|Overall Study|Lost to Follow-up|4
191842|NCT00396097|652577|P2|Overall Study|Withdrawal by Subject|17
191843|NCT00396097|652578|P1|Overall Study|Withdrawal by Subject|17
191844|NCT00396084|652606|P6|Overall Study|Withdrawal by Subject|0
191845|NCT00396084|652607|P5|Overall Study|Withdrawal by Subject|0
191846|NCT00396084|652608|P4|Overall Study|Withdrawal by Subject|1
191847|NCT00396084|652609|P3|Overall Study|Withdrawal by Subject|0
191848|NCT00396084|652610|P2|Overall Study|Withdrawal by Subject|0
191849|NCT00396084|652611|P1|Overall Study|Withdrawal by Subject|0
191850|NCT00396084|652606|P6|Overall Study|Adverse Event|2
191851|NCT00396084|652607|P5|Overall Study|Adverse Event|1
191852|NCT00396084|652608|P4|Overall Study|Adverse Event|0
191853|NCT00396084|652609|P3|Overall Study|Adverse Event|0
191854|NCT00396084|652610|P2|Overall Study|Adverse Event|0
191855|NCT00396084|652611|P1|Overall Study|Adverse Event|0
191856|NCT00395967|652740|P1|Follow-up Period|Lost to Follow-up|1
191857|NCT00395967|652740|P1|Follow-up Period|Death|1
191858|NCT00395967|652740|P1|Treatment Period|Failed Mobilization|1
191859|NCT00395863|652780|P2|Overall Study|Patients did not complete both exams|3
191860|NCT00395863|652781|P1|Overall Study|Patients did not complete both exams|2
191861|NCT00395850|652816|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
191862|NCT00395850|652817|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
191863|NCT00395850|652818|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
191864|NCT00395850|652819|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
191865|NCT00395850|652816|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
191866|NCT00395850|652817|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
191867|NCT00395850|652818|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
191868|NCT00395850|652819|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
191869|NCT00395850|652816|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
191870|NCT00395850|652817|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
191871|NCT00395850|652818|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
191872|NCT00395850|652819|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
191873|NCT00395850|652816|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
191874|NCT00395850|652817|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
191875|NCT00395850|652818|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
191876|NCT00395850|652819|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
191877|NCT00395850|652816|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
191878|NCT00395850|652817|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
191879|NCT00395850|652818|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
191880|NCT00395850|652819|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
191881|NCT00395850|652816|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
191882|NCT00395850|652817|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
191883|NCT00395850|652818|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
191884|NCT00395850|652819|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
191885|NCT00395850|652816|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
191886|NCT00395850|652817|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
191887|NCT00395850|652818|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
191888|NCT00395850|652819|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
191889|NCT00395746|652836|P3|Overall Study|Unable to visit site on schedule|0
191890|NCT00395746|652837|P2|Overall Study|Unable to visit site on schedule|0
191891|NCT00395746|652838|P1|Overall Study|Unable to visit site on schedule|1
191892|NCT00395746|652836|P3|Overall Study|Difficultulty in use of device|1
191893|NCT00395746|652837|P2|Overall Study|Difficultulty in use of device|0
191894|NCT00395746|652838|P1|Overall Study|Difficultulty in use of device|0
191895|NCT00395746|652836|P3|Overall Study|Withdrawal of consent|1
191896|NCT00395746|652837|P2|Overall Study|Withdrawal of consent|0
191897|NCT00395746|652838|P1|Overall Study|Withdrawal of consent|0
191898|NCT00395746|652836|P3|Overall Study|Subject decision|1
191899|NCT00395746|652837|P2|Overall Study|Subject decision|0
191900|NCT00395746|652838|P1|Overall Study|Subject decision|0
191901|NCT00395746|652836|P3|Overall Study|Hypoglycaemia|0
191902|NCT00395746|652837|P2|Overall Study|Hypoglycaemia|1
191903|NCT00395746|652838|P1|Overall Study|Hypoglycaemia|2
191904|NCT00395746|652836|P3|Overall Study|Lack of Efficacy|17
191905|NCT00395746|652837|P2|Overall Study|Lack of Efficacy|0
191906|NCT00395746|652838|P1|Overall Study|Lack of Efficacy|2
191907|NCT00395746|652836|P3|Overall Study|Protocol Violation|0
191908|NCT00395746|652837|P2|Overall Study|Protocol Violation|1
191909|NCT00395746|652838|P1|Overall Study|Protocol Violation|0
191910|NCT00395746|652836|P3|Overall Study|Adverse Event|2
191911|NCT00395746|652837|P2|Overall Study|Adverse Event|2
191912|NCT00395746|652838|P1|Overall Study|Adverse Event|5
191913|NCT00395733|652884|P2|Period 2|Technical problems|0
191914|NCT00395733|652885|P1|Period 2|Technical problems|1
191915|NCT00395733|652884|P2|Period 2|Adverse Event|2
191916|NCT00395733|652885|P1|Period 2|Adverse Event|0
191917|NCT00395733|652884|P2|Period 2|Protocol Violation|1
191918|NCT00395733|652885|P1|Period 2|Protocol Violation|0
191919|NCT00395733|652884|P2|Period 2|Withdrawal by Subject|2
191920|NCT00395733|652885|P1|Period 2|Withdrawal by Subject|1
191921|NCT00395694|652909|P2|Continuation Phase|Withdrawal by Subject|2
191922|NCT00395694|652910|P1|Continuation Phase|Withdrawal by Subject|0
191923|NCT00395694|652909|P2|Continuation Phase|Poor Compliance|0
191924|NCT00395694|652910|P1|Continuation Phase|Poor Compliance|1
191925|NCT00395694|652909|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
191926|NCT00395694|652910|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
191927|NCT00395694|652909|P2|Continuation Phase|Lack of Efficacy|11
191928|NCT00395694|652910|P1|Continuation Phase|Lack of Efficacy|12
191929|NCT00395694|652909|P2|Continuation Phase|Adverse Event|0
191930|NCT00395694|652910|P1|Continuation Phase|Adverse Event|1
191931|NCT00395694|652909|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
191932|NCT00395694|652910|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
191933|NCT00395642|652941|P1|Overall Study|Withdrawal by Subject|1
191934|NCT00395642|652941|P1|Overall Study|Physician Decision|7
191935|NCT00395642|652941|P1|Overall Study|Lost to Follow-up|1
191936|NCT00395642|652941|P1|Overall Study|Death|4
191937|NCT00395629|652948|P3|Extension Study|Administrative problems|1
191938|NCT00395629|652949|P2|Extension Study|Administrative problems|0
191939|NCT00395629|652950|P1|Extension Study|Administrative problems|0
191940|NCT00395629|652948|P3|Extension Study|Adverse Event|2
191941|NCT00395629|652949|P2|Extension Study|Adverse Event|0
191942|NCT00395629|652950|P1|Extension Study|Adverse Event|0
191943|NCT00395629|652948|P3|Core Study|Lost to Follow-up|1
191944|NCT00395629|652949|P2|Core Study|Lost to Follow-up|0
191945|NCT00395629|652950|P1|Core Study|Lost to Follow-up|0
191946|NCT00395629|652948|P3|Core Study|Withdrawal by Subject|1
191947|NCT00395629|652949|P2|Core Study|Withdrawal by Subject|1
191948|NCT00395629|652950|P1|Core Study|Withdrawal by Subject|0
191949|NCT00395629|652948|P3|Core Study|Protocol Violation|0
191950|NCT00395629|652949|P2|Core Study|Protocol Violation|0
191951|NCT00395629|652950|P1|Core Study|Protocol Violation|1
191952|NCT00395629|652948|P3|Core Study|Abnormal laboratory value(s)|1
191953|NCT00395629|652949|P2|Core Study|Abnormal laboratory value(s)|0
191954|NCT00395629|652950|P1|Core Study|Abnormal laboratory value(s)|0
191955|NCT00395629|652948|P3|Core Study|Adverse Event|4
191956|NCT00395629|652949|P2|Core Study|Adverse Event|3
191957|NCT00395629|652950|P1|Core Study|Adverse Event|0
191958|NCT00395512|652968|P4|Overall Study|Hyperglycemic Rescue|6
191959|NCT00395512|652969|P3|Overall Study|Hyperglycemic Rescue|4
191960|NCT00395512|652970|P2|Overall Study|Hyperglycemic Rescue|10
191961|NCT00395512|652971|P1|Overall Study|Hyperglycemic Rescue|18
191962|NCT00395512|652968|P4|Overall Study|Other|0
191963|NCT00395512|652969|P3|Overall Study|Other|0
191964|NCT00395512|652970|P2|Overall Study|Other|1
191965|NCT00395512|652971|P1|Overall Study|Other|1
191966|NCT00395512|652968|P4|Overall Study|Physician Decision|2
191967|NCT00395512|652969|P3|Overall Study|Physician Decision|2
191968|NCT00395512|652970|P2|Overall Study|Physician Decision|4
191969|NCT00395512|652971|P1|Overall Study|Physician Decision|6
191970|NCT00395512|652968|P4|Overall Study|Withdrawal by Subject|12
191971|NCT00395512|652969|P3|Overall Study|Withdrawal by Subject|5
191972|NCT00395512|652970|P2|Overall Study|Withdrawal by Subject|5
191973|NCT00395512|652971|P1|Overall Study|Withdrawal by Subject|6
191974|NCT00395512|652968|P4|Overall Study|Lost to Follow-up|5
191975|NCT00395512|652969|P3|Overall Study|Lost to Follow-up|5
191976|NCT00395512|652970|P2|Overall Study|Lost to Follow-up|6
191977|NCT00395512|652971|P1|Overall Study|Lost to Follow-up|2
191978|NCT00395512|652968|P4|Overall Study|Protocol Violation|7
191979|NCT00395512|652969|P3|Overall Study|Protocol Violation|6
191980|NCT00395512|652970|P2|Overall Study|Protocol Violation|3
191981|NCT00395512|652971|P1|Overall Study|Protocol Violation|2
191982|NCT00395512|652968|P4|Overall Study|Adverse Event|6
191983|NCT00395512|652969|P3|Overall Study|Adverse Event|6
191984|NCT00395512|652970|P2|Overall Study|Adverse Event|8
191985|NCT00395512|652971|P1|Overall Study|Adverse Event|3
191986|NCT00395486|653143|P2|Overall Study|Lost to Follow-up|1
191987|NCT00395486|653144|P1|Overall Study|Lost to Follow-up|0
191988|NCT00395486|653143|P2|Overall Study|Withdrawal by Subject|2
191989|NCT00395486|653144|P1|Overall Study|Withdrawal by Subject|5
191990|NCT00395486|653143|P2|Overall Study|Adverse Event|2
191991|NCT00395486|653144|P1|Overall Study|Adverse Event|1
191992|NCT00395460|653174|P2|Overall Study|Withdrawal by Subject|0
191993|NCT00395460|653175|P1|Overall Study|Withdrawal by Subject|1
191994|NCT00395447|653199|P2|Overall Study|Withdrawl - Other (not subject)|17
191995|NCT00395447|653200|P1|Overall Study|Withdrawl - Other (not subject)|8
191996|NCT00395447|653199|P2|Overall Study|Withdrawal by Subject|19
191997|NCT00395447|653200|P1|Overall Study|Withdrawal by Subject|24
191998|NCT00395447|653199|P2|Overall Study|Lost to Follow-up|43
191999|NCT00395447|653200|P1|Overall Study|Lost to Follow-up|52
192000|NCT00395447|653199|P2|Overall Study|Death|32
192001|NCT00395447|653200|P1|Overall Study|Death|37
192002|NCT00395343|653208|P2|Overall Study|Other|2
192003|NCT00395343|653209|P1|Overall Study|Other|5
192004|NCT00395343|653208|P2|Overall Study|Withdrawal by Subject|12
192005|NCT00395343|653209|P1|Overall Study|Withdrawal by Subject|11
192006|NCT00395343|653208|P2|Overall Study|Protocol Violation|8
192007|NCT00395343|653209|P1|Overall Study|Protocol Violation|6
192008|NCT00395343|653208|P2|Overall Study|Physician Decision|4
192009|NCT00395343|653209|P1|Overall Study|Physician Decision|2
192010|NCT00395343|653208|P2|Overall Study|Lost to Follow-up|4
192011|NCT00395343|653209|P1|Overall Study|Lost to Follow-up|4
192012|NCT00395343|653208|P2|Overall Study|Lack of Efficacy|1
192013|NCT00395343|653209|P1|Overall Study|Lack of Efficacy|0
192014|NCT00395343|653208|P2|Overall Study|Adverse Event|5
192015|NCT00395343|653209|P1|Overall Study|Adverse Event|13
192016|NCT00395304|653227|P6|Treatment Period 3|Other|0
192017|NCT00395304|653228|P5|Treatment Period 3|Other|0
192018|NCT00395304|653229|P4|Treatment Period 3|Other|1
192019|NCT00395304|653230|P3|Treatment Period 3|Other|0
192020|NCT00395304|653231|P2|Treatment Period 3|Other|0
192021|NCT00395304|653232|P1|Treatment Period 3|Other|0
192022|NCT00395304|653227|P6|Treatment Period 3|Physician Decision|0
192023|NCT00395304|653228|P5|Treatment Period 3|Physician Decision|0
192024|NCT00395304|653229|P4|Treatment Period 3|Physician Decision|0
192025|NCT00395304|653230|P3|Treatment Period 3|Physician Decision|0
192026|NCT00395304|653231|P2|Treatment Period 3|Physician Decision|1
192027|NCT00395304|653232|P1|Treatment Period 3|Physician Decision|0
192028|NCT00395304|653227|P6|Treatment Period 3|Lost to Follow-up|0
192029|NCT00395304|653228|P5|Treatment Period 3|Lost to Follow-up|0
192030|NCT00395304|653229|P4|Treatment Period 3|Lost to Follow-up|0
192031|NCT00395304|653230|P3|Treatment Period 3|Lost to Follow-up|0
192032|NCT00395304|653231|P2|Treatment Period 3|Lost to Follow-up|1
192033|NCT00395304|653232|P1|Treatment Period 3|Lost to Follow-up|1
192034|NCT00395304|653227|P6|Treatment Period 3|Withdrawal by Subject|1
192035|NCT00395304|653228|P5|Treatment Period 3|Withdrawal by Subject|0
192036|NCT00395304|653229|P4|Treatment Period 3|Withdrawal by Subject|1
192037|NCT00395304|653230|P3|Treatment Period 3|Withdrawal by Subject|0
192038|NCT00395304|653231|P2|Treatment Period 3|Withdrawal by Subject|0
192039|NCT00395304|653232|P1|Treatment Period 3|Withdrawal by Subject|0
192040|NCT00395304|653227|P6|Treatment Period 2|Other|0
192041|NCT00395304|653228|P5|Treatment Period 2|Other|0
192042|NCT00395304|653229|P4|Treatment Period 2|Other|0
192043|NCT00395304|653230|P3|Treatment Period 2|Other|0
192044|NCT00395304|653231|P2|Treatment Period 2|Other|1
192045|NCT00395304|653232|P1|Treatment Period 2|Other|0
192046|NCT00395304|653227|P6|Treatment Period 2|Physician Decision|0
192047|NCT00395304|653228|P5|Treatment Period 2|Physician Decision|0
192048|NCT00395304|653229|P4|Treatment Period 2|Physician Decision|0
192049|NCT00395304|653230|P3|Treatment Period 2|Physician Decision|1
192050|NCT00395304|653231|P2|Treatment Period 2|Physician Decision|0
192051|NCT00395304|653232|P1|Treatment Period 2|Physician Decision|0
192052|NCT00395304|653227|P6|Treatment Period 2|Lost to Follow-up|0
192053|NCT00395304|653228|P5|Treatment Period 2|Lost to Follow-up|0
192054|NCT00395304|653229|P4|Treatment Period 2|Lost to Follow-up|0
192055|NCT00395304|653230|P3|Treatment Period 2|Lost to Follow-up|0
192056|NCT00395304|653231|P2|Treatment Period 2|Lost to Follow-up|3
192057|NCT00395304|653232|P1|Treatment Period 2|Lost to Follow-up|0
192058|NCT00395304|653227|P6|Treatment Period 2|Withdrawal by Subject|2
192059|NCT00395304|653228|P5|Treatment Period 2|Withdrawal by Subject|0
192060|NCT00395304|653229|P4|Treatment Period 2|Withdrawal by Subject|1
192061|NCT00395304|653230|P3|Treatment Period 2|Withdrawal by Subject|0
192062|NCT00395304|653231|P2|Treatment Period 2|Withdrawal by Subject|0
192063|NCT00395304|653232|P1|Treatment Period 2|Withdrawal by Subject|0
192064|NCT00395304|653227|P6|Treatment Period 1|Physician Decision|0
192065|NCT00395304|653228|P5|Treatment Period 1|Physician Decision|0
192066|NCT00395304|653229|P4|Treatment Period 1|Physician Decision|0
192067|NCT00395304|653230|P3|Treatment Period 1|Physician Decision|0
192068|NCT00395304|653231|P2|Treatment Period 1|Physician Decision|1
192069|NCT00395304|653232|P1|Treatment Period 1|Physician Decision|0
192070|NCT00395304|653227|P6|Treatment Period 1|Lost to Follow-up|1
192071|NCT00395304|653228|P5|Treatment Period 1|Lost to Follow-up|0
192072|NCT00395304|653229|P4|Treatment Period 1|Lost to Follow-up|1
192073|NCT00395304|653230|P3|Treatment Period 1|Lost to Follow-up|0
192074|NCT00395304|653231|P2|Treatment Period 1|Lost to Follow-up|0
192075|NCT00395304|653232|P1|Treatment Period 1|Lost to Follow-up|1
192076|NCT00395304|653227|P6|Treatment Period 1|Withdrawal by Subject|1
192077|NCT00395304|653228|P5|Treatment Period 1|Withdrawal by Subject|1
192078|NCT00395304|653229|P4|Treatment Period 1|Withdrawal by Subject|2
192079|NCT00395304|653230|P3|Treatment Period 1|Withdrawal by Subject|0
192080|NCT00395304|653231|P2|Treatment Period 1|Withdrawal by Subject|3
192081|NCT00395304|653232|P1|Treatment Period 1|Withdrawal by Subject|0
192082|NCT00395226|653308|P2|Overall Study|Lost to Follow-up|1
192083|NCT00395226|653309|P1|Overall Study|Lost to Follow-up|0
192084|NCT00395226|653308|P2|Overall Study|Withdrawal by Subject|1
192085|NCT00395226|653309|P1|Overall Study|Withdrawal by Subject|0
192086|NCT00395226|653308|P2|Overall Study|Adverse Event|3
192087|NCT00395226|653309|P1|Overall Study|Adverse Event|4
192088|NCT00395083|653356|P2|Overall Study|Developed another disease|3
192089|NCT00395083|653357|P1|Overall Study|Developed another disease|4
192090|NCT00395083|653356|P2|Overall Study|Withdrawal by Subject|5
192091|NCT00395083|653357|P1|Overall Study|Withdrawal by Subject|6
192092|NCT00395018|653423|P1|Off-Treatment Follow-up|Poor/non-compliance|1
192093|NCT00395018|653423|P1|Off-Treatment Follow-up|Lost to Follow-up|2
192094|NCT00395018|653423|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
192095|NCT00395018|653423|P1|On-Treatment|Subject no longer meets study criteria|2
192096|NCT00395018|653423|P1|On-Treatment|Poor/non-compliance|2
192097|NCT00395018|653423|P1|On-Treatment|Other Reason|2
192098|NCT00395018|653423|P1|On-Treatment|Death|4
192099|NCT00394953|653444|P2|Second Treatment Period|Not defined|8
192100|NCT00394953|653445|P1|Second Treatment Period|Not defined|3
192101|NCT00394953|653444|P2|Second Treatment Period|Renal transplant|6
192102|NCT00394953|653445|P1|Second Treatment Period|Renal transplant|4
192103|NCT00394953|653444|P2|Second Treatment Period|Lost to Follow-up|1
192104|NCT00394953|653445|P1|Second Treatment Period|Lost to Follow-up|0
192105|NCT00394953|653444|P2|Second Treatment Period|Withdrawal by Subject|3
192106|NCT00394953|653445|P1|Second Treatment Period|Withdrawal by Subject|3
192107|NCT00394953|653444|P2|Second Treatment Period|Lack of Efficacy|47
192108|NCT00394953|653445|P1|Second Treatment Period|Lack of Efficacy|9
192109|NCT00394953|653444|P2|Second Treatment Period|Death|4
192110|NCT00394953|653445|P1|Second Treatment Period|Death|8
192111|NCT00394953|653444|P2|Second Treatment Period|Adverse Event|5
192112|NCT00394953|653445|P1|Second Treatment Period|Adverse Event|2
192113|NCT00394953|653444|P2|First Treatment Period|Not defined|1
192114|NCT00394953|653445|P1|First Treatment Period|Not defined|4
192115|NCT00394953|653444|P2|First Treatment Period|Renal transplant|7
192116|NCT00394953|653445|P1|First Treatment Period|Renal transplant|11
192117|NCT00394953|653444|P2|First Treatment Period|Lost to Follow-up|1
192118|NCT00394953|653445|P1|First Treatment Period|Lost to Follow-up|0
192119|NCT00394953|653444|P2|First Treatment Period|Withdrawal by Subject|3
192120|NCT00394953|653445|P1|First Treatment Period|Withdrawal by Subject|6
192121|NCT00394953|653444|P2|First Treatment Period|Lack of Efficacy|1
192122|NCT00394953|653445|P1|First Treatment Period|Lack of Efficacy|1
192123|NCT00394953|653444|P2|First Treatment Period|Death|7
192124|NCT00394953|653445|P1|First Treatment Period|Death|6
192125|NCT00394953|653444|P2|First Treatment Period|Adverse Event|2
192126|NCT00394953|653445|P1|First Treatment Period|Adverse Event|1
192127|NCT00394914|653463|P3|Treatment Period|Did not meet protocol eligibility|1
192128|NCT00394914|653464|P2|Treatment Period|Did not meet protocol eligibility|1
192129|NCT00394914|653465|P1|Treatment Period|Did not meet protocol eligibility|0
192130|NCT00394914|653463|P3|Treatment Period|Noncompliance with protocol|2
192131|NCT00394914|653464|P2|Treatment Period|Noncompliance with protocol|3
192132|NCT00394914|653465|P1|Treatment Period|Noncompliance with protocol|0
192133|NCT00394914|653463|P3|Treatment Period|Withdrawal by Subject|2
192134|NCT00394914|653464|P2|Treatment Period|Withdrawal by Subject|2
192135|NCT00394914|653465|P1|Treatment Period|Withdrawal by Subject|0
192136|NCT00394914|653463|P3|Treatment Period|Lost to Follow-up|0
192137|NCT00394914|653464|P2|Treatment Period|Lost to Follow-up|1
192138|NCT00394914|653465|P1|Treatment Period|Lost to Follow-up|0
192139|NCT00394914|653463|P3|Treatment Period|Adverse Event|1
192140|NCT00394914|653464|P2|Treatment Period|Adverse Event|3
192141|NCT00394914|653465|P1|Treatment Period|Adverse Event|0
192142|NCT00394901|653493|P4|Double-blind Phase|Found not to meet entrance criteria|1
192143|NCT00394901|653494|P3|Double-blind Phase|Found not to meet entrance criteria|0
192144|NCT00394901|653495|P2|Double-blind Phase|Found not to meet entrance criteria|0
192145|NCT00394901|653496|P1|Double-blind Phase|Found not to meet entrance criteria|0
192146|NCT00394901|653493|P4|Double-blind Phase|Entry into another study was found|0
192147|NCT00394901|653494|P3|Double-blind Phase|Entry into another study was found|1
192148|NCT00394901|653495|P2|Double-blind Phase|Entry into another study was found|0
192149|NCT00394901|653496|P1|Double-blind Phase|Entry into another study was found|0
192150|NCT00394901|653493|P4|Double-blind Phase|Lack of Compliance|0
192151|NCT00394901|653494|P3|Double-blind Phase|Lack of Compliance|0
192152|NCT00394901|653495|P2|Double-blind Phase|Lack of Compliance|3
192153|NCT00394901|653496|P1|Double-blind Phase|Lack of Compliance|0
192154|NCT00394901|653493|P4|Double-blind Phase|Subject's Personal Reason|1
192155|NCT00394901|653494|P3|Double-blind Phase|Subject's Personal Reason|0
192156|NCT00394901|653495|P2|Double-blind Phase|Subject's Personal Reason|0
192157|NCT00394901|653496|P1|Double-blind Phase|Subject's Personal Reason|1
192158|NCT00394901|653493|P4|Double-blind Phase|Death|0
192159|NCT00394901|653494|P3|Double-blind Phase|Death|0
192160|NCT00394901|653495|P2|Double-blind Phase|Death|0
192161|NCT00394901|653496|P1|Double-blind Phase|Death|1
192162|NCT00394901|653493|P4|Double-blind Phase|Protocol Violation|1
192163|NCT00394901|653494|P3|Double-blind Phase|Protocol Violation|0
192164|NCT00394901|653495|P2|Double-blind Phase|Protocol Violation|0
192165|NCT00394901|653496|P1|Double-blind Phase|Protocol Violation|0
192166|NCT00394901|653493|P4|Double-blind Phase|Lost to Follow-up|1
192167|NCT00394901|653494|P3|Double-blind Phase|Lost to Follow-up|0
192168|NCT00394901|653495|P2|Double-blind Phase|Lost to Follow-up|0
192169|NCT00394901|653496|P1|Double-blind Phase|Lost to Follow-up|0
192170|NCT00394901|653493|P4|Double-blind Phase|Withdrawal by Subject|0
192171|NCT00394901|653494|P3|Double-blind Phase|Withdrawal by Subject|0
192172|NCT00394901|653495|P2|Double-blind Phase|Withdrawal by Subject|0
192173|NCT00394901|653496|P1|Double-blind Phase|Withdrawal by Subject|2
192174|NCT00394901|653493|P4|Double-blind Phase|Lack of Efficacy|3
192175|NCT00394901|653494|P3|Double-blind Phase|Lack of Efficacy|1
192176|NCT00394901|653495|P2|Double-blind Phase|Lack of Efficacy|4
192177|NCT00394901|653496|P1|Double-blind Phase|Lack of Efficacy|6
192178|NCT00394901|653493|P4|Double-blind Phase|Adverse Event|20
192179|NCT00394901|653494|P3|Double-blind Phase|Adverse Event|16
192180|NCT00394901|653495|P2|Double-blind Phase|Adverse Event|7
192181|NCT00394901|653496|P1|Double-blind Phase|Adverse Event|5
192182|NCT00394901|653493|P4|Baseline Phase|Protocol Violation|0
192183|NCT00394901|653494|P3|Baseline Phase|Protocol Violation|1
192184|NCT00394901|653495|P2|Baseline Phase|Protocol Violation|0
192185|NCT00394901|653496|P1|Baseline Phase|Protocol Violation|0
192186|NCT00394836|653739|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
192187|NCT00394836|653740|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
192188|NCT00394836|653739|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
192189|NCT00394836|653740|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
192190|NCT00394836|653739|P2|Extended Follow-up Phase (2-5 Years)|Death|1
192191|NCT00394836|653740|P1|Extended Follow-up Phase (2-5 Years)|Death|0
192192|NCT00394836|653739|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
192193|NCT00394836|653740|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
192194|NCT00394836|653739|P2|Teatment or Follow-up Phase|Non compliance|1
192195|NCT00394836|653740|P1|Teatment or Follow-up Phase|Non compliance|0
192196|NCT00394836|653739|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
192197|NCT00394836|653740|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
192198|NCT00394836|653739|P2|Teatment or Follow-up Phase|Physician Decision|1
192199|NCT00394836|653740|P1|Teatment or Follow-up Phase|Physician Decision|0
192200|NCT00394836|653739|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
192201|NCT00394836|653740|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
192202|NCT00394836|653739|P2|Teatment or Follow-up Phase|Started alternative treatment|6
192203|NCT00394836|653740|P1|Teatment or Follow-up Phase|Started alternative treatment|0
192204|NCT00394836|653739|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
192205|NCT00394836|653740|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
192206|NCT00394836|653739|P2|Teatment or Follow-up Phase|Death|1
192207|NCT00394836|653740|P1|Teatment or Follow-up Phase|Death|0
192208|NCT00394836|653739|P2|Teatment or Follow-up Phase|Patient Refusal|2
192209|NCT00394836|653740|P1|Teatment or Follow-up Phase|Patient Refusal|1
192210|NCT00394836|653739|P2|Teatment or Follow-up Phase|Disease Progression|60
192211|NCT00394836|653740|P1|Teatment or Follow-up Phase|Disease Progression|27
192212|NCT00394836|653739|P2|Teatment or Follow-up Phase|Protocol Violation|2
192213|NCT00394836|653740|P1|Teatment or Follow-up Phase|Protocol Violation|0
192214|NCT00394836|653739|P2|Teatment or Follow-up Phase|Adverse Event|2
192215|NCT00394836|653740|P1|Teatment or Follow-up Phase|Adverse Event|0
192216|NCT00394771|653786|P4|Overall Study|Not specified|0
192217|NCT00394771|653787|P3|Overall Study|Not specified|1
192218|NCT00394771|653788|P2|Overall Study|Not specified|3
192219|NCT00394771|653789|P1|Overall Study|Not specified|3
192220|NCT00394771|653786|P4|Overall Study|Lost to Follow-up|10
192221|NCT00394771|653787|P3|Overall Study|Lost to Follow-up|13
192222|NCT00394771|653788|P2|Overall Study|Lost to Follow-up|15
192223|NCT00394771|653789|P1|Overall Study|Lost to Follow-up|15
192224|NCT00394771|653786|P4|Overall Study|Participant pregnant|2
192225|NCT00394771|653787|P3|Overall Study|Participant pregnant|2
192226|NCT00394771|653788|P2|Overall Study|Participant pregnant|1
192227|NCT00394771|653789|P1|Overall Study|Participant pregnant|0
192228|NCT00394771|653786|P4|Overall Study|Adverse Event|8
192229|NCT00394771|653787|P3|Overall Study|Adverse Event|12
192230|NCT00394771|653788|P2|Overall Study|Adverse Event|5
192231|NCT00394771|653789|P1|Overall Study|Adverse Event|10
192232|NCT00394771|653786|P4|Overall Study|Withdrawal by Subject|12
192233|NCT00394771|653787|P3|Overall Study|Withdrawal by Subject|8
192234|NCT00394771|653788|P2|Overall Study|Withdrawal by Subject|6
192235|NCT00394771|653789|P1|Overall Study|Withdrawal by Subject|10
192236|NCT00394771|653786|P4|Overall Study|Protocol Violation|7
192237|NCT00394771|653787|P3|Overall Study|Protocol Violation|9
192238|NCT00394771|653788|P2|Overall Study|Protocol Violation|4
192239|NCT00394771|653789|P1|Overall Study|Protocol Violation|2
192240|NCT00394771|653786|P4|Overall Study|Did not meet protocol requirements|0
192241|NCT00394771|653787|P3|Overall Study|Did not meet protocol requirements|2
192242|NCT00394771|653788|P2|Overall Study|Did not meet protocol requirements|0
192243|NCT00394771|653789|P1|Overall Study|Did not meet protocol requirements|1
192244|NCT00394706|653859|P8|Overall Study|Lost to Follow-up|0
192245|NCT00394706|653860|P7|Overall Study|Lost to Follow-up|2
192246|NCT00394706|653861|P6|Overall Study|Lost to Follow-up|5
192247|NCT00394706|653862|P5|Overall Study|Lost to Follow-up|2
192248|NCT00394706|653863|P4|Overall Study|Lost to Follow-up|1
192249|NCT00394706|653864|P3|Overall Study|Lost to Follow-up|8
192250|NCT00394706|653865|P2|Overall Study|Lost to Follow-up|2
192251|NCT00394706|653866|P1|Overall Study|Lost to Follow-up|2
192252|NCT00394706|653859|P8|Overall Study|Withdrawal by Subject|0
192253|NCT00394706|653860|P7|Overall Study|Withdrawal by Subject|1
192254|NCT00394706|653861|P6|Overall Study|Withdrawal by Subject|2
192255|NCT00394706|653862|P5|Overall Study|Withdrawal by Subject|0
192256|NCT00394706|653863|P4|Overall Study|Withdrawal by Subject|0
192257|NCT00394706|653864|P3|Overall Study|Withdrawal by Subject|1
192258|NCT00394706|653865|P2|Overall Study|Withdrawal by Subject|0
192259|NCT00394706|653866|P1|Overall Study|Withdrawal by Subject|2
192260|NCT00394654|653886|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
192261|NCT00394654|653887|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
192262|NCT00394654|653886|P2|Overall Study|Lost to Follow-up|0
192263|NCT00394654|653887|P1|Overall Study|Lost to Follow-up|1
192264|NCT00394589|653952|P3|Overall Study|Protocol Violation|2
192265|NCT00394589|653953|P2|Overall Study|Protocol Violation|0
192266|NCT00394589|653954|P1|Overall Study|Protocol Violation|4
192267|NCT00394589|653952|P3|Overall Study|Lack of Efficacy|3
192268|NCT00394589|653953|P2|Overall Study|Lack of Efficacy|2
192269|NCT00394589|653954|P1|Overall Study|Lack of Efficacy|2
192270|NCT00394589|653952|P3|Overall Study|Adverse Event|2
192271|NCT00394589|653953|P2|Overall Study|Adverse Event|1
192272|NCT00394589|653954|P1|Overall Study|Adverse Event|2
192273|NCT00394524|653964|P2|Overall Study|Withdrawal by Subject|10
192274|NCT00394524|653965|P1|Overall Study|Withdrawal by Subject|11
192275|NCT00394472|653977|P2|Overall Study|Lost to Follow-up|1
192276|NCT00394472|653978|P1|Overall Study|Lost to Follow-up|0
192277|NCT00394472|653977|P2|Overall Study|Physician Decision|1
192278|NCT00394472|653978|P1|Overall Study|Physician Decision|0
192279|NCT00394472|653977|P2|Overall Study|Withdrawal by Subject|2
192280|NCT00394472|653978|P1|Overall Study|Withdrawal by Subject|0
192281|NCT00394472|653977|P2|Overall Study|Adverse Event|2
192282|NCT00394472|653978|P1|Overall Study|Adverse Event|4
192283|NCT00394472|653977|P2|Overall Study|incorrect enrolment|2
192284|NCT00394472|653978|P1|Overall Study|incorrect enrolment|4
192285|NCT00394472|653977|P2|Overall Study|Protocol Violation|3
192286|NCT00394472|653978|P1|Overall Study|Protocol Violation|1
192287|NCT00394433|653986|P1|Overall Study|Alternative Therapy|1
192288|NCT00394433|653986|P1|Overall Study|Adverse Event|2
192289|NCT00394355|653997|P4|Overall Study|Lack of Efficacy|3
192290|NCT00394355|653998|P3|Overall Study|Lack of Efficacy|2
192291|NCT00394355|653999|P2|Overall Study|Lack of Efficacy|0
192292|NCT00394355|654000|P1|Overall Study|Lack of Efficacy|0
192293|NCT00394355|653997|P4|Overall Study|Administrative|1
192294|NCT00394355|653998|P3|Overall Study|Administrative|1
192295|NCT00394355|653999|P2|Overall Study|Administrative|1
192296|NCT00394355|654000|P1|Overall Study|Administrative|0
192297|NCT00394355|653997|P4|Overall Study|Noncompliance with protocol|8
192298|NCT00394355|653998|P3|Overall Study|Noncompliance with protocol|10
192299|NCT00394355|653999|P2|Overall Study|Noncompliance with protocol|3
192300|NCT00394355|654000|P1|Overall Study|Noncompliance with protocol|4
192301|NCT00394355|653997|P4|Overall Study|Lost to Follow-up|3
192302|NCT00394355|653998|P3|Overall Study|Lost to Follow-up|4
192303|NCT00394355|653999|P2|Overall Study|Lost to Follow-up|5
192304|NCT00394355|654000|P1|Overall Study|Lost to Follow-up|7
192305|NCT00394355|653997|P4|Overall Study|Subject withdrawal - related to drug|0
192306|NCT00394355|653998|P3|Overall Study|Subject withdrawal - related to drug|0
192307|NCT00394355|653999|P2|Overall Study|Subject withdrawal - related to drug|0
192308|NCT00394355|654000|P1|Overall Study|Subject withdrawal - related to drug|1
192309|NCT00394355|653997|P4|Overall Study|Subject withdrawal - unrelated to drug|6
192310|NCT00394355|653998|P3|Overall Study|Subject withdrawal - unrelated to drug|10
192311|NCT00394355|653999|P2|Overall Study|Subject withdrawal - unrelated to drug|14
192312|NCT00394355|654000|P1|Overall Study|Subject withdrawal - unrelated to drug|12
192313|NCT00394355|653997|P4|Overall Study|Did not meet protocol eligibility|2
192314|NCT00394355|653998|P3|Overall Study|Did not meet protocol eligibility|4
192315|NCT00394355|653999|P2|Overall Study|Did not meet protocol eligibility|5
192316|NCT00394355|654000|P1|Overall Study|Did not meet protocol eligibility|1
192317|NCT00394355|653997|P4|Overall Study|Adverse Event|8
192318|NCT00394355|653998|P3|Overall Study|Adverse Event|7
192319|NCT00394355|653999|P2|Overall Study|Adverse Event|6
192320|NCT00394355|654000|P1|Overall Study|Adverse Event|10
192321|NCT00394251|654106|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
192322|NCT00394251|654107|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
192323|NCT00394251|654106|P2|Overall Study|Withdrawal by Subject|11
192324|NCT00394251|654107|P1|Overall Study|Withdrawal by Subject|7
192325|NCT00394251|654106|P2|Overall Study|Protocol Violation|1
192326|NCT00394251|654107|P1|Overall Study|Protocol Violation|0
192327|NCT00394251|654106|P2|Overall Study|Physician Decision|1
192328|NCT00394251|654107|P1|Overall Study|Physician Decision|1
192329|NCT00394251|654106|P2|Overall Study|Unacceptable Toxicity|18
192330|NCT00394251|654107|P1|Overall Study|Unacceptable Toxicity|20
192331|NCT00394251|654106|P2|Overall Study|Adverse Event|5
192332|NCT00394251|654107|P1|Overall Study|Adverse Event|7
192333|NCT00394212|654135|P2|Overall Study|Withdrawal by Subject|1
192334|NCT00394212|654136|P1|Overall Study|Withdrawal by Subject|4
192335|NCT00394212|654135|P2|Overall Study|Lost to Follow-up|0
192336|NCT00394212|654136|P1|Overall Study|Lost to Follow-up|3
192337|NCT00394095|654150|P2|Overall Study|Adverse Event|0
192338|NCT00394095|654151|P1|Overall Study|Adverse Event|1
192339|NCT00394082|654159|P1|Overall Study|Not specified|1
192340|NCT00394082|654159|P1|Overall Study|Withdrawal by Subject|2
192341|NCT00394082|654159|P1|Overall Study|Physician Decision|4
192342|NCT00394082|654159|P1|Overall Study|Adverse Event|4
192343|NCT00394082|654159|P1|Overall Study|Unacceptable toxicity|15
192344|NCT00393939|654181|P2|Overall Study|Not specified|45
192345|NCT00393939|654182|P1|Overall Study|Not specified|37
192346|NCT00393939|654181|P2|Overall Study|Withdrawal by Subject|7
192347|NCT00393939|654182|P1|Overall Study|Withdrawal by Subject|2
192348|NCT00393939|654181|P2|Overall Study|Objective progression or relapse|223
192349|NCT00393939|654182|P1|Overall Study|Objective progression or relapse|239
192350|NCT00393939|654181|P2|Overall Study|Sponsor|13
192351|NCT00393939|654182|P1|Overall Study|Sponsor|5
192352|NCT00393939|654181|P2|Overall Study|Death|4
192353|NCT00393939|654182|P1|Overall Study|Death|10
192354|NCT00393939|654181|P2|Overall Study|Lost to Follow-up|4
192355|NCT00393939|654182|P1|Overall Study|Lost to Follow-up|2
192356|NCT00393939|654181|P2|Overall Study|Protocol Violation|1
192357|NCT00393939|654182|P1|Overall Study|Protocol Violation|1
192358|NCT00393913|654200|P1|CPAP|TEchnical problem with CPAP|3
192359|NCT00393913|654200|P1|CPAP|Physician Decision|1
192360|NCT00393913|654200|P1|CPAP|Withdrawal by Subject|3
192361|NCT00393913|654200|P1|Initial Assessment|Withdrawal by Subject|16
192362|NCT00393913|654200|P1|Initial Assessment|diagnosed with other sleep disorder|21
192363|NCT00393887|654208|P2|Overall Study|Lost to Follow-up|9
192364|NCT00393887|654209|P1|Overall Study|Lost to Follow-up|11
192365|NCT00393887|654208|P2|Overall Study|Physician Decision|0
192366|NCT00393887|654209|P1|Overall Study|Physician Decision|5
192367|NCT00393861|654237|P1|Overall Study|Disease Progression|24
192368|NCT00393861|654237|P1|Overall Study|Adverse Event|2
192369|NCT00393848|654248|P4|Overall Study|Personal reasons|0
192370|NCT00393848|654249|P3|Overall Study|Personal reasons|2
192371|NCT00393848|654250|P2|Overall Study|Personal reasons|0
192372|NCT00393848|654251|P1|Overall Study|Personal reasons|0
192373|NCT00393848|654248|P4|Overall Study|Surgical schedule|1
192374|NCT00393848|654249|P3|Overall Study|Surgical schedule|0
192375|NCT00393848|654250|P2|Overall Study|Surgical schedule|0
192376|NCT00393848|654251|P1|Overall Study|Surgical schedule|0
192377|NCT00393718|654274|P2|Overall Study|Move|0
192378|NCT00393718|654275|P1|Overall Study|Move|1
192379|NCT00393718|654274|P2|Overall Study|Missed measurement|0
192380|NCT00393718|654275|P1|Overall Study|Missed measurement|1
192381|NCT00393718|654274|P2|Overall Study|Withdrawal of consent|1
192382|NCT00393718|654275|P1|Overall Study|Withdrawal of consent|2
192383|NCT00393718|654274|P2|Overall Study|Subject decision|0
192384|NCT00393718|654275|P1|Overall Study|Subject decision|5
192385|NCT00393718|654274|P2|Overall Study|Hypoglycaemia|2
192386|NCT00393718|654275|P1|Overall Study|Hypoglycaemia|3
192387|NCT00393718|654274|P2|Overall Study|Lack of Efficacy|9
192388|NCT00393718|654275|P1|Overall Study|Lack of Efficacy|10
192389|NCT00393718|654274|P2|Overall Study|Protocol Violation|2
192390|NCT00393718|654275|P1|Overall Study|Protocol Violation|1
192391|NCT00393718|654274|P2|Overall Study|Adverse Event|8
192392|NCT00393718|654275|P1|Overall Study|Adverse Event|20
192393|NCT00393705|654307|P2|Overall Study|Physician Decision|2
192394|NCT00393705|654308|P1|Overall Study|Physician Decision|2
192395|NCT00393705|654307|P2|Overall Study|Withdrawal by Subject|3
192396|NCT00393705|654308|P1|Overall Study|Withdrawal by Subject|5
192397|NCT00393705|654307|P2|Overall Study|Protocol Violation|3
192398|NCT00393705|654308|P1|Overall Study|Protocol Violation|4
192399|NCT00393705|654307|P2|Overall Study|Entry Criteria Not Met|10
192400|NCT00393705|654308|P1|Overall Study|Entry Criteria Not Met|10
192401|NCT00393705|654307|P2|Overall Study|Lost to Follow-up|2
192402|NCT00393705|654308|P1|Overall Study|Lost to Follow-up|2
192403|NCT00393705|654307|P2|Overall Study|Death|1
192404|NCT00393705|654308|P1|Overall Study|Death|0
192405|NCT00393705|654307|P2|Overall Study|Adverse Event|2
192406|NCT00393705|654308|P1|Overall Study|Adverse Event|0
192407|NCT00393523|654337|P5|Overall Study|Vaccine supply issue|0
192408|NCT00393523|654338|P4|Overall Study|Vaccine supply issue|0
192409|NCT00393523|654339|P3|Overall Study|Vaccine supply issue|1
192410|NCT00393523|654340|P2|Overall Study|Vaccine supply issue|0
192411|NCT00393523|654341|P1|Overall Study|Vaccine supply issue|0
192412|NCT00393523|654337|P5|Overall Study|Difficulties in specimen collection|0
192413|NCT00393523|654338|P4|Overall Study|Difficulties in specimen collection|0
192414|NCT00393523|654339|P3|Overall Study|Difficulties in specimen collection|1
192415|NCT00393523|654340|P2|Overall Study|Difficulties in specimen collection|0
192416|NCT00393523|654341|P1|Overall Study|Difficulties in specimen collection|0
192417|NCT00393523|654337|P5|Overall Study|Withdrawal by Subject|0
192418|NCT00393523|654338|P4|Overall Study|Withdrawal by Subject|3
192419|NCT00393523|654339|P3|Overall Study|Withdrawal by Subject|2
192420|NCT00393523|654340|P2|Overall Study|Withdrawal by Subject|7
192421|NCT00393523|654341|P1|Overall Study|Withdrawal by Subject|6
192422|NCT00393523|654337|P5|Overall Study|Protocol Violation|0
192423|NCT00393523|654338|P4|Overall Study|Protocol Violation|1
192424|NCT00393523|654339|P3|Overall Study|Protocol Violation|0
192425|NCT00393523|654340|P2|Overall Study|Protocol Violation|2
192426|NCT00393523|654341|P1|Overall Study|Protocol Violation|6
192427|NCT00393523|654337|P5|Overall Study|Lost to Follow-up|1
192428|NCT00393523|654338|P4|Overall Study|Lost to Follow-up|2
192429|NCT00393523|654339|P3|Overall Study|Lost to Follow-up|0
192430|NCT00393523|654340|P2|Overall Study|Lost to Follow-up|0
192431|NCT00393523|654341|P1|Overall Study|Lost to Follow-up|0
192432|NCT00393510|654358|P2|Overall Study|Physician Decision|9
192433|NCT00393510|654359|P1|Overall Study|Physician Decision|3
192434|NCT00393484|654371|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
192435|NCT00393484|654372|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
192436|NCT00393484|654371|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
192437|NCT00393484|654372|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
192438|NCT00393484|654371|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
192439|NCT00393484|654372|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
192440|NCT00393484|654371|P2|Open-label Period (Weeks 96 to 240)|Death|0
192441|NCT00393484|654372|P1|Open-label Period (Weeks 96 to 240)|Death|1
192442|NCT00393484|654371|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
192443|NCT00393484|654372|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
192605|NCT00392210|654856|P2|First Voiding Trial|Physician Decision|2
192444|NCT00393484|654371|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
192445|NCT00393484|654372|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
192446|NCT00393484|654371|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
192447|NCT00393484|654372|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
192448|NCT00393484|654371|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
192449|NCT00393484|654372|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
192450|NCT00393484|654371|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
192451|NCT00393484|654372|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
192452|NCT00393484|654371|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
192453|NCT00393484|654372|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
192454|NCT00393458|654408|P4|Overall Study|Subject no longer requires study drug|0
192455|NCT00393458|654409|P3|Overall Study|Subject no longer requires study drug|0
192456|NCT00393458|654410|P2|Overall Study|Subject no longer requires study drug|1
192457|NCT00393458|654411|P1|Overall Study|Subject no longer requires study drug|0
192458|NCT00393458|654408|P4|Overall Study|Abnormal test procedure result(s)|2
192459|NCT00393458|654409|P3|Overall Study|Abnormal test procedure result(s)|1
192460|NCT00393458|654410|P2|Overall Study|Abnormal test procedure result(s)|1
192461|NCT00393458|654411|P1|Overall Study|Abnormal test procedure result(s)|0
192462|NCT00393458|654408|P4|Overall Study|Death|5
192463|NCT00393458|654409|P3|Overall Study|Death|5
192464|NCT00393458|654410|P2|Overall Study|Death|1
192465|NCT00393458|654411|P1|Overall Study|Death|1
192466|NCT00393458|654408|P4|Overall Study|Abnormal laboratory value(s)|0
192467|NCT00393458|654409|P3|Overall Study|Abnormal laboratory value(s)|0
192468|NCT00393458|654410|P2|Overall Study|Abnormal laboratory value(s)|1
192469|NCT00393458|654411|P1|Overall Study|Abnormal laboratory value(s)|1
192470|NCT00393458|654408|P4|Overall Study|Lost to Follow-up|3
192471|NCT00393458|654409|P3|Overall Study|Lost to Follow-up|5
192472|NCT00393458|654410|P2|Overall Study|Lost to Follow-up|6
192473|NCT00393458|654411|P1|Overall Study|Lost to Follow-up|5
192474|NCT00393458|654408|P4|Overall Study|Administrative problems|2
192475|NCT00393458|654409|P3|Overall Study|Administrative problems|5
192476|NCT00393458|654410|P2|Overall Study|Administrative problems|8
192477|NCT00393458|654411|P1|Overall Study|Administrative problems|7
192478|NCT00393458|654408|P4|Overall Study|Protocol deviation|10
192479|NCT00393458|654409|P3|Overall Study|Protocol deviation|11
192480|NCT00393458|654410|P2|Overall Study|Protocol deviation|11
192481|NCT00393458|654411|P1|Overall Study|Protocol deviation|11
192482|NCT00393458|654408|P4|Overall Study|Unsatisfactory therapeutic effect|30
192483|NCT00393458|654409|P3|Overall Study|Unsatisfactory therapeutic effect|12
192484|NCT00393458|654410|P2|Overall Study|Unsatisfactory therapeutic effect|9
192485|NCT00393458|654411|P1|Overall Study|Unsatisfactory therapeutic effect|12
192486|NCT00393458|654408|P4|Overall Study|Subject withdrew consent|50
192487|NCT00393458|654409|P3|Overall Study|Subject withdrew consent|33
192488|NCT00393458|654410|P2|Overall Study|Subject withdrew consent|40
192489|NCT00393458|654411|P1|Overall Study|Subject withdrew consent|27
192490|NCT00393458|654408|P4|Overall Study|Adverse Event|35
192491|NCT00393458|654409|P3|Overall Study|Adverse Event|40
192492|NCT00393458|654410|P2|Overall Study|Adverse Event|24
192493|NCT00393458|654411|P1|Overall Study|Adverse Event|35
192494|NCT00393367|654438|P2|Overall Study|Withdrawal by Subject|2
192495|NCT00393367|654439|P1|Overall Study|Withdrawal by Subject|0
192496|NCT00393367|654438|P2|Overall Study|Protocol Violation|5
192497|NCT00393367|654439|P1|Overall Study|Protocol Violation|2
192498|NCT00393094|654467|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
192499|NCT00393094|654467|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
192500|NCT00393042|654478|P2|Second Intervetion|Protocol Violation|1
192501|NCT00393042|654479|P1|Second Intervetion|Protocol Violation|1
192502|NCT00393042|654478|P2|Second Intervetion|Lost to Follow-up|2
192503|NCT00393042|654479|P1|Second Intervetion|Lost to Follow-up|0
192504|NCT00393042|654478|P2|Second Intervetion|Lack of Efficacy|0
192505|NCT00393042|654479|P1|Second Intervetion|Lack of Efficacy|1
192506|NCT00393042|654478|P2|Second Intervetion|Withdrawal by Subject|2
192507|NCT00393042|654479|P1|Second Intervetion|Withdrawal by Subject|0
192508|NCT00393042|654478|P2|Second Intervetion|Adverse Event|3
192509|NCT00393042|654479|P1|Second Intervetion|Adverse Event|0
192510|NCT00393042|654478|P2|First Intervention|Adverse Event|1
192511|NCT00393042|654479|P1|First Intervention|Adverse Event|0
192512|NCT00393042|654478|P2|First Intervention|Protocol Violation|0
192513|NCT00393042|654479|P1|First Intervention|Protocol Violation|1
192514|NCT00393042|654478|P2|First Intervention|Lost to Follow-up|3
192515|NCT00393042|654479|P1|First Intervention|Lost to Follow-up|3
192516|NCT00393042|654478|P2|First Intervention|Withdrawal by Subject|2
192517|NCT00393042|654479|P1|First Intervention|Withdrawal by Subject|1
192518|NCT00393029|654551|P2|Overall Study|Not treated|1
192519|NCT00393029|654552|P1|Overall Study|Not treated|0
192520|NCT00392925|654573|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
192521|NCT00392925|654574|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
192522|NCT00392925|654575|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
192523|NCT00392925|654576|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
192524|NCT00392925|654573|P4|Randomization to Treatment Group Period|Protocol Violation|1
192525|NCT00392925|654574|P3|Randomization to Treatment Group Period|Protocol Violation|2
192526|NCT00392925|654575|P2|Randomization to Treatment Group Period|Protocol Violation|0
192527|NCT00392925|654576|P1|Randomization to Treatment Group Period|Protocol Violation|0
192528|NCT00392925|654573|P4|Randomization to Treatment Group Period|Adverse Event|5
192529|NCT00392925|654574|P3|Randomization to Treatment Group Period|Adverse Event|3
192530|NCT00392925|654575|P2|Randomization to Treatment Group Period|Adverse Event|3
192531|NCT00392925|654576|P1|Randomization to Treatment Group Period|Adverse Event|0
192532|NCT00392925|654573|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
192533|NCT00392925|654574|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
192534|NCT00392925|654575|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
192535|NCT00392925|654576|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
192536|NCT00392925|654573|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
192537|NCT00392925|654574|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
192538|NCT00392925|654575|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
192539|NCT00392925|654576|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
192540|NCT00392925|654573|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
192541|NCT00392925|654574|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
192542|NCT00392925|654575|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
192543|NCT00392925|654576|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
192544|NCT00392925|654573|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
192545|NCT00392925|654574|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
192546|NCT00392925|654575|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
192547|NCT00392925|654576|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
192548|NCT00392925|654573|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
192549|NCT00392925|654574|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
192550|NCT00392925|654575|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
192551|NCT00392925|654576|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
192552|NCT00392925|654573|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
192553|NCT00392925|654574|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
192554|NCT00392925|654575|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
192555|NCT00392925|654576|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
192556|NCT00392808|654690|P4|Overall Study|Unable to withdraw blood|2
192557|NCT00392808|654691|P3|Overall Study|Unable to withdraw blood|1
192558|NCT00392808|654692|P2|Overall Study|Unable to withdraw blood|1
192559|NCT00392808|654693|P1|Overall Study|Unable to withdraw blood|3
192560|NCT00392808|654690|P4|Overall Study|Lost to Follow-up|2
192561|NCT00392808|654691|P3|Overall Study|Lost to Follow-up|1
192562|NCT00392808|654692|P2|Overall Study|Lost to Follow-up|2
192563|NCT00392808|654693|P1|Overall Study|Lost to Follow-up|3
192564|NCT00392769|654717|P1|Overall Study|Adverse Event|1
192565|NCT00392769|654717|P1|Overall Study|Clinical Deterioration|9
192566|NCT00392665|654769|P2|Overall Study|Lost to Follow-up|1
192567|NCT00392665|654770|P1|Overall Study|Lost to Follow-up|1
192568|NCT00392665|654769|P2|Overall Study|Death|14
192569|NCT00392665|654770|P1|Overall Study|Death|16
192570|NCT00392379|654796|P2|Overall Study|Adverse Event|1
192571|NCT00392379|654797|P1|Overall Study|Adverse Event|1
192572|NCT00392379|654796|P2|Overall Study|Lost to Follow-up|9
192573|NCT00392379|654797|P1|Overall Study|Lost to Follow-up|4
192574|NCT00392379|654796|P2|Overall Study|Withdrawal by Subject|28
192575|NCT00392379|654797|P1|Overall Study|Withdrawal by Subject|17
192576|NCT00392288|654810|P3|Overall Study|Other|1
192577|NCT00392288|654811|P2|Overall Study|Other|4
192578|NCT00392288|654812|P1|Overall Study|Other|3
192579|NCT00392288|654810|P3|Overall Study|Parent/legal guardian withdrawal|1
192580|NCT00392288|654811|P2|Overall Study|Parent/legal guardian withdrawal|2
192581|NCT00392288|654812|P1|Overall Study|Parent/legal guardian withdrawal|1
192582|NCT00392288|654810|P3|Overall Study|Withdrawal by Subject|2
192583|NCT00392288|654811|P2|Overall Study|Withdrawal by Subject|0
192584|NCT00392288|654812|P1|Overall Study|Withdrawal by Subject|1
192585|NCT00392288|654810|P3|Overall Study|Lost to Follow-up|1
192586|NCT00392288|654811|P2|Overall Study|Lost to Follow-up|1
192587|NCT00392288|654812|P1|Overall Study|Lost to Follow-up|1
192588|NCT00392288|654810|P3|Overall Study|Protocol Violation|1
192589|NCT00392288|654811|P2|Overall Study|Protocol Violation|3
192590|NCT00392288|654812|P1|Overall Study|Protocol Violation|1
192591|NCT00392288|654810|P3|Overall Study|Lack of Efficacy|3
192592|NCT00392288|654811|P2|Overall Study|Lack of Efficacy|5
192593|NCT00392288|654812|P1|Overall Study|Lack of Efficacy|8
192594|NCT00392288|654810|P3|Overall Study|Adverse Event|8
192595|NCT00392288|654811|P2|Overall Study|Adverse Event|7
192596|NCT00392288|654812|P1|Overall Study|Adverse Event|17
192597|NCT00392223|654837|P2|Overall Study|Withdrawal by Subject|2
192598|NCT00392223|654838|P1|Overall Study|Withdrawal by Subject|3
192599|NCT00392223|654837|P2|Overall Study|Protocol Violation|3
192600|NCT00392223|654838|P1|Overall Study|Protocol Violation|0
192601|NCT00392223|654837|P2|Overall Study|Lost to Follow-up|4
192602|NCT00392223|654838|P1|Overall Study|Lost to Follow-up|1
192603|NCT00392223|654837|P2|Overall Study|Adverse Event|4
192604|NCT00392223|654838|P1|Overall Study|Adverse Event|5
192606|NCT00392210|654857|P1|First Voiding Trial|Physician Decision|2
192607|NCT00392197|654865|P2|Overall Study|Withdrawal by Subject|6
192608|NCT00392197|654866|P1|Overall Study|Withdrawal by Subject|4
192609|NCT00392197|654865|P2|Overall Study|Protocol Violation|5
192610|NCT00392197|654866|P1|Overall Study|Protocol Violation|7
192611|NCT00392197|654865|P2|Overall Study|Physician Decision|2
192612|NCT00392197|654866|P1|Overall Study|Physician Decision|3
192613|NCT00392197|654865|P2|Overall Study|Lost to Follow-up|1
192614|NCT00392197|654866|P1|Overall Study|Lost to Follow-up|0
192615|NCT00392197|654865|P2|Overall Study|Lack of Efficacy|4
192616|NCT00392197|654866|P1|Overall Study|Lack of Efficacy|3
192617|NCT00392197|654865|P2|Overall Study|Adverse Event|12
192618|NCT00392197|654866|P1|Overall Study|Adverse Event|4
192619|NCT00392171|654874|P1|Overall Study|Disease progression|101
192620|NCT00392171|654874|P1|Overall Study|Did not meet inclusion criteria|4
192621|NCT00391976|654885|P3|Overall Study|Positive P. aeruginosa antibody test|31
192622|NCT00391976|654886|P2|Overall Study|Positive P. aeruginosa antibody test|0
192623|NCT00391976|654887|P1|Overall Study|Positive P. aeruginosa antibody test|0
192624|NCT00391976|654885|P3|Overall Study|Unable to classify|1
192625|NCT00391976|654886|P2|Overall Study|Unable to classify|0
192626|NCT00391976|654887|P1|Overall Study|Unable to classify|0
192627|NCT00391976|654885|P3|Overall Study|Recurrence/no eradication of infection|0
192628|NCT00391976|654886|P2|Overall Study|Recurrence/no eradication of infection|19
192629|NCT00391976|654887|P1|Overall Study|Recurrence/no eradication of infection|21
192630|NCT00391976|654885|P3|Overall Study|Protocol deviation/violation|1
192631|NCT00391976|654886|P2|Overall Study|Protocol deviation/violation|2
192632|NCT00391976|654887|P1|Overall Study|Protocol deviation/violation|4
192633|NCT00391976|654885|P3|Overall Study|Inappropriate enrollment|0
192634|NCT00391976|654886|P2|Overall Study|Inappropriate enrollment|1
192635|NCT00391976|654887|P1|Overall Study|Inappropriate enrollment|1
192636|NCT00391976|654885|P3|Overall Study|Lost to Follow-up|0
192637|NCT00391976|654886|P2|Overall Study|Lost to Follow-up|2
192638|NCT00391976|654887|P1|Overall Study|Lost to Follow-up|1
192639|NCT00391976|654885|P3|Overall Study|Withdrawal of consent|1
192640|NCT00391976|654886|P2|Overall Study|Withdrawal of consent|1
192641|NCT00391976|654887|P1|Overall Study|Withdrawal of consent|0
192642|NCT00391976|654885|P3|Overall Study|Adverse Event|1
192643|NCT00391976|654886|P2|Overall Study|Adverse Event|0
192644|NCT00391976|654887|P1|Overall Study|Adverse Event|0
192645|NCT00391898|654911|P2|Overall Study|Other|10
192646|NCT00391898|654912|P1|Overall Study|Other|8
192647|NCT00391898|654911|P2|Overall Study|Adverse Event|0
192648|NCT00391898|654912|P1|Overall Study|Adverse Event|3
192649|NCT00391872|654932|P2|Overall Study|Lost to Follow-up|0
192650|NCT00391872|654933|P1|Overall Study|Lost to Follow-up|2
192651|NCT00391872|654932|P2|Overall Study|Reason unknown|4
192652|NCT00391872|654933|P1|Overall Study|Reason unknown|2
192653|NCT00391872|654932|P2|Overall Study|Withdrawal by Subject|249
192654|NCT00391872|654933|P1|Overall Study|Withdrawal by Subject|296
192655|NCT00391872|654932|P2|Overall Study|Protocol Violation|2
192656|NCT00391872|654933|P1|Overall Study|Protocol Violation|7
192657|NCT00391846|654971|P2|Overall Study|Developed study specific DC criteria|1
192658|NCT00391846|654972|P1|Overall Study|Developed study specific DC criteria|0
192659|NCT00391846|654971|P2|Overall Study|Withdrawal by Subject|3
192660|NCT00391846|654972|P1|Overall Study|Withdrawal by Subject|2
192661|NCT00391846|654971|P2|Overall Study|Did not meet the required elig. crit|2
192662|NCT00391846|654972|P1|Overall Study|Did not meet the required elig. crit|2
192663|NCT00391846|654971|P2|Overall Study|Adverse Event|1
192664|NCT00391846|654972|P1|Overall Study|Adverse Event|4
192665|NCT00391807|654992|P1|Overall Study|Various|96
192666|NCT00391807|654992|P1|Overall Study|Protocol Violation|20
192667|NCT00391807|654992|P1|Overall Study|Withdrawal by Subject|147
192668|NCT00391807|654992|P1|Overall Study|Lost to Follow-up|227
192669|NCT00391807|654992|P1|Overall Study|Pregnancy|25
192670|NCT00391807|654992|P1|Overall Study|Adverse Event|177
192671|NCT00391807|654992|P1|Overall Study|Did not receive study medication|23
192672|NCT00391768|655019|P7|Overall Study|Lost to Follow-up|3
192673|NCT00391768|655020|P6|Overall Study|Lost to Follow-up|2
192674|NCT00391768|655021|P5|Overall Study|Lost to Follow-up|2
192675|NCT00391768|655022|P4|Overall Study|Lost to Follow-up|1
192676|NCT00391768|655023|P3|Overall Study|Lost to Follow-up|0
192677|NCT00391768|655024|P2|Overall Study|Lost to Follow-up|0
192678|NCT00391768|655025|P1|Overall Study|Lost to Follow-up|0
192679|NCT00391768|655019|P7|Overall Study|Withdrawal by Subject|1
192680|NCT00391768|655020|P6|Overall Study|Withdrawal by Subject|1
192681|NCT00391768|655021|P5|Overall Study|Withdrawal by Subject|0
192682|NCT00391768|655022|P4|Overall Study|Withdrawal by Subject|0
192683|NCT00391768|655023|P3|Overall Study|Withdrawal by Subject|1
192684|NCT00391768|655024|P2|Overall Study|Withdrawal by Subject|0
192685|NCT00391768|655025|P1|Overall Study|Withdrawal by Subject|0
192686|NCT00391625|655112|P1|Month 50|Physician Decision|1
192687|NCT00391625|655112|P1|Month 14|Withdrawal by Subject|1
192688|NCT00391586|655165|P1|Overall Study|Death|4
192689|NCT00391586|655165|P1|Overall Study|Physician Decision|2
192690|NCT00391586|655165|P1|Overall Study|Adverse Event|5
192691|NCT00391586|655165|P1|Overall Study|Progressive disease|13
192692|NCT00391391|655202|P4|Overall Study|Withdrawal by Subject|7
192693|NCT00391391|655203|P3|Overall Study|Withdrawal by Subject|10
192694|NCT00391391|655204|P2|Overall Study|Withdrawal by Subject|4
192695|NCT00391391|655205|P1|Overall Study|Withdrawal by Subject|6
192696|NCT00391391|655202|P4|Overall Study|Protocol Violation|7
192697|NCT00391391|655203|P3|Overall Study|Protocol Violation|6
192698|NCT00391391|655204|P2|Overall Study|Protocol Violation|3
192699|NCT00391391|655205|P1|Overall Study|Protocol Violation|2
192700|NCT00391391|655202|P4|Overall Study|Lost to Follow-up|4
192701|NCT00391391|655203|P3|Overall Study|Lost to Follow-up|7
192702|NCT00391391|655204|P2|Overall Study|Lost to Follow-up|3
192703|NCT00391391|655205|P1|Overall Study|Lost to Follow-up|1
192704|NCT00391391|655202|P4|Overall Study|Adverse Event|1
192705|NCT00391391|655203|P3|Overall Study|Adverse Event|0
192706|NCT00391391|655204|P2|Overall Study|Adverse Event|0
192707|NCT00391391|655205|P1|Overall Study|Adverse Event|0
192708|NCT00391274|655250|P2|Overall Study|Death Not Study Related|1
192709|NCT00391274|655251|P1|Overall Study|Death Not Study Related|0
192710|NCT00391274|655250|P2|Overall Study|Death Due to Indeterminate Cause|0
192711|NCT00391274|655251|P1|Overall Study|Death Due to Indeterminate Cause|1
192712|NCT00391274|655250|P2|Overall Study|Death Due to Adverse Event|3
192713|NCT00391274|655251|P1|Overall Study|Death Due to Adverse Event|1
192714|NCT00391274|655250|P2|Overall Study|Withdrawal by Subject|3
192715|NCT00391274|655251|P1|Overall Study|Withdrawal by Subject|0
192716|NCT00391274|655250|P2|Overall Study|Physician Decision|2
192717|NCT00391274|655251|P1|Overall Study|Physician Decision|4
192718|NCT00391274|655250|P2|Overall Study|Lost to Follow-up|3
192719|NCT00391274|655251|P1|Overall Study|Lost to Follow-up|0
192720|NCT00391274|655250|P2|Overall Study|Death Due to Study Disease|45
192721|NCT00391274|655251|P1|Overall Study|Death Due to Study Disease|55
192722|NCT00391222|655270|P4|Period III (Double-Blind Treatment)|Other|0
192723|NCT00391222|655271|P3|Period III (Double-Blind Treatment)|Other|6
192724|NCT00391222|655272|P2|Period III (Double-Blind Treatment)|Other|1
192725|NCT00391222|655273|P1|Period III (Double-Blind Treatment)|Other|6
192726|NCT00391222|655270|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
192727|NCT00391222|655271|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
192728|NCT00391222|655272|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
192729|NCT00391222|655273|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
192730|NCT00391222|655270|P4|Period III (Double-Blind Treatment)|Pregnancy|0
192731|NCT00391222|655271|P3|Period III (Double-Blind Treatment)|Pregnancy|0
192732|NCT00391222|655272|P2|Period III (Double-Blind Treatment)|Pregnancy|2
192733|NCT00391222|655273|P1|Period III (Double-Blind Treatment)|Pregnancy|0
192734|NCT00391222|655270|P4|Period III (Double-Blind Treatment)|Adverse Event|0
192735|NCT00391222|655271|P3|Period III (Double-Blind Treatment)|Adverse Event|4
192736|NCT00391222|655272|P2|Period III (Double-Blind Treatment)|Adverse Event|2
192737|NCT00391222|655273|P1|Period III (Double-Blind Treatment)|Adverse Event|5
192738|NCT00391222|655270|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
192739|NCT00391222|655271|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
192740|NCT00391222|655272|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
192741|NCT00391222|655273|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
192742|NCT00391222|655270|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
192743|NCT00391222|655271|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
192744|NCT00391222|655272|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
192745|NCT00391222|655273|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
192746|NCT00391222|655270|P4|Period II (Open-label Risperidone LAI)|Other|24
192747|NCT00391222|655271|P3|Period II (Open-label Risperidone LAI)|Other|0
192748|NCT00391222|655272|P2|Period II (Open-label Risperidone LAI)|Other|0
192749|NCT00391222|655273|P1|Period II (Open-label Risperidone LAI)|Other|0
192750|NCT00391222|655270|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
192751|NCT00391222|655271|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
192752|NCT00391222|655272|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
192753|NCT00391222|655273|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
192754|NCT00391222|655270|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
192755|NCT00391222|655271|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
192756|NCT00391222|655272|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
192757|NCT00391222|655273|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
192758|NCT00391222|655270|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
192759|NCT00391222|655271|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
192760|NCT00391222|655272|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
192761|NCT00391222|655273|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
192762|NCT00391222|655270|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
192763|NCT00391222|655271|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
192764|NCT00391222|655272|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
192765|NCT00391222|655273|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
192766|NCT00391092|655299|P2|Overall Study|Alive in follow-up|84
192767|NCT00391092|655300|P1|Overall Study|Alive in follow-up|88
192768|NCT00391092|655299|P2|Overall Study|Alive on treatment|33
192769|NCT00391092|655300|P1|Overall Study|Alive on treatment|29
192770|NCT00391092|655299|P2|Overall Study|Lost to Follow-up|18
192771|NCT00391092|655300|P1|Overall Study|Lost to Follow-up|13
192772|NCT00391092|655299|P2|Overall Study|Death|81
192773|NCT00391092|655300|P1|Overall Study|Death|78
192774|NCT00391053|655343|P4|Overall Study|Withdrawal by Subject|1
192775|NCT00391053|655344|P3|Overall Study|Withdrawal by Subject|1
192776|NCT00391053|655345|P2|Overall Study|Withdrawal by Subject|1
192777|NCT00391053|655346|P1|Overall Study|Withdrawal by Subject|5
192778|NCT00391053|655343|P4|Overall Study|Lost to Follow-up|5
192779|NCT00391053|655344|P3|Overall Study|Lost to Follow-up|0
192780|NCT00391053|655345|P2|Overall Study|Lost to Follow-up|0
192781|NCT00391053|655346|P1|Overall Study|Lost to Follow-up|1
192782|NCT00391053|655343|P4|Overall Study|Protocol Violation|0
192783|NCT00391053|655344|P3|Overall Study|Protocol Violation|0
192784|NCT00391053|655345|P2|Overall Study|Protocol Violation|0
192785|NCT00391053|655346|P1|Overall Study|Protocol Violation|2
192786|NCT00391053|655343|P4|Overall Study|Serious Adverse Events|4
192787|NCT00391053|655344|P3|Overall Study|Serious Adverse Events|1
192788|NCT00391053|655345|P2|Overall Study|Serious Adverse Events|0
192789|NCT00391053|655346|P1|Overall Study|Serious Adverse Events|1
192790|NCT00391027|655370|P2|Overall Study|Other|3
192791|NCT00391027|655371|P1|Overall Study|Other|4
192792|NCT00391027|655370|P2|Overall Study|Withdrawal by Subject|1
192793|NCT00391027|655371|P1|Overall Study|Withdrawal by Subject|10
192794|NCT00391027|655370|P2|Overall Study|Lack of Efficacy|0
192795|NCT00391027|655371|P1|Overall Study|Lack of Efficacy|3
192796|NCT00391027|655370|P2|Overall Study|Adverse Event|8
192797|NCT00391027|655371|P1|Overall Study|Adverse Event|8
192798|NCT00390884|655411|P2|Overall Study|Withdrawal by Subject|2
192799|NCT00390884|655412|P1|Overall Study|Withdrawal by Subject|2
192800|NCT00390858|655424|P2|Overall Study|Withdrawal by Subject|4
192801|NCT00390858|655425|P1|Overall Study|Withdrawal by Subject|3
192802|NCT00390858|655424|P2|Overall Study|Lack of Efficacy|1
192803|NCT00390858|655425|P1|Overall Study|Lack of Efficacy|0
192804|NCT00390858|655424|P2|Overall Study|Adverse Event|2
192805|NCT00390858|655425|P1|Overall Study|Adverse Event|6
192806|NCT00390806|655439|P2|Overall Study|Ongoing|2
192807|NCT00390806|655440|P1|Overall Study|Ongoing|4
192808|NCT00390806|655439|P2|Overall Study|Physician Decision|1
192809|NCT00390806|655440|P1|Overall Study|Physician Decision|0
192810|NCT00390806|655439|P2|Overall Study|Death|0
192811|NCT00390806|655440|P1|Overall Study|Death|1
192812|NCT00390806|655439|P2|Overall Study|Investigator Decision|6
192813|NCT00390806|655440|P1|Overall Study|Investigator Decision|4
192814|NCT00390806|655439|P2|Overall Study|Withdrawal by Subject|15
192815|NCT00390806|655440|P1|Overall Study|Withdrawal by Subject|12
192816|NCT00390806|655439|P2|Overall Study|Protocol Violation|2
192817|NCT00390806|655440|P1|Overall Study|Protocol Violation|2
192818|NCT00390806|655439|P2|Overall Study|Lost to Follow-up|6
192819|NCT00390806|655440|P1|Overall Study|Lost to Follow-up|7
192820|NCT00390780|655508|P2|Overall Study|SAE, death|1
192821|NCT00390780|655509|P1|Overall Study|SAE, death|0
192822|NCT00390780|655508|P2|Overall Study|Investigator decision, SAE, other reason|1
192823|NCT00390780|655509|P1|Overall Study|Investigator decision, SAE, other reason|0
192824|NCT00390780|655508|P2|Overall Study|Lost to follow up and other reasons|1
192825|NCT00390780|655509|P1|Overall Study|Lost to follow up and other reasons|0
192826|NCT00390780|655508|P2|Overall Study|Inclusion criteria not satisfied|2
192827|NCT00390780|655509|P1|Overall Study|Inclusion criteria not satisfied|0
192828|NCT00390780|655508|P2|Overall Study|Withdrawal by Subject|2
192829|NCT00390780|655509|P1|Overall Study|Withdrawal by Subject|1
192830|NCT00390780|655508|P2|Overall Study|Death|3
192831|NCT00390780|655509|P1|Overall Study|Death|1
192832|NCT00390780|655508|P2|Overall Study|Adverse Event|3
192833|NCT00390780|655509|P1|Overall Study|Adverse Event|2
192834|NCT00390780|655508|P2|Overall Study|Lost to Follow-up|6
192835|NCT00390780|655509|P1|Overall Study|Lost to Follow-up|3
192836|NCT00390780|655508|P2|Overall Study|Protocol Violation|4
192837|NCT00390780|655509|P1|Overall Study|Protocol Violation|6
192838|NCT00390780|655508|P2|Overall Study|Not completed|4
192839|NCT00390780|655509|P1|Overall Study|Not completed|10
192840|NCT00390689|655542|P3|Overall Study|Investigator's judgement|0
192841|NCT00390689|655543|P2|Overall Study|Investigator's judgement|0
192842|NCT00390689|655544|P1|Overall Study|Investigator's judgement|2
192843|NCT00390689|655542|P3|Overall Study|Protocol Violation|0
192844|NCT00390689|655543|P2|Overall Study|Protocol Violation|0
192845|NCT00390689|655544|P1|Overall Study|Protocol Violation|1
192846|NCT00390689|655542|P3|Overall Study|Lack of Efficacy|1
192847|NCT00390689|655543|P2|Overall Study|Lack of Efficacy|0
192848|NCT00390689|655544|P1|Overall Study|Lack of Efficacy|0
192849|NCT00390689|655542|P3|Overall Study|Adverse Event|2
192850|NCT00390689|655543|P2|Overall Study|Adverse Event|5
192851|NCT00390689|655544|P1|Overall Study|Adverse Event|2
192852|NCT00390572|655619|P2|Overall Study|health condition|1
192853|NCT00390572|655620|P1|Overall Study|health condition|0
192854|NCT00390572|655619|P2|Overall Study|Lost to Follow-up|4
192855|NCT00390572|655620|P1|Overall Study|Lost to Follow-up|8
192856|NCT00390546|655646|P2|Overall Study|Physician Decision|5
192857|NCT00390546|655647|P1|Overall Study|Physician Decision|5
192858|NCT00390546|655646|P2|Overall Study|Renal impairment|0
192859|NCT00390546|655647|P1|Overall Study|Renal impairment|1
192860|NCT00390468|655657|P1|Overall Study|Lack of Efficacy|1
192861|NCT00390468|655657|P1|Overall Study|Protocol Violation|2
192862|NCT00390455|655663|P2|Overall Study|Other Medical Reasons|11
192863|NCT00390455|655664|P1|Overall Study|Other Medical Reasons|7
192864|NCT00390455|655663|P2|Overall Study|Alternate Treatment|1
192865|NCT00390455|655664|P1|Overall Study|Alternate Treatment|0
192866|NCT00390455|655663|P2|Overall Study|Withdrawal by Subject|8
192867|NCT00390455|655664|P1|Overall Study|Withdrawal by Subject|8
192868|NCT00390455|655663|P2|Overall Study|Adverse Event|3
192869|NCT00390455|655664|P1|Overall Study|Adverse Event|17
192870|NCT00390416|655704|P1|Overall Study|Not treated|3
192871|NCT00390416|655704|P1|Overall Study|Withdrawal by Subject|1
192872|NCT00390221|655725|P3|Overall Study|Not Specified|2
192873|NCT00390221|655726|P2|Overall Study|Not Specified|4
192874|NCT00390221|655727|P1|Overall Study|Not Specified|3
192875|NCT00390221|655725|P3|Overall Study|Subject Non-compliance|2
192876|NCT00390221|655726|P2|Overall Study|Subject Non-compliance|0
192877|NCT00390221|655727|P1|Overall Study|Subject Non-compliance|1
192878|NCT00390221|655725|P3|Overall Study|Withdrawal by Subject|7
192879|NCT00390221|655726|P2|Overall Study|Withdrawal by Subject|9
192880|NCT00390221|655727|P1|Overall Study|Withdrawal by Subject|13
192881|NCT00390221|655725|P3|Overall Study|Investigator Decision|1
192882|NCT00390221|655726|P2|Overall Study|Investigator Decision|0
192883|NCT00390221|655727|P1|Overall Study|Investigator Decision|0
192884|NCT00390221|655725|P3|Overall Study|Adverse Event|3
192885|NCT00390221|655726|P2|Overall Study|Adverse Event|4
192886|NCT00390221|655727|P1|Overall Study|Adverse Event|1
192887|NCT00390221|655725|P3|Overall Study|Lost to Follow-up|0
192888|NCT00390221|655726|P2|Overall Study|Lost to Follow-up|3
192889|NCT00390221|655727|P1|Overall Study|Lost to Follow-up|0
192890|NCT00390013|655757|P4|Phase 2 First Treatment|Withdrawal by Subject|0
192891|NCT00390013|655758|P3|Phase 2 First Treatment|Withdrawal by Subject|0
192892|NCT00390013|655759|P2|Phase 2 First Treatment|Withdrawal by Subject|1
192893|NCT00390013|655760|P1|Phase 2 First Treatment|Withdrawal by Subject|0
192894|NCT00390013|655757|P4|Phase 2 First Treatment|tired|0
192895|NCT00390013|655758|P3|Phase 2 First Treatment|tired|0
192896|NCT00390013|655759|P2|Phase 2 First Treatment|tired|0
192897|NCT00390013|655760|P1|Phase 2 First Treatment|tired|1
192898|NCT00390013|655757|P4|Phase 1|tired|1
192899|NCT00390013|655758|P3|Phase 1|tired|0
192900|NCT00390013|655759|P2|Phase 1|tired|0
192901|NCT00390013|655760|P1|Phase 1|tired|0
192902|NCT00389831|655785|P2|Overall Study|Lost to Follow-up|1
192903|NCT00389831|655786|P1|Overall Study|Lost to Follow-up|0
192904|NCT00389831|655785|P2|Overall Study|Other reasons|2
192905|NCT00389831|655786|P1|Overall Study|Other reasons|0
192906|NCT00389831|655785|P2|Overall Study|Did not receive treatment.|2
192907|NCT00389831|655786|P1|Overall Study|Did not receive treatment.|0
192908|NCT00389831|655785|P2|Overall Study|Lack of Efficacy|2
192909|NCT00389831|655786|P1|Overall Study|Lack of Efficacy|0
192910|NCT00389597|655849|P4|Overall Study|Lost to Follow-up|6
192911|NCT00389597|655850|P3|Overall Study|Lost to Follow-up|4
192912|NCT00389597|655851|P2|Overall Study|Lost to Follow-up|6
192913|NCT00389597|655852|P1|Overall Study|Lost to Follow-up|8
192914|NCT00389519|655877|P4|Treated|Reason not specified|2
192915|NCT00389519|655878|P3|Treated|Reason not specified|0
192916|NCT00389519|655879|P2|Treated|Reason not specified|1
192917|NCT00389519|655880|P1|Treated|Reason not specified|1
192918|NCT00389519|655877|P4|Treated|Adverse Event|2
192919|NCT00389519|655878|P3|Treated|Adverse Event|0
192920|NCT00389519|655879|P2|Treated|Adverse Event|0
192921|NCT00389519|655880|P1|Treated|Adverse Event|1
192922|NCT00389519|655877|P4|Randomized|Did not receive study drug|0
192923|NCT00389519|655878|P3|Randomized|Did not receive study drug|0
192924|NCT00389519|655879|P2|Randomized|Did not receive study drug|0
192925|NCT00389519|655880|P1|Randomized|Did not receive study drug|2
192926|NCT00389519|655877|P4|Placebo Run-In|Reason not specified|0
192927|NCT00389519|655878|P3|Placebo Run-In|Reason not specified|0
192928|NCT00389519|655879|P2|Placebo Run-In|Reason not specified|0
192929|NCT00389519|655880|P1|Placebo Run-In|Reason not specified|40
192930|NCT00389519|655877|P4|Placebo Run-In|Withdrawal by Subject|0
192931|NCT00389519|655878|P3|Placebo Run-In|Withdrawal by Subject|0
192932|NCT00389519|655879|P2|Placebo Run-In|Withdrawal by Subject|0
192933|NCT00389519|655880|P1|Placebo Run-In|Withdrawal by Subject|19
192934|NCT00389519|655877|P4|Placebo Run-In|Did not meet blood pressure criteria|0
192935|NCT00389519|655878|P3|Placebo Run-In|Did not meet blood pressure criteria|0
192936|NCT00389519|655879|P2|Placebo Run-In|Did not meet blood pressure criteria|0
192937|NCT00389519|655880|P1|Placebo Run-In|Did not meet blood pressure criteria|119
192938|NCT00389441|655957|P1|Overall Study|Clinical progression|1
192939|NCT00389441|655957|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
192940|NCT00389441|655957|P1|Overall Study|Objective progression or relapse|26
192941|NCT00389441|655957|P1|Overall Study|Global deterioration of health status|4
192942|NCT00389441|655957|P1|Overall Study|Protocol Violation|1
192943|NCT00389441|655957|P1|Overall Study|Physician Decision|1
192944|NCT00389441|655957|P1|Overall Study|Withdrawal by Subject|4
192945|NCT00389441|655957|P1|Overall Study|Lost to Follow-up|2
192946|NCT00389441|655957|P1|Overall Study|Death|4
192947|NCT00389441|655957|P1|Overall Study|Adverse Event|7
192948|NCT00389324|655966|P1|Subcutaneous Phase|Lost to Follow-up|1
192949|NCT00389324|655966|P1|Subcutaneous Phase|Withdrawal by Subject|2
192950|NCT00389324|655966|P1|Subcutaneous Phase|Non-compliance with study medication|2
192951|NCT00389324|655966|P1|Subcutaneous Phase|Adverse Event|2
192952|NCT00389324|655966|P1|Run-In Phase|Withdrawal by Subject|1
192953|NCT00389324|655966|P1|Run-In Phase|Lost to Follow-up|1
192954|NCT00389324|655966|P1|Run-In Phase|Adverse Event|1
192955|NCT00389207|655976|P3|Overall Study|Not specified|9
192956|NCT00389207|655977|P2|Overall Study|Not specified|23
192957|NCT00389207|655978|P1|Overall Study|Not specified|17
192958|NCT00389207|655976|P3|Overall Study|Withdrawal by Subject|11
192959|NCT00389207|655977|P2|Overall Study|Withdrawal by Subject|7
192960|NCT00389207|655978|P1|Overall Study|Withdrawal by Subject|5
192961|NCT00389207|655976|P3|Overall Study|Lost to Follow-up|7
192962|NCT00389207|655977|P2|Overall Study|Lost to Follow-up|9
192963|NCT00389207|655978|P1|Overall Study|Lost to Follow-up|12
192964|NCT00389207|655976|P3|Overall Study|Protocol Violation|4
192965|NCT00389207|655977|P2|Overall Study|Protocol Violation|1
192966|NCT00389207|655978|P1|Overall Study|Protocol Violation|3
192967|NCT00389207|655976|P3|Overall Study|Adverse Event|10
192968|NCT00389207|655977|P2|Overall Study|Adverse Event|32
192969|NCT00389207|655978|P1|Overall Study|Adverse Event|26
192970|NCT00389064|656101|P2|Overall Study|Multiple Reasons|11
192971|NCT00389064|656102|P1|Overall Study|Multiple Reasons|9
192972|NCT00389064|656101|P2|Overall Study|Protocol Violation|0
192973|NCT00389064|656102|P1|Overall Study|Protocol Violation|2
192974|NCT00389064|656101|P2|Overall Study|Lost to Follow-up|2
192975|NCT00389064|656102|P1|Overall Study|Lost to Follow-up|1
192976|NCT00389064|656101|P2|Overall Study|Physician Decision|2
192977|NCT00389064|656102|P1|Overall Study|Physician Decision|2
192978|NCT00389064|656101|P2|Overall Study|Withdrawal by Subject|27
192979|NCT00389064|656102|P1|Overall Study|Withdrawal by Subject|17
192980|NCT00389064|656101|P2|Overall Study|Lack of Efficacy|14
192981|NCT00389064|656102|P1|Overall Study|Lack of Efficacy|3
192982|NCT00389064|656101|P2|Overall Study|Adverse Event|3
192983|NCT00389064|656102|P1|Overall Study|Adverse Event|11
192984|NCT00388973|656130|P2|Overall Study|Did not complete 2-week follow-up visit|17
192985|NCT00388973|656131|P1|Overall Study|Did not complete 2-week follow-up visit|17
192986|NCT00388973|656130|P2|Overall Study|Left region|1
192987|NCT00388973|656131|P1|Overall Study|Left region|0
192988|NCT00388973|656130|P2|Overall Study|Did not complete 61 days of treatment|4
192989|NCT00388973|656131|P1|Overall Study|Did not complete 61 days of treatment|5
192990|NCT00388973|656130|P2|Overall Study|Study specific Discontinuation Criteria|1
192991|NCT00388973|656131|P1|Overall Study|Study specific Discontinuation Criteria|0
192992|NCT00388973|656130|P2|Overall Study|Withdrawal by Subject|17
192993|NCT00388973|656131|P1|Overall Study|Withdrawal by Subject|14
192994|NCT00388973|656130|P2|Overall Study|Protocol Violation|0
192995|NCT00388973|656131|P1|Overall Study|Protocol Violation|3
192996|NCT00388973|656130|P2|Overall Study|Lack of Efficacy|12
192997|NCT00388973|656131|P1|Overall Study|Lack of Efficacy|1
192998|NCT00388973|656130|P2|Overall Study|Adverse Event|6
192999|NCT00388973|656131|P1|Overall Study|Adverse Event|16
193000|NCT00388947|656151|P1|Overall Study|Protocol Violation|47
193001|NCT00388726|656167|P2|Overall Study|Death|2
193002|NCT00388726|656168|P1|Overall Study|Death|3
193003|NCT00388726|656167|P2|Overall Study|Physician Decision|13
193004|NCT00388726|656168|P1|Overall Study|Physician Decision|18
193005|NCT00388726|656167|P2|Overall Study|Administrative|9
193006|NCT00388726|656168|P1|Overall Study|Administrative|6
193007|NCT00388726|656167|P2|Overall Study|Withdrawal by Subject|7
193008|NCT00388726|656168|P1|Overall Study|Withdrawal by Subject|10
193009|NCT00388726|656167|P2|Overall Study|Clinical Progression|36
193010|NCT00388726|656168|P1|Overall Study|Clinical Progression|61
193011|NCT00388726|656167|P2|Overall Study|Progressive Disease|153
193012|NCT00388726|656168|P1|Overall Study|Progressive Disease|336
193013|NCT00388726|656167|P2|Overall Study|Adverse Event|24
193014|NCT00388726|656168|P1|Overall Study|Adverse Event|50
193015|NCT00388583|656182|P2|Overall Study|Did not receive vaccine|1
193016|NCT00388583|656183|P1|Overall Study|Did not receive vaccine|0
193017|NCT00388583|656182|P2|Overall Study|Serious Adverse Event|0
193018|NCT00388583|656183|P1|Overall Study|Serious Adverse Event|2
193019|NCT00388583|656182|P2|Overall Study|Withdrawal by Subject|3
193020|NCT00388583|656183|P1|Overall Study|Withdrawal by Subject|3
193021|NCT00388583|656182|P2|Overall Study|Protocol Violation|0
193022|NCT00388583|656183|P1|Overall Study|Protocol Violation|1
193023|NCT00388505|656197|P2|Overall Study|Unable to classify|3
193024|NCT00388505|656198|P1|Overall Study|Unable to classify|4
193025|NCT00388505|656197|P2|Overall Study|Protocol Violation|5
193026|NCT00388505|656198|P1|Overall Study|Protocol Violation|6
193027|NCT00388505|656197|P2|Overall Study|Administrative Reason|0
193028|NCT00388505|656198|P1|Overall Study|Administrative Reason|1
193029|NCT00388505|656197|P2|Overall Study|Inappropriate Enrollment|1
193030|NCT00388505|656198|P1|Overall Study|Inappropriate Enrollment|0
193031|NCT00388505|656197|P2|Overall Study|Lost to Follow-up|3
193032|NCT00388505|656198|P1|Overall Study|Lost to Follow-up|5
193033|NCT00388505|656197|P2|Overall Study|Withdrawal by Subject|9
193034|NCT00388505|656198|P1|Overall Study|Withdrawal by Subject|24
193035|NCT00388505|656197|P2|Overall Study|Adverse Event or Death|17
193036|NCT00388505|656198|P1|Overall Study|Adverse Event or Death|43
193037|NCT00388362|656253|P1|Remained on Study Median of 514 Days|Death|2
193038|NCT00388362|656253|P1|Enrolled|Withdrawal by Subject|1
193039|NCT00388362|656253|P1|Enrolled|Loss insurance|1
193040|NCT00388362|656253|P1|Enrolled|Death|1
193041|NCT00388362|656253|P1|Enrolled|Adverse Event|9
193042|NCT00388362|656253|P1|Enrolled|Ineligible|1
193043|NCT00388349|656258|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
193044|NCT00388349|656259|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
193045|NCT00388154|656268|P1|Overall Study|Withdrawal by Subject|1
193046|NCT00388037|656273|P1|Overall Study|Protocol Violation|1
193047|NCT00387894|656281|P1|Overall Study|Withdrawal by Subject|1
193048|NCT00387881|656288|P2|Overall Study|Not otherwise specified|7
193049|NCT00387881|656289|P1|Overall Study|Not otherwise specified|11
193050|NCT00387881|656288|P2|Overall Study|No opportunity to treat headache|34
193051|NCT00387881|656289|P1|Overall Study|No opportunity to treat headache|32
193052|NCT00387881|656288|P2|Overall Study|Not eligible|7
193053|NCT00387881|656289|P1|Overall Study|Not eligible|6
193054|NCT00387881|656288|P2|Overall Study|Sponsor terminated Study|1
193055|NCT00387881|656289|P1|Overall Study|Sponsor terminated Study|0
193056|NCT00387881|656288|P2|Overall Study|Withdrawal by Subject|18
193057|NCT00387881|656289|P1|Overall Study|Withdrawal by Subject|15
193058|NCT00387881|656288|P2|Overall Study|Protocol Violation|12
193059|NCT00387881|656289|P1|Overall Study|Protocol Violation|2
193060|NCT00387881|656288|P2|Overall Study|Lost to Follow-up|23
193061|NCT00387881|656289|P1|Overall Study|Lost to Follow-up|23
193062|NCT00387790|656322|P1|Overall Study|Ineligible for study|2
193063|NCT00387790|656322|P1|Overall Study|Withdrawal by Subject|3
193064|NCT00387790|656322|P1|Overall Study|Physician Decision|2
193065|NCT00387790|656322|P1|Overall Study|Lack of Efficacy|2
193066|NCT00387790|656322|P1|Overall Study|Adverse Event|5
193067|NCT00387764|656328|P1|Overall Study|Death|7
193068|NCT00387764|656328|P1|Overall Study|Other|2
193069|NCT00387764|656328|P1|Overall Study|Physician Decision|1
193070|NCT00387764|656328|P1|Overall Study|Sponsor Terminated Study|1
193071|NCT00387764|656328|P1|Overall Study|Withdrawal by Subject|8
193072|NCT00387764|656328|P1|Overall Study|Adverse Event|12
193073|NCT00387725|656356|P4|Overall Study|Parent/legal guardian request|1
193074|NCT00387725|656357|P3|Overall Study|Parent/legal guardian request|1
193075|NCT00387725|656358|P2|Overall Study|Parent/legal guardian request|0
193076|NCT00387725|656359|P1|Overall Study|Parent/legal guardian request|0
193077|NCT00387725|656356|P4|Overall Study|Withdrawal by Subject|0
193078|NCT00387725|656357|P3|Overall Study|Withdrawal by Subject|1
193079|NCT00387725|656358|P2|Overall Study|Withdrawal by Subject|0
193080|NCT00387725|656359|P1|Overall Study|Withdrawal by Subject|1
193081|NCT00387725|656356|P4|Overall Study|Protocol Violation|0
193082|NCT00387725|656357|P3|Overall Study|Protocol Violation|0
193083|NCT00387725|656358|P2|Overall Study|Protocol Violation|1
193084|NCT00387725|656359|P1|Overall Study|Protocol Violation|0
193085|NCT00387725|656356|P4|Overall Study|Adverse Event|1
193086|NCT00387725|656357|P3|Overall Study|Adverse Event|0
193087|NCT00387725|656358|P2|Overall Study|Adverse Event|0
193088|NCT00387725|656359|P1|Overall Study|Adverse Event|0
193089|NCT00387712|656379|P2|Overall Study|Withdrawal by Subject|12
193090|NCT00387712|656380|P1|Overall Study|Withdrawal by Subject|6
193091|NCT00387712|656379|P2|Overall Study|Lost to Follow-up|20
193092|NCT00387712|656380|P1|Overall Study|Lost to Follow-up|17
193093|NCT00387712|656379|P2|Overall Study|Physician Decision|4
193094|NCT00387712|656380|P1|Overall Study|Physician Decision|6
193095|NCT00387647|656411|P1|Overall Study|Death|18
193096|NCT00387426|656451|P1|Overall Study|Disease Progression|3
193097|NCT00387426|656451|P1|Overall Study|Toxicities|4
193098|NCT00387426|656451|P1|Overall Study|Lack of Response|7
193099|NCT00387348|656458|P3|Overall Study|Adverse Event|1
193100|NCT00387348|656459|P2|Overall Study|Adverse Event|0
193101|NCT00387348|656460|P1|Overall Study|Adverse Event|1
193102|NCT00387348|656458|P3|Overall Study|Withdrawal by Subject|2
193103|NCT00387348|656459|P2|Overall Study|Withdrawal by Subject|2
193104|NCT00387348|656460|P1|Overall Study|Withdrawal by Subject|0
193105|NCT00387348|656458|P3|Overall Study|Physician Decision|1
193106|NCT00387348|656459|P2|Overall Study|Physician Decision|0
193107|NCT00387348|656460|P1|Overall Study|Physician Decision|1
193108|NCT00387348|656458|P3|Overall Study|Death|0
193109|NCT00387348|656459|P2|Overall Study|Death|1
193110|NCT00387348|656460|P1|Overall Study|Death|1
193111|NCT00387153|656489|P1|Overall Study|Lack of Response|4
193112|NCT00387153|656489|P1|Overall Study|Disease Progression|3
193113|NCT00387153|656489|P1|Overall Study|Adverse Event|1
193114|NCT00387127|656495|P2|Overall Study|Sponsor Unblinded|0
193115|NCT00387127|656496|P1|Overall Study|Sponsor Unblinded|1
193116|NCT00387127|656495|P2|Overall Study|Serious Adverse Event|1
193117|NCT00387127|656496|P1|Overall Study|Serious Adverse Event|1
193118|NCT00387127|656495|P2|Overall Study|Required by Protocol Amendment #4|10
193119|NCT00387127|656496|P1|Overall Study|Required by Protocol Amendment #4|12
193120|NCT00387127|656495|P2|Overall Study|Withdrawal by Subject|2
193121|NCT00387127|656496|P1|Overall Study|Withdrawal by Subject|3
193122|NCT00387127|656495|P2|Overall Study|Physician Decision|1
193123|NCT00387127|656496|P1|Overall Study|Physician Decision|0
193124|NCT00387127|656495|P2|Overall Study|Death|16
193125|NCT00387127|656496|P1|Overall Study|Death|16
193126|NCT00387127|656495|P2|Overall Study|Lost to Follow-up|4
193127|NCT00387127|656496|P1|Overall Study|Lost to Follow-up|0
193128|NCT00387088|656538|P2|Overall Study|Other|52
193129|NCT00387088|656539|P1|Overall Study|Other|58
193130|NCT00387088|656538|P2|Overall Study|Lost to Follow-up|28
193131|NCT00387088|656539|P1|Overall Study|Lost to Follow-up|22
193132|NCT00387088|656538|P2|Overall Study|Lack of Efficacy|67
193133|NCT00387088|656539|P1|Overall Study|Lack of Efficacy|28
193134|NCT00387088|656538|P2|Overall Study|Withdrawal by Subject|35
193135|NCT00387088|656539|P1|Overall Study|Withdrawal by Subject|20
193136|NCT00387088|656538|P2|Overall Study|Protocol Violation|35
193137|NCT00387088|656539|P1|Overall Study|Protocol Violation|47
193138|NCT00387088|656538|P2|Overall Study|Adverse Event|156
193139|NCT00387088|656539|P1|Overall Study|Adverse Event|143
193140|NCT00387010|656596|P1|Treatment Period|Participant reported study drug stolen|1
193141|NCT00387010|656596|P1|Treatment Period|Noncompliance with study procedures|3
193142|NCT00387010|656596|P1|Treatment Period|Noncompliance with study medication|2
193143|NCT00387010|656596|P1|Treatment Period|Withdrawal by Subject|1
193144|NCT00387010|656596|P1|Treatment Period|Adverse Event|4
193145|NCT00387010|656596|P1|Dose Titration Period|Noncompliance with study procedures|7
193146|NCT00387010|656596|P1|Dose Titration Period|Noncompliance with study medication|8
193147|NCT00387010|656596|P1|Dose Titration Period|Lost to Follow-up|2
193148|NCT00387010|656596|P1|Dose Titration Period|Protocol Violation|1
193149|NCT00387010|656596|P1|Dose Titration Period|Withdrawal by Subject|3
193150|NCT00387010|656596|P1|Dose Titration Period|Lack of Efficacy|5
193151|NCT00387010|656596|P1|Dose Titration Period|Adverse Event|12
193152|NCT00386776|656623|P1|Overall Study|Withdrawal by Subject|8
193153|NCT00386607|656633|P2|Extension|Unsatisfactory therapeutic effect|1
193154|NCT00386607|656634|P1|Extension|Unsatisfactory therapeutic effect|0
193155|NCT00386607|656633|P2|Extension|Patient withdrew consent|5
193156|NCT00386607|656634|P1|Extension|Patient withdrew consent|0
193157|NCT00386607|656633|P2|Extension|Lost to Follow-up|3
193158|NCT00386607|656634|P1|Extension|Lost to Follow-up|0
193159|NCT00386607|656633|P2|Extension|Administrative problems|1
193160|NCT00386607|656634|P1|Extension|Administrative problems|0
193161|NCT00386607|656633|P2|Extension|Abnormal laboratory value(s)|1
193162|NCT00386607|656634|P1|Extension|Abnormal laboratory value(s)|0
193163|NCT00386607|656633|P2|Extension|Adverse Event|6
193164|NCT00386607|656634|P1|Extension|Adverse Event|0
193165|NCT00386607|656633|P2|Core|Protocol Deviation|0
193166|NCT00386607|656634|P1|Core|Protocol Deviation|6
193167|NCT00386607|656633|P2|Core|Administrative problems|0
193168|NCT00386607|656634|P1|Core|Administrative problems|1
193169|NCT00386607|656633|P2|Core|Lost to Follow-up|0
193170|NCT00386607|656634|P1|Core|Lost to Follow-up|23
193171|NCT00386607|656633|P2|Core|Patient withdrew consent|0
193172|NCT00386607|656634|P1|Core|Patient withdrew consent|15
193173|NCT00386607|656633|P2|Core|Condition no longer requires study drug|0
193174|NCT00386607|656634|P1|Core|Condition no longer requires study drug|4
193175|NCT00386607|656633|P2|Core|Unsatisfactory therapeutic effect|0
193176|NCT00386607|656634|P1|Core|Unsatisfactory therapeutic effect|23
193177|NCT00386607|656633|P2|Core|Abnormal laboratory value(s)|0
193178|NCT00386607|656634|P1|Core|Abnormal laboratory value(s)|3
193179|NCT00386607|656633|P2|Core|Adverse Event|0
193180|NCT00386607|656634|P1|Core|Adverse Event|40
193181|NCT00386425|656662|P3|Overall Study|Withdrawal by Subject|0
193182|NCT00386425|656663|P2|Overall Study|Withdrawal by Subject|1
193183|NCT00386425|656664|P1|Overall Study|Withdrawal by Subject|0
193184|NCT00386425|656662|P3|Overall Study|Physician Decision|0
193185|NCT00386425|656663|P2|Overall Study|Physician Decision|0
193186|NCT00386425|656664|P1|Overall Study|Physician Decision|3
193187|NCT00386360|656690|P2|Overall Study|Did not take any study medication|2
193188|NCT00386360|656691|P1|Overall Study|Did not take any study medication|0
193189|NCT00386360|656690|P2|Overall Study|Withdrawal by Subject|6
193190|NCT00386360|656691|P1|Overall Study|Withdrawal by Subject|3
193191|NCT00386360|656690|P2|Overall Study|Protocol Violation|3
193192|NCT00386360|656691|P1|Overall Study|Protocol Violation|0
193193|NCT00386360|656690|P2|Overall Study|Lost to Follow-up|2
193194|NCT00386360|656691|P1|Overall Study|Lost to Follow-up|0
193195|NCT00386360|656690|P2|Overall Study|Physician Decision|2
193196|NCT00386360|656691|P1|Overall Study|Physician Decision|2
193197|NCT00386360|656690|P2|Overall Study|Adverse Event|2
193198|NCT00386360|656691|P1|Overall Study|Adverse Event|4
193199|NCT00386334|656725|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
193200|NCT00386334|656726|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
193201|NCT00386334|656725|P2|Double Blind Period|Other|3
193202|NCT00386334|656726|P1|Double Blind Period|Other|3
193203|NCT00386334|656725|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
193204|NCT00386334|656726|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
193205|NCT00386334|656725|P2|Double Blind Period|Lack of Efficacy|11
193206|NCT00386334|656726|P1|Double Blind Period|Lack of Efficacy|20
193207|NCT00386334|656725|P2|Double Blind Period|Withdrawal by Subject|13
193208|NCT00386334|656726|P1|Double Blind Period|Withdrawal by Subject|9
193209|NCT00386334|656725|P2|Double Blind Period|Protocol Violation|1
193210|NCT00386334|656726|P1|Double Blind Period|Protocol Violation|1
193211|NCT00386334|656725|P2|Double Blind Period|Adverse Event|14
193212|NCT00386334|656726|P1|Double Blind Period|Adverse Event|9
193213|NCT00386308|656870|P2|Overall Study|Other Event|1
193214|NCT00386308|656871|P1|Overall Study|Other Event|8
193215|NCT00386308|656870|P2|Overall Study|Withdrawal by Subject|2
193216|NCT00386308|656871|P1|Overall Study|Withdrawal by Subject|6
193217|NCT00386308|656870|P2|Overall Study|Lost to Follow-up|6
193218|NCT00386308|656871|P1|Overall Study|Lost to Follow-up|10
193219|NCT00386308|656870|P2|Overall Study|Lack of Efficacy|2
193220|NCT00386308|656871|P1|Overall Study|Lack of Efficacy|0
193221|NCT00386308|656870|P2|Overall Study|Protocol Violation|5
193222|NCT00386308|656871|P1|Overall Study|Protocol Violation|2
193223|NCT00386308|656870|P2|Overall Study|Adverse Event|3
193224|NCT00386308|656871|P1|Overall Study|Adverse Event|3
193225|NCT00386152|656918|P3|Overall Study|Withdrawal by Subject|10
193226|NCT00386152|656919|P2|Overall Study|Withdrawal by Subject|6
193227|NCT00386152|656920|P1|Overall Study|Withdrawal by Subject|3
193228|NCT00386152|656918|P3|Overall Study|Protocol Violation|2
193229|NCT00386152|656919|P2|Overall Study|Protocol Violation|5
193230|NCT00386152|656920|P1|Overall Study|Protocol Violation|3
193231|NCT00386152|656918|P3|Overall Study|Completed chemotherapy|1
193232|NCT00386152|656919|P2|Overall Study|Completed chemotherapy|5
193233|NCT00386152|656920|P1|Overall Study|Completed chemotherapy|4
193234|NCT00386152|656918|P3|Overall Study|Lost to Follow-up|0
193235|NCT00386152|656919|P2|Overall Study|Lost to Follow-up|0
193236|NCT00386152|656920|P1|Overall Study|Lost to Follow-up|1
193237|NCT00386152|656918|P3|Overall Study|Physician Decision|4
193238|NCT00386152|656919|P2|Overall Study|Physician Decision|10
193239|NCT00386152|656920|P1|Overall Study|Physician Decision|13
193240|NCT00386152|656918|P3|Overall Study|Disease progression|5
193241|NCT00386152|656919|P2|Overall Study|Disease progression|4
193242|NCT00386152|656920|P1|Overall Study|Disease progression|7
193243|NCT00386152|656918|P3|Overall Study|Death|1
193244|NCT00386152|656919|P2|Overall Study|Death|0
193245|NCT00386152|656920|P1|Overall Study|Death|3
193246|NCT00386152|656918|P3|Overall Study|Chang from original chemo stratification|6
193247|NCT00386152|656919|P2|Overall Study|Chang from original chemo stratification|5
193248|NCT00386152|656920|P1|Overall Study|Chang from original chemo stratification|4
193249|NCT00386152|656918|P3|Overall Study|Adverse Event|4
193250|NCT00386152|656919|P2|Overall Study|Adverse Event|5
193251|NCT00386152|656920|P1|Overall Study|Adverse Event|6
193252|NCT00386100|656939|P2|Overall Study|Participant randomized in error|0
193253|NCT00386100|656940|P1|Overall Study|Participant randomized in error|1
193254|NCT00386100|656939|P2|Overall Study|Hb1Ac >8%|1
193255|NCT00386100|656940|P1|Overall Study|Hb1Ac >8%|0
193256|NCT00386100|656939|P2|Overall Study|Out of country for 5 months|0
193257|NCT00386100|656940|P1|Overall Study|Out of country for 5 months|1
193258|NCT00386100|656939|P2|Overall Study|Positive pregnancy test|3
193259|NCT00386100|656940|P1|Overall Study|Positive pregnancy test|1
193260|NCT00386100|656939|P2|Overall Study|Osteoporosis|1
193261|NCT00386100|656940|P1|Overall Study|Osteoporosis|0
193262|NCT00386100|656939|P2|Overall Study|7.6% bone loss|0
193263|NCT00386100|656940|P1|Overall Study|7.6% bone loss|1
193264|NCT00386100|656939|P2|Overall Study|DBP 93 mmHg at randomization|0
193265|NCT00386100|656940|P1|Overall Study|DBP 93 mmHg at randomization|1
193266|NCT00386100|656939|P2|Overall Study|Bone loss by DXA bone scan|0
193267|NCT00386100|656940|P1|Overall Study|Bone loss by DXA bone scan|1
193268|NCT00386100|656939|P2|Overall Study|Bad metabolic control & patient security|0
193269|NCT00386100|656940|P1|Overall Study|Bad metabolic control & patient security|1
193270|NCT00386100|656939|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
193271|NCT00386100|656940|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
193272|NCT00386100|656939|P2|Overall Study|Participant's PCP wanted to stop drug|0
193273|NCT00386100|656940|P1|Overall Study|Participant's PCP wanted to stop drug|1
193274|NCT00386100|656939|P2|Overall Study|Didn't meet entry criteria|1
193275|NCT00386100|656940|P1|Overall Study|Didn't meet entry criteria|1
193276|NCT00386100|656939|P2|Overall Study|Excessive bone loss vs. baseline value|1
193277|NCT00386100|656940|P1|Overall Study|Excessive bone loss vs. baseline value|0
193278|NCT00386100|656939|P2|Overall Study|Participant moving out of state|0
193279|NCT00386100|656940|P1|Overall Study|Participant moving out of state|2
193280|NCT00386100|656939|P2|Overall Study|Participant's concern due to CPK levels|0
193281|NCT00386100|656940|P1|Overall Study|Participant's concern due to CPK levels|1
193282|NCT00386100|656939|P2|Overall Study|Laboratory findings|0
193283|NCT00386100|656940|P1|Overall Study|Laboratory findings|1
193284|NCT00386100|656939|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
193285|NCT00386100|656940|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
193286|NCT00386100|656939|P2|Overall Study|Consecutive elevated Hba1C|0
193287|NCT00386100|656940|P1|Overall Study|Consecutive elevated Hba1C|1
193288|NCT00386100|656939|P2|Overall Study|BMD <2.5|0
193289|NCT00386100|656940|P1|Overall Study|BMD <2.5|1
193290|NCT00386100|656939|P2|Overall Study|Bone mass density (BMD) loss >6%|4
193291|NCT00386100|656940|P1|Overall Study|Bone mass density (BMD) loss >6%|4
193292|NCT00386100|656939|P2|Overall Study|Withdrawal by Subject|31
193293|NCT00386100|656940|P1|Overall Study|Withdrawal by Subject|32
193294|NCT00386100|656939|P2|Overall Study|Protocol Violation|3
193295|NCT00386100|656940|P1|Overall Study|Protocol Violation|5
193296|NCT00386100|656939|P2|Overall Study|Non-compliance|19
193297|NCT00386100|656940|P1|Overall Study|Non-compliance|18
193298|NCT00386100|656939|P2|Overall Study|Lost to Follow-up|29
193299|NCT00386100|656940|P1|Overall Study|Lost to Follow-up|29
193300|NCT00386100|656939|P2|Overall Study|Insufficient therapeutic effect|6
193301|NCT00386100|656940|P1|Overall Study|Insufficient therapeutic effect|30
193302|NCT00386100|656939|P2|Overall Study|Death|1
193303|NCT00386100|656940|P1|Overall Study|Death|0
193304|NCT00386100|656939|P2|Overall Study|Adverse Event|25
193305|NCT00386100|656940|P1|Overall Study|Adverse Event|15
193306|NCT00386100|656939|P2|Overall Study|Did not receive study medication|4
193307|NCT00386100|656940|P1|Overall Study|Did not receive study medication|6
193308|NCT00386022|657004|P2|Plus Estrogen|Adverse Event|1
193309|NCT00386022|657005|P1|Plus Estrogen|Adverse Event|0
193310|NCT00386022|657004|P2|Plus Estrogen|Lost to Follow-up|0
193311|NCT00386022|657005|P1|Plus Estrogen|Lost to Follow-up|2
193312|NCT00386009|657015|P2|Overall Study|Withdrawal by Subject|4
193313|NCT00386009|657016|P1|Overall Study|Withdrawal by Subject|5
193314|NCT00386009|657015|P2|Overall Study|Sponsor Decision|1
193315|NCT00386009|657016|P1|Overall Study|Sponsor Decision|1
193316|NCT00386009|657015|P2|Overall Study|Protocol Violation|0
193317|NCT00386009|657016|P1|Overall Study|Protocol Violation|1
193318|NCT00386009|657015|P2|Overall Study|Lost to Follow-up|1
193319|NCT00386009|657016|P1|Overall Study|Lost to Follow-up|1
193320|NCT00386009|657015|P2|Overall Study|Entry Criteria Not Met|2
193321|NCT00386009|657016|P1|Overall Study|Entry Criteria Not Met|0
193322|NCT00386009|657015|P2|Overall Study|Death|0
193323|NCT00386009|657016|P1|Overall Study|Death|1
193324|NCT00386009|657015|P2|Overall Study|Adverse Event|2
193325|NCT00386009|657016|P1|Overall Study|Adverse Event|0
193326|NCT00385944|657061|P3|2nd Maintenance Dose Period|Invalid PD Data|0
193327|NCT00385944|657062|P2|2nd Maintenance Dose Period|Invalid PD Data|3
193328|NCT00385944|657063|P1|2nd Maintenance Dose Period|Invalid PD Data|2
193329|NCT00385944|657061|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
193330|NCT00385944|657062|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
193331|NCT00385944|657063|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
193332|NCT00385944|657061|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
193333|NCT00385944|657062|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
193334|NCT00385944|657063|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
193335|NCT00385944|657061|P3|1st Maintenance Dose Period|Physician Decision|0
193336|NCT00385944|657062|P2|1st Maintenance Dose Period|Physician Decision|0
193337|NCT00385944|657063|P1|1st Maintenance Dose Period|Physician Decision|1
193338|NCT00385918|657106|P3|Intervention Phase After Randomization|Lost to Follow-up|0
193339|NCT00385918|657107|P2|Intervention Phase After Randomization|Lost to Follow-up|0
193340|NCT00385918|657108|P1|Intervention Phase After Randomization|Lost to Follow-up|1
193341|NCT00385918|657106|P3|Intervention Phase After Randomization|Physician Decision|0
193342|NCT00385918|657107|P2|Intervention Phase After Randomization|Physician Decision|0
193343|NCT00385918|657108|P1|Intervention Phase After Randomization|Physician Decision|1
193344|NCT00385918|657106|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
193345|NCT00385918|657107|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
193346|NCT00385918|657108|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
193347|NCT00385918|657106|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
193348|NCT00385918|657107|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
193349|NCT00385918|657108|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
193350|NCT00385918|657106|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
193351|NCT00385918|657107|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
193352|NCT00385918|657108|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
193353|NCT00385918|657106|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
193354|NCT00385918|657107|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
193355|NCT00385918|657108|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
193356|NCT00385840|657132|P2|Overall Study|Lost to Follow-up|13
193357|NCT00385840|657133|P1|Overall Study|Lost to Follow-up|3
193358|NCT00385840|657132|P2|Overall Study|Adverse Event|1
193359|NCT00385840|657133|P1|Overall Study|Adverse Event|1
193360|NCT00385827|657156|P3|Part 2|Other|21
193361|NCT00385827|657157|P2|Part 2|Other|11
193362|NCT00385827|657158|P1|Part 2|Other|0
193363|NCT00385827|657156|P3|Part 2|Randomized but not treated|2
193364|NCT00385827|657157|P2|Part 2|Randomized but not treated|2
193365|NCT00385827|657158|P1|Part 2|Randomized but not treated|0
193366|NCT00385827|657156|P3|Part 2|Lack of Efficacy|13
193367|NCT00385827|657157|P2|Part 2|Lack of Efficacy|14
193368|NCT00385827|657158|P1|Part 2|Lack of Efficacy|0
193369|NCT00385827|657156|P3|Part 2|Death|2
193370|NCT00385827|657157|P2|Part 2|Death|0
193371|NCT00385827|657158|P1|Part 2|Death|0
193372|NCT00385827|657156|P3|Part 2|Adverse Event|10
193373|NCT00385827|657157|P2|Part 2|Adverse Event|6
193374|NCT00385827|657158|P1|Part 2|Adverse Event|0
193375|NCT00385827|657156|P3|Part 1|Other|0
193376|NCT00385827|657157|P2|Part 1|Other|0
193377|NCT00385827|657158|P1|Part 1|Other|1
193378|NCT00385827|657156|P3|Part 1|Lack of Efficacy|0
193379|NCT00385827|657157|P2|Part 1|Lack of Efficacy|0
193380|NCT00385827|657158|P1|Part 1|Lack of Efficacy|5
193381|NCT00385827|657156|P3|Part 1|Death|0
193382|NCT00385827|657157|P2|Part 1|Death|0
193383|NCT00385827|657158|P1|Part 1|Death|2
193384|NCT00385827|657156|P3|Part 1|Adverse Event|0
193385|NCT00385827|657157|P2|Part 1|Adverse Event|0
193386|NCT00385827|657158|P1|Part 1|Adverse Event|1
193387|NCT00385762|657202|P1|Overall Study|Lost to Follow-up|1
193388|NCT00385762|657202|P1|Overall Study|Adverse Event|1
193389|NCT00385736|657212|P3|Safety Analysis Set|Other|4
193390|NCT00385736|657213|P2|Safety Analysis Set|Other|4
193391|NCT00385736|657214|P1|Safety Analysis Set|Other|1
193392|NCT00385736|657212|P3|Safety Analysis Set|Protocol Violation|6
193393|NCT00385736|657213|P2|Safety Analysis Set|Protocol Violation|1
193394|NCT00385736|657214|P1|Safety Analysis Set|Protocol Violation|2
193395|NCT00385736|657212|P3|Safety Analysis Set|Lack of Efficacy|31
193396|NCT00385736|657213|P2|Safety Analysis Set|Lack of Efficacy|16
193397|NCT00385736|657214|P1|Safety Analysis Set|Lack of Efficacy|38
193398|NCT00385736|657212|P3|Safety Analysis Set|Lost to Follow-up|2
193399|NCT00385736|657213|P2|Safety Analysis Set|Lost to Follow-up|2
193400|NCT00385736|657214|P1|Safety Analysis Set|Lost to Follow-up|0
193401|NCT00385736|657212|P3|Safety Analysis Set|Withdrawal by Subject|14
193402|NCT00385736|657213|P2|Safety Analysis Set|Withdrawal by Subject|6
193403|NCT00385736|657214|P1|Safety Analysis Set|Withdrawal by Subject|6
193404|NCT00385736|657212|P3|Safety Analysis Set|Adverse Event|23
193405|NCT00385736|657213|P2|Safety Analysis Set|Adverse Event|15
193406|NCT00385736|657214|P1|Safety Analysis Set|Adverse Event|23
193407|NCT00385736|657212|P3|Efficacy Analysis Set - Maintenance|Other|4
193408|NCT00385736|657213|P2|Efficacy Analysis Set - Maintenance|Other|4
193409|NCT00385736|657214|P1|Efficacy Analysis Set - Maintenance|Other|0
193410|NCT00385736|657212|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
193411|NCT00385736|657213|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
193412|NCT00385736|657214|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
193413|NCT00385736|657212|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
193414|NCT00385736|657213|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
193415|NCT00385736|657214|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
193416|NCT00385736|657212|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
193417|NCT00385736|657213|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
193418|NCT00385736|657214|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
193419|NCT00385736|657212|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
193420|NCT00385736|657213|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
193421|NCT00385736|657214|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
193422|NCT00385736|657212|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
193423|NCT00385736|657213|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
193424|NCT00385736|657214|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
193425|NCT00385736|657212|P3|Efficacy Analysis Set - Induction|Other|1
193426|NCT00385736|657213|P2|Efficacy Analysis Set - Induction|Other|0
193427|NCT00385736|657214|P1|Efficacy Analysis Set - Induction|Other|0
193428|NCT00385736|657212|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
193429|NCT00385736|657213|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
193430|NCT00385736|657214|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
193431|NCT00385736|657212|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
193432|NCT00385736|657213|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
193433|NCT00385736|657214|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
193434|NCT00385736|657212|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
193435|NCT00385736|657213|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
193436|NCT00385736|657214|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
193437|NCT00385736|657212|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
193438|NCT00385736|657213|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
193439|NCT00385736|657214|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
193440|NCT00385736|657212|P3|Efficacy Analysis Set - Induction|Adverse Event|4
193441|NCT00385736|657213|P2|Efficacy Analysis Set - Induction|Adverse Event|6
193442|NCT00385736|657214|P1|Efficacy Analysis Set - Induction|Adverse Event|5
193443|NCT00385723|657259|P3|Overall Study|Withdrawal by Subject|2
193444|NCT00385723|657260|P2|Overall Study|Withdrawal by Subject|0
193445|NCT00385723|657261|P1|Overall Study|Withdrawal by Subject|1
193446|NCT00385723|657259|P3|Overall Study|Lost to Follow-up|0
193447|NCT00385723|657260|P2|Overall Study|Lost to Follow-up|1
193448|NCT00385723|657261|P1|Overall Study|Lost to Follow-up|1
193449|NCT00385684|657275|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
193450|NCT00385684|657276|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
193451|NCT00385684|657275|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
193452|NCT00385684|657276|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
193453|NCT00385684|657275|P2|FIRST INTERVENTION OF PHASE A|Death|0
193454|NCT00385684|657276|P1|FIRST INTERVENTION OF PHASE A|Death|1
193455|NCT00385671|657285|P3|Overall Study|Withdrawal by Subject|4
193456|NCT00385671|657286|P2|Overall Study|Withdrawal by Subject|4
193457|NCT00385671|657287|P1|Overall Study|Withdrawal by Subject|4
193458|NCT00385671|657285|P3|Overall Study|Sponsor Decision|1
193459|NCT00385671|657286|P2|Overall Study|Sponsor Decision|2
193460|NCT00385671|657287|P1|Overall Study|Sponsor Decision|2
193461|NCT00385671|657285|P3|Overall Study|Protocol Violation|1
193462|NCT00385671|657286|P2|Overall Study|Protocol Violation|2
193463|NCT00385671|657287|P1|Overall Study|Protocol Violation|5
193464|NCT00385671|657285|P3|Overall Study|Physician Decision|2
193465|NCT00385671|657286|P2|Overall Study|Physician Decision|1
193466|NCT00385671|657287|P1|Overall Study|Physician Decision|2
193467|NCT00385671|657285|P3|Overall Study|Lost to Follow-up|5
193468|NCT00385671|657286|P2|Overall Study|Lost to Follow-up|6
193469|NCT00385671|657287|P1|Overall Study|Lost to Follow-up|6
193470|NCT00385671|657285|P3|Overall Study|Lack of Efficacy|5
193471|NCT00385671|657286|P2|Overall Study|Lack of Efficacy|9
193472|NCT00385671|657287|P1|Overall Study|Lack of Efficacy|5
193473|NCT00385671|657285|P3|Overall Study|Adverse Event|18
193474|NCT00385671|657286|P2|Overall Study|Adverse Event|27
193475|NCT00385671|657287|P1|Overall Study|Adverse Event|14
193476|NCT00385593|657443|P2|Overall Study|Incorrect randomization|1
193477|NCT00385593|657444|P1|Overall Study|Incorrect randomization|0
193478|NCT00385593|657443|P2|Overall Study|Incorrect inclusion|0
193479|NCT00385593|657444|P1|Overall Study|Incorrect inclusion|2
193480|NCT00385593|657443|P2|Overall Study|Several reasons|15
193481|NCT00385593|657444|P1|Overall Study|Several reasons|17
193482|NCT00385593|657443|P2|Overall Study|Protocol Violation|4
193483|NCT00385593|657444|P1|Overall Study|Protocol Violation|7
193484|NCT00385593|657443|P2|Overall Study|Lost to Follow-up|8
193485|NCT00385593|657444|P1|Overall Study|Lost to Follow-up|12
193486|NCT00385593|657443|P2|Overall Study|Withdrawal by Subject|7
193487|NCT00385593|657444|P1|Overall Study|Withdrawal by Subject|17
193488|NCT00385593|657443|P2|Overall Study|Adverse Event|2
193489|NCT00385593|657444|P1|Overall Study|Adverse Event|3
193490|NCT00385541|657554|P2|Overall Study|severe pain, clinician requested unblind|1
193491|NCT00385541|657555|P1|Overall Study|severe pain, clinician requested unblind|0
193492|NCT00385203|657602|P2|Overall Study|Incorrect enrollment|0
193493|NCT00385203|657603|P1|Overall Study|Incorrect enrollment|2
193494|NCT00385203|657602|P2|Overall Study|Condition under investigation worsened|3
193495|NCT00385203|657603|P1|Overall Study|Condition under investigation worsened|18
193496|NCT00385203|657602|P2|Overall Study|Death|0
193497|NCT00385203|657603|P1|Overall Study|Death|1
193498|NCT00385203|657602|P2|Overall Study|Adverse Event|4
193499|NCT00385203|657603|P1|Overall Study|Adverse Event|5
193500|NCT00384956|657691|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
193501|NCT00384930|657708|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
193502|NCT00384930|657709|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
193503|NCT00384930|657710|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
193504|NCT00384930|657711|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
193505|NCT00384930|657712|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
193506|NCT00384930|657708|P5|Overall Study|Withdrawal by Subject|16
193507|NCT00384930|657709|P4|Overall Study|Withdrawal by Subject|6
193508|NCT00384930|657710|P3|Overall Study|Withdrawal by Subject|7
193509|NCT00384930|657711|P2|Overall Study|Withdrawal by Subject|7
193510|NCT00384930|657712|P1|Overall Study|Withdrawal by Subject|9
193511|NCT00384930|657708|P5|Overall Study|Sponsor Decision|0
193512|NCT00384930|657709|P4|Overall Study|Sponsor Decision|5
193513|NCT00384930|657710|P3|Overall Study|Sponsor Decision|0
193514|NCT00384930|657711|P2|Overall Study|Sponsor Decision|4
193515|NCT00384930|657712|P1|Overall Study|Sponsor Decision|3
193516|NCT00384930|657708|P5|Overall Study|Protocol Violation|4
193517|NCT00384930|657709|P4|Overall Study|Protocol Violation|6
193518|NCT00384930|657710|P3|Overall Study|Protocol Violation|1
193519|NCT00384930|657711|P2|Overall Study|Protocol Violation|0
193520|NCT00384930|657712|P1|Overall Study|Protocol Violation|1
193521|NCT00384930|657708|P5|Overall Study|Physician Decision|1
193522|NCT00384930|657709|P4|Overall Study|Physician Decision|0
193523|NCT00384930|657710|P3|Overall Study|Physician Decision|1
193524|NCT00384930|657711|P2|Overall Study|Physician Decision|1
193525|NCT00384930|657712|P1|Overall Study|Physician Decision|0
193526|NCT00384930|657708|P5|Overall Study|Lost to Follow-up|6
193527|NCT00384930|657709|P4|Overall Study|Lost to Follow-up|4
193528|NCT00384930|657710|P3|Overall Study|Lost to Follow-up|0
193529|NCT00384930|657711|P2|Overall Study|Lost to Follow-up|3
193530|NCT00384930|657712|P1|Overall Study|Lost to Follow-up|5
193531|NCT00384930|657708|P5|Overall Study|Lack of Efficacy|2
193532|NCT00384930|657709|P4|Overall Study|Lack of Efficacy|1
193533|NCT00384930|657710|P3|Overall Study|Lack of Efficacy|2
193534|NCT00384930|657711|P2|Overall Study|Lack of Efficacy|1
193535|NCT00384930|657712|P1|Overall Study|Lack of Efficacy|1
193536|NCT00384930|657708|P5|Overall Study|Entry Criteria Not Met|4
193537|NCT00384930|657709|P4|Overall Study|Entry Criteria Not Met|8
193538|NCT00384930|657710|P3|Overall Study|Entry Criteria Not Met|7
193539|NCT00384930|657711|P2|Overall Study|Entry Criteria Not Met|6
193540|NCT00384930|657712|P1|Overall Study|Entry Criteria Not Met|2
193541|NCT00384930|657708|P5|Overall Study|Adverse Event|14
193542|NCT00384930|657709|P4|Overall Study|Adverse Event|11
193543|NCT00384930|657710|P3|Overall Study|Adverse Event|12
193544|NCT00384930|657711|P2|Overall Study|Adverse Event|4
193545|NCT00384930|657712|P1|Overall Study|Adverse Event|5
193546|NCT00384397|657822|P3|Overall Study|Withdrawal by Subject|15
193547|NCT00384397|657823|P2|Overall Study|Withdrawal by Subject|17
193548|NCT00384397|657824|P1|Overall Study|Withdrawal by Subject|14
193549|NCT00384397|657822|P3|Overall Study|Lost to Follow-up|3
193550|NCT00384397|657823|P2|Overall Study|Lost to Follow-up|13
193551|NCT00384397|657824|P1|Overall Study|Lost to Follow-up|11
193552|NCT00384397|657822|P3|Overall Study|Protocol Violation|13
193553|NCT00384397|657823|P2|Overall Study|Protocol Violation|15
193554|NCT00384397|657824|P1|Overall Study|Protocol Violation|7
193555|NCT00384397|657822|P3|Overall Study|Adverse Event|2
193556|NCT00384397|657823|P2|Overall Study|Adverse Event|1
193557|NCT00384397|657824|P1|Overall Study|Adverse Event|0
193558|NCT00384332|657843|P2|Overall Study|Lost to Follow-up|0
193559|NCT00384332|657844|P1|Overall Study|Lost to Follow-up|4
193560|NCT00384293|657854|P3|Post-randomization Period|Patient Randomized in Error|1
193561|NCT00384293|657855|P2|Post-randomization Period|Patient Randomized in Error|0
193562|NCT00384293|657856|P1|Post-randomization Period|Patient Randomized in Error|0
193563|NCT00384293|657854|P3|Post-randomization Period|Trial Termination|204
193564|NCT00384293|657855|P2|Post-randomization Period|Trial Termination|180
193565|NCT00384293|657856|P1|Post-randomization Period|Trial Termination|0
193566|NCT00384293|657854|P3|Post-randomization Period|Withdrawal by Subject|6
193567|NCT00384293|657855|P2|Post-randomization Period|Withdrawal by Subject|8
193568|NCT00384293|657856|P1|Post-randomization Period|Withdrawal by Subject|0
193569|NCT00384293|657854|P3|Post-randomization Period|Protocol Violation|0
193570|NCT00384293|657855|P2|Post-randomization Period|Protocol Violation|1
193571|NCT00384293|657856|P1|Post-randomization Period|Protocol Violation|0
193572|NCT00384293|657854|P3|Post-randomization Period|Lost to Follow-up|1
193573|NCT00384293|657855|P2|Post-randomization Period|Lost to Follow-up|2
193574|NCT00384293|657856|P1|Post-randomization Period|Lost to Follow-up|0
193575|NCT00384293|657854|P3|Post-randomization Period|Adverse Event|7
193576|NCT00384293|657855|P2|Post-randomization Period|Adverse Event|23
193577|NCT00384293|657856|P1|Post-randomization Period|Adverse Event|0
193578|NCT00384293|657854|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
193579|NCT00384293|657855|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
193580|NCT00384293|657856|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
193581|NCT00384293|657854|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
193582|NCT00384293|657855|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
193583|NCT00384293|657856|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
193584|NCT00384293|657854|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
193585|NCT00384293|657855|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
193586|NCT00384293|657856|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
193587|NCT00384293|657854|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
193588|NCT00384293|657855|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
193589|NCT00384293|657856|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
193590|NCT00384293|657854|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
193591|NCT00384293|657855|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
193592|NCT00384293|657856|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
193593|NCT00384293|657854|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
193594|NCT00384293|657855|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
193595|NCT00384293|657856|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
193596|NCT00384293|657854|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
193597|NCT00384293|657855|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
193598|NCT00384293|657856|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
193599|NCT00384189|657880|P4|Overall Study|Reason Not Specified|40
193600|NCT00384189|657881|P3|Overall Study|Reason Not Specified|58
193601|NCT00384189|657882|P2|Overall Study|Reason Not Specified|57
193602|NCT00384189|657883|P1|Overall Study|Reason Not Specified|50
193603|NCT00384176|657944|P3|Overall Study|Liver metastases, colon resec. planned|0
193604|NCT00384176|657945|P2|Overall Study|Liver metastases, colon resec. planned|0
193605|NCT00384176|657946|P1|Overall Study|Liver metastases, colon resec. planned|1
193606|NCT00384176|657944|P3|Overall Study|Physician Decision|0
193607|NCT00384176|657945|P2|Overall Study|Physician Decision|2
193608|NCT00384176|657946|P1|Overall Study|Physician Decision|0
193609|NCT00384176|657944|P3|Overall Study|Did not receive study treatment|1
193610|NCT00384176|657945|P2|Overall Study|Did not receive study treatment|1
193611|NCT00384176|657946|P1|Overall Study|Did not receive study treatment|0
193612|NCT00384176|657944|P3|Overall Study|Toxicity of treatment|0
193613|NCT00384176|657945|P2|Overall Study|Toxicity of treatment|0
193614|NCT00384176|657946|P1|Overall Study|Toxicity of treatment|1
193615|NCT00384176|657944|P3|Overall Study|Longer QTC as Visit 1|0
193616|NCT00384176|657945|P2|Overall Study|Longer QTC as Visit 1|0
193617|NCT00384176|657946|P1|Overall Study|Longer QTC as Visit 1|1
193618|NCT00384176|657944|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
193619|NCT00384176|657945|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
193620|NCT00384176|657946|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
193621|NCT00384176|657944|P3|Overall Study|Lost to Follow-up|4
193622|NCT00384176|657945|P2|Overall Study|Lost to Follow-up|18
193623|NCT00384176|657946|P1|Overall Study|Lost to Follow-up|16
193624|NCT00384176|657944|P3|Overall Study|Withdrawal by Subject|22
193625|NCT00384176|657945|P2|Overall Study|Withdrawal by Subject|48
193626|NCT00384176|657946|P1|Overall Study|Withdrawal by Subject|52
193627|NCT00384176|657944|P3|Overall Study|Death|105
193628|NCT00384176|657945|P2|Overall Study|Death|247
193629|NCT00384176|657946|P1|Overall Study|Death|239
193630|NCT00384085|657972|P3|Overall Study|Patient required surgery|0
193631|NCT00384085|657973|P2|Overall Study|Patient required surgery|1
193632|NCT00384085|657974|P1|Overall Study|Patient required surgery|0
193633|NCT00384085|657972|P3|Overall Study|Patient moved|1
193634|NCT00384085|657973|P2|Overall Study|Patient moved|0
193635|NCT00384085|657974|P1|Overall Study|Patient moved|1
193636|NCT00384085|657972|P3|Overall Study|Sponsor decision|1
193637|NCT00384085|657973|P2|Overall Study|Sponsor decision|2
193638|NCT00384085|657974|P1|Overall Study|Sponsor decision|1
193639|NCT00384085|657972|P3|Overall Study|Loss of site personnel|1
193640|NCT00384085|657973|P2|Overall Study|Loss of site personnel|0
193641|NCT00384085|657974|P1|Overall Study|Loss of site personnel|1
193642|NCT00384085|657972|P3|Overall Study|Physician Decision|0
193643|NCT00384085|657973|P2|Overall Study|Physician Decision|0
193644|NCT00384085|657974|P1|Overall Study|Physician Decision|1
193645|NCT00384085|657972|P3|Overall Study|Patient non-compliant|5
193646|NCT00384085|657973|P2|Overall Study|Patient non-compliant|4
193647|NCT00384085|657974|P1|Overall Study|Patient non-compliant|4
193648|NCT00384085|657972|P3|Overall Study|Withdrawal by Subject|29
193649|NCT00384085|657973|P2|Overall Study|Withdrawal by Subject|19
193650|NCT00384085|657974|P1|Overall Study|Withdrawal by Subject|14
193651|NCT00384085|657972|P3|Overall Study|Progressive Disease|0
193652|NCT00384085|657973|P2|Overall Study|Progressive Disease|1
193653|NCT00384085|657974|P1|Overall Study|Progressive Disease|0
193654|NCT00384085|657972|P3|Overall Study|Lost to Follow-up|10
193655|NCT00384085|657973|P2|Overall Study|Lost to Follow-up|9
193656|NCT00384085|657974|P1|Overall Study|Lost to Follow-up|9
193657|NCT00384085|657972|P3|Overall Study|Protocol Violation|2
193658|NCT00384085|657973|P2|Overall Study|Protocol Violation|2
193659|NCT00384085|657974|P1|Overall Study|Protocol Violation|2
193660|NCT00384085|657972|P3|Overall Study|No longer Requires Study Treatment|1
193661|NCT00384085|657973|P2|Overall Study|No longer Requires Study Treatment|0
193662|NCT00384085|657974|P1|Overall Study|No longer Requires Study Treatment|1
193663|NCT00384085|657972|P3|Overall Study|Lack of Efficacy|2
193664|NCT00384085|657973|P2|Overall Study|Lack of Efficacy|3
193665|NCT00384085|657974|P1|Overall Study|Lack of Efficacy|0
193666|NCT00384085|657972|P3|Overall Study|Adverse Event|4
193667|NCT00384085|657973|P2|Overall Study|Adverse Event|5
193668|NCT00384085|657974|P1|Overall Study|Adverse Event|5
193669|NCT00384059|658000|P2|Toddler Dose|Failed to return|1
193670|NCT00384059|658001|P1|Toddler Dose|Failed to return|0
193671|NCT00384059|658000|P2|Toddler Dose|Lost to Follow-up|1
193672|NCT00384059|658001|P1|Toddler Dose|Lost to Follow-up|1
193673|NCT00384059|658000|P2|After Infant Series|Lost to Follow-up|1
193674|NCT00384059|658001|P1|After Infant Series|Lost to Follow-up|0
193675|NCT00384059|658000|P2|After Infant Series|Physician Decision|1
193676|NCT00384059|658001|P1|After Infant Series|Physician Decision|0
193677|NCT00384059|658000|P2|After Infant Series|Adverse Event|1
193678|NCT00384059|658001|P1|After Infant Series|Adverse Event|0
193679|NCT00384059|658000|P2|After Infant Series|Failed to Return|2
193680|NCT00384059|658001|P1|After Infant Series|Failed to Return|0
193681|NCT00384059|658000|P2|After Infant Series|Withdrawal by Subject|2
193682|NCT00384059|658001|P1|After Infant Series|Withdrawal by Subject|2
193683|NCT00384059|658000|P2|After Infant Series|Protocol Violation|3
193684|NCT00384059|658001|P1|After Infant Series|Protocol Violation|2
193685|NCT00384059|658000|P2|Infant Series|Lost to Follow-up|1
193686|NCT00384059|658001|P1|Infant Series|Lost to Follow-up|0
193687|NCT00384059|658000|P2|Infant Series|Protocol Violation|2
193688|NCT00384059|658001|P1|Infant Series|Protocol Violation|1
193689|NCT00384059|658000|P2|Infant Series|Adverse Event|2
193690|NCT00384059|658001|P1|Infant Series|Adverse Event|1
193691|NCT00384059|658000|P2|Infant Series|Withdrawal by Subject|2
193692|NCT00384059|658001|P1|Infant Series|Withdrawal by Subject|2
193693|NCT00384059|658000|P2|Infant Series|Not consented|6
193694|NCT00384059|658001|P1|Infant Series|Not consented|2
193695|NCT00384033|658051|P4|Overall Study|Randomized but not treated|2
193696|NCT00384033|658052|P3|Overall Study|Randomized but not treated|10
193697|NCT00384033|658053|P2|Overall Study|Randomized but not treated|7
193698|NCT00384033|658054|P1|Overall Study|Randomized but not treated|3
193699|NCT00384033|658051|P4|Overall Study|Lack of Efficacy|1
193700|NCT00384033|658052|P3|Overall Study|Lack of Efficacy|3
193701|NCT00384033|658053|P2|Overall Study|Lack of Efficacy|3
193702|NCT00384033|658054|P1|Overall Study|Lack of Efficacy|7
193703|NCT00384033|658051|P4|Overall Study|Withdrawal by Subject|2
193704|NCT00384033|658052|P3|Overall Study|Withdrawal by Subject|5
193705|NCT00384033|658053|P2|Overall Study|Withdrawal by Subject|2
193706|NCT00384033|658054|P1|Overall Study|Withdrawal by Subject|6
193707|NCT00384033|658051|P4|Overall Study|Protocol Violation|6
193708|NCT00384033|658052|P3|Overall Study|Protocol Violation|5
193709|NCT00384033|658053|P2|Overall Study|Protocol Violation|0
193710|NCT00384033|658054|P1|Overall Study|Protocol Violation|5
193711|NCT00384033|658051|P4|Overall Study|Other|0
193712|NCT00384033|658052|P3|Overall Study|Other|0
193713|NCT00384033|658053|P2|Overall Study|Other|0
193714|NCT00384033|658054|P1|Overall Study|Other|2
193715|NCT00384033|658051|P4|Overall Study|Lost to Follow-up|7
193716|NCT00384033|658052|P3|Overall Study|Lost to Follow-up|7
193717|NCT00384033|658053|P2|Overall Study|Lost to Follow-up|12
193718|NCT00384033|658054|P1|Overall Study|Lost to Follow-up|6
193719|NCT00384033|658051|P4|Overall Study|Physician Decision|0
193720|NCT00384033|658052|P3|Overall Study|Physician Decision|0
193721|NCT00384033|658053|P2|Overall Study|Physician Decision|0
193722|NCT00384033|658054|P1|Overall Study|Physician Decision|1
193723|NCT00384033|658051|P4|Overall Study|Failed to return|2
193724|NCT00384033|658052|P3|Overall Study|Failed to return|2
193725|NCT00384033|658053|P2|Overall Study|Failed to return|3
193726|NCT00384033|658054|P1|Overall Study|Failed to return|1
193727|NCT00384033|658051|P4|Overall Study|Adverse Event|20
193728|NCT00384033|658052|P3|Overall Study|Adverse Event|11
193729|NCT00384033|658053|P2|Overall Study|Adverse Event|8
193730|NCT00384033|658054|P1|Overall Study|Adverse Event|10
193731|NCT00383786|658107|P2|Overall Study|Physician Decision|1
193732|NCT00383786|658108|P1|Overall Study|Physician Decision|0
193733|NCT00383786|658107|P2|Overall Study|Withdrawal by Subject|5
193734|NCT00383786|658108|P1|Overall Study|Withdrawal by Subject|2
193735|NCT00383786|658107|P2|Overall Study|Protocol Violation|6
193736|NCT00383786|658108|P1|Overall Study|Protocol Violation|2
193737|NCT00383721|658158|P5|26-Week Treatment Safety Extension|Administrative|0
193738|NCT00383721|658159|P4|26-Week Treatment Safety Extension|Administrative|1
193739|NCT00383721|658160|P3|26-Week Treatment Safety Extension|Administrative|3
193740|NCT00383721|658161|P2|26-Week Treatment Safety Extension|Administrative|2
193741|NCT00383721|658162|P1|26-Week Treatment Safety Extension|Administrative|1
193742|NCT00383721|658158|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
193743|NCT00383721|658159|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
193744|NCT00383721|658160|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
193745|NCT00383721|658161|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
193746|NCT00383721|658162|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
193747|NCT00383721|658158|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
193748|NCT00383721|658159|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
193749|NCT00383721|658160|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
193750|NCT00383721|658161|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
193751|NCT00383721|658162|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
193752|NCT00383721|658158|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
193753|NCT00383721|658159|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
193754|NCT00383721|658160|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
193755|NCT00383721|658161|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
193756|NCT00383721|658162|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
193757|NCT00383721|658158|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
193758|NCT00383721|658159|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
193759|NCT00383721|658160|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
193760|NCT00383721|658161|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
193761|NCT00383721|658162|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
193762|NCT00383721|658158|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
193763|NCT00383721|658159|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
193764|NCT00383721|658160|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
193765|NCT00383721|658161|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
193766|NCT00383721|658162|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
193767|NCT00383721|658158|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
193768|NCT00383721|658159|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
193769|NCT00383721|658160|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
193770|NCT00383721|658161|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
193771|NCT00383721|658162|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
193772|NCT00383721|658158|P5|26-Week Treatment Safety Extension|Adverse Event|0
193773|NCT00383721|658159|P4|26-Week Treatment Safety Extension|Adverse Event|1
193774|NCT00383721|658160|P3|26-Week Treatment Safety Extension|Adverse Event|10
193775|NCT00383721|658161|P2|26-Week Treatment Safety Extension|Adverse Event|7
193776|NCT00383721|658162|P1|26-Week Treatment Safety Extension|Adverse Event|6
193777|NCT00383721|658158|P5|26-Week Double-Blind Treatment Period|Ongoing|0
193778|NCT00383721|658159|P4|26-Week Double-Blind Treatment Period|Ongoing|0
193779|NCT00383721|658160|P3|26-Week Double-Blind Treatment Period|Ongoing|0
193780|NCT00383721|658161|P2|26-Week Double-Blind Treatment Period|Ongoing|0
193781|NCT00383721|658162|P1|26-Week Double-Blind Treatment Period|Ongoing|1
193782|NCT00383721|658158|P5|26-Week Double-Blind Treatment Period|Administrative|3
193783|NCT00383721|658159|P4|26-Week Double-Blind Treatment Period|Administrative|3
193784|NCT00383721|658160|P3|26-Week Double-Blind Treatment Period|Administrative|3
193785|NCT00383721|658161|P2|26-Week Double-Blind Treatment Period|Administrative|3
193786|NCT00383721|658162|P1|26-Week Double-Blind Treatment Period|Administrative|1
193787|NCT00383721|658158|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
193788|NCT00383721|658159|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
193789|NCT00383721|658160|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
193790|NCT00383721|658161|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
193791|NCT00383721|658162|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
193792|NCT00383721|658158|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
193793|NCT00383721|658159|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
193794|NCT00383721|658160|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
193795|NCT00383721|658161|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
193796|NCT00383721|658162|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
193797|NCT00383721|658158|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
193798|NCT00383721|658159|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
193799|NCT00383721|658160|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
193800|NCT00383721|658161|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
193801|NCT00383721|658162|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
193802|NCT00383721|658158|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
193803|NCT00383721|658159|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
193804|NCT00383721|658160|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
193805|NCT00383721|658161|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
193806|NCT00383721|658162|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
193807|NCT00383721|658158|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
193808|NCT00383721|658159|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
193809|NCT00383721|658160|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
193810|NCT00383721|658161|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
193811|NCT00383721|658162|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
193812|NCT00383721|658158|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
193813|NCT00383721|658159|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
193814|NCT00383721|658160|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
193815|NCT00383721|658161|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
193816|NCT00383721|658162|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
193817|NCT00383721|658158|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
193818|NCT00383721|658159|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
193819|NCT00383721|658160|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
193820|NCT00383721|658161|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
193821|NCT00383721|658162|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
193822|NCT00383552|658234|P4|Overall Study|Administrative|1
193823|NCT00383552|658235|P3|Overall Study|Administrative|1
193824|NCT00383552|658236|P2|Overall Study|Administrative|0
193825|NCT00383552|658237|P1|Overall Study|Administrative|1
193826|NCT00383552|658234|P4|Overall Study|Did not meet protocol eligibility|3
193827|NCT00383552|658235|P3|Overall Study|Did not meet protocol eligibility|2
193828|NCT00383552|658236|P2|Overall Study|Did not meet protocol eligibility|6
193829|NCT00383552|658237|P1|Overall Study|Did not meet protocol eligibility|8
193830|NCT00383552|658234|P4|Overall Study|Noncompliance with the protocol|10
193831|NCT00383552|658235|P3|Overall Study|Noncompliance with the protocol|8
193832|NCT00383552|658236|P2|Overall Study|Noncompliance with the protocol|6
193833|NCT00383552|658237|P1|Overall Study|Noncompliance with the protocol|11
193834|NCT00383552|658234|P4|Overall Study|Did not wish to continue (related)|3
193835|NCT00383552|658235|P3|Overall Study|Did not wish to continue (related)|2
193836|NCT00383552|658236|P2|Overall Study|Did not wish to continue (related)|0
193837|NCT00383552|658237|P1|Overall Study|Did not wish to continue (related)|1
193838|NCT00383552|658234|P4|Overall Study|Did not wish to continue (unrelated)|6
193839|NCT00383552|658235|P3|Overall Study|Did not wish to continue (unrelated)|5
193840|NCT00383552|658236|P2|Overall Study|Did not wish to continue (unrelated)|9
193841|NCT00383552|658237|P1|Overall Study|Did not wish to continue (unrelated)|4
193842|NCT00383552|658234|P4|Overall Study|Lost to Follow-up|1
193843|NCT00383552|658235|P3|Overall Study|Lost to Follow-up|5
193844|NCT00383552|658236|P2|Overall Study|Lost to Follow-up|1
193845|NCT00383552|658237|P1|Overall Study|Lost to Follow-up|0
193846|NCT00383552|658234|P4|Overall Study|Lack of Efficacy|42
193847|NCT00383552|658235|P3|Overall Study|Lack of Efficacy|29
193848|NCT00383552|658236|P2|Overall Study|Lack of Efficacy|13
193849|NCT00383552|658237|P1|Overall Study|Lack of Efficacy|4
193850|NCT00383552|658234|P4|Overall Study|Adverse Event|6
193851|NCT00383552|658235|P3|Overall Study|Adverse Event|9
193852|NCT00383552|658236|P2|Overall Study|Adverse Event|6
193853|NCT00383552|658237|P1|Overall Study|Adverse Event|7
193854|NCT00383500|658279|P3|Overall Study|Lost to Follow-up|2
193855|NCT00383500|658280|P2|Overall Study|Lost to Follow-up|0
193856|NCT00383500|658281|P1|Overall Study|Lost to Follow-up|0
193857|NCT00383500|658279|P3|Overall Study|Withdrawal by Subject|0
193858|NCT00383500|658280|P2|Overall Study|Withdrawal by Subject|3
193859|NCT00383500|658281|P1|Overall Study|Withdrawal by Subject|8
193860|NCT00383435|658297|P5|26-Week Treatment Safety Extension|Administrative|0
193861|NCT00383435|658298|P4|26-Week Treatment Safety Extension|Administrative|1
193862|NCT00383435|658299|P3|26-Week Treatment Safety Extension|Administrative|0
193863|NCT00383435|658300|P2|26-Week Treatment Safety Extension|Administrative|1
193864|NCT00383435|658301|P1|26-Week Treatment Safety Extension|Administrative|1
193865|NCT00383435|658297|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
193866|NCT00383435|658298|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
193867|NCT00383435|658299|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
193868|NCT00383435|658300|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
193869|NCT00383435|658301|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
193870|NCT00383435|658297|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
193871|NCT00383435|658298|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
193872|NCT00383435|658299|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
193873|NCT00383435|658300|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
193874|NCT00383435|658301|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
193875|NCT00383435|658297|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
193876|NCT00383435|658298|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
193877|NCT00383435|658299|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
193878|NCT00383435|658300|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
193879|NCT00383435|658301|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
193880|NCT00383435|658297|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
193881|NCT00383435|658298|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
193882|NCT00383435|658299|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
193883|NCT00383435|658300|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
193884|NCT00383435|658301|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
193885|NCT00383435|658297|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
193886|NCT00383435|658298|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
193887|NCT00383435|658299|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
193888|NCT00383435|658300|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
193889|NCT00383435|658301|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
193890|NCT00383435|658297|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
193891|NCT00383435|658298|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
193892|NCT00383435|658299|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
193893|NCT00383435|658300|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
193894|NCT00383435|658301|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
193895|NCT00383435|658297|P5|26-Week Treatment Safety Extension|Adverse Event|1
193896|NCT00383435|658298|P4|26-Week Treatment Safety Extension|Adverse Event|5
193897|NCT00383435|658299|P3|26-Week Treatment Safety Extension|Adverse Event|5
193898|NCT00383435|658300|P2|26-Week Treatment Safety Extension|Adverse Event|2
193899|NCT00383435|658301|P1|26-Week Treatment Safety Extension|Adverse Event|4
193900|NCT00383435|658297|P5|26-Week Double-Blind Treatment Period|Administrative|1
193901|NCT00383435|658298|P4|26-Week Double-Blind Treatment Period|Administrative|1
193902|NCT00383435|658299|P3|26-Week Double-Blind Treatment Period|Administrative|1
193903|NCT00383435|658300|P2|26-Week Double-Blind Treatment Period|Administrative|3
193904|NCT00383435|658301|P1|26-Week Double-Blind Treatment Period|Administrative|5
193905|NCT00383435|658297|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
193906|NCT00383435|658298|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
193907|NCT00383435|658299|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
193908|NCT00383435|658300|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
193909|NCT00383435|658301|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
193910|NCT00383435|658297|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
193911|NCT00383435|658298|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
193912|NCT00383435|658299|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
193913|NCT00383435|658300|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
193914|NCT00383435|658301|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
193915|NCT00383435|658297|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
193916|NCT00383435|658298|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
193917|NCT00383435|658299|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
193918|NCT00383435|658300|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
193919|NCT00383435|658301|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
193920|NCT00383435|658297|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
193921|NCT00383435|658298|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
193922|NCT00383435|658299|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
193923|NCT00383435|658300|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
193924|NCT00383435|658301|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
193925|NCT00383435|658297|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
193926|NCT00383435|658298|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
193927|NCT00383435|658299|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
193928|NCT00383435|658300|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
193929|NCT00383435|658301|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
193930|NCT00383435|658297|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
193931|NCT00383435|658298|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
193932|NCT00383435|658299|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
193933|NCT00383435|658300|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
193934|NCT00383435|658301|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
193935|NCT00383435|658297|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
193936|NCT00383435|658298|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
193937|NCT00383435|658299|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
193938|NCT00383435|658300|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
193939|NCT00383435|658301|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
193940|NCT00383331|658340|P2|Overall Study|Protocol Violation|1
193941|NCT00383331|658341|P1|Overall Study|Protocol Violation|0
193942|NCT00383240|658370|P4|Overall Study|Administrative|0
193943|NCT00383240|658371|P3|Overall Study|Administrative|0
193944|NCT00383240|658372|P2|Overall Study|Administrative|1
193945|NCT00383240|658373|P1|Overall Study|Administrative|1
193946|NCT00383240|658370|P4|Overall Study|Did not meet protocol eligibility|3
193947|NCT00383240|658371|P3|Overall Study|Did not meet protocol eligibility|9
193948|NCT00383240|658372|P2|Overall Study|Did not meet protocol eligibility|4
193949|NCT00383240|658373|P1|Overall Study|Did not meet protocol eligibility|9
193950|NCT00383240|658370|P4|Overall Study|Protocol Violation|6
193951|NCT00383240|658371|P3|Overall Study|Protocol Violation|9
193952|NCT00383240|658372|P2|Overall Study|Protocol Violation|5
193953|NCT00383240|658373|P1|Overall Study|Protocol Violation|4
193954|NCT00383240|658370|P4|Overall Study|Withdrawal by subjects, reasons related|5
193955|NCT00383240|658371|P3|Overall Study|Withdrawal by subjects, reasons related|3
193956|NCT00383240|658372|P2|Overall Study|Withdrawal by subjects, reasons related|1
193957|NCT00383240|658373|P1|Overall Study|Withdrawal by subjects, reasons related|0
193958|NCT00383240|658370|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
193959|NCT00383240|658371|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
193960|NCT00383240|658372|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
193961|NCT00383240|658373|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
193962|NCT00383240|658370|P4|Overall Study|Lost to Follow-up|2
193963|NCT00383240|658371|P3|Overall Study|Lost to Follow-up|0
193964|NCT00383240|658372|P2|Overall Study|Lost to Follow-up|0
193965|NCT00383240|658373|P1|Overall Study|Lost to Follow-up|3
193966|NCT00383240|658370|P4|Overall Study|Treatment Failure|46
193967|NCT00383240|658371|P3|Overall Study|Treatment Failure|47
193968|NCT00383240|658372|P2|Overall Study|Treatment Failure|13
193969|NCT00383240|658373|P1|Overall Study|Treatment Failure|8
193970|NCT00383240|658370|P4|Overall Study|Adverse Event|7
193971|NCT00383240|658371|P3|Overall Study|Adverse Event|9
193972|NCT00383240|658372|P2|Overall Study|Adverse Event|6
193973|NCT00383240|658373|P1|Overall Study|Adverse Event|4
193974|NCT00383162|658404|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
193975|NCT00383162|658405|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
193976|NCT00383162|658404|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
193977|NCT00383162|658405|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
193978|NCT00383162|658404|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
193979|NCT00383162|658405|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
193980|NCT00383162|658404|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
193981|NCT00383162|658405|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
193982|NCT00383162|658404|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
193983|NCT00383162|658405|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
193984|NCT00383162|658404|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
193985|NCT00383162|658405|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
193986|NCT00383162|658404|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
193987|NCT00383162|658405|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
193988|NCT00383162|658404|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
193989|NCT00383162|658405|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
193990|NCT00383162|658404|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
193991|NCT00383162|658405|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
193992|NCT00383149|658447|P1|Overall Study|Participant Withdrew Consent|1
193993|NCT00383149|658447|P1|Overall Study|Request to Discontinue Treatment|4
193994|NCT00383149|658447|P1|Overall Study|Study Drug Toxicity|4
193995|NCT00383149|658447|P1|Overall Study|Other|1
193996|NCT00383149|658447|P1|Overall Study|Lost to Follow-up|1
193997|NCT00383149|658447|P1|Overall Study|Disease Progression|38
193998|NCT00383149|658447|P1|Overall Study|Death|2
193999|NCT00383149|658447|P1|Overall Study|Adverse Event not Related to Study Drug|3
194000|NCT00383123|658466|P2|Overall Study|Other reason|6
194001|NCT00383123|658467|P1|Overall Study|Other reason|10
194002|NCT00383123|658466|P2|Overall Study|Withdrawal by Subject|18
194003|NCT00383123|658467|P1|Overall Study|Withdrawal by Subject|27
194004|NCT00383123|658466|P2|Overall Study|Protocol Violation|1
194005|NCT00383123|658467|P1|Overall Study|Protocol Violation|5
194006|NCT00383123|658466|P2|Overall Study|Lost to Follow-up|61
194007|NCT00383123|658467|P1|Overall Study|Lost to Follow-up|68
194008|NCT00383123|658466|P2|Overall Study|Adverse Event|0
194009|NCT00383123|658467|P1|Overall Study|Adverse Event|1
194010|NCT00383084|658508|P2|Overall Study|Withdrawal by Subject|10
194011|NCT00383084|658509|P1|Overall Study|Withdrawal by Subject|12
194012|NCT00383019|658540|P2|Overall Study|Withdrawal by Subject|1
194013|NCT00383019|658541|P1|Overall Study|Withdrawal by Subject|0
194014|NCT00383019|658540|P2|Overall Study|Adverse Event|1
194015|NCT00383019|658541|P1|Overall Study|Adverse Event|5
194016|NCT00382993|658563|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
194017|NCT00382993|658564|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
194018|NCT00382993|658563|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
194019|NCT00382993|658564|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
194020|NCT00382993|658563|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
194021|NCT00382993|658564|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
194022|NCT00382993|658563|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
194023|NCT00382993|658564|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
194024|NCT00382993|658563|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
194025|NCT00382993|658564|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
194026|NCT00382993|658563|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
194027|NCT00382993|658564|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
194028|NCT00382993|658563|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
194029|NCT00382993|658564|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
194030|NCT00382993|658563|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
194031|NCT00382993|658564|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
194032|NCT00382993|658563|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
194033|NCT00382993|658564|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
194034|NCT00382993|658563|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
194035|NCT00382993|658564|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
194036|NCT00382967|658608|P2|Overall Study|Protocol Violation|1
194037|NCT00382967|658609|P1|Overall Study|Protocol Violation|1
194038|NCT00382863|658634|P2|Overall Study|Withdrawal by Subject|25
194039|NCT00382863|658635|P1|Overall Study|Withdrawal by Subject|5
194040|NCT00382863|658634|P2|Overall Study|Lost to Follow-up|2
194041|NCT00382863|658635|P1|Overall Study|Lost to Follow-up|1
194042|NCT00382863|658634|P2|Overall Study|Death|9
194043|NCT00382863|658635|P1|Overall Study|Death|9
194044|NCT00382733|658702|P5|Overall Study|Withdrawal by Subject|0
194045|NCT00382733|658703|P4|Overall Study|Withdrawal by Subject|0
194046|NCT00382733|658704|P3|Overall Study|Withdrawal by Subject|0
194047|NCT00382733|658705|P2|Overall Study|Withdrawal by Subject|1
194048|NCT00382733|658706|P1|Overall Study|Withdrawal by Subject|0
194049|NCT00382720|658727|P3|Overall Study|Discontinued at end of study|2
194050|NCT00382720|658728|P2|Overall Study|Discontinued at end of study|1
194051|NCT00382720|658729|P1|Overall Study|Discontinued at end of study|0
194052|NCT00382720|658727|P3|Overall Study|Investigator/Clinical decision|6
194053|NCT00382720|658728|P2|Overall Study|Investigator/Clinical decision|6
194054|NCT00382720|658729|P1|Overall Study|Investigator/Clinical decision|5
194055|NCT00382720|658727|P3|Overall Study|Good prognosis|0
194056|NCT00382720|658728|P2|Overall Study|Good prognosis|1
194057|NCT00382720|658729|P1|Overall Study|Good prognosis|0
194058|NCT00382720|658727|P3|Overall Study|Clinically progressive disease|0
194059|NCT00382720|658728|P2|Overall Study|Clinically progressive disease|1
194060|NCT00382720|658729|P1|Overall Study|Clinically progressive disease|0
194061|NCT00382720|658727|P3|Overall Study|Patient did not receive study medication|4
194062|NCT00382720|658728|P2|Overall Study|Patient did not receive study medication|1
194063|NCT00382720|658729|P1|Overall Study|Patient did not receive study medication|1
194064|NCT00382720|658727|P3|Overall Study|Surgery|4
194065|NCT00382720|658728|P2|Overall Study|Surgery|1
194066|NCT00382720|658729|P1|Overall Study|Surgery|1
194067|NCT00382720|658727|P3|Overall Study|Withdrawal by Subject|12
194068|NCT00382720|658728|P2|Overall Study|Withdrawal by Subject|20
194069|NCT00382720|658729|P1|Overall Study|Withdrawal by Subject|11
194070|NCT00382720|658727|P3|Overall Study|Withdrew consent|2
194071|NCT00382720|658728|P2|Overall Study|Withdrew consent|1
194072|NCT00382720|658729|P1|Overall Study|Withdrew consent|1
194073|NCT00382720|658727|P3|Overall Study|Progressive disease|38
194074|NCT00382720|658728|P2|Overall Study|Progressive disease|28
194075|NCT00382720|658729|P1|Overall Study|Progressive disease|37
194076|NCT00382720|658727|P3|Overall Study|Death|2
194077|NCT00382720|658728|P2|Overall Study|Death|1
194078|NCT00382720|658729|P1|Overall Study|Death|0
194079|NCT00382720|658727|P3|Overall Study|Protocol Violation|1
194080|NCT00382720|658728|P2|Overall Study|Protocol Violation|5
194081|NCT00382720|658729|P1|Overall Study|Protocol Violation|2
194082|NCT00382720|658727|P3|Overall Study|Adverse Event|15
194083|NCT00382720|658728|P2|Overall Study|Adverse Event|23
194084|NCT00382720|658729|P1|Overall Study|Adverse Event|21
194085|NCT00382408|658754|P2|Overall Study|Not specified|35
194086|NCT00382408|658755|P1|Overall Study|Not specified|100
194087|NCT00382408|658754|P2|Overall Study|Lost to Follow-up|8
194088|NCT00382408|658755|P1|Overall Study|Lost to Follow-up|19
194089|NCT00382408|658754|P2|Overall Study|Pregnancy|0
194090|NCT00382408|658755|P1|Overall Study|Pregnancy|2
194091|NCT00382408|658754|P2|Overall Study|Withdrawal by Subject|6
194092|NCT00382408|658755|P1|Overall Study|Withdrawal by Subject|17
194093|NCT00382408|658754|P2|Overall Study|Physician Decision|0
194094|NCT00382408|658755|P1|Overall Study|Physician Decision|1
194095|NCT00382408|658754|P2|Overall Study|Protocol Violation|2
194096|NCT00382408|658755|P1|Overall Study|Protocol Violation|2
194097|NCT00382408|658754|P2|Overall Study|Did not meet protocol requirement|3
194098|NCT00382408|658755|P1|Overall Study|Did not meet protocol requirement|3
194099|NCT00382291|658782|P3|Overall Study|Lack of Efficacy|1
194100|NCT00382291|658783|P2|Overall Study|Lack of Efficacy|0
194101|NCT00382291|658784|P1|Overall Study|Lack of Efficacy|0
194102|NCT00382291|658782|P3|Overall Study|Physician Decision|0
194103|NCT00382291|658783|P2|Overall Study|Physician Decision|1
194104|NCT00382291|658784|P1|Overall Study|Physician Decision|0
194105|NCT00382291|658782|P3|Overall Study|Withdrawal by Subject|0
194106|NCT00382291|658783|P2|Overall Study|Withdrawal by Subject|2
194107|NCT00382291|658784|P1|Overall Study|Withdrawal by Subject|0
194108|NCT00382291|658782|P3|Overall Study|Temporary study suspension|5
194109|NCT00382291|658783|P2|Overall Study|Temporary study suspension|2
194110|NCT00382291|658784|P1|Overall Study|Temporary study suspension|2
194111|NCT00382291|658782|P3|Overall Study|Protocol Violation|0
194112|NCT00382291|658783|P2|Overall Study|Protocol Violation|0
194113|NCT00382291|658784|P1|Overall Study|Protocol Violation|1
194114|NCT00382291|658782|P3|Overall Study|Adverse Event|2
194115|NCT00382291|658783|P2|Overall Study|Adverse Event|2
194116|NCT00382291|658784|P1|Overall Study|Adverse Event|1
194117|NCT00382174|658797|P3|Overall Study|Wounds merged|2
194118|NCT00382174|658798|P2|Overall Study|Wounds merged|2
194119|NCT00382174|658799|P1|Overall Study|Wounds merged|0
194120|NCT00382174|658797|P3|Overall Study|Failed to meet criteria|1
194121|NCT00382174|658798|P2|Overall Study|Failed to meet criteria|1
194122|NCT00382174|658799|P1|Overall Study|Failed to meet criteria|0
194123|NCT00382174|658797|P3|Overall Study|Physician Decision|2
194124|NCT00382174|658798|P2|Overall Study|Physician Decision|2
194125|NCT00382174|658799|P1|Overall Study|Physician Decision|0
194126|NCT00382174|658797|P3|Overall Study|Non compliance|1
194127|NCT00382174|658798|P2|Overall Study|Non compliance|0
194128|NCT00382174|658799|P1|Overall Study|Non compliance|1
194129|NCT00382174|658797|P3|Overall Study|Withdrawal by Subject|5
194130|NCT00382174|658798|P2|Overall Study|Withdrawal by Subject|4
194131|NCT00382174|658799|P1|Overall Study|Withdrawal by Subject|1
194132|NCT00382174|658797|P3|Overall Study|Adverse Event|5
194133|NCT00382174|658798|P2|Overall Study|Adverse Event|4
194134|NCT00382174|658799|P1|Overall Study|Adverse Event|1
194135|NCT00382174|658797|P3|Overall Study|Lost to Follow-up|5
194136|NCT00382174|658798|P2|Overall Study|Lost to Follow-up|4
194137|NCT00382174|658799|P1|Overall Study|Lost to Follow-up|1
194138|NCT00382109|658827|P2|Overall Study|consent withdrawal|1
194139|NCT00382109|658828|P1|Overall Study|consent withdrawal|0
194140|NCT00382109|658827|P2|Overall Study|Other|2
194141|NCT00382109|658828|P1|Overall Study|Other|0
194142|NCT00382109|658827|P2|Overall Study|ineligible|0
194143|NCT00382109|658828|P1|Overall Study|ineligible|2
194144|NCT00382109|658827|P2|Overall Study|Withdrawal by Subject|0
194145|NCT00382109|658828|P1|Overall Study|Withdrawal by Subject|1
194146|NCT00382109|658827|P2|Overall Study|Physician Decision|1
194147|NCT00382109|658828|P1|Overall Study|Physician Decision|6
194148|NCT00382109|658827|P2|Overall Study|Adverse Event|0
194149|NCT00382109|658828|P1|Overall Study|Adverse Event|3
194150|NCT00382018|658867|P4|Overall Study|Other, not protocol specified|1
194151|NCT00382018|658868|P3|Overall Study|Other, not protocol specified|3
194152|NCT00382018|658869|P2|Overall Study|Other, not protocol specified|16
194153|NCT00382018|658870|P1|Overall Study|Other, not protocol specified|0
194154|NCT00382018|658867|P4|Overall Study|Withdrawal by Subject|4
194155|NCT00382018|658868|P3|Overall Study|Withdrawal by Subject|3
194156|NCT00382018|658869|P2|Overall Study|Withdrawal by Subject|4
194157|NCT00382018|658870|P1|Overall Study|Withdrawal by Subject|0
194158|NCT00382018|658867|P4|Overall Study|Death|11
194159|NCT00382018|658868|P3|Overall Study|Death|7
194160|NCT00382018|658869|P2|Overall Study|Death|9
194161|NCT00382018|658870|P1|Overall Study|Death|0
194162|NCT00382018|658867|P4|Overall Study|Progression|43
194163|NCT00382018|658868|P3|Overall Study|Progression|51
194164|NCT00382018|658869|P2|Overall Study|Progression|136
194165|NCT00382018|658870|P1|Overall Study|Progression|0
194166|NCT00381940|658888|P1|Overall Study|Ineligible|1
194167|NCT00381940|658888|P1|Overall Study|Protocol Violation|1
194168|NCT00381940|658888|P1|Overall Study|Lack of Efficacy|3
194169|NCT00381888|658892|P1|Overall Study|Adverse Event|1
194170|NCT00381888|658892|P1|Overall Study|Surgery was cancelled|2
194171|NCT00381888|658892|P1|Overall Study|Had laparoscopic surgery|2
194172|NCT00381888|658892|P1|Overall Study|Protocol Violation|9
194173|NCT00381888|658892|P1|Overall Study|Physician Decision|1
194174|NCT00381888|658892|P1|Overall Study|Withdrawal by Subject|1
194175|NCT00381888|658892|P1|Overall Study|Death|1
194176|NCT00381849|658903|P2|Wash Out|Withdrawal by Subject|1
194177|NCT00381849|658904|P1|Wash Out|Withdrawal by Subject|0
194178|NCT00381797|658931|P5|Overall Study|Ineligible|0
194179|NCT00381797|658932|P4|Overall Study|Ineligible|1
194180|NCT00381797|658933|P3|Overall Study|Ineligible|0
194181|NCT00381797|658934|P2|Overall Study|Ineligible|0
194182|NCT00381797|658935|P1|Overall Study|Ineligible|0
194183|NCT00381797|658931|P5|Overall Study|Withdrawal by Subject|2
194184|NCT00381797|658932|P4|Overall Study|Withdrawal by Subject|0
194185|NCT00381797|658933|P3|Overall Study|Withdrawal by Subject|0
194186|NCT00381797|658934|P2|Overall Study|Withdrawal by Subject|1
194187|NCT00381797|658935|P1|Overall Study|Withdrawal by Subject|1
194188|NCT00381706|659010|P3|Overall Study|Never treated|1
194189|NCT00381706|659011|P2|Overall Study|Never treated|2
194190|NCT00381706|659012|P1|Overall Study|Never treated|7
194191|NCT00381693|659035|P1|Overall Study|Progression|2
194192|NCT00381693|659035|P1|Overall Study|Patient Choice|1
194193|NCT00381693|659035|P1|Overall Study|Adverse Event|4
194194|NCT00381693|659035|P1|Overall Study|Death|1
194195|NCT00381680|659044|P2|Overall Study|Ineligible|1
194196|NCT00381680|659045|P1|Overall Study|Ineligible|3
194197|NCT00381680|659044|P2|Overall Study|Other not otherwise specified|2
194198|NCT00381680|659045|P1|Overall Study|Other not otherwise specified|7
194199|NCT00381680|659044|P2|Overall Study|Progression|1
194200|NCT00381680|659045|P1|Overall Study|Progression|1
194201|NCT00381680|659044|P2|Overall Study|Induction Failure|1
194202|NCT00381680|659045|P1|Overall Study|Induction Failure|4
194203|NCT00381680|659044|P2|Overall Study|Relapse|9
194204|NCT00381680|659045|P1|Overall Study|Relapse|18
194205|NCT00381680|659044|P2|Overall Study|Stem Cell Transplant|10
194206|NCT00381680|659045|P1|Overall Study|Stem Cell Transplant|26
194207|NCT00381680|659044|P2|Overall Study|Delay initiation|0
194208|NCT00381680|659045|P1|Overall Study|Delay initiation|1
194209|NCT00381680|659044|P2|Overall Study|Secondary Malignancy|0
194210|NCT00381680|659045|P1|Overall Study|Secondary Malignancy|3
194211|NCT00381680|659044|P2|Overall Study|Alternative Therapy|5
194212|NCT00381680|659045|P1|Overall Study|Alternative Therapy|11
194213|NCT00381680|659044|P2|Overall Study|Entry onto another COG Trial|2
194214|NCT00381680|659045|P1|Overall Study|Entry onto another COG Trial|1
194215|NCT00381680|659044|P2|Overall Study|Withdrawal by Subject|1
194216|NCT00381680|659045|P1|Overall Study|Withdrawal by Subject|3
194217|NCT00381680|659044|P2|Overall Study|Physician Decision|6
194218|NCT00381680|659045|P1|Overall Study|Physician Decision|25
194219|NCT00381680|659044|P2|Overall Study|Lost to Follow-up|2
194220|NCT00381680|659045|P1|Overall Study|Lost to Follow-up|3
194221|NCT00381680|659044|P2|Overall Study|Death|7
194222|NCT00381680|659045|P1|Overall Study|Death|10
194223|NCT00381680|659044|P2|Overall Study|Adverse Event|3
194224|NCT00381680|659045|P1|Overall Study|Adverse Event|9
194225|NCT00381641|659062|P2|Overall Study|Withdrawal by Subject|2
194226|NCT00381641|659063|P1|Overall Study|Withdrawal by Subject|0
194227|NCT00381615|659096|P4|Overall Study|Protocol Violation|0
194228|NCT00381615|659097|P3|Overall Study|Protocol Violation|1
194229|NCT00381615|659098|P2|Overall Study|Protocol Violation|0
194230|NCT00381615|659099|P1|Overall Study|Protocol Violation|0
194231|NCT00381615|659096|P4|Overall Study|Lost to Follow-up|1
194232|NCT00381615|659097|P3|Overall Study|Lost to Follow-up|0
194233|NCT00381615|659098|P2|Overall Study|Lost to Follow-up|2
194234|NCT00381615|659099|P1|Overall Study|Lost to Follow-up|3
194235|NCT00381615|659096|P4|Overall Study|Withdrawal by Subject|1
194236|NCT00381615|659097|P3|Overall Study|Withdrawal by Subject|0
194237|NCT00381615|659098|P2|Overall Study|Withdrawal by Subject|3
194238|NCT00381615|659099|P1|Overall Study|Withdrawal by Subject|1
194239|NCT00381563|659151|P2|Overall Study|Protocol Violation|1
194240|NCT00381563|659152|P1|Overall Study|Protocol Violation|0
194241|NCT00381563|659151|P2|Overall Study|Lost to Follow-up|0
194242|NCT00381563|659152|P1|Overall Study|Lost to Follow-up|2
194243|NCT00381563|659151|P2|Overall Study|Withdrawal by Subject|5
194244|NCT00381563|659152|P1|Overall Study|Withdrawal by Subject|5
194245|NCT00381485|659167|P4|Double-Blind Treatment Period|Administrative|1
194246|NCT00381485|659168|P3|Double-Blind Treatment Period|Administrative|0
194247|NCT00381485|659169|P2|Double-Blind Treatment Period|Administrative|1
194248|NCT00381485|659170|P1|Double-Blind Treatment Period|Administrative|0
194249|NCT00381485|659167|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
194250|NCT00381485|659168|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
194251|NCT00381485|659169|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
194252|NCT00381485|659170|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
194253|NCT00381485|659167|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
194254|NCT00381485|659168|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
194255|NCT00381485|659169|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
194256|NCT00381485|659170|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
194257|NCT00381485|659167|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
194258|NCT00381485|659168|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
194259|NCT00381485|659169|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
194260|NCT00381485|659170|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
194261|NCT00381485|659167|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
194262|NCT00381485|659168|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
194263|NCT00381485|659169|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
194264|NCT00381485|659170|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
194265|NCT00381485|659167|P4|Double-Blind Treatment Period|Lost to Follow-up|1
194266|NCT00381485|659168|P3|Double-Blind Treatment Period|Lost to Follow-up|1
194267|NCT00381485|659169|P2|Double-Blind Treatment Period|Lost to Follow-up|0
194268|NCT00381485|659170|P1|Double-Blind Treatment Period|Lost to Follow-up|0
194269|NCT00381485|659167|P4|Double-Blind Treatment Period|Lack of Efficacy|13
194270|NCT00381485|659168|P3|Double-Blind Treatment Period|Lack of Efficacy|11
194271|NCT00381485|659169|P2|Double-Blind Treatment Period|Lack of Efficacy|8
194272|NCT00381485|659170|P1|Double-Blind Treatment Period|Lack of Efficacy|0
194273|NCT00381485|659167|P4|Double-Blind Treatment Period|Adverse Event|5
194274|NCT00381485|659168|P3|Double-Blind Treatment Period|Adverse Event|2
194275|NCT00381485|659169|P2|Double-Blind Treatment Period|Adverse Event|2
194276|NCT00381485|659170|P1|Double-Blind Treatment Period|Adverse Event|0
194277|NCT00381485|659167|P4|Open-Label Run-In Period|Treatment failure|0
194278|NCT00381485|659168|P3|Open-Label Run-In Period|Treatment failure|0
194279|NCT00381485|659169|P2|Open-Label Run-In Period|Treatment failure|0
194280|NCT00381485|659170|P1|Open-Label Run-In Period|Treatment failure|1
194281|NCT00381485|659167|P4|Open-Label Run-In Period|Lost to Follow-up|0
194282|NCT00381485|659168|P3|Open-Label Run-In Period|Lost to Follow-up|0
194283|NCT00381485|659169|P2|Open-Label Run-In Period|Lost to Follow-up|0
194284|NCT00381485|659170|P1|Open-Label Run-In Period|Lost to Follow-up|3
194285|NCT00381485|659167|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
194286|NCT00381485|659168|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
194287|NCT00381485|659169|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
194288|NCT00381485|659170|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
194289|NCT00381485|659167|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
194290|NCT00381485|659168|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
194291|NCT00381485|659169|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
194292|NCT00381485|659170|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
194293|NCT00381485|659167|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
194294|NCT00381485|659168|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
194295|NCT00381485|659169|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
194296|NCT00381485|659170|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
194297|NCT00381485|659167|P4|Open-Label Run-In Period|Adverse Event|0
194298|NCT00381485|659168|P3|Open-Label Run-In Period|Adverse Event|0
194299|NCT00381485|659169|P2|Open-Label Run-In Period|Adverse Event|0
194300|NCT00381485|659170|P1|Open-Label Run-In Period|Adverse Event|9
194301|NCT00381381|659188|P1|Overall Study|Withdrawal by Subject|9
194302|NCT00381381|659188|P1|Overall Study|Lost to Follow-up|52
194303|NCT00381381|659188|P1|Overall Study|Adverse Event|3
194304|NCT00381303|659197|P2|Overall Study|Subject primary physician's decision|0
194305|NCT00381303|659198|P1|Overall Study|Subject primary physician's decision|1
194306|NCT00381303|659197|P2|Overall Study|Subject did not continue visits|0
194307|NCT00381303|659198|P1|Overall Study|Subject did not continue visits|1
194308|NCT00381303|659197|P2|Overall Study|Subject was too busy for appointments|0
194309|NCT00381303|659198|P1|Overall Study|Subject was too busy for appointments|1
194310|NCT00381303|659197|P2|Overall Study|No virologic response by week 12|0
194311|NCT00381303|659198|P1|Overall Study|No virologic response by week 12|1
194312|NCT00381303|659197|P2|Overall Study|Subject taking too many different meds|0
194313|NCT00381303|659198|P1|Overall Study|Subject taking too many different meds|1
194314|NCT00381303|659197|P2|Overall Study|Subject moved out of state|0
194315|NCT00381303|659198|P1|Overall Study|Subject moved out of state|2
194316|NCT00381303|659197|P2|Overall Study|Physician's decision to close the site|1
194317|NCT00381303|659198|P1|Overall Study|Physician's decision to close the site|3
194318|NCT00381303|659197|P2|Overall Study|Physician Decision|0
194319|NCT00381303|659198|P1|Overall Study|Physician Decision|1
194320|NCT00381303|659197|P2|Overall Study|Pregnancy|0
194321|NCT00381303|659198|P1|Overall Study|Pregnancy|2
194322|NCT00381303|659197|P2|Overall Study|Ineligible to continue the trial|1
194323|NCT00381303|659198|P1|Overall Study|Ineligible to continue the trial|2
194324|NCT00381303|659197|P2|Overall Study|Virologic failure|4
194325|NCT00381303|659198|P1|Overall Study|Virologic failure|6
194326|NCT00381303|659197|P2|Overall Study|Withdrawal by Subject|6
194327|NCT00381303|659198|P1|Overall Study|Withdrawal by Subject|13
194328|NCT00381303|659197|P2|Overall Study|Non-Adherence|6
194329|NCT00381303|659198|P1|Overall Study|Non-Adherence|13
194330|NCT00381303|659197|P2|Overall Study|AE/HIV-related event|6
194331|NCT00381303|659198|P1|Overall Study|AE/HIV-related event|22
194332|NCT00381303|659197|P2|Overall Study|Lost to Follow-up|9
194333|NCT00381303|659198|P1|Overall Study|Lost to Follow-up|25
194334|NCT00381238|659258|P1|Overall Study|Disease progression|1
194335|NCT00381238|659258|P1|Overall Study|Withdrew by physician|1
194336|NCT00381238|659258|P1|Overall Study|Lack of Efficacy|2
194337|NCT00381238|659258|P1|Overall Study|Withdrawal by Subject|4
194338|NCT00381238|659258|P1|Overall Study|Protocol Violation|1
194339|NCT00381238|659258|P1|Overall Study|Adverse Event|3
194340|NCT00381095|659274|P2|Overall Study|Adverse Event|7
194341|NCT00381095|659275|P1|Overall Study|Adverse Event|2
194342|NCT00381095|659274|P2|Overall Study|Withdrawal by Subject|3
194343|NCT00381095|659275|P1|Overall Study|Withdrawal by Subject|3
194344|NCT00381095|659274|P2|Overall Study|Protocol Violation|1
194345|NCT00381095|659275|P1|Overall Study|Protocol Violation|1
194346|NCT00381095|659274|P2|Overall Study|Other|2
194347|NCT00381095|659275|P1|Overall Study|Other|2
194348|NCT00381095|659274|P2|Overall Study|Lack of Efficacy|4
194349|NCT00381095|659275|P1|Overall Study|Lack of Efficacy|2
194350|NCT00381095|659274|P2|Overall Study|Death|4
194351|NCT00381095|659275|P1|Overall Study|Death|3
194352|NCT00381043|659307|P2|Overall Study|incarcerated|0
194353|NCT00381043|659308|P1|Overall Study|incarcerated|1
194354|NCT00381043|659307|P2|Overall Study|wanted more care|1
194355|NCT00381043|659308|P1|Overall Study|wanted more care|0
194356|NCT00381043|659307|P2|Overall Study|Withdrawal by Subject|1
194357|NCT00381043|659308|P1|Overall Study|Withdrawal by Subject|3
194358|NCT00381043|659307|P2|Overall Study|Lost to Follow-up|6
194359|NCT00381043|659308|P1|Overall Study|Lost to Follow-up|8
194360|NCT00380978|659334|P2|Overall Study|Parous patient|0
194361|NCT00380978|659335|P1|Overall Study|Parous patient|1
194362|NCT00380978|659334|P2|Overall Study|Allocation prior to analgesia request|2
194363|NCT00380978|659335|P1|Overall Study|Allocation prior to analgesia request|1
194364|NCT00380978|659334|P2|Overall Study|Wrong study envelope|2
194365|NCT00380978|659335|P1|Overall Study|Wrong study envelope|0
194366|NCT00380978|659334|P2|Overall Study|Refused allocated intervention|6
194367|NCT00380978|659335|P1|Overall Study|Refused allocated intervention|0
194368|NCT00380874|659357|P2|Overall Study|Not related to study drug|2
194369|NCT00380874|659358|P1|Overall Study|Not related to study drug|3
194370|NCT00380874|659357|P2|Overall Study|Withdrawal by Subject|1
194371|NCT00380874|659358|P1|Overall Study|Withdrawal by Subject|2
194372|NCT00380874|659357|P2|Overall Study|Death|0
194373|NCT00380874|659358|P1|Overall Study|Death|1
194374|NCT00380874|659357|P2|Overall Study|Adverse Event|7
194375|NCT00380874|659358|P1|Overall Study|Adverse Event|7
194376|NCT00380718|659383|P1|Overall Study|Death after 30-day post-therapy followup|17
194377|NCT00380718|659383|P1|Overall Study|Adverse Event|1
194378|NCT00380692|659395|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
194379|NCT00380692|659396|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
194380|NCT00380692|659395|P2|Study Period III - Open Label|Lack of Efficacy|4
194381|NCT00380692|659396|P1|Study Period III - Open Label|Lack of Efficacy|0
194382|NCT00380692|659395|P2|Study Period III - Open Label|Physician Decision|3
194383|NCT00380692|659396|P1|Study Period III - Open Label|Physician Decision|0
194384|NCT00380692|659395|P2|Study Period III - Open Label|Withdrawal by Subject|1
194385|NCT00380692|659396|P1|Study Period III - Open Label|Withdrawal by Subject|0
194386|NCT00380692|659395|P2|Study Period III - Open Label|Protocol Violation|0
194387|NCT00380692|659396|P1|Study Period III - Open Label|Protocol Violation|0
194388|NCT00380692|659395|P2|Study Period III - Open Label|Adverse Event|3
194389|NCT00380692|659396|P1|Study Period III - Open Label|Adverse Event|5
194390|NCT00380692|659395|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
194391|NCT00380692|659396|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
194392|NCT00380692|659395|P2|Study Period II - Double Blind|Lack of Efficacy|0
194393|NCT00380692|659396|P1|Study Period II - Double Blind|Lack of Efficacy|1
194394|NCT00380692|659395|P2|Study Period II - Double Blind|Physician Decision|1
194395|NCT00380692|659396|P1|Study Period II - Double Blind|Physician Decision|0
194396|NCT00380692|659395|P2|Study Period II - Double Blind|Withdrawal by Subject|0
194397|NCT00380692|659396|P1|Study Period II - Double Blind|Withdrawal by Subject|0
194398|NCT00380692|659395|P2|Study Period II - Double Blind|Protocol Violation|2
194399|NCT00380692|659396|P1|Study Period II - Double Blind|Protocol Violation|2
194400|NCT00380692|659395|P2|Study Period II - Double Blind|Adverse Event|0
194401|NCT00380692|659396|P1|Study Period II - Double Blind|Adverse Event|1
194402|NCT00380588|659444|P2|Overall Study|Physician Decision|0
194403|NCT00380588|659445|P1|Overall Study|Physician Decision|2
194404|NCT00380588|659444|P2|Overall Study|Withdrawal by Subject|3
194405|NCT00380588|659445|P1|Overall Study|Withdrawal by Subject|1
194406|NCT00380588|659444|P2|Overall Study|Adverse Event|3
194407|NCT00380588|659445|P1|Overall Study|Adverse Event|7
194408|NCT00380588|659444|P2|Overall Study|Next Cycle Not Started|0
194409|NCT00380588|659445|P1|Overall Study|Next Cycle Not Started|4
194410|NCT00380588|659444|P2|Overall Study|Unequivocal Disease Progression|34
194411|NCT00380588|659445|P1|Overall Study|Unequivocal Disease Progression|25
194412|NCT00380367|659457|P1|Overall Study|Withdrawal by Subject|1
194413|NCT00380367|659457|P1|Overall Study|Lost to Follow-up|1
194414|NCT00380250|659464|P2|Overall Study|Physician Decision|0
194415|NCT00380250|659465|P1|Overall Study|Physician Decision|1
194416|NCT00380250|659464|P2|Overall Study|Lost to Follow-up|5
194417|NCT00380250|659465|P1|Overall Study|Lost to Follow-up|14
194418|NCT00380250|659464|P2|Overall Study|Protocol Violation|5
194419|NCT00380250|659465|P1|Overall Study|Protocol Violation|15
194420|NCT00380250|659464|P2|Overall Study|Lack of Efficacy|8
194421|NCT00380250|659465|P1|Overall Study|Lack of Efficacy|10
194422|NCT00380250|659464|P2|Overall Study|Adverse Event|9
194423|NCT00380250|659465|P1|Overall Study|Adverse Event|20
194424|NCT00380250|659464|P2|Overall Study|Withdrawal by Subject|28
194425|NCT00380250|659465|P1|Overall Study|Withdrawal by Subject|39
194426|NCT00380081|659533|P6|Overall Study|Family Emergency|1
194427|NCT00380081|659534|P5|Overall Study|Family Emergency|0
194428|NCT00380081|659535|P4|Overall Study|Family Emergency|0
194429|NCT00380081|659536|P3|Overall Study|Family Emergency|0
194430|NCT00380081|659537|P2|Overall Study|Family Emergency|0
194431|NCT00380081|659538|P1|Overall Study|Family Emergency|0
194432|NCT00380081|659533|P6|Overall Study|Withdrawal by Subject|0
194433|NCT00380081|659534|P5|Overall Study|Withdrawal by Subject|1
194434|NCT00380081|659535|P4|Overall Study|Withdrawal by Subject|0
194435|NCT00380081|659536|P3|Overall Study|Withdrawal by Subject|0
194436|NCT00380081|659537|P2|Overall Study|Withdrawal by Subject|0
194437|NCT00380081|659538|P1|Overall Study|Withdrawal by Subject|0
194438|NCT00380068|659588|P1|Overall Study|Lack of Efficacy|5
194439|NCT00380068|659588|P1|Overall Study|Partipant moved away|1
194440|NCT00380068|659588|P1|Overall Study|Physician Decision|2
194441|NCT00380068|659588|P1|Overall Study|Lung transplant|3
194442|NCT00380068|659588|P1|Overall Study|Addition of other PAH therapeutic agent|1
194443|NCT00380068|659588|P1|Overall Study|Lost to Follow-up|1
194444|NCT00380068|659588|P1|Overall Study|Not compliant|6
194445|NCT00380068|659588|P1|Overall Study|Withdrawal by Subject|10
194446|NCT00380068|659588|P1|Overall Study|Adverse Event|40
194447|NCT00379912|659620|P2|Overall Study|Lack of Efficacy|0
194448|NCT00379912|659621|P1|Overall Study|Lack of Efficacy|1
194449|NCT00379899|659643|P2|Overall Study|Other|1
194450|NCT00379899|659644|P1|Overall Study|Other|3
194451|NCT00379899|659643|P2|Overall Study|Other protocol-specified criteria|4
194452|NCT00379899|659644|P1|Overall Study|Other protocol-specified criteria|3
194453|NCT00379899|659643|P2|Overall Study|Coronary artery bypass graft|1
194454|NCT00379899|659644|P1|Overall Study|Coronary artery bypass graft|1
194455|NCT00379899|659643|P2|Overall Study|Renal transplantation|4
194456|NCT00379899|659644|P1|Overall Study|Renal transplantation|5
194457|NCT00379899|659643|P2|Overall Study|Parathyroidectomy|2
194458|NCT00379899|659644|P1|Overall Study|Parathyroidectomy|0
194459|NCT00379899|659643|P2|Overall Study|Noncompliance|1
194460|NCT00379899|659644|P1|Overall Study|Noncompliance|1
194461|NCT00379899|659643|P2|Overall Study|Ineligibility determined|1
194462|NCT00379899|659644|P1|Overall Study|Ineligibility determined|0
194463|NCT00379899|659643|P2|Overall Study|Withdrawal by Subject|5
194464|NCT00379899|659644|P1|Overall Study|Withdrawal by Subject|5
194465|NCT00379899|659643|P2|Overall Study|Physician Decision|4
194466|NCT00379899|659644|P1|Overall Study|Physician Decision|3
194467|NCT00379899|659643|P2|Overall Study|Lost to Follow-up|4
194468|NCT00379899|659644|P1|Overall Study|Lost to Follow-up|2
194469|NCT00379899|659643|P2|Overall Study|Death|10
194470|NCT00379899|659644|P1|Overall Study|Death|10
194471|NCT00379899|659643|P2|Overall Study|Adverse Event|3
194472|NCT00379899|659644|P1|Overall Study|Adverse Event|7
194473|NCT00379834|659672|P1|Overall Study|Time constraints|2
194474|NCT00379808|659824|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
194475|NCT00379808|659825|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
194476|NCT00379795|659846|P5|Overall Study|Sponsor's decision|10
194477|NCT00379795|659847|P4|Overall Study|Sponsor's decision|47
194478|NCT00379795|659848|P3|Overall Study|Sponsor's decision|54
194479|NCT00379795|659849|P2|Overall Study|Sponsor's decision|17
194480|NCT00379795|659850|P1|Overall Study|Sponsor's decision|257
194481|NCT00379795|659846|P5|Overall Study|Subjects condition mandated intervention|7
194482|NCT00379795|659847|P4|Overall Study|Subjects condition mandated intervention|5
194483|NCT00379795|659848|P3|Overall Study|Subjects condition mandated intervention|7
194484|NCT00379795|659849|P2|Overall Study|Subjects condition mandated intervention|9
194485|NCT00379795|659850|P1|Overall Study|Subjects condition mandated intervention|34
194486|NCT00379795|659846|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
194487|NCT00379795|659847|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
194488|NCT00379795|659848|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
194489|NCT00379795|659849|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
194490|NCT00379795|659850|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
194491|NCT00379795|659846|P5|Overall Study|Subject non-compliance|1
194492|NCT00379795|659847|P4|Overall Study|Subject non-compliance|0
194493|NCT00379795|659848|P3|Overall Study|Subject non-compliance|0
194494|NCT00379795|659849|P2|Overall Study|Subject non-compliance|2
194495|NCT00379795|659850|P1|Overall Study|Subject non-compliance|7
194496|NCT00379795|659846|P5|Overall Study|Withdrawal by Subject|14
194497|NCT00379795|659847|P4|Overall Study|Withdrawal by Subject|7
194498|NCT00379795|659848|P3|Overall Study|Withdrawal by Subject|19
194499|NCT00379795|659849|P2|Overall Study|Withdrawal by Subject|11
194500|NCT00379795|659850|P1|Overall Study|Withdrawal by Subject|94
194501|NCT00379795|659846|P5|Overall Study|Physician Decision|2
194502|NCT00379795|659847|P4|Overall Study|Physician Decision|2
194503|NCT00379795|659848|P3|Overall Study|Physician Decision|2
194504|NCT00379795|659849|P2|Overall Study|Physician Decision|0
194505|NCT00379795|659850|P1|Overall Study|Physician Decision|25
194506|NCT00379795|659846|P5|Overall Study|Lost to Follow-up|4
194507|NCT00379795|659847|P4|Overall Study|Lost to Follow-up|1
194508|NCT00379795|659848|P3|Overall Study|Lost to Follow-up|2
194509|NCT00379795|659849|P2|Overall Study|Lost to Follow-up|1
194510|NCT00379795|659850|P1|Overall Study|Lost to Follow-up|8
194511|NCT00379795|659846|P5|Overall Study|Adverse Event|4
194512|NCT00379795|659847|P4|Overall Study|Adverse Event|1
194513|NCT00379795|659848|P3|Overall Study|Adverse Event|3
194514|NCT00379795|659849|P2|Overall Study|Adverse Event|3
194515|NCT00379795|659850|P1|Overall Study|Adverse Event|17
194516|NCT00379795|659846|P5|Overall Study|Death|7
194517|NCT00379795|659847|P4|Overall Study|Death|4
194518|NCT00379795|659848|P3|Overall Study|Death|6
194519|NCT00379795|659849|P2|Overall Study|Death|8
194520|NCT00379795|659850|P1|Overall Study|Death|31
194521|NCT00379769|659880|P6|Observational Follow-up|Unknown; Reason Not Provided|1
194522|NCT00379769|659881|P5|Observational Follow-up|Unknown; Reason Not Provided|1
194523|NCT00379769|659882|P4|Observational Follow-up|Unknown; Reason Not Provided|0
194524|NCT00379769|659883|P3|Observational Follow-up|Unknown; Reason Not Provided|0
194525|NCT00379769|659884|P2|Observational Follow-up|Unknown; Reason Not Provided|0
194526|NCT00379769|659885|P1|Observational Follow-up|Unknown; Reason Not Provided|0
194527|NCT00379769|659880|P6|Observational Follow-up|Participant Moved|1
194528|NCT00379769|659881|P5|Observational Follow-up|Participant Moved|0
194529|NCT00379769|659882|P4|Observational Follow-up|Participant Moved|0
194530|NCT00379769|659883|P3|Observational Follow-up|Participant Moved|0
194531|NCT00379769|659884|P2|Observational Follow-up|Participant Moved|0
194532|NCT00379769|659885|P1|Observational Follow-up|Participant Moved|0
194533|NCT00379769|659880|P6|Observational Follow-up|Site Closed Early|7
194534|NCT00379769|659881|P5|Observational Follow-up|Site Closed Early|6
194535|NCT00379769|659882|P4|Observational Follow-up|Site Closed Early|0
194536|NCT00379769|659883|P3|Observational Follow-up|Site Closed Early|0
194537|NCT00379769|659884|P2|Observational Follow-up|Site Closed Early|0
194538|NCT00379769|659885|P1|Observational Follow-up|Site Closed Early|0
194539|NCT00379769|659880|P6|Observational Follow-up|Physician Decision|8
194540|NCT00379769|659881|P5|Observational Follow-up|Physician Decision|8
194541|NCT00379769|659882|P4|Observational Follow-up|Physician Decision|0
194542|NCT00379769|659883|P3|Observational Follow-up|Physician Decision|0
194543|NCT00379769|659884|P2|Observational Follow-up|Physician Decision|0
194544|NCT00379769|659885|P1|Observational Follow-up|Physician Decision|0
194545|NCT00379769|659880|P6|Observational Follow-up|Entered into Another Clinical Trial|22
194546|NCT00379769|659881|P5|Observational Follow-up|Entered into Another Clinical Trial|18
194547|NCT00379769|659882|P4|Observational Follow-up|Entered into Another Clinical Trial|0
194548|NCT00379769|659883|P3|Observational Follow-up|Entered into Another Clinical Trial|0
194549|NCT00379769|659884|P2|Observational Follow-up|Entered into Another Clinical Trial|0
194550|NCT00379769|659885|P1|Observational Follow-up|Entered into Another Clinical Trial|0
194551|NCT00379769|659880|P6|Observational Follow-up|Withdrawal by Subject|12
194552|NCT00379769|659881|P5|Observational Follow-up|Withdrawal by Subject|12
194553|NCT00379769|659882|P4|Observational Follow-up|Withdrawal by Subject|0
194554|NCT00379769|659883|P3|Observational Follow-up|Withdrawal by Subject|0
194555|NCT00379769|659884|P2|Observational Follow-up|Withdrawal by Subject|0
194556|NCT00379769|659885|P1|Observational Follow-up|Withdrawal by Subject|0
194557|NCT00379769|659880|P6|Observational Follow-up|Lost to Follow-up|27
194558|NCT00379769|659881|P5|Observational Follow-up|Lost to Follow-up|25
194559|NCT00379769|659882|P4|Observational Follow-up|Lost to Follow-up|0
194560|NCT00379769|659883|P3|Observational Follow-up|Lost to Follow-up|0
194561|NCT00379769|659884|P2|Observational Follow-up|Lost to Follow-up|0
194562|NCT00379769|659885|P1|Observational Follow-up|Lost to Follow-up|0
194563|NCT00379769|659880|P6|Observational Follow-up|Adverse Event|0
194564|NCT00379769|659881|P5|Observational Follow-up|Adverse Event|1
194565|NCT00379769|659882|P4|Observational Follow-up|Adverse Event|0
194566|NCT00379769|659883|P3|Observational Follow-up|Adverse Event|0
194567|NCT00379769|659884|P2|Observational Follow-up|Adverse Event|0
194568|NCT00379769|659885|P1|Observational Follow-up|Adverse Event|0
194569|NCT00379769|659880|P6|Observational Follow-up|Death|70
194570|NCT00379769|659881|P5|Observational Follow-up|Death|78
194571|NCT00379769|659882|P4|Observational Follow-up|Death|0
194572|NCT00379769|659883|P3|Observational Follow-up|Death|0
194573|NCT00379769|659884|P2|Observational Follow-up|Death|0
194574|NCT00379769|659885|P1|Observational Follow-up|Death|0
194575|NCT00379769|659880|P6|Main Study|Reason unspecified|0
194576|NCT00379769|659881|P5|Main Study|Reason unspecified|0
194577|NCT00379769|659882|P4|Main Study|Reason unspecified|0
194578|NCT00379769|659883|P3|Main Study|Reason unspecified|1
194579|NCT00379769|659884|P2|Main Study|Reason unspecified|0
194580|NCT00379769|659885|P1|Main Study|Reason unspecified|0
194581|NCT00379769|659880|P6|Main Study|Investigator refused to log temperature|0
194582|NCT00379769|659881|P5|Main Study|Investigator refused to log temperature|0
194583|NCT00379769|659882|P4|Main Study|Investigator refused to log temperature|0
194584|NCT00379769|659883|P3|Main Study|Investigator refused to log temperature|1
194585|NCT00379769|659884|P2|Main Study|Investigator refused to log temperature|0
194586|NCT00379769|659885|P1|Main Study|Investigator refused to log temperature|0
194587|NCT00379769|659880|P6|Main Study|Risk of heart failure|0
194588|NCT00379769|659881|P5|Main Study|Risk of heart failure|0
194589|NCT00379769|659882|P4|Main Study|Risk of heart failure|0
194590|NCT00379769|659883|P3|Main Study|Risk of heart failure|0
194591|NCT00379769|659884|P2|Main Study|Risk of heart failure|1
194592|NCT00379769|659885|P1|Main Study|Risk of heart failure|0
194593|NCT00379769|659880|P6|Main Study|Personal reasons|0
194594|NCT00379769|659881|P5|Main Study|Personal reasons|0
194595|NCT00379769|659882|P4|Main Study|Personal reasons|0
194596|NCT00379769|659883|P3|Main Study|Personal reasons|0
194597|NCT00379769|659884|P2|Main Study|Personal reasons|0
194598|NCT00379769|659885|P1|Main Study|Personal reasons|1
194599|NCT00379769|659880|P6|Main Study|Participant completed study at visit 27|0
194600|NCT00379769|659881|P5|Main Study|Participant completed study at visit 27|0
194601|NCT00379769|659882|P4|Main Study|Participant completed study at visit 27|0
194602|NCT00379769|659883|P3|Main Study|Participant completed study at visit 27|0
194603|NCT00379769|659884|P2|Main Study|Participant completed study at visit 27|0
194604|NCT00379769|659885|P1|Main Study|Participant completed study at visit 27|1
194605|NCT00379769|659880|P6|Main Study|Physician Decision|0
194606|NCT00379769|659881|P5|Main Study|Physician Decision|0
194607|NCT00379769|659882|P4|Main Study|Physician Decision|1
194608|NCT00379769|659883|P3|Main Study|Physician Decision|1
194609|NCT00379769|659884|P2|Main Study|Physician Decision|2
194610|NCT00379769|659885|P1|Main Study|Physician Decision|2
194611|NCT00379769|659880|P6|Main Study|Participant did not take study drug|0
194612|NCT00379769|659881|P5|Main Study|Participant did not take study drug|0
194613|NCT00379769|659882|P4|Main Study|Participant did not take study drug|0
194614|NCT00379769|659883|P3|Main Study|Participant did not take study drug|1
194615|NCT00379769|659884|P2|Main Study|Participant did not take study drug|0
194616|NCT00379769|659885|P1|Main Study|Participant did not take study drug|0
194617|NCT00379769|659880|P6|Main Study|Entry criteria violation|0
194618|NCT00379769|659881|P5|Main Study|Entry criteria violation|0
194619|NCT00379769|659882|P4|Main Study|Entry criteria violation|1
194620|NCT00379769|659883|P3|Main Study|Entry criteria violation|1
194621|NCT00379769|659884|P2|Main Study|Entry criteria violation|0
194622|NCT00379769|659885|P1|Main Study|Entry criteria violation|0
194623|NCT00379769|659880|P6|Main Study|Site closed|0
194624|NCT00379769|659881|P5|Main Study|Site closed|0
194625|NCT00379769|659882|P4|Main Study|Site closed|8
194626|NCT00379769|659883|P3|Main Study|Site closed|4
194627|NCT00379769|659884|P2|Main Study|Site closed|4
194628|NCT00379769|659885|P1|Main Study|Site closed|4
194629|NCT00379769|659880|P6|Main Study|Prohibited glucose lowering medication|0
194630|NCT00379769|659881|P5|Main Study|Prohibited glucose lowering medication|0
194631|NCT00379769|659882|P4|Main Study|Prohibited glucose lowering medication|1
194632|NCT00379769|659883|P3|Main Study|Prohibited glucose lowering medication|0
194633|NCT00379769|659884|P2|Main Study|Prohibited glucose lowering medication|3
194634|NCT00379769|659885|P1|Main Study|Prohibited glucose lowering medication|0
194635|NCT00379769|659880|P6|Main Study|Poor compliance|0
194636|NCT00379769|659881|P5|Main Study|Poor compliance|0
194637|NCT00379769|659882|P4|Main Study|Poor compliance|1
194638|NCT00379769|659883|P3|Main Study|Poor compliance|2
194639|NCT00379769|659884|P2|Main Study|Poor compliance|2
194640|NCT00379769|659885|P1|Main Study|Poor compliance|3
194641|NCT00379769|659880|P6|Main Study|Participant moved|0
194642|NCT00379769|659881|P5|Main Study|Participant moved|0
194643|NCT00379769|659882|P4|Main Study|Participant moved|3
194644|NCT00379769|659883|P3|Main Study|Participant moved|3
194645|NCT00379769|659884|P2|Main Study|Participant moved|2
194646|NCT00379769|659885|P1|Main Study|Participant moved|3
194647|NCT00379769|659880|P6|Main Study|Moved to survival status follow-up only|0
194648|NCT00379769|659881|P5|Main Study|Moved to survival status follow-up only|0
194649|NCT00379769|659882|P4|Main Study|Moved to survival status follow-up only|36
194650|NCT00379769|659883|P3|Main Study|Moved to survival status follow-up only|32
194651|NCT00379769|659884|P2|Main Study|Moved to survival status follow-up only|25
194652|NCT00379769|659885|P1|Main Study|Moved to survival status follow-up only|27
194653|NCT00379769|659880|P6|Main Study|Withdrawal by Subject|0
194654|NCT00379769|659881|P5|Main Study|Withdrawal by Subject|0
194655|NCT00379769|659882|P4|Main Study|Withdrawal by Subject|70
194656|NCT00379769|659883|P3|Main Study|Withdrawal by Subject|72
194657|NCT00379769|659884|P2|Main Study|Withdrawal by Subject|56
194658|NCT00379769|659885|P1|Main Study|Withdrawal by Subject|46
194659|NCT00379769|659880|P6|Main Study|Lost to Follow-up|0
194660|NCT00379769|659881|P5|Main Study|Lost to Follow-up|0
194661|NCT00379769|659882|P4|Main Study|Lost to Follow-up|26
194662|NCT00379769|659883|P3|Main Study|Lost to Follow-up|25
194663|NCT00379769|659884|P2|Main Study|Lost to Follow-up|29
194664|NCT00379769|659885|P1|Main Study|Lost to Follow-up|29
194665|NCT00379769|659880|P6|Main Study|Adverse Event|0
194666|NCT00379769|659881|P5|Main Study|Adverse Event|0
194667|NCT00379769|659882|P4|Main Study|Adverse Event|11
194668|NCT00379769|659883|P3|Main Study|Adverse Event|10
194669|NCT00379769|659884|P2|Main Study|Adverse Event|8
194670|NCT00379769|659885|P1|Main Study|Adverse Event|5
194671|NCT00379769|659880|P6|Main Study|Death|0
194672|NCT00379769|659881|P5|Main Study|Death|0
194673|NCT00379769|659882|P4|Main Study|Death|72
194674|NCT00379769|659883|P3|Main Study|Death|54
194675|NCT00379769|659884|P2|Main Study|Death|67
194676|NCT00379769|659885|P1|Main Study|Death|57
194677|NCT00379639|660044|P5|Overall Study|Other|0
194678|NCT00379639|660045|P4|Overall Study|Other|0
194679|NCT00379639|660046|P3|Overall Study|Other|3
194680|NCT00379639|660047|P2|Overall Study|Other|0
194681|NCT00379639|660048|P1|Overall Study|Other|0
194682|NCT00379639|660044|P5|Overall Study|Lost to Follow-up|0
194683|NCT00379639|660045|P4|Overall Study|Lost to Follow-up|1
194684|NCT00379639|660046|P3|Overall Study|Lost to Follow-up|0
194685|NCT00379639|660047|P2|Overall Study|Lost to Follow-up|0
194686|NCT00379639|660048|P1|Overall Study|Lost to Follow-up|0
194687|NCT00379639|660044|P5|Overall Study|Adverse Event|1
194688|NCT00379639|660045|P4|Overall Study|Adverse Event|0
194689|NCT00379639|660046|P3|Overall Study|Adverse Event|1
194690|NCT00379639|660047|P2|Overall Study|Adverse Event|0
194691|NCT00379639|660048|P1|Overall Study|Adverse Event|0
194692|NCT00379639|660044|P5|Overall Study|Symptomatic Deterioration|1
194693|NCT00379639|660045|P4|Overall Study|Symptomatic Deterioration|0
194694|NCT00379639|660046|P3|Overall Study|Symptomatic Deterioration|1
194695|NCT00379639|660047|P2|Overall Study|Symptomatic Deterioration|0
194696|NCT00379639|660048|P1|Overall Study|Symptomatic Deterioration|0
194697|NCT00379639|660044|P5|Overall Study|Physician Decision|0
194698|NCT00379639|660045|P4|Overall Study|Physician Decision|1
194699|NCT00379639|660046|P3|Overall Study|Physician Decision|1
194700|NCT00379639|660047|P2|Overall Study|Physician Decision|2
194701|NCT00379639|660048|P1|Overall Study|Physician Decision|0
194702|NCT00379639|660044|P5|Overall Study|Disease Progression|4
194703|NCT00379639|660045|P4|Overall Study|Disease Progression|4
194704|NCT00379639|660046|P3|Overall Study|Disease Progression|3
194705|NCT00379639|660047|P2|Overall Study|Disease Progression|3
194706|NCT00379639|660048|P1|Overall Study|Disease Progression|3
194707|NCT00379587|660070|P1|Overall Study|Lost to Follow-up|2
194708|NCT00379353|660084|P2|Overall Study|Conflicting drug treatment|1
194709|NCT00379353|660085|P1|Overall Study|Conflicting drug treatment|0
194710|NCT00379353|660084|P2|Overall Study|Non-compliance|0
194711|NCT00379353|660085|P1|Overall Study|Non-compliance|1
194712|NCT00379353|660084|P2|Overall Study|Cardiac Tamponade|0
194713|NCT00379353|660085|P1|Overall Study|Cardiac Tamponade|1
194714|NCT00379353|660084|P2|Overall Study|Death|0
194715|NCT00379353|660085|P1|Overall Study|Death|1
194716|NCT00379353|660084|P2|Overall Study|Withdrawal by Subject|2
194717|NCT00379353|660085|P1|Overall Study|Withdrawal by Subject|5
194718|NCT00379353|660084|P2|Overall Study|Hospitalization|3
194719|NCT00379353|660085|P1|Overall Study|Hospitalization|3
194720|NCT00379340|660120|P5|Overall Study|Delayed nephrectomy and anaplasia|1
194721|NCT00379340|660121|P4|Overall Study|Delayed nephrectomy and anaplasia|1
194722|NCT00379340|660122|P3|Overall Study|Delayed nephrectomy and anaplasia|0
194723|NCT00379340|660123|P2|Overall Study|Delayed nephrectomy and anaplasia|0
194724|NCT00379340|660124|P1|Overall Study|Delayed nephrectomy and anaplasia|0
194725|NCT00379340|660120|P5|Overall Study|On more than 1 tumor therapeutic study|0
194726|NCT00379340|660121|P4|Overall Study|On more than 1 tumor therapeutic study|2
194727|NCT00379340|660122|P3|Overall Study|On more than 1 tumor therapeutic study|0
194728|NCT00379340|660123|P2|Overall Study|On more than 1 tumor therapeutic study|0
194729|NCT00379340|660124|P1|Overall Study|On more than 1 tumor therapeutic study|0
194730|NCT00379340|660120|P5|Overall Study|Refusal of further protocol therapy|7
194731|NCT00379340|660121|P4|Overall Study|Refusal of further protocol therapy|1
194732|NCT00379340|660122|P3|Overall Study|Refusal of further protocol therapy|1
194733|NCT00379340|660123|P2|Overall Study|Refusal of further protocol therapy|0
194734|NCT00379340|660124|P1|Overall Study|Refusal of further protocol therapy|1
194735|NCT00379340|660120|P5|Overall Study|Withdrawal by Subject|0
194736|NCT00379340|660121|P4|Overall Study|Withdrawal by Subject|1
194737|NCT00379340|660122|P3|Overall Study|Withdrawal by Subject|0
194738|NCT00379340|660123|P2|Overall Study|Withdrawal by Subject|0
194739|NCT00379340|660124|P1|Overall Study|Withdrawal by Subject|0
194740|NCT00379340|660120|P5|Overall Study|Physician Decision|3
194741|NCT00379340|660121|P4|Overall Study|Physician Decision|2
194742|NCT00379340|660122|P3|Overall Study|Physician Decision|1
194743|NCT00379340|660123|P2|Overall Study|Physician Decision|2
194744|NCT00379340|660124|P1|Overall Study|Physician Decision|6
194745|NCT00379340|660120|P5|Overall Study|Lack of Efficacy|3
194746|NCT00379340|660121|P4|Overall Study|Lack of Efficacy|4
194747|NCT00379340|660122|P3|Overall Study|Lack of Efficacy|0
194748|NCT00379340|660123|P2|Overall Study|Lack of Efficacy|1
194749|NCT00379340|660124|P1|Overall Study|Lack of Efficacy|6
194750|NCT00379340|660120|P5|Overall Study|Death|0
194751|NCT00379340|660121|P4|Overall Study|Death|2
194752|NCT00379340|660122|P3|Overall Study|Death|0
194753|NCT00379340|660123|P2|Overall Study|Death|0
194754|NCT00379340|660124|P1|Overall Study|Death|0
194755|NCT00379288|660141|P4|Overall Study|Administrative|1
194756|NCT00379288|660142|P3|Overall Study|Administrative|0
194757|NCT00379288|660143|P2|Overall Study|Administrative|2
194758|NCT00379288|660144|P1|Overall Study|Administrative|2
194759|NCT00379288|660141|P4|Overall Study|Did not meet protocol eligibility|2
194760|NCT00379288|660142|P3|Overall Study|Did not meet protocol eligibility|0
194761|NCT00379288|660143|P2|Overall Study|Did not meet protocol eligibility|1
194762|NCT00379288|660144|P1|Overall Study|Did not meet protocol eligibility|0
194763|NCT00379288|660141|P4|Overall Study|Noncompliance with protocol|1
194764|NCT00379288|660142|P3|Overall Study|Noncompliance with protocol|2
194765|NCT00379288|660143|P2|Overall Study|Noncompliance with protocol|6
194766|NCT00379288|660144|P1|Overall Study|Noncompliance with protocol|8
194767|NCT00379288|660141|P4|Overall Study|Subject withdrew-related to study drug|1
194768|NCT00379288|660142|P3|Overall Study|Subject withdrew-related to study drug|0
194769|NCT00379288|660143|P2|Overall Study|Subject withdrew-related to study drug|0
194770|NCT00379288|660144|P1|Overall Study|Subject withdrew-related to study drug|1
194771|NCT00379288|660141|P4|Overall Study|Subject withdrew-unrelated to study drug|2
194772|NCT00379288|660142|P3|Overall Study|Subject withdrew-unrelated to study drug|4
194773|NCT00379288|660143|P2|Overall Study|Subject withdrew-unrelated to study drug|3
194774|NCT00379288|660144|P1|Overall Study|Subject withdrew-unrelated to study drug|0
194775|NCT00379288|660141|P4|Overall Study|Lost to Follow-up|0
194776|NCT00379288|660142|P3|Overall Study|Lost to Follow-up|2
194777|NCT00379288|660143|P2|Overall Study|Lost to Follow-up|3
194778|NCT00379288|660144|P1|Overall Study|Lost to Follow-up|3
194779|NCT00379288|660141|P4|Overall Study|Treatment Failure|1
194780|NCT00379288|660142|P3|Overall Study|Treatment Failure|0
194781|NCT00379288|660143|P2|Overall Study|Treatment Failure|1
194782|NCT00379288|660144|P1|Overall Study|Treatment Failure|0
194783|NCT00379288|660141|P4|Overall Study|Adverse Event|0
194784|NCT00379288|660142|P3|Overall Study|Adverse Event|2
194785|NCT00379288|660143|P2|Overall Study|Adverse Event|6
194786|NCT00379288|660144|P1|Overall Study|Adverse Event|5
194787|NCT00379236|660156|P3|Open-label Extension|Not specified|7
194788|NCT00379236|660157|P2|Open-label Extension|Not specified|0
194789|NCT00379236|660158|P1|Open-label Extension|Not specified|0
194790|NCT00379236|660156|P3|Open-label Extension|Use of exclusionary medication|3
194791|NCT00379236|660157|P2|Open-label Extension|Use of exclusionary medication|0
194792|NCT00379236|660158|P1|Open-label Extension|Use of exclusionary medication|0
194793|NCT00379236|660156|P3|Open-label Extension|Lost to Follow-up|12
194794|NCT00379236|660157|P2|Open-label Extension|Lost to Follow-up|0
194795|NCT00379236|660158|P1|Open-label Extension|Lost to Follow-up|0
194796|NCT00379236|660156|P3|Open-label Extension|Withdrawal by Subject|13
194797|NCT00379236|660157|P2|Open-label Extension|Withdrawal by Subject|0
194798|NCT00379236|660158|P1|Open-label Extension|Withdrawal by Subject|0
194799|NCT00379236|660156|P3|Open-label Extension|Protocol Violation|7
194800|NCT00379236|660157|P2|Open-label Extension|Protocol Violation|0
194801|NCT00379236|660158|P1|Open-label Extension|Protocol Violation|0
194802|NCT00379236|660156|P3|Open-label Extension|Adverse Event|13
194803|NCT00379236|660157|P2|Open-label Extension|Adverse Event|0
194804|NCT00379236|660158|P1|Open-label Extension|Adverse Event|0
194805|NCT00379236|660156|P3|Double-blind|Data could not be retrieved|0
194806|NCT00379236|660157|P2|Double-blind|Data could not be retrieved|2
194807|NCT00379236|660158|P1|Double-blind|Data could not be retrieved|2
194808|NCT00379236|660156|P3|Double-blind|Not specified|0
194809|NCT00379236|660157|P2|Double-blind|Not specified|7
194810|NCT00379236|660158|P1|Double-blind|Not specified|3
194811|NCT00379236|660156|P3|Double-blind|Use of exclusionary medication|0
194812|NCT00379236|660157|P2|Double-blind|Use of exclusionary medication|2
194813|NCT00379236|660158|P1|Double-blind|Use of exclusionary medication|1
194814|NCT00379236|660156|P3|Double-blind|Lost to Follow-up|0
194815|NCT00379236|660157|P2|Double-blind|Lost to Follow-up|3
194816|NCT00379236|660158|P1|Double-blind|Lost to Follow-up|4
194817|NCT00379236|660156|P3|Double-blind|Withdrawal by Subject|0
194818|NCT00379236|660157|P2|Double-blind|Withdrawal by Subject|13
194819|NCT00379236|660158|P1|Double-blind|Withdrawal by Subject|12
194820|NCT00379236|660156|P3|Double-blind|Protocol Violation|0
194821|NCT00379236|660157|P2|Double-blind|Protocol Violation|3
194822|NCT00379236|660158|P1|Double-blind|Protocol Violation|3
194823|NCT00379236|660156|P3|Double-blind|Adverse Event|0
194824|NCT00379236|660157|P2|Double-blind|Adverse Event|6
194825|NCT00379236|660158|P1|Double-blind|Adverse Event|11
194826|NCT00379210|660203|P2|Overall Study|Withdrawal by Subject|7
194827|NCT00379210|660204|P1|Overall Study|Withdrawal by Subject|10
194828|NCT00379080|660227|P3|Overall Study|Withdrawal by Subject|0
194829|NCT00379080|660228|P2|Overall Study|Withdrawal by Subject|4
194830|NCT00379080|660229|P1|Overall Study|Withdrawal by Subject|0
194831|NCT00378898|660274|P2|Overall Study|Protocol Violation|1
194832|NCT00378898|660275|P1|Overall Study|Protocol Violation|1
194833|NCT00378898|660274|P2|Overall Study|Withdrawal by Subject|5
194834|NCT00378898|660275|P1|Overall Study|Withdrawal by Subject|10
194835|NCT00378703|660287|P4|Overall Study|Other|3
194836|NCT00378703|660288|P3|Overall Study|Other|2
194837|NCT00378703|660289|P2|Overall Study|Other|1
194838|NCT00378703|660290|P1|Overall Study|Other|1
194839|NCT00378703|660287|P4|Overall Study|Never started treatment|0
194840|NCT00378703|660288|P3|Overall Study|Never started treatment|0
194841|NCT00378703|660289|P2|Overall Study|Never started treatment|4
194842|NCT00378703|660290|P1|Overall Study|Never started treatment|1
194843|NCT00378703|660287|P4|Overall Study|Ineligible|7
194844|NCT00378703|660288|P3|Overall Study|Ineligible|7
194845|NCT00378703|660289|P2|Overall Study|Ineligible|7
194846|NCT00378703|660290|P1|Overall Study|Ineligible|4
194847|NCT00378703|660287|P4|Overall Study|Relocation|0
194848|NCT00378703|660288|P3|Overall Study|Relocation|1
194849|NCT00378703|660289|P2|Overall Study|Relocation|0
194850|NCT00378703|660290|P1|Overall Study|Relocation|0
194851|NCT00378703|660287|P4|Overall Study|Adverse events and progressive disease|1
194852|NCT00378703|660288|P3|Overall Study|Adverse events and progressive disease|0
194853|NCT00378703|660289|P2|Overall Study|Adverse events and progressive disease|0
194854|NCT00378703|660290|P1|Overall Study|Adverse events and progressive disease|0
194855|NCT00378703|660287|P4|Overall Study|Joint decision of physician and patient|0
194856|NCT00378703|660288|P3|Overall Study|Joint decision of physician and patient|0
194857|NCT00378703|660289|P2|Overall Study|Joint decision of physician and patient|0
194858|NCT00378703|660290|P1|Overall Study|Joint decision of physician and patient|1
194859|NCT00378703|660287|P4|Overall Study|Surgery|1
194860|NCT00378703|660288|P3|Overall Study|Surgery|0
194861|NCT00378703|660289|P2|Overall Study|Surgery|0
194862|NCT00378703|660290|P1|Overall Study|Surgery|1
194863|NCT00378703|660287|P4|Overall Study|Symptomatic deterioration|2
194864|NCT00378703|660288|P3|Overall Study|Symptomatic deterioration|0
194865|NCT00378703|660289|P2|Overall Study|Symptomatic deterioration|1
194866|NCT00378703|660290|P1|Overall Study|Symptomatic deterioration|0
194867|NCT00378703|660287|P4|Overall Study|Other complicated disease|0
194868|NCT00378703|660288|P3|Overall Study|Other complicated disease|2
194869|NCT00378703|660289|P2|Overall Study|Other complicated disease|2
194870|NCT00378703|660290|P1|Overall Study|Other complicated disease|0
194871|NCT00378703|660287|P4|Overall Study|Alternative therapy|0
194872|NCT00378703|660288|P3|Overall Study|Alternative therapy|0
194873|NCT00378703|660289|P2|Overall Study|Alternative therapy|2
194874|NCT00378703|660290|P1|Overall Study|Alternative therapy|4
194875|NCT00378703|660287|P4|Overall Study|Physician Decision|0
194876|NCT00378703|660288|P3|Overall Study|Physician Decision|1
194877|NCT00378703|660289|P2|Overall Study|Physician Decision|4
194878|NCT00378703|660290|P1|Overall Study|Physician Decision|1
194879|NCT00378703|660287|P4|Overall Study|Withdrawal by Subject|7
194880|NCT00378703|660288|P3|Overall Study|Withdrawal by Subject|5
194881|NCT00378703|660289|P2|Overall Study|Withdrawal by Subject|8
194882|NCT00378703|660290|P1|Overall Study|Withdrawal by Subject|4
194883|NCT00378703|660287|P4|Overall Study|Death|3
194884|NCT00378703|660288|P3|Overall Study|Death|4
194885|NCT00378703|660289|P2|Overall Study|Death|2
194886|NCT00378703|660290|P1|Overall Study|Death|2
194887|NCT00378703|660287|P4|Overall Study|Adverse Event|18
194888|NCT00378703|660288|P3|Overall Study|Adverse Event|20
194889|NCT00378703|660289|P2|Overall Study|Adverse Event|17
194890|NCT00378703|660290|P1|Overall Study|Adverse Event|11
194891|NCT00378703|660287|P4|Overall Study|Disease progression|49
194892|NCT00378703|660288|P3|Overall Study|Disease progression|48
194893|NCT00378703|660289|P2|Overall Study|Disease progression|43
194894|NCT00378703|660290|P1|Overall Study|Disease progression|59
194895|NCT00378599|660312|P1|Overall Study|Withdrawal by Subject|5
194896|NCT00378599|660312|P1|Overall Study|Treatment failure|7
194897|NCT00378599|660312|P1|Overall Study|Protocol Violation|2
194898|NCT00378599|660312|P1|Overall Study|Adverse Event|38
194899|NCT00378573|660316|P1|Follow-up|Withdrawal by Subject|1
194900|NCT00378573|660316|P1|Follow-up|Lost to Follow-up|1
194901|NCT00378573|660316|P1|Follow-up|Death|12
194902|NCT00378573|660316|P1|Treatment Period|Sponsor decision to close study|1
194903|NCT00378573|660316|P1|Treatment Period|Disease Progression|4
194904|NCT00378573|660316|P1|Treatment Period|Withdrawal by Subject|2
194905|NCT00378573|660316|P1|Treatment Period|Physician Decision|1
194906|NCT00378573|660316|P1|Treatment Period|Adverse Event|9
194907|NCT00378560|660324|P2|Overall Study|Laboratory test values abnormal|0
194908|NCT00378560|660325|P1|Overall Study|Laboratory test values abnormal|1
194909|NCT00378560|660324|P2|Overall Study|Pregnancy|5
194910|NCT00378560|660325|P1|Overall Study|Pregnancy|7
194911|NCT00378560|660324|P2|Overall Study|Moved|3
194912|NCT00378560|660325|P1|Overall Study|Moved|4
194913|NCT00378560|660324|P2|Overall Study|Withdrawal by Subject|21
194914|NCT00378560|660325|P1|Overall Study|Withdrawal by Subject|17
194915|NCT00378560|660324|P2|Overall Study|Protocol Violation|0
194916|NCT00378560|660325|P1|Overall Study|Protocol Violation|2
194917|NCT00378560|660324|P2|Overall Study|Lost to Follow-up|29
194918|NCT00378560|660325|P1|Overall Study|Lost to Follow-up|24
194919|NCT00378560|660324|P2|Overall Study|Adverse Event|0
194920|NCT00378560|660325|P1|Overall Study|Adverse Event|1
194921|NCT00378534|660339|P1|Overall Study|Subjects did not receive a transplant|3
194922|NCT00378534|660339|P1|Overall Study|Donors|57
194923|NCT00378508|660345|P2|Overall Study|Lost to Follow-up|0
194924|NCT00378508|660346|P1|Overall Study|Lost to Follow-up|1
194925|NCT00378508|660345|P2|Overall Study|Withdrawal by Subject|3
194926|NCT00378508|660346|P1|Overall Study|Withdrawal by Subject|1
194927|NCT00378378|660365|P3|Overall Study|Non-compliance with protocol|1
194928|NCT00378378|660366|P2|Overall Study|Non-compliance with protocol|0
194929|NCT00378378|660367|P1|Overall Study|Non-compliance with protocol|0
194930|NCT00378378|660365|P3|Overall Study|Treatment Failure|1
194931|NCT00378378|660366|P2|Overall Study|Treatment Failure|0
194932|NCT00378378|660367|P1|Overall Study|Treatment Failure|0
194933|NCT00378378|660365|P3|Overall Study|Withdrawal by Subject|0
194934|NCT00378378|660366|P2|Overall Study|Withdrawal by Subject|1
194935|NCT00378378|660367|P1|Overall Study|Withdrawal by Subject|0
194936|NCT00378209|660413|P1|Overall Study|Treatment delay|1
194937|NCT00378209|660413|P1|Overall Study|Death|1
194938|NCT00378209|660413|P1|Overall Study|Physician Decision|3
194939|NCT00378209|660413|P1|Overall Study|Initiation of non-protocol therapy|3
194940|NCT00378209|660413|P1|Overall Study|Adverse Event|3
194941|NCT00378209|660413|P1|Overall Study|Progressive disease|11
194942|NCT00378105|660423|P2|Overall Study|necessity to increase lenalidomide dose|1
194943|NCT00378105|660424|P1|Overall Study|necessity to increase lenalidomide dose|0
194944|NCT00378105|660423|P2|Overall Study|Going non-protocol therapy|1
194945|NCT00378105|660424|P1|Overall Study|Going non-protocol therapy|0
194946|NCT00378105|660423|P2|Overall Study|Physician Decision|2
194947|NCT00378105|660424|P1|Overall Study|Physician Decision|0
194948|NCT00378105|660423|P2|Overall Study|remain on study|11
194949|NCT00378105|660424|P1|Overall Study|remain on study|3
194950|NCT00378105|660423|P2|Overall Study|Progressive disease|3
194951|NCT00378105|660424|P1|Overall Study|Progressive disease|3
194952|NCT00378105|660423|P2|Overall Study|Going to transplant|8
194953|NCT00378105|660424|P1|Overall Study|Going to transplant|7
194954|NCT00378105|660423|P2|Overall Study|Death|0
194955|NCT00378105|660424|P1|Overall Study|Death|1
194956|NCT00378105|660423|P2|Overall Study|Withdrawal by Subject|3
194957|NCT00378105|660424|P1|Overall Study|Withdrawal by Subject|3
194958|NCT00378105|660423|P2|Overall Study|Adverse Event|1
194959|NCT00378105|660424|P1|Overall Study|Adverse Event|3
194960|NCT00378079|660436|P3|Overall Study|Lost to Follow-up|0
194961|NCT00378079|660437|P2|Overall Study|Lost to Follow-up|1
194962|NCT00378079|660438|P1|Overall Study|Lost to Follow-up|6
194963|NCT00378014|660460|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
194964|NCT00378014|660461|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
194965|NCT00378014|660460|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
194966|NCT00378014|660461|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
194967|NCT00378014|660460|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
194968|NCT00378014|660461|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
194969|NCT00378014|660460|P2|Extension (Month 12 to Month 59)|Administrative problems|0
194970|NCT00378014|660461|P1|Extension (Month 12 to Month 59)|Administrative problems|1
194971|NCT00378014|660460|P2|Extension (Month 12 to Month 59)|Death|2
194972|NCT00378014|660461|P1|Extension (Month 12 to Month 59)|Death|1
194973|NCT00378014|660460|P2|Extension (Month 12 to Month 59)|Adverse Event|7
194974|NCT00378014|660461|P1|Extension (Month 12 to Month 59)|Adverse Event|8
194975|NCT00378014|660460|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
194976|NCT00378014|660461|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
194977|NCT00378014|660460|P2|Core (Randomization to Month 11)|Protocol deviation|1
194978|NCT00378014|660461|P1|Core (Randomization to Month 11)|Protocol deviation|0
194979|NCT00378014|660460|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
194980|NCT00378014|660461|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
194981|NCT00378014|660460|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
194982|NCT00378014|660461|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
194983|NCT00378014|660460|P2|Core (Randomization to Month 11)|Administrative Problems|2
194984|NCT00378014|660461|P1|Core (Randomization to Month 11)|Administrative Problems|2
194985|NCT00378014|660460|P2|Core (Randomization to Month 11)|Death|3
194986|NCT00378014|660461|P1|Core (Randomization to Month 11)|Death|5
194987|NCT00378014|660460|P2|Core (Randomization to Month 11)|Graft loss|2
194988|NCT00378014|660461|P1|Core (Randomization to Month 11)|Graft loss|1
194989|NCT00378014|660460|P2|Core (Randomization to Month 11)|Adverse Event|0
194990|NCT00378014|660461|P1|Core (Randomization to Month 11)|Adverse Event|1
194991|NCT00377962|660487|P2|Extension Study: 12-24 Months|Unspecified reason|3
194992|NCT00377962|660488|P1|Extension Study: 12-24 Months|Unspecified reason|0
194993|NCT00377962|660487|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
194994|NCT00377962|660488|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
194995|NCT00377962|660487|P2|Extension Study: 12-24 Months|Adverse Event|0
194996|NCT00377962|660488|P1|Extension Study: 12-24 Months|Adverse Event|8
194997|NCT00377962|660487|P2|Extension Study: 12-24 Months|Death|1
194998|NCT00377962|660488|P1|Extension Study: 12-24 Months|Death|1
194999|NCT00377962|660487|P2|Core Study: 0-12 Months|Unspecified reasons|4
195000|NCT00377962|660488|P1|Core Study: 0-12 Months|Unspecified reasons|1
195001|NCT00377962|660487|P2|Core Study: 0-12 Months|Administrative Reason|1
195002|NCT00377962|660488|P1|Core Study: 0-12 Months|Administrative Reason|1
195003|NCT00377962|660487|P2|Core Study: 0-12 Months|Withdrew Consent|2
195004|NCT00377962|660488|P1|Core Study: 0-12 Months|Withdrew Consent|5
195005|NCT00377962|660487|P2|Core Study: 0-12 Months|Death|0
195006|NCT00377962|660488|P1|Core Study: 0-12 Months|Death|3
195007|NCT00377962|660487|P2|Core Study: 0-12 Months|Adverse Event|2
195008|NCT00377962|660488|P1|Core Study: 0-12 Months|Adverse Event|18
195009|NCT00377858|660524|P2|Overall Study|Death|3
195010|NCT00377858|660525|P1|Overall Study|Death|0
195011|NCT00377858|660524|P2|Overall Study|Sponsor Decision|2
195012|NCT00377858|660525|P1|Overall Study|Sponsor Decision|1
195013|NCT00377858|660524|P2|Overall Study|Entry Criteria Not Met|0
195014|NCT00377858|660525|P1|Overall Study|Entry Criteria Not Met|2
195015|NCT00377858|660524|P2|Overall Study|Adverse Event|1
195016|NCT00377858|660525|P1|Overall Study|Adverse Event|2
195017|NCT00377858|660524|P2|Overall Study|Protocol Violation|4
195018|NCT00377858|660525|P1|Overall Study|Protocol Violation|3
195019|NCT00377858|660524|P2|Overall Study|Physician Decision|5
195020|NCT00377858|660525|P1|Overall Study|Physician Decision|5
195021|NCT00377858|660524|P2|Overall Study|Lost to Follow-up|1
195022|NCT00377858|660525|P1|Overall Study|Lost to Follow-up|6
195023|NCT00377858|660524|P2|Overall Study|Withdrawal by Subject|11
195024|NCT00377858|660525|P1|Overall Study|Withdrawal by Subject|12
195025|NCT00377819|660578|P2|Overall Study|Protocol Violation|1
195026|NCT00377819|660579|P1|Overall Study|Protocol Violation|1
195027|NCT00377819|660578|P2|Overall Study|Lost to Follow-up|1
195028|NCT00377819|660579|P1|Overall Study|Lost to Follow-up|0
195029|NCT00377819|660578|P2|Overall Study|Death|1
195030|NCT00377819|660579|P1|Overall Study|Death|0
195031|NCT00377819|660578|P2|Overall Study|Withdrawal by Subject|4
195032|NCT00377819|660579|P1|Overall Study|Withdrawal by Subject|10
195033|NCT00377819|660578|P2|Overall Study|Adverse Event|3
195034|NCT00377819|660579|P1|Overall Study|Adverse Event|2
195035|NCT00377676|660608|P2|Overall Study|not specified|58
195036|NCT00377676|660609|P1|Overall Study|not specified|118
195037|NCT00377676|660608|P2|Overall Study|Lost to Follow-up|56
195038|NCT00377676|660609|P1|Overall Study|Lost to Follow-up|120
195039|NCT00377676|660608|P2|Overall Study|Withdrawal by Subject|72
195040|NCT00377676|660609|P1|Overall Study|Withdrawal by Subject|187
195041|NCT00377676|660608|P2|Overall Study|Death|2
195042|NCT00377676|660609|P1|Overall Study|Death|5
195043|NCT00377676|660608|P2|Overall Study|Protocol Violation|27
195044|NCT00377676|660609|P1|Overall Study|Protocol Violation|33
195045|NCT00377676|660608|P2|Overall Study|Adverse Event|107
195046|NCT00377676|660609|P1|Overall Study|Adverse Event|498
195047|NCT00377637|660625|P4|Maintenance Phase|Death|1
195048|NCT00377637|660626|P3|Maintenance Phase|Death|0
195049|NCT00377637|660627|P2|Maintenance Phase|Death|0
195050|NCT00377637|660628|P1|Maintenance Phase|Death|0
195051|NCT00377637|660625|P4|Maintenance Phase|Study medication stopped > 14 days|1
195052|NCT00377637|660626|P3|Maintenance Phase|Study medication stopped > 14 days|0
195053|NCT00377637|660627|P2|Maintenance Phase|Study medication stopped > 14 days|0
195054|NCT00377637|660628|P1|Maintenance Phase|Study medication stopped > 14 days|0
195055|NCT00377637|660625|P4|Maintenance Phase|Non-compliance|1
195056|NCT00377637|660626|P3|Maintenance Phase|Non-compliance|1
195057|NCT00377637|660627|P2|Maintenance Phase|Non-compliance|0
195058|NCT00377637|660628|P1|Maintenance Phase|Non-compliance|0
195059|NCT00377637|660625|P4|Maintenance Phase|Sponsor decision|3
195060|NCT00377637|660626|P3|Maintenance Phase|Sponsor decision|2
195061|NCT00377637|660627|P2|Maintenance Phase|Sponsor decision|0
195062|NCT00377637|660628|P1|Maintenance Phase|Sponsor decision|0
195063|NCT00377637|660625|P4|Maintenance Phase|Withdrawal by Subject|3
195064|NCT00377637|660626|P3|Maintenance Phase|Withdrawal by Subject|3
195065|NCT00377637|660627|P2|Maintenance Phase|Withdrawal by Subject|0
195066|NCT00377637|660628|P1|Maintenance Phase|Withdrawal by Subject|0
195067|NCT00377637|660625|P4|Maintenance Phase|Lost to Follow-up|1
195068|NCT00377637|660626|P3|Maintenance Phase|Lost to Follow-up|3
195069|NCT00377637|660627|P2|Maintenance Phase|Lost to Follow-up|0
195070|NCT00377637|660628|P1|Maintenance Phase|Lost to Follow-up|0
195071|NCT00377637|660625|P4|Maintenance Phase|Physician Decision|4
195072|NCT00377637|660626|P3|Maintenance Phase|Physician Decision|5
195073|NCT00377637|660627|P2|Maintenance Phase|Physician Decision|0
195074|NCT00377637|660628|P1|Maintenance Phase|Physician Decision|0
195075|NCT00377637|660625|P4|Maintenance Phase|Adverse Event|43
195076|NCT00377637|660626|P3|Maintenance Phase|Adverse Event|29
195077|NCT00377637|660627|P2|Maintenance Phase|Adverse Event|0
195078|NCT00377637|660628|P1|Maintenance Phase|Adverse Event|0
195079|NCT00377637|660625|P4|Induction Phase|Reason for withdrawal is not noted|0
195080|NCT00377637|660626|P3|Induction Phase|Reason for withdrawal is not noted|0
195081|NCT00377637|660627|P2|Induction Phase|Reason for withdrawal is not noted|0
195082|NCT00377637|660628|P1|Induction Phase|Reason for withdrawal is not noted|2
195083|NCT00377637|660625|P4|Induction Phase|Non-Compliance|0
195084|NCT00377637|660626|P3|Induction Phase|Non-Compliance|0
195085|NCT00377637|660627|P2|Induction Phase|Non-Compliance|0
195086|NCT00377637|660628|P1|Induction Phase|Non-Compliance|1
195087|NCT00377637|660625|P4|Induction Phase|Sponsor decision|0
195088|NCT00377637|660626|P3|Induction Phase|Sponsor decision|0
195089|NCT00377637|660627|P2|Induction Phase|Sponsor decision|2
195090|NCT00377637|660628|P1|Induction Phase|Sponsor decision|1
195091|NCT00377637|660625|P4|Induction Phase|Physician Decision|0
195092|NCT00377637|660626|P3|Induction Phase|Physician Decision|0
195093|NCT00377637|660627|P2|Induction Phase|Physician Decision|1
195094|NCT00377637|660628|P1|Induction Phase|Physician Decision|3
195095|NCT00377637|660625|P4|Induction Phase|Withdrawal by Subject|0
195096|NCT00377637|660626|P3|Induction Phase|Withdrawal by Subject|0
195097|NCT00377637|660627|P2|Induction Phase|Withdrawal by Subject|6
195098|NCT00377637|660628|P1|Induction Phase|Withdrawal by Subject|5
195099|NCT00377637|660625|P4|Induction Phase|Death|0
195100|NCT00377637|660626|P3|Induction Phase|Death|0
195101|NCT00377637|660627|P2|Induction Phase|Death|3
195102|NCT00377637|660628|P1|Induction Phase|Death|1
195103|NCT00377637|660625|P4|Induction Phase|Lost to Follow-up|0
195104|NCT00377637|660626|P3|Induction Phase|Lost to Follow-up|0
195105|NCT00377637|660627|P2|Induction Phase|Lost to Follow-up|1
195106|NCT00377637|660628|P1|Induction Phase|Lost to Follow-up|2
195107|NCT00377637|660625|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
195108|NCT00377637|660626|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
195109|NCT00377637|660627|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
195110|NCT00377637|660628|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
195111|NCT00377637|660625|P4|Induction Phase|Deterioration/serum creatinine|0
195112|NCT00377637|660626|P3|Induction Phase|Deterioration/serum creatinine|0
195113|NCT00377637|660627|P2|Induction Phase|Deterioration/serum creatinine|0
195114|NCT00377637|660628|P1|Induction Phase|Deterioration/serum creatinine|2
195115|NCT00377637|660625|P4|Induction Phase|Adverse Event|0
195116|NCT00377637|660626|P3|Induction Phase|Adverse Event|0
195117|NCT00377637|660627|P2|Induction Phase|Adverse Event|21
195118|NCT00377637|660628|P1|Induction Phase|Adverse Event|12
195119|NCT00377520|660703|P1|Overall Study|Ineligible (Prior radiation)|1
195120|NCT00377455|660708|P1|Overall Study|Withdrawal by Subject|1
195121|NCT00377429|660716|P1|Overall Study|Patient non-compliance|1
195122|NCT00377429|660716|P1|Overall Study|Physician Decision|1
195123|NCT00377429|660716|P1|Overall Study|Adverse Event|8
195124|NCT00377429|660716|P1|Overall Study|Withdrawal by Subject|5
195125|NCT00377403|660727|P2|Overall Study|Unable to contact for telephone intervie|7
195126|NCT00377403|660728|P1|Overall Study|Unable to contact for telephone intervie|4
195127|NCT00377364|660736|P2|Overall Study|Withdrawal by Subject|0
195128|NCT00377364|660737|P1|Overall Study|Withdrawal by Subject|1
195129|NCT00377364|660736|P2|Overall Study|Lost to Follow-up|0
195130|NCT00377364|660737|P1|Overall Study|Lost to Follow-up|1
195131|NCT00377312|660763|P2|Overall Study|Adverse Event|1
195132|NCT00377312|660764|P1|Overall Study|Adverse Event|1
195133|NCT00377299|660796|P2|Overall Study|Withdrawal by Subject|4
195134|NCT00377299|660797|P1|Overall Study|Withdrawal by Subject|5
195135|NCT00377299|660796|P2|Overall Study|Adverse Event|1
195136|NCT00377299|660797|P1|Overall Study|Adverse Event|0
195137|NCT00377299|660796|P2|Overall Study|Lost to Follow-up|19
195138|NCT00377299|660797|P1|Overall Study|Lost to Follow-up|14
195139|NCT00377260|660813|P2|Overall Study|Withdrawal by Subject|4
195140|NCT00377260|660814|P1|Overall Study|Withdrawal by Subject|2
195141|NCT00377260|660813|P2|Overall Study|Lost to Follow-up|1
195142|NCT00377260|660814|P1|Overall Study|Lost to Follow-up|0
195143|NCT00377234|660868|P2|Overall Study|Not assigned|2
195144|NCT00377234|660869|P1|Overall Study|Not assigned|3
195145|NCT00377234|660868|P2|Overall Study|Administrative|1
195146|NCT00377234|660869|P1|Overall Study|Administrative|2
195147|NCT00377234|660868|P2|Overall Study|Lost to Follow-up|2
195148|NCT00377234|660869|P1|Overall Study|Lost to Follow-up|4
195149|NCT00377234|660868|P2|Overall Study|Withdrawal by Subject|9
195150|NCT00377234|660869|P1|Overall Study|Withdrawal by Subject|11
195151|NCT00377234|660868|P2|Overall Study|Adverse Event|17
195152|NCT00377234|660869|P1|Overall Study|Adverse Event|14
195153|NCT00377156|660887|P2|Overall Study|Other|2
195154|NCT00377156|660888|P1|Overall Study|Other|5
195155|NCT00377156|660887|P2|Overall Study|Disability or language problem|1
195156|NCT00377156|660888|P1|Overall Study|Disability or language problem|0
195157|NCT00377156|660887|P2|Overall Study|Ineligible|1
195158|NCT00377156|660888|P1|Overall Study|Ineligible|0
195159|NCT00377156|660887|P2|Overall Study|Refused testing|1
195160|NCT00377156|660888|P1|Overall Study|Refused testing|0
195161|NCT00377156|660887|P2|Overall Study|Cancellation|0
195162|NCT00377156|660888|P1|Overall Study|Cancellation|1
195163|NCT00377156|660887|P2|Overall Study|Had follow-up <90 d|6
195164|NCT00377156|660888|P1|Overall Study|Had follow-up <90 d|3
195165|NCT00377156|660887|P2|Overall Study|Withdrawal by Subject|24
195166|NCT00377156|660888|P1|Overall Study|Withdrawal by Subject|16
195167|NCT00377156|660887|P2|Overall Study|Death|19
195168|NCT00377156|660888|P1|Overall Study|Death|23
195169|NCT00376961|660902|P2|Maintenance|Ineligible|3
195170|NCT00376961|660903|P1|Maintenance|Ineligible|0
195171|NCT00376961|660902|P2|Maintenance|Progression/relapse|18
195172|NCT00376961|660903|P1|Maintenance|Progression/relapse|0
195173|NCT00376961|660902|P2|Maintenance|Refusal Unrelated to Adverse Event|1
195174|NCT00376961|660903|P1|Maintenance|Refusal Unrelated to Adverse Event|0
195175|NCT00376961|660902|P2|Maintenance|Adverse Event|1
195176|NCT00376961|660903|P1|Maintenance|Adverse Event|0
195177|NCT00376961|660902|P2|Initial Registration|Ineligible|0
195178|NCT00376961|660903|P1|Initial Registration|Ineligible|3
195179|NCT00376961|660902|P2|Initial Registration|Progression/relapse|0
195180|NCT00376961|660903|P1|Initial Registration|Progression/relapse|1
195181|NCT00376961|660902|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
195182|NCT00376961|660903|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
195183|NCT00376961|660902|P2|Initial Registration|Adverse Event|0
195184|NCT00376961|660903|P1|Initial Registration|Adverse Event|1
195185|NCT00376688|660969|P1|Overall Study|Death|1
195186|NCT00376688|660969|P1|Overall Study|Adverse Event|3
195187|NCT00376675|660975|P2|Overall Study|Other Reason|7
195188|NCT00376675|660976|P1|Overall Study|Other Reason|1
195189|NCT00376675|660975|P2|Overall Study|Adverse Event|5
195190|NCT00376675|660976|P1|Overall Study|Adverse Event|10
195191|NCT00376675|660975|P2|Overall Study|Withdrawal by Subject|2
195192|NCT00376675|660976|P1|Overall Study|Withdrawal by Subject|9
195193|NCT00376532|661025|P2|Overall Study|Lack sufficient blood sample|6
195194|NCT00376532|661026|P1|Overall Study|Lack sufficient blood sample|6
195195|NCT00376506|661036|P2|Overall Study|Death|2
195196|NCT00376506|661037|P1|Overall Study|Death|0
195197|NCT00376259|661068|P2|Overall Study|Patient request|0
195198|NCT00376259|661069|P1|Overall Study|Patient request|1
195199|NCT00376259|661068|P2|Overall Study|Sponsor request - study termination|21
195200|NCT00376259|661069|P1|Overall Study|Sponsor request - study termination|21
195201|NCT00376220|661083|P2|Overall Study|Withdrawal by Subject|2
195202|NCT00376220|661084|P1|Overall Study|Withdrawal by Subject|3
195203|NCT00376220|661083|P2|Overall Study|Lost to Follow-up|10
195204|NCT00376220|661084|P1|Overall Study|Lost to Follow-up|7
195205|NCT00376168|661092|P2|Overall Study|Pregnancy|0
195206|NCT00376168|661093|P1|Overall Study|Pregnancy|1
195207|NCT00376168|661092|P2|Overall Study|Adverse Event|1
195208|NCT00376168|661093|P1|Overall Study|Adverse Event|1
195209|NCT00375934|661134|P2|Overall Study|Physician Decision|1
195210|NCT00375934|661135|P1|Overall Study|Physician Decision|0
195211|NCT00375934|661134|P2|Overall Study|Lack of Efficacy|2
195212|NCT00375934|661135|P1|Overall Study|Lack of Efficacy|0
195213|NCT00375934|661134|P2|Overall Study|Withdrawal by Subject|2
195214|NCT00375934|661135|P1|Overall Study|Withdrawal by Subject|2
195215|NCT00375934|661134|P2|Overall Study|Adverse Event|1
195216|NCT00375934|661135|P1|Overall Study|Adverse Event|1
195217|NCT00375752|661163|P2|Overall Study|Administrative Problems|1
195218|NCT00375752|661164|P1|Overall Study|Administrative Problems|0
195219|NCT00375752|661163|P2|Overall Study|Protocol Violation|2
195220|NCT00375752|661164|P1|Overall Study|Protocol Violation|0
195221|NCT00375752|661163|P2|Overall Study|Abnormal Laboratory Value(s)|1
195222|NCT00375752|661164|P1|Overall Study|Abnormal Laboratory Value(s)|1
195223|NCT00375752|661163|P2|Overall Study|Withdrawal by Subject|1
195224|NCT00375752|661164|P1|Overall Study|Withdrawal by Subject|6
195225|NCT00375752|661163|P2|Overall Study|Adverse Event|6
195226|NCT00375752|661164|P1|Overall Study|Adverse Event|1
195227|NCT00375752|661163|P2|Overall Study|Lack of Efficacy|4
195228|NCT00375752|661164|P1|Overall Study|Lack of Efficacy|4
195229|NCT00375674|661195|P2|Overall Study|Lost to Follow-up|12
195230|NCT00375674|661196|P1|Overall Study|Lost to Follow-up|14
195231|NCT00375674|661195|P2|Overall Study|Subject refused further follow-up|23
195232|NCT00375674|661196|P1|Overall Study|Subject refused further follow-up|24
195233|NCT00375674|661195|P2|Overall Study|Death|64
195234|NCT00375674|661196|P1|Overall Study|Death|61
195235|NCT00375674|661195|P2|Overall Study|Not specified|16
195236|NCT00375674|661196|P1|Overall Study|Not specified|24
195237|NCT00375609|661225|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
195238|NCT00375609|661226|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
195239|NCT00375609|661227|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
195240|NCT00375609|661225|P3|Overall Study|Withdrawal by Subject|0
195241|NCT00375609|661226|P2|Overall Study|Withdrawal by Subject|4
195242|NCT00375609|661227|P1|Overall Study|Withdrawal by Subject|1
195243|NCT00375609|661225|P3|Overall Study|Physician Decision|1
195244|NCT00375609|661226|P2|Overall Study|Physician Decision|0
195245|NCT00375609|661227|P1|Overall Study|Physician Decision|0
195246|NCT00375609|661225|P3|Overall Study|Lost to Follow-up|0
195247|NCT00375609|661226|P2|Overall Study|Lost to Follow-up|0
195248|NCT00375609|661227|P1|Overall Study|Lost to Follow-up|1
195249|NCT00375609|661225|P3|Overall Study|Adverse Event|0
195250|NCT00375609|661226|P2|Overall Study|Adverse Event|3
195251|NCT00375609|661227|P1|Overall Study|Adverse Event|0
195252|NCT00375609|661225|P3|Overall Study|Did not receive treatment|0
195253|NCT00375609|661226|P2|Overall Study|Did not receive treatment|0
195254|NCT00375609|661227|P1|Overall Study|Did not receive treatment|1
195255|NCT00375518|661243|P2|Overall Study|Death|1
195256|NCT00375518|661244|P1|Overall Study|Death|0
195257|NCT00375518|661243|P2|Overall Study|Patient Not Treated|6
195258|NCT00375518|661244|P1|Overall Study|Patient Not Treated|6
195259|NCT00375518|661243|P2|Overall Study|Withdrawal by Subject|10
195260|NCT00375518|661244|P1|Overall Study|Withdrawal by Subject|2
195261|NCT00375505|661252|P2|Overall Study|Adverse Event|2
195262|NCT00375505|661253|P1|Overall Study|Adverse Event|1
195263|NCT00375492|661297|P2|Overall Study|Withdrawal by Subject|6
195264|NCT00375492|661298|P1|Overall Study|Withdrawal by Subject|6
195265|NCT00375492|661297|P2|Overall Study|Sponsor Decision|1
195266|NCT00375492|661298|P1|Overall Study|Sponsor Decision|0
195267|NCT00375492|661297|P2|Overall Study|Protocol Violation|3
195268|NCT00375492|661298|P1|Overall Study|Protocol Violation|6
195269|NCT00375492|661297|P2|Overall Study|Physician Decision|4
195270|NCT00375492|661298|P1|Overall Study|Physician Decision|0
195271|NCT00375492|661297|P2|Overall Study|Lost to Follow-up|5
195272|NCT00375492|661298|P1|Overall Study|Lost to Follow-up|10
195273|NCT00375492|661297|P2|Overall Study|Loss of Glucose Control|1
195274|NCT00375492|661298|P1|Overall Study|Loss of Glucose Control|0
195275|NCT00375492|661297|P2|Overall Study|Entry Criteria Not Met|1
195276|NCT00375492|661298|P1|Overall Study|Entry Criteria Not Met|0
195277|NCT00375492|661297|P2|Overall Study|Adverse Event|5
195278|NCT00375492|661298|P1|Overall Study|Adverse Event|4
195279|NCT00375427|661328|P2|Overall Study|Death|10
195280|NCT00375427|661329|P1|Overall Study|Death|11
195281|NCT00375427|661328|P2|Overall Study|Administrative reasons|1
195282|NCT00375427|661329|P1|Overall Study|Administrative reasons|0
195283|NCT00375427|661328|P2|Overall Study|Lost to Follow-up|1
195284|NCT00375427|661329|P1|Overall Study|Lost to Follow-up|1
195285|NCT00375427|661328|P2|Overall Study|Withdrawal by Subject|13
195286|NCT00375427|661329|P1|Overall Study|Withdrawal by Subject|9
195287|NCT00375427|661328|P2|Overall Study|Protocol Violation|8
195288|NCT00375427|661329|P1|Overall Study|Protocol Violation|10
195289|NCT00375427|661328|P2|Overall Study|Patient no longer requires study drug|7
195290|NCT00375427|661329|P1|Overall Study|Patient no longer requires study drug|3
195291|NCT00375427|661328|P2|Overall Study|Unsatisfactory therapeutic effect|4
195292|NCT00375427|661329|P1|Overall Study|Unsatisfactory therapeutic effect|4
195293|NCT00375427|661328|P2|Overall Study|Abnormal laboratory value(s)|2
195294|NCT00375427|661329|P1|Overall Study|Abnormal laboratory value(s)|1
195295|NCT00375427|661328|P2|Overall Study|Abnormal test procedure result(s)|1
195296|NCT00375427|661329|P1|Overall Study|Abnormal test procedure result(s)|0
195297|NCT00375427|661328|P2|Overall Study|Adverse Event|27
195298|NCT00375427|661329|P1|Overall Study|Adverse Event|21
195299|NCT00375219|661354|P3|Overall Study|Withdrawal by Subject|0
195300|NCT00375219|661355|P2|Overall Study|Withdrawal by Subject|0
195301|NCT00375219|661356|P1|Overall Study|Withdrawal by Subject|1
195302|NCT00375219|661354|P3|Overall Study|Cord blood transplantation|0
195303|NCT00375219|661355|P2|Overall Study|Cord blood transplantation|0
195304|NCT00375219|661356|P1|Overall Study|Cord blood transplantation|1
195305|NCT00375219|661354|P3|Overall Study|Allograft|0
195306|NCT00375219|661355|P2|Overall Study|Allograft|0
195307|NCT00375219|661356|P1|Overall Study|Allograft|2
195308|NCT00375219|661354|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
195309|NCT00375219|661355|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
195310|NCT00375219|661356|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
195311|NCT00375219|661354|P3|Overall Study|Hematologic resistance|0
195312|NCT00375219|661355|P2|Overall Study|Hematologic resistance|0
195313|NCT00375219|661356|P1|Overall Study|Hematologic resistance|1
195314|NCT00375219|661354|P3|Overall Study|Death|7
195315|NCT00375219|661355|P2|Overall Study|Death|3
195316|NCT00375219|661356|P1|Overall Study|Death|4
195317|NCT00375219|661354|P3|Overall Study|Disease progression|12
195318|NCT00375219|661355|P2|Overall Study|Disease progression|9
195319|NCT00375219|661356|P1|Overall Study|Disease progression|18
195320|NCT00375219|661354|P3|Overall Study|Lost to Follow-up|0
195321|NCT00375219|661355|P2|Overall Study|Lost to Follow-up|1
195322|NCT00375219|661356|P1|Overall Study|Lost to Follow-up|1
195323|NCT00375219|661354|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
195324|NCT00375219|661355|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
195325|NCT00375219|661356|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
195326|NCT00375219|661354|P3|Overall Study|Protocol Violation|1
195327|NCT00375219|661355|P2|Overall Study|Protocol Violation|0
195328|NCT00375219|661356|P1|Overall Study|Protocol Violation|1
195329|NCT00375219|661354|P3|Overall Study|Adverse Event|1
195330|NCT00375219|661355|P2|Overall Study|Adverse Event|2
195331|NCT00375219|661356|P1|Overall Study|Adverse Event|8
195332|NCT00375219|661354|P3|Overall Study|Failure to achieve a response|0
195333|NCT00375219|661355|P2|Overall Study|Failure to achieve a response|2
195334|NCT00375219|661356|P1|Overall Study|Failure to achieve a response|16
195335|NCT00374907|661424|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
195336|NCT00374907|661425|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
195337|NCT00374907|661424|P2|116-Week Short-term + Long-term Period|Adverse Event|2
195338|NCT00374907|661425|P1|116-Week Short-term + Long-term Period|Adverse Event|0
195339|NCT00374907|661424|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
195340|NCT00374907|661425|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
195341|NCT00374907|661424|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
195342|NCT00374907|661425|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
195343|NCT00374907|661424|P2|12-Week Short-term Period|Subject Withdrew Consent|1
195344|NCT00374907|661425|P1|12-Week Short-term Period|Subject Withdrew Consent|3
195345|NCT00374868|661437|P1|Overall Study|Other - Not Specified|1
195346|NCT00374868|661437|P1|Overall Study|Death|2
195347|NCT00374868|661437|P1|Overall Study|Lost to Follow-up|1
195348|NCT00374868|661437|P1|Overall Study|Physician Decision|13
195349|NCT00374868|661437|P1|Overall Study|Progressive Disease|7
195350|NCT00374868|661437|P1|Overall Study|Adverse Event|12
195351|NCT00374556|661501|P2|Overall Study|excluded at baseline due to medical cond|1
195352|NCT00374556|661502|P1|Overall Study|excluded at baseline due to medical cond|0
195353|NCT00374556|661501|P2|Overall Study|Lost to Follow-up|0
195354|NCT00374556|661502|P1|Overall Study|Lost to Follow-up|1
195355|NCT00374452|661563|P2|Overall Study|Withdrawal by Subject|2
195356|NCT00374452|661564|P1|Overall Study|Withdrawal by Subject|0
195357|NCT00374452|661563|P2|Overall Study|Left clinic after intervention started|1
195358|NCT00374452|661564|P1|Overall Study|Left clinic after intervention started|1
195359|NCT00374452|661563|P2|Overall Study|Change in job role before intervention|1
195360|NCT00374452|661564|P1|Overall Study|Change in job role before intervention|0
195361|NCT00374452|661563|P2|Overall Study|Left clinic before intervention started|1
195362|NCT00374452|661564|P1|Overall Study|Left clinic before intervention started|4
195363|NCT00374322|661577|P2|Overall Study|Did Not Receive Study Medication|6
195364|NCT00374322|661578|P1|Overall Study|Did Not Receive Study Medication|8
195365|NCT00374322|661577|P2|Overall Study|Withdrew Consent During Follow-up|5
195366|NCT00374322|661578|P1|Overall Study|Withdrew Consent During Follow-up|0
195367|NCT00374322|661577|P2|Overall Study|Noncompliance with Study Requirements|1
195368|NCT00374322|661578|P1|Overall Study|Noncompliance with Study Requirements|0
195369|NCT00374322|661577|P2|Overall Study|Started Another Chemotherapy Regimen|1
195370|NCT00374322|661578|P1|Overall Study|Started Another Chemotherapy Regimen|0
195371|NCT00374322|661577|P2|Overall Study|Participant Changed Physician|0
195372|NCT00374322|661578|P1|Overall Study|Participant Changed Physician|1
195373|NCT00374322|661577|P2|Overall Study|Site Closed|2
195374|NCT00374322|661578|P1|Overall Study|Site Closed|2
195375|NCT00374322|661577|P2|Overall Study|Severe Toxicity|0
195376|NCT00374322|661578|P1|Overall Study|Severe Toxicity|1
195377|NCT00374322|661577|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
195378|NCT00374322|661578|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
195379|NCT00374322|661577|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
195380|NCT00374322|661578|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
195381|NCT00374322|661577|P2|Overall Study|Sponsor Decision|3
195382|NCT00374322|661578|P1|Overall Study|Sponsor Decision|2
195383|NCT00374322|661577|P2|Overall Study|Par. Consented to Survival FU Only|1
195384|NCT00374322|661578|P1|Overall Study|Par. Consented to Survival FU Only|3
195385|NCT00374322|661577|P2|Overall Study|Physician Decision|32
195386|NCT00374322|661578|P1|Overall Study|Physician Decision|36
195387|NCT00374322|661577|P2|Overall Study|Sponsor Terminated Study|990
195388|NCT00374322|661578|P1|Overall Study|Sponsor Terminated Study|866
195389|NCT00374322|661577|P2|Overall Study|Withdrawal by Subject|167
195390|NCT00374322|661578|P1|Overall Study|Withdrawal by Subject|235
195391|NCT00374322|661577|P2|Overall Study|Protocol Violation|3
195392|NCT00374322|661578|P1|Overall Study|Protocol Violation|8
195393|NCT00374322|661577|P2|Overall Study|Lost to Follow-up|90
195394|NCT00374322|661578|P1|Overall Study|Lost to Follow-up|92
195395|NCT00374140|661669|P1|Overall Study|Protocol Violation|1
195396|NCT00374140|661669|P1|Overall Study|Lost to Follow-up|1
195397|NCT00374127|661676|P1|Overall Study|Pregnancy|1
195398|NCT00374127|661676|P1|Overall Study|Protocol Violation|5
195399|NCT00374127|661676|P1|Overall Study|Blood could not be drawn.|2
195400|NCT00374127|661676|P1|Overall Study|Did not inhale during smoking procedure.|3
195401|NCT00373958|661725|P2|Toddler Dose|Withdrawn after infant series|25
195402|NCT00373958|661726|P1|Toddler Dose|Withdrawn after infant series|22
195403|NCT00373958|661725|P2|Toddler Dose|Protocol Violation|1
195404|NCT00373958|661726|P1|Toddler Dose|Protocol Violation|0
195405|NCT00373958|661725|P2|Toddler Dose|Failed to return|2
195406|NCT00373958|661726|P1|Toddler Dose|Failed to return|1
195407|NCT00373958|661725|P2|Toddler Dose|Withdrawal by Subject|2
195408|NCT00373958|661726|P1|Toddler Dose|Withdrawal by Subject|2
195409|NCT00373958|661725|P2|Toddler Dose|Lost to Follow-up|8
195410|NCT00373958|661726|P1|Toddler Dose|Lost to Follow-up|5
195411|NCT00373958|661725|P2|Infant Series|Physician Decision|1
195412|NCT00373958|661726|P1|Infant Series|Physician Decision|1
195413|NCT00373958|661725|P2|Infant Series|Adverse Event|1
195414|NCT00373958|661726|P1|Infant Series|Adverse Event|3
195415|NCT00373958|661725|P2|Infant Series|Consent was not received|0
195416|NCT00373958|661726|P1|Infant Series|Consent was not received|1
195417|NCT00373958|661725|P2|Infant Series|Child relocated|0
195418|NCT00373958|661726|P1|Infant Series|Child relocated|1
195419|NCT00373958|661725|P2|Infant Series|Lost Kaiser coverage|0
195420|NCT00373958|661726|P1|Infant Series|Lost Kaiser coverage|4
195421|NCT00373958|661725|P2|Infant Series|Protocol Violation|7
195422|NCT00373958|661726|P1|Infant Series|Protocol Violation|3
195423|NCT00373958|661725|P2|Infant Series|Lost to Follow-up|5
195424|NCT00373958|661726|P1|Infant Series|Lost to Follow-up|6
195425|NCT00373958|661725|P2|Infant Series|Failed to return|13
195426|NCT00373958|661726|P1|Infant Series|Failed to return|8
195427|NCT00373958|661725|P2|Infant Series|Withdrawal by Subject|15
195428|NCT00373958|661726|P1|Infant Series|Withdrawal by Subject|13
195429|NCT00373880|661774|P1|Overall Study|Protocol Violation|14
195430|NCT00373880|661774|P1|Overall Study|Arrested|1
195431|NCT00373880|661774|P1|Overall Study|Physician Decision|3
195432|NCT00373685|661819|P2|Overall Study|Randomized, not treated|77
195433|NCT00373685|661820|P1|Overall Study|Randomized, not treated|51
195434|NCT00373685|661819|P2|Overall Study|Final Status Unknown|4
195435|NCT00373685|661820|P1|Overall Study|Final Status Unknown|12
195436|NCT00373685|661819|P2|Overall Study|Protocol Violation|182
195437|NCT00373685|661820|P1|Overall Study|Protocol Violation|191
195438|NCT00373685|661819|P2|Overall Study|Other|146
195439|NCT00373685|661820|P1|Overall Study|Other|149
195440|NCT00373685|661819|P2|Overall Study|No longer willing to participate|352
195441|NCT00373685|661820|P1|Overall Study|No longer willing to participate|337
195442|NCT00373685|661819|P2|Overall Study|Lost to follow up|103
195443|NCT00373685|661820|P1|Overall Study|Lost to follow up|83
195444|NCT00373685|661819|P2|Overall Study|Did not meet entrance criteria|184
195445|NCT00373685|661820|P1|Overall Study|Did not meet entrance criteria|167
195446|NCT00373685|661819|P2|Overall Study|Insufficient clinical response|119
195447|NCT00373685|661820|P1|Overall Study|Insufficient clinical response|169
195448|NCT00373685|661819|P2|Overall Study|Adverse Event|253
195449|NCT00373685|661820|P1|Overall Study|Adverse Event|278
195450|NCT00373685|661819|P2|Overall Study|Death|1
195451|NCT00373685|661820|P1|Overall Study|Death|2
195452|NCT00373529|661854|P1|Overall Study|Consent violation|1
195453|NCT00373529|661854|P1|Overall Study|Failed independent confirmation of AML|3
195454|NCT00373529|661854|P1|Overall Study|Not specified|8
195455|NCT00373529|661854|P1|Overall Study|Need for treatment prohibited by study|1
195456|NCT00373529|661854|P1|Overall Study|Death|16
195457|NCT00373529|661854|P1|Overall Study|Disease recurrence|10
195458|NCT00373529|661854|P1|Overall Study|Treatment failure|36
195459|NCT00373529|661854|P1|Overall Study|Adverse Event|7
195460|NCT00373529|661854|P1|Overall Study|Withdrawal by Subject|7
195461|NCT00373529|661854|P1|Overall Study|Physician Decision|19
195462|NCT00373490|661866|P2|Overall Study|Withdrawal by Subject|1
195463|NCT00373490|661867|P1|Overall Study|Withdrawal by Subject|0
195464|NCT00373490|661866|P2|Overall Study|Lack of Efficacy|4
195465|NCT00373490|661867|P1|Overall Study|Lack of Efficacy|9
195466|NCT00373490|661866|P2|Overall Study|Adverse Event|1
195467|NCT00373490|661867|P1|Overall Study|Adverse Event|0
195468|NCT00373425|661890|P5|Overall Study|Death|0
195469|NCT00373425|661891|P4|Overall Study|Death|1
195470|NCT00373425|661892|P3|Overall Study|Death|3
195471|NCT00373425|661893|P2|Overall Study|Death|0
195472|NCT00373425|661894|P1|Overall Study|Death|7
195473|NCT00373425|661890|P5|Overall Study|Medical/ethical/noncompliance reason|5
195474|NCT00373425|661891|P4|Overall Study|Medical/ethical/noncompliance reason|2
195475|NCT00373425|661892|P3|Overall Study|Medical/ethical/noncompliance reason|10
195476|NCT00373425|661893|P2|Overall Study|Medical/ethical/noncompliance reason|9
195477|NCT00373425|661894|P1|Overall Study|Medical/ethical/noncompliance reason|21
195478|NCT00373425|661890|P5|Overall Study|Patient request|7
195479|NCT00373425|661891|P4|Overall Study|Patient request|6
195480|NCT00373425|661892|P3|Overall Study|Patient request|43
195481|NCT00373425|661893|P2|Overall Study|Patient request|18
195482|NCT00373425|661894|P1|Overall Study|Patient request|35
195483|NCT00373425|661890|P5|Overall Study|Adverse Event|34
195484|NCT00373425|661891|P4|Overall Study|Adverse Event|0
195485|NCT00373425|661892|P3|Overall Study|Adverse Event|59
195486|NCT00373425|661893|P2|Overall Study|Adverse Event|22
195487|NCT00373425|661894|P1|Overall Study|Adverse Event|191
195488|NCT00373425|661890|P5|Overall Study|Relapse of NSCLC|26
195489|NCT00373425|661891|P4|Overall Study|Relapse of NSCLC|2
195490|NCT00373425|661892|P3|Overall Study|Relapse of NSCLC|19
195491|NCT00373425|661893|P2|Overall Study|Relapse of NSCLC|104
195492|NCT00373425|661894|P1|Overall Study|Relapse of NSCLC|116
195493|NCT00373295|661976|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
195494|NCT00373295|661977|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
195495|NCT00373295|661978|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
195496|NCT00373295|661979|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
195497|NCT00373295|661980|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
195498|NCT00373295|661981|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
195499|NCT00373256|662002|P2|Overall Study|Study Terminated by Sponsor|13
195500|NCT00373256|662003|P1|Overall Study|Study Terminated by Sponsor|41
195501|NCT00373256|662002|P2|Overall Study|Protocol Violation|2
195502|NCT00373256|662003|P1|Overall Study|Protocol Violation|0
195503|NCT00373256|662002|P2|Overall Study|Other|107
195504|NCT00373256|662003|P1|Overall Study|Other|73
195505|NCT00373256|662002|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
195506|NCT00373256|662003|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
195507|NCT00373256|662002|P2|Overall Study|Objective Progression or Relapse|104
195508|NCT00373256|662003|P1|Overall Study|Objective Progression or Relapse|111
195509|NCT00373256|662002|P2|Overall Study|Death|8
195510|NCT00373256|662003|P1|Overall Study|Death|9
195511|NCT00373256|662002|P2|Overall Study|Lost to Follow-up|1
195512|NCT00373256|662003|P1|Overall Study|Lost to Follow-up|2
195513|NCT00373256|662002|P2|Overall Study|Adverse Event (AE)|5
195514|NCT00373256|662003|P1|Overall Study|Adverse Event (AE)|1
195515|NCT00373113|662029|P2|Overall Study|Withdrawal by Subject|15
195516|NCT00373113|662030|P1|Overall Study|Withdrawal by Subject|10
195517|NCT00373113|662029|P2|Overall Study|Protocol Violation|1
195518|NCT00373113|662030|P1|Overall Study|Protocol Violation|5
195519|NCT00373113|662029|P2|Overall Study|Other|17
195520|NCT00373113|662030|P1|Overall Study|Other|14
195521|NCT00373113|662029|P2|Overall Study|Objective progression or relapse|169
195522|NCT00373113|662030|P1|Overall Study|Objective progression or relapse|150
195523|NCT00373113|662029|P2|Overall Study|Lost to Follow-up|3
195524|NCT00373113|662030|P1|Overall Study|Lost to Follow-up|1
195525|NCT00373113|662029|P2|Overall Study|Global deterioration of health status|7
195526|NCT00373113|662030|P1|Overall Study|Global deterioration of health status|10
195527|NCT00373113|662029|P2|Overall Study|Study terminated by sponsor|1
195528|NCT00373113|662030|P1|Overall Study|Study terminated by sponsor|9
195529|NCT00373113|662029|P2|Overall Study|Adverse Event|24
195530|NCT00373113|662030|P1|Overall Study|Adverse Event|38
195531|NCT00373113|662029|P2|Overall Study|Death|7
195532|NCT00373113|662030|P1|Overall Study|Death|1
195533|NCT00372996|662052|P4|Overall Study|Not specified|7
195534|NCT00372996|662053|P3|Overall Study|Not specified|7
195535|NCT00372996|662054|P2|Overall Study|Not specified|2
195536|NCT00372996|662055|P1|Overall Study|Not specified|10
195537|NCT00372996|662052|P4|Overall Study|Study Terminated by Sponsor|0
195538|NCT00372996|662053|P3|Overall Study|Study Terminated by Sponsor|4
195539|NCT00372996|662054|P2|Overall Study|Study Terminated by Sponsor|0
195540|NCT00372996|662055|P1|Overall Study|Study Terminated by Sponsor|4
195541|NCT00372996|662052|P4|Overall Study|Withdrawal by Subject|5
195542|NCT00372996|662053|P3|Overall Study|Withdrawal by Subject|9
195543|NCT00372996|662054|P2|Overall Study|Withdrawal by Subject|6
195544|NCT00372996|662055|P1|Overall Study|Withdrawal by Subject|12
195545|NCT00372996|662052|P4|Overall Study|Lost to Follow-up|1
195546|NCT00372996|662053|P3|Overall Study|Lost to Follow-up|0
195547|NCT00372996|662054|P2|Overall Study|Lost to Follow-up|2
195548|NCT00372996|662055|P1|Overall Study|Lost to Follow-up|0
195549|NCT00372996|662052|P4|Overall Study|Death|7
195550|NCT00372996|662053|P3|Overall Study|Death|8
195551|NCT00372996|662054|P2|Overall Study|Death|4
195552|NCT00372996|662055|P1|Overall Study|Death|11
195553|NCT00372775|662140|P1|Overall Study|Not Treated|2
195554|NCT00372775|662140|P1|Overall Study|Not specified|1
195555|NCT00372775|662140|P1|Overall Study|Withdrawal by Subject|1
195556|NCT00372775|662140|P1|Overall Study|Global deterioration of health status|6
195557|NCT00372775|662140|P1|Overall Study|Objective progression or relapse|30
195558|NCT00372775|662140|P1|Overall Study|Death|15
195559|NCT00372775|662140|P1|Overall Study|Adverse Event|8
195560|NCT00372697|662162|P2|Overall Study|Protocol Violation|1
195561|NCT00372697|662163|P1|Overall Study|Protocol Violation|1
195562|NCT00372619|662188|P7|Overall Study|Inevaluable|0
195563|NCT00372619|662189|P6|Overall Study|Inevaluable|1
195564|NCT00372619|662190|P5|Overall Study|Inevaluable|0
195565|NCT00372619|662191|P4|Overall Study|Inevaluable|0
195566|NCT00372619|662192|P3|Overall Study|Inevaluable|0
195567|NCT00372619|662193|P2|Overall Study|Inevaluable|0
195568|NCT00372619|662194|P1|Overall Study|Inevaluable|0
195569|NCT00372619|662188|P7|Overall Study|Ineligible|0
195570|NCT00372619|662189|P6|Overall Study|Ineligible|2
195571|NCT00372619|662190|P5|Overall Study|Ineligible|0
195572|NCT00372619|662191|P4|Overall Study|Ineligible|0
195573|NCT00372619|662192|P3|Overall Study|Ineligible|0
195574|NCT00372619|662193|P2|Overall Study|Ineligible|0
195575|NCT00372619|662194|P1|Overall Study|Ineligible|0
195576|NCT00372593|662227|P3|Overall Study|Ineligible|1
195577|NCT00372593|662228|P2|Overall Study|Ineligible|21
195578|NCT00372593|662229|P1|Overall Study|Ineligible|20
195579|NCT00372593|662227|P3|Overall Study|Physician Decision|0
195580|NCT00372593|662228|P2|Overall Study|Physician Decision|41
195581|NCT00372593|662229|P1|Overall Study|Physician Decision|42
195582|NCT00372593|662227|P3|Overall Study|Lost to Follow-up|0
195583|NCT00372593|662228|P2|Overall Study|Lost to Follow-up|0
195584|NCT00372593|662229|P1|Overall Study|Lost to Follow-up|1
195585|NCT00372593|662227|P3|Overall Study|Lack of Efficacy|2
195586|NCT00372593|662228|P2|Overall Study|Lack of Efficacy|71
195587|NCT00372593|662229|P1|Overall Study|Lack of Efficacy|82
195588|NCT00372593|662227|P3|Overall Study|Death|1
195589|NCT00372593|662228|P2|Overall Study|Death|20
195590|NCT00372593|662229|P1|Overall Study|Death|16
195591|NCT00372593|662227|P3|Overall Study|Adverse Event|0
195592|NCT00372593|662228|P2|Overall Study|Adverse Event|45
195593|NCT00372593|662229|P1|Overall Study|Adverse Event|43
195594|NCT00372567|662258|P3|Phase 3 Study|study terminated by sponsor|5
195595|NCT00372567|662259|P2|Phase 3 Study|study terminated by sponsor|8
195596|NCT00372567|662260|P1|Phase 3 Study|study terminated by sponsor|13
195597|NCT00372567|662258|P3|Phase 3 Study|not specified|1
195598|NCT00372567|662259|P2|Phase 3 Study|not specified|2
195599|NCT00372567|662260|P1|Phase 3 Study|not specified|2
195600|NCT00372567|662258|P3|Phase 3 Study|Global deterioration of health status|0
195601|NCT00372567|662259|P2|Phase 3 Study|Global deterioration of health status|1
195602|NCT00372567|662260|P1|Phase 3 Study|Global deterioration of health status|0
195603|NCT00372567|662258|P3|Phase 3 Study|Objective progression or relapse|4
195604|NCT00372567|662259|P2|Phase 3 Study|Objective progression or relapse|13
195605|NCT00372567|662260|P1|Phase 3 Study|Objective progression or relapse|10
195606|NCT00372567|662258|P3|Phase 3 Study|Protocol Violation|1
195607|NCT00372567|662259|P2|Phase 3 Study|Protocol Violation|0
195608|NCT00372567|662260|P1|Phase 3 Study|Protocol Violation|0
195609|NCT00372567|662258|P3|Phase 3 Study|Death|0
195610|NCT00372567|662259|P2|Phase 3 Study|Death|1
195611|NCT00372567|662260|P1|Phase 3 Study|Death|1
195612|NCT00372567|662258|P3|Phase 3 Study|Adverse Event|1
195613|NCT00372567|662259|P2|Phase 3 Study|Adverse Event|1
195614|NCT00372567|662260|P1|Phase 3 Study|Adverse Event|5
195615|NCT00372528|662288|P1|Overall Study|Other|1
195616|NCT00372528|662288|P1|Overall Study|Study Terminated by Sponsor|18
195617|NCT00372528|662288|P1|Overall Study|Adverse Event|1
195618|NCT00372528|662288|P1|Overall Study|Lack of Efficacy|1
195619|NCT00372489|662293|P1|Overall Study|Sponsor Decision to Terminate Study|41
195620|NCT00372489|662293|P1|Overall Study|Renal transplant|6
195621|NCT00372489|662293|P1|Overall Study|Patient Relocation|2
195622|NCT00372489|662293|P1|Overall Study|Withdrawal by Subject|5
195623|NCT00372489|662293|P1|Overall Study|Physician Decision|3
195624|NCT00372489|662293|P1|Overall Study|Lost to Follow-up|3
195625|NCT00372489|662293|P1|Overall Study|Lack of Efficacy|1
195626|NCT00372489|662293|P1|Overall Study|Adverse Event|18
195627|NCT00372424|662297|P1|Overall Study|Enrolled, Not Treated|1
195628|NCT00372424|662297|P1|Overall Study|Other|7
195629|NCT00372424|662297|P1|Overall Study|Objective Progression or Relapse|14
195630|NCT00372424|662297|P1|Overall Study|Death|1
195631|NCT00372424|662297|P1|Overall Study|Withdrawal by Subject|1
195632|NCT00372424|662297|P1|Overall Study|Adverse Event|2
195633|NCT00372411|662311|P3|Overall Study|Adverse Event|0
195634|NCT00372411|662312|P2|Overall Study|Adverse Event|1
195635|NCT00372411|662313|P1|Overall Study|Adverse Event|1
195636|NCT00372411|662311|P3|Overall Study|Lost to Follow-up|1
195637|NCT00372411|662312|P2|Overall Study|Lost to Follow-up|1
195638|NCT00372411|662313|P1|Overall Study|Lost to Follow-up|1
195639|NCT00372411|662311|P3|Overall Study|Death|1
195640|NCT00372411|662312|P2|Overall Study|Death|2
195641|NCT00372411|662313|P1|Overall Study|Death|0
195642|NCT00372411|662311|P3|Overall Study|Withdrawal by Subject|1
195643|NCT00372411|662312|P2|Overall Study|Withdrawal by Subject|4
195644|NCT00372411|662313|P1|Overall Study|Withdrawal by Subject|3
195645|NCT00372385|662337|P4|Overall Study|Virologic Stopping Rule|0
195646|NCT00372385|662338|P3|Overall Study|Virologic Stopping Rule|0
195647|NCT00372385|662339|P2|Overall Study|Virologic Stopping Rule|0
195648|NCT00372385|662340|P1|Overall Study|Virologic Stopping Rule|17
195649|NCT00372385|662337|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
195650|NCT00372385|662338|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
195651|NCT00372385|662339|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
195652|NCT00372385|662340|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
195653|NCT00372385|662337|P4|Overall Study|No Response|0
195654|NCT00372385|662338|P3|Overall Study|No Response|0
195655|NCT00372385|662339|P2|Overall Study|No Response|1
195656|NCT00372385|662340|P1|Overall Study|No Response|1
195657|NCT00372385|662337|P4|Overall Study|Refusal of Treatment|0
195658|NCT00372385|662338|P3|Overall Study|Refusal of Treatment|0
195659|NCT00372385|662339|P2|Overall Study|Refusal of Treatment|6
195660|NCT00372385|662340|P1|Overall Study|Refusal of Treatment|3
195661|NCT00372385|662337|P4|Overall Study|Withdrawal by Subject|0
195662|NCT00372385|662338|P3|Overall Study|Withdrawal by Subject|0
195663|NCT00372385|662339|P2|Overall Study|Withdrawal by Subject|1
195664|NCT00372385|662340|P1|Overall Study|Withdrawal by Subject|2
195665|NCT00372385|662337|P4|Overall Study|Lost to Follow-up|0
195666|NCT00372385|662338|P3|Overall Study|Lost to Follow-up|0
195667|NCT00372385|662339|P2|Overall Study|Lost to Follow-up|0
195668|NCT00372385|662340|P1|Overall Study|Lost to Follow-up|2
195669|NCT00372385|662337|P4|Overall Study|Physician Decision|0
195670|NCT00372385|662338|P3|Overall Study|Physician Decision|0
195671|NCT00372385|662339|P2|Overall Study|Physician Decision|0
195672|NCT00372385|662340|P1|Overall Study|Physician Decision|1
195673|NCT00372385|662337|P4|Overall Study|Noncompliance|1
195674|NCT00372385|662338|P3|Overall Study|Noncompliance|1
195675|NCT00372385|662339|P2|Overall Study|Noncompliance|1
195676|NCT00372385|662340|P1|Overall Study|Noncompliance|0
195677|NCT00372385|662337|P4|Overall Study|Adverse Event|7
195678|NCT00372385|662338|P3|Overall Study|Adverse Event|9
195679|NCT00372385|662339|P2|Overall Study|Adverse Event|11
195680|NCT00372385|662340|P1|Overall Study|Adverse Event|6
195681|NCT00372190|662369|P2|Overall Study|Lost to Follow-up|1
195682|NCT00372190|662370|P1|Overall Study|Lost to Follow-up|3
195683|NCT00372112|662386|P4|Overall Study|Other-protocol violation|0
195684|NCT00372112|662387|P3|Overall Study|Other-protocol violation|1
195685|NCT00372112|662388|P2|Overall Study|Other-protocol violation|0
195686|NCT00372112|662389|P1|Overall Study|Other-protocol violation|0
195687|NCT00372112|662386|P4|Overall Study|Hepatitis B|0
195688|NCT00372112|662387|P3|Overall Study|Hepatitis B|0
195689|NCT00372112|662388|P2|Overall Study|Hepatitis B|0
195690|NCT00372112|662389|P1|Overall Study|Hepatitis B|1
195691|NCT00372112|662386|P4|Overall Study|PR >240 at Visit 3|1
195692|NCT00372112|662387|P3|Overall Study|PR >240 at Visit 3|0
195693|NCT00372112|662388|P2|Overall Study|PR >240 at Visit 3|0
195694|NCT00372112|662389|P1|Overall Study|PR >240 at Visit 3|0
195695|NCT00372112|662386|P4|Overall Study|Exacerbation|1
195696|NCT00372112|662387|P3|Overall Study|Exacerbation|0
195697|NCT00372112|662388|P2|Overall Study|Exacerbation|0
195698|NCT00372112|662389|P1|Overall Study|Exacerbation|0
195699|NCT00372112|662386|P4|Overall Study|Withdrawal by Subject|1
195700|NCT00372112|662387|P3|Overall Study|Withdrawal by Subject|2
195701|NCT00372112|662388|P2|Overall Study|Withdrawal by Subject|0
195702|NCT00372112|662389|P1|Overall Study|Withdrawal by Subject|0
195703|NCT00372112|662386|P4|Overall Study|Adverse Event|1
195704|NCT00372112|662387|P3|Overall Study|Adverse Event|1
195705|NCT00372112|662388|P2|Overall Study|Adverse Event|1
195706|NCT00372112|662389|P1|Overall Study|Adverse Event|0
195707|NCT00372060|662520|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
195708|NCT00372060|662521|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
195709|NCT00372060|662520|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
195710|NCT00372060|662521|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
195711|NCT00372060|662520|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
195712|NCT00372060|662521|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
195713|NCT00372060|662520|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
195714|NCT00372060|662521|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
195715|NCT00372060|662520|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
195716|NCT00372060|662521|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
195717|NCT00372060|662520|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
195718|NCT00372060|662521|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
195719|NCT00371865|662536|P2|Overall Study|Withdrawal by Subject|10
195720|NCT00371865|662537|P1|Overall Study|Withdrawal by Subject|12
195721|NCT00371865|662536|P2|Overall Study|Protocol Violation|2
195722|NCT00371865|662537|P1|Overall Study|Protocol Violation|3
195723|NCT00371865|662536|P2|Overall Study|Lack of Efficacy|2
195724|NCT00371865|662537|P1|Overall Study|Lack of Efficacy|0
195725|NCT00371839|662554|P3|Overall Study|Lost to Follow-up|2
195726|NCT00371839|662555|P2|Overall Study|Lost to Follow-up|3
195727|NCT00371839|662556|P1|Overall Study|Lost to Follow-up|6
195728|NCT00371839|662554|P3|Overall Study|Withdrawal by Subject|0
195729|NCT00371839|662555|P2|Overall Study|Withdrawal by Subject|4
195730|NCT00371839|662556|P1|Overall Study|Withdrawal by Subject|7
195731|NCT00371839|662554|P3|Overall Study|Death|0
195732|NCT00371839|662555|P2|Overall Study|Death|0
195733|NCT00371839|662556|P1|Overall Study|Death|4
195734|NCT00371826|662565|P3|Extension Phase (24 Months)|Administrative problems|2
195735|NCT00371826|662566|P2|Extension Phase (24 Months)|Administrative problems|0
195736|NCT00371826|662567|P1|Extension Phase (24 Months)|Administrative problems|0
195737|NCT00371826|662565|P3|Extension Phase (24 Months)|Subject withdrew consent|0
195815|NCT00371566|662785|P1|Chemoradiation Phase|Progressive Disease|1
195738|NCT00371826|662566|P2|Extension Phase (24 Months)|Subject withdrew consent|2
195739|NCT00371826|662567|P1|Extension Phase (24 Months)|Subject withdrew consent|1
195740|NCT00371826|662565|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
195741|NCT00371826|662566|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
195742|NCT00371826|662567|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
195743|NCT00371826|662565|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
195744|NCT00371826|662566|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
195745|NCT00371826|662567|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
195746|NCT00371826|662565|P3|Extension Phase (24 Months)|Adverse Event|0
195747|NCT00371826|662566|P2|Extension Phase (24 Months)|Adverse Event|5
195748|NCT00371826|662567|P1|Extension Phase (24 Months)|Adverse Event|4
195749|NCT00371826|662565|P3|Core Phase (12 Months)|Graft Loss|0
195750|NCT00371826|662566|P2|Core Phase (12 Months)|Graft Loss|1
195751|NCT00371826|662567|P1|Core Phase (12 Months)|Graft Loss|0
195752|NCT00371826|662565|P3|Core Phase (12 Months)|Administrative problems|8
195753|NCT00371826|662566|P2|Core Phase (12 Months)|Administrative problems|0
195754|NCT00371826|662567|P1|Core Phase (12 Months)|Administrative problems|1
195755|NCT00371826|662565|P3|Core Phase (12 Months)|Subject withdrew consent|3
195756|NCT00371826|662566|P2|Core Phase (12 Months)|Subject withdrew consent|0
195757|NCT00371826|662567|P1|Core Phase (12 Months)|Subject withdrew consent|0
195758|NCT00371826|662565|P3|Core Phase (12 Months)|Protocol Violation|1
195759|NCT00371826|662566|P2|Core Phase (12 Months)|Protocol Violation|0
195760|NCT00371826|662567|P1|Core Phase (12 Months)|Protocol Violation|1
195761|NCT00371826|662565|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
195762|NCT00371826|662566|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
195763|NCT00371826|662567|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
195764|NCT00371826|662565|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
195765|NCT00371826|662566|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
195766|NCT00371826|662567|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
195767|NCT00371826|662565|P3|Core Phase (12 Months)|Adverse Event|9
195768|NCT00371826|662566|P2|Core Phase (12 Months)|Adverse Event|4
195769|NCT00371826|662567|P1|Core Phase (12 Months)|Adverse Event|15
195770|NCT00371787|662691|P2|Overall Study|Withdrawal by Subject|1
195771|NCT00371787|662692|P1|Overall Study|Withdrawal by Subject|3
195772|NCT00371761|662706|P2|Overall Study|Study termination|3
195773|NCT00371761|662707|P1|Overall Study|Study termination|4
195774|NCT00371761|662706|P2|Overall Study|Investigator Judgment|3
195775|NCT00371761|662707|P1|Overall Study|Investigator Judgment|2
195776|NCT00371761|662706|P2|Overall Study|Withdrawal by Subject|3
195777|NCT00371761|662707|P1|Overall Study|Withdrawal by Subject|1
195778|NCT00371761|662706|P2|Overall Study|Adverse Event|1
195779|NCT00371761|662707|P1|Overall Study|Adverse Event|1
195780|NCT00371683|662715|P2|Follow-Up Period - Randomized Patients|non-specified|12
195781|NCT00371683|662716|P1|Follow-Up Period - Randomized Patients|non-specified|6
195782|NCT00371683|662715|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
195783|NCT00371683|662716|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
195784|NCT00371683|662715|P2|Follow-Up Period - Randomized Patients|Death|2
195785|NCT00371683|662716|P1|Follow-Up Period - Randomized Patients|Death|0
195786|NCT00371683|662715|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
195787|NCT00371683|662716|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
195788|NCT00371683|662715|P2|DB Treatment Period-Randomized Patients|non-specified|8
195789|NCT00371683|662716|P1|DB Treatment Period-Randomized Patients|non-specified|9
195790|NCT00371683|662715|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
195791|NCT00371683|662716|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
195792|NCT00371683|662715|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
195793|NCT00371683|662716|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
195794|NCT00371683|662715|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
195795|NCT00371683|662716|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
195796|NCT00371683|662715|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
195797|NCT00371683|662716|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
195798|NCT00371683|662715|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
195799|NCT00371683|662716|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
195800|NCT00371683|662715|P2|DB Treatment Period-Randomized Patients|Death|1
195801|NCT00371683|662716|P1|DB Treatment Period-Randomized Patients|Death|1
195802|NCT00371566|662784|P2|Follow Up Phase|Lost to Follow-up|0
195803|NCT00371566|662785|P1|Follow Up Phase|Lost to Follow-up|1
195804|NCT00371566|662784|P2|Follow Up Phase|Physician Decision|1
195805|NCT00371566|662785|P1|Follow Up Phase|Physician Decision|1
195806|NCT00371566|662784|P2|Follow Up Phase|Withdrawal by Subject|1
195807|NCT00371566|662785|P1|Follow Up Phase|Withdrawal by Subject|0
195808|NCT00371566|662784|P2|Follow Up Phase|Disease progression|0
195809|NCT00371566|662785|P1|Follow Up Phase|Disease progression|1
195810|NCT00371566|662784|P2|Follow Up Phase|Death|5
195811|NCT00371566|662785|P1|Follow Up Phase|Death|0
195812|NCT00371566|662784|P2|Chemoradiation Phase|Death|0
195813|NCT00371566|662785|P1|Chemoradiation Phase|Death|2
195814|NCT00371566|662784|P2|Chemoradiation Phase|Progressive Disease|1
195816|NCT00371566|662784|P2|Chemoradiation Phase|Non compliant|1
195817|NCT00371566|662785|P1|Chemoradiation Phase|Non compliant|0
195818|NCT00371566|662784|P2|Chemoradiation Phase|Withdrawal by Subject|1
195819|NCT00371566|662785|P1|Chemoradiation Phase|Withdrawal by Subject|0
195820|NCT00371566|662784|P2|Chemoradiation Phase|Physician Decision|0
195821|NCT00371566|662785|P1|Chemoradiation Phase|Physician Decision|2
195822|NCT00371566|662784|P2|Treatment Phase|Protocol Violation|1
195823|NCT00371566|662785|P1|Treatment Phase|Protocol Violation|0
195824|NCT00371566|662784|P2|Treatment Phase|Adverse Event|1
195825|NCT00371566|662785|P1|Treatment Phase|Adverse Event|0
195826|NCT00371566|662784|P2|Treatment Phase|Withdrawal by Subject|1
195827|NCT00371566|662785|P1|Treatment Phase|Withdrawal by Subject|0
195828|NCT00371462|662870|P2|Overall Study|Other|8
195829|NCT00371462|662871|P1|Overall Study|Other|7
195830|NCT00371462|662870|P2|Overall Study|Withdrawal by Subject|0
195831|NCT00371462|662871|P1|Overall Study|Withdrawal by Subject|1
195832|NCT00371397|662895|P12|Session 1|Withdrawal by Subject|0
195833|NCT00371397|662896|P11|Session 1|Withdrawal by Subject|0
195834|NCT00371397|662897|P10|Session 1|Withdrawal by Subject|0
195835|NCT00371397|662898|P9|Session 1|Withdrawal by Subject|0
195836|NCT00371397|662899|P8|Session 1|Withdrawal by Subject|1
195837|NCT00371397|662900|P7|Session 1|Withdrawal by Subject|0
195838|NCT00371397|662901|P6|Session 1|Withdrawal by Subject|0
195839|NCT00371397|662902|P5|Session 1|Withdrawal by Subject|0
195840|NCT00371397|662903|P4|Session 1|Withdrawal by Subject|0
195841|NCT00371397|662904|P3|Session 1|Withdrawal by Subject|0
195842|NCT00371397|662905|P2|Session 1|Withdrawal by Subject|0
195843|NCT00371397|662906|P1|Session 1|Withdrawal by Subject|1
195844|NCT00371345|662914|P2|Overall Study|Participant Withdrew Consent|1
195845|NCT00371345|662915|P1|Overall Study|Participant Withdrew Consent|0
195846|NCT00371345|662914|P2|Overall Study|Participant Request|1
195847|NCT00371345|662915|P1|Overall Study|Participant Request|1
195848|NCT00371345|662914|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
195849|NCT00371345|662915|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
195850|NCT00371345|662914|P2|Overall Study|Study Drug Toxicity|7
195851|NCT00371345|662915|P1|Overall Study|Study Drug Toxicity|1
195852|NCT00371345|662914|P2|Overall Study|Disease Progression|35
195853|NCT00371345|662915|P1|Overall Study|Disease Progression|21
195854|NCT00371254|663016|P2|Overall Study|Withdrawal by Subject|1
195855|NCT00371254|663017|P1|Overall Study|Withdrawal by Subject|0
195856|NCT00371254|663016|P2|Overall Study|Lost to Follow-up|1
195857|NCT00371254|663017|P1|Overall Study|Lost to Follow-up|0
195858|NCT00371254|663016|P2|Overall Study|Adverse event unrelated to study drug|1
195859|NCT00371254|663017|P1|Overall Study|Adverse event unrelated to study drug|0
195860|NCT00371254|663016|P2|Overall Study|Investigator Decision|0
195861|NCT00371254|663017|P1|Overall Study|Investigator Decision|2
195862|NCT00371254|663016|P2|Overall Study|Subject request|0
195863|NCT00371254|663017|P1|Overall Study|Subject request|5
195864|NCT00371254|663016|P2|Overall Study|Study drug toxicity|5
195865|NCT00371254|663017|P1|Overall Study|Study drug toxicity|3
195866|NCT00371254|663016|P2|Overall Study|Disease progression|13
195867|NCT00371254|663017|P1|Overall Study|Disease progression|13
195868|NCT00371150|663100|P2|Overall Study|Lost to Follow-up|2
195869|NCT00371150|663101|P1|Overall Study|Lost to Follow-up|3
195870|NCT00371137|663136|P3|Overall Study|Protocol Violation|1
195871|NCT00371137|663137|P2|Overall Study|Protocol Violation|1
195872|NCT00371137|663138|P1|Overall Study|Protocol Violation|2
195873|NCT00371137|663136|P3|Overall Study|Physician Decision|1
195874|NCT00371137|663137|P2|Overall Study|Physician Decision|1
195875|NCT00371137|663138|P1|Overall Study|Physician Decision|1
195876|NCT00371137|663136|P3|Overall Study|Sponsor Decision|2
195877|NCT00371137|663137|P2|Overall Study|Sponsor Decision|1
195878|NCT00371137|663138|P1|Overall Study|Sponsor Decision|2
195879|NCT00371137|663136|P3|Overall Study|Lack of Efficacy|13
195880|NCT00371137|663137|P2|Overall Study|Lack of Efficacy|12
195881|NCT00371137|663138|P1|Overall Study|Lack of Efficacy|30
195882|NCT00371137|663136|P3|Overall Study|Lost to Follow-up|5
195883|NCT00371137|663137|P2|Overall Study|Lost to Follow-up|3
195884|NCT00371137|663138|P1|Overall Study|Lost to Follow-up|6
195885|NCT00371137|663136|P3|Overall Study|Withdrawal by Subject|15
195886|NCT00371137|663137|P2|Overall Study|Withdrawal by Subject|10
195887|NCT00371137|663138|P1|Overall Study|Withdrawal by Subject|11
195888|NCT00371137|663136|P3|Overall Study|Adverse Event|42
195889|NCT00371137|663137|P2|Overall Study|Adverse Event|35
195890|NCT00371137|663138|P1|Overall Study|Adverse Event|20
195891|NCT00370682|663181|P3|Overall Study|Lost to Follow-up|1
195892|NCT00370682|663182|P2|Overall Study|Lost to Follow-up|1
195893|NCT00370682|663183|P1|Overall Study|Lost to Follow-up|0
195894|NCT00370682|663181|P3|Overall Study|Moved from area|0
195895|NCT00370682|663182|P2|Overall Study|Moved from area|2
195896|NCT00370682|663183|P1|Overall Study|Moved from area|0
195897|NCT00370552|663225|P3|Overall Study|Planned radiation for palliation|0
195898|NCT00370552|663226|P2|Overall Study|Planned radiation for palliation|1
195899|NCT00370552|663227|P1|Overall Study|Planned radiation for palliation|0
195900|NCT00370552|663225|P3|Overall Study|High risk of allergic reaction|0
195901|NCT00370552|663226|P2|Overall Study|High risk of allergic reaction|1
195902|NCT00370552|663227|P1|Overall Study|High risk of allergic reaction|0
195903|NCT00370552|663225|P3|Overall Study|Investigator decision|0
195904|NCT00370552|663226|P2|Overall Study|Investigator decision|1
195905|NCT00370552|663227|P1|Overall Study|Investigator decision|2
195906|NCT00370552|663225|P3|Overall Study|Physician Decision|0
195907|NCT00370552|663226|P2|Overall Study|Physician Decision|1
195908|NCT00370552|663227|P1|Overall Study|Physician Decision|1
195909|NCT00370552|663225|P3|Overall Study|Never treated|0
195910|NCT00370552|663226|P2|Overall Study|Never treated|0
195911|NCT00370552|663227|P1|Overall Study|Never treated|1
195912|NCT00370552|663225|P3|Overall Study|Still on treatment|2
195913|NCT00370552|663226|P2|Overall Study|Still on treatment|3
195914|NCT00370552|663227|P1|Overall Study|Still on treatment|1
195915|NCT00370552|663225|P3|Overall Study|Withdrawal by Subject|1
195916|NCT00370552|663226|P2|Overall Study|Withdrawal by Subject|0
195917|NCT00370552|663227|P1|Overall Study|Withdrawal by Subject|2
195918|NCT00370552|663225|P3|Overall Study|Study drug toxicity|6
195919|NCT00370552|663226|P2|Overall Study|Study drug toxicity|8
195920|NCT00370552|663227|P1|Overall Study|Study drug toxicity|11
195921|NCT00370552|663225|P3|Overall Study|Poor or noncompliance|1
195922|NCT00370552|663226|P2|Overall Study|Poor or noncompliance|0
195923|NCT00370552|663227|P1|Overall Study|Poor or noncompliance|0
195924|NCT00370552|663225|P3|Overall Study|Maximum clinical benefit|5
195925|NCT00370552|663226|P2|Overall Study|Maximum clinical benefit|5
195926|NCT00370552|663227|P1|Overall Study|Maximum clinical benefit|3
195927|NCT00370552|663225|P3|Overall Study|Disease progression|15
195928|NCT00370552|663226|P2|Overall Study|Disease progression|23
195929|NCT00370552|663227|P1|Overall Study|Disease progression|23
195930|NCT00370552|663225|P3|Overall Study|Adverse Event|2
195931|NCT00370552|663226|P2|Overall Study|Adverse Event|2
195932|NCT00370552|663227|P1|Overall Study|Adverse Event|2
195933|NCT00370331|663267|P2|Overall Study|Protocol Violation|1
195934|NCT00370331|663268|P1|Overall Study|Protocol Violation|1
195935|NCT00370331|663267|P2|Overall Study|Non-compliance|1
195936|NCT00370331|663268|P1|Overall Study|Non-compliance|0
195937|NCT00370331|663267|P2|Overall Study|Lack of Efficacy|1
195938|NCT00370331|663268|P1|Overall Study|Lack of Efficacy|0
195939|NCT00370331|663267|P2|Overall Study|Lost to Follow-up|3
195940|NCT00370331|663268|P1|Overall Study|Lost to Follow-up|0
195941|NCT00370331|663267|P2|Overall Study|Withdrawal by Subject|4
195942|NCT00370331|663268|P1|Overall Study|Withdrawal by Subject|2
195943|NCT00370331|663267|P2|Overall Study|Adverse Event|13
195944|NCT00370331|663268|P1|Overall Study|Adverse Event|4
195945|NCT00370292|663294|P1|Overall Study|Physician Decision|2
195946|NCT00370292|663294|P1|Overall Study|Adverse Event|7
195947|NCT00370292|663294|P1|Overall Study|Disease Progression|4
195948|NCT00370149|663307|P2|Overall Study|Antibiotic coated dressing placed|1
195949|NCT00370149|663308|P1|Overall Study|Antibiotic coated dressing placed|0
195950|NCT00370149|663307|P2|Overall Study|Pre-existing infection|1
195951|NCT00370149|663308|P1|Overall Study|Pre-existing infection|0
195952|NCT00370149|663307|P2|Overall Study|Catheter inserted in wrong vessel-|1
195953|NCT00370149|663308|P1|Overall Study|Catheter inserted in wrong vessel-|2
195954|NCT00370149|663307|P2|Overall Study|Protocol Violation|0
195955|NCT00370149|663308|P1|Overall Study|Protocol Violation|1
195956|NCT00370149|663307|P2|Overall Study|Physician Decision|16
195957|NCT00370149|663308|P1|Overall Study|Physician Decision|16
195958|NCT00370071|663318|P1|Overall Study|Withdrawal by Subject|2
195959|NCT00370032|663335|P2|Follow-up Period|Withdrawal by Subject|0
195960|NCT00370032|663336|P1|Follow-up Period|Withdrawal by Subject|1
195961|NCT00370032|663335|P2|Washout Period|Adverse Event|0
195962|NCT00370032|663336|P1|Washout Period|Adverse Event|1
195963|NCT00370032|663335|P2|Washout Period|Lost to Follow-up|1
195964|NCT00370032|663336|P1|Washout Period|Lost to Follow-up|0
195965|NCT00370032|663335|P2|Washout Period|Withdrawal by Subject|1
195966|NCT00370032|663336|P1|Washout Period|Withdrawal by Subject|0
195967|NCT00370032|663335|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
195968|NCT00370032|663336|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
195969|NCT00369967|663356|P2|Overall Study|Lost to Follow-up|12
195970|NCT00369967|663357|P1|Overall Study|Lost to Follow-up|23
195971|NCT00369941|663375|P2|Overall Study|Miscellaneous|3
195972|NCT00369941|663376|P1|Overall Study|Miscellaneous|3
195973|NCT00369941|663375|P2|Overall Study|Study Site Terminated|0
195974|NCT00369941|663376|P1|Overall Study|Study Site Terminated|2
195975|NCT00369941|663375|P2|Overall Study|Employment Interfered with Study Visits|0
195976|NCT00369941|663376|P1|Overall Study|Employment Interfered with Study Visits|1
195977|NCT00369941|663375|P2|Overall Study|Treatment with Prohibited Medication|1
195978|NCT00369941|663376|P1|Overall Study|Treatment with Prohibited Medication|3
195979|NCT00369941|663375|P2|Overall Study|Moved|5
195980|NCT00369941|663376|P1|Overall Study|Moved|11
195981|NCT00369941|663375|P2|Overall Study|Completed, Did Not Enter Extension|6
195982|NCT00369941|663376|P1|Overall Study|Completed, Did Not Enter Extension|5
195983|NCT00369941|663375|P2|Overall Study|Pregnancy|2
195984|NCT00369941|663376|P1|Overall Study|Pregnancy|4
195985|NCT00369941|663375|P2|Overall Study|Withdrawal by Subject|18
195986|NCT00369941|663376|P1|Overall Study|Withdrawal by Subject|5
195987|NCT00369941|663375|P2|Overall Study|Protocol Violation|3
195988|NCT00369941|663376|P1|Overall Study|Protocol Violation|5
195989|NCT00369941|663375|P2|Overall Study|Lost to Follow-up|22
195990|NCT00369941|663376|P1|Overall Study|Lost to Follow-up|12
195991|NCT00369941|663375|P2|Overall Study|Lack of Efficacy|10
195992|NCT00369941|663376|P1|Overall Study|Lack of Efficacy|6
195993|NCT00369941|663375|P2|Overall Study|Adverse Event|28
195994|NCT00369941|663376|P1|Overall Study|Adverse Event|14
195995|NCT00369941|663375|P2|Overall Study|Never Treated|2
195996|NCT00369941|663376|P1|Overall Study|Never Treated|1
195997|NCT00369915|663541|P2|Overall Study|W/drawl by investigators|1
195998|NCT00369915|663542|P1|Overall Study|W/drawl by investigators|0
195999|NCT00369915|663541|P2|Overall Study|Withdrawal by Subject|1
196000|NCT00369915|663542|P1|Overall Study|Withdrawal by Subject|4
196001|NCT00369915|663541|P2|Overall Study|expected side effects|1
196002|NCT00369915|663542|P1|Overall Study|expected side effects|2
196003|NCT00369824|663556|P6|Overall Study|Other|3
196004|NCT00369824|663557|P5|Overall Study|Other|1
196005|NCT00369824|663558|P4|Overall Study|Other|2
196006|NCT00369824|663559|P3|Overall Study|Other|0
196007|NCT00369824|663560|P2|Overall Study|Other|0
196008|NCT00369824|663561|P1|Overall Study|Other|0
196009|NCT00369824|663556|P6|Overall Study|Lost to Follow-up|6
196010|NCT00369824|663557|P5|Overall Study|Lost to Follow-up|9
196011|NCT00369824|663558|P4|Overall Study|Lost to Follow-up|8
196012|NCT00369824|663559|P3|Overall Study|Lost to Follow-up|7
196013|NCT00369824|663560|P2|Overall Study|Lost to Follow-up|11
196014|NCT00369824|663561|P1|Overall Study|Lost to Follow-up|6
196015|NCT00369824|663556|P6|Overall Study|Withdrawal by Subject|2
196016|NCT00369824|663557|P5|Overall Study|Withdrawal by Subject|6
196017|NCT00369824|663558|P4|Overall Study|Withdrawal by Subject|4
196018|NCT00369824|663559|P3|Overall Study|Withdrawal by Subject|5
196019|NCT00369824|663560|P2|Overall Study|Withdrawal by Subject|5
196020|NCT00369824|663561|P1|Overall Study|Withdrawal by Subject|9
196021|NCT00369824|663556|P6|Overall Study|Protocol Violation|0
196022|NCT00369824|663557|P5|Overall Study|Protocol Violation|1
196023|NCT00369824|663558|P4|Overall Study|Protocol Violation|1
196024|NCT00369824|663559|P3|Overall Study|Protocol Violation|0
196025|NCT00369824|663560|P2|Overall Study|Protocol Violation|1
196026|NCT00369824|663561|P1|Overall Study|Protocol Violation|0
196027|NCT00369824|663556|P6|Overall Study|Adverse Event|0
196028|NCT00369824|663557|P5|Overall Study|Adverse Event|1
196029|NCT00369824|663558|P4|Overall Study|Adverse Event|0
196030|NCT00369824|663559|P3|Overall Study|Adverse Event|0
196031|NCT00369824|663560|P2|Overall Study|Adverse Event|2
196032|NCT00369824|663561|P1|Overall Study|Adverse Event|0
196033|NCT00369785|663661|P2|Overall Study|Multiple reasons|5
196034|NCT00369785|663662|P1|Overall Study|Multiple reasons|6
196035|NCT00369785|663661|P2|Overall Study|Progression|4
196036|NCT00369785|663662|P1|Overall Study|Progression|4
196037|NCT00369785|663661|P2|Overall Study|Never started|2
196038|NCT00369785|663662|P1|Overall Study|Never started|0
196039|NCT00369785|663661|P2|Overall Study|Toxicity|4
196040|NCT00369785|663662|P1|Overall Study|Toxicity|6
196041|NCT00369785|663661|P2|Overall Study|Withdrawal by Subject|6
196042|NCT00369785|663662|P1|Overall Study|Withdrawal by Subject|7
196043|NCT00369785|663661|P2|Overall Study|Death|2
196044|NCT00369785|663662|P1|Overall Study|Death|1
196045|NCT00369785|663661|P2|Overall Study|Physician Decision|2
196046|NCT00369785|663662|P1|Overall Study|Physician Decision|3
196047|NCT00369681|663683|P1|Overall Study|Inevaluable|1
196048|NCT00369668|663692|P3|Overall Study|Lack of Efficacy|7
196049|NCT00369668|663693|P2|Overall Study|Lack of Efficacy|5
196050|NCT00369668|663694|P1|Overall Study|Lack of Efficacy|4
196051|NCT00369655|663708|P1|Overall Study|Refusal of further treatment|2
196052|NCT00369577|663738|P3|Overall Study|Withdrawal by Subject|1
196053|NCT00369577|663739|P2|Overall Study|Withdrawal by Subject|0
196054|NCT00369577|663740|P1|Overall Study|Withdrawal by Subject|0
196055|NCT00369486|663777|P5|34-Week Visit|Dropped|3
196056|NCT00369486|663778|P4|34-Week Visit|Dropped|3
196057|NCT00369486|663779|P3|34-Week Visit|Dropped|1
196058|NCT00369486|663780|P2|34-Week Visit|Dropped|1
196059|NCT00369486|663781|P1|34-Week Visit|Dropped|0
196060|NCT00369486|663777|P5|17-Week Visit|Missed visit|1
196061|NCT00369486|663778|P4|17-Week Visit|Missed visit|1
196062|NCT00369486|663779|P3|17-Week Visit|Missed visit|1
196063|NCT00369486|663780|P2|17-Week Visit|Missed visit|0
196064|NCT00369486|663781|P1|17-Week Visit|Missed visit|0
196065|NCT00369486|663777|P5|8-Week Visit|Dropped|0
196066|NCT00369486|663778|P4|8-Week Visit|Dropped|1
196067|NCT00369486|663779|P3|8-Week Visit|Dropped|0
196068|NCT00369486|663780|P2|8-Week Visit|Dropped|0
196069|NCT00369486|663781|P1|8-Week Visit|Dropped|0
196070|NCT00369486|663777|P5|8-Week Visit|Missed visit|1
196071|NCT00369486|663778|P4|8-Week Visit|Missed visit|0
196072|NCT00369486|663779|P3|8-Week Visit|Missed visit|0
196073|NCT00369486|663780|P2|8-Week Visit|Missed visit|1
196074|NCT00369486|663781|P1|8-Week Visit|Missed visit|0
196075|NCT00369486|663777|P5|4-Week Visit|Dropped|0
196076|NCT00369486|663778|P4|4-Week Visit|Dropped|0
196077|NCT00369486|663779|P3|4-Week Visit|Dropped|1
196078|NCT00369486|663780|P2|4-Week Visit|Dropped|0
196079|NCT00369486|663781|P1|4-Week Visit|Dropped|0
196080|NCT00369486|663777|P5|4-Week Visit|Missed visit|1
196081|NCT00369486|663778|P4|4-Week Visit|Missed visit|2
196082|NCT00369486|663779|P3|4-Week Visit|Missed visit|0
196083|NCT00369486|663780|P2|4-Week Visit|Missed visit|2
196084|NCT00369486|663781|P1|4-Week Visit|Missed visit|2
196085|NCT00369382|663820|P2|Overall Study|Other|0
196086|NCT00369382|663821|P1|Overall Study|Other|1
196087|NCT00369382|663820|P2|Overall Study|Randomized, not treated|0
196088|NCT00369382|663821|P1|Overall Study|Randomized, not treated|2
196089|NCT00369382|663820|P2|Overall Study|Withdrawal by Subject|0
196090|NCT00369382|663821|P1|Overall Study|Withdrawal by Subject|5
196091|NCT00369382|663820|P2|Overall Study|Physician Decision|1
196092|NCT00369382|663821|P1|Overall Study|Physician Decision|2
196093|NCT00369382|663820|P2|Overall Study|Death|2
196094|NCT00369382|663821|P1|Overall Study|Death|0
196095|NCT00369343|663854|P2|Open-label Phase|did not take study drug|2
196096|NCT00369343|663855|P1|Open-label Phase|did not take study drug|1
196097|NCT00369343|663854|P2|Open-label Phase|Lack of continuance tolerability|4
196098|NCT00369343|663855|P1|Open-label Phase|Lack of continuance tolerability|3
196099|NCT00369343|663854|P2|Open-label Phase|Lack of Efficacy|3
196100|NCT00369343|663855|P1|Open-label Phase|Lack of Efficacy|4
196101|NCT00369343|663854|P2|Open-label Phase|Withdrawal by Subject|6
196102|NCT00369343|663855|P1|Open-label Phase|Withdrawal by Subject|15
196103|NCT00369343|663854|P2|Open-label Phase|Protocol Violation|3
196104|NCT00369343|663855|P1|Open-label Phase|Protocol Violation|1
196105|NCT00369343|663854|P2|Open-label Phase|inadvertently reported study completers|2
196106|NCT00369343|663855|P1|Open-label Phase|inadvertently reported study completers|3
196107|NCT00369343|663854|P2|Open-label Phase|Lost to Follow-up|3
196108|NCT00369343|663855|P1|Open-label Phase|Lost to Follow-up|5
196109|NCT00369343|663854|P2|Open-label Phase|Physician Decision|0
196110|NCT00369343|663855|P1|Open-label Phase|Physician Decision|2
196111|NCT00369343|663854|P2|Open-label Phase|Failed to return|0
196112|NCT00369343|663855|P1|Open-label Phase|Failed to return|4
196113|NCT00369343|663854|P2|Open-label Phase|Adverse Event|7
196114|NCT00369343|663855|P1|Open-label Phase|Adverse Event|19
196115|NCT00369343|663854|P2|Double-blind Phase|Protocol deviation|0
196116|NCT00369343|663855|P1|Double-blind Phase|Protocol deviation|4
196117|NCT00369343|663854|P2|Double-blind Phase|Lack of Efficacy|4
196118|NCT00369343|663855|P1|Double-blind Phase|Lack of Efficacy|0
196119|NCT00369343|663854|P2|Double-blind Phase|Withdrawal by Subject|6
196120|NCT00369343|663855|P1|Double-blind Phase|Withdrawal by Subject|8
196121|NCT00369343|663854|P2|Double-blind Phase|Protocol Violation|0
196122|NCT00369343|663855|P1|Double-blind Phase|Protocol Violation|2
196123|NCT00369343|663854|P2|Double-blind Phase|Lost to Follow-up|2
196124|NCT00369343|663855|P1|Double-blind Phase|Lost to Follow-up|9
196125|NCT00369343|663854|P2|Double-blind Phase|Failed to return|0
196126|NCT00369343|663855|P1|Double-blind Phase|Failed to return|2
196127|NCT00369343|663854|P2|Double-blind Phase|Adverse Event|4
196128|NCT00369343|663855|P1|Double-blind Phase|Adverse Event|19
196129|NCT00369317|663888|P1|Overall Study|Ineligible|1
196130|NCT00369317|663888|P1|Overall Study|Withdrawal by Subject|8
196131|NCT00369317|663888|P1|Overall Study|Physician Decision|2
196132|NCT00369317|663888|P1|Overall Study|Lack of Efficacy|5
196133|NCT00369317|663888|P1|Overall Study|Death|1
196134|NCT00369317|663888|P1|Overall Study|Adverse Event|3
196135|NCT00369278|663904|P2|Overall Study|Graft loss|2
196136|NCT00369278|663905|P1|Overall Study|Graft loss|1
196137|NCT00369278|663904|P2|Overall Study|Lost to Follow-up|0
196138|NCT00369278|663905|P1|Overall Study|Lost to Follow-up|1
196139|NCT00369278|663904|P2|Overall Study|Withdrawal by Subject|2
196140|NCT00369278|663905|P1|Overall Study|Withdrawal by Subject|2
196141|NCT00369278|663904|P2|Overall Study|Protocol Violation|1
196142|NCT00369278|663905|P1|Overall Study|Protocol Violation|2
196143|NCT00369278|663904|P2|Overall Study|Unsatisfactory therapeutic effect|5
196144|NCT00369278|663905|P1|Overall Study|Unsatisfactory therapeutic effect|4
196145|NCT00369278|663904|P2|Overall Study|Adverse Event|11
196146|NCT00369278|663905|P1|Overall Study|Adverse Event|14
196147|NCT00369265|663921|P2|Overall Study|Study terminated|7
196148|NCT00369265|663922|P1|Overall Study|Study terminated|4
196149|NCT00369161|663943|P2|Overall Study|Administrative Problem|2
196150|NCT00369161|663944|P1|Overall Study|Administrative Problem|2
196151|NCT00369161|663943|P2|Overall Study|Graft loss|0
196152|NCT00369161|663944|P1|Overall Study|Graft loss|4
196153|NCT00369161|663943|P2|Overall Study|Death|2
196154|NCT00369161|663944|P1|Overall Study|Death|1
196155|NCT00369161|663943|P2|Overall Study|Withdrawal by Subject|3
196156|NCT00369161|663944|P1|Overall Study|Withdrawal by Subject|2
196157|NCT00369161|663943|P2|Overall Study|Protocol Violation|2
196158|NCT00369161|663944|P1|Overall Study|Protocol Violation|0
196159|NCT00369161|663943|P2|Overall Study|Lack of Efficacy|1
196160|NCT00369161|663944|P1|Overall Study|Lack of Efficacy|3
196161|NCT00369161|663943|P2|Overall Study|Abnormal laboratory value|1
196162|NCT00369161|663944|P1|Overall Study|Abnormal laboratory value|0
196163|NCT00369161|663943|P2|Overall Study|Adverse Event|13
196164|NCT00369161|663944|P1|Overall Study|Adverse Event|15
196165|NCT00369122|663954|P1|Overall Study|No protocol treatment|1
196166|NCT00369122|663954|P1|Overall Study|Ineligible|10
196167|NCT00368992|663961|P1|Overall Study|Not Specified|9
196168|NCT00368992|663961|P1|Overall Study|Death|4
196169|NCT00368992|663961|P1|Overall Study|Adverse Event|26
196170|NCT00368992|663961|P1|Overall Study|Lack of Efficacy|63
196171|NCT00368992|663961|P1|Overall Study|Refused treatment|3
196172|NCT00368992|663961|P1|Overall Study|Ineligible|5
196173|NCT00368979|663970|P2|Overall Study|Withdrawal by Subject|9
196174|NCT00368979|663971|P1|Overall Study|Withdrawal by Subject|5
196175|NCT00368979|663970|P2|Overall Study|Protocol Violation|1
196176|NCT00368979|663971|P1|Overall Study|Protocol Violation|2
196177|NCT00368979|663970|P2|Overall Study|Lost to Follow-up|0
196178|NCT00368979|663971|P1|Overall Study|Lost to Follow-up|1
196179|NCT00368979|663970|P2|Overall Study|Not specified|1
196180|NCT00368979|663971|P1|Overall Study|Not specified|3
196181|NCT00368979|663970|P2|Overall Study|Lack of Efficacy|3
196182|NCT00368979|663971|P1|Overall Study|Lack of Efficacy|5
196183|NCT00368979|663970|P2|Overall Study|Adverse Event|16
196184|NCT00368979|663971|P1|Overall Study|Adverse Event|9
196185|NCT00368966|663987|P2|Toddler Dose|Lost to Follow-up|2
196186|NCT00368966|663988|P1|Toddler Dose|Lost to Follow-up|0
196187|NCT00368966|663987|P2|Toddler Dose|Withdrawal by Subject|1
196188|NCT00368966|663988|P1|Toddler Dose|Withdrawal by Subject|1
196189|NCT00368966|663987|P2|After Infant|Lost to Follow-up|1
196190|NCT00368966|663988|P1|After Infant|Lost to Follow-up|0
196191|NCT00368966|663987|P2|After Infant|Death|0
196192|NCT00368966|663988|P1|After Infant|Death|1
196193|NCT00368966|663987|P2|After Infant|Withdrawal by Subject|1
196194|NCT00368966|663988|P1|After Infant|Withdrawal by Subject|1
196195|NCT00368966|663987|P2|After Infant|Adverse Event|2
196196|NCT00368966|663988|P1|After Infant|Adverse Event|1
196197|NCT00368966|663987|P2|After Infant|Failed to return|1
196198|NCT00368966|663988|P1|After Infant|Failed to return|3
196199|NCT00368966|663987|P2|Infant Series|Failed to return|0
196200|NCT00368966|663988|P1|Infant Series|Failed to return|1
196201|NCT00368966|663987|P2|Infant Series|Adverse Event|1
196202|NCT00368966|663988|P1|Infant Series|Adverse Event|0
196203|NCT00368966|663987|P2|Infant Series|Failed to meet eligibility criteria|1
196204|NCT00368966|663988|P1|Infant Series|Failed to meet eligibility criteria|0
196205|NCT00368966|663987|P2|Infant Series|Randomization error|1
196206|NCT00368966|663988|P1|Infant Series|Randomization error|0
196207|NCT00368966|663987|P2|Infant Series|Lost to Follow-up|0
196208|NCT00368966|663988|P1|Infant Series|Lost to Follow-up|2
196209|NCT00368966|663987|P2|Infant Series|Protocol Violation|1
196210|NCT00368966|663988|P1|Infant Series|Protocol Violation|2
196211|NCT00368966|663987|P2|Infant Series|Withdrawal by Subject|6
196212|NCT00368966|663988|P1|Infant Series|Withdrawal by Subject|11
196213|NCT00368927|664059|P2|Overall Study|Physician Decision|0
196214|NCT00368927|664060|P1|Overall Study|Physician Decision|1
196215|NCT00368927|664059|P2|Overall Study|Withdrawal by Subject|2
196216|NCT00368927|664060|P1|Overall Study|Withdrawal by Subject|1
196217|NCT00368927|664059|P2|Overall Study|Adverse Event|1
196218|NCT00368927|664060|P1|Overall Study|Adverse Event|1
196219|NCT00368927|664059|P2|Overall Study|Lost to Follow-up|0
196220|NCT00368927|664060|P1|Overall Study|Lost to Follow-up|2
196221|NCT00368875|664068|P2|Overall Study|Alternative Therapy|1
196222|NCT00368875|664069|P1|Overall Study|Alternative Therapy|1
196223|NCT00368875|664068|P2|Overall Study|Other Reason|2
196224|NCT00368875|664069|P1|Overall Study|Other Reason|0
196225|NCT00368875|664068|P2|Overall Study|Withdrawal by Subject|6
196226|NCT00368875|664069|P1|Overall Study|Withdrawal by Subject|2
196227|NCT00368875|664068|P2|Overall Study|Progressive disease|27
196228|NCT00368875|664069|P1|Overall Study|Progressive disease|3
196229|NCT00368875|664068|P2|Overall Study|Adverse Event|12
196230|NCT00368875|664069|P1|Overall Study|Adverse Event|0
196231|NCT00368849|664077|P2|Overall Study|Physician Decision|1
196232|NCT00368849|664078|P1|Overall Study|Physician Decision|0
196233|NCT00368849|664077|P2|Overall Study|Withdrawal by Subject|1
196234|NCT00368849|664078|P1|Overall Study|Withdrawal by Subject|0
196235|NCT00368745|664094|P2|Double-blind Treatment Period|Other|6
196236|NCT00368745|664095|P1|Double-blind Treatment Period|Other|7
196237|NCT00368745|664094|P2|Double-blind Treatment Period|Withdrawal by Subject|3
196238|NCT00368745|664095|P1|Double-blind Treatment Period|Withdrawal by Subject|5
196239|NCT00368745|664094|P2|Double-blind Treatment Period|Lost to Follow-up|0
196240|NCT00368745|664095|P1|Double-blind Treatment Period|Lost to Follow-up|1
196241|NCT00368745|664094|P2|Double-blind Treatment Period|Lack of Efficacy|16
196242|NCT00368745|664095|P1|Double-blind Treatment Period|Lack of Efficacy|7
196243|NCT00368745|664094|P2|Double-blind Treatment Period|Adverse Event|6
196244|NCT00368745|664095|P1|Double-blind Treatment Period|Adverse Event|6
196245|NCT00368641|664127|P2|Overall Study|Sponsor decision to terminate study|5
196246|NCT00368641|664128|P1|Overall Study|Sponsor decision to terminate study|2
196247|NCT00368641|664127|P2|Overall Study|Withdrawal by Subject|0
196248|NCT00368641|664128|P1|Overall Study|Withdrawal by Subject|1
196249|NCT00368641|664127|P2|Overall Study|Death|0
196250|NCT00368641|664128|P1|Overall Study|Death|1
196251|NCT00368641|664127|P2|Overall Study|Adverse Event|1
196252|NCT00368641|664128|P1|Overall Study|Adverse Event|2
196253|NCT00368550|664136|P2|Overall Study|Withdrawal by Subject|10
196254|NCT00368550|664137|P1|Overall Study|Withdrawal by Subject|17
196255|NCT00368550|664136|P2|Overall Study|Lack of Efficacy|9
196256|NCT00368550|664137|P1|Overall Study|Lack of Efficacy|4
196257|NCT00368550|664136|P2|Overall Study|Adverse Event|4
196258|NCT00368550|664137|P1|Overall Study|Adverse Event|7
196259|NCT00368537|664149|P2|Baseline Participants|Patient uncompliant|1
196260|NCT00368537|664150|P1|Baseline Participants|Patient uncompliant|0
196261|NCT00368537|664149|P2|Baseline Participants|No susceptibility|0
196262|NCT00368537|664150|P1|Baseline Participants|No susceptibility|1
196263|NCT00368537|664149|P2|Baseline Participants|Death|2
196264|NCT00368537|664150|P1|Baseline Participants|Death|1
196265|NCT00368537|664149|P2|Baseline Participants|Withdrawal by Subject|4
196266|NCT00368537|664150|P1|Baseline Participants|Withdrawal by Subject|6
196267|NCT00368537|664149|P2|Baseline Participants|Lost to Follow-up|17
196268|NCT00368537|664150|P1|Baseline Participants|Lost to Follow-up|16
196269|NCT00368537|664149|P2|Randomization|No study drug dosed|6
196270|NCT00368537|664150|P1|Randomization|No study drug dosed|13
196271|NCT00368472|664164|P1|Overall Study|Missing Final Disposition Date|1
196272|NCT00368472|664164|P1|Overall Study|Not Specified|32
196273|NCT00368472|664164|P1|Overall Study|Diary non-compliance|1
196274|NCT00368472|664164|P1|Overall Study|Withdrawal by Subject|40
196275|NCT00368472|664164|P1|Overall Study|Request of Investigator or Sponsor|3
196276|NCT00368472|664164|P1|Overall Study|Protocol Violation|2
196277|NCT00368472|664164|P1|Overall Study|Medication non-compliance|4
196278|NCT00368472|664164|P1|Overall Study|Adverse Event|22
196279|NCT00368277|664223|P2|Overall Study|Lost to Follow-up|6
196280|NCT00368277|664224|P1|Overall Study|Lost to Follow-up|8
196281|NCT00368277|664223|P2|Overall Study|Patient withdrew consent|28
196282|NCT00368277|664224|P1|Overall Study|Patient withdrew consent|32
196283|NCT00368277|664223|P2|Overall Study|Protocol deviation|0
196284|NCT00368277|664224|P1|Overall Study|Protocol deviation|7
196285|NCT00368277|664223|P2|Overall Study|Unsatisfactory therapeutic effect|24
196286|NCT00368277|664224|P1|Overall Study|Unsatisfactory therapeutic effect|31
196287|NCT00368277|664223|P2|Overall Study|Death|1
196288|NCT00368277|664224|P1|Overall Study|Death|2
196289|NCT00368277|664223|P2|Overall Study|Adverse Event|49
196290|NCT00368277|664224|P1|Overall Study|Adverse Event|33
196291|NCT00368251|664239|P3|Overall Study|AE, non-serious non-fatal|1
196292|NCT00368251|664240|P2|Overall Study|AE, non-serious non-fatal|0
196293|NCT00368251|664241|P1|Overall Study|AE, non-serious non-fatal|0
196294|NCT00368251|664239|P3|Overall Study|SAE, non-fatal|0
196295|NCT00368251|664240|P2|Overall Study|SAE, non-fatal|0
196296|NCT00368251|664241|P1|Overall Study|SAE, non-fatal|1
196297|NCT00368108|664264|P3|Overall Study|Not Specified|1
196298|NCT00368108|664265|P2|Overall Study|Not Specified|7
196299|NCT00368108|664266|P1|Overall Study|Not Specified|3
196300|NCT00368108|664264|P3|Overall Study|Physician Decision|1
196301|NCT00368108|664265|P2|Overall Study|Physician Decision|0
196302|NCT00368108|664266|P1|Overall Study|Physician Decision|2
196303|NCT00368108|664264|P3|Overall Study|Lack of Efficacy|5
196304|NCT00368108|664265|P2|Overall Study|Lack of Efficacy|8
196305|NCT00368108|664266|P1|Overall Study|Lack of Efficacy|7
196306|NCT00368108|664264|P3|Overall Study|Withdrawal by Subject|5
196307|NCT00368108|664265|P2|Overall Study|Withdrawal by Subject|3
196308|NCT00368108|664266|P1|Overall Study|Withdrawal by Subject|9
196309|NCT00368108|664264|P3|Overall Study|Protocol Violation|9
196310|NCT00368108|664265|P2|Overall Study|Protocol Violation|9
196311|NCT00368108|664266|P1|Overall Study|Protocol Violation|5
196312|NCT00368108|664264|P3|Overall Study|Abnormal Laboratory Value|3
196313|NCT00368108|664265|P2|Overall Study|Abnormal Laboratory Value|0
196314|NCT00368108|664266|P1|Overall Study|Abnormal Laboratory Value|0
196315|NCT00368108|664264|P3|Overall Study|Adverse Event|44
196316|NCT00368108|664265|P2|Overall Study|Adverse Event|26
196317|NCT00368108|664266|P1|Overall Study|Adverse Event|38
196318|NCT00368069|664285|P2|Overall Study|no blood sampling possible|1
196319|NCT00368069|664286|P1|Overall Study|no blood sampling possible|0
196320|NCT00368069|664285|P2|Overall Study|Withdrawal of Consent|1
196321|NCT00368069|664286|P1|Overall Study|Withdrawal of Consent|2
196322|NCT00368069|664285|P2|Overall Study|Protocol Violation|2
196323|NCT00368069|664286|P1|Overall Study|Protocol Violation|0
196324|NCT00368069|664285|P2|Overall Study|Lost to Follow-up|0
196325|NCT00368069|664286|P1|Overall Study|Lost to Follow-up|1
196326|NCT00368069|664285|P2|Overall Study|Lack of Efficacy|1
196327|NCT00368069|664286|P1|Overall Study|Lack of Efficacy|0
196328|NCT00368069|664285|P2|Overall Study|Adverse Event|2
196329|NCT00368069|664286|P1|Overall Study|Adverse Event|5
196330|NCT00367991|664304|P2|Overall Study|Adverse Event|1
196331|NCT00367991|664305|P1|Overall Study|Adverse Event|1
196332|NCT00367991|664304|P2|Overall Study|Withdrawal by Subject|1
196333|NCT00367991|664305|P1|Overall Study|Withdrawal by Subject|1
196334|NCT00367835|664323|P2|Overall Study|History of lead poisoning|1
196335|NCT00367835|664324|P1|Overall Study|History of lead poisoning|0
196336|NCT00367835|664323|P2|Overall Study|Did not respond to calls|0
196337|NCT00367835|664324|P1|Overall Study|Did not respond to calls|1
196338|NCT00367835|664323|P2|Overall Study|refused blood collection|0
196339|NCT00367835|664324|P1|Overall Study|refused blood collection|1
196340|NCT00367835|664323|P2|Overall Study|Subject in juvenile detention center|0
196341|NCT00367835|664324|P1|Overall Study|Subject in juvenile detention center|1
196342|NCT00367835|664323|P2|Overall Study|Lack of Efficacy|12
196343|NCT00367835|664324|P1|Overall Study|Lack of Efficacy|3
196344|NCT00367835|664323|P2|Overall Study|Lost to Follow-up|4
196345|NCT00367835|664324|P1|Overall Study|Lost to Follow-up|1
196346|NCT00367835|664323|P2|Overall Study|Withdrawal by Subject|6
196347|NCT00367835|664324|P1|Overall Study|Withdrawal by Subject|7
196348|NCT00367835|664323|P2|Overall Study|Protocol Violation|7
196349|NCT00367835|664324|P1|Overall Study|Protocol Violation|1
196350|NCT00367835|664323|P2|Overall Study|Adverse Event|1
196351|NCT00367835|664324|P1|Overall Study|Adverse Event|14
196352|NCT00367770|664350|P1|Overall Study|Withdrawal by Subject|1
196353|NCT00367770|664350|P1|Overall Study|Adverse Event|1
196354|NCT00367744|664358|P2|Overall Study|Lost to Follow-up|5
196355|NCT00367744|664359|P1|Overall Study|Lost to Follow-up|4
196356|NCT00367640|664388|P4|Overall Study|Any other reason not above-mentioned|4
196357|NCT00367640|664389|P3|Overall Study|Any other reason not above-mentioned|3
196358|NCT00367640|664390|P2|Overall Study|Any other reason not above-mentioned|5
196359|NCT00367640|664391|P1|Overall Study|Any other reason not above-mentioned|7
196360|NCT00367640|664388|P4|Overall Study|Withdrawal by Subject|6
196361|NCT00367640|664389|P3|Overall Study|Withdrawal by Subject|8
196362|NCT00367640|664390|P2|Overall Study|Withdrawal by Subject|11
196363|NCT00367640|664391|P1|Overall Study|Withdrawal by Subject|8
196364|NCT00367640|664388|P4|Overall Study|Adverse Event|0
196365|NCT00367640|664389|P3|Overall Study|Adverse Event|8
196366|NCT00367640|664390|P2|Overall Study|Adverse Event|6
196367|NCT00367640|664391|P1|Overall Study|Adverse Event|3
196368|NCT00367484|664407|P1|Overall Study|Lack of Efficacy|1
196369|NCT00367484|664407|P1|Overall Study|The choice of the patient|1
196370|NCT00367484|664407|P1|Overall Study|Protocol Violation|1
196371|NCT00367484|664407|P1|Overall Study|Lost to Follow-up|1
196372|NCT00367484|664407|P1|Overall Study|Travel to USA|1
196373|NCT00367484|664407|P1|Overall Study|Withdrew informed consent|5
196374|NCT00367484|664407|P1|Overall Study|Adverse Event|7
196375|NCT00367432|664411|P2|Second Period (up to 54 Months)|Other Reason|2
196376|NCT00367432|664412|P1|Second Period (up to 54 Months)|Other Reason|6
196377|NCT00367432|664411|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
196378|NCT00367432|664412|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
196379|NCT00367432|664411|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
196380|NCT00367432|664412|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
196381|NCT00367432|664411|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
196382|NCT00367432|664412|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
196383|NCT00367432|664411|P2|Second Period (up to 54 Months)|Adverse Event|3
196384|NCT00367432|664412|P1|Second Period (up to 54 Months)|Adverse Event|14
196385|NCT00367432|664411|P2|First Period (16 Weeks)|Other Reason|0
196386|NCT00367432|664412|P1|First Period (16 Weeks)|Other Reason|2
196387|NCT00367432|664411|P2|First Period (16 Weeks)|Withdrawal by Subject|0
196388|NCT00367432|664412|P1|First Period (16 Weeks)|Withdrawal by Subject|6
196389|NCT00367432|664411|P2|First Period (16 Weeks)|Lack of Efficacy|0
196390|NCT00367432|664412|P1|First Period (16 Weeks)|Lack of Efficacy|24
196391|NCT00367432|664411|P2|First Period (16 Weeks)|Adverse Event|0
196392|NCT00367432|664412|P1|First Period (16 Weeks)|Adverse Event|6
196393|NCT00367341|664439|P2|Overall Study|Protocol Violation|0
196394|NCT00367341|664440|P1|Overall Study|Protocol Violation|1
196395|NCT00367341|664439|P2|Overall Study|Physician Decision|0
196396|NCT00367341|664440|P1|Overall Study|Physician Decision|1
196397|NCT00367237|664450|P2|Overall Study|Protocol Violation|5
196398|NCT00367237|664451|P1|Overall Study|Protocol Violation|2
196399|NCT00367237|664450|P2|Overall Study|Withdrawal by Subject|4
196400|NCT00367237|664451|P1|Overall Study|Withdrawal by Subject|0
196401|NCT00367237|664450|P2|Overall Study|Lost to Follow-up|0
196402|NCT00367237|664451|P1|Overall Study|Lost to Follow-up|1
196403|NCT00367237|664450|P2|Overall Study|Adverse Event|2
196404|NCT00367237|664451|P1|Overall Study|Adverse Event|7
196405|NCT00367133|664460|P3|2 Years|Missed visit|4
196406|NCT00367133|664461|P2|2 Years|Missed visit|5
196407|NCT00367133|664462|P1|2 Years|Missed visit|4
196408|NCT00367133|664460|P3|2 Years|Dropped|33
196409|NCT00367133|664461|P2|2 Years|Dropped|19
196410|NCT00367133|664462|P1|2 Years|Dropped|34
196411|NCT00367133|664460|P3|2 Years|Death|12
196412|NCT00367133|664461|P2|2 Years|Death|12
196413|NCT00367133|664462|P1|2 Years|Death|20
196414|NCT00367055|664514|P2|Overall Study|Participant Living too Far from Hospital|1
196415|NCT00367055|664515|P1|Overall Study|Participant Living too Far from Hospital|0
196416|NCT00367055|664514|P2|Overall Study|Stopping Criterion Met|1
196417|NCT00367055|664515|P1|Overall Study|Stopping Criterion Met|0
196418|NCT00367055|664514|P2|Overall Study|Protocol Violation|1
196419|NCT00367055|664515|P1|Overall Study|Protocol Violation|0
196420|NCT00367055|664514|P2|Overall Study|Lost to Follow-up|1
196421|NCT00367055|664515|P1|Overall Study|Lost to Follow-up|1
196422|NCT00367055|664514|P2|Overall Study|Lack of Efficacy|2
196423|NCT00367055|664515|P1|Overall Study|Lack of Efficacy|1
196424|NCT00367055|664514|P2|Overall Study|Patient's Willing|2
196425|NCT00367055|664515|P1|Overall Study|Patient's Willing|3
196426|NCT00367055|664514|P2|Overall Study|Adverse Event|3
196427|NCT00367055|664515|P1|Overall Study|Adverse Event|6
196428|NCT00366899|664531|P2|Toddler Dose|Protocol Violation|0
196429|NCT00366899|664532|P1|Toddler Dose|Protocol Violation|1
196430|NCT00366899|664531|P2|Toddler Dose|Withdrawal by Subject|1
196431|NCT00366899|664532|P1|Toddler Dose|Withdrawal by Subject|1
196432|NCT00366899|664531|P2|After Infant Series|Protocol Violation|0
196433|NCT00366899|664532|P1|After Infant Series|Protocol Violation|1
196434|NCT00366899|664531|P2|After Infant Series|Adverse Event|2
196435|NCT00366899|664532|P1|After Infant Series|Adverse Event|1
196436|NCT00366899|664531|P2|After Infant Series|Withdrawal by Subject|4
196437|NCT00366899|664532|P1|After Infant Series|Withdrawal by Subject|1
196438|NCT00366899|664531|P2|After Infant Series|Lost to Follow-up|3
196439|NCT00366899|664532|P1|After Infant Series|Lost to Follow-up|4
196440|NCT00366899|664531|P2|Infant Series|Randomized but not consented|0
196441|NCT00366899|664532|P1|Infant Series|Randomized but not consented|1
196442|NCT00366899|664531|P2|Infant Series|Physician Decision|0
196443|NCT00366899|664532|P1|Infant Series|Physician Decision|1
196444|NCT00366899|664531|P2|Infant Series|Adverse Event|1
196445|NCT00366899|664532|P1|Infant Series|Adverse Event|0
196446|NCT00366899|664531|P2|Infant Series|Lost to Follow-up|2
196447|NCT00366899|664532|P1|Infant Series|Lost to Follow-up|0
196448|NCT00366899|664531|P2|Infant Series|Failed to return|1
196449|NCT00366899|664532|P1|Infant Series|Failed to return|1
196450|NCT00366899|664531|P2|Infant Series|Protocol Violation|1
196451|NCT00366899|664532|P1|Infant Series|Protocol Violation|2
196452|NCT00366899|664531|P2|Infant Series|Withdrawal by Subject|7
196453|NCT00366899|664532|P1|Infant Series|Withdrawal by Subject|4
196454|NCT00366678|664592|P3|Toddler Dose|protocol deviation|0
196455|NCT00366678|664593|P2|Toddler Dose|protocol deviation|0
196456|NCT00366678|664594|P1|Toddler Dose|protocol deviation|1
196457|NCT00366678|664592|P3|Toddler Dose|Withdrawal by Subject|0
196458|NCT00366678|664593|P2|Toddler Dose|Withdrawal by Subject|0
196459|NCT00366678|664594|P1|Toddler Dose|Withdrawal by Subject|1
196460|NCT00366678|664592|P3|Toddler Dose|Failed to return|0
196461|NCT00366678|664593|P2|Toddler Dose|Failed to return|0
196462|NCT00366678|664594|P1|Toddler Dose|Failed to return|1
196463|NCT00366678|664592|P3|Toddler Dose|Protocol Violation|0
196464|NCT00366678|664593|P2|Toddler Dose|Protocol Violation|1
196465|NCT00366678|664594|P1|Toddler Dose|Protocol Violation|2
196466|NCT00366678|664592|P3|After Infant|Protocol Violation|0
196467|NCT00366678|664593|P2|After Infant|Protocol Violation|0
196468|NCT00366678|664594|P1|After Infant|Protocol Violation|1
196469|NCT00366678|664592|P3|After Infant|Adverse Event|0
196470|NCT00366678|664593|P2|After Infant|Adverse Event|0
196471|NCT00366678|664594|P1|After Infant|Adverse Event|1
196472|NCT00366678|664592|P3|After Infant|Failed to return|0
196473|NCT00366678|664593|P2|After Infant|Failed to return|5
196474|NCT00366678|664594|P1|After Infant|Failed to return|5
196475|NCT00366678|664592|P3|After Infant|Lost to Follow-up|0
196476|NCT00366678|664593|P2|After Infant|Lost to Follow-up|1
196477|NCT00366678|664594|P1|After Infant|Lost to Follow-up|2
196478|NCT00366678|664592|P3|After Infant|Withdrawal by Subject|0
196479|NCT00366678|664593|P2|After Infant|Withdrawal by Subject|4
196480|NCT00366678|664594|P1|After Infant|Withdrawal by Subject|8
196481|NCT00366678|664592|P3|Infant Series|Adverse Event|0
196482|NCT00366678|664593|P2|Infant Series|Adverse Event|0
196483|NCT00366678|664594|P1|Infant Series|Adverse Event|1
196484|NCT00366678|664592|P3|Infant Series|Failed to return|0
196485|NCT00366678|664593|P2|Infant Series|Failed to return|1
196486|NCT00366678|664594|P1|Infant Series|Failed to return|1
196487|NCT00366678|664592|P3|Infant Series|Protocol Violation|0
196488|NCT00366678|664593|P2|Infant Series|Protocol Violation|3
196489|NCT00366678|664594|P1|Infant Series|Protocol Violation|4
196490|NCT00366678|664592|P3|Infant Series|Withdrawal by Subject|0
196491|NCT00366678|664593|P2|Infant Series|Withdrawal by Subject|6
196492|NCT00366678|664594|P1|Infant Series|Withdrawal by Subject|8
196493|NCT00366548|664676|P2|After Infant Series|Lost to Follow-up|0
196494|NCT00366548|664677|P1|After Infant Series|Lost to Follow-up|1
196495|NCT00366548|664676|P2|After Infant Series|Adverse Event|0
196496|NCT00366548|664677|P1|After Infant Series|Adverse Event|2
196497|NCT00366548|664676|P2|After Infant Series|Withdrawal by Subject|1
196498|NCT00366548|664677|P1|After Infant Series|Withdrawal by Subject|3
196499|NCT00366548|664676|P2|Infant Series|Withdrawal by Subject|1
196500|NCT00366548|664677|P1|Infant Series|Withdrawal by Subject|3
196501|NCT00366548|664676|P2|Infant Series|Protocol Violation|1
196502|NCT00366548|664677|P1|Infant Series|Protocol Violation|0
196503|NCT00366548|664676|P2|Infant Series|Adverse Event|3
196504|NCT00366548|664677|P1|Infant Series|Adverse Event|1
196505|NCT00366457|664711|P1|Overall Study|never began study therapy|2
196506|NCT00366444|664720|P2|Overall Study|Lack of Efficacy|1
196507|NCT00366444|664721|P1|Overall Study|Lack of Efficacy|0
196508|NCT00366444|664720|P2|Overall Study|Withdrawal by Subject|1
196509|NCT00366444|664721|P1|Overall Study|Withdrawal by Subject|1
196510|NCT00366340|664749|P2|Toddler Dose|Parent/legal guardian request|1
196511|NCT00366340|664750|P1|Toddler Dose|Parent/legal guardian request|0
196512|NCT00366340|664749|P2|Toddler Dose|Failed to return|0
196513|NCT00366340|664750|P1|Toddler Dose|Failed to return|1
196514|NCT00366340|664749|P2|After the Infant Series|Lost to Follow-up|1
196515|NCT00366340|664750|P1|After the Infant Series|Lost to Follow-up|0
196516|NCT00366340|664749|P2|After the Infant Series|Adverse Event|1
196517|NCT00366340|664750|P1|After the Infant Series|Adverse Event|0
196518|NCT00366340|664749|P2|After the Infant Series|Protocol Violation|2
196519|NCT00366340|664750|P1|After the Infant Series|Protocol Violation|2
196520|NCT00366340|664749|P2|After the Infant Series|Failed to return|1
196521|NCT00366340|664750|P1|After the Infant Series|Failed to return|0
196522|NCT00366340|664749|P2|After the Infant Series|Parent/legal guardian request|1
196523|NCT00366340|664750|P1|After the Infant Series|Parent/legal guardian request|1
196524|NCT00366340|664749|P2|Infant Series|Failure to return|0
196525|NCT00366340|664750|P1|Infant Series|Failure to return|1
196526|NCT00366340|664749|P2|Infant Series|Lost to Follow-up|1
196527|NCT00366340|664750|P1|Infant Series|Lost to Follow-up|1
196528|NCT00366340|664749|P2|Infant Series|Adverse Event|2
196529|NCT00366340|664750|P1|Infant Series|Adverse Event|0
196530|NCT00366340|664749|P2|Infant Series|Withdrawal by Subject|3
196531|NCT00366340|664750|P1|Infant Series|Withdrawal by Subject|3
196532|NCT00366340|664749|P2|Infant Series|Protocol Violation|4
196533|NCT00366340|664750|P1|Infant Series|Protocol Violation|3
196534|NCT00366301|664808|P4|Overall Study|Withdrawal by Subject|1
196535|NCT00366301|664809|P3|Overall Study|Withdrawal by Subject|1
196536|NCT00366301|664810|P2|Overall Study|Withdrawal by Subject|2
196537|NCT00366301|664811|P1|Overall Study|Withdrawal by Subject|4
196538|NCT00366301|664808|P4|Overall Study|Lost to Follow-up|7
196539|NCT00366301|664809|P3|Overall Study|Lost to Follow-up|3
196540|NCT00366301|664810|P2|Overall Study|Lost to Follow-up|4
196541|NCT00366301|664811|P1|Overall Study|Lost to Follow-up|4
196542|NCT00366249|664827|P2|Overall Study|Most due to osteomylitis status|20
196543|NCT00366249|664828|P1|Overall Study|Most due to osteomylitis status|31
196544|NCT00366249|664827|P2|Overall Study|Lack of Efficacy|21
196545|NCT00366249|664828|P1|Overall Study|Lack of Efficacy|21
196546|NCT00366249|664827|P2|Overall Study|Withdrawal by Subject|4
196547|NCT00366249|664828|P1|Overall Study|Withdrawal by Subject|18
196548|NCT00366249|664827|P2|Overall Study|Protocol Violation|2
196549|NCT00366249|664828|P1|Overall Study|Protocol Violation|1
196550|NCT00366249|664827|P2|Overall Study|Lost to Follow-up|0
196551|NCT00366249|664828|P1|Overall Study|Lost to Follow-up|2
196552|NCT00366249|664827|P2|Overall Study|Physician Decision|2
196553|NCT00366249|664828|P1|Overall Study|Physician Decision|5
196554|NCT00366249|664827|P2|Overall Study|Death|1
196555|NCT00366249|664828|P1|Overall Study|Death|0
196556|NCT00366249|664827|P2|Overall Study|Adverse Event|28
196557|NCT00366249|664828|P1|Overall Study|Adverse Event|53
196558|NCT00365976|664862|P2|Overall Study|Withdrawal by Subject|5
196559|NCT00365976|664863|P1|Overall Study|Withdrawal by Subject|1
196560|NCT00365846|665001|P1|Overall Study|Lost to Follow-up|1
196561|NCT00365716|665026|P7|Extension 2|Withdrawal by Subject|5
196562|NCT00365716|665027|P6|Extension 2|Withdrawal by Subject|0
196563|NCT00365716|665028|P5|Extension 2|Withdrawal by Subject|0
196564|NCT00365716|665029|P4|Extension 2|Withdrawal by Subject|0
196565|NCT00365716|665030|P3|Extension 2|Withdrawal by Subject|0
196566|NCT00365716|665031|P2|Extension 2|Withdrawal by Subject|0
196567|NCT00365716|665032|P1|Extension 2|Withdrawal by Subject|0
196568|NCT00365716|665026|P7|Extension 2|Other|3
196569|NCT00365716|665027|P6|Extension 2|Other|0
196570|NCT00365716|665028|P5|Extension 2|Other|0
196571|NCT00365716|665029|P4|Extension 2|Other|0
196572|NCT00365716|665030|P3|Extension 2|Other|0
196573|NCT00365716|665031|P2|Extension 2|Other|0
196574|NCT00365716|665032|P1|Extension 2|Other|0
196575|NCT00365716|665026|P7|Extension 2|Lost to Follow-up|2
196576|NCT00365716|665027|P6|Extension 2|Lost to Follow-up|0
196577|NCT00365716|665028|P5|Extension 2|Lost to Follow-up|0
196578|NCT00365716|665029|P4|Extension 2|Lost to Follow-up|0
196579|NCT00365716|665030|P3|Extension 2|Lost to Follow-up|0
196580|NCT00365716|665031|P2|Extension 2|Lost to Follow-up|0
196581|NCT00365716|665032|P1|Extension 2|Lost to Follow-up|0
196582|NCT00365716|665026|P7|Extension 1|Protocol Violation|0
196583|NCT00365716|665027|P6|Extension 1|Protocol Violation|1
196584|NCT00365716|665028|P5|Extension 1|Protocol Violation|0
196585|NCT00365716|665029|P4|Extension 1|Protocol Violation|0
196586|NCT00365716|665030|P3|Extension 1|Protocol Violation|0
196587|NCT00365716|665031|P2|Extension 1|Protocol Violation|0
196588|NCT00365716|665032|P1|Extension 1|Protocol Violation|0
196589|NCT00365716|665026|P7|Extension 1|Pregnancy|0
196590|NCT00365716|665027|P6|Extension 1|Pregnancy|4
196591|NCT00365716|665028|P5|Extension 1|Pregnancy|0
196592|NCT00365716|665029|P4|Extension 1|Pregnancy|0
196593|NCT00365716|665030|P3|Extension 1|Pregnancy|0
196594|NCT00365716|665031|P2|Extension 1|Pregnancy|0
196595|NCT00365716|665032|P1|Extension 1|Pregnancy|0
196596|NCT00365716|665026|P7|Extension 1|Withdrawal by Subject|0
196597|NCT00365716|665027|P6|Extension 1|Withdrawal by Subject|3
196598|NCT00365716|665028|P5|Extension 1|Withdrawal by Subject|0
196599|NCT00365716|665029|P4|Extension 1|Withdrawal by Subject|0
196600|NCT00365716|665030|P3|Extension 1|Withdrawal by Subject|0
196601|NCT00365716|665031|P2|Extension 1|Withdrawal by Subject|0
196602|NCT00365716|665032|P1|Extension 1|Withdrawal by Subject|0
196603|NCT00365716|665026|P7|Extension 1|Moved|0
196604|NCT00365716|665027|P6|Extension 1|Moved|4
196605|NCT00365716|665028|P5|Extension 1|Moved|0
196606|NCT00365716|665029|P4|Extension 1|Moved|0
196607|NCT00365716|665030|P3|Extension 1|Moved|0
196608|NCT00365716|665031|P2|Extension 1|Moved|0
196609|NCT00365716|665032|P1|Extension 1|Moved|0
196610|NCT00365716|665026|P7|Extension 1|Other|0
196611|NCT00365716|665027|P6|Extension 1|Other|9
196612|NCT00365716|665028|P5|Extension 1|Other|0
196613|NCT00365716|665029|P4|Extension 1|Other|0
196614|NCT00365716|665030|P3|Extension 1|Other|0
196615|NCT00365716|665031|P2|Extension 1|Other|0
196616|NCT00365716|665032|P1|Extension 1|Other|0
196617|NCT00365716|665026|P7|Extension 1|Lost to Follow-up|0
196618|NCT00365716|665027|P6|Extension 1|Lost to Follow-up|1
196619|NCT00365716|665028|P5|Extension 1|Lost to Follow-up|0
196620|NCT00365716|665029|P4|Extension 1|Lost to Follow-up|0
196621|NCT00365716|665030|P3|Extension 1|Lost to Follow-up|0
196622|NCT00365716|665031|P2|Extension 1|Lost to Follow-up|0
196623|NCT00365716|665032|P1|Extension 1|Lost to Follow-up|0
196624|NCT00365716|665026|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
196625|NCT00365716|665027|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
196626|NCT00365716|665028|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
196627|NCT00365716|665029|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
196628|NCT00365716|665030|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
196629|NCT00365716|665031|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
196630|NCT00365716|665032|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
196631|NCT00365716|665026|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
196632|NCT00365716|665027|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
196633|NCT00365716|665028|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
196634|NCT00365716|665029|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
196635|NCT00365716|665030|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
196636|NCT00365716|665031|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
196637|NCT00365716|665032|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
196638|NCT00365716|665026|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
196639|NCT00365716|665027|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
196640|NCT00365716|665028|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
196641|NCT00365716|665029|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
196642|NCT00365716|665030|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
196643|NCT00365716|665031|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
196644|NCT00365716|665032|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
196645|NCT00365716|665026|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
196646|NCT00365716|665027|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
196647|NCT00365716|665028|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
196648|NCT00365716|665029|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
196649|NCT00365716|665030|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
196650|NCT00365716|665031|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
196651|NCT00365716|665032|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
196652|NCT00365716|665026|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
196653|NCT00365716|665027|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
196654|NCT00365716|665028|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
196655|NCT00365716|665029|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
196656|NCT00365716|665030|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
196657|NCT00365716|665031|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
196658|NCT00365716|665032|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
196659|NCT00365716|665026|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
196660|NCT00365716|665027|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
196661|NCT00365716|665028|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
196662|NCT00365716|665029|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
196663|NCT00365716|665030|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
196664|NCT00365716|665031|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
196665|NCT00365716|665032|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
196666|NCT00365716|665026|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
196667|NCT00365716|665027|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
196668|NCT00365716|665028|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
196669|NCT00365716|665029|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
196670|NCT00365716|665030|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
196671|NCT00365716|665031|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
196672|NCT00365716|665032|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
196673|NCT00365716|665026|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
196674|NCT00365716|665027|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
196675|NCT00365716|665028|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
196676|NCT00365716|665029|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
196677|NCT00365716|665030|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
196678|NCT00365716|665031|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
196679|NCT00365716|665032|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
196680|NCT00365716|665026|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
196681|NCT00365716|665027|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
196682|NCT00365716|665028|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
196683|NCT00365716|665029|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
196684|NCT00365716|665030|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
196685|NCT00365716|665031|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
196686|NCT00365716|665032|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
196687|NCT00365716|665026|P7|Base Study (Day 1 to Month 7)|Other|0
196688|NCT00365716|665027|P6|Base Study (Day 1 to Month 7)|Other|0
196689|NCT00365716|665028|P5|Base Study (Day 1 to Month 7)|Other|0
196690|NCT00365716|665029|P4|Base Study (Day 1 to Month 7)|Other|0
196691|NCT00365716|665030|P3|Base Study (Day 1 to Month 7)|Other|0
196692|NCT00365716|665031|P2|Base Study (Day 1 to Month 7)|Other|1
196693|NCT00365716|665032|P1|Base Study (Day 1 to Month 7)|Other|0
196694|NCT00365716|665026|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
196695|NCT00365716|665027|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
196696|NCT00365716|665028|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
196697|NCT00365716|665029|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
196698|NCT00365716|665030|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
196699|NCT00365716|665031|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
196700|NCT00365716|665032|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
196701|NCT00365716|665026|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
196702|NCT00365716|665027|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
196703|NCT00365716|665028|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
196704|NCT00365716|665029|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
196705|NCT00365716|665030|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
196706|NCT00365716|665031|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
196707|NCT00365716|665032|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
196708|NCT00365716|665026|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
196709|NCT00365716|665027|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
196710|NCT00365716|665028|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
196711|NCT00365716|665029|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
196712|NCT00365716|665030|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
196713|NCT00365716|665031|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
196714|NCT00365716|665032|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
196715|NCT00365547|665053|P1|Overall Study|Withdrawal by Subject|1
196716|NCT00365547|665053|P1|Overall Study|Screen failure|1
196717|NCT00365547|665053|P1|Overall Study|Insurance did not cover Avastin|1
196718|NCT00365508|665063|P2|Overall Study|Lost to Follow-up|154
196719|NCT00365508|665064|P1|Overall Study|Lost to Follow-up|139
196720|NCT00365456|665072|P2|Trial Period III (12 Months)|Other|1
196721|NCT00365456|665073|P1|Trial Period III (12 Months)|Other|1
196722|NCT00365456|665072|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
196723|NCT00365456|665073|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
196724|NCT00365456|665072|P2|Trial Period III (12 Months)|Adverse Event|3
196725|NCT00365456|665073|P1|Trial Period III (12 Months)|Adverse Event|13
196726|NCT00365456|665072|P2|Trial Period II (12 Months)|Other|1
196727|NCT00365456|665073|P1|Trial Period II (12 Months)|Other|0
196728|NCT00365456|665072|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
196729|NCT00365456|665073|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
196730|NCT00365456|665072|P2|Trial Period II (12 Months)|Non-compliance|2
196731|NCT00365456|665073|P1|Trial Period II (12 Months)|Non-compliance|0
196732|NCT00365456|665072|P2|Trial Period II (12 Months)|Adverse Event|6
196733|NCT00365456|665073|P1|Trial Period II (12 Months)|Adverse Event|0
196734|NCT00365456|665072|P2|Trial Period I (12 Months)|Other|0
196735|NCT00365456|665073|P1|Trial Period I (12 Months)|Other|11
196736|NCT00365456|665072|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
196737|NCT00365456|665073|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
196738|NCT00365456|665072|P2|Trial Period I (12 Months)|Non-compliance|0
196739|NCT00365456|665073|P1|Trial Period I (12 Months)|Non-compliance|3
196740|NCT00365456|665072|P2|Trial Period I (12 Months)|Adverse Event|0
196741|NCT00365456|665073|P1|Trial Period I (12 Months)|Adverse Event|84
196742|NCT00365378|665095|P3|Extension|Other|31
196743|NCT00365378|665096|P2|Extension|Other|0
196744|NCT00365378|665097|P1|Extension|Other|0
196745|NCT00365378|665095|P3|Extension|Withdrawal by Subject|98
196746|NCT00365378|665096|P2|Extension|Withdrawal by Subject|0
196747|NCT00365378|665097|P1|Extension|Withdrawal by Subject|0
196748|NCT00365378|665095|P3|Extension|Protocol Violation|2
196749|NCT00365378|665096|P2|Extension|Protocol Violation|0
196750|NCT00365378|665097|P1|Extension|Protocol Violation|0
196751|NCT00365378|665095|P3|Extension|Lost to Follow-up|57
196752|NCT00365378|665096|P2|Extension|Lost to Follow-up|0
196753|NCT00365378|665097|P1|Extension|Lost to Follow-up|0
196754|NCT00365378|665095|P3|Extension|Moved|8
196755|NCT00365378|665096|P2|Extension|Moved|0
196756|NCT00365378|665097|P1|Extension|Moved|0
196757|NCT00365378|665095|P3|Extension|Adverse Event|1
196758|NCT00365378|665096|P2|Extension|Adverse Event|0
196759|NCT00365378|665097|P1|Extension|Adverse Event|0
196760|NCT00365378|665095|P3|Follow-up (Month 7 Though Month 48)|Other|0
196761|NCT00365378|665096|P2|Follow-up (Month 7 Though Month 48)|Other|21
196762|NCT00365378|665097|P1|Follow-up (Month 7 Though Month 48)|Other|11
196763|NCT00365378|665095|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
196764|NCT00365378|665096|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
196765|NCT00365378|665097|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
196766|NCT00365378|665095|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
196767|NCT00365378|665096|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
196768|NCT00365378|665097|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
196769|NCT00365378|665095|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
196770|NCT00365378|665096|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
196771|NCT00365378|665097|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
196772|NCT00365378|665095|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
196773|NCT00365378|665096|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
196774|NCT00365378|665097|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
196775|NCT00365378|665095|P3|Follow-up (Month 7 Though Month 48)|Moved|0
196776|NCT00365378|665096|P2|Follow-up (Month 7 Though Month 48)|Moved|5
196777|NCT00365378|665097|P1|Follow-up (Month 7 Though Month 48)|Moved|6
196778|NCT00365378|665095|P3|Vaccination (Day 1 to Month 7)|Other|0
196779|NCT00365378|665096|P2|Vaccination (Day 1 to Month 7)|Other|9
196780|NCT00365378|665097|P1|Vaccination (Day 1 to Month 7)|Other|17
196781|NCT00365378|665095|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
196782|NCT00365378|665096|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
196783|NCT00365378|665097|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
196784|NCT00365378|665095|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
196785|NCT00365378|665096|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
196786|NCT00365378|665097|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
196787|NCT00365378|665095|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
196788|NCT00365378|665096|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
196789|NCT00365378|665097|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
196790|NCT00365378|665095|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
196791|NCT00365378|665096|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
196792|NCT00365378|665097|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
196793|NCT00365378|665095|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
196794|NCT00365378|665096|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
196795|NCT00365378|665097|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
196796|NCT00365378|665095|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
196797|NCT00365378|665096|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
196798|NCT00365378|665097|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
196799|NCT00365365|665111|P3|Overall Study|Patient/physician decision|1
196800|NCT00365365|665112|P2|Overall Study|Patient/physician decision|0
196801|NCT00365365|665113|P1|Overall Study|Patient/physician decision|0
196802|NCT00365365|665111|P3|Overall Study|Second malignancy|0
196803|NCT00365365|665112|P2|Overall Study|Second malignancy|1
196804|NCT00365365|665113|P1|Overall Study|Second malignancy|0
196805|NCT00365365|665111|P3|Overall Study|Withdrew consent|0
196806|NCT00365365|665112|P2|Overall Study|Withdrew consent|1
196807|NCT00365365|665113|P1|Overall Study|Withdrew consent|1
196808|NCT00365365|665111|P3|Overall Study|New cancer|0
196809|NCT00365365|665112|P2|Overall Study|New cancer|0
196810|NCT00365365|665113|P1|Overall Study|New cancer|1
196811|NCT00365365|665111|P3|Overall Study|Moved|0
196812|NCT00365365|665112|P2|Overall Study|Moved|0
196813|NCT00365365|665113|P1|Overall Study|Moved|2
196814|NCT00365365|665111|P3|Overall Study|Adverse Event|3
196815|NCT00365365|665112|P2|Overall Study|Adverse Event|6
196816|NCT00365365|665113|P1|Overall Study|Adverse Event|6
196817|NCT00365365|665111|P3|Overall Study|Disease progression/relapse|7
196818|NCT00365365|665112|P2|Overall Study|Disease progression/relapse|6
196819|NCT00365365|665113|P1|Overall Study|Disease progression/relapse|9
196820|NCT00365365|665111|P3|Overall Study|Subject's request|1
196821|NCT00365365|665112|P2|Overall Study|Subject's request|13
196822|NCT00365365|665113|P1|Overall Study|Subject's request|11
196823|NCT00365365|665111|P3|Overall Study|Death|0
196824|NCT00365365|665112|P2|Overall Study|Death|3
196825|NCT00365365|665113|P1|Overall Study|Death|1
196826|NCT00365365|665111|P3|Overall Study|Lost to Follow-up|3
196827|NCT00365365|665112|P2|Overall Study|Lost to Follow-up|3
196828|NCT00365365|665113|P1|Overall Study|Lost to Follow-up|3
196829|NCT00365365|665111|P3|Overall Study|Poor compliance to protocol|0
196830|NCT00365365|665112|P2|Overall Study|Poor compliance to protocol|1
196831|NCT00365365|665113|P1|Overall Study|Poor compliance to protocol|0
196832|NCT00365365|665111|P3|Overall Study|Randomized but not treated|0
196833|NCT00365365|665112|P2|Overall Study|Randomized but not treated|2
196834|NCT00365365|665113|P1|Overall Study|Randomized but not treated|0
196835|NCT00365352|665130|P3|Overall Study|Withdrawal of Participant by Sponsor|0
196836|NCT00365352|665131|P2|Overall Study|Withdrawal of Participant by Sponsor|0
196837|NCT00365352|665132|P1|Overall Study|Withdrawal of Participant by Sponsor|1
196838|NCT00365352|665130|P3|Overall Study|Lost to Follow-up|0
196839|NCT00365352|665131|P2|Overall Study|Lost to Follow-up|1
196840|NCT00365352|665132|P1|Overall Study|Lost to Follow-up|1
196841|NCT00365352|665130|P3|Overall Study|Non-Compliance (after Randomization)|1
196842|NCT00365352|665131|P2|Overall Study|Non-Compliance (after Randomization)|0
196843|NCT00365352|665132|P1|Overall Study|Non-Compliance (after Randomization)|1
196844|NCT00365352|665130|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
196845|NCT00365352|665131|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
196846|NCT00365352|665132|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
196847|NCT00365352|665130|P3|Overall Study|Lack of Efficacy|0
196848|NCT00365352|665131|P2|Overall Study|Lack of Efficacy|0
196849|NCT00365352|665132|P1|Overall Study|Lack of Efficacy|3
196850|NCT00365352|665130|P3|Overall Study|Participant Withdrew Consent|4
196851|NCT00365352|665131|P2|Overall Study|Participant Withdrew Consent|3
196852|NCT00365352|665132|P1|Overall Study|Participant Withdrew Consent|8
196853|NCT00365352|665130|P3|Overall Study|Adverse Event|8
196854|NCT00365352|665131|P2|Overall Study|Adverse Event|7
196855|NCT00365352|665132|P1|Overall Study|Adverse Event|6
196856|NCT00365300|665216|P2|Double-blind Phase|Lack of Efficacy|6
196857|NCT00365300|665217|P1|Double-blind Phase|Lack of Efficacy|6
196858|NCT00365300|665216|P2|Double-blind Phase|Protocol Violation|1
196859|NCT00365300|665217|P1|Double-blind Phase|Protocol Violation|3
196860|NCT00365300|665216|P2|Double-blind Phase|Withdrawal by Subject|1
196861|NCT00365300|665217|P1|Double-blind Phase|Withdrawal by Subject|0
196862|NCT00365300|665216|P2|Double-blind Phase|Noncompliance|1
196863|NCT00365300|665217|P1|Double-blind Phase|Noncompliance|1
196864|NCT00365300|665216|P2|Double-blind Phase|Failed to return|0
196865|NCT00365300|665217|P1|Double-blind Phase|Failed to return|1
196866|NCT00365300|665216|P2|Open-label Phase|Patient skipped open label phase|0
196867|NCT00365300|665217|P1|Open-label Phase|Patient skipped open label phase|1
196868|NCT00365300|665216|P2|Open-label Phase|Lack of Efficacy|0
196869|NCT00365300|665217|P1|Open-label Phase|Lack of Efficacy|1
196870|NCT00365300|665216|P2|Open-label Phase|Protocol Violation|0
196871|NCT00365300|665217|P1|Open-label Phase|Protocol Violation|1
196872|NCT00365300|665216|P2|Open-label Phase|Parent/Legal Guardian Request|0
196873|NCT00365300|665217|P1|Open-label Phase|Parent/Legal Guardian Request|4
196874|NCT00365300|665216|P2|Open-label Phase|Noncompliance|0
196875|NCT00365300|665217|P1|Open-label Phase|Noncompliance|9
196876|NCT00365300|665216|P2|Open-label Phase|Physician Decision|0
196877|NCT00365300|665217|P1|Open-label Phase|Physician Decision|1
196878|NCT00365300|665216|P2|Open-label Phase|Failed to Return|0
196879|NCT00365300|665217|P1|Open-label Phase|Failed to Return|1
196880|NCT00365300|665216|P2|Open-label Phase|Adverse Event|0
196881|NCT00365300|665217|P1|Open-label Phase|Adverse Event|4
196882|NCT00365105|665282|P2|Overall Study|Lost to Follow-up|0
196883|NCT00365105|665283|P1|Overall Study|Lost to Follow-up|1
196884|NCT00365105|665282|P2|Overall Study|Withdrawal by Subject|1
196885|NCT00365105|665283|P1|Overall Study|Withdrawal by Subject|1
196886|NCT00365105|665282|P2|Overall Study|Protocol Violation|3
196887|NCT00365105|665283|P1|Overall Study|Protocol Violation|4
196888|NCT00364923|665319|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
196889|NCT00364923|665319|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
196890|NCT00364858|665328|P2|Overall Study|Clinical baseline issue|1
196891|NCT00364858|665329|P1|Overall Study|Clinical baseline issue|0
196892|NCT00364858|665328|P2|Overall Study|Return to Q2 regimen|1
196893|NCT00364858|665329|P1|Overall Study|Return to Q2 regimen|0
196894|NCT00364858|665328|P2|Overall Study|Non-compliant|0
196895|NCT00364858|665329|P1|Overall Study|Non-compliant|1
196896|NCT00364858|665328|P2|Overall Study|Discontinuation at baseline|0
196897|NCT00364858|665329|P1|Overall Study|Discontinuation at baseline|1
196898|NCT00364858|665328|P2|Overall Study|Clinical failure|13
196899|NCT00364858|665329|P1|Overall Study|Clinical failure|2
196900|NCT00364858|665328|P2|Overall Study|Pregnancy|1
196901|NCT00364858|665329|P1|Overall Study|Pregnancy|1
196902|NCT00364858|665328|P2|Overall Study|Withdrawal by Subject|1
196903|NCT00364858|665329|P1|Overall Study|Withdrawal by Subject|1
196904|NCT00364858|665328|P2|Overall Study|Adverse Event|5
196905|NCT00364858|665329|P1|Overall Study|Adverse Event|1
196906|NCT00364845|665344|P2|Overall Study|Death|1
196907|NCT00364845|665345|P1|Overall Study|Death|0
196908|NCT00364845|665344|P2|Overall Study|Lost to Follow-up|1
196909|NCT00364845|665345|P1|Overall Study|Lost to Follow-up|0
196910|NCT00364845|665344|P2|Overall Study|Physician Decision|8
196911|NCT00364845|665345|P1|Overall Study|Physician Decision|8
196912|NCT00364845|665344|P2|Overall Study|Withdrawal by Subject|1
196913|NCT00364845|665345|P1|Overall Study|Withdrawal by Subject|2
196914|NCT00364845|665344|P2|Overall Study|Adverse Event|0
196915|NCT00364845|665345|P1|Overall Study|Adverse Event|1
196916|NCT00364832|665366|P12|Extension Year 2|Early Withdrawals|3
196917|NCT00364832|665367|P11|Extension Year 2|Early Withdrawals|5
196918|NCT00364832|665368|P10|Extension Year 2|Early Withdrawals|5
196919|NCT00364832|665369|P9|Extension Year 2|Early Withdrawals|0
196920|NCT00364832|665370|P8|Extension Year 2|Early Withdrawals|0
196921|NCT00364832|665371|P7|Extension Year 2|Early Withdrawals|0
196922|NCT00364832|665372|P6|Extension Year 2|Early Withdrawals|0
196923|NCT00364832|665373|P5|Extension Year 2|Early Withdrawals|0
196924|NCT00364832|665374|P4|Extension Year 2|Early Withdrawals|0
196925|NCT00364832|665375|P3|Extension Year 2|Early Withdrawals|0
196926|NCT00364832|665376|P2|Extension Year 2|Early Withdrawals|0
196927|NCT00364832|665377|P1|Extension Year 2|Early Withdrawals|0
196928|NCT00364832|665366|P12|Extension Year 1|Early Withdrawals|10
196929|NCT00364832|665367|P11|Extension Year 1|Early Withdrawals|2
196930|NCT00364832|665368|P10|Extension Year 1|Early Withdrawals|4
196931|NCT00364832|665369|P9|Extension Year 1|Early Withdrawals|0
196932|NCT00364832|665370|P8|Extension Year 1|Early Withdrawals|0
196933|NCT00364832|665371|P7|Extension Year 1|Early Withdrawals|0
196934|NCT00364832|665372|P6|Extension Year 1|Early Withdrawals|0
196935|NCT00364832|665373|P5|Extension Year 1|Early Withdrawals|0
196936|NCT00364832|665374|P4|Extension Year 1|Early Withdrawals|0
196937|NCT00364832|665375|P3|Extension Year 1|Early Withdrawals|0
196938|NCT00364832|665376|P2|Extension Year 1|Early Withdrawals|0
196939|NCT00364832|665377|P1|Extension Year 1|Early Withdrawals|0
196940|NCT00364832|665366|P12|Core Period|Early Withdrawals|0
196941|NCT00364832|665367|P11|Core Period|Early Withdrawals|0
196942|NCT00364832|665368|P10|Core Period|Early Withdrawals|0
196943|NCT00364832|665369|P9|Core Period|Early Withdrawals|0
196944|NCT00364832|665370|P8|Core Period|Early Withdrawals|1
196945|NCT00364832|665371|P7|Core Period|Early Withdrawals|4
196946|NCT00364832|665372|P6|Core Period|Early Withdrawals|0
196947|NCT00364832|665373|P5|Core Period|Early Withdrawals|0
196948|NCT00364832|665374|P4|Core Period|Early Withdrawals|1
196949|NCT00364832|665375|P3|Core Period|Early Withdrawals|1
196950|NCT00364832|665376|P2|Core Period|Early Withdrawals|2
196951|NCT00364832|665377|P1|Core Period|Early Withdrawals|2
196952|NCT00364793|665442|P4|Overall Study|Withdrawal by Subject|0
196953|NCT00364793|665443|P3|Overall Study|Withdrawal by Subject|0
196954|NCT00364793|665444|P2|Overall Study|Withdrawal by Subject|1
196955|NCT00364793|665445|P1|Overall Study|Withdrawal by Subject|0
196956|NCT00364793|665442|P4|Overall Study|No longer meets criteria|1
196957|NCT00364793|665443|P3|Overall Study|No longer meets criteria|0
196958|NCT00364793|665444|P2|Overall Study|No longer meets criteria|0
196959|NCT00364793|665445|P1|Overall Study|No longer meets criteria|0
196960|NCT00364793|665442|P4|Overall Study|Poor or non-compliance|1
196961|NCT00364793|665443|P3|Overall Study|Poor or non-compliance|0
196962|NCT00364793|665444|P2|Overall Study|Poor or non-compliance|1
196963|NCT00364793|665445|P1|Overall Study|Poor or non-compliance|1
196964|NCT00364793|665442|P4|Overall Study|Lost to Follow-up|0
196965|NCT00364793|665443|P3|Overall Study|Lost to Follow-up|2
196966|NCT00364793|665444|P2|Overall Study|Lost to Follow-up|0
196967|NCT00364793|665445|P1|Overall Study|Lost to Follow-up|1
196968|NCT00364793|665442|P4|Overall Study|Lack of Efficacy|1
196969|NCT00364793|665443|P3|Overall Study|Lack of Efficacy|1
196970|NCT00364793|665444|P2|Overall Study|Lack of Efficacy|3
196971|NCT00364793|665445|P1|Overall Study|Lack of Efficacy|3
196972|NCT00364793|665442|P4|Overall Study|Death|0
196973|NCT00364793|665443|P3|Overall Study|Death|1
196974|NCT00364793|665444|P2|Overall Study|Death|0
196975|NCT00364793|665445|P1|Overall Study|Death|1
196976|NCT00364793|665442|P4|Overall Study|Adverse Event|0
196977|NCT00364793|665443|P3|Overall Study|Adverse Event|0
196978|NCT00364793|665444|P2|Overall Study|Adverse Event|0
196979|NCT00364793|665445|P1|Overall Study|Adverse Event|2
196980|NCT00364611|665581|P2|Overall Study|Receiving Liver Ablation|1
196981|NCT00364611|665582|P1|Overall Study|Receiving Liver Ablation|0
196982|NCT00364611|665581|P2|Overall Study|Presumed CR on Study|1
196983|NCT00364611|665582|P1|Overall Study|Presumed CR on Study|0
196984|NCT00364611|665581|P2|Overall Study|Found Ineligible|0
196985|NCT00364611|665582|P1|Overall Study|Found Ineligible|1
196986|NCT00364611|665581|P2|Overall Study|Investigator decision|2
196987|NCT00364611|665582|P1|Overall Study|Investigator decision|2
196988|NCT00364611|665581|P2|Overall Study|Disease Progression|8
196989|NCT00364611|665582|P1|Overall Study|Disease Progression|38
196990|NCT00364611|665581|P2|Overall Study|Participant's Request|4
196991|NCT00364611|665582|P1|Overall Study|Participant's Request|3
196992|NCT00364611|665581|P2|Overall Study|Adverse Event|4
196993|NCT00364611|665582|P1|Overall Study|Adverse Event|7
196994|NCT00364611|665581|P2|Overall Study|Did not receive study medication|1
196995|NCT00364611|665582|P1|Overall Study|Did not receive study medication|0
196996|NCT00364533|665605|P5|Overall Study|Protocol Violation|0
196997|NCT00364533|665606|P4|Overall Study|Protocol Violation|0
196998|NCT00364533|665607|P3|Overall Study|Protocol Violation|0
196999|NCT00364533|665608|P2|Overall Study|Protocol Violation|1
197000|NCT00364533|665609|P1|Overall Study|Protocol Violation|1
197001|NCT00364533|665605|P5|Overall Study|Non-compliance|0
197002|NCT00364533|665606|P4|Overall Study|Non-compliance|0
197003|NCT00364533|665607|P3|Overall Study|Non-compliance|0
197004|NCT00364533|665608|P2|Overall Study|Non-compliance|0
197005|NCT00364533|665609|P1|Overall Study|Non-compliance|1
197006|NCT00364533|665605|P5|Overall Study|Variations in drug compliance|0
197007|NCT00364533|665606|P4|Overall Study|Variations in drug compliance|0
197008|NCT00364533|665607|P3|Overall Study|Variations in drug compliance|1
197009|NCT00364533|665608|P2|Overall Study|Variations in drug compliance|1
197010|NCT00364533|665609|P1|Overall Study|Variations in drug compliance|2
197011|NCT00364533|665605|P5|Overall Study|Subject discharged from hospital|1
197012|NCT00364533|665606|P4|Overall Study|Subject discharged from hospital|3
197013|NCT00364533|665607|P3|Overall Study|Subject discharged from hospital|2
197014|NCT00364533|665608|P2|Overall Study|Subject discharged from hospital|1
197015|NCT00364533|665609|P1|Overall Study|Subject discharged from hospital|4
197016|NCT00364533|665605|P5|Overall Study|Lack of Efficacy|42
197017|NCT00364533|665606|P4|Overall Study|Lack of Efficacy|17
197018|NCT00364533|665607|P3|Overall Study|Lack of Efficacy|21
197019|NCT00364533|665608|P2|Overall Study|Lack of Efficacy|22
197020|NCT00364533|665609|P1|Overall Study|Lack of Efficacy|22
197021|NCT00364533|665605|P5|Overall Study|Withdrawal by Subject|6
197022|NCT00364533|665606|P4|Overall Study|Withdrawal by Subject|6
197023|NCT00364533|665607|P3|Overall Study|Withdrawal by Subject|6
197024|NCT00364533|665608|P2|Overall Study|Withdrawal by Subject|8
197025|NCT00364533|665609|P1|Overall Study|Withdrawal by Subject|4
197026|NCT00364533|665605|P5|Overall Study|Adverse Event|2
197027|NCT00364533|665606|P4|Overall Study|Adverse Event|5
197028|NCT00364533|665607|P3|Overall Study|Adverse Event|15
197029|NCT00364533|665608|P2|Overall Study|Adverse Event|7
197030|NCT00364533|665609|P1|Overall Study|Adverse Event|8
197031|NCT00364351|665642|P2|Overall Study|Randomised treatment not started|3
197032|NCT00364351|665643|P1|Overall Study|Randomised treatment not started|0
197033|NCT00364351|665642|P2|Overall Study|Patient could not travel to site|1
197034|NCT00364351|665643|P1|Overall Study|Patient could not travel to site|0
197035|NCT00364351|665642|P2|Overall Study|Investigator error|2
197036|NCT00364351|665643|P1|Overall Study|Investigator error|0
197037|NCT00364351|665642|P2|Overall Study|Poor treatment compliance|3
197038|NCT00364351|665643|P1|Overall Study|Poor treatment compliance|0
197039|NCT00364351|665642|P2|Overall Study|Sponsor decision|0
197040|NCT00364351|665643|P1|Overall Study|Sponsor decision|1
197041|NCT00364351|665642|P2|Overall Study|Incorrect enrollment|1
197042|NCT00364351|665643|P1|Overall Study|Incorrect enrollment|1
197043|NCT00364351|665642|P2|Overall Study|Withdrawal by Subject|29
197044|NCT00364351|665643|P1|Overall Study|Withdrawal by Subject|30
197045|NCT00364351|665642|P2|Overall Study|Lost to Follow-up|1
197046|NCT00364351|665643|P1|Overall Study|Lost to Follow-up|1
197047|NCT00364351|665642|P2|Overall Study|Prohibited concomitant medication|2
197048|NCT00364351|665643|P1|Overall Study|Prohibited concomitant medication|0
197049|NCT00364351|665642|P2|Overall Study|Condition under investigation worsened|497
197050|NCT00364351|665643|P1|Overall Study|Condition under investigation worsened|469
197051|NCT00364351|665642|P2|Overall Study|Adverse Event|44
197052|NCT00364351|665643|P1|Overall Study|Adverse Event|90
197053|NCT00364286|665661|P1|Overall Study|Adverse Event|2
197054|NCT00364286|665661|P1|Overall Study|Withdrawal by Subject|1
197055|NCT00364182|665668|P3|Third Intervention|Lost to Follow-up|1
197056|NCT00364182|665669|P2|Third Intervention|Lost to Follow-up|0
197057|NCT00364182|665670|P1|Third Intervention|Lost to Follow-up|0
197058|NCT00364182|665668|P3|Third Intervention|non-compliance|0
197059|NCT00364182|665669|P2|Third Intervention|non-compliance|1
197060|NCT00364182|665670|P1|Third Intervention|non-compliance|0
197061|NCT00364182|665668|P3|Second Intervention|Adverse Event|1
197062|NCT00364182|665669|P2|Second Intervention|Adverse Event|0
197063|NCT00364182|665670|P1|Second Intervention|Adverse Event|0
197064|NCT00364182|665668|P3|Second Intervention|Protocol Violation|0
197065|NCT00364182|665669|P2|Second Intervention|Protocol Violation|1
197066|NCT00364182|665670|P1|Second Intervention|Protocol Violation|0
197067|NCT00364182|665668|P3|Second Intervention|non-compliance|1
197068|NCT00364182|665669|P2|Second Intervention|non-compliance|1
197069|NCT00364182|665670|P1|Second Intervention|non-compliance|0
197070|NCT00364182|665668|P3|First Intervention|Withdrawal by Subject|0
197071|NCT00364182|665669|P2|First Intervention|Withdrawal by Subject|0
197072|NCT00364182|665670|P1|First Intervention|Withdrawal by Subject|2
197073|NCT00364182|665668|P3|First Intervention|Secondary prophylaxis|0
197074|NCT00364182|665669|P2|First Intervention|Secondary prophylaxis|0
197075|NCT00364182|665670|P1|First Intervention|Secondary prophylaxis|1
197076|NCT00364156|665704|P2|Overall Study|Protocol Violation|1
197077|NCT00364156|665705|P1|Overall Study|Protocol Violation|6
197078|NCT00364156|665704|P2|Overall Study|Withdrawal by Subject|80
197079|NCT00364156|665705|P1|Overall Study|Withdrawal by Subject|73
197080|NCT00364130|665713|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
197081|NCT00364130|665714|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
197082|NCT00364130|665713|P2|Intervention Period|Withdrawal by Subject|5
197083|NCT00364130|665714|P1|Intervention Period|Withdrawal by Subject|4
197084|NCT00364130|665713|P2|Intervention Period|Pregnancy|0
197085|NCT00364130|665714|P1|Intervention Period|Pregnancy|1
197086|NCT00364130|665713|P2|Intervention Period|Lost to Follow-up|3
197087|NCT00364130|665714|P1|Intervention Period|Lost to Follow-up|4
197088|NCT00364013|665736|P2|Overall Study|Ongoing|13
197089|NCT00364013|665737|P1|Overall Study|Ongoing|20
197090|NCT00364013|665736|P2|Overall Study|Other|47
197091|NCT00364013|665737|P1|Overall Study|Other|41
197092|NCT00364013|665736|P2|Overall Study|Protocol-specified criteria|6
197093|NCT00364013|665737|P1|Overall Study|Protocol-specified criteria|6
197094|NCT00364013|665736|P2|Overall Study|Lost to Follow-up|3
197095|NCT00364013|665737|P1|Overall Study|Lost to Follow-up|10
197096|NCT00364013|665736|P2|Overall Study|Physician Decision|3
197097|NCT00364013|665737|P1|Overall Study|Physician Decision|3
197098|NCT00364013|665736|P2|Overall Study|Withdrawal by Subject|18
197099|NCT00364013|665737|P1|Overall Study|Withdrawal by Subject|13
197100|NCT00364013|665736|P2|Overall Study|Adverse Event|3
197101|NCT00364013|665737|P1|Overall Study|Adverse Event|4
197102|NCT00364013|665736|P2|Overall Study|Ineligibility determined|2
197103|NCT00364013|665737|P1|Overall Study|Ineligibility determined|4
197104|NCT00363896|665765|P2|Overall Study|Other|2
197105|NCT00363896|665766|P1|Overall Study|Other|1
197106|NCT00363896|665765|P2|Overall Study|Non-fulfilment of entry criteria|0
197107|NCT00363896|665766|P1|Overall Study|Non-fulfilment of entry criteria|1
197108|NCT00363896|665765|P2|Overall Study|Lost to Follow-up|0
197109|NCT00363896|665766|P1|Overall Study|Lost to Follow-up|3
197110|NCT00363896|665765|P2|Overall Study|Protocol Violation|1
197111|NCT00363896|665766|P1|Overall Study|Protocol Violation|6
197112|NCT00363896|665765|P2|Overall Study|Lack of Efficacy|8
197113|NCT00363896|665766|P1|Overall Study|Lack of Efficacy|12
197114|NCT00363896|665765|P2|Overall Study|COPD exacerbation|7
197115|NCT00363896|665766|P1|Overall Study|COPD exacerbation|13
197116|NCT00363896|665765|P2|Overall Study|Adverse Event|13
197117|NCT00363896|665766|P1|Overall Study|Adverse Event|24
197118|NCT00363896|665765|P2|Overall Study|Withdrawal by Subject|16
197119|NCT00363896|665766|P1|Overall Study|Withdrawal by Subject|29
197120|NCT00363545|665814|P2|Overall Study|Others|0
197121|NCT00363545|665815|P1|Overall Study|Others|1
197122|NCT00363545|665814|P2|Overall Study|Lost to follow-up (complete vaccination)|17
197123|NCT00363545|665815|P1|Overall Study|Lost to follow-up (complete vaccination)|14
197124|NCT00363545|665814|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
197125|NCT00363545|665815|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
197126|NCT00363545|665814|P2|Overall Study|Migrated/moved from study area|6
197127|NCT00363545|665815|P1|Overall Study|Migrated/moved from study area|3
197128|NCT00363545|665814|P2|Overall Study|Withdrawal by Subject|15
197129|NCT00363545|665815|P1|Overall Study|Withdrawal by Subject|12
197130|NCT00363545|665814|P2|Overall Study|Serious Adverse Event|1
197131|NCT00363545|665815|P1|Overall Study|Serious Adverse Event|0
197132|NCT00363480|665833|P1|Overall Study|Participant discontinued on its own|1
197133|NCT00363480|665833|P1|Overall Study|Non-compliance of subject|1
197134|NCT00363480|665833|P1|Overall Study|Withdrawal by Subject|5
197135|NCT00363480|665833|P1|Overall Study|Lost to Follow-up|5
197136|NCT00363480|665833|P1|Overall Study|Adverse Event|4
197137|NCT00363480|665833|P1|Overall Study|Criteria for treatment period not fulfil|1
197138|NCT00363467|665853|P1|Overall Study|Physician Decision|1
197139|NCT00363415|665863|P2|Overall Study|Protocol Violation|4
197140|NCT00363415|665864|P1|Overall Study|Protocol Violation|1
197141|NCT00363415|665863|P2|Overall Study|Lost to Follow-up|3
197142|NCT00363415|665864|P1|Overall Study|Lost to Follow-up|3
197143|NCT00363415|665863|P2|Overall Study|Withdrawal by Subject|15
197144|NCT00363415|665864|P1|Overall Study|Withdrawal by Subject|9
197145|NCT00363415|665863|P2|Overall Study|Entry Criteria Not Met|10
197146|NCT00363415|665864|P1|Overall Study|Entry Criteria Not Met|11
197147|NCT00363415|665863|P2|Overall Study|Physician Decision|35
197148|NCT00363415|665864|P1|Overall Study|Physician Decision|18
197149|NCT00363415|665863|P2|Overall Study|Adverse Event|15
197150|NCT00363415|665864|P1|Overall Study|Adverse Event|24
197151|NCT00363415|665863|P2|Overall Study|Death|29
197152|NCT00363415|665864|P1|Overall Study|Death|32
197153|NCT00363415|665863|P2|Overall Study|Sponsor Decision|31
197154|NCT00363415|665864|P1|Overall Study|Sponsor Decision|67
197155|NCT00363415|665863|P2|Overall Study|Progressive Disease|107
197156|NCT00363415|665864|P1|Overall Study|Progressive Disease|196
197157|NCT00363311|665882|P2|Overall Study|Participant Moved to Louisiana|1
197158|NCT00363311|665883|P1|Overall Study|Participant Moved to Louisiana|0
197159|NCT00363311|665882|P2|Overall Study|Withdrawn per Instructions of Monitor|1
197160|NCT00363311|665883|P1|Overall Study|Withdrawn per Instructions of Monitor|0
197161|NCT00363311|665882|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
197162|NCT00363311|665883|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
197163|NCT00363311|665882|P2|Overall Study|Participant Moved to Another Country|0
197164|NCT00363311|665883|P1|Overall Study|Participant Moved to Another Country|1
197165|NCT00363311|665882|P2|Overall Study|Participant Opted for Treatment|0
197166|NCT00363311|665883|P1|Overall Study|Participant Opted for Treatment|1
197167|NCT00363311|665882|P2|Overall Study|Prostate Volume/PSA Doubled|0
197168|NCT00363311|665883|P1|Overall Study|Prostate Volume/PSA Doubled|1
197169|NCT00363311|665882|P2|Overall Study|Participant Refused Biopsy|0
197170|NCT00363311|665883|P1|Overall Study|Participant Refused Biopsy|1
197171|NCT00363311|665882|P2|Overall Study|Non-Compliance|1
197172|NCT00363311|665883|P1|Overall Study|Non-Compliance|1
197173|NCT00363311|665882|P2|Overall Study|Disease Progression|26
197174|NCT00363311|665883|P1|Overall Study|Disease Progression|46
197175|NCT00363311|665882|P2|Overall Study|Sponsor Terminated Study|2
197176|NCT00363311|665883|P1|Overall Study|Sponsor Terminated Study|2
197177|NCT00363311|665882|P2|Overall Study|Physician Decision|1
197178|NCT00363311|665883|P1|Overall Study|Physician Decision|1
197179|NCT00363311|665882|P2|Overall Study|Withdrawal by Subject|6
197180|NCT00363311|665883|P1|Overall Study|Withdrawal by Subject|12
197181|NCT00363311|665882|P2|Overall Study|Protocol Violation|2
197182|NCT00363311|665883|P1|Overall Study|Protocol Violation|1
197183|NCT00363311|665882|P2|Overall Study|Lost to Follow-up|0
197184|NCT00363311|665883|P1|Overall Study|Lost to Follow-up|3
197185|NCT00363311|665882|P2|Overall Study|Adverse Event|4
197186|NCT00363311|665883|P1|Overall Study|Adverse Event|6
197187|NCT00363298|665949|P2|4-week Study Continuation Phase|Lack of Efficacy|0
197188|NCT00363298|665950|P1|4-week Study Continuation Phase|Lack of Efficacy|1
197189|NCT00363298|665949|P2|First Study Week|Lack of Efficacy|5
197190|NCT00363298|665950|P1|First Study Week|Lack of Efficacy|6
197191|NCT00363246|665958|P1|Overall Study|Eligibility changed due to Hospice move|5
197192|NCT00363246|665958|P1|Overall Study|Subject expressed security concerns|2
197193|NCT00363246|665958|P1|Overall Study|Stopped using wheelchair|11
197194|NCT00363246|665958|P1|Overall Study|Bad health|6
197195|NCT00363246|665958|P1|Overall Study|Lost to Follow-up|14
197196|NCT00363246|665958|P1|Overall Study|Withdrawal by Subject|19
197197|NCT00363246|665958|P1|Overall Study|Death|40
197198|NCT00363142|665976|P2|Overall Study|Withdrawal by Subject|1
197199|NCT00363142|665977|P1|Overall Study|Withdrawal by Subject|3
197200|NCT00363142|665976|P2|Overall Study|Non-compliance|1
197201|NCT00363142|665977|P1|Overall Study|Non-compliance|1
197202|NCT00363142|665976|P2|Overall Study|Lost to Follow-up|0
197203|NCT00363142|665977|P1|Overall Study|Lost to Follow-up|1
197204|NCT00363142|665976|P2|Overall Study|Lack of Efficacy|1
197205|NCT00363142|665977|P1|Overall Study|Lack of Efficacy|0
197206|NCT00363142|665976|P2|Overall Study|Adverse Event|0
197207|NCT00363142|665977|P1|Overall Study|Adverse Event|2
197208|NCT00363129|666006|P2|Overall Study|Other Reasons|3
197209|NCT00363129|666007|P1|Overall Study|Other Reasons|6
197210|NCT00363129|666006|P2|Overall Study|Death|1
197211|NCT00363129|666007|P1|Overall Study|Death|0
197212|NCT00363129|666006|P2|Overall Study|Other Medical Problems|4
197213|NCT00363129|666007|P1|Overall Study|Other Medical Problems|2
197214|NCT00363129|666006|P2|Overall Study|Alternate Treatment|4
197215|NCT00363129|666007|P1|Overall Study|Alternate Treatment|2
197216|NCT00363129|666006|P2|Overall Study|Adverse Event|3
197217|NCT00363129|666007|P1|Overall Study|Adverse Event|8
197218|NCT00363129|666006|P2|Overall Study|Withdrawal by Subject|18
197219|NCT00363129|666007|P1|Overall Study|Withdrawal by Subject|11
197220|NCT00363051|666050|P2|Overall Study|Death|2
197221|NCT00363051|666051|P1|Overall Study|Death|3
197222|NCT00363051|666050|P2|Overall Study|Protocol Violation|2
197223|NCT00363051|666051|P1|Overall Study|Protocol Violation|0
197224|NCT00363051|666050|P2|Overall Study|Lost to Follow-up|1
197225|NCT00363051|666051|P1|Overall Study|Lost to Follow-up|0
197226|NCT00363051|666050|P2|Overall Study|Withdrawal by Subject|3
197227|NCT00363051|666051|P1|Overall Study|Withdrawal by Subject|11
197228|NCT00363051|666050|P2|Overall Study|New Cancer Therapy|1
197229|NCT00363051|666051|P1|Overall Study|New Cancer Therapy|2
197230|NCT00363051|666050|P2|Overall Study|Adverse Event|12
197231|NCT00363051|666051|P1|Overall Study|Adverse Event|21
197232|NCT00363051|666050|P2|Overall Study|Adminstrative problems|1
197233|NCT00363051|666051|P1|Overall Study|Adminstrative problems|1
197234|NCT00362648|666100|P4|Overall Study|Withdrawal by Subject|6
197235|NCT00362648|666101|P3|Overall Study|Withdrawal by Subject|2
197236|NCT00362648|666102|P2|Overall Study|Withdrawal by Subject|42
197237|NCT00362648|666103|P1|Overall Study|Withdrawal by Subject|48
197238|NCT00362648|666100|P4|Overall Study|Protocol Violation|2
197239|NCT00362648|666101|P3|Overall Study|Protocol Violation|2
197240|NCT00362648|666102|P2|Overall Study|Protocol Violation|2
197241|NCT00362648|666103|P1|Overall Study|Protocol Violation|4
197242|NCT00362648|666100|P4|Overall Study|Lost to Follow-up|3
197243|NCT00362648|666101|P3|Overall Study|Lost to Follow-up|4
197244|NCT00362648|666102|P2|Overall Study|Lost to Follow-up|69
197245|NCT00362648|666103|P1|Overall Study|Lost to Follow-up|62
197246|NCT00362648|666100|P4|Overall Study|Adverse Event|0
197247|NCT00362648|666101|P3|Overall Study|Adverse Event|1
197248|NCT00362648|666102|P2|Overall Study|Adverse Event|21
197249|NCT00362648|666103|P1|Overall Study|Adverse Event|12
197250|NCT00362609|666121|P2|Overall Study|Protocol Violation|1
197251|NCT00362609|666122|P1|Overall Study|Protocol Violation|0
197252|NCT00362609|666121|P2|Overall Study|Withdrawal by Subject|1
197253|NCT00362609|666122|P1|Overall Study|Withdrawal by Subject|0
197254|NCT00362414|666203|P1|Overall Study|Adverse Event|1
197255|NCT00362414|666203|P1|Overall Study|Death|2
197256|NCT00362375|666232|P2|Overall Study|Lost to Follow-up|35
197257|NCT00362375|666233|P1|Overall Study|Lost to Follow-up|40
197258|NCT00362336|666250|P3|Overall Study|Withdrawal by Subject|1
197259|NCT00362336|666251|P2|Overall Study|Withdrawal by Subject|3
197260|NCT00362336|666252|P1|Overall Study|Withdrawal by Subject|3
197261|NCT00362336|666250|P3|Overall Study|Lost to Follow-up|0
197262|NCT00362336|666251|P2|Overall Study|Lost to Follow-up|4
197263|NCT00362336|666252|P1|Overall Study|Lost to Follow-up|6
197264|NCT00362336|666250|P3|Overall Study|Protocol Violation|1
197265|NCT00362336|666251|P2|Overall Study|Protocol Violation|0
197266|NCT00362336|666252|P1|Overall Study|Protocol Violation|0
197267|NCT00362336|666250|P3|Overall Study|Serious Adverse Event|1
197268|NCT00362336|666251|P2|Overall Study|Serious Adverse Event|0
197269|NCT00362336|666252|P1|Overall Study|Serious Adverse Event|1
197270|NCT00362297|666280|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
197271|NCT00362297|666281|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
197272|NCT00362232|666289|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
197273|NCT00362232|666290|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
197274|NCT00362232|666289|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
197275|NCT00362232|666290|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
197276|NCT00362232|666289|P2|Follow-up (30 (+ 5) Days)|Death|1
197277|NCT00362232|666290|P1|Follow-up (30 (+ 5) Days)|Death|1
197278|NCT00362232|666289|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
197279|NCT00362232|666290|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
197280|NCT00362232|666289|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
197281|NCT00362232|666290|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
197282|NCT00362232|666289|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
197283|NCT00362232|666290|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
197284|NCT00362232|666289|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
197285|NCT00362232|666290|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
197286|NCT00362232|666289|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
197287|NCT00362232|666290|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
197288|NCT00362232|666289|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
197289|NCT00362232|666290|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
197290|NCT00362232|666289|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
197291|NCT00362232|666290|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
197292|NCT00362232|666289|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
197293|NCT00362232|666290|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
197294|NCT00362232|666289|P2|Treatment (12 +/- 2 Days)|Death|3
197295|NCT00362232|666290|P1|Treatment (12 +/- 2 Days)|Death|1
197296|NCT00362232|666289|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
197297|NCT00362232|666290|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
197298|NCT00362180|666335|P9|Treated Period|Adverse Event|0
197299|NCT00362180|666336|P8|Treated Period|Adverse Event|1
197300|NCT00362180|666337|P7|Treated Period|Adverse Event|0
197301|NCT00362180|666338|P6|Treated Period|Adverse Event|1
197302|NCT00362180|666339|P5|Treated Period|Adverse Event|0
197303|NCT00362180|666340|P4|Treated Period|Adverse Event|0
197304|NCT00362180|666341|P3|Treated Period|Adverse Event|0
197305|NCT00362180|666342|P2|Treated Period|Adverse Event|0
197306|NCT00362180|666343|P1|Treated Period|Adverse Event|0
197307|NCT00362180|666335|P9|Treated Period|Withdrawal by Subject|0
197308|NCT00362180|666336|P8|Treated Period|Withdrawal by Subject|0
197309|NCT00362180|666337|P7|Treated Period|Withdrawal by Subject|0
197310|NCT00362180|666338|P6|Treated Period|Withdrawal by Subject|0
197311|NCT00362180|666339|P5|Treated Period|Withdrawal by Subject|0
197312|NCT00362180|666340|P4|Treated Period|Withdrawal by Subject|0
197313|NCT00362180|666341|P3|Treated Period|Withdrawal by Subject|0
197314|NCT00362180|666342|P2|Treated Period|Withdrawal by Subject|0
197315|NCT00362180|666343|P1|Treated Period|Withdrawal by Subject|1
197316|NCT00362115|666415|P7|Overall Study|Other|0
197317|NCT00362115|666416|P6|Overall Study|Other|1
197318|NCT00362115|666417|P5|Overall Study|Other|0
197319|NCT00362115|666418|P4|Overall Study|Other|1
197320|NCT00362115|666419|P3|Overall Study|Other|0
197321|NCT00362115|666420|P2|Overall Study|Other|1
197322|NCT00362115|666421|P1|Overall Study|Other|0
197323|NCT00362115|666415|P7|Overall Study|Physician Decision|3
197324|NCT00362115|666416|P6|Overall Study|Physician Decision|0
197325|NCT00362115|666417|P5|Overall Study|Physician Decision|0
197326|NCT00362115|666418|P4|Overall Study|Physician Decision|0
197327|NCT00362115|666419|P3|Overall Study|Physician Decision|0
197328|NCT00362115|666420|P2|Overall Study|Physician Decision|0
197329|NCT00362115|666421|P1|Overall Study|Physician Decision|0
197330|NCT00362115|666415|P7|Overall Study|Lack of Efficacy|3
197331|NCT00362115|666416|P6|Overall Study|Lack of Efficacy|0
197332|NCT00362115|666417|P5|Overall Study|Lack of Efficacy|2
197333|NCT00362115|666418|P4|Overall Study|Lack of Efficacy|2
197334|NCT00362115|666419|P3|Overall Study|Lack of Efficacy|5
197335|NCT00362115|666420|P2|Overall Study|Lack of Efficacy|0
197336|NCT00362115|666421|P1|Overall Study|Lack of Efficacy|1
197337|NCT00362115|666415|P7|Overall Study|Withdrawal by Subject|4
197338|NCT00362115|666416|P6|Overall Study|Withdrawal by Subject|3
197339|NCT00362115|666417|P5|Overall Study|Withdrawal by Subject|1
197340|NCT00362115|666418|P4|Overall Study|Withdrawal by Subject|0
197341|NCT00362115|666419|P3|Overall Study|Withdrawal by Subject|1
197342|NCT00362115|666420|P2|Overall Study|Withdrawal by Subject|3
197343|NCT00362115|666421|P1|Overall Study|Withdrawal by Subject|1
197344|NCT00362115|666415|P7|Overall Study|Lost to Follow-up|1
197345|NCT00362115|666416|P6|Overall Study|Lost to Follow-up|0
197346|NCT00362115|666417|P5|Overall Study|Lost to Follow-up|2
197347|NCT00362115|666418|P4|Overall Study|Lost to Follow-up|0
197348|NCT00362115|666419|P3|Overall Study|Lost to Follow-up|0
197349|NCT00362115|666420|P2|Overall Study|Lost to Follow-up|1
197350|NCT00362115|666421|P1|Overall Study|Lost to Follow-up|0
197351|NCT00362115|666415|P7|Overall Study|Protocol Violation|0
197352|NCT00362115|666416|P6|Overall Study|Protocol Violation|1
197353|NCT00362115|666417|P5|Overall Study|Protocol Violation|0
197354|NCT00362115|666418|P4|Overall Study|Protocol Violation|0
197355|NCT00362115|666419|P3|Overall Study|Protocol Violation|0
197356|NCT00362115|666420|P2|Overall Study|Protocol Violation|0
197357|NCT00362115|666421|P1|Overall Study|Protocol Violation|0
197358|NCT00362115|666415|P7|Overall Study|Adverse Event|1
197359|NCT00362115|666416|P6|Overall Study|Adverse Event|2
197360|NCT00362115|666417|P5|Overall Study|Adverse Event|2
197361|NCT00362115|666418|P4|Overall Study|Adverse Event|1
197362|NCT00362115|666419|P3|Overall Study|Adverse Event|1
197363|NCT00362115|666420|P2|Overall Study|Adverse Event|1
197364|NCT00362115|666421|P1|Overall Study|Adverse Event|0
197365|NCT00361634|666594|P1|Overall Study|Withdrawal by Subject|1
197366|NCT00361634|666594|P1|Overall Study|Lost to Follow-up|1
197367|NCT00361569|666623|P4|Overall Study|Not specified by investigator|1
197368|NCT00361569|666624|P3|Overall Study|Not specified by investigator|0
197369|NCT00361569|666625|P2|Overall Study|Not specified by investigator|0
197370|NCT00361569|666626|P1|Overall Study|Not specified by investigator|2
197371|NCT00361569|666623|P4|Overall Study|Lost to Follow-up|2
197372|NCT00361569|666624|P3|Overall Study|Lost to Follow-up|3
197373|NCT00361569|666625|P2|Overall Study|Lost to Follow-up|3
197374|NCT00361569|666626|P1|Overall Study|Lost to Follow-up|2
197375|NCT00361569|666623|P4|Overall Study|Adverse Event|2
197376|NCT00361569|666624|P3|Overall Study|Adverse Event|2
197377|NCT00361569|666625|P2|Overall Study|Adverse Event|5
197378|NCT00361569|666626|P1|Overall Study|Adverse Event|3
197379|NCT00361569|666623|P4|Overall Study|Withdrawal by Subject|14
197380|NCT00361569|666624|P3|Overall Study|Withdrawal by Subject|9
197381|NCT00361569|666625|P2|Overall Study|Withdrawal by Subject|1
197382|NCT00361569|666626|P1|Overall Study|Withdrawal by Subject|2
197383|NCT00361569|666623|P4|Overall Study|Protocol Violation|2
197384|NCT00361569|666624|P3|Overall Study|Protocol Violation|4
197385|NCT00361569|666625|P2|Overall Study|Protocol Violation|2
197386|NCT00361569|666626|P1|Overall Study|Protocol Violation|3
197387|NCT00361504|666650|P2|Overall Study|All other|3
197388|NCT00361504|666651|P1|Overall Study|All other|28
197389|NCT00361504|666650|P2|Overall Study|Study medication non compliant|15
197390|NCT00361504|666651|P1|Overall Study|Study medication non compliant|42
197391|NCT00361504|666650|P2|Overall Study|Resolution of Pain|0
197392|NCT00361504|666651|P1|Overall Study|Resolution of Pain|2
197393|NCT00361504|666650|P2|Overall Study|Lack of Efficacy|7
197394|NCT00361504|666651|P1|Overall Study|Lack of Efficacy|72
197395|NCT00361504|666650|P2|Overall Study|Adverse Event|82
197396|NCT00361504|666651|P1|Overall Study|Adverse Event|203
197397|NCT00361504|666650|P2|Overall Study|Lost to Follow-up|7
197398|NCT00361504|666651|P1|Overall Study|Lost to Follow-up|40
197399|NCT00361504|666650|P2|Overall Study|Withdrawal by Subject|31
197400|NCT00361504|666651|P1|Overall Study|Withdrawal by Subject|94
197401|NCT00361335|666692|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
197402|NCT00361335|666693|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
197403|NCT00361335|666694|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
197404|NCT00361335|666695|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
197405|NCT00361335|666696|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
197406|NCT00361335|666697|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
197407|NCT00361335|666698|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
197408|NCT00361335|666692|P7|SC Period: Week E0 to Week E24|Not specified|2
197409|NCT00361335|666693|P6|SC Period: Week E0 to Week E24|Not specified|1
197410|NCT00361335|666694|P5|SC Period: Week E0 to Week E24|Not specified|0
197411|NCT00361335|666695|P4|SC Period: Week E0 to Week E24|Not specified|1
197412|NCT00361335|666696|P3|SC Period: Week E0 to Week E24|Not specified|0
197413|NCT00361335|666697|P2|SC Period: Week E0 to Week E24|Not specified|0
197414|NCT00361335|666698|P1|SC Period: Week E0 to Week E24|Not specified|1
197415|NCT00361335|666692|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
197416|NCT00361335|666693|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
197417|NCT00361335|666694|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
197418|NCT00361335|666695|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
197419|NCT00361335|666696|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
197420|NCT00361335|666697|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
197421|NCT00361335|666698|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
197422|NCT00361335|666692|P7|SC Period: Week E0 to Week E24|Death|1
197423|NCT00361335|666693|P6|SC Period: Week E0 to Week E24|Death|0
197424|NCT00361335|666694|P5|SC Period: Week E0 to Week E24|Death|0
197425|NCT00361335|666695|P4|SC Period: Week E0 to Week E24|Death|0
197426|NCT00361335|666696|P3|SC Period: Week E0 to Week E24|Death|0
197427|NCT00361335|666697|P2|SC Period: Week E0 to Week E24|Death|0
197428|NCT00361335|666698|P1|SC Period: Week E0 to Week E24|Death|0
197429|NCT00361335|666692|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
197430|NCT00361335|666693|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
197431|NCT00361335|666694|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
197432|NCT00361335|666695|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
197433|NCT00361335|666696|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
197434|NCT00361335|666697|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
197435|NCT00361335|666698|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
197436|NCT00361335|666692|P7|SC Period: Week E0 to Week E24|Adverse Event|2
197437|NCT00361335|666693|P6|SC Period: Week E0 to Week E24|Adverse Event|0
197438|NCT00361335|666694|P5|SC Period: Week E0 to Week E24|Adverse Event|0
197439|NCT00361335|666695|P4|SC Period: Week E0 to Week E24|Adverse Event|2
197440|NCT00361335|666696|P3|SC Period: Week E0 to Week E24|Adverse Event|1
197441|NCT00361335|666697|P2|SC Period: Week E0 to Week E24|Adverse Event|2
197442|NCT00361335|666698|P1|SC Period: Week E0 to Week E24|Adverse Event|0
197443|NCT00361335|666692|P7|IV Period: Baseline to E0|Lack of Efficacy|0
197444|NCT00361335|666693|P6|IV Period: Baseline to E0|Lack of Efficacy|0
197445|NCT00361335|666694|P5|IV Period: Baseline to E0|Lack of Efficacy|8
197446|NCT00361335|666695|P4|IV Period: Baseline to E0|Lack of Efficacy|7
197447|NCT00361335|666696|P3|IV Period: Baseline to E0|Lack of Efficacy|3
197448|NCT00361335|666697|P2|IV Period: Baseline to E0|Lack of Efficacy|9
197449|NCT00361335|666698|P1|IV Period: Baseline to E0|Lack of Efficacy|5
197450|NCT00361335|666692|P7|IV Period: Baseline to E0|Not specified|0
197451|NCT00361335|666693|P6|IV Period: Baseline to E0|Not specified|0
197452|NCT00361335|666694|P5|IV Period: Baseline to E0|Not specified|2
197453|NCT00361335|666695|P4|IV Period: Baseline to E0|Not specified|3
197454|NCT00361335|666696|P3|IV Period: Baseline to E0|Not specified|9
197455|NCT00361335|666697|P2|IV Period: Baseline to E0|Not specified|9
197456|NCT00361335|666698|P1|IV Period: Baseline to E0|Not specified|2
197457|NCT00361335|666692|P7|IV Period: Baseline to E0|Worsening of RA|0
197458|NCT00361335|666693|P6|IV Period: Baseline to E0|Worsening of RA|0
197459|NCT00361335|666694|P5|IV Period: Baseline to E0|Worsening of RA|2
197460|NCT00361335|666695|P4|IV Period: Baseline to E0|Worsening of RA|4
197461|NCT00361335|666696|P3|IV Period: Baseline to E0|Worsening of RA|1
197462|NCT00361335|666697|P2|IV Period: Baseline to E0|Worsening of RA|5
197463|NCT00361335|666698|P1|IV Period: Baseline to E0|Worsening of RA|0
197464|NCT00361335|666692|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
197465|NCT00361335|666693|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
197466|NCT00361335|666694|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
197467|NCT00361335|666695|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
197468|NCT00361335|666696|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
197469|NCT00361335|666697|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
197470|NCT00361335|666698|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
197471|NCT00361335|666692|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
197472|NCT00361335|666693|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
197473|NCT00361335|666694|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
197474|NCT00361335|666695|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
197475|NCT00361335|666696|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
197476|NCT00361335|666697|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
197477|NCT00361335|666698|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
197478|NCT00361335|666692|P7|IV Period: Baseline to E0|Death|0
197479|NCT00361335|666693|P6|IV Period: Baseline to E0|Death|0
197480|NCT00361335|666694|P5|IV Period: Baseline to E0|Death|0
197481|NCT00361335|666695|P4|IV Period: Baseline to E0|Death|1
197482|NCT00361335|666696|P3|IV Period: Baseline to E0|Death|1
197483|NCT00361335|666697|P2|IV Period: Baseline to E0|Death|1
197484|NCT00361335|666698|P1|IV Period: Baseline to E0|Death|1
197485|NCT00361335|666692|P7|IV Period: Baseline to E0|Lost to Follow-up|0
197486|NCT00361335|666693|P6|IV Period: Baseline to E0|Lost to Follow-up|0
197487|NCT00361335|666694|P5|IV Period: Baseline to E0|Lost to Follow-up|2
197488|NCT00361335|666695|P4|IV Period: Baseline to E0|Lost to Follow-up|2
197489|NCT00361335|666696|P3|IV Period: Baseline to E0|Lost to Follow-up|0
197490|NCT00361335|666697|P2|IV Period: Baseline to E0|Lost to Follow-up|0
197491|NCT00361335|666698|P1|IV Period: Baseline to E0|Lost to Follow-up|1
197492|NCT00361335|666692|P7|IV Period: Baseline to E0|Adverse Event|0
197493|NCT00361335|666693|P6|IV Period: Baseline to E0|Adverse Event|0
197494|NCT00361335|666694|P5|IV Period: Baseline to E0|Adverse Event|8
197495|NCT00361335|666695|P4|IV Period: Baseline to E0|Adverse Event|9
197496|NCT00361335|666696|P3|IV Period: Baseline to E0|Adverse Event|5
197497|NCT00361335|666697|P2|IV Period: Baseline to E0|Adverse Event|4
197498|NCT00361335|666698|P1|IV Period: Baseline to E0|Adverse Event|9
197499|NCT00361283|666742|P1|Overall Study|Lost to Follow-up|27
197500|NCT00361270|666750|P4|Overall Study|Adverse Event|0
197501|NCT00361270|666751|P3|Overall Study|Adverse Event|1
197502|NCT00361270|666752|P2|Overall Study|Adverse Event|1
197503|NCT00361270|666753|P1|Overall Study|Adverse Event|0
197504|NCT00361270|666750|P4|Overall Study|Problems with Transportation|0
197505|NCT00361270|666751|P3|Overall Study|Problems with Transportation|0
197506|NCT00361270|666752|P2|Overall Study|Problems with Transportation|0
197507|NCT00361270|666753|P1|Overall Study|Problems with Transportation|4
197508|NCT00361270|666750|P4|Overall Study|Afraid of Hypnosis|0
197509|NCT00361270|666751|P3|Overall Study|Afraid of Hypnosis|0
197510|NCT00361270|666752|P2|Overall Study|Afraid of Hypnosis|2
197511|NCT00361270|666753|P1|Overall Study|Afraid of Hypnosis|1
197512|NCT00361270|666750|P4|Overall Study|Withdrawal by Subject|7
197513|NCT00361270|666751|P3|Overall Study|Withdrawal by Subject|3
197514|NCT00361270|666752|P2|Overall Study|Withdrawal by Subject|6
197515|NCT00361270|666753|P1|Overall Study|Withdrawal by Subject|6
197516|NCT00361270|666750|P4|Overall Study|Protocol Violation|4
197517|NCT00361270|666751|P3|Overall Study|Protocol Violation|5
197518|NCT00361270|666752|P2|Overall Study|Protocol Violation|4
197519|NCT00361270|666753|P1|Overall Study|Protocol Violation|9
197520|NCT00361270|666750|P4|Overall Study|Physician Decision|0
197521|NCT00361270|666751|P3|Overall Study|Physician Decision|1
197522|NCT00361270|666752|P2|Overall Study|Physician Decision|0
197523|NCT00361270|666753|P1|Overall Study|Physician Decision|0
197524|NCT00361270|666750|P4|Overall Study|Lost to Follow-up|0
197525|NCT00361270|666751|P3|Overall Study|Lost to Follow-up|0
197526|NCT00361270|666752|P2|Overall Study|Lost to Follow-up|1
197527|NCT00361270|666753|P1|Overall Study|Lost to Follow-up|4
197528|NCT00361270|666750|P4|Overall Study|Death|2
197529|NCT00361270|666751|P3|Overall Study|Death|0
197530|NCT00361270|666752|P2|Overall Study|Death|0
197531|NCT00361270|666753|P1|Overall Study|Death|0
197532|NCT00361231|666826|P1|Overall Study|Adverse Event|6
197533|NCT00361231|666826|P1|Overall Study|Withdrawal by Subject|4
197534|NCT00361231|666826|P1|Overall Study|Radiographic disease progression|16
197535|NCT00361231|666826|P1|Overall Study|Symptomatic deterioration|5
197536|NCT00361231|666826|P1|Overall Study|Physician Decision|3
197537|NCT00361218|666831|P1|Overall Study|terminated / withdrawn due to toxicity /|5
197538|NCT00361218|666831|P1|Overall Study|Personal Reasons|7
197539|NCT00361218|666831|P1|Overall Study|Lost to Follow-up|11
197540|NCT00360698|666910|P2|Treatment Period|Early termination by error|1
197541|NCT00360698|666911|P1|Treatment Period|Early termination by error|0
197542|NCT00360698|666910|P2|Treatment Period|Non compliance with treatment procedure|0
197543|NCT00360698|666911|P1|Treatment Period|Non compliance with treatment procedure|1
197544|NCT00360698|666910|P2|Run-In|Need of insulin with meals|1
197545|NCT00360698|666911|P1|Run-In|Need of insulin with meals|0
197546|NCT00360698|666910|P2|Run-In|Patient personal reasons|2
197547|NCT00360698|666911|P1|Run-In|Patient personal reasons|0
197548|NCT00360698|666910|P2|Run-In|Patient did not meet inclusion criteria|1
197549|NCT00360698|666911|P1|Run-In|Patient did not meet inclusion criteria|0
197550|NCT00360698|666910|P2|Run-In|Sponsor request|2
197551|NCT00360698|666911|P1|Run-In|Sponsor request|0
197552|NCT00360698|666910|P2|Run-In|Non compliance with treatment procedure|1
197553|NCT00360698|666911|P1|Run-In|Non compliance with treatment procedure|0
197554|NCT00360698|666910|P2|Run-In|Withdrawal by Subject|2
197555|NCT00360698|666911|P1|Run-In|Withdrawal by Subject|0
197556|NCT00360698|666910|P2|Run-In|Physician Decision|1
197557|NCT00360698|666911|P1|Run-In|Physician Decision|0
197558|NCT00360568|666956|P2|Overall Study|Withdrawal by Subject|3
197559|NCT00360568|666957|P1|Overall Study|Withdrawal by Subject|0
197560|NCT00360568|666956|P2|Overall Study|Lack of Efficacy|0
197561|NCT00360568|666957|P1|Overall Study|Lack of Efficacy|1
197562|NCT00360568|666956|P2|Overall Study|Adverse Event|2
197563|NCT00360568|666957|P1|Overall Study|Adverse Event|1
197564|NCT00360529|667088|P3|Overall Study|Reason discontinued not explained above|11
197565|NCT00360529|667089|P2|Overall Study|Reason discontinued not explained above|9
197566|NCT00360529|667090|P1|Overall Study|Reason discontinued not explained above|4
197567|NCT00360529|667088|P3|Overall Study|Lack of Efficacy|5
197568|NCT00360529|667089|P2|Overall Study|Lack of Efficacy|6
197569|NCT00360529|667090|P1|Overall Study|Lack of Efficacy|8
197570|NCT00360529|667088|P3|Overall Study|Withdrawal by Subject|18
197571|NCT00360529|667089|P2|Overall Study|Withdrawal by Subject|14
197572|NCT00360529|667090|P1|Overall Study|Withdrawal by Subject|22
197573|NCT00360529|667088|P3|Overall Study|Lost to Follow-up|13
197574|NCT00360529|667089|P2|Overall Study|Lost to Follow-up|10
197575|NCT00360529|667090|P1|Overall Study|Lost to Follow-up|14
197576|NCT00360529|667088|P3|Overall Study|Protocol Violation|11
197577|NCT00360529|667089|P2|Overall Study|Protocol Violation|3
197578|NCT00360529|667090|P1|Overall Study|Protocol Violation|3
197579|NCT00360529|667088|P3|Overall Study|Adverse Event|33
197580|NCT00360529|667089|P2|Overall Study|Adverse Event|23
197581|NCT00360529|667090|P1|Overall Study|Adverse Event|10
197582|NCT00360490|667118|P2|Overall Study|Withdrawal by Subject|3
197583|NCT00360490|667119|P1|Overall Study|Withdrawal by Subject|1
197584|NCT00360490|667118|P2|Overall Study|Protocol Violation|4
197585|NCT00360490|667119|P1|Overall Study|Protocol Violation|0
197586|NCT00360490|667118|P2|Overall Study|Physician Decision|1
197587|NCT00360490|667119|P1|Overall Study|Physician Decision|2
197588|NCT00360490|667118|P2|Overall Study|Lost to Follow-up|1
197589|NCT00360490|667119|P1|Overall Study|Lost to Follow-up|2
197590|NCT00360490|667118|P2|Overall Study|Adverse Event|2
197591|NCT00360490|667119|P1|Overall Study|Adverse Event|4
197592|NCT00360412|667154|P2|Overall Study|Study termination by Sponsor|469
197593|NCT00360412|667155|P1|Overall Study|Study termination by Sponsor|214
197594|NCT00360412|667154|P2|Overall Study|Not specified|6
197595|NCT00360412|667155|P1|Overall Study|Not specified|5
197596|NCT00360412|667154|P2|Overall Study|Physician Decision|4
197597|NCT00360412|667155|P1|Overall Study|Physician Decision|2
197598|NCT00360412|667154|P2|Overall Study|Lack of therapeutic efficacy|61
197599|NCT00360412|667155|P1|Overall Study|Lack of therapeutic efficacy|46
197600|NCT00360412|667154|P2|Overall Study|Patient withdrew consent|52
197601|NCT00360412|667155|P1|Overall Study|Patient withdrew consent|27
197602|NCT00360412|667154|P2|Overall Study|Protocol Violation|5
197603|NCT00360412|667155|P1|Overall Study|Protocol Violation|2
197604|NCT00360412|667154|P2|Overall Study|Adverse Event|65
197605|NCT00360412|667155|P1|Overall Study|Adverse Event|37
197606|NCT00360334|667202|P2|Overall Study|Subject decision|2
197607|NCT00360334|667203|P1|Overall Study|Subject decision|8
197608|NCT00360334|667202|P2|Overall Study|Entry criterion not met|2
197609|NCT00360334|667203|P1|Overall Study|Entry criterion not met|1
197610|NCT00360334|667202|P2|Overall Study|Lack of Efficacy|1
197611|NCT00360334|667203|P1|Overall Study|Lack of Efficacy|0
197612|NCT00360334|667202|P2|Overall Study|Physician Decision|3
197613|NCT00360334|667203|P1|Overall Study|Physician Decision|2
197614|NCT00360334|667202|P2|Overall Study|Protocol Violation|1
197615|NCT00360334|667203|P1|Overall Study|Protocol Violation|1
197616|NCT00360334|667202|P2|Overall Study|Adverse Event|4
197617|NCT00360334|667203|P1|Overall Study|Adverse Event|7
197618|NCT00360308|667266|P3|Overall Study|Study termination by sponsor|44
197619|NCT00360308|667267|P2|Overall Study|Study termination by sponsor|55
197620|NCT00360308|667268|P1|Overall Study|Study termination by sponsor|43
197621|NCT00360308|667266|P3|Overall Study|Not Specified|1
197622|NCT00360308|667267|P2|Overall Study|Not Specified|1
197623|NCT00360308|667268|P1|Overall Study|Not Specified|2
197624|NCT00360308|667266|P3|Overall Study|Lack of Efficacy|2
197625|NCT00360308|667267|P2|Overall Study|Lack of Efficacy|0
197626|NCT00360308|667268|P1|Overall Study|Lack of Efficacy|3
197627|NCT00360308|667266|P3|Overall Study|Withdrawal by Subject|14
197628|NCT00360308|667267|P2|Overall Study|Withdrawal by Subject|7
197629|NCT00360308|667268|P1|Overall Study|Withdrawal by Subject|11
197630|NCT00360308|667266|P3|Overall Study|Protocol Violation|2
197631|NCT00360308|667267|P2|Overall Study|Protocol Violation|1
197632|NCT00360308|667268|P1|Overall Study|Protocol Violation|2
197633|NCT00360308|667266|P3|Overall Study|Abnormal Laboratory Value(s)|0
197634|NCT00360308|667267|P2|Overall Study|Abnormal Laboratory Value(s)|1
197635|NCT00360308|667268|P1|Overall Study|Abnormal Laboratory Value(s)|0
197636|NCT00360308|667266|P3|Overall Study|Adverse Event|25
197637|NCT00360308|667267|P2|Overall Study|Adverse Event|14
197638|NCT00360308|667268|P1|Overall Study|Adverse Event|15
197639|NCT00360282|667285|P4|Second Intervention|Adverse Event|0
197640|NCT00360282|667286|P3|Second Intervention|Adverse Event|0
197641|NCT00360282|667287|P2|Second Intervention|Adverse Event|1
197642|NCT00360282|667288|P1|Second Intervention|Adverse Event|0
197643|NCT00360282|667285|P4|Washout 1-3 Weeks|Lost to Follow-up|0
197644|NCT00360282|667286|P3|Washout 1-3 Weeks|Lost to Follow-up|1
197645|NCT00360282|667287|P2|Washout 1-3 Weeks|Lost to Follow-up|0
197646|NCT00360282|667288|P1|Washout 1-3 Weeks|Lost to Follow-up|0
197647|NCT00360269|667300|P2|Overall Study|Withdrawal by Subject|1
197648|NCT00360269|667301|P1|Overall Study|Withdrawal by Subject|1
197649|NCT00360269|667300|P2|Overall Study|Adverse Event|0
197650|NCT00360269|667301|P1|Overall Study|Adverse Event|1
197651|NCT00360269|667300|P2|Overall Study|Physician Decision|2
197652|NCT00360269|667301|P1|Overall Study|Physician Decision|1
197653|NCT00360269|667300|P2|Overall Study|Lost to Follow-up|9
197654|NCT00360269|667301|P1|Overall Study|Lost to Follow-up|7
197655|NCT00360230|667343|P7|Overall Study|Death|1
197656|NCT00360230|667344|P6|Overall Study|Death|1
197657|NCT00360230|667345|P5|Overall Study|Death|0
197658|NCT00360230|667346|P4|Overall Study|Death|0
197659|NCT00360230|667347|P3|Overall Study|Death|0
197660|NCT00360230|667348|P2|Overall Study|Death|1
197661|NCT00360230|667349|P1|Overall Study|Death|0
197662|NCT00360230|667343|P7|Overall Study|Protocol Violation|0
197663|NCT00360230|667344|P6|Overall Study|Protocol Violation|1
197664|NCT00360230|667345|P5|Overall Study|Protocol Violation|0
197665|NCT00360230|667346|P4|Overall Study|Protocol Violation|0
197666|NCT00360230|667347|P3|Overall Study|Protocol Violation|0
197667|NCT00360230|667348|P2|Overall Study|Protocol Violation|0
197668|NCT00360230|667349|P1|Overall Study|Protocol Violation|0
197669|NCT00360230|667343|P7|Overall Study|Not specified|0
197670|NCT00360230|667344|P6|Overall Study|Not specified|0
197671|NCT00360230|667345|P5|Overall Study|Not specified|0
197672|NCT00360230|667346|P4|Overall Study|Not specified|0
197673|NCT00360230|667347|P3|Overall Study|Not specified|0
197674|NCT00360230|667348|P2|Overall Study|Not specified|0
197675|NCT00360230|667349|P1|Overall Study|Not specified|1
197676|NCT00360230|667343|P7|Overall Study|Migrated|1
197677|NCT00360230|667344|P6|Overall Study|Migrated|1
197678|NCT00360230|667345|P5|Overall Study|Migrated|4
197679|NCT00360230|667346|P4|Overall Study|Migrated|1
197680|NCT00360230|667347|P3|Overall Study|Migrated|3
197681|NCT00360230|667348|P2|Overall Study|Migrated|1
197682|NCT00360230|667349|P1|Overall Study|Migrated|4
197683|NCT00360230|667343|P7|Overall Study|Withdrawal by Subject|0
197684|NCT00360230|667344|P6|Overall Study|Withdrawal by Subject|1
197685|NCT00360230|667345|P5|Overall Study|Withdrawal by Subject|1
197686|NCT00360230|667346|P4|Overall Study|Withdrawal by Subject|1
197687|NCT00360230|667347|P3|Overall Study|Withdrawal by Subject|0
197688|NCT00360230|667348|P2|Overall Study|Withdrawal by Subject|1
197689|NCT00360230|667349|P1|Overall Study|Withdrawal by Subject|1
197690|NCT00359801|667505|P2|Overall Study|Sponsor Decision|16
197691|NCT00359801|667506|P1|Overall Study|Sponsor Decision|17
197692|NCT00359801|667505|P2|Overall Study|Final Status Unknown: missing data|4
197693|NCT00359801|667506|P1|Overall Study|Final Status Unknown: missing data|7
197694|NCT00359801|667505|P2|Overall Study|Other|46
197695|NCT00359801|667506|P1|Overall Study|Other|66
197696|NCT00359801|667505|P2|Overall Study|Withdrawal by Subject|96
197697|NCT00359801|667506|P1|Overall Study|Withdrawal by Subject|143
197698|NCT00359801|667505|P2|Overall Study|Lost to Follow-up|58
197699|NCT00359801|667506|P1|Overall Study|Lost to Follow-up|72
197700|NCT00359788|667540|P2|Overall Study|Protocol Violation|2
197701|NCT00359788|667541|P1|Overall Study|Protocol Violation|4
197702|NCT00359788|667540|P2|Overall Study|Withdrawal by Subject|1
197703|NCT00359788|667541|P1|Overall Study|Withdrawal by Subject|4
197704|NCT00359788|667540|P2|Overall Study|Lost to Follow-up|2
197705|NCT00359788|667541|P1|Overall Study|Lost to Follow-up|3
197706|NCT00359788|667540|P2|Overall Study|Lack of Efficacy|2
197707|NCT00359788|667541|P1|Overall Study|Lack of Efficacy|1
197708|NCT00359788|667540|P2|Overall Study|Adverse Event|10
197709|NCT00359788|667541|P1|Overall Study|Adverse Event|11
197710|NCT00359762|667775|P5|Period III|Subject Decision|0
197711|NCT00359762|667776|P4|Period III|Subject Decision|20
197712|NCT00359762|667777|P3|Period III|Subject Decision|8
197713|NCT00359762|667778|P2|Period III|Subject Decision|7
197714|NCT00359762|667779|P1|Period III|Subject Decision|0
197715|NCT00359762|667775|P5|Period III|Entry Criteria Not Met|0
197716|NCT00359762|667776|P4|Period III|Entry Criteria Not Met|1
197717|NCT00359762|667777|P3|Period III|Entry Criteria Not Met|0
197718|NCT00359762|667778|P2|Period III|Entry Criteria Not Met|1
197719|NCT00359762|667779|P1|Period III|Entry Criteria Not Met|0
197720|NCT00359762|667775|P5|Period III|Lost to follow up|0
197721|NCT00359762|667776|P4|Period III|Lost to follow up|2
197722|NCT00359762|667777|P3|Period III|Lost to follow up|1
197723|NCT00359762|667778|P2|Period III|Lost to follow up|1
197724|NCT00359762|667779|P1|Period III|Lost to follow up|0
197725|NCT00359762|667775|P5|Period III|Lack of Efficacy|0
197726|NCT00359762|667776|P4|Period III|Lack of Efficacy|9
197727|NCT00359762|667777|P3|Period III|Lack of Efficacy|5
197728|NCT00359762|667778|P2|Period III|Lack of Efficacy|7
197729|NCT00359762|667779|P1|Period III|Lack of Efficacy|0
197730|NCT00359762|667775|P5|Period III|Physician Decision|0
197731|NCT00359762|667776|P4|Period III|Physician Decision|15
197732|NCT00359762|667777|P3|Period III|Physician Decision|9
197733|NCT00359762|667778|P2|Period III|Physician Decision|5
197734|NCT00359762|667779|P1|Period III|Physician Decision|0
197735|NCT00359762|667775|P5|Period III|Adverse Event|0
197736|NCT00359762|667776|P4|Period III|Adverse Event|10
197737|NCT00359762|667777|P3|Period III|Adverse Event|4
197738|NCT00359762|667778|P2|Period III|Adverse Event|3
197739|NCT00359762|667779|P1|Period III|Adverse Event|0
197740|NCT00359762|667775|P5|Period III|Protocol Violation|0
197741|NCT00359762|667776|P4|Period III|Protocol Violation|8
197742|NCT00359762|667777|P3|Period III|Protocol Violation|3
197743|NCT00359762|667778|P2|Period III|Protocol Violation|5
197744|NCT00359762|667779|P1|Period III|Protocol Violation|0
197745|NCT00359762|667775|P5|Period II|Subject Decision|70
197746|NCT00359762|667776|P4|Period II|Subject Decision|0
197747|NCT00359762|667777|P3|Period II|Subject Decision|0
197748|NCT00359762|667778|P2|Period II|Subject Decision|0
197749|NCT00359762|667779|P1|Period II|Subject Decision|50
197750|NCT00359762|667775|P5|Period II|Entry Criteria Not Met|4
197751|NCT00359762|667776|P4|Period II|Entry Criteria Not Met|0
197752|NCT00359762|667777|P3|Period II|Entry Criteria Not Met|0
197753|NCT00359762|667778|P2|Period II|Entry Criteria Not Met|0
197754|NCT00359762|667779|P1|Period II|Entry Criteria Not Met|8
197755|NCT00359762|667775|P5|Period II|Lost to follow up|5
197756|NCT00359762|667776|P4|Period II|Lost to follow up|0
197757|NCT00359762|667777|P3|Period II|Lost to follow up|0
197758|NCT00359762|667778|P2|Period II|Lost to follow up|0
197759|NCT00359762|667779|P1|Period II|Lost to follow up|5
197760|NCT00359762|667775|P5|Period II|Lack of Efficacy|8
197761|NCT00359762|667776|P4|Period II|Lack of Efficacy|0
197762|NCT00359762|667777|P3|Period II|Lack of Efficacy|0
197763|NCT00359762|667778|P2|Period II|Lack of Efficacy|0
197764|NCT00359762|667779|P1|Period II|Lack of Efficacy|11
197765|NCT00359762|667775|P5|Period II|Death|4
197766|NCT00359762|667776|P4|Period II|Death|0
197767|NCT00359762|667777|P3|Period II|Death|0
197768|NCT00359762|667778|P2|Period II|Death|0
197769|NCT00359762|667779|P1|Period II|Death|2
197770|NCT00359762|667775|P5|Period II|Physician Decision|23
197771|NCT00359762|667776|P4|Period II|Physician Decision|0
197772|NCT00359762|667777|P3|Period II|Physician Decision|0
197773|NCT00359762|667778|P2|Period II|Physician Decision|0
197774|NCT00359762|667779|P1|Period II|Physician Decision|17
197775|NCT00359762|667775|P5|Period II|Protocol Violation|11
197776|NCT00359762|667776|P4|Period II|Protocol Violation|0
197777|NCT00359762|667777|P3|Period II|Protocol Violation|0
197778|NCT00359762|667778|P2|Period II|Protocol Violation|0
197779|NCT00359762|667779|P1|Period II|Protocol Violation|18
197780|NCT00359762|667775|P5|Period II|Adverse Event|49
197781|NCT00359762|667776|P4|Period II|Adverse Event|0
197782|NCT00359762|667777|P3|Period II|Adverse Event|0
197783|NCT00359762|667778|P2|Period II|Adverse Event|0
197784|NCT00359762|667779|P1|Period II|Adverse Event|17
197785|NCT00359632|667853|P2|Overall Study|Non-compliance with visit schedule|0
197786|NCT00359632|667854|P1|Overall Study|Non-compliance with visit schedule|1
197787|NCT00359632|667853|P2|Overall Study|Adverse Event|0
197788|NCT00359632|667854|P1|Overall Study|Adverse Event|1
197789|NCT00359632|667853|P2|Overall Study|Death|0
197790|NCT00359632|667854|P1|Overall Study|Death|2
197791|NCT00359619|667868|P7|Overall Study|Lost to Follow-up|0
197792|NCT00359619|667869|P6|Overall Study|Lost to Follow-up|5
197793|NCT00359619|667870|P5|Overall Study|Lost to Follow-up|1
197794|NCT00359619|667871|P4|Overall Study|Lost to Follow-up|1
197795|NCT00359619|667872|P3|Overall Study|Lost to Follow-up|2
197796|NCT00359619|667873|P2|Overall Study|Lost to Follow-up|4
197797|NCT00359619|667874|P1|Overall Study|Lost to Follow-up|4
197798|NCT00359619|667868|P7|Overall Study|Other|0
197799|NCT00359619|667869|P6|Overall Study|Other|0
197800|NCT00359619|667870|P5|Overall Study|Other|0
197801|NCT00359619|667871|P4|Overall Study|Other|0
197802|NCT00359619|667872|P3|Overall Study|Other|0
197803|NCT00359619|667873|P2|Overall Study|Other|0
197804|NCT00359619|667874|P1|Overall Study|Other|1
197805|NCT00359619|667868|P7|Overall Study|Withdrawal by Subject|3
197806|NCT00359619|667869|P6|Overall Study|Withdrawal by Subject|0
197807|NCT00359619|667870|P5|Overall Study|Withdrawal by Subject|2
197808|NCT00359619|667871|P4|Overall Study|Withdrawal by Subject|2
197809|NCT00359619|667872|P3|Overall Study|Withdrawal by Subject|4
197810|NCT00359619|667873|P2|Overall Study|Withdrawal by Subject|1
197811|NCT00359619|667874|P1|Overall Study|Withdrawal by Subject|3
197812|NCT00359619|667868|P7|Overall Study|Adverse Event|1
197813|NCT00359619|667869|P6|Overall Study|Adverse Event|0
197814|NCT00359619|667870|P5|Overall Study|Adverse Event|0
197815|NCT00359619|667871|P4|Overall Study|Adverse Event|0
197816|NCT00359619|667872|P3|Overall Study|Adverse Event|1
197817|NCT00359619|667873|P2|Overall Study|Adverse Event|0
197818|NCT00359619|667874|P1|Overall Study|Adverse Event|0
197819|NCT00359424|668004|P2|Overall Study|follow up not conducted|0
197820|NCT00359424|668005|P1|Overall Study|follow up not conducted|2
197821|NCT00359424|668004|P2|Overall Study|Withdrawal by Subject|2
197822|NCT00359424|668005|P1|Overall Study|Withdrawal by Subject|10
197823|NCT00359424|668004|P2|Overall Study|Lost to Follow-up|7
197824|NCT00359424|668005|P1|Overall Study|Lost to Follow-up|19
197825|NCT00359424|668004|P2|Overall Study|Death|58
197826|NCT00359424|668005|P1|Overall Study|Death|99
197827|NCT00359281|668044|P9|Overall Study|Withdrawal by Subject|0
197828|NCT00359281|668045|P8|Overall Study|Withdrawal by Subject|0
197829|NCT00359281|668046|P7|Overall Study|Withdrawal by Subject|1
197830|NCT00359281|668047|P6|Overall Study|Withdrawal by Subject|0
197831|NCT00359281|668048|P5|Overall Study|Withdrawal by Subject|0
197832|NCT00359281|668049|P4|Overall Study|Withdrawal by Subject|0
197833|NCT00359281|668050|P3|Overall Study|Withdrawal by Subject|0
197834|NCT00359281|668051|P2|Overall Study|Withdrawal by Subject|0
197835|NCT00359281|668052|P1|Overall Study|Withdrawal by Subject|0
197836|NCT00359281|668044|P9|Overall Study|Adverse Event|0
197837|NCT00359281|668045|P8|Overall Study|Adverse Event|0
197838|NCT00359281|668046|P7|Overall Study|Adverse Event|1
197839|NCT00359281|668047|P6|Overall Study|Adverse Event|0
197840|NCT00359281|668048|P5|Overall Study|Adverse Event|0
197841|NCT00359281|668049|P4|Overall Study|Adverse Event|0
197842|NCT00359281|668050|P3|Overall Study|Adverse Event|0
197843|NCT00359281|668051|P2|Overall Study|Adverse Event|0
197844|NCT00359281|668052|P1|Overall Study|Adverse Event|1
197845|NCT00359073|668115|P2|Overall Study|developed RV16 antibody|1
197846|NCT00359073|668116|P1|Overall Study|developed RV16 antibody|0
197847|NCT00359073|668115|P2|Overall Study|Eligibility criteria no longer met|0
197848|NCT00359073|668116|P1|Overall Study|Eligibility criteria no longer met|3
197849|NCT00359073|668115|P2|Overall Study|Withdrawal by Subject|1
197850|NCT00359073|668116|P1|Overall Study|Withdrawal by Subject|1
197851|NCT00359021|668128|P2|Overall Study|Pregnancy|0
197852|NCT00359021|668129|P1|Overall Study|Pregnancy|1
197853|NCT00359021|668128|P2|Overall Study|Not specified|1
197854|NCT00359021|668129|P1|Overall Study|Not specified|4
197855|NCT00359021|668128|P2|Overall Study|Lost to Follow-up|0
197856|NCT00359021|668129|P1|Overall Study|Lost to Follow-up|1
197857|NCT00359021|668128|P2|Overall Study|Withdrawal by Subject|9
197858|NCT00359021|668129|P1|Overall Study|Withdrawal by Subject|2
197859|NCT00359021|668128|P2|Overall Study|Subject Reached A Virologic Endpoint|32
197860|NCT00359021|668129|P1|Overall Study|Subject Reached A Virologic Endpoint|45
197861|NCT00359021|668128|P2|Overall Study|Subject Ineligible To Continue The Trial|0
197862|NCT00359021|668129|P1|Overall Study|Subject Ineligible To Continue The Trial|1
197863|NCT00359021|668128|P2|Overall Study|Subject Non-Compliant|2
197864|NCT00359021|668129|P1|Overall Study|Subject Non-Compliant|1
197865|NCT00359021|668128|P2|Overall Study|Adverse Event|8
197866|NCT00359021|668129|P1|Overall Study|Adverse Event|26
197867|NCT00358956|668141|P1|Overall Study|Withdrawal by Subject|1
197868|NCT00358956|668141|P1|Overall Study|condition under investigation worsened|4
197869|NCT00358956|668141|P1|Overall Study|Adverse Event|3
197870|NCT00358917|668153|P2|Overall Study|Unable to Continue Participation|2
197871|NCT00358917|668154|P1|Overall Study|Unable to Continue Participation|2
197872|NCT00358917|668153|P2|Overall Study|Virologic failure|8
197873|NCT00358917|668154|P1|Overall Study|Virologic failure|11
197874|NCT00358917|668153|P2|Overall Study|Death|3
197875|NCT00358917|668154|P1|Overall Study|Death|2
197876|NCT00358917|668153|P2|Overall Study|Noncompliance|11
197877|NCT00358917|668154|P1|Overall Study|Noncompliance|12
197878|NCT00358917|668153|P2|Overall Study|Lost to Follow-up|17
197879|NCT00358917|668154|P1|Overall Study|Lost to Follow-up|20
197880|NCT00358917|668153|P2|Overall Study|Withdrawal by Subject|7
197881|NCT00358917|668154|P1|Overall Study|Withdrawal by Subject|5
197882|NCT00358917|668153|P2|Overall Study|Adverse Event|21
197883|NCT00358917|668154|P1|Overall Study|Adverse Event|14
197884|NCT00358826|668172|P8|MDCT Substudy|Withdrawal by Subject|0
197885|NCT00358826|668173|P7|MDCT Substudy|Withdrawal by Subject|0
197886|NCT00358826|668174|P6|MDCT Substudy|Withdrawal by Subject|1
197887|NCT00358826|668175|P5|MDCT Substudy|Withdrawal by Subject|0
197888|NCT00358826|668176|P4|MDCT Substudy|Withdrawal by Subject|0
197889|NCT00358826|668177|P3|MDCT Substudy|Withdrawal by Subject|0
197890|NCT00358826|668178|P2|MDCT Substudy|Withdrawal by Subject|0
197891|NCT00358826|668179|P1|MDCT Substudy|Withdrawal by Subject|0
197892|NCT00358826|668172|P8|MDCT Substudy|Lost to Follow-up|0
197893|NCT00358826|668173|P7|MDCT Substudy|Lost to Follow-up|0
197894|NCT00358826|668174|P6|MDCT Substudy|Lost to Follow-up|1
197895|NCT00358826|668175|P5|MDCT Substudy|Lost to Follow-up|0
197896|NCT00358826|668176|P4|MDCT Substudy|Lost to Follow-up|0
197897|NCT00358826|668177|P3|MDCT Substudy|Lost to Follow-up|0
197898|NCT00358826|668178|P2|MDCT Substudy|Lost to Follow-up|0
197899|NCT00358826|668179|P1|MDCT Substudy|Lost to Follow-up|0
197900|NCT00358826|668172|P8|MDCT Substudy|Adverse Event|0
197901|NCT00358826|668173|P7|MDCT Substudy|Adverse Event|0
197902|NCT00358826|668174|P6|MDCT Substudy|Adverse Event|0
197903|NCT00358826|668175|P5|MDCT Substudy|Adverse Event|1
197904|NCT00358826|668176|P4|MDCT Substudy|Adverse Event|0
197905|NCT00358826|668177|P3|MDCT Substudy|Adverse Event|0
197906|NCT00358826|668178|P2|MDCT Substudy|Adverse Event|0
197907|NCT00358826|668179|P1|MDCT Substudy|Adverse Event|0
197908|NCT00358826|668172|P8|Core Study|Physician Decision|0
197909|NCT00358826|668173|P7|Core Study|Physician Decision|0
197910|NCT00358826|668174|P6|Core Study|Physician Decision|0
197911|NCT00358826|668175|P5|Core Study|Physician Decision|0
197912|NCT00358826|668176|P4|Core Study|Physician Decision|0
197913|NCT00358826|668177|P3|Core Study|Physician Decision|1
197914|NCT00358826|668178|P2|Core Study|Physician Decision|0
197915|NCT00358826|668179|P1|Core Study|Physician Decision|0
197916|NCT00358826|668172|P8|Core Study|Lost to Follow-up|0
197917|NCT00358826|668173|P7|Core Study|Lost to Follow-up|0
197918|NCT00358826|668174|P6|Core Study|Lost to Follow-up|0
197919|NCT00358826|668175|P5|Core Study|Lost to Follow-up|0
197920|NCT00358826|668176|P4|Core Study|Lost to Follow-up|1
197921|NCT00358826|668177|P3|Core Study|Lost to Follow-up|0
197922|NCT00358826|668178|P2|Core Study|Lost to Follow-up|0
197923|NCT00358826|668179|P1|Core Study|Lost to Follow-up|0
197924|NCT00358826|668172|P8|Core Study|Withdrawal by Subject|0
197925|NCT00358826|668173|P7|Core Study|Withdrawal by Subject|0
197926|NCT00358826|668174|P6|Core Study|Withdrawal by Subject|0
197927|NCT00358826|668175|P5|Core Study|Withdrawal by Subject|0
197928|NCT00358826|668176|P4|Core Study|Withdrawal by Subject|0
197929|NCT00358826|668177|P3|Core Study|Withdrawal by Subject|0
197930|NCT00358826|668178|P2|Core Study|Withdrawal by Subject|2
197931|NCT00358826|668179|P1|Core Study|Withdrawal by Subject|2
197932|NCT00358826|668172|P8|Core Study|Adverse Event|0
197933|NCT00358826|668173|P7|Core Study|Adverse Event|0
197934|NCT00358826|668174|P6|Core Study|Adverse Event|0
197935|NCT00358826|668175|P5|Core Study|Adverse Event|0
197936|NCT00358826|668176|P4|Core Study|Adverse Event|1
197937|NCT00358826|668177|P3|Core Study|Adverse Event|1
197938|NCT00358826|668178|P2|Core Study|Adverse Event|3
197939|NCT00358826|668179|P1|Core Study|Adverse Event|1
197940|NCT00358670|668246|P2|Overall Study|Administrative|125
197941|NCT00358670|668247|P1|Overall Study|Administrative|153
197942|NCT00358670|668246|P2|Overall Study|Did Not Meet Protocol Eligibility|3
197943|NCT00358670|668247|P1|Overall Study|Did Not Meet Protocol Eligibility|0
197944|NCT00358670|668246|P2|Overall Study|Protocol Defined Clinical Event|1
197945|NCT00358670|668247|P1|Overall Study|Protocol Defined Clinical Event|0
197946|NCT00358670|668246|P2|Overall Study|Withdrawal by Subject|24
197947|NCT00358670|668247|P1|Overall Study|Withdrawal by Subject|13
197948|NCT00358670|668246|P2|Overall Study|Lost to Follow-up|5
197949|NCT00358670|668247|P1|Overall Study|Lost to Follow-up|4
197950|NCT00358670|668246|P2|Overall Study|Protocol Violation|9
197951|NCT00358670|668247|P1|Overall Study|Protocol Violation|6
197952|NCT00358670|668246|P2|Overall Study|Lack of Efficacy|23
197953|NCT00358670|668247|P1|Overall Study|Lack of Efficacy|20
197954|NCT00358670|668246|P2|Overall Study|Adverse Event|29
197955|NCT00358670|668247|P1|Overall Study|Adverse Event|26
197956|NCT00358644|668261|P1|Overall Study|Patient not eligible for study|1
197957|NCT00358644|668261|P1|Overall Study|Physician Decision|6
197958|NCT00358644|668261|P1|Overall Study|Withdrawal by Subject|4
197959|NCT00358644|668261|P1|Overall Study|Death|11
197960|NCT00358644|668261|P1|Overall Study|Adverse Event|7
197961|NCT00358644|668261|P1|Overall Study|Progressive Disease|21
197962|NCT00358527|668284|P2|Overall Study|Administrative|1
197963|NCT00358527|668285|P1|Overall Study|Administrative|2
197964|NCT00358527|668284|P2|Overall Study|Non-compliance with protocol|1
197965|NCT00358527|668285|P1|Overall Study|Non-compliance with protocol|6
197966|NCT00358527|668284|P2|Overall Study|Withdrawal by Subject|1
197967|NCT00358527|668285|P1|Overall Study|Withdrawal by Subject|1
197968|NCT00358527|668284|P2|Overall Study|Adverse Event|0
197969|NCT00358527|668285|P1|Overall Study|Adverse Event|4
197970|NCT00358449|668323|P3|Overall Study|Steriod Inhaler was Increased|1
197971|NCT00358449|668324|P2|Overall Study|Steriod Inhaler was Increased|0
197972|NCT00358449|668325|P1|Overall Study|Steriod Inhaler was Increased|0
197973|NCT00358449|668323|P3|Overall Study|Lack of Efficacy|0
197974|NCT00358449|668324|P2|Overall Study|Lack of Efficacy|1
197975|NCT00358449|668325|P1|Overall Study|Lack of Efficacy|0
197976|NCT00358449|668323|P3|Overall Study|Withdrawal by Subject|0
197977|NCT00358449|668324|P2|Overall Study|Withdrawal by Subject|0
197978|NCT00358449|668325|P1|Overall Study|Withdrawal by Subject|2
197979|NCT00358449|668323|P3|Overall Study|Lost to Follow-up|0
197980|NCT00358449|668324|P2|Overall Study|Lost to Follow-up|0
197981|NCT00358449|668325|P1|Overall Study|Lost to Follow-up|1
197982|NCT00358449|668323|P3|Overall Study|Adverse Event|1
197983|NCT00358449|668324|P2|Overall Study|Adverse Event|0
197984|NCT00358449|668325|P1|Overall Study|Adverse Event|1
197985|NCT00358436|668428|P2|Overall Study|Other|1
197986|NCT00358436|668429|P1|Overall Study|Other|6
197987|NCT00358436|668428|P2|Overall Study|COPD exacerbation|10
197988|NCT00358436|668429|P1|Overall Study|COPD exacerbation|22
197989|NCT00358436|668428|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
197990|NCT00358436|668429|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
197991|NCT00358436|668428|P2|Overall Study|Withdrawal by Subject|17
197992|NCT00358436|668429|P1|Overall Study|Withdrawal by Subject|40
197993|NCT00358436|668428|P2|Overall Study|Protocol Violation|3
197994|NCT00358436|668429|P1|Overall Study|Protocol Violation|8
197995|NCT00358436|668428|P2|Overall Study|Lost to Follow-up|6
197996|NCT00358436|668429|P1|Overall Study|Lost to Follow-up|11
197997|NCT00358436|668428|P2|Overall Study|Lack of Efficacy|36
197998|NCT00358436|668429|P1|Overall Study|Lack of Efficacy|34
197999|NCT00358436|668428|P2|Overall Study|Adverse Event|13
198000|NCT00358436|668429|P1|Overall Study|Adverse Event|29
198001|NCT00358215|668500|P2|Overall Study|Did not receive investigational product|3
198002|NCT00358215|668501|P1|Overall Study|Did not receive investigational product|2
198003|NCT00358215|668500|P2|Overall Study|Other|14
198004|NCT00358215|668501|P1|Overall Study|Other|21
198005|NCT00358215|668500|P2|Overall Study|Pregnancy|0
198006|NCT00358215|668501|P1|Overall Study|Pregnancy|1
198007|NCT00358215|668500|P2|Overall Study|Protocol Violation|59
198008|NCT00358215|668501|P1|Overall Study|Protocol Violation|64
198009|NCT00358215|668500|P2|Overall Study|Death|281
198010|NCT00358215|668501|P1|Overall Study|Death|265
198011|NCT00358215|668500|P2|Overall Study|Lost to Follow-up|22
198012|NCT00358215|668501|P1|Overall Study|Lost to Follow-up|16
198013|NCT00358215|668500|P2|Overall Study|Physician Decision|39
198014|NCT00358215|668501|P1|Overall Study|Physician Decision|47
198015|NCT00358215|668500|P2|Overall Study|Participant request|64
198016|NCT00358215|668501|P1|Overall Study|Participant request|65
198017|NCT00358215|668500|P2|Overall Study|Withdrawal by Subject|102
198018|NCT00358215|668501|P1|Overall Study|Withdrawal by Subject|111
198019|NCT00358215|668500|P2|Overall Study|Adverse Event|65
198020|NCT00358215|668501|P1|Overall Study|Adverse Event|83
198021|NCT00358215|668500|P2|Overall Study|Ineligibility determined|3
198022|NCT00358215|668501|P1|Overall Study|Ineligibility determined|4
198023|NCT00358150|668515|P1|Overall Study|Undefined|3
198024|NCT00358150|668515|P1|Overall Study|Withdrawal by Subject|1
198025|NCT00358150|668515|P1|Overall Study|Adverse Event|3
198026|NCT00357994|668544|P2|Overall Study|Protocol Violation|0
198027|NCT00357994|668545|P1|Overall Study|Protocol Violation|1
198028|NCT00357994|668544|P2|Overall Study|Lack of Efficacy|1
198029|NCT00357994|668545|P1|Overall Study|Lack of Efficacy|0
198030|NCT00357994|668544|P2|Overall Study|Adverse Event|2
198031|NCT00357994|668545|P1|Overall Study|Adverse Event|1
198032|NCT00357968|668599|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
198033|NCT00357968|668600|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
198034|NCT00357968|668599|P2|First Maintenance Dose Phase|Not a PCI patient|42
198035|NCT00357968|668600|P1|First Maintenance Dose Phase|Not a PCI patient|47
198036|NCT00357903|668653|P2|Overall Study|Other|10
198037|NCT00357903|668654|P1|Overall Study|Other|49
198038|NCT00357903|668653|P2|Overall Study|Response status|9
198039|NCT00357903|668654|P1|Overall Study|Response status|61
198040|NCT00357903|668653|P2|Overall Study|Protocol issues|3
198041|NCT00357903|668654|P1|Overall Study|Protocol issues|14
198042|NCT00357903|668653|P2|Overall Study|Completed month 12 only|1
198043|NCT00357903|668654|P1|Overall Study|Completed month 12 only|0
198044|NCT00357903|668653|P2|Overall Study|Withdrawal by Subject|7
198045|NCT00357903|668654|P1|Overall Study|Withdrawal by Subject|57
198046|NCT00357903|668653|P2|Overall Study|Physician Decision|5
198047|NCT00357903|668654|P1|Overall Study|Physician Decision|39
198048|NCT00357903|668653|P2|Overall Study|Lost to Follow-up|4
198049|NCT00357903|668654|P1|Overall Study|Lost to Follow-up|23
198050|NCT00357903|668653|P2|Overall Study|Death|0
198051|NCT00357903|668654|P1|Overall Study|Death|33
198052|NCT00357903|668653|P2|Overall Study|Adverse Event|4
198053|NCT00357903|668654|P1|Overall Study|Adverse Event|87
198054|NCT00357877|668694|P2|Overall Study|Other|2
198055|NCT00357877|668695|P1|Overall Study|Other|0
198056|NCT00357877|668694|P2|Overall Study|Administrative withdrawal|1
198057|NCT00357877|668695|P1|Overall Study|Administrative withdrawal|1
198058|NCT00357877|668694|P2|Overall Study|Withdrawal by Subject|3
198059|NCT00357877|668695|P1|Overall Study|Withdrawal by Subject|3
198060|NCT00357877|668694|P2|Overall Study|Lost to Follow-up|23
198061|NCT00357877|668695|P1|Overall Study|Lost to Follow-up|20
198062|NCT00357877|668694|P2|Overall Study|Death|1
198063|NCT00357877|668695|P1|Overall Study|Death|2
198064|NCT00357760|668709|P2|Overall Study|To receive hospice care|1
198065|NCT00357760|668710|P1|Overall Study|To receive hospice care|0
198066|NCT00357760|668709|P2|Overall Study|Protocol Violation|1
198067|NCT00357760|668710|P1|Overall Study|Protocol Violation|0
198068|NCT00357760|668709|P2|Overall Study|Physician Decision|1
198069|NCT00357760|668710|P1|Overall Study|Physician Decision|2
198070|NCT00357760|668709|P2|Overall Study|Ineligible|2
198071|NCT00357760|668710|P1|Overall Study|Ineligible|0
198072|NCT00357760|668709|P2|Overall Study|Never started treatment|1
198073|NCT00357760|668710|P1|Overall Study|Never started treatment|2
198074|NCT00357760|668709|P2|Overall Study|Withdrawal by Subject|2
198075|NCT00357760|668710|P1|Overall Study|Withdrawal by Subject|0
198076|NCT00357760|668709|P2|Overall Study|Alternative therapy|0
198077|NCT00357760|668710|P1|Overall Study|Alternative therapy|1
198078|NCT00357760|668709|P2|Overall Study|Death|3
198079|NCT00357760|668710|P1|Overall Study|Death|0
198080|NCT00357760|668709|P2|Overall Study|Adverse Event|7
198081|NCT00357760|668710|P1|Overall Study|Adverse Event|10
198082|NCT00357760|668709|P2|Overall Study|Disease progression|17
198083|NCT00357760|668710|P1|Overall Study|Disease progression|44
198084|NCT00357656|668731|P2|Overall Study|Other, No surgery performed|3
198085|NCT00357656|668732|P1|Overall Study|Other, No surgery performed|0
198086|NCT00357552|668783|P1|Weeks 24 to 104|Not able to get to clinic|2
198087|NCT00357552|668783|P1|Weeks 24 to 104|Death|3
198088|NCT00357552|668783|P1|Weeks 0 to 24|Death|1
198089|NCT00357552|668783|P1|Screening|Did not meet eligibility criteria|84
198090|NCT00357500|668798|P1|Overall Study|Not Started Protocol Therapy|4
198091|NCT00357500|668798|P1|Overall Study|Progressive Disease|65
198092|NCT00357500|668798|P1|Overall Study|Withdrawal by Subject|5
198093|NCT00357500|668798|P1|Overall Study|Adverse Event|3
198094|NCT00357396|668807|P2|Overall Study|Adverse Event|0
198095|NCT00357396|668808|P1|Overall Study|Adverse Event|1
198096|NCT00357370|668816|P3|Cohort 2|Withdrawal by Subject|0
198097|NCT00357370|668817|P2|Cohort 2|Withdrawal by Subject|2
198098|NCT00357370|668818|P1|Cohort 2|Withdrawal by Subject|0
198099|NCT00357370|668816|P3|Cohort 2|non-compliance, not met criteria, etc|0
198100|NCT00357370|668817|P2|Cohort 2|non-compliance, not met criteria, etc|1
198101|NCT00357370|668818|P1|Cohort 2|non-compliance, not met criteria, etc|1
198102|NCT00357370|668816|P3|Cohort 2|Lost to Follow-up|0
198103|NCT00357370|668817|P2|Cohort 2|Lost to Follow-up|1
198104|NCT00357370|668818|P1|Cohort 2|Lost to Follow-up|0
198105|NCT00357370|668816|P3|Cohort 2|Adverse Event|1
198106|NCT00357370|668817|P2|Cohort 2|Adverse Event|1
198107|NCT00357370|668818|P1|Cohort 2|Adverse Event|1
198108|NCT00357370|668816|P3|Cohort 2|Lack of Efficacy|1
198109|NCT00357370|668817|P2|Cohort 2|Lack of Efficacy|2
198110|NCT00357370|668818|P1|Cohort 2|Lack of Efficacy|0
198111|NCT00357110|668864|P2|Overall Study|Early study termination|5
198112|NCT00357110|668865|P1|Overall Study|Early study termination|5
198113|NCT00357097|668873|P2|Overall Study|Increase of RLS Symptoms|1
198114|NCT00357097|668874|P1|Overall Study|Increase of RLS Symptoms|0
198115|NCT00357097|668873|P2|Overall Study|Other|1
198116|NCT00357097|668874|P1|Overall Study|Other|1
198117|NCT00357097|668873|P2|Overall Study|Met Exclusion Criteria|1
198118|NCT00357097|668874|P1|Overall Study|Met Exclusion Criteria|3
198119|NCT00357097|668873|P2|Overall Study|Lack of Efficacy|8
198120|NCT00357097|668874|P1|Overall Study|Lack of Efficacy|2
198121|NCT00357097|668873|P2|Overall Study|Non-compliance|2
198122|NCT00357097|668874|P1|Overall Study|Non-compliance|1
198123|NCT00357097|668873|P2|Overall Study|Withdrawal by Subject|7
198124|NCT00357097|668874|P1|Overall Study|Withdrawal by Subject|8
198125|NCT00357097|668873|P2|Overall Study|Adverse Event|6
198126|NCT00357097|668874|P1|Overall Study|Adverse Event|34
198127|NCT00357097|668873|P2|Overall Study|Did not meet inclusion criteria|3
198128|NCT00357097|668874|P1|Overall Study|Did not meet inclusion criteria|5
198129|NCT00357006|668928|P3|Overall Study|Withdrawal by Subject|2
198130|NCT00357006|668929|P2|Overall Study|Withdrawal by Subject|3
198131|NCT00357006|668930|P1|Overall Study|Withdrawal by Subject|1
198132|NCT00357006|668928|P3|Overall Study|Lost to Follow-up|1
198133|NCT00357006|668929|P2|Overall Study|Lost to Follow-up|2
198134|NCT00357006|668930|P1|Overall Study|Lost to Follow-up|1
198135|NCT00356915|668941|P3|Overall Study|Miscellaneous reasons|3
198136|NCT00356915|668942|P2|Overall Study|Miscellaneous reasons|8
198137|NCT00356915|668943|P1|Overall Study|Miscellaneous reasons|11
198138|NCT00356915|668941|P3|Overall Study|Adverse Event|8
198139|NCT00356915|668942|P2|Overall Study|Adverse Event|31
198140|NCT00356915|668943|P1|Overall Study|Adverse Event|21
198141|NCT00356915|668941|P3|Overall Study|Physician Decision|0
198142|NCT00356915|668942|P2|Overall Study|Physician Decision|2
198143|NCT00356915|668943|P1|Overall Study|Physician Decision|0
198144|NCT00356915|668941|P3|Overall Study|Administrative Decision|1
198145|NCT00356915|668942|P2|Overall Study|Administrative Decision|0
198146|NCT00356915|668943|P1|Overall Study|Administrative Decision|0
198147|NCT00356915|668941|P3|Overall Study|Lost to Follow-up|14
198148|NCT00356915|668942|P2|Overall Study|Lost to Follow-up|34
198149|NCT00356915|668943|P1|Overall Study|Lost to Follow-up|27
198150|NCT00356915|668941|P3|Overall Study|Lack of Efficacy|3
198151|NCT00356915|668942|P2|Overall Study|Lack of Efficacy|0
198152|NCT00356915|668943|P1|Overall Study|Lack of Efficacy|0
198153|NCT00356915|668941|P3|Overall Study|Withdrawal by Subject|10
198154|NCT00356915|668942|P2|Overall Study|Withdrawal by Subject|14
198155|NCT00356915|668943|P1|Overall Study|Withdrawal by Subject|14
198156|NCT00356915|668941|P3|Overall Study|Protocol Violation|2
198157|NCT00356915|668942|P2|Overall Study|Protocol Violation|3
198158|NCT00356915|668943|P1|Overall Study|Protocol Violation|2
198159|NCT00356915|668941|P3|Overall Study|Non compliance|1
198160|NCT00356915|668942|P2|Overall Study|Non compliance|2
198161|NCT00356915|668943|P1|Overall Study|Non compliance|1
198162|NCT00356889|668960|P1|Overall Study|Adverse Event|1
198163|NCT00356889|668960|P1|Overall Study|Protocol Violation|2
198164|NCT00356863|668969|P2|Overall Study|Lost to Follow-up|43
198165|NCT00356863|668970|P1|Overall Study|Lost to Follow-up|76
198166|NCT00356863|668969|P2|Overall Study|Death|32
198167|NCT00356863|668970|P1|Overall Study|Death|16
198168|NCT00356811|668996|P1|Overall Study|Site Closed during Follow-up|2
198169|NCT00356811|668996|P1|Overall Study|Study Is Terminating|3
198170|NCT00356811|668996|P1|Overall Study|Participant Could Not Make a Checkup|1
198171|NCT00356811|668996|P1|Overall Study|Withdrawal by Subject|6
198172|NCT00356811|668996|P1|Overall Study|Lost to Follow-up|2
198173|NCT00356811|668996|P1|Overall Study|Death|35
198174|NCT00356603|669011|P2|Overall Study|Other|3
198175|NCT00356603|669012|P1|Overall Study|Other|6
198176|NCT00356590|669026|P1|Overall Study|Other|52
198177|NCT00356590|669026|P1|Overall Study|Response status|28
198178|NCT00356590|669026|P1|Overall Study|Protocol issues|6
198179|NCT00356590|669026|P1|Overall Study|Completed month 12 only|2
198180|NCT00356590|669026|P1|Overall Study|Withdrawal by Subject|41
198181|NCT00356590|669026|P1|Overall Study|Physician Decision|46
198182|NCT00356590|669026|P1|Overall Study|Lost to Follow-up|35
198183|NCT00356590|669026|P1|Overall Study|Death|10
198184|NCT00356590|669026|P1|Overall Study|Adverse Event|54
198185|NCT00356525|669062|P4|Overall Study|Sponsor Decision|1
198186|NCT00356525|669063|P3|Overall Study|Sponsor Decision|0
198187|NCT00356525|669064|P2|Overall Study|Sponsor Decision|0
198188|NCT00356525|669065|P1|Overall Study|Sponsor Decision|0
198189|NCT00356525|669062|P4|Overall Study|Death|1
198190|NCT00356525|669063|P3|Overall Study|Death|0
198191|NCT00356525|669064|P2|Overall Study|Death|0
198192|NCT00356525|669065|P1|Overall Study|Death|0
198193|NCT00356525|669062|P4|Overall Study|Withdrawal by Subject|3
198194|NCT00356525|669063|P3|Overall Study|Withdrawal by Subject|0
198195|NCT00356525|669064|P2|Overall Study|Withdrawal by Subject|1
198196|NCT00356525|669065|P1|Overall Study|Withdrawal by Subject|1
198197|NCT00356525|669062|P4|Overall Study|Protocol Entry Criteria Not Met|0
198198|NCT00356525|669063|P3|Overall Study|Protocol Entry Criteria Not Met|0
198199|NCT00356525|669064|P2|Overall Study|Protocol Entry Criteria Not Met|0
198200|NCT00356525|669065|P1|Overall Study|Protocol Entry Criteria Not Met|1
198201|NCT00356525|669062|P4|Overall Study|Physician Decision|1
198202|NCT00356525|669063|P3|Overall Study|Physician Decision|2
198203|NCT00356525|669064|P2|Overall Study|Physician Decision|2
198204|NCT00356525|669065|P1|Overall Study|Physician Decision|2
198205|NCT00356525|669062|P4|Overall Study|Lost to Follow-up|0
198206|NCT00356525|669063|P3|Overall Study|Lost to Follow-up|0
198207|NCT00356525|669064|P2|Overall Study|Lost to Follow-up|0
198208|NCT00356525|669065|P1|Overall Study|Lost to Follow-up|1
198209|NCT00356525|669062|P4|Overall Study|Adverse Event|1
198210|NCT00356525|669063|P3|Overall Study|Adverse Event|1
198211|NCT00356525|669064|P2|Overall Study|Adverse Event|3
198212|NCT00356525|669065|P1|Overall Study|Adverse Event|1
198213|NCT00356525|669062|P4|Overall Study|Progressive Disease|2
198214|NCT00356525|669063|P3|Overall Study|Progressive Disease|4
198215|NCT00356525|669064|P2|Overall Study|Progressive Disease|5
198216|NCT00356525|669065|P1|Overall Study|Progressive Disease|8
198217|NCT00356421|669106|P2|Overall Study|Not related to study drug|3
198218|NCT00356421|669107|P1|Overall Study|Not related to study drug|5
198219|NCT00356421|669106|P2|Overall Study|Related to study drug|12
198220|NCT00356421|669107|P1|Overall Study|Related to study drug|15
198221|NCT00356421|669106|P2|Overall Study|Withdrawal by Subject|2
198222|NCT00356421|669107|P1|Overall Study|Withdrawal by Subject|9
198223|NCT00356421|669106|P2|Overall Study|Lack of Efficacy|0
198224|NCT00356421|669107|P1|Overall Study|Lack of Efficacy|3
198225|NCT00356408|669147|P1|Overall Study|Other: Subject chose commerical dosing|1
198226|NCT00356408|669147|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
198227|NCT00356408|669147|P1|Overall Study|Other: Azathioprine stopped|1
198228|NCT00356408|669147|P1|Overall Study|Other: Sponsor request|1
198229|NCT00356408|669147|P1|Overall Study|Other: Principal investigator discretion|3
198230|NCT00356408|669147|P1|Overall Study|Withdrawal by Subject|6
198231|NCT00356408|669147|P1|Overall Study|Lost to Follow-up|2
198232|NCT00356408|669147|P1|Overall Study|Lack of Efficacy|36
198233|NCT00356408|669147|P1|Overall Study|Adverse Event|9
198234|NCT00356278|669176|P3|Overall Study|Withdrawal by Subject|19
198235|NCT00356278|669177|P2|Overall Study|Withdrawal by Subject|15
198236|NCT00356278|669178|P1|Overall Study|Withdrawal by Subject|25
198237|NCT00356265|669216|P3|Overall Study|Withdrawal by Subject|1
198238|NCT00356265|669217|P2|Overall Study|Withdrawal by Subject|0
198239|NCT00356265|669218|P1|Overall Study|Withdrawal by Subject|0
198240|NCT00356200|669230|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
198241|NCT00356200|669231|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
198242|NCT00356200|669230|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
198243|NCT00356200|669231|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
198244|NCT00356148|669260|P2|Overall Study|Reoperation within 30 days|1
198245|NCT00356148|669261|P1|Overall Study|Reoperation within 30 days|2
198246|NCT00356135|669272|P3|Overall Study|Subject non-compliance|3
198247|NCT00356135|669273|P2|Overall Study|Subject non-compliance|1
198248|NCT00356135|669274|P1|Overall Study|Subject non-compliance|1
198249|NCT00356135|669272|P3|Overall Study|Physician Decision|1
198250|NCT00356135|669273|P2|Overall Study|Physician Decision|1
198251|NCT00356135|669274|P1|Overall Study|Physician Decision|1
198252|NCT00356135|669272|P3|Overall Study|Lost to Follow-up|1
198253|NCT00356135|669273|P2|Overall Study|Lost to Follow-up|0
198254|NCT00356135|669274|P1|Overall Study|Lost to Follow-up|0
198255|NCT00356135|669272|P3|Overall Study|Adverse Event|0
198256|NCT00356135|669273|P2|Overall Study|Adverse Event|0
198257|NCT00356135|669274|P1|Overall Study|Adverse Event|1
198258|NCT00356135|669272|P3|Overall Study|Protocol Violation|0
198259|NCT00356135|669273|P2|Overall Study|Protocol Violation|0
198260|NCT00356135|669274|P1|Overall Study|Protocol Violation|1
198261|NCT00356122|669296|P1|FOLLOW-UP|Other|2
198262|NCT00356122|669296|P1|FOLLOW-UP|Lost to Follow-up|2
198263|NCT00356122|669296|P1|FOLLOW-UP|Death|37
198264|NCT00356122|669296|P1|TREATMENT|Did not receive study medication|1
198265|NCT00356122|669296|P1|TREATMENT|Other|4
198266|NCT00356122|669296|P1|TREATMENT|Subject's request|4
198267|NCT00356122|669296|P1|TREATMENT|Adverse Event|10
198268|NCT00356122|669296|P1|TREATMENT|Lack of Efficacy|26
198269|NCT00355784|669404|P3|Overall Study|Withdrawal by Subject|2
198270|NCT00355784|669405|P2|Overall Study|Withdrawal by Subject|0
198271|NCT00355784|669406|P1|Overall Study|Withdrawal by Subject|0
198272|NCT00355615|669455|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
198273|NCT00355615|669456|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
198274|NCT00355615|669457|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
198275|NCT00355615|669458|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
198276|NCT00355615|669459|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
198277|NCT00355615|669455|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
198278|NCT00355615|669456|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
198279|NCT00355615|669457|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
198280|NCT00355615|669458|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
198281|NCT00355615|669459|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
198282|NCT00355615|669455|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
198283|NCT00355615|669456|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
198284|NCT00355615|669457|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
198285|NCT00355615|669458|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
198286|NCT00355615|669459|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
198287|NCT00355615|669455|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
198288|NCT00355615|669456|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
198289|NCT00355615|669457|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
198290|NCT00355615|669458|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
198291|NCT00355615|669459|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
198292|NCT00355615|669455|P5|Randomized Double Blind Period|Protocol Violation|0
198293|NCT00355615|669456|P4|Randomized Double Blind Period|Protocol Violation|1
198294|NCT00355615|669457|P3|Randomized Double Blind Period|Protocol Violation|1
198295|NCT00355615|669458|P2|Randomized Double Blind Period|Protocol Violation|0
198296|NCT00355615|669459|P1|Randomized Double Blind Period|Protocol Violation|0
198297|NCT00355615|669455|P5|Randomized Double Blind Period|Adverse Event|0
198298|NCT00355615|669456|P4|Randomized Double Blind Period|Adverse Event|0
198299|NCT00355615|669457|P3|Randomized Double Blind Period|Adverse Event|0
198300|NCT00355615|669458|P2|Randomized Double Blind Period|Adverse Event|0
198301|NCT00355615|669459|P1|Randomized Double Blind Period|Adverse Event|1
198302|NCT00355472|669518|P1|Overall Study|Physician Decision|1
198303|NCT00355368|669564|P2|Overall Study|cardiac arrest prior to intubation|2
198304|NCT00355368|669565|P1|Overall Study|cardiac arrest prior to intubation|2
198305|NCT00355368|669564|P2|Overall Study|Protocol Violation|7
198306|NCT00355368|669565|P1|Overall Study|Protocol Violation|8
198307|NCT00355342|669579|P2|Overall Study|Use of protocol excluded medication|1
198308|NCT00355342|669580|P1|Overall Study|Use of protocol excluded medication|0
198309|NCT00355342|669579|P2|Overall Study|Protocol Violation|1
198310|NCT00355342|669580|P1|Overall Study|Protocol Violation|0
198311|NCT00355342|669579|P2|Overall Study|Study management|1
198312|NCT00355342|669580|P1|Overall Study|Study management|0
198313|NCT00355342|669579|P2|Overall Study|Participant discontinued study drug|1
198314|NCT00355342|669580|P1|Overall Study|Participant discontinued study drug|0
198315|NCT00355342|669579|P2|Overall Study|Participant relocated|1
198316|NCT00355342|669580|P1|Overall Study|Participant relocated|0
198317|NCT00355342|669579|P2|Overall Study|Withdrawal by participant and physician|0
198318|NCT00355342|669580|P1|Overall Study|Withdrawal by participant and physician|1
198319|NCT00355342|669579|P2|Overall Study|Non-compliance with Dexa scans|0
198320|NCT00355342|669580|P1|Overall Study|Non-compliance with Dexa scans|1
198321|NCT00355342|669579|P2|Overall Study|Dispensed wrong study drug kit|0
198322|NCT00355342|669580|P1|Overall Study|Dispensed wrong study drug kit|1
198323|NCT00355342|669579|P2|Overall Study|COPD exacerbation|1
198324|NCT00355342|669580|P1|Overall Study|COPD exacerbation|1
198325|NCT00355342|669579|P2|Overall Study|Use of prohibited medication|0
198326|NCT00355342|669580|P1|Overall Study|Use of prohibited medication|1
198327|NCT00355342|669579|P2|Overall Study|Overcompliant-PL discretion|0
198328|NCT00355342|669580|P1|Overall Study|Overcompliant-PL discretion|1
198329|NCT00355342|669579|P2|Overall Study|Sponsor terminated study|2
198330|NCT00355342|669580|P1|Overall Study|Sponsor terminated study|2
198331|NCT00355342|669579|P2|Overall Study|Withdrawal by Subject|11
198332|NCT00355342|669580|P1|Overall Study|Withdrawal by Subject|14
198333|NCT00355342|669579|P2|Overall Study|Lost to Follow-up|2
198334|NCT00355342|669580|P1|Overall Study|Lost to Follow-up|4
198335|NCT00355342|669579|P2|Overall Study|Adverse Event|15
198336|NCT00355342|669580|P1|Overall Study|Adverse Event|13
198337|NCT00355147|669607|P2|Overall Study|Withdrawal by Subject|12
198338|NCT00355147|669608|P1|Overall Study|Withdrawal by Subject|8
198339|NCT00355147|669607|P2|Overall Study|Lost to Follow-up|8
198340|NCT00355147|669608|P1|Overall Study|Lost to Follow-up|10
198341|NCT00355134|669627|P5|Extension Phase|Protocol Violation|0
198342|NCT00355134|669628|P4|Extension Phase|Protocol Violation|1
198343|NCT00355134|669629|P3|Extension Phase|Protocol Violation|0
198344|NCT00355134|669630|P2|Extension Phase|Protocol Violation|0
198345|NCT00355134|669631|P1|Extension Phase|Protocol Violation|0
198346|NCT00355134|669627|P5|Extension Phase|Abnormal test procedure result(s)|1
198347|NCT00355134|669628|P4|Extension Phase|Abnormal test procedure result(s)|0
198348|NCT00355134|669629|P3|Extension Phase|Abnormal test procedure result(s)|0
198349|NCT00355134|669630|P2|Extension Phase|Abnormal test procedure result(s)|1
198350|NCT00355134|669631|P1|Extension Phase|Abnormal test procedure result(s)|0
198351|NCT00355134|669627|P5|Extension Phase|Unsatisfactory therapeutic effect|1
198352|NCT00355134|669628|P4|Extension Phase|Unsatisfactory therapeutic effect|0
198353|NCT00355134|669629|P3|Extension Phase|Unsatisfactory therapeutic effect|0
198354|NCT00355134|669630|P2|Extension Phase|Unsatisfactory therapeutic effect|4
198355|NCT00355134|669631|P1|Extension Phase|Unsatisfactory therapeutic effect|3
198356|NCT00355134|669627|P5|Extension Phase|Administrative problems|1
198357|NCT00355134|669628|P4|Extension Phase|Administrative problems|1
198358|NCT00355134|669629|P3|Extension Phase|Administrative problems|0
198359|NCT00355134|669630|P2|Extension Phase|Administrative problems|4
198360|NCT00355134|669631|P1|Extension Phase|Administrative problems|2
198361|NCT00355134|669627|P5|Extension Phase|Abnormal laboratory value(s)|2
198362|NCT00355134|669628|P4|Extension Phase|Abnormal laboratory value(s)|2
198363|NCT00355134|669629|P3|Extension Phase|Abnormal laboratory value(s)|0
198364|NCT00355134|669630|P2|Extension Phase|Abnormal laboratory value(s)|2
198365|NCT00355134|669631|P1|Extension Phase|Abnormal laboratory value(s)|4
198366|NCT00355134|669627|P5|Extension Phase|Lost to Follow-up|4
198367|NCT00355134|669628|P4|Extension Phase|Lost to Follow-up|2
198368|NCT00355134|669629|P3|Extension Phase|Lost to Follow-up|0
198369|NCT00355134|669630|P2|Extension Phase|Lost to Follow-up|6
198370|NCT00355134|669631|P1|Extension Phase|Lost to Follow-up|2
198371|NCT00355134|669627|P5|Extension Phase|Adverse Event|5
198372|NCT00355134|669628|P4|Extension Phase|Adverse Event|3
198373|NCT00355134|669629|P3|Extension Phase|Adverse Event|0
198374|NCT00355134|669630|P2|Extension Phase|Adverse Event|9
198375|NCT00355134|669631|P1|Extension Phase|Adverse Event|13
198376|NCT00355134|669627|P5|Extension Phase|Withdrawal by Subject|5
198377|NCT00355134|669628|P4|Extension Phase|Withdrawal by Subject|7
198378|NCT00355134|669629|P3|Extension Phase|Withdrawal by Subject|0
198379|NCT00355134|669630|P2|Extension Phase|Withdrawal by Subject|11
198380|NCT00355134|669631|P1|Extension Phase|Withdrawal by Subject|7
198381|NCT00355134|669627|P5|Core Phase|Condition no longer requires study drug|0
198382|NCT00355134|669628|P4|Core Phase|Condition no longer requires study drug|0
198383|NCT00355134|669629|P3|Core Phase|Condition no longer requires study drug|1
198384|NCT00355134|669630|P2|Core Phase|Condition no longer requires study drug|0
198385|NCT00355134|669631|P1|Core Phase|Condition no longer requires study drug|1
198386|NCT00355134|669627|P5|Core Phase|Abnormal test procedure result(s)|0
198387|NCT00355134|669628|P4|Core Phase|Abnormal test procedure result(s)|0
198388|NCT00355134|669629|P3|Core Phase|Abnormal test procedure result(s)|1
198389|NCT00355134|669630|P2|Core Phase|Abnormal test procedure result(s)|2
198390|NCT00355134|669631|P1|Core Phase|Abnormal test procedure result(s)|1
198391|NCT00355134|669627|P5|Core Phase|Protocol Violation|0
198392|NCT00355134|669628|P4|Core Phase|Protocol Violation|0
198393|NCT00355134|669629|P3|Core Phase|Protocol Violation|2
198394|NCT00355134|669630|P2|Core Phase|Protocol Violation|2
198395|NCT00355134|669631|P1|Core Phase|Protocol Violation|3
198396|NCT00355134|669627|P5|Core Phase|Administrative problems|0
198397|NCT00355134|669628|P4|Core Phase|Administrative problems|0
198398|NCT00355134|669629|P3|Core Phase|Administrative problems|5
198399|NCT00355134|669630|P2|Core Phase|Administrative problems|3
198400|NCT00355134|669631|P1|Core Phase|Administrative problems|5
198401|NCT00355134|669627|P5|Core Phase|Unsatisfactory therapeutic effect|0
198402|NCT00355134|669628|P4|Core Phase|Unsatisfactory therapeutic effect|0
198403|NCT00355134|669629|P3|Core Phase|Unsatisfactory therapeutic effect|17
198404|NCT00355134|669630|P2|Core Phase|Unsatisfactory therapeutic effect|6
198405|NCT00355134|669631|P1|Core Phase|Unsatisfactory therapeutic effect|10
198406|NCT00355134|669627|P5|Core Phase|Abnormal laboratory value(s)|0
198407|NCT00355134|669628|P4|Core Phase|Abnormal laboratory value(s)|0
198408|NCT00355134|669629|P3|Core Phase|Abnormal laboratory value(s)|2
198409|NCT00355134|669630|P2|Core Phase|Abnormal laboratory value(s)|14
198410|NCT00355134|669631|P1|Core Phase|Abnormal laboratory value(s)|19
198411|NCT00355134|669627|P5|Core Phase|Lost to Follow-up|0
198412|NCT00355134|669628|P4|Core Phase|Lost to Follow-up|0
198413|NCT00355134|669629|P3|Core Phase|Lost to Follow-up|21
198414|NCT00355134|669630|P2|Core Phase|Lost to Follow-up|13
198415|NCT00355134|669631|P1|Core Phase|Lost to Follow-up|17
198416|NCT00355134|669627|P5|Core Phase|Adverse Event|0
198417|NCT00355134|669628|P4|Core Phase|Adverse Event|0
198418|NCT00355134|669629|P3|Core Phase|Adverse Event|16
198419|NCT00355134|669630|P2|Core Phase|Adverse Event|22
198420|NCT00355134|669631|P1|Core Phase|Adverse Event|28
198421|NCT00355134|669627|P5|Core Phase|Withdrawal by Subject|0
198422|NCT00355134|669628|P4|Core Phase|Withdrawal by Subject|0
198423|NCT00355134|669629|P3|Core Phase|Withdrawal by Subject|35
198424|NCT00355134|669630|P2|Core Phase|Withdrawal by Subject|24
198425|NCT00355134|669631|P1|Core Phase|Withdrawal by Subject|35
198426|NCT00355121|669674|P3|Overall Study|Serious adverse events|0
198427|NCT00355121|669675|P2|Overall Study|Serious adverse events|2
198428|NCT00355121|669676|P1|Overall Study|Serious adverse events|0
198429|NCT00355121|669674|P3|Overall Study|Withdrawal by Subject|2
198430|NCT00355121|669675|P2|Overall Study|Withdrawal by Subject|10
198431|NCT00355121|669676|P1|Overall Study|Withdrawal by Subject|9
198432|NCT00355121|669674|P3|Overall Study|Lost to Follow-up|1
198433|NCT00355121|669675|P2|Overall Study|Lost to Follow-up|7
198434|NCT00355121|669676|P1|Overall Study|Lost to Follow-up|4
198435|NCT00355121|669674|P3|Overall Study|Protocol Violation|1
198436|NCT00355121|669675|P2|Overall Study|Protocol Violation|9
198437|NCT00355121|669676|P1|Overall Study|Protocol Violation|7
198438|NCT00355121|669674|P3|Overall Study|Adverse Event|0
198439|NCT00355121|669675|P2|Overall Study|Adverse Event|1
198440|NCT00355121|669676|P1|Overall Study|Adverse Event|0
198441|NCT00355121|669674|P3|Overall Study|Did not receive study vaccine|1
198442|NCT00355121|669675|P2|Overall Study|Did not receive study vaccine|0
198443|NCT00355121|669676|P1|Overall Study|Did not receive study vaccine|1
198444|NCT00355082|669707|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
198445|NCT00355082|669708|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
198446|NCT00355082|669709|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
198447|NCT00355082|669707|P3|Continuation Phase|Scheduling Error|0
198448|NCT00355082|669708|P2|Continuation Phase|Scheduling Error|0
198449|NCT00355082|669709|P1|Continuation Phase|Scheduling Error|1
198450|NCT00355082|669707|P3|Continuation Phase|Site Closed by Sponsor|0
198451|NCT00355082|669708|P2|Continuation Phase|Site Closed by Sponsor|0
198452|NCT00355082|669709|P1|Continuation Phase|Site Closed by Sponsor|8
198453|NCT00355082|669707|P3|Continuation Phase|Lack of Efficacy|0
198454|NCT00355082|669708|P2|Continuation Phase|Lack of Efficacy|0
198455|NCT00355082|669709|P1|Continuation Phase|Lack of Efficacy|5
198456|NCT00355082|669707|P3|Continuation Phase|Withdrawal by Subject|0
198457|NCT00355082|669708|P2|Continuation Phase|Withdrawal by Subject|0
198458|NCT00355082|669709|P1|Continuation Phase|Withdrawal by Subject|4
198459|NCT00355082|669707|P3|Continuation Phase|Protocol Violation|1
198460|NCT00355082|669708|P2|Continuation Phase|Protocol Violation|0
198461|NCT00355082|669709|P1|Continuation Phase|Protocol Violation|1
198462|NCT00355082|669707|P3|Continuation Phase|Lost to Follow-up|1
198463|NCT00355082|669708|P2|Continuation Phase|Lost to Follow-up|0
198464|NCT00355082|669709|P1|Continuation Phase|Lost to Follow-up|2
198465|NCT00355082|669707|P3|Continuation Phase|Adverse Event|1
198466|NCT00355082|669708|P2|Continuation Phase|Adverse Event|0
198467|NCT00355082|669709|P1|Continuation Phase|Adverse Event|2
198468|NCT00355082|669707|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
198469|NCT00355082|669708|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
198470|NCT00355082|669709|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
198471|NCT00355082|669707|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
198472|NCT00355082|669708|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
198473|NCT00355082|669709|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
198474|NCT00355082|669707|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
198475|NCT00355082|669708|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
198476|NCT00355082|669709|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
198477|NCT00355082|669707|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
198478|NCT00355082|669708|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
198479|NCT00355082|669709|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
198480|NCT00355082|669707|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
198481|NCT00355082|669708|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
198482|NCT00355082|669709|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
198483|NCT00355082|669707|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
198484|NCT00355082|669708|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
198485|NCT00355082|669709|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
198486|NCT00355030|669731|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
198487|NCT00355030|669732|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
198488|NCT00355030|669731|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
198489|NCT00355030|669732|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
198490|NCT00355030|669731|P2|Study Period 1 Treatment|Other|6
198491|NCT00355030|669732|P1|Study Period 1 Treatment|Other|2
198492|NCT00355030|669731|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
198493|NCT00355030|669732|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
198494|NCT00355030|669731|P2|Study Period 1 Treatment|Sponsor Decision|32
198495|NCT00355030|669732|P1|Study Period 1 Treatment|Sponsor Decision|34
198496|NCT00355030|669731|P2|Study Period 1 Treatment|Physician Decision|1
198497|NCT00355030|669732|P1|Study Period 1 Treatment|Physician Decision|0
198498|NCT00355030|669731|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
198499|NCT00355030|669732|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
198500|NCT00355030|669731|P2|Study Period 1 Treatment|Withdrawal by Subject|1
198501|NCT00355030|669732|P1|Study Period 1 Treatment|Withdrawal by Subject|4
198502|NCT00355030|669731|P2|Study Period 1 Treatment|Lost to Follow-up|0
198503|NCT00355030|669732|P1|Study Period 1 Treatment|Lost to Follow-up|3
198504|NCT00355030|669731|P2|Study Period 1 Treatment|Adverse Event|1
198505|NCT00355030|669732|P1|Study Period 1 Treatment|Adverse Event|1
198506|NCT00354835|669771|P2|Overall Study|Refusal of further therapy|8
198507|NCT00354835|669772|P1|Overall Study|Refusal of further therapy|3
198508|NCT00354835|669771|P2|Overall Study|Adverse Event|0
198509|NCT00354835|669772|P1|Overall Study|Adverse Event|6
198510|NCT00354835|669771|P2|Overall Study|Disease progression or relapse|22
198511|NCT00354835|669772|P1|Overall Study|Disease progression or relapse|15
198512|NCT00354835|669771|P2|Overall Study|Ineligible|16
198513|NCT00354835|669772|P1|Overall Study|Ineligible|17
198514|NCT00354835|669771|P2|Overall Study|Withdrawal by Subject|1
198515|NCT00354835|669772|P1|Overall Study|Withdrawal by Subject|2
198516|NCT00354835|669771|P2|Overall Study|Physician Decision|13
198517|NCT00354835|669772|P1|Overall Study|Physician Decision|8
198518|NCT00354835|669771|P2|Overall Study|Death|1
198519|NCT00354835|669772|P1|Overall Study|Death|1
198520|NCT00354744|669811|P1|Overall Study|Withdrawal by Subject|14
198521|NCT00354744|669811|P1|Overall Study|Physician Decision|11
198522|NCT00354744|669811|P1|Overall Study|Lost to Follow-up|2
198523|NCT00354744|669811|P1|Overall Study|Lack of Efficacy|11
198524|NCT00354744|669811|P1|Overall Study|Death|2
198525|NCT00354744|669811|P1|Overall Study|Adverse Event|2
198526|NCT00354679|669816|P1|Overall Study|Patient Not Treated|1
198527|NCT00354614|669825|P1|Overall Study|Lack of Efficacy|28
198528|NCT00354601|669829|P1|Overall Study|progression|1
198529|NCT00354601|669829|P1|Overall Study|Protocol Violation|1
198530|NCT00354432|669849|P4|Overall Study|Off/Toxicity|5
198531|NCT00354432|669850|P3|Overall Study|Off/Toxicity|5
198532|NCT00354432|669851|P2|Overall Study|Off/Toxicity|7
198533|NCT00354432|669852|P1|Overall Study|Off/Toxicity|3
198534|NCT00354432|669849|P4|Overall Study|Adverse Event|5
198535|NCT00354432|669850|P3|Overall Study|Adverse Event|5
198536|NCT00354432|669851|P2|Overall Study|Adverse Event|1
198537|NCT00354432|669852|P1|Overall Study|Adverse Event|3
198538|NCT00354341|669868|P2|Overall Study|Other|2
198539|NCT00354341|669869|P1|Overall Study|Other|1
198540|NCT00354341|669868|P2|Overall Study|Failure to return|1
198541|NCT00354341|669869|P1|Overall Study|Failure to return|0
198542|NCT00354341|669868|P2|Overall Study|Refused treatment|2
198543|NCT00354341|669869|P1|Overall Study|Refused treatment|1
198544|NCT00354341|669868|P2|Overall Study|Death|2
198545|NCT00354341|669869|P1|Overall Study|Death|0
198546|NCT00354341|669868|P2|Overall Study|Adverse Event|0
198547|NCT00354341|669869|P1|Overall Study|Adverse Event|1
198548|NCT00354172|669885|P1|Overall Study|Did not receive transplant|1
198549|NCT00354159|669905|P2|Long-term Follow-up|Study Closed|34
198550|NCT00354159|669906|P1|Long-term Follow-up|Study Closed|29
198551|NCT00354159|669905|P2|Long-term Follow-up|Death|11
198552|NCT00354159|669906|P1|Long-term Follow-up|Death|14
198553|NCT00354159|669905|P2|Long-term Follow-up|Lost to Follow-up|0
198554|NCT00354159|669906|P1|Long-term Follow-up|Lost to Follow-up|1
198555|NCT00354159|669905|P2|Long-term Follow-up|Physician Decision|122
198556|NCT00354159|669906|P1|Long-term Follow-up|Physician Decision|127
198557|NCT00354159|669905|P2|Long-term Follow-up|Withdrawal by Subject|9
198558|NCT00354159|669906|P1|Long-term Follow-up|Withdrawal by Subject|9
198559|NCT00354159|669905|P2|Randomized Study Period|Death|9
198560|NCT00354159|669906|P1|Randomized Study Period|Death|7
198561|NCT00354159|669905|P2|Randomized Study Period|Lost to Follow-up|0
198562|NCT00354159|669906|P1|Randomized Study Period|Lost to Follow-up|4
198563|NCT00354159|669905|P2|Randomized Study Period|Physician Decision|10
198564|NCT00354159|669906|P1|Randomized Study Period|Physician Decision|6
198565|NCT00354159|669905|P2|Randomized Study Period|Withdrawal by Subject|3
198566|NCT00354159|669906|P1|Randomized Study Period|Withdrawal by Subject|5
198567|NCT00354107|669949|P1|Overall Study|Withdrawal by Subject|1
198568|NCT00354107|669949|P1|Overall Study|Physician Decision|2
198569|NCT00354107|669949|P1|Overall Study|Adverse Event|2
198570|NCT00354029|669959|P2|Overall Study|Protocol Violation|2
198571|NCT00354029|669960|P1|Overall Study|Protocol Violation|4
198572|NCT00353873|669972|P2|Overall Study|Withdrawal by Subject|1
198573|NCT00353873|669973|P1|Overall Study|Withdrawal by Subject|1
198574|NCT00353873|669972|P2|Overall Study|Physician Decision|0
198575|NCT00353873|669973|P1|Overall Study|Physician Decision|2
198576|NCT00353873|669972|P2|Overall Study|Adverse Event|0
198577|NCT00353873|669973|P1|Overall Study|Adverse Event|1
198578|NCT00353873|669972|P2|Overall Study|Exacerbation|0
198579|NCT00353873|669973|P1|Overall Study|Exacerbation|1
198580|NCT00353873|669972|P2|Overall Study|Protocol Violation|2
198581|NCT00353873|669973|P1|Overall Study|Protocol Violation|1
198582|NCT00353704|670002|P2|Overall Study|Protocol Violation|1
198583|NCT00353704|670003|P1|Overall Study|Protocol Violation|3
198584|NCT00353496|670038|P2|Overall Study|Not otherwise specified|2
198585|NCT00353496|670039|P1|Overall Study|Not otherwise specified|4
198586|NCT00353496|670038|P2|Overall Study|Physician Decision|9
198587|NCT00353496|670039|P1|Overall Study|Physician Decision|6
198588|NCT00353496|670038|P2|Overall Study|Withdrawal by Subject|4
198589|NCT00353496|670039|P1|Overall Study|Withdrawal by Subject|3
198590|NCT00353496|670038|P2|Overall Study|Protocol Violation|2
198591|NCT00353496|670039|P1|Overall Study|Protocol Violation|2
198592|NCT00353496|670038|P2|Overall Study|Adverse Event|0
198593|NCT00353496|670039|P1|Overall Study|Adverse Event|1
198594|NCT00353366|670092|P1|Overall Study|Other|135
198595|NCT00353366|670092|P1|Overall Study|Adverse Event|8
198596|NCT00353262|670113|P1|Overall Study|Break from Chemotherapy|1
198597|NCT00353262|670113|P1|Overall Study|Surgery|4
198598|NCT00353262|670113|P1|Overall Study|Progression|1
198599|NCT00353262|670113|P1|Overall Study|Insufficient Therapeutic Response|13
198600|NCT00353262|670113|P1|Overall Study|Withdrawal by Subject|2
198601|NCT00353262|670113|P1|Overall Study|Adverse Event|8
198602|NCT00352846|670163|P2|Overall Study|Death|1
198603|NCT00352846|670164|P1|Overall Study|Death|0
198604|NCT00352846|670163|P2|Overall Study|Non-compliance|0
198605|NCT00352846|670164|P1|Overall Study|Non-compliance|2
198606|NCT00352846|670163|P2|Overall Study|Ineligible|2
198607|NCT00352846|670164|P1|Overall Study|Ineligible|3
198608|NCT00352846|670163|P2|Overall Study|Withdrawal by Subject|8
198609|NCT00352846|670164|P1|Overall Study|Withdrawal by Subject|3
198610|NCT00352846|670163|P2|Overall Study|Disease progression|2
198611|NCT00352846|670164|P1|Overall Study|Disease progression|0
198612|NCT00352755|670175|P1|Overall Study|Adverse Event|1
198613|NCT00352755|670175|P1|Overall Study|Physician Decision|1
198614|NCT00352690|670185|P2|Overall Study|Determined to be ineligible|0
198615|NCT00352690|670186|P1|Overall Study|Determined to be ineligible|2
198616|NCT00352664|670206|P2|Overall Study|Withdrawal by Subject|0
198617|NCT00352664|670207|P1|Overall Study|Withdrawal by Subject|7
198618|NCT00352534|670224|P7|Final Risk Group Assignment|Death|0
198619|NCT00352534|670225|P6|Final Risk Group Assignment|Death|2
198620|NCT00352534|670226|P5|Final Risk Group Assignment|Death|0
198621|NCT00352534|670227|P4|Final Risk Group Assignment|Death|0
198622|NCT00352534|670228|P3|Final Risk Group Assignment|Death|0
198623|NCT00352534|670229|P2|Final Risk Group Assignment|Death|0
198624|NCT00352534|670230|P1|Final Risk Group Assignment|Death|0
198625|NCT00352534|670224|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
198626|NCT00352534|670225|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
198627|NCT00352534|670226|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
198628|NCT00352534|670227|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
198629|NCT00352534|670228|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
198630|NCT00352534|670229|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
198631|NCT00352534|670230|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
198632|NCT00352534|670224|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
198633|NCT00352534|670225|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
198634|NCT00352534|670226|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
198635|NCT00352534|670227|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
198636|NCT00352534|670228|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
198637|NCT00352534|670229|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
198638|NCT00352534|670230|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
198639|NCT00352534|670224|P7|Final Risk Group Assignment|Ineligible|0
198640|NCT00352534|670225|P6|Final Risk Group Assignment|Ineligible|13
198641|NCT00352534|670226|P5|Final Risk Group Assignment|Ineligible|0
198642|NCT00352534|670227|P4|Final Risk Group Assignment|Ineligible|1
198643|NCT00352534|670228|P3|Final Risk Group Assignment|Ineligible|3
198644|NCT00352534|670229|P2|Final Risk Group Assignment|Ineligible|0
198645|NCT00352534|670230|P1|Final Risk Group Assignment|Ineligible|0
198646|NCT00352534|670224|P7|Final Risk Group Assignment|Withdrawal by Subject|0
198647|NCT00352534|670225|P6|Final Risk Group Assignment|Withdrawal by Subject|3
198648|NCT00352534|670226|P5|Final Risk Group Assignment|Withdrawal by Subject|0
198649|NCT00352534|670227|P4|Final Risk Group Assignment|Withdrawal by Subject|0
198650|NCT00352534|670228|P3|Final Risk Group Assignment|Withdrawal by Subject|0
198651|NCT00352534|670229|P2|Final Risk Group Assignment|Withdrawal by Subject|0
198652|NCT00352534|670230|P1|Final Risk Group Assignment|Withdrawal by Subject|0
198653|NCT00352534|670224|P7|Final Risk Group Assignment|Physician Decision|0
198654|NCT00352534|670225|P6|Final Risk Group Assignment|Physician Decision|8
198655|NCT00352534|670226|P5|Final Risk Group Assignment|Physician Decision|0
198656|NCT00352534|670227|P4|Final Risk Group Assignment|Physician Decision|0
198657|NCT00352534|670228|P3|Final Risk Group Assignment|Physician Decision|0
198658|NCT00352534|670229|P2|Final Risk Group Assignment|Physician Decision|0
198659|NCT00352534|670230|P1|Final Risk Group Assignment|Physician Decision|0
198660|NCT00352534|670224|P7|Final Risk Group Assignment|Lack of Efficacy|0
198661|NCT00352534|670225|P6|Final Risk Group Assignment|Lack of Efficacy|19
198662|NCT00352534|670226|P5|Final Risk Group Assignment|Lack of Efficacy|1
198663|NCT00352534|670227|P4|Final Risk Group Assignment|Lack of Efficacy|2
198664|NCT00352534|670228|P3|Final Risk Group Assignment|Lack of Efficacy|0
198665|NCT00352534|670229|P2|Final Risk Group Assignment|Lack of Efficacy|0
198666|NCT00352534|670230|P1|Final Risk Group Assignment|Lack of Efficacy|0
198667|NCT00352534|670224|P7|Initial Staging|Ineligible|0
198668|NCT00352534|670225|P6|Initial Staging|Ineligible|0
198669|NCT00352534|670226|P5|Initial Staging|Ineligible|0
198670|NCT00352534|670227|P4|Initial Staging|Ineligible|0
198671|NCT00352534|670228|P3|Initial Staging|Ineligible|0
198672|NCT00352534|670229|P2|Initial Staging|Ineligible|9
198673|NCT00352534|670230|P1|Initial Staging|Ineligible|8
198674|NCT00352417|670247|P2|Overall Study|Schedule Change|1
198675|NCT00352417|670248|P1|Overall Study|Schedule Change|2
198676|NCT00352417|670247|P2|Overall Study|Lost to Follow-up|0
198677|NCT00352417|670248|P1|Overall Study|Lost to Follow-up|1
198678|NCT00352417|670247|P2|Overall Study|Withdrawal by Subject|2
198679|NCT00352417|670248|P1|Overall Study|Withdrawal by Subject|1
198680|NCT00352417|670247|P2|Overall Study|Protocol Violation|2
198681|NCT00352417|670248|P1|Overall Study|Protocol Violation|0
198682|NCT00352417|670247|P2|Overall Study|Adverse Event|0
198683|NCT00352417|670248|P1|Overall Study|Adverse Event|1
198684|NCT00352365|670262|P1|Maintenance Therapy|Not eligible|4
198685|NCT00352365|670262|P1|Maintenance Therapy|Not protocol specified|3
198686|NCT00352365|670262|P1|Maintenance Therapy|Death|2
198687|NCT00352365|670262|P1|Maintenance Therapy|Progression/Relapse|3
198688|NCT00352365|670262|P1|Induction Therapy|Death before starting protocol therapy|1
198689|NCT00352365|670262|P1|Induction Therapy|Not eligible|3
198690|NCT00352365|670262|P1|Induction Therapy|Not protocol specified|1
198691|NCT00352365|670262|P1|Induction Therapy|Death|7
198692|NCT00352365|670262|P1|Induction Therapy|Progression/Relapse|8
198693|NCT00352365|670262|P1|Induction Therapy|Adverse Event|7
198694|NCT00352118|670272|P1|Overall Study|Physician Decision|4
198695|NCT00352105|670282|P1|Overall Study|Protocol Violation|2
198696|NCT00352105|670282|P1|Overall Study|Adverse Event|19
198697|NCT00352105|670282|P1|Overall Study|Lack of Efficacy|9
198698|NCT00352105|670282|P1|Overall Study|Withdrawal by Subject|5
198699|NCT00352105|670282|P1|Overall Study|Death|5
198700|NCT00352053|670293|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
198701|NCT00352053|670294|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
198702|NCT00352053|670293|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
198703|NCT00352053|670294|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
198704|NCT00352053|670293|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
198705|NCT00352053|670294|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
198706|NCT00352053|670293|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
198707|NCT00352053|670294|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
198708|NCT00352053|670293|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
198709|NCT00352053|670294|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
198710|NCT00352053|670293|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
198711|NCT00352053|670294|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
198712|NCT00352053|670293|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
198713|NCT00352053|670294|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
198714|NCT00352053|670293|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
198715|NCT00352053|670294|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
198716|NCT00352053|670293|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
198717|NCT00352053|670294|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
198718|NCT00352053|670293|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
198719|NCT00352053|670294|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
198720|NCT00352053|670293|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
198721|NCT00352053|670294|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
198722|NCT00352053|670293|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
198723|NCT00352053|670294|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
198724|NCT00352053|670293|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
198725|NCT00352053|670294|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
198726|NCT00352027|670461|P1|Overall Study|Progressive disease|3
198727|NCT00351819|670749|P2|Overall Study|Enrolled in another trial|1
198728|NCT00351819|670750|P1|Overall Study|Enrolled in another trial|0
198729|NCT00351819|670749|P2|Overall Study|Incarcerated|1
198730|NCT00351819|670750|P1|Overall Study|Incarcerated|0
198731|NCT00351819|670749|P2|Overall Study|Non-compliance|1
198732|NCT00351819|670750|P1|Overall Study|Non-compliance|0
198733|NCT00351819|670749|P2|Overall Study|Unprofessional behavior|0
198734|NCT00351819|670750|P1|Overall Study|Unprofessional behavior|1
198735|NCT00351819|670749|P2|Overall Study|Traumatic ankle fracture|0
198736|NCT00351819|670750|P1|Overall Study|Traumatic ankle fracture|1
198737|NCT00351819|670749|P2|Overall Study|Elevated PSA|1
198738|NCT00351819|670750|P1|Overall Study|Elevated PSA|1
198739|NCT00351819|670749|P2|Overall Study|Withdrawal by Subject|4
198740|NCT00351819|670750|P1|Overall Study|Withdrawal by Subject|0
198741|NCT00351819|670749|P2|Overall Study|Lost to Follow-up|4
198742|NCT00351819|670750|P1|Overall Study|Lost to Follow-up|4
198743|NCT00351533|670821|P2|Overall Study|Withdrawal by Subject|1
198744|NCT00351533|670822|P1|Overall Study|Withdrawal by Subject|0
198745|NCT00351533|670821|P2|Overall Study|Physician Decision|1
198746|NCT00351533|670822|P1|Overall Study|Physician Decision|0
198747|NCT00351533|670821|P2|Overall Study|Lost to Follow-up|3
198748|NCT00351533|670822|P1|Overall Study|Lost to Follow-up|1
198749|NCT00351533|670821|P2|Overall Study|Extubated before first BAL|0
198750|NCT00351533|670822|P1|Overall Study|Extubated before first BAL|1
198751|NCT00351468|670882|P1|Overall Study|Protocol Violation|3
198752|NCT00351468|670882|P1|Overall Study|Lost to Follow-up|4
198753|NCT00351468|670882|P1|Overall Study|Non-compliance|8
198754|NCT00351468|670882|P1|Overall Study|Lack of Efficacy|32
198755|NCT00351468|670882|P1|Overall Study|Various -follow up w clinical team|39
198756|NCT00351468|670882|P1|Overall Study|Withdrawal by Subject|39
198757|NCT00351468|670882|P1|Overall Study|Adverse Event|42
198758|NCT00351377|670906|P1|Overall Study|Unsatisfactory therapeutic effect|1
198759|NCT00351377|670906|P1|Overall Study|Death|1
198760|NCT00351377|670906|P1|Overall Study|Adverse Event|5
198761|NCT00351351|670920|P2|Overall Study|surgical access pbs; device issues|4
198762|NCT00351351|670921|P1|Overall Study|surgical access pbs; device issues|9
198763|NCT00351273|670947|P3|Overall Study|Lost to Follow-up|5
198764|NCT00351273|670948|P2|Overall Study|Lost to Follow-up|2
198765|NCT00351273|670949|P1|Overall Study|Lost to Follow-up|1
198766|NCT00350870|670977|P4|Overall Study|Physician Decision|1
198767|NCT00350870|670978|P3|Overall Study|Physician Decision|1
198768|NCT00350870|670979|P2|Overall Study|Physician Decision|0
198769|NCT00350870|670980|P1|Overall Study|Physician Decision|1
198770|NCT00350870|670977|P4|Overall Study|Withdrawal by Subject|14
198771|NCT00350870|670978|P3|Overall Study|Withdrawal by Subject|15
198772|NCT00350870|670979|P2|Overall Study|Withdrawal by Subject|17
198773|NCT00350870|670980|P1|Overall Study|Withdrawal by Subject|21
198774|NCT00350844|670994|P1|Overall Study|Lost to Follow-up|1
198775|NCT00350792|670998|P1|Overall Study|Lack of Efficacy|11
198776|NCT00350792|670998|P1|Overall Study|Physician Decision|2
198777|NCT00350792|670998|P1|Overall Study|Withdrawal by Subject|4
198778|NCT00350792|670998|P1|Overall Study|Protocol Violation|1
198779|NCT00350792|670998|P1|Overall Study|Death Not Study Drug Related|2
198780|NCT00350792|670998|P1|Overall Study|Death from Study Drug Toxicity|1
198781|NCT00350792|670998|P1|Overall Study|Death from Study Disease|1
198782|NCT00350792|670998|P1|Overall Study|Adverse Event|11
198783|NCT00350779|671008|P2|Overall Study|Non-compliance with study procedures|1
198784|NCT00350779|671009|P1|Overall Study|Non-compliance with study procedures|0
198785|NCT00350779|671008|P2|Overall Study|Patient Moved|1
198786|NCT00350779|671009|P1|Overall Study|Patient Moved|2
198787|NCT00350779|671008|P2|Overall Study|Withdrawal by Subject|8
198788|NCT00350779|671009|P1|Overall Study|Withdrawal by Subject|9
198789|NCT00350779|671008|P2|Overall Study|Protocol Violation|1
198790|NCT00350779|671009|P1|Overall Study|Protocol Violation|3
198791|NCT00350779|671008|P2|Overall Study|Physician Decision|4
198792|NCT00350779|671009|P1|Overall Study|Physician Decision|2
198793|NCT00350779|671008|P2|Overall Study|Lost to Follow-up|0
198794|NCT00350779|671009|P1|Overall Study|Lost to Follow-up|2
198795|NCT00350779|671008|P2|Overall Study|Lack of Efficacy|4
198796|NCT00350779|671009|P1|Overall Study|Lack of Efficacy|0
198797|NCT00350779|671008|P2|Overall Study|Adverse Event|2
198798|NCT00350779|671009|P1|Overall Study|Adverse Event|4
198799|NCT00350727|671030|P3|Phase II|Enrolled in Rollover Study|1
198800|NCT00350727|671031|P2|Phase II|Enrolled in Rollover Study|0
198801|NCT00350727|671032|P1|Phase II|Enrolled in Rollover Study|0
198802|NCT00350727|671030|P3|Phase II|Sponsor Terminated Study|1
198803|NCT00350727|671031|P2|Phase II|Sponsor Terminated Study|0
198804|NCT00350727|671032|P1|Phase II|Sponsor Terminated Study|0
198805|NCT00350727|671030|P3|Phase II|Death|2
198806|NCT00350727|671031|P2|Phase II|Death|0
198807|NCT00350727|671032|P1|Phase II|Death|0
198808|NCT00350727|671030|P3|Phase II|Adverse Event|1
198809|NCT00350727|671031|P2|Phase II|Adverse Event|1
198810|NCT00350727|671032|P1|Phase II|Adverse Event|0
198811|NCT00350727|671030|P3|Phase II|Withdrawal by Subject|1
198812|NCT00350727|671031|P2|Phase II|Withdrawal by Subject|2
198813|NCT00350727|671032|P1|Phase II|Withdrawal by Subject|0
198814|NCT00350727|671030|P3|Phase II|Clinical Deterioration|0
198815|NCT00350727|671031|P2|Phase II|Clinical Deterioration|1
198816|NCT00350727|671032|P1|Phase II|Clinical Deterioration|0
198817|NCT00350727|671030|P3|Phase II|Disease Progression|16
198818|NCT00350727|671031|P2|Phase II|Disease Progression|15
198819|NCT00350727|671032|P1|Phase II|Disease Progression|0
198820|NCT00350727|671030|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
198821|NCT00350727|671031|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
198822|NCT00350727|671032|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
198823|NCT00350727|671030|P3|Phase I: Dose Escalation|Physician Decision|0
198824|NCT00350727|671031|P2|Phase I: Dose Escalation|Physician Decision|0
198825|NCT00350727|671032|P1|Phase I: Dose Escalation|Physician Decision|1
198826|NCT00350727|671030|P3|Phase I: Dose Escalation|Death|0
198827|NCT00350727|671031|P2|Phase I: Dose Escalation|Death|0
198828|NCT00350727|671032|P1|Phase I: Dose Escalation|Death|1
198829|NCT00350727|671030|P3|Phase I: Dose Escalation|Lack of Efficacy|0
198830|NCT00350727|671031|P2|Phase I: Dose Escalation|Lack of Efficacy|0
198831|NCT00350727|671032|P1|Phase I: Dose Escalation|Lack of Efficacy|25
198832|NCT00350727|671030|P3|Phase I: Dose Escalation|Adverse Event|0
198833|NCT00350727|671031|P2|Phase I: Dose Escalation|Adverse Event|0
198834|NCT00350727|671032|P1|Phase I: Dose Escalation|Adverse Event|4
198835|NCT00350636|671176|P2|Overall Study|Other|2
198836|NCT00350636|671177|P1|Overall Study|Other|1
198837|NCT00350636|671176|P2|Overall Study|Physician Decision|2
198838|NCT00350636|671177|P1|Overall Study|Physician Decision|0
198839|NCT00350636|671176|P2|Overall Study|Lost to Follow-up|8
198840|NCT00350636|671177|P1|Overall Study|Lost to Follow-up|9
198841|NCT00350636|671176|P2|Overall Study|Withdrawal by Subject|17
198842|NCT00350636|671177|P1|Overall Study|Withdrawal by Subject|13
198843|NCT00350636|671176|P2|Overall Study|Protocol Violation|3
198844|NCT00350636|671177|P1|Overall Study|Protocol Violation|1
198845|NCT00350636|671176|P2|Overall Study|Adverse Event|13
198846|NCT00350636|671177|P1|Overall Study|Adverse Event|19
198847|NCT00350623|671196|P3|Overall Study|patient traveling outside the country|1
198848|NCT00350623|671197|P2|Overall Study|patient traveling outside the country|0
198849|NCT00350623|671198|P1|Overall Study|patient traveling outside the country|0
198850|NCT00350623|671196|P3|Overall Study|Withdrawal by Subject|1
198851|NCT00350623|671197|P2|Overall Study|Withdrawal by Subject|1
198852|NCT00350623|671198|P1|Overall Study|Withdrawal by Subject|0
198853|NCT00350623|671196|P3|Overall Study|Lost to Follow-up|4
198854|NCT00350623|671197|P2|Overall Study|Lost to Follow-up|3
198855|NCT00350623|671198|P1|Overall Study|Lost to Follow-up|8
198856|NCT00350545|671206|P1|Overall Study|Withdrawal by Subject|2
198857|NCT00350519|671225|P2|Overall Study|Withdrawal by Subject|2
198858|NCT00350519|671226|P1|Overall Study|Withdrawal by Subject|3
198859|NCT00350519|671225|P2|Overall Study|Protocol Violation|2
198860|NCT00350519|671226|P1|Overall Study|Protocol Violation|1
198861|NCT00350519|671225|P2|Overall Study|Physician Decision|1
198862|NCT00350519|671226|P1|Overall Study|Physician Decision|0
198863|NCT00350519|671225|P2|Overall Study|Death|1
198864|NCT00350519|671226|P1|Overall Study|Death|0
198865|NCT00350402|671240|P2|Overall Study|Lost to Follow-up|1
198866|NCT00350402|671241|P1|Overall Study|Lost to Follow-up|1
198867|NCT00350272|671259|P2|Open-Label 84 Week Treatment|Sponsor decision|1
198868|NCT00350272|671260|P1|Open-Label 84 Week Treatment|Sponsor decision|2
198869|NCT00350272|671259|P2|Open-Label 84 Week Treatment|Physician Decision|2
198870|NCT00350272|671260|P1|Open-Label 84 Week Treatment|Physician Decision|1
198871|NCT00350272|671259|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
198872|NCT00350272|671260|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
198873|NCT00350272|671259|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
198874|NCT00350272|671260|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
198875|NCT00350272|671259|P2|Open-Label 84 Week Treatment|Adverse Event|1
198876|NCT00350272|671260|P1|Open-Label 84 Week Treatment|Adverse Event|2
198877|NCT00350272|671259|P2|Blinded 12 Week Treatment|Sponsor decision|1
198878|NCT00350272|671260|P1|Blinded 12 Week Treatment|Sponsor decision|0
198879|NCT00350272|671259|P2|Blinded 12 Week Treatment|Physician Decision|1
198880|NCT00350272|671260|P1|Blinded 12 Week Treatment|Physician Decision|2
198881|NCT00350272|671259|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
198882|NCT00350272|671260|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
198883|NCT00350272|671259|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
198884|NCT00350272|671260|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
198885|NCT00350272|671259|P2|Blinded 12 Week Treatment|Death|0
198886|NCT00350272|671260|P1|Blinded 12 Week Treatment|Death|1
198887|NCT00350272|671259|P2|Blinded 12 Week Treatment|Adverse Event|0
198888|NCT00350272|671260|P1|Blinded 12 Week Treatment|Adverse Event|1
198889|NCT00350207|671282|P3|Overall Study|Other|1
198890|NCT00350207|671283|P2|Overall Study|Other|3
198891|NCT00350207|671284|P1|Overall Study|Other|1
198892|NCT00350207|671282|P3|Overall Study|Withdrawal by Subject|1
198893|NCT00350207|671283|P2|Overall Study|Withdrawal by Subject|1
198894|NCT00350207|671284|P1|Overall Study|Withdrawal by Subject|0
198895|NCT00350207|671282|P3|Overall Study|Lost to Follow-up|1
198896|NCT00350207|671283|P2|Overall Study|Lost to Follow-up|0
198897|NCT00350207|671284|P1|Overall Study|Lost to Follow-up|1
198898|NCT00350207|671282|P3|Overall Study|Lack of Efficacy|2
198899|NCT00350207|671283|P2|Overall Study|Lack of Efficacy|0
198900|NCT00350207|671284|P1|Overall Study|Lack of Efficacy|1
198901|NCT00350207|671282|P3|Overall Study|Adverse Event|2
198902|NCT00350207|671283|P2|Overall Study|Adverse Event|2
198903|NCT00350207|671284|P1|Overall Study|Adverse Event|5
198904|NCT00349921|671498|P4|First Spinal Injection|Adverse Event|0
198905|NCT00349921|671499|P3|First Spinal Injection|Adverse Event|1
198906|NCT00349921|671500|P2|First Spinal Injection|Adverse Event|0
198907|NCT00349921|671501|P1|First Spinal Injection|Adverse Event|0
198908|NCT00349921|671498|P4|First Spinal Injection|Physician Decision|0
198909|NCT00349921|671499|P3|First Spinal Injection|Physician Decision|0
198910|NCT00349921|671500|P2|First Spinal Injection|Physician Decision|0
198911|NCT00349921|671501|P1|First Spinal Injection|Physician Decision|1
198912|NCT00349908|671512|P2|Overall Study|Withdrawal by Subject|4
198913|NCT00349908|671513|P1|Overall Study|Withdrawal by Subject|0
198914|NCT00349752|671539|P2|Overall Study|Other:History of squamous cell carcinoma|0
198915|NCT00349752|671540|P1|Overall Study|Other:History of squamous cell carcinoma|1
198916|NCT00349752|671539|P2|Overall Study|Other: Inadvertently unblinded|0
198917|NCT00349752|671540|P1|Overall Study|Other: Inadvertently unblinded|1
198918|NCT00349752|671539|P2|Overall Study|Other: Ineligible|0
198919|NCT00349752|671540|P1|Overall Study|Other: Ineligible|1
198920|NCT00349752|671539|P2|Overall Study|Other: Patient's steroid use|0
198921|NCT00349752|671540|P1|Overall Study|Other: Patient's steroid use|1
198922|NCT00349752|671539|P2|Overall Study|Other: Patient stopped steroids|1
198923|NCT00349752|671540|P1|Overall Study|Other: Patient stopped steroids|0
198924|NCT00349752|671539|P2|Overall Study|Other: Non compliance|1
198925|NCT00349752|671540|P1|Overall Study|Other: Non compliance|0
198926|NCT00349752|671539|P2|Overall Study|Other: Required exclusionary medication|1
198927|NCT00349752|671540|P1|Overall Study|Other: Required exclusionary medication|0
198928|NCT00349752|671539|P2|Overall Study|Personal reasons|5
198929|NCT00349752|671540|P1|Overall Study|Personal reasons|6
198930|NCT00349752|671539|P2|Overall Study|Lost to Follow-up|2
198931|NCT00349752|671540|P1|Overall Study|Lost to Follow-up|4
198932|NCT00349752|671539|P2|Overall Study|Lack of Efficacy|42
198933|NCT00349752|671540|P1|Overall Study|Lack of Efficacy|37
198934|NCT00349752|671539|P2|Overall Study|Adverse Event|12
198935|NCT00349752|671540|P1|Overall Study|Adverse Event|8
198936|NCT00349622|671593|P2|Overall Study|Withdrawal by Subject|9
198937|NCT00349622|671594|P1|Overall Study|Withdrawal by Subject|5
198938|NCT00349622|671593|P2|Overall Study|Lost to Follow-up|1
198939|NCT00349622|671594|P1|Overall Study|Lost to Follow-up|5
198940|NCT00349622|671593|P2|Overall Study|Death|86
198941|NCT00349622|671594|P1|Overall Study|Death|168
198942|NCT00349349|671631|P3|Overall Study|New Malignancy (Bladder Cancer)|0
198943|NCT00349349|671632|P2|Overall Study|New Malignancy (Bladder Cancer)|1
198944|NCT00349349|671633|P1|Overall Study|New Malignancy (Bladder Cancer)|0
198945|NCT00349349|671631|P3|Overall Study|No Response|0
198946|NCT00349349|671632|P2|Overall Study|No Response|3
198947|NCT00349349|671633|P1|Overall Study|No Response|0
198948|NCT00349349|671631|P3|Overall Study|Physician Decision|1
198949|NCT00349349|671632|P2|Overall Study|Physician Decision|2
198950|NCT00349349|671633|P1|Overall Study|Physician Decision|1
198951|NCT00349349|671631|P3|Overall Study|Participant Reduced General Condition|0
198952|NCT00349349|671632|P2|Overall Study|Participant Reduced General Condition|1
198953|NCT00349349|671633|P1|Overall Study|Participant Reduced General Condition|0
198954|NCT00349349|671631|P3|Overall Study|Other Treatment Selected|0
198955|NCT00349349|671632|P2|Overall Study|Other Treatment Selected|0
198956|NCT00349349|671633|P1|Overall Study|Other Treatment Selected|2
198957|NCT00349349|671631|P3|Overall Study|Death|1
198958|NCT00349349|671632|P2|Overall Study|Death|10
198959|NCT00349349|671633|P1|Overall Study|Death|13
198960|NCT00349349|671631|P3|Overall Study|Withdrawn due to Disease Progression|1
198961|NCT00349349|671632|P2|Overall Study|Withdrawn due to Disease Progression|37
198962|NCT00349349|671633|P1|Overall Study|Withdrawn due to Disease Progression|27
198963|NCT00349349|671631|P3|Overall Study|Withdrawal by Subject|1
198964|NCT00349349|671632|P2|Overall Study|Withdrawal by Subject|2
198965|NCT00349349|671633|P1|Overall Study|Withdrawal by Subject|5
198966|NCT00349349|671631|P3|Overall Study|Adverse Event|2
198967|NCT00349349|671632|P2|Overall Study|Adverse Event|6
198968|NCT00349349|671633|P1|Overall Study|Adverse Event|5
198969|NCT00348933|671722|P1|Overall Study|Adverse Event|7
198970|NCT00348933|671722|P1|Overall Study|Protocol Violation|2
198971|NCT00348933|671722|P1|Overall Study|Lost to Follow-up|6
198972|NCT00348933|671722|P1|Overall Study|Withdrawal by Subject|10
198973|NCT00348881|671730|P2|Overall Study|Serious Adverse Event|2
198974|NCT00348881|671731|P1|Overall Study|Serious Adverse Event|0
198975|NCT00348881|671730|P2|Overall Study|Adverse Event|0
198976|NCT00348881|671731|P1|Overall Study|Adverse Event|2
198977|NCT00348881|671730|P2|Overall Study|Withdrawal by Subject|4
198978|NCT00348881|671731|P1|Overall Study|Withdrawal by Subject|3
198979|NCT00348881|671730|P2|Overall Study|Lost to Follow-up|6
198980|NCT00348881|671731|P1|Overall Study|Lost to Follow-up|12
198981|NCT00348816|671743|P1|Overall Study|Noncompliance with radiation treatment|1
198982|NCT00348790|671750|P1|Completed Treatment|Unable to travel to study site|1
198983|NCT00348790|671750|P1|Completed Treatment|Required surgery|2
198984|NCT00348790|671750|P1|Completed Treatment|Adverse Event|4
198985|NCT00348790|671750|P1|Completed Treatment|Disease progression|14
198986|NCT00348790|671750|P1|Completed Treatment|Withdrawal by Subject|4
198987|NCT00348686|671755|P1|Overall Study|Multiple Reasons|8
198988|NCT00348686|671755|P1|Overall Study|Lost to Follow-up|2
198989|NCT00348686|671755|P1|Overall Study|Protocol Violation|6
198990|NCT00348686|671755|P1|Overall Study|Adverse Event|5
198991|NCT00348686|671755|P1|Overall Study|Withdrawal by Subject|45
198992|NCT00348673|671772|P9|Stage 1|Randomized but not Treated|0
198993|NCT00348673|671773|P8|Stage 1|Randomized but not Treated|0
198994|NCT00348673|671774|P7|Stage 1|Randomized but not Treated|0
198995|NCT00348673|671775|P6|Stage 1|Randomized but not Treated|0
198996|NCT00348673|671776|P5|Stage 1|Randomized but not Treated|0
198997|NCT00348673|671777|P4|Stage 1|Randomized but not Treated|0
198998|NCT00348673|671778|P3|Stage 1|Randomized but not Treated|1
198999|NCT00348673|671779|P2|Stage 1|Randomized but not Treated|0
199000|NCT00348673|671780|P1|Stage 1|Randomized but not Treated|0
199001|NCT00348556|671827|P1|Overall Study|Adverse Event|1
199002|NCT00348374|671834|P2|Overall Study|randomized but did not receive treatment|7
199003|NCT00348374|671835|P1|Overall Study|randomized but did not receive treatment|0
199004|NCT00348374|671834|P2|Overall Study|ongoing at date of cutoff|1
199005|NCT00348374|671835|P1|Overall Study|ongoing at date of cutoff|1
199006|NCT00348374|671834|P2|Overall Study|Other|12
199007|NCT00348374|671835|P1|Overall Study|Other|11
199008|NCT00348374|671834|P2|Overall Study|Withdrawal by Subject|5
199009|NCT00348374|671835|P1|Overall Study|Withdrawal by Subject|5
199010|NCT00348374|671834|P2|Overall Study|Lost to Follow-up|3
199011|NCT00348374|671835|P1|Overall Study|Lost to Follow-up|1
199012|NCT00348374|671834|P2|Overall Study|Adverse Event|4
199013|NCT00348374|671835|P1|Overall Study|Adverse Event|1
199014|NCT00348348|671882|P2|Overall Study|Adverse event probably related to study|0
199015|NCT00348348|671883|P1|Overall Study|Adverse event probably related to study|1
199016|NCT00348348|671882|P2|Overall Study|Worsening of BC - Unlikely related|2
199017|NCT00348348|671883|P1|Overall Study|Worsening of BC - Unlikely related|1
199018|NCT00348348|671882|P2|Overall Study|Worsening of BC - Unrelated to study|3
199019|NCT00348348|671883|P1|Overall Study|Worsening of BC - Unrelated to study|0
199020|NCT00348348|671882|P2|Overall Study|Dissallowed Meds - possibly releated|1
199021|NCT00348348|671883|P1|Overall Study|Dissallowed Meds - possibly releated|1
199022|NCT00348348|671882|P2|Overall Study|Dissallowed Meds - unlikley related|1
199023|NCT00348348|671883|P1|Overall Study|Dissallowed Meds - unlikley related|1
199024|NCT00348348|671882|P2|Overall Study|Dissallowed Meds - unrelated to study|3
199025|NCT00348348|671883|P1|Overall Study|Dissallowed Meds - unrelated to study|1
199026|NCT00348348|671882|P2|Overall Study|Not specified|4
199027|NCT00348348|671883|P1|Overall Study|Not specified|7
199028|NCT00348348|671882|P2|Overall Study|Withdrawal by Subject|1
199029|NCT00348348|671883|P1|Overall Study|Withdrawal by Subject|4
199030|NCT00348348|671882|P2|Overall Study|Lost to Follow-up|10
199031|NCT00348348|671883|P1|Overall Study|Lost to Follow-up|8
199032|NCT00348348|671882|P2|Overall Study|Lack of Efficacy|1
199033|NCT00348348|671883|P1|Overall Study|Lack of Efficacy|1
199034|NCT00348348|671882|P2|Overall Study|Adverse event - unrelated to study drug|1
199035|NCT00348348|671883|P1|Overall Study|Adverse event - unrelated to study drug|0
199036|NCT00348309|671898|P3|Overall Study|HCV career|1
199037|NCT00348309|671899|P2|Overall Study|HCV career|0
199038|NCT00348309|671900|P1|Overall Study|HCV career|0
199039|NCT00348309|671898|P3|Overall Study|Cardiologist recommendations|1
199040|NCT00348309|671899|P2|Overall Study|Cardiologist recommendations|0
199041|NCT00348309|671900|P1|Overall Study|Cardiologist recommendations|0
199042|NCT00348309|671898|P3|Overall Study|ECG abnormal|2
199043|NCT00348309|671899|P2|Overall Study|ECG abnormal|0
199044|NCT00348309|671900|P1|Overall Study|ECG abnormal|0
199045|NCT00348309|671898|P3|Overall Study|Adverse event not attended|1
199046|NCT00348309|671899|P2|Overall Study|Adverse event not attended|0
199047|NCT00348309|671900|P1|Overall Study|Adverse event not attended|0
199048|NCT00348309|671898|P3|Overall Study|Site closure|1
199049|NCT00348309|671899|P2|Overall Study|Site closure|0
199050|NCT00348309|671900|P1|Overall Study|Site closure|0
199051|NCT00348309|671898|P3|Overall Study|Increased dose of Aricept|1
199052|NCT00348309|671899|P2|Overall Study|Increased dose of Aricept|0
199053|NCT00348309|671900|P1|Overall Study|Increased dose of Aricept|0
199054|NCT00348309|671898|P3|Overall Study|Medical Monitor decision|1
199055|NCT00348309|671899|P2|Overall Study|Medical Monitor decision|0
199056|NCT00348309|671900|P1|Overall Study|Medical Monitor decision|0
199057|NCT00348309|671898|P3|Overall Study|Forgot often medication|0
199058|NCT00348309|671899|P2|Overall Study|Forgot often medication|1
199059|NCT00348309|671900|P1|Overall Study|Forgot often medication|0
199060|NCT00348309|671898|P3|Overall Study|Sponsor refuseal|1
199061|NCT00348309|671899|P2|Overall Study|Sponsor refuseal|1
199062|NCT00348309|671900|P1|Overall Study|Sponsor refuseal|0
199063|NCT00348309|671898|P3|Overall Study|Participant was hospitalized|0
199064|NCT00348309|671899|P2|Overall Study|Participant was hospitalized|1
199065|NCT00348309|671900|P1|Overall Study|Participant was hospitalized|0
199066|NCT00348309|671898|P3|Overall Study|A foul of exclusion criteria|0
199067|NCT00348309|671899|P2|Overall Study|A foul of exclusion criteria|1
199068|NCT00348309|671900|P1|Overall Study|A foul of exclusion criteria|0
199069|NCT00348309|671898|P3|Overall Study|Ineffectiveness of treatment|0
199070|NCT00348309|671899|P2|Overall Study|Ineffectiveness of treatment|1
199071|NCT00348309|671900|P1|Overall Study|Ineffectiveness of treatment|0
199072|NCT00348309|671898|P3|Overall Study|Decision of sponsor|0
199073|NCT00348309|671899|P2|Overall Study|Decision of sponsor|0
199074|NCT00348309|671900|P1|Overall Study|Decision of sponsor|1
199075|NCT00348309|671898|P3|Overall Study|Participant died|1
199076|NCT00348309|671899|P2|Overall Study|Participant died|1
199077|NCT00348309|671900|P1|Overall Study|Participant died|2
199078|NCT00348309|671898|P3|Overall Study|Did not appear in time for Visit 3|0
199079|NCT00348309|671899|P2|Overall Study|Did not appear in time for Visit 3|0
199080|NCT00348309|671900|P1|Overall Study|Did not appear in time for Visit 3|1
199081|NCT00348309|671898|P3|Overall Study|Worsening of alzheimer|1
199082|NCT00348309|671899|P2|Overall Study|Worsening of alzheimer|0
199083|NCT00348309|671900|P1|Overall Study|Worsening of alzheimer|1
199084|NCT00348309|671898|P3|Overall Study|Cognitive and behaviour worsening|0
199085|NCT00348309|671899|P2|Overall Study|Cognitive and behaviour worsening|0
199086|NCT00348309|671900|P1|Overall Study|Cognitive and behaviour worsening|2
199087|NCT00348309|671898|P3|Overall Study|Worsened neurodegenerative disease|0
199088|NCT00348309|671899|P2|Overall Study|Worsened neurodegenerative disease|0
199089|NCT00348309|671900|P1|Overall Study|Worsened neurodegenerative disease|1
199090|NCT00348309|671898|P3|Overall Study|No disponibility of medication|0
199091|NCT00348309|671899|P2|Overall Study|No disponibility of medication|0
199092|NCT00348309|671900|P1|Overall Study|No disponibility of medication|1
199093|NCT00348309|671898|P3|Overall Study|Principal investigator's decision|0
199094|NCT00348309|671899|P2|Overall Study|Principal investigator's decision|0
199095|NCT00348309|671900|P1|Overall Study|Principal investigator's decision|1
199096|NCT00348309|671898|P3|Overall Study|PI closing medical practice|0
199097|NCT00348309|671899|P2|Overall Study|PI closing medical practice|0
199098|NCT00348309|671900|P1|Overall Study|PI closing medical practice|1
199099|NCT00348309|671898|P3|Overall Study|Unable to complete ET visit|0
199100|NCT00348309|671899|P2|Overall Study|Unable to complete ET visit|0
199101|NCT00348309|671900|P1|Overall Study|Unable to complete ET visit|1
199102|NCT00348309|671898|P3|Overall Study|Caregiver withdrawal|7
199103|NCT00348309|671899|P2|Overall Study|Caregiver withdrawal|0
199104|NCT00348309|671900|P1|Overall Study|Caregiver withdrawal|3
199105|NCT00348309|671898|P3|Overall Study|Use of prohibited medication|2
199106|NCT00348309|671899|P2|Overall Study|Use of prohibited medication|2
199107|NCT00348309|671900|P1|Overall Study|Use of prohibited medication|5
199108|NCT00348309|671898|P3|Overall Study|Caregiver sick|0
199109|NCT00348309|671899|P2|Overall Study|Caregiver sick|0
199110|NCT00348309|671900|P1|Overall Study|Caregiver sick|1
199111|NCT00348309|671898|P3|Overall Study|Wrong bottle allocated|0
199112|NCT00348309|671899|P2|Overall Study|Wrong bottle allocated|0
199113|NCT00348309|671900|P1|Overall Study|Wrong bottle allocated|1
199114|NCT00348309|671898|P3|Overall Study|Lack of insight, dementia|0
199115|NCT00348309|671899|P2|Overall Study|Lack of insight, dementia|0
199116|NCT00348309|671900|P1|Overall Study|Lack of insight, dementia|1
199117|NCT00348309|671898|P3|Overall Study|Death of caregiver|1
199118|NCT00348309|671899|P2|Overall Study|Death of caregiver|0
199119|NCT00348309|671900|P1|Overall Study|Death of caregiver|1
199120|NCT00348309|671898|P3|Overall Study|Non-compliance|8
199121|NCT00348309|671899|P2|Overall Study|Non-compliance|6
199122|NCT00348309|671900|P1|Overall Study|Non-compliance|8
199123|NCT00348309|671898|P3|Overall Study|Withdrawal by Subject|40
199124|NCT00348309|671899|P2|Overall Study|Withdrawal by Subject|37
199125|NCT00348309|671900|P1|Overall Study|Withdrawal by Subject|33
199126|NCT00348309|671898|P3|Overall Study|Protocol Violation|7
199127|NCT00348309|671899|P2|Overall Study|Protocol Violation|12
199128|NCT00348309|671900|P1|Overall Study|Protocol Violation|7
199129|NCT00348309|671898|P3|Overall Study|Lost to Follow-up|4
199130|NCT00348309|671899|P2|Overall Study|Lost to Follow-up|7
199131|NCT00348309|671900|P1|Overall Study|Lost to Follow-up|6
199132|NCT00348309|671898|P3|Overall Study|Adverse Event|63
199133|NCT00348309|671899|P2|Overall Study|Adverse Event|28
199134|NCT00348309|671900|P1|Overall Study|Adverse Event|56
199135|NCT00348283|671973|P2|Open Label|Sponsor decision|1
199136|NCT00348283|671974|P1|Open Label|Sponsor decision|0
199137|NCT00348283|671973|P2|Open Label|Pregnancy|1
199138|NCT00348283|671974|P1|Open Label|Pregnancy|0
199139|NCT00348283|671973|P2|Open Label|Subject moved to the United States|1
199140|NCT00348283|671974|P1|Open Label|Subject moved to the United States|0
199141|NCT00348283|671973|P2|Open Label|Administrative reasons|5
199142|NCT00348283|671974|P1|Open Label|Administrative reasons|0
199143|NCT00348283|671973|P2|Open Label|Lack of Efficacy|13
199144|NCT00348283|671974|P1|Open Label|Lack of Efficacy|0
199145|NCT00348283|671973|P2|Open Label|Lost to Follow-up|1
199146|NCT00348283|671974|P1|Open Label|Lost to Follow-up|0
199147|NCT00348283|671973|P2|Open Label|Withdrawal by Subject|4
199148|NCT00348283|671974|P1|Open Label|Withdrawal by Subject|0
199149|NCT00348283|671973|P2|Open Label|Adverse Event|8
199150|NCT00348283|671974|P1|Open Label|Adverse Event|0
199151|NCT00348283|671973|P2|Double Blind|Pregnancy|1
199152|NCT00348283|671974|P1|Double Blind|Pregnancy|0
199153|NCT00348283|671973|P2|Double Blind|Lack of Efficacy|2
199154|NCT00348283|671974|P1|Double Blind|Lack of Efficacy|2
199155|NCT00348283|671973|P2|Double Blind|Protocol Violation|1
199156|NCT00348283|671974|P1|Double Blind|Protocol Violation|0
199157|NCT00348283|671973|P2|Double Blind|Withdrawal by Subject|1
199158|NCT00348283|671974|P1|Double Blind|Withdrawal by Subject|1
199159|NCT00348283|671973|P2|Double Blind|Adverse Event|5
199160|NCT00348283|671974|P1|Double Blind|Adverse Event|2
199161|NCT00348283|671973|P2|Induction|Protocol Violation|4
199162|NCT00348283|671974|P1|Induction|Protocol Violation|0
199163|NCT00348283|671973|P2|Induction|Adverse Event|2
199164|NCT00348283|671974|P1|Induction|Adverse Event|0
199165|NCT00348140|671993|P3|Overall Study|Memory declined|1
199166|NCT00348140|671994|P2|Overall Study|Memory declined|0
199167|NCT00348140|671995|P1|Overall Study|Memory declined|0
199168|NCT00348140|671993|P3|Overall Study|Exclusion criteria met|1
199169|NCT00348140|671994|P2|Overall Study|Exclusion criteria met|0
199170|NCT00348140|671995|P1|Overall Study|Exclusion criteria met|0
199171|NCT00348140|671993|P3|Overall Study|Participant died|0
199172|NCT00348140|671994|P2|Overall Study|Participant died|1
199173|NCT00348140|671995|P1|Overall Study|Participant died|0
199174|NCT00348140|671993|P3|Overall Study|Abnormal ECG|3
199175|NCT00348140|671994|P2|Overall Study|Abnormal ECG|1
199176|NCT00348140|671995|P1|Overall Study|Abnormal ECG|0
199177|NCT00348140|671993|P3|Overall Study|Serious adverse event|0
199178|NCT00348140|671994|P2|Overall Study|Serious adverse event|1
199179|NCT00348140|671995|P1|Overall Study|Serious adverse event|0
199180|NCT00348140|671993|P3|Overall Study|Increased risk of cardiac infarction|0
199181|NCT00348140|671994|P2|Overall Study|Increased risk of cardiac infarction|1
199182|NCT00348140|671995|P1|Overall Study|Increased risk of cardiac infarction|0
199183|NCT00348140|671993|P3|Overall Study|Disease progression|5
199184|NCT00348140|671994|P2|Overall Study|Disease progression|2
199185|NCT00348140|671995|P1|Overall Study|Disease progression|1
199186|NCT00348140|671993|P3|Overall Study|Use of prohibited drug|2
199187|NCT00348140|671994|P2|Overall Study|Use of prohibited drug|0
199188|NCT00348140|671995|P1|Overall Study|Use of prohibited drug|1
199189|NCT00348140|671993|P3|Overall Study|Decided to discontinue on their own|1
199190|NCT00348140|671994|P2|Overall Study|Decided to discontinue on their own|4
199191|NCT00348140|671995|P1|Overall Study|Decided to discontinue on their own|1
199192|NCT00348140|671993|P3|Overall Study|Investigator decided to discontinue|4
199193|NCT00348140|671994|P2|Overall Study|Investigator decided to discontinue|1
199194|NCT00348140|671995|P1|Overall Study|Investigator decided to discontinue|4
199195|NCT00348140|671993|P3|Overall Study|Screen failure|0
199196|NCT00348140|671994|P2|Overall Study|Screen failure|0
199197|NCT00348140|671995|P1|Overall Study|Screen failure|1
199198|NCT00348140|671993|P3|Overall Study|Participant unwell|0
199199|NCT00348140|671994|P2|Overall Study|Participant unwell|0
199200|NCT00348140|671995|P1|Overall Study|Participant unwell|1
199201|NCT00348140|671993|P3|Overall Study|Unmet inclusion-exclusion criteria|1
199202|NCT00348140|671994|P2|Overall Study|Unmet inclusion-exclusion criteria|0
199203|NCT00348140|671995|P1|Overall Study|Unmet inclusion-exclusion criteria|1
199204|NCT00348140|671993|P3|Overall Study|Administration related|1
199205|NCT00348140|671994|P2|Overall Study|Administration related|1
199206|NCT00348140|671995|P1|Overall Study|Administration related|3
199207|NCT00348140|671993|P3|Overall Study|Efficacy related|0
199208|NCT00348140|671994|P2|Overall Study|Efficacy related|1
199209|NCT00348140|671995|P1|Overall Study|Efficacy related|1
199210|NCT00348140|671993|P3|Overall Study|Participant hospitalised|0
199211|NCT00348140|671994|P2|Overall Study|Participant hospitalised|0
199212|NCT00348140|671995|P1|Overall Study|Participant hospitalised|3
199213|NCT00348140|671993|P3|Overall Study|Caregiver related|3
199214|NCT00348140|671994|P2|Overall Study|Caregiver related|7
199215|NCT00348140|671995|P1|Overall Study|Caregiver related|4
199216|NCT00348140|671993|P3|Overall Study|Conditional medication increased dose|0
199217|NCT00348140|671994|P2|Overall Study|Conditional medication increased dose|0
199218|NCT00348140|671995|P1|Overall Study|Conditional medication increased dose|1
199219|NCT00348140|671993|P3|Overall Study|Participant at risk due to study drug|0
199220|NCT00348140|671994|P2|Overall Study|Participant at risk due to study drug|0
199221|NCT00348140|671995|P1|Overall Study|Participant at risk due to study drug|2
199222|NCT00348140|671993|P3|Overall Study|Non-compliance|5
199223|NCT00348140|671994|P2|Overall Study|Non-compliance|13
199224|NCT00348140|671995|P1|Overall Study|Non-compliance|8
199225|NCT00348140|671993|P3|Overall Study|Withdrawal by Subject|40
199226|NCT00348140|671994|P2|Overall Study|Withdrawal by Subject|40
199227|NCT00348140|671995|P1|Overall Study|Withdrawal by Subject|32
199228|NCT00348140|671993|P3|Overall Study|Protocol Violation|14
199229|NCT00348140|671994|P2|Overall Study|Protocol Violation|13
199230|NCT00348140|671995|P1|Overall Study|Protocol Violation|12
199231|NCT00348140|671993|P3|Overall Study|Lost to Follow-up|4
199232|NCT00348140|671994|P2|Overall Study|Lost to Follow-up|4
199233|NCT00348140|671995|P1|Overall Study|Lost to Follow-up|4
199234|NCT00348140|671993|P3|Overall Study|Adverse Event|78
199235|NCT00348140|671994|P2|Overall Study|Adverse Event|49
199236|NCT00348140|671995|P1|Overall Study|Adverse Event|46
199237|NCT00347958|672093|P1|Overall Study|Withdrawal by Subject|1
199238|NCT00347958|672093|P1|Overall Study|Protocol Violation|2
199239|NCT00347958|672093|P1|Overall Study|Adverse Event|1
199240|NCT00347932|672102|P2|Overall Study|Did not meet inclusion criteria|8
199241|NCT00347932|672103|P1|Overall Study|Did not meet inclusion criteria|4
199242|NCT00347932|672102|P2|Overall Study|Withdrawal by Subject|16
199243|NCT00347932|672103|P1|Overall Study|Withdrawal by Subject|10
199244|NCT00347932|672102|P2|Overall Study|Lost to Follow-up|9
199245|NCT00347932|672103|P1|Overall Study|Lost to Follow-up|10
199246|NCT00347932|672102|P2|Overall Study|Lack of Efficacy|14
199247|NCT00347932|672103|P1|Overall Study|Lack of Efficacy|3
199248|NCT00347932|672102|P2|Overall Study|Adverse Event|5
199249|NCT00347932|672103|P1|Overall Study|Adverse Event|4
199250|NCT00347919|672118|P3|Overall Study|Missing|2
199251|NCT00347919|672119|P2|Overall Study|Missing|1
199252|NCT00347919|672120|P1|Overall Study|Missing|2
199253|NCT00347919|672118|P3|Overall Study|Par. Started Other Treatment|1
199254|NCT00347919|672119|P2|Overall Study|Par. Started Other Treatment|1
199255|NCT00347919|672120|P1|Overall Study|Par. Started Other Treatment|1
199256|NCT00347919|672118|P3|Overall Study|Death|19
199257|NCT00347919|672119|P2|Overall Study|Death|42
199258|NCT00347919|672120|P1|Overall Study|Death|35
199259|NCT00347919|672118|P3|Overall Study|Sponsor terminated study|16
199260|NCT00347919|672119|P2|Overall Study|Sponsor terminated study|10
199261|NCT00347919|672120|P1|Overall Study|Sponsor terminated study|15
199262|NCT00347919|672118|P3|Overall Study|Physician Decision|0
199263|NCT00347919|672119|P2|Overall Study|Physician Decision|1
199264|NCT00347919|672120|P1|Overall Study|Physician Decision|1
199265|NCT00347919|672118|P3|Overall Study|Withdrawal by Subject|0
199266|NCT00347919|672119|P2|Overall Study|Withdrawal by Subject|8
199267|NCT00347919|672120|P1|Overall Study|Withdrawal by Subject|6
199268|NCT00347919|672118|P3|Overall Study|Lost to Follow-up|0
199269|NCT00347919|672119|P2|Overall Study|Lost to Follow-up|13
199270|NCT00347919|672120|P1|Overall Study|Lost to Follow-up|11
199271|NCT00347776|672143|P3|12 Month Follow-up|Reached endpoint|9
199272|NCT00347776|672144|P2|12 Month Follow-up|Reached endpoint|6
199273|NCT00347776|672145|P1|12 Month Follow-up|Reached endpoint|13
199274|NCT00347776|672143|P3|12 Month Follow-up|Death|4
199275|NCT00347776|672144|P2|12 Month Follow-up|Death|4
199276|NCT00347776|672145|P1|12 Month Follow-up|Death|3
199277|NCT00347776|672143|P3|12 Month Follow-up|Lost to Follow-up|6
199278|NCT00347776|672144|P2|12 Month Follow-up|Lost to Follow-up|6
199279|NCT00347776|672145|P1|12 Month Follow-up|Lost to Follow-up|7
199280|NCT00347776|672143|P3|6 Month Follow-up|reached endpont|15
199281|NCT00347776|672144|P2|6 Month Follow-up|reached endpont|12
199282|NCT00347776|672145|P1|6 Month Follow-up|reached endpont|20
199283|NCT00347776|672143|P3|6 Month Follow-up|Death|3
199284|NCT00347776|672144|P2|6 Month Follow-up|Death|1
199285|NCT00347776|672145|P1|6 Month Follow-up|Death|2
199286|NCT00347776|672143|P3|1.5 Month Follow-up|reached the endpoint|12
199287|NCT00347776|672144|P2|1.5 Month Follow-up|reached the endpoint|8
199288|NCT00347776|672145|P1|1.5 Month Follow-up|reached the endpoint|12
199289|NCT00347776|672143|P3|1.5 Month Follow-up|Death|0
199290|NCT00347776|672144|P2|1.5 Month Follow-up|Death|0
199291|NCT00347776|672145|P1|1.5 Month Follow-up|Death|2
199292|NCT00347438|672157|P1|Overall Study|Physician Decision|1
199293|NCT00347438|672157|P1|Overall Study|Withdrawal by Subject|1
199294|NCT00347360|672179|P15|Overall Study|Visits conflicted with new job|0
199295|NCT00347360|672180|P14|Overall Study|Visits conflicted with new job|0
199296|NCT00347360|672181|P13|Overall Study|Visits conflicted with new job|0
199297|NCT00347360|672182|P12|Overall Study|Visits conflicted with new job|0
199298|NCT00347360|672183|P11|Overall Study|Visits conflicted with new job|0
199299|NCT00347360|672184|P10|Overall Study|Visits conflicted with new job|0
199300|NCT00347360|672185|P9|Overall Study|Visits conflicted with new job|0
199301|NCT00347360|672186|P8|Overall Study|Visits conflicted with new job|0
199302|NCT00347360|672187|P7|Overall Study|Visits conflicted with new job|1
199303|NCT00347360|672188|P6|Overall Study|Visits conflicted with new job|0
199304|NCT00347360|672189|P5|Overall Study|Visits conflicted with new job|0
199305|NCT00347360|672190|P4|Overall Study|Visits conflicted with new job|0
199306|NCT00347360|672191|P3|Overall Study|Visits conflicted with new job|0
199307|NCT00347360|672192|P2|Overall Study|Visits conflicted with new job|0
199308|NCT00347360|672193|P1|Overall Study|Visits conflicted with new job|0
199309|NCT00347360|672179|P15|Overall Study|Subject refuse to sign updated consent|1
199310|NCT00347360|672180|P14|Overall Study|Subject refuse to sign updated consent|0
199311|NCT00347360|672181|P13|Overall Study|Subject refuse to sign updated consent|0
199312|NCT00347360|672182|P12|Overall Study|Subject refuse to sign updated consent|0
199313|NCT00347360|672183|P11|Overall Study|Subject refuse to sign updated consent|0
199314|NCT00347360|672184|P10|Overall Study|Subject refuse to sign updated consent|0
199315|NCT00347360|672185|P9|Overall Study|Subject refuse to sign updated consent|0
199316|NCT00347360|672186|P8|Overall Study|Subject refuse to sign updated consent|0
199317|NCT00347360|672187|P7|Overall Study|Subject refuse to sign updated consent|0
199318|NCT00347360|672188|P6|Overall Study|Subject refuse to sign updated consent|0
199319|NCT00347360|672189|P5|Overall Study|Subject refuse to sign updated consent|0
199320|NCT00347360|672190|P4|Overall Study|Subject refuse to sign updated consent|0
199321|NCT00347360|672191|P3|Overall Study|Subject refuse to sign updated consent|0
199322|NCT00347360|672192|P2|Overall Study|Subject refuse to sign updated consent|0
199323|NCT00347360|672193|P1|Overall Study|Subject refuse to sign updated consent|0
199324|NCT00347360|672179|P15|Overall Study|Subject left town, ran out of study drug|0
199325|NCT00347360|672180|P14|Overall Study|Subject left town, ran out of study drug|1
199326|NCT00347360|672181|P13|Overall Study|Subject left town, ran out of study drug|0
199327|NCT00347360|672182|P12|Overall Study|Subject left town, ran out of study drug|0
199328|NCT00347360|672183|P11|Overall Study|Subject left town, ran out of study drug|0
199329|NCT00347360|672184|P10|Overall Study|Subject left town, ran out of study drug|0
199330|NCT00347360|672185|P9|Overall Study|Subject left town, ran out of study drug|0
199331|NCT00347360|672186|P8|Overall Study|Subject left town, ran out of study drug|0
199332|NCT00347360|672187|P7|Overall Study|Subject left town, ran out of study drug|0
199333|NCT00347360|672188|P6|Overall Study|Subject left town, ran out of study drug|0
199334|NCT00347360|672189|P5|Overall Study|Subject left town, ran out of study drug|0
199335|NCT00347360|672190|P4|Overall Study|Subject left town, ran out of study drug|0
199336|NCT00347360|672191|P3|Overall Study|Subject left town, ran out of study drug|0
199337|NCT00347360|672192|P2|Overall Study|Subject left town, ran out of study drug|0
199338|NCT00347360|672193|P1|Overall Study|Subject left town, ran out of study drug|0
199339|NCT00347360|672179|P15|Overall Study|Prolonged duration between visits|0
199340|NCT00347360|672180|P14|Overall Study|Prolonged duration between visits|0
199341|NCT00347360|672181|P13|Overall Study|Prolonged duration between visits|1
199342|NCT00347360|672182|P12|Overall Study|Prolonged duration between visits|0
199343|NCT00347360|672183|P11|Overall Study|Prolonged duration between visits|0
199344|NCT00347360|672184|P10|Overall Study|Prolonged duration between visits|0
199345|NCT00347360|672185|P9|Overall Study|Prolonged duration between visits|0
199346|NCT00347360|672186|P8|Overall Study|Prolonged duration between visits|0
199347|NCT00347360|672187|P7|Overall Study|Prolonged duration between visits|0
199348|NCT00347360|672188|P6|Overall Study|Prolonged duration between visits|0
199349|NCT00347360|672189|P5|Overall Study|Prolonged duration between visits|0
199350|NCT00347360|672190|P4|Overall Study|Prolonged duration between visits|0
199351|NCT00347360|672191|P3|Overall Study|Prolonged duration between visits|0
199352|NCT00347360|672192|P2|Overall Study|Prolonged duration between visits|0
199353|NCT00347360|672193|P1|Overall Study|Prolonged duration between visits|0
199354|NCT00347360|672179|P15|Overall Study|Failed inclusion criteria #4|0
199355|NCT00347360|672180|P14|Overall Study|Failed inclusion criteria #4|0
199356|NCT00347360|672181|P13|Overall Study|Failed inclusion criteria #4|0
199357|NCT00347360|672182|P12|Overall Study|Failed inclusion criteria #4|1
199358|NCT00347360|672183|P11|Overall Study|Failed inclusion criteria #4|0
199359|NCT00347360|672184|P10|Overall Study|Failed inclusion criteria #4|0
199360|NCT00347360|672185|P9|Overall Study|Failed inclusion criteria #4|0
199361|NCT00347360|672186|P8|Overall Study|Failed inclusion criteria #4|0
199362|NCT00347360|672187|P7|Overall Study|Failed inclusion criteria #4|0
199363|NCT00347360|672188|P6|Overall Study|Failed inclusion criteria #4|0
199364|NCT00347360|672189|P5|Overall Study|Failed inclusion criteria #4|0
199365|NCT00347360|672190|P4|Overall Study|Failed inclusion criteria #4|0
199366|NCT00347360|672191|P3|Overall Study|Failed inclusion criteria #4|0
199367|NCT00347360|672192|P2|Overall Study|Failed inclusion criteria #4|0
199368|NCT00347360|672193|P1|Overall Study|Failed inclusion criteria #4|0
199369|NCT00347360|672179|P15|Overall Study|Randomized in error|0
199370|NCT00347360|672180|P14|Overall Study|Randomized in error|0
199371|NCT00347360|672181|P13|Overall Study|Randomized in error|0
199372|NCT00347360|672182|P12|Overall Study|Randomized in error|1
199373|NCT00347360|672183|P11|Overall Study|Randomized in error|0
199374|NCT00347360|672184|P10|Overall Study|Randomized in error|0
199375|NCT00347360|672185|P9|Overall Study|Randomized in error|0
199376|NCT00347360|672186|P8|Overall Study|Randomized in error|0
199377|NCT00347360|672187|P7|Overall Study|Randomized in error|0
199378|NCT00347360|672188|P6|Overall Study|Randomized in error|0
199379|NCT00347360|672189|P5|Overall Study|Randomized in error|0
199380|NCT00347360|672190|P4|Overall Study|Randomized in error|0
199381|NCT00347360|672191|P3|Overall Study|Randomized in error|0
199382|NCT00347360|672192|P2|Overall Study|Randomized in error|0
199383|NCT00347360|672193|P1|Overall Study|Randomized in error|0
199384|NCT00347360|672179|P15|Overall Study|Did not meet criteria before ABPM|0
199385|NCT00347360|672180|P14|Overall Study|Did not meet criteria before ABPM|0
199386|NCT00347360|672181|P13|Overall Study|Did not meet criteria before ABPM|0
199387|NCT00347360|672182|P12|Overall Study|Did not meet criteria before ABPM|0
199388|NCT00347360|672183|P11|Overall Study|Did not meet criteria before ABPM|1
199389|NCT00347360|672184|P10|Overall Study|Did not meet criteria before ABPM|0
199390|NCT00347360|672185|P9|Overall Study|Did not meet criteria before ABPM|0
199391|NCT00347360|672186|P8|Overall Study|Did not meet criteria before ABPM|0
199392|NCT00347360|672187|P7|Overall Study|Did not meet criteria before ABPM|0
199393|NCT00347360|672188|P6|Overall Study|Did not meet criteria before ABPM|0
199394|NCT00347360|672189|P5|Overall Study|Did not meet criteria before ABPM|0
199395|NCT00347360|672190|P4|Overall Study|Did not meet criteria before ABPM|0
199396|NCT00347360|672191|P3|Overall Study|Did not meet criteria before ABPM|0
199397|NCT00347360|672192|P2|Overall Study|Did not meet criteria before ABPM|0
199398|NCT00347360|672193|P1|Overall Study|Did not meet criteria before ABPM|0
199399|NCT00347360|672179|P15|Overall Study|PI recommended early withdrawal|0
199400|NCT00347360|672180|P14|Overall Study|PI recommended early withdrawal|0
199401|NCT00347360|672181|P13|Overall Study|PI recommended early withdrawal|0
199402|NCT00347360|672182|P12|Overall Study|PI recommended early withdrawal|0
199403|NCT00347360|672183|P11|Overall Study|PI recommended early withdrawal|0
199404|NCT00347360|672184|P10|Overall Study|PI recommended early withdrawal|1
199405|NCT00347360|672185|P9|Overall Study|PI recommended early withdrawal|0
199406|NCT00347360|672186|P8|Overall Study|PI recommended early withdrawal|0
199407|NCT00347360|672187|P7|Overall Study|PI recommended early withdrawal|0
199408|NCT00347360|672188|P6|Overall Study|PI recommended early withdrawal|0
199409|NCT00347360|672189|P5|Overall Study|PI recommended early withdrawal|0
199410|NCT00347360|672190|P4|Overall Study|PI recommended early withdrawal|0
199411|NCT00347360|672191|P3|Overall Study|PI recommended early withdrawal|0
199412|NCT00347360|672192|P2|Overall Study|PI recommended early withdrawal|0
199413|NCT00347360|672193|P1|Overall Study|PI recommended early withdrawal|0
199414|NCT00347360|672179|P15|Overall Study|Abnormal lab values|0
199415|NCT00347360|672180|P14|Overall Study|Abnormal lab values|0
199416|NCT00347360|672181|P13|Overall Study|Abnormal lab values|0
199417|NCT00347360|672182|P12|Overall Study|Abnormal lab values|0
199418|NCT00347360|672183|P11|Overall Study|Abnormal lab values|0
199419|NCT00347360|672184|P10|Overall Study|Abnormal lab values|0
199420|NCT00347360|672185|P9|Overall Study|Abnormal lab values|0
199421|NCT00347360|672186|P8|Overall Study|Abnormal lab values|0
199422|NCT00347360|672187|P7|Overall Study|Abnormal lab values|1
199423|NCT00347360|672188|P6|Overall Study|Abnormal lab values|0
199424|NCT00347360|672189|P5|Overall Study|Abnormal lab values|0
199425|NCT00347360|672190|P4|Overall Study|Abnormal lab values|0
199426|NCT00347360|672191|P3|Overall Study|Abnormal lab values|0
199427|NCT00347360|672192|P2|Overall Study|Abnormal lab values|0
199428|NCT00347360|672193|P1|Overall Study|Abnormal lab values|0
199429|NCT00347360|672179|P15|Overall Study|Subject did not meet end of study ABPM|0
199430|NCT00347360|672180|P14|Overall Study|Subject did not meet end of study ABPM|1
199431|NCT00347360|672181|P13|Overall Study|Subject did not meet end of study ABPM|1
199432|NCT00347360|672182|P12|Overall Study|Subject did not meet end of study ABPM|0
199433|NCT00347360|672183|P11|Overall Study|Subject did not meet end of study ABPM|1
199434|NCT00347360|672184|P10|Overall Study|Subject did not meet end of study ABPM|0
199435|NCT00347360|672185|P9|Overall Study|Subject did not meet end of study ABPM|0
199436|NCT00347360|672186|P8|Overall Study|Subject did not meet end of study ABPM|0
199437|NCT00347360|672187|P7|Overall Study|Subject did not meet end of study ABPM|1
199438|NCT00347360|672188|P6|Overall Study|Subject did not meet end of study ABPM|0
199439|NCT00347360|672189|P5|Overall Study|Subject did not meet end of study ABPM|0
199440|NCT00347360|672190|P4|Overall Study|Subject did not meet end of study ABPM|0
199441|NCT00347360|672191|P3|Overall Study|Subject did not meet end of study ABPM|0
199442|NCT00347360|672192|P2|Overall Study|Subject did not meet end of study ABPM|0
199443|NCT00347360|672193|P1|Overall Study|Subject did not meet end of study ABPM|0
199444|NCT00347360|672179|P15|Overall Study|P.I. recommended due to blood pressure|0
199445|NCT00347360|672180|P14|Overall Study|P.I. recommended due to blood pressure|0
199446|NCT00347360|672181|P13|Overall Study|P.I. recommended due to blood pressure|0
199447|NCT00347360|672182|P12|Overall Study|P.I. recommended due to blood pressure|0
199448|NCT00347360|672183|P11|Overall Study|P.I. recommended due to blood pressure|0
199449|NCT00347360|672184|P10|Overall Study|P.I. recommended due to blood pressure|0
199450|NCT00347360|672185|P9|Overall Study|P.I. recommended due to blood pressure|0
199451|NCT00347360|672186|P8|Overall Study|P.I. recommended due to blood pressure|0
199452|NCT00347360|672187|P7|Overall Study|P.I. recommended due to blood pressure|0
199453|NCT00347360|672188|P6|Overall Study|P.I. recommended due to blood pressure|0
199454|NCT00347360|672189|P5|Overall Study|P.I. recommended due to blood pressure|1
199455|NCT00347360|672190|P4|Overall Study|P.I. recommended due to blood pressure|0
199456|NCT00347360|672191|P3|Overall Study|P.I. recommended due to blood pressure|0
199457|NCT00347360|672192|P2|Overall Study|P.I. recommended due to blood pressure|0
199458|NCT00347360|672193|P1|Overall Study|P.I. recommended due to blood pressure|0
199459|NCT00347360|672179|P15|Overall Study|Per sponsors instruction|0
199460|NCT00347360|672180|P14|Overall Study|Per sponsors instruction|0
199461|NCT00347360|672181|P13|Overall Study|Per sponsors instruction|0
199462|NCT00347360|672182|P12|Overall Study|Per sponsors instruction|0
199463|NCT00347360|672183|P11|Overall Study|Per sponsors instruction|0
199464|NCT00347360|672184|P10|Overall Study|Per sponsors instruction|0
199465|NCT00347360|672185|P9|Overall Study|Per sponsors instruction|0
199466|NCT00347360|672186|P8|Overall Study|Per sponsors instruction|0
199467|NCT00347360|672187|P7|Overall Study|Per sponsors instruction|0
199468|NCT00347360|672188|P6|Overall Study|Per sponsors instruction|0
199469|NCT00347360|672189|P5|Overall Study|Per sponsors instruction|0
199470|NCT00347360|672190|P4|Overall Study|Per sponsors instruction|0
199471|NCT00347360|672191|P3|Overall Study|Per sponsors instruction|0
199472|NCT00347360|672192|P2|Overall Study|Per sponsors instruction|1
199473|NCT00347360|672193|P1|Overall Study|Per sponsors instruction|0
199474|NCT00347360|672179|P15|Overall Study|Reason not listed/blank|0
199475|NCT00347360|672180|P14|Overall Study|Reason not listed/blank|1
199476|NCT00347360|672181|P13|Overall Study|Reason not listed/blank|0
199477|NCT00347360|672182|P12|Overall Study|Reason not listed/blank|0
199478|NCT00347360|672183|P11|Overall Study|Reason not listed/blank|0
199479|NCT00347360|672184|P10|Overall Study|Reason not listed/blank|0
199480|NCT00347360|672185|P9|Overall Study|Reason not listed/blank|0
199481|NCT00347360|672186|P8|Overall Study|Reason not listed/blank|0
199482|NCT00347360|672187|P7|Overall Study|Reason not listed/blank|1
199483|NCT00347360|672188|P6|Overall Study|Reason not listed/blank|0
199484|NCT00347360|672189|P5|Overall Study|Reason not listed/blank|0
199485|NCT00347360|672190|P4|Overall Study|Reason not listed/blank|0
199486|NCT00347360|672191|P3|Overall Study|Reason not listed/blank|0
199487|NCT00347360|672192|P2|Overall Study|Reason not listed/blank|0
199488|NCT00347360|672193|P1|Overall Study|Reason not listed/blank|1
199489|NCT00347360|672179|P15|Overall Study|Lack of Efficacy|0
199490|NCT00347360|672180|P14|Overall Study|Lack of Efficacy|0
199491|NCT00347360|672181|P13|Overall Study|Lack of Efficacy|0
199492|NCT00347360|672182|P12|Overall Study|Lack of Efficacy|0
199493|NCT00347360|672183|P11|Overall Study|Lack of Efficacy|0
199494|NCT00347360|672184|P10|Overall Study|Lack of Efficacy|0
199495|NCT00347360|672185|P9|Overall Study|Lack of Efficacy|1
199496|NCT00347360|672186|P8|Overall Study|Lack of Efficacy|1
199497|NCT00347360|672187|P7|Overall Study|Lack of Efficacy|0
199498|NCT00347360|672188|P6|Overall Study|Lack of Efficacy|1
199499|NCT00347360|672189|P5|Overall Study|Lack of Efficacy|0
199500|NCT00347360|672190|P4|Overall Study|Lack of Efficacy|1
199501|NCT00347360|672191|P3|Overall Study|Lack of Efficacy|3
199502|NCT00347360|672192|P2|Overall Study|Lack of Efficacy|1
199503|NCT00347360|672193|P1|Overall Study|Lack of Efficacy|1
199504|NCT00347360|672179|P15|Overall Study|Withdrawal by Subject|1
199505|NCT00347360|672180|P14|Overall Study|Withdrawal by Subject|2
199506|NCT00347360|672181|P13|Overall Study|Withdrawal by Subject|4
199507|NCT00347360|672182|P12|Overall Study|Withdrawal by Subject|3
199508|NCT00347360|672183|P11|Overall Study|Withdrawal by Subject|0
199509|NCT00347360|672184|P10|Overall Study|Withdrawal by Subject|1
199510|NCT00347360|672185|P9|Overall Study|Withdrawal by Subject|1
199511|NCT00347360|672186|P8|Overall Study|Withdrawal by Subject|1
199512|NCT00347360|672187|P7|Overall Study|Withdrawal by Subject|1
199513|NCT00347360|672188|P6|Overall Study|Withdrawal by Subject|2
199514|NCT00347360|672189|P5|Overall Study|Withdrawal by Subject|1
199515|NCT00347360|672190|P4|Overall Study|Withdrawal by Subject|4
199516|NCT00347360|672191|P3|Overall Study|Withdrawal by Subject|2
199517|NCT00347360|672192|P2|Overall Study|Withdrawal by Subject|1
199518|NCT00347360|672193|P1|Overall Study|Withdrawal by Subject|0
199519|NCT00347360|672179|P15|Overall Study|Protocol Violation|0
199520|NCT00347360|672180|P14|Overall Study|Protocol Violation|1
199521|NCT00347360|672181|P13|Overall Study|Protocol Violation|0
199522|NCT00347360|672182|P12|Overall Study|Protocol Violation|0
199523|NCT00347360|672183|P11|Overall Study|Protocol Violation|0
199524|NCT00347360|672184|P10|Overall Study|Protocol Violation|2
199525|NCT00347360|672185|P9|Overall Study|Protocol Violation|1
199526|NCT00347360|672186|P8|Overall Study|Protocol Violation|0
199527|NCT00347360|672187|P7|Overall Study|Protocol Violation|0
199528|NCT00347360|672188|P6|Overall Study|Protocol Violation|2
199529|NCT00347360|672189|P5|Overall Study|Protocol Violation|1
199530|NCT00347360|672190|P4|Overall Study|Protocol Violation|2
199531|NCT00347360|672191|P3|Overall Study|Protocol Violation|1
199532|NCT00347360|672192|P2|Overall Study|Protocol Violation|3
199533|NCT00347360|672193|P1|Overall Study|Protocol Violation|2
199534|NCT00347360|672179|P15|Overall Study|Lost to Follow-up|0
199535|NCT00347360|672180|P14|Overall Study|Lost to Follow-up|0
199536|NCT00347360|672181|P13|Overall Study|Lost to Follow-up|1
199537|NCT00347360|672182|P12|Overall Study|Lost to Follow-up|0
199538|NCT00347360|672183|P11|Overall Study|Lost to Follow-up|0
199539|NCT00347360|672184|P10|Overall Study|Lost to Follow-up|2
199540|NCT00347360|672185|P9|Overall Study|Lost to Follow-up|1
199541|NCT00347360|672186|P8|Overall Study|Lost to Follow-up|1
199542|NCT00347360|672187|P7|Overall Study|Lost to Follow-up|0
199543|NCT00347360|672188|P6|Overall Study|Lost to Follow-up|1
199544|NCT00347360|672189|P5|Overall Study|Lost to Follow-up|1
199545|NCT00347360|672190|P4|Overall Study|Lost to Follow-up|2
199546|NCT00347360|672191|P3|Overall Study|Lost to Follow-up|0
199547|NCT00347360|672192|P2|Overall Study|Lost to Follow-up|0
199548|NCT00347360|672193|P1|Overall Study|Lost to Follow-up|0
199549|NCT00347360|672179|P15|Overall Study|Adverse Event|2
199550|NCT00347360|672180|P14|Overall Study|Adverse Event|2
199551|NCT00347360|672181|P13|Overall Study|Adverse Event|3
199552|NCT00347360|672182|P12|Overall Study|Adverse Event|1
199553|NCT00347360|672183|P11|Overall Study|Adverse Event|3
199554|NCT00347360|672184|P10|Overall Study|Adverse Event|3
199555|NCT00347360|672185|P9|Overall Study|Adverse Event|2
199556|NCT00347360|672186|P8|Overall Study|Adverse Event|0
199557|NCT00347360|672187|P7|Overall Study|Adverse Event|2
199558|NCT00347360|672188|P6|Overall Study|Adverse Event|2
199559|NCT00347360|672189|P5|Overall Study|Adverse Event|1
199560|NCT00347360|672190|P4|Overall Study|Adverse Event|4
199561|NCT00347360|672191|P3|Overall Study|Adverse Event|0
199562|NCT00347360|672192|P2|Overall Study|Adverse Event|2
199563|NCT00347360|672193|P1|Overall Study|Adverse Event|1
199564|NCT00347269|672381|P2|Overall Study|Death|3
199565|NCT00347269|672382|P1|Overall Study|Death|2
199566|NCT00347269|672381|P2|Overall Study|Withdrawal by Subject|38
199567|NCT00347269|672382|P1|Overall Study|Withdrawal by Subject|18
199568|NCT00347269|672381|P2|Overall Study|Lost to Follow-up|65
199569|NCT00347269|672382|P1|Overall Study|Lost to Follow-up|74
199570|NCT00347009|672397|P1|Overall Study|Serious Adverse Event|1
199571|NCT00347009|672397|P1|Overall Study|Increased ALT/HBV DNA|1
199572|NCT00347009|672397|P1|Overall Study|Insufficient Viral Suppression|3
199573|NCT00347009|672397|P1|Overall Study|Adverse Laboratory Experience|1
199574|NCT00347009|672397|P1|Overall Study|Protocol Violation|2
199575|NCT00347009|672397|P1|Overall Study|Lost to Follow-up|4
199576|NCT00347009|672397|P1|Overall Study|Physician Decision|5
199577|NCT00347009|672397|P1|Overall Study|Withdrawal by Subject|3
199578|NCT00347009|672397|P1|Overall Study|Adverse Event|6
199579|NCT00347009|672397|P1|Overall Study|Death|1
199580|NCT00346775|672418|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
199581|NCT00346775|672419|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
199582|NCT00346775|672418|P2|Period 1: Intervention Period 1|Protocol Violation|2
199583|NCT00346775|672419|P1|Period 1: Intervention Period 1|Protocol Violation|3
199584|NCT00346775|672418|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
199585|NCT00346775|672419|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
199586|NCT00346697|672431|P2|Overall Study|Lost to Follow-up|1
199587|NCT00346697|672432|P1|Overall Study|Lost to Follow-up|0
199588|NCT00346632|672468|P10|Overall Study|Not Stated|1
199589|NCT00346632|672469|P9|Overall Study|Not Stated|2
199590|NCT00346632|672470|P8|Overall Study|Not Stated|2
199591|NCT00346632|672471|P7|Overall Study|Not Stated|0
199592|NCT00346632|672472|P6|Overall Study|Not Stated|0
199593|NCT00346632|672473|P5|Overall Study|Not Stated|0
199594|NCT00346632|672474|P4|Overall Study|Not Stated|0
199595|NCT00346632|672475|P3|Overall Study|Not Stated|0
199596|NCT00346632|672476|P2|Overall Study|Not Stated|1
199597|NCT00346632|672477|P1|Overall Study|Not Stated|1
199598|NCT00346632|672468|P10|Overall Study|Switched to alternative treatment|0
199599|NCT00346632|672469|P9|Overall Study|Switched to alternative treatment|0
199600|NCT00346632|672470|P8|Overall Study|Switched to alternative treatment|0
199601|NCT00346632|672471|P7|Overall Study|Switched to alternative treatment|0
199602|NCT00346632|672472|P6|Overall Study|Switched to alternative treatment|0
199603|NCT00346632|672473|P5|Overall Study|Switched to alternative treatment|0
199604|NCT00346632|672474|P4|Overall Study|Switched to alternative treatment|0
199605|NCT00346632|672475|P3|Overall Study|Switched to alternative treatment|1
199606|NCT00346632|672476|P2|Overall Study|Switched to alternative treatment|0
199607|NCT00346632|672477|P1|Overall Study|Switched to alternative treatment|0
199608|NCT00346632|672468|P10|Overall Study|Withdrawal by Subject|0
199609|NCT00346632|672469|P9|Overall Study|Withdrawal by Subject|0
199610|NCT00346632|672470|P8|Overall Study|Withdrawal by Subject|0
199611|NCT00346632|672471|P7|Overall Study|Withdrawal by Subject|1
199612|NCT00346632|672472|P6|Overall Study|Withdrawal by Subject|0
199613|NCT00346632|672473|P5|Overall Study|Withdrawal by Subject|0
199614|NCT00346632|672474|P4|Overall Study|Withdrawal by Subject|0
199615|NCT00346632|672475|P3|Overall Study|Withdrawal by Subject|0
199616|NCT00346632|672476|P2|Overall Study|Withdrawal by Subject|0
199617|NCT00346632|672477|P1|Overall Study|Withdrawal by Subject|0
199618|NCT00346632|672468|P10|Overall Study|Protocol Violation|0
199619|NCT00346632|672469|P9|Overall Study|Protocol Violation|0
199620|NCT00346632|672470|P8|Overall Study|Protocol Violation|0
199621|NCT00346632|672471|P7|Overall Study|Protocol Violation|1
199622|NCT00346632|672472|P6|Overall Study|Protocol Violation|0
199623|NCT00346632|672473|P5|Overall Study|Protocol Violation|0
199624|NCT00346632|672474|P4|Overall Study|Protocol Violation|0
199625|NCT00346632|672475|P3|Overall Study|Protocol Violation|0
199626|NCT00346632|672476|P2|Overall Study|Protocol Violation|0
199627|NCT00346632|672477|P1|Overall Study|Protocol Violation|0
199628|NCT00346632|672468|P10|Overall Study|Death|0
199629|NCT00346632|672469|P9|Overall Study|Death|0
199630|NCT00346632|672470|P8|Overall Study|Death|0
199631|NCT00346632|672471|P7|Overall Study|Death|0
199632|NCT00346632|672472|P6|Overall Study|Death|0
199633|NCT00346632|672473|P5|Overall Study|Death|0
199634|NCT00346632|672474|P4|Overall Study|Death|0
199635|NCT00346632|672475|P3|Overall Study|Death|1
199636|NCT00346632|672476|P2|Overall Study|Death|0
199637|NCT00346632|672477|P1|Overall Study|Death|0
199638|NCT00346632|672468|P10|Overall Study|Adverse Event|0
199639|NCT00346632|672469|P9|Overall Study|Adverse Event|0
199640|NCT00346632|672470|P8|Overall Study|Adverse Event|0
199641|NCT00346632|672471|P7|Overall Study|Adverse Event|1
199642|NCT00346632|672472|P6|Overall Study|Adverse Event|1
199643|NCT00346632|672473|P5|Overall Study|Adverse Event|1
199644|NCT00346632|672474|P4|Overall Study|Adverse Event|0
199645|NCT00346632|672475|P3|Overall Study|Adverse Event|0
199646|NCT00346632|672476|P2|Overall Study|Adverse Event|0
199647|NCT00346632|672477|P1|Overall Study|Adverse Event|0
199648|NCT00346632|672468|P10|Overall Study|Progressive Disease|2
199649|NCT00346632|672469|P9|Overall Study|Progressive Disease|2
199650|NCT00346632|672470|P8|Overall Study|Progressive Disease|2
199651|NCT00346632|672471|P7|Overall Study|Progressive Disease|2
199652|NCT00346632|672472|P6|Overall Study|Progressive Disease|1
199653|NCT00346632|672473|P5|Overall Study|Progressive Disease|3
199654|NCT00346632|672474|P4|Overall Study|Progressive Disease|3
199655|NCT00346632|672475|P3|Overall Study|Progressive Disease|4
199656|NCT00346632|672476|P2|Overall Study|Progressive Disease|2
199657|NCT00346632|672477|P1|Overall Study|Progressive Disease|2
199658|NCT00346398|672627|P2|Overall Study|Withdrawal by Subject|2
199659|NCT00346398|672628|P1|Overall Study|Withdrawal by Subject|0
199660|NCT00346398|672627|P2|Overall Study|Lost to Follow-up|0
199661|NCT00346398|672628|P1|Overall Study|Lost to Follow-up|3
199662|NCT00346333|672640|P2|Overall Study|unwilling or unable to continue|8
199663|NCT00346333|672641|P1|Overall Study|unwilling or unable to continue|4
199664|NCT00346333|672640|P2|Overall Study|Death|0
199665|NCT00346333|672641|P1|Overall Study|Death|1
199666|NCT00346268|672657|P2|Overall Study|Participant refused|3
199667|NCT00346268|672658|P1|Overall Study|Participant refused|0
199668|NCT00346268|672657|P2|Overall Study|Protocol Violation|0
199669|NCT00346268|672658|P1|Overall Study|Protocol Violation|1
199670|NCT00346268|672657|P2|Overall Study|Adverse Event|0
199671|NCT00346268|672658|P1|Overall Study|Adverse Event|1
199672|NCT00346216|672693|P3|Overall Study|Missing Subject Summary Status|62
199673|NCT00346216|672694|P2|Overall Study|Missing Subject Summary Status|61
199674|NCT00346216|672695|P1|Overall Study|Missing Subject Summary Status|62
199675|NCT00346216|672693|P3|Overall Study|Study terminated by sponsor|8
199676|NCT00346216|672694|P2|Overall Study|Study terminated by sponsor|4
199677|NCT00346216|672695|P1|Overall Study|Study terminated by sponsor|11
199678|NCT00346216|672693|P3|Overall Study|Death|228
199679|NCT00346216|672694|P2|Overall Study|Death|192
199680|NCT00346216|672695|P1|Overall Study|Death|189
199681|NCT00346216|672693|P3|Overall Study|Does not meet entrance criteria|8
199682|NCT00346216|672694|P2|Overall Study|Does not meet entrance criteria|10
199683|NCT00346216|672695|P1|Overall Study|Does not meet entrance criteria|13
199684|NCT00346216|672693|P3|Overall Study|Physician Decision|59
199685|NCT00346216|672694|P2|Overall Study|Physician Decision|76
199686|NCT00346216|672695|P1|Overall Study|Physician Decision|80
199687|NCT00346216|672693|P3|Overall Study|Lost to Follow-up|542
199688|NCT00346216|672694|P2|Overall Study|Lost to Follow-up|588
199689|NCT00346216|672695|P1|Overall Study|Lost to Follow-up|611
199690|NCT00346216|672693|P3|Overall Study|Withdrawal by Subject|651
199691|NCT00346216|672694|P2|Overall Study|Withdrawal by Subject|692
199692|NCT00346216|672695|P1|Overall Study|Withdrawal by Subject|661
199693|NCT00346216|672693|P3|Overall Study|No longer willing to participate|585
199694|NCT00346216|672694|P2|Overall Study|No longer willing to participate|606
199695|NCT00346216|672695|P1|Overall Study|No longer willing to participate|600
199696|NCT00346216|672693|P3|Overall Study|Not specified|205
199697|NCT00346216|672694|P2|Overall Study|Not specified|231
199698|NCT00346216|672695|P1|Overall Study|Not specified|181
199699|NCT00346164|672716|P4|Overall Study|Inability to start week 16 tx on time|11
199700|NCT00346164|672717|P3|Overall Study|Inability to start week 16 tx on time|0
199701|NCT00346164|672718|P2|Overall Study|Inability to start week 16 tx on time|0
199702|NCT00346164|672719|P1|Overall Study|Inability to start week 16 tx on time|0
199703|NCT00346164|672716|P4|Overall Study|Refusal of further protocol therapy|15
199704|NCT00346164|672717|P3|Overall Study|Refusal of further protocol therapy|3
199705|NCT00346164|672718|P2|Overall Study|Refusal of further protocol therapy|1
199706|NCT00346164|672719|P1|Overall Study|Refusal of further protocol therapy|0
199707|NCT00346164|672716|P4|Overall Study|Ineligible|23
199708|NCT00346164|672717|P3|Overall Study|Ineligible|2
199709|NCT00346164|672718|P2|Overall Study|Ineligible|2
199710|NCT00346164|672719|P1|Overall Study|Ineligible|11
199711|NCT00346164|672716|P4|Overall Study|Withdrawal by Subject|0
199712|NCT00346164|672717|P3|Overall Study|Withdrawal by Subject|2
199713|NCT00346164|672718|P2|Overall Study|Withdrawal by Subject|0
199714|NCT00346164|672719|P1|Overall Study|Withdrawal by Subject|0
199715|NCT00346164|672716|P4|Overall Study|Protocol Violation|4
199716|NCT00346164|672717|P3|Overall Study|Protocol Violation|10
199717|NCT00346164|672718|P2|Overall Study|Protocol Violation|2
199718|NCT00346164|672719|P1|Overall Study|Protocol Violation|6
199719|NCT00346164|672716|P4|Overall Study|Physician Decision|27
199720|NCT00346164|672717|P3|Overall Study|Physician Decision|2
199721|NCT00346164|672718|P2|Overall Study|Physician Decision|1
199722|NCT00346164|672719|P1|Overall Study|Physician Decision|0
199723|NCT00346164|672716|P4|Overall Study|Lack of Efficacy|25
199724|NCT00346164|672717|P3|Overall Study|Lack of Efficacy|7
199725|NCT00346164|672718|P2|Overall Study|Lack of Efficacy|1
199726|NCT00346164|672719|P1|Overall Study|Lack of Efficacy|0
199727|NCT00346164|672716|P4|Overall Study|Adverse Event|1
199728|NCT00346164|672717|P3|Overall Study|Adverse Event|0
199729|NCT00346164|672718|P2|Overall Study|Adverse Event|0
199730|NCT00346164|672719|P1|Overall Study|Adverse Event|0
199731|NCT00346151|672754|P1|Overall Study|Withdrawal by Subject|3
199732|NCT00346034|672772|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
199733|NCT00346034|672772|P1|Overall Study|Patient Stopped Taking Study Drug|1
199734|NCT00346034|672772|P1|Overall Study|Withdrawal by Subject|13
199735|NCT00346034|672772|P1|Overall Study|Lack of Efficacy|8
199736|NCT00346034|672772|P1|Overall Study|Adverse Event|34
199737|NCT00345878|672812|P2|Overall Study|Other|0
199738|NCT00345878|672813|P1|Overall Study|Other|1
199739|NCT00345878|672812|P2|Overall Study|Lost to Follow-up|1
199740|NCT00345878|672813|P1|Overall Study|Lost to Follow-up|2
199741|NCT00345878|672812|P2|Overall Study|Adverse Event|0
199742|NCT00345878|672813|P1|Overall Study|Adverse Event|1
199743|NCT00345839|672831|P2|Overall Study|Lost to Follow-up|61
199744|NCT00345839|672832|P1|Overall Study|Lost to Follow-up|58
199745|NCT00345839|672831|P2|Overall Study|Withdrawal by Subject|98
199746|NCT00345839|672832|P1|Overall Study|Withdrawal by Subject|91
199747|NCT00345683|672858|P2|Overall Study|Other|2
199748|NCT00345683|672859|P1|Overall Study|Other|6
199749|NCT00345683|672858|P2|Overall Study|Lost to Follow-up|7
199750|NCT00345683|672859|P1|Overall Study|Lost to Follow-up|19
199751|NCT00345631|672882|P3|Overall Study|Other reasons|1
199752|NCT00345631|672883|P2|Overall Study|Other reasons|0
199753|NCT00345631|672884|P1|Overall Study|Other reasons|0
199754|NCT00345631|672882|P3|Overall Study|Lost to Follow-up|4
199755|NCT00345631|672883|P2|Overall Study|Lost to Follow-up|7
199756|NCT00345631|672884|P1|Overall Study|Lost to Follow-up|3
199757|NCT00345631|672882|P3|Overall Study|Adverse Event|0
199758|NCT00345631|672883|P2|Overall Study|Adverse Event|1
199759|NCT00345631|672884|P1|Overall Study|Adverse Event|0
199760|NCT00345631|672882|P3|Overall Study|Withdrawal by Subject|1
199761|NCT00345631|672883|P2|Overall Study|Withdrawal by Subject|0
199762|NCT00345631|672884|P1|Overall Study|Withdrawal by Subject|1
199763|NCT00345605|672916|P2|Arm 2, Opposite Treatment|Adverse Event|0
199764|NCT00345605|672917|P1|Arm 2, Opposite Treatment|Adverse Event|1
199765|NCT00345605|672916|P2|Arm 1|Adverse Event|1
199766|NCT00345605|672917|P1|Arm 1|Adverse Event|0
199767|NCT00345592|672937|P2|Overall Study|Withdrawal by Subject|8
199768|NCT00345592|672938|P1|Overall Study|Withdrawal by Subject|11
199769|NCT00345592|672937|P2|Overall Study|Death|16
199770|NCT00345592|672938|P1|Overall Study|Death|14
199771|NCT00345579|672946|P2|Overall Study|Other|1
199772|NCT00345579|672947|P1|Overall Study|Other|9
199773|NCT00345579|672946|P2|Overall Study|Lost to Follow-up|36
199774|NCT00345579|672947|P1|Overall Study|Lost to Follow-up|82
199775|NCT00345579|672946|P2|Overall Study|Withdrawal by Subject|17
199776|NCT00345579|672947|P1|Overall Study|Withdrawal by Subject|50
199777|NCT00345579|672946|P2|Overall Study|Protocol Violation|5
199778|NCT00345579|672947|P1|Overall Study|Protocol Violation|14
199779|NCT00345579|672946|P2|Overall Study|Adverse Event|6
199780|NCT00345579|672947|P1|Overall Study|Adverse Event|9
199781|NCT00345540|672967|P1|Overall Study|Withdrawal by Subject|1
199782|NCT00345397|672973|P1|Overall Study|Death|1
199783|NCT00345293|673011|P2|Overall Study|Withdrawal by Subject|0
199784|NCT00345293|673012|P1|Overall Study|Withdrawal by Subject|1
199785|NCT00345293|673011|P2|Overall Study|Unable to access line for sample|0
199786|NCT00345293|673012|P1|Overall Study|Unable to access line for sample|1
199787|NCT00345046|673058|P3|Overall Study|Protocol Violation|2
199788|NCT00345046|673059|P2|Overall Study|Protocol Violation|1
199789|NCT00345046|673060|P1|Overall Study|Protocol Violation|1
199790|NCT00344968|673090|P3|Overall Study|Other|0
199791|NCT00344968|673091|P2|Overall Study|Other|1
199792|NCT00344968|673092|P1|Overall Study|Other|0
199793|NCT00344968|673090|P3|Overall Study|Death|31
199794|NCT00344968|673091|P2|Overall Study|Death|27
199795|NCT00344968|673092|P1|Overall Study|Death|11
199796|NCT00344968|673090|P3|Overall Study|Lost to Follow-up|37
199797|NCT00344968|673091|P2|Overall Study|Lost to Follow-up|37
199798|NCT00344968|673092|P1|Overall Study|Lost to Follow-up|24
199799|NCT00344968|673090|P3|Overall Study|Withdrawal by Subject|27
199800|NCT00344968|673091|P2|Overall Study|Withdrawal by Subject|31
199801|NCT00344968|673092|P1|Overall Study|Withdrawal by Subject|14
199802|NCT00344968|673090|P3|Overall Study|Protocol Violation|5
199803|NCT00344968|673091|P2|Overall Study|Protocol Violation|2
199804|NCT00344968|673092|P1|Overall Study|Protocol Violation|2
199805|NCT00344968|673090|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
199806|NCT00344968|673091|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
199807|NCT00344968|673092|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
199808|NCT00344968|673090|P3|Overall Study|Adverse Event|15
199809|NCT00344968|673091|P2|Overall Study|Adverse Event|4
199810|NCT00344968|673092|P1|Overall Study|Adverse Event|5
199811|NCT00344773|673103|P1|Overall Study|Not Eligible for the study|2
199812|NCT00344773|673103|P1|Overall Study|Withdrawal by Subject|1
199813|NCT00344773|673103|P1|Overall Study|Objective Disease Progression|16
199814|NCT00344773|673103|P1|Overall Study|Adverse Event|2
199815|NCT00344500|673126|P3|Overall Study|Not Noted|0
199816|NCT00344500|673127|P2|Overall Study|Not Noted|3
199817|NCT00344500|673128|P1|Overall Study|Not Noted|1
199818|NCT00344500|673126|P3|Overall Study|Protocol Violation|1
199819|NCT00344500|673127|P2|Overall Study|Protocol Violation|7
199820|NCT00344500|673128|P1|Overall Study|Protocol Violation|4
199821|NCT00344500|673126|P3|Overall Study|Withdrawal by Subject|0
199822|NCT00344500|673127|P2|Overall Study|Withdrawal by Subject|10
199823|NCT00344500|673128|P1|Overall Study|Withdrawal by Subject|7
199824|NCT00344500|673126|P3|Overall Study|Lost to Follow-up|1
199825|NCT00344500|673127|P2|Overall Study|Lost to Follow-up|13
199826|NCT00344500|673128|P1|Overall Study|Lost to Follow-up|5
199827|NCT00344500|673126|P3|Overall Study|Adverse Event|0
199828|NCT00344500|673127|P2|Overall Study|Adverse Event|2
199829|NCT00344500|673128|P1|Overall Study|Adverse Event|6
199830|NCT00344487|673139|P1|Overall Study|immunologic failure|1
199831|NCT00344461|673143|P1|Overall Study|Withdrawal by Subject|2
199832|NCT00344461|673143|P1|Overall Study|Protocol Violation|6
199833|NCT00344461|673143|P1|Overall Study|Physician Decision|2
199834|NCT00344461|673143|P1|Overall Study|Lost to Follow-up|2
199835|NCT00344461|673143|P1|Overall Study|Lack of Efficacy|2
199836|NCT00344461|673143|P1|Overall Study|Death|1
199837|NCT00344461|673143|P1|Overall Study|Adverse Event|6
199838|NCT00344448|673154|P2|Open Label|Study terminated|0
199839|NCT00344448|673155|P1|Open Label|Study terminated|1
199840|NCT00344448|673154|P2|Open Label|Withdrawal by Subject|1
199841|NCT00344448|673155|P1|Open Label|Withdrawal by Subject|1
199842|NCT00344448|673154|P2|Double Blind, Placebo Controlled|Study terminated|0
199843|NCT00344448|673155|P1|Double Blind, Placebo Controlled|Study terminated|1
199844|NCT00344448|673154|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
199845|NCT00344448|673155|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
199846|NCT00344448|673154|P2|Screening|Withdrawal by Subject|1
199847|NCT00344448|673155|P1|Screening|Withdrawal by Subject|0
199848|NCT00344305|673174|P2|Overall Study|Participant was not contacted in window|1
199849|NCT00344305|673175|P1|Overall Study|Participant was not contacted in window|0
199850|NCT00344305|673174|P2|Overall Study|Lost to Follow-up|0
199851|NCT00344305|673175|P1|Overall Study|Lost to Follow-up|2
199852|NCT00344032|673225|P2|Overall Study|Physician Decision|1
199853|NCT00344032|673226|P1|Overall Study|Physician Decision|4
199854|NCT00344032|673225|P2|Overall Study|Lost to Follow-up|6
199855|NCT00344032|673226|P1|Overall Study|Lost to Follow-up|4
199856|NCT00344032|673225|P2|Overall Study|Withdrawal by Subject|2
199857|NCT00344032|673226|P1|Overall Study|Withdrawal by Subject|6
199858|NCT00344032|673225|P2|Overall Study|Adverse Event|1
199859|NCT00344032|673226|P1|Overall Study|Adverse Event|0
199860|NCT00344019|673245|P3|Overall Study|did not meet final inclusion criteria|74
199861|NCT00344019|673246|P2|Overall Study|did not meet final inclusion criteria|0
199862|NCT00344019|673247|P1|Overall Study|did not meet final inclusion criteria|0
199863|NCT00343915|673265|P2|Primary Study|Other|0
199864|NCT00343915|673266|P1|Primary Study|Other|1
199865|NCT00343915|673265|P2|Primary Study|Lost to Follow-up|3
199866|NCT00343915|673266|P1|Primary Study|Lost to Follow-up|2
199867|NCT00343915|673265|P2|Primary Study|Withdrawal by Subject|0
199868|NCT00343915|673266|P1|Primary Study|Withdrawal by Subject|1
199869|NCT00343889|673292|P2|Overall Study|Protocol Violation|0
199870|NCT00343889|673293|P1|Overall Study|Protocol Violation|1
199871|NCT00343889|673292|P2|Overall Study|Withdrawal by Subject|1
199872|NCT00343889|673293|P1|Overall Study|Withdrawal by Subject|0
199873|NCT00343889|673292|P2|Overall Study|Lost to Follow-up|0
199874|NCT00343889|673293|P1|Overall Study|Lost to Follow-up|2
199875|NCT00343512|673376|P1|Overall Study|Withdrawal by Subject|2
199876|NCT00343382|673464|P3|Overall Study|Other Reason Not Specified|4
199877|NCT00343382|673465|P2|Overall Study|Other Reason Not Specified|2
199878|NCT00343382|673466|P1|Overall Study|Other Reason Not Specified|1
199879|NCT00343382|673464|P3|Overall Study|Withdrawal by Subject|6
199880|NCT00343382|673465|P2|Overall Study|Withdrawal by Subject|2
199881|NCT00343382|673466|P1|Overall Study|Withdrawal by Subject|1
199882|NCT00343382|673464|P3|Overall Study|Adverse Event|7
199883|NCT00343382|673465|P2|Overall Study|Adverse Event|10
199884|NCT00343382|673466|P1|Overall Study|Adverse Event|2
199885|NCT00343291|673485|P2|Overall Study|Other|5
199886|NCT00343291|673486|P1|Overall Study|Other|8
199887|NCT00343291|673485|P2|Overall Study|Withdrawal by Subject|2
199888|NCT00343291|673486|P1|Overall Study|Withdrawal by Subject|0
199889|NCT00343291|673485|P2|Overall Study|Progressive disease|34
199890|NCT00343291|673486|P1|Overall Study|Progressive disease|33
199891|NCT00343291|673485|P2|Overall Study|Death|2
199892|NCT00343291|673486|P1|Overall Study|Death|3
199893|NCT00343291|673485|P2|Overall Study|Adverse Event|13
199894|NCT00343291|673486|P1|Overall Study|Adverse Event|13
199895|NCT00343252|673502|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
199896|NCT00343252|673503|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
199897|NCT00343252|673502|P2|18 Months (All Treated Participants)|Sponsor Decision|5
199898|NCT00343252|673503|P1|18 Months (All Treated Participants)|Sponsor Decision|8
199899|NCT00343252|673502|P2|18 Months (All Treated Participants)|Protocol Violation|3
199900|NCT00343252|673503|P1|18 Months (All Treated Participants)|Protocol Violation|3
199901|NCT00343252|673502|P2|18 Months (All Treated Participants)|Physician Decision|7
199902|NCT00343252|673503|P1|18 Months (All Treated Participants)|Physician Decision|4
199903|NCT00343252|673502|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
199904|NCT00343252|673503|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
199905|NCT00343252|673502|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
199906|NCT00343252|673503|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
199907|NCT00343252|673502|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
199908|NCT00343252|673503|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
199909|NCT00343252|673502|P2|18 Months (All Treated Participants)|Death|5
199910|NCT00343252|673503|P1|18 Months (All Treated Participants)|Death|4
199911|NCT00343252|673502|P2|18 Months (All Treated Participants)|Adverse Event|23
199912|NCT00343252|673503|P1|18 Months (All Treated Participants)|Adverse Event|31
199913|NCT00343252|673502|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
199914|NCT00343252|673503|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
199915|NCT00343252|673502|P2|12 Months (All Treated Participants)|Sponsor Decision|6
199916|NCT00343252|673503|P1|12 Months (All Treated Participants)|Sponsor Decision|9
199917|NCT00343252|673502|P2|12 Months (All Treated Participants)|Protocol Violation|2
199918|NCT00343252|673503|P1|12 Months (All Treated Participants)|Protocol Violation|3
199919|NCT00343252|673502|P2|12 Months (All Treated Participants)|Physician Decision|5
199920|NCT00343252|673503|P1|12 Months (All Treated Participants)|Physician Decision|4
199921|NCT00343252|673502|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
199922|NCT00343252|673503|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
199923|NCT00343252|673502|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
199924|NCT00343252|673503|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
199925|NCT00343252|673502|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
199926|NCT00343252|673503|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
199927|NCT00343252|673502|P2|12 Months (All Treated Participants)|Death|3
199928|NCT00343252|673503|P1|12 Months (All Treated Participants)|Death|3
199929|NCT00343252|673502|P2|12 Months (All Treated Participants)|Adverse Event|20
199930|NCT00343252|673503|P1|12 Months (All Treated Participants)|Adverse Event|22
199931|NCT00343252|673502|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
199932|NCT00343252|673503|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
199933|NCT00343252|673502|P2|6 Months (All Treated Participants)|Sponsor Decision|4
199934|NCT00343252|673503|P1|6 Months (All Treated Participants)|Sponsor Decision|7
199935|NCT00343252|673502|P2|6 Months (All Treated Participants)|Protocol Violation|2
199936|NCT00343252|673503|P1|6 Months (All Treated Participants)|Protocol Violation|2
199937|NCT00343252|673502|P2|6 Months (All Treated Participants)|Physician Decision|3
199938|NCT00343252|673503|P1|6 Months (All Treated Participants)|Physician Decision|1
199939|NCT00343252|673502|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
199940|NCT00343252|673503|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
199941|NCT00343252|673502|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
199942|NCT00343252|673503|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
199943|NCT00343252|673502|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
199944|NCT00343252|673503|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
199945|NCT00343252|673502|P2|6 Months (All Treated Participants)|Death|2
199946|NCT00343252|673503|P1|6 Months (All Treated Participants)|Death|0
199947|NCT00343252|673502|P2|6 Months (All Treated Participants)|Adverse Event|11
199948|NCT00343252|673503|P1|6 Months (All Treated Participants)|Adverse Event|17
199949|NCT00342628|673568|P3|Overall Study|moved residence|1
199950|NCT00342628|673569|P2|Overall Study|moved residence|1
199951|NCT00342628|673570|P1|Overall Study|moved residence|0
199952|NCT00342628|673568|P3|Overall Study|Death|0
199953|NCT00342628|673569|P2|Overall Study|Death|1
199954|NCT00342628|673570|P1|Overall Study|Death|1
199955|NCT00342628|673568|P3|Overall Study|Withdrawal by Subject|18
199956|NCT00342628|673569|P2|Overall Study|Withdrawal by Subject|19
199957|NCT00342628|673570|P1|Overall Study|Withdrawal by Subject|19
199958|NCT00340834|673636|P5|Extension Phase of Study|Death|1
199959|NCT00340834|673637|P4|Extension Phase of Study|Death|0
199960|NCT00340834|673638|P3|Extension Phase of Study|Death|0
199961|NCT00340834|673639|P2|Extension Phase of Study|Death|0
199962|NCT00340834|673640|P1|Extension Phase of Study|Death|0
199963|NCT00340834|673636|P5|Extension Phase of Study|Protocol Violation|0
199964|NCT00340834|673637|P4|Extension Phase of Study|Protocol Violation|0
199965|NCT00340834|673638|P3|Extension Phase of Study|Protocol Violation|0
199966|NCT00340834|673639|P2|Extension Phase of Study|Protocol Violation|0
199967|NCT00340834|673640|P1|Extension Phase of Study|Protocol Violation|3
199968|NCT00340834|673636|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
199969|NCT00340834|673637|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
199970|NCT00340834|673638|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
199971|NCT00340834|673639|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
199972|NCT00340834|673640|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
199973|NCT00340834|673636|P5|Extension Phase of Study|Administrative problems|1
199974|NCT00340834|673637|P4|Extension Phase of Study|Administrative problems|1
199975|NCT00340834|673638|P3|Extension Phase of Study|Administrative problems|0
199976|NCT00340834|673639|P2|Extension Phase of Study|Administrative problems|0
199977|NCT00340834|673640|P1|Extension Phase of Study|Administrative problems|3
199978|NCT00340834|673636|P5|Extension Phase of Study|Subject no longer requires study drug|2
199979|NCT00340834|673637|P4|Extension Phase of Study|Subject no longer requires study drug|0
199980|NCT00340834|673638|P3|Extension Phase of Study|Subject no longer requires study drug|0
199981|NCT00340834|673639|P2|Extension Phase of Study|Subject no longer requires study drug|0
199982|NCT00340834|673640|P1|Extension Phase of Study|Subject no longer requires study drug|4
199983|NCT00340834|673636|P5|Extension Phase of Study|Lost to Follow-up|3
199984|NCT00340834|673637|P4|Extension Phase of Study|Lost to Follow-up|2
199985|NCT00340834|673638|P3|Extension Phase of Study|Lost to Follow-up|0
199986|NCT00340834|673639|P2|Extension Phase of Study|Lost to Follow-up|1
199987|NCT00340834|673640|P1|Extension Phase of Study|Lost to Follow-up|1
199988|NCT00340834|673636|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
199989|NCT00340834|673637|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
199990|NCT00340834|673638|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
199991|NCT00340834|673639|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
199992|NCT00340834|673640|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
199993|NCT00340834|673636|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
199994|NCT00340834|673637|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
199995|NCT00340834|673638|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
199996|NCT00340834|673639|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
199997|NCT00340834|673640|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
199998|NCT00340834|673636|P5|Extension Phase of Study|Adverse Event|7
199999|NCT00340834|673637|P4|Extension Phase of Study|Adverse Event|19
200000|NCT00340834|673638|P3|Extension Phase of Study|Adverse Event|0
200001|NCT00340834|673639|P2|Extension Phase of Study|Adverse Event|22
200002|NCT00340834|673640|P1|Extension Phase of Study|Adverse Event|21
200003|NCT00340834|673636|P5|Extension Phase of Study|Subject withdrew consent|15
200004|NCT00340834|673637|P4|Extension Phase of Study|Subject withdrew consent|12
200005|NCT00340834|673638|P3|Extension Phase of Study|Subject withdrew consent|0
200006|NCT00340834|673639|P2|Extension Phase of Study|Subject withdrew consent|31
200007|NCT00340834|673640|P1|Extension Phase of Study|Subject withdrew consent|26
200008|NCT00340834|673636|P5|Extension Phase of Study|Subject did not receive study drug|0
200009|NCT00340834|673637|P4|Extension Phase of Study|Subject did not receive study drug|2
200010|NCT00340834|673638|P3|Extension Phase of Study|Subject did not receive study drug|0
200011|NCT00340834|673639|P2|Extension Phase of Study|Subject did not receive study drug|1
200012|NCT00340834|673640|P1|Extension Phase of Study|Subject did not receive study drug|0
200013|NCT00340834|673636|P5|Core Phase of Study|Protocol Violation|0
200014|NCT00340834|673637|P4|Core Phase of Study|Protocol Violation|0
200015|NCT00340834|673638|P3|Core Phase of Study|Protocol Violation|2
200016|NCT00340834|673639|P2|Core Phase of Study|Protocol Violation|0
200017|NCT00340834|673640|P1|Core Phase of Study|Protocol Violation|0
200018|NCT00340834|673636|P5|Core Phase of Study|Death|0
200019|NCT00340834|673637|P4|Core Phase of Study|Death|0
200020|NCT00340834|673638|P3|Core Phase of Study|Death|0
200021|NCT00340834|673639|P2|Core Phase of Study|Death|0
200022|NCT00340834|673640|P1|Core Phase of Study|Death|2
200023|NCT00340834|673636|P5|Core Phase of Study|Lost to Follow-up|0
200024|NCT00340834|673637|P4|Core Phase of Study|Lost to Follow-up|0
200025|NCT00340834|673638|P3|Core Phase of Study|Lost to Follow-up|4
200026|NCT00340834|673639|P2|Core Phase of Study|Lost to Follow-up|1
200027|NCT00340834|673640|P1|Core Phase of Study|Lost to Follow-up|1
200028|NCT00340834|673636|P5|Core Phase of Study|Abnormal test procedure result(s)|0
200029|NCT00340834|673637|P4|Core Phase of Study|Abnormal test procedure result(s)|0
200030|NCT00340834|673638|P3|Core Phase of Study|Abnormal test procedure result(s)|3
200031|NCT00340834|673639|P2|Core Phase of Study|Abnormal test procedure result(s)|3
200032|NCT00340834|673640|P1|Core Phase of Study|Abnormal test procedure result(s)|4
200033|NCT00340834|673636|P5|Core Phase of Study|Abnormal laboratory value(s)|0
200034|NCT00340834|673637|P4|Core Phase of Study|Abnormal laboratory value(s)|0
200035|NCT00340834|673638|P3|Core Phase of Study|Abnormal laboratory value(s)|1
200036|NCT00340834|673639|P2|Core Phase of Study|Abnormal laboratory value(s)|6
200037|NCT00340834|673640|P1|Core Phase of Study|Abnormal laboratory value(s)|4
200038|NCT00340834|673636|P5|Core Phase of Study|Lack of Efficacy|0
200039|NCT00340834|673637|P4|Core Phase of Study|Lack of Efficacy|0
200040|NCT00340834|673638|P3|Core Phase of Study|Lack of Efficacy|7
200041|NCT00340834|673639|P2|Core Phase of Study|Lack of Efficacy|3
200042|NCT00340834|673640|P1|Core Phase of Study|Lack of Efficacy|3
200043|NCT00340834|673636|P5|Core Phase of Study|Administrative Problems|0
200044|NCT00340834|673637|P4|Core Phase of Study|Administrative Problems|0
200045|NCT00340834|673638|P3|Core Phase of Study|Administrative Problems|7
200046|NCT00340834|673639|P2|Core Phase of Study|Administrative Problems|2
200047|NCT00340834|673640|P1|Core Phase of Study|Administrative Problems|6
200048|NCT00340834|673636|P5|Core Phase of Study|Withdrawal by Subject|0
200049|NCT00340834|673637|P4|Core Phase of Study|Withdrawal by Subject|0
200050|NCT00340834|673638|P3|Core Phase of Study|Withdrawal by Subject|16
200051|NCT00340834|673639|P2|Core Phase of Study|Withdrawal by Subject|9
200052|NCT00340834|673640|P1|Core Phase of Study|Withdrawal by Subject|11
200053|NCT00340834|673636|P5|Core Phase of Study|Adverse Event|0
200054|NCT00340834|673637|P4|Core Phase of Study|Adverse Event|0
200055|NCT00340834|673638|P3|Core Phase of Study|Adverse Event|9
200056|NCT00340834|673639|P2|Core Phase of Study|Adverse Event|9
200057|NCT00340834|673640|P1|Core Phase of Study|Adverse Event|26
200058|NCT00340704|673674|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
200059|NCT00340704|673675|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
200060|NCT00340704|673676|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
200061|NCT00340704|673677|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
200062|NCT00340704|673678|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
200063|NCT00340704|673679|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
200064|NCT00340704|673680|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
200065|NCT00340704|673681|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
200066|NCT00340704|673682|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
200067|NCT00340704|673674|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
200068|NCT00340704|673675|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
200069|NCT00340704|673676|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
200070|NCT00340704|673677|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
200071|NCT00340704|673678|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
200072|NCT00340704|673679|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
200073|NCT00340704|673680|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
200074|NCT00340704|673681|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
200075|NCT00340704|673682|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
200076|NCT00340704|673674|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
200077|NCT00340704|673675|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
200078|NCT00340704|673676|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
200079|NCT00340704|673677|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
200080|NCT00340704|673678|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
200081|NCT00340704|673679|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
200082|NCT00340704|673680|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
200083|NCT00340704|673681|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
200084|NCT00340704|673682|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
200085|NCT00340704|673674|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
200086|NCT00340704|673675|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
200087|NCT00340704|673676|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
200088|NCT00340704|673677|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
200089|NCT00340704|673678|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
200090|NCT00340704|673679|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
200091|NCT00340704|673680|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
200092|NCT00340704|673681|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
200093|NCT00340704|673682|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
200094|NCT00340704|673674|P9|PK Study|Not treated|0
200095|NCT00340704|673675|P8|PK Study|Not treated|0
200096|NCT00340704|673676|P7|PK Study|Not treated|0
200097|NCT00340704|673677|P6|PK Study|Not treated|0
200098|NCT00340704|673678|P5|PK Study|Not treated|0
200099|NCT00340704|673679|P4|PK Study|Not treated|0
200100|NCT00340704|673680|P3|PK Study|Not treated|1
200101|NCT00340704|673681|P2|PK Study|Not treated|0
200102|NCT00340704|673682|P1|PK Study|Not treated|0
200103|NCT00340704|673674|P9|PK Study|Adverse Event|0
200104|NCT00340704|673675|P8|PK Study|Adverse Event|0
200105|NCT00340704|673676|P7|PK Study|Adverse Event|0
200106|NCT00340704|673677|P6|PK Study|Adverse Event|0
200107|NCT00340704|673678|P5|PK Study|Adverse Event|0
200108|NCT00340704|673679|P4|PK Study|Adverse Event|0
200109|NCT00340704|673680|P3|PK Study|Adverse Event|0
200110|NCT00340704|673681|P2|PK Study|Adverse Event|1
200111|NCT00340704|673682|P1|PK Study|Adverse Event|0
200112|NCT00340678|673788|P4|Overall Study|Lost to Follow-up|0
200113|NCT00340678|673789|P3|Overall Study|Lost to Follow-up|0
200114|NCT00340678|673790|P2|Overall Study|Lost to Follow-up|0
200115|NCT00340678|673791|P1|Overall Study|Lost to Follow-up|1
200116|NCT00339833|673818|P2|Overall Study|Error in data records|0
200117|NCT00339833|673819|P1|Overall Study|Error in data records|1
200118|NCT00339833|673818|P2|Overall Study|anaemia or excess drop in glycaemia|0
200119|NCT00339833|673819|P1|Overall Study|anaemia or excess drop in glycaemia|2
200120|NCT00339833|673818|P2|Overall Study|Poor venous access|2
200121|NCT00339833|673819|P1|Overall Study|Poor venous access|2
200122|NCT00339833|673818|P2|Overall Study|minor infection|1
200123|NCT00339833|673819|P1|Overall Study|minor infection|0
200124|NCT00339833|673818|P2|Overall Study|Chest pain|1
200125|NCT00339833|673819|P1|Overall Study|Chest pain|0
200126|NCT00339833|673818|P2|Overall Study|indigestion|1
200127|NCT00339833|673819|P1|Overall Study|indigestion|0
200128|NCT00339833|673818|P2|Overall Study|toothache|1
200129|NCT00339833|673819|P1|Overall Study|toothache|0
200130|NCT00339833|673818|P2|Overall Study|Withdrawal by Subject|2
200131|NCT00339833|673819|P1|Overall Study|Withdrawal by Subject|1
200132|NCT00339183|673829|P2|Overall Study|Ongoing|13
200133|NCT00339183|673830|P1|Overall Study|Ongoing|20
200134|NCT00339183|673829|P2|Overall Study|Other|40
200135|NCT00339183|673830|P1|Overall Study|Other|46
200136|NCT00339183|673829|P2|Overall Study|Missing reason|1
200137|NCT00339183|673830|P1|Overall Study|Missing reason|3
200138|NCT00339183|673829|P2|Overall Study|Protocol-specified criteria|8
200139|NCT00339183|673830|P1|Overall Study|Protocol-specified criteria|12
200140|NCT00339183|673829|P2|Overall Study|Lost to Follow-up|17
200141|NCT00339183|673830|P1|Overall Study|Lost to Follow-up|17
200142|NCT00339183|673829|P2|Overall Study|Physician Decision|4
200143|NCT00339183|673830|P1|Overall Study|Physician Decision|2
200144|NCT00339183|673829|P2|Overall Study|Withdrawal by Subject|19
200145|NCT00339183|673830|P1|Overall Study|Withdrawal by Subject|16
200146|NCT00339183|673829|P2|Overall Study|Adverse Event|3
200147|NCT00339183|673830|P1|Overall Study|Adverse Event|5
200148|NCT00339144|673859|P3|Overall Study|Participant's request to discontinuation|1
200149|NCT00339144|673860|P2|Overall Study|Participant's request to discontinuation|0
200150|NCT00339144|673861|P1|Overall Study|Participant's request to discontinuation|1
200151|NCT00339144|673859|P3|Overall Study|Study drug toxicity|1
200152|NCT00339144|673860|P2|Overall Study|Study drug toxicity|1
200153|NCT00339144|673861|P1|Overall Study|Study drug toxicity|3
200154|NCT00339144|673859|P3|Overall Study|Disease progression|2
200155|NCT00339144|673860|P2|Overall Study|Disease progression|2
200156|NCT00339144|673861|P1|Overall Study|Disease progression|5
200157|NCT00339040|673966|P2|Stage II|Site closing|0
200158|NCT00339040|673967|P1|Stage II|Site closing|2
200159|NCT00339040|673966|P2|Stage II|Not able to attend clinic|0
200160|NCT00339040|673967|P1|Stage II|Not able to attend clinic|1
200161|NCT00339040|673966|P2|Stage II|Protocol Violation|0
200162|NCT00339040|673967|P1|Stage II|Protocol Violation|3
200163|NCT00339040|673966|P2|Stage II|Withdrawal by Subject|2
200164|NCT00339040|673967|P1|Stage II|Withdrawal by Subject|1
200165|NCT00339040|673966|P2|Stage II|Lost to Follow-up|0
200166|NCT00339040|673967|P1|Stage II|Lost to Follow-up|3
200167|NCT00339040|673966|P2|Stage I|Protocol Violation|1
200168|NCT00339040|673967|P1|Stage I|Protocol Violation|1
200169|NCT00339040|673966|P2|Stage I|Not able to attend clinic|0
200170|NCT00339040|673967|P1|Stage I|Not able to attend clinic|1
200171|NCT00338962|673994|P4|Overall Study|Poor Compliance|0
200172|NCT00338962|673995|P3|Overall Study|Poor Compliance|2
200173|NCT00338962|673996|P2|Overall Study|Poor Compliance|0
200174|NCT00338962|673997|P1|Overall Study|Poor Compliance|0
200175|NCT00338962|673994|P4|Overall Study|Adverse Event|0
200176|NCT00338962|673995|P3|Overall Study|Adverse Event|2
200177|NCT00338962|673996|P2|Overall Study|Adverse Event|0
200178|NCT00338962|673997|P1|Overall Study|Adverse Event|0
200179|NCT00338962|673994|P4|Overall Study|Moved|0
200180|NCT00338962|673995|P3|Overall Study|Moved|0
200181|NCT00338962|673996|P2|Overall Study|Moved|1
200182|NCT00338962|673997|P1|Overall Study|Moved|0
200183|NCT00338962|673994|P4|Overall Study|Time Constraint|0
200184|NCT00338962|673995|P3|Overall Study|Time Constraint|0
200185|NCT00338962|673996|P2|Overall Study|Time Constraint|0
200186|NCT00338962|673997|P1|Overall Study|Time Constraint|2
200187|NCT00338962|673994|P4|Overall Study|No Transportation|0
200188|NCT00338962|673995|P3|Overall Study|No Transportation|0
200189|NCT00338962|673996|P2|Overall Study|No Transportation|0
200190|NCT00338962|673997|P1|Overall Study|No Transportation|2
200191|NCT00338962|673994|P4|Overall Study|Withdrawal by Subject|0
200192|NCT00338962|673995|P3|Overall Study|Withdrawal by Subject|0
200193|NCT00338962|673996|P2|Overall Study|Withdrawal by Subject|0
200194|NCT00338962|673997|P1|Overall Study|Withdrawal by Subject|1
200195|NCT00338962|673994|P4|Overall Study|Lost to Follow-up|3
200196|NCT00338962|673995|P3|Overall Study|Lost to Follow-up|2
200197|NCT00338962|673996|P2|Overall Study|Lost to Follow-up|3
200198|NCT00338962|673997|P1|Overall Study|Lost to Follow-up|3
200199|NCT00338884|674019|P1|Overall Study|Randomized But Did Not Receive Treatment|1
200200|NCT00338884|674019|P1|Overall Study|Lost to Follow-up|1
200201|NCT00338884|674019|P1|Overall Study|Withdrawal by Subject|3
200202|NCT00338884|674019|P1|Overall Study|Global Deterioration of Health Status|3
200203|NCT00338884|674019|P1|Overall Study|Other|4
200204|NCT00338884|674019|P1|Overall Study|Death|8
200205|NCT00338884|674019|P1|Overall Study|Adverse Event|14
200206|NCT00338884|674019|P1|Overall Study|Objective Disease Progression or Relapse|44
200207|NCT00338806|674053|P2|Follow-up|Lost to Follow-up|3
200208|NCT00338806|674054|P1|Follow-up|Lost to Follow-up|1
200209|NCT00338806|674053|P2|Acute Phase|Withdrawal by Subject|1
200210|NCT00338806|674054|P1|Acute Phase|Withdrawal by Subject|0
200211|NCT00338741|674116|P2|Overall Study|Lost to Follow-up|0
200212|NCT00338741|674117|P1|Overall Study|Lost to Follow-up|2
200213|NCT00338455|674148|P2|Overall Study|Physician Decision|0
200214|NCT00338455|674149|P1|Overall Study|Physician Decision|1
200215|NCT00338455|674148|P2|Overall Study|Death|1
200216|NCT00338455|674149|P1|Overall Study|Death|2
200217|NCT00338286|674163|P2|Overall Study|Other|93
200218|NCT00338286|674164|P1|Overall Study|Other|103
200219|NCT00338286|674163|P2|Overall Study|Lost to Follow-up|66
200220|NCT00338286|674164|P1|Overall Study|Lost to Follow-up|80
200221|NCT00338286|674163|P2|Overall Study|Withdrawal by Subject|54
200222|NCT00338286|674164|P1|Overall Study|Withdrawal by Subject|50
200223|NCT00338104|674181|P3|Overall Study|Protocol Violation|3
200224|NCT00338104|674182|P2|Overall Study|Protocol Violation|1
200225|NCT00338104|674183|P1|Overall Study|Protocol Violation|2
200226|NCT00337935|674206|P2|Overall Study|Lack of Efficacy|1
200227|NCT00337935|674207|P1|Overall Study|Lack of Efficacy|0
200228|NCT00337935|674206|P2|Overall Study|Other|1
200229|NCT00337935|674207|P1|Overall Study|Other|0
200230|NCT00337935|674206|P2|Overall Study|Withdrawal by Subject|7
200231|NCT00337935|674207|P1|Overall Study|Withdrawal by Subject|1
200232|NCT00337935|674206|P2|Overall Study|Protocol Violation|3
200233|NCT00337935|674207|P1|Overall Study|Protocol Violation|4
200234|NCT00337935|674206|P2|Overall Study|Lost to Follow-up|1
200235|NCT00337935|674207|P1|Overall Study|Lost to Follow-up|0
200236|NCT00337935|674206|P2|Overall Study|Physician Decision|1
200237|NCT00337935|674207|P1|Overall Study|Physician Decision|1
200238|NCT00337935|674206|P2|Overall Study|Death|8
200239|NCT00337935|674207|P1|Overall Study|Death|2
200240|NCT00337935|674206|P2|Overall Study|Adverse Event|5
200241|NCT00337935|674207|P1|Overall Study|Adverse Event|2
200242|NCT00337818|674220|P3|Overall Study|Lost to Follow-up|107
200243|NCT00337818|674221|P2|Overall Study|Lost to Follow-up|91
200244|NCT00337818|674222|P1|Overall Study|Lost to Follow-up|289
200245|NCT00337779|674244|P2|Overall Study|Death|1
200246|NCT00337779|674245|P1|Overall Study|Death|0
200247|NCT00337779|674244|P2|Overall Study|Pregnancy|2
200248|NCT00337779|674245|P1|Overall Study|Pregnancy|3
200249|NCT00337779|674244|P2|Overall Study|Adverse Event|51
200250|NCT00337779|674245|P1|Overall Study|Adverse Event|28
200251|NCT00337779|674244|P2|Overall Study|Lost to Follow-up|5
200252|NCT00337779|674245|P1|Overall Study|Lost to Follow-up|6
200253|NCT00337779|674244|P2|Overall Study|Protocol Violation|1
200254|NCT00337779|674245|P1|Overall Study|Protocol Violation|1
200255|NCT00337779|674244|P2|Overall Study|Physician Decision|6
200256|NCT00337779|674245|P1|Overall Study|Physician Decision|3
200257|NCT00337779|674244|P2|Overall Study|Sponsor decision|1
200258|NCT00337779|674245|P1|Overall Study|Sponsor decision|1
200259|NCT00337779|674244|P2|Overall Study|Withdrawal by Subject|12
200260|NCT00337779|674245|P1|Overall Study|Withdrawal by Subject|10
200261|NCT00337727|674257|P2|Overall Study|Withdrawal by Subject|5
200262|NCT00337727|674258|P1|Overall Study|Withdrawal by Subject|3
200263|NCT00337727|674257|P2|Overall Study|Protocol Violation|0
200264|NCT00337727|674258|P1|Overall Study|Protocol Violation|4
200265|NCT00337727|674257|P2|Overall Study|Physician Decision|0
200266|NCT00337727|674258|P1|Overall Study|Physician Decision|1
200267|NCT00337727|674257|P2|Overall Study|Lost to Follow-up|4
200268|NCT00337727|674258|P1|Overall Study|Lost to Follow-up|5
200269|NCT00337727|674257|P2|Overall Study|Adverse Event|3
200270|NCT00337727|674258|P1|Overall Study|Adverse Event|5
200271|NCT00337675|674269|P3|Overall Study|Trial Terminated|2
200272|NCT00337675|674270|P2|Overall Study|Trial Terminated|0
200273|NCT00337675|674271|P1|Overall Study|Trial Terminated|0
200274|NCT00337675|674269|P3|Overall Study|Progressive Disease|0
200275|NCT00337675|674270|P2|Overall Study|Progressive Disease|2
200276|NCT00337675|674271|P1|Overall Study|Progressive Disease|0
200277|NCT00337675|674269|P3|Overall Study|Withdrawal by Subject|19
200278|NCT00337675|674270|P2|Overall Study|Withdrawal by Subject|25
200279|NCT00337675|674271|P1|Overall Study|Withdrawal by Subject|25
200280|NCT00337675|674269|P3|Overall Study|Protocol Violation|19
200281|NCT00337675|674270|P2|Overall Study|Protocol Violation|24
200282|NCT00337675|674271|P1|Overall Study|Protocol Violation|21
200283|NCT00337675|674269|P3|Overall Study|Physician Decision|14
200284|NCT00337675|674270|P2|Overall Study|Physician Decision|17
200285|NCT00337675|674271|P1|Overall Study|Physician Decision|9
200286|NCT00337675|674269|P3|Overall Study|Lost to Follow-up|17
200287|NCT00337675|674270|P2|Overall Study|Lost to Follow-up|19
200288|NCT00337675|674271|P1|Overall Study|Lost to Follow-up|22
200289|NCT00337675|674269|P3|Overall Study|Lack of Efficacy|9
200290|NCT00337675|674270|P2|Overall Study|Lack of Efficacy|7
200291|NCT00337675|674271|P1|Overall Study|Lack of Efficacy|10
200292|NCT00337675|674269|P3|Overall Study|Adverse Event|19
200293|NCT00337675|674270|P2|Overall Study|Adverse Event|9
200294|NCT00337675|674271|P1|Overall Study|Adverse Event|10
200295|NCT00337662|674288|P4|Study Period III|Clinical Relapse|0
200296|NCT00337662|674289|P3|Study Period III|Clinical Relapse|0
200297|NCT00337662|674290|P2|Study Period III|Clinical Relapse|0
200298|NCT00337662|674291|P1|Study Period III|Clinical Relapse|1
200299|NCT00337662|674288|P4|Study Period III|Sponsor Decision|0
200300|NCT00337662|674289|P3|Study Period III|Sponsor Decision|1
200301|NCT00337662|674290|P2|Study Period III|Sponsor Decision|0
200302|NCT00337662|674291|P1|Study Period III|Sponsor Decision|1
200303|NCT00337662|674288|P4|Study Period III|Parent/Caregiver Decision|0
200304|NCT00337662|674289|P3|Study Period III|Parent/Caregiver Decision|2
200305|NCT00337662|674290|P2|Study Period III|Parent/Caregiver Decision|0
200306|NCT00337662|674291|P1|Study Period III|Parent/Caregiver Decision|0
200307|NCT00337662|674288|P4|Study Period III|Lack of Efficacy|0
200308|NCT00337662|674289|P3|Study Period III|Lack of Efficacy|2
200309|NCT00337662|674290|P2|Study Period III|Lack of Efficacy|4
200310|NCT00337662|674291|P1|Study Period III|Lack of Efficacy|4
200311|NCT00337662|674288|P4|Study Period III|Entry Criteria Not Met|0
200312|NCT00337662|674289|P3|Study Period III|Entry Criteria Not Met|3
200313|NCT00337662|674290|P2|Study Period III|Entry Criteria Not Met|1
200314|NCT00337662|674291|P1|Study Period III|Entry Criteria Not Met|4
200315|NCT00337662|674288|P4|Study Period III|Physician Decision|0
200316|NCT00337662|674289|P3|Study Period III|Physician Decision|0
200317|NCT00337662|674290|P2|Study Period III|Physician Decision|5
200318|NCT00337662|674291|P1|Study Period III|Physician Decision|6
200319|NCT00337662|674288|P4|Study Period III|Protocol Violation|0
200320|NCT00337662|674289|P3|Study Period III|Protocol Violation|2
200321|NCT00337662|674290|P2|Study Period III|Protocol Violation|8
200322|NCT00337662|674291|P1|Study Period III|Protocol Violation|3
200323|NCT00337662|674288|P4|Study Period III|Adverse Event|0
200324|NCT00337662|674289|P3|Study Period III|Adverse Event|8
200325|NCT00337662|674290|P2|Study Period III|Adverse Event|10
200326|NCT00337662|674291|P1|Study Period III|Adverse Event|9
200327|NCT00337662|674288|P4|Study Period III|Withdrawal by Subject|0
200328|NCT00337662|674289|P3|Study Period III|Withdrawal by Subject|12
200329|NCT00337662|674290|P2|Study Period III|Withdrawal by Subject|14
200330|NCT00337662|674291|P1|Study Period III|Withdrawal by Subject|18
200331|NCT00337662|674288|P4|Study Period III|Lost to Follow-up|0
200332|NCT00337662|674289|P3|Study Period III|Lost to Follow-up|14
200333|NCT00337662|674290|P2|Study Period III|Lost to Follow-up|16
200334|NCT00337662|674291|P1|Study Period III|Lost to Follow-up|14
200335|NCT00337662|674288|P4|Study Period II|Parent/Caregiver Decision|1
200336|NCT00337662|674289|P3|Study Period II|Parent/Caregiver Decision|0
200337|NCT00337662|674290|P2|Study Period II|Parent/Caregiver Decision|0
200338|NCT00337662|674291|P1|Study Period II|Parent/Caregiver Decision|0
200339|NCT00337662|674288|P4|Study Period II|Sponsor Decision|2
200340|NCT00337662|674289|P3|Study Period II|Sponsor Decision|0
200341|NCT00337662|674290|P2|Study Period II|Sponsor Decision|0
200342|NCT00337662|674291|P1|Study Period II|Sponsor Decision|0
200343|NCT00337662|674288|P4|Study Period II|Lack of Efficacy|7
200344|NCT00337662|674289|P3|Study Period II|Lack of Efficacy|0
200345|NCT00337662|674290|P2|Study Period II|Lack of Efficacy|0
200346|NCT00337662|674291|P1|Study Period II|Lack of Efficacy|0
200347|NCT00337662|674288|P4|Study Period II|Protocol Violation|6
200348|NCT00337662|674289|P3|Study Period II|Protocol Violation|0
200349|NCT00337662|674290|P2|Study Period II|Protocol Violation|0
200350|NCT00337662|674291|P1|Study Period II|Protocol Violation|0
200351|NCT00337662|674288|P4|Study Period II|Entry Criteria Not Met|6
200352|NCT00337662|674289|P3|Study Period II|Entry Criteria Not Met|0
200353|NCT00337662|674290|P2|Study Period II|Entry Criteria Not Met|0
200354|NCT00337662|674291|P1|Study Period II|Entry Criteria Not Met|0
200355|NCT00337662|674288|P4|Study Period II|Physician Decision|13
200356|NCT00337662|674289|P3|Study Period II|Physician Decision|0
200357|NCT00337662|674290|P2|Study Period II|Physician Decision|0
200358|NCT00337662|674291|P1|Study Period II|Physician Decision|0
200359|NCT00337662|674288|P4|Study Period II|Adverse Event|16
200360|NCT00337662|674289|P3|Study Period II|Adverse Event|0
200361|NCT00337662|674290|P2|Study Period II|Adverse Event|0
200362|NCT00337662|674291|P1|Study Period II|Adverse Event|0
200363|NCT00337662|674288|P4|Study Period II|Withdrawal by Subject|20
200364|NCT00337662|674289|P3|Study Period II|Withdrawal by Subject|0
200365|NCT00337662|674290|P2|Study Period II|Withdrawal by Subject|0
200366|NCT00337662|674291|P1|Study Period II|Withdrawal by Subject|0
200367|NCT00337662|674288|P4|Study Period II|Lost to Follow-up|35
200368|NCT00337662|674289|P3|Study Period II|Lost to Follow-up|0
200369|NCT00337662|674290|P2|Study Period II|Lost to Follow-up|0
200370|NCT00337662|674291|P1|Study Period II|Lost to Follow-up|0
200371|NCT00337610|674345|P2|Overall Study|Withdrawal by Subject|5
200372|NCT00337610|674346|P1|Overall Study|Withdrawal by Subject|6
200373|NCT00337610|674345|P2|Overall Study|Lost to Follow-up|3
200374|NCT00337610|674346|P1|Overall Study|Lost to Follow-up|3
200375|NCT00337610|674345|P2|Overall Study|Lack of Efficacy|3
200376|NCT00337610|674346|P1|Overall Study|Lack of Efficacy|6
200377|NCT00337610|674345|P2|Overall Study|Death|1
200378|NCT00337610|674346|P1|Overall Study|Death|0
200379|NCT00337610|674345|P2|Overall Study|Adverse Event|2
200380|NCT00337610|674346|P1|Overall Study|Adverse Event|2
200381|NCT00337571|674362|P4|Overall Study|High Potassium level|1
200382|NCT00337571|674363|P3|Overall Study|High Potassium level|0
200383|NCT00337571|674364|P2|Overall Study|High Potassium level|0
200384|NCT00337571|674365|P1|Overall Study|High Potassium level|0
200385|NCT00337571|674362|P4|Overall Study|No longer met study criteria|0
200386|NCT00337571|674363|P3|Overall Study|No longer met study criteria|0
200387|NCT00337571|674364|P2|Overall Study|No longer met study criteria|0
200388|NCT00337571|674365|P1|Overall Study|No longer met study criteria|1
200389|NCT00337571|674362|P4|Overall Study|Poor/noncompliance|1
200390|NCT00337571|674363|P3|Overall Study|Poor/noncompliance|1
200391|NCT00337571|674364|P2|Overall Study|Poor/noncompliance|1
200392|NCT00337571|674365|P1|Overall Study|Poor/noncompliance|1
200393|NCT00337571|674362|P4|Overall Study|Lost to Follow-up|1
200394|NCT00337571|674363|P3|Overall Study|Lost to Follow-up|0
200395|NCT00337571|674364|P2|Overall Study|Lost to Follow-up|1
200396|NCT00337571|674365|P1|Overall Study|Lost to Follow-up|3
200397|NCT00337571|674362|P4|Overall Study|Withdrawal by Subject|0
200398|NCT00337571|674363|P3|Overall Study|Withdrawal by Subject|1
200399|NCT00337571|674364|P2|Overall Study|Withdrawal by Subject|2
200400|NCT00337571|674365|P1|Overall Study|Withdrawal by Subject|2
200401|NCT00337571|674362|P4|Overall Study|Adverse Event|4
200402|NCT00337571|674363|P3|Overall Study|Adverse Event|8
200403|NCT00337571|674364|P2|Overall Study|Adverse Event|5
200404|NCT00337571|674365|P1|Overall Study|Adverse Event|4
200405|NCT00337571|674362|P4|Overall Study|Lack of Efficacy|0
200406|NCT00337571|674363|P3|Overall Study|Lack of Efficacy|0
200407|NCT00337571|674364|P2|Overall Study|Lack of Efficacy|0
200408|NCT00337571|674365|P1|Overall Study|Lack of Efficacy|3
200409|NCT00337467|674403|P1|Overall Study|Subject No Longer Met Study Criteria|2
200410|NCT00337467|674403|P1|Overall Study|Lost to Follow-up|2
200411|NCT00337467|674403|P1|Overall Study|Pregnancy|1
200412|NCT00337467|674403|P1|Overall Study|Subject Withdrew Consent|2
200413|NCT00337467|674403|P1|Overall Study|Adverse Event|3
200414|NCT00337428|674422|P2|Overall Study|Anorexia|0
200415|NCT00337428|674423|P1|Overall Study|Anorexia|1
200416|NCT00337428|674422|P2|Overall Study|Unwilling to Continue|0
200417|NCT00337428|674423|P1|Overall Study|Unwilling to Continue|1
200418|NCT00337428|674422|P2|Overall Study|Lack of Time|1
200419|NCT00337428|674423|P1|Overall Study|Lack of Time|1
200420|NCT00337428|674422|P2|Overall Study|Withdrawal by Subject|2
200421|NCT00337428|674423|P1|Overall Study|Withdrawal by Subject|1
200422|NCT00337285|674474|P1|Overall Study|Lack of protocol compliance|7
200423|NCT00337285|674474|P1|Overall Study|Physician Decision|1
200424|NCT00337285|674474|P1|Overall Study|Death|1
200425|NCT00337285|674474|P1|Overall Study|Lack of Efficacy|11
200426|NCT00337285|674474|P1|Overall Study|Protocol Violation|27
200427|NCT00337285|674474|P1|Overall Study|Adverse Event|28
200428|NCT00337285|674474|P1|Overall Study|Lost to Follow-up|41
200429|NCT00337285|674474|P1|Overall Study|Withdrawal by Subject|42
200430|NCT00337272|674482|P2|Withdrawal Period|Non-compliance|1
200431|NCT00337272|674483|P1|Withdrawal Period|Non-compliance|0
200432|NCT00337272|674482|P2|Treatment Period|Withdrawal by Subject|1
200433|NCT00337272|674483|P1|Treatment Period|Withdrawal by Subject|0
200434|NCT00337272|674482|P2|Treatment Period|Non-compliance|1
200435|NCT00337272|674483|P1|Treatment Period|Non-compliance|1
200436|NCT00337272|674482|P2|Screening Period (Pre-randomization)|Screen failure|0
200437|NCT00337272|674483|P1|Screening Period (Pre-randomization)|Screen failure|3
200438|NCT00337272|674482|P2|Screening Period (Pre-randomization)|Non-compliance|0
200439|NCT00337272|674483|P1|Screening Period (Pre-randomization)|Non-compliance|1
200440|NCT00337272|674482|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
200441|NCT00337272|674483|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
200442|NCT00337207|674503|P1|Overall Study|Withdrawal by Subject|3
200443|NCT00337194|674509|P2|Overall Study|Subsequent non-protocol therapy|1
200444|NCT00337194|674510|P1|Overall Study|Subsequent non-protocol therapy|3
200445|NCT00337194|674509|P2|Overall Study|Disease progression|2
200446|NCT00337194|674510|P1|Overall Study|Disease progression|1
200447|NCT00337194|674509|P2|Overall Study|Withdrawal by Subject|0
200448|NCT00337194|674510|P1|Overall Study|Withdrawal by Subject|1
200449|NCT00337194|674509|P2|Overall Study|Death|0
200450|NCT00337194|674510|P1|Overall Study|Death|2
200451|NCT00337194|674509|P2|Overall Study|Adverse Event|1
200452|NCT00337194|674510|P1|Overall Study|Adverse Event|5
200453|NCT00337168|674525|P1|Overall Study|Did not start therapy|1
200454|NCT00337168|674525|P1|Overall Study|Not protocol specified|2
200455|NCT00337168|674525|P1|Overall Study|Death|5
200456|NCT00337129|674532|P1|Overall Study|not protocol specified|1
200457|NCT00337129|674532|P1|Overall Study|Death|2
200458|NCT00337129|674532|P1|Overall Study|Lack of Efficacy|32
200459|NCT00337129|674532|P1|Overall Study|Withdrawal by Subject|1
200460|NCT00337129|674532|P1|Overall Study|Adverse Event|4
200461|NCT00337103|674541|P2|Overall Study|Death|0
200462|NCT00337103|674542|P1|Overall Study|Death|1
200463|NCT00337103|674541|P2|Overall Study|Lost to Follow-up|2
200464|NCT00337103|674542|P1|Overall Study|Lost to Follow-up|1
200465|NCT00337103|674541|P2|Overall Study|Entry Criteria Not Met|1
200466|NCT00337103|674542|P1|Overall Study|Entry Criteria Not Met|4
200467|NCT00337103|674541|P2|Overall Study|Not specified|6
200468|NCT00337103|674542|P1|Overall Study|Not specified|5
200469|NCT00337103|674541|P2|Overall Study|Withdrawal by Subject|5
200470|NCT00337103|674542|P1|Overall Study|Withdrawal by Subject|8
200471|NCT00337103|674541|P2|Overall Study|Physician Decision|14
200472|NCT00337103|674542|P1|Overall Study|Physician Decision|15
200473|NCT00337103|674541|P2|Overall Study|Clinical Progression|24
200474|NCT00337103|674542|P1|Overall Study|Clinical Progression|27
200475|NCT00337103|674541|P2|Overall Study|Subject Choice|27
200476|NCT00337103|674542|P1|Overall Study|Subject Choice|34
200477|NCT00337103|674541|P2|Overall Study|Adverse Event|59
200478|NCT00337103|674542|P1|Overall Study|Adverse Event|45
200479|NCT00337103|674541|P2|Overall Study|Progressive Disease|405
200480|NCT00337103|674542|P1|Overall Study|Progressive Disease|409
200481|NCT00337077|674553|P3|Overall Study|Ineligible|1
200482|NCT00337077|674554|P2|Overall Study|Ineligible|1
200483|NCT00337077|674555|P1|Overall Study|Ineligible|1
200484|NCT00337077|674553|P3|Overall Study|Never started treatment|0
200485|NCT00337077|674554|P2|Overall Study|Never started treatment|1
200486|NCT00337077|674555|P1|Overall Study|Never started treatment|1
200487|NCT00337077|674553|P3|Overall Study|Physician Decision|2
200488|NCT00337077|674554|P2|Overall Study|Physician Decision|4
200489|NCT00337077|674555|P1|Overall Study|Physician Decision|1
200490|NCT00337077|674553|P3|Overall Study|Alternative therapy|0
200491|NCT00337077|674554|P2|Overall Study|Alternative therapy|0
200492|NCT00337077|674555|P1|Overall Study|Alternative therapy|1
200493|NCT00337077|674553|P3|Overall Study|Withdrawal by Subject|2
200494|NCT00337077|674554|P2|Overall Study|Withdrawal by Subject|2
200495|NCT00337077|674555|P1|Overall Study|Withdrawal by Subject|7
200496|NCT00337077|674553|P3|Overall Study|Death|0
200497|NCT00337077|674554|P2|Overall Study|Death|1
200498|NCT00337077|674555|P1|Overall Study|Death|0
200499|NCT00337077|674553|P3|Overall Study|Adverse Event|1
200500|NCT00337077|674554|P2|Overall Study|Adverse Event|7
200501|NCT00337077|674555|P1|Overall Study|Adverse Event|7
200502|NCT00337077|674553|P3|Overall Study|Progressive disease|19
200503|NCT00337077|674554|P2|Overall Study|Progressive disease|37
200504|NCT00337077|674555|P1|Overall Study|Progressive disease|25
200505|NCT00336895|674570|P1|Overall Study|screen failed|1
200506|NCT00336895|674570|P1|Overall Study|Physician Decision|1
200507|NCT00336895|674570|P1|Overall Study|nausea and upset stomach|1
200508|NCT00336895|674570|P1|Overall Study|diarrhea|1
200509|NCT00336856|674576|P1|Overall Study|Found ineligible at time of analysis|1
200510|NCT00336856|674576|P1|Overall Study|Withdrawal by Subject|3
200511|NCT00336583|674624|P1|Overall Study|Death|1
200512|NCT00336583|674624|P1|Overall Study|Lost to Follow-up|1
200513|NCT00336544|674631|P2|Overall Study|Other|5
200514|NCT00336544|674632|P1|Overall Study|Other|3
200515|NCT00336544|674631|P2|Overall Study|Withdrawal by Subject|3
200516|NCT00336544|674632|P1|Overall Study|Withdrawal by Subject|4
200517|NCT00336544|674631|P2|Overall Study|Adverse Event|9
200518|NCT00336544|674632|P1|Overall Study|Adverse Event|4
200519|NCT00336544|674631|P2|Overall Study|Lack of Efficacy|5
200520|NCT00336544|674632|P1|Overall Study|Lack of Efficacy|8
200521|NCT00336505|674646|P2|Overall Study|Other|7
200522|NCT00336505|674647|P1|Overall Study|Other|7
200523|NCT00336505|674646|P2|Overall Study|Withdrawal by Subject|3
200524|NCT00336505|674647|P1|Overall Study|Withdrawal by Subject|5
200525|NCT00336505|674646|P2|Overall Study|Lost to Follow-up|4
200526|NCT00336505|674647|P1|Overall Study|Lost to Follow-up|7
200527|NCT00336505|674646|P2|Overall Study|Lack of Efficacy|4
200528|NCT00336505|674647|P1|Overall Study|Lack of Efficacy|8
200529|NCT00336505|674646|P2|Overall Study|Adverse Event|9
200530|NCT00336505|674647|P1|Overall Study|Adverse Event|10
200531|NCT00336492|674662|P3|Overall Study|Other|1
200532|NCT00336492|674663|P2|Overall Study|Other|0
200533|NCT00336492|674664|P1|Overall Study|Other|5
200534|NCT00336492|674662|P3|Overall Study|Lack of Efficacy|4
200535|NCT00336492|674663|P2|Overall Study|Lack of Efficacy|1
200536|NCT00336492|674664|P1|Overall Study|Lack of Efficacy|6
200537|NCT00336492|674662|P3|Overall Study|Adverse Event|6
200538|NCT00336492|674663|P2|Overall Study|Adverse Event|3
200539|NCT00336492|674664|P1|Overall Study|Adverse Event|4
200540|NCT00336479|674676|P4|Overall Study|Virologic Stopping Rule|0
200541|NCT00336479|674677|P3|Overall Study|Virologic Stopping Rule|0
200542|NCT00336479|674678|P2|Overall Study|Virologic Stopping Rule|0
200543|NCT00336479|674679|P1|Overall Study|Virologic Stopping Rule|20
200544|NCT00336479|674676|P4|Overall Study|Other|0
200545|NCT00336479|674677|P3|Overall Study|Other|1
200546|NCT00336479|674678|P2|Overall Study|Other|0
200547|NCT00336479|674679|P1|Overall Study|Other|0
200548|NCT00336479|674676|P4|Overall Study|Withdrawal by Subject|0
200549|NCT00336479|674677|P3|Overall Study|Withdrawal by Subject|3
200550|NCT00336479|674678|P2|Overall Study|Withdrawal by Subject|2
200551|NCT00336479|674679|P1|Overall Study|Withdrawal by Subject|3
200552|NCT00336479|674676|P4|Overall Study|Lost to Follow-up|0
200553|NCT00336479|674677|P3|Overall Study|Lost to Follow-up|0
200554|NCT00336479|674678|P2|Overall Study|Lost to Follow-up|2
200555|NCT00336479|674679|P1|Overall Study|Lost to Follow-up|3
200556|NCT00336479|674676|P4|Overall Study|Physician Decision|0
200557|NCT00336479|674677|P3|Overall Study|Physician Decision|1
200558|NCT00336479|674678|P2|Overall Study|Physician Decision|3
200559|NCT00336479|674679|P1|Overall Study|Physician Decision|2
200560|NCT00336479|674676|P4|Overall Study|Noncompliant|0
200561|NCT00336479|674677|P3|Overall Study|Noncompliant|3
200562|NCT00336479|674678|P2|Overall Study|Noncompliant|7
200563|NCT00336479|674679|P1|Overall Study|Noncompliant|1
200564|NCT00336479|674676|P4|Overall Study|Adverse Event|4
200565|NCT00336479|674677|P3|Overall Study|Adverse Event|18
200566|NCT00336479|674678|P2|Overall Study|Adverse Event|11
200567|NCT00336479|674679|P1|Overall Study|Adverse Event|8
200568|NCT00336284|674768|P2|Overall Study|Withdrawal by Physician or Subject|64
200569|NCT00336284|674769|P1|Overall Study|Withdrawal by Physician or Subject|102
200570|NCT00336284|674768|P2|Overall Study|Lost to Follow-up|61
200571|NCT00336284|674769|P1|Overall Study|Lost to Follow-up|82
200572|NCT00336284|674768|P2|Overall Study|Death|26
200573|NCT00336284|674769|P1|Overall Study|Death|52
200574|NCT00335972|674787|P2|Overall Study|not given treatments|3
200575|NCT00335972|674788|P1|Overall Study|not given treatments|0
200576|NCT00335959|674798|P1|Overall Study|Ineligible|1
200577|NCT00335959|674798|P1|Overall Study|Adverse Event|2
200578|NCT00335829|674803|P1|Overall Study|Adverse Event|1
200579|NCT00335829|674803|P1|Overall Study|Lost to Follow-up|1
200580|NCT00335829|674803|P1|Overall Study|Withdrawal by Subject|1
200581|NCT00335777|674817|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
200582|NCT00335777|674817|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
200583|NCT00335777|674817|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
200584|NCT00335777|674817|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
200585|NCT00335777|674817|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
200586|NCT00335738|674824|P2|Overall Study|Ineligible|4
200587|NCT00335738|674825|P1|Overall Study|Ineligible|3
200588|NCT00335738|674824|P2|Overall Study|Withdrawal by Subject|0
200589|NCT00335738|674825|P1|Overall Study|Withdrawal by Subject|2
200590|NCT00335738|674824|P2|Overall Study|Physician Decision|0
200591|NCT00335738|674825|P1|Overall Study|Physician Decision|6
200592|NCT00335556|674857|P6|Overall Study|Refusal of further protocol therapy|0
200593|NCT00335556|674858|P5|Overall Study|Refusal of further protocol therapy|0
200594|NCT00335556|674859|P4|Overall Study|Refusal of further protocol therapy|1
200595|NCT00335556|674860|P3|Overall Study|Refusal of further protocol therapy|0
200596|NCT00335556|674861|P2|Overall Study|Refusal of further protocol therapy|4
200597|NCT00335556|674862|P1|Overall Study|Refusal of further protocol therapy|0
200598|NCT00335556|674857|P6|Overall Study|Ineligible|0
200599|NCT00335556|674858|P5|Overall Study|Ineligible|0
200600|NCT00335556|674859|P4|Overall Study|Ineligible|0
200601|NCT00335556|674860|P3|Overall Study|Ineligible|0
200602|NCT00335556|674861|P2|Overall Study|Ineligible|0
200603|NCT00335556|674862|P1|Overall Study|Ineligible|2
200604|NCT00335556|674857|P6|Overall Study|Physician Decision|0
200605|NCT00335556|674858|P5|Overall Study|Physician Decision|0
200606|NCT00335556|674859|P4|Overall Study|Physician Decision|1
200607|NCT00335556|674860|P3|Overall Study|Physician Decision|2
200608|NCT00335556|674861|P2|Overall Study|Physician Decision|6
200609|NCT00335556|674862|P1|Overall Study|Physician Decision|0
200610|NCT00335556|674857|P6|Overall Study|Lack of Efficacy|1
200611|NCT00335556|674858|P5|Overall Study|Lack of Efficacy|0
200612|NCT00335556|674859|P4|Overall Study|Lack of Efficacy|3
200613|NCT00335556|674860|P3|Overall Study|Lack of Efficacy|3
200614|NCT00335556|674861|P2|Overall Study|Lack of Efficacy|19
200615|NCT00335556|674862|P1|Overall Study|Lack of Efficacy|0
200616|NCT00335556|674857|P6|Overall Study|Death|0
200617|NCT00335556|674858|P5|Overall Study|Death|1
200618|NCT00335556|674859|P4|Overall Study|Death|0
200619|NCT00335556|674860|P3|Overall Study|Death|0
200620|NCT00335556|674861|P2|Overall Study|Death|5
200621|NCT00335556|674862|P1|Overall Study|Death|0
200622|NCT00335452|674924|P4|Overall Study|Lost to Follow-up|2
200623|NCT00335452|674925|P3|Overall Study|Lost to Follow-up|1
200624|NCT00335452|674926|P2|Overall Study|Lost to Follow-up|3
200625|NCT00335452|674927|P1|Overall Study|Lost to Follow-up|2
200626|NCT00335452|674924|P4|Overall Study|Death|129
200627|NCT00335452|674925|P3|Overall Study|Death|158
200628|NCT00335452|674926|P2|Overall Study|Death|144
200629|NCT00335452|674927|P1|Overall Study|Death|156
200630|NCT00335322|674952|P3|Overall Study|Randomised but withdrew prior to ART sta|2
200631|NCT00335322|674953|P2|Overall Study|Randomised but withdrew prior to ART sta|2
200632|NCT00335322|674954|P1|Overall Study|Randomised but withdrew prior to ART sta|1
200633|NCT00335153|674999|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
200634|NCT00335153|674999|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
200635|NCT00335153|674999|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
200636|NCT00335153|674999|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
200637|NCT00335153|674999|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
200638|NCT00335153|674999|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
200639|NCT00335153|674999|P1|Nasojejunal (NJ) Test Period|Administrative|1
200640|NCT00335153|674999|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
200641|NCT00335153|674999|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
200642|NCT00335153|674999|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
200643|NCT00335140|675036|P1|Overall Study|Ineligible|1
200644|NCT00334958|675042|P2|Overall Study|Not specified|2
200645|NCT00334958|675043|P1|Overall Study|Not specified|1
200646|NCT00334958|675042|P2|Overall Study|Adverse Event|12
200647|NCT00334958|675043|P1|Overall Study|Adverse Event|27
200648|NCT00334958|675042|P2|Overall Study|Withdrawal by Subject|4
200649|NCT00334958|675043|P1|Overall Study|Withdrawal by Subject|7
200650|NCT00334958|675042|P2|Overall Study|Request of the investigator or sponsor|1
200651|NCT00334958|675043|P1|Overall Study|Request of the investigator or sponsor|0
200652|NCT00334958|675042|P2|Overall Study|Protocol Violation|2
200653|NCT00334958|675043|P1|Overall Study|Protocol Violation|2
200654|NCT00334958|675042|P2|Overall Study|Medication Noncompliance|3
200655|NCT00334958|675043|P1|Overall Study|Medication Noncompliance|0
200656|NCT00334893|675057|P2|Overall Study|Not Treated|0
200657|NCT00334893|675058|P1|Overall Study|Not Treated|1
200658|NCT00334815|675068|P2|Overall Study|Physician Decision|4
200659|NCT00334815|675069|P1|Overall Study|Physician Decision|2
200660|NCT00334815|675068|P2|Overall Study|patient refused treatment|1
200661|NCT00334815|675069|P1|Overall Study|patient refused treatment|0
200662|NCT00334815|675068|P2|Overall Study|ineligible|1
200663|NCT00334815|675069|P1|Overall Study|ineligible|1
200664|NCT00334815|675068|P2|Overall Study|Progression|0
200665|NCT00334815|675069|P1|Overall Study|Progression|1
200666|NCT00334815|675068|P2|Overall Study|Death|2
200667|NCT00334815|675069|P1|Overall Study|Death|0
200668|NCT00334815|675068|P2|Overall Study|Adverse Event|2
200669|NCT00334815|675069|P1|Overall Study|Adverse Event|3
200670|NCT00334802|675083|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
200671|NCT00334802|675084|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
200672|NCT00334802|675083|P2|Overall Study|Adverse Event|3
200673|NCT00334802|675084|P1|Overall Study|Adverse Event|0
200674|NCT00334802|675083|P2|Overall Study|Withdrawal by Subject|4
200675|NCT00334802|675084|P1|Overall Study|Withdrawal by Subject|0
200676|NCT00334802|675083|P2|Overall Study|Physician Decision|0
200677|NCT00334802|675084|P1|Overall Study|Physician Decision|1
200678|NCT00334802|675083|P2|Overall Study|Patient Condition Aggrevated|0
200679|NCT00334802|675084|P1|Overall Study|Patient Condition Aggrevated|1
200680|NCT00334802|675083|P2|Overall Study|Lack of Efficacy|3
200681|NCT00334802|675084|P1|Overall Study|Lack of Efficacy|1
200682|NCT00334802|675083|P2|Overall Study|Toxicity|5
200683|NCT00334802|675084|P1|Overall Study|Toxicity|1
200684|NCT00334802|675083|P2|Overall Study|Progressive Disease|24
200685|NCT00334802|675084|P1|Overall Study|Progressive Disease|2
200686|NCT00334542|675117|P1|Overall Study|New cancer diagnosis|1
200687|NCT00334542|675117|P1|Overall Study|Withdrawal by Subject|1
200688|NCT00334542|675117|P1|Overall Study|Adverse Event|3
200689|NCT00334295|675122|P1|Overall Study|Patients received fewer than 3 injection|5
200690|NCT00334282|675132|P2|Overall Study|Death|100
200691|NCT00334282|675133|P1|Overall Study|Death|194
200692|NCT00334282|675132|P2|Overall Study|Withdrawal by Subject|3
200693|NCT00334282|675133|P1|Overall Study|Withdrawal by Subject|17
200694|NCT00334282|675132|P2|Overall Study|Lost to Follow-up|5
200695|NCT00334282|675133|P1|Overall Study|Lost to Follow-up|11
200696|NCT00334113|675164|P2|Overall Study|Withdrawal by Subject|1
200697|NCT00334113|675165|P1|Overall Study|Withdrawal by Subject|0
200698|NCT00334113|675164|P2|Overall Study|Lost to Follow-up|2
200699|NCT00334113|675165|P1|Overall Study|Lost to Follow-up|2
200700|NCT00333983|675188|P3|Overall Study|Withdrawal by Subject|1
200701|NCT00333983|675189|P2|Overall Study|Withdrawal by Subject|3
200702|NCT00333983|675190|P1|Overall Study|Withdrawal by Subject|0
200703|NCT00333983|675188|P3|Overall Study|Adverse Event|1
200704|NCT00333983|675189|P2|Overall Study|Adverse Event|1
200705|NCT00333983|675190|P1|Overall Study|Adverse Event|1
200706|NCT00333983|675188|P3|Overall Study|Lost to Follow-up|0
200707|NCT00333983|675189|P2|Overall Study|Lost to Follow-up|1
200708|NCT00333983|675190|P1|Overall Study|Lost to Follow-up|2
200709|NCT00333970|675200|P2|Overall Study|Withdrawal by Subject|7
200710|NCT00333970|675201|P1|Overall Study|Withdrawal by Subject|13
200711|NCT00333866|675216|P4|Overall Study|Randomized but not Treated|1
200712|NCT00333866|675217|P3|Overall Study|Randomized but not Treated|2
200713|NCT00333866|675218|P2|Overall Study|Randomized but not Treated|3
200714|NCT00333866|675219|P1|Overall Study|Randomized but not Treated|5
200715|NCT00333866|675216|P4|Overall Study|Withdrawal by Subject|9
200716|NCT00333866|675217|P3|Overall Study|Withdrawal by Subject|4
200717|NCT00333866|675218|P2|Overall Study|Withdrawal by Subject|14
200718|NCT00333866|675219|P1|Overall Study|Withdrawal by Subject|8
200719|NCT00333866|675216|P4|Overall Study|Lost to Follow-up|2
200720|NCT00333866|675217|P3|Overall Study|Lost to Follow-up|2
200721|NCT00333866|675218|P2|Overall Study|Lost to Follow-up|2
200722|NCT00333866|675219|P1|Overall Study|Lost to Follow-up|1
200723|NCT00333866|675216|P4|Overall Study|Lack of Efficacy|5
200724|NCT00333866|675217|P3|Overall Study|Lack of Efficacy|3
200725|NCT00333866|675218|P2|Overall Study|Lack of Efficacy|6
200726|NCT00333866|675219|P1|Overall Study|Lack of Efficacy|8
200727|NCT00333866|675216|P4|Overall Study|Other|2
200728|NCT00333866|675217|P3|Overall Study|Other|2
200729|NCT00333866|675218|P2|Overall Study|Other|2
200730|NCT00333866|675219|P1|Overall Study|Other|3
200731|NCT00333866|675216|P4|Overall Study|Adverse Event|47
200732|NCT00333866|675217|P3|Overall Study|Adverse Event|38
200733|NCT00333866|675218|P2|Overall Study|Adverse Event|37
200734|NCT00333866|675219|P1|Overall Study|Adverse Event|23
200735|NCT00333840|675279|P4|Second-line Treatment Period|Death|9
200736|NCT00333840|675280|P3|Second-line Treatment Period|Death|0
200737|NCT00333840|675281|P2|Second-line Treatment Period|Death|0
200738|NCT00333840|675282|P1|Second-line Treatment Period|Death|0
200739|NCT00333840|675279|P4|Second-line Treatment Period|Administrative problems|7
200740|NCT00333840|675280|P3|Second-line Treatment Period|Administrative problems|0
200741|NCT00333840|675281|P2|Second-line Treatment Period|Administrative problems|0
200742|NCT00333840|675282|P1|Second-line Treatment Period|Administrative problems|0
200743|NCT00333840|675279|P4|Second-line Treatment Period|Lost to Follow-up|6
200744|NCT00333840|675280|P3|Second-line Treatment Period|Lost to Follow-up|0
200745|NCT00333840|675281|P2|Second-line Treatment Period|Lost to Follow-up|0
200746|NCT00333840|675282|P1|Second-line Treatment Period|Lost to Follow-up|0
200747|NCT00333840|675279|P4|Second-line Treatment Period|Subject withdrew consent|34
200748|NCT00333840|675280|P3|Second-line Treatment Period|Subject withdrew consent|0
200749|NCT00333840|675281|P2|Second-line Treatment Period|Subject withdrew consent|0
200750|NCT00333840|675282|P1|Second-line Treatment Period|Subject withdrew consent|0
200751|NCT00333840|675279|P4|Second-line Treatment Period|Protocol Violation|10
200752|NCT00333840|675280|P3|Second-line Treatment Period|Protocol Violation|1
200753|NCT00333840|675281|P2|Second-line Treatment Period|Protocol Violation|0
200754|NCT00333840|675282|P1|Second-line Treatment Period|Protocol Violation|0
200755|NCT00333840|675279|P4|Second-line Treatment Period|No longer required study drug|14
200756|NCT00333840|675280|P3|Second-line Treatment Period|No longer required study drug|1
200757|NCT00333840|675281|P2|Second-line Treatment Period|No longer required study drug|0
200758|NCT00333840|675282|P1|Second-line Treatment Period|No longer required study drug|0
200759|NCT00333840|675279|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
200760|NCT00333840|675280|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
200761|NCT00333840|675281|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
200762|NCT00333840|675282|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
200763|NCT00333840|675279|P4|Second-line Treatment Period|Abnormal procedure|1
200764|NCT00333840|675280|P3|Second-line Treatment Period|Abnormal procedure|0
200765|NCT00333840|675281|P2|Second-line Treatment Period|Abnormal procedure|0
200766|NCT00333840|675282|P1|Second-line Treatment Period|Abnormal procedure|0
200767|NCT00333840|675279|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
200768|NCT00333840|675280|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
200769|NCT00333840|675281|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
200770|NCT00333840|675282|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
200771|NCT00333840|675279|P4|Second-line Treatment Period|Adverse Event|34
200772|NCT00333840|675280|P3|Second-line Treatment Period|Adverse Event|3
200773|NCT00333840|675281|P2|Second-line Treatment Period|Adverse Event|0
200774|NCT00333840|675282|P1|Second-line Treatment Period|Adverse Event|0
200775|NCT00333840|675279|P4|First-line Treatment Period|Crossed over to other treatment arm|0
200776|NCT00333840|675280|P3|First-line Treatment Period|Crossed over to other treatment arm|0
200777|NCT00333840|675281|P2|First-line Treatment Period|Crossed over to other treatment arm|363
200778|NCT00333840|675282|P1|First-line Treatment Period|Crossed over to other treatment arm|14
200779|NCT00333840|675279|P4|First-line Treatment Period|Death|0
200780|NCT00333840|675280|P3|First-line Treatment Period|Death|0
200781|NCT00333840|675281|P2|First-line Treatment Period|Death|2
200782|NCT00333840|675282|P1|First-line Treatment Period|Death|19
200783|NCT00333840|675279|P4|First-line Treatment Period|Administrative problems|0
200784|NCT00333840|675280|P3|First-line Treatment Period|Administrative problems|0
200785|NCT00333840|675281|P2|First-line Treatment Period|Administrative problems|6
200786|NCT00333840|675282|P1|First-line Treatment Period|Administrative problems|12
200787|NCT00333840|675279|P4|First-line Treatment Period|Lost to Follow-up|0
200788|NCT00333840|675280|P3|First-line Treatment Period|Lost to Follow-up|0
200789|NCT00333840|675281|P2|First-line Treatment Period|Lost to Follow-up|6
200790|NCT00333840|675282|P1|First-line Treatment Period|Lost to Follow-up|15
200791|NCT00333840|675279|P4|First-line Treatment Period|Subject withdrew consent|0
200792|NCT00333840|675280|P3|First-line Treatment Period|Subject withdrew consent|0
200793|NCT00333840|675281|P2|First-line Treatment Period|Subject withdrew consent|77
200794|NCT00333840|675282|P1|First-line Treatment Period|Subject withdrew consent|57
200795|NCT00333840|675279|P4|First-line Treatment Period|Protocol Violation|0
200796|NCT00333840|675280|P3|First-line Treatment Period|Protocol Violation|0
200797|NCT00333840|675281|P2|First-line Treatment Period|Protocol Violation|17
200798|NCT00333840|675282|P1|First-line Treatment Period|Protocol Violation|17
200799|NCT00333840|675279|P4|First-line Treatment Period|No longer required study drug|0
200800|NCT00333840|675280|P3|First-line Treatment Period|No longer required study drug|0
200801|NCT00333840|675281|P2|First-line Treatment Period|No longer required study drug|8
200802|NCT00333840|675282|P1|First-line Treatment Period|No longer required study drug|21
200803|NCT00333840|675279|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
200804|NCT00333840|675280|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
200805|NCT00333840|675281|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
200806|NCT00333840|675282|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
200807|NCT00333840|675279|P4|First-line Treatment Period|Abnormal procedure|0
200808|NCT00333840|675280|P3|First-line Treatment Period|Abnormal procedure|0
200809|NCT00333840|675281|P2|First-line Treatment Period|Abnormal procedure|0
200810|NCT00333840|675282|P1|First-line Treatment Period|Abnormal procedure|2
200811|NCT00333840|675279|P4|First-line Treatment Period|Abnormal laboratory values|0
200812|NCT00333840|675280|P3|First-line Treatment Period|Abnormal laboratory values|0
200813|NCT00333840|675281|P2|First-line Treatment Period|Abnormal laboratory values|1
200814|NCT00333840|675282|P1|First-line Treatment Period|Abnormal laboratory values|3
200815|NCT00333840|675279|P4|First-line Treatment Period|Adverse Event|0
200816|NCT00333840|675280|P3|First-line Treatment Period|Adverse Event|0
200817|NCT00333840|675281|P2|First-line Treatment Period|Adverse Event|37
200818|NCT00333840|675282|P1|First-line Treatment Period|Adverse Event|38
200819|NCT00333801|675328|P2|Overall Study|Withdrawal by Subject|1
200820|NCT00333801|675329|P1|Overall Study|Withdrawal by Subject|0
200821|NCT00333801|675328|P2|Overall Study|Incarcerated|2
200822|NCT00333801|675329|P1|Overall Study|Incarcerated|1
200823|NCT00333801|675328|P2|Overall Study|Lost to Follow-up|0
200824|NCT00333801|675329|P1|Overall Study|Lost to Follow-up|2
200825|NCT00333801|675328|P2|Overall Study|Moved to another state|3
200826|NCT00333801|675329|P1|Overall Study|Moved to another state|5
200827|NCT00333788|675347|P1|Overall Study|Other: Signed consent for another study|1
200828|NCT00333788|675347|P1|Overall Study|Other: Physician decision|1
200829|NCT00333788|675347|P1|Overall Study|Other: Medical monitor decision|1
200830|NCT00333788|675347|P1|Overall Study|Other: Subject in need of an Entocort|1
200831|NCT00333788|675347|P1|Overall Study|Other: Sponsor decision|1
200832|NCT00333788|675347|P1|Overall Study|Other: Quality of life concern|1
200833|NCT00333788|675347|P1|Overall Study|Other: Investigator decision|1
200834|NCT00333788|675347|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
200835|NCT00333788|675347|P1|Overall Study|Other: Moved|2
200836|NCT00333788|675347|P1|Overall Study|Other: Non-compliance|2
200837|NCT00333788|675347|P1|Overall Study|Withdrawal by Subject|24
200838|NCT00333788|675347|P1|Overall Study|Lost to Follow-up|2
200839|NCT00333788|675347|P1|Overall Study|Lack of Efficacy|80
200840|NCT00333788|675347|P1|Overall Study|Adverse Event|44
200841|NCT00333775|675377|P3|Overall Study|Lost to Follow-up|8
200842|NCT00333775|675378|P2|Overall Study|Lost to Follow-up|7
200843|NCT00333775|675379|P1|Overall Study|Lost to Follow-up|10
200844|NCT00333775|675377|P3|Overall Study|In Follow−up When Study Stopped|96
200845|NCT00333775|675378|P2|Overall Study|In Follow−up When Study Stopped|92
200846|NCT00333775|675379|P1|Overall Study|In Follow−up When Study Stopped|87
200847|NCT00333775|675377|P3|Overall Study|Death|143
200848|NCT00333775|675378|P2|Overall Study|Death|149
200849|NCT00333775|675379|P1|Overall Study|Death|144
200850|NCT00333619|675418|P2|Overall Study|Lost to Follow-up|3
200851|NCT00333619|675419|P1|Overall Study|Lost to Follow-up|3
200852|NCT00333619|675418|P2|Overall Study|Withdrawal by Subject|1
200853|NCT00333619|675419|P1|Overall Study|Withdrawal by Subject|6
200854|NCT00333619|675418|P2|Overall Study|Death|6
200855|NCT00333619|675419|P1|Overall Study|Death|12
200856|NCT00333359|675437|P2|Overall Study|Withdrew before Receiving One Dose|6
200857|NCT00333359|675438|P1|Overall Study|Withdrew before Receiving One Dose|2
200858|NCT00333359|675437|P2|Overall Study|Treatment Failure|8
200859|NCT00333359|675438|P1|Overall Study|Treatment Failure|3
200860|NCT00333359|675437|P2|Overall Study|Termination or Withdrawal by Sponsor|1
200861|NCT00333359|675438|P1|Overall Study|Termination or Withdrawal by Sponsor|1
200862|NCT00333359|675437|P2|Overall Study|Lost to Follow-up|25
200863|NCT00333359|675438|P1|Overall Study|Lost to Follow-up|15
200864|NCT00333359|675437|P2|Overall Study|Protocol Non-compliance|8
200865|NCT00333359|675438|P1|Overall Study|Protocol Non-compliance|2
200866|NCT00333359|675437|P2|Overall Study|Physician Decision|2
200867|NCT00333359|675438|P1|Overall Study|Physician Decision|2
200868|NCT00333359|675437|P2|Overall Study|Withdrawal by Subject|37
200869|NCT00333359|675438|P1|Overall Study|Withdrawal by Subject|19
200870|NCT00333359|675437|P2|Overall Study|Adverse Event|35
200871|NCT00333359|675438|P1|Overall Study|Adverse Event|29
200872|NCT00333229|675481|P2|Overall Study|Lack of Efficacy|1
200873|NCT00333229|675482|P1|Overall Study|Lack of Efficacy|0
200874|NCT00333138|675499|P3|Extension Study (Month6 to End of Study)|Death|0
200875|NCT00333138|675500|P2|Extension Study (Month6 to End of Study)|Death|1
200876|NCT00333138|675501|P1|Extension Study (Month6 to End of Study)|Death|0
200877|NCT00333138|675499|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
200878|NCT00333138|675500|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
200879|NCT00333138|675501|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
200880|NCT00333138|675499|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
200881|NCT00333138|675500|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
200882|NCT00333138|675501|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
200883|NCT00333138|675499|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
200884|NCT00333138|675500|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
200885|NCT00333138|675501|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
200886|NCT00333138|675499|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
200887|NCT00333138|675500|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
200888|NCT00333138|675501|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
200889|NCT00333138|675499|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
200890|NCT00333138|675500|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
200891|NCT00333138|675501|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
200892|NCT00333138|675499|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
200893|NCT00333138|675500|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
200894|NCT00333138|675501|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
200895|NCT00333138|675499|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
200896|NCT00333138|675500|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
200897|NCT00333138|675501|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
200898|NCT00333138|675499|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
200899|NCT00333138|675500|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
200900|NCT00333138|675501|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
200901|NCT00333138|675499|P3|Core Study (6 Months)|Laboratory abnormality|1
200902|NCT00333138|675500|P2|Core Study (6 Months)|Laboratory abnormality|0
200903|NCT00333138|675501|P1|Core Study (6 Months)|Laboratory abnormality|0
200904|NCT00333138|675499|P3|Core Study (6 Months)|Protocol Violation|1
200905|NCT00333138|675500|P2|Core Study (6 Months)|Protocol Violation|0
200906|NCT00333138|675501|P1|Core Study (6 Months)|Protocol Violation|1
200907|NCT00333138|675499|P3|Core Study (6 Months)|Lack of Efficacy|0
200908|NCT00333138|675500|P2|Core Study (6 Months)|Lack of Efficacy|0
200909|NCT00333138|675501|P1|Core Study (6 Months)|Lack of Efficacy|1
200910|NCT00333138|675499|P3|Core Study (6 Months)|Withdrawal by Subject|2
200911|NCT00333138|675500|P2|Core Study (6 Months)|Withdrawal by Subject|1
200912|NCT00333138|675501|P1|Core Study (6 Months)|Withdrawal by Subject|1
200913|NCT00333138|675499|P3|Core Study (6 Months)|Adverse Event|8
200914|NCT00333138|675500|P2|Core Study (6 Months)|Adverse Event|5
200915|NCT00333138|675501|P1|Core Study (6 Months)|Adverse Event|4
200916|NCT00332839|675540|P2|Follow-up (Months 12 - 60)|Death|1
200917|NCT00332839|675541|P1|Follow-up (Months 12 - 60)|Death|1
200918|NCT00332839|675540|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
200919|NCT00332839|675541|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
200920|NCT00332839|675540|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
200921|NCT00332839|675541|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
200922|NCT00332839|675540|P2|Core (Months 0 - 12)|Adverse Event|15
200923|NCT00332839|675541|P1|Core (Months 0 - 12)|Adverse Event|5
200924|NCT00332839|675540|P2|Core (Months 0 - 12)|Protocol deviation|1
200925|NCT00332839|675541|P1|Core (Months 0 - 12)|Protocol deviation|1
200926|NCT00332839|675540|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
200927|NCT00332839|675541|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
200928|NCT00332839|675540|P2|Core (Months 0 - 12)|Administrative problems|1
200929|NCT00332839|675541|P1|Core (Months 0 - 12)|Administrative problems|1
200930|NCT00332709|675572|P2|Overall Study|Abnormal test procedure result|0
200931|NCT00332709|675573|P1|Overall Study|Abnormal test procedure result|1
200932|NCT00332709|675572|P2|Overall Study|Administrative Problems|3
200933|NCT00332709|675573|P1|Overall Study|Administrative Problems|0
200934|NCT00332709|675572|P2|Overall Study|Lost to Follow-up|0
200935|NCT00332709|675573|P1|Overall Study|Lost to Follow-up|2
200936|NCT00332709|675572|P2|Overall Study|Withdrawal by Subject|3
200937|NCT00332709|675573|P1|Overall Study|Withdrawal by Subject|2
200938|NCT00332709|675572|P2|Overall Study|Adverse Event|14
200939|NCT00332709|675573|P1|Overall Study|Adverse Event|11
200940|NCT00332696|675597|P2|Overall Study|Withdrawal by Subject|0
200941|NCT00332696|675598|P1|Overall Study|Withdrawal by Subject|1
200942|NCT00332696|675597|P2|Overall Study|Lost to Follow-up|1
200943|NCT00332696|675598|P1|Overall Study|Lost to Follow-up|0
200944|NCT00332696|675597|P2|Overall Study|Condition does not justify treatment|2
200945|NCT00332696|675598|P1|Overall Study|Condition does not justify treatment|0
200946|NCT00332696|675597|P2|Overall Study|Adverse Event|2
200947|NCT00332696|675598|P1|Overall Study|Adverse Event|1
200948|NCT00332696|675597|P2|Overall Study|Insufficient therapeutic effect|11
200949|NCT00332696|675598|P1|Overall Study|Insufficient therapeutic effect|4
200950|NCT00332696|675597|P2|Overall Study|Death|14
200951|NCT00332696|675598|P1|Overall Study|Death|24
200952|NCT00332488|675674|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
200953|NCT00332488|675675|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
200954|NCT00332488|675676|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
200955|NCT00332488|675674|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
200956|NCT00332488|675675|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
200957|NCT00332488|675676|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
200958|NCT00332488|675674|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
200959|NCT00332488|675675|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
200960|NCT00332488|675676|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
200961|NCT00332488|675674|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
200962|NCT00332488|675675|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
200963|NCT00332488|675676|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
200964|NCT00332488|675674|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
200965|NCT00332488|675675|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
200966|NCT00332488|675676|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
200967|NCT00332488|675674|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
200968|NCT00332488|675675|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
200969|NCT00332488|675676|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
200970|NCT00332488|675674|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
200971|NCT00332488|675675|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
200972|NCT00332488|675676|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
200973|NCT00332488|675674|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
200974|NCT00332488|675675|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
200975|NCT00332488|675676|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
200976|NCT00332488|675674|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
200977|NCT00332488|675675|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
200978|NCT00332488|675676|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
200979|NCT00332488|675674|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
200980|NCT00332488|675675|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
200981|NCT00332488|675676|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
200982|NCT00332488|675674|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
200983|NCT00332488|675675|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
200984|NCT00332488|675676|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
200985|NCT00332488|675674|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
200986|NCT00332488|675675|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
200987|NCT00332488|675676|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
200988|NCT00332462|675688|P1|Overall Study|Graft Loss|2
200989|NCT00332462|675688|P1|Overall Study|Death|3
200990|NCT00332462|675688|P1|Overall Study|no longer requires study drug|1
200991|NCT00332462|675688|P1|Overall Study|Unsatisfactory therapeutic effect|4
200992|NCT00332462|675688|P1|Overall Study|Abnormal Lab Value|1
200993|NCT00332462|675688|P1|Overall Study|Adverse Event|5
200994|NCT00332332|675695|P1|Overall Study|Did not receive study treatment|16
200995|NCT00332332|675695|P1|Overall Study|Not specified|18
200996|NCT00332332|675695|P1|Overall Study|Disease progression|2
200997|NCT00332332|675695|P1|Overall Study|Noncompliance|2
200998|NCT00332332|675695|P1|Overall Study|Protocol deviation|4
200999|NCT00332332|675695|P1|Overall Study|Lost to Follow-up|3
201000|NCT00332332|675695|P1|Overall Study|Physician Decision|1
201001|NCT00332332|675695|P1|Overall Study|Withdrawal by Subject|8
201002|NCT00332332|675695|P1|Overall Study|Death|1
201003|NCT00332332|675695|P1|Overall Study|Adverse Event|13
201004|NCT00332241|675704|P2|Overall Study|Lost to Follow-up|1
201005|NCT00332241|675705|P1|Overall Study|Lost to Follow-up|4
201006|NCT00332241|675704|P2|Overall Study|Withdrawal by Subject|1
201007|NCT00332241|675705|P1|Overall Study|Withdrawal by Subject|2
201008|NCT00332241|675704|P2|Overall Study|Adverse Event|5
201009|NCT00332241|675705|P1|Overall Study|Adverse Event|3
201010|NCT00332241|675704|P2|Overall Study|Lack of Efficacy|1
201011|NCT00332241|675705|P1|Overall Study|Lack of Efficacy|6
201012|NCT00332189|675725|P1|Overall Study|Moved out of country|2
201013|NCT00332189|675725|P1|Overall Study|Lack of Efficacy|4
201014|NCT00332189|675725|P1|Overall Study|Withdrawal by Subject|9
201015|NCT00332189|675725|P1|Overall Study|Uncooperative/Noncompliant|3
201016|NCT00332189|675725|P1|Overall Study|Adverse Event|3
201017|NCT00331864|675767|P2|Overall Study|Death|0
201018|NCT00331864|675768|P1|Overall Study|Death|6
201019|NCT00331864|675767|P2|Overall Study|Administrative Problems|0
201020|NCT00331864|675768|P1|Overall Study|Administrative Problems|1
201021|NCT00331864|675767|P2|Overall Study|Lost to Follow-up|3
201022|NCT00331864|675768|P1|Overall Study|Lost to Follow-up|4
201023|NCT00331864|675767|P2|Overall Study|Withdrawal by Subject|0
201024|NCT00331864|675768|P1|Overall Study|Withdrawal by Subject|10
201025|NCT00331864|675767|P2|Overall Study|Protocol Violation|0
201026|NCT00331864|675768|P1|Overall Study|Protocol Violation|3
201027|NCT00331864|675767|P2|Overall Study|Lack of Efficacy|0
201028|NCT00331864|675768|P1|Overall Study|Lack of Efficacy|4
201029|NCT00331864|675767|P2|Overall Study|Adverse Event|1
201030|NCT00331864|675768|P1|Overall Study|Adverse Event|30
201031|NCT00331799|675787|P1|Overall Study|Sedation|1
201032|NCT00331799|675787|P1|Overall Study|Withdrawal by Subject|2
201033|NCT00331773|675793|P2|Overall Study|Protocol Violation|3
201034|NCT00331773|675794|P1|Overall Study|Protocol Violation|10
201035|NCT00331773|675793|P2|Overall Study|Withdrawal by Subject|4
201036|NCT00331773|675794|P1|Overall Study|Withdrawal by Subject|6
201037|NCT00331760|675822|P2|Overall Study|Ineligible / no protocol treatment|8
201038|NCT00331760|675823|P1|Overall Study|Ineligible / no protocol treatment|15
201039|NCT00331682|675829|P1|Overall Study|Adverse Event|1
201040|NCT00331552|675837|P2|Period 3: Phase II|Severe Nausea|0
201041|NCT00331552|675838|P1|Period 3: Phase II|Severe Nausea|1
201042|NCT00331552|675837|P2|Period 3: Phase II|Neurological Symptoms|0
201043|NCT00331552|675838|P1|Period 3: Phase II|Neurological Symptoms|1
201044|NCT00331422|675852|P1|Overall Study|Did not receive entire study regimen|5
201045|NCT00331409|675861|P1|Overall Study|Lack of Efficacy|4
201046|NCT00331344|675869|P9|Phase II|Death|4
201047|NCT00331344|675870|P8|Phase II|Death|0
201048|NCT00331344|675871|P7|Phase II|Death|0
201049|NCT00331344|675872|P6|Phase II|Death|0
201050|NCT00331344|675873|P5|Phase II|Death|0
201051|NCT00331344|675874|P4|Phase II|Death|0
201052|NCT00331344|675875|P3|Phase II|Death|0
201053|NCT00331344|675876|P2|Phase II|Death|0
201054|NCT00331344|675877|P1|Phase II|Death|0
201055|NCT00331344|675869|P9|Phase I|Adverse Event|0
201056|NCT00331344|675870|P8|Phase I|Adverse Event|1
201057|NCT00331344|675871|P7|Phase I|Adverse Event|0
201058|NCT00331344|675872|P6|Phase I|Adverse Event|2
201059|NCT00331344|675873|P5|Phase I|Adverse Event|2
201060|NCT00331344|675874|P4|Phase I|Adverse Event|1
201061|NCT00331344|675875|P3|Phase I|Adverse Event|0
201062|NCT00331344|675876|P2|Phase I|Adverse Event|0
201063|NCT00331344|675877|P1|Phase I|Adverse Event|0
201064|NCT00331006|675891|P1|Follow-Up Phase II|Lost to Follow-up|3
201065|NCT00331006|675891|P1|Follow-Up Phase I|Lost to Follow-up|1
201066|NCT00331006|675891|P1|Treatment Phase|Withdrawal by Subject|1
201067|NCT00331006|675891|P1|Screening Phase|Ineligible for treatment phase|4
201068|NCT00331006|675891|P1|Screening Phase|Lost to Follow-up|1
201069|NCT00331006|675891|P1|Screening Phase|enrollment halted|1
201070|NCT00331006|675891|P1|Screening Phase|Withdrawal by Subject|1
201071|NCT00330967|675904|P2|Overall Study|Physician Decision|9
201072|NCT00330967|675905|P1|Overall Study|Physician Decision|0
201073|NCT00330967|675904|P2|Overall Study|Withdrawal by Subject|5
201074|NCT00330967|675905|P1|Overall Study|Withdrawal by Subject|0
201075|NCT00330928|675916|P1|Overall Study|IVUS could not be performed.|1
201076|NCT00330928|675916|P1|Overall Study|Death|1
201077|NCT00330928|675916|P1|Overall Study|Physician Decision|9
201078|NCT00330928|675916|P1|Overall Study|Lost to Follow-up|6
201079|NCT00330759|675939|P2|Overall Study|Other|44
201080|NCT00330759|675940|P1|Overall Study|Other|36
201081|NCT00330759|675939|P2|Overall Study|Ineligibility determined|1
201082|NCT00330759|675940|P1|Overall Study|Ineligibility determined|2
201083|NCT00330759|675939|P2|Overall Study|Protocol deviation|2
201084|NCT00330759|675940|P1|Overall Study|Protocol deviation|0
201085|NCT00330759|675939|P2|Overall Study|Physician Decision|2
201086|NCT00330759|675940|P1|Overall Study|Physician Decision|1
201087|NCT00330759|675939|P2|Overall Study|Noncompliance|17
201088|NCT00330759|675940|P1|Overall Study|Noncompliance|15
201089|NCT00330759|675939|P2|Overall Study|Lost to Follow-up|22
201090|NCT00330759|675940|P1|Overall Study|Lost to Follow-up|16
201091|NCT00330759|675939|P2|Overall Study|Participant request|22
201092|NCT00330759|675940|P1|Overall Study|Participant request|31
201093|NCT00330759|675939|P2|Overall Study|Adverse Event|36
201094|NCT00330759|675940|P1|Overall Study|Adverse Event|48
201095|NCT00330759|675939|P2|Overall Study|Withdrawal by Subject|124
201096|NCT00330759|675940|P1|Overall Study|Withdrawal by Subject|143
201097|NCT00330759|675939|P2|Overall Study|Disease progression|126
201098|NCT00330759|675940|P1|Overall Study|Disease progression|104
201099|NCT00330759|675939|P2|Overall Study|Death|310
201100|NCT00330759|675940|P1|Overall Study|Death|316
201101|NCT00330681|675961|P2|Overall Study|Tracheotomy due to worsening of ALS|2
201102|NCT00330681|675962|P1|Overall Study|Tracheotomy due to worsening of ALS|1
201103|NCT00330681|675961|P2|Overall Study|Withdrawal by Subject|5
201104|NCT00330681|675962|P1|Overall Study|Withdrawal by Subject|5
201105|NCT00330681|675961|P2|Overall Study|Protocol Violation|1
201106|NCT00330681|675962|P1|Overall Study|Protocol Violation|0
201107|NCT00330681|675961|P2|Overall Study|Adverse Event|6
201108|NCT00330681|675962|P1|Overall Study|Adverse Event|3
201109|NCT00330668|675984|P1|Overall Study|Patient started Lupron|1
201110|NCT00330668|675984|P1|Overall Study|Use of exclusionary medication|1
201111|NCT00330668|675984|P1|Overall Study|Lack of Efficacy|1
201112|NCT00330668|675984|P1|Overall Study|Sponsor's decision|76
201113|NCT00330668|675984|P1|Overall Study|Withdrawal by Subject|20
201114|NCT00330668|675984|P1|Overall Study|Non-Compliance|5
201115|NCT00330668|675984|P1|Overall Study|Lost to Follow-up|9
201116|NCT00330668|675984|P1|Overall Study|Adverse Event|1
201117|NCT00330616|675991|P1|Overall Study|Not specified|1
201118|NCT00330616|675991|P1|Overall Study|Withdrawal by Subject|4
201119|NCT00330616|675991|P1|Overall Study|Lost to Follow-up|2
201120|NCT00330616|675991|P1|Overall Study|Lack of Efficacy|1
201121|NCT00330616|675991|P1|Overall Study|Adverse Event|13
201122|NCT00330460|676017|P2|Overall Study|Other|0
201123|NCT00330460|676018|P1|Overall Study|Other|1
201124|NCT00330460|676017|P2|Overall Study|Noncompliance|1
201125|NCT00330460|676018|P1|Overall Study|Noncompliance|2
201126|NCT00330460|676017|P2|Overall Study|Lost to Follow-up|3
201127|NCT00330460|676018|P1|Overall Study|Lost to Follow-up|8
201128|NCT00330460|676017|P2|Overall Study|Ineligibility determined|3
201129|NCT00330460|676018|P1|Overall Study|Ineligibility determined|1
201130|NCT00330460|676017|P2|Overall Study|Death|1
201131|NCT00330460|676018|P1|Overall Study|Death|1
201132|NCT00330460|676017|P2|Overall Study|Withdrawal by Subject|17
201133|NCT00330460|676018|P1|Overall Study|Withdrawal by Subject|18
201134|NCT00330460|676017|P2|Overall Study|Adverse Event|8
201135|NCT00330460|676018|P1|Overall Study|Adverse Event|10
201136|NCT00330460|676017|P2|Overall Study|Physician Decision|0
201137|NCT00330460|676018|P1|Overall Study|Physician Decision|1
201138|NCT00330343|676061|P1|Overall Study|Lost to Follow-up|5
201139|NCT00330174|676067|P2|Overall Study|Miscellaneous reasons|1
201140|NCT00330174|676068|P1|Overall Study|Miscellaneous reasons|7
201141|NCT00330174|676067|P2|Overall Study|Excessive missed visits|8
201142|NCT00330174|676068|P1|Overall Study|Excessive missed visits|3
201143|NCT00330174|676067|P2|Overall Study|Clinical deterioration|2
201144|NCT00330174|676068|P1|Overall Study|Clinical deterioration|1
201145|NCT00330174|676067|P2|Overall Study|Lost to Follow-up|1
201146|NCT00330174|676068|P1|Overall Study|Lost to Follow-up|4
201147|NCT00330174|676067|P2|Overall Study|Withdrawal by Subject|7
201148|NCT00330174|676068|P1|Overall Study|Withdrawal by Subject|7
201149|NCT00329901|676092|P3|Overall Study|Unable to classify|0
201150|NCT00329901|676093|P2|Overall Study|Unable to classify|2
201151|NCT00329901|676094|P1|Overall Study|Unable to classify|2
201152|NCT00329901|676092|P3|Overall Study|Protocol Violation|1
201153|NCT00329901|676093|P2|Overall Study|Protocol Violation|0
201154|NCT00329901|676094|P1|Overall Study|Protocol Violation|1
201155|NCT00329901|676092|P3|Overall Study|Lost to Follow-up|1
201156|NCT00329901|676093|P2|Overall Study|Lost to Follow-up|0
201157|NCT00329901|676094|P1|Overall Study|Lost to Follow-up|2
201158|NCT00329901|676092|P3|Overall Study|Withdrawal by Subject|2
201159|NCT00329901|676093|P2|Overall Study|Withdrawal by Subject|3
201160|NCT00329901|676094|P1|Overall Study|Withdrawal by Subject|4
201161|NCT00329849|676124|P2|Overall Study|Withdrawal by Subject|4
201162|NCT00329849|676125|P1|Overall Study|Withdrawal by Subject|6
201163|NCT00329797|676151|P2|Overall Study|Withdrawal by Subject|6
201164|NCT00329797|676152|P1|Overall Study|Withdrawal by Subject|6
201165|NCT00329797|676151|P2|Overall Study|Protocol Violation|0
201166|NCT00329797|676152|P1|Overall Study|Protocol Violation|1
201167|NCT00329784|676168|P4|Overall Study|Other|0
201168|NCT00329784|676169|P3|Overall Study|Other|0
201169|NCT00329784|676170|P2|Overall Study|Other|2
201170|NCT00329784|676171|P1|Overall Study|Other|1
201171|NCT00329784|676168|P4|Overall Study|Withdrawal by Subject|0
201172|NCT00329784|676169|P3|Overall Study|Withdrawal by Subject|0
201173|NCT00329784|676170|P2|Overall Study|Withdrawal by Subject|2
201174|NCT00329784|676171|P1|Overall Study|Withdrawal by Subject|4
201175|NCT00329784|676168|P4|Overall Study|Lost to Follow-up|0
201176|NCT00329784|676169|P3|Overall Study|Lost to Follow-up|0
201177|NCT00329784|676170|P2|Overall Study|Lost to Follow-up|1
201178|NCT00329784|676171|P1|Overall Study|Lost to Follow-up|0
201179|NCT00329745|676199|P2|Overall Study|Lost to Follow-up|101
201180|NCT00329745|676200|P1|Overall Study|Lost to Follow-up|86
201181|NCT00329745|676199|P2|Overall Study|Withdrawal by Subject|1
201182|NCT00329745|676200|P1|Overall Study|Withdrawal by Subject|0
201183|NCT00329745|676199|P2|Overall Study|Protocol Violation|0
201184|NCT00329745|676200|P1|Overall Study|Protocol Violation|1
201185|NCT00329719|676220|P4|Overall Study|Lost to Follow-up|1
201186|NCT00329719|676221|P3|Overall Study|Lost to Follow-up|0
201187|NCT00329719|676222|P2|Overall Study|Lost to Follow-up|0
201188|NCT00329719|676223|P1|Overall Study|Lost to Follow-up|0
201189|NCT00329641|676245|P1|Overall Study|Other reason, not protocol specified|1
201190|NCT00329641|676245|P1|Overall Study|Adverse Event|3
201191|NCT00329641|676245|P1|Overall Study|Not eligible|1
201192|NCT00329641|676245|P1|Overall Study|Did not start treatment|1
201193|NCT00329602|676254|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
201194|NCT00329602|676255|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
201195|NCT00329602|676256|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
201196|NCT00329602|676254|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
201197|NCT00329602|676255|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
201198|NCT00329602|676256|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
201199|NCT00329602|676254|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
201200|NCT00329602|676255|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
201201|NCT00329602|676256|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
201202|NCT00329602|676254|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
201203|NCT00329602|676255|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
201204|NCT00329602|676256|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
201205|NCT00329602|676254|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
201206|NCT00329602|676255|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
201207|NCT00329602|676256|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
201208|NCT00329602|676254|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
201209|NCT00329602|676255|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
201210|NCT00329602|676256|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
201211|NCT00329550|676294|P3|Overall Study|Due to Relocation|1
201212|NCT00329550|676295|P2|Overall Study|Due to Relocation|0
201213|NCT00329550|676296|P1|Overall Study|Due to Relocation|0
201214|NCT00329550|676294|P3|Overall Study|Withdrawal of Consent|1
201215|NCT00329550|676295|P2|Overall Study|Withdrawal of Consent|0
201216|NCT00329550|676296|P1|Overall Study|Withdrawal of Consent|1
201217|NCT00329550|676294|P3|Overall Study|Adverse Event|2
201218|NCT00329550|676295|P2|Overall Study|Adverse Event|4
201219|NCT00329550|676296|P1|Overall Study|Adverse Event|3
201220|NCT00329420|676561|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
201221|NCT00329420|676562|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
201222|NCT00329420|676563|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
201223|NCT00329420|676561|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
201224|NCT00329420|676562|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
201225|NCT00329420|676563|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
201226|NCT00329420|676561|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
201227|NCT00329420|676562|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
201228|NCT00329420|676563|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
201229|NCT00329420|676561|P3|Re-induction Phase|Did not respond to re-induction|7
201230|NCT00329420|676562|P2|Re-induction Phase|Did not respond to re-induction|5
201231|NCT00329420|676563|P1|Re-induction Phase|Did not respond to re-induction|6
201232|NCT00329420|676561|P3|Re-induction Phase|Withdrawal of Consent|1
201233|NCT00329420|676562|P2|Re-induction Phase|Withdrawal of Consent|0
201234|NCT00329420|676563|P1|Re-induction Phase|Withdrawal of Consent|0
201235|NCT00329420|676561|P3|Re-induction Phase|Lack of Efficacy|0
201236|NCT00329420|676562|P2|Re-induction Phase|Lack of Efficacy|1
201237|NCT00329420|676563|P1|Re-induction Phase|Lack of Efficacy|0
201238|NCT00329407|676942|P1|Overall Study|Withdrawal by Subject|1
201239|NCT00329238|676949|P2|Overall Study|Other reason (not specified)|54
201240|NCT00329238|676950|P1|Overall Study|Other reason (not specified)|40
201241|NCT00329238|676949|P2|Overall Study|Withdrawal by Subject|58
201242|NCT00329238|676950|P1|Overall Study|Withdrawal by Subject|64
201243|NCT00329238|676949|P2|Overall Study|Lost to Follow-up|6
201244|NCT00329238|676950|P1|Overall Study|Lost to Follow-up|2
201245|NCT00329238|676949|P2|Overall Study|Protocol Violation|34
201246|NCT00329238|676950|P1|Overall Study|Protocol Violation|23
201247|NCT00329238|676949|P2|Overall Study|Adverse Event|129
201248|NCT00329238|676950|P1|Overall Study|Adverse Event|147
201249|NCT00329160|676986|P1|Overall Study|Incomplete IVUS|45
201250|NCT00329160|676986|P1|Overall Study|Did not Receive Study Drug|1
201251|NCT00329160|676986|P1|Overall Study|Protocol Violation|2
201252|NCT00329160|676986|P1|Overall Study|Withdrawal by Subject|13
201253|NCT00329160|676986|P1|Overall Study|Adverse Event|27
201254|NCT00329108|676995|P2|Overall Study|Protocol Violation|2
201255|NCT00329108|676996|P1|Overall Study|Protocol Violation|0
201256|NCT00329108|676995|P2|Overall Study|withdrew patient after SAE resolved|0
201257|NCT00329108|676996|P1|Overall Study|withdrew patient after SAE resolved|1
201258|NCT00329108|676995|P2|Overall Study|study terminated by sponsor|0
201259|NCT00329108|676996|P1|Overall Study|study terminated by sponsor|1
201260|NCT00329108|676995|P2|Overall Study|Subject no longer willing to participate|2
201261|NCT00329108|676996|P1|Overall Study|Subject no longer willing to participate|2
201262|NCT00329108|676995|P2|Overall Study|symptomatic deterioration|1
201263|NCT00329108|676996|P1|Overall Study|symptomatic deterioration|1
201264|NCT00329108|676995|P2|Overall Study|Withdrawal by Subject|2
201265|NCT00329108|676996|P1|Overall Study|Withdrawal by Subject|0
201266|NCT00329108|676995|P2|Overall Study|Lack of Efficacy|3
201267|NCT00329108|676996|P1|Overall Study|Lack of Efficacy|3
201268|NCT00329108|676995|P2|Overall Study|Adverse Event|2
201269|NCT00329108|676996|P1|Overall Study|Adverse Event|2
201270|NCT00329030|677004|P2|Overall Study|Ineligible Pathology|1
201271|NCT00329030|677005|P1|Overall Study|Ineligible Pathology|1
201272|NCT00329030|677004|P2|Overall Study|Progressive Disease|2
201273|NCT00329030|677005|P1|Overall Study|Progressive Disease|6
201274|NCT00329030|677004|P2|Overall Study|Withdrawal by Subject|3
201275|NCT00329030|677005|P1|Overall Study|Withdrawal by Subject|1
201276|NCT00328926|677036|P3|Overall Study|Lack of ovarian response|0
201277|NCT00328926|677037|P2|Overall Study|Lack of ovarian response|1
201278|NCT00328926|677038|P1|Overall Study|Lack of ovarian response|0
201279|NCT00328926|677036|P3|Overall Study|In vitro fertilization treatment|1
201280|NCT00328926|677037|P2|Overall Study|In vitro fertilization treatment|0
201281|NCT00328926|677038|P1|Overall Study|In vitro fertilization treatment|0
201282|NCT00328926|677036|P3|Overall Study|Death|1
201283|NCT00328926|677037|P2|Overall Study|Death|0
201284|NCT00328926|677038|P1|Overall Study|Death|0
201285|NCT00328926|677036|P3|Overall Study|Lost to Follow-up|0
201286|NCT00328926|677037|P2|Overall Study|Lost to Follow-up|1
201287|NCT00328926|677038|P1|Overall Study|Lost to Follow-up|0
201288|NCT00328926|677036|P3|Overall Study|Pregnancy|0
201289|NCT00328926|677037|P2|Overall Study|Pregnancy|1
201290|NCT00328926|677038|P1|Overall Study|Pregnancy|2
201291|NCT00328783|677063|P1|Overall Study|Withdrawal by Subject|1
201292|NCT00328783|677063|P1|Overall Study|No heart in RT field|4
201293|NCT00328783|677063|P1|Overall Study|Could not tolerate ABC|21
201294|NCT00328627|677089|P12|Overall Study|Other|0
201295|NCT00328627|677090|P11|Overall Study|Other|1
201296|NCT00328627|677091|P10|Overall Study|Other|1
201297|NCT00328627|677092|P9|Overall Study|Other|0
201298|NCT00328627|677093|P8|Overall Study|Other|0
201299|NCT00328627|677094|P7|Overall Study|Other|1
201300|NCT00328627|677095|P6|Overall Study|Other|0
201301|NCT00328627|677096|P5|Overall Study|Other|0
201302|NCT00328627|677097|P4|Overall Study|Other|1
201303|NCT00328627|677098|P3|Overall Study|Other|0
201304|NCT00328627|677099|P2|Overall Study|Other|0
201305|NCT00328627|677100|P1|Overall Study|Other|0
201306|NCT00328627|677089|P12|Overall Study|Physician Decision|0
201307|NCT00328627|677090|P11|Overall Study|Physician Decision|1
201308|NCT00328627|677091|P10|Overall Study|Physician Decision|2
201309|NCT00328627|677092|P9|Overall Study|Physician Decision|3
201310|NCT00328627|677093|P8|Overall Study|Physician Decision|0
201311|NCT00328627|677094|P7|Overall Study|Physician Decision|1
201312|NCT00328627|677095|P6|Overall Study|Physician Decision|1
201313|NCT00328627|677096|P5|Overall Study|Physician Decision|1
201314|NCT00328627|677097|P4|Overall Study|Physician Decision|2
201315|NCT00328627|677098|P3|Overall Study|Physician Decision|1
201316|NCT00328627|677099|P2|Overall Study|Physician Decision|3
201317|NCT00328627|677100|P1|Overall Study|Physician Decision|4
201318|NCT00328627|677089|P12|Overall Study|Pregnancy|0
201319|NCT00328627|677090|P11|Overall Study|Pregnancy|0
201320|NCT00328627|677091|P10|Overall Study|Pregnancy|0
201321|NCT00328627|677092|P9|Overall Study|Pregnancy|0
201322|NCT00328627|677093|P8|Overall Study|Pregnancy|0
201323|NCT00328627|677094|P7|Overall Study|Pregnancy|0
201324|NCT00328627|677095|P6|Overall Study|Pregnancy|0
201325|NCT00328627|677096|P5|Overall Study|Pregnancy|0
201326|NCT00328627|677097|P4|Overall Study|Pregnancy|0
201327|NCT00328627|677098|P3|Overall Study|Pregnancy|0
201328|NCT00328627|677099|P2|Overall Study|Pregnancy|1
201329|NCT00328627|677100|P1|Overall Study|Pregnancy|0
201330|NCT00328627|677089|P12|Overall Study|Withdrawal by Subject|7
201331|NCT00328627|677090|P11|Overall Study|Withdrawal by Subject|2
201332|NCT00328627|677091|P10|Overall Study|Withdrawal by Subject|5
201333|NCT00328627|677092|P9|Overall Study|Withdrawal by Subject|4
201334|NCT00328627|677093|P8|Overall Study|Withdrawal by Subject|4
201335|NCT00328627|677094|P7|Overall Study|Withdrawal by Subject|4
201336|NCT00328627|677095|P6|Overall Study|Withdrawal by Subject|5
201337|NCT00328627|677096|P5|Overall Study|Withdrawal by Subject|2
201338|NCT00328627|677097|P4|Overall Study|Withdrawal by Subject|6
201339|NCT00328627|677098|P3|Overall Study|Withdrawal by Subject|5
201340|NCT00328627|677099|P2|Overall Study|Withdrawal by Subject|4
201341|NCT00328627|677100|P1|Overall Study|Withdrawal by Subject|5
201342|NCT00328627|677089|P12|Overall Study|Lost to Follow-up|1
201343|NCT00328627|677090|P11|Overall Study|Lost to Follow-up|0
201344|NCT00328627|677091|P10|Overall Study|Lost to Follow-up|2
201345|NCT00328627|677092|P9|Overall Study|Lost to Follow-up|3
201346|NCT00328627|677093|P8|Overall Study|Lost to Follow-up|0
201347|NCT00328627|677094|P7|Overall Study|Lost to Follow-up|3
201348|NCT00328627|677095|P6|Overall Study|Lost to Follow-up|2
201349|NCT00328627|677096|P5|Overall Study|Lost to Follow-up|0
201350|NCT00328627|677097|P4|Overall Study|Lost to Follow-up|4
201351|NCT00328627|677098|P3|Overall Study|Lost to Follow-up|2
201352|NCT00328627|677099|P2|Overall Study|Lost to Follow-up|2
201353|NCT00328627|677100|P1|Overall Study|Lost to Follow-up|4
201354|NCT00328627|677089|P12|Overall Study|Protocol Violation|2
201355|NCT00328627|677090|P11|Overall Study|Protocol Violation|6
201356|NCT00328627|677091|P10|Overall Study|Protocol Violation|4
201357|NCT00328627|677092|P9|Overall Study|Protocol Violation|1
201358|NCT00328627|677093|P8|Overall Study|Protocol Violation|2
201359|NCT00328627|677094|P7|Overall Study|Protocol Violation|6
201360|NCT00328627|677095|P6|Overall Study|Protocol Violation|5
201361|NCT00328627|677096|P5|Overall Study|Protocol Violation|5
201362|NCT00328627|677097|P4|Overall Study|Protocol Violation|8
201363|NCT00328627|677098|P3|Overall Study|Protocol Violation|2
201364|NCT00328627|677099|P2|Overall Study|Protocol Violation|2
201365|NCT00328627|677100|P1|Overall Study|Protocol Violation|2
201366|NCT00328627|677089|P12|Overall Study|Adverse Event|4
201367|NCT00328627|677090|P11|Overall Study|Adverse Event|5
201368|NCT00328627|677091|P10|Overall Study|Adverse Event|7
201369|NCT00328627|677092|P9|Overall Study|Adverse Event|0
201370|NCT00328627|677093|P8|Overall Study|Adverse Event|2
201371|NCT00328627|677094|P7|Overall Study|Adverse Event|1
201372|NCT00328627|677095|P6|Overall Study|Adverse Event|2
201373|NCT00328627|677096|P5|Overall Study|Adverse Event|1
201374|NCT00328627|677097|P4|Overall Study|Adverse Event|3
201375|NCT00328627|677098|P3|Overall Study|Adverse Event|2
201376|NCT00328627|677099|P2|Overall Study|Adverse Event|1
201377|NCT00328627|677100|P1|Overall Study|Adverse Event|3
201378|NCT00328627|677089|P12|Overall Study|Hyperglycemic Rescue|2
201379|NCT00328627|677090|P11|Overall Study|Hyperglycemic Rescue|3
201380|NCT00328627|677091|P10|Overall Study|Hyperglycemic Rescue|11
201381|NCT00328627|677092|P9|Overall Study|Hyperglycemic Rescue|6
201382|NCT00328627|677093|P8|Overall Study|Hyperglycemic Rescue|6
201383|NCT00328627|677094|P7|Overall Study|Hyperglycemic Rescue|19
201384|NCT00328627|677095|P6|Overall Study|Hyperglycemic Rescue|5
201385|NCT00328627|677096|P5|Overall Study|Hyperglycemic Rescue|6
201386|NCT00328627|677097|P4|Overall Study|Hyperglycemic Rescue|13
201387|NCT00328627|677098|P3|Overall Study|Hyperglycemic Rescue|16
201388|NCT00328627|677099|P2|Overall Study|Hyperglycemic Rescue|18
201389|NCT00328627|677100|P1|Overall Study|Hyperglycemic Rescue|41
201390|NCT00328562|678637|P1|Overall Study|Disease progression|1
201391|NCT00328510|678646|P2|Overall Study|Treatment changed to a single fraction|1
201392|NCT00328510|678647|P1|Overall Study|Treatment changed to a single fraction|1
201393|NCT00328510|678646|P2|Overall Study|Severe kyphosis, could not use mask|1
201394|NCT00328510|678647|P1|Overall Study|Severe kyphosis, could not use mask|0
201395|NCT00328510|678646|P2|Overall Study|Withdrawal by Subject|2
201396|NCT00328510|678647|P1|Overall Study|Withdrawal by Subject|4
201397|NCT00328510|678646|P2|Overall Study|Dentition problems, could not use frame|0
201398|NCT00328510|678647|P1|Overall Study|Dentition problems, could not use frame|1
201399|NCT00328510|678646|P2|Overall Study|Gag disorder, could not use frame|0
201400|NCT00328510|678647|P1|Overall Study|Gag disorder, could not use frame|4
201401|NCT00328198|678662|P1|Follow-up|Death|31
201402|NCT00328198|678662|P1|Follow-up|Lost to Follow-up|4
201403|NCT00328198|678662|P1|Treatment|Confirmed complete response, MRD -|3
201404|NCT00328198|678662|P1|Treatment|Non-compliance|1
201405|NCT00328198|678662|P1|Treatment|Evidence of disease progression|2
201406|NCT00328198|678662|P1|Treatment|Withdrawal by Subject|5
201407|NCT00328198|678662|P1|Treatment|Physician Decision|5
201408|NCT00328198|678662|P1|Treatment|Death|1
201409|NCT00328198|678662|P1|Treatment|Adverse Event|21
201410|NCT00328172|678677|P5|Overall Study|Other reason (not specified)|0
201411|NCT00328172|678678|P4|Overall Study|Other reason (not specified)|0
201412|NCT00328172|678679|P3|Overall Study|Other reason (not specified)|1
201413|NCT00328172|678680|P2|Overall Study|Other reason (not specified)|0
201414|NCT00328172|678681|P1|Overall Study|Other reason (not specified)|3
201415|NCT00328172|678677|P5|Overall Study|Lack of Efficacy|3
201416|NCT00328172|678678|P4|Overall Study|Lack of Efficacy|4
201417|NCT00328172|678679|P3|Overall Study|Lack of Efficacy|4
201418|NCT00328172|678680|P2|Overall Study|Lack of Efficacy|9
201419|NCT00328172|678681|P1|Overall Study|Lack of Efficacy|14
201420|NCT00328172|678677|P5|Overall Study|Withdrawal by Subject|0
201421|NCT00328172|678678|P4|Overall Study|Withdrawal by Subject|6
201422|NCT00328172|678679|P3|Overall Study|Withdrawal by Subject|1
201423|NCT00328172|678680|P2|Overall Study|Withdrawal by Subject|1
201424|NCT00328172|678681|P1|Overall Study|Withdrawal by Subject|1
201425|NCT00328172|678677|P5|Overall Study|Lost to Follow-up|1
201426|NCT00328172|678678|P4|Overall Study|Lost to Follow-up|1
201427|NCT00328172|678679|P3|Overall Study|Lost to Follow-up|2
201428|NCT00328172|678680|P2|Overall Study|Lost to Follow-up|1
201429|NCT00328172|678681|P1|Overall Study|Lost to Follow-up|1
201430|NCT00328172|678677|P5|Overall Study|Protocol Violation|0
201431|NCT00328172|678678|P4|Overall Study|Protocol Violation|0
201432|NCT00328172|678679|P3|Overall Study|Protocol Violation|1
201433|NCT00328172|678680|P2|Overall Study|Protocol Violation|1
201434|NCT00328172|678681|P1|Overall Study|Protocol Violation|0
201435|NCT00328172|678677|P5|Overall Study|Adverse Event|1
201436|NCT00328172|678678|P4|Overall Study|Adverse Event|2
201437|NCT00328172|678679|P3|Overall Study|Adverse Event|1
201438|NCT00328172|678680|P2|Overall Study|Adverse Event|2
201439|NCT00328172|678681|P1|Overall Study|Adverse Event|3
201440|NCT00328094|678705|P2|Overall Study|Physician Decision|3
201441|NCT00328094|678706|P1|Overall Study|Physician Decision|3
201442|NCT00327717|678740|P2|Overall Study|Withdrawal by Subject|7
201443|NCT00327717|678741|P1|Overall Study|Withdrawal by Subject|3
201444|NCT00327717|678740|P2|Overall Study|Lack of Efficacy|1
201445|NCT00327717|678741|P1|Overall Study|Lack of Efficacy|0
201446|NCT00327717|678740|P2|Overall Study|Adverse Event|6
201447|NCT00327717|678741|P1|Overall Study|Adverse Event|6
201448|NCT00327470|678767|P2|Overall Study|Death|4
201449|NCT00327470|678768|P1|Overall Study|Death|1
201450|NCT00327470|678767|P2|Overall Study|Withdrawal by Subject|12
201451|NCT00327470|678768|P1|Overall Study|Withdrawal by Subject|6
201452|NCT00327470|678767|P2|Overall Study|Lost to Follow-up|3
201453|NCT00327470|678768|P1|Overall Study|Lost to Follow-up|1
201454|NCT00327470|678767|P2|Overall Study|Other|9
201455|NCT00327470|678768|P1|Overall Study|Other|5
201456|NCT00327470|678767|P2|Overall Study|Lack of Efficacy|19
201457|NCT00327470|678768|P1|Overall Study|Lack of Efficacy|7
201458|NCT00327470|678767|P2|Overall Study|Adverse Event|14
201459|NCT00327470|678768|P1|Overall Study|Adverse Event|9
201460|NCT00327470|678767|P2|Overall Study|Randomized, but not treated|2
201461|NCT00327470|678768|P1|Overall Study|Randomized, but not treated|0
201462|NCT00327444|678788|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
201463|NCT00327444|678789|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
201464|NCT00327444|678788|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
201465|NCT00327444|678789|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
201466|NCT00327444|678788|P2|Open Label Treatment (OL) Period|Adverse Event|2
201467|NCT00327444|678789|P1|Open Label Treatment (OL) Period|Adverse Event|2
201468|NCT00327444|678788|P2|Open Label Treatment (OL) Period|Disease progression|7
201469|NCT00327444|678789|P1|Open Label Treatment (OL) Period|Disease progression|8
201470|NCT00327444|678788|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
201471|NCT00327444|678789|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
201472|NCT00327444|678788|P2|Double Blind Treatment (DB) Period|Subject request|1
201473|NCT00327444|678789|P1|Double Blind Treatment (DB) Period|Subject request|0
201474|NCT00327444|678788|P2|Double Blind Treatment (DB) Period|Adverse Event|5
201475|NCT00327444|678789|P1|Double Blind Treatment (DB) Period|Adverse Event|5
201476|NCT00327444|678788|P2|Double Blind Treatment (DB) Period|Disease progression|13
201477|NCT00327444|678789|P1|Double Blind Treatment (DB) Period|Disease progression|10
201478|NCT00327340|678807|P2|Overall Study|Adverse Event|3
201479|NCT00327340|678808|P1|Overall Study|Adverse Event|3
201480|NCT00327340|678807|P2|Overall Study|Symptomatic Disease|2
201481|NCT00327340|678808|P1|Overall Study|Symptomatic Disease|0
201482|NCT00327340|678807|P2|Overall Study|Disease Progression|19
201483|NCT00327340|678808|P1|Overall Study|Disease Progression|10
201484|NCT00327340|678807|P2|Overall Study|Physician Decision|1
201485|NCT00327340|678808|P1|Overall Study|Physician Decision|1
201486|NCT00327340|678807|P2|Overall Study|Withdrawal by Subject|5
201487|NCT00327340|678808|P1|Overall Study|Withdrawal by Subject|1
201488|NCT00327171|678822|P2|Overall Study|Other|0
201489|NCT00327171|678823|P1|Overall Study|Other|1
201490|NCT00327171|678822|P2|Overall Study|Undisclosed history of ischemia|1
201491|NCT00327171|678823|P1|Overall Study|Undisclosed history of ischemia|0
201492|NCT00327171|678822|P2|Overall Study|Clinical progression|8
201493|NCT00327171|678823|P1|Overall Study|Clinical progression|12
201494|NCT00327171|678822|P2|Overall Study|Investigator/participant request|8
201495|NCT00327171|678823|P1|Overall Study|Investigator/participant request|1
201496|NCT00327171|678822|P2|Overall Study|Disease progression/lack of efficacy|69
201497|NCT00327171|678823|P1|Overall Study|Disease progression/lack of efficacy|68
201498|NCT00327171|678822|P2|Overall Study|Adverse Event|23
201499|NCT00327171|678823|P1|Overall Study|Adverse Event|23
201500|NCT00327171|678822|P2|Overall Study|Did not receive study medication|0
201501|NCT00327171|678823|P1|Overall Study|Did not receive study medication|3
201502|NCT00327015|678855|P4|Overall Study|Administrative Reason by Sponsor|1
201503|NCT00327015|678856|P3|Overall Study|Administrative Reason by Sponsor|2
201504|NCT00327015|678857|P2|Overall Study|Administrative Reason by Sponsor|2
201505|NCT00327015|678858|P1|Overall Study|Administrative Reason by Sponsor|1
201506|NCT00327015|678855|P4|Overall Study|Pregnancy|1
201507|NCT00327015|678856|P3|Overall Study|Pregnancy|1
201508|NCT00327015|678857|P2|Overall Study|Pregnancy|2
201509|NCT00327015|678858|P1|Overall Study|Pregnancy|0
201510|NCT00327015|678855|P4|Overall Study|Death|3
201511|NCT00327015|678856|P3|Overall Study|Death|2
201512|NCT00327015|678857|P2|Overall Study|Death|2
201513|NCT00327015|678858|P1|Overall Study|Death|1
201514|NCT00327015|678855|P4|Overall Study|Physician Decision|2
201515|NCT00327015|678856|P3|Overall Study|Physician Decision|3
201516|NCT00327015|678857|P2|Overall Study|Physician Decision|1
201517|NCT00327015|678858|P1|Overall Study|Physician Decision|0
201518|NCT00327015|678855|P4|Overall Study|Poor/Noncompliance|5
201519|NCT00327015|678856|P3|Overall Study|Poor/Noncompliance|4
201520|NCT00327015|678857|P2|Overall Study|Poor/Noncompliance|8
201521|NCT00327015|678858|P1|Overall Study|Poor/Noncompliance|11
201522|NCT00327015|678855|P4|Overall Study|Subject no longer meets study criteria|7
201523|NCT00327015|678856|P3|Overall Study|Subject no longer meets study criteria|8
201524|NCT00327015|678857|P2|Overall Study|Subject no longer meets study criteria|2
201525|NCT00327015|678858|P1|Overall Study|Subject no longer meets study criteria|4
201526|NCT00327015|678855|P4|Overall Study|Adverse Event|14
201527|NCT00327015|678856|P3|Overall Study|Adverse Event|14
201528|NCT00327015|678857|P2|Overall Study|Adverse Event|10
201529|NCT00327015|678858|P1|Overall Study|Adverse Event|14
201530|NCT00327015|678855|P4|Overall Study|Lost to Follow-up|22
201531|NCT00327015|678856|P3|Overall Study|Lost to Follow-up|29
201532|NCT00327015|678857|P2|Overall Study|Lost to Follow-up|23
201533|NCT00327015|678858|P1|Overall Study|Lost to Follow-up|22
201534|NCT00327015|678855|P4|Overall Study|Withdrawal of Consent by Subject|25
201535|NCT00327015|678856|P3|Overall Study|Withdrawal of Consent by Subject|28
201536|NCT00327015|678857|P2|Overall Study|Withdrawal of Consent by Subject|24
201537|NCT00327015|678858|P1|Overall Study|Withdrawal of Consent by Subject|20
201538|NCT00327015|678855|P4|Overall Study|Lack of Efficacy|29
201539|NCT00327015|678856|P3|Overall Study|Lack of Efficacy|35
201540|NCT00327015|678857|P2|Overall Study|Lack of Efficacy|18
201541|NCT00327015|678858|P1|Overall Study|Lack of Efficacy|18
201542|NCT00326963|678900|P1|Overall Study|Administrative / other|1
201543|NCT00326963|678900|P1|Overall Study|Other protocol violation|1
201544|NCT00326963|678900|P1|Overall Study|Violation of selection criteria at entry|2
201545|NCT00326963|678900|P1|Overall Study|Refused treatment / did not cooperate|5
201546|NCT00326963|678900|P1|Overall Study|Withdrawal by Subject|10
201547|NCT00326963|678900|P1|Overall Study|Failure to return|10
201548|NCT00326963|678900|P1|Overall Study|Death|1
201549|NCT00326963|678900|P1|Overall Study|Injection site reaction|1
201550|NCT00326963|678900|P1|Overall Study|Adverse Event|2
201551|NCT00326950|678920|P1|Overall Study|Progressive Disease|1
201552|NCT00326911|678942|P2|Overall Study|Withdrawal by subject prior to treatment|1
201553|NCT00326911|678943|P1|Overall Study|Withdrawal by subject prior to treatment|0
201554|NCT00326911|678942|P2|Overall Study|Physician decision prior to treatment|0
201555|NCT00326911|678943|P1|Overall Study|Physician decision prior to treatment|1
201556|NCT00326911|678942|P2|Overall Study|Hospitalization prior to treatment|1
201557|NCT00326911|678943|P1|Overall Study|Hospitalization prior to treatment|0
201558|NCT00326898|678996|P3|Overall Study|Other/Missing/Unknown|32
201559|NCT00326898|678997|P2|Overall Study|Other/Missing/Unknown|28
201560|NCT00326898|678998|P1|Overall Study|Other/Missing/Unknown|33
201561|NCT00326898|678996|P3|Overall Study|Other complicating disease|4
201562|NCT00326898|678997|P2|Overall Study|Other complicating disease|5
201563|NCT00326898|678998|P1|Overall Study|Other complicating disease|5
201564|NCT00326898|678996|P3|Overall Study|Alternative therapy|0
201565|NCT00326898|678997|P2|Overall Study|Alternative therapy|0
201566|NCT00326898|678998|P1|Overall Study|Alternative therapy|1
201567|NCT00326898|678996|P3|Overall Study|Withdrawal by Subject|32
201568|NCT00326898|678997|P2|Overall Study|Withdrawal by Subject|128
201569|NCT00326898|678998|P1|Overall Study|Withdrawal by Subject|134
201570|NCT00326898|678996|P3|Overall Study|Death|0
201571|NCT00326898|678997|P2|Overall Study|Death|0
201572|NCT00326898|678998|P1|Overall Study|Death|2
201573|NCT00326898|678996|P3|Overall Study|Adverse Event|33
201574|NCT00326898|678997|P2|Overall Study|Adverse Event|128
201575|NCT00326898|678998|P1|Overall Study|Adverse Event|124
201576|NCT00326898|678996|P3|Overall Study|Disease progression|102
201577|NCT00326898|678997|P2|Overall Study|Disease progression|54
201578|NCT00326898|678998|P1|Overall Study|Disease progression|52
201579|NCT00326885|679015|P1|Overall Study|Hospice withdrew consent|2
201580|NCT00326885|679015|P1|Overall Study|Physician Decision|1
201581|NCT00326885|679015|P1|Overall Study|Withdrawal by Subject|3
201582|NCT00326885|679015|P1|Overall Study|Adverse Event|1
201583|NCT00326716|679046|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
201584|NCT00326716|679047|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
201585|NCT00326716|679048|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
201586|NCT00326716|679049|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
201587|NCT00326612|679121|P2|Overall Study|They did not have a seizure requiring tx|137
201588|NCT00326612|679122|P1|Overall Study|They did not have a seizure requiring tx|129
201589|NCT00326599|679144|P4|Overall Study|Other Unspecified Reason|1
201590|NCT00326599|679145|P3|Overall Study|Other Unspecified Reason|2
201591|NCT00326599|679146|P2|Overall Study|Other Unspecified Reason|0
201592|NCT00326599|679147|P1|Overall Study|Other Unspecified Reason|0
201593|NCT00326599|679144|P4|Overall Study|Death|2
201594|NCT00326599|679145|P3|Overall Study|Death|1
201595|NCT00326599|679146|P2|Overall Study|Death|0
201596|NCT00326599|679147|P1|Overall Study|Death|0
201597|NCT00326599|679144|P4|Overall Study|Alternate Treatment|0
201598|NCT00326599|679145|P3|Overall Study|Alternate Treatment|0
201599|NCT00326599|679146|P2|Overall Study|Alternate Treatment|0
201600|NCT00326599|679147|P1|Overall Study|Alternate Treatment|1
201601|NCT00326599|679144|P4|Overall Study|Disease Progression|11
201602|NCT00326599|679145|P3|Overall Study|Disease Progression|13
201603|NCT00326599|679146|P2|Overall Study|Disease Progression|1
201604|NCT00326599|679147|P1|Overall Study|Disease Progression|3
201605|NCT00326599|679144|P4|Overall Study|Adverse Event|3
201606|NCT00326599|679145|P3|Overall Study|Adverse Event|32
201607|NCT00326599|679146|P2|Overall Study|Adverse Event|0
201608|NCT00326599|679147|P1|Overall Study|Adverse Event|1
201609|NCT00326599|679144|P4|Overall Study|Withdrawal by Subject|2
201610|NCT00326599|679145|P3|Overall Study|Withdrawal by Subject|5
201611|NCT00326599|679146|P2|Overall Study|Withdrawal by Subject|0
201612|NCT00326599|679147|P1|Overall Study|Withdrawal by Subject|1
201613|NCT00326495|679166|P1|Overall Study|Subject off study before assessment|1
201614|NCT00326495|679166|P1|Overall Study|Refused further treatment|2
201615|NCT00326495|679166|P1|Overall Study|Disease progression before treatment|1
201616|NCT00326495|679166|P1|Overall Study|Switched to alternative treatment|1
201617|NCT00326417|679173|P4|Overall Study|Death|0
201618|NCT00326417|679174|P3|Overall Study|Death|0
201619|NCT00326417|679175|P2|Overall Study|Death|0
201620|NCT00326417|679176|P1|Overall Study|Death|7
201621|NCT00326417|679173|P4|Overall Study|Arm Closed|3
201622|NCT00326417|679174|P3|Overall Study|Arm Closed|0
201623|NCT00326417|679175|P2|Overall Study|Arm Closed|0
201624|NCT00326417|679176|P1|Overall Study|Arm Closed|7
201625|NCT00326417|679173|P4|Overall Study|Withdrawal by Subject|0
201626|NCT00326417|679174|P3|Overall Study|Withdrawal by Subject|1
201627|NCT00326417|679175|P2|Overall Study|Withdrawal by Subject|0
201628|NCT00326417|679176|P1|Overall Study|Withdrawal by Subject|0
201629|NCT00326183|679203|P2|Overall Study|Adverse Event|0
201630|NCT00326183|679204|P1|Overall Study|Adverse Event|1
201631|NCT00326183|679203|P2|Overall Study|Other|13
201632|NCT00326183|679204|P1|Overall Study|Other|47
201633|NCT00326183|679203|P2|Overall Study|Subject Moved|4
201634|NCT00326183|679204|P1|Overall Study|Subject Moved|7
201635|NCT00326183|679203|P2|Overall Study|Withdrawal by Subject|7
201636|NCT00326183|679204|P1|Overall Study|Withdrawal by Subject|35
201637|NCT00326183|679203|P2|Overall Study|Protocol Violation|3
201638|NCT00326183|679204|P1|Overall Study|Protocol Violation|6
201639|NCT00326183|679203|P2|Overall Study|Lost to Follow-up|56
201640|NCT00326183|679204|P1|Overall Study|Lost to Follow-up|104
201641|NCT00326118|679236|P2|Active Phase|Withdrawal by Subject|1
201642|NCT00326118|679237|P1|Active Phase|Withdrawal by Subject|4
201643|NCT00326001|679273|P2|Overall Study|Physician Decision|3
201644|NCT00326001|679274|P1|Overall Study|Physician Decision|3
201645|NCT00326001|679273|P2|Overall Study|Adverse Event|5
201646|NCT00326001|679274|P1|Overall Study|Adverse Event|4
201647|NCT00325897|679288|P2|Overall Study|Lost to Follow-up|13
201648|NCT00325897|679289|P1|Overall Study|Lost to Follow-up|12
201649|NCT00325819|679309|P2|Overall Study|Lost to Follow-up|3
201650|NCT00325819|679310|P1|Overall Study|Lost to Follow-up|3
201651|NCT00325819|679309|P2|Overall Study|Did not take a dose of study product|9
201652|NCT00325819|679310|P1|Overall Study|Did not take a dose of study product|4
201653|NCT00325819|679309|P2|Overall Study|Study product lost in mail|1
201654|NCT00325819|679310|P1|Overall Study|Study product lost in mail|2
201655|NCT00325754|679337|P2|Overall Study|Adverse Event|1
201656|NCT00325754|679338|P1|Overall Study|Adverse Event|4
201657|NCT00325468|679370|P5|Overall Study|site closure etc|1
201658|NCT00325468|679371|P4|Overall Study|site closure etc|8
201659|NCT00325468|679372|P3|Overall Study|site closure etc|1
201660|NCT00325468|679373|P2|Overall Study|site closure etc|2
201661|NCT00325468|679374|P1|Overall Study|site closure etc|4
201662|NCT00325468|679370|P5|Overall Study|Withdrawal by Subject|4
201663|NCT00325468|679371|P4|Overall Study|Withdrawal by Subject|14
201664|NCT00325468|679372|P3|Overall Study|Withdrawal by Subject|0
201665|NCT00325468|679373|P2|Overall Study|Withdrawal by Subject|1
201666|NCT00325468|679374|P1|Overall Study|Withdrawal by Subject|3
201667|NCT00325468|679370|P5|Overall Study|Physician Decision|0
201668|NCT00325468|679371|P4|Overall Study|Physician Decision|1
201669|NCT00325468|679372|P3|Overall Study|Physician Decision|0
201670|NCT00325468|679373|P2|Overall Study|Physician Decision|1
201671|NCT00325468|679374|P1|Overall Study|Physician Decision|1
201672|NCT00325468|679370|P5|Overall Study|Lost to Follow-up|2
201673|NCT00325468|679371|P4|Overall Study|Lost to Follow-up|2
201674|NCT00325468|679372|P3|Overall Study|Lost to Follow-up|1
201675|NCT00325468|679373|P2|Overall Study|Lost to Follow-up|0
201676|NCT00325468|679374|P1|Overall Study|Lost to Follow-up|0
201677|NCT00325468|679370|P5|Overall Study|Death|0
201678|NCT00325468|679371|P4|Overall Study|Death|4
201679|NCT00325468|679372|P3|Overall Study|Death|2
201680|NCT00325468|679373|P2|Overall Study|Death|0
201681|NCT00325468|679374|P1|Overall Study|Death|2
201682|NCT00325468|679370|P5|Overall Study|Adverse Event|1
201683|NCT00325468|679371|P4|Overall Study|Adverse Event|5
201684|NCT00325468|679372|P3|Overall Study|Adverse Event|0
201685|NCT00325468|679373|P2|Overall Study|Adverse Event|1
201686|NCT00325468|679374|P1|Overall Study|Adverse Event|1
201687|NCT00325416|679457|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
201688|NCT00325416|679458|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
201689|NCT00325416|679457|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
201690|NCT00325416|679458|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
201691|NCT00325416|679457|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
201692|NCT00325416|679458|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
201693|NCT00325416|679457|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
201694|NCT00325416|679458|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
201695|NCT00325416|679457|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
201696|NCT00325416|679458|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
201697|NCT00325416|679457|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
201698|NCT00325416|679458|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
201699|NCT00325234|679511|P2|Overall Study|Progressive Disease|37
201700|NCT00325234|679512|P1|Overall Study|Progressive Disease|34
201701|NCT00325234|679511|P2|Overall Study|Physician Decision|12
201702|NCT00325234|679512|P1|Overall Study|Physician Decision|17
201703|NCT00325234|679511|P2|Overall Study|Subject Decision|8
201704|NCT00325234|679512|P1|Overall Study|Subject Decision|6
201705|NCT00325234|679511|P2|Overall Study|Entry Criteria Not Met|2
201706|NCT00325234|679512|P1|Overall Study|Entry Criteria Not Met|1
201707|NCT00325234|679511|P2|Overall Study|Death due to Study Disease|0
201708|NCT00325234|679512|P1|Overall Study|Death due to Study Disease|1
201709|NCT00325234|679511|P2|Overall Study|Adverse Event|7
201710|NCT00325234|679512|P1|Overall Study|Adverse Event|10
201711|NCT00325195|679531|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
201712|NCT00325195|679532|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
201713|NCT00325195|679533|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
201714|NCT00325195|679531|P3|Received Intervention: ITT Population|Lost to Follow-up|2
201715|NCT00325195|679532|P2|Received Intervention: ITT Population|Lost to Follow-up|0
201716|NCT00325195|679533|P1|Received Intervention: ITT Population|Lost to Follow-up|0
201717|NCT00325195|679531|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
201718|NCT00325195|679532|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
201719|NCT00325195|679533|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
201720|NCT00325195|679531|P3|Received Intervention: ITT Population|Death|0
201721|NCT00325195|679532|P2|Received Intervention: ITT Population|Death|1
201722|NCT00325195|679533|P1|Received Intervention: ITT Population|Death|3
201723|NCT00325195|679531|P3|Received Intervention: ITT Population|Adverse Event|1
201724|NCT00325195|679532|P2|Received Intervention: ITT Population|Adverse Event|17
201725|NCT00325195|679533|P1|Received Intervention: ITT Population|Adverse Event|15
201726|NCT00325195|679531|P3|Randomized|Not dosed|3
201727|NCT00325195|679532|P2|Randomized|Not dosed|5
201728|NCT00325195|679533|P1|Randomized|Not dosed|5
201729|NCT00325156|679556|P1|Overall Study|Withdrawal by Subject|31
201730|NCT00325156|679556|P1|Overall Study|Other|1
201731|NCT00325156|679556|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
201732|NCT00325156|679556|P1|Overall Study|Adverse event, non-fatal|3
201733|NCT00325156|679556|P1|Overall Study|Migrated/moved from study area|12
201734|NCT00325156|679556|P1|Overall Study|Lost to follow-up (complete vaccination)|41
201735|NCT00325156|679556|P1|Overall Study|Protocol Violation|8
201736|NCT00325143|679563|P1|Overall Study|Withdrawal by Subject|8
201737|NCT00325143|679563|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
201738|NCT00325143|679563|P1|Overall Study|Migrated/moved from study area|1
201739|NCT00325143|679563|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
201740|NCT00325130|679572|P2|Overall Study|Patient Discontinued for Other|0
201741|NCT00325130|679573|P1|Overall Study|Patient Discontinued for Other|1
201742|NCT00325130|679572|P2|Overall Study|Moved|1
201743|NCT00325130|679573|P1|Overall Study|Moved|0
201744|NCT00325130|679572|P2|Overall Study|Protocol Deviation|1
201745|NCT00325130|679573|P1|Overall Study|Protocol Deviation|0
201746|NCT00325130|679572|P2|Overall Study|Withdrawal by Subject|14
201747|NCT00325130|679573|P1|Overall Study|Withdrawal by Subject|12
201748|NCT00325130|679572|P2|Overall Study|Lost to Follow-up|14
201749|NCT00325130|679573|P1|Overall Study|Lost to Follow-up|6
201750|NCT00325039|679630|P2|Overall Study|Lost to Follow-up|14
201751|NCT00325039|679631|P1|Overall Study|Lost to Follow-up|18
201752|NCT00324987|679647|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
201753|NCT00324987|679648|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
201754|NCT00324987|679647|P2|Overall Study|Progression|1
201755|NCT00324987|679648|P1|Overall Study|Progression|1
201756|NCT00324987|679647|P2|Overall Study|Withdrawal by Subject|1
201757|NCT00324987|679648|P1|Overall Study|Withdrawal by Subject|1
201758|NCT00324987|679647|P2|Overall Study|Adverse Event|1
201759|NCT00324987|679648|P1|Overall Study|Adverse Event|2
201760|NCT00324961|679662|P1|Overall Study|Other|2
201761|NCT00324961|679662|P1|Overall Study|Protocol Violation|3
201762|NCT00324961|679662|P1|Overall Study|Lost to Follow-up|22
201763|NCT00324961|679662|P1|Overall Study|Consent Withdrawn|11
201764|NCT00324961|679662|P1|Overall Study|Adverse Event|5
201765|NCT00324805|679709|P2|Overall Study|Did not start therapy|17
201766|NCT00324805|679710|P1|Overall Study|Did not start therapy|12
201767|NCT00324805|679709|P2|Overall Study|Other|2
201768|NCT00324805|679710|P1|Overall Study|Other|0
201769|NCT00324805|679709|P2|Overall Study|Other reasons|26
201770|NCT00324805|679710|P1|Overall Study|Other reasons|7
201771|NCT00324805|679709|P2|Overall Study|Other complicating disease|9
201772|NCT00324805|679710|P1|Overall Study|Other complicating disease|1
201773|NCT00324805|679709|P2|Overall Study|Alternative therapy|8
201774|NCT00324805|679710|P1|Overall Study|Alternative therapy|4
201775|NCT00324805|679709|P2|Overall Study|Death|9
201776|NCT00324805|679710|P1|Overall Study|Death|6
201777|NCT00324805|679709|P2|Overall Study|Withdrawal by Subject|174
201778|NCT00324805|679710|P1|Overall Study|Withdrawal by Subject|51
201779|NCT00324805|679709|P2|Overall Study|Progression|35
201780|NCT00324805|679710|P1|Overall Study|Progression|7
201781|NCT00324805|679709|P2|Overall Study|Adverse Event|203
201782|NCT00324805|679710|P1|Overall Study|Adverse Event|62
201783|NCT00324740|679722|P3|Overall Study|Withdrawal by Subject|1
201784|NCT00324740|679723|P2|Overall Study|Withdrawal by Subject|0
201785|NCT00324740|679724|P1|Overall Study|Withdrawal by Subject|1
201786|NCT00324675|679744|P2|Overall Study|Adverse Event|0
201787|NCT00324675|679745|P1|Overall Study|Adverse Event|1
201788|NCT00324649|679753|P2|Overall Study|Noncompliance|0
201789|NCT00324649|679754|P1|Overall Study|Noncompliance|1
201790|NCT00324649|679753|P2|Overall Study|Withdrawal by Subject|1
201791|NCT00324649|679754|P1|Overall Study|Withdrawal by Subject|0
201792|NCT00324649|679753|P2|Overall Study|Adverse Event|4
201793|NCT00324649|679754|P1|Overall Study|Adverse Event|1
201794|NCT00324233|679885|P2|Second Period|Protocol Violation|6
201795|NCT00324233|679886|P1|Second Period|Protocol Violation|4
201796|NCT00324233|679885|P2|Second Period|unable to insert catheter|1
201797|NCT00324233|679886|P1|Second Period|unable to insert catheter|1
201798|NCT00324233|679885|P2|First Period|unable to insert catheter|0
201799|NCT00324233|679886|P1|First Period|unable to insert catheter|1
201800|NCT00324168|679894|P2|Overall Study|Patient did not visit in f/u window|9
201801|NCT00324168|679895|P1|Overall Study|Patient did not visit in f/u window|6
201802|NCT00324168|679894|P2|Overall Study|Death|3
201803|NCT00324168|679895|P1|Overall Study|Death|3
201804|NCT00324168|679894|P2|Overall Study|Lost to Follow-up|18
201805|NCT00324168|679895|P1|Overall Study|Lost to Follow-up|19
201806|NCT00324155|679923|P2|Follow-up Phase|On-going participants still on drug|6
201807|NCT00324155|679924|P1|Follow-up Phase|On-going participants still on drug|11
201808|NCT00324155|679923|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
201809|NCT00324155|679924|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
201810|NCT00324155|679923|P2|Received Treatment in Maintenance Phase|Adverse Event|3
201811|NCT00324155|679924|P1|Received Treatment in Maintenance Phase|Adverse Event|0
201812|NCT00324155|679923|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
201813|NCT00324155|679924|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
201814|NCT00324155|679923|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
201815|NCT00324155|679924|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
201816|NCT00324155|679923|P2|Received Treatment in Maintenance Phase|Disease Progression|41
201817|NCT00324155|679924|P1|Received Treatment in Maintenance Phase|Disease Progression|26
201818|NCT00324155|679923|P2|Received Treatment in Induction Phase|Physician Decision|0
201819|NCT00324155|679924|P1|Received Treatment in Induction Phase|Physician Decision|2
201820|NCT00324155|679923|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
201821|NCT00324155|679924|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
201822|NCT00324155|679923|P2|Received Treatment in Induction Phase|Adverse Event|7
201823|NCT00324155|679924|P1|Received Treatment in Induction Phase|Adverse Event|6
201824|NCT00324155|679923|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
201825|NCT00324155|679924|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
201826|NCT00324155|679923|P2|Received Treatment in Induction Phase|Death|15
201827|NCT00324155|679924|P1|Received Treatment in Induction Phase|Death|8
201828|NCT00324155|679923|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
201829|NCT00324155|679924|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
201830|NCT00324155|679923|P2|Received Treatment in Induction Phase|Disease Progression|152
201831|NCT00324155|679924|P1|Received Treatment in Induction Phase|Disease Progression|88
201832|NCT00324155|679923|P2|Enrolled and Randomized|Lost to Follow-up|1
201833|NCT00324155|679924|P1|Enrolled and Randomized|Lost to Follow-up|0
201834|NCT00324155|679923|P2|Enrolled and Randomized|No longer met study criteria|0
201835|NCT00324155|679924|P1|Enrolled and Randomized|No longer met study criteria|3
201836|NCT00324116|679954|P1|Overall Study|Other|5
201837|NCT00324116|679954|P1|Overall Study|Withdrawal by Subject|5
201838|NCT00324116|679954|P1|Overall Study|Lack of Efficacy|17
201839|NCT00324116|679954|P1|Overall Study|Adverse Event|5
201840|NCT00324038|679966|P2|Overall Study|Other|13
201841|NCT00324038|679967|P1|Overall Study|Other|6
201842|NCT00324038|679966|P2|Overall Study|Lost to Follow-up|2
201843|NCT00324038|679967|P1|Overall Study|Lost to Follow-up|0
201844|NCT00324038|679966|P2|Overall Study|Lack of Efficacy|13
201845|NCT00324038|679967|P1|Overall Study|Lack of Efficacy|5
201846|NCT00324038|679966|P2|Overall Study|Adverse Event|23
201847|NCT00324038|679967|P1|Overall Study|Adverse Event|38
201848|NCT00323882|679978|P5|Overall Study|Not Specified|1
201849|NCT00323882|679979|P4|Overall Study|Not Specified|1
201850|NCT00323882|679980|P3|Overall Study|Not Specified|0
201851|NCT00323882|679981|P2|Overall Study|Not Specified|0
201852|NCT00323882|679982|P1|Overall Study|Not Specified|0
201853|NCT00323882|679978|P5|Overall Study|Lost to Follow-up|1
201854|NCT00323882|679979|P4|Overall Study|Lost to Follow-up|0
201855|NCT00323882|679980|P3|Overall Study|Lost to Follow-up|1
201856|NCT00323882|679981|P2|Overall Study|Lost to Follow-up|0
201857|NCT00323882|679982|P1|Overall Study|Lost to Follow-up|0
201858|NCT00323882|679978|P5|Overall Study|Death|5
201859|NCT00323882|679979|P4|Overall Study|Death|0
201860|NCT00323882|679980|P3|Overall Study|Death|1
201861|NCT00323882|679981|P2|Overall Study|Death|1
201862|NCT00323882|679982|P1|Overall Study|Death|0
201863|NCT00323882|679978|P5|Overall Study|Disease Progression|22
201864|NCT00323882|679979|P4|Overall Study|Disease Progression|5
201865|NCT00323882|679980|P3|Overall Study|Disease Progression|10
201866|NCT00323882|679981|P2|Overall Study|Disease Progression|4
201867|NCT00323882|679982|P1|Overall Study|Disease Progression|6
201868|NCT00323882|679978|P5|Overall Study|Adverse Event|3
201869|NCT00323882|679979|P4|Overall Study|Adverse Event|1
201870|NCT00323882|679980|P3|Overall Study|Adverse Event|1
201871|NCT00323882|679981|P2|Overall Study|Adverse Event|1
201872|NCT00323882|679982|P1|Overall Study|Adverse Event|2
201873|NCT00323869|680053|P1|Overall Study|Death|1
201874|NCT00323622|680109|P8|Overall Study|Death|2
201875|NCT00323622|680110|P7|Overall Study|Death|0
201876|NCT00323622|680111|P6|Overall Study|Death|0
201877|NCT00323622|680112|P5|Overall Study|Death|7
201878|NCT00323622|680113|P4|Overall Study|Death|0
201879|NCT00323622|680114|P3|Overall Study|Death|0
201880|NCT00323622|680115|P2|Overall Study|Death|1
201881|NCT00323622|680116|P1|Overall Study|Death|1
201882|NCT00323622|680109|P8|Overall Study|Other|13
201883|NCT00323622|680110|P7|Overall Study|Other|5
201884|NCT00323622|680111|P6|Overall Study|Other|74
201885|NCT00323622|680112|P5|Overall Study|Other|32
201886|NCT00323622|680113|P4|Overall Study|Other|12
201887|NCT00323622|680114|P3|Overall Study|Other|4
201888|NCT00323622|680115|P2|Overall Study|Other|91
201889|NCT00323622|680116|P1|Overall Study|Other|30
201890|NCT00323609|680158|P4|Overall Study|Other reason|9
201891|NCT00323609|680159|P3|Overall Study|Other reason|4
201892|NCT00323609|680160|P2|Overall Study|Other reason|8
201893|NCT00323609|680161|P1|Overall Study|Other reason|11
201894|NCT00323609|680158|P4|Overall Study|Logistical withdrawal|1
201895|NCT00323609|680159|P3|Overall Study|Logistical withdrawal|0
201896|NCT00323609|680160|P2|Overall Study|Logistical withdrawal|5
201897|NCT00323609|680161|P1|Overall Study|Logistical withdrawal|9
201898|NCT00323609|680158|P4|Overall Study|Unrelenting or severe back pain|0
201899|NCT00323609|680159|P3|Overall Study|Unrelenting or severe back pain|0
201900|NCT00323609|680160|P2|Overall Study|Unrelenting or severe back pain|1
201901|NCT00323609|680161|P1|Overall Study|Unrelenting or severe back pain|1
201902|NCT00323609|680158|P4|Overall Study|Sponsor discontinued trial|0
201903|NCT00323609|680159|P3|Overall Study|Sponsor discontinued trial|0
201904|NCT00323609|680160|P2|Overall Study|Sponsor discontinued trial|29
201905|NCT00323609|680161|P1|Overall Study|Sponsor discontinued trial|29
201906|NCT00323609|680158|P4|Overall Study|Other non-VCF-related medical condition|0
201907|NCT00323609|680159|P3|Overall Study|Other non-VCF-related medical condition|0
201908|NCT00323609|680160|P2|Overall Study|Other non-VCF-related medical condition|2
201909|NCT00323609|680161|P1|Overall Study|Other non-VCF-related medical condition|3
201910|NCT00323609|680158|P4|Overall Study|Withdrawal by Subject|4
201911|NCT00323609|680159|P3|Overall Study|Withdrawal by Subject|4
201912|NCT00323609|680160|P2|Overall Study|Withdrawal by Subject|23
201913|NCT00323609|680161|P1|Overall Study|Withdrawal by Subject|11
201914|NCT00323609|680158|P4|Overall Study|Physician Decision|1
201915|NCT00323609|680159|P3|Overall Study|Physician Decision|0
201916|NCT00323609|680160|P2|Overall Study|Physician Decision|0
201917|NCT00323609|680161|P1|Overall Study|Physician Decision|2
201918|NCT00323609|680158|P4|Overall Study|Lost to Follow-up|0
201919|NCT00323609|680159|P3|Overall Study|Lost to Follow-up|0
201920|NCT00323609|680160|P2|Overall Study|Lost to Follow-up|10
201921|NCT00323609|680161|P1|Overall Study|Lost to Follow-up|9
201922|NCT00323609|680158|P4|Overall Study|Death|0
201923|NCT00323609|680159|P3|Overall Study|Death|0
201924|NCT00323609|680160|P2|Overall Study|Death|21
201925|NCT00323609|680161|P1|Overall Study|Death|16
201926|NCT00323557|680197|P2|Overall Study|Physician Decision|0
201927|NCT00323557|680198|P1|Overall Study|Physician Decision|1
201928|NCT00323492|680207|P3|Study Phase 2|Protocol Violation|0
201929|NCT00323492|680208|P2|Study Phase 2|Protocol Violation|0
201930|NCT00323492|680209|P1|Study Phase 2|Protocol Violation|1
201931|NCT00323492|680207|P3|Study Phase 2|Noncompliance with study schedule|1
201932|NCT00323492|680208|P2|Study Phase 2|Noncompliance with study schedule|0
201933|NCT00323492|680209|P1|Study Phase 2|Noncompliance with study schedule|0
201934|NCT00323492|680207|P3|Study Phase 2|Withdrawal by Subject|0
201935|NCT00323492|680208|P2|Study Phase 2|Withdrawal by Subject|1
201936|NCT00323492|680209|P1|Study Phase 2|Withdrawal by Subject|0
201937|NCT00323492|680207|P3|Study Phase 2|Lost to Follow-up|0
201938|NCT00323492|680208|P2|Study Phase 2|Lost to Follow-up|0
201939|NCT00323492|680209|P1|Study Phase 2|Lost to Follow-up|1
201940|NCT00323492|680207|P3|Study Phase 2|Physician Decision|0
201941|NCT00323492|680208|P2|Study Phase 2|Physician Decision|0
201942|NCT00323492|680209|P1|Study Phase 2|Physician Decision|1
201943|NCT00323492|680207|P3|Study Phase 2|Adverse Event|0
201944|NCT00323492|680208|P2|Study Phase 2|Adverse Event|0
201945|NCT00323492|680209|P1|Study Phase 2|Adverse Event|1
201946|NCT00323492|680207|P3|Study Phase 1|Adverse Event|0
201947|NCT00323492|680208|P2|Study Phase 1|Adverse Event|0
201948|NCT00323492|680209|P1|Study Phase 1|Adverse Event|2
201949|NCT00323479|680240|P1|Overall Study|house moving|1
201950|NCT00323479|680240|P1|Overall Study|Protocol Violation|3
201951|NCT00323479|680240|P1|Overall Study|Withdrawal by Subject|2
201952|NCT00323479|680240|P1|Overall Study|Adverse Event|2
201953|NCT00323414|680264|P2|Overall Study|Withdrawal by Subject|1
201954|NCT00323414|680265|P1|Overall Study|Withdrawal by Subject|0
201955|NCT00323310|680287|P1|Overall Study|did not complete the 24-hr f-up visit|1
201956|NCT00323310|680287|P1|Overall Study|a parent refused blood draw|1
201957|NCT00323310|680287|P1|Overall Study|Withdrawal by Subject|1
201958|NCT00323297|680302|P2|Part B (Open-label)|Protocol Violation|1
201959|NCT00323297|680303|P1|Part B (Open-label)|Protocol Violation|0
201960|NCT00323297|680302|P2|Part B (Open-label)|Adverse Event|5
201961|NCT00323297|680303|P1|Part B (Open-label)|Adverse Event|5
201962|NCT00323297|680302|P2|Part B (Open-label)|Lack of Efficacy|1
201963|NCT00323297|680303|P1|Part B (Open-label)|Lack of Efficacy|3
201964|NCT00323297|680302|P2|Part B (Open-label)|Withdrawal by Subject|3
201965|NCT00323297|680303|P1|Part B (Open-label)|Withdrawal by Subject|1
201966|NCT00323297|680302|P2|Part B (Open-label)|Reason unspecified|1
201967|NCT00323297|680303|P1|Part B (Open-label)|Reason unspecified|0
201968|NCT00323297|680302|P2|Part B (Open-label)|Death|1
201969|NCT00323297|680303|P1|Part B (Open-label)|Death|0
201970|NCT00323297|680302|P2|Part A (Double Blind Randomized)|Related adverse event|2
201971|NCT00323297|680303|P1|Part A (Double Blind Randomized)|Related adverse event|2
201972|NCT00323297|680302|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
201973|NCT00323297|680303|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
201974|NCT00323297|680302|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
201975|NCT00323297|680303|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
201976|NCT00323297|680302|P2|Part A (Double Blind Randomized)|Protocol Violation|3
201977|NCT00323297|680303|P1|Part A (Double Blind Randomized)|Protocol Violation|1
201978|NCT00323297|680302|P2|Part A (Double Blind Randomized)|Death|1
201979|NCT00323297|680303|P1|Part A (Double Blind Randomized)|Death|0
201980|NCT00323297|680302|P2|Part A (Double Blind Randomized)|Reason unspecified|1
201981|NCT00323297|680303|P1|Part A (Double Blind Randomized)|Reason unspecified|0
201982|NCT00323258|680343|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
201983|NCT00323258|680344|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
201984|NCT00323258|680343|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
201985|NCT00323258|680344|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
201986|NCT00323258|680343|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
201987|NCT00323258|680344|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
201988|NCT00323258|680343|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
201989|NCT00323258|680344|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
201990|NCT00323258|680343|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
201991|NCT00323258|680344|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
201992|NCT00323258|680343|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
201993|NCT00323258|680344|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
201994|NCT00323258|680343|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
201995|NCT00323258|680344|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
201996|NCT00323115|680369|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
201997|NCT00323115|680369|P1|Vaccine Administration|Adverse Event|1
201998|NCT00323063|680376|P2|Overall Study|brain mets discovered prior to treatment|0
201999|NCT00323063|680377|P1|Overall Study|brain mets discovered prior to treatment|1
202000|NCT00323063|680376|P2|Overall Study|Adverse Event|0
202001|NCT00323063|680377|P1|Overall Study|Adverse Event|1
202002|NCT00322881|680394|P1|Overall Study|Disease Progression|2
202003|NCT00322881|680394|P1|Overall Study|Adverse Event|1
202004|NCT00322881|680394|P1|Overall Study|Death|2
202005|NCT00322868|680398|P1|Overall Study|disease progression|1
202006|NCT00322842|680423|P2|Overall Study|Death|0
202007|NCT00322842|680424|P1|Overall Study|Death|1
202008|NCT00322842|680423|P2|Overall Study|Refused transplant|0
202009|NCT00322842|680424|P1|Overall Study|Refused transplant|1
202010|NCT00322842|680423|P2|Overall Study|Lost to Follow-up|1
202011|NCT00322842|680424|P1|Overall Study|Lost to Follow-up|0
202012|NCT00322842|680423|P2|Overall Study|Withdrawal by Subject|1
202013|NCT00322842|680424|P1|Overall Study|Withdrawal by Subject|0
202014|NCT00322712|680462|P1|Overall Study|treated with bevacizumab not cetuximab|1
202015|NCT00322621|680466|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
202016|NCT00322621|680467|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
202017|NCT00322621|680468|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
202018|NCT00322621|680466|P3|Period III - Maintenance / Rescue Phase|Death|0
202019|NCT00322621|680467|P2|Period III - Maintenance / Rescue Phase|Death|1
202020|NCT00322621|680468|P1|Period III - Maintenance / Rescue Phase|Death|0
202021|NCT00322621|680466|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
202022|NCT00322621|680467|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
202023|NCT00322621|680468|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
202024|NCT00322621|680466|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
202025|NCT00322621|680467|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
202026|NCT00322621|680468|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
202027|NCT00322621|680466|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
202028|NCT00322621|680467|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
202029|NCT00322621|680468|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
202030|NCT00322621|680466|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
202031|NCT00322621|680467|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
202032|NCT00322621|680468|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
202033|NCT00322621|680466|P3|Period II - Acute Therapy Phase|Physician Decision|0
202034|NCT00322621|680467|P2|Period II - Acute Therapy Phase|Physician Decision|0
202035|NCT00322621|680468|P1|Period II - Acute Therapy Phase|Physician Decision|1
202036|NCT00322621|680466|P3|Period II - Acute Therapy Phase|Protocol Violation|0
202037|NCT00322621|680467|P2|Period II - Acute Therapy Phase|Protocol Violation|0
202038|NCT00322621|680468|P1|Period II - Acute Therapy Phase|Protocol Violation|2
202039|NCT00322621|680466|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
202040|NCT00322621|680467|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
202041|NCT00322621|680468|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
202042|NCT00322621|680466|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
202043|NCT00322621|680467|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
202044|NCT00322621|680468|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
202045|NCT00322621|680466|P3|Period II - Acute Therapy Phase|Adverse Event|0
202046|NCT00322621|680467|P2|Period II - Acute Therapy Phase|Adverse Event|0
202047|NCT00322621|680468|P1|Period II - Acute Therapy Phase|Adverse Event|20
202048|NCT00322556|680520|P1|Overall Study|Other Reason|7
202049|NCT00322556|680520|P1|Overall Study|Lost to Follow-up|3
202050|NCT00322556|680520|P1|Overall Study|Withdrawal by Subject|1
202051|NCT00322556|680520|P1|Overall Study|Adverse Event|1
202052|NCT00322491|680536|P2|Overall Study|Death|2
202053|NCT00322491|680537|P1|Overall Study|Death|1
202054|NCT00322491|680536|P2|Overall Study|Adverse Event|0
202055|NCT00322491|680537|P1|Overall Study|Adverse Event|1
202056|NCT00322452|680627|P2|Overall Study|Death|227
202057|NCT00322452|680628|P1|Overall Study|Death|223
202058|NCT00322452|680627|P2|Overall Study|Withdrawal by Subject|46
202059|NCT00322452|680628|P1|Overall Study|Withdrawal by Subject|19
202060|NCT00322452|680627|P2|Overall Study|Lost to Follow-up|2
202061|NCT00322452|680628|P1|Overall Study|Lost to Follow-up|5
202062|NCT00322452|680627|P2|Overall Study|Eligibility criteria not fulfilled|1
202063|NCT00322452|680628|P1|Overall Study|Eligibility criteria not fulfilled|0
202064|NCT00322387|680679|P2|Follow-up Period|Death|0
202065|NCT00322387|680680|P1|Follow-up Period|Death|1
202066|NCT00322387|680679|P2|Follow-up Period|Final assessment not done|3
202067|NCT00322387|680680|P1|Follow-up Period|Final assessment not done|1
202068|NCT00322387|680679|P2|Treatment Period|Adverse Event|1
202069|NCT00322387|680680|P1|Treatment Period|Adverse Event|0
202070|NCT00322374|680714|P4|Second Escalation|Study Drug Toxicity|0
202071|NCT00322374|680715|P3|Second Escalation|Study Drug Toxicity|1
202072|NCT00322374|680716|P2|Second Escalation|Study Drug Toxicity|0
202073|NCT00322374|680717|P1|Second Escalation|Study Drug Toxicity|0
202074|NCT00322374|680714|P4|Second Escalation|Physician Decision|0
202075|NCT00322374|680715|P3|Second Escalation|Physician Decision|5
202076|NCT00322374|680716|P2|Second Escalation|Physician Decision|0
202077|NCT00322374|680717|P1|Second Escalation|Physician Decision|0
202078|NCT00322374|680714|P4|First Escalation|Participant Request|0
202079|NCT00322374|680715|P3|First Escalation|Participant Request|0
202080|NCT00322374|680716|P2|First Escalation|Participant Request|1
202081|NCT00322374|680717|P1|First Escalation|Participant Request|0
202082|NCT00322374|680714|P4|First Escalation|Study Drug Toxicity|0
202083|NCT00322374|680715|P3|First Escalation|Study Drug Toxicity|0
202084|NCT00322374|680716|P2|First Escalation|Study Drug Toxicity|11
202085|NCT00322374|680717|P1|First Escalation|Study Drug Toxicity|0
202086|NCT00322374|680714|P4|First Escalation|Physician Decision|0
202087|NCT00322374|680715|P3|First Escalation|Physician Decision|0
202088|NCT00322374|680716|P2|First Escalation|Physician Decision|12
202089|NCT00322374|680717|P1|First Escalation|Physician Decision|0
202090|NCT00322374|680714|P4|First Escalation|Documented Disease Progression|0
202091|NCT00322374|680715|P3|First Escalation|Documented Disease Progression|0
202092|NCT00322374|680716|P2|First Escalation|Documented Disease Progression|6
202093|NCT00322374|680717|P1|First Escalation|Documented Disease Progression|0
202094|NCT00322374|680714|P4|Starting Dose|Study Drug Toxicity|0
202095|NCT00322374|680715|P3|Starting Dose|Study Drug Toxicity|0
202096|NCT00322374|680716|P2|Starting Dose|Study Drug Toxicity|0
202097|NCT00322374|680717|P1|Starting Dose|Study Drug Toxicity|4
202098|NCT00322374|680714|P4|Starting Dose|Physician Decision|0
202099|NCT00322374|680715|P3|Starting Dose|Physician Decision|0
202100|NCT00322374|680716|P2|Starting Dose|Physician Decision|0
202101|NCT00322374|680717|P1|Starting Dose|Physician Decision|2
202102|NCT00322348|680767|P2|Overall Study|Reasons not specified|1
202103|NCT00322348|680768|P1|Overall Study|Reasons not specified|5
202104|NCT00322348|680767|P2|Overall Study|Disease Progression|25
202105|NCT00322348|680768|P1|Overall Study|Disease Progression|30
202106|NCT00322348|680767|P2|Overall Study|Death|2
202107|NCT00322348|680768|P1|Overall Study|Death|0
202108|NCT00322348|680767|P2|Overall Study|Lost to Follow-up|0
202109|NCT00322348|680768|P1|Overall Study|Lost to Follow-up|1
202110|NCT00322348|680767|P2|Overall Study|Withdrawal by Subject|4
202111|NCT00322348|680768|P1|Overall Study|Withdrawal by Subject|1
202112|NCT00322348|680767|P2|Overall Study|Adverse Event|1
202113|NCT00322348|680768|P1|Overall Study|Adverse Event|0
202114|NCT00322153|680859|P2|Overall Study|Withdrawn for other reasons|4
202115|NCT00322153|680860|P1|Overall Study|Withdrawn for other reasons|5
202116|NCT00322153|680859|P2|Overall Study|Lost to Follow-up|4
202117|NCT00322153|680860|P1|Overall Study|Lost to Follow-up|5
202118|NCT00322153|680859|P2|Overall Study|Lack of Efficacy|3
202119|NCT00322153|680860|P1|Overall Study|Lack of Efficacy|8
202120|NCT00322153|680859|P2|Overall Study|Withdrawal by Subject|10
202121|NCT00322153|680860|P1|Overall Study|Withdrawal by Subject|18
202122|NCT00322153|680859|P2|Overall Study|Protocol Violation|14
202123|NCT00322153|680860|P1|Overall Study|Protocol Violation|6
202124|NCT00322153|680859|P2|Overall Study|Adverse Event|34
202125|NCT00322153|680860|P1|Overall Study|Adverse Event|21
202126|NCT00322049|680893|P4|Overall Study|Infected with Dengue during study|0
202127|NCT00322049|680894|P3|Overall Study|Infected with Dengue during study|0
202128|NCT00322049|680895|P2|Overall Study|Infected with Dengue during study|1
202129|NCT00322049|680896|P1|Overall Study|Infected with Dengue during study|0
202130|NCT00322049|680893|P4|Overall Study|Moved out of area|1
202131|NCT00322049|680894|P3|Overall Study|Moved out of area|0
202132|NCT00322049|680895|P2|Overall Study|Moved out of area|0
202133|NCT00322049|680896|P1|Overall Study|Moved out of area|0
202134|NCT00321984|680929|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
202135|NCT00321984|680930|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
202136|NCT00321984|680931|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
202137|NCT00321984|680929|P3|Overall Study|Per Investigator Request|0
202138|NCT00321984|680930|P2|Overall Study|Per Investigator Request|0
202139|NCT00321984|680931|P1|Overall Study|Per Investigator Request|1
202140|NCT00321984|680929|P3|Overall Study|Per Subject Request|0
202141|NCT00321984|680930|P2|Overall Study|Per Subject Request|0
202142|NCT00321984|680931|P1|Overall Study|Per Subject Request|1
202143|NCT00321984|680929|P3|Overall Study|Pregnancy|0
202144|NCT00321984|680930|P2|Overall Study|Pregnancy|1
202145|NCT00321984|680931|P1|Overall Study|Pregnancy|0
202146|NCT00321984|680929|P3|Overall Study|Noncompliant|2
202147|NCT00321984|680930|P2|Overall Study|Noncompliant|0
202148|NCT00321984|680931|P1|Overall Study|Noncompliant|0
202149|NCT00321984|680929|P3|Overall Study|Lack of Efficacy|3
202150|NCT00321984|680930|P2|Overall Study|Lack of Efficacy|1
202151|NCT00321984|680931|P1|Overall Study|Lack of Efficacy|3
202152|NCT00321984|680929|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
202153|NCT00321984|680930|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
202154|NCT00321984|680931|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
202155|NCT00321984|680929|P3|Overall Study|Withdrawal by Subject|5
202156|NCT00321984|680930|P2|Overall Study|Withdrawal by Subject|6
202157|NCT00321984|680931|P1|Overall Study|Withdrawal by Subject|8
202158|NCT00321984|680929|P3|Overall Study|Lost to Follow-up|2
202159|NCT00321984|680930|P2|Overall Study|Lost to Follow-up|4
202160|NCT00321984|680931|P1|Overall Study|Lost to Follow-up|2
202161|NCT00321984|680929|P3|Overall Study|Protocol Violation|1
202162|NCT00321984|680930|P2|Overall Study|Protocol Violation|1
202163|NCT00321984|680931|P1|Overall Study|Protocol Violation|0
202164|NCT00321984|680929|P3|Overall Study|Adverse Event|8
202165|NCT00321984|680930|P2|Overall Study|Adverse Event|6
202166|NCT00321984|680931|P1|Overall Study|Adverse Event|9
202167|NCT00321932|680959|P2|Overall Study|Missing data|1
202168|NCT00321932|680960|P1|Overall Study|Missing data|2
202169|NCT00321932|680959|P2|Overall Study|Early relapse|8
202170|NCT00321932|680960|P1|Overall Study|Early relapse|2
202171|NCT00321932|680959|P2|Overall Study|Withdrawal by Subject|6
202172|NCT00321932|680960|P1|Overall Study|Withdrawal by Subject|3
202173|NCT00321932|680959|P2|Overall Study|Death|6
202174|NCT00321932|680960|P1|Overall Study|Death|3
202175|NCT00321919|680984|P2|Overall Study|Other withdrawal reason|6
202176|NCT00321919|680985|P1|Overall Study|Other withdrawal reason|7
202177|NCT00321919|680984|P2|Overall Study|Failure to Return|1
202178|NCT00321919|680985|P1|Overall Study|Failure to Return|3
202179|NCT00321919|680984|P2|Overall Study|Other Protocol Violation|3
202180|NCT00321919|680985|P1|Overall Study|Other Protocol Violation|2
202181|NCT00321919|680984|P2|Overall Study|Refused Treatment|14
202182|NCT00321919|680985|P1|Overall Study|Refused Treatment|23
202183|NCT00321919|680984|P2|Overall Study|Violation of Selection Criteria at Entry|1
202184|NCT00321919|680985|P1|Overall Study|Violation of Selection Criteria at Entry|1
202185|NCT00321919|680984|P2|Overall Study|Insufficient Therapeutic Response|0
202186|NCT00321919|680985|P1|Overall Study|Insufficient Therapeutic Response|1
202187|NCT00321919|680984|P2|Overall Study|Death|17
202188|NCT00321919|680985|P1|Overall Study|Death|21
202189|NCT00321919|680984|P2|Overall Study|Adverse Event|10
202190|NCT00321919|680985|P1|Overall Study|Adverse Event|17
202191|NCT00321906|681027|P2|Overall Study|Withdrawal by Subject|4
202192|NCT00321906|681028|P1|Overall Study|Withdrawal by Subject|0
202193|NCT00321906|681027|P2|Overall Study|Lost to Follow-up|2
202194|NCT00321906|681028|P1|Overall Study|Lost to Follow-up|1
202195|NCT00321906|681027|P2|Overall Study|Death|6
202196|NCT00321906|681028|P1|Overall Study|Death|9
202197|NCT00321906|681027|P2|Overall Study|Adverse Event|44
202198|NCT00321906|681028|P1|Overall Study|Adverse Event|36
202199|NCT00321893|681050|P2|Overall Study|Adverse Event|3
202200|NCT00321893|681051|P1|Overall Study|Adverse Event|6
202201|NCT00321893|681050|P2|Overall Study|Lost to Follow-up|1
202202|NCT00321893|681051|P1|Overall Study|Lost to Follow-up|2
202203|NCT00321893|681050|P2|Overall Study|Non-Compliance/Refusal|10
202204|NCT00321893|681051|P1|Overall Study|Non-Compliance/Refusal|16
202205|NCT00321854|681065|P2|Overall Study|Other|1
202206|NCT00321854|681066|P1|Overall Study|Other|1
202207|NCT00321854|681065|P2|Overall Study|Withdrawal by Subject|17
202208|NCT00321854|681066|P1|Overall Study|Withdrawal by Subject|6
202209|NCT00321854|681065|P2|Overall Study|Lost to Follow-up|2
202210|NCT00321854|681066|P1|Overall Study|Lost to Follow-up|0
202211|NCT00321854|681065|P2|Overall Study|Protocol Violation|5
202212|NCT00321854|681066|P1|Overall Study|Protocol Violation|6
202213|NCT00321854|681065|P2|Overall Study|Lack of Efficacy|14
202214|NCT00321854|681066|P1|Overall Study|Lack of Efficacy|9
202215|NCT00321854|681065|P2|Overall Study|Adverse Event|43
202216|NCT00321854|681066|P1|Overall Study|Adverse Event|41
202217|NCT00321828|681184|P1|Overall Study|No follow up data|1
202218|NCT00321828|681184|P1|Overall Study|Ineligible|3
202219|NCT00321789|681190|P2|Overall Study|Protocol Violation|3
202220|NCT00321789|681191|P1|Overall Study|Protocol Violation|5
202221|NCT00321789|681190|P2|Overall Study|Withdrawal by Subject|6
202222|NCT00321789|681191|P1|Overall Study|Withdrawal by Subject|6
202223|NCT00321789|681190|P2|Overall Study|Lost to Follow-up|7
202224|NCT00321789|681191|P1|Overall Study|Lost to Follow-up|4
202225|NCT00321763|681223|P4|Overall Study|Lost to Follow-up|4
202226|NCT00321763|681224|P3|Overall Study|Lost to Follow-up|5
202227|NCT00321763|681225|P2|Overall Study|Lost to Follow-up|1
202228|NCT00321763|681226|P1|Overall Study|Lost to Follow-up|3
202229|NCT00321763|681223|P4|Overall Study|Withdrawal by Subject|0
202230|NCT00321763|681224|P3|Overall Study|Withdrawal by Subject|1
202231|NCT00321763|681225|P2|Overall Study|Withdrawal by Subject|0
202232|NCT00321763|681226|P1|Overall Study|Withdrawal by Subject|2
202233|NCT00321763|681223|P4|Overall Study|Adverse Event|1
202234|NCT00321763|681224|P3|Overall Study|Adverse Event|0
202235|NCT00321763|681225|P2|Overall Study|Adverse Event|1
202236|NCT00321763|681226|P1|Overall Study|Adverse Event|1
202237|NCT00321737|681286|P3|Overall Study|Subject Request/ Subject Unavailable|2
202238|NCT00321737|681287|P2|Overall Study|Subject Request/ Subject Unavailable|0
202239|NCT00321737|681288|P1|Overall Study|Subject Request/ Subject Unavailable|0
202240|NCT00321737|681286|P3|Overall Study|Noncompliance|0
202241|NCT00321737|681287|P2|Overall Study|Noncompliance|0
202242|NCT00321737|681288|P1|Overall Study|Noncompliance|2
202243|NCT00321737|681286|P3|Overall Study|Pregnancy|0
202244|NCT00321737|681287|P2|Overall Study|Pregnancy|2
202245|NCT00321737|681288|P1|Overall Study|Pregnancy|0
202246|NCT00321737|681286|P3|Overall Study|Therapeutic Failure|2
202247|NCT00321737|681287|P2|Overall Study|Therapeutic Failure|0
202248|NCT00321737|681288|P1|Overall Study|Therapeutic Failure|6
202249|NCT00321737|681286|P3|Overall Study|Possible Barrett's Esophagus|1
202250|NCT00321737|681287|P2|Overall Study|Possible Barrett's Esophagus|1
202251|NCT00321737|681288|P1|Overall Study|Possible Barrett's Esophagus|2
202252|NCT00321737|681286|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
202253|NCT00321737|681287|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
202254|NCT00321737|681288|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
202255|NCT00321737|681286|P3|Overall Study|Protocol Violation|1
202256|NCT00321737|681287|P2|Overall Study|Protocol Violation|0
202257|NCT00321737|681288|P1|Overall Study|Protocol Violation|0
202258|NCT00321737|681286|P3|Overall Study|Withdrawal by Subject|17
202259|NCT00321737|681287|P2|Overall Study|Withdrawal by Subject|12
202260|NCT00321737|681288|P1|Overall Study|Withdrawal by Subject|19
202261|NCT00321737|681286|P3|Overall Study|Lost to Follow-up|6
202262|NCT00321737|681287|P2|Overall Study|Lost to Follow-up|5
202263|NCT00321737|681288|P1|Overall Study|Lost to Follow-up|5
202264|NCT00321737|681286|P3|Overall Study|Adverse Event|6
202265|NCT00321737|681287|P2|Overall Study|Adverse Event|3
202266|NCT00321737|681288|P1|Overall Study|Adverse Event|11
202267|NCT00321737|681286|P3|Overall Study|Relapse of Erosive Esophagitis|19
202268|NCT00321737|681287|P2|Overall Study|Relapse of Erosive Esophagitis|25
202269|NCT00321737|681288|P1|Overall Study|Relapse of Erosive Esophagitis|76
202270|NCT00321711|681316|P5|Part B|Death|1
202271|NCT00321711|681317|P4|Part B|Death|2
202272|NCT00321711|681318|P3|Part B|Death|0
202273|NCT00321711|681319|P2|Part B|Death|0
202274|NCT00321711|681320|P1|Part B|Death|0
202275|NCT00321711|681316|P5|Part B|Physician Decision|2
202276|NCT00321711|681317|P4|Part B|Physician Decision|1
202277|NCT00321711|681318|P3|Part B|Physician Decision|0
202278|NCT00321711|681319|P2|Part B|Physician Decision|0
202279|NCT00321711|681320|P1|Part B|Physician Decision|0
202280|NCT00321711|681316|P5|Part B|Disease progression|0
202281|NCT00321711|681317|P4|Part B|Disease progression|1
202282|NCT00321711|681318|P3|Part B|Disease progression|0
202283|NCT00321711|681319|P2|Part B|Disease progression|0
202284|NCT00321711|681320|P1|Part B|Disease progression|0
202285|NCT00321711|681316|P5|Part B|Adverse Event|1
202286|NCT00321711|681317|P4|Part B|Adverse Event|2
202287|NCT00321711|681318|P3|Part B|Adverse Event|0
202288|NCT00321711|681319|P2|Part B|Adverse Event|0
202289|NCT00321711|681320|P1|Part B|Adverse Event|0
202290|NCT00321711|681316|P5|Part B|Noncompliance|1
202291|NCT00321711|681317|P4|Part B|Noncompliance|0
202292|NCT00321711|681318|P3|Part B|Noncompliance|0
202293|NCT00321711|681319|P2|Part B|Noncompliance|0
202294|NCT00321711|681320|P1|Part B|Noncompliance|0
202295|NCT00321711|681316|P5|Part A|Protocol deviation|0
202296|NCT00321711|681317|P4|Part A|Protocol deviation|0
202297|NCT00321711|681318|P3|Part A|Protocol deviation|1
202298|NCT00321711|681319|P2|Part A|Protocol deviation|0
202299|NCT00321711|681320|P1|Part A|Protocol deviation|0
202300|NCT00321711|681316|P5|Part A|Other|0
202301|NCT00321711|681317|P4|Part A|Other|0
202302|NCT00321711|681318|P3|Part A|Other|3
202303|NCT00321711|681319|P2|Part A|Other|2
202304|NCT00321711|681320|P1|Part A|Other|1
202305|NCT00321711|681316|P5|Part A|Physician Decision|0
202306|NCT00321711|681317|P4|Part A|Physician Decision|0
202307|NCT00321711|681318|P3|Part A|Physician Decision|3
202308|NCT00321711|681319|P2|Part A|Physician Decision|1
202309|NCT00321711|681320|P1|Part A|Physician Decision|0
202310|NCT00321711|681316|P5|Part A|Requirement for alternative therapy|0
202311|NCT00321711|681317|P4|Part A|Requirement for alternative therapy|0
202312|NCT00321711|681318|P3|Part A|Requirement for alternative therapy|1
202313|NCT00321711|681319|P2|Part A|Requirement for alternative therapy|2
202314|NCT00321711|681320|P1|Part A|Requirement for alternative therapy|0
202315|NCT00321711|681316|P5|Part A|Disease progression|0
202316|NCT00321711|681317|P4|Part A|Disease progression|0
202317|NCT00321711|681318|P3|Part A|Disease progression|0
202318|NCT00321711|681319|P2|Part A|Disease progression|1
202319|NCT00321711|681320|P1|Part A|Disease progression|0
202320|NCT00321711|681316|P5|Part A|Withdrawal by Subject|0
202321|NCT00321711|681317|P4|Part A|Withdrawal by Subject|0
202322|NCT00321711|681318|P3|Part A|Withdrawal by Subject|1
202323|NCT00321711|681319|P2|Part A|Withdrawal by Subject|1
202324|NCT00321711|681320|P1|Part A|Withdrawal by Subject|1
202325|NCT00321711|681316|P5|Part A|Adverse Event|0
202326|NCT00321711|681317|P4|Part A|Adverse Event|0
202327|NCT00321711|681318|P3|Part A|Adverse Event|2
202328|NCT00321711|681319|P2|Part A|Adverse Event|3
202329|NCT00321711|681320|P1|Part A|Adverse Event|3
202330|NCT00321685|681370|P1|Overall Study|Ineligible|2
202331|NCT00321685|681370|P1|Overall Study|Not start protocol therapy|2
202332|NCT00321685|681370|P1|Overall Study|Other|5
202333|NCT00321685|681370|P1|Overall Study|Complicating disese|1
202334|NCT00321685|681370|P1|Overall Study|Alternative therapy|1
202335|NCT00321685|681370|P1|Overall Study|Withdrawal by Subject|8
202336|NCT00321685|681370|P1|Overall Study|Death|2
202337|NCT00321685|681370|P1|Overall Study|Adverse Event|18
202338|NCT00321672|681382|P4|Overall Study|Extensive travel required for new job|0
202339|NCT00321672|681383|P3|Overall Study|Extensive travel required for new job|0
202340|NCT00321672|681384|P2|Overall Study|Extensive travel required for new job|1
202341|NCT00321672|681385|P1|Overall Study|Extensive travel required for new job|0
202342|NCT00321672|681382|P4|Overall Study|Diagnosis of testicular cancer|0
202343|NCT00321672|681383|P3|Overall Study|Diagnosis of testicular cancer|0
202344|NCT00321672|681384|P2|Overall Study|Diagnosis of testicular cancer|1
202345|NCT00321672|681385|P1|Overall Study|Diagnosis of testicular cancer|0
202346|NCT00321672|681382|P4|Overall Study|Protocol Violation|0
202347|NCT00321672|681383|P3|Overall Study|Protocol Violation|1
202348|NCT00321672|681384|P2|Overall Study|Protocol Violation|0
202349|NCT00321672|681385|P1|Overall Study|Protocol Violation|0
202350|NCT00321672|681382|P4|Overall Study|Moved out of state|0
202351|NCT00321672|681383|P3|Overall Study|Moved out of state|1
202352|NCT00321672|681384|P2|Overall Study|Moved out of state|1
202353|NCT00321672|681385|P1|Overall Study|Moved out of state|0
202354|NCT00321672|681382|P4|Overall Study|Incarcerated|0
202355|NCT00321672|681383|P3|Overall Study|Incarcerated|2
202356|NCT00321672|681384|P2|Overall Study|Incarcerated|0
202357|NCT00321672|681385|P1|Overall Study|Incarcerated|0
202358|NCT00321672|681382|P4|Overall Study|Too far to travel for visits|0
202359|NCT00321672|681383|P3|Overall Study|Too far to travel for visits|0
202360|NCT00321672|681384|P2|Overall Study|Too far to travel for visits|0
202361|NCT00321672|681385|P1|Overall Study|Too far to travel for visits|1
202362|NCT00321672|681382|P4|Overall Study|Death|0
202363|NCT00321672|681383|P3|Overall Study|Death|0
202364|NCT00321672|681384|P2|Overall Study|Death|0
202365|NCT00321672|681385|P1|Overall Study|Death|1
202366|NCT00321672|681382|P4|Overall Study|Lost to Follow-up|2
202367|NCT00321672|681383|P3|Overall Study|Lost to Follow-up|4
202368|NCT00321672|681384|P2|Overall Study|Lost to Follow-up|0
202369|NCT00321672|681385|P1|Overall Study|Lost to Follow-up|2
202370|NCT00321672|681382|P4|Overall Study|Lack of Efficacy|0
202371|NCT00321672|681383|P3|Overall Study|Lack of Efficacy|0
202372|NCT00321672|681384|P2|Overall Study|Lack of Efficacy|1
202373|NCT00321672|681385|P1|Overall Study|Lack of Efficacy|1
202374|NCT00321672|681382|P4|Overall Study|Adverse Event|0
202375|NCT00321672|681383|P3|Overall Study|Adverse Event|0
202376|NCT00321672|681384|P2|Overall Study|Adverse Event|1
202377|NCT00321672|681385|P1|Overall Study|Adverse Event|1
202378|NCT00321672|681382|P4|Overall Study|Noncompliance|0
202379|NCT00321672|681383|P3|Overall Study|Noncompliance|1
202380|NCT00321672|681384|P2|Overall Study|Noncompliance|2
202381|NCT00321672|681385|P1|Overall Study|Noncompliance|1
202382|NCT00321672|681382|P4|Overall Study|Withdrawal by Subject|0
202383|NCT00321672|681383|P3|Overall Study|Withdrawal by Subject|2
202384|NCT00321672|681384|P2|Overall Study|Withdrawal by Subject|1
202385|NCT00321672|681385|P1|Overall Study|Withdrawal by Subject|5
202386|NCT00321646|681411|P1|Neoadjuvant Chemotherapy|Disease progression|1
202387|NCT00321646|681411|P1|Neoadjuvant Chemotherapy|Adverse Event|2
202388|NCT00321646|681411|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
202389|NCT00321620|681418|P2|Overall Study|Other|33
202390|NCT00321620|681419|P1|Overall Study|Other|42
202391|NCT00321620|681418|P2|Overall Study|Participant request|52
202392|NCT00321620|681419|P1|Overall Study|Participant request|75
202393|NCT00321620|681418|P2|Overall Study|Ineligibility determined|3
202394|NCT00321620|681419|P1|Overall Study|Ineligibility determined|2
202395|NCT00321620|681418|P2|Overall Study|Protocol deviation|3
202396|NCT00321620|681419|P1|Overall Study|Protocol deviation|4
202397|NCT00321620|681418|P2|Overall Study|Noncompliance|7
202398|NCT00321620|681419|P1|Overall Study|Noncompliance|14
202399|NCT00321620|681418|P2|Overall Study|Physician Decision|1
202400|NCT00321620|681419|P1|Overall Study|Physician Decision|4
202401|NCT00321620|681418|P2|Overall Study|Lost to Follow-up|9
202402|NCT00321620|681419|P1|Overall Study|Lost to Follow-up|13
202403|NCT00321620|681418|P2|Overall Study|Adverse Event|56
202404|NCT00321620|681419|P1|Overall Study|Adverse Event|43
202405|NCT00321620|681418|P2|Overall Study|Disease progression|117
202406|NCT00321620|681419|P1|Overall Study|Disease progression|113
202407|NCT00321620|681418|P2|Overall Study|Withdrawal by Subject|147
202408|NCT00321620|681419|P1|Overall Study|Withdrawal by Subject|164
202409|NCT00321620|681418|P2|Overall Study|Death|294
202410|NCT00321620|681419|P1|Overall Study|Death|269
202411|NCT00321464|681449|P2|Overall Study|Other|18
202412|NCT00321464|681450|P1|Overall Study|Other|21
202413|NCT00321464|681449|P2|Overall Study|Ineligibility determined|1
202414|NCT00321464|681450|P1|Overall Study|Ineligibility determined|2
202415|NCT00321464|681449|P2|Overall Study|Protocol deviation|2
202416|NCT00321464|681450|P1|Overall Study|Protocol deviation|0
202417|NCT00321464|681449|P2|Overall Study|Lost to Follow-up|8
202418|NCT00321464|681450|P1|Overall Study|Lost to Follow-up|7
202419|NCT00321464|681449|P2|Overall Study|Noncompliance|10
202420|NCT00321464|681450|P1|Overall Study|Noncompliance|4
202421|NCT00321464|681449|P2|Overall Study|Physician Decision|14
202422|NCT00321464|681450|P1|Overall Study|Physician Decision|15
202423|NCT00321464|681449|P2|Overall Study|Adverse Event|28
202424|NCT00321464|681450|P1|Overall Study|Adverse Event|43
202425|NCT00321464|681449|P2|Overall Study|Participant request|61
202426|NCT00321464|681450|P1|Overall Study|Participant request|57
202427|NCT00321464|681449|P2|Overall Study|Withdrawal by Subject|118
202428|NCT00321464|681450|P1|Overall Study|Withdrawal by Subject|117
202429|NCT00321464|681449|P2|Overall Study|Disease progression|124
202430|NCT00321464|681450|P1|Overall Study|Disease progression|124
202431|NCT00321464|681449|P2|Overall Study|Death|174
202432|NCT00321464|681450|P1|Overall Study|Death|169
202433|NCT00321373|681463|P3|Overall Study|Other|1
202434|NCT00321373|681464|P2|Overall Study|Other|0
202435|NCT00321373|681465|P1|Overall Study|Other|0
202436|NCT00321373|681463|P3|Overall Study|Withdrawal by Subject|0
202437|NCT00321373|681464|P2|Overall Study|Withdrawal by Subject|0
202438|NCT00321373|681465|P1|Overall Study|Withdrawal by Subject|1
202439|NCT00321373|681463|P3|Overall Study|Lost to Follow-up|1
202440|NCT00321373|681464|P2|Overall Study|Lost to Follow-up|0
202441|NCT00321373|681465|P1|Overall Study|Lost to Follow-up|1
202442|NCT00321373|681463|P3|Overall Study|Adverse Event|1
202443|NCT00321373|681464|P2|Overall Study|Adverse Event|0
202444|NCT00321373|681465|P1|Overall Study|Adverse Event|0
202445|NCT00320801|681505|P4|Extension Phase|Lost to Follow-up|3
202446|NCT00320801|681506|P3|Extension Phase|Lost to Follow-up|0
202447|NCT00320801|681507|P2|Extension Phase|Lost to Follow-up|0
202448|NCT00320801|681508|P1|Extension Phase|Lost to Follow-up|0
202449|NCT00320801|681505|P4|Extension Phase|Lack of Efficacy|2
202450|NCT00320801|681506|P3|Extension Phase|Lack of Efficacy|0
202451|NCT00320801|681507|P2|Extension Phase|Lack of Efficacy|0
202452|NCT00320801|681508|P1|Extension Phase|Lack of Efficacy|0
202453|NCT00320801|681505|P4|Extension Phase|Administrative|29
202454|NCT00320801|681506|P3|Extension Phase|Administrative|0
202455|NCT00320801|681507|P2|Extension Phase|Administrative|0
202456|NCT00320801|681508|P1|Extension Phase|Administrative|0
202457|NCT00320801|681505|P4|Extension Phase|Adverse Event|8
202458|NCT00320801|681506|P3|Extension Phase|Adverse Event|0
202459|NCT00320801|681507|P2|Extension Phase|Adverse Event|0
202460|NCT00320801|681508|P1|Extension Phase|Adverse Event|0
202461|NCT00320801|681505|P4|Extension Phase|Withdrawal by Subject|6
202462|NCT00320801|681506|P3|Extension Phase|Withdrawal by Subject|0
202463|NCT00320801|681507|P2|Extension Phase|Withdrawal by Subject|0
202464|NCT00320801|681508|P1|Extension Phase|Withdrawal by Subject|0
202465|NCT00320801|681505|P4|Double-blind Phase|Lack of Efficacy|0
202466|NCT00320801|681506|P3|Double-blind Phase|Lack of Efficacy|1
202467|NCT00320801|681507|P2|Double-blind Phase|Lack of Efficacy|9
202468|NCT00320801|681508|P1|Double-blind Phase|Lack of Efficacy|0
202469|NCT00320801|681505|P4|Double-blind Phase|Administrative|0
202470|NCT00320801|681506|P3|Double-blind Phase|Administrative|4
202471|NCT00320801|681507|P2|Double-blind Phase|Administrative|0
202472|NCT00320801|681508|P1|Double-blind Phase|Administrative|0
202473|NCT00320801|681505|P4|Double-blind Phase|Adverse Event|0
202474|NCT00320801|681506|P3|Double-blind Phase|Adverse Event|8
202475|NCT00320801|681507|P2|Double-blind Phase|Adverse Event|2
202476|NCT00320801|681508|P1|Double-blind Phase|Adverse Event|0
202477|NCT00320801|681505|P4|Double-blind Phase|Withdrawal by Subject|0
202478|NCT00320801|681506|P3|Double-blind Phase|Withdrawal by Subject|1
202479|NCT00320801|681507|P2|Double-blind Phase|Withdrawal by Subject|0
202480|NCT00320801|681508|P1|Double-blind Phase|Withdrawal by Subject|0
202481|NCT00320801|681505|P4|Open-label Run-in Period|Did not qualify|0
202482|NCT00320801|681506|P3|Open-label Run-in Period|Did not qualify|0
202483|NCT00320801|681507|P2|Open-label Run-in Period|Did not qualify|0
202484|NCT00320801|681508|P1|Open-label Run-in Period|Did not qualify|1
202485|NCT00320801|681505|P4|Open-label Run-in Period|Lost to Follow-up|0
202486|NCT00320801|681506|P3|Open-label Run-in Period|Lost to Follow-up|0
202487|NCT00320801|681507|P2|Open-label Run-in Period|Lost to Follow-up|0
202488|NCT00320801|681508|P1|Open-label Run-in Period|Lost to Follow-up|2
202489|NCT00320801|681505|P4|Open-label Run-in Period|Lack of Efficacy|0
202490|NCT00320801|681506|P3|Open-label Run-in Period|Lack of Efficacy|0
202491|NCT00320801|681507|P2|Open-label Run-in Period|Lack of Efficacy|0
202492|NCT00320801|681508|P1|Open-label Run-in Period|Lack of Efficacy|44
202493|NCT00320801|681505|P4|Open-label Run-in Period|Administrative|0
202494|NCT00320801|681506|P3|Open-label Run-in Period|Administrative|0
202495|NCT00320801|681507|P2|Open-label Run-in Period|Administrative|0
202496|NCT00320801|681508|P1|Open-label Run-in Period|Administrative|10
202497|NCT00320801|681505|P4|Open-label Run-in Period|Adverse Event|0
202498|NCT00320801|681506|P3|Open-label Run-in Period|Adverse Event|0
202499|NCT00320801|681507|P2|Open-label Run-in Period|Adverse Event|0
202500|NCT00320801|681508|P1|Open-label Run-in Period|Adverse Event|33
202501|NCT00320801|681505|P4|Open-label Run-in Period|Withdrawal by Subject|0
202502|NCT00320801|681506|P3|Open-label Run-in Period|Withdrawal by Subject|0
202503|NCT00320801|681507|P2|Open-label Run-in Period|Withdrawal by Subject|0
202504|NCT00320801|681508|P1|Open-label Run-in Period|Withdrawal by Subject|2
202505|NCT00320788|681523|P5|Overall Study|Withdrawal by Subject|1
202506|NCT00320788|681524|P4|Overall Study|Withdrawal by Subject|3
202507|NCT00320788|681525|P3|Overall Study|Withdrawal by Subject|0
202508|NCT00320788|681526|P2|Overall Study|Withdrawal by Subject|0
202509|NCT00320788|681527|P1|Overall Study|Withdrawal by Subject|3
202510|NCT00320788|681523|P5|Overall Study|Protocol Violation|1
202511|NCT00320788|681524|P4|Overall Study|Protocol Violation|0
202512|NCT00320788|681525|P3|Overall Study|Protocol Violation|0
202513|NCT00320788|681526|P2|Overall Study|Protocol Violation|0
202514|NCT00320788|681527|P1|Overall Study|Protocol Violation|0
202515|NCT00320788|681523|P5|Overall Study|Physician Decision|0
202516|NCT00320788|681524|P4|Overall Study|Physician Decision|0
202517|NCT00320788|681525|P3|Overall Study|Physician Decision|0
202518|NCT00320788|681526|P2|Overall Study|Physician Decision|1
202519|NCT00320788|681527|P1|Overall Study|Physician Decision|1
202520|NCT00320788|681523|P5|Overall Study|Other|1
202521|NCT00320788|681524|P4|Overall Study|Other|1
202522|NCT00320788|681525|P3|Overall Study|Other|1
202523|NCT00320788|681526|P2|Overall Study|Other|2
202524|NCT00320788|681527|P1|Overall Study|Other|1
202525|NCT00320788|681523|P5|Overall Study|Decision by the Sponsor|1
202526|NCT00320788|681524|P4|Overall Study|Decision by the Sponsor|0
202527|NCT00320788|681525|P3|Overall Study|Decision by the Sponsor|0
202528|NCT00320788|681526|P2|Overall Study|Decision by the Sponsor|1
202529|NCT00320788|681527|P1|Overall Study|Decision by the Sponsor|1
202530|NCT00320788|681523|P5|Overall Study|Lost to Follow-up|0
202531|NCT00320788|681524|P4|Overall Study|Lost to Follow-up|0
202532|NCT00320788|681525|P3|Overall Study|Lost to Follow-up|1
202533|NCT00320788|681526|P2|Overall Study|Lost to Follow-up|2
202534|NCT00320788|681527|P1|Overall Study|Lost to Follow-up|0
202535|NCT00320788|681523|P5|Overall Study|Death|1
202536|NCT00320788|681524|P4|Overall Study|Death|0
202537|NCT00320788|681525|P3|Overall Study|Death|1
202538|NCT00320788|681526|P2|Overall Study|Death|0
202539|NCT00320788|681527|P1|Overall Study|Death|0
202540|NCT00320788|681523|P5|Overall Study|Adverse Event|0
202541|NCT00320788|681524|P4|Overall Study|Adverse Event|1
202542|NCT00320788|681525|P3|Overall Study|Adverse Event|0
202543|NCT00320788|681526|P2|Overall Study|Adverse Event|0
202544|NCT00320788|681527|P1|Overall Study|Adverse Event|0
202545|NCT00320710|681581|P3|Overall Study|Lost to Follow-up|0
202546|NCT00320710|681582|P2|Overall Study|Lost to Follow-up|0
202547|NCT00320710|681583|P1|Overall Study|Lost to Follow-up|1
202548|NCT00320710|681581|P3|Overall Study|Adverse Event|1
202549|NCT00320710|681582|P2|Overall Study|Adverse Event|14
202550|NCT00320710|681583|P1|Overall Study|Adverse Event|18
202551|NCT00320710|681581|P3|Overall Study|Abnormal laboratory value(s)|0
202552|NCT00320710|681582|P2|Overall Study|Abnormal laboratory value(s)|3
202553|NCT00320710|681583|P1|Overall Study|Abnormal laboratory value(s)|12
202554|NCT00320710|681581|P3|Overall Study|Abnormal test procedure result(s)|0
202555|NCT00320710|681582|P2|Overall Study|Abnormal test procedure result(s)|0
202556|NCT00320710|681583|P1|Overall Study|Abnormal test procedure result(s)|2
202557|NCT00320710|681581|P3|Overall Study|Protocol Violation|0
202558|NCT00320710|681582|P2|Overall Study|Protocol Violation|5
202559|NCT00320710|681583|P1|Overall Study|Protocol Violation|6
202560|NCT00320710|681581|P3|Overall Study|Withdrawal by Subject|1
202561|NCT00320710|681582|P2|Overall Study|Withdrawal by Subject|26
202562|NCT00320710|681583|P1|Overall Study|Withdrawal by Subject|20
202563|NCT00320710|681581|P3|Overall Study|Administrative problems|0
202564|NCT00320710|681582|P2|Overall Study|Administrative problems|2
202565|NCT00320710|681583|P1|Overall Study|Administrative problems|1
202566|NCT00320710|681581|P3|Overall Study|Death|1
202567|NCT00320710|681582|P2|Overall Study|Death|7
202568|NCT00320710|681583|P1|Overall Study|Death|10
202569|NCT00320710|681581|P3|Overall Study|Disease progression|2
202570|NCT00320710|681582|P2|Overall Study|Disease progression|19
202571|NCT00320710|681583|P1|Overall Study|Disease progression|24
202572|NCT00320606|681613|P1|Overall Study|Ongoing in study|12
202573|NCT00320606|681613|P1|Overall Study|Protocol Violation|1
202574|NCT00320606|681613|P1|Overall Study|Adverse Event|1
202575|NCT00320593|681619|P2|Overall Study|Withdrawal by clinical center|0
202576|NCT00320593|681620|P1|Overall Study|Withdrawal by clinical center|1
202577|NCT00320593|681619|P2|Overall Study|Withdrawal by Subject|1
202578|NCT00320593|681620|P1|Overall Study|Withdrawal by Subject|2
202579|NCT00320593|681619|P2|Overall Study|Moved to another state|0
202580|NCT00320593|681620|P1|Overall Study|Moved to another state|1
202581|NCT00320593|681619|P2|Overall Study|Lost to Follow-up|0
202582|NCT00320593|681620|P1|Overall Study|Lost to Follow-up|3
202583|NCT00320541|681644|P2|Overall Study|Protocol Entry Criterion Not Met|0
202584|NCT00320541|681645|P1|Overall Study|Protocol Entry Criterion Not Met|1
202585|NCT00320541|681644|P2|Overall Study|Death due to Adverse Event(s)|0
202586|NCT00320541|681645|P1|Overall Study|Death due to Adverse Event(s)|1
202587|NCT00320541|681644|P2|Overall Study|Death due to Study Disease|3
202588|NCT00320541|681645|P1|Overall Study|Death due to Study Disease|1
202589|NCT00320541|681644|P2|Overall Study|Sponsor Decision|1
202590|NCT00320541|681645|P1|Overall Study|Sponsor Decision|2
202591|NCT00320541|681644|P2|Overall Study|Other|4
202592|NCT00320541|681645|P1|Overall Study|Other|3
202593|NCT00320541|681644|P2|Overall Study|Physician Decision|13
202594|NCT00320541|681645|P1|Overall Study|Physician Decision|9
202595|NCT00320541|681644|P2|Overall Study|Withdrawal by Subject|16
202596|NCT00320541|681645|P1|Overall Study|Withdrawal by Subject|12
202597|NCT00320541|681644|P2|Overall Study|Protocol Violation|1
202598|NCT00320541|681645|P1|Overall Study|Protocol Violation|0
202599|NCT00320541|681644|P2|Overall Study|Adverse Event|19
202600|NCT00320541|681645|P1|Overall Study|Adverse Event|21
202601|NCT00320528|681672|P3|Study Period III|Atomoxetine Commercially Available|90
202602|NCT00320528|681673|P2|Study Period III|Atomoxetine Commercially Available|25
202603|NCT00320528|681674|P1|Study Period III|Atomoxetine Commercially Available|68
202604|NCT00320528|681672|P3|Study Period III|Sponsor Decision|1
202605|NCT00320528|681673|P2|Study Period III|Sponsor Decision|0
202606|NCT00320528|681674|P1|Study Period III|Sponsor Decision|0
202607|NCT00320528|681672|P3|Study Period III|Physician Decision|2
202608|NCT00320528|681673|P2|Study Period III|Physician Decision|1
202609|NCT00320528|681674|P1|Study Period III|Physician Decision|0
202610|NCT00320528|681672|P3|Study Period III|Protocol Violation|0
202611|NCT00320528|681673|P2|Study Period III|Protocol Violation|1
202612|NCT00320528|681674|P1|Study Period III|Protocol Violation|0
202613|NCT00320528|681672|P3|Study Period III|Parent/Caregiver Decision|11
202614|NCT00320528|681673|P2|Study Period III|Parent/Caregiver Decision|3
202615|NCT00320528|681674|P1|Study Period III|Parent/Caregiver Decision|14
202616|NCT00320528|681672|P3|Study Period III|Lack of Efficacy|0
202617|NCT00320528|681673|P2|Study Period III|Lack of Efficacy|0
202618|NCT00320528|681674|P1|Study Period III|Lack of Efficacy|2
202619|NCT00320528|681672|P3|Study Period III|Withdrawal by Subject|2
202620|NCT00320528|681673|P2|Study Period III|Withdrawal by Subject|1
202621|NCT00320528|681674|P1|Study Period III|Withdrawal by Subject|1
202622|NCT00320528|681672|P3|Study Period III|Lost to Follow-up|0
202623|NCT00320528|681673|P2|Study Period III|Lost to Follow-up|0
202624|NCT00320528|681674|P1|Study Period III|Lost to Follow-up|1
202625|NCT00320528|681672|P3|Study Period III|Adverse Event|0
202626|NCT00320528|681673|P2|Study Period III|Adverse Event|0
202627|NCT00320528|681674|P1|Study Period III|Adverse Event|1
202628|NCT00320528|681672|P3|Study Period II|Entry Criteria Exclusion|2
202629|NCT00320528|681673|P2|Study Period II|Entry Criteria Exclusion|2
202630|NCT00320528|681674|P1|Study Period II|Entry Criteria Exclusion|0
202631|NCT00320528|681672|P3|Study Period II|Withdrawal by Subject|1
202632|NCT00320528|681673|P2|Study Period II|Withdrawal by Subject|1
202633|NCT00320528|681674|P1|Study Period II|Withdrawal by Subject|0
202634|NCT00320528|681672|P3|Study Period II|Parent/Caregiver Decision|11
202635|NCT00320528|681673|P2|Study Period II|Parent/Caregiver Decision|3
202636|NCT00320528|681674|P1|Study Period II|Parent/Caregiver Decision|8
202637|NCT00320528|681672|P3|Study Period II|Adverse Event|8
202638|NCT00320528|681673|P2|Study Period II|Adverse Event|4
202639|NCT00320528|681674|P1|Study Period II|Adverse Event|3
202640|NCT00320515|681709|P1|Overall Study|Withdrawal by Subject|8
202641|NCT00320515|681709|P1|Overall Study|Physician Decision|2
202642|NCT00320515|681709|P1|Overall Study|Lost to Follow-up|6
202643|NCT00320515|681709|P1|Overall Study|Death|33
202644|NCT00320489|681718|P2|Overall Study|Withdrawal by Subject|41
202645|NCT00320489|681719|P1|Overall Study|Withdrawal by Subject|39
202646|NCT00320489|681718|P2|Overall Study|Sponsor Decision|3
202647|NCT00320489|681719|P1|Overall Study|Sponsor Decision|3
202648|NCT00320489|681718|P2|Overall Study|Protocol Violation|4
202649|NCT00320489|681719|P1|Overall Study|Protocol Violation|4
202650|NCT00320489|681718|P2|Overall Study|Physician Decision|8
202651|NCT00320489|681719|P1|Overall Study|Physician Decision|8
202652|NCT00320489|681718|P2|Overall Study|Lost to Follow-up|22
202653|NCT00320489|681719|P1|Overall Study|Lost to Follow-up|21
202654|NCT00320489|681718|P2|Overall Study|Lack of Efficacy|7
202655|NCT00320489|681719|P1|Overall Study|Lack of Efficacy|16
202656|NCT00320489|681718|P2|Overall Study|Entry Criteria Exclusion|4
202657|NCT00320489|681719|P1|Overall Study|Entry Criteria Exclusion|2
202658|NCT00320489|681718|P2|Overall Study|Death|2
202659|NCT00320489|681719|P1|Overall Study|Death|0
202660|NCT00320489|681718|P2|Overall Study|Clinical Relapse|20
202661|NCT00320489|681719|P1|Overall Study|Clinical Relapse|26
202662|NCT00320489|681718|P2|Overall Study|Adverse Event|25
202663|NCT00320489|681719|P1|Overall Study|Adverse Event|26
202664|NCT00320424|681775|P1|Overall Study|Other|3
202665|NCT00320424|681775|P1|Overall Study|Adverse Event|3
202666|NCT00320411|681789|P1|Overall Study|No investigational product admin.|4
202667|NCT00320398|681812|P2|Overall Study|Other|0
202668|NCT00320398|681813|P1|Overall Study|Other|1
202669|NCT00320398|681812|P2|Overall Study|Adverse Event|4
202670|NCT00320398|681813|P1|Overall Study|Adverse Event|1
202671|NCT00320385|681841|P2|Overall Study|Adverse Event|1
202672|NCT00320385|681842|P1|Overall Study|Adverse Event|0
202673|NCT00320385|681841|P2|Overall Study|Withdrew Consent|0
202674|NCT00320385|681842|P1|Overall Study|Withdrew Consent|1
202675|NCT00320385|681841|P2|Overall Study|Serious Adverse Event|0
202676|NCT00320385|681842|P1|Overall Study|Serious Adverse Event|1
202677|NCT00320385|681841|P2|Overall Study|Death|2
202678|NCT00320385|681842|P1|Overall Study|Death|1
202679|NCT00320385|681841|P2|Overall Study|Investigator Decision|1
202680|NCT00320385|681842|P1|Overall Study|Investigator Decision|0
202681|NCT00320385|681841|P2|Overall Study|Sponsor Terminated Study|1
202682|NCT00320385|681842|P1|Overall Study|Sponsor Terminated Study|2
202683|NCT00320385|681841|P2|Overall Study|Withdrawal by Subject|7
202684|NCT00320385|681842|P1|Overall Study|Withdrawal by Subject|6
202685|NCT00320385|681841|P2|Overall Study|Lost to Follow-up|10
202686|NCT00320385|681842|P1|Overall Study|Lost to Follow-up|7
202687|NCT00320372|681865|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
202688|NCT00320372|681866|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
202689|NCT00320372|681865|P2|Overall Study|Did not Meet (I/E)|1
202690|NCT00320372|681866|P1|Overall Study|Did not Meet (I/E)|3
202691|NCT00320372|681865|P2|Overall Study|Non-Compliance|39
202692|NCT00320372|681866|P1|Overall Study|Non-Compliance|40
202693|NCT00320372|681865|P2|Overall Study|Withdrawal by Subject|37
202694|NCT00320372|681866|P1|Overall Study|Withdrawal by Subject|55
202695|NCT00320372|681865|P2|Overall Study|Death|8
202696|NCT00320372|681866|P1|Overall Study|Death|7
202697|NCT00320372|681865|P2|Overall Study|Physician Decision|7
202698|NCT00320372|681866|P1|Overall Study|Physician Decision|4
202699|NCT00320255|681906|P6|Overall Study|Not specified|0
202700|NCT00320255|681907|P5|Overall Study|Not specified|0
202701|NCT00320255|681908|P4|Overall Study|Not specified|0
202702|NCT00320255|681909|P3|Overall Study|Not specified|1
202703|NCT00320255|681910|P2|Overall Study|Not specified|2
202704|NCT00320255|681911|P1|Overall Study|Not specified|3
202705|NCT00320255|681906|P6|Overall Study|No longer meets study criteria|0
202706|NCT00320255|681907|P5|Overall Study|No longer meets study criteria|0
202707|NCT00320255|681908|P4|Overall Study|No longer meets study criteria|1
202708|NCT00320255|681909|P3|Overall Study|No longer meets study criteria|0
202709|NCT00320255|681910|P2|Overall Study|No longer meets study criteria|0
202710|NCT00320255|681911|P1|Overall Study|No longer meets study criteria|0
202711|NCT00320255|681906|P6|Overall Study|Poor compliance/noncompliance|0
202712|NCT00320255|681907|P5|Overall Study|Poor compliance/noncompliance|0
202713|NCT00320255|681908|P4|Overall Study|Poor compliance/noncompliance|1
202714|NCT00320255|681909|P3|Overall Study|Poor compliance/noncompliance|0
202715|NCT00320255|681910|P2|Overall Study|Poor compliance/noncompliance|1
202716|NCT00320255|681911|P1|Overall Study|Poor compliance/noncompliance|1
202717|NCT00320255|681906|P6|Overall Study|Withdrawal by Subject|0
202718|NCT00320255|681907|P5|Overall Study|Withdrawal by Subject|0
202719|NCT00320255|681908|P4|Overall Study|Withdrawal by Subject|4
202720|NCT00320255|681909|P3|Overall Study|Withdrawal by Subject|2
202721|NCT00320255|681910|P2|Overall Study|Withdrawal by Subject|2
202722|NCT00320255|681911|P1|Overall Study|Withdrawal by Subject|1
202723|NCT00320255|681906|P6|Overall Study|Adverse Event|0
202724|NCT00320255|681907|P5|Overall Study|Adverse Event|0
202725|NCT00320255|681908|P4|Overall Study|Adverse Event|2
202726|NCT00320255|681909|P3|Overall Study|Adverse Event|3
202727|NCT00320255|681910|P2|Overall Study|Adverse Event|2
202728|NCT00320255|681911|P1|Overall Study|Adverse Event|5
202729|NCT00320255|681906|P6|Overall Study|Lack of Efficacy|0
202730|NCT00320255|681907|P5|Overall Study|Lack of Efficacy|0
202731|NCT00320255|681908|P4|Overall Study|Lack of Efficacy|0
202732|NCT00320255|681909|P3|Overall Study|Lack of Efficacy|0
202733|NCT00320255|681910|P2|Overall Study|Lack of Efficacy|0
202734|NCT00320255|681911|P1|Overall Study|Lack of Efficacy|1
202735|NCT00320216|682004|P5|Overall Study|Other|3
202736|NCT00320216|682005|P4|Overall Study|Other|1
202737|NCT00320216|682006|P3|Overall Study|Other|5
202738|NCT00320216|682007|P2|Overall Study|Other|2
202739|NCT00320216|682008|P1|Overall Study|Other|7
202740|NCT00320216|682004|P5|Overall Study|Lost to Follow-up|0
202741|NCT00320216|682005|P4|Overall Study|Lost to Follow-up|0
202742|NCT00320216|682006|P3|Overall Study|Lost to Follow-up|0
202743|NCT00320216|682007|P2|Overall Study|Lost to Follow-up|0
202744|NCT00320216|682008|P1|Overall Study|Lost to Follow-up|3
202745|NCT00320216|682004|P5|Overall Study|Lack of Efficacy|1
202746|NCT00320216|682005|P4|Overall Study|Lack of Efficacy|0
202747|NCT00320216|682006|P3|Overall Study|Lack of Efficacy|1
202748|NCT00320216|682007|P2|Overall Study|Lack of Efficacy|2
202749|NCT00320216|682008|P1|Overall Study|Lack of Efficacy|6
202750|NCT00320216|682004|P5|Overall Study|Adverse Event|2
202751|NCT00320216|682005|P4|Overall Study|Adverse Event|2
202752|NCT00320216|682006|P3|Overall Study|Adverse Event|0
202753|NCT00320216|682007|P2|Overall Study|Adverse Event|6
202754|NCT00320216|682008|P1|Overall Study|Adverse Event|0
202755|NCT00320190|682042|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
202756|NCT00320190|682043|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
202757|NCT00320190|682042|P2|Long-term (12-month) Extension|Lack of major molecular response|2
202758|NCT00320190|682043|P1|Long-term (12-month) Extension|Lack of major molecular response|1
202759|NCT00320190|682042|P2|Long-term (12-month) Extension|Sponsor terminated study|0
202760|NCT00320190|682043|P1|Long-term (12-month) Extension|Sponsor terminated study|7
202761|NCT00320190|682042|P2|First 12 Months|Withdrawal by Subject|1
202762|NCT00320190|682043|P1|First 12 Months|Withdrawal by Subject|0
202763|NCT00320190|682042|P2|First 12 Months|Study drug toxicity|1
202764|NCT00320190|682043|P1|First 12 Months|Study drug toxicity|0
202765|NCT00320190|682042|P2|First 12 Months|Investigator request|1
202766|NCT00320190|682043|P1|First 12 Months|Investigator request|0
202767|NCT00320190|682042|P2|First 12 Months|Adverse event unrelated to study drug|0
202768|NCT00320190|682043|P1|First 12 Months|Adverse event unrelated to study drug|1
202769|NCT00320190|682042|P2|First 12 Months|Enrollment failure|1
202770|NCT00320190|682043|P1|First 12 Months|Enrollment failure|0
202771|NCT00320190|682042|P2|First 12 Months|Lost to Follow-up|1
202772|NCT00320190|682043|P1|First 12 Months|Lost to Follow-up|0
202773|NCT00320190|682042|P2|First 12 Months|Sponsor terminated study|2
202774|NCT00320190|682043|P1|First 12 Months|Sponsor terminated study|2
202775|NCT00320190|682042|P2|First 12 Months|Completed but did not enter extension|3
202776|NCT00320190|682043|P1|First 12 Months|Completed but did not enter extension|5
202777|NCT00320112|682063|P2|Overall Study|Death|1
202778|NCT00320112|682064|P1|Overall Study|Death|2
202779|NCT00320112|682063|P2|Overall Study|Withdrawal by Subject|0
202780|NCT00320112|682064|P1|Overall Study|Withdrawal by Subject|3
202781|NCT00320112|682063|P2|Overall Study|Lost to Follow-up|4
202782|NCT00320112|682064|P1|Overall Study|Lost to Follow-up|3
202783|NCT00319982|682078|P2|Overall Study|Withdrawal by Subject|0
202784|NCT00319982|682079|P1|Overall Study|Withdrawal by Subject|1
202785|NCT00319839|682097|P1|Overall Study|Withdrawal by Subject|1
202786|NCT00319839|682097|P1|Overall Study|Adverse Event|5
202787|NCT00319735|682113|P1|Overall Study|Death|2
202788|NCT00319696|682126|P1|Overall Study|Lost to Follow-up|3
202789|NCT00319696|682126|P1|Overall Study|administrative|7
202790|NCT00319696|682126|P1|Overall Study|withdrawal of consent|14
202791|NCT00319696|682126|P1|Overall Study|Adverse Event|36
202792|NCT00319592|682163|P2|Overall Study|Physician Decision|1
202793|NCT00319592|682164|P1|Overall Study|Physician Decision|0
202794|NCT00319592|682163|P2|Overall Study|Protocol Violation|0
202795|NCT00319592|682164|P1|Overall Study|Protocol Violation|1
202796|NCT00319553|682180|P2|Overall Study|Withdrawal by Subject|1
202797|NCT00319553|682181|P1|Overall Study|Withdrawal by Subject|1
202798|NCT00319553|682180|P2|Overall Study|Lost to Follow-up|1
202799|NCT00319553|682181|P1|Overall Study|Lost to Follow-up|2
202800|NCT00319553|682180|P2|Overall Study|Protocol Violation|2
202801|NCT00319553|682181|P1|Overall Study|Protocol Violation|1
202802|NCT00319501|682195|P2|Open-label Extension Period|Withdrawal by Subject|0
202803|NCT00319501|682196|P1|Open-label Extension Period|Withdrawal by Subject|2
202804|NCT00319501|682195|P2|Open-label Extension Period|Sponsor request|0
202805|NCT00319501|682196|P1|Open-label Extension Period|Sponsor request|26
202806|NCT00319501|682195|P2|Open-label Extension Period|Principal investigator decision|0
202807|NCT00319501|682196|P1|Open-label Extension Period|Principal investigator decision|2
202808|NCT00319501|682195|P2|Open-label Extension Period|Not specified|0
202809|NCT00319501|682196|P1|Open-label Extension Period|Not specified|1
202810|NCT00319501|682195|P2|Open-label Extension Period|Did not receive treatment|0
202811|NCT00319501|682196|P1|Open-label Extension Period|Did not receive treatment|18
202812|NCT00319501|682195|P2|Open-label Extension Period|Adverse Event|0
202813|NCT00319501|682196|P1|Open-label Extension Period|Adverse Event|2
202814|NCT00319501|682195|P2|Open-label Period|Not specified|0
202815|NCT00319501|682196|P1|Open-label Period|Not specified|11
202816|NCT00319501|682195|P2|Open-label Period|Did not receive treatment|0
202817|NCT00319501|682196|P1|Open-label Period|Did not receive treatment|33
202818|NCT00319501|682195|P2|Open-label Period|Lost to Follow-up|0
202819|NCT00319501|682196|P1|Open-label Period|Lost to Follow-up|5
202820|NCT00319501|682195|P2|Open-label Period|Sponsor request|0
202821|NCT00319501|682196|P1|Open-label Period|Sponsor request|12
202822|NCT00319501|682195|P2|Open-label Period|Principal Investigator decision|0
202823|NCT00319501|682196|P1|Open-label Period|Principal Investigator decision|6
202824|NCT00319501|682195|P2|Open-label Period|Withdrawal by Subject|0
202825|NCT00319501|682196|P1|Open-label Period|Withdrawal by Subject|38
202826|NCT00319501|682195|P2|Open-label Period|Protocol Violation|0
202827|NCT00319501|682196|P1|Open-label Period|Protocol Violation|6
202828|NCT00319501|682195|P2|Open-label Period|Adverse Event|0
202829|NCT00319501|682196|P1|Open-label Period|Adverse Event|5
202830|NCT00319501|682195|P2|Double-blind Period|Did not receive treatment|29
202831|NCT00319501|682196|P1|Double-blind Period|Did not receive treatment|42
202832|NCT00319501|682195|P2|Double-blind Period|Sponsor Request|0
202833|NCT00319501|682196|P1|Double-blind Period|Sponsor Request|1
202834|NCT00319501|682195|P2|Double-blind Period|Withdrawal by Subject|3
202835|NCT00319501|682196|P1|Double-blind Period|Withdrawal by Subject|0
202836|NCT00319449|682222|P2|Overall Study|Noncompliance with the protocol|0
202837|NCT00319449|682223|P1|Overall Study|Noncompliance with the protocol|1
202838|NCT00319449|682222|P2|Overall Study|Subject did not wish to continue|0
202839|NCT00319449|682223|P1|Overall Study|Subject did not wish to continue|1
202840|NCT00319436|682235|P2|Overall Study|Withdrawal by Subject|7
202841|NCT00319436|682236|P1|Overall Study|Withdrawal by Subject|6
202842|NCT00319254|682254|P1|Overall Study|Enrolled, Not Treated|2
202843|NCT00319254|682254|P1|Overall Study|Lost to Follow-up|2
202844|NCT00319254|682254|P1|Overall Study|Death|46
202845|NCT00319254|682254|P1|Overall Study|Withdrawal by Subject|4
202846|NCT00319111|682267|P1|Overall Study|Treatment failure|1
202847|NCT00319111|682267|P1|Overall Study|Administrative|2
202848|NCT00319111|682267|P1|Overall Study|Lack of clinical improvement|4
202849|NCT00319111|682267|P1|Overall Study|Death|9
202850|NCT00319111|682267|P1|Overall Study|Withdrawal of consent|11
202851|NCT00319111|682267|P1|Overall Study|Adverse Event|20
202852|NCT00319098|682281|P2|Overall Study|Protocol Violation|1
202853|NCT00319098|682282|P1|Overall Study|Protocol Violation|3
202854|NCT00319098|682281|P2|Overall Study|Others|8
202855|NCT00319098|682282|P1|Overall Study|Others|33
202856|NCT00319098|682281|P2|Overall Study|Lost to Follow-up|13
202857|NCT00319098|682282|P1|Overall Study|Lost to Follow-up|37
202858|NCT00319098|682281|P2|Overall Study|Migrated/moved from study area|1
202859|NCT00319098|682282|P1|Overall Study|Migrated/moved from study area|2
202860|NCT00319098|682281|P2|Overall Study|Withdrawal by Subject|8
202861|NCT00319098|682282|P1|Overall Study|Withdrawal by Subject|37
202862|NCT00319098|682281|P2|Overall Study|Adverse Event|1
202863|NCT00319098|682282|P1|Overall Study|Adverse Event|20
202864|NCT00319098|682281|P2|Overall Study|Serious adverse event|0
202865|NCT00319098|682282|P1|Overall Study|Serious adverse event|3
202866|NCT00319046|682340|P1|Overall Study|administrative reason|1
202867|NCT00319046|682340|P1|Overall Study|withdrawal of subject's consent|7
202868|NCT00319020|682349|P2|Overall Study|Adverse Event|1
202869|NCT00319020|682350|P1|Overall Study|Adverse Event|0
202870|NCT00319020|682349|P2|Overall Study|Treatment failure|1
202871|NCT00319020|682350|P1|Overall Study|Treatment failure|0
202872|NCT00319020|682349|P2|Overall Study|Transplant|1
202873|NCT00319020|682350|P1|Overall Study|Transplant|0
202874|NCT00319020|682349|P2|Overall Study|Disease progression|2
202875|NCT00319020|682350|P1|Overall Study|Disease progression|0
202876|NCT00319020|682349|P2|Overall Study|Administrative reason|5
202877|NCT00319020|682350|P1|Overall Study|Administrative reason|0
202878|NCT00319020|682349|P2|Overall Study|F-1 completed but not enrolled in F-2|0
202879|NCT00319020|682350|P1|Overall Study|F-1 completed but not enrolled in F-2|1
202880|NCT00319020|682349|P2|Overall Study|Withdrawal by Subject|1
202881|NCT00319020|682350|P1|Overall Study|Withdrawal by Subject|4
202882|NCT00319020|682349|P2|Overall Study|Death|2
202883|NCT00319020|682350|P1|Overall Study|Death|2
202884|NCT00318656|682422|P2|Overall Study|Did not receive any treatment|1
202885|NCT00318656|682423|P1|Overall Study|Did not receive any treatment|0
202886|NCT00318656|682422|P2|Overall Study|Took Avandamet instead of Glim/Met|1
202887|NCT00318656|682423|P1|Overall Study|Took Avandamet instead of Glim/Met|0
202888|NCT00318565|682480|P1|Overall Study|Excluded per protocol|24
202889|NCT00318474|682487|P2|Overall Study|Trial terminated|7
202890|NCT00318474|682488|P1|Overall Study|Trial terminated|10
202891|NCT00318474|682487|P2|Overall Study|Post-therapy hyperflycemia|1
202892|NCT00318474|682488|P1|Overall Study|Post-therapy hyperflycemia|0
202893|NCT00318474|682487|P2|Overall Study|Fall in GFR|3
202894|NCT00318474|682488|P1|Overall Study|Fall in GFR|3
202895|NCT00318474|682487|P2|Overall Study|Withdrawal by Subject|2
202896|NCT00318474|682488|P1|Overall Study|Withdrawal by Subject|3
202897|NCT00318474|682487|P2|Overall Study|Protocol Violation|0
202898|NCT00318474|682488|P1|Overall Study|Protocol Violation|1
202899|NCT00318474|682487|P2|Overall Study|Pregnancy|2
202900|NCT00318474|682488|P1|Overall Study|Pregnancy|0
202901|NCT00318474|682487|P2|Overall Study|Lost to Follow-up|1
202902|NCT00318474|682488|P1|Overall Study|Lost to Follow-up|0
202903|NCT00318474|682487|P2|Overall Study|Adverse Event|1
202904|NCT00318474|682488|P1|Overall Study|Adverse Event|1
202905|NCT00318461|682499|P5|Open-Label Extension, 18 Months|Protocol Violation|6
202906|NCT00318461|682500|P4|Open-Label Extension, 18 Months|Protocol Violation|4
202907|NCT00318461|682501|P3|Open-Label Extension, 18 Months|Protocol Violation|3
202908|NCT00318461|682502|P2|Open-Label Extension, 18 Months|Protocol Violation|5
202909|NCT00318461|682503|P1|Open-Label Extension, 18 Months|Protocol Violation|7
202910|NCT00318461|682499|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
202911|NCT00318461|682500|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
202912|NCT00318461|682501|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
202913|NCT00318461|682502|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
202914|NCT00318461|682503|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
202915|NCT00318461|682499|P5|Open-Label Extension, 18 Months|Adverse Event|6
202916|NCT00318461|682500|P4|Open-Label Extension, 18 Months|Adverse Event|1
202917|NCT00318461|682501|P3|Open-Label Extension, 18 Months|Adverse Event|6
202918|NCT00318461|682502|P2|Open-Label Extension, 18 Months|Adverse Event|8
202919|NCT00318461|682503|P1|Open-Label Extension, 18 Months|Adverse Event|11
202920|NCT00318461|682499|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
202921|NCT00318461|682500|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
202922|NCT00318461|682501|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
202923|NCT00318461|682502|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
202924|NCT00318461|682503|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
202925|NCT00318461|682499|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
202926|NCT00318461|682500|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
202927|NCT00318461|682501|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
202928|NCT00318461|682502|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
202929|NCT00318461|682503|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
202930|NCT00318461|682499|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
202931|NCT00318461|682500|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
202932|NCT00318461|682501|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
202933|NCT00318461|682502|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
202934|NCT00318461|682503|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
202935|NCT00318461|682499|P5|Double-Blind, 6 Months|Hyperglicaemia|0
202936|NCT00318461|682500|P4|Double-Blind, 6 Months|Hyperglicaemia|1
202937|NCT00318461|682501|P3|Double-Blind, 6 Months|Hyperglicaemia|0
202938|NCT00318461|682502|P2|Double-Blind, 6 Months|Hyperglicaemia|0
202939|NCT00318461|682503|P1|Double-Blind, 6 Months|Hyperglicaemia|0
202940|NCT00318461|682499|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
202941|NCT00318461|682500|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
202942|NCT00318461|682501|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
202943|NCT00318461|682502|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
202944|NCT00318461|682503|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
202945|NCT00318461|682499|P5|Double-Blind, 6 Months|Lack of time|0
202946|NCT00318461|682500|P4|Double-Blind, 6 Months|Lack of time|0
202947|NCT00318461|682501|P3|Double-Blind, 6 Months|Lack of time|0
202948|NCT00318461|682502|P2|Double-Blind, 6 Months|Lack of time|0
202949|NCT00318461|682503|P1|Double-Blind, 6 Months|Lack of time|1
202950|NCT00318461|682499|P5|Double-Blind, 6 Months|Investigator decision|1
202951|NCT00318461|682500|P4|Double-Blind, 6 Months|Investigator decision|0
202952|NCT00318461|682501|P3|Double-Blind, 6 Months|Investigator decision|0
202953|NCT00318461|682502|P2|Double-Blind, 6 Months|Investigator decision|0
202954|NCT00318461|682503|P1|Double-Blind, 6 Months|Investigator decision|0
202955|NCT00318461|682499|P5|Double-Blind, 6 Months|Work commitment|1
202956|NCT00318461|682500|P4|Double-Blind, 6 Months|Work commitment|0
202957|NCT00318461|682501|P3|Double-Blind, 6 Months|Work commitment|0
202958|NCT00318461|682502|P2|Double-Blind, 6 Months|Work commitment|0
202959|NCT00318461|682503|P1|Double-Blind, 6 Months|Work commitment|0
202960|NCT00318461|682499|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
202961|NCT00318461|682500|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
202962|NCT00318461|682501|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
202963|NCT00318461|682502|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
202964|NCT00318461|682503|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
202965|NCT00318461|682499|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
202966|NCT00318461|682500|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
202967|NCT00318461|682501|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
202968|NCT00318461|682502|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
202969|NCT00318461|682503|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
202970|NCT00318461|682499|P5|Double-Blind, 6 Months|Move|0
202971|NCT00318461|682500|P4|Double-Blind, 6 Months|Move|0
202972|NCT00318461|682501|P3|Double-Blind, 6 Months|Move|0
202973|NCT00318461|682502|P2|Double-Blind, 6 Months|Move|1
202974|NCT00318461|682503|P1|Double-Blind, 6 Months|Move|0
202975|NCT00318461|682499|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
202976|NCT00318461|682500|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
202977|NCT00318461|682501|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
202978|NCT00318461|682502|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
202979|NCT00318461|682503|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
202980|NCT00318461|682499|P5|Double-Blind, 6 Months|Consent withdrawn|4
202981|NCT00318461|682500|P4|Double-Blind, 6 Months|Consent withdrawn|10
202982|NCT00318461|682501|P3|Double-Blind, 6 Months|Consent withdrawn|4
202983|NCT00318461|682502|P2|Double-Blind, 6 Months|Consent withdrawn|3
202984|NCT00318461|682503|P1|Double-Blind, 6 Months|Consent withdrawn|0
202985|NCT00318461|682499|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
202986|NCT00318461|682500|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
202987|NCT00318461|682501|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
202988|NCT00318461|682502|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
202989|NCT00318461|682503|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
202990|NCT00318461|682499|P5|Double-Blind, 6 Months|Lost to follow up|0
202991|NCT00318461|682500|P4|Double-Blind, 6 Months|Lost to follow up|0
202992|NCT00318461|682501|P3|Double-Blind, 6 Months|Lost to follow up|0
202993|NCT00318461|682502|P2|Double-Blind, 6 Months|Lost to follow up|1
202994|NCT00318461|682503|P1|Double-Blind, 6 Months|Lost to follow up|0
202995|NCT00318461|682499|P5|Double-Blind, 6 Months|Protocol Violation|5
202996|NCT00318461|682500|P4|Double-Blind, 6 Months|Protocol Violation|4
202997|NCT00318461|682501|P3|Double-Blind, 6 Months|Protocol Violation|4
202998|NCT00318461|682502|P2|Double-Blind, 6 Months|Protocol Violation|4
202999|NCT00318461|682503|P1|Double-Blind, 6 Months|Protocol Violation|2
203000|NCT00318461|682499|P5|Double-Blind, 6 Months|Lack of Efficacy|9
203001|NCT00318461|682500|P4|Double-Blind, 6 Months|Lack of Efficacy|29
203002|NCT00318461|682501|P3|Double-Blind, 6 Months|Lack of Efficacy|13
203003|NCT00318461|682502|P2|Double-Blind, 6 Months|Lack of Efficacy|8
203004|NCT00318461|682503|P1|Double-Blind, 6 Months|Lack of Efficacy|19
203005|NCT00318461|682499|P5|Double-Blind, 6 Months|Adverse Event|8
203006|NCT00318461|682500|P4|Double-Blind, 6 Months|Adverse Event|2
203007|NCT00318461|682501|P3|Double-Blind, 6 Months|Adverse Event|29
203008|NCT00318461|682502|P2|Double-Blind, 6 Months|Adverse Event|23
203009|NCT00318461|682503|P1|Double-Blind, 6 Months|Adverse Event|11
203010|NCT00318370|682602|P3|Period 3|Other|3
203011|NCT00318370|682603|P2|Period 3|Other|0
203012|NCT00318370|682604|P1|Period 3|Other|0
203013|NCT00318370|682602|P3|Period 3|Withdrawal by Subject|3
203014|NCT00318370|682603|P2|Period 3|Withdrawal by Subject|0
203015|NCT00318370|682604|P1|Period 3|Withdrawal by Subject|0
203016|NCT00318370|682602|P3|Period 3|Physician Decision|1
203017|NCT00318370|682603|P2|Period 3|Physician Decision|0
203018|NCT00318370|682604|P1|Period 3|Physician Decision|0
203019|NCT00318370|682602|P3|Period 3|Death|1
203020|NCT00318370|682603|P2|Period 3|Death|0
203021|NCT00318370|682604|P1|Period 3|Death|0
203022|NCT00318370|682602|P3|Period 3|Lack of Efficacy|24
203023|NCT00318370|682603|P2|Period 3|Lack of Efficacy|0
203024|NCT00318370|682604|P1|Period 3|Lack of Efficacy|0
203025|NCT00318370|682602|P3|Period 3|Adverse Event|1
203026|NCT00318370|682603|P2|Period 3|Adverse Event|0
203027|NCT00318370|682604|P1|Period 3|Adverse Event|0
203028|NCT00318370|682602|P3|Period 2|Other|0
203029|NCT00318370|682603|P2|Period 2|Other|1
203030|NCT00318370|682604|P1|Period 2|Other|0
203031|NCT00318370|682602|P3|Period 2|Withdrawal by Subject|0
203032|NCT00318370|682603|P2|Period 2|Withdrawal by Subject|1
203033|NCT00318370|682604|P1|Period 2|Withdrawal by Subject|0
203034|NCT00318370|682602|P3|Period 2|Physician Decision|0
203035|NCT00318370|682603|P2|Period 2|Physician Decision|1
203036|NCT00318370|682604|P1|Period 2|Physician Decision|0
203037|NCT00318370|682602|P3|Period 2|Lack of Efficacy|0
203038|NCT00318370|682603|P2|Period 2|Lack of Efficacy|5
203039|NCT00318370|682604|P1|Period 2|Lack of Efficacy|0
203040|NCT00318370|682602|P3|Period 2|Adverse Event|0
203041|NCT00318370|682603|P2|Period 2|Adverse Event|3
203042|NCT00318370|682604|P1|Period 2|Adverse Event|0
203043|NCT00318370|682602|P3|Period 1|Withdrawal by Subject|0
203044|NCT00318370|682603|P2|Period 1|Withdrawal by Subject|0
203045|NCT00318370|682604|P1|Period 1|Withdrawal by Subject|1
203046|NCT00318370|682602|P3|Period 1|Physician Decision|0
203047|NCT00318370|682603|P2|Period 1|Physician Decision|0
203048|NCT00318370|682604|P1|Period 1|Physician Decision|1
203049|NCT00318370|682602|P3|Period 1|Lack of Efficacy|0
203050|NCT00318370|682603|P2|Period 1|Lack of Efficacy|0
203051|NCT00318370|682604|P1|Period 1|Lack of Efficacy|5
203052|NCT00317642|682683|P2|Overall Study|AML Not Centrally Confirmed|5
203053|NCT00317642|682684|P1|Overall Study|AML Not Centrally Confirmed|1
203054|NCT00317642|682683|P2|Overall Study|Referred For Transplantation|0
203055|NCT00317642|682684|P1|Overall Study|Referred For Transplantation|1
203056|NCT00317642|682683|P2|Overall Study|Withdrawal by Subject|1
203057|NCT00317642|682684|P1|Overall Study|Withdrawal by Subject|0
203058|NCT00317642|682683|P2|Overall Study|Not Continue to Consolidation|0
203059|NCT00317642|682684|P1|Overall Study|Not Continue to Consolidation|2
203060|NCT00317642|682683|P2|Overall Study|Death|7
203061|NCT00317642|682684|P1|Overall Study|Death|14
203062|NCT00317642|682683|P2|Overall Study|Disease Recurrence|2
203063|NCT00317642|682684|P1|Overall Study|Disease Recurrence|1
203064|NCT00317642|682683|P2|Overall Study|Treatment Failure|102
203065|NCT00317642|682684|P1|Overall Study|Treatment Failure|56
203066|NCT00317642|682683|P2|Overall Study|Adverse Event|5
203067|NCT00317642|682684|P1|Overall Study|Adverse Event|17
203068|NCT00317642|682683|P2|Overall Study|Participant declined treatment|3
203069|NCT00317642|682684|P1|Overall Study|Participant declined treatment|14
203070|NCT00317642|682683|P2|Overall Study|Physician Decision|7
203071|NCT00317642|682684|P1|Overall Study|Physician Decision|15
203072|NCT00317642|682683|P2|Overall Study|Not Received Either Study Drug|3
203073|NCT00317642|682684|P1|Overall Study|Not Received Either Study Drug|1
203074|NCT00317473|682763|P6|Overall Study|Other|0
203075|NCT00317473|682764|P5|Overall Study|Other|0
203076|NCT00317473|682765|P4|Overall Study|Other|0
203077|NCT00317473|682766|P3|Overall Study|Other|0
203078|NCT00317473|682767|P2|Overall Study|Other|2
203079|NCT00317473|682768|P1|Overall Study|Other|0
203080|NCT00317473|682763|P6|Overall Study|Death|0
203081|NCT00317473|682764|P5|Overall Study|Death|0
203082|NCT00317473|682765|P4|Overall Study|Death|0
203083|NCT00317473|682766|P3|Overall Study|Death|0
203084|NCT00317473|682767|P2|Overall Study|Death|0
203085|NCT00317473|682768|P1|Overall Study|Death|1
203086|NCT00317473|682763|P6|Overall Study|Relocation|2
203087|NCT00317473|682764|P5|Overall Study|Relocation|5
203088|NCT00317473|682765|P4|Overall Study|Relocation|1
203089|NCT00317473|682766|P3|Overall Study|Relocation|1
203090|NCT00317473|682767|P2|Overall Study|Relocation|0
203091|NCT00317473|682768|P1|Overall Study|Relocation|1
203092|NCT00317473|682763|P6|Overall Study|Withdrawal by Subject|1
203093|NCT00317473|682764|P5|Overall Study|Withdrawal by Subject|3
203094|NCT00317473|682765|P4|Overall Study|Withdrawal by Subject|1
203095|NCT00317473|682766|P3|Overall Study|Withdrawal by Subject|2
203096|NCT00317473|682767|P2|Overall Study|Withdrawal by Subject|1
203097|NCT00317473|682768|P1|Overall Study|Withdrawal by Subject|2
203098|NCT00317109|682807|P2|Overall Study|Migated/moved from study area|0
203099|NCT00317109|682808|P1|Overall Study|Migated/moved from study area|1
203100|NCT00317109|682807|P2|Overall Study|Withdrawal by Subject|0
203101|NCT00317109|682808|P1|Overall Study|Withdrawal by Subject|2
203102|NCT00317044|682845|P3|Overall Study|Multiple Reasons|6
203103|NCT00317044|682846|P2|Overall Study|Multiple Reasons|2
203104|NCT00317044|682847|P1|Overall Study|Multiple Reasons|6
203105|NCT00317044|682845|P3|Overall Study|Lost to Follow-up|3
203106|NCT00317044|682846|P2|Overall Study|Lost to Follow-up|2
203107|NCT00317044|682847|P1|Overall Study|Lost to Follow-up|0
203108|NCT00317044|682845|P3|Overall Study|Withdrawal by Subject|12
203109|NCT00317044|682846|P2|Overall Study|Withdrawal by Subject|7
203110|NCT00317044|682847|P1|Overall Study|Withdrawal by Subject|10
203111|NCT00317044|682845|P3|Overall Study|Adverse Event|4
203112|NCT00317044|682846|P2|Overall Study|Adverse Event|7
203113|NCT00317044|682847|P1|Overall Study|Adverse Event|4
203114|NCT00317044|682845|P3|Overall Study|Protocol Violation|20
203115|NCT00317044|682846|P2|Overall Study|Protocol Violation|22
203116|NCT00317044|682847|P1|Overall Study|Protocol Violation|28
203117|NCT00316914|682893|P2|Overall Study|Missing end of treatment documentation|15
203118|NCT00316914|682894|P1|Overall Study|Missing end of treatment documentation|14
203119|NCT00316914|682893|P2|Overall Study|Other Problems|11
203120|NCT00316914|682894|P1|Overall Study|Other Problems|6
203121|NCT00316914|682893|P2|Overall Study|Adverse Event|7
203122|NCT00316914|682894|P1|Overall Study|Adverse Event|8
203123|NCT00316914|682893|P2|Overall Study|Withdrawal by Subject|3
203124|NCT00316914|682894|P1|Overall Study|Withdrawal by Subject|5
203125|NCT00316888|682924|P2|Overall Study|Not start protocol therapy|1
203126|NCT00316888|682925|P1|Overall Study|Not start protocol therapy|0
203127|NCT00316888|682924|P2|Overall Study|Withdrawal by Subject|2
203128|NCT00316888|682925|P1|Overall Study|Withdrawal by Subject|2
203129|NCT00316888|682924|P2|Overall Study|Adverse Event|5
203130|NCT00316888|682925|P1|Overall Study|Adverse Event|4
203131|NCT00316719|682947|P2|Overall Study|Consent withdrawn|0
203132|NCT00316719|682948|P1|Overall Study|Consent withdrawn|2
203133|NCT00316719|682947|P2|Overall Study|Adverse Event|6
203134|NCT00316719|682948|P1|Overall Study|Adverse Event|0
203135|NCT00316706|682974|P2|Overall Study|Lost to Follow-up|48
203136|NCT00316706|682975|P1|Overall Study|Lost to Follow-up|38
203137|NCT00316693|682991|P2|Overall Study|Other|44
203138|NCT00316693|682992|P1|Overall Study|Other|38
203139|NCT00316693|682991|P2|Overall Study|Lost to Follow-up|34
203140|NCT00316693|682992|P1|Overall Study|Lost to Follow-up|26
203141|NCT00316693|682991|P2|Overall Study|Withdrawal by Subject|6
203142|NCT00316693|682992|P1|Overall Study|Withdrawal by Subject|6
203143|NCT00316693|682991|P2|Overall Study|Protocol Violation|0
203144|NCT00316693|682992|P1|Overall Study|Protocol Violation|1
203145|NCT00316693|682991|P2|Overall Study|Adverse Event|1
203146|NCT00316693|682992|P1|Overall Study|Adverse Event|6
203147|NCT00316303|683045|P2|Overall Study|Lost to Follow-up|16
203148|NCT00316303|683046|P1|Overall Study|Lost to Follow-up|11
203149|NCT00316277|683062|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
203150|NCT00316277|683063|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
203151|NCT00316277|683062|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
203152|NCT00316277|683063|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
203153|NCT00316277|683062|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
203154|NCT00316277|683063|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
203155|NCT00316277|683062|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
203156|NCT00316277|683063|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
203157|NCT00316277|683062|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
203158|NCT00316277|683063|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
203159|NCT00316264|683084|P3|Overall Study|not specified|0
203160|NCT00316264|683085|P2|Overall Study|not specified|1
203161|NCT00316264|683086|P1|Overall Study|not specified|1
203162|NCT00316264|683084|P3|Overall Study|Death|0
203163|NCT00316264|683085|P2|Overall Study|Death|0
203164|NCT00316264|683086|P1|Overall Study|Death|2
203165|NCT00316264|683084|P3|Overall Study|Withdrawal of Consent|6
203166|NCT00316264|683085|P2|Overall Study|Withdrawal of Consent|5
203167|NCT00316264|683086|P1|Overall Study|Withdrawal of Consent|3
203168|NCT00316264|683084|P3|Overall Study|Lost to Follow-up|0
203169|NCT00316264|683085|P2|Overall Study|Lost to Follow-up|1
203170|NCT00316264|683086|P1|Overall Study|Lost to Follow-up|0
203171|NCT00316225|683154|P1|Overall Study|Death|2
203172|NCT00316225|683154|P1|Overall Study|Withdrawal by Subject|3
203173|NCT00316225|683154|P1|Overall Study|Progressive Disease|15
203174|NCT00316225|683154|P1|Overall Study|Physician Decision|3
203175|NCT00316225|683154|P1|Overall Study|Adverse Event|2
203176|NCT00316199|683163|P1|Overall Study|Lost to Follow-up|2
203177|NCT00316199|683163|P1|Overall Study|Death|8
203178|NCT00316199|683163|P1|Overall Study|Adverse Event|2
203179|NCT00316186|683171|P1|Overall Study|Other|1
203180|NCT00316186|683171|P1|Overall Study|Lost to Follow-up|1
203181|NCT00316186|683171|P1|Overall Study|Disease Progression|4
203182|NCT00316186|683171|P1|Overall Study|Adverse Event|6
203183|NCT00316173|683185|P2|Treatment Phase|Study Follow-up Stopped|34
203184|NCT00316173|683186|P1|Treatment Phase|Study Follow-up Stopped|0
203185|NCT00316173|683185|P2|Treatment Phase|Withdrawal by Subject|1
203186|NCT00316173|683186|P1|Treatment Phase|Withdrawal by Subject|0
203187|NCT00316173|683185|P2|Treatment Phase|Lost to Follow-up|3
203188|NCT00316173|683186|P1|Treatment Phase|Lost to Follow-up|0
203189|NCT00316173|683185|P2|Treatment Phase|Lack of Efficacy|3
203190|NCT00316173|683186|P1|Treatment Phase|Lack of Efficacy|0
203191|NCT00316173|683185|P2|Treatment Phase|Adverse Event|1
203192|NCT00316173|683186|P1|Treatment Phase|Adverse Event|0
203193|NCT00316173|683185|P2|Run-in Phase|Study Follow-up Stopped|0
203194|NCT00316173|683186|P1|Run-in Phase|Study Follow-up Stopped|5
203195|NCT00316173|683185|P2|Run-in Phase|Protocol Violation|0
203196|NCT00316173|683186|P1|Run-in Phase|Protocol Violation|1
203197|NCT00316173|683185|P2|Run-in Phase|Adverse Event|0
203198|NCT00316173|683186|P1|Run-in Phase|Adverse Event|1
203199|NCT00316121|683199|P2|Overall Study|Subject did not have 24 month visit|0
203200|NCT00316121|683200|P1|Overall Study|Subject did not have 24 month visit|1
203201|NCT00316121|683199|P2|Overall Study|Subject no show for visit x 3|0
203202|NCT00316121|683200|P1|Overall Study|Subject no show for visit x 3|1
203203|NCT00316121|683199|P2|Overall Study|Subject refused to return|0
203204|NCT00316121|683200|P1|Overall Study|Subject refused to return|1
203205|NCT00316121|683199|P2|Overall Study|Subject relocated|1
203206|NCT00316121|683200|P1|Overall Study|Subject relocated|1
203207|NCT00316121|683199|P2|Overall Study|Reason is missing|0
203208|NCT00316121|683200|P1|Overall Study|Reason is missing|1
203209|NCT00316121|683199|P2|Overall Study|Withdrawal by Subject|0
203210|NCT00316121|683200|P1|Overall Study|Withdrawal by Subject|2
203211|NCT00316121|683199|P2|Overall Study|Lost to Follow-up|8
203212|NCT00316121|683200|P1|Overall Study|Lost to Follow-up|14
203213|NCT00316121|683199|P2|Overall Study|Death|0
203214|NCT00316121|683200|P1|Overall Study|Death|1
203215|NCT00316082|683211|P5|Overall Study|Administrative reason by sponsor|0
203216|NCT00316082|683212|P4|Overall Study|Administrative reason by sponsor|0
203217|NCT00316082|683213|P3|Overall Study|Administrative reason by sponsor|1
203218|NCT00316082|683214|P2|Overall Study|Administrative reason by sponsor|0
203219|NCT00316082|683215|P1|Overall Study|Administrative reason by sponsor|0
203220|NCT00316082|683211|P5|Overall Study|Death|0
203221|NCT00316082|683212|P4|Overall Study|Death|0
203222|NCT00316082|683213|P3|Overall Study|Death|1
203223|NCT00316082|683214|P2|Overall Study|Death|0
203224|NCT00316082|683215|P1|Overall Study|Death|0
203225|NCT00316082|683211|P5|Overall Study|Physician Decision|1
203226|NCT00316082|683212|P4|Overall Study|Physician Decision|1
203227|NCT00316082|683213|P3|Overall Study|Physician Decision|2
203228|NCT00316082|683214|P2|Overall Study|Physician Decision|1
203229|NCT00316082|683215|P1|Overall Study|Physician Decision|1
203230|NCT00316082|683211|P5|Overall Study|Subject no longer meets study criteria|1
203231|NCT00316082|683212|P4|Overall Study|Subject no longer meets study criteria|2
203232|NCT00316082|683213|P3|Overall Study|Subject no longer meets study criteria|2
203233|NCT00316082|683214|P2|Overall Study|Subject no longer meets study criteria|1
203234|NCT00316082|683215|P1|Overall Study|Subject no longer meets study criteria|3
203235|NCT00316082|683211|P5|Overall Study|Adverse Event|3
203236|NCT00316082|683212|P4|Overall Study|Adverse Event|1
203237|NCT00316082|683213|P3|Overall Study|Adverse Event|5
203238|NCT00316082|683214|P2|Overall Study|Adverse Event|2
203239|NCT00316082|683215|P1|Overall Study|Adverse Event|4
203240|NCT00316082|683211|P5|Overall Study|Poor/noncompliance|4
203241|NCT00316082|683212|P4|Overall Study|Poor/noncompliance|1
203242|NCT00316082|683213|P3|Overall Study|Poor/noncompliance|4
203243|NCT00316082|683214|P2|Overall Study|Poor/noncompliance|1
203244|NCT00316082|683215|P1|Overall Study|Poor/noncompliance|6
203245|NCT00316082|683211|P5|Overall Study|Lost to Follow-up|6
203246|NCT00316082|683212|P4|Overall Study|Lost to Follow-up|8
203247|NCT00316082|683213|P3|Overall Study|Lost to Follow-up|7
203248|NCT00316082|683214|P2|Overall Study|Lost to Follow-up|6
203249|NCT00316082|683215|P1|Overall Study|Lost to Follow-up|7
203250|NCT00316082|683211|P5|Overall Study|Withdrawal of Consent by Subject|5
203251|NCT00316082|683212|P4|Overall Study|Withdrawal of Consent by Subject|9
203252|NCT00316082|683213|P3|Overall Study|Withdrawal of Consent by Subject|2
203253|NCT00316082|683214|P2|Overall Study|Withdrawal of Consent by Subject|8
203254|NCT00316082|683215|P1|Overall Study|Withdrawal of Consent by Subject|10
203255|NCT00316082|683211|P5|Overall Study|Lack of Efficacy|6
203256|NCT00316082|683212|P4|Overall Study|Lack of Efficacy|4
203257|NCT00316082|683213|P3|Overall Study|Lack of Efficacy|3
203258|NCT00316082|683214|P2|Overall Study|Lack of Efficacy|3
203259|NCT00316082|683215|P1|Overall Study|Lack of Efficacy|2
203260|NCT00316017|683246|P3|Overall Study|Protocol Violation|19
203261|NCT00316017|683247|P2|Overall Study|Protocol Violation|13
203262|NCT00316017|683248|P1|Overall Study|Protocol Violation|11
203263|NCT00316004|683322|P3|Overall Study|Subject was not given study fluid.|21
203264|NCT00316004|683323|P2|Overall Study|Subject was not given study fluid.|14
203265|NCT00316004|683324|P1|Overall Study|Subject was not given study fluid.|14
203266|NCT00315731|683395|P1|Overall Study|Death|5
203267|NCT00315731|683395|P1|Overall Study|Lost to Follow-up|1
203268|NCT00315705|683423|P1|Phase 2|Death|7
203269|NCT00315705|683423|P1|Phase 2|Other|1
203270|NCT00315705|683423|P1|Phase 2|Scheduled for transplant|8
203271|NCT00315705|683423|P1|Phase 2|Disease relapse|1
203272|NCT00315705|683423|P1|Phase 2|Failure to achieve response|3
203273|NCT00315705|683423|P1|Phase 2|Adverse Event|1
203274|NCT00315705|683423|P1|Phase 2|Physician Decision|4
203275|NCT00315705|683423|P1|Phase 1|Death|3
203276|NCT00315705|683423|P1|Phase 1|Scheduled for transplant|9
203277|NCT00315705|683423|P1|Phase 1|Disease relapse|4
203278|NCT00315705|683423|P1|Phase 1|Failure to achieve response|8
203279|NCT00315705|683423|P1|Phase 1|Refused further treatment|1
203280|NCT00315458|683484|P4|Overall Study|Did not qualify|0
203281|NCT00315458|683485|P3|Overall Study|Did not qualify|1
203282|NCT00315458|683486|P2|Overall Study|Did not qualify|0
203283|NCT00315458|683487|P1|Overall Study|Did not qualify|0
203284|NCT00315458|683484|P4|Overall Study|Lack of Efficacy|1
203285|NCT00315458|683485|P3|Overall Study|Lack of Efficacy|20
203286|NCT00315458|683486|P2|Overall Study|Lack of Efficacy|0
203287|NCT00315458|683487|P1|Overall Study|Lack of Efficacy|0
203288|NCT00315458|683484|P4|Overall Study|Withdrawal by Subject|2
203289|NCT00315458|683485|P3|Overall Study|Withdrawal by Subject|0
203290|NCT00315458|683486|P2|Overall Study|Withdrawal by Subject|3
203291|NCT00315458|683487|P1|Overall Study|Withdrawal by Subject|0
203292|NCT00315458|683484|P4|Overall Study|Lost to Follow-up|2
203293|NCT00315458|683485|P3|Overall Study|Lost to Follow-up|0
203294|NCT00315458|683486|P2|Overall Study|Lost to Follow-up|2
203295|NCT00315458|683487|P1|Overall Study|Lost to Follow-up|1
203296|NCT00315458|683484|P4|Overall Study|Adverse Event|3
203297|NCT00315458|683485|P3|Overall Study|Adverse Event|23
203298|NCT00315458|683486|P2|Overall Study|Adverse Event|4
203299|NCT00315458|683487|P1|Overall Study|Adverse Event|2
203300|NCT00315458|683484|P4|Overall Study|Administrative|21
203301|NCT00315458|683485|P3|Overall Study|Administrative|8
203302|NCT00315458|683486|P2|Overall Study|Administrative|3
203303|NCT00315458|683487|P1|Overall Study|Administrative|0
203304|NCT00315445|683500|P3|Overall Study|Other|0
203305|NCT00315445|683501|P2|Overall Study|Other|3
203306|NCT00315445|683502|P1|Overall Study|Other|1
203307|NCT00315445|683500|P3|Overall Study|Protocol Violation|1
203308|NCT00315445|683501|P2|Overall Study|Protocol Violation|0
203309|NCT00315445|683502|P1|Overall Study|Protocol Violation|2
203310|NCT00315445|683500|P3|Overall Study|Lost to Follow-up|1
203311|NCT00315445|683501|P2|Overall Study|Lost to Follow-up|0
203312|NCT00315445|683502|P1|Overall Study|Lost to Follow-up|1
203313|NCT00315445|683500|P3|Overall Study|Lack of Efficacy|7
203314|NCT00315445|683501|P2|Overall Study|Lack of Efficacy|1
203315|NCT00315445|683502|P1|Overall Study|Lack of Efficacy|16
203316|NCT00315445|683500|P3|Overall Study|Adverse Event|15
203317|NCT00315445|683501|P2|Overall Study|Adverse Event|12
203318|NCT00315445|683502|P1|Overall Study|Adverse Event|7
203319|NCT00315055|683792|P2|Overall Study|Lost to Follow-up|1
203320|NCT00315055|683793|P1|Overall Study|Lost to Follow-up|1
203321|NCT00315055|683792|P2|Overall Study|Protocol Violation|4
203322|NCT00315055|683793|P1|Overall Study|Protocol Violation|2
203323|NCT00314951|683811|P2|Follow-up|mITT failure|34
203324|NCT00314951|683812|P1|Follow-up|mITT failure|44
203325|NCT00314951|683811|P2|Treatment|Didn't meet criteria for mITT population|11
203326|NCT00314951|683812|P1|Treatment|Didn't meet criteria for mITT population|16
203327|NCT00314808|683822|P1|Overall Study|Withdrawal by Subject/PI without AE|4
203328|NCT00314808|683822|P1|Overall Study|Disease Progression without AE|4
203329|NCT00314574|683832|P2|Overall Study|Data unknown at database lock|1
203330|NCT00314574|683833|P1|Overall Study|Data unknown at database lock|0
203331|NCT00314574|683832|P2|Overall Study|Pregnancy|4
203332|NCT00314574|683833|P1|Overall Study|Pregnancy|6
203333|NCT00314574|683832|P2|Overall Study|Physician Decision|15
203334|NCT00314574|683833|P1|Overall Study|Physician Decision|22
203335|NCT00314574|683832|P2|Overall Study|Withdrawal by Subject|22
203336|NCT00314574|683833|P1|Overall Study|Withdrawal by Subject|33
203337|NCT00314574|683832|P2|Overall Study|Lost to Follow-up|25
203338|NCT00314574|683833|P1|Overall Study|Lost to Follow-up|19
203339|NCT00314574|683832|P2|Overall Study|Adverse Event|16
203340|NCT00314574|683833|P1|Overall Study|Adverse Event|11
203341|NCT00314574|683832|P2|Overall Study|Death|0
203342|NCT00314574|683833|P1|Overall Study|Death|3
203343|NCT00314366|683849|P2|Overall Study|not treated due to patient medical condi|0
203344|NCT00314366|683850|P1|Overall Study|not treated due to patient medical condi|1
203345|NCT00314340|683895|P1|Overall Study|lost interest|1
203346|NCT00314327|683901|P1|Overall Study|Withdrawal by Subject|1
203347|NCT00314262|683906|P1|Overall Study|Physician Decision|1
203348|NCT00314262|683906|P1|Overall Study|Withdrawal by Subject|2
203349|NCT00314262|683906|P1|Overall Study|Adverse Event|2
203350|NCT00314249|683914|P2|Overall Study|Non-Compliant|6
203351|NCT00314249|683915|P1|Overall Study|Non-Compliant|5
203352|NCT00314249|683914|P2|Overall Study|Withdrawn for other reasons|1
203353|NCT00314249|683915|P1|Overall Study|Withdrawn for other reasons|4
203354|NCT00314249|683914|P2|Overall Study|Physician Decision|1
203355|NCT00314249|683915|P1|Overall Study|Physician Decision|1
203356|NCT00314249|683914|P2|Overall Study|Lost to Follow-up|9
203357|NCT00314249|683915|P1|Overall Study|Lost to Follow-up|15
203358|NCT00314249|683914|P2|Overall Study|Withdrawal by Subject|28
203359|NCT00314249|683915|P1|Overall Study|Withdrawal by Subject|21
203360|NCT00314249|683914|P2|Overall Study|Lack of Efficacy|24
203361|NCT00314249|683915|P1|Overall Study|Lack of Efficacy|33
203362|NCT00314249|683914|P2|Overall Study|Adverse Event|94
203363|NCT00314249|683915|P1|Overall Study|Adverse Event|73
203364|NCT00314145|683948|P2|Overall Study|Sponsor Decision|0
203365|NCT00314145|683949|P1|Overall Study|Sponsor Decision|2
203366|NCT00314145|683948|P2|Overall Study|Protocol Violation|0
203367|NCT00314145|683949|P1|Overall Study|Protocol Violation|3
203368|NCT00314145|683948|P2|Overall Study|Adverse Event|3
203369|NCT00314145|683949|P1|Overall Study|Adverse Event|0
203370|NCT00314145|683948|P2|Overall Study|Physician Decision|4
203371|NCT00314145|683949|P1|Overall Study|Physician Decision|3
203372|NCT00314145|683948|P2|Overall Study|Lost to Follow-up|12
203373|NCT00314145|683949|P1|Overall Study|Lost to Follow-up|5
203374|NCT00314145|683948|P2|Overall Study|Withdrawal by Subject|10
203375|NCT00314145|683949|P1|Overall Study|Withdrawal by Subject|8
203376|NCT00314132|683963|P2|Overall Study|Physician Decision|0
203377|NCT00314132|683964|P1|Overall Study|Physician Decision|1
203378|NCT00314132|683963|P2|Overall Study|Adverse Event|0
203379|NCT00314132|683964|P1|Overall Study|Adverse Event|1
203380|NCT00314132|683963|P2|Overall Study|Withdrawal by Subject|5
203381|NCT00314132|683964|P1|Overall Study|Withdrawal by Subject|3
203382|NCT00314132|683963|P2|Overall Study|Lost to Follow-up|13
203383|NCT00314132|683964|P1|Overall Study|Lost to Follow-up|3
203384|NCT00313911|683985|P2|Overall Study|Did not meet age criteria|1
203385|NCT00313911|683986|P1|Overall Study|Did not meet age criteria|1
203386|NCT00313911|683985|P2|Overall Study|Withdrawal by Subject|12
203387|NCT00313911|683986|P1|Overall Study|Withdrawal by Subject|39
203388|NCT00313911|683985|P2|Overall Study|Lost to Follow-up|14
203389|NCT00313911|683986|P1|Overall Study|Lost to Follow-up|27
203390|NCT00313911|683985|P2|Overall Study|Protocol Violation|10
203391|NCT00313911|683986|P1|Overall Study|Protocol Violation|19
203392|NCT00313911|683985|P2|Overall Study|Adverse Event|3
203393|NCT00313911|683986|P1|Overall Study|Adverse Event|2
203394|NCT00313911|683985|P2|Overall Study|Serious adverse event|1
203395|NCT00313911|683986|P1|Overall Study|Serious adverse event|6
203396|NCT00313846|684000|P2|Overall Study|Administrative|3
203397|NCT00313846|684001|P1|Overall Study|Administrative|2
203398|NCT00313846|684000|P2|Overall Study|Adverse Event|8
203399|NCT00313846|684001|P1|Overall Study|Adverse Event|1
203400|NCT00313846|684000|P2|Overall Study|Withdrawal by Subject|0
203401|NCT00313846|684001|P1|Overall Study|Withdrawal by Subject|2
203402|NCT00313820|684012|P2|Pregabalin or Placebo Treatment Period|Other|3
203403|NCT00313820|684013|P1|Pregabalin or Placebo Treatment Period|Other|2
203404|NCT00313820|684012|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
203405|NCT00313820|684013|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
203406|NCT00313820|684012|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
203407|NCT00313820|684013|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
203408|NCT00313820|684012|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
203409|NCT00313820|684013|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
203410|NCT00313820|684012|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
203411|NCT00313820|684013|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
203412|NCT00313820|684012|P2|Assigned to Treatment|Other|0
203413|NCT00313820|684013|P1|Assigned to Treatment|Other|1
203414|NCT00313781|684051|P3|After Crossover|Other|18
203415|NCT00313781|684052|P2|After Crossover|Other|0
203416|NCT00313781|684053|P1|After Crossover|Other|0
203417|NCT00313781|684051|P3|After Crossover|Withdrawal by Subject|3
203418|NCT00313781|684052|P2|After Crossover|Withdrawal by Subject|0
203419|NCT00313781|684053|P1|After Crossover|Withdrawal by Subject|0
203420|NCT00313781|684051|P3|After Crossover|Death|6
203421|NCT00313781|684052|P2|After Crossover|Death|0
203422|NCT00313781|684053|P1|After Crossover|Death|0
203423|NCT00313781|684051|P3|Before Crossover|Randomized, not treated|0
203424|NCT00313781|684052|P2|Before Crossover|Randomized, not treated|0
203425|NCT00313781|684053|P1|Before Crossover|Randomized, not treated|5
203426|NCT00313781|684051|P3|Before Crossover|Crossover|0
203427|NCT00313781|684052|P2|Before Crossover|Crossover|37
203428|NCT00313781|684053|P1|Before Crossover|Crossover|0
203429|NCT00313781|684051|P3|Before Crossover|Other|0
203430|NCT00313781|684052|P2|Before Crossover|Other|30
203431|NCT00313781|684053|P1|Before Crossover|Other|45
203432|NCT00313781|684051|P3|Before Crossover|Withdrawal by Subject|0
203433|NCT00313781|684052|P2|Before Crossover|Withdrawal by Subject|1
203434|NCT00313781|684053|P1|Before Crossover|Withdrawal by Subject|3
203435|NCT00313781|684051|P3|Before Crossover|Lost to Follow-up|0
203436|NCT00313781|684052|P2|Before Crossover|Lost to Follow-up|3
203437|NCT00313781|684053|P1|Before Crossover|Lost to Follow-up|0
203438|NCT00313781|684051|P3|Before Crossover|Death|0
203439|NCT00313781|684052|P2|Before Crossover|Death|8
203440|NCT00313781|684053|P1|Before Crossover|Death|22
203441|NCT00313716|684093|P6|Overall Study|Withdrawal by Subject|0
203442|NCT00313716|684094|P5|Overall Study|Withdrawal by Subject|1
203443|NCT00313716|684095|P4|Overall Study|Withdrawal by Subject|0
203444|NCT00313716|684096|P3|Overall Study|Withdrawal by Subject|1
203445|NCT00313716|684097|P2|Overall Study|Withdrawal by Subject|1
203446|NCT00313716|684098|P1|Overall Study|Withdrawal by Subject|0
203447|NCT00313716|684093|P6|Overall Study|Lost to Follow-up|4
203448|NCT00313716|684094|P5|Overall Study|Lost to Follow-up|0
203449|NCT00313716|684095|P4|Overall Study|Lost to Follow-up|1
203450|NCT00313716|684096|P3|Overall Study|Lost to Follow-up|2
203451|NCT00313716|684097|P2|Overall Study|Lost to Follow-up|5
203452|NCT00313716|684098|P1|Overall Study|Lost to Follow-up|2
203453|NCT00313716|684093|P6|Overall Study|Death|9
203454|NCT00313716|684094|P5|Overall Study|Death|5
203455|NCT00313716|684095|P4|Overall Study|Death|3
203456|NCT00313716|684096|P3|Overall Study|Death|9
203457|NCT00313716|684097|P2|Overall Study|Death|2
203458|NCT00313716|684098|P1|Overall Study|Death|3
203459|NCT00313703|684125|P4|Overall Study|Lost to Follow-up|12
203460|NCT00313703|684126|P3|Overall Study|Lost to Follow-up|5
203461|NCT00313703|684127|P2|Overall Study|Lost to Follow-up|2
203462|NCT00313703|684128|P1|Overall Study|Lost to Follow-up|11
203463|NCT00313612|684144|P2|Overall Study|Patient never received treatment|1
203464|NCT00313612|684145|P1|Overall Study|Patient never received treatment|0
203465|NCT00313586|684157|P4|Overall Study|Death before starting treatment|0
203466|NCT00313586|684158|P3|Overall Study|Death before starting treatment|0
203467|NCT00313586|684159|P2|Overall Study|Death before starting treatment|0
203468|NCT00313586|684160|P1|Overall Study|Death before starting treatment|1
203469|NCT00313586|684157|P4|Overall Study|Moved|0
203470|NCT00313586|684158|P3|Overall Study|Moved|0
203471|NCT00313586|684159|P2|Overall Study|Moved|1
203472|NCT00313586|684160|P1|Overall Study|Moved|0
203473|NCT00313586|684157|P4|Overall Study|Lost insurance|0
203474|NCT00313586|684158|P3|Overall Study|Lost insurance|0
203475|NCT00313586|684159|P2|Overall Study|Lost insurance|1
203476|NCT00313586|684160|P1|Overall Study|Lost insurance|0
203477|NCT00313586|684157|P4|Overall Study|Absolute neutrophil count not recovered|0
203478|NCT00313586|684158|P3|Overall Study|Absolute neutrophil count not recovered|0
203479|NCT00313586|684159|P2|Overall Study|Absolute neutrophil count not recovered|1
203480|NCT00313586|684160|P1|Overall Study|Absolute neutrophil count not recovered|2
203481|NCT00313586|684157|P4|Overall Study|Physician Decision|0
203482|NCT00313586|684158|P3|Overall Study|Physician Decision|0
203483|NCT00313586|684159|P2|Overall Study|Physician Decision|1
203484|NCT00313586|684160|P1|Overall Study|Physician Decision|2
203485|NCT00313586|684157|P4|Overall Study|Did not achieve HI-major/better response|1
203486|NCT00313586|684158|P3|Overall Study|Did not achieve HI-major/better response|2
203487|NCT00313586|684159|P2|Overall Study|Did not achieve HI-major/better response|7
203488|NCT00313586|684160|P1|Overall Study|Did not achieve HI-major/better response|10
203489|NCT00313586|684157|P4|Overall Study|Other complicating disease|0
203490|NCT00313586|684158|P3|Overall Study|Other complicating disease|0
203491|NCT00313586|684159|P2|Overall Study|Other complicating disease|2
203492|NCT00313586|684160|P1|Overall Study|Other complicating disease|2
203493|NCT00313586|684157|P4|Overall Study|Alternative therapy|0
203494|NCT00313586|684158|P3|Overall Study|Alternative therapy|2
203495|NCT00313586|684159|P2|Overall Study|Alternative therapy|6
203496|NCT00313586|684160|P1|Overall Study|Alternative therapy|3
203497|NCT00313586|684157|P4|Overall Study|Withdrawal by Subject|2
203498|NCT00313586|684158|P3|Overall Study|Withdrawal by Subject|6
203499|NCT00313586|684159|P2|Overall Study|Withdrawal by Subject|6
203500|NCT00313586|684160|P1|Overall Study|Withdrawal by Subject|13
203501|NCT00313586|684157|P4|Overall Study|Death|7
203502|NCT00313586|684158|P3|Overall Study|Death|1
203503|NCT00313586|684159|P2|Overall Study|Death|8
203504|NCT00313586|684160|P1|Overall Study|Death|11
203505|NCT00313586|684157|P4|Overall Study|Adverse Event|10
203506|NCT00313586|684158|P3|Overall Study|Adverse Event|3
203507|NCT00313586|684159|P2|Overall Study|Adverse Event|18
203508|NCT00313586|684160|P1|Overall Study|Adverse Event|12
203509|NCT00313586|684157|P4|Overall Study|Disease progression|3
203510|NCT00313586|684158|P3|Overall Study|Disease progression|10
203511|NCT00313586|684159|P2|Overall Study|Disease progression|19
203512|NCT00313586|684160|P1|Overall Study|Disease progression|14
203513|NCT00313313|684179|P3|Overall Study|Subject No Longer Meets Study Criteria|2
203514|NCT00313313|684180|P2|Overall Study|Subject No Longer Meets Study Criteria|3
203515|NCT00313313|684181|P1|Overall Study|Subject No Longer Meets Study Criteria|0
203516|NCT00313313|684179|P3|Overall Study|Death|2
203517|NCT00313313|684180|P2|Overall Study|Death|0
203518|NCT00313313|684181|P1|Overall Study|Death|0
203519|NCT00313313|684179|P3|Overall Study|Pregnancy|0
203520|NCT00313313|684180|P2|Overall Study|Pregnancy|2
203521|NCT00313313|684181|P1|Overall Study|Pregnancy|1
203522|NCT00313313|684179|P3|Overall Study|Poor/Noncompliance|2
203523|NCT00313313|684180|P2|Overall Study|Poor/Noncompliance|6
203524|NCT00313313|684181|P1|Overall Study|Poor/Noncompliance|3
203525|NCT00313313|684179|P3|Overall Study|Physician Decision|4
203526|NCT00313313|684180|P2|Overall Study|Physician Decision|6
203527|NCT00313313|684181|P1|Overall Study|Physician Decision|2
203528|NCT00313313|684179|P3|Overall Study|Adverse Event|12
203529|NCT00313313|684180|P2|Overall Study|Adverse Event|16
203530|NCT00313313|684181|P1|Overall Study|Adverse Event|15
203531|NCT00313313|684179|P3|Overall Study|Lost to Follow-up|9
203532|NCT00313313|684180|P2|Overall Study|Lost to Follow-up|7
203533|NCT00313313|684181|P1|Overall Study|Lost to Follow-up|10
203534|NCT00313313|684179|P3|Overall Study|Withdrawal of consent by subject|31
203535|NCT00313313|684180|P2|Overall Study|Withdrawal of consent by subject|17
203536|NCT00313313|684181|P1|Overall Study|Withdrawal of consent by subject|18
203537|NCT00313313|684179|P3|Overall Study|Lack of Efficacy|20
203538|NCT00313313|684180|P2|Overall Study|Lack of Efficacy|9
203539|NCT00313313|684181|P1|Overall Study|Lack of Efficacy|14
203540|NCT00313300|684203|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
203541|NCT00313300|684204|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
203542|NCT00313300|684205|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
203543|NCT00313300|684206|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
203544|NCT00313300|684207|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
203545|NCT00313300|684203|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
203546|NCT00313300|684204|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
203547|NCT00313300|684205|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
203548|NCT00313300|684206|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
203549|NCT00313300|684207|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
203550|NCT00313300|684203|P5|Follow-Up(30days)-Randomized Phase B|Death|0
203551|NCT00313300|684204|P4|Follow-Up(30days)-Randomized Phase B|Death|0
203552|NCT00313300|684205|P3|Follow-Up(30days)-Randomized Phase B|Death|0
203553|NCT00313300|684206|P2|Follow-Up(30days)-Randomized Phase B|Death|0
203554|NCT00313300|684207|P1|Follow-Up(30days)-Randomized Phase B|Death|1
203555|NCT00313300|684203|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
203556|NCT00313300|684204|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
203557|NCT00313300|684205|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
203558|NCT00313300|684206|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
203559|NCT00313300|684207|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
203560|NCT00313300|684203|P5|Follow-Up(30days)-Randomized Phase A|Death|0
203561|NCT00313300|684204|P4|Follow-Up(30days)-Randomized Phase A|Death|0
203562|NCT00313300|684205|P3|Follow-Up(30days)-Randomized Phase A|Death|0
203563|NCT00313300|684206|P2|Follow-Up(30days)-Randomized Phase A|Death|1
203564|NCT00313300|684207|P1|Follow-Up(30days)-Randomized Phase A|Death|0
203565|NCT00313300|684203|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
203566|NCT00313300|684204|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
203567|NCT00313300|684205|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
203568|NCT00313300|684206|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
203569|NCT00313300|684207|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
203570|NCT00313300|684203|P5|Randomized in Phase B (26 Weeks)|non-specified|0
203571|NCT00313300|684204|P4|Randomized in Phase B (26 Weeks)|non-specified|0
203572|NCT00313300|684205|P3|Randomized in Phase B (26 Weeks)|non-specified|0
203573|NCT00313300|684206|P2|Randomized in Phase B (26 Weeks)|non-specified|0
203574|NCT00313300|684207|P1|Randomized in Phase B (26 Weeks)|non-specified|1
203575|NCT00313300|684203|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
203576|NCT00313300|684204|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
203577|NCT00313300|684205|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
203578|NCT00313300|684206|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
203579|NCT00313300|684207|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
203580|NCT00313300|684203|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
203581|NCT00313300|684204|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
203582|NCT00313300|684205|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
203583|NCT00313300|684206|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
203584|NCT00313300|684207|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
203585|NCT00313300|684203|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
203586|NCT00313300|684204|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
203587|NCT00313300|684205|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
203588|NCT00313300|684206|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
203589|NCT00313300|684207|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
203590|NCT00313300|684203|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
203591|NCT00313300|684204|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
203592|NCT00313300|684205|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
203593|NCT00313300|684206|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
203594|NCT00313300|684207|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
203595|NCT00313300|684203|P5|Randomized in Phase B (26 Weeks)|Death|1
203596|NCT00313300|684204|P4|Randomized in Phase B (26 Weeks)|Death|0
203597|NCT00313300|684205|P3|Randomized in Phase B (26 Weeks)|Death|1
203598|NCT00313300|684206|P2|Randomized in Phase B (26 Weeks)|Death|3
203599|NCT00313300|684207|P1|Randomized in Phase B (26 Weeks)|Death|5
203600|NCT00313300|684203|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
203601|NCT00313300|684204|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
203602|NCT00313300|684205|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
203603|NCT00313300|684206|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
203604|NCT00313300|684207|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
203605|NCT00313300|684203|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
203606|NCT00313300|684204|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
203607|NCT00313300|684205|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
203608|NCT00313300|684206|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
203609|NCT00313300|684207|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
203610|NCT00313300|684203|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
203611|NCT00313300|684204|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
203612|NCT00313300|684205|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
203613|NCT00313300|684206|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
203614|NCT00313300|684207|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
203615|NCT00313300|684203|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
203616|NCT00313300|684204|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
203617|NCT00313300|684205|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
203618|NCT00313300|684206|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
203619|NCT00313300|684207|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
203620|NCT00313300|684203|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
203621|NCT00313300|684204|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
203622|NCT00313300|684205|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
203623|NCT00313300|684206|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
203624|NCT00313300|684207|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
203625|NCT00313300|684203|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
203626|NCT00313300|684204|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
203627|NCT00313300|684205|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
203628|NCT00313300|684206|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
203629|NCT00313300|684207|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
203630|NCT00313300|684203|P5|Randomized in Phase A (26 Weeks)|Death|0
203631|NCT00313300|684204|P4|Randomized in Phase A (26 Weeks)|Death|0
203632|NCT00313300|684205|P3|Randomized in Phase A (26 Weeks)|Death|0
203633|NCT00313300|684206|P2|Randomized in Phase A (26 Weeks)|Death|4
203634|NCT00313300|684207|P1|Randomized in Phase A (26 Weeks)|Death|3
203635|NCT00313300|684203|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
203636|NCT00313300|684204|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
203637|NCT00313300|684205|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
203638|NCT00313300|684206|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
203639|NCT00313300|684207|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
203640|NCT00313300|684203|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
203641|NCT00313300|684204|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
203642|NCT00313300|684205|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
203643|NCT00313300|684206|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
203644|NCT00313300|684207|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
203645|NCT00313170|684277|P3|Overall Study|brain mets. after randomisation|1
203646|NCT00313170|684278|P2|Overall Study|brain mets. after randomisation|0
203647|NCT00313170|684279|P1|Overall Study|brain mets. after randomisation|0
203648|NCT00313170|684277|P3|Overall Study|dosing error|1
203649|NCT00313170|684278|P2|Overall Study|dosing error|0
203650|NCT00313170|684279|P1|Overall Study|dosing error|0
203651|NCT00313170|684277|P3|Overall Study|Clinical progression|0
203652|NCT00313170|684278|P2|Overall Study|Clinical progression|0
203653|NCT00313170|684279|P1|Overall Study|Clinical progression|1
203654|NCT00313170|684277|P3|Overall Study|Lost to Follow-up|1
203655|NCT00313170|684278|P2|Overall Study|Lost to Follow-up|0
203656|NCT00313170|684279|P1|Overall Study|Lost to Follow-up|0
203657|NCT00313170|684277|P3|Overall Study|Incorrect enrollment|1
203658|NCT00313170|684278|P2|Overall Study|Incorrect enrollment|1
203659|NCT00313170|684279|P1|Overall Study|Incorrect enrollment|0
203660|NCT00313170|684277|P3|Overall Study|Withdrawal by Subject|1
203661|NCT00313170|684278|P2|Overall Study|Withdrawal by Subject|1
203662|NCT00313170|684279|P1|Overall Study|Withdrawal by Subject|1
203663|NCT00313170|684277|P3|Overall Study|Disease progression|27
203664|NCT00313170|684278|P2|Overall Study|Disease progression|26
203665|NCT00313170|684279|P1|Overall Study|Disease progression|31
203666|NCT00313170|684277|P3|Overall Study|Adverse Event|0
203667|NCT00313170|684278|P2|Overall Study|Adverse Event|2
203668|NCT00313170|684279|P1|Overall Study|Adverse Event|2
203669|NCT00313170|684277|P3|Overall Study|Death|0
203670|NCT00313170|684278|P2|Overall Study|Death|4
203671|NCT00313170|684279|P1|Overall Study|Death|1
203672|NCT00313144|684295|P1|Overall Study|Due to termination of the study|66
203673|NCT00313144|684295|P1|Overall Study|Change to different product|1
203674|NCT00313144|684295|P1|Overall Study|Insurance (homecare provider) change|1
203675|NCT00313144|684295|P1|Overall Study|Liver transplant|1
203676|NCT00313144|684295|P1|Overall Study|Adverse event - transient|5
203677|NCT00313144|684295|P1|Overall Study|Physician Decision|4
203678|NCT00313144|684295|P1|Overall Study|Terminated by sponsor/ homecare provider|4
203679|NCT00313144|684295|P1|Overall Study|Withdrawal by Subject|4
203680|NCT00313144|684295|P1|Overall Study|Lost to Follow-up|5
203681|NCT00313144|684295|P1|Overall Study|Death|7
203682|NCT00313144|684295|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
203683|NCT00313014|684382|P3|Overall Study|Lack of Efficacy|16
203684|NCT00313014|684383|P2|Overall Study|Lack of Efficacy|25
203685|NCT00313014|684384|P1|Overall Study|Lack of Efficacy|52
203686|NCT00313014|684382|P3|Overall Study|Administrative|14
203687|NCT00313014|684383|P2|Overall Study|Administrative|6
203688|NCT00313014|684384|P1|Overall Study|Administrative|9
203689|NCT00313014|684382|P3|Overall Study|Lost to Follow-up|10
203690|NCT00313014|684383|P2|Overall Study|Lost to Follow-up|6
203691|NCT00313014|684384|P1|Overall Study|Lost to Follow-up|7
203692|NCT00313014|684382|P3|Overall Study|Adverse Event|16
203693|NCT00313014|684383|P2|Overall Study|Adverse Event|29
203694|NCT00313014|684384|P1|Overall Study|Adverse Event|14
203695|NCT00313014|684382|P3|Overall Study|Withdrawal by Subject|5
203696|NCT00313014|684383|P2|Overall Study|Withdrawal by Subject|7
203697|NCT00313014|684384|P1|Overall Study|Withdrawal by Subject|11
203698|NCT00312897|684415|P2|Overall Study|discontinued prior to getting treatment|3
203699|NCT00312897|684416|P1|Overall Study|discontinued prior to getting treatment|0
203700|NCT00312897|684415|P2|Overall Study|Pregnancy|0
203701|NCT00312897|684416|P1|Overall Study|Pregnancy|1
203702|NCT00312897|684415|P2|Overall Study|Withdrawal by Subject|3
203703|NCT00312897|684416|P1|Overall Study|Withdrawal by Subject|1
203704|NCT00312897|684415|P2|Overall Study|Physician Decision|0
203705|NCT00312897|684416|P1|Overall Study|Physician Decision|1
203706|NCT00312897|684415|P2|Overall Study|Lost to Follow-up|0
203707|NCT00312897|684416|P1|Overall Study|Lost to Follow-up|2
203708|NCT00312897|684415|P2|Overall Study|Adverse Event|0
203709|NCT00312897|684416|P1|Overall Study|Adverse Event|1
203710|NCT00312858|684441|P2|Overall Study|Other|12
203711|NCT00312858|684442|P1|Overall Study|Other|9
203712|NCT00312858|684441|P2|Overall Study|Participant Moved|10
203713|NCT00312858|684442|P1|Overall Study|Participant Moved|11
203714|NCT00312858|684441|P2|Overall Study|Withdraw by Participant|20
203715|NCT00312858|684442|P1|Overall Study|Withdraw by Participant|20
203716|NCT00312858|684441|P2|Overall Study|Protocol Violation|8
203717|NCT00312858|684442|P1|Overall Study|Protocol Violation|3
203718|NCT00312858|684441|P2|Overall Study|Lost to Follow-up|42
203719|NCT00312858|684442|P1|Overall Study|Lost to Follow-up|25
203720|NCT00312858|684441|P2|Overall Study|Adverse Event|1
203721|NCT00312858|684442|P1|Overall Study|Adverse Event|0
203722|NCT00312845|684496|P2|Overall Study|Other|5
203723|NCT00312845|684497|P1|Overall Study|Other|6
203724|NCT00312845|684496|P2|Overall Study|Lost to Follow-up|0
203725|NCT00312845|684497|P1|Overall Study|Lost to Follow-up|2
203726|NCT00312845|684496|P2|Overall Study|Disease Progression|77
203727|NCT00312845|684497|P1|Overall Study|Disease Progression|56
203728|NCT00312845|684496|P2|Overall Study|Withdrawal by Subject|6
203729|NCT00312845|684497|P1|Overall Study|Withdrawal by Subject|14
203730|NCT00312845|684496|P2|Overall Study|Death|2
203731|NCT00312845|684497|P1|Overall Study|Death|2
203732|NCT00312845|684496|P2|Overall Study|Adverse Event|5
203733|NCT00312845|684497|P1|Overall Study|Adverse Event|19
203734|NCT00312728|684505|P1|Overall Study|Other|1
203735|NCT00312728|684505|P1|Overall Study|Other|10
203736|NCT00312728|684505|P1|Overall Study|Protocol Violation|2
203737|NCT00312728|684505|P1|Overall Study|Required non-protocol cancer treatment|2
203738|NCT00312728|684505|P1|Overall Study|Withdrawal by Subject|10
203739|NCT00312728|684505|P1|Overall Study|Adverse Event|32
203740|NCT00312728|684505|P1|Overall Study|Progressive disease|53
203741|NCT00312572|684516|P2|Overall Study|Lack of Efficacy|2
203742|NCT00312572|684517|P1|Overall Study|Lack of Efficacy|1
203743|NCT00312572|684516|P2|Overall Study|Administrative|2
203744|NCT00312572|684517|P1|Overall Study|Administrative|4
203745|NCT00312572|684516|P2|Overall Study|Lost to Follow-up|1
203746|NCT00312572|684517|P1|Overall Study|Lost to Follow-up|1
203747|NCT00312572|684516|P2|Overall Study|Adverse Event|16
203748|NCT00312572|684517|P1|Overall Study|Adverse Event|10
203749|NCT00312494|684528|P3|Overall Study|Other|1
203750|NCT00312494|684529|P2|Overall Study|Other|10
203751|NCT00312494|684530|P1|Overall Study|Other|10
203752|NCT00312494|684528|P3|Overall Study|Withdrawal by Subject|10
203753|NCT00312494|684529|P2|Overall Study|Withdrawal by Subject|9
203754|NCT00312494|684530|P1|Overall Study|Withdrawal by Subject|6
203755|NCT00312494|684528|P3|Overall Study|Lost to Follow-up|8
203756|NCT00312494|684529|P2|Overall Study|Lost to Follow-up|8
203757|NCT00312494|684530|P1|Overall Study|Lost to Follow-up|8
203758|NCT00312494|684528|P3|Overall Study|Laboratory abnormality|0
203759|NCT00312494|684529|P2|Overall Study|Laboratory abnormality|0
203760|NCT00312494|684530|P1|Overall Study|Laboratory abnormality|1
203761|NCT00312494|684528|P3|Overall Study|Lack of Efficacy|8
203762|NCT00312494|684529|P2|Overall Study|Lack of Efficacy|6
203763|NCT00312494|684530|P1|Overall Study|Lack of Efficacy|4
203764|NCT00312494|684528|P3|Overall Study|Adverse Event|11
203765|NCT00312494|684529|P2|Overall Study|Adverse Event|15
203766|NCT00312494|684530|P1|Overall Study|Adverse Event|33
203767|NCT00312494|684528|P3|Overall Study|Randomized; not treated with study drug|5
203768|NCT00312494|684529|P2|Overall Study|Randomized; not treated with study drug|10
203769|NCT00312494|684530|P1|Overall Study|Randomized; not treated with study drug|9
203770|NCT00312377|684564|P2|Overall Study|Site ended participation in study|0
203771|NCT00312377|684565|P1|Overall Study|Site ended participation in study|1
203772|NCT00312377|684564|P2|Overall Study|Discontinue treatment survival follow up|200
203773|NCT00312377|684565|P1|Overall Study|Discontinue treatment survival follow up|202
203774|NCT00312377|684564|P2|Overall Study|Randomised but never received treatment|6
203775|NCT00312377|684565|P1|Overall Study|Randomised but never received treatment|6
203776|NCT00312377|684564|P2|Overall Study|Non-compliance|2
203777|NCT00312377|684565|P1|Overall Study|Non-compliance|0
203778|NCT00312377|684564|P2|Overall Study|Lost to Follow-up|12
203779|NCT00312377|684565|P1|Overall Study|Lost to Follow-up|9
203780|NCT00312377|684564|P2|Overall Study|Withdrawal by Subject|30
203781|NCT00312377|684565|P1|Overall Study|Withdrawal by Subject|23
203782|NCT00312377|684564|P2|Overall Study|Death|418
203783|NCT00312377|684565|P1|Overall Study|Death|403
203784|NCT00312338|684589|P2|Overall Study|Subsequent infection|0
203785|NCT00312338|684590|P1|Overall Study|Subsequent infection|2
203786|NCT00312338|684589|P2|Overall Study|Withdrawal by Subject|0
203787|NCT00312338|684590|P1|Overall Study|Withdrawal by Subject|4
203788|NCT00312338|684589|P2|Overall Study|Lost to Follow-up|1
203789|NCT00312338|684590|P1|Overall Study|Lost to Follow-up|9
203790|NCT00312338|684589|P2|Overall Study|Adverse Event|2
203791|NCT00312338|684590|P1|Overall Study|Adverse Event|7
203792|NCT00312221|684603|P4|Double-blind Phase|Lack of Efficacy|10
203793|NCT00312221|684604|P3|Double-blind Phase|Lack of Efficacy|6
203794|NCT00312221|684605|P2|Double-blind Phase|Lack of Efficacy|17
203795|NCT00312221|684606|P1|Double-blind Phase|Lack of Efficacy|0
203796|NCT00312221|684603|P4|Double-blind Phase|Administrative|33
203797|NCT00312221|684604|P3|Double-blind Phase|Administrative|37
203798|NCT00312221|684605|P2|Double-blind Phase|Administrative|26
203799|NCT00312221|684606|P1|Double-blind Phase|Administrative|0
203800|NCT00312221|684603|P4|Double-blind Phase|Lost to Follow-up|2
203801|NCT00312221|684604|P3|Double-blind Phase|Lost to Follow-up|2
203802|NCT00312221|684605|P2|Double-blind Phase|Lost to Follow-up|0
203803|NCT00312221|684606|P1|Double-blind Phase|Lost to Follow-up|0
203804|NCT00312221|684603|P4|Double-blind Phase|Adverse Event|18
203805|NCT00312221|684604|P3|Double-blind Phase|Adverse Event|19
203806|NCT00312221|684605|P2|Double-blind Phase|Adverse Event|10
203807|NCT00312221|684606|P1|Double-blind Phase|Adverse Event|0
203808|NCT00312221|684603|P4|Double-blind Phase|Withdrawal by Subject|7
203809|NCT00312221|684604|P3|Double-blind Phase|Withdrawal by Subject|8
203810|NCT00312221|684605|P2|Double-blind Phase|Withdrawal by Subject|6
203811|NCT00312221|684606|P1|Double-blind Phase|Withdrawal by Subject|0
203812|NCT00312221|684603|P4|Open-label Run-in Period|Did not qualify|0
203813|NCT00312221|684604|P3|Open-label Run-in Period|Did not qualify|0
203814|NCT00312221|684605|P2|Open-label Run-in Period|Did not qualify|0
203815|NCT00312221|684606|P1|Open-label Run-in Period|Did not qualify|5
203816|NCT00312221|684603|P4|Open-label Run-in Period|Lack of Efficacy|0
203817|NCT00312221|684604|P3|Open-label Run-in Period|Lack of Efficacy|0
203818|NCT00312221|684605|P2|Open-label Run-in Period|Lack of Efficacy|0
203819|NCT00312221|684606|P1|Open-label Run-in Period|Lack of Efficacy|102
203820|NCT00312221|684603|P4|Open-label Run-in Period|Administrative|0
203821|NCT00312221|684604|P3|Open-label Run-in Period|Administrative|0
203822|NCT00312221|684605|P2|Open-label Run-in Period|Administrative|0
203823|NCT00312221|684606|P1|Open-label Run-in Period|Administrative|42
203824|NCT00312221|684603|P4|Open-label Run-in Period|Lost to Follow-up|0
203825|NCT00312221|684604|P3|Open-label Run-in Period|Lost to Follow-up|0
203826|NCT00312221|684605|P2|Open-label Run-in Period|Lost to Follow-up|0
203827|NCT00312221|684606|P1|Open-label Run-in Period|Lost to Follow-up|5
203828|NCT00312221|684603|P4|Open-label Run-in Period|Adverse Event|0
203829|NCT00312221|684604|P3|Open-label Run-in Period|Adverse Event|0
203830|NCT00312221|684605|P2|Open-label Run-in Period|Adverse Event|0
203831|NCT00312221|684606|P1|Open-label Run-in Period|Adverse Event|74
203832|NCT00312221|684603|P4|Open-label Run-in Period|Withdrawal by Subject|0
203833|NCT00312221|684604|P3|Open-label Run-in Period|Withdrawal by Subject|0
203834|NCT00312221|684605|P2|Open-label Run-in Period|Withdrawal by Subject|0
203835|NCT00312221|684606|P1|Open-label Run-in Period|Withdrawal by Subject|6
203836|NCT00312208|684626|P2|Overall Study|Not specified|7
203837|NCT00312208|684627|P1|Overall Study|Not specified|5
203838|NCT00312208|684626|P2|Overall Study|Withdrawal by Subject|42
203839|NCT00312208|684627|P1|Overall Study|Withdrawal by Subject|53
203840|NCT00312208|684626|P2|Overall Study|Lost to Follow-up|5
203841|NCT00312208|684627|P1|Overall Study|Lost to Follow-up|3
203842|NCT00312208|684626|P2|Overall Study|Lack of Efficacy|4
203843|NCT00312208|684627|P1|Overall Study|Lack of Efficacy|7
203844|NCT00312208|684626|P2|Overall Study|Death|1
203845|NCT00312208|684627|P1|Overall Study|Death|2
203846|NCT00312208|684626|P2|Overall Study|Protocol Violation|3
203847|NCT00312208|684627|P1|Overall Study|Protocol Violation|5
203848|NCT00312208|684626|P2|Overall Study|Adverse Event|61
203849|NCT00312208|684627|P1|Overall Study|Adverse Event|97
203850|NCT00312195|684637|P2|Overall Study|Protocol Violation|0
203851|NCT00312195|684638|P1|Overall Study|Protocol Violation|1
203852|NCT00312195|684637|P2|Overall Study|Lost to Follow-up|0
203853|NCT00312195|684638|P1|Overall Study|Lost to Follow-up|1
203854|NCT00312195|684637|P2|Overall Study|Adverse Event|6
203855|NCT00312195|684638|P1|Overall Study|Adverse Event|4
203856|NCT00311584|684665|P2|Overall Study|ineligible|2
203857|NCT00311584|684666|P1|Overall Study|ineligible|2
203858|NCT00311584|684665|P2|Overall Study|Withdrawal by Subject|1
203859|NCT00311584|684666|P1|Overall Study|Withdrawal by Subject|1
203860|NCT00311584|684665|P2|Overall Study|Physician Decision|5
203861|NCT00311584|684666|P1|Overall Study|Physician Decision|4
203862|NCT00311584|684665|P2|Overall Study|Lack of Efficacy|15
203863|NCT00311584|684666|P1|Overall Study|Lack of Efficacy|12
203864|NCT00311584|684665|P2|Overall Study|Death|0
203865|NCT00311584|684666|P1|Overall Study|Death|1
203866|NCT00311402|684674|P2|Overall Study|IRB's rejection etc.|3
203867|NCT00311402|684675|P1|Overall Study|IRB's rejection etc.|10
203868|NCT00311402|684674|P2|Overall Study|Protocol Violation|6
203869|NCT00311402|684675|P1|Overall Study|Protocol Violation|7
203870|NCT00311402|684674|P2|Overall Study|Lack of Efficacy|42
203871|NCT00311402|684675|P1|Overall Study|Lack of Efficacy|58
203872|NCT00311402|684674|P2|Overall Study|Withdrawal by Subject|18
203873|NCT00311402|684675|P1|Overall Study|Withdrawal by Subject|17
203874|NCT00311402|684674|P2|Overall Study|Lost to Follow-up|3
203875|NCT00311402|684675|P1|Overall Study|Lost to Follow-up|0
203876|NCT00311402|684674|P2|Overall Study|Adverse Event|105
203877|NCT00311402|684675|P1|Overall Study|Adverse Event|118
203878|NCT00311363|684724|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
203879|NCT00311363|684725|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
203880|NCT00311363|684726|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
203881|NCT00311363|684724|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
203882|NCT00311363|684725|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
203883|NCT00311363|684726|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
203884|NCT00311363|684724|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
203885|NCT00311363|684725|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
203886|NCT00311363|684726|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
203887|NCT00311363|684724|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
203888|NCT00311363|684725|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
203889|NCT00311363|684726|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
203890|NCT00311363|684724|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
203891|NCT00311363|684725|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
203892|NCT00311363|684726|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
203893|NCT00311363|684724|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
203894|NCT00311363|684725|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
203895|NCT00311363|684726|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
203896|NCT00311363|684724|P3|24-Week Single-Blind Treatment Period|Death|0
203897|NCT00311363|684725|P2|24-Week Single-Blind Treatment Period|Death|0
203898|NCT00311363|684726|P1|24-Week Single-Blind Treatment Period|Death|1
203899|NCT00311363|684724|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
203900|NCT00311363|684725|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
203901|NCT00311363|684726|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
203902|NCT00311363|684724|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
203903|NCT00311363|684725|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
203904|NCT00311363|684726|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
203905|NCT00311363|684724|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
203906|NCT00311363|684725|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
203907|NCT00311363|684726|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
203908|NCT00311363|684724|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
203909|NCT00311363|684725|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
203910|NCT00311363|684726|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
203911|NCT00311363|684724|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
203912|NCT00311363|684725|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
203913|NCT00311363|684726|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
203914|NCT00311363|684724|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
203915|NCT00311363|684725|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
203916|NCT00311363|684726|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
203917|NCT00311363|684724|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
203918|NCT00311363|684725|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
203919|NCT00311363|684726|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
203920|NCT00311363|684724|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
203921|NCT00311363|684725|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
203922|NCT00311363|684726|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
203923|NCT00311311|684786|P2|Overall Study|Lack of ancillary assistance|1
203924|NCT00311311|684787|P1|Overall Study|Lack of ancillary assistance|0
203925|NCT00311311|684786|P2|Overall Study|Death|0
203926|NCT00311311|684787|P1|Overall Study|Death|1
203927|NCT00311311|684786|P2|Overall Study|Study Termination by Sponsor|4
203928|NCT00311311|684787|P1|Overall Study|Study Termination by Sponsor|3
203929|NCT00311311|684786|P2|Overall Study|Noncompliance|1
203930|NCT00311311|684787|P1|Overall Study|Noncompliance|0
203931|NCT00311311|684786|P2|Overall Study|Withdrawal by Subject|1
203932|NCT00311311|684787|P1|Overall Study|Withdrawal by Subject|1
203933|NCT00311311|684786|P2|Overall Study|Adverse Event|2
203934|NCT00311311|684787|P1|Overall Study|Adverse Event|3
203935|NCT00311181|684837|P1|Overall Study|Final DFTs were not obtained|96
203936|NCT00311155|684843|P1|Overall Study|Did not meet entry criteria|55
203937|NCT00311155|684843|P1|Overall Study|Withdrawal by Subject|17
203938|NCT00311155|684843|P1|Overall Study|Adverse Event|21
203939|NCT00310856|684855|P3|Overall Study|Unable to classify|0
203940|NCT00310856|684856|P2|Overall Study|Unable to classify|0
203941|NCT00310856|684857|P1|Overall Study|Unable to classify|1
203942|NCT00310856|684855|P3|Overall Study|Inappropriate enrollment|0
203943|NCT00310856|684856|P2|Overall Study|Inappropriate enrollment|1
203944|NCT00310856|684857|P1|Overall Study|Inappropriate enrollment|1
203945|NCT00310856|684855|P3|Overall Study|Lost to Follow-up|6
203946|NCT00310856|684856|P2|Overall Study|Lost to Follow-up|2
203947|NCT00310856|684857|P1|Overall Study|Lost to Follow-up|1
203948|NCT00310856|684855|P3|Overall Study|Withdrawal by Subject|2
203949|NCT00310856|684856|P2|Overall Study|Withdrawal by Subject|2
203950|NCT00310856|684857|P1|Overall Study|Withdrawal by Subject|2
203951|NCT00310817|684881|P4|Overall Study|Unable to classify|0
203952|NCT00310817|684882|P3|Overall Study|Unable to classify|0
203953|NCT00310817|684883|P2|Overall Study|Unable to classify|1
203954|NCT00310817|684884|P1|Overall Study|Unable to classify|3
203955|NCT00310817|684881|P4|Overall Study|Protocol Violation|1
203956|NCT00310817|684882|P3|Overall Study|Protocol Violation|1
203957|NCT00310817|684883|P2|Overall Study|Protocol Violation|1
203958|NCT00310817|684884|P1|Overall Study|Protocol Violation|1
203959|NCT00310817|684881|P4|Overall Study|Inappropriate Enrollment|0
203960|NCT00310817|684882|P3|Overall Study|Inappropriate Enrollment|1
203961|NCT00310817|684883|P2|Overall Study|Inappropriate Enrollment|0
203962|NCT00310817|684884|P1|Overall Study|Inappropriate Enrollment|1
203963|NCT00310817|684881|P4|Overall Study|Lost to Follow-up|0
203964|NCT00310817|684882|P3|Overall Study|Lost to Follow-up|0
203965|NCT00310817|684883|P2|Overall Study|Lost to Follow-up|1
203966|NCT00310817|684884|P1|Overall Study|Lost to Follow-up|2
203967|NCT00310817|684881|P4|Overall Study|Withdrawal by Subject|7
203968|NCT00310817|684882|P3|Overall Study|Withdrawal by Subject|6
203969|NCT00310817|684883|P2|Overall Study|Withdrawal by Subject|4
203970|NCT00310817|684884|P1|Overall Study|Withdrawal by Subject|1
203971|NCT00310817|684881|P4|Overall Study|AE or Death|0
203972|NCT00310817|684882|P3|Overall Study|AE or Death|0
203973|NCT00310817|684883|P2|Overall Study|AE or Death|1
203974|NCT00310817|684884|P1|Overall Study|AE or Death|3
203975|NCT00310804|684972|P2|Overall Study|Withdrawal by Subject|0
203976|NCT00310804|684973|P1|Overall Study|Withdrawal by Subject|3
203977|NCT00310804|684972|P2|Overall Study|Lost to Follow-up|0
203978|NCT00310804|684973|P1|Overall Study|Lost to Follow-up|2
203979|NCT00310440|685032|P2|Overall Study|Missed 12 Month Visit|4
203980|NCT00310440|685033|P1|Overall Study|Missed 12 Month Visit|7
203981|NCT00310440|685032|P2|Overall Study|Withdrawal by Subject|1
203982|NCT00310440|685033|P1|Overall Study|Withdrawal by Subject|2
203983|NCT00310440|685032|P2|Overall Study|Lost to Follow-up|8
203984|NCT00310440|685033|P1|Overall Study|Lost to Follow-up|17
203985|NCT00310375|685099|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
203986|NCT00310375|685100|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
203987|NCT00310375|685101|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
203988|NCT00310375|685099|P3|Primary Reporting Phase|Request of Ethics Committee|0
203989|NCT00310375|685100|P2|Primary Reporting Phase|Request of Ethics Committee|1
203990|NCT00310375|685101|P1|Primary Reporting Phase|Request of Ethics Committee|0
203991|NCT00310375|685099|P3|Primary Reporting Phase|Par. switched to commercial product|0
203992|NCT00310375|685100|P2|Primary Reporting Phase|Par. switched to commercial product|1
203993|NCT00310375|685101|P1|Primary Reporting Phase|Par. switched to commercial product|0
203994|NCT00310375|685099|P3|Primary Reporting Phase|Missed study drug for 2 months|0
203995|NCT00310375|685100|P2|Primary Reporting Phase|Missed study drug for 2 months|0
203996|NCT00310375|685101|P1|Primary Reporting Phase|Missed study drug for 2 months|1
203997|NCT00310375|685099|P3|Primary Reporting Phase|Site closure|0
203998|NCT00310375|685100|P2|Primary Reporting Phase|Site closure|0
203999|NCT00310375|685101|P1|Primary Reporting Phase|Site closure|3
204000|NCT00310375|685099|P3|Primary Reporting Phase|Missed study drug >5 days|0
204001|NCT00310375|685100|P2|Primary Reporting Phase|Missed study drug >5 days|0
204002|NCT00310375|685101|P1|Primary Reporting Phase|Missed study drug >5 days|1
204003|NCT00310375|685099|P3|Primary Reporting Phase|Going for temporal lobectomy|0
204004|NCT00310375|685100|P2|Primary Reporting Phase|Going for temporal lobectomy|0
204005|NCT00310375|685101|P1|Primary Reporting Phase|Going for temporal lobectomy|1
204006|NCT00310375|685099|P3|Primary Reporting Phase|Participant request unrelated to study|0
204007|NCT00310375|685100|P2|Primary Reporting Phase|Participant request unrelated to study|2
204008|NCT00310375|685101|P1|Primary Reporting Phase|Participant request unrelated to study|1
204009|NCT00310375|685099|P3|Primary Reporting Phase|Failed to return|0
204010|NCT00310375|685100|P2|Primary Reporting Phase|Failed to return|3
204011|NCT00310375|685101|P1|Primary Reporting Phase|Failed to return|1
204012|NCT00310375|685099|P3|Primary Reporting Phase|Request of the sponsor|0
204013|NCT00310375|685100|P2|Primary Reporting Phase|Request of the sponsor|2
204014|NCT00310375|685101|P1|Primary Reporting Phase|Request of the sponsor|2
204015|NCT00310375|685099|P3|Primary Reporting Phase|Physician Decision|0
204016|NCT00310375|685100|P2|Primary Reporting Phase|Physician Decision|3
204017|NCT00310375|685101|P1|Primary Reporting Phase|Physician Decision|5
204018|NCT00310375|685099|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
204019|NCT00310375|685100|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
204020|NCT00310375|685101|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
204021|NCT00310375|685099|P3|Primary Reporting Phase|Change in Par medical condition|0
204022|NCT00310375|685100|P2|Primary Reporting Phase|Change in Par medical condition|0
204023|NCT00310375|685101|P1|Primary Reporting Phase|Change in Par medical condition|2
204024|NCT00310375|685099|P3|Primary Reporting Phase|Protocol Violation|0
204025|NCT00310375|685100|P2|Primary Reporting Phase|Protocol Violation|5
204026|NCT00310375|685101|P1|Primary Reporting Phase|Protocol Violation|8
204027|NCT00310375|685099|P3|Primary Reporting Phase|Withdrawal by Subject|0
204028|NCT00310375|685100|P2|Primary Reporting Phase|Withdrawal by Subject|7
204029|NCT00310375|685101|P1|Primary Reporting Phase|Withdrawal by Subject|10
204030|NCT00310375|685099|P3|Primary Reporting Phase|Pregnancy|0
204031|NCT00310375|685100|P2|Primary Reporting Phase|Pregnancy|2
204032|NCT00310375|685101|P1|Primary Reporting Phase|Pregnancy|2
204033|NCT00310375|685099|P3|Primary Reporting Phase|Lack of Efficacy|0
204034|NCT00310375|685100|P2|Primary Reporting Phase|Lack of Efficacy|19
204035|NCT00310375|685101|P1|Primary Reporting Phase|Lack of Efficacy|24
204036|NCT00310375|685099|P3|Primary Reporting Phase|Adverse Event|0
204037|NCT00310375|685100|P2|Primary Reporting Phase|Adverse Event|22
204038|NCT00310375|685101|P1|Primary Reporting Phase|Adverse Event|28
204039|NCT00309985|685189|P2|Overall Study|Chemotherapy discontinued only|0
204040|NCT00309985|685190|P1|Overall Study|Chemotherapy discontinued only|1
204041|NCT00309985|685189|P2|Overall Study|Non-compliance|0
204042|NCT00309985|685190|P1|Overall Study|Non-compliance|1
204043|NCT00309985|685189|P2|Overall Study|Complicating disease|0
204044|NCT00309985|685190|P1|Overall Study|Complicating disease|1
204045|NCT00309985|685189|P2|Overall Study|Never started treatment|0
204046|NCT00309985|685190|P1|Overall Study|Never started treatment|7
204047|NCT00309985|685189|P2|Overall Study|Physician Decision|0
204048|NCT00309985|685190|P1|Overall Study|Physician Decision|3
204049|NCT00309985|685189|P2|Overall Study|Withdrawal by Subject|1
204050|NCT00309985|685190|P1|Overall Study|Withdrawal by Subject|5
204051|NCT00309985|685189|P2|Overall Study|Death|0
204052|NCT00309985|685190|P1|Overall Study|Death|2
204053|NCT00309985|685189|P2|Overall Study|Adverse Event|0
204054|NCT00309985|685190|P1|Overall Study|Adverse Event|30
204055|NCT00309985|685189|P2|Overall Study|Disease progression|0
204056|NCT00309985|685190|P1|Overall Study|Disease progression|12
204057|NCT00309946|685206|P1|Overall Study|Withdrawal by Subject|1
204058|NCT00309907|685212|P1|Overall Study|Major infectious event|4
204059|NCT00309907|685212|P1|Overall Study|Ineligible|11
204060|NCT00309907|685212|P1|Overall Study|Physician Decision|1
204061|NCT00309907|685212|P1|Overall Study|Death|4
204062|NCT00309777|685225|P4|Overall Study|Death|0
204063|NCT00309777|685226|P3|Overall Study|Death|0
204064|NCT00309777|685227|P2|Overall Study|Death|1
204065|NCT00309777|685228|P1|Overall Study|Death|0
204066|NCT00309777|685225|P4|Overall Study|Lost to Follow-up|0
204067|NCT00309777|685226|P3|Overall Study|Lost to Follow-up|1
204068|NCT00309777|685227|P2|Overall Study|Lost to Follow-up|0
204069|NCT00309777|685228|P1|Overall Study|Lost to Follow-up|0
204070|NCT00309777|685225|P4|Overall Study|Withdrawal by Subject|2
204071|NCT00309777|685226|P3|Overall Study|Withdrawal by Subject|7
204072|NCT00309777|685227|P2|Overall Study|Withdrawal by Subject|5
204073|NCT00309777|685228|P1|Overall Study|Withdrawal by Subject|6
204074|NCT00309777|685225|P4|Overall Study|Protocol Violation|1
204075|NCT00309777|685226|P3|Overall Study|Protocol Violation|3
204076|NCT00309777|685227|P2|Overall Study|Protocol Violation|1
204077|NCT00309777|685228|P1|Overall Study|Protocol Violation|4
204078|NCT00309777|685225|P4|Overall Study|Adverse Event|1
204079|NCT00309777|685226|P3|Overall Study|Adverse Event|8
204080|NCT00309777|685227|P2|Overall Study|Adverse Event|2
204081|NCT00309777|685228|P1|Overall Study|Adverse Event|13
204082|NCT00309608|685269|P5|Overall Study|Other incl. Lack of efficacy|0
204083|NCT00309608|685270|P4|Overall Study|Other incl. Lack of efficacy|4
204084|NCT00309608|685271|P3|Overall Study|Other incl. Lack of efficacy|3
204085|NCT00309608|685272|P2|Overall Study|Other incl. Lack of efficacy|4
204086|NCT00309608|685273|P1|Overall Study|Other incl. Lack of efficacy|10
204087|NCT00309608|685269|P5|Overall Study|Withdrawal by Subject|0
204088|NCT00309608|685270|P4|Overall Study|Withdrawal by Subject|0
204089|NCT00309608|685271|P3|Overall Study|Withdrawal by Subject|2
204090|NCT00309608|685272|P2|Overall Study|Withdrawal by Subject|4
204091|NCT00309608|685273|P1|Overall Study|Withdrawal by Subject|1
204092|NCT00309608|685269|P5|Overall Study|Lost to Follow-up|1
204093|NCT00309608|685270|P4|Overall Study|Lost to Follow-up|0
204094|NCT00309608|685271|P3|Overall Study|Lost to Follow-up|2
204095|NCT00309608|685272|P2|Overall Study|Lost to Follow-up|0
204096|NCT00309608|685273|P1|Overall Study|Lost to Follow-up|0
204097|NCT00309608|685269|P5|Overall Study|Protocol Violation|0
204098|NCT00309608|685270|P4|Overall Study|Protocol Violation|0
204099|NCT00309608|685271|P3|Overall Study|Protocol Violation|0
204100|NCT00309608|685272|P2|Overall Study|Protocol Violation|0
204101|NCT00309608|685273|P1|Overall Study|Protocol Violation|2
204102|NCT00309608|685269|P5|Overall Study|Adverse Event|3
204103|NCT00309608|685270|P4|Overall Study|Adverse Event|2
204104|NCT00309608|685271|P3|Overall Study|Adverse Event|3
204105|NCT00309608|685272|P2|Overall Study|Adverse Event|5
204106|NCT00309608|685273|P1|Overall Study|Adverse Event|1
204107|NCT00309452|685321|P2|Overall Study|Withdrawal by Subject|0
204108|NCT00309452|685322|P1|Overall Study|Withdrawal by Subject|3
204109|NCT00309387|685350|P2|Overall Study|Lost to Follow-up|86
204110|NCT00309387|685351|P1|Overall Study|Lost to Follow-up|70
204111|NCT00309387|685350|P2|Overall Study|Death|73
204112|NCT00309387|685351|P1|Overall Study|Death|72
204113|NCT00309244|685369|P2|Overall Study|Death|1
204114|NCT00309244|685370|P1|Overall Study|Death|4
204115|NCT00309244|685369|P2|Overall Study|Randomized but not dosed|12
204116|NCT00309244|685370|P1|Overall Study|Randomized but not dosed|11
204117|NCT00309244|685369|P2|Overall Study|Various|7
204118|NCT00309244|685370|P1|Overall Study|Various|7
204119|NCT00309244|685369|P2|Overall Study|Withdrawal by Subject|32
204120|NCT00309244|685370|P1|Overall Study|Withdrawal by Subject|50
204121|NCT00309244|685369|P2|Overall Study|Protocol Violation|3
204122|NCT00309244|685370|P1|Overall Study|Protocol Violation|6
204123|NCT00309244|685369|P2|Overall Study|Physician Decision|8
204124|NCT00309244|685370|P1|Overall Study|Physician Decision|5
204125|NCT00309244|685369|P2|Overall Study|Lost to Follow-up|22
204126|NCT00309244|685370|P1|Overall Study|Lost to Follow-up|6
204127|NCT00309244|685369|P2|Overall Study|Adverse Event|12
204128|NCT00309244|685370|P1|Overall Study|Adverse Event|29
204129|NCT00308997|685392|P2|Overall Study|Unable to tolerate intervention|0
204130|NCT00308997|685393|P1|Overall Study|Unable to tolerate intervention|1
204131|NCT00308997|685392|P2|Overall Study|Subject feigned clinical data|1
204132|NCT00308997|685393|P1|Overall Study|Subject feigned clinical data|0
204133|NCT00308737|685412|P3|Overall Study|Various|8
204134|NCT00308737|685413|P2|Overall Study|Various|20
204135|NCT00308737|685414|P1|Overall Study|Various|32
204136|NCT00308737|685412|P3|Overall Study|Withdrawal by Subject|18
204137|NCT00308737|685413|P2|Overall Study|Withdrawal by Subject|166
204138|NCT00308737|685414|P1|Overall Study|Withdrawal by Subject|218
204139|NCT00308737|685412|P3|Overall Study|Protocol Violation|5
204140|NCT00308737|685413|P2|Overall Study|Protocol Violation|9
204141|NCT00308737|685414|P1|Overall Study|Protocol Violation|34
204142|NCT00308737|685412|P3|Overall Study|Physician Decision|1
204143|NCT00308737|685413|P2|Overall Study|Physician Decision|2
204144|NCT00308737|685414|P1|Overall Study|Physician Decision|15
204145|NCT00308737|685412|P3|Overall Study|Lost to Follow-up|5
204146|NCT00308737|685413|P2|Overall Study|Lost to Follow-up|80
204147|NCT00308737|685414|P1|Overall Study|Lost to Follow-up|56
204148|NCT00308737|685412|P3|Overall Study|Death|0
204149|NCT00308737|685413|P2|Overall Study|Death|3
204150|NCT00308737|685414|P1|Overall Study|Death|4
204151|NCT00308737|685412|P3|Overall Study|Adverse Event|0
204152|NCT00308737|685413|P2|Overall Study|Adverse Event|9
204153|NCT00308737|685414|P1|Overall Study|Adverse Event|104
204154|NCT00308711|685454|P3|Overall Study|Subject incarcerated, data not allowed|1
204155|NCT00308711|685455|P2|Overall Study|Subject incarcerated, data not allowed|0
204156|NCT00308711|685456|P1|Overall Study|Subject incarcerated, data not allowed|0
204157|NCT00308711|685454|P3|Overall Study|Baby not born within 7 days of treatment|2
204158|NCT00308711|685455|P2|Overall Study|Baby not born within 7 days of treatment|2
204159|NCT00308711|685456|P1|Overall Study|Baby not born within 7 days of treatment|1
204160|NCT00308711|685454|P3|Overall Study|Lost to Follow-up|0
204161|NCT00308711|685455|P2|Overall Study|Lost to Follow-up|1
204162|NCT00308711|685456|P1|Overall Study|Lost to Follow-up|0
204163|NCT00308711|685454|P3|Overall Study|Protocol Violation|1
204164|NCT00308711|685455|P2|Overall Study|Protocol Violation|1
204165|NCT00308711|685456|P1|Overall Study|Protocol Violation|0
204166|NCT00308711|685454|P3|Overall Study|Withdrawal by Subject|1
204167|NCT00308711|685455|P2|Overall Study|Withdrawal by Subject|0
204168|NCT00308711|685456|P1|Overall Study|Withdrawal by Subject|1
204169|NCT00308620|685491|P3|Overall Study|Lost to Follow-up|1
204170|NCT00308620|685492|P2|Overall Study|Lost to Follow-up|0
204171|NCT00308620|685493|P1|Overall Study|Lost to Follow-up|0
204172|NCT00308620|685491|P3|Overall Study|Death|0
204173|NCT00308620|685492|P2|Overall Study|Death|1
204174|NCT00308620|685493|P1|Overall Study|Death|1
204175|NCT00308581|685502|P3|Randomized Maintenance Phase|Unknown reason|0
204176|NCT00308581|685503|P2|Randomized Maintenance Phase|Unknown reason|0
204177|NCT00308581|685504|P1|Randomized Maintenance Phase|Unknown reason|3
204178|NCT00308581|685502|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
204179|NCT00308581|685503|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
204180|NCT00308581|685504|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
204181|NCT00308581|685502|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
204182|NCT00308581|685503|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
204183|NCT00308581|685504|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
204184|NCT00308581|685502|P3|Randomized Maintenance Phase|Lost to Follow-up|0
204185|NCT00308581|685503|P2|Randomized Maintenance Phase|Lost to Follow-up|2
204186|NCT00308581|685504|P1|Randomized Maintenance Phase|Lost to Follow-up|0
204187|NCT00308581|685502|P3|Randomized Maintenance Phase|Lack of Efficacy|0
204188|NCT00308581|685503|P2|Randomized Maintenance Phase|Lack of Efficacy|21
204189|NCT00308581|685504|P1|Randomized Maintenance Phase|Lack of Efficacy|9
204190|NCT00308581|685502|P3|Randomized Maintenance Phase|Adverse Event|0
204191|NCT00308581|685503|P2|Randomized Maintenance Phase|Adverse Event|17
204192|NCT00308581|685504|P1|Randomized Maintenance Phase|Adverse Event|10
204193|NCT00308581|685502|P3|Induction Phase|Unknown reason|3
204194|NCT00308581|685503|P2|Induction Phase|Unknown reason|0
204195|NCT00308581|685504|P1|Induction Phase|Unknown reason|0
204196|NCT00308581|685502|P3|Induction Phase|Withdrawal by Subject|5
204197|NCT00308581|685503|P2|Induction Phase|Withdrawal by Subject|0
204198|NCT00308581|685504|P1|Induction Phase|Withdrawal by Subject|0
204199|NCT00308581|685502|P3|Induction Phase|Lack of Efficacy|121
204200|NCT00308581|685503|P2|Induction Phase|Lack of Efficacy|0
204201|NCT00308581|685504|P1|Induction Phase|Lack of Efficacy|0
204202|NCT00308581|685502|P3|Induction Phase|Adverse Event|37
204203|NCT00308581|685503|P2|Induction Phase|Adverse Event|0
204204|NCT00308581|685504|P1|Induction Phase|Adverse Event|0
204205|NCT00308555|685630|P2|Overall Study|Physician Decision|0
204206|NCT00308555|685631|P1|Overall Study|Physician Decision|2
204207|NCT00308555|685630|P2|Overall Study|Withdrawal by Subject|0
204208|NCT00308555|685631|P1|Overall Study|Withdrawal by Subject|1
204209|NCT00308308|685648|P2|Overall Study|Other|0
204210|NCT00308308|685649|P1|Overall Study|Other|1
204211|NCT00308308|685648|P2|Overall Study|Randomized but not dosed|16
204212|NCT00308308|685649|P1|Overall Study|Randomized but not dosed|8
204213|NCT00308308|685648|P2|Overall Study|Various|5
204214|NCT00308308|685649|P1|Overall Study|Various|7
204215|NCT00308308|685648|P2|Overall Study|Withdrawal by Subject|19
204216|NCT00308308|685649|P1|Overall Study|Withdrawal by Subject|47
204217|NCT00308308|685648|P2|Overall Study|Protocol Violation|14
204218|NCT00308308|685649|P1|Overall Study|Protocol Violation|3
204219|NCT00308308|685648|P2|Overall Study|Physician Decision|7
204220|NCT00308308|685649|P1|Overall Study|Physician Decision|15
204221|NCT00308308|685648|P2|Overall Study|Lost to Follow-up|5
204222|NCT00308308|685649|P1|Overall Study|Lost to Follow-up|5
204223|NCT00308308|685648|P2|Overall Study|Adverse Event|2
204224|NCT00308308|685649|P1|Overall Study|Adverse Event|17
204225|NCT00308139|685684|P2|Overall Study|Other|0
204226|NCT00308139|685685|P1|Overall Study|Other|1
204227|NCT00308139|685684|P2|Overall Study|Administrative|4
204228|NCT00308139|685685|P1|Overall Study|Administrative|1
204229|NCT00308139|685684|P2|Overall Study|Loss of Glucose Control|7
204230|NCT00308139|685685|P1|Overall Study|Loss of Glucose Control|5
204231|NCT00308139|685684|P2|Overall Study|Investigator Decision|10
204232|NCT00308139|685685|P1|Overall Study|Investigator Decision|11
204233|NCT00308139|685684|P2|Overall Study|Withdrawal of Consent|42
204234|NCT00308139|685685|P1|Overall Study|Withdrawal of Consent|40
204235|NCT00308139|685684|P2|Overall Study|Protocol Violation|2
204236|NCT00308139|685685|P1|Overall Study|Protocol Violation|3
204237|NCT00308139|685684|P2|Overall Study|Lost to Follow-up|8
204238|NCT00308139|685685|P1|Overall Study|Lost to Follow-up|13
204239|NCT00308139|685684|P2|Overall Study|Adverse Event|14
204240|NCT00308139|685685|P1|Overall Study|Adverse Event|20
204241|NCT00308113|685759|P4|Overall Study|Protocol closure|1
204242|NCT00308113|685760|P3|Overall Study|Protocol closure|0
204243|NCT00308113|685761|P2|Overall Study|Protocol closure|0
204244|NCT00308113|685762|P1|Overall Study|Protocol closure|0
204245|NCT00308087|685782|P2|Overall Study|Not Specified|3
204246|NCT00308087|685783|P1|Overall Study|Not Specified|4
204247|NCT00308087|685782|P2|Overall Study|Withdrawal by Subject|1
204248|NCT00308087|685783|P1|Overall Study|Withdrawal by Subject|2
204249|NCT00308087|685782|P2|Overall Study|Study Closure|12
204250|NCT00308087|685783|P1|Overall Study|Study Closure|11
204251|NCT00308087|685782|P2|Overall Study|Progressive Disease|21
204252|NCT00308087|685783|P1|Overall Study|Progressive Disease|19
204253|NCT00308074|685799|P1|Overall Study|Withdrawal by Subject|1
204254|NCT00307931|685816|P1|Overall Study|Adverse Event|1
204255|NCT00307801|685833|P2|Overall Study|Pregnancy|1
204256|NCT00307801|685834|P1|Overall Study|Pregnancy|0
204257|NCT00307801|685833|P2|Overall Study|No reason specified|0
204258|NCT00307801|685834|P1|Overall Study|No reason specified|2
204259|NCT00307801|685833|P2|Overall Study|Protocol Violation|2
204260|NCT00307801|685834|P1|Overall Study|Protocol Violation|3
204261|NCT00307801|685833|P2|Overall Study|Frustration with e-diary|0
204262|NCT00307801|685834|P1|Overall Study|Frustration with e-diary|1
204263|NCT00307801|685833|P2|Overall Study|Lost to Follow-up, moved abroad|1
204264|NCT00307801|685834|P1|Overall Study|Lost to Follow-up, moved abroad|1
204265|NCT00307801|685833|P2|Overall Study|Lack of Efficacy|2
204266|NCT00307801|685834|P1|Overall Study|Lack of Efficacy|0
204267|NCT00307801|685833|P2|Overall Study|Wrong Randomization|0
204268|NCT00307801|685834|P1|Overall Study|Wrong Randomization|1
204269|NCT00307801|685833|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
204270|NCT00307801|685834|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
204271|NCT00307801|685833|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
204272|NCT00307801|685834|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
204273|NCT00307801|685833|P2|Overall Study|Non-compliance, not taken all tablets|2
204274|NCT00307801|685834|P1|Overall Study|Non-compliance, not taken all tablets|1
204275|NCT00307801|685833|P2|Overall Study|Withdrawal by Subject|4
204276|NCT00307801|685834|P1|Overall Study|Withdrawal by Subject|9
204277|NCT00307801|685833|P2|Overall Study|Adverse Event|4
204278|NCT00307801|685834|P1|Overall Study|Adverse Event|12
204279|NCT00307736|685946|P4|Overall Study|Withdrawal by Subject|0
204280|NCT00307736|685947|P3|Overall Study|Withdrawal by Subject|2
204281|NCT00307736|685948|P2|Overall Study|Withdrawal by Subject|0
204282|NCT00307736|685949|P1|Overall Study|Withdrawal by Subject|0
204283|NCT00307736|685946|P4|Overall Study|Adverse Event|3
204284|NCT00307736|685947|P3|Overall Study|Adverse Event|1
204285|NCT00307736|685948|P2|Overall Study|Adverse Event|0
204286|NCT00307736|685949|P1|Overall Study|Adverse Event|0
204287|NCT00307684|685960|P3|Double Blind Phase|Lack of Efficacy|0
204288|NCT00307684|685961|P2|Double Blind Phase|Lack of Efficacy|5
204289|NCT00307684|685962|P1|Double Blind Phase|Lack of Efficacy|2
204290|NCT00307684|685960|P3|Open Label Phase|other|6
204291|NCT00307684|685961|P2|Open Label Phase|other|0
204292|NCT00307684|685962|P1|Open Label Phase|other|0
204293|NCT00307684|685960|P3|Open Label Phase|non compliance|5
204294|NCT00307684|685961|P2|Open Label Phase|non compliance|0
204295|NCT00307684|685962|P1|Open Label Phase|non compliance|0
204296|NCT00307684|685960|P3|Open Label Phase|Lost to Follow-up|11
204297|NCT00307684|685961|P2|Open Label Phase|Lost to Follow-up|0
204298|NCT00307684|685962|P1|Open Label Phase|Lost to Follow-up|0
204299|NCT00307684|685960|P3|Open Label Phase|Withdrawal by Subject|15
204300|NCT00307684|685961|P2|Open Label Phase|Withdrawal by Subject|0
204301|NCT00307684|685962|P1|Open Label Phase|Withdrawal by Subject|0
204302|NCT00307684|685960|P3|Open Label Phase|Adverse Event|16
204303|NCT00307684|685961|P2|Open Label Phase|Adverse Event|0
204304|NCT00307684|685962|P1|Open Label Phase|Adverse Event|0
204305|NCT00307684|685960|P3|Open Label Phase|Lack of Efficacy|3
204306|NCT00307684|685961|P2|Open Label Phase|Lack of Efficacy|0
204307|NCT00307684|685962|P1|Open Label Phase|Lack of Efficacy|0
204308|NCT00307489|685990|P2|Week 48 Through Week 168|Seroconversion|0
204309|NCT00307489|685991|P1|Week 48 Through Week 168|Seroconversion|1
204310|NCT00307489|685990|P2|Week 48 Through Week 168|Lost to Follow-up|1
204311|NCT00307489|685991|P1|Week 48 Through Week 168|Lost to Follow-up|0
204312|NCT00307489|685990|P2|Week 48 Through Week 168|Death|1
204313|NCT00307489|685991|P1|Week 48 Through Week 168|Death|0
204314|NCT00307489|685990|P2|Week 48 Through Week 168|Lack of Efficacy|2
204315|NCT00307489|685991|P1|Week 48 Through Week 168|Lack of Efficacy|2
204316|NCT00307489|685990|P2|Week 48 Through Week 168|Withdrawal by Subject|2
204317|NCT00307489|685991|P1|Week 48 Through Week 168|Withdrawal by Subject|1
204318|NCT00307489|685990|P2|Week 48 Through Week 168|Physician Decision|0
204319|NCT00307489|685991|P1|Week 48 Through Week 168|Physician Decision|1
204320|NCT00307489|685990|P2|Week 48 Through Week 168|Adverse Event|0
204321|NCT00307489|685991|P1|Week 48 Through Week 168|Adverse Event|1
204322|NCT00307489|685990|P2|Baseline Through Week 48|Withdrawal by Subject|1
204323|NCT00307489|685991|P1|Baseline Through Week 48|Withdrawal by Subject|0
204324|NCT00307489|685990|P2|Baseline Through Week 48|Physician Decision|0
204325|NCT00307489|685991|P1|Baseline Through Week 48|Physician Decision|1
204326|NCT00307489|685990|P2|Baseline Through Week 48|Lost to Follow-up|1
204327|NCT00307489|685991|P1|Baseline Through Week 48|Lost to Follow-up|0
204328|NCT00307437|686036|P7|After Controlled Period|Other|28
204329|NCT00307437|686037|P6|After Controlled Period|Other|40
204330|NCT00307437|686038|P5|After Controlled Period|Other|9
204331|NCT00307437|686039|P4|After Controlled Period|Other|15
204332|NCT00307437|686040|P3|After Controlled Period|Other|0
204333|NCT00307437|686041|P2|After Controlled Period|Other|0
204334|NCT00307437|686042|P1|After Controlled Period|Other|0
204335|NCT00307437|686036|P7|After Controlled Period|Lost to Follow-up|18
204336|NCT00307437|686037|P6|After Controlled Period|Lost to Follow-up|13
204337|NCT00307437|686038|P5|After Controlled Period|Lost to Follow-up|12
204338|NCT00307437|686039|P4|After Controlled Period|Lost to Follow-up|7
204339|NCT00307437|686040|P3|After Controlled Period|Lost to Follow-up|0
204340|NCT00307437|686041|P2|After Controlled Period|Lost to Follow-up|0
204341|NCT00307437|686042|P1|After Controlled Period|Lost to Follow-up|0
204342|NCT00307437|686036|P7|After Controlled Period|Lack of Efficacy|24
204343|NCT00307437|686037|P6|After Controlled Period|Lack of Efficacy|37
204344|NCT00307437|686038|P5|After Controlled Period|Lack of Efficacy|17
204345|NCT00307437|686039|P4|After Controlled Period|Lack of Efficacy|15
204346|NCT00307437|686040|P3|After Controlled Period|Lack of Efficacy|0
204347|NCT00307437|686041|P2|After Controlled Period|Lack of Efficacy|0
204348|NCT00307437|686042|P1|After Controlled Period|Lack of Efficacy|0
204349|NCT00307437|686036|P7|After Controlled Period|Death|3
204350|NCT00307437|686037|P6|After Controlled Period|Death|1
204351|NCT00307437|686038|P5|After Controlled Period|Death|1
204352|NCT00307437|686039|P4|After Controlled Period|Death|3
204353|NCT00307437|686040|P3|After Controlled Period|Death|0
204354|NCT00307437|686041|P2|After Controlled Period|Death|0
204355|NCT00307437|686042|P1|After Controlled Period|Death|0
204356|NCT00307437|686036|P7|After Controlled Period|Adverse Event|40
204357|NCT00307437|686037|P6|After Controlled Period|Adverse Event|31
204358|NCT00307437|686038|P5|After Controlled Period|Adverse Event|16
204359|NCT00307437|686039|P4|After Controlled Period|Adverse Event|18
204360|NCT00307437|686040|P3|After Controlled Period|Adverse Event|0
204361|NCT00307437|686041|P2|After Controlled Period|Adverse Event|0
204362|NCT00307437|686042|P1|After Controlled Period|Adverse Event|0
204363|NCT00307437|686036|P7|Controlled Period|Other|0
204364|NCT00307437|686037|P6|Controlled Period|Other|0
204365|NCT00307437|686038|P5|Controlled Period|Other|0
204366|NCT00307437|686039|P4|Controlled Period|Other|0
204367|NCT00307437|686040|P3|Controlled Period|Other|3
204368|NCT00307437|686041|P2|Controlled Period|Other|1
204369|NCT00307437|686042|P1|Controlled Period|Other|5
204370|NCT00307437|686036|P7|Controlled Period|Lost to Follow-up|0
204371|NCT00307437|686037|P6|Controlled Period|Lost to Follow-up|0
204372|NCT00307437|686038|P5|Controlled Period|Lost to Follow-up|0
204373|NCT00307437|686039|P4|Controlled Period|Lost to Follow-up|0
204374|NCT00307437|686040|P3|Controlled Period|Lost to Follow-up|0
204375|NCT00307437|686041|P2|Controlled Period|Lost to Follow-up|3
204376|NCT00307437|686042|P1|Controlled Period|Lost to Follow-up|2
204377|NCT00307437|686036|P7|Controlled Period|Lack of Efficacy|0
204378|NCT00307437|686037|P6|Controlled Period|Lack of Efficacy|0
204379|NCT00307437|686038|P5|Controlled Period|Lack of Efficacy|0
204380|NCT00307437|686039|P4|Controlled Period|Lack of Efficacy|0
204381|NCT00307437|686040|P3|Controlled Period|Lack of Efficacy|0
204382|NCT00307437|686041|P2|Controlled Period|Lack of Efficacy|0
204383|NCT00307437|686042|P1|Controlled Period|Lack of Efficacy|2
204384|NCT00307437|686036|P7|Controlled Period|Death|0
204385|NCT00307437|686037|P6|Controlled Period|Death|0
204386|NCT00307437|686038|P5|Controlled Period|Death|0
204387|NCT00307437|686039|P4|Controlled Period|Death|0
204388|NCT00307437|686040|P3|Controlled Period|Death|1
204389|NCT00307437|686041|P2|Controlled Period|Death|0
204390|NCT00307437|686042|P1|Controlled Period|Death|0
204391|NCT00307437|686036|P7|Controlled Period|Adverse Event|0
204392|NCT00307437|686037|P6|Controlled Period|Adverse Event|0
204393|NCT00307437|686038|P5|Controlled Period|Adverse Event|0
204394|NCT00307437|686039|P4|Controlled Period|Adverse Event|0
204395|NCT00307437|686040|P3|Controlled Period|Adverse Event|5
204396|NCT00307437|686041|P2|Controlled Period|Adverse Event|2
204397|NCT00307437|686042|P1|Controlled Period|Adverse Event|7
204398|NCT00307333|686068|P2|Overall Study|Lost to Follow-up|3
204399|NCT00307333|686069|P1|Overall Study|Lost to Follow-up|11
204400|NCT00307294|686081|P1|Overall Study|Withdrawal by Subject|1
204401|NCT00307164|686090|P2|Overall Study|Lost to Follow-up|1
204402|NCT00307164|686091|P1|Overall Study|Lost to Follow-up|6
204403|NCT00307164|686090|P2|Overall Study|Not compliant with requirements|4
204404|NCT00307164|686091|P1|Overall Study|Not compliant with requirements|4
204405|NCT00307164|686090|P2|Overall Study|Withdrawal by Subject|8
204406|NCT00307164|686091|P1|Overall Study|Withdrawal by Subject|1
204407|NCT00307164|686090|P2|Overall Study|Subject/parent not able to get to clinic|1
204408|NCT00307164|686091|P1|Overall Study|Subject/parent not able to get to clinic|2
204409|NCT00307164|686090|P2|Overall Study|Severe debilitation, unable to continue|0
204410|NCT00307164|686091|P1|Overall Study|Severe debilitation, unable to continue|1
204411|NCT00307164|686090|P2|Overall Study|Death|0
204412|NCT00307164|686091|P1|Overall Study|Death|1
204413|NCT00307151|686131|P4|Overall Study|Clinic unable to contact subject|1
204414|NCT00307151|686132|P3|Overall Study|Clinic unable to contact subject|1
204415|NCT00307151|686133|P2|Overall Study|Clinic unable to contact subject|3
204416|NCT00307151|686134|P1|Overall Study|Clinic unable to contact subject|3
204417|NCT00307151|686131|P4|Overall Study|Not willing to adhere to study reqs|2
204418|NCT00307151|686132|P3|Overall Study|Not willing to adhere to study reqs|2
204419|NCT00307151|686133|P2|Overall Study|Not willing to adhere to study reqs|0
204420|NCT00307151|686134|P1|Overall Study|Not willing to adhere to study reqs|2
204421|NCT00307151|686131|P4|Overall Study|Withdrew consent|3
204422|NCT00307151|686132|P3|Overall Study|Withdrew consent|1
204423|NCT00307151|686133|P2|Overall Study|Withdrew consent|1
204424|NCT00307151|686134|P1|Overall Study|Withdrew consent|0
204425|NCT00307151|686131|P4|Overall Study|Subject unable to get to clinic|2
204426|NCT00307151|686132|P3|Overall Study|Subject unable to get to clinic|6
204427|NCT00307151|686133|P2|Overall Study|Subject unable to get to clinic|0
204428|NCT00307151|686134|P1|Overall Study|Subject unable to get to clinic|1
204429|NCT00307151|686131|P4|Overall Study|Severe debilitation, unable to continue|0
204430|NCT00307151|686132|P3|Overall Study|Severe debilitation, unable to continue|0
204431|NCT00307151|686133|P2|Overall Study|Severe debilitation, unable to continue|0
204432|NCT00307151|686134|P1|Overall Study|Severe debilitation, unable to continue|1
204433|NCT00307151|686131|P4|Overall Study|Death|3
204434|NCT00307151|686132|P3|Overall Study|Death|10
204435|NCT00307151|686133|P2|Overall Study|Death|3
204436|NCT00307151|686134|P1|Overall Study|Death|4
204437|NCT00307125|686178|P3|Pilot Phase|Withdrawal by Subject|1
204438|NCT00307125|686179|P2|Pilot Phase|Withdrawal by Subject|1
204439|NCT00307125|686180|P1|Pilot Phase|Withdrawal by Subject|0
204440|NCT00307125|686178|P3|Pilot Phase|Lost to Follow-up|0
204441|NCT00307125|686179|P2|Pilot Phase|Lost to Follow-up|1
204442|NCT00307125|686180|P1|Pilot Phase|Lost to Follow-up|0
204443|NCT00307125|686178|P3|Screening Phase|Coronary artery bypass|0
204444|NCT00307125|686179|P2|Screening Phase|Coronary artery bypass|0
204445|NCT00307125|686180|P1|Screening Phase|Coronary artery bypass|1
204446|NCT00307125|686178|P3|Screening Phase|AMR and treated with rituximab|0
204447|NCT00307125|686179|P2|Screening Phase|AMR and treated with rituximab|0
204448|NCT00307125|686180|P1|Screening Phase|AMR and treated with rituximab|1
204449|NCT00307125|686178|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
204450|NCT00307125|686179|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
204451|NCT00307125|686180|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
204452|NCT00307125|686178|P3|Screening Phase|Screen Error|0
204453|NCT00307125|686179|P2|Screening Phase|Screen Error|0
204454|NCT00307125|686180|P1|Screening Phase|Screen Error|1
204455|NCT00307125|686178|P3|Screening Phase|Ineligible|0
204456|NCT00307125|686179|P2|Screening Phase|Ineligible|0
204457|NCT00307125|686180|P1|Screening Phase|Ineligible|1
204458|NCT00307125|686178|P3|Screening Phase|PAK|0
204459|NCT00307125|686179|P2|Screening Phase|PAK|0
204460|NCT00307125|686180|P1|Screening Phase|PAK|1
204461|NCT00307125|686178|P3|Screening Phase|Malignancy|0
204462|NCT00307125|686179|P2|Screening Phase|Malignancy|0
204463|NCT00307125|686180|P1|Screening Phase|Malignancy|1
204464|NCT00307125|686178|P3|Screening Phase|Metastatic colon cancer|0
204465|NCT00307125|686179|P2|Screening Phase|Metastatic colon cancer|0
204466|NCT00307125|686180|P1|Screening Phase|Metastatic colon cancer|1
204467|NCT00307125|686178|P3|Screening Phase|Developed acute leukemia|0
204468|NCT00307125|686179|P2|Screening Phase|Developed acute leukemia|0
204469|NCT00307125|686180|P1|Screening Phase|Developed acute leukemia|1
204470|NCT00307125|686178|P3|Screening Phase|Try to get pregnant|0
204471|NCT00307125|686179|P2|Screening Phase|Try to get pregnant|0
204472|NCT00307125|686180|P1|Screening Phase|Try to get pregnant|1
204473|NCT00307125|686178|P3|Screening Phase|Ineligible for pilot|0
204474|NCT00307125|686179|P2|Screening Phase|Ineligible for pilot|0
204475|NCT00307125|686180|P1|Screening Phase|Ineligible for pilot|4
204476|NCT00307125|686178|P3|Screening Phase|Received Pancreas Transplant|0
204477|NCT00307125|686179|P2|Screening Phase|Received Pancreas Transplant|0
204478|NCT00307125|686180|P1|Screening Phase|Received Pancreas Transplant|8
204479|NCT00307125|686178|P3|Screening Phase|Moved or transferred facilities|0
204480|NCT00307125|686179|P2|Screening Phase|Moved or transferred facilities|0
204481|NCT00307125|686180|P1|Screening Phase|Moved or transferred facilities|34
204482|NCT00307125|686178|P3|Screening Phase|Scheduling issues/Non-compliance|0
204483|NCT00307125|686179|P2|Screening Phase|Scheduling issues/Non-compliance|0
204484|NCT00307125|686180|P1|Screening Phase|Scheduling issues/Non-compliance|55
204485|NCT00307125|686178|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
204486|NCT00307125|686179|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
204487|NCT00307125|686180|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
204488|NCT00307125|686178|P3|Screening Phase|Graft Failure|0
204489|NCT00307125|686179|P2|Screening Phase|Graft Failure|0
204490|NCT00307125|686180|P1|Screening Phase|Graft Failure|8
204491|NCT00307125|686178|P3|Screening Phase|Graft Loss|0
204492|NCT00307125|686179|P2|Screening Phase|Graft Loss|0
204493|NCT00307125|686180|P1|Screening Phase|Graft Loss|3
204494|NCT00307125|686178|P3|Screening Phase|Study Terminated|0
204495|NCT00307125|686179|P2|Screening Phase|Study Terminated|0
204496|NCT00307125|686180|P1|Screening Phase|Study Terminated|17
204497|NCT00307125|686178|P3|Screening Phase|Sponsor Decision|0
204498|NCT00307125|686179|P2|Screening Phase|Sponsor Decision|0
204499|NCT00307125|686180|P1|Screening Phase|Sponsor Decision|4
204500|NCT00307125|686178|P3|Screening Phase|Physician Decision|0
204501|NCT00307125|686179|P2|Screening Phase|Physician Decision|0
204502|NCT00307125|686180|P1|Screening Phase|Physician Decision|26
204503|NCT00307125|686178|P3|Screening Phase|Withdrawal by Subject|0
204504|NCT00307125|686179|P2|Screening Phase|Withdrawal by Subject|0
204505|NCT00307125|686180|P1|Screening Phase|Withdrawal by Subject|77
204506|NCT00307125|686178|P3|Screening Phase|Death|0
204507|NCT00307125|686179|P2|Screening Phase|Death|0
204508|NCT00307125|686180|P1|Screening Phase|Death|10
204509|NCT00307125|686178|P3|Screening Phase|Lost to Follow-up|0
204510|NCT00307125|686179|P2|Screening Phase|Lost to Follow-up|0
204511|NCT00307125|686180|P1|Screening Phase|Lost to Follow-up|87
204512|NCT00307125|686178|P3|Screening Phase|Protocol Violation|0
204513|NCT00307125|686179|P2|Screening Phase|Protocol Violation|0
204514|NCT00307125|686180|P1|Screening Phase|Protocol Violation|27
204515|NCT00307125|686178|P3|Screening Phase|Adverse Event|0
204516|NCT00307125|686179|P2|Screening Phase|Adverse Event|0
204517|NCT00307125|686180|P1|Screening Phase|Adverse Event|1
204518|NCT00307086|686202|P1|Overall Study|ineligible|5
204519|NCT00307047|686208|P2|Overall Study|All death, all MI, all Revascularization|16
204520|NCT00307047|686209|P1|Overall Study|All death, all MI, all Revascularization|27
204521|NCT00307047|686208|P2|Overall Study|Lost to follow-up for other reasons|1
204522|NCT00307047|686209|P1|Overall Study|Lost to follow-up for other reasons|0
204523|NCT00307047|686208|P2|Overall Study|Physician Decision|2
204524|NCT00307047|686209|P1|Overall Study|Physician Decision|1
204525|NCT00307047|686208|P2|Overall Study|Withdrawal by Subject|6
204526|NCT00307047|686209|P1|Overall Study|Withdrawal by Subject|6
204527|NCT00307047|686208|P2|Overall Study|Lost to Follow-up|24
204528|NCT00307047|686209|P1|Overall Study|Lost to Follow-up|35
204529|NCT00307034|686347|P2|Overall Study|Lost to Follow-up|3
204530|NCT00307034|686348|P1|Overall Study|Lost to Follow-up|0
204531|NCT00307034|686347|P2|Overall Study|Withdrawal by Subject|2
204532|NCT00307034|686348|P1|Overall Study|Withdrawal by Subject|1
204533|NCT00307034|686347|P2|Overall Study|Adverse Event|2
204534|NCT00307034|686348|P1|Overall Study|Adverse Event|1
204535|NCT00306891|686399|P4|Part B|Development of study specific disc crit.|1
204536|NCT00306891|686400|P3|Part B|Development of study specific disc crit.|0
204537|NCT00306891|686401|P2|Part B|Development of study specific disc crit.|0
204538|NCT00306891|686402|P1|Part B|Development of study specific disc crit.|0
204539|NCT00306891|686399|P4|Part B|Condition under investigation worsened|8
204540|NCT00306891|686400|P3|Part B|Condition under investigation worsened|2
204541|NCT00306891|686401|P2|Part B|Condition under investigation worsened|0
204542|NCT00306891|686402|P1|Part B|Condition under investigation worsened|0
204543|NCT00306891|686399|P4|Part B|Withdrawal by Subject|1
204544|NCT00306891|686400|P3|Part B|Withdrawal by Subject|3
204545|NCT00306891|686401|P2|Part B|Withdrawal by Subject|0
204546|NCT00306891|686402|P1|Part B|Withdrawal by Subject|0
204547|NCT00306891|686399|P4|Part B|Adverse Event|5
204548|NCT00306891|686400|P3|Part B|Adverse Event|5
204549|NCT00306891|686401|P2|Part B|Adverse Event|0
204550|NCT00306891|686402|P1|Part B|Adverse Event|0
204551|NCT00306891|686399|P4|Part B|Death|2
204552|NCT00306891|686400|P3|Part B|Death|1
204553|NCT00306891|686401|P2|Part B|Death|0
204554|NCT00306891|686402|P1|Part B|Death|0
204555|NCT00306891|686399|P4|Part A|QTC interval outwith elig. criteria|0
204556|NCT00306891|686400|P3|Part A|QTC interval outwith elig. criteria|0
204557|NCT00306891|686401|P2|Part A|QTC interval outwith elig. criteria|0
204558|NCT00306891|686402|P1|Part A|QTC interval outwith elig. criteria|1
204559|NCT00306891|686399|P4|Part A|Suspicion of second malignancy|0
204560|NCT00306891|686400|P3|Part A|Suspicion of second malignancy|0
204561|NCT00306891|686401|P2|Part A|Suspicion of second malignancy|1
204562|NCT00306891|686402|P1|Part A|Suspicion of second malignancy|0
204563|NCT00306891|686399|P4|Part A|Reaccumul. of ascites following drainage|0
204564|NCT00306891|686400|P3|Part A|Reaccumul. of ascites following drainage|0
204565|NCT00306891|686401|P2|Part A|Reaccumul. of ascites following drainage|1
204566|NCT00306891|686402|P1|Part A|Reaccumul. of ascites following drainage|0
204567|NCT00306891|686399|P4|Part A|Partial bowel obstruction|0
204568|NCT00306891|686400|P3|Part A|Partial bowel obstruction|0
204569|NCT00306891|686401|P2|Part A|Partial bowel obstruction|0
204570|NCT00306891|686402|P1|Part A|Partial bowel obstruction|1
204571|NCT00306891|686399|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
204572|NCT00306891|686400|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
204573|NCT00306891|686401|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
204574|NCT00306891|686402|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
204575|NCT00306891|686399|P4|Part A|Condition under investigation worsened|0
204576|NCT00306891|686400|P3|Part A|Condition under investigation worsened|0
204577|NCT00306891|686401|P2|Part A|Condition under investigation worsened|2
204578|NCT00306891|686402|P1|Part A|Condition under investigation worsened|2
204579|NCT00306891|686399|P4|Part A|Withdrawal by Subject|0
204580|NCT00306891|686400|P3|Part A|Withdrawal by Subject|0
204581|NCT00306891|686401|P2|Part A|Withdrawal by Subject|1
204582|NCT00306891|686402|P1|Part A|Withdrawal by Subject|1
204583|NCT00306852|686425|P2|Overall Study|Lost to Follow-up|24
204584|NCT00306852|686426|P1|Overall Study|Lost to Follow-up|15
204585|NCT00306852|686425|P2|Overall Study|Death|14
204586|NCT00306852|686426|P1|Overall Study|Death|14
204587|NCT00306787|686444|P2|Overall Study|Abnormal laboratory value(s)|0
204588|NCT00306787|686445|P1|Overall Study|Abnormal laboratory value(s)|1
204589|NCT00306787|686444|P2|Overall Study|Administrative problems|0
204590|NCT00306787|686445|P1|Overall Study|Administrative problems|4
204591|NCT00306787|686444|P2|Overall Study|Lost to Follow-up|6
204592|NCT00306787|686445|P1|Overall Study|Lost to Follow-up|9
204593|NCT00306787|686444|P2|Overall Study|Withdrawal by Subject|9
204594|NCT00306787|686445|P1|Overall Study|Withdrawal by Subject|2
204595|NCT00306787|686444|P2|Overall Study|Protocol Violation|10
204596|NCT00306787|686445|P1|Overall Study|Protocol Violation|8
204597|NCT00306787|686444|P2|Overall Study|Lack of Efficacy|0
204598|NCT00306787|686445|P1|Overall Study|Lack of Efficacy|1
204599|NCT00306787|686444|P2|Overall Study|Adverse Event|1
204600|NCT00306787|686445|P1|Overall Study|Adverse Event|1
204601|NCT00306787|686444|P2|Overall Study|Discontinued without taking study drug|215
204602|NCT00306787|686445|P1|Overall Study|Discontinued without taking study drug|208
204603|NCT00306670|686463|P2|Overall Study|patients recruited; Genentech, the st|2
204604|NCT00306670|686464|P1|Overall Study|patients recruited; Genentech, the st|0
204605|NCT00306592|686470|P2|Overall Study|48-week Treatment Period Ongoing|20
204606|NCT00306592|686471|P1|Overall Study|48-week Treatment Period Ongoing|0
204607|NCT00306592|686470|P2|Overall Study|Other|2
204608|NCT00306592|686471|P1|Overall Study|Other|1
204609|NCT00306592|686470|P2|Overall Study|Not Specified|10
204610|NCT00306592|686471|P1|Overall Study|Not Specified|5
204611|NCT00306592|686470|P2|Overall Study|Voluntary|6
204612|NCT00306592|686471|P1|Overall Study|Voluntary|10
204613|NCT00306592|686470|P2|Overall Study|Persistent Antibodies|3
204614|NCT00306592|686471|P1|Overall Study|Persistent Antibodies|6
204615|NCT00306592|686470|P2|Overall Study|Noncompliance|2
204616|NCT00306592|686471|P1|Overall Study|Noncompliance|0
204617|NCT00306592|686470|P2|Overall Study|Lost to Follow-up|0
204618|NCT00306592|686471|P1|Overall Study|Lost to Follow-up|1
204619|NCT00306592|686470|P2|Overall Study|Adverse Event|15
204620|NCT00306592|686471|P1|Overall Study|Adverse Event|8
204621|NCT00306527|686481|P4|Overall Study|Death|2
204622|NCT00306527|686482|P3|Overall Study|Death|1
204623|NCT00306527|686483|P2|Overall Study|Death|0
204624|NCT00306527|686484|P1|Overall Study|Death|1
204625|NCT00306527|686481|P4|Overall Study|Adverse Event|1
204626|NCT00306527|686482|P3|Overall Study|Adverse Event|1
204627|NCT00306527|686483|P2|Overall Study|Adverse Event|0
204628|NCT00306527|686484|P1|Overall Study|Adverse Event|0
204629|NCT00306527|686481|P4|Overall Study|Withdrawal by Subject|3
204630|NCT00306527|686482|P3|Overall Study|Withdrawal by Subject|0
204631|NCT00306527|686483|P2|Overall Study|Withdrawal by Subject|3
204632|NCT00306527|686484|P1|Overall Study|Withdrawal by Subject|2
204633|NCT00306527|686481|P4|Overall Study|Lost to Follow-up|0
204634|NCT00306527|686482|P3|Overall Study|Lost to Follow-up|3
204635|NCT00306527|686483|P2|Overall Study|Lost to Follow-up|4
204636|NCT00306527|686484|P1|Overall Study|Lost to Follow-up|3
204637|NCT00306384|686553|P3|Overall Study|Site closure|0
204638|NCT00306384|686554|P2|Overall Study|Site closure|0
204639|NCT00306384|686555|P1|Overall Study|Site closure|2
204640|NCT00306384|686553|P3|Overall Study|Other|32
204641|NCT00306384|686554|P2|Overall Study|Other|70
204642|NCT00306384|686555|P1|Overall Study|Other|80
204643|NCT00306384|686553|P3|Overall Study|Investigator discretion|21
204644|NCT00306384|686554|P2|Overall Study|Investigator discretion|31
204645|NCT00306384|686555|P1|Overall Study|Investigator discretion|28
204646|NCT00306384|686553|P3|Overall Study|Lack of Efficacy|38
204647|NCT00306384|686554|P2|Overall Study|Lack of Efficacy|40
204648|NCT00306384|686555|P1|Overall Study|Lack of Efficacy|26
204649|NCT00306384|686553|P3|Overall Study|Pregnancy|1
204650|NCT00306384|686554|P2|Overall Study|Pregnancy|1
204651|NCT00306384|686555|P1|Overall Study|Pregnancy|3
204652|NCT00306384|686553|P3|Overall Study|Study termination|1
204653|NCT00306384|686554|P2|Overall Study|Study termination|0
204654|NCT00306384|686555|P1|Overall Study|Study termination|1
204655|NCT00306384|686553|P3|Overall Study|Voluntary withdrawal|91
204656|NCT00306384|686554|P2|Overall Study|Voluntary withdrawal|187
204657|NCT00306384|686555|P1|Overall Study|Voluntary withdrawal|199
204658|NCT00306384|686553|P3|Overall Study|Lost to Follow-up|35
204659|NCT00306384|686554|P2|Overall Study|Lost to Follow-up|41
204660|NCT00306384|686555|P1|Overall Study|Lost to Follow-up|57
204661|NCT00306384|686553|P3|Overall Study|Major protocol deviation|18
204662|NCT00306384|686554|P2|Overall Study|Major protocol deviation|51
204663|NCT00306384|686555|P1|Overall Study|Major protocol deviation|43
204664|NCT00306384|686553|P3|Overall Study|Adverse Event|40
204665|NCT00306384|686554|P2|Overall Study|Adverse Event|87
204666|NCT00306384|686555|P1|Overall Study|Adverse Event|103
204667|NCT00306293|686587|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
204668|NCT00306293|686588|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
204669|NCT00306293|686587|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
204670|NCT00306293|686588|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
204671|NCT00306293|686587|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
204672|NCT00306293|686588|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
204673|NCT00306293|686587|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
204674|NCT00306293|686588|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
204675|NCT00306293|686587|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
204676|NCT00306293|686588|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
204677|NCT00306293|686587|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
204678|NCT00306293|686588|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
204679|NCT00306293|686587|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
204680|NCT00306293|686588|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
204681|NCT00306293|686587|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
204682|NCT00306293|686588|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
204683|NCT00306202|686609|P3|Overall Study|Still on treatment|0
204684|NCT00306202|686610|P2|Overall Study|Still on treatment|1
204685|NCT00306202|686611|P1|Overall Study|Still on treatment|6
204686|NCT00306189|686771|P4|Overall Study|Other|0
204687|NCT00306189|686772|P3|Overall Study|Other|0
204688|NCT00306189|686773|P2|Overall Study|Other|0
204689|NCT00306189|686774|P1|Overall Study|Other|1
204690|NCT00306189|686771|P4|Overall Study|Ineligibility determined|1
204691|NCT00306189|686772|P3|Overall Study|Ineligibility determined|1
204692|NCT00306189|686773|P2|Overall Study|Ineligibility determined|1
204693|NCT00306189|686774|P1|Overall Study|Ineligibility determined|1
204694|NCT00306189|686771|P4|Overall Study|Withdrawal by Subject|1
204695|NCT00306189|686772|P3|Overall Study|Withdrawal by Subject|8
204696|NCT00306189|686773|P2|Overall Study|Withdrawal by Subject|2
204697|NCT00306189|686774|P1|Overall Study|Withdrawal by Subject|4
204698|NCT00306189|686771|P4|Overall Study|Adverse Event|2
204699|NCT00306189|686772|P3|Overall Study|Adverse Event|2
204700|NCT00306189|686773|P2|Overall Study|Adverse Event|3
204701|NCT00306189|686774|P1|Overall Study|Adverse Event|3
204702|NCT00306189|686771|P4|Overall Study|Physician Decision|1
204703|NCT00306189|686772|P3|Overall Study|Physician Decision|0
204704|NCT00306189|686773|P2|Overall Study|Physician Decision|0
204705|NCT00306189|686774|P1|Overall Study|Physician Decision|0
204706|NCT00305877|686801|P2|Overall Study|Transportation issue with daily RT|1
204707|NCT00305877|686802|P1|Overall Study|Transportation issue with daily RT|0
204708|NCT00305877|686801|P2|Overall Study|Ineligible|1
204709|NCT00305877|686802|P1|Overall Study|Ineligible|2
204710|NCT00305877|686801|P2|Overall Study|Never start treatment|5
204711|NCT00305877|686802|P1|Overall Study|Never start treatment|2
204712|NCT00305877|686801|P2|Overall Study|Physician Decision|1
204713|NCT00305877|686802|P1|Overall Study|Physician Decision|1
204714|NCT00305877|686801|P2|Overall Study|Withdrawal by Subject|2
204715|NCT00305877|686802|P1|Overall Study|Withdrawal by Subject|4
204716|NCT00305877|686801|P2|Overall Study|Death|1
204717|NCT00305877|686802|P1|Overall Study|Death|0
204718|NCT00305877|686801|P2|Overall Study|Adverse Event|14
204719|NCT00305877|686802|P1|Overall Study|Adverse Event|9
204720|NCT00305877|686801|P2|Overall Study|Lack of Efficacy|9
204721|NCT00305877|686802|P1|Overall Study|Lack of Efficacy|6
204722|NCT00305864|686816|P4|Overall Study|Ineligible / No protocol treatment|13
204723|NCT00305864|686817|P3|Overall Study|Ineligible / No protocol treatment|1
204724|NCT00305864|686818|P2|Overall Study|Ineligible / No protocol treatment|1
204725|NCT00305864|686819|P1|Overall Study|Ineligible / No protocol treatment|0
204726|NCT00305773|686832|P2|Overall Study|All other reasons|2
204727|NCT00305773|686833|P1|Overall Study|All other reasons|3
204728|NCT00305773|686832|P2|Overall Study|Disease Progression|3
204729|NCT00305773|686833|P1|Overall Study|Disease Progression|1
204730|NCT00305773|686832|P2|Overall Study|Withdrawal by Subject|4
204731|NCT00305773|686833|P1|Overall Study|Withdrawal by Subject|1
204732|NCT00305773|686832|P2|Overall Study|Physician Decision|1
204733|NCT00305773|686833|P1|Overall Study|Physician Decision|1
204734|NCT00305773|686832|P2|Overall Study|Alternative Treatment|4
204735|NCT00305773|686833|P1|Overall Study|Alternative Treatment|4
204736|NCT00305773|686832|P2|Overall Study|Adverse Event|2
204737|NCT00305773|686833|P1|Overall Study|Adverse Event|1
204738|NCT00305773|686832|P2|Overall Study|Death|2
204739|NCT00305773|686833|P1|Overall Study|Death|3
204740|NCT00305604|686864|P2|Overall Study|Patient moved|0
204741|NCT00305604|686865|P1|Overall Study|Patient moved|1
204742|NCT00305604|686864|P2|Overall Study|Withdrawal by Subject|21
204743|NCT00305604|686865|P1|Overall Study|Withdrawal by Subject|12
204744|NCT00305604|686864|P2|Overall Study|Protocol Violation|1
204745|NCT00305604|686865|P1|Overall Study|Protocol Violation|2
204746|NCT00305604|686864|P2|Overall Study|Lost to Follow-up|4
204747|NCT00305604|686865|P1|Overall Study|Lost to Follow-up|0
204748|NCT00305604|686864|P2|Overall Study|Lack of Efficacy|18
204749|NCT00305604|686865|P1|Overall Study|Lack of Efficacy|11
204750|NCT00305604|686864|P2|Overall Study|Adverse Event|3
204751|NCT00305604|686865|P1|Overall Study|Adverse Event|6
204752|NCT00305448|687009|P3|Overall Study|Tumor Marker Elevation|1
204753|NCT00305448|687010|P2|Overall Study|Tumor Marker Elevation|0
204754|NCT00305448|687011|P1|Overall Study|Tumor Marker Elevation|0
204755|NCT00305448|687009|P3|Overall Study|Subjective Disease Progression|2
204756|NCT00305448|687010|P2|Overall Study|Subjective Disease Progression|2
204757|NCT00305448|687011|P1|Overall Study|Subjective Disease Progression|1
204758|NCT00305448|687009|P3|Overall Study|Disease Progression|28
204759|NCT00305448|687010|P2|Overall Study|Disease Progression|31
204760|NCT00305448|687011|P1|Overall Study|Disease Progression|27
204761|NCT00305448|687009|P3|Overall Study|Adverse Event|1
204762|NCT00305448|687010|P2|Overall Study|Adverse Event|0
204763|NCT00305448|687011|P1|Overall Study|Adverse Event|1
204764|NCT00305448|687009|P3|Overall Study|Withdrawal by Subject|1
204765|NCT00305448|687010|P2|Overall Study|Withdrawal by Subject|0
204766|NCT00305448|687011|P1|Overall Study|Withdrawal by Subject|2
204767|NCT00305448|687009|P3|Overall Study|Protocol Violation|0
204768|NCT00305448|687010|P2|Overall Study|Protocol Violation|1
204769|NCT00305448|687011|P1|Overall Study|Protocol Violation|0
204770|NCT00305253|687033|P2|Overall Study|Withdrawal by Subject|1
204771|NCT00305253|687034|P1|Overall Study|Withdrawal by Subject|0
204772|NCT00305227|687046|P2|Overall Study|Lost to Follow-up|6
204773|NCT00305227|687047|P1|Overall Study|Lost to Follow-up|7
204774|NCT00304954|687098|P4|Overall Study|Adverse Event|0
204775|NCT00304954|687099|P3|Overall Study|Adverse Event|0
204776|NCT00304954|687100|P2|Overall Study|Adverse Event|0
204777|NCT00304954|687101|P1|Overall Study|Adverse Event|1
204778|NCT00304954|687098|P4|Overall Study|Withdrawal by Subject|0
204779|NCT00304954|687099|P3|Overall Study|Withdrawal by Subject|1
204780|NCT00304954|687100|P2|Overall Study|Withdrawal by Subject|0
204781|NCT00304954|687101|P1|Overall Study|Withdrawal by Subject|0
204782|NCT00304915|687121|P2|Overall Study|Withdrawal by Subject|0
204783|NCT00304915|687122|P1|Overall Study|Withdrawal by Subject|3
204784|NCT00304915|687121|P2|Overall Study|Death|5
204785|NCT00304915|687122|P1|Overall Study|Death|4
204786|NCT00304915|687121|P2|Overall Study|Lost to Follow-up|11
204787|NCT00304915|687122|P1|Overall Study|Lost to Follow-up|11
204788|NCT00304356|687148|P1|Nitazoxanide|Physician Decision|1
204789|NCT00304356|687148|P1|Nitazoxanide|Physician Decision|1
204790|NCT00304356|687148|P1|Nitazoxanide|Physician Decision|1
204791|NCT00304356|687148|P1|Nitazoxanide|number is 0|1
204792|NCT00304356|687148|P1|Nitazoxanide|Physician Decision|1
204793|NCT00304356|687148|P1|Nitazoxanide|Physician Decision|5
204794|NCT00304278|687152|P1|Overall Study|PT had medical condition preventing TX|1
204795|NCT00304278|687152|P1|Overall Study|lack of insurance coverage for chemoRT|1
204796|NCT00304083|687199|P2|Overall Study|Other|2
204797|NCT00304083|687200|P1|Overall Study|Other|5
204798|NCT00304083|687199|P2|Overall Study|Disease Progression|1
204799|NCT00304083|687200|P1|Overall Study|Disease Progression|5
204800|NCT00304083|687199|P2|Overall Study|Physician Decision|3
204801|NCT00304083|687200|P1|Overall Study|Physician Decision|8
204802|NCT00304083|687199|P2|Overall Study|Withdrawal by Subject|2
204803|NCT00304083|687200|P1|Overall Study|Withdrawal by Subject|4
204804|NCT00304070|687208|P3|Overall Study|Progressive Disease|4
204805|NCT00304070|687209|P2|Overall Study|Progressive Disease|7
204806|NCT00304070|687210|P1|Overall Study|Progressive Disease|3
204807|NCT00304070|687208|P3|Overall Study|Withdrawal by Subject|1
204808|NCT00304070|687209|P2|Overall Study|Withdrawal by Subject|0
204809|NCT00304070|687210|P1|Overall Study|Withdrawal by Subject|0
204810|NCT00304070|687208|P3|Overall Study|Physician Decision|3
204811|NCT00304070|687209|P2|Overall Study|Physician Decision|0
204812|NCT00304070|687210|P1|Overall Study|Physician Decision|0
204813|NCT00304070|687208|P3|Overall Study|Lost to Follow-up|1
204814|NCT00304070|687209|P2|Overall Study|Lost to Follow-up|0
204815|NCT00304070|687210|P1|Overall Study|Lost to Follow-up|0
204816|NCT00304070|687208|P3|Overall Study|Death|3
204817|NCT00304070|687209|P2|Overall Study|Death|0
204818|NCT00304070|687210|P1|Overall Study|Death|0
204819|NCT00304031|687225|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
204820|NCT00304031|687226|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
204821|NCT00304031|687227|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
204822|NCT00304031|687225|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
204823|NCT00304031|687226|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
204824|NCT00304031|687227|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
204825|NCT00304031|687225|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
204826|NCT00304031|687226|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
204827|NCT00304031|687227|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
204828|NCT00304031|687225|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
204829|NCT00304031|687226|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
204830|NCT00304031|687227|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
204831|NCT00304031|687225|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
204832|NCT00304031|687226|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
204833|NCT00304031|687227|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
204834|NCT00304031|687225|P3|Concomitant Radiation Therapy and TMZ|Death|0
204835|NCT00304031|687226|P2|Concomitant Radiation Therapy and TMZ|Death|0
204836|NCT00304031|687227|P1|Concomitant Radiation Therapy and TMZ|Death|18
204837|NCT00304031|687225|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
204838|NCT00304031|687226|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
205007|NCT00303329|687547|P1|Overall Study|Protocol Violation|3
204839|NCT00304031|687227|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
204840|NCT00304031|687225|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
204841|NCT00304031|687226|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
204842|NCT00304031|687227|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
204843|NCT00304031|687225|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
204844|NCT00304031|687226|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
204845|NCT00304031|687227|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
204846|NCT00304031|687225|P3|Registration|Ineligible|0
204847|NCT00304031|687226|P2|Registration|Ineligible|0
204848|NCT00304031|687227|P1|Registration|Ineligible|48
204849|NCT00303953|687258|P1|Overall Study|Physician Decision|1
204850|NCT00303953|687258|P1|Overall Study|Lack of Efficacy|12
204851|NCT00303953|687258|P1|Overall Study|Adverse Event|4
204852|NCT00303953|687258|P1|Overall Study|Death|1
204853|NCT00303953|687258|P1|Overall Study|Ineligible|1
204854|NCT00303667|687293|P2|Overall Study|Death|4
204855|NCT00303667|687294|P1|Overall Study|Death|0
204856|NCT00303628|687318|P2|Overall Study|Other|9
204857|NCT00303628|687319|P1|Overall Study|Other|8
204858|NCT00303628|687318|P2|Overall Study|Not start protocol therapy|5
204859|NCT00303628|687319|P1|Overall Study|Not start protocol therapy|3
204860|NCT00303628|687318|P2|Overall Study|Other complicating disease|1
204861|NCT00303628|687319|P1|Overall Study|Other complicating disease|0
204862|NCT00303628|687318|P2|Overall Study|Alternative therapy|0
204863|NCT00303628|687319|P1|Overall Study|Alternative therapy|2
204864|NCT00303628|687318|P2|Overall Study|Withdrawal by Subject|20
204865|NCT00303628|687319|P1|Overall Study|Withdrawal by Subject|11
204866|NCT00303628|687318|P2|Overall Study|Death|1
204867|NCT00303628|687319|P1|Overall Study|Death|0
204868|NCT00303628|687318|P2|Overall Study|Adverse Event|36
204869|NCT00303628|687319|P1|Overall Study|Adverse Event|26
204870|NCT00303628|687318|P2|Overall Study|Disease progression|1
204871|NCT00303628|687319|P1|Overall Study|Disease progression|0
204872|NCT00303602|687337|P2|Overall Study|Protocol Violation|0
204873|NCT00303602|687338|P1|Overall Study|Protocol Violation|1
204874|NCT00303602|687337|P2|Overall Study|Noncompliance|2
204875|NCT00303602|687338|P1|Overall Study|Noncompliance|2
204876|NCT00303602|687337|P2|Overall Study|Physician Decision|1
204877|NCT00303602|687338|P1|Overall Study|Physician Decision|2
204878|NCT00303602|687337|P2|Overall Study|Protocol entry criteria not met|2
204879|NCT00303602|687338|P1|Overall Study|Protocol entry criteria not met|2
204880|NCT00303602|687337|P2|Overall Study|Lost to Follow-up|2
204881|NCT00303602|687338|P1|Overall Study|Lost to Follow-up|5
204882|NCT00303602|687337|P2|Overall Study|Withdrawal by Subject|6
204883|NCT00303602|687338|P1|Overall Study|Withdrawal by Subject|5
204884|NCT00303602|687337|P2|Overall Study|Adverse Event|2
204885|NCT00303602|687338|P1|Overall Study|Adverse Event|2
204886|NCT00303485|687384|P2|Overall Study|Withdrawal by Subject|0
204887|NCT00303485|687385|P1|Overall Study|Withdrawal by Subject|1
204888|NCT00303485|687384|P2|Overall Study|Failure to return|1
204889|NCT00303485|687385|P1|Overall Study|Failure to return|0
204890|NCT00303485|687384|P2|Overall Study|Adverse Event/Intercurrent Illness|1
204891|NCT00303485|687385|P1|Overall Study|Adverse Event/Intercurrent Illness|0
204892|NCT00303472|687416|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
204893|NCT00303472|687417|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
204894|NCT00303472|687418|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
204895|NCT00303472|687419|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
204896|NCT00303472|687420|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
204897|NCT00303472|687421|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
204898|NCT00303472|687422|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
204899|NCT00303472|687416|P7|Treatment Extension (Optional)|Not specified|0
204900|NCT00303472|687417|P6|Treatment Extension (Optional)|Not specified|0
204901|NCT00303472|687418|P5|Treatment Extension (Optional)|Not specified|1
204902|NCT00303472|687419|P4|Treatment Extension (Optional)|Not specified|2
204903|NCT00303472|687420|P3|Treatment Extension (Optional)|Not specified|4
204904|NCT00303472|687421|P2|Treatment Extension (Optional)|Not specified|2
204905|NCT00303472|687422|P1|Treatment Extension (Optional)|Not specified|0
204906|NCT00303472|687416|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
204907|NCT00303472|687417|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
204908|NCT00303472|687418|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
204909|NCT00303472|687419|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
204910|NCT00303472|687420|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
204911|NCT00303472|687421|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
204912|NCT00303472|687422|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
204913|NCT00303472|687416|P7|Treatment Extension (Optional)|Physician Decision|0
204914|NCT00303472|687417|P6|Treatment Extension (Optional)|Physician Decision|0
204915|NCT00303472|687418|P5|Treatment Extension (Optional)|Physician Decision|2
204916|NCT00303472|687419|P4|Treatment Extension (Optional)|Physician Decision|3
204917|NCT00303472|687420|P3|Treatment Extension (Optional)|Physician Decision|2
204918|NCT00303472|687421|P2|Treatment Extension (Optional)|Physician Decision|4
204919|NCT00303472|687422|P1|Treatment Extension (Optional)|Physician Decision|0
204920|NCT00303472|687416|P7|Treatment Extension (Optional)|Lost to Follow-up|0
204921|NCT00303472|687417|P6|Treatment Extension (Optional)|Lost to Follow-up|0
204922|NCT00303472|687418|P5|Treatment Extension (Optional)|Lost to Follow-up|0
204923|NCT00303472|687419|P4|Treatment Extension (Optional)|Lost to Follow-up|1
204924|NCT00303472|687420|P3|Treatment Extension (Optional)|Lost to Follow-up|0
204925|NCT00303472|687421|P2|Treatment Extension (Optional)|Lost to Follow-up|0
204926|NCT00303472|687422|P1|Treatment Extension (Optional)|Lost to Follow-up|0
204927|NCT00303472|687416|P7|Treatment Extension (Optional)|Death|0
204928|NCT00303472|687417|P6|Treatment Extension (Optional)|Death|0
204929|NCT00303472|687418|P5|Treatment Extension (Optional)|Death|0
204930|NCT00303472|687419|P4|Treatment Extension (Optional)|Death|0
204931|NCT00303472|687420|P3|Treatment Extension (Optional)|Death|1
204932|NCT00303472|687421|P2|Treatment Extension (Optional)|Death|0
204933|NCT00303472|687422|P1|Treatment Extension (Optional)|Death|2
204934|NCT00303472|687416|P7|Treatment Extension (Optional)|Adverse Event|0
204935|NCT00303472|687417|P6|Treatment Extension (Optional)|Adverse Event|0
204936|NCT00303472|687418|P5|Treatment Extension (Optional)|Adverse Event|0
204937|NCT00303472|687419|P4|Treatment Extension (Optional)|Adverse Event|0
204938|NCT00303472|687420|P3|Treatment Extension (Optional)|Adverse Event|1
204939|NCT00303472|687421|P2|Treatment Extension (Optional)|Adverse Event|0
204940|NCT00303472|687422|P1|Treatment Extension (Optional)|Adverse Event|1
204941|NCT00303472|687416|P7|Treatment Period|Disease Progression (to AML)|0
204942|NCT00303472|687417|P6|Treatment Period|Disease Progression (to AML)|0
204943|NCT00303472|687418|P5|Treatment Period|Disease Progression (to AML)|1
204944|NCT00303472|687419|P4|Treatment Period|Disease Progression (to AML)|0
204945|NCT00303472|687420|P3|Treatment Period|Disease Progression (to AML)|0
204946|NCT00303472|687421|P2|Treatment Period|Disease Progression (to AML)|0
204947|NCT00303472|687422|P1|Treatment Period|Disease Progression (to AML)|0
204948|NCT00303472|687416|P7|Treatment Period|Not specified|1
204949|NCT00303472|687417|P6|Treatment Period|Not specified|0
204950|NCT00303472|687418|P5|Treatment Period|Not specified|1
204951|NCT00303472|687419|P4|Treatment Period|Not specified|0
204952|NCT00303472|687420|P3|Treatment Period|Not specified|0
204953|NCT00303472|687421|P2|Treatment Period|Not specified|0
204954|NCT00303472|687422|P1|Treatment Period|Not specified|0
204955|NCT00303472|687416|P7|Treatment Period|Withdrawal by Subject|0
204956|NCT00303472|687417|P6|Treatment Period|Withdrawal by Subject|1
204957|NCT00303472|687418|P5|Treatment Period|Withdrawal by Subject|0
204958|NCT00303472|687419|P4|Treatment Period|Withdrawal by Subject|1
204959|NCT00303472|687420|P3|Treatment Period|Withdrawal by Subject|0
204960|NCT00303472|687421|P2|Treatment Period|Withdrawal by Subject|0
204961|NCT00303472|687422|P1|Treatment Period|Withdrawal by Subject|0
204962|NCT00303472|687416|P7|Treatment Period|Death|1
204963|NCT00303472|687417|P6|Treatment Period|Death|0
204964|NCT00303472|687418|P5|Treatment Period|Death|0
204965|NCT00303472|687419|P4|Treatment Period|Death|1
204966|NCT00303472|687420|P3|Treatment Period|Death|0
204967|NCT00303472|687421|P2|Treatment Period|Death|0
204968|NCT00303472|687422|P1|Treatment Period|Death|0
204969|NCT00303472|687416|P7|Treatment Period|Adverse Event|0
204970|NCT00303472|687417|P6|Treatment Period|Adverse Event|0
204971|NCT00303472|687418|P5|Treatment Period|Adverse Event|1
204972|NCT00303472|687419|P4|Treatment Period|Adverse Event|0
204973|NCT00303472|687420|P3|Treatment Period|Adverse Event|0
204974|NCT00303472|687421|P2|Treatment Period|Adverse Event|0
204975|NCT00303472|687422|P1|Treatment Period|Adverse Event|0
204976|NCT00303459|687482|P2|Overall Study|Lung transplantation|1
204977|NCT00303459|687483|P1|Overall Study|Lung transplantation|1
204978|NCT00303459|687482|P2|Overall Study|Decision by the investigator|7
204979|NCT00303459|687483|P1|Overall Study|Decision by the investigator|5
204980|NCT00303459|687482|P2|Overall Study|Administrative reason|7
204981|NCT00303459|687483|P1|Overall Study|Administrative reason|7
204982|NCT00303459|687482|P2|Overall Study|Lost to Follow-up|4
204983|NCT00303459|687483|P1|Overall Study|Lost to Follow-up|5
204984|NCT00303459|687482|P2|Overall Study|Withdrawal of consent|26
204985|NCT00303459|687483|P1|Overall Study|Withdrawal of consent|32
204986|NCT00303459|687482|P2|Overall Study|Death|44
204987|NCT00303459|687483|P1|Overall Study|Death|33
204988|NCT00303446|687509|P2|Overall Study|Physician Decision|1
204989|NCT00303446|687510|P1|Overall Study|Physician Decision|0
204990|NCT00303446|687509|P2|Overall Study|Death|1
204991|NCT00303446|687510|P1|Overall Study|Death|0
204992|NCT00303446|687509|P2|Overall Study|Withdrawal by Subject|2
204993|NCT00303446|687510|P1|Overall Study|Withdrawal by Subject|2
204994|NCT00303329|687546|P2|Overall Study|Stopped at end of extension 1|0
204995|NCT00303329|687547|P1|Overall Study|Stopped at end of extension 1|1
204996|NCT00303329|687546|P2|Overall Study|Stopped at end of core|9
204997|NCT00303329|687547|P1|Overall Study|Stopped at end of core|3
204998|NCT00303329|687546|P2|Overall Study|Death|12
204999|NCT00303329|687547|P1|Overall Study|Death|2
205000|NCT00303329|687546|P2|Overall Study|Administrative problems|0
205001|NCT00303329|687547|P1|Overall Study|Administrative problems|1
205002|NCT00303329|687546|P2|Overall Study|Lost to Follow-up|1
205003|NCT00303329|687547|P1|Overall Study|Lost to Follow-up|0
205004|NCT00303329|687546|P2|Overall Study|Withdrawal by Subject|15
205005|NCT00303329|687547|P1|Overall Study|Withdrawal by Subject|9
205006|NCT00303329|687546|P2|Overall Study|Protocol Violation|0
205008|NCT00303329|687546|P2|Overall Study|Condition no longer requires study drug|8
205009|NCT00303329|687547|P1|Overall Study|Condition no longer requires study drug|0
205010|NCT00303329|687546|P2|Overall Study|Unsatisfactory therapeutic effect|2
205011|NCT00303329|687547|P1|Overall Study|Unsatisfactory therapeutic effect|9
205012|NCT00303329|687546|P2|Overall Study|Abnormal Laboratory Values|1
205013|NCT00303329|687547|P1|Overall Study|Abnormal Laboratory Values|0
205014|NCT00303329|687546|P2|Overall Study|Adverse Event|14
205015|NCT00303329|687547|P1|Overall Study|Adverse Event|7
205016|NCT00303316|687561|P2|Overall Study|Withdrawal by Subject|2
205017|NCT00303316|687562|P1|Overall Study|Withdrawal by Subject|1
205018|NCT00303316|687561|P2|Overall Study|Lost to Follow-up|1
205019|NCT00303316|687562|P1|Overall Study|Lost to Follow-up|0
205020|NCT00303316|687561|P2|Overall Study|Protocol Violation|0
205021|NCT00303316|687562|P1|Overall Study|Protocol Violation|1
205022|NCT00303186|687574|P1|Overall Study|Other|52
205023|NCT00303108|687608|P3|Overall Study|ineligible|0
205024|NCT00303108|687609|P2|Overall Study|ineligible|1
205025|NCT00303108|687610|P1|Overall Study|ineligible|2
205026|NCT00303108|687608|P3|Overall Study|Failed Entry|1
205027|NCT00303108|687609|P2|Overall Study|Failed Entry|0
205028|NCT00303108|687610|P1|Overall Study|Failed Entry|1
205029|NCT00303108|687608|P3|Overall Study|Patient Request|8
205030|NCT00303108|687609|P2|Overall Study|Patient Request|2
205031|NCT00303108|687610|P1|Overall Study|Patient Request|4
205032|NCT00303108|687608|P3|Overall Study|Adverse Event|7
205033|NCT00303108|687609|P2|Overall Study|Adverse Event|6
205034|NCT00303108|687610|P1|Overall Study|Adverse Event|5
205035|NCT00303069|687630|P4|Overall Study|Recruitment into Army Reserves|0
205036|NCT00303069|687631|P3|Overall Study|Recruitment into Army Reserves|1
205037|NCT00303069|687632|P2|Overall Study|Recruitment into Army Reserves|0
205038|NCT00303069|687633|P1|Overall Study|Recruitment into Army Reserves|0
205039|NCT00303069|687630|P4|Overall Study|subject moved|0
205040|NCT00303069|687631|P3|Overall Study|subject moved|0
205041|NCT00303069|687632|P2|Overall Study|subject moved|0
205042|NCT00303069|687633|P1|Overall Study|subject moved|1
205043|NCT00303069|687630|P4|Overall Study|Lost to Follow-up|2
205044|NCT00303069|687631|P3|Overall Study|Lost to Follow-up|0
205045|NCT00303069|687632|P2|Overall Study|Lost to Follow-up|0
205046|NCT00303069|687633|P1|Overall Study|Lost to Follow-up|1
205047|NCT00302952|687653|P2|Overall Study|Elevated SGOT (AST) lab value|1
205048|NCT00302952|687654|P1|Overall Study|Elevated SGOT (AST) lab value|0
205049|NCT00302952|687653|P2|Overall Study|Withdrawal by Subject|3
205050|NCT00302952|687654|P1|Overall Study|Withdrawal by Subject|2
205051|NCT00302952|687653|P2|Overall Study|Physician Decision|1
205052|NCT00302952|687654|P1|Overall Study|Physician Decision|1
205053|NCT00302731|687704|P4|Overall Study|cancer unrelated to study discovered|0
205054|NCT00302731|687705|P3|Overall Study|cancer unrelated to study discovered|1
205055|NCT00302731|687706|P2|Overall Study|cancer unrelated to study discovered|0
205056|NCT00302731|687707|P1|Overall Study|cancer unrelated to study discovered|1
205057|NCT00302731|687704|P4|Overall Study|Protocol Violation|0
205058|NCT00302731|687705|P3|Overall Study|Protocol Violation|0
205059|NCT00302731|687706|P2|Overall Study|Protocol Violation|0
205060|NCT00302731|687707|P1|Overall Study|Protocol Violation|1
205061|NCT00302731|687704|P4|Overall Study|Withdrawal by Subject|0
205062|NCT00302731|687705|P3|Overall Study|Withdrawal by Subject|0
205063|NCT00302731|687706|P2|Overall Study|Withdrawal by Subject|1
205064|NCT00302731|687707|P1|Overall Study|Withdrawal by Subject|1
205065|NCT00302731|687704|P4|Overall Study|Adverse Event|0
205066|NCT00302731|687705|P3|Overall Study|Adverse Event|2
205067|NCT00302731|687706|P2|Overall Study|Adverse Event|2
205068|NCT00302731|687707|P1|Overall Study|Adverse Event|0
205069|NCT00302731|687704|P4|Overall Study|Lost to Follow-up|0
205070|NCT00302731|687705|P3|Overall Study|Lost to Follow-up|0
205071|NCT00302731|687706|P2|Overall Study|Lost to Follow-up|2
205072|NCT00302731|687707|P1|Overall Study|Lost to Follow-up|1
205073|NCT00302718|687733|P4|Overall Study|Participant left primary care setting|1
205074|NCT00302718|687734|P3|Overall Study|Participant left primary care setting|2
205075|NCT00302718|687735|P2|Overall Study|Participant left primary care setting|0
205076|NCT00302718|687736|P1|Overall Study|Participant left primary care setting|0
205077|NCT00302718|687733|P4|Overall Study|Withdrawal by Subject|0
205078|NCT00302718|687734|P3|Overall Study|Withdrawal by Subject|0
205079|NCT00302718|687735|P2|Overall Study|Withdrawal by Subject|1
205080|NCT00302718|687736|P1|Overall Study|Withdrawal by Subject|0
205081|NCT00302718|687733|P4|Overall Study|Participant left the hospital|1
205082|NCT00302718|687734|P3|Overall Study|Participant left the hospital|0
205083|NCT00302718|687735|P2|Overall Study|Participant left the hospital|0
205084|NCT00302718|687736|P1|Overall Study|Participant left the hospital|1
205085|NCT00302458|687768|P1|Overall Study|Withdrawal by Subject|1
205086|NCT00302458|687768|P1|Overall Study|Ineligible after screening|1
205087|NCT00302458|687768|P1|Overall Study|Lost to Follow-up|1
205088|NCT00302328|687779|P3|Overall Study|Physician Decision|0
205089|NCT00302328|687780|P2|Overall Study|Physician Decision|1
205090|NCT00302328|687781|P1|Overall Study|Physician Decision|0
205091|NCT00302211|687798|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
205092|NCT00302211|687799|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
205167|NCT00302081|687847|P2|Overall Study|Death|1
205093|NCT00302211|687800|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
205094|NCT00302211|687801|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
205095|NCT00302211|687802|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
205096|NCT00302211|687798|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
205097|NCT00302211|687799|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
205098|NCT00302211|687800|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
205099|NCT00302211|687801|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
205100|NCT00302211|687802|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
205101|NCT00302211|687798|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
205102|NCT00302211|687799|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
205103|NCT00302211|687800|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
205104|NCT00302211|687801|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
205105|NCT00302211|687802|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
205106|NCT00302211|687798|P5|Open Label-Patients From Double-Blind|Death|1
205107|NCT00302211|687799|P4|Open Label-Patients From Double-Blind|Death|1
205108|NCT00302211|687800|P3|Open Label-Patients From Double-Blind|Death|0
205109|NCT00302211|687801|P2|Open Label-Patients From Double-Blind|Death|0
205110|NCT00302211|687802|P1|Open Label-Patients From Double-Blind|Death|0
205111|NCT00302211|687798|P5|Open Label-Patients From Double-Blind|Disease progression|2
205112|NCT00302211|687799|P4|Open Label-Patients From Double-Blind|Disease progression|1
205113|NCT00302211|687800|P3|Open Label-Patients From Double-Blind|Disease progression|0
205114|NCT00302211|687801|P2|Open Label-Patients From Double-Blind|Disease progression|0
205115|NCT00302211|687802|P1|Open Label-Patients From Double-Blind|Disease progression|0
205116|NCT00302211|687798|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
205117|NCT00302211|687799|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
205118|NCT00302211|687800|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
205119|NCT00302211|687801|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
205120|NCT00302211|687802|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
205121|NCT00302211|687798|P5|Open Label-Patients From Double-Blind|Adverse Event|0
205122|NCT00302211|687799|P4|Open Label-Patients From Double-Blind|Adverse Event|1
205123|NCT00302211|687800|P3|Open Label-Patients From Double-Blind|Adverse Event|0
205124|NCT00302211|687801|P2|Open Label-Patients From Double-Blind|Adverse Event|0
205125|NCT00302211|687802|P1|Open Label-Patients From Double-Blind|Adverse Event|0
205126|NCT00302211|687798|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
205127|NCT00302211|687799|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
205128|NCT00302211|687800|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
205129|NCT00302211|687801|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
205130|NCT00302211|687802|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
205131|NCT00302211|687798|P5|Double Blind Period (New Patients)|Disease progression|0
205132|NCT00302211|687799|P4|Double Blind Period (New Patients)|Disease progression|0
205133|NCT00302211|687800|P3|Double Blind Period (New Patients)|Disease progression|1
205134|NCT00302211|687801|P2|Double Blind Period (New Patients)|Disease progression|1
205135|NCT00302211|687802|P1|Double Blind Period (New Patients)|Disease progression|0
205136|NCT00302211|687798|P5|Double Blind Period (New Patients)|Investigator's judgement|0
205137|NCT00302211|687799|P4|Double Blind Period (New Patients)|Investigator's judgement|0
205138|NCT00302211|687800|P3|Double Blind Period (New Patients)|Investigator's judgement|0
205139|NCT00302211|687801|P2|Double Blind Period (New Patients)|Investigator's judgement|0
205140|NCT00302211|687802|P1|Double Blind Period (New Patients)|Investigator's judgement|1
205141|NCT00302211|687798|P5|Double Blind Period (New Patients)|Adverse Event|0
205142|NCT00302211|687799|P4|Double Blind Period (New Patients)|Adverse Event|0
205143|NCT00302211|687800|P3|Double Blind Period (New Patients)|Adverse Event|3
205144|NCT00302211|687801|P2|Double Blind Period (New Patients)|Adverse Event|0
205145|NCT00302211|687802|P1|Double Blind Period (New Patients)|Adverse Event|0
205146|NCT00302211|687798|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
205147|NCT00302211|687799|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
205148|NCT00302211|687800|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
205149|NCT00302211|687801|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
205150|NCT00302211|687802|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
205151|NCT00302159|687814|P1|Overall Study|pt started Avastin|1
205152|NCT00302159|687814|P1|Overall Study|pt declined before treatment started|1
205153|NCT00302107|687836|P2|Overall Study|Adverse Event|0
205154|NCT00302107|687837|P1|Overall Study|Adverse Event|1
205155|NCT00302107|687836|P2|Overall Study|Withdrawal by Subject|3
205156|NCT00302107|687837|P1|Overall Study|Withdrawal by Subject|0
205157|NCT00302107|687836|P2|Overall Study|Relocation|1
205158|NCT00302107|687837|P1|Overall Study|Relocation|0
205159|NCT00302107|687836|P2|Overall Study|Protocol Violation|0
205160|NCT00302107|687837|P1|Overall Study|Protocol Violation|1
205161|NCT00302107|687836|P2|Overall Study|Lost to Follow-up|5
205162|NCT00302107|687837|P1|Overall Study|Lost to Follow-up|6
205163|NCT00302081|687846|P3|Overall Study|Other|5
205164|NCT00302081|687847|P2|Overall Study|Other|6
205165|NCT00302081|687848|P1|Overall Study|Other|13
205166|NCT00302081|687846|P3|Overall Study|Death|0
205168|NCT00302081|687848|P1|Overall Study|Death|2
205169|NCT00302081|687846|P3|Overall Study|Lack of Efficacy|5
205170|NCT00302081|687847|P2|Overall Study|Lack of Efficacy|0
205171|NCT00302081|687848|P1|Overall Study|Lack of Efficacy|1
205172|NCT00302081|687846|P3|Overall Study|Protocol Violation|2
205173|NCT00302081|687847|P2|Overall Study|Protocol Violation|1
205174|NCT00302081|687848|P1|Overall Study|Protocol Violation|5
205175|NCT00302081|687846|P3|Overall Study|Withdrawal by Subject|8
205176|NCT00302081|687847|P2|Overall Study|Withdrawal by Subject|12
205177|NCT00302081|687848|P1|Overall Study|Withdrawal by Subject|8
205178|NCT00302081|687846|P3|Overall Study|Lost to Follow-up|28
205179|NCT00302081|687847|P2|Overall Study|Lost to Follow-up|18
205180|NCT00302081|687848|P1|Overall Study|Lost to Follow-up|21
205181|NCT00302081|687846|P3|Overall Study|Adverse Event|4
205182|NCT00302081|687847|P2|Overall Study|Adverse Event|5
205183|NCT00302081|687848|P1|Overall Study|Adverse Event|6
205184|NCT00302003|687905|P1|Overall Study|Protocol Violation|1
205185|NCT00302003|687905|P1|Overall Study|Ineligible|9
205186|NCT00302003|687905|P1|Overall Study|Withdrawal by Subject|5
205187|NCT00302003|687905|P1|Overall Study|Physician Decision|2
205188|NCT00302003|687905|P1|Overall Study|Lost to Follow-up|1
205189|NCT00302003|687905|P1|Overall Study|Lack of Efficacy|62
205190|NCT00301964|687912|P1|Overall Study|Inadequate pathology|1
205191|NCT00301964|687912|P1|Overall Study|Wrong primary|1
205192|NCT00301964|687912|P1|Overall Study|Second primary|2
205193|NCT00301834|687933|P1|Overall Study|Death|1
205194|NCT00301821|687942|P1|Overall Study|Cancel|1
205195|NCT00301821|687942|P1|Overall Study|Ineligible|25
205196|NCT00301808|687949|P1|Overall Study|Lack of Efficacy|4
205197|NCT00301808|687949|P1|Overall Study|Death|3
205198|NCT00301808|687949|P1|Overall Study|Adverse Event|5
205199|NCT00301366|687971|P1|Overall Study|Adverse Event|1
205200|NCT00301262|687977|P2|Open Label Phase (OL)|Other|0
205201|NCT00301262|687978|P1|Open Label Phase (OL)|Other|2
205202|NCT00301262|687977|P2|Open Label Phase (OL)|Lost to Follow-up|2
205203|NCT00301262|687978|P1|Open Label Phase (OL)|Lost to Follow-up|1
205204|NCT00301262|687977|P2|Open Label Phase (OL)|Adverse Event|0
205205|NCT00301262|687978|P1|Open Label Phase (OL)|Adverse Event|1
205206|NCT00301262|687977|P2|Double Blind Phase (DB)|Other|4
205207|NCT00301262|687978|P1|Double Blind Phase (DB)|Other|1
205208|NCT00301262|687977|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
205209|NCT00301262|687978|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
205210|NCT00301262|687977|P2|Double Blind Phase (DB)|Lost to Follow-up|3
205211|NCT00301262|687978|P1|Double Blind Phase (DB)|Lost to Follow-up|3
205212|NCT00301262|687977|P2|Double Blind Phase (DB)|Lack of Efficacy|1
205213|NCT00301262|687978|P1|Double Blind Phase (DB)|Lack of Efficacy|0
205214|NCT00301262|687977|P2|Double Blind Phase (DB)|Adverse Event|0
205215|NCT00301262|687978|P1|Double Blind Phase (DB)|Adverse Event|1
205216|NCT00301080|688136|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
205217|NCT00301080|688137|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
205218|NCT00301080|688138|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
205219|NCT00301080|688139|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
205220|NCT00301080|688140|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
205221|NCT00300885|688175|P2|Follow-up|Withdrawal by Subject|25
205222|NCT00300885|688176|P1|Follow-up|Withdrawal by Subject|26
205223|NCT00300885|688175|P2|Follow-up|Lost to Follow-up|7
205224|NCT00300885|688176|P1|Follow-up|Lost to Follow-up|11
205225|NCT00300885|688175|P2|Follow-up|Death|163
205226|NCT00300885|688176|P1|Follow-up|Death|141
205227|NCT00300885|688175|P2|Treatment|Non-compliant with study medication|4
205228|NCT00300885|688176|P1|Treatment|Non-compliant with study medication|3
205229|NCT00300885|688175|P2|Treatment|Random code broken (subject died)|1
205230|NCT00300885|688176|P1|Treatment|Random code broken (subject died)|0
205231|NCT00300885|688175|P2|Treatment|Disease progression|238
205232|NCT00300885|688176|P1|Treatment|Disease progression|171
205233|NCT00300885|688175|P2|Treatment|Withdrawal by Subject|23
205234|NCT00300885|688176|P1|Treatment|Withdrawal by Subject|26
205235|NCT00300885|688175|P2|Treatment|Protocol Violation|11
205236|NCT00300885|688176|P1|Treatment|Protocol Violation|11
205237|NCT00300885|688175|P2|Treatment|Physician Decision|5
205238|NCT00300885|688176|P1|Treatment|Physician Decision|4
205239|NCT00300885|688175|P2|Treatment|Lost to Follow-up|2
205240|NCT00300885|688176|P1|Treatment|Lost to Follow-up|3
205241|NCT00300885|688175|P2|Treatment|Lack of Efficacy|1
205242|NCT00300885|688176|P1|Treatment|Lack of Efficacy|1
205243|NCT00300885|688175|P2|Treatment|Death|7
205244|NCT00300885|688176|P1|Treatment|Death|20
205245|NCT00300885|688175|P2|Treatment|Adverse Event|82
205246|NCT00300885|688176|P1|Treatment|Adverse Event|134
205247|NCT00300781|688194|P2|Overall Study|Lost to Follow-up|1
205248|NCT00300781|688195|P1|Overall Study|Lost to Follow-up|0
205249|NCT00300781|688194|P2|Overall Study|Symptomatic Deterioration|0
205250|NCT00300781|688195|P1|Overall Study|Symptomatic Deterioration|1
205251|NCT00300781|688194|P2|Overall Study|Not Recorded|1
205252|NCT00300781|688195|P1|Overall Study|Not Recorded|0
205253|NCT00300781|688194|P2|Overall Study|Physician Decision|0
205254|NCT00300781|688195|P1|Overall Study|Physician Decision|1
205255|NCT00300781|688194|P2|Overall Study|Withdrawal by Subject|2
205256|NCT00300781|688195|P1|Overall Study|Withdrawal by Subject|1
205257|NCT00300781|688194|P2|Overall Study|Adverse Event|6
205258|NCT00300781|688195|P1|Overall Study|Adverse Event|5
205259|NCT00300781|688194|P2|Overall Study|Disease Progression|52
205260|NCT00300781|688195|P1|Overall Study|Disease Progression|55
205261|NCT00300755|688210|P3|Overall Study|Protocol Violation|1
205262|NCT00300755|688211|P2|Overall Study|Protocol Violation|0
205263|NCT00300755|688212|P1|Overall Study|Protocol Violation|0
205264|NCT00300755|688210|P3|Overall Study|Withdrawal by Subject|0
205265|NCT00300755|688211|P2|Overall Study|Withdrawal by Subject|2
205266|NCT00300755|688212|P1|Overall Study|Withdrawal by Subject|0
205267|NCT00300755|688210|P3|Overall Study|Adverse Event|1
205268|NCT00300755|688211|P2|Overall Study|Adverse Event|2
205269|NCT00300755|688212|P1|Overall Study|Adverse Event|1
205270|NCT00300495|688246|P2|Overall Study|Protocol Violation|1
205271|NCT00300495|688247|P1|Overall Study|Protocol Violation|4
205272|NCT00300365|688514|P2|Overall Study|Adverse Event|2
205273|NCT00300365|688515|P1|Overall Study|Adverse Event|0
205274|NCT00300365|688514|P2|Overall Study|Withdrawal by Subject|0
205275|NCT00300365|688515|P1|Overall Study|Withdrawal by Subject|1
205276|NCT00300365|688514|P2|Overall Study|Physician Decision|0
205277|NCT00300365|688515|P1|Overall Study|Physician Decision|2
205278|NCT00300365|688514|P2|Overall Study|Lost to Follow-up|0
205279|NCT00300365|688515|P1|Overall Study|Lost to Follow-up|1
205280|NCT00300274|688524|P3|Overall Study|Re-transplant|1
205281|NCT00300274|688525|P2|Overall Study|Re-transplant|0
205282|NCT00300274|688526|P1|Overall Study|Re-transplant|0
205283|NCT00300274|688524|P3|Overall Study|Death|25
205284|NCT00300274|688525|P2|Overall Study|Death|20
205285|NCT00300274|688526|P1|Overall Study|Death|31
205286|NCT00300274|688524|P3|Overall Study|Lost to Follow-up|5
205287|NCT00300274|688525|P2|Overall Study|Lost to Follow-up|4
205288|NCT00300274|688526|P1|Overall Study|Lost to Follow-up|3
205289|NCT00300274|688524|P3|Overall Study|Withdrawal by Subject|14
205290|NCT00300274|688525|P2|Overall Study|Withdrawal by Subject|3
205291|NCT00300274|688526|P1|Overall Study|Withdrawal by Subject|12
205292|NCT00299975|688585|P3|Overall Study|Physician Decision|1
205293|NCT00299975|688586|P2|Overall Study|Physician Decision|0
205294|NCT00299975|688587|P1|Overall Study|Physician Decision|0
205295|NCT00299975|688585|P3|Overall Study|Withdrawal by Subject|3
205296|NCT00299975|688586|P2|Overall Study|Withdrawal by Subject|1
205297|NCT00299975|688587|P1|Overall Study|Withdrawal by Subject|0
205298|NCT00299975|688585|P3|Overall Study|Lost to Follow-up|0
205299|NCT00299975|688586|P2|Overall Study|Lost to Follow-up|0
205300|NCT00299975|688587|P1|Overall Study|Lost to Follow-up|1
205301|NCT00299975|688585|P3|Overall Study|Lack of Efficacy|1
205302|NCT00299975|688586|P2|Overall Study|Lack of Efficacy|0
205303|NCT00299975|688587|P1|Overall Study|Lack of Efficacy|1
205304|NCT00299975|688585|P3|Overall Study|Pregnancy|1
205305|NCT00299975|688586|P2|Overall Study|Pregnancy|0
205306|NCT00299975|688587|P1|Overall Study|Pregnancy|0
205307|NCT00299975|688585|P3|Overall Study|Adverse Event|2
205308|NCT00299975|688586|P2|Overall Study|Adverse Event|0
205309|NCT00299975|688587|P1|Overall Study|Adverse Event|1
205310|NCT00299702|688644|P2|Overall Study|Admin issues, sponsor decision, etc.|9
205311|NCT00299702|688645|P1|Overall Study|Admin issues, sponsor decision, etc.|5
205312|NCT00299702|688644|P2|Overall Study|Insufficient Response|3
205313|NCT00299702|688645|P1|Overall Study|Insufficient Response|4
205314|NCT00299702|688644|P2|Overall Study|Pregnancy|1
205315|NCT00299702|688645|P1|Overall Study|Pregnancy|0
205316|NCT00299702|688644|P2|Overall Study|Withdrawal by Subject|23
205317|NCT00299702|688645|P1|Overall Study|Withdrawal by Subject|25
205318|NCT00299702|688644|P2|Overall Study|Lost to Follow-up|10
205319|NCT00299702|688645|P1|Overall Study|Lost to Follow-up|18
205320|NCT00299702|688644|P2|Overall Study|Adverse Event|4
205321|NCT00299702|688645|P1|Overall Study|Adverse Event|0
205322|NCT00299702|688644|P2|Overall Study|Death|0
205323|NCT00299702|688645|P1|Overall Study|Death|1
205324|NCT00299546|688660|P3|Overall Study|Not treated|1
205325|NCT00299546|688661|P2|Overall Study|Not treated|1
205326|NCT00299546|688662|P1|Overall Study|Not treated|0
205327|NCT00299546|688660|P3|Overall Study|Not specified|19
205328|NCT00299546|688661|P2|Overall Study|Not specified|26
205329|NCT00299546|688662|P1|Overall Study|Not specified|24
205330|NCT00299546|688660|P3|Overall Study|Unsatisfactory therapeutic effect|34
205331|NCT00299546|688661|P2|Overall Study|Unsatisfactory therapeutic effect|39
205332|NCT00299546|688662|P1|Overall Study|Unsatisfactory therapeutic effect|34
205333|NCT00299546|688660|P3|Overall Study|Adverse Event|27
205334|NCT00299546|688661|P2|Overall Study|Adverse Event|22
205335|NCT00299546|688662|P1|Overall Study|Adverse Event|37
205336|NCT00299546|688660|P3|Overall Study|Lost to Follow-up|5
205337|NCT00299546|688661|P2|Overall Study|Lost to Follow-up|2
205338|NCT00299546|688662|P1|Overall Study|Lost to Follow-up|2
205339|NCT00299546|688660|P3|Overall Study|Death|0
205340|NCT00299546|688661|P2|Overall Study|Death|2
205341|NCT00299546|688662|P1|Overall Study|Death|3
205342|NCT00299494|688693|P6|Overall Study|Other - site closure|1
205343|NCT00299494|688694|P5|Overall Study|Other - site closure|1
205344|NCT00299494|688695|P4|Overall Study|Other - site closure|1
205345|NCT00299494|688696|P3|Overall Study|Other - site closure|0
205346|NCT00299494|688697|P2|Overall Study|Other - site closure|0
205347|NCT00299494|688698|P1|Overall Study|Other - site closure|0
205348|NCT00299494|688693|P6|Overall Study|Other - Unspecified|1
205349|NCT00299494|688694|P5|Overall Study|Other - Unspecified|3
205350|NCT00299494|688695|P4|Overall Study|Other - Unspecified|0
205351|NCT00299494|688696|P3|Overall Study|Other - Unspecified|0
205352|NCT00299494|688697|P2|Overall Study|Other - Unspecified|0
205353|NCT00299494|688698|P1|Overall Study|Other - Unspecified|0
205354|NCT00299494|688693|P6|Overall Study|Lost to Follow-up|1
205355|NCT00299494|688694|P5|Overall Study|Lost to Follow-up|3
205356|NCT00299494|688695|P4|Overall Study|Lost to Follow-up|0
205357|NCT00299494|688696|P3|Overall Study|Lost to Follow-up|0
205358|NCT00299494|688697|P2|Overall Study|Lost to Follow-up|0
205359|NCT00299494|688698|P1|Overall Study|Lost to Follow-up|0
205360|NCT00299494|688693|P6|Overall Study|Death|19
205361|NCT00299494|688694|P5|Overall Study|Death|18
205362|NCT00299494|688695|P4|Overall Study|Death|6
205363|NCT00299494|688696|P3|Overall Study|Death|4
205364|NCT00299494|688697|P2|Overall Study|Death|1
205365|NCT00299494|688698|P1|Overall Study|Death|3
205366|NCT00299494|688693|P6|Overall Study|Physician Decision|0
205367|NCT00299494|688694|P5|Overall Study|Physician Decision|1
205368|NCT00299494|688695|P4|Overall Study|Physician Decision|0
205369|NCT00299494|688696|P3|Overall Study|Physician Decision|0
205370|NCT00299494|688697|P2|Overall Study|Physician Decision|0
205371|NCT00299494|688698|P1|Overall Study|Physician Decision|0
205372|NCT00299494|688693|P6|Overall Study|Withdrawal by Subject|4
205373|NCT00299494|688694|P5|Overall Study|Withdrawal by Subject|1
205374|NCT00299494|688695|P4|Overall Study|Withdrawal by Subject|3
205375|NCT00299494|688696|P3|Overall Study|Withdrawal by Subject|0
205376|NCT00299494|688697|P2|Overall Study|Withdrawal by Subject|0
205377|NCT00299494|688698|P1|Overall Study|Withdrawal by Subject|0
205378|NCT00299156|688827|P3|Period 2 (Randomized)|Screen Failure|0
205379|NCT00299156|688828|P2|Period 2 (Randomized)|Screen Failure|1
205380|NCT00299156|688829|P1|Period 2 (Randomized)|Screen Failure|0
205381|NCT00299130|688840|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
205382|NCT00299130|688841|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
205383|NCT00299130|688842|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
205384|NCT00299130|688840|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
205385|NCT00299130|688841|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
205386|NCT00299130|688842|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
205387|NCT00299130|688840|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
205388|NCT00299130|688841|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
205389|NCT00299130|688842|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
205390|NCT00299130|688840|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
205391|NCT00299130|688841|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
205392|NCT00299130|688842|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
205393|NCT00299130|688840|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
205394|NCT00299130|688841|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
205395|NCT00299130|688842|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
205396|NCT00299130|688840|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
205397|NCT00299130|688841|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
205398|NCT00299130|688842|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
205399|NCT00299130|688840|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
205400|NCT00299130|688841|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
205401|NCT00299130|688842|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
205402|NCT00299130|688840|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
205403|NCT00299130|688841|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
205404|NCT00299130|688842|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
205405|NCT00299130|688840|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
205406|NCT00299130|688841|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
205407|NCT00299130|688842|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
205408|NCT00299130|688840|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
205409|NCT00299130|688841|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
205410|NCT00299130|688842|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
205411|NCT00299130|688840|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
205412|NCT00299130|688841|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
205413|NCT00299130|688842|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
205414|NCT00299130|688840|P3|Treatment Period (up to 5 Years)|Failure to Return|6
205415|NCT00299130|688841|P2|Treatment Period (up to 5 Years)|Failure to Return|6
205416|NCT00299130|688842|P1|Treatment Period (up to 5 Years)|Failure to Return|4
205417|NCT00299130|688840|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
205418|NCT00299130|688841|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
205419|NCT00299130|688842|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
205420|NCT00299130|688840|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
205421|NCT00299130|688841|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
205422|NCT00299130|688842|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
205423|NCT00299130|688840|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
205424|NCT00299130|688841|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
205425|NCT00299130|688842|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
205426|NCT00299130|688840|P3|Treatment Period (up to 5 Years)|Death|1
205427|NCT00299130|688841|P2|Treatment Period (up to 5 Years)|Death|3
205428|NCT00299130|688842|P1|Treatment Period (up to 5 Years)|Death|1
205429|NCT00299130|688840|P3|Treatment Period (up to 5 Years)|Adverse Event|13
205430|NCT00299130|688841|P2|Treatment Period (up to 5 Years)|Adverse Event|8
205431|NCT00299130|688842|P1|Treatment Period (up to 5 Years)|Adverse Event|13
205432|NCT00299104|688947|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
205433|NCT00299104|688948|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
205434|NCT00299104|688949|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
205435|NCT00299104|688947|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
205436|NCT00299104|688948|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
205437|NCT00299104|688949|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
205438|NCT00299104|688947|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
205439|NCT00299104|688948|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
205440|NCT00299104|688949|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
205441|NCT00299104|688947|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
205442|NCT00299104|688948|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
205443|NCT00299104|688949|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
205444|NCT00299104|688947|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
205445|NCT00299104|688948|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
205446|NCT00299104|688949|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
205447|NCT00299104|688947|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
205448|NCT00299104|688948|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
205449|NCT00299104|688949|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
205450|NCT00299104|688947|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
205451|NCT00299104|688948|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
205452|NCT00299104|688949|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
205453|NCT00299104|688947|P3|Safety Follow-Up (SFU) Period|Death|1
205454|NCT00299104|688948|P2|Safety Follow-Up (SFU) Period|Death|2
205455|NCT00299104|688949|P1|Safety Follow-Up (SFU) Period|Death|3
205456|NCT00299104|688947|P3|Treatment Period|Administrative reasons|137
205457|NCT00299104|688948|P2|Treatment Period|Administrative reasons|120
205458|NCT00299104|688949|P1|Treatment Period|Administrative reasons|106
205459|NCT00299104|688947|P3|Treatment Period|Withdrew consent|9
205460|NCT00299104|688948|P2|Treatment Period|Withdrew consent|19
205461|NCT00299104|688949|P1|Treatment Period|Withdrew consent|14
205462|NCT00299104|688947|P3|Treatment Period|Refused treatment|2
205463|NCT00299104|688948|P2|Treatment Period|Refused treatment|2
205464|NCT00299104|688949|P1|Treatment Period|Refused treatment|9
205465|NCT00299104|688947|P3|Treatment Period|Protocol Violation|0
205466|NCT00299104|688948|P2|Treatment Period|Protocol Violation|1
205467|NCT00299104|688949|P1|Treatment Period|Protocol Violation|1
205468|NCT00299104|688947|P3|Treatment Period|Violation of selection criteria|0
205469|NCT00299104|688948|P2|Treatment Period|Violation of selection criteria|2
205470|NCT00299104|688949|P1|Treatment Period|Violation of selection criteria|1
205471|NCT00299104|688947|P3|Treatment Period|Failure to return|8
205472|NCT00299104|688948|P2|Treatment Period|Failure to return|8
205473|NCT00299104|688949|P1|Treatment Period|Failure to return|9
205474|NCT00299104|688947|P3|Treatment Period|Insufficient therapeutic response|8
205475|NCT00299104|688948|P2|Treatment Period|Insufficient therapeutic response|13
205476|NCT00299104|688949|P1|Treatment Period|Insufficient therapeutic response|34
205477|NCT00299104|688947|P3|Treatment Period|Death|1
205478|NCT00299104|688948|P2|Treatment Period|Death|1
205479|NCT00299104|688949|P1|Treatment Period|Death|1
205480|NCT00299104|688947|P3|Treatment Period|Adverse Event|7
205481|NCT00299104|688948|P2|Treatment Period|Adverse Event|9
205482|NCT00299104|688949|P1|Treatment Period|Adverse Event|14
205483|NCT00298766|689059|P1|Overall Study|Other|4
205484|NCT00298766|689059|P1|Overall Study|Subjects overall condition deterioration|4
205485|NCT00298766|689059|P1|Overall Study|Deterioration in KPS and organ function|1
205486|NCT00298766|689059|P1|Overall Study|Progression of amyloid markers|4
205487|NCT00298766|689059|P1|Overall Study|Treatment ongoing|4
205488|NCT00298766|689059|P1|Overall Study|Withdrawal by Subject|9
205489|NCT00298766|689059|P1|Overall Study|Death|2
205490|NCT00298766|689059|P1|Overall Study|Adverse Event|18
205491|NCT00298740|689068|P1|Overall Study|Withdrawal by Subject|3
205492|NCT00298740|689068|P1|Overall Study|Lack of Efficacy|6
205493|NCT00298363|689122|P3|Overall Study|Lack of Efficacy|0
205494|NCT00298363|689123|P2|Overall Study|Lack of Efficacy|3
205495|NCT00298363|689124|P1|Overall Study|Lack of Efficacy|2
205496|NCT00298363|689122|P3|Overall Study|Adverse Event|2
205497|NCT00298363|689123|P2|Overall Study|Adverse Event|2
205498|NCT00298363|689124|P1|Overall Study|Adverse Event|5
205499|NCT00298363|689122|P3|Overall Study|Withdrawal by Subject|3
205500|NCT00298363|689123|P2|Overall Study|Withdrawal by Subject|1
205501|NCT00298363|689124|P1|Overall Study|Withdrawal by Subject|5
205502|NCT00298363|689122|P3|Overall Study|Protocol Violation|0
205503|NCT00298363|689123|P2|Overall Study|Protocol Violation|1
205504|NCT00298363|689124|P1|Overall Study|Protocol Violation|1
205505|NCT00298363|689122|P3|Overall Study|Physician Decision|0
205506|NCT00298363|689123|P2|Overall Study|Physician Decision|1
205507|NCT00298363|689124|P1|Overall Study|Physician Decision|4
205508|NCT00298363|689122|P3|Overall Study|Lost to Follow-up|1
205509|NCT00298363|689123|P2|Overall Study|Lost to Follow-up|0
205510|NCT00298363|689124|P1|Overall Study|Lost to Follow-up|0
205511|NCT00298272|689282|P2|Safety Follow-up Phase|Administrative/Other Reason|1
205512|NCT00298272|689283|P1|Safety Follow-up Phase|Administrative/Other Reason|1
205513|NCT00298272|689282|P2|Safety Follow-up Phase|Withdrawal by Subject|2
205514|NCT00298272|689283|P1|Safety Follow-up Phase|Withdrawal by Subject|2
205515|NCT00298272|689282|P2|Safety Follow-up Phase|Failure to Return|1
205516|NCT00298272|689283|P1|Safety Follow-up Phase|Failure to Return|1
205517|NCT00298272|689282|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
205518|NCT00298272|689283|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
205519|NCT00298272|689282|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
205520|NCT00298272|689283|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
205521|NCT00298272|689282|P2|Open Label Retreatment Phase|Protocol Violation|1
205522|NCT00298272|689283|P1|Open Label Retreatment Phase|Protocol Violation|2
205523|NCT00298272|689282|P2|Open Label Retreatment Phase|Failure to Return|0
205524|NCT00298272|689283|P1|Open Label Retreatment Phase|Failure to Return|1
205525|NCT00298272|689282|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
205526|NCT00298272|689283|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
205527|NCT00298272|689282|P2|Open Label Retreatment Phase|Adverse Event|2
205528|NCT00298272|689283|P1|Open Label Retreatment Phase|Adverse Event|1
205529|NCT00298272|689282|P2|Double-blind Phase|Withdrawal by Subject|0
205530|NCT00298272|689283|P1|Double-blind Phase|Withdrawal by Subject|2
205531|NCT00298272|689282|P2|Double-blind Phase|Protocol Violation|0
205532|NCT00298272|689283|P1|Double-blind Phase|Protocol Violation|2
205533|NCT00298272|689282|P2|Double-blind Phase|Failure to Return|0
205534|NCT00298272|689283|P1|Double-blind Phase|Failure to Return|2
205535|NCT00298272|689282|P2|Double-blind Phase|Adverse Event|0
205536|NCT00298272|689283|P1|Double-blind Phase|Adverse Event|2
205537|NCT00297830|689348|P3|12 Month Visit|Withdrawal by Subject|0
205538|NCT00297830|689349|P2|12 Month Visit|Withdrawal by Subject|3
205539|NCT00297830|689350|P1|12 Month Visit|Withdrawal by Subject|0
205540|NCT00297830|689348|P3|12 Month Visit|Adverse Event|0
205541|NCT00297830|689349|P2|12 Month Visit|Adverse Event|3
205542|NCT00297830|689350|P1|12 Month Visit|Adverse Event|0
205543|NCT00297830|689348|P3|12 Month Visit|Lost to Follow-up|0
205544|NCT00297830|689349|P2|12 Month Visit|Lost to Follow-up|0
205545|NCT00297830|689350|P1|12 Month Visit|Lost to Follow-up|1
205546|NCT00297830|689348|P3|6 Month Visit|Adverse Event|0
205547|NCT00297830|689349|P2|6 Month Visit|Adverse Event|1
205548|NCT00297830|689350|P1|6 Month Visit|Adverse Event|0
205549|NCT00297830|689348|P3|6 Month Visit|Withdrawal by Subject|1
205550|NCT00297830|689349|P2|6 Month Visit|Withdrawal by Subject|1
205551|NCT00297830|689350|P1|6 Month Visit|Withdrawal by Subject|2
205552|NCT00297830|689348|P3|6 Month Visit|Death|2
205553|NCT00297830|689349|P2|6 Month Visit|Death|0
205554|NCT00297830|689350|P1|6 Month Visit|Death|1
205555|NCT00297778|689369|P2|Overall Study|Other|1
205556|NCT00297778|689370|P1|Overall Study|Other|0
205557|NCT00297778|689369|P2|Overall Study|Non-compliant with trial protocol|3
205558|NCT00297778|689370|P1|Overall Study|Non-compliant with trial protocol|0
205559|NCT00297778|689369|P2|Overall Study|Lack of Efficacy|1
205560|NCT00297778|689370|P1|Overall Study|Lack of Efficacy|2
205561|NCT00297778|689369|P2|Overall Study|Withdrawal by Subject|5
205562|NCT00297778|689370|P1|Overall Study|Withdrawal by Subject|1
205563|NCT00297778|689369|P2|Overall Study|Adverse Event|10
205564|NCT00297778|689370|P1|Overall Study|Adverse Event|16
205565|NCT00297648|689404|P1|Overall Study|Other: Incompliance|1
205566|NCT00297648|689404|P1|Overall Study|Withdrawal by Subject|3
205567|NCT00297648|689404|P1|Overall Study|Lost to Follow-up|1
205568|NCT00297648|689404|P1|Overall Study|Lack of Efficacy|18
205569|NCT00297648|689404|P1|Overall Study|Adverse Event|13
205570|NCT00297492|689450|P3|6 Month Follow-up|Lost to Follow-up|27
205571|NCT00297492|689451|P2|6 Month Follow-up|Lost to Follow-up|49
205572|NCT00297492|689452|P1|6 Month Follow-up|Lost to Follow-up|63
205573|NCT00297492|689450|P3|Set Quit Date|Lost to Follow-up|5
205574|NCT00297492|689451|P2|Set Quit Date|Lost to Follow-up|13
205575|NCT00297492|689452|P1|Set Quit Date|Lost to Follow-up|7
205576|NCT00297427|689462|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
205577|NCT00297427|689463|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
205578|NCT00297427|689462|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
205579|NCT00297427|689463|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
205580|NCT00297427|689462|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
205581|NCT00297427|689463|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
205582|NCT00297427|689462|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
205583|NCT00297427|689463|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
205584|NCT00297427|689462|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
205585|NCT00297427|689463|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
205586|NCT00297427|689462|P2|Phase 1: Initial Intervention|Death|1
205587|NCT00297427|689463|P1|Phase 1: Initial Intervention|Death|0
205588|NCT00297427|689462|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
205589|NCT00297427|689463|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
205590|NCT00297427|689462|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
205591|NCT00297427|689463|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
205592|NCT00297258|689504|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
205593|NCT00297258|689504|P1|Overall Study|Switch to Commercial Treatment|1
205594|NCT00297258|689504|P1|Overall Study|Surgery Performed on Target Lesion|1
205595|NCT00297258|689504|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
205596|NCT00297258|689504|P1|Overall Study|Deteriorization of General Condition|1
205597|NCT00297258|689504|P1|Overall Study|Intercurrent Death|2
205598|NCT00297258|689504|P1|Overall Study|Intercurrent Illness|3
205599|NCT00297258|689504|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
205600|NCT00297258|689504|P1|Overall Study|Toxicity (or Toxic Death)|10
205601|NCT00297258|689504|P1|Overall Study|Disease Progression, Relapse, Death|120
205602|NCT00297232|689523|P1|Overall Study|Other|1
205603|NCT00297232|689523|P1|Overall Study|No data available after Week 264|161
205604|NCT00297232|689523|P1|Overall Study|Did Not Enroll to Week 480|17
205605|NCT00297232|689523|P1|Overall Study|Did Not Enroll to Week 264|34
205606|NCT00297232|689523|P1|Overall Study|Investigator Withdrew From Program|19
205607|NCT00297232|689523|P1|Overall Study|Persistently Positive Antibodies|11
205608|NCT00297232|689523|P1|Overall Study|Subject Withdrew Consent|37
205609|NCT00297232|689523|P1|Overall Study|Subject Relocated|7
205610|NCT00297232|689523|P1|Overall Study|Sponsor Decision|34
205611|NCT00297232|689523|P1|Overall Study|Miscellaneous|5
205612|NCT00297232|689523|P1|Overall Study|Anti-JCV Antibody Positive|13
205613|NCT00297232|689523|P1|Overall Study|Fear of PML|10
205614|NCT00297232|689523|P1|Overall Study|Disease Progression|8
205615|NCT00297232|689523|P1|Overall Study|Switched to Commercial Tysabri|22
205616|NCT00297232|689523|P1|Overall Study|Anti-natalizumab Positive|8
205617|NCT00297232|689523|P1|Overall Study|Death|9
205618|NCT00297232|689523|P1|Overall Study|Subject was Noncompliant|9
205619|NCT00297232|689523|P1|Overall Study|Voluntary Withdrawal|120
205620|NCT00297232|689523|P1|Overall Study|Adverse Event|63
205621|NCT00297232|689523|P1|Overall Study|Lost to Follow-up|10
205622|NCT00297232|689523|P1|Overall Study|Lack of Efficacy|7
205623|NCT00297167|689529|P3|Second Double-blind Intervention Period|Protocol Violation|0
205624|NCT00297167|689530|P2|Second Double-blind Intervention Period|Protocol Violation|0
205625|NCT00297167|689531|P1|Second Double-blind Intervention Period|Protocol Violation|1
205626|NCT00297167|689529|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
205627|NCT00297167|689530|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
205628|NCT00297167|689531|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
205629|NCT00297037|689595|P2|Overall Study|Withdrawal by Subject|0
205630|NCT00297037|689596|P1|Overall Study|Withdrawal by Subject|2
205631|NCT00296816|689608|P1|Overall Study|ineligibility due to radiation treatment|1
205632|NCT00296816|689608|P1|Overall Study|Proteinuria|1
205633|NCT00296816|689608|P1|Overall Study|Neuropathy/patient preference|1
205634|NCT00296816|689608|P1|Overall Study|Urine protein/creatinine ratio delay|1
205635|NCT00296816|689608|P1|Overall Study|Noncompliance/decision to discontinue|1
205636|NCT00296816|689608|P1|Overall Study|Relocation to Florida|1
205637|NCT00296816|689608|P1|Overall Study|Poor performance status|1
205638|NCT00296816|689608|P1|Overall Study|Progression based on CA-125 (biomarker)|2
205639|NCT00296816|689608|P1|Overall Study|Missing for end of treatment|4
205640|NCT00296816|689608|P1|Overall Study|Non-compliance|1
205641|NCT00296816|689608|P1|Overall Study|Investigator/Participant request|5
205642|NCT00296816|689608|P1|Overall Study|Adverse Event|18
205643|NCT00296816|689608|P1|Overall Study|Disease Progression|37
205644|NCT00296647|689625|P5|Overall Study|Withdrawal by Subject|19
205645|NCT00296647|689626|P4|Overall Study|Withdrawal by Subject|16
205646|NCT00296647|689627|P3|Overall Study|Withdrawal by Subject|32
205647|NCT00296647|689628|P2|Overall Study|Withdrawal by Subject|27
205648|NCT00296647|689629|P1|Overall Study|Withdrawal by Subject|28
205649|NCT00296647|689625|P5|Overall Study|Death|1
205650|NCT00296647|689626|P4|Overall Study|Death|1
205651|NCT00296647|689627|P3|Overall Study|Death|2
205652|NCT00296647|689628|P2|Overall Study|Death|1
205653|NCT00296647|689629|P1|Overall Study|Death|4
205654|NCT00296517|689643|P2|Dose Level 3 - Weeks 3-12|Not specified|2
205655|NCT00296517|689644|P1|Dose Level 3 - Weeks 3-12|Not specified|0
205656|NCT00296517|689643|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
205657|NCT00296517|689644|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
205658|NCT00296517|689643|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
205659|NCT00296517|689644|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
205660|NCT00296517|689643|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
205661|NCT00296517|689644|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
205662|NCT00296517|689643|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
205663|NCT00296517|689644|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
205664|NCT00296517|689643|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
205665|NCT00296517|689644|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
205666|NCT00296517|689643|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
205667|NCT00296517|689644|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
205668|NCT00296517|689643|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
205669|NCT00296517|689644|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
205670|NCT00296517|689643|P2|Dose Level 2 - Week 2|Adverse Event|5
205671|NCT00296517|689644|P1|Dose Level 2 - Week 2|Adverse Event|1
205672|NCT00296504|689680|P9|Final Analysis|Poor Adherence|1
205673|NCT00296504|689681|P8|Final Analysis|Poor Adherence|0
205674|NCT00296504|689682|P7|Final Analysis|Poor Adherence|0
205675|NCT00296504|689683|P6|Final Analysis|Poor Adherence|0
205676|NCT00296504|689684|P5|Final Analysis|Poor Adherence|0
205677|NCT00296504|689685|P4|Final Analysis|Poor Adherence|0
205678|NCT00296504|689686|P3|Final Analysis|Poor Adherence|0
205679|NCT00296504|689687|P2|Final Analysis|Poor Adherence|0
205680|NCT00296504|689688|P1|Final Analysis|Poor Adherence|0
205681|NCT00296504|689680|P9|Final Analysis|Participant Moved to Another Country|1
205682|NCT00296504|689681|P8|Final Analysis|Participant Moved to Another Country|0
205683|NCT00296504|689682|P7|Final Analysis|Participant Moved to Another Country|0
205684|NCT00296504|689683|P6|Final Analysis|Participant Moved to Another Country|0
205685|NCT00296504|689684|P5|Final Analysis|Participant Moved to Another Country|0
205686|NCT00296504|689685|P4|Final Analysis|Participant Moved to Another Country|0
205687|NCT00296504|689686|P3|Final Analysis|Participant Moved to Another Country|0
205688|NCT00296504|689687|P2|Final Analysis|Participant Moved to Another Country|0
205689|NCT00296504|689688|P1|Final Analysis|Participant Moved to Another Country|0
205690|NCT00296504|689680|P9|Final Analysis|Tuberculosis|1
205691|NCT00296504|689681|P8|Final Analysis|Tuberculosis|0
205692|NCT00296504|689682|P7|Final Analysis|Tuberculosis|0
205693|NCT00296504|689683|P6|Final Analysis|Tuberculosis|0
205694|NCT00296504|689684|P5|Final Analysis|Tuberculosis|0
205695|NCT00296504|689685|P4|Final Analysis|Tuberculosis|0
205696|NCT00296504|689686|P3|Final Analysis|Tuberculosis|0
205697|NCT00296504|689687|P2|Final Analysis|Tuberculosis|0
205698|NCT00296504|689688|P1|Final Analysis|Tuberculosis|0
205699|NCT00296504|689680|P9|Final Analysis|Pregnancy|4
205700|NCT00296504|689681|P8|Final Analysis|Pregnancy|0
205701|NCT00296504|689682|P7|Final Analysis|Pregnancy|0
205702|NCT00296504|689683|P6|Final Analysis|Pregnancy|0
205703|NCT00296504|689684|P5|Final Analysis|Pregnancy|0
205704|NCT00296504|689685|P4|Final Analysis|Pregnancy|0
205705|NCT00296504|689686|P3|Final Analysis|Pregnancy|0
205706|NCT00296504|689687|P2|Final Analysis|Pregnancy|0
205707|NCT00296504|689688|P1|Final Analysis|Pregnancy|0
205708|NCT00296504|689680|P9|Final Analysis|Adverse Event|2
205709|NCT00296504|689681|P8|Final Analysis|Adverse Event|0
205710|NCT00296504|689682|P7|Final Analysis|Adverse Event|0
205711|NCT00296504|689683|P6|Final Analysis|Adverse Event|0
205712|NCT00296504|689684|P5|Final Analysis|Adverse Event|0
205713|NCT00296504|689685|P4|Final Analysis|Adverse Event|0
205714|NCT00296504|689686|P3|Final Analysis|Adverse Event|0
205715|NCT00296504|689687|P2|Final Analysis|Adverse Event|0
205716|NCT00296504|689688|P1|Final Analysis|Adverse Event|0
205717|NCT00296504|689680|P9|Final Analysis|Insufficient Viral Load Response|6
205718|NCT00296504|689681|P8|Final Analysis|Insufficient Viral Load Response|0
205719|NCT00296504|689682|P7|Final Analysis|Insufficient Viral Load Response|0
205720|NCT00296504|689683|P6|Final Analysis|Insufficient Viral Load Response|0
205721|NCT00296504|689684|P5|Final Analysis|Insufficient Viral Load Response|0
205722|NCT00296504|689685|P4|Final Analysis|Insufficient Viral Load Response|0
205723|NCT00296504|689686|P3|Final Analysis|Insufficient Viral Load Response|0
205724|NCT00296504|689687|P2|Final Analysis|Insufficient Viral Load Response|0
205725|NCT00296504|689688|P1|Final Analysis|Insufficient Viral Load Response|0
205726|NCT00296504|689680|P9|Final Analysis|Lost to Follow-up|5
205727|NCT00296504|689681|P8|Final Analysis|Lost to Follow-up|0
205728|NCT00296504|689682|P7|Final Analysis|Lost to Follow-up|0
205729|NCT00296504|689683|P6|Final Analysis|Lost to Follow-up|0
205730|NCT00296504|689684|P5|Final Analysis|Lost to Follow-up|0
205731|NCT00296504|689685|P4|Final Analysis|Lost to Follow-up|0
205732|NCT00296504|689686|P3|Final Analysis|Lost to Follow-up|0
205733|NCT00296504|689687|P2|Final Analysis|Lost to Follow-up|0
205734|NCT00296504|689688|P1|Final Analysis|Lost to Follow-up|0
205735|NCT00296504|689680|P9|Final Analysis|Withdrawal by Subject|1
205736|NCT00296504|689681|P8|Final Analysis|Withdrawal by Subject|0
205737|NCT00296504|689682|P7|Final Analysis|Withdrawal by Subject|0
205738|NCT00296504|689683|P6|Final Analysis|Withdrawal by Subject|0
205739|NCT00296504|689684|P5|Final Analysis|Withdrawal by Subject|0
205740|NCT00296504|689685|P4|Final Analysis|Withdrawal by Subject|0
205741|NCT00296504|689686|P3|Final Analysis|Withdrawal by Subject|0
205742|NCT00296504|689687|P2|Final Analysis|Withdrawal by Subject|0
205743|NCT00296504|689688|P1|Final Analysis|Withdrawal by Subject|0
205744|NCT00296504|689680|P9|Interim Analysis|Ongoing|0
205745|NCT00296504|689681|P8|Interim Analysis|Ongoing|1
205746|NCT00296504|689682|P7|Interim Analysis|Ongoing|30
205747|NCT00296504|689683|P6|Interim Analysis|Ongoing|0
205748|NCT00296504|689684|P5|Interim Analysis|Ongoing|0
205749|NCT00296504|689685|P4|Interim Analysis|Ongoing|22
205750|NCT00296504|689686|P3|Interim Analysis|Ongoing|16
205751|NCT00296504|689687|P2|Interim Analysis|Ongoing|12
205752|NCT00296504|689688|P1|Interim Analysis|Ongoing|32
205753|NCT00296504|689680|P9|Interim Analysis|Participant Needed Interferon|0
205754|NCT00296504|689681|P8|Interim Analysis|Participant Needed Interferon|1
205755|NCT00296504|689682|P7|Interim Analysis|Participant Needed Interferon|0
205756|NCT00296504|689683|P6|Interim Analysis|Participant Needed Interferon|0
205757|NCT00296504|689684|P5|Interim Analysis|Participant Needed Interferon|0
205758|NCT00296504|689685|P4|Interim Analysis|Participant Needed Interferon|0
205759|NCT00296504|689686|P3|Interim Analysis|Participant Needed Interferon|0
205760|NCT00296504|689687|P2|Interim Analysis|Participant Needed Interferon|0
205761|NCT00296504|689688|P1|Interim Analysis|Participant Needed Interferon|0
205762|NCT00296504|689680|P9|Interim Analysis|Study Ended|0
205763|NCT00296504|689681|P8|Interim Analysis|Study Ended|0
205764|NCT00296504|689682|P7|Interim Analysis|Study Ended|1
205765|NCT00296504|689683|P6|Interim Analysis|Study Ended|0
205766|NCT00296504|689684|P5|Interim Analysis|Study Ended|0
205767|NCT00296504|689685|P4|Interim Analysis|Study Ended|0
205768|NCT00296504|689686|P3|Interim Analysis|Study Ended|0
205769|NCT00296504|689687|P2|Interim Analysis|Study Ended|0
205770|NCT00296504|689688|P1|Interim Analysis|Study Ended|0
205771|NCT00296504|689680|P9|Interim Analysis|Participant Stopped HIV Medications|0
205772|NCT00296504|689681|P8|Interim Analysis|Participant Stopped HIV Medications|0
205773|NCT00296504|689682|P7|Interim Analysis|Participant Stopped HIV Medications|1
205774|NCT00296504|689683|P6|Interim Analysis|Participant Stopped HIV Medications|0
205775|NCT00296504|689684|P5|Interim Analysis|Participant Stopped HIV Medications|0
205776|NCT00296504|689685|P4|Interim Analysis|Participant Stopped HIV Medications|0
205777|NCT00296504|689686|P3|Interim Analysis|Participant Stopped HIV Medications|0
205778|NCT00296504|689687|P2|Interim Analysis|Participant Stopped HIV Medications|0
205779|NCT00296504|689688|P1|Interim Analysis|Participant Stopped HIV Medications|0
205780|NCT00296504|689680|P9|Interim Analysis|Physician and Participant Decision|0
205781|NCT00296504|689681|P8|Interim Analysis|Physician and Participant Decision|0
205782|NCT00296504|689682|P7|Interim Analysis|Physician and Participant Decision|0
205783|NCT00296504|689683|P6|Interim Analysis|Physician and Participant Decision|1
205784|NCT00296504|689684|P5|Interim Analysis|Physician and Participant Decision|0
205785|NCT00296504|689685|P4|Interim Analysis|Physician and Participant Decision|0
205786|NCT00296504|689686|P3|Interim Analysis|Physician and Participant Decision|0
205787|NCT00296504|689687|P2|Interim Analysis|Physician and Participant Decision|0
205788|NCT00296504|689688|P1|Interim Analysis|Physician and Participant Decision|0
205789|NCT00296504|689680|P9|Interim Analysis|Participant Stopped|0
205790|NCT00296504|689681|P8|Interim Analysis|Participant Stopped|0
205791|NCT00296504|689682|P7|Interim Analysis|Participant Stopped|0
205792|NCT00296504|689683|P6|Interim Analysis|Participant Stopped|0
205793|NCT00296504|689684|P5|Interim Analysis|Participant Stopped|1
205794|NCT00296504|689685|P4|Interim Analysis|Participant Stopped|0
205795|NCT00296504|689686|P3|Interim Analysis|Participant Stopped|0
205796|NCT00296504|689687|P2|Interim Analysis|Participant Stopped|0
205797|NCT00296504|689688|P1|Interim Analysis|Participant Stopped|0
205798|NCT00296504|689680|P9|Interim Analysis|Inclusion in Other Protocol|0
205799|NCT00296504|689681|P8|Interim Analysis|Inclusion in Other Protocol|0
205800|NCT00296504|689682|P7|Interim Analysis|Inclusion in Other Protocol|0
205801|NCT00296504|689683|P6|Interim Analysis|Inclusion in Other Protocol|0
205802|NCT00296504|689684|P5|Interim Analysis|Inclusion in Other Protocol|0
205803|NCT00296504|689685|P4|Interim Analysis|Inclusion in Other Protocol|1
205804|NCT00296504|689686|P3|Interim Analysis|Inclusion in Other Protocol|0
205805|NCT00296504|689687|P2|Interim Analysis|Inclusion in Other Protocol|0
205806|NCT00296504|689688|P1|Interim Analysis|Inclusion in Other Protocol|0
205807|NCT00296504|689680|P9|Interim Analysis|Missed Schedule Date|0
205808|NCT00296504|689681|P8|Interim Analysis|Missed Schedule Date|0
205809|NCT00296504|689682|P7|Interim Analysis|Missed Schedule Date|0
205810|NCT00296504|689683|P6|Interim Analysis|Missed Schedule Date|0
205811|NCT00296504|689684|P5|Interim Analysis|Missed Schedule Date|0
205812|NCT00296504|689685|P4|Interim Analysis|Missed Schedule Date|0
205813|NCT00296504|689686|P3|Interim Analysis|Missed Schedule Date|0
205814|NCT00296504|689687|P2|Interim Analysis|Missed Schedule Date|0
205815|NCT00296504|689688|P1|Interim Analysis|Missed Schedule Date|1
205816|NCT00296504|689680|P9|Interim Analysis|Lack of Personnel at Site|0
205817|NCT00296504|689681|P8|Interim Analysis|Lack of Personnel at Site|0
205818|NCT00296504|689682|P7|Interim Analysis|Lack of Personnel at Site|0
205819|NCT00296504|689683|P6|Interim Analysis|Lack of Personnel at Site|0
205820|NCT00296504|689684|P5|Interim Analysis|Lack of Personnel at Site|0
205821|NCT00296504|689685|P4|Interim Analysis|Lack of Personnel at Site|0
205822|NCT00296504|689686|P3|Interim Analysis|Lack of Personnel at Site|0
205823|NCT00296504|689687|P2|Interim Analysis|Lack of Personnel at Site|0
205824|NCT00296504|689688|P1|Interim Analysis|Lack of Personnel at Site|1
205825|NCT00296504|689680|P9|Interim Analysis|Site Closing|0
205826|NCT00296504|689681|P8|Interim Analysis|Site Closing|0
205827|NCT00296504|689682|P7|Interim Analysis|Site Closing|2
205828|NCT00296504|689683|P6|Interim Analysis|Site Closing|1
205829|NCT00296504|689684|P5|Interim Analysis|Site Closing|0
205830|NCT00296504|689685|P4|Interim Analysis|Site Closing|0
205831|NCT00296504|689686|P3|Interim Analysis|Site Closing|0
205832|NCT00296504|689687|P2|Interim Analysis|Site Closing|0
205833|NCT00296504|689688|P1|Interim Analysis|Site Closing|1
205834|NCT00296504|689680|P9|Interim Analysis|Non-adherence|0
205835|NCT00296504|689681|P8|Interim Analysis|Non-adherence|1
205836|NCT00296504|689682|P7|Interim Analysis|Non-adherence|0
205837|NCT00296504|689683|P6|Interim Analysis|Non-adherence|0
205838|NCT00296504|689684|P5|Interim Analysis|Non-adherence|1
205839|NCT00296504|689685|P4|Interim Analysis|Non-adherence|0
205840|NCT00296504|689686|P3|Interim Analysis|Non-adherence|0
205841|NCT00296504|689687|P2|Interim Analysis|Non-adherence|0
205842|NCT00296504|689688|P1|Interim Analysis|Non-adherence|2
205843|NCT00296504|689680|P9|Interim Analysis|Principle Investigator Terminated Study|0
205844|NCT00296504|689681|P8|Interim Analysis|Principle Investigator Terminated Study|0
205845|NCT00296504|689682|P7|Interim Analysis|Principle Investigator Terminated Study|0
205846|NCT00296504|689683|P6|Interim Analysis|Principle Investigator Terminated Study|0
205847|NCT00296504|689684|P5|Interim Analysis|Principle Investigator Terminated Study|0
205848|NCT00296504|689685|P4|Interim Analysis|Principle Investigator Terminated Study|0
205849|NCT00296504|689686|P3|Interim Analysis|Principle Investigator Terminated Study|1
205850|NCT00296504|689687|P2|Interim Analysis|Principle Investigator Terminated Study|0
205851|NCT00296504|689688|P1|Interim Analysis|Principle Investigator Terminated Study|0
205852|NCT00296504|689680|P9|Interim Analysis|Principle Investigator Discretion|0
205853|NCT00296504|689681|P8|Interim Analysis|Principle Investigator Discretion|0
205854|NCT00296504|689682|P7|Interim Analysis|Principle Investigator Discretion|0
205855|NCT00296504|689683|P6|Interim Analysis|Principle Investigator Discretion|0
205856|NCT00296504|689684|P5|Interim Analysis|Principle Investigator Discretion|0
205857|NCT00296504|689685|P4|Interim Analysis|Principle Investigator Discretion|1
205858|NCT00296504|689686|P3|Interim Analysis|Principle Investigator Discretion|1
205859|NCT00296504|689687|P2|Interim Analysis|Principle Investigator Discretion|0
205860|NCT00296504|689688|P1|Interim Analysis|Principle Investigator Discretion|2
205861|NCT00296504|689680|P9|Interim Analysis|Physician Decision|0
205862|NCT00296504|689681|P8|Interim Analysis|Physician Decision|0
205863|NCT00296504|689682|P7|Interim Analysis|Physician Decision|0
205864|NCT00296504|689683|P6|Interim Analysis|Physician Decision|0
205865|NCT00296504|689684|P5|Interim Analysis|Physician Decision|0
205866|NCT00296504|689685|P4|Interim Analysis|Physician Decision|0
205867|NCT00296504|689686|P3|Interim Analysis|Physician Decision|1
205868|NCT00296504|689687|P2|Interim Analysis|Physician Decision|0
205869|NCT00296504|689688|P1|Interim Analysis|Physician Decision|0
205870|NCT00296504|689680|P9|Interim Analysis|Resistance to FPV|0
205871|NCT00296504|689681|P8|Interim Analysis|Resistance to FPV|0
205872|NCT00296504|689682|P7|Interim Analysis|Resistance to FPV|0
205873|NCT00296504|689683|P6|Interim Analysis|Resistance to FPV|0
205874|NCT00296504|689684|P5|Interim Analysis|Resistance to FPV|0
205875|NCT00296504|689685|P4|Interim Analysis|Resistance to FPV|0
205876|NCT00296504|689686|P3|Interim Analysis|Resistance to FPV|1
205877|NCT00296504|689687|P2|Interim Analysis|Resistance to FPV|0
205878|NCT00296504|689688|P1|Interim Analysis|Resistance to FPV|0
205879|NCT00296504|689680|P9|Interim Analysis|Participant Was Incarcerated|0
205880|NCT00296504|689681|P8|Interim Analysis|Participant Was Incarcerated|0
205881|NCT00296504|689682|P7|Interim Analysis|Participant Was Incarcerated|0
205882|NCT00296504|689683|P6|Interim Analysis|Participant Was Incarcerated|0
205883|NCT00296504|689684|P5|Interim Analysis|Participant Was Incarcerated|0
205884|NCT00296504|689685|P4|Interim Analysis|Participant Was Incarcerated|0
205885|NCT00296504|689686|P3|Interim Analysis|Participant Was Incarcerated|1
205886|NCT00296504|689687|P2|Interim Analysis|Participant Was Incarcerated|0
205887|NCT00296504|689688|P1|Interim Analysis|Participant Was Incarcerated|2
205888|NCT00296504|689680|P9|Interim Analysis|Participant Moved|0
205889|NCT00296504|689681|P8|Interim Analysis|Participant Moved|0
205890|NCT00296504|689682|P7|Interim Analysis|Participant Moved|1
205891|NCT00296504|689683|P6|Interim Analysis|Participant Moved|1
205892|NCT00296504|689684|P5|Interim Analysis|Participant Moved|0
205893|NCT00296504|689685|P4|Interim Analysis|Participant Moved|0
205894|NCT00296504|689686|P3|Interim Analysis|Participant Moved|1
205895|NCT00296504|689687|P2|Interim Analysis|Participant Moved|0
205896|NCT00296504|689688|P1|Interim Analysis|Participant Moved|1
205897|NCT00296504|689680|P9|Interim Analysis|Participant Had Problems with Alcohol|0
205898|NCT00296504|689681|P8|Interim Analysis|Participant Had Problems with Alcohol|0
205899|NCT00296504|689682|P7|Interim Analysis|Participant Had Problems with Alcohol|0
205900|NCT00296504|689683|P6|Interim Analysis|Participant Had Problems with Alcohol|0
205901|NCT00296504|689684|P5|Interim Analysis|Participant Had Problems with Alcohol|0
205902|NCT00296504|689685|P4|Interim Analysis|Participant Had Problems with Alcohol|0
205903|NCT00296504|689686|P3|Interim Analysis|Participant Had Problems with Alcohol|1
205904|NCT00296504|689687|P2|Interim Analysis|Participant Had Problems with Alcohol|0
205905|NCT00296504|689688|P1|Interim Analysis|Participant Had Problems with Alcohol|0
205906|NCT00296504|689680|P9|Interim Analysis|To Simplify Treatment|0
205907|NCT00296504|689681|P8|Interim Analysis|To Simplify Treatment|0
205908|NCT00296504|689682|P7|Interim Analysis|To Simplify Treatment|2
205909|NCT00296504|689683|P6|Interim Analysis|To Simplify Treatment|0
205910|NCT00296504|689684|P5|Interim Analysis|To Simplify Treatment|0
205911|NCT00296504|689685|P4|Interim Analysis|To Simplify Treatment|0
205912|NCT00296504|689686|P3|Interim Analysis|To Simplify Treatment|1
205913|NCT00296504|689687|P2|Interim Analysis|To Simplify Treatment|0
205914|NCT00296504|689688|P1|Interim Analysis|To Simplify Treatment|0
205915|NCT00296504|689680|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
205916|NCT00296504|689681|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
205917|NCT00296504|689682|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
205918|NCT00296504|689683|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
205919|NCT00296504|689684|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
205920|NCT00296504|689685|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
205921|NCT00296504|689686|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
205922|NCT00296504|689687|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
205923|NCT00296504|689688|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
205924|NCT00296504|689680|P9|Interim Analysis|Participant Non-compliant|0
205925|NCT00296504|689681|P8|Interim Analysis|Participant Non-compliant|2
205926|NCT00296504|689682|P7|Interim Analysis|Participant Non-compliant|6
205927|NCT00296504|689683|P6|Interim Analysis|Participant Non-compliant|3
205928|NCT00296504|689684|P5|Interim Analysis|Participant Non-compliant|1
205929|NCT00296504|689685|P4|Interim Analysis|Participant Non-compliant|1
205930|NCT00296504|689686|P3|Interim Analysis|Participant Non-compliant|2
205931|NCT00296504|689687|P2|Interim Analysis|Participant Non-compliant|1
205932|NCT00296504|689688|P1|Interim Analysis|Participant Non-compliant|0
205933|NCT00296504|689680|P9|Interim Analysis|Death|0
205934|NCT00296504|689681|P8|Interim Analysis|Death|0
205935|NCT00296504|689682|P7|Interim Analysis|Death|0
205936|NCT00296504|689683|P6|Interim Analysis|Death|0
205937|NCT00296504|689684|P5|Interim Analysis|Death|0
205938|NCT00296504|689685|P4|Interim Analysis|Death|0
205939|NCT00296504|689686|P3|Interim Analysis|Death|3
205940|NCT00296504|689687|P2|Interim Analysis|Death|0
205941|NCT00296504|689688|P1|Interim Analysis|Death|1
205942|NCT00296504|689680|P9|Interim Analysis|Pregnancy|0
205943|NCT00296504|689681|P8|Interim Analysis|Pregnancy|1
205944|NCT00296504|689682|P7|Interim Analysis|Pregnancy|1
205945|NCT00296504|689683|P6|Interim Analysis|Pregnancy|1
205946|NCT00296504|689684|P5|Interim Analysis|Pregnancy|0
205947|NCT00296504|689685|P4|Interim Analysis|Pregnancy|2
205948|NCT00296504|689686|P3|Interim Analysis|Pregnancy|4
205949|NCT00296504|689687|P2|Interim Analysis|Pregnancy|1
205950|NCT00296504|689688|P1|Interim Analysis|Pregnancy|4
205951|NCT00296504|689680|P9|Interim Analysis|Switched to Commercially Available Drug|0
205952|NCT00296504|689681|P8|Interim Analysis|Switched to Commercially Available Drug|4
205953|NCT00296504|689682|P7|Interim Analysis|Switched to Commercially Available Drug|3
205954|NCT00296504|689683|P6|Interim Analysis|Switched to Commercially Available Drug|5
205955|NCT00296504|689684|P5|Interim Analysis|Switched to Commercially Available Drug|0
205956|NCT00296504|689685|P4|Interim Analysis|Switched to Commercially Available Drug|1
205957|NCT00296504|689686|P3|Interim Analysis|Switched to Commercially Available Drug|4
205958|NCT00296504|689687|P2|Interim Analysis|Switched to Commercially Available Drug|0
205959|NCT00296504|689688|P1|Interim Analysis|Switched to Commercially Available Drug|2
205960|NCT00296504|689680|P9|Interim Analysis|Insufficient CD4 Response|0
205961|NCT00296504|689681|P8|Interim Analysis|Insufficient CD4 Response|0
205962|NCT00296504|689682|P7|Interim Analysis|Insufficient CD4 Response|0
205963|NCT00296504|689683|P6|Interim Analysis|Insufficient CD4 Response|1
205964|NCT00296504|689684|P5|Interim Analysis|Insufficient CD4 Response|1
205965|NCT00296504|689685|P4|Interim Analysis|Insufficient CD4 Response|0
205966|NCT00296504|689686|P3|Interim Analysis|Insufficient CD4 Response|0
205967|NCT00296504|689687|P2|Interim Analysis|Insufficient CD4 Response|0
205968|NCT00296504|689688|P1|Interim Analysis|Insufficient CD4 Response|0
205969|NCT00296504|689680|P9|Interim Analysis|Protocol Violation|0
205970|NCT00296504|689681|P8|Interim Analysis|Protocol Violation|1
205971|NCT00296504|689682|P7|Interim Analysis|Protocol Violation|0
205972|NCT00296504|689683|P6|Interim Analysis|Protocol Violation|0
205973|NCT00296504|689684|P5|Interim Analysis|Protocol Violation|1
205974|NCT00296504|689685|P4|Interim Analysis|Protocol Violation|0
205975|NCT00296504|689686|P3|Interim Analysis|Protocol Violation|2
205976|NCT00296504|689687|P2|Interim Analysis|Protocol Violation|0
205977|NCT00296504|689688|P1|Interim Analysis|Protocol Violation|0
205978|NCT00296504|689680|P9|Interim Analysis|Adverse Event|0
205979|NCT00296504|689681|P8|Interim Analysis|Adverse Event|5
205980|NCT00296504|689682|P7|Interim Analysis|Adverse Event|4
205981|NCT00296504|689683|P6|Interim Analysis|Adverse Event|3
205982|NCT00296504|689684|P5|Interim Analysis|Adverse Event|6
205983|NCT00296504|689685|P4|Interim Analysis|Adverse Event|4
205984|NCT00296504|689686|P3|Interim Analysis|Adverse Event|13
205985|NCT00296504|689687|P2|Interim Analysis|Adverse Event|0
205986|NCT00296504|689688|P1|Interim Analysis|Adverse Event|0
205987|NCT00296504|689680|P9|Interim Analysis|Insufficient Viral Load Response|0
205988|NCT00296504|689681|P8|Interim Analysis|Insufficient Viral Load Response|24
205989|NCT00296504|689682|P7|Interim Analysis|Insufficient Viral Load Response|2
205990|NCT00296504|689683|P6|Interim Analysis|Insufficient Viral Load Response|9
205991|NCT00296504|689684|P5|Interim Analysis|Insufficient Viral Load Response|7
205992|NCT00296504|689685|P4|Interim Analysis|Insufficient Viral Load Response|2
205993|NCT00296504|689686|P3|Interim Analysis|Insufficient Viral Load Response|12
205994|NCT00296504|689687|P2|Interim Analysis|Insufficient Viral Load Response|1
205995|NCT00296504|689688|P1|Interim Analysis|Insufficient Viral Load Response|5
205996|NCT00296504|689680|P9|Interim Analysis|Clinical Progression|0
205997|NCT00296504|689681|P8|Interim Analysis|Clinical Progression|2
205998|NCT00296504|689682|P7|Interim Analysis|Clinical Progression|1
205999|NCT00296504|689683|P6|Interim Analysis|Clinical Progression|2
206000|NCT00296504|689684|P5|Interim Analysis|Clinical Progression|0
206001|NCT00296504|689685|P4|Interim Analysis|Clinical Progression|1
206002|NCT00296504|689686|P3|Interim Analysis|Clinical Progression|1
206003|NCT00296504|689687|P2|Interim Analysis|Clinical Progression|0
206004|NCT00296504|689688|P1|Interim Analysis|Clinical Progression|1
206005|NCT00296504|689680|P9|Interim Analysis|Lost to Follow-up|0
206006|NCT00296504|689681|P8|Interim Analysis|Lost to Follow-up|4
206007|NCT00296504|689682|P7|Interim Analysis|Lost to Follow-up|11
206008|NCT00296504|689683|P6|Interim Analysis|Lost to Follow-up|4
206009|NCT00296504|689684|P5|Interim Analysis|Lost to Follow-up|14
206010|NCT00296504|689685|P4|Interim Analysis|Lost to Follow-up|8
206011|NCT00296504|689686|P3|Interim Analysis|Lost to Follow-up|26
206012|NCT00296504|689687|P2|Interim Analysis|Lost to Follow-up|3
206013|NCT00296504|689688|P1|Interim Analysis|Lost to Follow-up|13
206014|NCT00296504|689680|P9|Interim Analysis|Withdrawal by Subject|0
206015|NCT00296504|689681|P8|Interim Analysis|Withdrawal by Subject|3
206016|NCT00296504|689682|P7|Interim Analysis|Withdrawal by Subject|9
206017|NCT00296504|689683|P6|Interim Analysis|Withdrawal by Subject|5
206018|NCT00296504|689684|P5|Interim Analysis|Withdrawal by Subject|5
206019|NCT00296504|689685|P4|Interim Analysis|Withdrawal by Subject|0
206020|NCT00296504|689686|P3|Interim Analysis|Withdrawal by Subject|12
206021|NCT00296504|689687|P2|Interim Analysis|Withdrawal by Subject|0
206022|NCT00296504|689688|P1|Interim Analysis|Withdrawal by Subject|8
206023|NCT00296491|689781|P4|Overall Study|Lost to Follow-up|0
206024|NCT00296491|689782|P3|Overall Study|Lost to Follow-up|2
206025|NCT00296491|689783|P2|Overall Study|Lost to Follow-up|2
206026|NCT00296491|689784|P1|Overall Study|Lost to Follow-up|0
206027|NCT00296491|689781|P4|Overall Study|Non-Compliance|14
206028|NCT00296491|689782|P3|Overall Study|Non-Compliance|10
206029|NCT00296491|689783|P2|Overall Study|Non-Compliance|13
206030|NCT00296491|689784|P1|Overall Study|Non-Compliance|12
206031|NCT00296491|689781|P4|Overall Study|Withdrawal by Subject|2
206032|NCT00296491|689782|P3|Overall Study|Withdrawal by Subject|3
206033|NCT00296491|689783|P2|Overall Study|Withdrawal by Subject|3
206034|NCT00296491|689784|P1|Overall Study|Withdrawal by Subject|7
206035|NCT00296491|689781|P4|Overall Study|Withdrawn due to Asthma|4
206036|NCT00296491|689782|P3|Overall Study|Withdrawn due to Asthma|0
206037|NCT00296491|689783|P2|Overall Study|Withdrawn due to Asthma|0
206038|NCT00296491|689784|P1|Overall Study|Withdrawn due to Asthma|0
206039|NCT00296491|689781|P4|Overall Study|Adverse Event|4
206040|NCT00296491|689782|P3|Overall Study|Adverse Event|1
206041|NCT00296491|689783|P2|Overall Study|Adverse Event|3
206042|NCT00296491|689784|P1|Overall Study|Adverse Event|1
206043|NCT00296491|689781|P4|Overall Study|Protocol Violation|3
206044|NCT00296491|689782|P3|Overall Study|Protocol Violation|2
206045|NCT00296491|689783|P2|Overall Study|Protocol Violation|6
206046|NCT00296491|689784|P1|Overall Study|Protocol Violation|4
206047|NCT00296491|689781|P4|Overall Study|Low Pollen Counts|16
206048|NCT00296491|689782|P3|Overall Study|Low Pollen Counts|25
206049|NCT00296491|689783|P2|Overall Study|Low Pollen Counts|26
206050|NCT00296491|689784|P1|Overall Study|Low Pollen Counts|18
206051|NCT00296400|689813|P3|Overall Study|Pregnancy|0
206052|NCT00296400|689814|P2|Overall Study|Pregnancy|2
206053|NCT00296400|689815|P1|Overall Study|Pregnancy|1
206054|NCT00296400|689813|P3|Overall Study|Visit 10 was performed earlier|0
206055|NCT00296400|689814|P2|Overall Study|Visit 10 was performed earlier|1
206056|NCT00296400|689815|P1|Overall Study|Visit 10 was performed earlier|0
206057|NCT00296400|689813|P3|Overall Study|Study specific discontinuation criteria|1
206058|NCT00296400|689814|P2|Overall Study|Study specific discontinuation criteria|0
206059|NCT00296400|689815|P1|Overall Study|Study specific discontinuation criteria|0
206060|NCT00296400|689813|P3|Overall Study|Lost to Follow-up|2
206061|NCT00296400|689814|P2|Overall Study|Lost to Follow-up|1
206062|NCT00296400|689815|P1|Overall Study|Lost to Follow-up|1
206063|NCT00296400|689813|P3|Overall Study|Protocol Violation|1
206064|NCT00296400|689814|P2|Overall Study|Protocol Violation|1
206065|NCT00296400|689815|P1|Overall Study|Protocol Violation|1
206066|NCT00296400|689813|P3|Overall Study|Incorrect enrollment|0
206067|NCT00296400|689814|P2|Overall Study|Incorrect enrollment|0
206068|NCT00296400|689815|P1|Overall Study|Incorrect enrollment|2
206069|NCT00296400|689813|P3|Overall Study|Withdrawal by Subject|2
206070|NCT00296400|689814|P2|Overall Study|Withdrawal by Subject|6
206071|NCT00296400|689815|P1|Overall Study|Withdrawal by Subject|5
206072|NCT00296400|689813|P3|Overall Study|Adverse Event|7
206073|NCT00296400|689814|P2|Overall Study|Adverse Event|7
206074|NCT00296400|689815|P1|Overall Study|Adverse Event|7
206075|NCT00296374|690039|P3|Overall Study|Not specified|1
206076|NCT00296374|690040|P2|Overall Study|Not specified|0
206077|NCT00296374|690041|P1|Overall Study|Not specified|0
206078|NCT00296374|690039|P3|Overall Study|Pregnancy|2
206079|NCT00296374|690040|P2|Overall Study|Pregnancy|0
206080|NCT00296374|690041|P1|Overall Study|Pregnancy|0
206081|NCT00296374|690039|P3|Overall Study|Nephrologist introduced ACE|0
206082|NCT00296374|690040|P2|Overall Study|Nephrologist introduced ACE|1
206083|NCT00296374|690041|P1|Overall Study|Nephrologist introduced ACE|0
206084|NCT00296374|690039|P3|Overall Study|Stopped drug before end of study visit|0
206085|NCT00296374|690040|P2|Overall Study|Stopped drug before end of study visit|1
206086|NCT00296374|690041|P1|Overall Study|Stopped drug before end of study visit|0
206087|NCT00296374|690039|P3|Overall Study|Relocated to another state|0
206088|NCT00296374|690040|P2|Overall Study|Relocated to another state|0
206089|NCT00296374|690041|P1|Overall Study|Relocated to another state|1
206090|NCT00296374|690039|P3|Overall Study|Lost to Follow-up|1
206091|NCT00296374|690040|P2|Overall Study|Lost to Follow-up|1
206092|NCT00296374|690041|P1|Overall Study|Lost to Follow-up|3
206093|NCT00296374|690039|P3|Overall Study|Protocol Violation|3
206094|NCT00296374|690040|P2|Overall Study|Protocol Violation|2
206095|NCT00296374|690041|P1|Overall Study|Protocol Violation|1
206096|NCT00296374|690039|P3|Overall Study|Incorrect enrollment|4
206097|NCT00296374|690040|P2|Overall Study|Incorrect enrollment|3
206098|NCT00296374|690041|P1|Overall Study|Incorrect enrollment|3
206099|NCT00296374|690039|P3|Overall Study|Withdrawal by Subject|11
206100|NCT00296374|690040|P2|Overall Study|Withdrawal by Subject|5
206101|NCT00296374|690041|P1|Overall Study|Withdrawal by Subject|3
206102|NCT00296374|690039|P3|Overall Study|Adverse Event|7
206103|NCT00296374|690040|P2|Overall Study|Adverse Event|10
206104|NCT00296374|690041|P1|Overall Study|Adverse Event|14
206105|NCT00296335|690264|P2|Overall Study|Physician Decision|11
206106|NCT00296335|690265|P1|Overall Study|Physician Decision|3
206107|NCT00296335|690264|P2|Overall Study|Lost to Follow-up|33
206108|NCT00296335|690265|P1|Overall Study|Lost to Follow-up|7
206109|NCT00296335|690264|P2|Overall Study|Adverse Event|27
206110|NCT00296335|690265|P1|Overall Study|Adverse Event|17
206111|NCT00296335|690264|P2|Overall Study|Recurrence|51
206112|NCT00296335|690265|P1|Overall Study|Recurrence|3
206113|NCT00296244|690305|P2|Overall Study|Underwent retransplant|1
206114|NCT00296244|690306|P1|Overall Study|Underwent retransplant|0
206115|NCT00296036|690370|P6|Overall Study|Protocol Violation|3
206116|NCT00296036|690371|P5|Overall Study|Protocol Violation|0
206117|NCT00296036|690372|P4|Overall Study|Protocol Violation|0
206118|NCT00296036|690373|P3|Overall Study|Protocol Violation|0
206119|NCT00296036|690374|P2|Overall Study|Protocol Violation|0
206120|NCT00296036|690375|P1|Overall Study|Protocol Violation|0
206121|NCT00296036|690370|P6|Overall Study|Withdrawal by Subject|1
206122|NCT00296036|690371|P5|Overall Study|Withdrawal by Subject|2
206123|NCT00296036|690372|P4|Overall Study|Withdrawal by Subject|1
206124|NCT00296036|690373|P3|Overall Study|Withdrawal by Subject|2
206125|NCT00296036|690374|P2|Overall Study|Withdrawal by Subject|0
206126|NCT00296036|690375|P1|Overall Study|Withdrawal by Subject|1
206127|NCT00295880|690401|P1|Overall Study|Unit randomization did not occur|1
206128|NCT00295880|690401|P1|Overall Study|IBMI unit could not be volume reduced|1
206129|NCT00295854|690415|P3|Overall Study|not specified|1
206130|NCT00295854|690416|P2|Overall Study|not specified|5
206131|NCT00295854|690417|P1|Overall Study|not specified|3
206132|NCT00295854|690415|P3|Overall Study|required a prohibited medication|0
206133|NCT00295854|690416|P2|Overall Study|required a prohibited medication|0
206134|NCT00295854|690417|P1|Overall Study|required a prohibited medication|1
206135|NCT00295854|690415|P3|Overall Study|did not continue to meet criteria|2
206136|NCT00295854|690416|P2|Overall Study|did not continue to meet criteria|1
206137|NCT00295854|690417|P1|Overall Study|did not continue to meet criteria|1
206138|NCT00295854|690415|P3|Overall Study|Withdrawal by Subject|4
206139|NCT00295854|690416|P2|Overall Study|Withdrawal by Subject|7
206140|NCT00295854|690417|P1|Overall Study|Withdrawal by Subject|3
206141|NCT00295854|690415|P3|Overall Study|Lost to Follow-up|1
206142|NCT00295854|690416|P2|Overall Study|Lost to Follow-up|0
206143|NCT00295854|690417|P1|Overall Study|Lost to Follow-up|2
206144|NCT00295854|690415|P3|Overall Study|Protocol Violation|1
206145|NCT00295854|690416|P2|Overall Study|Protocol Violation|1
206146|NCT00295854|690417|P1|Overall Study|Protocol Violation|1
206147|NCT00295854|690415|P3|Overall Study|Adverse Event|6
206148|NCT00295854|690416|P2|Overall Study|Adverse Event|7
206149|NCT00295854|690417|P1|Overall Study|Adverse Event|7
206150|NCT00295750|690431|P3|Overall Study|Protocol Violation|2
206151|NCT00295750|690432|P2|Overall Study|Protocol Violation|4
206152|NCT00295750|690433|P1|Overall Study|Protocol Violation|2
206153|NCT00295750|690431|P3|Overall Study|Withdrawal by Subject|7
206154|NCT00295750|690432|P2|Overall Study|Withdrawal by Subject|4
206155|NCT00295750|690433|P1|Overall Study|Withdrawal by Subject|9
206156|NCT00295750|690431|P3|Overall Study|Randomized but never received trial drug|3
206157|NCT00295750|690432|P2|Overall Study|Randomized but never received trial drug|3
206158|NCT00295750|690433|P1|Overall Study|Randomized but never received trial drug|4
206159|NCT00295750|690431|P3|Overall Study|Personal reasons|0
206160|NCT00295750|690432|P2|Overall Study|Personal reasons|1
206161|NCT00295750|690433|P1|Overall Study|Personal reasons|0
206162|NCT00295750|690431|P3|Overall Study|Disease progression|0
206163|NCT00295750|690432|P2|Overall Study|Disease progression|1
206164|NCT00295750|690433|P1|Overall Study|Disease progression|2
206165|NCT00295750|690431|P3|Overall Study|Trial drug errors|0
206166|NCT00295750|690432|P2|Overall Study|Trial drug errors|1
206167|NCT00295750|690433|P1|Overall Study|Trial drug errors|1
206168|NCT00295750|690431|P3|Overall Study|Administrative errors|5
206169|NCT00295750|690432|P2|Overall Study|Administrative errors|4
206170|NCT00295750|690433|P1|Overall Study|Administrative errors|2
206171|NCT00295750|690431|P3|Overall Study|Taking prohibited therapy|2
206172|NCT00295750|690432|P2|Overall Study|Taking prohibited therapy|3
206173|NCT00295750|690433|P1|Overall Study|Taking prohibited therapy|2
206174|NCT00295750|690431|P3|Overall Study|Lost to Follow-up|1
206175|NCT00295750|690432|P2|Overall Study|Lost to Follow-up|4
206176|NCT00295750|690433|P1|Overall Study|Lost to Follow-up|1
206177|NCT00295750|690431|P3|Overall Study|Lack of Efficacy|0
206178|NCT00295750|690432|P2|Overall Study|Lack of Efficacy|1
206179|NCT00295750|690433|P1|Overall Study|Lack of Efficacy|1
206180|NCT00295750|690431|P3|Overall Study|Adverse Event|12
206181|NCT00295750|690432|P2|Overall Study|Adverse Event|15
206182|NCT00295750|690433|P1|Overall Study|Adverse Event|19
206183|NCT00295633|690468|P3|Overall Study|Administrative reason by sponsor|1
206184|NCT00295633|690469|P2|Overall Study|Administrative reason by sponsor|0
206185|NCT00295633|690470|P1|Overall Study|Administrative reason by sponsor|0
206186|NCT00295633|690468|P3|Overall Study|Death|0
206187|NCT00295633|690469|P2|Overall Study|Death|1
206188|NCT00295633|690470|P1|Overall Study|Death|1
206189|NCT00295633|690468|P3|Overall Study|Subject No Longer Meets Study Criteria|3
206190|NCT00295633|690469|P2|Overall Study|Subject No Longer Meets Study Criteria|3
206191|NCT00295633|690470|P1|Overall Study|Subject No Longer Meets Study Criteria|0
206192|NCT00295633|690468|P3|Overall Study|Poor/Noncompliance|6
206193|NCT00295633|690469|P2|Overall Study|Poor/Noncompliance|2
206194|NCT00295633|690470|P1|Overall Study|Poor/Noncompliance|2
206195|NCT00295633|690468|P3|Overall Study|Physician Decision|8
206196|NCT00295633|690469|P2|Overall Study|Physician Decision|10
206197|NCT00295633|690470|P1|Overall Study|Physician Decision|9
206198|NCT00295633|690468|P3|Overall Study|Lost to Follow-up|7
206199|NCT00295633|690469|P2|Overall Study|Lost to Follow-up|11
206200|NCT00295633|690470|P1|Overall Study|Lost to Follow-up|6
206201|NCT00295633|690468|P3|Overall Study|Adverse Event|9
206202|NCT00295633|690469|P2|Overall Study|Adverse Event|17
206203|NCT00295633|690470|P1|Overall Study|Adverse Event|9
206204|NCT00295633|690468|P3|Overall Study|Withdrawal of consent by subject|26
206205|NCT00295633|690469|P2|Overall Study|Withdrawal of consent by subject|16
206206|NCT00295633|690470|P1|Overall Study|Withdrawal of consent by subject|16
206207|NCT00295633|690468|P3|Overall Study|Lack of Efficacy|16
206208|NCT00295633|690469|P2|Overall Study|Lack of Efficacy|7
206209|NCT00295633|690470|P1|Overall Study|Lack of Efficacy|19
206210|NCT00295490|690497|P4|Overall Study|Other|1
206211|NCT00295490|690498|P3|Overall Study|Other|0
206212|NCT00295490|690499|P2|Overall Study|Other|2
206213|NCT00295490|690500|P1|Overall Study|Other|0
206214|NCT00295490|690497|P4|Overall Study|Adverse Event|0
206215|NCT00295490|690498|P3|Overall Study|Adverse Event|0
206216|NCT00295490|690499|P2|Overall Study|Adverse Event|0
206217|NCT00295490|690500|P1|Overall Study|Adverse Event|1
206218|NCT00295490|690497|P4|Overall Study|Lost to Follow-up|0
206219|NCT00295490|690498|P3|Overall Study|Lost to Follow-up|1
206220|NCT00295490|690499|P2|Overall Study|Lost to Follow-up|0
206221|NCT00295490|690500|P1|Overall Study|Lost to Follow-up|0
206222|NCT00295490|690497|P4|Overall Study|Withdrawal by Subject|1
206223|NCT00295490|690498|P3|Overall Study|Withdrawal by Subject|0
206224|NCT00295490|690499|P2|Overall Study|Withdrawal by Subject|2
206225|NCT00295490|690500|P1|Overall Study|Withdrawal by Subject|0
206226|NCT00295490|690497|P4|Overall Study|Protocol Violation|3
206227|NCT00295490|690498|P3|Overall Study|Protocol Violation|3
206228|NCT00295490|690499|P2|Overall Study|Protocol Violation|0
206229|NCT00295490|690500|P1|Overall Study|Protocol Violation|0
206230|NCT00294762|690580|P2|Overall Study|Did not receive study treatment|3
206231|NCT00294762|690581|P1|Overall Study|Did not receive study treatment|3
206232|NCT00294723|690600|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
206233|NCT00294723|690601|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
206234|NCT00294723|690602|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
206235|NCT00294723|690600|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
206236|NCT00294723|690601|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
206237|NCT00294723|690602|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
206238|NCT00294723|690600|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
206239|NCT00294723|690601|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
206240|NCT00294723|690602|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
206241|NCT00294723|690600|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
206242|NCT00294723|690601|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
206243|NCT00294723|690602|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
206244|NCT00294723|690600|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
206245|NCT00294723|690601|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
206246|NCT00294723|690602|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
206247|NCT00294723|690600|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
206248|NCT00294723|690601|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
206249|NCT00294723|690602|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
206250|NCT00294723|690600|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
206251|NCT00294723|690601|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
206252|NCT00294723|690602|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
206253|NCT00294723|690600|P3|Open-Label Extension 52 Weeks|Adverse Event|2
206254|NCT00294723|690601|P2|Open-Label Extension 52 Weeks|Adverse Event|5
206255|NCT00294723|690602|P1|Open-Label Extension 52 Weeks|Adverse Event|5
206256|NCT00294723|690600|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
206257|NCT00294723|690601|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
206258|NCT00294723|690602|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
206259|NCT00294723|690600|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
206260|NCT00294723|690601|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
206261|NCT00294723|690602|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
206262|NCT00294723|690600|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
206263|NCT00294723|690601|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
206264|NCT00294723|690602|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
206265|NCT00294723|690600|P3|Double-Blind Period 52 Weeks|Adverse Event|15
206266|NCT00294723|690601|P2|Double-Blind Period 52 Weeks|Adverse Event|25
206267|NCT00294723|690602|P1|Double-Blind Period 52 Weeks|Adverse Event|18
206268|NCT00294684|690663|P2|Overall Study|Lost to Follow-up|8
206269|NCT00294684|690664|P1|Overall Study|Lost to Follow-up|5
206270|NCT00294671|690704|P2|Overall Study|Death|1
206271|NCT00294671|690705|P1|Overall Study|Death|0
206272|NCT00294671|690704|P2|Overall Study|Non-compliance|0
206273|NCT00294671|690705|P1|Overall Study|Non-compliance|1
206274|NCT00294671|690704|P2|Overall Study|Lost to Follow-up|3
206275|NCT00294671|690705|P1|Overall Study|Lost to Follow-up|1
206276|NCT00294671|690704|P2|Overall Study|Non-drug related AE|2
206277|NCT00294671|690705|P1|Overall Study|Non-drug related AE|3
206278|NCT00294671|690704|P2|Overall Study|Drug related adverse event (AE)|2
206279|NCT00294671|690705|P1|Overall Study|Drug related adverse event (AE)|4
206280|NCT00294671|690704|P2|Overall Study|Liver transplant|9
206281|NCT00294671|690705|P1|Overall Study|Liver transplant|7
206282|NCT00294671|690704|P2|Overall Study|Lack of Efficacy|23
206283|NCT00294671|690705|P1|Overall Study|Lack of Efficacy|11
206284|NCT00294658|690721|P2|Overall Study|Patient and family were not satisfied|1
206285|NCT00294658|690722|P1|Overall Study|Patient and family were not satisfied|0
206286|NCT00294658|690721|P2|Overall Study|Found to have invasive thymoma|0
206287|NCT00294658|690722|P1|Overall Study|Found to have invasive thymoma|1
206288|NCT00294658|690721|P2|Overall Study|Withdrawal by Subject|4
206289|NCT00294658|690722|P1|Overall Study|Withdrawal by Subject|0
206290|NCT00294658|690721|P2|Overall Study|Pregnancy|1
206291|NCT00294658|690722|P1|Overall Study|Pregnancy|0
206292|NCT00294658|690721|P2|Overall Study|Physician Decision|2
206293|NCT00294658|690722|P1|Overall Study|Physician Decision|1
206294|NCT00294658|690721|P2|Overall Study|Lost to Follow-up|0
206295|NCT00294658|690722|P1|Overall Study|Lost to Follow-up|4
206296|NCT00294658|690721|P2|Overall Study|Death|1
206297|NCT00294658|690722|P1|Overall Study|Death|0
206298|NCT00294645|690786|P2|Overall Study|Other|10
206299|NCT00294645|690787|P1|Overall Study|Other|4
206300|NCT00294645|690786|P2|Overall Study|Physician Decision|20
206301|NCT00294645|690787|P1|Overall Study|Physician Decision|15
206302|NCT00294645|690786|P2|Overall Study|Withdrawal by Subject|34
206303|NCT00294645|690787|P1|Overall Study|Withdrawal by Subject|18
206304|NCT00294645|690786|P2|Overall Study|Lost to Follow-up|10
206305|NCT00294645|690787|P1|Overall Study|Lost to Follow-up|1
206306|NCT00294645|690786|P2|Overall Study|Death|18
206307|NCT00294645|690787|P1|Overall Study|Death|10
206308|NCT00294554|690821|P2|Overall Study|Physician Decision|1
206309|NCT00294554|690822|P1|Overall Study|Physician Decision|0
206310|NCT00294554|690821|P2|Overall Study|Lack of Efficacy|1
206311|NCT00294554|690822|P1|Overall Study|Lack of Efficacy|0
206312|NCT00294398|690849|P2|Overall Study|Lost to Follow-up|26
206313|NCT00294398|690850|P1|Overall Study|Lost to Follow-up|21
206314|NCT00294060|690858|P1|Overall Study|Device explanted/not replaced|23
206315|NCT00294060|690858|P1|Overall Study|Medical condition|3
206316|NCT00294060|690858|P1|Overall Study|Physician Decision|797
206317|NCT00294060|690858|P1|Overall Study|Withdrawal by Subject|11
206318|NCT00294060|690858|P1|Overall Study|Lost to Follow-up|55
206319|NCT00294060|690858|P1|Overall Study|Other|59
206320|NCT00294060|690858|P1|Overall Study|Death|225
206321|NCT00294047|690866|P2|Month 84|No consent for Month 84 Follow-up|754
206322|NCT00294047|690867|P1|Month 84|No consent for Month 84 Follow-up|731
206323|NCT00294047|690866|P2|Month 84|Visit missed|1
206324|NCT00294047|690867|P1|Month 84|Visit missed|0
206325|NCT00294047|690866|P2|Month 84|Under investigation locally|0
206326|NCT00294047|690867|P1|Month 84|Under investigation locally|1
206327|NCT00294047|690866|P2|Month 84|Unable to reach study site|0
206328|NCT00294047|690867|P1|Month 84|Unable to reach study site|1
206329|NCT00294047|690866|P2|Month 84|Transport reimbursement delayed|1
206330|NCT00294047|690867|P1|Month 84|Transport reimbursement delayed|0
206331|NCT00294047|690866|P2|Month 84|Subject does not want male physician|0
206332|NCT00294047|690867|P1|Month 84|Subject does not want male physician|1
206333|NCT00294047|690866|P2|Month 84|Personal reason|4
206334|NCT00294047|690867|P1|Month 84|Personal reason|2
206335|NCT00294047|690866|P2|Month 84|Lack of time|1
206336|NCT00294047|690867|P1|Month 84|Lack of time|3
206337|NCT00294047|690866|P2|Month 84|Family problems|2
206338|NCT00294047|690867|P1|Month 84|Family problems|2
206339|NCT00294047|690866|P2|Month 84|Center closed, subject did not transfer|0
206340|NCT00294047|690867|P1|Month 84|Center closed, subject did not transfer|1
206341|NCT00294047|690866|P2|Month 84|Work related reasons|2
206342|NCT00294047|690867|P1|Month 84|Work related reasons|4
206343|NCT00294047|690866|P2|Month 84|Absent Cervix|0
206344|NCT00294047|690867|P1|Month 84|Absent Cervix|2
206345|NCT00294047|690866|P2|Month 84|Lost to Follow-up|190
206346|NCT00294047|690867|P1|Month 84|Lost to Follow-up|187
206347|NCT00294047|690866|P2|Month 84|Withdrawal by Subject|31
206348|NCT00294047|690867|P1|Month 84|Withdrawal by Subject|33
206349|NCT00294047|690866|P2|Month 84|Protocol Violation|1
206350|NCT00294047|690867|P1|Month 84|Protocol Violation|1
206351|NCT00294047|690866|P2|Month 84|Adverse Event|2
206352|NCT00294047|690867|P1|Month 84|Adverse Event|4
206353|NCT00294047|690866|P2|Month 48|Other|14
206354|NCT00294047|690867|P1|Month 48|Other|10
206355|NCT00294047|690866|P2|Month 48|Lost to Follow-up|287
206356|NCT00294047|690867|P1|Month 48|Lost to Follow-up|272
206357|NCT00294047|690866|P2|Month 48|Withdrawal by Subject|115
206358|NCT00294047|690867|P1|Month 48|Withdrawal by Subject|111
206359|NCT00294047|690866|P2|Month 48|Protocol Violation|4
206360|NCT00294047|690867|P1|Month 48|Protocol Violation|4
206361|NCT00294047|690866|P2|Month 48|Adverse Event|13
206362|NCT00294047|690867|P1|Month 48|Adverse Event|28
206363|NCT00293813|690972|P3|Overall Study|Noncompliance|0
206364|NCT00293813|690973|P2|Overall Study|Noncompliance|1
206365|NCT00293813|690974|P1|Overall Study|Noncompliance|0
206366|NCT00293813|690972|P3|Overall Study|Lost to Follow-up|3
206367|NCT00293813|690973|P2|Overall Study|Lost to Follow-up|2
206368|NCT00293813|690974|P1|Overall Study|Lost to Follow-up|3
206369|NCT00293813|690972|P3|Overall Study|Withdrawal by Subject|4
206370|NCT00293813|690973|P2|Overall Study|Withdrawal by Subject|4
206371|NCT00293813|690974|P1|Overall Study|Withdrawal by Subject|7
206372|NCT00293813|690972|P3|Overall Study|Adverse Event|1
206373|NCT00293813|690973|P2|Overall Study|Adverse Event|1
206374|NCT00293813|690974|P1|Overall Study|Adverse Event|3
206375|NCT00293813|690972|P3|Overall Study|Physician Decision|0
206376|NCT00293813|690973|P2|Overall Study|Physician Decision|1
206377|NCT00293813|690974|P1|Overall Study|Physician Decision|0
206378|NCT00293722|690985|P1|Overall Study|Other|427
206379|NCT00293709|690999|P1|Overall Study|Other|47
206380|NCT00293579|691013|P1|Overall Study|Withdrawal by Subject|1
206381|NCT00293462|691032|P3|Overall Study|Physician Decision|0
206382|NCT00293462|691033|P2|Overall Study|Physician Decision|1
206383|NCT00293462|691034|P1|Overall Study|Physician Decision|0
206384|NCT00293462|691032|P3|Overall Study|Low radiation dose in oral cavity|0
206385|NCT00293462|691033|P2|Overall Study|Low radiation dose in oral cavity|1
206386|NCT00293462|691034|P1|Overall Study|Low radiation dose in oral cavity|0
206387|NCT00293462|691032|P3|Overall Study|Possible Tracheostomy leakage|0
206388|NCT00293462|691033|P2|Overall Study|Possible Tracheostomy leakage|1
206389|NCT00293462|691034|P1|Overall Study|Possible Tracheostomy leakage|0
206390|NCT00293462|691032|P3|Overall Study|Ischemic stroke after chemotherapy|1
206391|NCT00293462|691033|P2|Overall Study|Ischemic stroke after chemotherapy|0
206392|NCT00293462|691034|P1|Overall Study|Ischemic stroke after chemotherapy|0
206393|NCT00293462|691032|P3|Overall Study|Blood clot after chemotherapy|1
206394|NCT00293462|691033|P2|Overall Study|Blood clot after chemotherapy|0
206395|NCT00293462|691034|P1|Overall Study|Blood clot after chemotherapy|0
206396|NCT00293462|691032|P3|Overall Study|Went back to his home country|1
206397|NCT00293462|691033|P2|Overall Study|Went back to his home country|0
206398|NCT00293462|691034|P1|Overall Study|Went back to his home country|0
206399|NCT00293462|691032|P3|Overall Study|No Show|1
206400|NCT00293462|691033|P2|Overall Study|No Show|0
206401|NCT00293462|691034|P1|Overall Study|No Show|0
206402|NCT00293462|691032|P3|Overall Study|Refuse Radiation Treatment|0
206403|NCT00293462|691033|P2|Overall Study|Refuse Radiation Treatment|0
206404|NCT00293462|691034|P1|Overall Study|Refuse Radiation Treatment|1
206405|NCT00293462|691032|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
206406|NCT00293462|691033|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
206407|NCT00293462|691034|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
206408|NCT00293462|691032|P3|Overall Study|Change Treatment Regimen (ineligible)|0
206409|NCT00293462|691033|P2|Overall Study|Change Treatment Regimen (ineligible)|0
206410|NCT00293462|691034|P1|Overall Study|Change Treatment Regimen (ineligible)|1
206411|NCT00293462|691032|P3|Overall Study|Lost to Follow-up|0
206412|NCT00293462|691033|P2|Overall Study|Lost to Follow-up|1
206413|NCT00293462|691034|P1|Overall Study|Lost to Follow-up|0
206414|NCT00293462|691032|P3|Overall Study|Death|0
206415|NCT00293462|691033|P2|Overall Study|Death|0
206416|NCT00293462|691034|P1|Overall Study|Death|1
206417|NCT00293462|691032|P3|Overall Study|Withdrawal by Subject|6
206418|NCT00293462|691033|P2|Overall Study|Withdrawal by Subject|3
206419|NCT00293462|691034|P1|Overall Study|Withdrawal by Subject|4
206420|NCT00293384|691053|P1|Overall Study|Ineligible|2
206421|NCT00293384|691053|P1|Overall Study|Missed dosage/study drug|1
206422|NCT00293384|691053|P1|Overall Study|Non-compliance|2
206423|NCT00293293|691062|P2|Overall Study|Patient discontinued chemotherapy|1
206424|NCT00293293|691063|P1|Overall Study|Patient discontinued chemotherapy|0
206425|NCT00293293|691062|P2|Overall Study|"Patient too anxious to complete trial"|0
206426|NCT00293293|691063|P1|Overall Study|"Patient too anxious to complete trial"|1
206427|NCT00293293|691062|P2|Overall Study|Withdrawal by Subject|1
206428|NCT00293293|691063|P1|Overall Study|Withdrawal by Subject|1
206429|NCT00293267|691091|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
206430|NCT00293267|691092|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
206431|NCT00293267|691091|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
206432|NCT00293267|691092|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
206433|NCT00293267|691091|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
206434|NCT00293267|691092|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
206435|NCT00293267|691091|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
206436|NCT00293267|691092|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
206437|NCT00293267|691091|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
206438|NCT00293267|691092|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
206439|NCT00293267|691091|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
206440|NCT00293267|691092|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
206441|NCT00293267|691091|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
206442|NCT00293267|691092|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
206443|NCT00293267|691091|P2|Extension - Open-Label Week 157-240|Other Reason|1
206444|NCT00293267|691092|P1|Extension - Open-Label Week 157-240|Other Reason|3
206445|NCT00293267|691091|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
206446|NCT00293267|691092|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
206447|NCT00293267|691091|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
206448|NCT00293267|691092|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
206449|NCT00293267|691091|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
206450|NCT00293267|691092|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
206451|NCT00293267|691091|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
206452|NCT00293267|691092|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
206453|NCT00293267|691091|P2|Extension - Open-Label Week 157-240|Adverse Event|0
206454|NCT00293267|691092|P1|Extension - Open-Label Week 157-240|Adverse Event|5
206455|NCT00293267|691091|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
206456|NCT00293267|691092|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
206457|NCT00293267|691091|P2|Extension - Double-Blind Week 49-156|Other Reason|0
206458|NCT00293267|691092|P1|Extension - Double-Blind Week 49-156|Other Reason|7
206459|NCT00293267|691091|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
206460|NCT00293267|691092|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
206461|NCT00293267|691091|P2|Extension - Double-Blind Week 49-156|Death|0
206462|NCT00293267|691092|P1|Extension - Double-Blind Week 49-156|Death|3
206463|NCT00293267|691091|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
206464|NCT00293267|691092|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
206465|NCT00293267|691091|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
206466|NCT00293267|691092|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
206467|NCT00293267|691091|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
206468|NCT00293267|691092|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
206469|NCT00293267|691091|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
206470|NCT00293267|691092|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
206471|NCT00293267|691091|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
206472|NCT00293267|691092|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
206473|NCT00293267|691091|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
206474|NCT00293267|691092|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
206475|NCT00293267|691091|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
206476|NCT00293267|691092|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
206477|NCT00293267|691091|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
206478|NCT00293267|691092|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
206479|NCT00293267|691091|P2|Primary Study - Double-Blind Week 0-48|Death|3
206480|NCT00293267|691092|P1|Primary Study - Double-Blind Week 0-48|Death|3
206481|NCT00293267|691091|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
206482|NCT00293267|691092|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
206483|NCT00293267|691091|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
206484|NCT00293267|691092|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
206485|NCT00293254|691132|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
206486|NCT00293254|691133|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
206487|NCT00293254|691132|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
206488|NCT00293254|691133|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
206489|NCT00293254|691132|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
206490|NCT00293254|691133|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
206491|NCT00293254|691132|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
206492|NCT00293254|691133|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
206493|NCT00293254|691132|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
206494|NCT00293254|691133|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
206495|NCT00293254|691132|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
206496|NCT00293254|691133|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
206497|NCT00293254|691132|P2|Extension - Open-Label Week 157-240|Other Reason|0
206498|NCT00293254|691133|P1|Extension - Open-Label Week 157-240|Other Reason|4
206499|NCT00293254|691132|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
206500|NCT00293254|691133|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
206501|NCT00293254|691132|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
206502|NCT00293254|691133|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
206503|NCT00293254|691132|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
206504|NCT00293254|691133|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
206505|NCT00293254|691132|P2|Extension - Open-Label Week 157-240|Adverse Event|1
206506|NCT00293254|691133|P1|Extension - Open-Label Week 157-240|Adverse Event|2
206507|NCT00293254|691132|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
206508|NCT00293254|691133|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
206509|NCT00293254|691132|P2|Extension - Double-Blind Week 49-156|Other Reason|2
206510|NCT00293254|691133|P1|Extension - Double-Blind Week 49-156|Other Reason|10
206511|NCT00293254|691132|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
206512|NCT00293254|691133|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
206513|NCT00293254|691132|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
206514|NCT00293254|691133|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
206515|NCT00293254|691132|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
206516|NCT00293254|691133|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
206517|NCT00293254|691132|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
206518|NCT00293254|691133|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
206519|NCT00293254|691132|P2|Extension - Double-Blind Week 49-156|Death|1
206520|NCT00293254|691133|P1|Extension - Double-Blind Week 49-156|Death|4
206521|NCT00293254|691132|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
206522|NCT00293254|691133|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
206523|NCT00293254|691132|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
206524|NCT00293254|691133|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
206525|NCT00293254|691132|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
206526|NCT00293254|691133|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
206527|NCT00293254|691132|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
206528|NCT00293254|691133|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
206529|NCT00293254|691132|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
206530|NCT00293254|691133|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
206531|NCT00293254|691132|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
206532|NCT00293254|691133|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
206533|NCT00293254|691132|P2|Primary Study - Double-Blind Week 0-48|Death|2
206534|NCT00293254|691133|P1|Primary Study - Double-Blind Week 0-48|Death|5
206535|NCT00293254|691132|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
206536|NCT00293254|691133|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
206537|NCT00293254|691132|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
206538|NCT00293254|691133|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
206539|NCT00293241|691173|P2|Overall Study|Withdrawal by Subject|8
206540|NCT00293241|691174|P1|Overall Study|Withdrawal by Subject|4
206541|NCT00293241|691173|P2|Overall Study|Physician Decision|17
206542|NCT00293241|691174|P1|Overall Study|Physician Decision|23
206543|NCT00293241|691173|P2|Overall Study|Lost to Follow-up|16
206544|NCT00293241|691174|P1|Overall Study|Lost to Follow-up|9
206545|NCT00293059|691218|P2|Overall Study|missing|5
206546|NCT00293059|691219|P1|Overall Study|missing|3
206547|NCT00293059|691218|P2|Overall Study|Noncompliant - sanitary pads collection|1
206548|NCT00293059|691219|P1|Overall Study|Noncompliant - sanitary pads collection|0
206549|NCT00293059|691218|P2|Overall Study|Participant stopped study drug|0
206550|NCT00293059|691219|P1|Overall Study|Participant stopped study drug|1
206551|NCT00293059|691218|P2|Overall Study|Participant moved out of state|0
206552|NCT00293059|691219|P1|Overall Study|Participant moved out of state|1
206553|NCT00293059|691218|P2|Overall Study|Withdrawal by Subject|5
206554|NCT00293059|691219|P1|Overall Study|Withdrawal by Subject|11
206555|NCT00293059|691218|P2|Overall Study|Protocol Violation|0
206556|NCT00293059|691219|P1|Overall Study|Protocol Violation|2
206557|NCT00293059|691218|P2|Overall Study|Pregnancy|1
206558|NCT00293059|691219|P1|Overall Study|Pregnancy|1
206559|NCT00293059|691218|P2|Overall Study|Lost to Follow-up|3
206560|NCT00293059|691219|P1|Overall Study|Lost to Follow-up|2
206561|NCT00293059|691218|P2|Overall Study|Lack of Efficacy|0
206562|NCT00293059|691219|P1|Overall Study|Lack of Efficacy|2
206563|NCT00293059|691218|P2|Overall Study|Adverse Event|4
206564|NCT00293059|691219|P1|Overall Study|Adverse Event|12
206565|NCT00293020|691331|P1|Overall Study|No dose taken|1
206566|NCT00293020|691331|P1|Overall Study|Other Reason|22
206567|NCT00293020|691331|P1|Overall Study|Physician Decision|21
206568|NCT00293020|691331|P1|Overall Study|Protocol Violation|6
206569|NCT00293020|691331|P1|Overall Study|Lost to Follow-up|4
206570|NCT00293020|691331|P1|Overall Study|Lack of Efficacy|12
206571|NCT00293020|691331|P1|Overall Study|Death|32
206572|NCT00293020|691331|P1|Overall Study|Adverse Event|30
206573|NCT00293020|691331|P1|Overall Study|Withdrawal by Subject|34
206574|NCT00292981|691335|P1|Overall Study|Not specified|3
206575|NCT00292981|691335|P1|Overall Study|Withdrawal by Subject|22
206576|NCT00292981|691335|P1|Overall Study|Lost to Follow-up|13
206577|NCT00292981|691335|P1|Overall Study|Adverse Event|1
206578|NCT00292461|691357|P2|Overall Study|Lost to Follow-up|0
206579|NCT00292461|691358|P1|Overall Study|Lost to Follow-up|1
206580|NCT00292461|691357|P2|Overall Study|Protocol Violation|3
206581|NCT00292461|691358|P1|Overall Study|Protocol Violation|4
206582|NCT00292461|691357|P2|Overall Study|Withdrawal by Subject|1
206583|NCT00292461|691358|P1|Overall Study|Withdrawal by Subject|0
206584|NCT00292461|691357|P2|Overall Study|Lack of Efficacy|0
206585|NCT00292461|691358|P1|Overall Study|Lack of Efficacy|1
206586|NCT00292461|691357|P2|Overall Study|Adverse Event|2
206587|NCT00292461|691358|P1|Overall Study|Adverse Event|4
206588|NCT00292370|691373|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
206589|NCT00292370|691374|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
206590|NCT00292370|691375|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
206591|NCT00292370|691373|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
206592|NCT00292370|691374|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
206593|NCT00292370|691375|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
206594|NCT00292370|691373|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
206595|NCT00292370|691374|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
206596|NCT00292370|691375|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
206597|NCT00292370|691373|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
206598|NCT00292370|691374|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
206599|NCT00292370|691375|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
206600|NCT00292370|691373|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
206601|NCT00292370|691374|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
206602|NCT00292370|691375|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
206603|NCT00292370|691373|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
206604|NCT00292370|691374|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
206605|NCT00292370|691375|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
206606|NCT00292318|691384|P2|Overall Study|Study terminated by officials|1
206607|NCT00292318|691385|P1|Overall Study|Study terminated by officials|2
206608|NCT00292227|691395|P3|Patch Period|Withdrawal by Subject|1
206609|NCT00292227|691396|P2|Patch Period|Withdrawal by Subject|0
206610|NCT00292227|691397|P1|Patch Period|Withdrawal by Subject|0
206611|NCT00292227|691395|P3|Patch Period|Adverse Event|2
206612|NCT00292227|691396|P2|Patch Period|Adverse Event|0
206613|NCT00292227|691397|P1|Patch Period|Adverse Event|1
206614|NCT00292188|691479|P3|Double-Blind|Laboratory Abnormality|1
206615|NCT00292188|691480|P2|Double-Blind|Laboratory Abnormality|0
206616|NCT00292188|691481|P1|Double-Blind|Laboratory Abnormality|0
206617|NCT00292188|691479|P3|Double-Blind|Withdrawal by Subject|3
206618|NCT00292188|691480|P2|Double-Blind|Withdrawal by Subject|0
206619|NCT00292188|691481|P1|Double-Blind|Withdrawal by Subject|0
206620|NCT00292188|691479|P3|Double-Blind|Other|4
206621|NCT00292188|691480|P2|Double-Blind|Other|3
206622|NCT00292188|691481|P1|Double-Blind|Other|0
206623|NCT00292188|691479|P3|Double-Blind|Lost to Follow-up|0
206624|NCT00292188|691480|P2|Double-Blind|Lost to Follow-up|1
206625|NCT00292188|691481|P1|Double-Blind|Lost to Follow-up|0
206626|NCT00292188|691479|P3|Double-Blind|Lack of Efficacy|12
206627|NCT00292188|691480|P2|Double-Blind|Lack of Efficacy|2
206628|NCT00292188|691481|P1|Double-Blind|Lack of Efficacy|0
206629|NCT00292188|691479|P3|Double-Blind|Adverse Event|9
206630|NCT00292188|691480|P2|Double-Blind|Adverse Event|25
206631|NCT00292188|691481|P1|Double-Blind|Adverse Event|0
206632|NCT00292188|691479|P3|Single-Blind|Did not receive treatment|0
206633|NCT00292188|691480|P2|Single-Blind|Did not receive treatment|0
206634|NCT00292188|691481|P1|Single-Blind|Did not receive treatment|1
206635|NCT00292188|691479|P3|Single-Blind|Withdrawal by Subject|0
206636|NCT00292188|691480|P2|Single-Blind|Withdrawal by Subject|0
206637|NCT00292188|691481|P1|Single-Blind|Withdrawal by Subject|12
206638|NCT00292188|691479|P3|Single-Blind|Other|0
206639|NCT00292188|691480|P2|Single-Blind|Other|0
206640|NCT00292188|691481|P1|Single-Blind|Other|77
206641|NCT00292188|691479|P3|Single-Blind|Lost to Follow-up|0
206642|NCT00292188|691480|P2|Single-Blind|Lost to Follow-up|0
206643|NCT00292188|691481|P1|Single-Blind|Lost to Follow-up|3
206644|NCT00292188|691479|P3|Single-Blind|Laboratory Abnormality|0
206645|NCT00292188|691480|P2|Single-Blind|Laboratory Abnormality|0
206646|NCT00292188|691481|P1|Single-Blind|Laboratory Abnormality|5
206647|NCT00292188|691479|P3|Single-Blind|Lack of Efficacy|0
206648|NCT00292188|691480|P2|Single-Blind|Lack of Efficacy|0
206649|NCT00292188|691481|P1|Single-Blind|Lack of Efficacy|2
206650|NCT00292188|691479|P3|Single-Blind|Adverse Event|0
206651|NCT00292188|691480|P2|Single-Blind|Adverse Event|0
206652|NCT00292188|691481|P1|Single-Blind|Adverse Event|14
206653|NCT00291577|691593|P1|Overall Study|Lack of Efficacy|14
206654|NCT00291577|691593|P1|Overall Study|Withdrawal by Subject|2
206655|NCT00291577|691593|P1|Overall Study|Other|4
206656|NCT00291577|691593|P1|Overall Study|Adverse Event|1
206657|NCT00291551|691612|P1|Overall Study|Withdrawal by Subject|6
206658|NCT00291551|691612|P1|Overall Study|Death|7
206659|NCT00291330|691660|P2|Overall Study|Other|1
206660|NCT00291330|691661|P1|Overall Study|Other|3
206661|NCT00291330|691660|P2|Overall Study|Withdrawal by Subject|25
206662|NCT00291330|691661|P1|Overall Study|Withdrawal by Subject|22
206663|NCT00291330|691660|P2|Overall Study|Lost to Follow-up|11
206664|NCT00291330|691661|P1|Overall Study|Lost to Follow-up|16
206665|NCT00291330|691660|P2|Overall Study|Protocol Violation|20
206666|NCT00291330|691661|P1|Overall Study|Protocol Violation|13
206667|NCT00291330|691660|P2|Overall Study|Adverse Event|40
206668|NCT00291330|691661|P1|Overall Study|Adverse Event|47
206669|NCT00291187|691703|P4|Overall Study|Protocol Violation- No Drug Administered|0
206670|NCT00291187|691704|P3|Overall Study|Protocol Violation- No Drug Administered|1
206671|NCT00291187|691705|P2|Overall Study|Protocol Violation- No Drug Administered|0
206672|NCT00291187|691706|P1|Overall Study|Protocol Violation- No Drug Administered|0
206673|NCT00291018|691750|P3|Overall Study|Lost to Follow-up|18
206674|NCT00291018|691751|P2|Overall Study|Lost to Follow-up|4
206675|NCT00291018|691752|P1|Overall Study|Lost to Follow-up|3
206676|NCT00291018|691750|P3|Overall Study|Failures|5
206677|NCT00291018|691751|P2|Overall Study|Failures|12
206678|NCT00291018|691752|P1|Overall Study|Failures|5
206679|NCT00291018|691750|P3|Overall Study|Withdrawal by Subject|1
206680|NCT00291018|691751|P2|Overall Study|Withdrawal by Subject|8
206681|NCT00291018|691752|P1|Overall Study|Withdrawal by Subject|2
206682|NCT00291018|691750|P3|Overall Study|Death|4
206683|NCT00291018|691751|P2|Overall Study|Death|3
206684|NCT00291018|691752|P1|Overall Study|Death|3
206685|NCT00291018|691750|P3|Overall Study|Not Consented or Declined PAS|15
206686|NCT00291018|691751|P2|Overall Study|Not Consented or Declined PAS|15
206687|NCT00291018|691752|P1|Overall Study|Not Consented or Declined PAS|12
206688|NCT00290888|691792|P2|Overall Study|Physician Decision|1
206689|NCT00290888|691793|P1|Overall Study|Physician Decision|3
206690|NCT00290771|691810|P2|Overall Study|Lost to Follow-up|1
206691|NCT00290771|691811|P1|Overall Study|Lost to Follow-up|0
206692|NCT00290771|691810|P2|Overall Study|Protocol Violation|0
206693|NCT00290771|691811|P1|Overall Study|Protocol Violation|2
206694|NCT00290771|691810|P2|Overall Study|Administrative problems|1
206695|NCT00290771|691811|P1|Overall Study|Administrative problems|2
206696|NCT00290771|691810|P2|Overall Study|Withdrawal by Subject|6
206697|NCT00290771|691811|P1|Overall Study|Withdrawal by Subject|5
206698|NCT00290771|691810|P2|Overall Study|Adverse Event|6
206699|NCT00290771|691811|P1|Overall Study|Adverse Event|12
206700|NCT00290771|691810|P2|Overall Study|Death|10
206701|NCT00290771|691811|P1|Overall Study|Death|11
206702|NCT00290771|691810|P2|Overall Study|Disease progression|73
206703|NCT00290771|691811|P1|Overall Study|Disease progression|95
206704|NCT00290758|691835|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
206705|NCT00290758|691836|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
206706|NCT00290758|691835|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
206707|NCT00290758|691836|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
206708|NCT00290758|691835|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
206709|NCT00290758|691836|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
206710|NCT00290758|691835|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
206711|NCT00290758|691836|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
206712|NCT00290758|691835|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
206713|NCT00290758|691836|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
206714|NCT00290758|691835|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
206715|NCT00290758|691836|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
206716|NCT00290758|691835|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
206717|NCT00290758|691836|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
206718|NCT00290758|691835|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
206719|NCT00290758|691836|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
206720|NCT00290732|691858|P5|Overall Study|Inability to instill drug intraductally.|0
206721|NCT00290732|691859|P4|Overall Study|Inability to instill drug intraductally.|0
206722|NCT00290732|691860|P3|Overall Study|Inability to instill drug intraductally.|1
206723|NCT00290732|691861|P2|Overall Study|Inability to instill drug intraductally.|1
206724|NCT00290732|691862|P1|Overall Study|Inability to instill drug intraductally.|0
206725|NCT00290693|691880|P1|Overall Study|Withdrawal by Subject|2
206726|NCT00290407|691929|P1|Overall Study|Physician Decision|2
206727|NCT00290290|691961|P2|Overall Study|Underwent clean surgical procedure|12
206728|NCT00290290|691962|P1|Overall Study|Underwent clean surgical procedure|13
206729|NCT00290290|691961|P2|Overall Study|Withdrawal by Subject|2
206730|NCT00290290|691962|P1|Overall Study|Withdrawal by Subject|2
206731|NCT00290290|691961|P2|Overall Study|Death|4
206732|NCT00290290|691962|P1|Overall Study|Death|3
206733|NCT00290251|691968|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
206734|NCT00290251|691969|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
206735|NCT00290251|691970|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
206736|NCT00290251|691968|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
206737|NCT00290251|691969|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
206738|NCT00290251|691970|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
206739|NCT00290251|691968|P3|Treatment 1 (Months 1 - 3)|headache|0
206740|NCT00290251|691969|P2|Treatment 1 (Months 1 - 3)|headache|1
206741|NCT00290251|691970|P1|Treatment 1 (Months 1 - 3)|headache|0
206742|NCT00290251|691968|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
206743|NCT00290251|691969|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
206744|NCT00290251|691970|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
206745|NCT00290238|691982|P2|Overall Study|Withdrawal by Subject|13
206746|NCT00290238|691983|P1|Overall Study|Withdrawal by Subject|15
206747|NCT00290238|691982|P2|Overall Study|Lost to Follow-up|1
206748|NCT00290238|691983|P1|Overall Study|Lost to Follow-up|0
206749|NCT00290238|691982|P2|Overall Study|Study terminated|27
206750|NCT00290238|691983|P1|Overall Study|Study terminated|27
206751|NCT00290186|692008|P2|Overall Study|Withdrawal by Subject|1
206752|NCT00290186|692009|P1|Overall Study|Withdrawal by Subject|0
206753|NCT00290186|692008|P2|Overall Study|Study was terminated prior to 3-month te|1
206754|NCT00290186|692009|P1|Overall Study|Study was terminated prior to 3-month te|1
206755|NCT00290186|692008|P2|Overall Study|Lost to Follow-up|2
206756|NCT00290186|692009|P1|Overall Study|Lost to Follow-up|3
206757|NCT00290186|692008|P2|Overall Study|Adverse Event|1
206758|NCT00290186|692009|P1|Overall Study|Adverse Event|1
206759|NCT00289991|692060|P2|Overall Study|Other|14
206760|NCT00289991|692061|P1|Overall Study|Other|5
206761|NCT00289991|692060|P2|Overall Study|Withdrawal by Subject|12
206762|NCT00289991|692061|P1|Overall Study|Withdrawal by Subject|2
206763|NCT00289991|692060|P2|Overall Study|Lost to Follow-up|1
206764|NCT00289991|692061|P1|Overall Study|Lost to Follow-up|0
206765|NCT00289991|692060|P2|Overall Study|Fungal breakthrough infection|1
206766|NCT00289991|692061|P1|Overall Study|Fungal breakthrough infection|0
206767|NCT00289991|692060|P2|Overall Study|Failure of prophylaxis|1
206768|NCT00289991|692061|P1|Overall Study|Failure of prophylaxis|1
206769|NCT00289991|692060|P2|Overall Study|Adverse Event|13
206770|NCT00289991|692061|P1|Overall Study|Adverse Event|15
206771|NCT00289991|692060|P2|Overall Study|Death|38
206772|NCT00289991|692061|P1|Overall Study|Death|35
206773|NCT00289978|692086|P3|Overall Study|Death|2
206774|NCT00289978|692087|P2|Overall Study|Death|0
206775|NCT00289978|692088|P1|Overall Study|Death|1
206776|NCT00289978|692086|P3|Overall Study|Abnormal test procedure result(s)|1
206777|NCT00289978|692087|P2|Overall Study|Abnormal test procedure result(s)|1
206778|NCT00289978|692088|P1|Overall Study|Abnormal test procedure result(s)|2
206779|NCT00289978|692086|P3|Overall Study|Protocol Violation|4
206780|NCT00289978|692087|P2|Overall Study|Protocol Violation|5
206781|NCT00289978|692088|P1|Overall Study|Protocol Violation|5
206782|NCT00289978|692086|P3|Overall Study|Lost to Follow-up|7
206783|NCT00289978|692087|P2|Overall Study|Lost to Follow-up|5
206784|NCT00289978|692088|P1|Overall Study|Lost to Follow-up|3
206785|NCT00289978|692086|P3|Overall Study|Abnormal laboratory value(s)|1
206786|NCT00289978|692087|P2|Overall Study|Abnormal laboratory value(s)|9
206787|NCT00289978|692088|P1|Overall Study|Abnormal laboratory value(s)|20
206788|NCT00289978|692086|P3|Overall Study|Lack of Efficacy|25
206789|NCT00289978|692087|P2|Overall Study|Lack of Efficacy|6
206790|NCT00289978|692088|P1|Overall Study|Lack of Efficacy|13
206791|NCT00289978|692086|P3|Overall Study|Adverse Event|18
206792|NCT00289978|692087|P2|Overall Study|Adverse Event|13
206793|NCT00289978|692088|P1|Overall Study|Adverse Event|22
206794|NCT00289978|692086|P3|Overall Study|Withdrawal by Subject|28
206795|NCT00289978|692087|P2|Overall Study|Withdrawal by Subject|17
206796|NCT00289978|692088|P1|Overall Study|Withdrawal by Subject|31
206797|NCT00289913|692107|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
206798|NCT00289913|692108|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
206799|NCT00289913|692109|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
206800|NCT00289913|692110|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
206801|NCT00289913|692111|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
206802|NCT00289913|692107|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
206803|NCT00289913|692108|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
206804|NCT00289913|692109|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
206805|NCT00289913|692110|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
206806|NCT00289913|692111|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
206807|NCT00289913|692107|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
206808|NCT00289913|692108|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
206809|NCT00289913|692109|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
206810|NCT00289913|692110|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
206811|NCT00289913|692111|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
206812|NCT00289913|692107|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
206813|NCT00289913|692108|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
206814|NCT00289913|692109|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
206815|NCT00289913|692110|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
206816|NCT00289913|692111|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
206817|NCT00289913|692107|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
206818|NCT00289913|692108|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
206819|NCT00289913|692109|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
206820|NCT00289913|692110|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
206821|NCT00289913|692111|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
206822|NCT00289913|692107|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
206823|NCT00289913|692108|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
206824|NCT00289913|692109|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
206825|NCT00289913|692110|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
206826|NCT00289913|692111|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
206827|NCT00289913|692107|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
206828|NCT00289913|692108|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
206829|NCT00289913|692109|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
206830|NCT00289913|692110|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
206831|NCT00289913|692111|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
206832|NCT00289913|692107|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206833|NCT00289913|692108|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206834|NCT00289913|692109|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206835|NCT00289913|692110|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
206836|NCT00289913|692111|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206837|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
206838|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
206839|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
206840|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
206841|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
206842|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
206843|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
206844|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
206845|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
206846|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
206847|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
206848|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
206849|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
206850|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
206851|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
206852|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
206853|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
206854|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
206855|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
206856|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
206857|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
206858|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
206859|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
206860|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
206861|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
206862|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
206863|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
206864|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
206865|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
206866|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
206867|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
206868|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
206869|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
206870|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
206871|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
206872|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
206873|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
206874|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
206875|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
206876|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
206877|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
206878|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
206879|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
206880|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
206881|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
206882|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
206883|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
206884|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
206885|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
206886|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
206887|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
206888|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
206889|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
206890|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
206891|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
206892|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
206893|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
206894|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
206895|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
206896|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
206897|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
206898|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
206899|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
206900|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
206901|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
206902|NCT00289913|692107|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206903|NCT00289913|692108|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206904|NCT00289913|692109|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
206905|NCT00289913|692110|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206906|NCT00289913|692111|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206907|NCT00289913|692107|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
206908|NCT00289913|692108|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
206909|NCT00289913|692109|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
206910|NCT00289913|692110|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
206911|NCT00289913|692111|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
206912|NCT00289913|692107|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
206913|NCT00289913|692108|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
206914|NCT00289913|692109|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
206915|NCT00289913|692110|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
206916|NCT00289913|692111|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
206917|NCT00289913|692107|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
206918|NCT00289913|692108|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
206919|NCT00289913|692109|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
206920|NCT00289913|692110|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
206921|NCT00289913|692111|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
206922|NCT00289913|692107|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
206923|NCT00289913|692108|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
206924|NCT00289913|692109|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
206925|NCT00289913|692110|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
206926|NCT00289913|692111|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
206927|NCT00289913|692107|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
206928|NCT00289913|692108|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
206929|NCT00289913|692109|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
206930|NCT00289913|692110|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
206931|NCT00289913|692111|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
206932|NCT00289913|692107|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
206933|NCT00289913|692108|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
206934|NCT00289913|692109|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
206935|NCT00289913|692110|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
206936|NCT00289913|692111|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
206937|NCT00289913|692107|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
206938|NCT00289913|692108|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
206939|NCT00289913|692109|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
206940|NCT00289913|692110|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
206941|NCT00289913|692111|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
206942|NCT00289913|692107|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
206943|NCT00289913|692108|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
206944|NCT00289913|692109|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
206945|NCT00289913|692110|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
206946|NCT00289913|692111|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
206947|NCT00289913|692107|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206948|NCT00289913|692108|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206949|NCT00289913|692109|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206950|NCT00289913|692110|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
206951|NCT00289913|692111|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
206952|NCT00289900|692142|P6|Overall Study|Not treated|0
206953|NCT00289900|692143|P5|Overall Study|Not treated|0
206954|NCT00289900|692144|P4|Overall Study|Not treated|0
206955|NCT00289900|692145|P3|Overall Study|Not treated|0
206956|NCT00289900|692146|P2|Overall Study|Not treated|1
206957|NCT00289900|692147|P1|Overall Study|Not treated|0
206958|NCT00289900|692142|P6|Overall Study|site terminated|0
206959|NCT00289900|692143|P5|Overall Study|site terminated|0
206960|NCT00289900|692144|P4|Overall Study|site terminated|0
206961|NCT00289900|692145|P3|Overall Study|site terminated|1
206962|NCT00289900|692146|P2|Overall Study|site terminated|0
206963|NCT00289900|692147|P1|Overall Study|site terminated|1
206964|NCT00289900|692142|P6|Overall Study|Protocol Violation|4
206965|NCT00289900|692143|P5|Overall Study|Protocol Violation|7
206966|NCT00289900|692144|P4|Overall Study|Protocol Violation|6
206967|NCT00289900|692145|P3|Overall Study|Protocol Violation|2
206968|NCT00289900|692146|P2|Overall Study|Protocol Violation|9
206969|NCT00289900|692147|P1|Overall Study|Protocol Violation|3
206970|NCT00289900|692142|P6|Overall Study|Withdrawal by Subject|11
206971|NCT00289900|692143|P5|Overall Study|Withdrawal by Subject|12
206972|NCT00289900|692144|P4|Overall Study|Withdrawal by Subject|18
206973|NCT00289900|692145|P3|Overall Study|Withdrawal by Subject|8
206974|NCT00289900|692146|P2|Overall Study|Withdrawal by Subject|21
206975|NCT00289900|692147|P1|Overall Study|Withdrawal by Subject|10
206976|NCT00289900|692142|P6|Overall Study|Participant moved|1
206977|NCT00289900|692143|P5|Overall Study|Participant moved|1
206978|NCT00289900|692144|P4|Overall Study|Participant moved|1
206979|NCT00289900|692145|P3|Overall Study|Participant moved|0
206980|NCT00289900|692146|P2|Overall Study|Participant moved|0
206981|NCT00289900|692147|P1|Overall Study|Participant moved|1
206982|NCT00289900|692142|P6|Overall Study|Other|0
206983|NCT00289900|692143|P5|Overall Study|Other|1
206984|NCT00289900|692144|P4|Overall Study|Other|5
206985|NCT00289900|692145|P3|Overall Study|Other|0
206986|NCT00289900|692146|P2|Overall Study|Other|0
206987|NCT00289900|692147|P1|Overall Study|Other|0
206988|NCT00289900|692142|P6|Overall Study|Participant had flushing|4
206989|NCT00289900|692143|P5|Overall Study|Participant had flushing|0
206990|NCT00289900|692144|P4|Overall Study|Participant had flushing|2
206991|NCT00289900|692145|P3|Overall Study|Participant had flushing|1
206992|NCT00289900|692146|P2|Overall Study|Participant had flushing|42
206993|NCT00289900|692147|P1|Overall Study|Participant had flushing|18
206994|NCT00289900|692142|P6|Overall Study|Lost to Follow-up|8
206995|NCT00289900|692143|P5|Overall Study|Lost to Follow-up|4
206996|NCT00289900|692144|P4|Overall Study|Lost to Follow-up|8
206997|NCT00289900|692145|P3|Overall Study|Lost to Follow-up|8
206998|NCT00289900|692146|P2|Overall Study|Lost to Follow-up|7
206999|NCT00289900|692147|P1|Overall Study|Lost to Follow-up|7
207000|NCT00289900|692142|P6|Overall Study|Adverse Event|33
207001|NCT00289900|692143|P5|Overall Study|Adverse Event|20
207002|NCT00289900|692144|P4|Overall Study|Adverse Event|19
207003|NCT00289900|692145|P3|Overall Study|Adverse Event|13
207004|NCT00289900|692146|P2|Overall Study|Adverse Event|40
207005|NCT00289900|692147|P1|Overall Study|Adverse Event|28
207006|NCT00289887|692251|P2|Overall Study|Other|3
207007|NCT00289887|692252|P1|Overall Study|Other|7
207008|NCT00289887|692251|P2|Overall Study|Withdrawal by Subject|8
207009|NCT00289887|692252|P1|Overall Study|Withdrawal by Subject|3
207010|NCT00289887|692251|P2|Overall Study|Protocol Violation|1
207011|NCT00289887|692252|P1|Overall Study|Protocol Violation|3
207012|NCT00289887|692251|P2|Overall Study|Lost to Follow-up|3
207013|NCT00289887|692252|P1|Overall Study|Lost to Follow-up|3
207014|NCT00289887|692251|P2|Overall Study|Lack of Efficacy|11
207015|NCT00289887|692252|P1|Overall Study|Lack of Efficacy|3
207016|NCT00289887|692251|P2|Overall Study|Adverse Event|3
207017|NCT00289887|692252|P1|Overall Study|Adverse Event|3
207018|NCT00289874|692270|P2|Overall Study|Did not meet eligibility|0
207019|NCT00289874|692271|P1|Overall Study|Did not meet eligibility|1
207020|NCT00289874|692270|P2|Overall Study|Protocol Violation|2
207021|NCT00289874|692271|P1|Overall Study|Protocol Violation|3
207022|NCT00289874|692270|P2|Overall Study|Lost to Follow-up|1
207023|NCT00289874|692271|P1|Overall Study|Lost to Follow-up|1
207024|NCT00289874|692270|P2|Overall Study|Adverse Event|5
207025|NCT00289874|692271|P1|Overall Study|Adverse Event|1
207026|NCT00289848|692281|P2|Overall Study|Open-Label AHA Treatment Requested|1
207027|NCT00289848|692282|P1|Overall Study|Open-Label AHA Treatment Requested|0
207028|NCT00289848|692281|P2|Overall Study|Patient Moved|2
207029|NCT00289848|692282|P1|Overall Study|Patient Moved|6
207030|NCT00289848|692281|P2|Overall Study|Withdrawal by Subject|11
207031|NCT00289848|692282|P1|Overall Study|Withdrawal by Subject|5
207032|NCT00289848|692281|P2|Overall Study|Protocol Violation|2
207033|NCT00289848|692282|P1|Overall Study|Protocol Violation|5
207034|NCT00289848|692281|P2|Overall Study|Lost to Follow-up|1
207035|NCT00289848|692282|P1|Overall Study|Lost to Follow-up|3
207036|NCT00289848|692281|P2|Overall Study|Lack of Efficacy|24
207037|NCT00289848|692282|P1|Overall Study|Lack of Efficacy|20
207038|NCT00289848|692281|P2|Overall Study|Death|0
207039|NCT00289848|692282|P1|Overall Study|Death|1
207040|NCT00289848|692281|P2|Overall Study|Adverse Event|4
207041|NCT00289848|692282|P1|Overall Study|Adverse Event|6
207042|NCT00289783|692294|P2|Fourth Dose Phase|Other|10
207043|NCT00289783|692295|P1|Fourth Dose Phase|Other|22
207044|NCT00289783|692294|P2|Fourth Dose Phase|Migration from the study area|1
207045|NCT00289783|692295|P1|Fourth Dose Phase|Migration from the study area|1
207046|NCT00289783|692294|P2|Fourth Dose Phase|Lost to Follow-up|12
207047|NCT00289783|692295|P1|Fourth Dose Phase|Lost to Follow-up|53
207048|NCT00289783|692294|P2|Fourth Dose Phase|Withdrawal by Subject|1
207049|NCT00289783|692295|P1|Fourth Dose Phase|Withdrawal by Subject|10
207050|NCT00289783|692294|P2|Fourth Dose Phase|Adverse Event|0
207051|NCT00289783|692295|P1|Fourth Dose Phase|Adverse Event|1
207052|NCT00289783|692294|P2|Primary Phase|Other|12
207053|NCT00289783|692295|P1|Primary Phase|Other|32
207054|NCT00289783|692294|P2|Primary Phase|Migration from the study area|10
207055|NCT00289783|692295|P1|Primary Phase|Migration from the study area|26
207056|NCT00289783|692294|P2|Primary Phase|Lost to Follow-up|14
207057|NCT00289783|692295|P1|Primary Phase|Lost to Follow-up|60
207058|NCT00289783|692294|P2|Primary Phase|Withdrawal by Subject|40
207059|NCT00289783|692295|P1|Primary Phase|Withdrawal by Subject|93
207060|NCT00289783|692294|P2|Primary Phase|Protocol Violation|6
207061|NCT00289783|692295|P1|Primary Phase|Protocol Violation|27
207062|NCT00289783|692294|P2|Primary Phase|Adverse Event|1
207063|NCT00289783|692295|P1|Primary Phase|Adverse Event|10
207064|NCT00289770|692473|P1|Year 15|Withdrawal by Subject|1
207065|NCT00289536|692531|P3|Period 3|Lost to Follow-up|1
207066|NCT00289536|692532|P2|Period 3|Lost to Follow-up|0
207067|NCT00289536|692533|P1|Period 3|Lost to Follow-up|0
207068|NCT00289458|692579|P3|Overall Study|Withdrawal by Subject|4
207069|NCT00289458|692580|P2|Overall Study|Withdrawal by Subject|2
207070|NCT00289458|692581|P1|Overall Study|Withdrawal by Subject|2
207071|NCT00289458|692579|P3|Overall Study|Physician Decision|2
207072|NCT00289458|692580|P2|Overall Study|Physician Decision|4
207073|NCT00289458|692581|P1|Overall Study|Physician Decision|3
207074|NCT00289458|692579|P3|Overall Study|Death|0
207075|NCT00289458|692580|P2|Overall Study|Death|0
207076|NCT00289458|692581|P1|Overall Study|Death|1
207077|NCT00289289|692620|P3|Overall Study|Other Exit Reason|12
207078|NCT00289289|692621|P2|Overall Study|Other Exit Reason|4
207079|NCT00289289|692622|P1|Overall Study|Other Exit Reason|6
207080|NCT00289289|692620|P3|Overall Study|Did not meet inclusion/exclusion|6
207081|NCT00289289|692621|P2|Overall Study|Did not meet inclusion/exclusion|0
207082|NCT00289289|692622|P1|Overall Study|Did not meet inclusion/exclusion|0
207083|NCT00289289|692620|P3|Overall Study|Non-study device implanted|3
207084|NCT00289289|692621|P2|Overall Study|Non-study device implanted|1
207085|NCT00289289|692622|P1|Overall Study|Non-study device implanted|2
207086|NCT00289289|692620|P3|Overall Study|Physician Decision|6
207087|NCT00289289|692621|P2|Overall Study|Physician Decision|0
207088|NCT00289289|692622|P1|Overall Study|Physician Decision|1
207089|NCT00289289|692620|P3|Overall Study|No implant attempted|1
207090|NCT00289289|692621|P2|Overall Study|No implant attempted|0
207091|NCT00289289|692622|P1|Overall Study|No implant attempted|0
207092|NCT00289289|692620|P3|Overall Study|Death|5
207093|NCT00289289|692621|P2|Overall Study|Death|2
207094|NCT00289289|692622|P1|Overall Study|Death|4
207095|NCT00289289|692620|P3|Overall Study|Lost to Follow-up|1
207096|NCT00289289|692621|P2|Overall Study|Lost to Follow-up|0
207097|NCT00289289|692622|P1|Overall Study|Lost to Follow-up|1
207098|NCT00289289|692620|P3|Overall Study|Withdrawal by Subject|15
207099|NCT00289289|692621|P2|Overall Study|Withdrawal by Subject|3
207100|NCT00289289|692622|P1|Overall Study|Withdrawal by Subject|5
207101|NCT00289276|692637|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
207102|NCT00289276|692638|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
207103|NCT00289276|692637|P2|Second Part of FAST Study (Expansion)|Death|2
207104|NCT00289276|692638|P1|Second Part of FAST Study (Expansion)|Death|0
207105|NCT00289198|692673|P2|Overall Study|Other: Impossible to come on visit|1
207106|NCT00289198|692674|P1|Overall Study|Other: Impossible to come on visit|0
207107|NCT00289198|692673|P2|Overall Study|Other: Miscalculation of the visit date|22
207108|NCT00289198|692674|P1|Overall Study|Other: Miscalculation of the visit date|21
207109|NCT00289198|692673|P2|Overall Study|Other: Unable to attend on schedule|1
207110|NCT00289198|692674|P1|Overall Study|Other: Unable to attend on schedule|2
207111|NCT00289198|692673|P2|Overall Study|Other: Physician's decision|1
207112|NCT00289198|692674|P1|Overall Study|Other: Physician's decision|0
207113|NCT00289198|692673|P2|Overall Study|Other: Low compliance|1
207114|NCT00289198|692674|P1|Overall Study|Other: Low compliance|0
207115|NCT00289198|692673|P2|Overall Study|Lack of Efficacy|0
207116|NCT00289198|692674|P1|Overall Study|Lack of Efficacy|2
207117|NCT00289198|692673|P2|Overall Study|Withdrawal by Subject|1
207118|NCT00289198|692674|P1|Overall Study|Withdrawal by Subject|4
207119|NCT00289198|692673|P2|Overall Study|Protocol Violation|1
207120|NCT00289198|692674|P1|Overall Study|Protocol Violation|2
207121|NCT00289198|692673|P2|Overall Study|Adverse Event|2
207122|NCT00289198|692674|P1|Overall Study|Adverse Event|0
207123|NCT00289185|692724|P2|Overall Study|Death|1
207124|NCT00289185|692725|P1|Overall Study|Death|1
207125|NCT00289185|692724|P2|Overall Study|Lost to Follow-up|17
207126|NCT00289185|692725|P1|Overall Study|Lost to Follow-up|23
207127|NCT00289185|692724|P2|Overall Study|Withdrawal by Subject|8
207128|NCT00289185|692725|P1|Overall Study|Withdrawal by Subject|4
207129|NCT00289133|692772|P2|Overall Study|Lost to Follow-up|115
207130|NCT00289133|692773|P1|Overall Study|Lost to Follow-up|92
207131|NCT00289133|692772|P2|Overall Study|Revision|6
207132|NCT00289133|692773|P1|Overall Study|Revision|8
207133|NCT00289133|692772|P2|Overall Study|Physician Decision|45
207134|NCT00289133|692773|P1|Overall Study|Physician Decision|41
207135|NCT00289133|692772|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
207136|NCT00289133|692773|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
207137|NCT00289133|692772|P2|Overall Study|Death|10
207138|NCT00289133|692773|P1|Overall Study|Death|5
207139|NCT00289133|692772|P2|Overall Study|Withdrawal by Subject|10
207140|NCT00289133|692773|P1|Overall Study|Withdrawal by Subject|9
207141|NCT00289133|692772|P2|Overall Study|Protocol Violation|38
207142|NCT00289133|692773|P1|Overall Study|Protocol Violation|32
207143|NCT00289133|692772|P2|Overall Study|Non-study device implanted|0
207144|NCT00289133|692773|P1|Overall Study|Non-study device implanted|12
207145|NCT00289016|692829|P1|Overall Study|Other|1
207146|NCT00289016|692829|P1|Overall Study|Adverse Event|1
207147|NCT00289016|692829|P1|Overall Study|Withdrawal by Subject|2
207148|NCT00289016|692829|P1|Overall Study|Unrelated Medical Condition or Accident|2
207149|NCT00289016|692829|P1|Overall Study|Death|2
207150|NCT00289016|692829|P1|Overall Study|Disease Progression|29
207151|NCT00288912|692841|P3|Overall Study|Withdrawal by Subject|12
207152|NCT00288912|692842|P2|Overall Study|Withdrawal by Subject|5
207153|NCT00288912|692843|P1|Overall Study|Withdrawal by Subject|4
207154|NCT00288912|692841|P3|Overall Study|Lost to Follow-up|9
207155|NCT00288912|692842|P2|Overall Study|Lost to Follow-up|6
207156|NCT00288912|692843|P1|Overall Study|Lost to Follow-up|9
207157|NCT00288912|692841|P3|Overall Study|Developed exclusion criterion|7
207158|NCT00288912|692842|P2|Overall Study|Developed exclusion criterion|6
207159|NCT00288912|692843|P1|Overall Study|Developed exclusion criterion|4
207160|NCT00288860|692883|P2|Overall Study|Lost to Follow-up|71
207161|NCT00288860|692884|P1|Overall Study|Lost to Follow-up|74
207162|NCT00288860|692883|P2|Overall Study|Withdrawal by Subject|15
207163|NCT00288860|692884|P1|Overall Study|Withdrawal by Subject|20
207164|NCT00288860|692883|P2|Overall Study|Death|3
207165|NCT00288860|692884|P1|Overall Study|Death|4
207166|NCT00288860|692883|P2|Overall Study|Did not complete intake|8
207167|NCT00288860|692884|P1|Overall Study|Did not complete intake|4
207168|NCT00288704|692897|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
207169|NCT00288704|692898|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
207170|NCT00288704|692899|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
207171|NCT00288704|692897|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
207172|NCT00288704|692898|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
207173|NCT00288704|692899|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
207174|NCT00288704|692897|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
207175|NCT00288704|692898|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
207176|NCT00288704|692899|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
207177|NCT00288704|692897|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
207178|NCT00288704|692898|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
207179|NCT00288704|692899|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
207180|NCT00288704|692897|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
207181|NCT00288704|692898|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
207182|NCT00288704|692899|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
207183|NCT00288704|692897|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
207184|NCT00288704|692898|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
207185|NCT00288704|692899|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
207186|NCT00288704|692897|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
207187|NCT00288704|692898|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
207188|NCT00288704|692899|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
207189|NCT00288639|692926|P1|Overall Study|Other|1
207190|NCT00288639|692926|P1|Overall Study|Withdrawal by Subject|2
207191|NCT00288639|692926|P1|Overall Study|Lack of Efficacy|4
207192|NCT00288639|692926|P1|Overall Study|Adverse Event|5
207193|NCT00288626|692943|P1|Overall Study|Withdrawal by Subject|4
207194|NCT00288626|692943|P1|Overall Study|Death|3
207195|NCT00288587|692977|P2|Overall Study|Severe Aortic Stenosis|0
207196|NCT00288587|692978|P1|Overall Study|Severe Aortic Stenosis|1
207197|NCT00288587|692977|P2|Overall Study|Physician Decision|2
207198|NCT00288587|692978|P1|Overall Study|Physician Decision|0
207199|NCT00288587|692977|P2|Overall Study|Adverse Event|1
207200|NCT00288587|692978|P1|Overall Study|Adverse Event|0
207201|NCT00288587|692977|P2|Overall Study|Transplant|3
207202|NCT00288587|692978|P1|Overall Study|Transplant|0
207203|NCT00288587|692977|P2|Overall Study|Death|4
207204|NCT00288587|692978|P1|Overall Study|Death|4
207205|NCT00288509|693021|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
207206|NCT00288509|693021|P1|Treatment Cycle 4|Physician Decision|4
207207|NCT00288509|693021|P1|Treatment Cycle 4|Withdrawal by Subject|3
207208|NCT00288509|693021|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
207209|NCT00288509|693021|P1|Treatment Cycle 3|Lost to Follow-up|2
207210|NCT00288509|693021|P1|Treatment Cycle 3|Withdrawal by Subject|1
207211|NCT00288509|693021|P1|Treatment Cycle 3|Lack of Efficacy|1
207212|NCT00288509|693021|P1|Treatment Cycle 2|Withdrawal by Subject|2
207213|NCT00288509|693021|P1|Treatment Cycle 2|Lack of Efficacy|1
207214|NCT00288509|693021|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
207215|NCT00288509|693021|P1|Treatment Cycle 1|Lost to Follow-up|2
207216|NCT00288509|693021|P1|Treatment Cycle 1|Withdrawal by Subject|1
207217|NCT00288509|693021|P1|Treatment Cycle 1|Lack of Efficacy|1
207218|NCT00288509|693021|P1|Treatment Cycle 1|Adverse Event|1
207219|NCT00288080|693030|P2|Overall Study|Protocol Violation|20
207220|NCT00288080|693031|P1|Overall Study|Protocol Violation|25
207221|NCT00288080|693030|P2|Overall Study|Withdrawal by Subject|3
207222|NCT00288080|693031|P1|Overall Study|Withdrawal by Subject|1
207223|NCT00288054|693053|P1|Overall Study|Not protocol specified|2
207224|NCT00288054|693053|P1|Overall Study|Withdrawal by Subject|1
207225|NCT00288054|693053|P1|Overall Study|Adverse Event|3
207226|NCT00288054|693053|P1|Overall Study|Lack of Efficacy|16
207227|NCT00288054|693053|P1|Overall Study|Protocol Violation|2
207228|NCT00287586|693128|P2|Overall Study|Recurrent Melanoma|1
207229|NCT00287586|693129|P1|Overall Study|Recurrent Melanoma|0
207230|NCT00287586|693128|P2|Overall Study|Itchy Swollen Eyes|1
207231|NCT00287586|693129|P1|Overall Study|Itchy Swollen Eyes|0
207232|NCT00287586|693128|P2|Overall Study|Bradycardia|1
207233|NCT00287586|693129|P1|Overall Study|Bradycardia|0
207234|NCT00287586|693128|P2|Overall Study|Mood Swings and Irritability|1
207235|NCT00287586|693129|P1|Overall Study|Mood Swings and Irritability|0
207236|NCT00287586|693128|P2|Overall Study|Mastodynia and Gynecomastia|1
207237|NCT00287586|693129|P1|Overall Study|Mastodynia and Gynecomastia|0
207238|NCT00287586|693128|P2|Overall Study|Retroperitoneal Cancer|1
207239|NCT00287586|693129|P1|Overall Study|Retroperitoneal Cancer|0
207240|NCT00287586|693128|P2|Overall Study|Elevated IPSS Score|1
207241|NCT00287586|693129|P1|Overall Study|Elevated IPSS Score|0
207242|NCT00287586|693128|P2|Overall Study|Lung Cancer|2
207243|NCT00287586|693129|P1|Overall Study|Lung Cancer|0
207244|NCT00287586|693128|P2|Overall Study|Major Depression|2
207245|NCT00287586|693129|P1|Overall Study|Major Depression|0
207246|NCT00287586|693128|P2|Overall Study|Enrolled in Another Study|0
207247|NCT00287586|693129|P1|Overall Study|Enrolled in Another Study|1
207248|NCT00287586|693128|P2|Overall Study|Nonadherence|1
207249|NCT00287586|693129|P1|Overall Study|Nonadherence|1
207250|NCT00287586|693128|P2|Overall Study|Inappropriate Behaviour with Staff|0
207251|NCT00287586|693129|P1|Overall Study|Inappropriate Behaviour with Staff|1
207252|NCT00287586|693128|P2|Overall Study|Shoulder Pain|0
207253|NCT00287586|693129|P1|Overall Study|Shoulder Pain|1
207254|NCT00287586|693128|P2|Overall Study|Sleep Apnea|0
207255|NCT00287586|693129|P1|Overall Study|Sleep Apnea|1
207256|NCT00287586|693128|P2|Overall Study|Pancreatic Cancer|3
207257|NCT00287586|693129|P1|Overall Study|Pancreatic Cancer|1
207258|NCT00287586|693128|P2|Overall Study|Cognitive Impairment|0
207259|NCT00287586|693129|P1|Overall Study|Cognitive Impairment|1
207260|NCT00287586|693128|P2|Overall Study|Lower Urinary Tract Symptoms|0
207261|NCT00287586|693129|P1|Overall Study|Lower Urinary Tract Symptoms|1
207262|NCT00287586|693128|P2|Overall Study|Myocardial Infarction|0
207263|NCT00287586|693129|P1|Overall Study|Myocardial Infarction|1
207264|NCT00287586|693128|P2|Overall Study|Stroke|0
207265|NCT00287586|693129|P1|Overall Study|Stroke|2
207266|NCT00287586|693128|P2|Overall Study|Elevated Prostate Specific Antigen|0
207267|NCT00287586|693129|P1|Overall Study|Elevated Prostate Specific Antigen|2
207268|NCT00287586|693128|P2|Overall Study|Rash|0
207269|NCT00287586|693129|P1|Overall Study|Rash|3
207270|NCT00287586|693128|P2|Overall Study|Elevated Hematocrit|0
207271|NCT00287586|693129|P1|Overall Study|Elevated Hematocrit|3
207272|NCT00287586|693128|P2|Overall Study|Death|3
207273|NCT00287586|693129|P1|Overall Study|Death|2
207274|NCT00287586|693128|P2|Overall Study|Lost to Follow-up|4
207275|NCT00287586|693129|P1|Overall Study|Lost to Follow-up|5
207276|NCT00287586|693128|P2|Overall Study|Withdrew Consent|30
207277|NCT00287586|693129|P1|Overall Study|Withdrew Consent|19
207278|NCT00287365|693165|P1|Overall Study|sample not acquired|13
207279|NCT00287118|693187|P1|Overall Study|Not specified|7
207280|NCT00287118|693187|P1|Overall Study|Protocol Violation|2
207281|NCT00287118|693187|P1|Overall Study|Lost to Follow-up|1
207282|NCT00287118|693187|P1|Overall Study|Lack of Efficacy|11
207283|NCT00287118|693187|P1|Overall Study|Death|1
207284|NCT00287118|693187|P1|Overall Study|Adverse Event|30
207285|NCT00287079|693193|P2|Overall Study|Other|0
207286|NCT00287079|693194|P1|Overall Study|Other|3
207287|NCT00287079|693193|P2|Overall Study|Protocol Violation|0
207288|NCT00287079|693194|P1|Overall Study|Protocol Violation|1
207289|NCT00287079|693193|P2|Overall Study|Adverse Event|0
207290|NCT00287079|693194|P1|Overall Study|Adverse Event|5
207291|NCT00287079|693193|P2|Overall Study|Non-qualifying relapse|0
207292|NCT00287079|693194|P1|Overall Study|Non-qualifying relapse|1
207293|NCT00287079|693193|P2|Overall Study|Qualifying relapse|1
207294|NCT00287079|693194|P1|Overall Study|Qualifying relapse|12
207295|NCT00286754|693222|P3|Overall Study|Moved out of state|1
207296|NCT00286754|693223|P2|Overall Study|Moved out of state|0
207297|NCT00286754|693224|P1|Overall Study|Moved out of state|0
207298|NCT00286754|693222|P3|Overall Study|Lost to Follow-up|6
207299|NCT00286754|693223|P2|Overall Study|Lost to Follow-up|14
207300|NCT00286754|693224|P1|Overall Study|Lost to Follow-up|12
207301|NCT00286754|693222|P3|Overall Study|Withdrawal by Subject|0
207302|NCT00286754|693223|P2|Overall Study|Withdrawal by Subject|2
207303|NCT00286754|693224|P1|Overall Study|Withdrawal by Subject|6
207304|NCT00286754|693222|P3|Overall Study|Adverse Event|3
207305|NCT00286754|693223|P2|Overall Study|Adverse Event|2
207306|NCT00286754|693224|P1|Overall Study|Adverse Event|2
207307|NCT00286494|693279|P3|Overall Study|Protocol Violation|2
207308|NCT00286494|693280|P2|Overall Study|Protocol Violation|1
207309|NCT00286494|693281|P1|Overall Study|Protocol Violation|1
207310|NCT00286494|693279|P3|Overall Study|Lost to Follow-up|3
207311|NCT00286494|693280|P2|Overall Study|Lost to Follow-up|1
207312|NCT00286494|693281|P1|Overall Study|Lost to Follow-up|3
207313|NCT00286494|693279|P3|Overall Study|Physician Decision|1
207314|NCT00286494|693280|P2|Overall Study|Physician Decision|5
207315|NCT00286494|693281|P1|Overall Study|Physician Decision|5
207316|NCT00286494|693279|P3|Overall Study|Adverse Event|6
207317|NCT00286494|693280|P2|Overall Study|Adverse Event|8
207318|NCT00286494|693281|P1|Overall Study|Adverse Event|3
207319|NCT00286494|693279|P3|Overall Study|Withdrawal by Subject|9
207320|NCT00286494|693280|P2|Overall Study|Withdrawal by Subject|10
207321|NCT00286494|693281|P1|Overall Study|Withdrawal by Subject|2
207322|NCT00286494|693279|P3|Overall Study|Hyperglycemic rescue|18
207323|NCT00286494|693280|P2|Overall Study|Hyperglycemic rescue|19
207324|NCT00286494|693281|P1|Overall Study|Hyperglycemic rescue|12
207325|NCT00286468|693442|P3|Overall Study|Physician Decision|1
207326|NCT00286468|693443|P2|Overall Study|Physician Decision|2
207327|NCT00286468|693444|P1|Overall Study|Physician Decision|3
207328|NCT00286468|693442|P3|Overall Study|Withdrawal by Subject|11
207329|NCT00286468|693443|P2|Overall Study|Withdrawal by Subject|8
207330|NCT00286468|693444|P1|Overall Study|Withdrawal by Subject|3
207331|NCT00286468|693442|P3|Overall Study|Lost to Follow-up|2
207332|NCT00286468|693443|P2|Overall Study|Lost to Follow-up|1
207333|NCT00286468|693444|P1|Overall Study|Lost to Follow-up|1
207334|NCT00286468|693442|P3|Overall Study|Protocol Violation|1
207335|NCT00286468|693443|P2|Overall Study|Protocol Violation|3
207336|NCT00286468|693444|P1|Overall Study|Protocol Violation|0
207337|NCT00286468|693442|P3|Overall Study|Adverse Event|4
207338|NCT00286468|693443|P2|Overall Study|Adverse Event|6
207339|NCT00286468|693444|P1|Overall Study|Adverse Event|2
207340|NCT00286468|693442|P3|Overall Study|Hyperglycemic Rescue|31
207341|NCT00286468|693443|P2|Overall Study|Hyperglycemic Rescue|30
207342|NCT00286468|693444|P1|Overall Study|Hyperglycemic Rescue|28
207343|NCT00286455|693605|P3|Overall Study|Withdrawal by Subject|7
207344|NCT00286455|693606|P2|Overall Study|Withdrawal by Subject|8
207345|NCT00286455|693607|P1|Overall Study|Withdrawal by Subject|0
207346|NCT00286455|693605|P3|Overall Study|Participant Non-compliance|0
207347|NCT00286455|693606|P2|Overall Study|Participant Non-compliance|0
207348|NCT00286455|693607|P1|Overall Study|Participant Non-compliance|1
207349|NCT00286455|693605|P3|Overall Study|Protocol Violation|0
207350|NCT00286455|693606|P2|Overall Study|Protocol Violation|1
207351|NCT00286455|693607|P1|Overall Study|Protocol Violation|1
207352|NCT00286455|693605|P3|Overall Study|Physician Decision|2
207353|NCT00286455|693606|P2|Overall Study|Physician Decision|0
207354|NCT00286455|693607|P1|Overall Study|Physician Decision|3
207355|NCT00286455|693605|P3|Overall Study|Lost to Follow-up|3
207356|NCT00286455|693606|P2|Overall Study|Lost to Follow-up|3
207357|NCT00286455|693607|P1|Overall Study|Lost to Follow-up|0
207358|NCT00286455|693605|P3|Overall Study|Adverse Event|2
207359|NCT00286455|693606|P2|Overall Study|Adverse Event|3
207360|NCT00286455|693607|P1|Overall Study|Adverse Event|1
207361|NCT00286455|693605|P3|Overall Study|Hyperglycemia rescue|10
207362|NCT00286455|693606|P2|Overall Study|Hyperglycemia rescue|13
207363|NCT00286455|693607|P1|Overall Study|Hyperglycemia rescue|19
207364|NCT00286442|693786|P3|Overall Study|Withdrawal by Subject|2
207365|NCT00286442|693787|P2|Overall Study|Withdrawal by Subject|14
207366|NCT00286442|693788|P1|Overall Study|Withdrawal by Subject|2
207367|NCT00286442|693786|P3|Overall Study|Administrative Error|0
207368|NCT00286442|693787|P2|Overall Study|Administrative Error|1
207369|NCT00286442|693788|P1|Overall Study|Administrative Error|1
207370|NCT00286442|693786|P3|Overall Study|Physician Decision|1
207371|NCT00286442|693787|P2|Overall Study|Physician Decision|1
207372|NCT00286442|693788|P1|Overall Study|Physician Decision|1
207373|NCT00286442|693786|P3|Overall Study|Lost to Follow-up|1
207374|NCT00286442|693787|P2|Overall Study|Lost to Follow-up|2
207375|NCT00286442|693788|P1|Overall Study|Lost to Follow-up|5
207376|NCT00286442|693786|P3|Overall Study|Protocol Violation|2
207377|NCT00286442|693787|P2|Overall Study|Protocol Violation|4
207378|NCT00286442|693788|P1|Overall Study|Protocol Violation|2
207379|NCT00286442|693786|P3|Overall Study|Adverse Event|1
207380|NCT00286442|693787|P2|Overall Study|Adverse Event|6
207381|NCT00286442|693788|P1|Overall Study|Adverse Event|7
207382|NCT00286442|693786|P3|Overall Study|Hyperglycemic Rescue|25
207383|NCT00286442|693787|P2|Overall Study|Hyperglycemic Rescue|17
207384|NCT00286442|693788|P1|Overall Study|Hyperglycemic Rescue|19
207385|NCT00286429|693949|P3|Overall Study|Administrative Decision|0
207386|NCT00286429|693950|P2|Overall Study|Administrative Decision|1
207387|NCT00286429|693951|P1|Overall Study|Administrative Decision|0
207388|NCT00286429|693949|P3|Overall Study|Administrative Error|1
207389|NCT00286429|693950|P2|Overall Study|Administrative Error|1
207390|NCT00286429|693951|P1|Overall Study|Administrative Error|1
207391|NCT00286429|693949|P3|Overall Study|Withdrawal by Subject|6
207392|NCT00286429|693950|P2|Overall Study|Withdrawal by Subject|2
207393|NCT00286429|693951|P1|Overall Study|Withdrawal by Subject|3
207394|NCT00286429|693949|P3|Overall Study|Protocol Violation|4
207395|NCT00286429|693950|P2|Overall Study|Protocol Violation|5
207396|NCT00286429|693951|P1|Overall Study|Protocol Violation|3
207397|NCT00286429|693949|P3|Overall Study|Physician Decision|7
207398|NCT00286429|693950|P2|Overall Study|Physician Decision|7
207399|NCT00286429|693951|P1|Overall Study|Physician Decision|10
207400|NCT00286429|693949|P3|Overall Study|Lost to Follow-up|3
207401|NCT00286429|693950|P2|Overall Study|Lost to Follow-up|4
207402|NCT00286429|693951|P1|Overall Study|Lost to Follow-up|2
207403|NCT00286429|693949|P3|Overall Study|Lack of Efficacy|25
207404|NCT00286429|693950|P2|Overall Study|Lack of Efficacy|27
207405|NCT00286429|693951|P1|Overall Study|Lack of Efficacy|52
207406|NCT00286429|693949|P3|Overall Study|Adverse Event|6
207407|NCT00286429|693950|P2|Overall Study|Adverse Event|1
207408|NCT00286429|693951|P1|Overall Study|Adverse Event|4
207409|NCT00286221|694067|P4|Overall Study|Unrecognized exclusion criteria met|0
207410|NCT00286221|694068|P3|Overall Study|Unrecognized exclusion criteria met|0
207411|NCT00286221|694069|P2|Overall Study|Unrecognized exclusion criteria met|1
207412|NCT00286221|694070|P1|Overall Study|Unrecognized exclusion criteria met|0
207413|NCT00286221|694067|P4|Overall Study|Inability to trigger PCA|0
207414|NCT00286221|694068|P3|Overall Study|Inability to trigger PCA|0
207415|NCT00286221|694069|P2|Overall Study|Inability to trigger PCA|0
207416|NCT00286221|694070|P1|Overall Study|Inability to trigger PCA|2
207417|NCT00286221|694067|P4|Overall Study|Unanticipated Neurosurgical Complication|2
207418|NCT00286221|694068|P3|Overall Study|Unanticipated Neurosurgical Complication|3
207419|NCT00286221|694069|P2|Overall Study|Unanticipated Neurosurgical Complication|3
207420|NCT00286221|694070|P1|Overall Study|Unanticipated Neurosurgical Complication|6
207421|NCT00286221|694067|P4|Overall Study|Protocol Violation|4
207422|NCT00286221|694068|P3|Overall Study|Protocol Violation|6
207423|NCT00286221|694069|P2|Overall Study|Protocol Violation|1
207424|NCT00286221|694070|P1|Overall Study|Protocol Violation|2
207425|NCT00286156|694096|P3|Overall Study|AE: pneumonia|0
207426|NCT00286156|694097|P2|Overall Study|AE: pneumonia|0
207427|NCT00286156|694098|P1|Overall Study|AE: pneumonia|1
207428|NCT00286156|694096|P3|Overall Study|AE: nephrotic-range proteinuruia|0
207429|NCT00286156|694097|P2|Overall Study|AE: nephrotic-range proteinuruia|0
207430|NCT00286156|694098|P1|Overall Study|AE: nephrotic-range proteinuruia|1
207431|NCT00286156|694096|P3|Overall Study|AE: pulmonary embolus|0
207432|NCT00286156|694097|P2|Overall Study|AE: pulmonary embolus|1
207433|NCT00286156|694098|P1|Overall Study|AE: pulmonary embolus|0
207434|NCT00286156|694096|P3|Overall Study|Missed 12 month visit|1
207435|NCT00286156|694097|P2|Overall Study|Missed 12 month visit|0
207436|NCT00286156|694098|P1|Overall Study|Missed 12 month visit|0
207437|NCT00286091|694111|P2|Open-label Treatment Phase|Missing End of Study Information|1
207438|NCT00286091|694112|P1|Open-label Treatment Phase|Missing End of Study Information|0
207439|NCT00286091|694111|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
207440|NCT00286091|694112|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
207441|NCT00286091|694111|P2|Open-label Treatment Phase|Lost to Follow-up|1
207442|NCT00286091|694112|P1|Open-label Treatment Phase|Lost to Follow-up|0
207443|NCT00286091|694111|P2|Open-label Treatment Phase|Noncompliance|1
207444|NCT00286091|694112|P1|Open-label Treatment Phase|Noncompliance|3
207445|NCT00286091|694111|P2|Open-label Treatment Phase|Disease Progression|3
207446|NCT00286091|694112|P1|Open-label Treatment Phase|Disease Progression|9
207447|NCT00286091|694111|P2|Open-label Treatment Phase|Death|7
207448|NCT00286091|694112|P1|Open-label Treatment Phase|Death|10
207449|NCT00286091|694111|P2|Open-label Treatment Phase|Withdrawal by Subject|10
207450|NCT00286091|694112|P1|Open-label Treatment Phase|Withdrawal by Subject|14
207451|NCT00286091|694111|P2|Open-label Treatment Phase|Other|11
207452|NCT00286091|694112|P1|Open-label Treatment Phase|Other|11
207453|NCT00286091|694111|P2|Open-label Treatment Phase|Adverse Event|16
207454|NCT00286091|694112|P1|Open-label Treatment Phase|Adverse Event|5
207455|NCT00286091|694111|P2|Open-label Treatment Phase|Physician Decision|21
207456|NCT00286091|694112|P1|Open-label Treatment Phase|Physician Decision|24
207457|NCT00286091|694111|P2|Double-blind Treatment Phase|Ineligibility Determined|2
207458|NCT00286091|694112|P1|Double-blind Treatment Phase|Ineligibility Determined|1
207459|NCT00286091|694111|P2|Double-blind Treatment Phase|Protocol Deviation|3
207460|NCT00286091|694112|P1|Double-blind Treatment Phase|Protocol Deviation|1
207461|NCT00286091|694111|P2|Double-blind Treatment Phase|Lost to Follow-up|4
207462|NCT00286091|694112|P1|Double-blind Treatment Phase|Lost to Follow-up|11
207463|NCT00286091|694111|P2|Double-blind Treatment Phase|Noncompliance|8
207464|NCT00286091|694112|P1|Double-blind Treatment Phase|Noncompliance|8
207465|NCT00286091|694111|P2|Double-blind Treatment Phase|Administrative Decision|21
207466|NCT00286091|694112|P1|Double-blind Treatment Phase|Administrative Decision|20
207467|NCT00286091|694111|P2|Double-blind Treatment Phase|Other|33
207468|NCT00286091|694112|P1|Double-blind Treatment Phase|Other|25
207469|NCT00286091|694111|P2|Double-blind Treatment Phase|Disease Progression|35
207470|NCT00286091|694112|P1|Double-blind Treatment Phase|Disease Progression|22
207471|NCT00286091|694111|P2|Double-blind Treatment Phase|Adverse Event|40
207472|NCT00286091|694112|P1|Double-blind Treatment Phase|Adverse Event|28
207473|NCT00286091|694111|P2|Double-blind Treatment Phase|Death|65
207474|NCT00286091|694112|P1|Double-blind Treatment Phase|Death|58
207475|NCT00286091|694111|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
207476|NCT00286091|694112|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
207477|NCT00286091|694111|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
207478|NCT00286091|694112|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
207479|NCT00285857|694135|P1|Overall Study|Adverse Event|1
207480|NCT00285857|694135|P1|Overall Study|Inadequate initial breast cytology|1
207481|NCT00285857|694135|P1|Overall Study|Withdrawal by Subject|2
207482|NCT00285818|694148|P2|Overall Study|Lost to Follow-up|0
207483|NCT00285818|694149|P1|Overall Study|Lost to Follow-up|1
207484|NCT00285818|694148|P2|Overall Study|Withdrawal by Subject|2
207485|NCT00285818|694149|P1|Overall Study|Withdrawal by Subject|3
207486|NCT00285649|694194|P3|Overall Study|Withdrawal by Subject|2
207487|NCT00285649|694195|P2|Overall Study|Withdrawal by Subject|2
207488|NCT00285649|694196|P1|Overall Study|Withdrawal by Subject|3
207489|NCT00285649|694194|P3|Overall Study|Lost to Follow-up|4
207490|NCT00285649|694195|P2|Overall Study|Lost to Follow-up|4
207491|NCT00285649|694196|P1|Overall Study|Lost to Follow-up|6
207492|NCT00285584|694206|P2|Month 6|Lost to Follow-up|1
207493|NCT00285584|694207|P1|Month 6|Lost to Follow-up|0
207494|NCT00285584|694206|P2|Month 3|Withdrawal by Subject|0
207495|NCT00285584|694207|P1|Month 3|Withdrawal by Subject|1
207496|NCT00285584|694206|P2|Month 3|Lost to Follow-up|3
207497|NCT00285584|694207|P1|Month 3|Lost to Follow-up|3
207498|NCT00285207|694239|P2|Overall Study|non-compliance|1
207499|NCT00285207|694240|P1|Overall Study|non-compliance|0
207500|NCT00285207|694239|P2|Overall Study|Pregnancy|1
207501|NCT00285207|694240|P1|Overall Study|Pregnancy|1
207502|NCT00285207|694239|P2|Overall Study|Withdrawal by Subject|2
207503|NCT00285207|694240|P1|Overall Study|Withdrawal by Subject|5
207504|NCT00285207|694239|P2|Overall Study|Lost to Follow-up|2
207505|NCT00285207|694240|P1|Overall Study|Lost to Follow-up|3
207506|NCT00285012|694248|P2|Received Study Tx|Other|5
207507|NCT00285012|694249|P1|Received Study Tx|Other|5
207508|NCT00285012|694248|P2|Received Study Tx|Withdrawal by Subject|43
207509|NCT00285012|694249|P1|Received Study Tx|Withdrawal by Subject|31
207510|NCT00285012|694248|P2|Received Study Tx|Lost to Follow-up|31
207511|NCT00285012|694249|P1|Received Study Tx|Lost to Follow-up|29
207512|NCT00285012|694248|P2|Received Study Tx|Lack of Efficacy|3
207513|NCT00285012|694249|P1|Received Study Tx|Lack of Efficacy|0
207514|NCT00285012|694248|P2|Received Study Tx|Adverse Event|11
207515|NCT00285012|694249|P1|Received Study Tx|Adverse Event|5
207516|NCT00285012|694248|P2|Received Study Tx|Death|1
207517|NCT00285012|694249|P1|Received Study Tx|Death|2
207518|NCT00285012|694248|P2|Assigned to Study Treatment (Tx)|Other|3
207519|NCT00285012|694249|P1|Assigned to Study Treatment (Tx)|Other|2
207520|NCT00284934|694275|P2|Overall Study|Other reasons|1
207521|NCT00284934|694276|P1|Overall Study|Other reasons|3
207522|NCT00284934|694275|P2|Overall Study|Adverse Event|2
207523|NCT00284934|694276|P1|Overall Study|Adverse Event|1
207524|NCT00284856|694291|P3|Overall Study|Other|4
207525|NCT00284856|694292|P2|Overall Study|Other|5
207526|NCT00284856|694293|P1|Overall Study|Other|4
207527|NCT00284856|694291|P3|Overall Study|Withdrawal by Subject|18
207528|NCT00284856|694292|P2|Overall Study|Withdrawal by Subject|16
207529|NCT00284856|694293|P1|Overall Study|Withdrawal by Subject|12
207530|NCT00284856|694291|P3|Overall Study|Protocol Violation|5
207531|NCT00284856|694292|P2|Overall Study|Protocol Violation|4
207532|NCT00284856|694293|P1|Overall Study|Protocol Violation|5
207533|NCT00284856|694291|P3|Overall Study|Lost to Follow-up|22
207534|NCT00284856|694292|P2|Overall Study|Lost to Follow-up|21
207535|NCT00284856|694293|P1|Overall Study|Lost to Follow-up|25
207536|NCT00284856|694291|P3|Overall Study|Lack of Efficacy|8
207537|NCT00284856|694292|P2|Overall Study|Lack of Efficacy|1
207538|NCT00284856|694293|P1|Overall Study|Lack of Efficacy|2
207539|NCT00284856|694291|P3|Overall Study|Adverse Event|3
207540|NCT00284856|694292|P2|Overall Study|Adverse Event|3
207541|NCT00284856|694293|P1|Overall Study|Adverse Event|3
207542|NCT00284141|694392|P1|Overall Study|Ongoing treatment|2
207543|NCT00284141|694392|P1|Overall Study|Did not take study medication|2
207544|NCT00284141|694392|P1|Overall Study|Pneumonia|1
207545|NCT00284141|694392|P1|Overall Study|General decline|1
207546|NCT00284141|694392|P1|Overall Study|Clinical deterioration / death|2
207547|NCT00284141|694392|P1|Overall Study|Symptomatic / Clinical Progression|11
207548|NCT00284141|694392|P1|Overall Study|Participant's request|9
207549|NCT00284141|694392|P1|Overall Study|Adverse Event|19
207550|NCT00284141|694392|P1|Overall Study|Disease Progression / Lack of efficacy|51
207551|NCT00284089|694415|P4|Extension Phase|Withdrawal by Subject|3
207552|NCT00284089|694416|P3|Extension Phase|Withdrawal by Subject|1
207553|NCT00284089|694417|P2|Extension Phase|Withdrawal by Subject|0
207554|NCT00284089|694418|P1|Extension Phase|Withdrawal by Subject|0
207555|NCT00284089|694415|P4|Extension Phase|Protocol Violation|0
207556|NCT00284089|694416|P3|Extension Phase|Protocol Violation|1
207557|NCT00284089|694417|P2|Extension Phase|Protocol Violation|0
207558|NCT00284089|694418|P1|Extension Phase|Protocol Violation|0
207559|NCT00284089|694415|P4|Extension Phase|condition no longer requires study drug|7
207560|NCT00284089|694416|P3|Extension Phase|condition no longer requires study drug|2
207561|NCT00284089|694417|P2|Extension Phase|condition no longer requires study drug|0
207562|NCT00284089|694418|P1|Extension Phase|condition no longer requires study drug|2
207563|NCT00284089|694415|P4|Extension Phase|Adverse Event|2
207564|NCT00284089|694416|P3|Extension Phase|Adverse Event|2
207565|NCT00284089|694417|P2|Extension Phase|Adverse Event|0
207566|NCT00284089|694418|P1|Extension Phase|Adverse Event|0
207567|NCT00284089|694415|P4|Multiple Dose Phase|Death|1
207568|NCT00284089|694416|P3|Multiple Dose Phase|Death|1
207569|NCT00284089|694417|P2|Multiple Dose Phase|Death|0
207570|NCT00284089|694418|P1|Multiple Dose Phase|Death|0
207571|NCT00284089|694415|P4|Multiple Dose Phase|Withdrawal by Subject|2
207572|NCT00284089|694416|P3|Multiple Dose Phase|Withdrawal by Subject|1
207573|NCT00284089|694417|P2|Multiple Dose Phase|Withdrawal by Subject|0
207574|NCT00284089|694418|P1|Multiple Dose Phase|Withdrawal by Subject|0
207575|NCT00284089|694415|P4|Multiple Dose Phase|Protocol Violation|0
207576|NCT00284089|694416|P3|Multiple Dose Phase|Protocol Violation|1
207577|NCT00284089|694417|P2|Multiple Dose Phase|Protocol Violation|0
207578|NCT00284089|694418|P1|Multiple Dose Phase|Protocol Violation|0
207579|NCT00284089|694415|P4|Multiple Dose Phase|Adverse Event|1
207580|NCT00284089|694416|P3|Multiple Dose Phase|Adverse Event|1
207581|NCT00284089|694417|P2|Multiple Dose Phase|Adverse Event|0
207582|NCT00284089|694418|P1|Multiple Dose Phase|Adverse Event|1
207583|NCT00284050|694447|P3|Overall Study|Death|0
207584|NCT00284050|694448|P2|Overall Study|Death|0
207585|NCT00284050|694449|P1|Overall Study|Death|1
207586|NCT00284050|694447|P3|Overall Study|Lost to Follow-up|1
207587|NCT00284050|694448|P2|Overall Study|Lost to Follow-up|0
207588|NCT00284050|694449|P1|Overall Study|Lost to Follow-up|1
207589|NCT00284050|694447|P3|Overall Study|Withdrawal by Subject|2
207590|NCT00284050|694448|P2|Overall Study|Withdrawal by Subject|2
207591|NCT00284050|694449|P1|Overall Study|Withdrawal by Subject|2
207592|NCT00284050|694447|P3|Overall Study|Protocol Violation|2
207593|NCT00284050|694448|P2|Overall Study|Protocol Violation|1
207594|NCT00284050|694449|P1|Overall Study|Protocol Violation|0
207595|NCT00284050|694447|P3|Overall Study|Lack of Efficacy|3
207596|NCT00284050|694448|P2|Overall Study|Lack of Efficacy|1
207597|NCT00284050|694449|P1|Overall Study|Lack of Efficacy|0
207598|NCT00284050|694447|P3|Overall Study|Adverse Event|1
207599|NCT00284050|694448|P2|Overall Study|Adverse Event|1
207600|NCT00284050|694449|P1|Overall Study|Adverse Event|1
207601|NCT00283868|694465|P2|Overall Study|Lost to Follow-up|8
207602|NCT00283868|694466|P1|Overall Study|Lost to Follow-up|7
207603|NCT00283842|694483|P5|Overall Study|Lost to Follow-up|1
207604|NCT00283842|694484|P4|Overall Study|Lost to Follow-up|1
207605|NCT00283842|694485|P3|Overall Study|Lost to Follow-up|4
207606|NCT00283842|694486|P2|Overall Study|Lost to Follow-up|2
207607|NCT00283842|694487|P1|Overall Study|Lost to Follow-up|0
207608|NCT00283842|694483|P5|Overall Study|Lack of Efficacy|3
207609|NCT00283842|694484|P4|Overall Study|Lack of Efficacy|0
207610|NCT00283842|694485|P3|Overall Study|Lack of Efficacy|1
207611|NCT00283842|694486|P2|Overall Study|Lack of Efficacy|3
207612|NCT00283842|694487|P1|Overall Study|Lack of Efficacy|1
207613|NCT00283842|694483|P5|Overall Study|Withdrawal by Subject|4
207614|NCT00283842|694484|P4|Overall Study|Withdrawal by Subject|5
207615|NCT00283842|694485|P3|Overall Study|Withdrawal by Subject|1
207616|NCT00283842|694486|P2|Overall Study|Withdrawal by Subject|1
207617|NCT00283842|694487|P1|Overall Study|Withdrawal by Subject|2
207618|NCT00283842|694483|P5|Overall Study|Protocol deviation|2
207619|NCT00283842|694484|P4|Overall Study|Protocol deviation|0
207620|NCT00283842|694485|P3|Overall Study|Protocol deviation|0
207621|NCT00283842|694486|P2|Overall Study|Protocol deviation|0
207622|NCT00283842|694487|P1|Overall Study|Protocol deviation|0
207623|NCT00283842|694483|P5|Overall Study|Protocol Violation|0
207624|NCT00283842|694484|P4|Overall Study|Protocol Violation|0
207625|NCT00283842|694485|P3|Overall Study|Protocol Violation|4
207626|NCT00283842|694486|P2|Overall Study|Protocol Violation|5
207627|NCT00283842|694487|P1|Overall Study|Protocol Violation|1
207628|NCT00283842|694483|P5|Overall Study|Adverse Event|5
207629|NCT00283842|694484|P4|Overall Study|Adverse Event|21
207630|NCT00283842|694485|P3|Overall Study|Adverse Event|21
207631|NCT00283842|694486|P2|Overall Study|Adverse Event|7
207632|NCT00283842|694487|P1|Overall Study|Adverse Event|8
207633|NCT00283803|694519|P1|Overall Study|Withdrawal by Subject|4
207634|NCT00283803|694519|P1|Overall Study|Physician Decision|9
207635|NCT00283712|694527|P2|Overall Study|Death|1
207636|NCT00283712|694528|P1|Overall Study|Death|0
207637|NCT00283686|694566|P4|Overall Study|Less than full participation|12
207638|NCT00283686|694567|P3|Overall Study|Less than full participation|6
207639|NCT00283686|694568|P2|Overall Study|Less than full participation|9
207640|NCT00283686|694569|P1|Overall Study|Less than full participation|7
207641|NCT00283686|694566|P4|Overall Study|Lost to Follow-up|20
207642|NCT00283686|694567|P3|Overall Study|Lost to Follow-up|26
207643|NCT00283686|694568|P2|Overall Study|Lost to Follow-up|31
207644|NCT00283686|694569|P1|Overall Study|Lost to Follow-up|21
207645|NCT00283686|694566|P4|Overall Study|Death|0
207646|NCT00283686|694567|P3|Overall Study|Death|1
207647|NCT00283686|694568|P2|Overall Study|Death|1
207648|NCT00283686|694569|P1|Overall Study|Death|1
207649|NCT00283595|694613|P2|Overall Study|Withdrawal by Subject|2
207650|NCT00283595|694614|P1|Overall Study|Withdrawal by Subject|1
207651|NCT00283439|694639|P4|Overall Study|Not specified|0
207652|NCT00283439|694640|P3|Overall Study|Not specified|0
207653|NCT00283439|694641|P2|Overall Study|Not specified|0
207654|NCT00283439|694642|P1|Overall Study|Not specified|1
207655|NCT00283439|694639|P4|Overall Study|Treatment discontinued|3
207656|NCT00283439|694640|P3|Overall Study|Treatment discontinued|1
207657|NCT00283439|694641|P2|Overall Study|Treatment discontinued|2
207658|NCT00283439|694642|P1|Overall Study|Treatment discontinued|0
207659|NCT00283439|694639|P4|Overall Study|Stem cell transplant|3
207660|NCT00283439|694640|P3|Overall Study|Stem cell transplant|4
207661|NCT00283439|694641|P2|Overall Study|Stem cell transplant|6
207662|NCT00283439|694642|P1|Overall Study|Stem cell transplant|6
207663|NCT00283439|694639|P4|Overall Study|Requirement for alternative therapy|2
207664|NCT00283439|694640|P3|Overall Study|Requirement for alternative therapy|5
207665|NCT00283439|694641|P2|Overall Study|Requirement for alternative therapy|2
207666|NCT00283439|694642|P1|Overall Study|Requirement for alternative therapy|1
207667|NCT00283439|694639|P4|Overall Study|Disease progression|0
207668|NCT00283439|694640|P3|Overall Study|Disease progression|0
207669|NCT00283439|694641|P2|Overall Study|Disease progression|1
207670|NCT00283439|694642|P1|Overall Study|Disease progression|0
207671|NCT00283439|694639|P4|Overall Study|Death|0
207672|NCT00283439|694640|P3|Overall Study|Death|1
207673|NCT00283439|694641|P2|Overall Study|Death|0
207674|NCT00283439|694642|P1|Overall Study|Death|0
207675|NCT00283439|694639|P4|Overall Study|Adverse Event|1
207676|NCT00283439|694640|P3|Overall Study|Adverse Event|0
207677|NCT00283439|694641|P2|Overall Study|Adverse Event|0
207678|NCT00283439|694642|P1|Overall Study|Adverse Event|0
207679|NCT00283400|694668|P4|Overall Study|Death|0
207680|NCT00283400|694669|P3|Overall Study|Death|1
207681|NCT00283400|694670|P2|Overall Study|Death|0
207682|NCT00283400|694671|P1|Overall Study|Death|1
207683|NCT00283400|694668|P4|Overall Study|Withdrawal by Subject|0
207684|NCT00283400|694669|P3|Overall Study|Withdrawal by Subject|0
207685|NCT00283400|694670|P2|Overall Study|Withdrawal by Subject|1
207686|NCT00283400|694671|P1|Overall Study|Withdrawal by Subject|1
207687|NCT00283387|694689|P2|First Intervention|Withdrawal by Subject|1
207688|NCT00283387|694690|P1|First Intervention|Withdrawal by Subject|0
207689|NCT00283387|694689|P2|First Intervention|Subject non-compliant|1
207690|NCT00283387|694690|P1|First Intervention|Subject non-compliant|1
207691|NCT00283296|694696|P1|Overall Study|in-home trial not completed|5
207692|NCT00283244|694705|P3|Overall Study|Clinical deterioration|3
207693|NCT00283244|694706|P2|Overall Study|Clinical deterioration|3
207694|NCT00283244|694707|P1|Overall Study|Clinical deterioration|1
207695|NCT00283244|694705|P3|Overall Study|Medical illness (other complicating dz)|6
207696|NCT00283244|694706|P2|Overall Study|Medical illness (other complicating dz)|3
207697|NCT00283244|694707|P1|Overall Study|Medical illness (other complicating dz)|4
207698|NCT00283244|694705|P3|Overall Study|Physician Decision|1
207699|NCT00283244|694706|P2|Overall Study|Physician Decision|0
207700|NCT00283244|694707|P1|Overall Study|Physician Decision|0
207701|NCT00283244|694705|P3|Overall Study|Withdrawal by Subject|2
207702|NCT00283244|694706|P2|Overall Study|Withdrawal by Subject|2
207703|NCT00283244|694707|P1|Overall Study|Withdrawal by Subject|1
207704|NCT00283244|694705|P3|Overall Study|Lack of Efficacy|26
207705|NCT00283244|694706|P2|Overall Study|Lack of Efficacy|32
207706|NCT00283244|694707|P1|Overall Study|Lack of Efficacy|8
207707|NCT00283244|694705|P3|Overall Study|Death|2
207708|NCT00283244|694706|P2|Overall Study|Death|3
207709|NCT00283244|694707|P1|Overall Study|Death|4
207710|NCT00283244|694705|P3|Overall Study|Adverse Event|11
207711|NCT00283244|694706|P2|Overall Study|Adverse Event|8
207712|NCT00283244|694707|P1|Overall Study|Adverse Event|0
207713|NCT00283062|694743|P4|Overall Study|chemotherapy not completed (cycle 6)|0
207714|NCT00283062|694744|P3|Overall Study|chemotherapy not completed (cycle 6)|0
207715|NCT00283062|694745|P2|Overall Study|chemotherapy not completed (cycle 6)|0
207716|NCT00283062|694746|P1|Overall Study|chemotherapy not completed (cycle 6)|1
207717|NCT00283062|694743|P4|Overall Study|Undefined|4
207718|NCT00283062|694744|P3|Overall Study|Undefined|1
207719|NCT00283062|694745|P2|Overall Study|Undefined|1
207720|NCT00283062|694746|P1|Overall Study|Undefined|0
207721|NCT00283062|694743|P4|Overall Study|Participant did not wish to continue|0
207722|NCT00283062|694744|P3|Overall Study|Participant did not wish to continue|1
207723|NCT00283062|694745|P2|Overall Study|Participant did not wish to continue|2
207724|NCT00283062|694746|P1|Overall Study|Participant did not wish to continue|3
207725|NCT00283062|694743|P4|Overall Study|Progressive disease|0
207726|NCT00283062|694744|P3|Overall Study|Progressive disease|1
207727|NCT00283062|694745|P2|Overall Study|Progressive disease|0
207728|NCT00283062|694746|P1|Overall Study|Progressive disease|0
207729|NCT00283062|694743|P4|Overall Study|Lost to Follow-up|0
207730|NCT00283062|694744|P3|Overall Study|Lost to Follow-up|1
207731|NCT00283062|694745|P2|Overall Study|Lost to Follow-up|0
207732|NCT00283062|694746|P1|Overall Study|Lost to Follow-up|1
207733|NCT00283062|694743|P4|Overall Study|Adverse Event|0
207734|NCT00283062|694744|P3|Overall Study|Adverse Event|1
207735|NCT00283062|694745|P2|Overall Study|Adverse Event|0
207736|NCT00283062|694746|P1|Overall Study|Adverse Event|2
207737|NCT00283062|694743|P4|Overall Study|Did not receive any study medication|45
207738|NCT00283062|694744|P3|Overall Study|Did not receive any study medication|36
207739|NCT00283062|694745|P2|Overall Study|Did not receive any study medication|4
207740|NCT00283062|694746|P1|Overall Study|Did not receive any study medication|5
207741|NCT00283049|694779|P3|Overall Study|No longer requires study treatment|1
207742|NCT00283049|694780|P2|Overall Study|No longer requires study treatment|0
207743|NCT00283049|694781|P1|Overall Study|No longer requires study treatment|0
207744|NCT00283049|694779|P3|Overall Study|Discontinuation of Study|20
207745|NCT00283049|694780|P2|Overall Study|Discontinuation of Study|16
207746|NCT00283049|694781|P1|Overall Study|Discontinuation of Study|18
207747|NCT00283049|694779|P3|Overall Study|Withdrawal by Subject|19
207748|NCT00283049|694780|P2|Overall Study|Withdrawal by Subject|24
207749|NCT00283049|694781|P1|Overall Study|Withdrawal by Subject|26
207750|NCT00283049|694779|P3|Overall Study|Lost to Follow-up|5
207751|NCT00283049|694780|P2|Overall Study|Lost to Follow-up|2
207752|NCT00283049|694781|P1|Overall Study|Lost to Follow-up|4
207753|NCT00283049|694779|P3|Overall Study|Lack of Efficacy|1
207754|NCT00283049|694780|P2|Overall Study|Lack of Efficacy|1
207755|NCT00283049|694781|P1|Overall Study|Lack of Efficacy|0
207756|NCT00283049|694779|P3|Overall Study|Death|1
207757|NCT00283049|694780|P2|Overall Study|Death|1
207758|NCT00283049|694781|P1|Overall Study|Death|1
207759|NCT00283049|694779|P3|Overall Study|Protocol Violation|3
207760|NCT00283049|694780|P2|Overall Study|Protocol Violation|0
207761|NCT00283049|694781|P1|Overall Study|Protocol Violation|3
207762|NCT00283049|694779|P3|Overall Study|Adverse Event|4
207763|NCT00283049|694780|P2|Overall Study|Adverse Event|1
207764|NCT00283049|694781|P1|Overall Study|Adverse Event|6
207765|NCT00282984|694809|P2|Overall Study|Protocol Violation|0
207766|NCT00282984|694810|P1|Overall Study|Protocol Violation|2
207767|NCT00282984|694809|P2|Overall Study|in prison|1
207768|NCT00282984|694810|P1|Overall Study|in prison|0
207769|NCT00282984|694809|P2|Overall Study|lack of motivation|0
207770|NCT00282984|694810|P1|Overall Study|lack of motivation|1
207771|NCT00282984|694809|P2|Overall Study|Participant used antipsychosis meds|1
207772|NCT00282984|694810|P1|Overall Study|Participant used antipsychosis meds|0
207773|NCT00282984|694809|P2|Overall Study|Participant only allowed phone follow-up|1
207774|NCT00282984|694810|P1|Overall Study|Participant only allowed phone follow-up|0
207775|NCT00282984|694809|P2|Overall Study|Participant stopped study medication|2
207776|NCT00282984|694810|P1|Overall Study|Participant stopped study medication|2
207777|NCT00282984|694809|P2|Overall Study|Withdrawal by Participant|34
207778|NCT00282984|694810|P1|Overall Study|Withdrawal by Participant|22
207779|NCT00282984|694809|P2|Overall Study|Lost to Follow-up|10
207780|NCT00282984|694810|P1|Overall Study|Lost to Follow-up|14
207781|NCT00282984|694809|P2|Overall Study|Lack of Efficacy|2
207782|NCT00282984|694810|P1|Overall Study|Lack of Efficacy|0
207783|NCT00282984|694809|P2|Overall Study|Adverse Event|5
207784|NCT00282984|694810|P1|Overall Study|Adverse Event|8
207785|NCT00282984|694809|P2|Overall Study|Death|5
207786|NCT00282984|694810|P1|Overall Study|Death|2
207787|NCT00282919|694847|P1|Overall Study|Asymptomatic Parasitemia|2
207788|NCT00282919|694847|P1|Overall Study|Withdrawal by Subject|1
207789|NCT00282919|694847|P1|Overall Study|Lack of Efficacy|4
207790|NCT00282867|694862|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
207791|NCT00282867|694863|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
207792|NCT00282867|694864|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
207793|NCT00282568|694961|P1|Extended Treatment Period|Lost to Follow-up|2
207794|NCT00282568|694961|P1|Extended Treatment Period|Physician Decision|1
207795|NCT00282568|694961|P1|Extended Treatment Period|Non-compliance|4
207796|NCT00282568|694961|P1|Extended Treatment Period|Adverse Event|17
207797|NCT00282568|694961|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
207798|NCT00282568|694961|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
207799|NCT00282464|694987|P2|Overall Study|dropped due to missed visits|1
207800|NCT00282464|694988|P1|Overall Study|dropped due to missed visits|0
207801|NCT00282464|694987|P2|Overall Study|dispensed wrong kit|1
207802|NCT00282464|694988|P1|Overall Study|dispensed wrong kit|0
207803|NCT00282464|694987|P2|Overall Study|family crisis|1
207804|NCT00282464|694988|P1|Overall Study|family crisis|0
207805|NCT00282464|694987|P2|Overall Study|patient incarcerated|1
207806|NCT00282464|694988|P1|Overall Study|patient incarcerated|0
207807|NCT00282464|694987|P2|Overall Study|patient no show|1
207808|NCT00282464|694988|P1|Overall Study|patient no show|0
207809|NCT00282464|694987|P2|Overall Study|patient non-compliant|0
207810|NCT00282464|694988|P1|Overall Study|patient non-compliant|3
207811|NCT00282464|694987|P2|Overall Study|Patient moved|0
207812|NCT00282464|694988|P1|Overall Study|Patient moved|1
207813|NCT00282464|694987|P2|Overall Study|Protocol Violation|7
207814|NCT00282464|694988|P1|Overall Study|Protocol Violation|0
207815|NCT00282464|694987|P2|Overall Study|laboratory abnormality|2
207816|NCT00282464|694988|P1|Overall Study|laboratory abnormality|1
207817|NCT00282464|694987|P2|Overall Study|Withdrawal by Subject|10
207818|NCT00282464|694988|P1|Overall Study|Withdrawal by Subject|24
207819|NCT00282464|694987|P2|Overall Study|Lost to Follow-up|10
207820|NCT00282464|694988|P1|Overall Study|Lost to Follow-up|10
207821|NCT00282464|694987|P2|Overall Study|Lack of Efficacy|8
207822|NCT00282464|694988|P1|Overall Study|Lack of Efficacy|8
207823|NCT00282464|694987|P2|Overall Study|Adverse Event|20
207824|NCT00282464|694988|P1|Overall Study|Adverse Event|26
207825|NCT00282438|695038|P2|Overall Study|Death|1
207826|NCT00282438|695039|P1|Overall Study|Death|0
207827|NCT00282438|695038|P2|Overall Study|Lack of Efficacy|0
207828|NCT00282438|695039|P1|Overall Study|Lack of Efficacy|1
207829|NCT00282347|695047|P2|B Cell Follow-up Period|Reason Not Specified|0
207830|NCT00282347|695048|P1|B Cell Follow-up Period|Reason Not Specified|2
207831|NCT00282347|695047|P2|B Cell Follow-up Period|Physician Decision|0
207832|NCT00282347|695048|P1|B Cell Follow-up Period|Physician Decision|1
207833|NCT00282347|695047|P2|B Cell Follow-up Period|Withdrawal by Subject|0
207834|NCT00282347|695048|P1|B Cell Follow-up Period|Withdrawal by Subject|2
207835|NCT00282347|695047|P2|Safety Follow-up Period|Protocol Deviation|2
207836|NCT00282347|695048|P1|Safety Follow-up Period|Protocol Deviation|0
207837|NCT00282347|695047|P2|Safety Follow-up Period|Physician Decision|1
207838|NCT00282347|695048|P1|Safety Follow-up Period|Physician Decision|1
207839|NCT00282347|695047|P2|Safety Follow-up Period|Withdrawal by Subject|1
207840|NCT00282347|695048|P1|Safety Follow-up Period|Withdrawal by Subject|2
207841|NCT00282347|695047|P2|Safety Follow-up Period|Lost to Follow-up|2
207842|NCT00282347|695048|P1|Safety Follow-up Period|Lost to Follow-up|0
207843|NCT00282347|695047|P2|Treatment Period|Physician Decision|1
207844|NCT00282347|695048|P1|Treatment Period|Physician Decision|0
207845|NCT00282347|695047|P2|Treatment Period|Withdrawal by Subject|3
207846|NCT00282347|695048|P1|Treatment Period|Withdrawal by Subject|1
207847|NCT00282347|695047|P2|Treatment Period|Lost to Follow-up|5
207848|NCT00282347|695048|P1|Treatment Period|Lost to Follow-up|2
207849|NCT00282347|695047|P2|Treatment Period|Death|0
207850|NCT00282347|695048|P1|Treatment Period|Death|2
207851|NCT00282334|695074|P2|Overall Study|Withdrawal by Subject|5
207852|NCT00282334|695075|P1|Overall Study|Withdrawal by Subject|8
207853|NCT00282308|695083|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
207854|NCT00282308|695084|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
207855|NCT00282308|695085|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
207856|NCT00282308|695083|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
207857|NCT00282308|695084|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
207858|NCT00282308|695085|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
207859|NCT00282308|695083|P3|Safety Follow-up Period|Lost to Follow-up|5
207860|NCT00282308|695084|P2|Safety Follow-up Period|Lost to Follow-up|0
207861|NCT00282308|695085|P1|Safety Follow-up Period|Lost to Follow-up|0
207862|NCT00282308|695083|P3|Safety Follow-up Period|Adverse Event|1
207863|NCT00282308|695084|P2|Safety Follow-up Period|Adverse Event|0
207864|NCT00282308|695085|P1|Safety Follow-up Period|Adverse Event|0
207865|NCT00282308|695083|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
207866|NCT00282308|695084|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
207867|NCT00282308|695085|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
207868|NCT00282308|695083|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
207869|NCT00282308|695084|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
207870|NCT00282308|695085|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
207871|NCT00282308|695083|P3|Optional Extension Re-treatment Period|Adverse Event|4
207872|NCT00282308|695084|P2|Optional Extension Re-treatment Period|Adverse Event|0
207873|NCT00282308|695085|P1|Optional Extension Re-treatment Period|Adverse Event|0
207874|NCT00282308|695083|P3|Treatment Period|Not Treated with Study Drug|0
207875|NCT00282308|695084|P2|Treatment Period|Not Treated with Study Drug|0
207876|NCT00282308|695085|P1|Treatment Period|Not Treated with Study Drug|1
207877|NCT00282308|695083|P3|Treatment Period|Adverse Event|0
207878|NCT00282308|695084|P2|Treatment Period|Adverse Event|2
207879|NCT00282308|695085|P1|Treatment Period|Adverse Event|0
207880|NCT00282308|695083|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
207881|NCT00282308|695084|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
207882|NCT00282308|695085|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
207883|NCT00282308|695083|P3|Treatment Period|Lost to Follow-up|0
207884|NCT00282308|695084|P2|Treatment Period|Lost to Follow-up|0
207885|NCT00282308|695085|P1|Treatment Period|Lost to Follow-up|1
207886|NCT00282295|695115|P3|Overall Study|Other|0
207887|NCT00282295|695116|P2|Overall Study|Other|1
207888|NCT00282295|695117|P1|Overall Study|Other|0
207889|NCT00282295|695115|P3|Overall Study|Lost to Follow-up|2
207890|NCT00282295|695116|P2|Overall Study|Lost to Follow-up|7
207891|NCT00282295|695117|P1|Overall Study|Lost to Follow-up|1
207892|NCT00282295|695115|P3|Overall Study|Withdrawal by Subject|4
207893|NCT00282295|695116|P2|Overall Study|Withdrawal by Subject|6
207894|NCT00282295|695117|P1|Overall Study|Withdrawal by Subject|2
207895|NCT00282295|695115|P3|Overall Study|Protocol Violation|1
207896|NCT00282295|695116|P2|Overall Study|Protocol Violation|2
207897|NCT00282295|695117|P1|Overall Study|Protocol Violation|0
207898|NCT00282295|695115|P3|Overall Study|Serious Adverse Events|1
207899|NCT00282295|695116|P2|Overall Study|Serious Adverse Events|0
207900|NCT00282295|695117|P1|Overall Study|Serious Adverse Events|0
207901|NCT00282295|695115|P3|Overall Study|Adverse Event|0
207902|NCT00282295|695116|P2|Overall Study|Adverse Event|1
207903|NCT00282295|695117|P1|Overall Study|Adverse Event|0
207904|NCT00282256|695172|P1|Extension Treatment Period|Adverse Event|2
207905|NCT00282256|695172|P1|Pharmacokinetic Treatment Period|Poor venous access|1
207906|NCT00282243|695193|P1|Extension Treatment Period|Physician Decision|1
207907|NCT00282243|695193|P1|Extension Treatment Period|Non-compliance|2
207908|NCT00282243|695193|P1|Extension Treatment Period|Withdrawal by Subject|4
207909|NCT00282243|695193|P1|Extension Treatment Period|Adverse Event|15
207910|NCT00282243|695193|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
207911|NCT00282243|695193|P1|Pharmacokinetic Treatment Period|Adverse Event|3
207912|NCT00282152|695219|P2|Overall Study|Withdrawal by Subject|0
207913|NCT00282152|695220|P1|Overall Study|Withdrawal by Subject|1
207914|NCT00282113|695241|P3|Overall Study|Removed at parents request|0
207915|NCT00282113|695242|P2|Overall Study|Removed at parents request|0
207916|NCT00282113|695243|P1|Overall Study|Removed at parents request|1
207917|NCT00282087|695257|P1|Overall Study|Death|1
207918|NCT00282048|695270|P1|Overall Study|Ongoing|1
207919|NCT00282048|695270|P1|Overall Study|Other|8
207920|NCT00282048|695270|P1|Overall Study|Withdrawal by Subject|1
207921|NCT00282048|695270|P1|Overall Study|Adverse Event|22
207922|NCT00282048|695270|P1|Overall Study|Lack of Efficacy|30
207923|NCT00281957|695284|P2|Overall Study|Refusal unrelated to adverse events|1
207924|NCT00281957|695285|P1|Overall Study|Refusal unrelated to adverse events|0
207925|NCT00281957|695284|P2|Overall Study|Did not start treatment|1
207926|NCT00281957|695285|P1|Overall Study|Did not start treatment|3
207927|NCT00281957|695284|P2|Overall Study|Not eligible|2
207928|NCT00281957|695285|P1|Overall Study|Not eligible|1
207929|NCT00281957|695284|P2|Overall Study|Not protocol specified|1
207930|NCT00281957|695285|P1|Overall Study|Not protocol specified|8
207931|NCT00281957|695284|P2|Overall Study|Progression/relapse|35
207932|NCT00281957|695285|P1|Overall Study|Progression/relapse|47
207933|NCT00281957|695284|P2|Overall Study|Death|0
207934|NCT00281957|695285|P1|Overall Study|Death|1
207935|NCT00281957|695284|P2|Overall Study|Adverse Event|2
207936|NCT00281957|695285|P1|Overall Study|Adverse Event|7
207937|NCT00281840|695359|P1|Overall Study|Complicating Disease|1
207938|NCT00281840|695359|P1|Overall Study|exceed maximum delay in treatment|1
207939|NCT00281840|695359|P1|Overall Study|Disease Progression|2
207940|NCT00281840|695359|P1|Overall Study|Withdrawal by Subject|3
207941|NCT00281840|695359|P1|Overall Study|Physician Decision|6
207942|NCT00281840|695359|P1|Overall Study|Adverse Event|12
207943|NCT00281697|695375|P2|Overall Study|Did not receive study drug|2
207944|NCT00281697|695376|P1|Overall Study|Did not receive study drug|3
207945|NCT00281697|695375|P2|Overall Study|Subject/guardian's decision to withdraw|6
207946|NCT00281697|695376|P1|Overall Study|Subject/guardian's decision to withdraw|33
207947|NCT00281697|695375|P2|Overall Study|Physician's decision to withdraw|12
207948|NCT00281697|695376|P1|Overall Study|Physician's decision to withdraw|15
207949|NCT00281697|695375|P2|Overall Study|Not specified|6
207950|NCT00281697|695376|P1|Overall Study|Not specified|5
207951|NCT00281697|695375|P2|Overall Study|Disease progression|149
207952|NCT00281697|695376|P1|Overall Study|Disease progression|279
207953|NCT00281697|695375|P2|Overall Study|Death|3
207954|NCT00281697|695376|P1|Overall Study|Death|8
207955|NCT00281697|695375|P2|Overall Study|Adverse Event|15
207956|NCT00281697|695376|P1|Overall Study|Adverse Event|54
207957|NCT00281697|695375|P2|Overall Study|> 60 days since last dose of study drug|4
207958|NCT00281697|695376|P1|Overall Study|> 60 days since last dose of study drug|4
207959|NCT00281658|695394|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
207960|NCT00281658|695395|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
207961|NCT00281658|695396|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
207962|NCT00281658|695394|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
207963|NCT00281658|695395|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
207964|NCT00281658|695396|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
207965|NCT00281658|695394|P3|Open-label Monotherapy Extension Phase|Death|97
207966|NCT00281658|695395|P2|Open-label Monotherapy Extension Phase|Death|0
207967|NCT00281658|695396|P1|Open-label Monotherapy Extension Phase|Death|0
207968|NCT00281658|695394|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
207969|NCT00281658|695395|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
207970|NCT00281658|695396|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
207971|NCT00281658|695394|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
207972|NCT00281658|695395|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
207973|NCT00281658|695396|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
207974|NCT00281658|695394|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
207975|NCT00281658|695395|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
207976|NCT00281658|695396|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
207977|NCT00281658|695394|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
207978|NCT00281658|695395|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
207979|NCT00281658|695396|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
207980|NCT00281658|695394|P3|Double-blind, Randomized Phase|Death|0
207981|NCT00281658|695395|P2|Double-blind, Randomized Phase|Death|46
207982|NCT00281658|695396|P1|Double-blind, Randomized Phase|Death|120
207983|NCT00281632|695413|P1|Overall Study|Ongoing|3
207984|NCT00281632|695413|P1|Overall Study|Physician Decision|1
207985|NCT00281632|695413|P1|Overall Study|Death|1
207986|NCT00281632|695413|P1|Overall Study|Disease Progression|22
207987|NCT00281632|695413|P1|Overall Study|Withdrawal by Subject|2
207988|NCT00281632|695413|P1|Overall Study|Adverse Event|7
207989|NCT00281580|695455|P16|Overall Study|Randomised in error; pregnancy; moving|2
207990|NCT00281580|695456|P15|Overall Study|Randomised in error; pregnancy; moving|1
207991|NCT00281580|695457|P14|Overall Study|Randomised in error; pregnancy; moving|0
207992|NCT00281580|695458|P13|Overall Study|Randomised in error; pregnancy; moving|2
207993|NCT00281580|695459|P12|Overall Study|Randomised in error; pregnancy; moving|1
207994|NCT00281580|695460|P11|Overall Study|Randomised in error; pregnancy; moving|1
207995|NCT00281580|695461|P10|Overall Study|Randomised in error; pregnancy; moving|1
207996|NCT00281580|695462|P9|Overall Study|Randomised in error; pregnancy; moving|2
207997|NCT00281580|695463|P8|Overall Study|Randomised in error; pregnancy; moving|0
207998|NCT00281580|695464|P7|Overall Study|Randomised in error; pregnancy; moving|1
207999|NCT00281580|695465|P6|Overall Study|Randomised in error; pregnancy; moving|0
208000|NCT00281580|695466|P5|Overall Study|Randomised in error; pregnancy; moving|0
208001|NCT00281580|695467|P4|Overall Study|Randomised in error; pregnancy; moving|2
208002|NCT00281580|695468|P3|Overall Study|Randomised in error; pregnancy; moving|0
208003|NCT00281580|695469|P2|Overall Study|Randomised in error; pregnancy; moving|0
208004|NCT00281580|695470|P1|Overall Study|Randomised in error; pregnancy; moving|0
208005|NCT00281580|695455|P16|Overall Study|Lost to Follow-up|0
208006|NCT00281580|695456|P15|Overall Study|Lost to Follow-up|0
208007|NCT00281580|695457|P14|Overall Study|Lost to Follow-up|0
208008|NCT00281580|695458|P13|Overall Study|Lost to Follow-up|1
208009|NCT00281580|695459|P12|Overall Study|Lost to Follow-up|0
208010|NCT00281580|695460|P11|Overall Study|Lost to Follow-up|1
208011|NCT00281580|695461|P10|Overall Study|Lost to Follow-up|1
208012|NCT00281580|695462|P9|Overall Study|Lost to Follow-up|2
208013|NCT00281580|695463|P8|Overall Study|Lost to Follow-up|1
208014|NCT00281580|695464|P7|Overall Study|Lost to Follow-up|0
208015|NCT00281580|695465|P6|Overall Study|Lost to Follow-up|1
208016|NCT00281580|695466|P5|Overall Study|Lost to Follow-up|0
208017|NCT00281580|695467|P4|Overall Study|Lost to Follow-up|3
208018|NCT00281580|695468|P3|Overall Study|Lost to Follow-up|0
208019|NCT00281580|695469|P2|Overall Study|Lost to Follow-up|0
208020|NCT00281580|695470|P1|Overall Study|Lost to Follow-up|0
208021|NCT00281580|695455|P16|Overall Study|Lack of Efficacy|0
208022|NCT00281580|695456|P15|Overall Study|Lack of Efficacy|1
208023|NCT00281580|695457|P14|Overall Study|Lack of Efficacy|2
208024|NCT00281580|695458|P13|Overall Study|Lack of Efficacy|0
208025|NCT00281580|695459|P12|Overall Study|Lack of Efficacy|1
208026|NCT00281580|695460|P11|Overall Study|Lack of Efficacy|0
208027|NCT00281580|695461|P10|Overall Study|Lack of Efficacy|0
208028|NCT00281580|695462|P9|Overall Study|Lack of Efficacy|0
208029|NCT00281580|695463|P8|Overall Study|Lack of Efficacy|0
208030|NCT00281580|695464|P7|Overall Study|Lack of Efficacy|0
208031|NCT00281580|695465|P6|Overall Study|Lack of Efficacy|0
208032|NCT00281580|695466|P5|Overall Study|Lack of Efficacy|2
208033|NCT00281580|695467|P4|Overall Study|Lack of Efficacy|6
208034|NCT00281580|695468|P3|Overall Study|Lack of Efficacy|1
208035|NCT00281580|695469|P2|Overall Study|Lack of Efficacy|1
208036|NCT00281580|695470|P1|Overall Study|Lack of Efficacy|2
208037|NCT00281580|695455|P16|Overall Study|Withdrawal by Subject|5
208038|NCT00281580|695456|P15|Overall Study|Withdrawal by Subject|1
208039|NCT00281580|695457|P14|Overall Study|Withdrawal by Subject|2
208040|NCT00281580|695458|P13|Overall Study|Withdrawal by Subject|2
208041|NCT00281580|695459|P12|Overall Study|Withdrawal by Subject|1
208042|NCT00281580|695460|P11|Overall Study|Withdrawal by Subject|1
208043|NCT00281580|695461|P10|Overall Study|Withdrawal by Subject|4
208044|NCT00281580|695462|P9|Overall Study|Withdrawal by Subject|1
208045|NCT00281580|695463|P8|Overall Study|Withdrawal by Subject|0
208046|NCT00281580|695464|P7|Overall Study|Withdrawal by Subject|2
208047|NCT00281580|695465|P6|Overall Study|Withdrawal by Subject|2
208048|NCT00281580|695466|P5|Overall Study|Withdrawal by Subject|1
208049|NCT00281580|695467|P4|Overall Study|Withdrawal by Subject|1
208050|NCT00281580|695468|P3|Overall Study|Withdrawal by Subject|1
208051|NCT00281580|695469|P2|Overall Study|Withdrawal by Subject|0
208052|NCT00281580|695470|P1|Overall Study|Withdrawal by Subject|3
208053|NCT00281580|695455|P16|Overall Study|Protocol Violation|3
208054|NCT00281580|695456|P15|Overall Study|Protocol Violation|1
208055|NCT00281580|695457|P14|Overall Study|Protocol Violation|1
208056|NCT00281580|695458|P13|Overall Study|Protocol Violation|0
208057|NCT00281580|695459|P12|Overall Study|Protocol Violation|2
208058|NCT00281580|695460|P11|Overall Study|Protocol Violation|1
208059|NCT00281580|695461|P10|Overall Study|Protocol Violation|0
208060|NCT00281580|695462|P9|Overall Study|Protocol Violation|2
208061|NCT00281580|695463|P8|Overall Study|Protocol Violation|0
208062|NCT00281580|695464|P7|Overall Study|Protocol Violation|1
208063|NCT00281580|695465|P6|Overall Study|Protocol Violation|0
208064|NCT00281580|695466|P5|Overall Study|Protocol Violation|0
208065|NCT00281580|695467|P4|Overall Study|Protocol Violation|1
208066|NCT00281580|695468|P3|Overall Study|Protocol Violation|1
208067|NCT00281580|695469|P2|Overall Study|Protocol Violation|0
208068|NCT00281580|695470|P1|Overall Study|Protocol Violation|0
208069|NCT00281580|695455|P16|Overall Study|Adverse Event|3
208070|NCT00281580|695456|P15|Overall Study|Adverse Event|3
208071|NCT00281580|695457|P14|Overall Study|Adverse Event|2
208072|NCT00281580|695458|P13|Overall Study|Adverse Event|8
208073|NCT00281580|695459|P12|Overall Study|Adverse Event|5
208074|NCT00281580|695460|P11|Overall Study|Adverse Event|0
208075|NCT00281580|695461|P10|Overall Study|Adverse Event|6
208076|NCT00281580|695462|P9|Overall Study|Adverse Event|1
208077|NCT00281580|695463|P8|Overall Study|Adverse Event|0
208078|NCT00281580|695464|P7|Overall Study|Adverse Event|1
208079|NCT00281580|695465|P6|Overall Study|Adverse Event|0
208080|NCT00281580|695466|P5|Overall Study|Adverse Event|1
208081|NCT00281580|695467|P4|Overall Study|Adverse Event|4
208082|NCT00281580|695468|P3|Overall Study|Adverse Event|2
208083|NCT00281580|695469|P2|Overall Study|Adverse Event|0
208084|NCT00281580|695470|P1|Overall Study|Adverse Event|2
208085|NCT00281528|695817|P3|Overall Study|Other|5
208086|NCT00281528|695818|P2|Overall Study|Other|3
208087|NCT00281528|695819|P1|Overall Study|Other|6
208088|NCT00281528|695817|P3|Overall Study|Withdrawal by Subject|7
208089|NCT00281528|695818|P2|Overall Study|Withdrawal by Subject|5
208090|NCT00281528|695819|P1|Overall Study|Withdrawal by Subject|5
208091|NCT00281528|695817|P3|Overall Study|Protocol Violation|1
208092|NCT00281528|695818|P2|Overall Study|Protocol Violation|0
208093|NCT00281528|695819|P1|Overall Study|Protocol Violation|1
208094|NCT00281528|695817|P3|Overall Study|Physician Decision|5
208095|NCT00281528|695818|P2|Overall Study|Physician Decision|4
208096|NCT00281528|695819|P1|Overall Study|Physician Decision|11
208097|NCT00281528|695817|P3|Overall Study|Adverse Event-unrelated to treatment|2
208098|NCT00281528|695818|P2|Overall Study|Adverse Event-unrelated to treatment|0
208099|NCT00281528|695819|P1|Overall Study|Adverse Event-unrelated to treatment|3
208100|NCT00281528|695817|P3|Overall Study|Unacceptable Toxicity-related to trt|32
208101|NCT00281528|695818|P2|Overall Study|Unacceptable Toxicity-related to trt|24
208102|NCT00281528|695819|P1|Overall Study|Unacceptable Toxicity-related to trt|21
208103|NCT00281528|695817|P3|Overall Study|Progressive Disease|27
208104|NCT00281528|695818|P2|Overall Study|Progressive Disease|18
208105|NCT00281528|695819|P1|Overall Study|Progressive Disease|28
208106|NCT00281320|695870|P2|Overall Study|Not specified|1
208107|NCT00281320|695871|P1|Overall Study|Not specified|3
208108|NCT00281320|695870|P2|Overall Study|Lost to Follow-up|2
208109|NCT00281320|695871|P1|Overall Study|Lost to Follow-up|1
208110|NCT00281320|695870|P2|Overall Study|Withdrawal by Subject|6
208111|NCT00281320|695871|P1|Overall Study|Withdrawal by Subject|5
208112|NCT00281320|695870|P2|Overall Study|Lack of Efficacy|3
208113|NCT00281320|695871|P1|Overall Study|Lack of Efficacy|4
208114|NCT00281320|695870|P2|Overall Study|Adverse Event|9
208115|NCT00281320|695871|P1|Overall Study|Adverse Event|12
208116|NCT00281099|695893|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
208117|NCT00281099|695894|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
208118|NCT00281099|695893|P2|Overall Study|Physician Decision|72
208119|NCT00281099|695894|P1|Overall Study|Physician Decision|79
208120|NCT00281099|695893|P2|Overall Study|Withdrawal by Subject|70
208121|NCT00281099|695894|P1|Overall Study|Withdrawal by Subject|65
208122|NCT00281099|695893|P2|Overall Study|Lost to Follow-up|19
208123|NCT00281099|695894|P1|Overall Study|Lost to Follow-up|10
208124|NCT00281099|695893|P2|Overall Study|Death|57
208125|NCT00281099|695894|P1|Overall Study|Death|46
208126|NCT00280917|695943|P4|Overall Study|Noncompliance|0
208127|NCT00280917|695944|P3|Overall Study|Noncompliance|2
208128|NCT00280917|695945|P2|Overall Study|Noncompliance|1
208129|NCT00280917|695946|P1|Overall Study|Noncompliance|0
208130|NCT00280917|695943|P4|Overall Study|Withdrawal by Subject|1
208131|NCT00280917|695944|P3|Overall Study|Withdrawal by Subject|0
208132|NCT00280917|695945|P2|Overall Study|Withdrawal by Subject|2
208133|NCT00280917|695946|P1|Overall Study|Withdrawal by Subject|0
208134|NCT00280917|695943|P4|Overall Study|Change Therapy|0
208135|NCT00280917|695944|P3|Overall Study|Change Therapy|0
208136|NCT00280917|695945|P2|Overall Study|Change Therapy|2
208137|NCT00280917|695946|P1|Overall Study|Change Therapy|1
208138|NCT00280917|695943|P4|Overall Study|Adverse Event|1
208139|NCT00280917|695944|P3|Overall Study|Adverse Event|4
208140|NCT00280917|695945|P2|Overall Study|Adverse Event|1
208141|NCT00280917|695946|P1|Overall Study|Adverse Event|1
208142|NCT00280748|695969|P1|Overall Study|Extra-cranial disease progression|1
208143|NCT00280748|695969|P1|Overall Study|Decline in performance|3
208144|NCT00280735|695979|P1|Overall Study|Intercurrent Illness|2
208145|NCT00280735|695979|P1|Overall Study|Withdrawal by Subject|8
208146|NCT00280735|695979|P1|Overall Study|Lack of Efficacy|3
208147|NCT00280735|695979|P1|Overall Study|Adverse Event|5
208148|NCT00280683|695991|P2|Overall Study|Adverse Event|1
208149|NCT00280683|695992|P1|Overall Study|Adverse Event|1
208150|NCT00280683|695991|P2|Overall Study|Withdrawal by Subject|2
208151|NCT00280683|695992|P1|Overall Study|Withdrawal by Subject|1
208152|NCT00280566|696002|P3|Period 2 Double Blind|miscellaneous|5
208153|NCT00280566|696003|P2|Period 2 Double Blind|miscellaneous|10
208154|NCT00280566|696004|P1|Period 2 Double Blind|miscellaneous|0
208155|NCT00280566|696002|P3|Period 2 Double Blind|Withdrawal by Subject|9
208156|NCT00280566|696003|P2|Period 2 Double Blind|Withdrawal by Subject|9
208157|NCT00280566|696004|P1|Period 2 Double Blind|Withdrawal by Subject|0
208158|NCT00280566|696002|P3|Period 2 Double Blind|Lost to Follow-up|6
208159|NCT00280566|696003|P2|Period 2 Double Blind|Lost to Follow-up|3
208160|NCT00280566|696004|P1|Period 2 Double Blind|Lost to Follow-up|0
208161|NCT00280566|696002|P3|Period 2 Double Blind|Adverse Event|15
208162|NCT00280566|696003|P2|Period 2 Double Blind|Adverse Event|11
208163|NCT00280566|696004|P1|Period 2 Double Blind|Adverse Event|0
208164|NCT00280566|696002|P3|Period 2 Double Blind|Laboratory Abnormality|0
208165|NCT00280566|696003|P2|Period 2 Double Blind|Laboratory Abnormality|1
208166|NCT00280566|696004|P1|Period 2 Double Blind|Laboratory Abnormality|0
208167|NCT00280566|696002|P3|Period 2 Double Blind|Lack of Efficacy|22
208168|NCT00280566|696003|P2|Period 2 Double Blind|Lack of Efficacy|9
208169|NCT00280566|696004|P1|Period 2 Double Blind|Lack of Efficacy|0
208170|NCT00280566|696002|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
208171|NCT00280566|696003|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
208172|NCT00280566|696004|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
208173|NCT00280566|696002|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
208174|NCT00280566|696003|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
208175|NCT00280566|696004|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
208176|NCT00280566|696002|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
208177|NCT00280566|696003|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
208178|NCT00280566|696004|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
208179|NCT00280566|696002|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
208180|NCT00280566|696003|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
208181|NCT00280566|696004|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
208182|NCT00280566|696002|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
208183|NCT00280566|696003|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
208184|NCT00280566|696004|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
208185|NCT00280566|696002|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
208186|NCT00280566|696003|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
208187|NCT00280566|696004|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
208188|NCT00280397|696029|P1|Overall Study|Adverse Event|1
208189|NCT00280293|696095|P2|Overall Study|Adverse Event|1
208190|NCT00280293|696096|P1|Overall Study|Adverse Event|0
208191|NCT00280293|696095|P2|Overall Study|Incarceration/Legal Reasons|1
208192|NCT00280293|696096|P1|Overall Study|Incarceration/Legal Reasons|1
208193|NCT00280293|696095|P2|Overall Study|Withdrawal by Subject|5
208194|NCT00280293|696096|P1|Overall Study|Withdrawal by Subject|3
208195|NCT00280293|696095|P2|Overall Study|Lost to Follow-up|12
208196|NCT00280293|696096|P1|Overall Study|Lost to Follow-up|14
208197|NCT00280293|696095|P2|Overall Study|Physician Decision|4
208198|NCT00280293|696096|P1|Overall Study|Physician Decision|5
208199|NCT00280293|696095|P2|Overall Study|Protocol Violation|0
208200|NCT00280293|696096|P1|Overall Study|Protocol Violation|3
208201|NCT00280150|696119|P4|Overall Study|Declining Performance Status|1
208202|NCT00280150|696120|P3|Overall Study|Declining Performance Status|0
208203|NCT00280150|696121|P2|Overall Study|Declining Performance Status|0
208204|NCT00280150|696122|P1|Overall Study|Declining Performance Status|0
208205|NCT00280150|696119|P4|Overall Study|Did not get consolidation therapy|0
208206|NCT00280150|696120|P3|Overall Study|Did not get consolidation therapy|3
208207|NCT00280150|696121|P2|Overall Study|Did not get consolidation therapy|0
208208|NCT00280150|696122|P1|Overall Study|Did not get consolidation therapy|3
208209|NCT00280150|696119|P4|Overall Study|Withdrawal by Subject|1
208210|NCT00280150|696120|P3|Overall Study|Withdrawal by Subject|0
208211|NCT00280150|696121|P2|Overall Study|Withdrawal by Subject|0
208212|NCT00280150|696122|P1|Overall Study|Withdrawal by Subject|0
208213|NCT00280150|696119|P4|Overall Study|Protocol Violation|1
208214|NCT00280150|696120|P3|Overall Study|Protocol Violation|0
208215|NCT00280150|696121|P2|Overall Study|Protocol Violation|0
208216|NCT00280150|696122|P1|Overall Study|Protocol Violation|0
208217|NCT00280150|696119|P4|Overall Study|Physician Decision|1
208218|NCT00280150|696120|P3|Overall Study|Physician Decision|0
208219|NCT00280150|696121|P2|Overall Study|Physician Decision|0
208220|NCT00280150|696122|P1|Overall Study|Physician Decision|0
208221|NCT00280150|696119|P4|Overall Study|Lack of Efficacy|3
208222|NCT00280150|696120|P3|Overall Study|Lack of Efficacy|0
208223|NCT00280150|696121|P2|Overall Study|Lack of Efficacy|0
208224|NCT00280150|696122|P1|Overall Study|Lack of Efficacy|0
208225|NCT00280150|696119|P4|Overall Study|Adverse Event|3
208226|NCT00280150|696120|P3|Overall Study|Adverse Event|2
208227|NCT00280150|696121|P2|Overall Study|Adverse Event|1
208228|NCT00280150|696122|P1|Overall Study|Adverse Event|0
208229|NCT00280059|696137|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
208230|NCT00280059|696138|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
208231|NCT00280059|696137|P2|Efficacy Assessment Phase|Other|8
208232|NCT00280059|696138|P1|Efficacy Assessment Phase|Other|7
208233|NCT00280059|696137|P2|Efficacy Assessment Phase|Lost to Follow-up|13
208234|NCT00280059|696138|P1|Efficacy Assessment Phase|Lost to Follow-up|6
208235|NCT00280059|696137|P2|Efficacy Assessment Phase|Lack of Efficacy|3
208236|NCT00280059|696138|P1|Efficacy Assessment Phase|Lack of Efficacy|19
208237|NCT00280059|696137|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
208238|NCT00280059|696138|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
208239|NCT00280059|696137|P2|Efficacy Assessment Phase|Adverse Event|31
208240|NCT00280059|696138|P1|Efficacy Assessment Phase|Adverse Event|33
208241|NCT00280059|696137|P2|Efficacy Assessment Phase|Death|0
208242|NCT00280059|696138|P1|Efficacy Assessment Phase|Death|2
208243|NCT00279916|696202|P2|Overall Study|Lost to Follow-up|2
208244|NCT00279916|696203|P1|Overall Study|Lost to Follow-up|3
208245|NCT00279916|696202|P2|Overall Study|Withdrawal by Subject|3
208246|NCT00279916|696203|P1|Overall Study|Withdrawal by Subject|4
208247|NCT00279708|696225|P2|Overall Study|Adverse Event|1
208248|NCT00279708|696226|P1|Overall Study|Adverse Event|1
208249|NCT00279708|696225|P2|Overall Study|Withdrawal by Subject|3
208250|NCT00279708|696226|P1|Overall Study|Withdrawal by Subject|2
208251|NCT00279305|696255|P2|Overall Study|FDA Safety Alert|1
208252|NCT00279305|696256|P1|Overall Study|FDA Safety Alert|4
208253|NCT00279305|696255|P2|Overall Study|Dificulting establishing IV|0
208254|NCT00279305|696256|P1|Overall Study|Dificulting establishing IV|1
208255|NCT00279305|696255|P2|Overall Study|Withdrawal by Subject|0
208256|NCT00279305|696256|P1|Overall Study|Withdrawal by Subject|2
208257|NCT00279305|696255|P2|Overall Study|Pregnancy|0
208258|NCT00279305|696256|P1|Overall Study|Pregnancy|1
208259|NCT00279214|696264|P2|Overall Study|Physician Decision|2
208260|NCT00279214|696265|P1|Overall Study|Physician Decision|3
208261|NCT00279201|696295|P6|Intensification Addendum|Death|0
208262|NCT00279201|696296|P5|Intensification Addendum|Death|1
208263|NCT00279201|696297|P4|Intensification Addendum|Death|0
208264|NCT00279201|696298|P3|Intensification Addendum|Death|0
208265|NCT00279201|696299|P2|Intensification Addendum|Death|0
208266|NCT00279201|696300|P1|Intensification Addendum|Death|0
208267|NCT00279201|696295|P6|Intensification Addendum|Lack of Efficacy|0
208268|NCT00279201|696296|P5|Intensification Addendum|Lack of Efficacy|1
208269|NCT00279201|696297|P4|Intensification Addendum|Lack of Efficacy|1
208270|NCT00279201|696298|P3|Intensification Addendum|Lack of Efficacy|0
208271|NCT00279201|696299|P2|Intensification Addendum|Lack of Efficacy|0
208272|NCT00279201|696300|P1|Intensification Addendum|Lack of Efficacy|0
208273|NCT00279201|696295|P6|Intensification Addendum|Entry Criteria Exclusion|0
208274|NCT00279201|696296|P5|Intensification Addendum|Entry Criteria Exclusion|0
208275|NCT00279201|696297|P4|Intensification Addendum|Entry Criteria Exclusion|0
208276|NCT00279201|696298|P3|Intensification Addendum|Entry Criteria Exclusion|1
208277|NCT00279201|696299|P2|Intensification Addendum|Entry Criteria Exclusion|0
208278|NCT00279201|696300|P1|Intensification Addendum|Entry Criteria Exclusion|0
208279|NCT00279201|696295|P6|Intensification Addendum|Sponsor Decision|1
208280|NCT00279201|696296|P5|Intensification Addendum|Sponsor Decision|1
208281|NCT00279201|696297|P4|Intensification Addendum|Sponsor Decision|0
208282|NCT00279201|696298|P3|Intensification Addendum|Sponsor Decision|0
208283|NCT00279201|696299|P2|Intensification Addendum|Sponsor Decision|0
208284|NCT00279201|696300|P1|Intensification Addendum|Sponsor Decision|0
208285|NCT00279201|696295|P6|Intensification Addendum|Physician Decision|2
208286|NCT00279201|696296|P5|Intensification Addendum|Physician Decision|3
208287|NCT00279201|696297|P4|Intensification Addendum|Physician Decision|1
208288|NCT00279201|696298|P3|Intensification Addendum|Physician Decision|4
208289|NCT00279201|696299|P2|Intensification Addendum|Physician Decision|0
208290|NCT00279201|696300|P1|Intensification Addendum|Physician Decision|0
208291|NCT00279201|696295|P6|Intensification Addendum|Adverse Event|3
208292|NCT00279201|696296|P5|Intensification Addendum|Adverse Event|1
208293|NCT00279201|696297|P4|Intensification Addendum|Adverse Event|4
208294|NCT00279201|696298|P3|Intensification Addendum|Adverse Event|0
208295|NCT00279201|696299|P2|Intensification Addendum|Adverse Event|0
208296|NCT00279201|696300|P1|Intensification Addendum|Adverse Event|0
208297|NCT00279201|696295|P6|Intensification Addendum|Protocol Violation|6
208298|NCT00279201|696296|P5|Intensification Addendum|Protocol Violation|6
208299|NCT00279201|696297|P4|Intensification Addendum|Protocol Violation|2
208300|NCT00279201|696298|P3|Intensification Addendum|Protocol Violation|2
208301|NCT00279201|696299|P2|Intensification Addendum|Protocol Violation|0
208302|NCT00279201|696300|P1|Intensification Addendum|Protocol Violation|0
208303|NCT00279201|696295|P6|Intensification Addendum|Lost to Follow-up|7
208304|NCT00279201|696296|P5|Intensification Addendum|Lost to Follow-up|7
208305|NCT00279201|696297|P4|Intensification Addendum|Lost to Follow-up|6
208306|NCT00279201|696298|P3|Intensification Addendum|Lost to Follow-up|4
208307|NCT00279201|696299|P2|Intensification Addendum|Lost to Follow-up|0
208308|NCT00279201|696300|P1|Intensification Addendum|Lost to Follow-up|0
208309|NCT00279201|696295|P6|Intensification Addendum|Withdrawal by Subject|18
208310|NCT00279201|696296|P5|Intensification Addendum|Withdrawal by Subject|9
208311|NCT00279201|696297|P4|Intensification Addendum|Withdrawal by Subject|14
208312|NCT00279201|696298|P3|Intensification Addendum|Withdrawal by Subject|12
208313|NCT00279201|696299|P2|Intensification Addendum|Withdrawal by Subject|0
208314|NCT00279201|696300|P1|Intensification Addendum|Withdrawal by Subject|0
208315|NCT00279201|696295|P6|Maintenance|HbA1c>7.5%|0
208316|NCT00279201|696296|P5|Maintenance|HbA1c>7.5%|0
208317|NCT00279201|696297|P4|Maintenance|HbA1c>7.5%|0
208318|NCT00279201|696298|P3|Maintenance|HbA1c>7.5%|0
208319|NCT00279201|696299|P2|Maintenance|HbA1c>7.5%|126
208320|NCT00279201|696300|P1|Maintenance|HbA1c>7.5%|123
208321|NCT00279201|696295|P6|Maintenance|Sponsor Decision|0
208322|NCT00279201|696296|P5|Maintenance|Sponsor Decision|0
208323|NCT00279201|696297|P4|Maintenance|Sponsor Decision|0
208324|NCT00279201|696298|P3|Maintenance|Sponsor Decision|0
208325|NCT00279201|696299|P2|Maintenance|Sponsor Decision|0
208326|NCT00279201|696300|P1|Maintenance|Sponsor Decision|4
208327|NCT00279201|696295|P6|Maintenance|Physician Decision|0
208328|NCT00279201|696296|P5|Maintenance|Physician Decision|0
208329|NCT00279201|696297|P4|Maintenance|Physician Decision|0
208330|NCT00279201|696298|P3|Maintenance|Physician Decision|0
208331|NCT00279201|696299|P2|Maintenance|Physician Decision|9
208332|NCT00279201|696300|P1|Maintenance|Physician Decision|9
208333|NCT00279201|696295|P6|Maintenance|Withdrawal by Subject|0
208334|NCT00279201|696296|P5|Maintenance|Withdrawal by Subject|0
208335|NCT00279201|696297|P4|Maintenance|Withdrawal by Subject|0
208336|NCT00279201|696298|P3|Maintenance|Withdrawal by Subject|0
208337|NCT00279201|696299|P2|Maintenance|Withdrawal by Subject|18
208338|NCT00279201|696300|P1|Maintenance|Withdrawal by Subject|18
208339|NCT00279201|696295|P6|Maintenance|Protocol Violation|0
208340|NCT00279201|696296|P5|Maintenance|Protocol Violation|0
208341|NCT00279201|696297|P4|Maintenance|Protocol Violation|0
208342|NCT00279201|696298|P3|Maintenance|Protocol Violation|0
208343|NCT00279201|696299|P2|Maintenance|Protocol Violation|24
208344|NCT00279201|696300|P1|Maintenance|Protocol Violation|16
208345|NCT00279201|696295|P6|Maintenance|Entry Criteria Exclusion|0
208346|NCT00279201|696296|P5|Maintenance|Entry Criteria Exclusion|0
208347|NCT00279201|696297|P4|Maintenance|Entry Criteria Exclusion|0
208348|NCT00279201|696298|P3|Maintenance|Entry Criteria Exclusion|0
208349|NCT00279201|696299|P2|Maintenance|Entry Criteria Exclusion|4
208350|NCT00279201|696300|P1|Maintenance|Entry Criteria Exclusion|1
208351|NCT00279201|696295|P6|Maintenance|Lost to Follow-up|0
208352|NCT00279201|696296|P5|Maintenance|Lost to Follow-up|0
208353|NCT00279201|696297|P4|Maintenance|Lost to Follow-up|0
208354|NCT00279201|696298|P3|Maintenance|Lost to Follow-up|0
208355|NCT00279201|696299|P2|Maintenance|Lost to Follow-up|13
208356|NCT00279201|696300|P1|Maintenance|Lost to Follow-up|17
208357|NCT00279201|696295|P6|Maintenance|Death|0
208358|NCT00279201|696296|P5|Maintenance|Death|0
208359|NCT00279201|696297|P4|Maintenance|Death|0
208360|NCT00279201|696298|P3|Maintenance|Death|0
208361|NCT00279201|696299|P2|Maintenance|Death|4
208362|NCT00279201|696300|P1|Maintenance|Death|4
208363|NCT00279201|696295|P6|Maintenance|Adverse Event|0
208364|NCT00279201|696296|P5|Maintenance|Adverse Event|0
208365|NCT00279201|696297|P4|Maintenance|Adverse Event|0
208366|NCT00279201|696298|P3|Maintenance|Adverse Event|0
208367|NCT00279201|696299|P2|Maintenance|Adverse Event|4
208368|NCT00279201|696300|P1|Maintenance|Adverse Event|4
208369|NCT00279201|696295|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
208370|NCT00279201|696296|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
208371|NCT00279201|696297|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
208372|NCT00279201|696298|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
208373|NCT00279201|696299|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
208374|NCT00279201|696300|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
208375|NCT00279201|696295|P6|Maintenance|Lack of Efficacy|0
208376|NCT00279201|696296|P5|Maintenance|Lack of Efficacy|0
208377|NCT00279201|696297|P4|Maintenance|Lack of Efficacy|0
208378|NCT00279201|696298|P3|Maintenance|Lack of Efficacy|0
208379|NCT00279201|696299|P2|Maintenance|Lack of Efficacy|30
208380|NCT00279201|696300|P1|Maintenance|Lack of Efficacy|32
208381|NCT00279201|696295|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
208382|NCT00279201|696296|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
208383|NCT00279201|696297|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
208384|NCT00279201|696298|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
208385|NCT00279201|696299|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
208386|NCT00279201|696300|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
208387|NCT00279201|696295|P6|Initiation|Sponsor Decision|0
208388|NCT00279201|696296|P5|Initiation|Sponsor Decision|0
208389|NCT00279201|696297|P4|Initiation|Sponsor Decision|0
208390|NCT00279201|696298|P3|Initiation|Sponsor Decision|0
208391|NCT00279201|696299|P2|Initiation|Sponsor Decision|5
208392|NCT00279201|696300|P1|Initiation|Sponsor Decision|13
208393|NCT00279201|696295|P6|Initiation|Physician Decision|0
208394|NCT00279201|696296|P5|Initiation|Physician Decision|0
208395|NCT00279201|696297|P4|Initiation|Physician Decision|0
208396|NCT00279201|696298|P3|Initiation|Physician Decision|0
208397|NCT00279201|696299|P2|Initiation|Physician Decision|18
208398|NCT00279201|696300|P1|Initiation|Physician Decision|15
208399|NCT00279201|696295|P6|Initiation|Withdrawal by Subject|0
208400|NCT00279201|696296|P5|Initiation|Withdrawal by Subject|0
208401|NCT00279201|696297|P4|Initiation|Withdrawal by Subject|0
208402|NCT00279201|696298|P3|Initiation|Withdrawal by Subject|0
208403|NCT00279201|696299|P2|Initiation|Withdrawal by Subject|41
208404|NCT00279201|696300|P1|Initiation|Withdrawal by Subject|35
208405|NCT00279201|696295|P6|Initiation|Protocol Violation|0
208406|NCT00279201|696296|P5|Initiation|Protocol Violation|0
208407|NCT00279201|696297|P4|Initiation|Protocol Violation|0
208408|NCT00279201|696298|P3|Initiation|Protocol Violation|0
208409|NCT00279201|696299|P2|Initiation|Protocol Violation|10
208410|NCT00279201|696300|P1|Initiation|Protocol Violation|9
208411|NCT00279201|696295|P6|Initiation|Entry Criteria Exclusion|0
208412|NCT00279201|696296|P5|Initiation|Entry Criteria Exclusion|0
208413|NCT00279201|696297|P4|Initiation|Entry Criteria Exclusion|0
208414|NCT00279201|696298|P3|Initiation|Entry Criteria Exclusion|0
208415|NCT00279201|696299|P2|Initiation|Entry Criteria Exclusion|9
208416|NCT00279201|696300|P1|Initiation|Entry Criteria Exclusion|7
208417|NCT00279201|696295|P6|Initiation|Lost to Follow-up|0
208418|NCT00279201|696296|P5|Initiation|Lost to Follow-up|0
208419|NCT00279201|696297|P4|Initiation|Lost to Follow-up|0
208420|NCT00279201|696298|P3|Initiation|Lost to Follow-up|0
208421|NCT00279201|696299|P2|Initiation|Lost to Follow-up|41
208422|NCT00279201|696300|P1|Initiation|Lost to Follow-up|42
208423|NCT00279201|696295|P6|Initiation|Adverse Event|0
208424|NCT00279201|696296|P5|Initiation|Adverse Event|0
208425|NCT00279201|696297|P4|Initiation|Adverse Event|0
208426|NCT00279201|696298|P3|Initiation|Adverse Event|0
208427|NCT00279201|696299|P2|Initiation|Adverse Event|15
208428|NCT00279201|696300|P1|Initiation|Adverse Event|6
208429|NCT00279201|696295|P6|Initiation|Death|0
208430|NCT00279201|696296|P5|Initiation|Death|0
208431|NCT00279201|696297|P4|Initiation|Death|0
208432|NCT00279201|696298|P3|Initiation|Death|0
208433|NCT00279201|696299|P2|Initiation|Death|5
208434|NCT00279201|696300|P1|Initiation|Death|1
208435|NCT00278993|696444|P1|Overall Study|Not Otherwise Specified|4
208436|NCT00278993|696444|P1|Overall Study|Physician Decision|9
208437|NCT00278993|696444|P1|Overall Study|Progressive Disease|65
208438|NCT00278993|696444|P1|Overall Study|Withdrawal by Subject|5
208439|NCT00278993|696444|P1|Overall Study|Adverse Event|24
208440|NCT00278954|696452|P1|Overall Study|Withdrawal by Subject|1
208441|NCT00278954|696452|P1|Overall Study|Lost to Follow-up|1
208442|NCT00278954|696452|P1|Overall Study|Adverse Event|3
208443|NCT00278915|696460|P1|Overall Study|Lack of Efficacy|1
208444|NCT00278889|696496|P3|Overall Study|Death|17
208445|NCT00278889|696497|P2|Overall Study|Death|21
208446|NCT00278889|696498|P1|Overall Study|Death|24
208447|NCT00278889|696496|P3|Overall Study|Lost to Follow-up|0
208448|NCT00278889|696497|P2|Overall Study|Lost to Follow-up|1
208449|NCT00278889|696498|P1|Overall Study|Lost to Follow-up|1
208450|NCT00278889|696496|P3|Overall Study|Withdrawal by Subject|3
208451|NCT00278889|696497|P2|Overall Study|Withdrawal by Subject|5
208452|NCT00278889|696498|P1|Overall Study|Withdrawal by Subject|0
208453|NCT00278473|696559|P2|Overall Study|drop out|3
208454|NCT00278473|696560|P1|Overall Study|drop out|4
208455|NCT00278395|696576|P1|Overall Study|Nonevaluable|1
208456|NCT00278395|696576|P1|Overall Study|Adverse Event|2
208457|NCT00277355|696632|P2|Overall Study|Physician Decision|0
208458|NCT00277355|696633|P1|Overall Study|Physician Decision|1
208459|NCT00277355|696632|P2|Overall Study|Death|0
208460|NCT00277355|696633|P1|Overall Study|Death|3
208461|NCT00277355|696632|P2|Overall Study|Adverse Event|0
208462|NCT00277355|696633|P1|Overall Study|Adverse Event|5
208463|NCT00277355|696632|P2|Overall Study|Lost to Follow-up|2
208464|NCT00277355|696633|P1|Overall Study|Lost to Follow-up|2
208465|NCT00277355|696632|P2|Overall Study|Withdrawal by Subject|3
208466|NCT00277355|696633|P1|Overall Study|Withdrawal by Subject|3
208467|NCT00277212|696641|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
208468|NCT00277212|696642|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
208469|NCT00277212|696643|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
208470|NCT00277212|696641|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
208471|NCT00277212|696642|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
208472|NCT00277212|696643|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
208473|NCT00277212|696641|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
208474|NCT00277212|696642|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
208475|NCT00277212|696643|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
208476|NCT00277212|696641|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
208477|NCT00277212|696642|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
208478|NCT00277212|696643|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
208479|NCT00277212|696641|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
208480|NCT00277212|696642|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
208481|NCT00277212|696643|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
208482|NCT00277212|696641|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
208483|NCT00277212|696642|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
208484|NCT00277212|696643|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
208485|NCT00277212|696641|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
208486|NCT00277212|696642|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
208487|NCT00277212|696643|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
208488|NCT00277212|696641|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
208489|NCT00277212|696642|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
208490|NCT00277212|696643|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
208491|NCT00277212|696641|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
208492|NCT00277212|696642|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
208493|NCT00277212|696643|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
208494|NCT00277212|696641|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
208495|NCT00277212|696642|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
208496|NCT00277212|696643|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
208497|NCT00277212|696641|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
208498|NCT00277212|696642|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
208499|NCT00277212|696643|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
208500|NCT00277212|696641|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
208501|NCT00277212|696642|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
208502|NCT00277212|696643|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
208503|NCT00277212|696641|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
208504|NCT00277212|696642|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
208505|NCT00277212|696643|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
208506|NCT00277212|696641|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
208507|NCT00277212|696642|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
208508|NCT00277212|696643|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
208509|NCT00277212|696641|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
208510|NCT00277212|696642|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
208511|NCT00277212|696643|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
208512|NCT00277212|696641|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
208513|NCT00277212|696642|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
208514|NCT00277212|696643|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
208515|NCT00277212|696641|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
208516|NCT00277212|696642|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
208517|NCT00277212|696643|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
208518|NCT00277212|696641|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
208519|NCT00277212|696642|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
208520|NCT00277212|696643|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
208521|NCT00277095|696681|P1|Overall Study|Physician Decision|1
208522|NCT00277095|696681|P1|Overall Study|Missed Follow-up|9
208523|NCT00277095|696681|P1|Overall Study|Lost to Follow-up|2
208524|NCT00277095|696681|P1|Overall Study|Explanted|7
208525|NCT00277095|696681|P1|Overall Study|Death|2
208526|NCT00276614|696690|P1|Overall Study|Progression of disease under study|3
208527|NCT00276484|696701|P2|Overall Study|Could not take time off work|1
208528|NCT00276484|696702|P1|Overall Study|Could not take time off work|0
208529|NCT00276484|696701|P2|Overall Study|Withdrawal by Subject|3
208530|NCT00276484|696702|P1|Overall Study|Withdrawal by Subject|4
208531|NCT00276484|696701|P2|Overall Study|Protocol Violation|1
208532|NCT00276484|696702|P1|Overall Study|Protocol Violation|0
208533|NCT00276484|696701|P2|Overall Study|Lost to Follow-up|1
208534|NCT00276484|696702|P1|Overall Study|Lost to Follow-up|1
208535|NCT00276484|696701|P2|Overall Study|Adverse Event|7
208536|NCT00276484|696702|P1|Overall Study|Adverse Event|4
208537|NCT00276458|696734|P2|Overall Study|Protocol Violation|3
208538|NCT00276458|696735|P1|Overall Study|Protocol Violation|4
208539|NCT00276458|696734|P2|Overall Study|Lost to Follow-up|2
208540|NCT00276458|696735|P1|Overall Study|Lost to Follow-up|2
208541|NCT00276458|696734|P2|Overall Study|Adverse Event|2
208542|NCT00276458|696735|P1|Overall Study|Adverse Event|0
208543|NCT00276419|696769|P2|First Intervention|Withdrawal by Subject|2
208544|NCT00276419|696770|P1|First Intervention|Withdrawal by Subject|0
208545|NCT00276419|696769|P2|First Intervention|Adverse Event|0
208546|NCT00276419|696770|P1|First Intervention|Adverse Event|1
208547|NCT00276380|696813|P2|Overall Study|Abnormal aPPT Levels|1
208548|NCT00276380|696814|P1|Overall Study|Abnormal aPPT Levels|0
208549|NCT00276380|696813|P2|Overall Study|Death|3
208550|NCT00276380|696814|P1|Overall Study|Death|5
208551|NCT00276380|696813|P2|Overall Study|Withdrawal by Subject|6
208552|NCT00276380|696814|P1|Overall Study|Withdrawal by Subject|3
208553|NCT00276380|696813|P2|Overall Study|Lost to Follow-up|1
208554|NCT00276380|696814|P1|Overall Study|Lost to Follow-up|1
208555|NCT00276380|696813|P2|Overall Study|Adverse Event|3
208556|NCT00276380|696814|P1|Overall Study|Adverse Event|5
208557|NCT00276159|696869|P1|Overall Study|Did not receive all 24 doses of 852A|6
208558|NCT00276094|696879|P3|Overall Study|Other-Study medication lost|1
208559|NCT00276094|696880|P2|Overall Study|Other-Study medication lost|0
208560|NCT00276094|696881|P1|Overall Study|Other-Study medication lost|0
208561|NCT00276094|696879|P3|Overall Study|Other-Relocation|0
208562|NCT00276094|696880|P2|Overall Study|Other-Relocation|1
208563|NCT00276094|696881|P1|Overall Study|Other-Relocation|0
208564|NCT00276094|696879|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
208565|NCT00276094|696880|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
208566|NCT00276094|696881|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
208567|NCT00276094|696879|P3|Overall Study|Other-Refused follow-up visit|0
208568|NCT00276094|696880|P2|Overall Study|Other-Refused follow-up visit|0
208569|NCT00276094|696881|P1|Overall Study|Other-Refused follow-up visit|1
208570|NCT00276094|696879|P3|Overall Study|Other-Lack of efficacy|0
208571|NCT00276094|696880|P2|Overall Study|Other-Lack of efficacy|0
208572|NCT00276094|696881|P1|Overall Study|Other-Lack of efficacy|1
208573|NCT00276094|696879|P3|Overall Study|Other-Scheduled gastroplasty|0
208574|NCT00276094|696880|P2|Overall Study|Other-Scheduled gastroplasty|0
208575|NCT00276094|696881|P1|Overall Study|Other-Scheduled gastroplasty|1
208576|NCT00276094|696879|P3|Overall Study|Other-Subject moved out of country|0
208577|NCT00276094|696880|P2|Overall Study|Other-Subject moved out of country|0
208578|NCT00276094|696881|P1|Overall Study|Other-Subject moved out of country|1
208579|NCT00276094|696879|P3|Overall Study|Lost to Follow-up|4
208580|NCT00276094|696880|P2|Overall Study|Lost to Follow-up|6
208581|NCT00276094|696881|P1|Overall Study|Lost to Follow-up|8
208582|NCT00276094|696879|P3|Overall Study|Protocol Violation|10
208583|NCT00276094|696880|P2|Overall Study|Protocol Violation|7
208584|NCT00276094|696881|P1|Overall Study|Protocol Violation|16
208585|NCT00276094|696879|P3|Overall Study|Withdrawal by Subject|12
208586|NCT00276094|696880|P2|Overall Study|Withdrawal by Subject|14
208587|NCT00276094|696881|P1|Overall Study|Withdrawal by Subject|14
208588|NCT00276094|696879|P3|Overall Study|Adverse Event|11
208589|NCT00276094|696880|P2|Overall Study|Adverse Event|13
208590|NCT00276094|696881|P1|Overall Study|Adverse Event|15
208591|NCT00276016|696934|P6|Intervention 1|Withdrawal by Subject|0
208592|NCT00276016|696935|P5|Intervention 1|Withdrawal by Subject|0
208593|NCT00276016|696936|P4|Intervention 1|Withdrawal by Subject|0
208594|NCT00276016|696937|P3|Intervention 1|Withdrawal by Subject|0
208595|NCT00276016|696938|P2|Intervention 1|Withdrawal by Subject|1
208596|NCT00276016|696939|P1|Intervention 1|Withdrawal by Subject|0
208597|NCT00275821|696985|P3|Overall Study|Protocol Violation|0
208598|NCT00275821|696986|P2|Overall Study|Protocol Violation|1
208599|NCT00275821|696987|P1|Overall Study|Protocol Violation|5
208600|NCT00275821|696985|P3|Overall Study|Lack of Efficacy|0
208601|NCT00275821|696986|P2|Overall Study|Lack of Efficacy|1
208602|NCT00275821|696987|P1|Overall Study|Lack of Efficacy|2
208603|NCT00275821|696985|P3|Overall Study|Death|1
208604|NCT00275821|696986|P2|Overall Study|Death|2
208605|NCT00275821|696987|P1|Overall Study|Death|0
208606|NCT00275821|696985|P3|Overall Study|Lost to Follow-up|1
208607|NCT00275821|696986|P2|Overall Study|Lost to Follow-up|1
208608|NCT00275821|696987|P1|Overall Study|Lost to Follow-up|0
208609|NCT00275821|696985|P3|Overall Study|Withdrawal by Subject|1
208610|NCT00275821|696986|P2|Overall Study|Withdrawal by Subject|2
208611|NCT00275821|696987|P1|Overall Study|Withdrawal by Subject|0
208612|NCT00275821|696985|P3|Overall Study|Administrative problems|4
208613|NCT00275821|696986|P2|Overall Study|Administrative problems|4
208614|NCT00275821|696987|P1|Overall Study|Administrative problems|3
208615|NCT00275821|696985|P3|Overall Study|Adverse Event|5
208616|NCT00275821|696986|P2|Overall Study|Adverse Event|12
208617|NCT00275821|696987|P1|Overall Study|Adverse Event|4
208618|NCT00275561|697006|P2|Overall Study|Family Issues|2
208619|NCT00275561|697007|P1|Overall Study|Family Issues|0
208620|NCT00275561|697006|P2|Overall Study|Scheduling|2
208621|NCT00275561|697007|P1|Overall Study|Scheduling|1
208622|NCT00275561|697006|P2|Overall Study|Travel|1
208623|NCT00275561|697007|P1|Overall Study|Travel|1
208624|NCT00275561|697006|P2|Overall Study|Withdrawal by Subject|1
208625|NCT00275561|697007|P1|Overall Study|Withdrawal by Subject|0
208626|NCT00275509|697019|P2|Overall Study|graft thrombosis, post-operative day #8|1
208627|NCT00275509|697020|P1|Overall Study|graft thrombosis, post-operative day #8|0
208628|NCT00275340|697043|P2|Overall Study|Lost to Follow-up|4
208629|NCT00275340|697044|P1|Overall Study|Lost to Follow-up|2
208630|NCT00275301|697048|P1|Overall Study|Adverse Event|5
208631|NCT00275262|697067|P2|Overall Study|Started Chemotherapy|0
208632|NCT00275262|697068|P1|Overall Study|Started Chemotherapy|1
208633|NCT00275262|697067|P2|Overall Study|Death|0
208634|NCT00275262|697068|P1|Overall Study|Death|1
208635|NCT00275262|697067|P2|Overall Study|Protocol Violation|2
208636|NCT00275262|697068|P1|Overall Study|Protocol Violation|0
208637|NCT00275262|697067|P2|Overall Study|Lost to Follow-up|2
208638|NCT00275262|697068|P1|Overall Study|Lost to Follow-up|0
208639|NCT00275262|697067|P2|Overall Study|Disease progression|5
208640|NCT00275262|697068|P1|Overall Study|Disease progression|2
208641|NCT00275262|697067|P2|Overall Study|Adverse Event|0
208642|NCT00275262|697068|P1|Overall Study|Adverse Event|2
208643|NCT00275028|697082|P1|Overall Study|Physician Decision|2
208644|NCT00275028|697082|P1|Overall Study|Progressive Disease|30
208645|NCT00275028|697082|P1|Overall Study|Adverse Event|9
208646|NCT00275028|697082|P1|Overall Study|Withdrawal by Subject|5
208647|NCT00275028|697082|P1|Overall Study|Withdrew consent before treatment began|1
208648|NCT00275002|697089|P2|Overall Study|Adverse Event|1
208649|NCT00275002|697090|P1|Overall Study|Adverse Event|0
208650|NCT00275002|697089|P2|Overall Study|Disease progression|15
208651|NCT00275002|697090|P1|Overall Study|Disease progression|21
208652|NCT00275002|697089|P2|Overall Study|Death|0
208653|NCT00275002|697090|P1|Overall Study|Death|1
208654|NCT00274937|697098|P1|Overall Study|Progressive Disease|4
208655|NCT00274937|697098|P1|Overall Study|Withdrawal by Subject|6
208656|NCT00274937|697098|P1|Overall Study|Physician Decision|10
208657|NCT00274924|697108|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
208658|NCT00274924|697109|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
208659|NCT00274924|697110|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
208660|NCT00274924|697108|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
208661|NCT00274924|697109|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
208662|NCT00274924|697110|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
208663|NCT00274924|697108|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
208664|NCT00274924|697109|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
208665|NCT00274924|697110|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
208666|NCT00274924|697108|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
208667|NCT00274924|697109|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
208668|NCT00274924|697110|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
208669|NCT00274924|697108|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
208670|NCT00274924|697109|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
208671|NCT00274924|697110|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
208672|NCT00274924|697108|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
208673|NCT00274924|697109|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
208674|NCT00274924|697110|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
208675|NCT00274924|697108|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
208676|NCT00274924|697109|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
208677|NCT00274924|697110|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
208678|NCT00274924|697108|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
208679|NCT00274924|697109|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
208680|NCT00274924|697110|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
208681|NCT00274924|697108|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
208682|NCT00274924|697109|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
208683|NCT00274924|697110|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
208684|NCT00274924|697108|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
208685|NCT00274924|697109|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
208686|NCT00274924|697110|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
208687|NCT00274924|697108|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
208688|NCT00274924|697109|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
208689|NCT00274924|697110|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
208690|NCT00274924|697108|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
208691|NCT00274924|697109|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
208692|NCT00274924|697110|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
208693|NCT00274924|697108|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
208694|NCT00274924|697109|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
208695|NCT00274924|697110|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
208696|NCT00274846|697119|P1|Overall Study|Did not receive adequate NK cells|1
208697|NCT00274742|697143|P6|Overall Study|Other|0
208698|NCT00274742|697144|P5|Overall Study|Other|2
208699|NCT00274742|697145|P4|Overall Study|Other|0
208700|NCT00274742|697146|P3|Overall Study|Other|0
208701|NCT00274742|697147|P2|Overall Study|Other|3
208702|NCT00274742|697148|P1|Overall Study|Other|0
208703|NCT00274742|697143|P6|Overall Study|Disease Progression|0
208704|NCT00274742|697144|P5|Overall Study|Disease Progression|1
208705|NCT00274742|697145|P4|Overall Study|Disease Progression|0
208706|NCT00274742|697146|P3|Overall Study|Disease Progression|1
208707|NCT00274742|697147|P2|Overall Study|Disease Progression|1
208708|NCT00274742|697148|P1|Overall Study|Disease Progression|0
208709|NCT00274742|697143|P6|Overall Study|End of Study|0
208710|NCT00274742|697144|P5|Overall Study|End of Study|0
208711|NCT00274742|697145|P4|Overall Study|End of Study|1
208712|NCT00274742|697146|P3|Overall Study|End of Study|0
208713|NCT00274742|697147|P2|Overall Study|End of Study|0
208714|NCT00274742|697148|P1|Overall Study|End of Study|0
208715|NCT00274742|697143|P6|Overall Study|Lost to Follow-up|0
208716|NCT00274742|697144|P5|Overall Study|Lost to Follow-up|1
208717|NCT00274742|697145|P4|Overall Study|Lost to Follow-up|0
208718|NCT00274742|697146|P3|Overall Study|Lost to Follow-up|0
208719|NCT00274742|697147|P2|Overall Study|Lost to Follow-up|0
208720|NCT00274742|697148|P1|Overall Study|Lost to Follow-up|0
208721|NCT00274742|697143|P6|Overall Study|Adverse Event|3
208722|NCT00274742|697144|P5|Overall Study|Adverse Event|12
208723|NCT00274742|697145|P4|Overall Study|Adverse Event|4
208724|NCT00274742|697146|P3|Overall Study|Adverse Event|1
208725|NCT00274742|697147|P2|Overall Study|Adverse Event|4
208726|NCT00274742|697148|P1|Overall Study|Adverse Event|0
208727|NCT00274716|697186|P6|Phase B|Lost to Follow-up|0
208728|NCT00274716|697187|P5|Phase B|Lost to Follow-up|0
208729|NCT00274716|697188|P4|Phase B|Lost to Follow-up|0
208730|NCT00274716|697189|P3|Phase B|Lost to Follow-up|0
208731|NCT00274716|697190|P2|Phase B|Lost to Follow-up|1
208732|NCT00274716|697191|P1|Phase B|Lost to Follow-up|0
208733|NCT00274716|697186|P6|Phase B|Other non-reported reason|0
208734|NCT00274716|697187|P5|Phase B|Other non-reported reason|0
208735|NCT00274716|697188|P4|Phase B|Other non-reported reason|1
208736|NCT00274716|697189|P3|Phase B|Other non-reported reason|1
208737|NCT00274716|697190|P2|Phase B|Other non-reported reason|0
208738|NCT00274716|697191|P1|Phase B|Other non-reported reason|0
208739|NCT00274716|697186|P6|Phase B|Participant moved|0
208740|NCT00274716|697187|P5|Phase B|Participant moved|0
208741|NCT00274716|697188|P4|Phase B|Participant moved|0
208742|NCT00274716|697189|P3|Phase B|Participant moved|0
208743|NCT00274716|697190|P2|Phase B|Participant moved|0
208744|NCT00274716|697191|P1|Phase B|Participant moved|1
208745|NCT00274716|697186|P6|Phase B|Withdrawal by Subject|0
208746|NCT00274716|697187|P5|Phase B|Withdrawal by Subject|0
208747|NCT00274716|697188|P4|Phase B|Withdrawal by Subject|0
208748|NCT00274716|697189|P3|Phase B|Withdrawal by Subject|0
208749|NCT00274716|697190|P2|Phase B|Withdrawal by Subject|1
208750|NCT00274716|697191|P1|Phase B|Withdrawal by Subject|0
208751|NCT00274716|697186|P6|Phase B|Protocol Violation|0
208752|NCT00274716|697187|P5|Phase B|Protocol Violation|0
208753|NCT00274716|697188|P4|Phase B|Protocol Violation|0
208754|NCT00274716|697189|P3|Phase B|Protocol Violation|0
208755|NCT00274716|697190|P2|Phase B|Protocol Violation|2
208756|NCT00274716|697191|P1|Phase B|Protocol Violation|0
208757|NCT00274716|697186|P6|Phase B|Adverse Event|1
208758|NCT00274716|697187|P5|Phase B|Adverse Event|0
208759|NCT00274716|697188|P4|Phase B|Adverse Event|0
208760|NCT00274716|697189|P3|Phase B|Adverse Event|2
208761|NCT00274716|697190|P2|Phase B|Adverse Event|0
208762|NCT00274716|697191|P1|Phase B|Adverse Event|0
208763|NCT00274716|697186|P6|Phase A|Completed but did not enter Phase B|1
208764|NCT00274716|697187|P5|Phase A|Completed but did not enter Phase B|1
208765|NCT00274716|697188|P4|Phase A|Completed but did not enter Phase B|2
208766|NCT00274716|697189|P3|Phase A|Completed but did not enter Phase B|2
208767|NCT00274716|697190|P2|Phase A|Completed but did not enter Phase B|2
208768|NCT00274716|697191|P1|Phase A|Completed but did not enter Phase B|1
208769|NCT00274716|697186|P6|Phase A|Adverse Event|0
208770|NCT00274716|697187|P5|Phase A|Adverse Event|2
208771|NCT00274716|697188|P4|Phase A|Adverse Event|0
208772|NCT00274716|697189|P3|Phase A|Adverse Event|3
208773|NCT00274716|697190|P2|Phase A|Adverse Event|3
208774|NCT00274716|697191|P1|Phase A|Adverse Event|2
208775|NCT00274716|697186|P6|Phase A|Withdrawal by Subject|1
208776|NCT00274716|697187|P5|Phase A|Withdrawal by Subject|0
208777|NCT00274716|697188|P4|Phase A|Withdrawal by Subject|3
208778|NCT00274716|697189|P3|Phase A|Withdrawal by Subject|1
208779|NCT00274716|697190|P2|Phase A|Withdrawal by Subject|2
208780|NCT00274716|697191|P1|Phase A|Withdrawal by Subject|2
208781|NCT00274716|697186|P6|Phase A|Met criteria for discontinuation|0
208782|NCT00274716|697187|P5|Phase A|Met criteria for discontinuation|0
208783|NCT00274716|697188|P4|Phase A|Met criteria for discontinuation|0
208784|NCT00274716|697189|P3|Phase A|Met criteria for discontinuation|0
208785|NCT00274716|697190|P2|Phase A|Met criteria for discontinuation|1
208786|NCT00274716|697191|P1|Phase A|Met criteria for discontinuation|1
208787|NCT00274716|697186|P6|Phase A|Protocol Violation|0
208788|NCT00274716|697187|P5|Phase A|Protocol Violation|0
208789|NCT00274716|697188|P4|Phase A|Protocol Violation|1
208790|NCT00274716|697189|P3|Phase A|Protocol Violation|0
208791|NCT00274716|697190|P2|Phase A|Protocol Violation|0
208792|NCT00274716|697191|P1|Phase A|Protocol Violation|1
208793|NCT00274716|697186|P6|Phase A|Site Terminated|0
208794|NCT00274716|697187|P5|Phase A|Site Terminated|0
208795|NCT00274716|697188|P4|Phase A|Site Terminated|1
208796|NCT00274716|697189|P3|Phase A|Site Terminated|0
208797|NCT00274716|697190|P2|Phase A|Site Terminated|0
208798|NCT00274716|697191|P1|Phase A|Site Terminated|0
208799|NCT00274716|697186|P6|Phase A|Participant moved|1
208800|NCT00274716|697187|P5|Phase A|Participant moved|0
208801|NCT00274716|697188|P4|Phase A|Participant moved|0
208802|NCT00274716|697189|P3|Phase A|Participant moved|1
208803|NCT00274716|697190|P2|Phase A|Participant moved|0
208804|NCT00274716|697191|P1|Phase A|Participant moved|0
208805|NCT00274716|697186|P6|Phase A|Other non-reported reason|1
208806|NCT00274716|697187|P5|Phase A|Other non-reported reason|0
208807|NCT00274716|697188|P4|Phase A|Other non-reported reason|2
208808|NCT00274716|697189|P3|Phase A|Other non-reported reason|1
208809|NCT00274716|697190|P2|Phase A|Other non-reported reason|2
208810|NCT00274716|697191|P1|Phase A|Other non-reported reason|4
208811|NCT00274651|697253|P2|Overall Study|Physician Decision|7
208812|NCT00274651|697254|P1|Overall Study|Physician Decision|8
208813|NCT00274651|697253|P2|Overall Study|Withdrawal by Subject|1
208814|NCT00274651|697254|P1|Overall Study|Withdrawal by Subject|0
208815|NCT00274651|697253|P2|Overall Study|Death|3
208816|NCT00274651|697254|P1|Overall Study|Death|1
208817|NCT00274651|697253|P2|Overall Study|Lack of Efficacy|6
208818|NCT00274651|697254|P1|Overall Study|Lack of Efficacy|13
208819|NCT00274651|697253|P2|Overall Study|Adverse Event|3
208820|NCT00274651|697254|P1|Overall Study|Adverse Event|6
208821|NCT00274625|697269|P2|Overall Study|Excluded from analysis|8
208822|NCT00274625|697270|P1|Overall Study|Excluded from analysis|14
208823|NCT00274625|697269|P2|Overall Study|Lost to Follow-up|54
208824|NCT00274625|697270|P1|Overall Study|Lost to Follow-up|46
208825|NCT00274469|697278|P2|Overall Study|Reasons not specified|8
208826|NCT00274469|697279|P1|Overall Study|Reasons not specified|5
208827|NCT00274469|697278|P2|Overall Study|Withdrawal by Subject|0
208828|NCT00274469|697279|P1|Overall Study|Withdrawal by Subject|2
208829|NCT00274469|697278|P2|Overall Study|Condition under investigation worsened|38
208830|NCT00274469|697279|P1|Overall Study|Condition under investigation worsened|28
208831|NCT00274469|697278|P2|Overall Study|Adverse Event|3
208832|NCT00274469|697279|P1|Overall Study|Adverse Event|2
208833|NCT00274469|697278|P2|Overall Study|Death|1
208834|NCT00274469|697279|P1|Overall Study|Death|1
208835|NCT00274456|697297|P4|Overall Study|Withdrawal by Subject|13
208836|NCT00274456|697298|P3|Overall Study|Withdrawal by Subject|9
208837|NCT00274456|697299|P2|Overall Study|Withdrawal by Subject|13
208838|NCT00274456|697300|P1|Overall Study|Withdrawal by Subject|18
208839|NCT00274456|697297|P4|Overall Study|Lost to Follow-up|0
208840|NCT00274456|697298|P3|Overall Study|Lost to Follow-up|1
208841|NCT00274456|697299|P2|Overall Study|Lost to Follow-up|0
208842|NCT00274456|697300|P1|Overall Study|Lost to Follow-up|0
208843|NCT00274456|697297|P4|Overall Study|Physician Decision|13
208844|NCT00274456|697298|P3|Overall Study|Physician Decision|6
208845|NCT00274456|697299|P2|Overall Study|Physician Decision|5
208846|NCT00274456|697300|P1|Overall Study|Physician Decision|7
208847|NCT00274456|697297|P4|Overall Study|Adverse Event|2
208848|NCT00274456|697298|P3|Overall Study|Adverse Event|2
208849|NCT00274456|697299|P2|Overall Study|Adverse Event|1
208850|NCT00274456|697300|P1|Overall Study|Adverse Event|0
208851|NCT00274456|697297|P4|Overall Study|Unacceptable toxicity|16
208852|NCT00274456|697298|P3|Overall Study|Unacceptable toxicity|12
208853|NCT00274456|697299|P2|Overall Study|Unacceptable toxicity|5
208854|NCT00274456|697300|P1|Overall Study|Unacceptable toxicity|10
208855|NCT00274456|697297|P4|Overall Study|Still on treatment|1
208856|NCT00274456|697298|P3|Overall Study|Still on treatment|5
208857|NCT00274456|697299|P2|Overall Study|Still on treatment|3
208858|NCT00274456|697300|P1|Overall Study|Still on treatment|2
208859|NCT00274287|697342|P1|Overall Study|subject non-compliance|1
208860|NCT00274287|697342|P1|Overall Study|Withdrawal by Subject|1
208861|NCT00274261|697348|P2|Overall Study|Lost to Follow-up|75
208862|NCT00274261|697349|P1|Overall Study|Lost to Follow-up|106
208863|NCT00274261|697348|P2|Overall Study|Protocol Violation|42
208864|NCT00274261|697349|P1|Overall Study|Protocol Violation|71
208865|NCT00274261|697348|P2|Overall Study|Withdrawal by Subject|126
208866|NCT00274261|697349|P1|Overall Study|Withdrawal by Subject|179
208867|NCT00274261|697348|P2|Overall Study|Pregnancy|83
208868|NCT00274261|697349|P1|Overall Study|Pregnancy|114
208869|NCT00274261|697348|P2|Overall Study|Adverse Event|11
208870|NCT00274261|697349|P1|Overall Study|Adverse Event|19
208871|NCT00273858|697388|P1|Overall Study|Adverse Event|81
208872|NCT00273858|697388|P1|Overall Study|Withdrawal by Subject|21
208873|NCT00273858|697388|P1|Overall Study|Lost to Follow-up|101
208874|NCT00273858|697388|P1|Overall Study|Not completed 24 month observation time|334
208875|NCT00273182|697447|P1|Overall Study|Site exit, system change, 36 m FU missed|36
208876|NCT00273182|697447|P1|Overall Study|Device/System Explant|154
208877|NCT00273182|697447|P1|Overall Study|Withdrawal by Subject|257
208878|NCT00273182|697447|P1|Overall Study|Lost to Follow-up|88
208879|NCT00273182|697447|P1|Overall Study|Death|450
208880|NCT00273052|697457|P2|Overall Study|Worsening serum lipid levels|2
208881|NCT00273052|697458|P1|Overall Study|Worsening serum lipid levels|0
208882|NCT00273052|697457|P2|Overall Study|Not specified|0
208883|NCT00273052|697458|P1|Overall Study|Not specified|2
208884|NCT00273052|697457|P2|Overall Study|Non-Compliance|1
208885|NCT00273052|697458|P1|Overall Study|Non-Compliance|3
208886|NCT00273052|697457|P2|Overall Study|Lack of Efficacy|4
208887|NCT00273052|697458|P1|Overall Study|Lack of Efficacy|6
208888|NCT00273052|697457|P2|Overall Study|Lost to Follow-up|25
208889|NCT00273052|697458|P1|Overall Study|Lost to Follow-up|7
208890|NCT00273052|697457|P2|Overall Study|Protocol Violation|18
208891|NCT00273052|697458|P1|Overall Study|Protocol Violation|14
208892|NCT00273052|697457|P2|Overall Study|Adverse Event|19
208893|NCT00273052|697458|P1|Overall Study|Adverse Event|21
208894|NCT00273052|697457|P2|Overall Study|Withdrawal by Subject|19
208895|NCT00273052|697458|P1|Overall Study|Withdrawal by Subject|16
208896|NCT00272987|697493|P3|Overall Study|Ongoing|15
208897|NCT00272987|697494|P2|Overall Study|Ongoing|14
208898|NCT00272987|697495|P1|Overall Study|Ongoing|20
208899|NCT00272987|697493|P3|Overall Study|Missed >3 Visits|1
208900|NCT00272987|697494|P2|Overall Study|Missed >3 Visits|0
208901|NCT00272987|697495|P1|Overall Study|Missed >3 Visits|0
208902|NCT00272987|697493|P3|Overall Study|Withdrawal by Subject|3
208903|NCT00272987|697494|P2|Overall Study|Withdrawal by Subject|0
208904|NCT00272987|697495|P1|Overall Study|Withdrawal by Subject|0
208905|NCT00272987|697493|P3|Overall Study|Adverse Event|0
208906|NCT00272987|697494|P2|Overall Study|Adverse Event|0
208907|NCT00272987|697495|P1|Overall Study|Adverse Event|1
208908|NCT00272961|697559|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
208909|NCT00272961|697560|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
208910|NCT00272961|697561|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
208911|NCT00272961|697562|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
208912|NCT00272961|697563|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
208913|NCT00272961|697559|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
208914|NCT00272961|697560|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
208915|NCT00272961|697561|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
208916|NCT00272961|697562|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
208917|NCT00272961|697563|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
208918|NCT00272961|697559|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
208919|NCT00272961|697560|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
208920|NCT00272961|697561|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
208921|NCT00272961|697562|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
208922|NCT00272961|697563|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
208923|NCT00272961|697559|P5|Placebo Run-in Phase: Up to Week 2|Other|0
208924|NCT00272961|697560|P4|Placebo Run-in Phase: Up to Week 2|Other|0
208925|NCT00272961|697561|P3|Placebo Run-in Phase: Up to Week 2|Other|0
208926|NCT00272961|697562|P2|Placebo Run-in Phase: Up to Week 2|Other|0
208927|NCT00272961|697563|P1|Placebo Run-in Phase: Up to Week 2|Other|2
208928|NCT00272961|697559|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
208929|NCT00272961|697560|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
208930|NCT00272961|697561|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
208931|NCT00272961|697562|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
208932|NCT00272961|697563|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
208933|NCT00272961|697559|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
208934|NCT00272961|697560|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
208935|NCT00272961|697561|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
208936|NCT00272961|697562|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
208937|NCT00272961|697563|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
208938|NCT00272961|697559|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
208939|NCT00272961|697560|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
208940|NCT00272961|697561|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
208941|NCT00272961|697562|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
208942|NCT00272961|697563|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
208943|NCT00272961|697559|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
208944|NCT00272961|697560|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
208945|NCT00272961|697561|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
208946|NCT00272961|697562|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
208947|NCT00272961|697563|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
208948|NCT00272844|697620|P1|Overall Study|Withdrawal by Subject|5
208949|NCT00272792|697628|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
208950|NCT00272792|697629|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
208951|NCT00272792|697628|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
208952|NCT00272792|697629|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
208953|NCT00272792|697628|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
208954|NCT00272792|697629|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
208955|NCT00272792|697628|P2|Part 1: Responsiveness|Lost to Follow-up|0
208956|NCT00272792|697629|P1|Part 1: Responsiveness|Lost to Follow-up|1
208957|NCT00272779|697639|P2|Baseline Through Week 96|Continuing on treatment|38
208958|NCT00272779|697640|P1|Baseline Through Week 96|Continuing on treatment|61
208959|NCT00272779|697639|P2|Baseline Through Week 96|Never treated|3
208960|NCT00272779|697640|P1|Baseline Through Week 96|Never treated|2
208961|NCT00272779|697639|P2|Baseline Through Week 96|Pregnancy at Week 96|0
208962|NCT00272779|697640|P1|Baseline Through Week 96|Pregnancy at Week 96|1
208963|NCT00272779|697639|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
208964|NCT00272779|697640|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
208965|NCT00272779|697639|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
208966|NCT00272779|697640|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
208967|NCT00272779|697639|P2|Baseline Through Week 96|Changed address before Week 96|1
208968|NCT00272779|697640|P1|Baseline Through Week 96|Changed address before Week 96|0
208969|NCT00272779|697639|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
208970|NCT00272779|697640|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
208971|NCT00272779|697639|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
208972|NCT00272779|697640|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
208973|NCT00272779|697639|P2|Baseline Through Week 96|Pregnancy before Week 96|7
208974|NCT00272779|697640|P1|Baseline Through Week 96|Pregnancy before Week 96|5
208975|NCT00272779|697639|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
208976|NCT00272779|697640|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
208977|NCT00272779|697639|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
208978|NCT00272779|697640|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
208979|NCT00272779|697639|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
208980|NCT00272779|697640|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
208981|NCT00272779|697639|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
208982|NCT00272779|697640|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
208983|NCT00272779|697639|P2|Baseline Through Week 96|Death before Week 96|5
208984|NCT00272779|697640|P1|Baseline Through Week 96|Death before Week 96|6
208985|NCT00272779|697639|P2|Baseline Through Week 96|Adverse event before Week 96|22
208986|NCT00272779|697640|P1|Baseline Through Week 96|Adverse event before Week 96|13
208987|NCT00272779|697639|P2|Baseline Through Week 48|Never treated|3
208988|NCT00272779|697640|P1|Baseline Through Week 48|Never treated|2
208989|NCT00272779|697639|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
208990|NCT00272779|697640|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
208991|NCT00272779|697639|P2|Baseline Through Week 48|Continuing treatment|368
208992|NCT00272779|697640|P1|Baseline Through Week 48|Continuing treatment|385
208993|NCT00272779|697639|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
208994|NCT00272779|697640|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
208995|NCT00272779|697639|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
208996|NCT00272779|697640|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
208997|NCT00272779|697639|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
208998|NCT00272779|697640|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
208999|NCT00272779|697639|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
209000|NCT00272779|697640|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
209001|NCT00272779|697639|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
209002|NCT00272779|697640|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
209003|NCT00272779|697639|P2|Baseline Through Week 48|Death on/after Week 48|1
209004|NCT00272779|697640|P1|Baseline Through Week 48|Death on/after Week 48|1
209005|NCT00272779|697639|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
209006|NCT00272779|697640|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
209007|NCT00272779|697639|P2|Baseline Through Week 48|Chose different site before wk 48|1
209008|NCT00272779|697640|P1|Baseline Through Week 48|Chose different site before wk 48|0
209009|NCT00272779|697639|P2|Baseline Through Week 48|Participant's decision before wk 48|1
209010|NCT00272779|697640|P1|Baseline Through Week 48|Participant's decision before wk 48|0
209011|NCT00272779|697639|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
209012|NCT00272779|697640|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
209013|NCT00272779|697639|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
209014|NCT00272779|697640|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
209015|NCT00272779|697639|P2|Baseline Through Week 48|Pregnancy before Week 48|2
209016|NCT00272779|697640|P1|Baseline Through Week 48|Pregnancy before Week 48|2
209017|NCT00272779|697639|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
209018|NCT00272779|697640|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
209019|NCT00272779|697639|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
209020|NCT00272779|697640|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
209021|NCT00272779|697639|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
209022|NCT00272779|697640|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
209023|NCT00272779|697639|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
209024|NCT00272779|697640|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
209025|NCT00272779|697639|P2|Baseline Through Week 48|Death before Week 48|4
209026|NCT00272779|697640|P1|Baseline Through Week 48|Death before Week 48|4
209027|NCT00272779|697639|P2|Baseline Through Week 48|Adverse event before Week 48|14
209028|NCT00272779|697640|P1|Baseline Through Week 48|Adverse event before Week 48|10
209029|NCT00272038|697880|P1|Overall Study|withdrew before they received 2 cycles|7
209030|NCT00271947|697885|P1|Overall Study|Lost to Follow-up|1
209031|NCT00271856|697891|P2|Overall Study|Lost to Follow-up|11
209032|NCT00271856|697892|P1|Overall Study|Lost to Follow-up|10
209033|NCT00271856|697891|P2|Overall Study|Withdrawal by Subject|7
209034|NCT00271856|697892|P1|Overall Study|Withdrawal by Subject|1
209035|NCT00271817|697911|P3|Part 2|LDL < 50 mg/dL|4
209036|NCT00271817|697912|P2|Part 2|LDL < 50 mg/dL|3
209037|NCT00271817|697913|P1|Part 2|LDL < 50 mg/dL|0
209038|NCT00271817|697911|P3|Part 2|Withdrawal by Subject|13
209039|NCT00271817|697912|P2|Part 2|Withdrawal by Subject|2
209040|NCT00271817|697913|P1|Part 2|Withdrawal by Subject|0
209041|NCT00271817|697911|P3|Part 2|Patient Moved|5
209042|NCT00271817|697912|P2|Part 2|Patient Moved|0
209043|NCT00271817|697913|P1|Part 2|Patient Moved|0
209044|NCT00271817|697911|P3|Part 2|Protocol Violation|5
209045|NCT00271817|697912|P2|Part 2|Protocol Violation|3
209046|NCT00271817|697913|P1|Part 2|Protocol Violation|0
209047|NCT00271817|697911|P3|Part 2|Lost to Follow-up|18
209048|NCT00271817|697912|P2|Part 2|Lost to Follow-up|6
209049|NCT00271817|697913|P1|Part 2|Lost to Follow-up|0
209050|NCT00271817|697911|P3|Part 2|Lack of Efficacy|6
209051|NCT00271817|697912|P2|Part 2|Lack of Efficacy|1
209052|NCT00271817|697913|P1|Part 2|Lack of Efficacy|0
209053|NCT00271817|697911|P3|Part 2|Adverse Event|33
209054|NCT00271817|697912|P2|Part 2|Adverse Event|17
209055|NCT00271817|697913|P1|Part 2|Adverse Event|0
209056|NCT00271817|697911|P3|Part 1|LDL < 50 mg/dL|48
209057|NCT00271817|697912|P2|Part 1|LDL < 50 mg/dL|4
209058|NCT00271817|697913|P1|Part 1|LDL < 50 mg/dL|1
209059|NCT00271817|697911|P3|Part 1|Withdrawal by Subject|45
209060|NCT00271817|697912|P2|Part 1|Withdrawal by Subject|17
209061|NCT00271817|697913|P1|Part 1|Withdrawal by Subject|23
209062|NCT00271817|697911|P3|Part 1|Patient Moved|5
209063|NCT00271817|697912|P2|Part 1|Patient Moved|1
209064|NCT00271817|697913|P1|Part 1|Patient Moved|3
209065|NCT00271817|697911|P3|Part 1|Protocol Violation|7
209066|NCT00271817|697912|P2|Part 1|Protocol Violation|4
209067|NCT00271817|697913|P1|Part 1|Protocol Violation|5
209068|NCT00271817|697911|P3|Part 1|Lost to Follow-up|24
209069|NCT00271817|697912|P2|Part 1|Lost to Follow-up|8
209070|NCT00271817|697913|P1|Part 1|Lost to Follow-up|6
209071|NCT00271817|697911|P3|Part 1|Adverse Event|156
209072|NCT00271817|697912|P2|Part 1|Adverse Event|25
209073|NCT00271817|697913|P1|Part 1|Adverse Event|68
209074|NCT00271609|697955|P2|Overall Study|Withdrawal by Subject|0
209075|NCT00271609|697956|P1|Overall Study|Withdrawal by Subject|2
209076|NCT00271609|697955|P2|Overall Study|Adverse Event|3
209077|NCT00271609|697956|P1|Overall Study|Adverse Event|11
209078|NCT00271596|697966|P2|Overall Study|Withdrawal by Subject|1
209079|NCT00271596|697967|P1|Overall Study|Withdrawal by Subject|0
209080|NCT00271596|697966|P2|Overall Study|Protocol Violation|0
209081|NCT00271596|697967|P1|Overall Study|Protocol Violation|1
209082|NCT00271544|698002|P1|Overall Study|Implant not attempted|4
209083|NCT00271544|698002|P1|Overall Study|Model 4196 lead not attempted|9
209084|NCT00271544|698002|P1|Overall Study|Subjects did not receive a 4196 lead|7
209085|NCT00271024|698107|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
209086|NCT00271024|698108|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
209087|NCT00271024|698109|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
209088|NCT00271024|698110|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
209089|NCT00271024|698107|P4|Overall Study|Unpleasant Reaction To Tablet|2
209090|NCT00271024|698108|P3|Overall Study|Unpleasant Reaction To Tablet|4
209091|NCT00271024|698109|P2|Overall Study|Unpleasant Reaction To Tablet|3
209092|NCT00271024|698110|P1|Overall Study|Unpleasant Reaction To Tablet|1
209093|NCT00271024|698107|P4|Overall Study|Protocol Violation|11
209094|NCT00271024|698108|P3|Overall Study|Protocol Violation|5
209095|NCT00271024|698109|P2|Overall Study|Protocol Violation|6
209096|NCT00271024|698110|P1|Overall Study|Protocol Violation|1
209097|NCT00271024|698107|P4|Overall Study|Unknown/Unspecified|4
209098|NCT00271024|698108|P3|Overall Study|Unknown/Unspecified|8
209099|NCT00271024|698109|P2|Overall Study|Unknown/Unspecified|11
209100|NCT00271024|698110|P1|Overall Study|Unknown/Unspecified|11
209101|NCT00271024|698107|P4|Overall Study|Lost Interest|3
209102|NCT00271024|698108|P3|Overall Study|Lost Interest|2
209103|NCT00271024|698109|P2|Overall Study|Lost Interest|4
209104|NCT00271024|698110|P1|Overall Study|Lost Interest|3
209105|NCT00270998|698160|P3|12 Month Follow-up|Received/desired alternate treatment|1
209106|NCT00270998|698161|P2|12 Month Follow-up|Received/desired alternate treatment|4
209107|NCT00270998|698162|P1|12 Month Follow-up|Received/desired alternate treatment|1
209108|NCT00270998|698160|P3|12 Month Follow-up|Personal/family health|1
209109|NCT00270998|698161|P2|12 Month Follow-up|Personal/family health|5
209110|NCT00270998|698162|P1|12 Month Follow-up|Personal/family health|0
209111|NCT00270998|698160|P3|12 Month Follow-up|Pessary did not fit|0
209112|NCT00270998|698161|P2|12 Month Follow-up|Pessary did not fit|0
209113|NCT00270998|698162|P1|12 Month Follow-up|Pessary did not fit|1
209114|NCT00270998|698160|P3|12 Month Follow-up|Withdrawal by Subject|16
209115|NCT00270998|698161|P2|12 Month Follow-up|Withdrawal by Subject|12
209116|NCT00270998|698162|P1|12 Month Follow-up|Withdrawal by Subject|7
209117|NCT00270998|698160|P3|12 Month Follow-up|Lack of Efficacy|3
209118|NCT00270998|698161|P2|12 Month Follow-up|Lack of Efficacy|4
209119|NCT00270998|698162|P1|12 Month Follow-up|Lack of Efficacy|5
209120|NCT00270998|698160|P3|3 Month Follow-up|Received/desired alternate treatment|2
209121|NCT00270998|698161|P2|3 Month Follow-up|Received/desired alternate treatment|5
209122|NCT00270998|698162|P1|3 Month Follow-up|Received/desired alternate treatment|13
209123|NCT00270998|698160|P3|3 Month Follow-up|Personal/family health|0
209124|NCT00270998|698161|P2|3 Month Follow-up|Personal/family health|1
209125|NCT00270998|698162|P1|3 Month Follow-up|Personal/family health|1
209126|NCT00270998|698160|P3|3 Month Follow-up|Pessary did not fit|0
209127|NCT00270998|698161|P2|3 Month Follow-up|Pessary did not fit|0
209128|NCT00270998|698162|P1|3 Month Follow-up|Pessary did not fit|12
209129|NCT00270998|698160|P3|3 Month Follow-up|Withdrawal by Subject|15
209130|NCT00270998|698161|P2|3 Month Follow-up|Withdrawal by Subject|14
209131|NCT00270998|698162|P1|3 Month Follow-up|Withdrawal by Subject|11
209132|NCT00270998|698160|P3|3 Month Follow-up|Lack of Efficacy|1
209133|NCT00270998|698161|P2|3 Month Follow-up|Lack of Efficacy|2
209134|NCT00270998|698162|P1|3 Month Follow-up|Lack of Efficacy|1
209135|NCT00270998|698160|P3|3 Month Follow-up|Adverse Event|0
209136|NCT00270998|698161|P2|3 Month Follow-up|Adverse Event|0
209137|NCT00270998|698162|P1|3 Month Follow-up|Adverse Event|1
209138|NCT00270894|698191|P1|Overall Study|Withdrawal by Subject|1
209139|NCT00270894|698191|P1|Overall Study|Adverse Event|1
209140|NCT00270855|698203|P2|Overall Study|Withdrawal by Subject|8
209141|NCT00270855|698204|P1|Overall Study|Withdrawal by Subject|8
209142|NCT00270257|698340|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
209143|NCT00270257|698341|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
209144|NCT00270231|698359|P2|Second Intervention|Lost to Follow-up|1
209145|NCT00270231|698360|P1|Second Intervention|Lost to Follow-up|0
209146|NCT00270231|698359|P2|Washout Period|Lost to Follow-up|0
209147|NCT00270231|698360|P1|Washout Period|Lost to Follow-up|1
209148|NCT00270231|698359|P2|First Intervention|Lost to Follow-up|1
209149|NCT00270231|698360|P1|First Intervention|Lost to Follow-up|1
209150|NCT00270205|698370|P4|Overall Study|Lost to Follow-up|1
209151|NCT00270205|698371|P3|Overall Study|Lost to Follow-up|0
209152|NCT00270205|698372|P2|Overall Study|Lost to Follow-up|0
209153|NCT00270205|698373|P1|Overall Study|Lost to Follow-up|1
209154|NCT00269919|698491|P1|Overall Study|Started but not treated|1
209155|NCT00269919|698491|P1|Overall Study|Other|26
209156|NCT00269633|698510|P2|Overall Study|Withdrawal by Subject|0
209157|NCT00269633|698511|P1|Overall Study|Withdrawal by Subject|1
209158|NCT00269477|698521|P4|Overall Study|Missed post-vaccination blood draw|0
209159|NCT00269477|698522|P3|Overall Study|Missed post-vaccination blood draw|0
209160|NCT00269477|698523|P2|Overall Study|Missed post-vaccination blood draw|1
209161|NCT00269477|698524|P1|Overall Study|Missed post-vaccination blood draw|0
209162|NCT00269477|698521|P4|Overall Study|Protocol Violation|0
209163|NCT00269477|698522|P3|Overall Study|Protocol Violation|1
209164|NCT00269477|698523|P2|Overall Study|Protocol Violation|5
209165|NCT00269477|698524|P1|Overall Study|Protocol Violation|5
209166|NCT00269152|698540|P2|Overall Study|Protocol Violation|1
209167|NCT00269152|698541|P1|Overall Study|Protocol Violation|0
209168|NCT00269152|698540|P2|Overall Study|Physician Decision|3
209169|NCT00269152|698541|P1|Overall Study|Physician Decision|2
209170|NCT00269152|698540|P2|Overall Study|Withdrawal by Subject|3
209171|NCT00269152|698541|P1|Overall Study|Withdrawal by Subject|7
209172|NCT00269152|698540|P2|Overall Study|Adverse Event|3
209173|NCT00269152|698541|P1|Overall Study|Adverse Event|9
209174|NCT00269113|698557|P2|Overall Study|Not specified|2
209175|NCT00269113|698558|P1|Overall Study|Not specified|0
209176|NCT00269113|698557|P2|Overall Study|Protocol Violation|5
209177|NCT00269113|698558|P1|Overall Study|Protocol Violation|15
209178|NCT00269113|698557|P2|Overall Study|Lost to Follow-up|1
209179|NCT00269113|698558|P1|Overall Study|Lost to Follow-up|2
209180|NCT00269113|698557|P2|Overall Study|Death|2
209181|NCT00269113|698558|P1|Overall Study|Death|6
209182|NCT00269113|698557|P2|Overall Study|Withdrawal by Subject|2
209183|NCT00269113|698558|P1|Overall Study|Withdrawal by Subject|0
209184|NCT00269113|698557|P2|Overall Study|Early Improvement|0
209185|NCT00269113|698558|P1|Overall Study|Early Improvement|2
209186|NCT00269113|698557|P2|Overall Study|Lack of Efficacy|18
209187|NCT00269113|698558|P1|Overall Study|Lack of Efficacy|35
209188|NCT00269113|698557|P2|Overall Study|Adverse Event|7
209189|NCT00269113|698558|P1|Overall Study|Adverse Event|14
209190|NCT00268996|698578|P2|Overall Study|Other|1
209191|NCT00268996|698579|P1|Overall Study|Other|1
209192|NCT00268996|698578|P2|Overall Study|Non-compliance|0
209193|NCT00268996|698579|P1|Overall Study|Non-compliance|1
209194|NCT00268996|698578|P2|Overall Study|Withdrawal by Subject|11
209195|NCT00268996|698579|P1|Overall Study|Withdrawal by Subject|5
209196|NCT00268996|698578|P2|Overall Study|Lost to Follow-up|1
209197|NCT00268996|698579|P1|Overall Study|Lost to Follow-up|3
209198|NCT00268996|698578|P2|Overall Study|Adverse Event|7
209199|NCT00268996|698579|P1|Overall Study|Adverse Event|11
209200|NCT00268983|698623|P2|Overall Study|Death|0
209201|NCT00268983|698624|P1|Overall Study|Death|3
209202|NCT00268905|698667|P3|Overall Study|Clinical Progression|1
209203|NCT00268905|698668|P2|Overall Study|Clinical Progression|4
209204|NCT00268905|698669|P1|Overall Study|Clinical Progression|9
209205|NCT00268905|698667|P3|Overall Study|Physician Decision|1
209206|NCT00268905|698668|P2|Overall Study|Physician Decision|0
209207|NCT00268905|698669|P1|Overall Study|Physician Decision|3
209208|NCT00268905|698667|P3|Overall Study|Progressive Disease|3
209209|NCT00268905|698668|P2|Overall Study|Progressive Disease|4
209210|NCT00268905|698669|P1|Overall Study|Progressive Disease|28
209211|NCT00268905|698667|P3|Overall Study|Withdrawal by Subject|3
209212|NCT00268905|698668|P2|Overall Study|Withdrawal by Subject|0
209213|NCT00268905|698669|P1|Overall Study|Withdrawal by Subject|0
209214|NCT00268905|698667|P3|Overall Study|Lost to Follow-up|0
209215|NCT00268905|698668|P2|Overall Study|Lost to Follow-up|1
209216|NCT00268905|698669|P1|Overall Study|Lost to Follow-up|0
209217|NCT00268905|698667|P3|Overall Study|Adverse Event|4
209218|NCT00268905|698668|P2|Overall Study|Adverse Event|0
209219|NCT00268905|698669|P1|Overall Study|Adverse Event|3
209220|NCT00268892|698686|P3|Overall Study|Trial Site Closed|2
209221|NCT00268892|698687|P2|Overall Study|Trial Site Closed|2
209222|NCT00268892|698688|P1|Overall Study|Trial Site Closed|4
209223|NCT00268892|698686|P3|Overall Study|Disease Progression|0
209224|NCT00268892|698687|P2|Overall Study|Disease Progression|1
209225|NCT00268892|698688|P1|Overall Study|Disease Progression|1
209226|NCT00268892|698686|P3|Overall Study|Protocol Violation|0
209227|NCT00268892|698687|P2|Overall Study|Protocol Violation|1
209228|NCT00268892|698688|P1|Overall Study|Protocol Violation|0
209229|NCT00268892|698686|P3|Overall Study|Lost to Follow-up|4
209230|NCT00268892|698687|P2|Overall Study|Lost to Follow-up|2
209231|NCT00268892|698688|P1|Overall Study|Lost to Follow-up|5
209232|NCT00268892|698686|P3|Overall Study|Physician Decision|0
209233|NCT00268892|698687|P2|Overall Study|Physician Decision|1
209234|NCT00268892|698688|P1|Overall Study|Physician Decision|0
209235|NCT00268892|698686|P3|Overall Study|Withdrawal by Subject|13
209236|NCT00268892|698687|P2|Overall Study|Withdrawal by Subject|15
209237|NCT00268892|698688|P1|Overall Study|Withdrawal by Subject|14
209238|NCT00268892|698686|P3|Overall Study|Lack of Efficacy|0
209239|NCT00268892|698687|P2|Overall Study|Lack of Efficacy|3
209240|NCT00268892|698688|P1|Overall Study|Lack of Efficacy|1
209241|NCT00268892|698686|P3|Overall Study|Adverse Event|20
209242|NCT00268892|698687|P2|Overall Study|Adverse Event|17
209243|NCT00268892|698688|P1|Overall Study|Adverse Event|14
209244|NCT00268463|698707|P2|Overall Study|study terminated due to low accrual|12
209245|NCT00268463|698708|P1|Overall Study|study terminated due to low accrual|10
209246|NCT00268437|698714|P1|Overall Study|Ineligible|1
209247|NCT00268346|698721|P2|Overall Study|Withdrawal by Subject|1
209248|NCT00268346|698722|P1|Overall Study|Withdrawal by Subject|0
209249|NCT00268346|698721|P2|Overall Study|Death|1
209250|NCT00268346|698722|P1|Overall Study|Death|0
209251|NCT00268346|698721|P2|Overall Study|Adverse Event|1
209252|NCT00268346|698722|P1|Overall Study|Adverse Event|0
209253|NCT00268242|698728|P1|Overall Study|Death|1
209254|NCT00268203|698737|P1|Overall Study|Completed 2 Years of Follow-up|62
209255|NCT00268203|698737|P1|Overall Study|Reason Not Specified|34
209256|NCT00268203|698737|P1|Overall Study|Death|84
209257|NCT00268203|698737|P1|Overall Study|Progressive Disease|359
209258|NCT00268203|698737|P1|Overall Study|Received Other NHL Therapy|7
209259|NCT00268203|698737|P1|Overall Study|Withdrawal by Subject|9
209260|NCT00268203|698737|P1|Overall Study|Lost to Follow-up|92
209261|NCT00267969|698751|P7|After Controlled Period|Not specified|25
209262|NCT00267969|698752|P6|After Controlled Period|Not specified|22
209263|NCT00267969|698753|P5|After Controlled Period|Not specified|11
209264|NCT00267969|698754|P4|After Controlled Period|Not specified|13
209265|NCT00267969|698755|P3|After Controlled Period|Not specified|0
209266|NCT00267969|698756|P2|After Controlled Period|Not specified|0
209267|NCT00267969|698757|P1|After Controlled Period|Not specified|0
209268|NCT00267969|698751|P7|After Controlled Period|Lost to Follow-up|10
209269|NCT00267969|698752|P6|After Controlled Period|Lost to Follow-up|9
209270|NCT00267969|698753|P5|After Controlled Period|Lost to Follow-up|8
209271|NCT00267969|698754|P4|After Controlled Period|Lost to Follow-up|5
209272|NCT00267969|698755|P3|After Controlled Period|Lost to Follow-up|0
209273|NCT00267969|698756|P2|After Controlled Period|Lost to Follow-up|0
209274|NCT00267969|698757|P1|After Controlled Period|Lost to Follow-up|0
209275|NCT00267969|698751|P7|After Controlled Period|Lack of Efficacy|15
209276|NCT00267969|698752|P6|After Controlled Period|Lack of Efficacy|28
209277|NCT00267969|698753|P5|After Controlled Period|Lack of Efficacy|6
209278|NCT00267969|698754|P4|After Controlled Period|Lack of Efficacy|10
209279|NCT00267969|698755|P3|After Controlled Period|Lack of Efficacy|0
209280|NCT00267969|698756|P2|After Controlled Period|Lack of Efficacy|0
209281|NCT00267969|698757|P1|After Controlled Period|Lack of Efficacy|0
209282|NCT00267969|698751|P7|After Controlled Period|Death|1
209283|NCT00267969|698752|P6|After Controlled Period|Death|0
209284|NCT00267969|698753|P5|After Controlled Period|Death|2
209285|NCT00267969|698754|P4|After Controlled Period|Death|1
209286|NCT00267969|698755|P3|After Controlled Period|Death|0
209287|NCT00267969|698756|P2|After Controlled Period|Death|0
209288|NCT00267969|698757|P1|After Controlled Period|Death|0
209289|NCT00267969|698751|P7|After Controlled Period|Adverse Event|21
209290|NCT00267969|698752|P6|After Controlled Period|Adverse Event|23
209291|NCT00267969|698753|P5|After Controlled Period|Adverse Event|8
209292|NCT00267969|698754|P4|After Controlled Period|Adverse Event|7
209293|NCT00267969|698755|P3|After Controlled Period|Adverse Event|0
209294|NCT00267969|698756|P2|After Controlled Period|Adverse Event|0
209295|NCT00267969|698757|P1|After Controlled Period|Adverse Event|0
209296|NCT00267969|698751|P7|Controlled Period|Not specified|0
209297|NCT00267969|698752|P6|Controlled Period|Not specified|0
209298|NCT00267969|698753|P5|Controlled Period|Not specified|0
209299|NCT00267969|698754|P4|Controlled Period|Not specified|0
209300|NCT00267969|698755|P3|Controlled Period|Not specified|6
209301|NCT00267969|698756|P2|Controlled Period|Not specified|1
209302|NCT00267969|698757|P1|Controlled Period|Not specified|2
209303|NCT00267969|698751|P7|Controlled Period|Randomized but not treated|0
209304|NCT00267969|698752|P6|Controlled Period|Randomized but not treated|0
209305|NCT00267969|698753|P5|Controlled Period|Randomized but not treated|0
209306|NCT00267969|698754|P4|Controlled Period|Randomized but not treated|0
209307|NCT00267969|698755|P3|Controlled Period|Randomized but not treated|1
209308|NCT00267969|698756|P2|Controlled Period|Randomized but not treated|0
209309|NCT00267969|698757|P1|Controlled Period|Randomized but not treated|0
209310|NCT00267969|698751|P7|Controlled Period|Lost to Follow-up|0
209311|NCT00267969|698752|P6|Controlled Period|Lost to Follow-up|0
209312|NCT00267969|698753|P5|Controlled Period|Lost to Follow-up|0
209313|NCT00267969|698754|P4|Controlled Period|Lost to Follow-up|0
209314|NCT00267969|698755|P3|Controlled Period|Lost to Follow-up|1
209315|NCT00267969|698756|P2|Controlled Period|Lost to Follow-up|0
209316|NCT00267969|698757|P1|Controlled Period|Lost to Follow-up|1
209317|NCT00267969|698751|P7|Controlled Period|Lack of Efficacy|0
209318|NCT00267969|698752|P6|Controlled Period|Lack of Efficacy|0
209319|NCT00267969|698753|P5|Controlled Period|Lack of Efficacy|0
209320|NCT00267969|698754|P4|Controlled Period|Lack of Efficacy|0
209321|NCT00267969|698755|P3|Controlled Period|Lack of Efficacy|1
209322|NCT00267969|698756|P2|Controlled Period|Lack of Efficacy|0
209323|NCT00267969|698757|P1|Controlled Period|Lack of Efficacy|3
209324|NCT00267969|698751|P7|Controlled Period|Adverse Event|0
209325|NCT00267969|698752|P6|Controlled Period|Adverse Event|0
209326|NCT00267969|698753|P5|Controlled Period|Adverse Event|0
209327|NCT00267969|698754|P4|Controlled Period|Adverse Event|0
209328|NCT00267969|698755|P3|Controlled Period|Adverse Event|2
209329|NCT00267969|698756|P2|Controlled Period|Adverse Event|0
209330|NCT00267969|698757|P1|Controlled Period|Adverse Event|6
209331|NCT00267956|698783|P4|After Controlled Period|Withdrew consent|0
209332|NCT00267956|698784|P3|After Controlled Period|Withdrew consent|1
209333|NCT00267956|698785|P2|After Controlled Period|Withdrew consent|0
209334|NCT00267956|698786|P1|After Controlled Period|Withdrew consent|0
209335|NCT00267956|698783|P4|After Controlled Period|Lost to Follow-up|0
209336|NCT00267956|698784|P3|After Controlled Period|Lost to Follow-up|1
209337|NCT00267956|698785|P2|After Controlled Period|Lost to Follow-up|0
209338|NCT00267956|698786|P1|After Controlled Period|Lost to Follow-up|0
209339|NCT00267956|698783|P4|After Controlled Period|Lack of Efficacy|1
209340|NCT00267956|698784|P3|After Controlled Period|Lack of Efficacy|1
209341|NCT00267956|698785|P2|After Controlled Period|Lack of Efficacy|0
209342|NCT00267956|698786|P1|After Controlled Period|Lack of Efficacy|0
209343|NCT00267956|698783|P4|After Controlled Period|Adverse Event|1
209344|NCT00267956|698784|P3|After Controlled Period|Adverse Event|2
209345|NCT00267956|698785|P2|After Controlled Period|Adverse Event|0
209346|NCT00267956|698786|P1|After Controlled Period|Adverse Event|0
209347|NCT00267956|698783|P4|Controlled Period|Withdrew consent|0
209348|NCT00267956|698784|P3|Controlled Period|Withdrew consent|0
209349|NCT00267956|698785|P2|Controlled Period|Withdrew consent|1
209350|NCT00267956|698786|P1|Controlled Period|Withdrew consent|3
209351|NCT00267956|698783|P4|Controlled Period|Lost to Follow-up|0
209352|NCT00267956|698784|P3|Controlled Period|Lost to Follow-up|0
209353|NCT00267956|698785|P2|Controlled Period|Lost to Follow-up|0
209354|NCT00267956|698786|P1|Controlled Period|Lost to Follow-up|2
209355|NCT00267956|698783|P4|Controlled Period|Lack of Efficacy|0
209356|NCT00267956|698784|P3|Controlled Period|Lack of Efficacy|0
209357|NCT00267956|698785|P2|Controlled Period|Lack of Efficacy|2
209358|NCT00267956|698786|P1|Controlled Period|Lack of Efficacy|4
209359|NCT00267956|698783|P4|Controlled Period|Adverse Event|0
209360|NCT00267956|698784|P3|Controlled Period|Adverse Event|0
209361|NCT00267956|698785|P2|Controlled Period|Adverse Event|1
209362|NCT00267956|698786|P1|Controlled Period|Adverse Event|4
209363|NCT00267748|698818|P3|Randomized Period|randomized but not treated|3
209364|NCT00267748|698819|P2|Randomized Period|randomized but not treated|0
209365|NCT00267748|698820|P1|Randomized Period|randomized but not treated|0
209366|NCT00267748|698818|P3|Randomized Period|Other|6
209367|NCT00267748|698819|P2|Randomized Period|Other|9
209368|NCT00267748|698820|P1|Randomized Period|Other|0
209369|NCT00267748|698818|P3|Randomized Period|Withdrawal by Subject|2
209370|NCT00267748|698819|P2|Randomized Period|Withdrawal by Subject|9
209371|NCT00267748|698820|P1|Randomized Period|Withdrawal by Subject|0
209372|NCT00267748|698818|P3|Randomized Period|Objective progression or relapse|86
209373|NCT00267748|698819|P2|Randomized Period|Objective progression or relapse|77
209374|NCT00267748|698820|P1|Randomized Period|Objective progression or relapse|0
209375|NCT00267748|698818|P3|Randomized Period|Lost to Follow-up|0
209376|NCT00267748|698819|P2|Randomized Period|Lost to Follow-up|1
209377|NCT00267748|698820|P1|Randomized Period|Lost to Follow-up|0
209378|NCT00267748|698818|P3|Randomized Period|Global deterioration of health status|7
209379|NCT00267748|698819|P2|Randomized Period|Global deterioration of health status|6
209380|NCT00267748|698820|P1|Randomized Period|Global deterioration of health status|0
209381|NCT00267748|698818|P3|Randomized Period|Adverse Event|25
209382|NCT00267748|698819|P2|Randomized Period|Adverse Event|23
209383|NCT00267748|698820|P1|Randomized Period|Adverse Event|0
209384|NCT00267748|698818|P3|Randomized Period|Death|3
209385|NCT00267748|698819|P2|Randomized Period|Death|2
209386|NCT00267748|698820|P1|Randomized Period|Death|0
209387|NCT00267748|698818|P3|Non-randomized Period|Other|0
209388|NCT00267748|698819|P2|Non-randomized Period|Other|0
209389|NCT00267748|698820|P1|Non-randomized Period|Other|3
209390|NCT00267748|698818|P3|Non-randomized Period|Participant not willing to participate|0
209391|NCT00267748|698819|P2|Non-randomized Period|Participant not willing to participate|0
209392|NCT00267748|698820|P1|Non-randomized Period|Participant not willing to participate|1
209393|NCT00267748|698818|P3|Non-randomized Period|Death|0
209394|NCT00267748|698819|P2|Non-randomized Period|Death|0
209395|NCT00267748|698820|P1|Non-randomized Period|Death|1
209396|NCT00267748|698818|P3|Non-randomized Period|Adverse Event|0
209397|NCT00267748|698819|P2|Non-randomized Period|Adverse Event|0
209398|NCT00267748|698820|P1|Non-randomized Period|Adverse Event|8
209399|NCT00267748|698818|P3|Non-randomized Period|Progressive disease|0
209400|NCT00267748|698819|P2|Non-randomized Period|Progressive disease|0
209401|NCT00267748|698820|P1|Non-randomized Period|Progressive disease|10
209402|NCT00267488|698877|P1|Overall Study|Other (Disease Progression)|1
209403|NCT00267488|698877|P1|Overall Study|Protocol Violation|1
209404|NCT00267488|698877|P1|Overall Study|Sponsor Terminated Study|9
209405|NCT00267202|698901|P2|Overall Study|Lost to Follow-up|0
209406|NCT00267202|698902|P1|Overall Study|Lost to Follow-up|3
209407|NCT00267202|698901|P2|Overall Study|Administrative problems|1
209408|NCT00267202|698902|P1|Overall Study|Administrative problems|2
209409|NCT00267202|698901|P2|Overall Study|Protocol Violation|3
209410|NCT00267202|698902|P1|Overall Study|Protocol Violation|2
209411|NCT00267202|698901|P2|Overall Study|Adverse Event|7
209412|NCT00267202|698902|P1|Overall Study|Adverse Event|13
209413|NCT00267202|698901|P2|Overall Study|Withdrawal by Subject|15
209414|NCT00267202|698902|P1|Overall Study|Withdrawal by Subject|12
209415|NCT00267202|698901|P2|Overall Study|Unsatisfactory therapeutic effect|8
209416|NCT00267202|698902|P1|Overall Study|Unsatisfactory therapeutic effect|21
209417|NCT00267189|698923|P2|Overall Study|Missing|0
209418|NCT00267189|698924|P1|Overall Study|Missing|3
209419|NCT00267189|698923|P2|Overall Study|Death|0
209420|NCT00267189|698924|P1|Overall Study|Death|1
209421|NCT00267189|698923|P2|Overall Study|Patient withdrew consent|1
209422|NCT00267189|698924|P1|Overall Study|Patient withdrew consent|1
209423|NCT00267150|698934|P1|Overall Study|Adverse Event|1
209424|NCT00267098|698958|P8|Overall Study|Sponsor withdrew subject|0
209425|NCT00267098|698959|P7|Overall Study|Sponsor withdrew subject|0
209426|NCT00267098|698960|P6|Overall Study|Sponsor withdrew subject|0
209427|NCT00267098|698961|P5|Overall Study|Sponsor withdrew subject|0
209428|NCT00267098|698962|P4|Overall Study|Sponsor withdrew subject|1
209429|NCT00267098|698963|P3|Overall Study|Sponsor withdrew subject|0
209430|NCT00267098|698964|P2|Overall Study|Sponsor withdrew subject|0
209431|NCT00267098|698965|P1|Overall Study|Sponsor withdrew subject|0
209432|NCT00267098|698958|P8|Overall Study|Subject listed for heart transplant|0
209433|NCT00267098|698959|P7|Overall Study|Subject listed for heart transplant|1
209434|NCT00267098|698960|P6|Overall Study|Subject listed for heart transplant|0
209435|NCT00267098|698961|P5|Overall Study|Subject listed for heart transplant|0
209436|NCT00267098|698962|P4|Overall Study|Subject listed for heart transplant|0
209437|NCT00267098|698963|P3|Overall Study|Subject listed for heart transplant|0
209438|NCT00267098|698964|P2|Overall Study|Subject listed for heart transplant|0
209439|NCT00267098|698965|P1|Overall Study|Subject listed for heart transplant|0
209440|NCT00267098|698958|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
209441|NCT00267098|698959|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
209442|NCT00267098|698960|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
209443|NCT00267098|698961|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
209444|NCT00267098|698962|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
209445|NCT00267098|698963|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
209446|NCT00267098|698964|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
209447|NCT00267098|698965|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
209448|NCT00267098|698958|P8|Overall Study|Explanted Medtronic device|0
209449|NCT00267098|698959|P7|Overall Study|Explanted Medtronic device|0
209450|NCT00267098|698960|P6|Overall Study|Explanted Medtronic device|0
209451|NCT00267098|698961|P5|Overall Study|Explanted Medtronic device|0
209452|NCT00267098|698962|P4|Overall Study|Explanted Medtronic device|1
209453|NCT00267098|698963|P3|Overall Study|Explanted Medtronic device|0
209454|NCT00267098|698964|P2|Overall Study|Explanted Medtronic device|0
209455|NCT00267098|698965|P1|Overall Study|Explanted Medtronic device|0
209456|NCT00267098|698958|P8|Overall Study|Site closure|0
209457|NCT00267098|698959|P7|Overall Study|Site closure|1
209458|NCT00267098|698960|P6|Overall Study|Site closure|1
209459|NCT00267098|698961|P5|Overall Study|Site closure|0
209460|NCT00267098|698962|P4|Overall Study|Site closure|1
209461|NCT00267098|698963|P3|Overall Study|Site closure|0
209462|NCT00267098|698964|P2|Overall Study|Site closure|0
209463|NCT00267098|698965|P1|Overall Study|Site closure|0
209464|NCT00267098|698958|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
209465|NCT00267098|698959|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
209466|NCT00267098|698960|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
209467|NCT00267098|698961|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
209468|NCT00267098|698962|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
209469|NCT00267098|698963|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
209470|NCT00267098|698964|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
209471|NCT00267098|698965|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
209472|NCT00267098|698958|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
209473|NCT00267098|698959|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
209474|NCT00267098|698960|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
209475|NCT00267098|698961|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
209476|NCT00267098|698962|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
209477|NCT00267098|698963|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
209478|NCT00267098|698964|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
209479|NCT00267098|698965|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
209480|NCT00267098|698958|P8|Overall Study|Physician Decision|0
209481|NCT00267098|698959|P7|Overall Study|Physician Decision|3
209482|NCT00267098|698960|P6|Overall Study|Physician Decision|4
209483|NCT00267098|698961|P5|Overall Study|Physician Decision|5
209484|NCT00267098|698962|P4|Overall Study|Physician Decision|11
209485|NCT00267098|698963|P3|Overall Study|Physician Decision|7
209486|NCT00267098|698964|P2|Overall Study|Physician Decision|0
209487|NCT00267098|698965|P1|Overall Study|Physician Decision|5
209488|NCT00267098|698958|P8|Overall Study|Withdrawal by Subject|5
209489|NCT00267098|698959|P7|Overall Study|Withdrawal by Subject|12
209490|NCT00267098|698960|P6|Overall Study|Withdrawal by Subject|9
209491|NCT00267098|698961|P5|Overall Study|Withdrawal by Subject|12
209492|NCT00267098|698962|P4|Overall Study|Withdrawal by Subject|21
209493|NCT00267098|698963|P3|Overall Study|Withdrawal by Subject|24
209494|NCT00267098|698964|P2|Overall Study|Withdrawal by Subject|0
209495|NCT00267098|698965|P1|Overall Study|Withdrawal by Subject|8
209496|NCT00267098|698958|P8|Overall Study|Lost to Follow-up|1
209497|NCT00267098|698959|P7|Overall Study|Lost to Follow-up|1
209498|NCT00267098|698960|P6|Overall Study|Lost to Follow-up|3
209499|NCT00267098|698961|P5|Overall Study|Lost to Follow-up|2
209500|NCT00267098|698962|P4|Overall Study|Lost to Follow-up|5
209501|NCT00267098|698963|P3|Overall Study|Lost to Follow-up|6
209502|NCT00267098|698964|P2|Overall Study|Lost to Follow-up|0
209503|NCT00267098|698965|P1|Overall Study|Lost to Follow-up|0
209504|NCT00267098|698958|P8|Overall Study|Death|9
209505|NCT00267098|698959|P7|Overall Study|Death|28
209506|NCT00267098|698960|P6|Overall Study|Death|23
209507|NCT00267098|698961|P5|Overall Study|Death|14
209508|NCT00267098|698962|P4|Overall Study|Death|66
209509|NCT00267098|698963|P3|Overall Study|Death|57
209510|NCT00267098|698964|P2|Overall Study|Death|0
209511|NCT00267098|698965|P1|Overall Study|Death|0
209512|NCT00267046|699108|P2|Overall Study|Radiation|1
209513|NCT00267046|699109|P1|Overall Study|Radiation|0
209514|NCT00267046|699108|P2|Overall Study|Withdrawal by Subject|0
209515|NCT00267046|699109|P1|Overall Study|Withdrawal by Subject|1
209516|NCT00267046|699108|P2|Overall Study|Surgery|1
209517|NCT00267046|699109|P1|Overall Study|Surgery|3
209518|NCT00267046|699108|P2|Overall Study|Open-label palifermin|7
209519|NCT00267046|699109|P1|Overall Study|Open-label palifermin|2
209520|NCT00267046|699108|P2|Overall Study|Chemotoxicity|0
209521|NCT00267046|699109|P1|Overall Study|Chemotoxicity|2
209522|NCT00267046|699108|P2|Overall Study|Disease progression|2
209523|NCT00267046|699109|P1|Overall Study|Disease progression|4
209524|NCT00267007|699119|P2|Overall Study|Adverse Event|0
209525|NCT00267007|699120|P1|Overall Study|Adverse Event|1
209526|NCT00267007|699119|P2|Overall Study|Non-compliance|1
209527|NCT00267007|699120|P1|Overall Study|Non-compliance|0
209528|NCT00267007|699119|P2|Overall Study|Lost to Follow-up|0
209529|NCT00267007|699120|P1|Overall Study|Lost to Follow-up|1
209530|NCT00267007|699119|P2|Overall Study|Withdrawal by Subject|0
209531|NCT00267007|699120|P1|Overall Study|Withdrawal by Subject|6
209532|NCT00266877|699131|P3|Overall Study|Concomitant Radiotherapy|0
209533|NCT00266877|699132|P2|Overall Study|Concomitant Radiotherapy|1
209534|NCT00266877|699133|P1|Overall Study|Concomitant Radiotherapy|0
209535|NCT00266877|699131|P3|Overall Study|Hospitalization|0
209536|NCT00266877|699132|P2|Overall Study|Hospitalization|0
209537|NCT00266877|699133|P1|Overall Study|Hospitalization|1
209538|NCT00266877|699131|P3|Overall Study|Symptomatic Deterioration|1
209539|NCT00266877|699132|P2|Overall Study|Symptomatic Deterioration|3
209540|NCT00266877|699133|P1|Overall Study|Symptomatic Deterioration|6
209541|NCT00266877|699131|P3|Overall Study|Disease Progression|23
209542|NCT00266877|699132|P2|Overall Study|Disease Progression|37
209543|NCT00266877|699133|P1|Overall Study|Disease Progression|72
209544|NCT00266877|699131|P3|Overall Study|Withdrawal by Subject|1
209545|NCT00266877|699132|P2|Overall Study|Withdrawal by Subject|1
209546|NCT00266877|699133|P1|Overall Study|Withdrawal by Subject|3
209547|NCT00266877|699131|P3|Overall Study|Physician Decision|1
209548|NCT00266877|699132|P2|Overall Study|Physician Decision|1
209549|NCT00266877|699133|P1|Overall Study|Physician Decision|2
209550|NCT00266877|699131|P3|Overall Study|Adverse Event|1
209551|NCT00266877|699132|P2|Overall Study|Adverse Event|4
209552|NCT00266877|699133|P1|Overall Study|Adverse Event|6
209553|NCT00266877|699131|P3|Overall Study|Death|1
209554|NCT00266877|699132|P2|Overall Study|Death|1
209555|NCT00266877|699133|P1|Overall Study|Death|1
209556|NCT00266864|699152|P2|Overall Study|Withdrawal by Subject|1
209557|NCT00266864|699153|P1|Overall Study|Withdrawal by Subject|1
209558|NCT00266864|699152|P2|Overall Study|Lost to Follow-up|1
209559|NCT00266864|699153|P1|Overall Study|Lost to Follow-up|4
209560|NCT00266825|699162|P2|Completed Follow-Up|Withdrawal by Subject|5
209561|NCT00266825|699163|P1|Completed Follow-Up|Withdrawal by Subject|11
209562|NCT00266825|699162|P2|Completed Follow-Up|Lost to Follow-up|19
209563|NCT00266825|699163|P1|Completed Follow-Up|Lost to Follow-up|14
209564|NCT00266812|699189|P2|Overall Study|Discontinued before starting study drug|0
209565|NCT00266812|699190|P1|Overall Study|Discontinued before starting study drug|4
209566|NCT00266812|699189|P2|Overall Study|Withdrawal by Subject|2
209567|NCT00266812|699190|P1|Overall Study|Withdrawal by Subject|0
209568|NCT00266812|699189|P2|Overall Study|Protocol Violation|1
209569|NCT00266812|699190|P1|Overall Study|Protocol Violation|0
209570|NCT00266812|699189|P2|Overall Study|Adverse Event|1
209571|NCT00266812|699190|P1|Overall Study|Adverse Event|3
209572|NCT00266812|699189|P2|Overall Study|Death|4
209573|NCT00266812|699190|P1|Overall Study|Death|5
209574|NCT00266812|699189|P2|Overall Study|Disease Progression|3
209575|NCT00266812|699190|P1|Overall Study|Disease Progression|9
209576|NCT00266695|699213|P1|Overall Study|Withdrawal by Subject|15
209577|NCT00266695|699213|P1|Overall Study|Lost to Follow-up|3
209578|NCT00266695|699213|P1|Overall Study|Physician Decision|1
209579|NCT00266695|699213|P1|Overall Study|Death|9
209580|NCT00266695|699213|P1|Overall Study|Adverse Event|1
209581|NCT00266656|699225|P2|Overall Study|Parent/Caregiver Decision|2
209582|NCT00266656|699226|P1|Overall Study|Parent/Caregiver Decision|1
209583|NCT00266656|699225|P2|Overall Study|Did Not Reach Final Height|8
209584|NCT00266656|699226|P1|Overall Study|Did Not Reach Final Height|4
209585|NCT00266656|699225|P2|Overall Study|Withdrawal by Subject|2
209586|NCT00266656|699226|P1|Overall Study|Withdrawal by Subject|4
209587|NCT00266656|699225|P2|Overall Study|Lost to Follow-up|1
209588|NCT00266656|699226|P1|Overall Study|Lost to Follow-up|4
209589|NCT00266656|699225|P2|Overall Study|Death|0
209590|NCT00266656|699226|P1|Overall Study|Death|1
209591|NCT00266630|699250|P2|Overall Study|Not Specified|11
209592|NCT00266630|699251|P1|Overall Study|Not Specified|19
209593|NCT00266630|699250|P2|Overall Study|Lost to Follow-up|0
209594|NCT00266630|699251|P1|Overall Study|Lost to Follow-up|1
209595|NCT00266630|699250|P2|Overall Study|Withdrawal by Subject|2
209596|NCT00266630|699251|P1|Overall Study|Withdrawal by Subject|10
209597|NCT00266630|699250|P2|Overall Study|Physician Decision|2
209598|NCT00266630|699251|P1|Overall Study|Physician Decision|1
209599|NCT00266630|699250|P2|Overall Study|Protocol Violation|3
209600|NCT00266630|699251|P1|Overall Study|Protocol Violation|1
209601|NCT00266630|699250|P2|Overall Study|Entry Criteria not met|0
209602|NCT00266630|699251|P1|Overall Study|Entry Criteria not met|1
209603|NCT00266630|699250|P2|Overall Study|Lack of Efficacy|4
209604|NCT00266630|699251|P1|Overall Study|Lack of Efficacy|1
209605|NCT00266630|699250|P2|Overall Study|Adverse Event|6
209606|NCT00266630|699251|P1|Overall Study|Adverse Event|8
209607|NCT00266409|699293|P4|Overall Study|Other|0
209608|NCT00266409|699294|P3|Overall Study|Other|2
209609|NCT00266409|699295|P2|Overall Study|Other|4
209610|NCT00266409|699296|P1|Overall Study|Other|7
209611|NCT00266409|699293|P4|Overall Study|Protocol Violation|2
209612|NCT00266409|699294|P3|Overall Study|Protocol Violation|4
209613|NCT00266409|699295|P2|Overall Study|Protocol Violation|3
209614|NCT00266409|699296|P1|Overall Study|Protocol Violation|5
209615|NCT00266409|699293|P4|Overall Study|Withdrawal by Subject|9
209616|NCT00266409|699294|P3|Overall Study|Withdrawal by Subject|3
209617|NCT00266409|699295|P2|Overall Study|Withdrawal by Subject|10
209618|NCT00266409|699296|P1|Overall Study|Withdrawal by Subject|6
209619|NCT00266409|699293|P4|Overall Study|Lost to Follow-up|8
209620|NCT00266409|699294|P3|Overall Study|Lost to Follow-up|6
209621|NCT00266409|699295|P2|Overall Study|Lost to Follow-up|21
209622|NCT00266409|699296|P1|Overall Study|Lost to Follow-up|18
209623|NCT00266409|699293|P4|Overall Study|Adverse Event|1
209624|NCT00266409|699294|P3|Overall Study|Adverse Event|1
209625|NCT00266409|699295|P2|Overall Study|Adverse Event|2
209626|NCT00266409|699296|P1|Overall Study|Adverse Event|7
209627|NCT00266409|699293|P4|Overall Study|Lack of Efficacy|2
209628|NCT00266409|699294|P3|Overall Study|Lack of Efficacy|1
209629|NCT00266409|699295|P2|Overall Study|Lack of Efficacy|6
209630|NCT00266409|699296|P1|Overall Study|Lack of Efficacy|2
209631|NCT00266227|699584|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
209632|NCT00266227|699585|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
209633|NCT00266227|699586|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
209634|NCT00266227|699584|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
209635|NCT00266227|699585|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
209636|NCT00266227|699586|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
209637|NCT00266227|699584|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
209638|NCT00266227|699585|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
209639|NCT00266227|699586|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
209640|NCT00266227|699584|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
209641|NCT00266227|699585|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
209642|NCT00266227|699586|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
209643|NCT00266227|699584|P3|Retreatment: Week 48 to Week 72|Death|0
209644|NCT00266227|699585|P2|Retreatment: Week 48 to Week 72|Death|1
209645|NCT00266227|699586|P1|Retreatment: Week 48 to Week 72|Death|1
209646|NCT00266227|699584|P3|Retreatment: Up to Week 48|Pregnancy|0
209647|NCT00266227|699585|P2|Retreatment: Up to Week 48|Pregnancy|0
209648|NCT00266227|699586|P1|Retreatment: Up to Week 48|Pregnancy|1
209649|NCT00266227|699584|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
209650|NCT00266227|699585|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
209651|NCT00266227|699586|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
209652|NCT00266227|699584|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
209653|NCT00266227|699585|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
209654|NCT00266227|699586|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
209655|NCT00266227|699584|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
209656|NCT00266227|699585|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
209657|NCT00266227|699586|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
209658|NCT00266227|699584|P3|Retreatment: Up to Week 48|Adverse Event|0
209659|NCT00266227|699585|P2|Retreatment: Up to Week 48|Adverse Event|7
209660|NCT00266227|699586|P1|Retreatment: Up to Week 48|Adverse Event|7
209661|NCT00266227|699584|P3|Retreatment: Up to Week 48|Death|0
209662|NCT00266227|699585|P2|Retreatment: Up to Week 48|Death|0
209663|NCT00266227|699586|P1|Retreatment: Up to Week 48|Death|1
209664|NCT00266227|699584|P3|Initial Treatment|Pregnancy|1
209665|NCT00266227|699585|P2|Initial Treatment|Pregnancy|0
209666|NCT00266227|699586|P1|Initial Treatment|Pregnancy|0
209667|NCT00266227|699584|P3|Initial Treatment|Physician decision to withdraw|12
209668|NCT00266227|699585|P2|Initial Treatment|Physician decision to withdraw|0
209669|NCT00266227|699586|P1|Initial Treatment|Physician decision to withdraw|0
209670|NCT00266227|699584|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
209671|NCT00266227|699585|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
209672|NCT00266227|699586|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
209673|NCT00266227|699584|P3|Initial Treatment|Lost to Follow-up|6
209674|NCT00266227|699585|P2|Initial Treatment|Lost to Follow-up|0
209675|NCT00266227|699586|P1|Initial Treatment|Lost to Follow-up|0
209676|NCT00266227|699584|P3|Initial Treatment|Adverse Event|13
209677|NCT00266227|699585|P2|Initial Treatment|Adverse Event|0
209678|NCT00266227|699586|P1|Initial Treatment|Adverse Event|0
209679|NCT00266032|699638|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
209680|NCT00266032|699639|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
209681|NCT00266032|699640|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
209682|NCT00266032|699638|P3|Open-label Safety Extension|Withdrawal by Subject|12
209683|NCT00266032|699639|P2|Open-label Safety Extension|Withdrawal by Subject|3
209684|NCT00266032|699640|P1|Open-label Safety Extension|Withdrawal by Subject|19
209685|NCT00266032|699638|P3|Open-label Safety Extension|Protocol Violation|2
209686|NCT00266032|699639|P2|Open-label Safety Extension|Protocol Violation|3
209687|NCT00266032|699640|P1|Open-label Safety Extension|Protocol Violation|1
209688|NCT00266032|699638|P3|Open-label Safety Extension|Pregnancy|2
209689|NCT00266032|699639|P2|Open-label Safety Extension|Pregnancy|1
209690|NCT00266032|699640|P1|Open-label Safety Extension|Pregnancy|4
209691|NCT00266032|699638|P3|Open-label Safety Extension|Lost to Follow-up|4
209692|NCT00266032|699639|P2|Open-label Safety Extension|Lost to Follow-up|5
209693|NCT00266032|699640|P1|Open-label Safety Extension|Lost to Follow-up|2
209694|NCT00266032|699638|P3|Open-label Safety Extension|Adverse Event|4
209695|NCT00266032|699639|P2|Open-label Safety Extension|Adverse Event|0
209696|NCT00266032|699640|P1|Open-label Safety Extension|Adverse Event|5
209697|NCT00266032|699638|P3|Treatment|patient moved/wish for pregnancy/no need|8
209698|NCT00266032|699639|P2|Treatment|patient moved/wish for pregnancy/no need|5
209699|NCT00266032|699640|P1|Treatment|patient moved/wish for pregnancy/no need|13
209700|NCT00266032|699638|P3|Treatment|Withdrawal by Subject|12
209701|NCT00266032|699639|P2|Treatment|Withdrawal by Subject|13
209702|NCT00266032|699640|P1|Treatment|Withdrawal by Subject|28
209703|NCT00266032|699638|P3|Treatment|Protocol Violation|13
209704|NCT00266032|699639|P2|Treatment|Protocol Violation|14
209705|NCT00266032|699640|P1|Treatment|Protocol Violation|6
209706|NCT00266032|699638|P3|Treatment|Pregnancy|2
209707|NCT00266032|699639|P2|Treatment|Pregnancy|2
209708|NCT00266032|699640|P1|Treatment|Pregnancy|3
209709|NCT00266032|699638|P3|Treatment|Lost to Follow-up|2
209710|NCT00266032|699639|P2|Treatment|Lost to Follow-up|4
209711|NCT00266032|699640|P1|Treatment|Lost to Follow-up|19
209712|NCT00266032|699638|P3|Treatment|Adverse Event|10
209713|NCT00266032|699639|P2|Treatment|Adverse Event|26
209714|NCT00266032|699640|P1|Treatment|Adverse Event|42
209715|NCT00265941|699670|P2|Overall Study|Lost to Follow-up|1
209716|NCT00265941|699671|P1|Overall Study|Lost to Follow-up|1
209717|NCT00265941|699670|P2|Overall Study|Protocol Violation|25
209718|NCT00265941|699671|P1|Overall Study|Protocol Violation|22
209719|NCT00265889|699703|P1|Overall Study|Insurance denied the request|3
209720|NCT00265889|699703|P1|Overall Study|Protocol Violation|1
209721|NCT00265889|699703|P1|Overall Study|Physician Decision|1
209722|NCT00265785|699730|P1|Overall Study|Did not receive protocol treatment|2
209723|NCT00265785|699730|P1|Overall Study|Ineligible|1
209724|NCT00265785|699730|P1|Overall Study|Not protocol specified|2
209725|NCT00265785|699730|P1|Overall Study|Progression/Relapse|15
209726|NCT00265785|699730|P1|Overall Study|Withdrawal by Subject|3
209727|NCT00265785|699730|P1|Overall Study|Adverse Event|4
209728|NCT00265759|699743|P4|Overall Study|Discontinued due to intolerability|1
209729|NCT00265759|699744|P3|Overall Study|Discontinued due to intolerability|0
209730|NCT00265759|699745|P2|Overall Study|Discontinued due to intolerability|0
209731|NCT00265759|699746|P1|Overall Study|Discontinued due to intolerability|0
209732|NCT00265759|699743|P4|Overall Study|Bilateral disease|2
209733|NCT00265759|699744|P3|Overall Study|Bilateral disease|0
209734|NCT00265759|699745|P2|Overall Study|Bilateral disease|0
209735|NCT00265759|699746|P1|Overall Study|Bilateral disease|0
209736|NCT00265759|699743|P4|Overall Study|Ineligible|1
209737|NCT00265759|699744|P3|Overall Study|Ineligible|0
209738|NCT00265759|699745|P2|Overall Study|Ineligible|0
209739|NCT00265759|699746|P1|Overall Study|Ineligible|0
209740|NCT00265759|699743|P4|Overall Study|Cancel|3
209741|NCT00265759|699744|P3|Overall Study|Cancel|0
209742|NCT00265759|699745|P2|Overall Study|Cancel|0
209743|NCT00265759|699746|P1|Overall Study|Cancel|0
209744|NCT00265759|699743|P4|Overall Study|Withdrawal by Subject|2
209745|NCT00265759|699744|P3|Overall Study|Withdrawal by Subject|2
209746|NCT00265759|699745|P2|Overall Study|Withdrawal by Subject|1
209747|NCT00265759|699746|P1|Overall Study|Withdrawal by Subject|0
209748|NCT00265395|699813|P2|Overall Study|Administrative|1
209749|NCT00265395|699814|P1|Overall Study|Administrative|0
209750|NCT00265395|699813|P2|Overall Study|Lack of Efficacy|1
209751|NCT00265395|699814|P1|Overall Study|Lack of Efficacy|0
209752|NCT00265395|699813|P2|Overall Study|Protocol Violation|2
209753|NCT00265395|699814|P1|Overall Study|Protocol Violation|2
209754|NCT00265395|699813|P2|Overall Study|Withdrawal by Subject|6
209755|NCT00265395|699814|P1|Overall Study|Withdrawal by Subject|1
209756|NCT00265395|699813|P2|Overall Study|Lost to Follow-up|1
209757|NCT00265395|699814|P1|Overall Study|Lost to Follow-up|2
209758|NCT00265395|699813|P2|Overall Study|Adverse Event|6
209759|NCT00265395|699814|P1|Overall Study|Adverse Event|3
209760|NCT00265382|699819|P1|Overall Study|Death|1
209761|NCT00265382|699819|P1|Overall Study|Study terminated by sponsor|94
209762|NCT00265382|699819|P1|Overall Study|Withdrawal by Subject|13
209763|NCT00265382|699819|P1|Overall Study|Miscellaneous|6
209764|NCT00265382|699819|P1|Overall Study|Lack of Efficacy|6
209765|NCT00265382|699819|P1|Overall Study|Lost to Follow-up|3
209766|NCT00265382|699819|P1|Overall Study|Laboratory Abnormality|1
209767|NCT00265382|699819|P1|Overall Study|Adverse Event|21
209768|NCT00265343|699839|P2|Overall Study|Other|3
209769|NCT00265343|699840|P1|Overall Study|Other|8
209770|NCT00265343|699839|P2|Overall Study|Withdrawal by Subject|9
209771|NCT00265343|699840|P1|Overall Study|Withdrawal by Subject|3
209772|NCT00265343|699839|P2|Overall Study|Adverse Event|7
209773|NCT00265343|699840|P1|Overall Study|Adverse Event|10
209774|NCT00265330|699848|P1|Overall Study|Protocol Violation|1
209775|NCT00265330|699848|P1|Overall Study|Withdrew Consent|1
209776|NCT00265330|699848|P1|Overall Study|Principal Investigators Request|1
209777|NCT00265330|699848|P1|Overall Study|Site Closed by Sponsor|1
209778|NCT00265330|699848|P1|Overall Study|Discharged from Unit for Long Term Care|1
209779|NCT00265330|699848|P1|Overall Study|Began Taking Formulary Geodon|1
209780|NCT00265330|699848|P1|Overall Study|Family Scheduling Conflicts|1
209781|NCT00265330|699848|P1|Overall Study|Lack of Efficacy|4
209782|NCT00265330|699848|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
209783|NCT00265330|699848|P1|Overall Study|Withdrawal by Subject|34
209784|NCT00265330|699848|P1|Overall Study|Lost to Follow-up|8
209785|NCT00265330|699848|P1|Overall Study|Adverse Event|41
209786|NCT00265317|699874|P4|Phase 2|Other|1
209787|NCT00265317|699875|P3|Phase 2|Other|1
209788|NCT00265317|699876|P2|Phase 2|Other|0
209789|NCT00265317|699877|P1|Phase 2|Other|0
209790|NCT00265317|699874|P4|Phase 2|Study terminated by sponsor|0
209791|NCT00265317|699875|P3|Phase 2|Study terminated by sponsor|1
209792|NCT00265317|699876|P2|Phase 2|Study terminated by sponsor|0
209793|NCT00265317|699877|P1|Phase 2|Study terminated by sponsor|0
209794|NCT00265317|699874|P4|Phase 2|Withdrawal/other than adverse event|1
209795|NCT00265317|699875|P3|Phase 2|Withdrawal/other than adverse event|2
209796|NCT00265317|699876|P2|Phase 2|Withdrawal/other than adverse event|0
209797|NCT00265317|699877|P1|Phase 2|Withdrawal/other than adverse event|0
209798|NCT00265317|699874|P4|Phase 2|Lost to Follow-up|1
209799|NCT00265317|699875|P3|Phase 2|Lost to Follow-up|0
209800|NCT00265317|699876|P2|Phase 2|Lost to Follow-up|0
209801|NCT00265317|699877|P1|Phase 2|Lost to Follow-up|0
209802|NCT00265317|699874|P4|Phase 2|Protocol Violation|4
209803|NCT00265317|699875|P3|Phase 2|Protocol Violation|1
209804|NCT00265317|699876|P2|Phase 2|Protocol Violation|0
209805|NCT00265317|699877|P1|Phase 2|Protocol Violation|0
209806|NCT00265317|699874|P4|Phase 2|Death|15
209807|NCT00265317|699875|P3|Phase 2|Death|12
209808|NCT00265317|699876|P2|Phase 2|Death|0
209809|NCT00265317|699877|P1|Phase 2|Death|0
209810|NCT00265317|699874|P4|Phase 2|Adverse Event|5
209811|NCT00265317|699875|P3|Phase 2|Adverse Event|7
209812|NCT00265317|699876|P2|Phase 2|Adverse Event|0
209813|NCT00265317|699877|P1|Phase 2|Adverse Event|0
209814|NCT00265317|699874|P4|Phase 2|Global deterioration of health status|0
209815|NCT00265317|699875|P3|Phase 2|Global deterioration of health status|3
209816|NCT00265317|699876|P2|Phase 2|Global deterioration of health status|0
209817|NCT00265317|699877|P1|Phase 2|Global deterioration of health status|0
209818|NCT00265317|699874|P4|Phase 2|Objective progression or relapse|38
209819|NCT00265317|699875|P3|Phase 2|Objective progression or relapse|37
209820|NCT00265317|699876|P2|Phase 2|Objective progression or relapse|0
209821|NCT00265317|699877|P1|Phase 2|Objective progression or relapse|0
209822|NCT00265317|699874|P4|Lead-In|Withdrawal/other than adverse event|0
209823|NCT00265317|699875|P3|Lead-In|Withdrawal/other than adverse event|0
209824|NCT00265317|699876|P2|Lead-In|Withdrawal/other than adverse event|0
209825|NCT00265317|699877|P1|Lead-In|Withdrawal/other than adverse event|1
209826|NCT00265317|699874|P4|Lead-In|Death|0
209827|NCT00265317|699875|P3|Lead-In|Death|0
209828|NCT00265317|699876|P2|Lead-In|Death|5
209829|NCT00265317|699877|P1|Lead-In|Death|3
209830|NCT00265317|699874|P4|Lead-In|Adverse Event|0
209831|NCT00265317|699875|P3|Lead-In|Adverse Event|0
209832|NCT00265317|699876|P2|Lead-In|Adverse Event|1
209833|NCT00265317|699877|P1|Lead-In|Adverse Event|2
209834|NCT00265317|699874|P4|Lead-In|Objective progression or relapse|0
209835|NCT00265317|699875|P3|Lead-In|Objective progression or relapse|0
209836|NCT00265317|699876|P2|Lead-In|Objective progression or relapse|11
209837|NCT00265317|699877|P1|Lead-In|Objective progression or relapse|6
209838|NCT00265239|699992|P2|Overall Study|Adverse Event|1
209839|NCT00265239|699993|P1|Overall Study|Adverse Event|2
209840|NCT00265122|700015|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
209841|NCT00265122|700016|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
209842|NCT00265122|700017|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
209843|NCT00265122|700018|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
209844|NCT00265122|700019|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
209845|NCT00265122|700020|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
209846|NCT00265122|700015|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
209847|NCT00265122|700016|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
209848|NCT00265122|700017|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
209849|NCT00265122|700018|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
209850|NCT00265122|700019|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
209851|NCT00265122|700020|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
209852|NCT00265122|700015|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
209853|NCT00265122|700016|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
209854|NCT00265122|700017|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
209855|NCT00265122|700018|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
209856|NCT00265122|700019|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
209857|NCT00265122|700020|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
209858|NCT00265122|700015|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
209859|NCT00265122|700016|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
209860|NCT00265122|700017|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
209861|NCT00265122|700018|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
209862|NCT00265122|700019|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
209863|NCT00265122|700020|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
209864|NCT00265122|700015|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
209865|NCT00265122|700016|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
209866|NCT00265122|700017|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
209867|NCT00265122|700018|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
209868|NCT00265122|700019|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
209869|NCT00265122|700020|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
209870|NCT00265122|700015|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
209871|NCT00265122|700016|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
209872|NCT00265122|700017|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
209873|NCT00265122|700018|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
209874|NCT00265122|700019|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
209875|NCT00265122|700020|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
209876|NCT00265109|700042|P1|Overall Study|Adverse Event|1
209877|NCT00265109|700042|P1|Overall Study|Withdrawal by Subject|5
209878|NCT00265096|700049|P3|Overall Study|Not Specified|10
209879|NCT00265096|700050|P2|Overall Study|Not Specified|19
209880|NCT00265096|700051|P1|Overall Study|Not Specified|11
209881|NCT00265096|700049|P3|Overall Study|Unsatisfactory therapeutic effect|6
209882|NCT00265096|700050|P2|Overall Study|Unsatisfactory therapeutic effect|8
209883|NCT00265096|700051|P1|Overall Study|Unsatisfactory therapeutic effect|9
209884|NCT00265096|700049|P3|Overall Study|Death|2
209885|NCT00265096|700050|P2|Overall Study|Death|1
209886|NCT00265096|700051|P1|Overall Study|Death|0
209887|NCT00265096|700049|P3|Overall Study|Lost to Follow-up|3
209888|NCT00265096|700050|P2|Overall Study|Lost to Follow-up|5
209889|NCT00265096|700051|P1|Overall Study|Lost to Follow-up|2
209890|NCT00265096|700049|P3|Overall Study|Adverse Event|18
209891|NCT00265096|700050|P2|Overall Study|Adverse Event|18
209892|NCT00265096|700051|P1|Overall Study|Adverse Event|14
209893|NCT00265083|700083|P3|Overall Study|Not specified|9
209894|NCT00265083|700084|P2|Overall Study|Not specified|12
209895|NCT00265083|700085|P1|Overall Study|Not specified|1
209896|NCT00265083|700083|P3|Overall Study|Unsatisfactory therapeutic effect|14
209897|NCT00265083|700084|P2|Overall Study|Unsatisfactory therapeutic effect|13
209898|NCT00265083|700085|P1|Overall Study|Unsatisfactory therapeutic effect|8
209899|NCT00265083|700083|P3|Overall Study|Lost to Follow-up|4
209900|NCT00265083|700084|P2|Overall Study|Lost to Follow-up|4
209901|NCT00265083|700085|P1|Overall Study|Lost to Follow-up|3
209902|NCT00265083|700083|P3|Overall Study|Adverse Event|15
209903|NCT00265083|700084|P2|Overall Study|Adverse Event|13
209904|NCT00265083|700085|P1|Overall Study|Adverse Event|5
209905|NCT00264875|700106|P1|Overall Study|Withdrawal by Subject|7
209906|NCT00264875|700106|P1|Overall Study|Protocol Violation|11
209907|NCT00264875|700106|P1|Overall Study|Lost to Follow-up|6
209908|NCT00264875|700106|P1|Overall Study|Adverse Event|6
209909|NCT00264849|700112|P2|Overall Study|Administrative Problems|0
209910|NCT00264849|700113|P1|Overall Study|Administrative Problems|2
209911|NCT00264849|700112|P2|Overall Study|Death|1
209912|NCT00264849|700113|P1|Overall Study|Death|0
209913|NCT00264849|700112|P2|Overall Study|Lost to Follow-up|2
209914|NCT00264849|700113|P1|Overall Study|Lost to Follow-up|0
209915|NCT00264849|700112|P2|Overall Study|Lack of Efficacy|6
209916|NCT00264849|700113|P1|Overall Study|Lack of Efficacy|1
209917|NCT00264849|700112|P2|Overall Study|Protocol Violation|3
209918|NCT00264849|700113|P1|Overall Study|Protocol Violation|5
209919|NCT00264849|700112|P2|Overall Study|Withdrawal by Subject|11
209920|NCT00264849|700113|P1|Overall Study|Withdrawal by Subject|7
209921|NCT00264849|700112|P2|Overall Study|Adverse Event|2
209922|NCT00264849|700113|P1|Overall Study|Adverse Event|7
209923|NCT00264810|700149|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
209924|NCT00264810|700150|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
209925|NCT00264810|700149|P2|Open Label Evaluation Period|Death|2
209926|NCT00264810|700150|P1|Open Label Evaluation Period|Death|3
209927|NCT00264810|700149|P2|Open Label Evaluation Period|Explant due to infection|1
209928|NCT00264810|700150|P1|Open Label Evaluation Period|Explant due to infection|1
209929|NCT00264810|700149|P2|Blinded Evaluation Period|Explant due to infection|1
209930|NCT00264810|700150|P1|Blinded Evaluation Period|Explant due to infection|1
209931|NCT00264810|700149|P2|Stimulation Optimization Period|Death|1
209932|NCT00264810|700150|P1|Stimulation Optimization Period|Death|0
209933|NCT00264810|700149|P2|Stimulation Optimization Period|Withdrawal by Subject|0
209934|NCT00264810|700150|P1|Stimulation Optimization Period|Withdrawal by Subject|1
209935|NCT00264810|700149|P2|Baseline|Other|1
209936|NCT00264810|700150|P1|Baseline|Other|0
209937|NCT00264810|700149|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
209938|NCT00264810|700150|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
209939|NCT00264810|700149|P2|Baseline|Insufficient Seizure Frequency|2
209940|NCT00264810|700150|P1|Baseline|Insufficient Seizure Frequency|2
209941|NCT00264810|700149|P2|Baseline|Subject Compliance Failure|3
209942|NCT00264810|700150|P1|Baseline|Subject Compliance Failure|3
209943|NCT00264810|700149|P2|Baseline|Physician Decision|8
209944|NCT00264810|700150|P1|Baseline|Physician Decision|7
209945|NCT00264810|700149|P2|Baseline|Withdrawal by Subject|10
209946|NCT00264810|700150|P1|Baseline|Withdrawal by Subject|10
209947|NCT00264797|700160|P2|Overall Study|Other|4
209948|NCT00264797|700161|P1|Overall Study|Other|3
209949|NCT00264797|700160|P2|Overall Study|Feels treatment not necessary, not worki|1
209950|NCT00264797|700161|P1|Overall Study|Feels treatment not necessary, not worki|0
209951|NCT00264797|700160|P2|Overall Study|Pressure/advice from Outsiders|1
209952|NCT00264797|700161|P1|Overall Study|Pressure/advice from Outsiders|1
209953|NCT00264797|700160|P2|Overall Study|Incarceration|5
209954|NCT00264797|700161|P1|Overall Study|Incarceration|4
209955|NCT00264797|700160|P2|Overall Study|Practical Problems|3
209956|NCT00264797|700161|P1|Overall Study|Practical Problems|2
209957|NCT00264797|700160|P2|Overall Study|Moved from area|1
209958|NCT00264797|700161|P1|Overall Study|Moved from area|3
209959|NCT00264797|700160|P2|Overall Study|Lost to Follow-up|17
209960|NCT00264797|700161|P1|Overall Study|Lost to Follow-up|9
209961|NCT00264797|700160|P2|Overall Study|Withdrawal by Subject|11
209962|NCT00264797|700161|P1|Overall Study|Withdrawal by Subject|11
209963|NCT00264576|700183|P2|Overall Study|Lost to Follow-up|1
209964|NCT00264576|700184|P1|Overall Study|Lost to Follow-up|1
209965|NCT00264550|700208|P4|Overall Study|Not specified|9
209966|NCT00264550|700209|P3|Overall Study|Not specified|3
209967|NCT00264550|700210|P2|Overall Study|Not specified|7
209968|NCT00264550|700211|P1|Overall Study|Not specified|13
209969|NCT00264550|700208|P4|Overall Study|Discontinued oral study agent|0
209970|NCT00264550|700209|P3|Overall Study|Discontinued oral study agent|0
209971|NCT00264550|700210|P2|Overall Study|Discontinued oral study agent|1
209972|NCT00264550|700211|P1|Overall Study|Discontinued oral study agent|0
209973|NCT00264550|700208|P4|Overall Study|Unsatisfactory therapeutic effect|6
209974|NCT00264550|700209|P3|Overall Study|Unsatisfactory therapeutic effect|4
209975|NCT00264550|700210|P2|Overall Study|Unsatisfactory therapeutic effect|11
209976|NCT00264550|700211|P1|Overall Study|Unsatisfactory therapeutic effect|4
209977|NCT00264550|700208|P4|Overall Study|Adverse Event|14
209978|NCT00264550|700209|P3|Overall Study|Adverse Event|9
209979|NCT00264550|700210|P2|Overall Study|Adverse Event|18
209980|NCT00264550|700211|P1|Overall Study|Adverse Event|23
209981|NCT00264550|700208|P4|Overall Study|Lost to Follow-up|1
209982|NCT00264550|700209|P3|Overall Study|Lost to Follow-up|1
209983|NCT00264550|700210|P2|Overall Study|Lost to Follow-up|1
209984|NCT00264550|700211|P1|Overall Study|Lost to Follow-up|3
209985|NCT00264550|700208|P4|Overall Study|Death|0
209986|NCT00264550|700209|P3|Overall Study|Death|0
209987|NCT00264550|700210|P2|Overall Study|Death|3
209988|NCT00264550|700211|P1|Overall Study|Death|0
209989|NCT00264537|700250|P4|Overall Study|Not treated|0
209990|NCT00264537|700251|P3|Overall Study|Not treated|1
209991|NCT00264537|700252|P2|Overall Study|Not treated|2
209992|NCT00264537|700253|P1|Overall Study|Not treated|0
209993|NCT00264537|700250|P4|Overall Study|Not specified|11
209994|NCT00264537|700251|P3|Overall Study|Not specified|10
209995|NCT00264537|700252|P2|Overall Study|Not specified|11
209996|NCT00264537|700253|P1|Overall Study|Not specified|21
209997|NCT00264537|700250|P4|Overall Study|Unsatisfactory therapeutic effect|7
209998|NCT00264537|700251|P3|Overall Study|Unsatisfactory therapeutic effect|5
209999|NCT00264537|700252|P2|Overall Study|Unsatisfactory therapeutic effect|6
210000|NCT00264537|700253|P1|Overall Study|Unsatisfactory therapeutic effect|5
210001|NCT00264537|700250|P4|Overall Study|Adverse Event|34
210002|NCT00264537|700251|P3|Overall Study|Adverse Event|24
210003|NCT00264537|700252|P2|Overall Study|Adverse Event|32
210004|NCT00264537|700253|P1|Overall Study|Adverse Event|21
210005|NCT00264537|700250|P4|Overall Study|Lost to Follow-up|6
210006|NCT00264537|700251|P3|Overall Study|Lost to Follow-up|7
210007|NCT00264537|700252|P2|Overall Study|Lost to Follow-up|4
210008|NCT00264537|700253|P1|Overall Study|Lost to Follow-up|3
210009|NCT00264537|700250|P4|Overall Study|Death|2
210010|NCT00264537|700251|P3|Overall Study|Death|3
210011|NCT00264537|700252|P2|Overall Study|Death|3
210012|NCT00264537|700253|P1|Overall Study|Death|0
210013|NCT00264498|700285|P2|Crossover Treatment|Withdrawal by Subject|0
210014|NCT00264498|700286|P1|Crossover Treatment|Withdrawal by Subject|1
210015|NCT00264498|700285|P2|Crossover Treatment|Study closure|1
210016|NCT00264498|700286|P1|Crossover Treatment|Study closure|0
210017|NCT00264498|700285|P2|Crossover Treatment|Objective disease progression|5
210018|NCT00264498|700286|P1|Crossover Treatment|Objective disease progression|4
210019|NCT00264498|700285|P2|Crossover Treatment|Death|3
210020|NCT00264498|700286|P1|Crossover Treatment|Death|1
210021|NCT00264498|700285|P2|Randomized Treatment|Protocol Violation|0
210022|NCT00264498|700286|P1|Randomized Treatment|Protocol Violation|1
210023|NCT00264498|700285|P2|Randomized Treatment|Study Closure|0
210024|NCT00264498|700286|P1|Randomized Treatment|Study Closure|1
210025|NCT00264498|700285|P2|Randomized Treatment|Incorrectly randomized|0
210026|NCT00264498|700286|P1|Randomized Treatment|Incorrectly randomized|1
210027|NCT00264498|700285|P2|Randomized Treatment|Physician Decision|0
210028|NCT00264498|700286|P1|Randomized Treatment|Physician Decision|1
210029|NCT00264498|700285|P2|Randomized Treatment|Objective disease Progression|14
210030|NCT00264498|700286|P1|Randomized Treatment|Objective disease Progression|13
210031|NCT00264498|700285|P2|Randomized Treatment|Withdrawal by Subject|1
210032|NCT00264498|700286|P1|Randomized Treatment|Withdrawal by Subject|0
210033|NCT00264498|700285|P2|Randomized Treatment|Death|3
210034|NCT00264498|700286|P1|Randomized Treatment|Death|0
210035|NCT00264303|700309|P2|Overall Study|Various reasons listed in study report|7
210036|NCT00264303|700310|P1|Overall Study|Various reasons listed in study report|6
210037|NCT00264303|700309|P2|Overall Study|Withdrawal by Subject|3
210038|NCT00264303|700310|P1|Overall Study|Withdrawal by Subject|2
210039|NCT00264303|700309|P2|Overall Study|Lost to Follow-up|3
210040|NCT00264303|700310|P1|Overall Study|Lost to Follow-up|3
210041|NCT00264303|700309|P2|Overall Study|Lack of Efficacy|13
210042|NCT00264303|700310|P1|Overall Study|Lack of Efficacy|10
210043|NCT00264303|700309|P2|Overall Study|Adverse Event|3
210044|NCT00264303|700310|P1|Overall Study|Adverse Event|4
210045|NCT00264290|700328|P2|Intervention (8 Weeks)|Adverse Event|0
210046|NCT00264290|700329|P1|Intervention (8 Weeks)|Adverse Event|1
210047|NCT00264238|700335|P1|Overall Study|Protocol Violation|1
210048|NCT00264147|700347|P6|Treatment II Period|Pre-scheduled total hip replacement|1
210049|NCT00264147|700348|P5|Treatment II Period|Pre-scheduled total hip replacement|0
210050|NCT00264147|700349|P4|Treatment II Period|Pre-scheduled total hip replacement|0
210051|NCT00264147|700350|P3|Treatment II Period|Pre-scheduled total hip replacement|0
210052|NCT00264147|700351|P2|Treatment II Period|Pre-scheduled total hip replacement|0
210053|NCT00264147|700352|P1|Treatment II Period|Pre-scheduled total hip replacement|0
210054|NCT00264147|700347|P6|Treatment II Period|Withdrawal by Subject|2
210055|NCT00264147|700348|P5|Treatment II Period|Withdrawal by Subject|3
210056|NCT00264147|700349|P4|Treatment II Period|Withdrawal by Subject|0
210057|NCT00264147|700350|P3|Treatment II Period|Withdrawal by Subject|0
210058|NCT00264147|700351|P2|Treatment II Period|Withdrawal by Subject|0
210059|NCT00264147|700352|P1|Treatment II Period|Withdrawal by Subject|0
210060|NCT00264147|700347|P6|Treatment II Period|Lost to Follow-up|1
210061|NCT00264147|700348|P5|Treatment II Period|Lost to Follow-up|1
210062|NCT00264147|700349|P4|Treatment II Period|Lost to Follow-up|0
210063|NCT00264147|700350|P3|Treatment II Period|Lost to Follow-up|0
210064|NCT00264147|700351|P2|Treatment II Period|Lost to Follow-up|0
210065|NCT00264147|700352|P1|Treatment II Period|Lost to Follow-up|0
210066|NCT00264147|700347|P6|Treatment II Period|Lack of Efficacy|19
210067|NCT00264147|700348|P5|Treatment II Period|Lack of Efficacy|20
210068|NCT00264147|700349|P4|Treatment II Period|Lack of Efficacy|0
210069|NCT00264147|700350|P3|Treatment II Period|Lack of Efficacy|0
210070|NCT00264147|700351|P2|Treatment II Period|Lack of Efficacy|0
210071|NCT00264147|700352|P1|Treatment II Period|Lack of Efficacy|0
210072|NCT00264147|700347|P6|Treatment II Period|Laboratory Adverse Event|1
210073|NCT00264147|700348|P5|Treatment II Period|Laboratory Adverse Event|0
210074|NCT00264147|700349|P4|Treatment II Period|Laboratory Adverse Event|0
210075|NCT00264147|700350|P3|Treatment II Period|Laboratory Adverse Event|0
210076|NCT00264147|700351|P2|Treatment II Period|Laboratory Adverse Event|0
210077|NCT00264147|700352|P1|Treatment II Period|Laboratory Adverse Event|0
210078|NCT00264147|700347|P6|Treatment II Period|Adverse Event|9
210079|NCT00264147|700348|P5|Treatment II Period|Adverse Event|9
210080|NCT00264147|700349|P4|Treatment II Period|Adverse Event|0
210081|NCT00264147|700350|P3|Treatment II Period|Adverse Event|0
210082|NCT00264147|700351|P2|Treatment II Period|Adverse Event|0
210083|NCT00264147|700352|P1|Treatment II Period|Adverse Event|0
210084|NCT00264147|700347|P6|Treatment I Period|Reassigned to Treatment II Period|0
210085|NCT00264147|700348|P5|Treatment I Period|Reassigned to Treatment II Period|45
210086|NCT00264147|700349|P4|Treatment I Period|Reassigned to Treatment II Period|63
210087|NCT00264147|700350|P3|Treatment I Period|Reassigned to Treatment II Period|65
210088|NCT00264147|700351|P2|Treatment I Period|Reassigned to Treatment II Period|72
210089|NCT00264147|700352|P1|Treatment I Period|Reassigned to Treatment II Period|84
210090|NCT00264147|700347|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
210091|NCT00264147|700348|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
210092|NCT00264147|700349|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
210093|NCT00264147|700350|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
210094|NCT00264147|700351|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
210095|NCT00264147|700352|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
210096|NCT00264147|700347|P6|Treatment I Period|Patient out of town for an extended time|0
210097|NCT00264147|700348|P5|Treatment I Period|Patient out of town for an extended time|0
210098|NCT00264147|700349|P4|Treatment I Period|Patient out of town for an extended time|0
210099|NCT00264147|700350|P3|Treatment I Period|Patient out of town for an extended time|0
210100|NCT00264147|700351|P2|Treatment I Period|Patient out of town for an extended time|1
210101|NCT00264147|700352|P1|Treatment I Period|Patient out of town for an extended time|0
210102|NCT00264147|700347|P6|Treatment I Period|Withdrawal by Subject|0
210103|NCT00264147|700348|P5|Treatment I Period|Withdrawal by Subject|2
210104|NCT00264147|700349|P4|Treatment I Period|Withdrawal by Subject|2
210105|NCT00264147|700350|P3|Treatment I Period|Withdrawal by Subject|0
210106|NCT00264147|700351|P2|Treatment I Period|Withdrawal by Subject|0
210107|NCT00264147|700352|P1|Treatment I Period|Withdrawal by Subject|2
210108|NCT00264147|700347|P6|Treatment I Period|Protocol Violation|0
210109|NCT00264147|700348|P5|Treatment I Period|Protocol Violation|0
210110|NCT00264147|700349|P4|Treatment I Period|Protocol Violation|0
210111|NCT00264147|700350|P3|Treatment I Period|Protocol Violation|0
210112|NCT00264147|700351|P2|Treatment I Period|Protocol Violation|2
210113|NCT00264147|700352|P1|Treatment I Period|Protocol Violation|2
210114|NCT00264147|700347|P6|Treatment I Period|Lost to Follow-up|0
210115|NCT00264147|700348|P5|Treatment I Period|Lost to Follow-up|1
210116|NCT00264147|700349|P4|Treatment I Period|Lost to Follow-up|1
210117|NCT00264147|700350|P3|Treatment I Period|Lost to Follow-up|0
210118|NCT00264147|700351|P2|Treatment I Period|Lost to Follow-up|0
210119|NCT00264147|700352|P1|Treatment I Period|Lost to Follow-up|1
210120|NCT00264147|700347|P6|Treatment I Period|Lack of Efficacy|0
210121|NCT00264147|700348|P5|Treatment I Period|Lack of Efficacy|1
210122|NCT00264147|700349|P4|Treatment I Period|Lack of Efficacy|0
210123|NCT00264147|700350|P3|Treatment I Period|Lack of Efficacy|8
210124|NCT00264147|700351|P2|Treatment I Period|Lack of Efficacy|2
210125|NCT00264147|700352|P1|Treatment I Period|Lack of Efficacy|6
210126|NCT00264147|700347|P6|Treatment I Period|Laboratory Adverse Event|0
210127|NCT00264147|700348|P5|Treatment I Period|Laboratory Adverse Event|0
210128|NCT00264147|700349|P4|Treatment I Period|Laboratory Adverse Event|1
210129|NCT00264147|700350|P3|Treatment I Period|Laboratory Adverse Event|0
210130|NCT00264147|700351|P2|Treatment I Period|Laboratory Adverse Event|0
210131|NCT00264147|700352|P1|Treatment I Period|Laboratory Adverse Event|0
210132|NCT00264147|700347|P6|Treatment I Period|Adverse Event|0
210133|NCT00264147|700348|P5|Treatment I Period|Adverse Event|7
210134|NCT00264147|700349|P4|Treatment I Period|Adverse Event|5
210135|NCT00264147|700350|P3|Treatment I Period|Adverse Event|3
210136|NCT00264147|700351|P2|Treatment I Period|Adverse Event|6
210137|NCT00264147|700352|P1|Treatment I Period|Adverse Event|3
210138|NCT00264004|700395|P4|Overall Study|Not treated|2
210139|NCT00264004|700396|P3|Overall Study|Not treated|2
210140|NCT00264004|700397|P2|Overall Study|Not treated|0
210141|NCT00264004|700398|P1|Overall Study|Not treated|3
210142|NCT00264004|700395|P4|Overall Study|Cond. under inv. worsened|4
210143|NCT00264004|700396|P3|Overall Study|Cond. under inv. worsened|3
210144|NCT00264004|700397|P2|Overall Study|Cond. under inv. worsened|5
210145|NCT00264004|700398|P1|Overall Study|Cond. under inv. worsened|9
210146|NCT00264004|700395|P4|Overall Study|Development study specific disc. crit.|0
210147|NCT00264004|700396|P3|Overall Study|Development study specific disc. crit.|1
210148|NCT00264004|700397|P2|Overall Study|Development study specific disc. crit.|0
210149|NCT00264004|700398|P1|Overall Study|Development study specific disc. crit.|1
210150|NCT00264004|700395|P4|Overall Study|Not specified|3
210151|NCT00264004|700396|P3|Overall Study|Not specified|0
210152|NCT00264004|700397|P2|Overall Study|Not specified|2
210153|NCT00264004|700398|P1|Overall Study|Not specified|2
210154|NCT00264004|700395|P4|Overall Study|Withdrawal by Subject|2
210155|NCT00264004|700396|P3|Overall Study|Withdrawal by Subject|2
210156|NCT00264004|700397|P2|Overall Study|Withdrawal by Subject|1
210157|NCT00264004|700398|P1|Overall Study|Withdrawal by Subject|0
210158|NCT00264004|700395|P4|Overall Study|Adverse Event|4
210159|NCT00264004|700396|P3|Overall Study|Adverse Event|6
210160|NCT00264004|700397|P2|Overall Study|Adverse Event|3
210161|NCT00264004|700398|P1|Overall Study|Adverse Event|2
210162|NCT00263887|700426|P2|Overall Study|Lack of Efficacy|1
210163|NCT00263887|700427|P1|Overall Study|Lack of Efficacy|0
210164|NCT00263887|700426|P2|Overall Study|Disease progression|1
210165|NCT00263887|700427|P1|Overall Study|Disease progression|0
210166|NCT00263887|700426|P2|Overall Study|Adverse Event|2
210167|NCT00263887|700427|P1|Overall Study|Adverse Event|0
210168|NCT00263887|700426|P2|Overall Study|Too ill to attend visit|0
210169|NCT00263887|700427|P1|Overall Study|Too ill to attend visit|1
210170|NCT00263887|700426|P2|Overall Study|Lung transplantation|2
210171|NCT00263887|700427|P1|Overall Study|Lung transplantation|1
210172|NCT00263887|700426|P2|Overall Study|Withdrawal by Subject|1
210173|NCT00263887|700427|P1|Overall Study|Withdrawal by Subject|1
210174|NCT00263757|700435|P2|Overall Study|Adverse Event|3
210175|NCT00263757|700436|P1|Overall Study|Adverse Event|3
210176|NCT00263757|700435|P2|Overall Study|Screen failure|1
210177|NCT00263757|700436|P1|Overall Study|Screen failure|0
210178|NCT00263757|700435|P2|Overall Study|Withdrawal by Subject|4
210179|NCT00263757|700436|P1|Overall Study|Withdrawal by Subject|5
210180|NCT00263666|700448|P2|Overall Study|Withdrawal by Subject|1
210181|NCT00263666|700449|P1|Overall Study|Withdrawal by Subject|0
210182|NCT00263666|700448|P2|Overall Study|Lost to Follow-up|2
210183|NCT00263666|700449|P1|Overall Study|Lost to Follow-up|1
210184|NCT00263666|700448|P2|Overall Study|Adverse Event|8
210185|NCT00263666|700449|P1|Overall Study|Adverse Event|6
210186|NCT00263328|700503|P3|Overall Study|Adverse Event|4
210187|NCT00263328|700504|P2|Overall Study|Adverse Event|1
210188|NCT00263328|700505|P1|Overall Study|Adverse Event|1
210189|NCT00263328|700503|P3|Overall Study|Not specified|1
210190|NCT00263328|700504|P2|Overall Study|Not specified|0
210191|NCT00263328|700505|P1|Overall Study|Not specified|3
210192|NCT00263328|700503|P3|Overall Study|Withdrawal by Subject|1
210193|NCT00263328|700504|P2|Overall Study|Withdrawal by Subject|0
210194|NCT00263328|700505|P1|Overall Study|Withdrawal by Subject|3
210195|NCT00263328|700503|P3|Overall Study|Lost to Follow-up|0
210196|NCT00263328|700504|P2|Overall Study|Lost to Follow-up|1
210197|NCT00263328|700505|P1|Overall Study|Lost to Follow-up|1
210198|NCT00263328|700503|P3|Overall Study|Death|1
210199|NCT00263328|700504|P2|Overall Study|Death|0
210200|NCT00263328|700505|P1|Overall Study|Death|0
210201|NCT00263211|700663|P2|Overall Study|Disease Progression|1
210202|NCT00263211|700664|P1|Overall Study|Disease Progression|0
210203|NCT00263211|700663|P2|Overall Study|Protocol Violation|0
210204|NCT00263211|700664|P1|Overall Study|Protocol Violation|1
210205|NCT00263211|700663|P2|Overall Study|Withdrawal by Subject|0
210206|NCT00263211|700664|P1|Overall Study|Withdrawal by Subject|3
210207|NCT00263211|700663|P2|Overall Study|Death|0
210208|NCT00263211|700664|P1|Overall Study|Death|1
210209|NCT00262951|700715|P1|Overall Study|Off treatment for other disease|1
210210|NCT00262951|700715|P1|Overall Study|Alternative treatment|3
210211|NCT00262951|700715|P1|Overall Study|Withdrawal by Subject|1
210212|NCT00262951|700715|P1|Overall Study|Death|1
210213|NCT00262951|700715|P1|Overall Study|Adverse Event|7
210214|NCT00262951|700715|P1|Overall Study|Progressive disease/relapse|3
210215|NCT00262925|700720|P1|Overall Study|Other|1
210216|NCT00262925|700720|P1|Overall Study|alternative therapy|1
210217|NCT00262925|700720|P1|Overall Study|Death|2
210218|NCT00262925|700720|P1|Overall Study|Adverse Event|4
210219|NCT00262925|700720|P1|Overall Study|Lack of Efficacy|3
210220|NCT00262873|700726|P1|Overall Study|Withdrawal by Subject|5
210221|NCT00262873|700726|P1|Overall Study|Adverse Event|3
210222|NCT00262860|700737|P1|Overall Study|Adverse Event|2
210223|NCT00262847|700746|P3|Overall Study|Did not receive study treatment|4
210224|NCT00262847|700747|P2|Overall Study|Did not receive study treatment|1
210225|NCT00262847|700748|P1|Overall Study|Did not receive study treatment|4
210226|NCT00262847|700746|P3|Overall Study|Other Reasons|27
210227|NCT00262847|700747|P2|Overall Study|Other Reasons|88
210228|NCT00262847|700748|P1|Overall Study|Other Reasons|79
210229|NCT00262847|700746|P3|Overall Study|Concomitant disease|4
210230|NCT00262847|700747|P2|Overall Study|Concomitant disease|2
210231|NCT00262847|700748|P1|Overall Study|Concomitant disease|3
210232|NCT00262847|700746|P3|Overall Study|Death|11
210233|NCT00262847|700747|P2|Overall Study|Death|8
210234|NCT00262847|700748|P1|Overall Study|Death|8
210235|NCT00262847|700746|P3|Overall Study|Adverse Event|108
210236|NCT00262847|700747|P2|Overall Study|Adverse Event|88
210237|NCT00262847|700748|P1|Overall Study|Adverse Event|74
210238|NCT00262847|700746|P3|Overall Study|Patient Refusal|47
210239|NCT00262847|700747|P2|Overall Study|Patient Refusal|52
210240|NCT00262847|700748|P1|Overall Study|Patient Refusal|41
210241|NCT00262847|700746|P3|Overall Study|Disease Progression|195
210242|NCT00262847|700747|P2|Overall Study|Disease Progression|274
210243|NCT00262847|700748|P1|Overall Study|Disease Progression|309
210244|NCT00262834|700767|P2|Overall Study|Surgery delayed/tissue not collected|4
210245|NCT00262834|700768|P1|Overall Study|Surgery delayed/tissue not collected|1
210246|NCT00262821|700781|P2|Overall Study|Inevaluable - inadequate data|4
210247|NCT00262821|700782|P1|Overall Study|Inevaluable - inadequate data|0
210248|NCT00262821|700781|P2|Overall Study|Ineligible - required test not done|4
210249|NCT00262821|700782|P1|Overall Study|Ineligible - required test not done|1
210250|NCT00262821|700781|P2|Overall Study|Ineligible - elevated creatinine|2
210251|NCT00262821|700782|P1|Overall Study|Ineligible - elevated creatinine|0
210252|NCT00262821|700781|P2|Overall Study|Ineligible - inadequate pathology|3
210253|NCT00262821|700782|P1|Overall Study|Ineligible - inadequate pathology|1
210254|NCT00262821|700781|P2|Overall Study|Ineligible - wrong primary|1
210255|NCT00262821|700782|P1|Overall Study|Ineligible - wrong primary|0
210256|NCT00262821|700781|P2|Overall Study|Ineligible - wrong cell type|2
210257|NCT00262821|700782|P1|Overall Study|Ineligible - wrong cell type|2
210258|NCT00262821|700781|P2|Overall Study|Ineligible - wrong stage|3
210259|NCT00262821|700782|P1|Overall Study|Ineligible - wrong stage|0
210260|NCT00262743|700794|P2|Overall Study|Disease progression|3
210261|NCT00262743|700795|P1|Overall Study|Disease progression|0
210262|NCT00262743|700794|P2|Overall Study|Adverse Event|9
210263|NCT00262743|700795|P1|Overall Study|Adverse Event|0
210264|NCT00262600|700830|P3|Overall Study|Not Specified|62
210265|NCT00262600|700831|P2|Overall Study|Not Specified|59
210266|NCT00262600|700832|P1|Overall Study|Not Specified|58
210267|NCT00262600|700830|P3|Overall Study|Not Treated|24
210268|NCT00262600|700831|P2|Overall Study|Not Treated|17
210269|NCT00262600|700832|P1|Overall Study|Not Treated|32
210270|NCT00262600|700830|P3|Overall Study|Withdrawal by Subject|139
210271|NCT00262600|700831|P2|Overall Study|Withdrawal by Subject|145
210272|NCT00262600|700832|P1|Overall Study|Withdrawal by Subject|128
210273|NCT00262600|700830|P3|Overall Study|Lost to Follow-up|41
210274|NCT00262600|700831|P2|Overall Study|Lost to Follow-up|31
210275|NCT00262600|700832|P1|Overall Study|Lost to Follow-up|17
210276|NCT00262522|700859|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
210277|NCT00262522|700860|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
210278|NCT00262522|700861|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
210279|NCT00262522|700862|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
210280|NCT00262522|700859|P4|Study Start Through 96 Weeks|Virologic failure|0
210281|NCT00262522|700860|P3|Study Start Through 96 Weeks|Virologic failure|8
210282|NCT00262522|700861|P2|Study Start Through 96 Weeks|Virologic failure|0
210283|NCT00262522|700862|P1|Study Start Through 96 Weeks|Virologic failure|5
210284|NCT00262522|700859|P4|Study Start Through 96 Weeks|Death|0
210285|NCT00262522|700860|P3|Study Start Through 96 Weeks|Death|2
210286|NCT00262522|700861|P2|Study Start Through 96 Weeks|Death|0
210287|NCT00262522|700862|P1|Study Start Through 96 Weeks|Death|2
210288|NCT00262522|700859|P4|Study Start Through 96 Weeks|Noncompliance|0
210289|NCT00262522|700860|P3|Study Start Through 96 Weeks|Noncompliance|11
210290|NCT00262522|700861|P2|Study Start Through 96 Weeks|Noncompliance|0
210291|NCT00262522|700862|P1|Study Start Through 96 Weeks|Noncompliance|6
210292|NCT00262522|700859|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
210293|NCT00262522|700860|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
210294|NCT00262522|700861|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
210295|NCT00262522|700862|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
210296|NCT00262522|700859|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
210297|NCT00262522|700860|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
210298|NCT00262522|700861|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
210299|NCT00262522|700862|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
210300|NCT00262522|700859|P4|Study Start Through 96 Weeks|Adverse Event|0
210301|NCT00262522|700860|P3|Study Start Through 96 Weeks|Adverse Event|16
210302|NCT00262522|700861|P2|Study Start Through 96 Weeks|Adverse Event|0
210303|NCT00262522|700862|P1|Study Start Through 96 Weeks|Adverse Event|20
210304|NCT00262522|700859|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
210305|NCT00262522|700860|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
210306|NCT00262522|700861|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
210307|NCT00262522|700862|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
210308|NCT00262522|700859|P4|Study Start Through 48 Weeks|Virologic failure|0
210309|NCT00262522|700860|P3|Study Start Through 48 Weeks|Virologic failure|4
210310|NCT00262522|700861|P2|Study Start Through 48 Weeks|Virologic failure|0
210311|NCT00262522|700862|P1|Study Start Through 48 Weeks|Virologic failure|2
210312|NCT00262522|700859|P4|Study Start Through 48 Weeks|Death|0
210313|NCT00262522|700860|P3|Study Start Through 48 Weeks|Death|1
210314|NCT00262522|700861|P2|Study Start Through 48 Weeks|Death|0
210315|NCT00262522|700862|P1|Study Start Through 48 Weeks|Death|2
210316|NCT00262522|700859|P4|Study Start Through 48 Weeks|Noncompliance|0
210317|NCT00262522|700860|P3|Study Start Through 48 Weeks|Noncompliance|8
210318|NCT00262522|700861|P2|Study Start Through 48 Weeks|Noncompliance|0
210319|NCT00262522|700862|P1|Study Start Through 48 Weeks|Noncompliance|3
210320|NCT00262522|700859|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
210321|NCT00262522|700860|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
210322|NCT00262522|700861|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
210323|NCT00262522|700862|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
210324|NCT00262522|700859|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
210325|NCT00262522|700860|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
210326|NCT00262522|700861|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
210327|NCT00262522|700862|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
210328|NCT00262522|700859|P4|Study Start Through 48 Weeks|Adverse Event|0
210329|NCT00262522|700860|P3|Study Start Through 48 Weeks|Adverse Event|10
210330|NCT00262522|700861|P2|Study Start Through 48 Weeks|Adverse Event|0
210331|NCT00262522|700862|P1|Study Start Through 48 Weeks|Adverse Event|16
210332|NCT00262522|700859|P4|Study Start Through 8 Weeks|Death|0
210333|NCT00262522|700860|P3|Study Start Through 8 Weeks|Death|0
210334|NCT00262522|700861|P2|Study Start Through 8 Weeks|Death|0
210335|NCT00262522|700862|P1|Study Start Through 8 Weeks|Death|1
210336|NCT00262522|700859|P4|Study Start Through 8 Weeks|Noncompliance|2
210337|NCT00262522|700860|P3|Study Start Through 8 Weeks|Noncompliance|2
210338|NCT00262522|700861|P2|Study Start Through 8 Weeks|Noncompliance|0
210339|NCT00262522|700862|P1|Study Start Through 8 Weeks|Noncompliance|0
210340|NCT00262522|700859|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
210341|NCT00262522|700860|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
210342|NCT00262522|700861|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
210343|NCT00262522|700862|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
210344|NCT00262522|700859|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
210345|NCT00262522|700860|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
210346|NCT00262522|700861|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
210347|NCT00262522|700862|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
210348|NCT00262522|700859|P4|Study Start Through 8 Weeks|Adverse Event|1
210349|NCT00262522|700860|P3|Study Start Through 8 Weeks|Adverse Event|3
210350|NCT00262522|700861|P2|Study Start Through 8 Weeks|Adverse Event|2
210351|NCT00262522|700862|P1|Study Start Through 8 Weeks|Adverse Event|1
210352|NCT00262314|700891|P1|Overall Study|Administrative withdrawal|30
210353|NCT00262314|700891|P1|Overall Study|Lost to Follow-up|70
210354|NCT00262314|700891|P1|Overall Study|Not specified|95
210355|NCT00262314|700891|P1|Overall Study|Patient's decision|92
210356|NCT00262314|700891|P1|Overall Study|Death|12
210357|NCT00262314|700891|P1|Overall Study|Changing physicians|38
210358|NCT00262301|700909|P3|Double-blind Phase|"worsening of HAE symptoms"|0
210359|NCT00262301|700910|P2|Double-blind Phase|"worsening of HAE symptoms"|1
210360|NCT00262301|700911|P1|Double-blind Phase|"worsening of HAE symptoms"|0
210361|NCT00262301|700909|P3|Double-blind Phase|Lost to Follow-up|0
210362|NCT00262301|700910|P2|Double-blind Phase|Lost to Follow-up|0
210363|NCT00262301|700911|P1|Double-blind Phase|Lost to Follow-up|1
210364|NCT00262223|700924|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
210365|NCT00262223|700925|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
210366|NCT00262223|700924|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
210367|NCT00262223|700925|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
210368|NCT00262223|700924|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
210369|NCT00262223|700925|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
210370|NCT00262223|700924|P2|Treatment Phase|Adverse Event|2
210371|NCT00262223|700925|P1|Treatment Phase|Adverse Event|1
210372|NCT00262223|700924|P2|Treatment Phase|Withdrawal by Subject|6
210373|NCT00262223|700925|P1|Treatment Phase|Withdrawal by Subject|3
210374|NCT00262119|700936|P3|Overall Study|Death|16
210375|NCT00262119|700937|P2|Overall Study|Death|19
210376|NCT00262119|700938|P1|Overall Study|Death|20
210377|NCT00262119|700936|P3|Overall Study|Lost to Follow-up|42
210378|NCT00262119|700937|P2|Overall Study|Lost to Follow-up|51
210379|NCT00262119|700938|P1|Overall Study|Lost to Follow-up|38
210380|NCT00262080|700958|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
210381|NCT00262080|700959|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
210382|NCT00262080|700960|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
210383|NCT00262080|700958|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
210384|NCT00262080|700959|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
210385|NCT00262080|700960|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
210386|NCT00262080|700958|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
210387|NCT00262080|700959|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
210388|NCT00262080|700960|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
210389|NCT00262080|700958|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
210390|NCT00262080|700959|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
210391|NCT00262080|700960|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
210392|NCT00262080|700958|P3|Repeat Dose Treatment Period|Adverse Event|0
210393|NCT00262080|700959|P2|Repeat Dose Treatment Period|Adverse Event|0
210394|NCT00262080|700960|P1|Repeat Dose Treatment Period|Adverse Event|1
210395|NCT00262080|700958|P3|Double Blind Treatment Period|Lost to Follow-up|0
210396|NCT00262080|700959|P2|Double Blind Treatment Period|Lost to Follow-up|0
210397|NCT00262080|700960|P1|Double Blind Treatment Period|Lost to Follow-up|1
210398|NCT00262067|700980|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
210399|NCT00262067|700981|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
210400|NCT00262067|700982|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
210401|NCT00262067|700983|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
210402|NCT00262067|700980|P4|Overall Study|Sponsor's Decision to Terminate Study|0
210403|NCT00262067|700981|P3|Overall Study|Sponsor's Decision to Terminate Study|0
210404|NCT00262067|700982|P2|Overall Study|Sponsor's Decision to Terminate Study|0
210405|NCT00262067|700983|P1|Overall Study|Sponsor's Decision to Terminate Study|1
210406|NCT00262067|700980|P4|Overall Study|Lost to Follow-up|5
210407|NCT00262067|700981|P3|Overall Study|Lost to Follow-up|7
210408|NCT00262067|700982|P2|Overall Study|Lost to Follow-up|4
210409|NCT00262067|700983|P1|Overall Study|Lost to Follow-up|5
210410|NCT00262067|700980|P4|Overall Study|Death|99
210411|NCT00262067|700981|P3|Overall Study|Death|186
210412|NCT00262067|700982|P2|Overall Study|Death|89
210413|NCT00262067|700983|P1|Overall Study|Death|190
210414|NCT00262041|701017|P3|Overall Study|Unable to classify|0
210415|NCT00262041|701018|P2|Overall Study|Unable to classify|0
210416|NCT00262041|701019|P1|Overall Study|Unable to classify|1
210417|NCT00262041|701017|P3|Overall Study|Lost to Follow-up|5
210418|NCT00262041|701018|P2|Overall Study|Lost to Follow-up|1
210419|NCT00262041|701019|P1|Overall Study|Lost to Follow-up|1
210420|NCT00262041|701017|P3|Overall Study|Withdrawal by Subject|1
210421|NCT00262041|701018|P2|Overall Study|Withdrawal by Subject|3
210422|NCT00262041|701019|P1|Overall Study|Withdrawal by Subject|0
210423|NCT00262028|701048|P9|Overall Study|Unable to classify|1
210424|NCT00262028|701049|P8|Overall Study|Unable to classify|0
210425|NCT00262028|701050|P7|Overall Study|Unable to classify|0
210426|NCT00262028|701051|P6|Overall Study|Unable to classify|0
210427|NCT00262028|701052|P5|Overall Study|Unable to classify|0
210428|NCT00262028|701053|P4|Overall Study|Unable to classify|0
210429|NCT00262028|701054|P3|Overall Study|Unable to classify|0
210430|NCT00262028|701055|P2|Overall Study|Unable to classify|3
210431|NCT00262028|701056|P1|Overall Study|Unable to classify|0
210432|NCT00262028|701048|P9|Overall Study|Protocol Violation|0
210433|NCT00262028|701049|P8|Overall Study|Protocol Violation|0
210434|NCT00262028|701050|P7|Overall Study|Protocol Violation|0
210435|NCT00262028|701051|P6|Overall Study|Protocol Violation|0
210436|NCT00262028|701052|P5|Overall Study|Protocol Violation|0
210437|NCT00262028|701053|P4|Overall Study|Protocol Violation|1
210438|NCT00262028|701054|P3|Overall Study|Protocol Violation|0
210439|NCT00262028|701055|P2|Overall Study|Protocol Violation|0
210440|NCT00262028|701056|P1|Overall Study|Protocol Violation|0
210441|NCT00262028|701048|P9|Overall Study|Administrative Reason|10
210442|NCT00262028|701049|P8|Overall Study|Administrative Reason|6
210443|NCT00262028|701050|P7|Overall Study|Administrative Reason|4
210444|NCT00262028|701051|P6|Overall Study|Administrative Reason|7
210445|NCT00262028|701052|P5|Overall Study|Administrative Reason|6
210446|NCT00262028|701053|P4|Overall Study|Administrative Reason|12
210447|NCT00262028|701054|P3|Overall Study|Administrative Reason|9
210448|NCT00262028|701055|P2|Overall Study|Administrative Reason|14
210449|NCT00262028|701056|P1|Overall Study|Administrative Reason|11
210450|NCT00262028|701048|P9|Overall Study|Lost to Follow-up|6
210451|NCT00262028|701049|P8|Overall Study|Lost to Follow-up|5
210452|NCT00262028|701050|P7|Overall Study|Lost to Follow-up|3
210453|NCT00262028|701051|P6|Overall Study|Lost to Follow-up|3
210454|NCT00262028|701052|P5|Overall Study|Lost to Follow-up|4
210455|NCT00262028|701053|P4|Overall Study|Lost to Follow-up|5
210456|NCT00262028|701054|P3|Overall Study|Lost to Follow-up|5
210457|NCT00262028|701055|P2|Overall Study|Lost to Follow-up|7
210458|NCT00262028|701056|P1|Overall Study|Lost to Follow-up|7
210459|NCT00262028|701048|P9|Overall Study|Withdrawal by Subject|2
210460|NCT00262028|701049|P8|Overall Study|Withdrawal by Subject|7
210461|NCT00262028|701050|P7|Overall Study|Withdrawal by Subject|5
210462|NCT00262028|701051|P6|Overall Study|Withdrawal by Subject|3
210463|NCT00262028|701052|P5|Overall Study|Withdrawal by Subject|2
210464|NCT00262028|701053|P4|Overall Study|Withdrawal by Subject|5
210465|NCT00262028|701054|P3|Overall Study|Withdrawal by Subject|6
210466|NCT00262028|701055|P2|Overall Study|Withdrawal by Subject|3
210467|NCT00262028|701056|P1|Overall Study|Withdrawal by Subject|6
210468|NCT00262002|701118|P7|Overall Study|Unable to classify|2
210469|NCT00262002|701119|P6|Overall Study|Unable to classify|0
210470|NCT00262002|701120|P5|Overall Study|Unable to classify|0
210471|NCT00262002|701121|P4|Overall Study|Unable to classify|0
210472|NCT00262002|701122|P3|Overall Study|Unable to classify|0
210473|NCT00262002|701123|P2|Overall Study|Unable to classify|0
210474|NCT00262002|701124|P1|Overall Study|Unable to classify|0
210475|NCT00262002|701118|P7|Overall Study|Protocol Violation|2
210476|NCT00262002|701119|P6|Overall Study|Protocol Violation|3
210477|NCT00262002|701120|P5|Overall Study|Protocol Violation|5
210478|NCT00262002|701121|P4|Overall Study|Protocol Violation|2
210479|NCT00262002|701122|P3|Overall Study|Protocol Violation|0
210480|NCT00262002|701123|P2|Overall Study|Protocol Violation|2
210481|NCT00262002|701124|P1|Overall Study|Protocol Violation|3
210482|NCT00262002|701118|P7|Overall Study|Inapropriate enrollment|0
210483|NCT00262002|701119|P6|Overall Study|Inapropriate enrollment|0
210484|NCT00262002|701120|P5|Overall Study|Inapropriate enrollment|0
210485|NCT00262002|701121|P4|Overall Study|Inapropriate enrollment|0
210486|NCT00262002|701122|P3|Overall Study|Inapropriate enrollment|0
210487|NCT00262002|701123|P2|Overall Study|Inapropriate enrollment|1
210488|NCT00262002|701124|P1|Overall Study|Inapropriate enrollment|0
210489|NCT00262002|701118|P7|Overall Study|Lost to Follow-up|0
210490|NCT00262002|701119|P6|Overall Study|Lost to Follow-up|1
210491|NCT00262002|701120|P5|Overall Study|Lost to Follow-up|0
210492|NCT00262002|701121|P4|Overall Study|Lost to Follow-up|2
210493|NCT00262002|701122|P3|Overall Study|Lost to Follow-up|0
210494|NCT00262002|701123|P2|Overall Study|Lost to Follow-up|0
210495|NCT00262002|701124|P1|Overall Study|Lost to Follow-up|2
210496|NCT00262002|701118|P7|Overall Study|Withdrawal by Subject|2
210497|NCT00262002|701119|P6|Overall Study|Withdrawal by Subject|2
210498|NCT00262002|701120|P5|Overall Study|Withdrawal by Subject|2
210499|NCT00262002|701121|P4|Overall Study|Withdrawal by Subject|1
210500|NCT00262002|701122|P3|Overall Study|Withdrawal by Subject|0
210501|NCT00262002|701123|P2|Overall Study|Withdrawal by Subject|2
210502|NCT00262002|701124|P1|Overall Study|Withdrawal by Subject|4
210503|NCT00262002|701118|P7|Overall Study|Adverse Event|0
210504|NCT00262002|701119|P6|Overall Study|Adverse Event|1
210505|NCT00262002|701120|P5|Overall Study|Adverse Event|0
210506|NCT00262002|701121|P4|Overall Study|Adverse Event|0
210507|NCT00262002|701122|P3|Overall Study|Adverse Event|0
210508|NCT00262002|701123|P2|Overall Study|Adverse Event|1
210509|NCT00262002|701124|P1|Overall Study|Adverse Event|2
210510|NCT00261950|701217|P1|Overall Study|Protocol specified Criteria|11
210511|NCT00261950|701217|P1|Overall Study|Physician Decision|1
210512|NCT00261950|701217|P1|Overall Study|not specified|1
210513|NCT00261950|701217|P1|Overall Study|Withdrawal by Subject|5
210514|NCT00261950|701217|P1|Overall Study|Death|6
210515|NCT00261950|701217|P1|Overall Study|Lost to Follow-up|2
210516|NCT00261846|701242|P12|Period 2: Part 2 (Efficacy)|Extension study|1
210517|NCT00261846|701243|P11|Period 2: Part 2 (Efficacy)|Extension study|1
210518|NCT00261846|701244|P10|Period 2: Part 2 (Efficacy)|Extension study|9
210519|NCT00261846|701245|P9|Period 2: Part 2 (Efficacy)|Extension study|5
210520|NCT00261846|701246|P8|Period 2: Part 2 (Efficacy)|Extension study|9
210521|NCT00261846|701247|P7|Period 2: Part 2 (Efficacy)|Extension study|4
210522|NCT00261846|701248|P6|Period 2: Part 2 (Efficacy)|Extension study|0
210523|NCT00261846|701249|P5|Period 2: Part 2 (Efficacy)|Extension study|27
210524|NCT00261846|701250|P4|Period 2: Part 2 (Efficacy)|Extension study|61
210525|NCT00261846|701251|P3|Period 2: Part 2 (Efficacy)|Extension study|0
210526|NCT00261846|701252|P2|Period 2: Part 2 (Efficacy)|Extension study|0
210527|NCT00261846|701253|P1|Period 2: Part 2 (Efficacy)|Extension study|0
210528|NCT00261846|701242|P12|Period 2: Part 2 (Efficacy)|Death|22
210529|NCT00261846|701243|P11|Period 2: Part 2 (Efficacy)|Death|44
210530|NCT00261846|701244|P10|Period 2: Part 2 (Efficacy)|Death|30
210531|NCT00261846|701245|P9|Period 2: Part 2 (Efficacy)|Death|3
210532|NCT00261846|701246|P8|Period 2: Part 2 (Efficacy)|Death|12
210533|NCT00261846|701247|P7|Period 2: Part 2 (Efficacy)|Death|10
210534|NCT00261846|701248|P6|Period 2: Part 2 (Efficacy)|Death|1
210535|NCT00261846|701249|P5|Period 2: Part 2 (Efficacy)|Death|7
210536|NCT00261846|701250|P4|Period 2: Part 2 (Efficacy)|Death|37
210537|NCT00261846|701251|P3|Period 2: Part 2 (Efficacy)|Death|0
210538|NCT00261846|701252|P2|Period 2: Part 2 (Efficacy)|Death|0
210539|NCT00261846|701253|P1|Period 2: Part 2 (Efficacy)|Death|0
210540|NCT00261846|701242|P12|Period 2: Part 2 (Efficacy)|Other|0
210541|NCT00261846|701243|P11|Period 2: Part 2 (Efficacy)|Other|0
210542|NCT00261846|701244|P10|Period 2: Part 2 (Efficacy)|Other|4
210543|NCT00261846|701245|P9|Period 2: Part 2 (Efficacy)|Other|4
210544|NCT00261846|701246|P8|Period 2: Part 2 (Efficacy)|Other|5
210545|NCT00261846|701247|P7|Period 2: Part 2 (Efficacy)|Other|1
210546|NCT00261846|701248|P6|Period 2: Part 2 (Efficacy)|Other|0
210547|NCT00261846|701249|P5|Period 2: Part 2 (Efficacy)|Other|4
210548|NCT00261846|701250|P4|Period 2: Part 2 (Efficacy)|Other|15
210549|NCT00261846|701251|P3|Period 2: Part 2 (Efficacy)|Other|0
210550|NCT00261846|701252|P2|Period 2: Part 2 (Efficacy)|Other|0
210551|NCT00261846|701253|P1|Period 2: Part 2 (Efficacy)|Other|0
210552|NCT00261846|701242|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
210553|NCT00261846|701243|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
210554|NCT00261846|701244|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
210555|NCT00261846|701245|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
210556|NCT00261846|701246|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
210557|NCT00261846|701247|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
210558|NCT00261846|701248|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
210559|NCT00261846|701249|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
210560|NCT00261846|701250|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
210561|NCT00261846|701251|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
210562|NCT00261846|701252|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
210563|NCT00261846|701253|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
210564|NCT00261846|701242|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
210565|NCT00261846|701243|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
210566|NCT00261846|701244|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
210567|NCT00261846|701245|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
210568|NCT00261846|701246|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
210569|NCT00261846|701247|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
210570|NCT00261846|701248|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
210571|NCT00261846|701249|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
210572|NCT00261846|701250|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
210573|NCT00261846|701251|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
210574|NCT00261846|701252|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
210575|NCT00261846|701253|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
210576|NCT00261846|701242|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210577|NCT00261846|701243|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210578|NCT00261846|701244|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210579|NCT00261846|701245|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
210580|NCT00261846|701246|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210581|NCT00261846|701247|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210582|NCT00261846|701248|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210583|NCT00261846|701249|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210584|NCT00261846|701250|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
210585|NCT00261846|701251|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210586|NCT00261846|701252|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210587|NCT00261846|701253|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
210588|NCT00261846|701242|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
210589|NCT00261846|701243|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
210590|NCT00261846|701244|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
210591|NCT00261846|701245|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
210592|NCT00261846|701246|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
210593|NCT00261846|701247|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
210594|NCT00261846|701248|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
210595|NCT00261846|701249|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
210596|NCT00261846|701250|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
210597|NCT00261846|701251|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
210598|NCT00261846|701252|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
210599|NCT00261846|701253|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
210600|NCT00261833|701512|P2|Overall Study|Not interested in being participant|1
210601|NCT00261833|701513|P1|Overall Study|Not interested in being participant|0
210602|NCT00261833|701512|P2|Overall Study|Missing reason|0
210603|NCT00261833|701513|P1|Overall Study|Missing reason|1
210604|NCT00261833|701512|P2|Overall Study|Lung transplantation|1
210605|NCT00261833|701513|P1|Overall Study|Lung transplantation|1
210606|NCT00261833|701512|P2|Overall Study|Suspicion of pulmonary cancer|1
210607|NCT00261833|701513|P1|Overall Study|Suspicion of pulmonary cancer|0
210608|NCT00261833|701512|P2|Overall Study|Protocol Violation|1
210609|NCT00261833|701513|P1|Overall Study|Protocol Violation|0
210610|NCT00261833|701512|P2|Overall Study|Withdrawal by Subject|7
210611|NCT00261833|701513|P1|Overall Study|Withdrawal by Subject|5
210612|NCT00261833|701512|P2|Overall Study|Adverse Event|4
210613|NCT00261833|701513|P1|Overall Study|Adverse Event|1
210614|NCT00261833|701512|P2|Overall Study|Death|3
210615|NCT00261833|701513|P1|Overall Study|Death|1
210616|NCT00261716|701547|P2|Overall Study|Lost to Follow-up|2
210617|NCT00261716|701548|P1|Overall Study|Lost to Follow-up|0
210618|NCT00261716|701547|P2|Overall Study|Withdrawal by Subject|8
210619|NCT00261716|701548|P1|Overall Study|Withdrawal by Subject|6
210620|NCT00261495|701568|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
210621|NCT00261495|701569|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
210622|NCT00261495|701568|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
210623|NCT00261495|701569|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
210624|NCT00261495|701568|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
210625|NCT00261495|701569|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
210626|NCT00261495|701568|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
210627|NCT00261495|701569|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
210628|NCT00261495|701568|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
210629|NCT00261495|701569|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
210630|NCT00261495|701568|P2|Extension Phase (Weeks 24 to 52)|Other|2
210631|NCT00261495|701569|P1|Extension Phase (Weeks 24 to 52)|Other|4
210632|NCT00261495|701568|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
210633|NCT00261495|701569|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
210634|NCT00261495|701568|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
210790|NCT00259740|702119|P2|Overall Study|Other|0
210635|NCT00261495|701569|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
210636|NCT00261495|701568|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
210637|NCT00261495|701569|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
210638|NCT00261495|701568|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
210639|NCT00261495|701569|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
210640|NCT00261495|701568|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
210641|NCT00261495|701569|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
210642|NCT00261495|701568|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
210643|NCT00261495|701569|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
210644|NCT00261495|701568|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
210645|NCT00261495|701569|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
210646|NCT00261495|701568|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
210647|NCT00261495|701569|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
210648|NCT00261495|701568|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
210649|NCT00261495|701569|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
210650|NCT00261495|701568|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
210651|NCT00261495|701569|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
210652|NCT00261495|701568|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
210653|NCT00261495|701569|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
210654|NCT00261495|701568|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
210655|NCT00261495|701569|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
210656|NCT00261495|701568|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
210657|NCT00261495|701569|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
210658|NCT00261495|701568|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
210659|NCT00261495|701569|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
210660|NCT00261495|701568|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
210661|NCT00261495|701569|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
210662|NCT00261443|701733|P3|4: Extension Phase|Lost to Follow-up|0
210663|NCT00261443|701734|P2|4: Extension Phase|Lost to Follow-up|1
210664|NCT00261443|701735|P1|4: Extension Phase|Lost to Follow-up|0
210665|NCT00261443|701733|P3|4: Extension Phase|Withdrawal by Subject|2
210666|NCT00261443|701734|P2|4: Extension Phase|Withdrawal by Subject|1
210667|NCT00261443|701735|P1|4: Extension Phase|Withdrawal by Subject|0
210668|NCT00261443|701733|P3|4: Extension Phase|Adverse Event|0
210669|NCT00261443|701734|P2|4: Extension Phase|Adverse Event|1
210670|NCT00261443|701735|P1|4: Extension Phase|Adverse Event|0
210671|NCT00261443|701733|P3|3: Assessment of Relapse|Other Reasons|3
210672|NCT00261443|701734|P2|3: Assessment of Relapse|Other Reasons|4
210673|NCT00261443|701735|P1|3: Assessment of Relapse|Other Reasons|0
210674|NCT00261443|701733|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
210675|NCT00261443|701734|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
210676|NCT00261443|701735|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
210677|NCT00261443|701733|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
210678|NCT00261443|701734|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
210679|NCT00261443|701735|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
210680|NCT00261443|701733|P3|3: Assessment of Relapse|Pregnancy|1
210681|NCT00261443|701734|P2|3: Assessment of Relapse|Pregnancy|2
210682|NCT00261443|701735|P1|3: Assessment of Relapse|Pregnancy|0
210683|NCT00261443|701733|P3|3: Assessment of Relapse|Poor/Noncompliance|3
210684|NCT00261443|701734|P2|3: Assessment of Relapse|Poor/Noncompliance|5
210685|NCT00261443|701735|P1|3: Assessment of Relapse|Poor/Noncompliance|0
210686|NCT00261443|701733|P3|3: Assessment of Relapse|Lost to Follow-up|6
210687|NCT00261443|701734|P2|3: Assessment of Relapse|Lost to Follow-up|7
210688|NCT00261443|701735|P1|3: Assessment of Relapse|Lost to Follow-up|0
210689|NCT00261443|701733|P3|3: Assessment of Relapse|Death|1
210690|NCT00261443|701734|P2|3: Assessment of Relapse|Death|0
210691|NCT00261443|701735|P1|3: Assessment of Relapse|Death|0
210692|NCT00261443|701733|P3|3: Assessment of Relapse|Withdrawal by Subject|15
210693|NCT00261443|701734|P2|3: Assessment of Relapse|Withdrawal by Subject|14
210694|NCT00261443|701735|P1|3: Assessment of Relapse|Withdrawal by Subject|0
210695|NCT00261443|701733|P3|3: Assessment of Relapse|Adverse Event|19
210696|NCT00261443|701734|P2|3: Assessment of Relapse|Adverse Event|15
210697|NCT00261443|701735|P1|3: Assessment of Relapse|Adverse Event|0
210698|NCT00261443|701733|P3|3: Assessment of Relapse|Lack of Efficacy|14
210699|NCT00261443|701734|P2|3: Assessment of Relapse|Lack of Efficacy|31
210700|NCT00261443|701735|P1|3: Assessment of Relapse|Lack of Efficacy|0
210701|NCT00261443|701733|P3|2: Stability & Maintenance of Stability|Other Reasons|0
210702|NCT00261443|701734|P2|2: Stability & Maintenance of Stability|Other Reasons|0
210703|NCT00261443|701735|P1|2: Stability & Maintenance of Stability|Other Reasons|13
210704|NCT00261443|701733|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
210705|NCT00261443|701734|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
210706|NCT00261443|701735|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
210707|NCT00261443|701733|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
210708|NCT00261443|701734|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
210709|NCT00261443|701735|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
210710|NCT00261443|701733|P3|2: Stability & Maintenance of Stability|Pregnancy|0
210711|NCT00261443|701734|P2|2: Stability & Maintenance of Stability|Pregnancy|0
210712|NCT00261443|701735|P1|2: Stability & Maintenance of Stability|Pregnancy|1
210713|NCT00261443|701733|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
210714|NCT00261443|701734|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
210715|NCT00261443|701735|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
210716|NCT00261443|701733|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
210717|NCT00261443|701734|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
210718|NCT00261443|701735|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
210719|NCT00261443|701733|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
210720|NCT00261443|701734|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
210721|NCT00261443|701735|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
210722|NCT00261443|701733|P3|2: Stability & Maintenance of Stability|Adverse Event|0
210723|NCT00261443|701734|P2|2: Stability & Maintenance of Stability|Adverse Event|0
210724|NCT00261443|701735|P1|2: Stability & Maintenance of Stability|Adverse Event|93
210725|NCT00261443|701733|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
210726|NCT00261443|701734|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
210727|NCT00261443|701735|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
210728|NCT00261443|701733|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
210729|NCT00261443|701734|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
210730|NCT00261443|701735|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
210731|NCT00261443|701733|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
210732|NCT00261443|701734|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
210733|NCT00261443|701735|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
210734|NCT00261443|701733|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
210735|NCT00261443|701734|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
210736|NCT00261443|701735|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
210737|NCT00261443|701733|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
210738|NCT00261443|701734|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
210739|NCT00261443|701735|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
210740|NCT00261443|701733|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
210741|NCT00261443|701734|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
210742|NCT00261443|701735|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
210743|NCT00261443|701733|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
210744|NCT00261443|701734|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
210745|NCT00261443|701735|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
210746|NCT00261443|701733|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
210747|NCT00261443|701734|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
210748|NCT00261443|701735|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
210749|NCT00260832|702003|P2|Overall Study|Protocol Violation|1
210750|NCT00260832|702004|P1|Overall Study|Protocol Violation|3
210751|NCT00260832|702003|P2|Overall Study|Not Specified|7
210752|NCT00260832|702004|P1|Overall Study|Not Specified|10
210753|NCT00260832|702003|P2|Overall Study|Death|62
210754|NCT00260832|702004|P1|Overall Study|Death|43
210755|NCT00260832|702003|P2|Overall Study|Physician Decision|9
210756|NCT00260832|702004|P1|Overall Study|Physician Decision|15
210757|NCT00260832|702003|P2|Overall Study|Withdrawal by Subject|17
210758|NCT00260832|702004|P1|Overall Study|Withdrawal by Subject|15
210759|NCT00260832|702003|P2|Overall Study|Progression|96
210760|NCT00260832|702004|P1|Overall Study|Progression|116
210761|NCT00260832|702003|P2|Overall Study|Adverse Event|19
210762|NCT00260832|702004|P1|Overall Study|Adverse Event|26
210763|NCT00260533|702031|P2|Overall Study|Other|3
210764|NCT00260533|702032|P1|Overall Study|Other|3
210765|NCT00260429|702040|P2|Overall Study|scheduled hand surgery|0
210766|NCT00260429|702041|P1|Overall Study|scheduled hand surgery|1
210767|NCT00260429|702040|P2|Overall Study|failure to follow appointments|0
210768|NCT00260429|702041|P1|Overall Study|failure to follow appointments|1
210769|NCT00260208|702049|P2|Overall Study|Missing|16
210770|NCT00260208|702050|P1|Overall Study|Missing|18
210771|NCT00260208|702049|P2|Overall Study|Death|10
210772|NCT00260208|702050|P1|Overall Study|Death|12
210773|NCT00260208|702049|P2|Overall Study|Lost to Follow-up|1
210774|NCT00260208|702050|P1|Overall Study|Lost to Follow-up|6
210775|NCT00260208|702049|P2|Overall Study|Subject withdrew consent|7
210776|NCT00260208|702050|P1|Overall Study|Subject withdrew consent|11
210777|NCT00260065|702093|P1|Overall Study|Medication Noncompliance|1
210778|NCT00260065|702093|P1|Overall Study|Not otherwise specified|8
210779|NCT00260065|702093|P1|Overall Study|Physician Decision|19
210780|NCT00260065|702093|P1|Overall Study|Withdrawal by Subject|13
210781|NCT00260065|702093|P1|Overall Study|Death|13
210782|NCT00260065|702093|P1|Overall Study|Adverse Event|17
210783|NCT00260065|702093|P1|Overall Study|Progressive Disease|22
210784|NCT00259857|702100|P2|24 Months Treatment|Lost to Follow-up|3
210785|NCT00259857|702101|P1|24 Months Treatment|Lost to Follow-up|0
210786|NCT00259857|702100|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
210787|NCT00259857|702101|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
210788|NCT00259740|702119|P2|Overall Study|Requirement for alternative therapy|4
210789|NCT00259740|702120|P1|Overall Study|Requirement for alternative therapy|0
210791|NCT00259740|702120|P1|Overall Study|Other|3
210792|NCT00259740|702119|P2|Overall Study|Ongoing|3
210793|NCT00259740|702120|P1|Overall Study|Ongoing|17
210794|NCT00259740|702119|P2|Overall Study|Disease progression|36
210795|NCT00259740|702120|P1|Overall Study|Disease progression|19
210796|NCT00259740|702119|P2|Overall Study|Death|1
210797|NCT00259740|702120|P1|Overall Study|Death|1
210798|NCT00259740|702119|P2|Overall Study|Withdrawal by Subject|6
210799|NCT00259740|702120|P1|Overall Study|Withdrawal by Subject|2
210800|NCT00259740|702119|P2|Overall Study|Adverse Event|2
210801|NCT00259740|702120|P1|Overall Study|Adverse Event|0
210802|NCT00259740|702119|P2|Overall Study|Physician Decision|1
210803|NCT00259740|702120|P1|Overall Study|Physician Decision|1
210804|NCT00259649|702130|P1|Overall Study|irregular menses|3
210805|NCT00259649|702130|P1|Overall Study|Lost to Follow-up|7
210806|NCT00259610|702138|P4|Overall Study|Serious Adverse Event|2
210807|NCT00259610|702139|P3|Overall Study|Serious Adverse Event|2
210808|NCT00259610|702140|P2|Overall Study|Serious Adverse Event|2
210809|NCT00259610|702141|P1|Overall Study|Serious Adverse Event|8
210810|NCT00259610|702138|P4|Overall Study|Adverse Event|2
210811|NCT00259610|702139|P3|Overall Study|Adverse Event|5
210812|NCT00259610|702140|P2|Overall Study|Adverse Event|4
210813|NCT00259610|702141|P1|Overall Study|Adverse Event|3
210814|NCT00259610|702138|P4|Overall Study|non medical reason|3
210815|NCT00259610|702139|P3|Overall Study|non medical reason|10
210816|NCT00259610|702140|P2|Overall Study|non medical reason|2
210817|NCT00259610|702141|P1|Overall Study|non medical reason|6
210818|NCT00259610|702138|P4|Overall Study|Death|0
210819|NCT00259610|702139|P3|Overall Study|Death|2
210820|NCT00259610|702140|P2|Overall Study|Death|1
210821|NCT00259610|702141|P1|Overall Study|Death|1
210822|NCT00259610|702138|P4|Overall Study|Physician Decision|2
210823|NCT00259610|702139|P3|Overall Study|Physician Decision|7
210824|NCT00259610|702140|P2|Overall Study|Physician Decision|4
210825|NCT00259610|702141|P1|Overall Study|Physician Decision|6
210826|NCT00259610|702138|P4|Overall Study|Lost to Follow-up|15
210827|NCT00259610|702139|P3|Overall Study|Lost to Follow-up|18
210828|NCT00259610|702140|P2|Overall Study|Lost to Follow-up|8
210829|NCT00259610|702141|P1|Overall Study|Lost to Follow-up|19
210830|NCT00259610|702138|P4|Overall Study|Withdrawal by Subject|19
210831|NCT00259610|702139|P3|Overall Study|Withdrawal by Subject|29
210832|NCT00259610|702140|P2|Overall Study|Withdrawal by Subject|25
210833|NCT00259610|702141|P1|Overall Study|Withdrawal by Subject|33
210834|NCT00259298|702155|P1|Overall Study|Physician Decision|2
210835|NCT00259298|702155|P1|Overall Study|Withdrawal by Subject|1
210836|NCT00259272|702173|P4|Overall Study|Lost to Follow-up|1
210837|NCT00259272|702174|P3|Overall Study|Lost to Follow-up|0
210838|NCT00259272|702175|P2|Overall Study|Lost to Follow-up|0
210839|NCT00259272|702176|P1|Overall Study|Lost to Follow-up|1
210840|NCT00259272|702173|P4|Overall Study|Withdrawal by Subject|7
210841|NCT00259272|702174|P3|Overall Study|Withdrawal by Subject|2
210842|NCT00259272|702175|P2|Overall Study|Withdrawal by Subject|2
210843|NCT00259272|702176|P1|Overall Study|Withdrawal by Subject|4
210844|NCT00259272|702173|P4|Overall Study|Sponsor Decision|0
210845|NCT00259272|702174|P3|Overall Study|Sponsor Decision|0
210846|NCT00259272|702175|P2|Overall Study|Sponsor Decision|1
210847|NCT00259272|702176|P1|Overall Study|Sponsor Decision|0
210848|NCT00259272|702173|P4|Overall Study|Protocol Violation|1
210849|NCT00259272|702174|P3|Overall Study|Protocol Violation|0
210850|NCT00259272|702175|P2|Overall Study|Protocol Violation|0
210851|NCT00259272|702176|P1|Overall Study|Protocol Violation|2
210852|NCT00259272|702173|P4|Overall Study|Physician Decision|3
210853|NCT00259272|702174|P3|Overall Study|Physician Decision|1
210854|NCT00259272|702175|P2|Overall Study|Physician Decision|2
210855|NCT00259272|702176|P1|Overall Study|Physician Decision|1
210856|NCT00259272|702173|P4|Overall Study|Lack of Efficacy|6
210857|NCT00259272|702174|P3|Overall Study|Lack of Efficacy|2
210858|NCT00259272|702175|P2|Overall Study|Lack of Efficacy|1
210859|NCT00259272|702176|P1|Overall Study|Lack of Efficacy|5
210860|NCT00259272|702173|P4|Overall Study|Adverse Event|3
210861|NCT00259272|702174|P3|Overall Study|Adverse Event|0
210862|NCT00259272|702175|P2|Overall Study|Adverse Event|1
210863|NCT00259272|702176|P1|Overall Study|Adverse Event|2
210864|NCT00259012|702272|P2|Overall Study|Protocol Violation|1
210865|NCT00259012|702273|P1|Overall Study|Protocol Violation|1
210866|NCT00259012|702272|P2|Overall Study|Lost to Follow-up|1
210867|NCT00259012|702273|P1|Overall Study|Lost to Follow-up|0
210868|NCT00259012|702272|P2|Overall Study|Physician Decision|1
210869|NCT00259012|702273|P1|Overall Study|Physician Decision|0
210870|NCT00259012|702272|P2|Overall Study|Withdrawal by Subject|0
210871|NCT00259012|702273|P1|Overall Study|Withdrawal by Subject|1
210872|NCT00259012|702272|P2|Overall Study|Adverse Event|1
210873|NCT00259012|702273|P1|Overall Study|Adverse Event|0
210874|NCT00258895|702313|P2|Overall Study|Withdrawal by Subject|0
210875|NCT00258895|702314|P1|Overall Study|Withdrawal by Subject|1
210876|NCT00258895|702313|P2|Overall Study|Protocol Violation|2
210877|NCT00258895|702314|P1|Overall Study|Protocol Violation|6
210878|NCT00258895|702313|P2|Overall Study|Lost to Follow-up|1
210879|NCT00258895|702314|P1|Overall Study|Lost to Follow-up|3
210880|NCT00258856|702350|P4|Overall Study|Non-compliance|1
210881|NCT00258856|702351|P3|Overall Study|Non-compliance|0
210882|NCT00258856|702352|P2|Overall Study|Non-compliance|0
210883|NCT00258856|702353|P1|Overall Study|Non-compliance|2
210884|NCT00258856|702350|P4|Overall Study|Lost to Follow-up|0
210885|NCT00258856|702351|P3|Overall Study|Lost to Follow-up|2
210886|NCT00258856|702352|P2|Overall Study|Lost to Follow-up|0
210887|NCT00258856|702353|P1|Overall Study|Lost to Follow-up|1
210888|NCT00258674|702394|P3|Overall Study|Death|34
210889|NCT00258674|702395|P2|Overall Study|Death|53
210890|NCT00258674|702396|P1|Overall Study|Death|32
210891|NCT00258440|702455|P3|Overall Study|Withdrawal by Subject|1
210892|NCT00258440|702456|P2|Overall Study|Withdrawal by Subject|0
210893|NCT00258440|702457|P1|Overall Study|Withdrawal by Subject|0
210894|NCT00258154|702490|P2|Overall Study|Patient Moved|1
210895|NCT00258154|702491|P1|Overall Study|Patient Moved|3
210896|NCT00258154|702490|P2|Overall Study|Withdrawal by Subject|4
210897|NCT00258154|702491|P1|Overall Study|Withdrawal by Subject|3
210898|NCT00258154|702490|P2|Overall Study|Protocol Violation|1
210899|NCT00258154|702491|P1|Overall Study|Protocol Violation|2
210900|NCT00258154|702490|P2|Overall Study|Lost to Follow-up|1
210901|NCT00258154|702491|P1|Overall Study|Lost to Follow-up|0
210902|NCT00258154|702490|P2|Overall Study|Adverse Event|0
210903|NCT00258154|702491|P1|Overall Study|Adverse Event|1
210904|NCT00257920|702575|P2|Period: Second Intervention|Other|1
210905|NCT00257920|702576|P1|Period: Second Intervention|Other|2
210906|NCT00257920|702575|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
210907|NCT00257920|702576|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
210908|NCT00257660|702632|P2|Overall Study|No longer wanted to do blood draws|0
210909|NCT00257660|702633|P1|Overall Study|No longer wanted to do blood draws|1
210910|NCT00257660|702632|P2|Overall Study|PI & Subject Schedule Conflicts|0
210911|NCT00257660|702633|P1|Overall Study|PI & Subject Schedule Conflicts|1
210912|NCT00257660|702632|P2|Overall Study|Lost to Follow-up|0
210913|NCT00257660|702633|P1|Overall Study|Lost to Follow-up|1
210914|NCT00257660|702632|P2|Overall Study|Withdrawal by Subject|0
210915|NCT00257660|702633|P1|Overall Study|Withdrawal by Subject|2
210916|NCT00257660|702632|P2|Overall Study|Lack of Efficacy|23
210917|NCT00257660|702633|P1|Overall Study|Lack of Efficacy|5
210918|NCT00257608|702663|P3|Post Chemotherapy Phase|Not treated|7
210919|NCT00257608|702664|P2|Post Chemotherapy Phase|Not treated|4
210920|NCT00257608|702665|P1|Post Chemotherapy Phase|Not treated|0
210921|NCT00257608|702663|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
210922|NCT00257608|702664|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
210923|NCT00257608|702665|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
210924|NCT00257608|702663|P3|Post Chemotherapy Phase|Physician Decision|11
210925|NCT00257608|702664|P2|Post Chemotherapy Phase|Physician Decision|8
210926|NCT00257608|702665|P1|Post Chemotherapy Phase|Physician Decision|0
210927|NCT00257608|702663|P3|Post Chemotherapy Phase|Lost to Follow-up|1
210928|NCT00257608|702664|P2|Post Chemotherapy Phase|Lost to Follow-up|0
210929|NCT00257608|702665|P1|Post Chemotherapy Phase|Lost to Follow-up|0
210930|NCT00257608|702663|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
210931|NCT00257608|702664|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
210932|NCT00257608|702665|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
210933|NCT00257608|702663|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
210934|NCT00257608|702664|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
210935|NCT00257608|702665|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
210936|NCT00257608|702663|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
210937|NCT00257608|702664|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
210938|NCT00257608|702665|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
210939|NCT00257608|702663|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
210940|NCT00257608|702664|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
210941|NCT00257608|702665|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
210942|NCT00257608|702663|P3|Post Chemotherapy Phase|Disease progression|168
210943|NCT00257608|702664|P2|Post Chemotherapy Phase|Disease progression|204
210944|NCT00257608|702665|P1|Post Chemotherapy Phase|Disease progression|0
210945|NCT00257608|702663|P3|Post Chemotherapy Phase|Adverse Event|38
210946|NCT00257608|702664|P2|Post Chemotherapy Phase|Adverse Event|34
210947|NCT00257608|702665|P1|Post Chemotherapy Phase|Adverse Event|0
210948|NCT00257608|702663|P3|Chemotherapy Phase|Physician Decision|0
210949|NCT00257608|702664|P2|Chemotherapy Phase|Physician Decision|0
210950|NCT00257608|702665|P1|Chemotherapy Phase|Physician Decision|28
210951|NCT00257608|702663|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
210952|NCT00257608|702664|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
210953|NCT00257608|702665|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
210954|NCT00257608|702663|P3|Chemotherapy Phase|Patient's decision to discontinue|0
210955|NCT00257608|702664|P2|Chemotherapy Phase|Patient's decision to discontinue|0
210956|NCT00257608|702665|P1|Chemotherapy Phase|Patient's decision to discontinue|35
210957|NCT00257608|702663|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
210958|NCT00257608|702664|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
210959|NCT00257608|702665|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
210960|NCT00257608|702663|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
210961|NCT00257608|702664|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
210962|NCT00257608|702665|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
210963|NCT00257608|702663|P3|Chemotherapy Phase|Disease progression|0
210964|NCT00257608|702664|P2|Chemotherapy Phase|Disease progression|0
210965|NCT00257608|702665|P1|Chemotherapy Phase|Disease progression|139
210966|NCT00257608|702663|P3|Chemotherapy Phase|Adverse Event|0
210967|NCT00257608|702664|P2|Chemotherapy Phase|Adverse Event|0
210968|NCT00257608|702665|P1|Chemotherapy Phase|Adverse Event|138
210969|NCT00257556|702691|P2|Overall Study|other reason|6
210970|NCT00257556|702692|P1|Overall Study|other reason|4
210971|NCT00257556|702691|P2|Overall Study|Did not meet hCG criterion|0
210972|NCT00257556|702692|P1|Overall Study|Did not meet hCG criterion|3
210973|NCT00257556|702691|P2|Overall Study|Physician Decision|0
210974|NCT00257556|702692|P1|Overall Study|Physician Decision|6
210975|NCT00257556|702691|P2|Overall Study|Adverse Event|4
210976|NCT00257556|702692|P1|Overall Study|Adverse Event|1
210977|NCT00257192|702736|P2|Overall Study|Miscellaneous|4
210978|NCT00257192|702737|P1|Overall Study|Miscellaneous|0
210979|NCT00257192|702736|P2|Overall Study|Study terminated by sponsor|0
210980|NCT00257192|702737|P1|Overall Study|Study terminated by sponsor|1
210981|NCT00257192|702736|P2|Overall Study|Randomized but not treated|1
210982|NCT00257192|702737|P1|Overall Study|Randomized but not treated|0
210983|NCT00257192|702736|P2|Overall Study|Withdrawal by Subject|2
210984|NCT00257192|702737|P1|Overall Study|Withdrawal by Subject|14
210985|NCT00257192|702736|P2|Overall Study|Insufficient clinical response|18
210986|NCT00257192|702737|P1|Overall Study|Insufficient clinical response|18
210987|NCT00257192|702736|P2|Overall Study|Lost to Follow-up|3
210988|NCT00257192|702737|P1|Overall Study|Lost to Follow-up|3
210989|NCT00257192|702736|P2|Overall Study|Laboratory abnormality|1
210990|NCT00257192|702737|P1|Overall Study|Laboratory abnormality|1
210991|NCT00257192|702736|P2|Overall Study|Adverse Event|10
210992|NCT00257192|702737|P1|Overall Study|Adverse Event|21
210993|NCT00257166|702781|P2|Overall Study|Randomized, but not treated|0
210994|NCT00257166|702782|P1|Overall Study|Randomized, but not treated|1
210995|NCT00257166|702781|P2|Overall Study|Other|21
210996|NCT00257166|702782|P1|Overall Study|Other|16
210997|NCT00257166|702781|P2|Overall Study|Withdrawal by Subject|2
210998|NCT00257166|702782|P1|Overall Study|Withdrawal by Subject|9
210999|NCT00257166|702781|P2|Overall Study|Lost to Follow-up|1
211000|NCT00257166|702782|P1|Overall Study|Lost to Follow-up|8
211001|NCT00257166|702781|P2|Overall Study|Laboratory abnormality|0
211002|NCT00257166|702782|P1|Overall Study|Laboratory abnormality|1
211003|NCT00257166|702781|P2|Overall Study|Adverse Event|13
211004|NCT00257166|702782|P1|Overall Study|Adverse Event|18
211005|NCT00257010|702794|P1|Overall Study|no headache reported|9
211006|NCT00257010|702794|P1|Overall Study|various|11
211007|NCT00257010|702794|P1|Overall Study|Adverse Event|10
211008|NCT00257010|702794|P1|Overall Study|Withdrawal by Subject|34
211009|NCT00257010|702794|P1|Overall Study|Lost to Follow-up|53
211010|NCT00257010|702794|P1|Overall Study|Lack of Efficacy|11
211011|NCT00256997|702805|P2|Overall Study|Investigator Withdrew Participant|1
211012|NCT00256997|702806|P1|Overall Study|Investigator Withdrew Participant|2
211013|NCT00256997|702805|P2|Overall Study|Participant Non-compliant|6
211014|NCT00256997|702806|P1|Overall Study|Participant Non-compliant|3
211015|NCT00256997|702805|P2|Overall Study|End of Study (As Per Sponsor)|24
211016|NCT00256997|702806|P1|Overall Study|End of Study (As Per Sponsor)|12
211017|NCT00256997|702805|P2|Overall Study|Other|8
211018|NCT00256997|702806|P1|Overall Study|Other|5
211019|NCT00256997|702805|P2|Overall Study|Started but not treated|0
211020|NCT00256997|702806|P1|Overall Study|Started but not treated|2
211021|NCT00256997|702805|P2|Overall Study|Withdrawal by Subject|3
211022|NCT00256997|702806|P1|Overall Study|Withdrawal by Subject|13
211023|NCT00256997|702805|P2|Overall Study|Lost to Follow-up|5
211024|NCT00256997|702806|P1|Overall Study|Lost to Follow-up|3
211025|NCT00256997|702805|P2|Overall Study|Adverse Event|0
211026|NCT00256997|702806|P1|Overall Study|Adverse Event|4
211027|NCT00256997|702805|P2|Overall Study|Death|0
211028|NCT00256997|702806|P1|Overall Study|Death|2
211029|NCT00256997|702805|P2|Overall Study|Lack of Efficacy|4
211030|NCT00256997|702806|P1|Overall Study|Lack of Efficacy|1
211031|NCT00256997|702805|P2|Overall Study|Protocol Violation|4
211032|NCT00256997|702806|P1|Overall Study|Protocol Violation|1
211033|NCT00256867|702848|P8|Overall Study|Withdrawal by participant|0
211034|NCT00256867|702849|P7|Overall Study|Withdrawal by participant|0
211035|NCT00256867|702850|P6|Overall Study|Withdrawal by participant|1
211036|NCT00256867|702851|P5|Overall Study|Withdrawal by participant|0
211037|NCT00256867|702852|P4|Overall Study|Withdrawal by participant|0
211038|NCT00256867|702853|P3|Overall Study|Withdrawal by participant|0
211039|NCT00256867|702854|P2|Overall Study|Withdrawal by participant|0
211040|NCT00256867|702855|P1|Overall Study|Withdrawal by participant|0
211041|NCT00256867|702848|P8|Overall Study|Participant was out of windows|0
211042|NCT00256867|702849|P7|Overall Study|Participant was out of windows|0
211043|NCT00256867|702850|P6|Overall Study|Participant was out of windows|0
211044|NCT00256867|702851|P5|Overall Study|Participant was out of windows|0
211045|NCT00256867|702852|P4|Overall Study|Participant was out of windows|0
211046|NCT00256867|702853|P3|Overall Study|Participant was out of windows|1
211047|NCT00256867|702854|P2|Overall Study|Participant was out of windows|0
211048|NCT00256867|702855|P1|Overall Study|Participant was out of windows|0
211049|NCT00256867|702848|P8|Overall Study|Participant travelled Overseas|0
211050|NCT00256867|702849|P7|Overall Study|Participant travelled Overseas|0
211051|NCT00256867|702850|P6|Overall Study|Participant travelled Overseas|0
211052|NCT00256867|702851|P5|Overall Study|Participant travelled Overseas|0
211053|NCT00256867|702852|P4|Overall Study|Participant travelled Overseas|0
211054|NCT00256867|702853|P3|Overall Study|Participant travelled Overseas|0
211055|NCT00256867|702854|P2|Overall Study|Participant travelled Overseas|1
211056|NCT00256867|702855|P1|Overall Study|Participant travelled Overseas|0
211057|NCT00256867|702848|P8|Overall Study|Non-compliance with study medication|1
211058|NCT00256867|702849|P7|Overall Study|Non-compliance with study medication|0
211059|NCT00256867|702850|P6|Overall Study|Non-compliance with study medication|0
211060|NCT00256867|702851|P5|Overall Study|Non-compliance with study medication|0
211061|NCT00256867|702852|P4|Overall Study|Non-compliance with study medication|0
211062|NCT00256867|702853|P3|Overall Study|Non-compliance with study medication|0
211063|NCT00256867|702854|P2|Overall Study|Non-compliance with study medication|0
211064|NCT00256867|702855|P1|Overall Study|Non-compliance with study medication|0
211065|NCT00256867|702848|P8|Overall Study|Investigator's Decision|0
211066|NCT00256867|702849|P7|Overall Study|Investigator's Decision|0
211067|NCT00256867|702850|P6|Overall Study|Investigator's Decision|0
211068|NCT00256867|702851|P5|Overall Study|Investigator's Decision|1
211069|NCT00256867|702852|P4|Overall Study|Investigator's Decision|0
211070|NCT00256867|702853|P3|Overall Study|Investigator's Decision|0
211071|NCT00256867|702854|P2|Overall Study|Investigator's Decision|0
211072|NCT00256867|702855|P1|Overall Study|Investigator's Decision|0
211073|NCT00256867|702848|P8|Overall Study|Glycemia over 13.3|1
211074|NCT00256867|702849|P7|Overall Study|Glycemia over 13.3|0
211075|NCT00256867|702850|P6|Overall Study|Glycemia over 13.3|0
211076|NCT00256867|702851|P5|Overall Study|Glycemia over 13.3|0
211077|NCT00256867|702852|P4|Overall Study|Glycemia over 13.3|0
211078|NCT00256867|702853|P3|Overall Study|Glycemia over 13.3|0
211079|NCT00256867|702854|P2|Overall Study|Glycemia over 13.3|0
211080|NCT00256867|702855|P1|Overall Study|Glycemia over 13.3|0
211081|NCT00256867|702848|P8|Overall Study|Fasting plasma glucose more than 240|0
211082|NCT00256867|702849|P7|Overall Study|Fasting plasma glucose more than 240|0
211083|NCT00256867|702850|P6|Overall Study|Fasting plasma glucose more than 240|0
211084|NCT00256867|702851|P5|Overall Study|Fasting plasma glucose more than 240|0
211085|NCT00256867|702852|P4|Overall Study|Fasting plasma glucose more than 240|0
211086|NCT00256867|702853|P3|Overall Study|Fasting plasma glucose more than 240|0
211087|NCT00256867|702854|P2|Overall Study|Fasting plasma glucose more than 240|1
211088|NCT00256867|702855|P1|Overall Study|Fasting plasma glucose more than 240|0
211089|NCT00256867|702848|P8|Overall Study|Withdrawal by Subject|2
211090|NCT00256867|702849|P7|Overall Study|Withdrawal by Subject|3
211091|NCT00256867|702850|P6|Overall Study|Withdrawal by Subject|2
211092|NCT00256867|702851|P5|Overall Study|Withdrawal by Subject|2
211093|NCT00256867|702852|P4|Overall Study|Withdrawal by Subject|1
211094|NCT00256867|702853|P3|Overall Study|Withdrawal by Subject|1
211095|NCT00256867|702854|P2|Overall Study|Withdrawal by Subject|0
211096|NCT00256867|702855|P1|Overall Study|Withdrawal by Subject|0
211097|NCT00256867|702848|P8|Overall Study|Protocol Violation|1
211098|NCT00256867|702849|P7|Overall Study|Protocol Violation|0
211099|NCT00256867|702850|P6|Overall Study|Protocol Violation|1
211100|NCT00256867|702851|P5|Overall Study|Protocol Violation|0
211101|NCT00256867|702852|P4|Overall Study|Protocol Violation|1
211102|NCT00256867|702853|P3|Overall Study|Protocol Violation|0
211103|NCT00256867|702854|P2|Overall Study|Protocol Violation|0
211104|NCT00256867|702855|P1|Overall Study|Protocol Violation|0
211105|NCT00256867|702848|P8|Overall Study|Lost to Follow-up|2
211106|NCT00256867|702849|P7|Overall Study|Lost to Follow-up|1
211107|NCT00256867|702850|P6|Overall Study|Lost to Follow-up|0
211108|NCT00256867|702851|P5|Overall Study|Lost to Follow-up|2
211109|NCT00256867|702852|P4|Overall Study|Lost to Follow-up|3
211110|NCT00256867|702853|P3|Overall Study|Lost to Follow-up|2
211111|NCT00256867|702854|P2|Overall Study|Lost to Follow-up|2
211112|NCT00256867|702855|P1|Overall Study|Lost to Follow-up|2
211113|NCT00256867|702848|P8|Overall Study|Adverse Event|4
211114|NCT00256867|702849|P7|Overall Study|Adverse Event|1
211115|NCT00256867|702850|P6|Overall Study|Adverse Event|2
211116|NCT00256867|702851|P5|Overall Study|Adverse Event|2
211117|NCT00256867|702852|P4|Overall Study|Adverse Event|1
211118|NCT00256867|702853|P3|Overall Study|Adverse Event|1
211119|NCT00256867|702854|P2|Overall Study|Adverse Event|1
211120|NCT00256867|702855|P1|Overall Study|Adverse Event|0
211121|NCT00256750|702942|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
211122|NCT00256750|702943|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
211123|NCT00256750|702944|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
211124|NCT00256750|702942|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
211125|NCT00256750|702943|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
211126|NCT00256750|702944|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
211127|NCT00256750|702942|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
211128|NCT00256750|702943|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
211129|NCT00256750|702944|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
211130|NCT00256750|702942|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
211131|NCT00256750|702943|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
211132|NCT00256750|702944|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
211133|NCT00256750|702942|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
211134|NCT00256750|702943|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
211135|NCT00256750|702944|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
211136|NCT00256750|702942|P3|Long Term Extension (LTE; 84 Months)|Death|4
211137|NCT00256750|702943|P2|Long Term Extension (LTE; 84 Months)|Death|4
211138|NCT00256750|702944|P1|Long Term Extension (LTE; 84 Months)|Death|9
211139|NCT00256750|702942|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
211140|NCT00256750|702943|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
211141|NCT00256750|702944|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
211142|NCT00256750|702942|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
211143|NCT00256750|702943|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
211144|NCT00256750|702944|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
211145|NCT00256750|702942|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
211146|NCT00256750|702943|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
211147|NCT00256750|702944|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
211148|NCT00256750|702942|P3|Post-Transplant Treated (36 Months)|Not specified|1
211149|NCT00256750|702943|P2|Post-Transplant Treated (36 Months)|Not specified|1
211150|NCT00256750|702944|P1|Post-Transplant Treated (36 Months)|Not specified|0
211151|NCT00256750|702942|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
211152|NCT00256750|702943|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
211153|NCT00256750|702944|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
211154|NCT00256750|702942|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
211155|NCT00256750|702943|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
211156|NCT00256750|702944|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
211157|NCT00256750|702942|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
211158|NCT00256750|702943|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
211159|NCT00256750|702944|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
211160|NCT00256750|702942|P3|Post-Transplant Treated (36 Months)|Death|1
211161|NCT00256750|702943|P2|Post-Transplant Treated (36 Months)|Death|2
211162|NCT00256750|702944|P1|Post-Transplant Treated (36 Months)|Death|0
211163|NCT00256750|702942|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
211164|NCT00256750|702943|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
211165|NCT00256750|702944|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
211166|NCT00256750|702942|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
211167|NCT00256750|702943|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
211168|NCT00256750|702944|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
211169|NCT00256750|702942|P3|Post-Transplant Treated (24 Months)|Not Specified|1
211170|NCT00256750|702943|P2|Post-Transplant Treated (24 Months)|Not Specified|0
211171|NCT00256750|702944|P1|Post-Transplant Treated (24 Months)|Not Specified|2
211172|NCT00256750|702942|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
211173|NCT00256750|702943|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
211174|NCT00256750|702944|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
211175|NCT00256750|702942|P3|Post-Transplant Treated (24 Months)|Death|0
211176|NCT00256750|702943|P2|Post-Transplant Treated (24 Months)|Death|0
211177|NCT00256750|702944|P1|Post-Transplant Treated (24 Months)|Death|3
211178|NCT00256750|702942|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
211179|NCT00256750|702943|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
211180|NCT00256750|702944|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
211181|NCT00256750|702942|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
211182|NCT00256750|702943|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
211183|NCT00256750|702944|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
211184|NCT00256750|702942|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
211185|NCT00256750|702943|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
211186|NCT00256750|702944|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
211187|NCT00256750|702942|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
211188|NCT00256750|702943|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
211189|NCT00256750|702944|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
211190|NCT00256750|702942|P3|Post-Transplant Treated (12 Months)|Not Specified|2
211191|NCT00256750|702943|P2|Post-Transplant Treated (12 Months)|Not Specified|4
211192|NCT00256750|702944|P1|Post-Transplant Treated (12 Months)|Not Specified|5
211193|NCT00256750|702942|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
211194|NCT00256750|702943|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
211195|NCT00256750|702944|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
211196|NCT00256750|702942|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
211197|NCT00256750|702943|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
211198|NCT00256750|702944|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
211199|NCT00256750|702942|P3|Post-Transplant Treated (12 Months)|Death|4
211200|NCT00256750|702943|P2|Post-Transplant Treated (12 Months)|Death|2
211201|NCT00256750|702944|P1|Post-Transplant Treated (12 Months)|Death|3
211202|NCT00256750|702942|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
211203|NCT00256750|702943|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
211204|NCT00256750|702944|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
211205|NCT00256750|702942|P3|Transplanted Pre-Treatment|Death|0
211206|NCT00256750|702943|P2|Transplanted Pre-Treatment|Death|0
211207|NCT00256750|702944|P1|Transplanted Pre-Treatment|Death|1
211208|NCT00256750|702942|P3|Transplanted Pre-Treatment|Not Specified|0
211209|NCT00256750|702943|P2|Transplanted Pre-Treatment|Not Specified|0
211210|NCT00256750|702944|P1|Transplanted Pre-Treatment|Not Specified|2
211211|NCT00256750|702942|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
211212|NCT00256750|702943|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
211213|NCT00256750|702944|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
211214|NCT00256724|703080|P2|Overall Study|Protocol Violation|3
211215|NCT00256724|703081|P1|Overall Study|Protocol Violation|3
211216|NCT00256724|703080|P2|Overall Study|Physician Decision|5
211217|NCT00256724|703081|P1|Overall Study|Physician Decision|2
211218|NCT00256698|703091|P2|Overall Study|Prematurely Discontinued|0
211219|NCT00256698|703092|P1|Overall Study|Prematurely Discontinued|1
211220|NCT00256698|703091|P2|Overall Study|withdrawn due to osteoporosis|0
211221|NCT00256698|703092|P1|Overall Study|withdrawn due to osteoporosis|1
211222|NCT00256698|703091|P2|Overall Study|still ongoing at data cut-off|46
211223|NCT00256698|703092|P1|Overall Study|still ongoing at data cut-off|41
211224|NCT00256698|703091|P2|Overall Study|disease progression|105
211225|NCT00256698|703092|P1|Overall Study|disease progression|97
211226|NCT00256698|703091|P2|Overall Study|Lost to Follow-up|3
211227|NCT00256698|703092|P1|Overall Study|Lost to Follow-up|1
211228|NCT00256698|703091|P2|Overall Study|Protocol Violation|5
211229|NCT00256698|703092|P1|Overall Study|Protocol Violation|6
211230|NCT00256698|703091|P2|Overall Study|Adverse Event|6
211231|NCT00256698|703092|P1|Overall Study|Adverse Event|13
211232|NCT00256698|703091|P2|Overall Study|Withdrawal by Subject|7
211233|NCT00256698|703092|P1|Overall Study|Withdrawal by Subject|7
211234|NCT00256308|703110|P1|Overall Study|Death|2
211235|NCT00256295|703118|P1|Overall Study|Death|1
211236|NCT00256295|703118|P1|Overall Study|Withdrawal by Subject|3
211237|NCT00256282|703124|P1|Overall Study|Physician Decision|1
211238|NCT00256282|703124|P1|Overall Study|Adverse Event|3
211239|NCT00256282|703124|P1|Overall Study|Disease progression, relapse during acti|12
211240|NCT00256243|703129|P1|Overall Study|Not treated|1
211241|NCT00256243|703129|P1|Overall Study|Death|7
211242|NCT00256243|703129|P1|Overall Study|Lost to Follow-up|2
211243|NCT00256204|703138|P4|Overall Study|Need for additional prohibited treatment|25
211244|NCT00256204|703139|P3|Overall Study|Need for additional prohibited treatment|27
211245|NCT00256204|703140|P2|Overall Study|Need for additional prohibited treatment|28
211246|NCT00256204|703141|P1|Overall Study|Need for additional prohibited treatment|38
211247|NCT00256204|703138|P4|Overall Study|Withdrawal by Subject|5
211248|NCT00256204|703139|P3|Overall Study|Withdrawal by Subject|7
211249|NCT00256204|703140|P2|Overall Study|Withdrawal by Subject|6
211250|NCT00256204|703141|P1|Overall Study|Withdrawal by Subject|17
211251|NCT00256204|703138|P4|Overall Study|Physician Decision|2
211252|NCT00256204|703139|P3|Overall Study|Physician Decision|1
211253|NCT00256204|703140|P2|Overall Study|Physician Decision|0
211254|NCT00256204|703141|P1|Overall Study|Physician Decision|0
211255|NCT00256204|703138|P4|Overall Study|Protocol Violation|1
211256|NCT00256204|703139|P3|Overall Study|Protocol Violation|2
211257|NCT00256204|703140|P2|Overall Study|Protocol Violation|0
211258|NCT00256204|703141|P1|Overall Study|Protocol Violation|1
211259|NCT00256204|703138|P4|Overall Study|Lost to Follow-up|2
211260|NCT00256204|703139|P3|Overall Study|Lost to Follow-up|1
211261|NCT00256204|703140|P2|Overall Study|Lost to Follow-up|1
211262|NCT00256204|703141|P1|Overall Study|Lost to Follow-up|1
211263|NCT00256204|703138|P4|Overall Study|Death|0
211264|NCT00256204|703139|P3|Overall Study|Death|0
211265|NCT00256204|703140|P2|Overall Study|Death|1
211266|NCT00256204|703141|P1|Overall Study|Death|0
211267|NCT00256204|703138|P4|Overall Study|Adverse Event|14
211268|NCT00256204|703139|P3|Overall Study|Adverse Event|16
211269|NCT00256204|703140|P2|Overall Study|Adverse Event|14
211270|NCT00256204|703141|P1|Overall Study|Adverse Event|10
211271|NCT00256126|703156|P2|Overall Study|Other|2
211272|NCT00256126|703157|P1|Overall Study|Other|1
211273|NCT00256126|703156|P2|Overall Study|Adverse Event|0
211274|NCT00256126|703157|P1|Overall Study|Adverse Event|1
211275|NCT00255840|703196|P2|Overall Study|Discontinued intervention|56
211276|NCT00255840|703197|P1|Overall Study|Discontinued intervention|53
211277|NCT00255840|703196|P2|Overall Study|Lost to Follow-up|14
211278|NCT00255840|703197|P1|Overall Study|Lost to Follow-up|10
211279|NCT00255723|703205|P2|Overall Study|Response Data Not Available|0
211280|NCT00255723|703206|P1|Overall Study|Response Data Not Available|1
211281|NCT00255723|703205|P2|Overall Study|Death|1
211282|NCT00255723|703206|P1|Overall Study|Death|0
211283|NCT00255723|703205|P2|Overall Study|Adverse Event|1
211284|NCT00255723|703206|P1|Overall Study|Adverse Event|1
211285|NCT00255190|703219|P2|Overall Study|Various|23
211286|NCT00255190|703220|P1|Overall Study|Various|4
211287|NCT00255190|703219|P2|Overall Study|Erosive esophagitis not healed|20
211288|NCT00255190|703220|P1|Overall Study|Erosive esophagitis not healed|0
211289|NCT00255190|703219|P2|Overall Study|Inclusion/Exclusion criteria not met|1
211290|NCT00255190|703220|P1|Overall Study|Inclusion/Exclusion criteria not met|0
211291|NCT00255190|703219|P2|Overall Study|Withdrew Consent|48
211292|NCT00255190|703220|P1|Overall Study|Withdrew Consent|17
211293|NCT00255190|703219|P2|Overall Study|Lost to Follow-up|27
211294|NCT00255190|703220|P1|Overall Study|Lost to Follow-up|10
211295|NCT00255190|703219|P2|Overall Study|Protocol Violation|2
211296|NCT00255190|703220|P1|Overall Study|Protocol Violation|2
211297|NCT00255190|703219|P2|Overall Study|Adverse Event|36
211298|NCT00255190|703220|P1|Overall Study|Adverse Event|17
211299|NCT00255164|703304|P3|Overall Study|Therapeutic Failure|3
211300|NCT00255164|703305|P2|Overall Study|Therapeutic Failure|2
211301|NCT00255164|703306|P1|Overall Study|Therapeutic Failure|11
211302|NCT00255164|703304|P3|Overall Study|Esophageal Stricture|1
211303|NCT00255164|703305|P2|Overall Study|Esophageal Stricture|0
211304|NCT00255164|703306|P1|Overall Study|Esophageal Stricture|0
211305|NCT00255164|703304|P3|Overall Study|Possible Barrett's Esophagus|8
211306|NCT00255164|703305|P2|Overall Study|Possible Barrett's Esophagus|3
211307|NCT00255164|703306|P1|Overall Study|Possible Barrett's Esophagus|1
211308|NCT00255164|703304|P3|Overall Study|Relapse of Erosive Esophagitis|12
211309|NCT00255164|703305|P2|Overall Study|Relapse of Erosive Esophagitis|16
211310|NCT00255164|703306|P1|Overall Study|Relapse of Erosive Esophagitis|78
211311|NCT00255164|703304|P3|Overall Study|Subject Request/Subject Unavailable|2
211312|NCT00255164|703305|P2|Overall Study|Subject Request/Subject Unavailable|1
211313|NCT00255164|703306|P1|Overall Study|Subject Request/Subject Unavailable|1
211314|NCT00255164|703304|P3|Overall Study|Noncompliance|2
211315|NCT00255164|703305|P2|Overall Study|Noncompliance|1
211316|NCT00255164|703306|P1|Overall Study|Noncompliance|0
211317|NCT00255164|703304|P3|Overall Study|Withdrawal by Subject|8
211318|NCT00255164|703305|P2|Overall Study|Withdrawal by Subject|17
211319|NCT00255164|703306|P1|Overall Study|Withdrawal by Subject|18
211320|NCT00255164|703304|P3|Overall Study|Lost to Follow-up|4
211321|NCT00255164|703305|P2|Overall Study|Lost to Follow-up|3
211322|NCT00255164|703306|P1|Overall Study|Lost to Follow-up|4
211323|NCT00255164|703304|P3|Overall Study|Adverse Event|9
211324|NCT00255164|703305|P2|Overall Study|Adverse Event|6
211325|NCT00255164|703306|P1|Overall Study|Adverse Event|10
211326|NCT00255151|703332|P3|Overall Study|Therapeutic Failure|3
211327|NCT00255151|703333|P2|Overall Study|Therapeutic Failure|2
211328|NCT00255151|703334|P1|Overall Study|Therapeutic Failure|11
211329|NCT00255151|703332|P3|Overall Study|Esophageal Stricture|1
211330|NCT00255151|703333|P2|Overall Study|Esophageal Stricture|0
211331|NCT00255151|703334|P1|Overall Study|Esophageal Stricture|0
211332|NCT00255151|703332|P3|Overall Study|Possible Barrett's Esophagus|8
211333|NCT00255151|703333|P2|Overall Study|Possible Barrett's Esophagus|3
211334|NCT00255151|703334|P1|Overall Study|Possible Barrett's Esophagus|1
211335|NCT00255151|703332|P3|Overall Study|Relapse of Erosive Esophagitis|12
211336|NCT00255151|703333|P2|Overall Study|Relapse of Erosive Esophagitis|16
211337|NCT00255151|703334|P1|Overall Study|Relapse of Erosive Esophagitis|78
211338|NCT00255151|703332|P3|Overall Study|Subject Request/Subject Unavailable|2
211339|NCT00255151|703333|P2|Overall Study|Subject Request/Subject Unavailable|1
211340|NCT00255151|703334|P1|Overall Study|Subject Request/Subject Unavailable|1
211341|NCT00255151|703332|P3|Overall Study|Noncompliance|2
211342|NCT00255151|703333|P2|Overall Study|Noncompliance|1
211343|NCT00255151|703334|P1|Overall Study|Noncompliance|0
211344|NCT00255151|703332|P3|Overall Study|Withdrawal by Subject|8
211345|NCT00255151|703333|P2|Overall Study|Withdrawal by Subject|17
211346|NCT00255151|703334|P1|Overall Study|Withdrawal by Subject|18
211347|NCT00255151|703332|P3|Overall Study|Lost to Follow-up|4
211348|NCT00255151|703333|P2|Overall Study|Lost to Follow-up|3
211349|NCT00255151|703334|P1|Overall Study|Lost to Follow-up|4
211350|NCT00255151|703332|P3|Overall Study|Adverse Event|9
211351|NCT00255151|703333|P2|Overall Study|Adverse Event|6
211352|NCT00255151|703334|P1|Overall Study|Adverse Event|10
211353|NCT00255086|703368|P2|Overall Study|Protocol Violation|1
211354|NCT00255086|703369|P1|Overall Study|Protocol Violation|1
211355|NCT00255086|703368|P2|Overall Study|Adverse Event|1
211356|NCT00255086|703369|P1|Overall Study|Adverse Event|1
211357|NCT00255047|703381|P4|Overall Study|Withdrawal by Subject|18
211358|NCT00255047|703382|P3|Overall Study|Withdrawal by Subject|25
211359|NCT00255047|703383|P2|Overall Study|Withdrawal by Subject|23
211360|NCT00255047|703384|P1|Overall Study|Withdrawal by Subject|24
211361|NCT00255047|703381|P4|Overall Study|Lost to Follow-up|6
211362|NCT00255047|703382|P3|Overall Study|Lost to Follow-up|5
211363|NCT00255047|703383|P2|Overall Study|Lost to Follow-up|8
211364|NCT00255047|703384|P1|Overall Study|Lost to Follow-up|9
211365|NCT00255047|703381|P4|Overall Study|Protocol Violation|20
211366|NCT00255047|703382|P3|Overall Study|Protocol Violation|16
211367|NCT00255047|703383|P2|Overall Study|Protocol Violation|13
211368|NCT00255047|703384|P1|Overall Study|Protocol Violation|13
211369|NCT00255047|703381|P4|Overall Study|Adverse Event|1
211370|NCT00255047|703382|P3|Overall Study|Adverse Event|2
211371|NCT00255047|703383|P2|Overall Study|Adverse Event|3
211372|NCT00255047|703384|P1|Overall Study|Adverse Event|0
211373|NCT00255047|703381|P4|Overall Study|Serious Adverse Events|1
211374|NCT00255047|703382|P3|Overall Study|Serious Adverse Events|2
211375|NCT00255047|703383|P2|Overall Study|Serious Adverse Events|1
211376|NCT00255047|703384|P1|Overall Study|Serious Adverse Events|2
211377|NCT00255034|703408|P2|Overall Study|Withdrawal by Subject|38
211378|NCT00255034|703409|P1|Overall Study|Withdrawal by Subject|15
211379|NCT00255008|703419|P4|Overall Study|Other|2
211380|NCT00255008|703420|P3|Overall Study|Other|3
211381|NCT00255008|703421|P2|Overall Study|Other|0
211382|NCT00255008|703422|P1|Overall Study|Other|7
211383|NCT00255008|703419|P4|Overall Study|Adverse lab experience|0
211384|NCT00255008|703420|P3|Overall Study|Adverse lab experience|0
211385|NCT00255008|703421|P2|Overall Study|Adverse lab experience|0
211386|NCT00255008|703422|P1|Overall Study|Adverse lab experience|1
211387|NCT00255008|703419|P4|Overall Study|Sponsor request|17
211388|NCT00255008|703420|P3|Overall Study|Sponsor request|8
211389|NCT00255008|703421|P2|Overall Study|Sponsor request|3
211390|NCT00255008|703422|P1|Overall Study|Sponsor request|18
211391|NCT00255008|703419|P4|Overall Study|Withdrew consent|0
211392|NCT00255008|703420|P3|Overall Study|Withdrew consent|2
211393|NCT00255008|703421|P2|Overall Study|Withdrew consent|0
211394|NCT00255008|703422|P1|Overall Study|Withdrew consent|0
211395|NCT00255008|703419|P4|Overall Study|Did not meet viral reduction criteria|1
211396|NCT00255008|703420|P3|Overall Study|Did not meet viral reduction criteria|0
211397|NCT00255008|703421|P2|Overall Study|Did not meet viral reduction criteria|5
211398|NCT00255008|703422|P1|Overall Study|Did not meet viral reduction criteria|4
211399|NCT00255008|703419|P4|Overall Study|Lost to Follow-up|2
211400|NCT00255008|703420|P3|Overall Study|Lost to Follow-up|1
211401|NCT00255008|703421|P2|Overall Study|Lost to Follow-up|0
211402|NCT00255008|703422|P1|Overall Study|Lost to Follow-up|1
211403|NCT00255008|703419|P4|Overall Study|Adverse Event|0
211404|NCT00255008|703420|P3|Overall Study|Adverse Event|2
211405|NCT00255008|703421|P2|Overall Study|Adverse Event|1
211406|NCT00255008|703422|P1|Overall Study|Adverse Event|1
211407|NCT00254982|703458|P2|Overall Study|Abnormal liver function tests|1
211408|NCT00254982|703459|P1|Overall Study|Abnormal liver function tests|2
211409|NCT00254982|703458|P2|Overall Study|Opportunistic infection|0
211410|NCT00254982|703459|P1|Overall Study|Opportunistic infection|1
211411|NCT00254982|703458|P2|Overall Study|Malignancy|2
211412|NCT00254982|703459|P1|Overall Study|Malignancy|0
211413|NCT00254982|703458|P2|Overall Study|Diagnosis of Tuberculosis|1
211414|NCT00254982|703459|P1|Overall Study|Diagnosis of Tuberculosis|1
211415|NCT00254982|703458|P2|Overall Study|Protocol deviation|1
211416|NCT00254982|703459|P1|Overall Study|Protocol deviation|1
211417|NCT00254982|703458|P2|Overall Study|Inclusion/exclusion criteria violation|2
211418|NCT00254982|703459|P1|Overall Study|Inclusion/exclusion criteria violation|0
211419|NCT00254982|703458|P2|Overall Study|Withdrawal by Subject|1
211420|NCT00254982|703459|P1|Overall Study|Withdrawal by Subject|1
211421|NCT00254982|703458|P2|Overall Study|Adverse Event|16
211422|NCT00254982|703459|P1|Overall Study|Adverse Event|18
211423|NCT00254982|703458|P2|Overall Study|Lost to Follow-up|3
211424|NCT00254982|703459|P1|Overall Study|Lost to Follow-up|5
211425|NCT00254982|703458|P2|Overall Study|Lack of Efficacy|3
211426|NCT00254982|703459|P1|Overall Study|Lack of Efficacy|5
211427|NCT00254982|703458|P2|Overall Study|Not specified|1
211428|NCT00254982|703459|P1|Overall Study|Not specified|2
211429|NCT00254566|703471|P2|Overall Study|Lost to Follow-up|2
211430|NCT00254566|703472|P1|Overall Study|Lost to Follow-up|7
211431|NCT00254566|703471|P2|Overall Study|Withdrawal by Subject|6
211432|NCT00254566|703472|P1|Overall Study|Withdrawal by Subject|5
211433|NCT00254566|703471|P2|Overall Study|Other|5
211434|NCT00254566|703472|P1|Overall Study|Other|1
211435|NCT00254566|703471|P2|Overall Study|Lack of Efficacy|9
211436|NCT00254566|703472|P1|Overall Study|Lack of Efficacy|12
211437|NCT00254566|703471|P2|Overall Study|Adverse Event|4
211438|NCT00254566|703472|P1|Overall Study|Adverse Event|5
211439|NCT00254566|703471|P2|Overall Study|Death|0
211440|NCT00254566|703472|P1|Overall Study|Death|1
211441|NCT00254540|703496|P2|Overall Study|Laboratory Test Abnormality|1
211442|NCT00254540|703497|P1|Overall Study|Laboratory Test Abnormality|0
211443|NCT00254540|703496|P2|Overall Study|Death|1
211444|NCT00254540|703497|P1|Overall Study|Death|0
211445|NCT00254540|703496|P2|Overall Study|Lack of Efficacy|13
211446|NCT00254540|703497|P1|Overall Study|Lack of Efficacy|13
211447|NCT00254540|703496|P2|Overall Study|Adverse Event|7
211448|NCT00254540|703497|P1|Overall Study|Adverse Event|6
211449|NCT00254501|703526|P2|Overall Study|Lost to Follow-up|1
211450|NCT00254501|703527|P1|Overall Study|Lost to Follow-up|1
211451|NCT00254293|703556|P7|LTE Open Label Fixed Dosing|not specified|1
211452|NCT00254293|703557|P6|LTE Open Label Fixed Dosing|not specified|0
211453|NCT00254293|703558|P5|LTE Open Label Fixed Dosing|not specified|0
211454|NCT00254293|703559|P4|LTE Open Label Fixed Dosing|not specified|0
211455|NCT00254293|703560|P3|LTE Open Label Fixed Dosing|not specified|0
211456|NCT00254293|703561|P2|LTE Open Label Fixed Dosing|not specified|0
211457|NCT00254293|703562|P1|LTE Open Label Fixed Dosing|not specified|0
211458|NCT00254293|703556|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
211459|NCT00254293|703557|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
211460|NCT00254293|703558|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
211461|NCT00254293|703559|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
211462|NCT00254293|703560|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
211463|NCT00254293|703561|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
211464|NCT00254293|703562|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
211465|NCT00254293|703556|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
211466|NCT00254293|703557|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
211467|NCT00254293|703558|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
211468|NCT00254293|703559|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
211469|NCT00254293|703560|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
211470|NCT00254293|703561|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
211471|NCT00254293|703562|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
211472|NCT00254293|703556|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
211473|NCT00254293|703557|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
211474|NCT00254293|703558|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
211475|NCT00254293|703559|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
211476|NCT00254293|703560|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
211477|NCT00254293|703561|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
211478|NCT00254293|703562|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
211479|NCT00254293|703556|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
211480|NCT00254293|703557|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
211481|NCT00254293|703558|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
211482|NCT00254293|703559|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
211483|NCT00254293|703560|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
211484|NCT00254293|703561|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
211485|NCT00254293|703562|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
211486|NCT00254293|703556|P7|LTE Open Label Fixed Dosing|Adverse Event|1
211487|NCT00254293|703557|P6|LTE Open Label Fixed Dosing|Adverse Event|0
211488|NCT00254293|703558|P5|LTE Open Label Fixed Dosing|Adverse Event|0
211489|NCT00254293|703559|P4|LTE Open Label Fixed Dosing|Adverse Event|0
211490|NCT00254293|703560|P3|LTE Open Label Fixed Dosing|Adverse Event|0
211491|NCT00254293|703561|P2|LTE Open Label Fixed Dosing|Adverse Event|0
211492|NCT00254293|703562|P1|LTE Open Label Fixed Dosing|Adverse Event|0
211493|NCT00254293|703556|P7|LTE Open Label Fixed Dosing|Death|3
211494|NCT00254293|703557|P6|LTE Open Label Fixed Dosing|Death|0
211495|NCT00254293|703558|P5|LTE Open Label Fixed Dosing|Death|0
211496|NCT00254293|703559|P4|LTE Open Label Fixed Dosing|Death|0
211497|NCT00254293|703560|P3|LTE Open Label Fixed Dosing|Death|0
211498|NCT00254293|703561|P2|LTE Open Label Fixed Dosing|Death|0
211499|NCT00254293|703562|P1|LTE Open Label Fixed Dosing|Death|0
211500|NCT00254293|703556|P7|LTE Open Label Variable SC Dosing|not specified|0
211501|NCT00254293|703557|P6|LTE Open Label Variable SC Dosing|not specified|0
211502|NCT00254293|703558|P5|LTE Open Label Variable SC Dosing|not specified|0
211503|NCT00254293|703559|P4|LTE Open Label Variable SC Dosing|not specified|0
211504|NCT00254293|703560|P3|LTE Open Label Variable SC Dosing|not specified|2
211505|NCT00254293|703561|P2|LTE Open Label Variable SC Dosing|not specified|0
211506|NCT00254293|703562|P1|LTE Open Label Variable SC Dosing|not specified|0
211507|NCT00254293|703556|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
211508|NCT00254293|703557|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
211509|NCT00254293|703558|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
211510|NCT00254293|703559|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
211511|NCT00254293|703560|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
211512|NCT00254293|703561|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
211513|NCT00254293|703562|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
211514|NCT00254293|703556|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
211515|NCT00254293|703557|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
211516|NCT00254293|703558|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
211517|NCT00254293|703559|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
211518|NCT00254293|703560|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
211519|NCT00254293|703561|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
211520|NCT00254293|703562|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
211521|NCT00254293|703556|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
211522|NCT00254293|703557|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
211523|NCT00254293|703558|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
211524|NCT00254293|703559|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
211525|NCT00254293|703560|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
211526|NCT00254293|703561|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
211527|NCT00254293|703562|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
211528|NCT00254293|703556|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
211529|NCT00254293|703557|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
211530|NCT00254293|703558|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
211531|NCT00254293|703559|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
211532|NCT00254293|703560|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
211533|NCT00254293|703561|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
211534|NCT00254293|703562|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
211535|NCT00254293|703556|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
211536|NCT00254293|703557|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
211537|NCT00254293|703558|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
211538|NCT00254293|703559|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
211539|NCT00254293|703560|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
211540|NCT00254293|703561|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
211541|NCT00254293|703562|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
211542|NCT00254293|703556|P7|LTE Open Label Variable SC Dosing|Death|0
211543|NCT00254293|703557|P6|LTE Open Label Variable SC Dosing|Death|0
211544|NCT00254293|703558|P5|LTE Open Label Variable SC Dosing|Death|0
211545|NCT00254293|703559|P4|LTE Open Label Variable SC Dosing|Death|0
211546|NCT00254293|703560|P3|LTE Open Label Variable SC Dosing|Death|1
211547|NCT00254293|703561|P2|LTE Open Label Variable SC Dosing|Death|0
211548|NCT00254293|703562|P1|LTE Open Label Variable SC Dosing|Death|0
211549|NCT00254293|703556|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
211550|NCT00254293|703557|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
211551|NCT00254293|703558|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
211552|NCT00254293|703559|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
211553|NCT00254293|703560|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
211554|NCT00254293|703561|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
211555|NCT00254293|703562|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
211556|NCT00254293|703556|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
211557|NCT00254293|703557|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
211558|NCT00254293|703558|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
211559|NCT00254293|703559|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
211560|NCT00254293|703560|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
211561|NCT00254293|703561|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
211562|NCT00254293|703562|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
211563|NCT00254293|703556|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
211564|NCT00254293|703557|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
211565|NCT00254293|703558|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
211566|NCT00254293|703559|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
211567|NCT00254293|703560|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
211568|NCT00254293|703561|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
211569|NCT00254293|703562|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
211570|NCT00254163|703645|P2|Overall Study|Other|8
211571|NCT00254163|703646|P1|Overall Study|Other|8
211572|NCT00254163|703645|P2|Overall Study|Death|1
211573|NCT00254163|703646|P1|Overall Study|Death|0
211574|NCT00254163|703645|P2|Overall Study|Progressive disease|1
211575|NCT00254163|703646|P1|Overall Study|Progressive disease|0
211576|NCT00254163|703645|P2|Overall Study|Failed entry|3
211577|NCT00254163|703646|P1|Overall Study|Failed entry|1
211578|NCT00254163|703645|P2|Overall Study|Investigator request|3
211579|NCT00254163|703646|P1|Overall Study|Investigator request|1
211580|NCT00254163|703645|P2|Overall Study|Patient request/withdrew consent|4
211581|NCT00254163|703646|P1|Overall Study|Patient request/withdrew consent|6
211582|NCT00254163|703645|P2|Overall Study|Adverse Event|26
211583|NCT00254163|703646|P1|Overall Study|Adverse Event|29
211584|NCT00253747|703697|P2|Overall Study|Administrative Discharge (1), Other (2)|2
211585|NCT00253747|703698|P1|Overall Study|Administrative Discharge (1), Other (2)|1
211586|NCT00253747|703697|P2|Overall Study|Withdrawal by Subject|11
211587|NCT00253747|703698|P1|Overall Study|Withdrawal by Subject|10
211588|NCT00253747|703697|P2|Overall Study|Lost to Follow-up|14
211589|NCT00253747|703698|P1|Overall Study|Lost to Follow-up|13
211590|NCT00253643|703751|P4|Overall Study|Non-Compliance|2
211591|NCT00253643|703752|P3|Overall Study|Non-Compliance|0
211592|NCT00253643|703753|P2|Overall Study|Non-Compliance|0
211593|NCT00253643|703754|P1|Overall Study|Non-Compliance|0
211594|NCT00253643|703751|P4|Overall Study|Withdrawal by Subject|1
211595|NCT00253643|703752|P3|Overall Study|Withdrawal by Subject|1
211596|NCT00253643|703753|P2|Overall Study|Withdrawal by Subject|0
211597|NCT00253643|703754|P1|Overall Study|Withdrawal by Subject|0
211598|NCT00253630|703768|P1|Overall Study|ineligible|2
211599|NCT00253448|703784|P1|Overall Study|Withdrawal by Subject|1
211600|NCT00253370|703803|P1|Overall Study|Abdominal pain due to disease|1
211601|NCT00253370|703803|P1|Overall Study|Protocol Violation|1
211602|NCT00253370|703803|P1|Overall Study|Physician Decision|1
211603|NCT00253370|703803|P1|Overall Study|Non-protocol therapy|1
211604|NCT00253370|703803|P1|Overall Study|Withdrawal by Subject|6
211605|NCT00253370|703803|P1|Overall Study|Death|2
211606|NCT00253370|703803|P1|Overall Study|Disease progression|13
211607|NCT00253370|703803|P1|Overall Study|Adverse Event|18
211608|NCT00252733|703849|P2|Overall Study|Multiple Reasons|14
211609|NCT00252733|703850|P1|Overall Study|Multiple Reasons|14
211610|NCT00252733|703849|P2|Overall Study|Lost to Follow-up|6
211611|NCT00252733|703850|P1|Overall Study|Lost to Follow-up|12
211612|NCT00252733|703849|P2|Overall Study|Death|5
211613|NCT00252733|703850|P1|Overall Study|Death|7
211614|NCT00252733|703849|P2|Overall Study|Withdrawal by Subject|67
211615|NCT00252733|703850|P1|Overall Study|Withdrawal by Subject|73
211616|NCT00252720|703860|P2|Overall Study|Mainly patients lost to follow-up|18
211617|NCT00252720|703861|P1|Overall Study|Mainly patients lost to follow-up|7
211618|NCT00252720|703860|P2|Overall Study|Moving|42
211619|NCT00252720|703861|P1|Overall Study|Moving|23
211620|NCT00252720|703860|P2|Overall Study|Death|8
211621|NCT00252720|703861|P1|Overall Study|Death|7
211622|NCT00252720|703860|P2|Overall Study|Withdrawal by Subject|97
211623|NCT00252720|703861|P1|Overall Study|Withdrawal by Subject|95
211624|NCT00252694|703875|P2|Overall Study|Patient Moving|16
211625|NCT00252694|703876|P1|Overall Study|Patient Moving|17
211626|NCT00252694|703875|P2|Overall Study|Mostly Lost to Follow Up|13
211627|NCT00252694|703876|P1|Overall Study|Mostly Lost to Follow Up|8
211628|NCT00252694|703875|P2|Overall Study|Death|34
211629|NCT00252694|703876|P1|Overall Study|Death|36
211630|NCT00252694|703875|P2|Overall Study|Withdrawal by Subject|91
211631|NCT00252694|703876|P1|Overall Study|Withdrawal by Subject|83
211632|NCT00252564|703924|P2|Overall Study|Withdrawal by Subject|2
211633|NCT00252564|703925|P1|Overall Study|Withdrawal by Subject|0
211634|NCT00252564|703924|P2|Overall Study|Patient Request|5
211635|NCT00252564|703925|P1|Overall Study|Patient Request|4
211636|NCT00252564|703924|P2|Overall Study|Lost to Follow-up|0
211637|NCT00252564|703925|P1|Overall Study|Lost to Follow-up|1
211638|NCT00252564|703924|P2|Overall Study|Physician Decision|0
211639|NCT00252564|703925|P1|Overall Study|Physician Decision|1
211640|NCT00252564|703924|P2|Overall Study|Protocol Violation|0
211641|NCT00252564|703925|P1|Overall Study|Protocol Violation|0
211642|NCT00252564|703924|P2|Overall Study|Death|3
211643|NCT00252564|703925|P1|Overall Study|Death|0
211644|NCT00252564|703924|P2|Overall Study|Disease Progression|20
211645|NCT00252564|703925|P1|Overall Study|Disease Progression|14
211646|NCT00252564|703924|P2|Overall Study|Unrelated Complication|1
211647|NCT00252564|703925|P1|Overall Study|Unrelated Complication|2
211648|NCT00252564|703924|P2|Overall Study|Adverse Event|13
211649|NCT00252564|703925|P1|Overall Study|Adverse Event|17
211650|NCT00252499|703955|P3|Overall Study|Lost to Follow-up|0
211651|NCT00252499|703956|P2|Overall Study|Lost to Follow-up|0
211652|NCT00252499|703957|P1|Overall Study|Lost to Follow-up|1
211653|NCT00252239|703989|P4|Overall Study|Lost to Follow-up|0
211654|NCT00252239|703990|P3|Overall Study|Lost to Follow-up|2
211655|NCT00252239|703991|P2|Overall Study|Lost to Follow-up|0
211656|NCT00252239|703992|P1|Overall Study|Lost to Follow-up|0
211657|NCT00252239|703989|P4|Overall Study|Withdrawal by Subject|1
211658|NCT00252239|703990|P3|Overall Study|Withdrawal by Subject|0
211659|NCT00252239|703991|P2|Overall Study|Withdrawal by Subject|0
211660|NCT00252239|703992|P1|Overall Study|Withdrawal by Subject|1
211661|NCT00252187|704004|P2|Overall Study|Withdrawal by Subject|0
211662|NCT00252187|704005|P1|Overall Study|Withdrawal by Subject|1
211663|NCT00252187|704004|P2|Overall Study|Adverse Event|1
211664|NCT00252187|704005|P1|Overall Study|Adverse Event|3
211665|NCT00252174|704028|P3|Overall Study|Withdrawal by Subject|0
211666|NCT00252174|704029|P2|Overall Study|Withdrawal by Subject|1
211667|NCT00252174|704030|P1|Overall Study|Withdrawal by Subject|0
211668|NCT00252057|704070|P2|Overall Study|Participant previously enrolled|1
211669|NCT00252057|704071|P1|Overall Study|Participant previously enrolled|0
211670|NCT00252057|704070|P2|Overall Study|Death|2
211671|NCT00252057|704071|P1|Overall Study|Death|1
211672|NCT00252057|704070|P2|Overall Study|Withdrawal by Subject|5
211673|NCT00252057|704071|P1|Overall Study|Withdrawal by Subject|2
211674|NCT00251979|704079|P2|Overall Study|Death|5
211675|NCT00251979|704080|P1|Overall Study|Death|3
211676|NCT00251979|704079|P2|Overall Study|Lost to Follow-up|6
211677|NCT00251979|704080|P1|Overall Study|Lost to Follow-up|8
211678|NCT00251979|704079|P2|Overall Study|Withdrawal by Subject|7
211679|NCT00251979|704080|P1|Overall Study|Withdrawal by Subject|13
211680|NCT00251979|704079|P2|Overall Study|Adverse Event|17
211681|NCT00251979|704080|P1|Overall Study|Adverse Event|11
211682|NCT00251979|704079|P2|Overall Study|Protocol Violation|5
211683|NCT00251979|704080|P1|Overall Study|Protocol Violation|3
211684|NCT00251927|704112|P2|Overall Study|Study procedure non-compliance|6
211685|NCT00251927|704113|P1|Overall Study|Study procedure non-compliance|5
211686|NCT00251927|704112|P2|Overall Study|Study-specific discont. achieved|2
211687|NCT00251927|704113|P1|Overall Study|Study-specific discont. achieved|13
211688|NCT00251927|704112|P2|Overall Study|Withdrawal by Subject|25
211689|NCT00251927|704113|P1|Overall Study|Withdrawal by Subject|40
211690|NCT00251927|704112|P2|Overall Study|Pregnancy|0
211691|NCT00251927|704113|P1|Overall Study|Pregnancy|2
211692|NCT00251927|704112|P2|Overall Study|Protocol Violation|2
211693|NCT00251927|704113|P1|Overall Study|Protocol Violation|1
211694|NCT00251927|704112|P2|Overall Study|Lost to Follow-up|8
211695|NCT00251927|704113|P1|Overall Study|Lost to Follow-up|22
211696|NCT00251927|704112|P2|Overall Study|Lack of Efficacy|16
211697|NCT00251927|704113|P1|Overall Study|Lack of Efficacy|22
211698|NCT00251927|704112|P2|Overall Study|Adverse Event|15
211699|NCT00251927|704113|P1|Overall Study|Adverse Event|3
211700|NCT00251758|704165|P3|Overall Study|Per Investigator Request|0
211701|NCT00251758|704166|P2|Overall Study|Per Investigator Request|0
211702|NCT00251758|704167|P1|Overall Study|Per Investigator Request|1
211703|NCT00251758|704165|P3|Overall Study|Per Subject Request|1
211704|NCT00251758|704166|P2|Overall Study|Per Subject Request|0
211705|NCT00251758|704167|P1|Overall Study|Per Subject Request|0
211706|NCT00251758|704165|P3|Overall Study|Pregnancy|0
211707|NCT00251758|704166|P2|Overall Study|Pregnancy|1
211708|NCT00251758|704167|P1|Overall Study|Pregnancy|0
211709|NCT00251758|704165|P3|Overall Study|Noncompliant|2
211710|NCT00251758|704166|P2|Overall Study|Noncompliant|2
211711|NCT00251758|704167|P1|Overall Study|Noncompliant|0
211712|NCT00251758|704165|P3|Overall Study|Lack of Efficacy|0
211713|NCT00251758|704166|P2|Overall Study|Lack of Efficacy|0
211714|NCT00251758|704167|P1|Overall Study|Lack of Efficacy|3
211715|NCT00251758|704165|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
211716|NCT00251758|704166|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
211717|NCT00251758|704167|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
211718|NCT00251758|704165|P3|Overall Study|Withdrawal by Subject|3
211719|NCT00251758|704166|P2|Overall Study|Withdrawal by Subject|7
211720|NCT00251758|704167|P1|Overall Study|Withdrawal by Subject|13
211721|NCT00251758|704165|P3|Overall Study|Lost to Follow-up|5
211722|NCT00251758|704166|P2|Overall Study|Lost to Follow-up|2
211723|NCT00251758|704167|P1|Overall Study|Lost to Follow-up|4
211724|NCT00251758|704165|P3|Overall Study|Adverse Event|11
211725|NCT00251758|704166|P2|Overall Study|Adverse Event|9
211726|NCT00251758|704167|P1|Overall Study|Adverse Event|7
211727|NCT00251745|704187|P3|Overall Study|Per Investigator Request|0
211728|NCT00251745|704188|P2|Overall Study|Per Investigator Request|0
211729|NCT00251745|704189|P1|Overall Study|Per Investigator Request|1
211730|NCT00251745|704187|P3|Overall Study|Per Subject Request|1
211731|NCT00251745|704188|P2|Overall Study|Per Subject Request|0
211732|NCT00251745|704189|P1|Overall Study|Per Subject Request|0
211733|NCT00251745|704187|P3|Overall Study|Pregnancy|0
211734|NCT00251745|704188|P2|Overall Study|Pregnancy|1
211735|NCT00251745|704189|P1|Overall Study|Pregnancy|0
211736|NCT00251745|704187|P3|Overall Study|Noncompliant|2
211737|NCT00251745|704188|P2|Overall Study|Noncompliant|2
211738|NCT00251745|704189|P1|Overall Study|Noncompliant|0
211739|NCT00251745|704187|P3|Overall Study|Lack of Efficacy|0
211740|NCT00251745|704188|P2|Overall Study|Lack of Efficacy|0
211741|NCT00251745|704189|P1|Overall Study|Lack of Efficacy|3
211742|NCT00251745|704187|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
211743|NCT00251745|704188|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
211744|NCT00251745|704189|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
211745|NCT00251745|704187|P3|Overall Study|Withdrawal by Subject|3
211746|NCT00251745|704188|P2|Overall Study|Withdrawal by Subject|7
211747|NCT00251745|704189|P1|Overall Study|Withdrawal by Subject|13
211748|NCT00251745|704187|P3|Overall Study|Lost to Follow-up|5
211749|NCT00251745|704188|P2|Overall Study|Lost to Follow-up|2
211750|NCT00251745|704189|P1|Overall Study|Lost to Follow-up|4
211751|NCT00251745|704187|P3|Overall Study|Adverse Event|11
211752|NCT00251745|704188|P2|Overall Study|Adverse Event|9
211753|NCT00251745|704189|P1|Overall Study|Adverse Event|7
211754|NCT00251719|704209|P3|Overall Study|Barrett's esophagus|0
211755|NCT00251719|704210|P2|Overall Study|Barrett's esophagus|2
211756|NCT00251719|704211|P1|Overall Study|Barrett's esophagus|2
211757|NCT00251719|704209|P3|Overall Study|Noncompliance|1
211758|NCT00251719|704210|P2|Overall Study|Noncompliance|3
211759|NCT00251719|704211|P1|Overall Study|Noncompliance|2
211760|NCT00251719|704209|P3|Overall Study|Investigator decision|0
211761|NCT00251719|704210|P2|Overall Study|Investigator decision|1
211762|NCT00251719|704211|P1|Overall Study|Investigator decision|1
211763|NCT00251719|704209|P3|Overall Study|Inclusion/exclusion criteria not met|2
211764|NCT00251719|704210|P2|Overall Study|Inclusion/exclusion criteria not met|6
211765|NCT00251719|704211|P1|Overall Study|Inclusion/exclusion criteria not met|12
211766|NCT00251719|704209|P3|Overall Study|Lack of Efficacy|0
211767|NCT00251719|704210|P2|Overall Study|Lack of Efficacy|1
211768|NCT00251719|704211|P1|Overall Study|Lack of Efficacy|2
211769|NCT00251719|704209|P3|Overall Study|Withdrawal by Subject|11
211770|NCT00251719|704210|P2|Overall Study|Withdrawal by Subject|12
211771|NCT00251719|704211|P1|Overall Study|Withdrawal by Subject|14
211772|NCT00251719|704209|P3|Overall Study|Lost to Follow-up|8
211773|NCT00251719|704210|P2|Overall Study|Lost to Follow-up|11
211774|NCT00251719|704211|P1|Overall Study|Lost to Follow-up|5
211775|NCT00251719|704209|P3|Overall Study|Protocol Violation|1
211776|NCT00251719|704210|P2|Overall Study|Protocol Violation|1
211777|NCT00251719|704211|P1|Overall Study|Protocol Violation|1
211778|NCT00251719|704209|P3|Overall Study|Adverse Event|7
211779|NCT00251719|704210|P2|Overall Study|Adverse Event|8
211780|NCT00251719|704211|P1|Overall Study|Adverse Event|14
211781|NCT00251693|704237|P3|Overall Study|Abnormal laboratory findings|1
211782|NCT00251693|704238|P2|Overall Study|Abnormal laboratory findings|0
211783|NCT00251693|704239|P1|Overall Study|Abnormal laboratory findings|0
211784|NCT00251693|704237|P3|Overall Study|Subject request/subject unavailable|0
211785|NCT00251693|704238|P2|Overall Study|Subject request/subject unavailable|2
211786|NCT00251693|704239|P1|Overall Study|Subject request/subject unavailable|1
211787|NCT00251693|704237|P3|Overall Study|Possible Barrett's esophagus|2
211788|NCT00251693|704238|P2|Overall Study|Possible Barrett's esophagus|5
211789|NCT00251693|704239|P1|Overall Study|Possible Barrett's esophagus|3
211790|NCT00251693|704237|P3|Overall Study|Noncompliant|2
211791|NCT00251693|704238|P2|Overall Study|Noncompliant|0
211792|NCT00251693|704239|P1|Overall Study|Noncompliant|0
211793|NCT00251693|704237|P3|Overall Study|Inclusion/exclusion criteria not met|8
211794|NCT00251693|704238|P2|Overall Study|Inclusion/exclusion criteria not met|3
211795|NCT00251693|704239|P1|Overall Study|Inclusion/exclusion criteria not met|5
211796|NCT00251693|704237|P3|Overall Study|Lack of Efficacy|0
211797|NCT00251693|704238|P2|Overall Study|Lack of Efficacy|1
211798|NCT00251693|704239|P1|Overall Study|Lack of Efficacy|0
211799|NCT00251693|704237|P3|Overall Study|Withdrawal by Subject|14
211800|NCT00251693|704238|P2|Overall Study|Withdrawal by Subject|17
211801|NCT00251693|704239|P1|Overall Study|Withdrawal by Subject|11
211802|NCT00251693|704237|P3|Overall Study|Lost to Follow-up|8
211803|NCT00251693|704238|P2|Overall Study|Lost to Follow-up|7
211804|NCT00251693|704239|P1|Overall Study|Lost to Follow-up|12
211805|NCT00251693|704237|P3|Overall Study|Protocol Violation|2
211806|NCT00251693|704238|P2|Overall Study|Protocol Violation|0
211807|NCT00251693|704239|P1|Overall Study|Protocol Violation|2
211808|NCT00251693|704237|P3|Overall Study|Adverse Event|9
211809|NCT00251693|704238|P2|Overall Study|Adverse Event|9
211810|NCT00251693|704239|P1|Overall Study|Adverse Event|17
211811|NCT00251641|704264|P2|Overall Study|Switched Treatment|63
211812|NCT00251641|704265|P1|Overall Study|Switched Treatment|9
211813|NCT00251641|704264|P2|Overall Study|Did not Meet protocol Eligibility|1
211814|NCT00251641|704265|P1|Overall Study|Did not Meet protocol Eligibility|2
211815|NCT00251641|704264|P2|Overall Study|Protocol Violation|2
211816|NCT00251641|704265|P1|Overall Study|Protocol Violation|10
211817|NCT00251641|704264|P2|Overall Study|Withdrawal by Subject|8
211818|NCT00251641|704265|P1|Overall Study|Withdrawal by Subject|6
211819|NCT00251641|704264|P2|Overall Study|Lost to Follow-up|3
211820|NCT00251641|704265|P1|Overall Study|Lost to Follow-up|3
211821|NCT00251641|704264|P2|Overall Study|Progression of Disease|2
211822|NCT00251641|704265|P1|Overall Study|Progression of Disease|0
211823|NCT00251641|704264|P2|Overall Study|Lack of Efficacy|1
211824|NCT00251641|704265|P1|Overall Study|Lack of Efficacy|2
211825|NCT00251641|704264|P2|Overall Study|Adverse Event|8
211826|NCT00251641|704265|P1|Overall Study|Adverse Event|80
211827|NCT00251589|704283|P4|Overall Study|Discontinued due to progressive disease|1
211828|NCT00251589|704284|P3|Overall Study|Discontinued due to progressive disease|0
211829|NCT00251589|704285|P2|Overall Study|Discontinued due to progressive disease|1
211830|NCT00251589|704286|P1|Overall Study|Discontinued due to progressive disease|9
211831|NCT00251589|704283|P4|Overall Study|Withdrawal by Subject|0
211832|NCT00251589|704284|P3|Overall Study|Withdrawal by Subject|0
211833|NCT00251589|704285|P2|Overall Study|Withdrawal by Subject|1
211834|NCT00251589|704286|P1|Overall Study|Withdrawal by Subject|1
211835|NCT00251589|704283|P4|Overall Study|Adverse Event|1
211836|NCT00251589|704284|P3|Overall Study|Adverse Event|2
211837|NCT00251589|704285|P2|Overall Study|Adverse Event|1
211838|NCT00251589|704286|P1|Overall Study|Adverse Event|5
211839|NCT00251316|704323|P2|Overall Study|Physician Decision|3
211840|NCT00251316|704324|P1|Overall Study|Physician Decision|2
211841|NCT00251004|704363|P3|Overall Study|Graft Loss|8
211842|NCT00251004|704364|P2|Overall Study|Graft Loss|13
211843|NCT00251004|704365|P1|Overall Study|Graft Loss|12
211844|NCT00251004|704363|P3|Overall Study|Lost to Follow-up|1
211845|NCT00251004|704364|P2|Overall Study|Lost to Follow-up|2
211846|NCT00251004|704365|P1|Overall Study|Lost to Follow-up|1
211847|NCT00251004|704363|P3|Overall Study|Death|8
211848|NCT00251004|704364|P2|Overall Study|Death|10
211849|NCT00251004|704365|P1|Overall Study|Death|9
211850|NCT00251004|704363|P3|Overall Study|Withdrawal by Subject|14
211851|NCT00251004|704364|P2|Overall Study|Withdrawal by Subject|16
211852|NCT00251004|704365|P1|Overall Study|Withdrawal by Subject|23
211853|NCT00250835|704389|P1|Overall Study|Withdrawal by Subject|1
211854|NCT00250718|704398|P1|Overall Study|Withdrawal by Subject|1
211855|NCT00250718|704398|P1|Overall Study|Adverse Event|1
211856|NCT00250718|704398|P1|Overall Study|Death|1
211857|NCT00250705|704403|P1|Overall Study|Lack of Efficacy|2
211858|NCT00250679|704414|P3|Overall Study|various single events: hip surgery,diary|1
211859|NCT00250679|704415|P2|Overall Study|various single events: hip surgery,diary|1
211860|NCT00250679|704416|P1|Overall Study|various single events: hip surgery,diary|3
211861|NCT00250679|704414|P3|Overall Study|Non-compliance|0
211862|NCT00250679|704415|P2|Overall Study|Non-compliance|1
211863|NCT00250679|704416|P1|Overall Study|Non-compliance|1
211864|NCT00250679|704414|P3|Overall Study|Moved|0
211865|NCT00250679|704415|P2|Overall Study|Moved|1
211866|NCT00250679|704416|P1|Overall Study|Moved|1
211867|NCT00250679|704414|P3|Overall Study|Technical Holter issues|2
211868|NCT00250679|704415|P2|Overall Study|Technical Holter issues|0
211869|NCT00250679|704416|P1|Overall Study|Technical Holter issues|1
211870|NCT00250679|704414|P3|Overall Study|Lack of Efficacy|3
211871|NCT00250679|704415|P2|Overall Study|Lack of Efficacy|1
211872|NCT00250679|704416|P1|Overall Study|Lack of Efficacy|0
211873|NCT00250679|704414|P3|Overall Study|Does Not Meet Entry Criteria|2
211874|NCT00250679|704415|P2|Overall Study|Does Not Meet Entry Criteria|4
211875|NCT00250679|704416|P1|Overall Study|Does Not Meet Entry Criteria|1
211876|NCT00250679|704414|P3|Overall Study|Lost to Follow-up|2
211877|NCT00250679|704415|P2|Overall Study|Lost to Follow-up|4
211878|NCT00250679|704416|P1|Overall Study|Lost to Follow-up|3
211879|NCT00250679|704414|P3|Overall Study|Withdrawal by Subject|15
211880|NCT00250679|704415|P2|Overall Study|Withdrawal by Subject|18
211881|NCT00250679|704416|P1|Overall Study|Withdrawal by Subject|15
211882|NCT00250679|704414|P3|Overall Study|Protocol Violation|3
211883|NCT00250679|704415|P2|Overall Study|Protocol Violation|4
211884|NCT00250679|704416|P1|Overall Study|Protocol Violation|2
211885|NCT00250679|704414|P3|Overall Study|Adverse Event|16
211886|NCT00250679|704415|P2|Overall Study|Adverse Event|15
211887|NCT00250679|704416|P1|Overall Study|Adverse Event|12
211888|NCT00250588|704517|P3|Overall Study|Lost to Follow-up|13
211889|NCT00250588|704518|P2|Overall Study|Lost to Follow-up|13
211890|NCT00250588|704519|P1|Overall Study|Lost to Follow-up|6
211891|NCT00250588|704517|P3|Overall Study|Withdrawal by Subject|0
211892|NCT00250588|704518|P2|Overall Study|Withdrawal by Subject|6
211893|NCT00250588|704519|P1|Overall Study|Withdrawal by Subject|3
211894|NCT00250458|704567|P2|Overall Study|Not Specified|0
211895|NCT00250458|704568|P1|Overall Study|Not Specified|1
211896|NCT00250458|704567|P2|Overall Study|Qualifying migraine but did not treat|3
211897|NCT00250458|704568|P1|Overall Study|Qualifying migraine but did not treat|3
211898|NCT00250458|704567|P2|Overall Study|Lack of Migraine Attack|9
211899|NCT00250458|704568|P1|Overall Study|Lack of Migraine Attack|20
211900|NCT00250458|704567|P2|Overall Study|Withdrawal by Subject|2
211901|NCT00250458|704568|P1|Overall Study|Withdrawal by Subject|4
211902|NCT00250458|704567|P2|Overall Study|Protocol Violation|1
211903|NCT00250458|704568|P1|Overall Study|Protocol Violation|0
211904|NCT00250458|704567|P2|Overall Study|Lost to Follow-up|2
211905|NCT00250458|704568|P1|Overall Study|Lost to Follow-up|4
211906|NCT00250432|704578|P2|Overall Study|Pt was considered untreatable|1
211907|NCT00250432|704579|P1|Overall Study|Pt was considered untreatable|0
211908|NCT00250432|704578|P2|Overall Study|Pt died out of posttherapy report period|5
211909|NCT00250432|704579|P1|Overall Study|Pt died out of posttherapy report period|6
211910|NCT00250432|704578|P2|Overall Study|Withdrawal by Subject|2
211911|NCT00250432|704579|P1|Overall Study|Withdrawal by Subject|6
211912|NCT00250432|704578|P2|Overall Study|Protocol Violation|3
211913|NCT00250432|704579|P1|Overall Study|Protocol Violation|0
211914|NCT00250432|704578|P2|Overall Study|Patient Moved|1
211915|NCT00250432|704579|P1|Overall Study|Patient Moved|0
211916|NCT00250432|704578|P2|Overall Study|Lost to Follow-up|5
211917|NCT00250432|704579|P1|Overall Study|Lost to Follow-up|6
211918|NCT00250432|704578|P2|Overall Study|Lack of Efficacy|1
211919|NCT00250432|704579|P1|Overall Study|Lack of Efficacy|2
211920|NCT00250432|704578|P2|Overall Study|Adverse Event|29
211921|NCT00250432|704579|P1|Overall Study|Adverse Event|25
211922|NCT00250276|704591|P4|Overall Study|Lost to Follow-up|8
211923|NCT00250276|704592|P3|Overall Study|Lost to Follow-up|13
211924|NCT00250276|704593|P2|Overall Study|Lost to Follow-up|18
211925|NCT00250276|704594|P1|Overall Study|Lost to Follow-up|11
211926|NCT00250276|704591|P4|Overall Study|Migrated/moved from study area|7
211927|NCT00250276|704592|P3|Overall Study|Migrated/moved from study area|2
211928|NCT00250276|704593|P2|Overall Study|Migrated/moved from study area|0
211929|NCT00250276|704594|P1|Overall Study|Migrated/moved from study area|3
211930|NCT00250276|704591|P4|Overall Study|Withdrawal by Subject|2
211931|NCT00250276|704592|P3|Overall Study|Withdrawal by Subject|3
211932|NCT00250276|704593|P2|Overall Study|Withdrawal by Subject|2
211933|NCT00250276|704594|P1|Overall Study|Withdrawal by Subject|1
211934|NCT00250276|704591|P4|Overall Study|Protocol Violation|0
211935|NCT00250276|704592|P3|Overall Study|Protocol Violation|0
211936|NCT00250276|704593|P2|Overall Study|Protocol Violation|1
211937|NCT00250276|704594|P1|Overall Study|Protocol Violation|0
211938|NCT00250276|704591|P4|Overall Study|Non-serious Adverse Event|2
211939|NCT00250276|704592|P3|Overall Study|Non-serious Adverse Event|0
211940|NCT00250276|704593|P2|Overall Study|Non-serious Adverse Event|0
211941|NCT00250276|704594|P1|Overall Study|Non-serious Adverse Event|2
211942|NCT00250276|704591|P4|Overall Study|Serious Adverse Event|0
211943|NCT00250276|704592|P3|Overall Study|Serious Adverse Event|1
211944|NCT00250276|704593|P2|Overall Study|Serious Adverse Event|0
211945|NCT00250276|704594|P1|Overall Study|Serious Adverse Event|0
211946|NCT00249873|704674|P2|Overall Study|Thromboembolic/outcome event|122
211947|NCT00249873|704675|P1|Overall Study|Thromboembolic/outcome event|82
211948|NCT00249873|704674|P2|Overall Study|Event related to cardiac condition|21
211949|NCT00249873|704675|P1|Overall Study|Event related to cardiac condition|12
211950|NCT00249873|704674|P2|Overall Study|Surgery/ procedure|9
211951|NCT00249873|704675|P1|Overall Study|Surgery/ procedure|9
211952|NCT00249873|704674|P2|Overall Study|Study drug intolerance|0
211953|NCT00249873|704675|P1|Overall Study|Study drug intolerance|5
211954|NCT00249873|704674|P2|Overall Study|Oral anticoagulant required|157
211955|NCT00249873|704675|P1|Overall Study|Oral anticoagulant required|159
211956|NCT00249873|704674|P2|Overall Study|Angiotensin II receptor blocker required|0
211957|NCT00249873|704675|P1|Overall Study|Angiotensin II receptor blocker required|1
211958|NCT00249873|704674|P2|Overall Study|Open label clopidogrel required|42
211959|NCT00249873|704675|P1|Overall Study|Open label clopidogrel required|31
211960|NCT00249873|704674|P2|Overall Study|Physician withdrew consent|60
211961|NCT00249873|704675|P1|Overall Study|Physician withdrew consent|59
211962|NCT00249873|704674|P2|Overall Study|Patient not wish to continue after May08|4
211963|NCT00249873|704675|P1|Overall Study|Patient not wish to continue after May08|3
211964|NCT00249873|704674|P2|Overall Study|Other contraindicated medication|0
211965|NCT00249873|704675|P1|Overall Study|Other contraindicated medication|1
211966|NCT00249873|704674|P2|Overall Study|Other non serious Adverse Event|108
211967|NCT00249873|704675|P1|Overall Study|Other non serious Adverse Event|112
211968|NCT00249873|704674|P2|Overall Study|Non-compliance|46
211969|NCT00249873|704675|P1|Overall Study|Non-compliance|41
211970|NCT00249873|704674|P2|Overall Study|Minor bleeding|37
211971|NCT00249873|704675|P1|Overall Study|Minor bleeding|99
211972|NCT00249873|704674|P2|Overall Study|Lost to Follow-up|7
211973|NCT00249873|704675|P1|Overall Study|Lost to Follow-up|4
211974|NCT00249873|704674|P2|Overall Study|Withdrawal by Subject|466
211975|NCT00249873|704675|P1|Overall Study|Withdrawal by Subject|504
211976|NCT00249873|704674|P2|Overall Study|Contraindication to oral anticoagulant|8
211977|NCT00249873|704675|P1|Overall Study|Contraindication to oral anticoagulant|4
211978|NCT00249873|704674|P2|Overall Study|Qualifying condition not present|23
211979|NCT00249873|704675|P1|Overall Study|Qualifying condition not present|20
211980|NCT00249873|704674|P2|Overall Study|Other Serious Adverse Event|97
211981|NCT00249873|704675|P1|Overall Study|Other Serious Adverse Event|86
211982|NCT00249873|704674|P2|Overall Study|Serious haemorrhagic Adverse Event|30
211983|NCT00249873|704675|P1|Overall Study|Serious haemorrhagic Adverse Event|74
211984|NCT00249873|704674|P2|Overall Study|Severe allergic reaction|1
211985|NCT00249873|704675|P1|Overall Study|Severe allergic reaction|8
211986|NCT00249873|704674|P2|Overall Study|Significant thrombocytopenia|8
211987|NCT00249873|704675|P1|Overall Study|Significant thrombocytopenia|9
211988|NCT00249873|704674|P2|Overall Study|Not treated|8
211989|NCT00249873|704675|P1|Overall Study|Not treated|7
211990|NCT00249834|704695|P8|Overall Study|Protocol Violation|0
211991|NCT00249834|704696|P7|Overall Study|Protocol Violation|0
211992|NCT00249834|704697|P6|Overall Study|Protocol Violation|2
211993|NCT00249834|704698|P5|Overall Study|Protocol Violation|5
211994|NCT00249834|704699|P4|Overall Study|Protocol Violation|8
211995|NCT00249834|704700|P3|Overall Study|Protocol Violation|14
211996|NCT00249834|704701|P2|Overall Study|Protocol Violation|19
211997|NCT00249834|704702|P1|Overall Study|Protocol Violation|0
211998|NCT00249834|704695|P8|Overall Study|Failure of down-regulation|0
211999|NCT00249834|704696|P7|Overall Study|Failure of down-regulation|1
212000|NCT00249834|704697|P6|Overall Study|Failure of down-regulation|0
212001|NCT00249834|704698|P5|Overall Study|Failure of down-regulation|0
212002|NCT00249834|704699|P4|Overall Study|Failure of down-regulation|0
212003|NCT00249834|704700|P3|Overall Study|Failure of down-regulation|0
212004|NCT00249834|704701|P2|Overall Study|Failure of down-regulation|0
212005|NCT00249834|704702|P1|Overall Study|Failure of down-regulation|0
212006|NCT00249834|704695|P8|Overall Study|Ovarian stimulation failed|0
212007|NCT00249834|704696|P7|Overall Study|Ovarian stimulation failed|0
212008|NCT00249834|704697|P6|Overall Study|Ovarian stimulation failed|0
212009|NCT00249834|704698|P5|Overall Study|Ovarian stimulation failed|0
212010|NCT00249834|704699|P4|Overall Study|Ovarian stimulation failed|0
212011|NCT00249834|704700|P3|Overall Study|Ovarian stimulation failed|0
212012|NCT00249834|704701|P2|Overall Study|Ovarian stimulation failed|0
212013|NCT00249834|704702|P1|Overall Study|Ovarian stimulation failed|1
212014|NCT00249821|704751|P2|Overall Study|Technical problem|1
212015|NCT00249821|704752|P1|Overall Study|Technical problem|0
212016|NCT00249808|704772|P1|Overall Study|Did Not Provide Post-Baseline Data|11
212017|NCT00249808|704772|P1|Overall Study|Lack of Efficacy|52
212018|NCT00249808|704772|P1|Overall Study|Adverse Event|81
212019|NCT00249808|704772|P1|Overall Study|Lost to Follow-up|8
212020|NCT00249808|704772|P1|Overall Study|Protocol Violation|3
212021|NCT00249808|704772|P1|Overall Study|Other|27
212022|NCT00249795|704780|P2|Overall Study|Missing|1
212023|NCT00249795|704781|P1|Overall Study|Missing|0
212024|NCT00249795|704780|P2|Overall Study|Lost to Follow-up|2
212025|NCT00249795|704781|P1|Overall Study|Lost to Follow-up|0
212026|NCT00249795|704780|P2|Overall Study|Site not agree to continue after May08|1
212027|NCT00249795|704781|P1|Overall Study|Site not agree to continue after May08|1
212028|NCT00249795|704780|P2|Overall Study|Patient not wish to continue after May08|6
212029|NCT00249795|704781|P1|Overall Study|Patient not wish to continue after May08|4
212030|NCT00249795|704780|P2|Overall Study|Event related to cardiac condition|16
212031|NCT00249795|704781|P1|Overall Study|Event related to cardiac condition|17
212032|NCT00249795|704780|P2|Overall Study|Other contraindicated medication|1
212033|NCT00249795|704781|P1|Overall Study|Other contraindicated medication|1
212034|NCT00249795|704780|P2|Overall Study|Hypotension (non-symptomatic)|5
212035|NCT00249795|704781|P1|Overall Study|Hypotension (non-symptomatic)|5
212036|NCT00249795|704780|P2|Overall Study|Lightheadedness / dizziness|11
212037|NCT00249795|704781|P1|Overall Study|Lightheadedness / dizziness|15
212038|NCT00249795|704780|P2|Overall Study|Angiotensin II receptor blocker required|58
212039|NCT00249795|704781|P1|Overall Study|Angiotensin II receptor blocker required|35
212040|NCT00249795|704780|P2|Overall Study|Surgery / procedure|5
212041|NCT00249795|704781|P1|Overall Study|Surgery / procedure|4
212042|NCT00249795|704780|P2|Overall Study|Physician withdrew consent|63
212043|NCT00249795|704781|P1|Overall Study|Physician withdrew consent|71
212044|NCT00249795|704780|P2|Overall Study|Other adverse events (non-serious)|159
212045|NCT00249795|704781|P1|Overall Study|Other adverse events (non-serious)|188
212046|NCT00249795|704780|P2|Overall Study|Study drug intolerance|3
212047|NCT00249795|704781|P1|Overall Study|Study drug intolerance|3
212048|NCT00249795|704780|P2|Overall Study|Non-compliance|69
212049|NCT00249795|704781|P1|Overall Study|Non-compliance|71
212050|NCT00249795|704780|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
212051|NCT00249795|704781|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
212052|NCT00249795|704780|P2|Overall Study|Oral anticoagulant required|0
212053|NCT00249795|704781|P1|Overall Study|Oral anticoagulant required|2
212054|NCT00249795|704780|P2|Overall Study|Thromboembolic / outcome event|45
212055|NCT00249795|704781|P1|Overall Study|Thromboembolic / outcome event|39
212056|NCT00249795|704780|P2|Overall Study|Withdrawal by Subject|742
212057|NCT00249795|704781|P1|Overall Study|Withdrawal by Subject|678
212058|NCT00249795|704780|P2|Overall Study|Qualifying condition not present|29
212059|NCT00249795|704781|P1|Overall Study|Qualifying condition not present|26
212060|NCT00249795|704780|P2|Overall Study|Other Serious Adverse Event|93
212061|NCT00249795|704781|P1|Overall Study|Other Serious Adverse Event|84
212062|NCT00249795|704780|P2|Overall Study|Symptomatic hypotension|64
212063|NCT00249795|704781|P1|Overall Study|Symptomatic hypotension|127
212064|NCT00249795|704780|P2|Overall Study|Not treated|14
212065|NCT00249795|704781|P1|Overall Study|Not treated|16
212066|NCT00249613|704801|P2|12 Month Follow-up|Lost to Follow-up|8
212067|NCT00249613|704802|P1|12 Month Follow-up|Lost to Follow-up|10
212068|NCT00249613|704801|P2|12 Month Follow-up|Withdrawal by Subject|6
212069|NCT00249613|704802|P1|12 Month Follow-up|Withdrawal by Subject|6
212070|NCT00249613|704801|P2|12 Month Follow-up|Death|1
212071|NCT00249613|704802|P1|12 Month Follow-up|Death|1
212072|NCT00249444|704843|P2|Overall Study|life event|1
212073|NCT00249444|704844|P1|Overall Study|life event|0
212074|NCT00249444|704843|P2|Overall Study|Adverse Event|1
212075|NCT00249444|704844|P1|Overall Study|Adverse Event|1
212076|NCT00249444|704843|P2|Overall Study|non-compliant|11
212077|NCT00249444|704844|P1|Overall Study|non-compliant|9
212078|NCT00249444|704843|P2|Overall Study|Lost to Follow-up|2
212079|NCT00249444|704844|P1|Overall Study|Lost to Follow-up|2
212080|NCT00249288|704869|P2|Overall Study|Withdrawal by Subject|2
212081|NCT00249288|704870|P1|Overall Study|Withdrawal by Subject|2
212082|NCT00249288|704869|P2|Overall Study|Lost to Follow-up|3
212083|NCT00249288|704870|P1|Overall Study|Lost to Follow-up|3
212084|NCT00249002|704962|P1|Overall Study|Other|2
212085|NCT00249002|704962|P1|Overall Study|Study cancellation|3
212086|NCT00249002|704962|P1|Overall Study|Adverse Event|2
212087|NCT00248794|704998|P3|Overall Study|Lost to Follow-up|3
212088|NCT00248794|704999|P2|Overall Study|Lost to Follow-up|8
212089|NCT00248794|705000|P1|Overall Study|Lost to Follow-up|6
212090|NCT00248651|705050|P3|Overall Study|Withdrawal by Subject|32
212091|NCT00248651|705051|P2|Overall Study|Withdrawal by Subject|40
212092|NCT00248651|705052|P1|Overall Study|Withdrawal by Subject|28
212093|NCT00248625|705088|P2|Overall Study|Withdrawal by Subject|2
212094|NCT00248625|705089|P1|Overall Study|Withdrawal by Subject|0
212095|NCT00248495|705171|P1|Overall Study|Withdrawal by Subject|1
212096|NCT00248287|705182|P2|Overall Study|Other|2
212097|NCT00248287|705183|P1|Overall Study|Other|3
212098|NCT00248287|705182|P2|Overall Study|Patient Request|3
212099|NCT00248287|705183|P1|Overall Study|Patient Request|5
212100|NCT00248287|705182|P2|Overall Study|Investigator Request|3
212101|NCT00248287|705183|P1|Overall Study|Investigator Request|4
212102|NCT00248287|705182|P2|Overall Study|Lost to Follow-up|1
212103|NCT00248287|705183|P1|Overall Study|Lost to Follow-up|0
212104|NCT00248287|705182|P2|Overall Study|Death|0
212105|NCT00248287|705183|P1|Overall Study|Death|1
212106|NCT00248287|705182|P2|Overall Study|Adverse Event|10
212107|NCT00248287|705183|P1|Overall Study|Adverse Event|11
212108|NCT00248170|705197|P2|Overall Study|Protocol deviation|19
212109|NCT00248170|705198|P1|Overall Study|Protocol deviation|17
212110|NCT00248170|705197|P2|Overall Study|Abnormal laboratory values|0
212111|NCT00248170|705198|P1|Overall Study|Abnormal laboratory values|4
212112|NCT00248170|705197|P2|Overall Study|Abnormal test procedure(s) result|61
212113|NCT00248170|705198|P1|Overall Study|Abnormal test procedure(s) result|49
212114|NCT00248170|705197|P2|Overall Study|Administrative problems|25
212115|NCT00248170|705198|P1|Overall Study|Administrative problems|22
212116|NCT00248170|705197|P2|Overall Study|Adverse Event|296
212117|NCT00248170|705198|P1|Overall Study|Adverse Event|311
212118|NCT00248170|705197|P2|Overall Study|Death|47
212119|NCT00248170|705198|P1|Overall Study|Death|28
212120|NCT00248170|705197|P2|Overall Study|Disease progression|216
212121|NCT00248170|705198|P1|Overall Study|Disease progression|196
212122|NCT00248170|705197|P2|Overall Study|Lost to Follow-up|35
212123|NCT00248170|705198|P1|Overall Study|Lost to Follow-up|28
212124|NCT00248170|705197|P2|Overall Study|Protocol Violation|30
212125|NCT00248170|705198|P1|Overall Study|Protocol Violation|35
212126|NCT00248170|705197|P2|Overall Study|Withdrawal by Subject|79
212127|NCT00248170|705198|P1|Overall Study|Withdrawal by Subject|71
212128|NCT00247962|705220|P2|Overall Study|Lack of Efficacy|2
212129|NCT00247962|705221|P1|Overall Study|Lack of Efficacy|4
212130|NCT00247962|705220|P2|Overall Study|Withdrawal by Subject|2
212131|NCT00247962|705221|P1|Overall Study|Withdrawal by Subject|3
212132|NCT00247962|705220|P2|Overall Study|Protocol Violation|1
212133|NCT00247962|705221|P1|Overall Study|Protocol Violation|1
212134|NCT00247962|705220|P2|Overall Study|Physician Decision|1
212135|NCT00247962|705221|P1|Overall Study|Physician Decision|0
212136|NCT00247962|705220|P2|Overall Study|Lost to Follow-up|1
212137|NCT00247962|705221|P1|Overall Study|Lost to Follow-up|3
212138|NCT00247962|705220|P2|Overall Study|Adverse Event|12
212139|NCT00247962|705221|P1|Overall Study|Adverse Event|15
212140|NCT00247676|705229|P1|Overall Study|Withdrawal by Subject|2
212141|NCT00247676|705229|P1|Overall Study|Other|3
212142|NCT00247676|705229|P1|Overall Study|Lack of Efficacy|15
212143|NCT00247676|705229|P1|Overall Study|Adverse Event|11
212144|NCT00247676|705229|P1|Overall Study|Death|5
212145|NCT00247611|705274|P2|Baselined|Completed baseline only|8
212146|NCT00247611|705275|P1|Baselined|Completed baseline only|9
212147|NCT00247611|705274|P2|Baselined|Completed baseline, never placed on ARVs|5
212148|NCT00247611|705275|P1|Baselined|Completed baseline, never placed on ARVs|8
212149|NCT00247416|705293|P2|Overall Study|3 patients were found to be ineligible|2
212150|NCT00247416|705294|P1|Overall Study|3 patients were found to be ineligible|1
212151|NCT00247273|705335|P2|Overall Study|Did not take any study drug|0
212152|NCT00247273|705336|P1|Overall Study|Did not take any study drug|2
212153|NCT00247273|705335|P2|Overall Study|Withdrawal by Subject|47
212154|NCT00247273|705336|P1|Overall Study|Withdrawal by Subject|46
212155|NCT00247273|705335|P2|Overall Study|Lost to Follow-up|7
212156|NCT00247273|705336|P1|Overall Study|Lost to Follow-up|7
212157|NCT00247273|705335|P2|Overall Study|Physician Decision|3
212158|NCT00247273|705336|P1|Overall Study|Physician Decision|6
212159|NCT00247273|705335|P2|Overall Study|Adverse Event|80
212160|NCT00247273|705336|P1|Overall Study|Adverse Event|85
212161|NCT00246805|705382|P2|Phase 1|Lost to Follow-up|0
212162|NCT00246805|705383|P1|Phase 1|Lost to Follow-up|1
212163|NCT00246753|705389|P1|Overall Study|Unacceptable toxicity|2
212164|NCT00246753|705389|P1|Overall Study|Adverse Event|2
212165|NCT00246753|705389|P1|Overall Study|Physician Decision|2
212166|NCT00246753|705389|P1|Overall Study|Withdrawal by Subject|2
212167|NCT00246740|705397|P2|Initial Enrollment|Other|2
212168|NCT00246740|705398|P1|Initial Enrollment|Other|1
212169|NCT00246740|705397|P2|Initial Enrollment|Surgery schedule change|4
212170|NCT00246740|705398|P1|Initial Enrollment|Surgery schedule change|4
212171|NCT00246740|705397|P2|Initial Enrollment|Additional surgery scheduled|2
212172|NCT00246740|705398|P1|Initial Enrollment|Additional surgery scheduled|0
212173|NCT00246740|705397|P2|Initial Enrollment|Death|0
212174|NCT00246740|705398|P1|Initial Enrollment|Death|1
212175|NCT00246571|705422|P2|Overall Study|Crossover participants|74
212176|NCT00246571|705423|P1|Overall Study|Crossover participants|0
212177|NCT00246571|705422|P2|Overall Study|Laboratory abnormalities|0
212178|NCT00246571|705423|P1|Overall Study|Laboratory abnormalities|1
212179|NCT00246571|705422|P2|Overall Study|Did not meet entrance criteria|1
212180|NCT00246571|705423|P1|Overall Study|Did not meet entrance criteria|2
212181|NCT00246571|705422|P2|Overall Study|Sponsor|1
212182|NCT00246571|705423|P1|Overall Study|Sponsor|0
212183|NCT00246571|705422|P2|Overall Study|Death|3
212184|NCT00246571|705423|P1|Overall Study|Death|17
212185|NCT00246571|705422|P2|Overall Study|Lack of Efficacy|21
212186|NCT00246571|705423|P1|Overall Study|Lack of Efficacy|84
212187|NCT00246571|705422|P2|Overall Study|Withdrawal by Subject|3
212188|NCT00246571|705423|P1|Overall Study|Withdrawal by Subject|2
212189|NCT00246571|705422|P2|Overall Study|Protocol Violation|1
212190|NCT00246571|705423|P1|Overall Study|Protocol Violation|0
212191|NCT00246571|705422|P2|Overall Study|Adverse Event|0
212192|NCT00246571|705423|P1|Overall Study|Adverse Event|7
212193|NCT00246376|705475|P5|Overall Study|Lost to Follow-up|13
212194|NCT00246376|705476|P4|Overall Study|Lost to Follow-up|16
212195|NCT00246376|705477|P3|Overall Study|Lost to Follow-up|11
212196|NCT00246376|705478|P2|Overall Study|Lost to Follow-up|11
212197|NCT00246376|705479|P1|Overall Study|Lost to Follow-up|2
212198|NCT00246376|705475|P5|Overall Study|Adverse Event|1
212199|NCT00246376|705476|P4|Overall Study|Adverse Event|3
212200|NCT00246376|705477|P3|Overall Study|Adverse Event|1
212201|NCT00246376|705478|P2|Overall Study|Adverse Event|3
212202|NCT00246376|705479|P1|Overall Study|Adverse Event|2
212203|NCT00246376|705475|P5|Overall Study|Dropped/withdrew during dietary run-in|3
212204|NCT00246376|705476|P4|Overall Study|Dropped/withdrew during dietary run-in|7
212205|NCT00246376|705477|P3|Overall Study|Dropped/withdrew during dietary run-in|4
212206|NCT00246376|705478|P2|Overall Study|Dropped/withdrew during dietary run-in|5
212207|NCT00246376|705479|P1|Overall Study|Dropped/withdrew during dietary run-in|11
212208|NCT00246337|705530|P9|Overall Study|Reported as completing trial in error|0
212209|NCT00246337|705531|P8|Overall Study|Reported as completing trial in error|1
212210|NCT00246337|705532|P7|Overall Study|Reported as completing trial in error|0
212211|NCT00246337|705533|P6|Overall Study|Reported as completing trial in error|0
212212|NCT00246337|705534|P5|Overall Study|Reported as completing trial in error|0
212213|NCT00246337|705535|P4|Overall Study|Reported as completing trial in error|0
212214|NCT00246337|705536|P3|Overall Study|Reported as completing trial in error|0
212215|NCT00246337|705537|P2|Overall Study|Reported as completing trial in error|0
212216|NCT00246337|705538|P1|Overall Study|Reported as completing trial in error|0
212217|NCT00246337|705530|P9|Overall Study|Protocol Violator|0
212218|NCT00246337|705531|P8|Overall Study|Protocol Violator|0
212219|NCT00246337|705532|P7|Overall Study|Protocol Violator|0
212220|NCT00246337|705533|P6|Overall Study|Protocol Violator|0
212221|NCT00246337|705534|P5|Overall Study|Protocol Violator|0
212222|NCT00246337|705535|P4|Overall Study|Protocol Violator|0
212223|NCT00246337|705536|P3|Overall Study|Protocol Violator|0
212224|NCT00246337|705537|P2|Overall Study|Protocol Violator|0
212225|NCT00246337|705538|P1|Overall Study|Protocol Violator|1
212226|NCT00246337|705530|P9|Overall Study|Overwhelmed|0
212227|NCT00246337|705531|P8|Overall Study|Overwhelmed|0
212228|NCT00246337|705532|P7|Overall Study|Overwhelmed|0
212229|NCT00246337|705533|P6|Overall Study|Overwhelmed|1
212230|NCT00246337|705534|P5|Overall Study|Overwhelmed|0
212231|NCT00246337|705535|P4|Overall Study|Overwhelmed|0
212232|NCT00246337|705536|P3|Overall Study|Overwhelmed|0
212233|NCT00246337|705537|P2|Overall Study|Overwhelmed|0
212234|NCT00246337|705538|P1|Overall Study|Overwhelmed|0
212235|NCT00246337|705530|P9|Overall Study|Abnormal baseline lab values|4
212236|NCT00246337|705531|P8|Overall Study|Abnormal baseline lab values|0
212237|NCT00246337|705532|P7|Overall Study|Abnormal baseline lab values|2
212238|NCT00246337|705533|P6|Overall Study|Abnormal baseline lab values|2
212239|NCT00246337|705534|P5|Overall Study|Abnormal baseline lab values|0
212240|NCT00246337|705535|P4|Overall Study|Abnormal baseline lab values|0
212241|NCT00246337|705536|P3|Overall Study|Abnormal baseline lab values|2
212242|NCT00246337|705537|P2|Overall Study|Abnormal baseline lab values|0
212243|NCT00246337|705538|P1|Overall Study|Abnormal baseline lab values|7
212244|NCT00246337|705530|P9|Overall Study|Site Terminated|2
212245|NCT00246337|705531|P8|Overall Study|Site Terminated|6
212246|NCT00246337|705532|P7|Overall Study|Site Terminated|1
212247|NCT00246337|705533|P6|Overall Study|Site Terminated|7
212248|NCT00246337|705534|P5|Overall Study|Site Terminated|0
212249|NCT00246337|705535|P4|Overall Study|Site Terminated|0
212250|NCT00246337|705536|P3|Overall Study|Site Terminated|0
212251|NCT00246337|705537|P2|Overall Study|Site Terminated|0
212252|NCT00246337|705538|P1|Overall Study|Site Terminated|10
212253|NCT00246337|705530|P9|Overall Study|Lack of Qualifying Event|5
212254|NCT00246337|705531|P8|Overall Study|Lack of Qualifying Event|2
212255|NCT00246337|705532|P7|Overall Study|Lack of Qualifying Event|3
212256|NCT00246337|705533|P6|Overall Study|Lack of Qualifying Event|3
212257|NCT00246337|705534|P5|Overall Study|Lack of Qualifying Event|1
212258|NCT00246337|705535|P4|Overall Study|Lack of Qualifying Event|1
212259|NCT00246337|705536|P3|Overall Study|Lack of Qualifying Event|1
212260|NCT00246337|705537|P2|Overall Study|Lack of Qualifying Event|2
212261|NCT00246337|705538|P1|Overall Study|Lack of Qualifying Event|8
212262|NCT00246337|705530|P9|Overall Study|Withdrawal by Subject|0
212263|NCT00246337|705531|P8|Overall Study|Withdrawal by Subject|1
212264|NCT00246337|705532|P7|Overall Study|Withdrawal by Subject|1
212265|NCT00246337|705533|P6|Overall Study|Withdrawal by Subject|0
212266|NCT00246337|705534|P5|Overall Study|Withdrawal by Subject|0
212267|NCT00246337|705535|P4|Overall Study|Withdrawal by Subject|0
212268|NCT00246337|705536|P3|Overall Study|Withdrawal by Subject|0
212269|NCT00246337|705537|P2|Overall Study|Withdrawal by Subject|0
212270|NCT00246337|705538|P1|Overall Study|Withdrawal by Subject|2
212271|NCT00246337|705530|P9|Overall Study|Protocol Violation|0
212272|NCT00246337|705531|P8|Overall Study|Protocol Violation|1
212273|NCT00246337|705532|P7|Overall Study|Protocol Violation|1
212274|NCT00246337|705533|P6|Overall Study|Protocol Violation|0
212275|NCT00246337|705534|P5|Overall Study|Protocol Violation|1
212276|NCT00246337|705535|P4|Overall Study|Protocol Violation|0
212277|NCT00246337|705536|P3|Overall Study|Protocol Violation|0
212278|NCT00246337|705537|P2|Overall Study|Protocol Violation|0
212279|NCT00246337|705538|P1|Overall Study|Protocol Violation|1
212280|NCT00246337|705530|P9|Overall Study|Lost to Follow-up|0
212281|NCT00246337|705531|P8|Overall Study|Lost to Follow-up|2
212282|NCT00246337|705532|P7|Overall Study|Lost to Follow-up|1
212283|NCT00246337|705533|P6|Overall Study|Lost to Follow-up|2
212284|NCT00246337|705534|P5|Overall Study|Lost to Follow-up|2
212285|NCT00246337|705535|P4|Overall Study|Lost to Follow-up|0
212286|NCT00246337|705536|P3|Overall Study|Lost to Follow-up|0
212287|NCT00246337|705537|P2|Overall Study|Lost to Follow-up|0
212288|NCT00246337|705538|P1|Overall Study|Lost to Follow-up|3
212289|NCT00246324|705585|P1|Overall Study|Withdrawal by Subject|1
212290|NCT00246259|705592|P2|Overall Study|randomly assigned, not eligible for ITT|6
212291|NCT00246259|705593|P1|Overall Study|randomly assigned, not eligible for ITT|2
212292|NCT00246259|705592|P2|Overall Study|Withdrawal by Subject|1
212293|NCT00246259|705593|P1|Overall Study|Withdrawal by Subject|5
212294|NCT00246259|705592|P2|Overall Study|Lost to Follow-up|4
212295|NCT00246259|705593|P1|Overall Study|Lost to Follow-up|3
212296|NCT00246259|705592|P2|Overall Study|Adverse Event|0
212297|NCT00246259|705593|P1|Overall Study|Adverse Event|5
212298|NCT00246259|705592|P2|Overall Study|Investigator withdrew participant|0
212299|NCT00246259|705593|P1|Overall Study|Investigator withdrew participant|2
212300|NCT00246259|705592|P2|Overall Study|Lack of Efficacy|2
212301|NCT00246259|705593|P1|Overall Study|Lack of Efficacy|2
212302|NCT00246259|705592|P2|Overall Study|Participant non-compliant|9
212303|NCT00246259|705593|P1|Overall Study|Participant non-compliant|4
212304|NCT00246259|705592|P2|Overall Study|Not stable by Week 18|1
212305|NCT00246259|705593|P1|Overall Study|Not stable by Week 18|2
212306|NCT00246259|705592|P2|Overall Study|Other|3
212307|NCT00246259|705593|P1|Overall Study|Other|3
212308|NCT00246090|705627|P1|Overall Study|Not Otherwise Specified|10
212309|NCT00246090|705627|P1|Overall Study|Physician Decision|11
212310|NCT00246090|705627|P1|Overall Study|Clinical Progression|30
212311|NCT00246090|705627|P1|Overall Study|Progressive Disease|212
212312|NCT00246090|705627|P1|Overall Study|Withdrawal by Subject|7
212313|NCT00246090|705627|P1|Overall Study|Adverse Event|25
212314|NCT00246025|705636|P4|Overall Study|unsuitable medical history was found|1
212315|NCT00246025|705637|P3|Overall Study|unsuitable medical history was found|0
212316|NCT00246025|705638|P2|Overall Study|unsuitable medical history was found|0
212317|NCT00246025|705639|P1|Overall Study|unsuitable medical history was found|0
212318|NCT00246025|705636|P4|Overall Study|Withdrawal by Subject|2
212319|NCT00246025|705637|P3|Overall Study|Withdrawal by Subject|1
212320|NCT00246025|705638|P2|Overall Study|Withdrawal by Subject|0
212321|NCT00246025|705639|P1|Overall Study|Withdrawal by Subject|3
212322|NCT00246025|705636|P4|Overall Study|Adverse Event|10
212323|NCT00246025|705637|P3|Overall Study|Adverse Event|9
212324|NCT00246025|705638|P2|Overall Study|Adverse Event|9
212325|NCT00246025|705639|P1|Overall Study|Adverse Event|7
212326|NCT00246012|705698|P9|Overall Study|Randomly assigned but not treated|0
212327|NCT00246012|705699|P8|Overall Study|Randomly assigned but not treated|0
212328|NCT00246012|705700|P7|Overall Study|Randomly assigned but not treated|1
212329|NCT00246012|705701|P6|Overall Study|Randomly assigned but not treated|1
212330|NCT00246012|705702|P5|Overall Study|Randomly assigned but not treated|0
212331|NCT00246012|705703|P4|Overall Study|Randomly assigned but not treated|0
212332|NCT00246012|705704|P3|Overall Study|Randomly assigned but not treated|0
212333|NCT00246012|705705|P2|Overall Study|Randomly assigned but not treated|0
212334|NCT00246012|705706|P1|Overall Study|Randomly assigned but not treated|0
212335|NCT00246012|705698|P9|Overall Study|Other|0
212336|NCT00246012|705699|P8|Overall Study|Other|1
212337|NCT00246012|705700|P7|Overall Study|Other|0
212338|NCT00246012|705701|P6|Overall Study|Other|0
212339|NCT00246012|705702|P5|Overall Study|Other|0
212340|NCT00246012|705703|P4|Overall Study|Other|0
212341|NCT00246012|705704|P3|Overall Study|Other|0
212342|NCT00246012|705705|P2|Overall Study|Other|0
212343|NCT00246012|705706|P1|Overall Study|Other|0
212344|NCT00246012|705698|P9|Overall Study|Disease progression|26
212345|NCT00246012|705699|P8|Overall Study|Disease progression|27
212346|NCT00246012|705700|P7|Overall Study|Disease progression|30
212347|NCT00246012|705701|P6|Overall Study|Disease progression|25
212348|NCT00246012|705702|P5|Overall Study|Disease progression|3
212349|NCT00246012|705703|P4|Overall Study|Disease progression|3
212350|NCT00246012|705704|P3|Overall Study|Disease progression|2
212351|NCT00246012|705705|P2|Overall Study|Disease progression|1
212352|NCT00246012|705706|P1|Overall Study|Disease progression|3
212353|NCT00246012|705698|P9|Overall Study|Withdrawal by Subject|0
212354|NCT00246012|705699|P8|Overall Study|Withdrawal by Subject|0
212355|NCT00246012|705700|P7|Overall Study|Withdrawal by Subject|0
212356|NCT00246012|705701|P6|Overall Study|Withdrawal by Subject|1
212357|NCT00246012|705702|P5|Overall Study|Withdrawal by Subject|0
212358|NCT00246012|705703|P4|Overall Study|Withdrawal by Subject|0
212359|NCT00246012|705704|P3|Overall Study|Withdrawal by Subject|0
212360|NCT00246012|705705|P2|Overall Study|Withdrawal by Subject|0
212361|NCT00246012|705706|P1|Overall Study|Withdrawal by Subject|0
212362|NCT00246012|705698|P9|Overall Study|Adverse Event|2
212363|NCT00246012|705699|P8|Overall Study|Adverse Event|0
212364|NCT00246012|705700|P7|Overall Study|Adverse Event|0
212365|NCT00246012|705701|P6|Overall Study|Adverse Event|1
212366|NCT00246012|705702|P5|Overall Study|Adverse Event|0
212367|NCT00246012|705703|P4|Overall Study|Adverse Event|0
212368|NCT00246012|705704|P3|Overall Study|Adverse Event|0
212369|NCT00246012|705705|P2|Overall Study|Adverse Event|0
212370|NCT00246012|705706|P1|Overall Study|Adverse Event|0
212371|NCT00245960|705801|P2|Overall Study|Lack of Efficacy|6
212372|NCT00245960|705802|P1|Overall Study|Lack of Efficacy|4
212373|NCT00245960|705801|P2|Overall Study|Withdrawal by Subject|7
212374|NCT00245960|705802|P1|Overall Study|Withdrawal by Subject|5
212375|NCT00245960|705801|P2|Overall Study|Protocol Violation|3
212376|NCT00245960|705802|P1|Overall Study|Protocol Violation|4
212377|NCT00245960|705801|P2|Overall Study|Lost to Follow-up|2
212378|NCT00245960|705802|P1|Overall Study|Lost to Follow-up|2
212379|NCT00245960|705801|P2|Overall Study|Adverse Event|10
212380|NCT00245960|705802|P1|Overall Study|Adverse Event|14
212381|NCT00245856|705810|P2|Period Two|Withdrawal by Subject|1
212382|NCT00245856|705811|P1|Period Two|Withdrawal by Subject|0
212383|NCT00245570|705827|P6|Washout Between Periods III and IV|Adverse Event|0
212384|NCT00245570|705828|P5|Washout Between Periods III and IV|Adverse Event|0
212385|NCT00245570|705829|P4|Washout Between Periods III and IV|Adverse Event|0
212386|NCT00245570|705830|P3|Washout Between Periods III and IV|Adverse Event|0
212387|NCT00245570|705831|P2|Washout Between Periods III and IV|Adverse Event|1
212388|NCT00245570|705832|P1|Washout Between Periods III and IV|Adverse Event|0
212389|NCT00245466|705966|P3|Overall Study|Administrative reasons|0
212390|NCT00245466|705967|P2|Overall Study|Administrative reasons|1
212391|NCT00245466|705968|P1|Overall Study|Administrative reasons|0
212392|NCT00245466|705966|P3|Overall Study|Death|0
212393|NCT00245466|705967|P2|Overall Study|Death|2
212394|NCT00245466|705968|P1|Overall Study|Death|0
212395|NCT00245466|705966|P3|Overall Study|Protocol Violation|2
212396|NCT00245466|705967|P2|Overall Study|Protocol Violation|2
212397|NCT00245466|705968|P1|Overall Study|Protocol Violation|1
212398|NCT00245466|705966|P3|Overall Study|Disease progression|1
212399|NCT00245466|705967|P2|Overall Study|Disease progression|3
212400|NCT00245466|705968|P1|Overall Study|Disease progression|0
212401|NCT00245466|705966|P3|Overall Study|Lost to Follow-up|0
212402|NCT00245466|705967|P2|Overall Study|Lost to Follow-up|0
212403|NCT00245466|705968|P1|Overall Study|Lost to Follow-up|3
212404|NCT00245466|705966|P3|Overall Study|Withdrawal by Subject|1
212405|NCT00245466|705967|P2|Overall Study|Withdrawal by Subject|2
212406|NCT00245466|705968|P1|Overall Study|Withdrawal by Subject|2
212407|NCT00245466|705966|P3|Overall Study|Insufficient PSA and testosterone suppr|3
212408|NCT00245466|705967|P2|Overall Study|Insufficient PSA and testosterone suppr|0
212409|NCT00245466|705968|P1|Overall Study|Insufficient PSA and testosterone suppr|0
212410|NCT00245466|705966|P3|Overall Study|Insufficient testosterone suppr|21
212411|NCT00245466|705967|P2|Overall Study|Insufficient testosterone suppr|12
212412|NCT00245466|705968|P1|Overall Study|Insufficient testosterone suppr|12
212413|NCT00245466|705966|P3|Overall Study|Low prostate specific antigen suppr|5
212414|NCT00245466|705967|P2|Overall Study|Low prostate specific antigen suppr|14
212415|NCT00245466|705968|P1|Overall Study|Low prostate specific antigen suppr|16
212416|NCT00245466|705966|P3|Overall Study|Adverse Event|4
212417|NCT00245466|705967|P2|Overall Study|Adverse Event|8
212418|NCT00245466|705968|P1|Overall Study|Adverse Event|2
212419|NCT00245102|706011|P6|Overall Study|Clinical progression|0
212420|NCT00245102|706012|P5|Overall Study|Clinical progression|0
212421|NCT00245102|706013|P4|Overall Study|Clinical progression|0
212422|NCT00245102|706014|P3|Overall Study|Clinical progression|0
212423|NCT00245102|706015|P2|Overall Study|Clinical progression|0
212424|NCT00245102|706016|P1|Overall Study|Clinical progression|1
212425|NCT00245102|706011|P6|Overall Study|Participant needed surgery|0
212426|NCT00245102|706012|P5|Overall Study|Participant needed surgery|0
212427|NCT00245102|706013|P4|Overall Study|Participant needed surgery|0
212428|NCT00245102|706014|P3|Overall Study|Participant needed surgery|1
212429|NCT00245102|706015|P2|Overall Study|Participant needed surgery|0
212430|NCT00245102|706016|P1|Overall Study|Participant needed surgery|0
212431|NCT00245102|706011|P6|Overall Study|Decline in performance|2
212432|NCT00245102|706012|P5|Overall Study|Decline in performance|0
212433|NCT00245102|706013|P4|Overall Study|Decline in performance|1
212434|NCT00245102|706014|P3|Overall Study|Decline in performance|0
212435|NCT00245102|706015|P2|Overall Study|Decline in performance|2
212436|NCT00245102|706016|P1|Overall Study|Decline in performance|0
212437|NCT00245102|706011|P6|Overall Study|Adverse Event|2
212438|NCT00245102|706012|P5|Overall Study|Adverse Event|0
212439|NCT00245102|706013|P4|Overall Study|Adverse Event|1
212440|NCT00245102|706014|P3|Overall Study|Adverse Event|5
212441|NCT00245102|706015|P2|Overall Study|Adverse Event|2
212442|NCT00245102|706016|P1|Overall Study|Adverse Event|4
212443|NCT00245102|706011|P6|Overall Study|Death|0
212444|NCT00245102|706012|P5|Overall Study|Death|0
212445|NCT00245102|706013|P4|Overall Study|Death|1
212446|NCT00245102|706014|P3|Overall Study|Death|0
212447|NCT00245102|706015|P2|Overall Study|Death|0
212448|NCT00245102|706016|P1|Overall Study|Death|0
212449|NCT00245102|706011|P6|Overall Study|Protocol Violation|0
212450|NCT00245102|706012|P5|Overall Study|Protocol Violation|0
212451|NCT00245102|706013|P4|Overall Study|Protocol Violation|0
212452|NCT00245102|706014|P3|Overall Study|Protocol Violation|0
212453|NCT00245102|706015|P2|Overall Study|Protocol Violation|0
212454|NCT00245102|706016|P1|Overall Study|Protocol Violation|1
212455|NCT00245102|706011|P6|Overall Study|Not Treated|0
212456|NCT00245102|706012|P5|Overall Study|Not Treated|0
212457|NCT00245102|706013|P4|Overall Study|Not Treated|0
212458|NCT00245102|706014|P3|Overall Study|Not Treated|1
212459|NCT00245102|706015|P2|Overall Study|Not Treated|0
212460|NCT00245102|706016|P1|Overall Study|Not Treated|1
212461|NCT00245063|706032|P2|Overall Study|Death|0
212462|NCT00245063|706033|P1|Overall Study|Death|1
212463|NCT00245063|706032|P2|Overall Study|Adverse Event|5
212464|NCT00245063|706033|P1|Overall Study|Adverse Event|6
212465|NCT00245050|706041|P2|Overall Study|Adverse Event|2
212466|NCT00245050|706042|P1|Overall Study|Adverse Event|3
212467|NCT00245037|706050|P1|Overall Study|Death|17
212468|NCT00245011|706060|P1|Overall Study|Lack of Efficacy|1
212469|NCT00244933|706072|P1|Overall Study|Not response evaluable|2
212470|NCT00244881|706076|P1|Overall Study|Withdrawal by Subject|3
212471|NCT00244855|706084|P2|Overall Study|Withdrawal by Subject|1
212472|NCT00244855|706085|P1|Overall Study|Withdrawal by Subject|0
212473|NCT00244764|706093|P1|Overall Study|Developed Secondary Malignancy|1
212474|NCT00244764|706093|P1|Overall Study|Sponsor Terminated Study|2
212475|NCT00244764|706093|P1|Overall Study|Primary Investigator Discretion|2
212476|NCT00244764|706093|P1|Overall Study|Participant was Hospitalized until Death|1
212477|NCT00244764|706093|P1|Overall Study|Declining Performance Status|1
212478|NCT00244764|706093|P1|Overall Study|Off Study Medication for >21 Days|1
212479|NCT00244764|706093|P1|Overall Study|Death|1
212480|NCT00244764|706093|P1|Overall Study|Protocol Violation|2
212481|NCT00244764|706093|P1|Overall Study|Disease Progression|13
212482|NCT00244764|706093|P1|Overall Study|Withdrawal by Subject|12
212483|NCT00244764|706093|P1|Overall Study|Lost to Follow-up|23
212484|NCT00244764|706093|P1|Overall Study|Adverse Event|37
212485|NCT00244751|706103|P3|Overall Study|Participant randomized by mistake|1
212486|NCT00244751|706104|P2|Overall Study|Participant randomized by mistake|0
212487|NCT00244751|706105|P1|Overall Study|Participant randomized by mistake|0
212488|NCT00244751|706103|P3|Overall Study|Safety reasons|0
212489|NCT00244751|706104|P2|Overall Study|Safety reasons|1
212490|NCT00244751|706105|P1|Overall Study|Safety reasons|0
212491|NCT00244751|706103|P3|Overall Study|Lack of compliance with protocol|0
212492|NCT00244751|706104|P2|Overall Study|Lack of compliance with protocol|1
212493|NCT00244751|706105|P1|Overall Study|Lack of compliance with protocol|0
212494|NCT00244751|706103|P3|Overall Study|Elevated liver enzymes|0
212495|NCT00244751|706104|P2|Overall Study|Elevated liver enzymes|0
212496|NCT00244751|706105|P1|Overall Study|Elevated liver enzymes|1
212497|NCT00244751|706103|P3|Overall Study|Withdrawal by Subject|3
212498|NCT00244751|706104|P2|Overall Study|Withdrawal by Subject|5
212499|NCT00244751|706105|P1|Overall Study|Withdrawal by Subject|7
212500|NCT00244751|706103|P3|Overall Study|Protocol Violation|1
212501|NCT00244751|706104|P2|Overall Study|Protocol Violation|0
212502|NCT00244751|706105|P1|Overall Study|Protocol Violation|1
212503|NCT00244751|706103|P3|Overall Study|Lost to Follow-up|0
212504|NCT00244751|706104|P2|Overall Study|Lost to Follow-up|1
212505|NCT00244751|706105|P1|Overall Study|Lost to Follow-up|0
212506|NCT00244751|706103|P3|Overall Study|Adverse Event|5
212507|NCT00244751|706104|P2|Overall Study|Adverse Event|7
212508|NCT00244751|706105|P1|Overall Study|Adverse Event|7
212509|NCT00244725|706206|P4|Overall Study|Failed to follow-up|1
212510|NCT00244725|706207|P3|Overall Study|Failed to follow-up|1
212511|NCT00244725|706208|P2|Overall Study|Failed to follow-up|0
212512|NCT00244725|706209|P1|Overall Study|Failed to follow-up|0
212513|NCT00244725|706206|P4|Overall Study|Vomit|0
212514|NCT00244725|706207|P3|Overall Study|Vomit|1
212515|NCT00244725|706208|P2|Overall Study|Vomit|0
212516|NCT00244725|706209|P1|Overall Study|Vomit|0
212517|NCT00244725|706206|P4|Overall Study|Administrative reason|0
212518|NCT00244725|706207|P3|Overall Study|Administrative reason|1
212519|NCT00244725|706208|P2|Overall Study|Administrative reason|0
212520|NCT00244725|706209|P1|Overall Study|Administrative reason|0
212521|NCT00244725|706206|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
212522|NCT00244725|706207|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
212523|NCT00244725|706208|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
212524|NCT00244725|706209|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
212525|NCT00244725|706206|P4|Overall Study|Received prohibited medication|1
212526|NCT00244725|706207|P3|Overall Study|Received prohibited medication|0
212527|NCT00244725|706208|P2|Overall Study|Received prohibited medication|1
212528|NCT00244725|706209|P1|Overall Study|Received prohibited medication|0
212529|NCT00244725|706206|P4|Overall Study|Headache|0
212530|NCT00244725|706207|P3|Overall Study|Headache|0
212531|NCT00244725|706208|P2|Overall Study|Headache|1
212532|NCT00244725|706209|P1|Overall Study|Headache|0
212533|NCT00244725|706206|P4|Overall Study|Rehab Refused to allow participantion|0
212534|NCT00244725|706207|P3|Overall Study|Rehab Refused to allow participantion|0
212535|NCT00244725|706208|P2|Overall Study|Rehab Refused to allow participantion|1
212536|NCT00244725|706209|P1|Overall Study|Rehab Refused to allow participantion|0
212537|NCT00244725|706206|P4|Overall Study|Mediciation Error|0
212538|NCT00244725|706207|P3|Overall Study|Mediciation Error|0
212539|NCT00244725|706208|P2|Overall Study|Mediciation Error|1
212540|NCT00244725|706209|P1|Overall Study|Mediciation Error|0
212541|NCT00244725|706206|P4|Overall Study|Sponsor withdrew the participant|1
212542|NCT00244725|706207|P3|Overall Study|Sponsor withdrew the participant|0
212543|NCT00244725|706208|P2|Overall Study|Sponsor withdrew the participant|0
212544|NCT00244725|706209|P1|Overall Study|Sponsor withdrew the participant|1
212545|NCT00244725|706206|P4|Overall Study|Liver function test abnormality|1
212546|NCT00244725|706207|P3|Overall Study|Liver function test abnormality|0
212547|NCT00244725|706208|P2|Overall Study|Liver function test abnormality|0
212548|NCT00244725|706209|P1|Overall Study|Liver function test abnormality|2
212549|NCT00244725|706206|P4|Overall Study|Withdrwal by participant|1
212550|NCT00244725|706207|P3|Overall Study|Withdrwal by participant|0
212551|NCT00244725|706208|P2|Overall Study|Withdrwal by participant|0
212552|NCT00244725|706209|P1|Overall Study|Withdrwal by participant|1
212553|NCT00244725|706206|P4|Overall Study|Adverse Events|4
212554|NCT00244725|706207|P3|Overall Study|Adverse Events|4
212555|NCT00244725|706208|P2|Overall Study|Adverse Events|1
212556|NCT00244725|706209|P1|Overall Study|Adverse Events|3
212557|NCT00244725|706206|P4|Overall Study|Physician Decision|2
212558|NCT00244725|706207|P3|Overall Study|Physician Decision|1
212559|NCT00244725|706208|P2|Overall Study|Physician Decision|0
212560|NCT00244725|706209|P1|Overall Study|Physician Decision|3
212561|NCT00244725|706206|P4|Overall Study|Not meet treatment eligibility criteria|0
212562|NCT00244725|706207|P3|Overall Study|Not meet treatment eligibility criteria|0
212563|NCT00244725|706208|P2|Overall Study|Not meet treatment eligibility criteria|2
212564|NCT00244725|706209|P1|Overall Study|Not meet treatment eligibility criteria|1
212565|NCT00244725|706206|P4|Overall Study|Withdrawal by Subject|8
212566|NCT00244725|706207|P3|Overall Study|Withdrawal by Subject|7
212567|NCT00244725|706208|P2|Overall Study|Withdrawal by Subject|7
212568|NCT00244725|706209|P1|Overall Study|Withdrawal by Subject|9
212569|NCT00244725|706206|P4|Overall Study|Lost to Follow-up|2
212570|NCT00244725|706207|P3|Overall Study|Lost to Follow-up|9
212571|NCT00244725|706208|P2|Overall Study|Lost to Follow-up|4
212572|NCT00244725|706209|P1|Overall Study|Lost to Follow-up|3
212573|NCT00244712|706265|P2|Overall Study|Protocol Violation, disease progression|11
212574|NCT00244712|706266|P1|Overall Study|Protocol Violation, disease progression|13
212575|NCT00244712|706265|P2|Overall Study|Withdrawal by Subject|23
212576|NCT00244712|706266|P1|Overall Study|Withdrawal by Subject|13
212577|NCT00244712|706265|P2|Overall Study|Lost to Follow-up|52
212578|NCT00244712|706266|P1|Overall Study|Lost to Follow-up|45
212579|NCT00244712|706265|P2|Overall Study|Lack of Compliance|11
212580|NCT00244712|706266|P1|Overall Study|Lack of Compliance|10
212581|NCT00244712|706265|P2|Overall Study|Protocol-Defined Virologic Failure|6
212582|NCT00244712|706266|P1|Overall Study|Protocol-Defined Virologic Failure|8
212583|NCT00244712|706265|P2|Overall Study|Adverse Event|21
212584|NCT00244712|706266|P1|Overall Study|Adverse Event|20
212585|NCT00244621|706301|P3|Open-label Treatment Period|Moved abroad|1
212586|NCT00244621|706302|P2|Open-label Treatment Period|Moved abroad|0
212587|NCT00244621|706303|P1|Open-label Treatment Period|Moved abroad|0
212588|NCT00244621|706301|P3|Open-label Treatment Period|Adverse Event|1
212589|NCT00244621|706302|P2|Open-label Treatment Period|Adverse Event|0
212590|NCT00244621|706303|P1|Open-label Treatment Period|Adverse Event|0
212591|NCT00244621|706301|P3|Open-label Treatment Period|Withdrawal by Subject|0
212592|NCT00244621|706302|P2|Open-label Treatment Period|Withdrawal by Subject|0
212593|NCT00244621|706303|P1|Open-label Treatment Period|Withdrawal by Subject|1
212594|NCT00244621|706301|P3|Open-label Treatment Period|Lost to Follow-up|0
212595|NCT00244621|706302|P2|Open-label Treatment Period|Lost to Follow-up|1
212596|NCT00244621|706303|P1|Open-label Treatment Period|Lost to Follow-up|0
212597|NCT00244621|706301|P3|Double-blind Treatment Period|Multiple Reasons|1
212598|NCT00244621|706302|P2|Double-blind Treatment Period|Multiple Reasons|1
212599|NCT00244621|706303|P1|Double-blind Treatment Period|Multiple Reasons|2
212600|NCT00244621|706301|P3|Double-blind Treatment Period|Lack of Efficacy|0
212601|NCT00244621|706302|P2|Double-blind Treatment Period|Lack of Efficacy|1
212602|NCT00244621|706303|P1|Double-blind Treatment Period|Lack of Efficacy|0
212603|NCT00244621|706301|P3|Double-blind Treatment Period|Withdrawal by Subject|0
212604|NCT00244621|706302|P2|Double-blind Treatment Period|Withdrawal by Subject|1
212605|NCT00244621|706303|P1|Double-blind Treatment Period|Withdrawal by Subject|0
212606|NCT00244621|706301|P3|Double-blind Treatment Period|Lost to Follow-up|1
212607|NCT00244621|706302|P2|Double-blind Treatment Period|Lost to Follow-up|0
212608|NCT00244621|706303|P1|Double-blind Treatment Period|Lost to Follow-up|0
212609|NCT00244374|706320|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
212610|NCT00244374|706321|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
212611|NCT00244374|706322|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
212612|NCT00244374|706323|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
212613|NCT00244374|706324|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
212614|NCT00244374|706320|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
212615|NCT00244374|706321|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
212616|NCT00244374|706322|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
212617|NCT00244374|706323|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
212618|NCT00244374|706324|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
212619|NCT00244374|706320|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
212620|NCT00244374|706321|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
212621|NCT00244374|706322|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
212622|NCT00244374|706323|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
212623|NCT00244374|706324|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
212624|NCT00244374|706320|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
212625|NCT00244374|706321|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
212626|NCT00244374|706322|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
212627|NCT00244374|706323|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
212628|NCT00244374|706324|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
212629|NCT00244374|706320|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
212630|NCT00244374|706321|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
212631|NCT00244374|706322|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
212632|NCT00244374|706323|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
212633|NCT00244374|706324|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
212634|NCT00244374|706320|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
212635|NCT00244374|706321|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
212636|NCT00244374|706322|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
212637|NCT00244374|706323|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
212638|NCT00244374|706324|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
212639|NCT00244374|706320|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
212640|NCT00244374|706321|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
212641|NCT00244374|706322|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
212642|NCT00244374|706323|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
212643|NCT00244374|706324|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
212644|NCT00244374|706320|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
212645|NCT00244374|706321|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
212646|NCT00244374|706322|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
212647|NCT00244374|706323|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
212648|NCT00244374|706324|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
212649|NCT00244374|706320|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
212650|NCT00244374|706321|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
212651|NCT00244374|706322|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
212652|NCT00244374|706323|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
212653|NCT00244374|706324|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
212654|NCT00243932|706380|P3|Stage 1: Dose Selection|Lost to Follow-up|0
212655|NCT00243932|706381|P2|Stage 1: Dose Selection|Lost to Follow-up|0
212656|NCT00243932|706382|P1|Stage 1: Dose Selection|Lost to Follow-up|2
212657|NCT00243919|706393|P3|Overall Study|Physician Decision|0
212658|NCT00243919|706394|P2|Overall Study|Physician Decision|1
212659|NCT00243919|706395|P1|Overall Study|Physician Decision|1
212660|NCT00243919|706393|P3|Overall Study|Administrative Error|0
212661|NCT00243919|706394|P2|Overall Study|Administrative Error|0
212662|NCT00243919|706395|P1|Overall Study|Administrative Error|1
212663|NCT00243919|706393|P3|Overall Study|Lost to Follow-up|3
212664|NCT00243919|706394|P2|Overall Study|Lost to Follow-up|7
212665|NCT00243919|706395|P1|Overall Study|Lost to Follow-up|6
212666|NCT00243919|706393|P3|Overall Study|Withdrawal by Subject|2
212667|NCT00243919|706394|P2|Overall Study|Withdrawal by Subject|6
212668|NCT00243919|706395|P1|Overall Study|Withdrawal by Subject|6
212669|NCT00243919|706393|P3|Overall Study|Death|6
212670|NCT00243919|706394|P2|Overall Study|Death|4
212671|NCT00243919|706395|P1|Overall Study|Death|3
212672|NCT00243659|706438|P2|Overall Study|Protocol Violation|2
212673|NCT00243659|706439|P1|Overall Study|Protocol Violation|1
212674|NCT00243659|706438|P2|Overall Study|Withdrawal by Subject|1
212675|NCT00243659|706439|P1|Overall Study|Withdrawal by Subject|1
212676|NCT00243503|706447|P1|Overall Study|Other|1
212677|NCT00243503|706447|P1|Overall Study|Death|1
212678|NCT00243503|706447|P1|Overall Study|Lack of Efficacy|44
212679|NCT00243503|706447|P1|Overall Study|Withdrawal by Subject|1
212680|NCT00243503|706447|P1|Overall Study|Adverse Event|11
212681|NCT00243412|706464|P2|Overall Study|not specified|1
212682|NCT00243412|706465|P1|Overall Study|not specified|1
212683|NCT00243412|706464|P2|Overall Study|Withdrawal by Subject|5
212684|NCT00243412|706465|P1|Overall Study|Withdrawal by Subject|4
212685|NCT00243412|706464|P2|Overall Study|Physician Decision|1
212686|NCT00243412|706465|P1|Overall Study|Physician Decision|1
212687|NCT00243412|706464|P2|Overall Study|Lost to Follow-up|1
212688|NCT00243412|706465|P1|Overall Study|Lost to Follow-up|0
212689|NCT00243412|706464|P2|Overall Study|Adverse Event|2
212690|NCT00243412|706465|P1|Overall Study|Adverse Event|4
212691|NCT00243412|706464|P2|Overall Study|Death|1
212692|NCT00243412|706465|P1|Overall Study|Death|0
212693|NCT00243386|706491|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
212694|NCT00243386|706492|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
212695|NCT00243386|706493|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
212696|NCT00243386|706491|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
212697|NCT00243386|706492|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
212698|NCT00243386|706493|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
212699|NCT00243386|706491|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
212700|NCT00243386|706492|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
212701|NCT00243386|706493|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
212702|NCT00243386|706491|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
212703|NCT00243386|706492|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
212704|NCT00243386|706493|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
212705|NCT00243386|706491|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
212706|NCT00243386|706492|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
212707|NCT00243386|706493|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
212708|NCT00243386|706491|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
212709|NCT00243386|706492|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
212710|NCT00243386|706493|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
212711|NCT00243386|706491|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
212712|NCT00243386|706492|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
212713|NCT00243386|706493|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
212714|NCT00243386|706491|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
212715|NCT00243386|706492|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
212716|NCT00243386|706493|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
212717|NCT00243347|706558|P1|Overall Study|Condition worsened|7
212718|NCT00243347|706558|P1|Overall Study|Withdrawal by Subject|5
212719|NCT00243347|706558|P1|Overall Study|Death|1
212720|NCT00243347|706558|P1|Overall Study|Adverse Event|2
212721|NCT00243347|706558|P1|Overall Study|Lack of Efficacy|4
212722|NCT00243269|706567|P4|Overall Study|Lost to Follow-up|3
212723|NCT00243269|706568|P3|Overall Study|Lost to Follow-up|1
212724|NCT00243269|706569|P2|Overall Study|Lost to Follow-up|0
212725|NCT00243269|706570|P1|Overall Study|Lost to Follow-up|1
212726|NCT00243269|706567|P4|Overall Study|Protocol Violation|1
212727|NCT00243269|706568|P3|Overall Study|Protocol Violation|0
212728|NCT00243269|706569|P2|Overall Study|Protocol Violation|1
212729|NCT00243269|706570|P1|Overall Study|Protocol Violation|2
212730|NCT00243074|706597|P1|Overall Study|Did not receive any treatment|1
212731|NCT00243074|706597|P1|Overall Study|not protocol specified|1
212732|NCT00243074|706597|P1|Overall Study|Death|2
212733|NCT00243074|706597|P1|Overall Study|Lack of Efficacy|36
212734|NCT00243074|706597|P1|Overall Study|Withdrawal by Subject|2
212735|NCT00243074|706597|P1|Overall Study|Adverse Event|6
212736|NCT00243074|706597|P1|Overall Study|Ineligible|6
212737|NCT00243022|706618|P2|Overall Study|Difficult Travel Distance|1
212738|NCT00243022|706619|P1|Overall Study|Difficult Travel Distance|0
212739|NCT00243022|706618|P2|Overall Study|Death|0
212740|NCT00243022|706619|P1|Overall Study|Death|1
212741|NCT00243022|706618|P2|Overall Study|Withdrawal by Subject|0
212742|NCT00243022|706619|P1|Overall Study|Withdrawal by Subject|1
212743|NCT00242710|706641|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
212744|NCT00242710|706642|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
212745|NCT00242710|706643|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
212746|NCT00242710|706644|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
212747|NCT00242710|706641|P4|Study Extension (up to Year 2)|Protocol Violation|1
212748|NCT00242710|706642|P3|Study Extension (up to Year 2)|Protocol Violation|0
212749|NCT00242710|706643|P2|Study Extension (up to Year 2)|Protocol Violation|2
212750|NCT00242710|706644|P1|Study Extension (up to Year 2)|Protocol Violation|0
212751|NCT00242710|706641|P4|Study Extension (up to Year 2)|Other|3
212752|NCT00242710|706642|P3|Study Extension (up to Year 2)|Other|4
212753|NCT00242710|706643|P2|Study Extension (up to Year 2)|Other|5
212754|NCT00242710|706644|P1|Study Extension (up to Year 2)|Other|3
212755|NCT00242710|706641|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
212756|NCT00242710|706642|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
212757|NCT00242710|706643|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
212758|NCT00242710|706644|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
212759|NCT00242710|706641|P4|Study Extension (up to Year 2)|Death|1
212760|NCT00242710|706642|P3|Study Extension (up to Year 2)|Death|0
212761|NCT00242710|706643|P2|Study Extension (up to Year 2)|Death|0
212762|NCT00242710|706644|P1|Study Extension (up to Year 2)|Death|0
212763|NCT00242710|706641|P4|Study Extension (up to Year 2)|Adverse Event|4
212764|NCT00242710|706642|P3|Study Extension (up to Year 2)|Adverse Event|2
212765|NCT00242710|706643|P2|Study Extension (up to Year 2)|Adverse Event|9
212766|NCT00242710|706644|P1|Study Extension (up to Year 2)|Adverse Event|7
212767|NCT00242710|706641|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
212768|NCT00242710|706642|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
212769|NCT00242710|706643|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
212770|NCT00242710|706644|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
212771|NCT00242710|706641|P4|Period Between Core Study and Extension|Protocol Violation|1
212772|NCT00242710|706642|P3|Period Between Core Study and Extension|Protocol Violation|2
212773|NCT00242710|706643|P2|Period Between Core Study and Extension|Protocol Violation|0
212774|NCT00242710|706644|P1|Period Between Core Study and Extension|Protocol Violation|0
212775|NCT00242710|706641|P4|Period Between Core Study and Extension|Extension not Available|7
212776|NCT00242710|706642|P3|Period Between Core Study and Extension|Extension not Available|8
212777|NCT00242710|706643|P2|Period Between Core Study and Extension|Extension not Available|21
212778|NCT00242710|706644|P1|Period Between Core Study and Extension|Extension not Available|17
212779|NCT00242710|706641|P4|Period Between Core Study and Extension|Other|11
212780|NCT00242710|706642|P3|Period Between Core Study and Extension|Other|9
212781|NCT00242710|706643|P2|Period Between Core Study and Extension|Other|24
212782|NCT00242710|706644|P1|Period Between Core Study and Extension|Other|24
212783|NCT00242710|706641|P4|Period Between Core Study and Extension|Physician Decision|0
212784|NCT00242710|706642|P3|Period Between Core Study and Extension|Physician Decision|0
212785|NCT00242710|706643|P2|Period Between Core Study and Extension|Physician Decision|1
212786|NCT00242710|706644|P1|Period Between Core Study and Extension|Physician Decision|1
212787|NCT00242710|706641|P4|Period Between Core Study and Extension|Adverse Event|2
212788|NCT00242710|706642|P3|Period Between Core Study and Extension|Adverse Event|5
212789|NCT00242710|706643|P2|Period Between Core Study and Extension|Adverse Event|3
212790|NCT00242710|706644|P1|Period Between Core Study and Extension|Adverse Event|2
212791|NCT00242710|706641|P4|Core Study (up to Year 1)|Randomized but not Treated|2
212792|NCT00242710|706642|P3|Core Study (up to Year 1)|Randomized but not Treated|4
212793|NCT00242710|706643|P2|Core Study (up to Year 1)|Randomized but not Treated|4
212794|NCT00242710|706644|P1|Core Study (up to Year 1)|Randomized but not Treated|12
212795|NCT00242710|706641|P4|Core Study (up to Year 1)|Lack of Efficacy|0
212796|NCT00242710|706642|P3|Core Study (up to Year 1)|Lack of Efficacy|0
212797|NCT00242710|706643|P2|Core Study (up to Year 1)|Lack of Efficacy|0
212798|NCT00242710|706644|P1|Core Study (up to Year 1)|Lack of Efficacy|1
212799|NCT00242710|706641|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
212800|NCT00242710|706642|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
212801|NCT00242710|706643|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
212802|NCT00242710|706644|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
212803|NCT00242710|706641|P4|Core Study (up to Year 1)|Protocol Violation|3
212804|NCT00242710|706642|P3|Core Study (up to Year 1)|Protocol Violation|1
212805|NCT00242710|706643|P2|Core Study (up to Year 1)|Protocol Violation|9
212806|NCT00242710|706644|P1|Core Study (up to Year 1)|Protocol Violation|2
212807|NCT00242710|706641|P4|Core Study (up to Year 1)|Other|2
212808|NCT00242710|706642|P3|Core Study (up to Year 1)|Other|0
212809|NCT00242710|706643|P2|Core Study (up to Year 1)|Other|1
212810|NCT00242710|706644|P1|Core Study (up to Year 1)|Other|6
212811|NCT00242710|706641|P4|Core Study (up to Year 1)|Lost to Follow-up|3
212812|NCT00242710|706642|P3|Core Study (up to Year 1)|Lost to Follow-up|7
212813|NCT00242710|706643|P2|Core Study (up to Year 1)|Lost to Follow-up|8
212814|NCT00242710|706644|P1|Core Study (up to Year 1)|Lost to Follow-up|8
212815|NCT00242710|706641|P4|Core Study (up to Year 1)|Physician Decision|1
212816|NCT00242710|706642|P3|Core Study (up to Year 1)|Physician Decision|0
212817|NCT00242710|706643|P2|Core Study (up to Year 1)|Physician Decision|1
212818|NCT00242710|706644|P1|Core Study (up to Year 1)|Physician Decision|0
212819|NCT00242710|706641|P4|Core Study (up to Year 1)|Death|0
212820|NCT00242710|706642|P3|Core Study (up to Year 1)|Death|1
212821|NCT00242710|706643|P2|Core Study (up to Year 1)|Death|0
212822|NCT00242710|706644|P1|Core Study (up to Year 1)|Death|0
212823|NCT00242710|706641|P4|Core Study (up to Year 1)|Adverse Event|14
212824|NCT00242710|706642|P3|Core Study (up to Year 1)|Adverse Event|23
212825|NCT00242710|706643|P2|Core Study (up to Year 1)|Adverse Event|25
212826|NCT00242710|706644|P1|Core Study (up to Year 1)|Adverse Event|30
212827|NCT00242658|706701|P2|Overall Study|Lost to Follow-up|19
212828|NCT00242658|706702|P1|Overall Study|Lost to Follow-up|22
212829|NCT00242580|706733|P3|Overall Study|Death|1
212830|NCT00242580|706734|P2|Overall Study|Death|2
212831|NCT00242580|706735|P1|Overall Study|Death|1
212832|NCT00242580|706733|P3|Overall Study|Lost to Follow-up|0
212833|NCT00242580|706734|P2|Overall Study|Lost to Follow-up|3
212834|NCT00242580|706735|P1|Overall Study|Lost to Follow-up|0
212835|NCT00242580|706733|P3|Overall Study|Subject withdrew consent|5
212836|NCT00242580|706734|P2|Overall Study|Subject withdrew consent|2
212837|NCT00242580|706735|P1|Overall Study|Subject withdrew consent|2
212838|NCT00242580|706733|P3|Overall Study|Protocol Violation|1
212839|NCT00242580|706734|P2|Overall Study|Protocol Violation|0
212840|NCT00242580|706735|P1|Overall Study|Protocol Violation|0
212841|NCT00242580|706733|P3|Overall Study|Unsatisfactory therapeutic effect|5
212842|NCT00242580|706734|P2|Overall Study|Unsatisfactory therapeutic effect|5
212843|NCT00242580|706735|P1|Overall Study|Unsatisfactory therapeutic effect|4
212844|NCT00242580|706733|P3|Overall Study|Adverse Event|2
212845|NCT00242580|706734|P2|Overall Study|Adverse Event|0
212846|NCT00242580|706735|P1|Overall Study|Adverse Event|3
212847|NCT00242567|706760|P2|Overall Study|Other|9
212848|NCT00242567|706761|P1|Overall Study|Other|14
212849|NCT00242567|706760|P2|Overall Study|Use of an inhibitor of bone resorption|2
212850|NCT00242567|706761|P1|Overall Study|Use of an inhibitor of bone resorption|0
212851|NCT00242567|706760|P2|Overall Study|Protocol Violation|12
212852|NCT00242567|706761|P1|Overall Study|Protocol Violation|12
212853|NCT00242567|706760|P2|Overall Study|Withdrawal by Subject|28
212854|NCT00242567|706761|P1|Overall Study|Withdrawal by Subject|33
212855|NCT00242567|706760|P2|Overall Study|Lost to Follow-up|19
212856|NCT00242567|706761|P1|Overall Study|Lost to Follow-up|9
212857|NCT00242567|706760|P2|Overall Study|Lack of Efficacy|2
212858|NCT00242567|706761|P1|Overall Study|Lack of Efficacy|2
212859|NCT00242567|706760|P2|Overall Study|Symptomatic deterioration|3
212860|NCT00242567|706761|P1|Overall Study|Symptomatic deterioration|9
212861|NCT00242567|706760|P2|Overall Study|Disease Progression|22
212862|NCT00242567|706761|P1|Overall Study|Disease Progression|17
212863|NCT00242567|706760|P2|Overall Study|Adverse Event|43
212864|NCT00242567|706761|P1|Overall Study|Adverse Event|70
212865|NCT00242216|706808|P2|Overall Study|no medicaiton dispensed|1
212866|NCT00242216|706809|P1|Overall Study|no medicaiton dispensed|1
212867|NCT00242216|706808|P2|Overall Study|Lack of Efficacy|2
212868|NCT00242216|706809|P1|Overall Study|Lack of Efficacy|1
212869|NCT00242216|706808|P2|Overall Study|Death|2
212870|NCT00242216|706809|P1|Overall Study|Death|4
212871|NCT00242216|706808|P2|Overall Study|Lost to Follow-up|17
212872|NCT00242216|706809|P1|Overall Study|Lost to Follow-up|12
212873|NCT00241839|706847|P2|Overall Study|Adverse Event|1
212874|NCT00241839|706848|P1|Overall Study|Adverse Event|1
212875|NCT00241839|706847|P2|Overall Study|Withdrawal by Subject|17
212876|NCT00241839|706848|P1|Overall Study|Withdrawal by Subject|18
212877|NCT00241644|706864|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
212878|NCT00241644|706865|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
212879|NCT00241644|706866|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
212880|NCT00241644|706867|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
212881|NCT00241644|706864|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
212882|NCT00241644|706865|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
212883|NCT00241644|706866|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
212884|NCT00241644|706867|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
212885|NCT00241644|706864|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
212886|NCT00241644|706865|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
212887|NCT00241644|706866|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
212888|NCT00241644|706867|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
212889|NCT00241644|706864|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
212890|NCT00241644|706865|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
212891|NCT00241644|706866|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
212892|NCT00241644|706867|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
212893|NCT00241644|706864|P4|Second Efficacy Period (Year 2)|Adverse Event|20
212894|NCT00241644|706865|P3|Second Efficacy Period (Year 2)|Adverse Event|12
212895|NCT00241644|706866|P2|Second Efficacy Period (Year 2)|Adverse Event|9
212896|NCT00241644|706867|P1|Second Efficacy Period (Year 2)|Adverse Event|11
212897|NCT00241644|706864|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
212898|NCT00241644|706865|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
212899|NCT00241644|706866|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
212900|NCT00241644|706867|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
212901|NCT00241644|706864|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
212902|NCT00241644|706865|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
212903|NCT00241644|706866|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
212904|NCT00241644|706867|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
212905|NCT00241644|706864|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
212906|NCT00241644|706865|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
212907|NCT00241644|706866|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
212908|NCT00241644|706867|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
212909|NCT00241644|706864|P4|First Efficacy Period (Year 1)|Non-compliance|3
212910|NCT00241644|706865|P3|First Efficacy Period (Year 1)|Non-compliance|2
212911|NCT00241644|706866|P2|First Efficacy Period (Year 1)|Non-compliance|1
212912|NCT00241644|706867|P1|First Efficacy Period (Year 1)|Non-compliance|2
212913|NCT00241644|706864|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
212914|NCT00241644|706865|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
212915|NCT00241644|706866|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
212916|NCT00241644|706867|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
212917|NCT00241644|706864|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
212918|NCT00241644|706865|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
212919|NCT00241644|706866|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
212920|NCT00241644|706867|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
212921|NCT00241644|706864|P4|First Efficacy Period (Year 1)|Protocol Violation|8
212922|NCT00241644|706865|P3|First Efficacy Period (Year 1)|Protocol Violation|4
212923|NCT00241644|706866|P2|First Efficacy Period (Year 1)|Protocol Violation|5
212924|NCT00241644|706867|P1|First Efficacy Period (Year 1)|Protocol Violation|3
212925|NCT00241644|706864|P4|First Efficacy Period (Year 1)|Adverse Event|91
212926|NCT00241644|706865|P3|First Efficacy Period (Year 1)|Adverse Event|45
212927|NCT00241644|706866|P2|First Efficacy Period (Year 1)|Adverse Event|45
212928|NCT00241644|706867|P1|First Efficacy Period (Year 1)|Adverse Event|46
212929|NCT00241358|706952|P3|Overall Study|Determined to be not ineligible|1
212930|NCT00241358|706953|P2|Overall Study|Determined to be not ineligible|1
212931|NCT00241358|706954|P1|Overall Study|Determined to be not ineligible|0
212932|NCT00241280|706987|P2|Overall Study|Excessive Dryness|1
212933|NCT00241280|706988|P1|Overall Study|Excessive Dryness|0
212934|NCT00241280|706987|P2|Overall Study|Coating on Lens|0
212935|NCT00241280|706988|P1|Overall Study|Coating on Lens|1
212936|NCT00241280|706987|P2|Overall Study|History of Ocular Surgery|1
212937|NCT00241280|706988|P1|Overall Study|History of Ocular Surgery|0
212938|NCT00241280|706987|P2|Overall Study|Scheduling Conflict|2
212939|NCT00241280|706988|P1|Overall Study|Scheduling Conflict|0
212940|NCT00241280|706987|P2|Overall Study|Unacceptable Fit|1
212941|NCT00241280|706988|P1|Overall Study|Unacceptable Fit|0
212942|NCT00241280|706987|P2|Overall Study|Dispensed incorrect test article|2
212943|NCT00241280|706988|P1|Overall Study|Dispensed incorrect test article|1
212944|NCT00241280|706987|P2|Overall Study|Subject Ineligible/Dispensed|6
212945|NCT00241280|706988|P1|Overall Study|Subject Ineligible/Dispensed|9
212946|NCT00241280|706987|P2|Overall Study|Diabetic|0
212947|NCT00241280|706988|P1|Overall Study|Diabetic|1
212948|NCT00241280|706987|P2|Overall Study|Unsatisfactory Visual Response|1
212949|NCT00241280|706988|P1|Overall Study|Unsatisfactory Visual Response|1
212950|NCT00241280|706987|P2|Overall Study|Unsatisfactory Physiological Response|1
212951|NCT00241280|706988|P1|Overall Study|Unsatisfactory Physiological Response|1
212952|NCT00241280|706987|P2|Overall Study|Relocation|4
212953|NCT00241280|706988|P1|Overall Study|Relocation|4
212954|NCT00241280|706987|P2|Overall Study|Protocol Violation|10
212955|NCT00241280|706988|P1|Overall Study|Protocol Violation|4
212956|NCT00241280|706987|P2|Overall Study|Withdrawal by Subject|4
212957|NCT00241280|706988|P1|Overall Study|Withdrawal by Subject|7
212958|NCT00241280|706987|P2|Overall Study|Lost to Follow-up|8
212959|NCT00241280|706988|P1|Overall Study|Lost to Follow-up|5
212960|NCT00241280|706987|P2|Overall Study|Pregnancy|5
212961|NCT00241280|706988|P1|Overall Study|Pregnancy|1
212962|NCT00241280|706987|P2|Overall Study|Discomfort|16
212963|NCT00241280|706988|P1|Overall Study|Discomfort|11
212964|NCT00241280|706987|P2|Overall Study|Adverse Event|6
212965|NCT00241280|706988|P1|Overall Study|Adverse Event|2
212966|NCT00240994|707003|P1|Overall Study|Graft failure|1
212967|NCT00240994|707003|P1|Overall Study|Protocol Violation|1
212968|NCT00240994|707003|P1|Overall Study|Lost to Follow-up|1
212969|NCT00240331|707138|P2|Overall Study|Option selected by investigator|2
212970|NCT00240331|707139|P1|Overall Study|Option selected by investigator|1
212971|NCT00240331|707138|P2|Overall Study|Withdrawal by Subject|132
212972|NCT00240331|707139|P1|Overall Study|Withdrawal by Subject|125
212973|NCT00240110|707172|P2|Overall Study|Lost to Follow-up|7
212974|NCT00240110|707173|P1|Overall Study|Lost to Follow-up|6
212975|NCT00240097|707181|P1|Part II|did not continue from Part I|23
212976|NCT00240097|707181|P1|Part I|unevaluable|1
212977|NCT00240097|707181|P1|Part I|histology|1
212978|NCT00240097|707181|P1|Part I|Death|1
212979|NCT00240097|707181|P1|Part I|Adverse Event|1
212980|NCT00240071|707191|P1|Overall Study|Withdrawal by Subject|3
212981|NCT00239928|707196|P1|Overall Study|Withdrawal by Subject|2
212982|NCT00239928|707196|P1|Overall Study|Not need to continue study|3
212983|NCT00239928|707196|P1|Overall Study|Adverse Event|4
212984|NCT00239928|707196|P1|Overall Study|Lack of Efficacy|1
212985|NCT00239837|707208|P2|Overall Study|Lost to Follow-up|7
212986|NCT00239837|707209|P1|Overall Study|Lost to Follow-up|3
212987|NCT00239720|707236|P2|Overall Study|Lost to Follow-up|1
212988|NCT00239720|707237|P1|Overall Study|Lost to Follow-up|0
212989|NCT00239720|707236|P2|Overall Study|Adverse Event|0
212990|NCT00239720|707237|P1|Overall Study|Adverse Event|1
212991|NCT00239681|707245|P2|Overall Study|No information chacked on CaseReportForm|84
212992|NCT00239681|707246|P1|Overall Study|No information chacked on CaseReportForm|90
212993|NCT00239681|707245|P2|Overall Study|Physician Decision|17
212994|NCT00239681|707246|P1|Overall Study|Physician Decision|13
212995|NCT00239681|707245|P2|Overall Study|Protocol Violation|4
212996|NCT00239681|707246|P1|Overall Study|Protocol Violation|4
212997|NCT00239681|707245|P2|Overall Study|Lost to Follow-up|22
212998|NCT00239681|707246|P1|Overall Study|Lost to Follow-up|28
212999|NCT00239681|707245|P2|Overall Study|Withdrawal by Subject|489
213000|NCT00239681|707246|P1|Overall Study|Withdrawal by Subject|458
213001|NCT00239681|707245|P2|Overall Study|Adverse Event|99
213002|NCT00239681|707246|P1|Overall Study|Adverse Event|100
213003|NCT00239356|707301|P2|Overall Study|Drug available on market|2
213004|NCT00239356|707302|P1|Overall Study|Drug available on market|11
213005|NCT00239356|707301|P2|Overall Study|Administrative reason|1
213006|NCT00239356|707302|P1|Overall Study|Administrative reason|0
213007|NCT00239356|707301|P2|Overall Study|Pregnancy|0
213008|NCT00239356|707302|P1|Overall Study|Pregnancy|1
213009|NCT00239356|707301|P2|Overall Study|poor/non-compliance|0
213010|NCT00239356|707302|P1|Overall Study|poor/non-compliance|2
213011|NCT00239356|707301|P2|Overall Study|Lost to Follow-up|0
213012|NCT00239356|707302|P1|Overall Study|Lost to Follow-up|3
213013|NCT00239356|707301|P2|Overall Study|Withdrawal by Subject|6
213014|NCT00239356|707302|P1|Overall Study|Withdrawal by Subject|15
213015|NCT00239356|707301|P2|Overall Study|Adverse Event|0
213016|NCT00239356|707302|P1|Overall Study|Adverse Event|6
213017|NCT00239356|707301|P2|Overall Study|Lack of Efficacy|0
213018|NCT00239356|707302|P1|Overall Study|Lack of Efficacy|1
213019|NCT00239226|707324|P4|Overall Study|Lost to Follow-up|0
213020|NCT00239226|707325|P3|Overall Study|Lost to Follow-up|1
213021|NCT00239226|707326|P2|Overall Study|Lost to Follow-up|0
213022|NCT00239226|707327|P1|Overall Study|Lost to Follow-up|1
213023|NCT00239226|707324|P4|Overall Study|permAF during stabilization period|3
213024|NCT00239226|707325|P3|Overall Study|permAF during stabilization period|0
213025|NCT00239226|707326|P2|Overall Study|permAF during stabilization period|0
213026|NCT00239226|707327|P1|Overall Study|permAF during stabilization period|0
213027|NCT00239005|707339|P2|Overall Study|Lost to Follow-up|1
213028|NCT00239005|707340|P1|Overall Study|Lost to Follow-up|0
213029|NCT00239005|707339|P2|Overall Study|Subj. cond. no longer needs study drug|1
213030|NCT00239005|707340|P1|Overall Study|Subj. cond. no longer needs study drug|0
213031|NCT00239005|707339|P2|Overall Study|Protocol Violation|0
213032|NCT00239005|707340|P1|Overall Study|Protocol Violation|1
213033|NCT00239005|707339|P2|Overall Study|Unsatisfactory Therapeutic effect|0
213034|NCT00239005|707340|P1|Overall Study|Unsatisfactory Therapeutic effect|2
213035|NCT00239005|707339|P2|Overall Study|Withdrawal by Subject|4
213036|NCT00239005|707340|P1|Overall Study|Withdrawal by Subject|3
213037|NCT00239005|707339|P2|Overall Study|Adverse Event|6
213038|NCT00239005|707340|P1|Overall Study|Adverse Event|6
213039|NCT00238433|707356|P1|Overall Study|Death|1
213040|NCT00238433|707356|P1|Overall Study|Lost to Follow-up|1
213041|NCT00238433|707356|P1|Overall Study|Screen failure|1
213042|NCT00238420|707363|P2|Overall Study|Protocol Violation|1
213043|NCT00238420|707364|P1|Overall Study|Protocol Violation|1
213044|NCT00238303|707381|P3|Overall Study|Adverse Event|3
213045|NCT00238303|707382|P2|Overall Study|Adverse Event|1
213046|NCT00238303|707383|P1|Overall Study|Adverse Event|0
213047|NCT00238303|707381|P3|Overall Study|Poor tolerance of study treatment|1
213048|NCT00238303|707382|P2|Overall Study|Poor tolerance of study treatment|0
213049|NCT00238303|707383|P1|Overall Study|Poor tolerance of study treatment|1
213050|NCT00238303|707381|P3|Overall Study|Other Medical Problems|2
213051|NCT00238303|707382|P2|Overall Study|Other Medical Problems|0
213052|NCT00238303|707383|P1|Overall Study|Other Medical Problems|2
213053|NCT00238303|707381|P3|Overall Study|Death|1
213054|NCT00238303|707382|P2|Overall Study|Death|0
213055|NCT00238303|707383|P1|Overall Study|Death|1
213056|NCT00238303|707381|P3|Overall Study|Withdrawal by Subject|2
213057|NCT00238303|707382|P2|Overall Study|Withdrawal by Subject|1
213058|NCT00238303|707383|P1|Overall Study|Withdrawal by Subject|11
213059|NCT00238264|707400|P1|Overall Study|Ineligible|7
213060|NCT00238264|707400|P1|Overall Study|Withdrawal by Subject|4
213061|NCT00238264|707400|P1|Overall Study|Lost to Follow-up|18
213062|NCT00238264|707400|P1|Overall Study|Death|7
213063|NCT00238238|707413|P3|Overall Study|Withdrawal by Subject|0
213064|NCT00238238|707414|P2|Overall Study|Withdrawal by Subject|3
213065|NCT00238238|707415|P1|Overall Study|Withdrawal by Subject|0
213066|NCT00238121|707428|P2|Overall Study|Adverse Event|1
213067|NCT00238121|707429|P1|Overall Study|Adverse Event|2
213068|NCT00238121|707428|P2|Overall Study|Withdrawal by Subject|1
213069|NCT00238121|707429|P1|Overall Study|Withdrawal by Subject|1
213070|NCT00237809|707455|P4|Overall Study|Lost to Follow-up|9
213071|NCT00237809|707456|P3|Overall Study|Lost to Follow-up|9
213072|NCT00237809|707457|P2|Overall Study|Lost to Follow-up|10
213073|NCT00237809|707458|P1|Overall Study|Lost to Follow-up|11
213074|NCT00237796|707494|P2|Overall Study|Baseline and one other ILSS required|5
213075|NCT00237796|707495|P1|Overall Study|Baseline and one other ILSS required|10
213076|NCT00237744|707529|P3|Overall Study|Withdrawal by Subject|0
213077|NCT00237744|707530|P2|Overall Study|Withdrawal by Subject|1
213078|NCT00237744|707531|P1|Overall Study|Withdrawal by Subject|3
213079|NCT00237692|707557|P4|Overall Study|Withdrawal by Subject|4
213080|NCT00237692|707558|P3|Overall Study|Withdrawal by Subject|10
213081|NCT00237692|707559|P2|Overall Study|Withdrawal by Subject|6
213082|NCT00237692|707560|P1|Overall Study|Withdrawal by Subject|4
213083|NCT00237692|707557|P4|Overall Study|Excluded - did not meet criteria|9
213084|NCT00237692|707558|P3|Overall Study|Excluded - did not meet criteria|5
213085|NCT00237692|707559|P2|Overall Study|Excluded - did not meet criteria|3
213086|NCT00237692|707560|P1|Overall Study|Excluded - did not meet criteria|4
213087|NCT00237692|707557|P4|Overall Study|Death|3
213088|NCT00237692|707558|P3|Overall Study|Death|2
213089|NCT00237692|707559|P2|Overall Study|Death|2
213090|NCT00237692|707560|P1|Overall Study|Death|1
213091|NCT00237692|707557|P4|Overall Study|Lost to Follow-up|3
213092|NCT00237692|707558|P3|Overall Study|Lost to Follow-up|5
213093|NCT00237692|707559|P2|Overall Study|Lost to Follow-up|3
213094|NCT00237692|707560|P1|Overall Study|Lost to Follow-up|9
213095|NCT00237458|707600|P1|Overall Study|Withdrawal by Subject|1
213096|NCT00237458|707600|P1|Overall Study|Adverse Event|1
213097|NCT00237458|707600|P1|Overall Study|Lack of Efficacy|1
213098|NCT00237185|707618|P2|Extension|Death|1
213099|NCT00237185|707619|P1|Extension|Death|1
213100|NCT00237185|707618|P2|Extension|Administrative problems|0
213101|NCT00237185|707619|P1|Extension|Administrative problems|1
213102|NCT00237185|707618|P2|Extension|Lost to Follow-up|0
213103|NCT00237185|707619|P1|Extension|Lost to Follow-up|1
213104|NCT00237185|707618|P2|Extension|Withdrawal by Subject|2
213105|NCT00237185|707619|P1|Extension|Withdrawal by Subject|3
213106|NCT00237185|707618|P2|Extension|Condition no longer required study drug|1
213107|NCT00237185|707619|P1|Extension|Condition no longer required study drug|0
213108|NCT00237185|707618|P2|Extension|Lack of Efficacy|14
213109|NCT00237185|707619|P1|Extension|Lack of Efficacy|9
213110|NCT00237185|707618|P2|Extension|Abnormal laboratory value|1
213111|NCT00237185|707619|P1|Extension|Abnormal laboratory value|0
213112|NCT00237185|707618|P2|Extension|Adverse Event|0
213113|NCT00237185|707619|P1|Extension|Adverse Event|1
213114|NCT00237185|707618|P2|Core|Determined ineligible post randomization|0
213115|NCT00237185|707619|P1|Core|Determined ineligible post randomization|1
213116|NCT00237185|707618|P2|Core|Death|0
213117|NCT00237185|707619|P1|Core|Death|4
213118|NCT00237185|707618|P2|Core|Administrative problems|1
213119|NCT00237185|707619|P1|Core|Administrative problems|0
213120|NCT00237185|707618|P2|Core|Withdrawal by Subject|4
213121|NCT00237185|707619|P1|Core|Withdrawal by Subject|4
213122|NCT00237185|707618|P2|Core|Protocol Violation|1
213123|NCT00237185|707619|P1|Core|Protocol Violation|1
213124|NCT00237185|707618|P2|Core|Lack of Efficacy|23
213125|NCT00237185|707619|P1|Core|Lack of Efficacy|30
213126|NCT00237185|707618|P2|Core|Abnormal test procedure results|0
213127|NCT00237185|707619|P1|Core|Abnormal test procedure results|1
213128|NCT00237185|707618|P2|Core|Abnormal laboratory value|4
213129|NCT00237185|707619|P1|Core|Abnormal laboratory value|0
213130|NCT00237185|707618|P2|Core|Adverse Event|4
213131|NCT00237185|707619|P1|Core|Adverse Event|3
213132|NCT00237042|707650|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
213133|NCT00237042|707651|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
213134|NCT00237042|707652|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
213135|NCT00237042|707650|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
213136|NCT00237042|707651|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
213137|NCT00237042|707652|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
213138|NCT00237042|707650|P3|Treatment|Completed no treatment|21
213139|NCT00237042|707651|P2|Treatment|Completed no treatment|5
213140|NCT00237042|707652|P1|Treatment|Completed no treatment|5
213141|NCT00237042|707650|P3|Treatment|Moved out of state|1
213142|NCT00237042|707651|P2|Treatment|Moved out of state|1
213143|NCT00237042|707652|P1|Treatment|Moved out of state|1
213144|NCT00237042|707650|P3|Treatment|Became ineligible post-randomization|16
213145|NCT00237042|707651|P2|Treatment|Became ineligible post-randomization|1
213146|NCT00237042|707652|P1|Treatment|Became ineligible post-randomization|0
213147|NCT00236899|707726|P4|Overall Study|Lack of Efficacy|23
213148|NCT00236899|707727|P3|Overall Study|Lack of Efficacy|25
213149|NCT00236899|707728|P2|Overall Study|Lack of Efficacy|18
213150|NCT00236899|707729|P1|Overall Study|Lack of Efficacy|18
213151|NCT00236899|707726|P4|Overall Study|Satisfactory Response|1
213152|NCT00236899|707727|P3|Overall Study|Satisfactory Response|0
213153|NCT00236899|707728|P2|Overall Study|Satisfactory Response|0
213154|NCT00236899|707729|P1|Overall Study|Satisfactory Response|2
213155|NCT00236899|707726|P4|Overall Study|Physician Decision|6
213156|NCT00236899|707727|P3|Overall Study|Physician Decision|7
213157|NCT00236899|707728|P2|Overall Study|Physician Decision|8
213158|NCT00236899|707729|P1|Overall Study|Physician Decision|7
213159|NCT00236899|707726|P4|Overall Study|Withdrawal by Subject|2
213160|NCT00236899|707727|P3|Overall Study|Withdrawal by Subject|5
213161|NCT00236899|707728|P2|Overall Study|Withdrawal by Subject|4
213162|NCT00236899|707729|P1|Overall Study|Withdrawal by Subject|6
213163|NCT00236899|707726|P4|Overall Study|Protocol Violation|0
213164|NCT00236899|707727|P3|Overall Study|Protocol Violation|0
213165|NCT00236899|707728|P2|Overall Study|Protocol Violation|0
213166|NCT00236899|707729|P1|Overall Study|Protocol Violation|1
213167|NCT00236899|707726|P4|Overall Study|Entry Criteria Exclusion|0
213168|NCT00236899|707727|P3|Overall Study|Entry Criteria Exclusion|1
213169|NCT00236899|707728|P2|Overall Study|Entry Criteria Exclusion|1
213170|NCT00236899|707729|P1|Overall Study|Entry Criteria Exclusion|0
213171|NCT00236899|707726|P4|Overall Study|Lost to Follow-up|0
213172|NCT00236899|707727|P3|Overall Study|Lost to Follow-up|0
213173|NCT00236899|707728|P2|Overall Study|Lost to Follow-up|1
213174|NCT00236899|707729|P1|Overall Study|Lost to Follow-up|0
213175|NCT00236899|707726|P4|Overall Study|Death (Study Drug Toxicity)|0
213176|NCT00236899|707727|P3|Overall Study|Death (Study Drug Toxicity)|0
213177|NCT00236899|707728|P2|Overall Study|Death (Study Drug Toxicity)|0
213178|NCT00236899|707729|P1|Overall Study|Death (Study Drug Toxicity)|1
213179|NCT00236899|707726|P4|Overall Study|Death (Not Study Related)|0
213180|NCT00236899|707727|P3|Overall Study|Death (Not Study Related)|0
213181|NCT00236899|707728|P2|Overall Study|Death (Not Study Related)|0
213182|NCT00236899|707729|P1|Overall Study|Death (Not Study Related)|2
213183|NCT00236899|707726|P4|Overall Study|Death (Study Disease)|0
213184|NCT00236899|707727|P3|Overall Study|Death (Study Disease)|0
213185|NCT00236899|707728|P2|Overall Study|Death (Study Disease)|4
213186|NCT00236899|707729|P1|Overall Study|Death (Study Disease)|1
213187|NCT00236899|707726|P4|Overall Study|Adverse Event (Not Study Related)|7
213188|NCT00236899|707727|P3|Overall Study|Adverse Event (Not Study Related)|4
213189|NCT00236899|707728|P2|Overall Study|Adverse Event (Not Study Related)|3
213190|NCT00236899|707729|P1|Overall Study|Adverse Event (Not Study Related)|3
213191|NCT00236899|707726|P4|Overall Study|Adverse Event (Study Related)|1
213192|NCT00236899|707727|P3|Overall Study|Adverse Event (Study Related)|2
213193|NCT00236899|707728|P2|Overall Study|Adverse Event (Study Related)|1
213194|NCT00236899|707729|P1|Overall Study|Adverse Event (Study Related)|1
213195|NCT00236197|707761|P2|Overall Study|Other|2
213196|NCT00236197|707762|P1|Overall Study|Other|0
213197|NCT00236197|707761|P2|Overall Study|Medication non-compliance|2
213198|NCT00236197|707762|P1|Overall Study|Medication non-compliance|1
213199|NCT00236197|707761|P2|Overall Study|Protocol Violation|3
213200|NCT00236197|707762|P1|Overall Study|Protocol Violation|0
213201|NCT00236197|707761|P2|Overall Study|Lost to Follow-up|5
213202|NCT00236197|707762|P1|Overall Study|Lost to Follow-up|1
213203|NCT00236197|707761|P2|Overall Study|Withdrawal by Subject|2
213204|NCT00236197|707762|P1|Overall Study|Withdrawal by Subject|3
213205|NCT00236184|707770|P2|Overall Study|other|2
213206|NCT00236184|707771|P1|Overall Study|other|1
213207|NCT00236184|707770|P2|Overall Study|non-compliance with study drug|1
213208|NCT00236184|707771|P1|Overall Study|non-compliance with study drug|2
213209|NCT00236184|707770|P2|Overall Study|Protocol Violation|0
213210|NCT00236184|707771|P1|Overall Study|Protocol Violation|3
213211|NCT00236184|707770|P2|Overall Study|Withdrawal by Subject|0
213212|NCT00236184|707771|P1|Overall Study|Withdrawal by Subject|3
213213|NCT00236184|707770|P2|Overall Study|Physician Decision|1
213214|NCT00236184|707771|P1|Overall Study|Physician Decision|1
213215|NCT00236184|707770|P2|Overall Study|Lost to Follow-up|4
213216|NCT00236184|707771|P1|Overall Study|Lost to Follow-up|3
213217|NCT00236184|707770|P2|Overall Study|Lack of Efficacy|1
213218|NCT00236184|707771|P1|Overall Study|Lack of Efficacy|0
213219|NCT00236184|707770|P2|Overall Study|Adverse Event|2
213220|NCT00236184|707771|P1|Overall Study|Adverse Event|5
213221|NCT00236080|707782|P5|Overall Study|Miscellaneous|0
213222|NCT00236080|707783|P4|Overall Study|Miscellaneous|0
213223|NCT00236080|707784|P3|Overall Study|Miscellaneous|1
213224|NCT00236080|707785|P2|Overall Study|Miscellaneous|0
213225|NCT00236080|707786|P1|Overall Study|Miscellaneous|0
213226|NCT00236080|707782|P5|Overall Study|Withdrawal by Subject|0
213227|NCT00236080|707783|P4|Overall Study|Withdrawal by Subject|0
213228|NCT00236080|707784|P3|Overall Study|Withdrawal by Subject|0
213229|NCT00236080|707785|P2|Overall Study|Withdrawal by Subject|0
213230|NCT00236080|707786|P1|Overall Study|Withdrawal by Subject|1
213231|NCT00236080|707782|P5|Overall Study|Physician Decision|1
213232|NCT00236080|707783|P4|Overall Study|Physician Decision|1
213233|NCT00236080|707784|P3|Overall Study|Physician Decision|1
213234|NCT00236080|707785|P2|Overall Study|Physician Decision|0
213235|NCT00236080|707786|P1|Overall Study|Physician Decision|1
213236|NCT00236080|707782|P5|Overall Study|Lost to Follow-up|0
213237|NCT00236080|707783|P4|Overall Study|Lost to Follow-up|0
213238|NCT00236080|707784|P3|Overall Study|Lost to Follow-up|0
213239|NCT00236080|707785|P2|Overall Study|Lost to Follow-up|1
213240|NCT00236080|707786|P1|Overall Study|Lost to Follow-up|0
213241|NCT00236080|707782|P5|Overall Study|Adverse Event|0
213242|NCT00236080|707783|P4|Overall Study|Adverse Event|1
213243|NCT00236080|707784|P3|Overall Study|Adverse Event|3
213244|NCT00236080|707785|P2|Overall Study|Adverse Event|0
213245|NCT00236080|707786|P1|Overall Study|Adverse Event|0
213246|NCT00235989|707807|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
213247|NCT00235989|707808|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
213248|NCT00235989|707809|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
213249|NCT00235989|707810|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
213250|NCT00235989|707811|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
213251|NCT00235989|707812|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
213252|NCT00235989|707807|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
213253|NCT00235989|707808|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
213254|NCT00235989|707809|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
213255|NCT00235989|707810|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
213256|NCT00235989|707811|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
213257|NCT00235989|707812|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
213258|NCT00235989|707807|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
213259|NCT00235989|707808|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
213260|NCT00235989|707809|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
213261|NCT00235989|707810|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
213262|NCT00235989|707811|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
213263|NCT00235989|707812|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
213264|NCT00235989|707807|P6|Extension Treatment Period (ET)|Adverse Event|0
213265|NCT00235989|707808|P5|Extension Treatment Period (ET)|Adverse Event|0
213266|NCT00235989|707809|P4|Extension Treatment Period (ET)|Adverse Event|0
213267|NCT00235989|707810|P3|Extension Treatment Period (ET)|Adverse Event|2
213268|NCT00235989|707811|P2|Extension Treatment Period (ET)|Adverse Event|0
213269|NCT00235989|707812|P1|Extension Treatment Period (ET)|Adverse Event|3
213270|NCT00235989|707807|P6|Core Treatment Period (CT)|Lost to Follow-up|2
213271|NCT00235989|707808|P5|Core Treatment Period (CT)|Lost to Follow-up|0
213272|NCT00235989|707809|P4|Core Treatment Period (CT)|Lost to Follow-up|0
213273|NCT00235989|707810|P3|Core Treatment Period (CT)|Lost to Follow-up|0
213274|NCT00235989|707811|P2|Core Treatment Period (CT)|Lost to Follow-up|0
213275|NCT00235989|707812|P1|Core Treatment Period (CT)|Lost to Follow-up|0
213276|NCT00235872|707826|P1|Overall Study|Administrative reason|61
213277|NCT00235872|707826|P1|Overall Study|Withdrawal by Subject|50
213278|NCT00235872|707826|P1|Overall Study|Lost to Follow-up|1
213279|NCT00235872|707826|P1|Overall Study|Death|1
213280|NCT00235872|707826|P1|Overall Study|Adverse Event|34
213281|NCT00235755|707857|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
213282|NCT00235755|707858|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
213283|NCT00235755|707859|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
213284|NCT00235755|707857|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
213285|NCT00235755|707858|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
213286|NCT00235755|707859|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
213287|NCT00235755|707857|P3|12-Week Maintenance Phase|Protocol Violation|2
213288|NCT00235755|707858|P2|12-Week Maintenance Phase|Protocol Violation|4
213289|NCT00235755|707859|P1|12-Week Maintenance Phase|Protocol Violation|0
213290|NCT00235755|707857|P3|12-Week Maintenance Phase|Lack of Efficacy|0
213291|NCT00235755|707858|P2|12-Week Maintenance Phase|Lack of Efficacy|0
213292|NCT00235755|707859|P1|12-Week Maintenance Phase|Lack of Efficacy|5
213293|NCT00235755|707857|P3|12-Week Maintenance Phase|Lost to Follow-up|0
213294|NCT00235755|707858|P2|12-Week Maintenance Phase|Lost to Follow-up|3
213295|NCT00235755|707859|P1|12-Week Maintenance Phase|Lost to Follow-up|2
213296|NCT00235755|707857|P3|12-Week Maintenance Phase|Adverse Event|26
213297|NCT00235755|707858|P2|12-Week Maintenance Phase|Adverse Event|12
213298|NCT00235755|707859|P1|12-Week Maintenance Phase|Adverse Event|8
213299|NCT00235755|707857|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
213300|NCT00235755|707858|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
213301|NCT00235755|707859|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
213302|NCT00235755|707857|P3|4-Week Titration Phase|Randomization Occurred in Error|0
213303|NCT00235755|707858|P2|4-Week Titration Phase|Randomization Occurred in Error|0
213304|NCT00235755|707859|P1|4-Week Titration Phase|Randomization Occurred in Error|1
213305|NCT00235755|707857|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
213306|NCT00235755|707858|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
213307|NCT00235755|707859|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
213308|NCT00235755|707857|P3|4-Week Titration Phase|Withdrawal by Subject|3
213309|NCT00235755|707858|P2|4-Week Titration Phase|Withdrawal by Subject|2
213310|NCT00235755|707859|P1|4-Week Titration Phase|Withdrawal by Subject|1
213311|NCT00235755|707857|P3|4-Week Titration Phase|Protocol Violation|1
213312|NCT00235755|707858|P2|4-Week Titration Phase|Protocol Violation|2
213313|NCT00235755|707859|P1|4-Week Titration Phase|Protocol Violation|2
213314|NCT00235755|707857|P3|4-Week Titration Phase|Lost to Follow-up|1
213315|NCT00235755|707858|P2|4-Week Titration Phase|Lost to Follow-up|1
213316|NCT00235755|707859|P1|4-Week Titration Phase|Lost to Follow-up|0
213317|NCT00235755|707857|P3|4-Week Titration Phase|Adverse Event|20
213318|NCT00235755|707858|P2|4-Week Titration Phase|Adverse Event|14
213319|NCT00235755|707859|P1|4-Week Titration Phase|Adverse Event|6
213320|NCT00235716|707937|P4|Overall Study|Physician Decision|3
213321|NCT00235716|707938|P3|Overall Study|Physician Decision|1
213322|NCT00235716|707939|P2|Overall Study|Physician Decision|1
213323|NCT00235716|707940|P1|Overall Study|Physician Decision|0
213324|NCT00235716|707937|P4|Overall Study|Adverse Event|0
213325|NCT00235716|707938|P3|Overall Study|Adverse Event|1
213326|NCT00235716|707939|P2|Overall Study|Adverse Event|1
213327|NCT00235716|707940|P1|Overall Study|Adverse Event|1
213328|NCT00235716|707937|P4|Overall Study|Lost to Follow-up|10
213329|NCT00235716|707938|P3|Overall Study|Lost to Follow-up|14
213330|NCT00235716|707939|P2|Overall Study|Lost to Follow-up|7
213331|NCT00235716|707940|P1|Overall Study|Lost to Follow-up|12
213332|NCT00235716|707937|P4|Overall Study|Withdrawal by Subject|18
213333|NCT00235716|707938|P3|Overall Study|Withdrawal by Subject|17
213334|NCT00235716|707939|P2|Overall Study|Withdrawal by Subject|19
213335|NCT00235716|707940|P1|Overall Study|Withdrawal by Subject|23
213336|NCT00235716|707937|P4|Overall Study|Death|31
213337|NCT00235716|707938|P3|Overall Study|Death|32
213338|NCT00235716|707939|P2|Overall Study|Death|39
213339|NCT00235716|707940|P1|Overall Study|Death|26
213340|NCT00235443|708003|P6|Overall Study|Other reasons for premature termination|6
213341|NCT00235443|708004|P5|Overall Study|Other reasons for premature termination|3
213342|NCT00235443|708005|P4|Overall Study|Other reasons for premature termination|7
213343|NCT00235443|708006|P3|Overall Study|Other reasons for premature termination|6
213344|NCT00235443|708007|P2|Overall Study|Other reasons for premature termination|6
213345|NCT00235443|708008|P1|Overall Study|Other reasons for premature termination|1
213346|NCT00235443|708003|P6|Overall Study|Unsatisfactory compliance|0
213347|NCT00235443|708004|P5|Overall Study|Unsatisfactory compliance|1
213348|NCT00235443|708005|P4|Overall Study|Unsatisfactory compliance|4
213349|NCT00235443|708006|P3|Overall Study|Unsatisfactory compliance|3
213350|NCT00235443|708007|P2|Overall Study|Unsatisfactory compliance|2
213351|NCT00235443|708008|P1|Overall Study|Unsatisfactory compliance|0
213352|NCT00235443|708003|P6|Overall Study|Lost to Follow-up|3
213353|NCT00235443|708004|P5|Overall Study|Lost to Follow-up|4
213354|NCT00235443|708005|P4|Overall Study|Lost to Follow-up|6
213355|NCT00235443|708006|P3|Overall Study|Lost to Follow-up|6
213356|NCT00235443|708007|P2|Overall Study|Lost to Follow-up|8
213357|NCT00235443|708008|P1|Overall Study|Lost to Follow-up|0
213358|NCT00235443|708003|P6|Overall Study|Withdrawal by Subject|12
213359|NCT00235443|708004|P5|Overall Study|Withdrawal by Subject|10
213360|NCT00235443|708005|P4|Overall Study|Withdrawal by Subject|24
213361|NCT00235443|708006|P3|Overall Study|Withdrawal by Subject|25
213362|NCT00235443|708007|P2|Overall Study|Withdrawal by Subject|9
213363|NCT00235443|708008|P1|Overall Study|Withdrawal by Subject|3
213364|NCT00235443|708003|P6|Overall Study|Lack of Efficacy|9
213365|NCT00235443|708004|P5|Overall Study|Lack of Efficacy|2
213366|NCT00235443|708005|P4|Overall Study|Lack of Efficacy|12
213367|NCT00235443|708006|P3|Overall Study|Lack of Efficacy|5
213368|NCT00235443|708007|P2|Overall Study|Lack of Efficacy|1
213369|NCT00235443|708008|P1|Overall Study|Lack of Efficacy|0
213370|NCT00235443|708003|P6|Overall Study|Adverse Event|15
213371|NCT00235443|708004|P5|Overall Study|Adverse Event|10
213372|NCT00235443|708005|P4|Overall Study|Adverse Event|44
213373|NCT00235443|708006|P3|Overall Study|Adverse Event|17
213374|NCT00235443|708007|P2|Overall Study|Adverse Event|12
213375|NCT00235443|708008|P1|Overall Study|Adverse Event|4
213376|NCT00235391|708149|P6|Overall Study|Death|0
213377|NCT00235391|708150|P5|Overall Study|Death|0
213378|NCT00235391|708151|P4|Overall Study|Death|4
213379|NCT00235391|708152|P3|Overall Study|Death|1
213380|NCT00235391|708153|P2|Overall Study|Death|0
213381|NCT00235391|708154|P1|Overall Study|Death|0
213382|NCT00235391|708149|P6|Overall Study|Administrative problems|0
213383|NCT00235391|708150|P5|Overall Study|Administrative problems|0
213384|NCT00235391|708151|P4|Overall Study|Administrative problems|1
213385|NCT00235391|708152|P3|Overall Study|Administrative problems|0
213386|NCT00235391|708153|P2|Overall Study|Administrative problems|0
213387|NCT00235391|708154|P1|Overall Study|Administrative problems|0
213388|NCT00235391|708149|P6|Overall Study|Lost to Follow-up|0
213389|NCT00235391|708150|P5|Overall Study|Lost to Follow-up|0
213390|NCT00235391|708151|P4|Overall Study|Lost to Follow-up|16
213391|NCT00235391|708152|P3|Overall Study|Lost to Follow-up|3
213392|NCT00235391|708153|P2|Overall Study|Lost to Follow-up|3
213393|NCT00235391|708154|P1|Overall Study|Lost to Follow-up|0
213394|NCT00235391|708149|P6|Overall Study|Withdrawal by Subject|0
213395|NCT00235391|708150|P5|Overall Study|Withdrawal by Subject|5
213396|NCT00235391|708151|P4|Overall Study|Withdrawal by Subject|61
213397|NCT00235391|708152|P3|Overall Study|Withdrawal by Subject|3
213398|NCT00235391|708153|P2|Overall Study|Withdrawal by Subject|3
213399|NCT00235391|708154|P1|Overall Study|Withdrawal by Subject|2
213400|NCT00235391|708149|P6|Overall Study|Protocol deviation|0
213401|NCT00235391|708150|P5|Overall Study|Protocol deviation|0
213402|NCT00235391|708151|P4|Overall Study|Protocol deviation|11
213403|NCT00235391|708152|P3|Overall Study|Protocol deviation|1
213404|NCT00235391|708153|P2|Overall Study|Protocol deviation|0
213405|NCT00235391|708154|P1|Overall Study|Protocol deviation|0
213406|NCT00235391|708149|P6|Overall Study|Condition no longer requires treatment|0
213407|NCT00235391|708150|P5|Overall Study|Condition no longer requires treatment|1
213408|NCT00235391|708151|P4|Overall Study|Condition no longer requires treatment|11
213409|NCT00235391|708152|P3|Overall Study|Condition no longer requires treatment|0
213410|NCT00235391|708153|P2|Overall Study|Condition no longer requires treatment|0
213411|NCT00235391|708154|P1|Overall Study|Condition no longer requires treatment|3
213412|NCT00235391|708149|P6|Overall Study|Unsatisfactory therapeutic effect|0
213413|NCT00235391|708150|P5|Overall Study|Unsatisfactory therapeutic effect|0
213414|NCT00235391|708151|P4|Overall Study|Unsatisfactory therapeutic effect|17
213415|NCT00235391|708152|P3|Overall Study|Unsatisfactory therapeutic effect|2
213416|NCT00235391|708153|P2|Overall Study|Unsatisfactory therapeutic effect|2
213417|NCT00235391|708154|P1|Overall Study|Unsatisfactory therapeutic effect|0
213418|NCT00235391|708149|P6|Overall Study|Abnormal laboratory value(s)|2
213419|NCT00235391|708150|P5|Overall Study|Abnormal laboratory value(s)|1
213420|NCT00235391|708151|P4|Overall Study|Abnormal laboratory value(s)|27
213421|NCT00235391|708152|P3|Overall Study|Abnormal laboratory value(s)|4
213422|NCT00235391|708153|P2|Overall Study|Abnormal laboratory value(s)|5
213423|NCT00235391|708154|P1|Overall Study|Abnormal laboratory value(s)|3
213424|NCT00235391|708149|P6|Overall Study|Adverse Event|2
213425|NCT00235391|708150|P5|Overall Study|Adverse Event|5
213426|NCT00235391|708151|P4|Overall Study|Adverse Event|72
213427|NCT00235391|708152|P3|Overall Study|Adverse Event|10
213428|NCT00235391|708153|P2|Overall Study|Adverse Event|5
213429|NCT00235391|708154|P1|Overall Study|Adverse Event|4
213430|NCT00235326|708171|P2|Overall Study|Lost to Follow-up|1400
213431|NCT00235326|708172|P1|Overall Study|Lost to Follow-up|746
213432|NCT00234494|708212|P1|Overall Study|Protocol Violation|2
213433|NCT00234104|708258|P4|Overall Study|Physician Decision|2
213434|NCT00234104|708259|P3|Overall Study|Physician Decision|2
213435|NCT00234104|708260|P2|Overall Study|Physician Decision|1
213436|NCT00234104|708261|P1|Overall Study|Physician Decision|0
213437|NCT00234104|708258|P4|Overall Study|Protocol Violation|1
213438|NCT00234104|708259|P3|Overall Study|Protocol Violation|0
213439|NCT00234104|708260|P2|Overall Study|Protocol Violation|0
213440|NCT00234104|708261|P1|Overall Study|Protocol Violation|0
213441|NCT00234104|708258|P4|Overall Study|Adverse Event|5
213442|NCT00234104|708259|P3|Overall Study|Adverse Event|3
213443|NCT00234104|708260|P2|Overall Study|Adverse Event|0
213444|NCT00234104|708261|P1|Overall Study|Adverse Event|4
213445|NCT00234065|708302|P2|Overall Study|Not Classified|112
213446|NCT00234065|708303|P1|Overall Study|Not Classified|111
213447|NCT00234065|708302|P2|Overall Study|Physician Decision|22
213448|NCT00234065|708303|P1|Overall Study|Physician Decision|23
213449|NCT00234065|708302|P2|Overall Study|Withdrawal by Subject|56
213450|NCT00234065|708303|P1|Overall Study|Withdrawal by Subject|73
213451|NCT00234065|708302|P2|Overall Study|Adverse Event|166
213452|NCT00234065|708303|P1|Overall Study|Adverse Event|268
213453|NCT00234039|708319|P1|Overall Study|No Protocol Treatment Received|2
213454|NCT00234039|708319|P1|Overall Study|Ineligible|9
213455|NCT00234039|708319|P1|Overall Study|Other - Not Protocol Specified|3
213456|NCT00234039|708319|P1|Overall Study|Progression/relapse|34
213457|NCT00234039|708319|P1|Overall Study|Adverse Event|2
213458|NCT00233987|708326|P1|Overall Study|Ineligible|4
213459|NCT00233987|708326|P1|Overall Study|Eligible but No Treatment Received|2
213460|NCT00233987|708326|P1|Overall Study|Other - Not Protocol Specified|5
213461|NCT00233987|708326|P1|Overall Study|Reason Under Review|1
213462|NCT00233987|708326|P1|Overall Study|Lack of Efficacy|2
213463|NCT00233987|708326|P1|Overall Study|Withdrawal by Subject|1
213464|NCT00233948|708335|P6|Overall Study|Adverse Event|0
213465|NCT00233948|708336|P5|Overall Study|Adverse Event|0
213466|NCT00233948|708337|P4|Overall Study|Adverse Event|0
213467|NCT00233948|708338|P3|Overall Study|Adverse Event|0
213468|NCT00233948|708339|P2|Overall Study|Adverse Event|0
213469|NCT00233948|708340|P1|Overall Study|Adverse Event|1
213470|NCT00233454|708364|P1|Overall Study|Death|6
213471|NCT00233402|708371|P2|Overall Study|Lost to follow up etc|21
213472|NCT00233402|708372|P1|Overall Study|Lost to follow up etc|3
213473|NCT00233402|708371|P2|Overall Study|No Ta/T1|94
213474|NCT00233402|708372|P1|Overall Study|No Ta/T1|89
213475|NCT00233402|708371|P2|Overall Study|No pathology data|9
213476|NCT00233402|708372|P1|Overall Study|No pathology data|12
213477|NCT00233324|708387|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
213478|NCT00233324|708388|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
213479|NCT00233324|708389|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
213480|NCT00233324|708390|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
213481|NCT00233324|708387|P4|Follow up at 18-22 Months Corrected Age|Death|4
213482|NCT00233324|708388|P3|Follow up at 18-22 Months Corrected Age|Death|5
213483|NCT00233324|708389|P2|Follow up at 18-22 Months Corrected Age|Death|7
213484|NCT00233324|708390|P1|Follow up at 18-22 Months Corrected Age|Death|5
213485|NCT00233324|708387|P4|Main Study|Death|47
213486|NCT00233324|708388|P3|Main Study|Death|62
213487|NCT00233324|708389|P2|Main Study|Death|60
213488|NCT00233324|708390|P1|Main Study|Death|68
213489|NCT00233064|708444|P2|Overall Study|Moved to Dom. Republic|0
213490|NCT00233064|708445|P1|Overall Study|Moved to Dom. Republic|1
213491|NCT00233064|708444|P2|Overall Study|Protocol Violation|0
213492|NCT00233064|708445|P1|Overall Study|Protocol Violation|1
213493|NCT00233064|708444|P2|Overall Study|Relocation|1
213494|NCT00233064|708445|P1|Overall Study|Relocation|0
213495|NCT00233064|708444|P2|Overall Study|Death|1
213496|NCT00233064|708445|P1|Overall Study|Death|0
213497|NCT00233064|708444|P2|Overall Study|Withdrawal by Subject|3
213498|NCT00233064|708445|P1|Overall Study|Withdrawal by Subject|5
213499|NCT00233064|708444|P2|Overall Study|Lost to Follow-up|7
213500|NCT00233064|708445|P1|Overall Study|Lost to Follow-up|7
213501|NCT00232596|708471|P2|12-Week Maintenance Phase|Other|3
213502|NCT00232596|708472|P1|12-Week Maintenance Phase|Other|1
213503|NCT00232596|708471|P2|12-Week Maintenance Phase|Protocol Violation|1
213504|NCT00232596|708472|P1|12-Week Maintenance Phase|Protocol Violation|3
213505|NCT00232596|708471|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
213506|NCT00232596|708472|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
213507|NCT00232596|708471|P2|12-Week Maintenance Phase|Adverse Event|22
213508|NCT00232596|708472|P1|12-Week Maintenance Phase|Adverse Event|7
213509|NCT00232596|708471|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
213510|NCT00232596|708472|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
213511|NCT00232596|708471|P2|6-Week Titration Phase|Other|3
213512|NCT00232596|708472|P1|6-Week Titration Phase|Other|3
213513|NCT00232596|708471|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
213514|NCT00232596|708472|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
213515|NCT00232596|708471|P2|6-Week Titration Phase|Protocol Violation|3
213516|NCT00232596|708472|P1|6-Week Titration Phase|Protocol Violation|1
213517|NCT00232596|708471|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
213518|NCT00232596|708472|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
213519|NCT00232596|708471|P2|6-Week Titration Phase|Failed to Return|1
213520|NCT00232596|708472|P1|6-Week Titration Phase|Failed to Return|2
213521|NCT00232596|708471|P2|6-Week Titration Phase|Adverse Event|19
213522|NCT00232596|708472|P1|6-Week Titration Phase|Adverse Event|6
213523|NCT00232557|708563|P2|Overall Study|Lost to Follow-up|5
213524|NCT00232557|708564|P1|Overall Study|Lost to Follow-up|3
213525|NCT00232544|708574|P2|Overall Study|Lost to Follow-up|15
213526|NCT00232544|708575|P1|Overall Study|Lost to Follow-up|20
213527|NCT00232180|708606|P3|Open Label Phase|Randomized but not treated|1
213528|NCT00232180|708607|P2|Open Label Phase|Randomized but not treated|0
213529|NCT00232180|708608|P1|Open Label Phase|Randomized but not treated|0
213530|NCT00232180|708606|P3|Open Label Phase|Laboratory abnormality|10
213531|NCT00232180|708607|P2|Open Label Phase|Laboratory abnormality|0
213532|NCT00232180|708608|P1|Open Label Phase|Laboratory abnormality|0
213533|NCT00232180|708606|P3|Open Label Phase|Adverse Event|25
213534|NCT00232180|708607|P2|Open Label Phase|Adverse Event|0
213535|NCT00232180|708608|P1|Open Label Phase|Adverse Event|0
213536|NCT00232180|708606|P3|Open Label Phase|Other|16
213537|NCT00232180|708607|P2|Open Label Phase|Other|0
213538|NCT00232180|708608|P1|Open Label Phase|Other|0
213539|NCT00232180|708606|P3|Open Label Phase|Withdrawal by Subject|37
213540|NCT00232180|708607|P2|Open Label Phase|Withdrawal by Subject|0
213541|NCT00232180|708608|P1|Open Label Phase|Withdrawal by Subject|0
213542|NCT00232180|708606|P3|Open Label Phase|Study terminated by sponsor|3
213543|NCT00232180|708607|P2|Open Label Phase|Study terminated by sponsor|0
213544|NCT00232180|708608|P1|Open Label Phase|Study terminated by sponsor|0
213545|NCT00232180|708606|P3|Open Label Phase|Protocol Violation|3
213546|NCT00232180|708607|P2|Open Label Phase|Protocol Violation|0
213547|NCT00232180|708608|P1|Open Label Phase|Protocol Violation|0
213548|NCT00232180|708606|P3|Open Label Phase|Lost to Follow-up|5
213549|NCT00232180|708607|P2|Open Label Phase|Lost to Follow-up|0
213550|NCT00232180|708608|P1|Open Label Phase|Lost to Follow-up|0
213551|NCT00232180|708606|P3|Open Label Phase|Death|48
213552|NCT00232180|708607|P2|Open Label Phase|Death|0
213553|NCT00232180|708608|P1|Open Label Phase|Death|0
213554|NCT00232180|708606|P3|Double-blind (DB) Phase|Laboratory abnormality|0
213555|NCT00232180|708607|P2|Double-blind (DB) Phase|Laboratory abnormality|7
213556|NCT00232180|708608|P1|Double-blind (DB) Phase|Laboratory abnormality|6
213557|NCT00232180|708606|P3|Double-blind (DB) Phase|Randomized but not treated|0
213558|NCT00232180|708607|P2|Double-blind (DB) Phase|Randomized but not treated|4
213559|NCT00232180|708608|P1|Double-blind (DB) Phase|Randomized but not treated|3
213560|NCT00232180|708606|P3|Double-blind (DB) Phase|Other|0
213561|NCT00232180|708607|P2|Double-blind (DB) Phase|Other|75
213562|NCT00232180|708608|P1|Double-blind (DB) Phase|Other|70
213563|NCT00232180|708606|P3|Double-blind (DB) Phase|Adverse Event|0
213564|NCT00232180|708607|P2|Double-blind (DB) Phase|Adverse Event|100
213565|NCT00232180|708608|P1|Double-blind (DB) Phase|Adverse Event|83
213566|NCT00232180|708606|P3|Double-blind (DB) Phase|Protocol Violation|0
213567|NCT00232180|708607|P2|Double-blind (DB) Phase|Protocol Violation|21
213568|NCT00232180|708608|P1|Double-blind (DB) Phase|Protocol Violation|28
213569|NCT00232180|708606|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
213570|NCT00232180|708607|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
213571|NCT00232180|708608|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
213572|NCT00232180|708606|P3|Double-blind (DB) Phase|Lost to Follow-up|0
213573|NCT00232180|708607|P2|Double-blind (DB) Phase|Lost to Follow-up|28
213574|NCT00232180|708608|P1|Double-blind (DB) Phase|Lost to Follow-up|34
213575|NCT00232180|708606|P3|Double-blind (DB) Phase|Death|0
213576|NCT00232180|708607|P2|Double-blind (DB) Phase|Death|222
213577|NCT00232180|708608|P1|Double-blind (DB) Phase|Death|186
213578|NCT00232141|708653|P2|Overall Study|Withdrawal by Subject|3
213579|NCT00232141|708654|P1|Overall Study|Withdrawal by Subject|5
213580|NCT00232141|708653|P2|Overall Study|Other|10
213581|NCT00232141|708654|P1|Overall Study|Other|8
213582|NCT00232141|708653|P2|Overall Study|Lost to Follow-up|6
213583|NCT00232141|708654|P1|Overall Study|Lost to Follow-up|9
213584|NCT00232141|708653|P2|Overall Study|Lack of Efficacy|3
213585|NCT00232141|708654|P1|Overall Study|Lack of Efficacy|0
213586|NCT00232141|708653|P2|Overall Study|Adverse Event|4
213587|NCT00232141|708654|P1|Overall Study|Adverse Event|9
213588|NCT00231894|708724|P2|Overall Study|Withdrawal by Subject|1
213589|NCT00231894|708725|P1|Overall Study|Withdrawal by Subject|1
213590|NCT00231816|708749|P2|Overall Study|Not Specified|1
213591|NCT00231816|708750|P1|Overall Study|Not Specified|2
213592|NCT00231816|708749|P2|Overall Study|Withdrawal by Subject|3
213593|NCT00231816|708750|P1|Overall Study|Withdrawal by Subject|3
213594|NCT00231816|708749|P2|Overall Study|Protocol Violation|3
213595|NCT00231816|708750|P1|Overall Study|Protocol Violation|2
213596|NCT00231816|708749|P2|Overall Study|Lost to Follow-up|5
213597|NCT00231816|708750|P1|Overall Study|Lost to Follow-up|8
213598|NCT00231816|708749|P2|Overall Study|Adverse Event|0
213599|NCT00231816|708750|P1|Overall Study|Adverse Event|1
213600|NCT00231777|708765|P2|Overall Study|Other|2
213601|NCT00231777|708766|P1|Overall Study|Other|3
213602|NCT00231777|708765|P2|Overall Study|Lost to Follow-up|0
213603|NCT00231777|708766|P1|Overall Study|Lost to Follow-up|3
213604|NCT00231478|708780|P2|Overall Study|Administrative|2
213605|NCT00231478|708781|P1|Overall Study|Administrative|3
213606|NCT00231478|708780|P2|Overall Study|Adverse Event|1
213607|NCT00231478|708781|P1|Overall Study|Adverse Event|0
213608|NCT00231478|708780|P2|Overall Study|Withdrawal by Subject|0
213609|NCT00231478|708781|P1|Overall Study|Withdrawal by Subject|1
213610|NCT00231478|708780|P2|Overall Study|Refused Treatment|1
213611|NCT00231478|708781|P1|Overall Study|Refused Treatment|1
213612|NCT00231478|708780|P2|Overall Study|Protocol Violation|2
213613|NCT00231478|708781|P1|Overall Study|Protocol Violation|3
213614|NCT00231465|708793|P1|Overall Study|Did not have follow up CT scans|1
213615|NCT00231465|708793|P1|Overall Study|Completed only one cycle|1
213616|NCT00231179|708813|P2|Overall Study|Withdrawal by Subject|3
213617|NCT00231179|708814|P1|Overall Study|Withdrawal by Subject|3
213618|NCT00231179|708813|P2|Overall Study|Lost to Follow-up|21
213619|NCT00231179|708814|P1|Overall Study|Lost to Follow-up|21
213620|NCT00231114|708841|P2|Post-Treatment Period|Withdrawal by Subject|0
213621|NCT00231114|708842|P1|Post-Treatment Period|Withdrawal by Subject|1
213622|NCT00231114|708841|P2|Post-Treatment Period|Physician Decision|0
213623|NCT00231114|708842|P1|Post-Treatment Period|Physician Decision|1
213624|NCT00231114|708841|P2|Post-Treatment Period|Lost to Follow-up|1
213625|NCT00231114|708842|P1|Post-Treatment Period|Lost to Follow-up|6
213626|NCT00231114|708841|P2|Treatment Period|Death: Motor Vehicle Accident|0
213627|NCT00231114|708842|P1|Treatment Period|Death: Motor Vehicle Accident|1
213628|NCT00231114|708841|P2|Randomized|Withdrawal by Subject|3
213629|NCT00231114|708842|P1|Randomized|Withdrawal by Subject|6
213630|NCT00231062|708878|P1|Overall Study|Physician Decision|6
213631|NCT00230971|708886|P2|Baseline Participants|Reintervention|0
213632|NCT00230971|708887|P1|Baseline Participants|Reintervention|1
213633|NCT00230971|708886|P2|Baseline Participants|Failure to return|1
213634|NCT00230971|708887|P1|Baseline Participants|Failure to return|1
213635|NCT00230971|708886|P2|Baseline Participants|No bacteria observed|0
213636|NCT00230971|708887|P1|Baseline Participants|No bacteria observed|1
213637|NCT00230971|708886|P2|Baseline Participants|Adverse Event|0
213638|NCT00230971|708887|P1|Baseline Participants|Adverse Event|1
213639|NCT00230971|708886|P2|Baseline Participants|Withdrawal by Subject|1
213640|NCT00230971|708887|P1|Baseline Participants|Withdrawal by Subject|7
213641|NCT00230971|708886|P2|Baseline Participants|Death|5
213642|NCT00230971|708887|P1|Baseline Participants|Death|6
213643|NCT00230971|708886|P2|Baseline Participants|Lost to Follow-up|12
213644|NCT00230971|708887|P1|Baseline Participants|Lost to Follow-up|5
213645|NCT00230971|708886|P2|Randomization|No study drug administered|3
213646|NCT00230971|708887|P1|Randomization|No study drug administered|3
213647|NCT00230282|708925|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
213648|NCT00230282|708925|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
213649|NCT00230282|708925|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
213650|NCT00230282|708925|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
213651|NCT00230178|708933|P3|Overall Study|Various other reasons|4
213652|NCT00230178|708934|P2|Overall Study|Various other reasons|2
213653|NCT00230178|708935|P1|Overall Study|Various other reasons|3
213654|NCT00230178|708933|P3|Overall Study|Withdrawal by Subject|1
213655|NCT00230178|708934|P2|Overall Study|Withdrawal by Subject|0
213656|NCT00230178|708935|P1|Overall Study|Withdrawal by Subject|0
213657|NCT00230178|708933|P3|Overall Study|Adverse Event|2
213658|NCT00230178|708934|P2|Overall Study|Adverse Event|5
213659|NCT00230178|708935|P1|Overall Study|Adverse Event|1
213660|NCT00230048|708987|P2|Overall Study|Lost to Follow-up|18
213661|NCT00230048|708988|P1|Overall Study|Lost to Follow-up|13
213662|NCT00229931|709046|P2|Overall Study|Lost to Follow-up|2
213663|NCT00229931|709047|P1|Overall Study|Lost to Follow-up|3
213664|NCT00229931|709046|P2|Overall Study|Death|0
213665|NCT00229931|709047|P1|Overall Study|Death|1
213666|NCT00229723|709062|P7|Maintenance Phase|Other|1
213667|NCT00229723|709063|P6|Maintenance Phase|Other|3
213668|NCT00229723|709064|P5|Maintenance Phase|Other|3
213669|NCT00229723|709065|P4|Maintenance Phase|Other|2
213670|NCT00229723|709066|P3|Maintenance Phase|Other|1
213671|NCT00229723|709067|P2|Maintenance Phase|Other|4
213672|NCT00229723|709068|P1|Maintenance Phase|Other|5
213673|NCT00229723|709062|P7|Maintenance Phase|Severe non-compliance|0
213674|NCT00229723|709063|P6|Maintenance Phase|Severe non-compliance|0
213675|NCT00229723|709064|P5|Maintenance Phase|Severe non-compliance|1
213676|NCT00229723|709065|P4|Maintenance Phase|Severe non-compliance|0
213677|NCT00229723|709066|P3|Maintenance Phase|Severe non-compliance|0
213678|NCT00229723|709067|P2|Maintenance Phase|Severe non-compliance|1
213679|NCT00229723|709068|P1|Maintenance Phase|Severe non-compliance|3
213680|NCT00229723|709062|P7|Maintenance Phase|Informed consent withdrawn|0
213681|NCT00229723|709063|P6|Maintenance Phase|Informed consent withdrawn|1
213682|NCT00229723|709064|P5|Maintenance Phase|Informed consent withdrawn|1
213683|NCT00229723|709065|P4|Maintenance Phase|Informed consent withdrawn|1
213684|NCT00229723|709066|P3|Maintenance Phase|Informed consent withdrawn|0
213685|NCT00229723|709067|P2|Maintenance Phase|Informed consent withdrawn|0
213686|NCT00229723|709068|P1|Maintenance Phase|Informed consent withdrawn|1
213687|NCT00229723|709062|P7|Maintenance Phase|Lost to Follow-up|1
213688|NCT00229723|709063|P6|Maintenance Phase|Lost to Follow-up|0
213689|NCT00229723|709064|P5|Maintenance Phase|Lost to Follow-up|0
213690|NCT00229723|709065|P4|Maintenance Phase|Lost to Follow-up|2
213691|NCT00229723|709066|P3|Maintenance Phase|Lost to Follow-up|2
213692|NCT00229723|709067|P2|Maintenance Phase|Lost to Follow-up|1
213693|NCT00229723|709068|P1|Maintenance Phase|Lost to Follow-up|0
213694|NCT00229723|709062|P7|Maintenance Phase|Clinical progression|1
213695|NCT00229723|709063|P6|Maintenance Phase|Clinical progression|1
213696|NCT00229723|709064|P5|Maintenance Phase|Clinical progression|1
213697|NCT00229723|709065|P4|Maintenance Phase|Clinical progression|2
213698|NCT00229723|709066|P3|Maintenance Phase|Clinical progression|2
213699|NCT00229723|709067|P2|Maintenance Phase|Clinical progression|1
213700|NCT00229723|709068|P1|Maintenance Phase|Clinical progression|4
213701|NCT00229723|709062|P7|Maintenance Phase|Objective disease progression|5
213702|NCT00229723|709063|P6|Maintenance Phase|Objective disease progression|9
213703|NCT00229723|709064|P5|Maintenance Phase|Objective disease progression|2
213704|NCT00229723|709065|P4|Maintenance Phase|Objective disease progression|6
213705|NCT00229723|709066|P3|Maintenance Phase|Objective disease progression|3
213706|NCT00229723|709067|P2|Maintenance Phase|Objective disease progression|5
213707|NCT00229723|709068|P1|Maintenance Phase|Objective disease progression|5
213708|NCT00229723|709062|P7|Maintenance Phase|Adverse Event|2
213709|NCT00229723|709063|P6|Maintenance Phase|Adverse Event|5
213710|NCT00229723|709064|P5|Maintenance Phase|Adverse Event|7
213711|NCT00229723|709065|P4|Maintenance Phase|Adverse Event|4
213712|NCT00229723|709066|P3|Maintenance Phase|Adverse Event|1
213713|NCT00229723|709067|P2|Maintenance Phase|Adverse Event|2
213714|NCT00229723|709068|P1|Maintenance Phase|Adverse Event|7
213715|NCT00229723|709062|P7|Concomitant Phase|Other|0
213716|NCT00229723|709063|P6|Concomitant Phase|Other|2
213717|NCT00229723|709064|P5|Concomitant Phase|Other|0
213718|NCT00229723|709065|P4|Concomitant Phase|Other|1
213719|NCT00229723|709066|P3|Concomitant Phase|Other|1
213720|NCT00229723|709067|P2|Concomitant Phase|Other|0
213721|NCT00229723|709068|P1|Concomitant Phase|Other|3
213722|NCT00229723|709062|P7|Concomitant Phase|Severe non-compliance|0
213723|NCT00229723|709063|P6|Concomitant Phase|Severe non-compliance|0
213724|NCT00229723|709064|P5|Concomitant Phase|Severe non-compliance|1
213725|NCT00229723|709065|P4|Concomitant Phase|Severe non-compliance|0
213726|NCT00229723|709066|P3|Concomitant Phase|Severe non-compliance|0
213727|NCT00229723|709067|P2|Concomitant Phase|Severe non-compliance|1
213728|NCT00229723|709068|P1|Concomitant Phase|Severe non-compliance|0
213729|NCT00229723|709062|P7|Concomitant Phase|Informed consent withdrawn|0
213730|NCT00229723|709063|P6|Concomitant Phase|Informed consent withdrawn|0
213731|NCT00229723|709064|P5|Concomitant Phase|Informed consent withdrawn|0
213732|NCT00229723|709065|P4|Concomitant Phase|Informed consent withdrawn|2
213733|NCT00229723|709066|P3|Concomitant Phase|Informed consent withdrawn|0
213734|NCT00229723|709067|P2|Concomitant Phase|Informed consent withdrawn|2
213735|NCT00229723|709068|P1|Concomitant Phase|Informed consent withdrawn|3
213736|NCT00229723|709062|P7|Concomitant Phase|Lost to Follow-up|0
213737|NCT00229723|709063|P6|Concomitant Phase|Lost to Follow-up|0
213738|NCT00229723|709064|P5|Concomitant Phase|Lost to Follow-up|1
213739|NCT00229723|709065|P4|Concomitant Phase|Lost to Follow-up|0
213740|NCT00229723|709066|P3|Concomitant Phase|Lost to Follow-up|0
213741|NCT00229723|709067|P2|Concomitant Phase|Lost to Follow-up|0
213742|NCT00229723|709068|P1|Concomitant Phase|Lost to Follow-up|0
213743|NCT00229723|709062|P7|Concomitant Phase|Clinical progression|1
213744|NCT00229723|709063|P6|Concomitant Phase|Clinical progression|0
213745|NCT00229723|709064|P5|Concomitant Phase|Clinical progression|0
213746|NCT00229723|709065|P4|Concomitant Phase|Clinical progression|0
213747|NCT00229723|709066|P3|Concomitant Phase|Clinical progression|0
213748|NCT00229723|709067|P2|Concomitant Phase|Clinical progression|0
213749|NCT00229723|709068|P1|Concomitant Phase|Clinical progression|0
213750|NCT00229723|709062|P7|Concomitant Phase|Objective disease progression|0
213751|NCT00229723|709063|P6|Concomitant Phase|Objective disease progression|0
213752|NCT00229723|709064|P5|Concomitant Phase|Objective disease progression|0
213753|NCT00229723|709065|P4|Concomitant Phase|Objective disease progression|0
213754|NCT00229723|709066|P3|Concomitant Phase|Objective disease progression|0
213755|NCT00229723|709067|P2|Concomitant Phase|Objective disease progression|0
213756|NCT00229723|709068|P1|Concomitant Phase|Objective disease progression|0
213757|NCT00229723|709062|P7|Concomitant Phase|Adverse Event|2
213758|NCT00229723|709063|P6|Concomitant Phase|Adverse Event|1
213759|NCT00229723|709064|P5|Concomitant Phase|Adverse Event|0
213760|NCT00229723|709065|P4|Concomitant Phase|Adverse Event|2
213761|NCT00229723|709066|P3|Concomitant Phase|Adverse Event|5
213762|NCT00229723|709067|P2|Concomitant Phase|Adverse Event|2
213763|NCT00229723|709068|P1|Concomitant Phase|Adverse Event|4
213764|NCT00229658|709121|P2|Overall Study|Withdrawal of consent|39
213765|NCT00229658|709122|P1|Overall Study|Withdrawal of consent|46
213766|NCT00229658|709121|P2|Overall Study|Serious Adverse Event|2
213767|NCT00229658|709122|P1|Overall Study|Serious Adverse Event|2
213768|NCT00229658|709121|P2|Overall Study|Lost to Follow-up|55
213769|NCT00229658|709122|P1|Overall Study|Lost to Follow-up|82
213770|NCT00229658|709121|P2|Overall Study|Other|60
213771|NCT00229658|709122|P1|Overall Study|Other|80
213772|NCT00229658|709121|P2|Overall Study|Investigator decision|10
213773|NCT00229658|709122|P1|Overall Study|Investigator decision|13
213774|NCT00229658|709121|P2|Overall Study|Administrative|1
213775|NCT00229658|709122|P1|Overall Study|Administrative|2
213776|NCT00229203|709156|P2|Overall Study|Withdrawal by Subject|4
213777|NCT00229203|709157|P1|Overall Study|Withdrawal by Subject|1
213778|NCT00229203|709156|P2|Overall Study|Other|3
213779|NCT00229203|709157|P1|Overall Study|Other|3
213780|NCT00229203|709156|P2|Overall Study|Death|2
213781|NCT00229203|709157|P1|Overall Study|Death|4
213782|NCT00229203|709156|P2|Overall Study|Toxicity|1
213783|NCT00229203|709157|P1|Overall Study|Toxicity|6
213784|NCT00229203|709156|P2|Overall Study|Progressive disease|9
213785|NCT00229203|709157|P1|Overall Study|Progressive disease|18
213786|NCT00228917|709181|P4|Overall Study|Migrated/moved from study area|0
213787|NCT00228917|709182|P3|Overall Study|Migrated/moved from study area|0
213788|NCT00228917|709183|P2|Overall Study|Migrated/moved from study area|3
213789|NCT00228917|709184|P1|Overall Study|Migrated/moved from study area|0
213790|NCT00228917|709181|P4|Overall Study|Lost to Follow-up|0
213791|NCT00228917|709182|P3|Overall Study|Lost to Follow-up|0
213792|NCT00228917|709183|P2|Overall Study|Lost to Follow-up|0
213793|NCT00228917|709184|P1|Overall Study|Lost to Follow-up|1
213794|NCT00228813|709210|P1|Overall Study|Death|4
213795|NCT00228566|709216|P1|Overall Study|Miscellaneous|1
213796|NCT00228566|709216|P1|Overall Study|Withdrawal by Subject|4
213797|NCT00228566|709216|P1|Overall Study|Physician Decision|5
213798|NCT00228566|709216|P1|Overall Study|Lost to Follow-up|16
213799|NCT00228566|709216|P1|Overall Study|Lack of Efficacy|14
213800|NCT00228566|709216|P1|Overall Study|Adverse Event|31
213801|NCT00228553|709220|P1|Overall Study|Miscellaneous|46
213802|NCT00228553|709220|P1|Overall Study|Pregnancy|2
213803|NCT00228553|709220|P1|Overall Study|Withdrawal by Subject|115
213804|NCT00228553|709220|P1|Overall Study|Protocol Violation|6
213805|NCT00228553|709220|P1|Overall Study|Physician Decision|48
213806|NCT00228553|709220|P1|Overall Study|Lost to Follow-up|67
213807|NCT00228553|709220|P1|Overall Study|Lack of Efficacy|34
213808|NCT00228553|709220|P1|Overall Study|Adverse Event|112
213809|NCT00228384|709226|P2|Overall Study|Physician Decision|1
213810|NCT00228384|709227|P1|Overall Study|Physician Decision|0
213811|NCT00228384|709226|P2|Overall Study|Withdrawal by Subject|10
213812|NCT00228384|709227|P1|Overall Study|Withdrawal by Subject|9
213813|NCT00228384|709226|P2|Overall Study|Surgical Intervention (bypass)|5
213814|NCT00228384|709227|P1|Overall Study|Surgical Intervention (bypass)|5
213815|NCT00228384|709226|P2|Overall Study|Lost to Follow-up|10
213816|NCT00228384|709227|P1|Overall Study|Lost to Follow-up|6
213817|NCT00228384|709226|P2|Overall Study|Death|3
213818|NCT00228384|709227|P1|Overall Study|Death|9
213819|NCT00227903|709278|P2|Overall Study|Miscarriage|0
213820|NCT00227903|709279|P1|Overall Study|Miscarriage|1
213821|NCT00227903|709278|P2|Overall Study|Lost to Follow-up|3
213822|NCT00227903|709279|P1|Overall Study|Lost to Follow-up|1
213823|NCT00227903|709278|P2|Overall Study|Subject moved out of area|2
213824|NCT00227903|709279|P1|Overall Study|Subject moved out of area|1
213825|NCT00227903|709278|P2|Overall Study|Withdrawal by Subject|5
213826|NCT00227903|709279|P1|Overall Study|Withdrawal by Subject|2
213827|NCT00227721|709345|P1|Overall Study|On study, but never treated.|1
213828|NCT00227591|709349|P1|Overall Study|Withdrawal by Subject|1
213829|NCT00227539|709353|P1|Overall Study|Protocol Violation|1
213830|NCT00227370|709361|P2|Overall Study|Other reasons|1
213831|NCT00227370|709362|P1|Overall Study|Other reasons|2
213832|NCT00227370|709361|P2|Overall Study|Physician Decision|6
213833|NCT00227370|709362|P1|Overall Study|Physician Decision|9
213834|NCT00227370|709361|P2|Overall Study|Adverse Event|11
213835|NCT00227370|709362|P1|Overall Study|Adverse Event|6
213836|NCT00227370|709361|P2|Overall Study|Death|4
213837|NCT00227370|709362|P1|Overall Study|Death|3
213838|NCT00227370|709361|P2|Overall Study|Withdrawal by Subject|2
213839|NCT00227370|709362|P1|Overall Study|Withdrawal by Subject|1
213840|NCT00227344|709382|P2|Overall Study|study terminated early|5
213841|NCT00227344|709383|P1|Overall Study|study terminated early|12
213842|NCT00227305|709403|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
213843|NCT00227305|709403|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
213844|NCT00227305|709403|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
213845|NCT00227305|709403|P1|Overall Study|Physician Decision|3
213846|NCT00227305|709403|P1|Overall Study|Lack of Efficacy|7
213847|NCT00227305|709403|P1|Overall Study|MOVED OUT OF AREA|3
213848|NCT00227305|709403|P1|Overall Study|Study specific discontinuation|13
213849|NCT00227305|709403|P1|Overall Study|Lost to Follow-up|33
213850|NCT00227305|709403|P1|Overall Study|Withdrawal by Subject|42
213851|NCT00227305|709403|P1|Overall Study|Adverse Event|40
213852|NCT00227266|709420|P3|Overall Study|Excessive weight gain|2
213853|NCT00227266|709421|P2|Overall Study|Excessive weight gain|0
213854|NCT00227266|709422|P1|Overall Study|Excessive weight gain|0
213855|NCT00227266|709420|P3|Overall Study|Protocol Violation|1
213856|NCT00227266|709421|P2|Overall Study|Protocol Violation|0
213857|NCT00227266|709422|P1|Overall Study|Protocol Violation|1
213858|NCT00227266|709420|P3|Overall Study|Withdrawal by Subject|1
213859|NCT00227266|709421|P2|Overall Study|Withdrawal by Subject|0
213860|NCT00227266|709422|P1|Overall Study|Withdrawal by Subject|0
213861|NCT00226941|709452|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
213862|NCT00226941|709453|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
213863|NCT00226941|709454|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
213864|NCT00226941|709455|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
213865|NCT00226941|709452|P4|Overall Study|Withdrawal by subject - toxicity|1
213866|NCT00226941|709453|P3|Overall Study|Withdrawal by subject - toxicity|0
213867|NCT00226941|709454|P2|Overall Study|Withdrawal by subject - toxicity|0
213868|NCT00226941|709455|P1|Overall Study|Withdrawal by subject - toxicity|0
213869|NCT00226811|709489|P1|Overall Study|Withdrawal by Subject|2
213870|NCT00226811|709489|P1|Overall Study|Lack of Efficacy|55
213871|NCT00226811|709489|P1|Overall Study|Adverse Event|11
213872|NCT00226811|709489|P1|Overall Study|Death|8
213873|NCT00226655|709499|P1|Overall Study|Clinical deterioration|10
213874|NCT00226655|709499|P1|Overall Study|Physician Decision|6
213875|NCT00226655|709499|P1|Overall Study|Adverse Event|35
213876|NCT00226655|709499|P1|Overall Study|Withdrawal by Subject|15
213877|NCT00226655|709499|P1|Overall Study|Death|13
213878|NCT00225277|709562|P2|Overall Study|Other|9
213879|NCT00225277|709563|P1|Overall Study|Other|7
213880|NCT00225277|709562|P2|Overall Study|Withdrawal by Subject|34
213881|NCT00225277|709563|P1|Overall Study|Withdrawal by Subject|40
213882|NCT00225277|709562|P2|Overall Study|Protocol Violation|3
213883|NCT00225277|709563|P1|Overall Study|Protocol Violation|6
213884|NCT00225277|709562|P2|Overall Study|Physician Decision|8
213885|NCT00225277|709563|P1|Overall Study|Physician Decision|6
213886|NCT00225277|709562|P2|Overall Study|Lost to Follow-up|6
213887|NCT00225277|709563|P1|Overall Study|Lost to Follow-up|4
213888|NCT00225277|709562|P2|Overall Study|Lack of Efficacy|1
213889|NCT00225277|709563|P1|Overall Study|Lack of Efficacy|4
213890|NCT00225277|709562|P2|Overall Study|Adverse Event|34
213891|NCT00225277|709563|P1|Overall Study|Adverse Event|30
213892|NCT00225251|709581|P2|Overall Study|Withdrawal by Subject|1
213893|NCT00225251|709582|P1|Overall Study|Withdrawal by Subject|1
213894|NCT00225212|709596|P1|Overall Study|Intercurrent illness|1
213895|NCT00225212|709596|P1|Overall Study|Adverse Event|2
213896|NCT00225212|709596|P1|Overall Study|Death|1
213897|NCT00225212|709596|P1|Overall Study|Disease progression|2
213898|NCT00225147|709605|P4|Open-label Phase|Withdrawal by Subject|6
213899|NCT00225147|709606|P3|Open-label Phase|Withdrawal by Subject|0
213900|NCT00225147|709607|P2|Open-label Phase|Withdrawal by Subject|0
213901|NCT00225147|709608|P1|Open-label Phase|Withdrawal by Subject|0
213902|NCT00225147|709605|P4|Open-label Phase|Lost to Follow-up|4
213903|NCT00225147|709606|P3|Open-label Phase|Lost to Follow-up|0
213904|NCT00225147|709607|P2|Open-label Phase|Lost to Follow-up|0
213905|NCT00225147|709608|P1|Open-label Phase|Lost to Follow-up|0
213906|NCT00224874|709655|P4|Overall Study|Withdrawal by Subject|0
213907|NCT00224874|709656|P3|Overall Study|Withdrawal by Subject|1
213908|NCT00224874|709657|P2|Overall Study|Withdrawal by Subject|0
213909|NCT00224874|709658|P1|Overall Study|Withdrawal by Subject|0
213910|NCT00224770|709703|P3|Overall Study|Lost to Follow-up|0
213911|NCT00224770|709704|P2|Overall Study|Lost to Follow-up|2
213912|NCT00224770|709705|P1|Overall Study|Lost to Follow-up|4
213913|NCT00224484|709740|P3|Overall Study|Reaon not specified|2
213914|NCT00224484|709741|P2|Overall Study|Reaon not specified|4
213915|NCT00224484|709742|P1|Overall Study|Reaon not specified|5
213916|NCT00224484|709740|P3|Overall Study|Lost to Follow-up|36
213917|NCT00224484|709741|P2|Overall Study|Lost to Follow-up|28
213918|NCT00224484|709742|P1|Overall Study|Lost to Follow-up|66
213919|NCT00224484|709740|P3|Overall Study|Migrated/moved from study area|5
213920|NCT00224484|709741|P2|Overall Study|Migrated/moved from study area|5
213921|NCT00224484|709742|P1|Overall Study|Migrated/moved from study area|18
213922|NCT00224484|709740|P3|Overall Study|Withdrawal by Subject|16
213923|NCT00224484|709741|P2|Overall Study|Withdrawal by Subject|18
213924|NCT00224484|709742|P1|Overall Study|Withdrawal by Subject|49
213925|NCT00224484|709740|P3|Overall Study|Protocol Violation|0
213926|NCT00224484|709741|P2|Overall Study|Protocol Violation|2
213927|NCT00224484|709742|P1|Overall Study|Protocol Violation|2
213928|NCT00224484|709740|P3|Overall Study|Non-Serious Adverse Event|3
213929|NCT00224484|709741|P2|Overall Study|Non-Serious Adverse Event|7
213930|NCT00224484|709742|P1|Overall Study|Non-Serious Adverse Event|5
213931|NCT00224484|709740|P3|Overall Study|Serious Adverse Event|0
213932|NCT00224484|709741|P2|Overall Study|Serious Adverse Event|1
213933|NCT00224484|709742|P1|Overall Study|Serious Adverse Event|1
213934|NCT00224133|709806|P1|Overall Study|Not specified|14
213935|NCT00224133|709806|P1|Overall Study|Physician Decision|1
213936|NCT00224133|709806|P1|Overall Study|Lost to Follow-up|21
213937|NCT00224133|709806|P1|Overall Study|Lack of Efficacy|58
213938|NCT00224133|709806|P1|Overall Study|Withdrawal by Subject|33
213939|NCT00224133|709806|P1|Overall Study|Protocol Violation|6
213940|NCT00224133|709806|P1|Overall Study|Adverse Event|93
213941|NCT00224120|709812|P2|Overall Study|Not specified|5
213942|NCT00224120|709813|P1|Overall Study|Not specified|4
213943|NCT00224120|709812|P2|Overall Study|Lost to Follow-up|3
213944|NCT00224120|709813|P1|Overall Study|Lost to Follow-up|2
213945|NCT00224120|709812|P2|Overall Study|Lack of Efficacy|2
213946|NCT00224120|709813|P1|Overall Study|Lack of Efficacy|0
213947|NCT00224120|709812|P2|Overall Study|Withdrawal by Subject|10
213948|NCT00224120|709813|P1|Overall Study|Withdrawal by Subject|5
213949|NCT00224120|709812|P2|Overall Study|Protocol Violation|0
213950|NCT00224120|709813|P1|Overall Study|Protocol Violation|1
213951|NCT00224120|709812|P2|Overall Study|Adverse Event|4
213952|NCT00224120|709813|P1|Overall Study|Adverse Event|10
213953|NCT00224107|709823|P2|Overall Study|Not specified|1
213954|NCT00224107|709824|P1|Overall Study|Not specified|1
213955|NCT00224107|709823|P2|Overall Study|Physician Decision|0
213956|NCT00224107|709824|P1|Overall Study|Physician Decision|1
213957|NCT00224107|709823|P2|Overall Study|Lost to Follow-up|0
213958|NCT00224107|709824|P1|Overall Study|Lost to Follow-up|4
213959|NCT00224107|709823|P2|Overall Study|Lack of Efficacy|0
213960|NCT00224107|709824|P1|Overall Study|Lack of Efficacy|2
213961|NCT00224107|709823|P2|Overall Study|Withdrawal by Subject|4
213962|NCT00224107|709824|P1|Overall Study|Withdrawal by Subject|1
213963|NCT00224107|709823|P2|Overall Study|Protocol Violation|3
213964|NCT00224107|709824|P1|Overall Study|Protocol Violation|2
213965|NCT00224107|709823|P2|Overall Study|Adverse Event|6
213966|NCT00224107|709824|P1|Overall Study|Adverse Event|20
213967|NCT00224055|709834|P2|Overall Study|Not Specified|0
213968|NCT00224055|709835|P1|Overall Study|Not Specified|1
213969|NCT00224055|709834|P2|Overall Study|Withdrawal by Subject|2
213970|NCT00224055|709835|P1|Overall Study|Withdrawal by Subject|0
213971|NCT00224055|709834|P2|Overall Study|Inclusion Violation|6
213972|NCT00224055|709835|P1|Overall Study|Inclusion Violation|3
213973|NCT00224055|709834|P2|Overall Study|Protocol Violation|1
213974|NCT00224055|709835|P1|Overall Study|Protocol Violation|1
213975|NCT00224055|709834|P2|Overall Study|Lost to Follow-up|2
213976|NCT00224055|709835|P1|Overall Study|Lost to Follow-up|1
213977|NCT00224055|709834|P2|Overall Study|Adverse Event|3
213978|NCT00224055|709835|P1|Overall Study|Adverse Event|9
213979|NCT00224042|709845|P2|Overall Study|Not specified|0
213980|NCT00224042|709846|P1|Overall Study|Not specified|2
213981|NCT00224042|709845|P2|Overall Study|Did not meet lab incusion criteria|3
213982|NCT00224042|709846|P1|Overall Study|Did not meet lab incusion criteria|2
213983|NCT00224042|709845|P2|Overall Study|Physician Decision|1
213984|NCT00224042|709846|P1|Overall Study|Physician Decision|0
213985|NCT00224042|709845|P2|Overall Study|Protocol Violation|1
213986|NCT00224042|709846|P1|Overall Study|Protocol Violation|0
213987|NCT00224042|709845|P2|Overall Study|Adverse Event|1
213988|NCT00224042|709846|P1|Overall Study|Adverse Event|2
213989|NCT00224029|709858|P1|Overall Study|Other|1
213990|NCT00224029|709858|P1|Overall Study|Withdrawal by Subject|4
213991|NCT00224029|709858|P1|Overall Study|Lost to Follow-up|1
213992|NCT00224016|709864|P2|Maintenance Period|Lost to Follow-up|1
213993|NCT00224016|709865|P1|Maintenance Period|Lost to Follow-up|0
213994|NCT00224016|709864|P2|Maintenance Period|Withdrawal by Subject|0
213995|NCT00224016|709865|P1|Maintenance Period|Withdrawal by Subject|2
213996|NCT00224016|709864|P2|Titration Period|Lost to Follow-up|0
213997|NCT00224016|709865|P1|Titration Period|Lost to Follow-up|1
213998|NCT00224016|709864|P2|Titration Period|Withdrawal by Subject|1
213999|NCT00224016|709865|P1|Titration Period|Withdrawal by Subject|0
214000|NCT00224003|709873|P1|Overall Study|unk|3
214001|NCT00224003|709873|P1|Overall Study|Withdrawal by Subject|1
214002|NCT00224003|709873|P1|Overall Study|Protocol Violation|2
214003|NCT00224003|709873|P1|Overall Study|Adverse Event|1
214004|NCT00223977|709880|P3|Overall Study|not specified|0
214005|NCT00223977|709881|P2|Overall Study|not specified|0
214006|NCT00223977|709882|P1|Overall Study|not specified|1
214007|NCT00223977|709880|P3|Overall Study|Withdrawal by Subject|2
214008|NCT00223977|709881|P2|Overall Study|Withdrawal by Subject|1
214009|NCT00223977|709882|P1|Overall Study|Withdrawal by Subject|1
214010|NCT00223977|709880|P3|Overall Study|Protocol Violation|1
214011|NCT00223977|709881|P2|Overall Study|Protocol Violation|0
214012|NCT00223977|709882|P1|Overall Study|Protocol Violation|0
214013|NCT00223977|709880|P3|Overall Study|Adverse Event|0
214014|NCT00223977|709881|P2|Overall Study|Adverse Event|10
214015|NCT00223977|709882|P1|Overall Study|Adverse Event|7
214016|NCT00223808|709916|P3|Overall Study|<5 hrs therapy before discharge|5
214017|NCT00223808|709917|P2|Overall Study|<5 hrs therapy before discharge|5
214018|NCT00223808|709918|P1|Overall Study|<5 hrs therapy before discharge|3
214019|NCT00223795|709935|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
214020|NCT00223795|709936|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
214021|NCT00223795|709935|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
214022|NCT00223795|709936|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
214023|NCT00223496|710014|P1|Overall Study|Physician Decision|2
214024|NCT00223496|710014|P1|Overall Study|Withdrawal by Subject|1
214025|NCT00223496|710014|P1|Overall Study|Lack of Efficacy|6
214026|NCT00223496|710014|P1|Overall Study|Lost to Follow-up|4
214027|NCT00223496|710014|P1|Overall Study|screen failure|9
214028|NCT00222729|710033|P1|Overall Study|Adverse Event|3
214029|NCT00222105|710040|P1|Overall Study|Death|2
214030|NCT00222105|710040|P1|Overall Study|Treatment delays|2
214031|NCT00222105|710040|P1|Overall Study|Adverse Event|8
214032|NCT00222105|710040|P1|Overall Study|Withdrawal by Subject|1
214033|NCT00222105|710040|P1|Overall Study|Removed due to wrong diagnosis|1
214034|NCT00221195|710061|P2|Overall Study|Lost to Follow-up|1
214035|NCT00221195|710062|P1|Overall Study|Lost to Follow-up|0
214036|NCT00221195|710061|P2|Overall Study|Death|1
214037|NCT00221195|710062|P1|Overall Study|Death|1
214038|NCT00221195|710061|P2|Overall Study|Withdrawal by Subject|1
214039|NCT00221195|710062|P1|Overall Study|Withdrawal by Subject|4
214040|NCT00221104|710082|P2|Overall Study|Others|47
214041|NCT00221104|710083|P1|Overall Study|Others|37
214042|NCT00221104|710082|P2|Overall Study|Withdrawal by Subject|29
214043|NCT00221104|710083|P1|Overall Study|Withdrawal by Subject|42
214044|NCT00221104|710082|P2|Overall Study|Protocol Violation|0
214045|NCT00221104|710083|P1|Overall Study|Protocol Violation|2
214046|NCT00221104|710082|P2|Overall Study|Physician Decision|0
214047|NCT00221104|710083|P1|Overall Study|Physician Decision|1
214048|NCT00221104|710082|P2|Overall Study|Adverse Event|0
214049|NCT00221104|710083|P1|Overall Study|Adverse Event|1
214050|NCT00220805|710116|P2|Overall Study|Develop. of choroidal neovascularization|8
214051|NCT00220805|710117|P1|Overall Study|Develop. of choroidal neovascularization|3
214052|NCT00220805|710116|P2|Overall Study|Lack of Efficacy|0
214053|NCT00220805|710117|P1|Overall Study|Lack of Efficacy|1
214054|NCT00220805|710116|P2|Overall Study|Withdrawal by Subject|0
214055|NCT00220805|710117|P1|Overall Study|Withdrawal by Subject|3
214056|NCT00220805|710116|P2|Overall Study|Adverse Event|3
214057|NCT00220805|710117|P1|Overall Study|Adverse Event|1
214058|NCT00220779|710138|P3|Overall Study|Lack of Efficacy|1
214059|NCT00220779|710139|P2|Overall Study|Lack of Efficacy|0
214060|NCT00220779|710140|P1|Overall Study|Lack of Efficacy|3
214061|NCT00220779|710138|P3|Overall Study|Pregnancy|2
214062|NCT00220779|710139|P2|Overall Study|Pregnancy|0
214063|NCT00220779|710140|P1|Overall Study|Pregnancy|0
214064|NCT00220779|710138|P3|Overall Study|Too time consuming|0
214065|NCT00220779|710139|P2|Overall Study|Too time consuming|0
214066|NCT00220779|710140|P1|Overall Study|Too time consuming|1
214067|NCT00220779|710138|P3|Overall Study|Non-compliance|0
214068|NCT00220779|710139|P2|Overall Study|Non-compliance|0
214069|NCT00220779|710140|P1|Overall Study|Non-compliance|1
214070|NCT00220779|710138|P3|Overall Study|Withdrawal by Subject|1
214071|NCT00220779|710139|P2|Overall Study|Withdrawal by Subject|4
214072|NCT00220779|710140|P1|Overall Study|Withdrawal by Subject|1
214073|NCT00220779|710138|P3|Overall Study|Adverse Event|0
214074|NCT00220779|710139|P2|Overall Study|Adverse Event|0
214075|NCT00220779|710140|P1|Overall Study|Adverse Event|1
214076|NCT00220740|710150|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
214077|NCT00220740|710151|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
214078|NCT00220740|710150|P2|Efficacy Period|Protocol Violation|0
214079|NCT00220740|710151|P1|Efficacy Period|Protocol Violation|1
214080|NCT00220740|710150|P2|Efficacy Period|Withdrawal by Subject|0
214081|NCT00220740|710151|P1|Efficacy Period|Withdrawal by Subject|1
214082|NCT00220740|710150|P2|Efficacy Period|Adverse Event|1
214083|NCT00220740|710151|P1|Efficacy Period|Adverse Event|1
214084|NCT00220740|710150|P2|Efficacy Period|Entered rescue treatment with placebo|0
214085|NCT00220740|710151|P1|Efficacy Period|Entered rescue treatment with placebo|23
214086|NCT00220727|710165|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
214087|NCT00220727|710166|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
214088|NCT00220701|710182|P2|Overall Study|Lost to Follow-up|4
214089|NCT00220701|710183|P1|Overall Study|Lost to Follow-up|5
214090|NCT00220636|710199|P1|Overall Study|Withdrawal by Subject|4
214091|NCT00219557|710209|P3|Phase 2|Treatment not received|3
214092|NCT00219557|710210|P2|Phase 2|Treatment not received|1
214093|NCT00219557|710211|P1|Phase 2|Treatment not received|0
214094|NCT00219557|710209|P3|Phase 2|Withdrawal by Subject|5
214095|NCT00219557|710210|P2|Phase 2|Withdrawal by Subject|9
214096|NCT00219557|710211|P1|Phase 2|Withdrawal by Subject|0
214097|NCT00219557|710209|P3|Phase 2|Other|6
214098|NCT00219557|710210|P2|Phase 2|Other|8
214099|NCT00219557|710211|P1|Phase 2|Other|0
214100|NCT00219557|710209|P3|Phase 2|Death|2
214101|NCT00219557|710210|P2|Phase 2|Death|8
214102|NCT00219557|710211|P1|Phase 2|Death|0
214103|NCT00219557|710209|P3|Phase 2|Adverse Event|2
214104|NCT00219557|710210|P2|Phase 2|Adverse Event|22
214105|NCT00219557|710211|P1|Phase 2|Adverse Event|0
214106|NCT00219557|710209|P3|Phase 2|Lack of Efficacy|15
214107|NCT00219557|710210|P2|Phase 2|Lack of Efficacy|21
214108|NCT00219557|710211|P1|Phase 2|Lack of Efficacy|0
214109|NCT00219557|710209|P3|Phase 1|Started chemotherapy at other institute|0
214110|NCT00219557|710210|P2|Phase 1|Started chemotherapy at other institute|0
214111|NCT00219557|710211|P1|Phase 1|Started chemotherapy at other institute|1
214112|NCT00219557|710209|P3|Phase 1|Withdrawal by Subject|0
214113|NCT00219557|710210|P2|Phase 1|Withdrawal by Subject|0
214114|NCT00219557|710211|P1|Phase 1|Withdrawal by Subject|1
214115|NCT00219557|710209|P3|Phase 1|Adverse Event|0
214116|NCT00219557|710210|P2|Phase 1|Adverse Event|0
214117|NCT00219557|710211|P1|Phase 1|Adverse Event|2
214118|NCT00219557|710209|P3|Phase 1|Lack of Efficacy|0
214119|NCT00219557|710210|P2|Phase 1|Lack of Efficacy|0
214120|NCT00219557|710211|P1|Phase 1|Lack of Efficacy|3
214121|NCT00219544|710239|P2|Single Blind Treatment Period|Withdrawal by Subject|0
214122|NCT00219544|710240|P1|Single Blind Treatment Period|Withdrawal by Subject|1
214123|NCT00219544|710239|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
214124|NCT00219544|710240|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
214125|NCT00219544|710239|P2|Single Blind Treatment Period|Lost to Follow-up|0
214126|NCT00219544|710240|P1|Single Blind Treatment Period|Lost to Follow-up|2
214127|NCT00219544|710239|P2|Single Blind Treatment Period|Protocol Violation|0
214128|NCT00219544|710240|P1|Single Blind Treatment Period|Protocol Violation|4
214129|NCT00219544|710239|P2|Single Blind Treatment Period|Adverse Event|0
214130|NCT00219544|710240|P1|Single Blind Treatment Period|Adverse Event|9
214131|NCT00219544|710239|P2|Single Blind Treatment Period|Lack of Efficacy|0
214132|NCT00219544|710240|P1|Single Blind Treatment Period|Lack of Efficacy|5
214133|NCT00219349|710278|P1|Escitalopram Phase|Withdrawal by Subject|3
214134|NCT00219349|710278|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
214135|NCT00219349|710278|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
214136|NCT00219349|710278|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
214137|NCT00219284|710291|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
214138|NCT00219284|710292|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
214139|NCT00219284|710291|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
214140|NCT00219284|710292|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
214141|NCT00219284|710291|P2|Extension Phase - 8 Weeks|Adverse Event|3
214142|NCT00219284|710292|P1|Extension Phase - 8 Weeks|Adverse Event|2
214143|NCT00219284|710291|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
214144|NCT00219284|710292|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
214145|NCT00219284|710291|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
214146|NCT00219284|710292|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
214147|NCT00219284|710291|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
214148|NCT00219284|710292|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
214149|NCT00219284|710291|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
214150|NCT00219284|710292|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
214151|NCT00219284|710291|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
214152|NCT00219284|710292|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
214153|NCT00219284|710291|P2|Treatment Phase - 16 Weeks|Adverse Event|24
214154|NCT00219284|710292|P1|Treatment Phase - 16 Weeks|Adverse Event|26
214155|NCT00219141|710317|P3|Overall Study|Condition no longer requires study drug|0
214156|NCT00219141|710318|P2|Overall Study|Condition no longer requires study drug|0
214157|NCT00219141|710319|P1|Overall Study|Condition no longer requires study drug|1
214158|NCT00219141|710317|P3|Overall Study|Withdrawal by Subject|5
214159|NCT00219141|710318|P2|Overall Study|Withdrawal by Subject|3
214160|NCT00219141|710319|P1|Overall Study|Withdrawal by Subject|1
214161|NCT00219141|710317|P3|Overall Study|Protocol Violation|1
214162|NCT00219141|710318|P2|Overall Study|Protocol Violation|1
214163|NCT00219141|710319|P1|Overall Study|Protocol Violation|3
214164|NCT00219141|710317|P3|Overall Study|Lost to Follow-up|1
214165|NCT00219141|710318|P2|Overall Study|Lost to Follow-up|4
214166|NCT00219141|710319|P1|Overall Study|Lost to Follow-up|2
214167|NCT00219141|710317|P3|Overall Study|Administrative problems|0
214168|NCT00219141|710318|P2|Overall Study|Administrative problems|1
214169|NCT00219141|710319|P1|Overall Study|Administrative problems|0
214170|NCT00219141|710317|P3|Overall Study|Lack of Efficacy|0
214171|NCT00219141|710318|P2|Overall Study|Lack of Efficacy|2
214172|NCT00219141|710319|P1|Overall Study|Lack of Efficacy|3
214173|NCT00219141|710317|P3|Overall Study|Adverse Event|5
214174|NCT00219141|710318|P2|Overall Study|Adverse Event|10
214175|NCT00219141|710319|P1|Overall Study|Adverse Event|4
214176|NCT00218634|710365|P2|Overall Study|Lost to Follow-up|15
214177|NCT00218634|710366|P1|Overall Study|Lost to Follow-up|8
214178|NCT00218543|710386|P1|Overall Study|Adverse Event|2
214179|NCT00218543|710386|P1|Overall Study|Physician Decision|3
214180|NCT00218543|710386|P1|Overall Study|Withdrawal by Subject|1
214181|NCT00218543|710386|P1|Overall Study|relocated|1
214182|NCT00218543|710386|P1|Overall Study|Lost to Follow-up|8
214183|NCT00218296|710492|P2|Overall Study|Randomized but did not enter treatment|67
214184|NCT00218296|710493|P1|Overall Study|Randomized but did not enter treatment|66
214185|NCT00218296|710492|P2|Overall Study|Withdrawal by Subject|47
214186|NCT00218296|710493|P1|Overall Study|Withdrawal by Subject|36
214187|NCT00218296|710492|P2|Overall Study|Lost to Follow-up|7
214188|NCT00218296|710493|P1|Overall Study|Lost to Follow-up|9
214189|NCT00217971|710565|P2|Overall Study|non compliant|0
214190|NCT00217971|710566|P1|Overall Study|non compliant|1
214191|NCT00217971|710565|P2|Overall Study|Withdrawal by Subject|12
214192|NCT00217971|710566|P1|Overall Study|Withdrawal by Subject|7
214193|NCT00217971|710565|P2|Overall Study|Physician Decision|1
214194|NCT00217971|710566|P1|Overall Study|Physician Decision|0
214195|NCT00217971|710565|P2|Overall Study|Lost to Follow-up|19
214196|NCT00217971|710566|P1|Overall Study|Lost to Follow-up|15
214197|NCT00217971|710565|P2|Overall Study|Adverse Event|1
214198|NCT00217971|710566|P1|Overall Study|Adverse Event|1
214199|NCT00217672|710581|P2|Follow-up|Lost to Follow-up|0
214200|NCT00217672|710582|P1|Follow-up|Lost to Follow-up|1
214201|NCT00217672|710581|P2|Follow-up|Withdrawal by Subject|0
214202|NCT00217672|710582|P1|Follow-up|Withdrawal by Subject|4
214203|NCT00217672|710581|P2|Treatment|secondary malignancy|0
214204|NCT00217672|710582|P1|Treatment|secondary malignancy|1
214205|NCT00217672|710581|P2|Treatment|Death|0
214206|NCT00217672|710582|P1|Treatment|Death|2
214207|NCT00217672|710581|P2|Treatment|insurance issues|1
214208|NCT00217672|710582|P1|Treatment|insurance issues|1
214209|NCT00217672|710581|P2|Treatment|Physician Decision|0
214210|NCT00217672|710582|P1|Treatment|Physician Decision|6
214211|NCT00217672|710581|P2|Treatment|reqd treatment not permitted by protocol|0
214212|NCT00217672|710582|P1|Treatment|reqd treatment not permitted by protocol|6
214213|NCT00217672|710581|P2|Treatment|Adverse Event|2
214214|NCT00217672|710582|P1|Treatment|Adverse Event|18
214215|NCT00217672|710581|P2|Treatment|disease progression|4
214216|NCT00217672|710582|P1|Treatment|disease progression|33
214217|NCT00217672|710581|P2|Allocation|Ineligible|0
214218|NCT00217672|710582|P1|Allocation|Ineligible|2
214219|NCT00217620|710588|P1|Overall Study|Never received treatment|1
214220|NCT00217620|710588|P1|Overall Study|Ineligible|13
214221|NCT00217620|710588|P1|Overall Study|Not Protocol Specified|4
214222|NCT00217620|710588|P1|Overall Study|Progression|31
214223|NCT00217620|710588|P1|Overall Study|Adverse Event|2
214224|NCT00217581|710599|P1|Overall Study|Withdrawal by Subject|1
214225|NCT00217464|710628|P1|Overall Study|not specified|2
214226|NCT00217464|710628|P1|Overall Study|Progression|15
214227|NCT00217425|710644|P1|Overall Study|Other|4
214228|NCT00217425|710644|P1|Overall Study|Other complicating disease|1
214229|NCT00217425|710644|P1|Overall Study|Withdrawal by Subject|4
214230|NCT00217425|710644|P1|Overall Study|Adverse Event|8
214231|NCT00217425|710644|P1|Overall Study|Lack of Efficacy|13
214232|NCT00217425|710644|P1|Overall Study|Patient ineligible|5
214233|NCT00217425|710644|P1|Overall Study|Never started treatment|2
214234|NCT00217087|710658|P2|Overall Study|completed less than 12 months return|18
214235|NCT00217087|710659|P1|Overall Study|completed less than 12 months return|10
214236|NCT00217087|710658|P2|Overall Study|decided to have esophagectomy|2
214237|NCT00217087|710659|P1|Overall Study|decided to have esophagectomy|1
214238|NCT00217022|710673|P2|Overall Study|Withdrawal by Subject|1
214239|NCT00217022|710674|P1|Overall Study|Withdrawal by Subject|1
214240|NCT00216736|710684|P2|Overall Study|Lost to Follow-up|1
214241|NCT00216736|710685|P1|Overall Study|Lost to Follow-up|1
214242|NCT00216671|710699|P2|Overall Study|Insufficient Response Adverse Event|1
214243|NCT00216671|710700|P1|Overall Study|Insufficient Response Adverse Event|2
214244|NCT00216671|710699|P2|Overall Study|Ineligible, no efficacy data|2
214245|NCT00216671|710700|P1|Overall Study|Ineligible, no efficacy data|2
214246|NCT00216671|710699|P2|Overall Study|Patient Moved|1
214247|NCT00216671|710700|P1|Overall Study|Patient Moved|0
214248|NCT00216671|710699|P2|Overall Study|Investigator Illness|1
214249|NCT00216671|710700|P1|Overall Study|Investigator Illness|0
214250|NCT00216671|710699|P2|Overall Study|Relapse|0
214251|NCT00216671|710700|P1|Overall Study|Relapse|1
214252|NCT00216671|710699|P2|Overall Study|Protocol Violation|5
214253|NCT00216671|710700|P1|Overall Study|Protocol Violation|3
214254|NCT00216671|710699|P2|Overall Study|Physician Decision|1
214255|NCT00216671|710700|P1|Overall Study|Physician Decision|1
214256|NCT00216671|710699|P2|Overall Study|Ineligible|2
214257|NCT00216671|710700|P1|Overall Study|Ineligible|0
214258|NCT00216671|710699|P2|Overall Study|Non compliant|2
214259|NCT00216671|710700|P1|Overall Study|Non compliant|2
214260|NCT00216671|710699|P2|Overall Study|Lost to Follow-up|5
214261|NCT00216671|710700|P1|Overall Study|Lost to Follow-up|3
214262|NCT00216671|710699|P2|Overall Study|Insufficient Response|4
214263|NCT00216671|710700|P1|Overall Study|Insufficient Response|9
214264|NCT00216671|710699|P2|Overall Study|No Need to Continue Medication|1
214265|NCT00216671|710700|P1|Overall Study|No Need to Continue Medication|1
214266|NCT00216671|710699|P2|Overall Study|Refused Injections|13
214267|NCT00216671|710700|P1|Overall Study|Refused Injections|3
214268|NCT00216671|710699|P2|Overall Study|Withdrawal by Subject|2
214269|NCT00216671|710700|P1|Overall Study|Withdrawal by Subject|4
214270|NCT00216671|710699|P2|Overall Study|Pregnancy|1
214271|NCT00216671|710700|P1|Overall Study|Pregnancy|0
214272|NCT00216671|710699|P2|Overall Study|Adverse Event|9
214273|NCT00216671|710700|P1|Overall Study|Adverse Event|4
214274|NCT00216476|710718|P3|Overall Study|Patient Moved|0
214275|NCT00216476|710719|P2|Overall Study|Patient Moved|2
214276|NCT00216476|710720|P1|Overall Study|Patient Moved|2
214277|NCT00216476|710718|P3|Overall Study|Protocol Deviation|0
214278|NCT00216476|710719|P2|Overall Study|Protocol Deviation|1
214279|NCT00216476|710720|P1|Overall Study|Protocol Deviation|5
214280|NCT00216476|710718|P3|Overall Study|Administrative Reasons|0
214281|NCT00216476|710719|P2|Overall Study|Administrative Reasons|1
214282|NCT00216476|710720|P1|Overall Study|Administrative Reasons|1
214283|NCT00216476|710718|P3|Overall Study|Higher dose/Extra Medication Required|2
214284|NCT00216476|710719|P2|Overall Study|Higher dose/Extra Medication Required|0
214285|NCT00216476|710720|P1|Overall Study|Higher dose/Extra Medication Required|2
214286|NCT00216476|710718|P3|Overall Study|Non-compliance|1
214287|NCT00216476|710719|P2|Overall Study|Non-compliance|4
214288|NCT00216476|710720|P1|Overall Study|Non-compliance|0
214289|NCT00216476|710718|P3|Overall Study|No Further Need for Treatment|1
214290|NCT00216476|710719|P2|Overall Study|No Further Need for Treatment|4
214291|NCT00216476|710720|P1|Overall Study|No Further Need for Treatment|3
214292|NCT00216476|710718|P3|Overall Study|Refuses Injection|0
214293|NCT00216476|710719|P2|Overall Study|Refuses Injection|0
214294|NCT00216476|710720|P1|Overall Study|Refuses Injection|11
214295|NCT00216476|710718|P3|Overall Study|Other|1
214296|NCT00216476|710719|P2|Overall Study|Other|0
214297|NCT00216476|710720|P1|Overall Study|Other|0
214298|NCT00216476|710718|P3|Overall Study|Pregnancy|1
214299|NCT00216476|710719|P2|Overall Study|Pregnancy|1
214300|NCT00216476|710720|P1|Overall Study|Pregnancy|0
214301|NCT00216476|710718|P3|Overall Study|Death|0
214302|NCT00216476|710719|P2|Overall Study|Death|0
214303|NCT00216476|710720|P1|Overall Study|Death|2
214304|NCT00216476|710718|P3|Overall Study|Lack of Efficacy|0
214305|NCT00216476|710719|P2|Overall Study|Lack of Efficacy|3
214306|NCT00216476|710720|P1|Overall Study|Lack of Efficacy|4
214307|NCT00216476|710718|P3|Overall Study|Adverse Event|1
214308|NCT00216476|710719|P2|Overall Study|Adverse Event|10
214309|NCT00216476|710720|P1|Overall Study|Adverse Event|6
214310|NCT00216476|710718|P3|Overall Study|Lost to Follow-up|1
214311|NCT00216476|710719|P2|Overall Study|Lost to Follow-up|9
214312|NCT00216476|710720|P1|Overall Study|Lost to Follow-up|10
214313|NCT00216476|710718|P3|Overall Study|Withdrawal by Subject|9
214314|NCT00216476|710719|P2|Overall Study|Withdrawal by Subject|72
214315|NCT00216476|710720|P1|Overall Study|Withdrawal by Subject|59
214316|NCT00216203|710757|P1|Overall Study|Withdrawal by Subject|2
214317|NCT00216086|710787|P1|Overall Study|Social Reasons|2
214318|NCT00216086|710787|P1|Overall Study|Diagnosis of Metastatic Disease|1
214319|NCT00216086|710787|P1|Overall Study|Protocol Violation|1
214320|NCT00215943|710819|P2|Overall Study|Other complications|1
214321|NCT00215943|710820|P1|Overall Study|Other complications|3
214322|NCT00215943|710819|P2|Overall Study|Other disease|1
214323|NCT00215943|710820|P1|Overall Study|Other disease|0
214324|NCT00215943|710819|P2|Overall Study|Adverse Event|6
214325|NCT00215943|710820|P1|Overall Study|Adverse Event|3
214326|NCT00215943|710819|P2|Overall Study|Alternate therapy|1
214327|NCT00215943|710820|P1|Overall Study|Alternate therapy|0
214328|NCT00215943|710819|P2|Overall Study|Disease Progression|5
214329|NCT00215943|710820|P1|Overall Study|Disease Progression|3
214330|NCT00215683|710845|P3|Overall Study|Intermittent therapy required|0
214331|NCT00215683|710846|P2|Overall Study|Intermittent therapy required|1
214332|NCT00215683|710847|P1|Overall Study|Intermittent therapy required|0
214333|NCT00215683|710845|P3|Overall Study|No study drug available|0
214334|NCT00215683|710846|P2|Overall Study|No study drug available|1
214335|NCT00215683|710847|P1|Overall Study|No study drug available|0
214336|NCT00215683|710845|P3|Overall Study|Difficult to attend visits|0
214337|NCT00215683|710846|P2|Overall Study|Difficult to attend visits|1
214338|NCT00215683|710847|P1|Overall Study|Difficult to attend visits|0
214339|NCT00215683|710845|P3|Overall Study|Physician Decision|1
214340|NCT00215683|710846|P2|Overall Study|Physician Decision|0
214341|NCT00215683|710847|P1|Overall Study|Physician Decision|0
214342|NCT00215683|710845|P3|Overall Study|Withdrawal by Subject|13
214343|NCT00215683|710846|P2|Overall Study|Withdrawal by Subject|4
214344|NCT00215683|710847|P1|Overall Study|Withdrawal by Subject|9
214345|NCT00215683|710845|P3|Overall Study|Lost to Follow-up|1
214346|NCT00215683|710846|P2|Overall Study|Lost to Follow-up|2
214347|NCT00215683|710847|P1|Overall Study|Lost to Follow-up|0
214348|NCT00215683|710845|P3|Overall Study|Lack of Efficacy|2
214349|NCT00215683|710846|P2|Overall Study|Lack of Efficacy|1
214350|NCT00215683|710847|P1|Overall Study|Lack of Efficacy|5
214351|NCT00215683|710845|P3|Overall Study|Adverse Event|15
214352|NCT00215683|710846|P2|Overall Study|Adverse Event|16
214353|NCT00215683|710847|P1|Overall Study|Adverse Event|15
214354|NCT00215657|710866|P8|Overall Study|Not specified|1
214355|NCT00215657|710867|P7|Overall Study|Not specified|6
214356|NCT00215657|710868|P6|Overall Study|Not specified|4
214357|NCT00215657|710869|P5|Overall Study|Not specified|5
214358|NCT00215657|710870|P4|Overall Study|Not specified|3
214359|NCT00215657|710871|P3|Overall Study|Not specified|2
214360|NCT00215657|710872|P2|Overall Study|Not specified|1
214361|NCT00215657|710873|P1|Overall Study|Not specified|3
214362|NCT00215657|710866|P8|Overall Study|Insufficient testosterone response|7
214363|NCT00215657|710867|P7|Overall Study|Insufficient testosterone response|4
214364|NCT00215657|710868|P6|Overall Study|Insufficient testosterone response|12
214365|NCT00215657|710869|P5|Overall Study|Insufficient testosterone response|8
214366|NCT00215657|710870|P4|Overall Study|Insufficient testosterone response|12
214367|NCT00215657|710871|P3|Overall Study|Insufficient testosterone response|1
214368|NCT00215657|710872|P2|Overall Study|Insufficient testosterone response|4
214369|NCT00215657|710873|P1|Overall Study|Insufficient testosterone response|5
214370|NCT00215657|710866|P8|Overall Study|Insuff prostate specific antigen resp|2
214371|NCT00215657|710867|P7|Overall Study|Insuff prostate specific antigen resp|3
214372|NCT00215657|710868|P6|Overall Study|Insuff prostate specific antigen resp|2
214373|NCT00215657|710869|P5|Overall Study|Insuff prostate specific antigen resp|1
214374|NCT00215657|710870|P4|Overall Study|Insuff prostate specific antigen resp|2
214375|NCT00215657|710871|P3|Overall Study|Insuff prostate specific antigen resp|2
214376|NCT00215657|710872|P2|Overall Study|Insuff prostate specific antigen resp|2
214377|NCT00215657|710873|P1|Overall Study|Insuff prostate specific antigen resp|3
214378|NCT00215657|710866|P8|Overall Study|Withdrawal by Subject|3
214379|NCT00215657|710867|P7|Overall Study|Withdrawal by Subject|10
214380|NCT00215657|710868|P6|Overall Study|Withdrawal by Subject|1
214381|NCT00215657|710869|P5|Overall Study|Withdrawal by Subject|6
214382|NCT00215657|710870|P4|Overall Study|Withdrawal by Subject|1
214383|NCT00215657|710871|P3|Overall Study|Withdrawal by Subject|3
214384|NCT00215657|710872|P2|Overall Study|Withdrawal by Subject|3
214385|NCT00215657|710873|P1|Overall Study|Withdrawal by Subject|6
214386|NCT00215657|710866|P8|Overall Study|Adverse Event|3
214387|NCT00215657|710867|P7|Overall Study|Adverse Event|0
214388|NCT00215657|710868|P6|Overall Study|Adverse Event|1
214389|NCT00215657|710869|P5|Overall Study|Adverse Event|3
214390|NCT00215657|710870|P4|Overall Study|Adverse Event|0
214391|NCT00215657|710871|P3|Overall Study|Adverse Event|3
214392|NCT00215657|710872|P2|Overall Study|Adverse Event|1
214393|NCT00215657|710873|P1|Overall Study|Adverse Event|5
214394|NCT00215540|710945|P3|Overall Study|Withdrew from study medication|0
214395|NCT00215540|710946|P2|Overall Study|Withdrew from study medication|0
214396|NCT00215540|710947|P1|Overall Study|Withdrew from study medication|1
214397|NCT00215150|710982|P1|Randomization Phase Placebo|Withdrawal by Subject|1
214398|NCT00215150|710982|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
214399|NCT00215150|710982|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
214400|NCT00215150|710982|P1|Open Label Phase|Did not meet randomization criteria|9
214401|NCT00215150|710982|P1|Open Label Phase|Did not complete a post base visit|13
214402|NCT00215150|710982|P1|Open Label Phase|Withdrawal by Subject|1
214403|NCT00215150|710982|P1|Open Label Phase|Lost to Follow-up|7
214404|NCT00215137|710990|P3|Randomization Period|Withdrawal by Subject|0
214405|NCT00215137|710991|P2|Randomization Period|Withdrawal by Subject|1
214406|NCT00215137|710992|P1|Randomization Period|Withdrawal by Subject|0
214407|NCT00215137|710990|P3|Randomization Period|Lost to Follow-up|0
214408|NCT00215137|710991|P2|Randomization Period|Lost to Follow-up|1
214409|NCT00215137|710992|P1|Randomization Period|Lost to Follow-up|0
214410|NCT00215137|710990|P3|Open Label Escitalopram|Lack of Efficacy|0
214411|NCT00215137|710991|P2|Open Label Escitalopram|Lack of Efficacy|0
214412|NCT00215137|710992|P1|Open Label Escitalopram|Lack of Efficacy|1
214413|NCT00214461|711103|P4|Overall Study|Withdrawal by Subject|0
214414|NCT00214461|711104|P3|Overall Study|Withdrawal by Subject|1
214415|NCT00214461|711105|P2|Overall Study|Withdrawal by Subject|0
214416|NCT00214461|711106|P1|Overall Study|Withdrawal by Subject|0
214417|NCT00214461|711103|P4|Overall Study|Adverse Event|1
214418|NCT00214461|711104|P3|Overall Study|Adverse Event|1
214419|NCT00214461|711105|P2|Overall Study|Adverse Event|0
214420|NCT00214461|711106|P1|Overall Study|Adverse Event|0
214421|NCT00214383|711122|P2|Overall Study|Lost to Follow-up|26
214422|NCT00214383|711123|P1|Overall Study|Lost to Follow-up|16
214423|NCT00214201|711135|P2|Overall Study|Death|2
214424|NCT00214201|711136|P1|Overall Study|Death|0
214425|NCT00214201|711135|P2|Overall Study|Withdrawal by Subject|0
214426|NCT00214201|711136|P1|Overall Study|Withdrawal by Subject|2
214427|NCT00214136|711146|P1|Overall Study|Death|5
214428|NCT00214019|711151|P1|Overall Study|Screen Failed prior to randomization|17
214429|NCT00214019|711151|P1|Overall Study|Withdrawal by Subject|2
214430|NCT00214019|711151|P1|Overall Study|Lost to Follow-up|11
214431|NCT00213980|711160|P2|Overall Study|Failed to obtain all 3 DXAs|3
214432|NCT00213980|711161|P1|Overall Study|Failed to obtain all 3 DXAs|1
214433|NCT00213980|711160|P2|Overall Study|Developed ovarian cancer|0
214434|NCT00213980|711161|P1|Overall Study|Developed ovarian cancer|1
214435|NCT00213980|711160|P2|Overall Study|Disease progression|2
214436|NCT00213980|711161|P1|Overall Study|Disease progression|0
214437|NCT00213980|711160|P2|Overall Study|Adverse Event|1
214438|NCT00213980|711161|P1|Overall Study|Adverse Event|1
214439|NCT00213980|711160|P2|Overall Study|Withdrawal by Subject|1
214440|NCT00213980|711161|P1|Overall Study|Withdrawal by Subject|3
214441|NCT00213135|711176|P3|Overall Study|Other|15
214442|NCT00213135|711177|P2|Overall Study|Other|12
214443|NCT00213135|711178|P1|Overall Study|Other|21
214444|NCT00213135|711176|P3|Overall Study|Disease progression|21
214445|NCT00213135|711177|P2|Overall Study|Disease progression|5
214446|NCT00213135|711178|P1|Overall Study|Disease progression|4
214447|NCT00213135|711176|P3|Overall Study|Death|2
214448|NCT00213135|711177|P2|Overall Study|Death|1
214449|NCT00213135|711178|P1|Overall Study|Death|1
214450|NCT00213135|711176|P3|Overall Study|Protocol Violation|10
214451|NCT00213135|711177|P2|Overall Study|Protocol Violation|4
214452|NCT00213135|711178|P1|Overall Study|Protocol Violation|4
214453|NCT00213135|711176|P3|Overall Study|Lost to Follow-up|4
214454|NCT00213135|711177|P2|Overall Study|Lost to Follow-up|8
214455|NCT00213135|711178|P1|Overall Study|Lost to Follow-up|11
214456|NCT00213135|711176|P3|Overall Study|Adverse Event|5
214457|NCT00213135|711177|P2|Overall Study|Adverse Event|5
214458|NCT00213135|711178|P1|Overall Study|Adverse Event|9
214459|NCT00212758|711195|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
214460|NCT00212758|711196|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
214461|NCT00212758|711195|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
214462|NCT00212758|711196|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
214463|NCT00212355|711202|P1|Overall Study|A change of address|1
214464|NCT00212355|711202|P1|Overall Study|Withdrawal by Subject|1
214465|NCT00212355|711202|P1|Overall Study|Adverse Event|1
214466|NCT00212134|711223|P2|Phase 3 (Age 10 Years)|On Going|21
214467|NCT00212134|711224|P1|Phase 3 (Age 10 Years)|On Going|21
214468|NCT00211887|711245|P3|Overall Study|Side effects|5
214469|NCT00211887|711246|P2|Overall Study|Side effects|13
214470|NCT00211887|711247|P1|Overall Study|Side effects|19
214471|NCT00211887|711245|P3|Overall Study|Other medical reason|7
214472|NCT00211887|711246|P2|Overall Study|Other medical reason|11
214473|NCT00211887|711247|P1|Overall Study|Other medical reason|15
214474|NCT00211887|711245|P3|Overall Study|Non-medical reason|8
214475|NCT00211887|711246|P2|Overall Study|Non-medical reason|14
214476|NCT00211887|711247|P1|Overall Study|Non-medical reason|31
214477|NCT00211887|711245|P3|Overall Study|Lost to Follow-up|9
214478|NCT00211887|711246|P2|Overall Study|Lost to Follow-up|13
214479|NCT00211887|711247|P1|Overall Study|Lost to Follow-up|28
214480|NCT00211887|711245|P3|Overall Study|Death|1
214481|NCT00211887|711246|P2|Overall Study|Death|1
214482|NCT00211887|711247|P1|Overall Study|Death|1
214483|NCT00211887|711245|P3|Overall Study|Adverse Event|6
214484|NCT00211887|711246|P2|Overall Study|Adverse Event|4
214485|NCT00211887|711247|P1|Overall Study|Adverse Event|8
214486|NCT00211809|711264|P1|Overall Study|side effects|2
214487|NCT00211809|711264|P1|Overall Study|Pregnancy|1
214488|NCT00211809|711264|P1|Overall Study|Lost to Follow-up|2
214489|NCT00211809|711264|P1|Overall Study|Lack of Efficacy|1
214490|NCT00211536|711291|P2|Overall Study|Adverse Event|0
214491|NCT00211536|711292|P1|Overall Study|Adverse Event|2
214492|NCT00211536|711291|P2|Overall Study|Physician Decision|5
214493|NCT00211536|711292|P1|Overall Study|Physician Decision|0
214494|NCT00211536|711291|P2|Overall Study|Withdrawal by Subject|2
214495|NCT00211536|711292|P1|Overall Study|Withdrawal by Subject|2
214496|NCT00211510|711308|P2|Overall Study|Withdrawal by Subject|1
214497|NCT00211510|711309|P1|Overall Study|Withdrawal by Subject|3
214498|NCT00211510|711308|P2|Overall Study|Physician Decision|1
214499|NCT00211510|711309|P1|Overall Study|Physician Decision|3
214500|NCT00211237|711327|P3|12 Months|unrelated medical problem|1
214501|NCT00211237|711328|P2|12 Months|unrelated medical problem|0
214502|NCT00211237|711329|P1|12 Months|unrelated medical problem|0
214503|NCT00211237|711327|P3|12 Months|Withdrew|1
214504|NCT00211237|711328|P2|12 Months|Withdrew|0
214505|NCT00211237|711329|P1|12 Months|Withdrew|0
214506|NCT00211237|711327|P3|12 Months|Lost to Follow-up|1
214507|NCT00211237|711328|P2|12 Months|Lost to Follow-up|0
214508|NCT00211237|711329|P1|12 Months|Lost to Follow-up|1
214509|NCT00211237|711327|P3|12 Months|Death|3
214510|NCT00211237|711328|P2|12 Months|Death|2
214511|NCT00211237|711329|P1|12 Months|Death|8
214512|NCT00211237|711327|P3|6 Months|Could not comply with protocol|0
214513|NCT00211237|711328|P2|6 Months|Could not comply with protocol|2
214514|NCT00211237|711329|P1|6 Months|Could not comply with protocol|0
214515|NCT00211237|711327|P3|6 Months|Lost to Follow-up|0
214516|NCT00211237|711328|P2|6 Months|Lost to Follow-up|0
214517|NCT00211237|711329|P1|6 Months|Lost to Follow-up|2
214518|NCT00211237|711327|P3|6 Months|Death|3
214519|NCT00211237|711328|P2|6 Months|Death|0
214520|NCT00211237|711329|P1|6 Months|Death|6
214521|NCT00211237|711327|P3|3 Months|Non-medical problem|1
214522|NCT00211237|711328|P2|3 Months|Non-medical problem|0
214523|NCT00211237|711329|P1|3 Months|Non-medical problem|0
214524|NCT00211237|711327|P3|3 Months|Withdrew|0
214525|NCT00211237|711328|P2|3 Months|Withdrew|1
214526|NCT00211237|711329|P1|3 Months|Withdrew|0
214527|NCT00211237|711327|P3|3 Months|Could not comply with protocol|0
214528|NCT00211237|711328|P2|3 Months|Could not comply with protocol|0
214529|NCT00211237|711329|P1|3 Months|Could not comply with protocol|1
214530|NCT00211237|711327|P3|3 Months|Death|0
214531|NCT00211237|711328|P2|3 Months|Death|3
214532|NCT00211237|711329|P1|3 Months|Death|7
214533|NCT00211237|711327|P3|1 Month|Non-medical problem|0
214534|NCT00211237|711328|P2|1 Month|Non-medical problem|2
214535|NCT00211237|711329|P1|1 Month|Non-medical problem|0
214536|NCT00211237|711327|P3|1 Month|Additional surgery needed|0
214537|NCT00211237|711328|P2|1 Month|Additional surgery needed|0
214538|NCT00211237|711329|P1|1 Month|Additional surgery needed|1
214539|NCT00211237|711327|P3|1 Month|Withdrew|0
214540|NCT00211237|711328|P2|1 Month|Withdrew|4
214541|NCT00211237|711329|P1|1 Month|Withdrew|0
214542|NCT00211237|711327|P3|1 Month|Lost to Follow-up|0
214543|NCT00211237|711328|P2|1 Month|Lost to Follow-up|2
214544|NCT00211237|711329|P1|1 Month|Lost to Follow-up|0
214545|NCT00211237|711327|P3|1 Month|Death|0
214546|NCT00211237|711328|P2|1 Month|Death|1
214547|NCT00211237|711329|P1|1 Month|Death|2
214548|NCT00211237|711327|P3|Baseline|Refused random assignment|0
214549|NCT00211237|711328|P2|Baseline|Refused random assignment|0
214550|NCT00211237|711329|P1|Baseline|Refused random assignment|1
214551|NCT00211237|711327|P3|Baseline|Withdrew|0
214552|NCT00211237|711328|P2|Baseline|Withdrew|3
214553|NCT00211237|711329|P1|Baseline|Withdrew|1
214554|NCT00211172|711421|P2|Overall Study|Died or lost health plan eligibility|32
214555|NCT00211172|711422|P1|Overall Study|Died or lost health plan eligibility|39
214556|NCT00211081|711428|P1|Overall Study|Withdrawal by Subject|2
214557|NCT00210639|711440|P2|Overall Study|Not specified|12
214558|NCT00210639|711441|P1|Overall Study|Not specified|18
214559|NCT00210639|711440|P2|Overall Study|Withdrawal by Subject|1
214560|NCT00210639|711441|P1|Overall Study|Withdrawal by Subject|8
214561|NCT00210639|711440|P2|Overall Study|Lost to Follow-up|29
214562|NCT00210639|711441|P1|Overall Study|Lost to Follow-up|37
214563|NCT00210626|711449|P2|Overall Study|Not Specified|5
214564|NCT00210626|711450|P1|Overall Study|Not Specified|4
214565|NCT00210626|711449|P2|Overall Study|Sponser Request|0
214566|NCT00210626|711450|P1|Overall Study|Sponser Request|1
214567|NCT00210626|711449|P2|Overall Study|Physician Decision|2
214568|NCT00210626|711450|P1|Overall Study|Physician Decision|0
214569|NCT00210626|711449|P2|Overall Study|Withdrawal by Subject|20
214570|NCT00210626|711450|P1|Overall Study|Withdrawal by Subject|29
214571|NCT00210626|711449|P2|Overall Study|Death|0
214572|NCT00210626|711450|P1|Overall Study|Death|1
214573|NCT00210626|711449|P2|Overall Study|Lost to Follow-up|11
214574|NCT00210626|711450|P1|Overall Study|Lost to Follow-up|11
214575|NCT00210626|711449|P2|Overall Study|Protocol Violation|5
214576|NCT00210626|711450|P1|Overall Study|Protocol Violation|1
214577|NCT00210626|711449|P2|Overall Study|Adverse Event|2
214578|NCT00210626|711450|P1|Overall Study|Adverse Event|1
214579|NCT00210470|711458|P1|Overall Study|Subject did not continue to surgery|1
214580|NCT00209560|711464|P2|Overall Study|Lack of Efficacy|0
214581|NCT00209560|711465|P1|Overall Study|Lack of Efficacy|1
214582|NCT00209339|711484|P1|At 5 Years Follow-up|Death|1
214583|NCT00209339|711484|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
214584|NCT00209339|711484|P1|At 5 Years Follow-up|Withdrawal by Subject|2
214585|NCT00209339|711484|P1|At 4 Years Follow-up|Death|1
214586|NCT00209339|711484|P1|At 4 Years Follow-up|Withdrawal by Subject|4
214587|NCT00209339|711484|P1|At 3 Years Follow-up|Withdrawal by Subject|1
214588|NCT00209339|711484|P1|At 24 Months Follow-up|Death|1
214589|NCT00209339|711484|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
214590|NCT00209339|711484|P1|At 24 Months Follow-up|Withdrawal by Subject|4
214591|NCT00209339|711484|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
214592|NCT00209339|711484|P1|At 12 Months Follow-up|Death|1
214593|NCT00209339|711484|P1|At 12 Months Follow-up|Withdrawal by Subject|8
214594|NCT00209274|711568|P2|Overall Study|Randomized not treated (RNT)|15
214595|NCT00209274|711569|P1|Overall Study|Randomized not treated (RNT)|6
214596|NCT00209274|711568|P2|Overall Study|Withdrawal by Subject|15
214597|NCT00209274|711569|P1|Overall Study|Withdrawal by Subject|30
214598|NCT00209274|711568|P2|Overall Study|Death|15
214599|NCT00209274|711569|P1|Overall Study|Death|32
214600|NCT00209274|711568|P2|Overall Study|Missed visit|2
214601|NCT00209274|711569|P1|Overall Study|Missed visit|3
214602|NCT00209170|711889|P2|Overall Study|Lack of Efficacy|1
214603|NCT00209170|711890|P1|Overall Study|Lack of Efficacy|0
214604|NCT00209170|711889|P2|Overall Study|Withdrawal by Subject|1
214605|NCT00209170|711890|P1|Overall Study|Withdrawal by Subject|2
214606|NCT00209170|711889|P2|Overall Study|Adverse Event|1
214607|NCT00209170|711890|P1|Overall Study|Adverse Event|0
214608|NCT00209131|711898|P2|Overall Study|Lack of personnel due to turnovers.|11
214609|NCT00209131|711899|P1|Overall Study|Lack of personnel due to turnovers.|15
214610|NCT00209092|711909|P2|Overall Study|Withdrawal by Subject|0
214611|NCT00209092|711910|P1|Overall Study|Withdrawal by Subject|1
214612|NCT00209092|711909|P2|Overall Study|Adverse Event|1
214613|NCT00209092|711910|P1|Overall Study|Adverse Event|0
214614|NCT00209092|711909|P2|Overall Study|Progression of disease|1
214615|NCT00209092|711910|P1|Overall Study|Progression of disease|7
214616|NCT00209027|711920|P2|Overall Study|study terminated|0
214617|NCT00209027|711921|P1|Overall Study|study terminated|10
214618|NCT00208767|711945|P2|Overall Study|Lost to Follow-up|3
214619|NCT00208767|711946|P1|Overall Study|Lost to Follow-up|3
214620|NCT00208767|711945|P2|Overall Study|Death|0
214621|NCT00208767|711946|P1|Overall Study|Death|1
214622|NCT00208767|711945|P2|Overall Study|Withdrawal by Subject|3
214623|NCT00208767|711946|P1|Overall Study|Withdrawal by Subject|14
214624|NCT00208767|711945|P2|Overall Study|Adverse Event|1
214625|NCT00208767|711946|P1|Overall Study|Adverse Event|9
214626|NCT00208325|711974|P4|Overall Study|Mis-Randomized|0
214627|NCT00208325|711975|P3|Overall Study|Mis-Randomized|0
214628|NCT00208325|711976|P2|Overall Study|Mis-Randomized|20
214629|NCT00208325|711977|P1|Overall Study|Mis-Randomized|17
214630|NCT00208325|711974|P4|Overall Study|Other|0
214631|NCT00208325|711975|P3|Overall Study|Other|1
214632|NCT00208325|711976|P2|Overall Study|Other|1
214633|NCT00208325|711977|P1|Overall Study|Other|2
214634|NCT00208325|711974|P4|Overall Study|Does not wish to Continue in Study|2
214635|NCT00208325|711975|P3|Overall Study|Does not wish to Continue in Study|3
214636|NCT00208325|711976|P2|Overall Study|Does not wish to Continue in Study|8
214637|NCT00208325|711977|P1|Overall Study|Does not wish to Continue in Study|5
214638|NCT00208325|711974|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
214639|NCT00208325|711975|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
214640|NCT00208325|711976|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
214641|NCT00208325|711977|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
214642|NCT00208325|711974|P4|Overall Study|Lost to Follow-up|0
214643|NCT00208325|711975|P3|Overall Study|Lost to Follow-up|2
214644|NCT00208325|711976|P2|Overall Study|Lost to Follow-up|0
214645|NCT00208325|711977|P1|Overall Study|Lost to Follow-up|1
214646|NCT00208325|711974|P4|Overall Study|Revision|4
214647|NCT00208325|711975|P3|Overall Study|Revision|0
214648|NCT00208325|711976|P2|Overall Study|Revision|1
214649|NCT00208325|711977|P1|Overall Study|Revision|4
214650|NCT00208325|711974|P4|Overall Study|Withdrawal by Subject|0
214651|NCT00208325|711975|P3|Overall Study|Withdrawal by Subject|0
214652|NCT00208325|711976|P2|Overall Study|Withdrawal by Subject|1
214653|NCT00208325|711977|P1|Overall Study|Withdrawal by Subject|0
214654|NCT00208325|711974|P4|Overall Study|Death|5
214655|NCT00208325|711975|P3|Overall Study|Death|7
214656|NCT00208325|711976|P2|Overall Study|Death|19
214657|NCT00208325|711977|P1|Overall Study|Death|18
214658|NCT00207740|712112|P4|Overall Study|Not Specified|5
214659|NCT00207740|712113|P3|Overall Study|Not Specified|7
214660|NCT00207740|712114|P2|Overall Study|Not Specified|10
214661|NCT00207740|712115|P1|Overall Study|Not Specified|2
214662|NCT00207740|712112|P4|Overall Study|Sponsor Directive|21
214663|NCT00207740|712113|P3|Overall Study|Sponsor Directive|16
214664|NCT00207740|712114|P2|Overall Study|Sponsor Directive|15
214665|NCT00207740|712115|P1|Overall Study|Sponsor Directive|22
214666|NCT00207740|712112|P4|Overall Study|Death|1
214667|NCT00207740|712113|P3|Overall Study|Death|0
214668|NCT00207740|712114|P2|Overall Study|Death|0
214669|NCT00207740|712115|P1|Overall Study|Death|0
214670|NCT00207740|712112|P4|Overall Study|Lost to Follow-up|1
214671|NCT00207740|712113|P3|Overall Study|Lost to Follow-up|1
214672|NCT00207740|712114|P2|Overall Study|Lost to Follow-up|2
214673|NCT00207740|712115|P1|Overall Study|Lost to Follow-up|0
214674|NCT00207740|712112|P4|Overall Study|Unsatisfactory therapeutic effect|4
214675|NCT00207740|712113|P3|Overall Study|Unsatisfactory therapeutic effect|2
214676|NCT00207740|712114|P2|Overall Study|Unsatisfactory therapeutic effect|0
214677|NCT00207740|712115|P1|Overall Study|Unsatisfactory therapeutic effect|1
214678|NCT00207740|712112|P4|Overall Study|Adverse Event|11
214679|NCT00207740|712113|P3|Overall Study|Adverse Event|14
214680|NCT00207740|712114|P2|Overall Study|Adverse Event|14
214681|NCT00207740|712115|P1|Overall Study|Adverse Event|4
214682|NCT00207727|712161|P5|Overall Study|Not specified|33
214683|NCT00207727|712162|P4|Overall Study|Not specified|37
214684|NCT00207727|712163|P3|Overall Study|Not specified|41
214685|NCT00207727|712164|P2|Overall Study|Not specified|41
214686|NCT00207727|712165|P1|Overall Study|Not specified|38
214687|NCT00207727|712161|P5|Overall Study|Lost to Follow-up|0
214688|NCT00207727|712162|P4|Overall Study|Lost to Follow-up|0
214689|NCT00207727|712163|P3|Overall Study|Lost to Follow-up|0
214690|NCT00207727|712164|P2|Overall Study|Lost to Follow-up|1
214691|NCT00207727|712165|P1|Overall Study|Lost to Follow-up|0
214692|NCT00207727|712161|P5|Overall Study|Withdrawal by Subject|1
214693|NCT00207727|712162|P4|Overall Study|Withdrawal by Subject|0
214694|NCT00207727|712163|P3|Overall Study|Withdrawal by Subject|0
214695|NCT00207727|712164|P2|Overall Study|Withdrawal by Subject|0
214696|NCT00207727|712165|P1|Overall Study|Withdrawal by Subject|0
214697|NCT00207714|712192|P5|Overall Study|Other|0
214698|NCT00207714|712193|P4|Overall Study|Other|1
214699|NCT00207714|712194|P3|Overall Study|Other|5
214700|NCT00207714|712195|P2|Overall Study|Other|2
214701|NCT00207714|712196|P1|Overall Study|Other|3
214702|NCT00207714|712192|P5|Overall Study|Unsatisfactory therapeutic effect|4
214703|NCT00207714|712193|P4|Overall Study|Unsatisfactory therapeutic effect|4
214704|NCT00207714|712194|P3|Overall Study|Unsatisfactory therapeutic effect|1
214705|NCT00207714|712195|P2|Overall Study|Unsatisfactory therapeutic effect|3
214706|NCT00207714|712196|P1|Overall Study|Unsatisfactory therapeutic effect|5
214707|NCT00207714|712192|P5|Overall Study|Adverse Event|1
214708|NCT00207714|712193|P4|Overall Study|Adverse Event|3
214709|NCT00207714|712194|P3|Overall Study|Adverse Event|4
214710|NCT00207714|712195|P2|Overall Study|Adverse Event|2
214711|NCT00207714|712196|P1|Overall Study|Adverse Event|6
214712|NCT00207142|712218|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
214713|NCT00207142|712219|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
214714|NCT00207142|712220|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
214715|NCT00207142|712221|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
214716|NCT00207142|712218|P4|Maintenance Phase/Rescue Phase|Death|1
214717|NCT00207142|712219|P3|Maintenance Phase/Rescue Phase|Death|0
214718|NCT00207142|712220|P2|Maintenance Phase/Rescue Phase|Death|0
214719|NCT00207142|712221|P1|Maintenance Phase/Rescue Phase|Death|0
214720|NCT00207142|712218|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
214721|NCT00207142|712219|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
214722|NCT00207142|712220|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
214723|NCT00207142|712221|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
214724|NCT00207142|712218|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
214725|NCT00207142|712219|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
214726|NCT00207142|712220|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
214727|NCT00207142|712221|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
214728|NCT00207142|712218|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
214729|NCT00207142|712219|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
214730|NCT00207142|712220|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
214731|NCT00207142|712221|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
214732|NCT00207142|712218|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
214733|NCT00207142|712219|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
214734|NCT00207142|712220|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
214735|NCT00207142|712221|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
214736|NCT00207142|712218|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
214737|NCT00207142|712219|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
214738|NCT00207142|712220|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
214739|NCT00207142|712221|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
214740|NCT00207142|712218|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
214741|NCT00207142|712219|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
214742|NCT00207142|712220|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
214743|NCT00207142|712221|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
214744|NCT00207142|712218|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
214745|NCT00207142|712219|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
214746|NCT00207142|712220|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
214747|NCT00207142|712221|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
214748|NCT00207142|712218|P4|Induction Phase|Missing lab data|0
214749|NCT00207142|712219|P3|Induction Phase|Missing lab data|0
214750|NCT00207142|712220|P2|Induction Phase|Missing lab data|0
214751|NCT00207142|712221|P1|Induction Phase|Missing lab data|1
214752|NCT00207142|712218|P4|Induction Phase|Incarceration|0
214753|NCT00207142|712219|P3|Induction Phase|Incarceration|0
214754|NCT00207142|712220|P2|Induction Phase|Incarceration|0
214755|NCT00207142|712221|P1|Induction Phase|Incarceration|1
214756|NCT00207142|712218|P4|Induction Phase|Withdrawal by Subject|0
214757|NCT00207142|712219|P3|Induction Phase|Withdrawal by Subject|0
214758|NCT00207142|712220|P2|Induction Phase|Withdrawal by Subject|0
214759|NCT00207142|712221|P1|Induction Phase|Withdrawal by Subject|4
214760|NCT00207142|712218|P4|Induction Phase|Subject no longer meets study criteria|0
214761|NCT00207142|712219|P3|Induction Phase|Subject no longer meets study criteria|0
214762|NCT00207142|712220|P2|Induction Phase|Subject no longer meets study criteria|0
214763|NCT00207142|712221|P1|Induction Phase|Subject no longer meets study criteria|3
214764|NCT00207142|712218|P4|Induction Phase|Pregnancy|0
214765|NCT00207142|712219|P3|Induction Phase|Pregnancy|0
214766|NCT00207142|712220|P2|Induction Phase|Pregnancy|0
214767|NCT00207142|712221|P1|Induction Phase|Pregnancy|1
214768|NCT00207142|712218|P4|Induction Phase|Poor/noncompliance|0
214769|NCT00207142|712219|P3|Induction Phase|Poor/noncompliance|0
214770|NCT00207142|712220|P2|Induction Phase|Poor/noncompliance|0
214771|NCT00207142|712221|P1|Induction Phase|Poor/noncompliance|2
214772|NCT00207142|712218|P4|Induction Phase|Physician Decision|0
214773|NCT00207142|712219|P3|Induction Phase|Physician Decision|0
214774|NCT00207142|712220|P2|Induction Phase|Physician Decision|0
214775|NCT00207142|712221|P1|Induction Phase|Physician Decision|2
214776|NCT00207142|712218|P4|Induction Phase|Lost to Follow-up|0
214777|NCT00207142|712219|P3|Induction Phase|Lost to Follow-up|0
214778|NCT00207142|712220|P2|Induction Phase|Lost to Follow-up|0
214779|NCT00207142|712221|P1|Induction Phase|Lost to Follow-up|5
214780|NCT00207142|712218|P4|Induction Phase|Lack of Efficacy|0
214781|NCT00207142|712219|P3|Induction Phase|Lack of Efficacy|0
214782|NCT00207142|712220|P2|Induction Phase|Lack of Efficacy|0
214783|NCT00207142|712221|P1|Induction Phase|Lack of Efficacy|1
214784|NCT00207142|712218|P4|Induction Phase|Death|0
214785|NCT00207142|712219|P3|Induction Phase|Death|0
214786|NCT00207142|712220|P2|Induction Phase|Death|0
214787|NCT00207142|712221|P1|Induction Phase|Death|1
214788|NCT00207142|712218|P4|Induction Phase|Adverse Event|0
214789|NCT00207142|712219|P3|Induction Phase|Adverse Event|0
214790|NCT00207142|712220|P2|Induction Phase|Adverse Event|0
214791|NCT00207142|712221|P1|Induction Phase|Adverse Event|9
214792|NCT00207090|712258|P1|Overall Study|Physician Decision|1
214793|NCT00207090|712258|P1|Overall Study|Disease progression/relapse|2
214794|NCT00207090|712258|P1|Overall Study|Chest wall mass larger|1
214795|NCT00207090|712258|P1|Overall Study|Study drug toxicity|3
214796|NCT00206726|712287|P1|Overall Study|Withdrawal by Subject|8
214797|NCT00206726|712287|P1|Overall Study|Protocol Violation|1
214798|NCT00206726|712287|P1|Overall Study|Death|4
214799|NCT00206726|712287|P1|Overall Study|Adverse Event|17
214800|NCT00206726|712287|P1|Overall Study|Bone marrow transplant|1
214801|NCT00206726|712287|P1|Overall Study|Placed on new protocol|1
214802|NCT00206726|712287|P1|Overall Study|Progressive disease or relapsed disease|18
214803|NCT00206726|712287|P1|Overall Study|Delayed recovery of blood counts|1
214804|NCT00206518|712298|P2|Overall Study|Protocol Violation|1
214805|NCT00206518|712299|P1|Overall Study|Protocol Violation|1
214806|NCT00206518|712298|P2|Overall Study|Physician Decision|0
214807|NCT00206518|712299|P1|Overall Study|Physician Decision|1
214808|NCT00206518|712298|P2|Overall Study|Adverse Event|1
214809|NCT00206518|712299|P1|Overall Study|Adverse Event|2
214810|NCT00206518|712298|P2|Overall Study|Lack of Efficacy|4
214811|NCT00206518|712299|P1|Overall Study|Lack of Efficacy|6
214812|NCT00206440|712311|P2|Overall Study|Adverse Event|2
214813|NCT00206440|712312|P1|Overall Study|Adverse Event|4
214814|NCT00206440|712311|P2|Overall Study|Protocol Violation|2
214815|NCT00206440|712312|P1|Overall Study|Protocol Violation|1
214816|NCT00206427|712318|P1|Overall Study|Adverse Event|2
214817|NCT00206323|712328|P2|Overall Study|Lost to Follow-up|1
214818|NCT00206323|712329|P1|Overall Study|Lost to Follow-up|1
214819|NCT00206323|712328|P2|Overall Study|Adverse Event|1
214820|NCT00206323|712329|P1|Overall Study|Adverse Event|1
214821|NCT00206323|712328|P2|Overall Study|Lack of Efficacy|1
214822|NCT00206323|712329|P1|Overall Study|Lack of Efficacy|4
214823|NCT00206102|712337|P2|Overall Study|None of those categories|36
214824|NCT00206102|712338|P1|Overall Study|None of those categories|42
214825|NCT00206102|712337|P2|Overall Study|Study-specific discontinuation criteria|17
214826|NCT00206102|712338|P1|Overall Study|Study-specific discontinuation criteria|18
214827|NCT00206102|712337|P2|Overall Study|Withdrawal by Subject|101
214828|NCT00206102|712338|P1|Overall Study|Withdrawal by Subject|118
214829|NCT00206102|712337|P2|Overall Study|Lost to Follow-up|66
214830|NCT00206102|712338|P1|Overall Study|Lost to Follow-up|95
214831|NCT00206102|712337|P2|Overall Study|Lack of therapeutic response|11
214832|NCT00206102|712338|P1|Overall Study|Lack of therapeutic response|16
214833|NCT00206102|712337|P2|Overall Study|Protocol Violation|2
214834|NCT00206102|712338|P1|Overall Study|Protocol Violation|0
214835|NCT00206102|712337|P2|Overall Study|Adverse Event|82
214836|NCT00206102|712338|P1|Overall Study|Adverse Event|119
214837|NCT00206076|712374|P2|Overall Study|Withdrawal by Subject|1
214838|NCT00206076|712375|P1|Overall Study|Withdrawal by Subject|1
214839|NCT00206076|712374|P2|Overall Study|Physician Decision|0
214840|NCT00206076|712375|P1|Overall Study|Physician Decision|2
214841|NCT00205881|712385|P1|Overall Study|Withdrawal by Subject|16
214842|NCT00205855|712390|P1|Overall Study|Withdrawal by Subject|5
214843|NCT00205855|712390|P1|Overall Study|Only received temporary implants|16
214844|NCT00205803|712396|P2|Toddler Dose|Lost to Follow-up|3
214845|NCT00205803|712397|P1|Toddler Dose|Lost to Follow-up|2
214846|NCT00205803|712396|P2|After Infant Series|Other|4
214847|NCT00205803|712397|P1|After Infant Series|Other|10
214848|NCT00205803|712396|P2|After Infant Series|Withdrawal by Subject|4
214849|NCT00205803|712397|P1|After Infant Series|Withdrawal by Subject|1
214850|NCT00205803|712396|P2|After Infant Series|Physician Decision|2
214851|NCT00205803|712397|P1|After Infant Series|Physician Decision|3
214852|NCT00205803|712396|P2|After Infant Series|Lost to Follow-up|1
214853|NCT00205803|712397|P1|After Infant Series|Lost to Follow-up|2
214854|NCT00205803|712396|P2|After Infant Series|Protocol Violation|1
214855|NCT00205803|712397|P1|After Infant Series|Protocol Violation|1
214856|NCT00205803|712396|P2|After Infant Series|Adverse Event|1
214857|NCT00205803|712397|P1|After Infant Series|Adverse Event|1
214858|NCT00205803|712396|P2|Infant Series|Sponsor request|0
214859|NCT00205803|712397|P1|Infant Series|Sponsor request|1
214860|NCT00205803|712396|P2|Infant Series|Non-compliant|0
214861|NCT00205803|712397|P1|Infant Series|Non-compliant|1
214862|NCT00205803|712396|P2|Infant Series|Lost Kaiser coverage|1
214863|NCT00205803|712397|P1|Infant Series|Lost Kaiser coverage|0
214864|NCT00205803|712396|P2|Infant Series|Protocol Violation|0
214865|NCT00205803|712397|P1|Infant Series|Protocol Violation|1
214866|NCT00205803|712396|P2|Infant Series|Physician Decision|1
214867|NCT00205803|712397|P1|Infant Series|Physician Decision|3
214868|NCT00205803|712396|P2|Infant Series|Withdrawal by Subject|5
214869|NCT00205803|712397|P1|Infant Series|Withdrawal by Subject|2
214870|NCT00205803|712396|P2|Infant Series|Lost to Follow-up|4
214871|NCT00205803|712397|P1|Infant Series|Lost to Follow-up|10
214872|NCT00205777|712453|P6|Study Extension II|Enrolled but not treated|131
214873|NCT00205777|712454|P5|Study Extension II|Enrolled but not treated|0
214874|NCT00205777|712455|P4|Study Extension II|Enrolled but not treated|71
214875|NCT00205777|712456|P3|Study Extension II|Enrolled but not treated|0
214876|NCT00205777|712457|P2|Study Extension II|Enrolled but not treated|0
214877|NCT00205777|712458|P1|Study Extension II|Enrolled but not treated|0
214878|NCT00205777|712453|P6|Study Extension II|Other Event|20
214879|NCT00205777|712454|P5|Study Extension II|Other Event|0
214880|NCT00205777|712455|P4|Study Extension II|Other Event|12
214881|NCT00205777|712456|P3|Study Extension II|Other Event|0
214882|NCT00205777|712457|P2|Study Extension II|Other Event|0
214883|NCT00205777|712458|P1|Study Extension II|Other Event|0
214884|NCT00205777|712453|P6|Study Extension II|Failed to return|26
214885|NCT00205777|712454|P5|Study Extension II|Failed to return|0
214886|NCT00205777|712455|P4|Study Extension II|Failed to return|14
214887|NCT00205777|712456|P3|Study Extension II|Failed to return|0
214888|NCT00205777|712457|P2|Study Extension II|Failed to return|0
214889|NCT00205777|712458|P1|Study Extension II|Failed to return|0
214890|NCT00205777|712453|P6|Study Extension II|Lack of Efficacy|1
214891|NCT00205777|712454|P5|Study Extension II|Lack of Efficacy|0
214892|NCT00205777|712455|P4|Study Extension II|Lack of Efficacy|0
214893|NCT00205777|712456|P3|Study Extension II|Lack of Efficacy|0
214894|NCT00205777|712457|P2|Study Extension II|Lack of Efficacy|0
214895|NCT00205777|712458|P1|Study Extension II|Lack of Efficacy|0
214896|NCT00205777|712453|P6|Study Extension II|Protocol Violation|10
214897|NCT00205777|712454|P5|Study Extension II|Protocol Violation|0
214898|NCT00205777|712455|P4|Study Extension II|Protocol Violation|1
214899|NCT00205777|712456|P3|Study Extension II|Protocol Violation|0
214900|NCT00205777|712457|P2|Study Extension II|Protocol Violation|0
214901|NCT00205777|712458|P1|Study Extension II|Protocol Violation|0
214902|NCT00205777|712453|P6|Study Extension II|Withdrawal by Subject|59
214903|NCT00205777|712454|P5|Study Extension II|Withdrawal by Subject|0
214904|NCT00205777|712455|P4|Study Extension II|Withdrawal by Subject|35
214905|NCT00205777|712456|P3|Study Extension II|Withdrawal by Subject|0
214906|NCT00205777|712457|P2|Study Extension II|Withdrawal by Subject|0
214907|NCT00205777|712458|P1|Study Extension II|Withdrawal by Subject|0
214908|NCT00205777|712453|P6|Study Extension II|Death|5
214909|NCT00205777|712454|P5|Study Extension II|Death|0
214910|NCT00205777|712455|P4|Study Extension II|Death|2
214911|NCT00205777|712456|P3|Study Extension II|Death|0
214912|NCT00205777|712457|P2|Study Extension II|Death|0
214913|NCT00205777|712458|P1|Study Extension II|Death|0
214914|NCT00205777|712453|P6|Study Extension II|Adverse Event|30
214915|NCT00205777|712454|P5|Study Extension II|Adverse Event|0
214916|NCT00205777|712455|P4|Study Extension II|Adverse Event|14
214917|NCT00205777|712456|P3|Study Extension II|Adverse Event|0
214918|NCT00205777|712457|P2|Study Extension II|Adverse Event|0
214919|NCT00205777|712458|P1|Study Extension II|Adverse Event|0
214920|NCT00205777|712453|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
214921|NCT00205777|712454|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
214922|NCT00205777|712455|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
214923|NCT00205777|712456|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
214924|NCT00205777|712457|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
214925|NCT00205777|712458|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
214926|NCT00205777|712453|P6|Study Extension I|Withdrawn as per protocol|0
214927|NCT00205777|712454|P5|Study Extension I|Withdrawn as per protocol|0
214928|NCT00205777|712455|P4|Study Extension I|Withdrawn as per protocol|0
214929|NCT00205777|712456|P3|Study Extension I|Withdrawn as per protocol|1070
214930|NCT00205777|712457|P2|Study Extension I|Withdrawn as per protocol|0
214931|NCT00205777|712458|P1|Study Extension I|Withdrawn as per protocol|0
214932|NCT00205777|712453|P6|Study Extension I|Other Event|0
214933|NCT00205777|712454|P5|Study Extension I|Other Event|29
214934|NCT00205777|712455|P4|Study Extension I|Other Event|34
214935|NCT00205777|712456|P3|Study Extension I|Other Event|0
214936|NCT00205777|712457|P2|Study Extension I|Other Event|0
214937|NCT00205777|712458|P1|Study Extension I|Other Event|34
214938|NCT00205777|712453|P6|Study Extension I|Failed to return|0
214939|NCT00205777|712454|P5|Study Extension I|Failed to return|13
214940|NCT00205777|712455|P4|Study Extension I|Failed to return|17
214941|NCT00205777|712456|P3|Study Extension I|Failed to return|0
214942|NCT00205777|712457|P2|Study Extension I|Failed to return|0
214943|NCT00205777|712458|P1|Study Extension I|Failed to return|15
214944|NCT00205777|712453|P6|Study Extension I|Lack of Efficacy|0
214945|NCT00205777|712454|P5|Study Extension I|Lack of Efficacy|2
214946|NCT00205777|712455|P4|Study Extension I|Lack of Efficacy|1
214947|NCT00205777|712456|P3|Study Extension I|Lack of Efficacy|0
214948|NCT00205777|712457|P2|Study Extension I|Lack of Efficacy|0
214949|NCT00205777|712458|P1|Study Extension I|Lack of Efficacy|0
214950|NCT00205777|712453|P6|Study Extension I|Protocol Violation|0
214951|NCT00205777|712454|P5|Study Extension I|Protocol Violation|8
214952|NCT00205777|712455|P4|Study Extension I|Protocol Violation|8
214953|NCT00205777|712456|P3|Study Extension I|Protocol Violation|0
214954|NCT00205777|712457|P2|Study Extension I|Protocol Violation|0
214955|NCT00205777|712458|P1|Study Extension I|Protocol Violation|4
214956|NCT00205777|712453|P6|Study Extension I|Withdrawal by Subject|0
214957|NCT00205777|712454|P5|Study Extension I|Withdrawal by Subject|89
214958|NCT00205777|712455|P4|Study Extension I|Withdrawal by Subject|106
214959|NCT00205777|712456|P3|Study Extension I|Withdrawal by Subject|0
214960|NCT00205777|712457|P2|Study Extension I|Withdrawal by Subject|0
214961|NCT00205777|712458|P1|Study Extension I|Withdrawal by Subject|99
214962|NCT00205777|712453|P6|Study Extension I|Death|0
214963|NCT00205777|712454|P5|Study Extension I|Death|2
214964|NCT00205777|712455|P4|Study Extension I|Death|1
214965|NCT00205777|712456|P3|Study Extension I|Death|0
214966|NCT00205777|712457|P2|Study Extension I|Death|0
214967|NCT00205777|712458|P1|Study Extension I|Death|5
214968|NCT00205777|712453|P6|Study Extension I|Adverse Event|0
214969|NCT00205777|712454|P5|Study Extension I|Adverse Event|58
214970|NCT00205777|712455|P4|Study Extension I|Adverse Event|61
214971|NCT00205777|712456|P3|Study Extension I|Adverse Event|0
214972|NCT00205777|712457|P2|Study Extension I|Adverse Event|0
214973|NCT00205777|712458|P1|Study Extension I|Adverse Event|57
214974|NCT00205777|712453|P6|Completed Core Study, Entered SE I|Other Event|0
214975|NCT00205777|712454|P5|Completed Core Study, Entered SE I|Other Event|0
214976|NCT00205777|712455|P4|Completed Core Study, Entered SE I|Other Event|50
214977|NCT00205777|712456|P3|Completed Core Study, Entered SE I|Other Event|47
214978|NCT00205777|712457|P2|Completed Core Study, Entered SE I|Other Event|46
214979|NCT00205777|712458|P1|Completed Core Study, Entered SE I|Other Event|52
214980|NCT00205777|712453|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
214981|NCT00205777|712454|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
214982|NCT00205777|712455|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
214983|NCT00205777|712456|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
214984|NCT00205777|712457|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
214985|NCT00205777|712458|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
214986|NCT00205777|712453|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
214987|NCT00205777|712454|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
214988|NCT00205777|712455|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
214989|NCT00205777|712456|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
214990|NCT00205777|712457|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
214991|NCT00205777|712458|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
214992|NCT00205777|712453|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
214993|NCT00205777|712454|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
214994|NCT00205777|712455|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
214995|NCT00205777|712456|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
214996|NCT00205777|712457|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
214997|NCT00205777|712458|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
214998|NCT00205777|712453|P6|Core Study (Up to 3 Years)|Protocol Violation|0
214999|NCT00205777|712454|P5|Core Study (Up to 3 Years)|Protocol Violation|0
215000|NCT00205777|712455|P4|Core Study (Up to 3 Years)|Protocol Violation|42
215001|NCT00205777|712456|P3|Core Study (Up to 3 Years)|Protocol Violation|50
215002|NCT00205777|712457|P2|Core Study (Up to 3 Years)|Protocol Violation|55
215003|NCT00205777|712458|P1|Core Study (Up to 3 Years)|Protocol Violation|53
215004|NCT00205777|712453|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
215005|NCT00205777|712454|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
215006|NCT00205777|712455|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
215007|NCT00205777|712456|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
215008|NCT00205777|712457|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
215009|NCT00205777|712458|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
215010|NCT00205777|712453|P6|Core Study (Up to 3 Years)|Other Event|0
215011|NCT00205777|712454|P5|Core Study (Up to 3 Years)|Other Event|0
215012|NCT00205777|712455|P4|Core Study (Up to 3 Years)|Other Event|58
215013|NCT00205777|712456|P3|Core Study (Up to 3 Years)|Other Event|41
215014|NCT00205777|712457|P2|Core Study (Up to 3 Years)|Other Event|52
215015|NCT00205777|712458|P1|Core Study (Up to 3 Years)|Other Event|49
215016|NCT00205777|712453|P6|Core Study (Up to 3 Years)|Failed to return|0
215017|NCT00205777|712454|P5|Core Study (Up to 3 Years)|Failed to return|0
215018|NCT00205777|712455|P4|Core Study (Up to 3 Years)|Failed to return|27
215019|NCT00205777|712456|P3|Core Study (Up to 3 Years)|Failed to return|27
215020|NCT00205777|712457|P2|Core Study (Up to 3 Years)|Failed to return|25
215021|NCT00205777|712458|P1|Core Study (Up to 3 Years)|Failed to return|40
215022|NCT00205777|712453|P6|Core Study (Up to 3 Years)|Death|0
215023|NCT00205777|712454|P5|Core Study (Up to 3 Years)|Death|0
215024|NCT00205777|712455|P4|Core Study (Up to 3 Years)|Death|7
215025|NCT00205777|712456|P3|Core Study (Up to 3 Years)|Death|14
215026|NCT00205777|712457|P2|Core Study (Up to 3 Years)|Death|7
215027|NCT00205777|712458|P1|Core Study (Up to 3 Years)|Death|9
215028|NCT00205777|712453|P6|Core Study (Up to 3 Years)|Adverse Event|0
215029|NCT00205777|712454|P5|Core Study (Up to 3 Years)|Adverse Event|0
215030|NCT00205777|712455|P4|Core Study (Up to 3 Years)|Adverse Event|232
215031|NCT00205777|712456|P3|Core Study (Up to 3 Years)|Adverse Event|252
215032|NCT00205777|712457|P2|Core Study (Up to 3 Years)|Adverse Event|267
215033|NCT00205777|712458|P1|Core Study (Up to 3 Years)|Adverse Event|260
215034|NCT00205712|712667|P2|Overall Study|Lost to Follow-up|1
215035|NCT00205712|712668|P1|Overall Study|Lost to Follow-up|0
215036|NCT00203996|712749|P10|Overall Study|Scheduling issue|0
215037|NCT00203996|712750|P9|Overall Study|Scheduling issue|0
215038|NCT00203996|712751|P8|Overall Study|Scheduling issue|2
215039|NCT00203996|712752|P7|Overall Study|Scheduling issue|0
215040|NCT00203996|712753|P6|Overall Study|Scheduling issue|0
215041|NCT00203996|712754|P5|Overall Study|Scheduling issue|0
215042|NCT00203996|712755|P4|Overall Study|Scheduling issue|0
215043|NCT00203996|712756|P3|Overall Study|Scheduling issue|0
215044|NCT00203996|712757|P2|Overall Study|Scheduling issue|0
215045|NCT00203996|712758|P1|Overall Study|Scheduling issue|0
215046|NCT00203996|712749|P10|Overall Study|CPAP machine malfunction|0
215047|NCT00203996|712750|P9|Overall Study|CPAP machine malfunction|0
215048|NCT00203996|712751|P8|Overall Study|CPAP machine malfunction|0
215049|NCT00203996|712752|P7|Overall Study|CPAP machine malfunction|0
215050|NCT00203996|712753|P6|Overall Study|CPAP machine malfunction|0
215051|NCT00203996|712754|P5|Overall Study|CPAP machine malfunction|0
215052|NCT00203996|712755|P4|Overall Study|CPAP machine malfunction|1
215053|NCT00203996|712756|P3|Overall Study|CPAP machine malfunction|0
215054|NCT00203996|712757|P2|Overall Study|CPAP machine malfunction|0
215055|NCT00203996|712758|P1|Overall Study|CPAP machine malfunction|0
215056|NCT00203996|712749|P10|Overall Study|Physician Decision|1
215057|NCT00203996|712750|P9|Overall Study|Physician Decision|0
215058|NCT00203996|712751|P8|Overall Study|Physician Decision|0
215059|NCT00203996|712752|P7|Overall Study|Physician Decision|0
215060|NCT00203996|712753|P6|Overall Study|Physician Decision|0
215061|NCT00203996|712754|P5|Overall Study|Physician Decision|0
215062|NCT00203996|712755|P4|Overall Study|Physician Decision|2
215063|NCT00203996|712756|P3|Overall Study|Physician Decision|0
215064|NCT00203996|712757|P2|Overall Study|Physician Decision|0
215065|NCT00203996|712758|P1|Overall Study|Physician Decision|0
215066|NCT00203996|712749|P10|Overall Study|Protocol Violation|0
215067|NCT00203996|712750|P9|Overall Study|Protocol Violation|0
215068|NCT00203996|712751|P8|Overall Study|Protocol Violation|0
215069|NCT00203996|712752|P7|Overall Study|Protocol Violation|0
215070|NCT00203996|712753|P6|Overall Study|Protocol Violation|0
215071|NCT00203996|712754|P5|Overall Study|Protocol Violation|1
215072|NCT00203996|712755|P4|Overall Study|Protocol Violation|6
215073|NCT00203996|712756|P3|Overall Study|Protocol Violation|0
215074|NCT00203996|712757|P2|Overall Study|Protocol Violation|0
215075|NCT00203996|712758|P1|Overall Study|Protocol Violation|0
215076|NCT00203996|712749|P10|Overall Study|Lost to Follow-up|0
215077|NCT00203996|712750|P9|Overall Study|Lost to Follow-up|0
215078|NCT00203996|712751|P8|Overall Study|Lost to Follow-up|0
215079|NCT00203996|712752|P7|Overall Study|Lost to Follow-up|0
215080|NCT00203996|712753|P6|Overall Study|Lost to Follow-up|0
215081|NCT00203996|712754|P5|Overall Study|Lost to Follow-up|0
215082|NCT00203996|712755|P4|Overall Study|Lost to Follow-up|1
215083|NCT00203996|712756|P3|Overall Study|Lost to Follow-up|0
215084|NCT00203996|712757|P2|Overall Study|Lost to Follow-up|0
215085|NCT00203996|712758|P1|Overall Study|Lost to Follow-up|0
215086|NCT00203892|712825|P3|Overall Study|Death|0
215087|NCT00203892|712826|P2|Overall Study|Death|0
215088|NCT00203892|712827|P1|Overall Study|Death|1
215089|NCT00203892|712825|P3|Overall Study|Physician Decision|0
215090|NCT00203892|712826|P2|Overall Study|Physician Decision|2
215091|NCT00203892|712827|P1|Overall Study|Physician Decision|1
215092|NCT00203502|712838|P1|Overall Study|Death|1
215093|NCT00203476|712849|P3|Overall Study|Withdrawal by Subject|0
215094|NCT00203476|712850|P2|Overall Study|Withdrawal by Subject|1
215095|NCT00203476|712851|P1|Overall Study|Withdrawal by Subject|0
215096|NCT00203476|712849|P3|Overall Study|Lost to Follow-up|0
215097|NCT00203476|712850|P2|Overall Study|Lost to Follow-up|0
215098|NCT00203476|712851|P1|Overall Study|Lost to Follow-up|1
215099|NCT00203424|712868|P1|Follow-up Period|Lost to Follow-up|1
215100|NCT00203424|712868|P1|Follow-up Period|progressive disease|4
215101|NCT00203424|712868|P1|Follow-up Period|Withdrawal by Subject|1
215102|NCT00203424|712868|P1|Treatment Period|progressive disease|2
215103|NCT00203424|712868|P1|Treatment Period|Adverse Event|5
215104|NCT00203424|712868|P1|Treatment Period|Withdrawal by Subject|4
215105|NCT00203411|712875|P1|Follow-up|Progressive Disease|4
215106|NCT00203307|712884|P2|First Intervention|Adverse Event|0
215107|NCT00203307|712885|P1|First Intervention|Adverse Event|2
215108|NCT00203294|712893|P2|Overall Study|Withdrawal by Subject|13
215109|NCT00203294|712894|P1|Overall Study|Withdrawal by Subject|8
215110|NCT00203268|712900|P1|Early Treatment|Withdrawal by Subject|1
215111|NCT00203268|712900|P1|Early Treatment|Lost to Follow-up|1
215112|NCT00203268|712900|P1|Early Treatment|only treated one headache|2
215113|NCT00203242|712906|P1|Overall Study|Lost to Follow-up|1
215114|NCT00203047|712958|P2|Overall Study|Not specified|5
215115|NCT00203047|712959|P1|Overall Study|Not specified|5
215116|NCT00203047|712958|P2|Overall Study|Pregnancy|0
215117|NCT00203047|712959|P1|Overall Study|Pregnancy|3
215118|NCT00203047|712958|P2|Overall Study|Death|2
215119|NCT00203047|712959|P1|Overall Study|Death|1
215120|NCT00203047|712958|P2|Overall Study|Adverse Event|18
215121|NCT00203047|712959|P1|Overall Study|Adverse Event|8
215122|NCT00203047|712958|P2|Overall Study|Lost to Follow-up|5
215123|NCT00203047|712959|P1|Overall Study|Lost to Follow-up|11
215124|NCT00203047|712958|P2|Overall Study|Protocol Violation|0
215125|NCT00203047|712959|P1|Overall Study|Protocol Violation|1
215126|NCT00203047|712958|P2|Overall Study|Non-compliance|8
215127|NCT00203047|712959|P1|Overall Study|Non-compliance|4
215128|NCT00203047|712958|P2|Overall Study|Physician Decision|7
215129|NCT00203047|712959|P1|Overall Study|Physician Decision|8
215130|NCT00203047|712958|P2|Overall Study|Teva requested participant withdrawal|1
215131|NCT00203047|712959|P1|Overall Study|Teva requested participant withdrawal|1
215132|NCT00203047|712958|P2|Overall Study|Withdrawal by Subject|47
215133|NCT00203047|712959|P1|Overall Study|Withdrawal by Subject|13
215134|NCT00203047|712958|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
215135|NCT00203047|712959|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
215136|NCT00203047|712958|P2|Overall Study|Ongoing: in database - January 29, 2009|109
215137|NCT00203047|712959|P1|Overall Study|Ongoing: in database - January 29, 2009|131
215138|NCT00202878|712973|P2|Overall Study|Withdrawal by Subject|808
215139|NCT00202878|712974|P1|Overall Study|Withdrawal by Subject|795
215140|NCT00202878|712973|P2|Overall Study|Site Closure|36
215141|NCT00202878|712974|P1|Overall Study|Site Closure|39
215142|NCT00202878|712973|P2|Overall Study|Lost to Follow-up|49
215143|NCT00202878|712974|P1|Overall Study|Lost to Follow-up|44
215144|NCT00202878|712973|P2|Overall Study|Only Vital Status Known|356
215145|NCT00202878|712974|P1|Overall Study|Only Vital Status Known|357
215146|NCT00202878|712973|P2|Overall Study|Death|968
215147|NCT00202878|712974|P1|Overall Study|Death|964
215148|NCT00202839|712988|P2|Overall Study|Lost to Follow-up|2
215149|NCT00202839|712989|P1|Overall Study|Lost to Follow-up|3
215150|NCT00202839|712988|P2|Overall Study|Protocol Violation|1
215151|NCT00202839|712989|P1|Overall Study|Protocol Violation|2
215152|NCT00202839|712988|P2|Overall Study|Withdrawal by Subject|2
215153|NCT00202839|712989|P1|Overall Study|Withdrawal by Subject|6
215154|NCT00202839|712988|P2|Overall Study|Physician Decision|0
215155|NCT00202839|712989|P1|Overall Study|Physician Decision|12
215156|NCT00202839|712988|P2|Overall Study|Adverse Event|5
215157|NCT00202839|712989|P1|Overall Study|Adverse Event|1
215158|NCT00202644|713004|P2|Overall Study|Other|1
215159|NCT00202644|713005|P1|Overall Study|Other|9
215160|NCT00202644|713004|P2|Overall Study|Lost to Follow-up|1
215161|NCT00202644|713005|P1|Overall Study|Lost to Follow-up|0
215162|NCT00202644|713004|P2|Overall Study|Lack of Efficacy|6
215163|NCT00202644|713005|P1|Overall Study|Lack of Efficacy|6
215164|NCT00202644|713004|P2|Overall Study|Withdrawal by Subject|6
215165|NCT00202644|713005|P1|Overall Study|Withdrawal by Subject|8
215166|NCT00202644|713004|P2|Overall Study|Adverse Event|13
215167|NCT00202644|713005|P1|Overall Study|Adverse Event|12
215168|NCT00201851|713066|P3|Overall Study|Ineligible post enrollment|1
215169|NCT00201851|713067|P2|Overall Study|Ineligible post enrollment|1
215170|NCT00201851|713068|P1|Overall Study|Ineligible post enrollment|6
215171|NCT00201851|713066|P3|Overall Study|Lost to Follow-up|0
215172|NCT00201851|713067|P2|Overall Study|Lost to Follow-up|1
215173|NCT00201851|713068|P1|Overall Study|Lost to Follow-up|2
215174|NCT00201643|713140|P2|Overall Study|Withdrawal by Subject|4
215175|NCT00201643|713141|P1|Overall Study|Withdrawal by Subject|5
215176|NCT00201201|713205|P2|Overall Study|Withdrawal by Subject|5
215177|NCT00201201|713206|P1|Overall Study|Withdrawal by Subject|5
215178|NCT00201201|713205|P2|Overall Study|Death|2
215179|NCT00201201|713206|P1|Overall Study|Death|0
215180|NCT00201006|713244|P3|Overall Study|Adverse Event|1
215181|NCT00201006|713245|P2|Overall Study|Adverse Event|0
215182|NCT00201006|713246|P1|Overall Study|Adverse Event|1
215183|NCT00201006|713244|P3|Overall Study|Withdrawal by Subject|3
215184|NCT00201006|713245|P2|Overall Study|Withdrawal by Subject|2
215185|NCT00201006|713246|P1|Overall Study|Withdrawal by Subject|7
215186|NCT00200967|713256|P2|Run-out Period|Lost to Follow-up|0
215187|NCT00200967|713257|P1|Run-out Period|Lost to Follow-up|1
215188|NCT00200967|713256|P2|Second Treatment Period|Withdrawal by Subject|2
215189|NCT00200967|713257|P1|Second Treatment Period|Withdrawal by Subject|1
215190|NCT00200967|713256|P2|Wash-out Period|Lost to Follow-up|1
215191|NCT00200967|713257|P1|Wash-out Period|Lost to Follow-up|0
215192|NCT00200967|713256|P2|First Treatment Period|Pregnancy|0
215193|NCT00200967|713257|P1|First Treatment Period|Pregnancy|1
215194|NCT00200967|713256|P2|First Treatment Period|Withdrawal by Subject|1
215195|NCT00200967|713257|P1|First Treatment Period|Withdrawal by Subject|5
215196|NCT00200356|713298|P2|Overall Study|Nontreatment|0
215197|NCT00200356|713299|P1|Overall Study|Nontreatment|1
215198|NCT00200356|713298|P2|Overall Study|Protocol Violation|4
215199|NCT00200356|713299|P1|Overall Study|Protocol Violation|4
215200|NCT00200356|713298|P2|Overall Study|Lack of Efficacy|3
215201|NCT00200356|713299|P1|Overall Study|Lack of Efficacy|3
215202|NCT00200057|713366|P1|Overall Study|Death|1
215203|NCT00200057|713366|P1|Overall Study|Infection|1
215204|NCT00200057|713366|P1|Overall Study|Change in medical condition|1
215205|NCT00200057|713366|P1|Overall Study|Withdrawal by Subject|1
215206|NCT00200057|713366|P1|Overall Study|Exited due to terminal illness of PI|2
215207|NCT00200057|713366|P1|Overall Study|Lack of Efficacy|3
215208|NCT00199381|713385|P1|Overall Study|Study termination by Sponsor|323
215209|NCT00199381|713385|P1|Overall Study|Not including due to early termination|37
215210|NCT00199381|713385|P1|Overall Study|Lack of Efficacy|27
215211|NCT00199381|713385|P1|Overall Study|Protocol Violation|6
215212|NCT00199381|713385|P1|Overall Study|Adverse Event|73
215213|NCT00199381|713385|P1|Overall Study|Withdrawal by Subject|38
215214|NCT00198822|713392|P3|Overall Study|Lost to Follow-up|21
215215|NCT00198822|713393|P2|Overall Study|Lost to Follow-up|20
215216|NCT00198822|713394|P1|Overall Study|Lost to Follow-up|14
215217|NCT00198133|713413|P2|Overall Study|Physician Decision|0
215218|NCT00198133|713414|P1|Overall Study|Physician Decision|1
215219|NCT00198133|713413|P2|Overall Study|Withdrawal by Subject|0
215220|NCT00198133|713414|P1|Overall Study|Withdrawal by Subject|1
215221|NCT00198133|713413|P2|Overall Study|Adverse Event|3
215222|NCT00198133|713414|P1|Overall Study|Adverse Event|1
215223|NCT00198133|713413|P2|Overall Study|Disease progression|5
215224|NCT00198133|713414|P1|Overall Study|Disease progression|2
215225|NCT00198029|713457|P1|Overall Study|Withdrawal by Subject|4
215226|NCT00197496|713464|P2|Follow-up|Lost to Follow-up|1
215227|NCT00197496|713465|P1|Follow-up|Lost to Follow-up|2
215228|NCT00197496|713464|P2|Baseline to Discharge|Protocol Violation|1
215229|NCT00197496|713465|P1|Baseline to Discharge|Protocol Violation|0
215230|NCT00197496|713464|P2|Baseline to Discharge|Physician Decision|1
215231|NCT00197496|713465|P1|Baseline to Discharge|Physician Decision|0
215232|NCT00197496|713464|P2|Baseline to Discharge|MRSA|0
215233|NCT00197496|713465|P1|Baseline to Discharge|MRSA|1
215234|NCT00197496|713464|P2|Baseline to Discharge|not interested|0
215235|NCT00197496|713465|P1|Baseline to Discharge|not interested|1
215236|NCT00197236|713513|P3|Overall Study|Returned out of specified time window|1
215237|NCT00197236|713514|P2|Overall Study|Returned out of specified time window|0
215238|NCT00197236|713515|P1|Overall Study|Returned out of specified time window|0
215239|NCT00197236|713513|P3|Overall Study|Study drug/medication expiration|3
215240|NCT00197236|713514|P2|Overall Study|Study drug/medication expiration|0
215241|NCT00197236|713515|P1|Overall Study|Study drug/medication expiration|1
215242|NCT00197236|713513|P3|Overall Study|Withdrawal by Subject|11
215243|NCT00197236|713514|P2|Overall Study|Withdrawal by Subject|3
215244|NCT00197236|713515|P1|Overall Study|Withdrawal by Subject|7
215245|NCT00197236|713513|P3|Overall Study|Protocol Violation|1
215246|NCT00197236|713514|P2|Overall Study|Protocol Violation|0
215247|NCT00197236|713515|P1|Overall Study|Protocol Violation|0
215248|NCT00197236|713513|P3|Overall Study|Lost to Follow-up|6
215249|NCT00197236|713514|P2|Overall Study|Lost to Follow-up|14
215250|NCT00197236|713515|P1|Overall Study|Lost to Follow-up|5
215251|NCT00197236|713513|P3|Overall Study|Adverse Event|1
215252|NCT00197236|713514|P2|Overall Study|Adverse Event|0
215253|NCT00197236|713515|P1|Overall Study|Adverse Event|1
215254|NCT00197106|713602|P3|Overall Treatment Period|Withdrawal by Subject|2
215255|NCT00197106|713603|P2|Overall Treatment Period|Withdrawal by Subject|0
215256|NCT00197106|713604|P1|Overall Treatment Period|Withdrawal by Subject|0
215257|NCT00197106|713602|P3|Overall Treatment Period|Protocol Violation|2
215258|NCT00197106|713603|P2|Overall Treatment Period|Protocol Violation|0
215259|NCT00197106|713604|P1|Overall Treatment Period|Protocol Violation|0
215260|NCT00197106|713602|P3|Overall Treatment Period|Lost to Follow-up|2
215261|NCT00197106|713603|P2|Overall Treatment Period|Lost to Follow-up|0
215262|NCT00197106|713604|P1|Overall Treatment Period|Lost to Follow-up|0
215263|NCT00197106|713602|P3|Overall Treatment Period|Lack of Efficacy|0
215264|NCT00197106|713603|P2|Overall Treatment Period|Lack of Efficacy|1
215265|NCT00197106|713604|P1|Overall Treatment Period|Lack of Efficacy|0
215266|NCT00197106|713602|P3|4-Week Run-In Period|Did not meet entry criteria|0
215267|NCT00197106|713603|P2|4-Week Run-In Period|Did not meet entry criteria|0
215268|NCT00197106|713604|P1|4-Week Run-In Period|Did not meet entry criteria|99
215269|NCT00197028|713640|P2|Overall Study|Other|6
215270|NCT00197028|713641|P1|Overall Study|Other|3
215271|NCT00197028|713640|P2|Overall Study|Lost to Follow-up|0
215272|NCT00197028|713641|P1|Overall Study|Lost to Follow-up|1
215273|NCT00197028|713640|P2|Overall Study|Withdrawal by Subject|12
215274|NCT00197028|713641|P1|Overall Study|Withdrawal by Subject|8
215275|NCT00197028|713640|P2|Overall Study|Protocol Violation|1
215276|NCT00197028|713641|P1|Overall Study|Protocol Violation|2
215277|NCT00197028|713640|P2|Overall Study|Adverse Event|2
215278|NCT00197028|713641|P1|Overall Study|Adverse Event|2
215279|NCT00197015|713684|P3|Overall Study|Other|2
215280|NCT00197015|713685|P2|Overall Study|Other|3
215281|NCT00197015|713686|P1|Overall Study|Other|2
215282|NCT00197015|713684|P3|Overall Study|Lost to Follow-up|37
215283|NCT00197015|713685|P2|Overall Study|Lost to Follow-up|46
215284|NCT00197015|713686|P1|Overall Study|Lost to Follow-up|28
215285|NCT00197015|713684|P3|Overall Study|Withdrawal by Subject|34
215286|NCT00197015|713685|P2|Overall Study|Withdrawal by Subject|37
215287|NCT00197015|713686|P1|Overall Study|Withdrawal by Subject|17
215288|NCT00197015|713684|P3|Overall Study|Protocol Violation|3
215289|NCT00197015|713685|P2|Overall Study|Protocol Violation|3
215290|NCT00197015|713686|P1|Overall Study|Protocol Violation|0
215291|NCT00197015|713684|P3|Overall Study|Adverse Event|1
215292|NCT00197015|713685|P2|Overall Study|Adverse Event|0
215293|NCT00197015|713686|P1|Overall Study|Adverse Event|3
215294|NCT00197002|713745|P3|Overall Study|Others|1
215295|NCT00197002|713746|P2|Overall Study|Others|1
215296|NCT00197002|713747|P1|Overall Study|Others|3
215297|NCT00197002|713745|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
215298|NCT00197002|713746|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
215299|NCT00197002|713747|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
215300|NCT00197002|713745|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
215301|NCT00197002|713746|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
215302|NCT00197002|713747|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
215303|NCT00197002|713745|P3|Overall Study|Migrated/moved from study area|1
215304|NCT00197002|713746|P2|Overall Study|Migrated/moved from study area|5
215305|NCT00197002|713747|P1|Overall Study|Migrated/moved from study area|3
215306|NCT00197002|713745|P3|Overall Study|Withdrawal by Subject|7
215307|NCT00197002|713746|P2|Overall Study|Withdrawal by Subject|5
215308|NCT00197002|713747|P1|Overall Study|Withdrawal by Subject|9
215309|NCT00197002|713745|P3|Overall Study|Protocol Violation|2
215310|NCT00197002|713746|P2|Overall Study|Protocol Violation|0
215311|NCT00197002|713747|P1|Overall Study|Protocol Violation|1
215312|NCT00197002|713745|P3|Overall Study|Adverse Event|0
215313|NCT00197002|713746|P2|Overall Study|Adverse Event|1
215314|NCT00197002|713747|P1|Overall Study|Adverse Event|0
215315|NCT00196976|713798|P14|Booster Study|Lost to Follow-up|0
215316|NCT00196976|713799|P13|Booster Study|Lost to Follow-up|0
215317|NCT00196976|713800|P12|Booster Study|Lost to Follow-up|2
215318|NCT00196976|713801|P11|Booster Study|Lost to Follow-up|1
215319|NCT00196976|713802|P10|Booster Study|Lost to Follow-up|0
215320|NCT00196976|713803|P9|Booster Study|Lost to Follow-up|0
215321|NCT00196976|713804|P8|Booster Study|Lost to Follow-up|0
215322|NCT00196976|713805|P7|Booster Study|Lost to Follow-up|0
215323|NCT00196976|713806|P6|Booster Study|Lost to Follow-up|0
215324|NCT00196976|713807|P5|Booster Study|Lost to Follow-up|0
215325|NCT00196976|713808|P4|Booster Study|Lost to Follow-up|0
215326|NCT00196976|713809|P3|Booster Study|Lost to Follow-up|0
215327|NCT00196976|713810|P2|Booster Study|Lost to Follow-up|0
215328|NCT00196976|713811|P1|Booster Study|Lost to Follow-up|0
215329|NCT00196976|713798|P14|Booster Study|Withdrawal by Subject|0
215330|NCT00196976|713799|P13|Booster Study|Withdrawal by Subject|0
215331|NCT00196976|713800|P12|Booster Study|Withdrawal by Subject|0
215332|NCT00196976|713801|P11|Booster Study|Withdrawal by Subject|1
215333|NCT00196976|713802|P10|Booster Study|Withdrawal by Subject|0
215334|NCT00196976|713803|P9|Booster Study|Withdrawal by Subject|0
215335|NCT00196976|713804|P8|Booster Study|Withdrawal by Subject|0
215336|NCT00196976|713805|P7|Booster Study|Withdrawal by Subject|0
215337|NCT00196976|713806|P6|Booster Study|Withdrawal by Subject|0
215338|NCT00196976|713807|P5|Booster Study|Withdrawal by Subject|0
215339|NCT00196976|713808|P4|Booster Study|Withdrawal by Subject|0
215340|NCT00196976|713809|P3|Booster Study|Withdrawal by Subject|0
215341|NCT00196976|713810|P2|Booster Study|Withdrawal by Subject|0
215342|NCT00196976|713811|P1|Booster Study|Withdrawal by Subject|0
215343|NCT00196976|713798|P14|Primary Study|Other|0
215344|NCT00196976|713799|P13|Primary Study|Other|0
215345|NCT00196976|713800|P12|Primary Study|Other|0
215346|NCT00196976|713801|P11|Primary Study|Other|0
215347|NCT00196976|713802|P10|Primary Study|Other|0
215348|NCT00196976|713803|P9|Primary Study|Other|0
215349|NCT00196976|713804|P8|Primary Study|Other|0
215350|NCT00196976|713805|P7|Primary Study|Other|0
215351|NCT00196976|713806|P6|Primary Study|Other|0
215352|NCT00196976|713807|P5|Primary Study|Other|0
215353|NCT00196976|713808|P4|Primary Study|Other|0
215354|NCT00196976|713809|P3|Primary Study|Other|2
215355|NCT00196976|713810|P2|Primary Study|Other|0
215356|NCT00196976|713811|P1|Primary Study|Other|0
215357|NCT00196976|713798|P14|Primary Study|Lost to Follow-up|0
215358|NCT00196976|713799|P13|Primary Study|Lost to Follow-up|0
215359|NCT00196976|713800|P12|Primary Study|Lost to Follow-up|0
215360|NCT00196976|713801|P11|Primary Study|Lost to Follow-up|0
215361|NCT00196976|713802|P10|Primary Study|Lost to Follow-up|0
215362|NCT00196976|713803|P9|Primary Study|Lost to Follow-up|0
215363|NCT00196976|713804|P8|Primary Study|Lost to Follow-up|2
215364|NCT00196976|713805|P7|Primary Study|Lost to Follow-up|0
215365|NCT00196976|713806|P6|Primary Study|Lost to Follow-up|1
215366|NCT00196976|713807|P5|Primary Study|Lost to Follow-up|1
215367|NCT00196976|713808|P4|Primary Study|Lost to Follow-up|0
215368|NCT00196976|713809|P3|Primary Study|Lost to Follow-up|0
215369|NCT00196976|713810|P2|Primary Study|Lost to Follow-up|0
215370|NCT00196976|713811|P1|Primary Study|Lost to Follow-up|0
215371|NCT00196976|713798|P14|Primary Study|Withdrawal by Subject|0
215372|NCT00196976|713799|P13|Primary Study|Withdrawal by Subject|0
215373|NCT00196976|713800|P12|Primary Study|Withdrawal by Subject|0
215374|NCT00196976|713801|P11|Primary Study|Withdrawal by Subject|0
215375|NCT00196976|713802|P10|Primary Study|Withdrawal by Subject|1
215376|NCT00196976|713803|P9|Primary Study|Withdrawal by Subject|0
215377|NCT00196976|713804|P8|Primary Study|Withdrawal by Subject|0
215378|NCT00196976|713805|P7|Primary Study|Withdrawal by Subject|0
215379|NCT00196976|713806|P6|Primary Study|Withdrawal by Subject|1
215380|NCT00196976|713807|P5|Primary Study|Withdrawal by Subject|2
215381|NCT00196976|713808|P4|Primary Study|Withdrawal by Subject|1
215382|NCT00196976|713809|P3|Primary Study|Withdrawal by Subject|1
215383|NCT00196976|713810|P2|Primary Study|Withdrawal by Subject|0
215384|NCT00196976|713811|P1|Primary Study|Withdrawal by Subject|1
215385|NCT00196976|713798|P14|Primary Study|Protocol Violation|0
215386|NCT00196976|713799|P13|Primary Study|Protocol Violation|0
215387|NCT00196976|713800|P12|Primary Study|Protocol Violation|0
215388|NCT00196976|713801|P11|Primary Study|Protocol Violation|0
215389|NCT00196976|713802|P10|Primary Study|Protocol Violation|0
215390|NCT00196976|713803|P9|Primary Study|Protocol Violation|0
215391|NCT00196976|713804|P8|Primary Study|Protocol Violation|0
215392|NCT00196976|713805|P7|Primary Study|Protocol Violation|0
215393|NCT00196976|713806|P6|Primary Study|Protocol Violation|0
215394|NCT00196976|713807|P5|Primary Study|Protocol Violation|0
215395|NCT00196976|713808|P4|Primary Study|Protocol Violation|0
215396|NCT00196976|713809|P3|Primary Study|Protocol Violation|1
215397|NCT00196976|713810|P2|Primary Study|Protocol Violation|1
215398|NCT00196976|713811|P1|Primary Study|Protocol Violation|0
215399|NCT00196976|713798|P14|Primary Study|Migrated from study area|0
215400|NCT00196976|713799|P13|Primary Study|Migrated from study area|0
215401|NCT00196976|713800|P12|Primary Study|Migrated from study area|0
215402|NCT00196976|713801|P11|Primary Study|Migrated from study area|0
215403|NCT00196976|713802|P10|Primary Study|Migrated from study area|0
215404|NCT00196976|713803|P9|Primary Study|Migrated from study area|0
215405|NCT00196976|713804|P8|Primary Study|Migrated from study area|1
215406|NCT00196976|713805|P7|Primary Study|Migrated from study area|0
215407|NCT00196976|713806|P6|Primary Study|Migrated from study area|0
215408|NCT00196976|713807|P5|Primary Study|Migrated from study area|0
215409|NCT00196976|713808|P4|Primary Study|Migrated from study area|0
215410|NCT00196976|713809|P3|Primary Study|Migrated from study area|0
215411|NCT00196976|713810|P2|Primary Study|Migrated from study area|0
215412|NCT00196976|713811|P1|Primary Study|Migrated from study area|0
215413|NCT00196937|714007|P3|Overall Study|Withdrawal by Subject|3
215414|NCT00196937|714008|P2|Overall Study|Withdrawal by Subject|0
215415|NCT00196937|714009|P1|Overall Study|Withdrawal by Subject|0
215416|NCT00196937|714007|P3|Overall Study|Lost to Follow-up|3
215417|NCT00196937|714008|P2|Overall Study|Lost to Follow-up|3
215418|NCT00196937|714009|P1|Overall Study|Lost to Follow-up|4
215419|NCT00196937|714007|P3|Overall Study|Subject did not come due to holidays|0
215420|NCT00196937|714008|P2|Overall Study|Subject did not come due to holidays|1
215421|NCT00196937|714009|P1|Overall Study|Subject did not come due to holidays|3
215422|NCT00196937|714007|P3|Overall Study|Adverse Event|1
215423|NCT00196937|714008|P2|Overall Study|Adverse Event|1
215424|NCT00196937|714009|P1|Overall Study|Adverse Event|2
215425|NCT00196326|714057|P1|Overall Study|Not specified|22
215426|NCT00196326|714057|P1|Overall Study|Lost to Follow-up|304
215427|NCT00196326|714057|P1|Overall Study|Pregnancy|34
215428|NCT00196326|714057|P1|Overall Study|Adverse Event|253
215429|NCT00196326|714057|P1|Overall Study|Withdrawal by Subject|225
215430|NCT00196326|714057|P1|Overall Study|Physician Decision|3
215431|NCT00196326|714057|P1|Overall Study|Non-compliance with the protocol|81
215432|NCT00196326|714057|P1|Overall Study|Did not meet protocol requirements|64
215433|NCT00196313|714065|P2|Overall Study|Lost to Follow-up|2
215434|NCT00196313|714066|P1|Overall Study|Lost to Follow-up|2
215435|NCT00196313|714065|P2|Overall Study|Subject Pregnant|1
215436|NCT00196313|714066|P1|Overall Study|Subject Pregnant|1
215437|NCT00196313|714065|P2|Overall Study|Adverse Event|1
215438|NCT00196313|714066|P1|Overall Study|Adverse Event|3
215439|NCT00196313|714065|P2|Overall Study|Withdrawal by Subject|1
215440|NCT00196313|714066|P1|Overall Study|Withdrawal by Subject|3
215441|NCT00196313|714065|P2|Overall Study|Protocol Violation|3
215442|NCT00196313|714066|P1|Overall Study|Protocol Violation|2
215443|NCT00196196|714080|P1|Overall Study|Did not have required condition (hydroce|5
215444|NCT00196196|714080|P1|Overall Study|Withdrawal by Subject|2
215445|NCT00196105|714088|P3|Overall Study|Lost to Follow-up|7
215446|NCT00196105|714089|P2|Overall Study|Lost to Follow-up|5
215447|NCT00196105|714090|P1|Overall Study|Lost to Follow-up|4
215448|NCT00195819|714110|P2|Open-label|Withdrawal by Subject|5
215449|NCT00195819|714111|P1|Open-label|Withdrawal by Subject|0
215450|NCT00195819|714110|P2|Open-label|Moved|1
215451|NCT00195819|714111|P1|Open-label|Moved|0
215452|NCT00195819|714110|P2|Open-label|Protocol Violation|2
215453|NCT00195819|714111|P1|Open-label|Protocol Violation|0
215454|NCT00195819|714110|P2|Open-label|Pregnancy|1
215455|NCT00195819|714111|P1|Open-label|Pregnancy|0
215456|NCT00195819|714110|P2|Open-label|Lack of Efficacy|2
215457|NCT00195819|714111|P1|Open-label|Lack of Efficacy|0
215458|NCT00195819|714110|P2|Open-label|Adverse Event|9
215459|NCT00195819|714111|P1|Open-label|Adverse Event|0
215460|NCT00195819|714110|P2|Double-Blind|Moved|0
215461|NCT00195819|714111|P1|Double-Blind|Moved|1
215462|NCT00195819|714110|P2|Double-Blind|Withdrawal by Subject|0
215463|NCT00195819|714111|P1|Double-Blind|Withdrawal by Subject|1
215464|NCT00195715|714161|P1|Overall Study|Sponsor discretion - trial ended early|1
215465|NCT00195715|714161|P1|Overall Study|Sponsor discontinued trial|1
215466|NCT00195715|714161|P1|Overall Study|Colonic stricture|1
215467|NCT00195715|714161|P1|Overall Study|Ineligible|1
215468|NCT00195715|714161|P1|Overall Study|Increased infection rate|1
215469|NCT00195715|714161|P1|Overall Study|Planned surgery|2
215470|NCT00195715|714161|P1|Overall Study|Use of prohibited medication|2
215471|NCT00195715|714161|P1|Overall Study|Subject wants to get pregnant|4
215472|NCT00195715|714161|P1|Overall Study|Investigator's decision|2
215473|NCT00195715|714161|P1|Overall Study|Administrative reasons|2
215474|NCT00195715|714161|P1|Overall Study|Sponsor stopped study|1
215475|NCT00195715|714161|P1|Overall Study|Loss of response/no improvement|3
215476|NCT00195715|714161|P1|Overall Study|Subject choice|3
215477|NCT00195715|714161|P1|Overall Study|Subject started commercial Humira|5
215478|NCT00195715|714161|P1|Overall Study|Subject non-compliance|6
215479|NCT00195715|714161|P1|Overall Study|Subject moved/relocated|7
215480|NCT00195715|714161|P1|Overall Study|Investigative site closure|8
215481|NCT00195715|714161|P1|Overall Study|Pregnancy|14
215482|NCT00195715|714161|P1|Overall Study|Lack of Efficacy|93
215483|NCT00195715|714161|P1|Overall Study|Protocol Violation|13
215484|NCT00195715|714161|P1|Overall Study|Lost to Follow-up|27
215485|NCT00195715|714161|P1|Overall Study|Withdrawal by Subject|58
215486|NCT00195715|714161|P1|Overall Study|Adverse Event|122
215487|NCT00195676|714261|P1|Period R - Retreatment 16 Weeks|Other reasons|6
215488|NCT00195676|714261|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
215489|NCT00195676|714261|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
215490|NCT00195676|714261|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
215491|NCT00195676|714261|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
215492|NCT00195676|714261|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
215493|NCT00195676|714261|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
215494|NCT00195676|714261|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
215495|NCT00195676|714261|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
215496|NCT00195676|714261|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
215497|NCT00195676|714261|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
215498|NCT00195676|714261|P1|Period W (Withdrawal) - No Treatment|Death|2
215499|NCT00195676|714261|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
215500|NCT00195676|714261|P1|Period O - Open-label Treatment|Other reasons|68
215501|NCT00195676|714261|P1|Period O - Open-label Treatment|Administrative reasons|2
215502|NCT00195676|714261|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
215503|NCT00195676|714261|P1|Period O - Open-label Treatment|Protocol Violation|12
215504|NCT00195676|714261|P1|Period O - Open-label Treatment|Lost to Follow-up|91
215505|NCT00195676|714261|P1|Period O - Open-label Treatment|Lack of Efficacy|198
215506|NCT00195676|714261|P1|Period O - Open-label Treatment|Death|6
215507|NCT00195676|714261|P1|Period O - Open-label Treatment|Adverse Event|82
215508|NCT00195663|714275|P3|Open-Label Extension Period|Administrative reasons|13
215509|NCT00195663|714276|P2|Open-Label Extension Period|Administrative reasons|11
215510|NCT00195663|714277|P1|Open-Label Extension Period|Administrative reasons|11
215511|NCT00195663|714275|P3|Open-Label Extension Period|Lack of Efficacy|12
215512|NCT00195663|714276|P2|Open-Label Extension Period|Lack of Efficacy|6
215513|NCT00195663|714277|P1|Open-Label Extension Period|Lack of Efficacy|14
215514|NCT00195663|714275|P3|Open-Label Extension Period|Withdrawal by Subject|22
215515|NCT00195663|714276|P2|Open-Label Extension Period|Withdrawal by Subject|15
215516|NCT00195663|714277|P1|Open-Label Extension Period|Withdrawal by Subject|16
215517|NCT00195663|714275|P3|Open-Label Extension Period|Death|2
215518|NCT00195663|714276|P2|Open-Label Extension Period|Death|2
215519|NCT00195663|714277|P1|Open-Label Extension Period|Death|2
215520|NCT00195663|714275|P3|Open-Label Extension Period|Protocol Violation|4
215521|NCT00195663|714276|P2|Open-Label Extension Period|Protocol Violation|4
215522|NCT00195663|714277|P1|Open-Label Extension Period|Protocol Violation|3
215523|NCT00195663|714275|P3|Open-Label Extension Period|Recovery|2
215524|NCT00195663|714276|P2|Open-Label Extension Period|Recovery|2
215525|NCT00195663|714277|P1|Open-Label Extension Period|Recovery|0
215526|NCT00195663|714275|P3|Open-Label Extension Period|Lost to Follow-up|6
215527|NCT00195663|714276|P2|Open-Label Extension Period|Lost to Follow-up|2
215528|NCT00195663|714277|P1|Open-Label Extension Period|Lost to Follow-up|9
215529|NCT00195663|714275|P3|Open-Label Extension Period|Adverse Event|36
215530|NCT00195663|714276|P2|Open-Label Extension Period|Adverse Event|32
215531|NCT00195663|714277|P1|Open-Label Extension Period|Adverse Event|21
215532|NCT00195663|714275|P3|2-year Double-blind Treatment Period|Administrative reasons|9
215533|NCT00195663|714276|P2|2-year Double-blind Treatment Period|Administrative reasons|2
215534|NCT00195663|714277|P1|2-year Double-blind Treatment Period|Administrative reasons|3
215535|NCT00195663|714275|P3|2-year Double-blind Treatment Period|Recovery|1
215536|NCT00195663|714276|P2|2-year Double-blind Treatment Period|Recovery|0
215537|NCT00195663|714277|P1|2-year Double-blind Treatment Period|Recovery|1
215538|NCT00195663|714275|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
215539|NCT00195663|714276|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
215540|NCT00195663|714277|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
215541|NCT00195663|714275|P3|2-year Double-blind Treatment Period|Protocol Violation|4
215542|NCT00195663|714276|P2|2-year Double-blind Treatment Period|Protocol Violation|6
215543|NCT00195663|714277|P1|2-year Double-blind Treatment Period|Protocol Violation|6
215544|NCT00195663|714275|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
215545|NCT00195663|714276|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
215546|NCT00195663|714277|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
215547|NCT00195663|714275|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
215548|NCT00195663|714276|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
215549|NCT00195663|714277|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
215550|NCT00195663|714275|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
215551|NCT00195663|714276|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
215552|NCT00195663|714277|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
215553|NCT00195663|714275|P3|2-year Double-blind Treatment Period|Death|0
215554|NCT00195663|714276|P2|2-year Double-blind Treatment Period|Death|2
215555|NCT00195663|714277|P1|2-year Double-blind Treatment Period|Death|0
215556|NCT00195663|714275|P3|2-year Double-blind Treatment Period|Adverse Event|32
215557|NCT00195663|714276|P2|2-year Double-blind Treatment Period|Adverse Event|27
215558|NCT00195663|714277|P1|2-year Double-blind Treatment Period|Adverse Event|21
215559|NCT00195650|714371|P1|Overall Study|Administrative reasons|83
215560|NCT00195650|714371|P1|Overall Study|Protocol Violation|15
215561|NCT00195650|714371|P1|Overall Study|Death|23
215562|NCT00195650|714371|P1|Overall Study|Lost to Follow-up|44
215563|NCT00195650|714371|P1|Overall Study|Withdrawal by Subject|67
215564|NCT00195650|714371|P1|Overall Study|Lack of Efficacy|99
215565|NCT00195650|714371|P1|Overall Study|Adverse Event|194
215566|NCT00195507|714387|P2|Overall Study|Protocol Deviation|3
215567|NCT00195507|714388|P1|Overall Study|Protocol Deviation|6
215568|NCT00195507|714387|P2|Overall Study|Withdrawal by Subject|23
215569|NCT00195507|714388|P1|Overall Study|Withdrawal by Subject|16
215570|NCT00195507|714387|P2|Overall Study|Lack of Efficacy|67
215571|NCT00195507|714388|P1|Overall Study|Lack of Efficacy|40
215572|NCT00195507|714387|P2|Overall Study|Protocol Violation|4
215573|NCT00195507|714388|P1|Overall Study|Protocol Violation|5
215574|NCT00195507|714387|P2|Overall Study|Lost to Follow-up|2
215575|NCT00195507|714388|P1|Overall Study|Lost to Follow-up|3
215576|NCT00195507|714387|P2|Overall Study|Physician Decision|2
215577|NCT00195507|714388|P1|Overall Study|Physician Decision|1
215578|NCT00195507|714387|P2|Overall Study|Failed to Return|3
215579|NCT00195507|714388|P1|Overall Study|Failed to Return|4
215580|NCT00195507|714387|P2|Overall Study|Death|1
215581|NCT00195507|714388|P1|Overall Study|Death|0
215582|NCT00195507|714387|P2|Overall Study|Adverse Event|13
215583|NCT00195507|714388|P1|Overall Study|Adverse Event|24
215584|NCT00195494|714402|P6|Year 2|System toxicity|0
215585|NCT00195494|714403|P5|Year 2|System toxicity|0
215586|NCT00195494|714404|P4|Year 2|System toxicity|1
215587|NCT00195494|714405|P3|Year 2|System toxicity|0
215588|NCT00195494|714406|P2|Year 2|System toxicity|0
215589|NCT00195494|714407|P1|Year 2|System toxicity|0
215590|NCT00195494|714402|P6|Year 2|Withdrawal by Subject|0
215591|NCT00195494|714403|P5|Year 2|Withdrawal by Subject|0
215592|NCT00195494|714404|P4|Year 2|Withdrawal by Subject|3
215593|NCT00195494|714405|P3|Year 2|Withdrawal by Subject|4
215594|NCT00195494|714406|P2|Year 2|Withdrawal by Subject|5
215595|NCT00195494|714407|P1|Year 2|Withdrawal by Subject|1
215596|NCT00195494|714402|P6|Year 2|Physician Decision|0
215597|NCT00195494|714403|P5|Year 2|Physician Decision|0
215598|NCT00195494|714404|P4|Year 2|Physician Decision|0
215599|NCT00195494|714405|P3|Year 2|Physician Decision|0
215600|NCT00195494|714406|P2|Year 2|Physician Decision|1
215601|NCT00195494|714407|P1|Year 2|Physician Decision|1
215602|NCT00195494|714402|P6|Year 2|Protocol deviation|0
215603|NCT00195494|714403|P5|Year 2|Protocol deviation|0
215604|NCT00195494|714404|P4|Year 2|Protocol deviation|0
215605|NCT00195494|714405|P3|Year 2|Protocol deviation|0
215606|NCT00195494|714406|P2|Year 2|Protocol deviation|1
215607|NCT00195494|714407|P1|Year 2|Protocol deviation|0
215608|NCT00195494|714402|P6|Year 2|Missed >4 consecutive doses|0
215609|NCT00195494|714403|P5|Year 2|Missed >4 consecutive doses|0
215610|NCT00195494|714404|P4|Year 2|Missed >4 consecutive doses|0
215611|NCT00195494|714405|P3|Year 2|Missed >4 consecutive doses|1
215612|NCT00195494|714406|P2|Year 2|Missed >4 consecutive doses|1
215613|NCT00195494|714407|P1|Year 2|Missed >4 consecutive doses|1
215614|NCT00195494|714402|P6|Year 2|Lost to Follow-up|0
215615|NCT00195494|714403|P5|Year 2|Lost to Follow-up|0
215616|NCT00195494|714404|P4|Year 2|Lost to Follow-up|1
215617|NCT00195494|714405|P3|Year 2|Lost to Follow-up|1
215618|NCT00195494|714406|P2|Year 2|Lost to Follow-up|0
215619|NCT00195494|714407|P1|Year 2|Lost to Follow-up|0
215620|NCT00195494|714402|P6|Year 2|Compliance|0
215621|NCT00195494|714403|P5|Year 2|Compliance|0
215622|NCT00195494|714404|P4|Year 2|Compliance|2
215623|NCT00195494|714405|P3|Year 2|Compliance|0
215624|NCT00195494|714406|P2|Year 2|Compliance|0
215625|NCT00195494|714407|P1|Year 2|Compliance|1
215626|NCT00195494|714402|P6|Year 2|Lack of Efficacy|0
215627|NCT00195494|714403|P5|Year 2|Lack of Efficacy|0
215628|NCT00195494|714404|P4|Year 2|Lack of Efficacy|7
215629|NCT00195494|714405|P3|Year 2|Lack of Efficacy|7
215630|NCT00195494|714406|P2|Year 2|Lack of Efficacy|1
215631|NCT00195494|714407|P1|Year 2|Lack of Efficacy|0
215632|NCT00195494|714402|P6|Year 2|Adverse Event|0
215633|NCT00195494|714403|P5|Year 2|Adverse Event|0
215634|NCT00195494|714404|P4|Year 2|Adverse Event|9
215635|NCT00195494|714405|P3|Year 2|Adverse Event|5
215636|NCT00195494|714406|P2|Year 2|Adverse Event|7
215637|NCT00195494|714407|P1|Year 2|Adverse Event|3
215638|NCT00195494|714402|P6|Year 1|Protocol Violation|1
215639|NCT00195494|714403|P5|Year 1|Protocol Violation|1
215640|NCT00195494|714404|P4|Year 1|Protocol Violation|0
215641|NCT00195494|714405|P3|Year 1|Protocol Violation|0
215642|NCT00195494|714406|P2|Year 1|Protocol Violation|0
215643|NCT00195494|714407|P1|Year 1|Protocol Violation|0
215644|NCT00195494|714402|P6|Year 1|Withdrawal by Subject|9
215645|NCT00195494|714403|P5|Year 1|Withdrawal by Subject|8
215646|NCT00195494|714404|P4|Year 1|Withdrawal by Subject|0
215647|NCT00195494|714405|P3|Year 1|Withdrawal by Subject|0
215648|NCT00195494|714406|P2|Year 1|Withdrawal by Subject|0
215649|NCT00195494|714407|P1|Year 1|Withdrawal by Subject|0
215650|NCT00195494|714402|P6|Year 1|Physician Decision|0
215651|NCT00195494|714403|P5|Year 1|Physician Decision|1
215652|NCT00195494|714404|P4|Year 1|Physician Decision|0
215653|NCT00195494|714405|P3|Year 1|Physician Decision|0
215654|NCT00195494|714406|P2|Year 1|Physician Decision|0
215655|NCT00195494|714407|P1|Year 1|Physician Decision|0
215656|NCT00195494|714402|P6|Year 1|Protocol deviation|3
215657|NCT00195494|714403|P5|Year 1|Protocol deviation|2
215658|NCT00195494|714404|P4|Year 1|Protocol deviation|0
215659|NCT00195494|714405|P3|Year 1|Protocol deviation|0
215660|NCT00195494|714406|P2|Year 1|Protocol deviation|0
215661|NCT00195494|714407|P1|Year 1|Protocol deviation|0
215662|NCT00195494|714402|P6|Year 1|Missed >4 consecutive doses|2
215663|NCT00195494|714403|P5|Year 1|Missed >4 consecutive doses|3
215664|NCT00195494|714404|P4|Year 1|Missed >4 consecutive doses|0
215665|NCT00195494|714405|P3|Year 1|Missed >4 consecutive doses|0
215666|NCT00195494|714406|P2|Year 1|Missed >4 consecutive doses|0
215667|NCT00195494|714407|P1|Year 1|Missed >4 consecutive doses|0
215668|NCT00195494|714402|P6|Year 1|Lost to Follow-up|0
215669|NCT00195494|714403|P5|Year 1|Lost to Follow-up|1
215670|NCT00195494|714404|P4|Year 1|Lost to Follow-up|0
215671|NCT00195494|714405|P3|Year 1|Lost to Follow-up|0
215672|NCT00195494|714406|P2|Year 1|Lost to Follow-up|0
215673|NCT00195494|714407|P1|Year 1|Lost to Follow-up|0
215674|NCT00195494|714402|P6|Year 1|Compliance|1
215675|NCT00195494|714403|P5|Year 1|Compliance|5
215676|NCT00195494|714404|P4|Year 1|Compliance|0
215677|NCT00195494|714405|P3|Year 1|Compliance|0
215678|NCT00195494|714406|P2|Year 1|Compliance|0
215679|NCT00195494|714407|P1|Year 1|Compliance|0
215680|NCT00195494|714402|P6|Year 1|Lack of Efficacy|9
215681|NCT00195494|714403|P5|Year 1|Lack of Efficacy|24
215682|NCT00195494|714404|P4|Year 1|Lack of Efficacy|0
215683|NCT00195494|714405|P3|Year 1|Lack of Efficacy|0
215684|NCT00195494|714406|P2|Year 1|Lack of Efficacy|0
215685|NCT00195494|714407|P1|Year 1|Lack of Efficacy|0
215686|NCT00195494|714402|P6|Year 1|System Toxicity|1
215687|NCT00195494|714403|P5|Year 1|System Toxicity|0
215688|NCT00195494|714404|P4|Year 1|System Toxicity|0
215689|NCT00195494|714405|P3|Year 1|System Toxicity|0
215690|NCT00195494|714406|P2|Year 1|System Toxicity|0
215691|NCT00195494|714407|P1|Year 1|System Toxicity|0
215692|NCT00195494|714402|P6|Year 1|Adverse Event|27
215693|NCT00195494|714403|P5|Year 1|Adverse Event|34
215694|NCT00195494|714404|P4|Year 1|Adverse Event|0
215695|NCT00195494|714405|P3|Year 1|Adverse Event|0
215696|NCT00195494|714406|P2|Year 1|Adverse Event|0
215697|NCT00195494|714407|P1|Year 1|Adverse Event|0
215698|NCT00195442|714425|P1|Overall Study|Other|14
215699|NCT00195442|714425|P1|Overall Study|Poor cooperation|2
215700|NCT00195442|714425|P1|Overall Study|No reason specified|4
215701|NCT00195442|714425|P1|Overall Study|Death|7
215702|NCT00195442|714425|P1|Overall Study|Intermittent product shortage|21
215703|NCT00195442|714425|P1|Overall Study|Switch to other Factor VIII preparation|23
215704|NCT00195442|714425|P1|Overall Study|Lost to Follow-up|27
215705|NCT00195442|714425|P1|Overall Study|Less than expected therapeutic effect|38
215706|NCT00195429|714444|P2|Overall Study|Lost to Follow-up|0
215707|NCT00195429|714445|P1|Overall Study|Lost to Follow-up|1
215708|NCT00195429|714444|P2|Overall Study|Lack of Efficacy|1
215709|NCT00195429|714445|P1|Overall Study|Lack of Efficacy|2
215710|NCT00195429|714444|P2|Overall Study|Adverse Event|4
215711|NCT00195429|714445|P1|Overall Study|Adverse Event|2
215712|NCT00195351|714461|P2|Overall Study|Lack of Efficacy|1
215713|NCT00195351|714462|P1|Overall Study|Lack of Efficacy|0
215714|NCT00195351|714461|P2|Overall Study|Death|1
215715|NCT00195351|714462|P1|Overall Study|Death|3
215716|NCT00195351|714461|P2|Overall Study|Protocol Deviation|2
215717|NCT00195351|714462|P1|Overall Study|Protocol Deviation|3
215718|NCT00195351|714461|P2|Overall Study|Withdrawal by Subject|3
215719|NCT00195351|714462|P1|Overall Study|Withdrawal by Subject|6
215720|NCT00195351|714461|P2|Overall Study|Lost to Follow-up|9
215721|NCT00195351|714462|P1|Overall Study|Lost to Follow-up|9
215722|NCT00195338|714472|P1|Overall Study|Early closure of the site|4
215723|NCT00195338|714472|P1|Overall Study|Lack of Efficacy|1
215724|NCT00195338|714472|P1|Overall Study|Adverse Event|5
215725|NCT00195338|714472|P1|Overall Study|Lost to Follow-up|2
215726|NCT00195273|714482|P2|Overall Study|Procedural complications|3
215727|NCT00195273|714483|P1|Overall Study|Procedural complications|9
215728|NCT00195273|714482|P2|Overall Study|Lack of Efficacy|1
215729|NCT00195273|714483|P1|Overall Study|Lack of Efficacy|3
215730|NCT00195273|714482|P2|Overall Study|Protocol deviation|1
215731|NCT00195273|714483|P1|Overall Study|Protocol deviation|0
215732|NCT00195273|714482|P2|Overall Study|Adverse Event|9
215733|NCT00195273|714483|P1|Overall Study|Adverse Event|9
215734|NCT00195260|714497|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
215735|NCT00195260|714498|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
215736|NCT00195260|714499|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
215737|NCT00195260|714500|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
215738|NCT00195260|714501|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
215739|NCT00195260|714502|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
215740|NCT00195260|714503|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
215741|NCT00195260|714504|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
215742|NCT00195260|714505|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
215743|NCT00195260|714506|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
215744|NCT00195260|714507|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
215745|NCT00195260|714497|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
215746|NCT00195260|714498|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
215747|NCT00195260|714499|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
215748|NCT00195260|714500|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
215749|NCT00195260|714501|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
215750|NCT00195260|714502|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
215751|NCT00195260|714503|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
215752|NCT00195260|714504|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
215753|NCT00195260|714505|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
215754|NCT00195260|714506|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
215755|NCT00195260|714507|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
215756|NCT00195260|714497|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
215757|NCT00195260|714498|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
215758|NCT00195260|714499|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
215759|NCT00195260|714500|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
215760|NCT00195260|714501|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
215761|NCT00195260|714502|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
215762|NCT00195260|714503|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
215763|NCT00195260|714504|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
215764|NCT00195260|714505|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
215765|NCT00195260|714506|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
215766|NCT00195260|714507|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
215767|NCT00195260|714497|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
215768|NCT00195260|714498|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
215769|NCT00195260|714499|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
215770|NCT00195260|714500|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
215771|NCT00195260|714501|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
215772|NCT00195260|714502|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
215773|NCT00195260|714503|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
215774|NCT00195260|714504|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
215775|NCT00195260|714505|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
215776|NCT00195260|714506|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
215777|NCT00195260|714507|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
215778|NCT00195260|714497|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
215779|NCT00195260|714498|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
215780|NCT00195260|714499|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
215781|NCT00195260|714500|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
215782|NCT00195260|714501|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
215783|NCT00195260|714502|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
215784|NCT00195260|714503|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
215785|NCT00195260|714504|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
215786|NCT00195260|714505|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
215787|NCT00195260|714506|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
215788|NCT00195260|714507|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
215789|NCT00195260|714497|P11|Part 1: Dose Escalation|Disease Progression|0
215790|NCT00195260|714498|P10|Part 1: Dose Escalation|Disease Progression|0
215791|NCT00195260|714499|P9|Part 1: Dose Escalation|Disease Progression|0
215792|NCT00195260|714500|P8|Part 1: Dose Escalation|Disease Progression|4
215793|NCT00195260|714501|P7|Part 1: Dose Escalation|Disease Progression|7
215794|NCT00195260|714502|P6|Part 1: Dose Escalation|Disease Progression|6
215795|NCT00195260|714503|P5|Part 1: Dose Escalation|Disease Progression|4
215796|NCT00195260|714504|P4|Part 1: Dose Escalation|Disease Progression|6
215797|NCT00195260|714505|P3|Part 1: Dose Escalation|Disease Progression|5
215798|NCT00195260|714506|P2|Part 1: Dose Escalation|Disease Progression|2
215799|NCT00195260|714507|P1|Part 1: Dose Escalation|Disease Progression|3
215800|NCT00195260|714497|P11|Part 1: Dose Escalation|Death|0
215801|NCT00195260|714498|P10|Part 1: Dose Escalation|Death|0
215802|NCT00195260|714499|P9|Part 1: Dose Escalation|Death|0
215803|NCT00195260|714500|P8|Part 1: Dose Escalation|Death|1
215804|NCT00195260|714501|P7|Part 1: Dose Escalation|Death|0
215805|NCT00195260|714502|P6|Part 1: Dose Escalation|Death|0
215806|NCT00195260|714503|P5|Part 1: Dose Escalation|Death|0
215807|NCT00195260|714504|P4|Part 1: Dose Escalation|Death|0
215808|NCT00195260|714505|P3|Part 1: Dose Escalation|Death|0
215809|NCT00195260|714506|P2|Part 1: Dose Escalation|Death|0
215810|NCT00195260|714507|P1|Part 1: Dose Escalation|Death|0
215811|NCT00195260|714497|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
215812|NCT00195260|714498|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
215813|NCT00195260|714499|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
215814|NCT00195260|714500|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
215815|NCT00195260|714501|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
215816|NCT00195260|714502|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
215817|NCT00195260|714503|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
215818|NCT00195260|714504|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
215819|NCT00195260|714505|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
215820|NCT00195260|714506|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
215821|NCT00195260|714507|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
215822|NCT00195260|714497|P11|Part 1: Dose Escalation|Adverse Event|0
215823|NCT00195260|714498|P10|Part 1: Dose Escalation|Adverse Event|0
215824|NCT00195260|714499|P9|Part 1: Dose Escalation|Adverse Event|0
215825|NCT00195260|714500|P8|Part 1: Dose Escalation|Adverse Event|0
215826|NCT00195260|714501|P7|Part 1: Dose Escalation|Adverse Event|3
215827|NCT00195260|714502|P6|Part 1: Dose Escalation|Adverse Event|0
215828|NCT00195260|714503|P5|Part 1: Dose Escalation|Adverse Event|1
215829|NCT00195260|714504|P4|Part 1: Dose Escalation|Adverse Event|1
215830|NCT00195260|714505|P3|Part 1: Dose Escalation|Adverse Event|0
215831|NCT00195260|714506|P2|Part 1: Dose Escalation|Adverse Event|1
215832|NCT00195260|714507|P1|Part 1: Dose Escalation|Adverse Event|0
215833|NCT00194792|714694|P1|Overall Study|Withdrawal by Subject|1
215834|NCT00194675|714718|P2|Overall Study|Death|0
215835|NCT00194675|714719|P1|Overall Study|Death|1
215836|NCT00194675|714718|P2|Overall Study|Protocol Violation|0
215837|NCT00194675|714719|P1|Overall Study|Protocol Violation|1
215838|NCT00194675|714718|P2|Overall Study|"withdrew due to edgy feeling"|0
215839|NCT00194675|714719|P1|Overall Study|"withdrew due to edgy feeling"|1
215840|NCT00194675|714718|P2|Overall Study|lack of interest|1
215841|NCT00194675|714719|P1|Overall Study|lack of interest|1
215842|NCT00194675|714718|P2|Overall Study|Lost to Follow-up|1
215843|NCT00194675|714719|P1|Overall Study|Lost to Follow-up|1
215844|NCT00194077|714773|P2|Overall Study|Withdrawal by Subject|1
215845|NCT00194077|714774|P1|Overall Study|Withdrawal by Subject|1
215846|NCT00194077|714773|P2|Overall Study|Study nonadherence|0
215847|NCT00194077|714774|P1|Overall Study|Study nonadherence|1
215848|NCT00194077|714773|P2|Overall Study|Lack of Efficacy|29
215849|NCT00194077|714774|P1|Overall Study|Lack of Efficacy|22
215850|NCT00194025|714780|P1|Overall Study|non-adherence with study medication|4
215851|NCT00194025|714780|P1|Overall Study|Adverse Event|1
215852|NCT00194012|714795|P2|Open Label Extension (OLE)|Lack of Efficacy|0
215853|NCT00194012|714796|P1|Open Label Extension (OLE)|Lack of Efficacy|1
215854|NCT00194012|714795|P2|Open Label Extension (OLE)|Lost to Follow-up|5
215855|NCT00194012|714796|P1|Open Label Extension (OLE)|Lost to Follow-up|3
215856|NCT00194012|714795|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
215857|NCT00194012|714796|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
215858|NCT00194012|714795|P2|Open Label Extension (OLE)|Weight Gain|0
215859|NCT00194012|714796|P1|Open Label Extension (OLE)|Weight Gain|1
215860|NCT00194012|714795|P2|Randomized Phase|Oral/nasal twitching|1
215861|NCT00194012|714796|P1|Randomized Phase|Oral/nasal twitching|0
215862|NCT00194012|714795|P2|Randomized Phase|Emesis and enuresis|1
215863|NCT00194012|714796|P1|Randomized Phase|Emesis and enuresis|0
215864|NCT00194012|714795|P2|Randomized Phase|Participant reported having a rash|0
215865|NCT00194012|714796|P1|Randomized Phase|Participant reported having a rash|1
215866|NCT00194012|714795|P2|Randomized Phase|Adverse Event|1
215867|NCT00194012|714796|P1|Randomized Phase|Adverse Event|2
215868|NCT00194012|714795|P2|Randomized Phase|Withdrawal by Subject|3
215869|NCT00194012|714796|P1|Randomized Phase|Withdrawal by Subject|3
215870|NCT00194012|714795|P2|Randomized Phase|Study nonadherence|1
215871|NCT00194012|714796|P1|Randomized Phase|Study nonadherence|2
215872|NCT00194012|714795|P2|Randomized Phase|Lack of Efficacy|18
215873|NCT00194012|714796|P1|Randomized Phase|Lack of Efficacy|8
215874|NCT00193609|714832|P1|Overall Study|Adverse Event|2
215875|NCT00193609|714832|P1|Overall Study|Lack of Efficacy|2
215876|NCT00193479|714859|P1|Induction Chemotherapy|Disease Progression|1
215877|NCT00193479|714859|P1|Induction Chemotherapy|Adverse Event|2
215878|NCT00193206|714900|P1|Postoperative Therapy|Protocol Violation|1
215879|NCT00193206|714900|P1|Postoperative Therapy|Lack of Efficacy|1
215880|NCT00193206|714900|P1|Postoperative Therapy|Intercurrent Illness|2
215881|NCT00193206|714900|P1|Postoperative Therapy|Physician Decision|3
215882|NCT00193206|714900|P1|Postoperative Therapy|Withdrawal by Subject|7
215883|NCT00193206|714900|P1|Preoperative Therapy|False Positive Pregnancy Test|1
215884|NCT00193206|714900|P1|Preoperative Therapy|Withdrawal by Subject|2
215885|NCT00193206|714900|P1|Preoperative Therapy|Adverse Event|2
215886|NCT00193206|714900|P1|Preoperative Therapy|Lack of Efficacy|2
215887|NCT00193180|714904|P1|Overall Study|Protocol Violation|1
215888|NCT00193180|714904|P1|Overall Study|Adverse Event|8
215889|NCT00193180|714904|P1|Overall Study|Lack of Efficacy|1
215890|NCT00193063|714919|P1|Overall Study|Adverse Event|1
215891|NCT00193063|714919|P1|Overall Study|Lack of Efficacy|3
215892|NCT00193050|714925|P1|Adjuvant|Lack of Efficacy|2
215893|NCT00193050|714925|P1|Adjuvant|Intercurrent Hospitalization|3
215894|NCT00193050|714925|P1|Adjuvant|Physician Decision|5
215895|NCT00193050|714925|P1|Neoadjuvant Treatment|Adverse Event|2
215896|NCT00193050|714925|P1|Neoadjuvant Treatment|Physician Decision|2
215897|NCT00193050|714925|P1|Neoadjuvant Treatment|Intercurrent Illness|3
215898|NCT00193050|714925|P1|Neoadjuvant Treatment|Lack of Efficacy|2
215899|NCT00192647|714942|P2|Overall Study|Other/Administrative|3
215900|NCT00192647|714943|P1|Overall Study|Other/Administrative|5
215901|NCT00192647|714942|P2|Overall Study|Failure to Return|13
215902|NCT00192647|714943|P1|Overall Study|Failure to Return|11
215903|NCT00192647|714942|P2|Overall Study|Refused Treatment/Did not Cooperate|8
215904|NCT00192647|714943|P1|Overall Study|Refused Treatment/Did not Cooperate|10
215905|NCT00192647|714942|P2|Overall Study|Protocol Violation|1
215906|NCT00192647|714943|P1|Overall Study|Protocol Violation|3
215907|NCT00192647|714942|P2|Overall Study|Entry Criteria Violation|6
215908|NCT00192647|714943|P1|Overall Study|Entry Criteria Violation|6
215909|NCT00192647|714942|P2|Overall Study|Insufficient Therapeutic Response|83
215910|NCT00192647|714943|P1|Overall Study|Insufficient Therapeutic Response|53
215911|NCT00192647|714942|P2|Overall Study|Laboratory Test Abnormality|2
215912|NCT00192647|714943|P1|Overall Study|Laboratory Test Abnormality|4
215913|NCT00192647|714942|P2|Overall Study|Adverse Event|29
215914|NCT00192647|714943|P1|Overall Study|Adverse Event|35
215915|NCT00192647|714942|P2|Overall Study|Death|1
215916|NCT00192647|714943|P1|Overall Study|Death|1
215917|NCT00192296|714963|P4|Overall Study|Withdrawal by Subject|0
215918|NCT00192296|714964|P3|Overall Study|Withdrawal by Subject|0
215919|NCT00192296|714965|P2|Overall Study|Withdrawal by Subject|1
215920|NCT00192296|714966|P1|Overall Study|Withdrawal by Subject|0
215921|NCT00192075|715022|P2|Overall Study|Other|2
215922|NCT00192075|715023|P1|Overall Study|Other|5
215923|NCT00192075|715022|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
215924|NCT00192075|715023|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
215925|NCT00192075|715022|P2|Overall Study|Patient Non-Compliance|1
215926|NCT00192075|715023|P1|Overall Study|Patient Non-Compliance|0
215927|NCT00192075|715022|P2|Overall Study|Withdrawal by Subject|5
215928|NCT00192075|715023|P1|Overall Study|Withdrawal by Subject|5
215929|NCT00192075|715022|P2|Overall Study|Physician Decision|0
215930|NCT00192075|715023|P1|Overall Study|Physician Decision|3
215931|NCT00192075|715022|P2|Overall Study|Lack of Efficacy|0
215932|NCT00192075|715023|P1|Overall Study|Lack of Efficacy|0
215933|NCT00192075|715022|P2|Overall Study|Death|1
215934|NCT00192075|715023|P1|Overall Study|Death|0
215935|NCT00192075|715022|P2|Overall Study|Adverse Event|3
215936|NCT00192075|715023|P1|Overall Study|Adverse Event|1
215937|NCT00192075|715022|P2|Overall Study|Disease Progression|6
215938|NCT00192075|715023|P1|Overall Study|Disease Progression|23
215939|NCT00192036|715048|P1|Overall Study|Unknown or Not Specified|5
215940|NCT00192036|715048|P1|Overall Study|Death|1
215941|NCT00192036|715048|P1|Overall Study|Clinical Disease Progression|1
215942|NCT00192036|715048|P1|Overall Study|Objective Tumor Progression|4
215943|NCT00192036|715048|P1|Overall Study|Patient/Physician Perception|1
215944|NCT00192036|715048|P1|Overall Study|Adverse Event|6
215945|NCT00192036|715048|P1|Overall Study|Protocol Violation|3
215946|NCT00192023|715058|P2|Period IV - Optional Open-Label|Physician Decision|0
215947|NCT00192023|715059|P1|Period IV - Optional Open-Label|Physician Decision|9
215948|NCT00192023|715058|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
215949|NCT00192023|715059|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
215950|NCT00192023|715058|P2|Period IV - Optional Open-Label|Protocol Violation|0
215951|NCT00192023|715059|P1|Period IV - Optional Open-Label|Protocol Violation|1
215952|NCT00192023|715058|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
215953|NCT00192023|715059|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
215954|NCT00192023|715058|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
215955|NCT00192023|715059|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
215956|NCT00192023|715058|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
215957|NCT00192023|715059|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
215958|NCT00192023|715058|P2|Period IV - Optional Open-Label|Adverse Event|0
215959|NCT00192023|715059|P1|Period IV - Optional Open-Label|Adverse Event|6
215960|NCT00192023|715058|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
215961|NCT00192023|715059|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
215962|NCT00192023|715058|P2|Period III - Double-Blind|Physician Decision|0
215963|NCT00192023|715059|P1|Period III - Double-Blind|Physician Decision|2
215964|NCT00192023|715058|P2|Period III - Double-Blind|Adverse Event|0
215965|NCT00192023|715059|P1|Period III - Double-Blind|Adverse Event|3
215966|NCT00191984|715081|P1|Overall Study|Physician Decision|4
215967|NCT00191984|715081|P1|Overall Study|Withdrawal by Subject|7
215968|NCT00191984|715081|P1|Overall Study|Entry Criteria Exclusion|1
215969|NCT00191984|715081|P1|Overall Study|Death|2
215970|NCT00191984|715081|P1|Overall Study|Adverse Event|4
215971|NCT00191984|715081|P1|Overall Study|Disease Progression|21
215972|NCT00191945|715091|P2|Double-Blind Acute Treatment|Physician Decision|2
215973|NCT00191945|715092|P1|Double-Blind Acute Treatment|Physician Decision|0
215974|NCT00191945|715091|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
215975|NCT00191945|715092|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
215976|NCT00191945|715091|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
215977|NCT00191945|715092|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
215978|NCT00191945|715091|P2|Double-Blind Acute Treatment|Parent's Decision|0
215979|NCT00191945|715092|P1|Double-Blind Acute Treatment|Parent's Decision|3
215980|NCT00191906|715128|P4|Study Period III|Lack of Efficacy|0
215981|NCT00191906|715129|P3|Study Period III|Lack of Efficacy|0
215982|NCT00191906|715130|P2|Study Period III|Lack of Efficacy|3
215983|NCT00191906|715131|P1|Study Period III|Lack of Efficacy|3
215984|NCT00191906|715128|P4|Study Period III|Parent/Caregiver Decision|0
215985|NCT00191906|715129|P3|Study Period III|Parent/Caregiver Decision|0
215986|NCT00191906|715130|P2|Study Period III|Parent/Caregiver Decision|0
215987|NCT00191906|715131|P1|Study Period III|Parent/Caregiver Decision|1
215988|NCT00191906|715128|P4|Study Period III|Lost to Follow-up|0
215989|NCT00191906|715129|P3|Study Period III|Lost to Follow-up|0
215990|NCT00191906|715130|P2|Study Period III|Lost to Follow-up|1
215991|NCT00191906|715131|P1|Study Period III|Lost to Follow-up|0
215992|NCT00191906|715128|P4|Study Period III|Adverse Event|0
215993|NCT00191906|715129|P3|Study Period III|Adverse Event|0
215994|NCT00191906|715130|P2|Study Period III|Adverse Event|0
215995|NCT00191906|715131|P1|Study Period III|Adverse Event|1
215996|NCT00191906|715128|P4|Study Period II|Entry Criteria Exclusion|0
215997|NCT00191906|715129|P3|Study Period II|Entry Criteria Exclusion|1
215998|NCT00191906|715130|P2|Study Period II|Entry Criteria Exclusion|0
215999|NCT00191906|715131|P1|Study Period II|Entry Criteria Exclusion|0
216000|NCT00191906|715128|P4|Study Period II|Parent/Caregiver Decision|0
216001|NCT00191906|715129|P3|Study Period II|Parent/Caregiver Decision|0
216002|NCT00191906|715130|P2|Study Period II|Parent/Caregiver Decision|1
216003|NCT00191906|715131|P1|Study Period II|Parent/Caregiver Decision|0
216004|NCT00191906|715128|P4|Study Period II|Withdrawal by Subject|0
216005|NCT00191906|715129|P3|Study Period II|Withdrawal by Subject|0
216006|NCT00191906|715130|P2|Study Period II|Withdrawal by Subject|3
216007|NCT00191906|715131|P1|Study Period II|Withdrawal by Subject|0
216008|NCT00191906|715128|P4|Study Period II|Adverse Event|0
216009|NCT00191906|715129|P3|Study Period II|Adverse Event|0
216010|NCT00191906|715130|P2|Study Period II|Adverse Event|1
216011|NCT00191906|715131|P1|Study Period II|Adverse Event|0
216012|NCT00191854|715174|P3|Overall Study|Screen Failure|1
216013|NCT00191854|715175|P2|Overall Study|Screen Failure|0
216014|NCT00191854|715176|P1|Overall Study|Screen Failure|0
216015|NCT00191854|715174|P3|Overall Study|Sponsor Decision|1
216016|NCT00191854|715175|P2|Overall Study|Sponsor Decision|0
216017|NCT00191854|715176|P1|Overall Study|Sponsor Decision|0
216018|NCT00191854|715174|P3|Overall Study|Withdrawal by Subject|3
216019|NCT00191854|715175|P2|Overall Study|Withdrawal by Subject|2
216020|NCT00191854|715176|P1|Overall Study|Withdrawal by Subject|4
216021|NCT00191854|715174|P3|Overall Study|Lost to Follow-up|5
216022|NCT00191854|715175|P2|Overall Study|Lost to Follow-up|5
216023|NCT00191854|715176|P1|Overall Study|Lost to Follow-up|7
216024|NCT00191854|715174|P3|Overall Study|Death|29
216025|NCT00191854|715175|P2|Overall Study|Death|23
216026|NCT00191854|715176|P1|Overall Study|Death|26
216027|NCT00191815|715196|P1|Overall Study|Withdrawal by Subject|7
216028|NCT00191815|715196|P1|Overall Study|Physician Decision|2
216029|NCT00191815|715196|P1|Overall Study|Protocol Violation|3
216030|NCT00191815|715196|P1|Overall Study|Death|2
216031|NCT00191815|715196|P1|Overall Study|Disease progression or relapse|24
216032|NCT00191815|715196|P1|Overall Study|Adverse Event|2
216033|NCT00191789|715208|P1|Overall Study|Death - Not Study-Drug Related|1
216034|NCT00191789|715208|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
216035|NCT00191789|715208|P1|Overall Study|Death - Possibly Study Drug Related|4
216036|NCT00191789|715208|P1|Overall Study|Withdrawal by Subject|4
216037|NCT00191789|715208|P1|Overall Study|Patient/Physician: Satisfactory Response|4
216038|NCT00191789|715208|P1|Overall Study|Patient: Satisfactory Response|5
216039|NCT00191789|715208|P1|Overall Study|Adverse Event|5
216040|NCT00191724|715225|P5|Overall Study|Withdrawal by Subject|0
216041|NCT00191724|715226|P4|Overall Study|Withdrawal by Subject|1
216042|NCT00191724|715227|P3|Overall Study|Withdrawal by Subject|0
216043|NCT00191724|715228|P2|Overall Study|Withdrawal by Subject|0
216044|NCT00191724|715229|P1|Overall Study|Withdrawal by Subject|0
216045|NCT00191724|715225|P5|Overall Study|Lost to Follow-up|3
216046|NCT00191724|715226|P4|Overall Study|Lost to Follow-up|2
216047|NCT00191724|715227|P3|Overall Study|Lost to Follow-up|0
216048|NCT00191724|715228|P2|Overall Study|Lost to Follow-up|1
216049|NCT00191724|715229|P1|Overall Study|Lost to Follow-up|1
216050|NCT00191724|715225|P5|Overall Study|Adverse Event|0
216051|NCT00191724|715226|P4|Overall Study|Adverse Event|0
216052|NCT00191724|715227|P3|Overall Study|Adverse Event|1
216053|NCT00191724|715228|P2|Overall Study|Adverse Event|0
216054|NCT00191724|715229|P1|Overall Study|Adverse Event|0
216055|NCT00191646|715258|P2|Overall Study|Missing Data|11
216056|NCT00191646|715259|P1|Overall Study|Missing Data|18
216057|NCT00191646|715258|P2|Overall Study|Other|34
216058|NCT00191646|715259|P1|Overall Study|Other|33
216059|NCT00191646|715258|P2|Overall Study|Death|8
216060|NCT00191646|715259|P1|Overall Study|Death|6
216061|NCT00191646|715258|P2|Overall Study|Protocol Violation|7
216062|NCT00191646|715259|P1|Overall Study|Protocol Violation|5
216063|NCT00191646|715258|P2|Overall Study|Withdrawal by Subject|39
216064|NCT00191646|715259|P1|Overall Study|Withdrawal by Subject|58
216065|NCT00191646|715258|P2|Overall Study|Physician Decision|11
216066|NCT00191646|715259|P1|Overall Study|Physician Decision|20
216067|NCT00191646|715258|P2|Overall Study|Disease Progression|6
216068|NCT00191646|715259|P1|Overall Study|Disease Progression|5
216069|NCT00191646|715258|P2|Overall Study|Toxicity|37
216070|NCT00191646|715259|P1|Overall Study|Toxicity|26
216071|NCT00191477|715279|P2|Overall Study|Discontinued Prior to Instillation|14
216072|NCT00191477|715280|P1|Overall Study|Discontinued Prior to Instillation|13
216073|NCT00191477|715279|P2|Overall Study|Pathological Specimen Lost|0
216074|NCT00191477|715280|P1|Overall Study|Pathological Specimen Lost|1
216075|NCT00191477|715279|P2|Overall Study|Not Eligible|38
216076|NCT00191477|715280|P1|Overall Study|Not Eligible|41
216077|NCT00191477|715279|P2|Overall Study|Other|0
216078|NCT00191477|715280|P1|Overall Study|Other|2
216079|NCT00191477|715279|P2|Overall Study|Withdrawal by Subject|0
216080|NCT00191477|715280|P1|Overall Study|Withdrawal by Subject|2
216081|NCT00191477|715279|P2|Overall Study|Treatment Change|0
216082|NCT00191477|715280|P1|Overall Study|Treatment Change|2
216083|NCT00191477|715279|P2|Overall Study|Protocol Violation|1
216084|NCT00191477|715280|P1|Overall Study|Protocol Violation|1
216085|NCT00191477|715279|P2|Overall Study|Lost to Follow-up|21
216086|NCT00191477|715280|P1|Overall Study|Lost to Follow-up|23
216087|NCT00191477|715279|P2|Overall Study|Death, Other Cause|6
216088|NCT00191477|715280|P1|Overall Study|Death, Other Cause|3
216089|NCT00191477|715279|P2|Overall Study|Death, Study Disease|1
216090|NCT00191477|715280|P1|Overall Study|Death, Study Disease|1
216091|NCT00191477|715279|P2|Overall Study|Tumor Recurrence|48
216092|NCT00191477|715280|P1|Overall Study|Tumor Recurrence|49
216093|NCT00191451|715299|P3|Overall Study|Reason Not Specified|3
216094|NCT00191451|715300|P2|Overall Study|Reason Not Specified|1
216095|NCT00191451|715301|P1|Overall Study|Reason Not Specified|2
216096|NCT00191451|715299|P3|Overall Study|Ineligible|0
216097|NCT00191451|715300|P2|Overall Study|Ineligible|1
216098|NCT00191451|715301|P1|Overall Study|Ineligible|0
216099|NCT00191451|715299|P3|Overall Study|Sponsor Decision|0
216100|NCT00191451|715300|P2|Overall Study|Sponsor Decision|0
216101|NCT00191451|715301|P1|Overall Study|Sponsor Decision|1
216102|NCT00191451|715299|P3|Overall Study|Physician Decision|6
216103|NCT00191451|715300|P2|Overall Study|Physician Decision|9
216104|NCT00191451|715301|P1|Overall Study|Physician Decision|2
216105|NCT00191451|715299|P3|Overall Study|Withdrawal by Subject|5
216106|NCT00191451|715300|P2|Overall Study|Withdrawal by Subject|3
216107|NCT00191451|715301|P1|Overall Study|Withdrawal by Subject|2
216108|NCT00191386|715321|P1|Overall Study|Lack of Efficacy|15
216109|NCT00191386|715321|P1|Overall Study|Physician Decision|11
216110|NCT00191386|715321|P1|Overall Study|Withdrawal by Subject|96
216111|NCT00191386|715321|P1|Overall Study|Protocol Violation|18
216112|NCT00191386|715321|P1|Overall Study|Entry Criteria Exclusion|3
216113|NCT00191386|715321|P1|Overall Study|Lost to Follow-up|1
216114|NCT00191386|715321|P1|Overall Study|Adverse Event|16
216115|NCT00191334|715328|P1|Overall Study|Withdrawal by Subject|4
216116|NCT00191334|715328|P1|Overall Study|Physician Decision|1
216117|NCT00191334|715328|P1|Overall Study|Disease Progression or Relapse|8
216118|NCT00191334|715328|P1|Overall Study|Adverse Event|4
216119|NCT00191308|715336|P1|Overall Study|Adverse Event|1
216120|NCT00191282|715346|P2|Overall Study|Lost to Follow-up|31
216121|NCT00191282|715347|P1|Overall Study|Lost to Follow-up|24
216122|NCT00191282|715346|P2|Overall Study|Sponsor's decision|2
216123|NCT00191282|715347|P1|Overall Study|Sponsor's decision|2
216124|NCT00191282|715346|P2|Overall Study|Severity of outcome|5
216125|NCT00191282|715347|P1|Overall Study|Severity of outcome|2
216126|NCT00191282|715346|P2|Overall Study|Protocol Violation|12
216127|NCT00191282|715347|P1|Overall Study|Protocol Violation|9
216128|NCT00191282|715346|P2|Overall Study|Protocol entry criteria not met|9
216129|NCT00191282|715347|P1|Overall Study|Protocol entry criteria not met|14
216130|NCT00191282|715346|P2|Overall Study|Physician Decision|15
216131|NCT00191282|715347|P1|Overall Study|Physician Decision|18
216132|NCT00191282|715346|P2|Overall Study|Withdrawal by Subject|44
216133|NCT00191282|715347|P1|Overall Study|Withdrawal by Subject|59
216134|NCT00191282|715346|P2|Overall Study|Patient moved|14
216135|NCT00191282|715347|P1|Overall Study|Patient moved|11
216136|NCT00191282|715346|P2|Overall Study|Noncompliance|17
216137|NCT00191282|715347|P1|Overall Study|Noncompliance|14
216138|NCT00191282|715346|P2|Overall Study|Lack of Efficacy|6
216139|NCT00191282|715347|P1|Overall Study|Lack of Efficacy|11
216140|NCT00191282|715346|P2|Overall Study|Death|51
216141|NCT00191282|715347|P1|Overall Study|Death|51
216142|NCT00191282|715346|P2|Overall Study|Adverse Event|6
216143|NCT00191282|715347|P1|Overall Study|Adverse Event|5
216144|NCT00191269|715407|P2|Overall Study|Physician Decision|3
216145|NCT00191269|715408|P1|Overall Study|Physician Decision|0
216146|NCT00191269|715407|P2|Overall Study|Pathologic Aggrevation|1
216147|NCT00191269|715408|P1|Overall Study|Pathologic Aggrevation|0
216148|NCT00191269|715407|P2|Overall Study|Withdrawal by Subject|1
216149|NCT00191269|715408|P1|Overall Study|Withdrawal by Subject|0
216150|NCT00191269|715407|P2|Overall Study|Lack of Efficacy|5
216151|NCT00191269|715408|P1|Overall Study|Lack of Efficacy|1
216152|NCT00191269|715407|P2|Overall Study|Progression of Disease|42
216153|NCT00191269|715408|P1|Overall Study|Progression of Disease|4
216154|NCT00191269|715407|P2|Overall Study|Adverse Event|4
216155|NCT00191269|715408|P1|Overall Study|Adverse Event|1
216156|NCT00191269|715407|P2|Overall Study|Protocol Violation|2
216157|NCT00191269|715408|P1|Overall Study|Protocol Violation|0
216158|NCT00191191|715424|P2|Overall Study|Good Clinical Practice Violation|1
216159|NCT00191191|715425|P1|Overall Study|Good Clinical Practice Violation|0
216160|NCT00191191|715424|P2|Overall Study|Physician Decision|2
216161|NCT00191191|715425|P1|Overall Study|Physician Decision|3
216162|NCT00191191|715424|P2|Overall Study|Lost to Follow-up|0
216163|NCT00191191|715425|P1|Overall Study|Lost to Follow-up|1
216164|NCT00191191|715424|P2|Overall Study|Family/Caregiver Decision|7
216165|NCT00191191|715425|P1|Overall Study|Family/Caregiver Decision|5
216166|NCT00191191|715424|P2|Overall Study|Toxicity After Dose Reduction|8
216167|NCT00191191|715425|P1|Overall Study|Toxicity After Dose Reduction|7
216168|NCT00191191|715424|P2|Overall Study|Progressive Disease|72
216169|NCT00191191|715425|P1|Overall Study|Progressive Disease|84
216170|NCT00191191|715424|P2|Overall Study|Adverse Event|21
216171|NCT00191191|715425|P1|Overall Study|Adverse Event|11
216172|NCT00191191|715424|P2|Overall Study|Treated with Another Systemic Agent|1
216173|NCT00191191|715425|P1|Overall Study|Treated with Another Systemic Agent|1
216174|NCT00191191|715424|P2|Overall Study|Entry Criteria Exclusion|0
216175|NCT00191191|715425|P1|Overall Study|Entry Criteria Exclusion|2
216176|NCT00191165|715441|P2|Overall Study|Participant Moved Away|1
216177|NCT00191165|715442|P1|Overall Study|Participant Moved Away|0
216178|NCT00191165|715441|P2|Overall Study|Protocol Violation|1
216179|NCT00191165|715442|P1|Overall Study|Protocol Violation|0
216180|NCT00191165|715441|P2|Overall Study|Adverse Event|0
216181|NCT00191165|715442|P1|Overall Study|Adverse Event|2
216182|NCT00191152|715454|P2|Crossover Treatment|Not Specified|3
216183|NCT00191152|715455|P1|Crossover Treatment|Not Specified|4
216184|NCT00191152|715454|P2|Crossover Treatment|Lost to Follow-up|1
216185|NCT00191152|715455|P1|Crossover Treatment|Lost to Follow-up|2
216186|NCT00191152|715454|P2|Crossover Treatment|Withdrawal by Subject|9
216187|NCT00191152|715455|P1|Crossover Treatment|Withdrawal by Subject|6
216188|NCT00191152|715454|P2|Crossover Treatment|Physician Decision|7
216189|NCT00191152|715455|P1|Crossover Treatment|Physician Decision|7
216190|NCT00191152|715454|P2|Crossover Treatment|Adverse Event|8
216191|NCT00191152|715455|P1|Crossover Treatment|Adverse Event|8
216192|NCT00191152|715454|P2|Initial Treatment|not specified|21
216193|NCT00191152|715455|P1|Initial Treatment|not specified|18
216194|NCT00191152|715454|P2|Initial Treatment|Lost to Follow-up|6
216195|NCT00191152|715455|P1|Initial Treatment|Lost to Follow-up|0
216196|NCT00191152|715454|P2|Initial Treatment|Withdrawal by Subject|28
216197|NCT00191152|715455|P1|Initial Treatment|Withdrawal by Subject|40
216198|NCT00191152|715454|P2|Initial Treatment|Physician Decision|31
216199|NCT00191152|715455|P1|Initial Treatment|Physician Decision|40
216200|NCT00191152|715454|P2|Initial Treatment|Adverse Event|67
216201|NCT00191152|715455|P1|Initial Treatment|Adverse Event|43
216202|NCT00191139|715487|P2|Overall Study|Other|2
216203|NCT00191139|715488|P1|Overall Study|Other|1
216204|NCT00191139|715487|P2|Overall Study|Disease Progression|1
216205|NCT00191139|715488|P1|Overall Study|Disease Progression|0
216206|NCT00191139|715487|P2|Overall Study|Withdrawal by Subject|3
216207|NCT00191139|715488|P1|Overall Study|Withdrawal by Subject|0
216208|NCT00191139|715487|P2|Overall Study|Death|0
216209|NCT00191139|715488|P1|Overall Study|Death|2
216210|NCT00191139|715487|P2|Overall Study|Adverse Event|6
216211|NCT00191139|715488|P1|Overall Study|Adverse Event|2
216212|NCT00191113|715504|P2|Core Study|Death|0
216213|NCT00191113|715505|P1|Core Study|Death|1
216214|NCT00191113|715504|P2|Core Study|Lack of Efficacy|2
216215|NCT00191113|715505|P1|Core Study|Lack of Efficacy|0
216216|NCT00191113|715504|P2|Core Study|Adverse Event|2
216217|NCT00191113|715505|P1|Core Study|Adverse Event|0
216218|NCT00191113|715504|P2|Core Study|Lost to Follow-up|0
216219|NCT00191113|715505|P1|Core Study|Lost to Follow-up|3
216220|NCT00191113|715504|P2|Core Study|Protocol Violation|2
216221|NCT00191113|715505|P1|Core Study|Protocol Violation|6
216222|NCT00191113|715504|P2|Core Study|Withdrawal by Subject|9
216223|NCT00191113|715505|P1|Core Study|Withdrawal by Subject|25
216224|NCT00191100|715547|P2|Overall Study|Reason Not Specified|1
216225|NCT00191100|715548|P1|Overall Study|Reason Not Specified|0
216226|NCT00191100|715547|P2|Overall Study|Death from Other Cause|0
216227|NCT00191100|715548|P1|Overall Study|Death from Other Cause|1
216228|NCT00191100|715547|P2|Overall Study|Protocol Violation|1
216229|NCT00191100|715548|P1|Overall Study|Protocol Violation|1
216230|NCT00191100|715547|P2|Overall Study|Death from Study Drug Toxicity|0
216231|NCT00191100|715548|P1|Overall Study|Death from Study Drug Toxicity|2
216232|NCT00191100|715547|P2|Overall Study|Physician Decision|1
216233|NCT00191100|715548|P1|Overall Study|Physician Decision|3
216234|NCT00191100|715547|P2|Overall Study|Lack of Efficacy, Stable Disease|0
216235|NCT00191100|715548|P1|Overall Study|Lack of Efficacy, Stable Disease|1
216236|NCT00191100|715547|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
216237|NCT00191100|715548|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
216238|NCT00191100|715547|P2|Overall Study|Clinical Relapse|1
216239|NCT00191100|715548|P1|Overall Study|Clinical Relapse|2
216240|NCT00191100|715547|P2|Overall Study|Protocol Entry Criteria Not Met|1
216241|NCT00191100|715548|P1|Overall Study|Protocol Entry Criteria Not Met|2
216242|NCT00191100|715547|P2|Overall Study|Withdrawal by Subject|3
216243|NCT00191100|715548|P1|Overall Study|Withdrawal by Subject|9
216244|NCT00191100|715547|P2|Overall Study|Patient Moved|1
216245|NCT00191100|715548|P1|Overall Study|Patient Moved|0
216246|NCT00191100|715547|P2|Overall Study|Lost to Follow-up|0
216247|NCT00191100|715548|P1|Overall Study|Lost to Follow-up|2
216248|NCT00191100|715547|P2|Overall Study|Adverse Event|1
216249|NCT00191100|715548|P1|Overall Study|Adverse Event|18
216250|NCT00190983|715564|P1|Overall Study|Inevaluable (never treated)|2
216251|NCT00190775|715573|P2|Overall Study|Exclusion Criteria Met|3
216252|NCT00190775|715574|P1|Overall Study|Exclusion Criteria Met|1
216253|NCT00190775|715573|P2|Overall Study|Protocol Violation|1
216254|NCT00190775|715574|P1|Overall Study|Protocol Violation|0
216255|NCT00190775|715573|P2|Overall Study|Noncompliance|5
216256|NCT00190775|715574|P1|Overall Study|Noncompliance|3
216257|NCT00190775|715573|P2|Overall Study|Physician Decision|0
216258|NCT00190775|715574|P1|Overall Study|Physician Decision|3
216259|NCT00190775|715573|P2|Overall Study|Sponsor Decision|0
216260|NCT00190775|715574|P1|Overall Study|Sponsor Decision|1
216261|NCT00190775|715573|P2|Overall Study|Withdrawal by Subject|13
216262|NCT00190775|715574|P1|Overall Study|Withdrawal by Subject|24
216263|NCT00190775|715573|P2|Overall Study|Participant Moved|1
216264|NCT00190775|715574|P1|Overall Study|Participant Moved|0
216265|NCT00190775|715573|P2|Overall Study|Lost to Follow-up|23
216266|NCT00190775|715574|P1|Overall Study|Lost to Follow-up|31
216267|NCT00190775|715573|P2|Overall Study|Lack of Efficacy|32
216268|NCT00190775|715574|P1|Overall Study|Lack of Efficacy|28
216269|NCT00190775|715573|P2|Overall Study|Satisfactory Response|0
216270|NCT00190775|715574|P1|Overall Study|Satisfactory Response|1
216271|NCT00190775|715573|P2|Overall Study|Adverse Event|22
216272|NCT00190775|715574|P1|Overall Study|Adverse Event|57
216273|NCT00190749|715645|P2|Overall Study|Sponsor Decision|0
216274|NCT00190749|715646|P1|Overall Study|Sponsor Decision|1
216275|NCT00190749|715645|P2|Overall Study|Reason Not Specified|2
216276|NCT00190749|715646|P1|Overall Study|Reason Not Specified|0
216277|NCT00190749|715645|P2|Overall Study|Lack of Efficacy|3
216278|NCT00190749|715646|P1|Overall Study|Lack of Efficacy|2
216279|NCT00190749|715645|P2|Overall Study|Adverse Event|5
216280|NCT00190749|715646|P1|Overall Study|Adverse Event|0
216281|NCT00190749|715645|P2|Overall Study|Protocol Violation|4
216282|NCT00190749|715646|P1|Overall Study|Protocol Violation|5
216283|NCT00190749|715645|P2|Overall Study|Withdrawal by Subject|6
216284|NCT00190749|715646|P1|Overall Study|Withdrawal by Subject|10
216285|NCT00190749|715645|P2|Overall Study|Lost to Follow-up|11
216286|NCT00190749|715646|P1|Overall Study|Lost to Follow-up|8
216287|NCT00190684|715710|P1|Overall Study|Study Period V Completed|1
216288|NCT00190684|715710|P1|Overall Study|Study Period III Completed|103
216289|NCT00190684|715710|P1|Overall Study|Protocol Violation|123
216290|NCT00190684|715710|P1|Overall Study|Physician Decision|84
216291|NCT00190684|715710|P1|Overall Study|Sponsor's decision|17
216292|NCT00190684|715710|P1|Overall Study|Clinical relapse|67
216293|NCT00190684|715710|P1|Overall Study|Patient Decision|432
216294|NCT00190684|715710|P1|Overall Study|Patient moved|60
216295|NCT00190684|715710|P1|Overall Study|Lost to Follow-up|232
216296|NCT00190684|715710|P1|Overall Study|Lack of efficacy|204
216297|NCT00190684|715710|P1|Overall Study|Satisfactory response|80
216298|NCT00190684|715710|P1|Overall Study|Adverse Event|86
216299|NCT00190671|715731|P2|Overall Study|Withdrawal by Subject|2
216300|NCT00190671|715732|P1|Overall Study|Withdrawal by Subject|0
216301|NCT00190671|715731|P2|Overall Study|Protocol Violation|1
216302|NCT00190671|715732|P1|Overall Study|Protocol Violation|0
216303|NCT00190671|715731|P2|Overall Study|Death from Other Causes|2
216304|NCT00190671|715732|P1|Overall Study|Death from Other Causes|0
216305|NCT00190671|715731|P2|Overall Study|Death from Study-Drug Toxicity|2
216306|NCT00190671|715732|P1|Overall Study|Death from Study-Drug Toxicity|0
216307|NCT00190671|715731|P2|Overall Study|Clinical Relapse|1
216308|NCT00190671|715732|P1|Overall Study|Clinical Relapse|0
216309|NCT00190671|715731|P2|Overall Study|Adverse Event|2
216310|NCT00190671|715732|P1|Overall Study|Adverse Event|3
216311|NCT00190671|715731|P2|Overall Study|Death from Study Disease|1
216312|NCT00190671|715732|P1|Overall Study|Death from Study Disease|1
216313|NCT00190671|715731|P2|Overall Study|Lack of Efficacy|24
216314|NCT00190671|715732|P1|Overall Study|Lack of Efficacy|19
216315|NCT00190671|715731|P2|Overall Study|Satisfactory Response|7
216316|NCT00190671|715732|P1|Overall Study|Satisfactory Response|4
216317|NCT00189540|715752|P2|Overall Study|Death|1
216318|NCT00189540|715753|P1|Overall Study|Death|4
216319|NCT00189540|715752|P2|Overall Study|Withdrawal by Subject|0
216320|NCT00189540|715753|P1|Overall Study|Withdrawal by Subject|3
216321|NCT00189488|715771|P2|Overall Study|Other|0
216322|NCT00189488|715772|P1|Overall Study|Other|1
216323|NCT00189488|715771|P2|Overall Study|Death|8
216324|NCT00189488|715772|P1|Overall Study|Death|5
216325|NCT00189488|715771|P2|Overall Study|Administrative Decision|2
216326|NCT00189488|715772|P1|Overall Study|Administrative Decision|0
216327|NCT00189488|715771|P2|Overall Study|Disease progression|4
216328|NCT00189488|715772|P1|Overall Study|Disease progression|2
216329|NCT00189488|715771|P2|Overall Study|Withdrawal by Subject|6
216330|NCT00189488|715772|P1|Overall Study|Withdrawal by Subject|2
216331|NCT00189488|715771|P2|Overall Study|Adverse Event|1
216332|NCT00189488|715772|P1|Overall Study|Adverse Event|2
216333|NCT00189488|715771|P2|Overall Study|Protocol deviation|1
216334|NCT00189488|715772|P1|Overall Study|Protocol deviation|2
216335|NCT00189488|715771|P2|Overall Study|Ineligibility determined|0
216336|NCT00189488|715772|P1|Overall Study|Ineligibility determined|1
216337|NCT00189462|715803|P2|Overall Study|Lost to Follow-up|20
216338|NCT00189462|715804|P1|Overall Study|Lost to Follow-up|18
216339|NCT00189462|715803|P2|Overall Study|Lack of Efficacy|1
216340|NCT00189462|715804|P1|Overall Study|Lack of Efficacy|5
216341|NCT00189423|715821|P2|Overall Study|Lost to Follow-up|10
216342|NCT00189423|715822|P1|Overall Study|Lost to Follow-up|10
216343|NCT00189423|715821|P2|Overall Study|Withdrawal by Subject|9
216344|NCT00189423|715822|P1|Overall Study|Withdrawal by Subject|9
216345|NCT00189423|715821|P2|Overall Study|Death|747
216346|NCT00189423|715822|P1|Overall Study|Death|746
216347|NCT00189306|715844|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
216348|NCT00189306|715844|P1|Long-Term Follow-up|Lost to Follow-up|9
216349|NCT00189306|715844|P1|Long-Term Follow-up|Intercurrent disease|2
216350|NCT00189306|715844|P1|Long-Term Follow-up|Withdrawal by Subject|1
216351|NCT00189306|715844|P1|Long-Term Follow-up|Death|4
216352|NCT00189306|715844|P1|Long-Term Follow-up|Adverse Event|2
216353|NCT00189306|715844|P1|Posttreatment Period|Local skin reaction/sign|1
216354|NCT00189306|715844|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
216355|NCT00189306|715844|P1|Posttreatment Period|Protocol Violation|1
216356|NCT00189306|715844|P1|Posttreatment Period|Target lesion excised|1
216357|NCT00189306|715844|P1|Posttreatment Period|Noncompliance|1
216358|NCT00189306|715844|P1|Posttreatment Period|Withdrawal by Subject|2
216359|NCT00189306|715844|P1|Posttreatment Period|Death|1
216360|NCT00189306|715844|P1|Treatment Period|Protocol Violation|1
216361|NCT00189306|715844|P1|Treatment Period|Adverse Event|2
216362|NCT00189306|715844|P1|Treatment Period|Withdrawal by Subject|2
216363|NCT00189202|715849|P1|Overall Study|Physician Decision|5
216364|NCT00187889|715890|P2|Overall Study|Withdrawal by Subject|4
216365|NCT00187889|715891|P1|Overall Study|Withdrawal by Subject|6
216366|NCT00187486|715933|P1|Overall Study|Protocol Violation|1
216367|NCT00187135|715984|P6|Visit Three|Study Discontinued|6
216368|NCT00187135|715985|P5|Visit Three|Study Discontinued|7
216369|NCT00187135|715986|P4|Visit Three|Study Discontinued|7
216370|NCT00187135|715987|P3|Visit Three|Study Discontinued|7
216371|NCT00187135|715988|P2|Visit Three|Study Discontinued|6
216372|NCT00187135|715989|P1|Visit Three|Study Discontinued|7
216373|NCT00187135|715984|P6|Visit Three|Withdrawal by Subject|0
216374|NCT00187135|715985|P5|Visit Three|Withdrawal by Subject|0
216375|NCT00187135|715986|P4|Visit Three|Withdrawal by Subject|2
216376|NCT00187135|715987|P3|Visit Three|Withdrawal by Subject|1
216377|NCT00187135|715988|P2|Visit Three|Withdrawal by Subject|1
216378|NCT00187135|715989|P1|Visit Three|Withdrawal by Subject|0
216379|NCT00187135|715984|P6|Visit Three|Death|0
216380|NCT00187135|715985|P5|Visit Three|Death|1
216381|NCT00187135|715986|P4|Visit Three|Death|0
216382|NCT00187135|715987|P3|Visit Three|Death|1
216383|NCT00187135|715988|P2|Visit Three|Death|0
216384|NCT00187135|715989|P1|Visit Three|Death|0
216385|NCT00187135|715984|P6|Visit Two|Study Discontinued|6
216386|NCT00187135|715985|P5|Visit Two|Study Discontinued|5
216387|NCT00187135|715986|P4|Visit Two|Study Discontinued|7
216388|NCT00187135|715987|P3|Visit Two|Study Discontinued|1
216389|NCT00187135|715988|P2|Visit Two|Study Discontinued|2
216390|NCT00187135|715989|P1|Visit Two|Study Discontinued|3
216391|NCT00187135|715984|P6|Visit Two|Withdrawal by Subject|1
216392|NCT00187135|715985|P5|Visit Two|Withdrawal by Subject|1
216393|NCT00187135|715986|P4|Visit Two|Withdrawal by Subject|0
216394|NCT00187135|715987|P3|Visit Two|Withdrawal by Subject|1
216395|NCT00187135|715988|P2|Visit Two|Withdrawal by Subject|1
216396|NCT00187135|715989|P1|Visit Two|Withdrawal by Subject|1
216397|NCT00187135|715984|P6|Visit Two|Physician Decision|0
216398|NCT00187135|715985|P5|Visit Two|Physician Decision|0
216399|NCT00187135|715986|P4|Visit Two|Physician Decision|0
216400|NCT00187135|715987|P3|Visit Two|Physician Decision|0
216401|NCT00187135|715988|P2|Visit Two|Physician Decision|0
216402|NCT00187135|715989|P1|Visit Two|Physician Decision|1
216403|NCT00187135|715984|P6|Visit Two|Death|1
216404|NCT00187135|715985|P5|Visit Two|Death|0
216405|NCT00187135|715986|P4|Visit Two|Death|1
216406|NCT00187135|715987|P3|Visit Two|Death|0
216407|NCT00187135|715988|P2|Visit Two|Death|0
216408|NCT00187135|715989|P1|Visit Two|Death|0
216409|NCT00187135|715984|P6|Visit One|Physician Decision|1
216410|NCT00187135|715985|P5|Visit One|Physician Decision|0
216411|NCT00187135|715986|P4|Visit One|Physician Decision|0
216412|NCT00187135|715987|P3|Visit One|Physician Decision|0
216413|NCT00187135|715988|P2|Visit One|Physician Decision|1
216414|NCT00187135|715989|P1|Visit One|Physician Decision|3
216415|NCT00187135|715984|P6|Visit One|Withdrawal by Subject|1
216416|NCT00187135|715985|P5|Visit One|Withdrawal by Subject|0
216417|NCT00187135|715986|P4|Visit One|Withdrawal by Subject|0
216418|NCT00187135|715987|P3|Visit One|Withdrawal by Subject|0
216419|NCT00187135|715988|P2|Visit One|Withdrawal by Subject|0
216420|NCT00187135|715989|P1|Visit One|Withdrawal by Subject|1
216421|NCT00187096|716012|P3|Overall Study|unacceptable toxicity|1
216422|NCT00187096|716013|P2|Overall Study|unacceptable toxicity|0
216423|NCT00187096|716014|P1|Overall Study|unacceptable toxicity|0
216424|NCT00186901|716052|P3|Overall Study|Bone Mineral Density > 0|149
216425|NCT00186901|716053|P2|Overall Study|Bone Mineral Density > 0|0
216426|NCT00186901|716054|P1|Overall Study|Bone Mineral Density > 0|0
216427|NCT00186901|716052|P3|Overall Study|Limited adherence to study requirements|0
216428|NCT00186901|716053|P2|Overall Study|Limited adherence to study requirements|23
216429|NCT00186901|716054|P1|Overall Study|Limited adherence to study requirements|20
216430|NCT00186901|716052|P3|Overall Study|Open label|0
216431|NCT00186901|716053|P2|Overall Study|Open label|2
216432|NCT00186901|716054|P1|Overall Study|Open label|3
216433|NCT00186901|716052|P3|Overall Study|Withdrawal by Subject|0
216434|NCT00186901|716053|P2|Overall Study|Withdrawal by Subject|5
216435|NCT00186901|716054|P1|Overall Study|Withdrawal by Subject|4
216436|NCT00186901|716052|P3|Overall Study|ALL relapse or second malignancy|0
216437|NCT00186901|716053|P2|Overall Study|ALL relapse or second malignancy|2
216438|NCT00186901|716054|P1|Overall Study|ALL relapse or second malignancy|1
216439|NCT00186901|716052|P3|Overall Study|Bone Mineral Density dropped > 5%|0
216440|NCT00186901|716053|P2|Overall Study|Bone Mineral Density dropped > 5%|7
216441|NCT00186901|716054|P1|Overall Study|Bone Mineral Density dropped > 5%|9
216442|NCT00186901|716052|P3|Overall Study|Lost to Follow-up|0
216443|NCT00186901|716053|P2|Overall Study|Lost to Follow-up|3
216444|NCT00186901|716054|P1|Overall Study|Lost to Follow-up|6
216445|NCT00186901|716052|P3|Overall Study|Pregnancy|0
216446|NCT00186901|716053|P2|Overall Study|Pregnancy|3
216447|NCT00186901|716054|P1|Overall Study|Pregnancy|6
216448|NCT00186888|716094|P3|Overall Study|Relapse or progression of disease|0
216449|NCT00186888|716095|P2|Overall Study|Relapse or progression of disease|2
216450|NCT00186888|716096|P1|Overall Study|Relapse or progression of disease|4
216451|NCT00186888|716094|P3|Overall Study|Toxicity|0
216452|NCT00186888|716095|P2|Overall Study|Toxicity|1
216453|NCT00186888|716096|P1|Overall Study|Toxicity|0
216454|NCT00186628|716188|P1|Overall Study|Withdrawal by subject (before treatment)|1
216455|NCT00186628|716188|P1|Overall Study|Death|2
216456|NCT00186537|716199|P3|Overall Study|ALT > 1.5 x ULN|0
216457|NCT00186537|716200|P2|Overall Study|ALT > 1.5 x ULN|0
216458|NCT00186537|716201|P1|Overall Study|ALT > 1.5 x ULN|3
216459|NCT00186537|716199|P3|Overall Study|Withdrawal by Subject|3
216460|NCT00186537|716200|P2|Overall Study|Withdrawal by Subject|0
216461|NCT00186537|716201|P1|Overall Study|Withdrawal by Subject|4
216462|NCT00186485|716215|P1|Overall Study|Lost to Follow-up|3
216463|NCT00186186|716227|P1|Overall Study|Not reported as to reason|2
216464|NCT00186186|716227|P1|Overall Study|Withdrawal by Subject|3
216465|NCT00186186|716227|P1|Overall Study|Lack of Efficacy|3
216466|NCT00186121|716232|P1|Overall Study|Not eligible (no treatment)|1
216467|NCT00186121|716232|P1|Overall Study|Underwent oophorectomy (no treatment)|1
216468|NCT00186121|716232|P1|Overall Study|Subject withdrawal (no treatment)|1
216469|NCT00186043|716266|P2|Overall Study|Protocol Violation|1
216470|NCT00186043|716267|P1|Overall Study|Protocol Violation|2
216471|NCT00186043|716266|P2|Overall Study|Adverse Event|3
216472|NCT00186043|716267|P1|Overall Study|Adverse Event|7
216473|NCT00186043|716266|P2|Overall Study|Withdrawal by Subject|0
216474|NCT00186043|716267|P1|Overall Study|Withdrawal by Subject|1
216475|NCT00186043|716266|P2|Overall Study|Lost to Follow-up|6
216476|NCT00186043|716267|P1|Overall Study|Lost to Follow-up|4
216477|NCT00186043|716266|P2|Overall Study|Lack of Efficacy|3
216478|NCT00186043|716267|P1|Overall Study|Lack of Efficacy|1
216479|NCT00185965|716294|P2|Overall Study|Adverse Event|1
216480|NCT00185965|716295|P1|Overall Study|Adverse Event|0
216481|NCT00185731|716301|P1|Overall Study|Not Eligible|1
216482|NCT00185731|716301|P1|Overall Study|Withdrawal by Subject|1
216483|NCT00185640|716318|P1|Overall Study|Death|138
216484|NCT00185640|716318|P1|Overall Study|Withdrawal by Subject|3
216485|NCT00185640|716318|P1|Overall Study|Not Eligible|4
216486|NCT00185614|716327|P1|Inter-treatment Period|Lack of allogenic donor|1
216487|NCT00185614|716327|P1|Inter-treatment Period|Relapse|2
216488|NCT00185614|716327|P1|Inter-treatment Period|Physician Decision|1
216489|NCT00185588|716339|P4|Overall Study|Physician Decision|0
216490|NCT00185588|716340|P3|Overall Study|Physician Decision|1
216491|NCT00185588|716341|P2|Overall Study|Physician Decision|0
216492|NCT00185588|716342|P1|Overall Study|Physician Decision|0
216493|NCT00185588|716339|P4|Overall Study|Withdrawal by Subject|0
216494|NCT00185588|716340|P3|Overall Study|Withdrawal by Subject|0
216495|NCT00185588|716341|P2|Overall Study|Withdrawal by Subject|1
216496|NCT00185588|716342|P1|Overall Study|Withdrawal by Subject|0
216497|NCT00185588|716339|P4|Overall Study|Lost to Follow-up|2
216498|NCT00185588|716340|P3|Overall Study|Lost to Follow-up|1
216499|NCT00185588|716341|P2|Overall Study|Lost to Follow-up|0
216500|NCT00185588|716342|P1|Overall Study|Lost to Follow-up|0
216501|NCT00185588|716339|P4|Overall Study|Adverse Event|2
216502|NCT00185588|716340|P3|Overall Study|Adverse Event|4
216503|NCT00185588|716341|P2|Overall Study|Adverse Event|1
216504|NCT00185588|716342|P1|Overall Study|Adverse Event|3
216505|NCT00185458|716356|P1|HRT Phase|Withdrawal by Subject|3
216506|NCT00185458|716356|P1|HRT Phase|Protocol Violation|2
216507|NCT00185458|716356|P1|HRT Phase|Lost to Follow-up|4
216508|NCT00185458|716356|P1|HRT Phase|Adverse Event|18
216509|NCT00185458|716356|P1|Contraception Phase|Withdrawal by Subject|7
216510|NCT00185458|716356|P1|Contraception Phase|Physician Decision|2
216511|NCT00185458|716356|P1|Contraception Phase|Protocol Violation|2
216512|NCT00185458|716356|P1|Contraception Phase|Lost to Follow-up|10
216513|NCT00185458|716356|P1|Contraception Phase|Adverse Event|37
216514|NCT00185380|716419|P3|Overall Study|personal reason|1
216515|NCT00185380|716420|P2|Overall Study|personal reason|1
216516|NCT00185380|716421|P1|Overall Study|personal reason|6
216517|NCT00185380|716419|P3|Overall Study|Could not attend visits|4
216518|NCT00185380|716420|P2|Overall Study|Could not attend visits|0
216519|NCT00185380|716421|P1|Overall Study|Could not attend visits|2
216520|NCT00185380|716419|P3|Overall Study|No need for contraception|3
216521|NCT00185380|716420|P2|Overall Study|No need for contraception|3
216522|NCT00185380|716421|P1|Overall Study|No need for contraception|3
216523|NCT00185380|716419|P3|Overall Study|Planned pregnancy|12
216524|NCT00185380|716420|P2|Overall Study|Planned pregnancy|12
216525|NCT00185380|716421|P1|Overall Study|Planned pregnancy|9
216526|NCT00185380|716419|P3|Overall Study|Failed insertion|2
216527|NCT00185380|716420|P2|Overall Study|Failed insertion|1
216528|NCT00185380|716421|P1|Overall Study|Failed insertion|1
216529|NCT00185380|716419|P3|Overall Study|Withdrawal by Subject|0
216530|NCT00185380|716420|P2|Overall Study|Withdrawal by Subject|2
216531|NCT00185380|716421|P1|Overall Study|Withdrawal by Subject|1
216532|NCT00185380|716419|P3|Overall Study|Protocol Violation|1
216533|NCT00185380|716420|P2|Overall Study|Protocol Violation|2
216534|NCT00185380|716421|P1|Overall Study|Protocol Violation|2
216535|NCT00185380|716419|P3|Overall Study|Pregnancy|0
216536|NCT00185380|716420|P2|Overall Study|Pregnancy|4
216537|NCT00185380|716421|P1|Overall Study|Pregnancy|1
216538|NCT00185380|716419|P3|Overall Study|Lost to Follow-up|3
216539|NCT00185380|716420|P2|Overall Study|Lost to Follow-up|4
216540|NCT00185380|716421|P1|Overall Study|Lost to Follow-up|0
216541|NCT00185380|716419|P3|Overall Study|Adverse Event|48
216542|NCT00185380|716420|P2|Overall Study|Adverse Event|43
216543|NCT00185380|716421|P1|Overall Study|Adverse Event|41
216544|NCT00185211|716449|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
216545|NCT00185211|716450|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
216546|NCT00185211|716449|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
216547|NCT00185211|716450|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
216548|NCT00185211|716449|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
216549|NCT00185211|716450|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
216550|NCT00185211|716449|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
216551|NCT00185211|716450|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
216552|NCT00185211|716449|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
216553|NCT00185211|716450|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
216554|NCT00185211|716449|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
216555|NCT00185211|716450|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
216556|NCT00185211|716449|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
216557|NCT00185211|716450|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
216558|NCT00185211|716449|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
216559|NCT00185211|716450|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
216560|NCT00185211|716449|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
216561|NCT00185211|716450|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
216562|NCT00185211|716449|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
216563|NCT00185211|716450|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
216564|NCT00185211|716449|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
216565|NCT00185211|716450|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
216566|NCT00185211|716449|P2|Placebo-controlled Study (92012)|Adverse Event|0
216567|NCT00185211|716450|P1|Placebo-controlled Study (92012)|Adverse Event|8
216568|NCT00184600|716523|P3|Overall Study|Unclassified|3
216569|NCT00184600|716524|P2|Overall Study|Unclassified|5
216570|NCT00184600|716525|P1|Overall Study|Unclassified|4
216571|NCT00184600|716523|P3|Overall Study|Withdrawal by Subject|12
216572|NCT00184600|716524|P2|Overall Study|Withdrawal by Subject|28
216573|NCT00184600|716525|P1|Overall Study|Withdrawal by Subject|20
216574|NCT00184600|716523|P3|Overall Study|Protocol Violation|3
216575|NCT00184600|716524|P2|Overall Study|Protocol Violation|2
216576|NCT00184600|716525|P1|Overall Study|Protocol Violation|2
216577|NCT00184600|716523|P3|Overall Study|Lost to Follow-up|1
216578|NCT00184600|716524|P2|Overall Study|Lost to Follow-up|6
216579|NCT00184600|716525|P1|Overall Study|Lost to Follow-up|4
216580|NCT00184600|716523|P3|Overall Study|Lack of Efficacy|3
216581|NCT00184600|716524|P2|Overall Study|Lack of Efficacy|1
216582|NCT00184600|716525|P1|Overall Study|Lack of Efficacy|3
216583|NCT00184600|716523|P3|Overall Study|Death|7
216584|NCT00184600|716524|P2|Overall Study|Death|9
216585|NCT00184600|716525|P1|Overall Study|Death|3
216586|NCT00184600|716523|P3|Overall Study|Adverse Event|5
216587|NCT00184600|716524|P2|Overall Study|Adverse Event|0
216588|NCT00184600|716525|P1|Overall Study|Adverse Event|9
216589|NCT00184093|716616|P1|Overall Study|Withdrawal by Subject|2
216590|NCT00184093|716616|P1|Overall Study|Physician Decision|1
216591|NCT00184093|716616|P1|Overall Study|Lost to Follow-up|3
216592|NCT00184093|716616|P1|Overall Study|Adverse Event|3
216593|NCT00184054|716621|P1|Overall Study|Adverse Event|1
216594|NCT00184028|716626|P1|Overall Study|Non-compliance|2
216595|NCT00184028|716626|P1|Overall Study|Withdrawal by Subject|1
216596|NCT00184028|716626|P1|Overall Study|Adverse Event|2
216597|NCT00184028|716626|P1|Overall Study|Lack of Efficacy|4
216598|NCT00184028|716626|P1|Overall Study|Death|1
216599|NCT00184002|716631|P1|Overall Study|Withdrawal by Subject|4
216600|NCT00184002|716631|P1|Overall Study|Physician Decision|1
216601|NCT00184002|716631|P1|Overall Study|Death|3
216602|NCT00184002|716631|P1|Overall Study|Adverse Event|9
216603|NCT00183872|716657|P1|Overall Study|Drug delayed more than 28 days|2
216604|NCT00183872|716657|P1|Overall Study|Withdrawal by Subject|2
216605|NCT00183872|716657|P1|Overall Study|Adverse Event|9
216606|NCT00183872|716657|P1|Overall Study|Death|3
216607|NCT00183625|716686|P4|Overall Study|Withdrawal by Subject|14
216608|NCT00183625|716687|P3|Overall Study|Withdrawal by Subject|19
216609|NCT00183625|716688|P2|Overall Study|Withdrawal by Subject|18
216610|NCT00183625|716689|P1|Overall Study|Withdrawal by Subject|18
216611|NCT00183430|716761|P2|Overall Study|Withdrawal by Subject|0
216612|NCT00183430|716762|P1|Overall Study|Withdrawal by Subject|1
216613|NCT00183430|716761|P2|Overall Study|did not meet inclusion criteria|0
216614|NCT00183430|716762|P1|Overall Study|did not meet inclusion criteria|1
216615|NCT00183430|716761|P2|Overall Study|Lost to Follow-up|0
216616|NCT00183430|716762|P1|Overall Study|Lost to Follow-up|3
216617|NCT00183430|716761|P2|Overall Study|Adverse Event|0
216618|NCT00183430|716762|P1|Overall Study|Adverse Event|1
216619|NCT00183274|716787|P6|Phase 3: Double-Blind|Relapsed|2
216620|NCT00183274|716788|P5|Phase 3: Double-Blind|Relapsed|11
216621|NCT00183274|716789|P4|Phase 3: Double-Blind|Relapsed|1
216622|NCT00183274|716790|P3|Phase 3: Double-Blind|Relapsed|0
216623|NCT00183274|716791|P2|Phase 3: Double-Blind|Relapsed|0
216624|NCT00183274|716792|P1|Phase 3: Double-Blind|Relapsed|0
216625|NCT00183274|716787|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
216626|NCT00183274|716788|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
216627|NCT00183274|716789|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
216628|NCT00183274|716790|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
216629|NCT00183274|716791|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
216630|NCT00183274|716792|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
216631|NCT00183274|716787|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
216632|NCT00183274|716788|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
216633|NCT00183274|716789|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
216634|NCT00183274|716790|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
216635|NCT00183274|716791|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
216636|NCT00183274|716792|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
216637|NCT00183274|716787|P6|Phase 2: Double-Blind|Relapsed|0
216638|NCT00183274|716788|P5|Phase 2: Double-Blind|Relapsed|0
216639|NCT00183274|716789|P4|Phase 2: Double-Blind|Relapsed|0
216640|NCT00183274|716790|P3|Phase 2: Double-Blind|Relapsed|29
216641|NCT00183274|716791|P2|Phase 2: Double-Blind|Relapsed|8
216642|NCT00183274|716792|P1|Phase 2: Double-Blind|Relapsed|0
216643|NCT00183274|716787|P6|Phase 1: Open-Label|Other|0
216644|NCT00183274|716788|P5|Phase 1: Open-Label|Other|0
216645|NCT00183274|716789|P4|Phase 1: Open-Label|Other|0
216646|NCT00183274|716790|P3|Phase 1: Open-Label|Other|0
216647|NCT00183274|716791|P2|Phase 1: Open-Label|Other|0
216648|NCT00183274|716792|P1|Phase 1: Open-Label|Other|9
216649|NCT00183274|716787|P6|Phase 1: Open-Label|Lost to Follow-up|0
216650|NCT00183274|716788|P5|Phase 1: Open-Label|Lost to Follow-up|0
216651|NCT00183274|716789|P4|Phase 1: Open-Label|Lost to Follow-up|0
216652|NCT00183274|716790|P3|Phase 1: Open-Label|Lost to Follow-up|0
216653|NCT00183274|716791|P2|Phase 1: Open-Label|Lost to Follow-up|0
216654|NCT00183274|716792|P1|Phase 1: Open-Label|Lost to Follow-up|33
216655|NCT00183274|716787|P6|Phase 1: Open-Label|Withdrawal by Subject|0
216656|NCT00183274|716788|P5|Phase 1: Open-Label|Withdrawal by Subject|0
216657|NCT00183274|716789|P4|Phase 1: Open-Label|Withdrawal by Subject|0
216658|NCT00183274|716790|P3|Phase 1: Open-Label|Withdrawal by Subject|0
216659|NCT00183274|716791|P2|Phase 1: Open-Label|Withdrawal by Subject|0
216660|NCT00183274|716792|P1|Phase 1: Open-Label|Withdrawal by Subject|13
216661|NCT00183274|716787|P6|Phase 1: Open-Label|Protocol Violation|0
216662|NCT00183274|716788|P5|Phase 1: Open-Label|Protocol Violation|0
216663|NCT00183274|716789|P4|Phase 1: Open-Label|Protocol Violation|0
216664|NCT00183274|716790|P3|Phase 1: Open-Label|Protocol Violation|0
216665|NCT00183274|716791|P2|Phase 1: Open-Label|Protocol Violation|0
216666|NCT00183274|716792|P1|Phase 1: Open-Label|Protocol Violation|11
216667|NCT00183274|716787|P6|Phase 1: Open-Label|Lack of Efficacy|0
216668|NCT00183274|716788|P5|Phase 1: Open-Label|Lack of Efficacy|0
216669|NCT00183274|716789|P4|Phase 1: Open-Label|Lack of Efficacy|0
216670|NCT00183274|716790|P3|Phase 1: Open-Label|Lack of Efficacy|0
216671|NCT00183274|716791|P2|Phase 1: Open-Label|Lack of Efficacy|0
216672|NCT00183274|716792|P1|Phase 1: Open-Label|Lack of Efficacy|13
216673|NCT00183274|716787|P6|Phase 1: Open-Label|Adverse Event|0
216674|NCT00183274|716788|P5|Phase 1: Open-Label|Adverse Event|0
216675|NCT00183274|716789|P4|Phase 1: Open-Label|Adverse Event|0
216676|NCT00183274|716790|P3|Phase 1: Open-Label|Adverse Event|0
216677|NCT00183274|716791|P2|Phase 1: Open-Label|Adverse Event|0
216678|NCT00183274|716792|P1|Phase 1: Open-Label|Adverse Event|31
216679|NCT00183248|716809|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
216680|NCT00183248|716810|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
216681|NCT00183248|716809|P2|Overall Study|Lost to Follow-up|1
216682|NCT00183248|716810|P1|Overall Study|Lost to Follow-up|0
216683|NCT00183196|716831|P3|Overall Study|Required more intensive care|2
216684|NCT00183196|716832|P2|Overall Study|Required more intensive care|1
216685|NCT00183196|716833|P1|Overall Study|Required more intensive care|0
216686|NCT00183196|716831|P3|Overall Study|Legal event|1
216687|NCT00183196|716832|P2|Overall Study|Legal event|1
216688|NCT00183196|716833|P1|Overall Study|Legal event|1
216689|NCT00183196|716831|P3|Overall Study|Adverse Event|2
216690|NCT00183196|716832|P2|Overall Study|Adverse Event|2
216691|NCT00183196|716833|P1|Overall Study|Adverse Event|1
216692|NCT00183196|716831|P3|Overall Study|Withdrawal by Subject|13
216693|NCT00183196|716832|P2|Overall Study|Withdrawal by Subject|11
216694|NCT00183196|716833|P1|Overall Study|Withdrawal by Subject|18
216695|NCT00182689|716916|P2|Overall Study|Never received treatment|0
216696|NCT00182689|716917|P1|Overall Study|Never received treatment|1
216697|NCT00182689|716916|P2|Overall Study|Ineligible|4
216698|NCT00182689|716917|P1|Overall Study|Ineligible|1
216699|NCT00182689|716916|P2|Overall Study|not protocol specified|3
216700|NCT00182689|716917|P1|Overall Study|not protocol specified|0
216701|NCT00182689|716916|P2|Overall Study|Death|0
216702|NCT00182689|716917|P1|Overall Study|Death|1
216703|NCT00182689|716916|P2|Overall Study|Progression|29
216704|NCT00182689|716917|P1|Overall Study|Progression|27
216705|NCT00182689|716916|P2|Overall Study|Withdrawal by Subject|2
216706|NCT00182689|716917|P1|Overall Study|Withdrawal by Subject|2
216707|NCT00182689|716916|P2|Overall Study|Adverse Event|11
216708|NCT00182689|716917|P1|Overall Study|Adverse Event|8
216709|NCT00182637|716927|P1|Overall Study|Disease Progression|1
216710|NCT00182637|716927|P1|Overall Study|Adverse Event|2
216711|NCT00182091|716937|P4|Overall Study|Withdrawal by Subject|0
216712|NCT00182091|716938|P3|Overall Study|Withdrawal by Subject|0
216713|NCT00182091|716939|P2|Overall Study|Withdrawal by Subject|0
216714|NCT00182091|716940|P1|Overall Study|Withdrawal by Subject|1
216715|NCT00182078|716956|P2|Overall Study|Withdrawal by Subject|0
216716|NCT00182078|716957|P1|Overall Study|Withdrawal by Subject|1
216717|NCT00181883|716976|P1|Overall Study|Lost to Follow-up|1
216718|NCT00181883|716976|P1|Overall Study|Withdrawal by Subject|4
216719|NCT00181883|716976|P1|Overall Study|Treatment Limiting AEs|3
216720|NCT00181883|716976|P1|Overall Study|Lack of Efficacy|2
216721|NCT00181844|716980|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
216722|NCT00181844|716980|P1|Exposed to Study Medication|Withdrawal by Subject|1
216723|NCT00181844|716980|P1|Exposed to Study Medication|Non-compliance|2
216724|NCT00181844|716980|P1|Exposed to Study Medication|Lack of Efficacy|2
216725|NCT00181844|716980|P1|Exposed to Study Medication|Adverse Event|10
216726|NCT00181844|716980|P1|Signed Consent|Did not meet entrance criteria|7
216727|NCT00181844|716980|P1|Signed Consent|Withdrawal by Subject|5
216728|NCT00181766|716984|P1|Overall Study|non-compliance|2
216729|NCT00181766|716984|P1|Overall Study|Adverse Event|4
216730|NCT00181766|716984|P1|Overall Study|Lost to Follow-up|6
216731|NCT00181155|717014|P2|Overall Study|Withdrawal by Subject|0
216732|NCT00181155|717015|P1|Overall Study|Withdrawal by Subject|1
216733|NCT00181155|717014|P2|Overall Study|Physician Decision|0
216734|NCT00181155|717015|P1|Overall Study|Physician Decision|1
216735|NCT00180479|717054|P2|Overall Study|Informed consent not signed|1
216736|NCT00180479|717055|P1|Overall Study|Informed consent not signed|0
216737|NCT00180479|717054|P2|Overall Study|Withdrawal by Subject|3
216738|NCT00180479|717055|P1|Overall Study|Withdrawal by Subject|3
216739|NCT00180479|717054|P2|Overall Study|Lost to Follow-up|7
216740|NCT00180479|717055|P1|Overall Study|Lost to Follow-up|9
216741|NCT00180479|717054|P2|Overall Study|Death|2
216742|NCT00180479|717055|P1|Overall Study|Death|4
216743|NCT00179959|717165|P2|Overall Study|Withdrawal by Subject|2
216744|NCT00179959|717166|P1|Overall Study|Withdrawal by Subject|3
216745|NCT00179959|717165|P2|Overall Study|Lost to Follow-up|1
216746|NCT00179959|717166|P1|Overall Study|Lost to Follow-up|3
216747|NCT00179673|717172|P1|Overall Study|Other Observations and options|14
216748|NCT00179673|717172|P1|Overall Study|Death|4
216749|NCT00179673|717172|P1|Overall Study|Withdrawal by Subject|3
216750|NCT00179673|717172|P1|Overall Study|Lack of Efficacy|15
216751|NCT00179673|717172|P1|Overall Study|Adverse Event|7
216752|NCT00179660|717180|P1|Overall Study|Other - Unspecified|9
216753|NCT00179660|717180|P1|Overall Study|Death|3
216754|NCT00179660|717180|P1|Overall Study|Lost to Follow-up|1
216755|NCT00179660|717180|P1|Overall Study|Withdrawal by Subject|2
216756|NCT00179660|717180|P1|Overall Study|Lack of therapeutic effect|28
216757|NCT00179660|717180|P1|Overall Study|Adverse Event|7
216758|NCT00179647|717189|P1|Overall Study|Not specified|960
216759|NCT00179647|717189|P1|Overall Study|Death|94
216760|NCT00179647|717189|P1|Overall Study|Lost to Follow-up|4
216761|NCT00179647|717189|P1|Overall Study|Withdrawal by Subject|83
216762|NCT00179647|717189|P1|Overall Study|Lack of Efficacy|478
216763|NCT00179647|717189|P1|Overall Study|Adverse Event|294
216764|NCT00179621|717196|P4|Open-Label Period|Other|2
216765|NCT00179621|717197|P3|Open-Label Period|Other|1
216766|NCT00179621|717198|P2|Open-Label Period|Other|1
216767|NCT00179621|717199|P1|Open-Label Period|Other|0
216768|NCT00179621|717196|P4|Open-Label Period|Death|2
216769|NCT00179621|717197|P3|Open-Label Period|Death|1
216770|NCT00179621|717198|P2|Open-Label Period|Death|0
216771|NCT00179621|717199|P1|Open-Label Period|Death|0
216772|NCT00179621|717196|P4|Open-Label Period|Withdrawal by Subject|2
216773|NCT00179621|717197|P3|Open-Label Period|Withdrawal by Subject|2
216774|NCT00179621|717198|P2|Open-Label Period|Withdrawal by Subject|2
216775|NCT00179621|717199|P1|Open-Label Period|Withdrawal by Subject|0
216776|NCT00179621|717196|P4|Open-Label Period|Adverse Event|6
216777|NCT00179621|717197|P3|Open-Label Period|Adverse Event|5
216778|NCT00179621|717198|P2|Open-Label Period|Adverse Event|6
216779|NCT00179621|717199|P1|Open-Label Period|Adverse Event|0
216780|NCT00179621|717196|P4|Open-Label Period|Lack of Therapeutic Effect|31
216781|NCT00179621|717197|P3|Open-Label Period|Lack of Therapeutic Effect|19
216782|NCT00179621|717198|P2|Open-Label Period|Lack of Therapeutic Effect|19
216783|NCT00179621|717199|P1|Open-Label Period|Lack of Therapeutic Effect|0
216784|NCT00179621|717196|P4|Double-Blind Period|Other|0
216785|NCT00179621|717197|P3|Double-Blind Period|Other|2
216786|NCT00179621|717198|P2|Double-Blind Period|Other|2
216787|NCT00179621|717199|P1|Double-Blind Period|Other|0
216788|NCT00179621|717196|P4|Double-Blind Period|Protocol Violation|0
216789|NCT00179621|717197|P3|Double-Blind Period|Protocol Violation|0
216790|NCT00179621|717198|P2|Double-Blind Period|Protocol Violation|0
216791|NCT00179621|717199|P1|Double-Blind Period|Protocol Violation|1
216792|NCT00179621|717196|P4|Double-Blind Period|Death|0
216793|NCT00179621|717197|P3|Double-Blind Period|Death|2
216794|NCT00179621|717198|P2|Double-Blind Period|Death|1
216795|NCT00179621|717199|P1|Double-Blind Period|Death|0
216796|NCT00179621|717196|P4|Double-Blind Period|Withdrawal by Subject|0
216797|NCT00179621|717197|P3|Double-Blind Period|Withdrawal by Subject|3
216798|NCT00179621|717198|P2|Double-Blind Period|Withdrawal by Subject|1
216799|NCT00179621|717199|P1|Double-Blind Period|Withdrawal by Subject|2
216800|NCT00179621|717196|P4|Double-Blind Period|Adverse Event|0
216801|NCT00179621|717197|P3|Double-Blind Period|Adverse Event|4
216802|NCT00179621|717198|P2|Double-Blind Period|Adverse Event|7
216803|NCT00179621|717199|P1|Double-Blind Period|Adverse Event|2
216804|NCT00179621|717196|P4|Double-Blind Period|Lack of Therapeutic Effect|0
216805|NCT00179621|717197|P3|Double-Blind Period|Lack of Therapeutic Effect|19
216806|NCT00179621|717198|P2|Double-Blind Period|Lack of Therapeutic Effect|35
216807|NCT00179621|717199|P1|Double-Blind Period|Lack of Therapeutic Effect|59
216808|NCT00179517|717252|P2|Overall Study|Withdrawal by Subject|1
216809|NCT00179517|717253|P1|Overall Study|Withdrawal by Subject|2
216810|NCT00179413|717291|P2|Overall Study|Withdrawal by Subject|95
216811|NCT00179413|717292|P1|Overall Study|Withdrawal by Subject|87
216812|NCT00179413|717291|P2|Overall Study|Adverse Event|20
216813|NCT00179413|717292|P1|Overall Study|Adverse Event|38
216814|NCT00179309|717304|P2|Treatment|Allergy|0
216815|NCT00179309|717305|P1|Treatment|Allergy|1
216816|NCT00179309|717304|P2|Treatment|Withdrawal by Subject|2
216817|NCT00179309|717305|P1|Treatment|Withdrawal by Subject|1
216818|NCT00179309|717304|P2|Treatment|Toxicity|3
216819|NCT00179309|717305|P1|Treatment|Toxicity|2
216820|NCT00178685|717344|P3|Overall Study|Withdrawal by Subject|7
216821|NCT00178685|717345|P2|Overall Study|Withdrawal by Subject|14
216822|NCT00178685|717346|P1|Overall Study|Withdrawal by Subject|8
216823|NCT00178685|717344|P3|Overall Study|Lost to Follow-up|183
216824|NCT00178685|717345|P2|Overall Study|Lost to Follow-up|187
216825|NCT00178685|717346|P1|Overall Study|Lost to Follow-up|100
216826|NCT00178685|717344|P3|Overall Study|Death|6
216827|NCT00178685|717345|P2|Overall Study|Death|3
216828|NCT00178685|717346|P1|Overall Study|Death|3
216829|NCT00178633|717357|P1|Overall Study|Lost to Follow-up|6
216830|NCT00178464|717387|P1|Overall Study|Physician Decision|1
216831|NCT00178464|717387|P1|Overall Study|Withdrawal by Subject|1
216832|NCT00178256|717392|P4|Overall Study|Cancer progression|1
216833|NCT00178256|717393|P3|Overall Study|Cancer progression|0
216834|NCT00178256|717394|P2|Overall Study|Cancer progression|0
216835|NCT00178256|717395|P1|Overall Study|Cancer progression|2
216836|NCT00178256|717392|P4|Overall Study|Death|1
216837|NCT00178256|717393|P3|Overall Study|Death|0
216838|NCT00178256|717394|P2|Overall Study|Death|1
216839|NCT00178256|717395|P1|Overall Study|Death|0
216840|NCT00178256|717392|P4|Overall Study|Adverse Event|0
216841|NCT00178256|717393|P3|Overall Study|Adverse Event|0
216842|NCT00178256|717394|P2|Overall Study|Adverse Event|0
216843|NCT00178256|717395|P1|Overall Study|Adverse Event|2
216844|NCT00178126|717434|P2|Overall Study|did not receive intervention|6
216845|NCT00178126|717435|P1|Overall Study|did not receive intervention|4
216846|NCT00178126|717434|P2|Overall Study|Lost to Follow-up|21
216847|NCT00178126|717435|P1|Overall Study|Lost to Follow-up|21
216848|NCT00177671|717477|P2|Overall Study|Physician Decision|8
216849|NCT00177671|717478|P1|Overall Study|Physician Decision|12
216850|NCT00177671|717477|P2|Overall Study|Adverse Event|0
216851|NCT00177671|717478|P1|Overall Study|Adverse Event|6
216852|NCT00177671|717477|P2|Overall Study|medical complications|0
216853|NCT00177671|717478|P1|Overall Study|medical complications|2
216854|NCT00177671|717477|P2|Overall Study|Withdrawal by Subject|6
216855|NCT00177671|717478|P1|Overall Study|Withdrawal by Subject|5
216856|NCT00177307|717490|P1|Overall Study|Withdrawal by Subject|1
216857|NCT00177294|717499|P2|Overall Study|Withdrawal by Subject|5
216858|NCT00177294|717500|P1|Overall Study|Withdrawal by Subject|7
216859|NCT00177216|717514|P3|Overall Study|Withdrawal by Subject|1
216860|NCT00177216|717515|P2|Overall Study|Withdrawal by Subject|3
216861|NCT00177216|717516|P1|Overall Study|Withdrawal by Subject|6
216862|NCT00177164|717532|P2|Overall Study|Pregnancy|1
216863|NCT00177164|717533|P1|Overall Study|Pregnancy|0
216864|NCT00177164|717532|P2|Overall Study|Lack of Efficacy|1
216865|NCT00177164|717533|P1|Overall Study|Lack of Efficacy|2
216866|NCT00177164|717532|P2|Overall Study|discharge from hospital|0
216867|NCT00177164|717533|P1|Overall Study|discharge from hospital|1
216868|NCT00177164|717532|P2|Overall Study|Adverse Event|0
216869|NCT00177164|717533|P1|Overall Study|Adverse Event|1
216870|NCT00177164|717532|P2|Overall Study|increase in alcohol and drug use|2
216871|NCT00177164|717533|P1|Overall Study|increase in alcohol and drug use|1
216872|NCT00177164|717532|P2|Overall Study|Lost to Follow-up|5
216873|NCT00177164|717533|P1|Overall Study|Lost to Follow-up|4
216874|NCT00177164|717532|P2|Overall Study|Protocol Violation|7
216875|NCT00177164|717533|P1|Overall Study|Protocol Violation|0
216876|NCT00176644|717698|P1|Overall Study|Withdrawal by Subject|1
216877|NCT00176605|717711|P1|Overall Study|Withdrawal by Subject|2
216878|NCT00176488|717722|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
216879|NCT00176462|717730|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
216880|NCT00176462|717731|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
216881|NCT00176462|717730|P2|Intensive Continuation (8X8-week Cycles)|Death|0
216882|NCT00176462|717731|P1|Intensive Continuation (8X8-week Cycles)|Death|1
216883|NCT00176462|717730|P2|Consolidation (12 Weeks)|Not documented|1
216884|NCT00176462|717731|P1|Consolidation (12 Weeks)|Not documented|0
216885|NCT00176462|717730|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
216886|NCT00176462|717731|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
216887|NCT00176462|717730|P2|Consolidation (12 Weeks)|Adverse Event|1
216888|NCT00176462|717731|P1|Consolidation (12 Weeks)|Adverse Event|0
216889|NCT00176462|717730|P2|Consolidation (12 Weeks)|Patient moved to another state|1
216890|NCT00176462|717731|P1|Consolidation (12 Weeks)|Patient moved to another state|0
216891|NCT00176462|717730|P2|Induction (4 Weeks)|Lack of Efficacy|1
216892|NCT00176462|717731|P1|Induction (4 Weeks)|Lack of Efficacy|0
216893|NCT00176462|717730|P2|Induction (4 Weeks)|Death|2
216894|NCT00176462|717731|P1|Induction (4 Weeks)|Death|1
216895|NCT00176462|717730|P2|Induction (4 Weeks)|Withdrawal by Subject|2
216896|NCT00176462|717731|P1|Induction (4 Weeks)|Withdrawal by Subject|0
216897|NCT00176254|717751|P1|Overall Study|Lost to Follow-up|1
216898|NCT00175877|717779|P1|Overall Study|Withdrawal by subject & Other|1
216899|NCT00175877|717779|P1|Overall Study|AE & Other|1
216900|NCT00175877|717779|P1|Overall Study|Other Reason|20
216901|NCT00175877|717779|P1|Overall Study|Protocol Violation|15
216902|NCT00175877|717779|P1|Overall Study|Lack of Efficacy|26
216903|NCT00175877|717779|P1|Overall Study|Lost to Follow-up|9
216904|NCT00175877|717779|P1|Overall Study|Withdrawal by Subject|141
216905|NCT00175877|717779|P1|Overall Study|Adverse Event|136
216906|NCT00175019|717813|P3|Overall Study|Reason Not Specified|11
216907|NCT00175019|717814|P2|Overall Study|Reason Not Specified|34
216908|NCT00175019|717815|P1|Overall Study|Reason Not Specified|40
216909|NCT00175019|717813|P3|Overall Study|Gout Flare|0
216910|NCT00175019|717814|P2|Overall Study|Gout Flare|3
216911|NCT00175019|717815|P1|Overall Study|Gout Flare|2
216912|NCT00175019|717813|P3|Overall Study|Therapeutic Failure|22
216913|NCT00175019|717814|P2|Overall Study|Therapeutic Failure|38
216914|NCT00175019|717815|P1|Overall Study|Therapeutic Failure|10
216915|NCT00175019|717813|P3|Overall Study|Personal Reason(s)|8
216916|NCT00175019|717814|P2|Overall Study|Personal Reason(s)|31
216917|NCT00175019|717815|P1|Overall Study|Personal Reason(s)|39
216918|NCT00175019|717813|P3|Overall Study|Did not continue under Amendment 4|2
216919|NCT00175019|717814|P2|Overall Study|Did not continue under Amendment 4|1
216920|NCT00175019|717815|P1|Overall Study|Did not continue under Amendment 4|1
216921|NCT00175019|717813|P3|Overall Study|Lost to Follow-up|9
216922|NCT00175019|717814|P2|Overall Study|Lost to Follow-up|39
216923|NCT00175019|717815|P1|Overall Study|Lost to Follow-up|42
216924|NCT00175019|717813|P3|Overall Study|Protocol Violation|3
216925|NCT00175019|717814|P2|Overall Study|Protocol Violation|3
216926|NCT00175019|717815|P1|Overall Study|Protocol Violation|6
216927|NCT00175019|717813|P3|Overall Study|Adverse Event|2
216928|NCT00175019|717814|P2|Overall Study|Adverse Event|22
216929|NCT00175019|717815|P1|Overall Study|Adverse Event|54
216930|NCT00174967|717868|P4|Overall Study|Not Specified|0
216931|NCT00174967|717869|P3|Overall Study|Not Specified|0
216932|NCT00174967|717870|P2|Overall Study|Not Specified|1
216933|NCT00174967|717871|P1|Overall Study|Not Specified|0
216934|NCT00174967|717868|P4|Overall Study|Gout Flare|1
216935|NCT00174967|717869|P3|Overall Study|Gout Flare|0
216936|NCT00174967|717870|P2|Overall Study|Gout Flare|0
216937|NCT00174967|717871|P1|Overall Study|Gout Flare|0
216938|NCT00174967|717868|P4|Overall Study|Adverse Event|1
216939|NCT00174967|717869|P3|Overall Study|Adverse Event|2
216940|NCT00174967|717870|P2|Overall Study|Adverse Event|2
216941|NCT00174967|717871|P1|Overall Study|Adverse Event|1
216942|NCT00174954|717917|P1|Overall Study|Physician Decision|1
216943|NCT00174954|717917|P1|Overall Study|No tophi found in MRI|1
216944|NCT00174954|717917|P1|Overall Study|Adverse Event|2
216945|NCT00174941|717925|P4|Overall Study|Reason Not Specified|9
216946|NCT00174941|717926|P3|Overall Study|Reason Not Specified|2
216947|NCT00174941|717927|P2|Overall Study|Reason Not Specified|6
216948|NCT00174941|717928|P1|Overall Study|Reason Not Specified|1
216949|NCT00174941|717925|P4|Overall Study|Gout Flare|8
216950|NCT00174941|717926|P3|Overall Study|Gout Flare|4
216951|NCT00174941|717927|P2|Overall Study|Gout Flare|4
216952|NCT00174941|717928|P1|Overall Study|Gout Flare|0
216953|NCT00174941|717925|P4|Overall Study|Personal Reason(s)|22
216954|NCT00174941|717926|P3|Overall Study|Personal Reason(s)|8
216955|NCT00174941|717927|P2|Overall Study|Personal Reason(s)|14
216956|NCT00174941|717928|P1|Overall Study|Personal Reason(s)|0
216957|NCT00174941|717925|P4|Overall Study|Lost to Follow-up|5
216958|NCT00174941|717926|P3|Overall Study|Lost to Follow-up|2
216959|NCT00174941|717927|P2|Overall Study|Lost to Follow-up|3
216960|NCT00174941|717928|P1|Overall Study|Lost to Follow-up|0
216961|NCT00174941|717925|P4|Overall Study|Protocol Violation|1
216962|NCT00174941|717926|P3|Overall Study|Protocol Violation|0
216963|NCT00174941|717927|P2|Overall Study|Protocol Violation|1
216964|NCT00174941|717928|P1|Overall Study|Protocol Violation|0
216965|NCT00174941|717925|P4|Overall Study|Adverse Event|13
216966|NCT00174941|717926|P3|Overall Study|Adverse Event|2
216967|NCT00174941|717927|P2|Overall Study|Adverse Event|10
216968|NCT00174941|717928|P1|Overall Study|Adverse Event|1
216969|NCT00174915|718003|P5|Overall Study|Therapeutic Failure|3
216970|NCT00174915|718004|P4|Overall Study|Therapeutic Failure|1
216971|NCT00174915|718005|P3|Overall Study|Therapeutic Failure|2
216972|NCT00174915|718006|P2|Overall Study|Therapeutic Failure|3
216973|NCT00174915|718007|P1|Overall Study|Therapeutic Failure|6
216974|NCT00174915|718003|P5|Overall Study|Protocol Violation|3
216975|NCT00174915|718004|P4|Overall Study|Protocol Violation|6
216976|NCT00174915|718005|P3|Overall Study|Protocol Violation|3
216977|NCT00174915|718006|P2|Overall Study|Protocol Violation|3
216978|NCT00174915|718007|P1|Overall Study|Protocol Violation|6
216979|NCT00174915|718003|P5|Overall Study|Gout Flare|0
216980|NCT00174915|718004|P4|Overall Study|Gout Flare|1
216981|NCT00174915|718005|P3|Overall Study|Gout Flare|8
216982|NCT00174915|718006|P2|Overall Study|Gout Flare|6
216983|NCT00174915|718007|P1|Overall Study|Gout Flare|13
216984|NCT00174915|718003|P5|Overall Study|Other|3
216985|NCT00174915|718004|P4|Overall Study|Other|5
216986|NCT00174915|718005|P3|Overall Study|Other|6
216987|NCT00174915|718006|P2|Overall Study|Other|8
216988|NCT00174915|718007|P1|Overall Study|Other|15
216989|NCT00174915|718003|P5|Overall Study|Personal Reason(s)|9
216990|NCT00174915|718004|P4|Overall Study|Personal Reason(s)|9
216991|NCT00174915|718005|P3|Overall Study|Personal Reason(s)|9
216992|NCT00174915|718006|P2|Overall Study|Personal Reason(s)|16
216993|NCT00174915|718007|P1|Overall Study|Personal Reason(s)|16
216994|NCT00174915|718003|P5|Overall Study|Adverse Event|5
216995|NCT00174915|718004|P4|Overall Study|Adverse Event|18
216996|NCT00174915|718005|P3|Overall Study|Adverse Event|11
216997|NCT00174915|718006|P2|Overall Study|Adverse Event|16
216998|NCT00174915|718007|P1|Overall Study|Adverse Event|18
216999|NCT00174915|718003|P5|Overall Study|Lost to Follow-up|10
217000|NCT00174915|718004|P4|Overall Study|Lost to Follow-up|17
217001|NCT00174915|718005|P3|Overall Study|Lost to Follow-up|9
217002|NCT00174915|718006|P2|Overall Study|Lost to Follow-up|17
217003|NCT00174915|718007|P1|Overall Study|Lost to Follow-up|19
217004|NCT00174785|718066|P2|Overall Study|Not pre-specified/Not coded|70
217005|NCT00174785|718067|P1|Overall Study|Not pre-specified/Not coded|56
217006|NCT00174785|718066|P2|Overall Study|Family request|8
217007|NCT00174785|718067|P1|Overall Study|Family request|6
217008|NCT00174785|718066|P2|Overall Study|Other prohibited medication|3
217009|NCT00174785|718067|P1|Overall Study|Other prohibited medication|5
217010|NCT00174785|718066|P2|Overall Study|Prohibited antiarrhythmic medication|88
217011|NCT00174785|718067|P1|Overall Study|Prohibited antiarrhythmic medication|39
217012|NCT00174785|718066|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
217013|NCT00174785|718067|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
217014|NCT00174785|718066|P2|Overall Study|Withdrawal by Subject|175
217015|NCT00174785|718067|P1|Overall Study|Withdrawal by Subject|173
217016|NCT00174785|718066|P2|Overall Study|Protocol Violation|14
217017|NCT00174785|718067|P1|Overall Study|Protocol Violation|14
217018|NCT00174785|718066|P2|Overall Study|Adverse Event|191
217019|NCT00174785|718067|P1|Overall Study|Adverse Event|293
217020|NCT00174460|718083|P2|Overall Study|Withdrawal by Subject|1
217021|NCT00174460|718084|P1|Overall Study|Withdrawal by Subject|0
217022|NCT00174447|718130|P1|Overall Study|Administrative reason/Other|2
217023|NCT00174447|718130|P1|Overall Study|Lack of Efficacy|1
217024|NCT00174447|718130|P1|Overall Study|Protocol Violation|1
217025|NCT00174447|718130|P1|Overall Study|Withdrawal by Subject|15
217026|NCT00174447|718130|P1|Overall Study|Adverse Event|19
217027|NCT00174382|718139|P1|Overall Study|Lost to Follow-up|1
217028|NCT00174382|718139|P1|Overall Study|Subject felt pill not effective enough|1
217029|NCT00174382|718139|P1|Overall Study|Arrived early for last visit in error|1
217030|NCT00174382|718139|P1|Overall Study|Protocol Violation|3
217031|NCT00174382|718139|P1|Overall Study|Withdrawal by Subject|6
217032|NCT00174382|718139|P1|Overall Study|Adverse Event|19
217033|NCT00174382|718139|P1|Overall Study|Death|2
217034|NCT00174291|718158|P2|Overall Study|Withdrawal by Subject|3
217035|NCT00174291|718159|P1|Overall Study|Withdrawal by Subject|3
217036|NCT00174291|718158|P2|Overall Study|Study terminated by sponsor|0
217037|NCT00174291|718159|P1|Overall Study|Study terminated by sponsor|1
217038|NCT00174291|718158|P2|Overall Study|Protocol Violation|2
217039|NCT00174291|718159|P1|Overall Study|Protocol Violation|0
217040|NCT00174291|718158|P2|Overall Study|Lost to Follow-up|1
217041|NCT00174291|718159|P1|Overall Study|Lost to Follow-up|1
217042|NCT00174265|718189|P2|Overall Study|Other (Not specified)|10
217043|NCT00174265|718190|P1|Overall Study|Other (Not specified)|16
217044|NCT00174265|718189|P2|Overall Study|Lost to Follow-up|0
217045|NCT00174265|718190|P1|Overall Study|Lost to Follow-up|1
217046|NCT00174265|718189|P2|Overall Study|Withdrawal by Subject|5
217047|NCT00174265|718190|P1|Overall Study|Withdrawal by Subject|3
217048|NCT00174265|718189|P2|Overall Study|Lack of Efficacy|2
217049|NCT00174265|718190|P1|Overall Study|Lack of Efficacy|2
217050|NCT00174265|718189|P2|Overall Study|Adverse Event|4
217051|NCT00174265|718190|P1|Overall Study|Adverse Event|7
217052|NCT00174252|718198|P1|Overall Study|Protocol Violation|2
217053|NCT00174187|718233|P3|Period 2 (After 3 Years)|Other|5
217054|NCT00174187|718234|P2|Period 2 (After 3 Years)|Other|0
217055|NCT00174187|718235|P1|Period 2 (After 3 Years)|Other|0
217056|NCT00174187|718233|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
217057|NCT00174187|718234|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
217058|NCT00174187|718235|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
217059|NCT00174187|718233|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
217060|NCT00174187|718234|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
217061|NCT00174187|718235|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
217062|NCT00174187|718233|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
217063|NCT00174187|718234|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
217064|NCT00174187|718235|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
217065|NCT00174187|718233|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
217066|NCT00174187|718234|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
217067|NCT00174187|718235|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
217068|NCT00174187|718233|P3|Period 1 (up to 3 Years)|Other|0
217069|NCT00174187|718234|P2|Period 1 (up to 3 Years)|Other|1
217070|NCT00174187|718235|P1|Period 1 (up to 3 Years)|Other|0
217071|NCT00174187|718233|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
217072|NCT00174187|718234|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
217073|NCT00174187|718235|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
217074|NCT00174187|718233|P3|Period 1 (up to 3 Years)|Non compliance|0
217075|NCT00174187|718234|P2|Period 1 (up to 3 Years)|Non compliance|1
217076|NCT00174187|718235|P1|Period 1 (up to 3 Years)|Non compliance|0
217077|NCT00174187|718233|P3|Period 1 (up to 3 Years)|Serious adverse event|0
217078|NCT00174187|718234|P2|Period 1 (up to 3 Years)|Serious adverse event|1
217079|NCT00174187|718235|P1|Period 1 (up to 3 Years)|Serious adverse event|0
217080|NCT00172185|718300|P4|Overall Study|Withdrawal by Subject|0
217081|NCT00172185|718301|P3|Overall Study|Withdrawal by Subject|1
217082|NCT00172185|718302|P2|Overall Study|Withdrawal by Subject|0
217083|NCT00172185|718303|P1|Overall Study|Withdrawal by Subject|0
217084|NCT00172185|718300|P4|Overall Study|SPONSOR Decision|0
217085|NCT00172185|718301|P3|Overall Study|SPONSOR Decision|0
217086|NCT00172185|718302|P2|Overall Study|SPONSOR Decision|1
217087|NCT00172185|718303|P1|Overall Study|SPONSOR Decision|0
217088|NCT00172185|718300|P4|Overall Study|Physician Decision|0
217089|NCT00172185|718301|P3|Overall Study|Physician Decision|1
217090|NCT00172185|718302|P2|Overall Study|Physician Decision|0
217091|NCT00172185|718303|P1|Overall Study|Physician Decision|0
217092|NCT00172185|718300|P4|Overall Study|Adverse Event|4
217093|NCT00172185|718301|P3|Overall Study|Adverse Event|3
217094|NCT00172185|718302|P2|Overall Study|Adverse Event|1
217095|NCT00172185|718303|P1|Overall Study|Adverse Event|0
217096|NCT00172042|718319|P2|Overall Study|Death|42
217097|NCT00172042|718320|P1|Overall Study|Death|42
217098|NCT00172042|718319|P2|Overall Study|Administrative problems|10
217099|NCT00172042|718320|P1|Overall Study|Administrative problems|13
217100|NCT00172042|718319|P2|Overall Study|Lost to Follow-up|5
217101|NCT00172042|718320|P1|Overall Study|Lost to Follow-up|3
217102|NCT00172042|718319|P2|Overall Study|Withdrawal by Subject|25
217103|NCT00172042|718320|P1|Overall Study|Withdrawal by Subject|37
217104|NCT00172042|718319|P2|Overall Study|Protocol Violation|7
217105|NCT00172042|718320|P1|Overall Study|Protocol Violation|8
217106|NCT00172042|718319|P2|Overall Study|Patient no longer requires study drug|8
217107|NCT00172042|718320|P1|Overall Study|Patient no longer requires study drug|10
217108|NCT00172042|718319|P2|Overall Study|Unsatisfactory therapeutic effect|11
217109|NCT00172042|718320|P1|Overall Study|Unsatisfactory therapeutic effect|13
217110|NCT00172042|718319|P2|Overall Study|Abnormal test procedure(s)|3
217111|NCT00172042|718320|P1|Overall Study|Abnormal test procedure(s)|0
217112|NCT00172042|718319|P2|Overall Study|Abnormal laboratory value(s)|1
217113|NCT00172042|718320|P1|Overall Study|Abnormal laboratory value(s)|5
217114|NCT00172042|718319|P2|Overall Study|Adverse Event|13
217115|NCT00172042|718320|P1|Overall Study|Adverse Event|27
217116|NCT00171925|718342|P2|Overall Study|Death|2
217117|NCT00171925|718343|P1|Overall Study|Death|1
217118|NCT00171925|718342|P2|Overall Study|Administrative problems|11
217119|NCT00171925|718343|P1|Overall Study|Administrative problems|10
217120|NCT00171925|718342|P2|Overall Study|Lost to Follow-up|2
217121|NCT00171925|718343|P1|Overall Study|Lost to Follow-up|2
217122|NCT00171925|718342|P2|Overall Study|Withdrawal by Subject|9
217123|NCT00171925|718343|P1|Overall Study|Withdrawal by Subject|6
217124|NCT00171925|718342|P2|Overall Study|Protocol Violation|1
217125|NCT00171925|718343|P1|Overall Study|Protocol Violation|1
217126|NCT00171925|718342|P2|Overall Study|Adverse Event|6
217127|NCT00171925|718343|P1|Overall Study|Adverse Event|10
217128|NCT00171873|718355|P2|Overall Study|Switched to Octreotide|1
217129|NCT00171873|718356|P1|Overall Study|Switched to Octreotide|0
217130|NCT00171873|718355|P2|Overall Study|Adverse Event|0
217131|NCT00171873|718356|P1|Overall Study|Adverse Event|5
217132|NCT00171873|718355|P2|Overall Study|Withdrawal by Subject|2
217133|NCT00171873|718356|P1|Overall Study|Withdrawal by Subject|4
217134|NCT00171834|718369|P7|Overall Study|Treatment Duration Completed|0
217135|NCT00171834|718370|P6|Overall Study|Treatment Duration Completed|1
217136|NCT00171834|718371|P5|Overall Study|Treatment Duration Completed|2
217137|NCT00171834|718372|P4|Overall Study|Treatment Duration Completed|0
217138|NCT00171834|718373|P3|Overall Study|Treatment Duration Completed|1
217139|NCT00171834|718374|P2|Overall Study|Treatment Duration Completed|0
217140|NCT00171834|718375|P1|Overall Study|Treatment Duration Completed|0
217141|NCT00171834|718369|P7|Overall Study|Disease Progression|3
217142|NCT00171834|718370|P6|Overall Study|Disease Progression|18
217143|NCT00171834|718371|P5|Overall Study|Disease Progression|2
217144|NCT00171834|718372|P4|Overall Study|Disease Progression|9
217145|NCT00171834|718373|P3|Overall Study|Disease Progression|8
217146|NCT00171834|718374|P2|Overall Study|Disease Progression|8
217147|NCT00171834|718375|P1|Overall Study|Disease Progression|4
217148|NCT00171834|718369|P7|Overall Study|Death from study indication|0
217149|NCT00171834|718370|P6|Overall Study|Death from study indication|0
217150|NCT00171834|718371|P5|Overall Study|Death from study indication|1
217151|NCT00171834|718372|P4|Overall Study|Death from study indication|0
217152|NCT00171834|718373|P3|Overall Study|Death from study indication|0
217153|NCT00171834|718374|P2|Overall Study|Death from study indication|1
217154|NCT00171834|718375|P1|Overall Study|Death from study indication|0
217155|NCT00171834|718369|P7|Overall Study|Withdrawal by Subject|0
217156|NCT00171834|718370|P6|Overall Study|Withdrawal by Subject|1
217157|NCT00171834|718371|P5|Overall Study|Withdrawal by Subject|1
217158|NCT00171834|718372|P4|Overall Study|Withdrawal by Subject|1
217159|NCT00171834|718373|P3|Overall Study|Withdrawal by Subject|0
217160|NCT00171834|718374|P2|Overall Study|Withdrawal by Subject|2
217161|NCT00171834|718375|P1|Overall Study|Withdrawal by Subject|0
217162|NCT00171834|718369|P7|Overall Study|Adverse Event|1
217163|NCT00171834|718370|P6|Overall Study|Adverse Event|15
217164|NCT00171834|718371|P5|Overall Study|Adverse Event|2
217165|NCT00171834|718372|P4|Overall Study|Adverse Event|2
217166|NCT00171834|718373|P3|Overall Study|Adverse Event|3
217167|NCT00171834|718374|P2|Overall Study|Adverse Event|1
217168|NCT00171834|718375|P1|Overall Study|Adverse Event|2
217169|NCT00171704|718415|P2|Overall Study|Protocol Violation|1
217170|NCT00171704|718416|P1|Overall Study|Protocol Violation|0
217171|NCT00171704|718415|P2|Overall Study|Withdrawal by Subject|3
217172|NCT00171704|718416|P1|Overall Study|Withdrawal by Subject|1
217173|NCT00171704|718415|P2|Overall Study|Death|2
217174|NCT00171704|718416|P1|Overall Study|Death|2
217175|NCT00171704|718415|P2|Overall Study|Administrative Problems|1
217176|NCT00171704|718416|P1|Overall Study|Administrative Problems|2
217177|NCT00171704|718415|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
217178|NCT00171704|718416|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
217179|NCT00171704|718415|P2|Overall Study|Disease Progression|9
217180|NCT00171704|718416|P1|Overall Study|Disease Progression|14
217181|NCT00171704|718415|P2|Overall Study|Adverse Event|33
217182|NCT00171704|718416|P1|Overall Study|Adverse Event|24
217183|NCT00171340|718438|P2|Overall Study|Death|6
217184|NCT00171340|718439|P1|Overall Study|Death|6
217185|NCT00171340|718438|P2|Overall Study|Administrative Problems|2
217186|NCT00171340|718439|P1|Overall Study|Administrative Problems|5
217187|NCT00171340|718438|P2|Overall Study|No Longer Required Study Drug|1
217188|NCT00171340|718439|P1|Overall Study|No Longer Required Study Drug|1
217189|NCT00171340|718438|P2|Overall Study|Abnormal Test Procedure Results|11
217190|NCT00171340|718439|P1|Overall Study|Abnormal Test Procedure Results|6
217191|NCT00171340|718438|P2|Overall Study|Abnormal Laboratory Results|0
217192|NCT00171340|718439|P1|Overall Study|Abnormal Laboratory Results|2
217193|NCT00171340|718438|P2|Overall Study|Lost to Follow-up|5
217194|NCT00171340|718439|P1|Overall Study|Lost to Follow-up|0
217195|NCT00171340|718438|P2|Overall Study|Withdrawal by Subject|19
217196|NCT00171340|718439|P1|Overall Study|Withdrawal by Subject|22
217197|NCT00171340|718438|P2|Overall Study|Protocol Violation|8
217198|NCT00171340|718439|P1|Overall Study|Protocol Violation|7
217199|NCT00171340|718438|P2|Overall Study|Lack of Efficacy|41
217200|NCT00171340|718439|P1|Overall Study|Lack of Efficacy|29
217201|NCT00171340|718438|P2|Overall Study|Adverse Event|42
217202|NCT00171340|718439|P1|Overall Study|Adverse Event|46
217203|NCT00171314|718455|P2|Overall Study|Death|1
217204|NCT00171314|718456|P1|Overall Study|Death|2
217205|NCT00171314|718455|P2|Overall Study|Lost to Follow-up|3
217206|NCT00171314|718456|P1|Overall Study|Lost to Follow-up|1
217207|NCT00171314|718455|P2|Overall Study|Administrative Problems|3
217208|NCT00171314|718456|P1|Overall Study|Administrative Problems|4
217209|NCT00171314|718455|P2|Overall Study|Protocol Violation|7
217210|NCT00171314|718456|P1|Overall Study|Protocol Violation|3
217211|NCT00171314|718455|P2|Overall Study|Abnormal Test Procedure Results|3
217212|NCT00171314|718456|P1|Overall Study|Abnormal Test Procedure Results|9
217213|NCT00171314|718455|P2|Overall Study|Withdrawal by Subject|6
217214|NCT00171314|718456|P1|Overall Study|Withdrawal by Subject|9
217215|NCT00171314|718455|P2|Overall Study|Lack of Efficacy|14
217216|NCT00171314|718456|P1|Overall Study|Lack of Efficacy|19
217217|NCT00171314|718455|P2|Overall Study|Adverse Event|41
217218|NCT00171314|718456|P1|Overall Study|Adverse Event|44
217219|NCT00171301|718472|P2|Overall Study|Withdrawal by Subject|1
217220|NCT00171301|718473|P1|Overall Study|Withdrawal by Subject|0
217221|NCT00171301|718472|P2|Overall Study|Protocol Violation|2
217222|NCT00171301|718473|P1|Overall Study|Protocol Violation|0
217223|NCT00171301|718472|P2|Overall Study|Lost to Follow-up|2
217224|NCT00171301|718473|P1|Overall Study|Lost to Follow-up|6
217225|NCT00171301|718472|P2|Overall Study|Adverse Event|2
217226|NCT00171301|718473|P1|Overall Study|Adverse Event|1
217227|NCT00171301|718472|P2|Overall Study|Death|2
217228|NCT00171301|718473|P1|Overall Study|Death|1
217229|NCT00171210|718486|P2|Overall Study|Stopped at end of extension 1|1
217230|NCT00171210|718487|P1|Overall Study|Stopped at end of extension 1|0
217231|NCT00171210|718486|P2|Overall Study|Stopped at end of core|32
217232|NCT00171210|718487|P1|Overall Study|Stopped at end of core|0
217233|NCT00171210|718486|P2|Overall Study|Death|3
217234|NCT00171210|718487|P1|Overall Study|Death|2
217235|NCT00171210|718486|P2|Overall Study|Administrative problems|1
217236|NCT00171210|718487|P1|Overall Study|Administrative problems|1
217237|NCT00171210|718486|P2|Overall Study|Lost to Follow-up|0
217238|NCT00171210|718487|P1|Overall Study|Lost to Follow-up|1
217239|NCT00171210|718486|P2|Overall Study|Withdrawal by Subject|30
217240|NCT00171210|718487|P1|Overall Study|Withdrawal by Subject|32
217241|NCT00171210|718486|P2|Overall Study|Protocol Violation|2
217242|NCT00171210|718487|P1|Overall Study|Protocol Violation|0
217243|NCT00171210|718486|P2|Overall Study|Unsatisfactory therapeutic effect|15
217244|NCT00171210|718487|P1|Overall Study|Unsatisfactory therapeutic effect|11
217245|NCT00171210|718486|P2|Overall Study|Abnormal test procedure result(s)|1
217246|NCT00171210|718487|P1|Overall Study|Abnormal test procedure result(s)|0
217247|NCT00171210|718486|P2|Overall Study|Abnormal laboratory value(s)|3
217248|NCT00171210|718487|P1|Overall Study|Abnormal laboratory value(s)|6
217249|NCT00171210|718486|P2|Overall Study|Adverse Event|27
217250|NCT00171210|718487|P1|Overall Study|Adverse Event|16
217251|NCT00171054|718517|P2|Overall Study|Condition no longer required study drug|1
217252|NCT00171054|718518|P1|Overall Study|Condition no longer required study drug|0
217253|NCT00171054|718517|P2|Overall Study|Adverse Event|8
217254|NCT00171054|718518|P1|Overall Study|Adverse Event|8
217255|NCT00171054|718517|P2|Overall Study|Lost to Follow-up|1
217256|NCT00171054|718518|P1|Overall Study|Lost to Follow-up|0
217257|NCT00171054|718517|P2|Overall Study|Patient withdrew consent|0
217258|NCT00171054|718518|P1|Overall Study|Patient withdrew consent|1
217259|NCT00171054|718517|P2|Overall Study|Protocol Violation|2
217260|NCT00171054|718518|P1|Overall Study|Protocol Violation|1
217261|NCT00170950|718550|P2|Overall Study|Termination Data Not Recorded|22
217262|NCT00170950|718551|P1|Overall Study|Termination Data Not Recorded|17
217263|NCT00170950|718550|P2|Overall Study|Missing|1
217264|NCT00170950|718551|P1|Overall Study|Missing|2
217265|NCT00170950|718550|P2|Overall Study|Lost to Follow-up|115
217266|NCT00170950|718551|P1|Overall Study|Lost to Follow-up|134
217267|NCT00170950|718550|P2|Overall Study|Withdrawal by Subject|498
217268|NCT00170950|718551|P1|Overall Study|Withdrawal by Subject|496
217269|NCT00170950|718550|P2|Overall Study|Death|274
217270|NCT00170950|718551|P1|Overall Study|Death|236
217271|NCT00170846|718564|P3|Overall Study|Reason Missing|0
217272|NCT00170846|718565|P2|Overall Study|Reason Missing|1
217273|NCT00170846|718566|P1|Overall Study|Reason Missing|0
217274|NCT00170846|718564|P3|Overall Study|Death|3
217275|NCT00170846|718565|P2|Overall Study|Death|3
217276|NCT00170846|718566|P1|Overall Study|Death|0
217277|NCT00170846|718564|P3|Overall Study|Lost to Follow-up|2
217278|NCT00170846|718565|P2|Overall Study|Lost to Follow-up|3
217279|NCT00170846|718566|P1|Overall Study|Lost to Follow-up|6
217280|NCT00170846|718564|P3|Overall Study|Subject withdrew Informed Consent|8
217281|NCT00170846|718565|P2|Overall Study|Subject withdrew Informed Consent|12
217282|NCT00170846|718566|P1|Overall Study|Subject withdrew Informed Consent|5
217283|NCT00169442|718598|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
217284|NCT00169442|718599|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
217285|NCT00169442|718600|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
217286|NCT00169442|718601|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
217287|NCT00169442|718602|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
217288|NCT00169442|718603|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
217289|NCT00169442|718598|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
217290|NCT00169442|718599|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
217291|NCT00169442|718600|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
217292|NCT00169442|718601|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
217293|NCT00169442|718602|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
217294|NCT00169442|718603|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
217295|NCT00169442|718598|P6|Overall Study|Migrated/moved from study area|2
217296|NCT00169442|718599|P5|Overall Study|Migrated/moved from study area|0
217297|NCT00169442|718600|P4|Overall Study|Migrated/moved from study area|0
217298|NCT00169442|718601|P3|Overall Study|Migrated/moved from study area|0
217299|NCT00169442|718602|P2|Overall Study|Migrated/moved from study area|0
217300|NCT00169442|718603|P1|Overall Study|Migrated/moved from study area|0
217301|NCT00169442|718598|P6|Overall Study|Withdrawal by Subject|0
217302|NCT00169442|718599|P5|Overall Study|Withdrawal by Subject|0
217303|NCT00169442|718600|P4|Overall Study|Withdrawal by Subject|0
217304|NCT00169442|718601|P3|Overall Study|Withdrawal by Subject|1
217305|NCT00169442|718602|P2|Overall Study|Withdrawal by Subject|0
217306|NCT00169442|718603|P1|Overall Study|Withdrawal by Subject|0
217307|NCT00168844|718713|P3|Overall Study|Other|9
217308|NCT00168844|718714|P2|Overall Study|Other|7
217309|NCT00168844|718715|P1|Overall Study|Other|6
217310|NCT00168844|718713|P3|Overall Study|Protocol Violation|4
217311|NCT00168844|718714|P2|Overall Study|Protocol Violation|2
217312|NCT00168844|718715|P1|Overall Study|Protocol Violation|2
217313|NCT00168844|718713|P3|Overall Study|Withdrawal by Subject|19
217314|NCT00168844|718714|P2|Overall Study|Withdrawal by Subject|9
217315|NCT00168844|718715|P1|Overall Study|Withdrawal by Subject|12
217316|NCT00168844|718713|P3|Overall Study|Lost to Follow-up|11
217317|NCT00168844|718714|P2|Overall Study|Lost to Follow-up|5
217318|NCT00168844|718715|P1|Overall Study|Lost to Follow-up|4
217319|NCT00168844|718713|P3|Overall Study|Adverse Event|48
217320|NCT00168844|718714|P2|Overall Study|Adverse Event|32
217321|NCT00168844|718715|P1|Overall Study|Adverse Event|31
217322|NCT00168831|718897|P3|Overall Study|Other|6
217323|NCT00168831|718898|P2|Overall Study|Other|3
217324|NCT00168831|718899|P1|Overall Study|Other|6
217325|NCT00168831|718897|P3|Overall Study|Protocol Violation|11
217326|NCT00168831|718898|P2|Overall Study|Protocol Violation|11
217327|NCT00168831|718899|P1|Overall Study|Protocol Violation|6
217328|NCT00168831|718897|P3|Overall Study|Withdrawal by Subject|19
217329|NCT00168831|718898|P2|Overall Study|Withdrawal by Subject|14
217330|NCT00168831|718899|P1|Overall Study|Withdrawal by Subject|7
217331|NCT00168831|718897|P3|Overall Study|Lost to Follow-up|4
217332|NCT00168831|718898|P2|Overall Study|Lost to Follow-up|6
217333|NCT00168831|718899|P1|Overall Study|Lost to Follow-up|5
217334|NCT00168831|718897|P3|Overall Study|Adverse Event|74
217335|NCT00168831|718898|P2|Overall Study|Adverse Event|47
217336|NCT00168831|718899|P1|Overall Study|Adverse Event|36
217337|NCT00168818|719081|P3|Treatment|not specified|31
217338|NCT00168818|719082|P2|Treatment|not specified|29
217339|NCT00168818|719083|P1|Treatment|not specified|23
217340|NCT00168818|719081|P3|Treatment|Withdrawal by Subject|22
217341|NCT00168818|719082|P2|Treatment|Withdrawal by Subject|20
217342|NCT00168818|719083|P1|Treatment|Withdrawal by Subject|25
217343|NCT00168818|719081|P3|Treatment|Lost to Follow-up|1
217344|NCT00168818|719082|P2|Treatment|Lost to Follow-up|2
217345|NCT00168818|719083|P1|Treatment|Lost to Follow-up|0
217346|NCT00168818|719081|P3|Treatment|Protocol Violation|11
217347|NCT00168818|719082|P2|Treatment|Protocol Violation|11
217348|NCT00168818|719083|P1|Treatment|Protocol Violation|8
217349|NCT00168818|719081|P3|Treatment|Adverse Event|68
217350|NCT00168818|719082|P2|Treatment|Adverse Event|89
217351|NCT00168818|719083|P1|Treatment|Adverse Event|77
217352|NCT00168818|719081|P3|Overall Study|not specified|30
217353|NCT00168818|719082|P2|Overall Study|not specified|24
217354|NCT00168818|719083|P1|Overall Study|not specified|22
217355|NCT00168818|719081|P3|Overall Study|Withdrawal by Subject|37
217356|NCT00168818|719082|P2|Overall Study|Withdrawal by Subject|41
217357|NCT00168818|719083|P1|Overall Study|Withdrawal by Subject|43
217358|NCT00168818|719081|P3|Overall Study|Lost to Follow-up|15
217359|NCT00168818|719082|P2|Overall Study|Lost to Follow-up|4
217360|NCT00168818|719083|P1|Overall Study|Lost to Follow-up|13
217361|NCT00168818|719081|P3|Overall Study|Protocol Violation|11
217362|NCT00168818|719082|P2|Overall Study|Protocol Violation|11
217363|NCT00168818|719083|P1|Overall Study|Protocol Violation|16
217364|NCT00168818|719081|P3|Overall Study|Adverse Event|31
217365|NCT00168818|719082|P2|Overall Study|Adverse Event|29
217366|NCT00168818|719083|P1|Overall Study|Adverse Event|23
217367|NCT00168805|719127|P3|Treatment|not specified|17
217368|NCT00168805|719128|P2|Treatment|not specified|18
217369|NCT00168805|719129|P1|Treatment|not specified|18
217370|NCT00168805|719127|P3|Treatment|Withdrawal by Subject|8
217371|NCT00168805|719128|P2|Treatment|Withdrawal by Subject|7
217372|NCT00168805|719129|P1|Treatment|Withdrawal by Subject|3
217373|NCT00168805|719127|P3|Treatment|Protocol Violation|5
217374|NCT00168805|719128|P2|Treatment|Protocol Violation|5
217375|NCT00168805|719129|P1|Treatment|Protocol Violation|3
217376|NCT00168805|719127|P3|Treatment|Adverse Event|32
217377|NCT00168805|719128|P2|Treatment|Adverse Event|26
217378|NCT00168805|719129|P1|Treatment|Adverse Event|25
217379|NCT00168805|719127|P3|Overall Study|not specified|22
217380|NCT00168805|719128|P2|Overall Study|not specified|21
217381|NCT00168805|719129|P1|Overall Study|not specified|24
217382|NCT00168805|719127|P3|Overall Study|Withdrawal by Subject|21
217383|NCT00168805|719128|P2|Overall Study|Withdrawal by Subject|18
217384|NCT00168805|719129|P1|Overall Study|Withdrawal by Subject|16
217385|NCT00168805|719127|P3|Overall Study|Lost to Follow-up|11
217386|NCT00168805|719128|P2|Overall Study|Lost to Follow-up|17
217387|NCT00168805|719129|P1|Overall Study|Lost to Follow-up|12
217388|NCT00168805|719127|P3|Overall Study|Protocol Violation|8
217389|NCT00168805|719128|P2|Overall Study|Protocol Violation|11
217390|NCT00168805|719129|P1|Overall Study|Protocol Violation|12
217391|NCT00168805|719127|P3|Overall Study|Adverse Event|16
217392|NCT00168805|719128|P2|Overall Study|Adverse Event|11
217393|NCT00168805|719129|P1|Overall Study|Adverse Event|7
217394|NCT00168103|719365|P4|Overall Study|Lost to Follow-up|0
217395|NCT00168103|719366|P3|Overall Study|Lost to Follow-up|0
217396|NCT00168103|719367|P2|Overall Study|Lost to Follow-up|3
217397|NCT00168103|719368|P1|Overall Study|Lost to Follow-up|1
217398|NCT00168103|719365|P4|Overall Study|Withdrawal by Subject|0
217399|NCT00168103|719366|P3|Overall Study|Withdrawal by Subject|1
217400|NCT00168103|719367|P2|Overall Study|Withdrawal by Subject|2
217401|NCT00168103|719368|P1|Overall Study|Withdrawal by Subject|1
217402|NCT00168064|719390|P2|Overall Study|Various|3
217403|NCT00168064|719391|P1|Overall Study|Various|4
217404|NCT00168064|719390|P2|Overall Study|Subject's Best interest|2
217405|NCT00168064|719391|P1|Overall Study|Subject's Best interest|2
217406|NCT00168064|719390|P2|Overall Study|Concurrent Illness|3
217407|NCT00168064|719391|P1|Overall Study|Concurrent Illness|4
217408|NCT00168064|719390|P2|Overall Study|Non-compliance|3
217409|NCT00168064|719391|P1|Overall Study|Non-compliance|2
217410|NCT00168064|719390|P2|Overall Study|Lost to Follow-up|3
217411|NCT00168064|719391|P1|Overall Study|Lost to Follow-up|4
217412|NCT00168064|719390|P2|Overall Study|Lack of Efficacy|4
217413|NCT00168064|719391|P1|Overall Study|Lack of Efficacy|4
217414|NCT00168064|719390|P2|Overall Study|Withdrawal by Subject|4
217415|NCT00168064|719391|P1|Overall Study|Withdrawal by Subject|3
217416|NCT00168064|719390|P2|Overall Study|Adverse Event|22
217417|NCT00168064|719391|P1|Overall Study|Adverse Event|26
217418|NCT00168038|719399|P1|Overall Study|Therapy failure|1
217419|NCT00168038|719399|P1|Overall Study|Adverse Event|1
217420|NCT00167778|719411|P1|Overall Study|Withdrawal by Subject|1
217421|NCT00167414|719477|P1|Overall Study|Death|10
217422|NCT00167310|719502|P2|Overall Study|Withdrawal by Subject|7
217423|NCT00167310|719503|P1|Overall Study|Withdrawal by Subject|3
217424|NCT00167310|719502|P2|Overall Study|Protocol Violation|3
217425|NCT00167310|719503|P1|Overall Study|Protocol Violation|5
217426|NCT00167245|719513|P2|Overall Study|Drowsy|0
217427|NCT00167245|719514|P1|Overall Study|Drowsy|1
217428|NCT00167245|719513|P2|Overall Study|Incarcerated|2
217429|NCT00167245|719514|P1|Overall Study|Incarcerated|3
217430|NCT00167245|719513|P2|Overall Study|Withdrawal by Subject|8
217431|NCT00167245|719514|P1|Overall Study|Withdrawal by Subject|5
217432|NCT00167245|719513|P2|Overall Study|Lost to Follow-up|31
217433|NCT00167245|719514|P1|Overall Study|Lost to Follow-up|20
217434|NCT00166712|719564|P2|Overall Study|Physician Decision|2
217435|NCT00166712|719565|P1|Overall Study|Physician Decision|0
217436|NCT00166712|719564|P2|Overall Study|Withdrawal by Subject|2
217437|NCT00166712|719565|P1|Overall Study|Withdrawal by Subject|1
217438|NCT00166712|719564|P2|Overall Study|Adverse Event|0
217439|NCT00166712|719565|P1|Overall Study|Adverse Event|1
217440|NCT00166712|719564|P2|Overall Study|Death|1
217441|NCT00166712|719565|P1|Overall Study|Death|0
217442|NCT00166517|719582|P2|Overall Study|Withdrawal by Subject|1
217443|NCT00166517|719583|P1|Overall Study|Withdrawal by Subject|0
217444|NCT00166517|719582|P2|Overall Study|Protocol Violation|1
217445|NCT00166517|719583|P1|Overall Study|Protocol Violation|4
217446|NCT00166517|719582|P2|Overall Study|Lost to Follow-up|0
217447|NCT00166517|719583|P1|Overall Study|Lost to Follow-up|1
217448|NCT00166504|719593|P2|Overall Study|Withdrawal by Subject|0
217449|NCT00166504|719594|P1|Overall Study|Withdrawal by Subject|1
217450|NCT00166504|719593|P2|Overall Study|Lost to Follow-up|1
217451|NCT00166504|719594|P1|Overall Study|Lost to Follow-up|1
217452|NCT00166504|719593|P2|Overall Study|Adverse Event|3
217453|NCT00166504|719594|P1|Overall Study|Adverse Event|3
217454|NCT00166296|719611|P2|Overall Study|Lost to Follow-up|2
217455|NCT00166296|719612|P1|Overall Study|Lost to Follow-up|4
217456|NCT00166296|719611|P2|Overall Study|Adverse Event|4
217457|NCT00166296|719612|P1|Overall Study|Adverse Event|2
217458|NCT00166296|719611|P2|Overall Study|Withdrawal by Subject|3
217459|NCT00166296|719612|P1|Overall Study|Withdrawal by Subject|1
217460|NCT00166114|719664|P2|Overall Study|Adverse Event|1
217461|NCT00166114|719665|P1|Overall Study|Adverse Event|2
217462|NCT00166114|719664|P2|Overall Study|Withdrawal by Subject|4
217463|NCT00166114|719665|P1|Overall Study|Withdrawal by Subject|10
217464|NCT00166114|719664|P2|Overall Study|Protocol Violation|1
217465|NCT00166114|719665|P1|Overall Study|Protocol Violation|2
217466|NCT00165984|719682|P1|Overall Study|Death|15
217467|NCT00165841|719700|P2|Overall Study|Medication Noncompliance|1
217468|NCT00165841|719701|P1|Overall Study|Medication Noncompliance|1
217469|NCT00165841|719700|P2|Overall Study|Other|5
217470|NCT00165841|719701|P1|Overall Study|Other|3
217471|NCT00165841|719700|P2|Overall Study|Protocol Violation|8
217472|NCT00165841|719701|P1|Overall Study|Protocol Violation|6
217473|NCT00165841|719700|P2|Overall Study|Physician Decision|0
217474|NCT00165841|719701|P1|Overall Study|Physician Decision|1
217475|NCT00165841|719700|P2|Overall Study|Withdrawal by Subject|8
217476|NCT00165841|719701|P1|Overall Study|Withdrawal by Subject|7
217477|NCT00165841|719700|P2|Overall Study|Lost to Follow-up|4
217478|NCT00165841|719701|P1|Overall Study|Lost to Follow-up|4
217479|NCT00165841|719700|P2|Overall Study|Lack of Efficacy|33
217480|NCT00165841|719701|P1|Overall Study|Lack of Efficacy|6
217481|NCT00165841|719700|P2|Overall Study|Adverse Event|3
217482|NCT00165841|719701|P1|Overall Study|Adverse Event|2
217483|NCT00165789|719711|P4|Overall Study|Withdrawal by Subject|2
217484|NCT00165789|719712|P3|Overall Study|Withdrawal by Subject|1
217485|NCT00165789|719713|P2|Overall Study|Withdrawal by Subject|1
217486|NCT00165789|719714|P1|Overall Study|Withdrawal by Subject|0
217487|NCT00165789|719711|P4|Overall Study|Adverse Event|12
217488|NCT00165789|719712|P3|Overall Study|Adverse Event|0
217489|NCT00165789|719713|P2|Overall Study|Adverse Event|3
217490|NCT00165789|719714|P1|Overall Study|Adverse Event|0
217491|NCT00165776|719768|P4|Overall Study|Worsening of Cervical Dystonia|1
217492|NCT00165776|719769|P3|Overall Study|Worsening of Cervical Dystonia|0
217493|NCT00165776|719770|P2|Overall Study|Worsening of Cervical Dystonia|0
217494|NCT00165776|719771|P1|Overall Study|Worsening of Cervical Dystonia|0
217495|NCT00165776|719768|P4|Overall Study|Withdrawal by Subject|0
217496|NCT00165776|719769|P3|Overall Study|Withdrawal by Subject|2
217497|NCT00165776|719770|P2|Overall Study|Withdrawal by Subject|1
217498|NCT00165776|719771|P1|Overall Study|Withdrawal by Subject|4
217499|NCT00165776|719768|P4|Overall Study|Lack of Efficacy|1
217500|NCT00165776|719769|P3|Overall Study|Lack of Efficacy|0
217501|NCT00165776|719770|P2|Overall Study|Lack of Efficacy|0
217502|NCT00165776|719771|P1|Overall Study|Lack of Efficacy|0
217503|NCT00165698|719807|P2|Overall Study|Not Taken/Lost the medicine|2
217504|NCT00165698|719808|P1|Overall Study|Not Taken/Lost the medicine|1
217505|NCT00165698|719807|P2|Overall Study|Protocol Violation|0
217506|NCT00165698|719808|P1|Overall Study|Protocol Violation|1
217507|NCT00165698|719807|P2|Overall Study|Withdrawal by Subject|1
217508|NCT00165698|719808|P1|Overall Study|Withdrawal by Subject|2
217509|NCT00165698|719807|P2|Overall Study|Lost to Follow-up|2
217510|NCT00165698|719808|P1|Overall Study|Lost to Follow-up|2
217511|NCT00165698|719807|P2|Overall Study|Adverse Event|10
217512|NCT00165698|719808|P1|Overall Study|Adverse Event|2
217513|NCT00165672|719834|P2|Overall Study|Adverse Event|1
217514|NCT00165672|719835|P1|Overall Study|Adverse Event|0
217515|NCT00165646|719844|P3|Overall Study|Protocol Violation|0
217516|NCT00165646|719845|P2|Overall Study|Protocol Violation|0
217517|NCT00165646|719846|P1|Overall Study|Protocol Violation|1
217518|NCT00165646|719844|P3|Overall Study|Physician Decision|2
217519|NCT00165646|719845|P2|Overall Study|Physician Decision|0
217520|NCT00165646|719846|P1|Overall Study|Physician Decision|2
217521|NCT00165646|719844|P3|Overall Study|Withdrawal by Subject|1
217522|NCT00165646|719845|P2|Overall Study|Withdrawal by Subject|2
217523|NCT00165646|719846|P1|Overall Study|Withdrawal by Subject|0
217524|NCT00165646|719844|P3|Overall Study|Lack of Efficacy|0
217525|NCT00165646|719845|P2|Overall Study|Lack of Efficacy|2
217526|NCT00165646|719846|P1|Overall Study|Lack of Efficacy|1
217527|NCT00165646|719844|P3|Overall Study|Adverse Event|1
217528|NCT00165646|719845|P2|Overall Study|Adverse Event|1
217529|NCT00165646|719846|P1|Overall Study|Adverse Event|1
217530|NCT00165503|719854|P1|Overall Study|Unresectable|3
217531|NCT00165503|719854|P1|Overall Study|Lost to Follow-up|12
217532|NCT00165503|719854|P1|Overall Study|Death|1
217533|NCT00163657|719861|P3|Overall Study|Other reason|3
217534|NCT00163657|719862|P2|Overall Study|Other reason|1
217535|NCT00163657|719863|P1|Overall Study|Other reason|0
217536|NCT00163657|719861|P3|Overall Study|Lost to Follow-up|10
217537|NCT00163657|719862|P2|Overall Study|Lost to Follow-up|3
217538|NCT00163657|719863|P1|Overall Study|Lost to Follow-up|1
217539|NCT00163657|719861|P3|Overall Study|Non Compliance|0
217540|NCT00163657|719862|P2|Overall Study|Non Compliance|0
217541|NCT00163657|719863|P1|Overall Study|Non Compliance|1
217542|NCT00163657|719861|P3|Overall Study|Physician Decision|1
217543|NCT00163657|719862|P2|Overall Study|Physician Decision|1
217544|NCT00163657|719863|P1|Overall Study|Physician Decision|0
217545|NCT00163657|719861|P3|Overall Study|Withdrawal by Subject|2
217546|NCT00163657|719862|P2|Overall Study|Withdrawal by Subject|3
217547|NCT00163657|719863|P1|Overall Study|Withdrawal by Subject|2
217548|NCT00163657|719861|P3|Overall Study|graft loss|2
217549|NCT00163657|719862|P2|Overall Study|graft loss|1
217550|NCT00163657|719863|P1|Overall Study|graft loss|4
217551|NCT00163657|719861|P3|Overall Study|Death|19
217552|NCT00163657|719862|P2|Overall Study|Death|14
217553|NCT00163657|719863|P1|Overall Study|Death|12
217554|NCT00163215|719953|P1|Overall Study|Other|7
217555|NCT00163215|719953|P1|Overall Study|Withdrawal by Subject|5
217556|NCT00163215|719953|P1|Overall Study|Lack of Efficacy|3
217557|NCT00163189|719973|P1|Overall Study|Did not meet continuation criterion|16
217558|NCT00163189|719973|P1|Overall Study|Withdrawal by Subject|11
217559|NCT00163189|719973|P1|Overall Study|Study terminated by sponsor|11
217560|NCT00163189|719973|P1|Overall Study|Lack of Efficacy|7
217561|NCT00163189|719973|P1|Overall Study|Adverse Event|6
217562|NCT00163189|719973|P1|Overall Study|Death|3
217563|NCT00163189|719973|P1|Overall Study|Protocol Violation|2
217564|NCT00163189|719973|P1|Overall Study|Lost to Follow-up|1
217565|NCT00163189|719973|P1|Overall Study|Other|6
217566|NCT00163020|719997|P2|Overall Study|Lost to Follow-up|2
217567|NCT00163020|719998|P1|Overall Study|Lost to Follow-up|0
217568|NCT00162981|720038|P2|Overall Study|Physician Decision|0
217569|NCT00162981|720039|P1|Overall Study|Physician Decision|1
217570|NCT00162981|720038|P2|Overall Study|Withdrawal by Subject|1
217571|NCT00162981|720039|P1|Overall Study|Withdrawal by Subject|1
217572|NCT00162981|720038|P2|Overall Study|Adverse Event|5
217573|NCT00162981|720039|P1|Overall Study|Adverse Event|2
217574|NCT00162942|720055|P2|Overall Study|2 or more consecutive treatments missed|0
217575|NCT00162942|720056|P1|Overall Study|2 or more consecutive treatments missed|1
217576|NCT00162942|720055|P2|Overall Study|Flare During Active Treatment|3
217577|NCT00162942|720056|P1|Overall Study|Flare During Active Treatment|7
217578|NCT00162942|720055|P2|Overall Study|Lack of Efficacy|0
217579|NCT00162942|720056|P1|Overall Study|Lack of Efficacy|1
217580|NCT00162942|720055|P2|Overall Study|Alternate Therapy|2
217581|NCT00162942|720056|P1|Overall Study|Alternate Therapy|6
217582|NCT00162942|720055|P2|Overall Study|Enter Open-Label Study|35
217583|NCT00162942|720056|P1|Overall Study|Enter Open-Label Study|76
217584|NCT00162942|720055|P2|Overall Study|Physician Decision|0
217585|NCT00162942|720056|P1|Overall Study|Physician Decision|1
217586|NCT00162942|720055|P2|Overall Study|Withdrawal by Subject|6
217587|NCT00162942|720056|P1|Overall Study|Withdrawal by Subject|3
217588|NCT00162942|720055|P2|Overall Study|Death|0
217589|NCT00162942|720056|P1|Overall Study|Death|1
217590|NCT00162942|720055|P2|Overall Study|Adverse Event|6
217591|NCT00162942|720056|P1|Overall Study|Adverse Event|10
217592|NCT00162773|720104|P1|Overall Study|P.I, Left institution. Study terminated|22
217593|NCT00162370|720108|P1|Efficacy Population|Lost to Follow-up|51
217594|NCT00162266|720116|P4|Open-Label Period|Other Reasons|15
217595|NCT00162266|720117|P3|Open-Label Period|Other Reasons|0
217596|NCT00162266|720118|P2|Open-Label Period|Other Reasons|0
217597|NCT00162266|720119|P1|Open-Label Period|Other Reasons|0
217598|NCT00162266|720116|P4|Open-Label Period|Administrative Reason By Sponsor|9
217599|NCT00162266|720117|P3|Open-Label Period|Administrative Reason By Sponsor|0
217600|NCT00162266|720118|P2|Open-Label Period|Administrative Reason By Sponsor|0
217601|NCT00162266|720119|P1|Open-Label Period|Administrative Reason By Sponsor|0
217602|NCT00162266|720116|P4|Open-Label Period|Withdrawal by Subject|31
217603|NCT00162266|720117|P3|Open-Label Period|Withdrawal by Subject|0
217604|NCT00162266|720118|P2|Open-Label Period|Withdrawal by Subject|0
217605|NCT00162266|720119|P1|Open-Label Period|Withdrawal by Subject|0
217606|NCT00162266|720116|P4|Open-Label Period|Lost to Follow-up|3
217607|NCT00162266|720117|P3|Open-Label Period|Lost to Follow-up|0
217608|NCT00162266|720118|P2|Open-Label Period|Lost to Follow-up|0
217609|NCT00162266|720119|P1|Open-Label Period|Lost to Follow-up|0
217610|NCT00162266|720116|P4|Open-Label Period|Lack of Efficacy|26
217611|NCT00162266|720117|P3|Open-Label Period|Lack of Efficacy|0
217612|NCT00162266|720118|P2|Open-Label Period|Lack of Efficacy|0
217613|NCT00162266|720119|P1|Open-Label Period|Lack of Efficacy|0
217614|NCT00162266|720116|P4|Open-Label Period|Adverse Event|46
217615|NCT00162266|720117|P3|Open-Label Period|Adverse Event|0
217616|NCT00162266|720118|P2|Open-Label Period|Adverse Event|0
217617|NCT00162266|720119|P1|Open-Label Period|Adverse Event|0
217618|NCT00162266|720116|P4|Open-Label Period|Death|7
217619|NCT00162266|720117|P3|Open-Label Period|Death|0
217620|NCT00162266|720118|P2|Open-Label Period|Death|0
217621|NCT00162266|720119|P1|Open-Label Period|Death|0
217622|NCT00162266|720116|P4|Double-Blind Period|Withdrawal by Subject|0
217623|NCT00162266|720117|P3|Double-Blind Period|Withdrawal by Subject|6
217624|NCT00162266|720118|P2|Double-Blind Period|Withdrawal by Subject|2
217625|NCT00162266|720119|P1|Double-Blind Period|Withdrawal by Subject|5
217626|NCT00162266|720116|P4|Double-Blind Period|Lack of Efficacy|0
217627|NCT00162266|720117|P3|Double-Blind Period|Lack of Efficacy|30
217628|NCT00162266|720118|P2|Double-Blind Period|Lack of Efficacy|17
217629|NCT00162266|720119|P1|Double-Blind Period|Lack of Efficacy|13
217630|NCT00162266|720116|P4|Double-Blind Period|Other Reason|0
217631|NCT00162266|720117|P3|Double-Blind Period|Other Reason|1
217632|NCT00162266|720118|P2|Double-Blind Period|Other Reason|0
217633|NCT00162266|720119|P1|Double-Blind Period|Other Reason|1
217634|NCT00162266|720116|P4|Double-Blind Period|Lost to Follow-up|0
217635|NCT00162266|720117|P3|Double-Blind Period|Lost to Follow-up|0
217636|NCT00162266|720118|P2|Double-Blind Period|Lost to Follow-up|2
217637|NCT00162266|720119|P1|Double-Blind Period|Lost to Follow-up|1
217638|NCT00162266|720116|P4|Double-Blind Period|Death|0
217639|NCT00162266|720117|P3|Double-Blind Period|Death|0
217640|NCT00162266|720118|P2|Double-Blind Period|Death|1
217641|NCT00162266|720119|P1|Double-Blind Period|Death|0
217642|NCT00162266|720116|P4|Double-Blind Period|Adverse Event|0
217643|NCT00162266|720117|P3|Double-Blind Period|Adverse Event|11
217644|NCT00162266|720118|P2|Double-Blind Period|Adverse Event|9
217645|NCT00162266|720119|P1|Double-Blind Period|Adverse Event|5
217646|NCT00162136|720320|P1|Overall Study|Withdrawal by Subject|1
217647|NCT00162136|720320|P1|Overall Study|Study Drug Toxicity|4
217648|NCT00162136|720320|P1|Overall Study|Investigator Request|5
217649|NCT00162136|720320|P1|Overall Study|Disease Progression/Relapse|23
217650|NCT00162136|720320|P1|Overall Study|Death|1
217651|NCT00162136|720320|P1|Overall Study|Adverse Event|1
217652|NCT00162123|720352|P8|Overall Study|Follow-up only (not treated or assessed)|57
217653|NCT00162123|720353|P7|Overall Study|Follow-up only (not treated or assessed)|0
217654|NCT00162123|720354|P6|Overall Study|Follow-up only (not treated or assessed)|0
217655|NCT00162123|720355|P5|Overall Study|Follow-up only (not treated or assessed)|0
217656|NCT00162123|720356|P4|Overall Study|Follow-up only (not treated or assessed)|0
217657|NCT00162123|720357|P3|Overall Study|Follow-up only (not treated or assessed)|0
217658|NCT00162123|720358|P2|Overall Study|Follow-up only (not treated or assessed)|0
217659|NCT00162123|720359|P1|Overall Study|Follow-up only (not treated or assessed)|0
217660|NCT00162123|720352|P8|Overall Study|Tumor assessment only (not treated)|1
217661|NCT00162123|720353|P7|Overall Study|Tumor assessment only (not treated)|0
217662|NCT00162123|720354|P6|Overall Study|Tumor assessment only (not treated)|0
217663|NCT00162123|720355|P5|Overall Study|Tumor assessment only (not treated)|0
217664|NCT00162123|720356|P4|Overall Study|Tumor assessment only (not treated)|0
217665|NCT00162123|720357|P3|Overall Study|Tumor assessment only (not treated)|0
217666|NCT00162123|720358|P2|Overall Study|Tumor assessment only (not treated)|0
217667|NCT00162123|720359|P1|Overall Study|Tumor assessment only (not treated)|0
217668|NCT00162123|720352|P8|Overall Study|Physician Decision|0
217669|NCT00162123|720353|P7|Overall Study|Physician Decision|1
217670|NCT00162123|720354|P6|Overall Study|Physician Decision|1
217671|NCT00162123|720355|P5|Overall Study|Physician Decision|0
217672|NCT00162123|720356|P4|Overall Study|Physician Decision|0
217673|NCT00162123|720357|P3|Overall Study|Physician Decision|0
217674|NCT00162123|720358|P2|Overall Study|Physician Decision|2
217675|NCT00162123|720359|P1|Overall Study|Physician Decision|1
217676|NCT00162123|720352|P8|Overall Study|Not specified (after start of treatment)|0
217677|NCT00162123|720353|P7|Overall Study|Not specified (after start of treatment)|0
217678|NCT00162123|720354|P6|Overall Study|Not specified (after start of treatment)|0
217679|NCT00162123|720355|P5|Overall Study|Not specified (after start of treatment)|3
217680|NCT00162123|720356|P4|Overall Study|Not specified (after start of treatment)|0
217681|NCT00162123|720357|P3|Overall Study|Not specified (after start of treatment)|0
217682|NCT00162123|720358|P2|Overall Study|Not specified (after start of treatment)|0
217683|NCT00162123|720359|P1|Overall Study|Not specified (after start of treatment)|0
217684|NCT00162123|720352|P8|Overall Study|Not specified (before treatment)|0
217685|NCT00162123|720353|P7|Overall Study|Not specified (before treatment)|0
217686|NCT00162123|720354|P6|Overall Study|Not specified (before treatment)|1
217687|NCT00162123|720355|P5|Overall Study|Not specified (before treatment)|12
217688|NCT00162123|720356|P4|Overall Study|Not specified (before treatment)|0
217689|NCT00162123|720357|P3|Overall Study|Not specified (before treatment)|0
217690|NCT00162123|720358|P2|Overall Study|Not specified (before treatment)|0
217691|NCT00162123|720359|P1|Overall Study|Not specified (before treatment)|2
217692|NCT00162123|720352|P8|Overall Study|Adverse Event|0
217693|NCT00162123|720353|P7|Overall Study|Adverse Event|0
217694|NCT00162123|720354|P6|Overall Study|Adverse Event|0
217695|NCT00162123|720355|P5|Overall Study|Adverse Event|1
217696|NCT00162123|720356|P4|Overall Study|Adverse Event|2
217697|NCT00162123|720357|P3|Overall Study|Adverse Event|0
217698|NCT00162123|720358|P2|Overall Study|Adverse Event|2
217699|NCT00162123|720359|P1|Overall Study|Adverse Event|1
217700|NCT00162123|720352|P8|Overall Study|Deterioration without progression|0
217701|NCT00162123|720353|P7|Overall Study|Deterioration without progression|0
217702|NCT00162123|720354|P6|Overall Study|Deterioration without progression|0
217703|NCT00162123|720355|P5|Overall Study|Deterioration without progression|1
217704|NCT00162123|720356|P4|Overall Study|Deterioration without progression|0
217705|NCT00162123|720357|P3|Overall Study|Deterioration without progression|3
217706|NCT00162123|720358|P2|Overall Study|Deterioration without progression|2
217707|NCT00162123|720359|P1|Overall Study|Deterioration without progression|2
217708|NCT00162123|720352|P8|Overall Study|Withdrawal by Subject|0
217709|NCT00162123|720353|P7|Overall Study|Withdrawal by Subject|1
217710|NCT00162123|720354|P6|Overall Study|Withdrawal by Subject|2
217711|NCT00162123|720355|P5|Overall Study|Withdrawal by Subject|1
217712|NCT00162123|720356|P4|Overall Study|Withdrawal by Subject|1
217713|NCT00162123|720357|P3|Overall Study|Withdrawal by Subject|2
217714|NCT00162123|720358|P2|Overall Study|Withdrawal by Subject|0
217715|NCT00162123|720359|P1|Overall Study|Withdrawal by Subject|2
217716|NCT00162123|720352|P8|Overall Study|Death|0
217717|NCT00162123|720353|P7|Overall Study|Death|0
217718|NCT00162123|720354|P6|Overall Study|Death|1
217719|NCT00162123|720355|P5|Overall Study|Death|1
217720|NCT00162123|720356|P4|Overall Study|Death|1
217721|NCT00162123|720357|P3|Overall Study|Death|1
217722|NCT00162123|720358|P2|Overall Study|Death|3
217723|NCT00162123|720359|P1|Overall Study|Death|3
217724|NCT00162123|720352|P8|Overall Study|Study drug toxicity|0
217725|NCT00162123|720353|P7|Overall Study|Study drug toxicity|1
217726|NCT00162123|720354|P6|Overall Study|Study drug toxicity|1
217727|NCT00162123|720355|P5|Overall Study|Study drug toxicity|4
217728|NCT00162123|720356|P4|Overall Study|Study drug toxicity|0
217729|NCT00162123|720357|P3|Overall Study|Study drug toxicity|5
217730|NCT00162123|720358|P2|Overall Study|Study drug toxicity|1
217731|NCT00162123|720359|P1|Overall Study|Study drug toxicity|6
217732|NCT00162123|720352|P8|Overall Study|Disease progression|0
217733|NCT00162123|720353|P7|Overall Study|Disease progression|1
217734|NCT00162123|720354|P6|Overall Study|Disease progression|3
217735|NCT00162123|720355|P5|Overall Study|Disease progression|8
217736|NCT00162123|720356|P4|Overall Study|Disease progression|4
217737|NCT00162123|720357|P3|Overall Study|Disease progression|10
217738|NCT00162123|720358|P2|Overall Study|Disease progression|19
217739|NCT00162123|720359|P1|Overall Study|Disease progression|27
217740|NCT00162097|720392|P4|Overall Study|Participant no longer met study criteria|1
217741|NCT00162097|720393|P3|Overall Study|Participant no longer met study criteria|0
217742|NCT00162097|720394|P2|Overall Study|Participant no longer met study criteria|0
217743|NCT00162097|720395|P1|Overall Study|Participant no longer met study criteria|0
217744|NCT00162032|720457|P2|Overall Study|Reason not specified|0
217745|NCT00162032|720458|P1|Overall Study|Reason not specified|1
217746|NCT00162032|720457|P2|Overall Study|Lost to Follow-up|2
217747|NCT00162032|720458|P1|Overall Study|Lost to Follow-up|4
217748|NCT00161616|720468|P2|Overall Study|Protocol deviation|0
217749|NCT00161616|720469|P1|Overall Study|Protocol deviation|1
217750|NCT00161616|720468|P2|Overall Study|Lost to Follow-up|13
217751|NCT00161616|720469|P1|Overall Study|Lost to Follow-up|17
217752|NCT00161616|720468|P2|Overall Study|Death|1
217753|NCT00161616|720469|P1|Overall Study|Death|1
217754|NCT00161616|720468|P2|Overall Study|Physician Decision|0
217755|NCT00161616|720469|P1|Overall Study|Physician Decision|1
217756|NCT00161616|720468|P2|Overall Study|Withdrawal by Subject|5
217757|NCT00161616|720469|P1|Overall Study|Withdrawal by Subject|6
217758|NCT00161213|720501|P1|Overall Study|Evaluable for toxicity but not response|1
217759|NCT00161213|720501|P1|Overall Study|Withdrawal by Subject|1
217760|NCT00160706|720508|P1|Overall Study|Other Reason|11
217761|NCT00160706|720508|P1|Overall Study|Lack of Efficacy and Other|1
217762|NCT00160706|720508|P1|Overall Study|Lack of Efficacy|42
217763|NCT00160706|720508|P1|Overall Study|Lost to Follow-up and Other|1
217764|NCT00160706|720508|P1|Overall Study|Lost to Follow-up|4
217765|NCT00160706|720508|P1|Overall Study|Physician Decision and Other|3
217766|NCT00160706|720508|P1|Overall Study|Physician Decision|10
217767|NCT00160706|720508|P1|Overall Study|Withdrawal by Subject and Other|12
217768|NCT00160706|720508|P1|Overall Study|Withdrawal by Subject|41
217769|NCT00160706|720508|P1|Overall Study|Protocol Violation|3
217770|NCT00160706|720508|P1|Overall Study|Adverse Event and Other Reason|105
217771|NCT00160706|720508|P1|Overall Study|Adverse Event|53
217772|NCT00160693|720520|P1|Overall Study|Study terminated by sponsor|15
217773|NCT00160693|720520|P1|Overall Study|Withdrawal by Subject|54
217774|NCT00160693|720520|P1|Overall Study|Lost to Follow-up|15
217775|NCT00160693|720520|P1|Overall Study|Protocol Violation|24
217776|NCT00160693|720520|P1|Overall Study|Lack of Efficacy|30
217777|NCT00160693|720520|P1|Overall Study|Adverse Event|97
217778|NCT00160641|720537|P1|Overall Study|Other|9
217779|NCT00160641|720537|P1|Overall Study|Protocol Violation|3
217780|NCT00160641|720537|P1|Overall Study|Lack of Efficacy|12
217781|NCT00160641|720537|P1|Overall Study|Lost to Follow-up|8
217782|NCT00160641|720537|P1|Overall Study|Withdrawal by Subject|87
217783|NCT00160641|720537|P1|Overall Study|Adverse Event|102
217784|NCT00160563|720571|P3|Overall Study|Missing reason|0
217785|NCT00160563|720572|P2|Overall Study|Missing reason|1
217786|NCT00160563|720573|P1|Overall Study|Missing reason|0
217787|NCT00160563|720571|P3|Overall Study|Other (listed in the study report)|81
217788|NCT00160563|720572|P2|Overall Study|Other (listed in the study report)|40
217789|NCT00160563|720573|P1|Overall Study|Other (listed in the study report)|48
217790|NCT00160563|720571|P3|Overall Study|Withdrawal by Subject|3
217791|NCT00160563|720572|P2|Overall Study|Withdrawal by Subject|2
217792|NCT00160563|720573|P1|Overall Study|Withdrawal by Subject|1
217793|NCT00160563|720571|P3|Overall Study|Protocol Violation|3
217794|NCT00160563|720572|P2|Overall Study|Protocol Violation|0
217795|NCT00160563|720573|P1|Overall Study|Protocol Violation|0
217796|NCT00160563|720571|P3|Overall Study|Lost to Follow-up|2
217797|NCT00160563|720572|P2|Overall Study|Lost to Follow-up|1
217798|NCT00160563|720573|P1|Overall Study|Lost to Follow-up|1
217799|NCT00160563|720571|P3|Overall Study|Adverse Event|1
217800|NCT00160563|720572|P2|Overall Study|Adverse Event|1
217801|NCT00160563|720573|P1|Overall Study|Adverse Event|1
217802|NCT00160524|720585|P1|Overall Study|Other|20
217803|NCT00160524|720585|P1|Overall Study|Lack of Efficacy and Other|1
217804|NCT00160524|720585|P1|Overall Study|Lack of Efficacy|21
217805|NCT00160524|720585|P1|Overall Study|Lost to Follow-up and Other|1
217806|NCT00160524|720585|P1|Overall Study|Lost to Follow-up|13
217807|NCT00160524|720585|P1|Overall Study|Physician Decision and Other|6
217808|NCT00160524|720585|P1|Overall Study|Physician Decision|27
217809|NCT00160524|720585|P1|Overall Study|Withdrawal by Subject and Other|17
217810|NCT00160524|720585|P1|Overall Study|Withdrawal by Subject|141
217811|NCT00160524|720585|P1|Overall Study|Protocol Violation and Other|2
217812|NCT00160524|720585|P1|Overall Study|Protocol Violation|16
217813|NCT00160524|720585|P1|Overall Study|Adverse Event and Other|94
217814|NCT00160524|720585|P1|Overall Study|Adverse Event|119
217815|NCT00160251|720602|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
217816|NCT00160251|720603|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
217817|NCT00160251|720604|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
217818|NCT00160251|720605|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
217819|NCT00160251|720606|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
217820|NCT00160251|720607|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
217821|NCT00160251|720608|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
217822|NCT00160251|720609|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
217823|NCT00160251|720602|P8|Post-amendment 2|Lack of Efficacy|24
217824|NCT00160251|720603|P7|Post-amendment 2|Lack of Efficacy|0
217825|NCT00160251|720604|P6|Post-amendment 2|Lack of Efficacy|0
217826|NCT00160251|720605|P5|Post-amendment 2|Lack of Efficacy|0
217827|NCT00160251|720606|P4|Post-amendment 2|Lack of Efficacy|0
217828|NCT00160251|720607|P3|Post-amendment 2|Lack of Efficacy|0
217829|NCT00160251|720608|P2|Post-amendment 2|Lack of Efficacy|0
217830|NCT00160251|720609|P1|Post-amendment 2|Lack of Efficacy|0
217831|NCT00160251|720602|P8|Post-amendment 2|Adverse Event|20
217832|NCT00160251|720603|P7|Post-amendment 2|Adverse Event|0
217833|NCT00160251|720604|P6|Post-amendment 2|Adverse Event|0
217834|NCT00160251|720605|P5|Post-amendment 2|Adverse Event|0
217835|NCT00160251|720606|P4|Post-amendment 2|Adverse Event|0
217836|NCT00160251|720607|P3|Post-amendment 2|Adverse Event|0
217837|NCT00160251|720608|P2|Post-amendment 2|Adverse Event|0
217838|NCT00160251|720609|P1|Post-amendment 2|Adverse Event|0
217839|NCT00160251|720602|P8|Prior to Amendment 2|Completed Treatment Phase|0
217840|NCT00160251|720603|P7|Prior to Amendment 2|Completed Treatment Phase|0
217841|NCT00160251|720604|P6|Prior to Amendment 2|Completed Treatment Phase|23
217842|NCT00160251|720605|P5|Prior to Amendment 2|Completed Treatment Phase|0
217843|NCT00160251|720606|P4|Prior to Amendment 2|Completed Treatment Phase|0
217844|NCT00160251|720607|P3|Prior to Amendment 2|Completed Treatment Phase|0
217845|NCT00160251|720608|P2|Prior to Amendment 2|Completed Treatment Phase|0
217846|NCT00160251|720609|P1|Prior to Amendment 2|Completed Treatment Phase|3
217847|NCT00160251|720602|P8|Prior to Amendment 2|Noncompliance with protocol|0
217848|NCT00160251|720603|P7|Prior to Amendment 2|Noncompliance with protocol|0
217849|NCT00160251|720604|P6|Prior to Amendment 2|Noncompliance with protocol|0
217850|NCT00160251|720605|P5|Prior to Amendment 2|Noncompliance with protocol|0
217851|NCT00160251|720606|P4|Prior to Amendment 2|Noncompliance with protocol|0
217852|NCT00160251|720607|P3|Prior to Amendment 2|Noncompliance with protocol|0
217853|NCT00160251|720608|P2|Prior to Amendment 2|Noncompliance with protocol|0
217854|NCT00160251|720609|P1|Prior to Amendment 2|Noncompliance with protocol|1
217855|NCT00160251|720602|P8|Prior to Amendment 2|Withdrawal by Subject|0
217856|NCT00160251|720603|P7|Prior to Amendment 2|Withdrawal by Subject|3
217857|NCT00160251|720604|P6|Prior to Amendment 2|Withdrawal by Subject|3
217858|NCT00160251|720605|P5|Prior to Amendment 2|Withdrawal by Subject|2
217859|NCT00160251|720606|P4|Prior to Amendment 2|Withdrawal by Subject|4
217860|NCT00160251|720607|P3|Prior to Amendment 2|Withdrawal by Subject|3
217861|NCT00160251|720608|P2|Prior to Amendment 2|Withdrawal by Subject|1
217862|NCT00160251|720609|P1|Prior to Amendment 2|Withdrawal by Subject|3
217863|NCT00160251|720602|P8|Prior to Amendment 2|Lost to Follow-up|0
217864|NCT00160251|720603|P7|Prior to Amendment 2|Lost to Follow-up|0
217865|NCT00160251|720604|P6|Prior to Amendment 2|Lost to Follow-up|1
217866|NCT00160251|720605|P5|Prior to Amendment 2|Lost to Follow-up|1
217867|NCT00160251|720606|P4|Prior to Amendment 2|Lost to Follow-up|0
217868|NCT00160251|720607|P3|Prior to Amendment 2|Lost to Follow-up|1
217869|NCT00160251|720608|P2|Prior to Amendment 2|Lost to Follow-up|0
217870|NCT00160251|720609|P1|Prior to Amendment 2|Lost to Follow-up|0
217871|NCT00160251|720602|P8|Prior to Amendment 2|Lack of Efficacy|0
217872|NCT00160251|720603|P7|Prior to Amendment 2|Lack of Efficacy|0
217873|NCT00160251|720604|P6|Prior to Amendment 2|Lack of Efficacy|55
217874|NCT00160251|720605|P5|Prior to Amendment 2|Lack of Efficacy|24
217875|NCT00160251|720606|P4|Prior to Amendment 2|Lack of Efficacy|35
217876|NCT00160251|720607|P3|Prior to Amendment 2|Lack of Efficacy|37
217877|NCT00160251|720608|P2|Prior to Amendment 2|Lack of Efficacy|4
217878|NCT00160251|720609|P1|Prior to Amendment 2|Lack of Efficacy|0
217879|NCT00160251|720602|P8|Prior to Amendment 2|Adverse Event|0
217880|NCT00160251|720603|P7|Prior to Amendment 2|Adverse Event|1
217881|NCT00160251|720604|P6|Prior to Amendment 2|Adverse Event|1
217882|NCT00160251|720605|P5|Prior to Amendment 2|Adverse Event|1
217883|NCT00160251|720606|P4|Prior to Amendment 2|Adverse Event|1
217884|NCT00160251|720607|P3|Prior to Amendment 2|Adverse Event|3
217885|NCT00160251|720608|P2|Prior to Amendment 2|Adverse Event|1
217886|NCT00160251|720609|P1|Prior to Amendment 2|Adverse Event|2
217887|NCT00160199|720685|P2|Overall Study|Protocol Violation|8
217888|NCT00160199|720686|P1|Overall Study|Protocol Violation|8
217889|NCT00160199|720685|P2|Overall Study|Administrative|1
217890|NCT00160199|720686|P1|Overall Study|Administrative|0
217891|NCT00160199|720685|P2|Overall Study|Withdrawal by Subject|6
217892|NCT00160199|720686|P1|Overall Study|Withdrawal by Subject|4
217893|NCT00160199|720685|P2|Overall Study|Lost to Follow-up|7
217894|NCT00160199|720686|P1|Overall Study|Lost to Follow-up|7
217895|NCT00160199|720685|P2|Overall Study|Lack of Efficacy|1
217896|NCT00160199|720686|P1|Overall Study|Lack of Efficacy|0
217897|NCT00160199|720685|P2|Overall Study|Adverse Event|14
217898|NCT00160199|720686|P1|Overall Study|Adverse Event|5
217899|NCT00159913|720743|P4|Overall Study|Protocol Violation|0
217900|NCT00159913|720744|P3|Overall Study|Protocol Violation|1
217901|NCT00159913|720745|P2|Overall Study|Protocol Violation|0
217902|NCT00159913|720746|P1|Overall Study|Protocol Violation|1
217903|NCT00159913|720743|P4|Overall Study|Lost to Follow-up|1
217904|NCT00159913|720744|P3|Overall Study|Lost to Follow-up|0
217905|NCT00159913|720745|P2|Overall Study|Lost to Follow-up|0
217906|NCT00159913|720746|P1|Overall Study|Lost to Follow-up|0
217907|NCT00159913|720743|P4|Overall Study|Withdrawal by Subject|1
217908|NCT00159913|720744|P3|Overall Study|Withdrawal by Subject|0
217909|NCT00159913|720745|P2|Overall Study|Withdrawal by Subject|0
217910|NCT00159913|720746|P1|Overall Study|Withdrawal by Subject|0
217911|NCT00159913|720743|P4|Overall Study|Adverse Event|0
217912|NCT00159913|720744|P3|Overall Study|Adverse Event|1
217913|NCT00159913|720745|P2|Overall Study|Adverse Event|0
217914|NCT00159913|720746|P1|Overall Study|Adverse Event|1
217915|NCT00159874|720820|P7|Overall Study|Pregnancy|0
217916|NCT00159874|720821|P6|Overall Study|Pregnancy|0
217917|NCT00159874|720822|P5|Overall Study|Pregnancy|0
217918|NCT00159874|720823|P4|Overall Study|Pregnancy|0
217919|NCT00159874|720824|P3|Overall Study|Pregnancy|0
217920|NCT00159874|720825|P2|Overall Study|Pregnancy|1
217921|NCT00159874|720826|P1|Overall Study|Pregnancy|1
217922|NCT00159874|720820|P7|Overall Study|Withdrawal by Subject|1
217923|NCT00159874|720821|P6|Overall Study|Withdrawal by Subject|2
217924|NCT00159874|720822|P5|Overall Study|Withdrawal by Subject|3
217925|NCT00159874|720823|P4|Overall Study|Withdrawal by Subject|4
217926|NCT00159874|720824|P3|Overall Study|Withdrawal by Subject|8
217927|NCT00159874|720825|P2|Overall Study|Withdrawal by Subject|6
217928|NCT00159874|720826|P1|Overall Study|Withdrawal by Subject|2
217929|NCT00159874|720820|P7|Overall Study|Death|0
217930|NCT00159874|720821|P6|Overall Study|Death|2
217931|NCT00159874|720822|P5|Overall Study|Death|1
217932|NCT00159874|720823|P4|Overall Study|Death|0
217933|NCT00159874|720824|P3|Overall Study|Death|15
217934|NCT00159874|720825|P2|Overall Study|Death|8
217935|NCT00159874|720826|P1|Overall Study|Death|3
217936|NCT00159874|720820|P7|Overall Study|Protocol Violation|0
217937|NCT00159874|720821|P6|Overall Study|Protocol Violation|0
217938|NCT00159874|720822|P5|Overall Study|Protocol Violation|0
217939|NCT00159874|720823|P4|Overall Study|Protocol Violation|0
217940|NCT00159874|720824|P3|Overall Study|Protocol Violation|2
217941|NCT00159874|720825|P2|Overall Study|Protocol Violation|5
217942|NCT00159874|720826|P1|Overall Study|Protocol Violation|0
217943|NCT00159874|720820|P7|Overall Study|Not specified|3
217944|NCT00159874|720821|P6|Overall Study|Not specified|1
217945|NCT00159874|720822|P5|Overall Study|Not specified|2
217946|NCT00159874|720823|P4|Overall Study|Not specified|0
217947|NCT00159874|720824|P3|Overall Study|Not specified|8
217948|NCT00159874|720825|P2|Overall Study|Not specified|8
217949|NCT00159874|720826|P1|Overall Study|Not specified|8
217950|NCT00159874|720820|P7|Overall Study|Lost to Follow-up|1
217951|NCT00159874|720821|P6|Overall Study|Lost to Follow-up|2
217952|NCT00159874|720822|P5|Overall Study|Lost to Follow-up|1
217953|NCT00159874|720823|P4|Overall Study|Lost to Follow-up|0
217954|NCT00159874|720824|P3|Overall Study|Lost to Follow-up|3
217955|NCT00159874|720825|P2|Overall Study|Lost to Follow-up|0
217956|NCT00159874|720826|P1|Overall Study|Lost to Follow-up|1
217957|NCT00159874|720820|P7|Overall Study|Lack of Efficacy|0
217958|NCT00159874|720821|P6|Overall Study|Lack of Efficacy|3
217959|NCT00159874|720822|P5|Overall Study|Lack of Efficacy|0
217960|NCT00159874|720823|P4|Overall Study|Lack of Efficacy|1
217961|NCT00159874|720824|P3|Overall Study|Lack of Efficacy|1
217962|NCT00159874|720825|P2|Overall Study|Lack of Efficacy|0
217963|NCT00159874|720826|P1|Overall Study|Lack of Efficacy|2
217964|NCT00159874|720820|P7|Overall Study|Does Not Meet Entrance Criteria|0
217965|NCT00159874|720821|P6|Overall Study|Does Not Meet Entrance Criteria|0
217966|NCT00159874|720822|P5|Overall Study|Does Not Meet Entrance Criteria|0
217967|NCT00159874|720823|P4|Overall Study|Does Not Meet Entrance Criteria|0
217968|NCT00159874|720824|P3|Overall Study|Does Not Meet Entrance Criteria|1
217969|NCT00159874|720825|P2|Overall Study|Does Not Meet Entrance Criteria|0
217970|NCT00159874|720826|P1|Overall Study|Does Not Meet Entrance Criteria|1
217971|NCT00159874|720820|P7|Overall Study|Adverse Event|0
217972|NCT00159874|720821|P6|Overall Study|Adverse Event|2
217973|NCT00159874|720822|P5|Overall Study|Adverse Event|1
217974|NCT00159874|720823|P4|Overall Study|Adverse Event|1
217975|NCT00159874|720824|P3|Overall Study|Adverse Event|5
217976|NCT00159874|720825|P2|Overall Study|Adverse Event|2
217977|NCT00159874|720826|P1|Overall Study|Adverse Event|2
217978|NCT00159861|720996|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
217979|NCT00159861|720997|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
217980|NCT00159861|720996|P2|Extension Study - up to 3 Years|Reason Unspecified|19
217981|NCT00159861|720997|P1|Extension Study - up to 3 Years|Reason Unspecified|12
217982|NCT00159861|720996|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
217983|NCT00159861|720997|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
217984|NCT00159861|720996|P2|Extension Study - up to 3 Years|Adverse Event|14
217985|NCT00159861|720997|P1|Extension Study - up to 3 Years|Adverse Event|14
217986|NCT00159861|720996|P2|Extension Study - up to 3 Years|Death|28
217987|NCT00159861|720997|P1|Extension Study - up to 3 Years|Death|24
217988|NCT00159861|720996|P2|Core Study - 16 Weeks|Randomized but not Treated|0
217989|NCT00159861|720997|P1|Core Study - 16 Weeks|Randomized but not Treated|2
217990|NCT00159861|720996|P2|Core Study - 16 Weeks|Subject Defaulted|0
217991|NCT00159861|720997|P1|Core Study - 16 Weeks|Subject Defaulted|1
217992|NCT00159861|720996|P2|Core Study - 16 Weeks|Reason Unspecified|3
217993|NCT00159861|720997|P1|Core Study - 16 Weeks|Reason Unspecified|5
217994|NCT00159861|720996|P2|Core Study - 16 Weeks|Lack of Efficacy|3
217995|NCT00159861|720997|P1|Core Study - 16 Weeks|Lack of Efficacy|2
217996|NCT00159861|720996|P2|Core Study - 16 Weeks|Adverse Event|6
217997|NCT00159861|720997|P1|Core Study - 16 Weeks|Adverse Event|12
217998|NCT00159861|720996|P2|Core Study - 16 Weeks|Death|0
217999|NCT00159861|720997|P1|Core Study - 16 Weeks|Death|3
218000|NCT00159822|721018|P1|Post-treatment Follow-up Period|Reason unspecified|1
218001|NCT00159822|721018|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
218002|NCT00159822|721018|P1|Post-treatment Follow-up Period|Death|1
218003|NCT00159822|721018|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
218004|NCT00159822|721018|P1|Voriconazole Treatment Period|Lost to Follow-up|2
218005|NCT00159822|721018|P1|Voriconazole Treatment Period|Protocol Violation|2
218006|NCT00159822|721018|P1|Voriconazole Treatment Period|Death|4
218007|NCT00159822|721018|P1|Voriconazole Treatment Period|Adverse Event|9
218008|NCT00159822|721018|P1|Voriconazole Treatment Period|Lack of Efficacy|3
218009|NCT00159783|721036|P3|Overall Study|not specified|4
218010|NCT00159783|721037|P2|Overall Study|not specified|2
218011|NCT00159783|721038|P1|Overall Study|not specified|0
218012|NCT00159783|721036|P3|Overall Study|Lost to Follow-up|11
218013|NCT00159783|721037|P2|Overall Study|Lost to Follow-up|5
218014|NCT00159783|721038|P1|Overall Study|Lost to Follow-up|6
218015|NCT00159783|721036|P3|Overall Study|Withdrawal by Subject|12
218016|NCT00159783|721037|P2|Overall Study|Withdrawal by Subject|11
218017|NCT00159783|721038|P1|Overall Study|Withdrawal by Subject|7
218018|NCT00159783|721036|P3|Overall Study|Lack of Efficacy|3
218019|NCT00159783|721037|P2|Overall Study|Lack of Efficacy|2
218020|NCT00159783|721038|P1|Overall Study|Lack of Efficacy|1
218021|NCT00159783|721036|P3|Overall Study|Adverse Event|9
218022|NCT00159783|721037|P2|Overall Study|Adverse Event|7
218023|NCT00159783|721038|P1|Overall Study|Adverse Event|5
218024|NCT00159432|721068|P1|Overall Study|Lack of Efficacy|8
218025|NCT00159432|721068|P1|Overall Study|Death|1
218026|NCT00159432|721068|P1|Overall Study|Adverse Event|1
218027|NCT00158756|721095|P5|Overall Study|Serious adverse event|0
218028|NCT00158756|721096|P4|Overall Study|Serious adverse event|0
218029|NCT00158756|721097|P3|Overall Study|Serious adverse event|1
218030|NCT00158756|721098|P2|Overall Study|Serious adverse event|0
218031|NCT00158756|721099|P1|Overall Study|Serious adverse event|0
218032|NCT00158756|721095|P5|Overall Study|Adverse Event|0
218033|NCT00158756|721096|P4|Overall Study|Adverse Event|0
218034|NCT00158756|721097|P3|Overall Study|Adverse Event|1
218035|NCT00158756|721098|P2|Overall Study|Adverse Event|0
218036|NCT00158756|721099|P1|Overall Study|Adverse Event|0
218037|NCT00158756|721095|P5|Overall Study|Withdrawal by Subject|3
218038|NCT00158756|721096|P4|Overall Study|Withdrawal by Subject|1
218039|NCT00158756|721097|P3|Overall Study|Withdrawal by Subject|6
218040|NCT00158756|721098|P2|Overall Study|Withdrawal by Subject|0
218041|NCT00158756|721099|P1|Overall Study|Withdrawal by Subject|5
218042|NCT00158600|721205|P2|Overall Study|Withdrawal by Subject|2
218043|NCT00158600|721206|P1|Overall Study|Withdrawal by Subject|2
218044|NCT00158600|721205|P2|Overall Study|Death|0
218045|NCT00158600|721206|P1|Overall Study|Death|1
218046|NCT00158600|721205|P2|Overall Study|Adverse Event|1
218047|NCT00158600|721206|P1|Overall Study|Adverse Event|2
218048|NCT00158600|721205|P2|Overall Study|unable to commit time to study|1
218049|NCT00158600|721206|P1|Overall Study|unable to commit time to study|0
218050|NCT00158262|721231|P2|Overall Study|Lost to Follow-up|1
218051|NCT00158262|721232|P1|Overall Study|Lost to Follow-up|1
218052|NCT00158184|721293|P2|Overall Study|Adverse Event|1
218053|NCT00158184|721294|P1|Overall Study|Adverse Event|1
218054|NCT00158184|721293|P2|Overall Study|failed for follow unit/study rules|0
218055|NCT00158184|721294|P1|Overall Study|failed for follow unit/study rules|2
218056|NCT00158184|721293|P2|Overall Study|personal issues|1
218057|NCT00158184|721294|P1|Overall Study|personal issues|3
218058|NCT00158054|721304|P2|Overall Study|Unavailable for follow up|3
218059|NCT00158054|721305|P1|Overall Study|Unavailable for follow up|7
218060|NCT00158054|721304|P2|Overall Study|Refused to continue|0
218061|NCT00158054|721305|P1|Overall Study|Refused to continue|3
218062|NCT00157950|721319|P2|Overall Study|Death|0
218063|NCT00157950|721320|P1|Overall Study|Death|1
218064|NCT00157820|721337|P3|2nd 8 Months|Premature cross-over|9
218065|NCT00157820|721338|P2|2nd 8 Months|Premature cross-over|7
218066|NCT00157820|721339|P1|2nd 8 Months|Premature cross-over|1
218067|NCT00157820|721337|P3|2nd 8 Months|Lost to Follow-up|2
218068|NCT00157820|721338|P2|2nd 8 Months|Lost to Follow-up|5
218069|NCT00157820|721339|P1|2nd 8 Months|Lost to Follow-up|1
218070|NCT00157820|721337|P3|2nd 8 Months|Death|3
218071|NCT00157820|721338|P2|2nd 8 Months|Death|1
218072|NCT00157820|721339|P1|2nd 8 Months|Death|3
218073|NCT00157820|721337|P3|1st 8 Month|Premature cross-over|2
218074|NCT00157820|721338|P2|1st 8 Month|Premature cross-over|2
218075|NCT00157820|721339|P1|1st 8 Month|Premature cross-over|0
218076|NCT00157820|721337|P3|1st 8 Month|Lost to Follow-up|1
218077|NCT00157820|721338|P2|1st 8 Month|Lost to Follow-up|2
218078|NCT00157820|721339|P1|1st 8 Month|Lost to Follow-up|1
218079|NCT00157820|721337|P3|1st 8 Month|Death|3
218080|NCT00157820|721338|P2|1st 8 Month|Death|8
218081|NCT00157820|721339|P1|1st 8 Month|Death|7
218082|NCT00157820|721337|P3|Randomized|Protocol Violation|2
218083|NCT00157820|721338|P2|Randomized|Protocol Violation|1
218084|NCT00157820|721339|P1|Randomized|Protocol Violation|2
218085|NCT00157820|721337|P3|Randomized|Withdrawal by Subject|3
218086|NCT00157820|721338|P2|Randomized|Withdrawal by Subject|2
218087|NCT00157820|721339|P1|Randomized|Withdrawal by Subject|1
218088|NCT00157820|721337|P3|Randomized|Physician Decision|3
218089|NCT00157820|721338|P2|Randomized|Physician Decision|2
218090|NCT00157820|721339|P1|Randomized|Physician Decision|4
218091|NCT00157755|721352|P6|Overall Study|Study completion|2
218092|NCT00157755|721353|P5|Overall Study|Study completion|1
218093|NCT00157755|721354|P4|Overall Study|Study completion|0
218094|NCT00157755|721355|P3|Overall Study|Study completion|0
218095|NCT00157755|721356|P2|Overall Study|Study completion|0
218096|NCT00157755|721357|P1|Overall Study|Study completion|0
218097|NCT00157755|721352|P6|Overall Study|Subject non-compliance|1
218098|NCT00157755|721353|P5|Overall Study|Subject non-compliance|0
218099|NCT00157755|721354|P4|Overall Study|Subject non-compliance|0
218100|NCT00157755|721355|P3|Overall Study|Subject non-compliance|0
218101|NCT00157755|721356|P2|Overall Study|Subject non-compliance|0
218102|NCT00157755|721357|P1|Overall Study|Subject non-compliance|0
218103|NCT00157755|721352|P6|Overall Study|Study site closure|0
218104|NCT00157755|721353|P5|Overall Study|Study site closure|0
218105|NCT00157755|721354|P4|Overall Study|Study site closure|0
218106|NCT00157755|721355|P3|Overall Study|Study site closure|0
218107|NCT00157755|721356|P2|Overall Study|Study site closure|1
218108|NCT00157755|721357|P1|Overall Study|Study site closure|0
218109|NCT00157755|721352|P6|Overall Study|Medical reason|0
218110|NCT00157755|721353|P5|Overall Study|Medical reason|0
218111|NCT00157755|721354|P4|Overall Study|Medical reason|1
218112|NCT00157755|721355|P3|Overall Study|Medical reason|1
218113|NCT00157755|721356|P2|Overall Study|Medical reason|0
218114|NCT00157755|721357|P1|Overall Study|Medical reason|0
218115|NCT00157755|721352|P6|Overall Study|Explant due to infection|0
218116|NCT00157755|721353|P5|Overall Study|Explant due to infection|0
218117|NCT00157755|721354|P4|Overall Study|Explant due to infection|0
218118|NCT00157755|721355|P3|Overall Study|Explant due to infection|1
218119|NCT00157755|721356|P2|Overall Study|Explant due to infection|0
218120|NCT00157755|721357|P1|Overall Study|Explant due to infection|0
218121|NCT00157755|721352|P6|Overall Study|Withdrawal by Subject|2
218122|NCT00157755|721353|P5|Overall Study|Withdrawal by Subject|1
218123|NCT00157755|721354|P4|Overall Study|Withdrawal by Subject|1
218124|NCT00157755|721355|P3|Overall Study|Withdrawal by Subject|1
218125|NCT00157755|721356|P2|Overall Study|Withdrawal by Subject|0
218126|NCT00157755|721357|P1|Overall Study|Withdrawal by Subject|0
218127|NCT00157755|721352|P6|Overall Study|Lost to Follow-up|0
218128|NCT00157755|721353|P5|Overall Study|Lost to Follow-up|0
218129|NCT00157755|721354|P4|Overall Study|Lost to Follow-up|0
218130|NCT00157755|721355|P3|Overall Study|Lost to Follow-up|1
218131|NCT00157755|721356|P2|Overall Study|Lost to Follow-up|0
218132|NCT00157755|721357|P1|Overall Study|Lost to Follow-up|0
218133|NCT00157755|721352|P6|Overall Study|Death|0
218134|NCT00157755|721353|P5|Overall Study|Death|0
218135|NCT00157755|721354|P4|Overall Study|Death|2
218136|NCT00157755|721355|P3|Overall Study|Death|3
218137|NCT00157755|721356|P2|Overall Study|Death|3
218138|NCT00157755|721357|P1|Overall Study|Death|2
218139|NCT00157248|721393|P4|Overall Study|site closures, subject moving|9
218140|NCT00157248|721394|P3|Overall Study|site closures, subject moving|3
218141|NCT00157248|721395|P2|Overall Study|site closures, subject moving|7
218142|NCT00157248|721396|P1|Overall Study|site closures, subject moving|7
218143|NCT00157248|721393|P4|Overall Study|Withdrawal by Subject|3
218144|NCT00157248|721394|P3|Overall Study|Withdrawal by Subject|3
218145|NCT00157248|721395|P2|Overall Study|Withdrawal by Subject|4
218146|NCT00157248|721396|P1|Overall Study|Withdrawal by Subject|1
218147|NCT00157248|721393|P4|Overall Study|Lost to Follow-up|0
218148|NCT00157248|721394|P3|Overall Study|Lost to Follow-up|0
218149|NCT00157248|721395|P2|Overall Study|Lost to Follow-up|1
218150|NCT00157248|721396|P1|Overall Study|Lost to Follow-up|0
218151|NCT00157248|721393|P4|Overall Study|Protocol Violation|2
218152|NCT00157248|721394|P3|Overall Study|Protocol Violation|2
218153|NCT00157248|721395|P2|Overall Study|Protocol Violation|0
218154|NCT00157248|721396|P1|Overall Study|Protocol Violation|4
218155|NCT00157248|721393|P4|Overall Study|Adverse Event|33
218156|NCT00157248|721394|P3|Overall Study|Adverse Event|13
218157|NCT00157248|721395|P2|Overall Study|Adverse Event|25
218158|NCT00157248|721396|P1|Overall Study|Adverse Event|36
218159|NCT00157209|721502|P2|Overall Study|Ongoing at data cut-off|0
218160|NCT00157209|721503|P1|Overall Study|Ongoing at data cut-off|10
218161|NCT00157196|721517|P1|Overall Study|Ongoing at data cut-off|9
218162|NCT00157157|721523|P1|Overall Study|Inclusion not met- baseline FVIII value|1
218163|NCT00157157|721523|P1|Overall Study|Met exclusion criteria|1
218164|NCT00157157|721523|P1|Overall Study|Enrolled in another study|1
218165|NCT00157157|721523|P1|Overall Study|Lost to Follow-up|1
218166|NCT00157157|721523|P1|Overall Study|Physician Decision|1
218167|NCT00157157|721523|P1|Overall Study|Withdrawal by Subject|6
218168|NCT00157014|721550|P4|Overall Study|Withdrawal by Subject|0
218169|NCT00157014|721551|P3|Overall Study|Withdrawal by Subject|0
218170|NCT00157014|721552|P2|Overall Study|Withdrawal by Subject|0
218171|NCT00157014|721553|P1|Overall Study|Withdrawal by Subject|1
218172|NCT00157014|721550|P4|Overall Study|Patient would not receive transplant|0
218173|NCT00157014|721551|P3|Overall Study|Patient would not receive transplant|0
218174|NCT00157014|721552|P2|Overall Study|Patient would not receive transplant|1
218175|NCT00157014|721553|P1|Overall Study|Patient would not receive transplant|0
218176|NCT00157014|721550|P4|Overall Study|Patient unable to return in nursing home|0
218177|NCT00157014|721551|P3|Overall Study|Patient unable to return in nursing home|0
218178|NCT00157014|721552|P2|Overall Study|Patient unable to return in nursing home|0
218179|NCT00157014|721553|P1|Overall Study|Patient unable to return in nursing home|1
218180|NCT00157014|721550|P4|Overall Study|Patient withdrawn by investigator|0
218181|NCT00157014|721551|P3|Overall Study|Patient withdrawn by investigator|0
218182|NCT00157014|721552|P2|Overall Study|Patient withdrawn by investigator|0
218183|NCT00157014|721553|P1|Overall Study|Patient withdrawn by investigator|1
218184|NCT00157014|721550|P4|Overall Study|Medications withdrawn on family request|0
218185|NCT00157014|721551|P3|Overall Study|Medications withdrawn on family request|0
218186|NCT00157014|721552|P2|Overall Study|Medications withdrawn on family request|1
218187|NCT00157014|721553|P1|Overall Study|Medications withdrawn on family request|0
218188|NCT00157014|721550|P4|Overall Study|Physician Decision|0
218189|NCT00157014|721551|P3|Overall Study|Physician Decision|0
218190|NCT00157014|721552|P2|Overall Study|Physician Decision|1
218191|NCT00157014|721553|P1|Overall Study|Physician Decision|0
218192|NCT00157014|721550|P4|Overall Study|Death|1
218193|NCT00157014|721551|P3|Overall Study|Death|1
218194|NCT00157014|721552|P2|Overall Study|Death|2
218195|NCT00157014|721553|P1|Overall Study|Death|4
218196|NCT00156819|721669|P3|Overall Study|Lost to Follow-up|3
218197|NCT00156819|721670|P2|Overall Study|Lost to Follow-up|1
218198|NCT00156819|721671|P1|Overall Study|Lost to Follow-up|1
218199|NCT00156533|721688|P4|Overall Study|Failed Screening|1
218200|NCT00156533|721689|P3|Overall Study|Failed Screening|1
218201|NCT00156533|721690|P2|Overall Study|Failed Screening|0
218202|NCT00156533|721691|P1|Overall Study|Failed Screening|1
218203|NCT00156533|721688|P4|Overall Study|Withdrawal by Subject|1
218204|NCT00156533|721689|P3|Overall Study|Withdrawal by Subject|0
218205|NCT00156533|721690|P2|Overall Study|Withdrawal by Subject|0
218206|NCT00156533|721691|P1|Overall Study|Withdrawal by Subject|1
218207|NCT00156533|721688|P4|Overall Study|Withdrawn - Medication Expiration|0
218208|NCT00156533|721689|P3|Overall Study|Withdrawn - Medication Expiration|1
218209|NCT00156533|721690|P2|Overall Study|Withdrawn - Medication Expiration|2
218210|NCT00156533|721691|P1|Overall Study|Withdrawn - Medication Expiration|0
218211|NCT00156065|721725|P3|Overall Study|Other|3
218212|NCT00156065|721726|P2|Overall Study|Other|9
218213|NCT00156065|721727|P1|Overall Study|Other|2
218214|NCT00156065|721725|P3|Overall Study|Lost to Follow-up|1
218215|NCT00156065|721726|P2|Overall Study|Lost to Follow-up|7
218216|NCT00156065|721727|P1|Overall Study|Lost to Follow-up|5
218217|NCT00156065|721725|P3|Overall Study|Withdrawal by Subject|16
218218|NCT00156065|721726|P2|Overall Study|Withdrawal by Subject|26
218219|NCT00156065|721727|P1|Overall Study|Withdrawal by Subject|13
218220|NCT00156065|721725|P3|Overall Study|Lack of Efficacy|3
218221|NCT00156065|721726|P2|Overall Study|Lack of Efficacy|9
218222|NCT00156065|721727|P1|Overall Study|Lack of Efficacy|2
218223|NCT00156065|721725|P3|Overall Study|Adverse Event|4
218224|NCT00156065|721726|P2|Overall Study|Adverse Event|11
218225|NCT00156065|721727|P1|Overall Study|Adverse Event|8
218226|NCT00156065|721725|P3|Overall Study|Enrolled But Never Received Treatment|0
218227|NCT00156065|721726|P2|Overall Study|Enrolled But Never Received Treatment|1
218228|NCT00156065|721727|P1|Overall Study|Enrolled But Never Received Treatment|1
218229|NCT00154375|721761|P2|Overall Study|Suspected progression of disease|30
218230|NCT00154375|721762|P1|Overall Study|Suspected progression of disease|44
218231|NCT00154375|721761|P2|Overall Study|Protocol Violation|1
218232|NCT00154375|721762|P1|Overall Study|Protocol Violation|0
218233|NCT00154375|721761|P2|Overall Study|Abnormal laboratory value(s)|2
218234|NCT00154375|721762|P1|Overall Study|Abnormal laboratory value(s)|0
218235|NCT00154375|721761|P2|Overall Study|Lost to Follow-up|1
218236|NCT00154375|721762|P1|Overall Study|Lost to Follow-up|2
218237|NCT00154375|721761|P2|Overall Study|Study drug no longer required|3
218238|NCT00154375|721762|P1|Overall Study|Study drug no longer required|5
218239|NCT00154375|721761|P2|Overall Study|Death|13
218240|NCT00154375|721762|P1|Overall Study|Death|5
218241|NCT00154375|721761|P2|Overall Study|Withdrawal by Subject|10
218242|NCT00154375|721762|P1|Overall Study|Withdrawal by Subject|14
218243|NCT00154375|721761|P2|Overall Study|Adverse Event|20
218244|NCT00154375|721762|P1|Overall Study|Adverse Event|18
218245|NCT00154375|721761|P2|Overall Study|Unsatisfactory therapeutic effect|26
218246|NCT00154375|721762|P1|Overall Study|Unsatisfactory therapeutic effect|25
218247|NCT00154310|721773|P2|Overall Study|Death|1
218248|NCT00154310|721774|P1|Overall Study|Death|0
218249|NCT00154310|721773|P2|Overall Study|Administrative problems|1
218250|NCT00154310|721774|P1|Overall Study|Administrative problems|0
218251|NCT00154310|721773|P2|Overall Study|Lost to Follow-up|8
218252|NCT00154310|721774|P1|Overall Study|Lost to Follow-up|0
218253|NCT00154310|721773|P2|Overall Study|Withdrawal by Subject|3
218254|NCT00154310|721774|P1|Overall Study|Withdrawal by Subject|9
218255|NCT00154310|721773|P2|Overall Study|Protocol Violation|2
218256|NCT00154310|721774|P1|Overall Study|Protocol Violation|4
218257|NCT00154310|721773|P2|Overall Study|Lack of Efficacy|4
218258|NCT00154310|721774|P1|Overall Study|Lack of Efficacy|5
218259|NCT00154310|721773|P2|Overall Study|Adverse Event|9
218260|NCT00154310|721774|P1|Overall Study|Adverse Event|19
218261|NCT00154297|721790|P2|Overall Study|Lost to Follow-up|0
218262|NCT00154297|721791|P1|Overall Study|Lost to Follow-up|3
218263|NCT00154297|721790|P2|Overall Study|Withdrawal by Subject|5
218264|NCT00154297|721791|P1|Overall Study|Withdrawal by Subject|0
218265|NCT00154297|721790|P2|Overall Study|Death|2
218266|NCT00154297|721791|P1|Overall Study|Death|5
218267|NCT00154284|721809|P2|Overall Study|Protocol Violation|1
218268|NCT00154284|721810|P1|Overall Study|Protocol Violation|0
218269|NCT00154284|721809|P2|Overall Study|Lack of Efficacy|2
218270|NCT00154284|721810|P1|Overall Study|Lack of Efficacy|1
218271|NCT00154284|721809|P2|Overall Study|Abnormal laboratory value(s)|1
218272|NCT00154284|721810|P1|Overall Study|Abnormal laboratory value(s)|0
218273|NCT00154284|721809|P2|Overall Study|Adverse Event|9
218274|NCT00154284|721810|P1|Overall Study|Adverse Event|6
218275|NCT00154102|721824|P2|Overall Study|investigational study phase ongoing|2
218276|NCT00154102|721825|P1|Overall Study|investigational study phase ongoing|7
218277|NCT00154063|721861|P2|Overall Study|Not specified|3
218278|NCT00154063|721862|P1|Overall Study|Not specified|3
218279|NCT00154063|721861|P2|Overall Study|Withdrawal by Subject|9
218280|NCT00154063|721862|P1|Overall Study|Withdrawal by Subject|4
218281|NCT00154063|721861|P2|Overall Study|Investigator or Sponsor Request|1
218282|NCT00154063|721862|P1|Overall Study|Investigator or Sponsor Request|0
218283|NCT00154063|721861|P2|Overall Study|Protocol Violation|1
218284|NCT00154063|721862|P1|Overall Study|Protocol Violation|1
218285|NCT00154063|721861|P2|Overall Study|Adverse Event|8
218286|NCT00154063|721862|P1|Overall Study|Adverse Event|4
218287|NCT00153920|721924|P1|Overall Study|Progressive Disease before Trt|1
218288|NCT00153920|721924|P1|Overall Study|Withdrawal of Consent before Trt|1
218289|NCT00153920|721924|P1|Overall Study|Non-Protocol Therapy|1
218290|NCT00153920|721924|P1|Overall Study|Withdrawal by Subject|1
218291|NCT00153920|721924|P1|Overall Study|Death|2
218292|NCT00153920|721924|P1|Overall Study|Lack of Response|3
218293|NCT00153920|721924|P1|Overall Study|Physician Decision|3
218294|NCT00153920|721924|P1|Overall Study|Progressive Disease|9
218295|NCT00153920|721924|P1|Overall Study|Adverse Event|9
218296|NCT00153816|721939|P6|Overall Study|Follow-up exam done, histology missing|2
218297|NCT00153816|721940|P5|Overall Study|Follow-up exam done, histology missing|1
218298|NCT00153816|721941|P4|Overall Study|Follow-up exam done, histology missing|3
218299|NCT00153816|721942|P3|Overall Study|Follow-up exam done, histology missing|3
218300|NCT00153816|721943|P2|Overall Study|Follow-up exam done, histology missing|3
218301|NCT00153816|721944|P1|Overall Study|Follow-up exam done, histology missing|2
218302|NCT00153816|721939|P6|Overall Study|Follow-up exam not done|9
218303|NCT00153816|721940|P5|Overall Study|Follow-up exam not done|8
218304|NCT00153816|721941|P4|Overall Study|Follow-up exam not done|10
218305|NCT00153816|721942|P3|Overall Study|Follow-up exam not done|11
218306|NCT00153816|721943|P2|Overall Study|Follow-up exam not done|7
218307|NCT00153816|721944|P1|Overall Study|Follow-up exam not done|8
218308|NCT00153816|721939|P6|Overall Study|Withdrawal by Subject|5
218309|NCT00153816|721940|P5|Overall Study|Withdrawal by Subject|1
218310|NCT00153816|721941|P4|Overall Study|Withdrawal by Subject|4
218311|NCT00153816|721942|P3|Overall Study|Withdrawal by Subject|9
218312|NCT00153816|721943|P2|Overall Study|Withdrawal by Subject|9
218313|NCT00153816|721944|P1|Overall Study|Withdrawal by Subject|9
218314|NCT00153816|721939|P6|Overall Study|Lost to Follow-up|9
218315|NCT00153816|721940|P5|Overall Study|Lost to Follow-up|7
218316|NCT00153816|721941|P4|Overall Study|Lost to Follow-up|8
218317|NCT00153816|721942|P3|Overall Study|Lost to Follow-up|5
218318|NCT00153816|721943|P2|Overall Study|Lost to Follow-up|8
218319|NCT00153816|721944|P1|Overall Study|Lost to Follow-up|7
218320|NCT00153816|721939|P6|Overall Study|Death|2
218321|NCT00153816|721940|P5|Overall Study|Death|0
218322|NCT00153816|721941|P4|Overall Study|Death|6
218323|NCT00153816|721942|P3|Overall Study|Death|4
218324|NCT00153816|721943|P2|Overall Study|Death|5
218325|NCT00153816|721944|P1|Overall Study|Death|6
218326|NCT00153101|721999|P5|Overall Study|Withdrawal by Subject|5
218327|NCT00153101|722000|P4|Overall Study|Withdrawal by Subject|3
218328|NCT00153101|722001|P3|Overall Study|Withdrawal by Subject|3
218329|NCT00153101|722002|P2|Overall Study|Withdrawal by Subject|4
218330|NCT00153101|722003|P1|Overall Study|Withdrawal by Subject|3
218331|NCT00153101|721999|P5|Overall Study|Lost to Follow-up|5
218332|NCT00153101|722000|P4|Overall Study|Lost to Follow-up|5
218333|NCT00153101|722001|P3|Overall Study|Lost to Follow-up|12
218334|NCT00153101|722002|P2|Overall Study|Lost to Follow-up|14
218335|NCT00153101|722003|P1|Overall Study|Lost to Follow-up|14
218336|NCT00153062|722111|P4|Overall Study|Other|0
218337|NCT00153062|722112|P3|Overall Study|Other|1
218338|NCT00153062|722113|P2|Overall Study|Other|0
218339|NCT00153062|722114|P1|Overall Study|Other|0
218340|NCT00153062|722111|P4|Overall Study|No disposition data available|1
218341|NCT00153062|722112|P3|Overall Study|No disposition data available|1
218342|NCT00153062|722113|P2|Overall Study|No disposition data available|1
218343|NCT00153062|722114|P1|Overall Study|No disposition data available|1
218344|NCT00153062|722111|P4|Overall Study|Protocol Violation|1
218345|NCT00153062|722112|P3|Overall Study|Protocol Violation|1
218346|NCT00153062|722113|P2|Overall Study|Protocol Violation|2
218347|NCT00153062|722114|P1|Overall Study|Protocol Violation|0
218348|NCT00153062|722111|P4|Overall Study|Adverse Event|0
218349|NCT00153062|722112|P3|Overall Study|Adverse Event|1
218350|NCT00153062|722113|P2|Overall Study|Adverse Event|1
218351|NCT00153062|722114|P1|Overall Study|Adverse Event|0
218352|NCT00153062|722111|P4|Overall Study|Lost to Follow-up|16
218353|NCT00153062|722112|P3|Overall Study|Lost to Follow-up|15
218354|NCT00153062|722113|P2|Overall Study|Lost to Follow-up|20
218355|NCT00153062|722114|P1|Overall Study|Lost to Follow-up|12
218356|NCT00153062|722111|P4|Overall Study|Withdrawal by Subject|28
218357|NCT00153062|722112|P3|Overall Study|Withdrawal by Subject|27
218358|NCT00153062|722113|P2|Overall Study|Withdrawal by Subject|30
218359|NCT00153062|722114|P1|Overall Study|Withdrawal by Subject|14
218360|NCT00153062|722111|P4|Overall Study|Death|365
218361|NCT00153062|722112|P3|Overall Study|Death|369
218362|NCT00153062|722113|P2|Overall Study|Death|352
218363|NCT00153062|722114|P1|Overall Study|Death|360
218364|NCT00152971|722133|P3|Treatment|not specified|10
218365|NCT00152971|722134|P2|Treatment|not specified|11
218366|NCT00152971|722135|P1|Treatment|not specified|9
218367|NCT00152971|722133|P3|Treatment|Withdrawal by Subject|5
218368|NCT00152971|722134|P2|Treatment|Withdrawal by Subject|4
218369|NCT00152971|722135|P1|Treatment|Withdrawal by Subject|4
218370|NCT00152971|722133|P3|Treatment|Lost to Follow-up|1
218371|NCT00152971|722134|P2|Treatment|Lost to Follow-up|2
218372|NCT00152971|722135|P1|Treatment|Lost to Follow-up|1
218373|NCT00152971|722133|P3|Treatment|Protocol Violation|10
218374|NCT00152971|722134|P2|Treatment|Protocol Violation|6
218375|NCT00152971|722135|P1|Treatment|Protocol Violation|8
218376|NCT00152971|722133|P3|Treatment|Adverse Event|54
218377|NCT00152971|722134|P2|Treatment|Adverse Event|40
218378|NCT00152971|722135|P1|Treatment|Adverse Event|49
218379|NCT00152971|722133|P3|Overall Study|not specified|5
218380|NCT00152971|722134|P2|Overall Study|not specified|5
218381|NCT00152971|722135|P1|Overall Study|not specified|3
218382|NCT00152971|722133|P3|Overall Study|Withdrawal by Subject|14
218383|NCT00152971|722134|P2|Overall Study|Withdrawal by Subject|8
218384|NCT00152971|722135|P1|Overall Study|Withdrawal by Subject|9
218385|NCT00152971|722133|P3|Overall Study|Lost to Follow-up|13
218386|NCT00152971|722134|P2|Overall Study|Lost to Follow-up|14
218387|NCT00152971|722135|P1|Overall Study|Lost to Follow-up|17
218388|NCT00152971|722133|P3|Overall Study|Protocol Violation|8
218389|NCT00152971|722134|P2|Overall Study|Protocol Violation|11
218390|NCT00152971|722135|P1|Overall Study|Protocol Violation|10
218391|NCT00152971|722133|P3|Overall Study|Adverse Event|9
218392|NCT00152971|722134|P2|Overall Study|Adverse Event|10
218393|NCT00152971|722135|P1|Overall Study|Adverse Event|12
218394|NCT00152763|722171|P4|Overall Study|Lost to Follow-up|13
218395|NCT00152763|722172|P3|Overall Study|Lost to Follow-up|2
218396|NCT00152763|722173|P2|Overall Study|Lost to Follow-up|4
218397|NCT00152763|722174|P1|Overall Study|Lost to Follow-up|6
218398|NCT00152763|722171|P4|Overall Study|Death|1
218399|NCT00152763|722172|P3|Overall Study|Death|2
218400|NCT00152763|722173|P2|Overall Study|Death|1
218401|NCT00152763|722174|P1|Overall Study|Death|4
218402|NCT00152516|722290|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
218403|NCT00152516|722290|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
218404|NCT00152516|722290|P1|Overall Study|Other: Moved Out Of State|1
218405|NCT00152516|722290|P1|Overall Study|Other: Primary Care Physician's Decision|1
218406|NCT00152516|722290|P1|Overall Study|Other: Non-Compliance|2
218407|NCT00152516|722290|P1|Overall Study|Other: Parents Withdrew Consent|2
218408|NCT00152516|722290|P1|Overall Study|Other: Given Commercial Drug in Error|2
218409|NCT00152516|722290|P1|Overall Study|Other: Mother Refused To Cooperate|1
218410|NCT00152516|722290|P1|Overall Study|Protocol Violation|3
218411|NCT00152516|722290|P1|Overall Study|Withdrawal by Subject|8
218412|NCT00152516|722290|P1|Overall Study|Lost to Follow-up|5
218413|NCT00152516|722290|P1|Overall Study|Lack and Loss of Efficacy|30
218414|NCT00152516|722290|P1|Overall Study|Adverse Event|18
218415|NCT00152009|722318|P4|Overall Study|Sponsor's decision|3
218416|NCT00152009|722319|P3|Overall Study|Sponsor's decision|1
218417|NCT00152009|722320|P2|Overall Study|Sponsor's decision|3
218418|NCT00152009|722321|P1|Overall Study|Sponsor's decision|3
218419|NCT00152009|722318|P4|Overall Study|ECG abnormalities|1
218420|NCT00152009|722319|P3|Overall Study|ECG abnormalities|2
218421|NCT00152009|722320|P2|Overall Study|ECG abnormalities|2
218422|NCT00152009|722321|P1|Overall Study|ECG abnormalities|2
218423|NCT00152009|722318|P4|Overall Study|Lack of Efficacy|15
218424|NCT00152009|722319|P3|Overall Study|Lack of Efficacy|7
218425|NCT00152009|722320|P2|Overall Study|Lack of Efficacy|6
218426|NCT00152009|722321|P1|Overall Study|Lack of Efficacy|8
218427|NCT00152009|722318|P4|Overall Study|Lost to Follow-up|3
218428|NCT00152009|722319|P3|Overall Study|Lost to Follow-up|3
218429|NCT00152009|722320|P2|Overall Study|Lost to Follow-up|4
218430|NCT00152009|722321|P1|Overall Study|Lost to Follow-up|2
218431|NCT00152009|722318|P4|Overall Study|Withdrawal by Subject|9
218432|NCT00152009|722319|P3|Overall Study|Withdrawal by Subject|4
218433|NCT00152009|722320|P2|Overall Study|Withdrawal by Subject|3
218434|NCT00152009|722321|P1|Overall Study|Withdrawal by Subject|2
218435|NCT00152009|722318|P4|Overall Study|Protocol Violation|1
218436|NCT00152009|722319|P3|Overall Study|Protocol Violation|0
218437|NCT00152009|722320|P2|Overall Study|Protocol Violation|0
218438|NCT00152009|722321|P1|Overall Study|Protocol Violation|3
218439|NCT00152009|722318|P4|Overall Study|Adverse Event|1
218440|NCT00152009|722319|P3|Overall Study|Adverse Event|20
218441|NCT00152009|722320|P2|Overall Study|Adverse Event|13
218442|NCT00152009|722321|P1|Overall Study|Adverse Event|9
218443|NCT00151996|722353|P2|Overall Study|Sponsor's decision|2
218444|NCT00151996|722354|P1|Overall Study|Sponsor's decision|0
218445|NCT00151996|722353|P2|Overall Study|Protocol Violation|2
218446|NCT00151996|722354|P1|Overall Study|Protocol Violation|1
218447|NCT00151996|722353|P2|Overall Study|Withdrawal by Subject|1
218448|NCT00151996|722354|P1|Overall Study|Withdrawal by Subject|1
218449|NCT00151996|722353|P2|Overall Study|Adverse Event|2
218450|NCT00151996|722354|P1|Overall Study|Adverse Event|3
218451|NCT00151892|722370|P2|Overall Study|Lack of study medication at center|1
218452|NCT00151892|722371|P1|Overall Study|Lack of study medication at center|0
218453|NCT00151892|722370|P2|Overall Study|Used prohibited corticosteroids|0
218454|NCT00151892|722371|P1|Overall Study|Used prohibited corticosteroids|1
218455|NCT00151892|722370|P2|Overall Study|Did not return for a visit|0
218456|NCT00151892|722371|P1|Overall Study|Did not return for a visit|1
218457|NCT00151892|722370|P2|Overall Study|Pregnancy|1
218458|NCT00151892|722371|P1|Overall Study|Pregnancy|0
218459|NCT00151892|722370|P2|Overall Study|Non-compliance|1
218460|NCT00151892|722371|P1|Overall Study|Non-compliance|0
218461|NCT00151892|722370|P2|Overall Study|Protocol Violation|3
218462|NCT00151892|722371|P1|Overall Study|Protocol Violation|3
218463|NCT00151892|722370|P2|Overall Study|Adverse Event|3
218464|NCT00151892|722371|P1|Overall Study|Adverse Event|6
218465|NCT00151892|722370|P2|Overall Study|Lost to Follow-up|10
218466|NCT00151892|722371|P1|Overall Study|Lost to Follow-up|5
218467|NCT00151892|722370|P2|Overall Study|Patient request|7
218468|NCT00151892|722371|P1|Overall Study|Patient request|10
218469|NCT00151892|722370|P2|Overall Study|Lack of Efficacy|57
218470|NCT00151892|722371|P1|Overall Study|Lack of Efficacy|50
218471|NCT00151775|722416|P12|Period 4: Open Label|Protocol Violation|0
218472|NCT00151775|722417|P11|Period 4: Open Label|Protocol Violation|0
218473|NCT00151775|722418|P10|Period 4: Open Label|Protocol Violation|0
218474|NCT00151775|722419|P9|Period 4: Open Label|Protocol Violation|0
218475|NCT00151775|722420|P8|Period 4: Open Label|Protocol Violation|0
218476|NCT00151775|722421|P7|Period 4: Open Label|Protocol Violation|0
218477|NCT00151775|722422|P6|Period 4: Open Label|Protocol Violation|0
218478|NCT00151775|722423|P5|Period 4: Open Label|Protocol Violation|1
218479|NCT00151775|722424|P4|Period 4: Open Label|Protocol Violation|0
218480|NCT00151775|722425|P3|Period 4: Open Label|Protocol Violation|0
218481|NCT00151775|722426|P2|Period 4: Open Label|Protocol Violation|0
218482|NCT00151775|722427|P1|Period 4: Open Label|Protocol Violation|0
218483|NCT00151775|722416|P12|Period 4: Open Label|Physician Decision|0
218484|NCT00151775|722417|P11|Period 4: Open Label|Physician Decision|0
218485|NCT00151775|722418|P10|Period 4: Open Label|Physician Decision|2
218486|NCT00151775|722419|P9|Period 4: Open Label|Physician Decision|0
218487|NCT00151775|722420|P8|Period 4: Open Label|Physician Decision|0
218488|NCT00151775|722421|P7|Period 4: Open Label|Physician Decision|0
218489|NCT00151775|722422|P6|Period 4: Open Label|Physician Decision|0
218490|NCT00151775|722423|P5|Period 4: Open Label|Physician Decision|0
218491|NCT00151775|722424|P4|Period 4: Open Label|Physician Decision|0
218492|NCT00151775|722425|P3|Period 4: Open Label|Physician Decision|0
218493|NCT00151775|722426|P2|Period 4: Open Label|Physician Decision|0
218494|NCT00151775|722427|P1|Period 4: Open Label|Physician Decision|0
218495|NCT00151775|722416|P12|Period 4: Open Label|Other|0
218496|NCT00151775|722417|P11|Period 4: Open Label|Other|0
218497|NCT00151775|722418|P10|Period 4: Open Label|Other|3
218498|NCT00151775|722419|P9|Period 4: Open Label|Other|0
218499|NCT00151775|722420|P8|Period 4: Open Label|Other|0
218500|NCT00151775|722421|P7|Period 4: Open Label|Other|0
218501|NCT00151775|722422|P6|Period 4: Open Label|Other|0
218502|NCT00151775|722423|P5|Period 4: Open Label|Other|1
218503|NCT00151775|722424|P4|Period 4: Open Label|Other|0
218504|NCT00151775|722425|P3|Period 4: Open Label|Other|0
218505|NCT00151775|722426|P2|Period 4: Open Label|Other|0
218506|NCT00151775|722427|P1|Period 4: Open Label|Other|0
218507|NCT00151775|722416|P12|Period 4: Open Label|Non-compliance with protocol|0
218508|NCT00151775|722417|P11|Period 4: Open Label|Non-compliance with protocol|0
218509|NCT00151775|722418|P10|Period 4: Open Label|Non-compliance with protocol|4
218510|NCT00151775|722419|P9|Period 4: Open Label|Non-compliance with protocol|0
218511|NCT00151775|722420|P8|Period 4: Open Label|Non-compliance with protocol|0
218512|NCT00151775|722421|P7|Period 4: Open Label|Non-compliance with protocol|0
218513|NCT00151775|722422|P6|Period 4: Open Label|Non-compliance with protocol|0
218514|NCT00151775|722423|P5|Period 4: Open Label|Non-compliance with protocol|4
218515|NCT00151775|722424|P4|Period 4: Open Label|Non-compliance with protocol|0
218516|NCT00151775|722425|P3|Period 4: Open Label|Non-compliance with protocol|0
218517|NCT00151775|722426|P2|Period 4: Open Label|Non-compliance with protocol|0
218518|NCT00151775|722427|P1|Period 4: Open Label|Non-compliance with protocol|0
218519|NCT00151775|722416|P12|Period 4: Open Label|Lost to Follow-up|0
218520|NCT00151775|722417|P11|Period 4: Open Label|Lost to Follow-up|0
218521|NCT00151775|722418|P10|Period 4: Open Label|Lost to Follow-up|7
218522|NCT00151775|722419|P9|Period 4: Open Label|Lost to Follow-up|0
218523|NCT00151775|722420|P8|Period 4: Open Label|Lost to Follow-up|0
218524|NCT00151775|722421|P7|Period 4: Open Label|Lost to Follow-up|0
218525|NCT00151775|722422|P6|Period 4: Open Label|Lost to Follow-up|0
218526|NCT00151775|722423|P5|Period 4: Open Label|Lost to Follow-up|17
218527|NCT00151775|722424|P4|Period 4: Open Label|Lost to Follow-up|0
218528|NCT00151775|722425|P3|Period 4: Open Label|Lost to Follow-up|0
218529|NCT00151775|722426|P2|Period 4: Open Label|Lost to Follow-up|0
218530|NCT00151775|722427|P1|Period 4: Open Label|Lost to Follow-up|0
218531|NCT00151775|722416|P12|Period 4: Open Label|Adverse Event|0
218532|NCT00151775|722417|P11|Period 4: Open Label|Adverse Event|0
218533|NCT00151775|722418|P10|Period 4: Open Label|Adverse Event|2
218534|NCT00151775|722419|P9|Period 4: Open Label|Adverse Event|0
218535|NCT00151775|722420|P8|Period 4: Open Label|Adverse Event|0
218536|NCT00151775|722421|P7|Period 4: Open Label|Adverse Event|0
218537|NCT00151775|722422|P6|Period 4: Open Label|Adverse Event|0
218538|NCT00151775|722423|P5|Period 4: Open Label|Adverse Event|1
218539|NCT00151775|722424|P4|Period 4: Open Label|Adverse Event|0
218540|NCT00151775|722425|P3|Period 4: Open Label|Adverse Event|0
218541|NCT00151775|722426|P2|Period 4: Open Label|Adverse Event|0
218542|NCT00151775|722427|P1|Period 4: Open Label|Adverse Event|0
218543|NCT00151775|722416|P12|Period 4: Open Label|Withdrawal by Subject|0
218544|NCT00151775|722417|P11|Period 4: Open Label|Withdrawal by Subject|0
218545|NCT00151775|722418|P10|Period 4: Open Label|Withdrawal by Subject|2
218546|NCT00151775|722419|P9|Period 4: Open Label|Withdrawal by Subject|0
218547|NCT00151775|722420|P8|Period 4: Open Label|Withdrawal by Subject|0
218548|NCT00151775|722421|P7|Period 4: Open Label|Withdrawal by Subject|0
218549|NCT00151775|722422|P6|Period 4: Open Label|Withdrawal by Subject|0
218550|NCT00151775|722423|P5|Period 4: Open Label|Withdrawal by Subject|5
218551|NCT00151775|722424|P4|Period 4: Open Label|Withdrawal by Subject|0
218552|NCT00151775|722425|P3|Period 4: Open Label|Withdrawal by Subject|0
218553|NCT00151775|722426|P2|Period 4: Open Label|Withdrawal by Subject|0
218554|NCT00151775|722427|P1|Period 4: Open Label|Withdrawal by Subject|0
218555|NCT00151775|722416|P12|Period 4: Open Label|Increased blood pressure|0
218556|NCT00151775|722417|P11|Period 4: Open Label|Increased blood pressure|0
218557|NCT00151775|722418|P10|Period 4: Open Label|Increased blood pressure|1
218558|NCT00151775|722419|P9|Period 4: Open Label|Increased blood pressure|0
218559|NCT00151775|722420|P8|Period 4: Open Label|Increased blood pressure|0
218560|NCT00151775|722421|P7|Period 4: Open Label|Increased blood pressure|0
218561|NCT00151775|722422|P6|Period 4: Open Label|Increased blood pressure|0
218562|NCT00151775|722423|P5|Period 4: Open Label|Increased blood pressure|1
218563|NCT00151775|722424|P4|Period 4: Open Label|Increased blood pressure|0
218564|NCT00151775|722425|P3|Period 4: Open Label|Increased blood pressure|0
218565|NCT00151775|722426|P2|Period 4: Open Label|Increased blood pressure|0
218566|NCT00151775|722427|P1|Period 4: Open Label|Increased blood pressure|0
218567|NCT00151775|722416|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
218568|NCT00151775|722417|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218569|NCT00151775|722418|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218570|NCT00151775|722419|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218571|NCT00151775|722420|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218572|NCT00151775|722421|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218573|NCT00151775|722422|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218574|NCT00151775|722423|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218575|NCT00151775|722424|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218576|NCT00151775|722425|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218577|NCT00151775|722426|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218578|NCT00151775|722427|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
218579|NCT00151775|722416|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218580|NCT00151775|722417|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218581|NCT00151775|722418|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218582|NCT00151775|722419|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218583|NCT00151775|722420|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218584|NCT00151775|722421|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218585|NCT00151775|722422|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218586|NCT00151775|722423|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218587|NCT00151775|722424|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218588|NCT00151775|722425|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
218589|NCT00151775|722426|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218590|NCT00151775|722427|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
218591|NCT00151775|722416|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
218592|NCT00151775|722417|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
218593|NCT00151775|722418|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
218594|NCT00151775|722419|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
218595|NCT00151775|722420|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
218596|NCT00151775|722421|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
218597|NCT00151775|722422|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
218598|NCT00151775|722423|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
218599|NCT00151775|722424|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
218600|NCT00151775|722425|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
218601|NCT00151775|722426|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
218602|NCT00151775|722427|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
218603|NCT00151775|722416|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218604|NCT00151775|722417|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218605|NCT00151775|722418|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218606|NCT00151775|722419|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218607|NCT00151775|722420|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218608|NCT00151775|722421|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
218609|NCT00151775|722422|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218610|NCT00151775|722423|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218611|NCT00151775|722424|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218612|NCT00151775|722425|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218613|NCT00151775|722426|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218614|NCT00151775|722427|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
218615|NCT00151775|722416|P12|Period 3: Double-blind, Withdrawal|Other|0
218616|NCT00151775|722417|P11|Period 3: Double-blind, Withdrawal|Other|0
218617|NCT00151775|722418|P10|Period 3: Double-blind, Withdrawal|Other|0
218618|NCT00151775|722419|P9|Period 3: Double-blind, Withdrawal|Other|0
218619|NCT00151775|722420|P8|Period 3: Double-blind, Withdrawal|Other|1
218620|NCT00151775|722421|P7|Period 3: Double-blind, Withdrawal|Other|0
218621|NCT00151775|722422|P6|Period 3: Double-blind, Withdrawal|Other|0
218622|NCT00151775|722423|P5|Period 3: Double-blind, Withdrawal|Other|0
218623|NCT00151775|722424|P4|Period 3: Double-blind, Withdrawal|Other|0
218624|NCT00151775|722425|P3|Period 3: Double-blind, Withdrawal|Other|1
218625|NCT00151775|722426|P2|Period 3: Double-blind, Withdrawal|Other|0
218626|NCT00151775|722427|P1|Period 3: Double-blind, Withdrawal|Other|0
218627|NCT00151775|722416|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218628|NCT00151775|722417|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218629|NCT00151775|722418|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218630|NCT00151775|722419|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218631|NCT00151775|722420|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218632|NCT00151775|722421|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218633|NCT00151775|722422|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
218634|NCT00151775|722423|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218635|NCT00151775|722424|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218636|NCT00151775|722425|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218637|NCT00151775|722426|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218638|NCT00151775|722427|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
218639|NCT00151775|722416|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218640|NCT00151775|722417|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218641|NCT00151775|722418|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218642|NCT00151775|722419|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218643|NCT00151775|722420|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218644|NCT00151775|722421|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
218645|NCT00151775|722422|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218646|NCT00151775|722423|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218647|NCT00151775|722424|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218648|NCT00151775|722425|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218649|NCT00151775|722426|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218650|NCT00151775|722427|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
218651|NCT00151775|722416|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
218652|NCT00151775|722417|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
218653|NCT00151775|722418|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
218654|NCT00151775|722419|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
218655|NCT00151775|722420|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
218656|NCT00151775|722421|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
218657|NCT00151775|722422|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
218658|NCT00151775|722423|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
218659|NCT00151775|722424|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
218660|NCT00151775|722425|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
218661|NCT00151775|722426|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
218662|NCT00151775|722427|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
218663|NCT00151775|722416|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
218664|NCT00151775|722417|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
218665|NCT00151775|722418|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
218666|NCT00151775|722419|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
218667|NCT00151775|722420|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
218668|NCT00151775|722421|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
218669|NCT00151775|722422|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
218670|NCT00151775|722423|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
218671|NCT00151775|722424|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
218672|NCT00151775|722425|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
218673|NCT00151775|722426|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
218674|NCT00151775|722427|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
218675|NCT00151775|722416|P12|Period 2 - Double-Blind Dose Response|Other|0
218676|NCT00151775|722417|P11|Period 2 - Double-Blind Dose Response|Other|0
218677|NCT00151775|722418|P10|Period 2 - Double-Blind Dose Response|Other|0
218678|NCT00151775|722419|P9|Period 2 - Double-Blind Dose Response|Other|0
218679|NCT00151775|722420|P8|Period 2 - Double-Blind Dose Response|Other|0
218680|NCT00151775|722421|P7|Period 2 - Double-Blind Dose Response|Other|1
218681|NCT00151775|722422|P6|Period 2 - Double-Blind Dose Response|Other|0
218682|NCT00151775|722423|P5|Period 2 - Double-Blind Dose Response|Other|0
218683|NCT00151775|722424|P4|Period 2 - Double-Blind Dose Response|Other|0
218684|NCT00151775|722425|P3|Period 2 - Double-Blind Dose Response|Other|0
218685|NCT00151775|722426|P2|Period 2 - Double-Blind Dose Response|Other|0
218686|NCT00151775|722427|P1|Period 2 - Double-Blind Dose Response|Other|0
218687|NCT00151775|722416|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218688|NCT00151775|722417|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218689|NCT00151775|722418|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218690|NCT00151775|722419|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218691|NCT00151775|722420|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218692|NCT00151775|722421|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218693|NCT00151775|722422|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218694|NCT00151775|722423|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218695|NCT00151775|722424|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218696|NCT00151775|722425|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218697|NCT00151775|722426|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
218698|NCT00151775|722427|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
218699|NCT00151775|722416|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
218700|NCT00151775|722417|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
218701|NCT00151775|722418|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
218702|NCT00151775|722419|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
218703|NCT00151775|722420|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
218704|NCT00151775|722421|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
218705|NCT00151775|722422|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
218706|NCT00151775|722423|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
218707|NCT00151775|722424|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
218708|NCT00151775|722425|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
218709|NCT00151775|722426|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
218710|NCT00151775|722427|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
218711|NCT00151775|722416|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
218712|NCT00151775|722417|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
218713|NCT00151775|722418|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
218714|NCT00151775|722419|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
218715|NCT00151775|722420|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
218716|NCT00151775|722421|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
218717|NCT00151775|722422|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
218718|NCT00151775|722423|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
218719|NCT00151775|722424|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
218720|NCT00151775|722425|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
218721|NCT00151775|722426|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
218722|NCT00151775|722427|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
218723|NCT00151476|722471|P2|FAP Analyzed Subjects|Other study participation|1
218724|NCT00151476|722472|P1|FAP Analyzed Subjects|Other study participation|0
218725|NCT00151476|722471|P2|FAP Analyzed Subjects|Lost to Follow-up|2
218726|NCT00151476|722472|P1|FAP Analyzed Subjects|Lost to Follow-up|0
218727|NCT00151476|722471|P2|FAP Identified Subjects|Protocol Violation|1
218728|NCT00151476|722472|P1|FAP Identified Subjects|Protocol Violation|0
218729|NCT00151411|722529|P2|Overall Study|Pregnancy|4
218730|NCT00151411|722530|P1|Overall Study|Pregnancy|0
218731|NCT00151411|722529|P2|Overall Study|Adverse Event|0
218732|NCT00151411|722530|P1|Overall Study|Adverse Event|6
218733|NCT00151411|722529|P2|Overall Study|Withdrawal by Subject|20
218734|NCT00151411|722530|P1|Overall Study|Withdrawal by Subject|12
218735|NCT00151411|722529|P2|Overall Study|Lost to Follow-up|19
218736|NCT00151411|722530|P1|Overall Study|Lost to Follow-up|15
218737|NCT00151372|722542|P2|Overall Study|Withdrawal by Subject|7
218738|NCT00151372|722543|P1|Overall Study|Withdrawal by Subject|7
218739|NCT00151372|722542|P2|Overall Study|Too sick medically to continue|6
218740|NCT00151372|722543|P1|Overall Study|Too sick medically to continue|5
218741|NCT00151372|722542|P2|Overall Study|Lost to Follow-up|5
218742|NCT00151372|722543|P1|Overall Study|Lost to Follow-up|5
218743|NCT00151372|722542|P2|Overall Study|Death|11
218744|NCT00151372|722543|P1|Overall Study|Death|12
218745|NCT00151281|722558|P1|Overall Study|Not evaluable|3
218746|NCT00150969|722567|P2|24-48 Month Extension|Other Reason|91
218747|NCT00150969|722568|P1|24-48 Month Extension|Other Reason|81
218748|NCT00150969|722567|P2|24-48 Month Extension|Adverse Event|3
218749|NCT00150969|722568|P1|24-48 Month Extension|Adverse Event|1
218750|NCT00150969|722567|P2|24-48 Month Extension|Lack of Efficacy|1
218751|NCT00150969|722568|P1|24-48 Month Extension|Lack of Efficacy|0
218752|NCT00150969|722567|P2|24-48 Month Extension|Withdrawal by Subject|5
218753|NCT00150969|722568|P1|24-48 Month Extension|Withdrawal by Subject|6
218754|NCT00150969|722567|P2|24 Month Main Study|Withdrawal by Subject|4
218755|NCT00150969|722568|P1|24 Month Main Study|Withdrawal by Subject|7
218756|NCT00150969|722567|P2|24 Month Main Study|Protocol Violation|2
218757|NCT00150969|722568|P1|24 Month Main Study|Protocol Violation|4
218758|NCT00150969|722567|P2|24 Month Main Study|Lost to Follow-up|2
218759|NCT00150969|722568|P1|24 Month Main Study|Lost to Follow-up|3
218760|NCT00150969|722567|P2|24 Month Main Study|Lack of Efficacy|8
218761|NCT00150969|722568|P1|24 Month Main Study|Lack of Efficacy|1
218762|NCT00150969|722567|P2|24 Month Main Study|Death|1
218763|NCT00150969|722568|P1|24 Month Main Study|Death|1
218764|NCT00150969|722567|P2|24 Month Main Study|Adverse Event|4
218765|NCT00150969|722568|P1|24 Month Main Study|Adverse Event|3
218766|NCT00150618|722605|P5|Overall Study|Sponsor's decision|0
218767|NCT00150618|722606|P4|Overall Study|Sponsor's decision|1
218768|NCT00150618|722607|P3|Overall Study|Sponsor's decision|0
218769|NCT00150618|722608|P2|Overall Study|Sponsor's decision|0
218770|NCT00150618|722609|P1|Overall Study|Sponsor's decision|0
218771|NCT00150618|722605|P5|Overall Study|Abnormal ECG|0
218772|NCT00150618|722606|P4|Overall Study|Abnormal ECG|0
218773|NCT00150618|722607|P3|Overall Study|Abnormal ECG|0
218774|NCT00150618|722608|P2|Overall Study|Abnormal ECG|0
218775|NCT00150618|722609|P1|Overall Study|Abnormal ECG|1
218776|NCT00150618|722605|P5|Overall Study|Lack of compliance|1
218777|NCT00150618|722606|P4|Overall Study|Lack of compliance|0
218778|NCT00150618|722607|P3|Overall Study|Lack of compliance|1
218779|NCT00150618|722608|P2|Overall Study|Lack of compliance|1
218780|NCT00150618|722609|P1|Overall Study|Lack of compliance|2
218781|NCT00150618|722605|P5|Overall Study|Physician Decision|1
218782|NCT00150618|722606|P4|Overall Study|Physician Decision|0
218783|NCT00150618|722607|P3|Overall Study|Physician Decision|0
218784|NCT00150618|722608|P2|Overall Study|Physician Decision|2
218785|NCT00150618|722609|P1|Overall Study|Physician Decision|0
218786|NCT00150618|722605|P5|Overall Study|No study meds|2
218787|NCT00150618|722606|P4|Overall Study|No study meds|0
218788|NCT00150618|722607|P3|Overall Study|No study meds|0
218789|NCT00150618|722608|P2|Overall Study|No study meds|0
218790|NCT00150618|722609|P1|Overall Study|No study meds|0
218791|NCT00150618|722605|P5|Overall Study|Lack of Efficacy|6
218792|NCT00150618|722606|P4|Overall Study|Lack of Efficacy|4
218793|NCT00150618|722607|P3|Overall Study|Lack of Efficacy|7
218794|NCT00150618|722608|P2|Overall Study|Lack of Efficacy|4
218795|NCT00150618|722609|P1|Overall Study|Lack of Efficacy|1
218796|NCT00150618|722605|P5|Overall Study|Protocol Violation|1
218797|NCT00150618|722606|P4|Overall Study|Protocol Violation|0
218798|NCT00150618|722607|P3|Overall Study|Protocol Violation|0
218799|NCT00150618|722608|P2|Overall Study|Protocol Violation|0
218800|NCT00150618|722609|P1|Overall Study|Protocol Violation|1
218801|NCT00150618|722605|P5|Overall Study|Lost to Follow-up|4
218802|NCT00150618|722606|P4|Overall Study|Lost to Follow-up|8
218803|NCT00150618|722607|P3|Overall Study|Lost to Follow-up|5
218804|NCT00150618|722608|P2|Overall Study|Lost to Follow-up|1
218805|NCT00150618|722609|P1|Overall Study|Lost to Follow-up|4
218806|NCT00150618|722605|P5|Overall Study|Withdrawal by Subject|5
218807|NCT00150618|722606|P4|Overall Study|Withdrawal by Subject|4
218808|NCT00150618|722607|P3|Overall Study|Withdrawal by Subject|8
218809|NCT00150618|722608|P2|Overall Study|Withdrawal by Subject|8
218810|NCT00150618|722609|P1|Overall Study|Withdrawal by Subject|6
218811|NCT00150618|722605|P5|Overall Study|Adverse Event|5
218812|NCT00150618|722606|P4|Overall Study|Adverse Event|9
218813|NCT00150618|722607|P3|Overall Study|Adverse Event|6
218814|NCT00150618|722608|P2|Overall Study|Adverse Event|2
218815|NCT00150618|722609|P1|Overall Study|Adverse Event|2
218816|NCT00150592|722643|P2|Overall Study|Non-compliance|0
218817|NCT00150592|722644|P1|Overall Study|Non-compliance|1
218818|NCT00150592|722643|P2|Overall Study|Withdrawal by Subject|2
218819|NCT00150592|722644|P1|Overall Study|Withdrawal by Subject|1
218820|NCT00150592|722643|P2|Overall Study|Protocol Violation|0
218821|NCT00150592|722644|P1|Overall Study|Protocol Violation|1
218822|NCT00150592|722643|P2|Overall Study|Adverse Event|1
218823|NCT00150592|722644|P1|Overall Study|Adverse Event|4
218824|NCT00150462|722675|P11|Overall Study|Other|1
218825|NCT00150462|722676|P10|Overall Study|Other|1
218826|NCT00150462|722677|P9|Overall Study|Other|0
218827|NCT00150462|722678|P8|Overall Study|Other|0
218828|NCT00150462|722679|P7|Overall Study|Other|0
218829|NCT00150462|722680|P6|Overall Study|Other|0
218830|NCT00150462|722681|P5|Overall Study|Other|0
218831|NCT00150462|722682|P4|Overall Study|Other|0
218832|NCT00150462|722683|P3|Overall Study|Other|0
218833|NCT00150462|722684|P2|Overall Study|Other|0
218834|NCT00150462|722685|P1|Overall Study|Other|0
218835|NCT00150462|722675|P11|Overall Study|Physician Decision|0
218836|NCT00150462|722676|P10|Overall Study|Physician Decision|0
218837|NCT00150462|722677|P9|Overall Study|Physician Decision|0
218838|NCT00150462|722678|P8|Overall Study|Physician Decision|0
218839|NCT00150462|722679|P7|Overall Study|Physician Decision|0
218840|NCT00150462|722680|P6|Overall Study|Physician Decision|0
218841|NCT00150462|722681|P5|Overall Study|Physician Decision|0
218842|NCT00150462|722682|P4|Overall Study|Physician Decision|1
218843|NCT00150462|722683|P3|Overall Study|Physician Decision|1
218844|NCT00150462|722684|P2|Overall Study|Physician Decision|0
218845|NCT00150462|722685|P1|Overall Study|Physician Decision|0
218846|NCT00150462|722675|P11|Overall Study|Adverse Event|0
218847|NCT00150462|722676|P10|Overall Study|Adverse Event|1
218848|NCT00150462|722677|P9|Overall Study|Adverse Event|0
218849|NCT00150462|722678|P8|Overall Study|Adverse Event|2
218850|NCT00150462|722679|P7|Overall Study|Adverse Event|0
218851|NCT00150462|722680|P6|Overall Study|Adverse Event|0
218852|NCT00150462|722681|P5|Overall Study|Adverse Event|0
218853|NCT00150462|722682|P4|Overall Study|Adverse Event|1
218854|NCT00150462|722683|P3|Overall Study|Adverse Event|0
218855|NCT00150462|722684|P2|Overall Study|Adverse Event|0
218856|NCT00150462|722685|P1|Overall Study|Adverse Event|0
218857|NCT00150462|722675|P11|Overall Study|Death|0
218858|NCT00150462|722676|P10|Overall Study|Death|0
218859|NCT00150462|722677|P9|Overall Study|Death|1
218860|NCT00150462|722678|P8|Overall Study|Death|0
218861|NCT00150462|722679|P7|Overall Study|Death|0
218862|NCT00150462|722680|P6|Overall Study|Death|0
218863|NCT00150462|722681|P5|Overall Study|Death|0
218864|NCT00150462|722682|P4|Overall Study|Death|0
218865|NCT00150462|722683|P3|Overall Study|Death|0
218866|NCT00150462|722684|P2|Overall Study|Death|1
218867|NCT00150462|722685|P1|Overall Study|Death|0
218868|NCT00150462|722675|P11|Overall Study|Withdrawal by Subject|0
218869|NCT00150462|722676|P10|Overall Study|Withdrawal by Subject|1
218870|NCT00150462|722677|P9|Overall Study|Withdrawal by Subject|0
218871|NCT00150462|722678|P8|Overall Study|Withdrawal by Subject|1
218872|NCT00150462|722679|P7|Overall Study|Withdrawal by Subject|0
218873|NCT00150462|722680|P6|Overall Study|Withdrawal by Subject|2
218874|NCT00150462|722681|P5|Overall Study|Withdrawal by Subject|1
218875|NCT00150462|722682|P4|Overall Study|Withdrawal by Subject|0
218876|NCT00150462|722683|P3|Overall Study|Withdrawal by Subject|1
218877|NCT00150462|722684|P2|Overall Study|Withdrawal by Subject|1
218878|NCT00150462|722685|P1|Overall Study|Withdrawal by Subject|0
218879|NCT00150462|722675|P11|Overall Study|Disease Progression or Relapse|2
218880|NCT00150462|722676|P10|Overall Study|Disease Progression or Relapse|3
218881|NCT00150462|722677|P9|Overall Study|Disease Progression or Relapse|5
218882|NCT00150462|722678|P8|Overall Study|Disease Progression or Relapse|5
218883|NCT00150462|722679|P7|Overall Study|Disease Progression or Relapse|3
218884|NCT00150462|722680|P6|Overall Study|Disease Progression or Relapse|2
218885|NCT00150462|722681|P5|Overall Study|Disease Progression or Relapse|2
218886|NCT00150462|722682|P4|Overall Study|Disease Progression or Relapse|1
218887|NCT00150462|722683|P3|Overall Study|Disease Progression or Relapse|2
218888|NCT00150462|722684|P2|Overall Study|Disease Progression or Relapse|1
218889|NCT00150462|722685|P1|Overall Study|Disease Progression or Relapse|3
218890|NCT00150345|722795|P2|Overall Study|Other|14
218891|NCT00150345|722796|P1|Overall Study|Other|12
218892|NCT00150345|722795|P2|Overall Study|Laboratory abnormality|2
218893|NCT00150345|722796|P1|Overall Study|Laboratory abnormality|1
218894|NCT00150345|722795|P2|Overall Study|Withdrawal by Subject|4
218895|NCT00150345|722796|P1|Overall Study|Withdrawal by Subject|3
218896|NCT00150345|722795|P2|Overall Study|Lack of Efficacy|4
218897|NCT00150345|722796|P1|Overall Study|Lack of Efficacy|5
218898|NCT00150345|722795|P2|Overall Study|Adverse Event|6
218899|NCT00150345|722796|P1|Overall Study|Adverse Event|8
218900|NCT00150345|722795|P2|Overall Study|Death|2
218901|NCT00150345|722796|P1|Overall Study|Death|5
218902|NCT00150176|722860|P2|Overall Study|OTHER|13
218903|NCT00150176|722861|P1|Overall Study|OTHER|11
218904|NCT00150176|722860|P2|Overall Study|Lost to Follow-up|3
218905|NCT00150176|722861|P1|Overall Study|Lost to Follow-up|3
218906|NCT00150176|722860|P2|Overall Study|Withdrawal by Subject|12
218907|NCT00150176|722861|P1|Overall Study|Withdrawal by Subject|19
218908|NCT00150176|722860|P2|Overall Study|Relapse/Impending relapse, non-AE|39
218909|NCT00150176|722861|P1|Overall Study|Relapse/Impending relapse, non-AE|10
218910|NCT00150176|722860|P2|Overall Study|Adverse Event|53
218911|NCT00150176|722861|P1|Overall Study|Adverse Event|16
218912|NCT00149994|722872|P2|Overall Study|Protocol Violation|1
218913|NCT00149994|722873|P1|Overall Study|Protocol Violation|0
218914|NCT00149994|722872|P2|Overall Study|Administrative problems:|0
218915|NCT00149994|722873|P1|Overall Study|Administrative problems:|1
218916|NCT00149890|722881|P2|Overall Study|Graft Loss|1
218917|NCT00149890|722882|P1|Overall Study|Graft Loss|2
218918|NCT00149890|722881|P2|Overall Study|Lost to Follow-up|0
218919|NCT00149890|722882|P1|Overall Study|Lost to Follow-up|1
218920|NCT00149890|722881|P2|Overall Study|Protocol Violation|0
218921|NCT00149890|722882|P1|Overall Study|Protocol Violation|1
218922|NCT00149890|722881|P2|Overall Study|Lack of Efficacy|9
218923|NCT00149890|722882|P1|Overall Study|Lack of Efficacy|8
218924|NCT00149890|722881|P2|Overall Study|Adverse Event|8
218925|NCT00149890|722882|P1|Overall Study|Adverse Event|1
218926|NCT00149825|722902|P2|Overall Study|Other|0
218927|NCT00149825|722903|P1|Overall Study|Other|1
218928|NCT00149825|722902|P2|Overall Study|Not liking insomnia therapy|0
218929|NCT00149825|722903|P1|Overall Study|Not liking insomnia therapy|1
218930|NCT00149825|722902|P2|Overall Study|Time commitments|1
218931|NCT00149825|722903|P1|Overall Study|Time commitments|2
218932|NCT00149825|722902|P2|Overall Study|Intolerance to medication side effects|2
218933|NCT00149825|722903|P1|Overall Study|Intolerance to medication side effects|1
218934|NCT00149747|722931|P2|Overall Study|Withdrawal by Subject|3
218935|NCT00149747|722932|P1|Overall Study|Withdrawal by Subject|3
218936|NCT00149747|722931|P2|Overall Study|Death|0
218937|NCT00149747|722932|P1|Overall Study|Death|1
218938|NCT00149630|722978|P2|Overall Study|Adverse Event|0
218939|NCT00149630|722979|P1|Overall Study|Adverse Event|2
218940|NCT00149630|722978|P2|Overall Study|Treatment Programs|5
218941|NCT00149630|722979|P1|Overall Study|Treatment Programs|4
218942|NCT00149630|722978|P2|Overall Study|Incarceration|0
218943|NCT00149630|722979|P1|Overall Study|Incarceration|2
218944|NCT00149396|722989|P1|Overall Study|other treatment|5
218945|NCT00149396|722989|P1|Overall Study|Subject noncompliance|2
218946|NCT00149396|722989|P1|Overall Study|Withdrawal by Subject|1
218947|NCT00149396|722989|P1|Overall Study|Death|15
218948|NCT00149214|723059|P2|Overall Study|Progressive Disease|3
218949|NCT00149214|723060|P1|Overall Study|Progressive Disease|7
218950|NCT00149214|723059|P2|Overall Study|Sponsor Decision|1
218951|NCT00149214|723060|P1|Overall Study|Sponsor Decision|0
218952|NCT00149214|723059|P2|Overall Study|Physician Decision|3
218953|NCT00149214|723060|P1|Overall Study|Physician Decision|3
218954|NCT00149214|723059|P2|Overall Study|Withdrawal by Subject|1
218955|NCT00149214|723060|P1|Overall Study|Withdrawal by Subject|4
218956|NCT00149214|723059|P2|Overall Study|Adverse Event|9
218957|NCT00149214|723060|P1|Overall Study|Adverse Event|12
218958|NCT00148759|723108|P2|Overall Study|Lost to Follow-up|0
218959|NCT00148759|723109|P1|Overall Study|Lost to Follow-up|1
218960|NCT00148759|723108|P2|Overall Study|Withdrawal by Subject|1
218961|NCT00148759|723109|P1|Overall Study|Withdrawal by Subject|1
218962|NCT00148317|723135|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
218963|NCT00148317|723135|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
218964|NCT00148317|723135|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
218965|NCT00148122|723142|P1|Overall Study|Withdrawal by Subject|2
218966|NCT00148109|723150|P2|Overall Study|Withdrawal by Subject|0
218967|NCT00148109|723151|P1|Overall Study|Withdrawal by Subject|2
218968|NCT00148109|723150|P2|Overall Study|Adverse Event|2
218969|NCT00148109|723151|P1|Overall Study|Adverse Event|0
218970|NCT00148109|723150|P2|Overall Study|Lack of Efficacy|18
218971|NCT00148109|723151|P1|Overall Study|Lack of Efficacy|10
218972|NCT00147823|723167|P2|Overall Study|Did not receive vitoss due to infection|2
218973|NCT00147823|723168|P1|Overall Study|Did not receive vitoss due to infection|6
218974|NCT00147823|723167|P2|Overall Study|Withdrawal by Subject|1
218975|NCT00147823|723168|P1|Overall Study|Withdrawal by Subject|0
218976|NCT00147823|723167|P2|Overall Study|Physician Decision|0
218977|NCT00147823|723168|P1|Overall Study|Physician Decision|1
218978|NCT00147823|723167|P2|Overall Study|Lost to Follow-up|12
218979|NCT00147823|723168|P1|Overall Study|Lost to Follow-up|6
218980|NCT00147745|723199|P3|Overall Study|Withdrawal by Subject|0
218981|NCT00147745|723200|P2|Overall Study|Withdrawal by Subject|0
218982|NCT00147745|723201|P1|Overall Study|Withdrawal by Subject|1
218983|NCT00147537|723223|P11|Phase 2|Randomized but not treated|1
218984|NCT00147537|723224|P10|Phase 2|Randomized but not treated|1
218985|NCT00147537|723225|P9|Phase 2|Randomized but not treated|0
218986|NCT00147537|723226|P8|Phase 2|Randomized but not treated|0
218987|NCT00147537|723227|P7|Phase 2|Randomized but not treated|0
218988|NCT00147537|723228|P6|Phase 2|Randomized but not treated|0
218989|NCT00147537|723229|P5|Phase 2|Randomized but not treated|0
218990|NCT00147537|723230|P4|Phase 2|Randomized but not treated|0
218991|NCT00147537|723231|P3|Phase 2|Randomized but not treated|0
218992|NCT00147537|723232|P2|Phase 2|Randomized but not treated|0
218993|NCT00147537|723233|P1|Phase 2|Randomized but not treated|0
218994|NCT00147537|723223|P11|Phase 2|Withdrawal by Subject|4
218995|NCT00147537|723224|P10|Phase 2|Withdrawal by Subject|16
218996|NCT00147537|723225|P9|Phase 2|Withdrawal by Subject|0
218997|NCT00147537|723226|P8|Phase 2|Withdrawal by Subject|0
218998|NCT00147537|723227|P7|Phase 2|Withdrawal by Subject|0
218999|NCT00147537|723228|P6|Phase 2|Withdrawal by Subject|0
219000|NCT00147537|723229|P5|Phase 2|Withdrawal by Subject|0
219001|NCT00147537|723230|P4|Phase 2|Withdrawal by Subject|0
219002|NCT00147537|723231|P3|Phase 2|Withdrawal by Subject|0
219003|NCT00147537|723232|P2|Phase 2|Withdrawal by Subject|0
219004|NCT00147537|723233|P1|Phase 2|Withdrawal by Subject|0
219005|NCT00147537|723223|P11|Phase 2|Other|12
219006|NCT00147537|723224|P10|Phase 2|Other|47
219007|NCT00147537|723225|P9|Phase 2|Other|0
219008|NCT00147537|723226|P8|Phase 2|Other|0
219009|NCT00147537|723227|P7|Phase 2|Other|0
219010|NCT00147537|723228|P6|Phase 2|Other|0
219011|NCT00147537|723229|P5|Phase 2|Other|0
219012|NCT00147537|723230|P4|Phase 2|Other|0
219013|NCT00147537|723231|P3|Phase 2|Other|0
219014|NCT00147537|723232|P2|Phase 2|Other|0
219015|NCT00147537|723233|P1|Phase 2|Other|0
219016|NCT00147537|723223|P11|Phase 2|Lost to Follow-up|4
219017|NCT00147537|723224|P10|Phase 2|Lost to Follow-up|12
219018|NCT00147537|723225|P9|Phase 2|Lost to Follow-up|0
219019|NCT00147537|723226|P8|Phase 2|Lost to Follow-up|0
219020|NCT00147537|723227|P7|Phase 2|Lost to Follow-up|0
219021|NCT00147537|723228|P6|Phase 2|Lost to Follow-up|0
219022|NCT00147537|723229|P5|Phase 2|Lost to Follow-up|0
219023|NCT00147537|723230|P4|Phase 2|Lost to Follow-up|0
219024|NCT00147537|723231|P3|Phase 2|Lost to Follow-up|0
219025|NCT00147537|723232|P2|Phase 2|Lost to Follow-up|0
219026|NCT00147537|723233|P1|Phase 2|Lost to Follow-up|0
219027|NCT00147537|723223|P11|Phase 2|Death|31
219028|NCT00147537|723224|P10|Phase 2|Death|85
219029|NCT00147537|723225|P9|Phase 2|Death|0
219030|NCT00147537|723226|P8|Phase 2|Death|0
219031|NCT00147537|723227|P7|Phase 2|Death|0
219032|NCT00147537|723228|P6|Phase 2|Death|0
219033|NCT00147537|723229|P5|Phase 2|Death|0
219034|NCT00147537|723230|P4|Phase 2|Death|0
219035|NCT00147537|723231|P3|Phase 2|Death|0
219036|NCT00147537|723232|P2|Phase 2|Death|0
219037|NCT00147537|723233|P1|Phase 2|Death|0
219038|NCT00147537|723223|P11|Phase 1b|Randomized but not treated|0
219039|NCT00147537|723224|P10|Phase 1b|Randomized but not treated|0
219040|NCT00147537|723225|P9|Phase 1b|Randomized but not treated|1
219041|NCT00147537|723226|P8|Phase 1b|Randomized but not treated|0
219042|NCT00147537|723227|P7|Phase 1b|Randomized but not treated|1
219043|NCT00147537|723228|P6|Phase 1b|Randomized but not treated|0
219044|NCT00147537|723229|P5|Phase 1b|Randomized but not treated|0
219045|NCT00147537|723230|P4|Phase 1b|Randomized but not treated|0
219046|NCT00147537|723231|P3|Phase 1b|Randomized but not treated|0
219047|NCT00147537|723232|P2|Phase 1b|Randomized but not treated|0
219048|NCT00147537|723233|P1|Phase 1b|Randomized but not treated|0
219049|NCT00147537|723223|P11|Phase 1b|Withdrawal by Subject|0
219050|NCT00147537|723224|P10|Phase 1b|Withdrawal by Subject|0
219051|NCT00147537|723225|P9|Phase 1b|Withdrawal by Subject|2
219052|NCT00147537|723226|P8|Phase 1b|Withdrawal by Subject|0
219053|NCT00147537|723227|P7|Phase 1b|Withdrawal by Subject|0
219054|NCT00147537|723228|P6|Phase 1b|Withdrawal by Subject|0
219055|NCT00147537|723229|P5|Phase 1b|Withdrawal by Subject|0
219056|NCT00147537|723230|P4|Phase 1b|Withdrawal by Subject|0
219057|NCT00147537|723231|P3|Phase 1b|Withdrawal by Subject|0
219058|NCT00147537|723232|P2|Phase 1b|Withdrawal by Subject|0
219059|NCT00147537|723233|P1|Phase 1b|Withdrawal by Subject|0
219060|NCT00147537|723223|P11|Phase 1b|Other|0
219061|NCT00147537|723224|P10|Phase 1b|Other|0
219062|NCT00147537|723225|P9|Phase 1b|Other|4
219063|NCT00147537|723226|P8|Phase 1b|Other|4
219064|NCT00147537|723227|P7|Phase 1b|Other|14
219065|NCT00147537|723228|P6|Phase 1b|Other|1
219066|NCT00147537|723229|P5|Phase 1b|Other|1
219067|NCT00147537|723230|P4|Phase 1b|Other|1
219068|NCT00147537|723231|P3|Phase 1b|Other|2
219069|NCT00147537|723232|P2|Phase 1b|Other|0
219070|NCT00147537|723233|P1|Phase 1b|Other|0
219071|NCT00147537|723223|P11|Phase 1b|Lost to Follow-up|0
219072|NCT00147537|723224|P10|Phase 1b|Lost to Follow-up|0
219073|NCT00147537|723225|P9|Phase 1b|Lost to Follow-up|1
219074|NCT00147537|723226|P8|Phase 1b|Lost to Follow-up|0
219075|NCT00147537|723227|P7|Phase 1b|Lost to Follow-up|2
219076|NCT00147537|723228|P6|Phase 1b|Lost to Follow-up|0
219077|NCT00147537|723229|P5|Phase 1b|Lost to Follow-up|0
219078|NCT00147537|723230|P4|Phase 1b|Lost to Follow-up|0
219079|NCT00147537|723231|P3|Phase 1b|Lost to Follow-up|0
219080|NCT00147537|723232|P2|Phase 1b|Lost to Follow-up|1
219081|NCT00147537|723233|P1|Phase 1b|Lost to Follow-up|2
219082|NCT00147537|723223|P11|Phase 1b|Death|0
219083|NCT00147537|723224|P10|Phase 1b|Death|0
219084|NCT00147537|723225|P9|Phase 1b|Death|9
219085|NCT00147537|723226|P8|Phase 1b|Death|3
219086|NCT00147537|723227|P7|Phase 1b|Death|1
219087|NCT00147537|723228|P6|Phase 1b|Death|2
219088|NCT00147537|723229|P5|Phase 1b|Death|2
219089|NCT00147537|723230|P4|Phase 1b|Death|1
219090|NCT00147537|723231|P3|Phase 1b|Death|2
219091|NCT00147537|723232|P2|Phase 1b|Death|1
219092|NCT00147537|723233|P1|Phase 1b|Death|0
219093|NCT00147498|723416|P4|Overall Study|Other|3
219094|NCT00147498|723417|P3|Overall Study|Other|3
219095|NCT00147498|723418|P2|Overall Study|Other|1
219096|NCT00147498|723419|P1|Overall Study|Other|1
219097|NCT00147498|723416|P4|Overall Study|Participant defaulted|3
219098|NCT00147498|723417|P3|Overall Study|Participant defaulted|4
219099|NCT00147498|723418|P2|Overall Study|Participant defaulted|1
219100|NCT00147498|723419|P1|Overall Study|Participant defaulted|0
219101|NCT00147498|723416|P4|Overall Study|Laboratory abnormality|0
219102|NCT00147498|723417|P3|Overall Study|Laboratory abnormality|2
219103|NCT00147498|723418|P2|Overall Study|Laboratory abnormality|0
219104|NCT00147498|723419|P1|Overall Study|Laboratory abnormality|0
219105|NCT00147498|723416|P4|Overall Study|Lack of Efficacy|8
219106|NCT00147498|723417|P3|Overall Study|Lack of Efficacy|1
219107|NCT00147498|723418|P2|Overall Study|Lack of Efficacy|1
219108|NCT00147498|723419|P1|Overall Study|Lack of Efficacy|1
219109|NCT00147498|723416|P4|Overall Study|Adverse Event|3
219110|NCT00147498|723417|P3|Overall Study|Adverse Event|7
219111|NCT00147498|723418|P2|Overall Study|Adverse Event|6
219112|NCT00147498|723419|P1|Overall Study|Adverse Event|1
219113|NCT00147238|723543|P1|Overall Study|Inevaluable|8
219114|NCT00147225|723553|P6|Overall Study|Chemotherapy Changed|1
219115|NCT00147225|723554|P5|Overall Study|Chemotherapy Changed|0
219116|NCT00147225|723555|P4|Overall Study|Chemotherapy Changed|0
219117|NCT00147225|723556|P3|Overall Study|Chemotherapy Changed|0
219118|NCT00147225|723557|P2|Overall Study|Chemotherapy Changed|0
219119|NCT00147225|723558|P1|Overall Study|Chemotherapy Changed|0
219120|NCT00147225|723553|P6|Overall Study|Screen Failure|0
219121|NCT00147225|723554|P5|Overall Study|Screen Failure|1
219122|NCT00147225|723555|P4|Overall Study|Screen Failure|0
219123|NCT00147225|723556|P3|Overall Study|Screen Failure|0
219124|NCT00147225|723557|P2|Overall Study|Screen Failure|0
219125|NCT00147225|723558|P1|Overall Study|Screen Failure|0
219126|NCT00147225|723553|P6|Overall Study|Adverse Event|0
219127|NCT00147225|723554|P5|Overall Study|Adverse Event|0
219128|NCT00147225|723555|P4|Overall Study|Adverse Event|1
219129|NCT00147225|723556|P3|Overall Study|Adverse Event|1
219130|NCT00147225|723557|P2|Overall Study|Adverse Event|0
219131|NCT00147225|723558|P1|Overall Study|Adverse Event|0
219132|NCT00147225|723553|P6|Overall Study|Withdrawal by Subject|1
219133|NCT00147225|723554|P5|Overall Study|Withdrawal by Subject|0
219134|NCT00147225|723555|P4|Overall Study|Withdrawal by Subject|0
219135|NCT00147225|723556|P3|Overall Study|Withdrawal by Subject|1
219136|NCT00147225|723557|P2|Overall Study|Withdrawal by Subject|0
219137|NCT00147225|723558|P1|Overall Study|Withdrawal by Subject|1
219138|NCT00146848|723661|P3|Post-randomization|Withdrawn|27
219139|NCT00146848|723662|P2|Post-randomization|Withdrawn|32
219140|NCT00146848|723663|P1|Post-randomization|Withdrawn|26
219141|NCT00146848|723661|P3|Post-randomization|Lost to Follow-up|12
219142|NCT00146848|723662|P2|Post-randomization|Lost to Follow-up|15
219143|NCT00146848|723663|P1|Post-randomization|Lost to Follow-up|12
219144|NCT00146848|723661|P3|Pre-randomization|Withdrawal by Subject|0
219145|NCT00146848|723662|P2|Pre-randomization|Withdrawal by Subject|0
219146|NCT00146848|723663|P1|Pre-randomization|Withdrawal by Subject|40
219147|NCT00146848|723661|P3|Pre-randomization|Protocol Violation|0
219148|NCT00146848|723662|P2|Pre-randomization|Protocol Violation|0
219149|NCT00146848|723663|P1|Pre-randomization|Protocol Violation|172
219150|NCT00146848|723661|P3|Pre-randomization|Physician Decision|0
219151|NCT00146848|723662|P2|Pre-randomization|Physician Decision|0
219152|NCT00146848|723663|P1|Pre-randomization|Physician Decision|8
219153|NCT00146848|723661|P3|Pre-randomization|Lost to Follow-up|0
219154|NCT00146848|723662|P2|Pre-randomization|Lost to Follow-up|0
219155|NCT00146848|723663|P1|Pre-randomization|Lost to Follow-up|70
219156|NCT00146848|723661|P3|Pre-randomization|Death|0
219157|NCT00146848|723662|P2|Pre-randomization|Death|0
219158|NCT00146848|723663|P1|Pre-randomization|Death|19
219159|NCT00146770|723679|P2|Overall Study|Withdrawal by Subject|0
219160|NCT00146770|723680|P1|Overall Study|Withdrawal by Subject|2
219161|NCT00146770|723679|P2|Overall Study|Pregnancy|0
219162|NCT00146770|723680|P1|Overall Study|Pregnancy|1
219163|NCT00146770|723679|P2|Overall Study|Adverse Event|0
219164|NCT00146770|723680|P1|Overall Study|Adverse Event|2
219165|NCT00146757|723698|P2|Overall Study|Adverse Event|0
219166|NCT00146757|723699|P1|Overall Study|Adverse Event|1
219167|NCT00146757|723698|P2|Overall Study|Death|0
219168|NCT00146757|723699|P1|Overall Study|Death|1
219169|NCT00146640|723718|P2|Overall Study|Non-Medical Reasons|4
219170|NCT00146640|723719|P1|Overall Study|Non-Medical Reasons|8
219171|NCT00146640|723718|P2|Overall Study|Medical Reasons|0
219172|NCT00146640|723719|P1|Overall Study|Medical Reasons|3
219173|NCT00146640|723718|P2|Overall Study|Adverse Event|10
219174|NCT00146640|723719|P1|Overall Study|Adverse Event|12
219175|NCT00146328|723742|P3|Overall Study|Interaction with other medication|1
219176|NCT00146328|723743|P2|Overall Study|Interaction with other medication|0
219177|NCT00146328|723744|P1|Overall Study|Interaction with other medication|2
219178|NCT00146328|723742|P3|Overall Study|Moved|0
219179|NCT00146328|723743|P2|Overall Study|Moved|0
219180|NCT00146328|723744|P1|Overall Study|Moved|2
219181|NCT00146328|723742|P3|Overall Study|Death|1
219182|NCT00146328|723743|P2|Overall Study|Death|1
219183|NCT00146328|723744|P1|Overall Study|Death|0
219184|NCT00146328|723742|P3|Overall Study|Enroll into other trial|2
219185|NCT00146328|723743|P2|Overall Study|Enroll into other trial|4
219186|NCT00146328|723744|P1|Overall Study|Enroll into other trial|2
219187|NCT00146328|723742|P3|Overall Study|Patient decision to end|6
219188|NCT00146328|723743|P2|Overall Study|Patient decision to end|1
219189|NCT00146328|723744|P1|Overall Study|Patient decision to end|0
219190|NCT00146328|723742|P3|Overall Study|Trial ended/site closed|19
219191|NCT00146328|723743|P2|Overall Study|Trial ended/site closed|2
219192|NCT00146328|723744|P1|Overall Study|Trial ended/site closed|8
219193|NCT00146328|723742|P3|Overall Study|Virologic Failure/lack of efficacy|142
219194|NCT00146328|723743|P2|Overall Study|Virologic Failure/lack of efficacy|72
219195|NCT00146328|723744|P1|Overall Study|Virologic Failure/lack of efficacy|54
219196|NCT00146328|723742|P3|Overall Study|Withdrawal by Subject|22
219197|NCT00146328|723743|P2|Overall Study|Withdrawal by Subject|16
219198|NCT00146328|723744|P1|Overall Study|Withdrawal by Subject|16
219199|NCT00146328|723742|P3|Overall Study|Lost to Follow-up|7
219200|NCT00146328|723743|P2|Overall Study|Lost to Follow-up|4
219201|NCT00146328|723744|P1|Overall Study|Lost to Follow-up|7
219202|NCT00146328|723742|P3|Overall Study|Protocol Violation|12
219203|NCT00146328|723743|P2|Overall Study|Protocol Violation|6
219204|NCT00146328|723744|P1|Overall Study|Protocol Violation|11
219205|NCT00146328|723742|P3|Overall Study|Adverse Event|79
219206|NCT00146328|723743|P2|Overall Study|Adverse Event|48
219207|NCT00146328|723744|P1|Overall Study|Adverse Event|39
219208|NCT00146172|723835|P8|Overall Study|Symptomatic Deterioration|2
219209|NCT00146172|723836|P7|Overall Study|Symptomatic Deterioration|0
219210|NCT00146172|723837|P6|Overall Study|Symptomatic Deterioration|2
219211|NCT00146172|723838|P5|Overall Study|Symptomatic Deterioration|1
219212|NCT00146172|723839|P4|Overall Study|Symptomatic Deterioration|0
219213|NCT00146172|723840|P3|Overall Study|Symptomatic Deterioration|1
219214|NCT00146172|723841|P2|Overall Study|Symptomatic Deterioration|0
219215|NCT00146172|723842|P1|Overall Study|Symptomatic Deterioration|1
219216|NCT00146172|723835|P8|Overall Study|Withdrawal by Subject|4
219217|NCT00146172|723836|P7|Overall Study|Withdrawal by Subject|1
219218|NCT00146172|723837|P6|Overall Study|Withdrawal by Subject|1
219219|NCT00146172|723838|P5|Overall Study|Withdrawal by Subject|0
219220|NCT00146172|723839|P4|Overall Study|Withdrawal by Subject|0
219221|NCT00146172|723840|P3|Overall Study|Withdrawal by Subject|0
219222|NCT00146172|723841|P2|Overall Study|Withdrawal by Subject|0
219223|NCT00146172|723842|P1|Overall Study|Withdrawal by Subject|0
219224|NCT00146172|723835|P8|Overall Study|Physician Decision|1
219225|NCT00146172|723836|P7|Overall Study|Physician Decision|0
219226|NCT00146172|723837|P6|Overall Study|Physician Decision|0
219227|NCT00146172|723838|P5|Overall Study|Physician Decision|0
219228|NCT00146172|723839|P4|Overall Study|Physician Decision|0
219229|NCT00146172|723840|P3|Overall Study|Physician Decision|0
219230|NCT00146172|723841|P2|Overall Study|Physician Decision|0
219231|NCT00146172|723842|P1|Overall Study|Physician Decision|0
219232|NCT00146172|723835|P8|Overall Study|Death|0
219233|NCT00146172|723836|P7|Overall Study|Death|1
219234|NCT00146172|723837|P6|Overall Study|Death|0
219235|NCT00146172|723838|P5|Overall Study|Death|0
219236|NCT00146172|723839|P4|Overall Study|Death|0
219237|NCT00146172|723840|P3|Overall Study|Death|0
219238|NCT00146172|723841|P2|Overall Study|Death|0
219239|NCT00146172|723842|P1|Overall Study|Death|0
219240|NCT00146172|723835|P8|Overall Study|Disease Progression|22
219241|NCT00146172|723836|P7|Overall Study|Disease Progression|1
219242|NCT00146172|723837|P6|Overall Study|Disease Progression|2
219243|NCT00146172|723838|P5|Overall Study|Disease Progression|2
219244|NCT00146172|723839|P4|Overall Study|Disease Progression|5
219245|NCT00146172|723840|P3|Overall Study|Disease Progression|2
219246|NCT00146172|723841|P2|Overall Study|Disease Progression|4
219247|NCT00146172|723842|P1|Overall Study|Disease Progression|2
219248|NCT00146172|723835|P8|Overall Study|Lost to Follow-up|1
219249|NCT00146172|723836|P7|Overall Study|Lost to Follow-up|0
219250|NCT00146172|723837|P6|Overall Study|Lost to Follow-up|0
219251|NCT00146172|723838|P5|Overall Study|Lost to Follow-up|0
219252|NCT00146172|723839|P4|Overall Study|Lost to Follow-up|0
219253|NCT00146172|723840|P3|Overall Study|Lost to Follow-up|0
219254|NCT00146172|723841|P2|Overall Study|Lost to Follow-up|0
219255|NCT00146172|723842|P1|Overall Study|Lost to Follow-up|0
219256|NCT00146172|723835|P8|Overall Study|Adverse Event|10
219257|NCT00146172|723836|P7|Overall Study|Adverse Event|3
219258|NCT00146172|723837|P6|Overall Study|Adverse Event|2
219259|NCT00146172|723838|P5|Overall Study|Adverse Event|0
219260|NCT00146172|723839|P4|Overall Study|Adverse Event|1
219261|NCT00146172|723840|P3|Overall Study|Adverse Event|1
219262|NCT00146172|723841|P2|Overall Study|Adverse Event|0
219263|NCT00146172|723842|P1|Overall Study|Adverse Event|0
219264|NCT00145795|723876|P2|Overall Study|Adverse Event|0
219265|NCT00145795|723877|P1|Overall Study|Adverse Event|1
219266|NCT00145626|723912|P1|Overall Study|Withdrawal by Subject|1
219267|NCT00145626|723912|P1|Overall Study|Death|1
219268|NCT00145626|723912|P1|Overall Study|Turned 2 years old before treatment|1
219269|NCT00145626|723912|P1|Overall Study|Did not have NK infusions|2
219270|NCT00145600|723958|P4|Overall Study|Withdrawal by Subject|1
219271|NCT00145600|723959|P3|Overall Study|Withdrawal by Subject|0
219272|NCT00145600|723960|P2|Overall Study|Withdrawal by Subject|2
219273|NCT00145600|723961|P1|Overall Study|Withdrawal by Subject|1
219274|NCT00145600|723958|P4|Overall Study|Noncompliance|0
219275|NCT00145600|723959|P3|Overall Study|Noncompliance|0
219276|NCT00145600|723960|P2|Overall Study|Noncompliance|0
219277|NCT00145600|723961|P1|Overall Study|Noncompliance|1
219278|NCT00145600|723958|P4|Overall Study|Lost to Follow-up|4
219279|NCT00145600|723959|P3|Overall Study|Lost to Follow-up|2
219280|NCT00145600|723960|P2|Overall Study|Lost to Follow-up|6
219281|NCT00145600|723961|P1|Overall Study|Lost to Follow-up|2
219282|NCT00145600|723958|P4|Overall Study|Ineligible|5
219283|NCT00145600|723959|P3|Overall Study|Ineligible|1
219284|NCT00145600|723960|P2|Overall Study|Ineligible|0
219285|NCT00145600|723961|P1|Overall Study|Ineligible|3
219286|NCT00145600|723958|P4|Overall Study|Death|6
219287|NCT00145600|723959|P3|Overall Study|Death|2
219288|NCT00145600|723960|P2|Overall Study|Death|2
219289|NCT00145600|723961|P1|Overall Study|Death|1
219290|NCT00145574|724085|P3|Open Label Long-term Extension|required restricted medicine|1
219291|NCT00145574|724086|P2|Open Label Long-term Extension|required restricted medicine|0
219292|NCT00145574|724087|P1|Open Label Long-term Extension|required restricted medicine|0
219293|NCT00145574|724085|P3|Open Label Long-term Extension|Withdrawal by Subject|4
219294|NCT00145574|724086|P2|Open Label Long-term Extension|Withdrawal by Subject|0
219295|NCT00145574|724087|P1|Open Label Long-term Extension|Withdrawal by Subject|0
219296|NCT00145574|724085|P3|Open Label Long-term Extension|Lost to Follow-up|1
219297|NCT00145574|724086|P2|Open Label Long-term Extension|Lost to Follow-up|0
219298|NCT00145574|724087|P1|Open Label Long-term Extension|Lost to Follow-up|0
219299|NCT00145574|724085|P3|Open Label Long-term Extension|Adverse Event|5
219300|NCT00145574|724086|P2|Open Label Long-term Extension|Adverse Event|0
219301|NCT00145574|724087|P1|Open Label Long-term Extension|Adverse Event|0
219302|NCT00145574|724085|P3|Double Blind|required restricted medicine|0
219303|NCT00145574|724086|P2|Double Blind|required restricted medicine|1
219304|NCT00145574|724087|P1|Double Blind|required restricted medicine|0
219305|NCT00145574|724085|P3|Double Blind|Withdrawal by Subject|1
219306|NCT00145574|724086|P2|Double Blind|Withdrawal by Subject|1
219307|NCT00145574|724087|P1|Double Blind|Withdrawal by Subject|1
219308|NCT00145574|724085|P3|Double Blind|Adverse Event|1
219309|NCT00145574|724086|P2|Double Blind|Adverse Event|3
219310|NCT00145574|724087|P1|Double Blind|Adverse Event|0
219311|NCT00145509|724144|P2|Overall Study|Reason not provided|1
219312|NCT00145509|724145|P1|Overall Study|Reason not provided|2
219313|NCT00145509|724144|P2|Overall Study|Withdrew Consent|7
219314|NCT00145509|724145|P1|Overall Study|Withdrew Consent|2
219315|NCT00145509|724144|P2|Overall Study|Lost to Follow-up|9
219316|NCT00145509|724145|P1|Overall Study|Lost to Follow-up|5
219317|NCT00145509|724144|P2|Overall Study|Lack of Efficacy|1
219318|NCT00145509|724145|P1|Overall Study|Lack of Efficacy|3
219319|NCT00145509|724144|P2|Overall Study|Adverse Event|3
219320|NCT00145509|724145|P1|Overall Study|Adverse Event|10
219321|NCT00145496|724159|P2|Overall Study|Other|13
219322|NCT00145496|724160|P1|Overall Study|Other|25
219323|NCT00145496|724159|P2|Overall Study|Lost to Follow-up|5
219324|NCT00145496|724160|P1|Overall Study|Lost to Follow-up|12
219325|NCT00145496|724159|P2|Overall Study|Withdrawal by Subject|26
219326|NCT00145496|724160|P1|Overall Study|Withdrawal by Subject|32
219327|NCT00145496|724159|P2|Overall Study|Lack of Efficacy|7
219328|NCT00145496|724160|P1|Overall Study|Lack of Efficacy|12
219329|NCT00145496|724159|P2|Overall Study|Adverse Event|30
219330|NCT00145496|724160|P1|Overall Study|Adverse Event|42
219331|NCT00145327|724180|P3|Overall Study|Missing – not stated|1
219332|NCT00145327|724181|P2|Overall Study|Missing – not stated|0
219333|NCT00145327|724182|P1|Overall Study|Missing – not stated|1
219334|NCT00145327|724180|P3|Overall Study|Abnormal laboratory value(s)|2
219335|NCT00145327|724181|P2|Overall Study|Abnormal laboratory value(s)|0
219336|NCT00145327|724182|P1|Overall Study|Abnormal laboratory value(s)|1
219337|NCT00145327|724180|P3|Overall Study|Protocol Violation|2
219338|NCT00145327|724181|P2|Overall Study|Protocol Violation|0
219339|NCT00145327|724182|P1|Overall Study|Protocol Violation|2
219340|NCT00145327|724180|P3|Overall Study|Administrative problems|13
219341|NCT00145327|724181|P2|Overall Study|Administrative problems|9
219342|NCT00145327|724182|P1|Overall Study|Administrative problems|12
219343|NCT00145327|724180|P3|Overall Study|Lost to Follow-up|14
219344|NCT00145327|724181|P2|Overall Study|Lost to Follow-up|14
219345|NCT00145327|724182|P1|Overall Study|Lost to Follow-up|9
219346|NCT00145327|724180|P3|Overall Study|Adverse Event|22
219347|NCT00145327|724181|P2|Overall Study|Adverse Event|11
219348|NCT00145327|724182|P1|Overall Study|Adverse Event|14
219349|NCT00145327|724180|P3|Overall Study|Death|30
219350|NCT00145327|724181|P2|Overall Study|Death|18
219351|NCT00145327|724182|P1|Overall Study|Death|26
219352|NCT00145327|724180|P3|Overall Study|Withdrawal by Subject|164
219353|NCT00145327|724181|P2|Overall Study|Withdrawal by Subject|72
219354|NCT00145327|724182|P1|Overall Study|Withdrawal by Subject|77
219355|NCT00145119|724281|P1|Overall Study|Death|45
219356|NCT00144781|724299|P4|Overall Study|Non-compliant|0
219357|NCT00144781|724300|P3|Overall Study|Non-compliant|0
219358|NCT00144781|724301|P2|Overall Study|Non-compliant|1
219359|NCT00144781|724302|P1|Overall Study|Non-compliant|0
219360|NCT00144781|724299|P4|Overall Study|Adverse Event|0
219361|NCT00144781|724300|P3|Overall Study|Adverse Event|0
219362|NCT00144781|724301|P2|Overall Study|Adverse Event|1
219363|NCT00144781|724302|P1|Overall Study|Adverse Event|0
219364|NCT00144339|724331|P2|Overall Study|Other|60
219365|NCT00144339|724332|P1|Overall Study|Other|58
219366|NCT00144339|724331|P2|Overall Study|Lost to Follow-up|64
219367|NCT00144339|724332|P1|Overall Study|Lost to Follow-up|76
219368|NCT00144339|724331|P2|Overall Study|Withdrawal by Subject|300
219369|NCT00144339|724332|P1|Overall Study|Withdrawal by Subject|403
219370|NCT00144339|724331|P2|Overall Study|Protocol Violation|48
219371|NCT00144339|724332|P1|Overall Study|Protocol Violation|75
219372|NCT00144339|724331|P2|Overall Study|Adverse Event|627
219373|NCT00144339|724332|P1|Overall Study|Adverse Event|746
219374|NCT00144300|724540|P2|Overall Study|Other reason (not specified)|3
219375|NCT00144300|724541|P1|Overall Study|Other reason (not specified)|1
219376|NCT00144300|724540|P2|Overall Study|Withdrawal by Subject|6
219377|NCT00144300|724541|P1|Overall Study|Withdrawal by Subject|6
219378|NCT00144300|724540|P2|Overall Study|Lost to Follow-up|0
219379|NCT00144300|724541|P1|Overall Study|Lost to Follow-up|3
219380|NCT00144300|724540|P2|Overall Study|Protocol Violation|3
219381|NCT00144300|724541|P1|Overall Study|Protocol Violation|1
219382|NCT00144300|724540|P2|Overall Study|Adverse Event|16
219383|NCT00144300|724541|P1|Overall Study|Adverse Event|18
219384|NCT00144170|724589|P2|Overall Study|Other reason not defined above|316
219385|NCT00144170|724590|P1|Overall Study|Other reason not defined above|211
219386|NCT00144170|724589|P2|Overall Study|Withdrawal by Subject|13
219387|NCT00144170|724590|P1|Overall Study|Withdrawal by Subject|29
219388|NCT00144170|724589|P2|Overall Study|Lost to Follow-up|10
219389|NCT00144170|724590|P1|Overall Study|Lost to Follow-up|5
219390|NCT00144170|724589|P2|Overall Study|Protocol Violation|16
219391|NCT00144170|724590|P1|Overall Study|Protocol Violation|23
219392|NCT00144170|724589|P2|Overall Study|Adverse Event|41
219393|NCT00144170|724590|P1|Overall Study|Adverse Event|84
219394|NCT00144027|724780|P2|Overall Study|did not complete baseline assessment|6
219395|NCT00144027|724781|P1|Overall Study|did not complete baseline assessment|0
219396|NCT00144027|724780|P2|Overall Study|Withdrawal by Subject|2
219397|NCT00144027|724781|P1|Overall Study|Withdrawal by Subject|2
219398|NCT00144027|724780|P2|Overall Study|Lost to Follow-up|3
219399|NCT00144027|724781|P1|Overall Study|Lost to Follow-up|1
219400|NCT00143598|724811|P2|Overall Study|Death|36
219401|NCT00143598|724812|P1|Overall Study|Death|36
219402|NCT00143598|724811|P2|Overall Study|Withdrawal by Subject|37
219403|NCT00143598|724812|P1|Overall Study|Withdrawal by Subject|33
219404|NCT00143598|724811|P2|Overall Study|Lost to Follow-up|21
219405|NCT00143598|724812|P1|Overall Study|Lost to Follow-up|23
219406|NCT00143507|724826|P2|Overall Study|Withdrawn by sponsor's decision|3
219407|NCT00143507|724827|P1|Overall Study|Withdrawn by sponsor's decision|0
219408|NCT00143507|724826|P2|Overall Study|Lost to Follow-up|0
219409|NCT00143507|724827|P1|Overall Study|Lost to Follow-up|1
219410|NCT00143507|724826|P2|Overall Study|Withdrawal by Subject|102
219411|NCT00143507|724827|P1|Overall Study|Withdrawal by Subject|114
219412|NCT00143507|724826|P2|Overall Study|Death|547
219413|NCT00143507|724827|P1|Overall Study|Death|572
219414|NCT00143455|724861|P4|Cohort 2|Randomized But Not Treated|1
219415|NCT00143455|724862|P3|Cohort 2|Randomized But Not Treated|1
219416|NCT00143455|724863|P2|Cohort 2|Randomized But Not Treated|0
219417|NCT00143455|724864|P1|Cohort 2|Randomized But Not Treated|0
219418|NCT00143455|724861|P4|Cohort 2|Other|6
219419|NCT00143455|724862|P3|Cohort 2|Other|7
219420|NCT00143455|724863|P2|Cohort 2|Other|0
219421|NCT00143455|724864|P1|Cohort 2|Other|0
219422|NCT00143455|724861|P4|Cohort 2|Withdrawal by Subject|12
219423|NCT00143455|724862|P3|Cohort 2|Withdrawal by Subject|13
219424|NCT00143455|724863|P2|Cohort 2|Withdrawal by Subject|0
219425|NCT00143455|724864|P1|Cohort 2|Withdrawal by Subject|0
219426|NCT00143455|724861|P4|Cohort 2|Progressive Disease|27
219427|NCT00143455|724862|P3|Cohort 2|Progressive Disease|20
219428|NCT00143455|724863|P2|Cohort 2|Progressive Disease|0
219429|NCT00143455|724864|P1|Cohort 2|Progressive Disease|0
219430|NCT00143455|724861|P4|Cohort 2|Death|12
219431|NCT00143455|724862|P3|Cohort 2|Death|20
219432|NCT00143455|724863|P2|Cohort 2|Death|0
219433|NCT00143455|724864|P1|Cohort 2|Death|0
219434|NCT00143455|724861|P4|Cohort 2|Lost to Follow-up|4
219435|NCT00143455|724862|P3|Cohort 2|Lost to Follow-up|1
219436|NCT00143455|724863|P2|Cohort 2|Lost to Follow-up|0
219437|NCT00143455|724864|P1|Cohort 2|Lost to Follow-up|0
219438|NCT00143455|724861|P4|Cohort 2|Protocol Violation|1
219439|NCT00143455|724862|P3|Cohort 2|Protocol Violation|1
219440|NCT00143455|724863|P2|Cohort 2|Protocol Violation|0
219441|NCT00143455|724864|P1|Cohort 2|Protocol Violation|0
219442|NCT00143455|724861|P4|Cohort 2|No Longer Required Study Treatment|0
219443|NCT00143455|724862|P3|Cohort 2|No Longer Required Study Treatment|1
219444|NCT00143455|724863|P2|Cohort 2|No Longer Required Study Treatment|0
219445|NCT00143455|724864|P1|Cohort 2|No Longer Required Study Treatment|0
219446|NCT00143455|724861|P4|Cohort 2|Adverse Event|30
219447|NCT00143455|724862|P3|Cohort 2|Adverse Event|42
219448|NCT00143455|724863|P2|Cohort 2|Adverse Event|0
219449|NCT00143455|724864|P1|Cohort 2|Adverse Event|0
219450|NCT00143455|724861|P4|Cohort 1|Randomized But Not Treated|0
219451|NCT00143455|724862|P3|Cohort 1|Randomized But Not Treated|0
219452|NCT00143455|724863|P2|Cohort 1|Randomized But Not Treated|1
219453|NCT00143455|724864|P1|Cohort 1|Randomized But Not Treated|0
219454|NCT00143455|724861|P4|Cohort 1|Withdrawal by Subject|0
219455|NCT00143455|724862|P3|Cohort 1|Withdrawal by Subject|0
219456|NCT00143455|724863|P2|Cohort 1|Withdrawal by Subject|4
219457|NCT00143455|724864|P1|Cohort 1|Withdrawal by Subject|1
219458|NCT00143455|724861|P4|Cohort 1|Progressive Disease|0
219459|NCT00143455|724862|P3|Cohort 1|Progressive Disease|0
219460|NCT00143455|724863|P2|Cohort 1|Progressive Disease|6
219461|NCT00143455|724864|P1|Cohort 1|Progressive Disease|0
219462|NCT00143455|724861|P4|Cohort 1|Death|0
219463|NCT00143455|724862|P3|Cohort 1|Death|0
219464|NCT00143455|724863|P2|Cohort 1|Death|2
219465|NCT00143455|724864|P1|Cohort 1|Death|5
219466|NCT00143455|724861|P4|Cohort 1|Adverse Event|0
219467|NCT00143455|724862|P3|Cohort 1|Adverse Event|0
219468|NCT00143455|724863|P2|Cohort 1|Adverse Event|4
219469|NCT00143455|724864|P1|Cohort 1|Adverse Event|8
219470|NCT00143403|724898|P2|Overall Study|Randomized Not Treated|8
219471|NCT00143403|724899|P1|Overall Study|Randomized Not Treated|7
219472|NCT00143403|724898|P2|Overall Study|specified by site|9
219473|NCT00143403|724899|P1|Overall Study|specified by site|4
219474|NCT00143403|724898|P2|Overall Study|Protocol Violation|2
219475|NCT00143403|724899|P1|Overall Study|Protocol Violation|2
219476|NCT00143403|724898|P2|Overall Study|Relapse|7
219477|NCT00143403|724899|P1|Overall Study|Relapse|15
219478|NCT00143403|724898|P2|Overall Study|Withdrawal by Subject|12
219479|NCT00143403|724899|P1|Overall Study|Withdrawal by Subject|3
219480|NCT00143403|724898|P2|Overall Study|Death|0
219481|NCT00143403|724899|P1|Overall Study|Death|1
219482|NCT00143403|724898|P2|Overall Study|Adverse Event|8
219483|NCT00143403|724899|P1|Overall Study|Adverse Event|3
219484|NCT00143390|724909|P2|Overall Study|Other|2
219485|NCT00143390|724910|P1|Overall Study|Other|1
219486|NCT00143390|724909|P2|Overall Study|Adverse Event|8
219487|NCT00143390|724910|P1|Overall Study|Adverse Event|9
219488|NCT00143390|724909|P2|Overall Study|Study termination|15
219489|NCT00143390|724910|P1|Overall Study|Study termination|10
219490|NCT00143390|724909|P2|Overall Study|Protocol Violation|0
219491|NCT00143390|724910|P1|Overall Study|Protocol Violation|2
219492|NCT00143390|724909|P2|Overall Study|Progressive disease|115
219493|NCT00143390|724910|P1|Overall Study|Progressive disease|119
219494|NCT00143390|724909|P2|Overall Study|Withdrawal by Subject|4
219495|NCT00143390|724910|P1|Overall Study|Withdrawal by Subject|4
219496|NCT00143390|724909|P2|Overall Study|Not meeting entry criteria|5
219497|NCT00143390|724910|P1|Overall Study|Not meeting entry criteria|2
219498|NCT00143390|724909|P2|Overall Study|Death|0
219499|NCT00143390|724910|P1|Overall Study|Death|2
219500|NCT00143312|724926|P1|Overall Study|Withdrawal by Subject|1
219501|NCT00143312|724926|P1|Overall Study|Other|1
219502|NCT00143312|724926|P1|Overall Study|Lost to Follow-up|1
219503|NCT00143312|724926|P1|Overall Study|Adverse Event|2
219504|NCT00143312|724926|P1|Overall Study|Death|11
219505|NCT00143247|724936|P1|Overall Study|Other|12
219506|NCT00143247|724936|P1|Overall Study|following inaccurate lab adverse event|1
219507|NCT00143247|724936|P1|Overall Study|Lost to Follow-up|12
219508|NCT00143247|724936|P1|Overall Study|Protocol Violation|15
219509|NCT00143247|724936|P1|Overall Study|Study terminated by sponsor|31
219510|NCT00143247|724936|P1|Overall Study|Withdrawal by Subject|55
219511|NCT00143247|724936|P1|Overall Study|Lack of Efficacy|3
219512|NCT00143247|724936|P1|Overall Study|Adverse Event|19
219513|NCT00143247|724936|P1|Overall Study|Death|8
219514|NCT00142935|724953|P3|Overall Study|Death|1
219515|NCT00142935|724954|P2|Overall Study|Death|2
219516|NCT00142935|724955|P1|Overall Study|Death|0
219517|NCT00142935|724953|P3|Overall Study|Lost to Follow-up|5
219518|NCT00142935|724954|P2|Overall Study|Lost to Follow-up|5
219519|NCT00142935|724955|P1|Overall Study|Lost to Follow-up|2
219520|NCT00142935|724953|P3|Overall Study|Other reason|1
219521|NCT00142935|724954|P2|Overall Study|Other reason|1
219522|NCT00142935|724955|P1|Overall Study|Other reason|1
219523|NCT00142909|724980|P2|Medications Begin|Withdrawal by Subject|0
219524|NCT00142909|724981|P1|Medications Begin|Withdrawal by Subject|2
219525|NCT00142909|724980|P2|Medications Begin|Withdrawal by Subject|3
219526|NCT00142909|724981|P1|Medications Begin|Withdrawal by Subject|5
219527|NCT00142909|724980|P2|Medications Begin|Protocol Violation|0
219528|NCT00142909|724981|P1|Medications Begin|Protocol Violation|2
219529|NCT00142909|724980|P2|Randomization|Various Reasons|10
219530|NCT00142909|724981|P1|Randomization|Various Reasons|7
219531|NCT00142792|725017|P3|Overall Study|No category|1
219532|NCT00142792|725018|P2|Overall Study|No category|2
219533|NCT00142792|725019|P1|Overall Study|No category|1
219534|NCT00142792|725017|P3|Overall Study|Lost to Follow-up|7
219535|NCT00142792|725018|P2|Overall Study|Lost to Follow-up|11
219536|NCT00142792|725019|P1|Overall Study|Lost to Follow-up|8
219537|NCT00142792|725017|P3|Overall Study|Withdrawal by Subject|3
219538|NCT00142792|725018|P2|Overall Study|Withdrawal by Subject|2
219539|NCT00142792|725019|P1|Overall Study|Withdrawal by Subject|3
219540|NCT00142792|725017|P3|Overall Study|Death|1
219541|NCT00142792|725018|P2|Overall Study|Death|0
219542|NCT00142792|725019|P1|Overall Study|Death|0
219543|NCT00142415|725054|P6|Overall Study|Physician Decision|2
219544|NCT00142415|725055|P5|Overall Study|Physician Decision|1
219545|NCT00142415|725056|P4|Overall Study|Physician Decision|0
219546|NCT00142415|725057|P3|Overall Study|Physician Decision|0
219547|NCT00142415|725058|P2|Overall Study|Physician Decision|0
219548|NCT00142415|725059|P1|Overall Study|Physician Decision|0
219549|NCT00142298|725097|P10|Overall Study|Treatment Failure|0
219550|NCT00142298|725098|P9|Overall Study|Treatment Failure|0
219551|NCT00142298|725099|P8|Overall Study|Treatment Failure|0
219552|NCT00142298|725100|P7|Overall Study|Treatment Failure|2
219553|NCT00142298|725101|P6|Overall Study|Treatment Failure|2
219554|NCT00142298|725102|P5|Overall Study|Treatment Failure|0
219555|NCT00142298|725103|P4|Overall Study|Treatment Failure|0
219556|NCT00142298|725104|P3|Overall Study|Treatment Failure|0
219557|NCT00142298|725105|P2|Overall Study|Treatment Failure|0
219558|NCT00142298|725106|P1|Overall Study|Treatment Failure|0
219559|NCT00142298|725097|P10|Overall Study|Lost to Follow-up|0
219560|NCT00142298|725098|P9|Overall Study|Lost to Follow-up|0
219561|NCT00142298|725099|P8|Overall Study|Lost to Follow-up|0
219562|NCT00142298|725100|P7|Overall Study|Lost to Follow-up|2
219563|NCT00142298|725101|P6|Overall Study|Lost to Follow-up|0
219564|NCT00142298|725102|P5|Overall Study|Lost to Follow-up|0
219565|NCT00142298|725103|P4|Overall Study|Lost to Follow-up|0
219566|NCT00142298|725104|P3|Overall Study|Lost to Follow-up|0
219567|NCT00142298|725105|P2|Overall Study|Lost to Follow-up|0
219568|NCT00142298|725106|P1|Overall Study|Lost to Follow-up|0
219569|NCT00142298|725097|P10|Overall Study|Other- not specified|0
219570|NCT00142298|725098|P9|Overall Study|Other- not specified|0
219571|NCT00142298|725099|P8|Overall Study|Other- not specified|0
219572|NCT00142298|725100|P7|Overall Study|Other- not specified|0
219573|NCT00142298|725101|P6|Overall Study|Other- not specified|0
219574|NCT00142298|725102|P5|Overall Study|Other- not specified|0
219575|NCT00142298|725103|P4|Overall Study|Other- not specified|1
219576|NCT00142298|725104|P3|Overall Study|Other- not specified|0
219577|NCT00142298|725105|P2|Overall Study|Other- not specified|3
219578|NCT00142298|725106|P1|Overall Study|Other- not specified|0
219579|NCT00142298|725097|P10|Overall Study|Virologic breakthrough|0
219580|NCT00142298|725098|P9|Overall Study|Virologic breakthrough|0
219581|NCT00142298|725099|P8|Overall Study|Virologic breakthrough|0
219582|NCT00142298|725100|P7|Overall Study|Virologic breakthrough|3
219583|NCT00142298|725101|P6|Overall Study|Virologic breakthrough|3
219584|NCT00142298|725102|P5|Overall Study|Virologic breakthrough|2
219585|NCT00142298|725103|P4|Overall Study|Virologic breakthrough|7
219586|NCT00142298|725104|P3|Overall Study|Virologic breakthrough|9
219587|NCT00142298|725105|P2|Overall Study|Virologic breakthrough|23
219588|NCT00142298|725106|P1|Overall Study|Virologic breakthrough|19
219589|NCT00142298|725097|P10|Overall Study|Pregnancy|0
219590|NCT00142298|725098|P9|Overall Study|Pregnancy|1
219591|NCT00142298|725099|P8|Overall Study|Pregnancy|0
219592|NCT00142298|725100|P7|Overall Study|Pregnancy|0
219593|NCT00142298|725101|P6|Overall Study|Pregnancy|0
219594|NCT00142298|725102|P5|Overall Study|Pregnancy|0
219595|NCT00142298|725103|P4|Overall Study|Pregnancy|3
219596|NCT00142298|725104|P3|Overall Study|Pregnancy|2
219597|NCT00142298|725105|P2|Overall Study|Pregnancy|4
219598|NCT00142298|725106|P1|Overall Study|Pregnancy|4
219599|NCT00142298|725097|P10|Overall Study|Patient, Investigator,or Sponsor request|0
219600|NCT00142298|725098|P9|Overall Study|Patient, Investigator,or Sponsor request|1
219601|NCT00142298|725099|P8|Overall Study|Patient, Investigator,or Sponsor request|4
219602|NCT00142298|725100|P7|Overall Study|Patient, Investigator,or Sponsor request|1
219603|NCT00142298|725101|P6|Overall Study|Patient, Investigator,or Sponsor request|3
219604|NCT00142298|725102|P5|Overall Study|Patient, Investigator,or Sponsor request|4
219605|NCT00142298|725103|P4|Overall Study|Patient, Investigator,or Sponsor request|51
219606|NCT00142298|725104|P3|Overall Study|Patient, Investigator,or Sponsor request|11
219607|NCT00142298|725105|P2|Overall Study|Patient, Investigator,or Sponsor request|60
219608|NCT00142298|725106|P1|Overall Study|Patient, Investigator,or Sponsor request|66
219609|NCT00142298|725097|P10|Overall Study|Non-compliance|0
219610|NCT00142298|725098|P9|Overall Study|Non-compliance|3
219611|NCT00142298|725099|P8|Overall Study|Non-compliance|3
219612|NCT00142298|725100|P7|Overall Study|Non-compliance|0
219613|NCT00142298|725101|P6|Overall Study|Non-compliance|0
219614|NCT00142298|725102|P5|Overall Study|Non-compliance|1
219615|NCT00142298|725103|P4|Overall Study|Non-compliance|6
219616|NCT00142298|725104|P3|Overall Study|Non-compliance|0
219617|NCT00142298|725105|P2|Overall Study|Non-compliance|13
219618|NCT00142298|725106|P1|Overall Study|Non-compliance|15
219619|NCT00142298|725097|P10|Overall Study|Lack of Efficacy|0
219620|NCT00142298|725098|P9|Overall Study|Lack of Efficacy|0
219621|NCT00142298|725099|P8|Overall Study|Lack of Efficacy|1
219622|NCT00142298|725100|P7|Overall Study|Lack of Efficacy|0
219623|NCT00142298|725101|P6|Overall Study|Lack of Efficacy|0
219624|NCT00142298|725102|P5|Overall Study|Lack of Efficacy|1
219625|NCT00142298|725103|P4|Overall Study|Lack of Efficacy|12
219626|NCT00142298|725104|P3|Overall Study|Lack of Efficacy|9
219627|NCT00142298|725105|P2|Overall Study|Lack of Efficacy|62
219628|NCT00142298|725106|P1|Overall Study|Lack of Efficacy|44
219629|NCT00142298|725097|P10|Overall Study|Death|0
219630|NCT00142298|725098|P9|Overall Study|Death|0
219631|NCT00142298|725099|P8|Overall Study|Death|0
219632|NCT00142298|725100|P7|Overall Study|Death|0
219633|NCT00142298|725101|P6|Overall Study|Death|6
219634|NCT00142298|725102|P5|Overall Study|Death|0
219635|NCT00142298|725103|P4|Overall Study|Death|0
219636|NCT00142298|725104|P3|Overall Study|Death|1
219637|NCT00142298|725105|P2|Overall Study|Death|1
219638|NCT00142298|725106|P1|Overall Study|Death|1
219639|NCT00142298|725097|P10|Overall Study|Clinical disease progression|0
219640|NCT00142298|725098|P9|Overall Study|Clinical disease progression|0
219641|NCT00142298|725099|P8|Overall Study|Clinical disease progression|0
219642|NCT00142298|725100|P7|Overall Study|Clinical disease progression|0
219643|NCT00142298|725101|P6|Overall Study|Clinical disease progression|0
219644|NCT00142298|725102|P5|Overall Study|Clinical disease progression|0
219645|NCT00142298|725103|P4|Overall Study|Clinical disease progression|0
219646|NCT00142298|725104|P3|Overall Study|Clinical disease progression|0
219647|NCT00142298|725105|P2|Overall Study|Clinical disease progression|0
219648|NCT00142298|725106|P1|Overall Study|Clinical disease progression|1
219649|NCT00142298|725097|P10|Overall Study|Adverse Event|0
219650|NCT00142298|725098|P9|Overall Study|Adverse Event|0
219651|NCT00142298|725099|P8|Overall Study|Adverse Event|0
219652|NCT00142298|725100|P7|Overall Study|Adverse Event|0
219653|NCT00142298|725101|P6|Overall Study|Adverse Event|2
219654|NCT00142298|725102|P5|Overall Study|Adverse Event|2
219655|NCT00142298|725103|P4|Overall Study|Adverse Event|5
219656|NCT00142298|725104|P3|Overall Study|Adverse Event|1
219657|NCT00142298|725105|P2|Overall Study|Adverse Event|10
219658|NCT00142298|725106|P1|Overall Study|Adverse Event|10
219659|NCT00141921|725140|P1|Overall Study|Other|8
219660|NCT00141921|725140|P1|Overall Study|Ineligibility Determined|2
219661|NCT00141921|725140|P1|Overall Study|Pregnancy|4
219662|NCT00141921|725140|P1|Overall Study|Administrative Decision|2
219663|NCT00141921|725140|P1|Overall Study|Adverse Event|5
219664|NCT00141921|725140|P1|Overall Study|Protocol Deviation|7
219665|NCT00141921|725140|P1|Overall Study|Disease Progression|7
219666|NCT00141921|725140|P1|Overall Study|Noncompliance|17
219667|NCT00141921|725140|P1|Overall Study|Lost to Follow-up|19
219668|NCT00141921|725140|P1|Overall Study|Withdrawal by Subject|42
219669|NCT00141921|725140|P1|Overall Study|Remain on Study|28
219670|NCT00141817|725166|P4|Overall Study|Parent request|0
219671|NCT00141817|725167|P3|Overall Study|Parent request|0
219672|NCT00141817|725168|P2|Overall Study|Parent request|0
219673|NCT00141817|725169|P1|Overall Study|Parent request|1
219674|NCT00141817|725166|P4|Overall Study|Protocol Violation|0
219675|NCT00141817|725167|P3|Overall Study|Protocol Violation|1
219676|NCT00141817|725168|P2|Overall Study|Protocol Violation|0
219677|NCT00141817|725169|P1|Overall Study|Protocol Violation|0
219678|NCT00141778|725210|P3|Started Study Medication|Chest Discomfort|1
219679|NCT00141778|725211|P2|Started Study Medication|Chest Discomfort|0
219680|NCT00141778|725212|P1|Started Study Medication|Chest Discomfort|0
219681|NCT00141778|725210|P3|Started Study Medication|Difficulty Swallowing|0
219682|NCT00141778|725211|P2|Started Study Medication|Difficulty Swallowing|1
219683|NCT00141778|725212|P1|Started Study Medication|Difficulty Swallowing|0
219684|NCT00141778|725210|P3|Started Study Medication|Withdrawal by Subject|0
219685|NCT00141778|725211|P2|Started Study Medication|Withdrawal by Subject|2
219686|NCT00141778|725212|P1|Started Study Medication|Withdrawal by Subject|0
219687|NCT00141778|725210|P3|Started Study Medication|Met safety criteria for discontinuation|3
219688|NCT00141778|725211|P2|Started Study Medication|Met safety criteria for discontinuation|4
219689|NCT00141778|725212|P1|Started Study Medication|Met safety criteria for discontinuation|2
219690|NCT00141778|725210|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
219691|NCT00141778|725211|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
219692|NCT00141778|725212|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
219693|NCT00141726|725265|P1|Overall Study|Completed <50% Scheduled Dosing|3
219694|NCT00141518|725273|P3|Overall Study|Lack of Efficacy|0
219695|NCT00141518|725274|P2|Overall Study|Lack of Efficacy|0
219696|NCT00141518|725275|P1|Overall Study|Lack of Efficacy|5
219697|NCT00141518|725273|P3|Overall Study|Protocol Violation|2
219698|NCT00141518|725274|P2|Overall Study|Protocol Violation|1
219699|NCT00141518|725275|P1|Overall Study|Protocol Violation|1
219700|NCT00141518|725273|P3|Overall Study|Withdrawal by Subject|2
219701|NCT00141518|725274|P2|Overall Study|Withdrawal by Subject|0
219702|NCT00141518|725275|P1|Overall Study|Withdrawal by Subject|2
219703|NCT00141518|725273|P3|Overall Study|Adverse Event|2
219704|NCT00141518|725274|P2|Overall Study|Adverse Event|5
219705|NCT00141518|725275|P1|Overall Study|Adverse Event|7
219706|NCT00141518|725273|P3|Overall Study|Withdrew Consent Prior to Treatment|0
219707|NCT00141518|725274|P2|Overall Study|Withdrew Consent Prior to Treatment|0
219708|NCT00141518|725275|P1|Overall Study|Withdrew Consent Prior to Treatment|1
219709|NCT00141453|725464|P2|Overall Study|Protocol Violation|5
219710|NCT00141453|725465|P1|Overall Study|Protocol Violation|6
219711|NCT00141297|725479|P10|Overall Study|Transitioned|0
219712|NCT00141297|725480|P9|Overall Study|Transitioned|0
219713|NCT00141297|725481|P8|Overall Study|Transitioned|0
219714|NCT00141297|725482|P7|Overall Study|Transitioned|0
219715|NCT00141297|725483|P6|Overall Study|Transitioned|0
219716|NCT00141297|725484|P5|Overall Study|Transitioned|1
219717|NCT00141297|725485|P4|Overall Study|Transitioned|0
219718|NCT00141297|725486|P3|Overall Study|Transitioned|0
219719|NCT00141297|725487|P2|Overall Study|Transitioned|0
219720|NCT00141297|725488|P1|Overall Study|Transitioned|0
219721|NCT00141297|725479|P10|Overall Study|Progressive Disease|6
219722|NCT00141297|725480|P9|Overall Study|Progressive Disease|15
219723|NCT00141297|725481|P8|Overall Study|Progressive Disease|3
219724|NCT00141297|725482|P7|Overall Study|Progressive Disease|3
219725|NCT00141297|725483|P6|Overall Study|Progressive Disease|2
219726|NCT00141297|725484|P5|Overall Study|Progressive Disease|15
219727|NCT00141297|725485|P4|Overall Study|Progressive Disease|2
219728|NCT00141297|725486|P3|Overall Study|Progressive Disease|6
219729|NCT00141297|725487|P2|Overall Study|Progressive Disease|3
219730|NCT00141297|725488|P1|Overall Study|Progressive Disease|2
219731|NCT00141297|725479|P10|Overall Study|Other|0
219732|NCT00141297|725480|P9|Overall Study|Other|2
219733|NCT00141297|725481|P8|Overall Study|Other|0
219734|NCT00141297|725482|P7|Overall Study|Other|0
219735|NCT00141297|725483|P6|Overall Study|Other|0
219736|NCT00141297|725484|P5|Overall Study|Other|5
219737|NCT00141297|725485|P4|Overall Study|Other|1
219738|NCT00141297|725486|P3|Overall Study|Other|0
219739|NCT00141297|725487|P2|Overall Study|Other|0
219740|NCT00141297|725488|P1|Overall Study|Other|0
219741|NCT00141297|725479|P10|Overall Study|Withdrawal by Subject|0
219742|NCT00141297|725480|P9|Overall Study|Withdrawal by Subject|1
219743|NCT00141297|725481|P8|Overall Study|Withdrawal by Subject|0
219744|NCT00141297|725482|P7|Overall Study|Withdrawal by Subject|0
219745|NCT00141297|725483|P6|Overall Study|Withdrawal by Subject|0
219746|NCT00141297|725484|P5|Overall Study|Withdrawal by Subject|0
219747|NCT00141297|725485|P4|Overall Study|Withdrawal by Subject|0
219748|NCT00141297|725486|P3|Overall Study|Withdrawal by Subject|0
219749|NCT00141297|725487|P2|Overall Study|Withdrawal by Subject|0
219750|NCT00141297|725488|P1|Overall Study|Withdrawal by Subject|0
219751|NCT00141297|725479|P10|Overall Study|Death|0
219752|NCT00141297|725480|P9|Overall Study|Death|1
219753|NCT00141297|725481|P8|Overall Study|Death|0
219754|NCT00141297|725482|P7|Overall Study|Death|0
219755|NCT00141297|725483|P6|Overall Study|Death|0
219756|NCT00141297|725484|P5|Overall Study|Death|0
219757|NCT00141297|725485|P4|Overall Study|Death|0
219758|NCT00141297|725486|P3|Overall Study|Death|0
219759|NCT00141297|725487|P2|Overall Study|Death|0
219760|NCT00141297|725488|P1|Overall Study|Death|1
219761|NCT00141297|725479|P10|Overall Study|Adverse Event|0
219762|NCT00141297|725480|P9|Overall Study|Adverse Event|1
219763|NCT00141297|725481|P8|Overall Study|Adverse Event|1
219764|NCT00141297|725482|P7|Overall Study|Adverse Event|0
219765|NCT00141297|725483|P6|Overall Study|Adverse Event|1
219766|NCT00141297|725484|P5|Overall Study|Adverse Event|1
219767|NCT00141297|725485|P4|Overall Study|Adverse Event|0
219768|NCT00141297|725486|P3|Overall Study|Adverse Event|1
219769|NCT00141297|725487|P2|Overall Study|Adverse Event|0
219770|NCT00141297|725488|P1|Overall Study|Adverse Event|0
219771|NCT00141271|725766|P3|Overall Study|Other|5
219772|NCT00141271|725767|P2|Overall Study|Other|12
219773|NCT00141271|725768|P1|Overall Study|Other|11
219774|NCT00141271|725766|P3|Overall Study|Withdrawal by Subject|10
219775|NCT00141271|725767|P2|Overall Study|Withdrawal by Subject|9
219776|NCT00141271|725768|P1|Overall Study|Withdrawal by Subject|14
219777|NCT00141271|725766|P3|Overall Study|Lost to Follow-up|21
219778|NCT00141271|725767|P2|Overall Study|Lost to Follow-up|15
219779|NCT00141271|725768|P1|Overall Study|Lost to Follow-up|15
219780|NCT00141271|725766|P3|Overall Study|Lack of Efficacy|3
219781|NCT00141271|725767|P2|Overall Study|Lack of Efficacy|7
219782|NCT00141271|725768|P1|Overall Study|Lack of Efficacy|7
219783|NCT00141271|725766|P3|Overall Study|Laboratory Abnormality|1
219784|NCT00141271|725767|P2|Overall Study|Laboratory Abnormality|1
219785|NCT00141271|725768|P1|Overall Study|Laboratory Abnormality|2
219786|NCT00141271|725766|P3|Overall Study|Adverse Event|17
219787|NCT00141271|725767|P2|Overall Study|Adverse Event|19
219788|NCT00141271|725768|P1|Overall Study|Adverse Event|31
219789|NCT00141219|725889|P2|Overall Study|Withdrawal by Subject|2
219790|NCT00141219|725890|P1|Overall Study|Withdrawal by Subject|6
219791|NCT00141219|725889|P2|Overall Study|Lack of Efficacy|4
219792|NCT00141219|725890|P1|Overall Study|Lack of Efficacy|5
219793|NCT00141219|725889|P2|Overall Study|Adverse Event|6
219794|NCT00141219|725890|P1|Overall Study|Adverse Event|8
219795|NCT00141219|725889|P2|Overall Study|Protocol violations|4
219796|NCT00141219|725890|P1|Overall Study|Protocol violations|5
219797|NCT00141102|725946|P2|Overall Study|Death|2
219798|NCT00141102|725947|P1|Overall Study|Death|2
219799|NCT00141102|725946|P2|Overall Study|Randomized But Did Not Receive Treatment|9
219800|NCT00141102|725947|P1|Overall Study|Randomized But Did Not Receive Treatment|15
219801|NCT00141102|725946|P2|Overall Study|Withdrawal by Subject|142
219802|NCT00141102|725947|P1|Overall Study|Withdrawal by Subject|112
219803|NCT00141102|725946|P2|Overall Study|Other|76
219804|NCT00141102|725947|P1|Overall Study|Other|87
219805|NCT00141102|725946|P2|Overall Study|Lost to Follow-up|32
219806|NCT00141102|725947|P1|Overall Study|Lost to Follow-up|29
219807|NCT00141102|725946|P2|Overall Study|Lack of Efficacy|26
219808|NCT00141102|725947|P1|Overall Study|Lack of Efficacy|21
219809|NCT00141102|725946|P2|Overall Study|Laboratory Abnormality|33
219810|NCT00141102|725947|P1|Overall Study|Laboratory Abnormality|9
219811|NCT00141102|725946|P2|Overall Study|Adverse Event|305
219812|NCT00141102|725947|P1|Overall Study|Adverse Event|233
219813|NCT00141037|725987|P2|Overall Study|Graft Failure|4
219814|NCT00141037|725988|P1|Overall Study|Graft Failure|3
219815|NCT00141037|725987|P2|Overall Study|Moved from area|7
219816|NCT00141037|725988|P1|Overall Study|Moved from area|1
219817|NCT00141037|725987|P2|Overall Study|Other|1
219818|NCT00141037|725988|P1|Overall Study|Other|0
219819|NCT00141037|725987|P2|Overall Study|Withdrawal by Subject|1
219820|NCT00141037|725988|P1|Overall Study|Withdrawal by Subject|2
219821|NCT00141037|725987|P2|Overall Study|Protocol Violation|2
219822|NCT00141037|725988|P1|Overall Study|Protocol Violation|0
219823|NCT00141037|725987|P2|Overall Study|Lost to Follow-up|1
219824|NCT00141037|725988|P1|Overall Study|Lost to Follow-up|3
219825|NCT00141037|725987|P2|Overall Study|Physician Decision|2
219826|NCT00141037|725988|P1|Overall Study|Physician Decision|1
219827|NCT00140426|726023|P2|Overall Study|Withdrawal by Subject|3
219828|NCT00140426|726024|P1|Overall Study|Withdrawal by Subject|0
219829|NCT00140413|726057|P2|Overall Study|Withdrawal by Subject|0
219830|NCT00140413|726058|P1|Overall Study|Withdrawal by Subject|2
219831|NCT00140413|726057|P2|Overall Study|Lost to Follow-up|0
219832|NCT00140413|726058|P1|Overall Study|Lost to Follow-up|1
219833|NCT00140140|726118|P3|Overall Study|Physician Decision|0
219834|NCT00140140|726119|P2|Overall Study|Physician Decision|1
219835|NCT00140140|726120|P1|Overall Study|Physician Decision|1
219836|NCT00140140|726118|P3|Overall Study|Unacceptable toxicity|2
219837|NCT00140140|726119|P2|Overall Study|Unacceptable toxicity|1
219838|NCT00140140|726120|P1|Overall Study|Unacceptable toxicity|1
219839|NCT00139776|726170|P4|Period III|Withdrawal by Subject|21
219840|NCT00139776|726171|P3|Period III|Withdrawal by Subject|16
219841|NCT00139776|726172|P2|Period III|Withdrawal by Subject|0
219842|NCT00139776|726173|P1|Period III|Withdrawal by Subject|0
219843|NCT00139776|726170|P4|Period III|Lost to Follow-up|4
219844|NCT00139776|726171|P3|Period III|Lost to Follow-up|5
219845|NCT00139776|726172|P2|Period III|Lost to Follow-up|0
219846|NCT00139776|726173|P1|Period III|Lost to Follow-up|0
219847|NCT00139776|726170|P4|Period III|Lack of Efficacy|24
219848|NCT00139776|726171|P3|Period III|Lack of Efficacy|10
219849|NCT00139776|726172|P2|Period III|Lack of Efficacy|0
219850|NCT00139776|726173|P1|Period III|Lack of Efficacy|0
219851|NCT00139776|726170|P4|Period III|Other|34
219852|NCT00139776|726171|P3|Period III|Other|23
219853|NCT00139776|726172|P2|Period III|Other|0
219854|NCT00139776|726173|P1|Period III|Other|0
219855|NCT00139776|726170|P4|Period III|Adverse Event|23
219856|NCT00139776|726171|P3|Period III|Adverse Event|22
219857|NCT00139776|726172|P2|Period III|Adverse Event|0
219858|NCT00139776|726173|P1|Period III|Adverse Event|0
219859|NCT00139776|726170|P4|Period II|Not Randomized into Period III|0
219860|NCT00139776|726171|P3|Period II|Not Randomized into Period III|0
219861|NCT00139776|726172|P2|Period II|Not Randomized into Period III|322
219862|NCT00139776|726173|P1|Period II|Not Randomized into Period III|0
219863|NCT00139776|726170|P4|Period I|Did not enter Period II|0
219864|NCT00139776|726171|P3|Period I|Did not enter Period II|0
219865|NCT00139776|726172|P2|Period I|Did not enter Period II|0
219866|NCT00139776|726173|P1|Period I|Did not enter Period II|575
219867|NCT00139737|726208|P1|Overall Study|Screened, Not Treated|13
219868|NCT00139737|726208|P1|Overall Study|Did Not Meet Entrance Criteria|1
219869|NCT00139737|726208|P1|Overall Study|Withdrew During Screening Phase|8
219870|NCT00139737|726208|P1|Overall Study|Protocol Violation|18
219871|NCT00139737|726208|P1|Overall Study|Laboratory Abnormality|2
219872|NCT00139737|726208|P1|Overall Study|Death|3
219873|NCT00139737|726208|P1|Overall Study|Lost to Follow-up|8
219874|NCT00139737|726208|P1|Overall Study|Lack of Efficacy|40
219875|NCT00139737|726208|P1|Overall Study|Adverse Event|58
219876|NCT00139737|726208|P1|Overall Study|Withdrawal by Subject|190
219877|NCT00139659|726214|P2|Overall Study|Withdrawal by Subject|10
219878|NCT00139659|726215|P1|Overall Study|Withdrawal by Subject|14
219879|NCT00139659|726214|P2|Overall Study|Reason not Specified|3
219880|NCT00139659|726215|P1|Overall Study|Reason not Specified|6
219881|NCT00139659|726214|P2|Overall Study|Lost to Follow-up|3
219882|NCT00139659|726215|P1|Overall Study|Lost to Follow-up|7
219883|NCT00139659|726214|P2|Overall Study|Lack of Efficacy|1
219884|NCT00139659|726215|P1|Overall Study|Lack of Efficacy|1
219885|NCT00139659|726214|P2|Overall Study|Adverse Event|1
219886|NCT00139659|726215|P1|Overall Study|Adverse Event|12
219887|NCT00139477|726293|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
219888|NCT00139477|726294|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
219889|NCT00139477|726293|P2|Second Intervention -6Months to 12Months|Relocation|0
219890|NCT00139477|726294|P1|Second Intervention -6Months to 12Months|Relocation|1
219891|NCT00139477|726293|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
219892|NCT00139477|726294|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
219893|NCT00139477|726293|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
219894|NCT00139477|726294|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
219895|NCT00139477|726293|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
219896|NCT00139477|726294|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
219897|NCT00139477|726293|P2|First Intervention -Baseline to 6Months|Relocation|2
219898|NCT00139477|726294|P1|First Intervention -Baseline to 6Months|Relocation|1
219899|NCT00139477|726293|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
219900|NCT00139477|726294|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
219901|NCT00138671|726316|P2|Overall Study|Other|3
219902|NCT00138671|726317|P1|Overall Study|Other|3
219903|NCT00138671|726316|P2|Overall Study|Withdrawal by Subject|5
219904|NCT00138671|726317|P1|Overall Study|Withdrawal by Subject|3
219905|NCT00138671|726316|P2|Overall Study|Lost to Follow-up|2
219906|NCT00138671|726317|P1|Overall Study|Lost to Follow-up|1
219907|NCT00138671|726316|P2|Overall Study|Adverse Event|3
219908|NCT00138671|726317|P1|Overall Study|Adverse Event|6
219909|NCT00138671|726316|P2|Overall Study|Death|3
219910|NCT00138671|726317|P1|Overall Study|Death|0
219911|NCT00138658|726367|P1|Overall Study|Withdrawal by Subject|5
219912|NCT00138658|726367|P1|Overall Study|Physician Decision|11
219913|NCT00138658|726367|P1|Overall Study|Disease Progression|21
219914|NCT00138658|726367|P1|Overall Study|Death|1
219915|NCT00138658|726367|P1|Overall Study|Adverse Event|23
219916|NCT00138424|726390|P4|Overall Study|Physician Decision|0
219917|NCT00138424|726391|P3|Overall Study|Physician Decision|0
219918|NCT00138424|726392|P2|Overall Study|Physician Decision|1
219919|NCT00138424|726393|P1|Overall Study|Physician Decision|0
219920|NCT00138151|726476|P1|Overall Study|Physician Decision|1
219921|NCT00138151|726476|P1|Overall Study|Withdrawal by Subject|3
219922|NCT00138073|726486|P1|Overall Study|lack of resources|55
219923|NCT00137631|726527|P2|Overall Study|Lost to Follow-up|41
219924|NCT00137631|726528|P1|Overall Study|Lost to Follow-up|37
219925|NCT00137449|726544|P2|Overall Study|Withdrawal by Subject|1
219926|NCT00137449|726545|P1|Overall Study|Withdrawal by Subject|1
219927|NCT00137449|726544|P2|Overall Study|Adverse Event|1
219928|NCT00137449|726545|P1|Overall Study|Adverse Event|3
219929|NCT00137449|726544|P2|Overall Study|Death|3
219930|NCT00137449|726545|P1|Overall Study|Death|4
219931|NCT00137449|726544|P2|Overall Study|Disease Progression|13
219932|NCT00137449|726545|P1|Overall Study|Disease Progression|8
219933|NCT00137436|726582|P1|Overall Study|Other|5
219934|NCT00137436|726582|P1|Overall Study|Withdrawal by Subject|6
219935|NCT00137436|726582|P1|Overall Study|Lack of Efficacy|17
219936|NCT00137436|726582|P1|Overall Study|Death|2
219937|NCT00137436|726582|P1|Overall Study|Adverse Event|13
219938|NCT00137423|726601|P2|Overall Study|Death|1
219939|NCT00137423|726602|P1|Overall Study|Death|0
219940|NCT00137423|726601|P2|Overall Study|Lack of Efficacy|33
219941|NCT00137423|726602|P1|Overall Study|Lack of Efficacy|31
219942|NCT00137423|726601|P2|Overall Study|consent withdrawn|1
219943|NCT00137423|726602|P1|Overall Study|consent withdrawn|1
219944|NCT00137423|726601|P2|Overall Study|Adverse Event|9
219945|NCT00137423|726602|P1|Overall Study|Adverse Event|7
219946|NCT00137267|726639|P2|Overall Study|Lost to Follow-up|21
219947|NCT00137267|726640|P1|Overall Study|Lost to Follow-up|15
219948|NCT00137111|726652|P4|Total Therapy|Non Compliance|0
219949|NCT00137111|726653|P3|Total Therapy|Non Compliance|0
219950|NCT00137111|726654|P2|Total Therapy|Non Compliance|0
219951|NCT00137111|726655|P1|Total Therapy|Non Compliance|5
219952|NCT00137111|726652|P4|Total Therapy|Death|0
219953|NCT00137111|726653|P3|Total Therapy|Death|0
219954|NCT00137111|726654|P2|Total Therapy|Death|0
219955|NCT00137111|726655|P1|Total Therapy|Death|35
219956|NCT00137046|726669|P2|Overall Study|Withdrew prior to study treatment|1
219957|NCT00137046|726670|P1|Overall Study|Withdrew prior to study treatment|1
219958|NCT00137046|726669|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
219959|NCT00137046|726670|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
219960|NCT00137046|726669|P2|Overall Study|Withdrawal by Subject|42
219961|NCT00137046|726670|P1|Overall Study|Withdrawal by Subject|33
219962|NCT00137046|726669|P2|Overall Study|Other|19
219963|NCT00137046|726670|P1|Overall Study|Other|23
219964|NCT00137046|726669|P2|Overall Study|Lost to Follow-up|24
219965|NCT00137046|726670|P1|Overall Study|Lost to Follow-up|8
219966|NCT00137046|726669|P2|Overall Study|Lack of Efficacy|1
219967|NCT00137046|726670|P1|Overall Study|Lack of Efficacy|13
219968|NCT00137046|726669|P2|Overall Study|Laboratory Abnormality|0
219969|NCT00137046|726670|P1|Overall Study|Laboratory Abnormality|2
219970|NCT00137046|726669|P2|Overall Study|Adverse Event|5
219971|NCT00137046|726670|P1|Overall Study|Adverse Event|16
219972|NCT00137046|726669|P2|Overall Study|Death|1
219973|NCT00137046|726670|P1|Overall Study|Death|2
219974|NCT00136955|726718|P1|Overall Study|Incl. prog. disease, protocol violation|12
219975|NCT00136955|726718|P1|Overall Study|Withdrawal by Subject|2
219976|NCT00136955|726718|P1|Overall Study|Lost to Follow-up|1
219977|NCT00136955|726718|P1|Overall Study|Adverse Event|8
219978|NCT00136916|726727|P2|Overall Study|Discontinued in follow up period|0
219979|NCT00136916|726728|P1|Overall Study|Discontinued in follow up period|3
219980|NCT00136916|726727|P2|Overall Study|Other|24
219981|NCT00136916|726728|P1|Overall Study|Other|22
219982|NCT00136916|726727|P2|Overall Study|Withdrawal by Subject|46
219983|NCT00136916|726728|P1|Overall Study|Withdrawal by Subject|44
219984|NCT00136916|726727|P2|Overall Study|Lost to Follow-up|14
219985|NCT00136916|726728|P1|Overall Study|Lost to Follow-up|12
219986|NCT00136916|726727|P2|Overall Study|Lack of Efficacy|3
219987|NCT00136916|726728|P1|Overall Study|Lack of Efficacy|13
219988|NCT00136916|726727|P2|Overall Study|Laboratory abnormality|1
219989|NCT00136916|726728|P1|Overall Study|Laboratory abnormality|0
219990|NCT00136916|726727|P2|Overall Study|Adverse Event|8
219991|NCT00136916|726728|P1|Overall Study|Adverse Event|27
219992|NCT00136916|726727|P2|Overall Study|Death|3
219993|NCT00136916|726728|P1|Overall Study|Death|1
219994|NCT00136916|726727|P2|Overall Study|Never received study treatment|5
219995|NCT00136916|726728|P1|Overall Study|Never received study treatment|3
219996|NCT00136357|726832|P2|Overall Study|Withdrawal by Subject|2
219997|NCT00136357|726833|P1|Overall Study|Withdrawal by Subject|3
219998|NCT00136318|726841|P2|Overall Study|Withdrawal by Subject|2
219999|NCT00136318|726842|P1|Overall Study|Withdrawal by Subject|2
220000|NCT00136318|726841|P2|Overall Study|Adverse Event|5
220001|NCT00136318|726842|P1|Overall Study|Adverse Event|5
220002|NCT00136084|726858|P2|Overall Study|Withdrawal by Subject|1
220003|NCT00136084|726859|P1|Overall Study|Withdrawal by Subject|5
220004|NCT00136084|726858|P2|Overall Study|No Response|2
220005|NCT00136084|726859|P1|Overall Study|No Response|1
220006|NCT00136084|726858|P2|Overall Study|Lost to Follow-up|0
220007|NCT00136084|726859|P1|Overall Study|Lost to Follow-up|2
220008|NCT00136084|726858|P2|Overall Study|Relapse|23
220009|NCT00136084|726859|P1|Overall Study|Relapse|20
220010|NCT00136084|726858|P2|Overall Study|Unacceptable toxicity|11
220011|NCT00136084|726859|P1|Overall Study|Unacceptable toxicity|8
220012|NCT00136084|726858|P2|Overall Study|Death|5
220013|NCT00136084|726859|P1|Overall Study|Death|12
220014|NCT00135694|726896|P3|Overall Study|Ineligible for Random assignment|0
220015|NCT00135694|726897|P2|Overall Study|Ineligible for Random assignment|0
220016|NCT00135694|726898|P1|Overall Study|Ineligible for Random assignment|42
220017|NCT00135694|726896|P3|Overall Study|Hepatitis C related reasons|0
220018|NCT00135694|726897|P2|Overall Study|Hepatitis C related reasons|1
220019|NCT00135694|726898|P1|Overall Study|Hepatitis C related reasons|39
220020|NCT00135694|726896|P3|Overall Study|Protocol Violation|0
220021|NCT00135694|726897|P2|Overall Study|Protocol Violation|1
220022|NCT00135694|726898|P1|Overall Study|Protocol Violation|19
220023|NCT00135694|726896|P3|Overall Study|Withdrawal by Subject|4
220024|NCT00135694|726897|P2|Overall Study|Withdrawal by Subject|7
220025|NCT00135694|726898|P1|Overall Study|Withdrawal by Subject|41
220026|NCT00135694|726896|P3|Overall Study|Lost to Follow-up|1
220027|NCT00135694|726897|P2|Overall Study|Lost to Follow-up|7
220028|NCT00135694|726898|P1|Overall Study|Lost to Follow-up|8
220029|NCT00135694|726896|P3|Overall Study|Death|2
220030|NCT00135694|726897|P2|Overall Study|Death|1
220031|NCT00135694|726898|P1|Overall Study|Death|14
220032|NCT00135694|726896|P3|Overall Study|Adverse Event|0
220033|NCT00135694|726897|P2|Overall Study|Adverse Event|4
220034|NCT00135694|726898|P1|Overall Study|Adverse Event|17
220035|NCT00135356|726918|P2|Overall Study|Withdrawal by Subject|4
220036|NCT00135356|726919|P1|Overall Study|Withdrawal by Subject|2
220037|NCT00135356|726918|P2|Overall Study|No longer meets study criteria|0
220038|NCT00135356|726919|P1|Overall Study|No longer meets study criteria|2
220039|NCT00135356|726918|P2|Overall Study|Poor/noncompliance|1
220040|NCT00135356|726919|P1|Overall Study|Poor/noncompliance|1
220041|NCT00135356|726918|P2|Overall Study|Change in antiviral regimen|1
220042|NCT00135356|726919|P1|Overall Study|Change in antiviral regimen|0
220043|NCT00135356|726918|P2|Overall Study|Surgery for abdominal fat|0
220044|NCT00135356|726919|P1|Overall Study|Surgery for abdominal fat|1
220045|NCT00135356|726918|P2|Overall Study|Lost to Follow-up|1
220046|NCT00135356|726919|P1|Overall Study|Lost to Follow-up|3
220047|NCT00135356|726918|P2|Overall Study|Lack of Efficacy|0
220048|NCT00135356|726919|P1|Overall Study|Lack of Efficacy|2
220049|NCT00135356|726918|P2|Overall Study|Adverse Event|2
220050|NCT00135356|726919|P1|Overall Study|Adverse Event|6
220051|NCT00135330|726962|P3|Overall Study|Sponsor Decision|0
220052|NCT00135330|726963|P2|Overall Study|Sponsor Decision|1
220053|NCT00135330|726964|P1|Overall Study|Sponsor Decision|0
220054|NCT00135330|726962|P3|Overall Study|Patient Decision|4
220055|NCT00135330|726963|P2|Overall Study|Patient Decision|1
220056|NCT00135330|726964|P1|Overall Study|Patient Decision|5
220057|NCT00135330|726962|P3|Overall Study|Protocol Violation|3
220058|NCT00135330|726963|P2|Overall Study|Protocol Violation|3
220059|NCT00135330|726964|P1|Overall Study|Protocol Violation|4
220060|NCT00135330|726962|P3|Overall Study|Physician Decision|0
220061|NCT00135330|726963|P2|Overall Study|Physician Decision|1
220062|NCT00135330|726964|P1|Overall Study|Physician Decision|1
220063|NCT00135330|726962|P3|Overall Study|Lost to Follow-up|3
220064|NCT00135330|726963|P2|Overall Study|Lost to Follow-up|2
220065|NCT00135330|726964|P1|Overall Study|Lost to Follow-up|0
220066|NCT00135330|726962|P3|Overall Study|Adverse Event|1
220067|NCT00135330|726963|P2|Overall Study|Adverse Event|5
220068|NCT00135330|726964|P1|Overall Study|Adverse Event|2
220069|NCT00134901|727063|P2|Overall Study|discontinued intervention|10
220070|NCT00134901|727064|P1|Overall Study|discontinued intervention|12
220071|NCT00134901|727063|P2|Overall Study|Lost to Follow-up|5
220072|NCT00134901|727064|P1|Overall Study|Lost to Follow-up|5
220073|NCT00134784|727076|P4|Overall Study|Withdrawal by Subject|1
220074|NCT00134784|727077|P3|Overall Study|Withdrawal by Subject|2
220075|NCT00134784|727078|P2|Overall Study|Withdrawal by Subject|2
220076|NCT00134784|727079|P1|Overall Study|Withdrawal by Subject|2
220077|NCT00134719|727089|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
220078|NCT00134719|727090|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
220079|NCT00134719|727091|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
220080|NCT00134719|727089|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
220081|NCT00134719|727090|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
220082|NCT00134719|727091|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
220083|NCT00134719|727089|P3|Primary Vaccination Phase|Lost to Follow-up|3
220084|NCT00134719|727090|P2|Primary Vaccination Phase|Lost to Follow-up|3
220085|NCT00134719|727091|P1|Primary Vaccination Phase|Lost to Follow-up|7
220086|NCT00134719|727089|P3|Primary Vaccination Phase|Withdrawal by Subject|2
220087|NCT00134719|727090|P2|Primary Vaccination Phase|Withdrawal by Subject|3
220088|NCT00134719|727091|P1|Primary Vaccination Phase|Withdrawal by Subject|2
220089|NCT00134719|727089|P3|Primary Vaccination Phase|Protocol Violation|0
220090|NCT00134719|727090|P2|Primary Vaccination Phase|Protocol Violation|0
220091|NCT00134719|727091|P1|Primary Vaccination Phase|Protocol Violation|1
220092|NCT00134719|727089|P3|Primary Vaccination Phase|Adverse Event|0
220093|NCT00134719|727090|P2|Primary Vaccination Phase|Adverse Event|0
220094|NCT00134719|727091|P1|Primary Vaccination Phase|Adverse Event|4
220095|NCT00134563|727222|P3|Overall Study|Reason other than above|5
220096|NCT00134563|727223|P2|Overall Study|Reason other than above|2
220097|NCT00134563|727224|P1|Overall Study|Reason other than above|0
220098|NCT00134563|727222|P3|Overall Study|did not wish to continue|26
220099|NCT00134563|727223|P2|Overall Study|did not wish to continue|32
220100|NCT00134563|727224|P1|Overall Study|did not wish to continue|33
220101|NCT00134563|727222|P3|Overall Study|progressive disease|2
220102|NCT00134563|727223|P2|Overall Study|progressive disease|4
220103|NCT00134563|727224|P1|Overall Study|progressive disease|11
220104|NCT00134563|727222|P3|Overall Study|Lost to Follow-up|2
220105|NCT00134563|727223|P2|Overall Study|Lost to Follow-up|0
220106|NCT00134563|727224|P1|Overall Study|Lost to Follow-up|4
220107|NCT00134563|727222|P3|Overall Study|Protocol Violation|5
220108|NCT00134563|727223|P2|Overall Study|Protocol Violation|2
220109|NCT00134563|727224|P1|Overall Study|Protocol Violation|3
220110|NCT00134563|727222|P3|Overall Study|Lack of Efficacy|17
220111|NCT00134563|727223|P2|Overall Study|Lack of Efficacy|14
220112|NCT00134563|727224|P1|Overall Study|Lack of Efficacy|24
220113|NCT00134563|727222|P3|Overall Study|Adverse Event|38
220114|NCT00134563|727223|P2|Overall Study|Adverse Event|37
220115|NCT00134563|727224|P1|Overall Study|Adverse Event|29
220116|NCT00134563|727222|P3|Overall Study|Not treated due to protocol violation|1
220117|NCT00134563|727223|P2|Overall Study|Not treated due to protocol violation|1
220118|NCT00134563|727224|P1|Overall Study|Not treated due to protocol violation|0
220119|NCT00134056|727287|P2|Eligible for Protocol Assigned Treatment|Not specified|56
220120|NCT00134056|727288|P1|Eligible for Protocol Assigned Treatment|Not specified|55
220121|NCT00134056|727287|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
220122|NCT00134056|727288|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
220123|NCT00134056|727287|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
220124|NCT00134056|727288|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
220125|NCT00134056|727287|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
220126|NCT00134056|727288|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
220127|NCT00134056|727287|P2|Randomization|Not eligible for assigned treatment|20
220128|NCT00134056|727288|P1|Randomization|Not eligible for assigned treatment|22
220129|NCT00133952|727355|P2|Overall Study|Sponsor Decision|1
220130|NCT00133952|727356|P1|Overall Study|Sponsor Decision|0
220131|NCT00133952|727355|P2|Overall Study|Physician Decision|3
220132|NCT00133952|727356|P1|Overall Study|Physician Decision|4
220133|NCT00133952|727355|P2|Overall Study|Withdrawal by Subject|4
220134|NCT00133952|727356|P1|Overall Study|Withdrawal by Subject|20
220135|NCT00133952|727355|P2|Overall Study|Protocol Violation|1
220136|NCT00133952|727356|P1|Overall Study|Protocol Violation|1
220137|NCT00133952|727355|P2|Overall Study|Protocol Entry Criteria Exclusion|1
220138|NCT00133952|727356|P1|Overall Study|Protocol Entry Criteria Exclusion|4
220139|NCT00133952|727355|P2|Overall Study|Lost to Follow-up|14
220140|NCT00133952|727356|P1|Overall Study|Lost to Follow-up|9
220141|NCT00133952|727355|P2|Overall Study|Death|2
220142|NCT00133952|727356|P1|Overall Study|Death|3
220143|NCT00133952|727355|P2|Overall Study|Adverse Event|2
220144|NCT00133952|727356|P1|Overall Study|Adverse Event|1
220145|NCT00133705|727387|P2|Overall Study|Withdrawal by Subject|3
220146|NCT00133705|727388|P1|Overall Study|Withdrawal by Subject|2
220147|NCT00132873|727514|P1|Overall Study|Planned Pregnancy|1
220148|NCT00132873|727514|P1|Overall Study|Withdrawal by Subject|3
220149|NCT00132873|727514|P1|Overall Study|Lack of Efficacy|1
220150|NCT00132873|727514|P1|Overall Study|Lost to Follow-up|1
220151|NCT00132873|727514|P1|Overall Study|Adverse Event|3
220152|NCT00132808|727522|P3|Stratum II|Withdrawal by Subject|6
220153|NCT00132808|727523|P2|Stratum II|Withdrawal by Subject|9
220154|NCT00132808|727524|P1|Stratum II|Withdrawal by Subject|4
220155|NCT00132808|727522|P3|Stratum II|Protocol Violation|1
220156|NCT00132808|727523|P2|Stratum II|Protocol Violation|2
220157|NCT00132808|727524|P1|Stratum II|Protocol Violation|0
220158|NCT00132808|727522|P3|Stratum II|Lost to Follow-up|1
220159|NCT00132808|727523|P2|Stratum II|Lost to Follow-up|2
220160|NCT00132808|727524|P1|Stratum II|Lost to Follow-up|2
220161|NCT00132808|727522|P3|Stratum II|Death|0
220162|NCT00132808|727523|P2|Stratum II|Death|0
220163|NCT00132808|727524|P1|Stratum II|Death|1
220164|NCT00132808|727522|P3|Stratum II|Adverse Event|1
220165|NCT00132808|727523|P2|Stratum II|Adverse Event|2
220166|NCT00132808|727524|P1|Stratum II|Adverse Event|1
220167|NCT00132808|727522|P3|Stratum I|Abnormal test procedure result (s)|1
220168|NCT00132808|727523|P2|Stratum I|Abnormal test procedure result (s)|0
220169|NCT00132808|727524|P1|Stratum I|Abnormal test procedure result (s)|0
220170|NCT00132808|727522|P3|Stratum I|Withdrawal by Subject|3
220171|NCT00132808|727523|P2|Stratum I|Withdrawal by Subject|7
220172|NCT00132808|727524|P1|Stratum I|Withdrawal by Subject|4
220173|NCT00132808|727522|P3|Stratum I|Lost to Follow-up|1
220174|NCT00132808|727523|P2|Stratum I|Lost to Follow-up|4
220175|NCT00132808|727524|P1|Stratum I|Lost to Follow-up|3
220176|NCT00132808|727522|P3|Stratum I|Adverse Event|0
220177|NCT00132808|727523|P2|Stratum I|Adverse Event|1
220178|NCT00132808|727524|P1|Stratum I|Adverse Event|2
220179|NCT00132769|727549|P2|Overall Study|Protocol Violation|1
220180|NCT00132769|727550|P1|Overall Study|Protocol Violation|1
220181|NCT00132769|727549|P2|Overall Study|Adverse Event|1
220182|NCT00132769|727550|P1|Overall Study|Adverse Event|2
220183|NCT00132769|727549|P2|Overall Study|Lack of Efficacy|6
220184|NCT00132769|727550|P1|Overall Study|Lack of Efficacy|7
220185|NCT00132769|727549|P2|Overall Study|Withdrawal by Subject|3
220186|NCT00132769|727550|P1|Overall Study|Withdrawal by Subject|1
220187|NCT00132730|727576|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
220188|NCT00132730|727577|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
220189|NCT00132730|727578|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
220190|NCT00132730|727579|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
220191|NCT00132730|727580|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
220192|NCT00132730|727581|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
220193|NCT00132730|727576|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
220194|NCT00132730|727577|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
220195|NCT00132730|727578|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
220196|NCT00132730|727579|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
220197|NCT00132730|727580|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
220198|NCT00132730|727581|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
220199|NCT00132730|727576|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
220200|NCT00132730|727577|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
220201|NCT00132730|727578|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
220202|NCT00132730|727579|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
220203|NCT00132730|727580|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
220204|NCT00132730|727581|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
220205|NCT00132730|727576|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
220206|NCT00132730|727577|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
220207|NCT00132730|727578|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
220208|NCT00132730|727579|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
220209|NCT00132730|727580|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
220210|NCT00132730|727581|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
220211|NCT00132730|727576|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
220212|NCT00132730|727577|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
220213|NCT00132730|727578|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
220214|NCT00132730|727579|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
220215|NCT00132730|727580|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
220216|NCT00132730|727581|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
220217|NCT00132730|727576|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
220218|NCT00132730|727577|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
220219|NCT00132730|727578|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
220220|NCT00132730|727579|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
220221|NCT00132730|727580|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
220222|NCT00132730|727581|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
220223|NCT00132730|727576|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
220224|NCT00132730|727577|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
220225|NCT00132730|727578|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
220226|NCT00132730|727579|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
220227|NCT00132730|727580|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
220228|NCT00132730|727581|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
220229|NCT00132730|727576|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
220230|NCT00132730|727577|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
220231|NCT00132730|727578|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
220232|NCT00132730|727579|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
220233|NCT00132730|727580|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
220234|NCT00132730|727581|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
220235|NCT00132730|727576|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
220236|NCT00132730|727577|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
220237|NCT00132730|727578|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
220238|NCT00132730|727579|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
220239|NCT00132730|727580|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
220240|NCT00132730|727581|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
220241|NCT00132730|727576|P6|Period II - 12-week Treatment (Base)|Other reasons|0
220242|NCT00132730|727577|P5|Period II - 12-week Treatment (Base)|Other reasons|0
220243|NCT00132730|727578|P4|Period II - 12-week Treatment (Base)|Other reasons|13
220244|NCT00132730|727579|P3|Period II - 12-week Treatment (Base)|Other reasons|9
220245|NCT00132730|727580|P2|Period II - 12-week Treatment (Base)|Other reasons|10
220246|NCT00132730|727581|P1|Period II - 12-week Treatment (Base)|Other reasons|11
220247|NCT00132730|727576|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
220248|NCT00132730|727577|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
220249|NCT00132730|727578|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
220250|NCT00132730|727579|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
220251|NCT00132730|727580|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
220252|NCT00132730|727581|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
220253|NCT00132730|727576|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
220254|NCT00132730|727577|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
220255|NCT00132730|727578|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
220256|NCT00132730|727579|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
220257|NCT00132730|727580|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
220258|NCT00132730|727581|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
220259|NCT00132691|727625|P2|Overall Study|Death|0
220260|NCT00132691|727626|P1|Overall Study|Death|2
220261|NCT00132691|727625|P2|Overall Study|Missed 2-year visit|4
220262|NCT00132691|727626|P1|Overall Study|Missed 2-year visit|4
220263|NCT00132691|727625|P2|Overall Study|Lost to Follow-up|8
220264|NCT00132691|727626|P1|Overall Study|Lost to Follow-up|5
220265|NCT00132678|727666|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
220266|NCT00132678|727667|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
220267|NCT00132678|727668|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
220268|NCT00132678|727666|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
220269|NCT00132678|727667|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
220270|NCT00132678|727668|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
220271|NCT00132678|727666|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
220272|NCT00132678|727667|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
220273|NCT00132678|727668|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
220274|NCT00132678|727666|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
220275|NCT00132678|727667|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
220276|NCT00132678|727668|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
220277|NCT00132678|727666|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
220278|NCT00132678|727667|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
220279|NCT00132678|727668|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
220280|NCT00132678|727666|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
220281|NCT00132678|727667|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
220282|NCT00132678|727668|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
220283|NCT00132678|727666|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
220284|NCT00132678|727667|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
220285|NCT00132678|727668|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
220286|NCT00132678|727666|P3|Period III (Open-Label Stabilization)|Pregnancy|0
220287|NCT00132678|727667|P2|Period III (Open-Label Stabilization)|Pregnancy|0
220288|NCT00132678|727668|P1|Period III (Open-Label Stabilization)|Pregnancy|2
220289|NCT00132678|727666|P3|Period III (Open-Label Stabilization)|Physician Decision|0
220290|NCT00132678|727667|P2|Period III (Open-Label Stabilization)|Physician Decision|0
220291|NCT00132678|727668|P1|Period III (Open-Label Stabilization)|Physician Decision|1
220292|NCT00132678|727666|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
220293|NCT00132678|727667|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
220294|NCT00132678|727668|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
220295|NCT00132678|727666|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
220296|NCT00132678|727667|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
220297|NCT00132678|727668|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
220298|NCT00132678|727666|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
220299|NCT00132678|727667|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
220300|NCT00132678|727668|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
220301|NCT00132678|727666|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
220302|NCT00132678|727667|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
220303|NCT00132678|727668|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
220304|NCT00132678|727666|P3|Period III (Open-Label Stabilization)|Non responder|0
220305|NCT00132678|727667|P2|Period III (Open-Label Stabilization)|Non responder|0
220306|NCT00132678|727668|P1|Period III (Open-Label Stabilization)|Non responder|107
220307|NCT00132678|727666|P3|Period III (Open-Label Stabilization)|Adverse Event|0
220308|NCT00132678|727667|P2|Period III (Open-Label Stabilization)|Adverse Event|0
220309|NCT00132678|727668|P1|Period III (Open-Label Stabilization)|Adverse Event|12
220310|NCT00132678|727666|P3|Period III (Open-Label Stabilization)|Death|0
220311|NCT00132678|727667|P2|Period III (Open-Label Stabilization)|Death|0
220312|NCT00132678|727668|P1|Period III (Open-Label Stabilization)|Death|2
220313|NCT00132678|727666|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
220314|NCT00132678|727667|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
220315|NCT00132678|727668|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
220316|NCT00132678|727666|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
220317|NCT00132678|727667|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
220318|NCT00132678|727668|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
220319|NCT00132678|727666|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
220320|NCT00132678|727667|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
220321|NCT00132678|727668|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
220322|NCT00132678|727666|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
220323|NCT00132678|727667|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
220324|NCT00132678|727668|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
220325|NCT00132678|727666|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
220326|NCT00132678|727667|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
220327|NCT00132678|727668|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
220328|NCT00132678|727666|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
220329|NCT00132678|727667|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
220330|NCT00132678|727668|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
220331|NCT00132678|727666|P3|Period II (Open-Label Oral Risperidone)|Death|1
220332|NCT00132678|727667|P2|Period II (Open-Label Oral Risperidone)|Death|0
220333|NCT00132678|727668|P1|Period II (Open-Label Oral Risperidone)|Death|0
220334|NCT00132496|727682|P2|Overall Study|Physician Decision|0
220335|NCT00132496|727683|P1|Overall Study|Physician Decision|1
220336|NCT00132496|727682|P2|Overall Study|Withdrawal by Subject|2
220337|NCT00132496|727683|P1|Overall Study|Withdrawal by Subject|1
220338|NCT00132314|727691|P2|Overall Study|Refused intervention at baseline|7
220339|NCT00132314|727692|P1|Overall Study|Refused intervention at baseline|2
220340|NCT00132314|727691|P2|Overall Study|Lacked SSN|3
220341|NCT00132314|727692|P1|Overall Study|Lacked SSN|1
220342|NCT00132314|727691|P2|Overall Study|Lost to Follow-up|62
220343|NCT00132314|727692|P1|Overall Study|Lost to Follow-up|70
220344|NCT00132132|727702|P2|Overall Study|Lost to Follow-up|2
220345|NCT00132132|727703|P1|Overall Study|Lost to Follow-up|7
220346|NCT00132028|727711|P1|Overall Study|Physician Decision|3
220347|NCT00132028|727711|P1|Overall Study|not eligible|2
220348|NCT00132028|727711|P1|Overall Study|Withdrawal by Subject|2
220349|NCT00132028|727711|P1|Overall Study|Lack of Efficacy|11
220350|NCT00132028|727711|P1|Overall Study|Death|2
220351|NCT00132028|727711|P1|Overall Study|Adverse Event|7
220352|NCT00131937|727723|P1|Overall Study|Alternative therapy|1
220353|NCT00131937|727723|P1|Overall Study|Disease Progression|7
220354|NCT00131937|727723|P1|Overall Study|Physician Decision|1
220355|NCT00131937|727723|P1|Overall Study|Withdrawal by Subject|2
220356|NCT00131937|727723|P1|Overall Study|Adverse Event|3
220357|NCT00131911|727731|P2|Overall Study|Withdrawal by Subject|0
220358|NCT00131911|727732|P1|Overall Study|Withdrawal by Subject|1
220359|NCT00131664|727802|P6|Second Period (Additional Drug Added)|Administrative reasons|0
220360|NCT00131664|727803|P5|Second Period (Additional Drug Added)|Administrative reasons|1
220361|NCT00131664|727804|P4|Second Period (Additional Drug Added)|Administrative reasons|0
220362|NCT00131664|727805|P3|Second Period (Additional Drug Added)|Administrative reasons|0
220363|NCT00131664|727806|P2|Second Period (Additional Drug Added)|Administrative reasons|2
220364|NCT00131664|727807|P1|Second Period (Additional Drug Added)|Administrative reasons|4
220365|NCT00131664|727802|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
220366|NCT00131664|727803|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
220367|NCT00131664|727804|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
220368|NCT00131664|727805|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
220369|NCT00131664|727806|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
220370|NCT00131664|727807|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
220371|NCT00131664|727802|P6|Second Period (Additional Drug Added)|Adverse Event|1
220372|NCT00131664|727803|P5|Second Period (Additional Drug Added)|Adverse Event|0
220373|NCT00131664|727804|P4|Second Period (Additional Drug Added)|Adverse Event|0
220374|NCT00131664|727805|P3|Second Period (Additional Drug Added)|Adverse Event|0
220375|NCT00131664|727806|P2|Second Period (Additional Drug Added)|Adverse Event|1
220376|NCT00131664|727807|P1|Second Period (Additional Drug Added)|Adverse Event|0
220377|NCT00131664|727802|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
220378|NCT00131664|727803|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
220379|NCT00131664|727804|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
220380|NCT00131664|727805|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
220381|NCT00131664|727806|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
220382|NCT00131664|727807|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
220383|NCT00131664|727802|P6|Second Period (Additional Drug Added)|Protocol Violation|0
220384|NCT00131664|727803|P5|Second Period (Additional Drug Added)|Protocol Violation|0
220385|NCT00131664|727804|P4|Second Period (Additional Drug Added)|Protocol Violation|0
220386|NCT00131664|727805|P3|Second Period (Additional Drug Added)|Protocol Violation|1
220387|NCT00131664|727806|P2|Second Period (Additional Drug Added)|Protocol Violation|1
220388|NCT00131664|727807|P1|Second Period (Additional Drug Added)|Protocol Violation|0
220389|NCT00131664|727802|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
220390|NCT00131664|727803|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
220391|NCT00131664|727804|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
220392|NCT00131664|727805|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
220393|NCT00131664|727806|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
220394|NCT00131664|727807|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
220395|NCT00131664|727802|P6|First Period (First 6 Months)|Administrative reasons|0
220396|NCT00131664|727803|P5|First Period (First 6 Months)|Administrative reasons|0
220397|NCT00131664|727804|P4|First Period (First 6 Months)|Administrative reasons|0
220398|NCT00131664|727805|P3|First Period (First 6 Months)|Administrative reasons|5
220399|NCT00131664|727806|P2|First Period (First 6 Months)|Administrative reasons|0
220400|NCT00131664|727807|P1|First Period (First 6 Months)|Administrative reasons|2
220401|NCT00131664|727802|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
220402|NCT00131664|727803|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
220403|NCT00131664|727804|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
220404|NCT00131664|727805|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
220405|NCT00131664|727806|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
220406|NCT00131664|727807|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
220407|NCT00131664|727802|P6|First Period (First 6 Months)|Adverse Event|0
220408|NCT00131664|727803|P5|First Period (First 6 Months)|Adverse Event|0
220409|NCT00131664|727804|P4|First Period (First 6 Months)|Adverse Event|0
220410|NCT00131664|727805|P3|First Period (First 6 Months)|Adverse Event|5
220411|NCT00131664|727806|P2|First Period (First 6 Months)|Adverse Event|4
220412|NCT00131664|727807|P1|First Period (First 6 Months)|Adverse Event|9
220413|NCT00131664|727802|P6|First Period (First 6 Months)|Withdrawal by Subject|0
220414|NCT00131664|727803|P5|First Period (First 6 Months)|Withdrawal by Subject|0
220415|NCT00131664|727804|P4|First Period (First 6 Months)|Withdrawal by Subject|0
220416|NCT00131664|727805|P3|First Period (First 6 Months)|Withdrawal by Subject|2
220417|NCT00131664|727806|P2|First Period (First 6 Months)|Withdrawal by Subject|6
220418|NCT00131664|727807|P1|First Period (First 6 Months)|Withdrawal by Subject|4
220419|NCT00131664|727802|P6|First Period (First 6 Months)|Protocol Violation|0
220420|NCT00131664|727803|P5|First Period (First 6 Months)|Protocol Violation|0
220421|NCT00131664|727804|P4|First Period (First 6 Months)|Protocol Violation|0
220422|NCT00131664|727805|P3|First Period (First 6 Months)|Protocol Violation|1
220423|NCT00131664|727806|P2|First Period (First 6 Months)|Protocol Violation|2
220424|NCT00131664|727807|P1|First Period (First 6 Months)|Protocol Violation|2
220425|NCT00131664|727802|P6|First Period (First 6 Months)|Death|0
220426|NCT00131664|727803|P5|First Period (First 6 Months)|Death|0
220427|NCT00131664|727804|P4|First Period (First 6 Months)|Death|0
220428|NCT00131664|727805|P3|First Period (First 6 Months)|Death|0
220429|NCT00131664|727806|P2|First Period (First 6 Months)|Death|1
220430|NCT00131664|727807|P1|First Period (First 6 Months)|Death|0
220431|NCT00131664|727802|P6|First Period (First 6 Months)|Lost to Follow-up|0
220432|NCT00131664|727803|P5|First Period (First 6 Months)|Lost to Follow-up|0
220433|NCT00131664|727804|P4|First Period (First 6 Months)|Lost to Follow-up|0
220434|NCT00131664|727805|P3|First Period (First 6 Months)|Lost to Follow-up|3
220435|NCT00131664|727806|P2|First Period (First 6 Months)|Lost to Follow-up|3
220436|NCT00131664|727807|P1|First Period (First 6 Months)|Lost to Follow-up|7
220437|NCT00131508|727879|P2|Overall Study|Withdrawal by Subject|2
220438|NCT00131508|727880|P1|Overall Study|Withdrawal by Subject|1
220439|NCT00131508|727879|P2|Overall Study|Non-Compliance|4
220440|NCT00131508|727880|P1|Overall Study|Non-Compliance|2
220441|NCT00131508|727879|P2|Overall Study|Disease progression|2
220442|NCT00131508|727880|P1|Overall Study|Disease progression|0
220443|NCT00131352|727942|P2|Repeat Treatment Period|Other|0
220444|NCT00131352|727943|P1|Repeat Treatment Period|Other|1
220445|NCT00131352|727942|P2|Repeat Treatment Period|Adverse Event|0
220446|NCT00131352|727943|P1|Repeat Treatment Period|Adverse Event|1
220447|NCT00131352|727942|P2|Initial Treatment Period|Other|2
220448|NCT00131352|727943|P1|Initial Treatment Period|Other|0
220449|NCT00131352|727942|P2|Initial Treatment Period|Lack of Efficacy|4
220450|NCT00131352|727943|P1|Initial Treatment Period|Lack of Efficacy|6
220451|NCT00131352|727942|P2|Initial Treatment Period|Withdrawal by Subject|1
220452|NCT00131352|727943|P1|Initial Treatment Period|Withdrawal by Subject|1
220453|NCT00131352|727942|P2|Initial Treatment Period|Non-compliant|2
220454|NCT00131352|727943|P1|Initial Treatment Period|Non-compliant|1
220455|NCT00131352|727942|P2|Initial Treatment Period|Adverse Event|3
220456|NCT00131352|727943|P1|Initial Treatment Period|Adverse Event|1
220457|NCT00131248|727965|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
220458|NCT00131248|727966|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
220459|NCT00130832|727983|P2|Overall Study|Other|3
220460|NCT00130832|727984|P1|Overall Study|Other|0
220461|NCT00130832|727983|P2|Overall Study|Moved|2
220462|NCT00130832|727984|P1|Overall Study|Moved|2
220463|NCT00130832|727983|P2|Overall Study|Withdrawal by Subject|1
220464|NCT00130832|727984|P1|Overall Study|Withdrawal by Subject|6
220465|NCT00130832|727983|P2|Overall Study|Protocol Violation|8
220466|NCT00130832|727984|P1|Overall Study|Protocol Violation|6
220467|NCT00130832|727983|P2|Overall Study|Lost to Follow-up|2
220468|NCT00130832|727984|P1|Overall Study|Lost to Follow-up|1
220469|NCT00130832|727983|P2|Overall Study|Adverse Event|1
220470|NCT00130832|727984|P1|Overall Study|Adverse Event|1
220471|NCT00130793|727996|P2|Overall Study|Withdrew consent|0
220472|NCT00130793|727997|P1|Overall Study|Withdrew consent|2
220473|NCT00130793|727996|P2|Overall Study|Lost to Follow-up|4
220474|NCT00130793|727997|P1|Overall Study|Lost to Follow-up|1
220475|NCT00130728|728018|P2|Overall Study|Withdrawal by Subject|2
220476|NCT00130728|728019|P1|Overall Study|Withdrawal by Subject|0
220477|NCT00130728|728018|P2|Overall Study|Lost to Follow-up|0
220478|NCT00130728|728019|P1|Overall Study|Lost to Follow-up|4
220479|NCT00130728|728018|P2|Overall Study|Death|211
220480|NCT00130728|728019|P1|Overall Study|Death|207
220481|NCT00130689|728031|P1|Overall Study|Ineligible|6
220482|NCT00130689|728031|P1|Overall Study|Withdrawal by Subject|3
220483|NCT00130689|728031|P1|Overall Study|Clinical Deterioration|4
220484|NCT00130689|728031|P1|Overall Study|Death|1
220485|NCT00130689|728031|P1|Overall Study|Progressive Disease|29
220486|NCT00130637|728035|P1|Overall Study|Withdrawal by Subject|1
220487|NCT00130637|728035|P1|Overall Study|Adverse Event|2
220488|NCT00130520|728040|P1|Overall Study|Did not meet re-treatment criteria|1
220489|NCT00130520|728040|P1|Overall Study|Protocol non-compliance|1
220490|NCT00130520|728040|P1|Overall Study|Disease Progression|23
220491|NCT00130520|728040|P1|Overall Study|Withdrawal by Subject|1
220492|NCT00130520|728040|P1|Overall Study|Physician Decision|1
220493|NCT00130520|728040|P1|Overall Study|Death|1
220494|NCT00130520|728040|P1|Overall Study|Adverse Event|11
220495|NCT00130286|728050|P4|Overall Study|Missing lab specimens|0
220496|NCT00130286|728051|P3|Overall Study|Missing lab specimens|0
220497|NCT00130286|728052|P2|Overall Study|Missing lab specimens|2
220498|NCT00130286|728053|P1|Overall Study|Missing lab specimens|0
220499|NCT00130286|728050|P4|Overall Study|Adverse Event|0
220500|NCT00130286|728051|P3|Overall Study|Adverse Event|2
220501|NCT00130286|728052|P2|Overall Study|Adverse Event|0
220502|NCT00130286|728053|P1|Overall Study|Adverse Event|0
220503|NCT00130286|728050|P4|Overall Study|Withdrawal by Subject|2
220504|NCT00130286|728051|P3|Overall Study|Withdrawal by Subject|2
220505|NCT00130286|728052|P2|Overall Study|Withdrawal by Subject|1
220506|NCT00130286|728053|P1|Overall Study|Withdrawal by Subject|0
220507|NCT00130247|728073|P2|Overall Study|Not compliant with DOT|2
220508|NCT00130247|728074|P1|Overall Study|Not compliant with DOT|0
220509|NCT00130247|728073|P2|Overall Study|Post-randomization exclusion|2
220510|NCT00130247|728074|P1|Overall Study|Post-randomization exclusion|1
220511|NCT00130247|728073|P2|Overall Study|Pregnancy|0
220512|NCT00130247|728074|P1|Overall Study|Pregnancy|1
220513|NCT00130208|728092|P2|Washout Period (8 Weeks)|Other|1
220514|NCT00130208|728093|P1|Washout Period (8 Weeks)|Other|1
220515|NCT00130208|728092|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
220516|NCT00130208|728093|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
220517|NCT00130208|728092|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
220518|NCT00130208|728093|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
220519|NCT00130208|728092|P2|Washout Period (8 Weeks)|Adverse Event|6
220520|NCT00130208|728093|P1|Washout Period (8 Weeks)|Adverse Event|3
220521|NCT00130208|728092|P2|Maintenance Period (26 Weeks)|Other|1
220522|NCT00130208|728093|P1|Maintenance Period (26 Weeks)|Other|1
220523|NCT00130208|728092|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
220524|NCT00130208|728093|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
220525|NCT00130208|728092|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
220526|NCT00130208|728093|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
220527|NCT00130208|728092|P2|Maintenance Period (26 Weeks)|Physician Decision|2
220528|NCT00130208|728093|P1|Maintenance Period (26 Weeks)|Physician Decision|0
220529|NCT00130208|728092|P2|Maintenance Period (26 Weeks)|Adverse Event|12
220530|NCT00130208|728093|P1|Maintenance Period (26 Weeks)|Adverse Event|10
220531|NCT00130039|728129|P2|Overall Study|clinical events without follow up MRI|4
220532|NCT00130039|728130|P1|Overall Study|clinical events without follow up MRI|5
220533|NCT00130039|728129|P2|Overall Study|Physician Decision|0
220534|NCT00130039|728130|P1|Overall Study|Physician Decision|3
220535|NCT00130039|728129|P2|Overall Study|Adverse Event|2
220536|NCT00130039|728130|P1|Overall Study|Adverse Event|4
220537|NCT00130039|728129|P2|Overall Study|Lost to Follow-up|1
220538|NCT00130039|728130|P1|Overall Study|Lost to Follow-up|3
220539|NCT00130039|728129|P2|Overall Study|Withdrawal by Subject|11
220540|NCT00130039|728130|P1|Overall Study|Withdrawal by Subject|15
220541|NCT00129974|728146|P1|Overall Study|Other|1
220542|NCT00129961|728153|P2|Overall Study|Missing Record|1
220543|NCT00129961|728154|P1|Overall Study|Missing Record|0
220544|NCT00129961|728153|P2|Overall Study|Withdrawal by Subject|1
220545|NCT00129961|728154|P1|Overall Study|Withdrawal by Subject|2
220546|NCT00129961|728153|P2|Overall Study|Physician Decision|0
220547|NCT00129961|728154|P1|Overall Study|Physician Decision|1
220548|NCT00129961|728153|P2|Overall Study|Withdrawal by Sponsor|20
220549|NCT00129961|728154|P1|Overall Study|Withdrawal by Sponsor|14
220550|NCT00129961|728153|P2|Overall Study|Death|1
220551|NCT00129961|728154|P1|Overall Study|Death|1
220552|NCT00129961|728153|P2|Overall Study|Adverse Event|0
220553|NCT00129961|728154|P1|Overall Study|Adverse Event|1
220554|NCT00129766|728190|P2|Overall Study|Lost to Follow-up|21
220555|NCT00129766|728191|P1|Overall Study|Lost to Follow-up|26
220556|NCT00129766|728190|P2|Overall Study|Withdrawal of consent|30
220557|NCT00129766|728191|P1|Overall Study|Withdrawal of consent|31
220558|NCT00129766|728190|P2|Overall Study|Death|8
220559|NCT00129766|728191|P1|Overall Study|Death|3
220560|NCT00129623|728237|P2|Overall Study|Uncertainty to return|1
220561|NCT00129623|728238|P1|Overall Study|Uncertainty to return|0
220562|NCT00129623|728237|P2|Overall Study|Relocated job out of state|0
220563|NCT00129623|728238|P1|Overall Study|Relocated job out of state|1
220564|NCT00129623|728237|P2|Overall Study|Failure to Return|1
220565|NCT00129623|728238|P1|Overall Study|Failure to Return|1
220566|NCT00129623|728237|P2|Overall Study|Refused Treatment|3
220567|NCT00129623|728238|P1|Overall Study|Refused Treatment|5
220568|NCT00129623|728237|P2|Overall Study|Adverse Event|7
220569|NCT00129623|728238|P1|Overall Study|Adverse Event|3
220570|NCT00129545|728263|P3|Overall Study|Device not implanted|0
220571|NCT00129545|728264|P2|Overall Study|Device not implanted|61
220572|NCT00129545|728265|P1|Overall Study|Device not implanted|16
220573|NCT00129545|728263|P3|Overall Study|Physician Decision|10
220574|NCT00129545|728264|P2|Overall Study|Physician Decision|3
220575|NCT00129545|728265|P1|Overall Study|Physician Decision|0
220576|NCT00129545|728263|P3|Overall Study|Lost to Follow-up|13
220577|NCT00129545|728264|P2|Overall Study|Lost to Follow-up|22
220578|NCT00129545|728265|P1|Overall Study|Lost to Follow-up|2
220579|NCT00129545|728263|P3|Overall Study|Withdrawal by Subject|44
220580|NCT00129545|728264|P2|Overall Study|Withdrawal by Subject|18
220581|NCT00129545|728265|P1|Overall Study|Withdrawal by Subject|3
220582|NCT00129545|728263|P3|Overall Study|Death|44
220583|NCT00129545|728264|P2|Overall Study|Death|60
220584|NCT00129545|728265|P1|Overall Study|Death|5
220585|NCT00129467|728286|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
220586|NCT00129467|728287|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
220587|NCT00129467|728286|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
220588|NCT00129467|728287|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
220589|NCT00129467|728286|P2|Received Intervention|Dizzyness, fatigue|1
220590|NCT00129467|728287|P1|Received Intervention|Dizzyness, fatigue|0
220591|NCT00129467|728286|P2|Received Intervention|Intolerance to citalopram|1
220592|NCT00129467|728287|P1|Received Intervention|Intolerance to citalopram|0
220593|NCT00129467|728286|P2|Received Intervention|Nausea|0
220594|NCT00129467|728287|P1|Received Intervention|Nausea|1
220595|NCT00129467|728286|P2|Received Intervention|Withdrawal by Subject|0
220596|NCT00129467|728287|P1|Received Intervention|Withdrawal by Subject|1
220597|NCT00129467|728286|P2|Received Intervention|Delirium|0
220598|NCT00129467|728287|P1|Received Intervention|Delirium|2
220599|NCT00129467|728286|P2|Received Intervention|Cardiac SAE (hypertension)|1
220600|NCT00129467|728287|P1|Received Intervention|Cardiac SAE (hypertension)|1
220601|NCT00129467|728286|P2|Received Intervention|Death|1
220602|NCT00129467|728287|P1|Received Intervention|Death|1
220603|NCT00129402|728318|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
220604|NCT00129402|728319|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
220605|NCT00129402|728320|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
220606|NCT00129402|728321|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
220607|NCT00129402|728322|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
220608|NCT00129402|728323|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
220609|NCT00129402|728324|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
220610|NCT00129402|728318|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
220611|NCT00129402|728319|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
220612|NCT00129402|728320|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
220613|NCT00129402|728321|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
220614|NCT00129402|728322|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
220615|NCT00129402|728323|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
220616|NCT00129402|728324|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
220617|NCT00129402|728318|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
220618|NCT00129402|728319|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
220619|NCT00129402|728320|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
220620|NCT00129402|728321|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
220621|NCT00129402|728322|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
220622|NCT00129402|728323|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
220623|NCT00129402|728324|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
220624|NCT00129402|728318|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
220625|NCT00129402|728319|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
220626|NCT00129402|728320|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
220627|NCT00129402|728321|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
220628|NCT00129402|728322|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
220629|NCT00129402|728323|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
220630|NCT00129402|728324|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
220631|NCT00129402|728318|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
220632|NCT00129402|728319|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
220633|NCT00129402|728320|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
220634|NCT00129402|728321|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
220635|NCT00129402|728322|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
220636|NCT00129402|728323|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
220637|NCT00129402|728324|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
220638|NCT00129402|728318|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
220639|NCT00129402|728319|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
220640|NCT00129402|728320|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
220641|NCT00129402|728321|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
220642|NCT00129402|728322|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
220643|NCT00129402|728323|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
220644|NCT00129402|728324|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
220645|NCT00129402|728318|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
220646|NCT00129402|728319|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
220647|NCT00129402|728320|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
220648|NCT00129402|728321|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
220649|NCT00129402|728322|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
220650|NCT00129402|728323|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
220651|NCT00129402|728324|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
220652|NCT00129402|728318|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
220653|NCT00129402|728319|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
220654|NCT00129402|728320|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
220655|NCT00129402|728321|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
220656|NCT00129402|728322|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
220657|NCT00129402|728323|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
220658|NCT00129402|728324|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
220659|NCT00129402|728318|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
220660|NCT00129402|728319|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
220661|NCT00129402|728320|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
220662|NCT00129402|728321|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
220741|NCT00129220|728415|P1|Study Period II|Adverse Event|9
220663|NCT00129402|728322|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
220664|NCT00129402|728323|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
220665|NCT00129402|728324|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
220666|NCT00129402|728318|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
220667|NCT00129402|728319|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
220668|NCT00129402|728320|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
220669|NCT00129402|728321|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
220670|NCT00129402|728322|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
220671|NCT00129402|728323|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
220672|NCT00129402|728324|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
220673|NCT00129402|728318|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
220674|NCT00129402|728319|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
220675|NCT00129402|728320|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
220676|NCT00129402|728321|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
220677|NCT00129402|728322|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
220678|NCT00129402|728323|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
220679|NCT00129402|728324|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
220680|NCT00129402|728318|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
220681|NCT00129402|728319|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
220682|NCT00129402|728320|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
220683|NCT00129402|728321|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
220684|NCT00129402|728322|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
220685|NCT00129402|728323|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
220686|NCT00129402|728324|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
220687|NCT00129402|728318|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
220688|NCT00129402|728319|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
220689|NCT00129402|728320|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
220690|NCT00129402|728321|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
220691|NCT00129402|728322|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
220692|NCT00129402|728323|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
220693|NCT00129402|728324|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
220694|NCT00129311|728343|P2|Overall Study|Withdrawal by Subject|19
220695|NCT00129311|728344|P1|Overall Study|Withdrawal by Subject|12
220696|NCT00129272|728373|P2|Overall Study|Withdrawal by Subject|11
220697|NCT00129272|728374|P1|Overall Study|Withdrawal by Subject|5
220698|NCT00129272|728373|P2|Overall Study|Lost to Follow-up|11
220699|NCT00129272|728374|P1|Overall Study|Lost to Follow-up|12
220700|NCT00129259|728384|P2|Overall Study|Only available minimal phone assessments|1
220701|NCT00129259|728385|P1|Overall Study|Only available minimal phone assessments|0
220702|NCT00129259|728384|P2|Overall Study|Withdrawal by Subject|1
220703|NCT00129259|728385|P1|Overall Study|Withdrawal by Subject|2
220704|NCT00129259|728384|P2|Overall Study|Lost to Follow-up|1
220705|NCT00129259|728385|P1|Overall Study|Lost to Follow-up|1
220706|NCT00129220|728413|P3|Study Period III|Reason Not Specified|2
220707|NCT00129220|728414|P2|Study Period III|Reason Not Specified|0
220708|NCT00129220|728415|P1|Study Period III|Reason Not Specified|9
220709|NCT00129220|728413|P3|Study Period III|Sponsor Decision|0
220710|NCT00129220|728414|P2|Study Period III|Sponsor Decision|0
220711|NCT00129220|728415|P1|Study Period III|Sponsor Decision|1
220712|NCT00129220|728413|P3|Study Period III|Withdrawal by Subject|3
220713|NCT00129220|728414|P2|Study Period III|Withdrawal by Subject|0
220714|NCT00129220|728415|P1|Study Period III|Withdrawal by Subject|1
220715|NCT00129220|728413|P3|Study Period III|Protocol Violation|2
220716|NCT00129220|728414|P2|Study Period III|Protocol Violation|1
220717|NCT00129220|728415|P1|Study Period III|Protocol Violation|1
220718|NCT00129220|728413|P3|Study Period III|Adverse Event|3
220719|NCT00129220|728414|P2|Study Period III|Adverse Event|0
220720|NCT00129220|728415|P1|Study Period III|Adverse Event|1
220721|NCT00129220|728413|P3|Study Period II|Reason Not Specified|5
220722|NCT00129220|728414|P2|Study Period II|Reason Not Specified|0
220723|NCT00129220|728415|P1|Study Period II|Reason Not Specified|2
220724|NCT00129220|728413|P3|Study Period II|Withdrawal by Subject|4
220725|NCT00129220|728414|P2|Study Period II|Withdrawal by Subject|3
220726|NCT00129220|728415|P1|Study Period II|Withdrawal by Subject|1
220727|NCT00129220|728413|P3|Study Period II|Physician Decision|0
220728|NCT00129220|728414|P2|Study Period II|Physician Decision|1
220729|NCT00129220|728415|P1|Study Period II|Physician Decision|0
220730|NCT00129220|728413|P3|Study Period II|Protocol Violation|1
220731|NCT00129220|728414|P2|Study Period II|Protocol Violation|2
220732|NCT00129220|728415|P1|Study Period II|Protocol Violation|4
220733|NCT00129220|728413|P3|Study Period II|Entry Criteria Not Met|2
220734|NCT00129220|728414|P2|Study Period II|Entry Criteria Not Met|0
220735|NCT00129220|728415|P1|Study Period II|Entry Criteria Not Met|2
220736|NCT00129220|728413|P3|Study Period II|Lack of Efficacy|28
220737|NCT00129220|728414|P2|Study Period II|Lack of Efficacy|1
220738|NCT00129220|728415|P1|Study Period II|Lack of Efficacy|15
220739|NCT00129220|728413|P3|Study Period II|Adverse Event|7
220740|NCT00129220|728414|P2|Study Period II|Adverse Event|5
220742|NCT00129129|728455|P5|Fourth Dose Phase|Protocol Violation|0
220743|NCT00129129|728456|P4|Fourth Dose Phase|Protocol Violation|1
220744|NCT00129129|728457|P3|Fourth Dose Phase|Protocol Violation|0
220745|NCT00129129|728458|P2|Fourth Dose Phase|Protocol Violation|0
220746|NCT00129129|728459|P1|Fourth Dose Phase|Protocol Violation|0
220747|NCT00129129|728455|P5|Fourth Dose Phase|Other|1
220748|NCT00129129|728456|P4|Fourth Dose Phase|Other|1
220749|NCT00129129|728457|P3|Fourth Dose Phase|Other|0
220750|NCT00129129|728458|P2|Fourth Dose Phase|Other|0
220751|NCT00129129|728459|P1|Fourth Dose Phase|Other|0
220752|NCT00129129|728455|P5|Fourth Dose Phase|Migration from study area|2
220753|NCT00129129|728456|P4|Fourth Dose Phase|Migration from study area|0
220754|NCT00129129|728457|P3|Fourth Dose Phase|Migration from study area|0
220755|NCT00129129|728458|P2|Fourth Dose Phase|Migration from study area|0
220756|NCT00129129|728459|P1|Fourth Dose Phase|Migration from study area|0
220757|NCT00129129|728455|P5|Fourth Dose Phase|Withdrawal by Subject|1
220758|NCT00129129|728456|P4|Fourth Dose Phase|Withdrawal by Subject|0
220759|NCT00129129|728457|P3|Fourth Dose Phase|Withdrawal by Subject|0
220760|NCT00129129|728458|P2|Fourth Dose Phase|Withdrawal by Subject|0
220761|NCT00129129|728459|P1|Fourth Dose Phase|Withdrawal by Subject|0
220762|NCT00129129|728455|P5|Fourth Dose Phase|Lost to Follow-up|2
220763|NCT00129129|728456|P4|Fourth Dose Phase|Lost to Follow-up|2
220764|NCT00129129|728457|P3|Fourth Dose Phase|Lost to Follow-up|0
220765|NCT00129129|728458|P2|Fourth Dose Phase|Lost to Follow-up|0
220766|NCT00129129|728459|P1|Fourth Dose Phase|Lost to Follow-up|4
220767|NCT00129129|728455|P5|Primary Phase|Other|0
220768|NCT00129129|728456|P4|Primary Phase|Other|0
220769|NCT00129129|728457|P3|Primary Phase|Other|0
220770|NCT00129129|728458|P2|Primary Phase|Other|5
220771|NCT00129129|728459|P1|Primary Phase|Other|2
220772|NCT00129129|728455|P5|Primary Phase|Lost to Follow-up|0
220773|NCT00129129|728456|P4|Primary Phase|Lost to Follow-up|0
220774|NCT00129129|728457|P3|Primary Phase|Lost to Follow-up|0
220775|NCT00129129|728458|P2|Primary Phase|Lost to Follow-up|6
220776|NCT00129129|728459|P1|Primary Phase|Lost to Follow-up|8
220777|NCT00129129|728455|P5|Primary Phase|Migration from study area|0
220778|NCT00129129|728456|P4|Primary Phase|Migration from study area|0
220779|NCT00129129|728457|P3|Primary Phase|Migration from study area|0
220780|NCT00129129|728458|P2|Primary Phase|Migration from study area|3
220781|NCT00129129|728459|P1|Primary Phase|Migration from study area|1
220782|NCT00129129|728455|P5|Primary Phase|Withdrawal by Subject|0
220783|NCT00129129|728456|P4|Primary Phase|Withdrawal by Subject|0
220784|NCT00129129|728457|P3|Primary Phase|Withdrawal by Subject|0
220785|NCT00129129|728458|P2|Primary Phase|Withdrawal by Subject|10
220786|NCT00129129|728459|P1|Primary Phase|Withdrawal by Subject|12
220787|NCT00129129|728455|P5|Primary Phase|Adverse Event|0
220788|NCT00129129|728456|P4|Primary Phase|Adverse Event|0
220789|NCT00129129|728457|P3|Primary Phase|Adverse Event|0
220790|NCT00129129|728458|P2|Primary Phase|Adverse Event|1
220791|NCT00129129|728459|P1|Primary Phase|Adverse Event|2
220792|NCT00129116|728666|P5|Booster Phase|Lost to Follow-up|1
220793|NCT00129116|728667|P4|Booster Phase|Lost to Follow-up|0
220794|NCT00129116|728668|P3|Booster Phase|Lost to Follow-up|0
220795|NCT00129116|728669|P2|Booster Phase|Lost to Follow-up|0
220796|NCT00129116|728670|P1|Booster Phase|Lost to Follow-up|2
220797|NCT00129116|728666|P5|Primary Phase|Other|0
220798|NCT00129116|728667|P4|Primary Phase|Other|0
220799|NCT00129116|728668|P3|Primary Phase|Other|1
220800|NCT00129116|728669|P2|Primary Phase|Other|0
220801|NCT00129116|728670|P1|Primary Phase|Other|0
220802|NCT00129116|728666|P5|Primary Phase|Withdrawal by Subject|0
220803|NCT00129116|728667|P4|Primary Phase|Withdrawal by Subject|0
220804|NCT00129116|728668|P3|Primary Phase|Withdrawal by Subject|0
220805|NCT00129116|728669|P2|Primary Phase|Withdrawal by Subject|1
220806|NCT00129116|728670|P1|Primary Phase|Withdrawal by Subject|0
220807|NCT00129116|728666|P5|Primary Phase|Adverse Event|0
220808|NCT00129116|728667|P4|Primary Phase|Adverse Event|0
220809|NCT00129116|728668|P3|Primary Phase|Adverse Event|0
220810|NCT00129116|728669|P2|Primary Phase|Adverse Event|1
220811|NCT00129116|728670|P1|Primary Phase|Adverse Event|1
220812|NCT00129116|728666|P5|Primary Phase|Protocol Violation|0
220813|NCT00129116|728667|P4|Primary Phase|Protocol Violation|0
220814|NCT00129116|728668|P3|Primary Phase|Protocol Violation|0
220815|NCT00129116|728669|P2|Primary Phase|Protocol Violation|1
220816|NCT00129116|728670|P1|Primary Phase|Protocol Violation|0
220817|NCT00129116|728666|P5|Primary Phase|Lost to Follow-up|1
220818|NCT00129116|728667|P4|Primary Phase|Lost to Follow-up|1
220819|NCT00129116|728668|P3|Primary Phase|Lost to Follow-up|0
220820|NCT00129116|728669|P2|Primary Phase|Lost to Follow-up|1
220821|NCT00129116|728670|P1|Primary Phase|Lost to Follow-up|1
220822|NCT00128830|728954|P1|Overall Study|Other|9
220823|NCT00128830|728954|P1|Overall Study|Discontinued or ineligible for study|2
220824|NCT00128830|728954|P1|Overall Study|Non-compliant|4
220825|NCT00128830|728954|P1|Overall Study|Reached a virologic endpoint|29
220826|NCT00128830|728954|P1|Overall Study|Lost to Follow-up|4
220827|NCT00128830|728954|P1|Overall Study|Withdrawal by Subject|14
220828|NCT00128830|728954|P1|Overall Study|Adverse Event|10
220829|NCT00128661|728996|P2|Overall Study|Other|8
220830|NCT00128661|728997|P1|Overall Study|Other|7
220831|NCT00128661|728996|P2|Overall Study|Withdrawal by Subject|232
220832|NCT00128661|728997|P1|Overall Study|Withdrawal by Subject|243
220833|NCT00128661|728996|P2|Overall Study|Lost to Follow-up|7
220834|NCT00128661|728997|P1|Overall Study|Lost to Follow-up|10
220835|NCT00128661|728996|P2|Overall Study|Adverse Event|11
220836|NCT00128661|728997|P1|Overall Study|Adverse Event|14
220837|NCT00128492|729043|P2|Overall Study|Pregnancy|1
220838|NCT00128492|729044|P1|Overall Study|Pregnancy|0
220839|NCT00128492|729043|P2|Overall Study|Withdrawal by Subject|5
220840|NCT00128492|729044|P1|Overall Study|Withdrawal by Subject|3
220841|NCT00128492|729043|P2|Overall Study|Personal or administrative|22
220842|NCT00128492|729044|P1|Overall Study|Personal or administrative|10
220843|NCT00128492|729043|P2|Overall Study|Noncompliance|5
220844|NCT00128492|729044|P1|Overall Study|Noncompliance|0
220845|NCT00128492|729043|P2|Overall Study|Lost to Follow-up|5
220846|NCT00128492|729044|P1|Overall Study|Lost to Follow-up|1
220847|NCT00128492|729043|P2|Overall Study|Death|0
220848|NCT00128492|729044|P1|Overall Study|Death|1
220849|NCT00128492|729043|P2|Overall Study|AE related to study|4
220850|NCT00128492|729044|P1|Overall Study|AE related to study|1
220851|NCT00128492|729043|P2|Overall Study|Study drug intolerance (AE)|8
220852|NCT00128492|729044|P1|Overall Study|Study drug intolerance (AE)|2
220853|NCT00128492|729043|P2|Overall Study|AE unrelated to study|9
220854|NCT00128492|729044|P1|Overall Study|AE unrelated to study|2
220855|NCT00128206|729201|P2|Overall Study|Adverse Event|2
220856|NCT00128206|729202|P1|Overall Study|Adverse Event|0
220857|NCT00128206|729201|P2|Overall Study|Lost to Follow-up|118
220858|NCT00128206|729202|P1|Overall Study|Lost to Follow-up|137
220859|NCT00127933|729494|P2|Overall Study|Randomized but not dosed|0
220860|NCT00127933|729495|P1|Overall Study|Randomized but not dosed|1
220861|NCT00127855|729516|P5|Primary Vaccination Course|Other|1
220862|NCT00127855|729517|P4|Primary Vaccination Course|Other|0
220863|NCT00127855|729518|P3|Primary Vaccination Course|Other|0
220864|NCT00127855|729519|P2|Primary Vaccination Course|Other|0
220865|NCT00127855|729520|P1|Primary Vaccination Course|Other|0
220866|NCT00127855|729516|P5|Primary Vaccination Course|Lost to Follow-up|2
220867|NCT00127855|729517|P4|Primary Vaccination Course|Lost to Follow-up|0
220868|NCT00127855|729518|P3|Primary Vaccination Course|Lost to Follow-up|1
220869|NCT00127855|729519|P2|Primary Vaccination Course|Lost to Follow-up|1
220870|NCT00127855|729520|P1|Primary Vaccination Course|Lost to Follow-up|1
220871|NCT00127855|729516|P5|Primary Vaccination Course|Withdrawal by Subject|1
220872|NCT00127855|729517|P4|Primary Vaccination Course|Withdrawal by Subject|0
220873|NCT00127855|729518|P3|Primary Vaccination Course|Withdrawal by Subject|0
220874|NCT00127855|729519|P2|Primary Vaccination Course|Withdrawal by Subject|0
220875|NCT00127855|729520|P1|Primary Vaccination Course|Withdrawal by Subject|1
220876|NCT00127855|729516|P5|Primary Vaccination Course|Adverse Event|0
220877|NCT00127855|729517|P4|Primary Vaccination Course|Adverse Event|0
220878|NCT00127855|729518|P3|Primary Vaccination Course|Adverse Event|1
220879|NCT00127855|729519|P2|Primary Vaccination Course|Adverse Event|0
220880|NCT00127855|729520|P1|Primary Vaccination Course|Adverse Event|0
220881|NCT00127842|729702|P1|Overall Study|Other|5
220882|NCT00127842|729702|P1|Overall Study|Protocol Violation|1
220883|NCT00127842|729702|P1|Overall Study|Noncompliance|2
220884|NCT00127842|729702|P1|Overall Study|Lack of Efficacy|12
220885|NCT00127842|729702|P1|Overall Study|Lost to Follow-up|1
220886|NCT00127842|729702|P1|Overall Study|Withdrawal by Subject|3
220887|NCT00127842|729702|P1|Overall Study|Adverse Event|15
220888|NCT00127803|729720|P4|Overall Study|Lost to Follow-up|1
220889|NCT00127803|729721|P3|Overall Study|Lost to Follow-up|0
220890|NCT00127803|729722|P2|Overall Study|Lost to Follow-up|0
220891|NCT00127803|729723|P1|Overall Study|Lost to Follow-up|0
220892|NCT00127803|729720|P4|Overall Study|Withdrawal by Subject|0
220893|NCT00127803|729721|P3|Overall Study|Withdrawal by Subject|0
220894|NCT00127803|729722|P2|Overall Study|Withdrawal by Subject|0
220895|NCT00127803|729723|P1|Overall Study|Withdrawal by Subject|1
220896|NCT00127803|729720|P4|Overall Study|Adverse Event|0
220897|NCT00127803|729721|P3|Overall Study|Adverse Event|0
220898|NCT00127803|729722|P2|Overall Study|Adverse Event|0
220899|NCT00127803|729723|P1|Overall Study|Adverse Event|2
220900|NCT00127712|729772|P2|Overall Study|Lack of GI access to continue|0
220901|NCT00127712|729773|P1|Overall Study|Lack of GI access to continue|2
220902|NCT00127712|729772|P2|Overall Study|Adverse Event|0
220903|NCT00127712|729773|P1|Overall Study|Adverse Event|3
220904|NCT00127660|729789|P4|Overall Study|Protocol Violation|0
220905|NCT00127660|729790|P3|Overall Study|Protocol Violation|5
220906|NCT00127660|729791|P2|Overall Study|Protocol Violation|3
220907|NCT00127660|729792|P1|Overall Study|Protocol Violation|3
220908|NCT00127413|729840|P4|Overall Study|Lost to Follow-up|2
220909|NCT00127413|729841|P3|Overall Study|Lost to Follow-up|8
220910|NCT00127413|729842|P2|Overall Study|Lost to Follow-up|4
220911|NCT00127413|729843|P1|Overall Study|Lost to Follow-up|6
220912|NCT00127192|729886|P5|Overall Study|Adverse event in pre-treatment period|0
220913|NCT00127192|729887|P4|Overall Study|Adverse event in pre-treatment period|0
220914|NCT00127192|729888|P3|Overall Study|Adverse event in pre-treatment period|0
220915|NCT00127192|729889|P2|Overall Study|Adverse event in pre-treatment period|0
220916|NCT00127192|729890|P1|Overall Study|Adverse event in pre-treatment period|1
220917|NCT00127192|729886|P5|Overall Study|Withdrawal by Subject|3
220918|NCT00127192|729887|P4|Overall Study|Withdrawal by Subject|0
220919|NCT00127192|729888|P3|Overall Study|Withdrawal by Subject|1
220920|NCT00127192|729889|P2|Overall Study|Withdrawal by Subject|0
220921|NCT00127192|729890|P1|Overall Study|Withdrawal by Subject|0
220922|NCT00127192|729886|P5|Overall Study|Lack of Efficacy|2
220923|NCT00127192|729887|P4|Overall Study|Lack of Efficacy|0
220924|NCT00127192|729888|P3|Overall Study|Lack of Efficacy|0
220925|NCT00127192|729889|P2|Overall Study|Lack of Efficacy|0
220926|NCT00127192|729890|P1|Overall Study|Lack of Efficacy|2
220927|NCT00127192|729886|P5|Overall Study|Adverse Event|0
220928|NCT00127192|729887|P4|Overall Study|Adverse Event|1
220929|NCT00127192|729888|P3|Overall Study|Adverse Event|1
220930|NCT00127192|729889|P2|Overall Study|Adverse Event|1
220931|NCT00127192|729890|P1|Overall Study|Adverse Event|0
220932|NCT00127166|729914|P2|Period II|Patient did not perform Visit 6 exercise|0
220933|NCT00127166|729915|P1|Period II|Patient did not perform Visit 6 exercise|1
220934|NCT00127166|729914|P2|Period II|Withdrawal by Subject|0
220935|NCT00127166|729915|P1|Period II|Withdrawal by Subject|2
220936|NCT00127166|729914|P2|Washout Period|Patient did not meet inclusion criteria|1
220937|NCT00127166|729915|P1|Washout Period|Patient did not meet inclusion criteria|0
220938|NCT00127166|729914|P2|Period I|Patient did not meet inclusion criteria|0
220939|NCT00127166|729915|P1|Period I|Patient did not meet inclusion criteria|1
220940|NCT00127166|729914|P2|Period I|Withdrawal by Subject|0
220941|NCT00127166|729915|P1|Period I|Withdrawal by Subject|2
220942|NCT00127166|729914|P2|Period I|Protocol Violation|2
220943|NCT00127166|729915|P1|Period I|Protocol Violation|0
220944|NCT00127101|729935|P6|Continuation Phase|Withdrawal by Subject|1
220945|NCT00127101|729936|P5|Continuation Phase|Withdrawal by Subject|2
220946|NCT00127101|729937|P4|Continuation Phase|Withdrawal by Subject|0
220947|NCT00127101|729938|P3|Continuation Phase|Withdrawal by Subject|1
220948|NCT00127101|729939|P2|Continuation Phase|Withdrawal by Subject|0
220949|NCT00127101|729940|P1|Continuation Phase|Withdrawal by Subject|0
220950|NCT00127101|729935|P6|Continuation Phase|Lack of Efficacy|1
220951|NCT00127101|729936|P5|Continuation Phase|Lack of Efficacy|0
220952|NCT00127101|729937|P4|Continuation Phase|Lack of Efficacy|0
220953|NCT00127101|729938|P3|Continuation Phase|Lack of Efficacy|0
220954|NCT00127101|729939|P2|Continuation Phase|Lack of Efficacy|0
220955|NCT00127101|729940|P1|Continuation Phase|Lack of Efficacy|0
220956|NCT00127101|729935|P6|Continuation Phase|Adverse Event|1
220957|NCT00127101|729936|P5|Continuation Phase|Adverse Event|1
220958|NCT00127101|729937|P4|Continuation Phase|Adverse Event|0
220959|NCT00127101|729938|P3|Continuation Phase|Adverse Event|0
220960|NCT00127101|729939|P2|Continuation Phase|Adverse Event|0
220961|NCT00127101|729940|P1|Continuation Phase|Adverse Event|0
220962|NCT00127101|729935|P6|Base Protocol|Withdrawal by Subject|1
220963|NCT00127101|729936|P5|Base Protocol|Withdrawal by Subject|0
220964|NCT00127101|729937|P4|Base Protocol|Withdrawal by Subject|0
220965|NCT00127101|729938|P3|Base Protocol|Withdrawal by Subject|1
220966|NCT00127101|729939|P2|Base Protocol|Withdrawal by Subject|2
220967|NCT00127101|729940|P1|Base Protocol|Withdrawal by Subject|1
220968|NCT00127101|729935|P6|Base Protocol|Lack of Efficacy|0
220969|NCT00127101|729936|P5|Base Protocol|Lack of Efficacy|2
220970|NCT00127101|729937|P4|Base Protocol|Lack of Efficacy|0
220971|NCT00127101|729938|P3|Base Protocol|Lack of Efficacy|0
220972|NCT00127101|729939|P2|Base Protocol|Lack of Efficacy|0
220973|NCT00127101|729940|P1|Base Protocol|Lack of Efficacy|1
220974|NCT00127101|729935|P6|Base Protocol|Adverse Event|0
220975|NCT00127101|729936|P5|Base Protocol|Adverse Event|0
220976|NCT00127101|729937|P4|Base Protocol|Adverse Event|0
220977|NCT00127101|729938|P3|Base Protocol|Adverse Event|1
220978|NCT00127101|729939|P2|Base Protocol|Adverse Event|2
220979|NCT00127101|729940|P1|Base Protocol|Adverse Event|0
220980|NCT00127036|729962|P2|Overall Study|Screen Failure|0
220981|NCT00127036|729963|P1|Overall Study|Screen Failure|2
220982|NCT00127036|729962|P2|Overall Study|Insufficient Data for Analysis|11
220983|NCT00127036|729963|P1|Overall Study|Insufficient Data for Analysis|6
220984|NCT00126776|729975|P2|Overall Study|follow up complete on all patients|0
220985|NCT00126776|729976|P1|Overall Study|follow up complete on all patients|0
220986|NCT00126659|730025|P3|Overall Study|Adverse Event|2
220987|NCT00126659|730026|P2|Overall Study|Adverse Event|0
220988|NCT00126659|730027|P1|Overall Study|Adverse Event|0
220989|NCT00126594|730035|P2|Overall Study|Disease Progression|24
220990|NCT00126594|730036|P1|Overall Study|Disease Progression|29
220991|NCT00126594|730035|P2|Overall Study|Non-compliance|1
220992|NCT00126594|730036|P1|Overall Study|Non-compliance|0
220993|NCT00126594|730035|P2|Overall Study|Adverse Event|5
220994|NCT00126594|730036|P1|Overall Study|Adverse Event|7
220995|NCT00126594|730035|P2|Overall Study|Physician Decision|3
220996|NCT00126594|730036|P1|Overall Study|Physician Decision|1
220997|NCT00126594|730035|P2|Overall Study|Withdrawal by Subject|4
220998|NCT00126594|730036|P1|Overall Study|Withdrawal by Subject|0
220999|NCT00126594|730035|P2|Overall Study|Ineligible|0
221000|NCT00126594|730036|P1|Overall Study|Ineligible|2
221001|NCT00126581|730053|P2|Overall Study|Other illness/MD discretion|4
221002|NCT00126581|730054|P1|Overall Study|Other illness/MD discretion|3
221003|NCT00126581|730053|P2|Overall Study|Alternative therapy|3
221004|NCT00126581|730054|P1|Overall Study|Alternative therapy|3
221005|NCT00126581|730053|P2|Overall Study|Withdrawal by Subject|4
221006|NCT00126581|730054|P1|Overall Study|Withdrawal by Subject|1
221007|NCT00126581|730053|P2|Overall Study|Death|2
221008|NCT00126581|730054|P1|Overall Study|Death|3
221009|NCT00126581|730053|P2|Overall Study|Adverse Event|7
221010|NCT00126581|730054|P1|Overall Study|Adverse Event|3
221011|NCT00126568|730074|P1|Overall Study|Death|2
221012|NCT00126555|730081|P1|Overall Study|Progressive Disease|3
221013|NCT00126555|730081|P1|Overall Study|Adverse Event|2
221014|NCT00126555|730081|P1|Overall Study|Withdrawal by Subject|1
221015|NCT00126503|730097|P2|Overall Study|Physician Decision|1
221016|NCT00126503|730098|P1|Overall Study|Physician Decision|2
221017|NCT00126503|730097|P2|Overall Study|non-compliant|0
221018|NCT00126503|730098|P1|Overall Study|non-compliant|1
221019|NCT00126503|730097|P2|Overall Study|Adverse Event|3
221020|NCT00126503|730098|P1|Overall Study|Adverse Event|13
221021|NCT00126503|730097|P2|Overall Study|Death|0
221022|NCT00126503|730098|P1|Overall Study|Death|3
221023|NCT00126503|730097|P2|Overall Study|other complicating disease|1
221024|NCT00126503|730098|P1|Overall Study|other complicating disease|4
221025|NCT00126503|730097|P2|Overall Study|alternative therapy|1
221026|NCT00126503|730098|P1|Overall Study|alternative therapy|1
221027|NCT00126503|730097|P2|Overall Study|Withdrawal by Subject|1
221028|NCT00126503|730098|P1|Overall Study|Withdrawal by Subject|0
221029|NCT00126503|730097|P2|Overall Study|disease progression|14
221030|NCT00126503|730098|P1|Overall Study|disease progression|23
221031|NCT00126490|730110|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
221032|NCT00126438|730120|P2|Overall Study|Withdrawal by Subject|2
221033|NCT00126438|730121|P1|Overall Study|Withdrawal by Subject|3
221034|NCT00126438|730120|P2|Overall Study|Protocol Violation|8
221035|NCT00126438|730121|P1|Overall Study|Protocol Violation|8
221036|NCT00126438|730120|P2|Overall Study|Lost to Follow-up|0
221037|NCT00126438|730121|P1|Overall Study|Lost to Follow-up|22
221038|NCT00126438|730120|P2|Overall Study|Withdrawal due to adverse event|0
221039|NCT00126438|730121|P1|Overall Study|Withdrawal due to adverse event|1
221040|NCT00126425|730129|P2|Overall Study|Other|0
221041|NCT00126425|730130|P1|Overall Study|Other|5
221042|NCT00126425|730129|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
221043|NCT00126425|730130|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
221044|NCT00126425|730129|P2|Overall Study|Adverse Event|0
221045|NCT00126425|730130|P1|Overall Study|Adverse Event|1
221046|NCT00126425|730129|P2|Overall Study|Protocol Violation|6
221047|NCT00126425|730130|P1|Overall Study|Protocol Violation|9
221048|NCT00126425|730129|P2|Overall Study|Lost to Follow-up|4
221049|NCT00126425|730130|P1|Overall Study|Lost to Follow-up|8
221050|NCT00126425|730129|P2|Overall Study|Withdrawal by Subject|1
221051|NCT00126425|730130|P1|Overall Study|Withdrawal by Subject|17
221052|NCT00126191|730138|P2|Overall Study|Death|1
221053|NCT00126191|730139|P1|Overall Study|Death|0
221054|NCT00126191|730138|P2|Overall Study|Physician Decision|1
221055|NCT00126191|730139|P1|Overall Study|Physician Decision|0
221056|NCT00126126|730149|P2|Overall Study|Lost to Follow-up|2
221057|NCT00126126|730150|P1|Overall Study|Lost to Follow-up|0
221058|NCT00125268|730283|P2|Overall Study|Withdrawal by Subject|1
221059|NCT00125268|730284|P1|Overall Study|Withdrawal by Subject|1
221060|NCT00125242|730296|P2|Overall Study|did not qualify|2
221061|NCT00125242|730297|P1|Overall Study|did not qualify|7
221062|NCT00125190|730302|P1|Overall Study|Non-compliance|2
221063|NCT00125190|730302|P1|Overall Study|other|1
221064|NCT00125190|730302|P1|Overall Study|Patient/Parent Decision|7
221065|NCT00125190|730302|P1|Overall Study|Lost to Follow-up|4
221066|NCT00125190|730302|P1|Overall Study|Adverse Event|1
221067|NCT00125164|730320|P4|Overall Study|Withdrawal by Subject|1
221068|NCT00125164|730321|P3|Overall Study|Withdrawal by Subject|1
221069|NCT00125164|730322|P2|Overall Study|Withdrawal by Subject|0
221070|NCT00125164|730323|P1|Overall Study|Withdrawal by Subject|2
221071|NCT00125164|730320|P4|Overall Study|Lost to Follow-up|1
221072|NCT00125164|730321|P3|Overall Study|Lost to Follow-up|1
221073|NCT00125164|730322|P2|Overall Study|Lost to Follow-up|0
221074|NCT00125164|730323|P1|Overall Study|Lost to Follow-up|0
221075|NCT00125164|730320|P4|Overall Study|Adverse Event|4
221076|NCT00125164|730321|P3|Overall Study|Adverse Event|2
221077|NCT00125164|730322|P2|Overall Study|Adverse Event|0
221078|NCT00125164|730323|P1|Overall Study|Adverse Event|0
221079|NCT00125138|730377|P4|Overall Study|Sponsor decision-pt moved to assist care|1
221080|NCT00125138|730378|P3|Overall Study|Sponsor decision-pt moved to assist care|0
221081|NCT00125138|730379|P2|Overall Study|Sponsor decision-pt moved to assist care|0
221082|NCT00125138|730380|P1|Overall Study|Sponsor decision-pt moved to assist care|0
221083|NCT00125138|730377|P4|Overall Study|Lack of Efficacy|1
221084|NCT00125138|730378|P3|Overall Study|Lack of Efficacy|0
221085|NCT00125138|730379|P2|Overall Study|Lack of Efficacy|0
221086|NCT00125138|730380|P1|Overall Study|Lack of Efficacy|0
221087|NCT00125138|730377|P4|Overall Study|Withdrawal by Subject|1
221088|NCT00125138|730378|P3|Overall Study|Withdrawal by Subject|1
221089|NCT00125138|730379|P2|Overall Study|Withdrawal by Subject|3
221090|NCT00125138|730380|P1|Overall Study|Withdrawal by Subject|2
221091|NCT00125138|730377|P4|Overall Study|Adverse Event|2
221092|NCT00125138|730378|P3|Overall Study|Adverse Event|3
221093|NCT00125138|730379|P2|Overall Study|Adverse Event|0
221094|NCT00125138|730380|P1|Overall Study|Adverse Event|1
221095|NCT00124982|730429|P3|Long-term Period|Neurologist Recommendation|1
221096|NCT00124982|730430|P2|Long-term Period|Neurologist Recommendation|0
221097|NCT00124982|730431|P1|Long-term Period|Neurologist Recommendation|0
221098|NCT00124982|730429|P3|Long-term Period|Administrative Reason by Sponsor|1
221099|NCT00124982|730430|P2|Long-term Period|Administrative Reason by Sponsor|0
221100|NCT00124982|730431|P1|Long-term Period|Administrative Reason by Sponsor|0
221101|NCT00124982|730429|P3|Long-term Period|Poor/Non-compliance|2
221102|NCT00124982|730430|P2|Long-term Period|Poor/Non-compliance|0
221103|NCT00124982|730431|P1|Long-term Period|Poor/Non-compliance|0
221104|NCT00124982|730429|P3|Long-term Period|Pregnancy|1
221105|NCT00124982|730430|P2|Long-term Period|Pregnancy|0
221106|NCT00124982|730431|P1|Long-term Period|Pregnancy|0
221107|NCT00124982|730429|P3|Long-term Period|Withdrawal by Subject|16
221108|NCT00124982|730430|P2|Long-term Period|Withdrawal by Subject|0
221109|NCT00124982|730431|P1|Long-term Period|Withdrawal by Subject|0
221110|NCT00124982|730429|P3|Long-term Period|Lost to Follow-up|4
221111|NCT00124982|730430|P2|Long-term Period|Lost to Follow-up|0
221112|NCT00124982|730431|P1|Long-term Period|Lost to Follow-up|0
221113|NCT00124982|730429|P3|Long-term Period|Lack of Efficacy|46
221114|NCT00124982|730430|P2|Long-term Period|Lack of Efficacy|0
221115|NCT00124982|730431|P1|Long-term Period|Lack of Efficacy|0
221116|NCT00124982|730429|P3|Long-term Period|Adverse Event|17
221117|NCT00124982|730430|P2|Long-term Period|Adverse Event|0
221118|NCT00124982|730431|P1|Long-term Period|Adverse Event|0
221119|NCT00124982|730429|P3|Long-term Period|Death|1
221120|NCT00124982|730430|P2|Long-term Period|Death|0
221121|NCT00124982|730431|P1|Long-term Period|Death|0
221122|NCT00124982|730429|P3|Short-term Period|Participant Had Lymphopenia|0
221123|NCT00124982|730430|P2|Short-term Period|Participant Had Lymphopenia|0
221124|NCT00124982|730431|P1|Short-term Period|Participant Had Lymphopenia|1
221125|NCT00124982|730429|P3|Short-term Period|Investigator Decision-No Specific AE|0
221126|NCT00124982|730430|P2|Short-term Period|Investigator Decision-No Specific AE|0
221127|NCT00124982|730431|P1|Short-term Period|Investigator Decision-No Specific AE|1
221128|NCT00124982|730429|P3|Short-term Period|Participant Chose Own Doctor|0
221129|NCT00124982|730430|P2|Short-term Period|Participant Chose Own Doctor|1
221130|NCT00124982|730431|P1|Short-term Period|Participant Chose Own Doctor|0
221131|NCT00124982|730429|P3|Short-term Period|Participant Decision|0
221132|NCT00124982|730430|P2|Short-term Period|Participant Decision|0
221133|NCT00124982|730431|P1|Short-term Period|Participant Decision|1
221134|NCT00124982|730429|P3|Short-term Period|No Longer Meets Study Criteria|0
221135|NCT00124982|730430|P2|Short-term Period|No Longer Meets Study Criteria|2
221136|NCT00124982|730431|P1|Short-term Period|No Longer Meets Study Criteria|1
221137|NCT00124982|730429|P3|Short-term Period|Poor/Non-compliance|0
221138|NCT00124982|730430|P2|Short-term Period|Poor/Non-compliance|1
221139|NCT00124982|730431|P1|Short-term Period|Poor/Non-compliance|3
221140|NCT00124982|730429|P3|Short-term Period|Withdrawal of Consent|0
221141|NCT00124982|730430|P2|Short-term Period|Withdrawal of Consent|9
221142|NCT00124982|730431|P1|Short-term Period|Withdrawal of Consent|7
221143|NCT00124982|730429|P3|Short-term Period|Lost to Follow-up|0
221144|NCT00124982|730430|P2|Short-term Period|Lost to Follow-up|5
221145|NCT00124982|730431|P1|Short-term Period|Lost to Follow-up|8
221146|NCT00124982|730429|P3|Short-term Period|Lack of Efficacy|0
221147|NCT00124982|730430|P2|Short-term Period|Lack of Efficacy|73
221148|NCT00124982|730431|P1|Short-term Period|Lack of Efficacy|32
221149|NCT00124982|730429|P3|Short-term Period|Adverse Event|0
221150|NCT00124982|730430|P2|Short-term Period|Adverse Event|22
221151|NCT00124982|730431|P1|Short-term Period|Adverse Event|17
221152|NCT00124982|730429|P3|Short-term Period|Death|0
221153|NCT00124982|730430|P2|Short-term Period|Death|1
221154|NCT00124982|730431|P1|Short-term Period|Death|1
221155|NCT00124943|730513|P4|Phase II|Withdrawal by Subject|2
221156|NCT00124943|730514|P3|Phase II|Withdrawal by Subject|0
221157|NCT00124943|730515|P2|Phase II|Withdrawal by Subject|0
221158|NCT00124943|730516|P1|Phase II|Withdrawal by Subject|0
221159|NCT00124943|730513|P4|Phase II|Lost to Follow-up|1
221160|NCT00124943|730514|P3|Phase II|Lost to Follow-up|0
221161|NCT00124943|730515|P2|Phase II|Lost to Follow-up|0
221162|NCT00124943|730516|P1|Phase II|Lost to Follow-up|0
221163|NCT00124943|730513|P4|Phase II|Protocol Violation|1
221164|NCT00124943|730514|P3|Phase II|Protocol Violation|0
221165|NCT00124943|730515|P2|Phase II|Protocol Violation|0
221166|NCT00124943|730516|P1|Phase II|Protocol Violation|0
221167|NCT00124943|730513|P4|Phase II|Adverse Event|1
221168|NCT00124943|730514|P3|Phase II|Adverse Event|0
221169|NCT00124943|730515|P2|Phase II|Adverse Event|2
221170|NCT00124943|730516|P1|Phase II|Adverse Event|0
221171|NCT00124748|730556|P2|Overall Study|Death|3
221172|NCT00124748|730557|P1|Overall Study|Death|1
221173|NCT00124748|730556|P2|Overall Study|Administrative Problem(Study Terminated)|174
221174|NCT00124748|730557|P1|Overall Study|Administrative Problem(Study Terminated)|101
221175|NCT00124748|730556|P2|Overall Study|Lost to Follow-up|7
221176|NCT00124748|730557|P1|Overall Study|Lost to Follow-up|2
221177|NCT00124748|730556|P2|Overall Study|Withdrawal by Subject|15
221178|NCT00124748|730557|P1|Overall Study|Withdrawal by Subject|5
221179|NCT00124748|730556|P2|Overall Study|Protocol Violation|1
221180|NCT00124748|730557|P1|Overall Study|Protocol Violation|3
221181|NCT00124748|730556|P2|Overall Study|No longer requires study drug|1
221182|NCT00124748|730557|P1|Overall Study|No longer requires study drug|1
221183|NCT00124748|730556|P2|Overall Study|Lack of Efficacy|41
221184|NCT00124748|730557|P1|Overall Study|Lack of Efficacy|20
221185|NCT00124748|730556|P2|Overall Study|Abnormal Procedure|1
221186|NCT00124748|730557|P1|Overall Study|Abnormal Procedure|0
221187|NCT00124748|730556|P2|Overall Study|Abnormal laboratory Value|2
221188|NCT00124748|730557|P1|Overall Study|Abnormal laboratory Value|2
221189|NCT00124748|730556|P2|Overall Study|Adverse Event|39
221190|NCT00124748|730557|P1|Overall Study|Adverse Event|8
221191|NCT00124709|730664|P2|Overall Study|Lost to Follow-up|120
221192|NCT00124709|730665|P1|Overall Study|Lost to Follow-up|114
221193|NCT00124709|730664|P2|Overall Study|Withdrawal by Subject|136
221194|NCT00124709|730665|P1|Overall Study|Withdrawal by Subject|127
221195|NCT00124709|730664|P2|Overall Study|Protocol Violation|5
221196|NCT00124709|730665|P1|Overall Study|Protocol Violation|3
221197|NCT00124709|730664|P2|Overall Study|Lack of Efficacy|10
221198|NCT00124709|730665|P1|Overall Study|Lack of Efficacy|5
221199|NCT00124709|730664|P2|Overall Study|Adverse Event|0
221200|NCT00124709|730665|P1|Overall Study|Adverse Event|3
221201|NCT00124709|730664|P2|Overall Study|Randomized but did not take medication|1
221202|NCT00124709|730665|P1|Overall Study|Randomized but did not take medication|3
221203|NCT00124657|730682|P3|Overall Study|Intercurrent illness|0
221204|NCT00124657|730683|P2|Overall Study|Intercurrent illness|0
221205|NCT00124657|730684|P1|Overall Study|Intercurrent illness|1
221206|NCT00124657|730682|P3|Overall Study|Progressive disease|27
221207|NCT00124657|730683|P2|Overall Study|Progressive disease|5
221208|NCT00124657|730684|P1|Overall Study|Progressive disease|14
221209|NCT00124657|730682|P3|Overall Study|Non-compliance|4
221210|NCT00124657|730683|P2|Overall Study|Non-compliance|0
221211|NCT00124657|730684|P1|Overall Study|Non-compliance|1
221212|NCT00124657|730682|P3|Overall Study|Toxicity|1
221213|NCT00124657|730683|P2|Overall Study|Toxicity|0
221214|NCT00124657|730684|P1|Overall Study|Toxicity|0
221215|NCT00124618|730719|P1|Overall Study|Ineligible|1
221216|NCT00124462|730734|P2|Overall Study|Device fitting, n=2, other hlth issues|1
221217|NCT00124462|730735|P1|Overall Study|Device fitting, n=2, other hlth issues|1
221218|NCT00124462|730734|P2|Overall Study|Withdrawal by Subject|5
221219|NCT00124462|730735|P1|Overall Study|Withdrawal by Subject|4
221220|NCT00124462|730734|P2|Overall Study|Physician Decision|4
221221|NCT00124462|730735|P1|Overall Study|Physician Decision|3
221222|NCT00124462|730734|P2|Overall Study|Lost to Follow-up|3
221223|NCT00124462|730735|P1|Overall Study|Lost to Follow-up|3
221224|NCT00124449|730745|P2|18-Month Untreated Observation Period|Relocated|0
221225|NCT00124449|730746|P1|18-Month Untreated Observation Period|Relocated|1
221226|NCT00124449|730745|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
221227|NCT00124449|730746|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
221228|NCT00124449|730745|P2|18-Month Untreated Observation Period|Pregnancy|0
221229|NCT00124449|730746|P1|18-Month Untreated Observation Period|Pregnancy|1
221230|NCT00124449|730745|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
221231|NCT00124449|730746|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
221232|NCT00124449|730745|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
221233|NCT00124449|730746|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
221234|NCT00124449|730745|P2|18-Month Untreated Observation Period|Adverse Event|1
221235|NCT00124449|730746|P1|18-Month Untreated Observation Period|Adverse Event|0
221236|NCT00124449|730745|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
221237|NCT00124449|730746|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
221238|NCT00124449|730745|P2|6-month Double-Blind Treatment Period|Sponsor request|1
221239|NCT00124449|730746|P1|6-month Double-Blind Treatment Period|Sponsor request|0
221240|NCT00124449|730745|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
221241|NCT00124449|730746|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
221242|NCT00124449|730745|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
221243|NCT00124449|730746|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
221244|NCT00124449|730745|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
221245|NCT00124449|730746|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
221246|NCT00124449|730745|P2|6-month Double-Blind Treatment Period|Adverse Event|0
221247|NCT00124449|730746|P1|6-month Double-Blind Treatment Period|Adverse Event|1
221248|NCT00124072|730800|P4|Overall Study|Death|480
221249|NCT00124072|730801|P3|Overall Study|Death|471
221250|NCT00124072|730802|P2|Overall Study|Death|484
221251|NCT00124072|730803|P1|Overall Study|Death|499
221252|NCT00124072|730800|P4|Overall Study|Lost to Follow-up for Morbidity|18
221253|NCT00124072|730801|P3|Overall Study|Lost to Follow-up for Morbidity|19
221254|NCT00124072|730802|P2|Overall Study|Lost to Follow-up for Morbidity|25
221255|NCT00124072|730803|P1|Overall Study|Lost to Follow-up for Morbidity|15
221256|NCT00124072|730800|P4|Overall Study|Lost to Follow-up for Mortality|2
221257|NCT00124072|730801|P3|Overall Study|Lost to Follow-up for Mortality|2
221258|NCT00124072|730802|P2|Overall Study|Lost to Follow-up for Mortality|3
221259|NCT00124072|730803|P1|Overall Study|Lost to Follow-up for Mortality|0
221260|NCT00124020|730815|P2|Overall Study|Transfer to another hospital|0
221261|NCT00124020|730816|P1|Overall Study|Transfer to another hospital|2
221262|NCT00124020|730815|P2|Overall Study|Other|1
221263|NCT00124020|730816|P1|Overall Study|Other|1
221264|NCT00124020|730815|P2|Overall Study|Lost to Follow-up|8
221265|NCT00124020|730816|P1|Overall Study|Lost to Follow-up|5
221266|NCT00124020|730815|P2|Overall Study|Withdrawal by Subject|11
221267|NCT00124020|730816|P1|Overall Study|Withdrawal by Subject|13
221268|NCT00124020|730815|P2|Overall Study|Death|71
221269|NCT00124020|730816|P1|Overall Study|Death|67
221270|NCT00123955|730824|P2|Overall Study|Death|1
221271|NCT00123955|730825|P1|Overall Study|Death|0
221272|NCT00123955|730824|P2|Overall Study|Withdrawal by Subject|3
221273|NCT00123955|730825|P1|Overall Study|Withdrawal by Subject|4
221274|NCT00123955|730824|P2|Overall Study|Adverse Event|0
221275|NCT00123955|730825|P1|Overall Study|Adverse Event|1
221276|NCT00123734|730837|P1|Overall Study|Withdrawal by Subject|1
221277|NCT00123734|730837|P1|Overall Study|Dropout|1
221278|NCT00123734|730837|P1|Overall Study|Lost to Follow-up|3
221279|NCT00123734|730837|P1|Overall Study|Death|3
221280|NCT00123487|730922|P2|Treated With Study Drug|Unknown (case report form lost)|1
221281|NCT00123487|730923|P1|Treated With Study Drug|Unknown (case report form lost)|0
221282|NCT00123487|730922|P2|Treated With Study Drug|Withdrawal by Subject|13
221283|NCT00123487|730923|P1|Treated With Study Drug|Withdrawal by Subject|11
221284|NCT00123487|730922|P2|Treated With Study Drug|Study Drug Toxicity|80
221285|NCT00123487|730923|P1|Treated With Study Drug|Study Drug Toxicity|62
221286|NCT00123487|730922|P2|Treated With Study Drug|Not Specified|58
221287|NCT00123487|730923|P1|Treated With Study Drug|Not Specified|59
221288|NCT00123487|730922|P2|Treated With Study Drug|Physician Decision|9
221289|NCT00123487|730923|P1|Treated With Study Drug|Physician Decision|8
221290|NCT00123487|730922|P2|Treated With Study Drug|Disease Progression|122
221291|NCT00123487|730923|P1|Treated With Study Drug|Disease Progression|141
221292|NCT00123487|730922|P2|Treated With Study Drug|Adverse Event|22
221293|NCT00123487|730923|P1|Treated With Study Drug|Adverse Event|23
221294|NCT00123487|730922|P2|Randomized|SAE prior to starting treatment|0
221295|NCT00123487|730923|P1|Randomized|SAE prior to starting treatment|1
221296|NCT00123487|730922|P2|Randomized|Death prior to starting treatment|1
221297|NCT00123487|730923|P1|Randomized|Death prior to starting treatment|0
221298|NCT00123474|730967|P4|As Treated at Study Closure|Withdrawal by Subject|16
221299|NCT00123474|730968|P3|As Treated at Study Closure|Withdrawal by Subject|18
221300|NCT00123474|730969|P2|As Treated at Study Closure|Withdrawal by Subject|19
221301|NCT00123474|730970|P1|As Treated at Study Closure|Withdrawal by Subject|14
221302|NCT00123474|730967|P4|As Treated at Study Closure|Study Drug Toxicity|51
221303|NCT00123474|730968|P3|As Treated at Study Closure|Study Drug Toxicity|45
221304|NCT00123474|730969|P2|As Treated at Study Closure|Study Drug Toxicity|45
221305|NCT00123474|730970|P1|As Treated at Study Closure|Study Drug Toxicity|39
221306|NCT00123474|730967|P4|As Treated at Study Closure|non-specified|60
221307|NCT00123474|730968|P3|As Treated at Study Closure|non-specified|57
221308|NCT00123474|730969|P2|As Treated at Study Closure|non-specified|47
221309|NCT00123474|730970|P1|As Treated at Study Closure|non-specified|54
221310|NCT00123474|730967|P4|As Treated at Study Closure|Investigator Request|5
221311|NCT00123474|730968|P3|As Treated at Study Closure|Investigator Request|7
221312|NCT00123474|730969|P2|As Treated at Study Closure|Investigator Request|6
221313|NCT00123474|730970|P1|As Treated at Study Closure|Investigator Request|12
221314|NCT00123474|730967|P4|As Treated at Study Closure|Disease Progression|27
221315|NCT00123474|730968|P3|As Treated at Study Closure|Disease Progression|29
221316|NCT00123474|730969|P2|As Treated at Study Closure|Disease Progression|42
221317|NCT00123474|730970|P1|As Treated at Study Closure|Disease Progression|35
221318|NCT00123474|730967|P4|As Treated at Study Closure|Adverse Event|8
221319|NCT00123474|730968|P3|As Treated at Study Closure|Adverse Event|10
221320|NCT00123474|730969|P2|As Treated at Study Closure|Adverse Event|4
221321|NCT00123474|730970|P1|As Treated at Study Closure|Adverse Event|10
221322|NCT00123474|730967|P4|As Treated at Study Closure|not reported when site closed|0
221323|NCT00123474|730968|P3|As Treated at Study Closure|not reported when site closed|1
221324|NCT00123474|730969|P2|As Treated at Study Closure|not reported when site closed|0
221325|NCT00123474|730970|P1|As Treated at Study Closure|not reported when site closed|1
221326|NCT00123474|730967|P4|Randomized to Treatment|Randomized, never treated|1
221327|NCT00123474|730968|P3|Randomized to Treatment|Randomized, never treated|2
221328|NCT00123474|730969|P2|Randomized to Treatment|Randomized, never treated|4
221329|NCT00123474|730970|P1|Randomized to Treatment|Randomized, never treated|1
221330|NCT00123422|731064|P3|Overall Study|Lost to Follow-up|2
221331|NCT00123422|731065|P2|Overall Study|Lost to Follow-up|2
221332|NCT00123422|731066|P1|Overall Study|Lost to Follow-up|1
221333|NCT00123422|731064|P3|Overall Study|Withdrawal by Subject|2
221334|NCT00123422|731065|P2|Overall Study|Withdrawal by Subject|2
221335|NCT00123422|731066|P1|Overall Study|Withdrawal by Subject|1
221336|NCT00123422|731064|P3|Overall Study|Physician Decision|6
221337|NCT00123422|731065|P2|Overall Study|Physician Decision|2
221338|NCT00123422|731066|P1|Overall Study|Physician Decision|2
221339|NCT00122980|731117|P2|Overall Study|Study termination|35
221340|NCT00122980|731118|P1|Overall Study|Study termination|27
221341|NCT00122980|731117|P2|Overall Study|Adjudicated stroke (study endpoint)|0
221342|NCT00122980|731118|P1|Overall Study|Adjudicated stroke (study endpoint)|7
221343|NCT00122980|731117|P2|Overall Study|Withdrawal by Subject|3
221344|NCT00122980|731118|P1|Overall Study|Withdrawal by Subject|2
221345|NCT00122980|731117|P2|Overall Study|Protocol Violation|1
221346|NCT00122980|731118|P1|Overall Study|Protocol Violation|5
221347|NCT00122980|731117|P2|Overall Study|Physician Decision|0
221348|NCT00122980|731118|P1|Overall Study|Physician Decision|2
221349|NCT00122980|731117|P2|Overall Study|Death|1
221350|NCT00122980|731118|P1|Overall Study|Death|0
221351|NCT00122954|731142|P2|Overall Study|Protocol Violation|1
221352|NCT00122954|731143|P1|Overall Study|Protocol Violation|0
221353|NCT00122954|731142|P2|Overall Study|Withdrawal by Subject|2
221354|NCT00122954|731143|P1|Overall Study|Withdrawal by Subject|2
221355|NCT00122681|731153|P2|Overall Study|Personal reasons|147
221356|NCT00122681|731154|P1|Overall Study|Personal reasons|150
221357|NCT00122681|731153|P2|Overall Study|Withdrawal by Subject|251
221358|NCT00122681|731154|P1|Overall Study|Withdrawal by Subject|257
221359|NCT00122681|731153|P2|Overall Study|Protocol Violation|10
221360|NCT00122681|731154|P1|Overall Study|Protocol Violation|7
221361|NCT00122681|731153|P2|Overall Study|Lost to Follow-up|1097
221362|NCT00122681|731154|P1|Overall Study|Lost to Follow-up|1080
221363|NCT00122681|731153|P2|Overall Study|Adverse Event|16
221364|NCT00122681|731154|P1|Overall Study|Adverse Event|20
221365|NCT00122460|731228|P2|Overall Study|investigational study phase ongoing|1
221366|NCT00122460|731229|P1|Overall Study|investigational study phase ongoing|7
221367|NCT00122382|731278|P3|Open-Label Study|Withdrawal of Consent|4
221368|NCT00122382|731279|P2|Open-Label Study|Withdrawal of Consent|0
221369|NCT00122382|731280|P1|Open-Label Study|Withdrawal of Consent|0
221370|NCT00122382|731278|P3|Open-Label Study|Poor/Non-Compliance|1
221371|NCT00122382|731279|P2|Open-Label Study|Poor/Non-Compliance|0
221372|NCT00122382|731280|P1|Open-Label Study|Poor/Non-Compliance|0
221373|NCT00122382|731278|P3|Open-Label Study|Pregnancy|2
221374|NCT00122382|731279|P2|Open-Label Study|Pregnancy|0
221375|NCT00122382|731280|P1|Open-Label Study|Pregnancy|0
221376|NCT00122382|731278|P3|Open-Label Study|Lost to Follow-up|3
221377|NCT00122382|731279|P2|Open-Label Study|Lost to Follow-up|0
221378|NCT00122382|731280|P1|Open-Label Study|Lost to Follow-up|0
221379|NCT00122382|731278|P3|Open-Label Study|Lack of Efficacy|3
221380|NCT00122382|731279|P2|Open-Label Study|Lack of Efficacy|0
221381|NCT00122382|731280|P1|Open-Label Study|Lack of Efficacy|0
221382|NCT00122382|731278|P3|Open-Label Study|Death|2
221383|NCT00122382|731279|P2|Open-Label Study|Death|0
221384|NCT00122382|731280|P1|Open-Label Study|Death|0
221385|NCT00122382|731278|P3|Open-Label Study|Adverse Event|11
221386|NCT00122382|731279|P2|Open-Label Study|Adverse Event|0
221387|NCT00122382|731280|P1|Open-Label Study|Adverse Event|0
221388|NCT00122382|731278|P3|Double-Blind Study|Randomized but not treated|0
221389|NCT00122382|731279|P2|Double-Blind Study|Randomized but not treated|2
221390|NCT00122382|731280|P1|Double-Blind Study|Randomized but not treated|0
221391|NCT00122382|731278|P3|Double-Blind Study|Methotrexate Discontinued|0
221392|NCT00122382|731279|P2|Double-Blind Study|Methotrexate Discontinued|1
221393|NCT00122382|731280|P1|Double-Blind Study|Methotrexate Discontinued|0
221394|NCT00122382|731278|P3|Double-Blind Study|Protocol Violation|0
221395|NCT00122382|731279|P2|Double-Blind Study|Protocol Violation|0
221396|NCT00122382|731280|P1|Double-Blind Study|Protocol Violation|1
221397|NCT00122382|731278|P3|Double-Blind Study|Withdrawal of Consent|0
221398|NCT00122382|731279|P2|Double-Blind Study|Withdrawal of Consent|3
221399|NCT00122382|731280|P1|Double-Blind Study|Withdrawal of Consent|7
221400|NCT00122382|731278|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
221401|NCT00122382|731279|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
221402|NCT00122382|731280|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
221403|NCT00122382|731278|P3|Double-Blind Study|Pregnancy|0
221404|NCT00122382|731279|P2|Double-Blind Study|Pregnancy|0
221405|NCT00122382|731280|P1|Double-Blind Study|Pregnancy|2
221406|NCT00122382|731278|P3|Double-Blind Study|Lost to Follow-up|0
221407|NCT00122382|731279|P2|Double-Blind Study|Lost to Follow-up|1
221408|NCT00122382|731280|P1|Double-Blind Study|Lost to Follow-up|2
221409|NCT00122382|731278|P3|Double-Blind Study|Lack of Efficacy|0
221410|NCT00122382|731279|P2|Double-Blind Study|Lack of Efficacy|8
221411|NCT00122382|731280|P1|Double-Blind Study|Lack of Efficacy|0
221412|NCT00122382|731278|P3|Double-Blind Study|Death|0
221413|NCT00122382|731279|P2|Double-Blind Study|Death|2
221414|NCT00122382|731280|P1|Double-Blind Study|Death|2
221415|NCT00122382|731278|P3|Double-Blind Study|Adverse Event|0
221416|NCT00122382|731279|P2|Double-Blind Study|Adverse Event|11
221417|NCT00122382|731280|P1|Double-Blind Study|Adverse Event|9
221418|NCT00122317|731424|P1|Overall Study|Withdrawal by Subject|1
221419|NCT00122317|731424|P1|Overall Study|patient non-compliance|1
221420|NCT00122317|731424|P1|Overall Study|Physician Decision|2
221421|NCT00122317|731424|P1|Overall Study|Adverse Event|4
221422|NCT00122317|731424|P1|Overall Study|Death|3
221423|NCT00122187|731433|P2|Overall Study|Withdrew because of resource limitations|2
221424|NCT00122187|731434|P1|Overall Study|Withdrew because of resource limitations|2
221425|NCT00122135|731448|P2|Overall Study|Withdrawal by Subject|0
221426|NCT00122135|731449|P1|Overall Study|Withdrawal by Subject|3
221427|NCT00122109|731457|P2|Overall Study|Did not meet criteria|7
221428|NCT00122109|731458|P1|Overall Study|Did not meet criteria|6
221429|NCT00121719|731522|P14|Overall Study|Continuing/ongoing patients|0
221430|NCT00121719|731523|P13|Overall Study|Continuing/ongoing patients|3
221431|NCT00121719|731524|P12|Overall Study|Continuing/ongoing patients|1
221432|NCT00121719|731525|P11|Overall Study|Continuing/ongoing patients|1
221433|NCT00121719|731526|P10|Overall Study|Continuing/ongoing patients|0
221434|NCT00121719|731527|P9|Overall Study|Continuing/ongoing patients|0
221435|NCT00121719|731528|P8|Overall Study|Continuing/ongoing patients|1
221436|NCT00121719|731529|P7|Overall Study|Continuing/ongoing patients|0
221437|NCT00121719|731530|P6|Overall Study|Continuing/ongoing patients|0
221438|NCT00121719|731531|P5|Overall Study|Continuing/ongoing patients|0
221439|NCT00121719|731532|P4|Overall Study|Continuing/ongoing patients|0
221440|NCT00121719|731533|P3|Overall Study|Continuing/ongoing patients|0
221441|NCT00121719|731534|P2|Overall Study|Continuing/ongoing patients|0
221442|NCT00121719|731535|P1|Overall Study|Continuing/ongoing patients|0
221443|NCT00121719|731522|P14|Overall Study|Not specified|1
221444|NCT00121719|731523|P13|Overall Study|Not specified|1
221445|NCT00121719|731524|P12|Overall Study|Not specified|0
221446|NCT00121719|731525|P11|Overall Study|Not specified|0
221447|NCT00121719|731526|P10|Overall Study|Not specified|0
221448|NCT00121719|731527|P9|Overall Study|Not specified|1
221449|NCT00121719|731528|P8|Overall Study|Not specified|0
221450|NCT00121719|731529|P7|Overall Study|Not specified|1
221451|NCT00121719|731530|P6|Overall Study|Not specified|0
221452|NCT00121719|731531|P5|Overall Study|Not specified|0
221453|NCT00121719|731532|P4|Overall Study|Not specified|1
221454|NCT00121719|731533|P3|Overall Study|Not specified|1
221455|NCT00121719|731534|P2|Overall Study|Not specified|0
221456|NCT00121719|731535|P1|Overall Study|Not specified|0
221457|NCT00121719|731522|P14|Overall Study|Physician Decision|0
221458|NCT00121719|731523|P13|Overall Study|Physician Decision|1
221459|NCT00121719|731524|P12|Overall Study|Physician Decision|0
221460|NCT00121719|731525|P11|Overall Study|Physician Decision|0
221461|NCT00121719|731526|P10|Overall Study|Physician Decision|0
221462|NCT00121719|731527|P9|Overall Study|Physician Decision|0
221463|NCT00121719|731528|P8|Overall Study|Physician Decision|0
221464|NCT00121719|731529|P7|Overall Study|Physician Decision|0
221465|NCT00121719|731530|P6|Overall Study|Physician Decision|0
221466|NCT00121719|731531|P5|Overall Study|Physician Decision|0
221467|NCT00121719|731532|P4|Overall Study|Physician Decision|0
221468|NCT00121719|731533|P3|Overall Study|Physician Decision|0
221469|NCT00121719|731534|P2|Overall Study|Physician Decision|1
221470|NCT00121719|731535|P1|Overall Study|Physician Decision|0
221471|NCT00121719|731522|P14|Overall Study|Clinical deterioration|2
221472|NCT00121719|731523|P13|Overall Study|Clinical deterioration|2
221473|NCT00121719|731524|P12|Overall Study|Clinical deterioration|1
221474|NCT00121719|731525|P11|Overall Study|Clinical deterioration|0
221475|NCT00121719|731526|P10|Overall Study|Clinical deterioration|2
221476|NCT00121719|731527|P9|Overall Study|Clinical deterioration|2
221477|NCT00121719|731528|P8|Overall Study|Clinical deterioration|1
221478|NCT00121719|731529|P7|Overall Study|Clinical deterioration|2
221479|NCT00121719|731530|P6|Overall Study|Clinical deterioration|0
221480|NCT00121719|731531|P5|Overall Study|Clinical deterioration|1
221481|NCT00121719|731532|P4|Overall Study|Clinical deterioration|0
221482|NCT00121719|731533|P3|Overall Study|Clinical deterioration|1
221483|NCT00121719|731534|P2|Overall Study|Clinical deterioration|1
221484|NCT00121719|731535|P1|Overall Study|Clinical deterioration|0
221485|NCT00121719|731522|P14|Overall Study|Progressive disease|4
221486|NCT00121719|731523|P13|Overall Study|Progressive disease|13
221487|NCT00121719|731524|P12|Overall Study|Progressive disease|3
221488|NCT00121719|731525|P11|Overall Study|Progressive disease|4
221489|NCT00121719|731526|P10|Overall Study|Progressive disease|1
221490|NCT00121719|731527|P9|Overall Study|Progressive disease|3
221491|NCT00121719|731528|P8|Overall Study|Progressive disease|5
221492|NCT00121719|731529|P7|Overall Study|Progressive disease|7
221493|NCT00121719|731530|P6|Overall Study|Progressive disease|1
221494|NCT00121719|731531|P5|Overall Study|Progressive disease|2
221495|NCT00121719|731532|P4|Overall Study|Progressive disease|2
221496|NCT00121719|731533|P3|Overall Study|Progressive disease|0
221497|NCT00121719|731534|P2|Overall Study|Progressive disease|1
221498|NCT00121719|731535|P1|Overall Study|Progressive disease|2
221499|NCT00121719|731522|P14|Overall Study|Withdrawal by Subject|0
221500|NCT00121719|731523|P13|Overall Study|Withdrawal by Subject|0
221501|NCT00121719|731524|P12|Overall Study|Withdrawal by Subject|0
221502|NCT00121719|731525|P11|Overall Study|Withdrawal by Subject|0
221503|NCT00121719|731526|P10|Overall Study|Withdrawal by Subject|0
221504|NCT00121719|731527|P9|Overall Study|Withdrawal by Subject|0
221505|NCT00121719|731528|P8|Overall Study|Withdrawal by Subject|0
221506|NCT00121719|731529|P7|Overall Study|Withdrawal by Subject|0
221507|NCT00121719|731530|P6|Overall Study|Withdrawal by Subject|0
221508|NCT00121719|731531|P5|Overall Study|Withdrawal by Subject|0
221509|NCT00121719|731532|P4|Overall Study|Withdrawal by Subject|0
221510|NCT00121719|731533|P3|Overall Study|Withdrawal by Subject|0
221511|NCT00121719|731534|P2|Overall Study|Withdrawal by Subject|0
221512|NCT00121719|731535|P1|Overall Study|Withdrawal by Subject|1
221513|NCT00121719|731522|P14|Overall Study|Protocol deviation|0
221514|NCT00121719|731523|P13|Overall Study|Protocol deviation|0
221515|NCT00121719|731524|P12|Overall Study|Protocol deviation|0
221516|NCT00121719|731525|P11|Overall Study|Protocol deviation|0
221517|NCT00121719|731526|P10|Overall Study|Protocol deviation|0
221518|NCT00121719|731527|P9|Overall Study|Protocol deviation|0
221519|NCT00121719|731528|P8|Overall Study|Protocol deviation|0
221520|NCT00121719|731529|P7|Overall Study|Protocol deviation|0
221521|NCT00121719|731530|P6|Overall Study|Protocol deviation|0
221522|NCT00121719|731531|P5|Overall Study|Protocol deviation|0
221523|NCT00121719|731532|P4|Overall Study|Protocol deviation|0
221524|NCT00121719|731533|P3|Overall Study|Protocol deviation|1
221525|NCT00121719|731534|P2|Overall Study|Protocol deviation|0
221526|NCT00121719|731535|P1|Overall Study|Protocol deviation|0
221527|NCT00121719|731522|P14|Overall Study|Abnormal laboratory value|0
221528|NCT00121719|731523|P13|Overall Study|Abnormal laboratory value|1
221529|NCT00121719|731524|P12|Overall Study|Abnormal laboratory value|0
221530|NCT00121719|731525|P11|Overall Study|Abnormal laboratory value|0
221531|NCT00121719|731526|P10|Overall Study|Abnormal laboratory value|0
221532|NCT00121719|731527|P9|Overall Study|Abnormal laboratory value|0
221533|NCT00121719|731528|P8|Overall Study|Abnormal laboratory value|1
221534|NCT00121719|731529|P7|Overall Study|Abnormal laboratory value|0
221535|NCT00121719|731530|P6|Overall Study|Abnormal laboratory value|0
221536|NCT00121719|731531|P5|Overall Study|Abnormal laboratory value|0
221537|NCT00121719|731532|P4|Overall Study|Abnormal laboratory value|0
221538|NCT00121719|731533|P3|Overall Study|Abnormal laboratory value|0
221539|NCT00121719|731534|P2|Overall Study|Abnormal laboratory value|1
221540|NCT00121719|731535|P1|Overall Study|Abnormal laboratory value|1
221541|NCT00121719|731522|P14|Overall Study|Adverse Event|0
221542|NCT00121719|731523|P13|Overall Study|Adverse Event|3
221543|NCT00121719|731524|P12|Overall Study|Adverse Event|0
221544|NCT00121719|731525|P11|Overall Study|Adverse Event|1
221545|NCT00121719|731526|P10|Overall Study|Adverse Event|0
221546|NCT00121719|731527|P9|Overall Study|Adverse Event|0
221547|NCT00121719|731528|P8|Overall Study|Adverse Event|1
221548|NCT00121719|731529|P7|Overall Study|Adverse Event|2
221549|NCT00121719|731530|P6|Overall Study|Adverse Event|2
221550|NCT00121719|731531|P5|Overall Study|Adverse Event|0
221551|NCT00121719|731532|P4|Overall Study|Adverse Event|0
221552|NCT00121719|731533|P3|Overall Study|Adverse Event|1
221553|NCT00121719|731534|P2|Overall Study|Adverse Event|0
221554|NCT00121719|731535|P1|Overall Study|Adverse Event|0
221555|NCT00121667|731712|P4|Short Term (ST) + Long Term (LT) Period|Death|2
221556|NCT00121667|731713|P3|Short Term (ST) + Long Term (LT) Period|Death|0
221557|NCT00121667|731714|P2|Short Term (ST) + Long Term (LT) Period|Death|0
221558|NCT00121667|731715|P1|Short Term (ST) + Long Term (LT) Period|Death|1
221559|NCT00121667|731712|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
221560|NCT00121667|731713|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
221561|NCT00121667|731714|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
221562|NCT00121667|731715|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
221563|NCT00121667|731712|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
221564|NCT00121667|731713|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
221565|NCT00121667|731714|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
221566|NCT00121667|731715|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
221567|NCT00121667|731712|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
221568|NCT00121667|731713|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
221569|NCT00121667|731714|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
221570|NCT00121667|731715|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
221571|NCT00121667|731712|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
221572|NCT00121667|731713|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
221573|NCT00121667|731714|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
221574|NCT00121667|731715|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
221575|NCT00121667|731712|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
221576|NCT00121667|731713|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
221577|NCT00121667|731714|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
221578|NCT00121667|731715|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
221579|NCT00121667|731712|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
221580|NCT00121667|731713|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
221581|NCT00121667|731714|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
221582|NCT00121667|731715|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
221583|NCT00121667|731712|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
221584|NCT00121667|731713|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
221585|NCT00121667|731714|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
221586|NCT00121667|731715|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
221587|NCT00121667|731712|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
221588|NCT00121667|731713|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
221589|NCT00121667|731714|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
221590|NCT00121667|731715|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
221591|NCT00121667|731712|P4|Short Term (ST) Period|Pregnancy|1
221592|NCT00121667|731713|P3|Short Term (ST) Period|Pregnancy|0
221593|NCT00121667|731714|P2|Short Term (ST) Period|Pregnancy|0
221594|NCT00121667|731715|P1|Short Term (ST) Period|Pregnancy|0
221595|NCT00121667|731712|P4|Short Term (ST) Period|Death|1
221596|NCT00121667|731713|P3|Short Term (ST) Period|Death|0
221597|NCT00121667|731714|P2|Short Term (ST) Period|Death|0
221598|NCT00121667|731715|P1|Short Term (ST) Period|Death|0
221599|NCT00121667|731712|P4|Short Term (ST) Period|Other Reason|0
221600|NCT00121667|731713|P3|Short Term (ST) Period|Other Reason|0
221601|NCT00121667|731714|P2|Short Term (ST) Period|Other Reason|0
221602|NCT00121667|731715|P1|Short Term (ST) Period|Other Reason|3
221603|NCT00121667|731712|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
221604|NCT00121667|731713|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
221605|NCT00121667|731714|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
221606|NCT00121667|731715|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
221607|NCT00121667|731712|P4|Short Term (ST) Period|Poor / Non-compliance|2
221608|NCT00121667|731713|P3|Short Term (ST) Period|Poor / Non-compliance|1
221609|NCT00121667|731714|P2|Short Term (ST) Period|Poor / Non-compliance|1
221610|NCT00121667|731715|P1|Short Term (ST) Period|Poor / Non-compliance|0
221611|NCT00121667|731712|P4|Short Term (ST) Period|Lost to Follow-up|3
221612|NCT00121667|731713|P3|Short Term (ST) Period|Lost to Follow-up|4
221613|NCT00121667|731714|P2|Short Term (ST) Period|Lost to Follow-up|4
221614|NCT00121667|731715|P1|Short Term (ST) Period|Lost to Follow-up|3
221615|NCT00121667|731712|P4|Short Term (ST) Period|Adverse Event|3
221616|NCT00121667|731713|P3|Short Term (ST) Period|Adverse Event|5
221617|NCT00121667|731714|P2|Short Term (ST) Period|Adverse Event|6
221618|NCT00121667|731715|P1|Short Term (ST) Period|Adverse Event|5
221619|NCT00121667|731712|P4|Short Term (ST) Period|Subject Withdrew Consent|11
221620|NCT00121667|731713|P3|Short Term (ST) Period|Subject Withdrew Consent|4
221621|NCT00121667|731714|P2|Short Term (ST) Period|Subject Withdrew Consent|13
221622|NCT00121667|731715|P1|Short Term (ST) Period|Subject Withdrew Consent|8
221623|NCT00121667|731712|P4|Short Term (ST) Period|Lack of Efficacy|44
221624|NCT00121667|731713|P3|Short Term (ST) Period|Lack of Efficacy|27
221625|NCT00121667|731714|P2|Short Term (ST) Period|Lack of Efficacy|22
221626|NCT00121667|731715|P1|Short Term (ST) Period|Lack of Efficacy|25
221627|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Other Reason|1
221628|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Other Reason|0
221629|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Other Reason|2
221630|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Other Reason|3
221631|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Other Reason|5
221632|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Missing|0
221633|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Missing|0
221634|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Missing|1
221635|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Missing|0
221636|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Missing|0
221637|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Death|0
221638|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Death|1
221639|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Death|0
221640|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Death|0
221641|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Death|0
221642|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
221643|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
221644|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
221645|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
221646|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
221647|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Pregnancy|0
221648|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Pregnancy|1
221649|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Pregnancy|0
221650|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Pregnancy|1
221651|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Pregnancy|0
221652|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
221653|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
221654|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
221655|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
221656|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
221657|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
221658|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
221659|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
221660|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
221661|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
221662|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
221663|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
221664|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
221665|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
221666|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
221667|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Adverse Event|5
221668|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Adverse Event|5
221669|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Adverse Event|10
221670|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Adverse Event|10
221671|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Adverse Event|9
221672|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
221673|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
221674|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
221675|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
221676|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
221677|NCT00121641|731813|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
221678|NCT00121641|731814|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
221679|NCT00121641|731815|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
221680|NCT00121641|731816|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
221681|NCT00121641|731817|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
221682|NCT00121641|731813|P5|24-week Short-term Treatment Period|Other Reason|0
221683|NCT00121641|731814|P4|24-week Short-term Treatment Period|Other Reason|0
221684|NCT00121641|731815|P3|24-week Short-term Treatment Period|Other Reason|0
221685|NCT00121641|731816|P2|24-week Short-term Treatment Period|Other Reason|0
221686|NCT00121641|731817|P1|24-week Short-term Treatment Period|Other Reason|1
221687|NCT00121641|731813|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
221688|NCT00121641|731814|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
221689|NCT00121641|731815|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
221690|NCT00121641|731816|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
221691|NCT00121641|731817|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
221692|NCT00121641|731813|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
221693|NCT00121641|731814|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
221694|NCT00121641|731815|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
221695|NCT00121641|731816|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
221696|NCT00121641|731817|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
221697|NCT00121641|731813|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
221698|NCT00121641|731814|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
221699|NCT00121641|731815|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
221700|NCT00121641|731816|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
221701|NCT00121641|731817|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
221702|NCT00121641|731813|P5|24-week Short-term Treatment Period|Adverse Event|2
221703|NCT00121641|731814|P4|24-week Short-term Treatment Period|Adverse Event|0
221704|NCT00121641|731815|P3|24-week Short-term Treatment Period|Adverse Event|4
221705|NCT00121641|731816|P2|24-week Short-term Treatment Period|Adverse Event|3
221706|NCT00121641|731817|P1|24-week Short-term Treatment Period|Adverse Event|3
221707|NCT00121641|731813|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
221708|NCT00121641|731814|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
221709|NCT00121641|731815|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
221710|NCT00121641|731816|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
221711|NCT00121641|731817|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
221712|NCT00121641|731813|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
221713|NCT00121641|731814|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
221714|NCT00121641|731815|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
221715|NCT00121641|731816|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
221716|NCT00121641|731817|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
221717|NCT00121485|731930|P2|Overall Study|Crossover|2
221718|NCT00121485|731931|P1|Overall Study|Crossover|0
221719|NCT00121485|731930|P2|Overall Study|Not implanted|5
221720|NCT00121485|731931|P1|Overall Study|Not implanted|1
221721|NCT00121238|731976|P1|Overall Study|Protocol Violation|2
221722|NCT00121238|731976|P1|Overall Study|disease progression before intervention|1
221723|NCT00121199|731988|P1|Overall Study|Ineligible|9
221724|NCT00121199|731988|P1|Overall Study|Other - Not Protocol Specified|3
221725|NCT00121199|731988|P1|Overall Study|Death|3
221726|NCT00121199|731988|P1|Overall Study|Progression/Relapse|1
221727|NCT00121199|731988|P1|Overall Study|Refusal Unrelated to Adverse Event|1
221728|NCT00121199|731988|P1|Overall Study|Adverse Event|11
221729|NCT00121134|732004|P4|Overall Study|Patient Personal Reasons|0
221730|NCT00121134|732005|P3|Overall Study|Patient Personal Reasons|0
221731|NCT00121134|732006|P2|Overall Study|Patient Personal Reasons|1
221732|NCT00121134|732007|P1|Overall Study|Patient Personal Reasons|0
221733|NCT00121134|732004|P4|Overall Study|Intercurrent Illness|1
221734|NCT00121134|732005|P3|Overall Study|Intercurrent Illness|0
221735|NCT00121134|732006|P2|Overall Study|Intercurrent Illness|0
221736|NCT00121134|732007|P1|Overall Study|Intercurrent Illness|0
221737|NCT00121134|732004|P4|Overall Study|Treatment Delay|0
221738|NCT00121134|732005|P3|Overall Study|Treatment Delay|0
221739|NCT00121134|732006|P2|Overall Study|Treatment Delay|0
221740|NCT00121134|732007|P1|Overall Study|Treatment Delay|1
221741|NCT00121134|732004|P4|Overall Study|Physician Decision|1
221742|NCT00121134|732005|P3|Overall Study|Physician Decision|4
221743|NCT00121134|732006|P2|Overall Study|Physician Decision|4
221744|NCT00121134|732007|P1|Overall Study|Physician Decision|6
221745|NCT00121134|732004|P4|Overall Study|Toxicity|5
221746|NCT00121134|732005|P3|Overall Study|Toxicity|13
221747|NCT00121134|732006|P2|Overall Study|Toxicity|7
221748|NCT00121134|732007|P1|Overall Study|Toxicity|4
221749|NCT00121134|732004|P4|Overall Study|Progression of Disease|2
221750|NCT00121134|732005|P3|Overall Study|Progression of Disease|4
221751|NCT00121134|732006|P2|Overall Study|Progression of Disease|3
221752|NCT00121134|732007|P1|Overall Study|Progression of Disease|5
221753|NCT00120874|732019|P2|Overall Study|Death|1
221754|NCT00120874|732020|P1|Overall Study|Death|0
221755|NCT00120627|732058|P2|Overall Study|Withdrawal by Subject|5
221756|NCT00120627|732059|P1|Overall Study|Withdrawal by Subject|5
221757|NCT00120406|732110|P2|Overall Study|patient moved but has not withdrawn|1
221758|NCT00120406|732111|P1|Overall Study|patient moved but has not withdrawn|0
221759|NCT00120406|732110|P2|Overall Study|received non-study stent|2
221760|NCT00120406|732111|P1|Overall Study|received non-study stent|0
221761|NCT00120406|732110|P2|Overall Study|Lost to Follow-up|2
221762|NCT00120406|732111|P1|Overall Study|Lost to Follow-up|5
221763|NCT00120406|732110|P2|Overall Study|Withdrawal by Subject|7
221764|NCT00120406|732111|P1|Overall Study|Withdrawal by Subject|5
221765|NCT00120406|732110|P2|Overall Study|Death|4
221766|NCT00120406|732111|P1|Overall Study|Death|9
221767|NCT00120289|732121|P2|Overall Study|Withdrawal by Subject|13
221768|NCT00120289|732122|P1|Overall Study|Withdrawal by Subject|14
221769|NCT00120289|732121|P2|Overall Study|Lost to Follow-up|14
221770|NCT00120289|732122|P1|Overall Study|Lost to Follow-up|11
221771|NCT00120289|732121|P2|Overall Study|Death|82
221772|NCT00120289|732122|P1|Overall Study|Death|96
221773|NCT00120250|732134|P2|Overall Study|Protocol Violation|1
221774|NCT00120250|732135|P1|Overall Study|Protocol Violation|0
221775|NCT00120250|732134|P2|Overall Study|Lost to Follow-up|1
221776|NCT00120250|732135|P1|Overall Study|Lost to Follow-up|1
221777|NCT00120042|732151|P3|Overall Study|all completed protocl|0
221778|NCT00120042|732152|P2|Overall Study|all completed protocl|0
221779|NCT00120042|732153|P1|Overall Study|all completed protocl|0
221780|NCT00119678|732163|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
221781|NCT00119678|732164|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
221782|NCT00119678|732163|P2|Open-label Treatment Period|Pregnancy|0
221783|NCT00119678|732164|P1|Open-label Treatment Period|Pregnancy|1
221784|NCT00119678|732163|P2|Open-label Treatment Period|Participants not meeting study criteria|0
221785|NCT00119678|732164|P1|Open-label Treatment Period|Participants not meeting study criteria|2
221786|NCT00119678|732163|P2|Open-label Treatment Period|Participant withdrew consent|0
221787|NCT00119678|732164|P1|Open-label Treatment Period|Participant withdrew consent|4
221788|NCT00119678|732163|P2|Open-label Treatment Period|Lost to Follow-up|0
221789|NCT00119678|732164|P1|Open-label Treatment Period|Lost to Follow-up|3
221790|NCT00119678|732163|P2|Open-label Treatment Period|Lack of Efficacy|0
221791|NCT00119678|732164|P1|Open-label Treatment Period|Lack of Efficacy|9
221792|NCT00119678|732163|P2|Open-label Treatment Period|Adverse Event|0
221793|NCT00119678|732164|P1|Open-label Treatment Period|Adverse Event|3
221794|NCT00119678|732163|P2|Open-label Treatment Period|Death|0
221795|NCT00119678|732164|P1|Open-label Treatment Period|Death|1
221796|NCT00119678|732163|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
221797|NCT00119678|732164|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
221798|NCT00119678|732163|P2|Double-blind Treatment Period|Not treated|2
221799|NCT00119678|732164|P1|Double-blind Treatment Period|Not treated|1
221800|NCT00119678|732163|P2|Double-blind Treatment Period|Pregnancy|2
221801|NCT00119678|732164|P1|Double-blind Treatment Period|Pregnancy|0
221802|NCT00119678|732163|P2|Double-blind Treatment Period|Poor/Non-compliance|0
221803|NCT00119678|732164|P1|Double-blind Treatment Period|Poor/Non-compliance|3
221804|NCT00119678|732163|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
221805|NCT00119678|732164|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
221806|NCT00119678|732163|P2|Double-blind Treatment Period|Participant withdrew consent|4
221807|NCT00119678|732164|P1|Double-blind Treatment Period|Participant withdrew consent|4
221808|NCT00119678|732163|P2|Double-blind Treatment Period|Lost to Follow-up|2
221809|NCT00119678|732164|P1|Double-blind Treatment Period|Lost to Follow-up|1
221810|NCT00119678|732163|P2|Double-blind Treatment Period|Lack of Efficacy|12
221811|NCT00119678|732164|P1|Double-blind Treatment Period|Lack of Efficacy|21
221812|NCT00119678|732163|P2|Double-blind Treatment Period|Adverse Event|1
221813|NCT00119678|732164|P1|Double-blind Treatment Period|Adverse Event|7
221814|NCT00119678|732163|P2|Double-blind Treatment Period|Death|0
221815|NCT00119678|732164|P1|Double-blind Treatment Period|Death|1
221816|NCT00119405|732210|P1|Overall Study|Withdrawal by Subject|1
221817|NCT00119379|732224|P2|Overall Study|Adverse Event|1
221818|NCT00119379|732225|P1|Overall Study|Adverse Event|4
221819|NCT00119262|732243|P2|Overall Study|others|5
221820|NCT00119262|732244|P1|Overall Study|others|0
221821|NCT00119262|732243|P2|Overall Study|ineligble|2
221822|NCT00119262|732244|P1|Overall Study|ineligble|1
221823|NCT00119262|732243|P2|Overall Study|other disease|2
221824|NCT00119262|732244|P1|Overall Study|other disease|0
221825|NCT00119262|732243|P2|Overall Study|Adverse Event|35
221826|NCT00119262|732244|P1|Overall Study|Adverse Event|33
221827|NCT00119262|732243|P2|Overall Study|Withdrawal by Subject|11
221828|NCT00119262|732244|P1|Overall Study|Withdrawal by Subject|12
221829|NCT00119262|732243|P2|Overall Study|Lack of Efficacy|3
221830|NCT00119262|732244|P1|Overall Study|Lack of Efficacy|0
221831|NCT00119015|732281|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
221832|NCT00119015|732282|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
221833|NCT00119015|732283|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
221834|NCT00118911|732299|P2|Overall Study|Withdrawal by Subject|5
221835|NCT00118911|732300|P1|Overall Study|Withdrawal by Subject|2
221836|NCT00118898|732312|P4|Overall Study|Not able to get to clinic|40
221837|NCT00118898|732313|P3|Overall Study|Not able to get to clinic|31
221838|NCT00118898|732314|P2|Overall Study|Not able to get to clinic|43
221839|NCT00118898|732315|P1|Overall Study|Not able to get to clinic|34
221840|NCT00118898|732312|P4|Overall Study|Not compliant with requirements|11
221841|NCT00118898|732313|P3|Overall Study|Not compliant with requirements|11
221842|NCT00118898|732314|P2|Overall Study|Not compliant with requirements|13
221843|NCT00118898|732315|P1|Overall Study|Not compliant with requirements|11
221844|NCT00118898|732312|P4|Overall Study|Severe debilitation|4
221845|NCT00118898|732313|P3|Overall Study|Severe debilitation|6
221846|NCT00118898|732314|P2|Overall Study|Severe debilitation|4
221847|NCT00118898|732315|P1|Overall Study|Severe debilitation|1
221848|NCT00118898|732312|P4|Overall Study|Site Closure|37
221849|NCT00118898|732313|P3|Overall Study|Site Closure|28
221850|NCT00118898|732314|P2|Overall Study|Site Closure|31
221851|NCT00118898|732315|P1|Overall Study|Site Closure|33
221852|NCT00118898|732312|P4|Overall Study|Withdrawal by Subject|8
221853|NCT00118898|732313|P3|Overall Study|Withdrawal by Subject|8
221854|NCT00118898|732314|P2|Overall Study|Withdrawal by Subject|5
221855|NCT00118898|732315|P1|Overall Study|Withdrawal by Subject|10
221856|NCT00118898|732312|P4|Overall Study|Lost to Follow-up|33
221857|NCT00118898|732313|P3|Overall Study|Lost to Follow-up|33
221858|NCT00118898|732314|P2|Overall Study|Lost to Follow-up|34
221859|NCT00118898|732315|P1|Overall Study|Lost to Follow-up|26
221860|NCT00118898|732312|P4|Overall Study|Death|8
221861|NCT00118898|732313|P3|Overall Study|Death|6
221862|NCT00118898|732314|P2|Overall Study|Death|11
221863|NCT00118898|732315|P1|Overall Study|Death|6
221864|NCT00118703|732441|P2|Overall Study|Lost to Follow-up|2
221865|NCT00118703|732442|P1|Overall Study|Lost to Follow-up|1
221866|NCT00118703|732441|P2|Overall Study|Withdrawal by Subject|5
221867|NCT00118703|732442|P1|Overall Study|Withdrawal by Subject|2
221868|NCT00118703|732441|P2|Overall Study|Participant took two different treatment|1
221869|NCT00118703|732442|P1|Overall Study|Participant took two different treatment|0
221870|NCT00118703|732441|P2|Overall Study|Adverse Event|1
221871|NCT00118703|732442|P1|Overall Study|Adverse Event|1
221872|NCT00118703|732441|P2|Overall Study|Protocol Violation|0
221873|NCT00118703|732442|P1|Overall Study|Protocol Violation|1
221874|NCT00118482|732539|P2|Overall Study|Withdrawal by Subject|22
221875|NCT00118482|732540|P1|Overall Study|Withdrawal by Subject|23
221876|NCT00118482|732539|P2|Overall Study|Lost to Follow-up|7
221877|NCT00118482|732540|P1|Overall Study|Lost to Follow-up|7
221878|NCT00118430|732551|P3|Overall Study|Lost to Follow-up|28
221879|NCT00118430|732552|P2|Overall Study|Lost to Follow-up|22
221880|NCT00118430|732553|P1|Overall Study|Lost to Follow-up|15
221881|NCT00118430|732551|P3|Overall Study|Withdrawal by Subject|0
221882|NCT00118430|732552|P2|Overall Study|Withdrawal by Subject|2
221883|NCT00118430|732553|P1|Overall Study|Withdrawal by Subject|6
221884|NCT00118417|732568|P2|Phase II (Weeks 6 to 12)|Remission|2
221885|NCT00118417|732569|P1|Phase II (Weeks 6 to 12)|Remission|1
221886|NCT00118417|732568|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
221887|NCT00118417|732569|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
221888|NCT00118417|732568|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
221889|NCT00118417|732569|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
221890|NCT00118417|732568|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
221891|NCT00118417|732569|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
221892|NCT00118417|732568|P2|Phase I (Weeks 0 to 6)|Remission|0
221893|NCT00118417|732569|P1|Phase I (Weeks 0 to 6)|Remission|8
221894|NCT00118287|732713|P1|Overall Study|Muscle pain|1
221895|NCT00118287|732713|P1|Overall Study|Intracranial haemorrhage|1
221896|NCT00118157|732733|P1|Overall Study|Withdrawal by Subject|2
221897|NCT00118157|732733|P1|Overall Study|Death|8
221898|NCT00118157|732733|P1|Overall Study|Adverse Event|2
221899|NCT00118092|732751|P1|Overall Study|Protocol Violation|1
221900|NCT00118092|732751|P1|Overall Study|Withdrawal by Subject|1
221901|NCT00118040|732769|P3|Overall Study|Other|1
221902|NCT00118040|732770|P2|Overall Study|Other|0
221903|NCT00118040|732771|P1|Overall Study|Other|0
221904|NCT00118040|732769|P3|Overall Study|Non-Compliant Participant|2
221905|NCT00118040|732770|P2|Overall Study|Non-Compliant Participant|1
221906|NCT00118040|732771|P1|Overall Study|Non-Compliant Participant|1
221907|NCT00118040|732769|P3|Overall Study|Medical Contraindication|1
221908|NCT00118040|732770|P2|Overall Study|Medical Contraindication|0
221909|NCT00118040|732771|P1|Overall Study|Medical Contraindication|0
221910|NCT00118040|732769|P3|Overall Study|Withdrawal by Subject|2
221911|NCT00118040|732770|P2|Overall Study|Withdrawal by Subject|0
221912|NCT00118040|732771|P1|Overall Study|Withdrawal by Subject|0
221913|NCT00118040|732769|P3|Overall Study|Adverse Event|0
221914|NCT00118040|732770|P2|Overall Study|Adverse Event|1
221915|NCT00118040|732771|P1|Overall Study|Adverse Event|0
221916|NCT00117988|732832|P1|Overall Study|Adverse Event|1
221917|NCT00117988|732832|P1|Overall Study|Death|3
221918|NCT00117949|732855|P4|Overall Study|Hepatic abnormalities|1
221919|NCT00117949|732856|P3|Overall Study|Hepatic abnormalities|0
221920|NCT00117949|732857|P2|Overall Study|Hepatic abnormalities|1
221921|NCT00117949|732858|P1|Overall Study|Hepatic abnormalities|0
221922|NCT00117949|732855|P4|Overall Study|PSA reduction <=50%|4
221923|NCT00117949|732856|P3|Overall Study|PSA reduction <=50%|2
221924|NCT00117949|732857|P2|Overall Study|PSA reduction <=50%|2
221925|NCT00117949|732858|P1|Overall Study|PSA reduction <=50%|0
221926|NCT00117949|732855|P4|Overall Study|PSA increase >=10ng/mL|0
221927|NCT00117949|732856|P3|Overall Study|PSA increase >=10ng/mL|1
221928|NCT00117949|732857|P2|Overall Study|PSA increase >=10ng/mL|1
221929|NCT00117949|732858|P1|Overall Study|PSA increase >=10ng/mL|0
221930|NCT00117949|732855|P4|Overall Study|Prostate-specific antigen increase >=25%|2
221931|NCT00117949|732856|P3|Overall Study|Prostate-specific antigen increase >=25%|1
221932|NCT00117949|732857|P2|Overall Study|Prostate-specific antigen increase >=25%|1
221933|NCT00117949|732858|P1|Overall Study|Prostate-specific antigen increase >=25%|0
221934|NCT00117949|732855|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
221935|NCT00117949|732856|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
221936|NCT00117949|732857|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
221937|NCT00117949|732858|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
221938|NCT00117949|732855|P4|Overall Study|Testosterone >1.0 ng/mL|15
221939|NCT00117949|732856|P3|Overall Study|Testosterone >1.0 ng/mL|17
221940|NCT00117949|732857|P2|Overall Study|Testosterone >1.0 ng/mL|18
221941|NCT00117949|732858|P1|Overall Study|Testosterone >1.0 ng/mL|10
221942|NCT00117845|732892|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
221943|NCT00117793|732910|P1|Overall Study|Withdrawal by Subject|12
221944|NCT00117676|732933|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
221945|NCT00117676|732934|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
221946|NCT00117676|732933|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
221947|NCT00117676|732934|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
221948|NCT00117676|732933|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
221949|NCT00117676|732934|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
221950|NCT00117676|732933|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
221951|NCT00117676|732934|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
221952|NCT00117676|732933|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
221953|NCT00117676|732934|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
221954|NCT00117676|732933|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
221955|NCT00117676|732934|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
221956|NCT00117676|732933|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
221957|NCT00117676|732934|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
221958|NCT00117676|732933|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
221959|NCT00117676|732934|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
221960|NCT00117676|732933|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
221961|NCT00117676|732934|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
221962|NCT00117676|732933|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
221963|NCT00117676|732934|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
221964|NCT00117676|732933|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
221965|NCT00117676|732934|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
221966|NCT00117676|732933|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
221967|NCT00117676|732934|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
221968|NCT00117676|732933|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
221969|NCT00117676|732934|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
221970|NCT00117676|732933|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
221971|NCT00117676|732934|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
221972|NCT00117676|732933|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
221973|NCT00117676|732934|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
221974|NCT00117676|732933|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
221975|NCT00117676|732934|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
221976|NCT00117676|732933|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
221977|NCT00117676|732934|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
221978|NCT00117676|732933|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
221979|NCT00117676|732934|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
221980|NCT00117676|732933|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
221981|NCT00117676|732934|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
221982|NCT00117676|732933|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
221983|NCT00117676|732934|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
221984|NCT00117676|732933|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
221985|NCT00117676|732934|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
221986|NCT00117676|732933|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
221987|NCT00117676|732934|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
221988|NCT00117676|732933|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
221989|NCT00117676|732934|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
221990|NCT00117676|732933|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
221991|NCT00117676|732934|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
221992|NCT00117676|732933|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
221993|NCT00117676|732934|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
221994|NCT00117676|732933|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
221995|NCT00117676|732934|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
221996|NCT00117676|732933|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
221997|NCT00117676|732934|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
221998|NCT00117676|732933|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
221999|NCT00117676|732934|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
222000|NCT00117676|732933|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
222001|NCT00117676|732934|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
222002|NCT00117676|732933|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
222003|NCT00117676|732934|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
222004|NCT00117676|732933|P2|Double-blind Period Through Week 48|Withdrew Consent|1
222005|NCT00117676|732934|P1|Double-blind Period Through Week 48|Withdrew Consent|0
222006|NCT00117676|732933|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
222007|NCT00117676|732934|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
222008|NCT00117676|732933|P2|Double-blind Period Through Week 48|Protocol Violation|1
222009|NCT00117676|732934|P1|Double-blind Period Through Week 48|Protocol Violation|0
222010|NCT00117676|732933|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
222011|NCT00117676|732934|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
222012|NCT00117676|732933|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
222013|NCT00117676|732934|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
222014|NCT00117637|733023|P2|Second Intervention (Period 2)|reason not reported|0
222015|NCT00117637|733024|P1|Second Intervention (Period 2)|reason not reported|1
222016|NCT00117637|733023|P2|Second Intervention (Period 2)|non compliant with study medication|1
222017|NCT00117637|733024|P1|Second Intervention (Period 2)|non compliant with study medication|1
222018|NCT00117637|733023|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
222019|NCT00117637|733024|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
222020|NCT00117637|733023|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
222021|NCT00117637|733024|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
222022|NCT00117637|733023|P2|Second Intervention (Period 2)|Protocol Violation|0
222023|NCT00117637|733024|P1|Second Intervention (Period 2)|Protocol Violation|1
222024|NCT00117637|733023|P2|Second Intervention (Period 2)|Lost to Follow-up|0
222025|NCT00117637|733024|P1|Second Intervention (Period 2)|Lost to Follow-up|1
222026|NCT00117637|733023|P2|Second Intervention (Period 2)|Adverse Event|9
222027|NCT00117637|733024|P1|Second Intervention (Period 2)|Adverse Event|0
222028|NCT00117637|733023|P2|First Intervention (Period 1)|reason not reported|1
222029|NCT00117637|733024|P1|First Intervention (Period 1)|reason not reported|0
222030|NCT00117637|733023|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
222031|NCT00117637|733024|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
222032|NCT00117637|733023|P2|First Intervention (Period 1)|protocol driven decision point|0
222033|NCT00117637|733024|P1|First Intervention (Period 1)|protocol driven decision point|1
222034|NCT00117637|733023|P2|First Intervention (Period 1)|study terminated by the sponsor|1
222035|NCT00117637|733024|P1|First Intervention (Period 1)|study terminated by the sponsor|3
222036|NCT00117637|733023|P2|First Intervention (Period 1)|Withdrawal by Subject|4
222037|NCT00117637|733024|P1|First Intervention (Period 1)|Withdrawal by Subject|2
222038|NCT00117637|733023|P2|First Intervention (Period 1)|Protocol Violation|0
222039|NCT00117637|733024|P1|First Intervention (Period 1)|Protocol Violation|1
222040|NCT00117637|733023|P2|First Intervention (Period 1)|Lost to Follow-up|2
222041|NCT00117637|733024|P1|First Intervention (Period 1)|Lost to Follow-up|0
222042|NCT00117637|733023|P2|First Intervention (Period 1)|Adverse Event|16
222043|NCT00117637|733024|P1|First Intervention (Period 1)|Adverse Event|11
222044|NCT00117598|733099|P5|After Treament Cross Over|Other|2
222045|NCT00117598|733100|P4|After Treament Cross Over|Other|1
222046|NCT00117598|733101|P3|After Treament Cross Over|Other|0
222047|NCT00117598|733102|P2|After Treament Cross Over|Other|0
222048|NCT00117598|733103|P1|After Treament Cross Over|Other|0
222049|NCT00117598|733099|P5|After Treament Cross Over|Withdrawal by Subject|0
222050|NCT00117598|733100|P4|After Treament Cross Over|Withdrawal by Subject|1
222051|NCT00117598|733101|P3|After Treament Cross Over|Withdrawal by Subject|0
222052|NCT00117598|733102|P2|After Treament Cross Over|Withdrawal by Subject|0
222053|NCT00117598|733103|P1|After Treament Cross Over|Withdrawal by Subject|0
222054|NCT00117598|733099|P5|After Treament Cross Over|Death|2
222055|NCT00117598|733100|P4|After Treament Cross Over|Death|1
222056|NCT00117598|733101|P3|After Treament Cross Over|Death|0
222057|NCT00117598|733102|P2|After Treament Cross Over|Death|0
222058|NCT00117598|733103|P1|After Treament Cross Over|Death|0
222059|NCT00117598|733099|P5|Prior to Treatment Cross Over|Other|0
222060|NCT00117598|733100|P4|Prior to Treatment Cross Over|Other|0
222061|NCT00117598|733101|P3|Prior to Treatment Cross Over|Other|9
222062|NCT00117598|733102|P2|Prior to Treatment Cross Over|Other|9
222063|NCT00117598|733103|P1|Prior to Treatment Cross Over|Other|15
222064|NCT00117598|733099|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
222065|NCT00117598|733100|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
222066|NCT00117598|733101|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
222067|NCT00117598|733102|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
222068|NCT00117598|733103|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
222069|NCT00117598|733099|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
222070|NCT00117598|733100|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
222071|NCT00117598|733101|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
222072|NCT00117598|733102|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
222073|NCT00117598|733103|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
222074|NCT00117598|733099|P5|Prior to Treatment Cross Over|Death|0
222075|NCT00117598|733100|P4|Prior to Treatment Cross Over|Death|0
222076|NCT00117598|733101|P3|Prior to Treatment Cross Over|Death|37
222077|NCT00117598|733102|P2|Prior to Treatment Cross Over|Death|41
222078|NCT00117598|733103|P1|Prior to Treatment Cross Over|Death|40
222079|NCT00117572|733137|P2|Overall Study|Protocol Violation|0
222080|NCT00117572|733138|P1|Overall Study|Protocol Violation|1
222081|NCT00117572|733137|P2|Overall Study|Withdrawal by Subject|3
222082|NCT00117572|733138|P1|Overall Study|Withdrawal by Subject|3
222083|NCT00117572|733137|P2|Overall Study|Site withdrew before starting treatment|3
222084|NCT00117572|733138|P1|Overall Study|Site withdrew before starting treatment|2
222085|NCT00117338|733179|P2|Overall Study|Lack of Efficacy|1
222086|NCT00117338|733180|P1|Overall Study|Lack of Efficacy|0
222087|NCT00117338|733179|P2|Overall Study|Did not meet Inclusion Criteria|0
222088|NCT00117338|733180|P1|Overall Study|Did not meet Inclusion Criteria|1
222089|NCT00117338|733179|P2|Overall Study|Withdrawal by Subject|0
222090|NCT00117338|733180|P1|Overall Study|Withdrawal by Subject|1
222091|NCT00117338|733179|P2|Overall Study|Protocol Violation|2
222092|NCT00117338|733180|P1|Overall Study|Protocol Violation|3
222093|NCT00117338|733179|P2|Overall Study|Adverse Event|1
222094|NCT00117338|733180|P1|Overall Study|Adverse Event|0
222095|NCT00117325|733200|P2|Overall Study|Admisnitrative|0
222096|NCT00117325|733201|P1|Overall Study|Admisnitrative|1
222097|NCT00117325|733200|P2|Overall Study|Early termination|1
222098|NCT00117325|733201|P1|Overall Study|Early termination|1
222099|NCT00117325|733200|P2|Overall Study|Use of prohibited medicine|2
222100|NCT00117325|733201|P1|Overall Study|Use of prohibited medicine|1
222101|NCT00117325|733200|P2|Overall Study|Lack of Efficacy|0
222102|NCT00117325|733201|P1|Overall Study|Lack of Efficacy|1
222103|NCT00117325|733200|P2|Overall Study|Withdrawal by Subject|2
222104|NCT00117325|733201|P1|Overall Study|Withdrawal by Subject|3
222105|NCT00117325|733200|P2|Overall Study|Protocol Violation|3
222106|NCT00117325|733201|P1|Overall Study|Protocol Violation|2
222107|NCT00117325|733200|P2|Overall Study|Lost to Follow-up|1
222108|NCT00117325|733201|P1|Overall Study|Lost to Follow-up|1
222109|NCT00117325|733200|P2|Overall Study|Adverse Event|3
222110|NCT00117325|733201|P1|Overall Study|Adverse Event|3
222111|NCT00117312|733233|P4|Overall Study|Withdrawal by Subject|0
222112|NCT00117312|733234|P3|Overall Study|Withdrawal by Subject|0
222113|NCT00117312|733235|P2|Overall Study|Withdrawal by Subject|2
222114|NCT00117312|733236|P1|Overall Study|Withdrawal by Subject|0
222115|NCT00117312|733233|P4|Overall Study|Hepatic abnormality|1
222116|NCT00117312|733234|P3|Overall Study|Hepatic abnormality|0
222117|NCT00117312|733235|P2|Overall Study|Hepatic abnormality|1
222118|NCT00117312|733236|P1|Overall Study|Hepatic abnormality|0
222119|NCT00117312|733233|P4|Overall Study|PSA increase >= 10ng/mL|0
222120|NCT00117312|733234|P3|Overall Study|PSA increase >= 10ng/mL|1
222121|NCT00117312|733235|P2|Overall Study|PSA increase >= 10ng/mL|1
222122|NCT00117312|733236|P1|Overall Study|PSA increase >= 10ng/mL|0
222123|NCT00117312|733233|P4|Overall Study|PSA decrease <=50%|4
222124|NCT00117312|733234|P3|Overall Study|PSA decrease <=50%|2
222125|NCT00117312|733235|P2|Overall Study|PSA decrease <=50%|2
222126|NCT00117312|733236|P1|Overall Study|PSA decrease <=50%|0
222127|NCT00117312|733233|P4|Overall Study|Protocol Violation|0
222128|NCT00117312|733234|P3|Overall Study|Protocol Violation|3
222129|NCT00117312|733235|P2|Overall Study|Protocol Violation|1
222130|NCT00117312|733236|P1|Overall Study|Protocol Violation|0
222131|NCT00117312|733233|P4|Overall Study|Adverse Event|0
222132|NCT00117312|733234|P3|Overall Study|Adverse Event|0
222133|NCT00117312|733235|P2|Overall Study|Adverse Event|2
222134|NCT00117312|733236|P1|Overall Study|Adverse Event|0
222135|NCT00117312|733233|P4|Overall Study|Patient choice|1
222136|NCT00117312|733234|P3|Overall Study|Patient choice|2
222137|NCT00117312|733235|P2|Overall Study|Patient choice|0
222138|NCT00117312|733236|P1|Overall Study|Patient choice|0
222139|NCT00117312|733233|P4|Overall Study|Not specified|1
222140|NCT00117312|733234|P3|Overall Study|Not specified|3
222141|NCT00117312|733235|P2|Overall Study|Not specified|1
222142|NCT00117312|733236|P1|Overall Study|Not specified|0
222143|NCT00117312|733233|P4|Overall Study|Prostate-specific antigen increase >=25%|3
222144|NCT00117312|733234|P3|Overall Study|Prostate-specific antigen increase >=25%|5
222145|NCT00117312|733235|P2|Overall Study|Prostate-specific antigen increase >=25%|1
222146|NCT00117312|733236|P1|Overall Study|Prostate-specific antigen increase >=25%|0
222147|NCT00117312|733233|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
222148|NCT00117312|733234|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
222149|NCT00117312|733235|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
222150|NCT00117312|733236|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
222151|NCT00117312|733233|P4|Overall Study|Testosterone >1.0 ng/mL|9
222152|NCT00117312|733234|P3|Overall Study|Testosterone >1.0 ng/mL|5
222153|NCT00117312|733235|P2|Overall Study|Testosterone >1.0 ng/mL|9
222154|NCT00117312|733236|P1|Overall Study|Testosterone >1.0 ng/mL|9
222155|NCT00117286|733252|P2|Overall Study|Research site closing|2
222156|NCT00117286|733253|P1|Overall Study|Research site closing|0
222157|NCT00117286|733252|P2|Overall Study|Lack of Efficacy|1
222158|NCT00117286|733253|P1|Overall Study|Lack of Efficacy|2
222159|NCT00117286|733252|P2|Overall Study|Physician Decision|7
222160|NCT00117286|733253|P1|Overall Study|Physician Decision|3
222161|NCT00117286|733252|P2|Overall Study|Withdrawal by Subject|2
222162|NCT00117286|733253|P1|Overall Study|Withdrawal by Subject|6
222163|NCT00117286|733252|P2|Overall Study|Protocol Violation|3
222164|NCT00117286|733253|P1|Overall Study|Protocol Violation|3
222165|NCT00117286|733252|P2|Overall Study|Lost to Follow-up|0
222166|NCT00117286|733253|P1|Overall Study|Lost to Follow-up|2
222167|NCT00117286|733252|P2|Overall Study|Adverse Event|6
222168|NCT00117286|733253|P1|Overall Study|Adverse Event|12
222169|NCT00117156|733261|P1|Overall Study|Trt for Pre-Exist Second Primary|1
222170|NCT00117156|733261|P1|Overall Study|Physician Decision|1
222171|NCT00117156|733261|P1|Overall Study|Adverse Event|9
222172|NCT00116844|733280|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
222173|NCT00116844|733281|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
222174|NCT00116844|733280|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
222175|NCT00116844|733281|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
222176|NCT00116844|733280|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
222177|NCT00116844|733281|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
222178|NCT00116844|733280|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
222179|NCT00116844|733281|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
222180|NCT00116844|733280|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
222181|NCT00116844|733281|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
222182|NCT00116844|733280|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
222183|NCT00116844|733281|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
222184|NCT00116844|733280|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
222185|NCT00116844|733281|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
222186|NCT00116844|733280|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
222187|NCT00116844|733281|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
222188|NCT00116844|733280|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
222189|NCT00116844|733281|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
222190|NCT00116831|733299|P2|Overall Study|Missing data for participant|0
222191|NCT00116831|733300|P1|Overall Study|Missing data for participant|1
222192|NCT00116831|733299|P2|Overall Study|Insufficient therapeutic effect|1
222193|NCT00116831|733300|P1|Overall Study|Insufficient therapeutic effect|0
222194|NCT00116831|733299|P2|Overall Study|Withdrawal by Subject|32
222195|NCT00116831|733300|P1|Overall Study|Withdrawal by Subject|32
222196|NCT00116831|733299|P2|Overall Study|Withdrawn investigational product|0
222197|NCT00116831|733300|P1|Overall Study|Withdrawn investigational product|1
222198|NCT00116831|733299|P2|Overall Study|Low haemoglobin on screening|0
222199|NCT00116831|733300|P1|Overall Study|Low haemoglobin on screening|1
222200|NCT00116831|733299|P2|Overall Study|Hypoglycaemic events|0
222201|NCT00116831|733300|P1|Overall Study|Hypoglycaemic events|1
222202|NCT00116831|733299|P2|Overall Study|Protocol Violation|6
222203|NCT00116831|733300|P1|Overall Study|Protocol Violation|3
222204|NCT00116831|733299|P2|Overall Study|Lost to Follow-up|6
222205|NCT00116831|733300|P1|Overall Study|Lost to Follow-up|8
222206|NCT00116831|733299|P2|Overall Study|Baseline IVUS determined unevaluable|11
222207|NCT00116831|733300|P1|Overall Study|Baseline IVUS determined unevaluable|12
222208|NCT00116831|733299|P2|Overall Study|Adverse Event|16
222209|NCT00116831|733300|P1|Overall Study|Adverse Event|14
222210|NCT00116805|733378|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
222211|NCT00116805|733379|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
222212|NCT00116805|733378|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
222213|NCT00116805|733379|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
222214|NCT00116805|733378|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
222215|NCT00116805|733379|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
222216|NCT00116805|733378|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
222217|NCT00116805|733379|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
222218|NCT00116805|733378|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
222219|NCT00116805|733379|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
222220|NCT00116805|733378|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
222221|NCT00116805|733379|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
222222|NCT00116805|733378|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
222223|NCT00116805|733379|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
222224|NCT00116805|733378|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
222225|NCT00116805|733379|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
222226|NCT00116805|733378|P2|Open-label Period Weeks 337 - 384|Completed Study|0
222227|NCT00116805|733379|P1|Open-label Period Weeks 337 - 384|Completed Study|1
222228|NCT00116805|733378|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
222229|NCT00116805|733379|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
222230|NCT00116805|733378|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
222231|NCT00116805|733379|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
222232|NCT00116805|733378|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
222233|NCT00116805|733379|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
222234|NCT00116805|733378|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
222235|NCT00116805|733379|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
222236|NCT00116805|733378|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
222237|NCT00116805|733379|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
222238|NCT00116805|733378|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
222239|NCT00116805|733379|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
222240|NCT00116805|733378|P2|Open-label Period Weeks 289 - 336|Completed Study|1
222241|NCT00116805|733379|P1|Open-label Period Weeks 289 - 336|Completed Study|0
222242|NCT00116805|733378|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
222243|NCT00116805|733379|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
222244|NCT00116805|733378|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
222245|NCT00116805|733379|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
222246|NCT00116805|733378|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
222247|NCT00116805|733379|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
222248|NCT00116805|733378|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
222249|NCT00116805|733379|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
222250|NCT00116805|733378|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
222251|NCT00116805|733379|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
222252|NCT00116805|733378|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
222253|NCT00116805|733379|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
222254|NCT00116805|733378|P2|Open-label Period Weeks 193 - 240|Completed Study|1
222255|NCT00116805|733379|P1|Open-label Period Weeks 193 - 240|Completed Study|0
222256|NCT00116805|733378|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
222257|NCT00116805|733379|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
222258|NCT00116805|733378|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
222259|NCT00116805|733379|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
222260|NCT00116805|733378|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
222261|NCT00116805|733379|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
222262|NCT00116805|733378|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
222263|NCT00116805|733379|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
222264|NCT00116805|733378|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
222265|NCT00116805|733379|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
222266|NCT00116805|733378|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
222267|NCT00116805|733379|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
222268|NCT00116805|733378|P2|Open-label Period Weeks 145 - 192|Completed Study|1
222269|NCT00116805|733379|P1|Open-label Period Weeks 145 - 192|Completed Study|1
222270|NCT00116805|733378|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
222271|NCT00116805|733379|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
222272|NCT00116805|733378|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
222273|NCT00116805|733379|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
222274|NCT00116805|733378|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
222275|NCT00116805|733379|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
222276|NCT00116805|733378|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
222277|NCT00116805|733379|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
222278|NCT00116805|733378|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
222279|NCT00116805|733379|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
222280|NCT00116805|733378|P2|Open-label Period Weeks 97 - 144|Completed Study|0
222281|NCT00116805|733379|P1|Open-label Period Weeks 97 - 144|Completed Study|1
222282|NCT00116805|733378|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
222283|NCT00116805|733379|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
222284|NCT00116805|733378|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
222285|NCT00116805|733379|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
222286|NCT00116805|733378|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
222287|NCT00116805|733379|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
222288|NCT00116805|733378|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
222289|NCT00116805|733379|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
222290|NCT00116805|733378|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
222291|NCT00116805|733379|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
222292|NCT00116805|733378|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
222293|NCT00116805|733379|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
222294|NCT00116805|733378|P2|Double-blind Period Through Week 48|Withdrew Consent|2
222295|NCT00116805|733379|P1|Double-blind Period Through Week 48|Withdrew Consent|4
222296|NCT00116805|733378|P2|Double-blind Period Through Week 48|Protocol Violation|1
222297|NCT00116805|733379|P1|Double-blind Period Through Week 48|Protocol Violation|1
222298|NCT00116805|733378|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
222299|NCT00116805|733379|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
222300|NCT00116779|733472|P2|Overall Study|Elevated PSA levels|2
222301|NCT00116779|733473|P1|Overall Study|Elevated PSA levels|2
222302|NCT00116779|733472|P2|Overall Study|Physician Decision|1
222303|NCT00116779|733473|P1|Overall Study|Physician Decision|3
222392|NCT00115765|733775|P3|Overall Study|Physician Decision|18
222304|NCT00116779|733472|P2|Overall Study|Inadequate testosterone suppression|9
222305|NCT00116779|733473|P1|Overall Study|Inadequate testosterone suppression|7
222306|NCT00116779|733472|P2|Overall Study|Withdrawal by Subject|1
222307|NCT00116779|733473|P1|Overall Study|Withdrawal by Subject|4
222308|NCT00116779|733472|P2|Overall Study|Protocol Violation|4
222309|NCT00116779|733473|P1|Overall Study|Protocol Violation|1
222310|NCT00116779|733472|P2|Overall Study|Adverse Event|2
222311|NCT00116779|733473|P1|Overall Study|Adverse Event|4
222312|NCT00116753|733506|P3|Overall Study|Dosing Error|0
222313|NCT00116753|733507|P2|Overall Study|Dosing Error|1
222314|NCT00116753|733508|P1|Overall Study|Dosing Error|0
222315|NCT00116753|733506|P3|Overall Study|Progressive Parkinson's Disease|0
222316|NCT00116753|733507|P2|Overall Study|Progressive Parkinson's Disease|0
222317|NCT00116753|733508|P1|Overall Study|Progressive Parkinson's Disease|1
222318|NCT00116753|733506|P3|Overall Study|Abnormal Echocardiogram|1
222319|NCT00116753|733507|P2|Overall Study|Abnormal Echocardiogram|0
222320|NCT00116753|733508|P1|Overall Study|Abnormal Echocardiogram|0
222321|NCT00116753|733506|P3|Overall Study|Disease Progression|3
222322|NCT00116753|733507|P2|Overall Study|Disease Progression|4
222323|NCT00116753|733508|P1|Overall Study|Disease Progression|3
222324|NCT00116753|733506|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
222325|NCT00116753|733507|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
222326|NCT00116753|733508|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
222327|NCT00116753|733506|P3|Overall Study|Protocol Violation|1
222328|NCT00116753|733507|P2|Overall Study|Protocol Violation|0
222329|NCT00116753|733508|P1|Overall Study|Protocol Violation|0
222330|NCT00116753|733506|P3|Overall Study|Lost to Follow-up|1
222331|NCT00116753|733507|P2|Overall Study|Lost to Follow-up|2
222332|NCT00116753|733508|P1|Overall Study|Lost to Follow-up|0
222333|NCT00116753|733506|P3|Overall Study|Withdrawal by Subject|8
222334|NCT00116753|733507|P2|Overall Study|Withdrawal by Subject|12
222335|NCT00116753|733508|P1|Overall Study|Withdrawal by Subject|11
222336|NCT00116753|733506|P3|Overall Study|Adverse Event|7
222337|NCT00116753|733507|P2|Overall Study|Adverse Event|10
222338|NCT00116753|733508|P1|Overall Study|Adverse Event|16
222339|NCT00116688|733530|P2|Overall Study|Other|0
222340|NCT00116688|733531|P1|Overall Study|Other|11
222341|NCT00116688|733530|P2|Overall Study|Pregnancy|0
222342|NCT00116688|733531|P1|Overall Study|Pregnancy|1
222343|NCT00116688|733530|P2|Overall Study|Protocol-specified criteria|0
222344|NCT00116688|733531|P1|Overall Study|Protocol-specified criteria|3
222345|NCT00116688|733530|P2|Overall Study|Death|0
222346|NCT00116688|733531|P1|Overall Study|Death|15
222347|NCT00116688|733530|P2|Overall Study|Lost to Follow-up|0
222348|NCT00116688|733531|P1|Overall Study|Lost to Follow-up|3
222349|NCT00116688|733530|P2|Overall Study|Physician Decision|0
222350|NCT00116688|733531|P1|Overall Study|Physician Decision|7
222351|NCT00116688|733530|P2|Overall Study|Requirement for alternative therapy|1
222352|NCT00116688|733531|P1|Overall Study|Requirement for alternative therapy|11
222353|NCT00116688|733530|P2|Overall Study|Withdrawal by Subject|2
222354|NCT00116688|733531|P1|Overall Study|Withdrawal by Subject|26
222355|NCT00116688|733530|P2|Overall Study|Adverse Event|0
222356|NCT00116688|733531|P1|Overall Study|Adverse Event|11
222357|NCT00116688|733530|P2|Overall Study|Noncompliance|1
222358|NCT00116688|733531|P1|Overall Study|Noncompliance|3
222359|NCT00116688|733530|P2|Overall Study|Protocol deviation|0
222360|NCT00116688|733531|P1|Overall Study|Protocol deviation|1
222361|NCT00116649|733546|P1|Overall Study|Protocol Specified|7
222362|NCT00116649|733546|P1|Overall Study|Various Reasons|18
222363|NCT00116649|733546|P1|Overall Study|Local Skin Reaction|9
222364|NCT00116649|733546|P1|Overall Study|Withdrawal by Subject|68
222365|NCT00116649|733546|P1|Overall Study|Lost to Follow-up|32
222366|NCT00116649|733546|P1|Overall Study|Lack of Efficacy|1
222367|NCT00116649|733546|P1|Overall Study|Adverse Event|20
222368|NCT00116428|733553|P2|Overall Study|Did not meet inclusion criteria|0
222369|NCT00116428|733554|P1|Overall Study|Did not meet inclusion criteria|1
222370|NCT00116428|733553|P2|Overall Study|Withdrawal by Subject|5
222371|NCT00116428|733554|P1|Overall Study|Withdrawal by Subject|2
222372|NCT00116272|733572|P2|Overall Study|Lost to Follow-up|6
222373|NCT00116272|733573|P1|Overall Study|Lost to Follow-up|11
222374|NCT00116168|733642|P4|Overall Study|Lost to Follow-up|0
222375|NCT00116168|733643|P3|Overall Study|Lost to Follow-up|0
222376|NCT00116168|733644|P2|Overall Study|Lost to Follow-up|5
222377|NCT00116168|733645|P1|Overall Study|Lost to Follow-up|6
222378|NCT00115934|733709|P2|Overall Study|Did not receive intervention|2
222379|NCT00115934|733710|P1|Overall Study|Did not receive intervention|3
222380|NCT00115934|733709|P2|Overall Study|Lost to Follow-up|0
222381|NCT00115934|733710|P1|Overall Study|Lost to Follow-up|1
222382|NCT00115804|733759|P1|Overall Study|Adverse Event|2
222383|NCT00115765|733774|P4|Overall Study|Not specified|2
222384|NCT00115765|733775|P3|Overall Study|Not specified|9
222385|NCT00115765|733776|P2|Overall Study|Not specified|12
222386|NCT00115765|733777|P1|Overall Study|Not specified|6
222387|NCT00115765|733774|P4|Overall Study|Lost to Follow-up|1
222388|NCT00115765|733775|P3|Overall Study|Lost to Follow-up|18
222389|NCT00115765|733776|P2|Overall Study|Lost to Follow-up|20
222390|NCT00115765|733777|P1|Overall Study|Lost to Follow-up|3
222391|NCT00115765|733774|P4|Overall Study|Physician Decision|13
222393|NCT00115765|733776|P2|Overall Study|Physician Decision|15
222394|NCT00115765|733777|P1|Overall Study|Physician Decision|4
222395|NCT00115765|733774|P4|Overall Study|Withdrawal by Subject|15
222396|NCT00115765|733775|P3|Overall Study|Withdrawal by Subject|76
222397|NCT00115765|733776|P2|Overall Study|Withdrawal by Subject|53
222398|NCT00115765|733777|P1|Overall Study|Withdrawal by Subject|22
222399|NCT00115739|733815|P1|Overall Study|Lost to Follow-up|3
222400|NCT00115349|733824|P2|Overall Study|Study closed due to low enrollment.|9
222401|NCT00115349|733825|P1|Overall Study|Study closed due to low enrollment.|11
222402|NCT00115063|733846|P2|Overall Study|Death|0
222403|NCT00115063|733847|P1|Overall Study|Death|1
222404|NCT00115063|733846|P2|Overall Study|Lost to Follow-up|104
222405|NCT00115063|733847|P1|Overall Study|Lost to Follow-up|98
222406|NCT00114972|733865|P2|Overall Study|Lost to Follow-up|5
222407|NCT00114972|733866|P1|Overall Study|Lost to Follow-up|8
222408|NCT00114972|733865|P2|Overall Study|Withdrawal by Subject|7
222409|NCT00114972|733866|P1|Overall Study|Withdrawal by Subject|40
222410|NCT00114959|733886|P1|Overall Study|Death|1
222411|NCT00114959|733886|P1|Overall Study|Physician Decision|1
222412|NCT00114959|733886|P1|Overall Study|Lack of Efficacy|6
222413|NCT00114777|733896|P3|Long-Term Extension to Month 84|Not Specified|2
222414|NCT00114777|733897|P2|Long-Term Extension to Month 84|Not Specified|0
222415|NCT00114777|733898|P1|Long-Term Extension to Month 84|Not Specified|2
222416|NCT00114777|733896|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
222417|NCT00114777|733897|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
222418|NCT00114777|733898|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
222419|NCT00114777|733896|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
222420|NCT00114777|733897|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
222421|NCT00114777|733898|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
222422|NCT00114777|733896|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
222423|NCT00114777|733897|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
222424|NCT00114777|733898|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
222425|NCT00114777|733896|P3|Long-Term Extension to Month 84|Adverse Event|7
222426|NCT00114777|733897|P2|Long-Term Extension to Month 84|Adverse Event|14
222427|NCT00114777|733898|P1|Long-Term Extension to Month 84|Adverse Event|15
222428|NCT00114777|733896|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
222429|NCT00114777|733897|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
222430|NCT00114777|733898|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
222431|NCT00114777|733896|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
222432|NCT00114777|733897|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
222433|NCT00114777|733898|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
222434|NCT00114777|733896|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
222435|NCT00114777|733897|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
222436|NCT00114777|733898|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
222437|NCT00114777|733896|P3|Long-Term Extension to Month 84|Death|7
222438|NCT00114777|733897|P2|Long-Term Extension to Month 84|Death|13
222439|NCT00114777|733898|P1|Long-Term Extension to Month 84|Death|8
222440|NCT00114777|733896|P3|Randomization to Month 36|Not Specified|12
222441|NCT00114777|733897|P2|Randomization to Month 36|Not Specified|3
222442|NCT00114777|733898|P1|Randomization to Month 36|Not Specified|9
222443|NCT00114777|733896|P3|Randomization to Month 36|Withdrawal by Subject|5
222444|NCT00114777|733897|P2|Randomization to Month 36|Withdrawal by Subject|4
222445|NCT00114777|733898|P1|Randomization to Month 36|Withdrawal by Subject|3
222446|NCT00114777|733896|P3|Randomization to Month 36|Adverse Event|44
222447|NCT00114777|733897|P2|Randomization to Month 36|Adverse Event|35
222448|NCT00114777|733898|P1|Randomization to Month 36|Adverse Event|34
222449|NCT00114777|733896|P3|Randomization to Month 36|Poor or Non-Compliance|1
222450|NCT00114777|733897|P2|Randomization to Month 36|Poor or Non-Compliance|0
222451|NCT00114777|733898|P1|Randomization to Month 36|Poor or Non-Compliance|0
222452|NCT00114777|733896|P3|Randomization to Month 36|Lack of Efficacy|17
222453|NCT00114777|733897|P2|Randomization to Month 36|Lack of Efficacy|15
222454|NCT00114777|733898|P1|Randomization to Month 36|Lack of Efficacy|19
222455|NCT00114777|733896|P3|Randomization to Month 36|No Longer Met Study Criteria|2
222456|NCT00114777|733897|P2|Randomization to Month 36|No Longer Met Study Criteria|0
222457|NCT00114777|733898|P1|Randomization to Month 36|No Longer Met Study Criteria|0
222458|NCT00114777|733896|P3|Randomization to Month 36|Death|3
222459|NCT00114777|733897|P2|Randomization to Month 36|Death|4
222460|NCT00114777|733898|P1|Randomization to Month 36|Death|10
222461|NCT00114634|733972|P1|Overall Study|failure to return forms|3
222462|NCT00114530|733988|P2|Overall Study|Ineligible|0
222463|NCT00114530|733989|P1|Overall Study|Ineligible|1
222464|NCT00114530|733988|P2|Overall Study|Subject decision after endpoint failure|1
222465|NCT00114530|733989|P1|Overall Study|Subject decision after endpoint failure|0
222466|NCT00114530|733988|P2|Overall Study|Breast Cancer|0
222467|NCT00114530|733989|P1|Overall Study|Breast Cancer|1
222468|NCT00114530|733988|P2|Overall Study|Withdrawal by Subject|6
222469|NCT00114530|733989|P1|Overall Study|Withdrawal by Subject|2
222470|NCT00114530|733988|P2|Overall Study|Physician Decision|1
222471|NCT00114530|733989|P1|Overall Study|Physician Decision|1
222472|NCT00114530|733988|P2|Overall Study|Lost to Follow-up|1
222473|NCT00114530|733989|P1|Overall Study|Lost to Follow-up|1
222474|NCT00114530|733988|P2|Overall Study|Death|11
222475|NCT00114530|733989|P1|Overall Study|Death|3
222476|NCT00114244|734126|P2|Overall Study|Withdrawal by Subject|2
222477|NCT00114244|734127|P1|Overall Study|Withdrawal by Subject|0
222478|NCT00114244|734126|P2|Overall Study|Adverse Event|5
222479|NCT00114244|734127|P1|Overall Study|Adverse Event|2
222480|NCT00114231|734139|P2|Overall Study|Biopsy done after registration|0
222481|NCT00114231|734140|P1|Overall Study|Biopsy done after registration|1
222482|NCT00114231|734139|P2|Overall Study|No Absolute Neutrophil Count|0
222483|NCT00114231|734140|P1|Overall Study|No Absolute Neutrophil Count|2
222484|NCT00114231|734139|P2|Overall Study|Tumor fixed on digital exam|1
222485|NCT00114231|734140|P1|Overall Study|Tumor fixed on digital exam|0
222486|NCT00114231|734139|P2|Overall Study|Tumor size > 4cm|0
222487|NCT00114231|734140|P1|Overall Study|Tumor size > 4cm|1
222488|NCT00114231|734139|P2|Overall Study|Low creatinine clearance|1
222489|NCT00114231|734140|P1|Overall Study|Low creatinine clearance|0
222490|NCT00114231|734139|P2|Overall Study|No adenocarcinoma|0
222491|NCT00114231|734140|P1|Overall Study|No adenocarcinoma|1
222492|NCT00114231|734139|P2|Overall Study|Suspected metastatic disease|0
222493|NCT00114231|734140|P1|Overall Study|Suspected metastatic disease|1
222494|NCT00114231|734139|P2|Overall Study|QARC requirement not met|0
222495|NCT00114231|734140|P1|Overall Study|QARC requirement not met|1
222496|NCT00114231|734139|P2|Overall Study|No consent|0
222497|NCT00114231|734140|P1|Overall Study|No consent|2
222498|NCT00114166|734149|P1|Overall Study|Wrong primary|1
222499|NCT00114140|734155|P1|Overall Study|Protocol Violation|7
222500|NCT00114127|734169|P2|Overall Study|Withdrawal by Subject|3
222501|NCT00114127|734170|P1|Overall Study|Withdrawal by Subject|1
222502|NCT00114127|734169|P2|Overall Study|Lost to Follow-up|0
222503|NCT00114127|734170|P1|Overall Study|Lost to Follow-up|1
222504|NCT00114127|734169|P2|Overall Study|Adverse Event|1
222505|NCT00114127|734170|P1|Overall Study|Adverse Event|2
222506|NCT00113919|734193|P1|Overall Study|Death|6
222507|NCT00113919|734193|P1|Overall Study|Physician Decision|8
222508|NCT00113841|734261|P2|Overall Study|Non-compliant|0
222509|NCT00113841|734262|P1|Overall Study|Non-compliant|1
222510|NCT00113841|734261|P2|Overall Study|Disease progression|2
222511|NCT00113841|734262|P1|Overall Study|Disease progression|0
222512|NCT00113763|734270|P2|Overall Study|Ongoing|0
222513|NCT00113763|734271|P1|Overall Study|Ongoing|1
222514|NCT00113763|734270|P2|Overall Study|Non-compliance|0
222515|NCT00113763|734271|P1|Overall Study|Non-compliance|1
222516|NCT00113763|734270|P2|Overall Study|Not specified|6
222517|NCT00113763|734271|P1|Overall Study|Not specified|27
222518|NCT00113763|734270|P2|Overall Study|Withdrawal by Subject|4
222519|NCT00113763|734271|P1|Overall Study|Withdrawal by Subject|1
222520|NCT00113763|734270|P2|Overall Study|Lost to Follow-up|0
222521|NCT00113763|734271|P1|Overall Study|Lost to Follow-up|10
222522|NCT00113763|734270|P2|Overall Study|Disease Progression|14
222523|NCT00113763|734271|P1|Overall Study|Disease Progression|28
222524|NCT00113763|734270|P2|Overall Study|Adverse Event|2
222525|NCT00113763|734271|P1|Overall Study|Adverse Event|5
222526|NCT00113607|734297|P2|Overall Study|Other|32
222527|NCT00113607|734298|P1|Overall Study|Other|43
222528|NCT00113607|734297|P2|Overall Study|Complete Response (Confirmed)|24
222529|NCT00113607|734298|P1|Overall Study|Complete Response (Confirmed)|14
222530|NCT00113607|734297|P2|Overall Study|Disease Progression|142
222531|NCT00113607|734298|P1|Overall Study|Disease Progression|180
222532|NCT00113607|734297|P2|Overall Study|Lost to Follow-up|2
222533|NCT00113607|734298|P1|Overall Study|Lost to Follow-up|0
222534|NCT00113607|734297|P2|Overall Study|Withdrawal by Subject|58
222535|NCT00113607|734298|P1|Overall Study|Withdrawal by Subject|50
222536|NCT00113607|734297|P2|Overall Study|Death|8
222537|NCT00113607|734298|P1|Overall Study|Death|8
222538|NCT00113607|734297|P2|Overall Study|Adverse Event|71
222539|NCT00113607|734298|P1|Overall Study|Adverse Event|40
222540|NCT00113568|734312|P1|Overall Study|Other|112
222541|NCT00113568|734312|P1|Overall Study|Withdrawal by Subject|117
222542|NCT00113568|734312|P1|Overall Study|Protocol Violation|32
222543|NCT00113568|734312|P1|Overall Study|Lost to Follow-up|156
222544|NCT00113568|734312|P1|Overall Study|Lack of Efficacy|30
222545|NCT00113568|734312|P1|Overall Study|Death|1
222546|NCT00113568|734312|P1|Overall Study|Adverse Event|97
222547|NCT00113529|734324|P1|Overall Study|Withdrawal by Subject|4
222548|NCT00113529|734324|P1|Overall Study|Decision of sponsor|6
222549|NCT00113529|734324|P1|Overall Study|Lack of Efficacy|20
222550|NCT00113529|734324|P1|Overall Study|Adverse Event|4
222551|NCT00113516|734357|P2|Part 2|Ongoing|1
222552|NCT00113516|734358|P1|Part 2|Ongoing|0
222553|NCT00113516|734357|P2|Part 2|Laboratory Abnormality|1
222554|NCT00113516|734358|P1|Part 2|Laboratory Abnormality|0
222555|NCT00113516|734357|P2|Part 2|Other|3
222556|NCT00113516|734358|P1|Part 2|Other|0
222557|NCT00113516|734357|P2|Part 2|Withdrawal by Subject|3
222558|NCT00113516|734358|P1|Part 2|Withdrawal by Subject|0
222559|NCT00113516|734357|P2|Part 2|Lack of Efficacy|37
222560|NCT00113516|734358|P1|Part 2|Lack of Efficacy|0
222561|NCT00113516|734357|P2|Part 2|Death|5
222562|NCT00113516|734358|P1|Part 2|Death|0
222563|NCT00113516|734357|P2|Part 2|Adverse Event|16
222564|NCT00113516|734358|P1|Part 2|Adverse Event|0
222565|NCT00113516|734357|P2|Part 1|Missing|0
222566|NCT00113516|734358|P1|Part 1|Missing|65
222567|NCT00113516|734357|P2|Part 1|Ongoing|0
222568|NCT00113516|734358|P1|Part 1|Ongoing|1
222569|NCT00113516|734357|P2|Part 1|Laboratory Abnormality|0
222570|NCT00113516|734358|P1|Part 1|Laboratory Abnormality|1
222571|NCT00113516|734357|P2|Part 1|Did Not Meet Entrance Criteria|0
222572|NCT00113516|734358|P1|Part 1|Did Not Meet Entrance Criteria|1
222573|NCT00113516|734357|P2|Part 1|Lack of Efficacy|0
222574|NCT00113516|734358|P1|Part 1|Lack of Efficacy|2
222575|NCT00113516|734357|P2|Part 1|Withdrawal by Subject|0
222576|NCT00113516|734358|P1|Part 1|Withdrawal by Subject|2
222577|NCT00113516|734357|P2|Part 1|Other|0
222578|NCT00113516|734358|P1|Part 1|Other|3
222579|NCT00113516|734357|P2|Part 1|Death|0
222580|NCT00113516|734358|P1|Part 1|Death|3
222581|NCT00113516|734357|P2|Part 1|Adverse Event|0
222582|NCT00113516|734358|P1|Part 1|Adverse Event|6
222583|NCT00113490|734401|P2|Overall Study|Lost to Follow-up|0
222584|NCT00113490|734402|P1|Overall Study|Lost to Follow-up|1
222585|NCT00113490|734401|P2|Overall Study|Withdrawal by Subject|3
222586|NCT00113490|734402|P1|Overall Study|Withdrawal by Subject|1
222587|NCT00113399|734435|P2|Overall Study|Other|1
222588|NCT00113399|734436|P1|Overall Study|Other|0
222589|NCT00113399|734435|P2|Overall Study|Complete Response|1
222590|NCT00113399|734436|P1|Overall Study|Complete Response|0
222591|NCT00113399|734435|P2|Overall Study|Withdrawal by Subject|2
222592|NCT00113399|734436|P1|Overall Study|Withdrawal by Subject|1
222593|NCT00113399|734435|P2|Overall Study|Death|1
222594|NCT00113399|734436|P1|Overall Study|Death|1
222595|NCT00113386|734444|P2|Overall Study|Unknown - Lost to Follow-Up|1
222596|NCT00113386|734445|P1|Overall Study|Unknown - Lost to Follow-Up|2
222597|NCT00113386|734444|P2|Overall Study|Ineligible|2
222598|NCT00113386|734445|P1|Overall Study|Ineligible|1
222599|NCT00113386|734444|P2|Overall Study|Toxicity|0
222600|NCT00113386|734445|P1|Overall Study|Toxicity|3
222601|NCT00113386|734444|P2|Overall Study|Physician Decision|1
222602|NCT00113386|734445|P1|Overall Study|Physician Decision|0
222603|NCT00113386|734444|P2|Overall Study|Withdrawal by Subject|0
222604|NCT00113386|734445|P1|Overall Study|Withdrawal by Subject|1
222605|NCT00113373|734451|P1|Overall Study|Never Treated|1
222606|NCT00113373|734451|P1|Overall Study|Ineligible: second primary|1
222607|NCT00113373|734451|P1|Overall Study|Ineligible: wrong primary|1
222608|NCT00113360|734457|P1|Overall Study|Did not meet eligibility criteria|3
222609|NCT00113360|734457|P1|Overall Study|Subject required surgery|1
222610|NCT00113360|734457|P1|Overall Study|Adverse Event|3
222611|NCT00113295|734471|P2|Overall Study|Unrelated Medical Illness|0
222612|NCT00113295|734472|P1|Overall Study|Unrelated Medical Illness|1
222613|NCT00113295|734471|P2|Overall Study|Adverse Event|1
222614|NCT00113295|734472|P1|Overall Study|Adverse Event|4
222615|NCT00113269|734491|P4|Overall Study|Unable to return for follow up|0
222616|NCT00113269|734492|P3|Overall Study|Unable to return for follow up|0
222617|NCT00113269|734493|P2|Overall Study|Unable to return for follow up|1
222618|NCT00113269|734494|P1|Overall Study|Unable to return for follow up|2
222619|NCT00113269|734491|P4|Overall Study|Did not meet eligibility criteria|1
222620|NCT00113269|734492|P3|Overall Study|Did not meet eligibility criteria|0
222621|NCT00113269|734493|P2|Overall Study|Did not meet eligibility criteria|0
222622|NCT00113269|734494|P1|Overall Study|Did not meet eligibility criteria|1
222623|NCT00113269|734491|P4|Overall Study|Withdrew consent, Prednisone initiated|1
222624|NCT00113269|734492|P3|Overall Study|Withdrew consent, Prednisone initiated|0
222625|NCT00113269|734493|P2|Overall Study|Withdrew consent, Prednisone initiated|0
222626|NCT00113269|734494|P1|Overall Study|Withdrew consent, Prednisone initiated|0
222627|NCT00113269|734491|P4|Overall Study|Received pancreas transplant|2
222628|NCT00113269|734492|P3|Overall Study|Received pancreas transplant|0
222629|NCT00113269|734493|P2|Overall Study|Received pancreas transplant|0
222630|NCT00113269|734494|P1|Overall Study|Received pancreas transplant|0
222631|NCT00113269|734491|P4|Overall Study|Moved|3
222632|NCT00113269|734492|P3|Overall Study|Moved|0
222633|NCT00113269|734493|P2|Overall Study|Moved|1
222634|NCT00113269|734494|P1|Overall Study|Moved|0
222635|NCT00113269|734491|P4|Overall Study|Discontinued due to rejection|0
222636|NCT00113269|734492|P3|Overall Study|Discontinued due to rejection|1
222637|NCT00113269|734493|P2|Overall Study|Discontinued due to rejection|0
222638|NCT00113269|734494|P1|Overall Study|Discontinued due to rejection|0
222639|NCT00113269|734491|P4|Overall Study|Sponsor elected to discontinue patient|1
222640|NCT00113269|734492|P3|Overall Study|Sponsor elected to discontinue patient|0
222641|NCT00113269|734493|P2|Overall Study|Sponsor elected to discontinue patient|0
222642|NCT00113269|734494|P1|Overall Study|Sponsor elected to discontinue patient|1
222643|NCT00113269|734491|P4|Overall Study|Lost to Follow-up|3
222644|NCT00113269|734492|P3|Overall Study|Lost to Follow-up|6
222645|NCT00113269|734493|P2|Overall Study|Lost to Follow-up|3
222646|NCT00113269|734494|P1|Overall Study|Lost to Follow-up|2
222647|NCT00113269|734491|P4|Overall Study|Protocol Violation|2
222648|NCT00113269|734492|P3|Overall Study|Protocol Violation|4
222649|NCT00113269|734493|P2|Overall Study|Protocol Violation|0
222650|NCT00113269|734494|P1|Overall Study|Protocol Violation|1
222651|NCT00113269|734491|P4|Overall Study|Graft loss|9
222652|NCT00113269|734492|P3|Overall Study|Graft loss|4
222653|NCT00113269|734493|P2|Overall Study|Graft loss|6
222654|NCT00113269|734494|P1|Overall Study|Graft loss|6
222655|NCT00113269|734491|P4|Overall Study|Withdrawal by Subject|2
222656|NCT00113269|734492|P3|Overall Study|Withdrawal by Subject|4
222657|NCT00113269|734493|P2|Overall Study|Withdrawal by Subject|3
222658|NCT00113269|734494|P1|Overall Study|Withdrawal by Subject|4
222659|NCT00113269|734491|P4|Overall Study|Adverse Event|7
222660|NCT00113269|734492|P3|Overall Study|Adverse Event|11
222661|NCT00113269|734493|P2|Overall Study|Adverse Event|7
222662|NCT00113269|734494|P1|Overall Study|Adverse Event|2
222663|NCT00113269|734491|P4|Overall Study|Did not meet eligibility – pre-treatment|2
222664|NCT00113269|734492|P3|Overall Study|Did not meet eligibility – pre-treatment|0
222665|NCT00113269|734493|P2|Overall Study|Did not meet eligibility – pre-treatment|0
222666|NCT00113269|734494|P1|Overall Study|Did not meet eligibility – pre-treatment|0
222667|NCT00113269|734491|P4|Overall Study|Death in operating room|1
222668|NCT00113269|734492|P3|Overall Study|Death in operating room|0
222669|NCT00113269|734493|P2|Overall Study|Death in operating room|0
222670|NCT00113269|734494|P1|Overall Study|Death in operating room|0
222671|NCT00113269|734491|P4|Overall Study|Early graft loss, technical|0
222672|NCT00113269|734492|P3|Overall Study|Early graft loss, technical|2
222673|NCT00113269|734493|P2|Overall Study|Early graft loss, technical|0
222674|NCT00113269|734494|P1|Overall Study|Early graft loss, technical|0
222675|NCT00113269|734491|P4|Overall Study|Not transplanted, recipient issues|4
222676|NCT00113269|734492|P3|Overall Study|Not transplanted, recipient issues|7
222677|NCT00113269|734493|P2|Overall Study|Not transplanted, recipient issues|1
222678|NCT00113269|734494|P1|Overall Study|Not transplanted, recipient issues|2
222679|NCT00113269|734491|P4|Overall Study|Not transplanted, donor issues|2
222680|NCT00113269|734492|P3|Overall Study|Not transplanted, donor issues|2
222681|NCT00113269|734493|P2|Overall Study|Not transplanted, donor issues|0
222682|NCT00113269|734494|P1|Overall Study|Not transplanted, donor issues|4
222683|NCT00113087|734554|P2|Overall Study|Family or MD withdrew subject|5
222684|NCT00113087|734555|P1|Overall Study|Family or MD withdrew subject|10
222685|NCT00113087|734554|P2|Overall Study|Death or Transplant|16
222686|NCT00113087|734555|P1|Overall Study|Death or Transplant|14
222687|NCT00112957|734626|P1|Overall Study|Physician Decision|1
222688|NCT00112957|734626|P1|Overall Study|Progressive disease|18
222689|NCT00112905|734666|P1|Overall Study|performance status was deteiorating|1
222690|NCT00112905|734666|P1|Overall Study|Alternative treatment|1
222691|NCT00112905|734666|P1|Overall Study|Ineligibility|5
222692|NCT00112905|734666|P1|Overall Study|Death|1
222693|NCT00112905|734666|P1|Overall Study|Adverse Event|4
222694|NCT00112866|734675|P2|Overall Study|did not start treatment post-op|2
222695|NCT00112866|734676|P1|Overall Study|did not start treatment post-op|1
222696|NCT00112866|734675|P2|Overall Study|Protocol Violation|0
222697|NCT00112866|734676|P1|Overall Study|Protocol Violation|1
222698|NCT00112840|734698|P3|Overall Study|Protocol Violation|5
222699|NCT00112840|734699|P2|Overall Study|Protocol Violation|0
222700|NCT00112840|734700|P1|Overall Study|Protocol Violation|0
222701|NCT00112840|734698|P3|Overall Study|Withdrawal by Subject|1
222702|NCT00112840|734699|P2|Overall Study|Withdrawal by Subject|0
222703|NCT00112840|734700|P1|Overall Study|Withdrawal by Subject|1
222704|NCT00112840|734698|P3|Overall Study|Physician Decision|0
222705|NCT00112840|734699|P2|Overall Study|Physician Decision|0
222706|NCT00112840|734700|P1|Overall Study|Physician Decision|1
222707|NCT00112736|734719|P2|Overall Study|1 pt never had had RX due rapid decline|0
222708|NCT00112736|734720|P1|Overall Study|1 pt never had had RX due rapid decline|1
222709|NCT00112489|734775|P1|Overall Study|Ineligible|7
222710|NCT00112489|734775|P1|Overall Study|Patient never treated|2
222711|NCT00112489|734775|P1|Overall Study|Other, Not Specified|9
222712|NCT00112489|734775|P1|Overall Study|Death|2
222713|NCT00112489|734775|P1|Overall Study|Adverse Event|12
222714|NCT00112489|734775|P1|Overall Study|Refused further treatment|8
222715|NCT00112463|734779|P1|Overall Study|Never started treatment|2
222716|NCT00112463|734779|P1|Overall Study|Withdrawal by Subject|2
222717|NCT00112463|734779|P1|Overall Study|Toxicity|3
222718|NCT00112463|734779|P1|Overall Study|Second Primary|1
222719|NCT00112463|734779|P1|Overall Study|Progression|30
222720|NCT00112463|734779|P1|Overall Study|Physician Decision|1
222721|NCT00112437|734791|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
222722|NCT00112437|734792|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222723|NCT00112437|734793|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
222724|NCT00112437|734794|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
222725|NCT00112437|734795|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222726|NCT00112437|734796|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222727|NCT00112437|734797|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222728|NCT00112437|734798|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222729|NCT00112437|734799|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222730|NCT00112437|734800|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222731|NCT00112437|734801|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222732|NCT00112437|734802|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222733|NCT00112437|734803|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222734|NCT00112437|734804|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222735|NCT00112437|734805|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
226169|NCT00098475|740272|P1|Step 1|Death|8
222736|NCT00112437|734806|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222737|NCT00112437|734807|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222738|NCT00112437|734808|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222739|NCT00112437|734809|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222740|NCT00112437|734810|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222741|NCT00112437|734811|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222742|NCT00112437|734812|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222743|NCT00112437|734813|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222744|NCT00112437|734814|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222745|NCT00112437|734815|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222746|NCT00112437|734816|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
222747|NCT00112437|734791|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
222748|NCT00112437|734792|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
222749|NCT00112437|734793|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
222750|NCT00112437|734794|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
222751|NCT00112437|734795|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
222752|NCT00112437|734796|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
222753|NCT00112437|734797|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
222754|NCT00112437|734798|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
222755|NCT00112437|734799|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
222756|NCT00112437|734800|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
222757|NCT00112437|734801|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
222758|NCT00112437|734802|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
222759|NCT00112437|734803|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
222760|NCT00112437|734804|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
222761|NCT00112437|734805|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
222762|NCT00112437|734806|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
222763|NCT00112437|734807|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
222764|NCT00112437|734808|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
222765|NCT00112437|734809|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
222766|NCT00112437|734810|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
222767|NCT00112437|734811|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
222768|NCT00112437|734812|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
222769|NCT00112437|734813|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
222770|NCT00112437|734814|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
222771|NCT00112437|734815|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
222772|NCT00112437|734816|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
222773|NCT00112437|734791|P26|Years 6-10 (60-Month Extension)|Other|0
222774|NCT00112437|734792|P25|Years 6-10 (60-Month Extension)|Other|1
222775|NCT00112437|734793|P24|Years 6-10 (60-Month Extension)|Other|0
222776|NCT00112437|734794|P23|Years 6-10 (60-Month Extension)|Other|0
222777|NCT00112437|734795|P22|Years 6-10 (60-Month Extension)|Other|0
222778|NCT00112437|734796|P21|Years 6-10 (60-Month Extension)|Other|0
222779|NCT00112437|734797|P20|Years 6-10 (60-Month Extension)|Other|0
222780|NCT00112437|734798|P19|Years 6-10 (60-Month Extension)|Other|0
222781|NCT00112437|734799|P18|Years 6-10 (60-Month Extension)|Other|0
222782|NCT00112437|734800|P17|Years 6-10 (60-Month Extension)|Other|0
222783|NCT00112437|734801|P16|Years 6-10 (60-Month Extension)|Other|0
222784|NCT00112437|734802|P15|Years 6-10 (60-Month Extension)|Other|0
222785|NCT00112437|734803|P14|Years 6-10 (60-Month Extension)|Other|0
222786|NCT00112437|734804|P13|Years 6-10 (60-Month Extension)|Other|0
222787|NCT00112437|734805|P12|Years 6-10 (60-Month Extension)|Other|0
222788|NCT00112437|734806|P11|Years 6-10 (60-Month Extension)|Other|0
222789|NCT00112437|734807|P10|Years 6-10 (60-Month Extension)|Other|0
222790|NCT00112437|734808|P9|Years 6-10 (60-Month Extension)|Other|0
222791|NCT00112437|734809|P8|Years 6-10 (60-Month Extension)|Other|0
222792|NCT00112437|734810|P7|Years 6-10 (60-Month Extension)|Other|0
222793|NCT00112437|734811|P6|Years 6-10 (60-Month Extension)|Other|0
222794|NCT00112437|734812|P5|Years 6-10 (60-Month Extension)|Other|0
222795|NCT00112437|734813|P4|Years 6-10 (60-Month Extension)|Other|0
222796|NCT00112437|734814|P3|Years 6-10 (60-Month Extension)|Other|0
222797|NCT00112437|734815|P2|Years 6-10 (60-Month Extension)|Other|0
222798|NCT00112437|734816|P1|Years 6-10 (60-Month Extension)|Other|0
222799|NCT00112437|734791|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
222800|NCT00112437|734792|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222801|NCT00112437|734793|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222802|NCT00112437|734794|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222803|NCT00112437|734795|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222804|NCT00112437|734796|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222805|NCT00112437|734797|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222806|NCT00112437|734798|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222807|NCT00112437|734799|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222808|NCT00112437|734800|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222809|NCT00112437|734801|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222810|NCT00112437|734802|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222811|NCT00112437|734803|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222812|NCT00112437|734804|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222813|NCT00112437|734805|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222814|NCT00112437|734806|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222815|NCT00112437|734807|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222816|NCT00112437|734808|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222817|NCT00112437|734809|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222818|NCT00112437|734810|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222819|NCT00112437|734811|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222820|NCT00112437|734812|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222821|NCT00112437|734813|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222822|NCT00112437|734814|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222823|NCT00112437|734815|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222824|NCT00112437|734816|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
222825|NCT00112437|734791|P26|Years 6-10 (60-Month Extension)|Death|0
222826|NCT00112437|734792|P25|Years 6-10 (60-Month Extension)|Death|0
222827|NCT00112437|734793|P24|Years 6-10 (60-Month Extension)|Death|2
222828|NCT00112437|734794|P23|Years 6-10 (60-Month Extension)|Death|0
222829|NCT00112437|734795|P22|Years 6-10 (60-Month Extension)|Death|0
222830|NCT00112437|734796|P21|Years 6-10 (60-Month Extension)|Death|0
222831|NCT00112437|734797|P20|Years 6-10 (60-Month Extension)|Death|0
222832|NCT00112437|734798|P19|Years 6-10 (60-Month Extension)|Death|0
222833|NCT00112437|734799|P18|Years 6-10 (60-Month Extension)|Death|0
222834|NCT00112437|734800|P17|Years 6-10 (60-Month Extension)|Death|0
222835|NCT00112437|734801|P16|Years 6-10 (60-Month Extension)|Death|0
222836|NCT00112437|734802|P15|Years 6-10 (60-Month Extension)|Death|0
222837|NCT00112437|734803|P14|Years 6-10 (60-Month Extension)|Death|0
222838|NCT00112437|734804|P13|Years 6-10 (60-Month Extension)|Death|0
222839|NCT00112437|734805|P12|Years 6-10 (60-Month Extension)|Death|0
222840|NCT00112437|734806|P11|Years 6-10 (60-Month Extension)|Death|0
222841|NCT00112437|734807|P10|Years 6-10 (60-Month Extension)|Death|0
222842|NCT00112437|734808|P9|Years 6-10 (60-Month Extension)|Death|0
222843|NCT00112437|734809|P8|Years 6-10 (60-Month Extension)|Death|0
222844|NCT00112437|734810|P7|Years 6-10 (60-Month Extension)|Death|0
222845|NCT00112437|734811|P6|Years 6-10 (60-Month Extension)|Death|0
222846|NCT00112437|734812|P5|Years 6-10 (60-Month Extension)|Death|0
222847|NCT00112437|734813|P4|Years 6-10 (60-Month Extension)|Death|0
222848|NCT00112437|734814|P3|Years 6-10 (60-Month Extension)|Death|0
222849|NCT00112437|734815|P2|Years 6-10 (60-Month Extension)|Death|0
222850|NCT00112437|734816|P1|Years 6-10 (60-Month Extension)|Death|0
222851|NCT00112437|734791|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
222852|NCT00112437|734792|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
222853|NCT00112437|734793|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
222854|NCT00112437|734794|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
222855|NCT00112437|734795|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
222856|NCT00112437|734796|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
222857|NCT00112437|734797|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
222858|NCT00112437|734798|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
222859|NCT00112437|734799|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
222860|NCT00112437|734800|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
222861|NCT00112437|734801|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
222862|NCT00112437|734802|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
222863|NCT00112437|734803|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
222864|NCT00112437|734804|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
222865|NCT00112437|734805|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
222866|NCT00112437|734806|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
222867|NCT00112437|734807|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
222868|NCT00112437|734808|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
222869|NCT00112437|734809|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
222870|NCT00112437|734810|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
222871|NCT00112437|734811|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
222872|NCT00112437|734812|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
222873|NCT00112437|734813|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
222874|NCT00112437|734814|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
222875|NCT00112437|734815|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
222876|NCT00112437|734816|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
222877|NCT00112437|734791|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222878|NCT00112437|734792|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222879|NCT00112437|734793|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222880|NCT00112437|734794|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222881|NCT00112437|734795|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
222882|NCT00112437|734796|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
222883|NCT00112437|734797|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222884|NCT00112437|734798|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222885|NCT00112437|734799|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222886|NCT00112437|734800|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222887|NCT00112437|734801|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222888|NCT00112437|734802|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222889|NCT00112437|734803|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222890|NCT00112437|734804|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222891|NCT00112437|734805|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222892|NCT00112437|734806|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222893|NCT00112437|734807|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222894|NCT00112437|734808|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222895|NCT00112437|734809|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222896|NCT00112437|734810|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222897|NCT00112437|734811|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222898|NCT00112437|734812|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222899|NCT00112437|734813|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222900|NCT00112437|734814|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222901|NCT00112437|734815|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222902|NCT00112437|734816|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
222903|NCT00112437|734791|P26|Years 4-5 (24-Month Extension)|Participant moved|0
222904|NCT00112437|734792|P25|Years 4-5 (24-Month Extension)|Participant moved|0
222905|NCT00112437|734793|P24|Years 4-5 (24-Month Extension)|Participant moved|0
222906|NCT00112437|734794|P23|Years 4-5 (24-Month Extension)|Participant moved|0
222907|NCT00112437|734795|P22|Years 4-5 (24-Month Extension)|Participant moved|1
222908|NCT00112437|734796|P21|Years 4-5 (24-Month Extension)|Participant moved|0
222909|NCT00112437|734797|P20|Years 4-5 (24-Month Extension)|Participant moved|0
222910|NCT00112437|734798|P19|Years 4-5 (24-Month Extension)|Participant moved|0
222911|NCT00112437|734799|P18|Years 4-5 (24-Month Extension)|Participant moved|0
222912|NCT00112437|734800|P17|Years 4-5 (24-Month Extension)|Participant moved|0
222913|NCT00112437|734801|P16|Years 4-5 (24-Month Extension)|Participant moved|0
222914|NCT00112437|734802|P15|Years 4-5 (24-Month Extension)|Participant moved|0
222915|NCT00112437|734803|P14|Years 4-5 (24-Month Extension)|Participant moved|0
222916|NCT00112437|734804|P13|Years 4-5 (24-Month Extension)|Participant moved|0
222917|NCT00112437|734805|P12|Years 4-5 (24-Month Extension)|Participant moved|0
222918|NCT00112437|734806|P11|Years 4-5 (24-Month Extension)|Participant moved|0
222919|NCT00112437|734807|P10|Years 4-5 (24-Month Extension)|Participant moved|0
222920|NCT00112437|734808|P9|Years 4-5 (24-Month Extension)|Participant moved|0
222921|NCT00112437|734809|P8|Years 4-5 (24-Month Extension)|Participant moved|0
222922|NCT00112437|734810|P7|Years 4-5 (24-Month Extension)|Participant moved|0
222923|NCT00112437|734811|P6|Years 4-5 (24-Month Extension)|Participant moved|0
222924|NCT00112437|734812|P5|Years 4-5 (24-Month Extension)|Participant moved|0
222925|NCT00112437|734813|P4|Years 4-5 (24-Month Extension)|Participant moved|0
222926|NCT00112437|734814|P3|Years 4-5 (24-Month Extension)|Participant moved|0
222927|NCT00112437|734815|P2|Years 4-5 (24-Month Extension)|Participant moved|0
222928|NCT00112437|734816|P1|Years 4-5 (24-Month Extension)|Participant moved|0
222929|NCT00112437|734791|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
222930|NCT00112437|734792|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
222931|NCT00112437|734793|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
222932|NCT00112437|734794|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
222933|NCT00112437|734795|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
222934|NCT00112437|734796|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
222935|NCT00112437|734797|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
222936|NCT00112437|734798|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
222937|NCT00112437|734799|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
222938|NCT00112437|734800|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
222939|NCT00112437|734801|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
222940|NCT00112437|734802|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
222941|NCT00112437|734803|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
222942|NCT00112437|734804|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
222943|NCT00112437|734805|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
222944|NCT00112437|734806|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
222945|NCT00112437|734807|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
222946|NCT00112437|734808|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
222947|NCT00112437|734809|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
222948|NCT00112437|734810|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
222949|NCT00112437|734811|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
222950|NCT00112437|734812|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
222951|NCT00112437|734813|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
222952|NCT00112437|734814|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
222953|NCT00112437|734815|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
222954|NCT00112437|734816|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
222955|NCT00112437|734791|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222956|NCT00112437|734792|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222957|NCT00112437|734793|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222958|NCT00112437|734794|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222959|NCT00112437|734795|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222960|NCT00112437|734796|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
222961|NCT00112437|734797|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222962|NCT00112437|734798|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222963|NCT00112437|734799|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222964|NCT00112437|734800|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222965|NCT00112437|734801|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222966|NCT00112437|734802|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222967|NCT00112437|734803|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222968|NCT00112437|734804|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222969|NCT00112437|734805|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222970|NCT00112437|734806|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222971|NCT00112437|734807|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222972|NCT00112437|734808|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222973|NCT00112437|734809|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222974|NCT00112437|734810|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222975|NCT00112437|734811|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222976|NCT00112437|734812|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222977|NCT00112437|734813|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222978|NCT00112437|734814|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222979|NCT00112437|734815|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222980|NCT00112437|734816|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
222981|NCT00112437|734791|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222982|NCT00112437|734792|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222983|NCT00112437|734793|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222984|NCT00112437|734794|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222985|NCT00112437|734795|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
222986|NCT00112437|734796|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
222987|NCT00112437|734797|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222988|NCT00112437|734798|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222989|NCT00112437|734799|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222990|NCT00112437|734800|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222991|NCT00112437|734801|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222992|NCT00112437|734802|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222993|NCT00112437|734803|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222994|NCT00112437|734804|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222995|NCT00112437|734805|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222996|NCT00112437|734806|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222997|NCT00112437|734807|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222998|NCT00112437|734808|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
222999|NCT00112437|734809|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
223000|NCT00112437|734810|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
223001|NCT00112437|734811|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
223002|NCT00112437|734812|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
223003|NCT00112437|734813|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
223004|NCT00112437|734814|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
223005|NCT00112437|734815|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
223006|NCT00112437|734816|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
223007|NCT00112437|734791|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223008|NCT00112437|734792|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223009|NCT00112437|734793|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223010|NCT00112437|734794|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223011|NCT00112437|734795|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223012|NCT00112437|734796|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223013|NCT00112437|734797|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223014|NCT00112437|734798|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223015|NCT00112437|734799|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223016|NCT00112437|734800|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223017|NCT00112437|734801|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223018|NCT00112437|734802|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223019|NCT00112437|734803|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223020|NCT00112437|734804|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223021|NCT00112437|734805|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
223022|NCT00112437|734806|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
223023|NCT00112437|734807|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223024|NCT00112437|734808|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223025|NCT00112437|734809|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223026|NCT00112437|734810|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223027|NCT00112437|734811|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223028|NCT00112437|734812|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223029|NCT00112437|734813|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223030|NCT00112437|734814|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223031|NCT00112437|734815|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223032|NCT00112437|734816|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
223033|NCT00112437|734791|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223034|NCT00112437|734792|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223035|NCT00112437|734793|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223036|NCT00112437|734794|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223037|NCT00112437|734795|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223038|NCT00112437|734796|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223039|NCT00112437|734797|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223040|NCT00112437|734798|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223041|NCT00112437|734799|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223042|NCT00112437|734800|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223043|NCT00112437|734801|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223044|NCT00112437|734802|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
223045|NCT00112437|734803|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223046|NCT00112437|734804|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223047|NCT00112437|734805|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
223048|NCT00112437|734806|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223049|NCT00112437|734807|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223050|NCT00112437|734808|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223051|NCT00112437|734809|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223052|NCT00112437|734810|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223053|NCT00112437|734811|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223054|NCT00112437|734812|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223055|NCT00112437|734813|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223056|NCT00112437|734814|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223057|NCT00112437|734815|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223058|NCT00112437|734816|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
223059|NCT00112437|734791|P26|Year 3 (12-Month Extension)|Protocol Violation|0
223060|NCT00112437|734792|P25|Year 3 (12-Month Extension)|Protocol Violation|0
223061|NCT00112437|734793|P24|Year 3 (12-Month Extension)|Protocol Violation|0
223062|NCT00112437|734794|P23|Year 3 (12-Month Extension)|Protocol Violation|0
223063|NCT00112437|734795|P22|Year 3 (12-Month Extension)|Protocol Violation|0
223064|NCT00112437|734796|P21|Year 3 (12-Month Extension)|Protocol Violation|0
223065|NCT00112437|734797|P20|Year 3 (12-Month Extension)|Protocol Violation|0
223066|NCT00112437|734798|P19|Year 3 (12-Month Extension)|Protocol Violation|0
223067|NCT00112437|734799|P18|Year 3 (12-Month Extension)|Protocol Violation|0
223068|NCT00112437|734800|P17|Year 3 (12-Month Extension)|Protocol Violation|0
223069|NCT00112437|734801|P16|Year 3 (12-Month Extension)|Protocol Violation|1
223070|NCT00112437|734802|P15|Year 3 (12-Month Extension)|Protocol Violation|0
223071|NCT00112437|734803|P14|Year 3 (12-Month Extension)|Protocol Violation|0
223072|NCT00112437|734804|P13|Year 3 (12-Month Extension)|Protocol Violation|0
223073|NCT00112437|734805|P12|Year 3 (12-Month Extension)|Protocol Violation|0
223074|NCT00112437|734806|P11|Year 3 (12-Month Extension)|Protocol Violation|0
223075|NCT00112437|734807|P10|Year 3 (12-Month Extension)|Protocol Violation|0
223076|NCT00112437|734808|P9|Year 3 (12-Month Extension)|Protocol Violation|0
223077|NCT00112437|734809|P8|Year 3 (12-Month Extension)|Protocol Violation|0
223078|NCT00112437|734810|P7|Year 3 (12-Month Extension)|Protocol Violation|0
223079|NCT00112437|734811|P6|Year 3 (12-Month Extension)|Protocol Violation|0
223080|NCT00112437|734812|P5|Year 3 (12-Month Extension)|Protocol Violation|0
223081|NCT00112437|734813|P4|Year 3 (12-Month Extension)|Protocol Violation|0
223082|NCT00112437|734814|P3|Year 3 (12-Month Extension)|Protocol Violation|0
223083|NCT00112437|734815|P2|Year 3 (12-Month Extension)|Protocol Violation|0
223084|NCT00112437|734816|P1|Year 3 (12-Month Extension)|Protocol Violation|0
223085|NCT00112437|734791|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
223086|NCT00112437|734792|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
223087|NCT00112437|734793|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
223088|NCT00112437|734794|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
223089|NCT00112437|734795|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
223090|NCT00112437|734796|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
223091|NCT00112437|734797|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
223092|NCT00112437|734798|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
223093|NCT00112437|734799|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
223094|NCT00112437|734800|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
223095|NCT00112437|734801|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
223096|NCT00112437|734802|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
223097|NCT00112437|734803|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
223098|NCT00112437|734804|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
223099|NCT00112437|734805|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
223100|NCT00112437|734806|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
223101|NCT00112437|734807|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
223102|NCT00112437|734808|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
223103|NCT00112437|734809|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
223104|NCT00112437|734810|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
223105|NCT00112437|734811|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
223106|NCT00112437|734812|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
223107|NCT00112437|734813|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
223108|NCT00112437|734814|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
223109|NCT00112437|734815|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
223110|NCT00112437|734816|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
223111|NCT00112437|734791|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
223112|NCT00112437|734792|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
223113|NCT00112437|734793|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
223114|NCT00112437|734794|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
223115|NCT00112437|734795|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
223116|NCT00112437|734796|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
223117|NCT00112437|734797|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
223118|NCT00112437|734798|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
223119|NCT00112437|734799|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
223120|NCT00112437|734800|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
223121|NCT00112437|734801|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
223122|NCT00112437|734802|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
223123|NCT00112437|734803|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
223124|NCT00112437|734804|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
223125|NCT00112437|734805|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
223126|NCT00112437|734806|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
223127|NCT00112437|734807|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
223128|NCT00112437|734808|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
223129|NCT00112437|734809|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
223130|NCT00112437|734810|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
223131|NCT00112437|734811|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
223132|NCT00112437|734812|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
223133|NCT00112437|734813|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
223134|NCT00112437|734814|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
223135|NCT00112437|734815|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
223136|NCT00112437|734816|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
223137|NCT00112437|734791|P26|Year 3 (12-Month Extension)|Adverse Event|0
223138|NCT00112437|734792|P25|Year 3 (12-Month Extension)|Adverse Event|0
223139|NCT00112437|734793|P24|Year 3 (12-Month Extension)|Adverse Event|0
223140|NCT00112437|734794|P23|Year 3 (12-Month Extension)|Adverse Event|0
223141|NCT00112437|734795|P22|Year 3 (12-Month Extension)|Adverse Event|0
223142|NCT00112437|734796|P21|Year 3 (12-Month Extension)|Adverse Event|0
223143|NCT00112437|734797|P20|Year 3 (12-Month Extension)|Adverse Event|1
223144|NCT00112437|734798|P19|Year 3 (12-Month Extension)|Adverse Event|0
223145|NCT00112437|734799|P18|Year 3 (12-Month Extension)|Adverse Event|1
223146|NCT00112437|734800|P17|Year 3 (12-Month Extension)|Adverse Event|3
223147|NCT00112437|734801|P16|Year 3 (12-Month Extension)|Adverse Event|1
223148|NCT00112437|734802|P15|Year 3 (12-Month Extension)|Adverse Event|0
223149|NCT00112437|734803|P14|Year 3 (12-Month Extension)|Adverse Event|0
223150|NCT00112437|734804|P13|Year 3 (12-Month Extension)|Adverse Event|0
223151|NCT00112437|734805|P12|Year 3 (12-Month Extension)|Adverse Event|0
223152|NCT00112437|734806|P11|Year 3 (12-Month Extension)|Adverse Event|1
223153|NCT00112437|734807|P10|Year 3 (12-Month Extension)|Adverse Event|0
223154|NCT00112437|734808|P9|Year 3 (12-Month Extension)|Adverse Event|0
223155|NCT00112437|734809|P8|Year 3 (12-Month Extension)|Adverse Event|0
223156|NCT00112437|734810|P7|Year 3 (12-Month Extension)|Adverse Event|0
223157|NCT00112437|734811|P6|Year 3 (12-Month Extension)|Adverse Event|0
223158|NCT00112437|734812|P5|Year 3 (12-Month Extension)|Adverse Event|0
223159|NCT00112437|734813|P4|Year 3 (12-Month Extension)|Adverse Event|0
223160|NCT00112437|734814|P3|Year 3 (12-Month Extension)|Adverse Event|0
223161|NCT00112437|734815|P2|Year 3 (12-Month Extension)|Adverse Event|0
223162|NCT00112437|734816|P1|Year 3 (12-Month Extension)|Adverse Event|0
223163|NCT00112437|734791|P26|Year 2 (12-Month Extension)|Moved|0
223164|NCT00112437|734792|P25|Year 2 (12-Month Extension)|Moved|0
223165|NCT00112437|734793|P24|Year 2 (12-Month Extension)|Moved|0
223166|NCT00112437|734794|P23|Year 2 (12-Month Extension)|Moved|0
223167|NCT00112437|734795|P22|Year 2 (12-Month Extension)|Moved|0
223168|NCT00112437|734796|P21|Year 2 (12-Month Extension)|Moved|0
223169|NCT00112437|734797|P20|Year 2 (12-Month Extension)|Moved|0
223170|NCT00112437|734798|P19|Year 2 (12-Month Extension)|Moved|0
223171|NCT00112437|734799|P18|Year 2 (12-Month Extension)|Moved|0
223172|NCT00112437|734800|P17|Year 2 (12-Month Extension)|Moved|0
223173|NCT00112437|734801|P16|Year 2 (12-Month Extension)|Moved|0
223174|NCT00112437|734802|P15|Year 2 (12-Month Extension)|Moved|0
223175|NCT00112437|734803|P14|Year 2 (12-Month Extension)|Moved|0
223176|NCT00112437|734804|P13|Year 2 (12-Month Extension)|Moved|0
223177|NCT00112437|734805|P12|Year 2 (12-Month Extension)|Moved|0
223178|NCT00112437|734806|P11|Year 2 (12-Month Extension)|Moved|0
223179|NCT00112437|734807|P10|Year 2 (12-Month Extension)|Moved|1
223180|NCT00112437|734808|P9|Year 2 (12-Month Extension)|Moved|0
223181|NCT00112437|734809|P8|Year 2 (12-Month Extension)|Moved|0
223182|NCT00112437|734810|P7|Year 2 (12-Month Extension)|Moved|0
223183|NCT00112437|734811|P6|Year 2 (12-Month Extension)|Moved|0
223184|NCT00112437|734812|P5|Year 2 (12-Month Extension)|Moved|0
223185|NCT00112437|734813|P4|Year 2 (12-Month Extension)|Moved|0
223186|NCT00112437|734814|P3|Year 2 (12-Month Extension)|Moved|0
223187|NCT00112437|734815|P2|Year 2 (12-Month Extension)|Moved|0
223188|NCT00112437|734816|P1|Year 2 (12-Month Extension)|Moved|0
223189|NCT00112437|734791|P26|Year 2 (12-Month Extension)|patient was out of windows|0
223190|NCT00112437|734792|P25|Year 2 (12-Month Extension)|patient was out of windows|0
223191|NCT00112437|734793|P24|Year 2 (12-Month Extension)|patient was out of windows|0
223192|NCT00112437|734794|P23|Year 2 (12-Month Extension)|patient was out of windows|0
223193|NCT00112437|734795|P22|Year 2 (12-Month Extension)|patient was out of windows|0
223194|NCT00112437|734796|P21|Year 2 (12-Month Extension)|patient was out of windows|0
223195|NCT00112437|734797|P20|Year 2 (12-Month Extension)|patient was out of windows|0
223196|NCT00112437|734798|P19|Year 2 (12-Month Extension)|patient was out of windows|0
223197|NCT00112437|734799|P18|Year 2 (12-Month Extension)|patient was out of windows|0
223198|NCT00112437|734800|P17|Year 2 (12-Month Extension)|patient was out of windows|0
223199|NCT00112437|734801|P16|Year 2 (12-Month Extension)|patient was out of windows|0
223200|NCT00112437|734802|P15|Year 2 (12-Month Extension)|patient was out of windows|0
223201|NCT00112437|734803|P14|Year 2 (12-Month Extension)|patient was out of windows|0
223202|NCT00112437|734804|P13|Year 2 (12-Month Extension)|patient was out of windows|0
223203|NCT00112437|734805|P12|Year 2 (12-Month Extension)|patient was out of windows|0
223204|NCT00112437|734806|P11|Year 2 (12-Month Extension)|patient was out of windows|0
223205|NCT00112437|734807|P10|Year 2 (12-Month Extension)|patient was out of windows|1
223206|NCT00112437|734808|P9|Year 2 (12-Month Extension)|patient was out of windows|0
223207|NCT00112437|734809|P8|Year 2 (12-Month Extension)|patient was out of windows|0
223208|NCT00112437|734810|P7|Year 2 (12-Month Extension)|patient was out of windows|0
223209|NCT00112437|734811|P6|Year 2 (12-Month Extension)|patient was out of windows|0
223210|NCT00112437|734812|P5|Year 2 (12-Month Extension)|patient was out of windows|0
223211|NCT00112437|734813|P4|Year 2 (12-Month Extension)|patient was out of windows|0
223212|NCT00112437|734814|P3|Year 2 (12-Month Extension)|patient was out of windows|0
223213|NCT00112437|734815|P2|Year 2 (12-Month Extension)|patient was out of windows|0
223214|NCT00112437|734816|P1|Year 2 (12-Month Extension)|patient was out of windows|0
223215|NCT00112437|734791|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223216|NCT00112437|734792|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223217|NCT00112437|734793|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223218|NCT00112437|734794|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223219|NCT00112437|734795|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223220|NCT00112437|734796|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223221|NCT00112437|734797|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223222|NCT00112437|734798|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223223|NCT00112437|734799|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223224|NCT00112437|734800|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223225|NCT00112437|734801|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223226|NCT00112437|734802|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223227|NCT00112437|734803|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223228|NCT00112437|734804|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223229|NCT00112437|734805|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223230|NCT00112437|734806|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223231|NCT00112437|734807|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
223232|NCT00112437|734808|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223233|NCT00112437|734809|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223234|NCT00112437|734810|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223235|NCT00112437|734811|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223236|NCT00112437|734812|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223237|NCT00112437|734813|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223238|NCT00112437|734814|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223239|NCT00112437|734815|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223240|NCT00112437|734816|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
223241|NCT00112437|734791|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223242|NCT00112437|734792|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223243|NCT00112437|734793|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223244|NCT00112437|734794|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223245|NCT00112437|734795|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223246|NCT00112437|734796|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223247|NCT00112437|734797|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223248|NCT00112437|734798|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223249|NCT00112437|734799|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223250|NCT00112437|734800|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223251|NCT00112437|734801|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223252|NCT00112437|734802|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223253|NCT00112437|734803|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223254|NCT00112437|734804|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223255|NCT00112437|734805|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223256|NCT00112437|734806|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223257|NCT00112437|734807|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
223258|NCT00112437|734808|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
223259|NCT00112437|734809|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
223260|NCT00112437|734810|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
223261|NCT00112437|734811|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
223262|NCT00112437|734812|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223263|NCT00112437|734813|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223264|NCT00112437|734814|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223265|NCT00112437|734815|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223266|NCT00112437|734816|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
223267|NCT00112437|734791|P26|Year 2 (12-Month Extension)|Protocol Violation|0
223268|NCT00112437|734792|P25|Year 2 (12-Month Extension)|Protocol Violation|0
223269|NCT00112437|734793|P24|Year 2 (12-Month Extension)|Protocol Violation|0
223270|NCT00112437|734794|P23|Year 2 (12-Month Extension)|Protocol Violation|0
223271|NCT00112437|734795|P22|Year 2 (12-Month Extension)|Protocol Violation|0
223272|NCT00112437|734796|P21|Year 2 (12-Month Extension)|Protocol Violation|0
223273|NCT00112437|734797|P20|Year 2 (12-Month Extension)|Protocol Violation|0
223274|NCT00112437|734798|P19|Year 2 (12-Month Extension)|Protocol Violation|0
223275|NCT00112437|734799|P18|Year 2 (12-Month Extension)|Protocol Violation|0
223276|NCT00112437|734800|P17|Year 2 (12-Month Extension)|Protocol Violation|0
223277|NCT00112437|734801|P16|Year 2 (12-Month Extension)|Protocol Violation|0
223278|NCT00112437|734802|P15|Year 2 (12-Month Extension)|Protocol Violation|0
223279|NCT00112437|734803|P14|Year 2 (12-Month Extension)|Protocol Violation|0
223280|NCT00112437|734804|P13|Year 2 (12-Month Extension)|Protocol Violation|0
223281|NCT00112437|734805|P12|Year 2 (12-Month Extension)|Protocol Violation|0
223282|NCT00112437|734806|P11|Year 2 (12-Month Extension)|Protocol Violation|0
223283|NCT00112437|734807|P10|Year 2 (12-Month Extension)|Protocol Violation|0
223284|NCT00112437|734808|P9|Year 2 (12-Month Extension)|Protocol Violation|1
223285|NCT00112437|734809|P8|Year 2 (12-Month Extension)|Protocol Violation|0
223286|NCT00112437|734810|P7|Year 2 (12-Month Extension)|Protocol Violation|0
223287|NCT00112437|734811|P6|Year 2 (12-Month Extension)|Protocol Violation|0
223288|NCT00112437|734812|P5|Year 2 (12-Month Extension)|Protocol Violation|0
223289|NCT00112437|734813|P4|Year 2 (12-Month Extension)|Protocol Violation|0
223290|NCT00112437|734814|P3|Year 2 (12-Month Extension)|Protocol Violation|0
223291|NCT00112437|734815|P2|Year 2 (12-Month Extension)|Protocol Violation|0
223292|NCT00112437|734816|P1|Year 2 (12-Month Extension)|Protocol Violation|0
223293|NCT00112437|734791|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
223294|NCT00112437|734792|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
223295|NCT00112437|734793|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
223296|NCT00112437|734794|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
223297|NCT00112437|734795|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
223298|NCT00112437|734796|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
223299|NCT00112437|734797|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
223300|NCT00112437|734798|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
223301|NCT00112437|734799|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
223302|NCT00112437|734800|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
223303|NCT00112437|734801|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
223304|NCT00112437|734802|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
223305|NCT00112437|734803|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
223306|NCT00112437|734804|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
223307|NCT00112437|734805|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
223308|NCT00112437|734806|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
223309|NCT00112437|734807|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
223310|NCT00112437|734808|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
223311|NCT00112437|734809|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
223312|NCT00112437|734810|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
223313|NCT00112437|734811|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
223314|NCT00112437|734812|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
223315|NCT00112437|734813|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
223316|NCT00112437|734814|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
223317|NCT00112437|734815|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
223318|NCT00112437|734816|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
223319|NCT00112437|734791|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
223320|NCT00112437|734792|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
223321|NCT00112437|734793|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
223322|NCT00112437|734794|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
223323|NCT00112437|734795|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
223324|NCT00112437|734796|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
223325|NCT00112437|734797|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
223326|NCT00112437|734798|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
223327|NCT00112437|734799|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
223328|NCT00112437|734800|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
223329|NCT00112437|734801|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
223330|NCT00112437|734802|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
223331|NCT00112437|734803|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
223332|NCT00112437|734804|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
223333|NCT00112437|734805|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
223334|NCT00112437|734806|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
223335|NCT00112437|734807|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
223336|NCT00112437|734808|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
223337|NCT00112437|734809|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
223338|NCT00112437|734810|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
223339|NCT00112437|734811|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
223340|NCT00112437|734812|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
223341|NCT00112437|734813|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
223342|NCT00112437|734814|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
223343|NCT00112437|734815|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
223344|NCT00112437|734816|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
223345|NCT00112437|734791|P26|Year 2 (12-Month Extension)|Adverse Event|0
223346|NCT00112437|734792|P25|Year 2 (12-Month Extension)|Adverse Event|0
223347|NCT00112437|734793|P24|Year 2 (12-Month Extension)|Adverse Event|0
223348|NCT00112437|734794|P23|Year 2 (12-Month Extension)|Adverse Event|0
223349|NCT00112437|734795|P22|Year 2 (12-Month Extension)|Adverse Event|0
223350|NCT00112437|734796|P21|Year 2 (12-Month Extension)|Adverse Event|0
223351|NCT00112437|734797|P20|Year 2 (12-Month Extension)|Adverse Event|0
223352|NCT00112437|734798|P19|Year 2 (12-Month Extension)|Adverse Event|0
223353|NCT00112437|734799|P18|Year 2 (12-Month Extension)|Adverse Event|0
223354|NCT00112437|734800|P17|Year 2 (12-Month Extension)|Adverse Event|0
223355|NCT00112437|734801|P16|Year 2 (12-Month Extension)|Adverse Event|0
223356|NCT00112437|734802|P15|Year 2 (12-Month Extension)|Adverse Event|0
223357|NCT00112437|734803|P14|Year 2 (12-Month Extension)|Adverse Event|0
223358|NCT00112437|734804|P13|Year 2 (12-Month Extension)|Adverse Event|0
223359|NCT00112437|734805|P12|Year 2 (12-Month Extension)|Adverse Event|0
223360|NCT00112437|734806|P11|Year 2 (12-Month Extension)|Adverse Event|0
223361|NCT00112437|734807|P10|Year 2 (12-Month Extension)|Adverse Event|7
223362|NCT00112437|734808|P9|Year 2 (12-Month Extension)|Adverse Event|1
223363|NCT00112437|734809|P8|Year 2 (12-Month Extension)|Adverse Event|6
223364|NCT00112437|734810|P7|Year 2 (12-Month Extension)|Adverse Event|2
223365|NCT00112437|734811|P6|Year 2 (12-Month Extension)|Adverse Event|1
223366|NCT00112437|734812|P5|Year 2 (12-Month Extension)|Adverse Event|0
223367|NCT00112437|734813|P4|Year 2 (12-Month Extension)|Adverse Event|0
223368|NCT00112437|734814|P3|Year 2 (12-Month Extension)|Adverse Event|0
223369|NCT00112437|734815|P2|Year 2 (12-Month Extension)|Adverse Event|0
223370|NCT00112437|734816|P1|Year 2 (12-Month Extension)|Adverse Event|0
223371|NCT00112437|734791|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223372|NCT00112437|734792|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223373|NCT00112437|734793|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223374|NCT00112437|734794|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223375|NCT00112437|734795|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223376|NCT00112437|734796|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223377|NCT00112437|734797|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223378|NCT00112437|734798|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223379|NCT00112437|734799|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223380|NCT00112437|734800|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223381|NCT00112437|734801|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223382|NCT00112437|734802|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223383|NCT00112437|734803|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223384|NCT00112437|734804|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223385|NCT00112437|734805|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223386|NCT00112437|734806|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223387|NCT00112437|734807|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223388|NCT00112437|734808|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223389|NCT00112437|734809|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223390|NCT00112437|734810|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223391|NCT00112437|734811|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223392|NCT00112437|734812|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
223393|NCT00112437|734813|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223394|NCT00112437|734814|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223395|NCT00112437|734815|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223396|NCT00112437|734816|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
223397|NCT00112437|734791|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223398|NCT00112437|734792|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223399|NCT00112437|734793|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223400|NCT00112437|734794|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223401|NCT00112437|734795|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223402|NCT00112437|734796|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223403|NCT00112437|734797|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223404|NCT00112437|734798|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223405|NCT00112437|734799|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223406|NCT00112437|734800|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223407|NCT00112437|734801|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223408|NCT00112437|734802|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223409|NCT00112437|734803|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223410|NCT00112437|734804|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223411|NCT00112437|734805|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223412|NCT00112437|734806|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223413|NCT00112437|734807|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223414|NCT00112437|734808|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223415|NCT00112437|734809|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223416|NCT00112437|734810|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223417|NCT00112437|734811|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223418|NCT00112437|734812|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223419|NCT00112437|734813|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
223420|NCT00112437|734814|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223421|NCT00112437|734815|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223422|NCT00112437|734816|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
223423|NCT00112437|734791|P26|Year 1 (12-Month Base Study)|moved|0
223424|NCT00112437|734792|P25|Year 1 (12-Month Base Study)|moved|0
223425|NCT00112437|734793|P24|Year 1 (12-Month Base Study)|moved|0
223426|NCT00112437|734794|P23|Year 1 (12-Month Base Study)|moved|0
223427|NCT00112437|734795|P22|Year 1 (12-Month Base Study)|moved|0
223428|NCT00112437|734796|P21|Year 1 (12-Month Base Study)|moved|0
223429|NCT00112437|734797|P20|Year 1 (12-Month Base Study)|moved|0
223430|NCT00112437|734798|P19|Year 1 (12-Month Base Study)|moved|0
223431|NCT00112437|734799|P18|Year 1 (12-Month Base Study)|moved|0
223432|NCT00112437|734800|P17|Year 1 (12-Month Base Study)|moved|0
223433|NCT00112437|734801|P16|Year 1 (12-Month Base Study)|moved|0
223434|NCT00112437|734802|P15|Year 1 (12-Month Base Study)|moved|0
223435|NCT00112437|734803|P14|Year 1 (12-Month Base Study)|moved|0
223436|NCT00112437|734804|P13|Year 1 (12-Month Base Study)|moved|0
223437|NCT00112437|734805|P12|Year 1 (12-Month Base Study)|moved|0
223438|NCT00112437|734806|P11|Year 1 (12-Month Base Study)|moved|0
223439|NCT00112437|734807|P10|Year 1 (12-Month Base Study)|moved|0
223440|NCT00112437|734808|P9|Year 1 (12-Month Base Study)|moved|0
223441|NCT00112437|734809|P8|Year 1 (12-Month Base Study)|moved|0
223442|NCT00112437|734810|P7|Year 1 (12-Month Base Study)|moved|0
223443|NCT00112437|734811|P6|Year 1 (12-Month Base Study)|moved|0
223444|NCT00112437|734812|P5|Year 1 (12-Month Base Study)|moved|0
223445|NCT00112437|734813|P4|Year 1 (12-Month Base Study)|moved|0
223446|NCT00112437|734814|P3|Year 1 (12-Month Base Study)|moved|1
223447|NCT00112437|734815|P2|Year 1 (12-Month Base Study)|moved|1
223448|NCT00112437|734816|P1|Year 1 (12-Month Base Study)|moved|0
223449|NCT00112437|734791|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223450|NCT00112437|734792|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223451|NCT00112437|734793|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223452|NCT00112437|734794|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223453|NCT00112437|734795|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223454|NCT00112437|734796|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223455|NCT00112437|734797|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223456|NCT00112437|734798|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223457|NCT00112437|734799|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223458|NCT00112437|734800|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223459|NCT00112437|734801|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223460|NCT00112437|734802|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223461|NCT00112437|734803|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223462|NCT00112437|734804|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223463|NCT00112437|734805|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223464|NCT00112437|734806|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223465|NCT00112437|734807|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223466|NCT00112437|734808|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223467|NCT00112437|734809|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223468|NCT00112437|734810|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223469|NCT00112437|734811|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
223470|NCT00112437|734812|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
223471|NCT00112437|734813|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
223472|NCT00112437|734814|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
223473|NCT00112437|734815|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
223474|NCT00112437|734816|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
223475|NCT00112437|734791|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
223476|NCT00112437|734792|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
223477|NCT00112437|734793|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
223478|NCT00112437|734794|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
223479|NCT00112437|734795|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
223480|NCT00112437|734796|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
223481|NCT00112437|734797|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
223482|NCT00112437|734798|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
223483|NCT00112437|734799|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
223484|NCT00112437|734800|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
223485|NCT00112437|734801|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
223486|NCT00112437|734802|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
223487|NCT00112437|734803|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
223488|NCT00112437|734804|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
223489|NCT00112437|734805|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
223490|NCT00112437|734806|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
223491|NCT00112437|734807|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
223492|NCT00112437|734808|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
223493|NCT00112437|734809|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
223494|NCT00112437|734810|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
223495|NCT00112437|734811|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
223496|NCT00112437|734812|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
223497|NCT00112437|734813|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
223498|NCT00112437|734814|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
223499|NCT00112437|734815|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
223500|NCT00112437|734816|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
223501|NCT00112437|734791|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223502|NCT00112437|734792|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223503|NCT00112437|734793|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223504|NCT00112437|734794|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223505|NCT00112437|734795|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223506|NCT00112437|734796|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223507|NCT00112437|734797|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223508|NCT00112437|734798|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223509|NCT00112437|734799|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223510|NCT00112437|734800|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223511|NCT00112437|734801|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223512|NCT00112437|734802|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223513|NCT00112437|734803|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223514|NCT00112437|734804|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223515|NCT00112437|734805|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223516|NCT00112437|734806|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223517|NCT00112437|734807|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223518|NCT00112437|734808|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223519|NCT00112437|734809|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223520|NCT00112437|734810|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223521|NCT00112437|734811|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223522|NCT00112437|734812|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223523|NCT00112437|734813|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223524|NCT00112437|734814|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223525|NCT00112437|734815|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
223526|NCT00112437|734816|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
223527|NCT00112437|734791|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223528|NCT00112437|734792|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223529|NCT00112437|734793|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223530|NCT00112437|734794|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223531|NCT00112437|734795|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223532|NCT00112437|734796|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223533|NCT00112437|734797|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223534|NCT00112437|734798|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223535|NCT00112437|734799|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223536|NCT00112437|734800|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223537|NCT00112437|734801|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223538|NCT00112437|734802|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223539|NCT00112437|734803|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223540|NCT00112437|734804|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223541|NCT00112437|734805|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223542|NCT00112437|734806|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223543|NCT00112437|734807|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223544|NCT00112437|734808|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223545|NCT00112437|734809|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223546|NCT00112437|734810|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223547|NCT00112437|734811|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223548|NCT00112437|734812|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223549|NCT00112437|734813|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223550|NCT00112437|734814|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223551|NCT00112437|734815|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
223552|NCT00112437|734816|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
223553|NCT00112437|734791|P26|Year 1 (12-Month Base Study)|Adverse Event|0
223554|NCT00112437|734792|P25|Year 1 (12-Month Base Study)|Adverse Event|0
223555|NCT00112437|734793|P24|Year 1 (12-Month Base Study)|Adverse Event|0
223556|NCT00112437|734794|P23|Year 1 (12-Month Base Study)|Adverse Event|0
223557|NCT00112437|734795|P22|Year 1 (12-Month Base Study)|Adverse Event|0
223558|NCT00112437|734796|P21|Year 1 (12-Month Base Study)|Adverse Event|0
223559|NCT00112437|734797|P20|Year 1 (12-Month Base Study)|Adverse Event|0
223560|NCT00112437|734798|P19|Year 1 (12-Month Base Study)|Adverse Event|0
223561|NCT00112437|734799|P18|Year 1 (12-Month Base Study)|Adverse Event|0
223562|NCT00112437|734800|P17|Year 1 (12-Month Base Study)|Adverse Event|0
223563|NCT00112437|734801|P16|Year 1 (12-Month Base Study)|Adverse Event|0
223564|NCT00112437|734802|P15|Year 1 (12-Month Base Study)|Adverse Event|0
223565|NCT00112437|734803|P14|Year 1 (12-Month Base Study)|Adverse Event|0
223566|NCT00112437|734804|P13|Year 1 (12-Month Base Study)|Adverse Event|0
223567|NCT00112437|734805|P12|Year 1 (12-Month Base Study)|Adverse Event|0
223568|NCT00112437|734806|P11|Year 1 (12-Month Base Study)|Adverse Event|0
223569|NCT00112437|734807|P10|Year 1 (12-Month Base Study)|Adverse Event|0
223570|NCT00112437|734808|P9|Year 1 (12-Month Base Study)|Adverse Event|0
223571|NCT00112437|734809|P8|Year 1 (12-Month Base Study)|Adverse Event|0
223572|NCT00112437|734810|P7|Year 1 (12-Month Base Study)|Adverse Event|0
223573|NCT00112437|734811|P6|Year 1 (12-Month Base Study)|Adverse Event|0
223574|NCT00112437|734812|P5|Year 1 (12-Month Base Study)|Adverse Event|3
223575|NCT00112437|734813|P4|Year 1 (12-Month Base Study)|Adverse Event|4
223576|NCT00112437|734814|P3|Year 1 (12-Month Base Study)|Adverse Event|6
223577|NCT00112437|734815|P2|Year 1 (12-Month Base Study)|Adverse Event|10
223578|NCT00112437|734816|P1|Year 1 (12-Month Base Study)|Adverse Event|9
223579|NCT00112385|735096|P2|Overall Study|Withdrawal by Subject|1
223580|NCT00112385|735097|P1|Overall Study|Withdrawal by Subject|0
223581|NCT00112385|735096|P2|Overall Study|Lost to Follow-up|0
223582|NCT00112385|735097|P1|Overall Study|Lost to Follow-up|1
223583|NCT00112359|735187|P2|Overall Study|Other|0
223584|NCT00112359|735188|P1|Overall Study|Other|3
223585|NCT00112359|735187|P2|Overall Study|Personal/administrative|1
223586|NCT00112359|735188|P1|Overall Study|Personal/administrative|1
223587|NCT00112359|735187|P2|Overall Study|Lost to Follow-up|1
223588|NCT00112359|735188|P1|Overall Study|Lost to Follow-up|0
223589|NCT00112359|735187|P2|Overall Study|Related adverse event|3
223590|NCT00112359|735188|P1|Overall Study|Related adverse event|5
223591|NCT00112359|735187|P2|Overall Study|Trial drug intolerance (adverse event)|0
223592|NCT00112359|735188|P1|Overall Study|Trial drug intolerance (adverse event)|2
223593|NCT00112359|735187|P2|Overall Study|Unrelated adverse event|8
223594|NCT00112359|735188|P1|Overall Study|Unrelated adverse event|16
223595|NCT00112294|735214|P2|Overall Study|Still on study|0
223596|NCT00112294|735215|P1|Overall Study|Still on study|5
223597|NCT00112047|735438|P2|Atripla Phase|Not specified|1
223598|NCT00112047|735439|P1|Atripla Phase|Not specified|3
223599|NCT00112047|735438|P2|Atripla Phase|Non-compliance|0
223600|NCT00112047|735439|P1|Atripla Phase|Non-compliance|1
223601|NCT00112047|735438|P2|Atripla Phase|Sub-optimal virological response|1
223602|NCT00112047|735439|P1|Atripla Phase|Sub-optimal virological response|0
223603|NCT00112047|735438|P2|Atripla Phase|Withdrew consent|7
223604|NCT00112047|735439|P1|Atripla Phase|Withdrew consent|7
223605|NCT00112047|735438|P2|Atripla Phase|Death|2
223606|NCT00112047|735439|P1|Atripla Phase|Death|0
223607|NCT00112047|735438|P2|Atripla Phase|Pregnancy|1
223608|NCT00112047|735439|P1|Atripla Phase|Pregnancy|0
223609|NCT00112047|735438|P2|Atripla Phase|Lost to Follow-up|7
223610|NCT00112047|735439|P1|Atripla Phase|Lost to Follow-up|5
223611|NCT00112047|735438|P2|Atripla Phase|Adverse Event|1
223612|NCT00112047|735439|P1|Atripla Phase|Adverse Event|2
223613|NCT00112047|735438|P2|Randomized Phase|High Hepatitis B DNA|1
223614|NCT00112047|735439|P1|Randomized Phase|High Hepatitis B DNA|0
223615|NCT00112047|735438|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
223616|NCT00112047|735439|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
223617|NCT00112047|735438|P2|Randomized Phase|Moved out of State|1
223618|NCT00112047|735439|P1|Randomized Phase|Moved out of State|0
223619|NCT00112047|735438|P2|Randomized Phase|Incarceration|2
223620|NCT00112047|735439|P1|Randomized Phase|Incarceration|3
223621|NCT00112047|735438|P2|Randomized Phase|Inability to swallow pills|1
223622|NCT00112047|735439|P1|Randomized Phase|Inability to swallow pills|0
223623|NCT00112047|735438|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
223624|NCT00112047|735439|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
223625|NCT00112047|735438|P2|Randomized Phase|Death|3
223626|NCT00112047|735439|P1|Randomized Phase|Death|1
223627|NCT00112047|735438|P2|Randomized Phase|Pregnancy|1
223628|NCT00112047|735439|P1|Randomized Phase|Pregnancy|3
223629|NCT00112047|735438|P2|Randomized Phase|Protocol Violation|0
223630|NCT00112047|735439|P1|Randomized Phase|Protocol Violation|2
223631|NCT00112047|735438|P2|Randomized Phase|Noncompliance|4
223632|NCT00112047|735439|P1|Randomized Phase|Noncompliance|8
223633|NCT00112047|735438|P2|Randomized Phase|Sub-optimal virological response|13
223634|NCT00112047|735439|P1|Randomized Phase|Sub-optimal virological response|3
223635|NCT00112047|735438|P2|Randomized Phase|Withrawal of consent|18
223636|NCT00112047|735439|P1|Randomized Phase|Withrawal of consent|10
223637|NCT00112047|735438|P2|Randomized Phase|Adverse Event|10
223638|NCT00112047|735439|P1|Randomized Phase|Adverse Event|10
223639|NCT00112047|735438|P2|Randomized Phase|Lost to Follow-up|33
223640|NCT00112047|735439|P1|Randomized Phase|Lost to Follow-up|26
223641|NCT00111917|735539|P2|Overall Study|Withdrawal by Subject|1
223642|NCT00111917|735540|P1|Overall Study|Withdrawal by Subject|1
223643|NCT00111839|735555|P3|Overall Study|Randomized but Not Treated|2
223644|NCT00111839|735556|P2|Overall Study|Randomized but Not Treated|0
223645|NCT00111839|735557|P1|Overall Study|Randomized but Not Treated|0
223646|NCT00111839|735555|P3|Overall Study|Other|3
223647|NCT00111839|735556|P2|Overall Study|Other|3
223648|NCT00111839|735557|P1|Overall Study|Other|6
223649|NCT00111839|735555|P3|Overall Study|Logistical Constraint|0
223650|NCT00111839|735556|P2|Overall Study|Logistical Constraint|0
223651|NCT00111839|735557|P1|Overall Study|Logistical Constraint|1
223652|NCT00111839|735555|P3|Overall Study|Lost to Follow-up|0
223653|NCT00111839|735556|P2|Overall Study|Lost to Follow-up|0
223654|NCT00111839|735557|P1|Overall Study|Lost to Follow-up|1
223655|NCT00111839|735555|P3|Overall Study|Withdrawal by Subject|2
223656|NCT00111839|735556|P2|Overall Study|Withdrawal by Subject|2
223657|NCT00111839|735557|P1|Overall Study|Withdrawal by Subject|2
223658|NCT00111839|735555|P3|Overall Study|Death|6
223659|NCT00111839|735556|P2|Overall Study|Death|1
223660|NCT00111839|735557|P1|Overall Study|Death|1
223661|NCT00111839|735555|P3|Overall Study|Protocol Violation|2
223662|NCT00111839|735556|P2|Overall Study|Protocol Violation|4
223663|NCT00111839|735557|P1|Overall Study|Protocol Violation|2
223664|NCT00111839|735555|P3|Overall Study|Adverse Event|1
223665|NCT00111839|735556|P2|Overall Study|Adverse Event|3
223666|NCT00111839|735557|P1|Overall Study|Adverse Event|5
223667|NCT00111839|735555|P3|Overall Study|Disease Progression|33
223668|NCT00111839|735556|P2|Overall Study|Disease Progression|33
223669|NCT00111839|735557|P1|Overall Study|Disease Progression|30
223670|NCT00111813|735577|P6|Overall Study|Not specified|0
223671|NCT00111813|735578|P5|Overall Study|Not specified|0
223672|NCT00111813|735579|P4|Overall Study|Not specified|0
223673|NCT00111813|735580|P3|Overall Study|Not specified|1
223674|NCT00111813|735581|P2|Overall Study|Not specified|0
223675|NCT00111813|735582|P1|Overall Study|Not specified|0
223676|NCT00111813|735577|P6|Overall Study|Lack of Efficacy|1
223677|NCT00111813|735578|P5|Overall Study|Lack of Efficacy|0
223678|NCT00111813|735579|P4|Overall Study|Lack of Efficacy|0
223679|NCT00111813|735580|P3|Overall Study|Lack of Efficacy|0
223680|NCT00111813|735581|P2|Overall Study|Lack of Efficacy|0
223681|NCT00111813|735582|P1|Overall Study|Lack of Efficacy|0
223682|NCT00111813|735577|P6|Overall Study|Progressive disease|3
223683|NCT00111813|735578|P5|Overall Study|Progressive disease|4
223684|NCT00111813|735579|P4|Overall Study|Progressive disease|3
223685|NCT00111813|735580|P3|Overall Study|Progressive disease|5
223686|NCT00111813|735581|P2|Overall Study|Progressive disease|1
223687|NCT00111813|735582|P1|Overall Study|Progressive disease|2
223688|NCT00111813|735577|P6|Overall Study|Adverse Event|2
223689|NCT00111813|735578|P5|Overall Study|Adverse Event|2
223690|NCT00111813|735579|P4|Overall Study|Adverse Event|2
223691|NCT00111813|735580|P3|Overall Study|Adverse Event|4
223692|NCT00111813|735581|P2|Overall Study|Adverse Event|2
223693|NCT00111813|735582|P1|Overall Study|Adverse Event|1
223694|NCT00111800|735621|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
223695|NCT00111800|735622|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
223696|NCT00111800|735623|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
223697|NCT00111800|735624|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
223698|NCT00111800|735625|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
223699|NCT00111800|735626|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
223700|NCT00111800|735621|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
223701|NCT00111800|735622|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
223702|NCT00111800|735623|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
223703|NCT00111800|735624|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
223704|NCT00111800|735625|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
223705|NCT00111800|735626|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
223706|NCT00111800|735621|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
223707|NCT00111800|735622|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
223708|NCT00111800|735623|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
223709|NCT00111800|735624|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
223710|NCT00111800|735625|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
223711|NCT00111800|735626|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
223712|NCT00111800|735621|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
223713|NCT00111800|735622|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
223714|NCT00111800|735623|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
223715|NCT00111800|735624|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
223716|NCT00111800|735625|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
223717|NCT00111800|735626|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
223718|NCT00111800|735621|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
223719|NCT00111800|735622|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
223720|NCT00111800|735623|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
223721|NCT00111800|735624|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
223722|NCT00111800|735625|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
223723|NCT00111800|735626|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
223724|NCT00111800|735621|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
223725|NCT00111800|735622|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
223726|NCT00111800|735623|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
223727|NCT00111800|735624|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
223728|NCT00111800|735625|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
223729|NCT00111800|735626|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
223730|NCT00111800|735621|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
223731|NCT00111800|735622|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
223732|NCT00111800|735623|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
223733|NCT00111800|735624|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
223734|NCT00111800|735625|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
223735|NCT00111800|735626|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
223736|NCT00111800|735621|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
223737|NCT00111800|735622|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
223738|NCT00111800|735623|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
223739|NCT00111800|735624|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
223740|NCT00111800|735625|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
223741|NCT00111800|735626|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
223742|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
223743|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
223744|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
223745|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
223746|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
223747|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
223748|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
223749|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
223750|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
223751|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
223752|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
223753|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
223754|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
223755|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
223756|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
223757|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
223758|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
223759|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
223760|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
223761|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
223762|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
223763|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
223764|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
223765|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
223766|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
223767|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
223768|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
223769|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
223770|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
223771|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
223772|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
223773|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
223774|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
223775|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
223776|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
223777|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
223778|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
223779|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
223780|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
223781|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
223782|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
223783|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
223784|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
223785|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
223786|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
223787|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
223788|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
223789|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
223790|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
223791|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
223792|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
223793|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
223794|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
223795|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
223796|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
223797|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
223798|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
223799|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
223800|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
223801|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
223802|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
223803|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
223804|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
223805|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
223806|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
223807|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
223808|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
223809|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
223810|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
223811|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
223812|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
223813|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
223814|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
223815|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
223816|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
223817|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
223818|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
223819|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
223820|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
223821|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
223822|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
223823|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
223824|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
223825|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
223826|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
223827|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
223828|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
223829|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
223830|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
223831|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
223832|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
223833|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
223834|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
223835|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
223836|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
223837|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
223838|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
223839|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
223840|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
223841|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
223842|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
223843|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
223844|NCT00111800|735621|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
223845|NCT00111800|735622|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
223846|NCT00111800|735623|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
223847|NCT00111800|735624|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
223848|NCT00111800|735625|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
223849|NCT00111800|735626|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
223850|NCT00111761|735796|P2|Part 2|Other|0
223851|NCT00111761|735797|P1|Part 2|Other|1
223852|NCT00111761|735796|P2|Part 2|Protocol-specified criteria|0
223853|NCT00111761|735797|P1|Part 2|Protocol-specified criteria|1
223854|NCT00111761|735796|P2|Part 2|Disease progression|0
223855|NCT00111761|735797|P1|Part 2|Disease progression|3
223856|NCT00111761|735796|P2|Part 2|Death|0
223857|NCT00111761|735797|P1|Part 2|Death|1
223858|NCT00111761|735796|P2|Part 2|Physician Decision|0
223859|NCT00111761|735797|P1|Part 2|Physician Decision|1
223860|NCT00111761|735796|P2|Part 2|Adverse Event|0
223861|NCT00111761|735797|P1|Part 2|Adverse Event|1
223862|NCT00111761|735796|P2|Part 1|Withdrawal by Subject|1
223863|NCT00111761|735797|P1|Part 1|Withdrawal by Subject|0
223864|NCT00111761|735796|P2|Part 1|Other|1
223865|NCT00111761|735797|P1|Part 1|Other|0
223866|NCT00111761|735796|P2|Part 1|Death|2
223867|NCT00111761|735797|P1|Part 1|Death|0
223868|NCT00111761|735796|P2|Part 1|Physician Decision|1
223869|NCT00111761|735797|P1|Part 1|Physician Decision|0
223870|NCT00111007|735826|P2|Long Term Follow-up|Missing|3
223871|NCT00111007|735827|P1|Long Term Follow-up|Missing|10
223872|NCT00111007|735826|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
223873|NCT00111007|735827|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
223874|NCT00111007|735826|P2|Long Term Follow-up|Withdrawal by Subject|1
223875|NCT00111007|735827|P1|Long Term Follow-up|Withdrawal by Subject|0
223876|NCT00111007|735826|P2|Long Term Follow-up|Lost to Follow-up|1
223877|NCT00111007|735827|P1|Long Term Follow-up|Lost to Follow-up|1
223878|NCT00111007|735826|P2|Long Term Follow-up|Death|39
223879|NCT00111007|735827|P1|Long Term Follow-up|Death|34
223880|NCT00111007|735826|P2|Active Follow-up|Disease progression/recurrence/relapse|2
223881|NCT00111007|735827|P1|Active Follow-up|Disease progression/recurrence/relapse|3
223882|NCT00111007|735826|P2|Active Follow-up|Death|0
223883|NCT00111007|735827|P1|Active Follow-up|Death|2
223884|NCT00111007|735826|P2|Active Follow-up|Adverse Event|0
223885|NCT00111007|735827|P1|Active Follow-up|Adverse Event|1
223886|NCT00111007|735826|P2|Double-blind (DB) Treatment|Primary reason with other category|1
223887|NCT00111007|735827|P1|Double-blind (DB) Treatment|Primary reason with other category|0
223888|NCT00111007|735826|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
223889|NCT00111007|735827|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
223890|NCT00111007|735826|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
223891|NCT00111007|735827|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
223892|NCT00111007|735826|P2|Double-blind (DB) Treatment|Relapse|0
223893|NCT00111007|735827|P1|Double-blind (DB) Treatment|Relapse|1
223894|NCT00111007|735826|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
223895|NCT00111007|735827|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
223896|NCT00111007|735826|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
223897|NCT00111007|735827|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
223898|NCT00111007|735826|P2|Double-blind (DB) Treatment|Protocol Violation|1
223899|NCT00111007|735827|P1|Double-blind (DB) Treatment|Protocol Violation|0
223900|NCT00111007|735826|P2|Double-blind (DB) Treatment|Death|2
223901|NCT00111007|735827|P1|Double-blind (DB) Treatment|Death|5
223902|NCT00111007|735826|P2|Double-blind (DB) Treatment|Adverse Event|4
223903|NCT00111007|735827|P1|Double-blind (DB) Treatment|Adverse Event|12
223904|NCT00110994|735843|P2|Long Term Follow-up|Death|17
223905|NCT00110994|735844|P1|Long Term Follow-up|Death|19
223906|NCT00110994|735843|P2|Active Follow-up|Other reasons|2
223907|NCT00110994|735844|P1|Active Follow-up|Other reasons|0
223908|NCT00110994|735843|P2|Active Follow-up|Disease progression/recurrence/replace|0
223909|NCT00110994|735844|P1|Active Follow-up|Disease progression/recurrence/replace|1
223910|NCT00110994|735843|P2|Double-blind (DB) Treatment|other reasons|3
223911|NCT00110994|735844|P1|Double-blind (DB) Treatment|other reasons|2
223912|NCT00110994|735843|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
223913|NCT00110994|735844|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
223914|NCT00110994|735843|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
223915|NCT00110994|735844|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
223916|NCT00110994|735843|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
223917|NCT00110994|735844|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
223918|NCT00110994|735843|P2|Double-blind (DB) Treatment|Death|0
223919|NCT00110994|735844|P1|Double-blind (DB) Treatment|Death|1
223920|NCT00110994|735843|P2|Double-blind (DB) Treatment|Adverse Event|0
223921|NCT00110994|735844|P1|Double-blind (DB) Treatment|Adverse Event|3
223922|NCT00110890|735870|P2|Overall Study|Did not enter follow-up phase|4
223923|NCT00110890|735871|P1|Overall Study|Did not enter follow-up phase|10
223924|NCT00110890|735870|P2|Overall Study|Parathyroidectomy|1
223925|NCT00110890|735871|P1|Overall Study|Parathyroidectomy|0
223926|NCT00110890|735870|P2|Overall Study|Disease progression|1
223927|NCT00110890|735871|P1|Overall Study|Disease progression|0
223928|NCT00110890|735870|P2|Overall Study|Requirement for alternative therapy|1
223929|NCT00110890|735871|P1|Overall Study|Requirement for alternative therapy|0
223930|NCT00110890|735870|P2|Overall Study|Ineligibility determined|0
223931|NCT00110890|735871|P1|Overall Study|Ineligibility determined|3
223932|NCT00110890|735870|P2|Overall Study|Other|23
223933|NCT00110890|735871|P1|Overall Study|Other|34
223934|NCT00110890|735870|P2|Overall Study|Invest. Product Commercially Available|110
223935|NCT00110890|735871|P1|Overall Study|Invest. Product Commercially Available|217
223936|NCT00110890|735870|P2|Overall Study|Kidney Transplant|12
223937|NCT00110890|735871|P1|Overall Study|Kidney Transplant|16
223938|NCT00110890|735870|P2|Overall Study|Noncompliance|0
223939|NCT00110890|735871|P1|Overall Study|Noncompliance|10
223940|NCT00110890|735870|P2|Overall Study|Protocol Deviation|0
223941|NCT00110890|735871|P1|Overall Study|Protocol Deviation|1
223942|NCT00110890|735870|P2|Overall Study|Withdrawal by Subject|5
223943|NCT00110890|735871|P1|Overall Study|Withdrawal by Subject|17
223944|NCT00110890|735870|P2|Overall Study|Physician Decision|5
223945|NCT00110890|735871|P1|Overall Study|Physician Decision|4
223946|NCT00110890|735870|P2|Overall Study|Lost to Follow-up|1
223947|NCT00110890|735871|P1|Overall Study|Lost to Follow-up|3
223948|NCT00110890|735870|P2|Overall Study|Death|9
223949|NCT00110890|735871|P1|Overall Study|Death|16
223950|NCT00110890|735870|P2|Overall Study|Adverse Event|7
223951|NCT00110890|735871|P1|Overall Study|Adverse Event|30
223952|NCT00110812|735888|P3|Extended Follow-up|Lost to Follow-up|1
223953|NCT00110812|735889|P2|Extended Follow-up|Lost to Follow-up|3
223954|NCT00110812|735890|P1|Extended Follow-up|Lost to Follow-up|1
223955|NCT00110812|735888|P3|Extended Follow-up|Withdrawal by Subject|0
223956|NCT00110812|735889|P2|Extended Follow-up|Withdrawal by Subject|1
223957|NCT00110812|735890|P1|Extended Follow-up|Withdrawal by Subject|0
223958|NCT00110812|735888|P3|Extended Follow-up|Death|3
223959|NCT00110812|735889|P2|Extended Follow-up|Death|0
223960|NCT00110812|735890|P1|Extended Follow-up|Death|1
223961|NCT00110812|735888|P3|Main Study|Lost to Follow-up|10
223962|NCT00110812|735889|P2|Main Study|Lost to Follow-up|11
223963|NCT00110812|735890|P1|Main Study|Lost to Follow-up|8
223964|NCT00110812|735888|P3|Main Study|Withdrawal by Subject|1
223965|NCT00110812|735889|P2|Main Study|Withdrawal by Subject|0
223966|NCT00110812|735890|P1|Main Study|Withdrawal by Subject|0
223967|NCT00110812|735888|P3|Main Study|Death|2
223968|NCT00110812|735889|P2|Main Study|Death|0
223969|NCT00110812|735890|P1|Main Study|Death|0
223970|NCT00110617|735935|P2|Overall Study|Did not receive study drug|12
223971|NCT00110617|735936|P1|Overall Study|Did not receive study drug|0
223972|NCT00110617|735935|P2|Overall Study|Death|1
223973|NCT00110617|735936|P1|Overall Study|Death|1
223974|NCT00110617|735935|P2|Overall Study|Administrative problems|5
223975|NCT00110617|735936|P1|Overall Study|Administrative problems|6
223976|NCT00110617|735935|P2|Overall Study|Lost to Follow-up|1
223977|NCT00110617|735936|P1|Overall Study|Lost to Follow-up|9
223978|NCT00110617|735935|P2|Overall Study|Withdrawal by Subject|4
223979|NCT00110617|735936|P1|Overall Study|Withdrawal by Subject|10
223980|NCT00110617|735935|P2|Overall Study|Protocol Violation|0
223981|NCT00110617|735936|P1|Overall Study|Protocol Violation|5
223982|NCT00110617|735935|P2|Overall Study|Patient no longer requires study drug|0
223983|NCT00110617|735936|P1|Overall Study|Patient no longer requires study drug|1
223984|NCT00110617|735935|P2|Overall Study|Lack of Efficacy|0
223985|NCT00110617|735936|P1|Overall Study|Lack of Efficacy|1
223986|NCT00110617|735935|P2|Overall Study|Abnormal Laboratory Value|2
223987|NCT00110617|735936|P1|Overall Study|Abnormal Laboratory Value|4
223988|NCT00110617|735935|P2|Overall Study|Adverse Event|4
223989|NCT00110617|735936|P1|Overall Study|Adverse Event|2
223990|NCT00110396|736053|P1|Overall Study|Patient is to be administered copaxone|1
223991|NCT00110396|736053|P1|Overall Study|The patient has refused to visit site|1
223992|NCT00110396|736053|P1|Overall Study|The patient has refused|2
223993|NCT00110396|736053|P1|Overall Study|Patient refused to come back|1
223994|NCT00110396|736053|P1|Overall Study|Protocol Violation|2
223995|NCT00110396|736053|P1|Overall Study|Pregnancy (Protocol violation)|2
223996|NCT00110396|736053|P1|Overall Study|Pregnancy|1
223997|NCT00110396|736053|P1|Overall Study|Participation in MS vaccine study|1
223998|NCT00110396|736053|P1|Overall Study|Patient's decision|1
223999|NCT00110396|736053|P1|Overall Study|Patient will|1
224000|NCT00110396|736053|P1|Overall Study|Patient refused to participate|1
224001|NCT00110396|736053|P1|Overall Study|Patient refused to continue|1
224002|NCT00110396|736053|P1|Overall Study|Patient non-compliance|1
224003|NCT00110396|736053|P1|Overall Study|Decided not to continue treatment|1
224004|NCT00110396|736053|P1|Overall Study|Lack of Efficacy|1
224005|NCT00110396|736053|P1|Overall Study|Initiated mitoxantrone therapy|1
224006|NCT00110396|736053|P1|Overall Study|Administration of plasmapheresis|1
224007|NCT00110396|736053|P1|Overall Study|Lost to Follow-up|1
224008|NCT00110396|736053|P1|Overall Study|Adverse Event|15
224009|NCT00110357|736061|P2|Overall Study|Withdrawal by Subject|1
224010|NCT00110357|736062|P1|Overall Study|Withdrawal by Subject|3
224011|NCT00110357|736061|P2|Overall Study|Study Drug Toxicity|3
224012|NCT00110357|736062|P1|Overall Study|Study Drug Toxicity|1
224013|NCT00110357|736061|P2|Overall Study|Study Closure|0
224014|NCT00110357|736062|P1|Overall Study|Study Closure|1
224015|NCT00110357|736061|P2|Overall Study|Disease progression/relapse|15
224016|NCT00110357|736062|P1|Overall Study|Disease progression/relapse|20
224017|NCT00110357|736061|P2|Overall Study|Deterioration without progression|0
224018|NCT00110357|736062|P1|Overall Study|Deterioration without progression|2
224019|NCT00110305|736150|P2|Overall Study|Other|2
224020|NCT00110305|736151|P1|Overall Study|Other|8
224021|NCT00110305|736150|P2|Overall Study|Lost to Follow-up|3
224022|NCT00110305|736151|P1|Overall Study|Lost to Follow-up|20
224023|NCT00110305|736150|P2|Overall Study|Withdrawal by Subject|7
224024|NCT00110305|736151|P1|Overall Study|Withdrawal by Subject|7
224025|NCT00110305|736150|P2|Overall Study|Protocol Violation|1
224026|NCT00110305|736151|P1|Overall Study|Protocol Violation|0
224027|NCT00110305|736150|P2|Overall Study|Subject Reached A Virologic Endpoint|3
224028|NCT00110305|736151|P1|Overall Study|Subject Reached A Virologic Endpoint|21
224029|NCT00110305|736150|P2|Overall Study|Subject Ineligible To Continue The Trial|1
224030|NCT00110305|736151|P1|Overall Study|Subject Ineligible To Continue The Trial|2
224031|NCT00110305|736150|P2|Overall Study|Subject Non-Compliant|2
224032|NCT00110305|736151|P1|Overall Study|Subject Non-Compliant|9
224033|NCT00110305|736150|P2|Overall Study|Sponsors Decision|0
224034|NCT00110305|736151|P1|Overall Study|Sponsors Decision|1
224035|NCT00110305|736150|P2|Overall Study|Adverse Event|13
224036|NCT00110305|736151|P1|Overall Study|Adverse Event|46
224037|NCT00110214|736204|P2|Overall Study|Other (not specified)|75
224038|NCT00110214|736205|P1|Overall Study|Other (not specified)|61
224039|NCT00110214|736204|P2|Overall Study|Refused further treatment|65
224040|NCT00110214|736205|P1|Overall Study|Refused further treatment|52
224041|NCT00110214|736204|P2|Overall Study|Adverse Event|192
224042|NCT00110214|736205|P1|Overall Study|Adverse Event|115
224043|NCT00110214|736204|P2|Overall Study|Disease progression or death|151
224044|NCT00110214|736205|P1|Overall Study|Disease progression or death|260
224045|NCT00110214|736204|P2|Overall Study|Never started treatment|20
224046|NCT00110214|736205|P1|Overall Study|Never started treatment|21
224047|NCT00110149|736217|P1|Overall Study|Physician Decision|3
224048|NCT00110084|736231|P1|Overall Study|Other|2
224049|NCT00110084|736231|P1|Overall Study|Intercurrent Illness|1
224050|NCT00110084|736231|P1|Overall Study|Alternate Therapy|5
224051|NCT00110084|736231|P1|Overall Study|Patient Refusal|10
224052|NCT00110084|736231|P1|Overall Study|Death|1
224053|NCT00110084|736231|P1|Overall Study|Adverse Event|9
224054|NCT00110019|736240|P2|Overall Study|other reasons|30
224055|NCT00110019|736241|P1|Overall Study|other reasons|22
224056|NCT00110019|736240|P2|Overall Study|Not start protocol therapy|16
224057|NCT00110019|736241|P1|Overall Study|Not start protocol therapy|17
224058|NCT00110019|736240|P2|Overall Study|symptom deterioration|16
224059|NCT00110019|736241|P1|Overall Study|symptom deterioration|13
224060|NCT00110019|736240|P2|Overall Study|complicating disease|1
224061|NCT00110019|736241|P1|Overall Study|complicating disease|1
224062|NCT00110019|736240|P2|Overall Study|alternative therapy|1
224063|NCT00110019|736241|P1|Overall Study|alternative therapy|5
224064|NCT00110019|736240|P2|Overall Study|Withdrawal by Subject|9
224065|NCT00110019|736241|P1|Overall Study|Withdrawal by Subject|21
224066|NCT00110019|736240|P2|Overall Study|Death|15
224067|NCT00110019|736241|P1|Overall Study|Death|13
224068|NCT00110019|736240|P2|Overall Study|Adverse Event|40
224069|NCT00110019|736241|P1|Overall Study|Adverse Event|61
224070|NCT00110019|736240|P2|Overall Study|Lack of Efficacy|285
224071|NCT00110019|736241|P1|Overall Study|Lack of Efficacy|253
224072|NCT00109967|736253|P2|Overall Study|Death|2
224073|NCT00109967|736254|P1|Overall Study|Death|0
224074|NCT00109967|736253|P2|Overall Study|Physician Decision|3
224075|NCT00109967|736254|P1|Overall Study|Physician Decision|1
224076|NCT00109967|736253|P2|Overall Study|Withdrawal by Subject|0
224077|NCT00109967|736254|P1|Overall Study|Withdrawal by Subject|5
224078|NCT00109967|736253|P2|Overall Study|Adverse Event|1
224079|NCT00109967|736254|P1|Overall Study|Adverse Event|12
224080|NCT00109967|736253|P2|Overall Study|Cancel Prior to Treatment|0
224081|NCT00109967|736254|P1|Overall Study|Cancel Prior to Treatment|2
224082|NCT00109928|736268|P1|Overall Study|not eligible|1
224083|NCT00109928|736268|P1|Overall Study|not protocol specified|2
224084|NCT00109928|736268|P1|Overall Study|Death|2
224085|NCT00109928|736268|P1|Overall Study|Progression|6
224086|NCT00109928|736268|P1|Overall Study|Adverse Event|2
224087|NCT00109850|736285|P1|Overall Study|Ineligible|1
224088|NCT00109850|736285|P1|Overall Study|Death|2
224089|NCT00109850|736285|P1|Overall Study|Adverse Event|1
224090|NCT00109837|736292|P1|Overall Study|Ineligible|1
224091|NCT00109837|736292|P1|Overall Study|Not treated|1
224092|NCT00109837|736292|P1|Overall Study|BCR/ABL+ or Ph+|17
224093|NCT00109837|736292|P1|Overall Study|Death|1
224094|NCT00109837|736292|P1|Overall Study|Refusal unrelated to adverse effects|1
224095|NCT00109837|736292|P1|Overall Study|Adverse Event|2
224096|NCT00109772|736302|P2|Open-label Extension|not specified|10
224097|NCT00109772|736303|P1|Open-label Extension|not specified|4
224098|NCT00109772|736302|P2|Open-label Extension|Protocol Violation|2
224099|NCT00109772|736303|P1|Open-label Extension|Protocol Violation|2
224100|NCT00109772|736302|P2|Open-label Extension|Death|1
224101|NCT00109772|736303|P1|Open-label Extension|Death|0
224102|NCT00109772|736302|P2|Open-label Extension|Lost to Follow-up|0
224103|NCT00109772|736303|P1|Open-label Extension|Lost to Follow-up|1
224104|NCT00109772|736302|P2|Open-label Extension|Withdrawal by Subject|6
224105|NCT00109772|736303|P1|Open-label Extension|Withdrawal by Subject|9
224106|NCT00109772|736302|P2|Open-label Extension|Lack of Efficacy|11
224107|NCT00109772|736303|P1|Open-label Extension|Lack of Efficacy|19
224108|NCT00109772|736302|P2|Open-label Extension|Adverse Event|19
224109|NCT00109772|736303|P1|Open-label Extension|Adverse Event|10
224110|NCT00109772|736302|P2|Double-blind Treatment|Withdrew prior to treatment|1
224111|NCT00109772|736303|P1|Double-blind Treatment|Withdrew prior to treatment|3
224112|NCT00109772|736302|P2|Double-blind Treatment|not specified|4
224113|NCT00109772|736303|P1|Double-blind Treatment|not specified|0
224114|NCT00109772|736302|P2|Double-blind Treatment|Protocol Violation|1
224115|NCT00109772|736303|P1|Double-blind Treatment|Protocol Violation|0
224116|NCT00109772|736302|P2|Double-blind Treatment|Lost to Follow-up|3
224117|NCT00109772|736303|P1|Double-blind Treatment|Lost to Follow-up|2
224118|NCT00109772|736302|P2|Double-blind Treatment|Withdrawal by Subject|1
224119|NCT00109772|736303|P1|Double-blind Treatment|Withdrawal by Subject|2
224120|NCT00109772|736302|P2|Double-blind Treatment|Lack of Efficacy|0
224121|NCT00109772|736303|P1|Double-blind Treatment|Lack of Efficacy|1
224122|NCT00109772|736302|P2|Double-blind Treatment|Adverse Event|5
224123|NCT00109772|736303|P1|Double-blind Treatment|Adverse Event|14
224124|NCT00109733|736343|P2|Overall Study|Could not commit time for study|1
224125|NCT00109733|736344|P1|Overall Study|Could not commit time for study|1
224126|NCT00109733|736343|P2|Overall Study|Non-compliant|1
224127|NCT00109733|736344|P1|Overall Study|Non-compliant|0
224128|NCT00109733|736343|P2|Overall Study|Stopped taking study drug|1
224129|NCT00109733|736344|P1|Overall Study|Stopped taking study drug|1
224130|NCT00109733|736343|P2|Overall Study|Protocol Violation|1
224131|NCT00109733|736344|P1|Overall Study|Protocol Violation|0
224132|NCT00109590|736361|P3|Overall Study|Never Started Treatment|3
224133|NCT00109590|736362|P2|Overall Study|Never Started Treatment|2
224134|NCT00109590|736363|P1|Overall Study|Never Started Treatment|1
224135|NCT00109590|736361|P3|Overall Study|Lost to Follow-up|1
224136|NCT00109590|736362|P2|Overall Study|Lost to Follow-up|0
224137|NCT00109590|736363|P1|Overall Study|Lost to Follow-up|1
224138|NCT00109577|736405|P2|Overall Study|Withdrawal by Subject|3
224139|NCT00109577|736406|P1|Overall Study|Withdrawal by Subject|3
224140|NCT00109343|736437|P3|Overall Study|Other|1
224141|NCT00109343|736438|P2|Overall Study|Other|2
224142|NCT00109343|736439|P1|Overall Study|Other|5
224143|NCT00109343|736437|P3|Overall Study|Subject Moved|1
224144|NCT00109343|736438|P2|Overall Study|Subject Moved|2
224145|NCT00109343|736439|P1|Overall Study|Subject Moved|6
224146|NCT00109343|736437|P3|Overall Study|Withdrawal by Subject|10
224147|NCT00109343|736438|P2|Overall Study|Withdrawal by Subject|11
224148|NCT00109343|736439|P1|Overall Study|Withdrawal by Subject|15
224149|NCT00109343|736437|P3|Overall Study|Protocol Violation|2
224150|NCT00109343|736438|P2|Overall Study|Protocol Violation|2
224151|NCT00109343|736439|P1|Overall Study|Protocol Violation|1
224152|NCT00109343|736437|P3|Overall Study|Lost to Follow-up|14
224153|NCT00109343|736438|P2|Overall Study|Lost to Follow-up|20
224154|NCT00109343|736439|P1|Overall Study|Lost to Follow-up|35
224155|NCT00109343|736437|P3|Overall Study|Lack of Efficacy|0
224156|NCT00109343|736438|P2|Overall Study|Lack of Efficacy|0
224157|NCT00109343|736439|P1|Overall Study|Lack of Efficacy|1
224158|NCT00109343|736437|P3|Overall Study|Adverse Event|2
224159|NCT00109343|736438|P2|Overall Study|Adverse Event|0
224160|NCT00109343|736439|P1|Overall Study|Adverse Event|1
224161|NCT00109031|736484|P4|Overall Study|Protocol Violation|0
224162|NCT00109031|736485|P3|Overall Study|Protocol Violation|1
224163|NCT00109031|736486|P2|Overall Study|Protocol Violation|0
224164|NCT00109031|736487|P1|Overall Study|Protocol Violation|0
224165|NCT00109031|736484|P4|Overall Study|Physician Decision|0
224166|NCT00109031|736485|P3|Overall Study|Physician Decision|0
224167|NCT00109031|736486|P2|Overall Study|Physician Decision|1
224168|NCT00109031|736487|P1|Overall Study|Physician Decision|0
224169|NCT00109031|736484|P4|Overall Study|Withdrawal by Subject|0
224170|NCT00109031|736485|P3|Overall Study|Withdrawal by Subject|0
224171|NCT00109031|736486|P2|Overall Study|Withdrawal by Subject|1
224172|NCT00109031|736487|P1|Overall Study|Withdrawal by Subject|0
224173|NCT00109031|736484|P4|Overall Study|Adverse Event|0
224174|NCT00109031|736485|P3|Overall Study|Adverse Event|1
224175|NCT00109031|736486|P2|Overall Study|Adverse Event|0
224176|NCT00109031|736487|P1|Overall Study|Adverse Event|0
224177|NCT00108953|736538|P2|Follow-up|Study terminated by sponsor|6
224178|NCT00108953|736539|P1|Follow-up|Study terminated by sponsor|10
224179|NCT00108953|736538|P2|Follow-up|Lost to Follow-up|1
224180|NCT00108953|736539|P1|Follow-up|Lost to Follow-up|1
224181|NCT00108953|736538|P2|Follow-up|Death|26
224182|NCT00108953|736539|P1|Follow-up|Death|18
224183|NCT00108862|736561|P2|Overall Study|Lost to Follow-up|19
224184|NCT00108862|736562|P1|Overall Study|Lost to Follow-up|27
224185|NCT00108862|736561|P2|Overall Study|Withdrawal by Subject|6
224186|NCT00108862|736562|P1|Overall Study|Withdrawal by Subject|10
224187|NCT00108862|736561|P2|Overall Study|Death|37
224188|NCT00108862|736562|P1|Overall Study|Death|31
224189|NCT00108732|736590|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
224190|NCT00108732|736590|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
224191|NCT00108732|736590|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
224192|NCT00108732|736590|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
224193|NCT00108732|736590|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
224194|NCT00108732|736590|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
224195|NCT00108732|736590|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
224196|NCT00108628|736599|P2|Overall Study|Death|0
224197|NCT00108628|736600|P1|Overall Study|Death|1
224198|NCT00108628|736599|P2|Overall Study|Lack of Efficacy|1
224199|NCT00108628|736600|P1|Overall Study|Lack of Efficacy|2
224200|NCT00108628|736599|P2|Overall Study|Withdrawal by Subject|9
224201|NCT00108628|736600|P1|Overall Study|Withdrawal by Subject|17
224202|NCT00108485|736650|P2|Overall Study|Lost to Follow-up|2
224203|NCT00108485|736651|P1|Overall Study|Lost to Follow-up|0
224204|NCT00108485|736650|P2|Overall Study|Withdrawal by Subject|0
224205|NCT00108485|736651|P1|Overall Study|Withdrawal by Subject|3
224206|NCT00108433|736659|P2|Overall Study|Other|14
224207|NCT00108433|736660|P1|Overall Study|Other|14
224208|NCT00108433|736659|P2|Overall Study|Adverse Event|1
224209|NCT00108433|736660|P1|Overall Study|Adverse Event|3
224210|NCT00108433|736659|P2|Overall Study|Death|0
224211|NCT00108433|736660|P1|Overall Study|Death|3
224212|NCT00108433|736659|P2|Overall Study|Lack of Efficacy|2
224213|NCT00108433|736660|P1|Overall Study|Lack of Efficacy|1
224214|NCT00108355|736676|P2|Overall Study|Loculated ascites, limiting paracentesis|1
224215|NCT00108355|736677|P1|Overall Study|Loculated ascites, limiting paracentesis|1
224216|NCT00108355|736676|P2|Overall Study|Peritonitis at index paracentesis|1
224217|NCT00108355|736677|P1|Overall Study|Peritonitis at index paracentesis|1
224218|NCT00108160|736726|P2|Overall Study|Protocol Violation|5
224219|NCT00108160|736727|P1|Overall Study|Protocol Violation|9
224220|NCT00108160|736726|P2|Overall Study|Withdrawal by Subject|2
224221|NCT00108160|736727|P1|Overall Study|Withdrawal by Subject|4
224222|NCT00108160|736726|P2|Overall Study|Death|2
224223|NCT00108160|736727|P1|Overall Study|Death|1
224224|NCT00108160|736726|P2|Overall Study|Lost to Follow-up|12
224225|NCT00108160|736727|P1|Overall Study|Lost to Follow-up|25
224226|NCT00108082|736740|P3|Overall Study|Blood Pressure Not Controlled|0
224227|NCT00108082|736741|P2|Overall Study|Blood Pressure Not Controlled|0
224228|NCT00108082|736742|P1|Overall Study|Blood Pressure Not Controlled|1
224229|NCT00108082|736740|P3|Overall Study|Investigator Not at Site|0
224230|NCT00108082|736741|P2|Overall Study|Investigator Not at Site|0
224231|NCT00108082|736742|P1|Overall Study|Investigator Not at Site|1
224232|NCT00108082|736740|P3|Overall Study|Subject Left Site Location|0
224233|NCT00108082|736741|P2|Overall Study|Subject Left Site Location|0
224234|NCT00108082|736742|P1|Overall Study|Subject Left Site Location|1
224235|NCT00108082|736740|P3|Overall Study|Study Medication Not Tapered|0
224236|NCT00108082|736741|P2|Overall Study|Study Medication Not Tapered|1
224237|NCT00108082|736742|P1|Overall Study|Study Medication Not Tapered|0
224238|NCT00108082|736740|P3|Overall Study|Protocol Amendment|0
224239|NCT00108082|736741|P2|Overall Study|Protocol Amendment|1
224240|NCT00108082|736742|P1|Overall Study|Protocol Amendment|0
224241|NCT00108082|736740|P3|Overall Study|Site Closed Study|0
224242|NCT00108082|736741|P2|Overall Study|Site Closed Study|2
224243|NCT00108082|736742|P1|Overall Study|Site Closed Study|0
224244|NCT00108082|736740|P3|Overall Study|Stopped Study Medication|1
224245|NCT00108082|736741|P2|Overall Study|Stopped Study Medication|0
224246|NCT00108082|736742|P1|Overall Study|Stopped Study Medication|0
224247|NCT00108082|736740|P3|Overall Study|Non-compliance|2
224248|NCT00108082|736741|P2|Overall Study|Non-compliance|0
224249|NCT00108082|736742|P1|Overall Study|Non-compliance|1
224250|NCT00108082|736740|P3|Overall Study|Incorrectly Randomized|2
224251|NCT00108082|736741|P2|Overall Study|Incorrectly Randomized|0
224252|NCT00108082|736742|P1|Overall Study|Incorrectly Randomized|0
224253|NCT00108082|736740|P3|Overall Study|Woman of Child-bearing Potential|2
224254|NCT00108082|736741|P2|Overall Study|Woman of Child-bearing Potential|0
224255|NCT00108082|736742|P1|Overall Study|Woman of Child-bearing Potential|2
224256|NCT00108082|736740|P3|Overall Study|Amendment 4: > Month 12|5
224257|NCT00108082|736741|P2|Overall Study|Amendment 4: > Month 12|7
224258|NCT00108082|736742|P1|Overall Study|Amendment 4: > Month 12|5
224259|NCT00108082|736740|P3|Overall Study|Lack of Efficacy|2
224260|NCT00108082|736741|P2|Overall Study|Lack of Efficacy|1
224261|NCT00108082|736742|P1|Overall Study|Lack of Efficacy|3
224262|NCT00108082|736740|P3|Overall Study|Protocol Violation|0
224263|NCT00108082|736741|P2|Overall Study|Protocol Violation|2
224264|NCT00108082|736742|P1|Overall Study|Protocol Violation|1
224265|NCT00108082|736740|P3|Overall Study|Consent Withdrawn|5
224266|NCT00108082|736741|P2|Overall Study|Consent Withdrawn|3
224267|NCT00108082|736742|P1|Overall Study|Consent Withdrawn|3
224268|NCT00108082|736740|P3|Overall Study|Lost to Follow-up|7
224269|NCT00108082|736741|P2|Overall Study|Lost to Follow-up|3
224270|NCT00108082|736742|P1|Overall Study|Lost to Follow-up|6
224271|NCT00108082|736740|P3|Overall Study|Adverse Event|17
224272|NCT00108082|736741|P2|Overall Study|Adverse Event|12
224273|NCT00108082|736742|P1|Overall Study|Adverse Event|14
224274|NCT00108069|736791|P2|Overall Study|Progessive disease|11
224275|NCT00108069|736792|P1|Overall Study|Progessive disease|27
224276|NCT00108069|736791|P2|Overall Study|Death|0
224277|NCT00108069|736792|P1|Overall Study|Death|1
224278|NCT00108069|736791|P2|Overall Study|Withdrawal by Subject|0
224279|NCT00108069|736792|P1|Overall Study|Withdrawal by Subject|1
224280|NCT00108069|736791|P2|Overall Study|Adverse Event|1
224281|NCT00108069|736792|P1|Overall Study|Adverse Event|1
224282|NCT00108069|736791|P2|Overall Study|Never rec'd study drug|1
224283|NCT00108069|736792|P1|Overall Study|Never rec'd study drug|0
224284|NCT00107991|736806|P1|18-Week Post Treatment Assessment|Adverse Event|2
224285|NCT00107991|736806|P1|12 Week Treatment Period|Incarcerated|1
224286|NCT00107991|736806|P1|12 Week Treatment Period|Protocol Violation|1
224287|NCT00107991|736806|P1|12 Week Treatment Period|Adverse Event|1
224288|NCT00107991|736806|P1|12 Week Treatment Period|Lack of Efficacy|2
224289|NCT00107991|736806|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
224290|NCT00107991|736806|P1|Eligibility Assessment|chronic uncontrolled asthma|1
224291|NCT00107991|736806|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
224292|NCT00107991|736806|P1|Eligibility Assessment|Abnormal labs|2
224293|NCT00107991|736806|P1|Eligibility Assessment|Positive purified protein derivative|4
224294|NCT00107991|736806|P1|Eligibility Assessment|Unwilling to participate|7
224295|NCT00107991|736806|P1|Eligibility Assessment|Disease not severe enough|7
224296|NCT00107978|736816|P2|Overall Study|Other|4
224297|NCT00107978|736817|P1|Overall Study|Other|5
224298|NCT00107978|736816|P2|Overall Study|Protocol Violation|1
224299|NCT00107978|736817|P1|Overall Study|Protocol Violation|0
224300|NCT00107978|736816|P2|Overall Study|Withdrawal by Subject|9
224301|NCT00107978|736817|P1|Overall Study|Withdrawal by Subject|4
224302|NCT00107978|736816|P2|Overall Study|Lost to Follow-up|28
224303|NCT00107978|736817|P1|Overall Study|Lost to Follow-up|20
224304|NCT00107978|736816|P2|Overall Study|Death|3
224305|NCT00107978|736817|P1|Overall Study|Death|3
224306|NCT00107978|736816|P2|Overall Study|Adverse Event|5
224307|NCT00107978|736817|P1|Overall Study|Adverse Event|1
224308|NCT00107952|736825|P2|Overall Study|Never received study treatment|6
224309|NCT00107952|736826|P1|Overall Study|Never received study treatment|9
224310|NCT00107952|736825|P2|Overall Study|Other|5
224311|NCT00107952|736826|P1|Overall Study|Other|2
224312|NCT00107952|736825|P2|Overall Study|Withdrawal by Subject|6
224313|NCT00107952|736826|P1|Overall Study|Withdrawal by Subject|9
224314|NCT00107952|736825|P2|Overall Study|Lost to Follow-up|3
224315|NCT00107952|736826|P1|Overall Study|Lost to Follow-up|0
224316|NCT00107952|736825|P2|Overall Study|Death|61
224317|NCT00107952|736826|P1|Overall Study|Death|75
224318|NCT00107900|736838|P6|Overall Study|Administrative Reasons|0
224319|NCT00107900|736839|P5|Overall Study|Administrative Reasons|2
224320|NCT00107900|736840|P4|Overall Study|Administrative Reasons|2
224321|NCT00107900|736841|P3|Overall Study|Administrative Reasons|2
224322|NCT00107900|736842|P2|Overall Study|Administrative Reasons|0
224323|NCT00107900|736843|P1|Overall Study|Administrative Reasons|1
224324|NCT00107900|736838|P6|Overall Study|Withdrawal by Subject|1
224325|NCT00107900|736839|P5|Overall Study|Withdrawal by Subject|1
224326|NCT00107900|736840|P4|Overall Study|Withdrawal by Subject|0
224327|NCT00107900|736841|P3|Overall Study|Withdrawal by Subject|5
224328|NCT00107900|736842|P2|Overall Study|Withdrawal by Subject|0
224329|NCT00107900|736843|P1|Overall Study|Withdrawal by Subject|1
224330|NCT00107900|736838|P6|Overall Study|Protocol Violation|0
224331|NCT00107900|736839|P5|Overall Study|Protocol Violation|7
224332|NCT00107900|736840|P4|Overall Study|Protocol Violation|5
224333|NCT00107900|736841|P3|Overall Study|Protocol Violation|5
224334|NCT00107900|736842|P2|Overall Study|Protocol Violation|0
224335|NCT00107900|736843|P1|Overall Study|Protocol Violation|1
224336|NCT00107900|736838|P6|Overall Study|Lost to Follow-up|5
224337|NCT00107900|736839|P5|Overall Study|Lost to Follow-up|5
224338|NCT00107900|736840|P4|Overall Study|Lost to Follow-up|2
224339|NCT00107900|736841|P3|Overall Study|Lost to Follow-up|3
224340|NCT00107900|736842|P2|Overall Study|Lost to Follow-up|1
224341|NCT00107900|736843|P1|Overall Study|Lost to Follow-up|4
224342|NCT00107900|736838|P6|Overall Study|Death|0
224343|NCT00107900|736839|P5|Overall Study|Death|1
224344|NCT00107900|736840|P4|Overall Study|Death|0
224345|NCT00107900|736841|P3|Overall Study|Death|0
224346|NCT00107900|736842|P2|Overall Study|Death|0
224347|NCT00107900|736843|P1|Overall Study|Death|0
224348|NCT00107900|736838|P6|Overall Study|Adverse Event|3
224349|NCT00107900|736839|P5|Overall Study|Adverse Event|5
224350|NCT00107900|736840|P4|Overall Study|Adverse Event|3
224351|NCT00107900|736841|P3|Overall Study|Adverse Event|10
224352|NCT00107900|736842|P2|Overall Study|Adverse Event|2
224353|NCT00107900|736843|P1|Overall Study|Adverse Event|3
224354|NCT00107783|736877|P2|Overall Study|Second hip replacement|1
224355|NCT00107783|736878|P1|Overall Study|Second hip replacement|1
224356|NCT00107783|736877|P2|Overall Study|Withdrawal by Subject|0
224357|NCT00107783|736878|P1|Overall Study|Withdrawal by Subject|2
224358|NCT00107783|736877|P2|Overall Study|Death|1
224359|NCT00107783|736878|P1|Overall Study|Death|0
224360|NCT00107783|736877|P2|Overall Study|Adverse Event|2
224361|NCT00107783|736878|P1|Overall Study|Adverse Event|0
224362|NCT00107653|736894|P2|Overall Study|Administrative Reasons|3
224363|NCT00107653|736895|P1|Overall Study|Administrative Reasons|3
224364|NCT00107653|736894|P2|Overall Study|Lost to Follow-up|5
224365|NCT00107653|736895|P1|Overall Study|Lost to Follow-up|13
224366|NCT00107653|736894|P2|Overall Study|Withdrawal by Subject|13
224367|NCT00107653|736895|P1|Overall Study|Withdrawal by Subject|12
224368|NCT00107653|736894|P2|Overall Study|Protocol Violation|0
224369|NCT00107653|736895|P1|Overall Study|Protocol Violation|1
224370|NCT00107653|736894|P2|Overall Study|Violation of Selection Criteria at Entry|1
224371|NCT00107653|736895|P1|Overall Study|Violation of Selection Criteria at Entry|1
224372|NCT00107653|736894|P2|Overall Study|Insufficient Therapeutic Response|11
224373|NCT00107653|736895|P1|Overall Study|Insufficient Therapeutic Response|25
224374|NCT00107653|736894|P2|Overall Study|Adverse Event|43
224375|NCT00107653|736895|P1|Overall Study|Adverse Event|24
224376|NCT00107614|736941|P1|Overall Study|Death|2
224377|NCT00107614|736941|P1|Overall Study|Physician Decision|10
224378|NCT00107380|736972|P1|Overall Study|Ineligible|2
224379|NCT00107380|736972|P1|Overall Study|Other - not protocol specified|7
224380|NCT00107380|736972|P1|Overall Study|Death|3
224381|NCT00107380|736972|P1|Overall Study|Progression/relapse|4
224382|NCT00107380|736972|P1|Overall Study|Refusal Unrelated to Adverse Event|7
224383|NCT00107380|736972|P1|Overall Study|Adverse Event|7
224384|NCT00107315|736978|P1|Overall Study|Withdrawal by Subject|2
224385|NCT00107315|736978|P1|Overall Study|Adverse Event|4
224386|NCT00107315|736978|P1|Overall Study|Disease Progression|9
224387|NCT00107276|736985|P1|Overall Study|Ineligible|16
224388|NCT00107276|736985|P1|Overall Study|Death|1
224389|NCT00107276|736985|P1|Overall Study|Patient refusal|1
224390|NCT00107276|736985|P1|Overall Study|M.D. decision|2
224391|NCT00107276|736985|P1|Overall Study|Adverse Event|6
224392|NCT00107276|736985|P1|Overall Study|Progression|46
224393|NCT00107198|736991|P1|Overall Study|Ineligible|5
224394|NCT00107198|736991|P1|Overall Study|Withdrawal by Subject|6
224395|NCT00107198|736991|P1|Overall Study|Protocol Violation|1
224396|NCT00107198|736991|P1|Overall Study|Lost to Follow-up|12
224397|NCT00107198|736991|P1|Overall Study|Lack of Efficacy|28
224398|NCT00107172|737001|P2|Overall Study|Other Reason|3
224399|NCT00107172|737002|P1|Overall Study|Other Reason|4
224400|NCT00107172|737001|P2|Overall Study|Death|2
224401|NCT00107172|737002|P1|Overall Study|Death|0
224402|NCT00107172|737001|P2|Overall Study|Withdrawal by Subject|0
224403|NCT00107172|737002|P1|Overall Study|Withdrawal by Subject|1
224404|NCT00107120|737032|P2|Overall Study|death of parent|1
224405|NCT00107120|737033|P1|Overall Study|death of parent|0
224406|NCT00107120|737032|P2|Overall Study|moving away from site|1
224407|NCT00107120|737033|P1|Overall Study|moving away from site|1
224408|NCT00107120|737032|P2|Overall Study|Pregnancy|1
224409|NCT00107120|737033|P1|Overall Study|Pregnancy|0
224410|NCT00107120|737032|P2|Overall Study|Lost to Follow-up|6
224411|NCT00107120|737033|P1|Overall Study|Lost to Follow-up|8
224412|NCT00107120|737032|P2|Overall Study|Withdrawal by Subject|9
224413|NCT00107120|737033|P1|Overall Study|Withdrawal by Subject|8
224414|NCT00107120|737032|P2|Overall Study|Protocol Violation|0
224415|NCT00107120|737033|P1|Overall Study|Protocol Violation|3
224416|NCT00107120|737032|P2|Overall Study|Lack of Efficacy|5
224417|NCT00107120|737033|P1|Overall Study|Lack of Efficacy|5
224418|NCT00107120|737032|P2|Overall Study|Adverse Event|1
224419|NCT00107120|737033|P1|Overall Study|Adverse Event|4
224420|NCT00107042|737045|P2|Overall Study|Disallowed medications|2
224421|NCT00107042|737046|P1|Overall Study|Disallowed medications|0
224422|NCT00107042|737045|P2|Overall Study|vaccinated outside window|1
224423|NCT00107042|737046|P1|Overall Study|vaccinated outside window|1
224424|NCT00107042|737045|P2|Overall Study|Inadvertent enrollment|1
224425|NCT00107042|737046|P1|Overall Study|Inadvertent enrollment|0
224426|NCT00107042|737045|P2|Overall Study|Pregnancy|1
224427|NCT00107042|737046|P1|Overall Study|Pregnancy|1
224428|NCT00107042|737045|P2|Overall Study|Moved out of area|3
224429|NCT00107042|737046|P1|Overall Study|Moved out of area|5
224430|NCT00107042|737045|P2|Overall Study|Withdrawal by Subject|1
224431|NCT00107042|737046|P1|Overall Study|Withdrawal by Subject|6
224432|NCT00107042|737045|P2|Overall Study|Lost to Follow-up|7
224433|NCT00107042|737046|P1|Overall Study|Lost to Follow-up|9
224434|NCT00106964|737112|P3|Overall Study|Required disallowed medication|0
224435|NCT00106964|737113|P2|Overall Study|Required disallowed medication|1
224436|NCT00106964|737114|P1|Overall Study|Required disallowed medication|0
224437|NCT00106964|737112|P3|Overall Study|Did not meet eligibility criteria|2
224438|NCT00106964|737113|P2|Overall Study|Did not meet eligibility criteria|2
224439|NCT00106964|737114|P1|Overall Study|Did not meet eligibility criteria|0
224440|NCT00106964|737112|P3|Overall Study|Failure to adhere|0
224441|NCT00106964|737113|P2|Overall Study|Failure to adhere|0
224442|NCT00106964|737114|P1|Overall Study|Failure to adhere|2
224443|NCT00106964|737112|P3|Overall Study|Site Funding Terminated|1
224444|NCT00106964|737113|P2|Overall Study|Site Funding Terminated|1
224445|NCT00106964|737114|P1|Overall Study|Site Funding Terminated|0
224446|NCT00106964|737112|P3|Overall Study|Incarceration|0
224447|NCT00106964|737113|P2|Overall Study|Incarceration|1
224448|NCT00106964|737114|P1|Overall Study|Incarceration|0
224449|NCT00106964|737112|P3|Overall Study|Death|0
224450|NCT00106964|737113|P2|Overall Study|Death|1
224451|NCT00106964|737114|P1|Overall Study|Death|1
224452|NCT00106964|737112|P3|Overall Study|Pregnancy|2
224453|NCT00106964|737113|P2|Overall Study|Pregnancy|3
224454|NCT00106964|737114|P1|Overall Study|Pregnancy|2
224455|NCT00106964|737112|P3|Overall Study|Lost to Follow-up|2
224456|NCT00106964|737113|P2|Overall Study|Lost to Follow-up|6
224457|NCT00106964|737114|P1|Overall Study|Lost to Follow-up|8
224458|NCT00106704|737209|P2|Overall Study|Laboratory test|1
224459|NCT00106704|737210|P1|Overall Study|Laboratory test|1
224460|NCT00106704|737209|P2|Overall Study|Unable to re-enter US|0
224461|NCT00106704|737210|P1|Overall Study|Unable to re-enter US|1
224462|NCT00106704|737209|P2|Overall Study|Patient Received Glycemic Medication|41
224463|NCT00106704|737210|P1|Overall Study|Patient Received Glycemic Medication|22
224464|NCT00106704|737209|P2|Overall Study|Planned major surgery|0
224465|NCT00106704|737210|P1|Overall Study|Planned major surgery|1
224466|NCT00106704|737209|P2|Overall Study|Site terminated|1
224467|NCT00106704|737210|P1|Overall Study|Site terminated|0
224468|NCT00106704|737209|P2|Overall Study|Patient moved|0
224469|NCT00106704|737210|P1|Overall Study|Patient moved|1
224470|NCT00106704|737209|P2|Overall Study|Withdrawal by Subject|21
224471|NCT00106704|737210|P1|Overall Study|Withdrawal by Subject|14
224472|NCT00106704|737209|P2|Overall Study|Protocol Violation|7
224473|NCT00106704|737210|P1|Overall Study|Protocol Violation|4
224474|NCT00106704|737209|P2|Overall Study|Pregnancy|0
224475|NCT00106704|737210|P1|Overall Study|Pregnancy|1
224476|NCT00106704|737209|P2|Overall Study|Lost to Follow-up|3
224477|NCT00106704|737210|P1|Overall Study|Lost to Follow-up|7
224478|NCT00106704|737209|P2|Overall Study|Lack of Efficacy|69
224479|NCT00106704|737210|P1|Overall Study|Lack of Efficacy|67
224480|NCT00106704|737209|P2|Overall Study|Death|1
224481|NCT00106704|737210|P1|Overall Study|Death|2
224482|NCT00106704|737209|P2|Overall Study|Adverse Event|7
224483|NCT00106704|737210|P1|Overall Study|Adverse Event|10
224484|NCT00106639|737221|P3|Overall Study|Participant defaulted|1
224485|NCT00106639|737222|P2|Overall Study|Participant defaulted|1
224486|NCT00106639|737223|P1|Overall Study|Participant defaulted|0
224487|NCT00106639|737221|P3|Overall Study|Withdrawal by Subject|0
224488|NCT00106639|737222|P2|Overall Study|Withdrawal by Subject|1
224489|NCT00106639|737223|P1|Overall Study|Withdrawal by Subject|0
224490|NCT00106639|737221|P3|Overall Study|Protocol Violation|0
224491|NCT00106639|737222|P2|Overall Study|Protocol Violation|1
224492|NCT00106639|737223|P1|Overall Study|Protocol Violation|0
224493|NCT00106639|737221|P3|Overall Study|Adverse Event|1
224494|NCT00106639|737222|P2|Overall Study|Adverse Event|4
224495|NCT00106639|737223|P1|Overall Study|Adverse Event|3
224496|NCT00106626|737350|P4|Overall Study|> 14 day delay in therapy start|0
224497|NCT00106626|737351|P3|Overall Study|> 14 day delay in therapy start|0
224498|NCT00106626|737352|P2|Overall Study|> 14 day delay in therapy start|1
224499|NCT00106626|737353|P1|Overall Study|> 14 day delay in therapy start|0
224500|NCT00106626|737350|P4|Overall Study|Received radiation on new therapy|0
224501|NCT00106626|737351|P3|Overall Study|Received radiation on new therapy|0
224502|NCT00106626|737352|P2|Overall Study|Received radiation on new therapy|0
224503|NCT00106626|737353|P1|Overall Study|Received radiation on new therapy|1
224504|NCT00106626|737350|P4|Overall Study|Progressive Disease|10
224505|NCT00106626|737351|P3|Overall Study|Progressive Disease|9
224506|NCT00106626|737352|P2|Overall Study|Progressive Disease|1
224507|NCT00106626|737353|P1|Overall Study|Progressive Disease|4
224508|NCT00106626|737350|P4|Overall Study|Adverse Event|3
224509|NCT00106626|737351|P3|Overall Study|Adverse Event|3
224510|NCT00106626|737352|P2|Overall Study|Adverse Event|4
224511|NCT00106626|737353|P1|Overall Study|Adverse Event|5
224512|NCT00106353|737698|P7|Part 2|Physician Decision|0
224513|NCT00106353|737699|P6|Part 2|Physician Decision|1
224514|NCT00106353|737700|P5|Part 2|Physician Decision|0
224515|NCT00106353|737701|P4|Part 2|Physician Decision|0
224516|NCT00106353|737702|P3|Part 2|Physician Decision|0
224517|NCT00106353|737703|P2|Part 2|Physician Decision|0
224518|NCT00106353|737704|P1|Part 2|Physician Decision|0
224519|NCT00106353|737698|P7|Part 2|Withdrawal by Subject|0
224520|NCT00106353|737699|P6|Part 2|Withdrawal by Subject|0
224521|NCT00106353|737700|P5|Part 2|Withdrawal by Subject|1
224522|NCT00106353|737701|P4|Part 2|Withdrawal by Subject|0
224523|NCT00106353|737702|P3|Part 2|Withdrawal by Subject|0
224524|NCT00106353|737703|P2|Part 2|Withdrawal by Subject|0
224525|NCT00106353|737704|P1|Part 2|Withdrawal by Subject|0
224526|NCT00106353|737698|P7|Part 2|Other|1
224527|NCT00106353|737699|P6|Part 2|Other|1
224528|NCT00106353|737700|P5|Part 2|Other|1
224529|NCT00106353|737701|P4|Part 2|Other|0
224530|NCT00106353|737702|P3|Part 2|Other|0
224531|NCT00106353|737703|P2|Part 2|Other|0
224532|NCT00106353|737704|P1|Part 2|Other|0
224533|NCT00106353|737698|P7|Part 2|Adverse Event|1
224534|NCT00106353|737699|P6|Part 2|Adverse Event|2
224535|NCT00106353|737700|P5|Part 2|Adverse Event|0
224536|NCT00106353|737701|P4|Part 2|Adverse Event|0
224537|NCT00106353|737702|P3|Part 2|Adverse Event|0
224538|NCT00106353|737703|P2|Part 2|Adverse Event|0
224539|NCT00106353|737704|P1|Part 2|Adverse Event|0
224540|NCT00106353|737698|P7|Part 2|Symptomatic deterioration|0
224541|NCT00106353|737699|P6|Part 2|Symptomatic deterioration|0
224542|NCT00106353|737700|P5|Part 2|Symptomatic deterioration|3
224543|NCT00106353|737701|P4|Part 2|Symptomatic deterioration|0
224544|NCT00106353|737702|P3|Part 2|Symptomatic deterioration|0
224545|NCT00106353|737703|P2|Part 2|Symptomatic deterioration|0
224546|NCT00106353|737704|P1|Part 2|Symptomatic deterioration|0
224547|NCT00106353|737698|P7|Part 2|Death|1
224548|NCT00106353|737699|P6|Part 2|Death|0
224549|NCT00106353|737700|P5|Part 2|Death|3
224550|NCT00106353|737701|P4|Part 2|Death|0
224551|NCT00106353|737702|P3|Part 2|Death|0
224552|NCT00106353|737703|P2|Part 2|Death|0
224553|NCT00106353|737704|P1|Part 2|Death|0
224554|NCT00106353|737698|P7|Part 2|Disease progression|13
224555|NCT00106353|737699|P6|Part 2|Disease progression|14
224556|NCT00106353|737700|P5|Part 2|Disease progression|8
224557|NCT00106353|737701|P4|Part 2|Disease progression|0
224558|NCT00106353|737702|P3|Part 2|Disease progression|0
224559|NCT00106353|737703|P2|Part 2|Disease progression|0
224560|NCT00106353|737704|P1|Part 2|Disease progression|0
224561|NCT00106353|737698|P7|Part 1|Adverse Event|0
224562|NCT00106353|737699|P6|Part 1|Adverse Event|0
224563|NCT00106353|737700|P5|Part 1|Adverse Event|0
224564|NCT00106353|737701|P4|Part 1|Adverse Event|1
224565|NCT00106353|737702|P3|Part 1|Adverse Event|0
224566|NCT00106353|737703|P2|Part 1|Adverse Event|0
224567|NCT00106353|737704|P1|Part 1|Adverse Event|0
224568|NCT00106353|737698|P7|Part 1|Entered follow-up phase|0
224569|NCT00106353|737699|P6|Part 1|Entered follow-up phase|0
224570|NCT00106353|737700|P5|Part 1|Entered follow-up phase|0
224571|NCT00106353|737701|P4|Part 1|Entered follow-up phase|1
224572|NCT00106353|737702|P3|Part 1|Entered follow-up phase|0
224573|NCT00106353|737703|P2|Part 1|Entered follow-up phase|1
224574|NCT00106353|737704|P1|Part 1|Entered follow-up phase|1
224575|NCT00106353|737698|P7|Part 1|Symptomatic deterioration|0
224576|NCT00106353|737699|P6|Part 1|Symptomatic deterioration|0
224577|NCT00106353|737700|P5|Part 1|Symptomatic deterioration|0
224578|NCT00106353|737701|P4|Part 1|Symptomatic deterioration|0
224579|NCT00106353|737702|P3|Part 1|Symptomatic deterioration|1
224580|NCT00106353|737703|P2|Part 1|Symptomatic deterioration|0
224581|NCT00106353|737704|P1|Part 1|Symptomatic deterioration|0
224582|NCT00106353|737698|P7|Part 1|Withdrawal by Subject|0
224583|NCT00106353|737699|P6|Part 1|Withdrawal by Subject|0
224584|NCT00106353|737700|P5|Part 1|Withdrawal by Subject|0
224585|NCT00106353|737701|P4|Part 1|Withdrawal by Subject|2
224586|NCT00106353|737702|P3|Part 1|Withdrawal by Subject|1
224587|NCT00106353|737703|P2|Part 1|Withdrawal by Subject|0
224588|NCT00106353|737704|P1|Part 1|Withdrawal by Subject|0
224589|NCT00106353|737698|P7|Part 1|Disease progression|0
224590|NCT00106353|737699|P6|Part 1|Disease progression|0
224591|NCT00106353|737700|P5|Part 1|Disease progression|0
224592|NCT00106353|737701|P4|Part 1|Disease progression|3
224593|NCT00106353|737702|P3|Part 1|Disease progression|1
224594|NCT00106353|737703|P2|Part 1|Disease progression|4
224595|NCT00106353|737704|P1|Part 1|Disease progression|3
224596|NCT00106249|737831|P2|Overall Study|Lost to Follow-up|2
224597|NCT00106249|737832|P1|Overall Study|Lost to Follow-up|3
224598|NCT00106184|737844|P2|Overall Study|Withdrawal by Subject|2
224599|NCT00106184|737845|P1|Overall Study|Withdrawal by Subject|3
224600|NCT00106080|737887|P2|Overall Study|Withdrew/Loss to follow-up|27
224601|NCT00106080|737888|P1|Overall Study|Withdrew/Loss to follow-up|43
224602|NCT00106028|737898|P2|Overall Study|Lost to Follow-up|1
224603|NCT00106028|737899|P1|Overall Study|Lost to Follow-up|0
224604|NCT00106028|737898|P2|Overall Study|Withdrawal by Subject|8
224605|NCT00106028|737899|P1|Overall Study|Withdrawal by Subject|2
224606|NCT00106028|737898|P2|Overall Study|Protocol Violation|1
224607|NCT00106028|737899|P1|Overall Study|Protocol Violation|1
224608|NCT00106028|737898|P2|Overall Study|Adverse Event|2
224609|NCT00106028|737899|P1|Overall Study|Adverse Event|3
224610|NCT00106002|737993|P1|Overall Study|Ineligible after Registration|1
224611|NCT00106002|737993|P1|Overall Study|Did not take any study drug|1
224612|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
224613|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
224614|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
224615|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
224616|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Death|0
224617|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Death|0
224618|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
224619|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
224620|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
224621|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
224622|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
224623|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
224624|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
224625|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
224626|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
224627|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
224628|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
224629|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
224630|NCT00105989|738001|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
224631|NCT00105989|738002|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
224632|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
224633|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
224634|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
224635|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
224636|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Death|0
224637|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Death|0
224638|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
224639|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
224640|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
224641|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
224642|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
224643|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
224644|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
224645|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
224646|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
224647|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
224648|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
224649|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
224650|NCT00105989|738001|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
224651|NCT00105989|738002|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
224652|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
224653|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
224654|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
224655|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
224656|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Death|0
224657|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Death|1
224658|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Physician Decision|0
224659|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Physician Decision|0
224660|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
224661|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
224662|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
224663|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
224664|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
224665|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
224666|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
224667|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
224668|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
224669|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
224670|NCT00105989|738001|P2|Acute - Open Label: Week 0-10|Adverse Event|0
224671|NCT00105989|738002|P1|Acute - Open Label: Week 0-10|Adverse Event|33
224672|NCT00105586|738118|P2|Overall Study|Physician Decision|13
224673|NCT00105586|738119|P1|Overall Study|Physician Decision|13
224674|NCT00105586|738118|P2|Overall Study|Adverse Event|3
224675|NCT00105586|738119|P1|Overall Study|Adverse Event|4
224676|NCT00105560|738127|P1|Overall Study|Lost to Follow-up|1
224677|NCT00105534|738149|P2|Overall Study|Other Reason|2
224678|NCT00105534|738150|P1|Overall Study|Other Reason|0
224679|NCT00105534|738149|P2|Overall Study|Treatment unmasked|0
224680|NCT00105534|738150|P1|Overall Study|Treatment unmasked|1
224681|NCT00105534|738149|P2|Overall Study|Lack of Efficacy|15
224682|NCT00105534|738150|P1|Overall Study|Lack of Efficacy|7
224683|NCT00105534|738149|P2|Overall Study|Lost to Follow-up|1
224684|NCT00105534|738150|P1|Overall Study|Lost to Follow-up|5
224685|NCT00105534|738149|P2|Overall Study|Withdrawal by Subject|6
224686|NCT00105534|738150|P1|Overall Study|Withdrawal by Subject|6
224687|NCT00105534|738149|P2|Overall Study|Protocol Violation|4
224688|NCT00105534|738150|P1|Overall Study|Protocol Violation|1
224689|NCT00105534|738149|P2|Overall Study|Adverse Event|5
224690|NCT00105534|738150|P1|Overall Study|Adverse Event|2
224691|NCT00105521|738162|P4|Overall Study|Lost to Follow-up|0
224692|NCT00105521|738163|P3|Overall Study|Lost to Follow-up|0
224693|NCT00105521|738164|P2|Overall Study|Lost to Follow-up|1
224694|NCT00105521|738165|P1|Overall Study|Lost to Follow-up|0
224695|NCT00105521|738162|P4|Overall Study|Protocol Violation|4
224696|NCT00105521|738163|P3|Overall Study|Protocol Violation|4
224697|NCT00105521|738164|P2|Overall Study|Protocol Violation|5
224698|NCT00105521|738165|P1|Overall Study|Protocol Violation|3
224699|NCT00105521|738162|P4|Overall Study|Lack of Efficacy|1
224700|NCT00105521|738163|P3|Overall Study|Lack of Efficacy|0
224701|NCT00105521|738164|P2|Overall Study|Lack of Efficacy|0
224702|NCT00105521|738165|P1|Overall Study|Lack of Efficacy|0
224703|NCT00105521|738162|P4|Overall Study|Withdrawal by Subject|4
224704|NCT00105521|738163|P3|Overall Study|Withdrawal by Subject|1
224705|NCT00105521|738164|P2|Overall Study|Withdrawal by Subject|0
224706|NCT00105521|738165|P1|Overall Study|Withdrawal by Subject|1
224707|NCT00105521|738162|P4|Overall Study|Adverse Event|8
224708|NCT00105521|738163|P3|Overall Study|Adverse Event|10
224709|NCT00105521|738164|P2|Overall Study|Adverse Event|4
224710|NCT00105521|738165|P1|Overall Study|Adverse Event|10
224711|NCT00105521|738162|P4|Overall Study|Other|0
224712|NCT00105521|738163|P3|Overall Study|Other|2
224713|NCT00105521|738164|P2|Overall Study|Other|1
224714|NCT00105521|738165|P1|Overall Study|Other|1
224715|NCT00105482|738189|P2|Overall Study|Withdrawn by PI|1
224716|NCT00105482|738190|P1|Overall Study|Withdrawn by PI|1
224717|NCT00105482|738189|P2|Overall Study|Scheduling Conflict|3
224718|NCT00105482|738190|P1|Overall Study|Scheduling Conflict|2
224719|NCT00105482|738189|P2|Overall Study|Lost Interest|32
224720|NCT00105482|738190|P1|Overall Study|Lost Interest|29
224721|NCT00105482|738189|P2|Overall Study|Withdrawal by Subject|1
224722|NCT00105482|738190|P1|Overall Study|Withdrawal by Subject|0
224723|NCT00105482|738189|P2|Overall Study|Lost to Follow-up|17
224724|NCT00105482|738190|P1|Overall Study|Lost to Follow-up|26
224725|NCT00105482|738189|P2|Overall Study|Adverse Event|1
224726|NCT00105482|738190|P1|Overall Study|Adverse Event|1
224727|NCT00105469|738206|P2|Overall Study|Other Reason|0
224728|NCT00105469|738207|P1|Overall Study|Other Reason|4
224729|NCT00105469|738206|P2|Overall Study|Lack of Efficacy|0
224730|NCT00105469|738207|P1|Overall Study|Lack of Efficacy|2
224731|NCT00105469|738206|P2|Overall Study|Lost to Follow-up|0
224732|NCT00105469|738207|P1|Overall Study|Lost to Follow-up|1
224733|NCT00105469|738206|P2|Overall Study|Withdrawal by Subject|3
224734|NCT00105469|738207|P1|Overall Study|Withdrawal by Subject|2
224735|NCT00105469|738206|P2|Overall Study|Protocol Violation|0
224736|NCT00105469|738207|P1|Overall Study|Protocol Violation|4
224737|NCT00105469|738206|P2|Overall Study|Adverse Event|8
224738|NCT00105469|738207|P1|Overall Study|Adverse Event|9
224739|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
224740|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
224741|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
224742|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
224743|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
224744|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
224745|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
224746|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
224747|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
224748|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
224749|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
224750|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
224751|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
224752|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
224753|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
224754|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
224755|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
224756|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
224757|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
224758|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
224759|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
224760|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
224761|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
224762|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
224763|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
224764|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
224765|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
224766|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
224767|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
224768|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
224769|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
224770|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
224771|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
224772|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
224773|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
224774|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
224775|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
224776|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
224777|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
224778|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
224779|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
224780|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
224781|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
224782|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
224783|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
224784|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
224785|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
224786|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
224787|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
224788|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
224789|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
224790|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
224791|NCT00105443|738217|P4|Follow-up and/or Open Label Nexavar|Death|4
224792|NCT00105443|738218|P3|Follow-up and/or Open Label Nexavar|Death|219
224793|NCT00105443|738219|P2|Follow-up and/or Open Label Nexavar|Death|7
224794|NCT00105443|738220|P1|Follow-up and/or Open Label Nexavar|Death|180
224795|NCT00105443|738217|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
224796|NCT00105443|738218|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
224797|NCT00105443|738219|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
224798|NCT00105443|738220|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
224799|NCT00105443|738217|P4|Double-Blind Treatment|Physician Decision|0
224800|NCT00105443|738218|P3|Double-Blind Treatment|Physician Decision|2
224801|NCT00105443|738219|P2|Double-Blind Treatment|Physician Decision|0
224802|NCT00105443|738220|P1|Double-Blind Treatment|Physician Decision|1
224803|NCT00105443|738217|P4|Double-Blind Treatment|Withdrawal by Subject|0
224804|NCT00105443|738218|P3|Double-Blind Treatment|Withdrawal by Subject|7
224805|NCT00105443|738219|P2|Double-Blind Treatment|Withdrawal by Subject|0
224806|NCT00105443|738220|P1|Double-Blind Treatment|Withdrawal by Subject|8
224807|NCT00105443|738217|P4|Double-Blind Treatment|Lost to Follow-up|0
224808|NCT00105443|738218|P3|Double-Blind Treatment|Lost to Follow-up|1
224809|NCT00105443|738219|P2|Double-Blind Treatment|Lost to Follow-up|0
224810|NCT00105443|738220|P1|Double-Blind Treatment|Lost to Follow-up|0
224811|NCT00105443|738217|P4|Double-Blind Treatment|Adverse Event|0
224812|NCT00105443|738218|P3|Double-Blind Treatment|Adverse Event|0
224813|NCT00105443|738219|P2|Double-Blind Treatment|Adverse Event|0
224814|NCT00105443|738220|P1|Double-Blind Treatment|Adverse Event|1
224815|NCT00105235|738247|P1|Overall Study|Withdrawal by Subject|2
224816|NCT00105235|738247|P1|Overall Study|Physician Decision|1
224817|NCT00105235|738247|P1|Overall Study|Death|4
224818|NCT00105196|738260|P2|Overall Study|Subject became unblinded|1
224819|NCT00105196|738261|P1|Overall Study|Subject became unblinded|0
224820|NCT00105196|738260|P2|Overall Study|marijuana use|1
224821|NCT00105196|738261|P1|Overall Study|marijuana use|0
224822|NCT00105196|738260|P2|Overall Study|pending surgery|1
224823|NCT00105196|738261|P1|Overall Study|pending surgery|0
224824|NCT00105196|738260|P2|Overall Study|Protocol Violation|2
224825|NCT00105196|738261|P1|Overall Study|Protocol Violation|5
224826|NCT00105196|738260|P2|Overall Study|Poor/noncompliance|4
224827|NCT00105196|738261|P1|Overall Study|Poor/noncompliance|3
224828|NCT00105196|738260|P2|Overall Study|Lost to Follow-up|2
224829|NCT00105196|738261|P1|Overall Study|Lost to Follow-up|3
224830|NCT00105196|738260|P2|Overall Study|Withdrawal by Subject|6
224831|NCT00105196|738261|P1|Overall Study|Withdrawal by Subject|6
224832|NCT00105196|738260|P2|Overall Study|Adverse Event|3
224833|NCT00105196|738261|P1|Overall Study|Adverse Event|11
224834|NCT00105196|738260|P2|Overall Study|Lack of Efficacy|3
224835|NCT00105196|738261|P1|Overall Study|Lack of Efficacy|2
224836|NCT00105183|738284|P3|Overall Study|Other reason|0
224837|NCT00105183|738285|P2|Overall Study|Other reason|2
224838|NCT00105183|738286|P1|Overall Study|Other reason|1
224839|NCT00105183|738284|P3|Overall Study|Lost to Follow-up|1
224840|NCT00105183|738285|P2|Overall Study|Lost to Follow-up|1
224841|NCT00105183|738286|P1|Overall Study|Lost to Follow-up|0
224842|NCT00105183|738284|P3|Overall Study|Physician Decision|3
224843|NCT00105183|738285|P2|Overall Study|Physician Decision|2
224844|NCT00105183|738286|P1|Overall Study|Physician Decision|1
224845|NCT00105183|738284|P3|Overall Study|Withdrawal by Subject|4
224846|NCT00105183|738285|P2|Overall Study|Withdrawal by Subject|1
224847|NCT00105183|738286|P1|Overall Study|Withdrawal by Subject|1
224848|NCT00105183|738284|P3|Overall Study|Death|15
224849|NCT00105183|738285|P2|Overall Study|Death|13
224850|NCT00105183|738286|P1|Overall Study|Death|19
224851|NCT00105157|738322|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
224852|NCT00105157|738323|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
224853|NCT00105157|738324|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
224854|NCT00105157|738325|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
224855|NCT00105157|738322|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
224856|NCT00105157|738323|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
224857|NCT00105157|738324|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
224858|NCT00105157|738325|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
224859|NCT00105157|738322|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
224860|NCT00105157|738323|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
224861|NCT00105157|738324|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
224862|NCT00105157|738325|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
224863|NCT00105157|738322|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
224864|NCT00105157|738323|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
224865|NCT00105157|738324|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
224866|NCT00105157|738325|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
224867|NCT00105157|738322|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
224868|NCT00105157|738323|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
224869|NCT00105157|738324|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
224870|NCT00105157|738325|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
224871|NCT00105157|738322|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
224872|NCT00105157|738323|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
224873|NCT00105157|738324|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
224874|NCT00105157|738325|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
224875|NCT00105157|738322|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
224876|NCT00105157|738323|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
224877|NCT00105157|738324|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
224878|NCT00105157|738325|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
224879|NCT00105157|738322|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
224880|NCT00105157|738323|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
224881|NCT00105157|738324|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
224882|NCT00105157|738325|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
224883|NCT00105157|738322|P4|Open-Label Continuation of DB|Lost to Follow-up|0
224884|NCT00105157|738323|P3|Open-Label Continuation of DB|Lost to Follow-up|1
224885|NCT00105157|738324|P2|Open-Label Continuation of DB|Lost to Follow-up|1
224886|NCT00105157|738325|P1|Open-Label Continuation of DB|Lost to Follow-up|1
224887|NCT00105157|738322|P4|Open-Label Continuation of DB|Lack of Efficacy|1
224888|NCT00105157|738323|P3|Open-Label Continuation of DB|Lack of Efficacy|3
224889|NCT00105157|738324|P2|Open-Label Continuation of DB|Lack of Efficacy|4
224890|NCT00105157|738325|P1|Open-Label Continuation of DB|Lack of Efficacy|1
224891|NCT00105157|738322|P4|Open-Label Continuation of DB|Adverse Event|0
224892|NCT00105157|738323|P3|Open-Label Continuation of DB|Adverse Event|0
224893|NCT00105157|738324|P2|Open-Label Continuation of DB|Adverse Event|1
224894|NCT00105157|738325|P1|Open-Label Continuation of DB|Adverse Event|3
224895|NCT00105157|738322|P4|Double-Blind (DB)|Lack of Efficacy|38
224896|NCT00105157|738323|P3|Double-Blind (DB)|Lack of Efficacy|11
224897|NCT00105157|738324|P2|Double-Blind (DB)|Lack of Efficacy|14
224898|NCT00105157|738325|P1|Double-Blind (DB)|Lack of Efficacy|11
224899|NCT00105157|738322|P4|Double-Blind (DB)|Adverse Event|1
224900|NCT00105157|738323|P3|Double-Blind (DB)|Adverse Event|1
224901|NCT00105157|738324|P2|Double-Blind (DB)|Adverse Event|0
224902|NCT00105157|738325|P1|Double-Blind (DB)|Adverse Event|2
224903|NCT00105157|738322|P4|Double-Blind (DB)|Never Treated|0
224904|NCT00105157|738323|P3|Double-Blind (DB)|Never Treated|0
224905|NCT00105157|738324|P2|Double-Blind (DB)|Never Treated|0
224906|NCT00105157|738325|P1|Double-Blind (DB)|Never Treated|1
224907|NCT00105079|738519|P2|Overall Study|not specified|1
224908|NCT00105079|738520|P1|Overall Study|not specified|3
224909|NCT00105079|738519|P2|Overall Study|Protocol Violation|0
224910|NCT00105079|738520|P1|Overall Study|Protocol Violation|1
224911|NCT00105079|738519|P2|Overall Study|Violation of selection criteria at entry|2
224912|NCT00105079|738520|P1|Overall Study|Violation of selection criteria at entry|0
224913|NCT00105079|738519|P2|Overall Study|Refused treatment|4
224914|NCT00105079|738520|P1|Overall Study|Refused treatment|6
224915|NCT00105079|738519|P2|Overall Study|Lack of Efficacy|3
224916|NCT00105079|738520|P1|Overall Study|Lack of Efficacy|9
224917|NCT00105079|738519|P2|Overall Study|Lost to Follow-up|12
224918|NCT00105079|738520|P1|Overall Study|Lost to Follow-up|12
224919|NCT00105079|738519|P2|Overall Study|Death|1
224920|NCT00105079|738520|P1|Overall Study|Death|3
224921|NCT00105079|738519|P2|Overall Study|Adverse Event|12
224922|NCT00105079|738520|P1|Overall Study|Adverse Event|5
224923|NCT00105066|738538|P2|Overall Study|Adverse Event|5
224924|NCT00105066|738539|P1|Overall Study|Adverse Event|2
224925|NCT00104884|738599|P1|Overall Study|Disease progression|4
224926|NCT00104871|738603|P1|Overall Study|Not evaluable|1
224927|NCT00104728|738608|P1|Overall Study|screen failures|19
224928|NCT00104650|738616|P3|Follow-up Period|Other|0
224929|NCT00104650|738617|P2|Follow-up Period|Other|1
224930|NCT00104650|738618|P1|Follow-up Period|Other|0
224931|NCT00104650|738616|P3|Follow-up Period|Lost to Follow-up|2
224932|NCT00104650|738617|P2|Follow-up Period|Lost to Follow-up|1
224933|NCT00104650|738618|P1|Follow-up Period|Lost to Follow-up|0
224934|NCT00104650|738616|P3|Follow-up Period|Disease progression|0
224935|NCT00104650|738617|P2|Follow-up Period|Disease progression|1
224936|NCT00104650|738618|P1|Follow-up Period|Disease progression|3
224937|NCT00104650|738616|P3|Follow-up Period|Death|4
224938|NCT00104650|738617|P2|Follow-up Period|Death|6
224939|NCT00104650|738618|P1|Follow-up Period|Death|6
224940|NCT00104650|738616|P3|Follow-up Period|Withdrawal by Subject|3
224941|NCT00104650|738617|P2|Follow-up Period|Withdrawal by Subject|3
224942|NCT00104650|738618|P1|Follow-up Period|Withdrawal by Subject|0
224943|NCT00104650|738616|P3|Follow-up Period|Adverse Event|1
224944|NCT00104650|738617|P2|Follow-up Period|Adverse Event|0
224945|NCT00104650|738618|P1|Follow-up Period|Adverse Event|1
224946|NCT00104650|738616|P3|Follow-up Period|Physician Decision|0
224947|NCT00104650|738617|P2|Follow-up Period|Physician Decision|1
224948|NCT00104650|738618|P1|Follow-up Period|Physician Decision|1
224949|NCT00104650|738616|P3|Treatment Period (25 Weeks)|Protocol deviation|0
224950|NCT00104650|738617|P2|Treatment Period (25 Weeks)|Protocol deviation|1
224951|NCT00104650|738618|P1|Treatment Period (25 Weeks)|Protocol deviation|0
224952|NCT00104650|738616|P3|Treatment Period (25 Weeks)|Other|0
224953|NCT00104650|738617|P2|Treatment Period (25 Weeks)|Other|0
224954|NCT00104650|738618|P1|Treatment Period (25 Weeks)|Other|1
224955|NCT00104650|738616|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
224956|NCT00104650|738617|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
224957|NCT00104650|738618|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
224958|NCT00104650|738616|P3|Treatment Period (25 Weeks)|Disease progression|2
224959|NCT00104650|738617|P2|Treatment Period (25 Weeks)|Disease progression|3
224960|NCT00104650|738618|P1|Treatment Period (25 Weeks)|Disease progression|2
224961|NCT00104650|738616|P3|Treatment Period (25 Weeks)|Death|6
224962|NCT00104650|738617|P2|Treatment Period (25 Weeks)|Death|5
224963|NCT00104650|738618|P1|Treatment Period (25 Weeks)|Death|7
224964|NCT00104650|738616|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
224965|NCT00104650|738617|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
224966|NCT00104650|738618|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
224967|NCT00104650|738616|P3|Treatment Period (25 Weeks)|Physician Decision|1
224968|NCT00104650|738617|P2|Treatment Period (25 Weeks)|Physician Decision|0
224969|NCT00104650|738618|P1|Treatment Period (25 Weeks)|Physician Decision|0
224970|NCT00104637|738650|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
224971|NCT00104637|738651|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
224972|NCT00104572|738680|P3|Overall Study|Withdrawal by Subject|0
224973|NCT00104572|738681|P2|Overall Study|Withdrawal by Subject|3
224974|NCT00104572|738682|P1|Overall Study|Withdrawal by Subject|3
224975|NCT00104520|738692|P2|Overall Study|Other|5
224976|NCT00104520|738693|P1|Overall Study|Other|1
224977|NCT00104520|738692|P2|Overall Study|Personal/administrative|1
224978|NCT00104520|738693|P1|Overall Study|Personal/administrative|1
224979|NCT00104520|738692|P2|Overall Study|Noncompliance|2
224980|NCT00104520|738693|P1|Overall Study|Noncompliance|0
224981|NCT00104520|738692|P2|Overall Study|Lost to Follow-up|0
224982|NCT00104520|738693|P1|Overall Study|Lost to Follow-up|1
224983|NCT00104520|738692|P2|Overall Study|Related adverse event|15
224984|NCT00104520|738693|P1|Overall Study|Related adverse event|13
224985|NCT00104520|738692|P2|Overall Study|Study drug intolerance|1
224986|NCT00104520|738693|P1|Overall Study|Study drug intolerance|0
224987|NCT00104520|738692|P2|Overall Study|Unrelated adverse event|47
224988|NCT00104520|738693|P1|Overall Study|Unrelated adverse event|34
224989|NCT00104416|738713|P5|Continuation Phase|Non-compliance|1
224990|NCT00104416|738714|P4|Continuation Phase|Non-compliance|0
224991|NCT00104416|738715|P3|Continuation Phase|Non-compliance|0
224992|NCT00104416|738716|P2|Continuation Phase|Non-compliance|0
224993|NCT00104416|738717|P1|Continuation Phase|Non-compliance|0
224994|NCT00104416|738713|P5|Continuation Phase|Pregnancy|0
224995|NCT00104416|738714|P4|Continuation Phase|Pregnancy|1
224996|NCT00104416|738715|P3|Continuation Phase|Pregnancy|1
224997|NCT00104416|738716|P2|Continuation Phase|Pregnancy|0
224998|NCT00104416|738717|P1|Continuation Phase|Pregnancy|0
224999|NCT00104416|738713|P5|Continuation Phase|Withdrawal by Subject|1
225000|NCT00104416|738714|P4|Continuation Phase|Withdrawal by Subject|1
225001|NCT00104416|738715|P3|Continuation Phase|Withdrawal by Subject|2
225002|NCT00104416|738716|P2|Continuation Phase|Withdrawal by Subject|0
225003|NCT00104416|738717|P1|Continuation Phase|Withdrawal by Subject|0
225004|NCT00104416|738713|P5|Continuation Phase|Lost to Follow-up|1
225005|NCT00104416|738714|P4|Continuation Phase|Lost to Follow-up|0
225006|NCT00104416|738715|P3|Continuation Phase|Lost to Follow-up|1
225007|NCT00104416|738716|P2|Continuation Phase|Lost to Follow-up|0
225008|NCT00104416|738717|P1|Continuation Phase|Lost to Follow-up|0
225009|NCT00104416|738713|P5|Continuation Phase|Adverse Event|2
225010|NCT00104416|738714|P4|Continuation Phase|Adverse Event|0
225011|NCT00104416|738715|P3|Continuation Phase|Adverse Event|2
225012|NCT00104416|738716|P2|Continuation Phase|Adverse Event|0
225013|NCT00104416|738717|P1|Continuation Phase|Adverse Event|0
225014|NCT00104416|738713|P5|Double-Blind Phase|Participant Did Not Take Drug|0
225015|NCT00104416|738714|P4|Double-Blind Phase|Participant Did Not Take Drug|0
225016|NCT00104416|738715|P3|Double-Blind Phase|Participant Did Not Take Drug|0
225017|NCT00104416|738716|P2|Double-Blind Phase|Participant Did Not Take Drug|4
225018|NCT00104416|738717|P1|Double-Blind Phase|Participant Did Not Take Drug|3
225019|NCT00104416|738713|P5|Double-Blind Phase|Pregnancy|0
225020|NCT00104416|738714|P4|Double-Blind Phase|Pregnancy|0
225021|NCT00104416|738715|P3|Double-Blind Phase|Pregnancy|0
225022|NCT00104416|738716|P2|Double-Blind Phase|Pregnancy|0
225023|NCT00104416|738717|P1|Double-Blind Phase|Pregnancy|1
225024|NCT00104416|738713|P5|Double-Blind Phase|Withdrawal by Subject|0
225025|NCT00104416|738714|P4|Double-Blind Phase|Withdrawal by Subject|0
225026|NCT00104416|738715|P3|Double-Blind Phase|Withdrawal by Subject|0
225027|NCT00104416|738716|P2|Double-Blind Phase|Withdrawal by Subject|3
225028|NCT00104416|738717|P1|Double-Blind Phase|Withdrawal by Subject|2
225029|NCT00104416|738713|P5|Double-Blind Phase|Protocol Violation|0
225030|NCT00104416|738714|P4|Double-Blind Phase|Protocol Violation|0
225031|NCT00104416|738715|P3|Double-Blind Phase|Protocol Violation|0
225032|NCT00104416|738716|P2|Double-Blind Phase|Protocol Violation|1
225033|NCT00104416|738717|P1|Double-Blind Phase|Protocol Violation|0
225034|NCT00104416|738713|P5|Double-Blind Phase|Lost to Follow-up|0
225035|NCT00104416|738714|P4|Double-Blind Phase|Lost to Follow-up|0
225036|NCT00104416|738715|P3|Double-Blind Phase|Lost to Follow-up|0
225037|NCT00104416|738716|P2|Double-Blind Phase|Lost to Follow-up|1
225038|NCT00104416|738717|P1|Double-Blind Phase|Lost to Follow-up|0
225039|NCT00104416|738713|P5|Double-Blind Phase|Adverse Event|0
225040|NCT00104416|738714|P4|Double-Blind Phase|Adverse Event|0
225041|NCT00104416|738715|P3|Double-Blind Phase|Adverse Event|0
225042|NCT00104416|738716|P2|Double-Blind Phase|Adverse Event|1
225043|NCT00104416|738717|P1|Double-Blind Phase|Adverse Event|2
225044|NCT00104299|738762|P2|Overall Study|To have renal transplant|0
225045|NCT00104299|738763|P1|Overall Study|To have renal transplant|1
225046|NCT00104299|738762|P2|Overall Study|Physician Decision|1
225047|NCT00104299|738763|P1|Overall Study|Physician Decision|1
225048|NCT00104299|738762|P2|Overall Study|Withdrawal by Subject|6
225049|NCT00104299|738763|P1|Overall Study|Withdrawal by Subject|2
225050|NCT00104299|738762|P2|Overall Study|Death|2
225051|NCT00104299|738763|P1|Overall Study|Death|2
225052|NCT00104299|738762|P2|Overall Study|Adverse Event|1
225053|NCT00104299|738763|P1|Overall Study|Adverse Event|3
225054|NCT00104247|738785|P2|Overall Study|Noncompliant with dosing|1
225055|NCT00104247|738786|P1|Overall Study|Noncompliant with dosing|0
225056|NCT00104247|738785|P2|Overall Study|Withdrawal by Subject|0
225057|NCT00104247|738786|P1|Overall Study|Withdrawal by Subject|1
225058|NCT00104104|738805|P2|Overall Study|Death|6
225059|NCT00104104|738806|P1|Overall Study|Death|9
225060|NCT00104104|738805|P2|Overall Study|Administrative problems|13
225061|NCT00104104|738806|P1|Overall Study|Administrative problems|12
225062|NCT00104104|738805|P2|Overall Study|Lost to Follow-up|7
225063|NCT00104104|738806|P1|Overall Study|Lost to Follow-up|3
225064|NCT00104104|738805|P2|Overall Study|Withdrawal by Subject|15
225065|NCT00104104|738806|P1|Overall Study|Withdrawal by Subject|11
225066|NCT00104104|738805|P2|Overall Study|Protocol Violation|2
225067|NCT00104104|738806|P1|Overall Study|Protocol Violation|5
225068|NCT00104104|738805|P2|Overall Study|Condition no longer requires study drug|4
225069|NCT00104104|738806|P1|Overall Study|Condition no longer requires study drug|7
225070|NCT00104104|738805|P2|Overall Study|Lack of Efficacy|3
225071|NCT00104104|738806|P1|Overall Study|Lack of Efficacy|0
225072|NCT00104104|738805|P2|Overall Study|Abnormal laboratory value(s)|14
225073|NCT00104104|738806|P1|Overall Study|Abnormal laboratory value(s)|20
225074|NCT00104104|738805|P2|Overall Study|Adverse Event|8
225075|NCT00104104|738806|P1|Overall Study|Adverse Event|8
225076|NCT00104052|738820|P1|Overall Study|Discontinuation unrelated to treatment|2
225077|NCT00104052|738820|P1|Overall Study|Lack of Efficacy|26
225078|NCT00104052|738820|P1|Overall Study|Adverse Event|1
225079|NCT00103857|738831|P7|50-Week Extension Study|reason unspecified|0
225080|NCT00103857|738832|P6|50-Week Extension Study|reason unspecified|0
225081|NCT00103857|738833|P5|50-Week Extension Study|reason unspecified|1
225082|NCT00103857|738834|P4|50-Week Extension Study|reason unspecified|0
225083|NCT00103857|738835|P3|50-Week Extension Study|reason unspecified|0
225084|NCT00103857|738836|P2|50-Week Extension Study|reason unspecified|0
225085|NCT00103857|738837|P1|50-Week Extension Study|reason unspecified|0
225086|NCT00103857|738831|P7|50-Week Extension Study|patient scheduled for elective surgery|0
225087|NCT00103857|738832|P6|50-Week Extension Study|patient scheduled for elective surgery|0
225088|NCT00103857|738833|P5|50-Week Extension Study|patient scheduled for elective surgery|0
225089|NCT00103857|738834|P4|50-Week Extension Study|patient scheduled for elective surgery|0
225090|NCT00103857|738835|P3|50-Week Extension Study|patient scheduled for elective surgery|1
225091|NCT00103857|738836|P2|50-Week Extension Study|patient scheduled for elective surgery|0
225092|NCT00103857|738837|P1|50-Week Extension Study|patient scheduled for elective surgery|0
225093|NCT00103857|738831|P7|50-Week Extension Study|patient moved|0
225094|NCT00103857|738832|P6|50-Week Extension Study|patient moved|0
225095|NCT00103857|738833|P5|50-Week Extension Study|patient moved|0
225096|NCT00103857|738834|P4|50-Week Extension Study|patient moved|2
225097|NCT00103857|738835|P3|50-Week Extension Study|patient moved|1
225098|NCT00103857|738836|P2|50-Week Extension Study|patient moved|0
225099|NCT00103857|738837|P1|50-Week Extension Study|patient moved|0
225100|NCT00103857|738831|P7|50-Week Extension Study|non-compliance with study procedures|0
225101|NCT00103857|738832|P6|50-Week Extension Study|non-compliance with study procedures|0
225102|NCT00103857|738833|P5|50-Week Extension Study|non-compliance with study procedures|1
225103|NCT00103857|738834|P4|50-Week Extension Study|non-compliance with study procedures|1
225104|NCT00103857|738835|P3|50-Week Extension Study|non-compliance with study procedures|0
225105|NCT00103857|738836|P2|50-Week Extension Study|non-compliance with study procedures|0
225106|NCT00103857|738837|P1|50-Week Extension Study|non-compliance with study procedures|1
225107|NCT00103857|738831|P7|50-Week Extension Study|protocol discontinuation criteria|0
225108|NCT00103857|738832|P6|50-Week Extension Study|protocol discontinuation criteria|3
225109|NCT00103857|738833|P5|50-Week Extension Study|protocol discontinuation criteria|3
225110|NCT00103857|738834|P4|50-Week Extension Study|protocol discontinuation criteria|2
225111|NCT00103857|738835|P3|50-Week Extension Study|protocol discontinuation criteria|3
225112|NCT00103857|738836|P2|50-Week Extension Study|protocol discontinuation criteria|2
225113|NCT00103857|738837|P1|50-Week Extension Study|protocol discontinuation criteria|2
225114|NCT00103857|738831|P7|50-Week Extension Study|Withdrawal by Subject|0
225115|NCT00103857|738832|P6|50-Week Extension Study|Withdrawal by Subject|3
225116|NCT00103857|738833|P5|50-Week Extension Study|Withdrawal by Subject|3
225117|NCT00103857|738834|P4|50-Week Extension Study|Withdrawal by Subject|8
225118|NCT00103857|738835|P3|50-Week Extension Study|Withdrawal by Subject|2
225119|NCT00103857|738836|P2|50-Week Extension Study|Withdrawal by Subject|5
225120|NCT00103857|738837|P1|50-Week Extension Study|Withdrawal by Subject|2
225121|NCT00103857|738831|P7|50-Week Extension Study|Protocol Violation|0
225122|NCT00103857|738832|P6|50-Week Extension Study|Protocol Violation|1
225123|NCT00103857|738833|P5|50-Week Extension Study|Protocol Violation|0
225124|NCT00103857|738834|P4|50-Week Extension Study|Protocol Violation|2
225125|NCT00103857|738835|P3|50-Week Extension Study|Protocol Violation|1
225126|NCT00103857|738836|P2|50-Week Extension Study|Protocol Violation|1
225127|NCT00103857|738837|P1|50-Week Extension Study|Protocol Violation|1
225128|NCT00103857|738831|P7|50-Week Extension Study|Pregnancy|0
225129|NCT00103857|738832|P6|50-Week Extension Study|Pregnancy|0
225130|NCT00103857|738833|P5|50-Week Extension Study|Pregnancy|1
225131|NCT00103857|738834|P4|50-Week Extension Study|Pregnancy|0
225132|NCT00103857|738835|P3|50-Week Extension Study|Pregnancy|1
225133|NCT00103857|738836|P2|50-Week Extension Study|Pregnancy|0
225134|NCT00103857|738837|P1|50-Week Extension Study|Pregnancy|0
225135|NCT00103857|738831|P7|50-Week Extension Study|Physician Decision|0
225136|NCT00103857|738832|P6|50-Week Extension Study|Physician Decision|0
225137|NCT00103857|738833|P5|50-Week Extension Study|Physician Decision|0
225138|NCT00103857|738834|P4|50-Week Extension Study|Physician Decision|0
225139|NCT00103857|738835|P3|50-Week Extension Study|Physician Decision|1
225140|NCT00103857|738836|P2|50-Week Extension Study|Physician Decision|1
225141|NCT00103857|738837|P1|50-Week Extension Study|Physician Decision|0
225142|NCT00103857|738831|P7|50-Week Extension Study|Lost to Follow-up|0
225143|NCT00103857|738832|P6|50-Week Extension Study|Lost to Follow-up|3
225144|NCT00103857|738833|P5|50-Week Extension Study|Lost to Follow-up|3
225145|NCT00103857|738834|P4|50-Week Extension Study|Lost to Follow-up|4
225146|NCT00103857|738835|P3|50-Week Extension Study|Lost to Follow-up|1
225147|NCT00103857|738836|P2|50-Week Extension Study|Lost to Follow-up|0
225148|NCT00103857|738837|P1|50-Week Extension Study|Lost to Follow-up|4
225149|NCT00103857|738831|P7|50-Week Extension Study|Lack of Efficacy|0
225150|NCT00103857|738832|P6|50-Week Extension Study|Lack of Efficacy|8
225151|NCT00103857|738833|P5|50-Week Extension Study|Lack of Efficacy|8
225152|NCT00103857|738834|P4|50-Week Extension Study|Lack of Efficacy|16
225153|NCT00103857|738835|P3|50-Week Extension Study|Lack of Efficacy|13
225154|NCT00103857|738836|P2|50-Week Extension Study|Lack of Efficacy|15
225155|NCT00103857|738837|P1|50-Week Extension Study|Lack of Efficacy|26
225156|NCT00103857|738831|P7|50-Week Extension Study|Death|0
225157|NCT00103857|738832|P6|50-Week Extension Study|Death|1
225158|NCT00103857|738833|P5|50-Week Extension Study|Death|0
225159|NCT00103857|738834|P4|50-Week Extension Study|Death|1
225160|NCT00103857|738835|P3|50-Week Extension Study|Death|0
225161|NCT00103857|738836|P2|50-Week Extension Study|Death|0
225162|NCT00103857|738837|P1|50-Week Extension Study|Death|0
225163|NCT00103857|738831|P7|50-Week Extension Study|Adverse Event|0
225164|NCT00103857|738832|P6|50-Week Extension Study|Adverse Event|1
225165|NCT00103857|738833|P5|50-Week Extension Study|Adverse Event|1
225166|NCT00103857|738834|P4|50-Week Extension Study|Adverse Event|0
225167|NCT00103857|738835|P3|50-Week Extension Study|Adverse Event|2
225168|NCT00103857|738836|P2|50-Week Extension Study|Adverse Event|3
225169|NCT00103857|738837|P1|50-Week Extension Study|Adverse Event|2
225170|NCT00103857|738831|P7|54-Week Base Study|patient intolerance to rescue therapy|0
225171|NCT00103857|738832|P6|54-Week Base Study|patient intolerance to rescue therapy|0
225172|NCT00103857|738833|P5|54-Week Base Study|patient intolerance to rescue therapy|0
225173|NCT00103857|738834|P4|54-Week Base Study|patient intolerance to rescue therapy|0
225174|NCT00103857|738835|P3|54-Week Base Study|patient intolerance to rescue therapy|0
225175|NCT00103857|738836|P2|54-Week Base Study|patient intolerance to rescue therapy|0
225176|NCT00103857|738837|P1|54-Week Base Study|patient intolerance to rescue therapy|1
225177|NCT00103857|738831|P7|54-Week Base Study|site error|0
225178|NCT00103857|738832|P6|54-Week Base Study|site error|1
225179|NCT00103857|738833|P5|54-Week Base Study|site error|0
225180|NCT00103857|738834|P4|54-Week Base Study|site error|0
225181|NCT00103857|738835|P3|54-Week Base Study|site error|0
225182|NCT00103857|738836|P2|54-Week Base Study|site error|0
225183|NCT00103857|738837|P1|54-Week Base Study|site error|0
225184|NCT00103857|738831|P7|54-Week Base Study|laboratory reporting error|0
225185|NCT00103857|738832|P6|54-Week Base Study|laboratory reporting error|0
225186|NCT00103857|738833|P5|54-Week Base Study|laboratory reporting error|1
225187|NCT00103857|738834|P4|54-Week Base Study|laboratory reporting error|0
225188|NCT00103857|738835|P3|54-Week Base Study|laboratory reporting error|0
225189|NCT00103857|738836|P2|54-Week Base Study|laboratory reporting error|0
225190|NCT00103857|738837|P1|54-Week Base Study|laboratory reporting error|0
225191|NCT00103857|738831|P7|54-Week Base Study|patient incarcerated|0
225192|NCT00103857|738832|P6|54-Week Base Study|patient incarcerated|1
225193|NCT00103857|738833|P5|54-Week Base Study|patient incarcerated|1
225194|NCT00103857|738834|P4|54-Week Base Study|patient incarcerated|0
225195|NCT00103857|738835|P3|54-Week Base Study|patient incarcerated|0
225196|NCT00103857|738836|P2|54-Week Base Study|patient incarcerated|0
225197|NCT00103857|738837|P1|54-Week Base Study|patient incarcerated|0
225198|NCT00103857|738831|P7|54-Week Base Study|non-compliance with study procedures|0
225199|NCT00103857|738832|P6|54-Week Base Study|non-compliance with study procedures|2
225200|NCT00103857|738833|P5|54-Week Base Study|non-compliance with study procedures|0
225201|NCT00103857|738834|P4|54-Week Base Study|non-compliance with study procedures|0
225202|NCT00103857|738835|P3|54-Week Base Study|non-compliance with study procedures|0
225203|NCT00103857|738836|P2|54-Week Base Study|non-compliance with study procedures|2
225204|NCT00103857|738837|P1|54-Week Base Study|non-compliance with study procedures|1
225205|NCT00103857|738831|P7|54-Week Base Study|patient moved|0
225206|NCT00103857|738832|P6|54-Week Base Study|patient moved|1
225207|NCT00103857|738833|P5|54-Week Base Study|patient moved|3
225208|NCT00103857|738834|P4|54-Week Base Study|patient moved|2
225209|NCT00103857|738835|P3|54-Week Base Study|patient moved|1
225210|NCT00103857|738836|P2|54-Week Base Study|patient moved|1
225211|NCT00103857|738837|P1|54-Week Base Study|patient moved|0
225212|NCT00103857|738831|P7|54-Week Base Study|protocol discontinuation criteria|5
225213|NCT00103857|738832|P6|54-Week Base Study|protocol discontinuation criteria|3
225214|NCT00103857|738833|P5|54-Week Base Study|protocol discontinuation criteria|5
225215|NCT00103857|738834|P4|54-Week Base Study|protocol discontinuation criteria|6
225216|NCT00103857|738835|P3|54-Week Base Study|protocol discontinuation criteria|2
225217|NCT00103857|738836|P2|54-Week Base Study|protocol discontinuation criteria|5
225218|NCT00103857|738837|P1|54-Week Base Study|protocol discontinuation criteria|2
225219|NCT00103857|738831|P7|54-Week Base Study|Withdrawal by Subject|4
225220|NCT00103857|738832|P6|54-Week Base Study|Withdrawal by Subject|15
225221|NCT00103857|738833|P5|54-Week Base Study|Withdrawal by Subject|10
225222|NCT00103857|738834|P4|54-Week Base Study|Withdrawal by Subject|15
225223|NCT00103857|738835|P3|54-Week Base Study|Withdrawal by Subject|16
225224|NCT00103857|738836|P2|54-Week Base Study|Withdrawal by Subject|16
225225|NCT00103857|738837|P1|54-Week Base Study|Withdrawal by Subject|17
225226|NCT00103857|738831|P7|54-Week Base Study|Protocol Violation|3
225227|NCT00103857|738832|P6|54-Week Base Study|Protocol Violation|3
225228|NCT00103857|738833|P5|54-Week Base Study|Protocol Violation|0
225229|NCT00103857|738834|P4|54-Week Base Study|Protocol Violation|4
225230|NCT00103857|738835|P3|54-Week Base Study|Protocol Violation|2
225231|NCT00103857|738836|P2|54-Week Base Study|Protocol Violation|4
225232|NCT00103857|738837|P1|54-Week Base Study|Protocol Violation|6
225233|NCT00103857|738831|P7|54-Week Base Study|Pregnancy|1
225234|NCT00103857|738832|P6|54-Week Base Study|Pregnancy|0
225235|NCT00103857|738833|P5|54-Week Base Study|Pregnancy|1
225236|NCT00103857|738834|P4|54-Week Base Study|Pregnancy|0
225237|NCT00103857|738835|P3|54-Week Base Study|Pregnancy|0
225238|NCT00103857|738836|P2|54-Week Base Study|Pregnancy|0
225239|NCT00103857|738837|P1|54-Week Base Study|Pregnancy|1
225240|NCT00103857|738831|P7|54-Week Base Study|Physician Decision|0
225241|NCT00103857|738832|P6|54-Week Base Study|Physician Decision|0
225242|NCT00103857|738833|P5|54-Week Base Study|Physician Decision|1
225243|NCT00103857|738834|P4|54-Week Base Study|Physician Decision|0
225244|NCT00103857|738835|P3|54-Week Base Study|Physician Decision|0
225245|NCT00103857|738836|P2|54-Week Base Study|Physician Decision|1
225246|NCT00103857|738837|P1|54-Week Base Study|Physician Decision|1
225247|NCT00103857|738831|P7|54-Week Base Study|Lost to Follow-up|3
225248|NCT00103857|738832|P6|54-Week Base Study|Lost to Follow-up|9
225249|NCT00103857|738833|P5|54-Week Base Study|Lost to Follow-up|10
225250|NCT00103857|738834|P4|54-Week Base Study|Lost to Follow-up|5
225251|NCT00103857|738835|P3|54-Week Base Study|Lost to Follow-up|7
225252|NCT00103857|738836|P2|54-Week Base Study|Lost to Follow-up|4
225253|NCT00103857|738837|P1|54-Week Base Study|Lost to Follow-up|5
225254|NCT00103857|738831|P7|54-Week Base Study|Lack of Efficacy|19
225255|NCT00103857|738832|P6|54-Week Base Study|Lack of Efficacy|14
225256|NCT00103857|738833|P5|54-Week Base Study|Lack of Efficacy|3
225257|NCT00103857|738834|P4|54-Week Base Study|Lack of Efficacy|4
225258|NCT00103857|738835|P3|54-Week Base Study|Lack of Efficacy|8
225259|NCT00103857|738836|P2|54-Week Base Study|Lack of Efficacy|14
225260|NCT00103857|738837|P1|54-Week Base Study|Lack of Efficacy|11
225261|NCT00103857|738831|P7|54-Week Base Study|Death|0
225262|NCT00103857|738832|P6|54-Week Base Study|Death|1
225263|NCT00103857|738833|P5|54-Week Base Study|Death|1
225264|NCT00103857|738834|P4|54-Week Base Study|Death|0
225265|NCT00103857|738835|P3|54-Week Base Study|Death|0
225266|NCT00103857|738836|P2|54-Week Base Study|Death|0
225267|NCT00103857|738837|P1|54-Week Base Study|Death|0
225268|NCT00103857|738831|P7|54-Week Base Study|Adverse Event|3
225269|NCT00103857|738832|P6|54-Week Base Study|Adverse Event|11
225270|NCT00103857|738833|P5|54-Week Base Study|Adverse Event|5
225271|NCT00103857|738834|P4|54-Week Base Study|Adverse Event|6
225272|NCT00103857|738835|P3|54-Week Base Study|Adverse Event|11
225273|NCT00103857|738836|P2|54-Week Base Study|Adverse Event|9
225274|NCT00103857|738837|P1|54-Week Base Study|Adverse Event|12
225275|NCT00103740|738936|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
225276|NCT00103740|738937|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
225277|NCT00103740|738936|P2|Period 2 - Extended Observation Period|Death|2
225278|NCT00103740|738937|P1|Period 2 - Extended Observation Period|Death|6
225279|NCT00103740|738936|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
225280|NCT00103740|738937|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
225281|NCT00103740|738936|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
225282|NCT00103740|738937|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
225283|NCT00103740|738936|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
225284|NCT00103740|738937|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
225285|NCT00103740|738936|P2|Period 1 - Core|Patient withdrew consent|2
225286|NCT00103740|738937|P1|Period 1 - Core|Patient withdrew consent|3
225287|NCT00103740|738936|P2|Period 1 - Core|Protocol Violation|2
225288|NCT00103740|738937|P1|Period 1 - Core|Protocol Violation|3
225289|NCT00103740|738936|P2|Period 1 - Core|Adverse Event|0
225290|NCT00103740|738937|P1|Period 1 - Core|Adverse Event|1
225291|NCT00103662|738965|P2|Overall Study|Intercurrent illness|0
225292|NCT00103662|738966|P1|Overall Study|Intercurrent illness|1
225293|NCT00103662|738965|P2|Overall Study|Failed mobilization|4
225294|NCT00103662|738966|P1|Overall Study|Failed mobilization|0
225295|NCT00103662|738965|P2|Overall Study|Other|9
225296|NCT00103662|738966|P1|Overall Study|Other|6
225297|NCT00103662|738965|P2|Overall Study|Lost to Follow-up|1
225298|NCT00103662|738966|P1|Overall Study|Lost to Follow-up|0
225299|NCT00103662|738965|P2|Overall Study|Elective Withdrawal|5
225300|NCT00103662|738966|P1|Overall Study|Elective Withdrawal|5
225301|NCT00103662|738965|P2|Overall Study|Death|7
225302|NCT00103662|738966|P1|Overall Study|Death|7
225303|NCT00103662|738965|P2|Overall Study|Entered Rescue Procedure|7
225304|NCT00103662|738966|P1|Overall Study|Entered Rescue Procedure|0
225305|NCT00103610|738992|P2|Overall Study|Noncompliance|1
225306|NCT00103610|738993|P1|Overall Study|Noncompliance|0
225307|NCT00103610|738992|P2|Overall Study|Failed mobilization|5
225308|NCT00103610|738993|P1|Overall Study|Failed mobilization|1
225309|NCT00103610|738992|P2|Overall Study|Other|7
225310|NCT00103610|738993|P1|Overall Study|Other|2
225311|NCT00103610|738992|P2|Overall Study|Adverse Event|2
225312|NCT00103610|738993|P1|Overall Study|Adverse Event|2
225313|NCT00103610|738992|P2|Overall Study|Lost to Follow-up|1
225314|NCT00103610|738993|P1|Overall Study|Lost to Follow-up|3
225315|NCT00103610|738992|P2|Overall Study|Elective Withdrawal|0
225316|NCT00103610|738993|P1|Overall Study|Elective Withdrawal|4
225317|NCT00103610|738992|P2|Overall Study|Death|12
225318|NCT00103610|738993|P1|Overall Study|Death|16
225319|NCT00103610|738992|P2|Overall Study|Entered Rescue Procedure|52
225320|NCT00103610|738993|P1|Overall Study|Entered Rescue Procedure|10
225321|NCT00103506|739017|P2|Overall Study|Withdrawal by Subject|21
225322|NCT00103506|739018|P1|Overall Study|Withdrawal by Subject|18
225323|NCT00103506|739017|P2|Overall Study|Lost to Follow-up|13
225324|NCT00103506|739018|P1|Overall Study|Lost to Follow-up|13
225325|NCT00103506|739017|P2|Overall Study|Death|253
225326|NCT00103506|739018|P1|Overall Study|Death|257
225327|NCT00103506|739017|P2|Overall Study|Study closed by sponsor|37
225328|NCT00103506|739018|P1|Overall Study|Study closed by sponsor|34
225329|NCT00103311|739030|P2|Overall Study|Adverse Event|0
225330|NCT00103311|739031|P1|Overall Study|Adverse Event|1
225331|NCT00103311|739030|P2|Overall Study|Withdrawal by Subject|1
225332|NCT00103311|739031|P1|Overall Study|Withdrawal by Subject|2
225333|NCT00103311|739030|P2|Overall Study|Lost to Follow-up|0
225334|NCT00103311|739031|P1|Overall Study|Lost to Follow-up|1
225335|NCT00103259|739043|P2|Overall Study|ineligible/no protocol therapy|6
225336|NCT00103259|739044|P1|Overall Study|ineligible/no protocol therapy|4
225337|NCT00103259|739043|P2|Overall Study|other (reasons were not specified)|1
225338|NCT00103259|739044|P1|Overall Study|other (reasons were not specified)|2
225339|NCT00103259|739043|P2|Overall Study|alternative therapy|0
225340|NCT00103259|739044|P1|Overall Study|alternative therapy|1
225341|NCT00103259|739043|P2|Overall Study|Withdrawal by Subject|3
225342|NCT00103259|739044|P1|Overall Study|Withdrawal by Subject|2
225343|NCT00103259|739043|P2|Overall Study|Death|2
225344|NCT00103259|739044|P1|Overall Study|Death|3
225345|NCT00103207|739056|P1|Overall Study|Diagnosis of BAC not confirmed|27
225346|NCT00103207|739056|P1|Overall Study|Ineligible|4
225347|NCT00103207|739056|P1|Overall Study|Other complicating disease|1
225348|NCT00103207|739056|P1|Overall Study|Withdrawal by Subject|2
225349|NCT00103207|739056|P1|Overall Study|Death|1
225350|NCT00103207|739056|P1|Overall Study|Adverse Event|3
225351|NCT00103142|739075|P2|Overall Study|Progression of disease|1
225352|NCT00103142|739076|P1|Overall Study|Progression of disease|2
225353|NCT00103142|739075|P2|Overall Study|Adverse Event|0
225354|NCT00103142|739076|P1|Overall Study|Adverse Event|1
225355|NCT00103012|739092|P3|Overall Study|Subject non-compliant with medications|1
225356|NCT00103012|739093|P2|Overall Study|Subject non-compliant with medications|0
225357|NCT00103012|739094|P1|Overall Study|Subject non-compliant with medications|0
225358|NCT00103012|739092|P3|Overall Study|Adverse Event|1
225359|NCT00103012|739093|P2|Overall Study|Adverse Event|0
225360|NCT00103012|739094|P1|Overall Study|Adverse Event|0
225361|NCT00103012|739092|P3|Overall Study|Pregnancy|0
225362|NCT00103012|739093|P2|Overall Study|Pregnancy|0
225363|NCT00103012|739094|P1|Overall Study|Pregnancy|1
225364|NCT00103012|739092|P3|Overall Study|Withdrawal by Subject|2
225365|NCT00103012|739093|P2|Overall Study|Withdrawal by Subject|1
225366|NCT00103012|739094|P1|Overall Study|Withdrawal by Subject|2
225367|NCT00102804|739104|P2|Overall Study|Alive, Receiving Treatment|2
225368|NCT00102804|739105|P1|Overall Study|Alive, Receiving Treatment|7
225369|NCT00102804|739104|P2|Overall Study|Sponsor Decision|0
225370|NCT00102804|739105|P1|Overall Study|Sponsor Decision|1
225371|NCT00102804|739104|P2|Overall Study|Satisfactory Response|0
225372|NCT00102804|739105|P1|Overall Study|Satisfactory Response|2
225373|NCT00102804|739104|P2|Overall Study|Protocol Violation|1
225374|NCT00102804|739105|P1|Overall Study|Protocol Violation|2
225375|NCT00102804|739104|P2|Overall Study|Lost to Follow-up|1
225376|NCT00102804|739105|P1|Overall Study|Lost to Follow-up|4
225377|NCT00102804|739104|P2|Overall Study|Enrollment Criteria Not Met|0
225378|NCT00102804|739105|P1|Overall Study|Enrollment Criteria Not Met|6
225379|NCT00102804|739104|P2|Overall Study|Death|6
225380|NCT00102804|739105|P1|Overall Study|Death|5
225381|NCT00102804|739104|P2|Overall Study|Physician Decision|6
225382|NCT00102804|739105|P1|Overall Study|Physician Decision|24
225383|NCT00102804|739104|P2|Overall Study|Adverse Event|3
225384|NCT00102804|739105|P1|Overall Study|Adverse Event|37
225385|NCT00102804|739104|P2|Overall Study|Withdrawal by Subject|7
225386|NCT00102804|739105|P1|Overall Study|Withdrawal by Subject|46
225387|NCT00102804|739104|P2|Overall Study|Progressive Disease (PD)|196
225388|NCT00102804|739105|P1|Overall Study|Progressive Disease (PD)|307
225389|NCT00102687|739126|P5|Maintenance Period|Death|1
225390|NCT00102687|739127|P4|Maintenance Period|Death|1
225391|NCT00102687|739128|P3|Maintenance Period|Death|0
225392|NCT00102687|739129|P2|Maintenance Period|Death|0
225393|NCT00102687|739130|P1|Maintenance Period|Death|0
225394|NCT00102687|739126|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
225395|NCT00102687|739127|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
225396|NCT00102687|739128|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
225397|NCT00102687|739129|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
225398|NCT00102687|739130|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
225399|NCT00102687|739126|P5|Maintenance Period|Sponsor decision|0
225400|NCT00102687|739127|P4|Maintenance Period|Sponsor decision|0
225401|NCT00102687|739128|P3|Maintenance Period|Sponsor decision|0
225402|NCT00102687|739129|P2|Maintenance Period|Sponsor decision|0
225403|NCT00102687|739130|P1|Maintenance Period|Sponsor decision|0
225404|NCT00102687|739126|P5|Maintenance Period|Physician Decision|4
225405|NCT00102687|739127|P4|Maintenance Period|Physician Decision|0
225406|NCT00102687|739128|P3|Maintenance Period|Physician Decision|3
225407|NCT00102687|739129|P2|Maintenance Period|Physician Decision|2
225408|NCT00102687|739130|P1|Maintenance Period|Physician Decision|1
225409|NCT00102687|739126|P5|Maintenance Period|Protocol Violation|0
225410|NCT00102687|739127|P4|Maintenance Period|Protocol Violation|0
225411|NCT00102687|739128|P3|Maintenance Period|Protocol Violation|0
225412|NCT00102687|739129|P2|Maintenance Period|Protocol Violation|0
225413|NCT00102687|739130|P1|Maintenance Period|Protocol Violation|0
225414|NCT00102687|739126|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
225415|NCT00102687|739127|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
225416|NCT00102687|739128|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
225417|NCT00102687|739129|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
225418|NCT00102687|739130|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
225419|NCT00102687|739126|P5|Maintenance Period|Adverse Event|3
225420|NCT00102687|739127|P4|Maintenance Period|Adverse Event|1
225421|NCT00102687|739128|P3|Maintenance Period|Adverse Event|0
225422|NCT00102687|739129|P2|Maintenance Period|Adverse Event|0
225423|NCT00102687|739130|P1|Maintenance Period|Adverse Event|1
225424|NCT00102687|739126|P5|Maintenance Period|Withdrawal by Subject|1
225425|NCT00102687|739127|P4|Maintenance Period|Withdrawal by Subject|3
225426|NCT00102687|739128|P3|Maintenance Period|Withdrawal by Subject|2
225427|NCT00102687|739129|P2|Maintenance Period|Withdrawal by Subject|0
225428|NCT00102687|739130|P1|Maintenance Period|Withdrawal by Subject|4
225429|NCT00102687|739126|P5|Initial Period|Death|0
225430|NCT00102687|739127|P4|Initial Period|Death|0
225431|NCT00102687|739128|P3|Initial Period|Death|1
225432|NCT00102687|739129|P2|Initial Period|Death|1
225433|NCT00102687|739130|P1|Initial Period|Death|1
225434|NCT00102687|739126|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
225435|NCT00102687|739127|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
225436|NCT00102687|739128|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
225437|NCT00102687|739129|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
225438|NCT00102687|739130|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
225439|NCT00102687|739126|P5|Initial Period|Sponsor's decision|0
225440|NCT00102687|739127|P4|Initial Period|Sponsor's decision|0
225441|NCT00102687|739128|P3|Initial Period|Sponsor's decision|1
225442|NCT00102687|739129|P2|Initial Period|Sponsor's decision|1
225443|NCT00102687|739130|P1|Initial Period|Sponsor's decision|0
225444|NCT00102687|739126|P5|Initial Period|Physician Decision|0
225445|NCT00102687|739127|P4|Initial Period|Physician Decision|0
225446|NCT00102687|739128|P3|Initial Period|Physician Decision|6
225447|NCT00102687|739129|P2|Initial Period|Physician Decision|9
225448|NCT00102687|739130|P1|Initial Period|Physician Decision|2
225449|NCT00102687|739126|P5|Initial Period|Protocol Violation|0
225450|NCT00102687|739127|P4|Initial Period|Protocol Violation|0
225451|NCT00102687|739128|P3|Initial Period|Protocol Violation|2
225452|NCT00102687|739129|P2|Initial Period|Protocol Violation|0
225453|NCT00102687|739130|P1|Initial Period|Protocol Violation|0
225454|NCT00102687|739126|P5|Initial Period|Transformation to AML (blast > 30%)|0
225455|NCT00102687|739127|P4|Initial Period|Transformation to AML (blast > 30%)|0
225456|NCT00102687|739128|P3|Initial Period|Transformation to AML (blast > 30%)|0
225457|NCT00102687|739129|P2|Initial Period|Transformation to AML (blast > 30%)|3
225458|NCT00102687|739130|P1|Initial Period|Transformation to AML (blast > 30%)|1
225459|NCT00102687|739126|P5|Initial Period|Adverse Event|0
225460|NCT00102687|739127|P4|Initial Period|Adverse Event|0
225461|NCT00102687|739128|P3|Initial Period|Adverse Event|9
225462|NCT00102687|739129|P2|Initial Period|Adverse Event|7
225463|NCT00102687|739130|P1|Initial Period|Adverse Event|4
225464|NCT00102687|739126|P5|Initial Period|Withdrawal by Subject|0
225465|NCT00102687|739127|P4|Initial Period|Withdrawal by Subject|0
225466|NCT00102687|739128|P3|Initial Period|Withdrawal by Subject|5
225467|NCT00102687|739129|P2|Initial Period|Withdrawal by Subject|3
225468|NCT00102687|739130|P1|Initial Period|Withdrawal by Subject|6
225469|NCT00102596|739194|P2|Part A|Adverse Event|0
225470|NCT00102596|739195|P1|Part A|Adverse Event|1
225471|NCT00102596|739194|P2|Part A|Screen failures|0
225472|NCT00102596|739195|P1|Part A|Screen failures|6
225473|NCT00102531|739206|P2|Overall Study|Physician Decision|1
225474|NCT00102531|739207|P1|Overall Study|Physician Decision|0
225475|NCT00102531|739206|P2|Overall Study|Disease Progression|9
225476|NCT00102531|739207|P1|Overall Study|Disease Progression|5
225477|NCT00102531|739206|P2|Overall Study|Adverse Event|1
225478|NCT00102531|739207|P1|Overall Study|Adverse Event|0
225479|NCT00102440|739222|P3|Overall Study|Protocol Violation|1
225480|NCT00102440|739223|P2|Overall Study|Protocol Violation|2
225481|NCT00102440|739224|P1|Overall Study|Protocol Violation|7
225482|NCT00102440|739222|P3|Overall Study|Other|14
225483|NCT00102440|739223|P2|Overall Study|Other|14
225484|NCT00102440|739224|P1|Overall Study|Other|11
225485|NCT00102440|739222|P3|Overall Study|Personal Reason(s)|13
225486|NCT00102440|739223|P2|Overall Study|Personal Reason(s)|13
225487|NCT00102440|739224|P1|Overall Study|Personal Reason(s)|19
225488|NCT00102440|739222|P3|Overall Study|Gout Flare|9
225489|NCT00102440|739223|P2|Overall Study|Gout Flare|28
225490|NCT00102440|739224|P1|Overall Study|Gout Flare|10
225491|NCT00102440|739222|P3|Overall Study|Adverse Event|8
225492|NCT00102440|739223|P2|Overall Study|Adverse Event|23
225493|NCT00102440|739224|P1|Overall Study|Adverse Event|16
225494|NCT00102440|739222|P3|Overall Study|Lost to Follow-up|21
225495|NCT00102440|739223|P2|Overall Study|Lost to Follow-up|18
225496|NCT00102440|739224|P1|Overall Study|Lost to Follow-up|25
225497|NCT00102063|739274|P3|Overall Study|Protocol Violation|1
225498|NCT00102063|739275|P2|Overall Study|Protocol Violation|1
225499|NCT00102063|739276|P1|Overall Study|Protocol Violation|0
225500|NCT00102063|739274|P3|Overall Study|Lost to Follow-up|1
225501|NCT00102063|739275|P2|Overall Study|Lost to Follow-up|0
225502|NCT00102063|739276|P1|Overall Study|Lost to Follow-up|0
225503|NCT00102063|739274|P3|Overall Study|Withdrawal by Subject|5
225504|NCT00102063|739275|P2|Overall Study|Withdrawal by Subject|12
225505|NCT00102063|739276|P1|Overall Study|Withdrawal by Subject|4
225506|NCT00102063|739274|P3|Overall Study|Adverse Event|2
225507|NCT00102063|739275|P2|Overall Study|Adverse Event|4
225508|NCT00102063|739276|P1|Overall Study|Adverse Event|7
225509|NCT00102063|739274|P3|Overall Study|Lack of Efficacy|1
225510|NCT00102063|739275|P2|Overall Study|Lack of Efficacy|1
225511|NCT00102063|739276|P1|Overall Study|Lack of Efficacy|5
225512|NCT00101907|739334|P6|Overall Study|Withdrawal by Subject|0
225513|NCT00101907|739335|P5|Overall Study|Withdrawal by Subject|1
225514|NCT00101907|739336|P4|Overall Study|Withdrawal by Subject|0
225515|NCT00101907|739337|P3|Overall Study|Withdrawal by Subject|1
225516|NCT00101907|739338|P2|Overall Study|Withdrawal by Subject|0
225517|NCT00101907|739339|P1|Overall Study|Withdrawal by Subject|1
225518|NCT00101907|739334|P6|Overall Study|Physician Decision|0
225519|NCT00101907|739335|P5|Overall Study|Physician Decision|1
225520|NCT00101907|739336|P4|Overall Study|Physician Decision|1
225521|NCT00101907|739337|P3|Overall Study|Physician Decision|0
225522|NCT00101907|739338|P2|Overall Study|Physician Decision|0
225523|NCT00101907|739339|P1|Overall Study|Physician Decision|0
225524|NCT00101907|739334|P6|Overall Study|Death|0
225525|NCT00101907|739335|P5|Overall Study|Death|3
225526|NCT00101907|739336|P4|Overall Study|Death|0
225527|NCT00101907|739337|P3|Overall Study|Death|0
225528|NCT00101907|739338|P2|Overall Study|Death|1
225529|NCT00101907|739339|P1|Overall Study|Death|0
225530|NCT00101907|739334|P6|Overall Study|Adverse Event|0
225531|NCT00101907|739335|P5|Overall Study|Adverse Event|0
225532|NCT00101907|739336|P4|Overall Study|Adverse Event|0
225533|NCT00101907|739337|P3|Overall Study|Adverse Event|0
225534|NCT00101907|739338|P2|Overall Study|Adverse Event|0
225535|NCT00101907|739339|P1|Overall Study|Adverse Event|1
225536|NCT00101868|739381|P2|Overall Study|Lost to Follow-up|13
225537|NCT00101868|739382|P1|Overall Study|Lost to Follow-up|8
225538|NCT00101868|739381|P2|Overall Study|Protocol Violation|0
225539|NCT00101868|739382|P1|Overall Study|Protocol Violation|3
225540|NCT00101868|739381|P2|Overall Study|Withdrawal by Subject|9
225541|NCT00101868|739382|P1|Overall Study|Withdrawal by Subject|8
225542|NCT00101868|739381|P2|Overall Study|Death|10
225543|NCT00101868|739382|P1|Overall Study|Death|10
225544|NCT00101686|739452|P10|Overall Study|Withdrawal by Subject|9
225545|NCT00101686|739453|P9|Overall Study|Withdrawal by Subject|8
225546|NCT00101686|739454|P8|Overall Study|Withdrawal by Subject|7
225547|NCT00101686|739455|P7|Overall Study|Withdrawal by Subject|7
225548|NCT00101686|739456|P6|Overall Study|Withdrawal by Subject|7
225549|NCT00101686|739457|P5|Overall Study|Withdrawal by Subject|8
225550|NCT00101686|739458|P4|Overall Study|Withdrawal by Subject|8
225551|NCT00101686|739459|P3|Overall Study|Withdrawal by Subject|6
225552|NCT00101686|739460|P2|Overall Study|Withdrawal by Subject|8
225553|NCT00101686|739461|P1|Overall Study|Withdrawal by Subject|9
225554|NCT00101686|739452|P10|Overall Study|Other|3
225555|NCT00101686|739453|P9|Overall Study|Other|3
225556|NCT00101686|739454|P8|Overall Study|Other|5
225557|NCT00101686|739455|P7|Overall Study|Other|1
225558|NCT00101686|739456|P6|Overall Study|Other|12
225559|NCT00101686|739457|P5|Overall Study|Other|2
225560|NCT00101686|739458|P4|Overall Study|Other|6
225561|NCT00101686|739459|P3|Overall Study|Other|1
225562|NCT00101686|739460|P2|Overall Study|Other|4
225563|NCT00101686|739461|P1|Overall Study|Other|1
225564|NCT00101686|739452|P10|Overall Study|Physician Decision|1
225565|NCT00101686|739453|P9|Overall Study|Physician Decision|1
225566|NCT00101686|739454|P8|Overall Study|Physician Decision|5
225567|NCT00101686|739455|P7|Overall Study|Physician Decision|5
225568|NCT00101686|739456|P6|Overall Study|Physician Decision|9
225569|NCT00101686|739457|P5|Overall Study|Physician Decision|8
225570|NCT00101686|739458|P4|Overall Study|Physician Decision|7
225571|NCT00101686|739459|P3|Overall Study|Physician Decision|6
225572|NCT00101686|739460|P2|Overall Study|Physician Decision|13
225573|NCT00101686|739461|P1|Overall Study|Physician Decision|10
225574|NCT00101686|739452|P10|Overall Study|intercurrent non-cancer related illness|1
225575|NCT00101686|739453|P9|Overall Study|intercurrent non-cancer related illness|1
225576|NCT00101686|739454|P8|Overall Study|intercurrent non-cancer related illness|0
225577|NCT00101686|739455|P7|Overall Study|intercurrent non-cancer related illness|1
225578|NCT00101686|739456|P6|Overall Study|intercurrent non-cancer related illness|3
225579|NCT00101686|739457|P5|Overall Study|intercurrent non-cancer related illness|1
225580|NCT00101686|739458|P4|Overall Study|intercurrent non-cancer related illness|0
225581|NCT00101686|739459|P3|Overall Study|intercurrent non-cancer related illness|2
225582|NCT00101686|739460|P2|Overall Study|intercurrent non-cancer related illness|0
225583|NCT00101686|739461|P1|Overall Study|intercurrent non-cancer related illness|0
225584|NCT00101686|739452|P10|Overall Study|Randomized but did not receive treament|1
225585|NCT00101686|739453|P9|Overall Study|Randomized but did not receive treament|0
225586|NCT00101686|739454|P8|Overall Study|Randomized but did not receive treament|1
225587|NCT00101686|739455|P7|Overall Study|Randomized but did not receive treament|0
225588|NCT00101686|739456|P6|Overall Study|Randomized but did not receive treament|2
225589|NCT00101686|739457|P5|Overall Study|Randomized but did not receive treament|2
225590|NCT00101686|739458|P4|Overall Study|Randomized but did not receive treament|2
225591|NCT00101686|739459|P3|Overall Study|Randomized but did not receive treament|2
225592|NCT00101686|739460|P2|Overall Study|Randomized but did not receive treament|6
225593|NCT00101686|739461|P1|Overall Study|Randomized but did not receive treament|1
225594|NCT00101686|739452|P10|Overall Study|unacceptable toxicity|4
225595|NCT00101686|739453|P9|Overall Study|unacceptable toxicity|1
225596|NCT00101686|739454|P8|Overall Study|unacceptable toxicity|2
225597|NCT00101686|739455|P7|Overall Study|unacceptable toxicity|4
225598|NCT00101686|739456|P6|Overall Study|unacceptable toxicity|10
225599|NCT00101686|739457|P5|Overall Study|unacceptable toxicity|16
225600|NCT00101686|739458|P4|Overall Study|unacceptable toxicity|6
225601|NCT00101686|739459|P3|Overall Study|unacceptable toxicity|10
225602|NCT00101686|739460|P2|Overall Study|unacceptable toxicity|9
225603|NCT00101686|739461|P1|Overall Study|unacceptable toxicity|3
225604|NCT00101686|739452|P10|Overall Study|>3 week delay treatment due toxicity|0
225605|NCT00101686|739453|P9|Overall Study|>3 week delay treatment due toxicity|3
225606|NCT00101686|739454|P8|Overall Study|>3 week delay treatment due toxicity|1
225607|NCT00101686|739455|P7|Overall Study|>3 week delay treatment due toxicity|2
225608|NCT00101686|739456|P6|Overall Study|>3 week delay treatment due toxicity|3
225609|NCT00101686|739457|P5|Overall Study|>3 week delay treatment due toxicity|7
225610|NCT00101686|739458|P4|Overall Study|>3 week delay treatment due toxicity|2
225611|NCT00101686|739459|P3|Overall Study|>3 week delay treatment due toxicity|1
225612|NCT00101686|739460|P2|Overall Study|>3 week delay treatment due toxicity|2
225613|NCT00101686|739461|P1|Overall Study|>3 week delay treatment due toxicity|6
225614|NCT00101686|739452|P10|Overall Study|initiation other anti-cancer treatment|3
225615|NCT00101686|739453|P9|Overall Study|initiation other anti-cancer treatment|3
225616|NCT00101686|739454|P8|Overall Study|initiation other anti-cancer treatment|2
225617|NCT00101686|739455|P7|Overall Study|initiation other anti-cancer treatment|2
225618|NCT00101686|739456|P6|Overall Study|initiation other anti-cancer treatment|1
225619|NCT00101686|739457|P5|Overall Study|initiation other anti-cancer treatment|1
225620|NCT00101686|739458|P4|Overall Study|initiation other anti-cancer treatment|3
225621|NCT00101686|739459|P3|Overall Study|initiation other anti-cancer treatment|4
225622|NCT00101686|739460|P2|Overall Study|initiation other anti-cancer treatment|3
225623|NCT00101686|739461|P1|Overall Study|initiation other anti-cancer treatment|4
225624|NCT00101686|739452|P10|Overall Study|Progressive Disease|8
225625|NCT00101686|739453|P9|Overall Study|Progressive Disease|10
225626|NCT00101686|739454|P8|Overall Study|Progressive Disease|7
225627|NCT00101686|739455|P7|Overall Study|Progressive Disease|5
225628|NCT00101686|739456|P6|Overall Study|Progressive Disease|25
225629|NCT00101686|739457|P5|Overall Study|Progressive Disease|28
225630|NCT00101686|739458|P4|Overall Study|Progressive Disease|38
225631|NCT00101686|739459|P3|Overall Study|Progressive Disease|37
225632|NCT00101686|739460|P2|Overall Study|Progressive Disease|28
225633|NCT00101686|739461|P1|Overall Study|Progressive Disease|37
225634|NCT00101582|739578|P2|Overall Study|Other|1
225635|NCT00101582|739579|P1|Overall Study|Other|0
225636|NCT00101582|739578|P2|Overall Study|Death|5
225637|NCT00101582|739579|P1|Overall Study|Death|3
225638|NCT00101582|739578|P2|Overall Study|Physician Decision|0
225639|NCT00101582|739579|P1|Overall Study|Physician Decision|1
225640|NCT00101582|739578|P2|Overall Study|Withdrawal by Subject|4
225641|NCT00101582|739579|P1|Overall Study|Withdrawal by Subject|6
225642|NCT00101582|739578|P2|Overall Study|Adverse Event|4
225643|NCT00101582|739579|P1|Overall Study|Adverse Event|1
225644|NCT00101582|739578|P2|Overall Study|Ineligibility determined|1
225645|NCT00101582|739579|P1|Overall Study|Ineligibility determined|0
225646|NCT00101452|739602|P3|Overall Study|Other|12
225647|NCT00101452|739603|P2|Overall Study|Other|16
225648|NCT00101452|739604|P1|Overall Study|Other|15
225649|NCT00101452|739602|P3|Overall Study|Protocol Violation|3
225650|NCT00101452|739603|P2|Overall Study|Protocol Violation|1
225651|NCT00101452|739604|P1|Overall Study|Protocol Violation|2
225652|NCT00101452|739602|P3|Overall Study|Physician Decision|2
225653|NCT00101452|739603|P2|Overall Study|Physician Decision|3
225654|NCT00101452|739604|P1|Overall Study|Physician Decision|0
225655|NCT00101452|739602|P3|Overall Study|Baseline Fail|2
225656|NCT00101452|739603|P2|Overall Study|Baseline Fail|1
225657|NCT00101452|739604|P1|Overall Study|Baseline Fail|2
225658|NCT00101452|739602|P3|Overall Study|Withdrawal by Subject|9
225659|NCT00101452|739603|P2|Overall Study|Withdrawal by Subject|14
225660|NCT00101452|739604|P1|Overall Study|Withdrawal by Subject|10
225661|NCT00101452|739602|P3|Overall Study|Lost to Follow-up|14
225662|NCT00101452|739603|P2|Overall Study|Lost to Follow-up|8
225663|NCT00101452|739604|P1|Overall Study|Lost to Follow-up|13
225664|NCT00101452|739602|P3|Overall Study|Adverse Event|1
225665|NCT00101452|739603|P2|Overall Study|Adverse Event|0
225666|NCT00101452|739604|P1|Overall Study|Adverse Event|2
225667|NCT00101439|739618|P2|Period 2|Withdrawal by Subject|2
225668|NCT00101439|739619|P1|Period 2|Withdrawal by Subject|0
225669|NCT00101400|739635|P1|Survival Follow-Up|Alive|7
225670|NCT00101283|739655|P2|Overall Study|Prostate Cancer Recurrence|1
225671|NCT00101283|739656|P1|Overall Study|Prostate Cancer Recurrence|0
225672|NCT00101283|739655|P2|Overall Study|Insurance Refusal|1
225673|NCT00101283|739656|P1|Overall Study|Insurance Refusal|0
225674|NCT00101283|739655|P2|Overall Study|Withdrawal by Subject|1
225675|NCT00101283|739656|P1|Overall Study|Withdrawal by Subject|0
225676|NCT00101192|739666|P1|Overall Study|Inevaluable|1
225677|NCT00101192|739666|P1|Overall Study|Ineligible|6
225678|NCT00101166|739670|P1|Overall Study|progressive disease|10
225679|NCT00101101|739678|P1|Overall Study|never received vaccine|20
225680|NCT00100932|739701|P2|Overall Study|Not specified|2
225681|NCT00100932|739702|P1|Overall Study|Not specified|5
225682|NCT00100932|739701|P2|Overall Study|Physician Decision|5
225683|NCT00100932|739702|P1|Overall Study|Physician Decision|7
225684|NCT00100932|739701|P2|Overall Study|Progressive Disease|18
225685|NCT00100932|739702|P1|Overall Study|Progressive Disease|44
225686|NCT00100932|739701|P2|Overall Study|Withdrawal by Subject|0
225687|NCT00100932|739702|P1|Overall Study|Withdrawal by Subject|6
225688|NCT00100932|739701|P2|Overall Study|Adverse Event|2
225689|NCT00100932|739702|P1|Overall Study|Adverse Event|11
225690|NCT00100815|739717|P1|Overall Study|not specified|3
225691|NCT00100815|739717|P1|Overall Study|Death|4
225692|NCT00100815|739717|P1|Overall Study|Adverse Event|18
225693|NCT00100815|739717|P1|Overall Study|Progression|24
225694|NCT00100802|739725|P1|Overall Study|Ineligible|12
225695|NCT00100802|739725|P1|Overall Study|Withdrawal by Subject|5
225696|NCT00100802|739725|P1|Overall Study|Protocol Violation|1
225697|NCT00100802|739725|P1|Overall Study|Physician Decision|5
225698|NCT00100802|739725|P1|Overall Study|Lack of Efficacy|47
225699|NCT00100802|739725|P1|Overall Study|Death|1
225700|NCT00100802|739725|P1|Overall Study|Adverse Event|9
225701|NCT00100789|739730|P1|Overall Study|Never received treatment|1
225702|NCT00100789|739730|P1|Overall Study|Ineligible|3
225703|NCT00100789|739730|P1|Overall Study|Not protocol specified|5
225704|NCT00100789|739730|P1|Overall Study|Death|2
225705|NCT00100789|739730|P1|Overall Study|Progression/relapse|42
225706|NCT00100789|739730|P1|Overall Study|Withdrawal by Subject|1
225707|NCT00100789|739730|P1|Overall Study|Adverse Event|10
225708|NCT00100178|739805|P3|Overall Study|Physician Decision|3
225709|NCT00100178|739806|P2|Overall Study|Physician Decision|1
225710|NCT00100178|739807|P1|Overall Study|Physician Decision|6
225711|NCT00100178|739805|P3|Overall Study|Withdrawal by Subject|1
225712|NCT00100178|739806|P2|Overall Study|Withdrawal by Subject|1
225713|NCT00100178|739807|P1|Overall Study|Withdrawal by Subject|1
225714|NCT00100178|739805|P3|Overall Study|Adverse Event|1
225715|NCT00100178|739806|P2|Overall Study|Adverse Event|2
225716|NCT00100178|739807|P1|Overall Study|Adverse Event|2
225717|NCT00100178|739805|P3|Overall Study|Lost to Follow-up|5
225718|NCT00100178|739806|P2|Overall Study|Lost to Follow-up|6
225719|NCT00100178|739807|P1|Overall Study|Lost to Follow-up|0
225720|NCT00100048|739820|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
225721|NCT00100048|739821|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
225722|NCT00100048|739822|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
225723|NCT00100048|739823|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
225724|NCT00100048|739824|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
225725|NCT00100048|739825|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
225726|NCT00100048|739820|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
225727|NCT00100048|739821|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
225728|NCT00100048|739822|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
225729|NCT00100048|739823|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
225730|NCT00100048|739824|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
225731|NCT00100048|739825|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
225732|NCT00100048|739820|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
225733|NCT00100048|739821|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
225734|NCT00100048|739822|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
225735|NCT00100048|739823|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
225736|NCT00100048|739824|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
225737|NCT00100048|739825|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
225738|NCT00100048|739820|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
225739|NCT00100048|739821|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
225740|NCT00100048|739822|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
225741|NCT00100048|739823|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
225742|NCT00100048|739824|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
225743|NCT00100048|739825|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
225744|NCT00100048|739820|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
225745|NCT00100048|739821|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
225746|NCT00100048|739822|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
225747|NCT00100048|739823|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
225748|NCT00100048|739824|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
225749|NCT00100048|739825|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
225750|NCT00100048|739820|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
225751|NCT00100048|739821|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
225752|NCT00100048|739822|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
225753|NCT00100048|739823|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
225754|NCT00100048|739824|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
225755|NCT00100048|739825|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
225756|NCT00100048|739820|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
225757|NCT00100048|739821|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
225758|NCT00100048|739822|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
225759|NCT00100048|739823|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
225760|NCT00100048|739824|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
225761|NCT00100048|739825|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
225762|NCT00100048|739820|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
225763|NCT00100048|739821|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
225764|NCT00100048|739822|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
225765|NCT00100048|739823|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
225766|NCT00100048|739824|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
225767|NCT00100048|739825|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
225768|NCT00099983|739934|P2|Overall Study|Other issue|0
225769|NCT00099983|739935|P1|Overall Study|Other issue|1
225770|NCT00099983|739934|P2|Overall Study|Intolerant of burden of visits|1
225771|NCT00099983|739935|P1|Overall Study|Intolerant of burden of visits|0
225772|NCT00099983|739934|P2|Overall Study|Incarcerated|1
225773|NCT00099983|739935|P1|Overall Study|Incarcerated|0
225774|NCT00099983|739934|P2|Overall Study|Other psychiatric problem|0
225775|NCT00099983|739935|P1|Overall Study|Other psychiatric problem|1
225776|NCT00099983|739934|P2|Overall Study|Moved|0
225777|NCT00099983|739935|P1|Overall Study|Moved|1
225778|NCT00099983|739934|P2|Overall Study|Unable to return for appointments|1
225779|NCT00099983|739935|P1|Overall Study|Unable to return for appointments|1
225780|NCT00099983|739934|P2|Overall Study|Lack of Efficacy|1
225781|NCT00099983|739935|P1|Overall Study|Lack of Efficacy|0
225782|NCT00099983|739934|P2|Overall Study|Adverse Event|1
225783|NCT00099983|739935|P1|Overall Study|Adverse Event|1
225784|NCT00099983|739934|P2|Overall Study|Withdrawal by Subject|2
225785|NCT00099983|739935|P1|Overall Study|Withdrawal by Subject|3
225786|NCT00099983|739934|P2|Overall Study|Missing Source Documents|15
225787|NCT00099983|739935|P1|Overall Study|Missing Source Documents|14
225788|NCT00099983|739934|P2|Overall Study|Lost to Follow-up|3
225789|NCT00099983|739935|P1|Overall Study|Lost to Follow-up|2
225790|NCT00099632|739947|P6|Overall Study|Protocol Violation|1
225791|NCT00099632|739948|P5|Overall Study|Protocol Violation|0
225792|NCT00099632|739949|P4|Overall Study|Protocol Violation|0
225793|NCT00099632|739950|P3|Overall Study|Protocol Violation|0
225794|NCT00099632|739951|P2|Overall Study|Protocol Violation|0
225795|NCT00099632|739952|P1|Overall Study|Protocol Violation|0
225796|NCT00099632|739947|P6|Overall Study|Withdrawal by Subject|1
225797|NCT00099632|739948|P5|Overall Study|Withdrawal by Subject|0
225798|NCT00099632|739949|P4|Overall Study|Withdrawal by Subject|0
225799|NCT00099632|739950|P3|Overall Study|Withdrawal by Subject|0
225800|NCT00099632|739951|P2|Overall Study|Withdrawal by Subject|1
225801|NCT00099632|739952|P1|Overall Study|Withdrawal by Subject|0
225802|NCT00099632|739947|P6|Overall Study|Lost to Follow-up|0
225803|NCT00099632|739948|P5|Overall Study|Lost to Follow-up|1
225804|NCT00099632|739949|P4|Overall Study|Lost to Follow-up|1
225805|NCT00099632|739950|P3|Overall Study|Lost to Follow-up|3
225806|NCT00099632|739951|P2|Overall Study|Lost to Follow-up|0
225807|NCT00099632|739952|P1|Overall Study|Lost to Follow-up|1
225808|NCT00099437|739992|P2|Overall Study|Ongoing in FU but not on treatment|45
225809|NCT00099437|739993|P1|Overall Study|Ongoing in FU but not on treatment|37
225810|NCT00099437|739992|P2|Overall Study|Withdrawal by Subject|10
225811|NCT00099437|739993|P1|Overall Study|Withdrawal by Subject|6
225812|NCT00099437|739992|P2|Overall Study|Death|261
225813|NCT00099437|739993|P1|Overall Study|Death|293
225814|NCT00099437|739992|P2|Overall Study|Lost to Follow-up|33
225815|NCT00099437|739993|P1|Overall Study|Lost to Follow-up|30
225816|NCT00099359|740016|P3|Overall Study|moved out of area|4
225817|NCT00099359|740017|P2|Overall Study|moved out of area|7
225818|NCT00099359|740018|P1|Overall Study|moved out of area|9
225819|NCT00099359|740016|P3|Overall Study|Lost to Follow-up|24
225820|NCT00099359|740017|P2|Overall Study|Lost to Follow-up|24
225821|NCT00099359|740018|P1|Overall Study|Lost to Follow-up|15
225822|NCT00099359|740016|P3|Overall Study|Withdrawal by Subject|23
225823|NCT00099359|740017|P2|Overall Study|Withdrawal by Subject|19
225824|NCT00099359|740018|P1|Overall Study|Withdrawal by Subject|19
225825|NCT00099359|740016|P3|Overall Study|Death|17
225826|NCT00099359|740017|P2|Overall Study|Death|15
225827|NCT00099359|740018|P1|Overall Study|Death|11
225828|NCT00099268|740041|P2|Overall Study|Death|1
225829|NCT00099268|740042|P1|Overall Study|Death|3
225830|NCT00099268|740041|P2|Overall Study|Administrative problems|4
225831|NCT00099268|740042|P1|Overall Study|Administrative problems|4
225832|NCT00099268|740041|P2|Overall Study|Lack of Efficacy|18
225833|NCT00099268|740042|P1|Overall Study|Lack of Efficacy|5
225834|NCT00099268|740041|P2|Overall Study|Lost to Follow-up|4
225835|NCT00099268|740042|P1|Overall Study|Lost to Follow-up|6
225836|NCT00099268|740041|P2|Overall Study|Protocol Violation|8
225837|NCT00099268|740042|P1|Overall Study|Protocol Violation|9
225838|NCT00099268|740041|P2|Overall Study|Adverse Event|19
225839|NCT00099268|740042|P1|Overall Study|Adverse Event|19
225840|NCT00099268|740041|P2|Overall Study|Withdrawal by Subject|28
225841|NCT00099268|740042|P1|Overall Study|Withdrawal by Subject|46
225842|NCT00098865|740078|P1|Overall Study|Alternative Therapy|1
225843|NCT00098865|740078|P1|Overall Study|Adverse Event|2
225844|NCT00098865|740078|P1|Overall Study|Progressive Disease|6
225845|NCT00098839|740086|P2|Overall Study|Ineligible|0
225846|NCT00098839|740087|P1|Overall Study|Ineligible|2
225847|NCT00098839|740086|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
225848|NCT00098839|740087|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
225849|NCT00098839|740086|P2|Overall Study|Relapse|3
225850|NCT00098839|740087|P1|Overall Study|Relapse|6
225851|NCT00098839|740086|P2|Overall Study|Refusal of further protocol therapy|1
225852|NCT00098839|740087|P1|Overall Study|Refusal of further protocol therapy|3
225853|NCT00098839|740086|P2|Overall Study|Withdrawal by Subject|0
225854|NCT00098839|740087|P1|Overall Study|Withdrawal by Subject|1
225855|NCT00098839|740086|P2|Overall Study|Physician Decision|14
225856|NCT00098839|740087|P1|Overall Study|Physician Decision|4
225857|NCT00098839|740086|P2|Overall Study|Death|2
225858|NCT00098839|740087|P1|Overall Study|Death|1
225859|NCT00098839|740086|P2|Overall Study|Adverse Event|2
225860|NCT00098839|740087|P1|Overall Study|Adverse Event|5
225861|NCT00098813|740098|P1|Overall Study|Reversal of RAI resistance|1
225862|NCT00098813|740098|P1|Overall Study|Other complicating disease|1
225863|NCT00098813|740098|P1|Overall Study|Progression of Disease|1
225864|NCT00098813|740098|P1|Overall Study|Withdrawal by Subject|7
225865|NCT00098813|740098|P1|Overall Study|Protocol Violation|1
225866|NCT00098813|740098|P1|Overall Study|Death|8
225867|NCT00098787|740105|P3|Overall Study|Other|9
225868|NCT00098787|740106|P2|Overall Study|Other|6
225869|NCT00098787|740107|P1|Overall Study|Other|7
225870|NCT00098787|740105|P3|Overall Study|Alternative therapy|13
225871|NCT00098787|740106|P2|Overall Study|Alternative therapy|13
225872|NCT00098787|740107|P1|Overall Study|Alternative therapy|8
225873|NCT00098787|740105|P3|Overall Study|Withdrawal by Subject|6
225874|NCT00098787|740106|P2|Overall Study|Withdrawal by Subject|12
225875|NCT00098787|740107|P1|Overall Study|Withdrawal by Subject|4
225876|NCT00098787|740105|P3|Overall Study|Death|0
225877|NCT00098787|740106|P2|Overall Study|Death|1
225878|NCT00098787|740107|P1|Overall Study|Death|6
225879|NCT00098787|740105|P3|Overall Study|Adverse Event|8
225880|NCT00098787|740106|P2|Overall Study|Adverse Event|17
225881|NCT00098787|740107|P1|Overall Study|Adverse Event|8
225882|NCT00098787|740105|P3|Overall Study|Disease progression|23
225883|NCT00098787|740106|P2|Overall Study|Disease progression|17
225884|NCT00098787|740107|P1|Overall Study|Disease progression|28
225885|NCT00098787|740105|P3|Overall Study|Ineligible|3
225886|NCT00098787|740106|P2|Overall Study|Ineligible|7
225887|NCT00098787|740107|P1|Overall Study|Ineligible|9
225888|NCT00098787|740105|P3|Overall Study|Never started treatment|1
225889|NCT00098787|740106|P2|Overall Study|Never started treatment|2
225890|NCT00098787|740107|P1|Overall Study|Never started treatment|3
225891|NCT00098774|740121|P1|Overall Study|Physician Decision|2
225892|NCT00098774|740121|P1|Overall Study|Failed (to respond) during induction|4
225893|NCT00098774|740121|P1|Overall Study|Withdrawal by Subject|1
225894|NCT00098774|740121|P1|Overall Study|Disease Progression|9
225895|NCT00098774|740121|P1|Overall Study|Adverse Event|2
225896|NCT00098748|740131|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
225897|NCT00098748|740132|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
225898|NCT00098748|740133|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
225899|NCT00098748|740131|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
225900|NCT00098748|740132|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
225901|NCT00098748|740133|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
225902|NCT00098748|740131|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
225903|NCT00098748|740132|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
225904|NCT00098748|740133|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
225905|NCT00098748|740131|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
225906|NCT00098748|740132|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
225907|NCT00098748|740133|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
225908|NCT00098748|740131|P3|Continued on Open-Label Treatment|Adverse Event|0
225909|NCT00098748|740132|P2|Continued on Open-Label Treatment|Adverse Event|1
225910|NCT00098748|740133|P1|Continued on Open-Label Treatment|Adverse Event|0
225911|NCT00098748|740131|P3|Received Study Treatment|Subject defaulted|4
225912|NCT00098748|740132|P2|Received Study Treatment|Subject defaulted|4
225913|NCT00098748|740133|P1|Received Study Treatment|Subject defaulted|3
225914|NCT00098748|740131|P3|Received Study Treatment|Other|6
225915|NCT00098748|740132|P2|Received Study Treatment|Other|2
225916|NCT00098748|740133|P1|Received Study Treatment|Other|2
225917|NCT00098748|740131|P3|Received Study Treatment|Lack of Efficacy|27
225918|NCT00098748|740132|P2|Received Study Treatment|Lack of Efficacy|27
225919|NCT00098748|740133|P1|Received Study Treatment|Lack of Efficacy|40
225920|NCT00098748|740131|P3|Received Study Treatment|Adverse Event|5
225921|NCT00098748|740132|P2|Received Study Treatment|Adverse Event|2
225922|NCT00098748|740133|P1|Received Study Treatment|Adverse Event|1
225923|NCT00098748|740131|P3|Received Study Treatment|Death|2
225924|NCT00098748|740132|P2|Received Study Treatment|Death|1
225925|NCT00098748|740133|P1|Received Study Treatment|Death|2
225926|NCT00098748|740131|P3|Assigned to Study Treatment|Randomized, but not treated|2
225927|NCT00098748|740132|P2|Assigned to Study Treatment|Randomized, but not treated|2
225928|NCT00098748|740133|P1|Assigned to Study Treatment|Randomized, but not treated|0
225929|NCT00098722|740189|P7|Observation Phase|Other|10
225930|NCT00098722|740190|P6|Observation Phase|Other|21
225931|NCT00098722|740191|P5|Observation Phase|Other|0
225932|NCT00098722|740192|P4|Observation Phase|Other|0
225933|NCT00098722|740193|P3|Observation Phase|Other|0
225934|NCT00098722|740194|P2|Observation Phase|Other|0
225935|NCT00098722|740195|P1|Observation Phase|Other|0
225936|NCT00098722|740189|P7|Observation Phase|Participant defaulted|4
225937|NCT00098722|740190|P6|Observation Phase|Participant defaulted|17
225938|NCT00098722|740191|P5|Observation Phase|Participant defaulted|0
225939|NCT00098722|740192|P4|Observation Phase|Participant defaulted|0
225940|NCT00098722|740193|P3|Observation Phase|Participant defaulted|0
225941|NCT00098722|740194|P2|Observation Phase|Participant defaulted|0
225942|NCT00098722|740195|P1|Observation Phase|Participant defaulted|0
225943|NCT00098722|740189|P7|Observation Phase|Lack of Efficacy|0
225944|NCT00098722|740190|P6|Observation Phase|Lack of Efficacy|2
225945|NCT00098722|740191|P5|Observation Phase|Lack of Efficacy|0
225946|NCT00098722|740192|P4|Observation Phase|Lack of Efficacy|0
225947|NCT00098722|740193|P3|Observation Phase|Lack of Efficacy|0
225948|NCT00098722|740194|P2|Observation Phase|Lack of Efficacy|0
225949|NCT00098722|740195|P1|Observation Phase|Lack of Efficacy|0
225950|NCT00098722|740189|P7|Observation Phase|Death|3
225951|NCT00098722|740190|P6|Observation Phase|Death|5
225952|NCT00098722|740191|P5|Observation Phase|Death|0
225953|NCT00098722|740192|P4|Observation Phase|Death|0
225954|NCT00098722|740193|P3|Observation Phase|Death|0
225955|NCT00098722|740194|P2|Observation Phase|Death|0
225956|NCT00098722|740195|P1|Observation Phase|Death|0
225957|NCT00098722|740189|P7|Open Label Phase|Other|0
225958|NCT00098722|740190|P6|Open Label Phase|Other|0
225959|NCT00098722|740191|P5|Open Label Phase|Other|0
225960|NCT00098722|740192|P4|Open Label Phase|Other|18
225961|NCT00098722|740193|P3|Open Label Phase|Other|0
225962|NCT00098722|740194|P2|Open Label Phase|Other|0
225963|NCT00098722|740195|P1|Open Label Phase|Other|0
225964|NCT00098722|740189|P7|Open Label Phase|Ongoing at cut-off date|0
225965|NCT00098722|740190|P6|Open Label Phase|Ongoing at cut-off date|0
225966|NCT00098722|740191|P5|Open Label Phase|Ongoing at cut-off date|50
225967|NCT00098722|740192|P4|Open Label Phase|Ongoing at cut-off date|220
225968|NCT00098722|740193|P3|Open Label Phase|Ongoing at cut-off date|0
225969|NCT00098722|740194|P2|Open Label Phase|Ongoing at cut-off date|0
225970|NCT00098722|740195|P1|Open Label Phase|Ongoing at cut-off date|0
225971|NCT00098722|740189|P7|Open Label Phase|Participant defaulted|0
225972|NCT00098722|740190|P6|Open Label Phase|Participant defaulted|0
225973|NCT00098722|740191|P5|Open Label Phase|Participant defaulted|0
225974|NCT00098722|740192|P4|Open Label Phase|Participant defaulted|18
225975|NCT00098722|740193|P3|Open Label Phase|Participant defaulted|0
225976|NCT00098722|740194|P2|Open Label Phase|Participant defaulted|0
225977|NCT00098722|740195|P1|Open Label Phase|Participant defaulted|0
225978|NCT00098722|740189|P7|Open Label Phase|Pregnancy|0
225979|NCT00098722|740190|P6|Open Label Phase|Pregnancy|0
225980|NCT00098722|740191|P5|Open Label Phase|Pregnancy|0
225981|NCT00098722|740192|P4|Open Label Phase|Pregnancy|1
225982|NCT00098722|740193|P3|Open Label Phase|Pregnancy|0
225983|NCT00098722|740194|P2|Open Label Phase|Pregnancy|0
225984|NCT00098722|740195|P1|Open Label Phase|Pregnancy|0
225985|NCT00098722|740189|P7|Open Label Phase|Lack of Efficacy|0
225986|NCT00098722|740190|P6|Open Label Phase|Lack of Efficacy|0
225987|NCT00098722|740191|P5|Open Label Phase|Lack of Efficacy|0
225988|NCT00098722|740192|P4|Open Label Phase|Lack of Efficacy|8
225989|NCT00098722|740193|P3|Open Label Phase|Lack of Efficacy|0
225990|NCT00098722|740194|P2|Open Label Phase|Lack of Efficacy|0
225991|NCT00098722|740195|P1|Open Label Phase|Lack of Efficacy|0
225992|NCT00098722|740189|P7|Open Label Phase|Death|0
225993|NCT00098722|740190|P6|Open Label Phase|Death|0
225994|NCT00098722|740191|P5|Open Label Phase|Death|0
225995|NCT00098722|740192|P4|Open Label Phase|Death|2
225996|NCT00098722|740193|P3|Open Label Phase|Death|0
225997|NCT00098722|740194|P2|Open Label Phase|Death|0
225998|NCT00098722|740195|P1|Open Label Phase|Death|0
225999|NCT00098722|740189|P7|Open Label Phase|Adverse Event|0
226000|NCT00098722|740190|P6|Open Label Phase|Adverse Event|0
226001|NCT00098722|740191|P5|Open Label Phase|Adverse Event|0
226002|NCT00098722|740192|P4|Open Label Phase|Adverse Event|5
226003|NCT00098722|740193|P3|Open Label Phase|Adverse Event|0
226004|NCT00098722|740194|P2|Open Label Phase|Adverse Event|0
226005|NCT00098722|740195|P1|Open Label Phase|Adverse Event|0
226006|NCT00098722|740189|P7|Double Blind Phase|Other|0
226007|NCT00098722|740190|P6|Double Blind Phase|Other|0
226008|NCT00098722|740191|P5|Double Blind Phase|Other|0
226009|NCT00098722|740192|P4|Double Blind Phase|Other|0
226010|NCT00098722|740193|P3|Double Blind Phase|Other|7
226011|NCT00098722|740194|P2|Double Blind Phase|Other|8
226012|NCT00098722|740195|P1|Double Blind Phase|Other|7
226013|NCT00098722|740189|P7|Double Blind Phase|Ongoing at cut-off date|0
226014|NCT00098722|740190|P6|Double Blind Phase|Ongoing at cut-off date|0
226015|NCT00098722|740191|P5|Double Blind Phase|Ongoing at cut-off date|0
226016|NCT00098722|740192|P4|Double Blind Phase|Ongoing at cut-off date|0
226017|NCT00098722|740193|P3|Double Blind Phase|Ongoing at cut-off date|57
226018|NCT00098722|740194|P2|Double Blind Phase|Ongoing at cut-off date|137
226019|NCT00098722|740195|P1|Double Blind Phase|Ongoing at cut-off date|128
226020|NCT00098722|740189|P7|Double Blind Phase|Randomized, not treated|0
226021|NCT00098722|740190|P6|Double Blind Phase|Randomized, not treated|0
226022|NCT00098722|740191|P5|Double Blind Phase|Randomized, not treated|0
226023|NCT00098722|740192|P4|Double Blind Phase|Randomized, not treated|0
226024|NCT00098722|740193|P3|Double Blind Phase|Randomized, not treated|3
226025|NCT00098722|740194|P2|Double Blind Phase|Randomized, not treated|3
226026|NCT00098722|740195|P1|Double Blind Phase|Randomized, not treated|4
226027|NCT00098722|740189|P7|Double Blind Phase|Pregnancy|0
226028|NCT00098722|740190|P6|Double Blind Phase|Pregnancy|0
226029|NCT00098722|740191|P5|Double Blind Phase|Pregnancy|0
226030|NCT00098722|740192|P4|Double Blind Phase|Pregnancy|0
226031|NCT00098722|740193|P3|Double Blind Phase|Pregnancy|0
226032|NCT00098722|740194|P2|Double Blind Phase|Pregnancy|0
226033|NCT00098722|740195|P1|Double Blind Phase|Pregnancy|1
226034|NCT00098722|740189|P7|Double Blind Phase|Participant defaulted|0
226035|NCT00098722|740190|P6|Double Blind Phase|Participant defaulted|0
226036|NCT00098722|740191|P5|Double Blind Phase|Participant defaulted|0
226037|NCT00098722|740192|P4|Double Blind Phase|Participant defaulted|0
226038|NCT00098722|740193|P3|Double Blind Phase|Participant defaulted|9
226039|NCT00098722|740194|P2|Double Blind Phase|Participant defaulted|11
226040|NCT00098722|740195|P1|Double Blind Phase|Participant defaulted|16
226041|NCT00098722|740189|P7|Double Blind Phase|Lack of Efficacy|0
226042|NCT00098722|740190|P6|Double Blind Phase|Lack of Efficacy|0
226043|NCT00098722|740191|P5|Double Blind Phase|Lack of Efficacy|0
226044|NCT00098722|740192|P4|Double Blind Phase|Lack of Efficacy|0
226045|NCT00098722|740193|P3|Double Blind Phase|Lack of Efficacy|15
226046|NCT00098722|740194|P2|Double Blind Phase|Lack of Efficacy|23
226047|NCT00098722|740195|P1|Double Blind Phase|Lack of Efficacy|21
226048|NCT00098722|740189|P7|Double Blind Phase|Death|0
226049|NCT00098722|740190|P6|Double Blind Phase|Death|0
226050|NCT00098722|740191|P5|Double Blind Phase|Death|0
226051|NCT00098722|740192|P4|Double Blind Phase|Death|0
226052|NCT00098722|740193|P3|Double Blind Phase|Death|0
226053|NCT00098722|740194|P2|Double Blind Phase|Death|5
226054|NCT00098722|740195|P1|Double Blind Phase|Death|2
226055|NCT00098722|740189|P7|Double Blind Phase|Adverse Event|0
226056|NCT00098722|740190|P6|Double Blind Phase|Adverse Event|0
226057|NCT00098722|740191|P5|Double Blind Phase|Adverse Event|0
226058|NCT00098722|740192|P4|Double Blind Phase|Adverse Event|0
226059|NCT00098722|740193|P3|Double Blind Phase|Adverse Event|3
226060|NCT00098722|740194|P2|Double Blind Phase|Adverse Event|7
226061|NCT00098722|740195|P1|Double Blind Phase|Adverse Event|7
226062|NCT00098475|740269|P4|Step 2|Never started treatment|0
226063|NCT00098475|740270|P3|Step 2|Never started treatment|0
226064|NCT00098475|740271|P2|Step 2|Never started treatment|1
226065|NCT00098475|740272|P1|Step 2|Never started treatment|1
226066|NCT00098475|740269|P4|Step 2|Alternative therapy|0
226067|NCT00098475|740270|P3|Step 2|Alternative therapy|0
226068|NCT00098475|740271|P2|Step 2|Alternative therapy|2
226069|NCT00098475|740272|P1|Step 2|Alternative therapy|1
226070|NCT00098475|740269|P4|Step 2|Physician Decision|0
226071|NCT00098475|740270|P3|Step 2|Physician Decision|0
226072|NCT00098475|740271|P2|Step 2|Physician Decision|1
226073|NCT00098475|740272|P1|Step 2|Physician Decision|0
226074|NCT00098475|740269|P4|Step 2|Withdrawal by Subject|0
226075|NCT00098475|740270|P3|Step 2|Withdrawal by Subject|0
226076|NCT00098475|740271|P2|Step 2|Withdrawal by Subject|2
226077|NCT00098475|740272|P1|Step 2|Withdrawal by Subject|0
226078|NCT00098475|740269|P4|Step 2|Adverse Event|0
226079|NCT00098475|740270|P3|Step 2|Adverse Event|0
226080|NCT00098475|740271|P2|Step 2|Adverse Event|0
226081|NCT00098475|740272|P1|Step 2|Adverse Event|2
226082|NCT00098475|740269|P4|Step 2|Disease progression|0
226083|NCT00098475|740270|P3|Step 2|Disease progression|0
226084|NCT00098475|740271|P2|Step 2|Disease progression|4
226085|NCT00098475|740272|P1|Step 2|Disease progression|1
226086|NCT00098475|740269|P4|Step 1|Not documented|0
226087|NCT00098475|740270|P3|Step 1|Not documented|0
226088|NCT00098475|740271|P2|Step 1|Not documented|1
226089|NCT00098475|740272|P1|Step 1|Not documented|0
226090|NCT00098475|740269|P4|Step 1|Patient fell with fracture|0
226091|NCT00098475|740270|P3|Step 1|Patient fell with fracture|0
226092|NCT00098475|740271|P2|Step 1|Patient fell with fracture|0
226093|NCT00098475|740272|P1|Step 1|Patient fell with fracture|1
226094|NCT00098475|740269|P4|Step 1|Misinterpretation of lab data|0
226095|NCT00098475|740270|P3|Step 1|Misinterpretation of lab data|0
226096|NCT00098475|740271|P2|Step 1|Misinterpretation of lab data|1
226097|NCT00098475|740272|P1|Step 1|Misinterpretation of lab data|0
226098|NCT00098475|740269|P4|Step 1|Criteria to continue treatment not met|0
226099|NCT00098475|740270|P3|Step 1|Criteria to continue treatment not met|0
226100|NCT00098475|740271|P2|Step 1|Criteria to continue treatment not met|1
226101|NCT00098475|740272|P1|Step 1|Criteria to continue treatment not met|0
226102|NCT00098475|740269|P4|Step 1|Referred to other physicians|0
226103|NCT00098475|740270|P3|Step 1|Referred to other physicians|0
226104|NCT00098475|740271|P2|Step 1|Referred to other physicians|1
226105|NCT00098475|740272|P1|Step 1|Referred to other physicians|0
226106|NCT00098475|740269|P4|Step 1|Rising paraprotein|0
226107|NCT00098475|740270|P3|Step 1|Rising paraprotein|0
226108|NCT00098475|740271|P2|Step 1|Rising paraprotein|1
226109|NCT00098475|740272|P1|Step 1|Rising paraprotein|0
226110|NCT00098475|740269|P4|Step 1|Insurance issue|0
226111|NCT00098475|740270|P3|Step 1|Insurance issue|0
226112|NCT00098475|740271|P2|Step 1|Insurance issue|1
226113|NCT00098475|740272|P1|Step 1|Insurance issue|0
226114|NCT00098475|740269|P4|Step 1|Declining performance status|0
226115|NCT00098475|740270|P3|Step 1|Declining performance status|0
226116|NCT00098475|740271|P2|Step 1|Declining performance status|1
226117|NCT00098475|740272|P1|Step 1|Declining performance status|0
226118|NCT00098475|740269|P4|Step 1|Off treatment for > specified timeframe|0
226119|NCT00098475|740270|P3|Step 1|Off treatment for > specified timeframe|0
226120|NCT00098475|740271|P2|Step 1|Off treatment for > specified timeframe|1
226121|NCT00098475|740272|P1|Step 1|Off treatment for > specified timeframe|1
226122|NCT00098475|740269|P4|Step 1|Incorrect disease assessment|0
226123|NCT00098475|740270|P3|Step 1|Incorrect disease assessment|0
226124|NCT00098475|740271|P2|Step 1|Incorrect disease assessment|0
226125|NCT00098475|740272|P1|Step 1|Incorrect disease assessment|2
226126|NCT00098475|740269|P4|Step 1|Both patient and physician's decision|0
226127|NCT00098475|740270|P3|Step 1|Both patient and physician's decision|0
226128|NCT00098475|740271|P2|Step 1|Both patient and physician's decision|1
226129|NCT00098475|740272|P1|Step 1|Both patient and physician's decision|2
226130|NCT00098475|740269|P4|Step 1|Cannot comply due to other tx|0
226131|NCT00098475|740270|P3|Step 1|Cannot comply due to other tx|0
226132|NCT00098475|740271|P2|Step 1|Cannot comply due to other tx|1
226133|NCT00098475|740272|P1|Step 1|Cannot comply due to other tx|0
226134|NCT00098475|740269|P4|Step 1|Complications|0
226135|NCT00098475|740270|P3|Step 1|Complications|0
226136|NCT00098475|740271|P2|Step 1|Complications|0
226137|NCT00098475|740272|P1|Step 1|Complications|1
226138|NCT00098475|740269|P4|Step 1|Knee surgery|0
226139|NCT00098475|740270|P3|Step 1|Knee surgery|0
226140|NCT00098475|740271|P2|Step 1|Knee surgery|0
226141|NCT00098475|740272|P1|Step 1|Knee surgery|1
226142|NCT00098475|740269|P4|Step 1|Still on treatment as of this analysis|0
226143|NCT00098475|740270|P3|Step 1|Still on treatment as of this analysis|0
226144|NCT00098475|740271|P2|Step 1|Still on treatment as of this analysis|27
226145|NCT00098475|740272|P1|Step 1|Still on treatment as of this analysis|14
226146|NCT00098475|740269|P4|Step 1|Never started treatment|0
226147|NCT00098475|740270|P3|Step 1|Never started treatment|0
226148|NCT00098475|740271|P2|Step 1|Never started treatment|2
226149|NCT00098475|740272|P1|Step 1|Never started treatment|0
226150|NCT00098475|740269|P4|Step 1|Other disease|0
226151|NCT00098475|740270|P3|Step 1|Other disease|1
226152|NCT00098475|740271|P2|Step 1|Other disease|1
226153|NCT00098475|740272|P1|Step 1|Other disease|2
226154|NCT00098475|740269|P4|Step 1|Alternative therapy|0
226155|NCT00098475|740270|P3|Step 1|Alternative therapy|1
226156|NCT00098475|740271|P2|Step 1|Alternative therapy|43
226157|NCT00098475|740272|P1|Step 1|Alternative therapy|31
226158|NCT00098475|740269|P4|Step 1|Physician Decision|0
226159|NCT00098475|740270|P3|Step 1|Physician Decision|0
226160|NCT00098475|740271|P2|Step 1|Physician Decision|2
226161|NCT00098475|740272|P1|Step 1|Physician Decision|5
226162|NCT00098475|740269|P4|Step 1|Withdrawal by Subject|0
226163|NCT00098475|740270|P3|Step 1|Withdrawal by Subject|0
226164|NCT00098475|740271|P2|Step 1|Withdrawal by Subject|11
226165|NCT00098475|740272|P1|Step 1|Withdrawal by Subject|14
226166|NCT00098475|740269|P4|Step 1|Death|1
226167|NCT00098475|740270|P3|Step 1|Death|0
226168|NCT00098475|740271|P2|Step 1|Death|5
226170|NCT00098475|740269|P4|Step 1|Adverse Event|1
226171|NCT00098475|740270|P3|Step 1|Adverse Event|0
226172|NCT00098475|740271|P2|Step 1|Adverse Event|37
226173|NCT00098475|740272|P1|Step 1|Adverse Event|56
226174|NCT00098475|740269|P4|Step 1|Progressive disease|1
226175|NCT00098475|740270|P3|Step 1|Progressive disease|2
226176|NCT00098475|740271|P2|Step 1|Progressive disease|35
226177|NCT00098475|740272|P1|Step 1|Progressive disease|33
226178|NCT00098345|740309|P1|Overall Study|progression|4
226179|NCT00098345|740309|P1|Overall Study|Withdrawal by Subject|2
226180|NCT00098345|740309|P1|Overall Study|Adverse Event|7
226181|NCT00098306|740322|P7|Observational Phase|Un-specified|4
226182|NCT00098306|740323|P6|Observational Phase|Un-specified|7
226183|NCT00098306|740324|P5|Observational Phase|Un-specified|0
226184|NCT00098306|740325|P4|Observational Phase|Un-specified|0
226185|NCT00098306|740326|P3|Observational Phase|Un-specified|0
226186|NCT00098306|740327|P2|Observational Phase|Un-specified|0
226187|NCT00098306|740328|P1|Observational Phase|Un-specified|0
226188|NCT00098306|740322|P7|Observational Phase|Participant defaulted|18
226189|NCT00098306|740323|P6|Observational Phase|Participant defaulted|34
226190|NCT00098306|740324|P5|Observational Phase|Participant defaulted|0
226191|NCT00098306|740325|P4|Observational Phase|Participant defaulted|0
226192|NCT00098306|740326|P3|Observational Phase|Participant defaulted|0
226193|NCT00098306|740327|P2|Observational Phase|Participant defaulted|0
226194|NCT00098306|740328|P1|Observational Phase|Participant defaulted|0
226195|NCT00098306|740322|P7|Observational Phase|Death|4
226196|NCT00098306|740323|P6|Observational Phase|Death|5
226197|NCT00098306|740324|P5|Observational Phase|Death|0
226198|NCT00098306|740325|P4|Observational Phase|Death|0
226199|NCT00098306|740326|P3|Observational Phase|Death|0
226200|NCT00098306|740327|P2|Observational Phase|Death|0
226201|NCT00098306|740328|P1|Observational Phase|Death|0
226202|NCT00098306|740322|P7|Open Label|Ongoing at cut-off date|0
226203|NCT00098306|740323|P6|Open Label|Ongoing at cut-off date|0
226204|NCT00098306|740324|P5|Open Label|Ongoing at cut-off date|62
226205|NCT00098306|740325|P4|Open Label|Ongoing at cut-off date|269
226206|NCT00098306|740326|P3|Open Label|Ongoing at cut-off date|0
226207|NCT00098306|740327|P2|Open Label|Ongoing at cut-off date|0
226208|NCT00098306|740328|P1|Open Label|Ongoing at cut-off date|0
226209|NCT00098306|740322|P7|Open Label|Un-specified|0
226210|NCT00098306|740323|P6|Open Label|Un-specified|0
226211|NCT00098306|740324|P5|Open Label|Un-specified|0
226212|NCT00098306|740325|P4|Open Label|Un-specified|15
226213|NCT00098306|740326|P3|Open Label|Un-specified|0
226214|NCT00098306|740327|P2|Open Label|Un-specified|0
226215|NCT00098306|740328|P1|Open Label|Un-specified|0
226216|NCT00098306|740322|P7|Open Label|Participant defaulted|0
226217|NCT00098306|740323|P6|Open Label|Participant defaulted|0
226218|NCT00098306|740324|P5|Open Label|Participant defaulted|0
226219|NCT00098306|740325|P4|Open Label|Participant defaulted|24
226220|NCT00098306|740326|P3|Open Label|Participant defaulted|0
226221|NCT00098306|740327|P2|Open Label|Participant defaulted|0
226222|NCT00098306|740328|P1|Open Label|Participant defaulted|0
226223|NCT00098306|740322|P7|Open Label|Death|0
226224|NCT00098306|740323|P6|Open Label|Death|0
226225|NCT00098306|740324|P5|Open Label|Death|0
226226|NCT00098306|740325|P4|Open Label|Death|4
226227|NCT00098306|740326|P3|Open Label|Death|0
226228|NCT00098306|740327|P2|Open Label|Death|0
226229|NCT00098306|740328|P1|Open Label|Death|0
226230|NCT00098306|740322|P7|Open Label|Adverse Event|0
226231|NCT00098306|740323|P6|Open Label|Adverse Event|0
226232|NCT00098306|740324|P5|Open Label|Adverse Event|0
226233|NCT00098306|740325|P4|Open Label|Adverse Event|2
226234|NCT00098306|740326|P3|Open Label|Adverse Event|0
226235|NCT00098306|740327|P2|Open Label|Adverse Event|0
226236|NCT00098306|740328|P1|Open Label|Adverse Event|0
226237|NCT00098306|740322|P7|Open Label|Lack of Efficacy|0
226238|NCT00098306|740323|P6|Open Label|Lack of Efficacy|0
226239|NCT00098306|740324|P5|Open Label|Lack of Efficacy|0
226240|NCT00098306|740325|P4|Open Label|Lack of Efficacy|13
226241|NCT00098306|740326|P3|Open Label|Lack of Efficacy|0
226242|NCT00098306|740327|P2|Open Label|Lack of Efficacy|0
226243|NCT00098306|740328|P1|Open Label|Lack of Efficacy|0
226244|NCT00098306|740322|P7|Double Blind|Un-specified|0
226245|NCT00098306|740323|P6|Double Blind|Un-specified|0
226246|NCT00098306|740324|P5|Double Blind|Un-specified|0
226247|NCT00098306|740325|P4|Double Blind|Un-specified|0
226248|NCT00098306|740326|P3|Double Blind|Un-specified|11
226249|NCT00098306|740327|P2|Double Blind|Un-specified|3
226250|NCT00098306|740328|P1|Double Blind|Un-specified|7
226251|NCT00098306|740322|P7|Double Blind|Participant defaulted|0
226252|NCT00098306|740323|P6|Double Blind|Participant defaulted|0
226253|NCT00098306|740324|P5|Double Blind|Participant defaulted|0
226254|NCT00098306|740325|P4|Double Blind|Participant defaulted|0
226255|NCT00098306|740326|P3|Double Blind|Participant defaulted|11
226256|NCT00098306|740327|P2|Double Blind|Participant defaulted|18
226257|NCT00098306|740328|P1|Double Blind|Participant defaulted|19
226258|NCT00098306|740322|P7|Double Blind|Death|0
226259|NCT00098306|740323|P6|Double Blind|Death|0
226260|NCT00098306|740324|P5|Double Blind|Death|0
226261|NCT00098306|740325|P4|Double Blind|Death|0
226262|NCT00098306|740326|P3|Double Blind|Death|1
226263|NCT00098306|740327|P2|Double Blind|Death|4
226264|NCT00098306|740328|P1|Double Blind|Death|1
226265|NCT00098306|740322|P7|Double Blind|Lack of Efficacy|0
226266|NCT00098306|740323|P6|Double Blind|Lack of Efficacy|0
226267|NCT00098306|740324|P5|Double Blind|Lack of Efficacy|0
226268|NCT00098306|740325|P4|Double Blind|Lack of Efficacy|0
226269|NCT00098306|740326|P3|Double Blind|Lack of Efficacy|17
226270|NCT00098306|740327|P2|Double Blind|Lack of Efficacy|34
226271|NCT00098306|740328|P1|Double Blind|Lack of Efficacy|43
226272|NCT00098306|740322|P7|Double Blind|Adverse Event|0
226273|NCT00098306|740323|P6|Double Blind|Adverse Event|0
226274|NCT00098306|740324|P5|Double Blind|Adverse Event|0
226275|NCT00098306|740325|P4|Double Blind|Adverse Event|0
226276|NCT00098306|740326|P3|Double Blind|Adverse Event|6
226277|NCT00098306|740327|P2|Double Blind|Adverse Event|10
226278|NCT00098306|740328|P1|Double Blind|Adverse Event|11
226279|NCT00098306|740322|P7|Double Blind|Ongoing at cut-off date|0
226280|NCT00098306|740323|P6|Double Blind|Ongoing at cut-off date|0
226281|NCT00098306|740324|P5|Double Blind|Ongoing at cut-off date|0
226282|NCT00098306|740325|P4|Double Blind|Ongoing at cut-off date|0
226283|NCT00098306|740326|P3|Double Blind|Ongoing at cut-off date|72
226284|NCT00098306|740327|P2|Double Blind|Ongoing at cut-off date|166
226285|NCT00098306|740328|P1|Double Blind|Ongoing at cut-off date|151
226286|NCT00098306|740322|P7|Double Blind|Randomized, not treated|0
226287|NCT00098306|740323|P6|Double Blind|Randomized, not treated|0
226288|NCT00098306|740324|P5|Double Blind|Randomized, not treated|0
226289|NCT00098306|740325|P4|Double Blind|Randomized, not treated|0
226290|NCT00098306|740326|P3|Double Blind|Randomized, not treated|2
226291|NCT00098306|740327|P2|Double Blind|Randomized, not treated|5
226292|NCT00098306|740328|P1|Double Blind|Randomized, not treated|9
226293|NCT00098293|740394|P5|Supplemental Phase (SP)|Other|22
226294|NCT00098293|740395|P4|Supplemental Phase (SP)|Other|0
226295|NCT00098293|740396|P3|Supplemental Phase (SP)|Other|0
226296|NCT00098293|740397|P2|Supplemental Phase (SP)|Other|0
226297|NCT00098293|740398|P1|Supplemental Phase (SP)|Other|0
226298|NCT00098293|740394|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
226299|NCT00098293|740395|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
226300|NCT00098293|740396|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
226301|NCT00098293|740397|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
226302|NCT00098293|740398|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
226303|NCT00098293|740394|P5|Supplemental Phase (SP)|Lost to Follow-up|2
226304|NCT00098293|740395|P4|Supplemental Phase (SP)|Lost to Follow-up|0
226305|NCT00098293|740396|P3|Supplemental Phase (SP)|Lost to Follow-up|0
226306|NCT00098293|740397|P2|Supplemental Phase (SP)|Lost to Follow-up|0
226307|NCT00098293|740398|P1|Supplemental Phase (SP)|Lost to Follow-up|0
226308|NCT00098293|740394|P5|Supplemental Phase (SP)|Death|1
226309|NCT00098293|740395|P4|Supplemental Phase (SP)|Death|0
226310|NCT00098293|740396|P3|Supplemental Phase (SP)|Death|0
226311|NCT00098293|740397|P2|Supplemental Phase (SP)|Death|0
226312|NCT00098293|740398|P1|Supplemental Phase (SP)|Death|0
226313|NCT00098293|740394|P5|Open-label (OL) Phase|Death|0
226314|NCT00098293|740395|P4|Open-label (OL) Phase|Death|0
226315|NCT00098293|740396|P3|Open-label (OL) Phase|Death|3
226316|NCT00098293|740397|P2|Open-label (OL) Phase|Death|2
226317|NCT00098293|740398|P1|Open-label (OL) Phase|Death|0
226318|NCT00098293|740394|P5|Open-label (OL) Phase|Participant Defaulted|0
226319|NCT00098293|740395|P4|Open-label (OL) Phase|Participant Defaulted|20
226320|NCT00098293|740396|P3|Open-label (OL) Phase|Participant Defaulted|16
226321|NCT00098293|740397|P2|Open-label (OL) Phase|Participant Defaulted|6
226322|NCT00098293|740398|P1|Open-label (OL) Phase|Participant Defaulted|0
226323|NCT00098293|740394|P5|Open-label (OL) Phase|Protocol Violation|0
226324|NCT00098293|740395|P4|Open-label (OL) Phase|Protocol Violation|16
226325|NCT00098293|740396|P3|Open-label (OL) Phase|Protocol Violation|13
226326|NCT00098293|740397|P2|Open-label (OL) Phase|Protocol Violation|6
226327|NCT00098293|740398|P1|Open-label (OL) Phase|Protocol Violation|0
226328|NCT00098293|740394|P5|Open-label (OL) Phase|Pregnancy|0
226329|NCT00098293|740395|P4|Open-label (OL) Phase|Pregnancy|3
226330|NCT00098293|740396|P3|Open-label (OL) Phase|Pregnancy|0
226331|NCT00098293|740397|P2|Open-label (OL) Phase|Pregnancy|1
226332|NCT00098293|740398|P1|Open-label (OL) Phase|Pregnancy|0
226333|NCT00098293|740394|P5|Open-label (OL) Phase|Lack of Efficacy|0
226334|NCT00098293|740395|P4|Open-label (OL) Phase|Lack of Efficacy|20
226335|NCT00098293|740396|P3|Open-label (OL) Phase|Lack of Efficacy|2
226336|NCT00098293|740397|P2|Open-label (OL) Phase|Lack of Efficacy|7
226337|NCT00098293|740398|P1|Open-label (OL) Phase|Lack of Efficacy|0
226338|NCT00098293|740394|P5|Open-label (OL) Phase|Adverse Event|0
226339|NCT00098293|740395|P4|Open-label (OL) Phase|Adverse Event|6
226340|NCT00098293|740396|P3|Open-label (OL) Phase|Adverse Event|7
226341|NCT00098293|740397|P2|Open-label (OL) Phase|Adverse Event|3
226342|NCT00098293|740398|P1|Open-label (OL) Phase|Adverse Event|0
226343|NCT00098293|740394|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
226344|NCT00098293|740395|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
226345|NCT00098293|740396|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
226346|NCT00098293|740397|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
226347|NCT00098293|740398|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
226348|NCT00098293|740394|P5|Double-blind (DB) Phase|Terminated by sponsor|0
226349|NCT00098293|740395|P4|Double-blind (DB) Phase|Terminated by sponsor|0
226350|NCT00098293|740396|P3|Double-blind (DB) Phase|Terminated by sponsor|0
226351|NCT00098293|740397|P2|Double-blind (DB) Phase|Terminated by sponsor|0
226352|NCT00098293|740398|P1|Double-blind (DB) Phase|Terminated by sponsor|135
226353|NCT00098293|740394|P5|Double-blind (DB) Phase|Protocol Violation|0
226354|NCT00098293|740395|P4|Double-blind (DB) Phase|Protocol Violation|0
226355|NCT00098293|740396|P3|Double-blind (DB) Phase|Protocol Violation|22
226356|NCT00098293|740397|P2|Double-blind (DB) Phase|Protocol Violation|18
226357|NCT00098293|740398|P1|Double-blind (DB) Phase|Protocol Violation|2
226358|NCT00098293|740394|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
226359|NCT00098293|740395|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
226360|NCT00098293|740396|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
226361|NCT00098293|740397|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
226362|NCT00098293|740398|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
226363|NCT00098293|740394|P5|Double-blind (DB) Phase|Death|0
226364|NCT00098293|740395|P4|Double-blind (DB) Phase|Death|0
226365|NCT00098293|740396|P3|Double-blind (DB) Phase|Death|2
226366|NCT00098293|740397|P2|Double-blind (DB) Phase|Death|2
226367|NCT00098293|740398|P1|Double-blind (DB) Phase|Death|1
226368|NCT00098293|740394|P5|Double-blind (DB) Phase|Lack of Efficacy|0
226369|NCT00098293|740395|P4|Double-blind (DB) Phase|Lack of Efficacy|0
226370|NCT00098293|740396|P3|Double-blind (DB) Phase|Lack of Efficacy|30
226371|NCT00098293|740397|P2|Double-blind (DB) Phase|Lack of Efficacy|64
226372|NCT00098293|740398|P1|Double-blind (DB) Phase|Lack of Efficacy|11
226373|NCT00098293|740394|P5|Double-blind (DB) Phase|Participant Defaulted|0
226374|NCT00098293|740395|P4|Double-blind (DB) Phase|Participant Defaulted|0
226375|NCT00098293|740396|P3|Double-blind (DB) Phase|Participant Defaulted|36
226376|NCT00098293|740397|P2|Double-blind (DB) Phase|Participant Defaulted|40
226377|NCT00098293|740398|P1|Double-blind (DB) Phase|Participant Defaulted|11
226378|NCT00098293|740394|P5|Double-blind (DB) Phase|Pregnancy|0
226379|NCT00098293|740395|P4|Double-blind (DB) Phase|Pregnancy|0
226380|NCT00098293|740396|P3|Double-blind (DB) Phase|Pregnancy|9
226381|NCT00098293|740397|P2|Double-blind (DB) Phase|Pregnancy|7
226382|NCT00098293|740398|P1|Double-blind (DB) Phase|Pregnancy|0
226383|NCT00098293|740394|P5|Double-blind (DB) Phase|Adverse Event|0
226384|NCT00098293|740395|P4|Double-blind (DB) Phase|Adverse Event|0
226385|NCT00098293|740396|P3|Double-blind (DB) Phase|Adverse Event|60
226386|NCT00098293|740397|P2|Double-blind (DB) Phase|Adverse Event|27
226387|NCT00098293|740398|P1|Double-blind (DB) Phase|Adverse Event|14
226388|NCT00098254|740451|P1|Overall Study|Death|1
226389|NCT00098254|740451|P1|Overall Study|Adverse Event|2
226390|NCT00098020|740517|P1|Overall Study|Low epidermal growth factor receptor|1
226391|NCT00098020|740517|P1|Overall Study|Low urine PCR|1
226392|NCT00098020|740517|P1|Overall Study|elevated liver enzymes|1
226393|NCT00098020|740517|P1|Overall Study|Lost to Follow-up|1
226394|NCT00098020|740517|P1|Overall Study|Adverse Event|2
226395|NCT00097981|740524|P2|Overall Study|Other|13
226396|NCT00097981|740525|P1|Overall Study|Other|19
226397|NCT00097981|740524|P2|Overall Study|Transplant planned|27
226398|NCT00097981|740525|P1|Overall Study|Transplant planned|28
226399|NCT00097981|740524|P2|Overall Study|Disease Progression|2
226400|NCT00097981|740525|P1|Overall Study|Disease Progression|8
226401|NCT00097981|740524|P2|Overall Study|Physician Decision|1
226402|NCT00097981|740525|P1|Overall Study|Physician Decision|7
226403|NCT00097981|740524|P2|Overall Study|Death|4
226404|NCT00097981|740525|P1|Overall Study|Death|2
226405|NCT00097981|740524|P2|Overall Study|Protocol Violation|1
226406|NCT00097981|740525|P1|Overall Study|Protocol Violation|1
226407|NCT00097981|740524|P2|Overall Study|Withdrawal by Subject|8
226408|NCT00097981|740525|P1|Overall Study|Withdrawal by Subject|10
226409|NCT00097981|740524|P2|Overall Study|Adverse Event|44
226410|NCT00097981|740525|P1|Overall Study|Adverse Event|31
226411|NCT00097786|740547|P4|Overall Study|lost to follow-up for all-cause death|310
226412|NCT00097786|740548|P3|Overall Study|lost to follow-up for all-cause death|313
226413|NCT00097786|740549|P2|Overall Study|lost to follow-up for all-cause death|292
226414|NCT00097786|740550|P1|Overall Study|lost to follow-up for all-cause death|296
226415|NCT00097773|740572|P4|Overall Study|Other|0
226416|NCT00097773|740573|P3|Overall Study|Other|2
226417|NCT00097773|740574|P2|Overall Study|Other|0
226418|NCT00097773|740575|P1|Overall Study|Other|1
226419|NCT00097773|740572|P4|Overall Study|Adverse Event|0
226420|NCT00097773|740573|P3|Overall Study|Adverse Event|0
226421|NCT00097773|740574|P2|Overall Study|Adverse Event|1
226422|NCT00097773|740575|P1|Overall Study|Adverse Event|0
226423|NCT00097773|740572|P4|Overall Study|Withdrawal by Subject|1
226424|NCT00097773|740573|P3|Overall Study|Withdrawal by Subject|3
226425|NCT00097773|740574|P2|Overall Study|Withdrawal by Subject|3
226426|NCT00097773|740575|P1|Overall Study|Withdrawal by Subject|3
226427|NCT00097773|740572|P4|Overall Study|Physician Decision|1
226428|NCT00097773|740573|P3|Overall Study|Physician Decision|3
226429|NCT00097773|740574|P2|Overall Study|Physician Decision|2
226430|NCT00097773|740575|P1|Overall Study|Physician Decision|2
226431|NCT00097773|740572|P4|Overall Study|Lost to Follow-up|1
226432|NCT00097773|740573|P3|Overall Study|Lost to Follow-up|0
226433|NCT00097773|740574|P2|Overall Study|Lost to Follow-up|2
226434|NCT00097773|740575|P1|Overall Study|Lost to Follow-up|2
226435|NCT00097721|740595|P2|Overall Study|Reason not given|1
226436|NCT00097721|740596|P1|Overall Study|Reason not given|1
226437|NCT00097721|740595|P2|Overall Study|Physician Decision|3
226438|NCT00097721|740596|P1|Overall Study|Physician Decision|1
226439|NCT00097721|740595|P2|Overall Study|Progressive Disease|27
226440|NCT00097721|740596|P1|Overall Study|Progressive Disease|55
226441|NCT00097721|740595|P2|Overall Study|Withdrawal by Subject|1
226442|NCT00097721|740596|P1|Overall Study|Withdrawal by Subject|6
226443|NCT00097721|740595|P2|Overall Study|Adverse Event|1
226444|NCT00097721|740596|P1|Overall Study|Adverse Event|8
226445|NCT00097591|740646|P2|Overall Study|Other|3
226446|NCT00097591|740647|P1|Overall Study|Other|0
226447|NCT00097591|740646|P2|Overall Study|Lost to follow up|10
226448|NCT00097591|740647|P1|Overall Study|Lost to follow up|6
226449|NCT00097591|740646|P2|Overall Study|Unable to attend termination visit|51
226450|NCT00097591|740647|P1|Overall Study|Unable to attend termination visit|53
226451|NCT00097591|740646|P2|Overall Study|Less than 6 months on study drug|7
226452|NCT00097591|740647|P1|Overall Study|Less than 6 months on study drug|9
226453|NCT00097591|740646|P2|Overall Study|Withdrawal of consent|323
226454|NCT00097591|740647|P1|Overall Study|Withdrawal of consent|342
226455|NCT00097539|740670|P7|Overall Study|Reason not Specified|2
226456|NCT00097539|740671|P6|Overall Study|Reason not Specified|40
226457|NCT00097539|740672|P5|Overall Study|Reason not Specified|11
226458|NCT00097539|740673|P4|Overall Study|Reason not Specified|21
226459|NCT00097539|740674|P3|Overall Study|Reason not Specified|53
226460|NCT00097539|740675|P2|Overall Study|Reason not Specified|49
226461|NCT00097539|740676|P1|Overall Study|Reason not Specified|111
226462|NCT00097539|740670|P7|Overall Study|Reasons Other Than Above|34
226463|NCT00097539|740671|P6|Overall Study|Reasons Other Than Above|1244
226464|NCT00097539|740672|P5|Overall Study|Reasons Other Than Above|361
226465|NCT00097539|740673|P4|Overall Study|Reasons Other Than Above|692
226466|NCT00097539|740674|P3|Overall Study|Reasons Other Than Above|1757
226467|NCT00097539|740675|P2|Overall Study|Reasons Other Than Above|1382
226468|NCT00097539|740676|P1|Overall Study|Reasons Other Than Above|3602
226469|NCT00097539|740670|P7|Overall Study|Death|0
226470|NCT00097539|740671|P6|Overall Study|Death|3
226471|NCT00097539|740672|P5|Overall Study|Death|1
226472|NCT00097539|740673|P4|Overall Study|Death|0
226473|NCT00097539|740674|P3|Overall Study|Death|0
226474|NCT00097539|740675|P2|Overall Study|Death|7
226475|NCT00097539|740676|P1|Overall Study|Death|2
226476|NCT00097539|740670|P7|Overall Study|Adverse Event|1
226477|NCT00097539|740671|P6|Overall Study|Adverse Event|59
226478|NCT00097539|740672|P5|Overall Study|Adverse Event|30
226479|NCT00097539|740673|P4|Overall Study|Adverse Event|27
226480|NCT00097539|740674|P3|Overall Study|Adverse Event|37
226481|NCT00097539|740675|P2|Overall Study|Adverse Event|133
226482|NCT00097539|740676|P1|Overall Study|Adverse Event|78
226483|NCT00097539|740670|P7|Overall Study|Lack of Efficacy|5
226484|NCT00097539|740671|P6|Overall Study|Lack of Efficacy|228
226485|NCT00097539|740672|P5|Overall Study|Lack of Efficacy|45
226486|NCT00097539|740673|P4|Overall Study|Lack of Efficacy|105
226487|NCT00097539|740674|P3|Overall Study|Lack of Efficacy|202
226488|NCT00097539|740675|P2|Overall Study|Lack of Efficacy|122
226489|NCT00097539|740676|P1|Overall Study|Lack of Efficacy|249
226490|NCT00097539|740670|P7|Overall Study|Participant Non-compliant|18
226491|NCT00097539|740671|P6|Overall Study|Participant Non-compliant|543
226492|NCT00097539|740672|P5|Overall Study|Participant Non-compliant|136
226493|NCT00097539|740673|P4|Overall Study|Participant Non-compliant|353
226494|NCT00097539|740674|P3|Overall Study|Participant Non-compliant|1067
226495|NCT00097539|740675|P2|Overall Study|Participant Non-compliant|567
226496|NCT00097539|740676|P1|Overall Study|Participant Non-compliant|2140
226497|NCT00097539|740670|P7|Overall Study|Withdrawal by Subject|3
226498|NCT00097539|740671|P6|Overall Study|Withdrawal by Subject|229
226499|NCT00097539|740672|P5|Overall Study|Withdrawal by Subject|68
226500|NCT00097539|740673|P4|Overall Study|Withdrawal by Subject|217
226501|NCT00097539|740674|P3|Overall Study|Withdrawal by Subject|346
226502|NCT00097539|740675|P2|Overall Study|Withdrawal by Subject|323
226503|NCT00097539|740676|P1|Overall Study|Withdrawal by Subject|925
226504|NCT00097539|740670|P7|Overall Study|Status Unknown (Or no final evaluation)|108
226505|NCT00097539|740671|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
226506|NCT00097539|740672|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
226507|NCT00097539|740673|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
226508|NCT00097539|740674|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
226509|NCT00097539|740675|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
226510|NCT00097539|740676|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
226511|NCT00097500|740722|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
226512|NCT00097500|740723|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
226513|NCT00097500|740722|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
226514|NCT00097500|740723|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
226515|NCT00097500|740722|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
226516|NCT00097500|740723|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
226517|NCT00097500|740722|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
226518|NCT00097500|740723|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
226519|NCT00097500|740722|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
226520|NCT00097500|740723|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
226521|NCT00097500|740722|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
226522|NCT00097500|740723|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
226523|NCT00097500|740722|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
226524|NCT00097500|740723|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
226525|NCT00097370|740754|P1|Stage 3|Lost to Follow-up|1
226526|NCT00097370|740754|P1|Stage 3|Sponsor Terminated Study|52
226527|NCT00097370|740754|P1|Stage 3|Lack of Efficacy|1
226528|NCT00097370|740754|P1|Stage 3|Withdrawal by Subject|3
226529|NCT00097370|740754|P1|Stage 3|Adverse Event|2
226530|NCT00097370|740754|P1|Stage 2|Lost to Follow-up|1
226531|NCT00097370|740754|P1|Stage 2|Sponsor Terminated Study|2
226532|NCT00097370|740754|P1|Stage 2|Pregnancy|1
226533|NCT00097370|740754|P1|Stage 2|Lack of Efficacy|3
226534|NCT00097370|740754|P1|Stage 2|Withdrawal by Subject|1
226535|NCT00097370|740754|P1|Stage 2|Adverse Event|5
226536|NCT00097370|740754|P1|Stage 1|Lack of Efficacy|2
226537|NCT00097370|740754|P1|Stage 1|Withdrawal by Subject|1
226538|NCT00097370|740754|P1|Stage 1|Adverse Event|3
226539|NCT00096993|740788|P2|Overall Study|Other unspecified|1
226540|NCT00096993|740789|P1|Overall Study|Other unspecified|1
226541|NCT00096993|740788|P2|Overall Study|Non-compliance|1
226542|NCT00096993|740789|P1|Overall Study|Non-compliance|0
226543|NCT00096993|740788|P2|Overall Study|Physician Decision|1
226544|NCT00096993|740789|P1|Overall Study|Physician Decision|2
226545|NCT00096993|740788|P2|Overall Study|Subject's decision|1
226546|NCT00096993|740789|P1|Overall Study|Subject's decision|3
226547|NCT00096993|740788|P2|Overall Study|Adverse Event|8
226548|NCT00096993|740789|P1|Overall Study|Adverse Event|2
226549|NCT00096993|740788|P2|Overall Study|Disease progression|53
226550|NCT00096993|740789|P1|Overall Study|Disease progression|56
226551|NCT00096993|740788|P2|Overall Study|Death|0
226552|NCT00096993|740789|P1|Overall Study|Death|1
226553|NCT00096954|740805|P2|Overall Study|Lost to Follow-up|5
226554|NCT00096954|740806|P1|Overall Study|Lost to Follow-up|8
226555|NCT00096954|740805|P2|Overall Study|Non-compliance|3
226556|NCT00096954|740806|P1|Overall Study|Non-compliance|0
226557|NCT00096954|740805|P2|Overall Study|Initiation of immunotherapy|0
226558|NCT00096954|740806|P1|Overall Study|Initiation of immunotherapy|1
226559|NCT00096954|740805|P2|Overall Study|Pregnancy|1
226560|NCT00096954|740806|P1|Overall Study|Pregnancy|1
226561|NCT00096954|740805|P2|Overall Study|Sponsors Decision|1
226562|NCT00096954|740806|P1|Overall Study|Sponsors Decision|1
226563|NCT00096954|740805|P2|Overall Study|Physician Decision|1
226564|NCT00096954|740806|P1|Overall Study|Physician Decision|1
226565|NCT00096954|740805|P2|Overall Study|Withdrawal by Subject|8
226566|NCT00096954|740806|P1|Overall Study|Withdrawal by Subject|9
226567|NCT00096954|740805|P2|Overall Study|Adverse Event|1
226568|NCT00096954|740806|P1|Overall Study|Adverse Event|3
226569|NCT00096941|740818|P1|Overall Study|disease progression|3
226570|NCT00096785|740825|P2|Overall Study|Relocated|0
226571|NCT00096785|740826|P1|Overall Study|Relocated|1
226572|NCT00096785|740825|P2|Overall Study|Withdrawal by Subject|1
226573|NCT00096785|740826|P1|Overall Study|Withdrawal by Subject|0
226574|NCT00096785|740825|P2|Overall Study|Lost to Follow-up|0
226575|NCT00096785|740826|P1|Overall Study|Lost to Follow-up|1
226576|NCT00096538|740855|P1|Overall Study|Withdrawal by Subject|1
226577|NCT00096486|740863|P4|Overall Study|Not Treated|1
226578|NCT00096486|740864|P3|Overall Study|Not Treated|1
226579|NCT00096486|740865|P2|Overall Study|Not Treated|0
226580|NCT00096486|740866|P1|Overall Study|Not Treated|0
226581|NCT00096486|740863|P4|Overall Study|Withdrawal by Subject|1
226582|NCT00096486|740864|P3|Overall Study|Withdrawal by Subject|1
226583|NCT00096486|740865|P2|Overall Study|Withdrawal by Subject|0
226584|NCT00096486|740866|P1|Overall Study|Withdrawal by Subject|0
226585|NCT00096447|740885|P1|Overall Study|Never treated|1
226586|NCT00096382|740901|P2|Overall Study|Death during treatment|0
226587|NCT00096382|740902|P1|Overall Study|Death during treatment|1
226588|NCT00096382|740901|P2|Overall Study|Not treated|0
226589|NCT00096382|740902|P1|Overall Study|Not treated|1
226590|NCT00096356|740912|P2|Overall Study|multiple reasons|18
226591|NCT00096356|740913|P1|Overall Study|multiple reasons|10
226592|NCT00096356|740912|P2|Overall Study|Lack of Efficacy|0
226593|NCT00096356|740913|P1|Overall Study|Lack of Efficacy|1
226594|NCT00096356|740912|P2|Overall Study|Withdrawal by Subject|23
226595|NCT00096356|740913|P1|Overall Study|Withdrawal by Subject|17
226596|NCT00096356|740912|P2|Overall Study|Physician Decision|3
226597|NCT00096356|740913|P1|Overall Study|Physician Decision|5
226598|NCT00096356|740912|P2|Overall Study|Adverse Event|9
226599|NCT00096356|740913|P1|Overall Study|Adverse Event|11
226600|NCT00096278|740925|P2|Overall Study|Patient not at risk for primary endpoint|2
226601|NCT00096278|740926|P1|Overall Study|Patient not at risk for primary endpoint|3
226602|NCT00096278|740925|P2|Overall Study|No follow-up data|18
226603|NCT00096278|740926|P1|Overall Study|No follow-up data|15
226604|NCT00096265|740935|P3|Overall Study|Ineligible|0
226605|NCT00096265|740936|P2|Overall Study|Ineligible|0
226606|NCT00096265|740937|P1|Overall Study|Ineligible|1
226607|NCT00096226|740963|P1|Overall Study|Surgery but inadequate nodal sampling|1
226608|NCT00096226|740963|P1|Overall Study|Surgical restaging not performed|13
226609|NCT00096226|740963|P1|Overall Study|Protocol treatment not started|1
226610|NCT00096226|740963|P1|Overall Study|Ineligible|2
226611|NCT00096200|740970|P3|Overall Study|Ineligible pathology|0
226612|NCT00096200|740971|P2|Overall Study|Ineligible pathology|1
226613|NCT00096200|740972|P1|Overall Study|Ineligible pathology|0
226614|NCT00096200|740970|P3|Overall Study|Withdrawal by Subject|0
226615|NCT00096200|740971|P2|Overall Study|Withdrawal by Subject|2
226616|NCT00096200|740972|P1|Overall Study|Withdrawal by Subject|1
226617|NCT00096200|740970|P3|Overall Study|Adverse Event|0
226618|NCT00096200|740971|P2|Overall Study|Adverse Event|4
226619|NCT00096200|740972|P1|Overall Study|Adverse Event|0
226620|NCT00096174|740980|P1|Overall Study|other reason|8
226621|NCT00096174|740980|P1|Overall Study|Ineligible|6
226622|NCT00096174|740980|P1|Overall Study|Not started protocol therapy|3
226623|NCT00096174|740980|P1|Overall Study|Withdrawal by Subject|15
226624|NCT00096174|740980|P1|Overall Study|Death|6
226625|NCT00096174|740980|P1|Overall Study|Adverse Event|15
226626|NCT00096174|740980|P1|Overall Study|Lack of Efficacy|9
226627|NCT00096135|741025|P2|Overall Study|Ineligible|0
226628|NCT00096135|741026|P1|Overall Study|Ineligible|2
226629|NCT00096135|741025|P2|Overall Study|Other, specify|3
226630|NCT00096135|741026|P1|Overall Study|Other, specify|15
226631|NCT00096135|741025|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
226632|NCT00096135|741026|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
226633|NCT00096135|741025|P2|Overall Study|Refusal of further protocol therapy|1
226634|NCT00096135|741026|P1|Overall Study|Refusal of further protocol therapy|4
226635|NCT00096135|741025|P2|Overall Study|Physician Decision|4
226636|NCT00096135|741026|P1|Overall Study|Physician Decision|20
226637|NCT00096044|741042|P1|Overall Study|Disease Progression|4
226638|NCT00096044|741042|P1|Overall Study|Adverse Event|21
226639|NCT00096044|741042|P1|Overall Study|Withdrawal by Subject|9
226640|NCT00096031|741051|P1|Overall Study|Not protocol specified|5
226641|NCT00096031|741051|P1|Overall Study|Ineligible|8
226642|NCT00096031|741051|P1|Overall Study|Withdrawal by Subject|1
226643|NCT00096031|741051|P1|Overall Study|Death|4
226644|NCT00096031|741051|P1|Overall Study|Lack of Efficacy|42
226645|NCT00096031|741051|P1|Overall Study|Adverse Event|3
226646|NCT00096018|741059|P2|Overall Study|Miscellaneous|1
226647|NCT00096018|741060|P1|Overall Study|Miscellaneous|2
226648|NCT00096018|741059|P2|Overall Study|Withdrawal by Subject|2
226649|NCT00096018|741060|P1|Overall Study|Withdrawal by Subject|0
226650|NCT00096018|741059|P2|Overall Study|Death|1
226651|NCT00096018|741060|P1|Overall Study|Death|0
226652|NCT00096018|741059|P2|Overall Study|Adverse Event|5
226653|NCT00096018|741060|P1|Overall Study|Adverse Event|0
226654|NCT00096018|741059|P2|Overall Study|Miscellaneous (not treated)|2
226655|NCT00096018|741060|P1|Overall Study|Miscellaneous (not treated)|0
226656|NCT00096018|741059|P2|Overall Study|Became Ineligible (not treated)|3
226657|NCT00096018|741060|P1|Overall Study|Became Ineligible (not treated)|0
226658|NCT00095979|741068|P1|Overall Study|Ineligible: Second primary cancer site|2
226659|NCT00095940|741086|P9|Lapatinib Continuation/Phase II|Adverse Event|0
226660|NCT00095940|741087|P8|Lapatinib Continuation/Phase II|Adverse Event|1
226661|NCT00095940|741088|P7|Lapatinib Continuation/Phase II|Adverse Event|0
226662|NCT00095940|741089|P6|Lapatinib Continuation/Phase II|Adverse Event|0
226663|NCT00095940|741090|P5|Lapatinib Continuation/Phase II|Adverse Event|0
226664|NCT00095940|741091|P4|Lapatinib Continuation/Phase II|Adverse Event|0
226665|NCT00095940|741092|P3|Lapatinib Continuation/Phase II|Adverse Event|0
226666|NCT00095940|741093|P2|Lapatinib Continuation/Phase II|Adverse Event|0
226667|NCT00095940|741094|P1|Lapatinib Continuation/Phase II|Adverse Event|0
226668|NCT00095940|741086|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
226669|NCT00095940|741087|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
226670|NCT00095940|741088|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
226671|NCT00095940|741089|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
226672|NCT00095940|741090|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
226673|NCT00095940|741091|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
226674|NCT00095940|741092|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
226675|NCT00095940|741093|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
226676|NCT00095940|741094|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
226677|NCT00095940|741086|P9|Lapatinib Continuation/Phase II|Disease Progression|12
226678|NCT00095940|741087|P8|Lapatinib Continuation/Phase II|Disease Progression|1
226679|NCT00095940|741088|P7|Lapatinib Continuation/Phase II|Disease Progression|2
226680|NCT00095940|741089|P6|Lapatinib Continuation/Phase II|Disease Progression|13
226681|NCT00095940|741090|P5|Lapatinib Continuation/Phase II|Disease Progression|0
226682|NCT00095940|741091|P4|Lapatinib Continuation/Phase II|Disease Progression|0
226683|NCT00095940|741092|P3|Lapatinib Continuation/Phase II|Disease Progression|15
226684|NCT00095940|741093|P2|Lapatinib Continuation/Phase II|Disease Progression|1
226685|NCT00095940|741094|P1|Lapatinib Continuation/Phase II|Disease Progression|1
226686|NCT00095836|741127|P1|Overall Study|Death|2
226687|NCT00095836|741127|P1|Overall Study|Adverse Event|1
226688|NCT00095836|741127|P1|Overall Study|Lost to Follow-up|1
226689|NCT00095628|741157|P1|Overall Study|Disease progression prior to treatment|1
226690|NCT00095576|741168|P2|Overall Study|Subject moved|36
226691|NCT00095576|741169|P1|Overall Study|Subject moved|30
226692|NCT00095576|741168|P2|Overall Study|Site terminated|67
226693|NCT00095576|741169|P1|Overall Study|Site terminated|75
226694|NCT00095576|741168|P2|Overall Study|Option to switch to a rollover study|1099
226695|NCT00095576|741169|P1|Overall Study|Option to switch to a rollover study|1097
226696|NCT00095576|741168|P2|Overall Study|Withdrawal by Subject|47
226697|NCT00095576|741169|P1|Overall Study|Withdrawal by Subject|34
226698|NCT00095576|741168|P2|Overall Study|Protocol Violation|0
226699|NCT00095576|741169|P1|Overall Study|Protocol Violation|1
226700|NCT00095576|741168|P2|Overall Study|Lost to Follow-up|229
226701|NCT00095576|741169|P1|Overall Study|Lost to Follow-up|233
226702|NCT00095576|741168|P2|Overall Study|Adverse Event|3
226703|NCT00095576|741169|P1|Overall Study|Adverse Event|5
226704|NCT00095498|741193|P3|Overall Study|Requirement for alternative therapy|2
226705|NCT00095498|741194|P2|Overall Study|Requirement for alternative therapy|0
226706|NCT00095498|741195|P1|Overall Study|Requirement for alternative therapy|1
226707|NCT00095498|741193|P3|Overall Study|Protocol Violation|1
226708|NCT00095498|741194|P2|Overall Study|Protocol Violation|0
226709|NCT00095498|741195|P1|Overall Study|Protocol Violation|0
226710|NCT00095498|741193|P3|Overall Study|Other|6
226711|NCT00095498|741194|P2|Overall Study|Other|7
226712|NCT00095498|741195|P1|Overall Study|Other|6
226713|NCT00095498|741193|P3|Overall Study|Noncompliance|1
226714|NCT00095498|741194|P2|Overall Study|Noncompliance|0
226715|NCT00095498|741195|P1|Overall Study|Noncompliance|1
226716|NCT00095498|741193|P3|Overall Study|Lost to Follow-up|2
226717|NCT00095498|741194|P2|Overall Study|Lost to Follow-up|1
226718|NCT00095498|741195|P1|Overall Study|Lost to Follow-up|1
226719|NCT00095498|741193|P3|Overall Study|Ineligibility determined|2
226720|NCT00095498|741194|P2|Overall Study|Ineligibility determined|0
226721|NCT00095498|741195|P1|Overall Study|Ineligibility determined|3
226722|NCT00095498|741193|P3|Overall Study|Disease progression|1
226723|NCT00095498|741194|P2|Overall Study|Disease progression|1
226724|NCT00095498|741195|P1|Overall Study|Disease progression|0
226725|NCT00095498|741193|P3|Overall Study|Withdrawal by Subject|15
226726|NCT00095498|741194|P2|Overall Study|Withdrawal by Subject|16
226727|NCT00095498|741195|P1|Overall Study|Withdrawal by Subject|15
226728|NCT00095498|741193|P3|Overall Study|Adverse Event|1
226729|NCT00095498|741194|P2|Overall Study|Adverse Event|0
226730|NCT00095498|741195|P1|Overall Study|Adverse Event|1
226731|NCT00095498|741193|P3|Overall Study|Physician Decision|8
226732|NCT00095498|741194|P2|Overall Study|Physician Decision|10
226733|NCT00095498|741195|P1|Overall Study|Physician Decision|9
226734|NCT00095303|741622|P2|Follow Up Study|Lost to Follow-up|58
226735|NCT00095303|741623|P1|Follow Up Study|Lost to Follow-up|59
226736|NCT00095303|741622|P2|Main Study|Lost to Follow-up|87
226737|NCT00095303|741623|P1|Main Study|Lost to Follow-up|91
226738|NCT00095238|741691|P2|Overall Study|Other Reasons|88
226739|NCT00095238|741692|P1|Overall Study|Other Reasons|87
226740|NCT00095238|741691|P2|Overall Study|Missing|0
226741|NCT00095238|741692|P1|Overall Study|Missing|1
226742|NCT00095238|741691|P2|Overall Study|Study terminated by sponsor|1
226743|NCT00095238|741692|P1|Overall Study|Study terminated by sponsor|0
226744|NCT00095238|741691|P2|Overall Study|No longer met study criteria|5
226745|NCT00095238|741692|P1|Overall Study|No longer met study criteria|4
226746|NCT00095238|741691|P2|Overall Study|Noncompliance|45
226747|NCT00095238|741692|P1|Overall Study|Noncompliance|44
226748|NCT00095238|741691|P2|Overall Study|Lost to Follow-up|24
226749|NCT00095238|741692|P1|Overall Study|Lost to Follow-up|19
226750|NCT00095238|741691|P2|Overall Study|Death|170
226751|NCT00095238|741692|P1|Overall Study|Death|154
226752|NCT00095238|741691|P2|Overall Study|Subject Withdrew Consent|223
226753|NCT00095238|741692|P1|Overall Study|Subject Withdrew Consent|208
226754|NCT00095238|741691|P2|Overall Study|Adverse Event|287
226755|NCT00095238|741692|P1|Overall Study|Adverse Event|331
226756|NCT00095238|741691|P2|Overall Study|Lack of Efficacy|9
226757|NCT00095238|741692|P1|Overall Study|Lack of Efficacy|9
226758|NCT00095212|741754|P2|Overall Study|Withdrawal by Subject|3
226759|NCT00095212|741755|P1|Overall Study|Withdrawal by Subject|1
226760|NCT00095199|741785|P4|Overall Study|Data inadvertently lost by site|0
226761|NCT00095199|741786|P3|Overall Study|Data inadvertently lost by site|0
226762|NCT00095199|741787|P2|Overall Study|Data inadvertently lost by site|0
226763|NCT00095199|741788|P1|Overall Study|Data inadvertently lost by site|1
226764|NCT00095199|741785|P4|Overall Study|Primary tumor removed in other surgery|0
226765|NCT00095199|741786|P3|Overall Study|Primary tumor removed in other surgery|0
226766|NCT00095199|741787|P2|Overall Study|Primary tumor removed in other surgery|1
226767|NCT00095199|741788|P1|Overall Study|Primary tumor removed in other surgery|0
226768|NCT00095199|741785|P4|Overall Study|Started radiotherapy regimen|0
226769|NCT00095199|741786|P3|Overall Study|Started radiotherapy regimen|0
226770|NCT00095199|741787|P2|Overall Study|Started radiotherapy regimen|1
226771|NCT00095199|741788|P1|Overall Study|Started radiotherapy regimen|0
226772|NCT00095199|741785|P4|Overall Study|Started Palliative Radiotherapy|0
226773|NCT00095199|741786|P3|Overall Study|Started Palliative Radiotherapy|0
226774|NCT00095199|741787|P2|Overall Study|Started Palliative Radiotherapy|0
226775|NCT00095199|741788|P1|Overall Study|Started Palliative Radiotherapy|1
226776|NCT00095199|741785|P4|Overall Study|Not eligible|1
226777|NCT00095199|741786|P3|Overall Study|Not eligible|0
226778|NCT00095199|741787|P2|Overall Study|Not eligible|7
226779|NCT00095199|741788|P1|Overall Study|Not eligible|1
226780|NCT00095199|741785|P4|Overall Study|Physician Decision|1
226781|NCT00095199|741786|P3|Overall Study|Physician Decision|1
226782|NCT00095199|741787|P2|Overall Study|Physician Decision|6
226783|NCT00095199|741788|P1|Overall Study|Physician Decision|5
226784|NCT00095199|741785|P4|Overall Study|Surgery needed could not start in 7 days|0
226785|NCT00095199|741786|P3|Overall Study|Surgery needed could not start in 7 days|1
226786|NCT00095199|741787|P2|Overall Study|Surgery needed could not start in 7 days|0
226787|NCT00095199|741788|P1|Overall Study|Surgery needed could not start in 7 days|0
226788|NCT00095199|741785|P4|Overall Study|Liver function test results elevated|1
226789|NCT00095199|741786|P3|Overall Study|Liver function test results elevated|1
226790|NCT00095199|741787|P2|Overall Study|Liver function test results elevated|0
226791|NCT00095199|741788|P1|Overall Study|Liver function test results elevated|0
226792|NCT00095199|741785|P4|Overall Study|Protocol Violation|0
226793|NCT00095199|741786|P3|Overall Study|Protocol Violation|2
226794|NCT00095199|741787|P2|Overall Study|Protocol Violation|4
226795|NCT00095199|741788|P1|Overall Study|Protocol Violation|4
226796|NCT00095199|741785|P4|Overall Study|Withdrawal by Subject|22
226797|NCT00095199|741786|P3|Overall Study|Withdrawal by Subject|13
226798|NCT00095199|741787|P2|Overall Study|Withdrawal by Subject|16
226799|NCT00095199|741788|P1|Overall Study|Withdrawal by Subject|21
226800|NCT00095199|741785|P4|Overall Study|Death|9
226801|NCT00095199|741786|P3|Overall Study|Death|11
226802|NCT00095199|741787|P2|Overall Study|Death|6
226803|NCT00095199|741788|P1|Overall Study|Death|10
226804|NCT00095199|741785|P4|Overall Study|Progressive disease|98
226805|NCT00095199|741786|P3|Overall Study|Progressive disease|105
226806|NCT00095199|741787|P2|Overall Study|Progressive disease|179
226807|NCT00095199|741788|P1|Overall Study|Progressive disease|213
226808|NCT00095199|741785|P4|Overall Study|Adverse Event|11
226809|NCT00095199|741786|P3|Overall Study|Adverse Event|26
226810|NCT00095199|741787|P2|Overall Study|Adverse Event|22
226811|NCT00095199|741788|P1|Overall Study|Adverse Event|40
226812|NCT00095173|741826|P6|Open-Label Extension Phase (Period C)|Not Specified|8
226813|NCT00095173|741827|P5|Open-Label Extension Phase (Period C)|Not Specified|6
226814|NCT00095173|741828|P4|Open-Label Extension Phase (Period C)|Not Specified|4
226815|NCT00095173|741829|P3|Open-Label Extension Phase (Period C)|Not Specified|0
226816|NCT00095173|741830|P2|Open-Label Extension Phase (Period C)|Not Specified|0
226817|NCT00095173|741831|P1|Open-Label Extension Phase (Period C)|Not Specified|0
226818|NCT00095173|741826|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
226819|NCT00095173|741827|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
226820|NCT00095173|741828|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
226821|NCT00095173|741829|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
226822|NCT00095173|741830|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
226823|NCT00095173|741831|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
226824|NCT00095173|741826|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
226825|NCT00095173|741827|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
226826|NCT00095173|741828|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
226827|NCT00095173|741829|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
226828|NCT00095173|741830|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
226829|NCT00095173|741831|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
226830|NCT00095173|741826|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
226831|NCT00095173|741827|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
226832|NCT00095173|741828|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
226833|NCT00095173|741829|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
226834|NCT00095173|741830|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
226835|NCT00095173|741831|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
226836|NCT00095173|741826|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
226837|NCT00095173|741827|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
226838|NCT00095173|741828|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
226839|NCT00095173|741829|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
226840|NCT00095173|741830|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
226841|NCT00095173|741831|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
226842|NCT00095173|741826|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
226843|NCT00095173|741827|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
226844|NCT00095173|741828|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
226845|NCT00095173|741829|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
226846|NCT00095173|741830|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
226847|NCT00095173|741831|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
226848|NCT00095173|741826|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
226849|NCT00095173|741827|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
226850|NCT00095173|741828|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
226851|NCT00095173|741829|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
226852|NCT00095173|741830|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
226853|NCT00095173|741831|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
226854|NCT00095173|741826|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
226855|NCT00095173|741827|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
226856|NCT00095173|741828|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
226857|NCT00095173|741829|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
226858|NCT00095173|741830|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
226859|NCT00095173|741831|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
226860|NCT00095173|741826|P6|Open-Label Extension Phase (Period C)|Death|1
226861|NCT00095173|741827|P5|Open-Label Extension Phase (Period C)|Death|0
226862|NCT00095173|741828|P4|Open-Label Extension Phase (Period C)|Death|0
226863|NCT00095173|741829|P3|Open-Label Extension Phase (Period C)|Death|0
226864|NCT00095173|741830|P2|Open-Label Extension Phase (Period C)|Death|0
226865|NCT00095173|741831|P1|Open-Label Extension Phase (Period C)|Death|0
226866|NCT00095173|741826|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
226867|NCT00095173|741827|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
226868|NCT00095173|741828|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
226869|NCT00095173|741829|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
226870|NCT00095173|741830|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
226871|NCT00095173|741831|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
226872|NCT00095173|741826|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
226873|NCT00095173|741827|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
226874|NCT00095173|741828|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
226875|NCT00095173|741829|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
226876|NCT00095173|741830|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
226877|NCT00095173|741831|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
226878|NCT00095173|741826|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
226879|NCT00095173|741827|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
226880|NCT00095173|741828|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
226881|NCT00095173|741829|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
226882|NCT00095173|741830|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
226883|NCT00095173|741831|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
226884|NCT00095173|741826|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
226885|NCT00095173|741827|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
226886|NCT00095173|741828|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
226887|NCT00095173|741829|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
226888|NCT00095173|741830|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
226889|NCT00095173|741831|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
226890|NCT00095173|741826|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
226891|NCT00095173|741827|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
226892|NCT00095173|741828|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
226893|NCT00095173|741829|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
226894|NCT00095173|741830|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
226895|NCT00095173|741831|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
226896|NCT00095173|741826|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
226897|NCT00095173|741827|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
226898|NCT00095173|741828|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
226899|NCT00095173|741829|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
226900|NCT00095173|741830|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
226901|NCT00095173|741831|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
226902|NCT00095147|741869|P5|Long-term Extension Period|Leaving country|1
226903|NCT00095147|741870|P4|Long-term Extension Period|Leaving country|0
226904|NCT00095147|741871|P3|Long-term Extension Period|Leaving country|0
226905|NCT00095147|741872|P2|Long-term Extension Period|Leaving country|0
226906|NCT00095147|741873|P1|Long-term Extension Period|Leaving country|0
226907|NCT00095147|741869|P5|Long-term Extension Period|Participant chose to use Revellex|1
226908|NCT00095147|741870|P4|Long-term Extension Period|Participant chose to use Revellex|0
226909|NCT00095147|741871|P3|Long-term Extension Period|Participant chose to use Revellex|0
226910|NCT00095147|741872|P2|Long-term Extension Period|Participant chose to use Revellex|0
226911|NCT00095147|741873|P1|Long-term Extension Period|Participant chose to use Revellex|0
226912|NCT00095147|741869|P5|Long-term Extension Period|No longer meets study criteria|1
226913|NCT00095147|741870|P4|Long-term Extension Period|No longer meets study criteria|0
226914|NCT00095147|741871|P3|Long-term Extension Period|No longer meets study criteria|0
226915|NCT00095147|741872|P2|Long-term Extension Period|No longer meets study criteria|0
226916|NCT00095147|741873|P1|Long-term Extension Period|No longer meets study criteria|0
226917|NCT00095147|741869|P5|Long-term Extension Period|Pregnancy|1
226918|NCT00095147|741870|P4|Long-term Extension Period|Pregnancy|0
226919|NCT00095147|741871|P3|Long-term Extension Period|Pregnancy|0
226920|NCT00095147|741872|P2|Long-term Extension Period|Pregnancy|0
226921|NCT00095147|741873|P1|Long-term Extension Period|Pregnancy|0
226922|NCT00095147|741869|P5|Long-term Extension Period|Withdrawal of consent|12
226923|NCT00095147|741870|P4|Long-term Extension Period|Withdrawal of consent|0
226924|NCT00095147|741871|P3|Long-term Extension Period|Withdrawal of consent|0
226925|NCT00095147|741872|P2|Long-term Extension Period|Withdrawal of consent|0
226926|NCT00095147|741873|P1|Long-term Extension Period|Withdrawal of consent|0
226927|NCT00095147|741869|P5|Long-term Extension Period|Lost to Follow-up|6
226928|NCT00095147|741870|P4|Long-term Extension Period|Lost to Follow-up|0
226929|NCT00095147|741871|P3|Long-term Extension Period|Lost to Follow-up|0
226930|NCT00095147|741872|P2|Long-term Extension Period|Lost to Follow-up|0
226931|NCT00095147|741873|P1|Long-term Extension Period|Lost to Follow-up|0
226932|NCT00095147|741869|P5|Long-term Extension Period|Lack of Efficacy|9
226933|NCT00095147|741870|P4|Long-term Extension Period|Lack of Efficacy|0
226934|NCT00095147|741871|P3|Long-term Extension Period|Lack of Efficacy|0
226935|NCT00095147|741872|P2|Long-term Extension Period|Lack of Efficacy|0
226936|NCT00095147|741873|P1|Long-term Extension Period|Lack of Efficacy|0
226937|NCT00095147|741869|P5|Long-term Extension Period|Adverse Event|11
226938|NCT00095147|741870|P4|Long-term Extension Period|Adverse Event|0
226939|NCT00095147|741871|P3|Long-term Extension Period|Adverse Event|0
226940|NCT00095147|741872|P2|Long-term Extension Period|Adverse Event|0
226941|NCT00095147|741873|P1|Long-term Extension Period|Adverse Event|0
226942|NCT00095147|741869|P5|Long-term Extension Period|Death|3
226943|NCT00095147|741870|P4|Long-term Extension Period|Death|0
226944|NCT00095147|741871|P3|Long-term Extension Period|Death|0
226945|NCT00095147|741872|P2|Long-term Extension Period|Death|0
226946|NCT00095147|741873|P1|Long-term Extension Period|Death|0
226947|NCT00095147|741869|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
226948|NCT00095147|741870|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
226949|NCT00095147|741871|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
226950|NCT00095147|741872|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
226951|NCT00095147|741873|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
226952|NCT00095147|741869|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
226953|NCT00095147|741870|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
226954|NCT00095147|741871|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
226955|NCT00095147|741872|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
226956|NCT00095147|741873|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
226957|NCT00095147|741869|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
226958|NCT00095147|741870|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
226959|NCT00095147|741871|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
226960|NCT00095147|741872|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
226961|NCT00095147|741873|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
226962|NCT00095147|741869|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
226963|NCT00095147|741870|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
226964|NCT00095147|741871|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
226965|NCT00095147|741872|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
226966|NCT00095147|741873|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
226967|NCT00095147|741869|P5|Double-blind Period 2 (Days 198-365)|Death|0
226968|NCT00095147|741870|P4|Double-blind Period 2 (Days 198-365)|Death|1
226969|NCT00095147|741871|P3|Double-blind Period 2 (Days 198-365)|Death|0
226970|NCT00095147|741872|P2|Double-blind Period 2 (Days 198-365)|Death|1
226971|NCT00095147|741873|P1|Double-blind Period 2 (Days 198-365)|Death|0
226972|NCT00095147|741869|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
226973|NCT00095147|741870|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
226974|NCT00095147|741871|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
226975|NCT00095147|741872|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
226976|NCT00095147|741873|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
226977|NCT00095147|741869|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
226978|NCT00095147|741870|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
226979|NCT00095147|741871|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
226980|NCT00095147|741872|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
226981|NCT00095147|741873|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
226982|NCT00095147|741869|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
226983|NCT00095147|741870|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
226984|NCT00095147|741871|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
226985|NCT00095147|741872|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
226986|NCT00095147|741873|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
226987|NCT00095147|741869|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
226988|NCT00095147|741870|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
226989|NCT00095147|741871|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
226990|NCT00095147|741872|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
226991|NCT00095147|741873|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
226992|NCT00095147|741869|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
226993|NCT00095147|741870|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
226994|NCT00095147|741871|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
226995|NCT00095147|741872|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
226996|NCT00095147|741873|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
226997|NCT00095147|741869|P5|Double-blind Period 1 (Days 1-197)|Death|0
226998|NCT00095147|741870|P4|Double-blind Period 1 (Days 1-197)|Death|0
226999|NCT00095147|741871|P3|Double-blind Period 1 (Days 1-197)|Death|0
227000|NCT00095147|741872|P2|Double-blind Period 1 (Days 1-197)|Death|0
227001|NCT00095147|741873|P1|Double-blind Period 1 (Days 1-197)|Death|1
227002|NCT00095121|742068|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
227003|NCT00095121|742069|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
227004|NCT00095121|742068|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
227005|NCT00095121|742069|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
227006|NCT00095056|742115|P2|Phase B (Weeks 12-54)|Protocol Violation|1
227007|NCT00095056|742116|P1|Phase B (Weeks 12-54)|Protocol Violation|0
227008|NCT00095056|742115|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
227009|NCT00095056|742116|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
227010|NCT00095056|742115|P2|Phase B (Weeks 12-54)|Death|1
227011|NCT00095056|742116|P1|Phase B (Weeks 12-54)|Death|3
227012|NCT00095056|742115|P2|Phase B (Weeks 12-54)|Patient Moved|0
227013|NCT00095056|742116|P1|Phase B (Weeks 12-54)|Patient Moved|1
227014|NCT00095056|742115|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
227015|NCT00095056|742116|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
227016|NCT00095056|742115|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
227017|NCT00095056|742116|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
227018|NCT00095056|742115|P2|Phase B (Weeks 12-54)|Adverse Event|2
227019|NCT00095056|742116|P1|Phase B (Weeks 12-54)|Adverse Event|2
227020|NCT00095056|742115|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
227021|NCT00095056|742116|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
227022|NCT00095056|742115|P2|Phase A (Weeks 0-12)|Death|0
227023|NCT00095056|742116|P1|Phase A (Weeks 0-12)|Death|1
227024|NCT00095056|742115|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
227025|NCT00095056|742116|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
227026|NCT00095056|742115|P2|Phase A (Weeks 0-12)|Adverse Event|1
227027|NCT00095056|742116|P1|Phase A (Weeks 0-12)|Adverse Event|1
227028|NCT00094887|742226|P2|Overall Study|Physician Decision|2
227029|NCT00094887|742227|P1|Overall Study|Physician Decision|2
227030|NCT00094887|742226|P2|Overall Study|Family emergency, Subject noncompliance|4
227031|NCT00094887|742227|P1|Overall Study|Family emergency, Subject noncompliance|3
227032|NCT00094861|742235|P2|Overall Study|Other|0
227033|NCT00094861|742236|P1|Overall Study|Other|3
227034|NCT00094861|742235|P2|Overall Study|Death|2
227035|NCT00094861|742236|P1|Overall Study|Death|4
227036|NCT00094861|742235|P2|Overall Study|Lost to Follow-up|1
227037|NCT00094861|742236|P1|Overall Study|Lost to Follow-up|0
227038|NCT00094861|742235|P2|Overall Study|Physician Decision|1
227039|NCT00094861|742236|P1|Overall Study|Physician Decision|1
227040|NCT00094861|742235|P2|Overall Study|Withdrawal by Subject|3
227041|NCT00094861|742236|P1|Overall Study|Withdrawal by Subject|5
227042|NCT00094861|742235|P2|Overall Study|Adverse Event|2
227043|NCT00094861|742236|P1|Overall Study|Adverse Event|5
227044|NCT00094835|742263|P7|Overall Study|Other|0
227045|NCT00094835|742264|P6|Overall Study|Other|0
227046|NCT00094835|742265|P5|Overall Study|Other|0
227047|NCT00094835|742266|P4|Overall Study|Other|1
227048|NCT00094835|742267|P3|Overall Study|Other|1
227049|NCT00094835|742268|P2|Overall Study|Other|1
227050|NCT00094835|742269|P1|Overall Study|Other|1
227051|NCT00094835|742263|P7|Overall Study|Non-compliance|1
227052|NCT00094835|742264|P6|Overall Study|Non-compliance|2
227053|NCT00094835|742265|P5|Overall Study|Non-compliance|2
227054|NCT00094835|742266|P4|Overall Study|Non-compliance|0
227055|NCT00094835|742267|P3|Overall Study|Non-compliance|2
227056|NCT00094835|742268|P2|Overall Study|Non-compliance|2
227057|NCT00094835|742269|P1|Overall Study|Non-compliance|1
227058|NCT00094835|742263|P7|Overall Study|Death|0
227059|NCT00094835|742264|P6|Overall Study|Death|0
227060|NCT00094835|742265|P5|Overall Study|Death|1
227061|NCT00094835|742266|P4|Overall Study|Death|0
227062|NCT00094835|742267|P3|Overall Study|Death|0
227063|NCT00094835|742268|P2|Overall Study|Death|0
227064|NCT00094835|742269|P1|Overall Study|Death|1
227065|NCT00094835|742263|P7|Overall Study|Lost to Follow-up|0
227066|NCT00094835|742264|P6|Overall Study|Lost to Follow-up|0
227067|NCT00094835|742265|P5|Overall Study|Lost to Follow-up|1
227068|NCT00094835|742266|P4|Overall Study|Lost to Follow-up|0
227069|NCT00094835|742267|P3|Overall Study|Lost to Follow-up|0
227070|NCT00094835|742268|P2|Overall Study|Lost to Follow-up|0
227071|NCT00094835|742269|P1|Overall Study|Lost to Follow-up|0
227072|NCT00094835|742263|P7|Overall Study|Withdrawal by Subject|1
227073|NCT00094835|742264|P6|Overall Study|Withdrawal by Subject|0
227074|NCT00094835|742265|P5|Overall Study|Withdrawal by Subject|0
227075|NCT00094835|742266|P4|Overall Study|Withdrawal by Subject|0
227076|NCT00094835|742267|P3|Overall Study|Withdrawal by Subject|0
227077|NCT00094835|742268|P2|Overall Study|Withdrawal by Subject|0
227078|NCT00094835|742269|P1|Overall Study|Withdrawal by Subject|0
227079|NCT00094835|742263|P7|Overall Study|Physician Decision|0
227080|NCT00094835|742264|P6|Overall Study|Physician Decision|1
227081|NCT00094835|742265|P5|Overall Study|Physician Decision|0
227082|NCT00094835|742266|P4|Overall Study|Physician Decision|0
227083|NCT00094835|742267|P3|Overall Study|Physician Decision|0
227084|NCT00094835|742268|P2|Overall Study|Physician Decision|0
227085|NCT00094835|742269|P1|Overall Study|Physician Decision|1
227086|NCT00094809|742347|P2|Overall Study|Other|1
227087|NCT00094809|742348|P1|Overall Study|Other|1
227088|NCT00094809|742347|P2|Overall Study|Study drug not received|8
227089|NCT00094809|742348|P1|Overall Study|Study drug not received|2
227090|NCT00094809|742347|P2|Overall Study|Informed consent signed after treatment|0
227091|NCT00094809|742348|P1|Overall Study|Informed consent signed after treatment|1
227092|NCT00094809|742347|P2|Overall Study|Other|4
227093|NCT00094809|742348|P1|Overall Study|Other|2
227094|NCT00094809|742347|P2|Overall Study|Protocol-specified criteria|1
227095|NCT00094809|742348|P1|Overall Study|Protocol-specified criteria|1
227096|NCT00094809|742347|P2|Overall Study|Death|25
227097|NCT00094809|742348|P1|Overall Study|Death|19
227098|NCT00094809|742347|P2|Overall Study|Lost to Follow-up|6
227099|NCT00094809|742348|P1|Overall Study|Lost to Follow-up|6
227100|NCT00094809|742347|P2|Overall Study|Physician Decision|5
227101|NCT00094809|742348|P1|Overall Study|Physician Decision|3
227102|NCT00094809|742347|P2|Overall Study|Disease progression|3
227103|NCT00094809|742348|P1|Overall Study|Disease progression|3
227104|NCT00094809|742347|P2|Overall Study|Withdrawal by Subject|9
227105|NCT00094809|742348|P1|Overall Study|Withdrawal by Subject|8
227106|NCT00094809|742347|P2|Overall Study|Adverse Event|1
227107|NCT00094809|742348|P1|Overall Study|Adverse Event|3
227108|NCT00094809|742347|P2|Overall Study|Noncompliance|0
227109|NCT00094809|742348|P1|Overall Study|Noncompliance|1
227110|NCT00094809|742347|P2|Overall Study|Protocol deviation|2
227111|NCT00094809|742348|P1|Overall Study|Protocol deviation|2
227112|NCT00094770|742374|P2|Year 2 (Week 0 to Week 104)|Other|23
227113|NCT00094770|742375|P1|Year 2 (Week 0 to Week 104)|Other|15
227114|NCT00094770|742374|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
227115|NCT00094770|742375|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
227116|NCT00094770|742374|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
227117|NCT00094770|742375|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
227118|NCT00094770|742374|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
227119|NCT00094770|742375|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
227120|NCT00094770|742374|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
227121|NCT00094770|742375|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
227122|NCT00094770|742374|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
227123|NCT00094770|742375|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
227124|NCT00094770|742374|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
227125|NCT00094770|742375|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
227126|NCT00094770|742374|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
227127|NCT00094770|742375|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
227128|NCT00094770|742374|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
227129|NCT00094770|742375|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
227130|NCT00094770|742374|P2|Year 1 ( Week 0 to Week 52)|Other|11
227131|NCT00094770|742375|P1|Year 1 ( Week 0 to Week 52)|Other|10
227132|NCT00094770|742374|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
227133|NCT00094770|742375|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
227134|NCT00094770|742374|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
227135|NCT00094770|742375|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
227136|NCT00094770|742374|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
227137|NCT00094770|742375|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
227138|NCT00094770|742374|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
227139|NCT00094770|742375|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
227140|NCT00094770|742374|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
227141|NCT00094770|742375|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
227142|NCT00094770|742374|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
227143|NCT00094770|742375|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
227144|NCT00094770|742374|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
227145|NCT00094770|742375|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
227146|NCT00094770|742374|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
227147|NCT00094770|742375|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
227148|NCT00094757|742406|P3|Overall Study|Protocol specified discontinuation|0
227149|NCT00094757|742407|P2|Overall Study|Protocol specified discontinuation|3
227150|NCT00094757|742408|P1|Overall Study|Protocol specified discontinuation|1
227151|NCT00094757|742406|P3|Overall Study|Other|1
227152|NCT00094757|742407|P2|Overall Study|Other|3
227153|NCT00094757|742408|P1|Overall Study|Other|3
227154|NCT00094757|742406|P3|Overall Study|Withdrawal by Subject|5
227155|NCT00094757|742407|P2|Overall Study|Withdrawal by Subject|21
227156|NCT00094757|742408|P1|Overall Study|Withdrawal by Subject|14
227157|NCT00094757|742406|P3|Overall Study|Protocol Violation|3
227158|NCT00094757|742407|P2|Overall Study|Protocol Violation|5
227159|NCT00094757|742408|P1|Overall Study|Protocol Violation|8
227160|NCT00094757|742406|P3|Overall Study|Patient Moved|1
227161|NCT00094757|742407|P2|Overall Study|Patient Moved|1
227162|NCT00094757|742408|P1|Overall Study|Patient Moved|2
227163|NCT00094757|742406|P3|Overall Study|Lost to Follow-up|6
227164|NCT00094757|742407|P2|Overall Study|Lost to Follow-up|5
227165|NCT00094757|742408|P1|Overall Study|Lost to Follow-up|3
227166|NCT00094757|742406|P3|Overall Study|Lack of Efficacy|8
227167|NCT00094757|742407|P2|Overall Study|Lack of Efficacy|15
227168|NCT00094757|742408|P1|Overall Study|Lack of Efficacy|11
227169|NCT00094757|742406|P3|Overall Study|Adverse Event|6
227170|NCT00094757|742407|P2|Overall Study|Adverse Event|9
227171|NCT00094757|742408|P1|Overall Study|Adverse Event|11
227172|NCT00094653|742428|P3|Overall Study|Protocol Violation|1
227173|NCT00094653|742429|P2|Overall Study|Protocol Violation|0
227174|NCT00094653|742430|P1|Overall Study|Protocol Violation|0
227175|NCT00094653|742428|P3|Overall Study|Lost to Follow-up|1
227176|NCT00094653|742429|P2|Overall Study|Lost to Follow-up|2
227177|NCT00094653|742430|P1|Overall Study|Lost to Follow-up|3
227178|NCT00094653|742428|P3|Overall Study|Not specified|2
227179|NCT00094653|742429|P2|Overall Study|Not specified|2
227180|NCT00094653|742430|P1|Overall Study|Not specified|2
227181|NCT00094653|742428|P3|Overall Study|Subject Withdrew Consent|3
227182|NCT00094653|742429|P2|Overall Study|Subject Withdrew Consent|2
227183|NCT00094653|742430|P1|Overall Study|Subject Withdrew Consent|10
227184|NCT00094653|742428|P3|Overall Study|Death|119
227185|NCT00094653|742429|P2|Overall Study|Death|100
227186|NCT00094653|742430|P1|Overall Study|Death|306
227187|NCT00094575|742493|P2|Overall Study|Death|146
227188|NCT00094575|742494|P1|Overall Study|Death|146
227189|NCT00094536|742514|P1|Treatment and Follow-up|Unable to attend visits|1
227190|NCT00094536|742514|P1|Treatment and Follow-up|Subject non-compliance|9
227191|NCT00094536|742514|P1|Treatment and Follow-up|Withdrawal by Subject|1
227192|NCT00094536|742514|P1|Treatment and Follow-up|Lost to Follow-up|7
227193|NCT00094536|742514|P1|Treatment and Follow-up|Lack of Efficacy|9
227194|NCT00094536|742514|P1|Treatment and Follow-up|Adverse Event|4
227195|NCT00094536|742514|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
227196|NCT00094458|742538|P6|OLE: Open-Label Extension|Patient decision|0
227197|NCT00094458|742539|P5|OLE: Open-Label Extension|Patient decision|1
227198|NCT00094458|742540|P4|OLE: Open-Label Extension|Patient decision|0
227199|NCT00094458|742541|P3|OLE: Open-Label Extension|Patient decision|0
227200|NCT00094458|742542|P2|OLE: Open-Label Extension|Patient decision|0
227201|NCT00094458|742543|P1|OLE: Open-Label Extension|Patient decision|0
227202|NCT00094458|742538|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
227203|NCT00094458|742539|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
227204|NCT00094458|742540|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
227205|NCT00094458|742541|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
227206|NCT00094458|742542|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
227207|NCT00094458|742543|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
227208|NCT00094458|742538|P6|OLE: Open-Label Extension|Adverse Event|4
227209|NCT00094458|742539|P5|OLE: Open-Label Extension|Adverse Event|3
227210|NCT00094458|742540|P4|OLE: Open-Label Extension|Adverse Event|0
227211|NCT00094458|742541|P3|OLE: Open-Label Extension|Adverse Event|0
227212|NCT00094458|742542|P2|OLE: Open-Label Extension|Adverse Event|0
227213|NCT00094458|742543|P1|OLE: Open-Label Extension|Adverse Event|0
227214|NCT00094458|742538|P6|Study Extension: Week 30 Through Week 50|Other|0
227215|NCT00094458|742539|P5|Study Extension: Week 30 Through Week 50|Other|0
227216|NCT00094458|742540|P4|Study Extension: Week 30 Through Week 50|Other|0
227217|NCT00094458|742541|P3|Study Extension: Week 30 Through Week 50|Other|3
227218|NCT00094458|742542|P2|Study Extension: Week 30 Through Week 50|Other|2
227219|NCT00094458|742543|P1|Study Extension: Week 30 Through Week 50|Other|1
227220|NCT00094458|742538|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
227221|NCT00094458|742539|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
227222|NCT00094458|742540|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
227223|NCT00094458|742541|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
227224|NCT00094458|742542|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
227225|NCT00094458|742543|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
227226|NCT00094458|742538|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
227227|NCT00094458|742539|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
227228|NCT00094458|742540|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
227229|NCT00094458|742541|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
227230|NCT00094458|742542|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
227231|NCT00094458|742543|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
227232|NCT00094458|742538|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
227233|NCT00094458|742539|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
227234|NCT00094458|742540|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
227235|NCT00094458|742541|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
227236|NCT00094458|742542|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
227237|NCT00094458|742543|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
227238|NCT00094458|742538|P6|Main Study: Through Week 30|Other|0
227239|NCT00094458|742539|P5|Main Study: Through Week 30|Other|0
227240|NCT00094458|742540|P4|Main Study: Through Week 30|Other|0
227241|NCT00094458|742541|P3|Main Study: Through Week 30|Other|9
227242|NCT00094458|742542|P2|Main Study: Through Week 30|Other|16
227243|NCT00094458|742543|P1|Main Study: Through Week 30|Other|19
227244|NCT00094458|742538|P6|Main Study: Through Week 30|Death|0
227245|NCT00094458|742539|P5|Main Study: Through Week 30|Death|0
227246|NCT00094458|742540|P4|Main Study: Through Week 30|Death|0
227247|NCT00094458|742541|P3|Main Study: Through Week 30|Death|0
227248|NCT00094458|742542|P2|Main Study: Through Week 30|Death|0
227249|NCT00094458|742543|P1|Main Study: Through Week 30|Death|1
227250|NCT00094458|742538|P6|Main Study: Through Week 30|Adverse Event|0
227251|NCT00094458|742539|P5|Main Study: Through Week 30|Adverse Event|0
227252|NCT00094458|742540|P4|Main Study: Through Week 30|Adverse Event|0
227253|NCT00094458|742541|P3|Main Study: Through Week 30|Adverse Event|28
227254|NCT00094458|742542|P2|Main Study: Through Week 30|Adverse Event|20
227255|NCT00094458|742543|P1|Main Study: Through Week 30|Adverse Event|38
227256|NCT00094458|742538|P6|Main Study: Through Week 30|Withdrawal by Subject|0
227257|NCT00094458|742539|P5|Main Study: Through Week 30|Withdrawal by Subject|0
227258|NCT00094458|742540|P4|Main Study: Through Week 30|Withdrawal by Subject|0
227259|NCT00094458|742541|P3|Main Study: Through Week 30|Withdrawal by Subject|7
227260|NCT00094458|742542|P2|Main Study: Through Week 30|Withdrawal by Subject|9
227261|NCT00094458|742543|P1|Main Study: Through Week 30|Withdrawal by Subject|18
227262|NCT00094458|742538|P6|Main Study: Through Week 30|Lost to Follow-up|0
227263|NCT00094458|742539|P5|Main Study: Through Week 30|Lost to Follow-up|0
227264|NCT00094458|742540|P4|Main Study: Through Week 30|Lost to Follow-up|0
227265|NCT00094458|742541|P3|Main Study: Through Week 30|Lost to Follow-up|2
227266|NCT00094458|742542|P2|Main Study: Through Week 30|Lost to Follow-up|5
227267|NCT00094458|742543|P1|Main Study: Through Week 30|Lost to Follow-up|5
227268|NCT00094458|742538|P6|Main Study: Through Week 30|Eligibility criteria not met|0
227269|NCT00094458|742539|P5|Main Study: Through Week 30|Eligibility criteria not met|0
227270|NCT00094458|742540|P4|Main Study: Through Week 30|Eligibility criteria not met|0
227271|NCT00094458|742541|P3|Main Study: Through Week 30|Eligibility criteria not met|2
227272|NCT00094458|742542|P2|Main Study: Through Week 30|Eligibility criteria not met|8
227273|NCT00094458|742543|P1|Main Study: Through Week 30|Eligibility criteria not met|3
227274|NCT00094328|742581|P1|Overall Study|Lost to Follow-up|1
227275|NCT00094302|742591|P2|Overall Study|Death|246
227276|NCT00094302|742592|P1|Overall Study|Death|266
227277|NCT00094302|742591|P2|Overall Study|Withdrawal by Subject|111
227278|NCT00094302|742592|P1|Overall Study|Withdrawal by Subject|103
227279|NCT00094302|742591|P2|Overall Study|Physician Decision|8
227280|NCT00094302|742592|P1|Overall Study|Physician Decision|5
227281|NCT00094302|742591|P2|Overall Study|Lost to Follow-up|41
227282|NCT00094302|742592|P1|Overall Study|Lost to Follow-up|43
227283|NCT00094172|742648|P2|Overall Study|Started other MS therapy due to disease|0
227284|NCT00094172|742649|P1|Overall Study|Started other MS therapy due to disease|1
227285|NCT00094172|742648|P2|Overall Study|Primary endpoint met.|0
227286|NCT00094172|742649|P1|Overall Study|Primary endpoint met.|1
227287|NCT00094172|742648|P2|Overall Study|Withdrawal by Subject|5
227288|NCT00094172|742649|P1|Overall Study|Withdrawal by Subject|10
227289|NCT00094172|742648|P2|Overall Study|Protocol Violation|1
227290|NCT00094172|742649|P1|Overall Study|Protocol Violation|0
227291|NCT00094172|742648|P2|Overall Study|Lost to Follow-up|0
227292|NCT00094172|742649|P1|Overall Study|Lost to Follow-up|2
227293|NCT00094172|742648|P2|Overall Study|Adverse Event|1
227294|NCT00094172|742649|P1|Overall Study|Adverse Event|0
227295|NCT00094107|742659|P1|Overall Study|Withdrawal due to Disease Progression|1
227296|NCT00094107|742659|P1|Overall Study|Adverse Event|3
227297|NCT00094107|742659|P1|Overall Study|Death|5
227298|NCT00094107|742659|P1|Overall Study|Lack of Efficacy|23
227299|NCT00094094|742668|P1|Overall Study|Adverse Event|7
227300|NCT00094094|742668|P1|Overall Study|Lack of Efficacy|23
227301|NCT00094094|742668|P1|Overall Study|Death|2
227302|NCT00094055|742677|P1|Overall Study|Withdrawal by Subject|9
227303|NCT00094055|742677|P1|Overall Study|roll-over to another study|14
227304|NCT00094055|742677|P1|Overall Study|clinical progression|1
227305|NCT00094055|742677|P1|Overall Study|progressive disease|2
227306|NCT00094055|742677|P1|Overall Study|Lost to Follow-up|2
227307|NCT00094055|742677|P1|Overall Study|Lack of Efficacy|17
227308|NCT00094055|742677|P1|Overall Study|Death|4
227309|NCT00094055|742677|P1|Overall Study|Adverse Event|11
227310|NCT00093808|742697|P1|Overall Study|Protocol Violation|1
227311|NCT00093808|742697|P1|Overall Study|Cancel participation before receiving tx|1
227312|NCT00093795|742707|P3|Overall Study|No follow up data|17
227313|NCT00093795|742708|P2|Overall Study|No follow up data|16
227314|NCT00093795|742709|P1|Overall Study|No follow up data|20
227315|NCT00093496|742754|P2|Overall Study|Protocol Violation|3
227316|NCT00093496|742755|P1|Overall Study|Protocol Violation|1
227317|NCT00093470|742768|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
227318|NCT00093470|742769|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
227319|NCT00093470|742768|P2|Overall Study|Never started treatment|0
227320|NCT00093470|742769|P1|Overall Study|Never started treatment|1
227321|NCT00093470|742768|P2|Overall Study|Physician Decision|0
227322|NCT00093470|742769|P1|Overall Study|Physician Decision|2
227323|NCT00093470|742768|P2|Overall Study|Other complicating disease|0
227324|NCT00093470|742769|P1|Overall Study|Other complicating disease|3
227325|NCT00093470|742768|P2|Overall Study|Alternative therapy|0
227326|NCT00093470|742769|P1|Overall Study|Alternative therapy|2
227327|NCT00093470|742768|P2|Overall Study|Withdrawal by Subject|0
227328|NCT00093470|742769|P1|Overall Study|Withdrawal by Subject|8
227329|NCT00093470|742768|P2|Overall Study|Death|0
227330|NCT00093470|742769|P1|Overall Study|Death|2
227331|NCT00093470|742768|P2|Overall Study|Adverse Event|0
227332|NCT00093470|742769|P1|Overall Study|Adverse Event|15
227333|NCT00093470|742768|P2|Overall Study|Disease progression|0
227334|NCT00093470|742769|P1|Overall Study|Disease progression|39
227335|NCT00093145|742783|P1|Overall Study|Other|1
227336|NCT00093145|742783|P1|Overall Study|Withdrawal by Subject|9
227337|NCT00093145|742783|P1|Overall Study|Physician Decision|5
227338|NCT00093145|742783|P1|Overall Study|Unacceptable Toxicity Only|2
227339|NCT00093015|742825|P2|Overall Study|Death|385
227340|NCT00093015|742826|P1|Overall Study|Death|375
227341|NCT00093015|742825|P2|Overall Study|Lost to Follow-up|108
227342|NCT00093015|742826|P1|Overall Study|Lost to Follow-up|96
227343|NCT00093015|742825|P2|Overall Study|Withdrawal by Subject|171
227344|NCT00093015|742826|P1|Overall Study|Withdrawal by Subject|194
227345|NCT00092677|742854|P2|Overall Study|Adminstrative|9
227346|NCT00092677|742855|P1|Overall Study|Adminstrative|5
227347|NCT00092677|742854|P2|Overall Study|Lost to Follow-up|2
227348|NCT00092677|742855|P1|Overall Study|Lost to Follow-up|0
227349|NCT00092547|742899|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
227350|NCT00092547|742900|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
227351|NCT00092547|742901|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
227352|NCT00092547|742899|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
227353|NCT00092547|742900|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
227354|NCT00092547|742901|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
227355|NCT00092547|742899|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
227356|NCT00092547|742900|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
227357|NCT00092547|742901|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
227358|NCT00092547|742899|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
227359|NCT00092547|742900|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
227360|NCT00092547|742901|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
227361|NCT00092547|742899|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
227362|NCT00092547|742900|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
227363|NCT00092547|742901|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
227364|NCT00092547|742899|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
227365|NCT00092547|742900|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
227366|NCT00092547|742901|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
227367|NCT00092547|742899|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
227368|NCT00092547|742900|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
227369|NCT00092547|742901|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
227370|NCT00092547|742899|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
227371|NCT00092547|742900|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
227372|NCT00092547|742901|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
227373|NCT00092547|742899|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
227374|NCT00092547|742900|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
227375|NCT00092547|742901|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
227376|NCT00092547|742899|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
227377|NCT00092547|742900|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
227378|NCT00092547|742901|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
227379|NCT00092547|742899|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
227380|NCT00092547|742900|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
227381|NCT00092547|742901|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
227382|NCT00092547|742899|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
227383|NCT00092547|742900|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
227384|NCT00092547|742901|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
227385|NCT00092547|742899|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
227386|NCT00092547|742900|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
227387|NCT00092547|742901|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
227388|NCT00092547|742899|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
227389|NCT00092547|742900|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
227390|NCT00092547|742901|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
227391|NCT00092547|742899|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
227392|NCT00092547|742900|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
227393|NCT00092547|742901|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
227394|NCT00092547|742899|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
227395|NCT00092547|742900|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
227396|NCT00092547|742901|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
227397|NCT00092547|742899|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
227398|NCT00092547|742900|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
227399|NCT00092547|742901|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
227400|NCT00092547|742899|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
227401|NCT00092547|742900|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
227402|NCT00092547|742901|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
227403|NCT00092547|742899|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
227404|NCT00092547|742900|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
227405|NCT00092547|742901|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
227406|NCT00092547|742899|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
227407|NCT00092547|742900|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
227408|NCT00092547|742901|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
227409|NCT00092547|742899|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
227410|NCT00092547|742900|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
227411|NCT00092547|742901|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
227412|NCT00092534|742945|P3|Extension Study|Protocol Deviation|15
227413|NCT00092534|742946|P2|Extension Study|Protocol Deviation|0
227414|NCT00092534|742947|P1|Extension Study|Protocol Deviation|0
227415|NCT00092534|742945|P3|Extension Study|Study Ended|29
227416|NCT00092534|742946|P2|Extension Study|Study Ended|0
227417|NCT00092534|742947|P1|Extension Study|Study Ended|0
227418|NCT00092534|742945|P3|Extension Study|Site Closed|21
227419|NCT00092534|742946|P2|Extension Study|Site Closed|0
227420|NCT00092534|742947|P1|Extension Study|Site Closed|0
227421|NCT00092534|742945|P3|Extension Study|Travel|2
227422|NCT00092534|742946|P2|Extension Study|Travel|0
227423|NCT00092534|742947|P1|Extension Study|Travel|0
227424|NCT00092534|742945|P3|Extension Study|Moved|6
227425|NCT00092534|742946|P2|Extension Study|Moved|0
227426|NCT00092534|742947|P1|Extension Study|Moved|0
227427|NCT00092534|742945|P3|Extension Study|Withdrawal by Subject|18
227428|NCT00092534|742946|P2|Extension Study|Withdrawal by Subject|0
227429|NCT00092534|742947|P1|Extension Study|Withdrawal by Subject|0
227430|NCT00092534|742945|P3|Extension Study|Pregnancy|12
227431|NCT00092534|742946|P2|Extension Study|Pregnancy|0
227432|NCT00092534|742947|P1|Extension Study|Pregnancy|0
227433|NCT00092534|742945|P3|Extension Study|Physician Decision|1
227434|NCT00092534|742946|P2|Extension Study|Physician Decision|0
227435|NCT00092534|742947|P1|Extension Study|Physician Decision|0
227436|NCT00092534|742945|P3|Extension Study|Lost to Follow-up|41
227437|NCT00092534|742946|P2|Extension Study|Lost to Follow-up|0
227438|NCT00092534|742947|P1|Extension Study|Lost to Follow-up|0
227439|NCT00092534|742945|P3|Base Study Follow Up Period|Subjects in extension|0
227440|NCT00092534|742946|P2|Base Study Follow Up Period|Subjects in extension|371
227441|NCT00092534|742947|P1|Base Study Follow Up Period|Subjects in extension|15
227442|NCT00092534|742945|P3|Base Study Follow Up Period|Subjects continuing|0
227443|NCT00092534|742946|P2|Base Study Follow Up Period|Subjects continuing|31
227444|NCT00092534|742947|P1|Base Study Follow Up Period|Subjects continuing|27
227445|NCT00092534|742945|P3|Base Study Follow Up Period|Site Closed|0
227446|NCT00092534|742946|P2|Base Study Follow Up Period|Site Closed|2
227447|NCT00092534|742947|P1|Base Study Follow Up Period|Site Closed|0
227448|NCT00092534|742945|P3|Base Study Follow Up Period|Travel|0
227449|NCT00092534|742946|P2|Base Study Follow Up Period|Travel|7
227450|NCT00092534|742947|P1|Base Study Follow Up Period|Travel|10
227451|NCT00092534|742945|P3|Base Study Follow Up Period|Moved|0
227452|NCT00092534|742946|P2|Base Study Follow Up Period|Moved|58
227453|NCT00092534|742947|P1|Base Study Follow Up Period|Moved|62
227454|NCT00092534|742945|P3|Base Study Follow Up Period|Withdrawal by Subject|0
227455|NCT00092534|742946|P2|Base Study Follow Up Period|Withdrawal by Subject|62
227456|NCT00092534|742947|P1|Base Study Follow Up Period|Withdrawal by Subject|71
227457|NCT00092534|742945|P3|Base Study Follow Up Period|Protocol Violation|0
227458|NCT00092534|742946|P2|Base Study Follow Up Period|Protocol Violation|2
227459|NCT00092534|742947|P1|Base Study Follow Up Period|Protocol Violation|1
227460|NCT00092534|742945|P3|Base Study Follow Up Period|Pregnancy|0
227461|NCT00092534|742946|P2|Base Study Follow Up Period|Pregnancy|10
227462|NCT00092534|742947|P1|Base Study Follow Up Period|Pregnancy|6
227463|NCT00092534|742945|P3|Base Study Follow Up Period|Lost to Follow-up|0
227464|NCT00092534|742946|P2|Base Study Follow Up Period|Lost to Follow-up|146
227465|NCT00092534|742947|P1|Base Study Follow Up Period|Lost to Follow-up|120
227466|NCT00092534|742945|P3|Base Study Follow Up Period|Death|0
227467|NCT00092534|742946|P2|Base Study Follow Up Period|Death|1
227468|NCT00092534|742947|P1|Base Study Follow Up Period|Death|2
227469|NCT00092534|742945|P3|Base Study Follow Up Period|Adverse Event|0
227470|NCT00092534|742946|P2|Base Study Follow Up Period|Adverse Event|4
227471|NCT00092534|742947|P1|Base Study Follow Up Period|Adverse Event|2
227472|NCT00092534|742945|P3|Base Study Vaccination Period|Site Closed|0
227473|NCT00092534|742946|P2|Base Study Vaccination Period|Site Closed|1
227474|NCT00092534|742947|P1|Base Study Vaccination Period|Site Closed|0
227475|NCT00092534|742945|P3|Base Study Vaccination Period|Travel|0
227476|NCT00092534|742946|P2|Base Study Vaccination Period|Travel|0
227477|NCT00092534|742947|P1|Base Study Vaccination Period|Travel|1
227478|NCT00092534|742945|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
227479|NCT00092534|742946|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
227480|NCT00092534|742947|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
227481|NCT00092534|742945|P3|Base Study Vaccination Period|Moved|0
227482|NCT00092534|742946|P2|Base Study Vaccination Period|Moved|12
227483|NCT00092534|742947|P1|Base Study Vaccination Period|Moved|14
227484|NCT00092534|742945|P3|Base Study Vaccination Period|Withdrawal by Subject|0
227485|NCT00092534|742946|P2|Base Study Vaccination Period|Withdrawal by Subject|58
227486|NCT00092534|742947|P1|Base Study Vaccination Period|Withdrawal by Subject|85
227487|NCT00092534|742945|P3|Base Study Vaccination Period|Protocol Violation|0
227488|NCT00092534|742946|P2|Base Study Vaccination Period|Protocol Violation|1
227489|NCT00092534|742947|P1|Base Study Vaccination Period|Protocol Violation|2
227490|NCT00092534|742945|P3|Base Study Vaccination Period|Pregnancy|0
227491|NCT00092534|742946|P2|Base Study Vaccination Period|Pregnancy|7
227492|NCT00092534|742947|P1|Base Study Vaccination Period|Pregnancy|9
227493|NCT00092534|742945|P3|Base Study Vaccination Period|Physician Decision|0
227494|NCT00092534|742946|P2|Base Study Vaccination Period|Physician Decision|0
227495|NCT00092534|742947|P1|Base Study Vaccination Period|Physician Decision|1
227496|NCT00092534|742945|P3|Base Study Vaccination Period|Lost to Follow-up|0
227497|NCT00092534|742946|P2|Base Study Vaccination Period|Lost to Follow-up|37
227498|NCT00092534|742947|P1|Base Study Vaccination Period|Lost to Follow-up|41
227499|NCT00092534|742945|P3|Base Study Vaccination Period|Death|0
227500|NCT00092534|742946|P2|Base Study Vaccination Period|Death|4
227501|NCT00092534|742947|P1|Base Study Vaccination Period|Death|5
227502|NCT00092534|742945|P3|Base Study Vaccination Period|Adverse Event|0
227503|NCT00092534|742946|P2|Base Study Vaccination Period|Adverse Event|1
227504|NCT00092534|742947|P1|Base Study Vaccination Period|Adverse Event|3
227505|NCT00092534|742945|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
227506|NCT00092534|742946|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
227507|NCT00092534|742947|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
227508|NCT00092521|742965|P4|Extension Study (Group 4)|Unable/unwilling to return|25
227509|NCT00092521|742966|P3|Extension Study (Group 4)|Unable/unwilling to return|0
227510|NCT00092521|742967|P2|Extension Study (Group 4)|Unable/unwilling to return|0
227511|NCT00092521|742968|P1|Extension Study (Group 4)|Unable/unwilling to return|0
227512|NCT00092521|742965|P4|Extension Study (Group 4)|Site Terminated|4
227513|NCT00092521|742966|P3|Extension Study (Group 4)|Site Terminated|0
227514|NCT00092521|742967|P2|Extension Study (Group 4)|Site Terminated|0
227515|NCT00092521|742968|P1|Extension Study (Group 4)|Site Terminated|0
227516|NCT00092521|742965|P4|Extension Study (Group 4)|Moved|16
227517|NCT00092521|742966|P3|Extension Study (Group 4)|Moved|0
227518|NCT00092521|742967|P2|Extension Study (Group 4)|Moved|0
227519|NCT00092521|742968|P1|Extension Study (Group 4)|Moved|0
227520|NCT00092521|742965|P4|Extension Study (Group 4)|Withdrawal by Subject|46
227521|NCT00092521|742966|P3|Extension Study (Group 4)|Withdrawal by Subject|0
227522|NCT00092521|742967|P2|Extension Study (Group 4)|Withdrawal by Subject|0
227523|NCT00092521|742968|P1|Extension Study (Group 4)|Withdrawal by Subject|0
227524|NCT00092521|742965|P4|Extension Study (Group 4)|Protocol Violation|2
227525|NCT00092521|742966|P3|Extension Study (Group 4)|Protocol Violation|0
227526|NCT00092521|742967|P2|Extension Study (Group 4)|Protocol Violation|0
227527|NCT00092521|742968|P1|Extension Study (Group 4)|Protocol Violation|0
227528|NCT00092521|742965|P4|Extension Study (Group 4)|Pregnancy|4
227529|NCT00092521|742966|P3|Extension Study (Group 4)|Pregnancy|0
227530|NCT00092521|742967|P2|Extension Study (Group 4)|Pregnancy|0
227531|NCT00092521|742968|P1|Extension Study (Group 4)|Pregnancy|0
227532|NCT00092521|742965|P4|Extension Study (Group 4)|Lost to Follow-up|87
227533|NCT00092521|742966|P3|Extension Study (Group 4)|Lost to Follow-up|0
227534|NCT00092521|742967|P2|Extension Study (Group 4)|Lost to Follow-up|0
227535|NCT00092521|742968|P1|Extension Study (Group 4)|Lost to Follow-up|0
227536|NCT00092521|742965|P4|Extension Study (Group 4)|Adverse Event|2
227537|NCT00092521|742966|P3|Extension Study (Group 4)|Adverse Event|0
227538|NCT00092521|742967|P2|Extension Study (Group 4)|Adverse Event|0
227539|NCT00092521|742968|P1|Extension Study (Group 4)|Adverse Event|0
227540|NCT00092521|742965|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
227541|NCT00092521|742966|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
227542|NCT00092521|742967|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
227543|NCT00092521|742968|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
227544|NCT00092521|742965|P4|Follow-Up (After Month 7)|Visits Compressed|0
227545|NCT00092521|742966|P3|Follow-Up (After Month 7)|Visits Compressed|5
227546|NCT00092521|742967|P2|Follow-Up (After Month 7)|Visits Compressed|0
227547|NCT00092521|742968|P1|Follow-Up (After Month 7)|Visits Compressed|5
227548|NCT00092521|742965|P4|Follow-Up (After Month 7)|Travel|0
227549|NCT00092521|742966|P3|Follow-Up (After Month 7)|Travel|0
227550|NCT00092521|742967|P2|Follow-Up (After Month 7)|Travel|0
227551|NCT00092521|742968|P1|Follow-Up (After Month 7)|Travel|2
227552|NCT00092521|742965|P4|Follow-Up (After Month 7)|Site Terminated|0
227553|NCT00092521|742966|P3|Follow-Up (After Month 7)|Site Terminated|3
227554|NCT00092521|742967|P2|Follow-Up (After Month 7)|Site Terminated|0
227555|NCT00092521|742968|P1|Follow-Up (After Month 7)|Site Terminated|3
227556|NCT00092521|742965|P4|Follow-Up (After Month 7)|Moved|0
227557|NCT00092521|742966|P3|Follow-Up (After Month 7)|Moved|28
227558|NCT00092521|742967|P2|Follow-Up (After Month 7)|Moved|2
227559|NCT00092521|742968|P1|Follow-Up (After Month 7)|Moved|32
227560|NCT00092521|742965|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
227561|NCT00092521|742966|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
227562|NCT00092521|742967|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
227563|NCT00092521|742968|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
227564|NCT00092521|742965|P4|Follow-Up (After Month 7)|Protocol Violation|0
227565|NCT00092521|742966|P3|Follow-Up (After Month 7)|Protocol Violation|5
227566|NCT00092521|742967|P2|Follow-Up (After Month 7)|Protocol Violation|1
227567|NCT00092521|742968|P1|Follow-Up (After Month 7)|Protocol Violation|1
227568|NCT00092521|742965|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
227569|NCT00092521|742966|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
227570|NCT00092521|742967|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
227571|NCT00092521|742968|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
227572|NCT00092521|742965|P4|Follow-Up (After Month 7)|Death|0
227573|NCT00092521|742966|P3|Follow-Up (After Month 7)|Death|1
227574|NCT00092521|742967|P2|Follow-Up (After Month 7)|Death|0
227575|NCT00092521|742968|P1|Follow-Up (After Month 7)|Death|2
227576|NCT00092521|742965|P4|Follow-Up (After Month 7)|Adverse Event|0
227577|NCT00092521|742966|P3|Follow-Up (After Month 7)|Adverse Event|0
227578|NCT00092521|742967|P2|Follow-Up (After Month 7)|Adverse Event|0
227579|NCT00092521|742968|P1|Follow-Up (After Month 7)|Adverse Event|1
227580|NCT00092521|742965|P4|Follow-Up (After Month 7)|Subjects in Extension|0
227581|NCT00092521|742966|P3|Follow-Up (After Month 7)|Subjects in Extension|412
227582|NCT00092521|742967|P2|Follow-Up (After Month 7)|Subjects in Extension|109
227583|NCT00092521|742968|P1|Follow-Up (After Month 7)|Subjects in Extension|13
227584|NCT00092521|742965|P4|Follow-Up (After Month 7)|Subjects Continuing|0
227585|NCT00092521|742966|P3|Follow-Up (After Month 7)|Subjects Continuing|35
227586|NCT00092521|742967|P2|Follow-Up (After Month 7)|Subjects Continuing|4
227587|NCT00092521|742968|P1|Follow-Up (After Month 7)|Subjects Continuing|34
227588|NCT00092521|742965|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
227589|NCT00092521|742966|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
227590|NCT00092521|742967|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
227591|NCT00092521|742968|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
227592|NCT00092521|742965|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
227593|NCT00092521|742966|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
227594|NCT00092521|742967|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
227595|NCT00092521|742968|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
227596|NCT00092521|742965|P4|Vaccination (Day 1 Through Month 7)|Moved|0
227597|NCT00092521|742966|P3|Vaccination (Day 1 Through Month 7)|Moved|18
227598|NCT00092521|742967|P2|Vaccination (Day 1 Through Month 7)|Moved|1
227599|NCT00092521|742968|P1|Vaccination (Day 1 Through Month 7)|Moved|14
227600|NCT00092521|742965|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
227601|NCT00092521|742966|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
227602|NCT00092521|742967|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
227603|NCT00092521|742968|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
227604|NCT00092521|742965|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
227605|NCT00092521|742966|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
227606|NCT00092521|742967|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
227607|NCT00092521|742968|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
227608|NCT00092521|742965|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
227609|NCT00092521|742966|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
227610|NCT00092521|742967|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
227611|NCT00092521|742968|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
227612|NCT00092521|742965|P4|Vaccination (Day 1 Through Month 7)|Death|0
227613|NCT00092521|742966|P3|Vaccination (Day 1 Through Month 7)|Death|1
227614|NCT00092521|742967|P2|Vaccination (Day 1 Through Month 7)|Death|0
227615|NCT00092521|742968|P1|Vaccination (Day 1 Through Month 7)|Death|0
227616|NCT00092521|742965|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
227617|NCT00092521|742966|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
227618|NCT00092521|742967|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
227619|NCT00092521|742968|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
227620|NCT00092521|742965|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
227621|NCT00092521|742966|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
227622|NCT00092521|742967|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
227623|NCT00092521|742968|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
227624|NCT00092495|742982|P5|Base Study Follow-up Period|Withdrawal by Subject|0
227625|NCT00092495|742983|P4|Base Study Follow-up Period|Withdrawal by Subject|0
227626|NCT00092495|742984|P3|Base Study Follow-up Period|Withdrawal by Subject|0
227627|NCT00092495|742985|P2|Base Study Follow-up Period|Withdrawal by Subject|0
227628|NCT00092495|742986|P1|Base Study Follow-up Period|Withdrawal by Subject|2
227629|NCT00092495|742982|P5|Base Study Follow-up Period|Lost to Follow-up|0
227630|NCT00092495|742983|P4|Base Study Follow-up Period|Lost to Follow-up|12
227631|NCT00092495|742984|P3|Base Study Follow-up Period|Lost to Follow-up|3
227632|NCT00092495|742985|P2|Base Study Follow-up Period|Lost to Follow-up|3
227633|NCT00092495|742986|P1|Base Study Follow-up Period|Lost to Follow-up|1
227634|NCT00092495|742982|P5|Base Study Follow-up Period|Extended|0
227635|NCT00092495|742983|P4|Base Study Follow-up Period|Extended|2
227636|NCT00092495|742984|P3|Base Study Follow-up Period|Extended|1
227637|NCT00092495|742985|P2|Base Study Follow-up Period|Extended|0
227638|NCT00092495|742986|P1|Base Study Follow-up Period|Extended|0
227639|NCT00092495|742982|P5|Base Study Vaccination Period|Withdrawal by Subject|0
227640|NCT00092495|742983|P4|Base Study Vaccination Period|Withdrawal by Subject|25
227641|NCT00092495|742984|P3|Base Study Vaccination Period|Withdrawal by Subject|14
227642|NCT00092495|742985|P2|Base Study Vaccination Period|Withdrawal by Subject|10
227643|NCT00092495|742986|P1|Base Study Vaccination Period|Withdrawal by Subject|9
227644|NCT00092495|742982|P5|Base Study Vaccination Period|Protocol Violation|0
227645|NCT00092495|742983|P4|Base Study Vaccination Period|Protocol Violation|0
227646|NCT00092495|742984|P3|Base Study Vaccination Period|Protocol Violation|0
227647|NCT00092495|742985|P2|Base Study Vaccination Period|Protocol Violation|0
227648|NCT00092495|742986|P1|Base Study Vaccination Period|Protocol Violation|1
227649|NCT00092495|742982|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
227650|NCT00092495|742983|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
227651|NCT00092495|742984|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
227652|NCT00092495|742985|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
227653|NCT00092495|742986|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
227654|NCT00092495|742982|P5|Base Study Vaccination Period|Pregnancy|0
227655|NCT00092495|742983|P4|Base Study Vaccination Period|Pregnancy|0
227656|NCT00092495|742984|P3|Base Study Vaccination Period|Pregnancy|0
227657|NCT00092495|742985|P2|Base Study Vaccination Period|Pregnancy|0
227658|NCT00092495|742986|P1|Base Study Vaccination Period|Pregnancy|2
227659|NCT00092495|742982|P5|Base Study Vaccination Period|Other|0
227660|NCT00092495|742983|P4|Base Study Vaccination Period|Other|2
227661|NCT00092495|742984|P3|Base Study Vaccination Period|Other|0
227662|NCT00092495|742985|P2|Base Study Vaccination Period|Other|1
227663|NCT00092495|742986|P1|Base Study Vaccination Period|Other|1
227664|NCT00092495|742982|P5|Base Study Vaccination Period|Moved|0
227665|NCT00092495|742983|P4|Base Study Vaccination Period|Moved|2
227666|NCT00092495|742984|P3|Base Study Vaccination Period|Moved|2
227667|NCT00092495|742985|P2|Base Study Vaccination Period|Moved|1
227668|NCT00092495|742986|P1|Base Study Vaccination Period|Moved|3
227669|NCT00092495|742982|P5|Base Study Vaccination Period|Lost to Follow-up|0
227670|NCT00092495|742983|P4|Base Study Vaccination Period|Lost to Follow-up|36
227671|NCT00092495|742984|P3|Base Study Vaccination Period|Lost to Follow-up|11
227672|NCT00092495|742985|P2|Base Study Vaccination Period|Lost to Follow-up|6
227673|NCT00092495|742986|P1|Base Study Vaccination Period|Lost to Follow-up|16
227674|NCT00092495|742982|P5|Base Study Vaccination Period|Adverse Event|0
227675|NCT00092495|742983|P4|Base Study Vaccination Period|Adverse Event|3
227676|NCT00092495|742984|P3|Base Study Vaccination Period|Adverse Event|0
227677|NCT00092495|742985|P2|Base Study Vaccination Period|Adverse Event|0
227678|NCT00092495|742986|P1|Base Study Vaccination Period|Adverse Event|1
227679|NCT00092495|742982|P5|Base Study Vaccination Period|*Pregnancy|0
227680|NCT00092495|742983|P4|Base Study Vaccination Period|*Pregnancy|7
227681|NCT00092495|742984|P3|Base Study Vaccination Period|*Pregnancy|5
227682|NCT00092495|742985|P2|Base Study Vaccination Period|*Pregnancy|2
227683|NCT00092495|742986|P1|Base Study Vaccination Period|*Pregnancy|0
227684|NCT00092495|742982|P5|Base Study Vaccination Period|*Other reasons|0
227685|NCT00092495|742983|P4|Base Study Vaccination Period|*Other reasons|1
227686|NCT00092495|742984|P3|Base Study Vaccination Period|*Other reasons|0
227687|NCT00092495|742985|P2|Base Study Vaccination Period|*Other reasons|0
227688|NCT00092495|742986|P1|Base Study Vaccination Period|*Other reasons|1
227689|NCT00092495|742982|P5|Base Study Vaccination Period|*Clinical AE|0
227690|NCT00092495|742983|P4|Base Study Vaccination Period|*Clinical AE|2
227691|NCT00092495|742984|P3|Base Study Vaccination Period|*Clinical AE|1
227692|NCT00092495|742985|P2|Base Study Vaccination Period|*Clinical AE|0
227693|NCT00092495|742986|P1|Base Study Vaccination Period|*Clinical AE|1
227694|NCT00092495|742982|P5|Base Study Vaccination Period|Extended|0
227695|NCT00092495|742983|P4|Base Study Vaccination Period|Extended|1
227696|NCT00092495|742984|P3|Base Study Vaccination Period|Extended|0
227697|NCT00092495|742985|P2|Base Study Vaccination Period|Extended|0
227698|NCT00092495|742986|P1|Base Study Vaccination Period|Extended|0
227699|NCT00092495|742982|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
227700|NCT00092495|742983|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
227701|NCT00092495|742984|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
227702|NCT00092495|742985|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
227703|NCT00092495|742986|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
227704|NCT00092456|743052|P4|Overall Study|Not Specified|0
227705|NCT00092456|743053|P3|Overall Study|Not Specified|3
227706|NCT00092456|743054|P2|Overall Study|Not Specified|2
227707|NCT00092456|743055|P1|Overall Study|Not Specified|4
227708|NCT00092456|743052|P4|Overall Study|Moved|1
227709|NCT00092456|743053|P3|Overall Study|Moved|0
227710|NCT00092456|743054|P2|Overall Study|Moved|1
227711|NCT00092456|743055|P1|Overall Study|Moved|1
227712|NCT00092456|743052|P4|Overall Study|Withdrawal by Subject|6
227713|NCT00092456|743053|P3|Overall Study|Withdrawal by Subject|16
227714|NCT00092456|743054|P2|Overall Study|Withdrawal by Subject|5
227715|NCT00092456|743055|P1|Overall Study|Withdrawal by Subject|13
227716|NCT00092456|743052|P4|Overall Study|Protocol Violation|6
227717|NCT00092456|743053|P3|Overall Study|Protocol Violation|8
227718|NCT00092456|743054|P2|Overall Study|Protocol Violation|7
227719|NCT00092456|743055|P1|Overall Study|Protocol Violation|5
227720|NCT00092456|743052|P4|Overall Study|Lost to Follow-up|2
227721|NCT00092456|743053|P3|Overall Study|Lost to Follow-up|1
227722|NCT00092456|743054|P2|Overall Study|Lost to Follow-up|2
227723|NCT00092456|743055|P1|Overall Study|Lost to Follow-up|2
227724|NCT00092456|743052|P4|Overall Study|Adverse Event|1
227725|NCT00092456|743053|P3|Overall Study|Adverse Event|1
227726|NCT00092456|743054|P2|Overall Study|Adverse Event|0
227727|NCT00092456|743055|P1|Overall Study|Adverse Event|0
227728|NCT00092443|743103|P2|Overall Study|Not Specified|13
227729|NCT00092443|743104|P1|Overall Study|Not Specified|17
227730|NCT00092443|743103|P2|Overall Study|Moved|5
227731|NCT00092443|743104|P1|Overall Study|Moved|5
227732|NCT00092443|743103|P2|Overall Study|Withdrawal by Subject|11
227733|NCT00092443|743104|P1|Overall Study|Withdrawal by Subject|9
227734|NCT00092443|743103|P2|Overall Study|Protocol Violation|9
227735|NCT00092443|743104|P1|Overall Study|Protocol Violation|11
227736|NCT00092443|743103|P2|Overall Study|Lost to Follow-up|3
227737|NCT00092443|743104|P1|Overall Study|Lost to Follow-up|7
227738|NCT00092443|743103|P2|Overall Study|Adverse Event|13
227739|NCT00092443|743104|P1|Overall Study|Adverse Event|9
227740|NCT00092417|743122|P2|Overall Study|Not Specified|0
227741|NCT00092417|743123|P1|Overall Study|Not Specified|1
227742|NCT00092417|743122|P2|Overall Study|Withdrawal by Subject|1
227743|NCT00092417|743123|P1|Overall Study|Withdrawal by Subject|2
227744|NCT00092417|743122|P2|Overall Study|Lost to Follow-up|0
227745|NCT00092417|743123|P1|Overall Study|Lost to Follow-up|2
227746|NCT00092131|743137|P2|Treatment Period II|Adverse Event|1
227747|NCT00092131|743138|P1|Treatment Period II|Adverse Event|0
227748|NCT00092131|743137|P2|Treatment Period I|Adverse Event|0
227749|NCT00092131|743138|P1|Treatment Period I|Adverse Event|1
227750|NCT00092118|743168|P2|Overall Study|Not Specified|5
227751|NCT00092118|743169|P1|Overall Study|Not Specified|6
227752|NCT00092118|743168|P2|Overall Study|Withdrawal by Subject|10
227753|NCT00092118|743169|P1|Overall Study|Withdrawal by Subject|4
227754|NCT00092118|743168|P2|Overall Study|Protocol Violation|25
227755|NCT00092118|743169|P1|Overall Study|Protocol Violation|23
227756|NCT00092118|743168|P2|Overall Study|Lost to Follow-up|3
227757|NCT00092118|743169|P1|Overall Study|Lost to Follow-up|4
227758|NCT00092118|743168|P2|Overall Study|Lack of Efficacy|14
227759|NCT00092118|743169|P1|Overall Study|Lack of Efficacy|12
227760|NCT00092118|743168|P2|Overall Study|Adverse Event|32
227761|NCT00092118|743169|P1|Overall Study|Adverse Event|35
227762|NCT00091949|743203|P2|Overall Study|Lost to Follow-up|41
227763|NCT00091949|743204|P1|Overall Study|Lost to Follow-up|58
227764|NCT00091949|743203|P2|Overall Study|Withdrawal by Subject|110
227765|NCT00091949|743204|P1|Overall Study|Withdrawal by Subject|117
227766|NCT00091832|743228|P6|Overall Study|Protocol Violation|1
227767|NCT00091832|743229|P5|Overall Study|Protocol Violation|0
227768|NCT00091832|743230|P4|Overall Study|Protocol Violation|0
227769|NCT00091832|743231|P3|Overall Study|Protocol Violation|1
227770|NCT00091832|743232|P2|Overall Study|Protocol Violation|0
227771|NCT00091832|743233|P1|Overall Study|Protocol Violation|0
227772|NCT00091832|743228|P6|Overall Study|Other|0
227773|NCT00091832|743229|P5|Overall Study|Other|0
227774|NCT00091832|743230|P4|Overall Study|Other|0
227775|NCT00091832|743231|P3|Overall Study|Other|2
227776|NCT00091832|743232|P2|Overall Study|Other|1
227777|NCT00091832|743233|P1|Overall Study|Other|0
227778|NCT00091832|743228|P6|Overall Study|Noncompliance|0
227779|NCT00091832|743229|P5|Overall Study|Noncompliance|0
227780|NCT00091832|743230|P4|Overall Study|Noncompliance|0
227781|NCT00091832|743231|P3|Overall Study|Noncompliance|0
227782|NCT00091832|743232|P2|Overall Study|Noncompliance|1
227783|NCT00091832|743233|P1|Overall Study|Noncompliance|0
227784|NCT00091832|743228|P6|Overall Study|Lost to Follow-up|1
227785|NCT00091832|743229|P5|Overall Study|Lost to Follow-up|2
227786|NCT00091832|743230|P4|Overall Study|Lost to Follow-up|3
227787|NCT00091832|743231|P3|Overall Study|Lost to Follow-up|3
227788|NCT00091832|743232|P2|Overall Study|Lost to Follow-up|0
227789|NCT00091832|743233|P1|Overall Study|Lost to Follow-up|1
227790|NCT00091832|743228|P6|Overall Study|Ineligibility Determined|0
227791|NCT00091832|743229|P5|Overall Study|Ineligibility Determined|1
227792|NCT00091832|743230|P4|Overall Study|Ineligibility Determined|0
227793|NCT00091832|743231|P3|Overall Study|Ineligibility Determined|1
227794|NCT00091832|743232|P2|Overall Study|Ineligibility Determined|0
227795|NCT00091832|743233|P1|Overall Study|Ineligibility Determined|0
227796|NCT00091832|743228|P6|Overall Study|Disease Progression|2
227797|NCT00091832|743229|P5|Overall Study|Disease Progression|1
227798|NCT00091832|743230|P4|Overall Study|Disease Progression|1
227799|NCT00091832|743231|P3|Overall Study|Disease Progression|0
227800|NCT00091832|743232|P2|Overall Study|Disease Progression|0
227801|NCT00091832|743233|P1|Overall Study|Disease Progression|2
227802|NCT00091832|743228|P6|Overall Study|Death|6
227803|NCT00091832|743229|P5|Overall Study|Death|5
227804|NCT00091832|743230|P4|Overall Study|Death|8
227805|NCT00091832|743231|P3|Overall Study|Death|5
227806|NCT00091832|743232|P2|Overall Study|Death|4
227807|NCT00091832|743233|P1|Overall Study|Death|6
227808|NCT00091832|743228|P6|Overall Study|Withdrawal by Subject|1
227809|NCT00091832|743229|P5|Overall Study|Withdrawal by Subject|3
227810|NCT00091832|743230|P4|Overall Study|Withdrawal by Subject|1
227811|NCT00091832|743231|P3|Overall Study|Withdrawal by Subject|0
227812|NCT00091832|743232|P2|Overall Study|Withdrawal by Subject|5
227813|NCT00091832|743233|P1|Overall Study|Withdrawal by Subject|4
227814|NCT00091832|743228|P6|Overall Study|Adverse Event|0
227815|NCT00091832|743229|P5|Overall Study|Adverse Event|3
227816|NCT00091832|743230|P4|Overall Study|Adverse Event|1
227817|NCT00091832|743231|P3|Overall Study|Adverse Event|0
227818|NCT00091832|743232|P2|Overall Study|Adverse Event|0
227819|NCT00091832|743233|P1|Overall Study|Adverse Event|0
227820|NCT00091832|743228|P6|Overall Study|Physician Decision|0
227821|NCT00091832|743229|P5|Overall Study|Physician Decision|0
227822|NCT00091832|743230|P4|Overall Study|Physician Decision|0
227823|NCT00091832|743231|P3|Overall Study|Physician Decision|0
227824|NCT00091832|743232|P2|Overall Study|Physician Decision|0
227825|NCT00091832|743233|P1|Overall Study|Physician Decision|1
227826|NCT00091819|743351|P2|Overall Study|Never received study treatment|4
227827|NCT00091819|743352|P1|Overall Study|Never received study treatment|3
227828|NCT00091819|743351|P2|Overall Study|Other|3
227829|NCT00091819|743352|P1|Overall Study|Other|2
227830|NCT00091819|743351|P2|Overall Study|Protocol Violation|2
227831|NCT00091819|743352|P1|Overall Study|Protocol Violation|1
227832|NCT00091819|743351|P2|Overall Study|Withdrawal by Subject|8
227833|NCT00091819|743352|P1|Overall Study|Withdrawal by Subject|5
227834|NCT00091819|743351|P2|Overall Study|Lost to Follow-up|23
227835|NCT00091819|743352|P1|Overall Study|Lost to Follow-up|26
227836|NCT00091819|743351|P2|Overall Study|Death|5
227837|NCT00091819|743352|P1|Overall Study|Death|4
227838|NCT00091819|743351|P2|Overall Study|Adverse Event|1
227839|NCT00091819|743352|P1|Overall Study|Adverse Event|1
227840|NCT00091793|743360|P2|Overall Study|Other|0
227841|NCT00091793|743361|P1|Overall Study|Other|2
227842|NCT00091793|743360|P2|Overall Study|Noncompliance|0
227843|NCT00091793|743361|P1|Overall Study|Noncompliance|2
227844|NCT00091793|743360|P2|Overall Study|Lost to Follow-up|5
227845|NCT00091793|743361|P1|Overall Study|Lost to Follow-up|7
227846|NCT00091793|743360|P2|Overall Study|Ineligibility determined|0
227847|NCT00091793|743361|P1|Overall Study|Ineligibility determined|2
227848|NCT00091793|743360|P2|Overall Study|Withdrawal by Subject|15
227849|NCT00091793|743361|P1|Overall Study|Withdrawal by Subject|10
227850|NCT00091793|743360|P2|Overall Study|Adverse Event|2
227851|NCT00091793|743361|P1|Overall Study|Adverse Event|1
227852|NCT00091572|743385|P2|Overall Study|Toxicity (Related AE)|9
227853|NCT00091572|743386|P1|Overall Study|Toxicity (Related AE)|53
227854|NCT00091572|743385|P2|Overall Study|Major Protocol Violation|0
227855|NCT00091572|743386|P1|Overall Study|Major Protocol Violation|2
227856|NCT00091572|743385|P2|Overall Study|Ongoing (still on treatment)|12
227857|NCT00091572|743386|P1|Overall Study|Ongoing (still on treatment)|8
227858|NCT00091572|743385|P2|Overall Study|Other Reason|13
227859|NCT00091572|743386|P1|Overall Study|Other Reason|6
227860|NCT00091572|743385|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
227861|NCT00091572|743386|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
227862|NCT00091572|743385|P2|Overall Study|Death not due to malignancy/toxicity|3
227863|NCT00091572|743386|P1|Overall Study|Death not due to malignancy/toxicity|1
227864|NCT00091572|743385|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
227865|NCT00091572|743386|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
227866|NCT00091572|743385|P2|Overall Study|Lost to Follow-up|1
227867|NCT00091572|743386|P1|Overall Study|Lost to Follow-up|1
227868|NCT00091442|743417|P2|Overall Study|Not Specified|6
227869|NCT00091442|743418|P1|Overall Study|Not Specified|2
227870|NCT00091442|743417|P2|Overall Study|Lost to Follow-up|3
227871|NCT00091442|743418|P1|Overall Study|Lost to Follow-up|1
227872|NCT00091442|743417|P2|Overall Study|Death|7
227873|NCT00091442|743418|P1|Overall Study|Death|9
227874|NCT00091442|743417|P2|Overall Study|2cycles therapy beyond Complete response|16
227875|NCT00091442|743418|P1|Overall Study|2cycles therapy beyond Complete response|9
227876|NCT00091442|743417|P2|Overall Study|Adverse Event|48
227877|NCT00091442|743418|P1|Overall Study|Adverse Event|29
227878|NCT00091442|743417|P2|Overall Study|Withdrawal by Subject|46
227879|NCT00091442|743418|P1|Overall Study|Withdrawal by Subject|38
227880|NCT00091442|743417|P2|Overall Study|Physician Decision|58
227881|NCT00091442|743418|P1|Overall Study|Physician Decision|61
227882|NCT00091442|743417|P2|Overall Study|Progressive Disease|189
227883|NCT00091442|743418|P1|Overall Study|Progressive Disease|220
227884|NCT00091390|743428|P1|Overall Study|Protocol Violation|2
227885|NCT00091390|743428|P1|Overall Study|Withdrawal by Subject|2
227886|NCT00091169|743446|P2|Overall Study|Not start protocol therapy|17
227887|NCT00091169|743447|P1|Overall Study|Not start protocol therapy|26
227888|NCT00091169|743446|P2|Overall Study|Other|4
227889|NCT00091169|743447|P1|Overall Study|Other|3
227890|NCT00091169|743446|P2|Overall Study|Withdrawal by Subject|13
227891|NCT00091169|743447|P1|Overall Study|Withdrawal by Subject|10
227892|NCT00091169|743446|P2|Overall Study|Death|1
227893|NCT00091169|743447|P1|Overall Study|Death|4
227894|NCT00091169|743446|P2|Overall Study|Adverse Event|17
227895|NCT00091169|743447|P1|Overall Study|Adverse Event|11
227896|NCT00091169|743446|P2|Overall Study|Disease progression|1
227897|NCT00091169|743447|P1|Overall Study|Disease progression|3
227898|NCT00091026|743465|P2|Overall Study|Unknown-never received treatment|1
227899|NCT00091026|743466|P1|Overall Study|Unknown-never received treatment|0
227900|NCT00091026|743465|P2|Overall Study|Patient withdrew and never received trea|2
227901|NCT00091026|743466|P1|Overall Study|Patient withdrew and never received trea|0
227902|NCT00091026|743465|P2|Overall Study|Patient deemed non eligible-never receiv|0
227903|NCT00091026|743466|P1|Overall Study|Patient deemed non eligible-never receiv|1
227904|NCT00090987|743476|P1|Overall Study|Incarcerated|1
227905|NCT00090987|743476|P1|Overall Study|Non-compliance|4
227906|NCT00090987|743476|P1|Overall Study|alternative therapy|1
227907|NCT00090987|743476|P1|Overall Study|Withdrawal by Subject|3
227908|NCT00090987|743476|P1|Overall Study|Lack of Efficacy|7
227909|NCT00090987|743476|P1|Overall Study|Adverse Event|5
227910|NCT00090857|743482|P2|Overall Study|Adverse Event|2
227911|NCT00090857|743483|P1|Overall Study|Adverse Event|2
227912|NCT00090857|743482|P2|Overall Study|Withdrawal by Subject|0
227913|NCT00090857|743483|P1|Overall Study|Withdrawal by Subject|2
227914|NCT00090857|743482|P2|Overall Study|Lost to Follow-up|1
227915|NCT00090857|743483|P1|Overall Study|Lost to Follow-up|0
227916|NCT00090779|743522|P2|Step 3|Off extended study due to study closure|3
227917|NCT00090779|743523|P1|Step 3|Off extended study due to study closure|4
227918|NCT00090779|743522|P2|Step 3|Initiation of ART and off extended study|2
227919|NCT00090779|743523|P1|Step 3|Initiation of ART and off extended study|3
227920|NCT00090779|743522|P2|Step 2|Non-compliance to study requirements|1
227921|NCT00090779|743523|P1|Step 2|Non-compliance to study requirements|0
227922|NCT00090779|743522|P2|Step 2|Subject relocated|1
227923|NCT00090779|743523|P1|Step 2|Subject relocated|0
227924|NCT00090779|743522|P2|Step 2|Off study per study closure|16
227925|NCT00090779|743523|P1|Step 2|Off study per study closure|6
227926|NCT00090779|743522|P2|Step 1|Subject relocated|8
227927|NCT00090779|743523|P1|Step 1|Subject relocated|2
227928|NCT00090779|743522|P2|Step 1|Non-compliance to study requirements|1
227929|NCT00090779|743523|P1|Step 1|Non-compliance to study requirements|0
227930|NCT00090779|743522|P2|Step 1|Pregnancy|0
227931|NCT00090779|743523|P1|Step 1|Pregnancy|1
227932|NCT00090779|743522|P2|Step 1|Physician Decision|0
227933|NCT00090779|743523|P1|Step 1|Physician Decision|1
227934|NCT00090779|743522|P2|Step 1|Death|2
227935|NCT00090779|743523|P1|Step 1|Death|0
227936|NCT00090779|743522|P2|Step 1|Lost to Follow-up|2
227937|NCT00090779|743523|P1|Step 1|Lost to Follow-up|3
227938|NCT00090779|743522|P2|Step 1|Withdrawal by Subject|2
227939|NCT00090779|743523|P1|Step 1|Withdrawal by Subject|4
227940|NCT00090766|743547|P3|Overall Study|Lost to Follow-up|2
227941|NCT00090766|743548|P2|Overall Study|Lost to Follow-up|0
227942|NCT00090766|743549|P1|Overall Study|Lost to Follow-up|2
227943|NCT00090766|743547|P3|Overall Study|Admin|0
227944|NCT00090766|743548|P2|Overall Study|Admin|2
227945|NCT00090766|743549|P1|Overall Study|Admin|0
227946|NCT00090766|743547|P3|Overall Study|Death|0
227947|NCT00090766|743548|P2|Overall Study|Death|0
227948|NCT00090766|743549|P1|Overall Study|Death|1
227949|NCT00090766|743547|P3|Overall Study|Nephrectomy Planned|1
227950|NCT00090766|743548|P2|Overall Study|Nephrectomy Planned|0
227951|NCT00090766|743549|P1|Overall Study|Nephrectomy Planned|0
227952|NCT00090753|743591|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
227953|NCT00090753|743592|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
227954|NCT00090753|743591|P2|Extended Treatment Period|Mircera Commercialization|93
227955|NCT00090753|743592|P1|Extended Treatment Period|Mircera Commercialization|188
227956|NCT00090753|743591|P2|Extended Treatment Period|Renal Transplant|12
227957|NCT00090753|743592|P1|Extended Treatment Period|Renal Transplant|15
227958|NCT00090753|743591|P2|Extended Treatment Period|Lost to Follow-up|1
227959|NCT00090753|743592|P1|Extended Treatment Period|Lost to Follow-up|3
227960|NCT00090753|743591|P2|Extended Treatment Period|Refused Treatment|12
227961|NCT00090753|743592|P1|Extended Treatment Period|Refused Treatment|18
227962|NCT00090753|743591|P2|Extended Treatment Period|Lack of Efficacy|0
227963|NCT00090753|743592|P1|Extended Treatment Period|Lack of Efficacy|1
227964|NCT00090753|743591|P2|Extended Treatment Period|Death|30
227965|NCT00090753|743592|P1|Extended Treatment Period|Death|58
227966|NCT00090753|743591|P2|Extended Treatment Period|Adverse Event|0
227967|NCT00090753|743592|P1|Extended Treatment Period|Adverse Event|11
227968|NCT00090753|743591|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
227969|NCT00090753|743592|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
227970|NCT00090753|743591|P2|First Treatment Period|Mircera Commercialization|0
227971|NCT00090753|743592|P1|First Treatment Period|Mircera Commercialization|1
227972|NCT00090753|743591|P2|First Treatment Period|Renal Transplant|50
227973|NCT00090753|743592|P1|First Treatment Period|Renal Transplant|70
227974|NCT00090753|743591|P2|First Treatment Period|Lost to Follow-up|4
227975|NCT00090753|743592|P1|First Treatment Period|Lost to Follow-up|4
227976|NCT00090753|743591|P2|First Treatment Period|Refused Treatment|25
227977|NCT00090753|743592|P1|First Treatment Period|Refused Treatment|32
227978|NCT00090753|743591|P2|First Treatment Period|Lack of Efficacy|1
227979|NCT00090753|743592|P1|First Treatment Period|Lack of Efficacy|2
227980|NCT00090753|743591|P2|First Treatment Period|Death|62
227981|NCT00090753|743592|P1|First Treatment Period|Death|88
227982|NCT00090753|743591|P2|First Treatment Period|Adverse Event|8
227983|NCT00090753|743592|P1|First Treatment Period|Adverse Event|20
227984|NCT00090610|743602|P2|Overall Study|Withdrawal by Subject|1
227985|NCT00090610|743603|P1|Overall Study|Withdrawal by Subject|1
227986|NCT00090584|743619|P2|Baseline to 8 Months|Lost to Follow-up|41
227987|NCT00090584|743620|P1|Baseline to 8 Months|Lost to Follow-up|44
227988|NCT00090584|743619|P2|Baseline to 10 Weeks|Lost to Follow-up|12
227989|NCT00090584|743620|P1|Baseline to 10 Weeks|Lost to Follow-up|15
227990|NCT00090519|743652|P2|Overall Study|Sponsor Decision|1
227991|NCT00090519|743653|P1|Overall Study|Sponsor Decision|3
227992|NCT00090519|743652|P2|Overall Study|Physician Decision|3
227993|NCT00090519|743653|P1|Overall Study|Physician Decision|2
227994|NCT00090519|743652|P2|Overall Study|Withdrawal by Subject|29
227995|NCT00090519|743653|P1|Overall Study|Withdrawal by Subject|28
227996|NCT00090519|743652|P2|Overall Study|Lost to Follow-up|29
227997|NCT00090519|743653|P1|Overall Study|Lost to Follow-up|26
227998|NCT00090519|743652|P2|Overall Study|Death|9
227999|NCT00090519|743653|P1|Overall Study|Death|9
228000|NCT00090519|743652|P2|Overall Study|Adverse Event|4
228001|NCT00090519|743653|P1|Overall Study|Adverse Event|5
228002|NCT00090493|743677|P1|Overall Study|Physician Decision|2
228003|NCT00090363|743684|P3|Overall Study|Continuing on study off treatment|16
228004|NCT00090363|743685|P2|Overall Study|Continuing on study off treatment|13
228005|NCT00090363|743686|P1|Overall Study|Continuing on study off treatment|14
228006|NCT00090363|743684|P3|Overall Study|Reasons not specified|1
228007|NCT00090363|743685|P2|Overall Study|Reasons not specified|1
228008|NCT00090363|743686|P1|Overall Study|Reasons not specified|2
228009|NCT00090363|743684|P3|Overall Study|Consent expired|9
228010|NCT00090363|743685|P2|Overall Study|Consent expired|10
228011|NCT00090363|743686|P1|Overall Study|Consent expired|7
228012|NCT00090363|743684|P3|Overall Study|Eligibility criteria not fulfilled|1
228013|NCT00090363|743685|P2|Overall Study|Eligibility criteria not fulfilled|0
228014|NCT00090363|743686|P1|Overall Study|Eligibility criteria not fulfilled|0
228015|NCT00090363|743684|P3|Overall Study|Study-specific discontinuation criteria|62
228016|NCT00090363|743685|P2|Overall Study|Study-specific discontinuation criteria|74
228017|NCT00090363|743686|P1|Overall Study|Study-specific discontinuation criteria|75
228018|NCT00090363|743684|P3|Overall Study|Withdrawal by Subject|6
228019|NCT00090363|743685|P2|Overall Study|Withdrawal by Subject|7
228020|NCT00090363|743686|P1|Overall Study|Withdrawal by Subject|7
228021|NCT00090363|743684|P3|Overall Study|Lost to Follow-up|1
228022|NCT00090363|743685|P2|Overall Study|Lost to Follow-up|2
228023|NCT00090363|743686|P1|Overall Study|Lost to Follow-up|1
228024|NCT00090545|743708|P2|Overall Study|Adverse Event|2
228025|NCT00090545|743709|P1|Overall Study|Adverse Event|0
228026|NCT00090545|743708|P2|Overall Study|Death|1
228027|NCT00090545|743709|P1|Overall Study|Death|0
228028|NCT00090545|743708|P2|Overall Study|Refused further treatment|4
228029|NCT00090545|743709|P1|Overall Study|Refused further treatment|1
228030|NCT00090545|743708|P2|Overall Study|Disease progression on study|17
228031|NCT00090545|743709|P1|Overall Study|Disease progression on study|21
228032|NCT00090285|743719|P6|Long-term Follow-up (EXT2)|Physician Decision|5
228033|NCT00090285|743720|P5|Long-term Follow-up (EXT2)|Physician Decision|6
228034|NCT00090285|743721|P4|Long-term Follow-up (EXT2)|Physician Decision|0
228035|NCT00090285|743722|P3|Long-term Follow-up (EXT2)|Physician Decision|0
228036|NCT00090285|743723|P2|Long-term Follow-up (EXT2)|Physician Decision|0
228037|NCT00090285|743724|P1|Long-term Follow-up (EXT2)|Physician Decision|0
228038|NCT00090285|743719|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
228039|NCT00090285|743720|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
228040|NCT00090285|743721|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
228041|NCT00090285|743722|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
228042|NCT00090285|743723|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
228043|NCT00090285|743724|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
228044|NCT00090285|743719|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
228045|NCT00090285|743720|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
228046|NCT00090285|743721|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
228047|NCT00090285|743722|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
228048|NCT00090285|743723|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
228049|NCT00090285|743724|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
228050|NCT00090285|743719|P6|Long-term Follow-up (EXT2)|Adverse Event|2
228051|NCT00090285|743720|P5|Long-term Follow-up (EXT2)|Adverse Event|5
228052|NCT00090285|743721|P4|Long-term Follow-up (EXT2)|Adverse Event|0
228053|NCT00090285|743722|P3|Long-term Follow-up (EXT2)|Adverse Event|0
228054|NCT00090285|743723|P2|Long-term Follow-up (EXT2)|Adverse Event|0
228055|NCT00090285|743724|P1|Long-term Follow-up (EXT2)|Adverse Event|0
228056|NCT00090285|743719|P6|Extension 1|Moved|0
228057|NCT00090285|743720|P5|Extension 1|Moved|0
228058|NCT00090285|743721|P4|Extension 1|Moved|0
228059|NCT00090285|743722|P3|Extension 1|Moved|3
228060|NCT00090285|743723|P2|Extension 1|Moved|0
228061|NCT00090285|743724|P1|Extension 1|Moved|0
228062|NCT00090285|743719|P6|Extension 1|Other|0
228063|NCT00090285|743720|P5|Extension 1|Other|0
228064|NCT00090285|743721|P4|Extension 1|Other|0
228065|NCT00090285|743722|P3|Extension 1|Other|4
228066|NCT00090285|743723|P2|Extension 1|Other|0
228067|NCT00090285|743724|P1|Extension 1|Other|0
228068|NCT00090285|743719|P6|Extension 1|Withdrawal by Subject|0
228069|NCT00090285|743720|P5|Extension 1|Withdrawal by Subject|0
228070|NCT00090285|743721|P4|Extension 1|Withdrawal by Subject|1
228071|NCT00090285|743722|P3|Extension 1|Withdrawal by Subject|13
228072|NCT00090285|743723|P2|Extension 1|Withdrawal by Subject|0
228073|NCT00090285|743724|P1|Extension 1|Withdrawal by Subject|0
228074|NCT00090285|743719|P6|Extension 1|Lost to Follow-up|0
228075|NCT00090285|743720|P5|Extension 1|Lost to Follow-up|0
228076|NCT00090285|743721|P4|Extension 1|Lost to Follow-up|0
228077|NCT00090285|743722|P3|Extension 1|Lost to Follow-up|35
228078|NCT00090285|743723|P2|Extension 1|Lost to Follow-up|0
228079|NCT00090285|743724|P1|Extension 1|Lost to Follow-up|0
228080|NCT00090285|743719|P6|Extension 1|Adverse Event|0
228081|NCT00090285|743720|P5|Extension 1|Adverse Event|0
228082|NCT00090285|743721|P4|Extension 1|Adverse Event|0
228083|NCT00090285|743722|P3|Extension 1|Adverse Event|2
228084|NCT00090285|743723|P2|Extension 1|Adverse Event|0
228085|NCT00090285|743724|P1|Extension 1|Adverse Event|0
228086|NCT00090285|743719|P6|Base Study Follow-up Period|Subject Incarcerated|0
228087|NCT00090285|743720|P5|Base Study Follow-up Period|Subject Incarcerated|0
228088|NCT00090285|743721|P4|Base Study Follow-up Period|Subject Incarcerated|0
228089|NCT00090285|743722|P3|Base Study Follow-up Period|Subject Incarcerated|0
228090|NCT00090285|743723|P2|Base Study Follow-up Period|Subject Incarcerated|2
228091|NCT00090285|743724|P1|Base Study Follow-up Period|Subject Incarcerated|0
228092|NCT00090285|743719|P6|Base Study Follow-up Period|Uncooperative|0
228093|NCT00090285|743720|P5|Base Study Follow-up Period|Uncooperative|0
228094|NCT00090285|743721|P4|Base Study Follow-up Period|Uncooperative|0
228095|NCT00090285|743722|P3|Base Study Follow-up Period|Uncooperative|0
228096|NCT00090285|743723|P2|Base Study Follow-up Period|Uncooperative|4
228097|NCT00090285|743724|P1|Base Study Follow-up Period|Uncooperative|3
228098|NCT00090285|743719|P6|Base Study Follow-up Period|Protocol Violation|0
228099|NCT00090285|743720|P5|Base Study Follow-up Period|Protocol Violation|0
228100|NCT00090285|743721|P4|Base Study Follow-up Period|Protocol Violation|0
228101|NCT00090285|743722|P3|Base Study Follow-up Period|Protocol Violation|0
228102|NCT00090285|743723|P2|Base Study Follow-up Period|Protocol Violation|0
228103|NCT00090285|743724|P1|Base Study Follow-up Period|Protocol Violation|1
228104|NCT00090285|743719|P6|Base Study Follow-up Period|Other|0
228105|NCT00090285|743720|P5|Base Study Follow-up Period|Other|0
228106|NCT00090285|743721|P4|Base Study Follow-up Period|Other|0
228107|NCT00090285|743722|P3|Base Study Follow-up Period|Other|0
228108|NCT00090285|743723|P2|Base Study Follow-up Period|Other|0
228109|NCT00090285|743724|P1|Base Study Follow-up Period|Other|2
228110|NCT00090285|743719|P6|Base Study Follow-up Period|Moved|0
228111|NCT00090285|743720|P5|Base Study Follow-up Period|Moved|0
228112|NCT00090285|743721|P4|Base Study Follow-up Period|Moved|0
228113|NCT00090285|743722|P3|Base Study Follow-up Period|Moved|0
228114|NCT00090285|743723|P2|Base Study Follow-up Period|Moved|36
228115|NCT00090285|743724|P1|Base Study Follow-up Period|Moved|41
228116|NCT00090285|743719|P6|Base Study Follow-up Period|Withdrawal by Subject|0
228117|NCT00090285|743720|P5|Base Study Follow-up Period|Withdrawal by Subject|0
228118|NCT00090285|743721|P4|Base Study Follow-up Period|Withdrawal by Subject|0
228119|NCT00090285|743722|P3|Base Study Follow-up Period|Withdrawal by Subject|0
228120|NCT00090285|743723|P2|Base Study Follow-up Period|Withdrawal by Subject|64
228121|NCT00090285|743724|P1|Base Study Follow-up Period|Withdrawal by Subject|53
228122|NCT00090285|743719|P6|Base Study Follow-up Period|Lost to Follow-up|0
228123|NCT00090285|743720|P5|Base Study Follow-up Period|Lost to Follow-up|0
228124|NCT00090285|743721|P4|Base Study Follow-up Period|Lost to Follow-up|0
228125|NCT00090285|743722|P3|Base Study Follow-up Period|Lost to Follow-up|0
228126|NCT00090285|743723|P2|Base Study Follow-up Period|Lost to Follow-up|226
228127|NCT00090285|743724|P1|Base Study Follow-up Period|Lost to Follow-up|232
228128|NCT00090285|743719|P6|Base Study Follow-up Period|Adverse Event|0
228129|NCT00090285|743720|P5|Base Study Follow-up Period|Adverse Event|0
228130|NCT00090285|743721|P4|Base Study Follow-up Period|Adverse Event|0
228131|NCT00090285|743722|P3|Base Study Follow-up Period|Adverse Event|0
228132|NCT00090285|743723|P2|Base Study Follow-up Period|Adverse Event|10
228133|NCT00090285|743724|P1|Base Study Follow-up Period|Adverse Event|3
228134|NCT00090285|743719|P6|Base Study Vaccination Period|HIV positive|0
228135|NCT00090285|743720|P5|Base Study Vaccination Period|HIV positive|0
228136|NCT00090285|743721|P4|Base Study Vaccination Period|HIV positive|0
228137|NCT00090285|743722|P3|Base Study Vaccination Period|HIV positive|0
228138|NCT00090285|743723|P2|Base Study Vaccination Period|HIV positive|1
228139|NCT00090285|743724|P1|Base Study Vaccination Period|HIV positive|1
228140|NCT00090285|743719|P6|Base Study Vaccination Period|Subject Incarcerated|0
228141|NCT00090285|743720|P5|Base Study Vaccination Period|Subject Incarcerated|0
228142|NCT00090285|743721|P4|Base Study Vaccination Period|Subject Incarcerated|0
228143|NCT00090285|743722|P3|Base Study Vaccination Period|Subject Incarcerated|0
228144|NCT00090285|743723|P2|Base Study Vaccination Period|Subject Incarcerated|2
228145|NCT00090285|743724|P1|Base Study Vaccination Period|Subject Incarcerated|2
228146|NCT00090285|743719|P6|Base Study Vaccination Period|Other|0
228147|NCT00090285|743720|P5|Base Study Vaccination Period|Other|0
228148|NCT00090285|743721|P4|Base Study Vaccination Period|Other|0
228149|NCT00090285|743722|P3|Base Study Vaccination Period|Other|0
228150|NCT00090285|743723|P2|Base Study Vaccination Period|Other|2
228151|NCT00090285|743724|P1|Base Study Vaccination Period|Other|2
228152|NCT00090285|743719|P6|Base Study Vaccination Period|Site Terminated|0
228153|NCT00090285|743720|P5|Base Study Vaccination Period|Site Terminated|0
228154|NCT00090285|743721|P4|Base Study Vaccination Period|Site Terminated|0
228155|NCT00090285|743722|P3|Base Study Vaccination Period|Site Terminated|0
228156|NCT00090285|743723|P2|Base Study Vaccination Period|Site Terminated|0
228157|NCT00090285|743724|P1|Base Study Vaccination Period|Site Terminated|1
228158|NCT00090285|743719|P6|Base Study Vaccination Period|Moved|0
228159|NCT00090285|743720|P5|Base Study Vaccination Period|Moved|0
228160|NCT00090285|743721|P4|Base Study Vaccination Period|Moved|0
228161|NCT00090285|743722|P3|Base Study Vaccination Period|Moved|0
228162|NCT00090285|743723|P2|Base Study Vaccination Period|Moved|21
228163|NCT00090285|743724|P1|Base Study Vaccination Period|Moved|20
228164|NCT00090285|743719|P6|Base Study Vaccination Period|Uncooperative|0
228165|NCT00090285|743720|P5|Base Study Vaccination Period|Uncooperative|0
228166|NCT00090285|743721|P4|Base Study Vaccination Period|Uncooperative|0
228167|NCT00090285|743722|P3|Base Study Vaccination Period|Uncooperative|0
228168|NCT00090285|743723|P2|Base Study Vaccination Period|Uncooperative|2
228169|NCT00090285|743724|P1|Base Study Vaccination Period|Uncooperative|2
228170|NCT00090285|743719|P6|Base Study Vaccination Period|Withdrawal by Subject|0
228171|NCT00090285|743720|P5|Base Study Vaccination Period|Withdrawal by Subject|0
228172|NCT00090285|743721|P4|Base Study Vaccination Period|Withdrawal by Subject|0
228173|NCT00090285|743722|P3|Base Study Vaccination Period|Withdrawal by Subject|0
228174|NCT00090285|743723|P2|Base Study Vaccination Period|Withdrawal by Subject|69
228175|NCT00090285|743724|P1|Base Study Vaccination Period|Withdrawal by Subject|64
228176|NCT00090285|743719|P6|Base Study Vaccination Period|Protocol Violation|0
228177|NCT00090285|743720|P5|Base Study Vaccination Period|Protocol Violation|0
228178|NCT00090285|743721|P4|Base Study Vaccination Period|Protocol Violation|0
228179|NCT00090285|743722|P3|Base Study Vaccination Period|Protocol Violation|0
228180|NCT00090285|743723|P2|Base Study Vaccination Period|Protocol Violation|3
228181|NCT00090285|743724|P1|Base Study Vaccination Period|Protocol Violation|2
228182|NCT00090285|743719|P6|Base Study Vaccination Period|Lost to Follow-up|0
228183|NCT00090285|743720|P5|Base Study Vaccination Period|Lost to Follow-up|0
228184|NCT00090285|743721|P4|Base Study Vaccination Period|Lost to Follow-up|0
228185|NCT00090285|743722|P3|Base Study Vaccination Period|Lost to Follow-up|0
228186|NCT00090285|743723|P2|Base Study Vaccination Period|Lost to Follow-up|112
228187|NCT00090285|743724|P1|Base Study Vaccination Period|Lost to Follow-up|111
228188|NCT00090285|743719|P6|Base Study Vaccination Period|Adverse Event|0
228189|NCT00090285|743720|P5|Base Study Vaccination Period|Adverse Event|0
228190|NCT00090285|743721|P4|Base Study Vaccination Period|Adverse Event|0
228191|NCT00090285|743722|P3|Base Study Vaccination Period|Adverse Event|0
228192|NCT00090285|743723|P2|Base Study Vaccination Period|Adverse Event|4
228193|NCT00090285|743724|P1|Base Study Vaccination Period|Adverse Event|2
228194|NCT00090285|743719|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
228195|NCT00090285|743720|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
228196|NCT00090285|743721|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
228197|NCT00090285|743722|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
228198|NCT00090285|743723|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
228199|NCT00090285|743724|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
228200|NCT00090259|743761|P2|Overall Study|Investigator site closed|7
228201|NCT00090259|743762|P1|Overall Study|Investigator site closed|11
228202|NCT00090259|743761|P2|Overall Study|Withdrawal by Subject|15
228203|NCT00090259|743762|P1|Overall Study|Withdrawal by Subject|21
228204|NCT00090259|743761|P2|Overall Study|Lost to Follow-up|26
228205|NCT00090259|743762|P1|Overall Study|Lost to Follow-up|30
228206|NCT00090233|743778|P2|Overall Study|Data not available at data cut-off point|1563
228207|NCT00090233|743779|P1|Overall Study|Data not available at data cut-off point|1552
228208|NCT00090233|743778|P2|Overall Study|Not Specified|1160
228209|NCT00090233|743779|P1|Overall Study|Not Specified|1211
228210|NCT00090233|743778|P2|Overall Study|Moved|189
228211|NCT00090233|743779|P1|Overall Study|Moved|203
228212|NCT00090233|743778|P2|Overall Study|Withdrawal by Subject|211
228213|NCT00090233|743779|P1|Overall Study|Withdrawal by Subject|182
228214|NCT00090233|743778|P2|Overall Study|Protocol Violation|1022
228215|NCT00090233|743779|P1|Overall Study|Protocol Violation|960
228216|NCT00090233|743778|P2|Overall Study|Lost to Follow-up|95
228217|NCT00090233|743779|P1|Overall Study|Lost to Follow-up|68
228218|NCT00090233|743778|P2|Overall Study|Adverse Event|198
228219|NCT00090233|743779|P1|Overall Study|Adverse Event|214
228220|NCT00090233|743778|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
228221|NCT00090233|743779|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
228222|NCT00090220|743803|P6|Long-term Follow-up (EXT2)|Other|0
228223|NCT00090220|743804|P5|Long-term Follow-up (EXT2)|Other|1
228224|NCT00090220|743805|P4|Long-term Follow-up (EXT2)|Other|0
228225|NCT00090220|743806|P3|Long-term Follow-up (EXT2)|Other|0
228226|NCT00090220|743807|P2|Long-term Follow-up (EXT2)|Other|0
228227|NCT00090220|743808|P1|Long-term Follow-up (EXT2)|Other|0
228228|NCT00090220|743803|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
228229|NCT00090220|743804|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
228230|NCT00090220|743805|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
228231|NCT00090220|743806|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
228232|NCT00090220|743807|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
228233|NCT00090220|743808|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
228234|NCT00090220|743803|P6|Long-term Follow-up (EXT2)|Death|1
228235|NCT00090220|743804|P5|Long-term Follow-up (EXT2)|Death|1
228236|NCT00090220|743805|P4|Long-term Follow-up (EXT2)|Death|0
228237|NCT00090220|743806|P3|Long-term Follow-up (EXT2)|Death|0
228238|NCT00090220|743807|P2|Long-term Follow-up (EXT2)|Death|0
228239|NCT00090220|743808|P1|Long-term Follow-up (EXT2)|Death|0
228240|NCT00090220|743803|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
228241|NCT00090220|743804|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
228242|NCT00090220|743805|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
228243|NCT00090220|743806|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
228244|NCT00090220|743807|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
228245|NCT00090220|743808|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
228246|NCT00090220|743803|P6|Extension 1 (EXT1)|Other reason|0
228247|NCT00090220|743804|P5|Extension 1 (EXT1)|Other reason|0
228248|NCT00090220|743805|P4|Extension 1 (EXT1)|Other reason|0
228249|NCT00090220|743806|P3|Extension 1 (EXT1)|Other reason|2
228250|NCT00090220|743807|P2|Extension 1 (EXT1)|Other reason|0
228251|NCT00090220|743808|P1|Extension 1 (EXT1)|Other reason|0
228252|NCT00090220|743803|P6|Extension 1 (EXT1)|Protocol Violation|0
228253|NCT00090220|743804|P5|Extension 1 (EXT1)|Protocol Violation|0
228254|NCT00090220|743805|P4|Extension 1 (EXT1)|Protocol Violation|1
228255|NCT00090220|743806|P3|Extension 1 (EXT1)|Protocol Violation|0
228256|NCT00090220|743807|P2|Extension 1 (EXT1)|Protocol Violation|0
228257|NCT00090220|743808|P1|Extension 1 (EXT1)|Protocol Violation|0
228258|NCT00090220|743803|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
228259|NCT00090220|743804|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
228260|NCT00090220|743805|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
228261|NCT00090220|743806|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
228262|NCT00090220|743807|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
228263|NCT00090220|743808|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
228264|NCT00090220|743803|P6|Extension 1 (EXT1)|Moved|0
228265|NCT00090220|743804|P5|Extension 1 (EXT1)|Moved|0
228266|NCT00090220|743805|P4|Extension 1 (EXT1)|Moved|1
228267|NCT00090220|743806|P3|Extension 1 (EXT1)|Moved|2
228268|NCT00090220|743807|P2|Extension 1 (EXT1)|Moved|0
228269|NCT00090220|743808|P1|Extension 1 (EXT1)|Moved|0
228270|NCT00090220|743803|P6|Extension 1 (EXT1)|Lost to Follow-up|0
228271|NCT00090220|743804|P5|Extension 1 (EXT1)|Lost to Follow-up|0
228272|NCT00090220|743805|P4|Extension 1 (EXT1)|Lost to Follow-up|0
228273|NCT00090220|743806|P3|Extension 1 (EXT1)|Lost to Follow-up|22
228274|NCT00090220|743807|P2|Extension 1 (EXT1)|Lost to Follow-up|0
228275|NCT00090220|743808|P1|Extension 1 (EXT1)|Lost to Follow-up|0
228276|NCT00090220|743803|P6|Extension 1 (EXT1)|Adverse Event|0
228277|NCT00090220|743804|P5|Extension 1 (EXT1)|Adverse Event|0
228278|NCT00090220|743805|P4|Extension 1 (EXT1)|Adverse Event|0
228279|NCT00090220|743806|P3|Extension 1 (EXT1)|Adverse Event|4
228280|NCT00090220|743807|P2|Extension 1 (EXT1)|Adverse Event|0
228281|NCT00090220|743808|P1|Extension 1 (EXT1)|Adverse Event|0
228282|NCT00090220|743803|P6|Base Study Follow-up Period|Other|0
228283|NCT00090220|743804|P5|Base Study Follow-up Period|Other|0
228284|NCT00090220|743805|P4|Base Study Follow-up Period|Other|0
228285|NCT00090220|743806|P3|Base Study Follow-up Period|Other|0
228286|NCT00090220|743807|P2|Base Study Follow-up Period|Other|21
228287|NCT00090220|743808|P1|Base Study Follow-up Period|Other|19
228288|NCT00090220|743803|P6|Base Study Follow-up Period|Patient Moved|0
228289|NCT00090220|743804|P5|Base Study Follow-up Period|Patient Moved|0
228290|NCT00090220|743805|P4|Base Study Follow-up Period|Patient Moved|0
228291|NCT00090220|743806|P3|Base Study Follow-up Period|Patient Moved|0
228292|NCT00090220|743807|P2|Base Study Follow-up Period|Patient Moved|28
228293|NCT00090220|743808|P1|Base Study Follow-up Period|Patient Moved|20
228294|NCT00090220|743803|P6|Base Study Follow-up Period|Withdrawal by Subject|0
228295|NCT00090220|743804|P5|Base Study Follow-up Period|Withdrawal by Subject|0
228296|NCT00090220|743805|P4|Base Study Follow-up Period|Withdrawal by Subject|0
228297|NCT00090220|743806|P3|Base Study Follow-up Period|Withdrawal by Subject|0
228298|NCT00090220|743807|P2|Base Study Follow-up Period|Withdrawal by Subject|36
228299|NCT00090220|743808|P1|Base Study Follow-up Period|Withdrawal by Subject|27
228300|NCT00090220|743803|P6|Base Study Follow-up Period|Lost to Follow-up|0
228301|NCT00090220|743804|P5|Base Study Follow-up Period|Lost to Follow-up|0
228302|NCT00090220|743805|P4|Base Study Follow-up Period|Lost to Follow-up|0
228303|NCT00090220|743806|P3|Base Study Follow-up Period|Lost to Follow-up|0
228304|NCT00090220|743807|P2|Base Study Follow-up Period|Lost to Follow-up|78
228305|NCT00090220|743808|P1|Base Study Follow-up Period|Lost to Follow-up|88
228306|NCT00090220|743803|P6|Base Study Follow-up Period|Adverse Event|0
228307|NCT00090220|743804|P5|Base Study Follow-up Period|Adverse Event|0
228308|NCT00090220|743805|P4|Base Study Follow-up Period|Adverse Event|0
228309|NCT00090220|743806|P3|Base Study Follow-up Period|Adverse Event|0
228310|NCT00090220|743807|P2|Base Study Follow-up Period|Adverse Event|1
228311|NCT00090220|743808|P1|Base Study Follow-up Period|Adverse Event|6
228312|NCT00090220|743803|P6|Base Study Vaccination Period|Other|0
228313|NCT00090220|743804|P5|Base Study Vaccination Period|Other|0
228314|NCT00090220|743805|P4|Base Study Vaccination Period|Other|0
228315|NCT00090220|743806|P3|Base Study Vaccination Period|Other|0
228316|NCT00090220|743807|P2|Base Study Vaccination Period|Other|4
228317|NCT00090220|743808|P1|Base Study Vaccination Period|Other|4
228318|NCT00090220|743803|P6|Base Study Vaccination Period|Patient Moved|0
228319|NCT00090220|743804|P5|Base Study Vaccination Period|Patient Moved|0
228320|NCT00090220|743805|P4|Base Study Vaccination Period|Patient Moved|0
228321|NCT00090220|743806|P3|Base Study Vaccination Period|Patient Moved|0
228322|NCT00090220|743807|P2|Base Study Vaccination Period|Patient Moved|2
228323|NCT00090220|743808|P1|Base Study Vaccination Period|Patient Moved|6
228324|NCT00090220|743803|P6|Base Study Vaccination Period|Withdrawal by Subject|0
228325|NCT00090220|743804|P5|Base Study Vaccination Period|Withdrawal by Subject|0
228326|NCT00090220|743805|P4|Base Study Vaccination Period|Withdrawal by Subject|0
228327|NCT00090220|743806|P3|Base Study Vaccination Period|Withdrawal by Subject|0
228328|NCT00090220|743807|P2|Base Study Vaccination Period|Withdrawal by Subject|27
228329|NCT00090220|743808|P1|Base Study Vaccination Period|Withdrawal by Subject|23
228330|NCT00090220|743803|P6|Base Study Vaccination Period|Lost to Follow-up|0
228331|NCT00090220|743804|P5|Base Study Vaccination Period|Lost to Follow-up|0
228332|NCT00090220|743805|P4|Base Study Vaccination Period|Lost to Follow-up|0
228333|NCT00090220|743806|P3|Base Study Vaccination Period|Lost to Follow-up|0
228334|NCT00090220|743807|P2|Base Study Vaccination Period|Lost to Follow-up|28
228335|NCT00090220|743808|P1|Base Study Vaccination Period|Lost to Follow-up|24
228336|NCT00090220|743803|P6|Base Study Vaccination Period|Adverse Event|0
228337|NCT00090220|743804|P5|Base Study Vaccination Period|Adverse Event|0
228338|NCT00090220|743805|P4|Base Study Vaccination Period|Adverse Event|0
228339|NCT00090220|743806|P3|Base Study Vaccination Period|Adverse Event|0
228340|NCT00090220|743807|P2|Base Study Vaccination Period|Adverse Event|1
228341|NCT00090220|743808|P1|Base Study Vaccination Period|Adverse Event|6
228342|NCT00090220|743803|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
228343|NCT00090220|743804|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
228344|NCT00090220|743805|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
228345|NCT00090220|743806|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
228346|NCT00090220|743807|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
228347|NCT00090220|743808|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
228348|NCT00090402|743903|P3|Overall Study|stopped taking study medication|1
228349|NCT00090402|743904|P2|Overall Study|stopped taking study medication|0
228350|NCT00090402|743905|P1|Overall Study|stopped taking study medication|1
228351|NCT00090402|743903|P3|Overall Study|subject moved|0
228352|NCT00090402|743904|P2|Overall Study|subject moved|1
228353|NCT00090402|743905|P1|Overall Study|subject moved|0
228354|NCT00090402|743903|P3|Overall Study|Death|0
228355|NCT00090402|743904|P2|Overall Study|Death|1
228356|NCT00090402|743905|P1|Overall Study|Death|1
228357|NCT00090142|743919|P2|Treatment Period II|Not Specified|0
228358|NCT00090142|743920|P1|Treatment Period II|Not Specified|1
228359|NCT00090142|743919|P2|Treatment Period I|Not Specified|1
228360|NCT00090142|743920|P1|Treatment Period I|Not Specified|0
228361|NCT00090142|743919|P2|Treatment Period I|Withdrawal by Subject|0
228362|NCT00090142|743920|P1|Treatment Period I|Withdrawal by Subject|2
228363|NCT00090142|743919|P2|Treatment Period I|Protocol Violation|0
228364|NCT00090142|743920|P1|Treatment Period I|Protocol Violation|2
228365|NCT00090142|743919|P2|Treatment Period I|Lost to Follow-up|2
228366|NCT00090142|743920|P1|Treatment Period I|Lost to Follow-up|1
228367|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Other|0
228368|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Other|1
228369|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Other|0
228370|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Jailed|0
228371|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Jailed|1
228372|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Jailed|0
228373|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
228374|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
228375|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
228376|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Depression|0
228377|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Depression|1
228378|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Depression|0
228379|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
228380|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
228381|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
228382|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
228383|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
228384|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
228385|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Back Pain|0
228386|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Back Pain|1
228387|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Back Pain|0
228388|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
228389|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
228390|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
228391|NCT00090103|743951|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
228392|NCT00090103|743952|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
228393|NCT00090103|743953|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
228394|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
228395|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
228396|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
228397|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Gyneomastia|0
228398|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Gyneomastia|0
228399|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Gyneomastia|1
228400|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Death|1
228401|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Death|0
228402|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Death|1
228403|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
228404|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
228405|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
228406|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Enrollment Error|2
228407|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Enrollment Error|0
228408|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Enrollment Error|1
228409|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Loss of Libido|0
228410|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Loss of Libido|0
228411|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Loss of Libido|1
228412|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
228413|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
228414|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
228415|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
228416|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
228417|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
228418|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
228419|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
228420|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
228421|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
228422|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
228423|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
228424|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Participant relocated|1
228425|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Participant relocated|3
228426|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Participant relocated|2
228427|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
228428|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
228429|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
228430|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Loss of Contact|2
228431|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Loss of Contact|0
228432|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Loss of Contact|4
228433|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
228434|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
228435|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
228436|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
228437|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
228438|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
228439|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Protocol Violation|17
228440|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Protocol Violation|18
228441|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Protocol Violation|18
228442|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
228443|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
228444|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
228445|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
228446|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
228447|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
228448|NCT00090103|743951|P3|16-Week Safety Follow-up Period|Adverse Event|44
228449|NCT00090103|743952|P2|16-Week Safety Follow-up Period|Adverse Event|39
228450|NCT00090103|743953|P1|16-Week Safety Follow-up Period|Adverse Event|34
228451|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
228452|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
228453|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
228454|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
228455|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
228456|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
228457|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
228458|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
228459|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
228460|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
228461|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
228462|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
228463|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
228464|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
228465|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
228466|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
228467|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
228468|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
228469|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
228470|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
228471|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
228472|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
228473|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
228474|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
228475|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
228476|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
228477|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
228478|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
228479|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
228480|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
228481|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
228482|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
228483|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
228484|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
228485|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
228486|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
228487|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
228488|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
228489|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
228490|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
228491|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
228492|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
228493|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
228494|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
228495|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
228496|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
228497|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
228498|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
228499|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
228500|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
228501|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
228502|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
228503|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
228504|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
228505|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
228506|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
228507|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
228508|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
228509|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
228510|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
228511|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
228512|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
228513|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
228514|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
228515|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
228516|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
228517|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
228518|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
228519|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
228520|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
228521|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
228522|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
228523|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
228524|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
228525|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
228526|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
228527|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
228528|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
228529|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
228530|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
228531|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
228532|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
228533|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
228534|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
228535|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
228536|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
228537|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
228538|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
228539|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
228540|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
228541|NCT00090103|743951|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
228542|NCT00090103|743952|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
228543|NCT00090103|743953|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
228544|NCT00089999|744119|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
228545|NCT00089999|744120|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
228546|NCT00089999|744119|P2|Overall Study|Patient Underwent Surgery|0
228547|NCT00089999|744120|P1|Overall Study|Patient Underwent Surgery|2
228548|NCT00089999|744119|P2|Overall Study|Physician Decision|2
228549|NCT00089999|744120|P1|Overall Study|Physician Decision|2
228550|NCT00089999|744119|P2|Overall Study|Clinical Progression|2
228551|NCT00089999|744120|P1|Overall Study|Clinical Progression|1
228552|NCT00089999|744119|P2|Overall Study|Poor General Condition|0
228553|NCT00089999|744120|P1|Overall Study|Poor General Condition|1
228554|NCT00089999|744119|P2|Overall Study|Death|3
228555|NCT00089999|744120|P1|Overall Study|Death|3
228556|NCT00089999|744119|P2|Overall Study|Symptomatic Progression of Cancer|5
228557|NCT00089999|744120|P1|Overall Study|Symptomatic Progression of Cancer|2
228558|NCT00089999|744119|P2|Overall Study|Radiological Progression of Cancer|44
228559|NCT00089999|744120|P1|Overall Study|Radiological Progression of Cancer|52
228560|NCT00089999|744119|P2|Overall Study|Lost to Follow-up|1
228561|NCT00089999|744120|P1|Overall Study|Lost to Follow-up|2
228562|NCT00089999|744119|P2|Overall Study|Withdrawal by Subject|4
228563|NCT00089999|744120|P1|Overall Study|Withdrawal by Subject|0
228564|NCT00089999|744119|P2|Overall Study|Adverse Event|7
228565|NCT00089999|744120|P1|Overall Study|Adverse Event|4
228566|NCT00089986|744143|P3|Overall Study|Withdrawal by Subject|2
228567|NCT00089986|744144|P2|Overall Study|Withdrawal by Subject|6
228568|NCT00089986|744145|P1|Overall Study|Withdrawal by Subject|3
228569|NCT00089986|744143|P3|Overall Study|Do not resuscitate (DNR)|1
228570|NCT00089986|744144|P2|Overall Study|Do not resuscitate (DNR)|0
228571|NCT00089986|744145|P1|Overall Study|Do not resuscitate (DNR)|0
228572|NCT00089986|744143|P3|Overall Study|Family decision|0
228573|NCT00089986|744144|P2|Overall Study|Family decision|1
228574|NCT00089986|744145|P1|Overall Study|Family decision|0
228575|NCT00089986|744143|P3|Overall Study|Enrollment in another study|0
228576|NCT00089986|744144|P2|Overall Study|Enrollment in another study|1
228577|NCT00089986|744145|P1|Overall Study|Enrollment in another study|0
228578|NCT00089986|744143|P3|Overall Study|Investigator decision to withdrew|0
228579|NCT00089986|744144|P2|Overall Study|Investigator decision to withdrew|1
228580|NCT00089986|744145|P1|Overall Study|Investigator decision to withdrew|0
228581|NCT00089986|744143|P3|Overall Study|Hemohlobin stopping rule|0
228582|NCT00089986|744144|P2|Overall Study|Hemohlobin stopping rule|1
228583|NCT00089986|744145|P1|Overall Study|Hemohlobin stopping rule|0
228584|NCT00089986|744143|P3|Overall Study|Subject withdrew but agreed follow up|0
228585|NCT00089986|744144|P2|Overall Study|Subject withdrew but agreed follow up|2
228586|NCT00089986|744145|P1|Overall Study|Subject withdrew but agreed follow up|1
228587|NCT00089986|744143|P3|Overall Study|Patient transferred to another hospital|0
228588|NCT00089986|744144|P2|Overall Study|Patient transferred to another hospital|1
228589|NCT00089986|744145|P1|Overall Study|Patient transferred to another hospital|2
228590|NCT00089986|744143|P3|Overall Study|Protocol Violation|0
228591|NCT00089986|744144|P2|Overall Study|Protocol Violation|1
228592|NCT00089986|744145|P1|Overall Study|Protocol Violation|0
228593|NCT00089986|744143|P3|Overall Study|Lost to Follow-up|1
228594|NCT00089986|744144|P2|Overall Study|Lost to Follow-up|1
228595|NCT00089986|744145|P1|Overall Study|Lost to Follow-up|3
228596|NCT00089986|744143|P3|Overall Study|Adverse Event|6
228597|NCT00089986|744144|P2|Overall Study|Adverse Event|9
228598|NCT00089986|744145|P1|Overall Study|Adverse Event|6
228599|NCT00089973|744162|P1|Overall Study|Death|1
228600|NCT00089973|744162|P1|Overall Study|Disease progression|45
228601|NCT00089973|744162|P1|Overall Study|Withdrawal by Subject|1
228602|NCT00089973|744162|P1|Overall Study|Adverse Event|3
228603|NCT00089895|744177|P2|Overall Study|Missing|2
228604|NCT00089895|744178|P1|Overall Study|Missing|4
228605|NCT00089895|744177|P2|Overall Study|Not otherwise specified|8
228606|NCT00089895|744178|P1|Overall Study|Not otherwise specified|4
228607|NCT00089895|744177|P2|Overall Study|Exclusion criteria met|6
228608|NCT00089895|744178|P1|Overall Study|Exclusion criteria met|6
228609|NCT00089895|744177|P2|Overall Study|Physician Decision|7
228610|NCT00089895|744178|P1|Overall Study|Physician Decision|3
228611|NCT00089895|744177|P2|Overall Study|Bleeding|2
228612|NCT00089895|744178|P1|Overall Study|Bleeding|0
228613|NCT00089895|744177|P2|Overall Study|Surgery|1
228614|NCT00089895|744178|P1|Overall Study|Surgery|0
228615|NCT00089895|744177|P2|Overall Study|Technical reason|2
228616|NCT00089895|744178|P1|Overall Study|Technical reason|7
228617|NCT00089895|744177|P2|Overall Study|Consent Withdrawn|14
228618|NCT00089895|744178|P1|Overall Study|Consent Withdrawn|11
228619|NCT00089843|744190|P4|Overall Study|Physician Decision|1
228620|NCT00089843|744191|P3|Overall Study|Physician Decision|0
228621|NCT00089843|744192|P2|Overall Study|Physician Decision|0
228622|NCT00089843|744193|P1|Overall Study|Physician Decision|1
228623|NCT00089843|744190|P4|Overall Study|Withdrawal by Subject|6
228624|NCT00089843|744191|P3|Overall Study|Withdrawal by Subject|5
228625|NCT00089843|744192|P2|Overall Study|Withdrawal by Subject|4
228626|NCT00089843|744193|P1|Overall Study|Withdrawal by Subject|1
228627|NCT00089791|744205|P2|Overall Study|Requirement for alternative therapy|4
228628|NCT00089791|744206|P1|Overall Study|Requirement for alternative therapy|7
228629|NCT00089791|744205|P2|Overall Study|Protocol deviation|10
228630|NCT00089791|744206|P1|Overall Study|Protocol deviation|12
228631|NCT00089791|744205|P2|Overall Study|Other|32
228632|NCT00089791|744206|P1|Overall Study|Other|20
228633|NCT00089791|744205|P2|Overall Study|Noncompliance|13
228634|NCT00089791|744206|P1|Overall Study|Noncompliance|17
228635|NCT00089791|744205|P2|Overall Study|Lost to Follow-up|57
228636|NCT00089791|744206|P1|Overall Study|Lost to Follow-up|57
228637|NCT00089791|744205|P2|Overall Study|Ineligibility determined|9
228638|NCT00089791|744206|P1|Overall Study|Ineligibility determined|12
228639|NCT00089791|744205|P2|Overall Study|Disease progression|3
228640|NCT00089791|744206|P1|Overall Study|Disease progression|7
228641|NCT00089791|744205|P2|Overall Study|Death|62
228642|NCT00089791|744206|P1|Overall Study|Death|78
228643|NCT00089791|744205|P2|Overall Study|Withdrawal by Subject|344
228644|NCT00089791|744206|P1|Overall Study|Withdrawal by Subject|403
228645|NCT00089791|744205|P2|Overall Study|Adverse Event|93
228646|NCT00089791|744206|P1|Overall Study|Adverse Event|81
228647|NCT00089791|744205|P2|Overall Study|Physician Decision|3
228648|NCT00089791|744206|P1|Overall Study|Physician Decision|6
228649|NCT00089778|744240|P3|Overall Study|Protocol Violation|1
228650|NCT00089778|744241|P2|Overall Study|Protocol Violation|0
228651|NCT00089778|744242|P1|Overall Study|Protocol Violation|0
228652|NCT00089674|744255|P2|Overall Study|Requirement for alternative therapy|4
228653|NCT00089674|744256|P1|Overall Study|Requirement for alternative therapy|14
228654|NCT00089674|744255|P2|Overall Study|Other|9
228655|NCT00089674|744256|P1|Overall Study|Other|5
228656|NCT00089674|744255|P2|Overall Study|Noncompliance|3
228657|NCT00089674|744256|P1|Overall Study|Noncompliance|7
228658|NCT00089674|744255|P2|Overall Study|Lost to Follow-up|17
228659|NCT00089674|744256|P1|Overall Study|Lost to Follow-up|21
228660|NCT00089674|744255|P2|Overall Study|Ineligibility determined|10
228661|NCT00089674|744256|P1|Overall Study|Ineligibility determined|8
228662|NCT00089674|744255|P2|Overall Study|Disease progression|23
228663|NCT00089674|744256|P1|Overall Study|Disease progression|21
228664|NCT00089674|744255|P2|Overall Study|Death|43
228665|NCT00089674|744256|P1|Overall Study|Death|43
228666|NCT00089674|744255|P2|Overall Study|Withdrawal by Subject|127
228667|NCT00089674|744256|P1|Overall Study|Withdrawal by Subject|143
228668|NCT00089674|744255|P2|Overall Study|Adverse Event|29
228669|NCT00089674|744256|P1|Overall Study|Adverse Event|23
228670|NCT00089674|744255|P2|Overall Study|Physician Decision|2
228671|NCT00089674|744256|P1|Overall Study|Physician Decision|4
228672|NCT00089661|744282|P2|Overall Study|Other|1
228673|NCT00089661|744283|P1|Overall Study|Other|2
228674|NCT00089661|744282|P2|Overall Study|Noncompliance|4
228675|NCT00089661|744283|P1|Overall Study|Noncompliance|2
228676|NCT00089661|744282|P2|Overall Study|Ineligibility determined|4
228677|NCT00089661|744283|P1|Overall Study|Ineligibility determined|4
228678|NCT00089661|744282|P2|Overall Study|Disease progression|3
228679|NCT00089661|744283|P1|Overall Study|Disease progression|1
228680|NCT00089661|744282|P2|Overall Study|Withdrawal by Subject|9
228681|NCT00089661|744283|P1|Overall Study|Withdrawal by Subject|11
228682|NCT00089661|744282|P2|Overall Study|Lost to Follow-up|3
228683|NCT00089661|744283|P1|Overall Study|Lost to Follow-up|0
228684|NCT00089661|744282|P2|Overall Study|Death|0
228685|NCT00089661|744283|P1|Overall Study|Death|1
228686|NCT00089661|744282|P2|Overall Study|Adverse Event|2
228687|NCT00089661|744283|P1|Overall Study|Adverse Event|0
228688|NCT00089648|744299|P1|Overall Study|Lack of Efficacy|33
228689|NCT00089648|744299|P1|Overall Study|Withdrawal by Subject|1
228690|NCT00089648|744299|P1|Overall Study|Adverse Event|7
228691|NCT00089635|744315|P1|Overall Study|Not specified|2
228692|NCT00089635|744315|P1|Overall Study|Ineligibility determined|1
228693|NCT00089635|744315|P1|Overall Study|Withdrawal by Subject|6
228694|NCT00089635|744315|P1|Overall Study|Lost to Follow-up|3
228695|NCT00089635|744315|P1|Overall Study|Disease Progression|12
228696|NCT00089635|744315|P1|Overall Study|Death|17
228697|NCT00089635|744315|P1|Overall Study|Adverse Event|2
228698|NCT00089583|744329|P2|Overall Study|Participant Incarcerated|1
228699|NCT00089583|744330|P1|Overall Study|Participant Incarcerated|0
228700|NCT00089583|744329|P2|Overall Study|Necessity to Use Prohibited Drug|0
228701|NCT00089583|744330|P1|Overall Study|Necessity to Use Prohibited Drug|1
228702|NCT00089583|744329|P2|Overall Study|Start of Disallowed Medication|1
228703|NCT00089583|744330|P1|Overall Study|Start of Disallowed Medication|0
228704|NCT00089583|744329|P2|Overall Study|Principal Investigator Decision|10
228705|NCT00089583|744330|P1|Overall Study|Principal Investigator Decision|0
228706|NCT00089583|744329|P2|Overall Study|Protocol Violation|3
228707|NCT00089583|744330|P1|Overall Study|Protocol Violation|0
228708|NCT00089583|744329|P2|Overall Study|Reason Not Provided|1
228709|NCT00089583|744330|P1|Overall Study|Reason Not Provided|0
228710|NCT00089583|744329|P2|Overall Study|Participant Management Criteria Met|1
228711|NCT00089583|744330|P1|Overall Study|Participant Management Criteria Met|0
228712|NCT00089583|744329|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
228713|NCT00089583|744330|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
228714|NCT00089583|744329|P2|Overall Study|Non-Compliance|4
228715|NCT00089583|744330|P1|Overall Study|Non-Compliance|0
228716|NCT00089583|744329|P2|Overall Study|Participant Refused Study Medication|2
228717|NCT00089583|744330|P1|Overall Study|Participant Refused Study Medication|0
228718|NCT00089583|744329|P2|Overall Study|Participant (Par) Didn't Take Medication|0
228719|NCT00089583|744330|P1|Overall Study|Participant (Par) Didn't Take Medication|1
228720|NCT00089583|744329|P2|Overall Study|Withdrawal by Subject|4
228721|NCT00089583|744330|P1|Overall Study|Withdrawal by Subject|0
228722|NCT00089583|744329|P2|Overall Study|Insufficient Viral Load Response|5
228723|NCT00089583|744330|P1|Overall Study|Insufficient Viral Load Response|5
228724|NCT00089583|744329|P2|Overall Study|Adverse Event|3
228725|NCT00089583|744330|P1|Overall Study|Adverse Event|0
228726|NCT00089609|744424|P2|Overall Study|Withdrawal by Subject|1
228727|NCT00089609|744425|P1|Overall Study|Withdrawal by Subject|3
228728|NCT00089544|744444|P2|Overall Study|Ineligible|0
228729|NCT00089544|744445|P1|Overall Study|Ineligible|1
228730|NCT00089505|744459|P4|Overall Study|Protocol Violation|0
228731|NCT00089505|744460|P3|Overall Study|Protocol Violation|1
228732|NCT00089505|744461|P2|Overall Study|Protocol Violation|0
228733|NCT00089505|744462|P1|Overall Study|Protocol Violation|0
228734|NCT00089505|744459|P4|Overall Study|Physician Decision|0
228735|NCT00089505|744460|P3|Overall Study|Physician Decision|0
228736|NCT00089505|744461|P2|Overall Study|Physician Decision|0
228737|NCT00089505|744462|P1|Overall Study|Physician Decision|1
228738|NCT00089505|744459|P4|Overall Study|Lost to Follow-up|7
228739|NCT00089505|744460|P3|Overall Study|Lost to Follow-up|9
228740|NCT00089505|744461|P2|Overall Study|Lost to Follow-up|1
228741|NCT00089505|744462|P1|Overall Study|Lost to Follow-up|1
228742|NCT00089505|744459|P4|Overall Study|Withdrawal by Subject|6
228743|NCT00089505|744460|P3|Overall Study|Withdrawal by Subject|6
228744|NCT00089505|744461|P2|Overall Study|Withdrawal by Subject|0
228745|NCT00089505|744462|P1|Overall Study|Withdrawal by Subject|3
228746|NCT00089505|744459|P4|Overall Study|Death|8
228747|NCT00089505|744460|P3|Overall Study|Death|5
228748|NCT00089505|744461|P2|Overall Study|Death|1
228749|NCT00089505|744462|P1|Overall Study|Death|4
228750|NCT00089479|744506|P2|Overall Study|Lost to Follow-up|107
228751|NCT00089479|744507|P1|Overall Study|Lost to Follow-up|137
228752|NCT00089479|744506|P2|Overall Study|Withdrawal by Subject|107
228753|NCT00089479|744507|P1|Overall Study|Withdrawal by Subject|86
228754|NCT00089479|744506|P2|Overall Study|Death|75
228755|NCT00089479|744507|P1|Overall Study|Death|108
228756|NCT00089297|744550|P1|Overall Study|Non-compliance|1
228757|NCT00089297|744550|P1|Overall Study|IRB approval not ready|1
228758|NCT00089297|744550|P1|Overall Study|Secondary malignancy|1
228759|NCT00089297|744550|P1|Overall Study|Ineligible|11
228760|NCT00089297|744550|P1|Overall Study|Disease progression|2
228761|NCT00089297|744550|P1|Overall Study|Withdrawal by Subject|12
228762|NCT00089297|744550|P1|Overall Study|Death|1
228763|NCT00089297|744550|P1|Overall Study|Adverse Event|9
228764|NCT00089141|744559|P2|Overall Study|Termination of trial|24
228765|NCT00089141|744560|P1|Overall Study|Termination of trial|18
228766|NCT00089076|744582|P1|Overall Study|Progression|7
228767|NCT00089076|744582|P1|Overall Study|Withdrawal by Subject|2
228768|NCT00089076|744582|P1|Overall Study|Alternate Therapy|1
228769|NCT00088907|744634|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
228770|NCT00088907|744635|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
228771|NCT00088907|744634|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
228772|NCT00088907|744635|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
228773|NCT00088907|744634|P2|Single Gefitinib Treatment (Step 2)|Death|0
228774|NCT00088907|744635|P1|Single Gefitinib Treatment (Step 2)|Death|1
228775|NCT00088907|744634|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
228776|NCT00088907|744635|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
228777|NCT00088907|744634|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
228778|NCT00088907|744635|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
228779|NCT00088907|744634|P2|Randomized Study (Step 1)|unknown/not specify|13
228780|NCT00088907|744635|P1|Randomized Study (Step 1)|unknown/not specify|24
228781|NCT00088907|744634|P2|Randomized Study (Step 1)|complicating disease|1
228782|NCT00088907|744635|P1|Randomized Study (Step 1)|complicating disease|3
228783|NCT00088907|744634|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
228784|NCT00088907|744635|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
228785|NCT00088907|744634|P2|Randomized Study (Step 1)|Death|12
228786|NCT00088907|744635|P1|Randomized Study (Step 1)|Death|11
228787|NCT00088907|744634|P2|Randomized Study (Step 1)|Adverse Event|19
228788|NCT00088907|744635|P1|Randomized Study (Step 1)|Adverse Event|14
228789|NCT00088907|744634|P2|Randomized Study (Step 1)|Lack of Efficacy|62
228790|NCT00088907|744635|P1|Randomized Study (Step 1)|Lack of Efficacy|55
228791|NCT00088881|744646|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
228792|NCT00088881|744646|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
228793|NCT00088881|744646|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
228794|NCT00088881|744646|P1|Step 1 - R-CHOP|Physician Decision|1
228795|NCT00088881|744646|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
228796|NCT00088881|744646|P1|Step 1 - R-CHOP|Adverse Event|1
228797|NCT00088881|744646|P1|Step 1 - R-CHOP|Patient ineligible|9
228798|NCT00088595|744674|P1|Overall Study|New Cancer Therapy|2
228799|NCT00088595|744674|P1|Overall Study|Ongoing (After Core)|7
228800|NCT00088595|744674|P1|Overall Study|Withdrawal by Subject|8
228801|NCT00088595|744674|P1|Overall Study|Adverse Event|11
228802|NCT00088530|744692|P2|Overall Study|Patient never treated|0
228803|NCT00088530|744693|P1|Overall Study|Patient never treated|1
228804|NCT00088530|744692|P2|Overall Study|Sponsor decision|1
228805|NCT00088530|744693|P1|Overall Study|Sponsor decision|0
228806|NCT00088530|744692|P2|Overall Study|Physician Decision|0
228807|NCT00088530|744693|P1|Overall Study|Physician Decision|2
228808|NCT00088530|744692|P2|Overall Study|Lost to Follow-up|0
228809|NCT00088530|744693|P1|Overall Study|Lost to Follow-up|2
228810|NCT00088530|744692|P2|Overall Study|Withdrawal by Subject|5
228811|NCT00088530|744693|P1|Overall Study|Withdrawal by Subject|2
228812|NCT00088530|744692|P2|Overall Study|Adverse Event|9
228813|NCT00088530|744693|P1|Overall Study|Adverse Event|15
228814|NCT00088530|744692|P2|Overall Study|Progressive/Relapsed Disease|39
228815|NCT00088530|744693|P1|Overall Study|Progressive/Relapsed Disease|28
228816|NCT00088465|744705|P1|Overall Study|Death|11
228817|NCT00088465|744705|P1|Overall Study|Protocol Violation|17
228818|NCT00088465|744705|P1|Overall Study|Lack of Efficacy|27
228819|NCT00088465|744705|P1|Overall Study|Sponsor Decision|37
228820|NCT00088465|744705|P1|Overall Study|Physician Decision|45
228821|NCT00088465|744705|P1|Overall Study|Lost to Follow-up|57
228822|NCT00088465|744705|P1|Overall Study|Adverse Event|77
228823|NCT00088465|744705|P1|Overall Study|Withdrawal by Subject|290
228824|NCT00088374|744728|P1|Overall Study|patient received <1 cycle only of 17AAG|1
228825|NCT00088374|744728|P1|Overall Study|patient did not receive any 17AAG|1
228826|NCT00088166|744748|P2|Overall Study|Withdrawal by Subject|5
228827|NCT00088166|744749|P1|Overall Study|Withdrawal by Subject|5
228828|NCT00088166|744748|P2|Overall Study|Patient deterioration|39
228829|NCT00088166|744749|P1|Overall Study|Patient deterioration|29
228830|NCT00088166|744748|P2|Overall Study|Protocol Violation|5
228831|NCT00088166|744749|P1|Overall Study|Protocol Violation|1
228832|NCT00088166|744748|P2|Overall Study|Physician Decision|1
228833|NCT00088166|744749|P1|Overall Study|Physician Decision|4
228834|NCT00088166|744748|P2|Overall Study|Lost to Follow-up|1
228835|NCT00088166|744749|P1|Overall Study|Lost to Follow-up|0
228836|NCT00088166|744748|P2|Overall Study|Death|1
228837|NCT00088166|744749|P1|Overall Study|Death|3
228838|NCT00088166|744748|P2|Overall Study|Adverse Event|9
228839|NCT00088166|744749|P1|Overall Study|Adverse Event|11
228840|NCT00088153|744773|P2|Overall Study|Lost to Follow-up|12
228841|NCT00088153|744774|P1|Overall Study|Lost to Follow-up|11
228842|NCT00088153|744773|P2|Overall Study|Withdrawal by Subject|10
228843|NCT00088153|744774|P1|Overall Study|Withdrawal by Subject|10
228844|NCT00088153|744773|P2|Overall Study|Physician Decision|3
228845|NCT00088153|744774|P1|Overall Study|Physician Decision|3
228846|NCT00087698|744784|P1|Overall Study|Protocol Violation|1
228847|NCT00087698|744784|P1|Overall Study|Death from Study Drug Toxicity|2
228848|NCT00087698|744784|P1|Overall Study|Death from Study Disease|2
228849|NCT00087698|744784|P1|Overall Study|Clinical Relapse|1
228850|NCT00087698|744784|P1|Overall Study|Protocol Entry Criteria Not Met|2
228851|NCT00087698|744784|P1|Overall Study|Lack of Efficacy, Physician Perception|3
228852|NCT00087698|744784|P1|Overall Study|Withdrawal by Subject|4
228853|NCT00087698|744784|P1|Overall Study|Adverse Event|4
228854|NCT00087698|744784|P1|Overall Study|Death from Other Causes|3
228855|NCT00087698|744784|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
228856|NCT00087685|744793|P1|Overall Study|Withdrawal by Subject|3
228857|NCT00087685|744793|P1|Overall Study|Progressive Disease|5
228858|NCT00087685|744793|P1|Overall Study|Non-Compliance|1
228859|NCT00087685|744793|P1|Overall Study|Adverse Event|5
228860|NCT00087646|744806|P4|Overall Study|Violation of Selection Criteria at Entry|1
228861|NCT00087646|744807|P3|Overall Study|Violation of Selection Criteria at Entry|0
228862|NCT00087646|744808|P2|Overall Study|Violation of Selection Criteria at Entry|0
228863|NCT00087646|744809|P1|Overall Study|Violation of Selection Criteria at Entry|1
228864|NCT00087646|744806|P4|Overall Study|Other Protocol Violation|0
228865|NCT00087646|744807|P3|Overall Study|Other Protocol Violation|0
228866|NCT00087646|744808|P2|Overall Study|Other Protocol Violation|1
228867|NCT00087646|744809|P1|Overall Study|Other Protocol Violation|3
228868|NCT00087646|744806|P4|Overall Study|Administrative/Other|2
228869|NCT00087646|744807|P3|Overall Study|Administrative/Other|1
228870|NCT00087646|744808|P2|Overall Study|Administrative/Other|1
228871|NCT00087646|744809|P1|Overall Study|Administrative/Other|6
228872|NCT00087646|744806|P4|Overall Study|Failure to Return|3
228873|NCT00087646|744807|P3|Overall Study|Failure to Return|2
228874|NCT00087646|744808|P2|Overall Study|Failure to Return|2
228875|NCT00087646|744809|P1|Overall Study|Failure to Return|5
228876|NCT00087646|744806|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
228877|NCT00087646|744807|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
228878|NCT00087646|744808|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
228879|NCT00087646|744809|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
228880|NCT00087646|744806|P4|Overall Study|Insufficient therapeutic response|51
228881|NCT00087646|744807|P3|Overall Study|Insufficient therapeutic response|38
228882|NCT00087646|744808|P2|Overall Study|Insufficient therapeutic response|24
228883|NCT00087646|744809|P1|Overall Study|Insufficient therapeutic response|64
228884|NCT00087646|744806|P4|Overall Study|Withdrawal by Subject|2
228885|NCT00087646|744807|P3|Overall Study|Withdrawal by Subject|2
228886|NCT00087646|744808|P2|Overall Study|Withdrawal by Subject|1
228887|NCT00087646|744809|P1|Overall Study|Withdrawal by Subject|6
228888|NCT00087646|744806|P4|Overall Study|Death|0
228889|NCT00087646|744807|P3|Overall Study|Death|0
228890|NCT00087646|744808|P2|Overall Study|Death|1
228891|NCT00087646|744809|P1|Overall Study|Death|0
228892|NCT00087646|744806|P4|Overall Study|Adverse Event|20
228893|NCT00087646|744807|P3|Overall Study|Adverse Event|18
228894|NCT00087646|744808|P2|Overall Study|Adverse Event|6
228895|NCT00087646|744809|P1|Overall Study|Adverse Event|37
228896|NCT00087607|744848|P2|Overall Study|Violation of Selection Criteria at Entry|1
228897|NCT00087607|744849|P1|Overall Study|Violation of Selection Criteria at Entry|0
228898|NCT00087607|744848|P2|Overall Study|Other Protocol Violation|2
228899|NCT00087607|744849|P1|Overall Study|Other Protocol Violation|5
228900|NCT00087607|744848|P2|Overall Study|Refused Treatment|7
228901|NCT00087607|744849|P1|Overall Study|Refused Treatment|5
228902|NCT00087607|744848|P2|Overall Study|Administrative|12
228903|NCT00087607|744849|P1|Overall Study|Administrative|12
228904|NCT00087607|744848|P2|Overall Study|Withdrew Consent|16
228905|NCT00087607|744849|P1|Overall Study|Withdrew Consent|12
228906|NCT00087607|744848|P2|Overall Study|Failure to return|17
228907|NCT00087607|744849|P1|Overall Study|Failure to return|21
228908|NCT00087607|744848|P2|Overall Study|Insufficient Therapeutic Response|42
228909|NCT00087607|744849|P1|Overall Study|Insufficient Therapeutic Response|53
228910|NCT00087607|744848|P2|Overall Study|Death|1
228911|NCT00087607|744849|P1|Overall Study|Death|0
228912|NCT00087607|744848|P2|Overall Study|Adverse Event|24
228913|NCT00087607|744849|P1|Overall Study|Adverse Event|14
228914|NCT00087594|744889|P2|Overall Study|Lack of Efficacy|5
228915|NCT00087594|744890|P1|Overall Study|Lack of Efficacy|2
228916|NCT00087594|744889|P2|Overall Study|Withdrawal by Subject|2
228917|NCT00087594|744890|P1|Overall Study|Withdrawal by Subject|4
228918|NCT00087594|744889|P2|Overall Study|Lost to Follow-up|2
228919|NCT00087594|744890|P1|Overall Study|Lost to Follow-up|0
228920|NCT00087594|744889|P2|Overall Study|Adverse Event|3
228921|NCT00087594|744890|P1|Overall Study|Adverse Event|2
228922|NCT00087568|744924|P2|Overall Study|Lack of Efficacy|1
228923|NCT00087568|744925|P1|Overall Study|Lack of Efficacy|24
228924|NCT00087568|744924|P2|Overall Study|Lost to Follow-up|0
228925|NCT00087568|744925|P1|Overall Study|Lost to Follow-up|1
228926|NCT00087568|744924|P2|Overall Study|Withdrawal by Subject|1
228927|NCT00087568|744925|P1|Overall Study|Withdrawal by Subject|1
228928|NCT00087568|744924|P2|Overall Study|Adverse Event|0
228929|NCT00087568|744925|P1|Overall Study|Adverse Event|4
228930|NCT00087555|744952|P3|Overall Study|Patient wanted to go back on Med|0
228931|NCT00087555|744953|P2|Overall Study|Patient wanted to go back on Med|0
228932|NCT00087555|744954|P1|Overall Study|Patient wanted to go back on Med|1
228933|NCT00087555|744952|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
228934|NCT00087555|744953|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
228935|NCT00087555|744954|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
228936|NCT00087555|744952|P3|Overall Study|Non Compliance|1
228937|NCT00087555|744953|P2|Overall Study|Non Compliance|0
228938|NCT00087555|744954|P1|Overall Study|Non Compliance|0
228939|NCT00087555|744952|P3|Overall Study|Lack of Efficacy|1
228940|NCT00087555|744953|P2|Overall Study|Lack of Efficacy|0
228941|NCT00087555|744954|P1|Overall Study|Lack of Efficacy|2
228942|NCT00087555|744952|P3|Overall Study|Withdrawal by Subject|1
228943|NCT00087555|744953|P2|Overall Study|Withdrawal by Subject|2
228944|NCT00087555|744954|P1|Overall Study|Withdrawal by Subject|3
228945|NCT00087555|744952|P3|Overall Study|Pregnancy|1
228946|NCT00087555|744953|P2|Overall Study|Pregnancy|1
228947|NCT00087555|744954|P1|Overall Study|Pregnancy|0
228948|NCT00087555|744952|P3|Overall Study|Screen Failure|0
228949|NCT00087555|744953|P2|Overall Study|Screen Failure|1
228950|NCT00087555|744954|P1|Overall Study|Screen Failure|1
228951|NCT00087555|744952|P3|Overall Study|Protocol Violation|2
228952|NCT00087555|744953|P2|Overall Study|Protocol Violation|0
228953|NCT00087555|744954|P1|Overall Study|Protocol Violation|0
228954|NCT00087555|744952|P3|Overall Study|Non - Compliance|0
228955|NCT00087555|744953|P2|Overall Study|Non - Compliance|0
228956|NCT00087555|744954|P1|Overall Study|Non - Compliance|1
228957|NCT00087555|744952|P3|Overall Study|Lost to Follow-up|1
228958|NCT00087555|744953|P2|Overall Study|Lost to Follow-up|1
228959|NCT00087555|744954|P1|Overall Study|Lost to Follow-up|0
228960|NCT00087555|744952|P3|Overall Study|Adverse Event|14
228961|NCT00087555|744953|P2|Overall Study|Adverse Event|6
228962|NCT00087555|744954|P1|Overall Study|Adverse Event|3
228963|NCT00087529|744964|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
228964|NCT00087529|744965|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
228965|NCT00087529|744964|P2|Overall Study|Disease Progression|4
228966|NCT00087529|744965|P1|Overall Study|Disease Progression|5
228967|NCT00087529|744964|P2|Overall Study|Participant Noncompliance|1
228968|NCT00087529|744965|P1|Overall Study|Participant Noncompliance|0
228969|NCT00087529|744964|P2|Overall Study|Initiation of Excluded Therapy|1
228970|NCT00087529|744965|P1|Overall Study|Initiation of Excluded Therapy|0
228971|NCT00087529|744964|P2|Overall Study|Physician Decision|8
228972|NCT00087529|744965|P1|Overall Study|Physician Decision|4
228973|NCT00087529|744964|P2|Overall Study|Participant Decision|37
228974|NCT00087529|744965|P1|Overall Study|Participant Decision|14
228975|NCT00087529|744964|P2|Overall Study|Lost to Follow-up|3
228976|NCT00087529|744965|P1|Overall Study|Lost to Follow-up|2
228977|NCT00087529|744964|P2|Overall Study|Pregnancy|1
228978|NCT00087529|744965|P1|Overall Study|Pregnancy|0
228979|NCT00087529|744964|P2|Overall Study|Adverse Event|8
228980|NCT00087529|744965|P1|Overall Study|Adverse Event|0
228981|NCT00087529|744964|P2|Overall Study|Death|0
228982|NCT00087529|744965|P1|Overall Study|Death|1
228983|NCT00087516|744980|P4|Overall Study|Other|0
228984|NCT00087516|744981|P3|Overall Study|Other|1
228985|NCT00087516|744982|P2|Overall Study|Other|0
228986|NCT00087516|744983|P1|Overall Study|Other|0
228987|NCT00087516|744980|P4|Overall Study|Recommendation of Primary Care Physician|1
228988|NCT00087516|744981|P3|Overall Study|Recommendation of Primary Care Physician|0
228989|NCT00087516|744982|P2|Overall Study|Recommendation of Primary Care Physician|0
228990|NCT00087516|744983|P1|Overall Study|Recommendation of Primary Care Physician|0
228991|NCT00087516|744980|P4|Overall Study|Patient was non-compliant|0
228992|NCT00087516|744981|P3|Overall Study|Patient was non-compliant|0
228993|NCT00087516|744982|P2|Overall Study|Patient was non-compliant|1
228994|NCT00087516|744983|P1|Overall Study|Patient was non-compliant|3
228995|NCT00087516|744980|P4|Overall Study|Patient moved|0
228996|NCT00087516|744981|P3|Overall Study|Patient moved|1
228997|NCT00087516|744982|P2|Overall Study|Patient moved|2
228998|NCT00087516|744983|P1|Overall Study|Patient moved|3
228999|NCT00087516|744980|P4|Overall Study|Protocol specified discontinuation|26
229000|NCT00087516|744981|P3|Overall Study|Protocol specified discontinuation|33
229001|NCT00087516|744982|P2|Overall Study|Protocol specified discontinuation|33
229002|NCT00087516|744983|P1|Overall Study|Protocol specified discontinuation|35
229003|NCT00087516|744980|P4|Overall Study|Site terminated|0
229004|NCT00087516|744981|P3|Overall Study|Site terminated|1
229005|NCT00087516|744982|P2|Overall Study|Site terminated|2
229006|NCT00087516|744983|P1|Overall Study|Site terminated|0
229007|NCT00087516|744980|P4|Overall Study|Withdrawal by Subject|12
229008|NCT00087516|744981|P3|Overall Study|Withdrawal by Subject|11
229009|NCT00087516|744982|P2|Overall Study|Withdrawal by Subject|27
229010|NCT00087516|744983|P1|Overall Study|Withdrawal by Subject|16
229011|NCT00087516|744980|P4|Overall Study|Protocol Violation|6
229012|NCT00087516|744981|P3|Overall Study|Protocol Violation|3
229013|NCT00087516|744982|P2|Overall Study|Protocol Violation|8
229014|NCT00087516|744983|P1|Overall Study|Protocol Violation|4
229015|NCT00087516|744980|P4|Overall Study|Lost to Follow-up|5
229016|NCT00087516|744981|P3|Overall Study|Lost to Follow-up|5
229017|NCT00087516|744982|P2|Overall Study|Lost to Follow-up|6
229018|NCT00087516|744983|P1|Overall Study|Lost to Follow-up|8
229019|NCT00087516|744980|P4|Overall Study|Lack of Efficacy|29
229020|NCT00087516|744981|P3|Overall Study|Lack of Efficacy|39
229021|NCT00087516|744982|P2|Overall Study|Lack of Efficacy|80
229022|NCT00087516|744983|P1|Overall Study|Lack of Efficacy|82
229023|NCT00087516|744980|P4|Overall Study|Adverse Event|6
229024|NCT00087516|744981|P3|Overall Study|Adverse Event|3
229025|NCT00087516|744982|P2|Overall Study|Adverse Event|10
229026|NCT00087516|744983|P1|Overall Study|Adverse Event|10
229027|NCT00087490|745012|P2|Overall Study|Randomized but not treated|18
229028|NCT00087490|745013|P1|Overall Study|Randomized but not treated|7
229029|NCT00087490|745012|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
229030|NCT00087490|745013|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
229031|NCT00087490|745012|P2|Overall Study|Protocol Violation or (/) Unspecified|201
229032|NCT00087490|745013|P1|Overall Study|Protocol Violation or (/) Unspecified|214
229033|NCT00087490|745012|P2|Overall Study|Lack of Efficacy|2
229034|NCT00087490|745013|P1|Overall Study|Lack of Efficacy|0
229035|NCT00087490|745012|P2|Overall Study|Adverse Event|8
229036|NCT00087490|745013|P1|Overall Study|Adverse Event|3
229037|NCT00087490|745012|P2|Overall Study|Death|4
229038|NCT00087490|745013|P1|Overall Study|Death|6
229039|NCT00087438|745047|P1|Overall Study|Ineligible / No protocol treatment|4
229040|NCT00087152|745051|P1|Overall Study|Ineligible|6
229041|NCT00087139|745060|P3|Overall Study|Extradural disease|1
229042|NCT00087139|745061|P2|Overall Study|Extradural disease|0
229043|NCT00087139|745062|P1|Overall Study|Extradural disease|0
229044|NCT00087139|745060|P3|Overall Study|Response achieved|0
229045|NCT00087139|745061|P2|Overall Study|Response achieved|1
229046|NCT00087139|745062|P1|Overall Study|Response achieved|0
229047|NCT00087139|745060|P3|Overall Study|Use of coumadin|0
229048|NCT00087139|745061|P2|Overall Study|Use of coumadin|0
229049|NCT00087139|745062|P1|Overall Study|Use of coumadin|1
229050|NCT00087139|745060|P3|Overall Study|Symptomatic deterioration|3
229051|NCT00087139|745061|P2|Overall Study|Symptomatic deterioration|1
229052|NCT00087139|745062|P1|Overall Study|Symptomatic deterioration|1
229053|NCT00087139|745060|P3|Overall Study|Ineligible|4
229054|NCT00087139|745061|P2|Overall Study|Ineligible|7
229055|NCT00087139|745062|P1|Overall Study|Ineligible|4
229056|NCT00087139|745060|P3|Overall Study|Disease progression|12
229057|NCT00087139|745061|P2|Overall Study|Disease progression|19
229058|NCT00087139|745062|P1|Overall Study|Disease progression|9
229059|NCT00087139|745060|P3|Overall Study|Physician Decision|1
229060|NCT00087139|745061|P2|Overall Study|Physician Decision|1
229061|NCT00087139|745062|P1|Overall Study|Physician Decision|1
229062|NCT00087139|745060|P3|Overall Study|Withdrawal by Subject|2
229063|NCT00087139|745061|P2|Overall Study|Withdrawal by Subject|2
229064|NCT00087139|745062|P1|Overall Study|Withdrawal by Subject|3
229065|NCT00087139|745060|P3|Overall Study|Death|0
229066|NCT00087139|745061|P2|Overall Study|Death|1
229067|NCT00087139|745062|P1|Overall Study|Death|2
229068|NCT00087139|745060|P3|Overall Study|Adverse Event|13
229069|NCT00087139|745061|P2|Overall Study|Adverse Event|17
229070|NCT00087139|745062|P1|Overall Study|Adverse Event|18
229071|NCT00086996|745077|P1|Overall Study|not eligible|5
229072|NCT00086996|745077|P1|Overall Study|not specified|6
229073|NCT00086996|745077|P1|Overall Study|Withdrawal by Subject|13
229074|NCT00086996|745077|P1|Overall Study|progression/relapse|7
229075|NCT00086996|745077|P1|Overall Study|Death|4
229076|NCT00086996|745077|P1|Overall Study|Adverse Event|29
229077|NCT00086684|745099|P3|Overall Study|Not specified|3
229078|NCT00086684|745100|P2|Overall Study|Not specified|2
229079|NCT00086684|745101|P1|Overall Study|Not specified|4
229080|NCT00086684|745099|P3|Overall Study|WITHDRAWAL OF CONSENT|5
229081|NCT00086684|745100|P2|Overall Study|WITHDRAWAL OF CONSENT|7
229082|NCT00086684|745101|P1|Overall Study|WITHDRAWAL OF CONSENT|5
229083|NCT00086684|745099|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
229084|NCT00086684|745100|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
229085|NCT00086684|745101|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
229086|NCT00086684|745099|P3|Overall Study|NONCOMPLIANCE|6
229087|NCT00086684|745100|P2|Overall Study|NONCOMPLIANCE|7
229088|NCT00086684|745101|P1|Overall Study|NONCOMPLIANCE|5
229089|NCT00086684|745099|P3|Overall Study|Withdrawal by Subject|10
229090|NCT00086684|745100|P2|Overall Study|Withdrawal by Subject|4
229091|NCT00086684|745101|P1|Overall Study|Withdrawal by Subject|0
229092|NCT00086684|745099|P3|Overall Study|Protocol Violation|0
229093|NCT00086684|745100|P2|Overall Study|Protocol Violation|3
229094|NCT00086684|745101|P1|Overall Study|Protocol Violation|8
229095|NCT00086684|745099|P3|Overall Study|Lost to Follow-up|10
229096|NCT00086684|745100|P2|Overall Study|Lost to Follow-up|8
229097|NCT00086684|745101|P1|Overall Study|Lost to Follow-up|15
229098|NCT00086684|745099|P3|Overall Study|Lack of Efficacy|5
229099|NCT00086684|745100|P2|Overall Study|Lack of Efficacy|6
229100|NCT00086684|745101|P1|Overall Study|Lack of Efficacy|6
229101|NCT00086684|745099|P3|Overall Study|Adverse Event|14
229102|NCT00086684|745100|P2|Overall Study|Adverse Event|17
229103|NCT00086684|745101|P1|Overall Study|Adverse Event|12
229104|NCT00086619|745114|P2|Overall Study|Protocol Violation|1
229105|NCT00086619|745115|P1|Overall Study|Protocol Violation|1
229106|NCT00086619|745114|P2|Overall Study|Adverse Event|10
229107|NCT00086619|745115|P1|Overall Study|Adverse Event|8
229108|NCT00086619|745114|P2|Overall Study|Withdrawal by Subject|6
229109|NCT00086619|745115|P1|Overall Study|Withdrawal by Subject|6
229110|NCT00086580|745125|P2|Observation Period|Not specified|7
229111|NCT00086580|745126|P1|Observation Period|Not specified|8
229112|NCT00086580|745125|P2|Observation Period|Death|55
229113|NCT00086580|745126|P1|Observation Period|Death|33
229114|NCT00086580|745125|P2|Observation Period|Withdrawal by Subject|2
229115|NCT00086580|745126|P1|Observation Period|Withdrawal by Subject|4
229116|NCT00086580|745125|P2|Observation Period|Unable to comply with protocol|1
229117|NCT00086580|745126|P1|Observation Period|Unable to comply with protocol|1
229118|NCT00086580|745125|P2|Follow-up Period|Not specified|6
229119|NCT00086580|745126|P1|Follow-up Period|Not specified|7
229120|NCT00086580|745125|P2|Follow-up Period|Death|7
229121|NCT00086580|745126|P1|Follow-up Period|Death|13
229122|NCT00086580|745125|P2|Follow-up Period|AE - not related|0
229123|NCT00086580|745126|P1|Follow-up Period|AE - not related|1
229124|NCT00086580|745125|P2|Follow-up Period|Physician Decision|1
229125|NCT00086580|745126|P1|Follow-up Period|Physician Decision|0
229126|NCT00086580|745125|P2|Follow-up Period|Withdrawal by Subject|6
229127|NCT00086580|745126|P1|Follow-up Period|Withdrawal by Subject|6
229128|NCT00086580|745125|P2|Follow-up Period|Unable to comply with protocol|0
229129|NCT00086580|745126|P1|Follow-up Period|Unable to comply with protocol|5
229130|NCT00086580|745125|P2|Follow-up Period|Disease progression|99
229131|NCT00086580|745126|P1|Follow-up Period|Disease progression|72
229132|NCT00086580|745125|P2|Treatment Period|Not specified|3
229133|NCT00086580|745126|P1|Treatment Period|Not specified|5
229134|NCT00086580|745125|P2|Treatment Period|Death|7
229135|NCT00086580|745126|P1|Treatment Period|Death|5
229136|NCT00086580|745125|P2|Treatment Period|Anemia or thrombocytopenia|4
229137|NCT00086580|745126|P1|Treatment Period|Anemia or thrombocytopenia|1
229138|NCT00086580|745125|P2|Treatment Period|Toxicity - treatment related|15
229139|NCT00086580|745126|P1|Treatment Period|Toxicity - treatment related|15
229140|NCT00086580|745125|P2|Treatment Period|AE - not treatment related|7
229141|NCT00086580|745126|P1|Treatment Period|AE - not treatment related|7
229142|NCT00086580|745125|P2|Treatment Period|Physician Decision|7
229143|NCT00086580|745126|P1|Treatment Period|Physician Decision|13
229144|NCT00086580|745125|P2|Treatment Period|Withdrawal by Subject|8
229145|NCT00086580|745126|P1|Treatment Period|Withdrawal by Subject|7
229146|NCT00086580|745125|P2|Treatment Period|Unable to comply with protocol|1
229147|NCT00086580|745126|P1|Treatment Period|Unable to comply with protocol|3
229148|NCT00086580|745125|P2|Treatment Period|Disease progression|8
229149|NCT00086580|745126|P1|Treatment Period|Disease progression|9
229150|NCT00086411|745174|P4|Overall Study|Lost to Follow-up|12
229151|NCT00086411|745175|P3|Overall Study|Lost to Follow-up|13
229152|NCT00086411|745176|P2|Overall Study|Lost to Follow-up|11
229153|NCT00086411|745177|P1|Overall Study|Lost to Follow-up|11
229154|NCT00086385|745191|P4|Overall Study|Death|1
229155|NCT00086385|745192|P3|Overall Study|Death|1
229156|NCT00086385|745193|P2|Overall Study|Death|2
229157|NCT00086385|745194|P1|Overall Study|Death|2
229158|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Discontinued in error|0
229159|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Discontinued in error|1
229160|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
229161|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
229162|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
229163|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
229164|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Patient Died|1
229165|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Patient Died|3
229166|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
229167|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
229168|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
229169|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
229170|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Patient Moved|2
229171|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Patient Moved|2
229172|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
229173|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
229174|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Protocol Violation|0
229175|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Protocol Violation|1
229176|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Physician Decision|0
229177|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Physician Decision|3
229178|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
229179|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
229180|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
229181|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
229182|NCT00086515|745206|P2|Phase B (Weeks 24-104)|Adverse Event|10
229183|NCT00086515|745207|P1|Phase B (Weeks 24-104)|Adverse Event|16
229184|NCT00086515|745206|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
229185|NCT00086515|745207|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
229186|NCT00086515|745206|P2|Phase A to Phase B Transition Period|Poor compliance|0
229187|NCT00086515|745207|P1|Phase A to Phase B Transition Period|Poor compliance|1
229188|NCT00086515|745206|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
229189|NCT00086515|745207|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
229190|NCT00086515|745206|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
229191|NCT00086515|745207|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
229192|NCT00086515|745206|P2|Phase A to Phase B Transition Period|Protocol Violation|1
229193|NCT00086515|745207|P1|Phase A to Phase B Transition Period|Protocol Violation|0
229194|NCT00086515|745206|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
229195|NCT00086515|745207|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
229196|NCT00086515|745206|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
229197|NCT00086515|745207|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
229198|NCT00086515|745206|P2|Phase A to Phase B Transition Period|Adverse Event|1
229199|NCT00086515|745207|P1|Phase A to Phase B Transition Period|Adverse Event|2
229200|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
229201|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
229202|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
229203|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
229204|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Poor compliance|0
229205|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Poor compliance|1
229206|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
229207|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
229208|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Patient Moved|3
229209|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Patient Moved|2
229210|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
229211|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
229212|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Protocol Violation|1
229213|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Protocol Violation|3
229214|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
229215|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
229216|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
229217|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
229218|NCT00086515|745206|P2|Phase A (Weeks 0-24)|Adverse Event|9
229219|NCT00086515|745207|P1|Phase A (Weeks 0-24)|Adverse Event|17
229220|NCT00086502|745219|P2|Overall Study|Patient Accidentally Unblinded|0
229221|NCT00086502|745220|P1|Overall Study|Patient Accidentally Unblinded|1
229222|NCT00086502|745219|P2|Overall Study|Protocol Discontinuation Criteria|3
229223|NCT00086502|745220|P1|Overall Study|Protocol Discontinuation Criteria|1
229224|NCT00086502|745219|P2|Overall Study|Patient Moved|1
229225|NCT00086502|745220|P1|Overall Study|Patient Moved|1
229226|NCT00086502|745219|P2|Overall Study|Withdrawal by Subject|6
229227|NCT00086502|745220|P1|Overall Study|Withdrawal by Subject|5
229228|NCT00086502|745219|P2|Overall Study|Protocol Violation|3
229229|NCT00086502|745220|P1|Overall Study|Protocol Violation|3
229230|NCT00086502|745219|P2|Overall Study|Pregnancy|1
229231|NCT00086502|745220|P1|Overall Study|Pregnancy|0
229232|NCT00086502|745219|P2|Overall Study|Physician Decision|1
229233|NCT00086502|745220|P1|Overall Study|Physician Decision|1
229234|NCT00086502|745219|P2|Overall Study|Lost to Follow-up|1
229235|NCT00086502|745220|P1|Overall Study|Lost to Follow-up|3
229236|NCT00086502|745219|P2|Overall Study|Lack of Efficacy|2
229237|NCT00086502|745220|P1|Overall Study|Lack of Efficacy|0
229238|NCT00086502|745219|P2|Overall Study|Adverse Event|2
229239|NCT00086502|745220|P1|Overall Study|Adverse Event|11
229240|NCT00086346|745245|P2|Patients Dosed With Test Article|Lack of Efficacy|0
229241|NCT00086346|745246|P1|Patients Dosed With Test Article|Lack of Efficacy|11
229242|NCT00086346|745245|P2|Patients Dosed With Test Article|Protocol Violation|3
229243|NCT00086346|745246|P1|Patients Dosed With Test Article|Protocol Violation|11
229244|NCT00086346|745245|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
229245|NCT00086346|745246|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
229246|NCT00086346|745245|P2|Patients Dosed With Test Article|Nonmedical event|3
229247|NCT00086346|745246|P1|Patients Dosed With Test Article|Nonmedical event|7
229248|NCT00086346|745245|P2|Patients Dosed With Test Article|Lost to Follow-up|3
229249|NCT00086346|745246|P1|Patients Dosed With Test Article|Lost to Follow-up|1
229250|NCT00086346|745245|P2|Patients Dosed With Test Article|Adverse Event|11
229251|NCT00086346|745246|P1|Patients Dosed With Test Article|Adverse Event|94
229252|NCT00086346|745245|P2|Randomization|Did not receive test article|4
229253|NCT00086346|745246|P1|Randomization|Did not receive test article|4
229254|NCT00086281|745273|P15|Phase 2|Adverse Event|0
229255|NCT00086281|745274|P14|Phase 2|Adverse Event|1
229256|NCT00086281|745275|P13|Phase 2|Adverse Event|1
229257|NCT00086281|745276|P12|Phase 2|Adverse Event|0
229258|NCT00086281|745277|P11|Phase 2|Adverse Event|0
229259|NCT00086281|745278|P10|Phase 2|Adverse Event|0
229260|NCT00086281|745279|P9|Phase 2|Adverse Event|0
229261|NCT00086281|745280|P8|Phase 2|Adverse Event|0
229262|NCT00086281|745281|P7|Phase 2|Adverse Event|0
229263|NCT00086281|745282|P6|Phase 2|Adverse Event|0
229264|NCT00086281|745283|P5|Phase 2|Adverse Event|0
229265|NCT00086281|745284|P4|Phase 2|Adverse Event|0
229266|NCT00086281|745285|P3|Phase 2|Adverse Event|0
229267|NCT00086281|745286|P2|Phase 2|Adverse Event|0
229268|NCT00086281|745287|P1|Phase 2|Adverse Event|0
229269|NCT00086281|745273|P15|Phase 1|Serious Adverse Event|1
229270|NCT00086281|745274|P14|Phase 1|Serious Adverse Event|0
229271|NCT00086281|745275|P13|Phase 1|Serious Adverse Event|0
229272|NCT00086281|745276|P12|Phase 1|Serious Adverse Event|0
229273|NCT00086281|745277|P11|Phase 1|Serious Adverse Event|0
229274|NCT00086281|745278|P10|Phase 1|Serious Adverse Event|0
229275|NCT00086281|745279|P9|Phase 1|Serious Adverse Event|0
229276|NCT00086281|745280|P8|Phase 1|Serious Adverse Event|0
229277|NCT00086281|745281|P7|Phase 1|Serious Adverse Event|0
229278|NCT00086281|745282|P6|Phase 1|Serious Adverse Event|0
229279|NCT00086281|745283|P5|Phase 1|Serious Adverse Event|0
229280|NCT00086281|745284|P4|Phase 1|Serious Adverse Event|0
229281|NCT00086281|745285|P3|Phase 1|Serious Adverse Event|0
229282|NCT00086281|745286|P2|Phase 1|Serious Adverse Event|0
229283|NCT00086281|745287|P1|Phase 1|Serious Adverse Event|0
229284|NCT00086281|745273|P15|Phase 1|Protocol Violation|0
229285|NCT00086281|745274|P14|Phase 1|Protocol Violation|0
229286|NCT00086281|745275|P13|Phase 1|Protocol Violation|0
229287|NCT00086281|745276|P12|Phase 1|Protocol Violation|0
229288|NCT00086281|745277|P11|Phase 1|Protocol Violation|1
229289|NCT00086281|745278|P10|Phase 1|Protocol Violation|0
229290|NCT00086281|745279|P9|Phase 1|Protocol Violation|0
229291|NCT00086281|745280|P8|Phase 1|Protocol Violation|0
229292|NCT00086281|745281|P7|Phase 1|Protocol Violation|0
229293|NCT00086281|745282|P6|Phase 1|Protocol Violation|0
229294|NCT00086281|745283|P5|Phase 1|Protocol Violation|0
229295|NCT00086281|745284|P4|Phase 1|Protocol Violation|0
229296|NCT00086281|745285|P3|Phase 1|Protocol Violation|0
229297|NCT00086281|745286|P2|Phase 1|Protocol Violation|0
229298|NCT00086281|745287|P1|Phase 1|Protocol Violation|0
229299|NCT00086281|745273|P15|Phase 1|Adverse Event|2
229300|NCT00086281|745274|P14|Phase 1|Adverse Event|1
229301|NCT00086281|745275|P13|Phase 1|Adverse Event|1
229302|NCT00086281|745276|P12|Phase 1|Adverse Event|1
229303|NCT00086281|745277|P11|Phase 1|Adverse Event|2
229304|NCT00086281|745278|P10|Phase 1|Adverse Event|1
229305|NCT00086281|745279|P9|Phase 1|Adverse Event|0
229306|NCT00086281|745280|P8|Phase 1|Adverse Event|0
229307|NCT00086281|745281|P7|Phase 1|Adverse Event|0
229308|NCT00086281|745282|P6|Phase 1|Adverse Event|0
229309|NCT00086281|745283|P5|Phase 1|Adverse Event|0
229310|NCT00086281|745284|P4|Phase 1|Adverse Event|0
229311|NCT00086281|745285|P3|Phase 1|Adverse Event|0
229312|NCT00086281|745286|P2|Phase 1|Adverse Event|0
229313|NCT00086281|745287|P1|Phase 1|Adverse Event|0
229314|NCT00086307|745300|P3|Overall Study|Withdrawal by Subject|2
229315|NCT00086307|745301|P2|Overall Study|Withdrawal by Subject|0
229316|NCT00086307|745302|P1|Overall Study|Withdrawal by Subject|0
229317|NCT00086307|745300|P3|Overall Study|Fatigue and difficulty falling asleep|1
229318|NCT00086307|745301|P2|Overall Study|Fatigue and difficulty falling asleep|0
229319|NCT00086307|745302|P1|Overall Study|Fatigue and difficulty falling asleep|0
229320|NCT00086307|745300|P3|Overall Study|Suicidal ideation|1
229321|NCT00086307|745301|P2|Overall Study|Suicidal ideation|0
229322|NCT00086307|745302|P1|Overall Study|Suicidal ideation|0
229323|NCT00086307|745300|P3|Overall Study|Constipation and sleepiness|1
229324|NCT00086307|745301|P2|Overall Study|Constipation and sleepiness|0
229325|NCT00086307|745302|P1|Overall Study|Constipation and sleepiness|0
229326|NCT00086307|745300|P3|Overall Study|Nausea and headaches|1
229327|NCT00086307|745301|P2|Overall Study|Nausea and headaches|0
229328|NCT00086307|745302|P1|Overall Study|Nausea and headaches|0
229329|NCT00086307|745300|P3|Overall Study|Shortness of breath and muscle spasms|0
229330|NCT00086307|745301|P2|Overall Study|Shortness of breath and muscle spasms|0
229331|NCT00086307|745302|P1|Overall Study|Shortness of breath and muscle spasms|1
229332|NCT00086307|745300|P3|Overall Study|Lack of Efficacy|2
229333|NCT00086307|745301|P2|Overall Study|Lack of Efficacy|1
229334|NCT00086307|745302|P1|Overall Study|Lack of Efficacy|1
229335|NCT00086190|745313|P3|Overall Study|Worsening depression|2
229336|NCT00086190|745314|P2|Overall Study|Worsening depression|0
229337|NCT00086190|745315|P1|Overall Study|Worsening depression|0
229338|NCT00086190|745313|P3|Overall Study|Moved|0
229339|NCT00086190|745314|P2|Overall Study|Moved|0
229340|NCT00086190|745315|P1|Overall Study|Moved|1
229341|NCT00086190|745313|P3|Overall Study|Protocol Violation|0
229342|NCT00086190|745314|P2|Overall Study|Protocol Violation|0
229343|NCT00086190|745315|P1|Overall Study|Protocol Violation|1
229344|NCT00086190|745313|P3|Overall Study|Withdrawal by Subject|2
229345|NCT00086190|745314|P2|Overall Study|Withdrawal by Subject|2
229346|NCT00086190|745315|P1|Overall Study|Withdrawal by Subject|0
229347|NCT00086190|745313|P3|Overall Study|Adverse Event|2
229348|NCT00086190|745314|P2|Overall Study|Adverse Event|2
229349|NCT00086190|745315|P1|Overall Study|Adverse Event|6
229350|NCT00086047|745384|P2|Overall Study|Physician Decision|1
229351|NCT00086047|745385|P1|Overall Study|Physician Decision|0
229352|NCT00086047|745384|P2|Overall Study|Lost to Follow-up|6
229353|NCT00086047|745385|P1|Overall Study|Lost to Follow-up|7
229354|NCT00085917|745393|P2|Overall Study|Adverse Event|3
229355|NCT00085917|745394|P1|Overall Study|Adverse Event|4
229356|NCT00085735|745423|P6|Overall Study|Pt transferred to inst w/out study open|0
229357|NCT00085735|745424|P5|Overall Study|Pt transferred to inst w/out study open|0
229358|NCT00085735|745425|P4|Overall Study|Pt transferred to inst w/out study open|0
229359|NCT00085735|745426|P3|Overall Study|Pt transferred to inst w/out study open|0
229360|NCT00085735|745427|P2|Overall Study|Pt transferred to inst w/out study open|0
229361|NCT00085735|745428|P1|Overall Study|Pt transferred to inst w/out study open|1
229362|NCT00085735|745423|P6|Overall Study|Reason not documented|0
229363|NCT00085735|745424|P5|Overall Study|Reason not documented|1
229364|NCT00085735|745425|P4|Overall Study|Reason not documented|0
229365|NCT00085735|745426|P3|Overall Study|Reason not documented|1
229366|NCT00085735|745427|P2|Overall Study|Reason not documented|0
229367|NCT00085735|745428|P1|Overall Study|Reason not documented|1
229368|NCT00085735|745423|P6|Overall Study|Excess residual disease|4
229369|NCT00085735|745424|P5|Overall Study|Excess residual disease|1
229370|NCT00085735|745425|P4|Overall Study|Excess residual disease|1
229371|NCT00085735|745426|P3|Overall Study|Excess residual disease|1
229372|NCT00085735|745427|P2|Overall Study|Excess residual disease|2
229373|NCT00085735|745428|P1|Overall Study|Excess residual disease|2
229374|NCT00085735|745423|P6|Overall Study|Patient ineligible|8
229375|NCT00085735|745424|P5|Overall Study|Patient ineligible|17
229376|NCT00085735|745425|P4|Overall Study|Patient ineligible|7
229377|NCT00085735|745426|P3|Overall Study|Patient ineligible|3
229378|NCT00085735|745427|P2|Overall Study|Patient ineligible|0
229379|NCT00085735|745428|P1|Overall Study|Patient ineligible|1
229380|NCT00085735|745423|P6|Overall Study|Withdrawal by Subject|8
229381|NCT00085735|745424|P5|Overall Study|Withdrawal by Subject|7
229382|NCT00085735|745425|P4|Overall Study|Withdrawal by Subject|5
229383|NCT00085735|745426|P3|Overall Study|Withdrawal by Subject|4
229384|NCT00085735|745427|P2|Overall Study|Withdrawal by Subject|0
229385|NCT00085735|745428|P1|Overall Study|Withdrawal by Subject|1
229386|NCT00085735|745423|P6|Overall Study|Protocol Violation|0
229387|NCT00085735|745424|P5|Overall Study|Protocol Violation|0
229388|NCT00085735|745425|P4|Overall Study|Protocol Violation|0
229389|NCT00085735|745426|P3|Overall Study|Protocol Violation|0
229390|NCT00085735|745427|P2|Overall Study|Protocol Violation|0
229391|NCT00085735|745428|P1|Overall Study|Protocol Violation|1
229392|NCT00085735|745423|P6|Overall Study|Physician Decision|8
229393|NCT00085735|745424|P5|Overall Study|Physician Decision|11
229394|NCT00085735|745425|P4|Overall Study|Physician Decision|3
229395|NCT00085735|745426|P3|Overall Study|Physician Decision|2
229396|NCT00085735|745427|P2|Overall Study|Physician Decision|3
229397|NCT00085735|745428|P1|Overall Study|Physician Decision|2
229398|NCT00085735|745423|P6|Overall Study|Lost to Follow-up|0
229399|NCT00085735|745424|P5|Overall Study|Lost to Follow-up|1
229400|NCT00085735|745425|P4|Overall Study|Lost to Follow-up|0
229401|NCT00085735|745426|P3|Overall Study|Lost to Follow-up|0
229402|NCT00085735|745427|P2|Overall Study|Lost to Follow-up|1
229403|NCT00085735|745428|P1|Overall Study|Lost to Follow-up|0
229404|NCT00085735|745423|P6|Overall Study|Lack of Efficacy|3
229405|NCT00085735|745424|P5|Overall Study|Lack of Efficacy|4
229406|NCT00085735|745425|P4|Overall Study|Lack of Efficacy|3
229407|NCT00085735|745426|P3|Overall Study|Lack of Efficacy|6
229408|NCT00085735|745427|P2|Overall Study|Lack of Efficacy|4
229409|NCT00085735|745428|P1|Overall Study|Lack of Efficacy|2
229410|NCT00085735|745423|P6|Overall Study|Adverse Event|0
229411|NCT00085735|745424|P5|Overall Study|Adverse Event|0
229412|NCT00085735|745425|P4|Overall Study|Adverse Event|0
229413|NCT00085735|745426|P3|Overall Study|Adverse Event|0
229414|NCT00085735|745427|P2|Overall Study|Adverse Event|0
229415|NCT00085735|745428|P1|Overall Study|Adverse Event|1
229416|NCT00085709|745456|P2|Overall Study|Withdrawal by Subject|1
229417|NCT00085709|745457|P1|Overall Study|Withdrawal by Subject|2
229418|NCT00085709|745456|P2|Overall Study|Not eligible|19
229419|NCT00085709|745457|P1|Overall Study|Not eligible|19
229420|NCT00085709|745456|P2|Overall Study|Not protocol specified|22
229421|NCT00085709|745457|P1|Overall Study|Not protocol specified|12
229422|NCT00085709|745456|P2|Overall Study|Progression|4
229423|NCT00085709|745457|P1|Overall Study|Progression|3
229424|NCT00085709|745456|P2|Overall Study|Refusal unrelated to adverse events|2
229425|NCT00085709|745457|P1|Overall Study|Refusal unrelated to adverse events|1
229426|NCT00085709|745456|P2|Overall Study|Death|2
229427|NCT00085709|745457|P1|Overall Study|Death|8
229428|NCT00085709|745456|P2|Overall Study|Adverse Event|0
229429|NCT00085709|745457|P1|Overall Study|Adverse Event|8
229430|NCT00085644|745473|P3|Open-Label Period|Personal reason|4
229431|NCT00085644|745474|P2|Open-Label Period|Personal reason|0
229432|NCT00085644|745475|P1|Open-Label Period|Personal reason|0
229433|NCT00085644|745473|P3|Open-Label Period|Protocol Violation|4
229434|NCT00085644|745474|P2|Open-Label Period|Protocol Violation|0
229435|NCT00085644|745475|P1|Open-Label Period|Protocol Violation|0
229436|NCT00085644|745473|P3|Open-Label Period|Contemplating pregnancy|3
229437|NCT00085644|745474|P2|Open-Label Period|Contemplating pregnancy|0
229438|NCT00085644|745475|P1|Open-Label Period|Contemplating pregnancy|0
229439|NCT00085644|745473|P3|Open-Label Period|Pregnancy|3
229440|NCT00085644|745474|P2|Open-Label Period|Pregnancy|0
229441|NCT00085644|745475|P1|Open-Label Period|Pregnancy|0
229442|NCT00085644|745473|P3|Open-Label Period|Lack of Efficacy|15
229443|NCT00085644|745474|P2|Open-Label Period|Lack of Efficacy|0
229444|NCT00085644|745475|P1|Open-Label Period|Lack of Efficacy|0
229445|NCT00085644|745473|P3|Open-Label Period|Lost to Follow-up|13
229446|NCT00085644|745474|P2|Open-Label Period|Lost to Follow-up|0
229447|NCT00085644|745475|P1|Open-Label Period|Lost to Follow-up|0
229448|NCT00085644|745473|P3|Open-Label Period|Withdrawal by Subject|29
229449|NCT00085644|745474|P2|Open-Label Period|Withdrawal by Subject|0
229450|NCT00085644|745475|P1|Open-Label Period|Withdrawal by Subject|0
229451|NCT00085644|745473|P3|Open-Label Period|Adverse Event|38
229452|NCT00085644|745474|P2|Open-Label Period|Adverse Event|0
229453|NCT00085644|745475|P1|Open-Label Period|Adverse Event|0
229454|NCT00085644|745473|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
229455|NCT00085644|745474|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
229456|NCT00085644|745475|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
229457|NCT00085644|745473|P3|Double-Blind Period|Contemplating pregnancy|0
229458|NCT00085644|745474|P2|Double-Blind Period|Contemplating pregnancy|0
229459|NCT00085644|745475|P1|Double-Blind Period|Contemplating pregnancy|1
229460|NCT00085644|745473|P3|Double-Blind Period|Lack/loss of efficacy|0
229461|NCT00085644|745474|P2|Double-Blind Period|Lack/loss of efficacy|2
229462|NCT00085644|745475|P1|Double-Blind Period|Lack/loss of efficacy|2
229463|NCT00085644|745473|P3|Double-Blind Period|Lost to Follow-up|0
229464|NCT00085644|745474|P2|Double-Blind Period|Lost to Follow-up|1
229465|NCT00085644|745475|P1|Double-Blind Period|Lost to Follow-up|2
229466|NCT00085644|745473|P3|Double-Blind Period|Withdrawal by Subject|0
229467|NCT00085644|745474|P2|Double-Blind Period|Withdrawal by Subject|0
229468|NCT00085644|745475|P1|Double-Blind Period|Withdrawal by Subject|3
229469|NCT00085644|745473|P3|Double-Blind Period|Adverse Event|0
229470|NCT00085644|745474|P2|Double-Blind Period|Adverse Event|2
229471|NCT00085644|745475|P1|Double-Blind Period|Adverse Event|5
229472|NCT00085631|745516|P3|Overall Study|Missing Data|7
229473|NCT00085631|745517|P2|Overall Study|Missing Data|11
229474|NCT00085631|745518|P1|Overall Study|Missing Data|4
229475|NCT00085566|745528|P3|Overall Study|Clinical progression|1
229476|NCT00085566|745529|P2|Overall Study|Clinical progression|0
229477|NCT00085566|745530|P1|Overall Study|Clinical progression|0
229478|NCT00085566|745528|P3|Overall Study|Patient Not treated|3
229479|NCT00085566|745529|P2|Overall Study|Patient Not treated|0
229480|NCT00085566|745530|P1|Overall Study|Patient Not treated|0
229481|NCT00085566|745528|P3|Overall Study|Adverse Event|10
229482|NCT00085566|745529|P2|Overall Study|Adverse Event|0
229483|NCT00085566|745530|P1|Overall Study|Adverse Event|0
229484|NCT00085540|745540|P2|Overall Study|Protocol Violation|1
229485|NCT00085540|745541|P1|Overall Study|Protocol Violation|0
229486|NCT00085540|745540|P2|Overall Study|Withdrawal by Subject|1
229487|NCT00085540|745541|P1|Overall Study|Withdrawal by Subject|0
229488|NCT00085423|745552|P1|Overall Study|screen failure|1
229489|NCT00085423|745552|P1|Overall Study|Withdrawal by Subject|1
229490|NCT00085202|745598|P2|Overall Study|Progressive disease|11
229491|NCT00085202|745599|P1|Overall Study|Progressive disease|1
229492|NCT00085202|745598|P2|Overall Study|Physician Decision|1
229493|NCT00085202|745599|P1|Overall Study|Physician Decision|4
229494|NCT00085202|745598|P2|Overall Study|Withdrawal by Subject|1
229495|NCT00085202|745599|P1|Overall Study|Withdrawal by Subject|2
229496|NCT00085202|745598|P2|Overall Study|Non-specified|5
229497|NCT00085202|745599|P1|Overall Study|Non-specified|3
229498|NCT00085202|745598|P2|Overall Study|Excessive toxicity|5
229499|NCT00085202|745599|P1|Overall Study|Excessive toxicity|6
229500|NCT00085202|745598|P2|Overall Study|Bone involvement confirmed by bone scan|1
229501|NCT00085202|745599|P1|Overall Study|Bone involvement confirmed by bone scan|0
229502|NCT00085202|745598|P2|Overall Study|Still on therapy|0
229503|NCT00085202|745599|P1|Overall Study|Still on therapy|2
229504|NCT00085098|745620|P2|Overall Study|Ineligible|1
229505|NCT00085098|745621|P1|Overall Study|Ineligible|1
229506|NCT00085098|745620|P2|Overall Study|Withdrawal by Subject|1
229507|NCT00085098|745621|P1|Overall Study|Withdrawal by Subject|0
229508|NCT00084864|745631|P4|Overall Study|Adverse Event|0
229509|NCT00084864|745632|P3|Overall Study|Adverse Event|0
229510|NCT00084864|745633|P2|Overall Study|Adverse Event|0
229511|NCT00084864|745634|P1|Overall Study|Adverse Event|1
229512|NCT00084838|745660|P1|Overall Study|Ineligible|4
229513|NCT00084838|745660|P1|Overall Study|Pt Non-Compliance|1
229514|NCT00084838|745660|P1|Overall Study|Progressive Disease|4
229515|NCT00084838|745660|P1|Overall Study|Withdrawal by Subject|1
229516|NCT00084838|745660|P1|Overall Study|Adverse Event|2
229517|NCT00084838|745660|P1|Overall Study|Death|1
229518|NCT00084747|745682|P1|Overall Study|Withdrawal by Subject|2
229519|NCT00084747|745682|P1|Overall Study|Death|3
229520|NCT00084747|745682|P1|Overall Study|Relapsed|8
229521|NCT00084682|745687|P1|Overall Study|Withdrawal by Subject|1
229522|NCT00084617|745691|P1|Overall Study|Protocol Violation|1
229523|NCT00084617|745691|P1|Overall Study|Lack of Efficacy|1
229524|NCT00084617|745691|P1|Overall Study|Withdrawal by Subject|7
229525|NCT00084487|745697|P1|Overall Study|Death|1
229526|NCT00084318|745743|P2|Overall Study|No protocol treatment|0
229527|NCT00084318|745744|P1|Overall Study|No protocol treatment|2
229528|NCT00084318|745743|P2|Overall Study|Protocol Violation|11
229529|NCT00084318|745744|P1|Overall Study|Protocol Violation|15
229530|NCT00084318|745743|P2|Overall Study|Withdrawal by Subject|2
229531|NCT00084318|745744|P1|Overall Study|Withdrawal by Subject|5
229532|NCT00084266|745762|P2|Overall Study|Randomized not treated|20
229533|NCT00084266|745763|P1|Overall Study|Randomized not treated|21
229534|NCT00084266|745762|P2|Overall Study|Other|344
229535|NCT00084266|745763|P1|Overall Study|Other|360
229536|NCT00084266|745762|P2|Overall Study|Participant not willing to participate|8
229537|NCT00084266|745763|P1|Overall Study|Participant not willing to participate|3
229538|NCT00084266|745762|P2|Overall Study|Lost to Follow-up|3
229539|NCT00084266|745763|P1|Overall Study|Lost to Follow-up|5
229540|NCT00084266|745762|P2|Overall Study|Lack of Efficacy|4
229541|NCT00084266|745763|P1|Overall Study|Lack of Efficacy|2
229542|NCT00084266|745762|P2|Overall Study|Adverse Event|5
229543|NCT00084266|745763|P1|Overall Study|Adverse Event|8
229544|NCT00084266|745762|P2|Overall Study|Death|39
229545|NCT00084266|745763|P1|Overall Study|Death|42
229546|NCT00084136|745800|P3|NRTI Comparison|Not reason above|0
229547|NCT00084136|745801|P2|NRTI Comparison|Not reason above|0
229548|NCT00084136|745802|P1|NRTI Comparison|Not reason above|1
229549|NCT00084136|745800|P3|NRTI Comparison|Clinic site closed|14
229550|NCT00084136|745801|P2|NRTI Comparison|Clinic site closed|0
229551|NCT00084136|745802|P1|NRTI Comparison|Clinic site closed|12
229552|NCT00084136|745800|P3|NRTI Comparison|Withdrawal by Subject|38
229553|NCT00084136|745801|P2|NRTI Comparison|Withdrawal by Subject|0
229554|NCT00084136|745802|P1|NRTI Comparison|Withdrawal by Subject|54
229555|NCT00084136|745800|P3|NRTI Comparison|Lost to Follow-up|12
229556|NCT00084136|745801|P2|NRTI Comparison|Lost to Follow-up|0
229557|NCT00084136|745802|P1|NRTI Comparison|Lost to Follow-up|14
229558|NCT00084136|745800|P3|NRTI Comparison|Death|18
229559|NCT00084136|745801|P2|NRTI Comparison|Death|0
229560|NCT00084136|745802|P1|NRTI Comparison|Death|20
229561|NCT00084136|745800|P3|PI Comparison|Clinic site closed|0
229562|NCT00084136|745801|P2|PI Comparison|Clinic site closed|0
229563|NCT00084136|745802|P1|PI Comparison|Clinic site closed|1
229564|NCT00084136|745800|P3|PI Comparison|Withdrawal by Subject|0
229565|NCT00084136|745801|P2|PI Comparison|Withdrawal by Subject|30
229566|NCT00084136|745802|P1|PI Comparison|Withdrawal by Subject|33
229567|NCT00084136|745800|P3|PI Comparison|Lost to Follow-up|0
229568|NCT00084136|745801|P2|PI Comparison|Lost to Follow-up|8
229569|NCT00084136|745802|P1|PI Comparison|Lost to Follow-up|11
229570|NCT00084136|745800|P3|PI Comparison|Death|0
229571|NCT00084136|745801|P2|PI Comparison|Death|9
229572|NCT00084136|745802|P1|PI Comparison|Death|10
229573|NCT00084084|745861|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
229574|NCT00084084|745861|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
229575|NCT00083915|745871|P2|Overall Study|Insurance issues|1
229576|NCT00083915|745872|P1|Overall Study|Insurance issues|1
229577|NCT00083915|745871|P2|Overall Study|No response|1
229578|NCT00083915|745872|P1|Overall Study|No response|3
229579|NCT00083915|745871|P2|Overall Study|Failure to collect|0
229580|NCT00083915|745872|P1|Overall Study|Failure to collect|3
229581|NCT00083915|745871|P2|Overall Study|disease progression|23
229582|NCT00083915|745872|P1|Overall Study|disease progression|18
229583|NCT00083915|745871|P2|Overall Study|Withdrawal by Subject|3
229584|NCT00083915|745872|P1|Overall Study|Withdrawal by Subject|8
229585|NCT00083915|745871|P2|Overall Study|Physician Decision|6
229586|NCT00083915|745872|P1|Overall Study|Physician Decision|11
229587|NCT00083915|745871|P2|Overall Study|Death|3
229588|NCT00083915|745872|P1|Overall Study|Death|6
229589|NCT00083889|745880|P2|Overall Study|Crossover to SU011248|25
229590|NCT00083889|745881|P1|Overall Study|Crossover to SU011248|0
229591|NCT00083889|745880|P2|Overall Study|Completed on marketed sunitinub|0
229592|NCT00083889|745881|P1|Overall Study|Completed on marketed sunitinub|3
229593|NCT00083889|745880|P2|Overall Study|Randomized: did not take study drug|15
229594|NCT00083889|745881|P1|Overall Study|Randomized: did not take study drug|0
229595|NCT00083889|745880|P2|Overall Study|Decision of sponsor|4
229596|NCT00083889|745881|P1|Overall Study|Decision of sponsor|32
229597|NCT00083889|745880|P2|Overall Study|Lack of Efficacy|219
229598|NCT00083889|745881|P1|Overall Study|Lack of Efficacy|240
229599|NCT00083889|745880|P2|Overall Study|Withdrawal by Subject|24
229600|NCT00083889|745881|P1|Overall Study|Withdrawal by Subject|22
229601|NCT00083889|745880|P2|Overall Study|Protocol Violation|2
229602|NCT00083889|745881|P1|Overall Study|Protocol Violation|2
229603|NCT00083889|745880|P2|Overall Study|Adverse Event|86
229604|NCT00083889|745881|P1|Overall Study|Adverse Event|76
229605|NCT00083759|745939|P2|Overall Study|Other|13
229606|NCT00083759|745940|P1|Overall Study|Other|14
229607|NCT00083759|745939|P2|Overall Study|Sponsor's Discretion|29
229608|NCT00083759|745940|P1|Overall Study|Sponsor's Discretion|28
229609|NCT00083759|745939|P2|Overall Study|Non-Compliance|0
229610|NCT00083759|745940|P1|Overall Study|Non-Compliance|1
229611|NCT00083759|745939|P2|Overall Study|Subject Withdrew Consent|2
229612|NCT00083759|745940|P1|Overall Study|Subject Withdrew Consent|2
229613|NCT00083759|745939|P2|Overall Study|Inadequate Therapeutic Response|35
229614|NCT00083759|745940|P1|Overall Study|Inadequate Therapeutic Response|32
229615|NCT00083759|745939|P2|Overall Study|Death|1
229616|NCT00083759|745940|P1|Overall Study|Death|1
229617|NCT00083759|745939|P2|Overall Study|Lost to Follow-up|0
229618|NCT00083759|745940|P1|Overall Study|Lost to Follow-up|1
229619|NCT00083759|745939|P2|Overall Study|Adverse Event|3
229620|NCT00083759|745940|P1|Overall Study|Adverse Event|5
229621|NCT00083616|745958|P1|Overall Study|Other|6
229622|NCT00083616|745958|P1|Overall Study|Non-compliance|1
229623|NCT00083616|745958|P1|Overall Study|Ineligibility determined|2
229624|NCT00083616|745958|P1|Overall Study|Withdrawal by Subject|3
229625|NCT00083616|745958|P1|Overall Study|Physician Decision|2
229626|NCT00083616|745958|P1|Overall Study|Lost to Follow-up|1
229627|NCT00083616|745958|P1|Overall Study|Disease Progression|16
229628|NCT00082888|745983|P1|Overall Study|Still receiving treatment|4
229629|NCT00082888|745983|P1|Overall Study|Other Medical Problems|2
229630|NCT00082888|745983|P1|Overall Study|Alternate Treatment|1
229631|NCT00082888|745983|P1|Overall Study|Withdrawal by Subject|9
229632|NCT00082888|745983|P1|Overall Study|Adverse Event|4
229633|NCT00082888|745983|P1|Overall Study|Death|2
229634|NCT00082810|745987|P1|Overall Study|Withdrawal by Subject|4
229635|NCT00082810|745987|P1|Overall Study|Progressive disease|24
229636|NCT00082810|745987|P1|Overall Study|Adverse Event|3
229637|NCT00082758|745997|P3|Overall Study|Protocol Violation|0
229638|NCT00082758|745998|P2|Overall Study|Protocol Violation|1
229639|NCT00082758|745999|P1|Overall Study|Protocol Violation|0
229640|NCT00082758|745997|P3|Overall Study|Withdrawal by Subject|0
229641|NCT00082758|745998|P2|Overall Study|Withdrawal by Subject|0
229642|NCT00082758|745999|P1|Overall Study|Withdrawal by Subject|3
229643|NCT00082758|745997|P3|Overall Study|Physician Decision|0
229644|NCT00082758|745998|P2|Overall Study|Physician Decision|1
229645|NCT00082758|745999|P1|Overall Study|Physician Decision|0
229646|NCT00082758|745997|P3|Overall Study|Lack of Efficacy|0
229647|NCT00082758|745998|P2|Overall Study|Lack of Efficacy|13
229648|NCT00082758|745999|P1|Overall Study|Lack of Efficacy|12
229649|NCT00082758|745997|P3|Overall Study|Adverse Event|0
229650|NCT00082758|745998|P2|Overall Study|Adverse Event|2
229651|NCT00082758|745999|P1|Overall Study|Adverse Event|0
229652|NCT00083226|746007|P1|Overall Study|ineligible or not receiving treatment|4
229653|NCT00083226|746007|P1|Overall Study|Other|2
229654|NCT00083226|746007|P1|Overall Study|Withdrawal by Subject|4
229655|NCT00083226|746007|P1|Overall Study|Death|4
229656|NCT00083226|746007|P1|Overall Study|Adverse Event|9
229657|NCT00083226|746007|P1|Overall Study|Lack of Efficacy|19
229658|NCT00082433|746051|P2|Overall Study|Impending surgery|1
229659|NCT00082433|746052|P1|Overall Study|Impending surgery|0
229660|NCT00082433|746051|P2|Overall Study|New primary cancer|0
229661|NCT00082433|746052|P1|Overall Study|New primary cancer|1
229662|NCT00082433|746051|P2|Overall Study|Noncompliance|1
229663|NCT00082433|746052|P1|Overall Study|Noncompliance|2
229664|NCT00082433|746051|P2|Overall Study|Ineligible|1
229665|NCT00082433|746052|P1|Overall Study|Ineligible|2
229666|NCT00082433|746051|P2|Overall Study|Not Treated|11
229667|NCT00082433|746052|P1|Overall Study|Not Treated|12
229668|NCT00082433|746051|P2|Overall Study|Still On Treatment|1
229669|NCT00082433|746052|P1|Overall Study|Still On Treatment|2
229670|NCT00082433|746051|P2|Overall Study|Withdrawal by Subject|30
229671|NCT00082433|746052|P1|Overall Study|Withdrawal by Subject|55
229672|NCT00082433|746051|P2|Overall Study|Study Drug Toxicity|66
229673|NCT00082433|746052|P1|Overall Study|Study Drug Toxicity|179
229674|NCT00082433|746051|P2|Overall Study|Lost to Follow-up|2
229675|NCT00082433|746052|P1|Overall Study|Lost to Follow-up|1
229676|NCT00082433|746051|P2|Overall Study|Physician Decision|61
229677|NCT00082433|746052|P1|Overall Study|Physician Decision|50
229678|NCT00082433|746051|P2|Overall Study|Disease Progression/Relapse|388
229679|NCT00082433|746052|P1|Overall Study|Disease Progression/Relapse|270
229680|NCT00082433|746051|P2|Overall Study|Death|18
229681|NCT00082433|746052|P1|Overall Study|Death|8
229682|NCT00082433|746051|P2|Overall Study|Adverse Event|17
229683|NCT00082433|746052|P1|Overall Study|Adverse Event|12
229684|NCT00082381|746072|P2|Overall Study|Loss of Glucose Control|0
229685|NCT00082381|746073|P1|Overall Study|Loss of Glucose Control|4
229686|NCT00082381|746072|P2|Overall Study|Protocol Violation|11
229687|NCT00082381|746073|P1|Overall Study|Protocol Violation|10
229688|NCT00082381|746072|P2|Overall Study|Physician Decision|2
229689|NCT00082381|746073|P1|Overall Study|Physician Decision|1
229690|NCT00082381|746072|P2|Overall Study|Patient Decision|4
229691|NCT00082381|746073|P1|Overall Study|Patient Decision|8
229692|NCT00082381|746072|P2|Overall Study|Lost to Follow-up|7
229693|NCT00082381|746073|P1|Overall Study|Lost to Follow-up|5
229694|NCT00082381|746072|P2|Overall Study|Adverse Event|2
229695|NCT00082381|746073|P1|Overall Study|Adverse Event|27
229696|NCT00082407|746093|P2|Overall Study|Lost to Follow-up|3
229697|NCT00082407|746094|P1|Overall Study|Lost to Follow-up|0
229698|NCT00082407|746093|P2|Overall Study|Death|1
229699|NCT00082407|746094|P1|Overall Study|Death|2
229700|NCT00082407|746093|P2|Overall Study|Loss of Glucose Control|2
229701|NCT00082407|746094|P1|Overall Study|Loss of Glucose Control|2
229702|NCT00082407|746093|P2|Overall Study|Physician Decision|3
229703|NCT00082407|746094|P1|Overall Study|Physician Decision|5
229704|NCT00082407|746093|P2|Overall Study|Patient Decision|6
229705|NCT00082407|746094|P1|Overall Study|Patient Decision|13
229706|NCT00082407|746093|P2|Overall Study|Protocol Violation|12
229707|NCT00082407|746094|P1|Overall Study|Protocol Violation|14
229708|NCT00082407|746093|P2|Overall Study|Adverse Event|0
229709|NCT00082407|746094|P1|Overall Study|Adverse Event|20
229710|NCT00082368|746112|P1|Overall Study|Not treated-pt had poor IV access|1
229711|NCT00082355|746117|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
229712|NCT00082355|746117|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
229713|NCT00082355|746117|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
229714|NCT00082173|746151|P2|Overall Study|Culture negative or resistant at baselin|6
229715|NCT00082173|746152|P1|Overall Study|Culture negative or resistant at baselin|5
229716|NCT00082173|746151|P2|Overall Study|Adverse Event|0
229717|NCT00082173|746152|P1|Overall Study|Adverse Event|1
229718|NCT00082173|746151|P2|Overall Study|Lost to Follow-up|0
229719|NCT00082173|746152|P1|Overall Study|Lost to Follow-up|1
229720|NCT00082173|746151|P2|Overall Study|Withdrawal by Subject|5
229721|NCT00082173|746152|P1|Overall Study|Withdrawal by Subject|3
229722|NCT00081770|746192|P3|Overall Study|Not Specified|8
229723|NCT00081770|746193|P2|Overall Study|Not Specified|7
229724|NCT00081770|746194|P1|Overall Study|Not Specified|2
229725|NCT00081770|746192|P3|Overall Study|Administrative|1
229726|NCT00081770|746193|P2|Overall Study|Administrative|0
229727|NCT00081770|746194|P1|Overall Study|Administrative|1
229728|NCT00081770|746192|P3|Overall Study|Did not meet protocol eligibility|3
229729|NCT00081770|746193|P2|Overall Study|Did not meet protocol eligibility|0
229730|NCT00081770|746194|P1|Overall Study|Did not meet protocol eligibility|2
229731|NCT00081770|746192|P3|Overall Study|Withdrawal by Subject|42
229732|NCT00081770|746193|P2|Overall Study|Withdrawal by Subject|40
229733|NCT00081770|746194|P1|Overall Study|Withdrawal by Subject|45
229734|NCT00081770|746192|P3|Overall Study|Protocol Violation|10
229735|NCT00081770|746193|P2|Overall Study|Protocol Violation|10
229736|NCT00081770|746194|P1|Overall Study|Protocol Violation|15
229737|NCT00081770|746192|P3|Overall Study|Lost to Follow-up|45
229738|NCT00081770|746193|P2|Overall Study|Lost to Follow-up|34
229739|NCT00081770|746194|P1|Overall Study|Lost to Follow-up|45
229740|NCT00081770|746192|P3|Overall Study|Lack of Efficacy|211
229741|NCT00081770|746193|P2|Overall Study|Lack of Efficacy|357
229742|NCT00081770|746194|P1|Overall Study|Lack of Efficacy|262
229743|NCT00081770|746192|P3|Overall Study|Adverse Event|136
229744|NCT00081770|746193|P2|Overall Study|Adverse Event|98
229745|NCT00081770|746194|P1|Overall Study|Adverse Event|130
229746|NCT00081731|746213|P2|Overall Study|scientific integrity issue|8
229747|NCT00081731|746214|P1|Overall Study|scientific integrity issue|8
229748|NCT00081653|746234|P2|Overall Study|Loss of bone mass|2
229749|NCT00081653|746235|P1|Overall Study|Loss of bone mass|0
229750|NCT00081653|746234|P2|Overall Study|Participant leaving country|0
229751|NCT00081653|746235|P1|Overall Study|Participant leaving country|1
229752|NCT00081653|746234|P2|Overall Study|Bone loss|0
229753|NCT00081653|746235|P1|Overall Study|Bone loss|2
229754|NCT00081653|746234|P2|Overall Study|Low bone mineral density|0
229755|NCT00081653|746235|P1|Overall Study|Low bone mineral density|1
229756|NCT00081653|746234|P2|Overall Study|Refused Treatment|14
229757|NCT00081653|746235|P1|Overall Study|Refused Treatment|18
229758|NCT00081653|746234|P2|Overall Study|Lost to Follow-up|4
229759|NCT00081653|746235|P1|Overall Study|Lost to Follow-up|2
229760|NCT00081653|746234|P2|Overall Study|Adverse Event|17
229761|NCT00081653|746235|P1|Overall Study|Adverse Event|23
229762|NCT00081497|746253|P2|Overall Study|Non-compliance|1
229763|NCT00081497|746254|P1|Overall Study|Non-compliance|0
229764|NCT00081497|746253|P2|Overall Study|Withdrawal by Subject|0
229765|NCT00081497|746254|P1|Overall Study|Withdrawal by Subject|1
229766|NCT00081497|746253|P2|Overall Study|Death|1
229767|NCT00081497|746254|P1|Overall Study|Death|0
229768|NCT00081497|746253|P2|Overall Study|Adverse Event|0
229769|NCT00081497|746254|P1|Overall Study|Adverse Event|2
229770|NCT00081458|746272|P3|Overall Study|Randomized but not dosed|1
229771|NCT00081458|746273|P2|Overall Study|Randomized but not dosed|0
229772|NCT00081458|746274|P1|Overall Study|Randomized but not dosed|0
229773|NCT00081458|746272|P3|Overall Study|Withdrawal by Subject|1
229774|NCT00081458|746273|P2|Overall Study|Withdrawal by Subject|3
229775|NCT00081458|746274|P1|Overall Study|Withdrawal by Subject|0
229776|NCT00081458|746272|P3|Overall Study|Adverse Event|2
229777|NCT00081458|746273|P2|Overall Study|Adverse Event|5
229778|NCT00081458|746274|P1|Overall Study|Adverse Event|1
229779|NCT00081289|746330|P2|Overall Study|Ineligible / no protocol treatment|4
229780|NCT00081289|746331|P1|Overall Study|Ineligible / no protocol treatment|3
229781|NCT00081289|746330|P2|Overall Study|Accrued prior to chemotherapy amendment|17
229782|NCT00081289|746331|P1|Overall Study|Accrued prior to chemotherapy amendment|18
229783|NCT00081263|746339|P2|Overall Study|Inadequate data|10
229784|NCT00081263|746340|P1|Overall Study|Inadequate data|5
229785|NCT00081263|746339|P2|Overall Study|Never treated|5
229786|NCT00081263|746340|P1|Overall Study|Never treated|4
229787|NCT00081263|746339|P2|Overall Study|Inadequate pathology|1
229788|NCT00081263|746340|P1|Overall Study|Inadequate pathology|0
229789|NCT00081263|746339|P2|Overall Study|improper pre-protocol therapy|1
229790|NCT00081263|746340|P1|Overall Study|improper pre-protocol therapy|0
229791|NCT00081263|746339|P2|Overall Study|wrong cell type|5
229792|NCT00081263|746340|P1|Overall Study|wrong cell type|7
229793|NCT00081263|746339|P2|Overall Study|clerical error|0
229794|NCT00081263|746340|P1|Overall Study|clerical error|1
229795|NCT00081159|746350|P2|Overall Study|Lost to Follow-up|1
229796|NCT00081159|746351|P1|Overall Study|Lost to Follow-up|2
229797|NCT00081159|746350|P2|Overall Study|Myelosuppression prior to treatment|1
229798|NCT00081159|746351|P1|Overall Study|Myelosuppression prior to treatment|0
229799|NCT00081159|746350|P2|Overall Study|Withdrawal by Subject|3
229800|NCT00081159|746351|P1|Overall Study|Withdrawal by Subject|0
229801|NCT00080938|746361|P1|Overall Study|Ineligible|4
229802|NCT00080938|746361|P1|Overall Study|Not started protocol therapy|1
229803|NCT00080938|746361|P1|Overall Study|other disease|1
229804|NCT00080938|746361|P1|Overall Study|Lack of Efficacy|7
229805|NCT00080938|746361|P1|Overall Study|Death|2
229806|NCT00080938|746361|P1|Overall Study|Withdrawal by Subject|6
229807|NCT00080938|746361|P1|Overall Study|Adverse Event|3
229808|NCT00080899|746377|P1|Overall Study|Adverse Event|1
229809|NCT00080483|746389|P2|Overall Study|Physician Decision|1
229810|NCT00080483|746390|P1|Overall Study|Physician Decision|1
229811|NCT00080483|746389|P2|Overall Study|Lost to Follow-up|1
229812|NCT00080483|746390|P1|Overall Study|Lost to Follow-up|1
229813|NCT00002525|746398|P2|Overall Study|Never start protocol therapy|0
229814|NCT00002525|746399|P1|Overall Study|Never start protocol therapy|8
229815|NCT00002525|746398|P2|Overall Study|Other|0
229816|NCT00002525|746399|P1|Overall Study|Other|26
229817|NCT00002525|746398|P2|Overall Study|Error|0
229818|NCT00002525|746399|P1|Overall Study|Error|6
229819|NCT00002525|746398|P2|Overall Study|Duke's A, B1, D disease|0
229820|NCT00002525|746399|P1|Overall Study|Duke's A, B1, D disease|92
229821|NCT00002525|746398|P2|Overall Study|Other complicating disease|0
229822|NCT00002525|746399|P1|Overall Study|Other complicating disease|1
229823|NCT00002525|746398|P2|Overall Study|Start non-protocol therapy|0
229824|NCT00002525|746399|P1|Overall Study|Start non-protocol therapy|1
229825|NCT00002525|746398|P2|Overall Study|Withdrawal by Subject|0
229826|NCT00002525|746399|P1|Overall Study|Withdrawal by Subject|11
229827|NCT00002525|746398|P2|Overall Study|Death|0
229828|NCT00002525|746399|P1|Overall Study|Death|5
229829|NCT00002525|746398|P2|Overall Study|Adverse Event|0
229830|NCT00002525|746399|P1|Overall Study|Adverse Event|36
229831|NCT00080301|746426|P2|Overall Study|Still on Treatment as of CSR date|1
229832|NCT00080301|746427|P1|Overall Study|Still on Treatment as of CSR date|0
229833|NCT00080301|746426|P2|Overall Study|Randomized but Never Treated|10
229834|NCT00080301|746427|P1|Overall Study|Randomized but Never Treated|5
229835|NCT00080288|746447|P2|Overall Study|Miscellaneous|11
229836|NCT00080288|746448|P1|Overall Study|Miscellaneous|11
229837|NCT00080288|746447|P2|Overall Study|Withdrawal by Subject|16
229838|NCT00080288|746448|P1|Overall Study|Withdrawal by Subject|3
229839|NCT00080288|746447|P2|Overall Study|Physician Decision|2
229840|NCT00080288|746448|P1|Overall Study|Physician Decision|6
229841|NCT00080288|746447|P2|Overall Study|Lost to Follow-up|5
229842|NCT00080288|746448|P1|Overall Study|Lost to Follow-up|3
229843|NCT00080288|746447|P2|Overall Study|Adverse Event|4
229844|NCT00080288|746448|P1|Overall Study|Adverse Event|7
229845|NCT00080223|746456|P1|Overall Study|Physician Decision|1
229846|NCT00080223|746456|P1|Overall Study|Participant unwilling to continue|2
229847|NCT00080223|746456|P1|Overall Study|Non-compliance With Study Treatment|7
229848|NCT00080223|746456|P1|Overall Study|Lung Transplantation|9
229849|NCT00080223|746456|P1|Overall Study|Withdrawal by Subject|13
229850|NCT00080223|746456|P1|Overall Study|Death|21
229851|NCT00080223|746456|P1|Overall Study|Adverse Event|23
229852|NCT00002540|746466|P2|Overall Study|Refused Screen (Prostate Screening)|2433
229853|NCT00002540|746467|P1|Overall Study|Refused Screen (Prostate Screening)|0
229854|NCT00002540|746466|P2|Overall Study|Refused ASU (Control)|0
229855|NCT00002540|746467|P1|Overall Study|Refused ASU (Control)|597
229856|NCT00002540|746466|P2|Overall Study|Died Before ASU (Control)|0
229857|NCT00002540|746467|P1|Overall Study|Died Before ASU (Control)|202
229858|NCT00002540|746466|P2|Overall Study|Died Before Randomization|6
229859|NCT00002540|746467|P1|Overall Study|Died Before Randomization|2
229860|NCT00002540|746466|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
229861|NCT00002540|746467|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
229862|NCT00080119|746497|P4|Overall Study|Lost to Follow-up|14
229863|NCT00080119|746498|P3|Overall Study|Lost to Follow-up|19
229864|NCT00080119|746499|P2|Overall Study|Lost to Follow-up|19
229865|NCT00080119|746500|P1|Overall Study|Lost to Follow-up|16
229866|NCT00080119|746497|P4|Overall Study|Unwilling to adhere to study requirement|1
229867|NCT00080119|746498|P3|Overall Study|Unwilling to adhere to study requirement|5
229868|NCT00080119|746499|P2|Overall Study|Unwilling to adhere to study requirement|2
229869|NCT00080119|746500|P1|Overall Study|Unwilling to adhere to study requirement|3
229870|NCT00080119|746497|P4|Overall Study|Consent withdrawn|6
229871|NCT00080119|746498|P3|Overall Study|Consent withdrawn|4
229872|NCT00080119|746499|P2|Overall Study|Consent withdrawn|17
229873|NCT00080119|746500|P1|Overall Study|Consent withdrawn|13
229874|NCT00080119|746497|P4|Overall Study|Unable to get to clinic|1
229875|NCT00080119|746498|P3|Overall Study|Unable to get to clinic|7
229876|NCT00080119|746499|P2|Overall Study|Unable to get to clinic|24
229877|NCT00080119|746500|P1|Overall Study|Unable to get to clinic|24
229878|NCT00080119|746497|P4|Overall Study|Discontinued because of study closure|141
229879|NCT00080119|746498|P3|Overall Study|Discontinued because of study closure|130
229880|NCT00080119|746499|P2|Overall Study|Discontinued because of study closure|0
229881|NCT00080119|746500|P1|Overall Study|Discontinued because of study closure|0
229882|NCT00079937|746534|P2|Overall Study|Administrative problems|11
229883|NCT00079937|746535|P1|Overall Study|Administrative problems|22
229884|NCT00079937|746534|P2|Overall Study|Lost to Follow-up|5
229885|NCT00079937|746535|P1|Overall Study|Lost to Follow-up|12
229886|NCT00079937|746534|P2|Overall Study|Withdrawal by Subject|7
229887|NCT00079937|746535|P1|Overall Study|Withdrawal by Subject|21
229888|NCT00079937|746534|P2|Overall Study|Protocol Violation|6
229889|NCT00079937|746535|P1|Overall Study|Protocol Violation|8
229890|NCT00079937|746534|P2|Overall Study|Subject no longer requires study drug|0
229891|NCT00079937|746535|P1|Overall Study|Subject no longer requires study drug|3
229892|NCT00079937|746534|P2|Overall Study|Unsatisfactory therapeutic effect|2
229893|NCT00079937|746535|P1|Overall Study|Unsatisfactory therapeutic effect|1
229894|NCT00079937|746534|P2|Overall Study|Adverse Event|1
229895|NCT00079937|746535|P1|Overall Study|Adverse Event|2
229896|NCT00009737|746553|P2|Overall Study|Administrative/Other Reasons|1
229897|NCT00009737|746554|P1|Overall Study|Administrative/Other Reasons|7
229898|NCT00009737|746553|P2|Overall Study|Lost to Follow-up|1
229899|NCT00009737|746554|P1|Overall Study|Lost to Follow-up|1
229900|NCT00009737|746553|P2|Overall Study|Refused Treatment|16
229901|NCT00009737|746554|P1|Overall Study|Refused Treatment|15
229902|NCT00009737|746553|P2|Overall Study|Other Protocol Violation|0
229903|NCT00009737|746554|P1|Overall Study|Other Protocol Violation|1
229904|NCT00009737|746553|P2|Overall Study|Violation of Selection Criteria at Entry|9
229905|NCT00009737|746554|P1|Overall Study|Violation of Selection Criteria at Entry|13
229906|NCT00009737|746553|P2|Overall Study|Lack of Efficacy|15
229907|NCT00009737|746554|P1|Overall Study|Lack of Efficacy|17
229908|NCT00009737|746553|P2|Overall Study|Death|6
229909|NCT00009737|746554|P1|Overall Study|Death|4
229910|NCT00009737|746553|P2|Overall Study|Adverse Event|75
229911|NCT00009737|746554|P1|Overall Study|Adverse Event|112
229912|NCT00079781|746573|P3|Follow-up Period|Death|1
229913|NCT00079781|746574|P2|Follow-up Period|Death|0
229914|NCT00079781|746575|P1|Follow-up Period|Death|0
229915|NCT00079781|746573|P3|Follow-up Period|Lost to Follow-up|0
229916|NCT00079781|746574|P2|Follow-up Period|Lost to Follow-up|0
229917|NCT00079781|746575|P1|Follow-up Period|Lost to Follow-up|1
229918|NCT00079781|746573|P3|Follow-up Period|Withdrawal by Subject|1
229919|NCT00079781|746574|P2|Follow-up Period|Withdrawal by Subject|0
229920|NCT00079781|746575|P1|Follow-up Period|Withdrawal by Subject|3
229921|NCT00079781|746573|P3|Pre-implant Period|Did not meet I/E criteria|1
229922|NCT00079781|746574|P2|Pre-implant Period|Did not meet I/E criteria|1
229923|NCT00079781|746575|P1|Pre-implant Period|Did not meet I/E criteria|1
229924|NCT00079781|746573|P3|Pre-implant Period|Withdrawal by Subject|0
229925|NCT00079781|746574|P2|Pre-implant Period|Withdrawal by Subject|0
229926|NCT00079781|746575|P1|Pre-implant Period|Withdrawal by Subject|2
229927|NCT00079677|746584|P2|Overall Study|Miscellaneous|0
229928|NCT00079677|746585|P1|Overall Study|Miscellaneous|2
229929|NCT00079677|746584|P2|Overall Study|Withdrawal by Subject|3
229930|NCT00079677|746585|P1|Overall Study|Withdrawal by Subject|5
229931|NCT00079677|746584|P2|Overall Study|Protocol Violation|3
229932|NCT00079677|746585|P1|Overall Study|Protocol Violation|2
229933|NCT00079677|746584|P2|Overall Study|Physician Decision|0
229934|NCT00079677|746585|P1|Overall Study|Physician Decision|3
229935|NCT00079677|746584|P2|Overall Study|Lost to Follow-up|2
229936|NCT00079677|746585|P1|Overall Study|Lost to Follow-up|2
229937|NCT00079677|746584|P2|Overall Study|Lack of Efficacy|0
229938|NCT00079677|746585|P1|Overall Study|Lack of Efficacy|1
229939|NCT00079677|746584|P2|Overall Study|Adverse Event|6
229940|NCT00079677|746585|P1|Overall Study|Adverse Event|5
229941|NCT00079417|746601|P1|Overall Study|ineligible|1
229942|NCT00079417|746601|P1|Overall Study|Tumor requires non-protocol radiotherapy|2
229943|NCT00079417|746601|P1|Overall Study|Tumor requires non-protocol chemotherapy|1
229944|NCT00079417|746601|P1|Overall Study|Physician Decision|5
229945|NCT00079391|746605|P1|Overall Study|Withdrawal by Subject|1
229946|NCT00079339|746617|P3|Overall Study|Disease progression|2
229947|NCT00079339|746618|P2|Overall Study|Disease progression|28
229948|NCT00079339|746619|P1|Overall Study|Disease progression|3
229949|NCT00079339|746617|P3|Overall Study|Withdrawal by Subject|1
229950|NCT00079339|746618|P2|Overall Study|Withdrawal by Subject|4
229951|NCT00079339|746619|P1|Overall Study|Withdrawal by Subject|0
229952|NCT00079339|746617|P3|Overall Study|Non-compliance|1
229953|NCT00079339|746618|P2|Overall Study|Non-compliance|0
229954|NCT00079339|746619|P1|Overall Study|Non-compliance|0
229955|NCT00079339|746617|P3|Overall Study|Death|0
229956|NCT00079339|746618|P2|Overall Study|Death|0
229957|NCT00079339|746619|P1|Overall Study|Death|1
229958|NCT00079339|746617|P3|Overall Study|Adverse Event|2
229959|NCT00079339|746618|P2|Overall Study|Adverse Event|7
229960|NCT00079339|746619|P1|Overall Study|Adverse Event|1
229961|NCT00079274|746650|P7|Overall Study|Not Specified|0
229962|NCT00079274|746651|P6|Overall Study|Not Specified|2
229963|NCT00079274|746652|P5|Overall Study|Not Specified|1
229964|NCT00079274|746653|P4|Overall Study|Not Specified|55
229965|NCT00079274|746654|P3|Overall Study|Not Specified|5
229966|NCT00079274|746655|P2|Overall Study|Not Specified|7
229967|NCT00079274|746656|P1|Overall Study|Not Specified|43
229968|NCT00079274|746650|P7|Overall Study|Cytogenetic resistance|0
229969|NCT00079274|746651|P6|Overall Study|Cytogenetic resistance|0
229970|NCT00079274|746652|P5|Overall Study|Cytogenetic resistance|0
229971|NCT00079274|746653|P4|Overall Study|Cytogenetic resistance|2
229972|NCT00079274|746654|P3|Overall Study|Cytogenetic resistance|0
229973|NCT00079274|746655|P2|Overall Study|Cytogenetic resistance|0
229974|NCT00079274|746656|P1|Overall Study|Cytogenetic resistance|0
229975|NCT00079274|746650|P7|Overall Study|Death|0
229976|NCT00079274|746651|P6|Overall Study|Death|0
229977|NCT00079274|746652|P5|Overall Study|Death|0
229978|NCT00079274|746653|P4|Overall Study|Death|15
229979|NCT00079274|746654|P3|Overall Study|Death|1
229980|NCT00079274|746655|P2|Overall Study|Death|0
229981|NCT00079274|746656|P1|Overall Study|Death|4
229982|NCT00079274|746650|P7|Overall Study|Other Medical Problems|0
229983|NCT00079274|746651|P6|Overall Study|Other Medical Problems|0
229984|NCT00079274|746652|P5|Overall Study|Other Medical Problems|0
229985|NCT00079274|746653|P4|Overall Study|Other Medical Problems|7
229986|NCT00079274|746654|P3|Overall Study|Other Medical Problems|0
229987|NCT00079274|746655|P2|Overall Study|Other Medical Problems|1
229988|NCT00079274|746656|P1|Overall Study|Other Medical Problems|6
229989|NCT00079274|746650|P7|Overall Study|Alternate Treatment|0
229990|NCT00079274|746651|P6|Overall Study|Alternate Treatment|0
229991|NCT00079274|746652|P5|Overall Study|Alternate Treatment|0
229992|NCT00079274|746653|P4|Overall Study|Alternate Treatment|3
229993|NCT00079274|746654|P3|Overall Study|Alternate Treatment|0
229994|NCT00079274|746655|P2|Overall Study|Alternate Treatment|1
229995|NCT00079274|746656|P1|Overall Study|Alternate Treatment|6
229996|NCT00079274|746650|P7|Overall Study|Recurrence|0
229997|NCT00079274|746651|P6|Overall Study|Recurrence|2
229998|NCT00079274|746652|P5|Overall Study|Recurrence|0
229999|NCT00079274|746653|P4|Overall Study|Recurrence|15
230000|NCT00079274|746654|P3|Overall Study|Recurrence|1
230001|NCT00079274|746655|P2|Overall Study|Recurrence|0
230002|NCT00079274|746656|P1|Overall Study|Recurrence|21
230003|NCT00079274|746650|P7|Overall Study|Adverse Event|0
230004|NCT00079274|746651|P6|Overall Study|Adverse Event|8
230005|NCT00079274|746652|P5|Overall Study|Adverse Event|7
230006|NCT00079274|746653|P4|Overall Study|Adverse Event|184
230007|NCT00079274|746654|P3|Overall Study|Adverse Event|8
230008|NCT00079274|746655|P2|Overall Study|Adverse Event|8
230009|NCT00079274|746656|P1|Overall Study|Adverse Event|130
230010|NCT00079274|746650|P7|Overall Study|Withdrawal by Subject|0
230011|NCT00079274|746651|P6|Overall Study|Withdrawal by Subject|8
230012|NCT00079274|746652|P5|Overall Study|Withdrawal by Subject|7
230013|NCT00079274|746653|P4|Overall Study|Withdrawal by Subject|163
230014|NCT00079274|746654|P3|Overall Study|Withdrawal by Subject|12
230015|NCT00079274|746655|P2|Overall Study|Withdrawal by Subject|10
230016|NCT00079274|746656|P1|Overall Study|Withdrawal by Subject|111
230017|NCT00079183|746669|P1|Overall Study|Specimen collection non-compliance|1
230018|NCT00079183|746669|P1|Overall Study|Study medication non-compliance|2
230019|NCT00079183|746669|P1|Overall Study|Withdrawal by Subject|4
230020|NCT00079040|746684|P1|Overall Study|Ineligible|1
230021|NCT00079040|746684|P1|Overall Study|Withdrew before treatment|1
230022|NCT00078949|746707|P4|Maintenance|No treated|3
230023|NCT00078949|746708|P3|Maintenance|No treated|3
230024|NCT00078949|746709|P2|Maintenance|No treated|0
230025|NCT00078949|746710|P1|Maintenance|No treated|0
230026|NCT00078949|746707|P4|Salvage|No treated|0
230027|NCT00078949|746708|P3|Salvage|No treated|0
230028|NCT00078949|746709|P2|Salvage|No treated|5
230029|NCT00078949|746710|P1|Salvage|No treated|4
230030|NCT00078767|746724|P2|Overall Study|Withdrawal by Subject|1
230031|NCT00078767|746725|P1|Overall Study|Withdrawal by Subject|1
230032|NCT00005947|746772|P2|Overall Study|Site Closure|0
230033|NCT00005947|746773|P1|Overall Study|Site Closure|1
230034|NCT00005947|746772|P2|Overall Study|Patient Refused to Continue|1
230035|NCT00005947|746773|P1|Overall Study|Patient Refused to Continue|2
230036|NCT00005947|746772|P2|Overall Study|Death|40
230037|NCT00005947|746773|P1|Overall Study|Death|54
230038|NCT00002597|746809|P2|Overall Study|Withdrawal by Subject|6
230039|NCT00002597|746810|P1|Overall Study|Withdrawal by Subject|7
230040|NCT00002597|746809|P2|Overall Study|Protocol Violation|17
230041|NCT00002597|746810|P1|Overall Study|Protocol Violation|19
230042|NCT00078377|746835|P3|Overall Study|Miscellaneous|1
230043|NCT00078377|746836|P2|Overall Study|Miscellaneous|6
230044|NCT00078377|746837|P1|Overall Study|Miscellaneous|2
230045|NCT00078377|746835|P3|Overall Study|Withdrawal by Subject|4
230046|NCT00078377|746836|P2|Overall Study|Withdrawal by Subject|4
230047|NCT00078377|746837|P1|Overall Study|Withdrawal by Subject|3
230048|NCT00078377|746835|P3|Overall Study|Physician Decision|0
230049|NCT00078377|746836|P2|Overall Study|Physician Decision|0
230050|NCT00078377|746837|P1|Overall Study|Physician Decision|2
230051|NCT00078377|746835|P3|Overall Study|Lost to Follow-up|1
230052|NCT00078377|746836|P2|Overall Study|Lost to Follow-up|1
230053|NCT00078377|746837|P1|Overall Study|Lost to Follow-up|0
230054|NCT00078377|746835|P3|Overall Study|Lack of Efficacy|2
230055|NCT00078377|746836|P2|Overall Study|Lack of Efficacy|0
230056|NCT00078377|746837|P1|Overall Study|Lack of Efficacy|2
230057|NCT00078377|746835|P3|Overall Study|Adverse Event|1
230058|NCT00078377|746836|P2|Overall Study|Adverse Event|5
230059|NCT00078377|746837|P1|Overall Study|Adverse Event|2
230060|NCT00078325|746937|P3|Overall Study|Miscellaneous|1
230061|NCT00078325|746938|P2|Overall Study|Miscellaneous|1
230062|NCT00078325|746939|P1|Overall Study|Miscellaneous|1
230063|NCT00078325|746937|P3|Overall Study|Physician Decision|1
230064|NCT00078325|746938|P2|Overall Study|Physician Decision|0
230065|NCT00078325|746939|P1|Overall Study|Physician Decision|2
230066|NCT00078325|746937|P3|Overall Study|Lost to Follow-up|1
230067|NCT00078325|746938|P2|Overall Study|Lost to Follow-up|1
230068|NCT00078325|746939|P1|Overall Study|Lost to Follow-up|0
230069|NCT00078325|746937|P3|Overall Study|Withdrawal by Subject|3
230070|NCT00078325|746938|P2|Overall Study|Withdrawal by Subject|5
230071|NCT00078325|746939|P1|Overall Study|Withdrawal by Subject|1
230072|NCT00078325|746937|P3|Overall Study|Protocol Violation|0
230073|NCT00078325|746938|P2|Overall Study|Protocol Violation|2
230074|NCT00078325|746939|P1|Overall Study|Protocol Violation|2
230075|NCT00078325|746937|P3|Overall Study|Adverse Event|5
230076|NCT00078325|746938|P2|Overall Study|Adverse Event|10
230077|NCT00078325|746939|P1|Overall Study|Adverse Event|15
230078|NCT00078312|746950|P1|Overall Study|Miscellaneous|33
230079|NCT00078312|746950|P1|Overall Study|Withdrawal by Subject|33
230080|NCT00078312|746950|P1|Overall Study|Protocol Violation|3
230081|NCT00078312|746950|P1|Overall Study|Physician Decision|9
230082|NCT00078312|746950|P1|Overall Study|Lost to Follow-up|41
230083|NCT00078312|746950|P1|Overall Study|Lack of Efficacy|15
230084|NCT00078312|746950|P1|Overall Study|Adverse Event|43
230085|NCT00077974|746965|P1|Overall Study|Decision of Sponsor|2
230086|NCT00077974|746965|P1|Overall Study|Lack of Efficacy|76
230087|NCT00077974|746965|P1|Overall Study|Withdrawal by Subject|3
230088|NCT00077974|746965|P1|Overall Study|Protocol Violation|1
230089|NCT00077974|746965|P1|Overall Study|Adverse Event|22
230090|NCT00077857|746982|P2|Overall Study|Other|13
230091|NCT00077857|746983|P1|Overall Study|Other|15
230092|NCT00077857|746982|P2|Overall Study|Failure to return|5
230093|NCT00077857|746983|P1|Overall Study|Failure to return|5
230094|NCT00077857|746982|P2|Overall Study|Refused treatment|21
230095|NCT00077857|746983|P1|Overall Study|Refused treatment|29
230096|NCT00077857|746982|P2|Overall Study|Other protocol violation|1
230097|NCT00077857|746983|P1|Overall Study|Other protocol violation|0
230098|NCT00077857|746982|P2|Overall Study|Violation of selection criteria at entry|1
230099|NCT00077857|746983|P1|Overall Study|Violation of selection criteria at entry|3
230100|NCT00077857|746982|P2|Overall Study|Insufficient therapeutic response|128
230101|NCT00077857|746983|P1|Overall Study|Insufficient therapeutic response|112
230102|NCT00077857|746982|P2|Overall Study|Death|3
230103|NCT00077857|746983|P1|Overall Study|Death|7
230104|NCT00077857|746982|P2|Overall Study|Adverse Event|32
230105|NCT00077857|746983|P1|Overall Study|Adverse Event|30
230106|NCT00077766|747003|P2|Overall Study|Participants Vacation|1
230107|NCT00077766|747004|P1|Overall Study|Participants Vacation|2
230108|NCT00077766|747003|P2|Overall Study|Stop Dialysis|1
230109|NCT00077766|747004|P1|Overall Study|Stop Dialysis|0
230110|NCT00077766|747003|P2|Overall Study|Started Nocturnal Dialysis|1
230111|NCT00077766|747004|P1|Overall Study|Started Nocturnal Dialysis|0
230112|NCT00077766|747003|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
230113|NCT00077766|747004|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
230114|NCT00077766|747003|P2|Overall Study|Dialysis|1
230115|NCT00077766|747004|P1|Overall Study|Dialysis|0
230116|NCT00077766|747003|P2|Overall Study|Dialysis Discontinued|0
230117|NCT00077766|747004|P1|Overall Study|Dialysis Discontinued|1
230118|NCT00077766|747003|P2|Overall Study|Participant's decision|0
230119|NCT00077766|747004|P1|Overall Study|Participant's decision|1
230120|NCT00077766|747003|P2|Overall Study|Investigators Discretion|0
230121|NCT00077766|747004|P1|Overall Study|Investigators Discretion|1
230122|NCT00077766|747003|P2|Overall Study|Transplantation|1
230123|NCT00077766|747004|P1|Overall Study|Transplantation|5
230124|NCT00077766|747003|P2|Overall Study|Kidney Transplantation|5
230125|NCT00077766|747004|P1|Overall Study|Kidney Transplantation|9
230126|NCT00077766|747003|P2|Overall Study|Protocol Violation|0
230127|NCT00077766|747004|P1|Overall Study|Protocol Violation|1
230128|NCT00077766|747003|P2|Overall Study|Lost to Follow-up|0
230129|NCT00077766|747004|P1|Overall Study|Lost to Follow-up|2
230130|NCT00077766|747003|P2|Overall Study|Death|10
230131|NCT00077766|747004|P1|Overall Study|Death|12
230132|NCT00077766|747003|P2|Overall Study|Withdrawal by Subject|3
230133|NCT00077766|747004|P1|Overall Study|Withdrawal by Subject|4
230134|NCT00077766|747003|P2|Overall Study|Adverse Event|1
230135|NCT00077766|747004|P1|Overall Study|Adverse Event|1
230136|NCT00077675|747029|P2|Overall Study|Never received study treatment|3
230137|NCT00077675|747030|P1|Overall Study|Never received study treatment|3
230138|NCT00077675|747029|P2|Overall Study|Other|1
230139|NCT00077675|747030|P1|Overall Study|Other|0
230140|NCT00077675|747029|P2|Overall Study|Withdrawal by Subject|0
230141|NCT00077675|747030|P1|Overall Study|Withdrawal by Subject|1
230142|NCT00077675|747029|P2|Overall Study|Lost to Follow-up|3
230143|NCT00077675|747030|P1|Overall Study|Lost to Follow-up|6
230144|NCT00077675|747029|P2|Overall Study|Adverse Event|2
230145|NCT00077675|747030|P1|Overall Study|Adverse Event|1
230146|NCT00077649|747040|P4|Overall Study|Randomized but never dosed|0
230147|NCT00077649|747041|P3|Overall Study|Randomized but never dosed|0
230148|NCT00077649|747042|P2|Overall Study|Randomized but never dosed|0
230149|NCT00077649|747043|P1|Overall Study|Randomized but never dosed|1
230150|NCT00077649|747040|P4|Overall Study|Abnormality of Laboratory Test|2
230151|NCT00077649|747041|P3|Overall Study|Abnormality of Laboratory Test|1
230152|NCT00077649|747042|P2|Overall Study|Abnormality of Laboratory Test|2
230153|NCT00077649|747043|P1|Overall Study|Abnormality of Laboratory Test|1
230154|NCT00077649|747040|P4|Overall Study|Lost to Follow-up|2
230155|NCT00077649|747041|P3|Overall Study|Lost to Follow-up|3
230156|NCT00077649|747042|P2|Overall Study|Lost to Follow-up|2
230157|NCT00077649|747043|P1|Overall Study|Lost to Follow-up|2
230158|NCT00077649|747040|P4|Overall Study|Withdrawal by Subject|2
230159|NCT00077649|747041|P3|Overall Study|Withdrawal by Subject|1
230160|NCT00077649|747042|P2|Overall Study|Withdrawal by Subject|1
230161|NCT00077649|747043|P1|Overall Study|Withdrawal by Subject|0
230162|NCT00077649|747040|P4|Overall Study|Lack of Efficacy|2
230163|NCT00077649|747041|P3|Overall Study|Lack of Efficacy|3
230164|NCT00077649|747042|P2|Overall Study|Lack of Efficacy|3
230165|NCT00077649|747043|P1|Overall Study|Lack of Efficacy|5
230166|NCT00077649|747040|P4|Overall Study|Adverse Event|9
230167|NCT00077649|747041|P3|Overall Study|Adverse Event|7
230168|NCT00077649|747042|P2|Overall Study|Adverse Event|1
230169|NCT00077649|747043|P1|Overall Study|Adverse Event|5
230170|NCT00077636|747091|P2|Overall Study|Abnormality Of Laboratory Test|2
230171|NCT00077636|747092|P1|Overall Study|Abnormality Of Laboratory Test|3
230172|NCT00077636|747091|P2|Overall Study|Lost to Follow-up|18
230173|NCT00077636|747092|P1|Overall Study|Lost to Follow-up|10
230174|NCT00077636|747091|P2|Overall Study|Protocol Violation|2
230175|NCT00077636|747092|P1|Overall Study|Protocol Violation|0
230176|NCT00077636|747091|P2|Overall Study|Adverse Event|34
230177|NCT00077636|747092|P1|Overall Study|Adverse Event|17
230178|NCT00077636|747091|P2|Overall Study|Withdrawal by Subject|2
230179|NCT00077636|747092|P1|Overall Study|Withdrawal by Subject|2
230180|NCT00077636|747091|P2|Overall Study|Admin|3
230181|NCT00077636|747092|P1|Overall Study|Admin|3
230182|NCT00077636|747091|P2|Overall Study|Refused Treatment|31
230183|NCT00077636|747092|P1|Overall Study|Refused Treatment|9
230184|NCT00077623|747113|P3|Overall Study|Failure to return|0
230185|NCT00077623|747114|P2|Overall Study|Failure to return|0
230186|NCT00077623|747115|P1|Overall Study|Failure to return|1
230187|NCT00077623|747113|P3|Overall Study|Death|11
230188|NCT00077623|747114|P2|Overall Study|Death|18
230189|NCT00077623|747115|P1|Overall Study|Death|12
230190|NCT00077623|747113|P3|Overall Study|Insufficient therapeutic response|0
230191|NCT00077623|747114|P2|Overall Study|Insufficient therapeutic response|0
230192|NCT00077623|747115|P1|Overall Study|Insufficient therapeutic response|2
230193|NCT00077623|747113|P3|Overall Study|Other-Non safety reason|19
230194|NCT00077623|747114|P2|Overall Study|Other-Non safety reason|15
230195|NCT00077623|747115|P1|Overall Study|Other-Non safety reason|18
230196|NCT00077623|747113|P3|Overall Study|Withdrawal by Subject|1
230197|NCT00077623|747114|P2|Overall Study|Withdrawal by Subject|10
230198|NCT00077623|747115|P1|Overall Study|Withdrawal by Subject|2
230199|NCT00077623|747113|P3|Overall Study|Adverse Event|1
230200|NCT00077623|747114|P2|Overall Study|Adverse Event|0
230201|NCT00077623|747115|P1|Overall Study|Adverse Event|1
230202|NCT00077610|747150|P3|Overall Study|Sponsors decision to withdraw|1
230203|NCT00077610|747151|P2|Overall Study|Sponsors decision to withdraw|0
230204|NCT00077610|747152|P1|Overall Study|Sponsors decision to withdraw|0
230205|NCT00077610|747150|P3|Overall Study|Financial issues|0
230206|NCT00077610|747151|P2|Overall Study|Financial issues|1
230207|NCT00077610|747152|P1|Overall Study|Financial issues|0
230208|NCT00077610|747150|P3|Overall Study|Relocation|5
230209|NCT00077610|747151|P2|Overall Study|Relocation|8
230210|NCT00077610|747152|P1|Overall Study|Relocation|0
230211|NCT00077610|747150|P3|Overall Study|Change in dialysis modality|0
230212|NCT00077610|747151|P2|Overall Study|Change in dialysis modality|0
230213|NCT00077610|747152|P1|Overall Study|Change in dialysis modality|1
230214|NCT00077610|747150|P3|Overall Study|Transfer to other center for surgery|0
230215|NCT00077610|747151|P2|Overall Study|Transfer to other center for surgery|0
230216|NCT00077610|747152|P1|Overall Study|Transfer to other center for surgery|1
230217|NCT00077610|747150|P3|Overall Study|Transfer to satellite unit|0
230218|NCT00077610|747151|P2|Overall Study|Transfer to satellite unit|0
230219|NCT00077610|747152|P1|Overall Study|Transfer to satellite unit|1
230220|NCT00077610|747150|P3|Overall Study|Transferred to nursing home|1
230221|NCT00077610|747151|P2|Overall Study|Transferred to nursing home|0
230222|NCT00077610|747152|P1|Overall Study|Transferred to nursing home|0
230223|NCT00077610|747150|P3|Overall Study|Transferred to other unit|1
230224|NCT00077610|747151|P2|Overall Study|Transferred to other unit|0
230225|NCT00077610|747152|P1|Overall Study|Transferred to other unit|0
230226|NCT00077610|747150|P3|Overall Study|Given Epogen in hospital|0
230227|NCT00077610|747151|P2|Overall Study|Given Epogen in hospital|0
230228|NCT00077610|747152|P1|Overall Study|Given Epogen in hospital|1
230229|NCT00077610|747150|P3|Overall Study|Worsening of health condition|0
230230|NCT00077610|747151|P2|Overall Study|Worsening of health condition|1
230231|NCT00077610|747152|P1|Overall Study|Worsening of health condition|1
230232|NCT00077610|747150|P3|Overall Study|Principal Investigator's decision|1
230233|NCT00077610|747151|P2|Overall Study|Principal Investigator's decision|0
230234|NCT00077610|747152|P1|Overall Study|Principal Investigator's decision|1
230235|NCT00077610|747150|P3|Overall Study|Multiple blood transfusions|1
230236|NCT00077610|747151|P2|Overall Study|Multiple blood transfusions|0
230237|NCT00077610|747152|P1|Overall Study|Multiple blood transfusions|0
230238|NCT00077610|747150|P3|Overall Study|Insufficient Therapeutic Response|0
230239|NCT00077610|747151|P2|Overall Study|Insufficient Therapeutic Response|0
230240|NCT00077610|747152|P1|Overall Study|Insufficient Therapeutic Response|1
230241|NCT00077610|747150|P3|Overall Study|Withdrew from dialysis care|3
230242|NCT00077610|747151|P2|Overall Study|Withdrew from dialysis care|0
230243|NCT00077610|747152|P1|Overall Study|Withdrew from dialysis care|5
230244|NCT00077610|747150|P3|Overall Study|Renal transplant|11
230245|NCT00077610|747151|P2|Overall Study|Renal transplant|15
230246|NCT00077610|747152|P1|Overall Study|Renal transplant|12
230247|NCT00077610|747150|P3|Overall Study|Death|13
230248|NCT00077610|747151|P2|Overall Study|Death|13
230249|NCT00077610|747152|P1|Overall Study|Death|17
230250|NCT00077610|747150|P3|Overall Study|Withdrawal by Subject|6
230251|NCT00077610|747151|P2|Overall Study|Withdrawal by Subject|10
230252|NCT00077610|747152|P1|Overall Study|Withdrawal by Subject|4
230253|NCT00077610|747150|P3|Overall Study|Lost to Follow-up|2
230254|NCT00077610|747151|P2|Overall Study|Lost to Follow-up|1
230255|NCT00077610|747152|P1|Overall Study|Lost to Follow-up|0
230256|NCT00077610|747150|P3|Overall Study|Adverse Event|1
230257|NCT00077610|747151|P2|Overall Study|Adverse Event|7
230258|NCT00077610|747152|P1|Overall Study|Adverse Event|9
230259|NCT00077376|747181|P1|Overall Study|Insurance ran out|1
230260|NCT00077376|747181|P1|Overall Study|Surgery|1
230261|NCT00077376|747181|P1|Overall Study|Symptomatic deterioration|1
230262|NCT00077376|747181|P1|Overall Study|Still on treatment|1
230263|NCT00077376|747181|P1|Overall Study|Complicating disease|1
230264|NCT00077376|747181|P1|Overall Study|Alternative therapy|5
230265|NCT00077376|747181|P1|Overall Study|Physician Decision|1
230266|NCT00077376|747181|P1|Overall Study|Death|1
230267|NCT00077376|747181|P1|Overall Study|Withdrawal by Subject|2
230268|NCT00077376|747181|P1|Overall Study|Adverse Event|8
230269|NCT00077207|747192|P1|Overall Study|Ineligible|1
230270|NCT00077207|747192|P1|Overall Study|Withdrawal by Subject|6
230271|NCT00077207|747192|P1|Overall Study|Physician Decision|6
230272|NCT00077207|747192|P1|Overall Study|Lack of Efficacy|12
230273|NCT00077207|747192|P1|Overall Study|Adverse Event|5
230274|NCT00077064|747204|P2|Overall Study|Patient refusal|2
230275|NCT00077064|747205|P1|Overall Study|Patient refusal|0
230276|NCT00077064|747204|P2|Overall Study|Adverse Event|4
230277|NCT00077064|747205|P1|Overall Study|Adverse Event|0
230278|NCT00076999|747221|P5|Overall Study|Other reason (not specified)|13
230279|NCT00076999|747222|P4|Overall Study|Other reason (not specified)|1
230280|NCT00076999|747223|P3|Overall Study|Other reason (not specified)|4
230281|NCT00076999|747224|P2|Overall Study|Other reason (not specified)|8
230282|NCT00076999|747225|P1|Overall Study|Other reason (not specified)|8
230283|NCT00076999|747221|P5|Overall Study|Withdrawal by Subject|1
230284|NCT00076999|747222|P4|Overall Study|Withdrawal by Subject|0
230285|NCT00076999|747223|P3|Overall Study|Withdrawal by Subject|3
230286|NCT00076999|747224|P2|Overall Study|Withdrawal by Subject|4
230287|NCT00076999|747225|P1|Overall Study|Withdrawal by Subject|0
230288|NCT00076999|747221|P5|Overall Study|Lost to Follow-up|0
230289|NCT00076999|747222|P4|Overall Study|Lost to Follow-up|0
230290|NCT00076999|747223|P3|Overall Study|Lost to Follow-up|0
230291|NCT00076999|747224|P2|Overall Study|Lost to Follow-up|1
230292|NCT00076999|747225|P1|Overall Study|Lost to Follow-up|2
230293|NCT00076999|747221|P5|Overall Study|Protocol Violation|9
230294|NCT00076999|747222|P4|Overall Study|Protocol Violation|0
230295|NCT00076999|747223|P3|Overall Study|Protocol Violation|4
230296|NCT00076999|747224|P2|Overall Study|Protocol Violation|3
230297|NCT00076999|747225|P1|Overall Study|Protocol Violation|0
230298|NCT00076999|747221|P5|Overall Study|Adverse Event|2
230299|NCT00076999|747222|P4|Overall Study|Adverse Event|0
230300|NCT00076999|747223|P3|Overall Study|Adverse Event|6
230301|NCT00076999|747224|P2|Overall Study|Adverse Event|8
230302|NCT00076999|747225|P1|Overall Study|Adverse Event|2
230303|NCT00003222|747344|P2|Overall Study|Physician Decision|1
230304|NCT00003222|747345|P1|Overall Study|Physician Decision|0
230305|NCT00076804|747357|P2|Overall Study|Early study Closure|32
230306|NCT00076804|747358|P1|Overall Study|Early study Closure|32
230307|NCT00076804|747357|P2|Overall Study|Withdrawal by Subject|8
230308|NCT00076804|747358|P1|Overall Study|Withdrawal by Subject|10
230309|NCT00076804|747357|P2|Overall Study|Lost to Follow-up|9
230310|NCT00076804|747358|P1|Overall Study|Lost to Follow-up|9
230311|NCT00076804|747357|P2|Overall Study|Death|20
230312|NCT00076804|747358|P1|Overall Study|Death|9
230313|NCT00076752|747370|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
230314|NCT00076752|747370|P1|Overall Study|Death|2
230315|NCT00076570|747416|P2|Overall Study|Drug intolerance|8
230316|NCT00076570|747417|P1|Overall Study|Drug intolerance|8
230317|NCT00003298|747425|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
230318|NCT00003298|747425|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
230319|NCT00003298|747425|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
230320|NCT00003298|747425|P1|Step 2 (Adjuvant Therapy)|Death|1
230321|NCT00003298|747425|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
230322|NCT00003298|747425|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
230323|NCT00003298|747425|P1|Re-register to Step 2 After Surgery|Reason unknown|1
230324|NCT00003298|747425|P1|Re-register to Step 2 After Surgery|Other complications|2
230325|NCT00003298|747425|P1|Re-register to Step 2 After Surgery|Positive margins|5
230326|NCT00003298|747425|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
230327|NCT00003298|747425|P1|Surgery|Unevaluable and off study|2
230328|NCT00003298|747425|P1|Surgery|Progression before surgery|2
230329|NCT00003298|747425|P1|Surgery|Unresectable at surgery|3
230330|NCT00003298|747425|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
230331|NCT00003298|747425|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
230332|NCT00076336|747435|P2|Overall Study|Treatment failure|5
230333|NCT00076336|747436|P1|Overall Study|Treatment failure|4
230334|NCT00076336|747435|P2|Overall Study|Virologic Breakthrough|16
230335|NCT00076336|747436|P1|Overall Study|Virologic Breakthrough|14
230336|NCT00076336|747435|P2|Overall Study|Liver Transplantation|3
230337|NCT00076336|747436|P1|Overall Study|Liver Transplantation|3
230338|NCT00076336|747435|P2|Overall Study|Patient, Investigator, Sponsor request|6
230339|NCT00076336|747436|P1|Overall Study|Patient, Investigator, Sponsor request|8
230340|NCT00076336|747435|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
230341|NCT00076336|747436|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
230342|NCT00076336|747435|P2|Overall Study|Non-Compliance|0
230343|NCT00076336|747436|P1|Overall Study|Non-Compliance|2
230344|NCT00076336|747435|P2|Overall Study|Lost to Follow-up|4
230345|NCT00076336|747436|P1|Overall Study|Lost to Follow-up|4
230346|NCT00076336|747435|P2|Overall Study|Adverse Event|4
230347|NCT00076336|747436|P1|Overall Study|Adverse Event|4
230348|NCT00076336|747435|P2|Overall Study|Death|17
230349|NCT00076336|747436|P1|Overall Study|Death|13
230350|NCT00076102|747489|P1|Overall Study|refusal of further therapy|2
230351|NCT00076102|747489|P1|Overall Study|plexiform neurofibroma surgery|1
230352|NCT00076102|747489|P1|Overall Study|Progression in pre-existing brain tumor|1
230353|NCT00076102|747489|P1|Overall Study|Clinical progression|1
230354|NCT00076024|747517|P4|Phase 2, Open-label|Other|2
230355|NCT00076024|747518|P3|Phase 2, Open-label|Other|0
230356|NCT00076024|747519|P2|Phase 2, Open-label|Other|0
230357|NCT00076024|747520|P1|Phase 2, Open-label|Other|0
230358|NCT00076024|747517|P4|Phase 2, Open-label|Withdrawal by Subject|1
230359|NCT00076024|747518|P3|Phase 2, Open-label|Withdrawal by Subject|0
230360|NCT00076024|747519|P2|Phase 2, Open-label|Withdrawal by Subject|0
230361|NCT00076024|747520|P1|Phase 2, Open-label|Withdrawal by Subject|0
230362|NCT00076024|747517|P4|Phase 2, Open-label|Lack of Efficacy|11
230363|NCT00076024|747518|P3|Phase 2, Open-label|Lack of Efficacy|0
230364|NCT00076024|747519|P2|Phase 2, Open-label|Lack of Efficacy|0
230365|NCT00076024|747520|P1|Phase 2, Open-label|Lack of Efficacy|0
230366|NCT00076024|747517|P4|Phase 2, Open-label|Adverse Event|2
230367|NCT00076024|747518|P3|Phase 2, Open-label|Adverse Event|0
230368|NCT00076024|747519|P2|Phase 2, Open-label|Adverse Event|0
230369|NCT00076024|747520|P1|Phase 2, Open-label|Adverse Event|0
230370|NCT00076024|747517|P4|Phase 2, Double-blind|Randomized but not treated|0
230371|NCT00076024|747518|P3|Phase 2, Double-blind|Randomized but not treated|0
230372|NCT00076024|747519|P2|Phase 2, Double-blind|Randomized but not treated|1
230373|NCT00076024|747520|P1|Phase 2, Double-blind|Randomized but not treated|0
230374|NCT00076024|747517|P4|Phase 2, Double-blind|Un-specified|0
230375|NCT00076024|747518|P3|Phase 2, Double-blind|Un-specified|6
230376|NCT00076024|747519|P2|Phase 2, Double-blind|Un-specified|14
230377|NCT00076024|747520|P1|Phase 2, Double-blind|Un-specified|0
230378|NCT00076024|747517|P4|Phase 2, Double-blind|Adverse Event|0
230379|NCT00076024|747518|P3|Phase 2, Double-blind|Adverse Event|6
230380|NCT00076024|747519|P2|Phase 2, Double-blind|Adverse Event|25
230381|NCT00076024|747520|P1|Phase 2, Double-blind|Adverse Event|0
230382|NCT00076024|747517|P4|Phase 2, Double-blind|Withdrawal by Subject|0
230383|NCT00076024|747518|P3|Phase 2, Double-blind|Withdrawal by Subject|4
230384|NCT00076024|747519|P2|Phase 2, Double-blind|Withdrawal by Subject|13
230385|NCT00076024|747520|P1|Phase 2, Double-blind|Withdrawal by Subject|0
230386|NCT00076024|747517|P4|Phase 2, Double-blind|Lack of Efficacy|0
230387|NCT00076024|747518|P3|Phase 2, Double-blind|Lack of Efficacy|40
230388|NCT00076024|747519|P2|Phase 2, Double-blind|Lack of Efficacy|59
230389|NCT00076024|747520|P1|Phase 2, Double-blind|Lack of Efficacy|0
230390|NCT00076024|747517|P4|Phase 1, Lead-in|Clinical progression|0
230391|NCT00076024|747518|P3|Phase 1, Lead-in|Clinical progression|0
230392|NCT00076024|747519|P2|Phase 1, Lead-in|Clinical progression|0
230393|NCT00076024|747520|P1|Phase 1, Lead-in|Clinical progression|1
230394|NCT00076024|747517|P4|Phase 1, Lead-in|Adverse Event|0
230395|NCT00076024|747518|P3|Phase 1, Lead-in|Adverse Event|0
230396|NCT00076024|747519|P2|Phase 1, Lead-in|Adverse Event|0
230397|NCT00076024|747520|P1|Phase 1, Lead-in|Adverse Event|1
230398|NCT00076024|747517|P4|Phase 1, Lead-in|Lack of Efficacy|0
230399|NCT00076024|747518|P3|Phase 1, Lead-in|Lack of Efficacy|0
230400|NCT00076024|747519|P2|Phase 1, Lead-in|Lack of Efficacy|0
230401|NCT00076024|747520|P1|Phase 1, Lead-in|Lack of Efficacy|4
230402|NCT00076011|747534|P1|Overall Study|Ongoing|1
230403|NCT00076011|747534|P1|Overall Study|Other|11
230404|NCT00076011|747534|P1|Overall Study|Study terminated by sponsor|3
230405|NCT00076011|747534|P1|Overall Study|Withdrawal by Subject|1
230406|NCT00076011|747534|P1|Overall Study|Lack of Efficacy|25
230407|NCT00076011|747534|P1|Overall Study|Adverse Event|10
230408|NCT00076011|747534|P1|Overall Study|Death|1
230409|NCT00075946|747546|P5|Overall Study|Other|0
230410|NCT00075946|747547|P4|Overall Study|Other|2
230411|NCT00075946|747548|P3|Overall Study|Other|0
230412|NCT00075946|747549|P2|Overall Study|Other|13
230413|NCT00075946|747550|P1|Overall Study|Other|5
230414|NCT00075946|747546|P5|Overall Study|Time to progression less than 6 months|0
230415|NCT00075946|747547|P4|Overall Study|Time to progression less than 6 months|3
230416|NCT00075946|747548|P3|Overall Study|Time to progression less than 6 months|8
230417|NCT00075946|747549|P2|Overall Study|Time to progression less than 6 months|30
230418|NCT00075946|747550|P1|Overall Study|Time to progression less than 6 months|15
230419|NCT00075946|747546|P5|Overall Study|No response to retreatment|0
230420|NCT00075946|747547|P4|Overall Study|No response to retreatment|0
230421|NCT00075946|747548|P3|Overall Study|No response to retreatment|2
230422|NCT00075946|747549|P2|Overall Study|No response to retreatment|0
230423|NCT00075946|747550|P1|Overall Study|No response to retreatment|23
230424|NCT00075946|747546|P5|Overall Study|Other complicating disease|0
230425|NCT00075946|747547|P4|Overall Study|Other complicating disease|4
230426|NCT00075946|747548|P3|Overall Study|Other complicating disease|1
230427|NCT00075946|747549|P2|Overall Study|Other complicating disease|13
230428|NCT00075946|747550|P1|Overall Study|Other complicating disease|7
230429|NCT00075946|747546|P5|Overall Study|Alternative therapy|0
230430|NCT00075946|747547|P4|Overall Study|Alternative therapy|0
230431|NCT00075946|747548|P3|Overall Study|Alternative therapy|5
230432|NCT00075946|747549|P2|Overall Study|Alternative therapy|2
230433|NCT00075946|747550|P1|Overall Study|Alternative therapy|16
230434|NCT00075946|747546|P5|Overall Study|Withdrawal by Subject|0
230435|NCT00075946|747547|P4|Overall Study|Withdrawal by Subject|9
230436|NCT00075946|747548|P3|Overall Study|Withdrawal by Subject|4
230437|NCT00075946|747549|P2|Overall Study|Withdrawal by Subject|58
230438|NCT00075946|747550|P1|Overall Study|Withdrawal by Subject|23
230439|NCT00075946|747546|P5|Overall Study|Death|0
230440|NCT00075946|747547|P4|Overall Study|Death|0
230441|NCT00075946|747548|P3|Overall Study|Death|0
230442|NCT00075946|747549|P2|Overall Study|Death|1
230443|NCT00075946|747550|P1|Overall Study|Death|0
230444|NCT00075946|747546|P5|Overall Study|Adverse Event|0
230445|NCT00075946|747547|P4|Overall Study|Adverse Event|2
230446|NCT00075946|747548|P3|Overall Study|Adverse Event|0
230447|NCT00075946|747549|P2|Overall Study|Adverse Event|10
230448|NCT00075946|747550|P1|Overall Study|Adverse Event|2
230449|NCT00075946|747546|P5|Overall Study|Still on treatment at time of analysis|0
230450|NCT00075946|747547|P4|Overall Study|Still on treatment at time of analysis|9
230451|NCT00075946|747548|P3|Overall Study|Still on treatment at time of analysis|3
230452|NCT00075946|747549|P2|Overall Study|Still on treatment at time of analysis|19
230453|NCT00075946|747550|P1|Overall Study|Still on treatment at time of analysis|52
230454|NCT00075946|747546|P5|Overall Study|Incorrectly randomized (no response)|0
230455|NCT00075946|747547|P4|Overall Study|Incorrectly randomized (no response)|1
230456|NCT00075946|747548|P3|Overall Study|Incorrectly randomized (no response)|5
230457|NCT00075946|747549|P2|Overall Study|Incorrectly randomized (no response)|5
230458|NCT00075946|747550|P1|Overall Study|Incorrectly randomized (no response)|5
230459|NCT00075946|747546|P5|Overall Study|Did not achieve response after induction|182
230460|NCT00075946|747547|P4|Overall Study|Did not achieve response after induction|0
230461|NCT00075946|747548|P3|Overall Study|Did not achieve response after induction|0
230462|NCT00075946|747549|P2|Overall Study|Did not achieve response after induction|0
230463|NCT00075946|747550|P1|Overall Study|Did not achieve response after induction|0
230464|NCT00075946|747546|P5|Overall Study|Path ineligible: undetermined histology|6
230465|NCT00075946|747547|P4|Overall Study|Path ineligible: undetermined histology|0
230466|NCT00075946|747548|P3|Overall Study|Path ineligible: undetermined histology|0
230467|NCT00075946|747549|P2|Overall Study|Path ineligible: undetermined histology|0
230468|NCT00075946|747550|P1|Overall Study|Path ineligible: undetermined histology|0
230469|NCT00075881|747565|P1|Overall Study|never start protocol therapy|1
230470|NCT00075881|747565|P1|Overall Study|Ineligible|1
230471|NCT00075881|747565|P1|Overall Study|missing data|2
230472|NCT00075881|747565|P1|Overall Study|other|4
230473|NCT00075881|747565|P1|Overall Study|other complicating disease|3
230474|NCT00075881|747565|P1|Overall Study|Protocol Violation|4
230475|NCT00075881|747565|P1|Overall Study|Withdrawal by Subject|2
230476|NCT00075881|747565|P1|Overall Study|Death|1
230477|NCT00075881|747565|P1|Overall Study|Adverse Event|7
230478|NCT00075881|747565|P1|Overall Study|Lack of Efficacy|18
230479|NCT00075816|747609|P2|Overall Study|Did not undergo transplantation|11
230480|NCT00075816|747610|P1|Overall Study|Did not undergo transplantation|14
230481|NCT00075764|747679|P2|Overall Study|Under review|1
230482|NCT00075764|747680|P1|Overall Study|Under review|0
230483|NCT00075764|747679|P2|Overall Study|Not protocol specified|19
230484|NCT00075764|747680|P1|Overall Study|Not protocol specified|27
230485|NCT00075764|747679|P2|Overall Study|Delinquent|2
230486|NCT00075764|747680|P1|Overall Study|Delinquent|4
230487|NCT00075764|747679|P2|Overall Study|Still on treatment|15
230488|NCT00075764|747680|P1|Overall Study|Still on treatment|8
230489|NCT00075764|747679|P2|Overall Study|Progression|274
230490|NCT00075764|747680|P1|Overall Study|Progression|269
230491|NCT00075764|747679|P2|Overall Study|Withdrawal by Subject|18
230492|NCT00075764|747680|P1|Overall Study|Withdrawal by Subject|28
230493|NCT00075764|747679|P2|Overall Study|Death|8
230494|NCT00075764|747680|P1|Overall Study|Death|4
230495|NCT00075764|747679|P2|Overall Study|Adverse Event|12
230496|NCT00075764|747680|P1|Overall Study|Adverse Event|5
230497|NCT00075725|747704|P12|Overall Study|Pt incarcerated|0
230498|NCT00075725|747705|P11|Overall Study|Pt incarcerated|0
230499|NCT00075725|747706|P10|Overall Study|Pt incarcerated|0
230500|NCT00075725|747707|P9|Overall Study|Pt incarcerated|0
230501|NCT00075725|747708|P8|Overall Study|Pt incarcerated|1
230502|NCT00075725|747709|P7|Overall Study|Pt incarcerated|0
230503|NCT00075725|747710|P6|Overall Study|Pt incarcerated|0
230504|NCT00075725|747711|P5|Overall Study|Pt incarcerated|0
230505|NCT00075725|747712|P4|Overall Study|Pt incarcerated|0
230506|NCT00075725|747713|P3|Overall Study|Pt incarcerated|0
230507|NCT00075725|747714|P2|Overall Study|Pt incarcerated|0
230508|NCT00075725|747715|P1|Overall Study|Pt incarcerated|0
230509|NCT00075725|747704|P12|Overall Study|Pt care terminated due to pt behavior|0
230510|NCT00075725|747705|P11|Overall Study|Pt care terminated due to pt behavior|0
230511|NCT00075725|747706|P10|Overall Study|Pt care terminated due to pt behavior|0
230512|NCT00075725|747707|P9|Overall Study|Pt care terminated due to pt behavior|0
230513|NCT00075725|747708|P8|Overall Study|Pt care terminated due to pt behavior|1
230514|NCT00075725|747709|P7|Overall Study|Pt care terminated due to pt behavior|0
230515|NCT00075725|747710|P6|Overall Study|Pt care terminated due to pt behavior|0
230516|NCT00075725|747711|P5|Overall Study|Pt care terminated due to pt behavior|0
230517|NCT00075725|747712|P4|Overall Study|Pt care terminated due to pt behavior|0
230518|NCT00075725|747713|P3|Overall Study|Pt care terminated due to pt behavior|0
230519|NCT00075725|747714|P2|Overall Study|Pt care terminated due to pt behavior|0
230520|NCT00075725|747715|P1|Overall Study|Pt care terminated due to pt behavior|0
230521|NCT00075725|747704|P12|Overall Study|Other complications|0
230522|NCT00075725|747705|P11|Overall Study|Other complications|0
230523|NCT00075725|747706|P10|Overall Study|Other complications|0
230524|NCT00075725|747707|P9|Overall Study|Other complications|0
230525|NCT00075725|747708|P8|Overall Study|Other complications|0
230526|NCT00075725|747709|P7|Overall Study|Other complications|0
230527|NCT00075725|747710|P6|Overall Study|Other complications|1
230528|NCT00075725|747711|P5|Overall Study|Other complications|0
230529|NCT00075725|747712|P4|Overall Study|Other complications|0
230530|NCT00075725|747713|P3|Overall Study|Other complications|0
230531|NCT00075725|747714|P2|Overall Study|Other complications|0
230532|NCT00075725|747715|P1|Overall Study|Other complications|0
230533|NCT00075725|747704|P12|Overall Study|Study Closure|0
230534|NCT00075725|747705|P11|Overall Study|Study Closure|0
230535|NCT00075725|747706|P10|Overall Study|Study Closure|0
230536|NCT00075725|747707|P9|Overall Study|Study Closure|0
230537|NCT00075725|747708|P8|Overall Study|Study Closure|1
230538|NCT00075725|747709|P7|Overall Study|Study Closure|0
230539|NCT00075725|747710|P6|Overall Study|Study Closure|3
230540|NCT00075725|747711|P5|Overall Study|Study Closure|1
230541|NCT00075725|747712|P4|Overall Study|Study Closure|0
230542|NCT00075725|747713|P3|Overall Study|Study Closure|0
230543|NCT00075725|747714|P2|Overall Study|Study Closure|0
230544|NCT00075725|747715|P1|Overall Study|Study Closure|1
230545|NCT00075725|747704|P12|Overall Study|Institution Terminated|0
230546|NCT00075725|747705|P11|Overall Study|Institution Terminated|0
230547|NCT00075725|747706|P10|Overall Study|Institution Terminated|0
230548|NCT00075725|747707|P9|Overall Study|Institution Terminated|0
230549|NCT00075725|747708|P8|Overall Study|Institution Terminated|3
230550|NCT00075725|747709|P7|Overall Study|Institution Terminated|0
230551|NCT00075725|747710|P6|Overall Study|Institution Terminated|0
230552|NCT00075725|747711|P5|Overall Study|Institution Terminated|1
230553|NCT00075725|747712|P4|Overall Study|Institution Terminated|0
230554|NCT00075725|747713|P3|Overall Study|Institution Terminated|0
230555|NCT00075725|747714|P2|Overall Study|Institution Terminated|0
230556|NCT00075725|747715|P1|Overall Study|Institution Terminated|0
230557|NCT00075725|747704|P12|Overall Study|Pt relocated|0
230558|NCT00075725|747705|P11|Overall Study|Pt relocated|0
230559|NCT00075725|747706|P10|Overall Study|Pt relocated|0
230560|NCT00075725|747707|P9|Overall Study|Pt relocated|1
230561|NCT00075725|747708|P8|Overall Study|Pt relocated|2
230562|NCT00075725|747709|P7|Overall Study|Pt relocated|1
230563|NCT00075725|747710|P6|Overall Study|Pt relocated|1
230564|NCT00075725|747711|P5|Overall Study|Pt relocated|0
230565|NCT00075725|747712|P4|Overall Study|Pt relocated|2
230566|NCT00075725|747713|P3|Overall Study|Pt relocated|0
230567|NCT00075725|747714|P2|Overall Study|Pt relocated|0
230568|NCT00075725|747715|P1|Overall Study|Pt relocated|0
230569|NCT00075725|747704|P12|Overall Study|Pt received additional steroids|0
230570|NCT00075725|747705|P11|Overall Study|Pt received additional steroids|0
230571|NCT00075725|747706|P10|Overall Study|Pt received additional steroids|0
230572|NCT00075725|747707|P9|Overall Study|Pt received additional steroids|0
230573|NCT00075725|747708|P8|Overall Study|Pt received additional steroids|0
230574|NCT00075725|747709|P7|Overall Study|Pt received additional steroids|0
230575|NCT00075725|747710|P6|Overall Study|Pt received additional steroids|0
230576|NCT00075725|747711|P5|Overall Study|Pt received additional steroids|0
230577|NCT00075725|747712|P4|Overall Study|Pt received additional steroids|1
230578|NCT00075725|747713|P3|Overall Study|Pt received additional steroids|0
230579|NCT00075725|747714|P2|Overall Study|Pt received additional steroids|0
230580|NCT00075725|747715|P1|Overall Study|Pt received additional steroids|0
230581|NCT00075725|747704|P12|Overall Study|Pt went to transplant|0
230582|NCT00075725|747705|P11|Overall Study|Pt went to transplant|0
230583|NCT00075725|747706|P10|Overall Study|Pt went to transplant|0
230584|NCT00075725|747707|P9|Overall Study|Pt went to transplant|0
230585|NCT00075725|747708|P8|Overall Study|Pt went to transplant|0
230586|NCT00075725|747709|P7|Overall Study|Pt went to transplant|0
230587|NCT00075725|747710|P6|Overall Study|Pt went to transplant|1
230588|NCT00075725|747711|P5|Overall Study|Pt went to transplant|0
230589|NCT00075725|747712|P4|Overall Study|Pt went to transplant|1
230590|NCT00075725|747713|P3|Overall Study|Pt went to transplant|0
230591|NCT00075725|747714|P2|Overall Study|Pt went to transplant|0
230592|NCT00075725|747715|P1|Overall Study|Pt went to transplant|0
230593|NCT00075725|747704|P12|Overall Study|specimen(s) not submitted|0
230594|NCT00075725|747705|P11|Overall Study|specimen(s) not submitted|0
230595|NCT00075725|747706|P10|Overall Study|specimen(s) not submitted|0
230596|NCT00075725|747707|P9|Overall Study|specimen(s) not submitted|0
230597|NCT00075725|747708|P8|Overall Study|specimen(s) not submitted|0
230598|NCT00075725|747709|P7|Overall Study|specimen(s) not submitted|0
230599|NCT00075725|747710|P6|Overall Study|specimen(s) not submitted|0
230600|NCT00075725|747711|P5|Overall Study|specimen(s) not submitted|0
230601|NCT00075725|747712|P4|Overall Study|specimen(s) not submitted|0
230602|NCT00075725|747713|P3|Overall Study|specimen(s) not submitted|2
230603|NCT00075725|747714|P2|Overall Study|specimen(s) not submitted|0
230604|NCT00075725|747715|P1|Overall Study|specimen(s) not submitted|0
230605|NCT00075725|747704|P12|Overall Study|Unsuccessful institutional transfer|0
230606|NCT00075725|747705|P11|Overall Study|Unsuccessful institutional transfer|0
230607|NCT00075725|747706|P10|Overall Study|Unsuccessful institutional transfer|1
230608|NCT00075725|747707|P9|Overall Study|Unsuccessful institutional transfer|0
230609|NCT00075725|747708|P8|Overall Study|Unsuccessful institutional transfer|0
230610|NCT00075725|747709|P7|Overall Study|Unsuccessful institutional transfer|0
230611|NCT00075725|747710|P6|Overall Study|Unsuccessful institutional transfer|0
230612|NCT00075725|747711|P5|Overall Study|Unsuccessful institutional transfer|0
230613|NCT00075725|747712|P4|Overall Study|Unsuccessful institutional transfer|0
230614|NCT00075725|747713|P3|Overall Study|Unsuccessful institutional transfer|2
230615|NCT00075725|747714|P2|Overall Study|Unsuccessful institutional transfer|0
230616|NCT00075725|747715|P1|Overall Study|Unsuccessful institutional transfer|0
230617|NCT00075725|747704|P12|Overall Study|Clinic chart lost unable to recreate|0
230618|NCT00075725|747705|P11|Overall Study|Clinic chart lost unable to recreate|0
230619|NCT00075725|747706|P10|Overall Study|Clinic chart lost unable to recreate|0
230620|NCT00075725|747707|P9|Overall Study|Clinic chart lost unable to recreate|0
230621|NCT00075725|747708|P8|Overall Study|Clinic chart lost unable to recreate|0
230622|NCT00075725|747709|P7|Overall Study|Clinic chart lost unable to recreate|0
230623|NCT00075725|747710|P6|Overall Study|Clinic chart lost unable to recreate|0
230624|NCT00075725|747711|P5|Overall Study|Clinic chart lost unable to recreate|0
230625|NCT00075725|747712|P4|Overall Study|Clinic chart lost unable to recreate|0
230626|NCT00075725|747713|P3|Overall Study|Clinic chart lost unable to recreate|1
230627|NCT00075725|747714|P2|Overall Study|Clinic chart lost unable to recreate|0
230628|NCT00075725|747715|P1|Overall Study|Clinic chart lost unable to recreate|0
230629|NCT00075725|747704|P12|Overall Study|Pt trying to find a BM donor|0
230630|NCT00075725|747705|P11|Overall Study|Pt trying to find a BM donor|0
230631|NCT00075725|747706|P10|Overall Study|Pt trying to find a BM donor|0
230632|NCT00075725|747707|P9|Overall Study|Pt trying to find a BM donor|0
230633|NCT00075725|747708|P8|Overall Study|Pt trying to find a BM donor|0
230634|NCT00075725|747709|P7|Overall Study|Pt trying to find a BM donor|0
230635|NCT00075725|747710|P6|Overall Study|Pt trying to find a BM donor|0
230636|NCT00075725|747711|P5|Overall Study|Pt trying to find a BM donor|0
230637|NCT00075725|747712|P4|Overall Study|Pt trying to find a BM donor|0
230638|NCT00075725|747713|P3|Overall Study|Pt trying to find a BM donor|0
230639|NCT00075725|747714|P2|Overall Study|Pt trying to find a BM donor|1
230640|NCT00075725|747715|P1|Overall Study|Pt trying to find a BM donor|0
230641|NCT00075725|747704|P12|Overall Study|Other|3
230642|NCT00075725|747705|P11|Overall Study|Other|0
230643|NCT00075725|747706|P10|Overall Study|Other|1
230644|NCT00075725|747707|P9|Overall Study|Other|2
230645|NCT00075725|747708|P8|Overall Study|Other|9
230646|NCT00075725|747709|P7|Overall Study|Other|2
230647|NCT00075725|747710|P6|Overall Study|Other|4
230648|NCT00075725|747711|P5|Overall Study|Other|1
230649|NCT00075725|747712|P4|Overall Study|Other|1
230650|NCT00075725|747713|P3|Overall Study|Other|1
230651|NCT00075725|747714|P2|Overall Study|Other|2
230652|NCT00075725|747715|P1|Overall Study|Other|4
230653|NCT00075725|747704|P12|Overall Study|Inevaluable|0
230654|NCT00075725|747705|P11|Overall Study|Inevaluable|1
230655|NCT00075725|747706|P10|Overall Study|Inevaluable|0
230656|NCT00075725|747707|P9|Overall Study|Inevaluable|2
230657|NCT00075725|747708|P8|Overall Study|Inevaluable|11
230658|NCT00075725|747709|P7|Overall Study|Inevaluable|1
230659|NCT00075725|747710|P6|Overall Study|Inevaluable|9
230660|NCT00075725|747711|P5|Overall Study|Inevaluable|2
230661|NCT00075725|747712|P4|Overall Study|Inevaluable|2
230662|NCT00075725|747713|P3|Overall Study|Inevaluable|4
230663|NCT00075725|747714|P2|Overall Study|Inevaluable|1
230664|NCT00075725|747715|P1|Overall Study|Inevaluable|1
230665|NCT00075725|747704|P12|Overall Study|Pt has very high risk ALL characteristic|3
230666|NCT00075725|747705|P11|Overall Study|Pt has very high risk ALL characteristic|0
230667|NCT00075725|747706|P10|Overall Study|Pt has very high risk ALL characteristic|1
230668|NCT00075725|747707|P9|Overall Study|Pt has very high risk ALL characteristic|29
230669|NCT00075725|747708|P8|Overall Study|Pt has very high risk ALL characteristic|74
230670|NCT00075725|747709|P7|Overall Study|Pt has very high risk ALL characteristic|23
230671|NCT00075725|747710|P6|Overall Study|Pt has very high risk ALL characteristic|75
230672|NCT00075725|747711|P5|Overall Study|Pt has very high risk ALL characteristic|11
230673|NCT00075725|747712|P4|Overall Study|Pt has very high risk ALL characteristic|18
230674|NCT00075725|747713|P3|Overall Study|Pt has very high risk ALL characteristic|26
230675|NCT00075725|747714|P2|Overall Study|Pt has very high risk ALL characteristic|11
230676|NCT00075725|747715|P1|Overall Study|Pt has very high risk ALL characteristic|15
230677|NCT00075725|747704|P12|Overall Study|MRD positive after extended ind|0
230678|NCT00075725|747705|P11|Overall Study|MRD positive after extended ind|0
230679|NCT00075725|747706|P10|Overall Study|MRD positive after extended ind|0
230680|NCT00075725|747707|P9|Overall Study|MRD positive after extended ind|0
230681|NCT00075725|747708|P8|Overall Study|MRD positive after extended ind|1
230682|NCT00075725|747709|P7|Overall Study|MRD positive after extended ind|0
230683|NCT00075725|747710|P6|Overall Study|MRD positive after extended ind|2
230684|NCT00075725|747711|P5|Overall Study|MRD positive after extended ind|1
230685|NCT00075725|747712|P4|Overall Study|MRD positive after extended ind|0
230686|NCT00075725|747713|P3|Overall Study|MRD positive after extended ind|1
230687|NCT00075725|747714|P2|Overall Study|MRD positive after extended ind|1
230688|NCT00075725|747715|P1|Overall Study|MRD positive after extended ind|0
230689|NCT00075725|747704|P12|Overall Study|Insurance issues|0
230690|NCT00075725|747705|P11|Overall Study|Insurance issues|0
230691|NCT00075725|747706|P10|Overall Study|Insurance issues|0
230692|NCT00075725|747707|P9|Overall Study|Insurance issues|0
230693|NCT00075725|747708|P8|Overall Study|Insurance issues|1
230694|NCT00075725|747709|P7|Overall Study|Insurance issues|0
230695|NCT00075725|747710|P6|Overall Study|Insurance issues|1
230696|NCT00075725|747711|P5|Overall Study|Insurance issues|1
230697|NCT00075725|747712|P4|Overall Study|Insurance issues|1
230698|NCT00075725|747713|P3|Overall Study|Insurance issues|0
230699|NCT00075725|747714|P2|Overall Study|Insurance issues|1
230700|NCT00075725|747715|P1|Overall Study|Insurance issues|0
230701|NCT00075725|747704|P12|Overall Study|Pt age out of range for treatment|0
230702|NCT00075725|747705|P11|Overall Study|Pt age out of range for treatment|0
230703|NCT00075725|747706|P10|Overall Study|Pt age out of range for treatment|0
230704|NCT00075725|747707|P9|Overall Study|Pt age out of range for treatment|0
230705|NCT00075725|747708|P8|Overall Study|Pt age out of range for treatment|1
230706|NCT00075725|747709|P7|Overall Study|Pt age out of range for treatment|0
230707|NCT00075725|747710|P6|Overall Study|Pt age out of range for treatment|1
230708|NCT00075725|747711|P5|Overall Study|Pt age out of range for treatment|0
230709|NCT00075725|747712|P4|Overall Study|Pt age out of range for treatment|0
230710|NCT00075725|747713|P3|Overall Study|Pt age out of range for treatment|0
230711|NCT00075725|747714|P2|Overall Study|Pt age out of range for treatment|1
230712|NCT00075725|747715|P1|Overall Study|Pt age out of range for treatment|0
230713|NCT00075725|747704|P12|Overall Study|Pt non compliant with therapy|0
230714|NCT00075725|747705|P11|Overall Study|Pt non compliant with therapy|0
230715|NCT00075725|747706|P10|Overall Study|Pt non compliant with therapy|0
230716|NCT00075725|747707|P9|Overall Study|Pt non compliant with therapy|3
230717|NCT00075725|747708|P8|Overall Study|Pt non compliant with therapy|5
230718|NCT00075725|747709|P7|Overall Study|Pt non compliant with therapy|2
230719|NCT00075725|747710|P6|Overall Study|Pt non compliant with therapy|14
230720|NCT00075725|747711|P5|Overall Study|Pt non compliant with therapy|2
230721|NCT00075725|747712|P4|Overall Study|Pt non compliant with therapy|0
230722|NCT00075725|747713|P3|Overall Study|Pt non compliant with therapy|1
230723|NCT00075725|747714|P2|Overall Study|Pt non compliant with therapy|1
230724|NCT00075725|747715|P1|Overall Study|Pt non compliant with therapy|2
230725|NCT00075725|747704|P12|Overall Study|Pt/Guardian refused RT therapy|0
230726|NCT00075725|747705|P11|Overall Study|Pt/Guardian refused RT therapy|0
230727|NCT00075725|747706|P10|Overall Study|Pt/Guardian refused RT therapy|0
230728|NCT00075725|747707|P9|Overall Study|Pt/Guardian refused RT therapy|0
230729|NCT00075725|747708|P8|Overall Study|Pt/Guardian refused RT therapy|0
230730|NCT00075725|747709|P7|Overall Study|Pt/Guardian refused RT therapy|0
230731|NCT00075725|747710|P6|Overall Study|Pt/Guardian refused RT therapy|0
230732|NCT00075725|747711|P5|Overall Study|Pt/Guardian refused RT therapy|1
230733|NCT00075725|747712|P4|Overall Study|Pt/Guardian refused RT therapy|2
230734|NCT00075725|747713|P3|Overall Study|Pt/Guardian refused RT therapy|1
230735|NCT00075725|747714|P2|Overall Study|Pt/Guardian refused RT therapy|0
230736|NCT00075725|747715|P1|Overall Study|Pt/Guardian refused RT therapy|1
230737|NCT00075725|747704|P12|Overall Study|Ineligible or wrong diagnosis|4
230738|NCT00075725|747705|P11|Overall Study|Ineligible or wrong diagnosis|2
230739|NCT00075725|747706|P10|Overall Study|Ineligible or wrong diagnosis|1
230740|NCT00075725|747707|P9|Overall Study|Ineligible or wrong diagnosis|10
230741|NCT00075725|747708|P8|Overall Study|Ineligible or wrong diagnosis|9
230742|NCT00075725|747709|P7|Overall Study|Ineligible or wrong diagnosis|6
230743|NCT00075725|747710|P6|Overall Study|Ineligible or wrong diagnosis|17
230744|NCT00075725|747711|P5|Overall Study|Ineligible or wrong diagnosis|3
230745|NCT00075725|747712|P4|Overall Study|Ineligible or wrong diagnosis|10
230746|NCT00075725|747713|P3|Overall Study|Ineligible or wrong diagnosis|3
230747|NCT00075725|747714|P2|Overall Study|Ineligible or wrong diagnosis|3
230748|NCT00075725|747715|P1|Overall Study|Ineligible or wrong diagnosis|8
230749|NCT00075725|747704|P12|Overall Study|Patient off treatment|0
230750|NCT00075725|747705|P11|Overall Study|Patient off treatment|0
230751|NCT00075725|747706|P10|Overall Study|Patient off treatment|0
230752|NCT00075725|747707|P9|Overall Study|Patient off treatment|1
230753|NCT00075725|747708|P8|Overall Study|Patient off treatment|2
230754|NCT00075725|747709|P7|Overall Study|Patient off treatment|0
230755|NCT00075725|747710|P6|Overall Study|Patient off treatment|0
230756|NCT00075725|747711|P5|Overall Study|Patient off treatment|1
230757|NCT00075725|747712|P4|Overall Study|Patient off treatment|2
230758|NCT00075725|747713|P3|Overall Study|Patient off treatment|1
230759|NCT00075725|747714|P2|Overall Study|Patient off treatment|0
230760|NCT00075725|747715|P1|Overall Study|Patient off treatment|0
230761|NCT00075725|747704|P12|Overall Study|Disease Progression, all other reasons|5
230762|NCT00075725|747705|P11|Overall Study|Disease Progression, all other reasons|0
230763|NCT00075725|747706|P10|Overall Study|Disease Progression, all other reasons|4
230764|NCT00075725|747707|P9|Overall Study|Disease Progression, all other reasons|21
230765|NCT00075725|747708|P8|Overall Study|Disease Progression, all other reasons|46
230766|NCT00075725|747709|P7|Overall Study|Disease Progression, all other reasons|20
230767|NCT00075725|747710|P6|Overall Study|Disease Progression, all other reasons|59
230768|NCT00075725|747711|P5|Overall Study|Disease Progression, all other reasons|21
230769|NCT00075725|747712|P4|Overall Study|Disease Progression, all other reasons|6
230770|NCT00075725|747713|P3|Overall Study|Disease Progression, all other reasons|33
230771|NCT00075725|747714|P2|Overall Study|Disease Progression, all other reasons|5
230772|NCT00075725|747715|P1|Overall Study|Disease Progression, all other reasons|17
230773|NCT00075725|747704|P12|Overall Study|Withdrawal by Subject|0
230774|NCT00075725|747705|P11|Overall Study|Withdrawal by Subject|0
230775|NCT00075725|747706|P10|Overall Study|Withdrawal by Subject|2
230776|NCT00075725|747707|P9|Overall Study|Withdrawal by Subject|10
230777|NCT00075725|747708|P8|Overall Study|Withdrawal by Subject|31
230778|NCT00075725|747709|P7|Overall Study|Withdrawal by Subject|7
230779|NCT00075725|747710|P6|Overall Study|Withdrawal by Subject|27
230780|NCT00075725|747711|P5|Overall Study|Withdrawal by Subject|6
230781|NCT00075725|747712|P4|Overall Study|Withdrawal by Subject|10
230782|NCT00075725|747713|P3|Overall Study|Withdrawal by Subject|6
230783|NCT00075725|747714|P2|Overall Study|Withdrawal by Subject|3
230784|NCT00075725|747715|P1|Overall Study|Withdrawal by Subject|12
230785|NCT00075725|747704|P12|Overall Study|Protocol Violation|1
230786|NCT00075725|747705|P11|Overall Study|Protocol Violation|0
230787|NCT00075725|747706|P10|Overall Study|Protocol Violation|0
230788|NCT00075725|747707|P9|Overall Study|Protocol Violation|3
230789|NCT00075725|747708|P8|Overall Study|Protocol Violation|2
230790|NCT00075725|747709|P7|Overall Study|Protocol Violation|1
230791|NCT00075725|747710|P6|Overall Study|Protocol Violation|2
230792|NCT00075725|747711|P5|Overall Study|Protocol Violation|3
230793|NCT00075725|747712|P4|Overall Study|Protocol Violation|3
230794|NCT00075725|747713|P3|Overall Study|Protocol Violation|0
230795|NCT00075725|747714|P2|Overall Study|Protocol Violation|1
230796|NCT00075725|747715|P1|Overall Study|Protocol Violation|1
230797|NCT00075725|747704|P12|Overall Study|Pregnancy|0
230798|NCT00075725|747705|P11|Overall Study|Pregnancy|0
230799|NCT00075725|747706|P10|Overall Study|Pregnancy|0
230800|NCT00075725|747707|P9|Overall Study|Pregnancy|0
230801|NCT00075725|747708|P8|Overall Study|Pregnancy|1
230802|NCT00075725|747709|P7|Overall Study|Pregnancy|0
230803|NCT00075725|747710|P6|Overall Study|Pregnancy|1
230804|NCT00075725|747711|P5|Overall Study|Pregnancy|0
230805|NCT00075725|747712|P4|Overall Study|Pregnancy|0
230806|NCT00075725|747713|P3|Overall Study|Pregnancy|0
230807|NCT00075725|747714|P2|Overall Study|Pregnancy|0
230808|NCT00075725|747715|P1|Overall Study|Pregnancy|0
230809|NCT00075725|747704|P12|Overall Study|Physician Decision|0
230810|NCT00075725|747705|P11|Overall Study|Physician Decision|1
230811|NCT00075725|747706|P10|Overall Study|Physician Decision|0
230812|NCT00075725|747707|P9|Overall Study|Physician Decision|5
230813|NCT00075725|747708|P8|Overall Study|Physician Decision|17
230814|NCT00075725|747709|P7|Overall Study|Physician Decision|3
230815|NCT00075725|747710|P6|Overall Study|Physician Decision|19
230816|NCT00075725|747711|P5|Overall Study|Physician Decision|4
230817|NCT00075725|747712|P4|Overall Study|Physician Decision|8
230818|NCT00075725|747713|P3|Overall Study|Physician Decision|5
230819|NCT00075725|747714|P2|Overall Study|Physician Decision|6
230820|NCT00075725|747715|P1|Overall Study|Physician Decision|2
230821|NCT00075725|747704|P12|Overall Study|Lost to Follow-up|0
230822|NCT00075725|747705|P11|Overall Study|Lost to Follow-up|0
230823|NCT00075725|747706|P10|Overall Study|Lost to Follow-up|0
230824|NCT00075725|747707|P9|Overall Study|Lost to Follow-up|1
230825|NCT00075725|747708|P8|Overall Study|Lost to Follow-up|4
230826|NCT00075725|747709|P7|Overall Study|Lost to Follow-up|2
230827|NCT00075725|747710|P6|Overall Study|Lost to Follow-up|13
230828|NCT00075725|747711|P5|Overall Study|Lost to Follow-up|0
230829|NCT00075725|747712|P4|Overall Study|Lost to Follow-up|1
230830|NCT00075725|747713|P3|Overall Study|Lost to Follow-up|4
230831|NCT00075725|747714|P2|Overall Study|Lost to Follow-up|1
230832|NCT00075725|747715|P1|Overall Study|Lost to Follow-up|1
230833|NCT00075725|747704|P12|Overall Study|Death|0
230834|NCT00075725|747705|P11|Overall Study|Death|3
230835|NCT00075725|747706|P10|Overall Study|Death|4
230836|NCT00075725|747707|P9|Overall Study|Death|14
230837|NCT00075725|747708|P8|Overall Study|Death|22
230838|NCT00075725|747709|P7|Overall Study|Death|4
230839|NCT00075725|747710|P6|Overall Study|Death|25
230840|NCT00075725|747711|P5|Overall Study|Death|3
230841|NCT00075725|747712|P4|Overall Study|Death|2
230842|NCT00075725|747713|P3|Overall Study|Death|10
230843|NCT00075725|747714|P2|Overall Study|Death|5
230844|NCT00075725|747715|P1|Overall Study|Death|3
230845|NCT00075725|747704|P12|Overall Study|Adverse Event|2
230846|NCT00075725|747705|P11|Overall Study|Adverse Event|2
230847|NCT00075725|747706|P10|Overall Study|Adverse Event|4
230848|NCT00075725|747707|P9|Overall Study|Adverse Event|15
230849|NCT00075725|747708|P8|Overall Study|Adverse Event|51
230850|NCT00075725|747709|P7|Overall Study|Adverse Event|3
230851|NCT00075725|747710|P6|Overall Study|Adverse Event|38
230852|NCT00075725|747711|P5|Overall Study|Adverse Event|4
230853|NCT00075725|747712|P4|Overall Study|Adverse Event|8
230854|NCT00075725|747713|P3|Overall Study|Adverse Event|20
230855|NCT00075725|747714|P2|Overall Study|Adverse Event|6
230856|NCT00075725|747715|P1|Overall Study|Adverse Event|6
230857|NCT00075582|747812|P2|Overall Study|Ineligible for study|16
230858|NCT00075582|747813|P1|Overall Study|Ineligible for study|36
230859|NCT00075582|747812|P2|Overall Study|Withdrawal by Subject|2
230860|NCT00075582|747813|P1|Overall Study|Withdrawal by Subject|2
230861|NCT00075582|747812|P2|Overall Study|Physician Decision|8
230862|NCT00075582|747813|P1|Overall Study|Physician Decision|5
230863|NCT00075582|747812|P2|Overall Study|Lack of Efficacy|8
230864|NCT00075582|747813|P1|Overall Study|Lack of Efficacy|4
230865|NCT00075582|747812|P2|Overall Study|Adverse Event|1
230866|NCT00075582|747813|P1|Overall Study|Adverse Event|3
230867|NCT00075504|747823|P2|Overall Study|Withdrawal by Subject|7
230868|NCT00075504|747824|P1|Overall Study|Withdrawal by Subject|9
230869|NCT00075478|747836|P2|Overall Study|Physician Decision|1
230870|NCT00075478|747837|P1|Overall Study|Physician Decision|0
230871|NCT00075478|747836|P2|Overall Study|not eligible|0
230872|NCT00075478|747837|P1|Overall Study|not eligible|1
230873|NCT00075400|747857|P1|Overall Study|Never treated|2
230874|NCT00075400|747857|P1|Overall Study|Ineligible: wrong primary|1
230875|NCT00075270|747878|P2|Overall Study|Missing|13
230876|NCT00075270|747879|P1|Overall Study|Missing|26
230877|NCT00075270|747878|P2|Overall Study|Other/Unknown|5
230878|NCT00075270|747879|P1|Overall Study|Other/Unknown|9
230879|NCT00075270|747878|P2|Overall Study|Death|215
230880|NCT00075270|747879|P1|Overall Study|Death|198
230881|NCT00075270|747878|P2|Overall Study|Protocol Violation|2
230882|NCT00075270|747879|P1|Overall Study|Protocol Violation|0
230883|NCT00075270|747878|P2|Overall Study|Lost to Follow-up|28
230884|NCT00075270|747879|P1|Overall Study|Lost to Follow-up|25
230885|NCT00075270|747878|P2|Overall Study|Withdrawal by Subject|21
230886|NCT00075270|747879|P1|Overall Study|Withdrawal by Subject|28
230887|NCT00075218|747925|P3|Open-Label Treatment|enrolled in a separate continuation|9
230888|NCT00075218|747926|P2|Open-Label Treatment|enrolled in a separate continuation|0
230889|NCT00075218|747927|P1|Open-Label Treatment|enrolled in a separate continuation|0
230890|NCT00075218|747925|P3|Open-Label Treatment|Protocol Violation|1
230891|NCT00075218|747926|P2|Open-Label Treatment|Protocol Violation|0
230892|NCT00075218|747927|P1|Open-Label Treatment|Protocol Violation|0
230893|NCT00075218|747925|P3|Open-Label Treatment|Decision of Sponsor|8
230894|NCT00075218|747926|P2|Open-Label Treatment|Decision of Sponsor|0
230895|NCT00075218|747927|P1|Open-Label Treatment|Decision of Sponsor|0
230896|NCT00075218|747925|P3|Open-Label Treatment|Withdrawal by Subject|12
230897|NCT00075218|747926|P2|Open-Label Treatment|Withdrawal by Subject|0
230898|NCT00075218|747927|P1|Open-Label Treatment|Withdrawal by Subject|0
230899|NCT00075218|747925|P3|Open-Label Treatment|Adverse Event|51
230900|NCT00075218|747926|P2|Open-Label Treatment|Adverse Event|0
230901|NCT00075218|747927|P1|Open-Label Treatment|Adverse Event|0
230902|NCT00075218|747925|P3|Open-Label Treatment|Lack of Efficacy|174
230903|NCT00075218|747926|P2|Open-Label Treatment|Lack of Efficacy|0
230904|NCT00075218|747927|P1|Open-Label Treatment|Lack of Efficacy|0
230905|NCT00075218|747925|P3|Double-Blind Treatment|No study medication taken|0
230906|NCT00075218|747926|P2|Double-Blind Treatment|No study medication taken|0
230907|NCT00075218|747927|P1|Double-Blind Treatment|No study medication taken|2
230908|NCT00075218|747925|P3|Double-Blind Treatment|Decision of Sponsor|0
230909|NCT00075218|747926|P2|Double-Blind Treatment|Decision of Sponsor|1
230910|NCT00075218|747927|P1|Double-Blind Treatment|Decision of Sponsor|0
230911|NCT00075218|747925|P3|Double-Blind Treatment|Lack of Efficacy|0
230912|NCT00075218|747926|P2|Double-Blind Treatment|Lack of Efficacy|6
230913|NCT00075218|747927|P1|Double-Blind Treatment|Lack of Efficacy|58
230914|NCT00075218|747925|P3|Double-Blind Treatment|Lost to Follow-up|0
230915|NCT00075218|747926|P2|Double-Blind Treatment|Lost to Follow-up|0
230916|NCT00075218|747927|P1|Double-Blind Treatment|Lost to Follow-up|1
230917|NCT00075218|747925|P3|Double-Blind Treatment|Withdrawal by Subject|0
230918|NCT00075218|747926|P2|Double-Blind Treatment|Withdrawal by Subject|4
230919|NCT00075218|747927|P1|Double-Blind Treatment|Withdrawal by Subject|7
230920|NCT00075218|747925|P3|Double-Blind Treatment|Adverse Event|0
230921|NCT00075218|747926|P2|Double-Blind Treatment|Adverse Event|4
230922|NCT00075218|747927|P1|Double-Blind Treatment|Adverse Event|23
230923|NCT00075023|747976|P2|Pilot Study|Withdrawal by Subject|0
230924|NCT00075023|747977|P1|Pilot Study|Withdrawal by Subject|1
230925|NCT00075023|747976|P2|Pilot Study|Physician Decision|2
230926|NCT00075023|747977|P1|Pilot Study|Physician Decision|1
230927|NCT00074984|747986|P2|Overall Study|Patient Withdrawn Per Protocol|3
230928|NCT00074984|747987|P1|Overall Study|Patient Withdrawn Per Protocol|0
230929|NCT00074984|747986|P2|Overall Study|Withdrawal by Subject|3
230930|NCT00074984|747987|P1|Overall Study|Withdrawal by Subject|2
230931|NCT00074984|747986|P2|Overall Study|Death|2
230932|NCT00074984|747987|P1|Overall Study|Death|1
230933|NCT00074958|748002|P1|Overall Study|Adverse Event|1
230934|NCT00074711|748043|P2|Overall Study|Participant stopped study drug|6
230935|NCT00074711|748044|P1|Overall Study|Participant stopped study drug|4
230936|NCT00074711|748043|P2|Overall Study|Lost to Follow-up|8
230937|NCT00074711|748044|P1|Overall Study|Lost to Follow-up|10
230938|NCT00074711|748043|P2|Overall Study|Withdrawal by Subject|1
230939|NCT00074711|748044|P1|Overall Study|Withdrawal by Subject|1
230940|NCT00074581|748062|P2|Overall Study|Other|19
230941|NCT00074581|748063|P1|Overall Study|Other|14
230942|NCT00074581|748062|P2|Overall Study|Ended relationship w. index participant|106
230943|NCT00074581|748063|P1|Overall Study|Ended relationship w. index participant|117
230944|NCT00074581|748062|P2|Overall Study|Lost to Follow-up|11
230945|NCT00074581|748063|P1|Overall Study|Lost to Follow-up|16
230946|NCT00074581|748062|P2|Overall Study|Were withdrawn by investigator|2
230947|NCT00074581|748063|P1|Overall Study|Were withdrawn by investigator|5
230948|NCT00074581|748062|P2|Overall Study|Relocated|9
230949|NCT00074581|748063|P1|Overall Study|Relocated|14
230950|NCT00074581|748062|P2|Overall Study|Unable to adhere to visit schedule|14
230951|NCT00074581|748063|P1|Overall Study|Unable to adhere to visit schedule|13
230952|NCT00074581|748062|P2|Overall Study|Withdrawal by Subject|49
230953|NCT00074581|748063|P1|Overall Study|Withdrawal by Subject|50
230954|NCT00074581|748062|P2|Overall Study|Death|16
230955|NCT00074581|748063|P1|Overall Study|Death|15
230956|NCT00074412|748073|P2|Overall Study|Lost to Follow-up|58
230957|NCT00074412|748074|P1|Overall Study|Lost to Follow-up|52
230958|NCT00074412|748073|P2|Overall Study|Death|26
230959|NCT00074412|748074|P1|Overall Study|Death|30
230960|NCT00074152|748121|P2|Overall Study|Lack of Efficacy|24
230961|NCT00074152|748122|P1|Overall Study|Lack of Efficacy|34
230962|NCT00074152|748121|P2|Overall Study|Death|9
230963|NCT00074152|748122|P1|Overall Study|Death|21
230964|NCT00073983|748139|P1|Overall Study|not evaluable|1
230965|NCT00073918|748160|P1|Overall Study|Eligibility requirement not met-low CD20|1
230966|NCT00073918|748160|P1|Overall Study|Rapid disease progression|2
230967|NCT00073918|748160|P1|Overall Study|Eligibility requirement not met - HAMA+|1
230968|NCT00073528|748169|P2|Overall Study|Ongoing|344
230969|NCT00073528|748170|P1|Overall Study|Ongoing|349
230970|NCT00073528|748169|P2|Overall Study|Non-compliance|1
230971|NCT00073528|748170|P1|Overall Study|Non-compliance|0
230972|NCT00073528|748169|P2|Overall Study|Enrolled in Error|1
230973|NCT00073528|748170|P1|Overall Study|Enrolled in Error|0
230974|NCT00073528|748169|P2|Overall Study|Participant Was Unblinded|1
230975|NCT00073528|748170|P1|Overall Study|Participant Was Unblinded|0
230976|NCT00073528|748169|P2|Overall Study|Progressive Disease|1
230977|NCT00073528|748170|P1|Overall Study|Progressive Disease|0
230978|NCT00073528|748169|P2|Overall Study|Randomized in Error; Not Treated|0
230979|NCT00073528|748170|P1|Overall Study|Randomized in Error; Not Treated|2
230980|NCT00073528|748169|P2|Overall Study|Mastectomy Intervention|0
230981|NCT00073528|748170|P1|Overall Study|Mastectomy Intervention|1
230982|NCT00073528|748169|P2|Overall Study|Death|238
230983|NCT00073528|748170|P1|Overall Study|Death|229
230984|NCT00073528|748169|P2|Overall Study|Protocol Violation|5
230985|NCT00073528|748170|P1|Overall Study|Protocol Violation|3
230986|NCT00073528|748169|P2|Overall Study|Lost to Follow-up|22
230987|NCT00073528|748170|P1|Overall Study|Lost to Follow-up|26
230988|NCT00073528|748169|P2|Overall Study|Withdrawal by Subject|29
230989|NCT00073528|748170|P1|Overall Study|Withdrawal by Subject|34
230990|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
230991|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
230992|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
230993|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
230994|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
230995|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
230996|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
230997|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
230998|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
230999|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
231000|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
231001|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
231002|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
231003|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
231004|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
231005|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
231006|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
231007|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
231008|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
231009|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
231010|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
231011|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
231012|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
231013|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
231014|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
231015|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
231016|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
231017|NCT00073307|748259|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
231018|NCT00073307|748260|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
231019|NCT00073307|748261|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
231020|NCT00073307|748259|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
231021|NCT00073307|748260|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
231022|NCT00073307|748261|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
231023|NCT00073307|748259|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
231024|NCT00073307|748260|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
231025|NCT00073307|748261|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
231026|NCT00073307|748259|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
231027|NCT00073307|748260|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
231028|NCT00073307|748261|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
231029|NCT00073307|748259|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
231030|NCT00073307|748260|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
231031|NCT00073307|748261|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
231032|NCT00073307|748259|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
231033|NCT00073307|748260|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
231034|NCT00073307|748261|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
231035|NCT00073307|748259|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
231036|NCT00073307|748260|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
231037|NCT00073307|748261|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
231038|NCT00073307|748259|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
231039|NCT00073307|748260|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
231040|NCT00073307|748261|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
231041|NCT00073307|748259|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
231042|NCT00073307|748260|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
231043|NCT00073307|748261|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
231044|NCT00073307|748259|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
231045|NCT00073307|748260|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
231046|NCT00073307|748261|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
231047|NCT00073021|748292|P2|Overall Study|Lack of Efficacy|5
231048|NCT00073021|748293|P1|Overall Study|Lack of Efficacy|11
231049|NCT00073021|748292|P2|Overall Study|Physician Decision|1
231050|NCT00073021|748293|P1|Overall Study|Physician Decision|3
231051|NCT00073021|748292|P2|Overall Study|Withdrawal by Subject|5
231052|NCT00073021|748293|P1|Overall Study|Withdrawal by Subject|6
231053|NCT00073021|748292|P2|Overall Study|Adverse Event|4
231054|NCT00073021|748293|P1|Overall Study|Adverse Event|4
231055|NCT00073021|748292|P2|Overall Study|Protocol Violation|1
231056|NCT00073021|748293|P1|Overall Study|Protocol Violation|2
231057|NCT00073008|748323|P2|Overall Study|"Other selected on Case Report Form"|5
231058|NCT00073008|748324|P1|Overall Study|"Other selected on Case Report Form"|7
231059|NCT00073008|748323|P2|Overall Study|Death|47
231060|NCT00073008|748324|P1|Overall Study|Death|46
231061|NCT00073008|748323|P2|Overall Study|Lost to Follow-up|3
231062|NCT00073008|748324|P1|Overall Study|Lost to Follow-up|1
231063|NCT00073008|748323|P2|Overall Study|Withdrawal by Subject|2
231064|NCT00073008|748324|P1|Overall Study|Withdrawal by Subject|2
231065|NCT00073008|748323|P2|Overall Study|Missing|6
231066|NCT00073008|748324|P1|Overall Study|Missing|6
231067|NCT00072475|748363|P1|Overall Study|Patient/Investigator Decision|4
231068|NCT00072475|748363|P1|Overall Study|Withdrawal by Subject|46
231069|NCT00072475|748363|P1|Overall Study|Death|3
231070|NCT00072475|748363|P1|Overall Study|Adverse Event|44
231071|NCT00072293|748380|P2|Overall Study|Withdrawal by Subject|1
231072|NCT00072293|748381|P1|Overall Study|Withdrawal by Subject|0
231073|NCT00072293|748380|P2|Overall Study|Lost to Follow-up|1
231074|NCT00072293|748381|P1|Overall Study|Lost to Follow-up|1
231075|NCT00072280|748393|P2|Follow-up|Early termination of study|2
231076|NCT00072280|748394|P1|Follow-up|Early termination of study|2
231077|NCT00072280|748393|P2|Treatment|Found ineligible|2
231078|NCT00072280|748394|P1|Treatment|Found ineligible|1
231079|NCT00072189|748399|P1|Overall Study|Withdrawal by Subject|1
231080|NCT00072176|748407|P2|Overall Study|Protocol Violation|1
231081|NCT00072176|748408|P1|Overall Study|Protocol Violation|0
231082|NCT00072176|748407|P2|Overall Study|Withdrawal by Subject|0
231083|NCT00072176|748408|P1|Overall Study|Withdrawal by Subject|1
231084|NCT00071981|748420|P4|Overall Study|others (not specified in the study)|0
231085|NCT00071981|748421|P3|Overall Study|others (not specified in the study)|2
231086|NCT00071981|748422|P2|Overall Study|others (not specified in the study)|2
231087|NCT00071981|748423|P1|Overall Study|others (not specified in the study)|0
231088|NCT00071981|748420|P4|Overall Study|No protocol therapy|0
231089|NCT00071981|748421|P3|Overall Study|No protocol therapy|1
231090|NCT00071981|748422|P2|Overall Study|No protocol therapy|5
231091|NCT00071981|748423|P1|Overall Study|No protocol therapy|2
231092|NCT00071981|748420|P4|Overall Study|Withdrawal by Subject|0
231093|NCT00071981|748421|P3|Overall Study|Withdrawal by Subject|0
231094|NCT00071981|748422|P2|Overall Study|Withdrawal by Subject|1
231095|NCT00071981|748423|P1|Overall Study|Withdrawal by Subject|3
231096|NCT00071981|748420|P4|Overall Study|Death|1
231097|NCT00071981|748421|P3|Overall Study|Death|1
231098|NCT00071981|748422|P2|Overall Study|Death|0
231099|NCT00071981|748423|P1|Overall Study|Death|0
231100|NCT00071981|748420|P4|Overall Study|Adverse Event|1
231101|NCT00071981|748421|P3|Overall Study|Adverse Event|3
231102|NCT00071981|748422|P2|Overall Study|Adverse Event|4
231103|NCT00071981|748423|P1|Overall Study|Adverse Event|4
231104|NCT00071981|748420|P4|Overall Study|Lack of Efficacy|43
231105|NCT00071981|748421|P3|Overall Study|Lack of Efficacy|30
231106|NCT00071981|748422|P2|Overall Study|Lack of Efficacy|29
231107|NCT00071981|748423|P1|Overall Study|Lack of Efficacy|37
231108|NCT00071812|748466|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
231109|NCT00071812|748467|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
231110|NCT00071812|748468|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
231111|NCT00071812|748469|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
231112|NCT00071812|748466|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
231113|NCT00071812|748467|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
231114|NCT00071812|748468|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
231115|NCT00071812|748469|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
231116|NCT00071812|748466|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
231117|NCT00071812|748467|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
231118|NCT00071812|748468|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
231119|NCT00071812|748469|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
231120|NCT00071812|748466|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
231121|NCT00071812|748467|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
231122|NCT00071812|748468|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
231123|NCT00071812|748469|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
231124|NCT00071812|748466|P4|24-Week Open-Label Extension Period|Adverse Event|7
231125|NCT00071812|748467|P3|24-Week Open-Label Extension Period|Adverse Event|0
231126|NCT00071812|748468|P2|24-Week Open-Label Extension Period|Adverse Event|0
231127|NCT00071812|748469|P1|24-Week Open-Label Extension Period|Adverse Event|0
231128|NCT00071812|748466|P4|24-Week Double-Blind Period|Protocol Violation|1
231129|NCT00071812|748467|P3|24-Week Double-Blind Period|Protocol Violation|0
231130|NCT00071812|748468|P2|24-Week Double-Blind Period|Protocol Violation|0
231131|NCT00071812|748469|P1|24-Week Double-Blind Period|Protocol Violation|0
231132|NCT00071812|748466|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
231133|NCT00071812|748467|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
231134|NCT00071812|748468|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
231302|NCT00070564|748787|P1|Overall Study|Adverse Event|150
231135|NCT00071812|748469|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
231136|NCT00071812|748466|P4|24-Week Double-Blind Period|Lost to Follow-up|0
231137|NCT00071812|748467|P3|24-Week Double-Blind Period|Lost to Follow-up|1
231138|NCT00071812|748468|P2|24-Week Double-Blind Period|Lost to Follow-up|1
231139|NCT00071812|748469|P1|24-Week Double-Blind Period|Lost to Follow-up|0
231140|NCT00071812|748466|P4|24-Week Double-Blind Period|Lack of Efficacy|1
231141|NCT00071812|748467|P3|24-Week Double-Blind Period|Lack of Efficacy|2
231142|NCT00071812|748468|P2|24-Week Double-Blind Period|Lack of Efficacy|1
231143|NCT00071812|748469|P1|24-Week Double-Blind Period|Lack of Efficacy|3
231144|NCT00071812|748466|P4|24-Week Double-Blind Period|Adverse Event|4
231145|NCT00071812|748467|P3|24-Week Double-Blind Period|Adverse Event|4
231146|NCT00071812|748468|P2|24-Week Double-Blind Period|Adverse Event|3
231147|NCT00071812|748469|P1|24-Week Double-Blind Period|Adverse Event|2
231148|NCT00071799|748511|P2|Overall Study|Not Documented|2
231149|NCT00071799|748512|P1|Overall Study|Not Documented|0
231150|NCT00071799|748511|P2|Overall Study|Different Central+Local Pathology Review|1
231151|NCT00071799|748512|P1|Overall Study|Different Central+Local Pathology Review|0
231152|NCT00071799|748511|P2|Overall Study|Disease Progression|20
231153|NCT00071799|748512|P1|Overall Study|Disease Progression|23
231154|NCT00071799|748511|P2|Overall Study|Lack of Efficacy|18
231155|NCT00071799|748512|P1|Overall Study|Lack of Efficacy|11
231156|NCT00071799|748511|P2|Overall Study|Physician Decision|2
231157|NCT00071799|748512|P1|Overall Study|Physician Decision|0
231158|NCT00071799|748511|P2|Overall Study|Withdrawal by Subject|37
231159|NCT00071799|748512|P1|Overall Study|Withdrawal by Subject|15
231160|NCT00071799|748511|P2|Overall Study|Lost to Follow-up|1
231161|NCT00071799|748512|P1|Overall Study|Lost to Follow-up|1
231162|NCT00071799|748511|P2|Overall Study|Protocol Violation|7
231163|NCT00071799|748512|P1|Overall Study|Protocol Violation|1
231164|NCT00071799|748511|P2|Overall Study|Adverse Event|10
231165|NCT00071799|748512|P1|Overall Study|Adverse Event|19
231166|NCT00071760|748565|P1|Overall Study|Ongoing|25
231167|NCT00071760|748565|P1|Overall Study|Study Team Rec./Resistance|1
231168|NCT00071760|748565|P1|Overall Study|Investigator's Recommendation (Rec.)|4
231169|NCT00071760|748565|P1|Overall Study|Relocation|1
231170|NCT00071760|748565|P1|Overall Study|Unavailability of RTV|8
231171|NCT00071760|748565|P1|Overall Study|Pulmonary Tuberculosis|1
231172|NCT00071760|748565|P1|Overall Study|Insufficient Viral Load Response|3
231173|NCT00071760|748565|P1|Overall Study|Withdrawal by Subject|3
231174|NCT00071760|748565|P1|Overall Study|Protocol Violation|1
231175|NCT00071760|748565|P1|Overall Study|Lost to Follow-up|4
231176|NCT00071760|748565|P1|Overall Study|Adverse Event|3
231177|NCT00071513|748645|P2|Follow-up Assessment|Withdrawal by Subject|6
231178|NCT00071513|748646|P1|Follow-up Assessment|Withdrawal by Subject|6
231179|NCT00071513|748645|P2|Intervention Component|Withdrawal by Subject|3
231180|NCT00071513|748646|P1|Intervention Component|Withdrawal by Subject|2
231181|NCT00071487|748658|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
231182|NCT00071487|748659|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
231183|NCT00071487|748660|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
231184|NCT00071487|748661|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
231185|NCT00071487|748658|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
231186|NCT00071487|748659|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
231187|NCT00071487|748660|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
231188|NCT00071487|748661|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
231189|NCT00071487|748658|P4|24-Week Open-Label Extension Period|Pregnancy|1
231190|NCT00071487|748659|P3|24-Week Open-Label Extension Period|Pregnancy|0
231191|NCT00071487|748660|P2|24-Week Open-Label Extension Period|Pregnancy|0
231192|NCT00071487|748661|P1|24-Week Open-Label Extension Period|Pregnancy|0
231193|NCT00071487|748658|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
231194|NCT00071487|748659|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
231195|NCT00071487|748660|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
231196|NCT00071487|748661|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
231197|NCT00071487|748658|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
231198|NCT00071487|748659|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
231199|NCT00071487|748660|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
231200|NCT00071487|748661|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
231201|NCT00071487|748658|P4|24-Week Open-Label Extension Period|Adverse Event|6
231202|NCT00071487|748659|P3|24-Week Open-Label Extension Period|Adverse Event|1
231203|NCT00071487|748660|P2|24-Week Open-Label Extension Period|Adverse Event|0
231204|NCT00071487|748661|P1|24-Week Open-Label Extension Period|Adverse Event|0
231205|NCT00071487|748658|P4|52-Week Double-Blind Period|Lack of Compliance|3
231206|NCT00071487|748659|P3|52-Week Double-Blind Period|Lack of Compliance|3
231207|NCT00071487|748660|P2|52-Week Double-Blind Period|Lack of Compliance|3
231208|NCT00071487|748661|P1|52-Week Double-Blind Period|Lack of Compliance|6
231209|NCT00071487|748658|P4|52-Week Double-Blind Period|Death|0
231210|NCT00071487|748659|P3|52-Week Double-Blind Period|Death|0
231211|NCT00071487|748660|P2|52-Week Double-Blind Period|Death|1
231212|NCT00071487|748661|P1|52-Week Double-Blind Period|Death|0
231213|NCT00071487|748658|P4|52-Week Double-Blind Period|Protocol Violation|0
231214|NCT00071487|748659|P3|52-Week Double-Blind Period|Protocol Violation|1
231215|NCT00071487|748660|P2|52-Week Double-Blind Period|Protocol Violation|1
231216|NCT00071487|748661|P1|52-Week Double-Blind Period|Protocol Violation|0
231217|NCT00071487|748658|P4|52-Week Double-Blind Period|Pregnancy|0
231218|NCT00071487|748659|P3|52-Week Double-Blind Period|Pregnancy|0
231219|NCT00071487|748660|P2|52-Week Double-Blind Period|Pregnancy|1
231220|NCT00071487|748661|P1|52-Week Double-Blind Period|Pregnancy|0
231221|NCT00071487|748658|P4|52-Week Double-Blind Period|Lost to Follow-up|2
231222|NCT00071487|748659|P3|52-Week Double-Blind Period|Lost to Follow-up|2
231223|NCT00071487|748660|P2|52-Week Double-Blind Period|Lost to Follow-up|0
231224|NCT00071487|748661|P1|52-Week Double-Blind Period|Lost to Follow-up|0
231225|NCT00071487|748658|P4|52-Week Double-Blind Period|Physician Decision|0
231226|NCT00071487|748659|P3|52-Week Double-Blind Period|Physician Decision|0
231227|NCT00071487|748660|P2|52-Week Double-Blind Period|Physician Decision|0
231228|NCT00071487|748661|P1|52-Week Double-Blind Period|Physician Decision|1
231229|NCT00071487|748658|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
231230|NCT00071487|748659|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
231231|NCT00071487|748660|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
231232|NCT00071487|748661|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
231233|NCT00071487|748658|P4|52-Week Double-Blind Period|Lack of Efficacy|1
231234|NCT00071487|748659|P3|52-Week Double-Blind Period|Lack of Efficacy|0
231235|NCT00071487|748660|P2|52-Week Double-Blind Period|Lack of Efficacy|2
231236|NCT00071487|748661|P1|52-Week Double-Blind Period|Lack of Efficacy|1
231237|NCT00071487|748658|P4|52-Week Double-Blind Period|Adverse Event|8
231238|NCT00071487|748659|P3|52-Week Double-Blind Period|Adverse Event|4
231239|NCT00071487|748660|P2|52-Week Double-Blind Period|Adverse Event|8
231240|NCT00071487|748661|P1|52-Week Double-Blind Period|Adverse Event|5
231241|NCT00071396|748705|P1|Overall Study|Physician Decision|2
231242|NCT00071396|748705|P1|Overall Study|Withdrawal by Subject|1
231243|NCT00071110|748711|P2|Overall Study|Protocol Violation|4
231244|NCT00071110|748712|P1|Overall Study|Protocol Violation|0
231245|NCT00071032|748726|P2|Overall Study|Missing Primary Outcome|1
231246|NCT00071032|748727|P1|Overall Study|Missing Primary Outcome|0
231247|NCT00071032|748726|P2|Overall Study|Withdrawal by Subject|6
231248|NCT00071032|748727|P1|Overall Study|Withdrawal by Subject|8
231249|NCT00071032|748726|P2|Overall Study|Lost to Follow-up|1
231250|NCT00071032|748727|P1|Overall Study|Lost to Follow-up|1
231251|NCT00071006|748735|P1|Overall Study|Other|3
231252|NCT00071006|748735|P1|Overall Study|Withdrawal by Subject|1
231253|NCT00071006|748735|P1|Overall Study|Adverse Event|1
231254|NCT00071006|748735|P1|Overall Study|Lack of Efficacy|7
231255|NCT00070941|748748|P3|Overall Study|Adverse Event|4
231256|NCT00070941|748749|P2|Overall Study|Adverse Event|8
231257|NCT00070941|748750|P1|Overall Study|Adverse Event|10
231258|NCT00071058|748758|P1|Overall Study|brain tumor-removed from study|1
231259|NCT00003907|748765|P2|Overall Study|ineligible or not treated|2
231260|NCT00003907|748766|P1|Overall Study|ineligible or not treated|2
231261|NCT00003907|748765|P2|Overall Study|Not specified|3
231262|NCT00003907|748766|P1|Overall Study|Not specified|1
231263|NCT00003907|748765|P2|Overall Study|Complicating disease|0
231264|NCT00003907|748766|P1|Overall Study|Complicating disease|1
231265|NCT00003907|748765|P2|Overall Study|Progressive disease|4
231266|NCT00003907|748766|P1|Overall Study|Progressive disease|4
231267|NCT00003907|748765|P2|Overall Study|Withdrawal by Subject|3
231268|NCT00003907|748766|P1|Overall Study|Withdrawal by Subject|1
231269|NCT00003907|748765|P2|Overall Study|Death|0
231270|NCT00003907|748766|P1|Overall Study|Death|2
231271|NCT00003907|748765|P2|Overall Study|Adverse Event|11
231272|NCT00003907|748766|P1|Overall Study|Adverse Event|2
231273|NCT00070564|748782|P6|Overall Study|Not reported|0
231274|NCT00070564|748783|P5|Overall Study|Not reported|1
231275|NCT00070564|748784|P4|Overall Study|Not reported|0
231276|NCT00070564|748785|P3|Overall Study|Not reported|0
231277|NCT00070564|748786|P2|Overall Study|Not reported|0
231278|NCT00070564|748787|P1|Overall Study|Not reported|0
231279|NCT00070564|748782|P6|Overall Study|Withdrawal by Subject|8
231280|NCT00070564|748783|P5|Overall Study|Withdrawal by Subject|8
231281|NCT00070564|748784|P4|Overall Study|Withdrawal by Subject|30
231282|NCT00070564|748785|P3|Overall Study|Withdrawal by Subject|23
231283|NCT00070564|748786|P2|Overall Study|Withdrawal by Subject|37
231284|NCT00070564|748787|P1|Overall Study|Withdrawal by Subject|26
231285|NCT00070564|748782|P6|Overall Study|Other, not protocol specified|7
231286|NCT00070564|748783|P5|Overall Study|Other, not protocol specified|6
231287|NCT00070564|748784|P4|Overall Study|Other, not protocol specified|19
231288|NCT00070564|748785|P3|Overall Study|Other, not protocol specified|14
231289|NCT00070564|748786|P2|Overall Study|Other, not protocol specified|15
231290|NCT00070564|748787|P1|Overall Study|Other, not protocol specified|17
231291|NCT00070564|748782|P6|Overall Study|Death|1
231292|NCT00070564|748783|P5|Overall Study|Death|0
231293|NCT00070564|748784|P4|Overall Study|Death|3
231294|NCT00070564|748785|P3|Overall Study|Death|5
231295|NCT00070564|748786|P2|Overall Study|Death|1
231296|NCT00070564|748787|P1|Overall Study|Death|4
231297|NCT00070564|748782|P6|Overall Study|Adverse Event|36
231298|NCT00070564|748783|P5|Overall Study|Adverse Event|63
231299|NCT00070564|748784|P4|Overall Study|Adverse Event|108
231300|NCT00070564|748785|P3|Overall Study|Adverse Event|120
231301|NCT00070564|748786|P2|Overall Study|Adverse Event|142
231303|NCT00070564|748782|P6|Overall Study|Delinquent|0
231304|NCT00070564|748783|P5|Overall Study|Delinquent|0
231305|NCT00070564|748784|P4|Overall Study|Delinquent|0
231306|NCT00070564|748785|P3|Overall Study|Delinquent|2
231307|NCT00070564|748786|P2|Overall Study|Delinquent|4
231308|NCT00070564|748787|P1|Overall Study|Delinquent|1
231309|NCT00070564|748782|P6|Overall Study|Progression|0
231310|NCT00070564|748783|P5|Overall Study|Progression|1
231311|NCT00070564|748784|P4|Overall Study|Progression|7
231312|NCT00070564|748785|P3|Overall Study|Progression|7
231313|NCT00070564|748786|P2|Overall Study|Progression|4
231314|NCT00070564|748787|P1|Overall Study|Progression|2
231315|NCT00070499|748841|P4|Overall Study|Not eligible|2
231316|NCT00070499|748842|P3|Overall Study|Not eligible|3
231317|NCT00070499|748843|P2|Overall Study|Not eligible|5
231318|NCT00070499|748844|P1|Overall Study|Not eligible|2
231319|NCT00070499|748841|P4|Overall Study|Did not start treatment|2
231320|NCT00070499|748842|P3|Overall Study|Did not start treatment|0
231321|NCT00070499|748843|P2|Overall Study|Did not start treatment|0
231322|NCT00070499|748844|P1|Overall Study|Did not start treatment|1
231323|NCT00070499|748841|P4|Overall Study|Still on protocol treatment|57
231324|NCT00070499|748842|P3|Overall Study|Still on protocol treatment|79
231325|NCT00070499|748843|P2|Overall Study|Still on protocol treatment|4
231326|NCT00070499|748844|P1|Overall Study|Still on protocol treatment|10
231327|NCT00070499|748841|P4|Overall Study|Other - not protocol specified|20
231328|NCT00070499|748842|P3|Overall Study|Other - not protocol specified|12
231329|NCT00070499|748843|P2|Overall Study|Other - not protocol specified|3
231330|NCT00070499|748844|P1|Overall Study|Other - not protocol specified|7
231331|NCT00070499|748841|P4|Overall Study|Death|2
231332|NCT00070499|748842|P3|Overall Study|Death|1
231333|NCT00070499|748843|P2|Overall Study|Death|1
231334|NCT00070499|748844|P1|Overall Study|Death|1
231335|NCT00070499|748841|P4|Overall Study|Progression/relapse|4
231336|NCT00070499|748842|P3|Overall Study|Progression/relapse|1
231337|NCT00070499|748843|P2|Overall Study|Progression/relapse|2
231338|NCT00070499|748844|P1|Overall Study|Progression/relapse|4
231339|NCT00070499|748841|P4|Overall Study|Refusal unrelated to adverse effects|8
231340|NCT00070499|748842|P3|Overall Study|Refusal unrelated to adverse effects|5
231341|NCT00070499|748843|P2|Overall Study|Refusal unrelated to adverse effects|5
231342|NCT00070499|748844|P1|Overall Study|Refusal unrelated to adverse effects|7
231343|NCT00070499|748841|P4|Overall Study|Adverse Event|15
231344|NCT00070499|748842|P3|Overall Study|Adverse Event|19
231345|NCT00070499|748843|P2|Overall Study|Adverse Event|6
231346|NCT00070499|748844|P1|Overall Study|Adverse Event|6
231347|NCT00070317|748870|P1|Overall Study|Ineligible-Inadequate pathology|6
231348|NCT00070317|748870|P1|Overall Study|Ineligible-Improper prior treatment|2
231349|NCT00070317|748870|P1|Overall Study|Ineligible required test not done|1
231350|NCT00070317|748870|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
231351|NCT00070317|748870|P1|Overall Study|Inevaluable (Never Treated)|1
231352|NCT00070291|748875|P1|Step 2|Adverse Event|1
231353|NCT00070291|748875|P1|Step 1|Adverse Event|1
231354|NCT00070291|748875|P1|Step 1|Withdrawal by Subject|1
231355|NCT00070109|748891|P5|Overall Study|removed from prot thpy prior to chemo|0
231356|NCT00070109|748892|P4|Overall Study|removed from prot thpy prior to chemo|1
231357|NCT00070109|748893|P3|Overall Study|removed from prot thpy prior to chemo|0
231358|NCT00070109|748894|P2|Overall Study|removed from prot thpy prior to chemo|0
231359|NCT00070109|748895|P1|Overall Study|removed from prot thpy prior to chemo|0
231360|NCT00070109|748891|P5|Overall Study|Adverse Event|2
231361|NCT00070109|748892|P4|Overall Study|Adverse Event|4
231362|NCT00070109|748893|P3|Overall Study|Adverse Event|2
231363|NCT00070109|748894|P2|Overall Study|Adverse Event|0
231364|NCT00070109|748895|P1|Overall Study|Adverse Event|0
231365|NCT00070109|748891|P5|Overall Study|Withdrawal by Subject|0
231366|NCT00070109|748892|P4|Overall Study|Withdrawal by Subject|0
231367|NCT00070109|748893|P3|Overall Study|Withdrawal by Subject|1
231368|NCT00070109|748894|P2|Overall Study|Withdrawal by Subject|1
231369|NCT00070109|748895|P1|Overall Study|Withdrawal by Subject|0
231370|NCT00070109|748891|P5|Overall Study|Physician Decision|0
231371|NCT00070109|748892|P4|Overall Study|Physician Decision|0
231372|NCT00070109|748893|P3|Overall Study|Physician Decision|0
231373|NCT00070109|748894|P2|Overall Study|Physician Decision|0
231374|NCT00070109|748895|P1|Overall Study|Physician Decision|1
231375|NCT00070109|748891|P5|Overall Study|Lack of Efficacy|5
231376|NCT00070109|748892|P4|Overall Study|Lack of Efficacy|15
231377|NCT00070109|748893|P3|Overall Study|Lack of Efficacy|5
231378|NCT00070109|748894|P2|Overall Study|Lack of Efficacy|4
231379|NCT00070109|748895|P1|Overall Study|Lack of Efficacy|6
231380|NCT00070109|748891|P5|Overall Study|Death|1
231381|NCT00070109|748892|P4|Overall Study|Death|0
231382|NCT00070109|748893|P3|Overall Study|Death|0
231383|NCT00070109|748894|P2|Overall Study|Death|1
231384|NCT00070109|748895|P1|Overall Study|Death|1
231385|NCT00070018|748908|P1|Overall Study|Withdrawal by Subject|1
231386|NCT00070018|748908|P1|Overall Study|Lack of Efficacy|1
231387|NCT00070018|748908|P1|Overall Study|Adverse Event|2
231388|NCT00069953|748912|P1|Overall Study|Protocol Violation|2
231389|NCT00069784|748918|P2|Overall Study|Other|0
231390|NCT00069784|748919|P1|Overall Study|Other|17
231391|NCT00069784|748918|P2|Overall Study|Withdrawal by Subject|0
231392|NCT00069784|748919|P1|Overall Study|Withdrawal by Subject|1090
231393|NCT00069784|748918|P2|Overall Study|Adverse Event|0
231394|NCT00069784|748919|P1|Overall Study|Adverse Event|105
231395|NCT00069823|748939|P2|Overall Study|Did not have follow-up diary cards|3
231396|NCT00069823|748940|P1|Overall Study|Did not have follow-up diary cards|6
231397|NCT00069641|748983|P3|Overall Study|Death|1
231398|NCT00069641|748984|P2|Overall Study|Death|0
231399|NCT00069641|748985|P1|Overall Study|Death|1
231400|NCT00069277|749010|P1|Overall Study|Physician Decision|2
231401|NCT00069277|749010|P1|Overall Study|Progressive Disease|15
231402|NCT00069277|749010|P1|Overall Study|Withdrawal by Subject|1
231403|NCT00069277|749010|P1|Overall Study|Adverse Event|3
231404|NCT00069264|749014|P1|Overall Study|Discon Therapy|3
231405|NCT00069264|749014|P1|Overall Study|Withdrawal by Subject|3
231406|NCT00069264|749014|P1|Overall Study|Progressive Disease|23
231407|NCT00069264|749014|P1|Overall Study|Adverse Event|3
231408|NCT00069238|749042|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
231409|NCT00069238|749043|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
231410|NCT00069238|749044|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
231411|NCT00069238|749042|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
231412|NCT00069238|749043|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
231413|NCT00069238|749044|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
231414|NCT00069238|749042|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
231415|NCT00069238|749043|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
231416|NCT00069238|749044|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
231417|NCT00069121|749052|P2|Overall Study|Lost to Follow-up|57
231418|NCT00069121|749053|P1|Overall Study|Lost to Follow-up|57
231419|NCT00069121|749052|P2|Overall Study|Withdrawal by Subject|22
231420|NCT00069121|749053|P1|Overall Study|Withdrawal by Subject|20
231421|NCT00069121|749052|P2|Overall Study|Death|197
231422|NCT00069121|749053|P1|Overall Study|Death|225
231423|NCT00069108|749075|P2|Overall Study|Refused treatment|10
231424|NCT00069108|749076|P1|Overall Study|Refused treatment|5
231425|NCT00069108|749075|P2|Overall Study|Violation criteria|4
231426|NCT00069108|749076|P1|Overall Study|Violation criteria|1
231427|NCT00069108|749075|P2|Overall Study|Insufficient therapy|144
231428|NCT00069108|749076|P1|Overall Study|Insufficient therapy|117
231429|NCT00069108|749075|P2|Overall Study|Administration|4
231430|NCT00069108|749076|P1|Overall Study|Administration|15
231431|NCT00069108|749075|P2|Overall Study|Death|6
231432|NCT00069108|749076|P1|Overall Study|Death|6
231433|NCT00069108|749075|P2|Overall Study|Adverse Event|42
231434|NCT00069108|749076|P1|Overall Study|Adverse Event|64
231435|NCT00069108|749075|P2|Overall Study|Withdrawal by Subject|9
231436|NCT00069108|749076|P1|Overall Study|Withdrawal by Subject|5
231437|NCT00069095|749108|P6|Follow-up Phase|Death|101
231438|NCT00069095|749109|P5|Follow-up Phase|Death|92
231439|NCT00069095|749110|P4|Follow-up Phase|Death|112
231440|NCT00069095|749111|P3|Follow-up Phase|Death|120
231441|NCT00069095|749112|P2|Follow-up Phase|Death|206
231442|NCT00069095|749113|P1|Follow-up Phase|Death|174
231443|NCT00069095|749108|P6|Post-study Treatment Phase|Investigator decision|1
231444|NCT00069095|749109|P5|Post-study Treatment Phase|Investigator decision|0
231445|NCT00069095|749110|P4|Post-study Treatment Phase|Investigator decision|0
231446|NCT00069095|749111|P3|Post-study Treatment Phase|Investigator decision|0
231447|NCT00069095|749112|P2|Post-study Treatment Phase|Investigator decision|0
231448|NCT00069095|749113|P1|Post-study Treatment Phase|Investigator decision|0
231449|NCT00069095|749108|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
231450|NCT00069095|749109|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
231451|NCT00069095|749110|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
231452|NCT00069095|749111|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
231453|NCT00069095|749112|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
231454|NCT00069095|749113|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
231455|NCT00069095|749108|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
231456|NCT00069095|749109|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
231457|NCT00069095|749110|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
231458|NCT00069095|749111|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
231459|NCT00069095|749112|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
231460|NCT00069095|749113|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
231461|NCT00069095|749108|P6|Post-study Treatment Phase|Participant had progressive disease|0
231462|NCT00069095|749109|P5|Post-study Treatment Phase|Participant had progressive disease|1
231463|NCT00069095|749110|P4|Post-study Treatment Phase|Participant had progressive disease|0
231464|NCT00069095|749111|P3|Post-study Treatment Phase|Participant had progressive disease|0
231465|NCT00069095|749112|P2|Post-study Treatment Phase|Participant had progressive disease|0
231466|NCT00069095|749113|P1|Post-study Treatment Phase|Participant had progressive disease|0
231467|NCT00069095|749108|P6|Post-study Treatment Phase|Death|0
231468|NCT00069095|749109|P5|Post-study Treatment Phase|Death|1
231469|NCT00069095|749110|P4|Post-study Treatment Phase|Death|0
231470|NCT00069095|749111|P3|Post-study Treatment Phase|Death|0
231471|NCT00069095|749112|P2|Post-study Treatment Phase|Death|0
231472|NCT00069095|749113|P1|Post-study Treatment Phase|Death|0
231473|NCT00069095|749108|P6|Post-study Treatment Phase|Surgery|0
231474|NCT00069095|749109|P5|Post-study Treatment Phase|Surgery|1
231475|NCT00069095|749110|P4|Post-study Treatment Phase|Surgery|1
231476|NCT00069095|749111|P3|Post-study Treatment Phase|Surgery|0
231477|NCT00069095|749112|P2|Post-study Treatment Phase|Surgery|0
231478|NCT00069095|749113|P1|Post-study Treatment Phase|Surgery|0
231479|NCT00069095|749108|P6|Post-study Treatment Phase|Participant completed treatment|0
231480|NCT00069095|749109|P5|Post-study Treatment Phase|Participant completed treatment|0
231481|NCT00069095|749110|P4|Post-study Treatment Phase|Participant completed treatment|1
231482|NCT00069095|749111|P3|Post-study Treatment Phase|Participant completed treatment|0
231483|NCT00069095|749112|P2|Post-study Treatment Phase|Participant completed treatment|0
231484|NCT00069095|749113|P1|Post-study Treatment Phase|Participant completed treatment|0
231485|NCT00069095|749108|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
231486|NCT00069095|749109|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
231487|NCT00069095|749110|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
231488|NCT00069095|749111|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
231489|NCT00069095|749112|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
231490|NCT00069095|749113|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
231491|NCT00069095|749108|P6|Post-study Treatment Phase|Participant will start new treatment|0
231492|NCT00069095|749109|P5|Post-study Treatment Phase|Participant will start new treatment|0
231493|NCT00069095|749110|P4|Post-study Treatment Phase|Participant will start new treatment|0
231494|NCT00069095|749111|P3|Post-study Treatment Phase|Participant will start new treatment|1
231495|NCT00069095|749112|P2|Post-study Treatment Phase|Participant will start new treatment|0
231496|NCT00069095|749113|P1|Post-study Treatment Phase|Participant will start new treatment|0
231497|NCT00069095|749108|P6|Post-study Treatment Phase|Participant withdrew consent|0
231498|NCT00069095|749109|P5|Post-study Treatment Phase|Participant withdrew consent|0
231499|NCT00069095|749110|P4|Post-study Treatment Phase|Participant withdrew consent|0
231500|NCT00069095|749111|P3|Post-study Treatment Phase|Participant withdrew consent|1
231501|NCT00069095|749112|P2|Post-study Treatment Phase|Participant withdrew consent|0
231502|NCT00069095|749113|P1|Post-study Treatment Phase|Participant withdrew consent|0
231503|NCT00069095|749108|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
231504|NCT00069095|749109|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
231505|NCT00069095|749110|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
231506|NCT00069095|749111|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
231507|NCT00069095|749112|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
231508|NCT00069095|749113|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
231509|NCT00069095|749108|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
231510|NCT00069095|749109|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
231511|NCT00069095|749110|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
231512|NCT00069095|749111|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
231513|NCT00069095|749112|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
231514|NCT00069095|749113|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
231515|NCT00069095|749108|P6|Post-study Treatment Phase|Participant had complete response|0
231516|NCT00069095|749109|P5|Post-study Treatment Phase|Participant had complete response|0
231517|NCT00069095|749110|P4|Post-study Treatment Phase|Participant had complete response|0
231518|NCT00069095|749111|P3|Post-study Treatment Phase|Participant had complete response|0
231519|NCT00069095|749112|P2|Post-study Treatment Phase|Participant had complete response|1
231520|NCT00069095|749113|P1|Post-study Treatment Phase|Participant had complete response|1
231521|NCT00069095|749108|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
231522|NCT00069095|749109|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
231523|NCT00069095|749110|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
231524|NCT00069095|749111|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
231525|NCT00069095|749112|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
231526|NCT00069095|749113|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
231527|NCT00069095|749108|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
231528|NCT00069095|749109|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
231529|NCT00069095|749110|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
231530|NCT00069095|749111|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
231531|NCT00069095|749112|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
231532|NCT00069095|749113|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
231533|NCT00069095|749108|P6|Post-study Treatment Phase|Eligible for surgery|0
231534|NCT00069095|749109|P5|Post-study Treatment Phase|Eligible for surgery|0
231535|NCT00069095|749110|P4|Post-study Treatment Phase|Eligible for surgery|0
231536|NCT00069095|749111|P3|Post-study Treatment Phase|Eligible for surgery|0
231537|NCT00069095|749112|P2|Post-study Treatment Phase|Eligible for surgery|0
231538|NCT00069095|749113|P1|Post-study Treatment Phase|Eligible for surgery|2
231539|NCT00069095|749108|P6|Post-study Treatment Phase|Adverse Event|1
231540|NCT00069095|749109|P5|Post-study Treatment Phase|Adverse Event|5
231541|NCT00069095|749110|P4|Post-study Treatment Phase|Adverse Event|0
231542|NCT00069095|749111|P3|Post-study Treatment Phase|Adverse Event|1
231543|NCT00069095|749112|P2|Post-study Treatment Phase|Adverse Event|3
231544|NCT00069095|749113|P1|Post-study Treatment Phase|Adverse Event|2
231545|NCT00069095|749108|P6|Post-study Treatment Phase|Missing reason|17
231546|NCT00069095|749109|P5|Post-study Treatment Phase|Missing reason|18
231547|NCT00069095|749110|P4|Post-study Treatment Phase|Missing reason|8
231548|NCT00069095|749111|P3|Post-study Treatment Phase|Missing reason|12
231549|NCT00069095|749112|P2|Post-study Treatment Phase|Missing reason|3
231550|NCT00069095|749113|P1|Post-study Treatment Phase|Missing reason|1
231551|NCT00069095|749108|P6|Primary Treatment Phase|Violation criteria|5
231552|NCT00069095|749109|P5|Primary Treatment Phase|Violation criteria|1
231553|NCT00069095|749110|P4|Primary Treatment Phase|Violation criteria|3
231554|NCT00069095|749111|P3|Primary Treatment Phase|Violation criteria|4
231555|NCT00069095|749112|P2|Primary Treatment Phase|Violation criteria|2
231556|NCT00069095|749113|P1|Primary Treatment Phase|Violation criteria|0
231557|NCT00069095|749108|P6|Primary Treatment Phase|Other Violation|1
231558|NCT00069095|749109|P5|Primary Treatment Phase|Other Violation|0
231559|NCT00069095|749110|P4|Primary Treatment Phase|Other Violation|1
231560|NCT00069095|749111|P3|Primary Treatment Phase|Other Violation|1
231561|NCT00069095|749112|P2|Primary Treatment Phase|Other Violation|1
231562|NCT00069095|749113|P1|Primary Treatment Phase|Other Violation|0
231563|NCT00069095|749108|P6|Primary Treatment Phase|Withdrew|9
231564|NCT00069095|749109|P5|Primary Treatment Phase|Withdrew|4
231565|NCT00069095|749110|P4|Primary Treatment Phase|Withdrew|2
231566|NCT00069095|749111|P3|Primary Treatment Phase|Withdrew|8
231567|NCT00069095|749112|P2|Primary Treatment Phase|Withdrew|3
231568|NCT00069095|749113|P1|Primary Treatment Phase|Withdrew|2
231569|NCT00069095|749108|P6|Primary Treatment Phase|Refused treatment|27
231570|NCT00069095|749109|P5|Primary Treatment Phase|Refused treatment|24
231571|NCT00069095|749110|P4|Primary Treatment Phase|Refused treatment|31
231572|NCT00069095|749111|P3|Primary Treatment Phase|Refused treatment|17
231573|NCT00069095|749112|P2|Primary Treatment Phase|Refused treatment|26
231574|NCT00069095|749113|P1|Primary Treatment Phase|Refused treatment|15
231575|NCT00069095|749108|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
231576|NCT00069095|749109|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
231577|NCT00069095|749110|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
231578|NCT00069095|749111|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
231579|NCT00069095|749112|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
231580|NCT00069095|749113|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
231581|NCT00069095|749108|P6|Primary Treatment Phase|Failure to return|2
231582|NCT00069095|749109|P5|Primary Treatment Phase|Failure to return|0
231583|NCT00069095|749110|P4|Primary Treatment Phase|Failure to return|0
231584|NCT00069095|749111|P3|Primary Treatment Phase|Failure to return|0
231585|NCT00069095|749112|P2|Primary Treatment Phase|Failure to return|5
231586|NCT00069095|749113|P1|Primary Treatment Phase|Failure to return|5
231587|NCT00069095|749108|P6|Primary Treatment Phase|Death|8
231588|NCT00069095|749109|P5|Primary Treatment Phase|Death|8
231589|NCT00069095|749110|P4|Primary Treatment Phase|Death|5
231590|NCT00069095|749111|P3|Primary Treatment Phase|Death|2
231591|NCT00069095|749112|P2|Primary Treatment Phase|Death|8
231592|NCT00069095|749113|P1|Primary Treatment Phase|Death|14
231593|NCT00069095|749108|P6|Primary Treatment Phase|Adverse Event|101
231594|NCT00069095|749109|P5|Primary Treatment Phase|Adverse Event|109
231595|NCT00069095|749110|P4|Primary Treatment Phase|Adverse Event|72
231596|NCT00069095|749111|P3|Primary Treatment Phase|Adverse Event|71
231597|NCT00069095|749112|P2|Primary Treatment Phase|Adverse Event|92
231598|NCT00069095|749113|P1|Primary Treatment Phase|Adverse Event|99
231599|NCT00069095|749108|P6|Primary Treatment Phase|Admin/Other|42
231600|NCT00069095|749109|P5|Primary Treatment Phase|Admin/Other|48
231601|NCT00069095|749110|P4|Primary Treatment Phase|Admin/Other|45
231602|NCT00069095|749111|P3|Primary Treatment Phase|Admin/Other|31
231603|NCT00069095|749112|P2|Primary Treatment Phase|Admin/Other|38
231604|NCT00069095|749113|P1|Primary Treatment Phase|Admin/Other|29
231605|NCT00069095|749108|P6|Primary Treatment Phase|Ongoing|4
231606|NCT00069095|749109|P5|Primary Treatment Phase|Ongoing|7
231607|NCT00069095|749110|P4|Primary Treatment Phase|Ongoing|7
231608|NCT00069095|749111|P3|Primary Treatment Phase|Ongoing|5
231609|NCT00069095|749112|P2|Primary Treatment Phase|Ongoing|0
231610|NCT00069095|749113|P1|Primary Treatment Phase|Ongoing|0
231611|NCT00068822|749183|P2|First Randomized Intervention|Lost to Follow-up|2
231612|NCT00068822|749184|P1|First Randomized Intervention|Lost to Follow-up|1
231613|NCT00068601|749217|P2|Overall Study|Missing primary outcome data|34
231614|NCT00068601|749218|P1|Overall Study|Missing primary outcome data|30
231615|NCT00068601|749217|P2|Overall Study|Lost to Follow-up|2
231616|NCT00068601|749218|P1|Overall Study|Lost to Follow-up|3
231617|NCT00068601|749217|P2|Overall Study|Death|3
231618|NCT00068601|749218|P1|Overall Study|Death|11
231619|NCT00068601|749217|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
231620|NCT00068601|749218|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
231621|NCT00068601|749217|P2|Overall Study|Not evaluable: withdrew consent|4
231622|NCT00068601|749218|P1|Overall Study|Not evaluable: withdrew consent|5
231623|NCT00068601|749217|P2|Overall Study|Ineligible|13
231624|NCT00068601|749218|P1|Overall Study|Ineligible|11
231625|NCT00068588|749231|P3|Overall Study|Poor KPS|1
231626|NCT00068588|749232|P2|Overall Study|Poor KPS|0
231627|NCT00068588|749233|P1|Overall Study|Poor KPS|0
231628|NCT00068588|749231|P3|Overall Study|Withdrawal by Subject|1
231629|NCT00068588|749232|P2|Overall Study|Withdrawal by Subject|0
231630|NCT00068588|749233|P1|Overall Study|Withdrawal by Subject|0
231631|NCT00068588|749231|P3|Overall Study|Adverse Event|2
231632|NCT00068588|749232|P2|Overall Study|Adverse Event|0
231633|NCT00068588|749233|P1|Overall Study|Adverse Event|0
231634|NCT00068445|749249|P2|Treatment|Other (Specifics not available)|5
231635|NCT00068445|749250|P1|Treatment|Other (Specifics not available)|9
231636|NCT00068445|749249|P2|Treatment|Adverse Event|1
231637|NCT00068445|749250|P1|Treatment|Adverse Event|7
231638|NCT00068445|749249|P2|Treatment|Refused Further Treatment|10
231639|NCT00068445|749250|P1|Treatment|Refused Further Treatment|13
231640|NCT00068445|749249|P2|Randomization|Ineligible|1
231641|NCT00068445|749250|P1|Randomization|Ineligible|1
231642|NCT00068445|749249|P2|Randomization|Cancel|3
231643|NCT00068445|749250|P1|Randomization|Cancel|1
231644|NCT00068419|749274|P1|Overall Study|Ineligible|11
231645|NCT00068419|749274|P1|Overall Study|Withdrawal by Subject|14
231646|NCT00068419|749274|P1|Overall Study|Physician Decision|7
231647|NCT00068419|749274|P1|Overall Study|Lost to Follow-up|1
231648|NCT00068419|749274|P1|Overall Study|Lack of Efficacy|24
231649|NCT00068419|749274|P1|Overall Study|Adverse Event|3
231650|NCT00068406|749278|P1|Overall Study|Ineligible-Inadequate Pathology|2
231651|NCT00068406|749278|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
231652|NCT00068393|749283|P1|Overall Study|Quality of life worsening|1
231653|NCT00068393|749283|P1|Overall Study|Alternative treatment|1
231654|NCT00068393|749283|P1|Overall Study|Withdrawal by Subject|3
231655|NCT00068393|749283|P1|Overall Study|Death|3
231656|NCT00068393|749283|P1|Overall Study|Adverse Event|2
231657|NCT00068380|749289|P1|Overall Study|Adverse Event|2
231658|NCT00068380|749289|P1|Overall Study|Withdrawal by Subject|3
231659|NCT00068250|749333|P4|Phase I: Dose Level 2|Protocol Violation|0
231660|NCT00068250|749334|P3|Phase I: Dose Level 2|Protocol Violation|0
231661|NCT00068250|749335|P2|Phase I: Dose Level 2|Protocol Violation|1
231662|NCT00068250|749336|P1|Phase I: Dose Level 2|Protocol Violation|0
231663|NCT00068237|749346|P1|Overall Study|No protocol treatment received|2
231664|NCT00068237|749346|P1|Overall Study|Ineligible|3
231665|NCT00068107|749350|P1|Overall Study|Withdrawal by Subject|1
231666|NCT00068107|749350|P1|Overall Study|Death|2
231667|NCT00068107|749350|P1|Overall Study|end-stage renal disease|6
231668|NCT00067990|749363|P2|Overall Study|Withdrawal by Subject|12
231669|NCT00067990|749364|P1|Overall Study|Withdrawal by Subject|4
231670|NCT00067990|749363|P2|Overall Study|ESRD, Non IF/TA|3
231671|NCT00067990|749364|P1|Overall Study|ESRD, Non IF/TA|1
231672|NCT00067990|749363|P2|Overall Study|Death|7
231673|NCT00067990|749364|P1|Overall Study|Death|5
231674|NCT00067470|749387|P2|Overall Study|Withdrawal by Subject|1
231675|NCT00067470|749388|P1|Overall Study|Withdrawal by Subject|0
231676|NCT00066807|749451|P2|Overall Study|Study was terminated early|15
231677|NCT00066807|749452|P1|Overall Study|Study was terminated early|14
231678|NCT00066742|749477|P1|Consolidation Chemotherapy|Ineligible|2
231679|NCT00066742|749477|P1|Consolidation Chemotherapy|not protocol specified|1
231680|NCT00066742|749477|P1|Induction Chemoradiotherapy|Ineligible|3
231681|NCT00066742|749477|P1|Induction Chemoradiotherapy|not protocol specified|2
231682|NCT00066742|749477|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
231683|NCT00066742|749477|P1|Induction Chemoradiotherapy|Adverse Event|21
231684|NCT00066742|749477|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
231685|NCT00066703|749486|P2|Overall Study|Treatment ongoing|311
231686|NCT00066703|749487|P1|Overall Study|Treatment ongoing|346
231687|NCT00066703|749486|P2|Overall Study|Withdrawal by Subject|63
231688|NCT00066703|749487|P1|Overall Study|Withdrawal by Subject|38
231689|NCT00066703|749486|P2|Overall Study|Lost to Follow-up|28
231690|NCT00066703|749487|P1|Overall Study|Lost to Follow-up|31
231691|NCT00066703|749486|P2|Overall Study|Lack of Efficacy|69
231692|NCT00066703|749487|P1|Overall Study|Lack of Efficacy|114
231693|NCT00066703|749486|P2|Overall Study|Death|0
231694|NCT00066703|749487|P1|Overall Study|Death|3
231695|NCT00066703|749486|P2|Overall Study|Adverse Event|111
231696|NCT00066703|749487|P1|Overall Study|Adverse Event|80
231697|NCT00066690|749500|P3|Overall Study|Treatment Ongoing|282
231698|NCT00066690|749501|P2|Overall Study|Treatment Ongoing|278
231699|NCT00066690|749502|P1|Overall Study|Treatment Ongoing|246
231700|NCT00066690|749500|P3|Overall Study|Withdrawal by Subject|49
231701|NCT00066690|749501|P2|Overall Study|Withdrawal by Subject|55
231702|NCT00066690|749502|P1|Overall Study|Withdrawal by Subject|50
231703|NCT00066690|749500|P3|Overall Study|Lost to Follow-up|29
231704|NCT00066690|749501|P2|Overall Study|Lost to Follow-up|21
231705|NCT00066690|749502|P1|Overall Study|Lost to Follow-up|40
231706|NCT00066690|749500|P3|Overall Study|Lack of Efficacy|76
231707|NCT00066690|749501|P2|Overall Study|Lack of Efficacy|110
231708|NCT00066690|749502|P1|Overall Study|Lack of Efficacy|114
231709|NCT00066690|749500|P3|Overall Study|Death|2
231710|NCT00066690|749501|P2|Overall Study|Death|0
231711|NCT00066690|749502|P1|Overall Study|Death|3
231712|NCT00066690|749500|P3|Overall Study|Adverse Event|126
231713|NCT00066690|749501|P2|Overall Study|Adverse Event|58
231714|NCT00066690|749502|P1|Overall Study|Adverse Event|145
231715|NCT00066573|749518|P2|Overall Study|Did not received protocol treatment|28
231716|NCT00066573|749519|P1|Overall Study|Did not received protocol treatment|28
231717|NCT00066469|749531|P1|Overall Study|ineligible|1
231718|NCT00066469|749531|P1|Overall Study|Withdrawal by Subject|1
231719|NCT00066469|749531|P1|Overall Study|Physician Decision|1
231720|NCT00066469|749531|P1|Overall Study|Lost to Follow-up|1
231721|NCT00066469|749531|P1|Overall Study|Lack of Efficacy|9
231722|NCT00066469|749531|P1|Overall Study|Death|3
231723|NCT00066365|749537|P2|Overall Study|Ineligible|2
231724|NCT00066365|749538|P1|Overall Study|Ineligible|4
231725|NCT00066365|749537|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
231726|NCT00066365|749538|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
231727|NCT00066365|749537|P2|Overall Study|Physician Decision|0
231728|NCT00066365|749538|P1|Overall Study|Physician Decision|1
231729|NCT00066365|749537|P2|Overall Study|Lack of Efficacy|12
231730|NCT00066365|749538|P1|Overall Study|Lack of Efficacy|15
231731|NCT00066365|749537|P2|Overall Study|Adverse Event|0
231732|NCT00066365|749538|P1|Overall Study|Adverse Event|1
231733|NCT00066222|749566|P1|Overall Study|No protocol treatment received|1
231734|NCT00066170|749579|P4|Overall Study|Other|0
231735|NCT00066170|749580|P3|Overall Study|Other|2
231736|NCT00066170|749581|P2|Overall Study|Other|5
231737|NCT00066170|749582|P1|Overall Study|Other|1
231738|NCT00066170|749579|P4|Overall Study|Protocol Violation|0
231739|NCT00066170|749580|P3|Overall Study|Protocol Violation|0
231740|NCT00066170|749581|P2|Overall Study|Protocol Violation|0
231741|NCT00066170|749582|P1|Overall Study|Protocol Violation|3
231742|NCT00066170|749579|P4|Overall Study|Non-Compliance with Trial Medicine|1
231743|NCT00066170|749580|P3|Overall Study|Non-Compliance with Trial Medicine|0
231744|NCT00066170|749581|P2|Overall Study|Non-Compliance with Trial Medicine|0
231745|NCT00066170|749582|P1|Overall Study|Non-Compliance with Trial Medicine|1
231746|NCT00066170|749579|P4|Overall Study|Lost to Follow-up|0
231747|NCT00066170|749580|P3|Overall Study|Lost to Follow-up|0
231748|NCT00066170|749581|P2|Overall Study|Lost to Follow-up|1
231749|NCT00066170|749582|P1|Overall Study|Lost to Follow-up|0
231750|NCT00066170|749579|P4|Overall Study|Serious Adverse Event|1
231751|NCT00066170|749580|P3|Overall Study|Serious Adverse Event|1
231752|NCT00066170|749581|P2|Overall Study|Serious Adverse Event|0
231753|NCT00066170|749582|P1|Overall Study|Serious Adverse Event|0
231754|NCT00066170|749579|P4|Overall Study|Adverse Event|7
231755|NCT00066170|749580|P3|Overall Study|Adverse Event|1
231756|NCT00066170|749581|P2|Overall Study|Adverse Event|4
231757|NCT00066170|749582|P1|Overall Study|Adverse Event|2
231758|NCT00066066|749595|P6|Overall Study|Lost to Follow-up|5
231759|NCT00066066|749596|P5|Overall Study|Lost to Follow-up|3
231760|NCT00066066|749597|P4|Overall Study|Lost to Follow-up|4
231761|NCT00066066|749598|P3|Overall Study|Lost to Follow-up|7
231762|NCT00066066|749599|P2|Overall Study|Lost to Follow-up|4
231763|NCT00066066|749600|P1|Overall Study|Lost to Follow-up|6
231764|NCT00065507|749678|P2|Overall Study|Subject No Longer Meets Study Criteria|0
231765|NCT00065507|749679|P1|Overall Study|Subject No Longer Meets Study Criteria|1
231766|NCT00065507|749678|P2|Overall Study|Subject Withdrew Consent|1
231767|NCT00065507|749679|P1|Overall Study|Subject Withdrew Consent|2
231768|NCT00065507|749678|P2|Overall Study|Lost to Follow-up|0
231769|NCT00065507|749679|P1|Overall Study|Lost to Follow-up|3
231770|NCT00065507|749678|P2|Overall Study|Poor/Non-compliance|2
231771|NCT00065507|749679|P1|Overall Study|Poor/Non-compliance|3
231772|NCT00065507|749678|P2|Overall Study|Lack of Efficacy|6
231773|NCT00065507|749679|P1|Overall Study|Lack of Efficacy|0
231774|NCT00065507|749678|P2|Overall Study|Adverse Event|3
231775|NCT00065507|749679|P1|Overall Study|Adverse Event|4
231776|NCT00065507|749678|P2|Overall Study|Death|17
231777|NCT00065507|749679|P1|Overall Study|Death|16
231778|NCT00065468|749744|P3|Overall Study|Other|18
231779|NCT00065468|749745|P2|Overall Study|Other|24
231780|NCT00065468|749746|P1|Overall Study|Other|14
231781|NCT00065468|749744|P3|Overall Study|Disease progression|1
231782|NCT00065468|749745|P2|Overall Study|Disease progression|0
231783|NCT00065468|749746|P1|Overall Study|Disease progression|0
231784|NCT00065468|749744|P3|Overall Study|Discontinuation of study by Sponsor|13
231785|NCT00065468|749745|P2|Overall Study|Discontinuation of study by Sponsor|9
231786|NCT00065468|749746|P1|Overall Study|Discontinuation of study by Sponsor|13
231787|NCT00065468|749744|P3|Overall Study|Lost to Follow-up|2
231788|NCT00065468|749745|P2|Overall Study|Lost to Follow-up|3
231789|NCT00065468|749746|P1|Overall Study|Lost to Follow-up|5
231790|NCT00065468|749744|P3|Overall Study|Withdrawal by Subject|5
231791|NCT00065468|749745|P2|Overall Study|Withdrawal by Subject|4
231792|NCT00065468|749746|P1|Overall Study|Withdrawal by Subject|3
231793|NCT00065468|749744|P3|Overall Study|Death|171
231794|NCT00065468|749745|P2|Overall Study|Death|169
231795|NCT00065468|749746|P1|Overall Study|Death|172
231796|NCT00065442|749777|P2|Overall Study|Withdrawal by Subject|9
231797|NCT00065442|749778|P1|Overall Study|Withdrawal by Subject|3
231798|NCT00065442|749777|P2|Overall Study|Death|210
231799|NCT00065442|749778|P1|Overall Study|Death|121
231800|NCT00065442|749777|P2|Overall Study|Lost to Follow-up|1
231801|NCT00065442|749778|P1|Overall Study|Lost to Follow-up|1
231802|NCT00065429|749793|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
231803|NCT00065429|749794|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
231804|NCT00065429|749795|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
231805|NCT00065429|749796|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
231806|NCT00065429|749797|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
231807|NCT00065429|749798|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
231808|NCT00065429|749799|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
231809|NCT00065429|749793|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
231810|NCT00065429|749794|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
231811|NCT00065429|749795|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
231812|NCT00065429|749796|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
231813|NCT00065429|749797|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
231814|NCT00065429|749798|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
231815|NCT00065429|749799|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
231816|NCT00065429|749793|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
231817|NCT00065429|749794|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
231818|NCT00065429|749795|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
231819|NCT00065429|749796|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
231820|NCT00065429|749797|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
231821|NCT00065429|749798|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
231822|NCT00065429|749799|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
231823|NCT00065429|749793|P7|Phase I - May 2001 - Oct 2002|Death|0
231824|NCT00065429|749794|P6|Phase I - May 2001 - Oct 2002|Death|0
231825|NCT00065429|749795|P5|Phase I - May 2001 - Oct 2002|Death|1
231826|NCT00065429|749796|P4|Phase I - May 2001 - Oct 2002|Death|0
231827|NCT00065429|749797|P3|Phase I - May 2001 - Oct 2002|Death|0
231828|NCT00065429|749798|P2|Phase I - May 2001 - Oct 2002|Death|0
231829|NCT00065429|749799|P1|Phase I - May 2001 - Oct 2002|Death|0
231830|NCT00065429|749793|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
231831|NCT00065429|749794|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
231832|NCT00065429|749795|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
231833|NCT00065429|749796|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
231834|NCT00065429|749797|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
231835|NCT00065429|749798|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
231836|NCT00065429|749799|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
231837|NCT00065429|749793|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
231838|NCT00065429|749794|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
231839|NCT00065429|749795|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
231840|NCT00065429|749796|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
231841|NCT00065429|749797|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
231842|NCT00065429|749798|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
231843|NCT00065429|749799|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
231844|NCT00065429|749793|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
231845|NCT00065429|749794|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
231846|NCT00065429|749795|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
231847|NCT00065429|749796|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
231848|NCT00065429|749797|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
231849|NCT00065429|749798|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
231850|NCT00065429|749799|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
231851|NCT00065260|749813|P2|Overall Study|Death|1
231852|NCT00065260|749814|P1|Overall Study|Death|0
231853|NCT00065156|749820|P1|Overall Study|Secondary Malign Disease|1
231854|NCT00065156|749820|P1|Overall Study|Loss of Response|1
231855|NCT00065156|749820|P1|Overall Study|Non-Compliance|2
231856|NCT00065156|749820|P1|Overall Study|Investigator Decision|2
231857|NCT00065156|749820|P1|Overall Study|Disease Progression|7
231858|NCT00065156|749820|P1|Overall Study|Study Closed by Sponsor|2
231859|NCT00065156|749820|P1|Overall Study|Death|11
231860|NCT00065156|749820|P1|Overall Study|Lost to Follow-up|1
231861|NCT00065156|749820|P1|Overall Study|Withdrawal by Subject|8
231862|NCT00065156|749820|P1|Overall Study|Lack of Efficacy|52
231863|NCT00065156|749820|P1|Overall Study|Adverse Event|37
231864|NCT00065065|749837|P2|Overall Study|Other|2
231865|NCT00065065|749838|P1|Overall Study|Other|2
231866|NCT00065065|749837|P2|Overall Study|Lack of Efficacy|11
231867|NCT00065065|749838|P1|Overall Study|Lack of Efficacy|4
231868|NCT00065065|749837|P2|Overall Study|Withdrawal by Subject|5
231869|NCT00065065|749838|P1|Overall Study|Withdrawal by Subject|1
231870|NCT00065065|749837|P2|Overall Study|Adverse Event|2
231871|NCT00065065|749838|P1|Overall Study|Adverse Event|3
231872|NCT00003895|749850|P2|Overall Study|Withdrawal by Subject|3
231873|NCT00003895|749851|P1|Overall Study|Withdrawal by Subject|0
231874|NCT00003895|749850|P2|Overall Study|Patient Vacation|0
231875|NCT00003895|749851|P1|Overall Study|Patient Vacation|2
231876|NCT00003895|749850|P2|Overall Study|Lack of Efficacy|1
231877|NCT00003895|749851|P1|Overall Study|Lack of Efficacy|1
231878|NCT00003895|749850|P2|Overall Study|Adverse Event|0
231879|NCT00003895|749851|P1|Overall Study|Adverse Event|4
231880|NCT00064987|749859|P2|Overall Study|Physician Decision|0
231881|NCT00064987|749860|P1|Overall Study|Physician Decision|3
231882|NCT00064753|749891|P2|Overall Study|Lost to Follow-up|235
231883|NCT00064753|749892|P1|Overall Study|Lost to Follow-up|225
231884|NCT00064753|749891|P2|Overall Study|Withdrawal by Subject|171
231885|NCT00064753|749892|P1|Overall Study|Withdrawal by Subject|198
231886|NCT00064753|749891|P2|Overall Study|Death|242
231887|NCT00064753|749892|P1|Overall Study|Death|251
231888|NCT00064792|749922|P2|Overall Study|Adverse Event|0
231889|NCT00064792|749923|P1|Overall Study|Adverse Event|3
231890|NCT00064792|749922|P2|Overall Study|Withdrawal by Subject|0
231891|NCT00064792|749923|P1|Overall Study|Withdrawal by Subject|2
231892|NCT00064701|749934|P3|Clinical Continuation Phase|Patient opted out|1
231893|NCT00064701|749935|P2|Clinical Continuation Phase|Patient opted out|0
231894|NCT00064701|749936|P1|Clinical Continuation Phase|Patient opted out|0
231895|NCT00064701|749934|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
231896|NCT00064701|749935|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
231897|NCT00064701|749936|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
231898|NCT00064701|749934|P3|Clinical Continuation Phase|Discharged to nursing home|0
231899|NCT00064701|749935|P2|Clinical Continuation Phase|Discharged to nursing home|1
231900|NCT00064701|749936|P1|Clinical Continuation Phase|Discharged to nursing home|0
231901|NCT00064701|749934|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
231902|NCT00064701|749935|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
231903|NCT00064701|749936|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
231904|NCT00064701|749934|P3|Clinical Continuation Phase|Pancreas transplant|0
231905|NCT00064701|749935|P2|Clinical Continuation Phase|Pancreas transplant|0
231906|NCT00064701|749936|P1|Clinical Continuation Phase|Pancreas transplant|1
231907|NCT00064701|749934|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
231908|NCT00064701|749935|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
231909|NCT00064701|749936|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
231910|NCT00064701|749934|P3|Clinical Continuation Phase|Physician Decision|0
231911|NCT00064701|749935|P2|Clinical Continuation Phase|Physician Decision|3
231912|NCT00064701|749936|P1|Clinical Continuation Phase|Physician Decision|1
231913|NCT00064701|749934|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
231914|NCT00064701|749935|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
231915|NCT00064701|749936|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
231916|NCT00064701|749934|P3|Clinical Continuation Phase|Sponsor discontinued study|79
231917|NCT00064701|749935|P2|Clinical Continuation Phase|Sponsor discontinued study|129
231918|NCT00064701|749936|P1|Clinical Continuation Phase|Sponsor discontinued study|113
231919|NCT00064701|749934|P3|Clinical Continuation Phase|Rejection|2
231920|NCT00064701|749935|P2|Clinical Continuation Phase|Rejection|2
231921|NCT00064701|749936|P1|Clinical Continuation Phase|Rejection|1
231922|NCT00064701|749934|P3|Clinical Continuation Phase|Graft Failure|2
231923|NCT00064701|749935|P2|Clinical Continuation Phase|Graft Failure|5
231924|NCT00064701|749936|P1|Clinical Continuation Phase|Graft Failure|5
231925|NCT00064701|749934|P3|Clinical Continuation Phase|Lost to Follow-up|6
231926|NCT00064701|749935|P2|Clinical Continuation Phase|Lost to Follow-up|3
231927|NCT00064701|749936|P1|Clinical Continuation Phase|Lost to Follow-up|6
231928|NCT00064701|749934|P3|Clinical Continuation Phase|Withdrawal by Subject|22
231929|NCT00064701|749935|P2|Clinical Continuation Phase|Withdrawal by Subject|3
231930|NCT00064701|749936|P1|Clinical Continuation Phase|Withdrawal by Subject|22
231931|NCT00064701|749934|P3|Clinical Continuation Phase|Non-compliance|7
231932|NCT00064701|749935|P2|Clinical Continuation Phase|Non-compliance|6
231933|NCT00064701|749936|P1|Clinical Continuation Phase|Non-compliance|8
231934|NCT00064701|749934|P3|Clinical Continuation Phase|Adverse Event|14
231935|NCT00064701|749935|P2|Clinical Continuation Phase|Adverse Event|21
231936|NCT00064701|749936|P1|Clinical Continuation Phase|Adverse Event|12
231937|NCT00064701|749934|P3|One Year Post-transplant|Pancreas transplant|1
231938|NCT00064701|749935|P2|One Year Post-transplant|Pancreas transplant|0
231939|NCT00064701|749936|P1|One Year Post-transplant|Pancreas transplant|0
231940|NCT00064701|749934|P3|One Year Post-transplant|Poor absorption|0
231941|NCT00064701|749935|P2|One Year Post-transplant|Poor absorption|1
231942|NCT00064701|749936|P1|One Year Post-transplant|Poor absorption|0
231943|NCT00064701|749934|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
231944|NCT00064701|749935|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
231945|NCT00064701|749936|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
231946|NCT00064701|749934|P3|One Year Post-transplant|Incorrect study drug dispensed|0
231947|NCT00064701|749935|P2|One Year Post-transplant|Incorrect study drug dispensed|1
231948|NCT00064701|749936|P1|One Year Post-transplant|Incorrect study drug dispensed|0
231949|NCT00064701|749934|P3|One Year Post-transplant|Acute tubular necrosis|0
231950|NCT00064701|749935|P2|One Year Post-transplant|Acute tubular necrosis|0
231951|NCT00064701|749936|P1|One Year Post-transplant|Acute tubular necrosis|1
231952|NCT00064701|749934|P3|One Year Post-transplant|Converted to rapamycin|0
231953|NCT00064701|749935|P2|One Year Post-transplant|Converted to rapamycin|0
231954|NCT00064701|749936|P1|One Year Post-transplant|Converted to rapamycin|1
231955|NCT00064701|749934|P3|One Year Post-transplant|Lost to Follow-up|0
231956|NCT00064701|749935|P2|One Year Post-transplant|Lost to Follow-up|0
231957|NCT00064701|749936|P1|One Year Post-transplant|Lost to Follow-up|1
231958|NCT00064701|749934|P3|One Year Post-transplant|Withdrawal by Subject|1
231959|NCT00064701|749935|P2|One Year Post-transplant|Withdrawal by Subject|4
231960|NCT00064701|749936|P1|One Year Post-transplant|Withdrawal by Subject|0
231961|NCT00064701|749934|P3|One Year Post-transplant|Graft Failure|1
231962|NCT00064701|749935|P2|One Year Post-transplant|Graft Failure|2
231963|NCT00064701|749936|P1|One Year Post-transplant|Graft Failure|3
231964|NCT00064701|749934|P3|One Year Post-transplant|Non-compliance|5
231965|NCT00064701|749935|P2|One Year Post-transplant|Non-compliance|2
231966|NCT00064701|749936|P1|One Year Post-transplant|Non-compliance|4
231967|NCT00064701|749934|P3|One Year Post-transplant|Rejection|16
231968|NCT00064701|749935|P2|One Year Post-transplant|Rejection|1
231969|NCT00064701|749936|P1|One Year Post-transplant|Rejection|0
231970|NCT00064701|749934|P3|One Year Post-transplant|Adverse Event|37
231971|NCT00064701|749935|P2|One Year Post-transplant|Adverse Event|19
231972|NCT00064701|749936|P1|One Year Post-transplant|Adverse Event|23
231973|NCT00064701|749934|P3|One Year Post-transplant|Did not receive study drug|11
231974|NCT00064701|749935|P2|One Year Post-transplant|Did not receive study drug|12
231975|NCT00064701|749936|P1|One Year Post-transplant|Did not receive study drug|7
231976|NCT00064662|749988|P2|Overall Study|Administratively withdrawn|2
231977|NCT00064662|749989|P1|Overall Study|Administratively withdrawn|2
231978|NCT00064662|749988|P2|Overall Study|Withdrawal by Subject|14
231979|NCT00064662|749989|P1|Overall Study|Withdrawal by Subject|14
231980|NCT00064662|749988|P2|Overall Study|Lost to Follow-up|44
231981|NCT00064662|749989|P1|Overall Study|Lost to Follow-up|57
231982|NCT00064662|749988|P2|Overall Study|Death|1
231983|NCT00064662|749989|P1|Overall Study|Death|1
231984|NCT00064350|750000|P3|Cross-Over|Other|0
231985|NCT00064350|750001|P2|Cross-Over|Other|2
231986|NCT00064350|750002|P1|Cross-Over|Other|0
231987|NCT00064350|750000|P3|Cross-Over|Ineligible or never started treatment|0
231988|NCT00064350|750001|P2|Cross-Over|Ineligible or never started treatment|6
231989|NCT00064350|750002|P1|Cross-Over|Ineligible or never started treatment|3
231990|NCT00064350|750000|P3|Cross-Over|Withdrawal by Subject|0
231991|NCT00064350|750001|P2|Cross-Over|Withdrawal by Subject|2
231992|NCT00064350|750002|P1|Cross-Over|Withdrawal by Subject|2
231993|NCT00064350|750000|P3|Cross-Over|Death|0
231994|NCT00064350|750001|P2|Cross-Over|Death|3
231995|NCT00064350|750002|P1|Cross-Over|Death|1
231996|NCT00064350|750000|P3|Cross-Over|Adverse Event|0
231997|NCT00064350|750001|P2|Cross-Over|Adverse Event|1
231998|NCT00064350|750002|P1|Cross-Over|Adverse Event|0
231999|NCT00064350|750000|P3|Randomization|Other|0
232000|NCT00064350|750001|P2|Randomization|Other|0
232001|NCT00064350|750002|P1|Randomization|Other|5
232002|NCT00064350|750000|P3|Randomization|Ineligible or never started treatment|0
232003|NCT00064350|750001|P2|Randomization|Ineligible or never started treatment|15
232004|NCT00064350|750002|P1|Randomization|Ineligible or never started treatment|9
232005|NCT00064350|750000|P3|Randomization|Withdrawal by Subject|0
232006|NCT00064350|750001|P2|Randomization|Withdrawal by Subject|0
232007|NCT00064350|750002|P1|Randomization|Withdrawal by Subject|1
232008|NCT00064350|750000|P3|Randomization|Death|0
232009|NCT00064350|750001|P2|Randomization|Death|0
232010|NCT00064350|750002|P1|Randomization|Death|3
232011|NCT00064350|750000|P3|Randomization|Adverse Event|0
232012|NCT00064350|750001|P2|Randomization|Adverse Event|3
232013|NCT00064350|750002|P1|Randomization|Adverse Event|8
232014|NCT00064350|750000|P3|Induction Treatment|Other|13
232015|NCT00064350|750001|P2|Induction Treatment|Other|0
232016|NCT00064350|750002|P1|Induction Treatment|Other|0
232017|NCT00064350|750000|P3|Induction Treatment|Ineligible or never started treatment|34
232018|NCT00064350|750001|P2|Induction Treatment|Ineligible or never started treatment|6
232019|NCT00064350|750002|P1|Induction Treatment|Ineligible or never started treatment|3
232020|NCT00064350|750000|P3|Induction Treatment|Withdrawal by Subject|21
232021|NCT00064350|750001|P2|Induction Treatment|Withdrawal by Subject|0
232022|NCT00064350|750002|P1|Induction Treatment|Withdrawal by Subject|0
232023|NCT00064350|750000|P3|Induction Treatment|Death|9
232024|NCT00064350|750001|P2|Induction Treatment|Death|0
232025|NCT00064350|750002|P1|Induction Treatment|Death|0
232026|NCT00064350|750000|P3|Induction Treatment|Adverse Event|49
232027|NCT00064350|750001|P2|Induction Treatment|Adverse Event|2
232028|NCT00064350|750002|P1|Induction Treatment|Adverse Event|0
232029|NCT00064350|750000|P3|Induction Treatment|Disease Progression|110
232030|NCT00064350|750001|P2|Induction Treatment|Disease Progression|1
232031|NCT00064350|750002|P1|Induction Treatment|Disease Progression|5
232032|NCT00064337|750017|P1|Maintenance|Death|1
232033|NCT00064337|750017|P1|Maintenance|Not protocol-specified|2
232034|NCT00064337|750017|P1|Maintenance|On treatment at time of analysis|2
232035|NCT00064337|750017|P1|Maintenance|Progression|2
232036|NCT00064337|750017|P1|Maintenance|Adverse Event|3
232037|NCT00064337|750017|P1|Transplant|Progression|2
232038|NCT00064337|750017|P1|Transplant|Patient Refusal|2
232039|NCT00064337|750017|P1|Transplant|Death|3
232040|NCT00064337|750017|P1|Transplant|Not protocol-specified|5
232041|NCT00064337|750017|P1|Transplant|Adverse Event|9
232042|NCT00064337|750017|P1|PBSCC or Induction/PBSCC|Death|2
232043|NCT00064337|750017|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
232044|NCT00064337|750017|P1|PBSCC or Induction/PBSCC|Progression|3
232045|NCT00064337|750017|P1|PBSCC or Induction/PBSCC|Adverse Event|6
232046|NCT00064337|750017|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
232047|NCT00064298|750026|P2|Overall Study|Disease Progression|1
232048|NCT00064298|750027|P1|Overall Study|Disease Progression|2
232049|NCT00064298|750026|P2|Overall Study|Death|1
232050|NCT00064298|750027|P1|Overall Study|Death|0
232051|NCT00064298|750026|P2|Overall Study|Lost to Follow-up|2
232052|NCT00064298|750027|P1|Overall Study|Lost to Follow-up|2
232053|NCT00064298|750026|P2|Overall Study|Withdrawal by Subject|1
232054|NCT00064298|750027|P1|Overall Study|Withdrawal by Subject|2
232055|NCT00064259|750035|P4|Overall Study|Adverse Event|1
232056|NCT00064259|750036|P3|Overall Study|Adverse Event|0
232057|NCT00064259|750037|P2|Overall Study|Adverse Event|0
232058|NCT00064259|750038|P1|Overall Study|Adverse Event|1
232059|NCT00064025|750056|P1|Overall Study|Inevaluable|3
232060|NCT00064025|750056|P1|Overall Study|Ineligible|4
232061|NCT00063999|750065|P2|Overall Study|Ineligible|24
232062|NCT00063999|750066|P1|Overall Study|Ineligible|44
232063|NCT00063999|750065|P2|Overall Study|Withdrawal by Subject|0
232064|NCT00063999|750066|P1|Overall Study|Withdrawal by Subject|1
232065|NCT00063986|750082|P1|Overall Study|Intra-operatively ineligible|4
232066|NCT00063986|750082|P1|Overall Study|Ineligible|1
232067|NCT00063986|750082|P1|Overall Study|Withdrawal by Subject|1
232068|NCT00063934|750094|P1|Overall Study|Ineligible|1
232069|NCT00063258|750199|P2|Overall Study|Lack of Efficacy|0
232070|NCT00063258|750200|P1|Overall Study|Lack of Efficacy|2
232071|NCT00063258|750199|P2|Overall Study|Physician Decision|0
232072|NCT00063258|750200|P1|Overall Study|Physician Decision|2
232073|NCT00063154|750206|P1|Overall Study|Did not receive treatment|8
232074|NCT00063154|750206|P1|Overall Study|Reason unspecified|1
232075|NCT00063154|750206|P1|Overall Study|Death|3
232076|NCT00063154|750206|P1|Overall Study|Physician Decision|10
232077|NCT00063154|750206|P1|Overall Study|Adverse Event|2
232078|NCT00063154|750206|P1|Overall Study|Disease progression|27
232079|NCT00062751|750232|P5|Overall Study|Death|0
232080|NCT00062751|750233|P4|Overall Study|Death|0
232081|NCT00062751|750234|P3|Overall Study|Death|1
232082|NCT00062751|750235|P2|Overall Study|Death|0
232083|NCT00062751|750236|P1|Overall Study|Death|1
232084|NCT00062751|750232|P5|Overall Study|Symptomatic deterioration|1
232085|NCT00062751|750233|P4|Overall Study|Symptomatic deterioration|0
232086|NCT00062751|750234|P3|Overall Study|Symptomatic deterioration|0
232087|NCT00062751|750235|P2|Overall Study|Symptomatic deterioration|1
232088|NCT00062751|750236|P1|Overall Study|Symptomatic deterioration|1
232089|NCT00062751|750232|P5|Overall Study|Withdrawal by Subject|0
232090|NCT00062751|750233|P4|Overall Study|Withdrawal by Subject|1
232091|NCT00062751|750234|P3|Overall Study|Withdrawal by Subject|2
232092|NCT00062751|750235|P2|Overall Study|Withdrawal by Subject|2
232093|NCT00062751|750236|P1|Overall Study|Withdrawal by Subject|1
232094|NCT00062751|750232|P5|Overall Study|Other|1
232095|NCT00062751|750233|P4|Overall Study|Other|0
232096|NCT00062751|750234|P3|Overall Study|Other|1
232097|NCT00062751|750235|P2|Overall Study|Other|3
232098|NCT00062751|750236|P1|Overall Study|Other|2
232099|NCT00062751|750232|P5|Overall Study|Adverse Event|2
232100|NCT00062751|750233|P4|Overall Study|Adverse Event|2
232101|NCT00062751|750234|P3|Overall Study|Adverse Event|2
232102|NCT00062751|750235|P2|Overall Study|Adverse Event|7
232103|NCT00062751|750236|P1|Overall Study|Adverse Event|4
232104|NCT00062751|750232|P5|Overall Study|Disease progression|2
232105|NCT00062751|750233|P4|Overall Study|Disease progression|2
232106|NCT00062751|750234|P3|Overall Study|Disease progression|24
232107|NCT00062751|750235|P2|Overall Study|Disease progression|17
232108|NCT00062751|750236|P1|Overall Study|Disease progression|24
232109|NCT00062647|750322|P2|Overall Study|Never received study treatment|1
232110|NCT00062647|750323|P1|Overall Study|Never received study treatment|1
232111|NCT00062647|750322|P2|Overall Study|Other|4
232112|NCT00062647|750323|P1|Overall Study|Other|4
232113|NCT00062647|750322|P2|Overall Study|Failed continuation criteria|2
232114|NCT00062647|750323|P1|Overall Study|Failed continuation criteria|4
232115|NCT00062647|750322|P2|Overall Study|Lost to Follow-up|2
232116|NCT00062647|750323|P1|Overall Study|Lost to Follow-up|1
232117|NCT00062647|750322|P2|Overall Study|Protocol Violation|0
232118|NCT00062647|750323|P1|Overall Study|Protocol Violation|1
232119|NCT00062647|750322|P2|Overall Study|Withdrawal by Subject|1
232120|NCT00062647|750323|P1|Overall Study|Withdrawal by Subject|2
232121|NCT00062647|750322|P2|Overall Study|Adverse Event|1
232122|NCT00062647|750323|P1|Overall Study|Adverse Event|1
232123|NCT00062647|750322|P2|Overall Study|Death|2
232124|NCT00062647|750323|P1|Overall Study|Death|2
232125|NCT00062439|750329|P1|Consolidation Chemotherapy|Adverse Event|2
232126|NCT00062439|750329|P1|Surgery|Adverse Event|2
232127|NCT00062439|750329|P1|Surgery|Death|1
232128|NCT00062439|750329|P1|Surgery|Physician Decision|4
232129|NCT00062439|750329|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
232130|NCT00062439|750329|P1|Post Chemoradiation Assessment|Physician Decision|1
232131|NCT00062439|750329|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
232132|NCT00062439|750329|P1|Post Chemoradiation Assessment|Disease progression|2
232133|NCT00062439|750329|P1|Post Chemoradiation Assessment|Death|1
232134|NCT00062439|750329|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
232135|NCT00062439|750329|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
232136|NCT00062439|750329|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
232137|NCT00062439|750329|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
232138|NCT00062374|750341|P1|Overall Study|Not treated|12
232139|NCT00062010|750346|P1|Overall Study|Ineligible|3
232140|NCT00061945|750354|P2|Course IV: Alemtuzumab|Early exits|15
232141|NCT00061945|750355|P1|Course IV: Alemtuzumab|Early exits|6
232142|NCT00061945|750354|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
232143|NCT00061945|750355|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
232144|NCT00061945|750354|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
232145|NCT00061945|750355|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
232146|NCT00061945|750354|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
232147|NCT00061945|750355|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
232148|NCT00061932|750365|P2|Overall Study|Withdrawal by Subject|4
232149|NCT00061932|750366|P1|Overall Study|Withdrawal by Subject|13
232150|NCT00061633|750379|P2|Overall Study|Never received study treatment|2
232151|NCT00061633|750380|P1|Overall Study|Never received study treatment|0
232152|NCT00061633|750379|P2|Overall Study|Other|1
232153|NCT00061633|750380|P1|Overall Study|Other|1
232154|NCT00061633|750379|P2|Overall Study|Lost to Follow-up|4
232155|NCT00061633|750380|P1|Overall Study|Lost to Follow-up|1
232156|NCT00061633|750379|P2|Overall Study|Withdrawal by Subject|2
232157|NCT00061633|750380|P1|Overall Study|Withdrawal by Subject|2
232158|NCT00061633|750379|P2|Overall Study|Adverse Event|2
232159|NCT00061633|750380|P1|Overall Study|Adverse Event|1
232160|NCT00061048|750405|P1|Overall Study|disease progression|20
232161|NCT00061048|750405|P1|Overall Study|Adverse Event|2
232162|NCT00060944|750415|P2|Overall Study|randomized but not treated|4
232163|NCT00060944|750416|P1|Overall Study|randomized but not treated|6
232164|NCT00060944|750415|P2|Overall Study|Not specified|4
232165|NCT00060944|750416|P1|Overall Study|Not specified|2
232166|NCT00060944|750415|P2|Overall Study|Treatment Switch|13
232167|NCT00060944|750416|P1|Overall Study|Treatment Switch|0
232168|NCT00060944|750415|P2|Overall Study|Subject Ineligible To Continue|1
232169|NCT00060944|750416|P1|Overall Study|Subject Ineligible To Continue|2
232170|NCT00060944|750415|P2|Overall Study|Lost to Follow-up|0
232171|NCT00060944|750416|P1|Overall Study|Lost to Follow-up|1
232172|NCT00060944|750415|P2|Overall Study|Disease Progression|94
232173|NCT00060944|750416|P1|Overall Study|Disease Progression|93
232174|NCT00060944|750415|P2|Overall Study|Withdrawal by Subject|5
232175|NCT00060944|750416|P1|Overall Study|Withdrawal by Subject|18
232176|NCT00060944|750415|P2|Overall Study|Death|3
232177|NCT00060944|750416|P1|Overall Study|Death|2
232178|NCT00060944|750415|P2|Overall Study|Adverse Event|10
232179|NCT00060944|750416|P1|Overall Study|Adverse Event|12
232180|NCT00060840|750432|P2|Overall Study|Other|0
232181|NCT00060840|750433|P1|Overall Study|Other|1
232182|NCT00060840|750432|P2|Overall Study|Physician Decision|0
232183|NCT00060840|750433|P1|Overall Study|Physician Decision|1
232184|NCT00060840|750432|P2|Overall Study|Subinvestigator unavailable|1
232185|NCT00060840|750433|P1|Overall Study|Subinvestigator unavailable|0
232186|NCT00060840|750432|P2|Overall Study|Withdrawal by Subject|1
232187|NCT00060840|750433|P1|Overall Study|Withdrawal by Subject|0
232188|NCT00060840|750432|P2|Overall Study|Death|1
232189|NCT00060840|750433|P1|Overall Study|Death|0
232190|NCT00060840|750432|P2|Overall Study|Change in surgical plan|6
232191|NCT00060840|750433|P1|Overall Study|Change in surgical plan|2
232192|NCT00059839|750486|P2|Overall Study|Ineligible|3
232193|NCT00059839|750487|P1|Overall Study|Ineligible|1
232194|NCT00059839|750486|P2|Overall Study|Withdrawal by Subject|6
232195|NCT00059839|750487|P1|Overall Study|Withdrawal by Subject|1
232196|NCT00059839|750486|P2|Overall Study|Physician Decision|2
232197|NCT00059839|750487|P1|Overall Study|Physician Decision|1
232198|NCT00059839|750486|P2|Overall Study|Lost to Follow-up|0
232199|NCT00059839|750487|P1|Overall Study|Lost to Follow-up|2
232200|NCT00059839|750486|P2|Overall Study|Lack of Efficacy|5
232201|NCT00059839|750487|P1|Overall Study|Lack of Efficacy|6
232202|NCT00059839|750486|P2|Overall Study|Death|1
232203|NCT00059839|750487|P1|Overall Study|Death|1
232204|NCT00059787|750493|P1|Overall Study|Other|4
232205|NCT00059787|750493|P1|Overall Study|ineligible|1
232206|NCT00059787|750493|P1|Overall Study|disease progression|2
232207|NCT00059787|750493|P1|Overall Study|Adverse Event|13
232208|NCT00059332|750544|P2|Overall Study|Lost to Follow-up|1
232209|NCT00059332|750545|P1|Overall Study|Lost to Follow-up|1
232210|NCT00059332|750544|P2|Overall Study|Withdrawal by Subject|1
232211|NCT00059332|750545|P1|Overall Study|Withdrawal by Subject|2
232212|NCT00059215|750571|P4|Overall Study|Physician Decision|1
232213|NCT00059215|750572|P3|Overall Study|Physician Decision|1
232214|NCT00059215|750573|P2|Overall Study|Physician Decision|2
232215|NCT00059215|750574|P1|Overall Study|Physician Decision|1
232216|NCT00059215|750571|P4|Overall Study|Protocol entry criteria not met|2
232217|NCT00059215|750572|P3|Overall Study|Protocol entry criteria not met|0
232218|NCT00059215|750573|P2|Overall Study|Protocol entry criteria not met|1
232219|NCT00059215|750574|P1|Overall Study|Protocol entry criteria not met|1
232220|NCT00059215|750571|P4|Overall Study|Protocol Violation|0
232221|NCT00059215|750572|P3|Overall Study|Protocol Violation|1
232222|NCT00059215|750573|P2|Overall Study|Protocol Violation|0
232223|NCT00059215|750574|P1|Overall Study|Protocol Violation|1
232224|NCT00059215|750571|P4|Overall Study|Withdrawal by Subject|3
232225|NCT00059215|750572|P3|Overall Study|Withdrawal by Subject|1
232226|NCT00059215|750573|P2|Overall Study|Withdrawal by Subject|4
232227|NCT00059215|750574|P1|Overall Study|Withdrawal by Subject|4
232228|NCT00059215|750571|P4|Overall Study|Lost to Follow-up|0
232229|NCT00059215|750572|P3|Overall Study|Lost to Follow-up|0
232230|NCT00059215|750573|P2|Overall Study|Lost to Follow-up|2
232231|NCT00059215|750574|P1|Overall Study|Lost to Follow-up|1
232232|NCT00059215|750571|P4|Overall Study|Death|0
232233|NCT00059215|750572|P3|Overall Study|Death|3
232234|NCT00059215|750573|P2|Overall Study|Death|0
232235|NCT00059215|750574|P1|Overall Study|Death|0
232236|NCT00059215|750571|P4|Overall Study|Adverse Event|9
232237|NCT00059215|750572|P3|Overall Study|Adverse Event|9
232238|NCT00059215|750573|P2|Overall Study|Adverse Event|5
232239|NCT00059215|750574|P1|Overall Study|Adverse Event|5
232240|NCT00058825|750600|P1|Overall Study|Death|3
232241|NCT00058825|750600|P1|Overall Study|Graft Failure|5
232242|NCT00058825|750600|P1|Overall Study|Progressive Disease|5
232243|NCT00058825|750600|P1|Overall Study|Relapse|9
232244|NCT00058552|750616|P2|Overall Study|Clinical disease progression|4
232245|NCT00058552|750617|P1|Overall Study|Clinical disease progression|0
232246|NCT00058552|750616|P2|Overall Study|Physician Decision|5
232247|NCT00058552|750617|P1|Overall Study|Physician Decision|2
232248|NCT00058552|750616|P2|Overall Study|Withdrawal by Subject|5
232249|NCT00058552|750617|P1|Overall Study|Withdrawal by Subject|3
232250|NCT00058552|750616|P2|Overall Study|Adverse Event|2
232251|NCT00058552|750617|P1|Overall Study|Adverse Event|4
232252|NCT00058552|750616|P2|Overall Study|Disease progression|44
232253|NCT00058552|750617|P1|Overall Study|Disease progression|52
232254|NCT00058552|750616|P2|Overall Study|Died prior to receiving treatment|2
232255|NCT00058552|750617|P1|Overall Study|Died prior to receiving treatment|4
232256|NCT00058539|750635|P1|Overall Study|Death|1
232257|NCT00058539|750635|P1|Overall Study|Physician Decision|9
232258|NCT00058539|750635|P1|Overall Study|Withdrawal by Subject|5
232259|NCT00058539|750635|P1|Overall Study|Adverse Event|3
232260|NCT00058539|750635|P1|Overall Study|Disease progression|24
232261|NCT00058214|750662|P1|Overall Study|Adverse Event|1
232262|NCT00057954|750683|P1|Overall Study|Disease progression|1
232263|NCT00057954|750683|P1|Overall Study|Death|1
232264|NCT00057941|750691|P2|Overall Study|Ineligible|5
232265|NCT00057941|750692|P1|Overall Study|Ineligible|2
232266|NCT00057941|750691|P2|Overall Study|insurance, symptomatic deterioration|3
232267|NCT00057941|750692|P1|Overall Study|insurance, symptomatic deterioration|1
232268|NCT00057941|750691|P2|Overall Study|still on treatment|1
232269|NCT00057941|750692|P1|Overall Study|still on treatment|3
232270|NCT00057941|750691|P2|Overall Study|Withdrawal by Subject|1
232271|NCT00057941|750692|P1|Overall Study|Withdrawal by Subject|6
232272|NCT00057941|750691|P2|Overall Study|Lack of Efficacy|53
232273|NCT00057941|750692|P1|Overall Study|Lack of Efficacy|54
232274|NCT00057941|750691|P2|Overall Study|Adverse Event|9
232275|NCT00057941|750692|P1|Overall Study|Adverse Event|7
232276|NCT00057941|750691|P2|Overall Study|Death|2
232277|NCT00057941|750692|P1|Overall Study|Death|1
232278|NCT00057876|750700|P2|Overall Study|other complicating disease|0
232279|NCT00057876|750701|P1|Overall Study|other complicating disease|1
232280|NCT00057876|750700|P2|Overall Study|other reason|2
232281|NCT00057876|750701|P1|Overall Study|other reason|2
232282|NCT00057876|750700|P2|Overall Study|Ineligible|2
232283|NCT00057876|750701|P1|Overall Study|Ineligible|1
232284|NCT00057876|750700|P2|Overall Study|Lack of Efficacy|8
232285|NCT00057876|750701|P1|Overall Study|Lack of Efficacy|10
232286|NCT00057876|750700|P2|Overall Study|Withdrawal by Subject|6
232287|NCT00057876|750701|P1|Overall Study|Withdrawal by Subject|5
232288|NCT00057876|750700|P2|Overall Study|Death|1
232289|NCT00057876|750701|P1|Overall Study|Death|2
232290|NCT00057876|750700|P2|Overall Study|Adverse Event|8
232291|NCT00057876|750701|P1|Overall Study|Adverse Event|8
232292|NCT00057863|750711|P1|Overall Study|Withdrawal by Subject|2
232293|NCT00057863|750711|P1|Overall Study|Death|1
232294|NCT00057837|750720|P2|Overall Study|Never started treatment|1
232295|NCT00057837|750721|P1|Overall Study|Never started treatment|1
232296|NCT00057837|750720|P2|Overall Study|Ineligible|3
232297|NCT00057837|750721|P1|Overall Study|Ineligible|3
232298|NCT00057837|750720|P2|Overall Study|Physician Decision|0
232299|NCT00057837|750721|P1|Overall Study|Physician Decision|1
232300|NCT00057837|750720|P2|Overall Study|Other complicating disease|1
232301|NCT00057837|750721|P1|Overall Study|Other complicating disease|2
232302|NCT00057837|750720|P2|Overall Study|Alternative therapy|1
232303|NCT00057837|750721|P1|Overall Study|Alternative therapy|0
232304|NCT00057837|750720|P2|Overall Study|Withdrawal by Subject|3
232305|NCT00057837|750721|P1|Overall Study|Withdrawal by Subject|5
232306|NCT00057837|750720|P2|Overall Study|Death|4
232307|NCT00057837|750721|P1|Overall Study|Death|5
232308|NCT00057837|750720|P2|Overall Study|Adverse Event|12
232309|NCT00057837|750721|P1|Overall Study|Adverse Event|2
232310|NCT00057837|750720|P2|Overall Study|Progression/relapse|14
232311|NCT00057837|750721|P1|Overall Study|Progression/relapse|12
232312|NCT00057811|750733|P2|Overall Study|Inevaluable|2
232313|NCT00057811|750734|P1|Overall Study|Inevaluable|1
232314|NCT00057811|750733|P2|Overall Study|Ineligible|2
232315|NCT00057811|750734|P1|Overall Study|Ineligible|4
232316|NCT00057811|750733|P2|Overall Study|Withdrawal by Subject|4
232317|NCT00057811|750734|P1|Overall Study|Withdrawal by Subject|3
232318|NCT00057811|750733|P2|Overall Study|Physician Decision|0
232319|NCT00057811|750734|P1|Overall Study|Physician Decision|1
232320|NCT00057811|750733|P2|Overall Study|Lack of Efficacy|4
232321|NCT00057811|750734|P1|Overall Study|Lack of Efficacy|1
232322|NCT00057746|750753|P3|Overall Study|Withdrawal by Subject|1
232323|NCT00057746|750754|P2|Overall Study|Withdrawal by Subject|0
232324|NCT00057746|750755|P1|Overall Study|Withdrawal by Subject|0
232325|NCT00023673|750766|P4|Overall Study|Patient withdrew consent|1
232326|NCT00023673|750767|P3|Overall Study|Patient withdrew consent|0
232327|NCT00023673|750768|P2|Overall Study|Patient withdrew consent|0
232328|NCT00023673|750769|P1|Overall Study|Patient withdrew consent|0
232329|NCT00023673|750766|P4|Overall Study|Ineligible / no protocol treatment|1
232330|NCT00023673|750767|P3|Overall Study|Ineligible / no protocol treatment|0
232331|NCT00023673|750768|P2|Overall Study|Ineligible / no protocol treatment|0
232332|NCT00023673|750769|P1|Overall Study|Ineligible / no protocol treatment|0
232333|NCT00057330|750833|P2|Overall Study|Other|206
232334|NCT00057330|750834|P1|Overall Study|Other|260
232335|NCT00057330|750833|P2|Overall Study|Physician Decision|0
232336|NCT00057330|750834|P1|Overall Study|Physician Decision|1
232337|NCT00057330|750833|P2|Overall Study|Lost to Follow-up|617
232338|NCT00057330|750834|P1|Overall Study|Lost to Follow-up|745
232339|NCT00057330|750833|P2|Overall Study|Withdrawal by Subject|84
232340|NCT00057330|750834|P1|Overall Study|Withdrawal by Subject|115
232341|NCT00057330|750833|P2|Overall Study|Protocol Violation|1
232342|NCT00057330|750834|P1|Overall Study|Protocol Violation|1
232343|NCT00057330|750833|P2|Overall Study|Death|0
232344|NCT00057330|750834|P1|Overall Study|Death|1
232345|NCT00057330|750833|P2|Overall Study|Adverse Event|12
232346|NCT00057330|750834|P1|Overall Study|Adverse Event|9
232347|NCT00056862|750864|P2|Overall Study|Protocol Violation|0
232348|NCT00056862|750865|P1|Overall Study|Protocol Violation|1
232349|NCT00056407|750923|P2|Overall Study|Missing|34
232350|NCT00056407|750924|P1|Overall Study|Missing|25
232351|NCT00056407|750923|P2|Overall Study|"Listed as Other on Case Report Form"|60
232352|NCT00056407|750924|P1|Overall Study|"Listed as Other on Case Report Form"|98
232353|NCT00056407|750923|P2|Overall Study|Diagnosed with Prostate Cancer|166
232354|NCT00056407|750924|P1|Overall Study|Diagnosed with Prostate Cancer|202
232355|NCT00056407|750923|P2|Overall Study|Protocol Violation|95
232356|NCT00056407|750924|P1|Overall Study|Protocol Violation|104
232357|NCT00056407|750923|P2|Overall Study|Lost to Follow-up|113
232358|NCT00056407|750924|P1|Overall Study|Lost to Follow-up|123
232359|NCT00056407|750923|P2|Overall Study|Withdrawal by Subject|361
232360|NCT00056407|750924|P1|Overall Study|Withdrawal by Subject|377
232361|NCT00056407|750923|P2|Overall Study|Adverse Event|364
232362|NCT00056407|750924|P1|Overall Study|Adverse Event|282
232363|NCT00056316|750982|P2|Overall Study|Death/NH placement of pt|1
232364|NCT00056316|750983|P1|Overall Study|Death/NH placement of pt|1
232365|NCT00056316|750982|P2|Overall Study|Withdrawal by Subject|2
232366|NCT00056316|750983|P1|Overall Study|Withdrawal by Subject|2
232367|NCT00056160|750997|P2|Final Follow-up|Adverse Event|0
232368|NCT00056160|750998|P1|Final Follow-up|Adverse Event|1
232369|NCT00056160|750997|P2|Final Follow-up|Transferred into RevAssist Program|0
232370|NCT00056160|750998|P1|Final Follow-up|Transferred into RevAssist Program|2
232371|NCT00056160|750997|P2|Final Follow-up|Transferred into expanded access study.|0
232372|NCT00056160|750998|P1|Final Follow-up|Transferred into expanded access study.|3
232373|NCT00056160|750997|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
232374|NCT00056160|750998|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
232375|NCT00056160|750997|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
232376|NCT00056160|750998|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
232377|NCT00056160|750997|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
232378|NCT00056160|750998|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
232379|NCT00056160|750997|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
232380|NCT00056160|750998|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
232381|NCT00056160|750997|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
232382|NCT00056160|750998|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
232383|NCT00056160|750997|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
232384|NCT00056160|750998|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
232385|NCT00056160|750997|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
232386|NCT00056160|750998|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
232387|NCT00056160|750997|P2|Up to Unblinding (07 Jun 2005)|Death|1
232388|NCT00056160|750998|P1|Up to Unblinding (07 Jun 2005)|Death|2
232389|NCT00056160|750997|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
232390|NCT00056160|750998|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
232391|NCT00056160|750997|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
232392|NCT00056160|750998|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
232393|NCT00056160|750997|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
232394|NCT00056160|750998|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
232395|NCT00056160|750997|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
232396|NCT00056160|750998|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
232397|NCT00055601|751021|P2|Overall Study|No protocol treatment received|1
232398|NCT00055601|751022|P1|Overall Study|No protocol treatment received|1
232399|NCT00055601|751021|P2|Overall Study|Protocol Violation|1
232400|NCT00055601|751022|P1|Overall Study|Protocol Violation|1
232401|NCT00055497|751036|P4|Overall Study|Other|11
232402|NCT00055497|751037|P3|Overall Study|Other|0
232403|NCT00055497|751038|P2|Overall Study|Other|0
232404|NCT00055497|751039|P1|Overall Study|Other|0
232405|NCT00055497|751036|P4|Overall Study|Administrative Reasons|1
232406|NCT00055497|751037|P3|Overall Study|Administrative Reasons|0
232407|NCT00055497|751038|P2|Overall Study|Administrative Reasons|0
232408|NCT00055497|751039|P1|Overall Study|Administrative Reasons|0
232409|NCT00055497|751036|P4|Overall Study|Lack of Efficacy|27
232410|NCT00055497|751037|P3|Overall Study|Lack of Efficacy|0
232411|NCT00055497|751038|P2|Overall Study|Lack of Efficacy|0
232412|NCT00055497|751039|P1|Overall Study|Lack of Efficacy|1
232413|NCT00055497|751036|P4|Overall Study|Protocol Violation|3
232414|NCT00055497|751037|P3|Overall Study|Protocol Violation|0
232415|NCT00055497|751038|P2|Overall Study|Protocol Violation|0
232416|NCT00055497|751039|P1|Overall Study|Protocol Violation|0
232417|NCT00055497|751036|P4|Overall Study|Lost to Follow-up|5
232418|NCT00055497|751037|P3|Overall Study|Lost to Follow-up|0
232419|NCT00055497|751038|P2|Overall Study|Lost to Follow-up|1
232420|NCT00055497|751039|P1|Overall Study|Lost to Follow-up|0
232421|NCT00055497|751036|P4|Overall Study|Withdrawal by Subject|15
232422|NCT00055497|751037|P3|Overall Study|Withdrawal by Subject|1
232423|NCT00055497|751038|P2|Overall Study|Withdrawal by Subject|1
232424|NCT00055497|751039|P1|Overall Study|Withdrawal by Subject|3
232425|NCT00055497|751036|P4|Overall Study|Adverse Event|28
232426|NCT00055497|751037|P3|Overall Study|Adverse Event|1
232427|NCT00055497|751038|P2|Overall Study|Adverse Event|1
232428|NCT00055497|751039|P1|Overall Study|Adverse Event|1
232429|NCT00055471|751084|P3|Period 1: Dose Escalation Period|Disease progression|0
232430|NCT00055471|751085|P2|Period 1: Dose Escalation Period|Disease progression|1
232431|NCT00055471|751086|P1|Period 1: Dose Escalation Period|Disease progression|0
232432|NCT00055471|751084|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
232433|NCT00055471|751085|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
232434|NCT00055471|751086|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
232435|NCT00055471|751084|P3|Period 1: Dose Escalation Period|Adverse Event|2
232436|NCT00055471|751085|P2|Period 1: Dose Escalation Period|Adverse Event|1
232437|NCT00055471|751086|P1|Period 1: Dose Escalation Period|Adverse Event|0
232438|NCT00054717|751137|P2|Overall Study|Other reason not defined above|217
232439|NCT00054717|751138|P1|Overall Study|Other reason not defined above|117
232440|NCT00054717|751137|P2|Overall Study|Withdrawal by Subject|20
232441|NCT00054717|751138|P1|Overall Study|Withdrawal by Subject|32
232442|NCT00054717|751137|P2|Overall Study|Lost to Follow-up|13
232443|NCT00054717|751138|P1|Overall Study|Lost to Follow-up|23
232444|NCT00054717|751137|P2|Overall Study|Protocol Violation|19
232445|NCT00054717|751138|P1|Overall Study|Protocol Violation|18
232446|NCT00054717|751137|P2|Overall Study|Adverse Event|22
232447|NCT00054717|751138|P1|Overall Study|Adverse Event|70
232448|NCT00054717|751137|P2|Overall Study|Randomized but not treated|8
232449|NCT00054717|751138|P1|Overall Study|Randomized but not treated|2
232450|NCT00054704|751326|P2|Overall Study|Lost to Follow-up|0
232451|NCT00054704|751327|P1|Overall Study|Lost to Follow-up|1
232452|NCT00054704|751326|P2|Overall Study|Adverse Event|2
232453|NCT00054704|751327|P1|Overall Study|Adverse Event|3
232454|NCT00054704|751326|P2|Overall Study|Lack of Efficacy|3
232455|NCT00054704|751327|P1|Overall Study|Lack of Efficacy|1
232456|NCT00054691|751333|P1|Overall Study|Noncompliant|1
232457|NCT00054691|751333|P1|Overall Study|Unmeasurable Disease|2
232458|NCT00054639|751347|P1|Overall Study|Physician Decision|1
232459|NCT00054639|751347|P1|Overall Study|Lack of Efficacy|1
232460|NCT00054327|751380|P6|Overall Study|Engraftment failure|0
232461|NCT00054327|751381|P5|Overall Study|Engraftment failure|0
232462|NCT00054327|751382|P4|Overall Study|Engraftment failure|0
232463|NCT00054327|751383|P3|Overall Study|Engraftment failure|0
232464|NCT00054327|751384|P2|Overall Study|Engraftment failure|0
232465|NCT00054327|751385|P1|Overall Study|Engraftment failure|1
232466|NCT00054275|751423|P1|Overall Study|Physician Decision|1
232467|NCT00054275|751423|P1|Overall Study|Progressive disease in cycle 1|1
232468|NCT00054275|751423|P1|Overall Study|Adverse Event|5
232469|NCT00054275|751423|P1|Overall Study|Withdrawal by Subject|4
232470|NCT00054132|751429|P1|Overall Study|Not Treated|1
232471|NCT00053898|751448|P2|Overall Study|Follow-up from telephone contact only|1
232472|NCT00053898|751449|P1|Overall Study|Follow-up from telephone contact only|5
232473|NCT00053898|751448|P2|Overall Study|No follow-up data from any source|12
232474|NCT00053898|751449|P1|Overall Study|No follow-up data from any source|9
232475|NCT00053846|751473|P2|Overall Study|Pills too large|1
232476|NCT00053846|751474|P1|Overall Study|Pills too large|0
232477|NCT00053846|751473|P2|Overall Study|Quit due to side effects|3
232478|NCT00053846|751474|P1|Overall Study|Quit due to side effects|1
232479|NCT00053846|751473|P2|Overall Study|Did not return data|2
232480|NCT00053846|751474|P1|Overall Study|Did not return data|1
232481|NCT00053846|751473|P2|Overall Study|Became ineligible|1
232482|NCT00053846|751474|P1|Overall Study|Became ineligible|3
232483|NCT00053846|751473|P2|Overall Study|Expired|0
232484|NCT00053846|751474|P1|Overall Study|Expired|5
232485|NCT00053846|751473|P2|Overall Study|Became too ill|7
232486|NCT00053846|751474|P1|Overall Study|Became too ill|8
232487|NCT00053846|751473|P2|Overall Study|Changed mind|13
232488|NCT00053846|751474|P1|Overall Study|Changed mind|8
232489|NCT00053417|751633|P4|Overall Study|Lost to Follow-up|0
232490|NCT00053417|751634|P3|Overall Study|Lost to Follow-up|0
232491|NCT00053417|751635|P2|Overall Study|Lost to Follow-up|1
232492|NCT00053417|751636|P1|Overall Study|Lost to Follow-up|1
232493|NCT00053417|751633|P4|Overall Study|Withdrawal by Subject|0
232494|NCT00053417|751634|P3|Overall Study|Withdrawal by Subject|0
232495|NCT00053417|751635|P2|Overall Study|Withdrawal by Subject|1
232496|NCT00053417|751636|P1|Overall Study|Withdrawal by Subject|0
232497|NCT00053417|751633|P4|Overall Study|Non-Compliance|1
232498|NCT00053417|751634|P3|Overall Study|Non-Compliance|0
232499|NCT00053417|751635|P2|Overall Study|Non-Compliance|0
232500|NCT00053417|751636|P1|Overall Study|Non-Compliance|0
232501|NCT00053417|751633|P4|Overall Study|Adverse Event|5
232502|NCT00053417|751634|P3|Overall Study|Adverse Event|1
232503|NCT00053417|751635|P2|Overall Study|Adverse Event|0
232504|NCT00053417|751636|P1|Overall Study|Adverse Event|1
232505|NCT00053365|751646|P1|Overall Study|Never treated|4
232506|NCT00053365|751646|P1|Overall Study|Platinum-sensitive interval >12 months|1
232507|NCT00053365|751646|P1|Overall Study|Incorrect cell type|1
232508|NCT00053352|751656|P2|Overall Study|Disease at new site|0
232509|NCT00053352|751657|P1|Overall Study|Disease at new site|1
232510|NCT00053352|751656|P2|Overall Study|Ineligible|8
232511|NCT00053352|751657|P1|Overall Study|Ineligible|8
232512|NCT00053352|751656|P2|Overall Study|Withdrawal by Subject|0
232513|NCT00053352|751657|P1|Overall Study|Withdrawal by Subject|1
232514|NCT00053352|751656|P2|Overall Study|Physician Decision|1
232515|NCT00053352|751657|P1|Overall Study|Physician Decision|11
232516|NCT00053352|751656|P2|Overall Study|Lost to Follow-up|1
232517|NCT00053352|751657|P1|Overall Study|Lost to Follow-up|0
232518|NCT00003830|751673|P2|Overall Study|Sentinel node positive patients|793
232519|NCT00003830|751674|P1|Overall Study|Sentinel node positive patients|829
232520|NCT00003830|751673|P2|Overall Study|No follow up data|0
232521|NCT00003830|751674|P1|Overall Study|No follow up data|3
232522|NCT00052962|751700|P2|Overall Study|Not randomized/not evaluable|0
232523|NCT00052962|751701|P1|Overall Study|Not randomized/not evaluable|1
232524|NCT00052962|751700|P2|Overall Study|Not evaluable|2
232525|NCT00052962|751701|P1|Overall Study|Not evaluable|0
232526|NCT00052715|751709|P1|Overall Study|wrong histology|1
232527|NCT00049543|751723|P2|Overall Study|still on treatment|9
232528|NCT00049543|751724|P1|Overall Study|still on treatment|2
232529|NCT00049530|751734|P1|Overall Study|ineligible|3
232530|NCT00049530|751734|P1|Overall Study|symptomatic deterioration|1
232531|NCT00049530|751734|P1|Overall Study|Death|1
232532|NCT00049530|751734|P1|Overall Study|Adverse Event|2
232533|NCT00049530|751734|P1|Overall Study|Lack of Efficacy|25
232534|NCT00049517|751743|P6|Conditioning/Transplant|Reasons not reported|5
232535|NCT00049517|751744|P5|Conditioning/Transplant|Reasons not reported|5
232536|NCT00049517|751745|P4|Conditioning/Transplant|Reasons not reported|15
232537|NCT00049517|751746|P3|Conditioning/Transplant|Reasons not reported|18
232538|NCT00049517|751747|P2|Conditioning/Transplant|Reasons not reported|31
232539|NCT00049517|751748|P1|Conditioning/Transplant|Reasons not reported|25
232540|NCT00049517|751743|P6|Conditioning/Transplant|Other complicating disease|1
232541|NCT00049517|751744|P5|Conditioning/Transplant|Other complicating disease|0
232542|NCT00049517|751745|P4|Conditioning/Transplant|Other complicating disease|4
232543|NCT00049517|751746|P3|Conditioning/Transplant|Other complicating disease|0
232544|NCT00049517|751747|P2|Conditioning/Transplant|Other complicating disease|0
232545|NCT00049517|751748|P1|Conditioning/Transplant|Other complicating disease|2
232546|NCT00049517|751743|P6|Conditioning/Transplant|Alternative therapy|0
232547|NCT00049517|751744|P5|Conditioning/Transplant|Alternative therapy|1
232548|NCT00049517|751745|P4|Conditioning/Transplant|Alternative therapy|1
232549|NCT00049517|751746|P3|Conditioning/Transplant|Alternative therapy|2
232550|NCT00049517|751747|P2|Conditioning/Transplant|Alternative therapy|4
232551|NCT00049517|751748|P1|Conditioning/Transplant|Alternative therapy|4
232552|NCT00049517|751743|P6|Conditioning/Transplant|Withdrawal by Subject|0
232553|NCT00049517|751744|P5|Conditioning/Transplant|Withdrawal by Subject|0
232554|NCT00049517|751745|P4|Conditioning/Transplant|Withdrawal by Subject|7
232555|NCT00049517|751746|P3|Conditioning/Transplant|Withdrawal by Subject|4
232556|NCT00049517|751747|P2|Conditioning/Transplant|Withdrawal by Subject|8
232557|NCT00049517|751748|P1|Conditioning/Transplant|Withdrawal by Subject|4
232558|NCT00049517|751743|P6|Conditioning/Transplant|Death|0
232559|NCT00049517|751744|P5|Conditioning/Transplant|Death|0
232560|NCT00049517|751745|P4|Conditioning/Transplant|Death|2
232561|NCT00049517|751746|P3|Conditioning/Transplant|Death|0
232562|NCT00049517|751747|P2|Conditioning/Transplant|Death|0
232563|NCT00049517|751748|P1|Conditioning/Transplant|Death|1
232564|NCT00049517|751743|P6|Conditioning/Transplant|Adverse Event|0
232565|NCT00049517|751744|P5|Conditioning/Transplant|Adverse Event|0
232566|NCT00049517|751745|P4|Conditioning/Transplant|Adverse Event|8
232567|NCT00049517|751746|P3|Conditioning/Transplant|Adverse Event|4
232568|NCT00049517|751747|P2|Conditioning/Transplant|Adverse Event|1
232569|NCT00049517|751748|P1|Conditioning/Transplant|Adverse Event|2
232570|NCT00049517|751743|P6|Conditioning/Transplant|Disease progression|0
232571|NCT00049517|751744|P5|Conditioning/Transplant|Disease progression|0
232572|NCT00049517|751745|P4|Conditioning/Transplant|Disease progression|6
232573|NCT00049517|751746|P3|Conditioning/Transplant|Disease progression|10
232574|NCT00049517|751747|P2|Conditioning/Transplant|Disease progression|6
232575|NCT00049517|751748|P1|Conditioning/Transplant|Disease progression|14
232576|NCT00049517|751743|P6|Induction|Reasons not reported|25
232577|NCT00049517|751744|P5|Induction|Reasons not reported|22
232578|NCT00049517|751745|P4|Induction|Reasons not reported|0
232579|NCT00049517|751746|P3|Induction|Reasons not reported|0
232580|NCT00049517|751747|P2|Induction|Reasons not reported|0
232581|NCT00049517|751748|P1|Induction|Reasons not reported|0
232582|NCT00049517|751743|P6|Induction|Other complicating disease|0
232583|NCT00049517|751744|P5|Induction|Other complicating disease|3
232584|NCT00049517|751745|P4|Induction|Other complicating disease|0
232585|NCT00049517|751746|P3|Induction|Other complicating disease|0
232586|NCT00049517|751747|P2|Induction|Other complicating disease|0
232587|NCT00049517|751748|P1|Induction|Other complicating disease|0
232588|NCT00049517|751743|P6|Induction|Alternative therapy|2
232589|NCT00049517|751744|P5|Induction|Alternative therapy|2
232590|NCT00049517|751745|P4|Induction|Alternative therapy|0
232591|NCT00049517|751746|P3|Induction|Alternative therapy|0
232592|NCT00049517|751747|P2|Induction|Alternative therapy|0
232593|NCT00049517|751748|P1|Induction|Alternative therapy|0
232594|NCT00049517|751743|P6|Induction|Withdrawal by Subject|3
232595|NCT00049517|751744|P5|Induction|Withdrawal by Subject|1
232596|NCT00049517|751745|P4|Induction|Withdrawal by Subject|0
232597|NCT00049517|751746|P3|Induction|Withdrawal by Subject|0
232598|NCT00049517|751747|P2|Induction|Withdrawal by Subject|0
232599|NCT00049517|751748|P1|Induction|Withdrawal by Subject|0
232600|NCT00049517|751743|P6|Induction|Death|6
232601|NCT00049517|751744|P5|Induction|Death|9
232602|NCT00049517|751745|P4|Induction|Death|0
232603|NCT00049517|751746|P3|Induction|Death|0
232604|NCT00049517|751747|P2|Induction|Death|0
232605|NCT00049517|751748|P1|Induction|Death|0
232606|NCT00049517|751743|P6|Induction|Adverse Event|7
232607|NCT00049517|751744|P5|Induction|Adverse Event|5
232608|NCT00049517|751745|P4|Induction|Adverse Event|0
232609|NCT00049517|751746|P3|Induction|Adverse Event|0
232610|NCT00049517|751747|P2|Induction|Adverse Event|0
232611|NCT00049517|751748|P1|Induction|Adverse Event|0
232612|NCT00049517|751743|P6|Induction|Disease progression|11
232613|NCT00049517|751744|P5|Induction|Disease progression|18
232614|NCT00049517|751745|P4|Induction|Disease progression|0
232615|NCT00049517|751746|P3|Induction|Disease progression|0
232616|NCT00049517|751747|P2|Induction|Disease progression|0
232617|NCT00049517|751748|P1|Induction|Disease progression|0
232618|NCT00049322|751766|P2|Overall Study|refused angio|3
232619|NCT00049322|751767|P1|Overall Study|refused angio|0
232620|NCT00049322|751766|P2|Overall Study|Adverse Event|0
232621|NCT00049322|751767|P1|Overall Study|Adverse Event|1
232622|NCT00049322|751766|P2|Overall Study|disease burden|3
232623|NCT00049322|751767|P1|Overall Study|disease burden|0
232624|NCT00049257|751779|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
232625|NCT00049257|751779|P1|Carboplatin, Paclitaxel|Death|2
232626|NCT00049257|751779|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
232627|NCT00049257|751779|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
232628|NCT00049127|751791|P5|Overall Study|Withdrawal by Subject|0
232629|NCT00049127|751792|P4|Overall Study|Withdrawal by Subject|0
232630|NCT00049127|751793|P3|Overall Study|Withdrawal by Subject|1
232631|NCT00049127|751794|P2|Overall Study|Withdrawal by Subject|0
232632|NCT00049127|751795|P1|Overall Study|Withdrawal by Subject|0
232633|NCT00048997|751833|P2|Overall Study|Withdrawal by Subject|1
232634|NCT00048997|751834|P1|Overall Study|Withdrawal by Subject|6
232635|NCT00048997|751833|P2|Overall Study|Protocol Violation|2
232636|NCT00048997|751834|P1|Overall Study|Protocol Violation|7
232637|NCT00047385|751841|P2|Overall Study|Eligible for screening but had no screen|492
232638|NCT00047385|751842|P1|Overall Study|Eligible for screening but had no screen|260
232639|NCT00047385|751841|P2|Overall Study|Lung Cancer diagnosed before screening|3
232640|NCT00047385|751842|P1|Overall Study|Lung Cancer diagnosed before screening|5
232641|NCT00047385|751841|P2|Overall Study|Death before any screening|5
232642|NCT00047385|751842|P1|Overall Study|Death before any screening|2
232643|NCT00047320|751860|P1|Overall Study|Ineligible|2
232644|NCT00047320|751860|P1|Overall Study|Withdrawal by Subject|9
232645|NCT00047320|751860|P1|Overall Study|Physician Decision|8
232646|NCT00047320|751860|P1|Overall Study|Lost to Follow-up|1
232647|NCT00047320|751860|P1|Overall Study|Lack of Efficacy|8
232648|NCT00047008|751871|P2|Overall Study|Ineligible|8
232649|NCT00047008|751872|P1|Overall Study|Ineligible|9
232650|NCT00047008|751871|P2|Overall Study|Withdrawn consent|3
232651|NCT00047008|751872|P1|Overall Study|Withdrawn consent|2
232652|NCT00046930|751880|P2|Overall Study|Ineligible|4
232653|NCT00046930|751881|P1|Overall Study|Ineligible|12
232654|NCT00046891|751896|P2|Overall Study|Adverse Event|5
232655|NCT00046891|751897|P1|Overall Study|Adverse Event|5
232656|NCT00046891|751896|P2|Overall Study|Withdrawal by Subject|15
232657|NCT00046891|751897|P1|Overall Study|Withdrawal by Subject|18
232658|NCT00046891|751896|P2|Overall Study|Ineligible|1
232659|NCT00046891|751897|P1|Overall Study|Ineligible|1
232660|NCT00046891|751896|P2|Overall Study|Cancels|9
232661|NCT00046891|751897|P1|Overall Study|Cancels|5
232662|NCT00046839|751917|P2|Overall Study|Withdrawal of consent|0
232663|NCT00046839|751918|P1|Overall Study|Withdrawal of consent|1
232664|NCT00046839|751917|P2|Overall Study|Ineligible / No protocol treatment|2
232665|NCT00046839|751918|P1|Overall Study|Ineligible / No protocol treatment|0
232666|NCT00045734|751925|P1|Overall Study|Protocol Violation|1
232667|NCT00045708|751940|P3|Phase 1|early progressive disease|0
232668|NCT00045708|751941|P2|Phase 1|early progressive disease|1
232669|NCT00045708|751942|P1|Phase 1|early progressive disease|0
232670|NCT00045630|751967|P1|Overall Study|Ineligible|2
232671|NCT00045630|751967|P1|Overall Study|Death|1
232672|NCT00045630|751967|P1|Overall Study|Progression/relapse|1
232673|NCT00045630|751967|P1|Overall Study|Refusal unrelated to adverse event|1
232674|NCT00045630|751967|P1|Overall Study|Adverse Event|1
232675|NCT00045305|751986|P1|Overall Study|site error|2
232676|NCT00045305|751986|P1|Overall Study|Death|3
232677|NCT00045305|751986|P1|Overall Study|Adverse Event|3
232678|NCT00045305|751986|P1|Overall Study|Lack of Efficacy|6
232679|NCT00045162|751997|P2|Overall Study|Not specified|16
232680|NCT00045162|751998|P1|Overall Study|Not specified|21
232681|NCT00045162|751997|P2|Overall Study|Withdrawal by Subject|3
232682|NCT00045162|751998|P1|Overall Study|Withdrawal by Subject|5
232683|NCT00045162|751997|P2|Overall Study|Death|10
232684|NCT00045162|751998|P1|Overall Study|Death|10
232685|NCT00045162|751997|P2|Overall Study|Lack of Efficacy|29
232686|NCT00045162|751998|P1|Overall Study|Lack of Efficacy|32
232687|NCT00045162|751997|P2|Overall Study|Adverse Event|50
232688|NCT00045162|751998|P1|Overall Study|Adverse Event|55
232689|NCT00045162|751997|P2|Overall Study|Not treated|2
232690|NCT00045162|751998|P1|Overall Study|Not treated|7
232691|NCT00045162|751997|P2|Overall Study|Ineligible|8
232692|NCT00045162|751998|P1|Overall Study|Ineligible|12
232693|NCT00045110|752013|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
232694|NCT00045110|752014|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
232695|NCT00045110|752015|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
232696|NCT00045110|752013|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
232697|NCT00045110|752014|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
232698|NCT00045110|752015|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
232699|NCT00045110|752013|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
232700|NCT00045110|752014|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
232701|NCT00045110|752015|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
232702|NCT00045032|752064|P3|Overall Study|Not Specified|105
232703|NCT00045032|752065|P2|Overall Study|Not Specified|84
232704|NCT00045032|752066|P1|Overall Study|Not Specified|93
232705|NCT00045032|752064|P3|Overall Study|Failure to Return|61
232706|NCT00045032|752065|P2|Overall Study|Failure to Return|62
232707|NCT00045032|752066|P1|Overall Study|Failure to Return|57
232708|NCT00045032|752064|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
232709|NCT00045032|752065|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
232710|NCT00045032|752066|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
232711|NCT00045032|752064|P3|Overall Study|Other Protocol Violation|1
232712|NCT00045032|752065|P2|Overall Study|Other Protocol Violation|0
232713|NCT00045032|752066|P1|Overall Study|Other Protocol Violation|2
232714|NCT00045032|752064|P3|Overall Study|Violation of Selection Criteria at Entry|6
232715|NCT00045032|752065|P2|Overall Study|Violation of Selection Criteria at Entry|6
232716|NCT00045032|752066|P1|Overall Study|Violation of Selection Criteria at Entry|3
232717|NCT00045032|752064|P3|Overall Study|Insufficient Therapeutic Response|445
232718|NCT00045032|752065|P2|Overall Study|Insufficient Therapeutic Response|437
232719|NCT00045032|752066|P1|Overall Study|Insufficient Therapeutic Response|542
232720|NCT00045032|752064|P3|Overall Study|Death|17
232721|NCT00045032|752065|P2|Overall Study|Death|24
232722|NCT00045032|752066|P1|Overall Study|Death|22
232723|NCT00045032|752064|P3|Overall Study|Adverse Event/Intercurrent Illness|7
232724|NCT00045032|752065|P2|Overall Study|Adverse Event/Intercurrent Illness|2
232725|NCT00045032|752066|P1|Overall Study|Adverse Event/Intercurrent Illness|2
232726|NCT00042991|752200|P7|Overall Study|Alternative Therapy|0
232727|NCT00042991|752201|P6|Overall Study|Alternative Therapy|0
232728|NCT00042991|752202|P5|Overall Study|Alternative Therapy|1
232729|NCT00042991|752203|P4|Overall Study|Alternative Therapy|0
232730|NCT00042991|752204|P3|Overall Study|Alternative Therapy|0
232731|NCT00042991|752205|P2|Overall Study|Alternative Therapy|0
232732|NCT00042991|752206|P1|Overall Study|Alternative Therapy|0
232733|NCT00042991|752200|P7|Overall Study|Disease Progression|2
232734|NCT00042991|752201|P6|Overall Study|Disease Progression|4
232735|NCT00042991|752202|P5|Overall Study|Disease Progression|1
232736|NCT00042991|752203|P4|Overall Study|Disease Progression|2
232737|NCT00042991|752204|P3|Overall Study|Disease Progression|2
232738|NCT00042991|752205|P2|Overall Study|Disease Progression|29
232739|NCT00042991|752206|P1|Overall Study|Disease Progression|5
232740|NCT00042991|752200|P7|Overall Study|Withdrawal by Subject|0
232741|NCT00042991|752201|P6|Overall Study|Withdrawal by Subject|0
232742|NCT00042991|752202|P5|Overall Study|Withdrawal by Subject|1
232743|NCT00042991|752203|P4|Overall Study|Withdrawal by Subject|0
232744|NCT00042991|752204|P3|Overall Study|Withdrawal by Subject|2
232745|NCT00042991|752205|P2|Overall Study|Withdrawal by Subject|7
232746|NCT00042991|752206|P1|Overall Study|Withdrawal by Subject|0
232747|NCT00042991|752200|P7|Overall Study|Adverse Event|0
232748|NCT00042991|752201|P6|Overall Study|Adverse Event|1
232749|NCT00042991|752202|P5|Overall Study|Adverse Event|0
232750|NCT00042991|752203|P4|Overall Study|Adverse Event|0
232751|NCT00042991|752204|P3|Overall Study|Adverse Event|2
232752|NCT00042991|752205|P2|Overall Study|Adverse Event|4
232753|NCT00042991|752206|P1|Overall Study|Adverse Event|1
232754|NCT00042939|752249|P2|Overall Study|Did not start treatment|1
232755|NCT00042939|752250|P1|Overall Study|Did not start treatment|2
232756|NCT00042939|752249|P2|Overall Study|Treatment break > 4 weeks|1
232757|NCT00042939|752250|P1|Overall Study|Treatment break > 4 weeks|0
232758|NCT00042939|752249|P2|Overall Study|Still on treatment|0
232759|NCT00042939|752250|P1|Overall Study|Still on treatment|1
232760|NCT00042939|752249|P2|Overall Study|Patient non-compliance|0
232761|NCT00042939|752250|P1|Overall Study|Patient non-compliance|1
232762|NCT00042939|752249|P2|Overall Study|Rising ca 19-9|0
232763|NCT00042939|752250|P1|Overall Study|Rising ca 19-9|1
232764|NCT00042939|752249|P2|Overall Study|QOL diminished|0
232765|NCT00042939|752250|P1|Overall Study|QOL diminished|1
232766|NCT00042939|752249|P2|Overall Study|Deterioration of health|4
232767|NCT00042939|752250|P1|Overall Study|Deterioration of health|3
232768|NCT00042939|752249|P2|Overall Study|Ineligible|2
232769|NCT00042939|752250|P1|Overall Study|Ineligible|2
232770|NCT00042939|752249|P2|Overall Study|Other disease|0
232771|NCT00042939|752250|P1|Overall Study|Other disease|1
232772|NCT00042939|752249|P2|Overall Study|Withdrawal by Subject|4
232773|NCT00042939|752250|P1|Overall Study|Withdrawal by Subject|3
232774|NCT00042939|752249|P2|Overall Study|Death|2
232775|NCT00042939|752250|P1|Overall Study|Death|3
232776|NCT00042939|752249|P2|Overall Study|Adverse Event|7
232777|NCT00042939|752250|P1|Overall Study|Adverse Event|6
232778|NCT00041132|752264|P1|Overall Study|Physician Decision|2
232779|NCT00041132|752264|P1|Overall Study|Withdrawal by Subject|1
232780|NCT00041132|752264|P1|Overall Study|Not Eligible|7
232781|NCT00041132|752264|P1|Overall Study|Death|1
232782|NCT00041132|752264|P1|Overall Study|Adverse Event|19
232783|NCT00041080|752299|P2|Overall Study|Ineligible|0
232784|NCT00041080|752300|P1|Overall Study|Ineligible|1
232785|NCT00041080|752299|P2|Overall Study|Did not start therapy|1
232786|NCT00041080|752300|P1|Overall Study|Did not start therapy|1
232787|NCT00041080|752299|P2|Overall Study|Concommitant Illness/Other|2
232788|NCT00041080|752300|P1|Overall Study|Concommitant Illness/Other|1
232789|NCT00041080|752299|P2|Overall Study|Withdrawal by Subject|6
232790|NCT00041080|752300|P1|Overall Study|Withdrawal by Subject|6
232791|NCT00041080|752299|P2|Overall Study|Adverse Event|1
232792|NCT00041080|752300|P1|Overall Study|Adverse Event|21
232793|NCT00041067|752306|P1|Overall Study|Ineligible|2
232794|NCT00041067|752306|P1|Overall Study|Other reasons|23
232795|NCT00041067|752306|P1|Overall Study|Patient refusal|12
232796|NCT00041067|752306|P1|Overall Study|Progression|19
232797|NCT00041067|752306|P1|Overall Study|Adverse Event|20
232798|NCT00040742|752373|P4|Overall Study|Other medical|5
232799|NCT00040742|752374|P3|Overall Study|Other medical|5
232800|NCT00040742|752375|P2|Overall Study|Other medical|5
232801|NCT00040742|752376|P1|Overall Study|Other medical|7
232802|NCT00040742|752373|P4|Overall Study|Incomplete Forms|5
232803|NCT00040742|752374|P3|Overall Study|Incomplete Forms|4
232804|NCT00040742|752375|P2|Overall Study|Incomplete Forms|10
232805|NCT00040742|752376|P1|Overall Study|Incomplete Forms|6
232806|NCT00040742|752373|P4|Overall Study|Chemotoxicity|2
232807|NCT00040742|752374|P3|Overall Study|Chemotoxicity|5
232808|NCT00040742|752375|P2|Overall Study|Chemotoxicity|3
232809|NCT00040742|752376|P1|Overall Study|Chemotoxicity|4
232810|NCT00040742|752373|P4|Overall Study|Withdrawal by Subject|13
232811|NCT00040742|752374|P3|Overall Study|Withdrawal by Subject|10
232812|NCT00040742|752375|P2|Overall Study|Withdrawal by Subject|15
232813|NCT00040742|752376|P1|Overall Study|Withdrawal by Subject|7
232814|NCT00040742|752373|P4|Overall Study|Adverse Event|9
232815|NCT00040742|752374|P3|Overall Study|Adverse Event|21
232816|NCT00040742|752375|P2|Overall Study|Adverse Event|16
232817|NCT00040742|752376|P1|Overall Study|Adverse Event|15
232818|NCT00040742|752373|P4|Overall Study|Death|0
232819|NCT00040742|752374|P3|Overall Study|Death|1
232820|NCT00040742|752375|P2|Overall Study|Death|0
232821|NCT00040742|752376|P1|Overall Study|Death|0
232822|NCT00039377|752390|P4|Initial Registration|Withdrawal by Subject|0
232823|NCT00039377|752391|P3|Initial Registration|Withdrawal by Subject|0
232824|NCT00039377|752392|P2|Initial Registration|Withdrawal by Subject|0
232825|NCT00039377|752393|P1|Initial Registration|Withdrawal by Subject|3
232826|NCT00039377|752390|P4|Initial Registration|Received non-protocol therapy|0
232827|NCT00039377|752391|P3|Initial Registration|Received non-protocol therapy|0
232828|NCT00039377|752392|P2|Initial Registration|Received non-protocol therapy|0
232829|NCT00039377|752393|P1|Initial Registration|Received non-protocol therapy|11
232830|NCT00039377|752390|P4|Initial Registration|Relapsed|0
232831|NCT00039377|752391|P3|Initial Registration|Relapsed|0
232832|NCT00039377|752392|P2|Initial Registration|Relapsed|0
232833|NCT00039377|752393|P1|Initial Registration|Relapsed|6
232834|NCT00039377|752390|P4|Initial Registration|Adverse Event|0
232835|NCT00039377|752391|P3|Initial Registration|Adverse Event|0
232836|NCT00039377|752392|P2|Initial Registration|Adverse Event|0
232837|NCT00039377|752393|P1|Initial Registration|Adverse Event|2
232838|NCT00039130|752409|P1|Overall Study|Physician Decision|3
232839|NCT00039130|752409|P1|Overall Study|Subsequent treatment|2
232840|NCT00039130|752409|P1|Overall Study|Progression|2
232841|NCT00039130|752409|P1|Overall Study|Withdrawal by Subject|3
232842|NCT00039130|752409|P1|Overall Study|Death|9
232843|NCT00039130|752409|P1|Overall Study|Adverse Event|11
232844|NCT00033657|752423|P2|Adjuvant Chemotherapy|Other|2
232845|NCT00033657|752424|P1|Adjuvant Chemotherapy|Other|0
232846|NCT00033657|752423|P2|Adjuvant Chemotherapy|alternative therapy|0
232847|NCT00033657|752424|P1|Adjuvant Chemotherapy|alternative therapy|1
232848|NCT00033657|752423|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
232849|NCT00033657|752424|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
232850|NCT00033657|752423|P2|Adjuvant Chemotherapy|Death|1
232851|NCT00033657|752424|P1|Adjuvant Chemotherapy|Death|2
232852|NCT00033657|752423|P2|Adjuvant Chemotherapy|Adverse Event|10
232853|NCT00033657|752424|P1|Adjuvant Chemotherapy|Adverse Event|7
232854|NCT00033657|752423|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
232855|NCT00033657|752424|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
232856|NCT00033657|752423|P2|Surgical Resection|not complete resection|3
232857|NCT00033657|752424|P1|Surgical Resection|not complete resection|0
232858|NCT00033657|752423|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
232859|NCT00033657|752424|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
232860|NCT00033657|752423|P2|Neoadjuvant Chemotherapy|Ineligible|4
232861|NCT00033657|752424|P1|Neoadjuvant Chemotherapy|Ineligible|8
232862|NCT00033657|752423|P2|Neoadjuvant Chemotherapy|other complicating disease|1
232863|NCT00033657|752424|P1|Neoadjuvant Chemotherapy|other complicating disease|0
232864|NCT00033657|752423|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
232865|NCT00033657|752424|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
232866|NCT00033657|752423|P2|Neoadjuvant Chemotherapy|Death|1
232867|NCT00033657|752424|P1|Neoadjuvant Chemotherapy|Death|1
232868|NCT00033657|752423|P2|Neoadjuvant Chemotherapy|Adverse Event|2
232869|NCT00033657|752424|P1|Neoadjuvant Chemotherapy|Adverse Event|0
232870|NCT00033657|752423|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
232871|NCT00033657|752424|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
232872|NCT00033631|752438|P2|Overall Study|Withdrawal by Subject|4
232873|NCT00033631|752439|P1|Overall Study|Withdrawal by Subject|4
232874|NCT00033631|752438|P2|Overall Study|Protocol Violation|11
232875|NCT00033631|752439|P1|Overall Study|Protocol Violation|14
232876|NCT00033540|752457|P1|Overall Study|Never received treatment|2
232877|NCT00033540|752457|P1|Overall Study|Ineligible|3
232878|NCT00033540|752457|P1|Overall Study|Not specified|5
232879|NCT00033540|752457|P1|Overall Study|Withdrawal by Subject|6
232880|NCT00033540|752457|P1|Overall Study|Progression|26
232881|NCT00033540|752457|P1|Overall Study|Death|1
232882|NCT00033540|752457|P1|Overall Study|Adverse Event|14
232883|NCT00033514|752467|P2|Overall Study|Withdrawal by Subject|3
232884|NCT00033514|752468|P1|Overall Study|Withdrawal by Subject|0
232885|NCT00033514|752467|P2|Overall Study|Lost to Follow-up|1
232886|NCT00033514|752468|P1|Overall Study|Lost to Follow-up|1
232887|NCT00033371|752478|P2|Overall Study|Disease Progression|1
232888|NCT00033371|752479|P1|Overall Study|Disease Progression|0
232889|NCT00033371|752478|P2|Overall Study|Withdrawal by Subject|3
232890|NCT00033371|752479|P1|Overall Study|Withdrawal by Subject|3
232891|NCT00033371|752478|P2|Overall Study|Lost to Follow-up|1
232892|NCT00033371|752479|P1|Overall Study|Lost to Follow-up|2
232893|NCT00033371|752478|P2|Overall Study|Adverse Event|5
232894|NCT00033371|752479|P1|Overall Study|Adverse Event|1
232895|NCT00033293|752487|P2|Overall Study|Treatment refused|6
232896|NCT00033293|752488|P1|Overall Study|Treatment refused|0
232897|NCT00033293|752487|P2|Overall Study|Could not be weaned from steroid therapy|1
232898|NCT00033293|752488|P1|Overall Study|Could not be weaned from steroid therapy|1
232899|NCT00033293|752487|P2|Overall Study|Withdrawal by Subject|0
232900|NCT00033293|752488|P1|Overall Study|Withdrawal by Subject|1
232901|NCT00033293|752487|P2|Overall Study|Physician Decision|1
232902|NCT00033293|752488|P1|Overall Study|Physician Decision|3
232903|NCT00033293|752487|P2|Overall Study|Lost to Follow-up|1
232904|NCT00033293|752488|P1|Overall Study|Lost to Follow-up|0
232905|NCT00033293|752487|P2|Overall Study|Lack of Efficacy|8
232906|NCT00033293|752488|P1|Overall Study|Lack of Efficacy|5
232907|NCT00033293|752487|P2|Overall Study|Death|1
232908|NCT00033293|752488|P1|Overall Study|Death|0
232909|NCT00031694|752506|P1|Overall Study|Withdrawal by Subject|5
232910|NCT00031694|752506|P1|Overall Study|Death|2
232911|NCT00031694|752506|P1|Overall Study|Adverse Event|12
232912|NCT00030901|752512|P3|Randomization|Ineligible|14
232913|NCT00030901|752513|P2|Randomization|Ineligible|15
232914|NCT00030901|752514|P1|Randomization|Ineligible|0
232915|NCT00030901|752512|P3|Randomization|Other|33
232916|NCT00030901|752513|P2|Randomization|Other|36
232917|NCT00030901|752514|P1|Randomization|Other|0
232918|NCT00030901|752512|P3|Randomization|Death|3
232919|NCT00030901|752513|P2|Randomization|Death|1
232920|NCT00030901|752514|P1|Randomization|Death|0
232921|NCT00030901|752512|P3|Randomization|Progression/Relapse|21
232922|NCT00030901|752513|P2|Randomization|Progression/Relapse|22
232923|NCT00030901|752514|P1|Randomization|Progression/Relapse|0
232924|NCT00030901|752512|P3|Randomization|Refusal Unrelated to Adverse Event|10
232925|NCT00030901|752513|P2|Randomization|Refusal Unrelated to Adverse Event|16
232926|NCT00030901|752514|P1|Randomization|Refusal Unrelated to Adverse Event|0
232927|NCT00030901|752512|P3|Randomization|Adverse Event|7
232928|NCT00030901|752513|P2|Randomization|Adverse Event|11
232929|NCT00030901|752514|P1|Randomization|Adverse Event|0
232930|NCT00030901|752512|P3|Initial Registration|Ineligible|0
232931|NCT00030901|752513|P2|Initial Registration|Ineligible|0
232932|NCT00030901|752514|P1|Initial Registration|Ineligible|167
232933|NCT00030823|752522|P1|Overall Study|Withdrawal by Subject|1
232934|NCT00028769|752526|P1|Overall Study|Not Analyzable|1
232935|NCT00028769|752526|P1|Overall Study|Ineligible|5
232936|NCT00028769|752526|P1|Overall Study|Other - Not Protocol Specified|1
232937|NCT00028769|752526|P1|Overall Study|Progression or Death|31
232938|NCT00028769|752526|P1|Overall Study|Refusal Unrelated to Adverse Events|1
232939|NCT00028769|752526|P1|Overall Study|Adverse Event|2
232940|NCT00028002|752532|P1|Overall Study|Ineligible|8
232941|NCT00028002|752532|P1|Overall Study|Withdrawal by Subject|3
232942|NCT00027846|752539|P3|Overall Study|Neuraxis dissemination during/after ther|5
232943|NCT00027846|752540|P2|Overall Study|Neuraxis dissemination during/after ther|2
232944|NCT00027846|752541|P1|Overall Study|Neuraxis dissemination during/after ther|0
232945|NCT00027846|752539|P3|Overall Study|Entry into another COG therapeutic study|2
232946|NCT00027846|752540|P2|Overall Study|Entry into another COG therapeutic study|5
232947|NCT00027846|752541|P1|Overall Study|Entry into another COG therapeutic study|0
232948|NCT00027846|752539|P3|Overall Study|Ineligible for study|14
232949|NCT00027846|752540|P2|Overall Study|Ineligible for study|6
232950|NCT00027846|752541|P1|Overall Study|Ineligible for study|2
232951|NCT00027846|752539|P3|Overall Study|Withdrawal by Subject|7
232952|NCT00027846|752540|P2|Overall Study|Withdrawal by Subject|14
232953|NCT00027846|752541|P1|Overall Study|Withdrawal by Subject|0
232954|NCT00027846|752539|P3|Overall Study|Lost to Follow-up|9
232955|NCT00027846|752540|P2|Overall Study|Lost to Follow-up|41
232956|NCT00027846|752541|P1|Overall Study|Lost to Follow-up|0
232957|NCT00027560|752559|P1|Overall Study|Withdrawal by Subject|1
232958|NCT00026494|752572|P4|Overall Study|Clinical progression|0
232959|NCT00026494|752573|P3|Overall Study|Clinical progression|3
232960|NCT00026494|752574|P2|Overall Study|Clinical progression|0
232961|NCT00026494|752575|P1|Overall Study|Clinical progression|0
232962|NCT00026494|752572|P4|Overall Study|Patient not treated|0
232963|NCT00026494|752573|P3|Overall Study|Patient not treated|2
232964|NCT00026494|752574|P2|Overall Study|Patient not treated|0
232965|NCT00026494|752575|P1|Overall Study|Patient not treated|0
232966|NCT00026494|752572|P4|Overall Study|Patient non-compliance|0
232967|NCT00026494|752573|P3|Overall Study|Patient non-compliance|0
232968|NCT00026494|752574|P2|Overall Study|Patient non-compliance|0
232969|NCT00026494|752575|P1|Overall Study|Patient non-compliance|1
232970|NCT00026494|752572|P4|Overall Study|Withdrawal by Subject|0
232971|NCT00026494|752573|P3|Overall Study|Withdrawal by Subject|1
232972|NCT00026494|752574|P2|Overall Study|Withdrawal by Subject|0
232973|NCT00026494|752575|P1|Overall Study|Withdrawal by Subject|1
232974|NCT00026312|752587|P2|Overall Study|Refusal by patient/parent/guardian|59
232975|NCT00026312|752588|P1|Overall Study|Refusal by patient/parent/guardian|8
232976|NCT00026312|752587|P2|Overall Study|Entry onto another COG study|1
232977|NCT00026312|752588|P1|Overall Study|Entry onto another COG study|0
232978|NCT00026312|752587|P2|Overall Study|Ineligible|5
232979|NCT00026312|752588|P1|Overall Study|Ineligible|4
232980|NCT00026312|752587|P2|Overall Study|Withdrawal by Subject|6
232981|NCT00026312|752588|P1|Overall Study|Withdrawal by Subject|1
232982|NCT00026312|752587|P2|Overall Study|Protocol Violation|3
232983|NCT00026312|752588|P1|Overall Study|Protocol Violation|0
232984|NCT00026312|752587|P2|Overall Study|Physician Decision|37
232985|NCT00026312|752588|P1|Overall Study|Physician Decision|1
232986|NCT00026312|752587|P2|Overall Study|Lost to Follow-up|5
232987|NCT00026312|752588|P1|Overall Study|Lost to Follow-up|0
232988|NCT00026312|752587|P2|Overall Study|Lack of Efficacy|114
232989|NCT00026312|752588|P1|Overall Study|Lack of Efficacy|19
232990|NCT00026312|752587|P2|Overall Study|Death|7
232991|NCT00026312|752588|P1|Overall Study|Death|1
232992|NCT00026312|752587|P2|Overall Study|Adverse Event|32
232993|NCT00026312|752588|P1|Overall Study|Adverse Event|0
232994|NCT00026208|752627|P2|Overall Study|Lost to Follow-up|0
232995|NCT00026208|752628|P1|Overall Study|Lost to Follow-up|1
232996|NCT00026208|752627|P2|Overall Study|Complications of auto accident|0
232997|NCT00026208|752628|P1|Overall Study|Complications of auto accident|1
232998|NCT00025662|752644|P1|Overall Study|Technical failure of manipulation|1
232999|NCT00025662|752644|P1|Overall Study|Withdrawal by Subject|2
233000|NCT00025506|752652|P1|Overall Study|Never Treated|2
233001|NCT00025506|752652|P1|Overall Study|Ineligible: inadequate pathology|2
233002|NCT00025506|752652|P1|Overall Study|Ineligible: wrong cell type|5
233003|NCT00025506|752652|P1|Overall Study|Ineligible: clerical error|1
233004|NCT00025259|752673|P7|Overall Study|Adverse Event|0
233005|NCT00025259|752674|P6|Overall Study|Adverse Event|0
233006|NCT00025259|752675|P5|Overall Study|Adverse Event|0
233007|NCT00025259|752676|P4|Overall Study|Adverse Event|0
233008|NCT00025259|752677|P3|Overall Study|Adverse Event|0
233009|NCT00025259|752678|P2|Overall Study|Adverse Event|0
233010|NCT00025259|752679|P1|Overall Study|Adverse Event|1
233011|NCT00025259|752673|P7|Overall Study|Randomization error|2
233012|NCT00025259|752674|P6|Overall Study|Randomization error|7
233013|NCT00025259|752675|P5|Overall Study|Randomization error|1
233014|NCT00025259|752676|P4|Overall Study|Randomization error|0
233015|NCT00025259|752677|P3|Overall Study|Randomization error|0
233016|NCT00025259|752678|P2|Overall Study|Randomization error|0
233017|NCT00025259|752679|P1|Overall Study|Randomization error|1
233018|NCT00025259|752673|P7|Overall Study|Ineligible|1
233019|NCT00025259|752674|P6|Overall Study|Ineligible|0
233020|NCT00025259|752675|P5|Overall Study|Ineligible|6
233021|NCT00025259|752676|P4|Overall Study|Ineligible|0
233022|NCT00025259|752677|P3|Overall Study|Ineligible|0
233023|NCT00025259|752678|P2|Overall Study|Ineligible|1
233024|NCT00025259|752679|P1|Overall Study|Ineligible|14
233025|NCT00025259|752673|P7|Overall Study|Withdrawal by Subject|3
233026|NCT00025259|752674|P6|Overall Study|Withdrawal by Subject|8
233027|NCT00025259|752675|P5|Overall Study|Withdrawal by Subject|11
233028|NCT00025259|752676|P4|Overall Study|Withdrawal by Subject|14
233029|NCT00025259|752677|P3|Overall Study|Withdrawal by Subject|6
233030|NCT00025259|752678|P2|Overall Study|Withdrawal by Subject|27
233031|NCT00025259|752679|P1|Overall Study|Withdrawal by Subject|9
233032|NCT00025259|752673|P7|Overall Study|Protocol Violation|3
233033|NCT00025259|752674|P6|Overall Study|Protocol Violation|1
233034|NCT00025259|752675|P5|Overall Study|Protocol Violation|2
233035|NCT00025259|752676|P4|Overall Study|Protocol Violation|1
233036|NCT00025259|752677|P3|Overall Study|Protocol Violation|2
233037|NCT00025259|752678|P2|Overall Study|Protocol Violation|2
233038|NCT00025259|752679|P1|Overall Study|Protocol Violation|3
233039|NCT00025259|752673|P7|Overall Study|Physician Decision|1
233040|NCT00025259|752674|P6|Overall Study|Physician Decision|2
233041|NCT00025259|752675|P5|Overall Study|Physician Decision|4
233042|NCT00025259|752676|P4|Overall Study|Physician Decision|5
233043|NCT00025259|752677|P3|Overall Study|Physician Decision|0
233044|NCT00025259|752678|P2|Overall Study|Physician Decision|1
233045|NCT00025259|752679|P1|Overall Study|Physician Decision|12
233046|NCT00025259|752673|P7|Overall Study|Lost to Follow-up|1
233047|NCT00025259|752674|P6|Overall Study|Lost to Follow-up|3
233048|NCT00025259|752675|P5|Overall Study|Lost to Follow-up|1
233049|NCT00025259|752676|P4|Overall Study|Lost to Follow-up|13
233050|NCT00025259|752677|P3|Overall Study|Lost to Follow-up|13
233051|NCT00025259|752678|P2|Overall Study|Lost to Follow-up|9
233052|NCT00025259|752679|P1|Overall Study|Lost to Follow-up|2
233053|NCT00025259|752673|P7|Overall Study|Lack of Efficacy|38
233054|NCT00025259|752674|P6|Overall Study|Lack of Efficacy|30
233055|NCT00025259|752675|P5|Overall Study|Lack of Efficacy|11
233056|NCT00025259|752676|P4|Overall Study|Lack of Efficacy|78
233057|NCT00025259|752677|P3|Overall Study|Lack of Efficacy|60
233058|NCT00025259|752678|P2|Overall Study|Lack of Efficacy|46
233059|NCT00025259|752679|P1|Overall Study|Lack of Efficacy|2
233060|NCT00025259|752673|P7|Overall Study|Death|2
233061|NCT00025259|752674|P6|Overall Study|Death|1
233062|NCT00025259|752675|P5|Overall Study|Death|0
233063|NCT00025259|752676|P4|Overall Study|Death|3
233064|NCT00025259|752677|P3|Overall Study|Death|0
233065|NCT00025259|752678|P2|Overall Study|Death|3
233066|NCT00025259|752679|P1|Overall Study|Death|1
233067|NCT00025233|752715|P1|Overall Study|Never treated|1
233068|NCT00025233|752715|P1|Overall Study|Ineligible: improper prior treatment|1
233069|NCT00025233|752715|P1|Overall Study|Ineligible: wrong primary|1
233070|NCT00025233|752715|P1|Overall Study|Ineligible: wrong cell type|1
233071|NCT00025155|752730|P1|Overall Study|Ineligible: Second primary cancer site|1
233072|NCT00025155|752730|P1|Overall Study|Ineligible: Wrong primary cancer site|1
233073|NCT00024258|752741|P1|Overall Study|Disease Progression|8
233074|NCT00024258|752741|P1|Overall Study|Withdrawal by Subject|1
233075|NCT00024167|752748|P2|Overall Study|Death|47
233076|NCT00024167|752749|P1|Overall Study|Death|53
233077|NCT00023764|752773|P1|Overall Study|delay in obtaining staging images|1
233078|NCT00023764|752773|P1|Overall Study|patient received other treatment|1
233079|NCT00023764|752773|P1|Overall Study|Progression of disease|6
233080|NCT00023764|752773|P1|Overall Study|Withdrawal by Subject|1
233081|NCT00023764|752773|P1|Overall Study|Adverse Event|4
233082|NCT00023764|752773|P1|Overall Study|Other|1
233083|NCT00023712|752780|P2|Overall Study|Never treated|1
233084|NCT00023712|752781|P1|Overall Study|Never treated|1
233085|NCT00023712|752780|P2|Overall Study|Not platinum sensitive|0
233086|NCT00023712|752781|P1|Overall Study|Not platinum sensitive|1
233087|NCT00022698|752805|P2|Overall Study|Administrative /other|7
233088|NCT00022698|752806|P1|Overall Study|Administrative /other|1
233089|NCT00022698|752805|P2|Overall Study|Insufficient therapeutic response|14
233090|NCT00022698|752806|P1|Overall Study|Insufficient therapeutic response|2
233091|NCT00022698|752805|P2|Overall Study|Refused treatment|2
233092|NCT00022698|752806|P1|Overall Study|Refused treatment|0
233093|NCT00022698|752805|P2|Overall Study|Failure to return|1
233094|NCT00022698|752806|P1|Overall Study|Failure to return|0
233095|NCT00022698|752805|P2|Overall Study|Death|2
233096|NCT00022698|752806|P1|Overall Study|Death|0
233097|NCT00022698|752805|P2|Overall Study|Adverse Event|9
233098|NCT00022698|752806|P1|Overall Study|Adverse Event|5
233099|NCT00022672|752831|P2|Extension Phase|Other|1
233100|NCT00022672|752832|P1|Extension Phase|Other|1
233101|NCT00022672|752831|P2|Extension Phase|Refused Treatment|2
233102|NCT00022672|752832|P1|Extension Phase|Refused Treatment|0
233103|NCT00022672|752831|P2|Extension Phase|Insufficient Therapeutic Response|44
233104|NCT00022672|752832|P1|Extension Phase|Insufficient Therapeutic Response|1
233105|NCT00022672|752831|P2|Extension Phase|Death|1
233106|NCT00022672|752832|P1|Extension Phase|Death|0
233107|NCT00022672|752831|P2|Extension Phase|Adverse Event|3
233108|NCT00022672|752832|P1|Extension Phase|Adverse Event|1
233109|NCT00022672|752831|P2|Main Phase: 24 Months|Other|0
233110|NCT00022672|752832|P1|Main Phase: 24 Months|Other|1
233111|NCT00022672|752831|P2|Main Phase: 24 Months|Failure to Return|1
233112|NCT00022672|752832|P1|Main Phase: 24 Months|Failure to Return|1
233113|NCT00022672|752831|P2|Main Phase: 24 Months|Refused Treatment|4
233114|NCT00022672|752832|P1|Main Phase: 24 Months|Refused Treatment|3
233115|NCT00022672|752831|P2|Main Phase: 24 Months|Other Protocol Violation|0
233116|NCT00022672|752832|P1|Main Phase: 24 Months|Other Protocol Violation|1
233117|NCT00022672|752831|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
233118|NCT00022672|752832|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
233119|NCT00022672|752831|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
233120|NCT00022672|752832|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
233121|NCT00022672|752831|P2|Main Phase: 24 Months|Death|3
233122|NCT00022672|752832|P1|Main Phase: 24 Months|Death|0
233123|NCT00022672|752831|P2|Main Phase: 24 Months|Adverse Event|0
233124|NCT00022672|752832|P1|Main Phase: 24 Months|Adverse Event|6
233125|NCT00022659|752865|P1|Overall Study|Never treated|1
233126|NCT00022659|752865|P1|Overall Study|Ineligible: wrong primary|1
233127|NCT00022633|752878|P2|Overall Study|Ineligible|0
233128|NCT00022633|752879|P1|Overall Study|Ineligible|4
233129|NCT00022633|752878|P2|Overall Study|Other - not protocol specified|2
233130|NCT00022633|752879|P1|Overall Study|Other - not protocol specified|3
233131|NCT00022633|752878|P2|Overall Study|Death|0
233132|NCT00022633|752879|P1|Overall Study|Death|4
233133|NCT00022633|752878|P2|Overall Study|Progression/relapse|2
233134|NCT00022633|752879|P1|Overall Study|Progression/relapse|9
233135|NCT00022633|752878|P2|Overall Study|Refusal unrelated to adverse event|0
233136|NCT00022633|752879|P1|Overall Study|Refusal unrelated to adverse event|1
233137|NCT00022633|752878|P2|Overall Study|Adverse Event|1
233138|NCT00022633|752879|P1|Overall Study|Adverse Event|11
233139|NCT00022516|752892|P2|Overall Study|Incomplete documentation|27
233140|NCT00022516|752893|P1|Overall Study|Incomplete documentation|0
233141|NCT00022516|752892|P2|Overall Study|Withdrawal by Subject|113
233142|NCT00022516|752893|P1|Overall Study|Withdrawal by Subject|2
233143|NCT00022516|752892|P2|Overall Study|Protocol Violation|3
233144|NCT00022516|752893|P1|Overall Study|Protocol Violation|1
233145|NCT00022516|752892|P2|Overall Study|Physician Decision|1
233146|NCT00022516|752893|P1|Overall Study|Physician Decision|0
233147|NCT00022516|752892|P2|Overall Study|Lack of Efficacy|27
233148|NCT00022516|752893|P1|Overall Study|Lack of Efficacy|0
233149|NCT00022516|752892|P2|Overall Study|Adverse Event|59
233150|NCT00022516|752893|P1|Overall Study|Adverse Event|0
233151|NCT00021255|752912|P3|Overall Study|Randomized but not treated|18
233152|NCT00021255|752913|P2|Overall Study|Randomized but not treated|2
233153|NCT00021255|752914|P1|Overall Study|Randomized but not treated|28
233154|NCT00021255|752912|P3|Overall Study|Missing|13
233155|NCT00021255|752913|P2|Overall Study|Missing|27
233156|NCT00021255|752914|P1|Overall Study|Missing|0
233157|NCT00021255|752912|P3|Overall Study|Other than specified above|19
233158|NCT00021255|752913|P2|Overall Study|Other than specified above|38
233159|NCT00021255|752914|P1|Overall Study|Other than specified above|0
233160|NCT00021255|752912|P3|Overall Study|Protocol Violation|0
233161|NCT00021255|752913|P2|Overall Study|Protocol Violation|2
233162|NCT00021255|752914|P1|Overall Study|Protocol Violation|0
233163|NCT00021255|752912|P3|Overall Study|Adverse Event|18
233164|NCT00021255|752913|P2|Overall Study|Adverse Event|30
233165|NCT00021255|752914|P1|Overall Study|Adverse Event|46
233166|NCT00021255|752912|P3|Overall Study|Herceptin toxicity|6
233167|NCT00021255|752913|P2|Overall Study|Herceptin toxicity|22
233168|NCT00021255|752914|P1|Overall Study|Herceptin toxicity|0
233169|NCT00021255|752912|P3|Overall Study|Cardiac toxicity|32
233170|NCT00021255|752913|P2|Overall Study|Cardiac toxicity|61
233171|NCT00021255|752914|P1|Overall Study|Cardiac toxicity|0
233172|NCT00021255|752912|P3|Overall Study|Lost to Follow-up|3
233173|NCT00021255|752913|P2|Overall Study|Lost to Follow-up|2
233174|NCT00021255|752914|P1|Overall Study|Lost to Follow-up|0
233175|NCT00021255|752912|P3|Overall Study|Withdrawal by Subject|26
233176|NCT00021255|752913|P2|Overall Study|Withdrawal by Subject|64
233177|NCT00021255|752914|P1|Overall Study|Withdrawal by Subject|41
233178|NCT00021255|752912|P3|Overall Study|Second primary malignancy|1
233179|NCT00021255|752913|P2|Overall Study|Second primary malignancy|4
233180|NCT00021255|752914|P1|Overall Study|Second primary malignancy|0
233181|NCT00021255|752912|P3|Overall Study|Breast cancer relapse|11
233182|NCT00021255|752913|P2|Overall Study|Breast cancer relapse|18
233183|NCT00021255|752914|P1|Overall Study|Breast cancer relapse|5
233184|NCT00021255|752912|P3|Overall Study|Death|2
233185|NCT00021255|752913|P2|Overall Study|Death|0
233186|NCT00021255|752914|P1|Overall Study|Death|1
233187|NCT00021229|752931|P3|Overall Study|Punctate hemmorrhage post RT|0
233188|NCT00021229|752932|P2|Overall Study|Punctate hemmorrhage post RT|0
233189|NCT00021229|752933|P1|Overall Study|Punctate hemmorrhage post RT|2
233190|NCT00021229|752931|P3|Overall Study|Physician Decision|1
233191|NCT00021229|752932|P2|Overall Study|Physician Decision|0
233192|NCT00021229|752933|P1|Overall Study|Physician Decision|0
233193|NCT00021229|752931|P3|Overall Study|Protocol Violation|0
233194|NCT00021229|752932|P2|Overall Study|Protocol Violation|1
233195|NCT00021229|752933|P1|Overall Study|Protocol Violation|1
233196|NCT00021229|752931|P3|Overall Study|Progressive Disease|12
233197|NCT00021229|752932|P2|Overall Study|Progressive Disease|19
233198|NCT00021229|752933|P1|Overall Study|Progressive Disease|15
233199|NCT00021229|752931|P3|Overall Study|Withdrawal by Subject|1
233200|NCT00021229|752932|P2|Overall Study|Withdrawal by Subject|7
233201|NCT00021229|752933|P1|Overall Study|Withdrawal by Subject|7
233202|NCT00021229|752931|P3|Overall Study|Death|0
233203|NCT00021229|752932|P2|Overall Study|Death|1
233204|NCT00021229|752933|P1|Overall Study|Death|0
233205|NCT00021229|752931|P3|Overall Study|Adverse Event|2
233206|NCT00021229|752932|P2|Overall Study|Adverse Event|5
233207|NCT00021229|752933|P1|Overall Study|Adverse Event|10
233208|NCT00019604|752988|P1|Overall Study|Details for other not available|4
233209|NCT00019604|752988|P1|Overall Study|Unable to evaluate|1
233210|NCT00019604|752988|P1|Overall Study|Too much disease|1
233211|NCT00019604|752988|P1|Overall Study|Pt going to immunotherapy study|1
233212|NCT00019604|752988|P1|Overall Study|Started new chemo regimen|1
233213|NCT00019604|752988|P1|Overall Study|Resectable disease|1
233214|NCT00019604|752988|P1|Overall Study|Non compliant|1
233215|NCT00019604|752988|P1|Overall Study|Non compliant on systemic CH|1
233216|NCT00019604|752988|P1|Overall Study|Move to a different study|1
233217|NCT00019604|752988|P1|Overall Study|Going to have liver transplant|1
233218|NCT00019604|752988|P1|Overall Study|Carcinoid tumor, not treatable|1
233219|NCT00019604|752988|P1|Overall Study|Refused treatment|1
233220|NCT00019604|752988|P1|Overall Study|Progressive disease|23
233221|NCT00019604|752988|P1|Overall Study|Death|1
233222|NCT00016354|753011|P8|Overall Study|Lack of Efficacy|1
233223|NCT00016354|753012|P7|Overall Study|Lack of Efficacy|0
233224|NCT00016354|753013|P6|Overall Study|Lack of Efficacy|0
233225|NCT00016354|753014|P5|Overall Study|Lack of Efficacy|0
233226|NCT00016354|753015|P4|Overall Study|Lack of Efficacy|0
233227|NCT00016354|753016|P3|Overall Study|Lack of Efficacy|0
233228|NCT00016354|753017|P2|Overall Study|Lack of Efficacy|0
233229|NCT00016354|753018|P1|Overall Study|Lack of Efficacy|0
233230|NCT00014495|753032|P4|Overall Study|Clinical deterioration|1
233231|NCT00014495|753033|P3|Overall Study|Clinical deterioration|0
233232|NCT00014495|753034|P2|Overall Study|Clinical deterioration|0
233233|NCT00014495|753035|P1|Overall Study|Clinical deterioration|0
233234|NCT00014495|753032|P4|Overall Study|Death|0
233235|NCT00014495|753033|P3|Overall Study|Death|1
233236|NCT00014495|753034|P2|Overall Study|Death|0
233237|NCT00014495|753035|P1|Overall Study|Death|0
233238|NCT00012012|753079|P2|Overall Study|Withdrawal by Subject|2
233239|NCT00012012|753080|P1|Overall Study|Withdrawal by Subject|0
233240|NCT00012012|753079|P2|Overall Study|Protocol Violation|1
233241|NCT00012012|753080|P1|Overall Study|Protocol Violation|1
233242|NCT00010257|753109|P2|Overall Study|Withdrawal by Subject|0
233243|NCT00010257|753110|P1|Overall Study|Withdrawal by Subject|1
233244|NCT00009945|753120|P2|Overall Study|no follow up data|5
233245|NCT00009945|753121|P1|Overall Study|no follow up data|7
233246|NCT00008385|753137|P2|Overall Study|Not start protocol therapy|175
233247|NCT00008385|753138|P1|Overall Study|Not start protocol therapy|44
233248|NCT00008385|753137|P2|Overall Study|Not specified|212
233249|NCT00008385|753138|P1|Overall Study|Not specified|105
233250|NCT00008385|753137|P2|Overall Study|Maximum dose reached|2
233251|NCT00008385|753138|P1|Overall Study|Maximum dose reached|0
233252|NCT00008385|753137|P2|Overall Study|Other complicating disease|30
233253|NCT00008385|753138|P1|Overall Study|Other complicating disease|17
233254|NCT00008385|753137|P2|Overall Study|Start non-protocol therapy|1
233255|NCT00008385|753138|P1|Overall Study|Start non-protocol therapy|3
233256|NCT00008385|753137|P2|Overall Study|Withdrawal by Subject|157
233257|NCT00008385|753138|P1|Overall Study|Withdrawal by Subject|67
233258|NCT00008385|753137|P2|Overall Study|Death|18
233259|NCT00008385|753138|P1|Overall Study|Death|12
233260|NCT00008385|753137|P2|Overall Study|Adverse Event|20
233261|NCT00008385|753138|P1|Overall Study|Adverse Event|8
233262|NCT00008385|753137|P2|Overall Study|Progressive disease|117
233263|NCT00008385|753138|P1|Overall Study|Progressive disease|52
233264|NCT00008385|753137|P2|Overall Study|Off treatment reasons not reported|70
233265|NCT00008385|753138|P1|Overall Study|Off treatment reasons not reported|79
233266|NCT00008138|753148|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
233267|NCT00008138|753148|P1|Post-Cytoreduction Chemotherapy|Progression|1
233268|NCT00008138|753148|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
233269|NCT00008138|753148|P1|Interval Debulking|Withdrawal by Subject|2
233270|NCT00008138|753148|P1|Neoadjuvant Chemotherapy|not protocol specified|8
233271|NCT00008138|753148|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
233272|NCT00008138|753148|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
233273|NCT00008138|753148|P1|Neoadjuvant Chemotherapy|Adverse Event|3
233274|NCT00006916|753154|P1|Overall Study|Complication of device insertion|1
233275|NCT00006916|753154|P1|Overall Study|Device not inserted|4
233276|NCT00006903|753160|P3|Overall Study|Ineligible|2
233277|NCT00006903|753161|P2|Overall Study|Ineligible|1
233278|NCT00006903|753162|P1|Overall Study|Ineligible|10
233279|NCT00006903|753160|P3|Overall Study|Patient never treated|1
233280|NCT00006903|753161|P2|Overall Study|Patient never treated|0
233281|NCT00006903|753162|P1|Overall Study|Patient never treated|0
233282|NCT00006903|753160|P3|Overall Study|Death|0
233283|NCT00006903|753161|P2|Overall Study|Death|1
233284|NCT00006903|753162|P1|Overall Study|Death|0
233285|NCT00006903|753160|P3|Overall Study|Adverse Event|1
233286|NCT00006903|753161|P2|Overall Study|Adverse Event|0
233287|NCT00006903|753162|P1|Overall Study|Adverse Event|0
233288|NCT00006903|753160|P3|Overall Study|Refused further treatment|1
233289|NCT00006903|753161|P2|Overall Study|Refused further treatment|2
233290|NCT00006903|753162|P1|Overall Study|Refused further treatment|0
233291|NCT00006903|753160|P3|Overall Study|Still receiving treatment|1
233292|NCT00006903|753161|P2|Overall Study|Still receiving treatment|0
233293|NCT00006903|753162|P1|Overall Study|Still receiving treatment|0
233294|NCT00006721|753175|P3|Overall Study|Eligible but no Treatment Received|0
233295|NCT00006721|753176|P2|Overall Study|Eligible but no Treatment Received|0
233296|NCT00006721|753177|P1|Overall Study|Eligible but no Treatment Received|1
233297|NCT00006721|753175|P3|Overall Study|Ineligible|10
233298|NCT00006721|753176|P2|Overall Study|Ineligible|12
233299|NCT00006721|753177|P1|Overall Study|Ineligible|2
233300|NCT00006721|753175|P3|Overall Study|Other - Not Protocol Specified|7
233301|NCT00006721|753176|P2|Overall Study|Other - Not Protocol Specified|7
233302|NCT00006721|753177|P1|Overall Study|Other - Not Protocol Specified|0
233303|NCT00006721|753175|P3|Overall Study|Death|2
233304|NCT00006721|753176|P2|Overall Study|Death|1
233305|NCT00006721|753177|P1|Overall Study|Death|0
233306|NCT00006721|753175|P3|Overall Study|Progression/Relapse|2
233307|NCT00006721|753176|P2|Overall Study|Progression/Relapse|1
233308|NCT00006721|753177|P1|Overall Study|Progression/Relapse|0
233309|NCT00006721|753175|P3|Overall Study|Refusal Unrelated to Adverse Event|8
233310|NCT00006721|753176|P2|Overall Study|Refusal Unrelated to Adverse Event|0
233311|NCT00006721|753177|P1|Overall Study|Refusal Unrelated to Adverse Event|1
233312|NCT00006721|753175|P3|Overall Study|Adverse Event|4
233313|NCT00006721|753176|P2|Overall Study|Adverse Event|4
233314|NCT00006721|753177|P1|Overall Study|Adverse Event|0
233315|NCT00006478|753195|P1|Overall Study|Physician Decision|6
233316|NCT00006478|753195|P1|Overall Study|Vaccine could not be produced|1
233317|NCT00006392|753203|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
233318|NCT00006392|753204|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
233319|NCT00006392|753205|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
233320|NCT00006392|753206|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
233321|NCT00006392|753203|P4|Overall Study|Ineligible|5
233322|NCT00006392|753204|P3|Overall Study|Ineligible|5
233323|NCT00006392|753205|P2|Overall Study|Ineligible|3
233324|NCT00006392|753206|P1|Overall Study|Ineligible|11
233325|NCT00006389|753236|P1|Overall Study|Adverse Event|1
233326|NCT00006237|753253|P2|Overall Study|Not protocol specified|5
233327|NCT00006237|753254|P1|Overall Study|Not protocol specified|14
233328|NCT00006237|753253|P2|Overall Study|Withdrawal by Subject|1
233329|NCT00006237|753254|P1|Overall Study|Withdrawal by Subject|0
233330|NCT00006237|753253|P2|Overall Study|Not eligible|20
233331|NCT00006237|753254|P1|Overall Study|Not eligible|9
233332|NCT00006237|753253|P2|Overall Study|Progression/relapse|2
233333|NCT00006237|753254|P1|Overall Study|Progression/relapse|54
233334|NCT00006237|753253|P2|Overall Study|Refusal unrelated to adverse effects|4
233335|NCT00006237|753254|P1|Overall Study|Refusal unrelated to adverse effects|8
233336|NCT00006237|753253|P2|Overall Study|Death|0
233337|NCT00006237|753254|P1|Overall Study|Death|1
233338|NCT00006237|753253|P2|Overall Study|Adverse Event|29
233339|NCT00006237|753254|P1|Overall Study|Adverse Event|39
233340|NCT00006011|753291|P3|Overall Study|Ineligible|9
233341|NCT00006011|753292|P2|Overall Study|Ineligible|16
233342|NCT00006011|753293|P1|Overall Study|Ineligible|18
233343|NCT00006011|753291|P3|Overall Study|Not specified|5
233344|NCT00006011|753292|P2|Overall Study|Not specified|2
233345|NCT00006011|753293|P1|Overall Study|Not specified|4
233346|NCT00006011|753291|P3|Overall Study|Death|2
233347|NCT00006011|753292|P2|Overall Study|Death|1
233348|NCT00006011|753293|P1|Overall Study|Death|0
233349|NCT00006011|753291|P3|Overall Study|Adverse Event|5
233350|NCT00006011|753292|P2|Overall Study|Adverse Event|39
233351|NCT00006011|753293|P1|Overall Study|Adverse Event|15
233352|NCT00006011|753291|P3|Overall Study|Refused further treatment|26
233353|NCT00006011|753292|P2|Overall Study|Refused further treatment|13
233354|NCT00006011|753293|P1|Overall Study|Refused further treatment|15
233355|NCT00006011|753291|P3|Overall Study|Disease progression|26
233356|NCT00006011|753292|P2|Overall Study|Disease progression|6
233357|NCT00006011|753293|P1|Overall Study|Disease progression|13
233358|NCT00005957|753301|P2|Overall Study|Crossover to the other arm|19
233359|NCT00005957|753302|P1|Overall Study|Crossover to the other arm|5
233360|NCT00005957|753301|P2|Overall Study|No treated|9
233361|NCT00005957|753302|P1|Overall Study|No treated|3
233362|NCT00005879|753312|P2|Overall Study|Withdrawal by Subject|10
233363|NCT00005879|753313|P1|Overall Study|Withdrawal by Subject|8
233364|NCT00005047|753336|P4|Overall Study|Lack of Efficacy|0
233365|NCT00005047|753337|P3|Overall Study|Lack of Efficacy|0
233366|NCT00005047|753338|P2|Overall Study|Lack of Efficacy|0
233367|NCT00005047|753339|P1|Overall Study|Lack of Efficacy|1
233368|NCT00005047|753336|P4|Overall Study|Lost to Follow-up|0
233369|NCT00005047|753337|P3|Overall Study|Lost to Follow-up|0
233370|NCT00005047|753338|P2|Overall Study|Lost to Follow-up|0
233371|NCT00005047|753339|P1|Overall Study|Lost to Follow-up|1
233372|NCT00005047|753336|P4|Overall Study|Adverse Event|0
233373|NCT00005047|753337|P3|Overall Study|Adverse Event|0
233374|NCT00005047|753338|P2|Overall Study|Adverse Event|0
233375|NCT00005047|753339|P1|Overall Study|Adverse Event|5
233376|NCT00005047|753336|P4|Overall Study|Withdrawal by Subject|0
233377|NCT00005047|753337|P3|Overall Study|Withdrawal by Subject|0
233378|NCT00005047|753338|P2|Overall Study|Withdrawal by Subject|0
233379|NCT00005047|753339|P1|Overall Study|Withdrawal by Subject|12
233380|NCT00005044|753355|P2|Overall Study|No protocol treatment|1
233381|NCT00005044|753356|P1|Overall Study|No protocol treatment|0
233382|NCT00005044|753355|P2|Overall Study|Withdrawal by Subject|5
233383|NCT00005044|753356|P1|Overall Study|Withdrawal by Subject|1
233384|NCT00005044|753355|P2|Overall Study|Protocol Violation|46
233385|NCT00005044|753356|P1|Overall Study|Protocol Violation|37
233386|NCT00004888|753376|P2|Overall Study|Toxic death|0
233387|NCT00004888|753377|P1|Overall Study|Toxic death|1
233388|NCT00004888|753376|P2|Overall Study|Death without progressive disease|1
233389|NCT00004888|753377|P1|Overall Study|Death without progressive disease|0
233390|NCT00004888|753376|P2|Overall Study|Progressive Disease|9
233391|NCT00004888|753377|P1|Overall Study|Progressive Disease|4
233392|NCT00004888|753376|P2|Overall Study|Physician Decision|1
233393|NCT00004888|753377|P1|Overall Study|Physician Decision|1
233394|NCT00004888|753376|P2|Overall Study|Withdrawal by Subject|3
233395|NCT00004888|753377|P1|Overall Study|Withdrawal by Subject|0
233396|NCT00004888|753376|P2|Overall Study|Adverse Event|10
233397|NCT00004888|753377|P1|Overall Study|Adverse Event|5
233398|NCT00004859|753395|P2|Overall Study|Not specified|21
233399|NCT00004859|753396|P1|Overall Study|Not specified|13
233400|NCT00004859|753395|P2|Overall Study|missing data|11
233401|NCT00004859|753396|P1|Overall Study|missing data|14
233402|NCT00004859|753395|P2|Overall Study|error|1
233403|NCT00004859|753396|P1|Overall Study|error|3
233404|NCT00004859|753395|P2|Overall Study|other disease|3
233405|NCT00004859|753396|P1|Overall Study|other disease|0
233406|NCT00004859|753395|P2|Overall Study|Protocol Violation|2
233407|NCT00004859|753396|P1|Overall Study|Protocol Violation|2
233408|NCT00004859|753395|P2|Overall Study|Withdrawal by Subject|33
233409|NCT00004859|753396|P1|Overall Study|Withdrawal by Subject|7
233410|NCT00004859|753395|P2|Overall Study|Death|5
233411|NCT00004859|753396|P1|Overall Study|Death|5
233412|NCT00004859|753395|P2|Overall Study|Adverse Event|93
233413|NCT00004859|753396|P1|Overall Study|Adverse Event|31
233414|NCT00004859|753395|P2|Overall Study|Lack of Efficacy|113
233415|NCT00004859|753396|P1|Overall Study|Lack of Efficacy|43
233416|NCT00004259|753410|P4|Overall Study|Withdrawal by Subject|0
233417|NCT00004259|753411|P3|Overall Study|Withdrawal by Subject|0
233418|NCT00004259|753412|P2|Overall Study|Withdrawal by Subject|2
233419|NCT00004259|753413|P1|Overall Study|Withdrawal by Subject|0
233420|NCT00004259|753410|P4|Overall Study|Protocol Violation|0
233421|NCT00004259|753411|P3|Overall Study|Protocol Violation|0
233422|NCT00004259|753412|P2|Overall Study|Protocol Violation|2
233423|NCT00004259|753413|P1|Overall Study|Protocol Violation|1
233424|NCT00004228|753434|P7|Overall Study|ineligible|5
233425|NCT00004228|753435|P6|Overall Study|ineligible|2
233426|NCT00004228|753436|P5|Overall Study|ineligible|1
233427|NCT00004228|753437|P4|Overall Study|ineligible|1
233428|NCT00004228|753438|P3|Overall Study|ineligible|4
233429|NCT00004228|753439|P2|Overall Study|ineligible|2
233430|NCT00004228|753440|P1|Overall Study|ineligible|4
233431|NCT00004228|753434|P7|Overall Study|Other|0
233432|NCT00004228|753435|P6|Overall Study|Other|0
233433|NCT00004228|753436|P5|Overall Study|Other|0
233434|NCT00004228|753437|P4|Overall Study|Other|0
233435|NCT00004228|753438|P3|Overall Study|Other|1
233436|NCT00004228|753439|P2|Overall Study|Other|0
233437|NCT00004228|753440|P1|Overall Study|Other|0
233438|NCT00004228|753434|P7|Overall Study|Withdrawal by Subject|2
233439|NCT00004228|753435|P6|Overall Study|Withdrawal by Subject|1
233440|NCT00004228|753436|P5|Overall Study|Withdrawal by Subject|2
233441|NCT00004228|753437|P4|Overall Study|Withdrawal by Subject|0
233442|NCT00004228|753438|P3|Overall Study|Withdrawal by Subject|1
233443|NCT00004228|753439|P2|Overall Study|Withdrawal by Subject|0
233444|NCT00004228|753440|P1|Overall Study|Withdrawal by Subject|3
233445|NCT00004228|753434|P7|Overall Study|Protocol Violation|0
233446|NCT00004228|753435|P6|Overall Study|Protocol Violation|2
233447|NCT00004228|753436|P5|Overall Study|Protocol Violation|1
233448|NCT00004228|753437|P4|Overall Study|Protocol Violation|1
233449|NCT00004228|753438|P3|Overall Study|Protocol Violation|2
233450|NCT00004228|753439|P2|Overall Study|Protocol Violation|5
233451|NCT00004228|753440|P1|Overall Study|Protocol Violation|0
233452|NCT00004228|753434|P7|Overall Study|Physician Decision|1
233453|NCT00004228|753435|P6|Overall Study|Physician Decision|1
233454|NCT00004228|753436|P5|Overall Study|Physician Decision|1
233455|NCT00004228|753437|P4|Overall Study|Physician Decision|2
233456|NCT00004228|753438|P3|Overall Study|Physician Decision|3
233457|NCT00004228|753439|P2|Overall Study|Physician Decision|0
233458|NCT00004228|753440|P1|Overall Study|Physician Decision|1
233459|NCT00004228|753434|P7|Overall Study|Lost to Follow-up|0
233460|NCT00004228|753435|P6|Overall Study|Lost to Follow-up|0
233461|NCT00004228|753436|P5|Overall Study|Lost to Follow-up|0
233462|NCT00004228|753437|P4|Overall Study|Lost to Follow-up|0
233463|NCT00004228|753438|P3|Overall Study|Lost to Follow-up|1
233464|NCT00004228|753439|P2|Overall Study|Lost to Follow-up|0
233465|NCT00004228|753440|P1|Overall Study|Lost to Follow-up|0
233466|NCT00004228|753434|P7|Overall Study|Lack of Efficacy|4
233467|NCT00004228|753435|P6|Overall Study|Lack of Efficacy|8
233468|NCT00004228|753436|P5|Overall Study|Lack of Efficacy|9
233469|NCT00004228|753437|P4|Overall Study|Lack of Efficacy|3
233470|NCT00004228|753438|P3|Overall Study|Lack of Efficacy|5
233471|NCT00004228|753439|P2|Overall Study|Lack of Efficacy|6
233472|NCT00004228|753440|P1|Overall Study|Lack of Efficacy|1
233473|NCT00004228|753434|P7|Overall Study|Death|0
233474|NCT00004228|753435|P6|Overall Study|Death|0
233475|NCT00004228|753436|P5|Overall Study|Death|1
233476|NCT00004228|753437|P4|Overall Study|Death|0
233477|NCT00004228|753438|P3|Overall Study|Death|2
233478|NCT00004228|753439|P2|Overall Study|Death|1
233479|NCT00004228|753440|P1|Overall Study|Death|0
233480|NCT00004228|753434|P7|Overall Study|Adverse Event|0
233481|NCT00004228|753435|P6|Overall Study|Adverse Event|0
233482|NCT00004228|753436|P5|Overall Study|Adverse Event|1
233483|NCT00004228|753437|P4|Overall Study|Adverse Event|0
233484|NCT00004228|753438|P3|Overall Study|Adverse Event|0
233485|NCT00004228|753439|P2|Overall Study|Adverse Event|1
233486|NCT00004228|753440|P1|Overall Study|Adverse Event|0
233487|NCT00003901|753506|P1|Overall Study|Medical problems|6
233488|NCT00003901|753506|P1|Overall Study|Chest X-Ray not done prior registration|1
233489|NCT00003901|753506|P1|Overall Study|CT Scan not within protocol requirement|2
233490|NCT00003901|753506|P1|Overall Study|Ineligible|6
233491|NCT00003901|753506|P1|Overall Study|Withdrawal by Subject|1
233492|NCT00003901|753506|P1|Overall Study|Adverse Event|1
233493|NCT00003896|753517|P1|Overall Study|ineligible|5
233494|NCT00003896|753517|P1|Overall Study|not protocol specified|3
233495|NCT00003896|753517|P1|Overall Study|Death|3
233496|NCT00003896|753517|P1|Overall Study|Lack of Efficacy|1
233497|NCT00003896|753517|P1|Overall Study|Withdrawal by Subject|1
233498|NCT00003896|753517|P1|Overall Study|Adverse Event|16
233499|NCT00003875|753523|P1|Overall Study|Screen Failed|1
233500|NCT00003869|753532|P2|Overall Study|Alternative treatmnt, medical problems|4
233501|NCT00003869|753533|P1|Overall Study|Alternative treatmnt, medical problems|5
233502|NCT00003869|753532|P2|Overall Study|Death|2
233503|NCT00003869|753533|P1|Overall Study|Death|1
233504|NCT00003869|753532|P2|Overall Study|Withdrawal by Subject|3
233505|NCT00003869|753533|P1|Overall Study|Withdrawal by Subject|21
233506|NCT00003869|753532|P2|Overall Study|Adverse Event|3
233507|NCT00003869|753533|P1|Overall Study|Adverse Event|14
233508|NCT00003782|753559|P3|Overall Study|No follow up data|26
233509|NCT00003782|753560|P2|Overall Study|No follow up data|31
233510|NCT00003782|753561|P1|Overall Study|No follow up data|30
233511|NCT00003702|753571|P2|Overall Study|Inadequate documentation of disease|3
233512|NCT00003702|753572|P1|Overall Study|Inadequate documentation of disease|1
233513|NCT00003702|753571|P2|Overall Study|WHO score > 6|1
233514|NCT00003702|753572|P1|Overall Study|WHO score > 6|2
233515|NCT00003702|753571|P2|Overall Study|Did not meet criteria for persistence|5
233516|NCT00003702|753572|P1|Overall Study|Did not meet criteria for persistence|8
233517|NCT00003702|753571|P2|Overall Study|Ineligible cell types|2
233518|NCT00003702|753572|P1|Overall Study|Ineligible cell types|2
233519|NCT00003659|753581|P1|Overall Study|Withdrawal by Subject|3
233520|NCT00003641|753589|P2|Overall Study|Never started interferon|12
233521|NCT00003641|753590|P1|Overall Study|Never started interferon|567
233522|NCT00003641|753589|P2|Overall Study|Should not receive interferon therapy|0
233523|NCT00003641|753590|P1|Overall Study|Should not receive interferon therapy|2
233524|NCT00003641|753589|P2|Overall Study|Unknown/missing|22
233525|NCT00003641|753590|P1|Overall Study|Unknown/missing|0
233526|NCT00003641|753589|P2|Overall Study|Disease progression|2
233527|NCT00003641|753590|P1|Overall Study|Disease progression|0
233528|NCT00003641|753589|P2|Overall Study|Adverse Event|38
233529|NCT00003641|753590|P1|Overall Study|Adverse Event|0
233530|NCT00003641|753589|P2|Overall Study|Withdrawal by Subject|100
233531|NCT00003641|753590|P1|Overall Study|Withdrawal by Subject|0
233532|NCT00003631|753601|P3|Overall Study|Evaluable for toxicity only|2
233533|NCT00003631|753602|P2|Overall Study|Evaluable for toxicity only|0
233534|NCT00003631|753603|P1|Overall Study|Evaluable for toxicity only|0
233535|NCT00003631|753601|P3|Overall Study|Death|1
233536|NCT00003631|753602|P2|Overall Study|Death|0
233537|NCT00003631|753603|P1|Overall Study|Death|0
233538|NCT00003631|753601|P3|Overall Study|Adverse Event|5
233539|NCT00003631|753602|P2|Overall Study|Adverse Event|1
233540|NCT00003631|753603|P1|Overall Study|Adverse Event|1
233541|NCT00003631|753601|P3|Overall Study|Protocol Violation|0
233542|NCT00003631|753602|P2|Overall Study|Protocol Violation|0
233543|NCT00003631|753603|P1|Overall Study|Protocol Violation|1
233544|NCT00003631|753601|P3|Overall Study|Patient not treated|1
233545|NCT00003631|753602|P2|Overall Study|Patient not treated|0
233546|NCT00003631|753603|P1|Overall Study|Patient not treated|1
233547|NCT00003590|753611|P1|Overall Study|Physician Decision|1
233548|NCT00003590|753611|P1|Overall Study|Death|1
233549|NCT00003590|753611|P1|Overall Study|Lack of Efficacy|11
233550|NCT00003590|753611|P1|Overall Study|Withdrawal by Subject|1
233551|NCT00003590|753611|P1|Overall Study|Adverse Event|7
233552|NCT00003590|753611|P1|Overall Study|Ineligible Patient|1
233553|NCT00003537|753616|P1|Overall Study|Not evalauable|1
233554|NCT00003535|753621|P1|Overall Study|Not evaluable|5
233555|NCT00003483|753626|P1|Overall Study|Not evaluable|1
233556|NCT00003479|753631|P1|Overall Study|Not evaluable|3
233557|NCT00003477|753636|P1|Overall Study|Not evalauable|4
233558|NCT00003476|753641|P1|Overall Study|Not evaluable|1
233559|NCT00003475|753646|P1|Overall Study|Not evaluable|13
233560|NCT00003474|753651|P1|Overall Study|Not Evaluable|14
233561|NCT00003473|753656|P1|Overall Study|Three patients were not evaluable.|3
233562|NCT00003472|753661|P1|Overall Study|Not evaluable|3
233563|NCT00003471|753666|P1|Overall Study|Not evaluable|4
233564|NCT00003470|753671|P1|Overall Study|Not evaluable|6
233565|NCT00003458|753696|P1|Overall Study|Not evaluable|4
233566|NCT00003457|753701|P1|Overall Study|Not evaluable|9
233567|NCT00003456|753706|P1|Overall Study|Not evaluable|8
233568|NCT00003389|753718|P2|Overall Study|Ineligible|27
233569|NCT00003389|753719|P1|Overall Study|Ineligible|33
233570|NCT00003389|753718|P2|Overall Study|Off-treatment reason missing|21
233571|NCT00003389|753719|P1|Overall Study|Off-treatment reason missing|31
233572|NCT00003389|753718|P2|Overall Study|Complicating disease|0
233573|NCT00003389|753719|P1|Overall Study|Complicating disease|1
233574|NCT00003389|753718|P2|Overall Study|Alternative therapy|1
233575|NCT00003389|753719|P1|Overall Study|Alternative therapy|2
233576|NCT00003389|753718|P2|Overall Study|Withdrawal by Subject|5
233577|NCT00003389|753719|P1|Overall Study|Withdrawal by Subject|12
233578|NCT00003389|753718|P2|Overall Study|Death|3
233579|NCT00003389|753719|P1|Overall Study|Death|0
233580|NCT00003389|753718|P2|Overall Study|Adverse Event|2
233581|NCT00003389|753719|P1|Overall Study|Adverse Event|13
233582|NCT00003389|753718|P2|Overall Study|Disease progression|1
233583|NCT00003389|753719|P1|Overall Study|Disease progression|6
233584|NCT00003377|753734|P5|Period II|Ureteral stent complications|1
233585|NCT00003377|753735|P4|Period II|Ureteral stent complications|0
233586|NCT00003377|753736|P3|Period II|Ureteral stent complications|0
233587|NCT00003377|753737|P2|Period II|Ureteral stent complications|0
233588|NCT00003377|753738|P1|Period II|Ureteral stent complications|0
233589|NCT00003377|753734|P5|Period I|Dose Limiting Toxicity(DLT)|0
233590|NCT00003377|753735|P4|Period I|Dose Limiting Toxicity(DLT)|1
233591|NCT00003377|753736|P3|Period I|Dose Limiting Toxicity(DLT)|1
233592|NCT00003377|753737|P2|Period I|Dose Limiting Toxicity(DLT)|0
233593|NCT00003377|753738|P1|Period I|Dose Limiting Toxicity(DLT)|0
233594|NCT00003199|753752|P1|Overall Study|Screen fail|15
233595|NCT00003199|753752|P1|Overall Study|Lack of insurance clearance|2
233596|NCT00003199|753752|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
233597|NCT00003138|753760|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
233598|NCT00003138|753761|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
233599|NCT00003138|753760|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
233600|NCT00003138|753761|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
233601|NCT00003138|753760|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
233602|NCT00003138|753761|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
233603|NCT00003138|753760|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
233604|NCT00003138|753761|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
233605|NCT00003138|753760|P2|Step 1|Never started treatment|0
233606|NCT00003138|753761|P1|Step 1|Never started treatment|1
233607|NCT00003138|753760|P2|Step 1|Reasons off treatment not documented|57
233608|NCT00003138|753761|P1|Step 1|Reasons off treatment not documented|60
233609|NCT00002931|753778|P1|Overall Study|rapidly progressing disease during|2
233610|NCT00002874|753786|P2|Overall Study|Protocol Violation|34
233611|NCT00002874|753787|P1|Overall Study|Protocol Violation|44
233612|NCT00002874|753786|P2|Overall Study|Withdrawal by Subject|1
233613|NCT00002874|753787|P1|Overall Study|Withdrawal by Subject|1
233614|NCT00002850|753812|P3|Overall Study|Withdrawal by Subject|0
233615|NCT00002850|753813|P2|Overall Study|Withdrawal by Subject|1
233616|NCT00002850|753814|P1|Overall Study|Withdrawal by Subject|0
233617|NCT00002850|753812|P3|Overall Study|Protocol Violation|1
233618|NCT00002850|753813|P2|Overall Study|Protocol Violation|0
233619|NCT00002850|753814|P1|Overall Study|Protocol Violation|1
233620|NCT00002850|753812|P3|Overall Study|Death|3
233621|NCT00002850|753813|P2|Overall Study|Death|1
233622|NCT00002850|753814|P1|Overall Study|Death|4
233623|NCT00002842|753822|P1|Overall Study|ineligible for surgical resection|27
233624|NCT00002766|753828|P2|Overall Study|Protocol Violation|0
233625|NCT00002766|753829|P1|Overall Study|Protocol Violation|1
233626|NCT00002766|753828|P2|Overall Study|Adverse Event|1
233627|NCT00002766|753829|P1|Overall Study|Adverse Event|1
233628|NCT00002766|753828|P2|Overall Study|Patient Not Treated|2
233629|NCT00002766|753829|P1|Overall Study|Patient Not Treated|1
233630|NCT00002766|753828|P2|Overall Study|Withdrawal by Subject|1
233631|NCT00002766|753829|P1|Overall Study|Withdrawal by Subject|0
233632|NCT00002651|753837|P3|Consolidation and Randomization|not eligible|112
233633|NCT00002651|753838|P2|Consolidation and Randomization|not eligible|102
233634|NCT00002651|753839|P1|Consolidation and Randomization|not eligible|0
233635|NCT00002651|753837|P3|Consolidation and Randomization|not specified|313
233636|NCT00002651|753838|P2|Consolidation and Randomization|not specified|314
233637|NCT00002651|753839|P1|Consolidation and Randomization|not specified|0
233638|NCT00002651|753837|P3|Consolidation and Randomization|Death|48
233639|NCT00002651|753838|P2|Consolidation and Randomization|Death|38
233640|NCT00002651|753839|P1|Consolidation and Randomization|Death|0
233641|NCT00002651|753837|P3|Consolidation and Randomization|Progression/relapse|298
233642|NCT00002651|753838|P2|Consolidation and Randomization|Progression/relapse|295
233643|NCT00002651|753839|P1|Consolidation and Randomization|Progression/relapse|0
233644|NCT00002651|753837|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
233645|NCT00002651|753838|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
233646|NCT00002651|753839|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
233647|NCT00002651|753837|P3|Consolidation and Randomization|Adverse Event|14
233648|NCT00002651|753838|P2|Consolidation and Randomization|Adverse Event|36
233649|NCT00002651|753839|P1|Consolidation and Randomization|Adverse Event|0
233650|NCT00002651|753837|P3|Induction|not eligible|0
233651|NCT00002651|753838|P2|Induction|not eligible|0
233652|NCT00002651|753839|P1|Induction|not eligible|90
233653|NCT00002651|753837|P3|Induction|not specified|0
233654|NCT00002651|753838|P2|Induction|not specified|0
233655|NCT00002651|753839|P1|Induction|not specified|823
233656|NCT00002651|753837|P3|Induction|Death|0
233657|NCT00002651|753838|P2|Induction|Death|0
233658|NCT00002651|753839|P1|Induction|Death|62
233659|NCT00002651|753837|P3|Induction|Progression/relapse|0
233660|NCT00002651|753838|P2|Induction|Progression/relapse|0
233661|NCT00002651|753839|P1|Induction|Progression/relapse|274
233662|NCT00002651|753837|P3|Induction|Refusal unrelated to adverse event|0
233663|NCT00002651|753838|P2|Induction|Refusal unrelated to adverse event|0
233664|NCT00002651|753839|P1|Induction|Refusal unrelated to adverse event|50
233665|NCT00002651|753837|P3|Induction|Adverse Event|0
233666|NCT00002651|753838|P2|Induction|Adverse Event|0
233667|NCT00002651|753839|P1|Induction|Adverse Event|44
233668|NCT00002558|753857|P2|Overall Study|Withdrawal by Subject|1
233669|NCT00002558|753858|P1|Overall Study|Withdrawal by Subject|0
233670|NCT00051636|753883|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
233671|NCT00051636|753884|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
233672|NCT00051636|753883|P2|Period 2- Extended Observation Period|Death|5
233673|NCT00051636|753884|P1|Period 2- Extended Observation Period|Death|4
233674|NCT00051636|753883|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
233675|NCT00051636|753884|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
233676|NCT00051636|753883|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
233677|NCT00051636|753884|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
233678|NCT00051636|753883|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
233679|NCT00051636|753884|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
233680|NCT00051636|753883|P2|Period 1 - Core|Lost to Follow-up|2
233681|NCT00051636|753884|P1|Period 1 - Core|Lost to Follow-up|0
233682|NCT00051636|753883|P2|Period 1 - Core|Withdrawal by Subject|2
233683|NCT00051636|753884|P1|Period 1 - Core|Withdrawal by Subject|1
233684|NCT00051636|753883|P2|Period 1 - Core|Protocol Violation|0
233685|NCT00051636|753884|P1|Period 1 - Core|Protocol Violation|1
233686|NCT00051636|753883|P2|Period 1 - Core|Adverse Event|2
233687|NCT00051636|753884|P1|Period 1 - Core|Adverse Event|2
233688|NCT00051558|753912|P2|Overall Study|Physician Decision|0
233689|NCT00051558|753913|P1|Overall Study|Physician Decision|5
233690|NCT00051558|753912|P2|Overall Study|Significant Lab Value|0
233691|NCT00051558|753913|P1|Overall Study|Significant Lab Value|2
233692|NCT00051558|753912|P2|Overall Study|Other|1
233693|NCT00051558|753913|P1|Overall Study|Other|2
233694|NCT00051558|753912|P2|Overall Study|Sponsor Decision|1
233695|NCT00051558|753913|P1|Overall Study|Sponsor Decision|6
233696|NCT00051558|753912|P2|Overall Study|Protocol Entry Criteria Unmet|2
233697|NCT00051558|753913|P1|Overall Study|Protocol Entry Criteria Unmet|1
233698|NCT00051558|753912|P2|Overall Study|Protocol Violation|4
233699|NCT00051558|753913|P1|Overall Study|Protocol Violation|3
233700|NCT00051558|753912|P2|Overall Study|Lost to Follow-up|13
233701|NCT00051558|753913|P1|Overall Study|Lost to Follow-up|4
233702|NCT00051558|753912|P2|Overall Study|Death|15
233703|NCT00051558|753913|P1|Overall Study|Death|9
233704|NCT00051558|753912|P2|Overall Study|Withdrawal by Subject|42
233705|NCT00051558|753913|P1|Overall Study|Withdrawal by Subject|29
233706|NCT00051558|753912|P2|Overall Study|Adverse Event|18
233707|NCT00051558|753913|P1|Overall Study|Adverse Event|30
233708|NCT00051363|753949|P2|Overall Study|Excluded Pre-Randomization|5
233709|NCT00051363|753950|P1|Overall Study|Excluded Pre-Randomization|2
233710|NCT00051363|753949|P2|Overall Study|Death|2
233711|NCT00051363|753950|P1|Overall Study|Death|2
233712|NCT00051363|753949|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
233713|NCT00051363|753950|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
233714|NCT00051363|753949|P2|Overall Study|Dropped Post-Rand for Any Reason|126
233715|NCT00051363|753950|P1|Overall Study|Dropped Post-Rand for Any Reason|102
233716|NCT00051025|753990|P2|Overall Study|Death|1
233717|NCT00051025|753991|P1|Overall Study|Death|0
233718|NCT00051025|753990|P2|Overall Study|Withdrawal by Subject|1
233719|NCT00051025|753991|P1|Overall Study|Withdrawal by Subject|0
233720|NCT00051025|753990|P2|Overall Study|Adverse Event|1
233721|NCT00051025|753991|P1|Overall Study|Adverse Event|1
233722|NCT00051025|753990|P2|Overall Study|Progressive Disease|1
233723|NCT00051025|753991|P1|Overall Study|Progressive Disease|1
233724|NCT00050960|754005|P2|Overall Study|Death|15
233725|NCT00050960|754006|P1|Overall Study|Death|13
233726|NCT00050960|754005|P2|Overall Study|Non-compliance|1
233727|NCT00050960|754006|P1|Overall Study|Non-compliance|3
233728|NCT00050960|754005|P2|Overall Study|Administrative|46
233729|NCT00050960|754006|P1|Overall Study|Administrative|31
233730|NCT00050960|754005|P2|Overall Study|Withdrawal by Subject|18
233731|NCT00050960|754006|P1|Overall Study|Withdrawal by Subject|23
233732|NCT00050960|754005|P2|Overall Study|Lost to Follow-up|1
233733|NCT00050960|754006|P1|Overall Study|Lost to Follow-up|0
233734|NCT00050960|754005|P2|Overall Study|Adverse Event|61
233735|NCT00050960|754006|P1|Overall Study|Adverse Event|62
233736|NCT00050960|754005|P2|Overall Study|Complete Response|2
233737|NCT00050960|754006|P1|Overall Study|Complete Response|0
233738|NCT00050960|754005|P2|Overall Study|Partial Response|19
233739|NCT00050960|754006|P1|Overall Study|Partial Response|14
233740|NCT00050960|754005|P2|Overall Study|Stable Disease|48
233741|NCT00050960|754006|P1|Overall Study|Stable Disease|19
233742|NCT00050960|754005|P2|Overall Study|Progressive Disease|93
233743|NCT00050960|754006|P1|Overall Study|Progressive Disease|137
233744|NCT00050778|754015|P3|Overall Study|Familial and personal reasons|0
233745|NCT00050778|754016|P2|Overall Study|Familial and personal reasons|0
233746|NCT00050778|754017|P1|Overall Study|Familial and personal reasons|1
233747|NCT00050778|754015|P3|Overall Study|Randomized but not treated|2
233748|NCT00050778|754016|P2|Overall Study|Randomized but not treated|5
233749|NCT00050778|754017|P1|Overall Study|Randomized but not treated|4
233750|NCT00050778|754015|P3|Overall Study|Withdrawal by Subject|4
233751|NCT00050778|754016|P2|Overall Study|Withdrawal by Subject|8
233752|NCT00050778|754017|P1|Overall Study|Withdrawal by Subject|6
233753|NCT00050778|754015|P3|Overall Study|Protocol Violation|1
233754|NCT00050778|754016|P2|Overall Study|Protocol Violation|0
233755|NCT00050778|754017|P1|Overall Study|Protocol Violation|2
233756|NCT00050778|754015|P3|Overall Study|Physician Decision|2
233757|NCT00050778|754016|P2|Overall Study|Physician Decision|0
233758|NCT00050778|754017|P1|Overall Study|Physician Decision|3
233759|NCT00050778|754015|P3|Overall Study|Lost to Follow-up|4
233760|NCT00050778|754016|P2|Overall Study|Lost to Follow-up|2
233761|NCT00050778|754017|P1|Overall Study|Lost to Follow-up|0
233762|NCT00050778|754015|P3|Overall Study|Lack of Efficacy|2
233763|NCT00050778|754016|P2|Overall Study|Lack of Efficacy|2
233764|NCT00050778|754017|P1|Overall Study|Lack of Efficacy|16
233765|NCT00050778|754015|P3|Overall Study|Death|1
233766|NCT00050778|754016|P2|Overall Study|Death|1
233767|NCT00050778|754017|P1|Overall Study|Death|0
233768|NCT00050778|754015|P3|Overall Study|Adverse Event|2
233769|NCT00050778|754016|P2|Overall Study|Adverse Event|3
233770|NCT00050778|754017|P1|Overall Study|Adverse Event|13
233771|NCT00050622|754043|P1|Overall Study|Adverse Event|1
233772|NCT00050167|754081|P2|Overall Study|not eligible not invasive|1
233773|NCT00050167|754082|P1|Overall Study|not eligible not invasive|1
233774|NCT00050011|754115|P2|Overall Study|Unknown - Reason is missing|2
233775|NCT00050011|754116|P1|Overall Study|Unknown - Reason is missing|0
233776|NCT00050011|754115|P2|Overall Study|Death|4
233777|NCT00050011|754116|P1|Overall Study|Death|7
233778|NCT00050011|754115|P2|Overall Study|Administrative problems|6
233779|NCT00050011|754116|P1|Overall Study|Administrative problems|10
233780|NCT00050011|754115|P2|Overall Study|Lost to Follow-up|9
233781|NCT00050011|754116|P1|Overall Study|Lost to Follow-up|7
233782|NCT00050011|754115|P2|Overall Study|Withdrawal by Subject|26
233783|NCT00050011|754116|P1|Overall Study|Withdrawal by Subject|34
233784|NCT00050011|754115|P2|Overall Study|Protocol Violation|10
233785|NCT00050011|754116|P1|Overall Study|Protocol Violation|4
233786|NCT00050011|754115|P2|Overall Study|Participant condition no longer required|0
233787|NCT00050011|754116|P1|Overall Study|Participant condition no longer required|1
233788|NCT00050011|754115|P2|Overall Study|Lack of Efficacy|21
233789|NCT00050011|754116|P1|Overall Study|Lack of Efficacy|16
233790|NCT00050011|754115|P2|Overall Study|Abnormal test procedure results|1
233791|NCT00050011|754116|P1|Overall Study|Abnormal test procedure results|0
233792|NCT00050011|754115|P2|Overall Study|Abnormal laboratory value(s)|1
233793|NCT00050011|754116|P1|Overall Study|Abnormal laboratory value(s)|1
233794|NCT00050011|754115|P2|Overall Study|Adverse Event|46
233795|NCT00050011|754116|P1|Overall Study|Adverse Event|41
233796|NCT00049842|754138|P2|Follow-up Phase|Not specified|4
233797|NCT00049842|754139|P1|Follow-up Phase|Not specified|1
233798|NCT00049842|754138|P2|Follow-up Phase|Adverse Event|1
233799|NCT00049842|754139|P1|Follow-up Phase|Adverse Event|6
233800|NCT00049842|754138|P2|Treatment Phase|Did not meet protocol eligibility|1
233801|NCT00049842|754139|P1|Treatment Phase|Did not meet protocol eligibility|0
233802|NCT00049842|754138|P2|Treatment Phase|Administrative|3
233803|NCT00049842|754139|P1|Treatment Phase|Administrative|0
233804|NCT00049842|754138|P2|Treatment Phase|Lost to Follow-up|8
233805|NCT00049842|754139|P1|Treatment Phase|Lost to Follow-up|4
233806|NCT00049842|754138|P2|Treatment Phase|Non-compliance with protocol|8
233807|NCT00049842|754139|P1|Treatment Phase|Non-compliance with protocol|7
233808|NCT00049842|754138|P2|Treatment Phase|Withdrawal by Subject|46
233809|NCT00049842|754139|P1|Treatment Phase|Withdrawal by Subject|35
233810|NCT00049842|754138|P2|Treatment Phase|Adverse Event|12
233811|NCT00049842|754139|P1|Treatment Phase|Adverse Event|47
233812|NCT00048932|754157|P3|Open Label Period (OL)|Participant Surgery|1
233813|NCT00048932|754158|P2|Open Label Period (OL)|Participant Surgery|0
233814|NCT00048932|754159|P1|Open Label Period (OL)|Participant Surgery|0
233815|NCT00048932|754157|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
233816|NCT00048932|754158|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
233817|NCT00048932|754159|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
233818|NCT00048932|754157|P3|Open Label Period (OL)|Site Staff Issues|2
233819|NCT00048932|754158|P2|Open Label Period (OL)|Site Staff Issues|0
233820|NCT00048932|754159|P1|Open Label Period (OL)|Site Staff Issues|0
233821|NCT00048932|754157|P3|Open Label Period (OL)|Investigator Decision|4
233822|NCT00048932|754158|P2|Open Label Period (OL)|Investigator Decision|0
233823|NCT00048932|754159|P1|Open Label Period (OL)|Investigator Decision|0
233824|NCT00048932|754157|P3|Open Label Period (OL)|Medication Lost Efficacy|1
233825|NCT00048932|754158|P2|Open Label Period (OL)|Medication Lost Efficacy|0
233826|NCT00048932|754159|P1|Open Label Period (OL)|Medication Lost Efficacy|0
233827|NCT00048932|754157|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
233828|NCT00048932|754158|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
233829|NCT00048932|754159|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
233830|NCT00048932|754157|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
233831|NCT00048932|754158|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
233832|NCT00048932|754159|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
233833|NCT00048932|754157|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
233834|NCT00048932|754158|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
233835|NCT00048932|754159|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
233836|NCT00048932|754157|P3|Open Label Period (OL)|Patient Decision|4
233837|NCT00048932|754158|P2|Open Label Period (OL)|Patient Decision|0
233838|NCT00048932|754159|P1|Open Label Period (OL)|Patient Decision|0
233839|NCT00048932|754157|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
233840|NCT00048932|754158|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
233841|NCT00048932|754159|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
233842|NCT00048932|754157|P3|Open Label Period (OL)|Trial Terminated|1
233843|NCT00048932|754158|P2|Open Label Period (OL)|Trial Terminated|0
233844|NCT00048932|754159|P1|Open Label Period (OL)|Trial Terminated|0
233845|NCT00048932|754157|P3|Open Label Period (OL)|Site Closure|3
233846|NCT00048932|754158|P2|Open Label Period (OL)|Site Closure|0
233847|NCT00048932|754159|P1|Open Label Period (OL)|Site Closure|0
233848|NCT00048932|754157|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
233849|NCT00048932|754158|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
233850|NCT00048932|754159|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
233851|NCT00048932|754157|P3|Open Label Period (OL)|Participant Relocated|6
233852|NCT00048932|754158|P2|Open Label Period (OL)|Participant Relocated|0
233853|NCT00048932|754159|P1|Open Label Period (OL)|Participant Relocated|0
233854|NCT00048932|754157|P3|Open Label Period (OL)|Participant Transportation Issues|1
233855|NCT00048932|754158|P2|Open Label Period (OL)|Participant Transportation Issues|0
233856|NCT00048932|754159|P1|Open Label Period (OL)|Participant Transportation Issues|0
233857|NCT00048932|754157|P3|Open Label Period (OL)|Investigator Retiring|2
233858|NCT00048932|754158|P2|Open Label Period (OL)|Investigator Retiring|0
233859|NCT00048932|754159|P1|Open Label Period (OL)|Investigator Retiring|0
233860|NCT00048932|754157|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
233861|NCT00048932|754158|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
233862|NCT00048932|754159|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
233863|NCT00048932|754157|P3|Open Label Period (OL)|Pregnancy|6
233864|NCT00048932|754158|P2|Open Label Period (OL)|Pregnancy|0
233865|NCT00048932|754159|P1|Open Label Period (OL)|Pregnancy|0
233866|NCT00048932|754157|P3|Open Label Period (OL)|Poor/Non-Compliance|13
233867|NCT00048932|754158|P2|Open Label Period (OL)|Poor/Non-Compliance|0
233868|NCT00048932|754159|P1|Open Label Period (OL)|Poor/Non-Compliance|0
233869|NCT00048932|754157|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
233870|NCT00048932|754158|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
233871|NCT00048932|754159|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
233872|NCT00048932|754157|P3|Open Label Period (OL)|Withdrawal by Subject|117
233873|NCT00048932|754158|P2|Open Label Period (OL)|Withdrawal by Subject|0
233874|NCT00048932|754159|P1|Open Label Period (OL)|Withdrawal by Subject|0
233875|NCT00048932|754157|P3|Open Label Period (OL)|Lost to Follow-up|27
233876|NCT00048932|754158|P2|Open Label Period (OL)|Lost to Follow-up|0
233877|NCT00048932|754159|P1|Open Label Period (OL)|Lost to Follow-up|0
233878|NCT00048932|754157|P3|Open Label Period (OL)|Lack of Efficacy|81
233879|NCT00048932|754158|P2|Open Label Period (OL)|Lack of Efficacy|0
233880|NCT00048932|754159|P1|Open Label Period (OL)|Lack of Efficacy|0
233881|NCT00048932|754157|P3|Open Label Period (OL)|Adverse Event|103
233882|NCT00048932|754158|P2|Open Label Period (OL)|Adverse Event|0
233883|NCT00048932|754159|P1|Open Label Period (OL)|Adverse Event|0
233884|NCT00048932|754157|P3|Open Label Period (OL)|Death|25
233885|NCT00048932|754158|P2|Open Label Period (OL)|Death|0
233886|NCT00048932|754159|P1|Open Label Period (OL)|Death|0
233887|NCT00048932|754157|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
233888|NCT00048932|754158|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
233889|NCT00048932|754159|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
233890|NCT00048932|754157|P3|Double Blind Period (DB)|Withdrawal by Subject|0
233891|NCT00048932|754158|P2|Double Blind Period (DB)|Withdrawal by Subject|10
233892|NCT00048932|754159|P1|Double Blind Period (DB)|Withdrawal by Subject|24
233893|NCT00048932|754157|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
233894|NCT00048932|754158|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
233895|NCT00048932|754159|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
233896|NCT00048932|754157|P3|Double Blind Period (DB)|Pregnancy|0
233897|NCT00048932|754158|P2|Double Blind Period (DB)|Pregnancy|0
233898|NCT00048932|754159|P1|Double Blind Period (DB)|Pregnancy|1
233899|NCT00048932|754157|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
233900|NCT00048932|754158|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
233901|NCT00048932|754159|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
233902|NCT00048932|754157|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
233903|NCT00048932|754158|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
233904|NCT00048932|754159|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
233905|NCT00048932|754157|P3|Double Blind Period (DB)|Relocation|0
233906|NCT00048932|754158|P2|Double Blind Period (DB)|Relocation|0
233907|NCT00048932|754159|P1|Double Blind Period (DB)|Relocation|1
233908|NCT00048932|754157|P3|Double Blind Period (DB)|Lost to Follow-up|0
233909|NCT00048932|754158|P2|Double Blind Period (DB)|Lost to Follow-up|4
233910|NCT00048932|754159|P1|Double Blind Period (DB)|Lost to Follow-up|3
233911|NCT00048932|754157|P3|Double Blind Period (DB)|Lack of Efficacy|0
233912|NCT00048932|754158|P2|Double Blind Period (DB)|Lack of Efficacy|44
233913|NCT00048932|754159|P1|Double Blind Period (DB)|Lack of Efficacy|26
233914|NCT00048932|754157|P3|Double Blind Period (DB)|Death|0
233915|NCT00048932|754158|P2|Double Blind Period (DB)|Death|3
233916|NCT00048932|754159|P1|Double Blind Period (DB)|Death|5
233917|NCT00048932|754157|P3|Double Blind Period (DB)|Adverse Event|0
233918|NCT00048932|754158|P2|Double Blind Period (DB)|Adverse Event|19
233919|NCT00048932|754159|P1|Double Blind Period (DB)|Adverse Event|51
233920|NCT00048932|754157|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
233921|NCT00048932|754158|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
233922|NCT00048932|754159|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
233923|NCT00048581|754201|P3|Open-Label Period|Study Ended By Sponsor|1
233924|NCT00048581|754202|P2|Open-Label Period|Study Ended By Sponsor|0
233925|NCT00048581|754203|P1|Open-Label Period|Study Ended By Sponsor|0
233926|NCT00048581|754201|P3|Open-Label Period|Primary Investigator Retired|2
233927|NCT00048581|754202|P2|Open-Label Period|Primary Investigator Retired|0
233928|NCT00048581|754203|P1|Open-Label Period|Primary Investigator Retired|0
233929|NCT00048581|754201|P3|Open-Label Period|Problem With Transportation To Site|1
233930|NCT00048581|754202|P2|Open-Label Period|Problem With Transportation To Site|0
233931|NCT00048581|754203|P1|Open-Label Period|Problem With Transportation To Site|0
233932|NCT00048581|754201|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
233933|NCT00048581|754202|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
233934|NCT00048581|754203|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
233935|NCT00048581|754201|P3|Open-Label Period|Study Site Closure|2
233936|NCT00048581|754202|P2|Open-Label Period|Study Site Closure|0
233937|NCT00048581|754203|P1|Open-Label Period|Study Site Closure|0
233938|NCT00048581|754201|P3|Open-Label Period|Pregnancy|7
233939|NCT00048581|754202|P2|Open-Label Period|Pregnancy|0
233940|NCT00048581|754203|P1|Open-Label Period|Pregnancy|0
233941|NCT00048581|754201|P3|Open-Label Period|Poor/Non-compliance|5
233942|NCT00048581|754202|P2|Open-Label Period|Poor/Non-compliance|0
233943|NCT00048581|754203|P1|Open-Label Period|Poor/Non-compliance|0
233944|NCT00048581|754201|P3|Open-Label Period|No Longer Meets Study Criteria|2
233945|NCT00048581|754202|P2|Open-Label Period|No Longer Meets Study Criteria|0
233946|NCT00048581|754203|P1|Open-Label Period|No Longer Meets Study Criteria|0
233947|NCT00048581|754201|P3|Open-Label Period|Withdrawal by Subject|20
233948|NCT00048581|754202|P2|Open-Label Period|Withdrawal by Subject|0
233949|NCT00048581|754203|P1|Open-Label Period|Withdrawal by Subject|0
233950|NCT00048581|754201|P3|Open-Label Period|Lost to Follow-up|14
233951|NCT00048581|754202|P2|Open-Label Period|Lost to Follow-up|0
233952|NCT00048581|754203|P1|Open-Label Period|Lost to Follow-up|0
233953|NCT00048581|754201|P3|Open-Label Period|Lack of Efficacy|69
233954|NCT00048581|754202|P2|Open-Label Period|Lack of Efficacy|0
233955|NCT00048581|754203|P1|Open-Label Period|Lack of Efficacy|0
233956|NCT00048581|754201|P3|Open-Label Period|Adverse Event|37
233957|NCT00048581|754202|P2|Open-Label Period|Adverse Event|0
233958|NCT00048581|754203|P1|Open-Label Period|Adverse Event|0
233959|NCT00048581|754201|P3|Open-Label Period|Death|4
233960|NCT00048581|754202|P2|Open-Label Period|Death|0
233961|NCT00048581|754203|P1|Open-Label Period|Death|0
233962|NCT00048581|754201|P3|Double-Blind Period|Investigator Decision|0
233963|NCT00048581|754202|P2|Double-Blind Period|Investigator Decision|0
233964|NCT00048581|754203|P1|Double-Blind Period|Investigator Decision|1
233965|NCT00048581|754201|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
233966|NCT00048581|754202|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
233967|NCT00048581|754203|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
233968|NCT00048581|754201|P3|Double-Blind Period|Withdrawal by Subject|0
233969|NCT00048581|754202|P2|Double-Blind Period|Withdrawal by Subject|2
233970|NCT00048581|754203|P1|Double-Blind Period|Withdrawal by Subject|5
233971|NCT00048581|754201|P3|Double-Blind Period|Lost to Follow-up|0
233972|NCT00048581|754202|P2|Double-Blind Period|Lost to Follow-up|0
233973|NCT00048581|754203|P1|Double-Blind Period|Lost to Follow-up|5
233974|NCT00048581|754201|P3|Double-Blind Period|Lack of Efficacy|0
233975|NCT00048581|754202|P2|Double-Blind Period|Lack of Efficacy|27
233976|NCT00048581|754203|P1|Double-Blind Period|Lack of Efficacy|14
233977|NCT00048581|754201|P3|Double-Blind Period|Adverse Event|0
233978|NCT00048581|754202|P2|Double-Blind Period|Adverse Event|5
233979|NCT00048581|754203|P1|Double-Blind Period|Adverse Event|9
233980|NCT00048568|754370|P3|Open-Label Period|Lost to Follow-up|7
233981|NCT00048568|754371|P2|Open-Label Period|Lost to Follow-up|0
233982|NCT00048568|754372|P1|Open-Label Period|Lost to Follow-up|0
233983|NCT00048568|754370|P3|Open-Label Period|Unknown Reasons|25
233984|NCT00048568|754371|P2|Open-Label Period|Unknown Reasons|0
233985|NCT00048568|754372|P1|Open-Label Period|Unknown Reasons|0
233986|NCT00048568|754370|P3|Open-Label Period|Administrative Decision By Sponsor|1
233987|NCT00048568|754371|P2|Open-Label Period|Administrative Decision By Sponsor|0
233988|NCT00048568|754372|P1|Open-Label Period|Administrative Decision By Sponsor|0
233989|NCT00048568|754370|P3|Open-Label Period|No Longer Met Study Criteria|2
233990|NCT00048568|754371|P2|Open-Label Period|No Longer Met Study Criteria|0
233991|NCT00048568|754372|P1|Open-Label Period|No Longer Met Study Criteria|0
233992|NCT00048568|754370|P3|Open-Label Period|Pregnancy|5
233993|NCT00048568|754371|P2|Open-Label Period|Pregnancy|0
233994|NCT00048568|754372|P1|Open-Label Period|Pregnancy|0
233995|NCT00048568|754370|P3|Open-Label Period|Withdrawal by Subject|26
233996|NCT00048568|754371|P2|Open-Label Period|Withdrawal by Subject|0
233997|NCT00048568|754372|P1|Open-Label Period|Withdrawal by Subject|0
233998|NCT00048568|754370|P3|Open-Label Period|Lack of Efficacy|32
233999|NCT00048568|754371|P2|Open-Label Period|Lack of Efficacy|0
234000|NCT00048568|754372|P1|Open-Label Period|Lack of Efficacy|0
234001|NCT00048568|754370|P3|Open-Label Period|Adverse Event|49
234002|NCT00048568|754371|P2|Open-Label Period|Adverse Event|0
234003|NCT00048568|754372|P1|Open-Label Period|Adverse Event|0
234004|NCT00048568|754370|P3|Open-Label Period|Death|13
234005|NCT00048568|754371|P2|Open-Label Period|Death|0
234006|NCT00048568|754372|P1|Open-Label Period|Death|0
234007|NCT00048568|754370|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
234008|NCT00048568|754371|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
234009|NCT00048568|754372|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
234010|NCT00048568|754370|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
234011|NCT00048568|754371|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
234012|NCT00048568|754372|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
234013|NCT00048568|754370|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
234014|NCT00048568|754371|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
234015|NCT00048568|754372|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
234016|NCT00048568|754370|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
234017|NCT00048568|754371|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
234018|NCT00048568|754372|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
234019|NCT00048568|754370|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
234020|NCT00048568|754371|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
234021|NCT00048568|754372|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
234022|NCT00048568|754370|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
234023|NCT00048568|754371|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
234024|NCT00048568|754372|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
234025|NCT00048568|754370|P3|Double-Blind Period Days 170 to 365|Death|0
234026|NCT00048568|754371|P2|Double-Blind Period Days 170 to 365|Death|1
234027|NCT00048568|754372|P1|Double-Blind Period Days 170 to 365|Death|1
234028|NCT00048568|754370|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
234029|NCT00048568|754371|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
234030|NCT00048568|754372|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
234031|NCT00048568|754370|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
234032|NCT00048568|754371|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
234033|NCT00048568|754372|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
234034|NCT00048568|754370|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
234035|NCT00048568|754371|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
234036|NCT00048568|754372|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
234037|NCT00048568|754370|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
234038|NCT00048568|754371|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
234039|NCT00048568|754372|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
234040|NCT00048568|754370|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
234041|NCT00048568|754371|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
234042|NCT00048568|754372|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
234043|NCT00048724|754677|P2|Overall Study|Administrative|1
234044|NCT00048724|754678|P1|Overall Study|Administrative|1
234045|NCT00048724|754677|P2|Overall Study|Did Not Meet Protocol Eligibility|2
234046|NCT00048724|754678|P1|Overall Study|Did Not Meet Protocol Eligibility|2
234047|NCT00048724|754677|P2|Overall Study|Noncompliance With Protocol|12
234048|NCT00048724|754678|P1|Overall Study|Noncompliance With Protocol|4
234049|NCT00048724|754677|P2|Overall Study|Protocol-defined Clinical Event|32
234050|NCT00048724|754678|P1|Overall Study|Protocol-defined Clinical Event|17
234051|NCT00048724|754677|P2|Overall Study|Lost to Follow-up|5
234052|NCT00048724|754678|P1|Overall Study|Lost to Follow-up|5
234053|NCT00048724|754677|P2|Overall Study|Withdrawal by Subject|54
234054|NCT00048724|754678|P1|Overall Study|Withdrawal by Subject|34
234055|NCT00048724|754677|P2|Overall Study|Adverse Event|12
234056|NCT00048724|754678|P1|Overall Study|Adverse Event|53
234057|NCT00048542|754690|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
234058|NCT00048542|754691|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
234059|NCT00048542|754692|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
234060|NCT00048542|754693|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
234061|NCT00048542|754694|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
234062|NCT00048542|754695|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
234063|NCT00048542|754696|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
234064|NCT00048542|754697|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
234065|NCT00048542|754690|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
234066|NCT00048542|754691|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
234067|NCT00048542|754692|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
234068|NCT00048542|754693|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
234069|NCT00048542|754694|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
234070|NCT00048542|754695|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
234071|NCT00048542|754696|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
234072|NCT00048542|754697|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
234073|NCT00048542|754690|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
234074|NCT00048542|754691|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
234075|NCT00048542|754692|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
234076|NCT00048542|754693|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
234077|NCT00048542|754694|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
234078|NCT00048542|754695|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
234079|NCT00048542|754696|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
234080|NCT00048542|754697|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
234081|NCT00048542|754690|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
234082|NCT00048542|754691|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
234083|NCT00048542|754692|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
234084|NCT00048542|754693|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
234085|NCT00048542|754694|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
234086|NCT00048542|754695|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
234087|NCT00048542|754696|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
234088|NCT00048542|754697|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
234089|NCT00048542|754690|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
234090|NCT00048542|754691|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
234091|NCT00048542|754692|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
234092|NCT00048542|754693|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
234093|NCT00048542|754694|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
234094|NCT00048542|754695|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
234095|NCT00048542|754696|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
234096|NCT00048542|754697|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
234097|NCT00048542|754690|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
234098|NCT00048542|754691|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
234099|NCT00048542|754692|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
234100|NCT00048542|754693|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
234101|NCT00048542|754694|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
234102|NCT00048542|754695|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
234103|NCT00048542|754696|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
234104|NCT00048542|754697|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
234105|NCT00048542|754690|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
234106|NCT00048542|754691|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
234107|NCT00048542|754692|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
234108|NCT00048542|754693|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
234109|NCT00048542|754694|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
234110|NCT00048542|754695|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
234111|NCT00048542|754696|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
234112|NCT00048542|754697|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
234113|NCT00048542|754690|P8|Open-Label Extension BSA Phase|Adverse Event|0
234114|NCT00048542|754691|P7|Open-Label Extension BSA Phase|Adverse Event|0
234115|NCT00048542|754692|P6|Open-Label Extension BSA Phase|Adverse Event|1
234116|NCT00048542|754693|P5|Open-Label Extension BSA Phase|Adverse Event|1
234117|NCT00048542|754694|P4|Open-Label Extension BSA Phase|Adverse Event|0
234118|NCT00048542|754695|P3|Open-Label Extension BSA Phase|Adverse Event|0
234119|NCT00048542|754696|P2|Open-Label Extension BSA Phase|Adverse Event|0
234120|NCT00048542|754697|P1|Open-Label Extension BSA Phase|Adverse Event|0
234121|NCT00048542|754690|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
234122|NCT00048542|754691|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
234123|NCT00048542|754692|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
234124|NCT00048542|754693|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
234125|NCT00048542|754694|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
234126|NCT00048542|754695|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
234127|NCT00048542|754696|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
234128|NCT00048542|754697|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
234129|NCT00048542|754690|P8|Open-Label Extension BSA Phase|Protocol Violation|0
234130|NCT00048542|754691|P7|Open-Label Extension BSA Phase|Protocol Violation|0
234131|NCT00048542|754692|P6|Open-Label Extension BSA Phase|Protocol Violation|1
234132|NCT00048542|754693|P5|Open-Label Extension BSA Phase|Protocol Violation|0
234133|NCT00048542|754694|P4|Open-Label Extension BSA Phase|Protocol Violation|0
234134|NCT00048542|754695|P3|Open-Label Extension BSA Phase|Protocol Violation|0
234135|NCT00048542|754696|P2|Open-Label Extension BSA Phase|Protocol Violation|0
234136|NCT00048542|754697|P1|Open-Label Extension BSA Phase|Protocol Violation|0
234137|NCT00048542|754690|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
234138|NCT00048542|754691|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
234139|NCT00048542|754692|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
234140|NCT00048542|754693|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
234141|NCT00048542|754694|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
234142|NCT00048542|754695|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
234143|NCT00048542|754696|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
234144|NCT00048542|754697|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
234145|NCT00048542|754690|P8|Double-Blind Phase|Randomized in error|0
234146|NCT00048542|754691|P7|Double-Blind Phase|Randomized in error|0
234147|NCT00048542|754692|P6|Double-Blind Phase|Randomized in error|0
234148|NCT00048542|754693|P5|Double-Blind Phase|Randomized in error|0
234149|NCT00048542|754694|P4|Double-Blind Phase|Randomized in error|0
234150|NCT00048542|754695|P3|Double-Blind Phase|Randomized in error|0
234151|NCT00048542|754696|P2|Double-Blind Phase|Randomized in error|0
234152|NCT00048542|754697|P1|Double-Blind Phase|Randomized in error|1
234153|NCT00048542|754690|P8|Double-Blind Phase|Sponsor request or decision|0
234154|NCT00048542|754691|P7|Double-Blind Phase|Sponsor request or decision|0
234155|NCT00048542|754692|P6|Double-Blind Phase|Sponsor request or decision|0
234156|NCT00048542|754693|P5|Double-Blind Phase|Sponsor request or decision|0
234157|NCT00048542|754694|P4|Double-Blind Phase|Sponsor request or decision|0
234158|NCT00048542|754695|P3|Double-Blind Phase|Sponsor request or decision|0
234159|NCT00048542|754696|P2|Double-Blind Phase|Sponsor request or decision|0
234160|NCT00048542|754697|P1|Double-Blind Phase|Sponsor request or decision|2
234161|NCT00048542|754690|P8|Double-Blind Phase|Protocol Violation|0
234162|NCT00048542|754691|P7|Double-Blind Phase|Protocol Violation|0
234163|NCT00048542|754692|P6|Double-Blind Phase|Protocol Violation|0
234164|NCT00048542|754693|P5|Double-Blind Phase|Protocol Violation|0
234165|NCT00048542|754694|P4|Double-Blind Phase|Protocol Violation|0
234166|NCT00048542|754695|P3|Double-Blind Phase|Protocol Violation|1
234167|NCT00048542|754696|P2|Double-Blind Phase|Protocol Violation|0
234168|NCT00048542|754697|P1|Double-Blind Phase|Protocol Violation|0
234169|NCT00048542|754690|P8|Double-Blind Phase|Withdrawal by Subject|0
234170|NCT00048542|754691|P7|Double-Blind Phase|Withdrawal by Subject|0
234171|NCT00048542|754692|P6|Double-Blind Phase|Withdrawal by Subject|0
234172|NCT00048542|754693|P5|Double-Blind Phase|Withdrawal by Subject|0
234173|NCT00048542|754694|P4|Double-Blind Phase|Withdrawal by Subject|0
234174|NCT00048542|754695|P3|Double-Blind Phase|Withdrawal by Subject|0
234175|NCT00048542|754696|P2|Double-Blind Phase|Withdrawal by Subject|1
234176|NCT00048542|754697|P1|Double-Blind Phase|Withdrawal by Subject|0
234177|NCT00048347|754763|P1|Overall Study|Screen failure|2
234178|NCT00048165|754769|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
234179|NCT00048165|754770|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
234180|NCT00048165|754769|P2|Completed 12 Months Study|Death|1
234181|NCT00048165|754770|P1|Completed 12 Months Study|Death|2
234182|NCT00048165|754769|P2|Completed 12 Months Study|Administration/Other|2
234183|NCT00048165|754770|P1|Completed 12 Months Study|Administration/Other|0
234184|NCT00048165|754769|P2|Completed 6 Months Study|Did not receive study drug|6
234185|NCT00048165|754770|P1|Completed 6 Months Study|Did not receive study drug|6
234186|NCT00048165|754769|P2|Completed 6 Months Study|Violation criteria|2
234187|NCT00048165|754770|P1|Completed 6 Months Study|Violation criteria|0
234188|NCT00048165|754769|P2|Completed 6 Months Study|Refused treatment|5
234189|NCT00048165|754770|P1|Completed 6 Months Study|Refused treatment|5
234190|NCT00048165|754769|P2|Completed 6 Months Study|Other violation|6
234191|NCT00048165|754770|P1|Completed 6 Months Study|Other violation|4
234192|NCT00048165|754769|P2|Completed 6 Months Study|Insufficient therapy|4
234193|NCT00048165|754770|P1|Completed 6 Months Study|Insufficient therapy|1
234194|NCT00048165|754769|P2|Completed 6 Months Study|Death|6
234195|NCT00048165|754770|P1|Completed 6 Months Study|Death|12
234196|NCT00048165|754769|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
234197|NCT00048165|754770|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
234198|NCT00048165|754769|P2|Completed 6 Months Study|Abnormality of laboratory test|0
234199|NCT00048165|754770|P1|Completed 6 Months Study|Abnormality of laboratory test|1
234200|NCT00048165|754769|P2|Completed 6 Months Study|Administration/Other|8
234201|NCT00048165|754770|P1|Completed 6 Months Study|Administration/Other|8
234202|NCT00048074|754805|P3|Overall Study|Social reasons|0
234203|NCT00048074|754806|P2|Overall Study|Social reasons|0
234204|NCT00048074|754807|P1|Overall Study|Social reasons|1
234205|NCT00048074|754805|P3|Overall Study|Out of station|1
234206|NCT00048074|754806|P2|Overall Study|Out of station|1
234207|NCT00048074|754807|P1|Overall Study|Out of station|0
234208|NCT00048074|754805|P3|Overall Study|Poor compliance|0
234209|NCT00048074|754806|P2|Overall Study|Poor compliance|1
234210|NCT00048074|754807|P1|Overall Study|Poor compliance|0
234211|NCT00048074|754805|P3|Overall Study|Husband ill|0
234212|NCT00048074|754806|P2|Overall Study|Husband ill|1
234213|NCT00048074|754807|P1|Overall Study|Husband ill|0
234214|NCT00048074|754805|P3|Overall Study|Study participation was terminated|0
234215|NCT00048074|754806|P2|Overall Study|Study participation was terminated|1
234216|NCT00048074|754807|P1|Overall Study|Study participation was terminated|0
234217|NCT00048074|754805|P3|Overall Study|Protocol Violation|0
234218|NCT00048074|754806|P2|Overall Study|Protocol Violation|3
234219|NCT00048074|754807|P1|Overall Study|Protocol Violation|1
234220|NCT00048074|754805|P3|Overall Study|Withdrawal by Subject|35
234221|NCT00048074|754806|P2|Overall Study|Withdrawal by Subject|30
234222|NCT00048074|754807|P1|Overall Study|Withdrawal by Subject|28
234223|NCT00048074|754805|P3|Overall Study|Lost to Follow-up|6
234224|NCT00048074|754806|P2|Overall Study|Lost to Follow-up|6
234225|NCT00048074|754807|P1|Overall Study|Lost to Follow-up|2
234226|NCT00048074|754805|P3|Overall Study|Death|2
234227|NCT00048074|754806|P2|Overall Study|Death|3
234228|NCT00048074|754807|P1|Overall Study|Death|3
234229|NCT00048074|754805|P3|Overall Study|Adverse Event|53
234230|NCT00048074|754806|P2|Overall Study|Adverse Event|41
234231|NCT00048074|754807|P1|Overall Study|Adverse Event|46
234232|NCT00048061|754864|P4|Overall Study|Early improvement|0
234233|NCT00048061|754865|P3|Overall Study|Early improvement|3
234234|NCT00048061|754866|P2|Overall Study|Early improvement|5
234235|NCT00048061|754867|P1|Overall Study|Early improvement|6
234236|NCT00048061|754864|P4|Overall Study|Did not follow-up|5
234237|NCT00048061|754865|P3|Overall Study|Did not follow-up|4
234238|NCT00048061|754866|P2|Overall Study|Did not follow-up|5
234239|NCT00048061|754867|P1|Overall Study|Did not follow-up|5
234240|NCT00048061|754864|P4|Overall Study|Withdrawal by Subject|32
234241|NCT00048061|754865|P3|Overall Study|Withdrawal by Subject|29
234242|NCT00048061|754866|P2|Overall Study|Withdrawal by Subject|29
234243|NCT00048061|754867|P1|Overall Study|Withdrawal by Subject|20
234244|NCT00048061|754864|P4|Overall Study|Lost to Follow-up|5
234245|NCT00048061|754865|P3|Overall Study|Lost to Follow-up|4
234246|NCT00048061|754866|P2|Overall Study|Lost to Follow-up|2
234247|NCT00048061|754867|P1|Overall Study|Lost to Follow-up|3
234248|NCT00048061|754864|P4|Overall Study|Adverse Event|37
234249|NCT00048061|754865|P3|Overall Study|Adverse Event|44
234250|NCT00048061|754866|P2|Overall Study|Adverse Event|32
234251|NCT00048061|754867|P1|Overall Study|Adverse Event|41
234252|NCT00048048|754946|P12|Extension Year 2|Early withdrawals|2
234253|NCT00048048|754947|P11|Extension Year 2|Early withdrawals|4
234254|NCT00048048|754948|P10|Extension Year 2|Early withdrawals|0
234255|NCT00048048|754949|P9|Extension Year 2|Early withdrawals|0
234256|NCT00048048|754950|P8|Extension Year 2|Early withdrawals|0
234257|NCT00048048|754951|P7|Extension Year 2|Early withdrawals|0
234258|NCT00048048|754952|P6|Extension Year 2|Early withdrawals|0
234259|NCT00048048|754953|P5|Extension Year 2|Early withdrawals|0
234260|NCT00048048|754954|P4|Extension Year 2|Early withdrawals|0
234261|NCT00048048|754955|P3|Extension Year 2|Early withdrawals|0
234262|NCT00048048|754956|P2|Extension Year 2|Early withdrawals|0
234263|NCT00048048|754957|P1|Extension Year 2|Early withdrawals|0
234264|NCT00048048|754946|P12|Extension Year 1|Early withdrawals|4
234265|NCT00048048|754947|P11|Extension Year 1|Early withdrawals|2
234266|NCT00048048|754948|P10|Extension Year 1|Early withdrawals|2
234267|NCT00048048|754949|P9|Extension Year 1|Early withdrawals|0
234268|NCT00048048|754950|P8|Extension Year 1|Early withdrawals|0
234269|NCT00048048|754951|P7|Extension Year 1|Early withdrawals|0
234270|NCT00048048|754952|P6|Extension Year 1|Early withdrawals|0
234271|NCT00048048|754953|P5|Extension Year 1|Early withdrawals|0
234272|NCT00048048|754954|P4|Extension Year 1|Early withdrawals|0
234273|NCT00048048|754955|P3|Extension Year 1|Early withdrawals|0
234274|NCT00048048|754956|P2|Extension Year 1|Early withdrawals|0
234275|NCT00048048|754957|P1|Extension Year 1|Early withdrawals|0
234276|NCT00048048|754946|P12|Core Treatment|Adverse Event|0
234277|NCT00048048|754947|P11|Core Treatment|Adverse Event|0
234278|NCT00048048|754948|P10|Core Treatment|Adverse Event|0
234279|NCT00048048|754949|P9|Core Treatment|Adverse Event|0
234280|NCT00048048|754950|P8|Core Treatment|Adverse Event|1
234281|NCT00048048|754951|P7|Core Treatment|Adverse Event|0
234282|NCT00048048|754952|P6|Core Treatment|Adverse Event|0
234283|NCT00048048|754953|P5|Core Treatment|Adverse Event|0
234284|NCT00048048|754954|P4|Core Treatment|Adverse Event|0
234285|NCT00048048|754955|P3|Core Treatment|Adverse Event|0
234286|NCT00048048|754956|P2|Core Treatment|Adverse Event|0
234287|NCT00048048|754957|P1|Core Treatment|Adverse Event|0
234288|NCT00048048|754946|P12|Core Treatment|Withdrawal by Subject|0
234289|NCT00048048|754947|P11|Core Treatment|Withdrawal by Subject|0
234290|NCT00048048|754948|P10|Core Treatment|Withdrawal by Subject|0
234291|NCT00048048|754949|P9|Core Treatment|Withdrawal by Subject|0
234292|NCT00048048|754950|P8|Core Treatment|Withdrawal by Subject|0
234293|NCT00048048|754951|P7|Core Treatment|Withdrawal by Subject|0
234294|NCT00048048|754952|P6|Core Treatment|Withdrawal by Subject|0
234295|NCT00048048|754953|P5|Core Treatment|Withdrawal by Subject|0
234296|NCT00048048|754954|P4|Core Treatment|Withdrawal by Subject|0
234297|NCT00048048|754955|P3|Core Treatment|Withdrawal by Subject|1
234298|NCT00048048|754956|P2|Core Treatment|Withdrawal by Subject|0
234299|NCT00048048|754957|P1|Core Treatment|Withdrawal by Subject|0
234300|NCT00048035|755013|P8|Extension Year 2|Early Withdrawals|3
234301|NCT00048035|755014|P7|Extension Year 2|Early Withdrawals|3
234302|NCT00048035|755015|P6|Extension Year 2|Early Withdrawals|0
234303|NCT00048035|755016|P5|Extension Year 2|Early Withdrawals|0
234304|NCT00048035|755017|P4|Extension Year 2|Early Withdrawals|0
234305|NCT00048035|755018|P3|Extension Year 2|Early Withdrawals|0
234306|NCT00048035|755019|P2|Extension Year 2|Early Withdrawals|0
234307|NCT00048035|755020|P1|Extension Year 2|Early Withdrawals|0
234308|NCT00048035|755013|P8|Extension Year 1|Early Withdrawals|11
234309|NCT00048035|755014|P7|Extension Year 1|Early Withdrawals|11
234310|NCT00048035|755015|P6|Extension Year 1|Early Withdrawals|0
234311|NCT00048035|755016|P5|Extension Year 1|Early Withdrawals|0
234312|NCT00048035|755017|P4|Extension Year 1|Early Withdrawals|0
234313|NCT00048035|755018|P3|Extension Year 1|Early Withdrawals|0
234314|NCT00048035|755019|P2|Extension Year 1|Early Withdrawals|0
234315|NCT00048035|755020|P1|Extension Year 1|Early Withdrawals|0
234316|NCT00048035|755013|P8|Core Period|Early Withdrawals|0
234317|NCT00048035|755014|P7|Core Period|Early Withdrawals|0
234318|NCT00048035|755015|P6|Core Period|Early Withdrawals|1
234319|NCT00048035|755016|P5|Core Period|Early Withdrawals|1
234320|NCT00048035|755017|P4|Core Period|Early Withdrawals|1
234321|NCT00048035|755018|P3|Core Period|Early Withdrawals|1
234322|NCT00048035|755019|P2|Core Period|Early Withdrawals|2
234323|NCT00048035|755020|P1|Core Period|Early Withdrawals|4
234324|NCT00047879|755058|P2|Overall Study|Progressive disease|3
234325|NCT00047879|755059|P1|Overall Study|Progressive disease|4
234326|NCT00047463|755095|P2|Overall Study|Withdrawal by Subject|3
234327|NCT00047463|755096|P1|Overall Study|Withdrawal by Subject|0
234328|NCT00045942|755213|P9|PKC412A2104E2|Death|0
234329|NCT00045942|755214|P8|PKC412A2104E2|Death|0
234330|NCT00045942|755215|P7|PKC412A2104E2|Death|2
234331|NCT00045942|755216|P6|PKC412A2104E2|Death|1
234332|NCT00045942|755217|P5|PKC412A2104E2|Death|0
234333|NCT00045942|755218|P4|PKC412A2104E2|Death|0
234334|NCT00045942|755219|P3|PKC412A2104E2|Death|0
234335|NCT00045942|755220|P2|PKC412A2104E2|Death|0
234336|NCT00045942|755221|P1|PKC412A2104E2|Death|0
234337|NCT00045942|755213|P9|PKC412A2104E2|Adverse Event|0
234338|NCT00045942|755214|P8|PKC412A2104E2|Adverse Event|1
234339|NCT00045942|755215|P7|PKC412A2104E2|Adverse Event|3
234340|NCT00045942|755216|P6|PKC412A2104E2|Adverse Event|4
234341|NCT00045942|755217|P5|PKC412A2104E2|Adverse Event|0
234342|NCT00045942|755218|P4|PKC412A2104E2|Adverse Event|0
234343|NCT00045942|755219|P3|PKC412A2104E2|Adverse Event|0
234344|NCT00045942|755220|P2|PKC412A2104E2|Adverse Event|0
234345|NCT00045942|755221|P1|PKC412A2104E2|Adverse Event|0
234346|NCT00045942|755213|P9|PKC412A2104E2|Lack of Efficacy|6
234347|NCT00045942|755214|P8|PKC412A2104E2|Lack of Efficacy|2
234348|NCT00045942|755215|P7|PKC412A2104E2|Lack of Efficacy|2
234349|NCT00045942|755216|P6|PKC412A2104E2|Lack of Efficacy|3
234350|NCT00045942|755217|P5|PKC412A2104E2|Lack of Efficacy|0
234351|NCT00045942|755218|P4|PKC412A2104E2|Lack of Efficacy|0
234352|NCT00045942|755219|P3|PKC412A2104E2|Lack of Efficacy|0
234353|NCT00045942|755220|P2|PKC412A2104E2|Lack of Efficacy|0
234354|NCT00045942|755221|P1|PKC412A2104E2|Lack of Efficacy|0
234355|NCT00045942|755213|P9|PKC412A2104E2|Withdrawal by Subject|0
234356|NCT00045942|755214|P8|PKC412A2104E2|Withdrawal by Subject|1
234357|NCT00045942|755215|P7|PKC412A2104E2|Withdrawal by Subject|0
234358|NCT00045942|755216|P6|PKC412A2104E2|Withdrawal by Subject|1
234359|NCT00045942|755217|P5|PKC412A2104E2|Withdrawal by Subject|0
234360|NCT00045942|755218|P4|PKC412A2104E2|Withdrawal by Subject|0
234361|NCT00045942|755219|P3|PKC412A2104E2|Withdrawal by Subject|0
234362|NCT00045942|755220|P2|PKC412A2104E2|Withdrawal by Subject|0
234363|NCT00045942|755221|P1|PKC412A2104E2|Withdrawal by Subject|0
234364|NCT00045942|755213|P9|PKC412A2104E2|Lost to Follow-up|0
234365|NCT00045942|755214|P8|PKC412A2104E2|Lost to Follow-up|3
234366|NCT00045942|755215|P7|PKC412A2104E2|Lost to Follow-up|0
234367|NCT00045942|755216|P6|PKC412A2104E2|Lost to Follow-up|0
234368|NCT00045942|755217|P5|PKC412A2104E2|Lost to Follow-up|0
234369|NCT00045942|755218|P4|PKC412A2104E2|Lost to Follow-up|0
234370|NCT00045942|755219|P3|PKC412A2104E2|Lost to Follow-up|0
234371|NCT00045942|755220|P2|PKC412A2104E2|Lost to Follow-up|0
234372|NCT00045942|755221|P1|PKC412A2104E2|Lost to Follow-up|0
234373|NCT00045942|755213|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
234374|NCT00045942|755214|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
234375|NCT00045942|755215|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
234376|NCT00045942|755216|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
234377|NCT00045942|755217|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
234378|NCT00045942|755218|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
234379|NCT00045942|755219|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
234380|NCT00045942|755220|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
234381|NCT00045942|755221|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
234382|NCT00045942|755213|P9|PKC412A2104E1|Death|0
234383|NCT00045942|755214|P8|PKC412A2104E1|Death|0
234384|NCT00045942|755215|P7|PKC412A2104E1|Death|0
234385|NCT00045942|755216|P6|PKC412A2104E1|Death|0
234386|NCT00045942|755217|P5|PKC412A2104E1|Death|1
234387|NCT00045942|755218|P4|PKC412A2104E1|Death|1
234388|NCT00045942|755219|P3|PKC412A2104E1|Death|1
234389|NCT00045942|755220|P2|PKC412A2104E1|Death|4
234390|NCT00045942|755221|P1|PKC412A2104E1|Death|0
234391|NCT00045942|755213|P9|PKC412A2104E1|Adverse Event|0
234392|NCT00045942|755214|P8|PKC412A2104E1|Adverse Event|0
234393|NCT00045942|755215|P7|PKC412A2104E1|Adverse Event|0
234394|NCT00045942|755216|P6|PKC412A2104E1|Adverse Event|0
234395|NCT00045942|755217|P5|PKC412A2104E1|Adverse Event|6
234396|NCT00045942|755218|P4|PKC412A2104E1|Adverse Event|3
234397|NCT00045942|755219|P3|PKC412A2104E1|Adverse Event|1
234398|NCT00045942|755220|P2|PKC412A2104E1|Adverse Event|1
234399|NCT00045942|755221|P1|PKC412A2104E1|Adverse Event|0
234400|NCT00045942|755213|P9|PKC412A2104E1|Abnormal laboratory value|0
234401|NCT00045942|755214|P8|PKC412A2104E1|Abnormal laboratory value|0
234402|NCT00045942|755215|P7|PKC412A2104E1|Abnormal laboratory value|0
234403|NCT00045942|755216|P6|PKC412A2104E1|Abnormal laboratory value|0
234404|NCT00045942|755217|P5|PKC412A2104E1|Abnormal laboratory value|0
234405|NCT00045942|755218|P4|PKC412A2104E1|Abnormal laboratory value|0
234406|NCT00045942|755219|P3|PKC412A2104E1|Abnormal laboratory value|0
234407|NCT00045942|755220|P2|PKC412A2104E1|Abnormal laboratory value|1
234408|NCT00045942|755221|P1|PKC412A2104E1|Abnormal laboratory value|0
234409|NCT00045942|755213|P9|PKC412A2104E1|Lack of Efficacy|0
234410|NCT00045942|755214|P8|PKC412A2104E1|Lack of Efficacy|0
234411|NCT00045942|755215|P7|PKC412A2104E1|Lack of Efficacy|0
234412|NCT00045942|755216|P6|PKC412A2104E1|Lack of Efficacy|0
234413|NCT00045942|755217|P5|PKC412A2104E1|Lack of Efficacy|17
234414|NCT00045942|755218|P4|PKC412A2104E1|Lack of Efficacy|23
234415|NCT00045942|755219|P3|PKC412A2104E1|Lack of Efficacy|11
234416|NCT00045942|755220|P2|PKC412A2104E1|Lack of Efficacy|11
234417|NCT00045942|755221|P1|PKC412A2104E1|Lack of Efficacy|0
234418|NCT00045942|755213|P9|PKC412A2104E1|Condition no longer requires study drug|0
234419|NCT00045942|755214|P8|PKC412A2104E1|Condition no longer requires study drug|0
234420|NCT00045942|755215|P7|PKC412A2104E1|Condition no longer requires study drug|0
234421|NCT00045942|755216|P6|PKC412A2104E1|Condition no longer requires study drug|0
234422|NCT00045942|755217|P5|PKC412A2104E1|Condition no longer requires study drug|1
234423|NCT00045942|755218|P4|PKC412A2104E1|Condition no longer requires study drug|0
234424|NCT00045942|755219|P3|PKC412A2104E1|Condition no longer requires study drug|1
234425|NCT00045942|755220|P2|PKC412A2104E1|Condition no longer requires study drug|1
234426|NCT00045942|755221|P1|PKC412A2104E1|Condition no longer requires study drug|0
234427|NCT00045942|755213|P9|PKC412A2104E1|Withdrawal by Subject|0
234428|NCT00045942|755214|P8|PKC412A2104E1|Withdrawal by Subject|0
234429|NCT00045942|755215|P7|PKC412A2104E1|Withdrawal by Subject|0
234430|NCT00045942|755216|P6|PKC412A2104E1|Withdrawal by Subject|0
234431|NCT00045942|755217|P5|PKC412A2104E1|Withdrawal by Subject|2
234432|NCT00045942|755218|P4|PKC412A2104E1|Withdrawal by Subject|5
234433|NCT00045942|755219|P3|PKC412A2104E1|Withdrawal by Subject|2
234434|NCT00045942|755220|P2|PKC412A2104E1|Withdrawal by Subject|0
234435|NCT00045942|755221|P1|PKC412A2104E1|Withdrawal by Subject|0
234436|NCT00045942|755213|P9|PKC412A2104 (Core)|Death|0
234437|NCT00045942|755214|P8|PKC412A2104 (Core)|Death|0
234438|NCT00045942|755215|P7|PKC412A2104 (Core)|Death|0
234439|NCT00045942|755216|P6|PKC412A2104 (Core)|Death|0
234440|NCT00045942|755217|P5|PKC412A2104 (Core)|Death|0
234441|NCT00045942|755218|P4|PKC412A2104 (Core)|Death|0
234442|NCT00045942|755219|P3|PKC412A2104 (Core)|Death|0
234443|NCT00045942|755220|P2|PKC412A2104 (Core)|Death|0
234444|NCT00045942|755221|P1|PKC412A2104 (Core)|Death|1
234445|NCT00045942|755213|P9|PKC412A2104 (Core)|Lack of Efficacy|0
234446|NCT00045942|755214|P8|PKC412A2104 (Core)|Lack of Efficacy|0
234447|NCT00045942|755215|P7|PKC412A2104 (Core)|Lack of Efficacy|0
234448|NCT00045942|755216|P6|PKC412A2104 (Core)|Lack of Efficacy|0
234449|NCT00045942|755217|P5|PKC412A2104 (Core)|Lack of Efficacy|0
234450|NCT00045942|755218|P4|PKC412A2104 (Core)|Lack of Efficacy|0
234451|NCT00045942|755219|P3|PKC412A2104 (Core)|Lack of Efficacy|0
234452|NCT00045942|755220|P2|PKC412A2104 (Core)|Lack of Efficacy|0
234453|NCT00045942|755221|P1|PKC412A2104 (Core)|Lack of Efficacy|13
234454|NCT00045942|755213|P9|PKC412A2104 (Core)|Adverse Event|0
234455|NCT00045942|755214|P8|PKC412A2104 (Core)|Adverse Event|0
234456|NCT00045942|755215|P7|PKC412A2104 (Core)|Adverse Event|0
234457|NCT00045942|755216|P6|PKC412A2104 (Core)|Adverse Event|0
234458|NCT00045942|755217|P5|PKC412A2104 (Core)|Adverse Event|0
234459|NCT00045942|755218|P4|PKC412A2104 (Core)|Adverse Event|0
234460|NCT00045942|755219|P3|PKC412A2104 (Core)|Adverse Event|0
234461|NCT00045942|755220|P2|PKC412A2104 (Core)|Adverse Event|0
234462|NCT00045942|755221|P1|PKC412A2104 (Core)|Adverse Event|5
234463|NCT00045942|755213|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
234464|NCT00045942|755214|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
234465|NCT00045942|755215|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
234466|NCT00045942|755216|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
234467|NCT00045942|755217|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
234468|NCT00045942|755218|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
234469|NCT00045942|755219|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
234470|NCT00045942|755220|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
234471|NCT00045942|755221|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
234472|NCT00044512|755310|P1|Follow Up|Lost to Follow-up|2
234473|NCT00044213|755325|P4|Overall Study|Lost to Follow-up|4
234474|NCT00044213|755326|P3|Overall Study|Lost to Follow-up|5
234475|NCT00044213|755327|P2|Overall Study|Lost to Follow-up|5
234476|NCT00044213|755328|P1|Overall Study|Lost to Follow-up|8
234477|NCT00044213|755325|P4|Overall Study|Death|49
234478|NCT00044213|755326|P3|Overall Study|Death|42
234479|NCT00044213|755327|P2|Overall Study|Death|42
234480|NCT00044213|755328|P1|Overall Study|Death|42
234481|NCT00044213|755325|P4|Overall Study|Withdrawal by Subject|83
234482|NCT00044213|755326|P3|Overall Study|Withdrawal by Subject|91
234483|NCT00044213|755327|P2|Overall Study|Withdrawal by Subject|65
234484|NCT00044213|755328|P1|Overall Study|Withdrawal by Subject|50
234485|NCT00043979|755393|P3|Period 1|recipient with progressive disease|3
234486|NCT00043979|755394|P2|Period 1|recipient with progressive disease|4
234487|NCT00043979|755395|P1|Period 1|recipient with progressive disease|7
234488|NCT00043550|755416|P3|Overall Study|Withdrawal by Subject|20
234489|NCT00043550|755417|P2|Overall Study|Withdrawal by Subject|12
234490|NCT00043550|755418|P1|Overall Study|Withdrawal by Subject|22
234491|NCT00043186|755435|P9|Overall Study|Other|0
234492|NCT00043186|755436|P8|Overall Study|Other|0
234493|NCT00043186|755437|P7|Overall Study|Other|0
234494|NCT00043186|755438|P6|Overall Study|Other|0
234495|NCT00043186|755439|P5|Overall Study|Other|0
234496|NCT00043186|755440|P4|Overall Study|Other|1
234497|NCT00043186|755441|P3|Overall Study|Other|1
234498|NCT00043186|755442|P2|Overall Study|Other|0
234499|NCT00043186|755443|P1|Overall Study|Other|0
234500|NCT00043186|755435|P9|Overall Study|Noncompliance|0
234501|NCT00043186|755436|P8|Overall Study|Noncompliance|0
234502|NCT00043186|755437|P7|Overall Study|Noncompliance|0
234503|NCT00043186|755438|P6|Overall Study|Noncompliance|0
234504|NCT00043186|755439|P5|Overall Study|Noncompliance|0
234505|NCT00043186|755440|P4|Overall Study|Noncompliance|1
234506|NCT00043186|755441|P3|Overall Study|Noncompliance|1
234507|NCT00043186|755442|P2|Overall Study|Noncompliance|0
234508|NCT00043186|755443|P1|Overall Study|Noncompliance|0
234509|NCT00043186|755435|P9|Overall Study|Lost to Follow-up|2
234510|NCT00043186|755436|P8|Overall Study|Lost to Follow-up|1
234511|NCT00043186|755437|P7|Overall Study|Lost to Follow-up|1
234512|NCT00043186|755438|P6|Overall Study|Lost to Follow-up|1
234513|NCT00043186|755439|P5|Overall Study|Lost to Follow-up|1
234514|NCT00043186|755440|P4|Overall Study|Lost to Follow-up|1
234515|NCT00043186|755441|P3|Overall Study|Lost to Follow-up|1
234516|NCT00043186|755442|P2|Overall Study|Lost to Follow-up|5
234517|NCT00043186|755443|P1|Overall Study|Lost to Follow-up|3
234518|NCT00043186|755435|P9|Overall Study|Ineligibility determined|1
234519|NCT00043186|755436|P8|Overall Study|Ineligibility determined|0
234520|NCT00043186|755437|P7|Overall Study|Ineligibility determined|0
234521|NCT00043186|755438|P6|Overall Study|Ineligibility determined|0
234522|NCT00043186|755439|P5|Overall Study|Ineligibility determined|0
234523|NCT00043186|755440|P4|Overall Study|Ineligibility determined|0
234524|NCT00043186|755441|P3|Overall Study|Ineligibility determined|0
234525|NCT00043186|755442|P2|Overall Study|Ineligibility determined|0
234526|NCT00043186|755443|P1|Overall Study|Ineligibility determined|0
234527|NCT00043186|755435|P9|Overall Study|Disease progression|0
234528|NCT00043186|755436|P8|Overall Study|Disease progression|4
234529|NCT00043186|755437|P7|Overall Study|Disease progression|0
234530|NCT00043186|755438|P6|Overall Study|Disease progression|0
234531|NCT00043186|755439|P5|Overall Study|Disease progression|0
234532|NCT00043186|755440|P4|Overall Study|Disease progression|3
234533|NCT00043186|755441|P3|Overall Study|Disease progression|0
234534|NCT00043186|755442|P2|Overall Study|Disease progression|0
234535|NCT00043186|755443|P1|Overall Study|Disease progression|1
234536|NCT00043186|755435|P9|Overall Study|Death|0
234537|NCT00043186|755436|P8|Overall Study|Death|0
234538|NCT00043186|755437|P7|Overall Study|Death|2
234539|NCT00043186|755438|P6|Overall Study|Death|0
234540|NCT00043186|755439|P5|Overall Study|Death|0
234541|NCT00043186|755440|P4|Overall Study|Death|0
234542|NCT00043186|755441|P3|Overall Study|Death|1
234543|NCT00043186|755442|P2|Overall Study|Death|0
234544|NCT00043186|755443|P1|Overall Study|Death|0
234545|NCT00043186|755435|P9|Overall Study|Withdrawal by Subject|10
234546|NCT00043186|755436|P8|Overall Study|Withdrawal by Subject|9
234547|NCT00043186|755437|P7|Overall Study|Withdrawal by Subject|12
234548|NCT00043186|755438|P6|Overall Study|Withdrawal by Subject|6
234549|NCT00043186|755439|P5|Overall Study|Withdrawal by Subject|14
234550|NCT00043186|755440|P4|Overall Study|Withdrawal by Subject|13
234551|NCT00043186|755441|P3|Overall Study|Withdrawal by Subject|11
234552|NCT00043186|755442|P2|Overall Study|Withdrawal by Subject|8
234553|NCT00043186|755443|P1|Overall Study|Withdrawal by Subject|11
234554|NCT00043186|755435|P9|Overall Study|Adverse Event|3
234555|NCT00043186|755436|P8|Overall Study|Adverse Event|1
234556|NCT00043186|755437|P7|Overall Study|Adverse Event|2
234557|NCT00043186|755438|P6|Overall Study|Adverse Event|1
234558|NCT00043186|755439|P5|Overall Study|Adverse Event|2
234559|NCT00043186|755440|P4|Overall Study|Adverse Event|3
234560|NCT00043186|755441|P3|Overall Study|Adverse Event|2
234561|NCT00043186|755442|P2|Overall Study|Adverse Event|2
234562|NCT00043186|755443|P1|Overall Study|Adverse Event|2
234563|NCT00043186|755435|P9|Overall Study|Physician Decision|1
234564|NCT00043186|755436|P8|Overall Study|Physician Decision|1
234565|NCT00043186|755437|P7|Overall Study|Physician Decision|0
234566|NCT00043186|755438|P6|Overall Study|Physician Decision|0
234567|NCT00043186|755439|P5|Overall Study|Physician Decision|1
234568|NCT00043186|755440|P4|Overall Study|Physician Decision|0
234569|NCT00043186|755441|P3|Overall Study|Physician Decision|3
234570|NCT00043186|755442|P2|Overall Study|Physician Decision|0
234571|NCT00043186|755443|P1|Overall Study|Physician Decision|0
234572|NCT00042432|755771|P2|Overall Study|Other|0
234573|NCT00042432|755772|P1|Overall Study|Other|2
234574|NCT00042432|755771|P2|Overall Study|Initiation of maintenance dialysis|1
234575|NCT00042432|755772|P1|Overall Study|Initiation of maintenance dialysis|1
234576|NCT00042432|755771|P2|Overall Study|Ineligibility determined|0
234577|NCT00042432|755772|P1|Overall Study|Ineligibility determined|1
234578|NCT00042432|755771|P2|Overall Study|Death|2
234579|NCT00042432|755772|P1|Overall Study|Death|0
234580|NCT00042432|755771|P2|Overall Study|Withdrawal by Subject|3
234581|NCT00042432|755772|P1|Overall Study|Withdrawal by Subject|1
234582|NCT00042432|755771|P2|Overall Study|Adverse Event|1
234583|NCT00042432|755772|P1|Overall Study|Adverse Event|4
234584|NCT00041756|755825|P5|Overall Study|Data Monitoring Committee Recommendation|21
234585|NCT00041756|755826|P4|Overall Study|Data Monitoring Committee Recommendation|0
234586|NCT00041756|755827|P3|Overall Study|Data Monitoring Committee Recommendation|0
234587|NCT00041756|755828|P2|Overall Study|Data Monitoring Committee Recommendation|0
234588|NCT00041756|755829|P1|Overall Study|Data Monitoring Committee Recommendation|0
234589|NCT00041756|755825|P5|Overall Study|Unable to meet protocol criteria|1
234590|NCT00041756|755826|P4|Overall Study|Unable to meet protocol criteria|0
234591|NCT00041756|755827|P3|Overall Study|Unable to meet protocol criteria|1
234592|NCT00041756|755828|P2|Overall Study|Unable to meet protocol criteria|0
234593|NCT00041756|755829|P1|Overall Study|Unable to meet protocol criteria|0
234594|NCT00041756|755825|P5|Overall Study|Lost to Follow-up|0
234595|NCT00041756|755826|P4|Overall Study|Lost to Follow-up|1
234596|NCT00041756|755827|P3|Overall Study|Lost to Follow-up|0
234597|NCT00041756|755828|P2|Overall Study|Lost to Follow-up|1
234598|NCT00041756|755829|P1|Overall Study|Lost to Follow-up|0
234599|NCT00041756|755825|P5|Overall Study|Withdrawal by Subject|3
234600|NCT00041756|755826|P4|Overall Study|Withdrawal by Subject|2
234601|NCT00041756|755827|P3|Overall Study|Withdrawal by Subject|4
234602|NCT00041756|755828|P2|Overall Study|Withdrawal by Subject|3
234603|NCT00041756|755829|P1|Overall Study|Withdrawal by Subject|3
234604|NCT00041756|755825|P5|Overall Study|Protocol Violation|1
234605|NCT00041756|755826|P4|Overall Study|Protocol Violation|2
234606|NCT00041756|755827|P3|Overall Study|Protocol Violation|2
234607|NCT00041756|755828|P2|Overall Study|Protocol Violation|1
234608|NCT00041756|755829|P1|Overall Study|Protocol Violation|1
234609|NCT00041756|755825|P5|Overall Study|Adverse Event|34
234610|NCT00041756|755826|P4|Overall Study|Adverse Event|11
234611|NCT00041756|755827|P3|Overall Study|Adverse Event|6
234612|NCT00041756|755828|P2|Overall Study|Adverse Event|10
234613|NCT00041756|755829|P1|Overall Study|Adverse Event|4
234614|NCT00041470|755857|P1|Overall Study|Loss of Funding|38
234615|NCT00040664|755862|P4|Overall Study|Non-viability of oral suspension|0
234616|NCT00040664|755863|P3|Overall Study|Non-viability of oral suspension|1
234617|NCT00040664|755864|P2|Overall Study|Non-viability of oral suspension|0
234618|NCT00040664|755865|P1|Overall Study|Non-viability of oral suspension|1
234619|NCT00040664|755862|P4|Overall Study|Change of formulation|0
234620|NCT00040664|755863|P3|Overall Study|Change of formulation|0
234621|NCT00040664|755864|P2|Overall Study|Change of formulation|2
234622|NCT00040664|755865|P1|Overall Study|Change of formulation|2
234623|NCT00040664|755862|P4|Overall Study|Pharmacokinetic target not achieved|1
234624|NCT00040664|755863|P3|Overall Study|Pharmacokinetic target not achieved|0
234625|NCT00040664|755864|P2|Overall Study|Pharmacokinetic target not achieved|1
234626|NCT00040664|755865|P1|Overall Study|Pharmacokinetic target not achieved|2
234627|NCT00040664|755862|P4|Overall Study|Poor taste|0
234628|NCT00040664|755863|P3|Overall Study|Poor taste|2
234629|NCT00040664|755864|P2|Overall Study|Poor taste|0
234630|NCT00040664|755865|P1|Overall Study|Poor taste|2
234631|NCT00040664|755862|P4|Overall Study|Medication adherence/compliance problems|5
234632|NCT00040664|755863|P3|Overall Study|Medication adherence/compliance problems|1
234633|NCT00040664|755864|P2|Overall Study|Medication adherence/compliance problems|2
234634|NCT00040664|755865|P1|Overall Study|Medication adherence/compliance problems|8
234635|NCT00040664|755862|P4|Overall Study|Pregnancy|3
234636|NCT00040664|755863|P3|Overall Study|Pregnancy|0
234637|NCT00040664|755864|P2|Overall Study|Pregnancy|0
234638|NCT00040664|755865|P1|Overall Study|Pregnancy|3
234639|NCT00040664|755862|P4|Overall Study|Withdrawal by Subject|4
234640|NCT00040664|755863|P3|Overall Study|Withdrawal by Subject|3
234641|NCT00040664|755864|P2|Overall Study|Withdrawal by Subject|0
234642|NCT00040664|755865|P1|Overall Study|Withdrawal by Subject|7
234643|NCT00040664|755862|P4|Overall Study|Protocol Violation|1
234644|NCT00040664|755863|P3|Overall Study|Protocol Violation|0
234645|NCT00040664|755864|P2|Overall Study|Protocol Violation|1
234646|NCT00040664|755865|P1|Overall Study|Protocol Violation|2
234647|NCT00040664|755862|P4|Overall Study|Lost to Follow-up|2
234648|NCT00040664|755863|P3|Overall Study|Lost to Follow-up|0
234649|NCT00040664|755864|P2|Overall Study|Lost to Follow-up|2
234650|NCT00040664|755865|P1|Overall Study|Lost to Follow-up|4
234651|NCT00040664|755862|P4|Overall Study|Insufficient CD4 response|0
234652|NCT00040664|755863|P3|Overall Study|Insufficient CD4 response|1
234653|NCT00040664|755864|P2|Overall Study|Insufficient CD4 response|0
234654|NCT00040664|755865|P1|Overall Study|Insufficient CD4 response|1
234655|NCT00040664|755862|P4|Overall Study|Lack of Efficacy|4
234656|NCT00040664|755863|P3|Overall Study|Lack of Efficacy|3
234657|NCT00040664|755864|P2|Overall Study|Lack of Efficacy|2
234658|NCT00040664|755865|P1|Overall Study|Lack of Efficacy|9
234659|NCT00040664|755862|P4|Overall Study|Adverse Event|7
234660|NCT00040664|755863|P3|Overall Study|Adverse Event|2
234661|NCT00040664|755864|P2|Overall Study|Adverse Event|3
234662|NCT00040664|755865|P1|Overall Study|Adverse Event|12
234663|NCT00040365|755922|P1|Overall Study|Lost to Follow-up|3
234664|NCT00040365|755922|P1|Overall Study|Progressive disease|7
234665|NCT00040365|755922|P1|Overall Study|Death|1
234666|NCT00039871|755931|P1|Overall Study|Never entered follow-up|7
234667|NCT00039871|755931|P1|Overall Study|Discontinued at Week 12 per protocol|1061
234668|NCT00039871|755931|P1|Overall Study|Administrative|1
234669|NCT00039871|755931|P1|Overall Study|Did not meet eligibility criteria|11
234670|NCT00039871|755931|P1|Overall Study|Withdrawal by Subject|97
234671|NCT00039871|755931|P1|Overall Study|Protocol Violation|24
234672|NCT00039871|755931|P1|Overall Study|Lost to Follow-up|18
234673|NCT00039871|755931|P1|Overall Study|Adverse Event|165
234674|NCT00039741|755941|P4|Overall Study|Missed final visit|2
234675|NCT00039741|755942|P3|Overall Study|Missed final visit|2
234676|NCT00039741|755943|P2|Overall Study|Missed final visit|1
234677|NCT00039741|755944|P1|Overall Study|Missed final visit|2
234678|NCT00039741|755941|P4|Overall Study|Withdrew consent|1
234679|NCT00039741|755942|P3|Overall Study|Withdrew consent|0
234680|NCT00039741|755943|P2|Overall Study|Withdrew consent|5
234681|NCT00039741|755944|P1|Overall Study|Withdrew consent|0
234682|NCT00039741|755941|P4|Overall Study|Non-compliance with protocol|0
234683|NCT00039741|755942|P3|Overall Study|Non-compliance with protocol|1
234684|NCT00039741|755943|P2|Overall Study|Non-compliance with protocol|0
234685|NCT00039741|755944|P1|Overall Study|Non-compliance with protocol|1
234686|NCT00039741|755941|P4|Overall Study|Moved|6
234687|NCT00039741|755942|P3|Overall Study|Moved|3
234688|NCT00039741|755943|P2|Overall Study|Moved|2
234689|NCT00039741|755944|P1|Overall Study|Moved|3
234690|NCT00039741|755941|P4|Overall Study|Not able to get to clinic|3
234691|NCT00039741|755942|P3|Overall Study|Not able to get to clinic|0
234692|NCT00039741|755943|P2|Overall Study|Not able to get to clinic|2
234693|NCT00039741|755944|P1|Overall Study|Not able to get to clinic|5
234694|NCT00039741|755941|P4|Overall Study|Confounding medical condition|0
234695|NCT00039741|755942|P3|Overall Study|Confounding medical condition|0
234696|NCT00039741|755943|P2|Overall Study|Confounding medical condition|0
234697|NCT00039741|755944|P1|Overall Study|Confounding medical condition|1
234698|NCT00039741|755941|P4|Overall Study|Lost to Follow-up|2
234699|NCT00039741|755942|P3|Overall Study|Lost to Follow-up|5
234700|NCT00039741|755943|P2|Overall Study|Lost to Follow-up|1
234701|NCT00039741|755944|P1|Overall Study|Lost to Follow-up|3
234702|NCT00039741|755941|P4|Overall Study|Death|0
234703|NCT00039741|755942|P3|Overall Study|Death|0
234704|NCT00039741|755943|P2|Overall Study|Death|1
234705|NCT00039741|755944|P1|Overall Study|Death|0
234706|NCT00038948|755988|P2|Overall Study|Lack of Efficacy|6
234707|NCT00038948|755989|P1|Overall Study|Lack of Efficacy|3
234708|NCT00038948|755988|P2|Overall Study|Protocol Violation|7
234709|NCT00038948|755989|P1|Overall Study|Protocol Violation|3
234710|NCT00038948|755988|P2|Overall Study|Withdrawal by Subject|10
234711|NCT00038948|755989|P1|Overall Study|Withdrawal by Subject|23
234712|NCT00038948|755988|P2|Overall Study|Nonmedical event|7
234713|NCT00038948|755989|P1|Overall Study|Nonmedical event|5
234714|NCT00038948|755988|P2|Overall Study|Lost to Follow-up|4
234715|NCT00038948|755989|P1|Overall Study|Lost to Follow-up|4
234716|NCT00038948|755988|P2|Overall Study|Adverse Event|43
234717|NCT00038948|755989|P1|Overall Study|Adverse Event|131
234718|NCT00038467|756029|P2|Overall Study|Other|28
234719|NCT00038467|756030|P1|Overall Study|Other|26
234720|NCT00038467|756029|P2|Overall Study|Randomized, but not treated|35
234721|NCT00038467|756030|P1|Overall Study|Randomized, but not treated|31
234722|NCT00038467|756029|P2|Overall Study|Recurrence|179
234723|NCT00038467|756030|P1|Overall Study|Recurrence|109
234724|NCT00038467|756029|P2|Overall Study|Lost to Follow-up|10
234725|NCT00038467|756030|P1|Overall Study|Lost to Follow-up|15
234726|NCT00038467|756029|P2|Overall Study|Death|16
234727|NCT00038467|756030|P1|Overall Study|Death|22
234728|NCT00038467|756029|P2|Overall Study|Protocol Violation|22
234729|NCT00038467|756030|P1|Overall Study|Protocol Violation|19
234730|NCT00038467|756029|P2|Overall Study|Withdrawal by Subject|107
234731|NCT00038467|756030|P1|Overall Study|Withdrawal by Subject|150
234732|NCT00038467|756029|P2|Overall Study|Adverse Event|145
234733|NCT00038467|756030|P1|Overall Study|Adverse Event|170
234734|NCT00038103|756092|P2|Overall Study|Randomized/never treated|0
234735|NCT00038103|756093|P1|Overall Study|Randomized/never treated|2
234736|NCT00038103|756092|P2|Overall Study|Sponsor Decision|1
234737|NCT00038103|756093|P1|Overall Study|Sponsor Decision|0
234738|NCT00038103|756092|P2|Overall Study|Protocol Violation|2
234739|NCT00038103|756093|P1|Overall Study|Protocol Violation|0
234740|NCT00038103|756092|P2|Overall Study|Lost to Follow-up|3
234741|NCT00038103|756093|P1|Overall Study|Lost to Follow-up|0
234742|NCT00038103|756092|P2|Overall Study|Withdrawal by Subject|3
234743|NCT00038103|756093|P1|Overall Study|Withdrawal by Subject|0
234744|NCT00038103|756092|P2|Overall Study|Lack of Efficacy|41
234745|NCT00038103|756093|P1|Overall Study|Lack of Efficacy|48
234746|NCT00038103|756092|P2|Overall Study|Adverse Event|6
234747|NCT00038103|756093|P1|Overall Study|Adverse Event|5
234748|NCT00037830|756116|P3|Overall Study|Unrelated Medical Problem|0
234749|NCT00037830|756117|P2|Overall Study|Unrelated Medical Problem|0
234750|NCT00037830|756118|P1|Overall Study|Unrelated Medical Problem|2
234751|NCT00037830|756116|P3|Overall Study|Protocol Violation|0
234752|NCT00037830|756117|P2|Overall Study|Protocol Violation|2
234753|NCT00037830|756118|P1|Overall Study|Protocol Violation|2
234754|NCT00037830|756116|P3|Overall Study|Withdrawal by Subject|1
234755|NCT00037830|756117|P2|Overall Study|Withdrawal by Subject|5
234756|NCT00037830|756118|P1|Overall Study|Withdrawal by Subject|4
234757|NCT00037830|756116|P3|Overall Study|Adverse Event|0
234758|NCT00037830|756117|P2|Overall Study|Adverse Event|0
234759|NCT00037830|756118|P1|Overall Study|Adverse Event|2
234760|NCT00036270|756150|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
234761|NCT00036270|756151|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
234762|NCT00036270|756150|P2|Study Treatment to 5 Year Report|Too early switch|103
234763|NCT00036270|756151|P1|Study Treatment to 5 Year Report|Too early switch|0
234764|NCT00036270|756150|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
234765|NCT00036270|756151|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
234766|NCT00036270|756150|P2|Study Treatment to 5 Year Report|Protocol Violation|91
234767|NCT00036270|756151|P1|Study Treatment to 5 Year Report|Protocol Violation|23
234768|NCT00036270|756150|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
234769|NCT00036270|756151|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
234770|NCT00036270|756150|P2|Study Treatment to 5 Year Report|Treatment refusal|208
234771|NCT00036270|756151|P1|Study Treatment to 5 Year Report|Treatment refusal|113
234772|NCT00036270|756150|P2|Study Treatment to 5 Year Report|Other|288
234773|NCT00036270|756151|P1|Study Treatment to 5 Year Report|Other|277
234774|NCT00036270|756150|P2|Study Treatment to 5 Year Report|Adverse Event|782
234775|NCT00036270|756151|P1|Study Treatment to 5 Year Report|Adverse Event|501
234776|NCT00036270|756150|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
234777|NCT00036270|756151|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
234778|NCT00036270|756150|P2|Study Treatment to 5 Year Report|Ongoing|736
234779|NCT00036270|756151|P1|Study Treatment to 5 Year Report|Ongoing|1081
234780|NCT00036270|756150|P2|Randomized to Study Treatment|Withdrawal by Subject|7
234781|NCT00036270|756151|P1|Randomized to Study Treatment|Withdrawal by Subject|6
234782|NCT00035932|756170|P3|Overall Study|Lack of Efficacy|28
234783|NCT00035932|756171|P2|Overall Study|Lack of Efficacy|33
234784|NCT00035932|756172|P1|Overall Study|Lack of Efficacy|33
234785|NCT00035932|756170|P3|Overall Study|Study Termination by Sponsor|0
234786|NCT00035932|756171|P2|Overall Study|Study Termination by Sponsor|0
234787|NCT00035932|756172|P1|Overall Study|Study Termination by Sponsor|1
234788|NCT00035932|756170|P3|Overall Study|Withdrawal by Subject|0
234789|NCT00035932|756171|P2|Overall Study|Withdrawal by Subject|5
234790|NCT00035932|756172|P1|Overall Study|Withdrawal by Subject|1
234791|NCT00035932|756170|P3|Overall Study|Protocol Violation While on Study|2
234792|NCT00035932|756171|P2|Overall Study|Protocol Violation While on Study|1
234793|NCT00035932|756172|P1|Overall Study|Protocol Violation While on Study|0
234794|NCT00035932|756170|P3|Overall Study|Noncompliance|6
234795|NCT00035932|756171|P2|Overall Study|Noncompliance|7
234796|NCT00035932|756172|P1|Overall Study|Noncompliance|6
234797|NCT00035932|756170|P3|Overall Study|Lost to Follow-up|3
234798|NCT00035932|756171|P2|Overall Study|Lost to Follow-up|4
234799|NCT00035932|756172|P1|Overall Study|Lost to Follow-up|4
234800|NCT00035932|756170|P3|Overall Study|Disease Progression / Relapse|0
234801|NCT00035932|756171|P2|Overall Study|Disease Progression / Relapse|1
234802|NCT00035932|756172|P1|Overall Study|Disease Progression / Relapse|1
234803|NCT00035932|756170|P3|Overall Study|Death|1
234804|NCT00035932|756171|P2|Overall Study|Death|0
234805|NCT00035932|756172|P1|Overall Study|Death|0
234806|NCT00035932|756170|P3|Overall Study|Adverse Event|9
234807|NCT00035932|756171|P2|Overall Study|Adverse Event|9
234808|NCT00035932|756172|P1|Overall Study|Adverse Event|10
234809|NCT00035815|756298|P2|Overall Study|Withdrawal by Subject|11
234810|NCT00035815|756299|P1|Overall Study|Withdrawal by Subject|17
234811|NCT00035555|756312|P3|Overall Study|Received cyclosporin in error|1
234812|NCT00035555|756313|P2|Overall Study|Received cyclosporin in error|0
234813|NCT00035555|756314|P1|Overall Study|Received cyclosporin in error|0
234814|NCT00035555|756312|P3|Overall Study|Investigator deemed not a good candidate|1
234815|NCT00035555|756313|P2|Overall Study|Investigator deemed not a good candidate|0
234816|NCT00035555|756314|P1|Overall Study|Investigator deemed not a good candidate|0
234817|NCT00035555|756312|P3|Overall Study|Withdrawal by Subject|2
234818|NCT00035555|756313|P2|Overall Study|Withdrawal by Subject|0
234819|NCT00035555|756314|P1|Overall Study|Withdrawal by Subject|2
234820|NCT00035555|756312|P3|Overall Study|Treatment failure/lack of efficacy|3
234821|NCT00035555|756313|P2|Overall Study|Treatment failure/lack of efficacy|5
234822|NCT00035555|756314|P1|Overall Study|Treatment failure/lack of efficacy|7
234823|NCT00035555|756312|P3|Overall Study|Prohibited medication|0
234824|NCT00035555|756313|P2|Overall Study|Prohibited medication|1
234825|NCT00035555|756314|P1|Overall Study|Prohibited medication|1
234826|NCT00035555|756312|P3|Overall Study|Noncompliance|1
234827|NCT00035555|756313|P2|Overall Study|Noncompliance|1
234828|NCT00035555|756314|P1|Overall Study|Noncompliance|0
234829|NCT00035555|756312|P3|Overall Study|Lost to Follow-up|1
234830|NCT00035555|756313|P2|Overall Study|Lost to Follow-up|0
234831|NCT00035555|756314|P1|Overall Study|Lost to Follow-up|0
234832|NCT00035555|756312|P3|Overall Study|Death|2
234833|NCT00035555|756313|P2|Overall Study|Death|0
234834|NCT00035555|756314|P1|Overall Study|Death|0
234835|NCT00035555|756312|P3|Overall Study|Allograft loss|2
234836|NCT00035555|756313|P2|Overall Study|Allograft loss|1
234837|NCT00035555|756314|P1|Overall Study|Allograft loss|1
234838|NCT00035555|756312|P3|Overall Study|Adverse Event|9
234839|NCT00035555|756313|P2|Overall Study|Adverse Event|8
234840|NCT00035555|756314|P1|Overall Study|Adverse Event|5
234841|NCT00032487|756398|P2|Overall Study|Had other reason|12
234842|NCT00032487|756399|P1|Overall Study|Had other reason|12
234843|NCT00032487|756398|P2|Overall Study|Lost to Follow-up|58
234844|NCT00032487|756399|P1|Overall Study|Lost to Follow-up|57
234845|NCT00032487|756398|P2|Overall Study|Adverse Event|7
234846|NCT00032487|756399|P1|Overall Study|Adverse Event|3
234847|NCT00032487|756398|P2|Overall Study|Withdrawal by Subject|43
234848|NCT00032487|756399|P1|Overall Study|Withdrawal by Subject|67
234849|NCT00031551|756409|P2|Overall Study|Withdrew due to chemotherapy effects|0
234850|NCT00031551|756410|P1|Overall Study|Withdrew due to chemotherapy effects|2
234851|NCT00031486|756422|P2|Overall Study|Other|1
234852|NCT00031486|756423|P1|Overall Study|Other|1
234853|NCT00031486|756422|P2|Overall Study|Did not meet eligibility requirement|1
234854|NCT00031486|756423|P1|Overall Study|Did not meet eligibility requirement|2
234855|NCT00031486|756422|P2|Overall Study|Non-compliant|4
234856|NCT00031486|756423|P1|Overall Study|Non-compliant|0
234857|NCT00031486|756422|P2|Overall Study|Death|3
234858|NCT00031486|756423|P1|Overall Study|Death|0
234859|NCT00031486|756422|P2|Overall Study|Withdrawal by Subject|2
234860|NCT00031486|756423|P1|Overall Study|Withdrawal by Subject|3
234861|NCT00031486|756422|P2|Overall Study|Lost to Follow-up|1
234862|NCT00031486|756423|P1|Overall Study|Lost to Follow-up|0
234863|NCT00031486|756422|P2|Overall Study|Adverse Event|0
234864|NCT00031486|756423|P1|Overall Study|Adverse Event|1
234865|NCT00031460|756449|P2|Overall Study|Confirmed unevaluable|1
234866|NCT00031460|756450|P1|Overall Study|Confirmed unevaluable|0
234867|NCT00031460|756449|P2|Overall Study|Disruption of blinded drug supply|0
234868|NCT00031460|756450|P1|Overall Study|Disruption of blinded drug supply|2
234869|NCT00031460|756449|P2|Overall Study|Reactivation of Disease|9
234870|NCT00031460|756450|P1|Overall Study|Reactivation of Disease|5
234871|NCT00031460|756449|P2|Overall Study|Death|1
234872|NCT00031460|756450|P1|Overall Study|Death|0
234873|NCT00031460|756449|P2|Overall Study|Non-Compliant|1
234874|NCT00031460|756450|P1|Overall Study|Non-Compliant|1
234875|NCT00031460|756449|P2|Overall Study|Withdrawal by Subject|1
234876|NCT00031460|756450|P1|Overall Study|Withdrawal by Subject|1
234877|NCT00031460|756449|P2|Overall Study|Lost to Follow-up|1
234878|NCT00031460|756450|P1|Overall Study|Lost to Follow-up|0
234879|NCT00031447|756464|P2|Overall Study|Disruption of blinded study drug supply|4
234880|NCT00031447|756465|P1|Overall Study|Disruption of blinded study drug supply|7
234881|NCT00031447|756464|P2|Overall Study|Re-activation of Disease|1
234882|NCT00031447|756465|P1|Overall Study|Re-activation of Disease|2
234883|NCT00031447|756464|P2|Overall Study|Non-compliant|1
234884|NCT00031447|756465|P1|Overall Study|Non-compliant|1
234885|NCT00031447|756464|P2|Overall Study|Lost to Follow-up|1
234886|NCT00031447|756465|P1|Overall Study|Lost to Follow-up|0
234887|NCT00029146|756540|P2|Overall Study|Lost to Follow-up|1
234888|NCT00029146|756541|P1|Overall Study|Lost to Follow-up|2
234889|NCT00027378|756592|P2|Overall Study|Physician Decision|3
234890|NCT00027378|756593|P1|Overall Study|Physician Decision|0
234891|NCT00027027|756606|P5|Overall Study|Withdrawal by Subject|1
234892|NCT00027027|756607|P4|Overall Study|Withdrawal by Subject|0
234893|NCT00027027|756608|P3|Overall Study|Withdrawal by Subject|0
234894|NCT00027027|756609|P2|Overall Study|Withdrawal by Subject|0
234895|NCT00027027|756610|P1|Overall Study|Withdrawal by Subject|0
234896|NCT00027027|756606|P5|Overall Study|Physician Decision Due To PD|5
234897|NCT00027027|756607|P4|Overall Study|Physician Decision Due To PD|3
234898|NCT00027027|756608|P3|Overall Study|Physician Decision Due To PD|2
234899|NCT00027027|756609|P2|Overall Study|Physician Decision Due To PD|3
234900|NCT00027027|756610|P1|Overall Study|Physician Decision Due To PD|2
234901|NCT00027027|756606|P5|Overall Study|PD Requiring Surgery|0
234902|NCT00027027|756607|P4|Overall Study|PD Requiring Surgery|0
234903|NCT00027027|756608|P3|Overall Study|PD Requiring Surgery|1
234904|NCT00027027|756609|P2|Overall Study|PD Requiring Surgery|0
234905|NCT00027027|756610|P1|Overall Study|PD Requiring Surgery|0
234906|NCT00027027|756606|P5|Overall Study|Clinical Symptoms Progression not PD|0
234907|NCT00027027|756607|P4|Overall Study|Clinical Symptoms Progression not PD|0
234908|NCT00027027|756608|P3|Overall Study|Clinical Symptoms Progression not PD|0
234909|NCT00027027|756609|P2|Overall Study|Clinical Symptoms Progression not PD|0
234910|NCT00027027|756610|P1|Overall Study|Clinical Symptoms Progression not PD|1
234911|NCT00027027|756606|P5|Overall Study|Admitted for Signs of PD|1
234912|NCT00027027|756607|P4|Overall Study|Admitted for Signs of PD|0
234913|NCT00027027|756608|P3|Overall Study|Admitted for Signs of PD|0
234914|NCT00027027|756609|P2|Overall Study|Admitted for Signs of PD|0
234915|NCT00027027|756610|P1|Overall Study|Admitted for Signs of PD|0
234916|NCT00027027|756606|P5|Overall Study|Adverse Event|1
234917|NCT00027027|756607|P4|Overall Study|Adverse Event|0
234918|NCT00027027|756608|P3|Overall Study|Adverse Event|1
234919|NCT00027027|756609|P2|Overall Study|Adverse Event|0
234920|NCT00027027|756610|P1|Overall Study|Adverse Event|0
234921|NCT00025883|756657|P1|Overall Study|didn't reach 6 months of Metreleptin|10
234922|NCT00025883|756657|P1|Overall Study|Adverse Event|1
234923|NCT00025883|756657|P1|Overall Study|Death|1
234924|NCT00025883|756657|P1|Overall Study|no baseline data|1
234925|NCT00025883|756657|P1|Overall Study|had atypical progeriod lipodystrophy|4
234926|NCT00023595|756669|P5|10 Year Follow up|Lost to Follow-up|0
234927|NCT00023595|756670|P4|10 Year Follow up|Lost to Follow-up|0
234928|NCT00023595|756671|P3|10 Year Follow up|Lost to Follow-up|3
234929|NCT00023595|756672|P2|10 Year Follow up|Lost to Follow-up|10
234930|NCT00023595|756673|P1|10 Year Follow up|Lost to Follow-up|12
234931|NCT00023595|756669|P5|5 Year Follow up|Lost to Follow-up|3
234932|NCT00023595|756670|P4|5 Year Follow up|Lost to Follow-up|7
234933|NCT00023595|756671|P3|5 Year Follow up|Lost to Follow-up|1
234934|NCT00023595|756672|P2|5 Year Follow up|Lost to Follow-up|2
234935|NCT00023595|756673|P1|5 Year Follow up|Lost to Follow-up|2
234936|NCT00023452|756884|P2|Overall Study|Other|69
234937|NCT00023452|756885|P1|Overall Study|Other|204
234938|NCT00023452|756884|P2|Overall Study|Pregnant|20
234939|NCT00023452|756885|P1|Overall Study|Pregnant|53
234940|NCT00023452|756884|P2|Overall Study|Refused Treatment (continued follow-up)|224
234941|NCT00023452|756885|P1|Overall Study|Refused Treatment (continued follow-up)|225
234942|NCT00023452|756884|P2|Overall Study|Physician Decision|21
234943|NCT00023452|756885|P1|Overall Study|Physician Decision|49
234944|NCT00023452|756884|P2|Overall Study|Lost to Follow-up|60
234945|NCT00023452|756885|P1|Overall Study|Lost to Follow-up|293
234946|NCT00023452|756884|P2|Overall Study|Adverse Event|196
234947|NCT00023452|756885|P1|Overall Study|Adverse Event|139
234948|NCT00023452|756884|P2|Overall Study|Withdrawal by Subject|54
234949|NCT00023452|756885|P1|Overall Study|Withdrawal by Subject|66
234950|NCT00023452|756884|P2|Overall Study|Death|0
234951|NCT00023452|756885|P1|Overall Study|Death|2
234952|NCT00023452|756884|P2|Overall Study|Out of Window|69
234953|NCT00023452|756885|P1|Overall Study|Out of Window|129
234954|NCT00023452|756884|P2|Overall Study|Ineligible for Study|159
234955|NCT00023452|756885|P1|Overall Study|Ineligible for Study|163
234956|NCT00023322|756909|P1|Overall Study|Lost to Follow-up|1
234957|NCT00022763|756933|P2|Overall Study|Admin|2
234958|NCT00022763|756934|P1|Overall Study|Admin|3
234959|NCT00022763|756933|P2|Overall Study|Insufficient Therapy|0
234960|NCT00022763|756934|P1|Overall Study|Insufficient Therapy|1
234961|NCT00022763|756933|P2|Overall Study|Withdrawal by Subject|7
234962|NCT00022763|756934|P1|Overall Study|Withdrawal by Subject|4
234963|NCT00022763|756933|P2|Overall Study|Lost to Follow-up|3
234964|NCT00022763|756934|P1|Overall Study|Lost to Follow-up|0
234965|NCT00022763|756933|P2|Overall Study|Death|1
234966|NCT00022763|756934|P1|Overall Study|Death|0
234967|NCT00022763|756933|P2|Overall Study|Injection Site Reactions|2
234968|NCT00022763|756934|P1|Overall Study|Injection Site Reactions|0
234969|NCT00022763|756933|P2|Overall Study|Adverse Event|2
234970|NCT00022763|756934|P1|Overall Study|Adverse Event|1
234971|NCT00014911|756976|P1|Overall Study|Immunosuppression-related Side Effects|1
234972|NCT00014911|756976|P1|Overall Study|Unknown Reasons|2
234973|NCT00014911|756976|P1|Overall Study|Withdrawal by Subject|6
234974|NCT00014911|756976|P1|Overall Study|Lost to Follow-up|1
234975|NCT00014911|756976|P1|Overall Study|Adverse Event|1
234976|NCT00006604|756992|P17|Overall Study|Other Reason|0
234977|NCT00006604|756993|P16|Overall Study|Other Reason|0
234978|NCT00006604|756994|P15|Overall Study|Other Reason|0
234979|NCT00006604|756995|P14|Overall Study|Other Reason|0
234980|NCT00006604|756996|P13|Overall Study|Other Reason|0
234981|NCT00006604|756997|P12|Overall Study|Other Reason|0
234982|NCT00006604|756998|P11|Overall Study|Other Reason|0
234983|NCT00006604|756999|P10|Overall Study|Other Reason|1
234984|NCT00006604|757000|P9|Overall Study|Other Reason|0
234985|NCT00006604|757001|P8|Overall Study|Other Reason|0
234986|NCT00006604|757002|P7|Overall Study|Other Reason|0
234987|NCT00006604|757003|P6|Overall Study|Other Reason|1
234988|NCT00006604|757004|P5|Overall Study|Other Reason|0
234989|NCT00006604|757005|P4|Overall Study|Other Reason|0
234990|NCT00006604|757006|P3|Overall Study|Other Reason|0
234991|NCT00006604|757007|P2|Overall Study|Other Reason|0
234992|NCT00006604|757008|P1|Overall Study|Other Reason|0
234993|NCT00006604|756992|P17|Overall Study|Lost to Follow-up|3
234994|NCT00006604|756993|P16|Overall Study|Lost to Follow-up|1
234995|NCT00006604|756994|P15|Overall Study|Lost to Follow-up|0
234996|NCT00006604|756995|P14|Overall Study|Lost to Follow-up|0
234997|NCT00006604|756996|P13|Overall Study|Lost to Follow-up|0
234998|NCT00006604|756997|P12|Overall Study|Lost to Follow-up|0
234999|NCT00006604|756998|P11|Overall Study|Lost to Follow-up|0
235000|NCT00006604|756999|P10|Overall Study|Lost to Follow-up|2
235001|NCT00006604|757000|P9|Overall Study|Lost to Follow-up|0
235002|NCT00006604|757001|P8|Overall Study|Lost to Follow-up|1
235003|NCT00006604|757002|P7|Overall Study|Lost to Follow-up|0
235004|NCT00006604|757003|P6|Overall Study|Lost to Follow-up|0
235005|NCT00006604|757004|P5|Overall Study|Lost to Follow-up|0
235006|NCT00006604|757005|P4|Overall Study|Lost to Follow-up|0
235007|NCT00006604|757006|P3|Overall Study|Lost to Follow-up|0
235008|NCT00006604|757007|P2|Overall Study|Lost to Follow-up|0
235009|NCT00006604|757008|P1|Overall Study|Lost to Follow-up|0
235010|NCT00006604|756992|P17|Overall Study|Subj/parent not willing to adhere to req|4
235011|NCT00006604|756993|P16|Overall Study|Subj/parent not willing to adhere to req|3
235012|NCT00006604|756994|P15|Overall Study|Subj/parent not willing to adhere to req|3
235013|NCT00006604|756995|P14|Overall Study|Subj/parent not willing to adhere to req|2
235014|NCT00006604|756996|P13|Overall Study|Subj/parent not willing to adhere to req|0
235015|NCT00006604|756997|P12|Overall Study|Subj/parent not willing to adhere to req|0
235016|NCT00006604|756998|P11|Overall Study|Subj/parent not willing to adhere to req|3
235017|NCT00006604|756999|P10|Overall Study|Subj/parent not willing to adhere to req|6
235018|NCT00006604|757000|P9|Overall Study|Subj/parent not willing to adhere to req|0
235019|NCT00006604|757001|P8|Overall Study|Subj/parent not willing to adhere to req|1
235020|NCT00006604|757002|P7|Overall Study|Subj/parent not willing to adhere to req|3
235021|NCT00006604|757003|P6|Overall Study|Subj/parent not willing to adhere to req|0
235022|NCT00006604|757004|P5|Overall Study|Subj/parent not willing to adhere to req|0
235023|NCT00006604|757005|P4|Overall Study|Subj/parent not willing to adhere to req|3
235024|NCT00006604|757006|P3|Overall Study|Subj/parent not willing to adhere to req|1
235025|NCT00006604|757007|P2|Overall Study|Subj/parent not willing to adhere to req|0
235026|NCT00006604|757008|P1|Overall Study|Subj/parent not willing to adhere to req|0
235027|NCT00006604|756992|P17|Overall Study|Withdrawal by Subject|1
235028|NCT00006604|756993|P16|Overall Study|Withdrawal by Subject|0
235029|NCT00006604|756994|P15|Overall Study|Withdrawal by Subject|1
235030|NCT00006604|756995|P14|Overall Study|Withdrawal by Subject|2
235031|NCT00006604|756996|P13|Overall Study|Withdrawal by Subject|1
235032|NCT00006604|756997|P12|Overall Study|Withdrawal by Subject|0
235033|NCT00006604|756998|P11|Overall Study|Withdrawal by Subject|2
235034|NCT00006604|756999|P10|Overall Study|Withdrawal by Subject|3
235035|NCT00006604|757000|P9|Overall Study|Withdrawal by Subject|1
235036|NCT00006604|757001|P8|Overall Study|Withdrawal by Subject|0
235037|NCT00006604|757002|P7|Overall Study|Withdrawal by Subject|2
235038|NCT00006604|757003|P6|Overall Study|Withdrawal by Subject|2
235039|NCT00006604|757004|P5|Overall Study|Withdrawal by Subject|1
235040|NCT00006604|757005|P4|Overall Study|Withdrawal by Subject|0
235041|NCT00006604|757006|P3|Overall Study|Withdrawal by Subject|2
235042|NCT00006604|757007|P2|Overall Study|Withdrawal by Subject|0
235043|NCT00006604|757008|P1|Overall Study|Withdrawal by Subject|1
235044|NCT00006604|756992|P17|Overall Study|Site closing|1
235045|NCT00006604|756993|P16|Overall Study|Site closing|0
235046|NCT00006604|756994|P15|Overall Study|Site closing|0
235047|NCT00006604|756995|P14|Overall Study|Site closing|1
235048|NCT00006604|756996|P13|Overall Study|Site closing|1
235049|NCT00006604|756997|P12|Overall Study|Site closing|1
235050|NCT00006604|756998|P11|Overall Study|Site closing|0
235051|NCT00006604|756999|P10|Overall Study|Site closing|0
235052|NCT00006604|757000|P9|Overall Study|Site closing|0
235053|NCT00006604|757001|P8|Overall Study|Site closing|1
235054|NCT00006604|757002|P7|Overall Study|Site closing|0
235055|NCT00006604|757003|P6|Overall Study|Site closing|0
235056|NCT00006604|757004|P5|Overall Study|Site closing|0
235057|NCT00006604|757005|P4|Overall Study|Site closing|1
235058|NCT00006604|757006|P3|Overall Study|Site closing|1
235059|NCT00006604|757007|P2|Overall Study|Site closing|0
235060|NCT00006604|757008|P1|Overall Study|Site closing|0
235061|NCT00006604|756992|P17|Overall Study|Subj/Parent not able to get to clinic|0
235062|NCT00006604|756993|P16|Overall Study|Subj/Parent not able to get to clinic|0
235063|NCT00006604|756994|P15|Overall Study|Subj/Parent not able to get to clinic|3
235064|NCT00006604|756995|P14|Overall Study|Subj/Parent not able to get to clinic|1
235065|NCT00006604|756996|P13|Overall Study|Subj/Parent not able to get to clinic|1
235066|NCT00006604|756997|P12|Overall Study|Subj/Parent not able to get to clinic|1
235067|NCT00006604|756998|P11|Overall Study|Subj/Parent not able to get to clinic|2
235068|NCT00006604|756999|P10|Overall Study|Subj/Parent not able to get to clinic|1
235069|NCT00006604|757000|P9|Overall Study|Subj/Parent not able to get to clinic|0
235070|NCT00006604|757001|P8|Overall Study|Subj/Parent not able to get to clinic|0
235071|NCT00006604|757002|P7|Overall Study|Subj/Parent not able to get to clinic|1
235072|NCT00006604|757003|P6|Overall Study|Subj/Parent not able to get to clinic|0
235073|NCT00006604|757004|P5|Overall Study|Subj/Parent not able to get to clinic|1
235074|NCT00006604|757005|P4|Overall Study|Subj/Parent not able to get to clinic|1
235075|NCT00006604|757006|P3|Overall Study|Subj/Parent not able to get to clinic|0
235076|NCT00006604|757007|P2|Overall Study|Subj/Parent not able to get to clinic|0
235077|NCT00006604|757008|P1|Overall Study|Subj/Parent not able to get to clinic|0
235078|NCT00006604|756992|P17|Overall Study|Severe debilitation, unable to continue|0
235079|NCT00006604|756993|P16|Overall Study|Severe debilitation, unable to continue|0
235080|NCT00006604|756994|P15|Overall Study|Severe debilitation, unable to continue|2
235081|NCT00006604|756995|P14|Overall Study|Severe debilitation, unable to continue|0
235082|NCT00006604|756996|P13|Overall Study|Severe debilitation, unable to continue|1
235083|NCT00006604|756997|P12|Overall Study|Severe debilitation, unable to continue|2
235084|NCT00006604|756998|P11|Overall Study|Severe debilitation, unable to continue|0
235085|NCT00006604|756999|P10|Overall Study|Severe debilitation, unable to continue|5
235086|NCT00006604|757000|P9|Overall Study|Severe debilitation, unable to continue|0
235087|NCT00006604|757001|P8|Overall Study|Severe debilitation, unable to continue|0
235088|NCT00006604|757002|P7|Overall Study|Severe debilitation, unable to continue|3
235089|NCT00006604|757003|P6|Overall Study|Severe debilitation, unable to continue|0
235090|NCT00006604|757004|P5|Overall Study|Severe debilitation, unable to continue|0
235091|NCT00006604|757005|P4|Overall Study|Severe debilitation, unable to continue|0
235092|NCT00006604|757006|P3|Overall Study|Severe debilitation, unable to continue|0
235093|NCT00006604|757007|P2|Overall Study|Severe debilitation, unable to continue|0
235094|NCT00006604|757008|P1|Overall Study|Severe debilitation, unable to continue|0
235095|NCT00006604|756992|P17|Overall Study|Death|0
235096|NCT00006604|756993|P16|Overall Study|Death|0
235097|NCT00006604|756994|P15|Overall Study|Death|0
235098|NCT00006604|756995|P14|Overall Study|Death|0
235099|NCT00006604|756996|P13|Overall Study|Death|0
235100|NCT00006604|756997|P12|Overall Study|Death|1
235101|NCT00006604|756998|P11|Overall Study|Death|1
235102|NCT00006604|756999|P10|Overall Study|Death|1
235103|NCT00006604|757000|P9|Overall Study|Death|0
235104|NCT00006604|757001|P8|Overall Study|Death|0
235105|NCT00006604|757002|P7|Overall Study|Death|0
235106|NCT00006604|757003|P6|Overall Study|Death|0
235107|NCT00006604|757004|P5|Overall Study|Death|0
235108|NCT00006604|757005|P4|Overall Study|Death|0
235109|NCT00006604|757006|P3|Overall Study|Death|0
235110|NCT00006604|757007|P2|Overall Study|Death|0
235111|NCT00006604|757008|P1|Overall Study|Death|0
235112|NCT00006604|756992|P17|Overall Study|Randomization entry error-no RX, no FU|0
235113|NCT00006604|756993|P16|Overall Study|Randomization entry error-no RX, no FU|0
235114|NCT00006604|756994|P15|Overall Study|Randomization entry error-no RX, no FU|0
235115|NCT00006604|756995|P14|Overall Study|Randomization entry error-no RX, no FU|0
235116|NCT00006604|756996|P13|Overall Study|Randomization entry error-no RX, no FU|0
235117|NCT00006604|756997|P12|Overall Study|Randomization entry error-no RX, no FU|1
235118|NCT00006604|756998|P11|Overall Study|Randomization entry error-no RX, no FU|0
235119|NCT00006604|756999|P10|Overall Study|Randomization entry error-no RX, no FU|0
235120|NCT00006604|757000|P9|Overall Study|Randomization entry error-no RX, no FU|0
235121|NCT00006604|757001|P8|Overall Study|Randomization entry error-no RX, no FU|0
235122|NCT00006604|757002|P7|Overall Study|Randomization entry error-no RX, no FU|0
235123|NCT00006604|757003|P6|Overall Study|Randomization entry error-no RX, no FU|0
235124|NCT00006604|757004|P5|Overall Study|Randomization entry error-no RX, no FU|0
235125|NCT00006604|757005|P4|Overall Study|Randomization entry error-no RX, no FU|0
235126|NCT00006604|757006|P3|Overall Study|Randomization entry error-no RX, no FU|0
235127|NCT00006604|757007|P2|Overall Study|Randomization entry error-no RX, no FU|0
235128|NCT00006604|757008|P1|Overall Study|Randomization entry error-no RX, no FU|0
235129|NCT00006604|756992|P17|Overall Study|Met study objective - no further FU|0
235130|NCT00006604|756993|P16|Overall Study|Met study objective - no further FU|1
235131|NCT00006604|756994|P15|Overall Study|Met study objective - no further FU|1
235132|NCT00006604|756995|P14|Overall Study|Met study objective - no further FU|0
235133|NCT00006604|756996|P13|Overall Study|Met study objective - no further FU|0
235134|NCT00006604|756997|P12|Overall Study|Met study objective - no further FU|0
235135|NCT00006604|756998|P11|Overall Study|Met study objective - no further FU|0
235136|NCT00006604|756999|P10|Overall Study|Met study objective - no further FU|0
235137|NCT00006604|757000|P9|Overall Study|Met study objective - no further FU|0
235138|NCT00006604|757001|P8|Overall Study|Met study objective - no further FU|0
235139|NCT00006604|757002|P7|Overall Study|Met study objective - no further FU|0
235140|NCT00006604|757003|P6|Overall Study|Met study objective - no further FU|0
235141|NCT00006604|757004|P5|Overall Study|Met study objective - no further FU|0
235142|NCT00006604|757005|P4|Overall Study|Met study objective - no further FU|0
235143|NCT00006604|757006|P3|Overall Study|Met study objective - no further FU|0
235144|NCT00006604|757007|P2|Overall Study|Met study objective - no further FU|0
235145|NCT00006604|757008|P1|Overall Study|Met study objective - no further FU|1
235146|NCT00004978|757124|P2|Overall Study|site closure - not in analysis cohort|20
235147|NCT00004978|757125|P1|Overall Study|site closure - not in analysis cohort|19
235148|NCT00004978|757124|P2|Overall Study|Withdrawal by Subject|26
235149|NCT00004978|757125|P1|Overall Study|Withdrawal by Subject|17
235150|NCT00004978|757124|P2|Overall Study|Lost to Follow-up|108
235151|NCT00004978|757125|P1|Overall Study|Lost to Follow-up|101
235152|NCT00004978|757124|P2|Overall Study|Death|116
235153|NCT00004978|757125|P1|Overall Study|Death|107
235154|NCT00021541|757151|P2|Period 2-crossover|Pts that did not progress|3
235155|NCT00021541|757152|P1|Period 2-crossover|Pts that did not progress|2
235156|NCT00021541|757151|P2|Period 2-crossover|non-adherence|0
235157|NCT00021541|757152|P1|Period 2-crossover|non-adherence|1
235158|NCT00021541|757151|P2|Period 2-crossover|Adverse Event|2
235159|NCT00021541|757152|P1|Period 2-crossover|Adverse Event|2
235160|NCT00021541|757151|P2|Period 2-crossover|Withdrawal by Subject|4
235161|NCT00021541|757152|P1|Period 2-crossover|Withdrawal by Subject|3
235162|NCT00021541|757151|P2|Period 2-crossover|refused phase B|2
235163|NCT00021541|757152|P1|Period 2-crossover|refused phase B|2
235164|NCT00021541|757151|P2|Period 1-First Treatment|Ineligible|2
235165|NCT00021541|757152|P1|Period 1-First Treatment|Ineligible|0
235166|NCT00021541|757151|P2|Period 1-First Treatment|Pts that did not progress|2
235167|NCT00021541|757152|P1|Period 1-First Treatment|Pts that did not progress|2
235168|NCT00021541|757151|P2|Period 1-First Treatment|Death|0
235169|NCT00021541|757152|P1|Period 1-First Treatment|Death|1
235170|NCT00021541|757151|P2|Period 1-First Treatment|non-adherence|0
235171|NCT00021541|757152|P1|Period 1-First Treatment|non-adherence|3
235172|NCT00021541|757151|P2|Period 1-First Treatment|Adverse Event|1
235173|NCT00021541|757152|P1|Period 1-First Treatment|Adverse Event|2
235174|NCT00021541|757151|P2|Period 1-First Treatment|Withdrawal by Subject|3
235175|NCT00021541|757152|P1|Period 1-First Treatment|Withdrawal by Subject|3
235176|NCT00015457|757166|P2|Second Intervention|Withdrawal by Subject|0
235177|NCT00015457|757167|P1|Second Intervention|Withdrawal by Subject|1
235178|NCT00015457|757166|P2|First Intervention|Lack of Efficacy|1
235179|NCT00015457|757167|P1|First Intervention|Lack of Efficacy|0
235180|NCT00015457|757166|P2|First Intervention|Adverse Event|2
235181|NCT00015457|757167|P1|First Intervention|Adverse Event|0
235182|NCT00013611|757177|P2|Overall Study|Lost to Follow-up|100
235183|NCT00013611|757178|P1|Overall Study|Lost to Follow-up|91
235184|NCT00010803|757196|P2|Overall Study|Withdrawal by Subject|98
235185|NCT00010803|757197|P1|Overall Study|Withdrawal by Subject|97
235186|NCT00007475|757224|P4|Overall Study|Adverse Event|0
235187|NCT00007475|757225|P3|Overall Study|Adverse Event|0
235188|NCT00007475|757226|P2|Overall Study|Adverse Event|0
235189|NCT00007475|757227|P1|Overall Study|Adverse Event|3
235190|NCT00007475|757224|P4|Overall Study|Withdrawal by Subject|0
235191|NCT00007475|757225|P3|Overall Study|Withdrawal by Subject|0
235192|NCT00007475|757226|P2|Overall Study|Withdrawal by Subject|0
235193|NCT00007475|757227|P1|Overall Study|Withdrawal by Subject|1
235194|NCT00007345|757249|P2|Overall Study|Death on study|1
235195|NCT00007345|757250|P1|Overall Study|Death on study|1
235196|NCT00007345|757249|P2|Overall Study|Intercurrent illness|0
235197|NCT00007345|757250|P1|Overall Study|Intercurrent illness|1
235198|NCT00007345|757249|P2|Overall Study|Switched to alternative treatment|3
235199|NCT00007345|757250|P1|Overall Study|Switched to alternative treatment|0
235200|NCT00007345|757249|P2|Overall Study|Refused further treatment|7
235201|NCT00007345|757250|P1|Overall Study|Refused further treatment|0
235202|NCT00006489|757272|P4|Overall Study|Death|1
235203|NCT00006489|757273|P3|Overall Study|Death|0
235204|NCT00006489|757274|P2|Overall Study|Death|0
235205|NCT00006489|757275|P1|Overall Study|Death|0
235206|NCT00006489|757272|P4|Overall Study|Scheduling Conflict|1
235207|NCT00006489|757273|P3|Overall Study|Scheduling Conflict|2
235208|NCT00006489|757274|P2|Overall Study|Scheduling Conflict|3
235209|NCT00006489|757275|P1|Overall Study|Scheduling Conflict|0
235210|NCT00006489|757272|P4|Overall Study|Withdrawal by Subject|6
235211|NCT00006489|757273|P3|Overall Study|Withdrawal by Subject|9
235212|NCT00006489|757274|P2|Overall Study|Withdrawal by Subject|9
235213|NCT00006489|757275|P1|Overall Study|Withdrawal by Subject|10
235214|NCT00006489|757272|P4|Overall Study|Adverse Event|3
235215|NCT00006489|757273|P3|Overall Study|Adverse Event|4
235216|NCT00006489|757274|P2|Overall Study|Adverse Event|2
235217|NCT00006489|757275|P1|Overall Study|Adverse Event|3
235218|NCT00006409|757299|P6|Post-3 Year Intervention|Protocol Violation|62
235219|NCT00006409|757300|P5|Post-3 Year Intervention|Protocol Violation|62
235220|NCT00006409|757301|P4|Post-3 Year Intervention|Protocol Violation|0
235221|NCT00006409|757302|P3|Post-3 Year Intervention|Protocol Violation|0
235222|NCT00006409|757303|P2|Post-3 Year Intervention|Protocol Violation|0
235223|NCT00006409|757304|P1|Post-3 Year Intervention|Protocol Violation|0
235224|NCT00006409|757299|P6|Post-2 Year Intervention|Protocol Violation|0
235225|NCT00006409|757300|P5|Post-2 Year Intervention|Protocol Violation|0
235226|NCT00006409|757301|P4|Post-2 Year Intervention|Protocol Violation|168
235227|NCT00006409|757302|P3|Post-2 Year Intervention|Protocol Violation|251
235228|NCT00006409|757303|P2|Post-2 Year Intervention|Protocol Violation|0
235229|NCT00006409|757304|P1|Post-2 Year Intervention|Protocol Violation|0
235230|NCT00006409|757299|P6|Baseline|Protocol Violation|0
235231|NCT00006409|757300|P5|Baseline|Protocol Violation|0
235232|NCT00006409|757301|P4|Baseline|Protocol Violation|0
235233|NCT00006409|757302|P3|Baseline|Protocol Violation|0
235234|NCT00006409|757303|P2|Baseline|Protocol Violation|70
235235|NCT00006409|757304|P1|Baseline|Protocol Violation|48
235236|NCT00006305|757328|P4|Overall Study|Withdrawal by Subject|14
235237|NCT00006305|757329|P3|Overall Study|Withdrawal by Subject|15
235238|NCT00006305|757330|P2|Overall Study|Withdrawal by Subject|10
235239|NCT00006305|757331|P1|Overall Study|Withdrawal by Subject|17
235240|NCT00006289|757347|P2|Second Intervention (5 Weeks)|Protocol Violation|1
235241|NCT00006289|757348|P1|Second Intervention (5 Weeks)|Protocol Violation|1
235242|NCT00006289|757347|P2|First Intervention (5 Weeks)|Adverse Event|0
235243|NCT00006289|757348|P1|First Intervention (5 Weeks)|Adverse Event|1
235244|NCT00006184|757366|P2|Overall Study|Death|0
235245|NCT00006184|757367|P1|Overall Study|Death|1
235246|NCT00006164|757418|P2|Overall Study|Withdrew or lost to follow-up|81
235247|NCT00006164|757419|P1|Overall Study|Withdrew or lost to follow-up|70
235248|NCT00005937|757462|P1|Overall Study|Lack of Efficacy|5
235249|NCT00005908|757466|P2|Overall Study|Withdrawal by Subject|0
235250|NCT00005908|757467|P1|Overall Study|Withdrawal by Subject|1
235251|NCT00005906|757476|P1|Overall Study|Lack of Efficacy|3
235252|NCT00004980|757520|P2|Overall Study|Physician Decision|1
235253|NCT00004980|757521|P1|Overall Study|Physician Decision|0
235254|NCT00004980|757520|P2|Overall Study|memory difficulties|1
235255|NCT00004980|757521|P1|Overall Study|memory difficulties|1
235256|NCT00004980|757520|P2|Overall Study|Withdrawal by Subject|0
235257|NCT00004980|757521|P1|Overall Study|Withdrawal by Subject|1
235258|NCT00004732|757535|P2|Overall Study|Lost to Follow-up|47
235259|NCT00004732|757536|P1|Overall Study|Lost to Follow-up|33
235260|NCT00004732|757535|P2|Overall Study|Withdrawal by Subject|64
235261|NCT00004732|757536|P1|Overall Study|Withdrawal by Subject|36
235262|NCT00004635|757546|P2|Period Two|discrepancy in data entry|1
235263|NCT00004635|757547|P1|Period Two|discrepancy in data entry|0
235264|NCT00004635|757546|P2|Period Two|Lost to Follow-up|0
235265|NCT00004635|757547|P1|Period Two|Lost to Follow-up|1
235266|NCT00004635|757546|P2|Period Two|secondary malignancy|1
235267|NCT00004635|757547|P1|Period Two|secondary malignancy|1
235268|NCT00004635|757546|P2|Period Two|travel issues|1
235269|NCT00004635|757547|P1|Period Two|travel issues|0
235270|NCT00004635|757546|P2|Period Two|health problem|1
235271|NCT00004635|757547|P1|Period Two|health problem|1
235272|NCT00004635|757546|P2|Period Two|refused|2
235273|NCT00004635|757547|P1|Period Two|refused|0
235274|NCT00004635|757546|P2|Period Two|Adverse Event|0
235275|NCT00004635|757547|P1|Period Two|Adverse Event|1
235276|NCT00004635|757546|P2|Period Two|progression|3
235277|NCT00004635|757547|P1|Period Two|progression|2
235278|NCT00004635|757546|P2|Period One|discrepancy in data entry|1
235279|NCT00004635|757547|P1|Period One|discrepancy in data entry|0
235280|NCT00004635|757546|P2|Period One|health problem|1
235281|NCT00004635|757547|P1|Period One|health problem|0
235282|NCT00004635|757546|P2|Period One|progressed|2
235283|NCT00004635|757547|P1|Period One|progressed|0
235284|NCT00004635|757546|P2|Period One|second malignancy|0
235285|NCT00004635|757547|P1|Period One|second malignancy|1
235286|NCT00004635|757546|P2|Period One|PSA did not go <5 ng/mL|0
235287|NCT00004635|757547|P1|Period One|PSA did not go <5 ng/mL|1
235288|NCT00004635|757546|P2|Period One|Protocol Violation|0
235289|NCT00004635|757547|P1|Period One|Protocol Violation|1
235290|NCT00004635|757546|P2|Period One|Withdrawal by Subject|1
235291|NCT00004635|757547|P1|Period One|Withdrawal by Subject|1
235292|NCT00004635|757546|P2|Period One|refused|1
235293|NCT00004635|757547|P1|Period One|refused|2
235294|NCT00004563|757559|P2|Overall Study|Death|3
235295|NCT00004563|757560|P1|Overall Study|Death|2
235296|NCT00004563|757559|P2|Overall Study|Lack of Efficacy|5
235297|NCT00004563|757560|P1|Overall Study|Lack of Efficacy|3
235298|NCT00004563|757559|P2|Overall Study|Withdrawal by Subject|16
235299|NCT00004563|757560|P1|Overall Study|Withdrawal by Subject|20
235300|NCT00004562|757572|P2|Overall Study|Lost to Follow-up|91
235301|NCT00004562|757573|P1|Overall Study|Lost to Follow-up|102
235302|NCT00001962|757614|P1|Overall Study|Adverse Event|1
235303|NCT00001962|757614|P1|Overall Study|Lost to Follow-up|2
235304|NCT00001962|757614|P1|Overall Study|Death|1
235305|NCT00001962|757614|P1|Overall Study|Lack of Accrual|6
235306|NCT00001962|757614|P1|Overall Study|Lack of Efficacy|18
235307|NCT00001959|757618|P1|Overall Study|non-compliance|1
235308|NCT00001959|757618|P1|Overall Study|disabling sedation|1
235309|NCT00001959|757618|P1|Overall Study|newly diagnosed colon cancer|1
235310|NCT00001941|757624|P5|Overall Study|not treated- rapidly progressing disease|1
235311|NCT00001941|757625|P4|Overall Study|not treated- rapidly progressing disease|0
235312|NCT00001941|757626|P3|Overall Study|not treated- rapidly progressing disease|0
235313|NCT00001941|757627|P2|Overall Study|not treated- rapidly progressing disease|0
235314|NCT00001941|757628|P1|Overall Study|not treated- rapidly progressing disease|0
235315|NCT00001832|757660|P15|Treatment Period|Not treated|0
235316|NCT00001832|757661|P14|Treatment Period|Not treated|0
235317|NCT00001832|757662|P13|Treatment Period|Not treated|0
235318|NCT00001832|757663|P12|Treatment Period|Not treated|0
235319|NCT00001832|757664|P11|Treatment Period|Not treated|0
235320|NCT00001832|757665|P10|Treatment Period|Not treated|0
235321|NCT00001832|757666|P9|Treatment Period|Not treated|0
235322|NCT00001832|757667|P8|Treatment Period|Not treated|1
235323|NCT00001832|757668|P7|Treatment Period|Not treated|0
235324|NCT00001832|757669|P6|Treatment Period|Not treated|0
235325|NCT00001832|757670|P5|Treatment Period|Not treated|0
235326|NCT00001832|757671|P4|Treatment Period|Not treated|0
235327|NCT00001832|757672|P3|Treatment Period|Not treated|0
235328|NCT00001832|757673|P2|Treatment Period|Not treated|0
235329|NCT00001832|757674|P1|Treatment Period|Not treated|0
235330|NCT00001832|757660|P15|Treatment Period|Death during treatment|0
235331|NCT00001832|757661|P14|Treatment Period|Death during treatment|0
235332|NCT00001832|757662|P13|Treatment Period|Death during treatment|0
235333|NCT00001832|757663|P12|Treatment Period|Death during treatment|0
235334|NCT00001832|757664|P11|Treatment Period|Death during treatment|0
235335|NCT00001832|757665|P10|Treatment Period|Death during treatment|0
235336|NCT00001832|757666|P9|Treatment Period|Death during treatment|0
235337|NCT00001832|757667|P8|Treatment Period|Death during treatment|0
235338|NCT00001832|757668|P7|Treatment Period|Death during treatment|0
235339|NCT00001832|757669|P6|Treatment Period|Death during treatment|1
235340|NCT00001832|757670|P5|Treatment Period|Death during treatment|0
235341|NCT00001832|757671|P4|Treatment Period|Death during treatment|0
235342|NCT00001832|757672|P3|Treatment Period|Death during treatment|0
235343|NCT00001832|757673|P2|Treatment Period|Death during treatment|0
235344|NCT00001832|757674|P1|Treatment Period|Death during treatment|0
235345|NCT00001832|757660|P15|Apheresis Period|not able to manufacture treatment cells|0
235346|NCT00001832|757661|P14|Apheresis Period|not able to manufacture treatment cells|0
235347|NCT00001832|757662|P13|Apheresis Period|not able to manufacture treatment cells|0
235348|NCT00001832|757663|P12|Apheresis Period|not able to manufacture treatment cells|0
235349|NCT00001832|757664|P11|Apheresis Period|not able to manufacture treatment cells|0
235350|NCT00001832|757665|P10|Apheresis Period|not able to manufacture treatment cells|0
235351|NCT00001832|757666|P9|Apheresis Period|not able to manufacture treatment cells|0
235352|NCT00001832|757667|P8|Apheresis Period|not able to manufacture treatment cells|0
235353|NCT00001832|757668|P7|Apheresis Period|not able to manufacture treatment cells|0
235354|NCT00001832|757669|P6|Apheresis Period|not able to manufacture treatment cells|0
235355|NCT00001832|757670|P5|Apheresis Period|not able to manufacture treatment cells|0
235356|NCT00001832|757671|P4|Apheresis Period|not able to manufacture treatment cells|0
235357|NCT00001832|757672|P3|Apheresis Period|not able to manufacture treatment cells|0
235358|NCT00001832|757673|P2|Apheresis Period|not able to manufacture treatment cells|0
235359|NCT00001832|757674|P1|Apheresis Period|not able to manufacture treatment cells|60
235360|NCT00001723|757720|P2|Overall Study|medication intolerance|2
235361|NCT00001723|757721|P1|Overall Study|medication intolerance|1
235362|NCT00001723|757720|P2|Overall Study|Lost to Follow-up|2
235363|NCT00001723|757721|P1|Overall Study|Lost to Follow-up|2
235364|NCT00001723|757720|P2|Overall Study|Lack of family interest|5
235365|NCT00001723|757721|P1|Overall Study|Lack of family interest|4
235366|NCT00001723|757720|P2|Overall Study|Lack of Efficacy|7
235367|NCT00001723|757721|P1|Overall Study|Lack of Efficacy|6
235368|NCT00001703|757737|P1|Overall Study|recurrent disease|2
235369|NCT00001703|757737|P1|Overall Study|No evidence of disease|1
235370|NCT00001703|757737|P1|Overall Study|progressed disease|2
235371|NCT00001596|757775|P2|Overall Study|Adverse Event|0
235372|NCT00001596|757776|P1|Overall Study|Adverse Event|1
235373|NCT00001596|757775|P2|Overall Study|Study Termination|9
235374|NCT00001596|757776|P1|Overall Study|Study Termination|12
235375|NCT00001596|757775|P2|Overall Study|Withdrawal by Subject|1
235376|NCT00001596|757776|P1|Overall Study|Withdrawal by Subject|3
235377|NCT00001596|757775|P2|Overall Study|Death|0
235378|NCT00001596|757776|P1|Overall Study|Death|1
235379|NCT00001575|757807|P1|Overall Study|Withdrawn/deaths|23
235380|NCT00001575|757807|P1|Overall Study|Screening failures-Ph I portion|22
235381|NCT00001566|757813|P1|Overall Study|unable to complete initial apheresis|1
235382|NCT00001566|757813|P1|Overall Study|Lost to Follow-up|1
235383|NCT00001566|757813|P1|Overall Study|Death|13
235384|NCT00001566|757813|P1|Overall Study|stopped after C3 due to symptomatic PD|1
235385|NCT00001566|757813|P1|Overall Study|patients' choice to discontinue protocol|3
235386|NCT00001262|757849|P3|Overall Study|Withdrawal by Subject|0
235387|NCT00001262|757850|P2|Overall Study|Withdrawal by Subject|3
235388|NCT00001262|757851|P1|Overall Study|Withdrawal by Subject|0
235389|NCT00001262|757849|P3|Overall Study|Death|0
235390|NCT00001262|757850|P2|Overall Study|Death|11
235391|NCT00001262|757851|P1|Overall Study|Death|10
235392|NCT00001213|757877|P1|Overall Study|Death|18
235393|NCT00000378|757888|P2|Overall Study|Lack of Efficacy|14
235394|NCT00000378|757889|P1|Overall Study|Lack of Efficacy|16
235395|NCT00000620|757906|P8|Overall Study|missed closeout visit|16
235396|NCT00000620|757907|P7|Overall Study|missed closeout visit|13
235397|NCT00000620|757908|P6|Overall Study|missed closeout visit|28
235398|NCT00000620|757909|P5|Overall Study|missed closeout visit|26
235399|NCT00000620|757910|P4|Overall Study|missed closeout visit|11
235400|NCT00000620|757911|P3|Overall Study|missed closeout visit|16
235401|NCT00000620|757912|P2|Overall Study|missed closeout visit|28
235402|NCT00000620|757913|P1|Overall Study|missed closeout visit|22
235403|NCT00000620|757906|P8|Overall Study|Withdrawal by Subject|21
235404|NCT00000620|757907|P7|Overall Study|Withdrawal by Subject|32
235405|NCT00000620|757908|P6|Overall Study|Withdrawal by Subject|32
235406|NCT00000620|757909|P5|Overall Study|Withdrawal by Subject|30
235407|NCT00000620|757910|P4|Overall Study|Withdrawal by Subject|27
235408|NCT00000620|757911|P3|Overall Study|Withdrawal by Subject|28
235409|NCT00000620|757912|P2|Overall Study|Withdrawal by Subject|27
235410|NCT00000620|757913|P1|Overall Study|Withdrawal by Subject|40
235411|NCT00000620|757906|P8|Overall Study|Lost to Follow-up|14
235412|NCT00000620|757907|P7|Overall Study|Lost to Follow-up|13
235413|NCT00000620|757908|P6|Overall Study|Lost to Follow-up|15
235414|NCT00000620|757909|P5|Overall Study|Lost to Follow-up|15
235415|NCT00000620|757910|P4|Overall Study|Lost to Follow-up|14
235416|NCT00000620|757911|P3|Overall Study|Lost to Follow-up|14
235417|NCT00000620|757912|P2|Overall Study|Lost to Follow-up|14
235418|NCT00000620|757913|P1|Overall Study|Lost to Follow-up|14
235419|NCT00000620|757906|P8|Overall Study|Death|95
235420|NCT00000620|757907|P7|Overall Study|Death|91
235421|NCT00000620|757908|P6|Overall Study|Death|77
235422|NCT00000620|757909|P5|Overall Study|Death|64
235423|NCT00000620|757910|P4|Overall Study|Death|126
235424|NCT00000620|757911|P3|Overall Study|Death|112
235425|NCT00000620|757912|P2|Overall Study|Death|67
235426|NCT00000620|757913|P1|Overall Study|Death|86
235427|NCT00004412|757997|P3|Randomized Period|Moved to Crossover Period|0
235428|NCT00004412|757998|P2|Randomized Period|Moved to Crossover Period|0
235429|NCT00004412|757999|P1|Randomized Period|Moved to Crossover Period|3
235430|NCT00000135|758040|P2|Overall Study|Death|14
235431|NCT00000135|758041|P1|Overall Study|Death|27
